id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
130875638|NCT00948064|471175449|FG000|Phase I|No treatment received|1|||
130875639|NCT00948064|471175450|FG001|Phase I|No treatment received|0|||
130875640|NCT00948064|471175451|FG002|Phase I|No treatment received|0|||
130875641|NCT00948064|471175449|FG000|Phase II|Physician Decision|0|||
130875642|NCT00948064|471175450|FG001|Phase II|Physician Decision|0|||
130875643|NCT00948064|471175451|FG002|Phase II|Physician Decision|1|||
130875644|NCT00948064|471175449|FG000|Phase II|Withdrawal by Subject|0|||
130875645|NCT00948064|471175450|FG001|Phase II|Withdrawal by Subject|1|||
130875646|NCT00948064|471175451|FG002|Phase II|Withdrawal by Subject|0|||
130875647|NCT03346434|471175462|FG000|Overall Study|Randomized in Error|0|||
130875648|NCT03346434|471175463|FG001|Overall Study|Randomized in Error|0|||
130875649|NCT03346434|471175464|FG002|Overall Study|Randomized in Error|0|||
130875650|NCT03346434|471175465|FG003|Overall Study|Randomized in Error|0|||
130875651|NCT03346434|471175466|FG004|Overall Study|Randomized in Error|1|||
130875652|NCT03346434|471175467|FG005|Overall Study|Randomized in Error|0|||
130875653|NCT03346434|471175462|FG000|Overall Study|Withdrawal by Subject|0|||
130875654|NCT03346434|471175463|FG001|Overall Study|Withdrawal by Subject|0|||
130875655|NCT03346434|471175464|FG002|Overall Study|Withdrawal by Subject|1|||
130875656|NCT03346434|471175465|FG003|Overall Study|Withdrawal by Subject|0|||
130875657|NCT03346434|471175466|FG004|Overall Study|Withdrawal by Subject|1|||
130875658|NCT03346434|471175467|FG005|Overall Study|Withdrawal by Subject|0|||
130875659|NCT03346434|471175462|FG000|Overall Study|Lost to Follow-up|0|||
130875660|NCT03346434|471175463|FG001|Overall Study|Lost to Follow-up|0|||
130875661|NCT03346434|471175464|FG002|Overall Study|Lost to Follow-up|0|||
130875662|NCT03346434|471175465|FG003|Overall Study|Lost to Follow-up|0|||
130875663|NCT03346434|471175466|FG004|Overall Study|Lost to Follow-up|1|||
130875664|NCT03346434|471175467|FG005|Overall Study|Lost to Follow-up|1|||
130875665|NCT03346434|471175462|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130875666|NCT03346434|471175463|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130875667|NCT03346434|471175464|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130875668|NCT03346434|471175465|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130875669|NCT03346434|471175466|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
130875670|NCT03346434|471175467|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
130875671|NCT02741128|471175468|FG000|Overall Study|Protocol Violation|4|||
130875672|NCT02741128|471175469|FG001|Overall Study|Protocol Violation|1|||
130875673|NCT02741128|471175468|FG000|Overall Study|Withdrawal by Subject|2|||
130875674|NCT02741128|471175469|FG001|Overall Study|Withdrawal by Subject|0|||
130875675|NCT02741128|471175468|FG000|Overall Study|Lost to Follow-up|1|||
130875676|NCT02741128|471175469|FG001|Overall Study|Lost to Follow-up|0|||
130875677|NCT02973100|471175470|FG000|Overall Study|Adverse Event|1|||
130875678|NCT02973100|471175471|FG001|Overall Study|Adverse Event|2|||
130875679|NCT02973100|471175472|FG002|Overall Study|Adverse Event|1|||
130875680|NCT02973100|471175473|FG003|Overall Study|Adverse Event|2|||
130875681|NCT02973100|471175470|FG000|Overall Study|Lost to Follow-up|3|||
130875682|NCT02973100|471175471|FG001|Overall Study|Lost to Follow-up|1|||
130875683|NCT02973100|471175472|FG002|Overall Study|Lost to Follow-up|1|||
130875684|NCT02973100|471175473|FG003|Overall Study|Lost to Follow-up|0|||
130875685|NCT02973100|471175470|FG000|Overall Study|Withdrawal by Subject|3|||
130875686|NCT02973100|471175471|FG001|Overall Study|Withdrawal by Subject|5|||
130875687|NCT02973100|471175472|FG002|Overall Study|Withdrawal by Subject|1|||
130875688|NCT02973100|471175473|FG003|Overall Study|Withdrawal by Subject|4|||
130875689|NCT02973100|471175470|FG000|Overall Study|Notification of change in address|0|||
130875690|NCT02973100|471175471|FG001|Overall Study|Notification of change in address|0|||
130875691|NCT02973100|471175472|FG002|Overall Study|Notification of change in address|0|||
130875692|NCT02973100|471175473|FG003|Overall Study|Notification of change in address|1|||
130875693|NCT02973100|471175470|FG000|Overall Study|Failed to attend Safety followup period|0|||
130875694|NCT02973100|471175471|FG001|Overall Study|Failed to attend Safety followup period|0|||
130875695|NCT02973100|471175472|FG002|Overall Study|Failed to attend Safety followup period|1|||
130875696|NCT02973100|471175473|FG003|Overall Study|Failed to attend Safety followup period|0|||
130875697|NCT01419769|471175474|FG000|Overall Study|Did not receive the AXIOS stent|3|||
130875698|NCT01419769|471175474|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
130875699|NCT00878501|471175475|FG000|Overall Study|Adverse Event|11|||
130875700|NCT00878501|471175476|FG001|Overall Study|Adverse Event|3|||
130875701|NCT00878501|471175477|FG002|Overall Study|Adverse Event|3|||
130875702|NCT00878501|471175475|FG000|Overall Study|Lack of Efficacy|2|||
130875703|NCT00878501|471175476|FG001|Overall Study|Lack of Efficacy|1|||
130875704|NCT00878501|471175477|FG002|Overall Study|Lack of Efficacy|0|||
130875705|NCT00878501|471175475|FG000|Overall Study|Withdrawal by Subject|2|||
131210269|NCT00451191|472393746|FG000|Overall Study|withdrawal or received alternate tx|15|||
130875706|NCT00878501|471175476|FG001|Overall Study|Withdrawal by Subject|1|||
131210270|NCT00451191|472393747|FG001|Overall Study|withdrawal or received alternate tx|11|||
130875707|NCT00878501|471175477|FG002|Overall Study|Withdrawal by Subject|2|||
130875708|NCT00878501|471175475|FG000|Overall Study|Protocol Violation|0|||
130875709|NCT00878501|471175476|FG001|Overall Study|Protocol Violation|0|||
130875710|NCT00878501|471175477|FG002|Overall Study|Protocol Violation|1|||
130875711|NCT00878501|471175475|FG000|Overall Study|Incorrect enrolment|1|||
130875712|NCT00878501|471175476|FG001|Overall Study|Incorrect enrolment|2|||
130875713|NCT00878501|471175477|FG002|Overall Study|Incorrect enrolment|0|||
130875714|NCT00878501|471175475|FG000|Overall Study|Intake of prohibited concom. medication|0|||
130875715|NCT00878501|471175476|FG001|Overall Study|Intake of prohibited concom. medication|0|||
130875716|NCT00878501|471175477|FG002|Overall Study|Intake of prohibited concom. medication|1|||
130875717|NCT00878501|471175475|FG000|Overall Study|Mis-randomisation of patient|1|||
130875718|NCT00878501|471175476|FG001|Overall Study|Mis-randomisation of patient|0|||
130875719|NCT00878501|471175477|FG002|Overall Study|Mis-randomisation of patient|0|||
130875720|NCT00878501|471175475|FG000|Overall Study|Administrative|0|||
130875721|NCT00878501|471175476|FG001|Overall Study|Administrative|0|||
130875722|NCT00878501|471175477|FG002|Overall Study|Administrative|1|||
130875723|NCT00812708|471175480|FG000|Overall Study|Device could not be implanted|2|||
131210271|NCT03575806|472393759|FG000|Overall Study|Withdrawal by Subject|0|||
131210272|NCT03575806|472393760|FG001|Overall Study|Withdrawal by Subject|2|||
131210273|NCT03575806|472393759|FG000|Overall Study|Protocol Violation|0|||
131210274|NCT03575806|472393760|FG001|Overall Study|Protocol Violation|2|||
131210275|NCT00219349|472393761|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
131210276|NCT00219349|472393761|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
131210277|NCT00219349|472393761|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
131210278|NCT00219349|472393761|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
131210279|NCT00270205|472393763|FG000|Overall Study|Lost to Follow-up|1|||
131210280|NCT00270205|472393764|FG001|Overall Study|Lost to Follow-up|0|||
131210281|NCT00270205|472393765|FG002|Overall Study|Lost to Follow-up|0|||
131210282|NCT00270205|472393766|FG003|Overall Study|Lost to Follow-up|1|||
131210283|NCT00869362|472393767|FG000|Overall Study|Death|0|||
131210284|NCT00869362|472393768|FG001|Overall Study|Death|2|||
131210285|NCT00869362|472393767|FG000|Overall Study|Lost to Follow-up|1|||
131210286|NCT00869362|472393768|FG001|Overall Study|Lost to Follow-up|3|||
131210287|NCT01241591|472393769|FG000|Overall Study|Lack of Efficacy|5|||
131210288|NCT01241591|472393770|FG001|Overall Study|Lack of Efficacy|2|||
131210289|NCT01241591|472393771|FG002|Overall Study|Lack of Efficacy|2|||
131210290|NCT01241591|472393772|FG003|Overall Study|Lack of Efficacy|3|||
131210291|NCT01241591|472393769|FG000|Overall Study|Protocol Violation|5|||
131210292|NCT01241591|472393770|FG001|Overall Study|Protocol Violation|2|||
131210293|NCT01241591|472393771|FG002|Overall Study|Protocol Violation|3|||
131210294|NCT01241591|472393772|FG003|Overall Study|Protocol Violation|0|||
131210295|NCT01241591|472393769|FG000|Overall Study|Lost to Follow-up|1|||
131210296|NCT01241591|472393770|FG001|Overall Study|Lost to Follow-up|2|||
131210297|NCT01241591|472393771|FG002|Overall Study|Lost to Follow-up|2|||
131210298|NCT01241591|472393772|FG003|Overall Study|Lost to Follow-up|2|||
131210299|NCT01241591|472393769|FG000|Overall Study|Screen Failure|3|||
131210300|NCT01241591|472393770|FG001|Overall Study|Screen Failure|2|||
131210301|NCT01241591|472393771|FG002|Overall Study|Screen Failure|1|||
131210302|NCT01241591|472393772|FG003|Overall Study|Screen Failure|0|||
131210303|NCT01241591|472393769|FG000|Overall Study|Withdrawal by Subject|6|||
131210304|NCT01241591|472393770|FG001|Overall Study|Withdrawal by Subject|4|||
131210305|NCT01241591|472393771|FG002|Overall Study|Withdrawal by Subject|2|||
131210306|NCT01241591|472393772|FG003|Overall Study|Withdrawal by Subject|2|||
131210307|NCT01241591|472393769|FG000|Overall Study|Other|0|||
131210308|NCT01241591|472393770|FG001|Overall Study|Other|1|||
131210309|NCT01241591|472393771|FG002|Overall Study|Other|0|||
131210310|NCT01241591|472393772|FG003|Overall Study|Other|1|||
131210311|NCT01241591|472393769|FG000|Overall Study|Adverse Event|3|||
131210312|NCT01241591|472393770|FG001|Overall Study|Adverse Event|11|||
131210313|NCT01241591|472393771|FG002|Overall Study|Adverse Event|12|||
131210314|NCT01241591|472393772|FG003|Overall Study|Adverse Event|4|||
131210315|NCT01945034|472393773|FG000|Overall Study|Medication Error|0|||
131210316|NCT01945034|472393774|FG001|Overall Study|Medication Error|1|||
131210317|NCT01945034|472393775|FG002|Overall Study|Medication Error|0|||
131210318|NCT01945034|472393773|FG000|Overall Study|Withdrawal by Subject|0|||
131210319|NCT01945034|472393774|FG001|Overall Study|Withdrawal by Subject|3|||
131210320|NCT01945034|472393775|FG002|Overall Study|Withdrawal by Subject|1|||
131210321|NCT01945034|472393773|FG000|Overall Study|Other|0|||
131210322|NCT01945034|472393774|FG001|Overall Study|Other|1|||
131210323|NCT01945034|472393775|FG002|Overall Study|Other|3|||
131210324|NCT01945034|472393773|FG000|Overall Study|Lost to Follow-up|0|||
131210325|NCT01945034|472393774|FG001|Overall Study|Lost to Follow-up|0|||
131210326|NCT01945034|472393775|FG002|Overall Study|Lost to Follow-up|2|||
131210327|NCT01945034|472393773|FG000|Overall Study|Protocol Violation|1|||
130875724|NCT00812708|471175480|FG000|Overall Study|Lack of medical insurance|1|||
130875725|NCT00812708|471175480|FG000|Overall Study|Switched to another study|1|||
130875726|NCT00812708|471175480|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
130875727|NCT00812708|471175480|FG000|Overall Study|Signed consent but later withdrew|3|||
131210328|NCT01945034|472393774|FG001|Overall Study|Protocol Violation|0|||
131210329|NCT01945034|472393775|FG002|Overall Study|Protocol Violation|1|||
131210330|NCT02147132|472393776|FG000|Overall Study|Lost to Follow-up|1|||
131210331|NCT02147132|472393777|FG001|Overall Study|Lost to Follow-up|0|||
131210332|NCT02147132|472393778|FG002|Overall Study|Lost to Follow-up|0|||
131210333|NCT02147132|472393779|FG003|Overall Study|Lost to Follow-up|0|||
131210334|NCT02646566|472393781|FG000|Overall Study|Lost to Follow-up|5|||
131210335|NCT02646566|472393782|FG001|Overall Study|Lost to Follow-up|4|||
131210336|NCT02646566|472393783|FG002|Overall Study|Lost to Follow-up|5|||
131210337|NCT02646566|472393781|FG000|Overall Study|Treatment failure|1|||
131210338|NCT02646566|472393782|FG001|Overall Study|Treatment failure|0|||
130875728|NCT01959503|471175481|FG000|Overall Study|Death|2|||
130875729|NCT01959503|471175482|FG001|Overall Study|Death|1|||
130875730|NCT01959503|471175481|FG000|Overall Study|Randomized but not treated|1|||
130875731|NCT01959503|471175482|FG001|Overall Study|Randomized but not treated|1|||
130875732|NCT01600326|471175483|FG000|Overall Study|Lost to Follow-up|1|||
130875733|NCT01600326|471175484|FG001|Overall Study|Lost to Follow-up|1|||
130875734|NCT03224130|471175485|FG000|Overall Study|consent issue|0|||
130875735|NCT03224130|471175486|FG001|Overall Study|consent issue|1|||
130875736|NCT03287791|471175489|FG000|Overall Study|Insufficient Therapeutic Response|0|||
130875737|NCT03287791|471175490|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130875738|NCT03287791|471175491|FG002|Overall Study|Insufficient Therapeutic Response|1|||
130875739|NCT03287791|471175489|FG000|Overall Study|Adverse Event|0|||
130875740|NCT03287791|471175490|FG001|Overall Study|Adverse Event|4|||
130875741|NCT03287791|471175491|FG002|Overall Study|Adverse Event|3|||
131210339|NCT02646566|472393783|FG002|Overall Study|Treatment failure|0|||
131210340|NCT02660489|472393786|FG000|Overall Study|Lost to Follow-up|1|||
131210341|NCT02660489|472393787|FG001|Overall Study|Lost to Follow-up|1|||
131210342|NCT02660489|472393786|FG000|Overall Study|Adverse Event|1|||
130875742|NCT03287791|471175489|FG000|Overall Study|Withdrawal by Subject|12|||
130875743|NCT03287791|471175490|FG001|Overall Study|Withdrawal by Subject|12|||
130875744|NCT03287791|471175491|FG002|Overall Study|Withdrawal by Subject|17|||
130875745|NCT03287791|471175489|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
130875746|NCT03287791|471175490|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
130875747|NCT03287791|471175491|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
130875748|NCT03287791|471175489|FG000|Overall Study|Lost to Follow-up|8|||
130875749|NCT03287791|471175490|FG001|Overall Study|Lost to Follow-up|14|||
130875750|NCT03287791|471175491|FG002|Overall Study|Lost to Follow-up|11|||
130875751|NCT03287791|471175489|FG000|Overall Study|Protocol Violation|7|||
130875752|NCT03287791|471175490|FG001|Overall Study|Protocol Violation|2|||
130875753|NCT03287791|471175491|FG002|Overall Study|Protocol Violation|1|||
130875754|NCT03287791|471175489|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
130875755|NCT03287791|471175490|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
130875756|NCT03287791|471175491|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
131210343|NCT02660489|472393787|FG001|Overall Study|Adverse Event|3|||
131210344|NCT02660489|472393786|FG000|Overall Study|no rhinovirus infection|4|||
131210345|NCT02660489|472393787|FG001|Overall Study|no rhinovirus infection|4|||
131210346|NCT02064231|472393788|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
131210347|NCT02064231|472393789|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
131210348|NCT02064231|472393790|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
131210349|NCT02064231|472393791|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
131210350|NCT02064231|472393788|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
131210351|NCT02064231|472393789|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
131210352|NCT02064231|472393790|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
131210353|NCT02064231|472393791|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
131210354|NCT02064231|472393788|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
131210355|NCT02064231|472393789|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
131210356|NCT02064231|472393790|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
131210357|NCT02064231|472393791|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
131210358|NCT02064231|472393788|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
131210359|NCT02064231|472393789|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
131210360|NCT02064231|472393790|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
131210361|NCT02064231|472393791|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
131210362|NCT02392078|472393792|FG000|Overall Study|Did not have procedure|32|||
131210363|NCT02392078|472393793|FG001|Overall Study|Did not have procedure|43|||
131210364|NCT02392078|472393794|FG002|Overall Study|Did not have procedure|20|||
131210365|NCT02392078|472393795|FG003|Overall Study|Did not have procedure|1|||
131210366|NCT02652793|472393796|FG000|Overall Study|Adverse Event|1|||
131210367|NCT02652793|472393796|FG000|Overall Study|Lost to Follow-up|2|||
131210368|NCT02652793|472393796|FG000|Overall Study|Withdrawal by Subject|1|||
131210369|NCT05450198|472393797|FG000|Overall Study|Withdrawal by Subject|1|||
131210370|NCT05450198|472393798|FG001|Overall Study|Withdrawal by Subject|1|||
131210371|NCT05450198|472393799|FG002|Overall Study|Withdrawal by Subject|2|||
131210372|NCT05450198|472393800|FG003|Overall Study|Withdrawal by Subject|0|||
130875757|NCT03287791|471175489|FG000|Overall Study|Too much time between 2 visits|0|||
131210373|NCT05450198|472393797|FG000|Overall Study|Lost to Follow-up|1|||
131210374|NCT05450198|472393798|FG001|Overall Study|Lost to Follow-up|0|||
131210375|NCT05450198|472393799|FG002|Overall Study|Lost to Follow-up|2|||
131210376|NCT05450198|472393800|FG003|Overall Study|Lost to Follow-up|1|||
131210377|NCT02059265|472393801|FG000|Overall Study|Ineligible|4|||
131210378|NCT01050998|472393806|FG000|Overall Study|Adverse Event|1|||
131210379|NCT01050998|472393807|FG001|Overall Study|Adverse Event|0|||
130875758|NCT03287791|471175490|FG001|Overall Study|Too much time between 2 visits|1|||
130875759|NCT03287791|471175491|FG002|Overall Study|Too much time between 2 visits|0|||
131210380|NCT01050998|472393808|FG002|Overall Study|Adverse Event|1|||
130875760|NCT03287791|471175489|FG000|Overall Study|Non-compliance|0|||
130875761|NCT03287791|471175490|FG001|Overall Study|Non-compliance|1|||
130875762|NCT03287791|471175491|FG002|Overall Study|Non-compliance|0|||
131210381|NCT01050998|472393809|FG003|Overall Study|Adverse Event|0|||
131210382|NCT01050998|472393810|FG004|Overall Study|Adverse Event|2|||
131210383|NCT01050998|472393806|FG000|Overall Study|Withdrawal by Subject|0|||
131210384|NCT01050998|472393807|FG001|Overall Study|Withdrawal by Subject|0|||
131210385|NCT01050998|472393808|FG002|Overall Study|Withdrawal by Subject|0|||
131210386|NCT01050998|472393809|FG003|Overall Study|Withdrawal by Subject|1|||
131210387|NCT01050998|472393810|FG004|Overall Study|Withdrawal by Subject|3|||
131210388|NCT01050998|472393806|FG000|Overall Study|Other|3|||
131210389|NCT01050998|472393807|FG001|Overall Study|Other|2|||
131210390|NCT01050998|472393808|FG002|Overall Study|Other|1|||
130875763|NCT03287791|471175489|FG000|Overall Study|Did not meet inclusion criteria|1|||
130875764|NCT03287791|471175490|FG001|Overall Study|Did not meet inclusion criteria|0|||
130875765|NCT03287791|471175491|FG002|Overall Study|Did not meet inclusion criteria|0|||
130875766|NCT03095651|471175493|FG000|Overall Study|Lost to Follow-up|1|||
130875767|NCT03095651|471175494|FG001|Overall Study|Lost to Follow-up|1|||
130875768|NCT03095651|471175495|FG002|Overall Study|Lost to Follow-up|0|||
130875769|NCT03095651|471175496|FG003|Overall Study|Lost to Follow-up|1|||
130875770|NCT03095651|471175497|FG004|Overall Study|Lost to Follow-up|0|||
130875771|NCT03095651|471175498|FG005|Overall Study|Lost to Follow-up|0|||
130875772|NCT03095651|471175499|FG006|Overall Study|Lost to Follow-up|0|||
130875773|NCT03095651|471175500|FG007|Overall Study|Lost to Follow-up|0|||
130875774|NCT03095651|471175493|FG000|Overall Study|Withdrawal by Subject|0|||
131210391|NCT01050998|472393809|FG003|Overall Study|Other|1|||
131210392|NCT01050998|472393810|FG004|Overall Study|Other|5|||
130875775|NCT03095651|471175494|FG001|Overall Study|Withdrawal by Subject|0|||
130875776|NCT03095651|471175495|FG002|Overall Study|Withdrawal by Subject|0|||
130875777|NCT03095651|471175496|FG003|Overall Study|Withdrawal by Subject|0|||
130875778|NCT03095651|471175497|FG004|Overall Study|Withdrawal by Subject|0|||
130875779|NCT03095651|471175498|FG005|Overall Study|Withdrawal by Subject|1|||
130875780|NCT03095651|471175499|FG006|Overall Study|Withdrawal by Subject|0|||
130875781|NCT03095651|471175500|FG007|Overall Study|Withdrawal by Subject|0|||
130875782|NCT02250326|471175501|FG000|Treatment|Death|1|||
130875783|NCT02250326|471175502|FG001|Treatment|Death|13|||
130875784|NCT02250326|471175503|FG002|Treatment|Death|2|||
130875785|NCT02250326|471175501|FG000|Treatment|Adverse Event|8|||
130875786|NCT02250326|471175502|FG001|Treatment|Adverse Event|8|||
130875787|NCT02250326|471175503|FG002|Treatment|Adverse Event|9|||
130875788|NCT02250326|471175501|FG000|Treatment|Progressive Disease|42|||
130875789|NCT02250326|471175502|FG001|Treatment|Progressive Disease|40|||
130875790|NCT02250326|471175503|FG002|Treatment|Progressive Disease|47|||
130875791|NCT02250326|471175501|FG000|Treatment|Symptomatic Deterioration|9|||
130875792|NCT02250326|471175502|FG001|Treatment|Symptomatic Deterioration|4|||
131210393|NCT01050998|472393806|FG000|Overall Study|Data integrity issues|0|||
131210394|NCT01050998|472393807|FG001|Overall Study|Data integrity issues|0|||
131210395|NCT01050998|472393808|FG002|Overall Study|Data integrity issues|1|||
130875793|NCT02250326|471175503|FG002|Treatment|Symptomatic Deterioration|10|||
130875794|NCT02250326|471175501|FG000|Treatment|Withdrawal by Subject|11|||
130875795|NCT02250326|471175502|FG001|Treatment|Withdrawal by Subject|6|||
130875796|NCT02250326|471175503|FG002|Treatment|Withdrawal by Subject|4|||
130875797|NCT02250326|471175501|FG000|Treatment|Other reasons|8|||
130875798|NCT02250326|471175502|FG001|Treatment|Other reasons|7|||
130875799|NCT02250326|471175503|FG002|Treatment|Other reasons|7|||
130875800|NCT02250326|471175501|FG000|Extension Period|Progressive Disease|0|||
130875801|NCT02250326|471175502|FG001|Extension Period|Progressive Disease|2|||
130875802|NCT02250326|471175503|FG002|Extension Period|Progressive Disease|0|||
130875803|NCT02250326|471175501|FG000|Extension Period|Withdrawal by Subject|0|||
130875804|NCT02250326|471175502|FG001|Extension Period|Withdrawal by Subject|1|||
131210396|NCT01050998|472393809|FG003|Overall Study|Data integrity issues|1|||
131210397|NCT01050998|472393810|FG004|Overall Study|Data integrity issues|4|||
130875805|NCT02250326|471175503|FG002|Extension Period|Withdrawal by Subject|0|||
130875806|NCT02250326|471175501|FG000|Extension Period|Withdrawal by investigator|0|||
130875807|NCT02250326|471175502|FG001|Extension Period|Withdrawal by investigator|1|||
130875808|NCT02250326|471175503|FG002|Extension Period|Withdrawal by investigator|0|||
130875809|NCT00866177|471175508|FG000|Overall Study|Withdrawal by Subject|1|||
130875810|NCT00866177|471175508|FG000|Overall Study|Not Treated|151|||
130875811|NCT04247347|471175511|FG000|Overall Study|Withdrawal by Subject|2|||
131210398|NCT01694849|472393813|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
130875812|NCT04247347|471175512|FG001|Overall Study|Withdrawal by Subject|3|||
131210399|NCT01694849|472393814|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
130875813|NCT04247347|471175513|FG002|Overall Study|Withdrawal by Subject|3|||
131210400|NCT01694849|472393815|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
130875814|NCT04247347|471175511|FG000|Overall Study|Lost to Follow-up|1|||
130875815|NCT04247347|471175512|FG001|Overall Study|Lost to Follow-up|1|||
130875816|NCT04247347|471175513|FG002|Overall Study|Lost to Follow-up|1|||
130875817|NCT03562195|471175514|FG000|Overall Study|Adverse Event|0|||
130875818|NCT03562195|471175515|FG001|Overall Study|Adverse Event|6|||
130875819|NCT03562195|471175514|FG000|Overall Study|Lack of Efficacy|0|||
130875820|NCT03562195|471175515|FG001|Overall Study|Lack of Efficacy|5|||
130875821|NCT03562195|471175514|FG000|Overall Study|Protocol Violation|0|||
130875822|NCT03562195|471175515|FG001|Overall Study|Protocol Violation|1|||
130875823|NCT03562195|471175514|FG000|Overall Study|Lost to Follow-up|0|||
130875824|NCT03562195|471175515|FG001|Overall Study|Lost to Follow-up|1|||
130875825|NCT03562195|471175514|FG000|Overall Study|Physician Decision|1|||
130875826|NCT03562195|471175515|FG001|Overall Study|Physician Decision|0|||
130875827|NCT03562195|471175514|FG000|Overall Study|Withdrawal by Subject|3|||
130875828|NCT03562195|471175515|FG001|Overall Study|Withdrawal by Subject|0|||
130875829|NCT02529852|471175516|FG000|Overall Study|Withdrawal by Subject|2|||
130875830|NCT04664153|471175517|FG000|Overall Study|Lack of Efficacy|0|||
130875831|NCT04664153|471175518|FG001|Overall Study|Lack of Efficacy|0|||
130875832|NCT04664153|471175519|FG002|Overall Study|Lack of Efficacy|1|||
130875833|NCT04664153|471175520|FG003|Overall Study|Lack of Efficacy|0|||
130875834|NCT04664153|471175517|FG000|Overall Study|Physician Decision|0|||
130875835|NCT04664153|471175518|FG001|Overall Study|Physician Decision|0|||
130875836|NCT04664153|471175519|FG002|Overall Study|Physician Decision|1|||
130875837|NCT04664153|471175520|FG003|Overall Study|Physician Decision|0|||
130875838|NCT04664153|471175517|FG000|Overall Study|Withdrawal by Subject|3|||
130875839|NCT04664153|471175518|FG001|Overall Study|Withdrawal by Subject|2|||
130875840|NCT04664153|471175519|FG002|Overall Study|Withdrawal by Subject|1|||
130875841|NCT04664153|471175520|FG003|Overall Study|Withdrawal by Subject|2|||
130875842|NCT04664153|471175517|FG000|Overall Study|Other|0|||
130875843|NCT04664153|471175518|FG001|Overall Study|Other|1|||
130875844|NCT04664153|471175519|FG002|Overall Study|Other|0|||
130875845|NCT04664153|471175520|FG003|Overall Study|Other|0|||
130875846|NCT04664153|471175517|FG000|Overall Study|Adverse Event|4|||
130875847|NCT04664153|471175518|FG001|Overall Study|Adverse Event|0|||
130875848|NCT04664153|471175519|FG002|Overall Study|Adverse Event|1|||
130875849|NCT04664153|471175520|FG003|Overall Study|Adverse Event|0|||
130875850|NCT00097500|471175521|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
130875851|NCT00097500|471175522|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
130875852|NCT00097500|471175521|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
130875853|NCT00097500|471175522|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
130875854|NCT00097500|471175521|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
130875855|NCT00097500|471175522|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
130875856|NCT00097500|471175521|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130875857|NCT00097500|471175522|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
130875858|NCT00097500|471175521|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
130875859|NCT00097500|471175522|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
130875860|NCT00097500|471175521|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
130875861|NCT00097500|471175522|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
130875862|NCT00097500|471175521|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
130875863|NCT00097500|471175522|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
130875864|NCT00642356|471175534|FG000|Overall Study|Adverse Event|1|||
130875865|NCT00642356|471175535|FG001|Overall Study|Adverse Event|0|||
130875866|NCT00642356|471175534|FG000|Overall Study|Protocol Violation|0|||
130875867|NCT00642356|471175535|FG001|Overall Study|Protocol Violation|3|||
130875868|NCT00642356|471175534|FG000|Overall Study|Lack of Efficacy|1|||
131210401|NCT01694849|472393813|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
131210402|NCT01694849|472393814|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
131210403|NCT01694849|472393815|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
131210404|NCT01694849|472393813|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
131210405|NCT01694849|472393814|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
131210406|NCT01694849|472393815|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
131210407|NCT01694849|472393813|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
131210408|NCT01694849|472393814|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
131210409|NCT01694849|472393815|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
130875869|NCT00642356|471175535|FG001|Overall Study|Lack of Efficacy|0|||
130875870|NCT01009060|471175536|FG000|Overall Study|Adverse Event|1|||
130875871|NCT01009060|471175537|FG001|Overall Study|Adverse Event|2|||
130875872|NCT01009060|471175536|FG000|Overall Study|Protocol Violation|0|||
130875873|NCT01009060|471175537|FG001|Overall Study|Protocol Violation|1|||
130875874|NCT01009060|471175536|FG000|Overall Study|Lost to Follow-up|1|||
130875875|NCT01009060|471175537|FG001|Overall Study|Lost to Follow-up|0|||
130875876|NCT01009060|471175536|FG000|Overall Study|Physician Decision|1|||
130875877|NCT01009060|471175537|FG001|Overall Study|Physician Decision|1|||
130875878|NCT01009060|471175536|FG000|Overall Study|Withdrawal by Subject|1|||
130875879|NCT01009060|471175537|FG001|Overall Study|Withdrawal by Subject|1|||
130875880|NCT00005906|471175538|FG000|Overall Study|Lack of Efficacy|3|||
130875881|NCT00265564|471175539|FG000|Overall Study|Lost to Follow-up|5|||
130875882|NCT00265564|471175540|FG001|Overall Study|Lost to Follow-up|7|||
130875883|NCT00265564|471175539|FG000|Overall Study|met exclusion criteria|5|||
130875884|NCT00265564|471175540|FG001|Overall Study|met exclusion criteria|2|||
130875885|NCT00286442|471175545|FG000|Overall Study|Hyperglycemic Rescue|19|||
130875886|NCT00286442|471175546|FG001|Overall Study|Hyperglycemic Rescue|17|||
131210410|NCT01694849|472393813|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
131210411|NCT01694849|472393814|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
131210412|NCT01694849|472393815|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
131210413|NCT01694849|472393813|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
131210414|NCT01694849|472393814|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
131210415|NCT01694849|472393815|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
131210416|NCT01694849|472393813|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
131210417|NCT01694849|472393814|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
130875887|NCT00286442|471175547|FG002|Overall Study|Hyperglycemic Rescue|25|||
130875888|NCT00286442|471175545|FG000|Overall Study|Adverse Event|7|||
131210418|NCT01694849|472393815|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
131210419|NCT01694849|472393813|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
131210420|NCT01694849|472393814|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
131210421|NCT01694849|472393815|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
131210422|NCT02304484|472393818|FG000|Overall Study|Death|9|||
130875889|NCT00286442|471175546|FG001|Overall Study|Adverse Event|6|||
130875890|NCT00286442|471175547|FG002|Overall Study|Adverse Event|1|||
130875891|NCT00286442|471175545|FG000|Overall Study|Protocol Violation|2|||
130875892|NCT00286442|471175546|FG001|Overall Study|Protocol Violation|4|||
130875893|NCT00286442|471175547|FG002|Overall Study|Protocol Violation|2|||
130875894|NCT00286442|471175545|FG000|Overall Study|Lost to Follow-up|5|||
130875895|NCT00286442|471175546|FG001|Overall Study|Lost to Follow-up|2|||
130875896|NCT00286442|471175547|FG002|Overall Study|Lost to Follow-up|1|||
130875897|NCT00286442|471175545|FG000|Overall Study|Physician Decision|1|||
130875898|NCT00286442|471175546|FG001|Overall Study|Physician Decision|1|||
130875899|NCT00286442|471175547|FG002|Overall Study|Physician Decision|1|||
130875900|NCT00286442|471175545|FG000|Overall Study|Administrative Error|1|||
130875901|NCT00286442|471175546|FG001|Overall Study|Administrative Error|1|||
130875902|NCT00286442|471175547|FG002|Overall Study|Administrative Error|0|||
130875903|NCT00286442|471175545|FG000|Overall Study|Withdrawal by Subject|2|||
130875904|NCT00286442|471175546|FG001|Overall Study|Withdrawal by Subject|14|||
130875905|NCT00286442|471175547|FG002|Overall Study|Withdrawal by Subject|2|||
130875906|NCT04571944|471175552|FG000|Overall Study|Death|1|||
130875907|NCT04571944|471175553|FG001|Overall Study|Death|0|||
130875908|NCT04571944|471175552|FG000|Overall Study|Withdrawal by Subject|3|||
130875909|NCT04571944|471175553|FG001|Overall Study|Withdrawal by Subject|0|||
130875910|NCT04571944|471175552|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
130875911|NCT04571944|471175553|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
130875912|NCT03740048|471175554|FG000|Overall Study|Withdrawal by Subject|1|||
130875913|NCT03740048|471175555|FG001|Overall Study|Withdrawal by Subject|1|||
130875914|NCT03740048|471175554|FG000|Overall Study|Death|1|||
130875915|NCT03740048|471175555|FG001|Overall Study|Death|6|||
130875916|NCT03740048|471175554|FG000|Overall Study|Switched to thrice-weekly HD|2|||
130875917|NCT03740048|471175555|FG001|Overall Study|Switched to thrice-weekly HD|0|||
130875918|NCT03740048|471175554|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
130875919|NCT03740048|471175555|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
130875920|NCT03740048|471175554|FG000|Overall Study|Lost to Follow-up|0|||
130875921|NCT03740048|471175555|FG001|Overall Study|Lost to Follow-up|1|||
131210423|NCT02304484|472393818|FG000|Overall Study|Withdrawal by Subject|14|||
131210424|NCT02304484|472393818|FG000|Overall Study|Lost to Follow-up|2|||
131210425|NCT00752206|472393820|FG000|Overall Study|Disease progression|8|||
131210426|NCT00752206|472393821|FG001|Overall Study|Disease progression|11|||
131210427|NCT00752206|472393820|FG000|Overall Study|Pregnancy|1|||
130875922|NCT03740048|471175554|FG000|Overall Study|Non-compliance with HD|0|||
130875923|NCT03740048|471175555|FG001|Overall Study|Non-compliance with HD|1|||
130875924|NCT01476722|471175556|FG000|Overall Study|Adverse Event|1|||
130875925|NCT03261336|471175557|FG000|Overall Study|Adverse Event|1|||
130875926|NCT00292942|471175558|FG000|Overall Study|Withdrawal by Subject|0|||
130875927|NCT00292942|471175559|FG001|Overall Study|Withdrawal by Subject|0|||
130875928|NCT00292942|471175560|FG002|Overall Study|Withdrawal by Subject|1|||
130875929|NCT00292942|471175561|FG003|Overall Study|Withdrawal by Subject|0|||
130875930|NCT00292942|471175558|FG000|Overall Study|Adverse Event|0|||
130875931|NCT00292942|471175559|FG001|Overall Study|Adverse Event|0|||
131210428|NCT00752206|472393821|FG001|Overall Study|Pregnancy|0|||
130875932|NCT00292942|471175560|FG002|Overall Study|Adverse Event|0|||
130875933|NCT00292942|471175561|FG003|Overall Study|Adverse Event|1|||
130875934|NCT00651924|471175562|FG000|Overall Study|Withdrawal by PI|0|||
130875935|NCT00651924|471175563|FG001|Overall Study|Withdrawal by PI|2|||
130875936|NCT00651924|471175562|FG000|Overall Study|Withdrawal by Subject|0|||
130875937|NCT00651924|471175563|FG001|Overall Study|Withdrawal by Subject|5|||
130875938|NCT00960063|471175564|FG000|Overall Study|Adverse Event|1|||
130875939|NCT00960063|471175565|FG001|Overall Study|Adverse Event|0|||
130875940|NCT00960063|471175566|FG002|Overall Study|Adverse Event|0|||
130875941|NCT00960063|471175564|FG000|Overall Study|Progression of Disease|0|||
130875942|NCT00960063|471175565|FG001|Overall Study|Progression of Disease|0|||
130875943|NCT00960063|471175566|FG002|Overall Study|Progression of Disease|3|||
130875944|NCT05083351|471175568|FG000|Overall Study|Adverse Event|3|||
130875945|NCT05083351|471175568|FG000|Overall Study|Did not meet data inclusion criteria|8|||
130875946|NCT05083351|471175568|FG000|Overall Study|Did not meet eligibility criteria|19|||
130875947|NCT05083351|471175568|FG000|Overall Study|Study Staff Decision|19|||
130875948|NCT01759420|471175570|FG000|Overall Study|Screen failure|5|||
130875949|NCT01759420|471175570|FG000|Overall Study|Inaccurate EKG machine readings|1|||
130875950|NCT04258423|471175579|FG000|Overall Study|Study Closure|2|||
130875951|NCT04258423|471175580|FG001|Overall Study|Study Closure|2|||
130875952|NCT00321789|471175581|FG000|Overall Study|Lost to Follow-up|4|||
130875953|NCT00321789|471175582|FG001|Overall Study|Lost to Follow-up|7|||
130875954|NCT00321789|471175581|FG000|Overall Study|Withdrawal by Subject|6|||
130875955|NCT00321789|471175582|FG001|Overall Study|Withdrawal by Subject|6|||
130875956|NCT00321789|471175581|FG000|Overall Study|Protocol Violation|5|||
130875957|NCT00321789|471175582|FG001|Overall Study|Protocol Violation|3|||
130875958|NCT03309020|471175585|FG000|Overall Study|Death|1|||
130875959|NCT03309020|471175586|FG001|Overall Study|Death|0|||
130875960|NCT03309020|471175585|FG000|Overall Study|Did not undergo surgery|2|||
130875961|NCT03309020|471175586|FG001|Overall Study|Did not undergo surgery|1|||
130875962|NCT00402168|471175587|FG000|Randomized|Lost to Follow-up|1|||
130875963|NCT00402168|471175588|FG001|Randomized|Lost to Follow-up|0|||
130875964|NCT00402168|471175587|FG000|Randomized|Withdrawal by Subject|0|||
130875965|NCT00402168|471175588|FG001|Randomized|Withdrawal by Subject|1|||
130875966|NCT00402168|471175587|FG000|Treatment (up to 12 Months)|Death|0|||
130875967|NCT00402168|471175588|FG001|Treatment (up to 12 Months)|Death|1|||
130875968|NCT00402168|471175587|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
130875969|NCT00402168|471175588|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
130875970|NCT00402168|471175587|FG000|Treatment (up to 12 Months)|non-specified|0|||
130875971|NCT00402168|471175588|FG001|Treatment (up to 12 Months)|non-specified|1|||
130875972|NCT00402168|471175587|FG000|Long Term (LT)|Adverse Event|1|||
130875973|NCT00402168|471175588|FG001|Long Term (LT)|Adverse Event|5|||
130875974|NCT00402168|471175587|FG000|Long Term (LT)|Withdrawal by Subject|4|||
130875975|NCT00402168|471175588|FG001|Long Term (LT)|Withdrawal by Subject|7|||
130875976|NCT00402168|471175587|FG000|Long Term (LT)|Pregnancy|0|||
130875977|NCT00402168|471175588|FG001|Long Term (LT)|Pregnancy|1|||
130764000|NCT02502266|470759948|FG000|Overall Study|Adverse Event|0|||
130764001|NCT02502266|470759949|FG001|Overall Study|Adverse Event|0|||
130764002|NCT02502266|470759950|FG002|Overall Study|Adverse Event|0|||
130764003|NCT02502266|470759951|FG003|Overall Study|Adverse Event|0|||
130764004|NCT02502266|470759952|FG004|Overall Study|Adverse Event|1|||
130764005|NCT02502266|470759953|FG005|Overall Study|Adverse Event|1|||
130764006|NCT02502266|470759954|FG006|Overall Study|Adverse Event|1|||
130764007|NCT02502266|470759948|FG000|Overall Study|Withdrawal by Subject|30|||
130764008|NCT02502266|470759949|FG001|Overall Study|Withdrawal by Subject|15|||
130764009|NCT02502266|470759950|FG002|Overall Study|Withdrawal by Subject|16|||
130764010|NCT02502266|470759951|FG003|Overall Study|Withdrawal by Subject|0|||
130764011|NCT02502266|470759952|FG004|Overall Study|Withdrawal by Subject|0|||
130764012|NCT02502266|470759953|FG005|Overall Study|Withdrawal by Subject|0|||
130764013|NCT02502266|470759954|FG006|Overall Study|Withdrawal by Subject|0|||
130764014|NCT02502266|470759948|FG000|Overall Study|Still on Treatment|0|||
130764015|NCT02502266|470759949|FG001|Overall Study|Still on Treatment|0|||
130764016|NCT02502266|470759950|FG002|Overall Study|Still on Treatment|1|||
130764017|NCT02502266|470759951|FG003|Overall Study|Still on Treatment|0|||
130764018|NCT02502266|470759952|FG004|Overall Study|Still on Treatment|0|||
130764019|NCT02502266|470759953|FG005|Overall Study|Still on Treatment|0|||
130764020|NCT02502266|470759954|FG006|Overall Study|Still on Treatment|0|||
130764021|NCT02502266|470759948|FG000|Overall Study|Other Reasons|19|||
130764022|NCT02502266|470759949|FG001|Overall Study|Other Reasons|6|||
130764023|NCT02502266|470759950|FG002|Overall Study|Other Reasons|14|||
130764024|NCT02502266|470759951|FG003|Overall Study|Other Reasons|0|||
130764025|NCT02502266|470759952|FG004|Overall Study|Other Reasons|1|||
130764026|NCT02502266|470759953|FG005|Overall Study|Other Reasons|1|||
130764027|NCT02502266|470759954|FG006|Overall Study|Other Reasons|0|||
130764028|NCT02502266|470759948|FG000|Overall Study|Arm 4 Discontinued|0|||
130764029|NCT02502266|470759949|FG001|Overall Study|Arm 4 Discontinued|0|||
130764030|NCT02502266|470759950|FG002|Overall Study|Arm 4 Discontinued|0|||
130764031|NCT02502266|470759951|FG003|Overall Study|Arm 4 Discontinued|52|||
130764032|NCT02502266|470759952|FG004|Overall Study|Arm 4 Discontinued|0|||
130875978|NCT00402168|471175587|FG000|Long Term (LT)|Lost to Follow-up|1|||
130764033|NCT02502266|470759953|FG005|Overall Study|Arm 4 Discontinued|0|||
130875979|NCT00402168|471175588|FG001|Long Term (LT)|Lost to Follow-up|0|||
130875980|NCT00402168|471175587|FG000|Long Term (LT)|Death|4|||
130875981|NCT00402168|471175588|FG001|Long Term (LT)|Death|0|||
130875982|NCT00402168|471175587|FG000|Long Term (LT)|Lack of Efficacy|0|||
130875983|NCT00402168|471175588|FG001|Long Term (LT)|Lack of Efficacy|2|||
130875984|NCT00402168|471175587|FG000|Long Term (LT)|non-specified|1|||
130875985|NCT00402168|471175588|FG001|Long Term (LT)|non-specified|2|||
130875986|NCT00402168|471175587|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
130875987|NCT00402168|471175588|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
130875988|NCT00402168|471175587|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
130875989|NCT00402168|471175588|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
130875990|NCT02362724|471175589|FG000|Overall Study|Withdrawal by Subject|3|||
130875991|NCT02362724|471175590|FG001|Overall Study|Withdrawal by Subject|1|||
130875992|NCT02362724|471175589|FG000|Overall Study|Adverse Event|3|||
130875993|NCT02362724|471175590|FG001|Overall Study|Adverse Event|0|||
130875994|NCT02025179|471175591|FG000|Overall Study|Lost to Follow-up|0|||
130875995|NCT02025179|471175592|FG001|Overall Study|Lost to Follow-up|0|||
130875996|NCT02025179|471175593|FG002|Overall Study|Lost to Follow-up|1|||
130875997|NCT00601835|471175599|FG000|Overall Study|Withdrawal by Subject|9|||
130875998|NCT00601835|471175600|FG001|Overall Study|Withdrawal by Subject|6|||
130875999|NCT00601835|471175599|FG000|Overall Study|Physician Decision|1|||
130876000|NCT00601835|471175600|FG001|Overall Study|Physician Decision|0|||
130876001|NCT00601835|471175599|FG000|Overall Study|Lost to Follow-up|37|||
130876002|NCT00601835|471175600|FG001|Overall Study|Lost to Follow-up|5|||
130876003|NCT00601835|471175599|FG000|Overall Study|Adverse Event|1|||
130876004|NCT00601835|471175600|FG001|Overall Study|Adverse Event|1|||
130876005|NCT00601835|471175599|FG000|Overall Study|Relocate|12|||
130876006|NCT00601835|471175600|FG001|Overall Study|Relocate|2|||
130876007|NCT02587520|471177359|FG000|Overall Study|Protocol Violation|2|||
130876008|NCT02587520|471177360|FG001|Overall Study|Protocol Violation|0|||
130876009|NCT02587520|471177361|FG002|Overall Study|Protocol Violation|0|||
130876010|NCT02587520|471177362|FG003|Overall Study|Protocol Violation|2|||
130876011|NCT02587520|471177363|FG004|Overall Study|Protocol Violation|0|||
130876012|NCT02587520|471177364|FG005|Overall Study|Protocol Violation|1|||
130876013|NCT02587520|471177365|FG006|Overall Study|Protocol Violation|1|||
130876014|NCT02587520|471177366|FG007|Overall Study|Protocol Violation|1|||
130876015|NCT02587520|471177367|FG008|Overall Study|Protocol Violation|3|||
130876016|NCT02587520|471177368|FG009|Overall Study|Protocol Violation|3|||
130876017|NCT02587520|471177369|FG010|Overall Study|Protocol Violation|1|||
130876018|NCT02587520|471177370|FG011|Overall Study|Protocol Violation|2|||
130876019|NCT02587520|471177371|FG012|Overall Study|Protocol Violation|0|||
130876020|NCT02587520|471177372|FG013|Overall Study|Protocol Violation|0|||
130876021|NCT02587520|471177373|FG014|Overall Study|Protocol Violation|0|||
130876022|NCT02587520|471177374|FG015|Overall Study|Protocol Violation|0|||
130876023|NCT02587520|471177375|FG016|Overall Study|Protocol Violation|0|||
130876024|NCT02587520|471177376|FG017|Overall Study|Protocol Violation|0|||
130876025|NCT02587520|471177359|FG000|Overall Study|Adverse Event|0|||
130876026|NCT02587520|471177360|FG001|Overall Study|Adverse Event|0|||
130876027|NCT02587520|471177361|FG002|Overall Study|Adverse Event|0|||
130876028|NCT02587520|471177362|FG003|Overall Study|Adverse Event|0|||
130876029|NCT02587520|471177363|FG004|Overall Study|Adverse Event|0|||
130876030|NCT02587520|471177364|FG005|Overall Study|Adverse Event|0|||
130876031|NCT02587520|471177365|FG006|Overall Study|Adverse Event|0|||
130876032|NCT02587520|471177366|FG007|Overall Study|Adverse Event|0|||
130876033|NCT02587520|471177367|FG008|Overall Study|Adverse Event|0|||
130876034|NCT02587520|471177368|FG009|Overall Study|Adverse Event|0|||
130876035|NCT02587520|471177369|FG010|Overall Study|Adverse Event|0|||
130876036|NCT02587520|471177370|FG011|Overall Study|Adverse Event|1|||
130876037|NCT02587520|471177371|FG012|Overall Study|Adverse Event|0|||
130876038|NCT02587520|471177372|FG013|Overall Study|Adverse Event|0|||
130876039|NCT02587520|471177373|FG014|Overall Study|Adverse Event|0|||
130876040|NCT02587520|471177374|FG015|Overall Study|Adverse Event|0|||
130876041|NCT02587520|471177375|FG016|Overall Study|Adverse Event|0|||
130876042|NCT02587520|471177376|FG017|Overall Study|Adverse Event|0|||
130876043|NCT02587520|471177359|FG000|Overall Study|Withdrawal by Subject|0|||
130876044|NCT02587520|471177360|FG001|Overall Study|Withdrawal by Subject|0|||
130876045|NCT02587520|471177361|FG002|Overall Study|Withdrawal by Subject|1|||
130876046|NCT02587520|471177362|FG003|Overall Study|Withdrawal by Subject|1|||
130876047|NCT02587520|471177363|FG004|Overall Study|Withdrawal by Subject|0|||
130876048|NCT02587520|471177364|FG005|Overall Study|Withdrawal by Subject|1|||
130876049|NCT02587520|471177365|FG006|Overall Study|Withdrawal by Subject|1|||
130876050|NCT02587520|471177366|FG007|Overall Study|Withdrawal by Subject|0|||
130876051|NCT02587520|471177367|FG008|Overall Study|Withdrawal by Subject|0|||
130876052|NCT02587520|471177368|FG009|Overall Study|Withdrawal by Subject|0|||
130876053|NCT02587520|471177369|FG010|Overall Study|Withdrawal by Subject|0|||
130876054|NCT02587520|471177370|FG011|Overall Study|Withdrawal by Subject|0|||
130876055|NCT02587520|471177371|FG012|Overall Study|Withdrawal by Subject|0|||
130876056|NCT02587520|471177372|FG013|Overall Study|Withdrawal by Subject|1|||
130876057|NCT02587520|471177373|FG014|Overall Study|Withdrawal by Subject|0|||
130876058|NCT02587520|471177374|FG015|Overall Study|Withdrawal by Subject|0|||
130876059|NCT02587520|471177375|FG016|Overall Study|Withdrawal by Subject|0|||
130876060|NCT02587520|471177376|FG017|Overall Study|Withdrawal by Subject|0|||
130876061|NCT02587520|471177359|FG000|Overall Study|Lost to Follow-up|0|||
130876062|NCT02587520|471177360|FG001|Overall Study|Lost to Follow-up|2|||
130876063|NCT02587520|471177361|FG002|Overall Study|Lost to Follow-up|0|||
130876064|NCT02587520|471177362|FG003|Overall Study|Lost to Follow-up|2|||
130876065|NCT02587520|471177363|FG004|Overall Study|Lost to Follow-up|0|||
130876066|NCT02587520|471177364|FG005|Overall Study|Lost to Follow-up|1|||
130876067|NCT02587520|471177365|FG006|Overall Study|Lost to Follow-up|1|||
130876068|NCT02587520|471177366|FG007|Overall Study|Lost to Follow-up|1|||
130876069|NCT02587520|471177367|FG008|Overall Study|Lost to Follow-up|0|||
130876070|NCT02587520|471177368|FG009|Overall Study|Lost to Follow-up|2|||
130876071|NCT02587520|471177369|FG010|Overall Study|Lost to Follow-up|2|||
130876072|NCT02587520|471177370|FG011|Overall Study|Lost to Follow-up|1|||
130876073|NCT02587520|471177371|FG012|Overall Study|Lost to Follow-up|0|||
130876074|NCT02587520|471177372|FG013|Overall Study|Lost to Follow-up|0|||
130876075|NCT02587520|471177373|FG014|Overall Study|Lost to Follow-up|0|||
130876076|NCT02587520|471177374|FG015|Overall Study|Lost to Follow-up|0|||
130876077|NCT02587520|471177375|FG016|Overall Study|Lost to Follow-up|0|||
130876078|NCT02587520|471177376|FG017|Overall Study|Lost to Follow-up|0|||
130876079|NCT03924622|471177377|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
130876080|NCT03924622|471177378|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130876081|NCT03924622|471177379|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
131210429|NCT00678652|472393822|FG000|Overall Study|Protocol Violation|2|||
131210430|NCT00678652|472393823|FG001|Overall Study|Protocol Violation|0|||
131210431|NCT00678652|472393824|FG002|Overall Study|Protocol Violation|0|||
131210432|NCT00678652|472393825|FG003|Overall Study|Protocol Violation|0|||
131210433|NCT00678652|472393822|FG000|Overall Study|Pregnancy|0|||
131210434|NCT00678652|472393823|FG001|Overall Study|Pregnancy|0|||
131210435|NCT00678652|472393824|FG002|Overall Study|Pregnancy|1|||
131210436|NCT00678652|472393825|FG003|Overall Study|Pregnancy|0|||
131210437|NCT00678652|472393822|FG000|Overall Study|Relocation|1|||
131210438|NCT00678652|472393823|FG001|Overall Study|Relocation|0|||
131210439|NCT00678652|472393824|FG002|Overall Study|Relocation|0|||
131210440|NCT00678652|472393825|FG003|Overall Study|Relocation|0|||
131210441|NCT03205605|472393826|FG000|Overall Study|Withdrawal by Subject|1|||
131210442|NCT03328325|472393829|FG000|Overall Study|Lost to Follow-up|4|||
131210443|NCT03328325|472393829|FG000|Overall Study|Physician Decision|1|||
131210444|NCT03328325|472393829|FG000|Overall Study|Withdrawal by Subject|3|||
131210445|NCT03328325|472393829|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
131210446|NCT04794491|472393830|FG000|Overall Study|Adverse Event|1|||
131210447|NCT04794491|472393830|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
131210448|NCT04794491|472393830|FG000|Overall Study|Noncompliance With Study Intervention|1|||
131210449|NCT04794491|472393830|FG000|Overall Study|Withdrawal by Subject|2|||
131210450|NCT00736840|472393831|FG000|Overall Study|Lost to Follow-up|13|||
131210451|NCT01990339|472393832|FG000|Overall Study|Data Not Available|49|||
131210452|NCT01990339|472393832|FG000|Overall Study|Voluntary Withdrawal|1402|||
131210453|NCT01990339|472393832|FG000|Overall Study|Lost to Follow-up|861|||
131210454|NCT01038609|472393833|FG000|Overall Study|Adverse Event|0|||
131210455|NCT01038609|472393834|FG001|Overall Study|Adverse Event|0|||
131210456|NCT01038609|472393835|FG002|Overall Study|Adverse Event|1|||
131210457|NCT01038609|472393836|FG003|Overall Study|Adverse Event|0|||
131210458|NCT01038609|472393837|FG004|Overall Study|Adverse Event|0|||
131210459|NCT01038609|472393833|FG000|Overall Study|Dosing Error|0|||
131210460|NCT01038609|472393834|FG001|Overall Study|Dosing Error|0|||
131210461|NCT01038609|472393835|FG002|Overall Study|Dosing Error|0|||
131210462|NCT01038609|472393836|FG003|Overall Study|Dosing Error|1|||
131210463|NCT01038609|472393837|FG004|Overall Study|Dosing Error|1|||
131210464|NCT01038609|472393833|FG000|Overall Study|Death in the Family|1|||
131210465|NCT01038609|472393834|FG001|Overall Study|Death in the Family|0|||
131210466|NCT01038609|472393835|FG002|Overall Study|Death in the Family|0|||
131210467|NCT01038609|472393836|FG003|Overall Study|Death in the Family|0|||
131210468|NCT01038609|472393837|FG004|Overall Study|Death in the Family|0|||
130876082|NCT03924622|471177380|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
130985394|NCT02496767|471572903|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131210469|NCT01038609|472393833|FG000|Overall Study|Refusal of Blood Draws|0|||
131210470|NCT01038609|472393834|FG001|Overall Study|Refusal of Blood Draws|1|||
131210471|NCT01038609|472393835|FG002|Overall Study|Refusal of Blood Draws|0|||
131210472|NCT01038609|472393836|FG003|Overall Study|Refusal of Blood Draws|0|||
131210473|NCT01038609|472393837|FG004|Overall Study|Refusal of Blood Draws|0|||
131210474|NCT03289676|472393840|FG000|Overall Study|Withdrawal by Subject|2|||
131210475|NCT03289676|472393841|FG001|Overall Study|Withdrawal by Subject|0|||
130876083|NCT03924622|471177381|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130876084|NCT03924622|471177382|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130876085|NCT02412306|471177384|FG000|Overall Study|Lost to Follow-up|0|||
130876086|NCT02412306|471177385|FG001|Overall Study|Lost to Follow-up|1|||
130876087|NCT02412306|471177386|FG002|Overall Study|Lost to Follow-up|0|||
130876088|NCT02412306|471177387|FG003|Overall Study|Lost to Follow-up|0|||
130876089|NCT02412306|471177388|FG004|Overall Study|Lost to Follow-up|0|||
130876090|NCT02412306|471177384|FG000|Overall Study|Withdrawal by Subject|0|||
130876091|NCT02412306|471177385|FG001|Overall Study|Withdrawal by Subject|0|||
131210476|NCT03289676|472393840|FG000|Overall Study|Protocol Violation|2|||
131210477|NCT03289676|472393841|FG001|Overall Study|Protocol Violation|0|||
131210478|NCT03289676|472393840|FG000|Overall Study|Lost to Follow-up|0|||
131210479|NCT03289676|472393841|FG001|Overall Study|Lost to Follow-up|1|||
130876092|NCT02412306|471177386|FG002|Overall Study|Withdrawal by Subject|1|||
130876093|NCT02412306|471177387|FG003|Overall Study|Withdrawal by Subject|0|||
130876094|NCT02412306|471177388|FG004|Overall Study|Withdrawal by Subject|0|||
130876095|NCT02412306|471177384|FG000|Overall Study|Death|5|||
130876096|NCT02412306|471177385|FG001|Overall Study|Death|7|||
130876097|NCT02412306|471177386|FG002|Overall Study|Death|15|||
130876098|NCT02412306|471177387|FG003|Overall Study|Death|0|||
130876099|NCT02412306|471177388|FG004|Overall Study|Death|2|||
130876100|NCT05543265|471177396|FG000|Overall Study|Lost to Follow-up|3|||
130876101|NCT05543265|471177397|FG001|Overall Study|Lost to Follow-up|3|||
130876102|NCT05543265|471177396|FG000|Overall Study|Withdrawal by Subject|0|||
130876103|NCT05543265|471177397|FG001|Overall Study|Withdrawal by Subject|1|||
130876104|NCT05316597|471177398|FG000|First Session|Withdrawal by Subject|0|||
130876105|NCT05316597|471177399|FG001|First Session|Withdrawal by Subject|1|||
130876106|NCT05316597|471177398|FG000|Washout Period|Lost to Follow-up|1|||
130876107|NCT05316597|471177399|FG001|Washout Period|Lost to Follow-up|2|||
130876108|NCT05316597|471177398|FG000|Washout Period|Physician Decision|1|||
130876109|NCT05316597|471177399|FG001|Washout Period|Physician Decision|1|||
131210480|NCT01314261|472393842|FG000|Overall Study|Adverse Event|1|||
131210481|NCT01314261|472393843|FG001|Overall Study|Adverse Event|0|||
131210482|NCT01314261|472393844|FG002|Overall Study|Adverse Event|0|||
131210483|NCT01314261|472393845|FG003|Overall Study|Adverse Event|0|||
131210484|NCT01314261|472393842|FG000|Overall Study|Withdrawal by Subject|0|||
131210485|NCT01314261|472393843|FG001|Overall Study|Withdrawal by Subject|3|||
130876110|NCT05316597|471177398|FG000|Washout Period|Excluded before second session|1|||
130876111|NCT05316597|471177399|FG001|Washout Period|Excluded before second session|1|||
130876112|NCT05316597|471177398|FG000|Washout Period|Withdrawal by Subject|0|||
130876113|NCT05316597|471177399|FG001|Washout Period|Withdrawal by Subject|4|||
130876114|NCT05526716|471177400|FG000|Overall Study|Death|1|||
130876115|NCT05526716|471177401|FG001|Overall Study|Death|2|||
130876116|NCT05526716|471177400|FG000|Overall Study|Lost to Follow-up|17|||
130876117|NCT05526716|471177401|FG001|Overall Study|Lost to Follow-up|15|||
130876118|NCT05526716|471177400|FG000|Overall Study|Physician Decision|0|||
130876119|NCT05526716|471177401|FG001|Overall Study|Physician Decision|1|||
131210486|NCT01314261|472393844|FG002|Overall Study|Withdrawal by Subject|1|||
131210487|NCT01314261|472393845|FG003|Overall Study|Withdrawal by Subject|0|||
131210488|NCT01314261|472393842|FG000|Overall Study|Lost to Follow-up|1|||
131210489|NCT01314261|472393843|FG001|Overall Study|Lost to Follow-up|0|||
131210490|NCT01314261|472393844|FG002|Overall Study|Lost to Follow-up|2|||
131210491|NCT01314261|472393845|FG003|Overall Study|Lost to Follow-up|2|||
131210492|NCT01314261|472393842|FG000|Overall Study|Virologic Failure|0|||
131210493|NCT01314261|472393843|FG001|Overall Study|Virologic Failure|1|||
131210494|NCT01314261|472393844|FG002|Overall Study|Virologic Failure|0|||
130876120|NCT05526716|471177400|FG000|Overall Study|Randomized by mistake without study treatment|0|||
130876121|NCT05526716|471177401|FG001|Overall Study|Randomized by mistake without study treatment|1|||
130876122|NCT05526716|471177400|FG000|Overall Study|Withdrawal by Subject|12|||
130876123|NCT05526716|471177401|FG001|Overall Study|Withdrawal by Subject|12|||
130876124|NCT05526716|471177400|FG000|Overall Study|Not reported|0|||
130876125|NCT05526716|471177401|FG001|Overall Study|Not reported|2|||
130876126|NCT04750824|471177405|FG000|Overall Study|Toxicity/intolerability|3|||
130876127|NCT04750824|471177406|FG001|Overall Study|Toxicity/intolerability|1|||
130876128|NCT04750824|471177405|FG000|Overall Study|Death|1|||
130876129|NCT04750824|471177406|FG001|Overall Study|Death|3|||
130876130|NCT04750824|471177405|FG000|Overall Study|Scheduled duration of therapy complete|1|||
130876131|NCT04750824|471177406|FG001|Overall Study|Scheduled duration of therapy complete|9|||
130876132|NCT04750824|471177405|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
130876133|NCT04750824|471177406|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
130876134|NCT00807911|471177407|FG000|Overall Study|Withdrawal by Subject|12|||
130876135|NCT00807911|471177408|FG001|Overall Study|Withdrawal by Subject|10|||
130876136|NCT00807911|471177407|FG000|Overall Study|Ineligible|0|||
131210495|NCT01314261|472393845|FG003|Overall Study|Virologic Failure|1|||
131210496|NCT04524507|472393846|FG000|Overall Study|Lost to Follow-up|2|||
131210497|NCT04524507|472393847|FG001|Overall Study|Lost to Follow-up|4|||
131210498|NCT04524507|472393846|FG000|Overall Study|Withdrawal by Subject|2|||
130876137|NCT00807911|471177408|FG001|Overall Study|Ineligible|4|||
130876138|NCT03547518|471177411|FG000|Overall Study|Lost to Follow-up|2|||
130876139|NCT03547518|471177412|FG001|Overall Study|Lost to Follow-up|0|||
130876140|NCT04349891|471177419|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
130876141|NCT04349891|471177420|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
130876142|NCT04349891|471177419|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
130876143|NCT04349891|471177420|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
130876144|NCT04349891|471177419|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
130876145|NCT04349891|471177420|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
130876146|NCT04349891|471177419|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
130876147|NCT04349891|471177420|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
130876148|NCT02927301|471177423|FG000|Overall Study|Death|39|||
130876149|NCT02927301|471177423|FG000|Overall Study|Lost to Follow-up|8|||
130876150|NCT02927301|471177423|FG000|Overall Study|Physician Decision|2|||
130876151|NCT02927301|471177423|FG000|Overall Study|Withdrawal by Subject|12|||
130876152|NCT02927301|471177423|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
130876153|NCT02201524|471177426|FG000|Overall Study|Adverse Event|0|||
130876154|NCT02201524|471177427|FG001|Overall Study|Adverse Event|2|||
130876155|NCT02201524|471177428|FG002|Overall Study|Adverse Event|1|||
130876156|NCT02201524|471177429|FG003|Overall Study|Adverse Event|0|||
130876157|NCT02201524|471177426|FG000|Overall Study|Insufficient clinical response|1|||
130876158|NCT02201524|471177427|FG001|Overall Study|Insufficient clinical response|0|||
130876159|NCT02201524|471177428|FG002|Overall Study|Insufficient clinical response|0|||
130876160|NCT02201524|471177429|FG003|Overall Study|Insufficient clinical response|0|||
130876161|NCT02201524|471177426|FG000|Overall Study|Lost to Follow-up|0|||
130876162|NCT02201524|471177427|FG001|Overall Study|Lost to Follow-up|0|||
130876163|NCT02201524|471177428|FG002|Overall Study|Lost to Follow-up|2|||
130876164|NCT02201524|471177429|FG003|Overall Study|Lost to Follow-up|0|||
130876165|NCT02201524|471177426|FG000|Overall Study|No longer meets eligibility criteria|0|||
130876166|NCT02201524|471177427|FG001|Overall Study|No longer meets eligibility criteria|0|||
130876167|NCT02201524|471177428|FG002|Overall Study|No longer meets eligibility criteria|0|||
130876168|NCT02201524|471177429|FG003|Overall Study|No longer meets eligibility criteria|2|||
130876169|NCT02201524|471177426|FG000|Overall Study|Protocol Violation|0|||
130876170|NCT02201524|471177427|FG001|Overall Study|Protocol Violation|0|||
130876171|NCT02201524|471177428|FG002|Overall Study|Protocol Violation|0|||
130876172|NCT02201524|471177429|FG003|Overall Study|Protocol Violation|1|||
130876173|NCT02201524|471177426|FG000|Overall Study|Withdrawal by Subject|0|||
130876174|NCT02201524|471177427|FG001|Overall Study|Withdrawal by Subject|0|||
130876175|NCT02201524|471177428|FG002|Overall Study|Withdrawal by Subject|1|||
130876176|NCT02201524|471177429|FG003|Overall Study|Withdrawal by Subject|1|||
130876177|NCT02201524|471177426|FG000|Overall Study|Other|1|||
130876178|NCT02201524|471177427|FG001|Overall Study|Other|1|||
130876179|NCT02201524|471177428|FG002|Overall Study|Other|0|||
130876180|NCT02201524|471177429|FG003|Overall Study|Other|0|||
130876181|NCT02914639|471177431|FG000|Overall Study|Withdrawal by Subject|0|||
130876182|NCT02914639|471177432|FG001|Overall Study|Withdrawal by Subject|2|||
130876183|NCT01018030|471177433|FG000|Overall Study|Adverse Event|10|||
130876184|NCT01018030|471177434|FG001|Overall Study|Adverse Event|5|||
130876185|NCT01018030|471177435|FG002|Overall Study|Adverse Event|5|||
130876186|NCT01018030|471177433|FG000|Overall Study|Withdrawal by Subject|2|||
130876187|NCT01018030|471177434|FG001|Overall Study|Withdrawal by Subject|2|||
130876188|NCT01018030|471177435|FG002|Overall Study|Withdrawal by Subject|4|||
130876189|NCT01018030|471177433|FG000|Overall Study|Lost to Follow-up|2|||
130876190|NCT01018030|471177434|FG001|Overall Study|Lost to Follow-up|0|||
130876191|NCT01018030|471177435|FG002|Overall Study|Lost to Follow-up|3|||
130876192|NCT01018030|471177433|FG000|Overall Study|Protocol Violation|2|||
130876193|NCT01018030|471177434|FG001|Overall Study|Protocol Violation|1|||
130876194|NCT01018030|471177435|FG002|Overall Study|Protocol Violation|0|||
130876195|NCT01018030|471177433|FG000|Overall Study|Physician Decision|1|||
130876196|NCT01018030|471177434|FG001|Overall Study|Physician Decision|0|||
130876197|NCT01018030|471177435|FG002|Overall Study|Physician Decision|1|||
130876198|NCT01018030|471177433|FG000|Overall Study|Lack of Efficacy|1|||
130876199|NCT01018030|471177434|FG001|Overall Study|Lack of Efficacy|0|||
130876200|NCT01018030|471177435|FG002|Overall Study|Lack of Efficacy|0|||
130876201|NCT01018030|471177433|FG000|Overall Study|Did Not Receive Study Drug|1|||
130876202|NCT01018030|471177434|FG001|Overall Study|Did Not Receive Study Drug|3|||
130876203|NCT01018030|471177435|FG002|Overall Study|Did Not Receive Study Drug|0|||
130876204|NCT03617172|471177436|FG000|Overall Study|Lost to Follow-up|1|||
130876205|NCT03617172|471177437|FG001|Overall Study|Lost to Follow-up|0|||
130876206|NCT00189540|471177438|FG000|Overall Study|Withdrawal by Subject|3|||
130876207|NCT00189540|471177439|FG001|Overall Study|Withdrawal by Subject|0|||
130876208|NCT00189540|471177438|FG000|Overall Study|Death|4|||
130876209|NCT00189540|471177439|FG001|Overall Study|Death|1|||
131210499|NCT04524507|472393847|FG001|Overall Study|Withdrawal by Subject|9|||
130876210|NCT01089504|471177440|FG000|Overall Study|Lost to Follow-up|1|||
130876211|NCT01089504|471177441|FG001|Overall Study|Lost to Follow-up|1|||
130876212|NCT01089504|471177440|FG000|Overall Study|Withdrawal by Subject|2|||
130876213|NCT01089504|471177441|FG001|Overall Study|Withdrawal by Subject|0|||
130876214|NCT01924845|471177442|FG000|Overall Study|Adverse Event|3|||
130876215|NCT01924845|471177442|FG000|Overall Study|Withdrawal by Subject|2|||
130876216|NCT01924845|471177442|FG000|Overall Study|Protocol Violation|1|||
130876217|NCT00062439|471177443|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
130876218|NCT00062439|471177443|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
130876219|NCT00062439|471177443|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
130876220|NCT00062439|471177443|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
130876221|NCT00062439|471177443|FG000|Post Chemoradiation Assessment|Death|1|||
130876222|NCT00062439|471177443|FG000|Post Chemoradiation Assessment|Disease progression|2|||
130876223|NCT00062439|471177443|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
130876224|NCT00062439|471177443|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
130876225|NCT00062439|471177443|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
130876226|NCT00062439|471177443|FG000|Surgery|Physician Decision|4|||
130876227|NCT00062439|471177443|FG000|Surgery|Death|1|||
130876228|NCT00062439|471177443|FG000|Surgery|Adverse Event|2|||
130876229|NCT00062439|471177443|FG000|Consolidation Chemotherapy|Adverse Event|2|||
130876230|NCT00001832|471177447|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
130876231|NCT00001832|471177448|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
130876232|NCT00001832|471177449|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
130876233|NCT00001832|471177450|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
130876234|NCT00001832|471177451|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
130876235|NCT00001832|471177452|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
130876236|NCT00001832|471177453|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
130876237|NCT00001832|471177454|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
130876238|NCT00001832|471177455|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
130876239|NCT00001832|471177456|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
130876240|NCT00001832|471177457|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
130876241|NCT00001832|471177458|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
130876242|NCT00001832|471177459|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
130876243|NCT00001832|471177460|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
130876244|NCT00001832|471177461|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
130876245|NCT00001832|471177447|FG000|Treatment Period|Death during treatment|0|||
130876246|NCT00001832|471177448|FG001|Treatment Period|Death during treatment|0|||
130876247|NCT00001832|471177449|FG002|Treatment Period|Death during treatment|0|||
130876248|NCT00001832|471177450|FG003|Treatment Period|Death during treatment|0|||
130876249|NCT00001832|471177451|FG004|Treatment Period|Death during treatment|0|||
130876250|NCT00001832|471177452|FG005|Treatment Period|Death during treatment|1|||
130876251|NCT00001832|471177453|FG006|Treatment Period|Death during treatment|0|||
130876252|NCT00001832|471177454|FG007|Treatment Period|Death during treatment|0|||
130876253|NCT00001832|471177455|FG008|Treatment Period|Death during treatment|0|||
130876254|NCT00001832|471177456|FG009|Treatment Period|Death during treatment|0|||
130876255|NCT00001832|471177457|FG010|Treatment Period|Death during treatment|0|||
130876256|NCT00001832|471177458|FG011|Treatment Period|Death during treatment|0|||
130876257|NCT00001832|471177459|FG012|Treatment Period|Death during treatment|0|||
130876258|NCT00001832|471177460|FG013|Treatment Period|Death during treatment|0|||
130876259|NCT00001832|471177461|FG014|Treatment Period|Death during treatment|0|||
130876260|NCT00001832|471177447|FG000|Treatment Period|Not treated|0|||
130876261|NCT00001832|471177448|FG001|Treatment Period|Not treated|0|||
130876262|NCT00001832|471177449|FG002|Treatment Period|Not treated|0|||
130876263|NCT00001832|471177450|FG003|Treatment Period|Not treated|0|||
130876264|NCT00001832|471177451|FG004|Treatment Period|Not treated|0|||
130876265|NCT00001832|471177452|FG005|Treatment Period|Not treated|0|||
130876266|NCT00001832|471177453|FG006|Treatment Period|Not treated|0|||
130876267|NCT00001832|471177454|FG007|Treatment Period|Not treated|1|||
130876268|NCT00001832|471177455|FG008|Treatment Period|Not treated|0|||
130876269|NCT00001832|471177456|FG009|Treatment Period|Not treated|0|||
130876270|NCT00001832|471177457|FG010|Treatment Period|Not treated|0|||
130876271|NCT00001832|471177458|FG011|Treatment Period|Not treated|0|||
130876272|NCT00001832|471177459|FG012|Treatment Period|Not treated|0|||
130876273|NCT00001832|471177460|FG013|Treatment Period|Not treated|0|||
130876274|NCT00001832|471177461|FG014|Treatment Period|Not treated|0|||
130876275|NCT02546609|471177462|FG000|Overall Study|Withdrawal by Subject|0|||
130876276|NCT02546609|471177463|FG001|Overall Study|Withdrawal by Subject|1|||
130876277|NCT02546609|471177464|FG002|Overall Study|Withdrawal by Subject|2|||
130876278|NCT02546609|471177462|FG000|Overall Study|Adverse Event|0|||
130876279|NCT02546609|471177463|FG001|Overall Study|Adverse Event|6|||
130876280|NCT02546609|471177464|FG002|Overall Study|Adverse Event|1|||
130876281|NCT02546609|471177462|FG000|Overall Study|Protocol Violation|0|||
130876282|NCT02546609|471177463|FG001|Overall Study|Protocol Violation|1|||
130876283|NCT02546609|471177464|FG002|Overall Study|Protocol Violation|1|||
130876284|NCT02546609|471177462|FG000|Overall Study|Lost to Follow-up|2|||
130764034|NCT02502266|470759954|FG006|Overall Study|Arm 4 Discontinued|0|||
130876285|NCT02546609|471177463|FG001|Overall Study|Lost to Follow-up|3|||
130876286|NCT02546609|471177464|FG002|Overall Study|Lost to Follow-up|1|||
130876287|NCT02546609|471177462|FG000|Overall Study|travel or work schedule restriction|0|||
130876288|NCT02546609|471177463|FG001|Overall Study|travel or work schedule restriction|0|||
130987264|NCT01493960|471580461|FG000|Overall Study|Adverse Event|0|||
130987265|NCT01493960|471580462|FG001|Overall Study|Adverse Event|1|||
130987266|NCT01493960|471580461|FG000|Overall Study|Lack of Efficacy|15|||
130987267|NCT01493960|471580462|FG001|Overall Study|Lack of Efficacy|9|||
130987268|NCT01493960|471580461|FG000|Overall Study|Protocol Violation|3|||
130987269|NCT01493960|471580462|FG001|Overall Study|Protocol Violation|0|||
130987270|NCT01493960|471580461|FG000|Overall Study|Withdrawal by Subject|10|||
130987271|NCT01493960|471580462|FG001|Overall Study|Withdrawal by Subject|4|||
130987272|NCT01493960|471580461|FG000|Overall Study|Non-specified|4|||
130987273|NCT01493960|471580462|FG001|Overall Study|Non-specified|4|||
130987274|NCT01782742|471580463|FG000|Double-blind Treatment Phase|Adverse Event|1|||
130987275|NCT01782742|471580464|FG001|Double-blind Treatment Phase|Adverse Event|0|||
130987276|NCT00803101|471580465|FG000|Overall Study|Death / Serious Adverse Event|4|||
130987277|NCT00803101|471580466|FG001|Overall Study|Death / Serious Adverse Event|6|||
130987278|NCT00803101|471580465|FG000|Overall Study|Withdrawal by Subject|6|||
130987279|NCT00803101|471580466|FG001|Overall Study|Withdrawal by Subject|4|||
130987280|NCT00803101|471580465|FG000|Overall Study|Lost to Follow-up|2|||
130987281|NCT00803101|471580466|FG001|Overall Study|Lost to Follow-up|2|||
130987282|NCT00803101|471580465|FG000|Overall Study|Protocol Violation|1|||
130987283|NCT00803101|471580466|FG001|Overall Study|Protocol Violation|7|||
130987284|NCT00803101|471580465|FG000|Overall Study|Surgery finished outside protocol window|1|||
130987285|NCT00803101|471580466|FG001|Overall Study|Surgery finished outside protocol window|1|||
130987286|NCT00803101|471580465|FG000|Overall Study|Patient died outside SAE report period|1|||
130987287|NCT00803101|471580466|FG001|Overall Study|Patient died outside SAE report period|0|||
130987288|NCT00803101|471580465|FG000|Overall Study|Patient did not attend scheduled visit|2|||
130987289|NCT00803101|471580466|FG001|Overall Study|Patient did not attend scheduled visit|1|||
130987290|NCT00803101|471580465|FG000|Overall Study|Patient did not have surgery|1|||
130987291|NCT00803101|471580466|FG001|Overall Study|Patient did not have surgery|1|||
130987292|NCT02026232|471580469|FG000|Overall Study|incomplete visit/missing data|3|||
130987293|NCT02026232|471580470|FG001|Overall Study|incomplete visit/missing data|2|||
130987294|NCT02790073|471580471|FG000|Overall Study|Death|1|||
130987295|NCT02790073|471580471|FG000|Overall Study|Withdrawal from HD|1|||
130987296|NCT02790073|471580471|FG000|Overall Study|Withdrawal by Subject|1|||
130987297|NCT00185640|471580479|FG000|Overall Study|Not Eligible|4|||
130987298|NCT00185640|471580479|FG000|Overall Study|Withdrawal by Subject|3|||
130987299|NCT00185640|471580479|FG000|Overall Study|Death|138|||
130987300|NCT00058422|471580480|FG000|Overall Study|Not treated|2|||
130987301|NCT02287584|471580481|FG000|the Double-blind Phase|Adverse Event|17|||
130987302|NCT02287584|471580482|FG001|the Double-blind Phase|Adverse Event|17|||
130987303|NCT02287584|471580483|FG002|the Double-blind Phase|Adverse Event|12|||
130987304|NCT02287584|471580484|FG003|the Double-blind Phase|Adverse Event|0|||
130987305|NCT02287584|471580485|FG004|the Double-blind Phase|Adverse Event|0|||
130987306|NCT02287584|471580486|FG005|the Double-blind Phase|Adverse Event|0|||
130987307|NCT02287584|471580481|FG000|the Double-blind Phase|Lack of Efficacy|18|||
130987308|NCT02287584|471580482|FG001|the Double-blind Phase|Lack of Efficacy|8|||
130987309|NCT02287584|471580483|FG002|the Double-blind Phase|Lack of Efficacy|8|||
130987310|NCT02287584|471580484|FG003|the Double-blind Phase|Lack of Efficacy|0|||
130987311|NCT02287584|471580485|FG004|the Double-blind Phase|Lack of Efficacy|0|||
130987312|NCT02287584|471580486|FG005|the Double-blind Phase|Lack of Efficacy|0|||
130987313|NCT02287584|471580481|FG000|the Double-blind Phase|Lost to Follow-up|0|||
130987314|NCT02287584|471580482|FG001|the Double-blind Phase|Lost to Follow-up|1|||
130987315|NCT02287584|471580483|FG002|the Double-blind Phase|Lost to Follow-up|1|||
130987316|NCT02287584|471580484|FG003|the Double-blind Phase|Lost to Follow-up|0|||
130987317|NCT02287584|471580485|FG004|the Double-blind Phase|Lost to Follow-up|0|||
130987318|NCT02287584|471580486|FG005|the Double-blind Phase|Lost to Follow-up|0|||
130987319|NCT02287584|471580481|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
130987320|NCT02287584|471580482|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
130764035|NCT02502266|470759948|FG000|Overall Study|Never treated|0|||
130764036|NCT02502266|470759949|FG001|Overall Study|Never treated|0|||
130987321|NCT02287584|471580483|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
130987322|NCT02287584|471580484|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
130987323|NCT02287584|471580485|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
130987324|NCT02287584|471580486|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
130987325|NCT02287584|471580481|FG000|the Double-blind Phase|Pregnancy|0|||
130987326|NCT02287584|471580482|FG001|the Double-blind Phase|Pregnancy|1|||
130987327|NCT02287584|471580483|FG002|the Double-blind Phase|Pregnancy|0|||
130987328|NCT02287584|471580484|FG003|the Double-blind Phase|Pregnancy|0|||
130987329|NCT02287584|471580485|FG004|the Double-blind Phase|Pregnancy|0|||
130987330|NCT02287584|471580486|FG005|the Double-blind Phase|Pregnancy|0|||
130987331|NCT02287584|471580481|FG000|the Double-blind Phase|Protocol Violation|0|||
130987332|NCT02287584|471580482|FG001|the Double-blind Phase|Protocol Violation|3|||
130987333|NCT02287584|471580483|FG002|the Double-blind Phase|Protocol Violation|0|||
130987334|NCT02287584|471580484|FG003|the Double-blind Phase|Protocol Violation|0|||
130987335|NCT02287584|471580485|FG004|the Double-blind Phase|Protocol Violation|0|||
130987336|NCT02287584|471580486|FG005|the Double-blind Phase|Protocol Violation|0|||
130987337|NCT02287584|471580481|FG000|the Double-blind Phase|other reasons|0|||
130987338|NCT02287584|471580482|FG001|the Double-blind Phase|other reasons|0|||
130987339|NCT02287584|471580483|FG002|the Double-blind Phase|other reasons|1|||
130987340|NCT02287584|471580484|FG003|the Double-blind Phase|other reasons|0|||
130987341|NCT02287584|471580485|FG004|the Double-blind Phase|other reasons|0|||
130987342|NCT02287584|471580486|FG005|the Double-blind Phase|other reasons|0|||
130987343|NCT02287584|471580481|FG000|the Open-label Phase|Did not receive drug|0|||
130987344|NCT02287584|471580482|FG001|the Open-label Phase|Did not receive drug|0|||
130987345|NCT02287584|471580483|FG002|the Open-label Phase|Did not receive drug|0|||
130987346|NCT02287584|471580484|FG003|the Open-label Phase|Did not receive drug|7|||
130987347|NCT02287584|471580485|FG004|the Open-label Phase|Did not receive drug|6|||
130987348|NCT02287584|471580486|FG005|the Open-label Phase|Did not receive drug|4|||
130987349|NCT02287584|471580481|FG000|the Open-label Phase|Adverse Event|0|||
130987350|NCT02287584|471580482|FG001|the Open-label Phase|Adverse Event|0|||
130987351|NCT02287584|471580483|FG002|the Open-label Phase|Adverse Event|0|||
130987352|NCT02287584|471580484|FG003|the Open-label Phase|Adverse Event|15|||
130987353|NCT02287584|471580485|FG004|the Open-label Phase|Adverse Event|12|||
130987354|NCT02287584|471580486|FG005|the Open-label Phase|Adverse Event|16|||
130987355|NCT02287584|471580481|FG000|the Open-label Phase|Lack of Efficacy|0|||
130987356|NCT02287584|471580482|FG001|the Open-label Phase|Lack of Efficacy|0|||
130987357|NCT02287584|471580483|FG002|the Open-label Phase|Lack of Efficacy|0|||
130987358|NCT02287584|471580484|FG003|the Open-label Phase|Lack of Efficacy|8|||
130987359|NCT02287584|471580485|FG004|the Open-label Phase|Lack of Efficacy|3|||
130987360|NCT02287584|471580486|FG005|the Open-label Phase|Lack of Efficacy|7|||
130987361|NCT02287584|471580481|FG000|the Open-label Phase|Lost to Follow-up|0|||
130987362|NCT02287584|471580482|FG001|the Open-label Phase|Lost to Follow-up|0|||
130987363|NCT02287584|471580483|FG002|the Open-label Phase|Lost to Follow-up|0|||
130987364|NCT02287584|471580484|FG003|the Open-label Phase|Lost to Follow-up|4|||
130987365|NCT02287584|471580485|FG004|the Open-label Phase|Lost to Follow-up|1|||
130987366|NCT02287584|471580486|FG005|the Open-label Phase|Lost to Follow-up|2|||
130987367|NCT02287584|471580481|FG000|the Open-label Phase|Withdrawal by Subject|0|||
130987368|NCT02287584|471580482|FG001|the Open-label Phase|Withdrawal by Subject|0|||
130987369|NCT02287584|471580483|FG002|the Open-label Phase|Withdrawal by Subject|0|||
131210500|NCT04524507|472393846|FG000|Overall Study|Death|2|||
131210501|NCT04524507|472393847|FG001|Overall Study|Death|10|||
131210502|NCT00412360|472393848|FG000|Overall Study|Lost to Follow-up|0|||
131210503|NCT00412360|472393849|FG001|Overall Study|Lost to Follow-up|1|||
130987370|NCT02287584|471580484|FG003|the Open-label Phase|Withdrawal by Subject|18|||
130987371|NCT02287584|471580485|FG004|the Open-label Phase|Withdrawal by Subject|29|||
130987372|NCT02287584|471580486|FG005|the Open-label Phase|Withdrawal by Subject|21|||
130987373|NCT02287584|471580481|FG000|the Open-label Phase|non-compliance|0|||
130987374|NCT02287584|471580482|FG001|the Open-label Phase|non-compliance|0|||
130987375|NCT02287584|471580483|FG002|the Open-label Phase|non-compliance|0|||
130987376|NCT02287584|471580484|FG003|the Open-label Phase|non-compliance|2|||
130987377|NCT02287584|471580485|FG004|the Open-label Phase|non-compliance|5|||
130987378|NCT02287584|471580486|FG005|the Open-label Phase|non-compliance|1|||
130987379|NCT02287584|471580481|FG000|the Open-label Phase|other reasons|0|||
130987380|NCT02287584|471580482|FG001|the Open-label Phase|other reasons|0|||
130987381|NCT02287584|471580483|FG002|the Open-label Phase|other reasons|0|||
130987382|NCT02287584|471580484|FG003|the Open-label Phase|other reasons|3|||
130987383|NCT02287584|471580485|FG004|the Open-label Phase|other reasons|6|||
130987384|NCT02287584|471580486|FG005|the Open-label Phase|other reasons|6|||
130987385|NCT03430063|471580490|FG000|Overall Study|Adverse Event|0|||
130987386|NCT03430063|471580491|FG001|Overall Study|Adverse Event|1|||
130987387|NCT03430063|471580492|FG002|Overall Study|Adverse Event|0|||
130987388|NCT03430063|471580490|FG000|Overall Study|Death|3|||
130987389|NCT03430063|471580491|FG001|Overall Study|Death|2|||
130987390|NCT03430063|471580492|FG002|Overall Study|Death|3|||
130987391|NCT03430063|471580490|FG000|Overall Study|Lost to Follow-up|0|||
130987392|NCT03430063|471580491|FG001|Overall Study|Lost to Follow-up|1|||
130987393|NCT03430063|471580492|FG002|Overall Study|Lost to Follow-up|0|||
130987394|NCT03430063|471580490|FG000|Overall Study|Withdrawal by Subject|0|||
130987395|NCT03430063|471580491|FG001|Overall Study|Withdrawal by Subject|0|||
130987396|NCT03430063|471580492|FG002|Overall Study|Withdrawal by Subject|1|||
130987397|NCT03430063|471580490|FG000|Overall Study|Withdrawal of consent|3|||
130987398|NCT03430063|471580491|FG001|Overall Study|Withdrawal of consent|1|||
130987399|NCT03430063|471580492|FG002|Overall Study|Withdrawal of consent|2|||
130987400|NCT03430063|471580490|FG000|Overall Study|Progressive disease|1|||
130987401|NCT03430063|471580491|FG001|Overall Study|Progressive disease|2|||
130987402|NCT03430063|471580492|FG002|Overall Study|Progressive disease|1|||
130987403|NCT03430063|471580490|FG000|Overall Study|Other un-specified|1|||
131210504|NCT00412360|472393848|FG000|Overall Study|Not Transplanted|1|||
130987404|NCT03430063|471580491|FG001|Overall Study|Other un-specified|1|||
130987405|NCT03430063|471580492|FG002|Overall Study|Other un-specified|0|||
130987406|NCT03430063|471580490|FG000|Overall Study|Randomized, but never treated|0|||
130987407|NCT03430063|471580491|FG001|Overall Study|Randomized, but never treated|0|||
130987408|NCT03430063|471580492|FG002|Overall Study|Randomized, but never treated|1|||
130987409|NCT01782872|471580494|FG000|Overall Study|Protocol Violation|0|||
130987410|NCT01782872|471580495|FG001|Overall Study|Protocol Violation|0|||
130987411|NCT01782872|471580496|FG002|Overall Study|Protocol Violation|0|||
130987412|NCT01782872|471580497|FG003|Overall Study|Protocol Violation|1|||
130987413|NCT01782872|471580494|FG000|Overall Study|Withdrawal by Subject|0|||
130987414|NCT01782872|471580495|FG001|Overall Study|Withdrawal by Subject|1|||
130987415|NCT01782872|471580496|FG002|Overall Study|Withdrawal by Subject|0|||
130987416|NCT01782872|471580497|FG003|Overall Study|Withdrawal by Subject|0|||
130987417|NCT04026165|471580501|FG000|Run-in Placebo Period|Enrollment Error|13|||
130987418|NCT04026165|471580502|FG001|Run-in Placebo Period|Enrollment Error|0|||
130987419|NCT04026165|471580503|FG002|Run-in Placebo Period|Enrollment Error|0|||
130987420|NCT04026165|471580504|FG003|Run-in Placebo Period|Enrollment Error|0|||
130987421|NCT04026165|471580501|FG000|Run-in Placebo Period|Run-in Failure|4|||
130987422|NCT04026165|471580502|FG001|Run-in Placebo Period|Run-in Failure|0|||
130987423|NCT04026165|471580503|FG002|Run-in Placebo Period|Run-in Failure|0|||
130987424|NCT04026165|471580504|FG003|Run-in Placebo Period|Run-in Failure|0|||
130987425|NCT04026165|471580501|FG000|Run-in Placebo Period|Protocol Violation|2|||
130987426|NCT04026165|471580502|FG001|Run-in Placebo Period|Protocol Violation|0|||
130987427|NCT04026165|471580503|FG002|Run-in Placebo Period|Protocol Violation|0|||
130987428|NCT04026165|471580504|FG003|Run-in Placebo Period|Protocol Violation|0|||
130987429|NCT04026165|471580501|FG000|Run-in Placebo Period|Withdrew Consent|2|||
130987430|NCT04026165|471580502|FG001|Run-in Placebo Period|Withdrew Consent|0|||
130987431|NCT04026165|471580503|FG002|Run-in Placebo Period|Withdrew Consent|0|||
130987432|NCT04026165|471580504|FG003|Run-in Placebo Period|Withdrew Consent|0|||
130987433|NCT04026165|471580501|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
130987434|NCT04026165|471580502|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
130987435|NCT04026165|471580503|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
130987436|NCT04026165|471580504|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
130987437|NCT04026165|471580501|FG000|Run-in SEL Period|Run-in Failure|0|||
130987438|NCT04026165|471580502|FG001|Run-in SEL Period|Run-in Failure|26|||
130987439|NCT04026165|471580503|FG002|Run-in SEL Period|Run-in Failure|0|||
130987440|NCT04026165|471580504|FG003|Run-in SEL Period|Run-in Failure|0|||
130987441|NCT04026165|471580501|FG000|Run-in SEL Period|Withdrew Consent|0|||
130987442|NCT04026165|471580502|FG001|Run-in SEL Period|Withdrew Consent|10|||
130987443|NCT04026165|471580503|FG002|Run-in SEL Period|Withdrew Consent|0|||
130987444|NCT04026165|471580504|FG003|Run-in SEL Period|Withdrew Consent|0|||
130987445|NCT04026165|471580501|FG000|Run-in SEL Period|Enrollment Error|0|||
130987446|NCT04026165|471580502|FG001|Run-in SEL Period|Enrollment Error|4|||
130987447|NCT04026165|471580503|FG002|Run-in SEL Period|Enrollment Error|0|||
130987448|NCT04026165|471580504|FG003|Run-in SEL Period|Enrollment Error|0|||
130987449|NCT04026165|471580501|FG000|Run-in SEL Period|Protocol Violation|0|||
130987450|NCT04026165|471580502|FG001|Run-in SEL Period|Protocol Violation|3|||
130987451|NCT04026165|471580503|FG002|Run-in SEL Period|Protocol Violation|0|||
130987452|NCT04026165|471580504|FG003|Run-in SEL Period|Protocol Violation|0|||
130987453|NCT04026165|471580501|FG000|Run-in SEL Period|Investigator's Discretion|0|||
130987454|NCT04026165|471580502|FG001|Run-in SEL Period|Investigator's Discretion|2|||
130987455|NCT04026165|471580503|FG002|Run-in SEL Period|Investigator's Discretion|0|||
130987456|NCT04026165|471580504|FG003|Run-in SEL Period|Investigator's Discretion|0|||
130987457|NCT04026165|471580501|FG000|Run-in SEL Period|Death|0|||
130987458|NCT04026165|471580502|FG001|Run-in SEL Period|Death|1|||
130987459|NCT04026165|471580503|FG002|Run-in SEL Period|Death|0|||
130987460|NCT04026165|471580504|FG003|Run-in SEL Period|Death|0|||
130987461|NCT04026165|471580501|FG000|Randomized Period|Withdrew Consent|0|||
130987462|NCT04026165|471580502|FG001|Randomized Period|Withdrew Consent|0|||
130987463|NCT04026165|471580503|FG002|Randomized Period|Withdrew Consent|5|||
130987464|NCT04026165|471580504|FG003|Randomized Period|Withdrew Consent|8|||
130987465|NCT04026165|471580501|FG000|Randomized Period|Death|0|||
130987466|NCT04026165|471580502|FG001|Randomized Period|Death|0|||
130987467|NCT04026165|471580503|FG002|Randomized Period|Death|5|||
130987468|NCT04026165|471580504|FG003|Randomized Period|Death|7|||
130987469|NCT04026165|471580501|FG000|Randomized Period|Investigator's Discretion|0|||
130987470|NCT04026165|471580502|FG001|Randomized Period|Investigator's Discretion|0|||
130987471|NCT04026165|471580503|FG002|Randomized Period|Investigator's Discretion|2|||
130987472|NCT04026165|471580504|FG003|Randomized Period|Investigator's Discretion|2|||
130987473|NCT04026165|471580501|FG000|Randomized Period|Lost to Follow-up|0|||
130987474|NCT04026165|471580502|FG001|Randomized Period|Lost to Follow-up|0|||
130987475|NCT04026165|471580503|FG002|Randomized Period|Lost to Follow-up|2|||
130987476|NCT04026165|471580504|FG003|Randomized Period|Lost to Follow-up|2|||
130987477|NCT00441701|471580505|FG000|Overall Study|Adverse Event|3|||
130987478|NCT00441701|471580506|FG001|Overall Study|Adverse Event|2|||
130987479|NCT00441701|471580507|FG002|Overall Study|Adverse Event|1|||
130764037|NCT02502266|470759950|FG002|Overall Study|Never treated|0|||
130987480|NCT00441701|471580508|FG003|Overall Study|Adverse Event|0|||
130987481|NCT00441701|471580509|FG004|Overall Study|Adverse Event|2|||
130987482|NCT00441701|471580510|FG005|Overall Study|Adverse Event|2|||
130987483|NCT00441701|471580511|FG006|Overall Study|Adverse Event|0|||
130987484|NCT00441701|471580512|FG007|Overall Study|Adverse Event|0|||
130987485|NCT00441701|471580513|FG008|Overall Study|Adverse Event|0|||
130987486|NCT00441701|471580514|FG009|Overall Study|Adverse Event|0|||
130987487|NCT00441701|471580505|FG000|Overall Study|Lack of Efficacy|2|||
130987488|NCT00441701|471580506|FG001|Overall Study|Lack of Efficacy|0|||
130987489|NCT00441701|471580507|FG002|Overall Study|Lack of Efficacy|2|||
130987490|NCT00441701|471580508|FG003|Overall Study|Lack of Efficacy|2|||
130987491|NCT00441701|471580509|FG004|Overall Study|Lack of Efficacy|0|||
130987492|NCT00441701|471580510|FG005|Overall Study|Lack of Efficacy|1|||
130987493|NCT00441701|471580511|FG006|Overall Study|Lack of Efficacy|0|||
130987494|NCT00441701|471580512|FG007|Overall Study|Lack of Efficacy|0|||
130987495|NCT00441701|471580513|FG008|Overall Study|Lack of Efficacy|0|||
130987496|NCT00441701|471580514|FG009|Overall Study|Lack of Efficacy|0|||
130987497|NCT00441701|471580505|FG000|Overall Study|Withdrawal by Subject|0|||
130987498|NCT00441701|471580506|FG001|Overall Study|Withdrawal by Subject|2|||
130764038|NCT02502266|470759951|FG003|Overall Study|Never treated|0|||
130764039|NCT02502266|470759952|FG004|Overall Study|Never treated|0|||
130764040|NCT02502266|470759953|FG005|Overall Study|Never treated|1|||
130764041|NCT02502266|470759954|FG006|Overall Study|Never treated|0|||
130764042|NCT03605849|470759955|FG000|Overall Study|Adverse Event|20|||
130764043|NCT03605849|470759956|FG001|Overall Study|Adverse Event|21|||
130764044|NCT03605849|470759957|FG002|Overall Study|Adverse Event|29|||
130764045|NCT03605849|470759958|FG003|Overall Study|Adverse Event|11|||
130876289|NCT02546609|471177464|FG002|Overall Study|travel or work schedule restriction|2|||
130876290|NCT00914849|471177465|FG000|Overall Study|Withdrawal by Subject|1|||
130876291|NCT00914849|471177466|FG001|Overall Study|Withdrawal by Subject|0|||
130876292|NCT00914849|471177465|FG000|Overall Study|Not eligible|0|||
130876293|NCT00914849|471177466|FG001|Overall Study|Not eligible|1|||
130876294|NCT05106959|471177467|FG000|Overall Study|Lost to Follow-up|1|||
130764046|NCT03605849|470759955|FG000|Overall Study|Lack of Efficacy|4|||
130764047|NCT03605849|470759956|FG001|Overall Study|Lack of Efficacy|7|||
130764048|NCT03605849|470759957|FG002|Overall Study|Lack of Efficacy|9|||
130764049|NCT03605849|470759958|FG003|Overall Study|Lack of Efficacy|2|||
130764050|NCT03605849|470759955|FG000|Overall Study|Lost to Follow-up|8|||
130764051|NCT03605849|470759956|FG001|Overall Study|Lost to Follow-up|8|||
130764052|NCT03605849|470759957|FG002|Overall Study|Lost to Follow-up|14|||
130764053|NCT03605849|470759958|FG003|Overall Study|Lost to Follow-up|11|||
130764054|NCT03605849|470759955|FG000|Overall Study|Non-compliance With IMP|6|||
130764055|NCT03605849|470759956|FG001|Overall Study|Non-compliance With IMP|5|||
130764056|NCT03605849|470759957|FG002|Overall Study|Non-compliance With IMP|2|||
130764057|NCT03605849|470759958|FG003|Overall Study|Non-compliance With IMP|1|||
130764058|NCT03605849|470759955|FG000|Overall Study|Protocol Deviation|1|||
130764059|NCT03605849|470759956|FG001|Overall Study|Protocol Deviation|2|||
130764060|NCT03605849|470759957|FG002|Overall Study|Protocol Deviation|1|||
130764061|NCT03605849|470759958|FG003|Overall Study|Protocol Deviation|3|||
130764062|NCT03605849|470759955|FG000|Overall Study|Withdrawal by Subject|33|||
130764063|NCT03605849|470759956|FG001|Overall Study|Withdrawal by Subject|28|||
130876295|NCT01292486|471177468|FG000|Overall Study|Protocol Violation|2|||
130876296|NCT01292486|471177468|FG000|Overall Study|Did not meet screening criteria|2|||
130876297|NCT01292486|471177468|FG000|Overall Study|Adverse Event|1|||
130876298|NCT01292486|471177468|FG000|Overall Study|Physician Decision|1|||
130876299|NCT04913610|471177471|FG000|Randomized Participants|Did Not Receive Treatment|0|||
130876300|NCT04913610|471177472|FG001|Randomized Participants|Did Not Receive Treatment|0|||
130876301|NCT04913610|471177473|FG002|Randomized Participants|Did Not Receive Treatment|1|||
130876302|NCT04913610|471177474|FG003|Randomized Participants|Did Not Receive Treatment|1|||
130876303|NCT04913610|471177475|FG004|Randomized Participants|Did Not Receive Treatment|0|||
130876304|NCT04913610|471177471|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
130876305|NCT04913610|471177472|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
130876306|NCT04913610|471177473|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
130764064|NCT03605849|470759957|FG002|Overall Study|Withdrawal by Subject|30|||
130764065|NCT03605849|470759958|FG003|Overall Study|Withdrawal by Subject|28|||
130764066|NCT03605849|470759955|FG000|Overall Study|Site Terminated by Sponsor|0|||
130764067|NCT03605849|470759956|FG001|Overall Study|Site Terminated by Sponsor|0|||
130764068|NCT03605849|470759957|FG002|Overall Study|Site Terminated by Sponsor|0|||
130764069|NCT03605849|470759958|FG003|Overall Study|Site Terminated by Sponsor|1|||
130764070|NCT03605849|470759955|FG000|Overall Study|Physician Decision|2|||
130764071|NCT03605849|470759956|FG001|Overall Study|Physician Decision|1|||
130764072|NCT03605849|470759957|FG002|Overall Study|Physician Decision|2|||
130876307|NCT04913610|471177474|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
130876308|NCT04913610|471177475|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
130876309|NCT00659061|471177476|FG000|Overall Study|Migration due to political unrest|21|||
130987499|NCT00441701|471580507|FG002|Overall Study|Withdrawal by Subject|1|||
130987500|NCT00441701|471580508|FG003|Overall Study|Withdrawal by Subject|1|||
130987501|NCT00441701|471580509|FG004|Overall Study|Withdrawal by Subject|0|||
130987502|NCT00441701|471580510|FG005|Overall Study|Withdrawal by Subject|0|||
130987503|NCT00441701|471580511|FG006|Overall Study|Withdrawal by Subject|0|||
130987504|NCT00441701|471580512|FG007|Overall Study|Withdrawal by Subject|0|||
130987505|NCT00441701|471580513|FG008|Overall Study|Withdrawal by Subject|0|||
130987506|NCT00441701|471580514|FG009|Overall Study|Withdrawal by Subject|0|||
130987507|NCT00077064|471580515|FG000|Overall Study|Adverse Event|0|||
130987508|NCT00077064|471580516|FG001|Overall Study|Adverse Event|4|||
130987509|NCT00077064|471580515|FG000|Overall Study|Patient refusal|0|||
130987510|NCT00077064|471580516|FG001|Overall Study|Patient refusal|2|||
130987511|NCT04710927|471580517|FG000|Overall Study|Lost to Follow-up|7|||
130987512|NCT04710927|471580518|FG001|Overall Study|Lost to Follow-up|6|||
130987513|NCT04710927|471580519|FG002|Overall Study|Lost to Follow-up|5|||
130987514|NCT00621543|471580520|FG000|Overall Study|Lost to Follow-up|23|||
130987515|NCT02007434|471580523|FG000|Overall Study|Lost to Follow-up|0|||
130987516|NCT02007434|471580524|FG001|Overall Study|Lost to Follow-up|1|||
130987517|NCT02007434|471580525|FG002|Overall Study|Lost to Follow-up|0|||
130987518|NCT02007434|471580526|FG003|Overall Study|Lost to Follow-up|0|||
130987519|NCT02007434|471580527|FG004|Overall Study|Lost to Follow-up|0|||
130987520|NCT02007434|471580528|FG005|Overall Study|Lost to Follow-up|0|||
130987521|NCT02007434|471580529|FG006|Overall Study|Lost to Follow-up|0|||
130987522|NCT02007434|471580530|FG007|Overall Study|Lost to Follow-up|0|||
130987523|NCT02007434|471580523|FG000|Overall Study|Non-compliance|1|||
130987524|NCT02007434|471580524|FG001|Overall Study|Non-compliance|0|||
130987525|NCT02007434|471580525|FG002|Overall Study|Non-compliance|1|||
130987526|NCT02007434|471580526|FG003|Overall Study|Non-compliance|0|||
130987527|NCT02007434|471580527|FG004|Overall Study|Non-compliance|0|||
130987528|NCT02007434|471580528|FG005|Overall Study|Non-compliance|0|||
130987529|NCT02007434|471580529|FG006|Overall Study|Non-compliance|0|||
130987530|NCT02007434|471580530|FG007|Overall Study|Non-compliance|0|||
130987531|NCT01287611|471580531|FG000|Overall Study|Lost to Follow-up|29|||
130987532|NCT01287611|471580532|FG001|Overall Study|Lost to Follow-up|16|||
130987533|NCT01287611|471580531|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
130987534|NCT01287611|471580532|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
130987535|NCT02192970|471580533|FG000|Overall Study|Lost to Follow-up|6|||
130987536|NCT02192970|471580534|FG001|Overall Study|Lost to Follow-up|0|||
130987537|NCT04074590|471580537|FG000|Overall Study|Adverse Event|1|||
130987538|NCT04074590|471580538|FG001|Overall Study|Adverse Event|0|||
130987539|NCT04074590|471580537|FG000|Overall Study|Physician Decision|1|||
130987540|NCT04074590|471580538|FG001|Overall Study|Physician Decision|0|||
130987541|NCT04074590|471580537|FG000|Overall Study|Withdrawal by Subject|2|||
130987542|NCT04074590|471580538|FG001|Overall Study|Withdrawal by Subject|0|||
130987543|NCT03299686|471580549|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
130987544|NCT03299686|471580550|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
130987545|NCT03299686|471580549|FG000|Treatment Epoch|Physician Decision|1|||
130987546|NCT03299686|471580550|FG001|Treatment Epoch|Physician Decision|0|||
130987547|NCT03299686|471580549|FG000|Treatment Epoch|Adverse Event|8|||
130987548|NCT03299686|471580550|FG001|Treatment Epoch|Adverse Event|4|||
130987549|NCT03299686|471580549|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
130987550|NCT03299686|471580550|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
130987551|NCT03745222|471580551|FG000|Overall Study|Withdrawal by Subject|0|||
130987552|NCT03745222|471580552|FG001|Overall Study|Withdrawal by Subject|1|||
130987553|NCT03745222|471580553|FG002|Overall Study|Withdrawal by Subject|0|||
130987554|NCT02709005|471580554|FG000|Overall Study|Lost to Follow-up|1|||
130987555|NCT02709005|471580555|FG001|Overall Study|Lost to Follow-up|1|||
130987556|NCT02709005|471580554|FG000|Overall Study|Withdrawal by Subject|3|||
130987557|NCT02709005|471580555|FG001|Overall Study|Withdrawal by Subject|0|||
130987558|NCT00691132|471580557|FG000|Overall Study|Adverse Event|2|||
130987559|NCT00691132|471580558|FG001|Overall Study|Adverse Event|3|||
130987560|NCT00691132|471580557|FG000|Overall Study|Withdrawal by Subject|10|||
130987561|NCT00691132|471580558|FG001|Overall Study|Withdrawal by Subject|10|||
130987562|NCT01959347|471580559|FG000|Overall Study|Protocol Violation|9|||
130987563|NCT01959347|471580560|FG001|Overall Study|Protocol Violation|7|||
130987564|NCT03954743|471580561|FG000|Overall Study|Adverse Event|1|||
131210505|NCT00412360|472393849|FG001|Overall Study|Not Transplanted|2|||
130987565|NCT03954743|471580562|FG001|Overall Study|Adverse Event|0|||
130987566|NCT03954743|471580561|FG000|Overall Study|Lost to Follow-up|6|||
130987567|NCT03954743|471580562|FG001|Overall Study|Lost to Follow-up|4|||
130987568|NCT03954743|471580561|FG000|Overall Study|Protocol Violation|1|||
130987569|NCT03954743|471580562|FG001|Overall Study|Protocol Violation|0|||
130987570|NCT03954743|471580561|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
130987571|NCT03954743|471580562|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
130987572|NCT03954743|471580561|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
130987573|NCT03954743|471580562|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130987574|NCT01282801|471580565|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
131210506|NCT02711306|472393850|FG000|Overall Study|Withdrawal by Subject|2|||
130987575|NCT01282801|471580566|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
130987576|NCT02387996|471580569|FG000|Overall Study|Disease Progression|167|||
130987577|NCT02387996|471580569|FG000|Overall Study|Study Drug Toxicity|31|||
130987578|NCT02387996|471580569|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
130987579|NCT02387996|471580569|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
130987580|NCT02387996|471580569|FG000|Overall Study|Subject Withdrew Consent|5|||
130987581|NCT02387996|471580569|FG000|Overall Study|Lost to Follow-up|1|||
130987582|NCT02387996|471580569|FG000|Overall Study|Poor/Non-Compliance|1|||
130987583|NCT02387996|471580569|FG000|Overall Study|Other Reasons|5|||
130987584|NCT02387996|471580569|FG000|Overall Study|Death|1|||
130987585|NCT01060553|471580570|FG000|Overall Study|Lost to Follow-up|3|||
130987586|NCT01060553|471580571|FG001|Overall Study|Lost to Follow-up|5|||
130987587|NCT01060553|471580570|FG000|Overall Study|Withdrawal by Subject|5|||
130987588|NCT01060553|471580571|FG001|Overall Study|Withdrawal by Subject|5|||
130987589|NCT01060553|471580570|FG000|Overall Study|Lack of Efficacy|1|||
130987590|NCT01060553|471580571|FG001|Overall Study|Lack of Efficacy|0|||
130987591|NCT04707196|471580574|FG000|Overall Study|Withdrawal by Subject|9|||
130987592|NCT04707196|471580575|FG001|Overall Study|Withdrawal by Subject|6|||
130987593|NCT04707196|471580574|FG000|Overall Study|Lost to Follow-up|1|||
130987594|NCT04707196|471580575|FG001|Overall Study|Lost to Follow-up|0|||
130987595|NCT04707196|471580574|FG000|Overall Study|Protocol Violation|4|||
130987596|NCT04707196|471580575|FG001|Overall Study|Protocol Violation|1|||
130987597|NCT04707196|471580574|FG000|Overall Study|Adverse Event|2|||
130987598|NCT04707196|471580575|FG001|Overall Study|Adverse Event|2|||
130987599|NCT04707196|471580574|FG000|Overall Study|Death|3|||
130987600|NCT04707196|471580575|FG001|Overall Study|Death|1|||
130987601|NCT04707196|471580574|FG000|Overall Study|Non-compliance with study drug|1|||
130987602|NCT04707196|471580575|FG001|Overall Study|Non-compliance with study drug|0|||
130987603|NCT04707196|471580574|FG000|Overall Study|Progressive disease|9|||
130987604|NCT04707196|471580575|FG001|Overall Study|Progressive disease|10|||
130987605|NCT01862796|471580576|FG000|Overall Study|Prohibited medications|0|||
130987606|NCT01862796|471580577|FG001|Overall Study|Prohibited medications|0|||
130987607|NCT01862796|471580578|FG002|Overall Study|Prohibited medications|1|||
130987608|NCT05375955|471580586|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
130987609|NCT05375955|471580587|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
130987610|NCT05375955|471580588|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
130987611|NCT05375955|471580589|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
130987612|NCT05375955|471580590|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
130987613|NCT05375955|471580591|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
130987614|NCT05375955|471580592|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
130987615|NCT05375955|471580586|FG000|Treatment (12 Weeks)|Physician Decision|4|||
130987616|NCT05375955|471580587|FG001|Treatment (12 Weeks)|Physician Decision|1|||
130987617|NCT05375955|471580588|FG002|Treatment (12 Weeks)|Physician Decision|3|||
130987618|NCT05375955|471580589|FG003|Treatment (12 Weeks)|Physician Decision|0|||
130987619|NCT05375955|471580590|FG004|Treatment (12 Weeks)|Physician Decision|0|||
130987620|NCT05375955|471580591|FG005|Treatment (12 Weeks)|Physician Decision|1|||
130987621|NCT05375955|471580592|FG006|Treatment (12 Weeks)|Physician Decision|0|||
130987622|NCT05375955|471580586|FG000|Treatment (12 Weeks)|Other|0|||
130987623|NCT05375955|471580587|FG001|Treatment (12 Weeks)|Other|1|||
130987624|NCT05375955|471580588|FG002|Treatment (12 Weeks)|Other|0|||
130987625|NCT05375955|471580589|FG003|Treatment (12 Weeks)|Other|0|||
130987626|NCT05375955|471580590|FG004|Treatment (12 Weeks)|Other|0|||
130987627|NCT05375955|471580591|FG005|Treatment (12 Weeks)|Other|0|||
130987628|NCT05375955|471580592|FG006|Treatment (12 Weeks)|Other|0|||
130987629|NCT05375955|471580586|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130987630|NCT05375955|471580587|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130987631|NCT05375955|471580588|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130987632|NCT05375955|471580589|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130987633|NCT05375955|471580590|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130987634|NCT05375955|471580591|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
130987635|NCT05375955|471580592|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
130987636|NCT05375955|471580586|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
130987637|NCT05375955|471580587|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
130987638|NCT05375955|471580588|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
130987639|NCT05375955|471580589|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
130987640|NCT05375955|471580590|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
130987641|NCT05375955|471580591|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
130987642|NCT05375955|471580592|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
130987643|NCT05375955|471580586|FG000|Treatment (12 Weeks)|Pregnancy|0|||
130987644|NCT05375955|471580587|FG001|Treatment (12 Weeks)|Pregnancy|0|||
130987645|NCT05375955|471580588|FG002|Treatment (12 Weeks)|Pregnancy|1|||
130987646|NCT05375955|471580589|FG003|Treatment (12 Weeks)|Pregnancy|0|||
130987647|NCT05375955|471580590|FG004|Treatment (12 Weeks)|Pregnancy|0|||
130987648|NCT05375955|471580591|FG005|Treatment (12 Weeks)|Pregnancy|0|||
130987649|NCT05375955|471580592|FG006|Treatment (12 Weeks)|Pregnancy|0|||
130987650|NCT05375955|471580586|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130987651|NCT05375955|471580587|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130987652|NCT05375955|471580588|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
130987653|NCT05375955|471580589|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130987654|NCT05375955|471580590|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130987655|NCT05375955|471580591|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130987656|NCT05375955|471580592|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130987657|NCT05375955|471580586|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
130987658|NCT05375955|471580587|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
130987659|NCT05375955|471580588|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
130987660|NCT05375955|471580589|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
130987661|NCT05375955|471580590|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
130987662|NCT05375955|471580591|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
130987663|NCT05375955|471580592|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
130987664|NCT05375955|471580586|FG000|Follow-up (up to 5 Weeks)|Other|0|||
130987665|NCT05375955|471580587|FG001|Follow-up (up to 5 Weeks)|Other|1|||
130987666|NCT05375955|471580588|FG002|Follow-up (up to 5 Weeks)|Other|0|||
130987667|NCT05375955|471580589|FG003|Follow-up (up to 5 Weeks)|Other|0|||
130987668|NCT05375955|471580590|FG004|Follow-up (up to 5 Weeks)|Other|0|||
130987669|NCT05375955|471580591|FG005|Follow-up (up to 5 Weeks)|Other|0|||
130987670|NCT05375955|471580592|FG006|Follow-up (up to 5 Weeks)|Other|0|||
130987671|NCT05375955|471580586|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
130987672|NCT05375955|471580587|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130987673|NCT05375955|471580588|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
130987674|NCT05375955|471580589|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130987675|NCT05375955|471580590|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130876310|NCT00659061|471177477|FG001|Overall Study|Migration due to political unrest|15|||
130876311|NCT01277744|471177480|FG000|Overall Study|Physician Decision|2|||
130876312|NCT01650558|471177483|FG000|Overall Study|Migration out of study area|61|||
130876313|NCT01650558|471177484|FG001|Overall Study|Migration out of study area|71|||
130876314|NCT01650558|471177485|FG002|Overall Study|Migration out of study area|56|||
130876315|NCT01650558|471177483|FG000|Overall Study|Lost to Follow-up|10|||
130876316|NCT01650558|471177484|FG001|Overall Study|Lost to Follow-up|13|||
130876317|NCT01650558|471177485|FG002|Overall Study|Lost to Follow-up|6|||
130876318|NCT01650558|471177483|FG000|Overall Study|Death|10|||
130876319|NCT01650558|471177484|FG001|Overall Study|Death|6|||
130876320|NCT01650558|471177485|FG002|Overall Study|Death|8|||
130876321|NCT01650558|471177483|FG000|Overall Study|Withdrawal by Subject|1|||
130876322|NCT01650558|471177484|FG001|Overall Study|Withdrawal by Subject|1|||
130876323|NCT01650558|471177485|FG002|Overall Study|Withdrawal by Subject|3|||
130876324|NCT01650558|471177483|FG000|Overall Study|Non-compliant participant|1|||
130876325|NCT01650558|471177484|FG001|Overall Study|Non-compliant participant|0|||
130876326|NCT01650558|471177485|FG002|Overall Study|Non-compliant participant|2|||
130876327|NCT01650558|471177483|FG000|Overall Study|Physician Decision|0|||
130876328|NCT01650558|471177484|FG001|Overall Study|Physician Decision|1|||
130876329|NCT01650558|471177485|FG002|Overall Study|Physician Decision|0|||
130876330|NCT01069484|471177489|FG000|Overall Study|Death-in-near-family|1|||
130987676|NCT05375955|471580591|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130987677|NCT05375955|471580592|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130987678|NCT05375955|471580586|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
130987679|NCT05375955|471580587|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
130987680|NCT05375955|471580588|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
130987681|NCT05375955|471580589|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
130987682|NCT05375955|471580590|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
130987683|NCT05375955|471580591|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
130987684|NCT05375955|471580592|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
130987685|NCT00728962|471580598|FG000|Implant Placement Surgery|Adverse Event|8|||
130987686|NCT00728962|471580598|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
130987687|NCT00728962|471580598|FG000|Implant Placement Surgery|Protocol Violation|1|||
130987688|NCT00728962|471580598|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
130987689|NCT00728962|471580598|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
130987690|NCT04954586|471580599|FG000|Overall Study|Withdrawal by Subject|5|||
130987691|NCT02063828|471580600|FG000|Overall Study|Withdrawal by Subject|4|||
131210507|NCT02711306|472393851|FG001|Overall Study|Withdrawal by Subject|2|||
131210508|NCT01383317|472393852|FG000|Overall Study|Lost to Follow-up|2|||
130876331|NCT01069484|471177490|FG001|Overall Study|Death-in-near-family|0|||
130876332|NCT01069484|471177489|FG000|Overall Study|No specific reason|8|||
130876333|NCT01069484|471177490|FG001|Overall Study|No specific reason|2|||
130987692|NCT02063828|471580601|FG001|Overall Study|Withdrawal by Subject|6|||
130987693|NCT02063828|471580602|FG002|Overall Study|Withdrawal by Subject|3|||
130987694|NCT02063828|471580600|FG000|Overall Study|Death|0|||
131210509|NCT01383317|472393853|FG001|Overall Study|Lost to Follow-up|1|||
130876334|NCT01069484|471177489|FG000|Overall Study|Illness mother or child|3|||
130987695|NCT02063828|471580601|FG001|Overall Study|Death|0|||
130987696|NCT02063828|471580602|FG002|Overall Study|Death|1|||
130987697|NCT01313286|471580607|FG000|Period 1|Withdrawal by Subject|2|||
130987698|NCT01313286|471580608|FG001|Period 1|Withdrawal by Subject|0|||
130987699|NCT00654901|471580609|FG000|Overall Study|Lost to Follow-up|1|||
130987700|NCT00654901|471580610|FG001|Overall Study|Lost to Follow-up|0|||
130987701|NCT00654901|471580611|FG002|Overall Study|Lost to Follow-up|1|||
130987702|NCT00654901|471580612|FG003|Overall Study|Lost to Follow-up|0|||
130987703|NCT00654901|471580609|FG000|Overall Study|Withdrawal by Subject|3|||
130987704|NCT00654901|471580610|FG001|Overall Study|Withdrawal by Subject|0|||
130987705|NCT00654901|471580611|FG002|Overall Study|Withdrawal by Subject|1|||
130987706|NCT00654901|471580612|FG003|Overall Study|Withdrawal by Subject|0|||
130987707|NCT02332590|471580616|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
130987708|NCT02332590|471580617|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
130987709|NCT02332590|471580616|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
131210510|NCT01383317|472393852|FG000|Overall Study|Death|1|||
131210511|NCT01383317|472393853|FG001|Overall Study|Death|0|||
131210512|NCT01383317|472393852|FG000|Overall Study|Adverse Event|0|||
131210513|NCT01383317|472393853|FG001|Overall Study|Adverse Event|1|||
131210514|NCT02569996|472393854|FG000|Overall Study|Adverse Event|6|||
131210515|NCT02569996|472393854|FG000|Overall Study|Physician Decision|3|||
131210516|NCT02569996|472393854|FG000|Overall Study|Progression of the disease|18|||
131210517|NCT02569996|472393854|FG000|Overall Study|New anti-lymphoma treatment|1|||
131210518|NCT02569996|472393854|FG000|Overall Study|Non-compliance|9|||
131210519|NCT02569996|472393854|FG000|Overall Study|Withdrawal by Subject|5|||
131210520|NCT02569996|472393854|FG000|Overall Study|Lost to Follow-up|5|||
131210521|NCT02569996|472393854|FG000|Overall Study|Complete remission|7|||
131210522|NCT02569996|472393854|FG000|Overall Study|Unknown reason|1|||
131210523|NCT01397409|472393856|FG000|Stage 2|Adverse Event|0|||
131210524|NCT01397409|472393857|FG001|Stage 2|Adverse Event|0|||
131210525|NCT01397409|472393858|FG002|Stage 2|Adverse Event|0|||
131210526|NCT01397409|472393859|FG003|Stage 2|Adverse Event|0|||
131210527|NCT01397409|472393860|FG004|Stage 2|Adverse Event|6|||
131210528|NCT01397409|472393861|FG005|Stage 2|Adverse Event|3|||
131210529|NCT01397409|472393862|FG006|Stage 2|Adverse Event|0|||
131210530|NCT01397409|472393863|FG007|Stage 2|Adverse Event|0|||
131210531|NCT01397409|472393864|FG008|Stage 2|Adverse Event|0|||
131210532|NCT01397409|472393865|FG009|Stage 2|Adverse Event|0|||
131210533|NCT01397409|472393856|FG000|Stage 2|Personal Reasons|0|||
131210534|NCT01397409|472393857|FG001|Stage 2|Personal Reasons|0|||
131210535|NCT01397409|472393858|FG002|Stage 2|Personal Reasons|0|||
131210536|NCT01397409|472393859|FG003|Stage 2|Personal Reasons|0|||
131210537|NCT01397409|472393860|FG004|Stage 2|Personal Reasons|1|||
131210538|NCT01397409|472393861|FG005|Stage 2|Personal Reasons|0|||
131210539|NCT01397409|472393862|FG006|Stage 2|Personal Reasons|0|||
131210540|NCT01397409|472393863|FG007|Stage 2|Personal Reasons|0|||
131210541|NCT01397409|472393864|FG008|Stage 2|Personal Reasons|0|||
131210542|NCT01397409|472393865|FG009|Stage 2|Personal Reasons|0|||
131210543|NCT01397409|472393856|FG000|Stage 2|Other Miscellaneous Reasons|0|||
131210544|NCT01397409|472393857|FG001|Stage 2|Other Miscellaneous Reasons|0|||
131210545|NCT01397409|472393858|FG002|Stage 2|Other Miscellaneous Reasons|0|||
131210546|NCT01397409|472393859|FG003|Stage 2|Other Miscellaneous Reasons|0|||
131210547|NCT01397409|472393860|FG004|Stage 2|Other Miscellaneous Reasons|1|||
131210548|NCT01397409|472393861|FG005|Stage 2|Other Miscellaneous Reasons|1|||
131210549|NCT01397409|472393862|FG006|Stage 2|Other Miscellaneous Reasons|0|||
131210550|NCT01397409|472393863|FG007|Stage 2|Other Miscellaneous Reasons|0|||
131210551|NCT01397409|472393864|FG008|Stage 2|Other Miscellaneous Reasons|0|||
131210552|NCT01397409|472393865|FG009|Stage 2|Other Miscellaneous Reasons|0|||
131210553|NCT01397409|472393856|FG000|Stage 3|Adverse Event|0|||
130987710|NCT02332590|471580617|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
130987711|NCT02332590|471580616|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
130987712|NCT02332590|471580617|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
130987713|NCT02332590|471580616|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
130987714|NCT02332590|471580617|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
130987715|NCT02332590|471580616|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
130987716|NCT02332590|471580617|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
130987717|NCT02332590|471580616|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
130987718|NCT02332590|471580617|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
130987719|NCT02332590|471580616|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
131210554|NCT01397409|472393857|FG001|Stage 3|Adverse Event|0|||
131210555|NCT01397409|472393858|FG002|Stage 3|Adverse Event|0|||
131210556|NCT01397409|472393859|FG003|Stage 3|Adverse Event|0|||
131210557|NCT01397409|472393860|FG004|Stage 3|Adverse Event|0|||
131210558|NCT01397409|472393861|FG005|Stage 3|Adverse Event|0|||
131210559|NCT01397409|472393862|FG006|Stage 3|Adverse Event|0|||
131210560|NCT01397409|472393863|FG007|Stage 3|Adverse Event|1|||
131210561|NCT01397409|472393864|FG008|Stage 3|Adverse Event|0|||
131210562|NCT01397409|472393865|FG009|Stage 3|Adverse Event|0|||
131210563|NCT01397409|472393856|FG000|Stage 3|Other Miscellaneous Reasons|0|||
131210564|NCT01397409|472393857|FG001|Stage 3|Other Miscellaneous Reasons|0|||
131210565|NCT01397409|472393858|FG002|Stage 3|Other Miscellaneous Reasons|0|||
131210566|NCT01397409|472393859|FG003|Stage 3|Other Miscellaneous Reasons|0|||
131210567|NCT01397409|472393860|FG004|Stage 3|Other Miscellaneous Reasons|0|||
131210568|NCT01397409|472393861|FG005|Stage 3|Other Miscellaneous Reasons|0|||
131210569|NCT01397409|472393862|FG006|Stage 3|Other Miscellaneous Reasons|0|||
131210570|NCT01397409|472393863|FG007|Stage 3|Other Miscellaneous Reasons|1|||
130987720|NCT02332590|471580617|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
130987721|NCT02332590|471580616|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
130987722|NCT02332590|471580617|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
130987723|NCT02332590|471580616|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
130987724|NCT02332590|471580617|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
130987725|NCT01679236|471582676|FG000|Overall Study|Lost to Follow-up|15|||
130987726|NCT01679236|471582677|FG001|Overall Study|Lost to Follow-up|15|||
130987727|NCT00975221|471582679|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
130987728|NCT00975221|471582680|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
130987729|NCT00975221|471582679|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
130987730|NCT00975221|471582680|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
130987731|NCT00975221|471582679|FG000|Titration Phase (Weeks 1-12)|Other|0|||
130987732|NCT00975221|471582680|FG001|Titration Phase (Weeks 1-12)|Other|1|||
130987733|NCT00975221|471582679|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
130987734|NCT00975221|471582680|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
130987735|NCT00975221|471582679|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
130987736|NCT00975221|471582680|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
130987737|NCT00975221|471582679|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
130987738|NCT00975221|471582680|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
130987739|NCT03935217|471582681|FG000|Overall Study|Adverse Event|1|||
130987740|NCT03935217|471582682|FG001|Overall Study|Adverse Event|0|||
130987741|NCT03935217|471582681|FG000|Overall Study|Lost to Follow-up|0|||
130987742|NCT03935217|471582682|FG001|Overall Study|Lost to Follow-up|1|||
130987743|NCT03935217|471582681|FG000|Overall Study|Withdrawal by Subject|0|||
130987744|NCT03935217|471582682|FG001|Overall Study|Withdrawal by Subject|2|||
130987745|NCT03559218|471582683|FG000|Overall Study|Withdrawal by Subject|1|||
130987746|NCT03559218|471582684|FG001|Overall Study|Withdrawal by Subject|0|||
130987747|NCT04170686|471582688|FG000|Screening|Physician Decision|12|||
130987748|NCT04170686|471582689|FG001|Screening|Physician Decision|13|||
130987749|NCT04170686|471582688|FG000|Randomization and Treatment|Lost to Follow-up|26|||
130987750|NCT04170686|471582689|FG001|Randomization and Treatment|Lost to Follow-up|15|||
130987751|NCT02305381|471582690|FG000|Overall Study|Unclassified|5|||
130987752|NCT02305381|471582691|FG001|Overall Study|Unclassified|5|||
130987753|NCT02305381|471582692|FG002|Overall Study|Unclassified|7|||
130987754|NCT02487498|471582693|FG000|Period: Period 1|Adverse Event|2|||
130987755|NCT02487498|471582694|FG001|Period: Period 1|Adverse Event|4|||
130987756|NCT02487498|471582693|FG000|Period: Period 1|Subject/guardian decision|2|||
130987757|NCT02487498|471582694|FG001|Period: Period 1|Subject/guardian decision|4|||
130987758|NCT02487498|471582693|FG000|Period: Period 1|Lost to Follow-up|0|||
130987759|NCT02487498|471582694|FG001|Period: Period 1|Lost to Follow-up|2|||
130987760|NCT02487498|471582693|FG000|Period: Period 1|Lack of Efficacy|1|||
130987761|NCT02487498|471582694|FG001|Period: Period 1|Lack of Efficacy|0|||
130987762|NCT02487498|471582693|FG000|Period: Period 1|Physician Decision|0|||
130987763|NCT02487498|471582694|FG001|Period: Period 1|Physician Decision|1|||
130987764|NCT02487498|471582693|FG000|Period: Period 1|Protocol deviation|1|||
130987765|NCT02487498|471582694|FG001|Period: Period 1|Protocol deviation|0|||
130987766|NCT02487498|471582693|FG000|Period: Washout|Subject/guardian decision|0|||
130987767|NCT02487498|471582694|FG001|Period: Washout|Subject/guardian decision|5|||
130987768|NCT02487498|471582693|FG000|Period: Washout|Lack of Efficacy|1|||
130987769|NCT02487498|471582694|FG001|Period: Washout|Lack of Efficacy|1|||
130987770|NCT02487498|471582693|FG000|Period: Washout|Physician Decision|1|||
130987771|NCT02487498|471582694|FG001|Period: Washout|Physician Decision|0|||
130987772|NCT02487498|471582693|FG000|Period: Washout|Non-compliance with study treatment|0|||
130987773|NCT02487498|471582694|FG001|Period: Washout|Non-compliance with study treatment|1|||
130987774|NCT02487498|471582693|FG000|Period: Period 2|Adverse Event|2|||
130987775|NCT02487498|471582694|FG001|Period: Period 2|Adverse Event|2|||
130987776|NCT02487498|471582693|FG000|Period: Period 2|Subject/guardian decision|2|||
130987777|NCT02487498|471582694|FG001|Period: Period 2|Subject/guardian decision|1|||
130987778|NCT02487498|471582693|FG000|Period: Period 2|Lost to Follow-up|1|||
130987779|NCT02487498|471582694|FG001|Period: Period 2|Lost to Follow-up|1|||
130987780|NCT02487498|471582693|FG000|Period: Period 2|Death|0|||
130987781|NCT02487498|471582694|FG001|Period: Period 2|Death|1|||
130987782|NCT02487498|471582693|FG000|Period: Period 2|Physician Decision|1|||
130987783|NCT02487498|471582694|FG001|Period: Period 2|Physician Decision|0|||
130987784|NCT05044325|471582695|FG000|Part A:Treatment Period 1|Adverse Event|0|||
130987785|NCT05044325|471582696|FG001|Part A:Treatment Period 1|Adverse Event|0|||
130987786|NCT05044325|471582697|FG002|Part A:Treatment Period 1|Adverse Event|0|||
130987787|NCT05044325|471582698|FG003|Part A:Treatment Period 1|Adverse Event|0|||
130987788|NCT05044325|471582699|FG004|Part A:Treatment Period 1|Adverse Event|0|||
130987789|NCT05044325|471582700|FG005|Part A:Treatment Period 1|Adverse Event|1|||
130987790|NCT05044325|471582701|FG006|Part A:Treatment Period 1|Adverse Event|0|||
130987791|NCT05044325|471582702|FG007|Part A:Treatment Period 1|Adverse Event|1|||
130987792|NCT05044325|471582703|FG008|Part A:Treatment Period 1|Adverse Event|0|||
130987793|NCT05044325|471582704|FG009|Part A:Treatment Period 1|Adverse Event|0|||
130987794|NCT05044325|471582695|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130987795|NCT05044325|471582696|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
131210571|NCT01397409|472393864|FG008|Stage 3|Other Miscellaneous Reasons|0|||
131210572|NCT01397409|472393865|FG009|Stage 3|Other Miscellaneous Reasons|0|||
131210573|NCT00422227|472393866|FG000|Overall Study|Adverse Event|3|||
131210574|NCT00422227|472393867|FG001|Overall Study|Adverse Event|8|||
131210575|NCT00422227|472393866|FG000|Overall Study|Lost to Follow-up|1|||
131210576|NCT00422227|472393867|FG001|Overall Study|Lost to Follow-up|3|||
131210577|NCT00422227|472393866|FG000|Overall Study|Withdrawal by Subject|0|||
131210578|NCT00422227|472393867|FG001|Overall Study|Withdrawal by Subject|4|||
131210579|NCT01207427|472393868|FG000|Double-blind Treatment Period|Adverse Event|0|||
131210580|NCT01207427|472393869|FG001|Double-blind Treatment Period|Adverse Event|1|||
131210581|NCT01207427|472393870|FG002|Double-blind Treatment Period|Adverse Event|0|||
131210582|NCT01207427|472393868|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
131210583|NCT01207427|472393869|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
131210584|NCT01207427|472393870|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
131210585|NCT01207427|472393868|FG000|Double-blind Treatment Period|Protocol Violation|2|||
131210586|NCT01207427|472393869|FG001|Double-blind Treatment Period|Protocol Violation|1|||
131210587|NCT01207427|472393870|FG002|Double-blind Treatment Period|Protocol Violation|1|||
131210588|NCT01207427|472393868|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
131210589|NCT01207427|472393869|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
131210590|NCT01207427|472393870|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131229084|NCT01626859|472465820|FG000|Overall Study|Withdrawal by Subject|1|||
131229085|NCT01626859|472465821|FG001|Overall Study|Withdrawal by Subject|4|||
131229086|NCT01626859|472465822|FG002|Overall Study|Withdrawal by Subject|2|||
131229087|NCT02629965|472465823|FG000|Period 1|Adverse Event|1|||
131229088|NCT02629965|472465824|FG001|Period 1|Adverse Event|0|||
131229089|NCT02629965|472465823|FG000|Period 1|Unexpected worsening of disease|2|||
131229090|NCT02629965|472465824|FG001|Period 1|Unexpected worsening of disease|0|||
131229091|NCT02629965|472465823|FG000|Period 1|Other than listed above|1|||
131229092|NCT02629965|472465824|FG001|Period 1|Other than listed above|2|||
131229093|NCT02629965|472465823|FG000|Period 2|Adverse Event|1|||
131229094|NCT02629965|472465824|FG001|Period 2|Adverse Event|0|||
131229095|NCT02330081|472465825|FG000|Overall Study|Adverse Event|1|||
131229096|NCT02330081|472465825|FG000|Overall Study|Donation did not meet criteria|1|||
131229097|NCT02330081|472465825|FG000|Overall Study|Protocol Violation|6|||
131229098|NCT02826603|472465826|FG000|Overall Study|Adverse Event|17|||
131229099|NCT02826603|472465827|FG001|Overall Study|Adverse Event|9|||
131229100|NCT02826603|472465826|FG000|Overall Study|Lack of Efficacy|4|||
131229101|NCT02826603|472465827|FG001|Overall Study|Lack of Efficacy|9|||
131229102|NCT02826603|472465826|FG000|Overall Study|Lost to Follow-up|13|||
131229103|NCT02826603|472465827|FG001|Overall Study|Lost to Follow-up|12|||
131229104|NCT02826603|472465826|FG000|Overall Study|Noncompliance with treatment|0|||
131229105|NCT02826603|472465827|FG001|Overall Study|Noncompliance with treatment|2|||
131229106|NCT02826603|472465826|FG000|Overall Study|Physician Decision|1|||
131229107|NCT02826603|472465827|FG001|Overall Study|Physician Decision|7|||
131229108|NCT02826603|472465826|FG000|Overall Study|Pregnancy|1|||
131229109|NCT02826603|472465827|FG001|Overall Study|Pregnancy|2|||
131229110|NCT02826603|472465826|FG000|Overall Study|Protocol Violation|3|||
131229111|NCT02826603|472465827|FG001|Overall Study|Protocol Violation|3|||
131229112|NCT02826603|472465826|FG000|Overall Study|Withdrawal by Subject|20|||
131229113|NCT02826603|472465827|FG001|Overall Study|Withdrawal by Subject|19|||
131229114|NCT02826603|472465826|FG000|Overall Study|Death|2|||
130987796|NCT05044325|471582697|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
131229115|NCT02826603|472465827|FG001|Overall Study|Death|0|||
130987797|NCT05044325|471582698|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
130987798|NCT05044325|471582699|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
131229116|NCT02826603|472465826|FG000|Overall Study|New therapy for study indication|0|||
131229117|NCT02826603|472465827|FG001|Overall Study|New therapy for study indication|1|||
131229118|NCT01337050|472465833|FG000|Overall Study|Death|0|||
131229119|NCT01337050|472465834|FG001|Overall Study|Death|0|||
131229120|NCT01337050|472465835|FG002|Overall Study|Death|4|||
131229121|NCT01337050|472465833|FG000|Overall Study|Other|4|||
131229122|NCT01337050|472465834|FG001|Overall Study|Other|6|||
131229123|NCT01337050|472465835|FG002|Overall Study|Other|8|||
131229124|NCT01337050|472465833|FG000|Overall Study|Participants refused further follow-up|0|||
131229125|NCT01337050|472465834|FG001|Overall Study|Participants refused further follow-up|7|||
131229126|NCT01337050|472465835|FG002|Overall Study|Participants refused further follow-up|7|||
130987799|NCT05044325|471582700|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
130987800|NCT05044325|471582701|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130987801|NCT05044325|471582702|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130987802|NCT05044325|471582703|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130987803|NCT05044325|471582704|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
130987804|NCT05044325|471582695|FG000|Part A:Treatment Period 1|Physician Decision|0|||
130987805|NCT05044325|471582696|FG001|Part A:Treatment Period 1|Physician Decision|0|||
130987806|NCT05044325|471582697|FG002|Part A:Treatment Period 1|Physician Decision|0|||
130987807|NCT05044325|471582698|FG003|Part A:Treatment Period 1|Physician Decision|0|||
130987808|NCT05044325|471582699|FG004|Part A:Treatment Period 1|Physician Decision|0|||
130987809|NCT05044325|471582700|FG005|Part A:Treatment Period 1|Physician Decision|0|||
130987810|NCT05044325|471582701|FG006|Part A:Treatment Period 1|Physician Decision|1|||
130987811|NCT05044325|471582702|FG007|Part A:Treatment Period 1|Physician Decision|0|||
130987812|NCT05044325|471582703|FG008|Part A:Treatment Period 1|Physician Decision|0|||
130987813|NCT05044325|471582704|FG009|Part A:Treatment Period 1|Physician Decision|0|||
130987814|NCT05044325|471582695|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130987815|NCT05044325|471582696|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130987816|NCT05044325|471582697|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
130987817|NCT05044325|471582698|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130987818|NCT05044325|471582699|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130987819|NCT05044325|471582700|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130987820|NCT05044325|471582701|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130987821|NCT05044325|471582702|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130987822|NCT05044325|471582703|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130987823|NCT05044325|471582704|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
130987824|NCT05044325|471582695|FG000|Part A:Treatment Period 2|Adverse Event|0|||
130987825|NCT05044325|471582696|FG001|Part A:Treatment Period 2|Adverse Event|1|||
130987826|NCT05044325|471582697|FG002|Part A:Treatment Period 2|Adverse Event|0|||
130987827|NCT05044325|471582698|FG003|Part A:Treatment Period 2|Adverse Event|0|||
130987828|NCT05044325|471582699|FG004|Part A:Treatment Period 2|Adverse Event|1|||
130987829|NCT05044325|471582700|FG005|Part A:Treatment Period 2|Adverse Event|1|||
130987830|NCT05044325|471582701|FG006|Part A:Treatment Period 2|Adverse Event|0|||
130987831|NCT05044325|471582702|FG007|Part A:Treatment Period 2|Adverse Event|0|||
130987832|NCT05044325|471582703|FG008|Part A:Treatment Period 2|Adverse Event|0|||
130987833|NCT05044325|471582704|FG009|Part A:Treatment Period 2|Adverse Event|0|||
130987834|NCT05044325|471582695|FG000|Part A:Treatment Period 2|Physician Decision|0|||
130987835|NCT05044325|471582696|FG001|Part A:Treatment Period 2|Physician Decision|0|||
130987836|NCT05044325|471582697|FG002|Part A:Treatment Period 2|Physician Decision|0|||
130987837|NCT05044325|471582698|FG003|Part A:Treatment Period 2|Physician Decision|0|||
130987838|NCT05044325|471582699|FG004|Part A:Treatment Period 2|Physician Decision|0|||
131210591|NCT02513732|472395277|FG000|Overall Study|Lost to Follow-up|11|||
131210592|NCT02513732|472395277|FG000|Overall Study|Death|9|||
131210593|NCT02513732|472395277|FG000|Overall Study|Changing hospital|2|||
131210594|NCT01740297|472395278|FG000|Overall Study|Withdrawal by Subject|4|||
131210595|NCT01740297|472395279|FG001|Overall Study|Withdrawal by Subject|16|||
131210596|NCT01740297|472395280|FG002|Overall Study|Withdrawal by Subject|17|||
131210597|NCT01740297|472395278|FG000|Overall Study|Death|8|||
131210598|NCT01740297|472395279|FG001|Overall Study|Death|46|||
131210599|NCT01740297|472395280|FG002|Overall Study|Death|40|||
131210600|NCT01740297|472395278|FG000|Overall Study|Lost to Follow-up|1|||
131210601|NCT01740297|472395279|FG001|Overall Study|Lost to Follow-up|2|||
131210602|NCT01740297|472395280|FG002|Overall Study|Lost to Follow-up|4|||
131210603|NCT01798056|472395282|FG000|Overall Study|Serious Adverse Event|13|||
131210604|NCT01798056|472395283|FG001|Overall Study|Serious Adverse Event|12|||
131210605|NCT01798056|472395282|FG000|Overall Study|Withdrawal by Subject|12|||
131210606|NCT01798056|472395283|FG001|Overall Study|Withdrawal by Subject|9|||
131210607|NCT01798056|472395282|FG000|Overall Study|Migrated/moved from study area|1|||
131210608|NCT01798056|472395283|FG001|Overall Study|Migrated/moved from study area|1|||
131210609|NCT01798056|472395282|FG000|Overall Study|Lost to Follow-up|1|||
131210610|NCT01798056|472395283|FG001|Overall Study|Lost to Follow-up|1|||
131210611|NCT01798056|472395282|FG000|Overall Study|Other|0|||
130987839|NCT05044325|471582700|FG005|Part A:Treatment Period 2|Physician Decision|1|||
130987840|NCT05044325|471582701|FG006|Part A:Treatment Period 2|Physician Decision|0|||
130987841|NCT05044325|471582702|FG007|Part A:Treatment Period 2|Physician Decision|0|||
130987842|NCT05044325|471582703|FG008|Part A:Treatment Period 2|Physician Decision|0|||
131098634|NCT02980731|471991005|FG000|Overall Study|Death|63|||
131210612|NCT01798056|472395283|FG001|Overall Study|Other|2|||
131210613|NCT02842736|472395288|FG000|Overall Study|Lost to Follow-up|13|||
131210614|NCT02842736|472395288|FG000|Overall Study|Intervention for menstrual bleeding|17|||
131210615|NCT02842736|472395288|FG000|Overall Study|Withdrawal by Subject|4|||
131210616|NCT02842736|472395288|FG000|Overall Study|Pregnancy|3|||
131210617|NCT02842736|472395288|FG000|Overall Study|Hysterectomy for fibroids|2|||
131210618|NCT02842736|472395288|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
131210619|NCT02842736|472395288|FG000|Overall Study|IUD: Mirena|1|||
131210620|NCT03323034|472395291|FG000|Overall Study|Lack of Efficacy|5|||
131210621|NCT03323034|472395292|FG001|Overall Study|Lack of Efficacy|5|||
131210622|NCT03323034|472395293|FG002|Overall Study|Lack of Efficacy|6|||
131210623|NCT03323034|472395294|FG003|Overall Study|Lack of Efficacy|5|||
131210624|NCT03323034|472395295|FG004|Overall Study|Lack of Efficacy|5|||
131210625|NCT03323034|472395291|FG000|Overall Study|Physician Decision|0|||
131210626|NCT03323034|472395292|FG001|Overall Study|Physician Decision|0|||
131210627|NCT03323034|472395293|FG002|Overall Study|Physician Decision|0|||
131210628|NCT03323034|472395294|FG003|Overall Study|Physician Decision|0|||
131210629|NCT03323034|472395295|FG004|Overall Study|Physician Decision|1|||
131210630|NCT03323034|472395291|FG000|Overall Study|Withdrawal by Subject|1|||
131210631|NCT03323034|472395292|FG001|Overall Study|Withdrawal by Subject|1|||
131210632|NCT03323034|472395293|FG002|Overall Study|Withdrawal by Subject|0|||
131210633|NCT03323034|472395294|FG003|Overall Study|Withdrawal by Subject|1|||
131210634|NCT03323034|472395295|FG004|Overall Study|Withdrawal by Subject|0|||
131210635|NCT02815540|472395298|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
131210636|NCT02222246|472395299|FG000|Overall Study|No Emergency Department Visits|27|||
131210637|NCT02222246|472395300|FG001|Overall Study|No Emergency Department Visits|26|||
130987843|NCT05044325|471582704|FG009|Part A:Treatment Period 2|Physician Decision|0|||
130987844|NCT05044325|471582695|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130987845|NCT05044325|471582696|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130987846|NCT05044325|471582697|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130987847|NCT05044325|471582698|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
130987848|NCT05044325|471582699|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
130987849|NCT05044325|471582700|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130987850|NCT05044325|471582701|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130987851|NCT05044325|471582702|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130987852|NCT05044325|471582703|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130987853|NCT05044325|471582704|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130987854|NCT00755222|471582705|FG000|Overall Study|Withdrawal by Subject|4|||
130987855|NCT00755222|471582706|FG001|Overall Study|Withdrawal by Subject|2|||
130987856|NCT00755222|471582705|FG000|Overall Study|Adverse Event|2|||
130987857|NCT00755222|471582706|FG001|Overall Study|Adverse Event|0|||
130987858|NCT00755222|471582705|FG000|Overall Study|Protocol Violation|2|||
130987859|NCT00755222|471582706|FG001|Overall Study|Protocol Violation|0|||
130987860|NCT02243202|471582707|FG000|Overall Study|Adverse Event|5|||
130987861|NCT02243202|471582708|FG001|Overall Study|Adverse Event|6|||
130987862|NCT02243202|471582709|FG002|Overall Study|Adverse Event|10|||
130987863|NCT02243202|471582710|FG003|Overall Study|Adverse Event|4|||
130987864|NCT02243202|471582707|FG000|Overall Study|Lost to Follow-up|9|||
130987865|NCT02243202|471582708|FG001|Overall Study|Lost to Follow-up|9|||
130987866|NCT02243202|471582709|FG002|Overall Study|Lost to Follow-up|14|||
130987867|NCT02243202|471582710|FG003|Overall Study|Lost to Follow-up|11|||
130987868|NCT02243202|471582707|FG000|Overall Study|Protocol Violation|3|||
130987869|NCT02243202|471582708|FG001|Overall Study|Protocol Violation|1|||
130987870|NCT02243202|471582709|FG002|Overall Study|Protocol Violation|2|||
130987871|NCT02243202|471582710|FG003|Overall Study|Protocol Violation|1|||
130987872|NCT02243202|471582707|FG000|Overall Study|Withdrawal by Subject|7|||
130987873|NCT02243202|471582708|FG001|Overall Study|Withdrawal by Subject|6|||
130987874|NCT02243202|471582709|FG002|Overall Study|Withdrawal by Subject|4|||
130987875|NCT02243202|471582710|FG003|Overall Study|Withdrawal by Subject|4|||
130987876|NCT02243202|471582707|FG000|Overall Study|Other|1|||
130987877|NCT02243202|471582708|FG001|Overall Study|Other|3|||
130987878|NCT02243202|471582709|FG002|Overall Study|Other|1|||
130987879|NCT02243202|471582710|FG003|Overall Study|Other|2|||
130987880|NCT02243202|471582707|FG000|Overall Study|Randomized but not received treatment|0|||
130987881|NCT02243202|471582708|FG001|Overall Study|Randomized but not received treatment|0|||
130987882|NCT02243202|471582709|FG002|Overall Study|Randomized but not received treatment|0|||
130987883|NCT02243202|471582710|FG003|Overall Study|Randomized but not received treatment|1|||
130987884|NCT04207840|471582713|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
130987885|NCT04207840|471582714|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
130987886|NCT04207840|471582715|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
130987887|NCT04207840|471582713|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
130987888|NCT04207840|471582714|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
130987889|NCT04207840|471582715|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
130987890|NCT03010462|471582719|FG000|Overall Study|Withdrawal by Subject|3|||
130987891|NCT03010462|471582720|FG001|Overall Study|Withdrawal by Subject|1|||
131210638|NCT02222246|472395299|FG000|Overall Study|Physician Decision|0|||
131210639|NCT02222246|472395300|FG001|Overall Study|Physician Decision|1|||
131210640|NCT01151085|472395301|FG000|Overall Study|Lost to Follow-up|31|||
130987892|NCT02799472|471582721|FG000|Overall Study|Withdrawal by Subject|2|||
130987893|NCT02799472|471582722|FG001|Overall Study|Withdrawal by Subject|4|||
130987894|NCT02799472|471582721|FG000|Overall Study|Lack of Efficacy|2|||
131210641|NCT01151085|472395301|FG000|Overall Study|Protocol Violation|25|||
131210642|NCT04196023|472395309|FG000|Overall Study|Withdrawal by Subject|0|||
131210643|NCT04196023|472395310|FG001|Overall Study|Withdrawal by Subject|1|||
131210644|NCT04196023|472395309|FG000|Overall Study|Adverse Event|3|||
131210645|NCT04196023|472395310|FG001|Overall Study|Adverse Event|1|||
131210646|NCT04196023|472395309|FG000|Overall Study|Lost to Follow-up|0|||
131210647|NCT04196023|472395310|FG001|Overall Study|Lost to Follow-up|1|||
131210648|NCT02985996|472395311|FG000|Overall Study|Withdrawal by Subject|0|||
131210649|NCT02985996|472395312|FG001|Overall Study|Withdrawal by Subject|0|||
131210650|NCT02985996|472395313|FG002|Overall Study|Withdrawal by Subject|1|||
131210651|NCT02985996|472395314|FG003|Overall Study|Withdrawal by Subject|0|||
131210652|NCT02985996|472395315|FG004|Overall Study|Withdrawal by Subject|0|||
131210653|NCT02985996|472395311|FG000|Overall Study|Protocol Violation|0|||
131210654|NCT02985996|472395312|FG001|Overall Study|Protocol Violation|1|||
131210655|NCT02985996|472395313|FG002|Overall Study|Protocol Violation|0|||
131210656|NCT02985996|472395314|FG003|Overall Study|Protocol Violation|0|||
131210657|NCT02985996|472395315|FG004|Overall Study|Protocol Violation|0|||
131210658|NCT00401726|472395316|FG000|Overall Study|Adverse Event|34|||
131210659|NCT00401726|472395317|FG001|Overall Study|Adverse Event|45|||
131210660|NCT00401726|472395316|FG000|Overall Study|Death|0|||
131210661|NCT00401726|472395317|FG001|Overall Study|Death|3|||
131210662|NCT00401726|472395316|FG000|Overall Study|Sponsor Request|0|||
131210663|NCT00401726|472395317|FG001|Overall Study|Sponsor Request|1|||
131210664|NCT00401726|472395316|FG000|Overall Study|Physician Decision|3|||
131210665|NCT00401726|472395317|FG001|Overall Study|Physician Decision|6|||
131210666|NCT00401726|472395316|FG000|Overall Study|Lost to Follow-up|23|||
131210667|NCT00401726|472395317|FG001|Overall Study|Lost to Follow-up|20|||
131210668|NCT00401726|472395316|FG000|Overall Study|Protocol Violation|6|||
131210669|NCT00401726|472395317|FG001|Overall Study|Protocol Violation|3|||
131210670|NCT00401726|472395316|FG000|Overall Study|Withdrawal by Subject|18|||
131210671|NCT00401726|472395317|FG001|Overall Study|Withdrawal by Subject|24|||
131210672|NCT00401726|472395316|FG000|Overall Study|Lack of Efficacy|4|||
131210673|NCT00401726|472395317|FG001|Overall Study|Lack of Efficacy|6|||
131210674|NCT00401726|472395316|FG000|Overall Study|Protocol Deviation|9|||
131210675|NCT00401726|472395317|FG001|Overall Study|Protocol Deviation|4|||
131210676|NCT00442572|472395318|FG000|Overall Study|Relapse|8|||
131210677|NCT00442572|472395319|FG001|Overall Study|Relapse|1|||
131210678|NCT00442572|472395318|FG000|Overall Study|Lost to Follow-up|0|||
131210679|NCT00442572|472395319|FG001|Overall Study|Lost to Follow-up|1|||
131210680|NCT00442572|472395318|FG000|Overall Study|Withdrawal by Subject|0|||
131210681|NCT00442572|472395319|FG001|Overall Study|Withdrawal by Subject|1|||
131210682|NCT01901393|472395320|FG000|Overall Study|Adverse Event|1|||
131210683|NCT01901393|472395321|FG001|Overall Study|Adverse Event|0|||
130987895|NCT02799472|471582722|FG001|Overall Study|Lack of Efficacy|0|||
130987896|NCT02799472|471582721|FG000|Overall Study|Lost to Follow-up|0|||
130987897|NCT02799472|471582722|FG001|Overall Study|Lost to Follow-up|1|||
130987898|NCT01492686|471582723|FG000|Double-blind Phase|Adverse Event|0|||
130987899|NCT01492686|471582724|FG001|Double-blind Phase|Adverse Event|2|||
130987900|NCT01492686|471582723|FG000|Double-blind Phase|Physician Decision|0|||
130987901|NCT01492686|471582724|FG001|Double-blind Phase|Physician Decision|1|||
130987902|NCT01492686|471582723|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130987903|NCT01492686|471582724|FG001|Double-blind Phase|Withdrawal by Subject|2|||
130987904|NCT01492686|471582723|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
130987905|NCT01492686|471582724|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
130987906|NCT01492686|471582723|FG000|Open-label Phase|Adverse Event|1|||
130987907|NCT01492686|471582724|FG001|Open-label Phase|Adverse Event|2|||
130987908|NCT01492686|471582723|FG000|Open-label Phase|Physician Decision|1|||
130987909|NCT01492686|471582724|FG001|Open-label Phase|Physician Decision|0|||
130987910|NCT01492686|471582723|FG000|Open-label Phase|Withdrawal by Subject|6|||
130987911|NCT01492686|471582724|FG001|Open-label Phase|Withdrawal by Subject|7|||
130987912|NCT01492686|471582723|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
130987913|NCT01492686|471582724|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
130987914|NCT01153269|471582725|FG000|Overall Study|Withdrawal by Subject|1|||
130987915|NCT01153269|471582725|FG000|Overall Study|Antiretroviral therapy break|1|||
130987916|NCT03541044|471582726|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
131210684|NCT00634933|472395322|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
131210685|NCT00634933|472395323|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
131210686|NCT00634933|472395324|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
131210687|NCT00634933|472395325|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
131210688|NCT00634933|472395326|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
131210689|NCT00634933|472395322|FG000|Part A: Baseline to Week 24|Death|1|||
130987917|NCT03541044|471582727|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
130987918|NCT03541044|471582726|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
130987919|NCT03541044|471582727|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
131210690|NCT00634933|472395323|FG001|Part A: Baseline to Week 24|Death|0|||
130987920|NCT02635724|471582738|FG000|Overall Study|Withdrawal by Subject|0|||
131210691|NCT00634933|472395324|FG002|Part A: Baseline to Week 24|Death|0|||
131210692|NCT00634933|472395325|FG003|Part A: Baseline to Week 24|Death|0|||
130987921|NCT02635724|471582739|FG001|Overall Study|Withdrawal by Subject|1|||
130987922|NCT02635724|471582740|FG002|Overall Study|Withdrawal by Subject|0|||
130987923|NCT00860067|471582741|FG000|Overall Study|Lost to Follow-up|46|||
130987924|NCT00860067|471582742|FG001|Overall Study|Lost to Follow-up|9|||
130987925|NCT00860067|471582743|FG002|Overall Study|Lost to Follow-up|9|||
130987926|NCT00860067|471582741|FG000|Overall Study|Withdrawal by Subject|4|||
130987927|NCT00860067|471582742|FG001|Overall Study|Withdrawal by Subject|0|||
130987928|NCT00860067|471582743|FG002|Overall Study|Withdrawal by Subject|0|||
130987929|NCT00860067|471582741|FG000|Overall Study|Pregnancy|1|||
130987930|NCT00860067|471582742|FG001|Overall Study|Pregnancy|0|||
130987931|NCT00860067|471582743|FG002|Overall Study|Pregnancy|0|||
130987932|NCT02424591|471582748|FG000|Overall Study|Protocol Violation|2|||
130987933|NCT02424591|471582749|FG001|Overall Study|Protocol Violation|3|||
131210693|NCT00634933|472395326|FG004|Part A: Baseline to Week 24|Death|0|||
131210694|NCT00634933|472395322|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
131210695|NCT00634933|472395323|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
131210696|NCT00634933|472395324|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
131210697|NCT00634933|472395325|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
131210698|NCT00634933|472395326|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
131210699|NCT00634933|472395322|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
131210700|NCT00634933|472395323|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
131210701|NCT00634933|472395324|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
131210702|NCT00634933|472395325|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
131210703|NCT00634933|472395326|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
131210704|NCT00634933|472395322|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
131210705|NCT00634933|472395323|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
131210706|NCT00634933|472395324|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
131210707|NCT00634933|472395325|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
131210708|NCT00634933|472395326|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
131210709|NCT00634933|472395322|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
131210710|NCT00634933|472395323|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
131210711|NCT00634933|472395324|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
131210712|NCT00634933|472395325|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
131210713|NCT00634933|472395326|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
130987934|NCT01446796|471582750|FG000|Overall Study|Withdrawal by Subject|1|||
130987935|NCT01446796|471582751|FG001|Overall Study|Withdrawal by Subject|0|||
130987936|NCT01498822|471582752|FG000|Overall Study|Protocol Violation|8|||
130987937|NCT01498822|471582753|FG001|Overall Study|Protocol Violation|4|||
130987938|NCT01498822|471582752|FG000|Overall Study|Other Reason|5|||
130987939|NCT01498822|471582753|FG001|Overall Study|Other Reason|2|||
130987940|NCT01498822|471582752|FG000|Overall Study|Lack of Efficacy|7|||
130987941|NCT01498822|471582753|FG001|Overall Study|Lack of Efficacy|2|||
130987942|NCT01498822|471582752|FG000|Overall Study|AE, non-serious non-fatal|8|||
130987943|NCT01498822|471582753|FG001|Overall Study|AE, non-serious non-fatal|17|||
130987944|NCT01498822|471582752|FG000|Overall Study|SAE, non-fatal|2|||
130987945|NCT01498822|471582753|FG001|Overall Study|SAE, non-fatal|2|||
130987946|NCT01498822|471582752|FG000|Overall Study|Adverse Event, serious fatal|1|||
130987947|NCT01498822|471582753|FG001|Overall Study|Adverse Event, serious fatal|1|||
130987948|NCT01498822|471582752|FG000|Overall Study|Withdrawal by Subject|15|||
130987949|NCT01498822|471582753|FG001|Overall Study|Withdrawal by Subject|25|||
130987950|NCT01498822|471582752|FG000|Overall Study|Lost to Follow-up|8|||
130987951|NCT01498822|471582753|FG001|Overall Study|Lost to Follow-up|3|||
130987952|NCT01674621|471582758|FG000|Overall Study|Adverse Event|3|||
130987953|NCT01674621|471582759|FG001|Overall Study|Adverse Event|2|||
130987954|NCT01674621|471582760|FG002|Overall Study|Adverse Event|5|||
130987955|NCT01674621|471582761|FG003|Overall Study|Adverse Event|5|||
130987956|NCT01674621|471582762|FG004|Overall Study|Adverse Event|1|||
130987957|NCT01674621|471582758|FG000|Overall Study|Inability to Complete Study Procedures|0|||
130987958|NCT01674621|471582759|FG001|Overall Study|Inability to Complete Study Procedures|0|||
130987959|NCT01674621|471582760|FG002|Overall Study|Inability to Complete Study Procedures|0|||
130987960|NCT01674621|471582761|FG003|Overall Study|Inability to Complete Study Procedures|0|||
130987961|NCT01674621|471582762|FG004|Overall Study|Inability to Complete Study Procedures|2|||
130987962|NCT01674621|471582758|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
130987963|NCT01674621|471582759|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
130987964|NCT01674621|471582760|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
131210714|NCT00634933|472395322|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
131210715|NCT00634933|472395323|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
131210716|NCT00634933|472395324|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
131210717|NCT00634933|472395325|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
130764073|NCT03605849|470759958|FG003|Overall Study|Physician Decision|1|||
130987965|NCT01674621|471582761|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
130987966|NCT01674621|471582762|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
130987967|NCT01674621|471582758|FG000|Overall Study|Withdrawal by Subject|2|||
130987968|NCT01674621|471582759|FG001|Overall Study|Withdrawal by Subject|5|||
131210718|NCT00634933|472395326|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
131210719|NCT00634933|472395322|FG000|Part A: Baseline to Week 24|Other|1|||
131210720|NCT00634933|472395323|FG001|Part A: Baseline to Week 24|Other|8|||
131210721|NCT00634933|472395324|FG002|Part A: Baseline to Week 24|Other|5|||
131210722|NCT00634933|472395325|FG003|Part A: Baseline to Week 24|Other|0|||
131210723|NCT00634933|472395326|FG004|Part A: Baseline to Week 24|Other|0|||
131210724|NCT00634933|472395322|FG000|Between Part A and Part B|Physician Decision|0|||
131210725|NCT00634933|472395323|FG001|Between Part A and Part B|Physician Decision|1|||
131210726|NCT00634933|472395324|FG002|Between Part A and Part B|Physician Decision|0|||
131210727|NCT00634933|472395325|FG003|Between Part A and Part B|Physician Decision|0|||
131210728|NCT00634933|472395326|FG004|Between Part A and Part B|Physician Decision|0|||
131210729|NCT00634933|472395322|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
131210730|NCT00634933|472395323|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
131210731|NCT00634933|472395324|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
131210732|NCT00634933|472395325|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
131210733|NCT00634933|472395326|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
131210734|NCT00634933|472395322|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
131210735|NCT00634933|472395323|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
131210736|NCT00634933|472395324|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
131210737|NCT00634933|472395325|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
131210738|NCT00634933|472395326|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
131210739|NCT00634933|472395322|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
131210740|NCT00634933|472395323|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
131210741|NCT00634933|472395324|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
131210742|NCT00634933|472395325|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
131210743|NCT00634933|472395326|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
131210744|NCT00634933|472395322|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
131210745|NCT00634933|472395323|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
131210746|NCT00634933|472395324|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
131210747|NCT00634933|472395325|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
131210748|NCT00634933|472395326|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
131210749|NCT00634933|472395322|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
131210750|NCT00634933|472395323|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
131210751|NCT00634933|472395324|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
131210752|NCT00634933|472395325|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
131210753|NCT00634933|472395326|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
131210754|NCT00634933|472395322|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
130987969|NCT01674621|471582760|FG002|Overall Study|Withdrawal by Subject|2|||
130987970|NCT01674621|471582761|FG003|Overall Study|Withdrawal by Subject|0|||
130987971|NCT01674621|471582762|FG004|Overall Study|Withdrawal by Subject|1|||
130987972|NCT01674621|471582758|FG000|Overall Study|Other than specified|0|||
130987973|NCT01674621|471582759|FG001|Overall Study|Other than specified|1|||
130987974|NCT01674621|471582760|FG002|Overall Study|Other than specified|0|||
130987975|NCT01674621|471582761|FG003|Overall Study|Other than specified|0|||
130987976|NCT01674621|471582762|FG004|Overall Study|Other than specified|2|||
130987977|NCT01148862|471582765|FG000|Second Intervention|Withdrawal by Subject|0|||
130987978|NCT01148862|471582766|FG001|Second Intervention|Withdrawal by Subject|2|||
130987979|NCT01597505|471582770|FG000|Overall Study|Physician Decision|5|||
130987980|NCT01597505|471582771|FG001|Overall Study|Physician Decision|0|||
130987981|NCT01597505|471582770|FG000|Overall Study|Adverse Event|19|||
130987982|NCT01597505|471582771|FG001|Overall Study|Adverse Event|7|||
130987983|NCT01597505|471582770|FG000|Overall Study|Lost to Follow-up|4|||
130987984|NCT01597505|471582771|FG001|Overall Study|Lost to Follow-up|2|||
130987985|NCT01597505|471582770|FG000|Overall Study|Withdrawal by Subject|10|||
130987986|NCT01597505|471582771|FG001|Overall Study|Withdrawal by Subject|18|||
130987987|NCT01597505|471582770|FG000|Overall Study|Other|5|||
130987988|NCT01597505|471582771|FG001|Overall Study|Other|6|||
130987989|NCT01597505|471582770|FG000|Overall Study|Missing|1|||
130987990|NCT01597505|471582771|FG001|Overall Study|Missing|0|||
130987991|NCT05454410|471582772|FG000|Overall Study|Withdrawal by Subject|0|||
130987992|NCT05454410|471582773|FG001|Overall Study|Withdrawal by Subject|0|||
130987993|NCT05454410|471582774|FG002|Overall Study|Withdrawal by Subject|1|||
130987994|NCT05454410|471582775|FG003|Overall Study|Withdrawal by Subject|1|||
130987995|NCT05004688|471582786|FG000|Overall Study|Protocol Violation|7|||
130987996|NCT05004688|471582786|FG000|Overall Study|Physician Decision|2|||
130987997|NCT05004688|471582786|FG000|Overall Study|Withdrawal by Subject|2|||
130987998|NCT00895622|471582787|FG000|Overall Study|Protocol Violation|5|||
130987999|NCT00895622|471582788|FG001|Overall Study|Protocol Violation|4|||
130988000|NCT00895622|471582789|FG002|Overall Study|Protocol Violation|4|||
130988001|NCT00733980|471582792|FG000|Overall Study|Adverse Event|5|||
130988002|NCT00733980|471582793|FG001|Overall Study|Adverse Event|2|||
130988003|NCT00733980|471582792|FG000|Overall Study|Lack of Efficacy|0|||
130988004|NCT00733980|471582793|FG001|Overall Study|Lack of Efficacy|1|||
130988005|NCT00733980|471582792|FG000|Overall Study|Protocol Violation|2|||
130988006|NCT00733980|471582793|FG001|Overall Study|Protocol Violation|1|||
130988007|NCT00733980|471582792|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
130988008|NCT00733980|471582793|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
130988009|NCT00733980|471582792|FG000|Overall Study|Lost to Follow-up|6|||
130988010|NCT00733980|471582793|FG001|Overall Study|Lost to Follow-up|11|||
130988011|NCT00733980|471582792|FG000|Overall Study|Physician Decision|2|||
130988012|NCT00733980|471582793|FG001|Overall Study|Physician Decision|3|||
130988013|NCT00733980|471582792|FG000|Overall Study|Withdrawal by Subject|6|||
130988014|NCT00733980|471582793|FG001|Overall Study|Withdrawal by Subject|2|||
130988015|NCT00779779|471582796|FG000|Overall Study|Adverse Event|1|||
130988016|NCT00779779|471582796|FG000|Overall Study|Protocol Violation|14|||
130988017|NCT00779779|471582796|FG000|Overall Study|Withdrawal by Subject|4|||
130988018|NCT00779779|471582796|FG000|Overall Study|Lost to Follow-up|5|||
130988019|NCT05158296|471582797|FG000|Overall Study|Sponsor Decision|2|||
130988020|NCT05158296|471582798|FG001|Overall Study|Sponsor Decision|3|||
130988021|NCT05158296|471582799|FG002|Overall Study|Sponsor Decision|2|||
131210755|NCT00634933|472395323|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
131210756|NCT00634933|472395324|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
131210757|NCT00634933|472395325|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
131210758|NCT00634933|472395326|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
130988022|NCT02552238|471582800|FG000|Overall Study|Withdrawal by Subject|2|||
130988023|NCT02552238|471582800|FG000|Overall Study|Adverse Event|2|||
130988024|NCT02036645|471582805|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988025|NCT02036645|471582806|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988026|NCT02036645|471582807|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988027|NCT02036645|471582808|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988028|NCT02036645|471582809|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988029|NCT02036645|471582810|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988030|NCT02036645|471582811|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
130988031|NCT02036645|471582812|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988032|NCT02036645|471582813|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988033|NCT02036645|471582814|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988034|NCT02036645|471582815|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988035|NCT02036645|471582816|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130988036|NCT02036645|471582805|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988037|NCT02036645|471582806|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988038|NCT02036645|471582807|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988039|NCT02036645|471582808|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
130988040|NCT02036645|471582809|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988041|NCT02036645|471582810|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988042|NCT02036645|471582811|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988043|NCT02036645|471582812|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988044|NCT02036645|471582813|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988045|NCT02036645|471582814|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988046|NCT02036645|471582815|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988047|NCT02036645|471582816|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130988048|NCT02010632|471582820|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
130988049|NCT02010632|471582821|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
130988050|NCT02404389|471582823|FG000|Overall Study|Adverse Event|1|||
130988051|NCT02404389|471582824|FG001|Overall Study|Adverse Event|0|||
130988052|NCT02404389|471582825|FG002|Overall Study|Adverse Event|1|||
130988053|NCT02404389|471582826|FG003|Overall Study|Adverse Event|0|||
130988054|NCT02404389|471582827|FG004|Overall Study|Adverse Event|2|||
130988055|NCT02404389|471582823|FG000|Overall Study|Subject/guardian decision|1|||
130988056|NCT02404389|471582824|FG001|Overall Study|Subject/guardian decision|0|||
130988057|NCT02404389|471582825|FG002|Overall Study|Subject/guardian decision|0|||
131210759|NCT00634933|472395322|FG000|Part B: Week 24 to Week 52|Other|0|||
131210760|NCT00634933|472395323|FG001|Part B: Week 24 to Week 52|Other|0|||
131210761|NCT00634933|472395324|FG002|Part B: Week 24 to Week 52|Other|5|||
131210762|NCT00634933|472395325|FG003|Part B: Week 24 to Week 52|Other|0|||
131210763|NCT00634933|472395326|FG004|Part B: Week 24 to Week 52|Other|1|||
131210764|NCT02058849|472395327|FG000|Overall Study|Hospitalization|1|||
131210765|NCT02058849|472395328|FG001|Overall Study|Hospitalization|1|||
131210766|NCT02058849|472395327|FG000|Overall Study|Death|1|||
131210767|NCT02058849|472395328|FG001|Overall Study|Death|0|||
131210768|NCT02058849|472395327|FG000|Overall Study|Lost to Follow-up|1|||
131210769|NCT02058849|472395328|FG001|Overall Study|Lost to Follow-up|0|||
131210770|NCT02058849|472395327|FG000|Overall Study|Withdrawal by Subject|4|||
131210771|NCT02058849|472395328|FG001|Overall Study|Withdrawal by Subject|0|||
131210772|NCT01049360|472395329|FG000|Period 1|Adverse Event|0|||
131210773|NCT01049360|472395330|FG001|Period 1|Adverse Event|1|||
131210774|NCT01049360|472395331|FG002|Period 1|Adverse Event|0|||
131210775|NCT01049360|472395332|FG003|Period 1|Adverse Event|1|||
131210776|NCT01049360|472395333|FG004|Period 1|Adverse Event|0|||
131210777|NCT01049360|472395334|FG005|Period 1|Adverse Event|0|||
131210778|NCT01049360|472395335|FG006|Period 1|Adverse Event|0|||
131210779|NCT01049360|472395336|FG007|Period 1|Adverse Event|1|||
131210780|NCT01049360|472395337|FG008|Period 1|Adverse Event|0|||
131210781|NCT01049360|472395338|FG009|Period 1|Adverse Event|0|||
131210782|NCT01049360|472395339|FG010|Period 1|Adverse Event|0|||
131210783|NCT01049360|472395340|FG011|Period 1|Adverse Event|0|||
131210784|NCT01049360|472395341|FG012|Period 1|Adverse Event|1|||
131210785|NCT01049360|472395342|FG013|Period 1|Adverse Event|1|||
131210786|NCT01049360|472395343|FG014|Period 1|Adverse Event|0|||
131210787|NCT01049360|472395344|FG015|Period 1|Adverse Event|0|||
131210788|NCT01049360|472395345|FG016|Period 1|Adverse Event|1|||
131210789|NCT01049360|472395346|FG017|Period 1|Adverse Event|0|||
131210790|NCT01049360|472395347|FG018|Period 1|Adverse Event|1|||
130988058|NCT02404389|471582826|FG003|Overall Study|Subject/guardian decision|1|||
130988059|NCT02404389|471582827|FG004|Overall Study|Subject/guardian decision|1|||
130988060|NCT03324880|471582831|FG000|Overall Study|Adverse Event|0|||
130988061|NCT03324880|471582832|FG001|Overall Study|Adverse Event|2|||
130988062|NCT03324880|471582831|FG000|Overall Study|Withdrawal by Subject|2|||
130988063|NCT03324880|471582832|FG001|Overall Study|Withdrawal by Subject|2|||
131210791|NCT01049360|472395348|FG019|Period 1|Adverse Event|0|||
131210792|NCT01049360|472395329|FG000|Period 1|Did not meet inc/exc criteria|0|||
131210793|NCT01049360|472395330|FG001|Period 1|Did not meet inc/exc criteria|0|||
131210794|NCT01049360|472395331|FG002|Period 1|Did not meet inc/exc criteria|0|||
131210795|NCT01049360|472395332|FG003|Period 1|Did not meet inc/exc criteria|0|||
131210796|NCT01049360|472395333|FG004|Period 1|Did not meet inc/exc criteria|0|||
131210797|NCT01049360|472395334|FG005|Period 1|Did not meet inc/exc criteria|0|||
131210798|NCT01049360|472395335|FG006|Period 1|Did not meet inc/exc criteria|0|||
131210799|NCT01049360|472395336|FG007|Period 1|Did not meet inc/exc criteria|1|||
131210800|NCT01049360|472395337|FG008|Period 1|Did not meet inc/exc criteria|1|||
131210801|NCT01049360|472395338|FG009|Period 1|Did not meet inc/exc criteria|0|||
131210802|NCT01049360|472395339|FG010|Period 1|Did not meet inc/exc criteria|0|||
131210803|NCT01049360|472395340|FG011|Period 1|Did not meet inc/exc criteria|0|||
131210804|NCT01049360|472395341|FG012|Period 1|Did not meet inc/exc criteria|0|||
131210805|NCT01049360|472395342|FG013|Period 1|Did not meet inc/exc criteria|0|||
131210806|NCT01049360|472395343|FG014|Period 1|Did not meet inc/exc criteria|0|||
131210807|NCT01049360|472395344|FG015|Period 1|Did not meet inc/exc criteria|0|||
131210808|NCT01049360|472395345|FG016|Period 1|Did not meet inc/exc criteria|0|||
131210809|NCT01049360|472395346|FG017|Period 1|Did not meet inc/exc criteria|0|||
131210810|NCT01049360|472395347|FG018|Period 1|Did not meet inc/exc criteria|0|||
131210811|NCT01049360|472395348|FG019|Period 1|Did not meet inc/exc criteria|0|||
131210812|NCT01049360|472395329|FG000|Period 1|Withdrawal by Subject|0|||
131210813|NCT01049360|472395330|FG001|Period 1|Withdrawal by Subject|0|||
131210814|NCT01049360|472395331|FG002|Period 1|Withdrawal by Subject|0|||
131210815|NCT01049360|472395332|FG003|Period 1|Withdrawal by Subject|0|||
131210816|NCT01049360|472395333|FG004|Period 1|Withdrawal by Subject|0|||
131210817|NCT01049360|472395334|FG005|Period 1|Withdrawal by Subject|0|||
131210818|NCT01049360|472395335|FG006|Period 1|Withdrawal by Subject|0|||
131210819|NCT01049360|472395336|FG007|Period 1|Withdrawal by Subject|0|||
131210820|NCT01049360|472395337|FG008|Period 1|Withdrawal by Subject|1|||
131210821|NCT01049360|472395338|FG009|Period 1|Withdrawal by Subject|0|||
131210822|NCT01049360|472395339|FG010|Period 1|Withdrawal by Subject|1|||
131210823|NCT01049360|472395340|FG011|Period 1|Withdrawal by Subject|0|||
131210824|NCT01049360|472395341|FG012|Period 1|Withdrawal by Subject|1|||
131210825|NCT01049360|472395342|FG013|Period 1|Withdrawal by Subject|0|||
131210826|NCT01049360|472395343|FG014|Period 1|Withdrawal by Subject|0|||
131210827|NCT01049360|472395344|FG015|Period 1|Withdrawal by Subject|0|||
131210828|NCT01049360|472395345|FG016|Period 1|Withdrawal by Subject|0|||
131210829|NCT01049360|472395346|FG017|Period 1|Withdrawal by Subject|0|||
131210830|NCT01049360|472395347|FG018|Period 1|Withdrawal by Subject|0|||
131210831|NCT01049360|472395348|FG019|Period 1|Withdrawal by Subject|0|||
131210832|NCT01049360|472395329|FG000|Period 2|Protocol Violation|0|||
131210833|NCT01049360|472395330|FG001|Period 2|Protocol Violation|0|||
131210834|NCT01049360|472395331|FG002|Period 2|Protocol Violation|0|||
131210835|NCT01049360|472395332|FG003|Period 2|Protocol Violation|1|||
131210836|NCT01049360|472395333|FG004|Period 2|Protocol Violation|0|||
130988064|NCT03324880|471582831|FG000|Overall Study|Lost to Follow-up|0|||
131210837|NCT01049360|472395334|FG005|Period 2|Protocol Violation|0|||
131210838|NCT01049360|472395335|FG006|Period 2|Protocol Violation|0|||
131210839|NCT01049360|472395336|FG007|Period 2|Protocol Violation|0|||
131210840|NCT01049360|472395337|FG008|Period 2|Protocol Violation|0|||
131210841|NCT01049360|472395338|FG009|Period 2|Protocol Violation|0|||
131210842|NCT01049360|472395339|FG010|Period 2|Protocol Violation|0|||
131210843|NCT01049360|472395340|FG011|Period 2|Protocol Violation|0|||
131210844|NCT01049360|472395341|FG012|Period 2|Protocol Violation|0|||
131210845|NCT01049360|472395342|FG013|Period 2|Protocol Violation|0|||
131210846|NCT01049360|472395343|FG014|Period 2|Protocol Violation|1|||
131210847|NCT01049360|472395344|FG015|Period 2|Protocol Violation|1|||
131210848|NCT01049360|472395345|FG016|Period 2|Protocol Violation|0|||
131210849|NCT01049360|472395346|FG017|Period 2|Protocol Violation|0|||
131210850|NCT01049360|472395347|FG018|Period 2|Protocol Violation|0|||
131210851|NCT01049360|472395348|FG019|Period 2|Protocol Violation|0|||
131210852|NCT01049360|472395329|FG000|Period 2|Adverse Event|0|||
131210853|NCT01049360|472395330|FG001|Period 2|Adverse Event|1|||
131210854|NCT01049360|472395331|FG002|Period 2|Adverse Event|0|||
131210855|NCT01049360|472395332|FG003|Period 2|Adverse Event|0|||
131210856|NCT01049360|472395333|FG004|Period 2|Adverse Event|0|||
131210857|NCT01049360|472395334|FG005|Period 2|Adverse Event|0|||
131210858|NCT01049360|472395335|FG006|Period 2|Adverse Event|0|||
131210859|NCT01049360|472395336|FG007|Period 2|Adverse Event|0|||
131210860|NCT01049360|472395337|FG008|Period 2|Adverse Event|1|||
131210861|NCT01049360|472395338|FG009|Period 2|Adverse Event|0|||
131210862|NCT01049360|472395339|FG010|Period 2|Adverse Event|0|||
131210863|NCT01049360|472395340|FG011|Period 2|Adverse Event|0|||
131210864|NCT01049360|472395341|FG012|Period 2|Adverse Event|0|||
131210865|NCT01049360|472395342|FG013|Period 2|Adverse Event|0|||
131210866|NCT01049360|472395343|FG014|Period 2|Adverse Event|0|||
131210867|NCT01049360|472395344|FG015|Period 2|Adverse Event|0|||
131210868|NCT01049360|472395345|FG016|Period 2|Adverse Event|0|||
131210869|NCT01049360|472395346|FG017|Period 2|Adverse Event|0|||
131210870|NCT01049360|472395347|FG018|Period 2|Adverse Event|0|||
131210871|NCT01049360|472395348|FG019|Period 2|Adverse Event|1|||
131210872|NCT01049360|472395329|FG000|Period 2|Withdrawal by Subject|0|||
131210873|NCT01049360|472395330|FG001|Period 2|Withdrawal by Subject|0|||
131210874|NCT01049360|472395331|FG002|Period 2|Withdrawal by Subject|0|||
131210875|NCT01049360|472395332|FG003|Period 2|Withdrawal by Subject|1|||
131210876|NCT01049360|472395333|FG004|Period 2|Withdrawal by Subject|0|||
131210877|NCT01049360|472395334|FG005|Period 2|Withdrawal by Subject|0|||
131210878|NCT01049360|472395335|FG006|Period 2|Withdrawal by Subject|0|||
131210879|NCT01049360|472395336|FG007|Period 2|Withdrawal by Subject|0|||
131210880|NCT01049360|472395337|FG008|Period 2|Withdrawal by Subject|0|||
131210881|NCT01049360|472395338|FG009|Period 2|Withdrawal by Subject|0|||
131210882|NCT01049360|472395339|FG010|Period 2|Withdrawal by Subject|0|||
131210883|NCT01049360|472395340|FG011|Period 2|Withdrawal by Subject|0|||
131210884|NCT01049360|472395341|FG012|Period 2|Withdrawal by Subject|0|||
131210885|NCT01049360|472395342|FG013|Period 2|Withdrawal by Subject|0|||
131210886|NCT01049360|472395343|FG014|Period 2|Withdrawal by Subject|1|||
131210887|NCT01049360|472395344|FG015|Period 2|Withdrawal by Subject|0|||
131210888|NCT01049360|472395345|FG016|Period 2|Withdrawal by Subject|0|||
131210889|NCT01049360|472395346|FG017|Period 2|Withdrawal by Subject|0|||
131210890|NCT01049360|472395347|FG018|Period 2|Withdrawal by Subject|0|||
131210891|NCT01049360|472395348|FG019|Period 2|Withdrawal by Subject|1|||
131210892|NCT01049360|472395329|FG000|Period 2|Lack of Efficacy|0|||
131210893|NCT01049360|472395330|FG001|Period 2|Lack of Efficacy|0|||
131210894|NCT01049360|472395331|FG002|Period 2|Lack of Efficacy|0|||
131210895|NCT01049360|472395332|FG003|Period 2|Lack of Efficacy|0|||
131210896|NCT01049360|472395333|FG004|Period 2|Lack of Efficacy|0|||
131210897|NCT01049360|472395334|FG005|Period 2|Lack of Efficacy|1|||
131210898|NCT01049360|472395335|FG006|Period 2|Lack of Efficacy|0|||
131210899|NCT01049360|472395336|FG007|Period 2|Lack of Efficacy|0|||
131210900|NCT01049360|472395337|FG008|Period 2|Lack of Efficacy|0|||
131210901|NCT01049360|472395338|FG009|Period 2|Lack of Efficacy|0|||
131210902|NCT01049360|472395339|FG010|Period 2|Lack of Efficacy|0|||
131210903|NCT01049360|472395340|FG011|Period 2|Lack of Efficacy|0|||
131210904|NCT01049360|472395341|FG012|Period 2|Lack of Efficacy|0|||
131210905|NCT01049360|472395342|FG013|Period 2|Lack of Efficacy|0|||
131210906|NCT01049360|472395343|FG014|Period 2|Lack of Efficacy|0|||
131210907|NCT01049360|472395344|FG015|Period 2|Lack of Efficacy|0|||
131210908|NCT01049360|472395345|FG016|Period 2|Lack of Efficacy|0|||
131210909|NCT01049360|472395346|FG017|Period 2|Lack of Efficacy|0|||
131210910|NCT01049360|472395347|FG018|Period 2|Lack of Efficacy|0|||
131210911|NCT01049360|472395348|FG019|Period 2|Lack of Efficacy|0|||
131210912|NCT01049360|472395329|FG000|Period 4|Protocol Violation|0|||
131210913|NCT01049360|472395330|FG001|Period 4|Protocol Violation|0|||
131210914|NCT01049360|472395331|FG002|Period 4|Protocol Violation|0|||
131210915|NCT01049360|472395332|FG003|Period 4|Protocol Violation|0|||
131210916|NCT01049360|472395333|FG004|Period 4|Protocol Violation|0|||
131210917|NCT01049360|472395334|FG005|Period 4|Protocol Violation|0|||
131210918|NCT01049360|472395335|FG006|Period 4|Protocol Violation|0|||
130876335|NCT01069484|471177490|FG001|Overall Study|Illness mother or child|1|||
131210919|NCT01049360|472395336|FG007|Period 4|Protocol Violation|0|||
131210920|NCT01049360|472395337|FG008|Period 4|Protocol Violation|0|||
131210921|NCT01049360|472395338|FG009|Period 4|Protocol Violation|0|||
131210922|NCT01049360|472395339|FG010|Period 4|Protocol Violation|0|||
131210923|NCT01049360|472395340|FG011|Period 4|Protocol Violation|0|||
131210924|NCT01049360|472395341|FG012|Period 4|Protocol Violation|0|||
131210925|NCT01049360|472395342|FG013|Period 4|Protocol Violation|0|||
131210926|NCT01049360|472395343|FG014|Period 4|Protocol Violation|0|||
131210927|NCT01049360|472395344|FG015|Period 4|Protocol Violation|0|||
131210928|NCT01049360|472395345|FG016|Period 4|Protocol Violation|0|||
131210929|NCT01049360|472395346|FG017|Period 4|Protocol Violation|1|||
131210930|NCT01049360|472395347|FG018|Period 4|Protocol Violation|0|||
131210931|NCT01049360|472395348|FG019|Period 4|Protocol Violation|0|||
131210932|NCT01049360|472395329|FG000|Period 4|Withdrawal by Subject|0|||
131210933|NCT01049360|472395330|FG001|Period 4|Withdrawal by Subject|0|||
131210934|NCT01049360|472395331|FG002|Period 4|Withdrawal by Subject|0|||
131210935|NCT01049360|472395332|FG003|Period 4|Withdrawal by Subject|1|||
131210936|NCT01049360|472395333|FG004|Period 4|Withdrawal by Subject|0|||
131210937|NCT01049360|472395334|FG005|Period 4|Withdrawal by Subject|0|||
131210938|NCT01049360|472395335|FG006|Period 4|Withdrawal by Subject|0|||
131210939|NCT01049360|472395336|FG007|Period 4|Withdrawal by Subject|0|||
131210940|NCT01049360|472395337|FG008|Period 4|Withdrawal by Subject|0|||
131210941|NCT01049360|472395338|FG009|Period 4|Withdrawal by Subject|0|||
131210942|NCT01049360|472395339|FG010|Period 4|Withdrawal by Subject|0|||
131210943|NCT01049360|472395340|FG011|Period 4|Withdrawal by Subject|0|||
131210944|NCT01049360|472395341|FG012|Period 4|Withdrawal by Subject|0|||
131210945|NCT01049360|472395342|FG013|Period 4|Withdrawal by Subject|0|||
131210946|NCT01049360|472395343|FG014|Period 4|Withdrawal by Subject|0|||
131210947|NCT01049360|472395344|FG015|Period 4|Withdrawal by Subject|0|||
131210948|NCT01049360|472395345|FG016|Period 4|Withdrawal by Subject|0|||
131210949|NCT01049360|472395346|FG017|Period 4|Withdrawal by Subject|0|||
131210950|NCT01049360|472395347|FG018|Period 4|Withdrawal by Subject|0|||
131210951|NCT01049360|472395348|FG019|Period 4|Withdrawal by Subject|0|||
131210952|NCT01326312|472395349|FG000|Overall Study|Adverse Event|11|||
131210953|NCT01326312|472395350|FG001|Overall Study|Adverse Event|11|||
131210954|NCT01326312|472395351|FG002|Overall Study|Adverse Event|1|||
131210955|NCT01326312|472395349|FG000|Overall Study|Withdrawal by Subject|1|||
131210956|NCT01326312|472395350|FG001|Overall Study|Withdrawal by Subject|2|||
131210957|NCT01326312|472395351|FG002|Overall Study|Withdrawal by Subject|1|||
131210958|NCT01326312|472395349|FG000|Overall Study|Protocol Violation|0|||
131210959|NCT01326312|472395350|FG001|Overall Study|Protocol Violation|1|||
131210960|NCT01326312|472395351|FG002|Overall Study|Protocol Violation|0|||
131210961|NCT01326312|472395349|FG000|Overall Study|Lack of Efficacy|13|||
131210962|NCT01326312|472395350|FG001|Overall Study|Lack of Efficacy|7|||
131210963|NCT01326312|472395351|FG002|Overall Study|Lack of Efficacy|1|||
131210964|NCT01326312|472395349|FG000|Overall Study|Death|1|||
131210965|NCT01326312|472395350|FG001|Overall Study|Death|0|||
131210966|NCT01326312|472395351|FG002|Overall Study|Death|1|||
131210967|NCT01326312|472395349|FG000|Overall Study|progressive disease|0|||
130876336|NCT00644358|471177491|FG000|Overall Study|Adverse Event|124|||
130876337|NCT00644358|471177491|FG000|Overall Study|Lost to Follow-up|105|||
130876338|NCT00644358|471177491|FG000|Overall Study|Consent Withdrawal|64|||
130876339|NCT00644358|471177491|FG000|Overall Study|Lack of Effectiveness|39|||
130876340|NCT00644358|471177491|FG000|Overall Study|Protocol Violation|5|||
130876341|NCT00644358|471177491|FG000|Overall Study|Noncompliance|14|||
130876342|NCT00644358|471177491|FG000|Overall Study|Other Unspecified|11|||
130876343|NCT00758771|471177498|FG000|Overall Study|Withdrawal by Subject|1|||
130876344|NCT00758771|471177499|FG001|Overall Study|Withdrawal by Subject|1|||
130876345|NCT00758771|471177498|FG000|Overall Study|Did not meet eligibility criteria|2|||
130764074|NCT03605849|470759955|FG000|Overall Study|Enrolled, but not Treated|2|||
130764075|NCT03605849|470759956|FG001|Overall Study|Enrolled, but not Treated|2|||
130764076|NCT03605849|470759957|FG002|Overall Study|Enrolled, but not Treated|3|||
130764077|NCT03605849|470759958|FG003|Overall Study|Enrolled, but not Treated|2|||
130764078|NCT03605849|470759955|FG000|Overall Study|Other (COVID-19 Related)|0|||
130764079|NCT03605849|470759956|FG001|Overall Study|Other (COVID-19 Related)|1|||
130764080|NCT03605849|470759957|FG002|Overall Study|Other (COVID-19 Related)|1|||
130764081|NCT03605849|470759958|FG003|Overall Study|Other (COVID-19 Related)|0|||
130764082|NCT03605849|470759955|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
130764083|NCT03605849|470759956|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
130764084|NCT03605849|470759957|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
130764085|NCT03605849|470759958|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
130764086|NCT00577005|470759959|FG000|Overall Study|Lost to Follow-up|3|||
130764087|NCT00577005|470759960|FG001|Overall Study|Lost to Follow-up|2|||
130764088|NCT00577005|470759959|FG000|Overall Study|Withdrawal by Subject|2|||
130764089|NCT00577005|470759960|FG001|Overall Study|Withdrawal by Subject|1|||
130876346|NCT00758771|471177499|FG001|Overall Study|Did not meet eligibility criteria|4|||
131210968|NCT01326312|472395350|FG001|Overall Study|progressive disease|1|||
131210969|NCT01326312|472395351|FG002|Overall Study|progressive disease|1|||
131210970|NCT01326312|472395349|FG000|Overall Study|Study terminated by Sponsor|8|||
131210971|NCT01326312|472395350|FG001|Overall Study|Study terminated by Sponsor|32|||
131210972|NCT01326312|472395351|FG002|Overall Study|Study terminated by Sponsor|46|||
131210973|NCT01326312|472395349|FG000|Overall Study|Treatment arm terminated|19|||
131210974|NCT01326312|472395350|FG001|Overall Study|Treatment arm terminated|0|||
131210975|NCT01326312|472395351|FG002|Overall Study|Treatment arm terminated|0|||
131210976|NCT01326312|472395349|FG000|Overall Study|QTc > 500|0|||
131210977|NCT01326312|472395350|FG001|Overall Study|QTc > 500|1|||
131210978|NCT01326312|472395351|FG002|Overall Study|QTc > 500|0|||
131210979|NCT00499694|472395352|FG000|Overall Study|Patient never received treatment.|1|||
131210980|NCT04338685|472395355|FG000|Overall Study|Death|3|||
131210981|NCT04338685|472395356|FG001|Overall Study|Death|4|||
131210982|NCT04338685|472395357|FG002|Overall Study|Death|2|||
131210983|NCT04338685|472395358|FG003|Overall Study|Death|4|||
131210984|NCT04338685|472395359|FG004|Overall Study|Death|4|||
131210985|NCT04338685|472395360|FG005|Overall Study|Death|8|||
131210986|NCT04338685|472395361|FG006|Overall Study|Death|1|||
131210987|NCT04338685|472395362|FG007|Overall Study|Death|0|||
131210988|NCT04338685|472395363|FG008|Overall Study|Death|0|||
131210989|NCT04338685|472395355|FG000|Overall Study|Study terminated by Sponsor|0|||
131210990|NCT04338685|472395356|FG001|Overall Study|Study terminated by Sponsor|0|||
131210991|NCT04338685|472395357|FG002|Overall Study|Study terminated by Sponsor|1|||
131210992|NCT04338685|472395358|FG003|Overall Study|Study terminated by Sponsor|4|||
131210993|NCT04338685|472395359|FG004|Overall Study|Study terminated by Sponsor|0|||
131210994|NCT04338685|472395360|FG005|Overall Study|Study terminated by Sponsor|5|||
131210995|NCT04338685|472395361|FG006|Overall Study|Study terminated by Sponsor|2|||
131210996|NCT04338685|472395362|FG007|Overall Study|Study terminated by Sponsor|4|||
131210997|NCT04338685|472395363|FG008|Overall Study|Study terminated by Sponsor|1|||
131210998|NCT04338685|472395355|FG000|Overall Study|Withdrawal by Subject|1|||
131210999|NCT04338685|472395356|FG001|Overall Study|Withdrawal by Subject|2|||
131211000|NCT04338685|472395357|FG002|Overall Study|Withdrawal by Subject|0|||
131211001|NCT04338685|472395358|FG003|Overall Study|Withdrawal by Subject|2|||
131211002|NCT04338685|472395359|FG004|Overall Study|Withdrawal by Subject|0|||
131211003|NCT04338685|472395360|FG005|Overall Study|Withdrawal by Subject|5|||
131211004|NCT04338685|472395361|FG006|Overall Study|Withdrawal by Subject|1|||
131211005|NCT04338685|472395362|FG007|Overall Study|Withdrawal by Subject|1|||
131211006|NCT04338685|472395363|FG008|Overall Study|Withdrawal by Subject|0|||
131211007|NCT02967055|472395364|FG000|Overall Study|Excluded|40|||
131211008|NCT02967055|472395364|FG000|Overall Study|Screen fail|3|||
131211009|NCT02967055|472395364|FG000|Overall Study|Lost to Follow-up|2|||
131211010|NCT02967055|472395364|FG000|Overall Study|Stopped due to side effects|3|||
131211011|NCT02967055|472395364|FG000|Overall Study|Stopped due to drug cost|1|||
131211012|NCT00145795|472395365|FG000|Overall Study|Adverse Event|1|||
131211013|NCT00145795|472395366|FG001|Overall Study|Adverse Event|0|||
131211014|NCT00570492|472395367|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
131211015|NCT00570492|472395368|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
131211016|NCT00570492|472395369|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
131211017|NCT00570492|472395367|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
131211018|NCT00570492|472395368|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
131211019|NCT00570492|472395369|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
131211020|NCT00570492|472395367|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
131211021|NCT00570492|472395368|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
131211022|NCT00570492|472395369|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
131211023|NCT00570492|472395367|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
131211024|NCT00570492|472395368|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
131211025|NCT00570492|472395369|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
131211026|NCT00570492|472395367|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
131211027|NCT00570492|472395368|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
131211028|NCT00570492|472395369|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
131211029|NCT00570492|472395367|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
131211030|NCT00570492|472395368|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
131211031|NCT00570492|472395369|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
131211032|NCT00570492|472395367|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
131211033|NCT00570492|472395368|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
131211034|NCT00570492|472395369|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
131211035|NCT00570492|472395367|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
131211036|NCT00570492|472395368|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
131211037|NCT00570492|472395369|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
131211038|NCT00570492|472395367|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
131211039|NCT00570492|472395368|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
131211040|NCT00570492|472395369|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
131211041|NCT00570492|472395367|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
131211042|NCT00570492|472395368|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
131211043|NCT00570492|472395369|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
131211044|NCT00570492|472395367|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
131211045|NCT00570492|472395368|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
131211046|NCT00570492|472395369|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
131211047|NCT00570492|472395367|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
131211048|NCT00570492|472395368|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
131211049|NCT00570492|472395369|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
131211050|NCT00570492|472395367|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
131211051|NCT00570492|472395368|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
131211052|NCT00570492|472395369|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
131211053|NCT00570492|472395367|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
131211054|NCT00570492|472395368|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
131211055|NCT00570492|472395369|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
131211056|NCT00908375|472395370|FG000|Overall Study|Withdrawal by Subject|2|||
131211057|NCT00908375|472395371|FG001|Overall Study|Withdrawal by Subject|4|||
131211058|NCT00908375|472395370|FG000|Overall Study|Lost to Follow-up|8|||
131211059|NCT00908375|472395371|FG001|Overall Study|Lost to Follow-up|6|||
131211060|NCT03958045|472395374|FG000|Overall Study|Withdrawal by Subject|1|||
131211061|NCT02283411|472395375|FG000|Overall Study|Withdrawal by Subject|3|||
131211062|NCT02283411|472395375|FG000|Overall Study|Screen Failed|28|||
131211063|NCT01298323|472395377|FG000|Overall Study|Adverse Event|2|||
131211064|NCT01298323|472395378|FG001|Overall Study|Adverse Event|4|||
131211065|NCT01298323|472395377|FG000|Overall Study|Death|11|||
131211066|NCT01298323|472395378|FG001|Overall Study|Death|16|||
131211067|NCT01298323|472395377|FG000|Overall Study|Lost to Follow-up|1|||
131211068|NCT01298323|472395378|FG001|Overall Study|Lost to Follow-up|0|||
131211069|NCT01298323|472395377|FG000|Overall Study|Withdrawal by Subject|6|||
131211070|NCT01298323|472395378|FG001|Overall Study|Withdrawal by Subject|3|||
131211071|NCT01298323|472395377|FG000|Overall Study|Protocol Violation|1|||
131211072|NCT01298323|472395378|FG001|Overall Study|Protocol Violation|0|||
131211073|NCT01298323|472395377|FG000|Overall Study|Other|10|||
131211074|NCT01298323|472395378|FG001|Overall Study|Other|9|||
131211075|NCT01298323|472395377|FG000|Overall Study|Ongoing|55|||
131211076|NCT01298323|472395378|FG001|Overall Study|Ongoing|55|||
131211077|NCT01298323|472395377|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131211078|NCT01298323|472395378|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131211079|NCT02500732|472395380|FG000|Overall Study|Physician Decision|0|||
131211080|NCT02500732|472395381|FG001|Overall Study|Physician Decision|1|||
131211081|NCT04409262|472395382|FG000|Overall Study|Adverse Event|0|||
131211082|NCT04409262|472395383|FG001|Overall Study|Adverse Event|2|||
131211083|NCT04409262|472395382|FG000|Overall Study|Death|55|||
131211084|NCT04409262|472395383|FG001|Overall Study|Death|97|||
131211085|NCT04409262|472395382|FG000|Overall Study|Lost to Follow-up|12|||
131211086|NCT04409262|472395383|FG001|Overall Study|Lost to Follow-up|23|||
131211087|NCT04409262|472395382|FG000|Overall Study|Lack of Staff|0|||
131211088|NCT04409262|472395383|FG001|Overall Study|Lack of Staff|1|||
131211089|NCT04409262|472395382|FG000|Overall Study|Protocol Violation|3|||
131211090|NCT04409262|472395383|FG001|Overall Study|Protocol Violation|1|||
131211091|NCT04409262|472395382|FG000|Overall Study|Withdrawal by Subject|5|||
131211092|NCT04409262|472395383|FG001|Overall Study|Withdrawal by Subject|10|||
131211093|NCT02396849|472395384|FG000|Overall Study|Lost to Follow-up|1|||
131211094|NCT02396849|472395385|FG001|Overall Study|Lost to Follow-up|1|||
131211095|NCT02396849|472395384|FG000|Overall Study|Did not tolerate intervention|1|||
131211096|NCT02396849|472395385|FG001|Overall Study|Did not tolerate intervention|1|||
131211097|NCT00931515|472395388|FG000|Overall Study|Lost to Follow-up|2|||
131211098|NCT00931515|472395389|FG001|Overall Study|Lost to Follow-up|5|||
131211099|NCT03759340|472395390|FG000|Overall Study|Adverse Event|2|||
131211100|NCT03759340|472395390|FG000|Overall Study|Lost to Follow-up|1|||
131211101|NCT03759340|472395390|FG000|Overall Study|Withdrawal by Subject|15|||
131211102|NCT03759340|472395390|FG000|Overall Study|Study Terminated by Sponsor|38|||
131211103|NCT02950831|472395391|FG000|Overall Study|Lost to Follow-up|1|||
131211104|NCT02950831|472395391|FG000|Overall Study|Withdrawal by Subject|3|||
131211105|NCT02950831|472395391|FG000|Overall Study|stimulation trail failure|5|||
131211106|NCT00945815|472395392|FG000|Overall Study|Death|3|||
131211107|NCT00945815|472395392|FG000|Overall Study|Not protocol specified|1|||
131211108|NCT00945815|472395392|FG000|Overall Study|Ineligible|3|||
131211109|NCT00945815|472395392|FG000|Overall Study|Did not begin protocol therapy|1|||
131211110|NCT01965600|472395393|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
131211111|NCT01965600|472395394|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
131211112|NCT01965600|472395395|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
131211113|NCT01965600|472395396|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
131211114|NCT01965600|472395393|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
131211115|NCT01965600|472395394|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
131211116|NCT01965600|472395395|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
131211117|NCT01965600|472395396|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
131211118|NCT01965600|472395393|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
131211119|NCT01965600|472395394|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
131211120|NCT01965600|472395395|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
131211121|NCT01965600|472395396|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
131211122|NCT01965600|472395393|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
131211123|NCT01965600|472395394|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
131211124|NCT01965600|472395395|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
131211125|NCT01965600|472395396|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
131211126|NCT01965600|472395393|FG000|Second Intervention|Study terminated by Sponsor|0|||
131211127|NCT01965600|472395394|FG001|Second Intervention|Study terminated by Sponsor|0|||
131211128|NCT01965600|472395395|FG002|Second Intervention|Study terminated by Sponsor|2|||
131211129|NCT01965600|472395396|FG003|Second Intervention|Study terminated by Sponsor|2|||
131211130|NCT03418727|472395404|FG000|Overall Study|Adverse Event|1|||
131211131|NCT03418727|472395405|FG001|Overall Study|Adverse Event|2|||
131211132|NCT03418727|472395406|FG002|Overall Study|Adverse Event|0|||
131211133|NCT03418727|472395404|FG000|Overall Study|Withdrawal by Subject|0|||
131211134|NCT03418727|472395405|FG001|Overall Study|Withdrawal by Subject|0|||
131211135|NCT03418727|472395406|FG002|Overall Study|Withdrawal by Subject|2|||
131211136|NCT00686894|472395408|FG000|Overall Study|Relapse|2|||
131211137|NCT00686894|472395408|FG000|Overall Study|Protocol Violation|4|||
131211138|NCT01790633|472395409|FG000|Overall Study|Protocol Violation|1|||
131211139|NCT01790633|472395410|FG001|Overall Study|Protocol Violation|2|||
131211140|NCT01790633|472395409|FG000|Overall Study|Did not have serology performed|47|||
131211141|NCT01790633|472395410|FG001|Overall Study|Did not have serology performed|0|||
131211142|NCT01790633|472395409|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
131211143|NCT01790633|472395410|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
131211144|NCT00157157|472395411|FG000|Overall Study|Withdrawal by Subject|6|||
131211145|NCT00157157|472395411|FG000|Overall Study|Physician Decision|1|||
131211146|NCT00157157|472395411|FG000|Overall Study|Lost to Follow-up|1|||
131211147|NCT00157157|472395411|FG000|Overall Study|Enrolled in another study|1|||
131211148|NCT00157157|472395411|FG000|Overall Study|Met exclusion criteria|1|||
131211149|NCT00157157|472395411|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
131211150|NCT02260804|472395418|FG000|Induction Study Period|Protocol Violation|2|||
131211151|NCT02260804|472395419|FG001|Induction Study Period|Protocol Violation|0|||
131211152|NCT02260804|472395418|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
131211153|NCT02260804|472395419|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
131211154|NCT02260804|472395418|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
131211155|NCT02260804|472395419|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
131211156|NCT02260804|472395418|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
131211157|NCT02260804|472395419|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
131211158|NCT02260804|472395418|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
131211159|NCT02260804|472395419|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
131211160|NCT02260804|472395418|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
131211161|NCT02260804|472395419|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
131211162|NCT02260804|472395418|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
131211163|NCT02260804|472395419|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
130764090|NCT01004432|470759961|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
130764091|NCT01004432|470759962|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130876347|NCT00528957|471177500|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
130876348|NCT00528957|471177501|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
130876349|NCT00528957|471177500|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
130876350|NCT00528957|471177501|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
130876351|NCT00528957|471177500|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
130876352|NCT00528957|471177501|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
131211164|NCT02260804|472395418|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
131211165|NCT02260804|472395419|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
130876353|NCT00528957|471177500|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
130876354|NCT00528957|471177501|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
130876355|NCT00528957|471177500|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
130876356|NCT00528957|471177501|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
131211166|NCT02260804|472395418|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
131211167|NCT02260804|472395419|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
131211168|NCT02260804|472395418|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
131211169|NCT02260804|472395419|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
131211170|NCT02260804|472395418|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
131211171|NCT02260804|472395419|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
131211172|NCT04887922|472397258|FG000|1st Randomization|Decided not to have surgery|0|||
131211173|NCT04887922|472397259|FG001|1st Randomization|Decided not to have surgery|1|||
131211174|NCT04887922|472397260|FG002|1st Randomization|Decided not to have surgery|0|||
131211175|NCT04887922|472397261|FG003|1st Randomization|Decided not to have surgery|0|||
131211176|NCT04887922|472397262|FG004|1st Randomization|Decided not to have surgery|0|||
131211177|NCT00953017|472397263|FG000|Overall Study|DId not show up for colonoscopy|4|||
131211178|NCT00953017|472397264|FG001|Overall Study|DId not show up for colonoscopy|4|||
131211179|NCT00953017|472397265|FG002|Overall Study|DId not show up for colonoscopy|5|||
131211180|NCT00953017|472397266|FG003|Overall Study|DId not show up for colonoscopy|4|||
131211181|NCT00953017|472397263|FG000|Overall Study|Incomplete data|1|||
131211182|NCT00953017|472397264|FG001|Overall Study|Incomplete data|1|||
131211183|NCT00953017|472397265|FG002|Overall Study|Incomplete data|0|||
131211184|NCT00953017|472397266|FG003|Overall Study|Incomplete data|0|||
131211185|NCT00953017|472397263|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
131211186|NCT00953017|472397264|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
131211187|NCT00953017|472397265|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
131211188|NCT00953017|472397266|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
131211189|NCT00953017|472397263|FG000|Overall Study|Brown stool prior to procedure|0|||
131211190|NCT00953017|472397264|FG001|Overall Study|Brown stool prior to procedure|0|||
131211191|NCT00953017|472397265|FG002|Overall Study|Brown stool prior to procedure|1|||
131211192|NCT00953017|472397266|FG003|Overall Study|Brown stool prior to procedure|0|||
131211193|NCT00718809|472397269|FG000|Overall Study|Disease progression|9|||
131211194|NCT00718809|472397270|FG001|Overall Study|Disease progression|7|||
131211195|NCT00718809|472397269|FG000|Overall Study|Adverse Event|1|||
131211196|NCT00718809|472397270|FG001|Overall Study|Adverse Event|1|||
131211197|NCT00718809|472397269|FG000|Overall Study|Withdrawal by Subject|0|||
131211198|NCT00718809|472397270|FG001|Overall Study|Withdrawal by Subject|1|||
131211199|NCT00718809|472397269|FG000|Overall Study|Lost to Follow-up|1|||
131211200|NCT00718809|472397270|FG001|Overall Study|Lost to Follow-up|0|||
131211201|NCT00718809|472397269|FG000|Overall Study|Noncompliance|1|||
131211202|NCT00718809|472397270|FG001|Overall Study|Noncompliance|0|||
131211203|NCT00463385|472397271|FG000|Overall Study|Other|4|||
131211204|NCT00463385|472397272|FG001|Overall Study|Other|3|||
130876357|NCT00528957|471177500|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
130876358|NCT00528957|471177501|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
130876359|NCT00528957|471177500|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
130876360|NCT00528957|471177501|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
130876361|NCT00528957|471177500|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
130876362|NCT00528957|471177501|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
130876363|NCT00528957|471177500|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
130876364|NCT00528957|471177501|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
130876365|NCT00528957|471177500|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
130876366|NCT00528957|471177501|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
130876367|NCT00528957|471177500|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
130876368|NCT00528957|471177501|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
130876369|NCT00528957|471177500|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
130876370|NCT00528957|471177501|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
130876371|NCT00528957|471177500|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
130876372|NCT00528957|471177501|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
130876373|NCT00528957|471177500|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
130876374|NCT00528957|471177501|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
130876375|NCT00528957|471177500|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
130876376|NCT00528957|471177501|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
130876377|NCT00528957|471177500|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
130876378|NCT00528957|471177501|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
130876379|NCT02051764|471177506|FG000|Overall Study|Study terminated by sponsor|0|||
130876380|NCT02051764|471177507|FG001|Overall Study|Study terminated by sponsor|7|||
130876381|NCT03624881|471177508|FG000|Overall Study|Screen Failure|14|||
130876382|NCT03624881|471177509|FG001|Overall Study|Screen Failure|0|||
130876383|NCT03624881|471177508|FG000|Overall Study|No Catheter Inserted|6|||
130876384|NCT03624881|471177509|FG001|Overall Study|No Catheter Inserted|1|||
130876385|NCT03624881|471177508|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
130876386|NCT03624881|471177509|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
131211205|NCT00463385|472397273|FG002|Overall Study|Other|6|||
131211206|NCT00463385|472397274|FG003|Overall Study|Other|4|||
131211207|NCT00463385|472397271|FG000|Overall Study|Adverse Event|5|||
131211208|NCT00463385|472397272|FG001|Overall Study|Adverse Event|8|||
131211209|NCT00463385|472397273|FG002|Overall Study|Adverse Event|4|||
131211210|NCT00463385|472397274|FG003|Overall Study|Adverse Event|2|||
131211211|NCT00463385|472397271|FG000|Overall Study|Lack of Efficacy|6|||
131211212|NCT00463385|472397272|FG001|Overall Study|Lack of Efficacy|6|||
131211213|NCT00463385|472397273|FG002|Overall Study|Lack of Efficacy|7|||
131211214|NCT00463385|472397274|FG003|Overall Study|Lack of Efficacy|9|||
131211215|NCT00463385|472397271|FG000|Overall Study|Withdrawal by Subject|3|||
131211216|NCT00463385|472397272|FG001|Overall Study|Withdrawal by Subject|3|||
131211217|NCT00463385|472397273|FG002|Overall Study|Withdrawal by Subject|3|||
131211218|NCT00463385|472397274|FG003|Overall Study|Withdrawal by Subject|4|||
131211219|NCT00463385|472397271|FG000|Overall Study|Lost to Follow-up|0|||
131211220|NCT00463385|472397272|FG001|Overall Study|Lost to Follow-up|0|||
131211221|NCT00463385|472397273|FG002|Overall Study|Lost to Follow-up|0|||
131211222|NCT00463385|472397274|FG003|Overall Study|Lost to Follow-up|1|||
131211223|NCT00463385|472397271|FG000|Overall Study|Death|2|||
130876387|NCT03624881|471177508|FG000|Overall Study|Death|2|||
130876388|NCT03624881|471177509|FG001|Overall Study|Death|0|||
130876389|NCT03624881|471177508|FG000|Overall Study|Lost to Follow-up|10|||
131211224|NCT00463385|472397272|FG001|Overall Study|Death|1|||
131211225|NCT00463385|472397273|FG002|Overall Study|Death|2|||
131211226|NCT00463385|472397274|FG003|Overall Study|Death|0|||
131211227|NCT00463385|472397271|FG000|Overall Study|Missing|2|||
131211228|NCT00463385|472397272|FG001|Overall Study|Missing|0|||
131211229|NCT00463385|472397273|FG002|Overall Study|Missing|0|||
131211230|NCT00463385|472397274|FG003|Overall Study|Missing|2|||
131211231|NCT00463385|472397271|FG000|Overall Study|1 participant received commercial drug|0|||
131211232|NCT00463385|472397272|FG001|Overall Study|1 participant received commercial drug|1|||
131211233|NCT00463385|472397273|FG002|Overall Study|1 participant received commercial drug|0|||
131211234|NCT00463385|472397274|FG003|Overall Study|1 participant received commercial drug|0|||
130876390|NCT03624881|471177509|FG001|Overall Study|Lost to Follow-up|4|||
131211235|NCT00449761|472397275|FG000|Overall Study|Disease progression|12|||
131211236|NCT00449761|472397275|FG000|Overall Study|Death|5|||
131211237|NCT00449761|472397275|FG000|Overall Study|New cancer therapy|1|||
131211238|NCT00344968|472397278|FG000|Overall Study|Adverse Event|5|||
131211239|NCT00344968|472397279|FG001|Overall Study|Adverse Event|4|||
131211240|NCT00344968|472397280|FG002|Overall Study|Adverse Event|15|||
131211241|NCT00344968|472397278|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131211242|NCT00344968|472397279|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131211243|NCT00344968|472397280|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
131211244|NCT00344968|472397278|FG000|Overall Study|Protocol Violation|2|||
131211245|NCT00344968|472397279|FG001|Overall Study|Protocol Violation|2|||
131211246|NCT00344968|472397280|FG002|Overall Study|Protocol Violation|5|||
131211247|NCT00344968|472397278|FG000|Overall Study|Withdrawal by Subject|14|||
131211248|NCT00344968|472397279|FG001|Overall Study|Withdrawal by Subject|31|||
131211249|NCT00344968|472397280|FG002|Overall Study|Withdrawal by Subject|27|||
131211250|NCT00344968|472397278|FG000|Overall Study|Lost to Follow-up|24|||
131211251|NCT00344968|472397279|FG001|Overall Study|Lost to Follow-up|37|||
131211252|NCT00344968|472397280|FG002|Overall Study|Lost to Follow-up|37|||
131211253|NCT00344968|472397278|FG000|Overall Study|Death|11|||
131211254|NCT00344968|472397279|FG001|Overall Study|Death|27|||
131211255|NCT00344968|472397280|FG002|Overall Study|Death|31|||
131211256|NCT00344968|472397278|FG000|Overall Study|Other|0|||
131211257|NCT00344968|472397279|FG001|Overall Study|Other|1|||
131211258|NCT00344968|472397280|FG002|Overall Study|Other|0|||
131211259|NCT03735680|472397281|FG000|Overall Study|Withdrawal by Subject|0|||
131211260|NCT03735680|472397282|FG001|Overall Study|Withdrawal by Subject|1|||
131211261|NCT03735680|472397283|FG002|Overall Study|Withdrawal by Subject|0|||
131211262|NCT03735680|472397284|FG003|Overall Study|Withdrawal by Subject|0|||
131211263|NCT03735680|472397285|FG004|Overall Study|Withdrawal by Subject|0|||
131211264|NCT03735680|472397286|FG005|Overall Study|Withdrawal by Subject|1|||
131211265|NCT03735680|472397281|FG000|Overall Study|Patient unable or unwilling to continue|0|||
131211266|NCT03735680|472397282|FG001|Overall Study|Patient unable or unwilling to continue|0|||
131211267|NCT03735680|472397283|FG002|Overall Study|Patient unable or unwilling to continue|1|||
131211268|NCT03735680|472397284|FG003|Overall Study|Patient unable or unwilling to continue|0|||
131211269|NCT03735680|472397285|FG004|Overall Study|Patient unable or unwilling to continue|0|||
131211270|NCT03735680|472397286|FG005|Overall Study|Patient unable or unwilling to continue|0|||
131211271|NCT01422876|472397288|FG000|Week 24|Lost to Follow-up|1|||
131211272|NCT01422876|472397289|FG001|Week 24|Lost to Follow-up|1|||
131211273|NCT01422876|472397290|FG002|Week 24|Lost to Follow-up|2|||
131211274|NCT01422876|472397291|FG003|Week 24|Lost to Follow-up|4|||
131211275|NCT01422876|472397292|FG004|Week 24|Lost to Follow-up|2|||
131211276|NCT01422876|472397293|FG005|Week 24|Lost to Follow-up|0|||
131211277|NCT01422876|472397294|FG006|Week 24|Lost to Follow-up|1|||
131211278|NCT01422876|472397295|FG007|Week 24|Lost to Follow-up|3|||
131211279|NCT01422876|472397296|FG008|Week 24|Lost to Follow-up|3|||
131211280|NCT01422876|472397297|FG009|Week 24|Lost to Follow-up|4|||
131211281|NCT01422876|472397288|FG000|Week 24|Consent withdrawn|5|||
131211282|NCT01422876|472397289|FG001|Week 24|Consent withdrawn|1|||
131211283|NCT01422876|472397290|FG002|Week 24|Consent withdrawn|3|||
131211284|NCT01422876|472397291|FG003|Week 24|Consent withdrawn|4|||
131211285|NCT01422876|472397292|FG004|Week 24|Consent withdrawn|5|||
131211286|NCT01422876|472397293|FG005|Week 24|Consent withdrawn|6|||
131211287|NCT01422876|472397294|FG006|Week 24|Consent withdrawn|5|||
130876391|NCT03624881|471177508|FG000|Overall Study|Withdrawal by Subject|12|||
130876392|NCT03624881|471177509|FG001|Overall Study|Withdrawal by Subject|1|||
130876393|NCT05435339|471177510|FG000|Overall Study|Death|1|||
130988065|NCT03324880|471582832|FG001|Overall Study|Lost to Follow-up|1|||
131211288|NCT01422876|472397295|FG007|Week 24|Consent withdrawn|4|||
131211289|NCT01422876|472397296|FG008|Week 24|Consent withdrawn|3|||
131211290|NCT01422876|472397297|FG009|Week 24|Consent withdrawn|6|||
131211291|NCT01422876|472397288|FG000|Week 24|Death|0|||
131211292|NCT01422876|472397289|FG001|Week 24|Death|1|||
131211293|NCT01422876|472397290|FG002|Week 24|Death|0|||
131211294|NCT01422876|472397291|FG003|Week 24|Death|0|||
131211295|NCT01422876|472397292|FG004|Week 24|Death|0|||
131211296|NCT01422876|472397293|FG005|Week 24|Death|0|||
131211297|NCT01422876|472397294|FG006|Week 24|Death|0|||
131211298|NCT01422876|472397295|FG007|Week 24|Death|0|||
131211299|NCT01422876|472397296|FG008|Week 24|Death|0|||
131211300|NCT01422876|472397297|FG009|Week 24|Death|0|||
131211301|NCT01422876|472397288|FG000|Week 52|Lost to Follow-up|3|||
131211302|NCT01422876|472397289|FG001|Week 52|Lost to Follow-up|5|||
131211303|NCT01422876|472397290|FG002|Week 52|Lost to Follow-up|7|||
131211304|NCT01422876|472397291|FG003|Week 52|Lost to Follow-up|5|||
131211305|NCT01422876|472397292|FG004|Week 52|Lost to Follow-up|8|||
131211306|NCT01422876|472397293|FG005|Week 52|Lost to Follow-up|5|||
131211307|NCT01422876|472397294|FG006|Week 52|Lost to Follow-up|5|||
131211308|NCT01422876|472397295|FG007|Week 52|Lost to Follow-up|8|||
131211309|NCT01422876|472397296|FG008|Week 52|Lost to Follow-up|7|||
131211310|NCT01422876|472397297|FG009|Week 52|Lost to Follow-up|8|||
131211311|NCT01422876|472397288|FG000|Week 52|Consent withdrawn|9|||
131211312|NCT01422876|472397289|FG001|Week 52|Consent withdrawn|4|||
131211313|NCT01422876|472397290|FG002|Week 52|Consent withdrawn|6|||
131211314|NCT01422876|472397291|FG003|Week 52|Consent withdrawn|12|||
131211315|NCT01422876|472397292|FG004|Week 52|Consent withdrawn|7|||
131211316|NCT01422876|472397293|FG005|Week 52|Consent withdrawn|12|||
131211317|NCT01422876|472397294|FG006|Week 52|Consent withdrawn|10|||
131211318|NCT01422876|472397295|FG007|Week 52|Consent withdrawn|12|||
131211319|NCT01422876|472397296|FG008|Week 52|Consent withdrawn|13|||
131211320|NCT01422876|472397297|FG009|Week 52|Consent withdrawn|9|||
131211321|NCT01422876|472397288|FG000|Week 52|Death|0|||
131211322|NCT01422876|472397289|FG001|Week 52|Death|1|||
131211323|NCT01422876|472397290|FG002|Week 52|Death|0|||
131211324|NCT01422876|472397291|FG003|Week 52|Death|1|||
131211325|NCT01422876|472397292|FG004|Week 52|Death|0|||
131211326|NCT01422876|472397293|FG005|Week 52|Death|0|||
131211327|NCT01422876|472397294|FG006|Week 52|Death|1|||
131211328|NCT01422876|472397295|FG007|Week 52|Death|3|||
131211329|NCT01422876|472397296|FG008|Week 52|Death|1|||
131211330|NCT01422876|472397297|FG009|Week 52|Death|0|||
131211331|NCT00536991|472397309|FG000|Overall Study|Withdrawal by Subject|10|||
131211332|NCT00536991|472397309|FG000|Overall Study|Physician Decision|1|||
131211333|NCT00536991|472397309|FG000|Overall Study|patient ineligible|2|||
131211334|NCT00054639|472397310|FG000|Overall Study|Lack of Efficacy|1|||
131211335|NCT00054639|472397310|FG000|Overall Study|Physician Decision|1|||
131211336|NCT01600755|472397311|FG000|Overall Study|Withdrawal by Subject|6|||
131211337|NCT04621227|472397320|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
131211338|NCT04621227|472397320|FG000|Period 3 (29 Days)|Adverse Event|1|||
131211339|NCT04621227|472397320|FG000|Period 8 (2 Days)|Adverse Event|1|||
131211340|NCT01548573|472397321|FG000|Overall Study|Death|3|||
131211341|NCT01548573|472397321|FG000|Overall Study|Withdrawal by Subject|2|||
131211342|NCT01366846|472397324|FG000|Overall Study|Withdrawal by Subject|2|||
131211343|NCT01366846|472397325|FG001|Overall Study|Withdrawal by Subject|0|||
131211344|NCT01366846|472397326|FG002|Overall Study|Withdrawal by Subject|0|||
131211345|NCT01366846|472397327|FG003|Overall Study|Withdrawal by Subject|0|||
131211346|NCT01366846|472397324|FG000|Overall Study|Communication Difficulties|1|||
131211347|NCT01366846|472397325|FG001|Overall Study|Communication Difficulties|4|||
131211348|NCT01366846|472397326|FG002|Overall Study|Communication Difficulties|0|||
130988066|NCT03324880|471582831|FG000|Overall Study|Product Recall|0|||
130988067|NCT03324880|471582832|FG001|Overall Study|Product Recall|1|||
130988068|NCT00652938|471582833|FG000|Overall Study|Adverse Event|1|||
130988069|NCT00652938|471582834|FG001|Overall Study|Adverse Event|0|||
130988070|NCT00652938|471582835|FG002|Overall Study|Adverse Event|2|||
130988071|NCT00652938|471582833|FG000|Overall Study|Withdrawal by Subject|0|||
130988072|NCT00652938|471582834|FG001|Overall Study|Withdrawal by Subject|6|||
130988073|NCT00652938|471582835|FG002|Overall Study|Withdrawal by Subject|1|||
130988074|NCT00652938|471582833|FG000|Overall Study|Lost to Follow-up|0|||
130988075|NCT00652938|471582834|FG001|Overall Study|Lost to Follow-up|0|||
130988076|NCT00652938|471582835|FG002|Overall Study|Lost to Follow-up|2|||
130988077|NCT00652938|471582833|FG000|Overall Study|fear of blood sampling|0|||
130988078|NCT00652938|471582834|FG001|Overall Study|fear of blood sampling|1|||
130988079|NCT00652938|471582835|FG002|Overall Study|fear of blood sampling|0|||
130988080|NCT01412801|471582836|FG000|Overall Study|Death|0|||
130988081|NCT01412801|471582837|FG001|Overall Study|Death|1|||
130988082|NCT01412801|471582838|FG002|Overall Study|Death|0|||
130988083|NCT01412801|471582839|FG003|Overall Study|Death|4|||
130988084|NCT01412801|471582840|FG004|Overall Study|Death|2|||
130988085|NCT01412801|471582841|FG005|Overall Study|Death|2|||
130988086|NCT01412801|471582836|FG000|Overall Study|Lost to Follow-up|1|||
130988087|NCT01412801|471582837|FG001|Overall Study|Lost to Follow-up|2|||
130988088|NCT01412801|471582838|FG002|Overall Study|Lost to Follow-up|4|||
130988089|NCT01412801|471582839|FG003|Overall Study|Lost to Follow-up|0|||
130988090|NCT01412801|471582840|FG004|Overall Study|Lost to Follow-up|1|||
130988091|NCT01412801|471582841|FG005|Overall Study|Lost to Follow-up|1|||
130988092|NCT01412801|471582836|FG000|Overall Study|Withdrawal by Subject|3|||
130988093|NCT01412801|471582837|FG001|Overall Study|Withdrawal by Subject|2|||
131211349|NCT01366846|472397327|FG003|Overall Study|Communication Difficulties|1|||
131211350|NCT01366846|472397324|FG000|Overall Study|Scheduling Conflicts|0|||
131211351|NCT01366846|472397325|FG001|Overall Study|Scheduling Conflicts|0|||
130988094|NCT01412801|471582838|FG002|Overall Study|Withdrawal by Subject|1|||
130988095|NCT01412801|471582839|FG003|Overall Study|Withdrawal by Subject|0|||
130988096|NCT01412801|471582840|FG004|Overall Study|Withdrawal by Subject|0|||
130988097|NCT01412801|471582841|FG005|Overall Study|Withdrawal by Subject|0|||
130988098|NCT01412801|471582836|FG000|Overall Study|Relocated to another area|0|||
130988099|NCT01412801|471582837|FG001|Overall Study|Relocated to another area|0|||
130988100|NCT01412801|471582838|FG002|Overall Study|Relocated to another area|2|||
130988101|NCT01412801|471582839|FG003|Overall Study|Relocated to another area|0|||
130988102|NCT01412801|471582840|FG004|Overall Study|Relocated to another area|0|||
130988103|NCT01412801|471582841|FG005|Overall Study|Relocated to another area|0|||
130988104|NCT00116272|471582842|FG000|Overall Study|Lost to Follow-up|11|||
130988105|NCT00116272|471582843|FG001|Overall Study|Lost to Follow-up|6|||
130988106|NCT01547299|471582846|FG000|Overall Study|Withdrawal by Subject|2|||
130988107|NCT01547299|471582847|FG001|Overall Study|Withdrawal by Subject|2|||
130988108|NCT01576718|471582848|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
130988109|NCT01576718|471582849|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130988110|NCT01576718|471582850|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130988111|NCT01576718|471582851|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130988112|NCT01576718|471582852|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130988113|NCT01576718|471582853|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130988114|NCT01576718|471582854|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130988115|NCT01576718|471582848|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
130988116|NCT01576718|471582849|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130988117|NCT01576718|471582850|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130988118|NCT01576718|471582851|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130988119|NCT01576718|471582852|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130988120|NCT01576718|471582853|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130988121|NCT01576718|471582854|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130988122|NCT01576718|471582848|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
130988123|NCT01576718|471582849|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130988124|NCT01576718|471582850|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130988125|NCT01576718|471582851|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130988126|NCT01576718|471582852|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130988127|NCT01576718|471582853|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130988128|NCT01576718|471582854|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130988129|NCT01576718|471582848|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
130988130|NCT01576718|471582849|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130988131|NCT01576718|471582850|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130988132|NCT01576718|471582851|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130988133|NCT01576718|471582852|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130988134|NCT01576718|471582853|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130988135|NCT01576718|471582854|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130988136|NCT01576718|471582848|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
130988137|NCT01576718|471582849|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130988138|NCT01576718|471582850|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130988139|NCT01576718|471582851|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130988140|NCT01576718|471582852|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130988141|NCT01576718|471582853|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130988142|NCT01576718|471582854|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130988143|NCT01576718|471582848|FG000|Treatment Period|Adverse Event|0|||
130988144|NCT01576718|471582849|FG001|Treatment Period|Adverse Event|1|||
130988145|NCT01576718|471582850|FG002|Treatment Period|Adverse Event|1|||
130988146|NCT01576718|471582851|FG003|Treatment Period|Adverse Event|1|||
130988147|NCT01576718|471582852|FG004|Treatment Period|Adverse Event|1|||
130988148|NCT01576718|471582853|FG005|Treatment Period|Adverse Event|1|||
130988149|NCT01576718|471582854|FG006|Treatment Period|Adverse Event|0|||
130988150|NCT01576718|471582848|FG000|Treatment Period|Withdrawal by Subject|0|||
130988151|NCT01576718|471582849|FG001|Treatment Period|Withdrawal by Subject|1|||
130988152|NCT01576718|471582850|FG002|Treatment Period|Withdrawal by Subject|1|||
130988153|NCT01576718|471582851|FG003|Treatment Period|Withdrawal by Subject|0|||
130988154|NCT01576718|471582852|FG004|Treatment Period|Withdrawal by Subject|2|||
130988155|NCT01576718|471582853|FG005|Treatment Period|Withdrawal by Subject|4|||
130988156|NCT01576718|471582854|FG006|Treatment Period|Withdrawal by Subject|2|||
130988157|NCT01576718|471582848|FG000|Treatment Period|Physician Decision|0|||
130988158|NCT01576718|471582849|FG001|Treatment Period|Physician Decision|1|||
130988159|NCT01576718|471582850|FG002|Treatment Period|Physician Decision|1|||
130988160|NCT01576718|471582851|FG003|Treatment Period|Physician Decision|1|||
131211352|NCT01366846|472397326|FG002|Overall Study|Scheduling Conflicts|1|||
131211353|NCT01366846|472397327|FG003|Overall Study|Scheduling Conflicts|0|||
131211354|NCT00558831|472397333|FG000|Overall Study|Lost to Follow-up|1|||
131211355|NCT00447265|472397334|FG000|Overall Study|Physician Decision|1|||
131211356|NCT00447265|472397335|FG001|Overall Study|Physician Decision|0|||
131211357|NCT02204449|472397338|FG000|Overall Study|Lost to Follow-up|7|||
131211358|NCT02204449|472397339|FG001|Overall Study|Lost to Follow-up|9|||
131211359|NCT02204449|472397338|FG000|Overall Study|Death|0|||
131211360|NCT02204449|472397339|FG001|Overall Study|Death|1|||
130988161|NCT01576718|471582852|FG004|Treatment Period|Physician Decision|1|||
130988162|NCT01576718|471582853|FG005|Treatment Period|Physician Decision|0|||
130988163|NCT01576718|471582854|FG006|Treatment Period|Physician Decision|0|||
130988164|NCT01576718|471582848|FG000|Treatment Period|Protocol Violation|0|||
130988165|NCT01576718|471582849|FG001|Treatment Period|Protocol Violation|5|||
131211361|NCT02204449|472397338|FG000|Overall Study|Withdrawal by Subject|0|||
131211362|NCT02204449|472397339|FG001|Overall Study|Withdrawal by Subject|1|||
131211363|NCT00503035|472397340|FG000|Overall Study|Lost to Follow-up|2|||
131211364|NCT00503035|472397340|FG000|Overall Study|Physician Decision|3|||
131211365|NCT00503035|472397340|FG000|Overall Study|Ineligible|15|||
130988166|NCT01576718|471582850|FG002|Treatment Period|Protocol Violation|4|||
131211366|NCT05028816|472397343|FG000|Overall Study|Lost to Follow-up|5|||
131211367|NCT05028816|472397344|FG001|Overall Study|Lost to Follow-up|3|||
131211368|NCT05028816|472397343|FG000|Overall Study|Withdrawal by Subject|4|||
131211369|NCT05028816|472397344|FG001|Overall Study|Withdrawal by Subject|1|||
131211370|NCT05028816|472397343|FG000|Overall Study|Physician Decision|1|||
131211371|NCT05028816|472397344|FG001|Overall Study|Physician Decision|0|||
131211372|NCT05064436|472397345|FG000|Overall Study|Other Reasons|1|||
131211373|NCT05064436|472397346|FG001|Overall Study|Other Reasons|0|||
131211374|NCT01711736|472397348|FG000|Overall Study|Lost to Follow-up|4|||
131211375|NCT01711736|472397349|FG001|Overall Study|Lost to Follow-up|1|||
131211376|NCT01711736|472397348|FG000|Overall Study|Withdrawal by Subject|6|||
130988167|NCT01576718|471582851|FG003|Treatment Period|Protocol Violation|10|||
130988168|NCT01576718|471582852|FG004|Treatment Period|Protocol Violation|6|||
130988169|NCT01576718|471582853|FG005|Treatment Period|Protocol Violation|8|||
130988170|NCT01576718|471582854|FG006|Treatment Period|Protocol Violation|12|||
130988171|NCT01576718|471582848|FG000|Treatment Period|Sponsor request|0|||
130988172|NCT01576718|471582849|FG001|Treatment Period|Sponsor request|1|||
130988173|NCT01576718|471582850|FG002|Treatment Period|Sponsor request|0|||
130988174|NCT01576718|471582851|FG003|Treatment Period|Sponsor request|0|||
130988175|NCT01576718|471582852|FG004|Treatment Period|Sponsor request|0|||
130988176|NCT01576718|471582853|FG005|Treatment Period|Sponsor request|1|||
130988177|NCT01576718|471582854|FG006|Treatment Period|Sponsor request|0|||
130988178|NCT01576718|471582848|FG000|Treatment Period|Met stopping criteria|0|||
130988179|NCT01576718|471582849|FG001|Treatment Period|Met stopping criteria|16|||
130988180|NCT01576718|471582850|FG002|Treatment Period|Met stopping criteria|13|||
130988181|NCT01576718|471582851|FG003|Treatment Period|Met stopping criteria|19|||
130988182|NCT01576718|471582852|FG004|Treatment Period|Met stopping criteria|16|||
130988183|NCT01576718|471582853|FG005|Treatment Period|Met stopping criteria|33|||
130988184|NCT01576718|471582854|FG006|Treatment Period|Met stopping criteria|15|||
130988185|NCT01576718|471582848|FG000|Treatment Period|Lost to Follow-up|0|||
130988186|NCT01576718|471582849|FG001|Treatment Period|Lost to Follow-up|0|||
130988187|NCT01576718|471582850|FG002|Treatment Period|Lost to Follow-up|0|||
130988188|NCT01576718|471582851|FG003|Treatment Period|Lost to Follow-up|0|||
130988189|NCT01576718|471582852|FG004|Treatment Period|Lost to Follow-up|1|||
130988190|NCT01576718|471582853|FG005|Treatment Period|Lost to Follow-up|0|||
130988191|NCT01576718|471582854|FG006|Treatment Period|Lost to Follow-up|0|||
130988192|NCT01576718|471582848|FG000|Treatment Period|Noncompliance to study medication|0|||
130988193|NCT01576718|471582849|FG001|Treatment Period|Noncompliance to study medication|0|||
130988194|NCT01576718|471582850|FG002|Treatment Period|Noncompliance to study medication|0|||
130988195|NCT01576718|471582851|FG003|Treatment Period|Noncompliance to study medication|0|||
130988196|NCT01576718|471582852|FG004|Treatment Period|Noncompliance to study medication|0|||
130988197|NCT01576718|471582853|FG005|Treatment Period|Noncompliance to study medication|1|||
130988198|NCT01576718|471582854|FG006|Treatment Period|Noncompliance to study medication|1|||
130988199|NCT06387472|471582861|FG000|Overall Study|Withdrawal by Subject|1|||
130988200|NCT06387472|471582861|FG000|Overall Study|Lost to Follow-up|2|||
130988201|NCT06387472|471582861|FG000|Overall Study|Physician Decision|1|||
130988202|NCT00045708|471585256|FG000|Phase 1|early progressive disease|0|||
130988203|NCT00045708|471585257|FG001|Phase 1|early progressive disease|1|||
130988204|NCT00045708|471585258|FG002|Phase 1|early progressive disease|0|||
130988205|NCT03237858|471585263|FG000|Overall Study|Death|19|||
130988206|NCT03237858|471585263|FG000|Overall Study|Withdrawal by Subject|37|||
130988207|NCT01862991|471585264|FG000|Overall Study|Lost to Follow-up|2|||
131211377|NCT01711736|472397349|FG001|Overall Study|Withdrawal by Subject|6|||
131211378|NCT01711736|472397348|FG000|Overall Study|Migrated/moved from study area|2|||
131211379|NCT01711736|472397349|FG001|Overall Study|Migrated/moved from study area|1|||
131211380|NCT01342445|472397350|FG000|Overall Study|Experienced side effects|0|||
131211381|NCT01342445|472397351|FG001|Overall Study|Experienced side effects|2|||
130988208|NCT01862991|471585265|FG001|Overall Study|Lost to Follow-up|1|||
130988209|NCT01862991|471585266|FG002|Overall Study|Lost to Follow-up|1|||
130988210|NCT01862991|471585264|FG000|Overall Study|Protocol Violation|1|||
130988211|NCT01862991|471585265|FG001|Overall Study|Protocol Violation|0|||
130988212|NCT01862991|471585266|FG002|Overall Study|Protocol Violation|0|||
130988213|NCT04858802|471585267|FG000|Overall Study|Lost to Follow-up|1|||
130988214|NCT04858802|471585268|FG001|Overall Study|Lost to Follow-up|1|||
130988215|NCT04858802|471585267|FG000|Overall Study|Withdrawal by Subject|1|||
130988216|NCT04858802|471585268|FG001|Overall Study|Withdrawal by Subject|1|||
130988217|NCT01108458|471585269|FG000|Overall Study|Withdrawal by Subject|1|||
130988218|NCT03328143|471585274|FG000|Overall Study|Declined|3|||
130988219|NCT03328143|471585274|FG000|Overall Study|Required increased sedation|4|||
130988220|NCT03328143|471585274|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
130988221|NCT03328143|471585274|FG000|Overall Study|Surgery cancelled|1|||
130988222|NCT02013388|471585282|FG000|Overall Study|work emergency|1|||
130988223|NCT02013388|471585283|FG001|Overall Study|work emergency|0|||
130988224|NCT02013388|471585284|FG002|Overall Study|work emergency|0|||
130988225|NCT02013388|471585285|FG003|Overall Study|work emergency|0|||
130988226|NCT02013388|471585286|FG004|Overall Study|work emergency|1|||
130988227|NCT02013388|471585287|FG005|Overall Study|work emergency|0|||
130988228|NCT02013388|471585288|FG006|Overall Study|work emergency|0|||
130988229|NCT02013388|471585289|FG007|Overall Study|work emergency|0|||
130988230|NCT03243422|471585290|FG000|Overall Study|Death|20|||
130988231|NCT03243422|471585291|FG001|Overall Study|Death|21|||
130988232|NCT03243422|471585290|FG000|Overall Study|Lost to Follow-up|9|||
130988233|NCT03243422|471585291|FG001|Overall Study|Lost to Follow-up|21|||
130988234|NCT03243422|471585290|FG000|Overall Study|Withdrawal by Subject|22|||
130988235|NCT03243422|471585291|FG001|Overall Study|Withdrawal by Subject|8|||
130988236|NCT02173054|471585292|FG000|Overall Study|lack of compliance|1|||
130988237|NCT02173054|471585293|FG001|Overall Study|lack of compliance|0|||
130988238|NCT02173054|471585294|FG002|Overall Study|lack of compliance|0|||
130988239|NCT02173054|471585292|FG000|Overall Study|Withdrawal by Subject|0|||
130988240|NCT02173054|471585293|FG001|Overall Study|Withdrawal by Subject|0|||
130988241|NCT02173054|471585294|FG002|Overall Study|Withdrawal by Subject|1|||
130988242|NCT01559454|471585297|FG000|Overall Study|Lost to Follow-up|3|||
130988243|NCT01559454|471585298|FG001|Overall Study|Lost to Follow-up|2|||
130988244|NCT01559454|471585297|FG000|Overall Study|Withdrawal by Subject|0|||
130988245|NCT01559454|471585298|FG001|Overall Study|Withdrawal by Subject|1|||
130988246|NCT01559454|471585297|FG000|Overall Study|Physician Decision|0|||
130988247|NCT01559454|471585298|FG001|Overall Study|Physician Decision|1|||
130988248|NCT01559454|471585297|FG000|Overall Study|Protocol Violation|0|||
130988249|NCT01559454|471585298|FG001|Overall Study|Protocol Violation|1|||
130988250|NCT01559454|471585297|FG000|Overall Study|Lack of Efficacy|0|||
130988251|NCT01559454|471585298|FG001|Overall Study|Lack of Efficacy|1|||
130988252|NCT00991341|471585303|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
130988253|NCT00991341|471585304|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
130988254|NCT00991341|471585303|FG000|Overall Study|Death|3|||
130988255|NCT00991341|471585304|FG001|Overall Study|Death|0|||
130988256|NCT00991341|471585303|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
130988257|NCT00991341|471585304|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
130988258|NCT00991341|471585303|FG000|Overall Study|Physician Decision|1|||
130988259|NCT00991341|471585304|FG001|Overall Study|Physician Decision|2|||
130988260|NCT00991341|471585303|FG000|Overall Study|Withdrawal by Subject|3|||
130988261|NCT00991341|471585304|FG001|Overall Study|Withdrawal by Subject|4|||
130988262|NCT01330316|471585320|FG000|Overall Study|Adverse Event|2|||
130988263|NCT01330316|471585321|FG001|Overall Study|Adverse Event|2|||
130988264|NCT01330316|471585320|FG000|Overall Study|Lack of Efficacy|0|||
131098635|NCT02980731|471991005|FG000|Overall Study|Withdrawal by Subject|6|||
131098636|NCT02980731|471991005|FG000|Overall Study|Lost to Follow-up|5|||
131098637|NCT02980731|471991005|FG000|Overall Study|Study terminated by Sponsor|4|||
131098638|NCT02980731|471991005|FG000|Overall Study|Completed survival follow-up period|65|||
131098639|NCT02980731|471991005|FG000|Overall Study|COVID-19 infection|1|||
131098640|NCT02980731|471991005|FG000|Overall Study|Other, not specified|66|||
131098641|NCT01290315|471991006|FG000|Overall Study|Adverse Event|0|||
131098642|NCT01290315|471991007|FG001|Overall Study|Adverse Event|0|||
131098643|NCT01290315|471991008|FG002|Overall Study|Adverse Event|0|||
131098644|NCT01290315|471991009|FG003|Overall Study|Adverse Event|3|||
131229127|NCT00003102|472465836|FG000|Overall Study|Physician Decision|1|||
131098645|NCT01290315|471991006|FG000|Overall Study|Selection criteria/compliance|2|||
131098646|NCT01290315|471991007|FG001|Overall Study|Selection criteria/compliance|1|||
131098647|NCT01290315|471991008|FG002|Overall Study|Selection criteria/compliance|0|||
131098648|NCT01290315|471991009|FG003|Overall Study|Selection criteria/compliance|2|||
131098649|NCT01290315|471991006|FG000|Overall Study|Lost to Follow-up|0|||
131098650|NCT01290315|471991007|FG001|Overall Study|Lost to Follow-up|1|||
131098651|NCT01290315|471991008|FG002|Overall Study|Lost to Follow-up|0|||
131098652|NCT01290315|471991009|FG003|Overall Study|Lost to Follow-up|0|||
131098653|NCT01290315|471991006|FG000|Overall Study|Withdrawal by Subject|1|||
131098654|NCT01290315|471991007|FG001|Overall Study|Withdrawal by Subject|1|||
130988265|NCT01330316|471585321|FG001|Overall Study|Lack of Efficacy|10|||
130988266|NCT01330316|471585320|FG000|Overall Study|Lost to Follow-up|0|||
130988267|NCT01330316|471585321|FG001|Overall Study|Lost to Follow-up|1|||
130988268|NCT01330316|471585320|FG000|Overall Study|Withdrawal by Subject|0|||
130988269|NCT01330316|471585321|FG001|Overall Study|Withdrawal by Subject|1|||
130988270|NCT01330316|471585320|FG000|Overall Study|other than above|0|||
130988271|NCT01330316|471585321|FG001|Overall Study|other than above|1|||
130988272|NCT00215540|471585322|FG000|Overall Study|Withdrew from study medication|1|||
130988273|NCT00215540|471585323|FG001|Overall Study|Withdrew from study medication|0|||
130988274|NCT00215540|471585324|FG002|Overall Study|Withdrew from study medication|0|||
130988275|NCT03145766|471585325|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
130988276|NCT03145766|471585326|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
130988277|NCT03145766|471585327|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
130988278|NCT03145766|471585328|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
130988279|NCT03145766|471585329|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
130988280|NCT03145766|471585325|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
130988281|NCT03145766|471585326|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
130988282|NCT03145766|471585327|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
130988283|NCT03145766|471585328|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
130988284|NCT03145766|471585329|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
130988285|NCT03145766|471585325|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
130988286|NCT03145766|471585326|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
130988287|NCT03145766|471585327|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
130988288|NCT03145766|471585328|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
130988289|NCT03145766|471585329|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
130988290|NCT03145766|471585325|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
130988291|NCT03145766|471585326|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
130988292|NCT03145766|471585327|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
130988293|NCT03145766|471585328|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
130988294|NCT03145766|471585329|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
130988295|NCT03145766|471585325|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
130988296|NCT03145766|471585326|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
130988297|NCT03145766|471585327|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
130988298|NCT03145766|471585328|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
130988299|NCT03145766|471585329|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
130988300|NCT03145766|471585325|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
130988301|NCT03145766|471585326|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
130988302|NCT03145766|471585327|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
130988303|NCT03145766|471585328|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
130988304|NCT03145766|471585329|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
130988305|NCT03145766|471585325|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
130988306|NCT03145766|471585326|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
130988307|NCT03145766|471585327|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
130988308|NCT03145766|471585328|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
130988309|NCT03145766|471585329|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
130988310|NCT02801669|471585333|FG000|Overall Study|Death|66|||
130988311|NCT02801669|471585334|FG001|Overall Study|Death|69|||
130988312|NCT02801669|471585333|FG000|Overall Study|Withdrawal by Subject|81|||
130988313|NCT02801669|471585334|FG001|Overall Study|Withdrawal by Subject|77|||
130988314|NCT02801669|471585333|FG000|Overall Study|Other|4|||
130988315|NCT02801669|471585334|FG001|Overall Study|Other|6|||
130988316|NCT01966003|471585335|FG000|Overall Study|Death|43|||
130988317|NCT01966003|471585336|FG001|Overall Study|Death|36|||
130988318|NCT01966003|471585335|FG000|Overall Study|Protocol Violation|6|||
130988319|NCT01966003|471585336|FG001|Overall Study|Protocol Violation|4|||
130988320|NCT01966003|471585335|FG000|Overall Study|Lost to Follow-up|4|||
130988321|NCT01966003|471585336|FG001|Overall Study|Lost to Follow-up|3|||
130988322|NCT01966003|471585335|FG000|Overall Study|Physician Decision|12|||
130988323|NCT01966003|471585336|FG001|Overall Study|Physician Decision|13|||
130988324|NCT01966003|471585335|FG000|Overall Study|Withdrawal by Subject|29|||
130988325|NCT01966003|471585336|FG001|Overall Study|Withdrawal by Subject|19|||
130988326|NCT01966003|471585335|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
130988327|NCT01966003|471585336|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
130988328|NCT01966003|471585335|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
130988329|NCT01966003|471585336|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
130988330|NCT01966003|471585335|FG000|Overall Study|Other|1|||
130988331|NCT01966003|471585336|FG001|Overall Study|Other|1|||
131229128|NCT00003102|472465837|FG001|Overall Study|Physician Decision|1|||
131211382|NCT05299359|472397352|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
131211383|NCT05299359|472397353|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
131211384|NCT05299359|472397352|FG000|Main Part: Day 1 up to Day 366|Other|2|||
131211385|NCT05299359|472397353|FG001|Main Part: Day 1 up to Day 366|Other|0|||
131211386|NCT05299359|472397352|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
131211387|NCT05299359|472397353|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
131211388|NCT05299359|472397352|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
131211389|NCT05299359|472397353|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
131211390|NCT05299359|472397352|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
131211391|NCT05299359|472397353|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
131211392|NCT05299359|472397352|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
131211393|NCT05299359|472397353|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
131211394|NCT05299359|472397352|FG000|Extension Part: Day 1 to Day 366|Other|0|||
131211395|NCT05299359|472397353|FG001|Extension Part: Day 1 to Day 366|Other|1|||
131211396|NCT03868410|472397356|FG000|Overall Study|Physician Decision|0|||
131211397|NCT03868410|472397357|FG001|Overall Study|Physician Decision|1|||
131211398|NCT01059175|472397358|FG000|Overall Study|Death|17|||
131211399|NCT01059175|472397359|FG001|Overall Study|Death|17|||
131211400|NCT01059175|472397358|FG000|Overall Study|Adverse Event|4|||
131211401|NCT01059175|472397359|FG001|Overall Study|Adverse Event|2|||
131211402|NCT01059175|472397358|FG000|Overall Study|Lost to Follow-up|0|||
131211403|NCT01059175|472397359|FG001|Overall Study|Lost to Follow-up|1|||
131211404|NCT04579666|472397360|FG000|RTP (Up to Week 52)|Adverse Event|4|||
131211405|NCT04579666|472397361|FG001|RTP (Up to Week 52)|Adverse Event|3|||
131211406|NCT04579666|472397362|FG002|RTP (Up to Week 52)|Adverse Event|0|||
131211407|NCT04579666|472397363|FG003|RTP (Up to Week 52)|Adverse Event|0|||
131211408|NCT04579666|472397360|FG000|RTP (Up to Week 52)|Death|24|||
131211409|NCT04579666|472397361|FG001|RTP (Up to Week 52)|Death|9|||
131211410|NCT04579666|472397362|FG002|RTP (Up to Week 52)|Death|0|||
131211411|NCT04579666|472397363|FG003|RTP (Up to Week 52)|Death|0|||
131211412|NCT04579666|472397360|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
131211413|NCT04579666|472397361|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
131211414|NCT04579666|472397362|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
131211415|NCT04579666|472397363|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
131211416|NCT04579666|472397360|FG000|RTP (Up to Week 52)|Physician Decision|4|||
131211417|NCT04579666|472397361|FG001|RTP (Up to Week 52)|Physician Decision|1|||
131211418|NCT04579666|472397362|FG002|RTP (Up to Week 52)|Physician Decision|0|||
131211419|NCT04579666|472397363|FG003|RTP (Up to Week 52)|Physician Decision|0|||
131211420|NCT04579666|472397360|FG000|RTP (Up to Week 52)|Progressive disease|1|||
131211421|NCT04579666|472397361|FG001|RTP (Up to Week 52)|Progressive disease|0|||
131211422|NCT04579666|472397362|FG002|RTP (Up to Week 52)|Progressive disease|0|||
131211423|NCT04579666|472397363|FG003|RTP (Up to Week 52)|Progressive disease|0|||
131211424|NCT04579666|472397360|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
130876394|NCT05435339|471177511|FG001|Overall Study|Death|0|||
130876395|NCT05435339|471177512|FG002|Overall Study|Death|3|||
130876396|NCT05435339|471177513|FG003|Overall Study|Death|1|||
130876397|NCT05435339|471177514|FG004|Overall Study|Death|3|||
130876398|NCT05435339|471177515|FG005|Overall Study|Death|2|||
130876399|NCT05435339|471177516|FG006|Overall Study|Death|4|||
130876400|NCT05435339|471177517|FG007|Overall Study|Death|6|||
130876401|NCT05435339|471177510|FG000|Overall Study|Sponsor Decision|0|||
130876402|NCT05435339|471177511|FG001|Overall Study|Sponsor Decision|1|||
130876403|NCT05435339|471177512|FG002|Overall Study|Sponsor Decision|0|||
130876404|NCT05435339|471177513|FG003|Overall Study|Sponsor Decision|0|||
130876405|NCT05435339|471177514|FG004|Overall Study|Sponsor Decision|2|||
130876406|NCT05435339|471177515|FG005|Overall Study|Sponsor Decision|1|||
130876407|NCT05435339|471177516|FG006|Overall Study|Sponsor Decision|2|||
130876408|NCT05435339|471177517|FG007|Overall Study|Sponsor Decision|2|||
130876409|NCT05435339|471177510|FG000|Overall Study|Withdrawal by Subject|0|||
130876410|NCT05435339|471177511|FG001|Overall Study|Withdrawal by Subject|0|||
130876411|NCT05435339|471177512|FG002|Overall Study|Withdrawal by Subject|0|||
130876412|NCT05435339|471177513|FG003|Overall Study|Withdrawal by Subject|0|||
130876413|NCT05435339|471177514|FG004|Overall Study|Withdrawal by Subject|1|||
130876414|NCT05435339|471177515|FG005|Overall Study|Withdrawal by Subject|0|||
131211425|NCT04579666|472397361|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
130876415|NCT05435339|471177516|FG006|Overall Study|Withdrawal by Subject|1|||
130876416|NCT05435339|471177517|FG007|Overall Study|Withdrawal by Subject|1|||
131211426|NCT04579666|472397362|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
131211427|NCT04579666|472397363|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
131211428|NCT04579666|472397360|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
130876417|NCT03473236|471177522|FG000|Overall Study|Withdrawal by Subject|0|||
130876418|NCT03473236|471177523|FG001|Overall Study|Withdrawal by Subject|0|||
130876419|NCT03473236|471177524|FG002|Overall Study|Withdrawal by Subject|0|||
130876420|NCT03473236|471177525|FG003|Overall Study|Withdrawal by Subject|0|||
130876421|NCT03473236|471177526|FG004|Overall Study|Withdrawal by Subject|0|||
130876422|NCT03473236|471177527|FG005|Overall Study|Withdrawal by Subject|1|||
130876423|NCT03473236|471177528|FG006|Overall Study|Withdrawal by Subject|0|||
130876424|NCT03473236|471177529|FG007|Overall Study|Withdrawal by Subject|0|||
130876425|NCT03473236|471177530|FG008|Overall Study|Withdrawal by Subject|1|||
130876426|NCT03473236|471177531|FG009|Overall Study|Withdrawal by Subject|0|||
130876427|NCT03155724|471177532|FG000|Overall Study|Death|3|||
130876428|NCT03155724|471177532|FG000|Overall Study|Physician Decision|1|||
130876429|NCT03155724|471177532|FG000|Overall Study|Study closure|7|||
130876430|NCT00849940|471177533|FG000|Overall Study|Physician Decision|4|||
130876431|NCT01400698|471177535|FG000|Overall Study|Lost to Follow-up|2|||
130876432|NCT01400698|471177536|FG001|Overall Study|Lost to Follow-up|5|||
130876433|NCT01400698|471177537|FG002|Overall Study|Lost to Follow-up|2|||
130876434|NCT01400698|471177538|FG003|Overall Study|Lost to Follow-up|1|||
130876435|NCT01400698|471177539|FG004|Overall Study|Lost to Follow-up|4|||
130876436|NCT01400698|471177540|FG005|Overall Study|Lost to Follow-up|3|||
130876437|NCT01400698|471177535|FG000|Overall Study|Withdrawal by Subject|8|||
130876438|NCT01400698|471177536|FG001|Overall Study|Withdrawal by Subject|2|||
130876439|NCT01400698|471177537|FG002|Overall Study|Withdrawal by Subject|0|||
130876440|NCT01400698|471177538|FG003|Overall Study|Withdrawal by Subject|4|||
130876441|NCT01400698|471177539|FG004|Overall Study|Withdrawal by Subject|1|||
130876442|NCT01400698|471177540|FG005|Overall Study|Withdrawal by Subject|3|||
130876443|NCT01400698|471177535|FG000|Overall Study|Protocol Violation|0|||
130876444|NCT01400698|471177536|FG001|Overall Study|Protocol Violation|1|||
130876445|NCT01400698|471177537|FG002|Overall Study|Protocol Violation|0|||
130876446|NCT01400698|471177538|FG003|Overall Study|Protocol Violation|0|||
130876447|NCT01400698|471177539|FG004|Overall Study|Protocol Violation|1|||
130876448|NCT01400698|471177540|FG005|Overall Study|Protocol Violation|0|||
130876449|NCT01400698|471177535|FG000|Overall Study|Non-compliance|0|||
130876450|NCT01400698|471177536|FG001|Overall Study|Non-compliance|1|||
130876451|NCT01400698|471177537|FG002|Overall Study|Non-compliance|0|||
130876452|NCT01400698|471177538|FG003|Overall Study|Non-compliance|1|||
130876453|NCT01400698|471177539|FG004|Overall Study|Non-compliance|0|||
130876454|NCT01400698|471177540|FG005|Overall Study|Non-compliance|0|||
130876455|NCT01400698|471177535|FG000|Overall Study|Adverse Event|1|||
130876456|NCT01400698|471177536|FG001|Overall Study|Adverse Event|0|||
130876457|NCT01400698|471177537|FG002|Overall Study|Adverse Event|0|||
130876458|NCT01400698|471177538|FG003|Overall Study|Adverse Event|0|||
130876459|NCT01400698|471177539|FG004|Overall Study|Adverse Event|0|||
130876460|NCT01400698|471177540|FG005|Overall Study|Adverse Event|0|||
130876461|NCT01400698|471177535|FG000|Overall Study|Other|4|||
131211429|NCT04579666|472397361|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
131211430|NCT04579666|472397362|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
131211431|NCT04579666|472397363|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
131211432|NCT04579666|472397360|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
131211433|NCT04579666|472397361|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
131211434|NCT04579666|472397362|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
131211435|NCT04579666|472397363|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
131211436|NCT04579666|472397360|FG000|RTP (Up to Week 52)|Other|2|||
131211437|NCT04579666|472397361|FG001|RTP (Up to Week 52)|Other|0|||
131211438|NCT04579666|472397362|FG002|RTP (Up to Week 52)|Other|0|||
131211439|NCT04579666|472397363|FG003|RTP (Up to Week 52)|Other|0|||
130876462|NCT01400698|471177536|FG001|Overall Study|Other|2|||
130876463|NCT01400698|471177537|FG002|Overall Study|Other|0|||
130876464|NCT01400698|471177538|FG003|Overall Study|Other|2|||
130876465|NCT01400698|471177539|FG004|Overall Study|Other|1|||
130876466|NCT01400698|471177540|FG005|Overall Study|Other|0|||
130876467|NCT03409796|471179549|FG000|Overall Study|Adverse Event|2|||
130876468|NCT03409796|471179550|FG001|Overall Study|Adverse Event|0|||
130876469|NCT03409796|471179549|FG000|Overall Study|Other|0|||
131211440|NCT04579666|472397360|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
131211441|NCT04579666|472397361|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
131211442|NCT04579666|472397362|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
131211443|NCT04579666|472397363|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
131211444|NCT04579666|472397360|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
131211445|NCT04579666|472397361|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
131211446|NCT04579666|472397362|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
131211447|NCT04579666|472397363|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
130876470|NCT03409796|471179550|FG001|Overall Study|Other|1|||
130876471|NCT00740220|471179551|FG000|Overall Study|screen failures (non-COPD patients)|9|||
130876472|NCT01602224|471179552|FG000|Overall Study|Adverse Event|0|||
131211448|NCT04579666|472397360|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
130876473|NCT01602224|471179553|FG001|Overall Study|Adverse Event|1|||
130876474|NCT01602224|471179554|FG002|Overall Study|Adverse Event|0|||
130876475|NCT01602224|471179552|FG000|Overall Study|Investigator Decison|1|||
130876476|NCT01602224|471179553|FG001|Overall Study|Investigator Decison|0|||
130876477|NCT01602224|471179554|FG002|Overall Study|Investigator Decison|0|||
130876478|NCT01602224|471179552|FG000|Overall Study|Lost to Follow-up|0|||
130876479|NCT01602224|471179553|FG001|Overall Study|Lost to Follow-up|0|||
130876480|NCT01602224|471179554|FG002|Overall Study|Lost to Follow-up|1|||
130876481|NCT01602224|471179552|FG000|Overall Study|Protocol Violation|0|||
130876482|NCT01602224|471179553|FG001|Overall Study|Protocol Violation|1|||
130876483|NCT01602224|471179554|FG002|Overall Study|Protocol Violation|0|||
130876484|NCT01602224|471179552|FG000|Overall Study|Sponsor Decision|2|||
130876485|NCT01602224|471179553|FG001|Overall Study|Sponsor Decision|3|||
130876486|NCT01602224|471179554|FG002|Overall Study|Sponsor Decision|2|||
130876487|NCT01602224|471179552|FG000|Overall Study|Withdrawal by Subject|5|||
130876488|NCT01602224|471179553|FG001|Overall Study|Withdrawal by Subject|3|||
130876489|NCT01602224|471179554|FG002|Overall Study|Withdrawal by Subject|3|||
130876490|NCT01352117|471179555|FG000|Overall Study|Death|15|||
130876491|NCT01352117|471179556|FG001|Overall Study|Death|16|||
131211449|NCT04579666|472397361|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
131211450|NCT04579666|472397362|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
131211451|NCT04579666|472397363|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
131211452|NCT04579666|472397360|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
131211453|NCT04579666|472397361|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
131211454|NCT04579666|472397362|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
131211455|NCT04579666|472397363|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
131211456|NCT04579666|472397360|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
131211457|NCT04579666|472397361|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
131211458|NCT04579666|472397362|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
131211459|NCT04579666|472397363|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
131211460|NCT00643006|472397367|FG000|Overall Study|Lost to Follow-up|5|||
131211461|NCT00643006|472397368|FG001|Overall Study|Lost to Follow-up|4|||
131211462|NCT02506101|472397369|FG000|Overall Study|Transportation issues|1|||
131211463|NCT02506101|472397370|FG001|Overall Study|Transportation issues|0|||
131211464|NCT02506101|472397369|FG000|Overall Study|No enrollment and staff unavailability|1|||
131211465|NCT02506101|472397370|FG001|Overall Study|No enrollment and staff unavailability|0|||
131211466|NCT01308476|472397372|FG000|Overall Study|Lost to Follow-up|2|||
131211467|NCT01308476|472397373|FG001|Overall Study|Lost to Follow-up|2|||
131211468|NCT01308476|472397372|FG000|Overall Study|Other|1|||
131211469|NCT01308476|472397373|FG001|Overall Study|Other|0|||
131211470|NCT00812968|472397374|FG000|Overall Study|Relapse after erythroid response|6|||
131211471|NCT00812968|472397374|FG000|Overall Study|Disease progression|1|||
131211472|NCT00812968|472397374|FG000|Overall Study|No further treatment required|1|||
130876492|NCT01352117|471179555|FG000|Overall Study|Withdrawal by Subject|1|||
130876493|NCT01352117|471179556|FG001|Overall Study|Withdrawal by Subject|0|||
130876494|NCT01352117|471179555|FG000|Overall Study|Lost to Follow-up|2|||
130876495|NCT01352117|471179556|FG001|Overall Study|Lost to Follow-up|7|||
130876496|NCT01352117|471179555|FG000|Overall Study|Non-adherent to study requirements|1|||
130876497|NCT01352117|471179556|FG001|Overall Study|Non-adherent to study requirements|1|||
130876498|NCT01352117|471179555|FG000|Overall Study|Did not initiate study treatment|1|||
130876499|NCT01352117|471179556|FG001|Overall Study|Did not initiate study treatment|0|||
130876500|NCT01352117|471179555|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
130876501|NCT01352117|471179556|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
130876502|NCT00770653|471179560|FG000|Overall Study|Adverse Event|13|||
130876503|NCT00770653|471179561|FG001|Overall Study|Adverse Event|5|||
130876504|NCT00770653|471179560|FG000|Overall Study|Protocol Violation|8|||
130876505|NCT00770653|471179561|FG001|Overall Study|Protocol Violation|6|||
130876506|NCT00770653|471179560|FG000|Overall Study|Withdrawal by Subject|4|||
130876507|NCT00770653|471179561|FG001|Overall Study|Withdrawal by Subject|7|||
130876508|NCT00770653|471179560|FG000|Overall Study|Lack of Compliance|1|||
130876509|NCT00770653|471179561|FG001|Overall Study|Lack of Compliance|4|||
130876510|NCT00770653|471179560|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
130876511|NCT00770653|471179561|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
130876512|NCT00770653|471179560|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
130876513|NCT00770653|471179561|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
130876514|NCT00770653|471179560|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
130876515|NCT00770653|471179561|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
130876516|NCT00770653|471179560|FG000|Overall Study|Lost to Follow-up|1|||
130876517|NCT00770653|471179561|FG001|Overall Study|Lost to Follow-up|2|||
130876518|NCT00770653|471179560|FG000|Overall Study|Physician Decision|1|||
131211473|NCT00812968|472397374|FG000|Overall Study|Study closed due to marketing approval|3|||
131211474|NCT01243762|472397375|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
131211475|NCT01243762|472397376|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
130876519|NCT00770653|471179561|FG001|Overall Study|Physician Decision|0|||
130876520|NCT04906499|471179566|FG000|Overall Study|Lack of time|1|||
130876521|NCT00262860|471179570|FG000|Overall Study|Adverse Event|2|||
130876522|NCT02891174|471179581|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
130876523|NCT02891174|471179582|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
130876524|NCT02891174|471179581|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
130876525|NCT02891174|471179582|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
130876526|NCT02891174|471179581|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
130876527|NCT02891174|471179582|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
130876528|NCT02891174|471179581|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
130876529|NCT02891174|471179582|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
130876530|NCT02891174|471179581|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
130876531|NCT02891174|471179582|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
130876532|NCT02891174|471179581|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
130876533|NCT02891174|471179582|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
130876534|NCT02891174|471179581|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
130876535|NCT02891174|471179582|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
130876536|NCT04124939|471179583|FG000|Overall Study|Lost to Follow-up|1|||
130876537|NCT04124939|471179584|FG001|Overall Study|Lost to Follow-up|3|||
130876538|NCT04516746|471179585|FG000|Overall Study|Randomized but not Treated|51|||
130876539|NCT04516746|471179586|FG001|Overall Study|Randomized but not Treated|19|||
130876540|NCT04516746|471179585|FG000|Overall Study|Adverse Event|0|||
130876541|NCT04516746|471179586|FG001|Overall Study|Adverse Event|1|||
130876542|NCT04516746|471179585|FG000|Overall Study|Death|62|||
130876543|NCT04516746|471179586|FG001|Overall Study|Death|32|||
130876544|NCT04516746|471179585|FG000|Overall Study|Lost to Follow-up|3431|||
130876545|NCT04516746|471179586|FG001|Overall Study|Lost to Follow-up|1831|||
130876546|NCT04516746|471179585|FG000|Overall Study|Withdrawal by Subject|1946|||
130876547|NCT04516746|471179586|FG001|Overall Study|Withdrawal by Subject|1696|||
130876548|NCT04516746|471179585|FG000|Overall Study|Physician Decision|10|||
130876549|NCT04516746|471179586|FG001|Overall Study|Physician Decision|8|||
130876550|NCT04516746|471179585|FG000|Overall Study|Other|35|||
130876551|NCT04516746|471179586|FG001|Overall Study|Other|16|||
130876552|NCT03115359|471179589|FG000|Overall Study|Withdrawal by Subject|29|||
130876553|NCT03115359|471179590|FG001|Overall Study|Withdrawal by Subject|39|||
130876554|NCT03115359|471179589|FG000|Overall Study|Scheduling conflict|25|||
131211476|NCT01243762|472397377|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
131211477|NCT01243762|472397378|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
131211478|NCT01243762|472397379|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
131211479|NCT01243762|472397380|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
131211480|NCT01243762|472397381|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
131211481|NCT01243762|472397375|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
131211482|NCT01243762|472397376|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
131211483|NCT01243762|472397377|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
131211484|NCT01243762|472397378|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
131211485|NCT01243762|472397379|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
131211486|NCT01243762|472397380|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
131211487|NCT01243762|472397381|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
131211488|NCT01243762|472397375|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
131211489|NCT01243762|472397376|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
131211490|NCT01243762|472397377|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
131211491|NCT01243762|472397378|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
131211492|NCT01243762|472397379|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
131211493|NCT01243762|472397380|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
131211494|NCT01243762|472397381|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
131211495|NCT01243762|472397375|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131211496|NCT01243762|472397376|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
131211497|NCT01243762|472397377|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131211498|NCT01243762|472397378|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131211499|NCT01243762|472397379|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131211500|NCT01243762|472397380|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131211501|NCT01243762|472397381|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
131211502|NCT01243762|472397375|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
131211503|NCT01243762|472397376|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
130876555|NCT03115359|471179590|FG001|Overall Study|Scheduling conflict|23|||
130876556|NCT03115359|471179589|FG000|Overall Study|Personal reasons including health|12|||
130876557|NCT03115359|471179590|FG001|Overall Study|Personal reasons including health|9|||
130876558|NCT03115359|471179589|FG000|Overall Study|Transportation barriers|3|||
130876559|NCT03115359|471179590|FG001|Overall Study|Transportation barriers|0|||
130876560|NCT03115359|471179589|FG000|Overall Study|No longer interested|5|||
130876561|NCT03115359|471179590|FG001|Overall Study|No longer interested|4|||
130876562|NCT03115359|471179589|FG000|Overall Study|No reason provided|45|||
130876563|NCT03115359|471179590|FG001|Overall Study|No reason provided|47|||
130876564|NCT02814916|471179597|FG000|Overall Study|Withdrawal of consent|0|||
131211504|NCT01243762|472397377|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
131211505|NCT01243762|472397378|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
131211506|NCT01243762|472397379|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
131211507|NCT01243762|472397380|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
131211508|NCT01243762|472397381|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
131211509|NCT01243762|472397375|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
131211510|NCT01243762|472397376|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
131211511|NCT01243762|472397377|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
131211512|NCT01243762|472397378|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
131211513|NCT01243762|472397379|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
131211514|NCT01243762|472397380|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
131211515|NCT01243762|472397381|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
131211516|NCT01243762|472397375|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
131211517|NCT01243762|472397376|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
131211518|NCT01243762|472397377|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
131211519|NCT01243762|472397378|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
131211520|NCT01243762|472397379|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
131211521|NCT01243762|472397380|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
131211522|NCT01243762|472397381|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
131211523|NCT01243762|472397375|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
131211524|NCT01243762|472397376|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
131211525|NCT01243762|472397377|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
131211526|NCT01243762|472397378|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
131211527|NCT01243762|472397379|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
131211528|NCT01243762|472397380|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
131211529|NCT01243762|472397381|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
131211530|NCT04359758|472397382|FG000|Overall Study|Protocol Violation|3|||
131211531|NCT04359758|472397383|FG001|Overall Study|Protocol Violation|2|||
131211532|NCT03358407|472397384|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131211533|NCT03358407|472397385|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131211534|NCT03358407|472397386|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
131211535|NCT03358407|472397387|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131211536|NCT03358407|472397388|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131211537|NCT03358407|472397389|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131211538|NCT03358407|472397390|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131211539|NCT03358407|472397391|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131211540|NCT03358407|472397392|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131211541|NCT03358407|472397393|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
131211542|NCT03358407|472397384|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211543|NCT03358407|472397385|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211544|NCT03358407|472397386|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211545|NCT03358407|472397387|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211546|NCT03358407|472397388|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
130876565|NCT02814916|471179598|FG001|Overall Study|Withdrawal of consent|2|||
130876566|NCT02814916|471179599|FG002|Overall Study|Withdrawal of consent|0|||
130876567|NCT02814916|471179597|FG000|Overall Study|Lost to Follow-up|0|||
130876568|NCT02814916|471179598|FG001|Overall Study|Lost to Follow-up|1|||
130876569|NCT02814916|471179599|FG002|Overall Study|Lost to Follow-up|0|||
130876570|NCT02814916|471179597|FG000|Overall Study|Other, not specified|0|||
130876571|NCT02814916|471179598|FG001|Overall Study|Other, not specified|1|||
130876572|NCT02814916|471179599|FG002|Overall Study|Other, not specified|0|||
130876573|NCT01706458|471179607|FG000|Overall Study|Physician Decision|3|||
130876574|NCT01706458|471179608|FG001|Overall Study|Physician Decision|4|||
130876575|NCT02384551|471179612|FG000|Overall Study|Lost to Follow-up|13|||
130876576|NCT02384551|471179613|FG001|Overall Study|Lost to Follow-up|14|||
130876577|NCT02384551|471179614|FG002|Overall Study|Lost to Follow-up|14|||
130876578|NCT02384551|471179615|FG003|Overall Study|Lost to Follow-up|14|||
130876579|NCT04742556|471179618|FG000|Overall Study|Withdrawal by Subject|0|||
131211547|NCT03358407|472397389|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211548|NCT03358407|472397390|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211549|NCT03358407|472397391|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211550|NCT03358407|472397392|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211551|NCT03358407|472397393|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211552|NCT03358407|472397384|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130876580|NCT04742556|471179619|FG001|Overall Study|Withdrawal by Subject|1|||
130876581|NCT04742556|471179620|FG002|Overall Study|Withdrawal by Subject|0|||
131211553|NCT03358407|472397385|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131211554|NCT03358407|472397386|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131211555|NCT03358407|472397387|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131211556|NCT03358407|472397388|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131211557|NCT03358407|472397389|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
131211558|NCT03358407|472397390|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131211559|NCT03358407|472397391|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
131211560|NCT03358407|472397392|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131211561|NCT03358407|472397393|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
131211562|NCT03358407|472397384|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131211563|NCT03358407|472397385|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131211564|NCT03358407|472397386|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131211565|NCT03358407|472397387|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131211566|NCT03358407|472397388|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131211567|NCT03358407|472397389|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
131211568|NCT03358407|472397390|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131211569|NCT03358407|472397391|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
131211570|NCT03358407|472397392|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131211571|NCT03358407|472397393|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
131211572|NCT03358407|472397384|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211573|NCT03358407|472397385|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211574|NCT03358407|472397386|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211575|NCT03358407|472397387|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211576|NCT03358407|472397388|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211577|NCT03358407|472397389|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
131211578|NCT03358407|472397390|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
131211579|NCT03358407|472397391|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211580|NCT03358407|472397392|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211581|NCT03358407|472397393|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
131211582|NCT03358407|472397384|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131211583|NCT03358407|472397385|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131211584|NCT03358407|472397386|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131211585|NCT03358407|472397387|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131211586|NCT03358407|472397388|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131211587|NCT03358407|472397389|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
131211588|NCT03358407|472397390|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
131211589|NCT03358407|472397391|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
131211590|NCT03358407|472397392|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131211591|NCT03358407|472397393|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
131211592|NCT03605758|472397394|FG000|Overall Study|Lost to Follow-up|2|||
131211593|NCT03605758|472397395|FG001|Overall Study|Lost to Follow-up|1|||
131211594|NCT03605758|472397394|FG000|Overall Study|Illness|0|||
131211595|NCT03605758|472397395|FG001|Overall Study|Illness|1|||
131211596|NCT03605758|472397394|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
131211597|NCT03605758|472397395|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
131211598|NCT00489411|472397396|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
131211599|NCT00489411|472397397|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
131211600|NCT00489411|472397396|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
131211601|NCT00489411|472397397|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
131211602|NCT00489411|472397396|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
131211603|NCT00489411|472397397|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
131211604|NCT00489411|472397396|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
131211605|NCT00489411|472397397|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
131211606|NCT00489411|472397396|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
131211607|NCT00489411|472397397|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
131211608|NCT00505765|472397398|FG000|Overall Study|Withdrawal by Subject|1|||
131211609|NCT00505765|472397399|FG001|Overall Study|Withdrawal by Subject|0|||
131211610|NCT00505765|472397400|FG002|Overall Study|Withdrawal by Subject|0|||
131211611|NCT00505765|472397398|FG000|Overall Study|Adverse Event|1|||
131211612|NCT00505765|472397399|FG001|Overall Study|Adverse Event|2|||
131211613|NCT00505765|472397400|FG002|Overall Study|Adverse Event|0|||
131211614|NCT00505765|472397398|FG000|Overall Study|Noncompliance|0|||
131211615|NCT00505765|472397399|FG001|Overall Study|Noncompliance|1|||
131211616|NCT00505765|472397400|FG002|Overall Study|Noncompliance|3|||
131211617|NCT03841331|472397401|FG000|Overall Study|Withdrawal by Subject|4|||
131211618|NCT03841331|472397402|FG001|Overall Study|Withdrawal by Subject|9|||
131211619|NCT03841331|472397401|FG000|Overall Study|Lost to Follow-up|5|||
131211620|NCT03841331|472397402|FG001|Overall Study|Lost to Follow-up|1|||
131211621|NCT03532048|472397404|FG000|Overall Study|Lost to Follow-up|12|||
131211622|NCT03532048|472397405|FG001|Overall Study|Lost to Follow-up|17|||
131211623|NCT03532048|472397404|FG000|Overall Study|Withdrawal by Subject|7|||
131211624|NCT03532048|472397405|FG001|Overall Study|Withdrawal by Subject|0|||
131211625|NCT04366258|472397406|FG000|Baseline Assessments|Screen Failure|21|||
131211626|NCT04366258|472397406|FG000|Baseline Assessments|Early Termination|3|||
131211627|NCT04113746|472397407|FG000|Overall Study|Lost to Follow-up|4|||
131211628|NCT04113746|472397408|FG001|Overall Study|Lost to Follow-up|4|||
131211629|NCT02594384|472397409|FG000|Overall Study|Disease Progression|3|||
131211630|NCT02594384|472397410|FG001|Overall Study|Disease Progression|7|||
131211631|NCT02594384|472397411|FG002|Overall Study|Disease Progression|0|||
131211632|NCT02594384|472397412|FG003|Overall Study|Disease Progression|2|||
131211633|NCT02594384|472397413|FG004|Overall Study|Disease Progression|2|||
131211634|NCT02594384|472397414|FG005|Overall Study|Disease Progression|12|||
131211635|NCT02594384|472397415|FG006|Overall Study|Disease Progression|5|||
131211636|NCT02594384|472397416|FG007|Overall Study|Disease Progression|5|||
131211637|NCT02594384|472397409|FG000|Overall Study|Adverse Event|0|||
131211638|NCT02594384|472397410|FG001|Overall Study|Adverse Event|1|||
131211639|NCT02594384|472397411|FG002|Overall Study|Adverse Event|4|||
131211640|NCT02594384|472397412|FG003|Overall Study|Adverse Event|1|||
131211641|NCT02594384|472397413|FG004|Overall Study|Adverse Event|0|||
131211642|NCT02594384|472397414|FG005|Overall Study|Adverse Event|6|||
131211643|NCT02594384|472397415|FG006|Overall Study|Adverse Event|1|||
131211644|NCT02594384|472397416|FG007|Overall Study|Adverse Event|1|||
131211645|NCT02594384|472397409|FG000|Overall Study|Withdrawal by Subject|0|||
131211646|NCT02594384|472397410|FG001|Overall Study|Withdrawal by Subject|0|||
131211647|NCT02594384|472397411|FG002|Overall Study|Withdrawal by Subject|0|||
131211648|NCT02594384|472397412|FG003|Overall Study|Withdrawal by Subject|1|||
131211649|NCT02594384|472397413|FG004|Overall Study|Withdrawal by Subject|0|||
131211650|NCT02594384|472397414|FG005|Overall Study|Withdrawal by Subject|0|||
131211651|NCT02594384|472397415|FG006|Overall Study|Withdrawal by Subject|0|||
131211652|NCT02594384|472397416|FG007|Overall Study|Withdrawal by Subject|1|||
131211653|NCT02594384|472397409|FG000|Overall Study|Physician Decision|0|||
131211654|NCT02594384|472397410|FG001|Overall Study|Physician Decision|0|||
131211655|NCT02594384|472397411|FG002|Overall Study|Physician Decision|0|||
131211656|NCT02594384|472397412|FG003|Overall Study|Physician Decision|0|||
131211657|NCT02594384|472397413|FG004|Overall Study|Physician Decision|0|||
131211658|NCT02594384|472397414|FG005|Overall Study|Physician Decision|1|||
131211659|NCT02594384|472397415|FG006|Overall Study|Physician Decision|2|||
131211660|NCT02594384|472397416|FG007|Overall Study|Physician Decision|0|||
131211661|NCT02594384|472397409|FG000|Overall Study|Progressive Leukocytosis|0|||
131211662|NCT02594384|472397410|FG001|Overall Study|Progressive Leukocytosis|0|||
131211663|NCT02594384|472397411|FG002|Overall Study|Progressive Leukocytosis|1|||
131211664|NCT02594384|472397412|FG003|Overall Study|Progressive Leukocytosis|0|||
131211665|NCT02594384|472397413|FG004|Overall Study|Progressive Leukocytosis|0|||
131211666|NCT02594384|472397414|FG005|Overall Study|Progressive Leukocytosis|0|||
131211667|NCT02594384|472397415|FG006|Overall Study|Progressive Leukocytosis|0|||
131211668|NCT02594384|472397416|FG007|Overall Study|Progressive Leukocytosis|0|||
131211669|NCT02594384|472397409|FG000|Overall Study|Lack of Efficacy|0|||
131211670|NCT02594384|472397410|FG001|Overall Study|Lack of Efficacy|0|||
131211671|NCT02594384|472397411|FG002|Overall Study|Lack of Efficacy|0|||
131211672|NCT02594384|472397412|FG003|Overall Study|Lack of Efficacy|0|||
131211673|NCT02594384|472397413|FG004|Overall Study|Lack of Efficacy|1|||
131211674|NCT02594384|472397414|FG005|Overall Study|Lack of Efficacy|0|||
131211675|NCT02594384|472397415|FG006|Overall Study|Lack of Efficacy|0|||
131211676|NCT02594384|472397416|FG007|Overall Study|Lack of Efficacy|0|||
131211677|NCT02594384|472397409|FG000|Overall Study|Substantial noncompliance|0|||
131211678|NCT02594384|472397410|FG001|Overall Study|Substantial noncompliance|0|||
131211679|NCT02594384|472397411|FG002|Overall Study|Substantial noncompliance|0|||
131211680|NCT02594384|472397412|FG003|Overall Study|Substantial noncompliance|0|||
131211681|NCT02594384|472397413|FG004|Overall Study|Substantial noncompliance|0|||
131211682|NCT02594384|472397414|FG005|Overall Study|Substantial noncompliance|0|||
131211683|NCT02594384|472397415|FG006|Overall Study|Substantial noncompliance|1|||
131211684|NCT02594384|472397416|FG007|Overall Study|Substantial noncompliance|0|||
131211685|NCT04964960|472397419|FG000|Overall Study|Withdrawal by Subject|1|||
131211686|NCT04246593|472397420|FG000|Overall Study|Withdrawal by Subject|14|||
131211687|NCT04246593|472397421|FG001|Overall Study|Withdrawal by Subject|13|||
131211688|NCT04246593|472397420|FG000|Overall Study|Lost to Follow-up|124|||
131211689|NCT04246593|472397421|FG001|Overall Study|Lost to Follow-up|71|||
131211690|NCT04246593|472397420|FG000|Overall Study|Moved out of area/became ineligible|3|||
131211691|NCT04246593|472397421|FG001|Overall Study|Moved out of area/became ineligible|1|||
131211692|NCT04246593|472397420|FG000|Overall Study|Reason unknown|4|||
131211693|NCT04246593|472397421|FG001|Overall Study|Reason unknown|2|||
131211694|NCT02369874|472397427|FG000|Overall Study|Lost to Follow-up|2|||
131211695|NCT02369874|472397428|FG001|Overall Study|Lost to Follow-up|2|||
131211696|NCT02369874|472397429|FG002|Overall Study|Lost to Follow-up|2|||
131211697|NCT02369874|472397427|FG000|Overall Study|Withdrawal by Subject|7|||
131211698|NCT02369874|472397428|FG001|Overall Study|Withdrawal by Subject|9|||
131211699|NCT02369874|472397429|FG002|Overall Study|Withdrawal by Subject|27|||
131211700|NCT02369874|472397427|FG000|Overall Study|Miscellaneous|1|||
131211701|NCT02369874|472397428|FG001|Overall Study|Miscellaneous|1|||
131211702|NCT02369874|472397429|FG002|Overall Study|Miscellaneous|0|||
131211703|NCT02369874|472397427|FG000|Overall Study|On Treatment/Off Study|34|||
131211704|NCT02369874|472397428|FG001|Overall Study|On Treatment/Off Study|45|||
131211705|NCT02369874|472397429|FG002|Overall Study|On Treatment/Off Study|32|||
131211706|NCT01012765|472397434|FG000|Treatment Period 1|Adverse Event|1|||
131211707|NCT01012765|472397435|FG001|Treatment Period 1|Adverse Event|0|||
131211708|NCT01012765|472397436|FG002|Treatment Period 1|Adverse Event|1|||
131211709|NCT01012765|472397437|FG003|Treatment Period 1|Adverse Event|0|||
131211710|NCT01012765|472397438|FG004|Treatment Period 1|Adverse Event|0|||
131211711|NCT01012765|472397439|FG005|Treatment Period 1|Adverse Event|0|||
131211712|NCT01012765|472397434|FG000|Treatment Period 1|Withdrawal by Subject|2|||
131211713|NCT01012765|472397435|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131211714|NCT01012765|472397436|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131211715|NCT01012765|472397437|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131211716|NCT01012765|472397438|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131211717|NCT01012765|472397439|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131211718|NCT01012765|472397434|FG000|Treatment Period 1|Administrative problems|0|||
131211719|NCT01012765|472397435|FG001|Treatment Period 1|Administrative problems|0|||
131211720|NCT01012765|472397436|FG002|Treatment Period 1|Administrative problems|1|||
131211721|NCT01012765|472397437|FG003|Treatment Period 1|Administrative problems|1|||
131211722|NCT01012765|472397438|FG004|Treatment Period 1|Administrative problems|1|||
131211723|NCT01012765|472397439|FG005|Treatment Period 1|Administrative problems|0|||
131211724|NCT01012765|472397434|FG000|Treatment Period 1|Protocol Violation|0|||
131211725|NCT01012765|472397435|FG001|Treatment Period 1|Protocol Violation|0|||
131211726|NCT01012765|472397436|FG002|Treatment Period 1|Protocol Violation|0|||
131211727|NCT01012765|472397437|FG003|Treatment Period 1|Protocol Violation|2|||
131211728|NCT01012765|472397438|FG004|Treatment Period 1|Protocol Violation|1|||
131211729|NCT01012765|472397439|FG005|Treatment Period 1|Protocol Violation|0|||
131211730|NCT01012765|472397434|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
131211731|NCT01012765|472397435|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
131211732|NCT01012765|472397436|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
131211733|NCT01012765|472397437|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
131211734|NCT01012765|472397438|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
131211735|NCT01012765|472397439|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
131211736|NCT01012765|472397434|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131211737|NCT01012765|472397435|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131211738|NCT01012765|472397436|FG002|Treatment Period 2|Withdrawal by Subject|1|||
131211739|NCT01012765|472397437|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131211740|NCT01012765|472397438|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131211741|NCT01012765|472397439|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131211742|NCT01012765|472397434|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
131211743|NCT01012765|472397435|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
131211744|NCT01012765|472397436|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
131211745|NCT01012765|472397437|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
131211746|NCT01012765|472397438|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
131211747|NCT01012765|472397439|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
131211748|NCT01012765|472397434|FG000|Treatment Period 2|Adverse Event|0|||
131211749|NCT01012765|472397435|FG001|Treatment Period 2|Adverse Event|1|||
131211750|NCT01012765|472397436|FG002|Treatment Period 2|Adverse Event|1|||
131211751|NCT01012765|472397437|FG003|Treatment Period 2|Adverse Event|0|||
131211752|NCT01012765|472397438|FG004|Treatment Period 2|Adverse Event|0|||
131211753|NCT01012765|472397439|FG005|Treatment Period 2|Adverse Event|0|||
131211754|NCT01012765|472397434|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
131211755|NCT01012765|472397435|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
131211756|NCT01012765|472397436|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
131211757|NCT01012765|472397437|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
131211758|NCT01012765|472397438|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
131211759|NCT01012765|472397439|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
131211760|NCT00596466|472397441|FG000|Overall Study|Lack of Efficacy|5|||
131211761|NCT00596466|472397441|FG000|Overall Study|Adverse Event|4|||
131211762|NCT00596466|472397441|FG000|Overall Study|Withdrawal by Subject|2|||
131211763|NCT00596466|472397441|FG000|Overall Study|Protocol Violation|2|||
131211764|NCT00596466|472397441|FG000|Overall Study|Unpecified|2|||
131211765|NCT00596466|472397441|FG000|Overall Study|Enrolled, not treated|2|||
131211766|NCT01683565|472397442|FG000|Overall Study|Lost to Follow-up|2|||
131211767|NCT01683565|472397443|FG001|Overall Study|Lost to Follow-up|0|||
130876582|NCT04742556|471179618|FG000|Overall Study|Adverse Event|0|||
131211768|NCT01683565|472397442|FG000|Overall Study|Discontinued Intervention|1|||
131211769|NCT01683565|472397443|FG001|Overall Study|Discontinued Intervention|1|||
131211770|NCT01302366|472399249|FG000|Overall Study|patient choice or noncompliance|5|||
131211771|NCT00467051|472399250|FG000|Overall Study|Adverse Event|2|||
131211772|NCT00934661|472399251|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
131211773|NCT00934661|472399252|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
131211774|NCT00761462|472399256|FG000|Treatment|Subjects never received study medication|23|||
131211775|NCT00761462|472399257|FG001|Treatment|Subjects never received study medication|12|||
131211776|NCT00761462|472399256|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
131211777|NCT00761462|472399257|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
131211778|NCT00761462|472399256|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
131211779|NCT00761462|472399257|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
131211780|NCT00761462|472399256|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
131211781|NCT00761462|472399257|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
131211782|NCT01479777|472399258|FG000|Overall Study|Physician Decision|2|||
131211783|NCT01013207|472399262|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
131211784|NCT01541644|472399267|FG000|Overall Study|Withdrawal by Subject|3|||
131211785|NCT02389621|472399268|FG000|Treatment Period|Withdrawal by Subject|1|||
131211786|NCT02389621|472399269|FG001|Treatment Period|Withdrawal by Subject|1|||
131211787|NCT02389621|472399268|FG000|Posttreatment Period|Adverse Event|3|||
131211788|NCT02389621|472399269|FG001|Posttreatment Period|Adverse Event|1|||
131211789|NCT02389621|472399268|FG000|Posttreatment Period|Withdrawal by Subject|3|||
131211790|NCT02389621|472399269|FG001|Posttreatment Period|Withdrawal by Subject|2|||
131211791|NCT02389621|472399268|FG000|Posttreatment Period|Lost to Follow-up|1|||
131211792|NCT02389621|472399269|FG001|Posttreatment Period|Lost to Follow-up|1|||
131211793|NCT02389621|472399268|FG000|Posttreatment Period|Other - Miscellaneous|2|||
131211794|NCT02389621|472399269|FG001|Posttreatment Period|Other - Miscellaneous|0|||
131211795|NCT04780776|472399284|FG000|Titration Week 1-5|Lost to Follow-up|2|||
131211796|NCT04780776|472399285|FG001|Titration Week 1-5|Lost to Follow-up|8|||
131211797|NCT04780776|472399284|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
131211798|NCT04780776|472399285|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
131211799|NCT04780776|472399284|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
131211800|NCT04780776|472399285|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
131211801|NCT03113760|472399286|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
131211802|NCT03113760|472399287|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
131211803|NCT03113760|472399288|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
131211804|NCT03113760|472399289|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
131211805|NCT03113760|472399286|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
131211806|NCT03113760|472399287|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
131211807|NCT03113760|472399288|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
131211808|NCT03113760|472399289|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
131211809|NCT03113760|472399286|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
131211810|NCT03113760|472399287|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
131211811|NCT03113760|472399288|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
131211812|NCT03113760|472399289|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
131211813|NCT02957149|472399290|FG000|Overall Study|Withdrawal by Subject|5|||
131211814|NCT00003526|472399291|FG000|Overall Study|Not evaluable|6|||
131211815|NCT04753606|472399298|FG000|Overall Study|Adverse Event|1|||
131211816|NCT04753606|472399299|FG001|Overall Study|Adverse Event|0|||
131211817|NCT04753606|472399300|FG002|Overall Study|Adverse Event|0|||
131211818|NCT01283009|472399301|FG000|Overall Study|Death|83|||
131211819|NCT01283009|472399302|FG001|Overall Study|Death|78|||
131211820|NCT01283009|472399301|FG000|Overall Study|Study ended early|23|||
131211821|NCT01283009|472399302|FG001|Overall Study|Study ended early|26|||
131211822|NCT01283009|472399301|FG000|Overall Study|Withdrawal by Subject|10|||
131211823|NCT01283009|472399302|FG001|Overall Study|Withdrawal by Subject|8|||
131211824|NCT01283009|472399301|FG000|Overall Study|Physician Decision|1|||
131211825|NCT01283009|472399302|FG001|Overall Study|Physician Decision|1|||
131211826|NCT01283009|472399301|FG000|Overall Study|Lost to Follow-up|1|||
131211827|NCT01283009|472399302|FG001|Overall Study|Lost to Follow-up|0|||
131211828|NCT01283009|472399301|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
131211829|NCT01283009|472399302|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
131211830|NCT01748162|472399305|FG000|Overall Study|no additional croup episodes to evaluate|2|||
131211831|NCT01748162|472399306|FG001|Overall Study|no additional croup episodes to evaluate|2|||
131211832|NCT01748162|472399305|FG000|Overall Study|participant consented but did not begin|0|||
131211833|NCT01748162|472399306|FG001|Overall Study|participant consented but did not begin|1|||
131211834|NCT01748162|472399305|FG000|Overall Study|reasons not available|3|||
131211835|NCT01748162|472399306|FG001|Overall Study|reasons not available|2|||
131211836|NCT02743117|472399307|FG000|Overall Study|Lost to Follow-up|0|||
131211837|NCT02743117|472399308|FG001|Overall Study|Lost to Follow-up|1|||
131211838|NCT02743117|472399307|FG000|Overall Study|Other|1|||
131211839|NCT02743117|472399308|FG001|Overall Study|Other|0|||
131211840|NCT01207219|472399309|FG000|Overall Study|changed diagnosis during study period|5|||
131211841|NCT01207219|472399310|FG001|Overall Study|changed diagnosis during study period|3|||
131211842|NCT01207219|472399311|FG002|Overall Study|changed diagnosis during study period|1|||
131211843|NCT01207219|472399309|FG000|Overall Study|Lost to Follow-up|6|||
131211844|NCT01207219|472399310|FG001|Overall Study|Lost to Follow-up|8|||
131211845|NCT01207219|472399311|FG002|Overall Study|Lost to Follow-up|6|||
131211846|NCT04640168|472399312|FG000|Overall Study|Withdrawal by Subject|8|||
131211847|NCT04640168|472399313|FG001|Overall Study|Withdrawal by Subject|7|||
131211848|NCT04640168|472399312|FG000|Overall Study|Lost to Follow-up|1|||
131211849|NCT04640168|472399313|FG001|Overall Study|Lost to Follow-up|0|||
131211850|NCT04640168|472399312|FG000|Overall Study|Enrolled but not treated|12|||
131211851|NCT04640168|472399313|FG001|Overall Study|Enrolled but not treated|12|||
131211852|NCT01453296|472399318|FG000|Treatment Period 1|Adverse Event|0|||
131211853|NCT01453296|472399319|FG001|Treatment Period 1|Adverse Event|1|||
131211854|NCT01453296|472399318|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
131211855|NCT01453296|472399319|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
131211856|NCT01453296|472399318|FG000|Treatment Period 2|Adverse Event|1|||
131211857|NCT01453296|472399319|FG001|Treatment Period 2|Adverse Event|0|||
131211858|NCT01453296|472399318|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131211859|NCT01453296|472399319|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131211860|NCT00620776|472399320|FG000|Overall Study|Did not receive treatment|3|||
131211861|NCT00620776|472399321|FG001|Overall Study|Did not receive treatment|5|||
131211862|NCT00620776|472399320|FG000|Overall Study|Adverse Event|2|||
131211863|NCT00620776|472399321|FG001|Overall Study|Adverse Event|3|||
131211864|NCT00620776|472399320|FG000|Overall Study|Lack of Efficacy|2|||
131211865|NCT00620776|472399321|FG001|Overall Study|Lack of Efficacy|1|||
131211866|NCT00620776|472399320|FG000|Overall Study|Lost to Follow-up|2|||
131211867|NCT00620776|472399321|FG001|Overall Study|Lost to Follow-up|5|||
131211868|NCT00620776|472399320|FG000|Overall Study|Withdrawal by Subject|3|||
131211869|NCT00620776|472399321|FG001|Overall Study|Withdrawal by Subject|2|||
131211870|NCT01725217|472399323|FG000|Overall Study|Withdrawal by Subject|1|||
131211871|NCT01725217|472399324|FG001|Overall Study|Withdrawal by Subject|0|||
131211872|NCT01725217|472399325|FG002|Overall Study|Withdrawal by Subject|0|||
131211873|NCT00308555|472399332|FG000|Overall Study|Withdrawal by Subject|1|||
131211874|NCT00308555|472399333|FG001|Overall Study|Withdrawal by Subject|0|||
131211875|NCT00308555|472399332|FG000|Overall Study|Physician Decision|2|||
131211876|NCT00308555|472399333|FG001|Overall Study|Physician Decision|0|||
131211877|NCT00276458|472399334|FG000|Overall Study|Adverse Event|0|||
131211878|NCT00276458|472399335|FG001|Overall Study|Adverse Event|2|||
131211879|NCT00276458|472399334|FG000|Overall Study|Lost to Follow-up|2|||
131211880|NCT00276458|472399335|FG001|Overall Study|Lost to Follow-up|2|||
131211881|NCT00276458|472399334|FG000|Overall Study|Protocol Violation|4|||
131211882|NCT00276458|472399335|FG001|Overall Study|Protocol Violation|3|||
131211883|NCT02940392|472399340|FG000|Overall Study|Lost to Follow-up|3|||
131211884|NCT02940392|472399340|FG000|Overall Study|Retreatment|3|||
131211885|NCT02940392|472399340|FG000|Overall Study|Death|2|||
131211886|NCT03205046|472399342|FG000|Overall Study|Death|10|||
131211887|NCT03205046|472399343|FG001|Overall Study|Death|6|||
131211888|NCT03205046|472399342|FG000|Overall Study|Withdrawal by Subject|1|||
131211889|NCT03205046|472399343|FG001|Overall Study|Withdrawal by Subject|2|||
131211890|NCT03205046|472399342|FG000|Overall Study|Lost to Follow-up|0|||
131211891|NCT03205046|472399343|FG001|Overall Study|Lost to Follow-up|1|||
131211892|NCT03205046|472399342|FG000|Overall Study|Study terminated by sponsor|2|||
131211893|NCT03205046|472399343|FG001|Overall Study|Study terminated by sponsor|1|||
131211894|NCT01023815|472399344|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
131211895|NCT01023815|472399345|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
131211896|NCT01023815|472399346|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
131211897|NCT01023815|472399347|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
131211898|NCT01023815|472399344|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
131211899|NCT01023815|472399345|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
131211900|NCT01023815|472399346|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
131211901|NCT01023815|472399347|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
131211902|NCT01023815|472399344|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
131211903|NCT01023815|472399345|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
131211904|NCT01023815|472399346|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
131211905|NCT01023815|472399347|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
131211906|NCT01023815|472399344|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
131211907|NCT01023815|472399345|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
131211908|NCT01023815|472399346|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
131211909|NCT01023815|472399347|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
131211910|NCT01023815|472399344|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
131211911|NCT01023815|472399345|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
131211912|NCT01023815|472399346|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
131211913|NCT01023815|472399347|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
131211914|NCT03253809|472399350|FG000|Overall Study|Unable to obtain study related data|14|||
131211915|NCT03992456|472399351|FG000|Overall Study|Withdrawal by Subject|1|||
131211916|NCT03992456|472399352|FG001|Overall Study|Withdrawal by Subject|0|||
131211917|NCT03992456|472399351|FG000|Overall Study|Disease progression|4|||
131211918|NCT03992456|472399352|FG001|Overall Study|Disease progression|5|||
131211919|NCT03992456|472399351|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
131211920|NCT03992456|472399352|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
131211921|NCT00910000|472399353|FG000|Overall Study|Adverse Event|0|||
131211922|NCT00910000|472399354|FG001|Overall Study|Adverse Event|3|||
131211923|NCT00910000|472399355|FG002|Overall Study|Adverse Event|2|||
131211924|NCT00910000|472399356|FG003|Overall Study|Adverse Event|2|||
131211925|NCT00910000|472399357|FG004|Overall Study|Adverse Event|0|||
131211926|NCT00910000|472399358|FG005|Overall Study|Adverse Event|1|||
131211927|NCT00910000|472399353|FG000|Overall Study|Withdrawal by Subject|0|||
131211928|NCT00910000|472399354|FG001|Overall Study|Withdrawal by Subject|0|||
131211929|NCT00910000|472399355|FG002|Overall Study|Withdrawal by Subject|1|||
131211930|NCT00910000|472399356|FG003|Overall Study|Withdrawal by Subject|0|||
131211931|NCT00910000|472399357|FG004|Overall Study|Withdrawal by Subject|1|||
131211932|NCT00910000|472399358|FG005|Overall Study|Withdrawal by Subject|0|||
131211933|NCT01977625|472399359|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
131211934|NCT01977625|472399360|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
131211935|NCT01977625|472399359|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
131211936|NCT01977625|472399360|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130876583|NCT04742556|471179619|FG001|Overall Study|Adverse Event|0|||
131211937|NCT03125382|472399362|FG000|Randomization|screening failure|1|||
131211938|NCT03125382|472399363|FG001|Randomization|screening failure|4|||
131211939|NCT03125382|472399364|FG002|Randomization|screening failure|2|||
131211940|NCT03125382|472399365|FG003|Randomization|screening failure|0|||
131211941|NCT03125382|472399362|FG000|Follow-up|Death|1|||
131211942|NCT03125382|472399363|FG001|Follow-up|Death|2|||
131211943|NCT03125382|472399364|FG002|Follow-up|Death|1|||
131211944|NCT03125382|472399365|FG003|Follow-up|Death|2|||
131211945|NCT03125382|472399362|FG000|Follow-up|Lost to Follow-up|1|||
131211946|NCT03125382|472399363|FG001|Follow-up|Lost to Follow-up|4|||
131211947|NCT03125382|472399364|FG002|Follow-up|Lost to Follow-up|3|||
131211948|NCT03125382|472399365|FG003|Follow-up|Lost to Follow-up|1|||
131211949|NCT02686749|472399366|FG000|Overall Study|terminated for poor enrollment|2|||
131211950|NCT02686749|472399367|FG001|Overall Study|terminated for poor enrollment|2|||
131211951|NCT04668066|472399368|FG000|Part 1: Treatment Phase|Adverse Event|0|||
131211952|NCT04668066|472399369|FG001|Part 1: Treatment Phase|Adverse Event|0|||
131211953|NCT04668066|472399370|FG002|Part 1: Treatment Phase|Adverse Event|0|||
131211954|NCT04668066|472399371|FG003|Part 1: Treatment Phase|Adverse Event|0|||
131211955|NCT04668066|472399372|FG004|Part 1: Treatment Phase|Adverse Event|0|||
131211956|NCT04668066|472399373|FG005|Part 1: Treatment Phase|Adverse Event|0|||
131211957|NCT04668066|472399374|FG006|Part 1: Treatment Phase|Adverse Event|0|||
131211958|NCT04668066|472399375|FG007|Part 1: Treatment Phase|Adverse Event|0|||
131211959|NCT04668066|472399376|FG008|Part 1: Treatment Phase|Adverse Event|0|||
131211960|NCT04668066|472399377|FG009|Part 1: Treatment Phase|Adverse Event|0|||
131211961|NCT04668066|472399378|FG010|Part 1: Treatment Phase|Adverse Event|0|||
131211962|NCT04668066|472399379|FG011|Part 1: Treatment Phase|Adverse Event|1|||
131211963|NCT04668066|472399380|FG012|Part 1: Treatment Phase|Adverse Event|1|||
131211964|NCT04668066|472399381|FG013|Part 1: Treatment Phase|Adverse Event|0|||
131211965|NCT04668066|472399382|FG014|Part 1: Treatment Phase|Adverse Event|0|||
131211966|NCT04668066|472399383|FG015|Part 1: Treatment Phase|Adverse Event|0|||
131211967|NCT04668066|472399384|FG016|Part 1: Treatment Phase|Adverse Event|0|||
131211968|NCT04668066|472399385|FG017|Part 1: Treatment Phase|Adverse Event|0|||
131211969|NCT04668066|472399386|FG018|Part 1: Treatment Phase|Adverse Event|0|||
131211970|NCT04668066|472399368|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211971|NCT04668066|472399369|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211972|NCT04668066|472399370|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
131211973|NCT04668066|472399371|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211974|NCT04668066|472399372|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211975|NCT04668066|472399373|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211976|NCT04668066|472399374|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211977|NCT04668066|472399375|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211978|NCT04668066|472399376|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211979|NCT04668066|472399377|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211980|NCT04668066|472399378|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211981|NCT04668066|472399379|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211982|NCT04668066|472399380|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211983|NCT04668066|472399381|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
130876584|NCT04742556|471179620|FG002|Overall Study|Adverse Event|2|||
131211984|NCT04668066|472399382|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211985|NCT04668066|472399383|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211986|NCT04668066|472399384|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
130876585|NCT04742556|471179618|FG000|Overall Study|Clinical disease progression|0|||
130876586|NCT04742556|471179619|FG001|Overall Study|Clinical disease progression|1|||
131211987|NCT04668066|472399385|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211988|NCT04668066|472399386|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
131211989|NCT04668066|472399368|FG000|Part 1: Treatment Phase|Other|0|||
131211990|NCT04668066|472399369|FG001|Part 1: Treatment Phase|Other|0|||
131211991|NCT04668066|472399370|FG002|Part 1: Treatment Phase|Other|0|||
131211992|NCT04668066|472399371|FG003|Part 1: Treatment Phase|Other|0|||
131211993|NCT04668066|472399372|FG004|Part 1: Treatment Phase|Other|0|||
131211994|NCT04668066|472399373|FG005|Part 1: Treatment Phase|Other|0|||
131211995|NCT04668066|472399374|FG006|Part 1: Treatment Phase|Other|0|||
131211996|NCT04668066|472399375|FG007|Part 1: Treatment Phase|Other|0|||
131211997|NCT04668066|472399376|FG008|Part 1: Treatment Phase|Other|0|||
131211998|NCT04668066|472399377|FG009|Part 1: Treatment Phase|Other|0|||
131211999|NCT04668066|472399378|FG010|Part 1: Treatment Phase|Other|0|||
131212000|NCT04668066|472399379|FG011|Part 1: Treatment Phase|Other|1|||
131212001|NCT04668066|472399380|FG012|Part 1: Treatment Phase|Other|0|||
131212002|NCT04668066|472399381|FG013|Part 1: Treatment Phase|Other|0|||
131212003|NCT04668066|472399382|FG014|Part 1: Treatment Phase|Other|0|||
131212004|NCT04668066|472399383|FG015|Part 1: Treatment Phase|Other|0|||
131212005|NCT04668066|472399384|FG016|Part 1: Treatment Phase|Other|0|||
131212006|NCT04668066|472399385|FG017|Part 1: Treatment Phase|Other|0|||
131212007|NCT04668066|472399386|FG018|Part 1: Treatment Phase|Other|0|||
131212008|NCT04668066|472399368|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212009|NCT04668066|472399369|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212010|NCT04668066|472399370|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212011|NCT04668066|472399371|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212012|NCT04668066|472399372|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212013|NCT04668066|472399373|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212014|NCT04668066|472399374|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212015|NCT04668066|472399375|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212016|NCT04668066|472399376|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212017|NCT04668066|472399377|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212018|NCT04668066|472399378|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212019|NCT04668066|472399379|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212020|NCT04668066|472399380|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
131212021|NCT04668066|472399381|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212022|NCT04668066|472399382|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212023|NCT04668066|472399383|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
131212024|NCT04668066|472399384|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212025|NCT04668066|472399385|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212026|NCT04668066|472399386|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
131212027|NCT04668066|472399368|FG000|Part 1: Follow-Up|Adverse Event|0|||
131212028|NCT04668066|472399369|FG001|Part 1: Follow-Up|Adverse Event|0|||
131212029|NCT04668066|472399370|FG002|Part 1: Follow-Up|Adverse Event|0|||
131212030|NCT04668066|472399371|FG003|Part 1: Follow-Up|Adverse Event|0|||
131212031|NCT04668066|472399372|FG004|Part 1: Follow-Up|Adverse Event|0|||
131212032|NCT04668066|472399373|FG005|Part 1: Follow-Up|Adverse Event|0|||
131212033|NCT04668066|472399374|FG006|Part 1: Follow-Up|Adverse Event|0|||
131212034|NCT04668066|472399375|FG007|Part 1: Follow-Up|Adverse Event|0|||
131212035|NCT04668066|472399376|FG008|Part 1: Follow-Up|Adverse Event|0|||
131212036|NCT04668066|472399377|FG009|Part 1: Follow-Up|Adverse Event|0|||
131212037|NCT04668066|472399378|FG010|Part 1: Follow-Up|Adverse Event|0|||
131212038|NCT04668066|472399379|FG011|Part 1: Follow-Up|Adverse Event|1|||
131212039|NCT04668066|472399380|FG012|Part 1: Follow-Up|Adverse Event|0|||
131212040|NCT04668066|472399381|FG013|Part 1: Follow-Up|Adverse Event|0|||
131212041|NCT04668066|472399382|FG014|Part 1: Follow-Up|Adverse Event|0|||
131212042|NCT04668066|472399383|FG015|Part 1: Follow-Up|Adverse Event|0|||
131212043|NCT04668066|472399384|FG016|Part 1: Follow-Up|Adverse Event|0|||
131212044|NCT04668066|472399385|FG017|Part 1: Follow-Up|Adverse Event|0|||
131212045|NCT04668066|472399386|FG018|Part 1: Follow-Up|Adverse Event|0|||
131212046|NCT04668066|472399368|FG000|Part 1: Follow-Up|Other|0|||
131212047|NCT04668066|472399369|FG001|Part 1: Follow-Up|Other|0|||
131212048|NCT04668066|472399370|FG002|Part 1: Follow-Up|Other|0|||
131212049|NCT04668066|472399371|FG003|Part 1: Follow-Up|Other|0|||
131212050|NCT04668066|472399372|FG004|Part 1: Follow-Up|Other|0|||
131212051|NCT04668066|472399373|FG005|Part 1: Follow-Up|Other|0|||
131212052|NCT04668066|472399374|FG006|Part 1: Follow-Up|Other|0|||
131212053|NCT04668066|472399375|FG007|Part 1: Follow-Up|Other|0|||
131212054|NCT04668066|472399376|FG008|Part 1: Follow-Up|Other|0|||
131212055|NCT04668066|472399377|FG009|Part 1: Follow-Up|Other|0|||
131212056|NCT04668066|472399378|FG010|Part 1: Follow-Up|Other|0|||
131212057|NCT04668066|472399379|FG011|Part 1: Follow-Up|Other|1|||
131212058|NCT04668066|472399380|FG012|Part 1: Follow-Up|Other|1|||
131212059|NCT04668066|472399381|FG013|Part 1: Follow-Up|Other|0|||
131212060|NCT04668066|472399382|FG014|Part 1: Follow-Up|Other|0|||
131212061|NCT04668066|472399383|FG015|Part 1: Follow-Up|Other|0|||
131212062|NCT04668066|472399384|FG016|Part 1: Follow-Up|Other|0|||
131212063|NCT04668066|472399385|FG017|Part 1: Follow-Up|Other|0|||
131212064|NCT04668066|472399386|FG018|Part 1: Follow-Up|Other|0|||
131212065|NCT04668066|472399368|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212066|NCT04668066|472399369|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212067|NCT04668066|472399370|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212068|NCT04668066|472399371|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212069|NCT04668066|472399372|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212070|NCT04668066|472399373|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212071|NCT04668066|472399374|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212072|NCT04668066|472399375|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212073|NCT04668066|472399376|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212074|NCT04668066|472399377|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212075|NCT04668066|472399378|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212076|NCT04668066|472399379|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212077|NCT04668066|472399380|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
131212078|NCT04668066|472399381|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212079|NCT04668066|472399382|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212080|NCT04668066|472399383|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
131212081|NCT04668066|472399384|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212082|NCT04668066|472399385|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212083|NCT04668066|472399386|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
131212084|NCT04668066|472399368|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212085|NCT04668066|472399369|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212086|NCT04668066|472399370|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212087|NCT04668066|472399371|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212088|NCT04668066|472399372|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212089|NCT04668066|472399373|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212090|NCT04668066|472399374|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212091|NCT04668066|472399375|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212092|NCT04668066|472399376|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212093|NCT04668066|472399377|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212094|NCT04668066|472399378|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212095|NCT04668066|472399379|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212096|NCT04668066|472399380|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212097|NCT04668066|472399381|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212098|NCT04668066|472399382|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212099|NCT04668066|472399383|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212100|NCT04668066|472399384|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212101|NCT04668066|472399385|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
131212102|NCT04668066|472399386|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
131212103|NCT04668066|472399368|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212104|NCT04668066|472399369|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212105|NCT04668066|472399370|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212106|NCT04668066|472399371|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212107|NCT04668066|472399372|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212108|NCT04668066|472399373|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212109|NCT04668066|472399374|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212110|NCT04668066|472399375|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212111|NCT04668066|472399376|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212112|NCT04668066|472399377|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212113|NCT04668066|472399378|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212114|NCT04668066|472399379|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212115|NCT04668066|472399380|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212116|NCT04668066|472399381|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212117|NCT04668066|472399382|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212118|NCT04668066|472399383|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212119|NCT04668066|472399384|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212120|NCT04668066|472399385|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
131212121|NCT04668066|472399386|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
131212122|NCT04668066|472399368|FG000|Part 2: Treatment Phase|Other|0|||
131212123|NCT04668066|472399369|FG001|Part 2: Treatment Phase|Other|0|||
131212124|NCT04668066|472399370|FG002|Part 2: Treatment Phase|Other|0|||
131212125|NCT04668066|472399371|FG003|Part 2: Treatment Phase|Other|0|||
131212126|NCT04668066|472399372|FG004|Part 2: Treatment Phase|Other|0|||
131212127|NCT04668066|472399373|FG005|Part 2: Treatment Phase|Other|0|||
131212128|NCT04668066|472399374|FG006|Part 2: Treatment Phase|Other|0|||
131212129|NCT04668066|472399375|FG007|Part 2: Treatment Phase|Other|0|||
131212130|NCT04668066|472399376|FG008|Part 2: Treatment Phase|Other|0|||
131212131|NCT04668066|472399377|FG009|Part 2: Treatment Phase|Other|0|||
131212132|NCT04668066|472399378|FG010|Part 2: Treatment Phase|Other|0|||
131212133|NCT04668066|472399379|FG011|Part 2: Treatment Phase|Other|0|||
131212134|NCT04668066|472399380|FG012|Part 2: Treatment Phase|Other|0|||
131212135|NCT04668066|472399381|FG013|Part 2: Treatment Phase|Other|0|||
131212136|NCT04668066|472399382|FG014|Part 2: Treatment Phase|Other|0|||
131212137|NCT04668066|472399383|FG015|Part 2: Treatment Phase|Other|0|||
130876587|NCT04742556|471179620|FG002|Overall Study|Clinical disease progression|2|||
131212138|NCT04668066|472399384|FG016|Part 2: Treatment Phase|Other|0|||
130988332|NCT00615264|471585340|FG000|Overall Study|Withdrawal by Subject|17|||
130876588|NCT04742556|471179618|FG000|Overall Study|Objective disease progression|3|||
130876589|NCT04742556|471179619|FG001|Overall Study|Objective disease progression|2|||
131212139|NCT04668066|472399385|FG017|Part 2: Treatment Phase|Other|0|||
131212140|NCT04668066|472399386|FG018|Part 2: Treatment Phase|Other|1|||
131212141|NCT04668066|472399368|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212142|NCT04668066|472399369|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212143|NCT04668066|472399370|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212144|NCT04668066|472399371|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212145|NCT04668066|472399372|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212146|NCT04668066|472399373|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212147|NCT04668066|472399374|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212148|NCT04668066|472399375|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212149|NCT04668066|472399376|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212150|NCT04668066|472399377|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212151|NCT04668066|472399378|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212152|NCT04668066|472399379|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212153|NCT04668066|472399380|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212154|NCT04668066|472399381|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212155|NCT04668066|472399382|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212156|NCT04668066|472399383|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212157|NCT04668066|472399384|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212158|NCT04668066|472399385|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
131212159|NCT04668066|472399386|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
131212160|NCT05147311|472399387|FG000|Overall Study|Did not complete survey|2|||
131212161|NCT05147311|472399388|FG001|Overall Study|Did not complete survey|1|||
131212162|NCT05147311|472399387|FG000|Overall Study|Patient too sick|1|||
131212163|NCT05147311|472399388|FG001|Overall Study|Patient too sick|2|||
131212164|NCT05147311|472399387|FG000|Overall Study|Death|0|||
131212165|NCT05147311|472399388|FG001|Overall Study|Death|1|||
131212166|NCT05147311|472399387|FG000|Overall Study|Declined survey|1|||
131212167|NCT05147311|472399388|FG001|Overall Study|Declined survey|0|||
131212168|NCT04505592|472399389|FG000|Overall Study|Death|2|||
131212169|NCT04505592|472399390|FG001|Overall Study|Death|1|||
131212170|NCT03522506|472399394|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131212171|NCT03522506|472399395|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131212172|NCT03522506|472399396|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131212173|NCT03522506|472399397|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
131212174|NCT03522506|472399394|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
131212175|NCT03522506|472399395|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
131212176|NCT03522506|472399396|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
131212177|NCT03522506|472399397|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
131212178|NCT03480243|472399398|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
131212179|NCT03480243|472399398|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
131212180|NCT02388906|472399406|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
131212181|NCT02388906|472399407|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
131212182|NCT02388906|472399406|FG000|Treatment Period|Disease progression|121|||
131212183|NCT02388906|472399407|FG001|Treatment Period|Disease progression|100|||
131212184|NCT02388906|472399406|FG000|Treatment Period|Study drug toxicity|41|||
131212185|NCT02388906|472399407|FG001|Treatment Period|Study drug toxicity|208|||
131212186|NCT02388906|472399406|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
131212187|NCT02388906|472399407|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
131212188|NCT02388906|472399406|FG000|Treatment Period|Participant request to stop treatment|5|||
131212189|NCT02388906|472399407|FG001|Treatment Period|Participant request to stop treatment|9|||
131212190|NCT02388906|472399406|FG000|Treatment Period|Participant withdrew consent|2|||
131212191|NCT02388906|472399407|FG001|Treatment Period|Participant withdrew consent|3|||
131212192|NCT02388906|472399406|FG000|Treatment Period|Poor/non-compliance|0|||
131212193|NCT02388906|472399407|FG001|Treatment Period|Poor/non-compliance|1|||
131212194|NCT02388906|472399406|FG000|Treatment Period|Participant no longer meets study criteria|0|||
131212195|NCT02388906|472399407|FG001|Treatment Period|Participant no longer meets study criteria|1|||
131212196|NCT02388906|472399406|FG000|Treatment Period|Other reasons|3|||
131212197|NCT02388906|472399407|FG001|Treatment Period|Other reasons|3|||
131212198|NCT04365387|472399416|FG000|Overall Study|Adverse Event|4|||
131212199|NCT04365387|472399417|FG001|Overall Study|Adverse Event|2|||
131212200|NCT04365387|472399416|FG000|Overall Study|Participants request|14|||
131212201|NCT04365387|472399417|FG001|Overall Study|Participants request|14|||
131212202|NCT04365387|472399416|FG000|Overall Study|Lost to Follow-up|8|||
131212203|NCT04365387|472399417|FG001|Overall Study|Lost to Follow-up|5|||
131212204|NCT04365387|472399416|FG000|Overall Study|Protocol deviation|3|||
131212205|NCT04365387|472399417|FG001|Overall Study|Protocol deviation|4|||
131212206|NCT04365387|472399416|FG000|Overall Study|Participant compliance with visit schedule|1|||
131212207|NCT04365387|472399417|FG001|Overall Study|Participant compliance with visit schedule|0|||
131212208|NCT04365387|472399416|FG000|Overall Study|Participant incarcerated|1|||
131212209|NCT04365387|472399417|FG001|Overall Study|Participant incarcerated|0|||
131212210|NCT04365387|472399416|FG000|Overall Study|Participant moved out of town (relocated)|0|||
131212211|NCT04365387|472399417|FG001|Overall Study|Participant moved out of town (relocated)|1|||
131212212|NCT04365387|472399416|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
131212213|NCT04365387|472399417|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
131212214|NCT04365387|472399416|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
131212215|NCT04365387|472399417|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
131212216|NCT05770401|472399418|FG000|Overall Study|Lost to Follow-up|5|||
131212217|NCT05770401|472399419|FG001|Overall Study|Lost to Follow-up|4|||
131212218|NCT00480077|472399420|FG000|Overall Study|Death|19|||
131212219|NCT00480077|472399421|FG001|Overall Study|Death|15|||
131212220|NCT00480077|472399420|FG000|Overall Study|early exit|12|||
131212221|NCT00480077|472399421|FG001|Overall Study|early exit|11|||
131212222|NCT00262119|472399427|FG000|Overall Study|Lost to Follow-up|38|||
131212223|NCT00262119|472399428|FG001|Overall Study|Lost to Follow-up|51|||
131212224|NCT00262119|472399429|FG002|Overall Study|Lost to Follow-up|42|||
131212225|NCT00262119|472399427|FG000|Overall Study|Death|20|||
131212226|NCT00262119|472399428|FG001|Overall Study|Death|19|||
131212227|NCT00262119|472399429|FG002|Overall Study|Death|16|||
131212228|NCT05261126|472399430|FG000|Overall Study|Death|0|||
131212229|NCT05261126|472399431|FG001|Overall Study|Death|0|||
131212230|NCT05261126|472399432|FG002|Overall Study|Death|1|||
131212231|NCT05261126|472399433|FG003|Overall Study|Death|0|||
131212232|NCT05261126|472399434|FG004|Overall Study|Death|0|||
131212233|NCT05261126|472399430|FG000|Overall Study|Lost to Follow-up|0|||
131212234|NCT05261126|472399431|FG001|Overall Study|Lost to Follow-up|0|||
131212235|NCT05261126|472399432|FG002|Overall Study|Lost to Follow-up|0|||
131212236|NCT05261126|472399433|FG003|Overall Study|Lost to Follow-up|0|||
131212237|NCT05261126|472399434|FG004|Overall Study|Lost to Follow-up|1|||
131212238|NCT05261126|472399430|FG000|Overall Study|Physician Decision|1|||
131212239|NCT05261126|472399431|FG001|Overall Study|Physician Decision|0|||
131212240|NCT05261126|472399432|FG002|Overall Study|Physician Decision|0|||
131212241|NCT05261126|472399433|FG003|Overall Study|Physician Decision|0|||
131212242|NCT05261126|472399434|FG004|Overall Study|Physician Decision|0|||
131212243|NCT05261126|472399430|FG000|Overall Study|Screen Failure|0|||
131212244|NCT05261126|472399431|FG001|Overall Study|Screen Failure|0|||
131212245|NCT05261126|472399432|FG002|Overall Study|Screen Failure|0|||
131212246|NCT05261126|472399433|FG003|Overall Study|Screen Failure|0|||
131212247|NCT05261126|472399434|FG004|Overall Study|Screen Failure|1|||
131212248|NCT05261126|472399430|FG000|Overall Study|Withdrawal by Subject|1|||
131212249|NCT05261126|472399431|FG001|Overall Study|Withdrawal by Subject|0|||
131212250|NCT05261126|472399432|FG002|Overall Study|Withdrawal by Subject|1|||
131212251|NCT05261126|472399433|FG003|Overall Study|Withdrawal by Subject|1|||
131212252|NCT05261126|472399434|FG004|Overall Study|Withdrawal by Subject|0|||
131212253|NCT05261126|472399430|FG000|Overall Study|Not Recorded|0|||
131212254|NCT05261126|472399431|FG001|Overall Study|Not Recorded|0|||
131212255|NCT05261126|472399432|FG002|Overall Study|Not Recorded|0|||
131212256|NCT05261126|472399433|FG003|Overall Study|Not Recorded|1|||
131212257|NCT05261126|472399434|FG004|Overall Study|Not Recorded|0|||
131212258|NCT05570604|472399435|FG000|Overall Study|Lost to Follow-up|1|||
131212259|NCT05570604|472399436|FG001|Overall Study|Lost to Follow-up|5|||
131212260|NCT05570604|472399435|FG000|Overall Study|Illness|2|||
131212261|NCT05570604|472399436|FG001|Overall Study|Illness|2|||
131212262|NCT01463631|472399441|FG000|Overall Study|Withdrawal by Subject|0|||
131212263|NCT01463631|472399442|FG001|Overall Study|Withdrawal by Subject|0|||
131212264|NCT01463631|472399443|FG002|Overall Study|Withdrawal by Subject|0|||
131212265|NCT01463631|472399444|FG003|Overall Study|Withdrawal by Subject|1|||
131212266|NCT01463631|472399441|FG000|Overall Study|Death|0|||
131212267|NCT01463631|472399442|FG001|Overall Study|Death|0|||
131212268|NCT01463631|472399443|FG002|Overall Study|Death|1|||
131212269|NCT01463631|472399444|FG003|Overall Study|Death|0|||
131212270|NCT01463631|472399441|FG000|Overall Study|Progressive Disease|0|||
131212271|NCT01463631|472399442|FG001|Overall Study|Progressive Disease|0|||
131212272|NCT01463631|472399443|FG002|Overall Study|Progressive Disease|0|||
131212273|NCT01463631|472399444|FG003|Overall Study|Progressive Disease|5|||
131212274|NCT05966129|472399445|FG000|Overall Study|Death|1|||
131212275|NCT05966129|472399446|FG001|Overall Study|Death|2|||
131212276|NCT05966129|472399445|FG000|Overall Study|Lost to Follow-up|63|||
131212277|NCT05966129|472399446|FG001|Overall Study|Lost to Follow-up|66|||
131212278|NCT05966129|472399445|FG000|Overall Study|Protocol Violation|1|||
131212279|NCT05966129|472399446|FG001|Overall Study|Protocol Violation|0|||
131212280|NCT05966129|472399445|FG000|Overall Study|Withdrawal by Subject|26|||
131212281|NCT05966129|472399446|FG001|Overall Study|Withdrawal by Subject|25|||
131212282|NCT05966129|472399445|FG000|Overall Study|Surgery not completed|63|||
131212283|NCT05966129|472399446|FG001|Overall Study|Surgery not completed|69|||
131212284|NCT05966129|472399445|FG000|Overall Study|Surgery logistics issue|2|||
131212285|NCT05966129|472399446|FG001|Overall Study|Surgery logistics issue|1|||
131212286|NCT03145207|472399450|FG000|Overall Study|volunteer started taking allergy shots|1|||
131212287|NCT03145207|472399450|FG000|Overall Study|baseline blood pressure high|1|||
131212288|NCT01396434|472399451|FG000|Overall Study|Lost to Follow-up|1|||
131212289|NCT01396434|472399452|FG001|Overall Study|Lost to Follow-up|0|||
131212290|NCT01396434|472399453|FG002|Overall Study|Lost to Follow-up|0|||
131212291|NCT01396434|472399451|FG000|Overall Study|Other|10|||
131212292|NCT01396434|472399452|FG001|Overall Study|Other|0|||
131212293|NCT01396434|472399453|FG002|Overall Study|Other|0|||
131212294|NCT04678557|472399454|FG000|Overall Study|Withdrawal by Subject|1|||
131212295|NCT04678557|472399455|FG001|Overall Study|Withdrawal by Subject|0|||
131212296|NCT04678557|472399454|FG000|Overall Study|Lack of Efficacy|0|||
131212297|NCT04678557|472399455|FG001|Overall Study|Lack of Efficacy|13|||
131212298|NCT04678557|472399454|FG000|Overall Study|Safety Evaluation|0|||
131212299|NCT04678557|472399455|FG001|Overall Study|Safety Evaluation|1|||
131212300|NCT02207413|472399456|FG000|Overall Study|Withdrawal by Subject|1|||
131212301|NCT02207413|472399457|FG001|Overall Study|Withdrawal by Subject|0|||
131212302|NCT02207413|472399458|FG002|Overall Study|Withdrawal by Subject|0|||
131212303|NCT02207413|472399459|FG003|Overall Study|Withdrawal by Subject|0|||
131212304|NCT02207413|472399460|FG004|Overall Study|Withdrawal by Subject|3|||
131212305|NCT02207413|472399461|FG005|Overall Study|Withdrawal by Subject|7|||
131212306|NCT02207413|472399456|FG000|Overall Study|Lost to Follow-up|0|||
131212307|NCT02207413|472399457|FG001|Overall Study|Lost to Follow-up|0|||
131212308|NCT02207413|472399458|FG002|Overall Study|Lost to Follow-up|0|||
131212309|NCT02207413|472399459|FG003|Overall Study|Lost to Follow-up|1|||
131212310|NCT02207413|472399460|FG004|Overall Study|Lost to Follow-up|1|||
131212311|NCT02207413|472399461|FG005|Overall Study|Lost to Follow-up|5|||
131212312|NCT02207413|472399456|FG000|Overall Study|Adverse Event|0|||
131212313|NCT02207413|472399457|FG001|Overall Study|Adverse Event|0|||
131212314|NCT02207413|472399458|FG002|Overall Study|Adverse Event|0|||
131212315|NCT02207413|472399459|FG003|Overall Study|Adverse Event|0|||
131212316|NCT02207413|472399460|FG004|Overall Study|Adverse Event|2|||
131212317|NCT02207413|472399461|FG005|Overall Study|Adverse Event|1|||
131212318|NCT02207413|472399456|FG000|Overall Study|Migrated/moved from study area|0|||
131212319|NCT02207413|472399457|FG001|Overall Study|Migrated/moved from study area|0|||
131212320|NCT02207413|472399458|FG002|Overall Study|Migrated/moved from study area|0|||
131212321|NCT02207413|472399459|FG003|Overall Study|Migrated/moved from study area|0|||
131212322|NCT02207413|472399460|FG004|Overall Study|Migrated/moved from study area|1|||
131212323|NCT02207413|472399461|FG005|Overall Study|Migrated/moved from study area|0|||
131212324|NCT00509223|472401443|FG000|Overall Study|Lost to Follow-up|1|||
131212325|NCT00509223|472401444|FG001|Overall Study|Lost to Follow-up|1|||
131212326|NCT00509223|472401443|FG000|Overall Study|Adverse Event|1|||
131212327|NCT00509223|472401444|FG001|Overall Study|Adverse Event|1|||
131212328|NCT00509223|472401443|FG000|Overall Study|Withdrawal by Subject|25|||
131212329|NCT00509223|472401444|FG001|Overall Study|Withdrawal by Subject|6|||
131212330|NCT00509223|472401443|FG000|Overall Study|Including: subject change of address|5|||
131212331|NCT00509223|472401444|FG001|Overall Study|Including: subject change of address|2|||
131212332|NCT00509223|472401443|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
131212333|NCT00509223|472401444|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
131212334|NCT00437294|472401448|FG000|Overall Study|Adverse Event|5|||
131212335|NCT00437294|472401449|FG001|Overall Study|Adverse Event|4|||
131212336|NCT00437294|472401448|FG000|Overall Study|Death|5|||
131212337|NCT00437294|472401449|FG001|Overall Study|Death|2|||
131212338|NCT00437294|472401448|FG000|Overall Study|Physician Decision|0|||
131212339|NCT00437294|472401449|FG001|Overall Study|Physician Decision|3|||
131212340|NCT00437294|472401448|FG000|Overall Study|Withdrawal by Subject|5|||
131212341|NCT00437294|472401449|FG001|Overall Study|Withdrawal by Subject|0|||
131212342|NCT00437294|472401448|FG000|Overall Study|Progressive Disease|19|||
131212343|NCT00437294|472401449|FG001|Overall Study|Progressive Disease|23|||
131212344|NCT00437294|472401448|FG000|Overall Study|Sponsor Decision|8|||
131212345|NCT00437294|472401449|FG001|Overall Study|Sponsor Decision|9|||
131212346|NCT00437294|472401448|FG000|Overall Study|Protocol Violation|0|||
131212347|NCT00437294|472401449|FG001|Overall Study|Protocol Violation|1|||
131212348|NCT00437294|472401448|FG000|Overall Study|Entry criteria not met|1|||
131212349|NCT00437294|472401449|FG001|Overall Study|Entry criteria not met|1|||
131212350|NCT01300741|472401456|FG000|Overall Study|Lens deposits|1|||
131212351|NCT01300741|472401456|FG000|Overall Study|Lost to Follow-up|1|||
131212352|NCT01300741|472401456|FG000|Overall Study|Discomfort|1|||
131212353|NCT01473602|472401457|FG000|Overall Study|Adverse Event|1|||
131212354|NCT01473602|472401458|FG001|Overall Study|Adverse Event|2|||
131212355|NCT01473602|472401457|FG000|Overall Study|Death|0|||
131212356|NCT01473602|472401458|FG001|Overall Study|Death|1|||
131212357|NCT01473602|472401457|FG000|Overall Study|Lost to Follow-up|1|||
131212358|NCT01473602|472401458|FG001|Overall Study|Lost to Follow-up|1|||
131212359|NCT01473602|472401457|FG000|Overall Study|Withdrawal by Subject|5|||
131212360|NCT01473602|472401458|FG001|Overall Study|Withdrawal by Subject|4|||
131212361|NCT01473602|472401457|FG000|Overall Study|Physician Decision|1|||
131212362|NCT01473602|472401458|FG001|Overall Study|Physician Decision|0|||
131212363|NCT00726882|472401460|FG000|Overall Study|Withdrawal by Subject|5|||
131212364|NCT00726882|472401460|FG000|Overall Study|Lost to Follow-up|7|||
131212365|NCT00726882|472401460|FG000|Overall Study|Other|10|||
131212366|NCT00560573|472401461|FG000|Overall Study|Death|4|||
131212367|NCT00560573|472401462|FG001|Overall Study|Death|1|||
131212368|NCT00560573|472401463|FG002|Overall Study|Death|4|||
131212369|NCT00560573|472401464|FG003|Overall Study|Death|5|||
131212370|NCT00560573|472401465|FG004|Overall Study|Death|1|||
131212371|NCT00560573|472401466|FG005|Overall Study|Death|10|||
131212372|NCT00560573|472401461|FG000|Overall Study|Lost to Follow-up|0|||
131212373|NCT00560573|472401462|FG001|Overall Study|Lost to Follow-up|0|||
131212374|NCT00560573|472401463|FG002|Overall Study|Lost to Follow-up|0|||
131212375|NCT00560573|472401464|FG003|Overall Study|Lost to Follow-up|1|||
131212376|NCT00560573|472401465|FG004|Overall Study|Lost to Follow-up|1|||
131212377|NCT00560573|472401466|FG005|Overall Study|Lost to Follow-up|0|||
131212378|NCT00560573|472401461|FG000|Overall Study|Withdrawal by Subject|0|||
131212379|NCT00560573|472401462|FG001|Overall Study|Withdrawal by Subject|0|||
131212380|NCT00560573|472401463|FG002|Overall Study|Withdrawal by Subject|0|||
131212381|NCT00560573|472401464|FG003|Overall Study|Withdrawal by Subject|1|||
131212382|NCT00560573|472401465|FG004|Overall Study|Withdrawal by Subject|1|||
131212383|NCT00560573|472401466|FG005|Overall Study|Withdrawal by Subject|0|||
131212384|NCT00560573|472401461|FG000|Overall Study|Other|2|||
131212385|NCT00560573|472401462|FG001|Overall Study|Other|2|||
131212386|NCT00560573|472401463|FG002|Overall Study|Other|2|||
131212387|NCT00560573|472401464|FG003|Overall Study|Other|3|||
131212388|NCT00560573|472401465|FG004|Overall Study|Other|3|||
131212389|NCT00560573|472401466|FG005|Overall Study|Other|3|||
131212390|NCT00560573|472401461|FG000|Overall Study|Enrolled, not treated|0|||
131212391|NCT00560573|472401462|FG001|Overall Study|Enrolled, not treated|0|||
131212392|NCT00560573|472401463|FG002|Overall Study|Enrolled, not treated|0|||
131212393|NCT00560573|472401464|FG003|Overall Study|Enrolled, not treated|0|||
131212394|NCT00560573|472401465|FG004|Overall Study|Enrolled, not treated|1|||
131212395|NCT00560573|472401466|FG005|Overall Study|Enrolled, not treated|0|||
131212396|NCT01339273|472401467|FG000|Overall Study|Lost to Follow-up|8|||
131212397|NCT01339273|472401468|FG001|Overall Study|Lost to Follow-up|8|||
131212398|NCT02526017|472401469|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131212399|NCT02526017|472401470|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131212400|NCT02526017|472401471|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131212401|NCT02526017|472401472|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131212402|NCT02526017|472401473|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
131212403|NCT02526017|472401474|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131212404|NCT02526017|472401475|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131212405|NCT02526017|472401476|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131212406|NCT02526017|472401477|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
131212407|NCT00968539|472401481|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
131212408|NCT00968539|472401482|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
131212409|NCT00326118|472401483|FG000|Active Phase|Withdrawal by Subject|4|||
131212410|NCT00326118|472401484|FG001|Active Phase|Withdrawal by Subject|1|||
131212411|NCT03526549|472401487|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
131212412|NCT03526549|472401488|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
131212413|NCT03526549|472401487|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
131212414|NCT03526549|472401488|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
131212415|NCT03526549|472401487|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
131212416|NCT03526549|472401488|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
131212417|NCT03526549|472401487|FG000|Open-label Phase|Adverse Event|4|||
131212418|NCT03526549|472401488|FG001|Open-label Phase|Adverse Event|0|||
131212419|NCT03526549|472401487|FG000|Open-label Phase|Withdrawal by Subject|54|||
131212420|NCT03526549|472401488|FG001|Open-label Phase|Withdrawal by Subject|0|||
131212421|NCT03526549|472401487|FG000|Open-label Phase|Lost to Follow-up|35|||
131212422|NCT03526549|472401488|FG001|Open-label Phase|Lost to Follow-up|0|||
131212423|NCT03526549|472401487|FG000|Open-label Phase|Other than Specified|5|||
131212424|NCT03526549|472401488|FG001|Open-label Phase|Other than Specified|0|||
131212425|NCT05981365|472401493|FG000|Period 1|Adverse Event|1|||
131212426|NCT05981365|472401494|FG001|Period 1|Adverse Event|0|||
131212427|NCT03927989|472401495|FG000|Overall Study|Withdrawal by Subject|0|||
131212428|NCT03927989|472401496|FG001|Overall Study|Withdrawal by Subject|1|||
131212429|NCT00779857|472401497|FG000|Overall Study|Death|1|||
131212430|NCT00779857|472401497|FG000|Overall Study|Withdrawal by Subject|3|||
131212431|NCT00779857|472401497|FG000|Overall Study|Missed Visit|2|||
131212432|NCT03919669|472401504|FG000|Overall Study|Withdrawal by Subject|1|||
131212433|NCT03919669|472401505|FG001|Overall Study|Withdrawal by Subject|0|||
131212434|NCT03919669|472401506|FG002|Overall Study|Withdrawal by Subject|0|||
131212435|NCT02319642|472401507|FG000|Overall Study|Adverse Event|2|||
131212436|NCT02319642|472401508|FG001|Overall Study|Adverse Event|4|||
131212437|NCT02319642|472401507|FG000|Overall Study|Lack of Efficacy|1|||
131212438|NCT02319642|472401508|FG001|Overall Study|Lack of Efficacy|1|||
131212439|NCT02319642|472401507|FG000|Overall Study|Withdrawal by Subject|1|||
131212440|NCT02319642|472401508|FG001|Overall Study|Withdrawal by Subject|1|||
131212441|NCT01015118|472401510|FG000|Overall Study|Protocol Violation|5|||
131212442|NCT01015118|472401511|FG001|Overall Study|Protocol Violation|6|||
131212443|NCT01015118|472401510|FG000|Overall Study|Withdrawal by Subject|103|||
131212444|NCT01015118|472401511|FG001|Overall Study|Withdrawal by Subject|27|||
131212445|NCT01015118|472401510|FG000|Overall Study|Other Adverse Event (AE)|141|||
131212446|NCT01015118|472401511|FG001|Overall Study|Other Adverse Event (AE)|33|||
131212447|NCT01015118|472401510|FG000|Overall Study|Worsening or AE of underlying disease|5|||
131212448|NCT01015118|472401511|FG001|Overall Study|Worsening or AE of underlying disease|4|||
131212449|NCT01015118|472401510|FG000|Overall Study|Progressive disease|364|||
131212450|NCT01015118|472401511|FG001|Overall Study|Progressive disease|229|||
131212451|NCT01015118|472401510|FG000|Overall Study|Not treated|9|||
131212452|NCT01015118|472401511|FG001|Overall Study|Not treated|5|||
131212453|NCT01015118|472401510|FG000|Overall Study|Other than stated above|42|||
131212454|NCT01015118|472401511|FG001|Overall Study|Other than stated above|23|||
131212455|NCT00402298|472401513|FG000|Overall Study|Withdrawal by Subject|1|||
131212456|NCT00402298|472401514|FG001|Overall Study|Withdrawal by Subject|0|||
131212457|NCT04784455|472401515|FG000|Overall Study|Death|4|||
131212458|NCT04298229|472401518|FG000|Overall Study|Physician Decision|1|||
131212459|NCT04298229|472401519|FG001|Overall Study|Physician Decision|1|||
131212460|NCT04298229|472401518|FG000|Overall Study|Withdrawal by Subject|1|||
131212461|NCT04298229|472401519|FG001|Overall Study|Withdrawal by Subject|1|||
131212462|NCT04298229|472401518|FG000|Overall Study|Did not receive IV loop diuretics|2|||
131212463|NCT04298229|472401519|FG001|Overall Study|Did not receive IV loop diuretics|0|||
131212464|NCT00859313|472401520|FG000|Overall Study|Lack of Efficacy|2|||
131212465|NCT00859313|472401520|FG000|Overall Study|Adverse Event|1|||
131212466|NCT00859313|472401520|FG000|Overall Study|staff error|1|||
131212467|NCT00071006|472401521|FG000|Overall Study|Lack of Efficacy|7|||
131212468|NCT00071006|472401521|FG000|Overall Study|Adverse Event|1|||
131212469|NCT00071006|472401521|FG000|Overall Study|Withdrawal by Subject|1|||
131212470|NCT00071006|472401521|FG000|Overall Study|Other|3|||
131212471|NCT03901274|472401522|FG000|Overall Study|Lost to Follow-up|120|||
131212472|NCT03901274|472401523|FG001|Overall Study|Lost to Follow-up|124|||
131212473|NCT03901274|472401522|FG000|Overall Study|Withdrawal by Subject|0|||
131212474|NCT03901274|472401523|FG001|Overall Study|Withdrawal by Subject|6|||
131212475|NCT00145119|472401526|FG000|Overall Study|Death|45|||
131212476|NCT04527380|472401527|FG000|Overall Study|Lack of Efficacy|0|||
131212477|NCT04527380|472401528|FG001|Overall Study|Lack of Efficacy|1|||
131212478|NCT04527380|472401527|FG000|Overall Study|Withdrawal by Subject|1|||
131212479|NCT04527380|472401528|FG001|Overall Study|Withdrawal by Subject|0|||
131212480|NCT05048875|472401529|FG000|Overall Study|Withdrawal by Subject|1|||
131212481|NCT05048875|472401530|FG001|Overall Study|Withdrawal by Subject|0|||
131212482|NCT05048875|472401531|FG002|Overall Study|Withdrawal by Subject|0|||
131212483|NCT05048875|472401532|FG003|Overall Study|Withdrawal by Subject|0|||
131212484|NCT05048875|472401533|FG004|Overall Study|Withdrawal by Subject|0|||
131212485|NCT05048875|472401534|FG005|Overall Study|Withdrawal by Subject|0|||
131212486|NCT05048875|472401535|FG006|Overall Study|Withdrawal by Subject|0|||
131212487|NCT05048875|472401536|FG007|Overall Study|Withdrawal by Subject|0|||
131212488|NCT05048875|472401529|FG000|Overall Study|Adverse Event|0|||
131212489|NCT05048875|472401530|FG001|Overall Study|Adverse Event|0|||
131212490|NCT05048875|472401531|FG002|Overall Study|Adverse Event|0|||
131212491|NCT05048875|472401532|FG003|Overall Study|Adverse Event|1|||
131212492|NCT05048875|472401533|FG004|Overall Study|Adverse Event|0|||
131212493|NCT05048875|472401534|FG005|Overall Study|Adverse Event|0|||
131212494|NCT05048875|472401535|FG006|Overall Study|Adverse Event|0|||
131212495|NCT05048875|472401536|FG007|Overall Study|Adverse Event|0|||
131212496|NCT05437211|472401541|FG000|Overall Study|Patient's decision|1|||
131212497|NCT05437211|472401542|FG001|Overall Study|Patient's decision|1|||
131212498|NCT04411641|472401543|FG000|DB Period|Other|7|||
131212499|NCT04411641|472401544|FG001|DB Period|Other|27|||
131212500|NCT04411641|472401545|FG002|DB Period|Other|0|||
131212501|NCT04411641|472401546|FG003|DB Period|Other|0|||
131212502|NCT04411641|472401543|FG000|DB Period|Withdrawal by Subject|67|||
131212503|NCT04411641|472401544|FG001|DB Period|Withdrawal by Subject|122|||
131212504|NCT04411641|472401545|FG002|DB Period|Withdrawal by Subject|0|||
131212505|NCT04411641|472401546|FG003|DB Period|Withdrawal by Subject|0|||
131212506|NCT04411641|472401543|FG000|DB Period|Progressive disease|76|||
131212507|NCT04411641|472401544|FG001|DB Period|Progressive disease|116|||
131212508|NCT04411641|472401545|FG002|DB Period|Progressive disease|0|||
131212509|NCT04411641|472401546|FG003|DB Period|Progressive disease|0|||
131212510|NCT04411641|472401543|FG000|DB Period|Poor compliance to protocol|1|||
131212511|NCT04411641|472401544|FG001|DB Period|Poor compliance to protocol|5|||
131212512|NCT04411641|472401545|FG002|DB Period|Poor compliance to protocol|0|||
131212513|NCT04411641|472401546|FG003|DB Period|Poor compliance to protocol|0|||
131212514|NCT04411641|472401543|FG000|DB Period|Lack of Efficacy|19|||
131212515|NCT04411641|472401544|FG001|DB Period|Lack of Efficacy|19|||
131212516|NCT04411641|472401545|FG002|DB Period|Lack of Efficacy|0|||
131212517|NCT04411641|472401546|FG003|DB Period|Lack of Efficacy|0|||
131212518|NCT04411641|472401543|FG000|DB Period|Adverse Event|13|||
131212519|NCT04411641|472401544|FG001|DB Period|Adverse Event|29|||
131212520|NCT04411641|472401545|FG002|DB Period|Adverse Event|0|||
131212521|NCT04411641|472401546|FG003|DB Period|Adverse Event|0|||
131212522|NCT04411641|472401543|FG000|DB Period|Randomized and not treated|2|||
131212523|NCT04411641|472401544|FG001|DB Period|Randomized and not treated|2|||
131212524|NCT04411641|472401545|FG002|DB Period|Randomized and not treated|0|||
131212525|NCT04411641|472401546|FG003|DB Period|Randomized and not treated|0|||
131212526|NCT04411641|472401543|FG000|OL|Withdrawal by Subject|0|||
131212527|NCT04411641|472401544|FG001|OL|Withdrawal by Subject|0|||
131212528|NCT04411641|472401545|FG002|OL|Withdrawal by Subject|6|||
131212529|NCT04411641|472401546|FG003|OL|Withdrawal by Subject|17|||
131212530|NCT04411641|472401543|FG000|OL|Progressive disease|0|||
131212531|NCT04411641|472401544|FG001|OL|Progressive disease|0|||
131212532|NCT04411641|472401545|FG002|OL|Progressive disease|1|||
131212533|NCT04411641|472401546|FG003|OL|Progressive disease|2|||
131212534|NCT04411641|472401543|FG000|OL|Poor compliance to protocol|0|||
131212535|NCT04411641|472401544|FG001|OL|Poor compliance to protocol|0|||
131212536|NCT04411641|472401545|FG002|OL|Poor compliance to protocol|1|||
131212537|NCT04411641|472401546|FG003|OL|Poor compliance to protocol|0|||
131212538|NCT04411641|472401543|FG000|OL|Adverse Event|0|||
131212539|NCT04411641|472401544|FG001|OL|Adverse Event|0|||
131212540|NCT04411641|472401545|FG002|OL|Adverse Event|1|||
131212541|NCT04411641|472401546|FG003|OL|Adverse Event|0|||
131212542|NCT04411641|472401543|FG000|OL|Other|0|||
131212543|NCT04411641|472401544|FG001|OL|Other|0|||
131212544|NCT04411641|472401545|FG002|OL|Other|0|||
131212545|NCT04411641|472401546|FG003|OL|Other|6|||
131212546|NCT04410991|472401551|FG000|Overall Study|Poor compliance to protocol|5|||
131212547|NCT04410991|472401552|FG001|Overall Study|Poor compliance to protocol|4|||
131212548|NCT04410991|472401551|FG000|Overall Study|Withdrawal by Subject|59|||
131212549|NCT04410991|472401552|FG001|Overall Study|Withdrawal by Subject|55|||
131212550|NCT04410991|472401551|FG000|Overall Study|Other|10|||
131212551|NCT04410991|472401552|FG001|Overall Study|Other|4|||
131212552|NCT03282123|472401553|FG000|Overall Study|Withdrawal by Subject|5|||
131212553|NCT01195662|472401554|FG000|Double Blind Treatment Period|Adverse Event|4|||
131212554|NCT01195662|472401555|FG001|Double Blind Treatment Period|Adverse Event|1|||
131212555|NCT01195662|472401556|FG002|Double Blind Treatment Period|Adverse Event|2|||
131212556|NCT01195662|472401554|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
131212557|NCT01195662|472401555|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
131212558|NCT01195662|472401556|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
131212559|NCT01195662|472401554|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
131212560|NCT01195662|472401555|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
131212561|NCT01195662|472401556|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
131212562|NCT01195662|472401554|FG000|Double Blind Treatment Period|Administrative reason|2|||
131212563|NCT01195662|472401555|FG001|Double Blind Treatment Period|Administrative reason|1|||
131212564|NCT01195662|472401556|FG002|Double Blind Treatment Period|Administrative reason|1|||
131212565|NCT01195662|472401554|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
131212566|NCT01195662|472401555|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
131212567|NCT01195662|472401556|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
131212568|NCT01195662|472401554|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
131212569|NCT01195662|472401555|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
131212570|NCT01195662|472401556|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
131212571|NCT01195662|472401554|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
130876590|NCT04742556|471179620|FG002|Overall Study|Objective disease progression|4|||
131212572|NCT01195662|472401555|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
131212573|NCT01195662|472401556|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
131212574|NCT01195662|472401554|FG000|Double Blind Treatment Period|Non-specified|3|||
131212575|NCT01195662|472401555|FG001|Double Blind Treatment Period|Non-specified|0|||
131212576|NCT01195662|472401556|FG002|Double Blind Treatment Period|Non-specified|0|||
131212577|NCT01195662|472401554|FG000|Double Blind Treatment Period|Missing disposition information|0|||
131212578|NCT01195662|472401555|FG001|Double Blind Treatment Period|Missing disposition information|1|||
131212579|NCT01195662|472401556|FG002|Double Blind Treatment Period|Missing disposition information|1|||
130876591|NCT01903356|471179626|FG000|Overall Study|Lost to Follow-up|7|||
130876592|NCT01903356|471179626|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
130876593|NCT01903356|471179626|FG000|Overall Study|Violated the dosage and administration|3|||
130876594|NCT04196686|471179631|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
131212580|NCT01195662|472401554|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
131212581|NCT01195662|472401555|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
131212582|NCT01195662|472401556|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
131212583|NCT01195662|472401554|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
131212584|NCT01195662|472401555|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
131212585|NCT01195662|472401556|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
131212586|NCT01215968|472401557|FG000|Overall Study|Adverse Event|0|||
131212587|NCT01215968|472401558|FG001|Overall Study|Adverse Event|2|||
131212588|NCT01215968|472401557|FG000|Overall Study|Protocol Violation|2|||
131212589|NCT01215968|472401558|FG001|Overall Study|Protocol Violation|4|||
131212590|NCT01215968|472401557|FG000|Overall Study|Not received study drug|0|||
131212591|NCT01215968|472401558|FG001|Overall Study|Not received study drug|1|||
131212592|NCT05182840|472401561|FG000|Run-in Period|Not treated|0|||
131212593|NCT05182840|472401562|FG001|Run-in Period|Not treated|1|||
131212594|NCT05182840|472401563|FG002|Run-in Period|Not treated|0|||
131212595|NCT05182840|472401564|FG003|Run-in Period|Not treated|0|||
131212596|NCT05182840|472401565|FG004|Run-in Period|Not treated|0|||
131212597|NCT05182840|472401566|FG005|Run-in Period|Not treated|0|||
131212598|NCT05182840|472401567|FG006|Run-in Period|Not treated|0|||
131212599|NCT05182840|472401568|FG007|Run-in Period|Not treated|0|||
131212600|NCT05182840|472401569|FG008|Run-in Period|Not treated|0|||
131212601|NCT05182840|472401570|FG009|Run-in Period|Not treated|0|||
131212602|NCT05182840|472401561|FG000|Run-in Period|Other reason but not sponsor termination|14|||
131212603|NCT05182840|472401562|FG001|Run-in Period|Other reason but not sponsor termination|18|||
131212604|NCT05182840|472401563|FG002|Run-in Period|Other reason but not sponsor termination|0|||
131212605|NCT05182840|472401564|FG003|Run-in Period|Other reason but not sponsor termination|0|||
131212606|NCT05182840|472401565|FG004|Run-in Period|Other reason but not sponsor termination|0|||
131212607|NCT05182840|472401566|FG005|Run-in Period|Other reason but not sponsor termination|0|||
131212608|NCT05182840|472401567|FG006|Run-in Period|Other reason but not sponsor termination|0|||
131212609|NCT05182840|472401568|FG007|Run-in Period|Other reason but not sponsor termination|0|||
131212610|NCT05182840|472401569|FG008|Run-in Period|Other reason but not sponsor termination|0|||
131212611|NCT05182840|472401570|FG009|Run-in Period|Other reason but not sponsor termination|0|||
131212612|NCT05182840|472401561|FG000|Run-in Period|No reason available|2|||
131212613|NCT05182840|472401562|FG001|Run-in Period|No reason available|2|||
131212614|NCT05182840|472401563|FG002|Run-in Period|No reason available|0|||
131212615|NCT05182840|472401564|FG003|Run-in Period|No reason available|0|||
131212616|NCT05182840|472401565|FG004|Run-in Period|No reason available|0|||
131212617|NCT05182840|472401566|FG005|Run-in Period|No reason available|0|||
131212618|NCT05182840|472401567|FG006|Run-in Period|No reason available|0|||
131212619|NCT05182840|472401568|FG007|Run-in Period|No reason available|0|||
131212620|NCT05182840|472401569|FG008|Run-in Period|No reason available|0|||
131212621|NCT05182840|472401570|FG009|Run-in Period|No reason available|0|||
131212622|NCT05182840|472401561|FG000|Run-in Period|Burden of study procedures|2|||
131212623|NCT05182840|472401562|FG001|Run-in Period|Burden of study procedures|2|||
131212624|NCT05182840|472401563|FG002|Run-in Period|Burden of study procedures|0|||
131212625|NCT05182840|472401564|FG003|Run-in Period|Burden of study procedures|0|||
131212626|NCT05182840|472401565|FG004|Run-in Period|Burden of study procedures|0|||
131212627|NCT05182840|472401566|FG005|Run-in Period|Burden of study procedures|0|||
131212628|NCT05182840|472401567|FG006|Run-in Period|Burden of study procedures|0|||
131212629|NCT05182840|472401568|FG007|Run-in Period|Burden of study procedures|0|||
131212630|NCT05182840|472401569|FG008|Run-in Period|Burden of study procedures|0|||
131212631|NCT05182840|472401570|FG009|Run-in Period|Burden of study procedures|0|||
131212632|NCT05182840|472401561|FG000|Run-in Period|Change of residence|1|||
131212633|NCT05182840|472401562|FG001|Run-in Period|Change of residence|0|||
131212634|NCT05182840|472401563|FG002|Run-in Period|Change of residence|0|||
131212635|NCT05182840|472401564|FG003|Run-in Period|Change of residence|0|||
131212636|NCT05182840|472401565|FG004|Run-in Period|Change of residence|0|||
131212637|NCT05182840|472401566|FG005|Run-in Period|Change of residence|0|||
131212638|NCT05182840|472401567|FG006|Run-in Period|Change of residence|0|||
131212639|NCT05182840|472401568|FG007|Run-in Period|Change of residence|0|||
131212640|NCT05182840|472401569|FG008|Run-in Period|Change of residence|0|||
131212641|NCT05182840|472401570|FG009|Run-in Period|Change of residence|0|||
131212642|NCT05182840|472401561|FG000|Run-in Period|Adverse Event|5|||
131212643|NCT05182840|472401562|FG001|Run-in Period|Adverse Event|5|||
131212644|NCT05182840|472401563|FG002|Run-in Period|Adverse Event|0|||
131212645|NCT05182840|472401564|FG003|Run-in Period|Adverse Event|0|||
131212646|NCT05182840|472401565|FG004|Run-in Period|Adverse Event|0|||
131212647|NCT05182840|472401566|FG005|Run-in Period|Adverse Event|0|||
131212648|NCT05182840|472401567|FG006|Run-in Period|Adverse Event|0|||
131212649|NCT05182840|472401568|FG007|Run-in Period|Adverse Event|0|||
131212650|NCT05182840|472401569|FG008|Run-in Period|Adverse Event|0|||
131212651|NCT05182840|472401570|FG009|Run-in Period|Adverse Event|0|||
131212652|NCT05182840|472401561|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
131212653|NCT05182840|472401562|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
131212654|NCT05182840|472401563|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131212655|NCT05182840|472401564|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131212656|NCT05182840|472401565|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131212657|NCT05182840|472401566|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131212658|NCT05182840|472401567|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131212659|NCT05182840|472401568|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131212660|NCT05182840|472401569|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131212661|NCT05182840|472401570|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
131212662|NCT05182840|472401561|FG000|Treatment Period|Reason missing|0|||
131212663|NCT05182840|472401562|FG001|Treatment Period|Reason missing|0|||
131212664|NCT05182840|472401563|FG002|Treatment Period|Reason missing|1|||
131212665|NCT05182840|472401564|FG003|Treatment Period|Reason missing|0|||
131212666|NCT05182840|472401565|FG004|Treatment Period|Reason missing|0|||
131212667|NCT05182840|472401566|FG005|Treatment Period|Reason missing|0|||
131212668|NCT05182840|472401567|FG006|Treatment Period|Reason missing|0|||
131212669|NCT05182840|472401568|FG007|Treatment Period|Reason missing|0|||
131212670|NCT05182840|472401569|FG008|Treatment Period|Reason missing|0|||
131212671|NCT05182840|472401570|FG009|Treatment Period|Reason missing|0|||
131212672|NCT05182840|472401561|FG000|Treatment Period|Other but not sponsor termination|0|||
131212673|NCT05182840|472401562|FG001|Treatment Period|Other but not sponsor termination|0|||
131212674|NCT05182840|472401563|FG002|Treatment Period|Other but not sponsor termination|8|||
131212675|NCT05182840|472401564|FG003|Treatment Period|Other but not sponsor termination|6|||
131212676|NCT05182840|472401565|FG004|Treatment Period|Other but not sponsor termination|6|||
131212677|NCT05182840|472401566|FG005|Treatment Period|Other but not sponsor termination|7|||
131212678|NCT05182840|472401567|FG006|Treatment Period|Other but not sponsor termination|5|||
131212679|NCT05182840|472401568|FG007|Treatment Period|Other but not sponsor termination|8|||
131212680|NCT05182840|472401569|FG008|Treatment Period|Other but not sponsor termination|7|||
131212681|NCT05182840|472401570|FG009|Treatment Period|Other but not sponsor termination|2|||
131212682|NCT05182840|472401561|FG000|Treatment Period|Protocol deviation|0|||
131212683|NCT05182840|472401562|FG001|Treatment Period|Protocol deviation|0|||
131212684|NCT05182840|472401563|FG002|Treatment Period|Protocol deviation|0|||
131212685|NCT05182840|472401564|FG003|Treatment Period|Protocol deviation|0|||
131212686|NCT05182840|472401565|FG004|Treatment Period|Protocol deviation|0|||
131212687|NCT05182840|472401566|FG005|Treatment Period|Protocol deviation|0|||
131212688|NCT05182840|472401567|FG006|Treatment Period|Protocol deviation|0|||
131212689|NCT05182840|472401568|FG007|Treatment Period|Protocol deviation|0|||
131212690|NCT05182840|472401569|FG008|Treatment Period|Protocol deviation|1|||
131212691|NCT05182840|472401570|FG009|Treatment Period|Protocol deviation|0|||
131212692|NCT05182840|472401561|FG000|Treatment Period|No reason available|0|||
131212693|NCT05182840|472401562|FG001|Treatment Period|No reason available|0|||
131212694|NCT05182840|472401563|FG002|Treatment Period|No reason available|0|||
131212695|NCT05182840|472401564|FG003|Treatment Period|No reason available|1|||
131212696|NCT05182840|472401565|FG004|Treatment Period|No reason available|0|||
131212697|NCT05182840|472401566|FG005|Treatment Period|No reason available|2|||
131212698|NCT05182840|472401567|FG006|Treatment Period|No reason available|0|||
131212699|NCT05182840|472401568|FG007|Treatment Period|No reason available|1|||
131212700|NCT05182840|472401569|FG008|Treatment Period|No reason available|0|||
131212701|NCT05182840|472401570|FG009|Treatment Period|No reason available|0|||
131212702|NCT05182840|472401561|FG000|Treatment Period|Burden of study procedures|0|||
131212703|NCT05182840|472401562|FG001|Treatment Period|Burden of study procedures|0|||
131212704|NCT05182840|472401563|FG002|Treatment Period|Burden of study procedures|0|||
131212705|NCT05182840|472401564|FG003|Treatment Period|Burden of study procedures|0|||
131212706|NCT05182840|472401565|FG004|Treatment Period|Burden of study procedures|1|||
131212707|NCT05182840|472401566|FG005|Treatment Period|Burden of study procedures|0|||
131212708|NCT05182840|472401567|FG006|Treatment Period|Burden of study procedures|0|||
131212709|NCT05182840|472401568|FG007|Treatment Period|Burden of study procedures|0|||
131212710|NCT05182840|472401569|FG008|Treatment Period|Burden of study procedures|0|||
131212711|NCT05182840|472401570|FG009|Treatment Period|Burden of study procedures|0|||
131212712|NCT05182840|472401561|FG000|Treatment Period|Change of residence|0|||
131212713|NCT05182840|472401562|FG001|Treatment Period|Change of residence|0|||
131212714|NCT05182840|472401563|FG002|Treatment Period|Change of residence|0|||
131212715|NCT05182840|472401564|FG003|Treatment Period|Change of residence|0|||
131212716|NCT05182840|472401565|FG004|Treatment Period|Change of residence|0|||
131212717|NCT05182840|472401566|FG005|Treatment Period|Change of residence|1|||
131212718|NCT05182840|472401567|FG006|Treatment Period|Change of residence|0|||
131212719|NCT05182840|472401568|FG007|Treatment Period|Change of residence|0|||
131212720|NCT05182840|472401569|FG008|Treatment Period|Change of residence|0|||
131212721|NCT05182840|472401570|FG009|Treatment Period|Change of residence|0|||
131212722|NCT05182840|472401561|FG000|Treatment Period|Adverse Event|0|||
131212723|NCT05182840|472401562|FG001|Treatment Period|Adverse Event|0|||
131212724|NCT05182840|472401563|FG002|Treatment Period|Adverse Event|4|||
131212725|NCT05182840|472401564|FG003|Treatment Period|Adverse Event|16|||
131212726|NCT05182840|472401565|FG004|Treatment Period|Adverse Event|12|||
131212727|NCT05182840|472401566|FG005|Treatment Period|Adverse Event|6|||
131212728|NCT05182840|472401567|FG006|Treatment Period|Adverse Event|4|||
131212729|NCT05182840|472401568|FG007|Treatment Period|Adverse Event|8|||
131212730|NCT05182840|472401569|FG008|Treatment Period|Adverse Event|16|||
131212731|NCT05182840|472401570|FG009|Treatment Period|Adverse Event|5|||
131212732|NCT05182840|472401561|FG000|Treatment Period|Not treated with study drug|0|||
131212733|NCT05182840|472401562|FG001|Treatment Period|Not treated with study drug|0|||
131212734|NCT05182840|472401563|FG002|Treatment Period|Not treated with study drug|0|||
131212735|NCT05182840|472401564|FG003|Treatment Period|Not treated with study drug|1|||
131212736|NCT05182840|472401565|FG004|Treatment Period|Not treated with study drug|0|||
131212737|NCT05182840|472401566|FG005|Treatment Period|Not treated with study drug|0|||
131212738|NCT05182840|472401567|FG006|Treatment Period|Not treated with study drug|1|||
131212739|NCT05182840|472401568|FG007|Treatment Period|Not treated with study drug|1|||
131212740|NCT05182840|472401569|FG008|Treatment Period|Not treated with study drug|0|||
131212741|NCT05182840|472401570|FG009|Treatment Period|Not treated with study drug|0|||
131212742|NCT02161380|472401571|FG000|Overall Study|Lost to Follow-up|0|||
131212743|NCT02161380|472401572|FG001|Overall Study|Lost to Follow-up|1|||
131212744|NCT02161380|472401573|FG002|Overall Study|Lost to Follow-up|0|||
131212745|NCT02161380|472401574|FG003|Overall Study|Lost to Follow-up|0|||
131212746|NCT04768881|472401583|FG000|Overall Study|Completed Study Follow-up|0|||
131212747|NCT04768881|472401584|FG001|Overall Study|Completed Study Follow-up|2|||
131212748|NCT04768881|472401583|FG000|Overall Study|Death|3|||
130988333|NCT00615264|471585341|FG001|Overall Study|Withdrawal by Subject|19|||
130988334|NCT00615264|471585340|FG000|Overall Study|Lost to Follow-up|6|||
131212749|NCT04768881|472401584|FG001|Overall Study|Death|2|||
131212750|NCT04768881|472401583|FG000|Overall Study|Study Terminated by Sponsor|2|||
131212751|NCT04768881|472401584|FG001|Overall Study|Study Terminated by Sponsor|2|||
131212752|NCT04768881|472401583|FG000|Overall Study|Withdrawal by Subject|2|||
131212753|NCT04768881|472401584|FG001|Overall Study|Withdrawal by Subject|0|||
131212754|NCT04768881|472401583|FG000|Overall Study|Other|2|||
131212755|NCT04768881|472401584|FG001|Overall Study|Other|0|||
131212756|NCT01958619|472401585|FG000|Overall Study|Protocol Violation|2|||
131212757|NCT01958619|472401586|FG001|Overall Study|Protocol Violation|0|||
131212758|NCT01958619|472401587|FG002|Overall Study|Protocol Violation|1|||
131212759|NCT01958619|472401588|FG003|Overall Study|Protocol Violation|0|||
131212760|NCT01003691|472401593|FG000|Overall Study|Adverse Event|0|||
131212761|NCT01003691|472401594|FG001|Overall Study|Adverse Event|0|||
131212762|NCT01003691|472401595|FG002|Overall Study|Adverse Event|0|||
131212763|NCT01003691|472401596|FG003|Overall Study|Adverse Event|1|||
131212764|NCT00157820|472401599|FG000|Randomized|Physician Decision|4|||
131212765|NCT00157820|472401600|FG001|Randomized|Physician Decision|2|||
131212766|NCT00157820|472401601|FG002|Randomized|Physician Decision|3|||
131212767|NCT00157820|472401599|FG000|Randomized|Withdrawal by Subject|1|||
131212768|NCT00157820|472401600|FG001|Randomized|Withdrawal by Subject|2|||
131212769|NCT00157820|472401601|FG002|Randomized|Withdrawal by Subject|3|||
131212770|NCT00157820|472401599|FG000|Randomized|Protocol Violation|2|||
131212771|NCT00157820|472401600|FG001|Randomized|Protocol Violation|1|||
131212772|NCT00157820|472401601|FG002|Randomized|Protocol Violation|2|||
131212773|NCT00157820|472401599|FG000|1st 8 Month|Death|7|||
131212774|NCT00157820|472401600|FG001|1st 8 Month|Death|8|||
131212775|NCT00157820|472401601|FG002|1st 8 Month|Death|3|||
131212776|NCT00157820|472401599|FG000|1st 8 Month|Lost to Follow-up|1|||
131212777|NCT00157820|472401600|FG001|1st 8 Month|Lost to Follow-up|2|||
131212778|NCT00157820|472401601|FG002|1st 8 Month|Lost to Follow-up|1|||
131212779|NCT00157820|472401599|FG000|1st 8 Month|Premature cross-over|0|||
131212780|NCT00157820|472401600|FG001|1st 8 Month|Premature cross-over|2|||
131212781|NCT00157820|472401601|FG002|1st 8 Month|Premature cross-over|2|||
131212782|NCT00157820|472401599|FG000|2nd 8 Months|Death|3|||
131212783|NCT00157820|472401600|FG001|2nd 8 Months|Death|1|||
131212784|NCT00157820|472401601|FG002|2nd 8 Months|Death|3|||
131212785|NCT00157820|472401599|FG000|2nd 8 Months|Lost to Follow-up|1|||
131212786|NCT00157820|472401600|FG001|2nd 8 Months|Lost to Follow-up|5|||
131212787|NCT00157820|472401601|FG002|2nd 8 Months|Lost to Follow-up|2|||
131212788|NCT00157820|472401599|FG000|2nd 8 Months|Premature cross-over|1|||
131212789|NCT00157820|472401600|FG001|2nd 8 Months|Premature cross-over|7|||
131212790|NCT00157820|472401601|FG002|2nd 8 Months|Premature cross-over|9|||
131212791|NCT00938392|472402971|FG000|Overall Study|Adverse Event|0|||
131212792|NCT00938392|472402972|FG001|Overall Study|Adverse Event|1|||
131212793|NCT00938392|472402971|FG000|Overall Study|Withdrawal by Subject|0|||
131212794|NCT00938392|472402972|FG001|Overall Study|Withdrawal by Subject|1|||
131212795|NCT00938392|472402971|FG000|Overall Study|Lost to Follow-up|2|||
131212796|NCT00938392|472402972|FG001|Overall Study|Lost to Follow-up|2|||
131212797|NCT00290511|472402973|FG000|Overall Study|Adverse Event|1|||
131212798|NCT00290511|472402973|FG000|Overall Study|Death|1|||
131212799|NCT00290511|472402973|FG000|Overall Study|Physician Decision|1|||
131212800|NCT00290511|472402973|FG000|Overall Study|Withdrawal by Subject|1|||
131212801|NCT04341727|472402981|FG000|Overall Study|Withdrawal by Subject|0|||
131212802|NCT04341727|472402982|FG001|Overall Study|Withdrawal by Subject|0|||
131212803|NCT04341727|472402983|FG002|Overall Study|Withdrawal by Subject|1|||
131212804|NCT04341727|472402984|FG003|Overall Study|Withdrawal by Subject|0|||
131212805|NCT04341727|472402981|FG000|Overall Study|Lost to Follow-up|0|||
131212806|NCT04341727|472402982|FG001|Overall Study|Lost to Follow-up|0|||
131212807|NCT04341727|472402983|FG002|Overall Study|Lost to Follow-up|0|||
131212808|NCT04341727|472402984|FG003|Overall Study|Lost to Follow-up|1|||
131212809|NCT05604521|472402985|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
131212810|NCT05604521|472402986|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
131212811|NCT05604521|472402985|FG000|Overall Study|Adverse Event|1|||
131212812|NCT05604521|472402986|FG001|Overall Study|Adverse Event|0|||
131212813|NCT01491737|472402992|FG000|Overall Study|Withdrawal by Subject|20|||
131212814|NCT01491737|472402993|FG001|Overall Study|Withdrawal by Subject|17|||
131212815|NCT01491737|472402992|FG000|Overall Study|Lost to Follow-up|2|||
131212816|NCT01491737|472402993|FG001|Overall Study|Lost to Follow-up|10|||
131212817|NCT01491737|472402992|FG000|Overall Study|Death|63|||
131212818|NCT01491737|472402993|FG001|Overall Study|Death|57|||
131212819|NCT01491737|472402992|FG000|Overall Study|Study Termination by Sponsor|36|||
131212820|NCT01491737|472402993|FG001|Overall Study|Study Termination by Sponsor|36|||
131212821|NCT01491737|472402992|FG000|Overall Study|Reason Not Specified|8|||
131212822|NCT01491737|472402993|FG001|Overall Study|Reason Not Specified|9|||
131212823|NCT01976663|472402994|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
131212824|NCT01976663|472402994|FG000|Overall Study|Personal Reasons|6|||
131212825|NCT01976663|472402994|FG000|Overall Study|Withdrawal by Subject|4|||
131212826|NCT01976663|472402994|FG000|Overall Study|Screen Failure|3|||
131212827|NCT01976663|472402994|FG000|Overall Study|Adverse Event|2|||
131212828|NCT01976663|472402994|FG000|Overall Study|Lost to Follow-up|3|||
131212829|NCT01817764|472402995|FG000|Overall Study|Adverse Event|7|||
131212830|NCT01817764|472402996|FG001|Overall Study|Adverse Event|10|||
131212831|NCT01817764|472402995|FG000|Overall Study|Lack of Efficacy|9|||
131212832|NCT01817764|472402996|FG001|Overall Study|Lack of Efficacy|7|||
131212833|NCT01817764|472402995|FG000|Overall Study|Protocol Violation|7|||
131212834|NCT01817764|472402996|FG001|Overall Study|Protocol Violation|5|||
131212835|NCT01817764|472402995|FG000|Overall Study|Lost to Follow-up|1|||
131212836|NCT01817764|472402996|FG001|Overall Study|Lost to Follow-up|4|||
131212837|NCT01817764|472402995|FG000|Overall Study|Withdrawal by Subject|10|||
131212838|NCT01817764|472402996|FG001|Overall Study|Withdrawal by Subject|12|||
131212839|NCT01471197|472402998|FG000|Overall Study|Disease Progression|4|||
131212840|NCT01471197|472402999|FG001|Overall Study|Disease Progression|2|||
131212841|NCT01471197|472402998|FG000|Overall Study|Death|1|||
131212842|NCT01471197|472402999|FG001|Overall Study|Death|0|||
131212843|NCT01471197|472402998|FG000|Overall Study|Study Drug Toxicity|1|||
131212844|NCT01471197|472402999|FG001|Overall Study|Study Drug Toxicity|0|||
131212845|NCT03557775|472403005|FG000|Overall Study|Withdrawal by Subject|1|||
131212846|NCT03557775|472403006|FG001|Overall Study|Withdrawal by Subject|2|||
131212847|NCT03557775|472403007|FG002|Overall Study|Withdrawal by Subject|4|||
131212848|NCT03557775|472403005|FG000|Overall Study|Physician Decision|0|||
131212849|NCT03557775|472403006|FG001|Overall Study|Physician Decision|1|||
131212850|NCT03557775|472403007|FG002|Overall Study|Physician Decision|0|||
131212851|NCT02255422|472403008|FG000|Overall Study|Withdrawal by Subject|0|||
131212852|NCT02255422|472403009|FG001|Overall Study|Withdrawal by Subject|0|||
131212853|NCT02255422|472403010|FG002|Overall Study|Withdrawal by Subject|0|||
131212854|NCT02255422|472403011|FG003|Overall Study|Withdrawal by Subject|0|||
131212855|NCT02255422|472403012|FG004|Overall Study|Withdrawal by Subject|0|||
131212856|NCT02255422|472403013|FG005|Overall Study|Withdrawal by Subject|0|||
131212857|NCT02255422|472403014|FG006|Overall Study|Withdrawal by Subject|2|||
131212858|NCT02255422|472403008|FG000|Overall Study|Lost to Follow-up|0|||
131212859|NCT02255422|472403009|FG001|Overall Study|Lost to Follow-up|0|||
131212860|NCT02255422|472403010|FG002|Overall Study|Lost to Follow-up|1|||
131212861|NCT02255422|472403011|FG003|Overall Study|Lost to Follow-up|0|||
131212862|NCT02255422|472403012|FG004|Overall Study|Lost to Follow-up|0|||
131212863|NCT02255422|472403013|FG005|Overall Study|Lost to Follow-up|0|||
131212864|NCT02255422|472403014|FG006|Overall Study|Lost to Follow-up|0|||
131212865|NCT00938366|472403017|FG000|Overall Study|Withdrawal by Subject|1|||
131212866|NCT00938366|472403018|FG001|Overall Study|Withdrawal by Subject|0|||
131212867|NCT01250418|472403024|FG000|Overall Study|monitor data failure|1|||
131212868|NCT01250418|472403025|FG001|Overall Study|monitor data failure|1|||
131212869|NCT01761565|472403026|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
131212870|NCT05643573|472403028|FG000|Overall Study|Adverse Event|117|||
131212871|NCT05643573|472403029|FG001|Overall Study|Adverse Event|90|||
131212872|NCT05643573|472403028|FG000|Overall Study|Death|53|||
131212873|NCT05643573|472403029|FG001|Overall Study|Death|57|||
131212874|NCT05643573|472403028|FG000|Overall Study|Lost to Follow-up|6|||
131212875|NCT05643573|472403029|FG001|Overall Study|Lost to Follow-up|3|||
131212876|NCT05643573|472403028|FG000|Overall Study|Other|18|||
131212877|NCT05643573|472403029|FG001|Overall Study|Other|15|||
131212878|NCT05643573|472403028|FG000|Overall Study|Outcome event|64|||
131212879|NCT05643573|472403029|FG001|Overall Study|Outcome event|36|||
131212880|NCT05643573|472403028|FG000|Overall Study|Physician Decision|33|||
131212881|NCT05643573|472403029|FG001|Overall Study|Physician Decision|19|||
131212882|NCT05643573|472403028|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
131212883|NCT05643573|472403029|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
131212884|NCT05643573|472403028|FG000|Overall Study|Site terminated by sponsor|10|||
131212885|NCT05643573|472403029|FG001|Overall Study|Site terminated by sponsor|10|||
131212886|NCT05643573|472403028|FG000|Overall Study|Study terminated by sponsor|1|||
131212887|NCT05643573|472403029|FG001|Overall Study|Study terminated by sponsor|0|||
131212888|NCT05643573|472403028|FG000|Overall Study|Withdrawal by Subject|178|||
131212889|NCT05643573|472403029|FG001|Overall Study|Withdrawal by Subject|130|||
131212890|NCT02268214|472403030|FG000|Overall Study|Subject no longer meets study criteria|0|||
131212891|NCT02268214|472403031|FG001|Overall Study|Subject no longer meets study criteria|2|||
131212892|NCT02268214|472403032|FG002|Overall Study|Subject no longer meets study criteria|0|||
131212893|NCT02268214|472403030|FG000|Overall Study|Pregnancy|2|||
131212894|NCT02268214|472403031|FG001|Overall Study|Pregnancy|2|||
131212895|NCT02268214|472403032|FG002|Overall Study|Pregnancy|1|||
131212896|NCT02268214|472403030|FG000|Overall Study|Lost to Follow-up|3|||
131212897|NCT02268214|472403031|FG001|Overall Study|Lost to Follow-up|3|||
131212898|NCT02268214|472403032|FG002|Overall Study|Lost to Follow-up|4|||
131212899|NCT02268214|472403030|FG000|Overall Study|Lack of Efficacy|1|||
131212900|NCT02268214|472403031|FG001|Overall Study|Lack of Efficacy|0|||
131212901|NCT02268214|472403032|FG002|Overall Study|Lack of Efficacy|2|||
131212902|NCT02268214|472403030|FG000|Overall Study|Adverse Event|11|||
131212903|NCT02268214|472403031|FG001|Overall Study|Adverse Event|14|||
131212904|NCT02268214|472403032|FG002|Overall Study|Adverse Event|9|||
131212905|NCT02268214|472403030|FG000|Overall Study|Withdrawal by Subject|4|||
131212906|NCT02268214|472403031|FG001|Overall Study|Withdrawal by Subject|5|||
131212907|NCT02268214|472403032|FG002|Overall Study|Withdrawal by Subject|10|||
131229129|NCT00003102|472465838|FG002|Overall Study|Physician Decision|0|||
131212908|NCT02268214|472403030|FG000|Overall Study|Subject request to discontinue treatment|10|||
131212909|NCT02268214|472403031|FG001|Overall Study|Subject request to discontinue treatment|8|||
131212910|NCT02268214|472403032|FG002|Overall Study|Subject request to discontinue treatment|6|||
131212911|NCT02268214|472403030|FG000|Overall Study|Poor/non-compliance|2|||
131212912|NCT02268214|472403031|FG001|Overall Study|Poor/non-compliance|1|||
131212913|NCT02268214|472403032|FG002|Overall Study|Poor/non-compliance|2|||
131212914|NCT02268214|472403030|FG000|Overall Study|Other reasons|7|||
131212915|NCT02268214|472403031|FG001|Overall Study|Other reasons|3|||
131212916|NCT02268214|472403032|FG002|Overall Study|Other reasons|3|||
131212917|NCT02268214|472403030|FG000|Overall Study|Not entering long-term period|2|||
131212918|NCT02268214|472403031|FG001|Overall Study|Not entering long-term period|3|||
131212919|NCT02268214|472403032|FG002|Overall Study|Not entering long-term period|5|||
131212920|NCT04342390|472403033|FG000|Overall Study|Lost to Follow-up|3|||
131212921|NCT04342390|472403034|FG001|Overall Study|Lost to Follow-up|0|||
131212922|NCT04089566|472403047|FG000|Overall Study|Death|0|||
131212923|NCT04089566|472403048|FG001|Overall Study|Death|6|||
131212924|NCT04089566|472403049|FG002|Overall Study|Death|10|||
131212925|NCT04089566|472403050|FG003|Overall Study|Death|0|||
131212926|NCT04089566|472403051|FG004|Overall Study|Death|0|||
131212927|NCT04089566|472403052|FG005|Overall Study|Death|0|||
131212928|NCT04089566|472403047|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
131212929|NCT04089566|472403048|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
131212930|NCT04089566|472403049|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
131212931|NCT04089566|472403050|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
131212932|NCT04089566|472403051|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
131212933|NCT04089566|472403052|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
131212934|NCT04089566|472403047|FG000|Overall Study|Reason not Specified|0|||
131212935|NCT04089566|472403048|FG001|Overall Study|Reason not Specified|4|||
131212936|NCT04089566|472403049|FG002|Overall Study|Reason not Specified|4|||
131212937|NCT04089566|472403050|FG003|Overall Study|Reason not Specified|1|||
131212938|NCT04089566|472403051|FG004|Overall Study|Reason not Specified|0|||
131212939|NCT04089566|472403052|FG005|Overall Study|Reason not Specified|0|||
131212940|NCT01083121|472403056|FG000|Overall Study|Use of Humira outside the approved label|81|||
131212941|NCT00948896|472403059|FG000|Randomization to 24 Months of Age|Death|1|||
131212942|NCT00948896|472403060|FG001|Randomization to 24 Months of Age|Death|0|||
131212943|NCT00948896|472403061|FG002|Randomization to 24 Months of Age|Death|0|||
131212944|NCT00948896|472403062|FG003|Randomization to 24 Months of Age|Death|0|||
131212945|NCT00948896|472403063|FG004|Randomization to 24 Months of Age|Death|2|||
131212946|NCT00948896|472403064|FG005|Randomization to 24 Months of Age|Death|1|||
131212947|NCT00948896|472403065|FG006|Randomization to 24 Months of Age|Death|2|||
131212948|NCT00948896|472403066|FG007|Randomization to 24 Months of Age|Death|1|||
131212949|NCT00948896|472403059|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
130876595|NCT04196686|471179632|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
130876596|NCT03448406|471179634|FG000|Overall Study|Noncompliance of scheduled visits|1|||
130876597|NCT03448406|471179635|FG001|Overall Study|Noncompliance of scheduled visits|2|||
130876598|NCT03448406|471179634|FG000|Overall Study|Withdrawal by Subject|1|||
130876599|NCT03448406|471179635|FG001|Overall Study|Withdrawal by Subject|2|||
130876600|NCT03448406|471179634|FG000|Overall Study|Protocol Violation|1|||
130876601|NCT03448406|471179635|FG001|Overall Study|Protocol Violation|0|||
130876602|NCT03448406|471179634|FG000|Overall Study|Adverse Event|8|||
130876603|NCT03448406|471179635|FG001|Overall Study|Adverse Event|9|||
130876604|NCT04602390|471179643|FG000|Overall Study|Withdrawal by Subject|0|||
130876605|NCT04602390|471179644|FG001|Overall Study|Withdrawal by Subject|0|||
130876606|NCT04602390|471179645|FG002|Overall Study|Withdrawal by Subject|0|||
130876607|NCT04602390|471179646|FG003|Overall Study|Withdrawal by Subject|0|||
130876608|NCT04602390|471179647|FG004|Overall Study|Withdrawal by Subject|1|||
130876609|NCT04602390|471179648|FG005|Overall Study|Withdrawal by Subject|0|||
130876610|NCT04602390|471179643|FG000|Overall Study|Adverse Event|0|||
130876611|NCT04602390|471179644|FG001|Overall Study|Adverse Event|0|||
130876612|NCT04602390|471179645|FG002|Overall Study|Adverse Event|0|||
130876613|NCT04602390|471179646|FG003|Overall Study|Adverse Event|0|||
130876614|NCT04602390|471179647|FG004|Overall Study|Adverse Event|0|||
131212950|NCT00948896|472403060|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
131212951|NCT00948896|472403061|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
131212952|NCT00948896|472403062|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
131212953|NCT00948896|472403063|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
130876615|NCT04602390|471179648|FG005|Overall Study|Adverse Event|1|||
130876616|NCT01553084|471179649|FG000|Overall Study|Withdrawal by Subject|15|||
130876617|NCT01553084|471179650|FG001|Overall Study|Withdrawal by Subject|13|||
130876618|NCT01553084|471179651|FG002|Overall Study|Withdrawal by Subject|35|||
130876619|NCT03988400|471179652|FG000|Overall Study|Adverse Event|1|||
131212954|NCT00948896|472403064|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
130876620|NCT03988400|471179653|FG001|Overall Study|Adverse Event|0|||
130876621|NCT03988400|471179652|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
130876622|NCT03988400|471179653|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
130876623|NCT03988400|471179652|FG000|Overall Study|Lost to Follow-up|0|||
130876624|NCT03988400|471179653|FG001|Overall Study|Lost to Follow-up|1|||
130876625|NCT04201431|471179655|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
130876626|NCT04201431|471179656|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
130876627|NCT04201431|471179657|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
130876628|NCT01546857|471179658|FG000|Overall Study|Withdrawal by Subject|2|||
130876629|NCT01546857|471179659|FG001|Overall Study|Withdrawal by Subject|3|||
130876630|NCT02542865|471179660|FG000|Overall Study|Identified as screen failure|1|||
130876631|NCT02542865|471179661|FG001|Overall Study|Identified as screen failure|0|||
130876632|NCT02542865|471179660|FG000|Overall Study|Withdrawal by Subject|16|||
130876633|NCT02542865|471179661|FG001|Overall Study|Withdrawal by Subject|0|||
130876634|NCT02358473|471179662|FG000|Overall Study|Disease Progession|6|||
130876635|NCT02358473|471179662|FG000|Overall Study|Adverse Event|3|||
130876636|NCT02358473|471179662|FG000|Overall Study|Withdrawal by Subject|2|||
130988335|NCT00615264|471585341|FG001|Overall Study|Lost to Follow-up|13|||
130988336|NCT00615264|471585340|FG000|Overall Study|Adverse Event|8|||
130876637|NCT02358473|471179662|FG000|Overall Study|Physician Decision|2|||
130876638|NCT02240485|471179663|FG000|3 Months Post-admission|Lost to Follow-up|1|||
130876639|NCT02240485|471179664|FG001|3 Months Post-admission|Lost to Follow-up|5|||
130876640|NCT02240485|471179663|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
130876641|NCT02240485|471179664|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
130876642|NCT02240485|471179663|FG000|9 Months Post-admission|Lost to Follow-up|3|||
130876643|NCT02240485|471179664|FG001|9 Months Post-admission|Lost to Follow-up|1|||
130876644|NCT02240485|471179663|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
130876645|NCT02240485|471179664|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
130876646|NCT02240485|471179663|FG000|18 Months Post-admission|Lost to Follow-up|1|||
130876647|NCT02240485|471179664|FG001|18 Months Post-admission|Lost to Follow-up|1|||
130876648|NCT02240485|471179663|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
130876649|NCT02240485|471179664|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
130876650|NCT00953667|471179665|FG000|Overall Study|Lost to Follow-up|11|||
130876651|NCT00953667|471179665|FG000|Overall Study|Physician Decision|35|||
130876652|NCT00953667|471179665|FG000|Overall Study|Withdrawal by Subject|63|||
130876653|NCT00953667|471179665|FG000|Overall Study|Adverse Event|10|||
130876654|NCT00953667|471179665|FG000|Overall Study|poor venous access,unable to draw blood|4|||
130876655|NCT04819945|471179666|FG000|Overall Study|Lost to Follow-up|1|||
130876656|NCT00475670|471179667|FG000|Overall Study|Death|0|||
130876657|NCT00475670|471179668|FG001|Overall Study|Death|1|||
130876658|NCT00475670|471179667|FG000|Overall Study|Lack of Efficacy|3|||
130876659|NCT00475670|471179668|FG001|Overall Study|Lack of Efficacy|34|||
130876660|NCT00475670|471179667|FG000|Overall Study|Refused treatment|0|||
130876661|NCT00475670|471179668|FG001|Overall Study|Refused treatment|2|||
130876662|NCT00475670|471179667|FG000|Overall Study|Failure to Return|0|||
130876663|NCT00475670|471179668|FG001|Overall Study|Failure to Return|1|||
130876664|NCT00475670|471179667|FG000|Overall Study|Other|0|||
130876665|NCT00475670|471179668|FG001|Overall Study|Other|3|||
130876666|NCT04949191|471179669|FG000|Overall Study|Non-compliance with Study Drug|1|||
130876667|NCT04949191|471179670|FG001|Overall Study|Non-compliance with Study Drug|0|||
130876668|NCT04949191|471179671|FG002|Overall Study|Non-compliance with Study Drug|0|||
130876669|NCT04949191|471179672|FG003|Overall Study|Non-compliance with Study Drug|0|||
130876670|NCT04949191|471179669|FG000|Overall Study|Progressive Disease|0|||
130876671|NCT04949191|471179670|FG001|Overall Study|Progressive Disease|1|||
130876672|NCT04949191|471179671|FG002|Overall Study|Progressive Disease|0|||
130876673|NCT04949191|471179672|FG003|Overall Study|Progressive Disease|0|||
130876674|NCT04949191|471179669|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
130876675|NCT04949191|471179670|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
130876676|NCT04949191|471179671|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
130876677|NCT04949191|471179672|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
130876678|NCT04949191|471179669|FG000|Overall Study|Sponsor Terminated Study|0|||
130876679|NCT04949191|471179670|FG001|Overall Study|Sponsor Terminated Study|0|||
130876680|NCT04949191|471179671|FG002|Overall Study|Sponsor Terminated Study|1|||
130876681|NCT04949191|471179672|FG003|Overall Study|Sponsor Terminated Study|1|||
130876682|NCT02913482|471179673|FG000|Overall Study|Death|0|||
130876683|NCT02913482|471179674|FG001|Overall Study|Death|2|||
130876684|NCT02913482|471179675|FG002|Overall Study|Death|2|||
130876685|NCT02913482|471179673|FG000|Overall Study|Progressive Disease|1|||
130876686|NCT02913482|471179674|FG001|Overall Study|Progressive Disease|1|||
130876687|NCT02913482|471179675|FG002|Overall Study|Progressive Disease|1|||
130876688|NCT02913482|471179673|FG000|Overall Study|Reason not specified|0|||
130876689|NCT02913482|471179674|FG001|Overall Study|Reason not specified|0|||
130876690|NCT02913482|471179675|FG002|Overall Study|Reason not specified|1|||
130876691|NCT02913482|471179673|FG000|Overall Study|Withdrawal by Subject|0|||
130876692|NCT02913482|471179674|FG001|Overall Study|Withdrawal by Subject|1|||
130876693|NCT02913482|471179675|FG002|Overall Study|Withdrawal by Subject|1|||
130876694|NCT01046565|471179680|FG000|Overall Study|Adverse Event|2|||
130876695|NCT01046565|471179680|FG000|Overall Study|Withdrawal by Subject|7|||
130876696|NCT00918385|471179681|FG000|Monotherapy|Adverse Event|1|||
130876697|NCT00918385|471179682|FG001|Monotherapy|Adverse Event|6|||
130876698|NCT00918385|471179681|FG000|Monotherapy|Complicating illness|1|||
130876699|NCT00918385|471179682|FG001|Monotherapy|Complicating illness|0|||
130988337|NCT00615264|471585341|FG001|Overall Study|Adverse Event|5|||
130720798|NCT00626392|470601520|FG003|Coadministration Period|Protocol Violation|1|||
130720799|NCT00626392|470601521|FG004|Coadministration Period|Protocol Violation|1|||
130720800|NCT00626392|470601522|FG005|Coadministration Period|Protocol Violation|0|||
130720801|NCT00626392|470601517|FG000|Coadministration Period|Other|0|||
130720802|NCT00626392|470601518|FG001|Coadministration Period|Other|2|||
130720803|NCT00626392|470601519|FG002|Coadministration Period|Other|3|||
130720804|NCT00626392|470601520|FG003|Coadministration Period|Other|1|||
130720805|NCT00626392|470601521|FG004|Coadministration Period|Other|1|||
130720806|NCT00626392|470601522|FG005|Coadministration Period|Other|1|||
130720807|NCT01085734|470601527|FG000|Overall Study|Adverse Event|0|||
130720808|NCT01085734|470601528|FG001|Overall Study|Adverse Event|2|||
130720809|NCT01085734|470601527|FG000|Overall Study|Death|1|||
130720810|NCT01085734|470601528|FG001|Overall Study|Death|0|||
130720811|NCT01085734|470601527|FG000|Overall Study|Lost to Follow-up|0|||
130720812|NCT01085734|470601528|FG001|Overall Study|Lost to Follow-up|1|||
130720813|NCT01085734|470601527|FG000|Overall Study|Withdrawal by Subject|0|||
130720814|NCT01085734|470601528|FG001|Overall Study|Withdrawal by Subject|1|||
130876700|NCT00918385|471179681|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
130876701|NCT00918385|471179682|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
130876702|NCT00918385|471179681|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
130876703|NCT00918385|471179682|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
130876704|NCT00918385|471179681|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
130876705|NCT00918385|471179682|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
130876706|NCT00918385|471179681|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
130876707|NCT00918385|471179682|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
130876708|NCT00771914|471179686|FG000|Overall Study|Physician Decision|0|||
130876709|NCT00771914|471179687|FG001|Overall Study|Physician Decision|0|||
130876710|NCT00771914|471179688|FG002|Overall Study|Physician Decision|0|||
130876711|NCT00771914|471179689|FG003|Overall Study|Physician Decision|1|||
130876712|NCT00771914|471179686|FG000|Overall Study|Lost to Follow-up|0|||
130876713|NCT00771914|471179687|FG001|Overall Study|Lost to Follow-up|0|||
130876714|NCT00771914|471179688|FG002|Overall Study|Lost to Follow-up|0|||
130876715|NCT00771914|471179689|FG003|Overall Study|Lost to Follow-up|1|||
130876716|NCT02978417|471179692|FG000|Overall Study|Lost to Follow-up|2|||
130876717|NCT02978417|471179693|FG001|Overall Study|Lost to Follow-up|2|||
130876718|NCT03416868|471179701|FG000|Overall Study|Withdrawal by Subject|2|||
130876719|NCT03416868|471179701|FG000|Overall Study|Lost to Follow-up|1|||
130876720|NCT01323582|471179702|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
130876721|NCT01323582|471179703|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
130876722|NCT01323582|471179702|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
130876723|NCT01323582|471179703|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
130876724|NCT01323582|471179702|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
130876725|NCT01323582|471179703|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
130876726|NCT00960375|471179706|FG000|Overall Study|Lost to Follow-up|20|||
130876727|NCT00960375|471179707|FG001|Overall Study|Lost to Follow-up|22|||
130876728|NCT00083889|471179708|FG000|Overall Study|Adverse Event|76|||
130876729|NCT00083889|471179709|FG001|Overall Study|Adverse Event|86|||
130876730|NCT00083889|471179708|FG000|Overall Study|Protocol Violation|2|||
130876731|NCT00083889|471179709|FG001|Overall Study|Protocol Violation|2|||
130876732|NCT00083889|471179708|FG000|Overall Study|Withdrawal by Subject|22|||
130876733|NCT00083889|471179709|FG001|Overall Study|Withdrawal by Subject|24|||
130876734|NCT00083889|471179708|FG000|Overall Study|Lack of Efficacy|240|||
131212955|NCT00948896|472403065|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
131212956|NCT00948896|472403066|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
131212957|NCT00948896|472403059|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
131212958|NCT00948896|472403060|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
131212959|NCT00948896|472403061|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
131212960|NCT00948896|472403062|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
131212961|NCT00948896|472403063|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
131212962|NCT00948896|472403064|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
131212963|NCT00948896|472403065|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
131212964|NCT00948896|472403066|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
131212965|NCT00948896|472403059|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
131212966|NCT00948896|472403060|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
131212967|NCT00948896|472403061|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
131212968|NCT00948896|472403062|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
131212969|NCT00948896|472403063|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
131212970|NCT00948896|472403064|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
131212971|NCT00948896|472403065|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
131212972|NCT00948896|472403066|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
131212973|NCT00948896|472403059|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
131212974|NCT00948896|472403060|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
131212975|NCT00948896|472403061|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
131212976|NCT00948896|472403062|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
131212977|NCT00948896|472403063|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
131212978|NCT00948896|472403064|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
131212979|NCT00948896|472403065|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
131212980|NCT00948896|472403066|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
131212981|NCT00948896|472403059|FG000|24 Months of Age to 36 Months of Age|Death|0|||
131212982|NCT00948896|472403060|FG001|24 Months of Age to 36 Months of Age|Death|2|||
131212983|NCT00948896|472403061|FG002|24 Months of Age to 36 Months of Age|Death|2|||
131212984|NCT00948896|472403062|FG003|24 Months of Age to 36 Months of Age|Death|0|||
131212985|NCT00948896|472403063|FG004|24 Months of Age to 36 Months of Age|Death|0|||
131212986|NCT00948896|472403064|FG005|24 Months of Age to 36 Months of Age|Death|1|||
131212987|NCT00948896|472403065|FG006|24 Months of Age to 36 Months of Age|Death|0|||
131212988|NCT00948896|472403066|FG007|24 Months of Age to 36 Months of Age|Death|0|||
131212989|NCT00948896|472403059|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
131212990|NCT00948896|472403060|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
131212991|NCT00948896|472403061|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
131212992|NCT00948896|472403062|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
131212993|NCT00948896|472403063|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
131212994|NCT00948896|472403064|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
131212995|NCT00948896|472403065|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
131212996|NCT00948896|472403066|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
131212997|NCT00948896|472403059|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
131212998|NCT00948896|472403060|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
131212999|NCT00948896|472403061|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
131213000|NCT00948896|472403062|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
131213001|NCT00948896|472403063|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
131213002|NCT00948896|472403064|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
131213003|NCT00948896|472403065|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
131213004|NCT00948896|472403066|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
131213005|NCT00948896|472403059|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131213006|NCT00948896|472403060|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131213007|NCT00948896|472403061|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
131213008|NCT00948896|472403062|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131213009|NCT00948896|472403063|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131213010|NCT00948896|472403064|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
131213011|NCT00948896|472403065|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131213012|NCT00948896|472403066|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
131213013|NCT00948896|472403059|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131213014|NCT00948896|472403060|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131213015|NCT00948896|472403061|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130876735|NCT00083889|471179709|FG001|Overall Study|Lack of Efficacy|219|||
130876736|NCT00083889|471179708|FG000|Overall Study|Decision of sponsor|32|||
130876737|NCT00083889|471179709|FG001|Overall Study|Decision of sponsor|4|||
130876738|NCT00083889|471179708|FG000|Overall Study|Randomized: did not take study drug|0|||
130876739|NCT00083889|471179709|FG001|Overall Study|Randomized: did not take study drug|15|||
130876740|NCT00083889|471179708|FG000|Overall Study|Completed on marketed sunitinub|3|||
130876741|NCT00083889|471179709|FG001|Overall Study|Completed on marketed sunitinub|0|||
130876742|NCT00083889|471179708|FG000|Overall Study|Crossover to SU011248|0|||
130876743|NCT00083889|471179709|FG001|Overall Study|Crossover to SU011248|25|||
130876744|NCT03557970|471179710|FG000|Overall Study|Study closure|1|||
130876745|NCT03557970|471179711|FG001|Overall Study|Study closure|0|||
130876746|NCT03557970|471179710|FG000|Overall Study|Physician Decision|0|||
130876747|NCT03557970|471179711|FG001|Overall Study|Physician Decision|1|||
130876748|NCT03557970|471179710|FG000|Overall Study|Death|0|||
130876749|NCT03557970|471179711|FG001|Overall Study|Death|1|||
130876750|NCT00112736|471179712|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
130876751|NCT00112736|471179713|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
130876752|NCT05135871|471179715|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
130876753|NCT05135871|471179716|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
130876754|NCT05135871|471179717|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
130876755|NCT05135871|471179718|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
130876756|NCT01927497|471179719|FG000|Overall Study|Death|0|||
130876757|NCT01927497|471179720|FG001|Overall Study|Death|1|||
130876758|NCT01927497|471179719|FG000|Overall Study|Protocol Violation|2|||
130876759|NCT01927497|471179720|FG001|Overall Study|Protocol Violation|0|||
130876760|NCT03914417|471179721|FG000|Overall Study|Withdrawal by Subject|2|||
130876761|NCT03836625|471179722|FG000|Overall Study|Lost to Follow-up|9|||
130876762|NCT03836625|471179723|FG001|Overall Study|Lost to Follow-up|9|||
130876763|NCT03836625|471179722|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
130876764|NCT03836625|471179723|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
130876765|NCT03836625|471179722|FG000|Overall Study|Death|0|||
130876766|NCT03836625|471179723|FG001|Overall Study|Death|1|||
130876767|NCT03836625|471179722|FG000|Overall Study|Refused follow-up|0|||
130876768|NCT03836625|471179723|FG001|Overall Study|Refused follow-up|1|||
130985395|NCT02496767|471572904|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
130985396|NCT02496767|471572905|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
130985397|NCT02496767|471572906|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130985398|NCT02496767|471572907|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130985399|NCT02496767|471572908|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130985400|NCT02496767|471572901|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130985401|NCT02496767|471572902|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
130985402|NCT02496767|471572903|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130985403|NCT02496767|471572904|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130985404|NCT02496767|471572905|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130985405|NCT02496767|471572906|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130985406|NCT02496767|471572907|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130985407|NCT02496767|471572908|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
130985408|NCT02496767|471572901|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
130985409|NCT02496767|471572902|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
130985410|NCT02496767|471572903|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
130985411|NCT02496767|471572904|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
130985412|NCT02496767|471572905|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
130985413|NCT02496767|471572906|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
130985414|NCT02496767|471572907|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
130985415|NCT02496767|471572908|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
130985416|NCT02496767|471572901|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
130985417|NCT02496767|471572902|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
130985418|NCT02496767|471572903|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
130985419|NCT02496767|471572904|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
130985420|NCT02496767|471572905|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
130985421|NCT02496767|471572906|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
130985422|NCT02496767|471572907|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
130985423|NCT02496767|471572908|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
130985424|NCT02496767|471572901|FG000|Double-blind, Withdrawal Phase|Death|0|||
130985425|NCT02496767|471572902|FG001|Double-blind, Withdrawal Phase|Death|0|||
130985426|NCT02496767|471572903|FG002|Double-blind, Withdrawal Phase|Death|0|||
130985427|NCT02496767|471572904|FG003|Double-blind, Withdrawal Phase|Death|0|||
130985428|NCT02496767|471572905|FG004|Double-blind, Withdrawal Phase|Death|0|||
130985429|NCT02496767|471572906|FG005|Double-blind, Withdrawal Phase|Death|0|||
130985430|NCT02496767|471572907|FG006|Double-blind, Withdrawal Phase|Death|1|||
130985431|NCT02496767|471572908|FG007|Double-blind, Withdrawal Phase|Death|2|||
130985432|NCT02496767|471572901|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
130985433|NCT02496767|471572902|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
130985434|NCT02496767|471572903|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
130985435|NCT02496767|471572904|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
130985436|NCT02496767|471572905|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
130985437|NCT02496767|471572906|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
130985438|NCT02496767|471572907|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
130985439|NCT02496767|471572908|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
130876769|NCT00633477|471181421|FG000|Overall Study|Death|1|||
130876770|NCT00633477|471181422|FG001|Overall Study|Death|0|||
130876771|NCT00633477|471181421|FG000|Overall Study|Randomized but not treated|1|||
130876772|NCT00633477|471181422|FG001|Overall Study|Randomized but not treated|0|||
130876773|NCT00179621|471181424|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
130876774|NCT00179621|471181425|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
130876775|NCT00179621|471181426|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
130876776|NCT00179621|471181427|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
130876777|NCT00179621|471181424|FG000|Double-Blind Period|Adverse Event|2|||
130876778|NCT00179621|471181425|FG001|Double-Blind Period|Adverse Event|7|||
130876779|NCT00179621|471181426|FG002|Double-Blind Period|Adverse Event|4|||
130876780|NCT00179621|471181427|FG003|Double-Blind Period|Adverse Event|0|||
130876781|NCT00179621|471181424|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130876782|NCT00179621|471181425|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130876783|NCT00179621|471181426|FG002|Double-Blind Period|Withdrawal by Subject|3|||
130876784|NCT00179621|471181427|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130876785|NCT00179621|471181424|FG000|Double-Blind Period|Death|0|||
130876786|NCT00179621|471181425|FG001|Double-Blind Period|Death|1|||
130876787|NCT00179621|471181426|FG002|Double-Blind Period|Death|2|||
130876788|NCT00179621|471181427|FG003|Double-Blind Period|Death|0|||
130876789|NCT00179621|471181424|FG000|Double-Blind Period|Protocol Violation|1|||
130876790|NCT00179621|471181425|FG001|Double-Blind Period|Protocol Violation|0|||
130876791|NCT00179621|471181426|FG002|Double-Blind Period|Protocol Violation|0|||
130876792|NCT00179621|471181427|FG003|Double-Blind Period|Protocol Violation|0|||
130876793|NCT00179621|471181424|FG000|Double-Blind Period|Other|0|||
130876794|NCT00179621|471181425|FG001|Double-Blind Period|Other|2|||
130876795|NCT00179621|471181426|FG002|Double-Blind Period|Other|2|||
130876796|NCT00179621|471181427|FG003|Double-Blind Period|Other|0|||
130876797|NCT00179621|471181424|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
130876798|NCT00179621|471181425|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
130876799|NCT00179621|471181426|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
130876800|NCT00179621|471181427|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
130876801|NCT00179621|471181424|FG000|Open-Label Period|Adverse Event|0|||
130876802|NCT00179621|471181425|FG001|Open-Label Period|Adverse Event|6|||
130876803|NCT00179621|471181426|FG002|Open-Label Period|Adverse Event|5|||
130876804|NCT00179621|471181427|FG003|Open-Label Period|Adverse Event|6|||
130876805|NCT00179621|471181424|FG000|Open-Label Period|Withdrawal by Subject|0|||
130876806|NCT00179621|471181425|FG001|Open-Label Period|Withdrawal by Subject|2|||
130876807|NCT00179621|471181426|FG002|Open-Label Period|Withdrawal by Subject|2|||
130876808|NCT00179621|471181427|FG003|Open-Label Period|Withdrawal by Subject|2|||
130876809|NCT00179621|471181424|FG000|Open-Label Period|Death|0|||
130876810|NCT00179621|471181425|FG001|Open-Label Period|Death|0|||
130876811|NCT00179621|471181426|FG002|Open-Label Period|Death|1|||
130876812|NCT00179621|471181427|FG003|Open-Label Period|Death|2|||
130876813|NCT00179621|471181424|FG000|Open-Label Period|Other|0|||
130876814|NCT00179621|471181425|FG001|Open-Label Period|Other|1|||
130876815|NCT00179621|471181426|FG002|Open-Label Period|Other|1|||
130876816|NCT00179621|471181427|FG003|Open-Label Period|Other|2|||
130876817|NCT04235140|471181437|FG000|Overall Study|Adverse Event|2|||
130876818|NCT04235140|471181437|FG000|Overall Study|Lost to Follow-up|1|||
130876819|NCT04235140|471181437|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
130876820|NCT04235140|471181437|FG000|Overall Study|Commercial drug is available for participants|7|||
130876821|NCT00672555|471181439|FG000|Overall Study|Lost to Follow-up|4|||
130876822|NCT00672555|471181439|FG000|Overall Study|Did not want to answer questionnaire|2|||
130876823|NCT00419393|471181440|FG000|Overall Study|Adverse Event|5|||
130876824|NCT00419393|471181440|FG000|Overall Study|Protocol Violation|5|||
130876825|NCT00419393|471181440|FG000|Overall Study|Withdrawal by Subject|7|||
130876826|NCT00419393|471181440|FG000|Overall Study|Other: Sponsor request|3|||
130876827|NCT00419393|471181440|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
130876828|NCT00419393|471181440|FG000|Overall Study|Other: Site closure|1|||
130876829|NCT00419393|471181440|FG000|Overall Study|Other: Other health problems|1|||
130876830|NCT00419393|471181440|FG000|Overall Study|Other: Investigator decision|1|||
130876831|NCT01751061|471181443|FG000|Overall Study|Death|1|||
130876832|NCT01751061|471181444|FG001|Overall Study|Death|0|||
130876833|NCT01751061|471181443|FG000|Overall Study|patient death|5|||
130876834|NCT01751061|471181444|FG001|Overall Study|patient death|0|||
130876835|NCT01751061|471181443|FG000|Overall Study|Lost to Follow-up|40|||
130876836|NCT01751061|471181444|FG001|Overall Study|Lost to Follow-up|25|||
130876837|NCT01751061|471181443|FG000|Overall Study|patient regained decisional capacity|4|||
130876838|NCT01751061|471181444|FG001|Overall Study|patient regained decisional capacity|8|||
130876839|NCT01751061|471181443|FG000|Overall Study|Withdrawal by Subject|4|||
130876840|NCT01751061|471181444|FG001|Overall Study|Withdrawal by Subject|1|||
130876841|NCT01751061|471181443|FG000|Overall Study|Physician Decision|2|||
130876842|NCT01751061|471181444|FG001|Overall Study|Physician Decision|0|||
130876843|NCT00446849|471181448|FG000|Acute Phase|Lack of Efficacy|64|||
130876844|NCT00446849|471181448|FG000|Acute Phase|Protocol Violation|10|||
130876845|NCT00446849|471181448|FG000|Acute Phase|Consent withdrawn|4|||
130876846|NCT00446849|471181448|FG000|Acute Phase|Lost to Follow-up|2|||
130876847|NCT00446849|471181448|FG000|Acute Phase|Physician Decision|1|||
130876848|NCT00446849|471181448|FG000|Acute Phase|noncompliance|1|||
130876849|NCT00446849|471181448|FG000|Maintenance Phase|Lack of Efficacy|40|||
130876850|NCT00446849|471181448|FG000|Maintenance Phase|Protocol Violation|7|||
130876851|NCT00446849|471181448|FG000|Maintenance Phase|Adverse Event|6|||
130876852|NCT00446849|471181448|FG000|Maintenance Phase|Consent withdrawn|5|||
130876853|NCT00446849|471181448|FG000|Maintenance Phase|Lost to Follow-up|3|||
130876854|NCT00446849|471181448|FG000|Maintenance Phase|Pregnancy|1|||
130876855|NCT00446849|471181448|FG000|Maintenance Phase|noncompliance|2|||
130876856|NCT00446849|471181448|FG000|Maintenance Phase|prohibited medication use|2|||
130876857|NCT00446849|471181448|FG000|Maintenance Phase|antibiotic use|1|||
130876858|NCT00446849|471181448|FG000|Maintenance Phase|study closure|1|||
130876859|NCT00446849|471181448|FG000|Maintenance Phase|hydrocodone use|1|||
130876860|NCT00446849|471181448|FG000|Maintenance Phase|concomitant medication use|1|||
130876861|NCT01194830|471181449|FG000|Overall Study|Adverse Event|3|||
130876862|NCT01194830|471181450|FG001|Overall Study|Adverse Event|2|||
130876863|NCT01194830|471181449|FG000|Overall Study|Protocol Violation|5|||
130876864|NCT01194830|471181450|FG001|Overall Study|Protocol Violation|4|||
130876865|NCT01194830|471181449|FG000|Overall Study|Lost to Follow-up|9|||
130876866|NCT01194830|471181450|FG001|Overall Study|Lost to Follow-up|7|||
130876867|NCT01194830|471181449|FG000|Overall Study|Withdrawal by Subject|2|||
130876868|NCT01194830|471181450|FG001|Overall Study|Withdrawal by Subject|1|||
130876869|NCT01194830|471181449|FG000|Overall Study|Lack of Efficacy|1|||
130876870|NCT01194830|471181450|FG001|Overall Study|Lack of Efficacy|1|||
130876871|NCT01194830|471181449|FG000|Overall Study|Non-compliance issues|4|||
130876872|NCT01194830|471181450|FG001|Overall Study|Non-compliance issues|4|||
130876873|NCT01194830|471181449|FG000|Overall Study|Other Reason|12|||
130876874|NCT01194830|471181450|FG001|Overall Study|Other Reason|8|||
130876875|NCT01815918|471181453|FG000|Overall Study|Patient samples not analyzable|3|||
130876876|NCT01815918|471181454|FG001|Overall Study|Patient samples not analyzable|4|||
130876877|NCT01815918|471181453|FG000|Overall Study|Lack of Efficacy|15|||
130876878|NCT01815918|471181454|FG001|Overall Study|Lack of Efficacy|15|||
130876879|NCT03284710|471181457|FG000|Overall Study|Withdrawal by Subject|1|||
130876880|NCT03284710|471181458|FG001|Overall Study|Withdrawal by Subject|0|||
130876881|NCT03284710|471181459|FG002|Overall Study|Withdrawal by Subject|1|||
130876882|NCT03284710|471181460|FG003|Overall Study|Withdrawal by Subject|6|||
130876883|NCT03284710|471181457|FG000|Overall Study|Lost to Follow-up|3|||
130876884|NCT03284710|471181458|FG001|Overall Study|Lost to Follow-up|3|||
130876885|NCT03284710|471181459|FG002|Overall Study|Lost to Follow-up|1|||
130876886|NCT03284710|471181460|FG003|Overall Study|Lost to Follow-up|0|||
130876887|NCT03284710|471181457|FG000|Overall Study|Physician Decision|1|||
130876888|NCT03284710|471181458|FG001|Overall Study|Physician Decision|0|||
130876889|NCT03284710|471181459|FG002|Overall Study|Physician Decision|0|||
130876890|NCT03284710|471181460|FG003|Overall Study|Physician Decision|0|||
130876891|NCT03284710|471181457|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
130876892|NCT03284710|471181458|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
130876893|NCT03284710|471181459|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
130876894|NCT03284710|471181460|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
130876895|NCT03284710|471181457|FG000|Overall Study|HIV Infection|0|||
130876896|NCT03284710|471181458|FG001|Overall Study|HIV Infection|2|||
130876897|NCT03284710|471181459|FG002|Overall Study|HIV Infection|2|||
130988338|NCT00615264|471585340|FG000|Overall Study|Death|1|||
130876898|NCT03284710|471181460|FG003|Overall Study|HIV Infection|1|||
130876899|NCT03035032|471181461|FG000|Overall Study|Adverse Event|2|||
130876900|NCT03035032|471181461|FG000|Overall Study|Death|9|||
130876901|NCT03035032|471181461|FG000|Overall Study|Lost to Follow-up|1|||
130876902|NCT03035032|471181461|FG000|Overall Study|Progressive Disease|22|||
130876903|NCT03035032|471181461|FG000|Overall Study|Protocol Violation|2|||
130876904|NCT03035032|471181461|FG000|Overall Study|Withdrawal by Subject|2|||
130876905|NCT03035032|471181461|FG000|Overall Study|Physician Decision|5|||
130876906|NCT00836589|471181462|FG000|Overall Study|Lost to Follow-up|246|||
130876907|NCT00836589|471181462|FG000|Overall Study|Death|429|||
130876908|NCT00836589|471181462|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
130876909|NCT02399215|471181484|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
130876910|NCT02399215|471181484|FG000|Overall Study|Withdrawal by Subject|1|||
130876911|NCT04529083|471181485|FG000|Overall Study|Withdrawal by Subject|3|||
130876912|NCT01176032|471181489|FG000|Overall Study|Adverse Event|1|||
130876913|NCT01176032|471181490|FG001|Overall Study|Adverse Event|0|||
130876914|NCT01176032|471181489|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130876915|NCT01176032|471181490|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130876916|NCT01176032|471181489|FG000|Overall Study|Protocol Violation|1|||
130876917|NCT01176032|471181490|FG001|Overall Study|Protocol Violation|0|||
130876918|NCT01176032|471181489|FG000|Overall Study|Informed consent withdrawn|3|||
130876919|NCT01176032|471181490|FG001|Overall Study|Informed consent withdrawn|0|||
130876920|NCT01176032|471181489|FG000|Overall Study|Other|1|||
130876921|NCT01176032|471181490|FG001|Overall Study|Other|0|||
130876922|NCT01469221|471181491|FG000|Double Blind Phase|Protocol Violation|1|||
130876923|NCT01469221|471181492|FG001|Double Blind Phase|Protocol Violation|0|||
130876924|NCT01469221|471181493|FG002|Double Blind Phase|Protocol Violation|0|||
130876925|NCT01469221|471181491|FG000|Double Blind Phase|Physician Decision|1|||
130876926|NCT01469221|471181492|FG001|Double Blind Phase|Physician Decision|1|||
130876927|NCT01469221|471181493|FG002|Double Blind Phase|Physician Decision|0|||
130876928|NCT01469221|471181491|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
130876929|NCT01469221|471181492|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
130876930|NCT01469221|471181493|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
130876931|NCT03186209|471181503|FG000|Overall Study|Withdrawal by Subject|11|||
130876932|NCT03186209|471181504|FG001|Overall Study|Withdrawal by Subject|22|||
130876933|NCT03186209|471181503|FG000|Overall Study|Pregnancy|1|||
130876934|NCT03186209|471181504|FG001|Overall Study|Pregnancy|0|||
130876935|NCT03186209|471181503|FG000|Overall Study|Adverse Event|4|||
130876936|NCT03186209|471181504|FG001|Overall Study|Adverse Event|0|||
130876937|NCT03186209|471181503|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
130876938|NCT03186209|471181504|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
130876939|NCT03186209|471181503|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
130876940|NCT03186209|471181504|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
130876941|NCT03186209|471181503|FG000|Overall Study|Fail to meet randomization criteria|0|||
130876942|NCT03186209|471181504|FG001|Overall Study|Fail to meet randomization criteria|1|||
130876943|NCT03186209|471181503|FG000|Overall Study|Lost to Follow-up|0|||
130876944|NCT03186209|471181504|FG001|Overall Study|Lost to Follow-up|1|||
130876945|NCT04739982|471181506|FG000|Overall Study|Lost to Follow-up|176|||
130876946|NCT04739982|471181507|FG001|Overall Study|Lost to Follow-up|65|||
130876947|NCT04739982|471181506|FG000|Overall Study|Withdrawal by Subject|19|||
130876948|NCT04739982|471181507|FG001|Overall Study|Withdrawal by Subject|0|||
130988339|NCT00615264|471585341|FG001|Overall Study|Death|1|||
130988340|NCT00615264|471585340|FG000|Overall Study|Protocol Violation|11|||
130988341|NCT00615264|471585341|FG001|Overall Study|Protocol Violation|7|||
130988342|NCT00615264|471585340|FG000|Overall Study|Not defined|7|||
130988343|NCT00615264|471585341|FG001|Overall Study|Not defined|4|||
130988344|NCT00615264|471585340|FG000|Overall Study|Dermal Hypersensitivity|0|||
130988345|NCT00615264|471585341|FG001|Overall Study|Dermal Hypersensitivity|3|||
130988346|NCT04415151|471585348|FG000|Overall Study|Death|1|||
130988347|NCT04415151|471585349|FG001|Overall Study|Death|1|||
130988348|NCT04415151|471585348|FG000|Overall Study|Withdrawal by Subject|1|||
130988349|NCT04415151|471585349|FG001|Overall Study|Withdrawal by Subject|0|||
130988350|NCT00638235|471585353|FG000|Overall Study|Lost to Follow-up|31|||
130988351|NCT00638235|471585354|FG001|Overall Study|Lost to Follow-up|3|||
130988352|NCT00638235|471585355|FG002|Overall Study|Lost to Follow-up|18|||
130988353|NCT00638235|471585356|FG003|Overall Study|Lost to Follow-up|10|||
130988354|NCT00638235|471585357|FG004|Overall Study|Lost to Follow-up|13|||
130988355|NCT00638235|471585358|FG005|Overall Study|Lost to Follow-up|26|||
130988356|NCT00638235|471585359|FG006|Overall Study|Lost to Follow-up|0|||
130988357|NCT00638235|471585360|FG007|Overall Study|Lost to Follow-up|1|||
130988358|NCT00638235|471585361|FG008|Overall Study|Lost to Follow-up|18|||
130988359|NCT03505476|471585366|FG000|Overall Study|Physician Decision|18|||
130876949|NCT04739982|471181506|FG000|Overall Study|Protocol Violation|0|||
130876950|NCT04739982|471181507|FG001|Overall Study|Protocol Violation|5|||
130876951|NCT04079296|471181508|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
130876952|NCT04079296|471181509|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
130876953|NCT04079296|471181510|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
130876954|NCT04079296|471181511|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
130876955|NCT04079296|471181512|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
130876956|NCT04079296|471181508|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
130876957|NCT04079296|471181509|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
130876958|NCT04079296|471181510|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
130876959|NCT04079296|471181511|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
130876960|NCT04079296|471181512|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
130876961|NCT04079296|471181508|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130876962|NCT04079296|471181509|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130876963|NCT04079296|471181510|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130876964|NCT04079296|471181511|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130876965|NCT04079296|471181512|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
130876966|NCT04079296|471181508|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130876967|NCT04079296|471181509|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130876968|NCT04079296|471181510|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130876969|NCT04079296|471181511|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130876970|NCT04079296|471181512|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
130876971|NCT04079296|471181508|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130876972|NCT04079296|471181509|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130876973|NCT04079296|471181510|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130876974|NCT04079296|471181511|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
130876975|NCT04079296|471181512|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130876976|NCT04079296|471181508|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
130876977|NCT04079296|471181509|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
130876978|NCT04079296|471181510|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
130876979|NCT04079296|471181511|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
130876980|NCT04079296|471181512|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
130876981|NCT04079296|471181508|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
130876982|NCT04079296|471181509|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
130876983|NCT04079296|471181510|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
130876984|NCT04079296|471181511|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
130876985|NCT04079296|471181512|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
130876986|NCT04079296|471181508|FG000|Dose Expansion Phase (168 Days)|Death|0|||
130876987|NCT04079296|471181509|FG001|Dose Expansion Phase (168 Days)|Death|0|||
130876988|NCT04079296|471181510|FG002|Dose Expansion Phase (168 Days)|Death|0|||
130876989|NCT04079296|471181511|FG003|Dose Expansion Phase (168 Days)|Death|1|||
130876990|NCT04079296|471181512|FG004|Dose Expansion Phase (168 Days)|Death|0|||
130876991|NCT01346358|471181525|FG000|Overall Study|Withdrawal by Subject|1|||
130876992|NCT01346358|471181526|FG001|Overall Study|Withdrawal by Subject|0|||
130876993|NCT01346358|471181527|FG002|Overall Study|Withdrawal by Subject|1|||
130876994|NCT01346358|471181528|FG003|Overall Study|Withdrawal by Subject|1|||
130876995|NCT01346358|471181529|FG004|Overall Study|Withdrawal by Subject|0|||
130876996|NCT01346358|471181530|FG005|Overall Study|Withdrawal by Subject|2|||
130988360|NCT03505476|471585366|FG000|Overall Study|Device Malfunctioned|101|||
130988361|NCT03505476|471585366|FG000|Overall Study|Data Corrupt|6|||
130988362|NCT03505476|471585366|FG000|Overall Study|Device application insufficiant|3|||
130876997|NCT01346358|471181531|FG006|Overall Study|Withdrawal by Subject|1|||
130876998|NCT01346358|471181532|FG007|Overall Study|Withdrawal by Subject|1|||
130876999|NCT01346358|471181533|FG008|Overall Study|Withdrawal by Subject|1|||
130877000|NCT01346358|471181525|FG000|Overall Study|Adverse Event|1|||
130877001|NCT01346358|471181526|FG001|Overall Study|Adverse Event|0|||
130877002|NCT01346358|471181527|FG002|Overall Study|Adverse Event|0|||
130877003|NCT01346358|471181528|FG003|Overall Study|Adverse Event|0|||
130877004|NCT01346358|471181529|FG004|Overall Study|Adverse Event|1|||
130877005|NCT01346358|471181530|FG005|Overall Study|Adverse Event|0|||
130877006|NCT01346358|471181531|FG006|Overall Study|Adverse Event|0|||
130877007|NCT01346358|471181532|FG007|Overall Study|Adverse Event|0|||
130877008|NCT01346358|471181533|FG008|Overall Study|Adverse Event|1|||
130877009|NCT01346358|471181525|FG000|Overall Study|Non-Compliance|0|||
130877010|NCT01346358|471181526|FG001|Overall Study|Non-Compliance|0|||
130877011|NCT01346358|471181527|FG002|Overall Study|Non-Compliance|0|||
130877012|NCT01346358|471181528|FG003|Overall Study|Non-Compliance|0|||
130877013|NCT01346358|471181529|FG004|Overall Study|Non-Compliance|0|||
130877014|NCT01346358|471181530|FG005|Overall Study|Non-Compliance|0|||
130877015|NCT01346358|471181531|FG006|Overall Study|Non-Compliance|0|||
130877016|NCT01346358|471181532|FG007|Overall Study|Non-Compliance|2|||
130877017|NCT01346358|471181533|FG008|Overall Study|Non-Compliance|0|||
130877018|NCT01346358|471181525|FG000|Overall Study|Physician Decision|0|||
130877019|NCT01346358|471181526|FG001|Overall Study|Physician Decision|1|||
130877020|NCT01346358|471181527|FG002|Overall Study|Physician Decision|0|||
130877021|NCT01346358|471181528|FG003|Overall Study|Physician Decision|0|||
130877022|NCT01346358|471181529|FG004|Overall Study|Physician Decision|0|||
130877023|NCT01346358|471181530|FG005|Overall Study|Physician Decision|0|||
130877024|NCT01346358|471181531|FG006|Overall Study|Physician Decision|0|||
130877025|NCT01346358|471181532|FG007|Overall Study|Physician Decision|1|||
130877026|NCT01346358|471181533|FG008|Overall Study|Physician Decision|1|||
130877027|NCT05058365|471181536|FG000|Overall Study|Migration|1|||
130877028|NCT05058365|471181537|FG001|Overall Study|Migration|1|||
130877029|NCT00702702|471181538|FG000|Overall Study|Study prematurely terminated|56|||
130877030|NCT04038359|471181539|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
130877031|NCT04038359|471181540|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
130877032|NCT04038359|471181539|FG000|Overall Study|Death|8|||
130877033|NCT04038359|471181540|FG001|Overall Study|Death|7|||
130877034|NCT04038359|471181539|FG000|Overall Study|Lost to Follow-up|3|||
130877035|NCT04038359|471181540|FG001|Overall Study|Lost to Follow-up|0|||
130877036|NCT04038359|471181539|FG000|Overall Study|Participant Moved|1|||
130877037|NCT04038359|471181540|FG001|Overall Study|Participant Moved|0|||
130877038|NCT04038359|471181539|FG000|Overall Study|Withdrawal by Subject|4|||
130877039|NCT04038359|471181540|FG001|Overall Study|Withdrawal by Subject|3|||
130877040|NCT04038359|471181539|FG000|Overall Study|Physician Decision|3|||
130877041|NCT04038359|471181540|FG001|Overall Study|Physician Decision|2|||
130877042|NCT04038359|471181539|FG000|Overall Study|Adverse Event|0|||
130877043|NCT04038359|471181540|FG001|Overall Study|Adverse Event|2|||
130877044|NCT04038359|471181539|FG000|Overall Study|Progressive Disease|0|||
130877045|NCT04038359|471181540|FG001|Overall Study|Progressive Disease|1|||
130877046|NCT02004236|471181541|FG000|Overall Study|Lack of Efficacy|0|||
130877047|NCT02004236|471181542|FG001|Overall Study|Lack of Efficacy|0|||
130877048|NCT02004236|471181543|FG002|Overall Study|Lack of Efficacy|16|||
130877049|NCT05121766|471181544|FG000|Overall Study|Covid reinfection|3|||
130877050|NCT05121766|471181545|FG001|Overall Study|Covid reinfection|0|||
130877051|NCT05121766|471181544|FG000|Overall Study|Withdrawal by Subject|3|||
130877052|NCT05121766|471181545|FG001|Overall Study|Withdrawal by Subject|1|||
130877053|NCT05121766|471181544|FG000|Overall Study|Adverse Event|2|||
130877054|NCT05121766|471181545|FG001|Overall Study|Adverse Event|4|||
130877055|NCT05121766|471181544|FG000|Overall Study|Lost to Follow-up|0|||
130877056|NCT05121766|471181545|FG001|Overall Study|Lost to Follow-up|1|||
130877057|NCT03259230|471181547|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
130877058|NCT03259230|471181548|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
130877059|NCT01033240|471181549|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
130877060|NCT01033240|471181550|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
130877061|NCT01033240|471181551|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
130877062|NCT01033240|471181549|FG000|Overall Study|Death|2|||
130877063|NCT01033240|471181550|FG001|Overall Study|Death|0|||
130877064|NCT01033240|471181551|FG002|Overall Study|Death|0|||
130877065|NCT01033240|471181549|FG000|Overall Study|Withdrew Consent|2|||
130877066|NCT01033240|471181550|FG001|Overall Study|Withdrew Consent|9|||
130877067|NCT01033240|471181551|FG002|Overall Study|Withdrew Consent|2|||
130877068|NCT01033240|471181549|FG000|Overall Study|Disease Progression|35|||
130877069|NCT01033240|471181550|FG001|Overall Study|Disease Progression|32|||
130877070|NCT01033240|471181551|FG002|Overall Study|Disease Progression|41|||
130877071|NCT01033240|471181549|FG000|Overall Study|Investigator Discretion|0|||
130877072|NCT01033240|471181550|FG001|Overall Study|Investigator Discretion|0|||
130877073|NCT01033240|471181551|FG002|Overall Study|Investigator Discretion|2|||
130877074|NCT01033240|471181549|FG000|Overall Study|Other|0|||
130877075|NCT01033240|471181550|FG001|Overall Study|Other|1|||
130877076|NCT01033240|471181551|FG002|Overall Study|Other|2|||
130877077|NCT02960217|471181553|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
130877078|NCT02960217|471181554|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
130877079|NCT02960217|471181553|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
130877080|NCT02960217|471181554|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
130877081|NCT02960217|471181553|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
130877082|NCT02960217|471181554|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
130877083|NCT02960217|471181553|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
130877084|NCT02960217|471181554|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
130877085|NCT02960217|471181553|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
130877086|NCT02960217|471181554|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
130877087|NCT02960217|471181553|FG000|Open-Label Extension Phase|Adverse Event|1|||
130877088|NCT02960217|471181554|FG001|Open-Label Extension Phase|Adverse Event|0|||
130877089|NCT02960217|471181553|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
130877090|NCT02960217|471181554|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
130877091|NCT02960217|471181553|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
130877092|NCT02960217|471181554|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
130877093|NCT02960217|471181553|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
130877094|NCT02960217|471181554|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
130877095|NCT01247324|471181560|FG000|Overall Study|Death|6|||
130877096|NCT01247324|471181561|FG001|Overall Study|Death|10|||
130877097|NCT01247324|471181560|FG000|Overall Study|Physician Decision|2|||
130877098|NCT01247324|471181561|FG001|Overall Study|Physician Decision|3|||
130877099|NCT01247324|471181560|FG000|Overall Study|Non-compliance with study drug|3|||
130877100|NCT01247324|471181561|FG001|Overall Study|Non-compliance with study drug|0|||
130877101|NCT01247324|471181560|FG000|Overall Study|Lack of Efficacy|24|||
130877102|NCT01247324|471181561|FG001|Overall Study|Lack of Efficacy|14|||
130877103|NCT01247324|471181560|FG000|Overall Study|Non-compliance|3|||
130877104|NCT01247324|471181561|FG001|Overall Study|Non-compliance|2|||
130877105|NCT01247324|471181560|FG000|Overall Study|Pregnancy|5|||
130877106|NCT01247324|471181561|FG001|Overall Study|Pregnancy|10|||
130877107|NCT01247324|471181560|FG000|Overall Study|Protocol Violation|1|||
130877108|NCT01247324|471181561|FG001|Overall Study|Protocol Violation|1|||
130877109|NCT01247324|471181560|FG000|Overall Study|Reason not specified|42|||
130877110|NCT01247324|471181561|FG001|Overall Study|Reason not specified|32|||
130877111|NCT01247324|471181560|FG000|Overall Study|Consent withdrawn by participant|41|||
130877112|NCT01247324|471181561|FG001|Overall Study|Consent withdrawn by participant|56|||
130877113|NCT01247324|471181560|FG000|Overall Study|Adverse Event|49|||
130877114|NCT01247324|471181561|FG001|Overall Study|Adverse Event|35|||
130877115|NCT01247324|471181560|FG000|Overall Study|Lost to Follow-up|3|||
130877116|NCT01247324|471181561|FG001|Overall Study|Lost to Follow-up|6|||
130877117|NCT01247324|471181560|FG000|Overall Study|Study Terminated by Sponsor|4|||
130877118|NCT01247324|471181561|FG001|Overall Study|Study Terminated by Sponsor|1|||
130877119|NCT01247324|471181560|FG000|Overall Study|Missing|2|||
130877120|NCT01247324|471181561|FG001|Overall Study|Missing|1|||
130877121|NCT02153086|471183563|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
130877122|NCT02153086|471183563|FG000|Overall Study|Other|2|||
130877123|NCT01317472|471183564|FG000|Overall Study|Withdrawal by Subject|1|||
130877124|NCT01317472|471183565|FG001|Overall Study|Withdrawal by Subject|0|||
130877125|NCT01317472|471183564|FG000|Overall Study|Unrelated hospitalization|1|||
130877126|NCT01317472|471183565|FG001|Overall Study|Unrelated hospitalization|0|||
130877127|NCT05546476|471183566|FG000|Period 1: Part A|Adverse Event|2|||
130877128|NCT05546476|471183567|FG001|Period 1: Part A|Adverse Event|0|||
130877129|NCT05546476|471183568|FG002|Period 1: Part A|Adverse Event|0|||
130877130|NCT05546476|471183569|FG003|Period 1: Part A|Adverse Event|1|||
130877131|NCT05546476|471183566|FG000|Period 1: Part A|Death|4|||
130877132|NCT05546476|471183567|FG001|Period 1: Part A|Death|4|||
130877133|NCT05546476|471183568|FG002|Period 1: Part A|Death|5|||
130877134|NCT05546476|471183569|FG003|Period 1: Part A|Death|6|||
130877135|NCT05546476|471183566|FG000|Period 1: Part A|Lack of Efficacy|0|||
130877136|NCT05546476|471183567|FG001|Period 1: Part A|Lack of Efficacy|0|||
130877137|NCT05546476|471183568|FG002|Period 1: Part A|Lack of Efficacy|0|||
130877138|NCT05546476|471183569|FG003|Period 1: Part A|Lack of Efficacy|1|||
130877139|NCT05546476|471183566|FG000|Period 1: Part A|Lost to Follow-up|0|||
130877140|NCT05546476|471183567|FG001|Period 1: Part A|Lost to Follow-up|0|||
130988363|NCT00659984|471585371|FG000|Overall Study|Adverse Event|1|||
130877141|NCT05546476|471183568|FG002|Period 1: Part A|Lost to Follow-up|0|||
130877142|NCT05546476|471183569|FG003|Period 1: Part A|Lost to Follow-up|1|||
130877143|NCT05546476|471183566|FG000|Period 1: Part A|Physician Decision|1|||
130877144|NCT05546476|471183567|FG001|Period 1: Part A|Physician Decision|0|||
130877145|NCT05546476|471183568|FG002|Period 1: Part A|Physician Decision|0|||
130877146|NCT05546476|471183569|FG003|Period 1: Part A|Physician Decision|0|||
130877147|NCT05546476|471183566|FG000|Period 1: Part A|Progressive disease|3|||
130877148|NCT05546476|471183567|FG001|Period 1: Part A|Progressive disease|5|||
130877149|NCT05546476|471183568|FG002|Period 1: Part A|Progressive disease|0|||
130877150|NCT05546476|471183569|FG003|Period 1: Part A|Progressive disease|1|||
130877151|NCT05546476|471183566|FG000|Period 1: Part A|Withdrawal by Subject|1|||
130877152|NCT05546476|471183567|FG001|Period 1: Part A|Withdrawal by Subject|1|||
130877153|NCT05546476|471183568|FG002|Period 1: Part A|Withdrawal by Subject|1|||
130877154|NCT05546476|471183569|FG003|Period 1: Part A|Withdrawal by Subject|2|||
130877155|NCT05546476|471183566|FG000|Period 1: Part A|Global deterioration of health status|2|||
130877156|NCT05546476|471183567|FG001|Period 1: Part A|Global deterioration of health status|2|||
130877157|NCT05546476|471183568|FG002|Period 1: Part A|Global deterioration of health status|1|||
130877158|NCT05546476|471183569|FG003|Period 1: Part A|Global deterioration of health status|4|||
130877159|NCT05546476|471183566|FG000|Period 1: Part A|Other: Unspecified|0|||
130877160|NCT05546476|471183567|FG001|Period 1: Part A|Other: Unspecified|2|||
130877161|NCT05546476|471183568|FG002|Period 1: Part A|Other: Unspecified|0|||
130877162|NCT05546476|471183569|FG003|Period 1: Part A|Other: Unspecified|0|||
130877163|NCT05546476|471183566|FG000|Period 2: Part B|Ongoing|26|||
130877164|NCT05546476|471183567|FG001|Period 2: Part B|Ongoing|27|||
130877165|NCT05546476|471183568|FG002|Period 2: Part B|Ongoing|35|||
130877166|NCT05546476|471183569|FG003|Period 2: Part B|Ongoing|29|||
130877167|NCT02953652|471183570|FG000|Overall Study|Adverse Event|18|||
130877168|NCT02953652|471183570|FG000|Overall Study|Withdrawal by Subject|6|||
130877169|NCT02953652|471183570|FG000|Overall Study|Protocol Violation|1|||
130877170|NCT02953652|471183570|FG000|Overall Study|Disease Progression|27|||
130877171|NCT00772538|471183571|FG000|Overall Study|Adverse Event|6|||
130877172|NCT00772538|471183572|FG001|Overall Study|Adverse Event|6|||
130877173|NCT00772538|471183571|FG000|Overall Study|Protocol Violation|3|||
130877174|NCT00772538|471183572|FG001|Overall Study|Protocol Violation|3|||
130877175|NCT00772538|471183571|FG000|Overall Study|Lost to Follow-up|1|||
130877176|NCT00772538|471183572|FG001|Overall Study|Lost to Follow-up|1|||
130988364|NCT02228395|471585372|FG000|First Intervention Period|No longer willing to participate|1|||
130877177|NCT00772538|471183571|FG000|Overall Study|Withdrawal by Subject|3|||
130877178|NCT00772538|471183572|FG001|Overall Study|Withdrawal by Subject|8|||
130877179|NCT00772538|471183571|FG000|Overall Study|Lack of Efficacy|0|||
130877180|NCT00772538|471183572|FG001|Overall Study|Lack of Efficacy|1|||
130877181|NCT00772538|471183571|FG000|Overall Study|Other|7|||
130877182|NCT00772538|471183572|FG001|Overall Study|Other|7|||
130877183|NCT00713609|471183575|FG000|Overall Study|Adverse Event|2|||
130877184|NCT00713609|471183576|FG001|Overall Study|Adverse Event|0|||
130877185|NCT00713609|471183577|FG002|Overall Study|Adverse Event|2|||
130877186|NCT00713609|471183578|FG003|Overall Study|Adverse Event|2|||
130877187|NCT00713609|471183579|FG004|Overall Study|Adverse Event|3|||
130877188|NCT00713609|471183580|FG005|Overall Study|Adverse Event|1|||
130877189|NCT00713609|471183575|FG000|Overall Study|Lost to Follow-up|5|||
130877190|NCT00713609|471183576|FG001|Overall Study|Lost to Follow-up|7|||
130877191|NCT00713609|471183577|FG002|Overall Study|Lost to Follow-up|5|||
130877192|NCT00713609|471183578|FG003|Overall Study|Lost to Follow-up|5|||
130877193|NCT00713609|471183579|FG004|Overall Study|Lost to Follow-up|7|||
130877194|NCT00713609|471183580|FG005|Overall Study|Lost to Follow-up|0|||
130877195|NCT00713609|471183575|FG000|Overall Study|Lack of Efficacy|1|||
130877196|NCT00713609|471183576|FG001|Overall Study|Lack of Efficacy|3|||
130877197|NCT00713609|471183577|FG002|Overall Study|Lack of Efficacy|0|||
130877198|NCT00713609|471183578|FG003|Overall Study|Lack of Efficacy|0|||
130877199|NCT00713609|471183579|FG004|Overall Study|Lack of Efficacy|1|||
130877200|NCT00713609|471183580|FG005|Overall Study|Lack of Efficacy|0|||
130877201|NCT00713609|471183575|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
130877202|NCT00713609|471183576|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
130877203|NCT00713609|471183577|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
130877204|NCT00713609|471183578|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
130877205|NCT00713609|471183579|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
130877206|NCT00713609|471183580|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
130877207|NCT00713609|471183575|FG000|Overall Study|Withdrawal by Subject|6|||
130877208|NCT00713609|471183576|FG001|Overall Study|Withdrawal by Subject|1|||
130877209|NCT00713609|471183577|FG002|Overall Study|Withdrawal by Subject|5|||
130877210|NCT00713609|471183578|FG003|Overall Study|Withdrawal by Subject|1|||
130877211|NCT00713609|471183579|FG004|Overall Study|Withdrawal by Subject|5|||
130877212|NCT00713609|471183580|FG005|Overall Study|Withdrawal by Subject|7|||
130877213|NCT00713609|471183575|FG000|Overall Study|Protocol Violation|6|||
130877214|NCT00713609|471183576|FG001|Overall Study|Protocol Violation|3|||
130877215|NCT00713609|471183577|FG002|Overall Study|Protocol Violation|1|||
130877216|NCT00713609|471183578|FG003|Overall Study|Protocol Violation|1|||
130877217|NCT00713609|471183579|FG004|Overall Study|Protocol Violation|2|||
130877218|NCT00713609|471183580|FG005|Overall Study|Protocol Violation|0|||
130877219|NCT03780452|471183584|FG000|Overall Study|Screening failure|2|||
130877220|NCT01001221|471183585|FG000|Overall Study|Adverse Event|1|||
130877221|NCT01001221|471183586|FG001|Overall Study|Adverse Event|2|||
130877222|NCT01001221|471183587|FG002|Overall Study|Adverse Event|0|||
130877223|NCT01001221|471183588|FG003|Overall Study|Adverse Event|2|||
130720815|NCT01715571|470601529|FG000|Overall Study|Lost to Follow-up|8|||
130720816|NCT04524364|470601530|FG000|Overall Study|Physician Decision|3|||
130877224|NCT01001221|471183589|FG004|Overall Study|Adverse Event|0|||
130877225|NCT01001221|471183585|FG000|Overall Study|Disease progression|3|||
130764092|NCT01004432|470759963|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130764093|NCT01004432|470759964|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130764094|NCT01004432|470759965|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130764095|NCT01004432|470759961|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
130764096|NCT01004432|470759962|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130764097|NCT01004432|470759963|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130764098|NCT01004432|470759964|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130764099|NCT01004432|470759965|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130764100|NCT01004432|470759961|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
130764101|NCT01004432|470759962|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130764102|NCT01004432|470759963|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130764103|NCT01004432|470759964|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130764104|NCT01004432|470759965|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130764105|NCT01004432|470759961|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
130764106|NCT01004432|470759962|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130764107|NCT01004432|470759963|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130764108|NCT01004432|470759964|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130764109|NCT01004432|470759965|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130764110|NCT01004432|470759961|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
130764111|NCT01004432|470759962|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130764112|NCT01004432|470759963|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130764113|NCT01004432|470759964|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130764114|NCT01004432|470759965|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130764115|NCT01004432|470759961|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
130764116|NCT01004432|470759962|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
130764117|NCT01004432|470759963|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
130764118|NCT01004432|470759964|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
130764119|NCT01004432|470759965|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
130764120|NCT01004432|470759961|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
130764121|NCT01004432|470759962|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
130764122|NCT01004432|470759963|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
130764123|NCT01004432|470759964|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
130764124|NCT01004432|470759965|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
130764125|NCT01004432|470759961|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
130764126|NCT01004432|470759962|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
130764127|NCT01004432|470759963|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
130764128|NCT01004432|470759964|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
130764129|NCT01004432|470759965|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
130764130|NCT01004432|470759961|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130764131|NCT01004432|470759962|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130764132|NCT01004432|470759963|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130764133|NCT01004432|470759964|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
130764134|NCT01004432|470759965|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130764135|NCT01004432|470759961|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
130764136|NCT01004432|470759962|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
130764137|NCT01004432|470759963|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
130764138|NCT01004432|470759964|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
130764139|NCT01004432|470759965|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
130764140|NCT01004432|470759961|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
130764141|NCT01004432|470759962|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
130877226|NCT01001221|471183586|FG001|Overall Study|Disease progression|2|||
130877227|NCT01001221|471183587|FG002|Overall Study|Disease progression|2|||
130877228|NCT01001221|471183588|FG003|Overall Study|Disease progression|4|||
130877229|NCT01001221|471183589|FG004|Overall Study|Disease progression|0|||
130877230|NCT01001221|471183585|FG000|Overall Study|Other|1|||
130877231|NCT01001221|471183586|FG001|Overall Study|Other|1|||
130877232|NCT01001221|471183587|FG002|Overall Study|Other|0|||
130877233|NCT01001221|471183588|FG003|Overall Study|Other|0|||
130877234|NCT01001221|471183589|FG004|Overall Study|Other|0|||
130877235|NCT01001221|471183585|FG000|Overall Study|Not treated; protocol exclusion|0|||
130877236|NCT01001221|471183586|FG001|Overall Study|Not treated; protocol exclusion|0|||
130877237|NCT01001221|471183587|FG002|Overall Study|Not treated; protocol exclusion|1|||
130877238|NCT01001221|471183588|FG003|Overall Study|Not treated; protocol exclusion|0|||
130877239|NCT01001221|471183589|FG004|Overall Study|Not treated; protocol exclusion|0|||
130877240|NCT02388269|471183590|FG000|Overall Study|Adverse Event|2|||
130877241|NCT02388269|471183591|FG001|Overall Study|Adverse Event|0|||
130877242|NCT02388269|471183592|FG002|Overall Study|Adverse Event|0|||
130877243|NCT02388269|471183590|FG000|Overall Study|Withdrawal by Subject|1|||
130877244|NCT02388269|471183591|FG001|Overall Study|Withdrawal by Subject|2|||
130877245|NCT02388269|471183592|FG002|Overall Study|Withdrawal by Subject|0|||
130877246|NCT02388269|471183590|FG000|Overall Study|less than 50% stimulations|1|||
130877247|NCT02388269|471183591|FG001|Overall Study|less than 50% stimulations|0|||
130877248|NCT02388269|471183592|FG002|Overall Study|less than 50% stimulations|0|||
130877249|NCT02388269|471183590|FG000|Overall Study|no diary data|3|||
130877250|NCT02388269|471183591|FG001|Overall Study|no diary data|0|||
130877251|NCT02388269|471183592|FG002|Overall Study|no diary data|0|||
130877252|NCT02388269|471183590|FG000|Overall Study|Protocol Violation|2|||
130877253|NCT02388269|471183591|FG001|Overall Study|Protocol Violation|0|||
130877254|NCT02388269|471183592|FG002|Overall Study|Protocol Violation|0|||
130877255|NCT02388269|471183590|FG000|Overall Study|Screen Failure|0|||
130877256|NCT02388269|471183591|FG001|Overall Study|Screen Failure|0|||
130877257|NCT02388269|471183592|FG002|Overall Study|Screen Failure|10|||
130877258|NCT00703014|471183595|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
131229130|NCT00003102|472465836|FG000|Overall Study|Progressive Disease|0|||
131229131|NCT00003102|472465837|FG001|Overall Study|Progressive Disease|1|||
131229132|NCT00003102|472465838|FG002|Overall Study|Progressive Disease|0|||
131229133|NCT00003102|472465836|FG000|Overall Study|Adverse Event|0|||
131229134|NCT00003102|472465837|FG001|Overall Study|Adverse Event|1|||
131229135|NCT00003102|472465838|FG002|Overall Study|Adverse Event|1|||
131229136|NCT00003102|472465836|FG000|Overall Study|Death|0|||
131229137|NCT00003102|472465837|FG001|Overall Study|Death|0|||
131229138|NCT00003102|472465838|FG002|Overall Study|Death|1|||
131229139|NCT00583596|472465839|FG000|Overall Study|Lost to Follow-up|110|||
131229140|NCT00583596|472465839|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
131229141|NCT00583596|472465839|FG000|Overall Study|Death|2|||
131229142|NCT00583596|472465839|FG000|Overall Study|Withdrawal by Subject|6|||
131229143|NCT00583596|472465839|FG000|Overall Study|Lost to Follow-up|94|||
131229144|NCT00583596|472465839|FG000|Overall Study|Data not complete|1|||
131229145|NCT00583596|472465839|FG000|Overall Study|Not consented|15|||
131229146|NCT00583596|472465839|FG000|Overall Study|Outside f-up window|26|||
131229147|NCT00656019|472465840|FG000|Overall Study|Not Eligible|10|||
131229148|NCT00656019|472465841|FG001|Overall Study|Not Eligible|0|||
131229149|NCT00656019|472465842|FG002|Overall Study|Not Eligible|0|||
131229150|NCT00656019|472465843|FG003|Overall Study|Not Eligible|0|||
131229151|NCT00656019|472465840|FG000|Overall Study|Withdrawal by Subject|2|||
131229152|NCT00656019|472465841|FG001|Overall Study|Withdrawal by Subject|0|||
131229153|NCT00656019|472465842|FG002|Overall Study|Withdrawal by Subject|0|||
131229154|NCT00656019|472465843|FG003|Overall Study|Withdrawal by Subject|0|||
131229155|NCT00656019|472465840|FG000|Overall Study|Lost to Follow-up|2|||
131229156|NCT00656019|472465841|FG001|Overall Study|Lost to Follow-up|1|||
131229157|NCT00656019|472465842|FG002|Overall Study|Lost to Follow-up|0|||
131229158|NCT00656019|472465843|FG003|Overall Study|Lost to Follow-up|0|||
131229159|NCT00096486|472465848|FG000|Overall Study|Withdrawal by Subject|0|||
131229160|NCT00096486|472465849|FG001|Overall Study|Withdrawal by Subject|0|||
131229161|NCT00096486|472465850|FG002|Overall Study|Withdrawal by Subject|1|||
131229162|NCT00096486|472465851|FG003|Overall Study|Withdrawal by Subject|1|||
131229163|NCT00096486|472465848|FG000|Overall Study|Not Treated|0|||
131229164|NCT00096486|472465849|FG001|Overall Study|Not Treated|0|||
131229165|NCT00096486|472465850|FG002|Overall Study|Not Treated|1|||
131229166|NCT00096486|472465851|FG003|Overall Study|Not Treated|1|||
131229167|NCT00895583|472465852|FG000|Overall Study|Adverse Event|28|||
131229168|NCT00895583|472465853|FG001|Overall Study|Adverse Event|4|||
131229169|NCT00895583|472465852|FG000|Overall Study|Death|2|||
131229170|NCT00895583|472465853|FG001|Overall Study|Death|1|||
131229171|NCT00895583|472465852|FG000|Overall Study|Physician Decision|3|||
131229172|NCT00895583|472465853|FG001|Overall Study|Physician Decision|1|||
131229173|NCT00895583|472465852|FG000|Overall Study|Lost to Follow-up|1|||
131229174|NCT00895583|472465853|FG001|Overall Study|Lost to Follow-up|3|||
131229175|NCT00895583|472465852|FG000|Overall Study|Protocol Violation|1|||
131229176|NCT00895583|472465853|FG001|Overall Study|Protocol Violation|0|||
131229177|NCT00895583|472465852|FG000|Overall Study|Withdrawal by Subject|4|||
131229178|NCT00895583|472465853|FG001|Overall Study|Withdrawal by Subject|2|||
131229179|NCT00895583|472465852|FG000|Overall Study|Lack of Efficacy|5|||
131229180|NCT00895583|472465853|FG001|Overall Study|Lack of Efficacy|0|||
131229181|NCT00895583|472465852|FG000|Overall Study|Other|0|||
131229182|NCT00895583|472465853|FG001|Overall Study|Other|1|||
131229183|NCT01512979|472465854|FG000|Overall Study|Adverse Event|2|||
131229184|NCT01512979|472465855|FG001|Overall Study|Adverse Event|2|||
131229185|NCT01512979|472465854|FG000|Overall Study|Protocol Violation|1|||
131229186|NCT01512979|472465855|FG001|Overall Study|Protocol Violation|4|||
131229187|NCT01512979|472465854|FG000|Overall Study|Lost to Follow-up|2|||
131229188|NCT01512979|472465855|FG001|Overall Study|Lost to Follow-up|5|||
131229189|NCT01512979|472465854|FG000|Overall Study|Withdrawal by Subject|1|||
131229190|NCT01512979|472465855|FG001|Overall Study|Withdrawal by Subject|2|||
131229191|NCT01512979|472465854|FG000|Overall Study|Reason other than stated above|13|||
131229192|NCT01512979|472465855|FG001|Overall Study|Reason other than stated above|9|||
131229193|NCT04535583|472465859|FG000|Overall Study|Lost to Follow-up|1|||
131229194|NCT04535583|472465859|FG000|Overall Study|Physician Decision|1|||
131229195|NCT04535583|472465859|FG000|Overall Study|Withdrawal by Subject|1|||
131229196|NCT01078090|472465860|FG000|Overall Study|Lost to Follow-up|2363|||
131229197|NCT01078090|472465860|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
131229198|NCT01078090|472465860|FG000|Overall Study|Lack of Efficacy|1193|||
131229199|NCT01078090|472465860|FG000|Overall Study|ADR and lack of efficacy|61|||
131229200|NCT01078090|472465860|FG000|Overall Study|Other|523|||
131229201|NCT04049552|472465862|FG000|Overall Study|Lost to Follow-up|1|||
131229202|NCT00526890|472465863|FG000|Overall Study|Adverse Event|2|||
131229203|NCT01360632|472465869|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
131229204|NCT01360632|472465870|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
131229205|NCT01360632|472465871|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
130720817|NCT04524364|470601531|FG001|Overall Study|Physician Decision|6|||
130720818|NCT04524364|470601530|FG000|Overall Study|Adverse Event|0|||
130720819|NCT04524364|470601531|FG001|Overall Study|Adverse Event|1|||
130877259|NCT00703014|471183596|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
130877260|NCT00703014|471183597|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130877261|NCT00703014|471183598|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130877262|NCT00703014|471183595|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130877263|NCT00703014|471183596|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130877264|NCT00703014|471183597|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
130877265|NCT00703014|471183598|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
130877266|NCT00625131|471183599|FG000|Overall Study|Lost to Follow-up|3|||
130877267|NCT00625131|471183600|FG001|Overall Study|Lost to Follow-up|2|||
130877268|NCT00625131|471183601|FG002|Overall Study|Lost to Follow-up|0|||
130877269|NCT00625131|471183599|FG000|Overall Study|Withdrawal by Subject|1|||
130877270|NCT00625131|471183600|FG001|Overall Study|Withdrawal by Subject|0|||
130877271|NCT00625131|471183601|FG002|Overall Study|Withdrawal by Subject|5|||
130877272|NCT00918281|471183604|FG000|Overall Study|Physician Decision|29|||
130877273|NCT01743469|471183605|FG000|Active Treatment Phase|Adverse Event|10|||
130877274|NCT01743469|471183606|FG001|Active Treatment Phase|Adverse Event|5|||
130877275|NCT01743469|471183607|FG002|Active Treatment Phase|Adverse Event|8|||
130877276|NCT01743469|471183608|FG003|Active Treatment Phase|Adverse Event|1|||
130877277|NCT01743469|471183605|FG000|Active Treatment Phase|Disease Progression|40|||
130877278|NCT01743469|471183606|FG001|Active Treatment Phase|Disease Progression|47|||
130988365|NCT02228395|471585373|FG001|First Intervention Period|No longer willing to participate|0|||
130720820|NCT04524364|470601530|FG000|Overall Study|Investigational device deficiency|0|||
130720821|NCT04524364|470601531|FG001|Overall Study|Investigational device deficiency|1|||
130720822|NCT04524364|470601530|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
130720823|NCT04524364|470601531|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
130720824|NCT04524364|470601530|FG000|Overall Study|Device unavailability|0|||
130720825|NCT04524364|470601531|FG001|Overall Study|Device unavailability|2|||
130720826|NCT04524364|470601530|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
130877279|NCT01743469|471183607|FG002|Active Treatment Phase|Disease Progression|30|||
130877280|NCT01743469|471183608|FG003|Active Treatment Phase|Disease Progression|20|||
130877281|NCT01743469|471183605|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
130877282|NCT01743469|471183606|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
130877283|NCT01743469|471183607|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
130877284|NCT01743469|471183608|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
130877285|NCT01743469|471183605|FG000|Active Treatment Phase|Missing|1|||
130877286|NCT01743469|471183606|FG001|Active Treatment Phase|Missing|0|||
130877287|NCT01743469|471183607|FG002|Active Treatment Phase|Missing|0|||
130877288|NCT01743469|471183608|FG003|Active Treatment Phase|Missing|0|||
130877289|NCT01743469|471183605|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
130877290|NCT01743469|471183606|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
130877291|NCT01743469|471183607|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
130877292|NCT01743469|471183608|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
130877293|NCT01743469|471183605|FG000|Follow-up Period - Post-Treatment|Death|43|||
130877294|NCT01743469|471183606|FG001|Follow-up Period - Post-Treatment|Death|47|||
130877295|NCT01743469|471183607|FG002|Follow-up Period - Post-Treatment|Death|22|||
130877296|NCT01743469|471183608|FG003|Follow-up Period - Post-Treatment|Death|16|||
130877297|NCT01743469|471183605|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
130877298|NCT01743469|471183606|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
130877299|NCT01743469|471183607|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
130877300|NCT01743469|471183608|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
130877301|NCT00317473|471183609|FG000|Overall Study|Withdrawal by Subject|2|||
130877302|NCT00317473|471183610|FG001|Overall Study|Withdrawal by Subject|1|||
130877303|NCT00317473|471183611|FG002|Overall Study|Withdrawal by Subject|2|||
130877304|NCT00317473|471183612|FG003|Overall Study|Withdrawal by Subject|1|||
130877305|NCT00317473|471183613|FG004|Overall Study|Withdrawal by Subject|3|||
130877306|NCT00317473|471183614|FG005|Overall Study|Withdrawal by Subject|1|||
130877307|NCT00317473|471183609|FG000|Overall Study|Relocation|1|||
130877308|NCT00317473|471183610|FG001|Overall Study|Relocation|0|||
130877309|NCT00317473|471183611|FG002|Overall Study|Relocation|1|||
130877310|NCT00317473|471183612|FG003|Overall Study|Relocation|1|||
130877311|NCT00317473|471183613|FG004|Overall Study|Relocation|5|||
130877312|NCT00317473|471183614|FG005|Overall Study|Relocation|2|||
130877313|NCT00317473|471183609|FG000|Overall Study|Death|1|||
130877314|NCT00317473|471183610|FG001|Overall Study|Death|0|||
130877315|NCT00317473|471183611|FG002|Overall Study|Death|0|||
130877316|NCT00317473|471183612|FG003|Overall Study|Death|0|||
130877317|NCT00317473|471183613|FG004|Overall Study|Death|0|||
130877318|NCT00317473|471183614|FG005|Overall Study|Death|0|||
130764142|NCT01004432|470759963|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
130764143|NCT01004432|470759964|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
130764144|NCT01004432|470759965|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
130764145|NCT01004432|470759961|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130764146|NCT01004432|470759962|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130764147|NCT01004432|470759963|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130764148|NCT01004432|470759964|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130764149|NCT01004432|470759965|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
130764150|NCT01004432|470759961|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130764151|NCT01004432|470759962|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130764152|NCT01004432|470759963|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130764153|NCT01004432|470759964|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130764154|NCT01004432|470759965|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
130764155|NCT01004432|470759961|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130764156|NCT01004432|470759962|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130764157|NCT01004432|470759963|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130764158|NCT01004432|470759964|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130764159|NCT01004432|470759965|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
130764160|NCT01004432|470759961|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130764161|NCT01004432|470759962|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130764162|NCT01004432|470759963|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130764163|NCT01004432|470759964|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130764164|NCT01004432|470759965|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
130764165|NCT02667626|470759966|FG000|Overall Study|Withdrawal by Subject|0|||
130764166|NCT02667626|470759967|FG001|Overall Study|Withdrawal by Subject|1|||
130764167|NCT00590538|470759968|FG000|Overall Study|Study terminated before completed|2|||
130764168|NCT02539134|470759969|FG000|Overall Study|Lost to Follow-up|1|||
130764169|NCT02539134|470759970|FG001|Overall Study|Lost to Follow-up|0|||
130764170|NCT02539134|470759971|FG002|Overall Study|Lost to Follow-up|0|||
130764171|NCT02539134|470759972|FG003|Overall Study|Lost to Follow-up|0|||
130764172|NCT02539134|470759973|FG004|Overall Study|Lost to Follow-up|0|||
130764173|NCT02539134|470759974|FG005|Overall Study|Lost to Follow-up|0|||
130764174|NCT00985426|470759975|FG000|Overall Study|Adverse Event|0|||
130764175|NCT00985426|470759976|FG001|Overall Study|Adverse Event|1|||
130764176|NCT00985426|470759975|FG000|Overall Study|Subject Non-Compliance|3|||
130764177|NCT00985426|470759976|FG001|Overall Study|Subject Non-Compliance|3|||
130764178|NCT00985426|470759975|FG000|Overall Study|Withdrawal by Subject|12|||
130764179|NCT00985426|470759976|FG001|Overall Study|Withdrawal by Subject|16|||
130764180|NCT00985426|470759975|FG000|Overall Study|Lost to Follow-up|8|||
130764181|NCT00985426|470759976|FG001|Overall Study|Lost to Follow-up|10|||
130764182|NCT00985426|470759975|FG000|Overall Study|Death|7|||
130764183|NCT00985426|470759976|FG001|Overall Study|Death|3|||
130764184|NCT00985426|470759975|FG000|Overall Study|Protocol Violation|2|||
130764185|NCT00985426|470759976|FG001|Overall Study|Protocol Violation|0|||
130764186|NCT00985426|470759975|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
130877319|NCT00317473|471183609|FG000|Overall Study|Other|0|||
130877320|NCT00317473|471183610|FG001|Overall Study|Other|2|||
130877321|NCT00317473|471183611|FG002|Overall Study|Other|0|||
130877322|NCT00317473|471183612|FG003|Overall Study|Other|0|||
130877323|NCT00317473|471183613|FG004|Overall Study|Other|0|||
130877324|NCT00317473|471183614|FG005|Overall Study|Other|0|||
130877325|NCT00388349|471183615|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
130877326|NCT00388349|471183616|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
130877327|NCT00168844|471183617|FG000|Overall Study|Adverse Event|31|||
130877328|NCT00168844|471183618|FG001|Overall Study|Adverse Event|32|||
130764187|NCT00985426|470759976|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
130764188|NCT02971800|470759977|FG000|Overall Study|Protocol Violation|1|||
130764189|NCT02971800|470759977|FG000|Overall Study|Withdrawal by Subject|1|||
130764190|NCT02971800|470759977|FG000|Overall Study|Exclusion criteria prior intervention|1|||
130764191|NCT02971800|470759977|FG000|Overall Study|Number evaluable participant already reached|4|||
130764192|NCT01149421|470759978|FG000|Overall Study|Adverse Event|22|||
130764193|NCT01149421|470759979|FG001|Overall Study|Adverse Event|6|||
130764194|NCT01149421|470759980|FG002|Overall Study|Adverse Event|11|||
130764195|NCT01149421|470759978|FG000|Overall Study|Withdrawal by Subject|20|||
130764196|NCT01149421|470759979|FG001|Overall Study|Withdrawal by Subject|12|||
130764197|NCT01149421|470759980|FG002|Overall Study|Withdrawal by Subject|13|||
130764198|NCT01149421|470759978|FG000|Overall Study|Sponsor Decision|0|||
130877329|NCT00168844|471183619|FG002|Overall Study|Adverse Event|48|||
130764199|NCT01149421|470759979|FG001|Overall Study|Sponsor Decision|1|||
130764200|NCT01149421|470759980|FG002|Overall Study|Sponsor Decision|1|||
130764201|NCT01149421|470759978|FG000|Overall Study|Lost to Follow-up|2|||
130764202|NCT01149421|470759979|FG001|Overall Study|Lost to Follow-up|4|||
130764203|NCT01149421|470759980|FG002|Overall Study|Lost to Follow-up|5|||
130877330|NCT00168844|471183617|FG000|Overall Study|Lost to Follow-up|4|||
130764204|NCT01149421|470759978|FG000|Overall Study|Physician Decision|5|||
130764205|NCT01149421|470759979|FG001|Overall Study|Physician Decision|3|||
130764206|NCT01149421|470759980|FG002|Overall Study|Physician Decision|6|||
130764207|NCT01149421|470759978|FG000|Overall Study|Entry Criteria Not Met|1|||
130877331|NCT00168844|471183618|FG001|Overall Study|Lost to Follow-up|5|||
130877332|NCT00168844|471183619|FG002|Overall Study|Lost to Follow-up|11|||
130877333|NCT00168844|471183617|FG000|Overall Study|Withdrawal by Subject|12|||
130877334|NCT00168844|471183618|FG001|Overall Study|Withdrawal by Subject|9|||
130877335|NCT00168844|471183619|FG002|Overall Study|Withdrawal by Subject|19|||
130877336|NCT00168844|471183617|FG000|Overall Study|Protocol Violation|2|||
130877337|NCT00168844|471183618|FG001|Overall Study|Protocol Violation|2|||
130877338|NCT00168844|471183619|FG002|Overall Study|Protocol Violation|4|||
130877339|NCT00168844|471183617|FG000|Overall Study|Other|6|||
130877340|NCT00168844|471183618|FG001|Overall Study|Other|7|||
130877341|NCT00168844|471183619|FG002|Overall Study|Other|9|||
130877342|NCT02138890|471183628|FG000|Overall Study|Adverse Event|1|||
130877343|NCT02138890|471183629|FG001|Overall Study|Adverse Event|0|||
130764208|NCT01149421|470759979|FG001|Overall Study|Entry Criteria Not Met|1|||
130764209|NCT01149421|470759980|FG002|Overall Study|Entry Criteria Not Met|2|||
130764210|NCT01149421|470759978|FG000|Overall Study|Protocol Violation|2|||
130764211|NCT01149421|470759979|FG001|Overall Study|Protocol Violation|2|||
130764212|NCT01149421|470759980|FG002|Overall Study|Protocol Violation|6|||
130764213|NCT03738800|470759983|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
130764214|NCT03738800|470759984|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130764215|NCT03738800|470759985|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130764216|NCT03738800|470759983|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
130764217|NCT03738800|470759984|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
130764218|NCT03738800|470759985|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
130764219|NCT03738800|470759983|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
130764220|NCT03738800|470759984|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
130764221|NCT03738800|470759985|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
130764222|NCT00766467|470759996|FG000|Overall Study|Withdrawal by Subject|7|||
130764223|NCT00766467|470759997|FG001|Overall Study|Withdrawal by Subject|2|||
130764224|NCT00766467|470759996|FG000|Overall Study|Adverse Event|1|||
130764225|NCT00766467|470759997|FG001|Overall Study|Adverse Event|1|||
130764226|NCT00766467|470759996|FG000|Overall Study|Protocol Violation|2|||
130764227|NCT00766467|470759997|FG001|Overall Study|Protocol Violation|4|||
130764228|NCT00766467|470759996|FG000|Overall Study|Tumor Progression on Study|0|||
130764229|NCT00766467|470759997|FG001|Overall Study|Tumor Progression on Study|1|||
130764230|NCT00766467|470759996|FG000|Overall Study|Physician Decision|1|||
130764231|NCT00766467|470759997|FG001|Overall Study|Physician Decision|0|||
130764232|NCT01404208|470760003|FG000|Overall Study|Discontinued|3|||
130764233|NCT01404208|470760004|FG001|Overall Study|Discontinued|0|||
130764234|NCT04068688|470760005|FG000|Overall Study|Lost to Follow-up|1|||
130764235|NCT04068688|470760006|FG001|Overall Study|Lost to Follow-up|1|||
130764236|NCT04068688|470760007|FG002|Overall Study|Lost to Follow-up|0|||
130764237|NCT04068688|470760008|FG003|Overall Study|Lost to Follow-up|0|||
130764238|NCT04068688|470760009|FG004|Overall Study|Lost to Follow-up|5|||
130764239|NCT04068688|470760010|FG005|Overall Study|Lost to Follow-up|5|||
130764240|NCT04068688|470760011|FG006|Overall Study|Lost to Follow-up|0|||
130764241|NCT04068688|470760012|FG007|Overall Study|Lost to Follow-up|0|||
130764242|NCT04068688|470760013|FG008|Overall Study|Lost to Follow-up|1|||
130764243|NCT04068688|470760014|FG009|Overall Study|Lost to Follow-up|0|||
130764244|NCT04068688|470760005|FG000|Overall Study|Withdrawal by Subject|1|||
130764245|NCT04068688|470760006|FG001|Overall Study|Withdrawal by Subject|1|||
130764246|NCT04068688|470760007|FG002|Overall Study|Withdrawal by Subject|0|||
130764247|NCT04068688|470760008|FG003|Overall Study|Withdrawal by Subject|0|||
130764248|NCT04068688|470760009|FG004|Overall Study|Withdrawal by Subject|0|||
130764249|NCT04068688|470760010|FG005|Overall Study|Withdrawal by Subject|0|||
130764250|NCT04068688|470760011|FG006|Overall Study|Withdrawal by Subject|0|||
130764251|NCT04068688|470760012|FG007|Overall Study|Withdrawal by Subject|0|||
130764252|NCT04068688|470760013|FG008|Overall Study|Withdrawal by Subject|0|||
130764253|NCT04068688|470760014|FG009|Overall Study|Withdrawal by Subject|0|||
130764254|NCT04068688|470760005|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
130764255|NCT04068688|470760006|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
130764256|NCT04068688|470760007|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130764257|NCT04068688|470760008|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130764258|NCT04068688|470760009|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130764259|NCT04068688|470760010|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130764260|NCT04068688|470760011|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130764261|NCT04068688|470760012|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130877344|NCT01446159|471183632|FG000|Overall Study|Withdrawal by Subject|1|||
130877345|NCT01446159|471183633|FG001|Overall Study|Withdrawal by Subject|0|||
130877346|NCT01446159|471183634|FG002|Overall Study|Withdrawal by Subject|14|||
130877347|NCT01446159|471183635|FG003|Overall Study|Withdrawal by Subject|11|||
130877348|NCT01446159|471183632|FG000|Overall Study|Lost to Follow-up|0|||
130877349|NCT01446159|471183633|FG001|Overall Study|Lost to Follow-up|0|||
130877350|NCT01446159|471183634|FG002|Overall Study|Lost to Follow-up|1|||
130877351|NCT01446159|471183635|FG003|Overall Study|Lost to Follow-up|2|||
130877352|NCT01446159|471183632|FG000|Overall Study|Death|2|||
130877353|NCT01446159|471183633|FG001|Overall Study|Death|3|||
130877354|NCT01446159|471183634|FG002|Overall Study|Death|43|||
130877355|NCT01446159|471183635|FG003|Overall Study|Death|36|||
130877356|NCT01446159|471183632|FG000|Overall Study|Other|0|||
130877357|NCT01446159|471183633|FG001|Overall Study|Other|0|||
130877358|NCT01446159|471183634|FG002|Overall Study|Other|13|||
130877359|NCT01446159|471183635|FG003|Overall Study|Other|13|||
130877360|NCT00537394|471183636|FG000|First Year of Follow-up|Death|7|||
130877361|NCT00537394|471183637|FG001|First Year of Follow-up|Death|0|||
130877362|NCT00537394|471183638|FG002|First Year of Follow-up|Death|0|||
130877363|NCT00537394|471183636|FG000|First Year of Follow-up|Severe debilitation|1|||
130877364|NCT00537394|471183637|FG001|First Year of Follow-up|Severe debilitation|0|||
130877365|NCT00537394|471183638|FG002|First Year of Follow-up|Severe debilitation|1|||
130877366|NCT00537394|471183636|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
130877367|NCT00537394|471183637|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
130877368|NCT00537394|471183638|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
130877369|NCT00537394|471183636|FG000|First Year of Follow-up|Lost to Follow-up|1|||
130877370|NCT00537394|471183637|FG001|First Year of Follow-up|Lost to Follow-up|5|||
130877371|NCT00537394|471183638|FG002|First Year of Follow-up|Lost to Follow-up|1|||
130877372|NCT00537394|471183636|FG000|2nd Year of Follow-up|Death|4|||
130877373|NCT00537394|471183637|FG001|2nd Year of Follow-up|Death|1|||
130877374|NCT00537394|471183638|FG002|2nd Year of Follow-up|Death|2|||
130877375|NCT00537394|471183636|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
130877376|NCT00537394|471183637|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
130877377|NCT00537394|471183638|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
130877378|NCT00537394|471183636|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
130877379|NCT00537394|471183637|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
130877380|NCT00537394|471183638|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
130877381|NCT00537394|471183636|FG000|2nd Year of Follow-up|Clinic site closure|1|||
130877382|NCT00537394|471183637|FG001|2nd Year of Follow-up|Clinic site closure|0|||
130877383|NCT00537394|471183638|FG002|2nd Year of Follow-up|Clinic site closure|0|||
130877384|NCT00685165|471183640|FG000|Washout Period of 14 Days|Adverse Event|1|||
130877385|NCT00685165|471183641|FG001|Washout Period of 14 Days|Adverse Event|0|||
130877386|NCT00795535|471183649|FG000|Overall Study|incomplete data and technical problems|20|||
130877387|NCT00556075|471183650|FG000|Overall Study|Lost to Follow-up|3|||
130877388|NCT00556075|471183651|FG001|Overall Study|Lost to Follow-up|0|||
130877389|NCT00556075|471183652|FG002|Overall Study|Lost to Follow-up|3|||
130877390|NCT00556075|471183650|FG000|Overall Study|Withdrawal by Subject|3|||
130877391|NCT00556075|471183651|FG001|Overall Study|Withdrawal by Subject|3|||
130877392|NCT00556075|471183652|FG002|Overall Study|Withdrawal by Subject|0|||
130877393|NCT00556075|471183650|FG000|Overall Study|Protocol Violation|1|||
130877394|NCT00556075|471183651|FG001|Overall Study|Protocol Violation|1|||
130877395|NCT00556075|471183652|FG002|Overall Study|Protocol Violation|3|||
130877396|NCT00556075|471183650|FG000|Overall Study|Not eligible|1|||
130877397|NCT00556075|471183651|FG001|Overall Study|Not eligible|1|||
130877398|NCT00556075|471183652|FG002|Overall Study|Not eligible|2|||
130877399|NCT00556075|471183650|FG000|Overall Study|Adverse Event|1|||
130877400|NCT00556075|471183651|FG001|Overall Study|Adverse Event|2|||
130877401|NCT00556075|471183652|FG002|Overall Study|Adverse Event|0|||
130877402|NCT00556075|471183650|FG000|Overall Study|Personal issues|4|||
130877403|NCT00556075|471183651|FG001|Overall Study|Personal issues|1|||
130877404|NCT00556075|471183652|FG002|Overall Study|Personal issues|0|||
130877405|NCT00556075|471183650|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
130877406|NCT00556075|471183651|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
130877407|NCT00556075|471183652|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
130877408|NCT02485691|471183653|FG000|Overall Study|Adverse Event|25|||
130877409|NCT02485691|471183654|FG001|Overall Study|Adverse Event|11|||
130877410|NCT02485691|471183653|FG000|Overall Study|Poor compliance to protocol|0|||
130877411|NCT02485691|471183654|FG001|Overall Study|Poor compliance to protocol|1|||
130877412|NCT02485691|471183653|FG000|Overall Study|Disease progression|57|||
130877413|NCT02485691|471183654|FG001|Overall Study|Disease progression|92|||
130877414|NCT02485691|471183653|FG000|Overall Study|Investigator's decision|23|||
130877415|NCT02485691|471183654|FG001|Overall Study|Investigator's decision|5|||
130877416|NCT02485691|471183653|FG000|Overall Study|Participant's request|13|||
130877417|NCT02485691|471183654|FG001|Overall Study|Participant's request|6|||
130877418|NCT02485691|471183653|FG000|Overall Study|Other reason|8|||
130877419|NCT02485691|471183654|FG001|Overall Study|Other reason|9|||
130877420|NCT02485691|471183653|FG000|Overall Study|Randomized and not treated|3|||
130877421|NCT02485691|471183654|FG001|Overall Study|Randomized and not treated|2|||
130877422|NCT01420861|471183655|FG000|Overall Study|Adverse Event|2|||
130877423|NCT01420861|471183655|FG000|Overall Study|Study terminated by Sponsor|7|||
130877424|NCT01420861|471183655|FG000|Overall Study|Screen failure|7|||
130877425|NCT01420861|471183655|FG000|Overall Study|Randomized not Treated|2|||
130877426|NCT04764162|471183656|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
130877427|NCT04764162|471183657|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
130877428|NCT03361137|471183658|FG000|Overall Study|Reason not specified|1|||
130877429|NCT03361137|471183659|FG001|Overall Study|Reason not specified|0|||
130877430|NCT03361137|471183660|FG002|Overall Study|Reason not specified|0|||
130877431|NCT03361137|471183661|FG003|Overall Study|Reason not specified|0|||
130877432|NCT03361137|471183662|FG004|Overall Study|Reason not specified|0|||
130877433|NCT03413891|471183663|FG000|Overall Study|Lost to Follow-up|2|||
130877434|NCT03413891|471183664|FG001|Overall Study|Lost to Follow-up|1|||
130877435|NCT03413891|471183663|FG000|Overall Study|Protocol Violation|0|||
130877436|NCT03413891|471183664|FG001|Overall Study|Protocol Violation|1|||
130877437|NCT04905134|471183667|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
130877438|NCT04905134|471183667|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
130877439|NCT03009058|471183668|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
130877440|NCT05556265|471183669|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130877441|NCT05556265|471183670|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
130877442|NCT05556265|471183671|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130877443|NCT05556265|471183672|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130877444|NCT05556265|471183673|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130877445|NCT05556265|471183669|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130877446|NCT05556265|471183670|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
130877447|NCT05556265|471183671|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130877448|NCT05556265|471183672|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130877449|NCT05556265|471183673|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130877450|NCT05556265|471183669|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130877451|NCT05556265|471183670|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
130877452|NCT05556265|471183671|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130877453|NCT05556265|471183672|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130877454|NCT05556265|471183673|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130877455|NCT05556265|471183669|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
130877456|NCT05556265|471183670|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
130877457|NCT05556265|471183671|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
130877458|NCT05556265|471183672|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
130877459|NCT05556265|471183673|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
130877460|NCT05556265|471183669|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
130877461|NCT05556265|471183670|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
130877462|NCT05556265|471183671|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
130877463|NCT05556265|471183672|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
130877464|NCT05556265|471183673|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
130877465|NCT05556265|471183669|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
130877466|NCT05556265|471183670|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
130877467|NCT05556265|471183671|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
130877468|NCT05556265|471183672|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
130877469|NCT05556265|471183673|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
130877470|NCT05556265|471183669|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
130877471|NCT05556265|471183670|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
130877472|NCT05556265|471183671|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
130877473|NCT05556265|471183672|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
130877474|NCT05556265|471183673|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
130877475|NCT05556265|471183669|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
130877476|NCT05556265|471183670|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
130877477|NCT05556265|471183671|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
130877478|NCT05556265|471183672|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
130877479|NCT05556265|471183673|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
130877480|NCT05556265|471183669|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
130877481|NCT05556265|471183670|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
130877482|NCT05556265|471183671|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
130877483|NCT05556265|471183672|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
130877484|NCT05556265|471183673|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
130988366|NCT02228395|471585374|FG002|First Intervention Period|No longer willing to participate|0|||
130877485|NCT01486966|471183676|FG000|Overall Study|Adverse Event|0|||
130877486|NCT01486966|471183677|FG001|Overall Study|Adverse Event|1|||
130877487|NCT01486966|471183676|FG000|Overall Study|Withdrawal by Subject|0|||
130877488|NCT01486966|471183677|FG001|Overall Study|Withdrawal by Subject|1|||
130877489|NCT04972786|471183678|FG000|First Intervention (1 Day)|Adverse Event|1|||
130877490|NCT04972786|471183679|FG001|First Intervention (1 Day)|Adverse Event|0|||
130877491|NCT00844844|471183680|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
130877492|NCT00844844|471183680|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
130877493|NCT00844844|471183680|FG000|Extension Treatment Period|Adverse Event|2|||
130877494|NCT00844844|471183680|FG000|Post Treatment Period|Withdrawal by Subject|1|||
130877495|NCT03905096|471183681|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
130877496|NCT03905096|471183682|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
130877497|NCT02016781|471183684|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
130877498|NCT02016781|471183685|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
130877499|NCT02016781|471183684|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
130877500|NCT02016781|471183685|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
130877501|NCT02016781|471183684|FG000|Final Database Lock|Withdrawal by Subject|2|||
130877502|NCT02016781|471183685|FG001|Final Database Lock|Withdrawal by Subject|1|||
130877503|NCT02016781|471183684|FG000|Final Database Lock|Lost to Follow-up|11|||
130877504|NCT02016781|471183685|FG001|Final Database Lock|Lost to Follow-up|4|||
130877505|NCT02016781|471183684|FG000|Final Database Lock|Missing data|0|||
130877506|NCT02016781|471183685|FG001|Final Database Lock|Missing data|3|||
130877507|NCT04886154|471183686|FG000|Overall Study|Adverse Event|0|||
130877508|NCT04886154|471183687|FG001|Overall Study|Adverse Event|0|||
130877509|NCT04886154|471183688|FG002|Overall Study|Adverse Event|0|||
130877510|NCT04886154|471183689|FG003|Overall Study|Adverse Event|0|||
130877511|NCT04886154|471183690|FG004|Overall Study|Adverse Event|1|||
130877512|NCT04886154|471183691|FG005|Overall Study|Adverse Event|0|||
130877513|NCT04886154|471183692|FG006|Overall Study|Adverse Event|0|||
130877514|NCT04886154|471183693|FG007|Overall Study|Adverse Event|1|||
130877515|NCT04886154|471183694|FG008|Overall Study|Adverse Event|1|||
130877516|NCT04886154|471183695|FG009|Overall Study|Adverse Event|0|||
130877517|NCT04886154|471183696|FG010|Overall Study|Adverse Event|0|||
130877518|NCT04886154|471183697|FG011|Overall Study|Adverse Event|1|||
130877519|NCT04886154|471183698|FG012|Overall Study|Adverse Event|0|||
130877520|NCT04886154|471183699|FG013|Overall Study|Adverse Event|0|||
130877521|NCT04886154|471183700|FG014|Overall Study|Adverse Event|3|||
130877522|NCT04886154|471183686|FG000|Overall Study|Lost to Follow-up|1|||
130877523|NCT04886154|471183687|FG001|Overall Study|Lost to Follow-up|0|||
130877524|NCT04886154|471183688|FG002|Overall Study|Lost to Follow-up|2|||
130877525|NCT04886154|471183689|FG003|Overall Study|Lost to Follow-up|0|||
130877526|NCT04886154|471183690|FG004|Overall Study|Lost to Follow-up|17|||
130877527|NCT04886154|471183691|FG005|Overall Study|Lost to Follow-up|7|||
130877528|NCT04886154|471183692|FG006|Overall Study|Lost to Follow-up|8|||
130877529|NCT04886154|471183693|FG007|Overall Study|Lost to Follow-up|7|||
130877530|NCT04886154|471183694|FG008|Overall Study|Lost to Follow-up|8|||
130877531|NCT04886154|471183695|FG009|Overall Study|Lost to Follow-up|0|||
130877532|NCT04886154|471183696|FG010|Overall Study|Lost to Follow-up|2|||
130877533|NCT04886154|471183697|FG011|Overall Study|Lost to Follow-up|0|||
130877534|NCT04886154|471183698|FG012|Overall Study|Lost to Follow-up|0|||
130877535|NCT04886154|471183699|FG013|Overall Study|Lost to Follow-up|0|||
130877536|NCT04886154|471183700|FG014|Overall Study|Lost to Follow-up|0|||
130877537|NCT04886154|471183686|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877538|NCT04886154|471183687|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877539|NCT04886154|471183688|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877540|NCT04886154|471183689|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877541|NCT04886154|471183690|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877542|NCT04886154|471183691|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877543|NCT04886154|471183692|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
130877544|NCT04886154|471183693|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877545|NCT04886154|471183694|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877546|NCT04886154|471183695|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877547|NCT04886154|471183696|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877548|NCT04886154|471183697|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877549|NCT04886154|471183698|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877550|NCT04886154|471183699|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877551|NCT04886154|471183700|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130877552|NCT04886154|471183686|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877553|NCT04886154|471183687|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877554|NCT04886154|471183688|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877555|NCT04886154|471183689|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877556|NCT04886154|471183690|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130877557|NCT04886154|471183691|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877558|NCT04886154|471183692|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130877559|NCT04886154|471183693|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130877560|NCT04886154|471183694|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877561|NCT04886154|471183695|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877562|NCT04886154|471183696|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877563|NCT04886154|471183697|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877564|NCT04886154|471183698|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877565|NCT04886154|471183699|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130877566|NCT04886154|471183700|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130877567|NCT04886154|471183686|FG000|Overall Study|Other, Not Specified|0|||
130877568|NCT04886154|471183687|FG001|Overall Study|Other, Not Specified|0|||
130877569|NCT04886154|471183688|FG002|Overall Study|Other, Not Specified|0|||
130877570|NCT04886154|471183689|FG003|Overall Study|Other, Not Specified|0|||
130877571|NCT04886154|471183690|FG004|Overall Study|Other, Not Specified|11|||
130877572|NCT04886154|471183691|FG005|Overall Study|Other, Not Specified|8|||
130877573|NCT04886154|471183692|FG006|Overall Study|Other, Not Specified|9|||
130877574|NCT04886154|471183693|FG007|Overall Study|Other, Not Specified|10|||
130877575|NCT04886154|471183694|FG008|Overall Study|Other, Not Specified|6|||
130877576|NCT04886154|471183695|FG009|Overall Study|Other, Not Specified|1|||
130877577|NCT04886154|471183696|FG010|Overall Study|Other, Not Specified|1|||
130877578|NCT04886154|471183697|FG011|Overall Study|Other, Not Specified|2|||
130877579|NCT04886154|471183698|FG012|Overall Study|Other, Not Specified|1|||
130877580|NCT04886154|471183699|FG013|Overall Study|Other, Not Specified|2|||
130877581|NCT04886154|471183700|FG014|Overall Study|Other, Not Specified|3|||
130877582|NCT02336282|471183715|FG000|Overall Study|Unrelated illness|1|||
130877583|NCT02336282|471183715|FG000|Overall Study|Uncomfortable with technology|1|||
130877584|NCT02336282|471183715|FG000|Overall Study|Lost to Follow-up|1|||
130877585|NCT02336282|471183715|FG000|Overall Study|Not enough time to complete sessions|2|||
130877586|NCT03724942|471183730|FG000|Overall Study|Adverse Event|20|||
130877587|NCT03724942|471183731|FG001|Overall Study|Adverse Event|14|||
130877588|NCT03724942|471183730|FG000|Overall Study|Lack of Efficacy|0|||
130877589|NCT03724942|471183731|FG001|Overall Study|Lack of Efficacy|1|||
130877590|NCT03724942|471183730|FG000|Overall Study|Physician Decision|5|||
130877591|NCT03724942|471183731|FG001|Overall Study|Physician Decision|2|||
130877592|NCT03724942|471183730|FG000|Overall Study|Protocol Violation|1|||
130877593|NCT03724942|471183731|FG001|Overall Study|Protocol Violation|0|||
130877594|NCT03724942|471183730|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
130877595|NCT03724942|471183731|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
130877596|NCT03724942|471183730|FG000|Overall Study|Withdrawal by Legal Representative|3|||
130877597|NCT03724942|471183731|FG001|Overall Study|Withdrawal by Legal Representative|0|||
130877598|NCT00668148|471183732|FG000|Overall Study|Adverse Event|5|||
130877599|NCT00668148|471183732|FG000|Overall Study|Subject Non-compliance|1|||
130877600|NCT00668148|471183732|FG000|Overall Study|Progressive Disease Before Treatment|2|||
130877601|NCT00668148|471183732|FG000|Overall Study|Withdrawal of Consent|2|||
130877602|NCT04875975|471183735|FG000|Overall Study|Adverse Event|1|||
130877603|NCT04875975|471183736|FG001|Overall Study|Adverse Event|2|||
130877604|NCT04875975|471183735|FG000|Overall Study|Lack of Efficacy|2|||
130877605|NCT04875975|471183736|FG001|Overall Study|Lack of Efficacy|2|||
130877606|NCT04875975|471183735|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
130877607|NCT04875975|471183736|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
130877608|NCT04875975|471183735|FG000|Overall Study|Relapse With Insults|0|||
130877609|NCT04875975|471183736|FG001|Overall Study|Relapse With Insults|1|||
130877610|NCT04875975|471183735|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
130877611|NCT04875975|471183736|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
130877612|NCT05472090|471183737|FG000|Overall Study|Adverse Event|2|||
130877613|NCT05472090|471183738|FG001|Overall Study|Adverse Event|3|||
130877614|NCT05472090|471183737|FG000|Overall Study|Lack of Efficacy|1|||
130877615|NCT05472090|471183738|FG001|Overall Study|Lack of Efficacy|0|||
130877616|NCT05472090|471183737|FG000|Overall Study|Physician Decision|1|||
130988367|NCT02228395|471585372|FG000|First Intervention Period|Unable to comply with study dates|0|||
130988368|NCT02228395|471585373|FG001|First Intervention Period|Unable to comply with study dates|1|||
130988369|NCT02228395|471585374|FG002|First Intervention Period|Unable to comply with study dates|1|||
130988370|NCT02569437|471585377|FG000|Overall Study|Lost to Follow-up|12|||
130988371|NCT02569437|471585378|FG001|Overall Study|Lost to Follow-up|14|||
130988372|NCT00985985|471585382|FG000|Overall Study|Adverse Event|4|||
130988373|NCT00985985|471585383|FG001|Overall Study|Adverse Event|2|||
130877617|NCT05472090|471183738|FG001|Overall Study|Physician Decision|0|||
130877618|NCT05472090|471183737|FG000|Overall Study|Withdrawal by Subject|2|||
130877619|NCT05472090|471183738|FG001|Overall Study|Withdrawal by Subject|0|||
130877620|NCT05472090|471183737|FG000|Overall Study|Lost to Follow-up|0|||
130877621|NCT05472090|471183738|FG001|Overall Study|Lost to Follow-up|3|||
130877622|NCT01350999|471183740|FG000|Overall Study|Adverse Event|4|||
130877623|NCT01350999|471183741|FG001|Overall Study|Adverse Event|9|||
130877624|NCT01350999|471183742|FG002|Overall Study|Adverse Event|10|||
130988374|NCT00985985|471585384|FG002|Overall Study|Adverse Event|2|||
130988375|NCT00985985|471585385|FG003|Overall Study|Adverse Event|2|||
130988376|NCT00985985|471585382|FG000|Overall Study|Lost to Follow-up|4|||
130988377|NCT00985985|471585383|FG001|Overall Study|Lost to Follow-up|11|||
130988378|NCT00985985|471585384|FG002|Overall Study|Lost to Follow-up|2|||
130988379|NCT00985985|471585385|FG003|Overall Study|Lost to Follow-up|3|||
130988380|NCT00985985|471585382|FG000|Overall Study|Protocol Violation|1|||
130988381|NCT00985985|471585383|FG001|Overall Study|Protocol Violation|2|||
130988382|NCT00985985|471585384|FG002|Overall Study|Protocol Violation|0|||
130988383|NCT00985985|471585385|FG003|Overall Study|Protocol Violation|1|||
130988384|NCT00985985|471585382|FG000|Overall Study|Lack of Efficacy|5|||
130988385|NCT00985985|471585383|FG001|Overall Study|Lack of Efficacy|6|||
130988386|NCT00985985|471585384|FG002|Overall Study|Lack of Efficacy|1|||
130988387|NCT00985985|471585385|FG003|Overall Study|Lack of Efficacy|3|||
130988388|NCT00985985|471585382|FG000|Overall Study|Withdrawal by Subject|4|||
130988389|NCT00985985|471585383|FG001|Overall Study|Withdrawal by Subject|2|||
130988390|NCT00985985|471585384|FG002|Overall Study|Withdrawal by Subject|2|||
130988391|NCT00985985|471585385|FG003|Overall Study|Withdrawal by Subject|2|||
130988392|NCT00985985|471585382|FG000|Overall Study|Other Reason|6|||
130988393|NCT00985985|471585383|FG001|Overall Study|Other Reason|1|||
130988394|NCT00985985|471585384|FG002|Overall Study|Other Reason|4|||
130988395|NCT00985985|471585385|FG003|Overall Study|Other Reason|2|||
130988396|NCT02255357|471585388|FG000|Overall Study|Physician Decision|10|||
130988397|NCT02255357|471585389|FG001|Overall Study|Physician Decision|24|||
130988398|NCT00509236|471585390|FG000|Overall Study|Adverse Event|7|||
130988399|NCT00509236|471585391|FG001|Overall Study|Adverse Event|9|||
130988400|NCT00509236|471585390|FG000|Overall Study|Withdrawal by Subject|5|||
130988401|NCT00509236|471585391|FG001|Overall Study|Withdrawal by Subject|10|||
130988402|NCT00509236|471585390|FG000|Overall Study|Protocol Violation|3|||
130988403|NCT00509236|471585391|FG001|Overall Study|Protocol Violation|0|||
130988404|NCT00509236|471585390|FG000|Overall Study|Excluded Medication|1|||
130988405|NCT00509236|471585391|FG001|Overall Study|Excluded Medication|1|||
130988406|NCT00509236|471585390|FG000|Overall Study|Scheduled Kidney Transplant|1|||
130988407|NCT00509236|471585391|FG001|Overall Study|Scheduled Kidney Transplant|0|||
130988408|NCT00927355|471585392|FG000|Overall Study|Adverse Event|1|||
130988409|NCT00927355|471585393|FG001|Overall Study|Adverse Event|1|||
130988410|NCT00792103|471585394|FG000|Overall Study|Enrolled, not treated|15|||
130988411|NCT00792103|471585394|FG000|Overall Study|Lost to Follow-up|17|||
130988412|NCT00792103|471585394|FG000|Overall Study|Adverse Event|25|||
130988413|NCT00792103|471585394|FG000|Overall Study|Withdrawal by Subject|52|||
130988414|NCT00792103|471585394|FG000|Overall Study|Protocol Violation|10|||
130988415|NCT00792103|471585394|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
130988416|NCT01572389|471585396|FG000|Overall Study|Death|1|||
130988417|NCT01572389|471585397|FG001|Overall Study|Death|3|||
130988418|NCT01572389|471585396|FG000|Overall Study|Withdrawal by Subject|14|||
130988419|NCT01572389|471585397|FG001|Overall Study|Withdrawal by Subject|2|||
130988420|NCT01572389|471585396|FG000|Overall Study|Lost to Follow-up|25|||
130988421|NCT01572389|471585397|FG001|Overall Study|Lost to Follow-up|14|||
130988422|NCT01572389|471585396|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
130988423|NCT01572389|471585397|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
130988424|NCT01287520|471585398|FG000|Overall Study|Adverse Event|2|||
130988425|NCT01287520|471585399|FG001|Overall Study|Adverse Event|2|||
130988426|NCT01287520|471585400|FG002|Overall Study|Adverse Event|2|||
130988427|NCT01287520|471585401|FG003|Overall Study|Adverse Event|1|||
130988428|NCT01287520|471585402|FG004|Overall Study|Adverse Event|1|||
130988429|NCT01287520|471585403|FG005|Overall Study|Adverse Event|2|||
130988430|NCT01287520|471585404|FG006|Overall Study|Adverse Event|0|||
130988431|NCT01287520|471585405|FG007|Overall Study|Adverse Event|2|||
130988432|NCT01287520|471585406|FG008|Overall Study|Adverse Event|0|||
130988433|NCT01287520|471585398|FG000|Overall Study|Physician Decision|1|||
130988434|NCT01287520|471585399|FG001|Overall Study|Physician Decision|1|||
130988435|NCT01287520|471585400|FG002|Overall Study|Physician Decision|2|||
130988436|NCT01287520|471585401|FG003|Overall Study|Physician Decision|0|||
130988437|NCT01287520|471585402|FG004|Overall Study|Physician Decision|1|||
130988438|NCT01287520|471585403|FG005|Overall Study|Physician Decision|1|||
130988439|NCT01287520|471585404|FG006|Overall Study|Physician Decision|0|||
130988440|NCT01287520|471585405|FG007|Overall Study|Physician Decision|1|||
130988441|NCT01287520|471585406|FG008|Overall Study|Physician Decision|0|||
130988442|NCT01287520|471585398|FG000|Overall Study|Progressive disease|0|||
130988443|NCT01287520|471585399|FG001|Overall Study|Progressive disease|4|||
130988444|NCT01287520|471585400|FG002|Overall Study|Progressive disease|1|||
130764262|NCT04068688|470760013|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130988445|NCT01287520|471585401|FG003|Overall Study|Progressive disease|6|||
130988446|NCT01287520|471585402|FG004|Overall Study|Progressive disease|1|||
130988447|NCT01287520|471585403|FG005|Overall Study|Progressive disease|0|||
130988448|NCT01287520|471585404|FG006|Overall Study|Progressive disease|2|||
130988449|NCT01287520|471585405|FG007|Overall Study|Progressive disease|2|||
130988450|NCT01287520|471585406|FG008|Overall Study|Progressive disease|4|||
130988451|NCT01287520|471585398|FG000|Overall Study|Withdrawal by Subject|0|||
130877625|NCT01350999|471183740|FG000|Overall Study|Voluntary withdrawal|3|||
130877626|NCT01350999|471183741|FG001|Overall Study|Voluntary withdrawal|4|||
130877627|NCT01350999|471183742|FG002|Overall Study|Voluntary withdrawal|6|||
130877628|NCT01350999|471183740|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
130877629|NCT01350999|471183741|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
130877630|NCT01350999|471183742|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
130877631|NCT01766050|471185775|FG000|Overall Study|Adverse Event|1|||
130877632|NCT01766050|471185775|FG000|Overall Study|Lost to Follow-up|1|||
130877633|NCT01766050|471185775|FG000|Overall Study|Withdrawal by Subject|2|||
130877634|NCT00089297|471185777|FG000|Overall Study|Adverse Event|9|||
130877635|NCT00089297|471185777|FG000|Overall Study|Death|1|||
130877636|NCT00089297|471185777|FG000|Overall Study|Withdrawal by Subject|12|||
130877637|NCT00089297|471185777|FG000|Overall Study|Disease progression|2|||
130877638|NCT00089297|471185777|FG000|Overall Study|Ineligible|11|||
130877639|NCT00089297|471185777|FG000|Overall Study|Secondary malignancy|1|||
130877640|NCT00089297|471185777|FG000|Overall Study|IRB approval not ready|1|||
130877641|NCT00089297|471185777|FG000|Overall Study|Non-compliance|1|||
130877642|NCT01910298|471185780|FG000|Overall Study|Adverse Event|1|||
130877643|NCT01910298|471185781|FG001|Overall Study|Adverse Event|0|||
130877644|NCT01910298|471185780|FG000|Overall Study|Withdrawal by Subject|2|||
130877645|NCT01910298|471185781|FG001|Overall Study|Withdrawal by Subject|7|||
130877646|NCT01910298|471185780|FG000|Overall Study|Protocol Deviation|0|||
130877647|NCT01910298|471185781|FG001|Overall Study|Protocol Deviation|5|||
130877648|NCT01910298|471185780|FG000|Overall Study|Lost to Follow-up|1|||
130877649|NCT01910298|471185781|FG001|Overall Study|Lost to Follow-up|1|||
130877650|NCT01910298|471185780|FG000|Overall Study|Study Terminated by Sponsor|1|||
130877651|NCT01910298|471185781|FG001|Overall Study|Study Terminated by Sponsor|17|||
130877652|NCT01910298|471185780|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130877653|NCT01910298|471185781|FG001|Overall Study|Other Miscellaneous Reasons|2|||
130877654|NCT03037385|471185784|FG000|Overall Study|Adverse Event|0|||
130877655|NCT03037385|471185785|FG001|Overall Study|Adverse Event|0|||
130877656|NCT03037385|471185786|FG002|Overall Study|Adverse Event|1|||
130877657|NCT03037385|471185787|FG003|Overall Study|Adverse Event|0|||
130877658|NCT03037385|471185788|FG004|Overall Study|Adverse Event|0|||
130877659|NCT03037385|471185789|FG005|Overall Study|Adverse Event|0|||
130877660|NCT03037385|471185790|FG006|Overall Study|Adverse Event|0|||
130877661|NCT03037385|471185791|FG007|Overall Study|Adverse Event|0|||
130877662|NCT03037385|471185792|FG008|Overall Study|Adverse Event|0|||
130877663|NCT03037385|471185793|FG009|Overall Study|Adverse Event|6|||
130877664|NCT03037385|471185784|FG000|Overall Study|Death|1|||
130877665|NCT03037385|471185785|FG001|Overall Study|Death|4|||
130877666|NCT03037385|471185786|FG002|Overall Study|Death|2|||
130877667|NCT03037385|471185787|FG003|Overall Study|Death|2|||
130877668|NCT03037385|471185788|FG004|Overall Study|Death|5|||
130877669|NCT03037385|471185789|FG005|Overall Study|Death|2|||
130877670|NCT03037385|471185790|FG006|Overall Study|Death|1|||
130877671|NCT03037385|471185791|FG007|Overall Study|Death|4|||
130877672|NCT03037385|471185792|FG008|Overall Study|Death|3|||
130877673|NCT03037385|471185793|FG009|Overall Study|Death|240|||
130877674|NCT03037385|471185784|FG000|Overall Study|Initiation of Another Therapy|1|||
130877675|NCT03037385|471185785|FG001|Overall Study|Initiation of Another Therapy|0|||
130877676|NCT03037385|471185786|FG002|Overall Study|Initiation of Another Therapy|0|||
130877677|NCT03037385|471185787|FG003|Overall Study|Initiation of Another Therapy|0|||
130877678|NCT03037385|471185788|FG004|Overall Study|Initiation of Another Therapy|0|||
130877679|NCT03037385|471185789|FG005|Overall Study|Initiation of Another Therapy|0|||
130877680|NCT03037385|471185790|FG006|Overall Study|Initiation of Another Therapy|0|||
130877681|NCT03037385|471185791|FG007|Overall Study|Initiation of Another Therapy|1|||
130877682|NCT03037385|471185792|FG008|Overall Study|Initiation of Another Therapy|0|||
130877683|NCT03037385|471185793|FG009|Overall Study|Initiation of Another Therapy|2|||
130877684|NCT03037385|471185784|FG000|Overall Study|Lost to Follow-up|0|||
130877685|NCT03037385|471185785|FG001|Overall Study|Lost to Follow-up|0|||
130877686|NCT03037385|471185786|FG002|Overall Study|Lost to Follow-up|0|||
130877687|NCT03037385|471185787|FG003|Overall Study|Lost to Follow-up|0|||
130877688|NCT03037385|471185788|FG004|Overall Study|Lost to Follow-up|0|||
130877689|NCT03037385|471185789|FG005|Overall Study|Lost to Follow-up|1|||
130877690|NCT03037385|471185790|FG006|Overall Study|Lost to Follow-up|0|||
130877691|NCT03037385|471185791|FG007|Overall Study|Lost to Follow-up|0|||
130877692|NCT03037385|471185792|FG008|Overall Study|Lost to Follow-up|0|||
130877693|NCT03037385|471185793|FG009|Overall Study|Lost to Follow-up|16|||
130877694|NCT03037385|471185784|FG000|Overall Study|Physician Decision|0|||
130877695|NCT03037385|471185785|FG001|Overall Study|Physician Decision|0|||
130877696|NCT03037385|471185786|FG002|Overall Study|Physician Decision|0|||
130877697|NCT03037385|471185787|FG003|Overall Study|Physician Decision|0|||
130877698|NCT03037385|471185788|FG004|Overall Study|Physician Decision|0|||
130877699|NCT03037385|471185789|FG005|Overall Study|Physician Decision|0|||
130877700|NCT03037385|471185790|FG006|Overall Study|Physician Decision|0|||
130877701|NCT03037385|471185791|FG007|Overall Study|Physician Decision|0|||
130877702|NCT03037385|471185792|FG008|Overall Study|Physician Decision|0|||
130877703|NCT03037385|471185793|FG009|Overall Study|Physician Decision|1|||
130877704|NCT03037385|471185784|FG000|Overall Study|Progressive Disease|0|||
130877705|NCT03037385|471185785|FG001|Overall Study|Progressive Disease|1|||
130877706|NCT03037385|471185786|FG002|Overall Study|Progressive Disease|1|||
130877707|NCT03037385|471185787|FG003|Overall Study|Progressive Disease|5|||
130877708|NCT03037385|471185788|FG004|Overall Study|Progressive Disease|2|||
130877709|NCT03037385|471185789|FG005|Overall Study|Progressive Disease|0|||
130877710|NCT03037385|471185790|FG006|Overall Study|Progressive Disease|1|||
130877711|NCT03037385|471185791|FG007|Overall Study|Progressive Disease|0|||
130877712|NCT03037385|471185792|FG008|Overall Study|Progressive Disease|0|||
130877713|NCT03037385|471185793|FG009|Overall Study|Progressive Disease|30|||
130877714|NCT03037385|471185784|FG000|Overall Study|Withdrawal by Subject|0|||
130877715|NCT03037385|471185785|FG001|Overall Study|Withdrawal by Subject|0|||
130877716|NCT03037385|471185786|FG002|Overall Study|Withdrawal by Subject|1|||
130877717|NCT03037385|471185787|FG003|Overall Study|Withdrawal by Subject|2|||
130877718|NCT03037385|471185788|FG004|Overall Study|Withdrawal by Subject|1|||
130877719|NCT03037385|471185789|FG005|Overall Study|Withdrawal by Subject|3|||
130877720|NCT03037385|471185790|FG006|Overall Study|Withdrawal by Subject|0|||
130877721|NCT03037385|471185791|FG007|Overall Study|Withdrawal by Subject|0|||
130877722|NCT03037385|471185792|FG008|Overall Study|Withdrawal by Subject|0|||
130877723|NCT03037385|471185793|FG009|Overall Study|Withdrawal by Subject|52|||
130877724|NCT03037385|471185784|FG000|Overall Study|Reason Not Specified|0|||
130877725|NCT03037385|471185785|FG001|Overall Study|Reason Not Specified|1|||
130877726|NCT03037385|471185786|FG002|Overall Study|Reason Not Specified|0|||
130877727|NCT03037385|471185787|FG003|Overall Study|Reason Not Specified|4|||
130877728|NCT03037385|471185788|FG004|Overall Study|Reason Not Specified|3|||
130877729|NCT03037385|471185789|FG005|Overall Study|Reason Not Specified|6|||
130877730|NCT03037385|471185790|FG006|Overall Study|Reason Not Specified|2|||
130877731|NCT03037385|471185791|FG007|Overall Study|Reason Not Specified|0|||
130877732|NCT03037385|471185792|FG008|Overall Study|Reason Not Specified|1|||
130877733|NCT03037385|471185793|FG009|Overall Study|Reason Not Specified|181|||
130877734|NCT04515771|471185798|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
130877735|NCT04515771|471185799|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
130877736|NCT04515771|471185798|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
130877737|NCT04515771|471185799|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
130877738|NCT04515771|471185798|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
130877739|NCT04515771|471185799|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
130877740|NCT01021020|471185800|FG000|Period I|Protocol Violation|1|||
130877741|NCT01021020|471185800|FG000|Period I|Withdrawal by Subject|1|||
130877742|NCT01021020|471185800|FG000|14 Day Washout Period A|Physician Decision|1|||
130877743|NCT00948246|471185803|FG000|Overall Study|Lost to Follow-up|11|||
130877744|NCT00948246|471185803|FG000|Overall Study|Adverse Event|11|||
130877745|NCT00948246|471185803|FG000|Overall Study|Death|1|||
130877746|NCT00948246|471185803|FG000|Overall Study|Withdrawal by Subject|1|||
130877747|NCT03598036|471185806|FG000|Overall Study|Withdrawal by Subject|1|||
130877748|NCT03598036|471185807|FG001|Overall Study|Withdrawal by Subject|0|||
130877749|NCT04199351|471185808|FG000|Overall Study|Decision by sponsor|0|||
130877750|NCT04199351|471185809|FG001|Overall Study|Decision by sponsor|0|||
130877751|NCT04199351|471185810|FG002|Overall Study|Decision by sponsor|0|||
130877752|NCT04199351|471185811|FG003|Overall Study|Decision by sponsor|2|||
130877753|NCT04199351|471185812|FG004|Overall Study|Decision by sponsor|0|||
130877754|NCT04199351|471185813|FG005|Overall Study|Decision by sponsor|0|||
130877755|NCT04199351|471185814|FG006|Overall Study|Decision by sponsor|0|||
130877756|NCT04199351|471185815|FG007|Overall Study|Decision by sponsor|0|||
130877757|NCT04199351|471185816|FG008|Overall Study|Decision by sponsor|0|||
130877758|NCT04199351|471185817|FG009|Overall Study|Decision by sponsor|6|||
130877759|NCT04199351|471185808|FG000|Overall Study|Lost to Follow-up|0|||
130877760|NCT04199351|471185809|FG001|Overall Study|Lost to Follow-up|0|||
130877761|NCT04199351|471185810|FG002|Overall Study|Lost to Follow-up|1|||
130877762|NCT04199351|471185811|FG003|Overall Study|Lost to Follow-up|0|||
130877763|NCT04199351|471185812|FG004|Overall Study|Lost to Follow-up|0|||
130877764|NCT04199351|471185813|FG005|Overall Study|Lost to Follow-up|1|||
130877765|NCT04199351|471185814|FG006|Overall Study|Lost to Follow-up|0|||
130877766|NCT04199351|471185815|FG007|Overall Study|Lost to Follow-up|0|||
130877767|NCT04199351|471185816|FG008|Overall Study|Lost to Follow-up|0|||
130877768|NCT04199351|471185817|FG009|Overall Study|Lost to Follow-up|0|||
130877769|NCT04199351|471185808|FG000|Overall Study|Withdrawal by Subject|0|||
130877770|NCT04199351|471185809|FG001|Overall Study|Withdrawal by Subject|1|||
130877771|NCT04199351|471185810|FG002|Overall Study|Withdrawal by Subject|0|||
130877772|NCT04199351|471185811|FG003|Overall Study|Withdrawal by Subject|0|||
130877773|NCT04199351|471185812|FG004|Overall Study|Withdrawal by Subject|1|||
130877774|NCT04199351|471185813|FG005|Overall Study|Withdrawal by Subject|4|||
130877775|NCT04199351|471185814|FG006|Overall Study|Withdrawal by Subject|2|||
130877776|NCT04199351|471185815|FG007|Overall Study|Withdrawal by Subject|0|||
130877777|NCT04199351|471185816|FG008|Overall Study|Withdrawal by Subject|3|||
130877778|NCT04199351|471185817|FG009|Overall Study|Withdrawal by Subject|0|||
130877779|NCT01838694|471185818|FG000|Overall Study|Adverse Event|0|||
130877780|NCT01838694|471185819|FG001|Overall Study|Adverse Event|1|||
130988452|NCT01287520|471585399|FG001|Overall Study|Withdrawal by Subject|0|||
130988453|NCT01287520|471585400|FG002|Overall Study|Withdrawal by Subject|0|||
130988454|NCT01287520|471585401|FG003|Overall Study|Withdrawal by Subject|0|||
130988455|NCT01287520|471585402|FG004|Overall Study|Withdrawal by Subject|0|||
130988456|NCT01287520|471585403|FG005|Overall Study|Withdrawal by Subject|1|||
130988457|NCT01287520|471585404|FG006|Overall Study|Withdrawal by Subject|0|||
130988458|NCT01287520|471585405|FG007|Overall Study|Withdrawal by Subject|0|||
130988459|NCT01287520|471585406|FG008|Overall Study|Withdrawal by Subject|1|||
130988460|NCT03587142|471585407|FG000|Overall Study|Lost to Follow-up|5|||
130988461|NCT03587142|471585408|FG001|Overall Study|Lost to Follow-up|3|||
130988462|NCT03587142|471585407|FG000|Overall Study|Did not complete the f4 visit|3|||
130988463|NCT03587142|471585408|FG001|Overall Study|Did not complete the f4 visit|7|||
130988464|NCT02768662|471585409|FG000|Overall Study|Adverse Event|1|||
130988465|NCT02768662|471585409|FG000|Overall Study|Lost to Follow-up|4|||
130988466|NCT02768662|471585409|FG000|Overall Study|Withdrawal by Subject|3|||
130988467|NCT02768662|471585409|FG000|Overall Study|Study terminated by Sponsor|78|||
130988468|NCT03673462|471585410|FG000|Overall Study|Adverse Event|11|||
130988469|NCT03673462|471585411|FG001|Overall Study|Adverse Event|1|||
130988470|NCT03673462|471585410|FG000|Overall Study|Protocol Violation|25|||
130988471|NCT03673462|471585411|FG001|Overall Study|Protocol Violation|11|||
130988472|NCT03673462|471585410|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
130988473|NCT03673462|471585411|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
130988474|NCT03673462|471585410|FG000|Overall Study|Lost to Follow-up|102|||
130988475|NCT03673462|471585411|FG001|Overall Study|Lost to Follow-up|19|||
130988476|NCT05061537|471585415|FG000|Treatment Phase|Progressive disease|0|||
130988477|NCT05061537|471585416|FG001|Treatment Phase|Progressive disease|1|||
130988478|NCT05061537|471585417|FG002|Treatment Phase|Progressive disease|2|||
130988479|NCT05061537|471585418|FG003|Treatment Phase|Progressive disease|0|||
130988480|NCT05061537|471585419|FG004|Treatment Phase|Progressive disease|0|||
130988481|NCT05061537|471585415|FG000|Treatment Phase|Adverse Event|0|||
130988482|NCT05061537|471585416|FG001|Treatment Phase|Adverse Event|0|||
130988483|NCT05061537|471585417|FG002|Treatment Phase|Adverse Event|2|||
130988484|NCT05061537|471585418|FG003|Treatment Phase|Adverse Event|0|||
130988485|NCT05061537|471585419|FG004|Treatment Phase|Adverse Event|0|||
130988486|NCT05061537|471585415|FG000|Treatment Phase|Global deterioration of health status|0|||
130988487|NCT05061537|471585416|FG001|Treatment Phase|Global deterioration of health status|1|||
130988488|NCT05061537|471585417|FG002|Treatment Phase|Global deterioration of health status|0|||
130988489|NCT05061537|471585418|FG003|Treatment Phase|Global deterioration of health status|0|||
130988490|NCT05061537|471585419|FG004|Treatment Phase|Global deterioration of health status|0|||
130988491|NCT05061537|471585415|FG000|Follow up|Other|2|||
130988492|NCT05061537|471585416|FG001|Follow up|Other|0|||
130988493|NCT05061537|471585417|FG002|Follow up|Other|2|||
130988494|NCT05061537|471585418|FG003|Follow up|Other|0|||
130988495|NCT05061537|471585419|FG004|Follow up|Other|0|||
130988496|NCT05061537|471585415|FG000|Follow up|Study terminated by sponsor|0|||
130988497|NCT05061537|471585416|FG001|Follow up|Study terminated by sponsor|0|||
130988498|NCT05061537|471585417|FG002|Follow up|Study terminated by sponsor|2|||
130988499|NCT05061537|471585418|FG003|Follow up|Study terminated by sponsor|0|||
130988500|NCT05061537|471585419|FG004|Follow up|Study terminated by sponsor|0|||
130988501|NCT05061537|471585415|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
130988502|NCT05061537|471585416|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
130988503|NCT05061537|471585417|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
130988504|NCT05061537|471585418|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
130988505|NCT05061537|471585419|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
130988506|NCT05061537|471585415|FG000|Long-term Follow-up|Death|0|||
130988507|NCT05061537|471585416|FG001|Long-term Follow-up|Death|1|||
130988508|NCT05061537|471585417|FG002|Long-term Follow-up|Death|0|||
130988509|NCT05061537|471585418|FG003|Long-term Follow-up|Death|0|||
130988510|NCT05061537|471585419|FG004|Long-term Follow-up|Death|0|||
130988511|NCT05807919|471585420|FG000|Overall Study|Received antibiotics - excluded|0|||
130988512|NCT05807919|471585421|FG001|Overall Study|Received antibiotics - excluded|1|||
130988513|NCT05807919|471585420|FG000|Overall Study|Withdrawal by Subject|0|||
130988514|NCT05807919|471585421|FG001|Overall Study|Withdrawal by Subject|3|||
130988515|NCT05807919|471585420|FG000|Overall Study|Adverse Event|1|||
130988516|NCT05807919|471585421|FG001|Overall Study|Adverse Event|1|||
130988517|NCT03489057|471585422|FG000|Overall Study|Lost to Follow-up|16|||
130988518|NCT03489057|471585423|FG001|Overall Study|Lost to Follow-up|16|||
130988519|NCT03489057|471585424|FG002|Overall Study|Lost to Follow-up|14|||
130988520|NCT03489057|471585425|FG003|Overall Study|Lost to Follow-up|14|||
130988521|NCT03489057|471585422|FG000|Overall Study|Withdrawal by Subject|12|||
130988522|NCT03489057|471585423|FG001|Overall Study|Withdrawal by Subject|12|||
130988523|NCT03489057|471585424|FG002|Overall Study|Withdrawal by Subject|8|||
130988524|NCT03489057|471585425|FG003|Overall Study|Withdrawal by Subject|8|||
130988525|NCT03489057|471585422|FG000|Overall Study|Protocol Violation|7|||
130988526|NCT03489057|471585423|FG001|Overall Study|Protocol Violation|7|||
130988527|NCT03489057|471585424|FG002|Overall Study|Protocol Violation|2|||
130988528|NCT03489057|471585425|FG003|Overall Study|Protocol Violation|2|||
130988529|NCT04027348|471585428|FG000|Overall Study|Adverse Event|2|||
130988530|NCT02487472|471585429|FG000|Overall Study|Did not complete telephonic interviews|9|||
130988531|NCT02487472|471585429|FG000|Overall Study|Other|2|||
130988532|NCT02034708|471585430|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
130988533|NCT02034708|471585431|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
130988534|NCT02034708|471585430|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
130988535|NCT02034708|471585431|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
130988536|NCT02034708|471585430|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
130988537|NCT02034708|471585431|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
130988538|NCT02034708|471585430|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
130988539|NCT02034708|471585431|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
130988540|NCT04843930|471585432|FG000|Randomization|Withdrawal by Subject|6|||
130988541|NCT04843930|471585433|FG001|Randomization|Withdrawal by Subject|6|||
130988542|NCT04843930|471585434|FG002|Randomization|Withdrawal by Subject|0|||
130988543|NCT04843930|471585435|FG003|Randomization|Withdrawal by Subject|0|||
130988544|NCT04843930|471585432|FG000|Week 6 Assessment|Adverse Event|3|||
130988545|NCT04843930|471585433|FG001|Week 6 Assessment|Adverse Event|0|||
130988546|NCT04843930|471585434|FG002|Week 6 Assessment|Adverse Event|0|||
130988547|NCT04843930|471585435|FG003|Week 6 Assessment|Adverse Event|0|||
130988548|NCT04843930|471585432|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
130988549|NCT04843930|471585433|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
130988550|NCT04843930|471585434|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
130988551|NCT04843930|471585435|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
130988552|NCT04843930|471585432|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
130988553|NCT04843930|471585433|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
130988554|NCT04843930|471585434|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
130988555|NCT04843930|471585435|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
130988556|NCT01833143|471585439|FG000|Overall Study|Not Treated|1|||
130988557|NCT03995784|471585440|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
130988558|NCT00284141|471587126|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
130988559|NCT00284141|471587126|FG000|Overall Study|Adverse Event|19|||
130988560|NCT00284141|471587126|FG000|Overall Study|Participant's request|9|||
130988561|NCT00284141|471587126|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
130988562|NCT00284141|471587126|FG000|Overall Study|Clinical deterioration / death|2|||
130988563|NCT00284141|471587126|FG000|Overall Study|General decline|1|||
130988564|NCT00284141|471587126|FG000|Overall Study|Pneumonia|1|||
130988565|NCT00284141|471587126|FG000|Overall Study|Did not take study medication|2|||
130988566|NCT00284141|471587126|FG000|Overall Study|Ongoing treatment|2|||
130988567|NCT02202434|471587127|FG000|Overall Study|Death|70|||
130988568|NCT02202434|471587128|FG001|Overall Study|Death|39|||
130988569|NCT02202434|471587129|FG002|Overall Study|Death|13|||
130988570|NCT02202434|471587130|FG003|Overall Study|Death|27|||
130988571|NCT02202434|471587127|FG000|Overall Study|Lost to Follow-up|1|||
130988572|NCT02202434|471587128|FG001|Overall Study|Lost to Follow-up|1|||
130988573|NCT02202434|471587129|FG002|Overall Study|Lost to Follow-up|1|||
130988574|NCT02202434|471587130|FG003|Overall Study|Lost to Follow-up|0|||
130988575|NCT02202434|471587127|FG000|Overall Study|Physician Decision|2|||
130988576|NCT02202434|471587128|FG001|Overall Study|Physician Decision|3|||
130988577|NCT02202434|471587129|FG002|Overall Study|Physician Decision|0|||
130988578|NCT02202434|471587130|FG003|Overall Study|Physician Decision|0|||
130988579|NCT02202434|471587127|FG000|Overall Study|Withdrawal by Subject|13|||
130988580|NCT02202434|471587128|FG001|Overall Study|Withdrawal by Subject|14|||
130988581|NCT02202434|471587129|FG002|Overall Study|Withdrawal by Subject|1|||
130988582|NCT02202434|471587130|FG003|Overall Study|Withdrawal by Subject|4|||
130988583|NCT02202434|471587127|FG000|Overall Study|Completed Study|1|||
130988584|NCT02202434|471587128|FG001|Overall Study|Completed Study|0|||
130988585|NCT02202434|471587129|FG002|Overall Study|Completed Study|0|||
130988586|NCT02202434|471587130|FG003|Overall Study|Completed Study|0|||
130988587|NCT02202434|471587127|FG000|Overall Study|Visit Missed|21|||
130988588|NCT02202434|471587128|FG001|Overall Study|Visit Missed|12|||
130988589|NCT02202434|471587129|FG002|Overall Study|Visit Missed|0|||
130988590|NCT02202434|471587130|FG003|Overall Study|Visit Missed|5|||
130988591|NCT02202434|471587127|FG000|Overall Study|Other|1|||
130988592|NCT02202434|471587128|FG001|Overall Study|Other|0|||
130988593|NCT02202434|471587129|FG002|Overall Study|Other|0|||
130988594|NCT02202434|471587130|FG003|Overall Study|Other|1|||
130988595|NCT03610737|471587133|FG000|Overall Study|Withdrawal by Subject|1|||
130988596|NCT03610737|471587134|FG001|Overall Study|Withdrawal by Subject|5|||
130988597|NCT03610737|471587133|FG000|Overall Study|Death|1|||
130988598|NCT03610737|471587134|FG001|Overall Study|Death|0|||
130988599|NCT03610737|471587133|FG000|Overall Study|Not treated|5|||
130988600|NCT03610737|471587134|FG001|Overall Study|Not treated|2|||
130988601|NCT03610737|471587133|FG000|Overall Study|Missed Visit|1|||
130988602|NCT03610737|471587134|FG001|Overall Study|Missed Visit|2|||
130988603|NCT00369681|471587136|FG000|Overall Study|Death|1|||
130988604|NCT02991482|471587137|FG000|Overall Study|Disease progression|56|||
130988605|NCT02991482|471587138|FG001|Overall Study|Disease progression|47|||
130988606|NCT02991482|471587137|FG000|Overall Study|Death|4|||
130988607|NCT02991482|471587138|FG001|Overall Study|Death|4|||
130988608|NCT02991482|471587137|FG000|Overall Study|Adverse Event|1|||
130988609|NCT02991482|471587138|FG001|Overall Study|Adverse Event|6|||
130988610|NCT02991482|471587137|FG000|Overall Study|Patient decision|1|||
130988611|NCT02991482|471587138|FG001|Overall Study|Patient decision|1|||
130988612|NCT02991482|471587137|FG000|Overall Study|Physician Decision|0|||
130988613|NCT02991482|471587138|FG001|Overall Study|Physician Decision|6|||
130988614|NCT02991482|471587137|FG000|Overall Study|Clinical deterioration|1|||
130988615|NCT02991482|471587138|FG001|Overall Study|Clinical deterioration|0|||
130988616|NCT02991482|471587137|FG000|Overall Study|Patient feeling too unwell|1|||
130988617|NCT02991482|471587138|FG001|Overall Study|Patient feeling too unwell|0|||
130988618|NCT02991482|471587137|FG000|Overall Study|Worsening of performance status|0|||
130988619|NCT02991482|471587138|FG001|Overall Study|Worsening of performance status|1|||
130988620|NCT02991482|471587137|FG000|Overall Study|Death prior to study drug initiation|1|||
130988621|NCT02991482|471587138|FG001|Overall Study|Death prior to study drug initiation|0|||
130988622|NCT02991482|471587137|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
130988623|NCT02991482|471587138|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
130988624|NCT04382924|471587141|FG000|Overall Study|Death|2|||
130988625|NCT04382924|471587142|FG001|Overall Study|Death|5|||
130988626|NCT04382924|471587143|FG002|Overall Study|Death|4|||
130988627|NCT04382924|471587141|FG000|Overall Study|Protocol Violation|0|||
130988628|NCT04382924|471587142|FG001|Overall Study|Protocol Violation|1|||
130988629|NCT04382924|471587143|FG002|Overall Study|Protocol Violation|1|||
130988630|NCT04382924|471587141|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
130988631|NCT04382924|471587142|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
130988632|NCT04382924|471587143|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
130988633|NCT04382924|471587141|FG000|Overall Study|Withdrawal by Subject|6|||
130988634|NCT04382924|471587142|FG001|Overall Study|Withdrawal by Subject|3|||
130988635|NCT04382924|471587143|FG002|Overall Study|Withdrawal by Subject|6|||
130988636|NCT02207725|471587144|FG000|Overall Study|Did Not Receive Treatment|0|||
130988637|NCT02207725|471587145|FG001|Overall Study|Did Not Receive Treatment|1|||
130988638|NCT02207725|471587146|FG002|Overall Study|Did Not Receive Treatment|1|||
130988639|NCT02207725|471587147|FG003|Overall Study|Did Not Receive Treatment|1|||
130988640|NCT02396537|471587152|FG000|Overall Study|Protocol Violation|0|||
130988641|NCT02396537|471587153|FG001|Overall Study|Protocol Violation|1|||
130988642|NCT00871403|471587154|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
130988643|NCT00871403|471587155|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
130988644|NCT00871403|471587156|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
130988645|NCT00871403|471587154|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
130988646|NCT00871403|471587155|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
130988647|NCT00871403|471587156|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
130988648|NCT00871403|471587154|FG000|Combination Treatment Phase|Adverse Event|0|||
130988649|NCT00871403|471587155|FG001|Combination Treatment Phase|Adverse Event|17|||
130988650|NCT00871403|471587156|FG002|Combination Treatment Phase|Adverse Event|2|||
130988651|NCT00871403|471587154|FG000|Combination Treatment Phase|Disease Progression|0|||
130988652|NCT00871403|471587155|FG001|Combination Treatment Phase|Disease Progression|8|||
130988653|NCT00871403|471587156|FG002|Combination Treatment Phase|Disease Progression|5|||
130988654|NCT00871403|471587154|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
130988655|NCT00871403|471587155|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
130988656|NCT00871403|471587156|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
130988657|NCT00871403|471587154|FG000|Combination Treatment Phase|Physician Decision|0|||
130988658|NCT00871403|471587155|FG001|Combination Treatment Phase|Physician Decision|1|||
130988659|NCT00871403|471587156|FG002|Combination Treatment Phase|Physician Decision|3|||
130988660|NCT00871403|471587154|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
130988661|NCT00871403|471587155|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
130988662|NCT00871403|471587156|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
130988663|NCT00871403|471587154|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
130988664|NCT00871403|471587155|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
130988665|NCT00871403|471587156|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
130988666|NCT04887948|471587160|FG000|Overall Study|Death|1|||
130988667|NCT04887948|471587161|FG001|Overall Study|Death|0|||
130988668|NCT04887948|471587162|FG002|Overall Study|Death|0|||
130988669|NCT04887948|471587160|FG000|Overall Study|Lost to Follow-up|1|||
130988670|NCT04887948|471587161|FG001|Overall Study|Lost to Follow-up|0|||
130988671|NCT04887948|471587162|FG002|Overall Study|Lost to Follow-up|3|||
130988672|NCT04887948|471587160|FG000|Overall Study|Physician Decision|0|||
130988673|NCT04887948|471587161|FG001|Overall Study|Physician Decision|4|||
130988674|NCT04887948|471587162|FG002|Overall Study|Physician Decision|1|||
130988675|NCT04887948|471587160|FG000|Overall Study|Protocol Violation|1|||
130988676|NCT04887948|471587161|FG001|Overall Study|Protocol Violation|1|||
130988677|NCT04887948|471587162|FG002|Overall Study|Protocol Violation|0|||
130988678|NCT04887948|471587160|FG000|Overall Study|Withdrawal by Subject|0|||
130988679|NCT04887948|471587161|FG001|Overall Study|Withdrawal by Subject|6|||
130988680|NCT04887948|471587162|FG002|Overall Study|Withdrawal by Subject|1|||
130988681|NCT04887948|471587160|FG000|Overall Study|No longer met eligibility criteria|1|||
130988682|NCT04887948|471587161|FG001|Overall Study|No longer met eligibility criteria|2|||
130988683|NCT04887948|471587162|FG002|Overall Study|No longer met eligibility criteria|1|||
130988684|NCT04887948|471587160|FG000|Overall Study|Other|2|||
130988685|NCT04887948|471587161|FG001|Overall Study|Other|1|||
130988686|NCT04887948|471587162|FG002|Overall Study|Other|1|||
130988687|NCT00787319|471587163|FG000|Overall Study|Lost to Follow-up|2|||
130988688|NCT00787319|471587163|FG000|Overall Study|Withdrawal by Subject|15|||
130988689|NCT00787319|471587163|FG000|Overall Study|Adverse Event|3|||
130988690|NCT00787319|471587163|FG000|Overall Study|Objective progression or relapse|30|||
130988691|NCT00787319|471587163|FG000|Overall Study|Lack of Efficacy|1|||
130988692|NCT00787319|471587163|FG000|Overall Study|Budget exhausted/exceeded|1|||
130988693|NCT00787319|471587163|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
130988694|NCT00787319|471587163|FG000|Overall Study|No health insurance reimbursement|2|||
130988695|NCT00787319|471587163|FG000|Overall Study|Stabilized disease findings|3|||
130988696|NCT00787319|471587163|FG000|Overall Study|Inactive disease|5|||
130988697|NCT02312856|471587164|FG000|Overall Study|Death|1|||
130988698|NCT02312856|471587164|FG000|Overall Study|Lost to Follow-up|3|||
130988699|NCT01932294|471587165|FG000|Overall Study|Death|43|||
130988700|NCT01932294|471587165|FG000|Overall Study|Lost to Follow-up|8|||
130877781|NCT03623243|471185820|FG000|Overall Study|Adverse Event|15|||
130877782|NCT03623243|471185820|FG000|Overall Study|Guardian Decision|1|||
130877783|NCT03623243|471185820|FG000|Overall Study|New Therapy for Study Indication|1|||
130877784|NCT03623243|471185820|FG000|Overall Study|Protocol Deviation|3|||
130877785|NCT03623243|471185820|FG000|Overall Study|Physician Decision|4|||
130877786|NCT03623243|471185820|FG000|Overall Study|Patient Decision|15|||
130877787|NCT02177695|471185824|FG000|ITT Analysis|Ineligible|5|||
130877788|NCT02177695|471185825|FG001|ITT Analysis|Ineligible|5|||
130877789|NCT02177695|471185824|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
130877790|NCT02177695|471185825|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
130877791|NCT02177695|471185824|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
130877792|NCT02177695|471185825|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
130877793|NCT02177695|471185824|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
130877794|NCT02177695|471185825|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
130877795|NCT00979901|471185826|FG000|Overall Study|Adverse Event|1|||
130877796|NCT00979901|471185827|FG001|Overall Study|Adverse Event|3|||
130877797|NCT00979901|471185828|FG002|Overall Study|Adverse Event|9|||
130877798|NCT00979901|471185829|FG003|Overall Study|Adverse Event|2|||
130877799|NCT00979901|471185826|FG000|Overall Study|Lack of Efficacy|8|||
130877800|NCT00979901|471185827|FG001|Overall Study|Lack of Efficacy|4|||
130877801|NCT00979901|471185828|FG002|Overall Study|Lack of Efficacy|9|||
130877802|NCT00979901|471185829|FG003|Overall Study|Lack of Efficacy|0|||
130877803|NCT00979901|471185826|FG000|Overall Study|Lost to Follow-up|1|||
130877804|NCT00979901|471185827|FG001|Overall Study|Lost to Follow-up|1|||
130877805|NCT00979901|471185828|FG002|Overall Study|Lost to Follow-up|2|||
130877806|NCT00979901|471185829|FG003|Overall Study|Lost to Follow-up|0|||
130877807|NCT00979901|471185826|FG000|Overall Study|Protocol Violation|2|||
130877808|NCT00979901|471185827|FG001|Overall Study|Protocol Violation|2|||
130877809|NCT00979901|471185828|FG002|Overall Study|Protocol Violation|7|||
130877810|NCT00979901|471185829|FG003|Overall Study|Protocol Violation|1|||
130877811|NCT00979901|471185826|FG000|Overall Study|Withdrawal by Subject|2|||
130877812|NCT00979901|471185827|FG001|Overall Study|Withdrawal by Subject|1|||
130877813|NCT00979901|471185828|FG002|Overall Study|Withdrawal by Subject|1|||
130877814|NCT00979901|471185829|FG003|Overall Study|Withdrawal by Subject|1|||
130877815|NCT00979901|471185826|FG000|Overall Study|Noncompliance|1|||
130877816|NCT00979901|471185827|FG001|Overall Study|Noncompliance|0|||
130877817|NCT00979901|471185828|FG002|Overall Study|Noncompliance|0|||
130877818|NCT00979901|471185829|FG003|Overall Study|Noncompliance|0|||
130877819|NCT00979901|471185826|FG000|Overall Study|out-of-state|1|||
130877820|NCT00979901|471185827|FG001|Overall Study|out-of-state|0|||
130877821|NCT00979901|471185828|FG002|Overall Study|out-of-state|0|||
130877822|NCT00979901|471185829|FG003|Overall Study|out-of-state|0|||
130877823|NCT00979901|471185826|FG000|Overall Study|vacation|1|||
130988701|NCT01932294|471587165|FG000|Overall Study|VAD Implantation|20|||
130988702|NCT01932294|471587165|FG000|Overall Study|Heart Transplantation|16|||
130877824|NCT00979901|471185827|FG001|Overall Study|vacation|0|||
130877825|NCT00979901|471185828|FG002|Overall Study|vacation|0|||
130877826|NCT00979901|471185829|FG003|Overall Study|vacation|0|||
130877827|NCT00979901|471185826|FG000|Overall Study|elevated lab values pre-randomization|1|||
130877828|NCT00979901|471185827|FG001|Overall Study|elevated lab values pre-randomization|0|||
130877829|NCT00979901|471185828|FG002|Overall Study|elevated lab values pre-randomization|0|||
130877830|NCT00979901|471185829|FG003|Overall Study|elevated lab values pre-randomization|0|||
130877831|NCT00979901|471185826|FG000|Overall Study|Discontinued in Error|0|||
130877832|NCT00979901|471185827|FG001|Overall Study|Discontinued in Error|1|||
130988703|NCT01932294|471587165|FG000|Overall Study|Transferred to other hospitals|12|||
130988704|NCT03075904|471587167|FG000|Overall Study|Physician Decision|3|||
130988705|NCT03075904|471587167|FG000|Overall Study|Need for Medication not Permitted|1|||
130988706|NCT01800201|471587168|FG000|Overall Study|Withdrawal by Subject|2|||
130988707|NCT01800201|471587169|FG001|Overall Study|Withdrawal by Subject|0|||
130988708|NCT01800201|471587168|FG000|Overall Study|patient privacy concerns|1|||
130988709|NCT01800201|471587169|FG001|Overall Study|patient privacy concerns|1|||
130988710|NCT01800201|471587168|FG000|Overall Study|did not want to use device|0|||
130988711|NCT01800201|471587169|FG001|Overall Study|did not want to use device|1|||
130988712|NCT01800201|471587168|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
130988713|NCT01800201|471587169|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
130988714|NCT00708435|471587170|FG000|Overall Study|Death / Serious Adverse Event|10|||
130988715|NCT00708435|471587171|FG001|Overall Study|Death / Serious Adverse Event|5|||
130988716|NCT00708435|471587170|FG000|Overall Study|Lost to Follow-up|9|||
130988717|NCT00708435|471587171|FG001|Overall Study|Lost to Follow-up|4|||
130988718|NCT00708435|471587170|FG000|Overall Study|Withdrawal by Subject|3|||
130988719|NCT00708435|471587171|FG001|Overall Study|Withdrawal by Subject|7|||
130988720|NCT00708435|471587170|FG000|Overall Study|Adverse Event|1|||
130988721|NCT00708435|471587171|FG001|Overall Study|Adverse Event|0|||
130988722|NCT00708435|471587170|FG000|Overall Study|Protocol Violation|0|||
130988723|NCT00708435|471587171|FG001|Overall Study|Protocol Violation|1|||
130988724|NCT00708435|471587170|FG000|Overall Study|Intervention by primary care physician|1|||
130988725|NCT00708435|471587171|FG001|Overall Study|Intervention by primary care physician|0|||
130988726|NCT00708435|471587170|FG000|Overall Study|Refused hospitalization|1|||
130988727|NCT00708435|471587171|FG001|Overall Study|Refused hospitalization|0|||
130988728|NCT03502616|471587174|FG000|Up to Week 16|Withdrawal by Subject|1|||
130988729|NCT03502616|471587175|FG001|Up to Week 16|Withdrawal by Subject|2|||
130988730|NCT03502616|471587174|FG000|Up to Week 16|Lost to Follow-up|0|||
130988731|NCT03502616|471587175|FG001|Up to Week 16|Lost to Follow-up|1|||
130988732|NCT03502616|471587174|FG000|Up to Week 16|Randomized, but not treated|1|||
130988733|NCT03502616|471587175|FG001|Up to Week 16|Randomized, but not treated|0|||
130988734|NCT03502616|471587174|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
130988735|NCT03502616|471587175|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
130988736|NCT03502616|471587174|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
130988737|NCT03502616|471587175|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
130988738|NCT01691521|471587176|FG000|Overall Study|Adverse Event|4|||
130988739|NCT01691521|471587177|FG001|Overall Study|Adverse Event|0|||
130988740|NCT01691521|471587178|FG002|Overall Study|Adverse Event|1|||
130988741|NCT01691521|471587176|FG000|Overall Study|Lack of Efficacy|1|||
130988742|NCT01691521|471587177|FG001|Overall Study|Lack of Efficacy|1|||
130988743|NCT01691521|471587178|FG002|Overall Study|Lack of Efficacy|2|||
130988744|NCT01691521|471587176|FG000|Overall Study|Protocol Violation|0|||
130988745|NCT01691521|471587177|FG001|Overall Study|Protocol Violation|3|||
130988746|NCT01691521|471587178|FG002|Overall Study|Protocol Violation|0|||
130988747|NCT01691521|471587176|FG000|Overall Study|Lost to Follow-up|0|||
130988748|NCT01691521|471587177|FG001|Overall Study|Lost to Follow-up|2|||
130988749|NCT01691521|471587178|FG002|Overall Study|Lost to Follow-up|2|||
130988750|NCT01691521|471587176|FG000|Overall Study|Physician Decision|2|||
130988751|NCT01691521|471587177|FG001|Overall Study|Physician Decision|1|||
130988752|NCT01691521|471587178|FG002|Overall Study|Physician Decision|0|||
130988753|NCT01691521|471587176|FG000|Overall Study|Withdrawal by Subject|5|||
130988754|NCT01691521|471587177|FG001|Overall Study|Withdrawal by Subject|9|||
130988755|NCT01691521|471587178|FG002|Overall Study|Withdrawal by Subject|4|||
130988756|NCT00770432|471587184|FG000|Overall Study|Other|4|||
130988757|NCT00770432|471587185|FG001|Overall Study|Other|6|||
130988758|NCT00770432|471587184|FG000|Overall Study|Non-compliance|0|||
130988759|NCT00770432|471587185|FG001|Overall Study|Non-compliance|1|||
130988760|NCT00312702|471587188|FG000|Immunization Phase|Lost to Follow-up|0|||
130988761|NCT00312702|471587189|FG001|Immunization Phase|Lost to Follow-up|1|||
130988762|NCT00312702|471587190|FG002|Immunization Phase|Lost to Follow-up|0|||
130988763|NCT00988221|471587191|FG000|Part I|Adverse Event|0|||
130988764|NCT00988221|471587192|FG001|Part I|Adverse Event|1|||
130988765|NCT00988221|471587193|FG002|Part I|Adverse Event|2|||
130988766|NCT00988221|471587194|FG003|Part I|Adverse Event|0|||
130988767|NCT00988221|471587191|FG000|Part I|Insufficient Therapeutic Response|4|||
130988768|NCT00988221|471587192|FG001|Part I|Insufficient Therapeutic Response|6|||
130988769|NCT00988221|471587193|FG002|Part I|Insufficient Therapeutic Response|5|||
130988770|NCT00988221|471587194|FG003|Part I|Insufficient Therapeutic Response|0|||
130988771|NCT00988221|471587191|FG000|Part I|Refused Treatment|0|||
130988772|NCT00988221|471587192|FG001|Part I|Refused Treatment|2|||
130988773|NCT00988221|471587193|FG002|Part I|Refused Treatment|1|||
130988774|NCT00988221|471587194|FG003|Part I|Refused Treatment|0|||
130988775|NCT00988221|471587191|FG000|Part I|Lost to Follow-up|0|||
130988776|NCT00988221|471587192|FG001|Part I|Lost to Follow-up|1|||
130988777|NCT00988221|471587193|FG002|Part I|Lost to Follow-up|0|||
130988778|NCT00988221|471587194|FG003|Part I|Lost to Follow-up|0|||
130988779|NCT00988221|471587191|FG000|Part II|Adverse Event|1|||
130988780|NCT00988221|471587192|FG001|Part II|Adverse Event|0|||
130988781|NCT00988221|471587193|FG002|Part II|Adverse Event|0|||
130988782|NCT00988221|471587194|FG003|Part II|Adverse Event|1|||
130988783|NCT00988221|471587191|FG000|Part II|Withdrawal by Subject|0|||
130988784|NCT00988221|471587192|FG001|Part II|Withdrawal by Subject|0|||
130988785|NCT00988221|471587193|FG002|Part II|Withdrawal by Subject|2|||
130988786|NCT00988221|471587194|FG003|Part II|Withdrawal by Subject|2|||
130988787|NCT00988221|471587191|FG000|Part II|Reason not Specified|0|||
130988788|NCT00988221|471587192|FG001|Part II|Reason not Specified|0|||
130988789|NCT00988221|471587193|FG002|Part II|Reason not Specified|1|||
130988790|NCT00988221|471587194|FG003|Part II|Reason not Specified|0|||
130988791|NCT00988221|471587191|FG000|Part III|Adverse Event|1|||
130988792|NCT00988221|471587192|FG001|Part III|Adverse Event|0|||
130988793|NCT00988221|471587193|FG002|Part III|Adverse Event|1|||
130988794|NCT00988221|471587194|FG003|Part III|Adverse Event|0|||
130988795|NCT00988221|471587191|FG000|Part III|Insufficient Therapeutic Response|0|||
130988796|NCT00988221|471587192|FG001|Part III|Insufficient Therapeutic Response|1|||
130988797|NCT00988221|471587193|FG002|Part III|Insufficient Therapeutic Response|1|||
130988798|NCT00988221|471587194|FG003|Part III|Insufficient Therapeutic Response|0|||
130988799|NCT00988221|471587191|FG000|Part III|Refused Treatment|0|||
130988800|NCT00988221|471587192|FG001|Part III|Refused Treatment|0|||
130988801|NCT00988221|471587193|FG002|Part III|Refused Treatment|1|||
130988802|NCT00988221|471587194|FG003|Part III|Refused Treatment|0|||
130988803|NCT02756832|471587197|FG000|Overall Study|Lost for Observation after Baseline|6|||
130988804|NCT02756832|471587197|FG000|Overall Study|Lost for Observation|13|||
130988805|NCT02756832|471587197|FG000|Overall Study|Patient's Unwillingness|12|||
130988806|NCT02756832|471587197|FG000|Overall Study|Insufficient Efficacy|2|||
130988807|NCT02756832|471587197|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
130988808|NCT02756832|471587197|FG000|Overall Study|Reason not Specified|9|||
130988809|NCT02756832|471587197|FG000|Overall Study|Protocol Deviation|10|||
130764263|NCT04068688|470760014|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130764264|NCT01522235|470760016|FG000|Overall Study|Physician Decision|1|||
130988906|NCT04581200|471587211|FG000|Overall Study|Lost to Follow-up|6|||
130988907|NCT04581200|471587212|FG001|Overall Study|Lost to Follow-up|5|||
130988908|NCT03579290|471587213|FG000|Overall Study|Lost to Follow-up|9|||
130988909|NCT03131960|471587216|FG000|Overall Study|Adverse Event|0|||
130988910|NCT03131960|471587217|FG001|Overall Study|Adverse Event|1|||
130988911|NCT01781390|471587218|FG000|Overall Study|Withdrawal of Consent|0|||
130988912|NCT01781390|471587219|FG001|Overall Study|Withdrawal of Consent|3|||
130988913|NCT01781390|471587220|FG002|Overall Study|Withdrawal of Consent|1|||
130988914|NCT01781390|471587218|FG000|Overall Study|Lost to Follow-up|1|||
130988915|NCT01781390|471587219|FG001|Overall Study|Lost to Follow-up|1|||
130988916|NCT01781390|471587220|FG002|Overall Study|Lost to Follow-up|1|||
130988917|NCT01781390|471587218|FG000|Overall Study|Adverse Event|1|||
130988918|NCT01781390|471587219|FG001|Overall Study|Adverse Event|2|||
130988919|NCT01781390|471587220|FG002|Overall Study|Adverse Event|1|||
130988920|NCT01781390|471587218|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
130988921|NCT01781390|471587219|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
130988922|NCT01781390|471587220|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
130988923|NCT00622713|471587223|FG000|Overall Study|Adverse Event|35|||
130988924|NCT00622713|471587223|FG000|Overall Study|Administrative problems|4|||
130988925|NCT00622713|471587223|FG000|Overall Study|Withdrawal by Subject|11|||
130988926|NCT00622713|471587223|FG000|Overall Study|Lost to Follow-up|5|||
130988927|NCT00622713|471587223|FG000|Overall Study|Death|2|||
130988928|NCT00622713|471587223|FG000|Overall Study|Subject no longer required study drug|1|||
130988929|NCT00622713|471587223|FG000|Overall Study|Did not meet eligibility criteria|1|||
130988930|NCT04404478|471587227|FG000|Overall Study|Withdrawal by Subject|1|||
130988931|NCT04404478|471587228|FG001|Overall Study|Withdrawal by Subject|3|||
130988932|NCT03485911|471587229|FG000|Part 1|Perceived lack of efficacy|1|||
130988933|NCT03485911|471587230|FG001|Part 1|Perceived lack of efficacy|1|||
130988934|NCT03485911|471587231|FG002|Part 1|Perceived lack of efficacy|2|||
130988935|NCT03485911|471587232|FG003|Part 1|Perceived lack of efficacy|0|||
130988936|NCT03485911|471587229|FG000|Part 1|Subject withdrew consent|0|||
130988937|NCT03485911|471587230|FG001|Part 1|Subject withdrew consent|1|||
130988938|NCT03485911|471587231|FG002|Part 1|Subject withdrew consent|0|||
130988939|NCT03485911|471587232|FG003|Part 1|Subject withdrew consent|1|||
130988940|NCT03485911|471587229|FG000|Part 1|Lab abnormalities/AEs|3|||
130988941|NCT03485911|471587230|FG001|Part 1|Lab abnormalities/AEs|1|||
130988942|NCT03485911|471587231|FG002|Part 1|Lab abnormalities/AEs|1|||
130988943|NCT03485911|471587232|FG003|Part 1|Lab abnormalities/AEs|0|||
130988944|NCT03485911|471587229|FG000|Part 1|Withdrew Consent prior to dosing|0|||
130988945|NCT03485911|471587230|FG001|Part 1|Withdrew Consent prior to dosing|0|||
130988946|NCT03485911|471587231|FG002|Part 1|Withdrew Consent prior to dosing|0|||
130988947|NCT03485911|471587232|FG003|Part 1|Withdrew Consent prior to dosing|1|||
130988948|NCT03485911|471587229|FG000|Part 1|Other NOS|0|||
130988949|NCT03485911|471587230|FG001|Part 1|Other NOS|0|||
130988950|NCT03485911|471587231|FG002|Part 1|Other NOS|0|||
130988951|NCT03485911|471587232|FG003|Part 1|Other NOS|1|||
130988952|NCT03485911|471587229|FG000|Part 2|Perceived lack of efficacy|5|||
130988953|NCT03485911|471587230|FG001|Part 2|Perceived lack of efficacy|3|||
130988954|NCT03485911|471587231|FG002|Part 2|Perceived lack of efficacy|0|||
130988955|NCT03485911|471587232|FG003|Part 2|Perceived lack of efficacy|2|||
130988956|NCT03485911|471587229|FG000|Part 2|Subject withdrew consent|1|||
130988957|NCT03485911|471587230|FG001|Part 2|Subject withdrew consent|0|||
130988958|NCT03485911|471587231|FG002|Part 2|Subject withdrew consent|2|||
130988959|NCT03485911|471587232|FG003|Part 2|Subject withdrew consent|1|||
130988960|NCT03485911|471587229|FG000|Part 2|Lab abnormalities/AEs|1|||
130988961|NCT03485911|471587230|FG001|Part 2|Lab abnormalities/AEs|2|||
130988962|NCT03485911|471587231|FG002|Part 2|Lab abnormalities/AEs|0|||
130988963|NCT03485911|471587232|FG003|Part 2|Lab abnormalities/AEs|0|||
130988964|NCT03485911|471587229|FG000|Part 2|Other NOS|0|||
130988965|NCT03485911|471587230|FG001|Part 2|Other NOS|1|||
130988966|NCT03485911|471587231|FG002|Part 2|Other NOS|0|||
130988967|NCT03485911|471587232|FG003|Part 2|Other NOS|0|||
130988968|NCT03485911|471587229|FG000|Part 2|Intercurrent illness/new medical condition|1|||
130988969|NCT03485911|471587230|FG001|Part 2|Intercurrent illness/new medical condition|0|||
130988970|NCT03485911|471587231|FG002|Part 2|Intercurrent illness/new medical condition|0|||
130988971|NCT03485911|471587232|FG003|Part 2|Intercurrent illness/new medical condition|0|||
130988972|NCT03485911|471587229|FG000|Part 2|Investigator judgement|1|||
130988973|NCT03485911|471587230|FG001|Part 2|Investigator judgement|0|||
130988974|NCT03485911|471587231|FG002|Part 2|Investigator judgement|0|||
130988975|NCT03485911|471587232|FG003|Part 2|Investigator judgement|0|||
130988976|NCT03485911|471587229|FG000|Part 3|Perceived lack of efficacy|2|||
130988977|NCT03485911|471587230|FG001|Part 3|Perceived lack of efficacy|2|||
130988978|NCT03485911|471587231|FG002|Part 3|Perceived lack of efficacy|2|||
130988979|NCT03485911|471587232|FG003|Part 3|Perceived lack of efficacy|0|||
130988980|NCT03485911|471587229|FG000|Part 3|Subject withdrew consent|1|||
130988981|NCT03485911|471587230|FG001|Part 3|Subject withdrew consent|4|||
130988982|NCT03485911|471587231|FG002|Part 3|Subject withdrew consent|0|||
130988983|NCT03485911|471587232|FG003|Part 3|Subject withdrew consent|1|||
130988984|NCT03485911|471587229|FG000|Part 3|Lab abnormalities/AEs|1|||
130988985|NCT03485911|471587230|FG001|Part 3|Lab abnormalities/AEs|1|||
130988986|NCT03485911|471587231|FG002|Part 3|Lab abnormalities/AEs|0|||
130988987|NCT03485911|471587232|FG003|Part 3|Lab abnormalities/AEs|2|||
130988988|NCT03485911|471587229|FG000|Part 3|Other NOS|1|||
130988989|NCT03485911|471587230|FG001|Part 3|Other NOS|1|||
130988990|NCT03485911|471587231|FG002|Part 3|Other NOS|0|||
130988991|NCT03485911|471587232|FG003|Part 3|Other NOS|0|||
130988992|NCT03485911|471587229|FG000|Part 3|Intercurrent illness/new medical condition|0|||
130988993|NCT03485911|471587230|FG001|Part 3|Intercurrent illness/new medical condition|1|||
130988994|NCT03485911|471587231|FG002|Part 3|Intercurrent illness/new medical condition|1|||
130988995|NCT03485911|471587232|FG003|Part 3|Intercurrent illness/new medical condition|0|||
130988996|NCT03485911|471587229|FG000|Part 3|Sponsor discontinuation|1|||
130988997|NCT03485911|471587230|FG001|Part 3|Sponsor discontinuation|0|||
130988998|NCT03485911|471587231|FG002|Part 3|Sponsor discontinuation|0|||
130988999|NCT03485911|471587232|FG003|Part 3|Sponsor discontinuation|0|||
130989000|NCT03485911|471587229|FG000|Part 3|Berotralstat provided by alternative means|13|||
130989001|NCT03485911|471587230|FG001|Part 3|Berotralstat provided by alternative means|13|||
130989002|NCT03485911|471587231|FG002|Part 3|Berotralstat provided by alternative means|7|||
130989003|NCT03485911|471587232|FG003|Part 3|Berotralstat provided by alternative means|7|||
130989004|NCT03528174|471587237|FG000|Overall Study|Adverse Event|1|||
130989005|NCT03528174|471587237|FG000|Overall Study|sensors dislodged|1|||
130989006|NCT03002038|471587238|FG000|Overall Study|Adverse Event|3|||
130989007|NCT03002038|471587239|FG001|Overall Study|Adverse Event|1|||
130989008|NCT03002038|471587238|FG000|Overall Study|Withdrawal by Subject|8|||
130989009|NCT03002038|471587239|FG001|Overall Study|Withdrawal by Subject|4|||
130989010|NCT03002038|471587238|FG000|Overall Study|Immigration to another region|0|||
130989011|NCT03002038|471587239|FG001|Overall Study|Immigration to another region|2|||
130989012|NCT01719237|471587246|FG000|Overall Study|Physician Decision|0|||
130989013|NCT01719237|471587247|FG001|Overall Study|Physician Decision|1|||
130989014|NCT03724396|471587252|FG000|Overall Study|Lost to Follow-up|1|||
130989015|NCT03724396|471587253|FG001|Overall Study|Lost to Follow-up|1|||
130989016|NCT03724396|471587252|FG000|Overall Study|Withdrawal by Subject|1|||
130989017|NCT03724396|471587253|FG001|Overall Study|Withdrawal by Subject|0|||
130989018|NCT03879408|471587254|FG000|Overall Study|Lost to Follow-up|0|||
130989019|NCT03879408|471587255|FG001|Overall Study|Lost to Follow-up|3|||
130989020|NCT03879408|471587256|FG002|Overall Study|Lost to Follow-up|2|||
130989021|NCT03879408|471587257|FG003|Overall Study|Lost to Follow-up|1|||
130989022|NCT03879408|471587258|FG004|Overall Study|Lost to Follow-up|0|||
130989023|NCT03879408|471587254|FG000|Overall Study|Withdrawal by Subject|2|||
130989024|NCT03879408|471587255|FG001|Overall Study|Withdrawal by Subject|1|||
130989025|NCT03879408|471587256|FG002|Overall Study|Withdrawal by Subject|1|||
130989026|NCT03879408|471587257|FG003|Overall Study|Withdrawal by Subject|0|||
130989027|NCT03879408|471587258|FG004|Overall Study|Withdrawal by Subject|1|||
130989028|NCT01490125|471587259|FG000|Period I|Adverse Event|4|||
130989029|NCT01490125|471587260|FG001|Period I|Adverse Event|1|||
130989030|NCT01490125|471587261|FG002|Period I|Adverse Event|1|||
130989031|NCT01490125|471587262|FG003|Period I|Adverse Event|3|||
130989032|NCT01490125|471587263|FG004|Period I|Adverse Event|2|||
130989033|NCT01490125|471587264|FG005|Period I|Adverse Event|4|||
130989034|NCT01490125|471587259|FG000|Period I|Protocol Violation|1|||
130989035|NCT01490125|471587260|FG001|Period I|Protocol Violation|1|||
130989036|NCT01490125|471587261|FG002|Period I|Protocol Violation|1|||
130989037|NCT01490125|471587262|FG003|Period I|Protocol Violation|1|||
130989038|NCT01490125|471587263|FG004|Period I|Protocol Violation|0|||
130989039|NCT01490125|471587264|FG005|Period I|Protocol Violation|0|||
130989040|NCT01490125|471587259|FG000|Period I|Withdrawal by Subject|1|||
130989041|NCT01490125|471587260|FG001|Period I|Withdrawal by Subject|3|||
130989042|NCT01490125|471587261|FG002|Period I|Withdrawal by Subject|2|||
130989043|NCT01490125|471587262|FG003|Period I|Withdrawal by Subject|1|||
130989044|NCT01490125|471587263|FG004|Period I|Withdrawal by Subject|2|||
130989045|NCT01490125|471587264|FG005|Period I|Withdrawal by Subject|1|||
130989046|NCT01490125|471587259|FG000|Period II|Adverse Event|2|||
130989047|NCT01490125|471587260|FG001|Period II|Adverse Event|3|||
130989048|NCT01490125|471587261|FG002|Period II|Adverse Event|2|||
130989049|NCT01490125|471587262|FG003|Period II|Adverse Event|2|||
130989050|NCT01490125|471587263|FG004|Period II|Adverse Event|4|||
130989051|NCT01490125|471587264|FG005|Period II|Adverse Event|2|||
130989052|NCT01490125|471587259|FG000|Period II|Protocol Violation|0|||
130989053|NCT01490125|471587260|FG001|Period II|Protocol Violation|0|||
130989054|NCT01490125|471587261|FG002|Period II|Protocol Violation|1|||
130989055|NCT01490125|471587262|FG003|Period II|Protocol Violation|1|||
130989056|NCT01490125|471587263|FG004|Period II|Protocol Violation|0|||
130989057|NCT01490125|471587264|FG005|Period II|Protocol Violation|0|||
130989058|NCT01490125|471587259|FG000|Period II|Lost to Follow-up|0|||
130989059|NCT01490125|471587260|FG001|Period II|Lost to Follow-up|1|||
130989060|NCT01490125|471587261|FG002|Period II|Lost to Follow-up|0|||
130989061|NCT01490125|471587262|FG003|Period II|Lost to Follow-up|0|||
130989062|NCT01490125|471587263|FG004|Period II|Lost to Follow-up|0|||
130989063|NCT01490125|471587264|FG005|Period II|Lost to Follow-up|0|||
130989064|NCT01490125|471587259|FG000|Period II|Withdrawal by Subject|1|||
130989065|NCT01490125|471587260|FG001|Period II|Withdrawal by Subject|0|||
130989066|NCT01490125|471587261|FG002|Period II|Withdrawal by Subject|0|||
130989067|NCT01490125|471587262|FG003|Period II|Withdrawal by Subject|0|||
130989068|NCT01490125|471587263|FG004|Period II|Withdrawal by Subject|0|||
130989069|NCT01490125|471587264|FG005|Period II|Withdrawal by Subject|0|||
130989070|NCT01490125|471587259|FG000|Period III|Adverse Event|3|||
130989071|NCT01490125|471587260|FG001|Period III|Adverse Event|1|||
130989072|NCT01490125|471587261|FG002|Period III|Adverse Event|0|||
130989073|NCT01490125|471587262|FG003|Period III|Adverse Event|1|||
130989074|NCT01490125|471587263|FG004|Period III|Adverse Event|0|||
130989075|NCT01490125|471587264|FG005|Period III|Adverse Event|0|||
130989076|NCT01490125|471587259|FG000|Period III|Death|0|||
130989077|NCT01490125|471587260|FG001|Period III|Death|0|||
130989078|NCT01490125|471587261|FG002|Period III|Death|0|||
130989079|NCT01490125|471587262|FG003|Period III|Death|1|||
130989080|NCT01490125|471587263|FG004|Period III|Death|0|||
130989081|NCT01490125|471587264|FG005|Period III|Death|0|||
130989082|NCT01490125|471587259|FG000|Period III|Lack of Efficacy|0|||
130989083|NCT01490125|471587260|FG001|Period III|Lack of Efficacy|0|||
130989084|NCT01490125|471587261|FG002|Period III|Lack of Efficacy|0|||
130989085|NCT01490125|471587262|FG003|Period III|Lack of Efficacy|0|||
130989086|NCT01490125|471587263|FG004|Period III|Lack of Efficacy|1|||
130989087|NCT01490125|471587264|FG005|Period III|Lack of Efficacy|0|||
130989088|NCT02237508|471587266|FG000|Overall Study|Withdrawal by Subject|0|||
130989089|NCT02237508|471587267|FG001|Overall Study|Withdrawal by Subject|2|||
130989090|NCT02237508|471587268|FG002|Overall Study|Withdrawal by Subject|0|||
130989091|NCT02237508|471587269|FG003|Overall Study|Withdrawal by Subject|1|||
130989092|NCT02237508|471587270|FG004|Overall Study|Withdrawal by Subject|0|||
130989093|NCT02237508|471587271|FG005|Overall Study|Withdrawal by Subject|1|||
130989094|NCT02237508|471587272|FG006|Overall Study|Withdrawal by Subject|1|||
130989095|NCT02237508|471587273|FG007|Overall Study|Withdrawal by Subject|0|||
130764265|NCT01522235|470760017|FG001|Overall Study|Physician Decision|1|||
130989096|NCT02237508|471587274|FG008|Overall Study|Withdrawal by Subject|1|||
130989097|NCT02237508|471587275|FG009|Overall Study|Withdrawal by Subject|0|||
130989098|NCT02237508|471587266|FG000|Overall Study|Physician Decision|0|||
130989099|NCT02237508|471587267|FG001|Overall Study|Physician Decision|1|||
130989100|NCT02237508|471587268|FG002|Overall Study|Physician Decision|0|||
130989101|NCT02237508|471587269|FG003|Overall Study|Physician Decision|0|||
130989102|NCT02237508|471587270|FG004|Overall Study|Physician Decision|0|||
130989103|NCT02237508|471587271|FG005|Overall Study|Physician Decision|0|||
130989104|NCT02237508|471587272|FG006|Overall Study|Physician Decision|0|||
130989105|NCT02237508|471587273|FG007|Overall Study|Physician Decision|0|||
130989106|NCT02237508|471587274|FG008|Overall Study|Physician Decision|0|||
130989107|NCT02237508|471587275|FG009|Overall Study|Physician Decision|0|||
130989108|NCT02237508|471587266|FG000|Overall Study|Protocol Violation|0|||
130989109|NCT02237508|471587267|FG001|Overall Study|Protocol Violation|0|||
130989110|NCT02237508|471587268|FG002|Overall Study|Protocol Violation|1|||
130989111|NCT02237508|471587269|FG003|Overall Study|Protocol Violation|0|||
130989112|NCT02237508|471587270|FG004|Overall Study|Protocol Violation|0|||
130989113|NCT02237508|471587271|FG005|Overall Study|Protocol Violation|0|||
130989114|NCT02237508|471587272|FG006|Overall Study|Protocol Violation|0|||
130989115|NCT02237508|471587273|FG007|Overall Study|Protocol Violation|0|||
130989116|NCT02237508|471587274|FG008|Overall Study|Protocol Violation|0|||
130989117|NCT02237508|471587275|FG009|Overall Study|Protocol Violation|0|||
130989118|NCT04000594|471587276|FG000|Overall Study|Withdrawal by Subject|1|||
130989119|NCT04000594|471587277|FG001|Overall Study|Withdrawal by Subject|0|||
130989120|NCT04000594|471587278|FG002|Overall Study|Withdrawal by Subject|0|||
130989121|NCT04522180|471587279|FG000|Overall Study|Investigator judgement|3|||
130989122|NCT04522180|471587280|FG001|Overall Study|Investigator judgement|4|||
130989123|NCT04522180|471587279|FG000|Overall Study|Voluntary withdrawal|1|||
130989124|NCT04522180|471587280|FG001|Overall Study|Voluntary withdrawal|0|||
130989125|NCT04522180|471587279|FG000|Overall Study|Pregnancy|0|||
130989126|NCT04522180|471587280|FG001|Overall Study|Pregnancy|1|||
130989127|NCT04522180|471587279|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
130989128|NCT04522180|471587280|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
130989129|NCT04522180|471587279|FG000|Overall Study|Reason not specified|8|||
130989130|NCT04522180|471587280|FG001|Overall Study|Reason not specified|5|||
130989131|NCT01905046|471587281|FG000|Months 13-24|Withdrawal by Subject|10|||
130989132|NCT01905046|471587282|FG001|Months 13-24|Withdrawal by Subject|10|||
130989133|NCT01905046|471587281|FG000|Months 13-24|Adverse Event|3|||
130989134|NCT01905046|471587282|FG001|Months 13-24|Adverse Event|2|||
130989135|NCT01905046|471587281|FG000|Months 13-24|Protocol Violation|3|||
130989136|NCT01905046|471587282|FG001|Months 13-24|Protocol Violation|3|||
130989137|NCT01905046|471587281|FG000|Months 13-24|Physician Decision|1|||
130989138|NCT01905046|471587282|FG001|Months 13-24|Physician Decision|0|||
130989139|NCT01368900|471587289|FG000|Overall Study|Lost to Follow-up|7|||
130989140|NCT01552954|471587292|FG000|Overall Study|Adverse Event|1|||
130989141|NCT01552954|471587293|FG001|Overall Study|Adverse Event|2|||
130989142|NCT01552954|471587292|FG000|Overall Study|Lost to Follow-up|1|||
130989143|NCT01552954|471587293|FG001|Overall Study|Lost to Follow-up|1|||
130989144|NCT01552954|471587292|FG000|Overall Study|Withdrawal by Subject|1|||
130989145|NCT01552954|471587293|FG001|Overall Study|Withdrawal by Subject|1|||
130989146|NCT01552954|471587292|FG000|Overall Study|Protocol Violation|1|||
130989147|NCT01552954|471587293|FG001|Overall Study|Protocol Violation|2|||
130989148|NCT01552954|471587292|FG000|Overall Study|diagnosed DM|1|||
130989149|NCT01552954|471587293|FG001|Overall Study|diagnosed DM|0|||
130989150|NCT01931735|471587294|FG000|Randomized Phase|Lost to Follow-up|2|||
130989151|NCT01931735|471587295|FG001|Randomized Phase|Lost to Follow-up|2|||
130989152|NCT01931735|471587296|FG002|Randomized Phase|Lost to Follow-up|5|||
130989153|NCT01931735|471587297|FG003|Randomized Phase|Lost to Follow-up|0|||
130989154|NCT01931735|471587294|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
130989155|NCT01931735|471587295|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
130989156|NCT01931735|471587296|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
130989157|NCT01931735|471587297|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
130989158|NCT01931735|471587294|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
130989159|NCT01931735|471587295|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
130989160|NCT01931735|471587296|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
130989161|NCT01931735|471587297|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
130989162|NCT02719990|471587298|FG000|Overall Study|Physician Decision|2|||
130989163|NCT02719990|471587298|FG000|Overall Study|Withdrawal by Subject|2|||
130989164|NCT02719990|471587298|FG000|Overall Study|Study Terminated By Sponsor|32|||
130989165|NCT01987817|471587299|FG000|Overall Study|Adverse Event|4|||
130989166|NCT01987817|471587300|FG001|Overall Study|Adverse Event|0|||
130989167|NCT01987817|471587299|FG000|Overall Study|Withdrawal by Subject|1|||
130989168|NCT01987817|471587300|FG001|Overall Study|Withdrawal by Subject|1|||
130989169|NCT01987817|471587299|FG000|Overall Study|Physician Decision|1|||
130989170|NCT01987817|471587300|FG001|Overall Study|Physician Decision|0|||
130989171|NCT01119898|471587301|FG000|Overall Study|Adverse Event|4|||
130989172|NCT01119898|471587302|FG001|Overall Study|Adverse Event|5|||
130989173|NCT01119898|471587301|FG000|Overall Study|Withdrawal by Subject|1|||
130989174|NCT01119898|471587302|FG001|Overall Study|Withdrawal by Subject|4|||
130989175|NCT01119898|471587301|FG000|Overall Study|Lack of Efficacy|0|||
130989176|NCT01119898|471587302|FG001|Overall Study|Lack of Efficacy|2|||
130989177|NCT01119898|471587301|FG000|Overall Study|Protocol Violation|1|||
130989178|NCT01119898|471587302|FG001|Overall Study|Protocol Violation|1|||
130989179|NCT01119898|471587301|FG000|Overall Study|Medical procedure|1|||
130989180|NCT01119898|471587302|FG001|Overall Study|Medical procedure|0|||
130989181|NCT01119898|471587301|FG000|Overall Study|Randomized in error did not participate|1|||
130989182|NCT01119898|471587302|FG001|Overall Study|Randomized in error did not participate|0|||
130989183|NCT04503096|471589478|FG000|Overall Study|Withdrawal by Subject|3|||
130989184|NCT01480596|471589479|FG000|Overall Study|Adverse Event|3|||
130989185|NCT01480596|471589480|FG001|Overall Study|Adverse Event|0|||
130989186|NCT01480596|471589479|FG000|Overall Study|MG exacerbation or change in medication|2|||
130989187|NCT01480596|471589480|FG001|Overall Study|MG exacerbation or change in medication|2|||
130989188|NCT02281760|471589481|FG000|Overall Study|Withdrawal by Subject|1|||
130989189|NCT01453348|471589482|FG000|Overall Study|Death|0|||
130989190|NCT01453348|471589483|FG001|Overall Study|Death|0|||
130989191|NCT01453348|471589484|FG002|Overall Study|Death|1|||
130989192|NCT01453348|471589482|FG000|Overall Study|Withdrawal by Subject|0|||
130989193|NCT01453348|471589483|FG001|Overall Study|Withdrawal by Subject|1|||
130989194|NCT01453348|471589484|FG002|Overall Study|Withdrawal by Subject|0|||
130989195|NCT01453348|471589482|FG000|Overall Study|Protocol Violation|1|||
130989196|NCT01453348|471589483|FG001|Overall Study|Protocol Violation|0|||
130989197|NCT01453348|471589484|FG002|Overall Study|Protocol Violation|0|||
130989198|NCT00954733|471589489|FG000|Overall Study|blood gas machine did not work|1|||
130989199|NCT00979602|471589494|FG000|Overall Study|Serious Adverse Event|5|||
130989200|NCT00979602|471589495|FG001|Overall Study|Serious Adverse Event|3|||
130989201|NCT00979602|471589494|FG000|Overall Study|Protocol Violation|3|||
130989202|NCT00979602|471589495|FG001|Overall Study|Protocol Violation|0|||
130989203|NCT00979602|471589494|FG000|Overall Study|Withdrawal by Subject|31|||
130989204|NCT00979602|471589495|FG001|Overall Study|Withdrawal by Subject|25|||
130989205|NCT00979602|471589494|FG000|Overall Study|Lost to Follow-up|100|||
130989206|NCT00979602|471589495|FG001|Overall Study|Lost to Follow-up|96|||
130989207|NCT00979602|471589494|FG000|Overall Study|Migrated/moved from study area|3|||
130989208|NCT00979602|471589495|FG001|Overall Study|Migrated/moved from study area|6|||
130989209|NCT00979602|471589494|FG000|Overall Study|Others|3|||
130989210|NCT00979602|471589495|FG001|Overall Study|Others|3|||
130989211|NCT02904902|471589496|FG000|Overall Study|Withdrawal by Subject|1|||
130989212|NCT02712398|471589497|FG000|Overall Study|Withdrawal by Subject|6|||
130989213|NCT02712398|471589497|FG000|Overall Study|Lost to Follow-up|6|||
130989214|NCT02712398|471589497|FG000|Overall Study|Sponsor Decision|1|||
130989215|NCT02712398|471589497|FG000|Overall Study|Physician Decision|1|||
130989216|NCT02712398|471589497|FG000|Overall Study|Death|2|||
130989217|NCT02712398|471589497|FG000|Overall Study|Re-operation|21|||
130989218|NCT01216163|471589502|FG000|Overall Study|Withdrawal by Subject|1|||
130989219|NCT01216163|471589503|FG001|Overall Study|Withdrawal by Subject|1|||
130989220|NCT01216163|471589504|FG002|Overall Study|Withdrawal by Subject|0|||
130989221|NCT02914314|471589505|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
130989222|NCT02914314|471589506|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
130989223|NCT02914314|471589507|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
130989224|NCT02914314|471589508|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
130989225|NCT02914314|471589505|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
130989226|NCT02914314|471589506|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
130989227|NCT02914314|471589507|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
130989228|NCT02914314|471589508|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
130989229|NCT02914314|471589505|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
130989230|NCT02914314|471589506|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
130989231|NCT02914314|471589507|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
130989232|NCT02914314|471589508|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
130989233|NCT02914314|471589505|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
130989234|NCT02914314|471589506|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
130989235|NCT02914314|471589507|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
130989236|NCT02914314|471589508|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
130989237|NCT02914314|471589505|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
130989238|NCT02914314|471589506|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
130989239|NCT02914314|471589507|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
130989240|NCT02914314|471589508|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
130989241|NCT01735396|471589512|FG000|Overall Study|not evaluable|1|||
130989242|NCT01224158|471589517|FG000|Overall Study|Withdrawal by Subject|1|||
130989243|NCT01224158|471589518|FG001|Overall Study|Withdrawal by Subject|0|||
130989244|NCT00733499|471589521|FG000|Pre-operative|Protocol Violation|0|||
130989245|NCT00733499|471589522|FG001|Pre-operative|Protocol Violation|1|||
130989246|NCT00733499|471589521|FG000|3 Months Follow-up|Death|1|||
130764266|NCT01870297|470760020|FG000|Overall Study|Adverse Event|0|||
130877833|NCT00979901|471185828|FG002|Overall Study|Discontinued in Error|0|||
130877834|NCT00979901|471185829|FG003|Overall Study|Discontinued in Error|0|||
130877835|NCT00979901|471185826|FG000|Overall Study|Left Country|0|||
130877836|NCT00979901|471185827|FG001|Overall Study|Left Country|0|||
130877837|NCT00979901|471185828|FG002|Overall Study|Left Country|1|||
130877838|NCT00979901|471185829|FG003|Overall Study|Left Country|0|||
130877839|NCT00979901|471185826|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
130877840|NCT00979901|471185827|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
130877841|NCT00979901|471185828|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
130877842|NCT00979901|471185829|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
130877843|NCT02182895|471185840|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
130877844|NCT02182895|471185841|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
130877845|NCT00286468|471185842|FG000|Overall Study|Hyperglycemic Rescue|28|||
130877846|NCT00286468|471185843|FG001|Overall Study|Hyperglycemic Rescue|30|||
130877847|NCT00286468|471185844|FG002|Overall Study|Hyperglycemic Rescue|31|||
130877848|NCT00286468|471185842|FG000|Overall Study|Adverse Event|2|||
130877849|NCT00286468|471185843|FG001|Overall Study|Adverse Event|6|||
130877850|NCT00286468|471185844|FG002|Overall Study|Adverse Event|4|||
130877851|NCT00286468|471185842|FG000|Overall Study|Protocol Violation|0|||
130877852|NCT00286468|471185843|FG001|Overall Study|Protocol Violation|3|||
130877853|NCT00286468|471185844|FG002|Overall Study|Protocol Violation|1|||
130877854|NCT00286468|471185842|FG000|Overall Study|Lost to Follow-up|1|||
130877855|NCT00286468|471185843|FG001|Overall Study|Lost to Follow-up|1|||
130877856|NCT00286468|471185844|FG002|Overall Study|Lost to Follow-up|2|||
130877857|NCT00286468|471185842|FG000|Overall Study|Withdrawal by Subject|3|||
130877858|NCT00286468|471185843|FG001|Overall Study|Withdrawal by Subject|8|||
130877859|NCT00286468|471185844|FG002|Overall Study|Withdrawal by Subject|11|||
130877860|NCT00286468|471185842|FG000|Overall Study|Physician Decision|3|||
130877861|NCT00286468|471185843|FG001|Overall Study|Physician Decision|2|||
130877862|NCT00286468|471185844|FG002|Overall Study|Physician Decision|1|||
130877863|NCT03305666|471185845|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
130877864|NCT03305666|471185846|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
130877865|NCT02230410|471185848|FG000|Overall Study|Screen Failure|3|||
130877866|NCT02587221|471185853|FG000|Overall Study|Adverse Event|3|||
130877867|NCT02587221|471185854|FG001|Overall Study|Adverse Event|3|||
130877868|NCT02587221|471185853|FG000|Overall Study|Death|33|||
130877869|NCT02587221|471185854|FG001|Overall Study|Death|34|||
130877870|NCT02587221|471185853|FG000|Overall Study|Withdrawal by Subject|66|||
130877871|NCT02587221|471185854|FG001|Overall Study|Withdrawal by Subject|61|||
130877872|NCT02587221|471185853|FG000|Overall Study|Lost to Follow-up|21|||
130877873|NCT02587221|471185854|FG001|Overall Study|Lost to Follow-up|19|||
130877874|NCT02587221|471185853|FG000|Overall Study|Protocol Violation|6|||
130877875|NCT02587221|471185854|FG001|Overall Study|Protocol Violation|5|||
130877876|NCT02587221|471185853|FG000|Overall Study|Other Reason or Unspecified|2|||
130877877|NCT02587221|471185854|FG001|Overall Study|Other Reason or Unspecified|1|||
130877878|NCT01791244|471185858|FG000|Overall Study|Adverse Event|5|||
130877879|NCT01791244|471185859|FG001|Overall Study|Adverse Event|7|||
130877880|NCT01791244|471185858|FG000|Overall Study|Insufficient clinical response|10|||
130877881|NCT01791244|471185859|FG001|Overall Study|Insufficient clinical response|10|||
130877882|NCT01791244|471185858|FG000|Overall Study|Laboratory Abnormality|0|||
130877883|NCT01791244|471185859|FG001|Overall Study|Laboratory Abnormality|1|||
130877884|NCT01383928|471185860|FG000|Overall Study|Initiation of ASCT|2|||
130877885|NCT01383928|471185861|FG001|Overall Study|Initiation of ASCT|1|||
130877886|NCT01383928|471185862|FG002|Overall Study|Initiation of ASCT|18|||
130877887|NCT01383928|471185860|FG000|Overall Study|Adverse Event|1|||
130877888|NCT01383928|471185861|FG001|Overall Study|Adverse Event|2|||
130877889|NCT01383928|471185862|FG002|Overall Study|Adverse Event|8|||
130877890|NCT01383928|471185860|FG000|Overall Study|Other|1|||
130877891|NCT01383928|471185861|FG001|Overall Study|Other|3|||
130877892|NCT01383928|471185862|FG002|Overall Study|Other|4|||
130877893|NCT01383928|471185860|FG000|Overall Study|Progressive Disease|1|||
130877894|NCT01383928|471185861|FG001|Overall Study|Progressive Disease|1|||
130877895|NCT01383928|471185862|FG002|Overall Study|Progressive Disease|5|||
130877896|NCT01383928|471185860|FG000|Overall Study|Withdrawal by Subject|0|||
130877897|NCT01383928|471185861|FG001|Overall Study|Withdrawal by Subject|0|||
130877898|NCT01383928|471185862|FG002|Overall Study|Withdrawal by Subject|4|||
130877899|NCT01383928|471185860|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
130877900|NCT01383928|471185861|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
130877901|NCT01383928|471185862|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
130877902|NCT01149096|471185864|FG000|Overall Study|Lost to Follow-up|0|||
130877903|NCT01149096|471185865|FG001|Overall Study|Lost to Follow-up|1|||
130877904|NCT03651765|471185867|FG000|Overall Study|Adverse Event|6|||
130877905|NCT03651765|471185867|FG000|Overall Study|Lack of Efficacy|18|||
130989247|NCT00733499|471589522|FG001|3 Months Follow-up|Death|2|||
130989248|NCT00733499|471589521|FG000|6 Months Follow-up|Death|0|||
130989249|NCT00733499|471589522|FG001|6 Months Follow-up|Death|2|||
130989250|NCT00733499|471589521|FG000|6 Months Follow-up|Adverse Event|0|||
130989251|NCT00733499|471589522|FG001|6 Months Follow-up|Adverse Event|1|||
130989252|NCT00733499|471589521|FG000|12 Months Follow-up|Death|2|||
130989253|NCT00733499|471589522|FG001|12 Months Follow-up|Death|1|||
130989254|NCT00733499|471589521|FG000|24 Months Follow-up|Death|0|||
130989255|NCT00733499|471589522|FG001|24 Months Follow-up|Death|1|||
130989256|NCT00733499|471589521|FG000|5 Year Followup|Adverse Event|2|||
130989257|NCT00733499|471589522|FG001|5 Year Followup|Adverse Event|2|||
130989258|NCT00733499|471589521|FG000|5 Year Followup|Non device related AE|0|||
130989259|NCT00733499|471589522|FG001|5 Year Followup|Non device related AE|1|||
130989260|NCT00733499|471589521|FG000|5 Year Followup|Revision of Study Implant|0|||
130989261|NCT00733499|471589522|FG001|5 Year Followup|Revision of Study Implant|1|||
130989262|NCT00733499|471589521|FG000|5 Year Followup|Lost to Follow-up|2|||
130989263|NCT00733499|471589522|FG001|5 Year Followup|Lost to Follow-up|0|||
130989264|NCT00733499|471589521|FG000|5 Year Followup|Death|13|||
130989265|NCT00733499|471589522|FG001|5 Year Followup|Death|19|||
130989266|NCT00733499|471589521|FG000|5 Year Followup|missing, unable to locate|0|||
130989267|NCT00733499|471589522|FG001|5 Year Followup|missing, unable to locate|1|||
130989268|NCT00733499|471589521|FG000|5 Year Followup|Withdrawal by Subject|4|||
130989269|NCT00733499|471589522|FG001|5 Year Followup|Withdrawal by Subject|1|||
130989270|NCT00733499|471589521|FG000|10 Year Followup|Death|9|||
130989271|NCT00733499|471589522|FG001|10 Year Followup|Death|7|||
130989272|NCT00733499|471589521|FG000|10 Year Followup|Adverse Event|3|||
130989273|NCT00733499|471589522|FG001|10 Year Followup|Adverse Event|3|||
130989274|NCT00733499|471589521|FG000|10 Year Followup|Lost to Follow-up|3|||
130989275|NCT00733499|471589522|FG001|10 Year Followup|Lost to Follow-up|2|||
130989276|NCT00733499|471589521|FG000|10 Year Followup|Withdrawal by Subject|5|||
130989277|NCT00733499|471589522|FG001|10 Year Followup|Withdrawal by Subject|5|||
130989278|NCT00733499|471589521|FG000|10 Year Followup|missing, unable to locate|0|||
130989279|NCT00733499|471589522|FG001|10 Year Followup|missing, unable to locate|2|||
130989280|NCT01778556|471589523|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
130989281|NCT01778556|471589524|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
130989282|NCT01778556|471589523|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130989283|NCT01778556|471589524|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
130989284|NCT01778556|471589523|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
130989285|NCT01778556|471589524|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
130989286|NCT01778556|471589523|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
130989287|NCT01778556|471589524|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
130989288|NCT01235403|471589528|FG000|Overall Study|Adverse Event|14|||
130989289|NCT01235403|471589528|FG000|Overall Study|Lost to Follow-up|2|||
130989290|NCT01235403|471589528|FG000|Overall Study|Withdrawal by Subject|4|||
130989291|NCT01235403|471589528|FG000|Overall Study|Lack of Efficacy|2|||
130989292|NCT01235403|471589528|FG000|Overall Study|Other reasons for premature termination|4|||
130989293|NCT02296190|471589529|FG000|Overall Study|Lost to Follow-up|0|||
130989294|NCT02296190|471589530|FG001|Overall Study|Lost to Follow-up|0|||
130989295|NCT02296190|471589531|FG002|Overall Study|Lost to Follow-up|0|||
130989296|NCT02296190|471589532|FG003|Overall Study|Lost to Follow-up|0|||
130989297|NCT02296190|471589533|FG004|Overall Study|Lost to Follow-up|1|||
130989298|NCT02296190|471589534|FG005|Overall Study|Lost to Follow-up|0|||
130989299|NCT02296190|471589529|FG000|Overall Study|Failure to induce PSVT|6|||
130989300|NCT02296190|471589530|FG001|Overall Study|Failure to induce PSVT|10|||
130989301|NCT02296190|471589531|FG002|Overall Study|Failure to induce PSVT|5|||
130989302|NCT02296190|471589532|FG003|Overall Study|Failure to induce PSVT|13|||
130989303|NCT02296190|471589533|FG004|Overall Study|Failure to induce PSVT|8|||
130989304|NCT02296190|471589534|FG005|Overall Study|Failure to induce PSVT|0|||
130989305|NCT02296190|471589529|FG000|Overall Study|Physician Decision|1|||
130989306|NCT02296190|471589530|FG001|Overall Study|Physician Decision|1|||
130989307|NCT02296190|471589531|FG002|Overall Study|Physician Decision|0|||
130989308|NCT02296190|471589532|FG003|Overall Study|Physician Decision|1|||
130989309|NCT02296190|471589533|FG004|Overall Study|Physician Decision|2|||
130989310|NCT02296190|471589534|FG005|Overall Study|Physician Decision|0|||
130989311|NCT02296190|471589529|FG000|Overall Study|Withdrawal by Subject|0|||
130989312|NCT02296190|471589530|FG001|Overall Study|Withdrawal by Subject|1|||
130989313|NCT02296190|471589531|FG002|Overall Study|Withdrawal by Subject|0|||
130989314|NCT02296190|471589532|FG003|Overall Study|Withdrawal by Subject|0|||
130989315|NCT02296190|471589533|FG004|Overall Study|Withdrawal by Subject|0|||
130989316|NCT02296190|471589534|FG005|Overall Study|Withdrawal by Subject|0|||
130989317|NCT02296190|471589529|FG000|Overall Study|PSVT < 5 minutes|5|||
130989318|NCT02296190|471589530|FG001|Overall Study|PSVT < 5 minutes|6|||
130989319|NCT02296190|471589531|FG002|Overall Study|PSVT < 5 minutes|6|||
130989320|NCT02296190|471589532|FG003|Overall Study|PSVT < 5 minutes|6|||
130989321|NCT02296190|471589533|FG004|Overall Study|PSVT < 5 minutes|5|||
130989322|NCT02296190|471589534|FG005|Overall Study|PSVT < 5 minutes|0|||
130989323|NCT02296190|471589529|FG000|Overall Study|Patient was given Propofol|0|||
130989324|NCT02296190|471589530|FG001|Overall Study|Patient was given Propofol|1|||
130989325|NCT02296190|471589531|FG002|Overall Study|Patient was given Propofol|0|||
130989326|NCT02296190|471589532|FG003|Overall Study|Patient was given Propofol|1|||
130989327|NCT02296190|471589533|FG004|Overall Study|Patient was given Propofol|0|||
130989328|NCT02296190|471589534|FG005|Overall Study|Patient was given Propofol|0|||
130989329|NCT02296190|471589529|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
130989330|NCT02296190|471589530|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
130989331|NCT02296190|471589531|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
130989332|NCT02296190|471589532|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
130989333|NCT02296190|471589533|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
130989334|NCT02296190|471589534|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
130989335|NCT02296190|471589529|FG000|Overall Study|Blood pressure <100 after sedation|0|||
130989336|NCT02296190|471589530|FG001|Overall Study|Blood pressure <100 after sedation|0|||
130989337|NCT02296190|471589531|FG002|Overall Study|Blood pressure <100 after sedation|0|||
130989338|NCT02296190|471589532|FG003|Overall Study|Blood pressure <100 after sedation|1|||
130989339|NCT02296190|471589533|FG004|Overall Study|Blood pressure <100 after sedation|0|||
130989340|NCT02296190|471589534|FG005|Overall Study|Blood pressure <100 after sedation|0|||
130989341|NCT02296190|471589529|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
130989342|NCT02296190|471589530|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
130989343|NCT02296190|471589531|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
130989344|NCT02296190|471589532|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
130989345|NCT02296190|471589533|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
130989346|NCT02296190|471589534|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
130989347|NCT02296190|471589529|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
130989348|NCT02296190|471589530|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
130989349|NCT02296190|471589531|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
130989350|NCT02296190|471589532|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
130989351|NCT02296190|471589533|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
130989352|NCT02296190|471589534|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
130989353|NCT02296190|471589529|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
130989354|NCT02296190|471589530|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
130989355|NCT02296190|471589531|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
130989356|NCT02296190|471589532|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
130989357|NCT02296190|471589533|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
130989358|NCT02296190|471589534|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
130989359|NCT02296190|471589529|FG000|Overall Study|Lab result not available in time|1|||
130989360|NCT02296190|471589530|FG001|Overall Study|Lab result not available in time|0|||
130989361|NCT02296190|471589531|FG002|Overall Study|Lab result not available in time|0|||
131213016|NCT00948896|472403062|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
131213017|NCT00948896|472403063|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131213018|NCT00948896|472403064|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131213019|NCT00948896|472403065|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131213020|NCT00948896|472403066|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
131213021|NCT03795233|472403067|FG000|Overall Study|Withdrawal by Subject|2|||
131213022|NCT03795233|472403068|FG001|Overall Study|Withdrawal by Subject|1|||
131213023|NCT03795233|472403067|FG000|Overall Study|Lost to Follow-up|1|||
131213024|NCT03795233|472403068|FG001|Overall Study|Lost to Follow-up|0|||
131213025|NCT03795233|472403067|FG000|Overall Study|Death|1|||
131213026|NCT03795233|472403068|FG001|Overall Study|Death|0|||
131213027|NCT05403502|472403069|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
131213028|NCT05403502|472403069|FG000|Humalog Lead-In Period|Physician Decision|2|||
131213029|NCT05403502|472403069|FG000|Humalog Lead-In Period|Protocol Violation|1|||
131213030|NCT05403502|472403069|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
131213031|NCT05403502|472403069|FG000|Lyumjev Treatment Period|Physician Decision|2|||
131213032|NCT01054443|472403070|FG000|Overall Study|Withdrawal by Subject|0|||
131213033|NCT01054443|472403071|FG001|Overall Study|Withdrawal by Subject|0|||
131213034|NCT01054443|472403072|FG002|Overall Study|Withdrawal by Subject|0|||
131213035|NCT01054443|472403073|FG003|Overall Study|Withdrawal by Subject|1|||
131213036|NCT00985114|472403075|FG000|Overall Study|Adverse Event|1|||
131213037|NCT00985114|472403076|FG001|Overall Study|Adverse Event|0|||
131213038|NCT00985114|472403075|FG000|Overall Study|Withdrawal by Subject|0|||
131213039|NCT00985114|472403076|FG001|Overall Study|Withdrawal by Subject|2|||
131213040|NCT01119118|472403077|FG000|Overall Study|Adverse Event|1|||
131213041|NCT00167414|472403081|FG000|Overall Study|Death|10|||
131213042|NCT01869959|472403088|FG000|Randomization Period|Physician Decision|0|||
131213043|NCT01869959|472403089|FG001|Randomization Period|Physician Decision|0|||
131213044|NCT01869959|472403090|FG002|Randomization Period|Physician Decision|0|||
131213045|NCT01869959|472403091|FG003|Randomization Period|Physician Decision|0|||
131213046|NCT01869959|472403092|FG004|Randomization Period|Physician Decision|1|||
131213047|NCT01869959|472403088|FG000|Treatment Period|Adverse Event|1|||
131213048|NCT01869959|472403089|FG001|Treatment Period|Adverse Event|0|||
131213049|NCT01869959|472403090|FG002|Treatment Period|Adverse Event|3|||
130764267|NCT01870297|470760021|FG001|Overall Study|Adverse Event|0|||
131213050|NCT01869959|472403091|FG003|Treatment Period|Adverse Event|1|||
131213051|NCT01869959|472403092|FG004|Treatment Period|Adverse Event|0|||
131213052|NCT01869959|472403088|FG000|Treatment Period|Sponsor decision|0|||
131213053|NCT01869959|472403089|FG001|Treatment Period|Sponsor decision|1|||
131213054|NCT01869959|472403090|FG002|Treatment Period|Sponsor decision|0|||
130989362|NCT02296190|471589532|FG003|Overall Study|Lab result not available in time|0|||
130989363|NCT02296190|471589533|FG004|Overall Study|Lab result not available in time|0|||
130989364|NCT02296190|471589534|FG005|Overall Study|Lab result not available in time|0|||
130989365|NCT00782496|471589535|FG000|Overall Study|Lost to Follow-up|14|||
130989366|NCT00782496|471589536|FG001|Overall Study|Lost to Follow-up|15|||
130989367|NCT03682705|471589539|FG000|Overall Study|Adverse Event|1|||
130989368|NCT03682705|471589540|FG001|Overall Study|Adverse Event|1|||
130989369|NCT03682705|471589541|FG002|Overall Study|Adverse Event|1|||
130989370|NCT03682705|471589542|FG003|Overall Study|Adverse Event|0|||
130989371|NCT03682705|471589543|FG004|Overall Study|Adverse Event|1|||
130989372|NCT03682705|471589544|FG005|Overall Study|Adverse Event|1|||
130989373|NCT03682705|471589539|FG000|Overall Study|Withdrawal by Subject|1|||
130989374|NCT03682705|471589540|FG001|Overall Study|Withdrawal by Subject|3|||
130989375|NCT03682705|471589541|FG002|Overall Study|Withdrawal by Subject|2|||
130989376|NCT03682705|471589542|FG003|Overall Study|Withdrawal by Subject|4|||
130989377|NCT03682705|471589543|FG004|Overall Study|Withdrawal by Subject|0|||
130989378|NCT03682705|471589544|FG005|Overall Study|Withdrawal by Subject|1|||
130989379|NCT03682705|471589539|FG000|Overall Study|Other, not specified|0|||
130989380|NCT03682705|471589540|FG001|Overall Study|Other, not specified|0|||
130989381|NCT03682705|471589541|FG002|Overall Study|Other, not specified|0|||
130989382|NCT03682705|471589542|FG003|Overall Study|Other, not specified|1|||
130989383|NCT03682705|471589543|FG004|Overall Study|Other, not specified|2|||
130989384|NCT03682705|471589544|FG005|Overall Study|Other, not specified|0|||
130989385|NCT03682705|471589539|FG000|Overall Study|Lost to Follow-up|0|||
130989386|NCT03682705|471589540|FG001|Overall Study|Lost to Follow-up|0|||
130989387|NCT03682705|471589541|FG002|Overall Study|Lost to Follow-up|0|||
130989388|NCT03682705|471589542|FG003|Overall Study|Lost to Follow-up|0|||
130989389|NCT03682705|471589543|FG004|Overall Study|Lost to Follow-up|3|||
130989390|NCT03682705|471589544|FG005|Overall Study|Lost to Follow-up|0|||
130989391|NCT00117156|471589545|FG000|Overall Study|Adverse Event|9|||
130989392|NCT00117156|471589545|FG000|Overall Study|Physician Decision|1|||
130989393|NCT00117156|471589545|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
130989394|NCT01919970|471589546|FG000|Overall Study|Withdrawal by Subject|3|||
130989395|NCT01919970|471589547|FG001|Overall Study|Withdrawal by Subject|0|||
130989396|NCT00990340|471589549|FG000|First 14-day Treatment|Not Compliant|2|||
130989397|NCT00990340|471589550|FG001|First 14-day Treatment|Not Compliant|1|||
130989398|NCT00990340|471589549|FG000|First 14-day Treatment|Lost to Follow-up|2|||
130989399|NCT00990340|471589550|FG001|First 14-day Treatment|Lost to Follow-up|1|||
130989400|NCT00990340|471589549|FG000|First 14-day Treatment|Protocol Violation|2|||
130989401|NCT00990340|471589550|FG001|First 14-day Treatment|Protocol Violation|2|||
130989402|NCT04615182|471589551|FG000|Overall Study|Re-transplanted|2|||
130989403|NCT04615182|471589551|FG000|Overall Study|Protocol Violation|6|||
130989404|NCT04615182|471589551|FG000|Overall Study|Death|6|||
130989405|NCT04615182|471589551|FG000|Overall Study|Death and protocol violation|1|||
130989406|NCT00402337|471589557|FG000|Overall Study|Adverse Event|0|||
130989407|NCT00402337|471589558|FG001|Overall Study|Adverse Event|2|||
130989408|NCT00402337|471589559|FG002|Overall Study|Adverse Event|2|||
130989409|NCT00402337|471589560|FG003|Overall Study|Adverse Event|3|||
130989410|NCT00402337|471589561|FG004|Overall Study|Adverse Event|2|||
130989411|NCT00402337|471589557|FG000|Overall Study|Noncompliance|0|||
130989412|NCT00402337|471589558|FG001|Overall Study|Noncompliance|0|||
130989413|NCT00402337|471589559|FG002|Overall Study|Noncompliance|0|||
130989414|NCT00402337|471589560|FG003|Overall Study|Noncompliance|0|||
130989415|NCT00402337|471589561|FG004|Overall Study|Noncompliance|2|||
130989416|NCT00402337|471589557|FG000|Overall Study|Withdrawal by Subject|5|||
130989417|NCT00402337|471589558|FG001|Overall Study|Withdrawal by Subject|3|||
130989418|NCT00402337|471589559|FG002|Overall Study|Withdrawal by Subject|1|||
130989419|NCT00402337|471589560|FG003|Overall Study|Withdrawal by Subject|6|||
130989420|NCT00402337|471589561|FG004|Overall Study|Withdrawal by Subject|4|||
130989421|NCT00402337|471589557|FG000|Overall Study|Lost to Follow-up|0|||
130989422|NCT00402337|471589558|FG001|Overall Study|Lost to Follow-up|0|||
130989423|NCT00402337|471589559|FG002|Overall Study|Lost to Follow-up|1|||
130989424|NCT00402337|471589560|FG003|Overall Study|Lost to Follow-up|2|||
130989425|NCT00402337|471589561|FG004|Overall Study|Lost to Follow-up|0|||
131213055|NCT01869959|472403091|FG003|Treatment Period|Sponsor decision|1|||
130989426|NCT00402337|471589557|FG000|Overall Study|Physician Decision|0|||
130989427|NCT00402337|471589558|FG001|Overall Study|Physician Decision|0|||
130989428|NCT00402337|471589559|FG002|Overall Study|Physician Decision|0|||
130989429|NCT00402337|471589560|FG003|Overall Study|Physician Decision|1|||
130989430|NCT00402337|471589561|FG004|Overall Study|Physician Decision|0|||
130989431|NCT00402337|471589557|FG000|Overall Study|Other Reason|0|||
130989432|NCT00402337|471589558|FG001|Overall Study|Other Reason|1|||
131213056|NCT01869959|472403092|FG004|Treatment Period|Sponsor decision|0|||
130989433|NCT00402337|471589559|FG002|Overall Study|Other Reason|0|||
130989434|NCT00402337|471589560|FG003|Overall Study|Other Reason|0|||
130989435|NCT00402337|471589561|FG004|Overall Study|Other Reason|0|||
130989436|NCT02178566|471589562|FG000|Overall Study|patient did not complete due to noncompliance|0|||
130989437|NCT02178566|471589563|FG001|Overall Study|patient did not complete due to noncompliance|1|||
130989438|NCT04631705|471589564|FG000|Overall Study|Withdrawal by Subject|0|||
130989439|NCT04631705|471589565|FG001|Overall Study|Withdrawal by Subject|0|||
130989440|NCT04631705|471589566|FG002|Overall Study|Withdrawal by Subject|0|||
130989441|NCT04631705|471589567|FG003|Overall Study|Withdrawal by Subject|0|||
130989442|NCT04631705|471589568|FG004|Overall Study|Withdrawal by Subject|0|||
130989443|NCT04631705|471589569|FG005|Overall Study|Withdrawal by Subject|0|||
130989444|NCT04631705|471589570|FG006|Overall Study|Withdrawal by Subject|1|||
130989445|NCT04631705|471589571|FG007|Overall Study|Withdrawal by Subject|0|||
130989446|NCT04631705|471589572|FG008|Overall Study|Withdrawal by Subject|0|||
130989447|NCT02070484|471589575|FG000|Overall Study|Withdrawal by Subject|1|||
130989448|NCT02070484|471589576|FG001|Overall Study|Withdrawal by Subject|0|||
130989449|NCT02658630|471589577|FG000|Overall Study|Withdrawal by Subject|4|||
130989450|NCT02130284|471589578|FG000|Overall Study|Withdrawal by Subject|3|||
130989451|NCT02130284|471589578|FG000|Overall Study|Subject Withdrew Consent|1|||
130989452|NCT02130284|471589578|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
130989453|NCT02130284|471589578|FG000|Overall Study|Subject was screened as backup for study|3|||
130989454|NCT02130284|471589578|FG000|Overall Study|Screen Failure|1|||
130989455|NCT00682643|471589579|FG000|Overall Study|Adverse Event|12|||
130989456|NCT00682643|471589580|FG001|Overall Study|Adverse Event|23|||
130989457|NCT00682643|471589579|FG000|Overall Study|Lack of Efficacy|2|||
130989458|NCT00682643|471589580|FG001|Overall Study|Lack of Efficacy|0|||
130989459|NCT00682643|471589579|FG000|Overall Study|Protocol Violation|38|||
130989460|NCT00682643|471589580|FG001|Overall Study|Protocol Violation|76|||
130989461|NCT00682643|471589579|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
130989462|NCT00682643|471589580|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
130989463|NCT00682643|471589579|FG000|Overall Study|Lost to Follow-up|1|||
130989464|NCT00682643|471589580|FG001|Overall Study|Lost to Follow-up|6|||
130989465|NCT00682643|471589579|FG000|Overall Study|Physician Decision|2|||
130989466|NCT00682643|471589580|FG001|Overall Study|Physician Decision|6|||
130989467|NCT00682643|471589579|FG000|Overall Study|Withdrawal by Subject|19|||
130989468|NCT00682643|471589580|FG001|Overall Study|Withdrawal by Subject|53|||
130989469|NCT00682643|471589579|FG000|Overall Study|Did Not Receive Study Drug|1|||
130989470|NCT00682643|471589580|FG001|Overall Study|Did Not Receive Study Drug|1|||
130989471|NCT00085202|471589581|FG000|Overall Study|Still on therapy|2|||
130989472|NCT00085202|471589582|FG001|Overall Study|Still on therapy|0|||
130989473|NCT00085202|471589581|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
130989474|NCT00085202|471589582|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
130989475|NCT00085202|471589581|FG000|Overall Study|Excessive toxicity|6|||
130989476|NCT00085202|471589582|FG001|Overall Study|Excessive toxicity|5|||
130989477|NCT00085202|471589581|FG000|Overall Study|Non-specified|3|||
130989478|NCT00085202|471589582|FG001|Overall Study|Non-specified|5|||
130989479|NCT00085202|471589581|FG000|Overall Study|Withdrawal by Subject|2|||
130989480|NCT00085202|471589582|FG001|Overall Study|Withdrawal by Subject|1|||
130989481|NCT00085202|471589581|FG000|Overall Study|Physician Decision|4|||
130989482|NCT00085202|471589582|FG001|Overall Study|Physician Decision|1|||
130989483|NCT00085202|471589581|FG000|Overall Study|Progressive disease|1|||
130989484|NCT00085202|471589582|FG001|Overall Study|Progressive disease|11|||
130989485|NCT01435655|471589587|FG000|Overall Study|Death|2|||
130989486|NCT01435655|471589587|FG000|Overall Study|Other|1|||
130989487|NCT01436201|471589588|FG000|Overall Study|Adverse Event|2|||
130989488|NCT01436201|471589588|FG000|Overall Study|Withdrawal by Subject|1|||
130989489|NCT01436201|471589588|FG000|Overall Study|Protocol Violation|1|||
130989490|NCT00110890|471589589|FG000|Overall Study|Adverse Event|30|||
130989491|NCT00110890|471589590|FG001|Overall Study|Adverse Event|7|||
130989492|NCT00110890|471589589|FG000|Overall Study|Death|16|||
130989493|NCT00110890|471589590|FG001|Overall Study|Death|9|||
130989494|NCT00110890|471589589|FG000|Overall Study|Lost to Follow-up|3|||
130989495|NCT00110890|471589590|FG001|Overall Study|Lost to Follow-up|1|||
130989496|NCT00110890|471589589|FG000|Overall Study|Physician Decision|4|||
130989497|NCT00110890|471589590|FG001|Overall Study|Physician Decision|5|||
130989498|NCT00110890|471589589|FG000|Overall Study|Withdrawal by Subject|17|||
130989499|NCT00110890|471589590|FG001|Overall Study|Withdrawal by Subject|5|||
130989500|NCT00110890|471589589|FG000|Overall Study|Protocol Deviation|1|||
130989501|NCT00110890|471589590|FG001|Overall Study|Protocol Deviation|0|||
130989502|NCT00110890|471589589|FG000|Overall Study|Noncompliance|10|||
130989503|NCT00110890|471589590|FG001|Overall Study|Noncompliance|0|||
130989504|NCT00110890|471589589|FG000|Overall Study|Kidney Transplant|16|||
130989505|NCT00110890|471589590|FG001|Overall Study|Kidney Transplant|12|||
130989506|NCT00110890|471589589|FG000|Overall Study|Invest. Product Commercially Available|217|||
130989507|NCT00110890|471589590|FG001|Overall Study|Invest. Product Commercially Available|110|||
130989508|NCT00110890|471589589|FG000|Overall Study|Other|34|||
130989509|NCT00110890|471589590|FG001|Overall Study|Other|23|||
130989510|NCT00110890|471589589|FG000|Overall Study|Ineligibility determined|3|||
130989511|NCT00110890|471589590|FG001|Overall Study|Ineligibility determined|0|||
130989512|NCT00110890|471589589|FG000|Overall Study|Requirement for alternative therapy|0|||
130989513|NCT00110890|471589590|FG001|Overall Study|Requirement for alternative therapy|1|||
130989514|NCT00110890|471589589|FG000|Overall Study|Disease progression|0|||
130989515|NCT00110890|471589590|FG001|Overall Study|Disease progression|1|||
130989516|NCT00110890|471589589|FG000|Overall Study|Parathyroidectomy|0|||
130989517|NCT00110890|471589590|FG001|Overall Study|Parathyroidectomy|1|||
130989518|NCT00110890|471589589|FG000|Overall Study|Did not enter follow-up phase|10|||
130989519|NCT00110890|471589590|FG001|Overall Study|Did not enter follow-up phase|4|||
130989520|NCT01975220|471589591|FG000|Test Period 1|Not treated|0|||
130989521|NCT01975220|471589592|FG001|Test Period 1|Not treated|1|||
130989522|NCT01975220|471589593|FG002|Test Period 1|Not treated|0|||
130989523|NCT01975220|471589594|FG003|Test Period 1|Not treated|0|||
130989524|NCT01975220|471589595|FG004|Test Period 1|Not treated|0|||
130989525|NCT01975220|471589596|FG005|Test Period 1|Not treated|0|||
130989526|NCT02839343|471589597|FG000|Overall Study|Withdrawal by Subject|3|||
130989527|NCT02839343|471589598|FG001|Overall Study|Withdrawal by Subject|1|||
130989528|NCT02839343|471589597|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
130989529|NCT02839343|471589598|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
130989530|NCT02839343|471589597|FG000|Overall Study|Adverse Event|1|||
130989531|NCT02839343|471589598|FG001|Overall Study|Adverse Event|0|||
130989532|NCT01852058|471589601|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
130989533|NCT01852058|471589602|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989534|NCT01852058|471589603|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989535|NCT01852058|471589604|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989536|NCT01852058|471589605|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989537|NCT01852058|471589606|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989538|NCT01852058|471589607|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989539|NCT01852058|471589608|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989540|NCT01852058|471589609|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989541|NCT01852058|471589610|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989542|NCT01852058|471589611|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989543|NCT01852058|471589612|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
130989544|NCT01852058|471589601|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989545|NCT01852058|471589602|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989546|NCT01852058|471589603|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989547|NCT01852058|471589604|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989548|NCT01852058|471589605|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
130989549|NCT01852058|471589606|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989550|NCT01852058|471589607|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989551|NCT01852058|471589608|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989552|NCT01852058|471589609|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989553|NCT01852058|471589610|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989554|NCT01852058|471589611|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989555|NCT01852058|471589612|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
130989556|NCT01852058|471589601|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130989557|NCT01852058|471589602|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130989558|NCT01852058|471589603|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130989559|NCT01852058|471589604|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130989560|NCT01852058|471589605|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
130989561|NCT01852058|471589606|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
130989562|NCT01852058|471589607|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130989563|NCT01852058|471589608|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130989564|NCT01852058|471589609|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130989565|NCT01852058|471589610|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130989566|NCT01852058|471589611|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130989567|NCT01852058|471589612|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130989568|NCT01852058|471589601|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130989569|NCT01852058|471589602|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130989570|NCT01852058|471589603|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130989571|NCT01852058|471589604|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130989572|NCT01852058|471589605|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
130989573|NCT01852058|471589606|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130989574|NCT01852058|471589607|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130989575|NCT01852058|471589608|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130989576|NCT01852058|471589609|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130877906|NCT03651765|471185867|FG000|Overall Study|Lost to Follow-up|5|||
130989577|NCT01852058|471589610|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130989578|NCT01852058|471589611|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130989579|NCT01852058|471589612|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
130989580|NCT01852058|471589601|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130989581|NCT01852058|471589602|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130989582|NCT01852058|471589603|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130989583|NCT01852058|471589604|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130989584|NCT01852058|471589605|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
130989585|NCT01852058|471589606|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
130989586|NCT01852058|471589607|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130989587|NCT01852058|471589608|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130989588|NCT01852058|471589609|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130989589|NCT01852058|471589610|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130989590|NCT01852058|471589611|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130989591|NCT01852058|471589612|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
130989592|NCT01852058|471589601|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130989593|NCT01852058|471589602|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130989594|NCT01852058|471589603|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130989595|NCT01852058|471589604|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
130989596|NCT01852058|471589605|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130989597|NCT01852058|471589606|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130989598|NCT01852058|471589607|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130989599|NCT01852058|471589608|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130989600|NCT01852058|471589609|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130989601|NCT01852058|471589610|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130989602|NCT01852058|471589611|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130989603|NCT01852058|471589612|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
130764268|NCT01870297|470760022|FG002|Overall Study|Adverse Event|0|||
130764269|NCT01870297|470760023|FG003|Overall Study|Adverse Event|0|||
130764270|NCT01870297|470760024|FG004|Overall Study|Adverse Event|2|||
130764271|NCT01870297|470760025|FG005|Overall Study|Adverse Event|0|||
130764272|NCT01870297|470760026|FG006|Overall Study|Adverse Event|0|||
130764273|NCT01870297|470760020|FG000|Overall Study|Lost to Follow-up|0|||
130764274|NCT01870297|470760021|FG001|Overall Study|Lost to Follow-up|1|||
130764275|NCT01870297|470760022|FG002|Overall Study|Lost to Follow-up|1|||
130764276|NCT01870297|470760023|FG003|Overall Study|Lost to Follow-up|0|||
130764277|NCT01870297|470760024|FG004|Overall Study|Lost to Follow-up|0|||
130764278|NCT01870297|470760025|FG005|Overall Study|Lost to Follow-up|0|||
130764279|NCT01870297|470760026|FG006|Overall Study|Lost to Follow-up|0|||
130764280|NCT01870297|470760020|FG000|Overall Study|Withdrawal by Subject|0|||
130764281|NCT01870297|470760021|FG001|Overall Study|Withdrawal by Subject|0|||
130764282|NCT01870297|470760022|FG002|Overall Study|Withdrawal by Subject|0|||
130764283|NCT01870297|470760023|FG003|Overall Study|Withdrawal by Subject|0|||
130764284|NCT01870297|470760024|FG004|Overall Study|Withdrawal by Subject|1|||
130764285|NCT01870297|470760025|FG005|Overall Study|Withdrawal by Subject|1|||
130764286|NCT01870297|470760026|FG006|Overall Study|Withdrawal by Subject|1|||
130764287|NCT01870297|470760020|FG000|Overall Study|Sponsor Decision|0|||
130764288|NCT01870297|470760021|FG001|Overall Study|Sponsor Decision|6|||
130764289|NCT01870297|470760022|FG002|Overall Study|Sponsor Decision|0|||
130764290|NCT01870297|470760023|FG003|Overall Study|Sponsor Decision|0|||
130764291|NCT01870297|470760024|FG004|Overall Study|Sponsor Decision|0|||
130764292|NCT01870297|470760025|FG005|Overall Study|Sponsor Decision|0|||
130764293|NCT01870297|470760026|FG006|Overall Study|Sponsor Decision|1|||
130764294|NCT00337779|470760027|FG000|Overall Study|Withdrawal by Subject|10|||
130764295|NCT00337779|470760028|FG001|Overall Study|Withdrawal by Subject|12|||
130764296|NCT00337779|470760027|FG000|Overall Study|Sponsor decision|1|||
130764297|NCT00337779|470760028|FG001|Overall Study|Sponsor decision|1|||
130764298|NCT00337779|470760027|FG000|Overall Study|Physician Decision|3|||
130764299|NCT00337779|470760028|FG001|Overall Study|Physician Decision|6|||
130764300|NCT00337779|470760027|FG000|Overall Study|Protocol Violation|1|||
130764301|NCT00337779|470760028|FG001|Overall Study|Protocol Violation|1|||
130764302|NCT00337779|470760027|FG000|Overall Study|Lost to Follow-up|6|||
130764303|NCT00337779|470760028|FG001|Overall Study|Lost to Follow-up|5|||
130877907|NCT03651765|471185867|FG000|Overall Study|Non-Compliance with Study Drug|4|||
130877908|NCT03651765|471185867|FG000|Overall Study|Physician Decision|6|||
130764304|NCT00337779|470760027|FG000|Overall Study|Adverse Event|28|||
130764305|NCT00337779|470760028|FG001|Overall Study|Adverse Event|51|||
130877909|NCT03651765|471185867|FG000|Overall Study|Pregnancy|1|||
130764306|NCT00337779|470760027|FG000|Overall Study|Pregnancy|3|||
130764307|NCT00337779|470760028|FG001|Overall Study|Pregnancy|2|||
130764308|NCT00337779|470760027|FG000|Overall Study|Death|0|||
130989604|NCT01852058|471589601|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130989605|NCT01852058|471589602|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130989606|NCT01852058|471589603|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130989607|NCT01852058|471589604|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130989608|NCT01852058|471589605|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
130989609|NCT01852058|471589606|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
130989610|NCT01852058|471589607|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130989611|NCT01852058|471589608|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130989612|NCT01852058|471589609|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130989613|NCT01852058|471589610|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130989614|NCT01852058|471589611|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130989615|NCT01852058|471589612|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
130989616|NCT01852058|471589601|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989617|NCT01852058|471589602|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989618|NCT01852058|471589603|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989619|NCT01852058|471589604|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989620|NCT01852058|471589605|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989621|NCT01852058|471589606|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989622|NCT01852058|471589607|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989623|NCT01852058|471589608|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
130989624|NCT01852058|471589609|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989625|NCT01852058|471589610|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989626|NCT01852058|471589611|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989627|NCT01852058|471589612|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
130989628|NCT01852058|471589601|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989629|NCT01852058|471589602|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989630|NCT01852058|471589603|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989631|NCT01852058|471589604|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989632|NCT01852058|471589605|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989633|NCT01852058|471589606|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989634|NCT01852058|471589607|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989635|NCT01852058|471589608|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989636|NCT01852058|471589609|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
130989637|NCT01852058|471589610|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989638|NCT01852058|471589611|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989639|NCT01852058|471589612|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
130989640|NCT00263328|471589613|FG000|Overall Study|Death|0|||
130989641|NCT00263328|471589614|FG001|Overall Study|Death|0|||
130989642|NCT00263328|471589615|FG002|Overall Study|Death|1|||
130989643|NCT00263328|471589613|FG000|Overall Study|Lost to Follow-up|1|||
130989644|NCT00263328|471589614|FG001|Overall Study|Lost to Follow-up|1|||
130989645|NCT00263328|471589615|FG002|Overall Study|Lost to Follow-up|0|||
130989646|NCT00263328|471589613|FG000|Overall Study|Withdrawal by Subject|3|||
130989647|NCT00263328|471589614|FG001|Overall Study|Withdrawal by Subject|0|||
130989648|NCT00263328|471589615|FG002|Overall Study|Withdrawal by Subject|1|||
130989649|NCT00263328|471589613|FG000|Overall Study|Other|3|||
130989650|NCT00263328|471589614|FG001|Overall Study|Other|0|||
130989651|NCT00263328|471589615|FG002|Overall Study|Other|1|||
130989652|NCT00263328|471589613|FG000|Overall Study|Adverse Event|1|||
130989653|NCT00263328|471589614|FG001|Overall Study|Adverse Event|1|||
130989654|NCT00263328|471589615|FG002|Overall Study|Adverse Event|4|||
130989655|NCT00622180|471589616|FG000|Overall Study|Lost to Follow-up|1|||
130989656|NCT00622180|471589617|FG001|Overall Study|Lost to Follow-up|2|||
130989657|NCT01301274|471589623|FG000|Overall Study|Physician Decision|2|||
130989658|NCT01301274|471589624|FG001|Overall Study|Physician Decision|1|||
130989659|NCT00661661|471589625|FG000|Overall Study|Adverse Event|99|||
130989660|NCT00661661|471589626|FG001|Overall Study|Adverse Event|24|||
130989661|NCT00661661|471589625|FG000|Overall Study|Lack of Efficacy|3|||
130989662|NCT00661661|471589626|FG001|Overall Study|Lack of Efficacy|2|||
130989663|NCT00661661|471589625|FG000|Overall Study|Lost to Follow-up|0|||
130989664|NCT00661661|471589626|FG001|Overall Study|Lost to Follow-up|1|||
130989665|NCT00661661|471589625|FG000|Overall Study|Withdrawal by Subject|15|||
130989666|NCT00661661|471589626|FG001|Overall Study|Withdrawal by Subject|5|||
130989667|NCT00661661|471589625|FG000|Overall Study|Other|22|||
130989668|NCT00661661|471589626|FG001|Overall Study|Other|7|||
130989669|NCT00661661|471589625|FG000|Overall Study|Not assigned treatment|1|||
130989670|NCT00661661|471589626|FG001|Overall Study|Not assigned treatment|0|||
130989671|NCT04512066|471589629|FG000|Double-blind Treatment Period|Adverse Event|6|||
130989672|NCT04512066|471589630|FG001|Double-blind Treatment Period|Adverse Event|4|||
130989673|NCT04512066|471589631|FG002|Double-blind Treatment Period|Adverse Event|5|||
130989674|NCT04512066|471589632|FG003|Double-blind Treatment Period|Adverse Event|1|||
130989675|NCT04512066|471589633|FG004|Double-blind Treatment Period|Adverse Event|0|||
130989676|NCT04512066|471589634|FG005|Double-blind Treatment Period|Adverse Event|0|||
130989677|NCT04512066|471589629|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
130989678|NCT04512066|471589630|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
130989679|NCT04512066|471589631|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
130989680|NCT04512066|471589632|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
130989681|NCT04512066|471589633|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
130989682|NCT04512066|471589634|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
130989683|NCT04512066|471589629|FG000|Double-blind Treatment Period|Physician Decision|1|||
130989684|NCT04512066|471589630|FG001|Double-blind Treatment Period|Physician Decision|0|||
130989685|NCT04512066|471589631|FG002|Double-blind Treatment Period|Physician Decision|1|||
130989686|NCT04512066|471589632|FG003|Double-blind Treatment Period|Physician Decision|0|||
130989687|NCT04512066|471589633|FG004|Double-blind Treatment Period|Physician Decision|0|||
130989688|NCT04512066|471589634|FG005|Double-blind Treatment Period|Physician Decision|0|||
130989689|NCT04512066|471589629|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
130989690|NCT04512066|471589630|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
130989691|NCT04512066|471589631|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
130989692|NCT04512066|471589632|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
130989693|NCT04512066|471589633|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
130989694|NCT04512066|471589634|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
130989695|NCT04512066|471589629|FG000|Extension Period|Adverse Event|0|||
130989696|NCT04512066|471589630|FG001|Extension Period|Adverse Event|1|||
130989697|NCT04512066|471589631|FG002|Extension Period|Adverse Event|4|||
130989698|NCT04512066|471589632|FG003|Extension Period|Adverse Event|3|||
130989699|NCT04512066|471589633|FG004|Extension Period|Adverse Event|1|||
130989700|NCT04512066|471589634|FG005|Extension Period|Adverse Event|3|||
130989701|NCT04512066|471589629|FG000|Extension Period|Death|0|||
130989702|NCT04512066|471589630|FG001|Extension Period|Death|0|||
130989703|NCT04512066|471589631|FG002|Extension Period|Death|0|||
130989704|NCT04512066|471589632|FG003|Extension Period|Death|0|||
130989705|NCT04512066|471589633|FG004|Extension Period|Death|0|||
130989706|NCT04512066|471589634|FG005|Extension Period|Death|1|||
130989707|NCT04512066|471589629|FG000|Extension Period|Lack of Efficacy|0|||
130989708|NCT04512066|471589630|FG001|Extension Period|Lack of Efficacy|4|||
130989709|NCT04512066|471589631|FG002|Extension Period|Lack of Efficacy|4|||
130989710|NCT04512066|471589632|FG003|Extension Period|Lack of Efficacy|1|||
130989711|NCT04512066|471589633|FG004|Extension Period|Lack of Efficacy|3|||
130989712|NCT04512066|471589634|FG005|Extension Period|Lack of Efficacy|3|||
130989713|NCT04512066|471589629|FG000|Extension Period|Lost to Follow-up|0|||
130989714|NCT04512066|471589630|FG001|Extension Period|Lost to Follow-up|1|||
130989715|NCT04512066|471589631|FG002|Extension Period|Lost to Follow-up|5|||
130989716|NCT04512066|471589632|FG003|Extension Period|Lost to Follow-up|2|||
130989717|NCT04512066|471589633|FG004|Extension Period|Lost to Follow-up|3|||
130989718|NCT04512066|471589634|FG005|Extension Period|Lost to Follow-up|2|||
130989719|NCT04512066|471589629|FG000|Extension Period|Non-compliance with study drug|0|||
130989720|NCT04512066|471589630|FG001|Extension Period|Non-compliance with study drug|1|||
130989721|NCT04512066|471589631|FG002|Extension Period|Non-compliance with study drug|0|||
130989722|NCT04512066|471589632|FG003|Extension Period|Non-compliance with study drug|0|||
130989723|NCT04512066|471589633|FG004|Extension Period|Non-compliance with study drug|0|||
130989724|NCT04512066|471589634|FG005|Extension Period|Non-compliance with study drug|1|||
130989725|NCT04512066|471589629|FG000|Extension Period|Other|0|||
130989726|NCT04512066|471589630|FG001|Extension Period|Other|2|||
130989727|NCT04512066|471589631|FG002|Extension Period|Other|0|||
130989728|NCT04512066|471589632|FG003|Extension Period|Other|0|||
130989729|NCT04512066|471589633|FG004|Extension Period|Other|0|||
130989730|NCT04512066|471589634|FG005|Extension Period|Other|0|||
130989731|NCT04512066|471589629|FG000|Extension Period|Physician Decision|0|||
130989732|NCT04512066|471589630|FG001|Extension Period|Physician Decision|2|||
130989733|NCT04512066|471589631|FG002|Extension Period|Physician Decision|0|||
130989734|NCT04512066|471589632|FG003|Extension Period|Physician Decision|1|||
130989735|NCT04512066|471589633|FG004|Extension Period|Physician Decision|1|||
130989736|NCT04512066|471589634|FG005|Extension Period|Physician Decision|0|||
130989737|NCT04512066|471589629|FG000|Extension Period|Withdrawal by Subject|0|||
130989738|NCT04512066|471589630|FG001|Extension Period|Withdrawal by Subject|3|||
130989739|NCT04512066|471589631|FG002|Extension Period|Withdrawal by Subject|7|||
130989740|NCT04512066|471589632|FG003|Extension Period|Withdrawal by Subject|11|||
130989741|NCT04512066|471589633|FG004|Extension Period|Withdrawal by Subject|8|||
130989742|NCT04512066|471589634|FG005|Extension Period|Withdrawal by Subject|4|||
130989743|NCT03520400|471589635|FG000|Overall Study|Physician Decision|15|||
130989744|NCT03520400|471589636|FG001|Overall Study|Physician Decision|7|||
130989745|NCT00445679|471589637|FG000|Overall Study|Adverse Event|22|||
130989746|NCT00445679|471589638|FG001|Overall Study|Adverse Event|12|||
130989747|NCT00445679|471589639|FG002|Overall Study|Adverse Event|30|||
130989748|NCT00445679|471589640|FG003|Overall Study|Adverse Event|19|||
130989749|NCT00445679|471589637|FG000|Overall Study|Failed to return|1|||
130989750|NCT00445679|471589638|FG001|Overall Study|Failed to return|3|||
130989751|NCT00445679|471589639|FG002|Overall Study|Failed to return|2|||
130989752|NCT00445679|471589640|FG003|Overall Study|Failed to return|2|||
130989753|NCT00445679|471589637|FG000|Overall Study|Physician Decision|0|||
130989754|NCT00445679|471589638|FG001|Overall Study|Physician Decision|0|||
130764309|NCT00337779|470760028|FG001|Overall Study|Death|1|||
130764310|NCT03008278|470760029|FG000|Overall Study|Progressive Disease|0|||
130989755|NCT00445679|471589639|FG002|Overall Study|Physician Decision|1|||
130989756|NCT00445679|471589640|FG003|Overall Study|Physician Decision|0|||
130989757|NCT00445679|471589637|FG000|Overall Study|Lost to Follow-up|10|||
130989758|NCT00445679|471589638|FG001|Overall Study|Lost to Follow-up|6|||
130989759|NCT00445679|471589639|FG002|Overall Study|Lost to Follow-up|6|||
130989760|NCT00445679|471589640|FG003|Overall Study|Lost to Follow-up|5|||
130764311|NCT03008278|470760030|FG001|Overall Study|Progressive Disease|0|||
130764312|NCT03008278|470760031|FG002|Overall Study|Progressive Disease|32|||
130764313|NCT03008278|470760029|FG000|Overall Study|Adverse Event|0|||
130764314|NCT03008278|470760030|FG001|Overall Study|Adverse Event|0|||
130764315|NCT03008278|470760031|FG002|Overall Study|Adverse Event|4|||
130764316|NCT03008278|470760029|FG000|Overall Study|Withdrawal by Subject|0|||
130764317|NCT03008278|470760030|FG001|Overall Study|Withdrawal by Subject|0|||
130764318|NCT03008278|470760031|FG002|Overall Study|Withdrawal by Subject|3|||
130764319|NCT03008278|470760029|FG000|Overall Study|Physician Decision|0|||
130764320|NCT03008278|470760030|FG001|Overall Study|Physician Decision|2|||
130764321|NCT03008278|470760031|FG002|Overall Study|Physician Decision|0|||
130764322|NCT00513357|470760032|FG000|Overall Study|did not receive allocated placebo|2|||
130764323|NCT00513357|470760033|FG001|Overall Study|did not receive allocated placebo|3|||
130764324|NCT00513357|470760032|FG000|Overall Study|Adverse Event|4|||
130764325|NCT00513357|470760033|FG001|Overall Study|Adverse Event|2|||
130764326|NCT00513357|470760032|FG000|Overall Study|Death|2|||
130764327|NCT00513357|470760033|FG001|Overall Study|Death|0|||
130764328|NCT00513357|470760032|FG000|Overall Study|Withdrawal by Subject|5|||
130989761|NCT00445679|471589637|FG000|Overall Study|Compliance|3|||
130989762|NCT00445679|471589638|FG001|Overall Study|Compliance|2|||
130989763|NCT00445679|471589639|FG002|Overall Study|Compliance|1|||
130989764|NCT00445679|471589640|FG003|Overall Study|Compliance|2|||
130989765|NCT00445679|471589637|FG000|Overall Study|Withdrawal of Informed Consent|0|||
130989766|NCT00445679|471589638|FG001|Overall Study|Withdrawal of Informed Consent|0|||
130989767|NCT00445679|471589639|FG002|Overall Study|Withdrawal of Informed Consent|1|||
130989768|NCT00445679|471589640|FG003|Overall Study|Withdrawal of Informed Consent|0|||
130989769|NCT00445679|471589637|FG000|Overall Study|Protocol Violation|2|||
130989770|NCT00445679|471589638|FG001|Overall Study|Protocol Violation|3|||
130989771|NCT00445679|471589639|FG002|Overall Study|Protocol Violation|3|||
130989772|NCT00445679|471589640|FG003|Overall Study|Protocol Violation|1|||
130989773|NCT00445679|471589637|FG000|Overall Study|Withdrawal by Subject|8|||
130989774|NCT00445679|471589638|FG001|Overall Study|Withdrawal by Subject|14|||
130989775|NCT00445679|471589639|FG002|Overall Study|Withdrawal by Subject|20|||
130989776|NCT00445679|471589640|FG003|Overall Study|Withdrawal by Subject|18|||
130989777|NCT00445679|471589637|FG000|Overall Study|Lack of Efficacy|2|||
130989778|NCT00445679|471589638|FG001|Overall Study|Lack of Efficacy|6|||
130989779|NCT00445679|471589639|FG002|Overall Study|Lack of Efficacy|2|||
130764329|NCT00513357|470760033|FG001|Overall Study|Withdrawal by Subject|4|||
130764330|NCT00513357|470760032|FG000|Overall Study|Disease Progression|2|||
130764331|NCT00513357|470760033|FG001|Overall Study|Disease Progression|1|||
130989780|NCT00445679|471589640|FG003|Overall Study|Lack of Efficacy|0|||
130989781|NCT01353222|471589643|FG000|Overall Study|Death|30|||
130989782|NCT01353222|471589644|FG001|Overall Study|Death|30|||
130989783|NCT01353222|471589643|FG000|Overall Study|Withdrawal by Subject|8|||
130989784|NCT01353222|471589644|FG001|Overall Study|Withdrawal by Subject|5|||
130989785|NCT01353222|471589643|FG000|Overall Study|Study Terminated|31|||
130989786|NCT01353222|471589644|FG001|Overall Study|Study Terminated|37|||
130989787|NCT01353222|471589643|FG000|Overall Study|Site closed research department|1|||
130989788|NCT01353222|471589644|FG001|Overall Study|Site closed research department|0|||
130989789|NCT01654601|471589648|FG000|1st Administration|Withdrawal by Subject|2|||
130989790|NCT01654601|471589649|FG001|1st Administration|Withdrawal by Subject|0|||
130989791|NCT01654601|471589648|FG000|1st Administration|Protocol Violation|0|||
131213057|NCT01869959|472403088|FG000|Treatment Period|Withdrawal by Subject|0|||
130764332|NCT01162122|470760034|FG000|Overall Study|Withdrawal by Subject|52|||
130764333|NCT01162122|470760035|FG001|Overall Study|Withdrawal by Subject|43|||
130989792|NCT01654601|471589649|FG001|1st Administration|Protocol Violation|2|||
130989793|NCT01654601|471589648|FG000|2nd Administration|Adverse Event|1|||
130989794|NCT01654601|471589649|FG001|2nd Administration|Adverse Event|0|||
130989795|NCT01654601|471589648|FG000|2nd Administration|Protocol Violation|0|||
130989796|NCT01654601|471589649|FG001|2nd Administration|Protocol Violation|1|||
130764334|NCT01162122|470760034|FG000|Overall Study|Lost to Follow-up|73|||
130989797|NCT02636270|471589650|FG000|Overall Study|Adverse Event|1|||
130989798|NCT02636270|471589651|FG001|Overall Study|Adverse Event|0|||
130989799|NCT02636270|471589652|FG002|Overall Study|Adverse Event|0|||
131045794|NCT03582033|471802281|FG003|Part B|Study terminated by sponsor|0|||
131213058|NCT01869959|472403089|FG001|Treatment Period|Withdrawal by Subject|1|||
131213059|NCT01869959|472403090|FG002|Treatment Period|Withdrawal by Subject|0|||
131213060|NCT01869959|472403091|FG003|Treatment Period|Withdrawal by Subject|0|||
131213061|NCT01869959|472403092|FG004|Treatment Period|Withdrawal by Subject|0|||
131213062|NCT01875731|472403093|FG000|Overall Study|Fail to obtain lab sample|1|||
131213063|NCT01875731|472403094|FG001|Overall Study|Fail to obtain lab sample|0|||
131213064|NCT00223990|472403100|FG000|Overall Study|Moved from area|2|||
131213065|NCT00223990|472403101|FG001|Overall Study|Moved from area|1|||
131213066|NCT00223990|472403100|FG000|Overall Study|Withdrawal by Subject|4|||
130764335|NCT01162122|470760035|FG001|Overall Study|Lost to Follow-up|91|||
130764336|NCT01162122|470760034|FG000|Overall Study|Adverse Event|3|||
130764337|NCT01162122|470760035|FG001|Overall Study|Adverse Event|2|||
130764338|NCT01162122|470760034|FG000|Overall Study|Death|51|||
130764339|NCT01162122|470760035|FG001|Overall Study|Death|46|||
130764340|NCT01162122|470760034|FG000|Overall Study|Protocol Violation|2|||
131213067|NCT00223990|472403101|FG001|Overall Study|Withdrawal by Subject|8|||
131213068|NCT00223990|472403100|FG000|Overall Study|Lost to Follow-up|1|||
131213069|NCT00223990|472403101|FG001|Overall Study|Lost to Follow-up|0|||
131213070|NCT02674568|472405260|FG000|Overall Study|Withdrawal by Subject|5|||
131213071|NCT02674568|472405260|FG000|Overall Study|Death|303|||
131213072|NCT02674568|472405260|FG000|Overall Study|Physician Decision|2|||
131213073|NCT02674568|472405260|FG000|Overall Study|Lost to Follow-up|9|||
131213074|NCT02674568|472405260|FG000|Overall Study|Other, Not Specified|20|||
131213075|NCT00457249|472405261|FG000|Overall Study|Lost to Follow-up|3|||
130764341|NCT01162122|470760035|FG001|Overall Study|Protocol Violation|2|||
130764342|NCT01162122|470760034|FG000|Overall Study|Inappropriate enrollment|5|||
130764343|NCT01162122|470760035|FG001|Overall Study|Inappropriate enrollment|4|||
130764344|NCT01162122|470760034|FG000|Overall Study|Administrative reason|1|||
130764345|NCT01162122|470760035|FG001|Overall Study|Administrative reason|1|||
130989800|NCT02636270|471589650|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
130989801|NCT02636270|471589651|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
130989802|NCT02636270|471589652|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
130989803|NCT01806584|471589653|FG000|Overall Study|Adverse Event|2|||
130989804|NCT01806584|471589654|FG001|Overall Study|Adverse Event|1|||
130989805|NCT01806584|471589653|FG000|Overall Study|Death|1|||
130989806|NCT01806584|471589654|FG001|Overall Study|Death|0|||
130764346|NCT01162122|470760034|FG000|Overall Study|Unable to classify|3|||
130764347|NCT01162122|470760035|FG001|Overall Study|Unable to classify|7|||
130764348|NCT01162122|470760034|FG000|Overall Study|Missing primary reason|1|||
130764349|NCT01162122|470760035|FG001|Overall Study|Missing primary reason|0|||
130764350|NCT03313310|470760036|FG000|Phase 2|Lost to Follow-up|4|||
130764351|NCT03313310|470760037|FG001|Phase 2|Lost to Follow-up|0|||
130764352|NCT03313310|470760036|FG000|Phase 3|Lost to Follow-up|0|||
130764353|NCT03313310|470760037|FG001|Phase 3|Lost to Follow-up|1|||
130764354|NCT01217385|470760038|FG000|Overall Study|Withdrawal by Subject|3|||
130764355|NCT01217385|470760038|FG000|Overall Study|DOSI not performed/not eval|12|||
130764356|NCT01217385|470760038|FG000|Overall Study|Central Path not Available|1|||
130764357|NCT01217385|470760038|FG000|Overall Study|Normal Breast TOI not available|10|||
130764358|NCT00090987|470760039|FG000|Overall Study|Adverse Event|5|||
130764359|NCT00090987|470760039|FG000|Overall Study|Lack of Efficacy|7|||
130764360|NCT00090987|470760039|FG000|Overall Study|Withdrawal by Subject|3|||
130764361|NCT00090987|470760039|FG000|Overall Study|alternative therapy|1|||
130764362|NCT00090987|470760039|FG000|Overall Study|Non-compliance|4|||
130764363|NCT00090987|470760039|FG000|Overall Study|Incarcerated|1|||
130764364|NCT02079636|470760041|FG000|Overall Study|Death|2|||
130764365|NCT02079636|470760042|FG001|Overall Study|Death|1|||
130764366|NCT02079636|470760043|FG002|Overall Study|Death|0|||
130764367|NCT02079636|470760044|FG003|Overall Study|Death|5|||
130764368|NCT02079636|470760045|FG004|Overall Study|Death|1|||
130764369|NCT02079636|470760046|FG005|Overall Study|Death|2|||
130764370|NCT02079636|470760047|FG006|Overall Study|Death|1|||
130764371|NCT02079636|470760048|FG007|Overall Study|Death|0|||
130764372|NCT02079636|470760049|FG008|Overall Study|Death|0|||
130764373|NCT02079636|470760050|FG009|Overall Study|Death|0|||
130764374|NCT02079636|470760051|FG010|Overall Study|Death|0|||
130764375|NCT02079636|470760052|FG011|Overall Study|Death|1|||
130764376|NCT02079636|470760053|FG012|Overall Study|Death|1|||
130989807|NCT01806584|471589653|FG000|Overall Study|Lost to Follow-up|0|||
131213076|NCT00457249|472405262|FG001|Overall Study|Lost to Follow-up|0|||
130764377|NCT02079636|470760054|FG013|Overall Study|Death|0|||
130764378|NCT02079636|470760055|FG014|Overall Study|Death|2|||
131213077|NCT00457249|472405261|FG000|Overall Study|Protocol Violation|4|||
131213078|NCT00457249|472405262|FG001|Overall Study|Protocol Violation|1|||
130764379|NCT02079636|470760041|FG000|Overall Study|Adverse Event|1|||
130764380|NCT02079636|470760042|FG001|Overall Study|Adverse Event|1|||
130764381|NCT02079636|470760043|FG002|Overall Study|Adverse Event|0|||
130764382|NCT02079636|470760044|FG003|Overall Study|Adverse Event|1|||
131213079|NCT00457249|472405261|FG000|Overall Study|Withdrawal by Subject|3|||
131213080|NCT00457249|472405262|FG001|Overall Study|Withdrawal by Subject|1|||
130764383|NCT02079636|470760045|FG004|Overall Study|Adverse Event|1|||
130764384|NCT02079636|470760046|FG005|Overall Study|Adverse Event|2|||
130764385|NCT02079636|470760047|FG006|Overall Study|Adverse Event|0|||
130764386|NCT02079636|470760048|FG007|Overall Study|Adverse Event|0|||
130764387|NCT02079636|470760049|FG008|Overall Study|Adverse Event|0|||
130764388|NCT02079636|470760050|FG009|Overall Study|Adverse Event|0|||
130764389|NCT02079636|470760051|FG010|Overall Study|Adverse Event|0|||
130764390|NCT02079636|470760052|FG011|Overall Study|Adverse Event|0|||
130764391|NCT02079636|470760053|FG012|Overall Study|Adverse Event|0|||
130764392|NCT02079636|470760054|FG013|Overall Study|Adverse Event|0|||
130764393|NCT02079636|470760055|FG014|Overall Study|Adverse Event|0|||
130764394|NCT02079636|470760041|FG000|Overall Study|Progressive disease|0|||
130764395|NCT02079636|470760042|FG001|Overall Study|Progressive disease|0|||
130764396|NCT02079636|470760043|FG002|Overall Study|Progressive disease|0|||
130764397|NCT02079636|470760044|FG003|Overall Study|Progressive disease|2|||
130764398|NCT02079636|470760045|FG004|Overall Study|Progressive disease|0|||
130764399|NCT02079636|470760046|FG005|Overall Study|Progressive disease|0|||
130764400|NCT02079636|470760047|FG006|Overall Study|Progressive disease|0|||
130764401|NCT02079636|470760048|FG007|Overall Study|Progressive disease|0|||
130764402|NCT02079636|470760049|FG008|Overall Study|Progressive disease|0|||
130764403|NCT02079636|470760050|FG009|Overall Study|Progressive disease|0|||
130764404|NCT02079636|470760051|FG010|Overall Study|Progressive disease|0|||
130764405|NCT02079636|470760052|FG011|Overall Study|Progressive disease|0|||
130764406|NCT02079636|470760053|FG012|Overall Study|Progressive disease|1|||
130764407|NCT02079636|470760054|FG013|Overall Study|Progressive disease|0|||
130764408|NCT02079636|470760055|FG014|Overall Study|Progressive disease|0|||
130764409|NCT02079636|470760041|FG000|Overall Study|Withdrawal by Subject|0|||
130764410|NCT02079636|470760042|FG001|Overall Study|Withdrawal by Subject|0|||
130764411|NCT02079636|470760043|FG002|Overall Study|Withdrawal by Subject|0|||
130764412|NCT02079636|470760044|FG003|Overall Study|Withdrawal by Subject|4|||
130764413|NCT02079636|470760045|FG004|Overall Study|Withdrawal by Subject|0|||
130764414|NCT02079636|470760046|FG005|Overall Study|Withdrawal by Subject|1|||
130764415|NCT02079636|470760047|FG006|Overall Study|Withdrawal by Subject|0|||
130764416|NCT02079636|470760048|FG007|Overall Study|Withdrawal by Subject|0|||
130764417|NCT02079636|470760049|FG008|Overall Study|Withdrawal by Subject|0|||
130764418|NCT02079636|470760050|FG009|Overall Study|Withdrawal by Subject|2|||
130764419|NCT02079636|470760051|FG010|Overall Study|Withdrawal by Subject|1|||
130764420|NCT02079636|470760052|FG011|Overall Study|Withdrawal by Subject|1|||
130764421|NCT02079636|470760053|FG012|Overall Study|Withdrawal by Subject|1|||
130764422|NCT02079636|470760054|FG013|Overall Study|Withdrawal by Subject|0|||
130764423|NCT02079636|470760055|FG014|Overall Study|Withdrawal by Subject|2|||
130764424|NCT02079636|470760041|FG000|Overall Study|Physician Decision|0|||
130764425|NCT02079636|470760042|FG001|Overall Study|Physician Decision|0|||
130764426|NCT02079636|470760043|FG002|Overall Study|Physician Decision|0|||
130764427|NCT02079636|470760044|FG003|Overall Study|Physician Decision|0|||
130764428|NCT02079636|470760045|FG004|Overall Study|Physician Decision|0|||
130764429|NCT02079636|470760046|FG005|Overall Study|Physician Decision|1|||
130764430|NCT02079636|470760047|FG006|Overall Study|Physician Decision|0|||
130764431|NCT02079636|470760048|FG007|Overall Study|Physician Decision|0|||
130764432|NCT02079636|470760049|FG008|Overall Study|Physician Decision|0|||
130764433|NCT02079636|470760050|FG009|Overall Study|Physician Decision|1|||
130764434|NCT02079636|470760051|FG010|Overall Study|Physician Decision|1|||
130764435|NCT02079636|470760052|FG011|Overall Study|Physician Decision|0|||
130764436|NCT02079636|470760053|FG012|Overall Study|Physician Decision|0|||
130764437|NCT02079636|470760054|FG013|Overall Study|Physician Decision|0|||
130764438|NCT02079636|470760055|FG014|Overall Study|Physician Decision|1|||
130764439|NCT02079636|470760041|FG000|Overall Study|Lost to Follow-up|0|||
130764440|NCT02079636|470760042|FG001|Overall Study|Lost to Follow-up|0|||
130764441|NCT02079636|470760043|FG002|Overall Study|Lost to Follow-up|0|||
130764442|NCT02079636|470760044|FG003|Overall Study|Lost to Follow-up|0|||
130764443|NCT02079636|470760045|FG004|Overall Study|Lost to Follow-up|0|||
130764444|NCT02079636|470760046|FG005|Overall Study|Lost to Follow-up|0|||
130764445|NCT02079636|470760047|FG006|Overall Study|Lost to Follow-up|0|||
130764446|NCT02079636|470760048|FG007|Overall Study|Lost to Follow-up|1|||
130764447|NCT02079636|470760049|FG008|Overall Study|Lost to Follow-up|0|||
130764448|NCT02079636|470760050|FG009|Overall Study|Lost to Follow-up|0|||
130764449|NCT02079636|470760051|FG010|Overall Study|Lost to Follow-up|0|||
130764450|NCT02079636|470760052|FG011|Overall Study|Lost to Follow-up|0|||
130764451|NCT02079636|470760053|FG012|Overall Study|Lost to Follow-up|0|||
130877910|NCT03651765|471185867|FG000|Overall Study|Discontinued by Sponsor|40|||
130764452|NCT02079636|470760054|FG013|Overall Study|Lost to Follow-up|0|||
130764453|NCT02079636|470760055|FG014|Overall Study|Lost to Follow-up|0|||
130764454|NCT00725101|470760056|FG000|Overall Study|Death|3|||
130764455|NCT00725101|470760056|FG000|Overall Study|Lost to Follow-up|353|||
130764456|NCT00725101|470760056|FG000|Overall Study|Protocol Violation|1|||
130764457|NCT00725101|470760056|FG000|Overall Study|Withdrawal by Subject|127|||
130877911|NCT03651765|471185867|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
130989808|NCT01806584|471589654|FG001|Overall Study|Lost to Follow-up|2|||
130764458|NCT00725101|470760056|FG000|Overall Study|not specified/no reason given|11|||
130764459|NCT01592292|470760057|FG000|Overall Study|Follow-up loss|3|||
130877912|NCT03651765|471185867|FG000|Overall Study|Withdrawal by Subject|24|||
130877913|NCT03651765|471185867|FG000|Overall Study|Miscellaneous|6|||
130877914|NCT02242942|471185877|FG000|Overall Study|Death|17|||
130877915|NCT02242942|471185878|FG001|Overall Study|Death|20|||
130877916|NCT02242942|471185879|FG002|Overall Study|Death|2|||
130877917|NCT02242942|471185877|FG000|Overall Study|Physician Decision|1|||
130877918|NCT02242942|471185878|FG001|Overall Study|Physician Decision|0|||
130877919|NCT02242942|471185879|FG002|Overall Study|Physician Decision|0|||
130877920|NCT02242942|471185877|FG000|Overall Study|Withdrawal by Subject|8|||
130877921|NCT02242942|471185878|FG001|Overall Study|Withdrawal by Subject|10|||
130877922|NCT02242942|471185879|FG002|Overall Study|Withdrawal by Subject|0|||
130877923|NCT02242942|471185877|FG000|Overall Study|On-going in Study|190|||
130877924|NCT02242942|471185878|FG001|Overall Study|On-going in Study|186|||
130877925|NCT02242942|471185879|FG002|Overall Study|On-going in Study|11|||
130877926|NCT05468814|471185880|FG000|Overall Study|Lost to Follow-up|5|||
130877927|NCT05468814|471185881|FG001|Overall Study|Lost to Follow-up|6|||
130877928|NCT04716426|471185882|FG000|Overall Study|Vaccination|1|||
130877929|NCT04716426|471185883|FG001|Overall Study|Vaccination|1|||
130877930|NCT04716426|471185882|FG000|Overall Study|Contamination|1|||
130877931|NCT04716426|471185883|FG001|Overall Study|Contamination|0|||
130877932|NCT00551759|471185884|FG000|Overall Study|Adverse Event|7|||
130877933|NCT00551759|471185884|FG000|Overall Study|Death|5|||
130877934|NCT00551759|471185884|FG000|Overall Study|Ineligible|1|||
130877935|NCT01451606|471185889|FG000|Overall Study|Withdrawal by Subject|4|||
130877936|NCT01451606|471185890|FG001|Overall Study|Withdrawal by Subject|3|||
130877937|NCT02163538|471185894|FG000|Overall Study|Protocol Violation|1|||
130877938|NCT02163538|471185895|FG001|Overall Study|Protocol Violation|0|||
130877939|NCT02163538|471185894|FG000|Overall Study|Physician Decision|0|||
130877940|NCT02163538|471185895|FG001|Overall Study|Physician Decision|1|||
130877941|NCT01283139|471185896|FG000|Overall Study|Lost to Follow-up|5|||
130877942|NCT01283139|471185897|FG001|Overall Study|Lost to Follow-up|2|||
130877943|NCT01283139|471185898|FG002|Overall Study|Lost to Follow-up|3|||
130877944|NCT01283139|471185899|FG003|Overall Study|Lost to Follow-up|1|||
130877945|NCT01283139|471185896|FG000|Overall Study|Withdrawal by Subject|8|||
130877946|NCT01283139|471185897|FG001|Overall Study|Withdrawal by Subject|8|||
130877947|NCT01283139|471185898|FG002|Overall Study|Withdrawal by Subject|6|||
130877948|NCT01283139|471185899|FG003|Overall Study|Withdrawal by Subject|8|||
130877949|NCT01283139|471185896|FG000|Overall Study|Death|2|||
130877950|NCT01283139|471185897|FG001|Overall Study|Death|0|||
130877951|NCT01283139|471185898|FG002|Overall Study|Death|2|||
130877952|NCT01283139|471185899|FG003|Overall Study|Death|2|||
130877953|NCT01283139|471185896|FG000|Overall Study|Lack of Efficacy|1|||
130877954|NCT01283139|471185897|FG001|Overall Study|Lack of Efficacy|2|||
130877955|NCT01283139|471185898|FG002|Overall Study|Lack of Efficacy|2|||
130877956|NCT01283139|471185899|FG003|Overall Study|Lack of Efficacy|1|||
130877957|NCT01283139|471185896|FG000|Overall Study|Early termination due to AE/SAE|1|||
130877958|NCT01283139|471185897|FG001|Overall Study|Early termination due to AE/SAE|1|||
130877959|NCT01283139|471185898|FG002|Overall Study|Early termination due to AE/SAE|0|||
130877960|NCT01283139|471185899|FG003|Overall Study|Early termination due to AE/SAE|0|||
130877961|NCT01283139|471185896|FG000|Overall Study|Participant's refusal to continue|0|||
130877962|NCT01283139|471185897|FG001|Overall Study|Participant's refusal to continue|3|||
130877963|NCT01283139|471185898|FG002|Overall Study|Participant's refusal to continue|1|||
130877964|NCT01283139|471185899|FG003|Overall Study|Participant's refusal to continue|1|||
130877965|NCT01283139|471185896|FG000|Overall Study|Pregnancy|0|||
130877966|NCT01283139|471185897|FG001|Overall Study|Pregnancy|1|||
130877967|NCT01283139|471185898|FG002|Overall Study|Pregnancy|1|||
130877968|NCT01283139|471185899|FG003|Overall Study|Pregnancy|0|||
130877969|NCT01283139|471185896|FG000|Overall Study|Missed follow-up visit|0|||
130877970|NCT01283139|471185897|FG001|Overall Study|Missed follow-up visit|1|||
130877971|NCT01283139|471185898|FG002|Overall Study|Missed follow-up visit|2|||
130877972|NCT01283139|471185899|FG003|Overall Study|Missed follow-up visit|2|||
130877973|NCT01283139|471185896|FG000|Overall Study|Participant randomized in error|0|||
130877974|NCT01283139|471185897|FG001|Overall Study|Participant randomized in error|0|||
130877975|NCT01283139|471185898|FG002|Overall Study|Participant randomized in error|1|||
130877976|NCT01283139|471185899|FG003|Overall Study|Participant randomized in error|0|||
130877977|NCT03668873|471185900|FG000|Overall Study|Lost to Follow-up|6|||
130877978|NCT03668873|471185901|FG001|Overall Study|Lost to Follow-up|3|||
130877979|NCT01521117|471185902|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
130877980|NCT01521117|471185903|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
130877981|NCT01521117|471185902|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
130877982|NCT01521117|471185903|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
130877983|NCT01521117|471185902|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
130877984|NCT01521117|471185903|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
130877985|NCT00784563|471185904|FG000|Years 1 & 2|Withdrawal by Subject|3|||
130877986|NCT00784563|471185905|FG001|Years 1 & 2|Withdrawal by Subject|2|||
130877987|NCT00784563|471185906|FG002|Years 1 & 2|Withdrawal by Subject|0|||
130877988|NCT00784563|471185904|FG000|Years 1 & 2|Adverse Event|0|||
130877989|NCT00784563|471185905|FG001|Years 1 & 2|Adverse Event|3|||
130877990|NCT00784563|471185906|FG002|Years 1 & 2|Adverse Event|0|||
130764460|NCT01592292|470760058|FG001|Overall Study|Follow-up loss|3|||
130877991|NCT00784563|471185904|FG000|Year 3|Withdrawal by Subject|0|||
130877992|NCT00784563|471185905|FG001|Year 3|Withdrawal by Subject|0|||
130877993|NCT00784563|471185906|FG002|Year 3|Withdrawal by Subject|2|||
130877994|NCT00784563|471185904|FG000|Year 3|Adverse Event|0|||
130989809|NCT01806584|471589653|FG000|Overall Study|Study terminated by sponsor|9|||
130989810|NCT01806584|471589654|FG001|Overall Study|Study terminated by sponsor|14|||
130989811|NCT01806584|471589653|FG000|Overall Study|Withdrawal by Subject|1|||
130989812|NCT01806584|471589654|FG001|Overall Study|Withdrawal by Subject|1|||
130989813|NCT01806584|471589653|FG000|Overall Study|Other unspecified|1|||
130989814|NCT01806584|471589654|FG001|Overall Study|Other unspecified|0|||
130989815|NCT04398537|471589663|FG000|Overall Study|Physician Decision|10|||
130989816|NCT04398537|471589664|FG001|Overall Study|Physician Decision|15|||
130989817|NCT03535337|471589665|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
130989818|NCT03535337|471589666|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
130989819|NCT03535337|471589667|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
130989820|NCT03535337|471589668|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
130989821|NCT03535337|471589669|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
130989822|NCT03535337|471589670|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
130989823|NCT03535337|471589671|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
130989824|NCT03535337|471589672|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
130989825|NCT03535337|471589673|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
130989826|NCT03535337|471589674|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
130989827|NCT02272725|471589675|FG000|Overall Study|equipment malfunction|2|||
130989828|NCT02272725|471589676|FG001|Overall Study|equipment malfunction|0|||
130989829|NCT00519896|471591499|FG000|Overall Study|Protocol Violation|1|||
130989830|NCT00519896|471591499|FG000|Overall Study|Adverse Event|1|||
130989831|NCT02367716|471591500|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
130989832|NCT00539643|471591501|FG000|Overall Study|Adverse Event|1|||
130989833|NCT00539643|471591502|FG001|Overall Study|Adverse Event|0|||
130989834|NCT00539643|471591501|FG000|Overall Study|Death|2|||
130989835|NCT00539643|471591502|FG001|Overall Study|Death|1|||
130989836|NCT00539643|471591501|FG000|Overall Study|Physician Decision|3|||
130989837|NCT00539643|471591502|FG001|Overall Study|Physician Decision|1|||
130989838|NCT00539643|471591501|FG000|Overall Study|Withdrawal by Subject|0|||
130989839|NCT00539643|471591502|FG001|Overall Study|Withdrawal by Subject|1|||
130989840|NCT02343003|471591505|FG000|Overall Study|Withdrawal by Subject|9|||
130989841|NCT02343003|471591506|FG001|Overall Study|Withdrawal by Subject|4|||
130989842|NCT02343003|471591505|FG000|Overall Study|Lost to Follow-up|5|||
130989843|NCT02343003|471591506|FG001|Overall Study|Lost to Follow-up|1|||
130989844|NCT02343003|471591505|FG000|Overall Study|Protocol Violation|1|||
130989845|NCT02343003|471591506|FG001|Overall Study|Protocol Violation|0|||
130989846|NCT02343003|471591505|FG000|Overall Study|Death|0|||
130989847|NCT02343003|471591506|FG001|Overall Study|Death|1|||
130989848|NCT02343003|471591505|FG000|Overall Study|exclusion criteria met|1|||
130989849|NCT02343003|471591506|FG001|Overall Study|exclusion criteria met|1|||
130989850|NCT02343003|471591505|FG000|Overall Study|terminated by sponsor|2|||
130989851|NCT02343003|471591506|FG001|Overall Study|terminated by sponsor|0|||
131213081|NCT00457249|472405261|FG000|Overall Study|Serious Adverse Events|2|||
131213082|NCT00457249|472405262|FG001|Overall Study|Serious Adverse Events|0|||
131213083|NCT00396318|472405263|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
131213084|NCT02916056|472405264|FG000|Overall Study|Adverse Event|6|||
131213085|NCT02916056|472405264|FG000|Overall Study|Lost to Follow-up|1|||
131213086|NCT02916056|472405264|FG000|Overall Study|Other|12|||
131213087|NCT02916056|472405264|FG000|Overall Study|Protocol Violation|1|||
131213088|NCT02916056|472405264|FG000|Overall Study|Withdrawal by Subject|8|||
131213089|NCT02916056|472405264|FG000|Overall Study|Study Terminated by Sponsor|269|||
131213090|NCT00124709|472405265|FG000|Overall Study|Randomized but did not take medication|3|||
131213091|NCT00124709|472405266|FG001|Overall Study|Randomized but did not take medication|1|||
131213092|NCT00124709|472405265|FG000|Overall Study|Adverse Event|3|||
131213093|NCT00124709|472405266|FG001|Overall Study|Adverse Event|0|||
131213094|NCT00124709|472405265|FG000|Overall Study|Lack of Efficacy|5|||
131213095|NCT00124709|472405266|FG001|Overall Study|Lack of Efficacy|10|||
131213096|NCT00124709|472405265|FG000|Overall Study|Protocol Violation|3|||
131213097|NCT00124709|472405266|FG001|Overall Study|Protocol Violation|5|||
131213098|NCT00124709|472405265|FG000|Overall Study|Withdrawal by Subject|127|||
131213099|NCT00124709|472405266|FG001|Overall Study|Withdrawal by Subject|136|||
131213100|NCT00124709|472405265|FG000|Overall Study|Lost to Follow-up|114|||
131213101|NCT00124709|472405266|FG001|Overall Study|Lost to Follow-up|120|||
131213102|NCT00122954|472405267|FG000|Overall Study|Withdrawal by Subject|2|||
131213103|NCT00122954|472405268|FG001|Overall Study|Withdrawal by Subject|2|||
131213104|NCT00122954|472405267|FG000|Overall Study|Protocol Violation|0|||
131213105|NCT00122954|472405268|FG001|Overall Study|Protocol Violation|1|||
131213106|NCT01728376|472405269|FG000|Overall Study|Adverse Event|1|||
131213107|NCT01728376|472405270|FG001|Overall Study|Adverse Event|1|||
131213108|NCT01728376|472405271|FG002|Overall Study|Adverse Event|1|||
131213109|NCT01728376|472405272|FG003|Overall Study|Adverse Event|1|||
131213110|NCT01728376|472405273|FG004|Overall Study|Adverse Event|1|||
131213111|NCT01728376|472405274|FG005|Overall Study|Adverse Event|0|||
131213112|NCT01728376|472405269|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
131213113|NCT01728376|472405270|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
131213114|NCT01728376|472405271|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
131213115|NCT01728376|472405272|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
131213116|NCT01728376|472405273|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
131213117|NCT01728376|472405274|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
131213118|NCT01728376|472405269|FG000|Overall Study|No relevant bacteria|2|||
131213119|NCT01728376|472405270|FG001|Overall Study|No relevant bacteria|0|||
131213120|NCT01728376|472405271|FG002|Overall Study|No relevant bacteria|0|||
131213121|NCT01728376|472405272|FG003|Overall Study|No relevant bacteria|0|||
131213122|NCT01728376|472405273|FG004|Overall Study|No relevant bacteria|1|||
131213123|NCT01728376|472405274|FG005|Overall Study|No relevant bacteria|1|||
131213124|NCT01728376|472405269|FG000|Overall Study|Did not receive treatment|0|||
131213125|NCT01728376|472405270|FG001|Overall Study|Did not receive treatment|1|||
131213126|NCT01728376|472405271|FG002|Overall Study|Did not receive treatment|0|||
131213127|NCT01728376|472405272|FG003|Overall Study|Did not receive treatment|0|||
131213128|NCT01728376|472405273|FG004|Overall Study|Did not receive treatment|0|||
131213129|NCT01728376|472405274|FG005|Overall Study|Did not receive treatment|0|||
131213130|NCT01728376|472405269|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
131213131|NCT01728376|472405270|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
131213132|NCT01728376|472405271|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
131213133|NCT01728376|472405272|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
131213134|NCT01728376|472405273|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
131213135|NCT01728376|472405274|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
131213136|NCT04311411|472405280|FG000|Overall Study|Adverse Event|2|||
131213137|NCT04311411|472405281|FG001|Overall Study|Adverse Event|3|||
131213138|NCT04311411|472405282|FG002|Overall Study|Adverse Event|2|||
131213139|NCT04311411|472405280|FG000|Overall Study|Withdrawal by Subject|3|||
131213140|NCT04311411|472405281|FG001|Overall Study|Withdrawal by Subject|3|||
131213141|NCT04311411|472405282|FG002|Overall Study|Withdrawal by Subject|0|||
131213142|NCT04888377|472405286|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
131213143|NCT04888377|472405287|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
131213144|NCT04888377|472405286|FG000|Overall Study|Physician Decision|6|||
131213145|NCT04888377|472405287|FG001|Overall Study|Physician Decision|6|||
130764461|NCT01592292|470760059|FG002|Overall Study|Follow-up loss|1|||
130764462|NCT01592292|470760060|FG003|Overall Study|Follow-up loss|0|||
130764463|NCT01592292|470760057|FG000|Overall Study|Withdrew consent|2|||
130764464|NCT01592292|470760058|FG001|Overall Study|Withdrew consent|1|||
130764465|NCT01592292|470760059|FG002|Overall Study|Withdrew consent|0|||
130764466|NCT01592292|470760060|FG003|Overall Study|Withdrew consent|0|||
130764467|NCT01592292|470760057|FG000|Overall Study|Other|1|||
130764468|NCT01592292|470760058|FG001|Overall Study|Other|1|||
130764469|NCT01592292|470760059|FG002|Overall Study|Other|2|||
130764470|NCT01592292|470760060|FG003|Overall Study|Other|1|||
130764471|NCT04148287|470760062|FG000|Overall Study|Death|2|||
130764472|NCT03164265|470760063|FG000|Overall Study|Physician Decision|3|||
130764473|NCT03912428|470760066|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
130764474|NCT03912428|470760067|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
130764475|NCT03912428|470760068|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
130764476|NCT03912428|470760069|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
130764477|NCT03912428|470760066|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
130877995|NCT00784563|471185905|FG001|Year 3|Adverse Event|0|||
131213146|NCT04888377|472405286|FG000|Overall Study|Withdrawal by Subject|7|||
131213147|NCT04888377|472405287|FG001|Overall Study|Withdrawal by Subject|3|||
131213148|NCT00526162|472405288|FG000|Overall Study|Device not implanted|3|||
130764478|NCT03912428|470760067|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
130764479|NCT03912428|470760068|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
130764480|NCT03912428|470760069|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
130764481|NCT03912428|470760066|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
130764482|NCT03912428|470760067|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
130764483|NCT03912428|470760068|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
130764484|NCT03912428|470760069|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
130764485|NCT03233204|470760070|FG000|Overall Study|Adverse Event|1|||
130764486|NCT03233204|470760070|FG000|Overall Study|Death|1|||
130764487|NCT03233204|470760070|FG000|Overall Study|Withdrawal by Subject|1|||
130764488|NCT03233204|470760070|FG000|Overall Study|Progressive Disease|3|||
130764489|NCT02680834|470760071|FG000|Overall Study|Physician Decision|5|||
130764490|NCT02680834|470760072|FG001|Overall Study|Physician Decision|2|||
130764491|NCT02680834|470760071|FG000|Overall Study|Withdrawal by Subject|6|||
130764492|NCT02680834|470760072|FG001|Overall Study|Withdrawal by Subject|0|||
130764493|NCT02680834|470760071|FG000|Overall Study|Lost to Follow-up|0|||
130764494|NCT02680834|470760072|FG001|Overall Study|Lost to Follow-up|1|||
130764495|NCT02407054|470760073|FG000|Overall Study|Adverse Event|1|||
130764496|NCT02407054|470760074|FG001|Overall Study|Adverse Event|4|||
130764497|NCT02407054|470760075|FG002|Overall Study|Adverse Event|1|||
130764498|NCT02407054|470760073|FG000|Overall Study|Non-compliance with Study|0|||
130764499|NCT02407054|470760074|FG001|Overall Study|Non-compliance with Study|2|||
130764500|NCT02407054|470760075|FG002|Overall Study|Non-compliance with Study|1|||
130764501|NCT02407054|470760073|FG000|Overall Study|Physician Decision|1|||
130764502|NCT02407054|470760074|FG001|Overall Study|Physician Decision|3|||
130764503|NCT02407054|470760075|FG002|Overall Study|Physician Decision|3|||
130764504|NCT02407054|470760073|FG000|Overall Study|Withdrawal by Subject|5|||
130764505|NCT02407054|470760074|FG001|Overall Study|Withdrawal by Subject|9|||
130764506|NCT02407054|470760075|FG002|Overall Study|Withdrawal by Subject|2|||
130764507|NCT02044874|470760076|FG000|Overall Study|Adverse Event|5|||
130764508|NCT02044874|470760077|FG001|Overall Study|Adverse Event|6|||
130764509|NCT02044874|470760078|FG002|Overall Study|Adverse Event|6|||
130764510|NCT02044874|470760076|FG000|Overall Study|Withdrawal by Subject|8|||
130764511|NCT02044874|470760077|FG001|Overall Study|Withdrawal by Subject|16|||
130764512|NCT02044874|470760078|FG002|Overall Study|Withdrawal by Subject|23|||
130764513|NCT02044874|470760076|FG000|Overall Study|Physician Decision|0|||
130764514|NCT02044874|470760077|FG001|Overall Study|Physician Decision|2|||
130764515|NCT02044874|470760078|FG002|Overall Study|Physician Decision|1|||
130764516|NCT02044874|470760076|FG000|Overall Study|Lost to Follow-up|10|||
130764517|NCT02044874|470760077|FG001|Overall Study|Lost to Follow-up|27|||
130764518|NCT02044874|470760078|FG002|Overall Study|Lost to Follow-up|21|||
130764519|NCT02044874|470760076|FG000|Overall Study|Sponsor Decision|0|||
130764520|NCT02044874|470760077|FG001|Overall Study|Sponsor Decision|1|||
130764521|NCT02044874|470760078|FG002|Overall Study|Sponsor Decision|1|||
130764522|NCT02044874|470760076|FG000|Overall Study|Other|7|||
130764523|NCT02044874|470760077|FG001|Overall Study|Other|3|||
130764524|NCT02044874|470760078|FG002|Overall Study|Other|8|||
130764525|NCT02889835|470760079|FG000|Overall Study|Lost to Follow-up|13|||
130764526|NCT02889835|470760080|FG001|Overall Study|Lost to Follow-up|13|||
130764527|NCT02889835|470760081|FG002|Overall Study|Lost to Follow-up|13|||
130764528|NCT02889835|470760079|FG000|Overall Study|Withdrawal by Subject|2|||
130764529|NCT02889835|470760080|FG001|Overall Study|Withdrawal by Subject|2|||
130764530|NCT02889835|470760081|FG002|Overall Study|Withdrawal by Subject|2|||
131213149|NCT05279807|472405289|FG000|Overall Study|Withdrawal by Subject|1|||
131213150|NCT05279807|472405290|FG001|Overall Study|Withdrawal by Subject|0|||
131213151|NCT05279807|472405289|FG000|Overall Study|Adverse Event|0|||
131213152|NCT05279807|472405290|FG001|Overall Study|Adverse Event|1|||
131213153|NCT05279807|472405289|FG000|Overall Study|Laboratory Abnormal Results|1|||
131213154|NCT05279807|472405290|FG001|Overall Study|Laboratory Abnormal Results|0|||
131213155|NCT05644756|472405291|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
131213156|NCT05644756|472405291|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
131213157|NCT03110107|472405292|FG000|Treatment Period|Disease Progression|3|||
131213158|NCT03110107|472405293|FG001|Treatment Period|Disease Progression|9|||
131213159|NCT03110107|472405294|FG002|Treatment Period|Disease Progression|8|||
131213160|NCT03110107|472405295|FG003|Treatment Period|Disease Progression|11|||
131213161|NCT03110107|472405296|FG004|Treatment Period|Disease Progression|8|||
131213162|NCT03110107|472405297|FG005|Treatment Period|Disease Progression|4|||
131213163|NCT03110107|472405298|FG006|Treatment Period|Disease Progression|6|||
131213164|NCT03110107|472405299|FG007|Treatment Period|Disease Progression|7|||
131213165|NCT03110107|472405300|FG008|Treatment Period|Disease Progression|2|||
130764531|NCT02889835|470760079|FG000|Overall Study|Protocol Violation|1|||
130764532|NCT02889835|470760080|FG001|Overall Study|Protocol Violation|1|||
130764533|NCT02889835|470760081|FG002|Overall Study|Protocol Violation|1|||
130764534|NCT02889835|470760079|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
130764535|NCT02889835|470760080|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
130764536|NCT02889835|470760081|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
131213166|NCT03110107|472405301|FG009|Treatment Period|Disease Progression|10|||
131213167|NCT03110107|472405302|FG010|Treatment Period|Disease Progression|5|||
131213168|NCT03110107|472405303|FG011|Treatment Period|Disease Progression|2|||
131213169|NCT03110107|472405304|FG012|Treatment Period|Disease Progression|0|||
131213170|NCT03110107|472405305|FG013|Treatment Period|Disease Progression|5|||
131213171|NCT03110107|472405306|FG014|Treatment Period|Disease Progression|14|||
131213172|NCT03110107|472405307|FG015|Treatment Period|Disease Progression|14|||
130764537|NCT02889835|470760079|FG000|Overall Study|Death|1|||
130764538|NCT02889835|470760080|FG001|Overall Study|Death|1|||
130764539|NCT02889835|470760081|FG002|Overall Study|Death|1|||
130764540|NCT01447927|470760082|FG000|Overall Study|Adverse Event|4|||
130764541|NCT01447927|470760083|FG001|Overall Study|Adverse Event|3|||
130764542|NCT01447927|470760082|FG000|Overall Study|Withdrawal by Subject|1|||
130764543|NCT01447927|470760083|FG001|Overall Study|Withdrawal by Subject|0|||
130764544|NCT04102865|470760085|FG000|Overall Study|Adverse Event|4|||
130764545|NCT04102865|470760086|FG001|Overall Study|Adverse Event|0|||
131213173|NCT03110107|472405308|FG016|Treatment Period|Disease Progression|4|||
130764546|NCT04102865|470760085|FG000|Overall Study|Lost to Follow-up|1|||
130764547|NCT04102865|470760086|FG001|Overall Study|Lost to Follow-up|0|||
130764548|NCT04102865|470760085|FG000|Overall Study|Withdrawal by Subject|2|||
130764549|NCT04102865|470760086|FG001|Overall Study|Withdrawal by Subject|0|||
130764550|NCT04683939|470760090|FG000|Overall Study|Study termination by the sponsor|0|||
130764551|NCT04683939|470760091|FG001|Overall Study|Study termination by the sponsor|1|||
130764552|NCT04683939|470760092|FG002|Overall Study|Study termination by the sponsor|2|||
130764553|NCT04683939|470760093|FG003|Overall Study|Study termination by the sponsor|2|||
130764554|NCT04683939|470760090|FG000|Overall Study|Death|1|||
130764555|NCT04683939|470760091|FG001|Overall Study|Death|1|||
130764556|NCT04683939|470760092|FG002|Overall Study|Death|2|||
130764557|NCT04683939|470760093|FG003|Overall Study|Death|1|||
130764558|NCT04683939|470760090|FG000|Overall Study|Withdrawal by Subject|1|||
130764559|NCT04683939|470760091|FG001|Overall Study|Withdrawal by Subject|0|||
130764560|NCT04683939|470760092|FG002|Overall Study|Withdrawal by Subject|0|||
130764561|NCT04683939|470760093|FG003|Overall Study|Withdrawal by Subject|0|||
130764562|NCT04683939|470760090|FG000|Overall Study|Physician Decision|1|||
130764563|NCT04683939|470760091|FG001|Overall Study|Physician Decision|0|||
130764564|NCT04683939|470760092|FG002|Overall Study|Physician Decision|0|||
130764565|NCT04683939|470760093|FG003|Overall Study|Physician Decision|0|||
130764566|NCT04683939|470760090|FG000|Overall Study|Lost to Follow-up|0|||
130764567|NCT04683939|470760091|FG001|Overall Study|Lost to Follow-up|1|||
130764568|NCT04683939|470760092|FG002|Overall Study|Lost to Follow-up|0|||
130764569|NCT04683939|470760093|FG003|Overall Study|Lost to Follow-up|0|||
130764570|NCT00224406|470761943|FG000|Overall Study|Re-transplant|0|||
130764571|NCT00224406|470761944|FG001|Overall Study|Re-transplant|2|||
130764572|NCT00224406|470761943|FG000|Overall Study|Death|0|||
130764573|NCT00224406|470761944|FG001|Overall Study|Death|1|||
130764574|NCT00224406|470761943|FG000|Overall Study|Transplant cancelled|0|||
131213174|NCT03110107|472405309|FG017|Treatment Period|Disease Progression|3|||
131213175|NCT03110107|472405310|FG018|Treatment Period|Disease Progression|16|||
131213176|NCT03110107|472405311|FG019|Treatment Period|Disease Progression|14|||
131213177|NCT03110107|472405312|FG020|Treatment Period|Disease Progression|12|||
131213178|NCT03110107|472405313|FG021|Treatment Period|Disease Progression|16|||
131213179|NCT03110107|472405314|FG022|Treatment Period|Disease Progression|18|||
131213180|NCT03110107|472405315|FG023|Treatment Period|Disease Progression|13|||
131213181|NCT03110107|472405316|FG024|Treatment Period|Disease Progression|16|||
131213182|NCT03110107|472405317|FG025|Treatment Period|Disease Progression|31|||
131213183|NCT03110107|472405292|FG000|Treatment Period|Study drug toxicity|1|||
131213184|NCT03110107|472405293|FG001|Treatment Period|Study drug toxicity|0|||
131213185|NCT03110107|472405294|FG002|Treatment Period|Study drug toxicity|1|||
131213186|NCT03110107|472405295|FG003|Treatment Period|Study drug toxicity|2|||
131213187|NCT03110107|472405296|FG004|Treatment Period|Study drug toxicity|0|||
131213188|NCT03110107|472405297|FG005|Treatment Period|Study drug toxicity|3|||
130764575|NCT00224406|470761944|FG001|Overall Study|Transplant cancelled|4|||
130764576|NCT00224406|470761943|FG000|Overall Study|Drug not delivered|2|||
130764577|NCT00224406|470761944|FG001|Overall Study|Drug not delivered|0|||
130764578|NCT00224406|470761943|FG000|Overall Study|Other|4|||
130764579|NCT00224406|470761944|FG001|Overall Study|Other|0|||
130764580|NCT00224406|470761943|FG000|Overall Study|Transplant cancelled|3|||
130764581|NCT00224406|470761944|FG001|Overall Study|Transplant cancelled|0|||
130764582|NCT01556997|470761945|FG000|Overall Study|Adverse Event|10|||
130764583|NCT01556997|470761946|FG001|Overall Study|Adverse Event|12|||
130764584|NCT01556997|470761947|FG002|Overall Study|Adverse Event|12|||
130764585|NCT01556997|470761945|FG000|Overall Study|Lost to Follow-up|6|||
130764586|NCT01556997|470761946|FG001|Overall Study|Lost to Follow-up|6|||
130764587|NCT01556997|470761947|FG002|Overall Study|Lost to Follow-up|4|||
130764588|NCT01556997|470761945|FG000|Overall Study|Physician Decision|1|||
131213189|NCT03110107|472405298|FG006|Treatment Period|Study drug toxicity|1|||
131213190|NCT03110107|472405299|FG007|Treatment Period|Study drug toxicity|1|||
130764589|NCT01556997|470761946|FG001|Overall Study|Physician Decision|1|||
130877996|NCT00784563|471185906|FG002|Year 3|Adverse Event|1|||
131213191|NCT03110107|472405300|FG008|Treatment Period|Study drug toxicity|3|||
130764590|NCT01556997|470761947|FG002|Overall Study|Physician Decision|1|||
130764591|NCT01556997|470761945|FG000|Overall Study|Withdrawal by Subject|7|||
130764592|NCT01556997|470761946|FG001|Overall Study|Withdrawal by Subject|6|||
130764593|NCT01556997|470761947|FG002|Overall Study|Withdrawal by Subject|8|||
130764594|NCT01556997|470761945|FG000|Overall Study|Other|2|||
130764595|NCT01556997|470761946|FG001|Overall Study|Other|3|||
130764596|NCT01556997|470761947|FG002|Overall Study|Other|7|||
130764597|NCT05459558|470761959|FG000|Overall Study|Adverse Event|1|||
130764598|NCT05459558|470761960|FG001|Overall Study|Adverse Event|0|||
130764599|NCT05459558|470761961|FG002|Overall Study|Adverse Event|0|||
130764600|NCT05459558|470761959|FG000|Overall Study|Scheduling issue|0|||
130764601|NCT05459558|470761960|FG001|Overall Study|Scheduling issue|1|||
130764602|NCT05459558|470761961|FG002|Overall Study|Scheduling issue|3|||
130764603|NCT05459558|470761959|FG000|Overall Study|Withdrawal by Subject|0|||
130764604|NCT05459558|470761960|FG001|Overall Study|Withdrawal by Subject|0|||
130764605|NCT05459558|470761961|FG002|Overall Study|Withdrawal by Subject|2|||
130764606|NCT01777139|470761962|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
130764607|NCT01777139|470761963|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
130764608|NCT01777139|470761962|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
130764609|NCT01777139|470761963|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
130764610|NCT01777139|470761962|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
130764611|NCT01777139|470761963|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
130764612|NCT01777139|470761962|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
130764613|NCT01777139|470761963|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
130764614|NCT01777139|470761962|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
130764615|NCT01777139|470761963|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
130764616|NCT01777139|470761962|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
130764617|NCT01777139|470761963|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
130764618|NCT01777139|470761962|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
130764619|NCT01777139|470761963|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
130764620|NCT01777139|470761962|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
130764621|NCT01777139|470761963|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
130764622|NCT05625477|470761964|FG000|Overall Study|Lost to Follow-up|2|||
130764623|NCT05625477|470761965|FG001|Overall Study|Lost to Follow-up|2|||
130764624|NCT05625477|470761966|FG002|Overall Study|Lost to Follow-up|1|||
130764625|NCT05625477|470761967|FG003|Overall Study|Lost to Follow-up|1|||
130764626|NCT05625477|470761968|FG004|Overall Study|Lost to Follow-up|0|||
130764627|NCT05625477|470761964|FG000|Overall Study|Covid quarantine|1|||
130764628|NCT05625477|470761965|FG001|Overall Study|Covid quarantine|0|||
130764629|NCT05625477|470761966|FG002|Overall Study|Covid quarantine|0|||
130764630|NCT05625477|470761967|FG003|Overall Study|Covid quarantine|0|||
130764631|NCT05625477|470761968|FG004|Overall Study|Covid quarantine|0|||
130764632|NCT01092637|470761969|FG000|Overall Study|Death|47|||
130764633|NCT01092637|470761970|FG001|Overall Study|Death|49|||
130764634|NCT03292458|470761971|FG000|Period 1|Adverse Event|2|||
130764635|NCT03292458|470761972|FG001|Period 1|Adverse Event|0|||
130764636|NCT00593606|470761973|FG000|Overall Study|Adverse Event|13|||
130764637|NCT00593606|470761973|FG000|Overall Study|Withdrawal by Subject|1|||
130764638|NCT00593606|470761973|FG000|Overall Study|Protocol Violation|3|||
130764639|NCT00593606|470761973|FG000|Overall Study|Lost to Follow-up|2|||
130764640|NCT00593606|470761973|FG000|Overall Study|Run-In Failure|5|||
130764641|NCT00593606|470761973|FG000|Overall Study|Screen Failure|3|||
130764642|NCT02278367|470761974|FG000|Overall Study|Physician Decision|5|||
130764643|NCT02278367|470761975|FG001|Overall Study|Physician Decision|0|||
130764644|NCT02278367|470761974|FG000|Overall Study|Withdrawal by Subject|5|||
130764645|NCT02278367|470761975|FG001|Overall Study|Withdrawal by Subject|0|||
130764646|NCT04643964|470761976|FG000|Overall Study|Lost to Follow-up|55|||
130764647|NCT04643964|470761977|FG001|Overall Study|Lost to Follow-up|59|||
130764648|NCT04643964|470761978|FG002|Overall Study|Lost to Follow-up|54|||
130764649|NCT04643964|470761979|FG003|Overall Study|Lost to Follow-up|129|||
130764650|NCT04643964|470761980|FG004|Overall Study|Lost to Follow-up|48|||
130764651|NCT04643964|470761976|FG000|Overall Study|Failed attention check|1|||
130764652|NCT04643964|470761977|FG001|Overall Study|Failed attention check|8|||
130764653|NCT04643964|470761978|FG002|Overall Study|Failed attention check|2|||
130764654|NCT04643964|470761979|FG003|Overall Study|Failed attention check|14|||
130764655|NCT04643964|470761980|FG004|Overall Study|Failed attention check|11|||
130764656|NCT05932225|470761981|FG000|Overall Study|Lost to Follow-up|0|||
130764657|NCT05932225|470761982|FG001|Overall Study|Lost to Follow-up|1|||
130764658|NCT05932225|470761983|FG002|Overall Study|Lost to Follow-up|0|||
130764659|NCT05932225|470761981|FG000|Overall Study|Withdrawal by Subject|1|||
130764660|NCT05932225|470761982|FG001|Overall Study|Withdrawal by Subject|0|||
130764661|NCT05932225|470761983|FG002|Overall Study|Withdrawal by Subject|0|||
130764662|NCT05932225|470761981|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
130764663|NCT05932225|470761982|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
130989852|NCT01576367|471591511|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130764664|NCT05932225|470761983|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
130764665|NCT02638129|470761984|FG000|Overall Study|Study terminated|28|||
130764666|NCT02638129|470761985|FG001|Overall Study|Study terminated|30|||
130764667|NCT02949908|470761988|FG000|Overall Study|Study termination|2|||
130764668|NCT00114738|470761989|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
130764669|NCT00114738|470761990|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
130764670|NCT00114738|470761991|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
130764671|NCT00114738|470761989|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
130764672|NCT00114738|470761990|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
130764673|NCT00114738|470761991|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
130764674|NCT00114738|470761989|FG000|Screening for Randomization|Neuropathy|17|||
130764675|NCT00114738|470761990|FG001|Screening for Randomization|Neuropathy|0|||
130764676|NCT00114738|470761991|FG002|Screening for Randomization|Neuropathy|0|||
130764677|NCT00114738|470761989|FG000|Screening for Randomization|Progressive disease|2|||
130764678|NCT00114738|470761990|FG001|Screening for Randomization|Progressive disease|0|||
130764679|NCT00114738|470761991|FG002|Screening for Randomization|Progressive disease|0|||
130764680|NCT00114738|470761989|FG000|Screening for Randomization|CNS Hemorrhage|1|||
130764681|NCT00114738|470761990|FG001|Screening for Randomization|CNS Hemorrhage|0|||
130764682|NCT00114738|470761991|FG002|Screening for Randomization|CNS Hemorrhage|0|||
130764683|NCT00114738|470761989|FG000|Screening for Randomization|Other|1|||
130764684|NCT00114738|470761990|FG001|Screening for Randomization|Other|0|||
130764685|NCT00114738|470761991|FG002|Screening for Randomization|Other|0|||
130764686|NCT00308750|470761996|FG000|Overall Study|Adverse Event|9|||
130764687|NCT00308750|470761997|FG001|Overall Study|Adverse Event|9|||
130764688|NCT00308750|470761998|FG002|Overall Study|Adverse Event|13|||
130764689|NCT00308750|470761996|FG000|Overall Study|Withdrawal by Subject|6|||
130764690|NCT00308750|470761997|FG001|Overall Study|Withdrawal by Subject|2|||
130764691|NCT00308750|470761998|FG002|Overall Study|Withdrawal by Subject|3|||
130764692|NCT00308750|470761996|FG000|Overall Study|Physician Decision|3|||
130877997|NCT00762164|471185907|FG000|Overall Study|Lost to Follow-up|1|||
130877998|NCT00762164|471185908|FG001|Overall Study|Lost to Follow-up|1|||
130877999|NCT00762164|471185907|FG000|Overall Study|Discontinued medication|2|||
130878000|NCT00762164|471185908|FG001|Overall Study|Discontinued medication|0|||
130878001|NCT00762164|471185907|FG000|Overall Study|Withdrawal by Subject|0|||
130878002|NCT00762164|471185908|FG001|Overall Study|Withdrawal by Subject|1|||
130878003|NCT00374140|471185915|FG000|Overall Study|Lost to Follow-up|1|||
130878004|NCT00374140|471185915|FG000|Overall Study|Protocol Violation|1|||
130878005|NCT04576988|471185916|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
130878006|NCT04576988|471185917|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
130878007|NCT04576988|471185916|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
130878008|NCT04576988|471185917|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
130878009|NCT04576988|471185916|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
130878010|NCT04576988|471185917|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
130878011|NCT04576988|471185916|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
130878012|NCT04576988|471185917|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
130878013|NCT04576988|471185916|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
130878014|NCT04576988|471185917|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
130878015|NCT04576988|471185916|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
130878016|NCT04576988|471185917|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
130878017|NCT04576988|471185916|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
130878018|NCT04576988|471185917|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
130878019|NCT04576988|471185916|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
130878020|NCT04576988|471185917|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
130878021|NCT04576988|471185916|FG000|Long Term Double Blind (LTDB)|Death|2|||
130878022|NCT04576988|471185917|FG001|Long Term Double Blind (LTDB)|Death|1|||
130878023|NCT04576988|471185916|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
130878024|NCT04576988|471185917|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
130878025|NCT00617734|471185918|FG000|Overall Study|Withdrew Consent|2|||
130878026|NCT00617734|471185919|FG001|Overall Study|Withdrew Consent|0|||
130878027|NCT00617734|471185918|FG000|Overall Study|Adverse Event|4|||
130878028|NCT00617734|471185919|FG001|Overall Study|Adverse Event|1|||
130878029|NCT00617734|471185918|FG000|Overall Study|Protocol Violation|1|||
130878030|NCT00617734|471185919|FG001|Overall Study|Protocol Violation|0|||
130878031|NCT00617734|471185918|FG000|Overall Study|Found Ineligible After Randomization|1|||
130878032|NCT00617734|471185919|FG001|Overall Study|Found Ineligible After Randomization|4|||
130878033|NCT00617734|471185918|FG000|Overall Study|Lost to Follow-up|0|||
130878034|NCT00617734|471185919|FG001|Overall Study|Lost to Follow-up|1|||
130878035|NCT01844765|471185920|FG000|Overall Study|Adverse Event|6|||
130878036|NCT01844765|471185921|FG001|Overall Study|Adverse Event|8|||
130878037|NCT01844765|471185920|FG000|Overall Study|Withdrawal by Subject|2|||
130878038|NCT01844765|471185921|FG001|Overall Study|Withdrawal by Subject|3|||
130764693|NCT00308750|470761997|FG001|Overall Study|Physician Decision|4|||
130764694|NCT00308750|470761998|FG002|Overall Study|Physician Decision|3|||
130764695|NCT00308750|470761996|FG000|Overall Study|Sponsor Decision|1|||
130764696|NCT00308750|470761997|FG001|Overall Study|Sponsor Decision|0|||
130764697|NCT00308750|470761998|FG002|Overall Study|Sponsor Decision|0|||
130764698|NCT00308750|470761996|FG000|Overall Study|Disease Progression|47|||
130764699|NCT00308750|470761997|FG001|Overall Study|Disease Progression|24|||
130764700|NCT00308750|470761998|FG002|Overall Study|Disease Progression|28|||
130764701|NCT00308750|470761996|FG000|Overall Study|Unrelated Complication|3|||
130764702|NCT00308750|470761997|FG001|Overall Study|Unrelated Complication|0|||
130764703|NCT00308750|470761998|FG002|Overall Study|Unrelated Complication|1|||
130764704|NCT00308750|470761996|FG000|Overall Study|Death|1|||
130764705|NCT00308750|470761997|FG001|Overall Study|Death|0|||
130764706|NCT00308750|470761998|FG002|Overall Study|Death|1|||
130764707|NCT00308750|470761996|FG000|Overall Study|Protocol Violation|1|||
130764708|NCT00308750|470761997|FG001|Overall Study|Protocol Violation|0|||
130764709|NCT00308750|470761998|FG002|Overall Study|Protocol Violation|0|||
130764710|NCT00308750|470761996|FG000|Overall Study|New Primary Disease Identified|1|||
130764711|NCT00308750|470761997|FG001|Overall Study|New Primary Disease Identified|1|||
130764712|NCT00308750|470761998|FG002|Overall Study|New Primary Disease Identified|0|||
130764713|NCT01358578|470761999|FG000|Induction Period|Adverse Event|2|||
130764714|NCT01358578|470762000|FG001|Induction Period|Adverse Event|4|||
130764715|NCT01358578|470762001|FG002|Induction Period|Adverse Event|2|||
130764716|NCT01358578|470762002|FG003|Induction Period|Adverse Event|6|||
130764717|NCT01358578|470762003|FG004|Induction Period|Adverse Event|0|||
130764718|NCT01358578|470762004|FG005|Induction Period|Adverse Event|0|||
130764719|NCT01358578|470761999|FG000|Induction Period|Lack of Efficacy|0|||
130764720|NCT01358578|470762000|FG001|Induction Period|Lack of Efficacy|0|||
130764721|NCT01358578|470762001|FG002|Induction Period|Lack of Efficacy|9|||
130764722|NCT01358578|470762002|FG003|Induction Period|Lack of Efficacy|1|||
130764723|NCT01358578|470762003|FG004|Induction Period|Lack of Efficacy|0|||
130764724|NCT01358578|470762004|FG005|Induction Period|Lack of Efficacy|0|||
130764725|NCT01358578|470761999|FG000|Induction Period|Lost to Follow-up|0|||
130764726|NCT01358578|470762000|FG001|Induction Period|Lost to Follow-up|0|||
130764727|NCT01358578|470762001|FG002|Induction Period|Lost to Follow-up|1|||
130764728|NCT01358578|470762002|FG003|Induction Period|Lost to Follow-up|4|||
130764729|NCT01358578|470762003|FG004|Induction Period|Lost to Follow-up|0|||
130764730|NCT01358578|470762004|FG005|Induction Period|Lost to Follow-up|0|||
130764731|NCT01358578|470761999|FG000|Induction Period|Physician Decision|2|||
130764732|NCT01358578|470762000|FG001|Induction Period|Physician Decision|1|||
130764733|NCT01358578|470762001|FG002|Induction Period|Physician Decision|2|||
130764734|NCT01358578|470762002|FG003|Induction Period|Physician Decision|0|||
130764735|NCT01358578|470762003|FG004|Induction Period|Physician Decision|0|||
130764736|NCT01358578|470762004|FG005|Induction Period|Physician Decision|0|||
130764737|NCT01358578|470761999|FG000|Induction Period|Protocol Deviation|3|||
130764738|NCT01358578|470762000|FG001|Induction Period|Protocol Deviation|5|||
130764739|NCT01358578|470762001|FG002|Induction Period|Protocol Deviation|0|||
130764740|NCT01358578|470762002|FG003|Induction Period|Protocol Deviation|3|||
130764741|NCT01358578|470762003|FG004|Induction Period|Protocol Deviation|0|||
130764742|NCT01358578|470762004|FG005|Induction Period|Protocol Deviation|0|||
130764743|NCT01358578|470761999|FG000|Induction Period|technical problems|0|||
130764744|NCT01358578|470762000|FG001|Induction Period|technical problems|0|||
130764745|NCT01358578|470762001|FG002|Induction Period|technical problems|1|||
130764746|NCT01358578|470762002|FG003|Induction Period|technical problems|1|||
130764747|NCT01358578|470762003|FG004|Induction Period|technical problems|0|||
130764748|NCT01358578|470762004|FG005|Induction Period|technical problems|0|||
130764749|NCT01358578|470761999|FG000|Induction Period|Withdrawal by Subject|5|||
130764750|NCT01358578|470762000|FG001|Induction Period|Withdrawal by Subject|5|||
130764751|NCT01358578|470762001|FG002|Induction Period|Withdrawal by Subject|10|||
130764752|NCT01358578|470762002|FG003|Induction Period|Withdrawal by Subject|6|||
130764753|NCT01358578|470762003|FG004|Induction Period|Withdrawal by Subject|0|||
130764754|NCT01358578|470762004|FG005|Induction Period|Withdrawal by Subject|0|||
130764755|NCT01358578|470761999|FG000|Maintenance Period|Adverse Event|2|||
130764756|NCT01358578|470762000|FG001|Maintenance Period|Adverse Event|7|||
130764757|NCT01358578|470762001|FG002|Maintenance Period|Adverse Event|0|||
130764758|NCT01358578|470762002|FG003|Maintenance Period|Adverse Event|6|||
130764759|NCT01358578|470762003|FG004|Maintenance Period|Adverse Event|4|||
130764760|NCT01358578|470762004|FG005|Maintenance Period|Adverse Event|3|||
130764761|NCT01358578|470761999|FG000|Maintenance Period|Lack of Efficacy|10|||
130764762|NCT01358578|470762000|FG001|Maintenance Period|Lack of Efficacy|2|||
130764763|NCT01358578|470762001|FG002|Maintenance Period|Lack of Efficacy|0|||
130764764|NCT01358578|470762002|FG003|Maintenance Period|Lack of Efficacy|11|||
130764765|NCT01358578|470762003|FG004|Maintenance Period|Lack of Efficacy|3|||
130764766|NCT01358578|470762004|FG005|Maintenance Period|Lack of Efficacy|0|||
130764767|NCT01358578|470761999|FG000|Maintenance Period|Lost to Follow-up|4|||
130764768|NCT01358578|470762000|FG001|Maintenance Period|Lost to Follow-up|0|||
130764769|NCT01358578|470762001|FG002|Maintenance Period|Lost to Follow-up|0|||
130764770|NCT01358578|470762002|FG003|Maintenance Period|Lost to Follow-up|5|||
130878039|NCT01844765|471185920|FG000|Overall Study|Disease progression|1|||
130878040|NCT01844765|471185921|FG001|Overall Study|Disease progression|0|||
130878041|NCT01844765|471185920|FG000|Overall Study|Administrative problems|3|||
130878042|NCT01844765|471185921|FG001|Overall Study|Administrative problems|4|||
130878043|NCT01844765|471185920|FG000|Overall Study|Protocol deviation|2|||
130764771|NCT01358578|470762003|FG004|Maintenance Period|Lost to Follow-up|1|||
130764772|NCT01358578|470762004|FG005|Maintenance Period|Lost to Follow-up|1|||
130764773|NCT01358578|470761999|FG000|Maintenance Period|Non-compliance with study treatment|3|||
130764774|NCT01358578|470762000|FG001|Maintenance Period|Non-compliance with study treatment|1|||
130764775|NCT01358578|470762001|FG002|Maintenance Period|Non-compliance with study treatment|0|||
130764776|NCT01358578|470762002|FG003|Maintenance Period|Non-compliance with study treatment|2|||
130764777|NCT01358578|470762003|FG004|Maintenance Period|Non-compliance with study treatment|1|||
130764778|NCT01358578|470762004|FG005|Maintenance Period|Non-compliance with study treatment|2|||
130764779|NCT01358578|470761999|FG000|Maintenance Period|Physician Decision|0|||
130764780|NCT01358578|470762000|FG001|Maintenance Period|Physician Decision|1|||
130764781|NCT01358578|470762001|FG002|Maintenance Period|Physician Decision|0|||
130764782|NCT01358578|470762002|FG003|Maintenance Period|Physician Decision|1|||
130764783|NCT01358578|470762003|FG004|Maintenance Period|Physician Decision|0|||
130764784|NCT01358578|470762004|FG005|Maintenance Period|Physician Decision|0|||
130764785|NCT01358578|470761999|FG000|Maintenance Period|Pregnancy|1|||
130764786|NCT01358578|470762000|FG001|Maintenance Period|Pregnancy|0|||
130764787|NCT01358578|470762001|FG002|Maintenance Period|Pregnancy|0|||
130878044|NCT01844765|471185921|FG001|Overall Study|Protocol deviation|0|||
130878045|NCT01844765|471185920|FG000|Overall Study|Untreated|1|||
130878046|NCT01844765|471185921|FG001|Overall Study|Untreated|0|||
130878047|NCT03221556|471185923|FG000|Allocation|post-randomization exclusion|0|||
130878048|NCT03221556|471185924|FG001|Allocation|post-randomization exclusion|1|||
130878049|NCT03221556|471185923|FG000|Follow-Up|Withdrawal by Subject|0|||
130878050|NCT03221556|471185924|FG001|Follow-Up|Withdrawal by Subject|1|||
130878051|NCT00506350|471185925|FG000|Overall Study|Serious Adverse Event|1|||
130878052|NCT00506350|471185926|FG001|Overall Study|Serious Adverse Event|0|||
130878053|NCT00506350|471185927|FG002|Overall Study|Serious Adverse Event|0|||
130878054|NCT00506350|471185928|FG003|Overall Study|Serious Adverse Event|0|||
130878055|NCT00506350|471185929|FG004|Overall Study|Serious Adverse Event|0|||
130878056|NCT00506350|471185930|FG005|Overall Study|Serious Adverse Event|0|||
130878057|NCT00506350|471185931|FG006|Overall Study|Serious Adverse Event|0|||
130878058|NCT00506350|471185932|FG007|Overall Study|Serious Adverse Event|0|||
130878059|NCT00506350|471185933|FG008|Overall Study|Serious Adverse Event|0|||
130878060|NCT00506350|471185925|FG000|Overall Study|Adverse Event|0|||
130878061|NCT00506350|471185926|FG001|Overall Study|Adverse Event|0|||
130878062|NCT00506350|471185927|FG002|Overall Study|Adverse Event|0|||
130878063|NCT00506350|471185928|FG003|Overall Study|Adverse Event|0|||
130878064|NCT00506350|471185929|FG004|Overall Study|Adverse Event|0|||
130878065|NCT00506350|471185930|FG005|Overall Study|Adverse Event|0|||
130878066|NCT00506350|471185931|FG006|Overall Study|Adverse Event|0|||
130878067|NCT00506350|471185932|FG007|Overall Study|Adverse Event|1|||
130878068|NCT00506350|471185933|FG008|Overall Study|Adverse Event|1|||
130878069|NCT00506350|471185925|FG000|Overall Study|Protocol Violation|0|||
130878070|NCT00506350|471185926|FG001|Overall Study|Protocol Violation|0|||
130878071|NCT00506350|471185927|FG002|Overall Study|Protocol Violation|1|||
130878072|NCT00506350|471185928|FG003|Overall Study|Protocol Violation|0|||
130878073|NCT00506350|471185929|FG004|Overall Study|Protocol Violation|0|||
130878074|NCT00506350|471185930|FG005|Overall Study|Protocol Violation|0|||
130878075|NCT00506350|471185931|FG006|Overall Study|Protocol Violation|1|||
130878076|NCT00506350|471185932|FG007|Overall Study|Protocol Violation|0|||
130878077|NCT00506350|471185933|FG008|Overall Study|Protocol Violation|0|||
130878078|NCT00506350|471185925|FG000|Overall Study|Withdrawal by Subject|0|||
130878079|NCT00506350|471185926|FG001|Overall Study|Withdrawal by Subject|1|||
130878080|NCT00506350|471185927|FG002|Overall Study|Withdrawal by Subject|1|||
130878081|NCT00506350|471185928|FG003|Overall Study|Withdrawal by Subject|1|||
130878082|NCT00506350|471185929|FG004|Overall Study|Withdrawal by Subject|4|||
130878083|NCT00506350|471185930|FG005|Overall Study|Withdrawal by Subject|1|||
130878084|NCT00506350|471185931|FG006|Overall Study|Withdrawal by Subject|1|||
130878085|NCT00506350|471185932|FG007|Overall Study|Withdrawal by Subject|2|||
130878086|NCT00506350|471185933|FG008|Overall Study|Withdrawal by Subject|0|||
130878087|NCT00506350|471185925|FG000|Overall Study|Lost to Follow-up|1|||
130878088|NCT00506350|471185926|FG001|Overall Study|Lost to Follow-up|1|||
130878089|NCT00506350|471185927|FG002|Overall Study|Lost to Follow-up|1|||
130878090|NCT00506350|471185928|FG003|Overall Study|Lost to Follow-up|1|||
130878091|NCT00506350|471185929|FG004|Overall Study|Lost to Follow-up|2|||
130878092|NCT00506350|471185930|FG005|Overall Study|Lost to Follow-up|1|||
130878093|NCT00506350|471185931|FG006|Overall Study|Lost to Follow-up|0|||
130878094|NCT00506350|471185932|FG007|Overall Study|Lost to Follow-up|0|||
130878095|NCT00506350|471185933|FG008|Overall Study|Lost to Follow-up|2|||
130878096|NCT00506350|471185925|FG000|Overall Study|Medical Reason|0|||
130878097|NCT00506350|471185926|FG001|Overall Study|Medical Reason|0|||
130764788|NCT01358578|470762002|FG003|Maintenance Period|Pregnancy|0|||
130878098|NCT00506350|471185927|FG002|Overall Study|Medical Reason|0|||
130878099|NCT00506350|471185928|FG003|Overall Study|Medical Reason|0|||
130764789|NCT01358578|470762003|FG004|Maintenance Period|Pregnancy|0|||
130764790|NCT01358578|470762004|FG005|Maintenance Period|Pregnancy|0|||
130764791|NCT01358578|470761999|FG000|Maintenance Period|Protocol deviation|7|||
130764792|NCT01358578|470762000|FG001|Maintenance Period|Protocol deviation|4|||
130764793|NCT01358578|470762001|FG002|Maintenance Period|Protocol deviation|0|||
130764794|NCT01358578|470762002|FG003|Maintenance Period|Protocol deviation|2|||
130764795|NCT01358578|470762003|FG004|Maintenance Period|Protocol deviation|2|||
130764796|NCT01358578|470762004|FG005|Maintenance Period|Protocol deviation|2|||
130764797|NCT01358578|470761999|FG000|Maintenance Period|Withdrawal by Subject|12|||
130764798|NCT01358578|470762000|FG001|Maintenance Period|Withdrawal by Subject|7|||
130764799|NCT01358578|470762001|FG002|Maintenance Period|Withdrawal by Subject|2|||
130764800|NCT01358578|470762002|FG003|Maintenance Period|Withdrawal by Subject|15|||
130764801|NCT01358578|470762003|FG004|Maintenance Period|Withdrawal by Subject|6|||
130764802|NCT01358578|470762004|FG005|Maintenance Period|Withdrawal by Subject|3|||
130764803|NCT01358578|470761999|FG000|Follow-up Period|Adverse Event|1|||
130764804|NCT01358578|470762000|FG001|Follow-up Period|Adverse Event|1|||
130764805|NCT01358578|470762001|FG002|Follow-up Period|Adverse Event|0|||
130764806|NCT01358578|470762002|FG003|Follow-up Period|Adverse Event|0|||
130764807|NCT01358578|470762003|FG004|Follow-up Period|Adverse Event|0|||
130764808|NCT01358578|470762004|FG005|Follow-up Period|Adverse Event|0|||
130764809|NCT01358578|470761999|FG000|Follow-up Period|Lack of Efficacy|3|||
130764810|NCT01358578|470762000|FG001|Follow-up Period|Lack of Efficacy|0|||
130764811|NCT01358578|470762001|FG002|Follow-up Period|Lack of Efficacy|4|||
130764812|NCT01358578|470762002|FG003|Follow-up Period|Lack of Efficacy|1|||
130764813|NCT01358578|470762003|FG004|Follow-up Period|Lack of Efficacy|0|||
130764814|NCT01358578|470762004|FG005|Follow-up Period|Lack of Efficacy|0|||
130764815|NCT01358578|470761999|FG000|Follow-up Period|Lost to Follow-up|0|||
130764816|NCT01358578|470762000|FG001|Follow-up Period|Lost to Follow-up|1|||
130764817|NCT01358578|470762001|FG002|Follow-up Period|Lost to Follow-up|0|||
130764818|NCT01358578|470762002|FG003|Follow-up Period|Lost to Follow-up|4|||
130764819|NCT01358578|470762003|FG004|Follow-up Period|Lost to Follow-up|0|||
130764820|NCT01358578|470762004|FG005|Follow-up Period|Lost to Follow-up|0|||
130764821|NCT01358578|470761999|FG000|Follow-up Period|non- compliance with study treatment|1|||
130764822|NCT01358578|470762000|FG001|Follow-up Period|non- compliance with study treatment|0|||
130764823|NCT01358578|470762001|FG002|Follow-up Period|non- compliance with study treatment|0|||
130764824|NCT01358578|470762002|FG003|Follow-up Period|non- compliance with study treatment|0|||
130764825|NCT01358578|470762003|FG004|Follow-up Period|non- compliance with study treatment|0|||
130764826|NCT01358578|470762004|FG005|Follow-up Period|non- compliance with study treatment|0|||
130764827|NCT01358578|470761999|FG000|Follow-up Period|Pregnancy|1|||
130764828|NCT01358578|470762000|FG001|Follow-up Period|Pregnancy|0|||
130764829|NCT01358578|470762001|FG002|Follow-up Period|Pregnancy|0|||
130764830|NCT01358578|470762002|FG003|Follow-up Period|Pregnancy|0|||
130764831|NCT01358578|470762003|FG004|Follow-up Period|Pregnancy|0|||
130764832|NCT01358578|470762004|FG005|Follow-up Period|Pregnancy|0|||
130764833|NCT01358578|470761999|FG000|Follow-up Period|Withdrawal by Subject|3|||
130764834|NCT01358578|470762000|FG001|Follow-up Period|Withdrawal by Subject|3|||
130764835|NCT01358578|470762001|FG002|Follow-up Period|Withdrawal by Subject|1|||
130764836|NCT01358578|470762002|FG003|Follow-up Period|Withdrawal by Subject|12|||
130764837|NCT01358578|470762003|FG004|Follow-up Period|Withdrawal by Subject|0|||
130764838|NCT01358578|470762004|FG005|Follow-up Period|Withdrawal by Subject|0|||
130764839|NCT01358578|470761999|FG000|Follow-up Period|Physician Decision|1|||
130764840|NCT01358578|470762000|FG001|Follow-up Period|Physician Decision|1|||
130764841|NCT01358578|470762001|FG002|Follow-up Period|Physician Decision|0|||
130764842|NCT01358578|470762002|FG003|Follow-up Period|Physician Decision|2|||
130764843|NCT01358578|470762003|FG004|Follow-up Period|Physician Decision|0|||
130764844|NCT01358578|470762004|FG005|Follow-up Period|Physician Decision|0|||
130764845|NCT02304380|470762005|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130764846|NCT02304380|470762006|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130764847|NCT02304380|470762007|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130764848|NCT02304380|470762008|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
130764849|NCT02304380|470762009|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130764850|NCT02304380|470762010|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130764851|NCT01125813|470762011|FG000|Overall Study|Death|1|||
130764852|NCT01125813|470762011|FG000|Overall Study|Withdrawal by Subject|1|||
130764853|NCT01125813|470762011|FG000|Overall Study|Screen Failures|4|||
130764854|NCT02327013|470762012|FG000|Overall Study|Adverse Event|4|||
130764855|NCT02327013|470762013|FG001|Overall Study|Adverse Event|4|||
130764856|NCT02327013|470762014|FG002|Overall Study|Adverse Event|3|||
130764857|NCT02327013|470762015|FG003|Overall Study|Adverse Event|0|||
130764858|NCT02327013|470762016|FG004|Overall Study|Adverse Event|1|||
130764859|NCT02327013|470762012|FG000|Overall Study|Lack of Efficacy|2|||
130764860|NCT02327013|470762013|FG001|Overall Study|Lack of Efficacy|0|||
130764861|NCT02327013|470762014|FG002|Overall Study|Lack of Efficacy|5|||
130764862|NCT02327013|470762015|FG003|Overall Study|Lack of Efficacy|0|||
130878100|NCT00506350|471185929|FG004|Overall Study|Medical Reason|1|||
130764863|NCT02327013|470762016|FG004|Overall Study|Lack of Efficacy|1|||
130764864|NCT02327013|470762012|FG000|Overall Study|Non-compliance with IMP|1|||
130764865|NCT02327013|470762013|FG001|Overall Study|Non-compliance with IMP|2|||
130764866|NCT02327013|470762014|FG002|Overall Study|Non-compliance with IMP|7|||
130764867|NCT02327013|470762015|FG003|Overall Study|Non-compliance with IMP|0|||
130764868|NCT02327013|470762016|FG004|Overall Study|Non-compliance with IMP|0|||
130764869|NCT02327013|470762012|FG000|Overall Study|Withdrawal of Consent|1|||
130764870|NCT02327013|470762013|FG001|Overall Study|Withdrawal of Consent|0|||
130764871|NCT02327013|470762014|FG002|Overall Study|Withdrawal of Consent|3|||
130764872|NCT02327013|470762015|FG003|Overall Study|Withdrawal of Consent|0|||
130764873|NCT02327013|470762016|FG004|Overall Study|Withdrawal of Consent|0|||
130764874|NCT02327013|470762012|FG000|Overall Study|Lost to Follow-up|2|||
130764875|NCT02327013|470762013|FG001|Overall Study|Lost to Follow-up|4|||
130764876|NCT02327013|470762014|FG002|Overall Study|Lost to Follow-up|5|||
130764877|NCT02327013|470762015|FG003|Overall Study|Lost to Follow-up|0|||
130764878|NCT02327013|470762016|FG004|Overall Study|Lost to Follow-up|0|||
130764879|NCT02327013|470762012|FG000|Overall Study|Administrative or other reason(s)|1|||
130764880|NCT02327013|470762013|FG001|Overall Study|Administrative or other reason(s)|5|||
130764881|NCT02327013|470762014|FG002|Overall Study|Administrative or other reason(s)|11|||
130764882|NCT02327013|470762015|FG003|Overall Study|Administrative or other reason(s)|1|||
130764883|NCT02327013|470762016|FG004|Overall Study|Administrative or other reason(s)|1|||
130764884|NCT02327013|470762012|FG000|Overall Study|Protocol Violation|0|||
130764885|NCT02327013|470762013|FG001|Overall Study|Protocol Violation|0|||
130764886|NCT02327013|470762014|FG002|Overall Study|Protocol Violation|3|||
130764887|NCT02327013|470762015|FG003|Overall Study|Protocol Violation|0|||
130764888|NCT02327013|470762016|FG004|Overall Study|Protocol Violation|1|||
130764889|NCT02327013|470762012|FG000|Overall Study|Withdrawal before treatment|2|||
130764890|NCT02327013|470762013|FG001|Overall Study|Withdrawal before treatment|1|||
130764891|NCT02327013|470762014|FG002|Overall Study|Withdrawal before treatment|5|||
130764892|NCT02327013|470762015|FG003|Overall Study|Withdrawal before treatment|0|||
130764893|NCT02327013|470762016|FG004|Overall Study|Withdrawal before treatment|0|||
130764894|NCT04258254|470762017|FG000|Overall Study|Withdrawal by Subject|0|||
130764895|NCT04258254|470762018|FG001|Overall Study|Withdrawal by Subject|1|||
130764896|NCT04258254|470762019|FG002|Overall Study|Withdrawal by Subject|0|||
130764897|NCT04829331|470762020|FG000|Overall Study|Lost to Follow-up|1|||
130764898|NCT04829331|470762021|FG001|Overall Study|Lost to Follow-up|0|||
130764899|NCT00616603|470762023|FG000|Overall Study|Physician Decision|2|||
130764900|NCT00616603|470762024|FG001|Overall Study|Physician Decision|0|||
130764901|NCT00616603|470762025|FG002|Overall Study|Physician Decision|2|||
130764902|NCT02223819|470762031|FG000|Overall Study|Lost to Follow-up|2|||
130764903|NCT02956057|470762032|FG000|Overall Study|Discontinued intervention|14|||
130764904|NCT02956057|470762033|FG001|Overall Study|Discontinued intervention|10|||
130764905|NCT02956057|470762034|FG002|Overall Study|Discontinued intervention|7|||
130764906|NCT02956057|470762035|FG003|Overall Study|Discontinued intervention|14|||
130764907|NCT02956057|470762036|FG004|Overall Study|Discontinued intervention|4|||
130764908|NCT02956057|470762037|FG005|Overall Study|Discontinued intervention|17|||
130764909|NCT02956057|470762032|FG000|Overall Study|Lost to Follow-up|0|||
130764910|NCT02956057|470762033|FG001|Overall Study|Lost to Follow-up|2|||
130764911|NCT02956057|470762034|FG002|Overall Study|Lost to Follow-up|1|||
130764912|NCT02956057|470762035|FG003|Overall Study|Lost to Follow-up|1|||
130764913|NCT02956057|470762036|FG004|Overall Study|Lost to Follow-up|1|||
130764914|NCT02956057|470762037|FG005|Overall Study|Lost to Follow-up|0|||
130764915|NCT00367484|470762044|FG000|Overall Study|Adverse Event|7|||
130764916|NCT00367484|470762044|FG000|Overall Study|Withdrew informed consent|5|||
130764917|NCT00367484|470762044|FG000|Overall Study|Travel to USA|1|||
130764918|NCT00367484|470762044|FG000|Overall Study|Lost to Follow-up|1|||
130764919|NCT00367484|470762044|FG000|Overall Study|Protocol Violation|1|||
130764920|NCT00367484|470762044|FG000|Overall Study|The choice of the patient|1|||
130764921|NCT00367484|470762044|FG000|Overall Study|Lack of Efficacy|1|||
130764922|NCT00908076|470762045|FG000|Overall Study|Lack of Efficacy|1|||
130764923|NCT00908076|470762046|FG001|Overall Study|Lack of Efficacy|1|||
130764924|NCT02382796|470762047|FG000|Overall Study|Global deterioration of health status|1|||
130764925|NCT02382796|470762047|FG000|Overall Study|Objective progression or relapse|3|||
130764926|NCT02382796|470762047|FG000|Overall Study|Commercial dacomitinib became available|3|||
130764927|NCT04007107|470762054|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
130764928|NCT04007107|470762055|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
130764929|NCT04007107|470762056|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
130764930|NCT04007107|470762057|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
130764931|NCT04679051|470762063|FG000|Overall Study|felt tired after restricted time in bed|3|||
130764932|NCT04679051|470762064|FG001|Overall Study|felt tired after restricted time in bed|0|||
130764933|NCT04679051|470762063|FG000|Overall Study|discomfort with blood pressure cuff|2|||
130764934|NCT04679051|470762064|FG001|Overall Study|discomfort with blood pressure cuff|0|||
130764935|NCT04679051|470762063|FG000|Overall Study|scheduling conflict|1|||
130764936|NCT04679051|470762064|FG001|Overall Study|scheduling conflict|1|||
130764937|NCT04679051|470762063|FG000|Overall Study|Protocol Violation|0|||
130764938|NCT04679051|470762064|FG001|Overall Study|Protocol Violation|4|||
130878101|NCT00506350|471185930|FG005|Overall Study|Medical Reason|0|||
130878102|NCT00506350|471185931|FG006|Overall Study|Medical Reason|0|||
130878103|NCT00506350|471185932|FG007|Overall Study|Medical Reason|0|||
130878104|NCT00506350|471185933|FG008|Overall Study|Medical Reason|0|||
130878105|NCT00506350|471185925|FG000|Overall Study|Other|1|||
130878106|NCT00506350|471185926|FG001|Overall Study|Other|1|||
130878107|NCT00506350|471185927|FG002|Overall Study|Other|3|||
130878108|NCT00506350|471185928|FG003|Overall Study|Other|0|||
130878109|NCT00506350|471185929|FG004|Overall Study|Other|3|||
130764939|NCT02554318|470762065|FG000|Overall Study|Withdrawal by Subject|10|||
130878110|NCT00506350|471185930|FG005|Overall Study|Other|0|||
130878111|NCT00506350|471185931|FG006|Overall Study|Other|0|||
130878112|NCT00506350|471185932|FG007|Overall Study|Other|2|||
130878113|NCT00506350|471185933|FG008|Overall Study|Other|2|||
130878114|NCT01691794|471185934|FG000|Overall Study|Poor/Non-Compliance|1|||
130878115|NCT01691794|471185935|FG001|Overall Study|Poor/Non-Compliance|4|||
130878116|NCT01691794|471185936|FG002|Overall Study|Poor/Non-Compliance|1|||
130878117|NCT01691794|471185934|FG000|Overall Study|Death|0|||
130878118|NCT01691794|471185935|FG001|Overall Study|Death|0|||
130878119|NCT01691794|471185936|FG002|Overall Study|Death|1|||
130878120|NCT01691794|471185934|FG000|Overall Study|Lack of Efficacy|0|||
130878121|NCT01691794|471185935|FG001|Overall Study|Lack of Efficacy|7|||
130878122|NCT01691794|471185936|FG002|Overall Study|Lack of Efficacy|1|||
130878123|NCT01691794|471185934|FG000|Overall Study|Participant request to discontinue|0|||
130878124|NCT01691794|471185935|FG001|Overall Study|Participant request to discontinue|1|||
130878125|NCT01691794|471185936|FG002|Overall Study|Participant request to discontinue|0|||
130764940|NCT02554318|470762066|FG001|Overall Study|Withdrawal by Subject|8|||
130764941|NCT03515629|470762067|FG000|Overall Study|Death|0|||
130764942|NCT03515629|470762068|FG001|Overall Study|Death|1|||
130764943|NCT03515629|470762069|FG002|Overall Study|Death|1|||
130764944|NCT03515629|470762067|FG000|Overall Study|Progressive disease|0|||
130764945|NCT03515629|470762068|FG001|Overall Study|Progressive disease|1|||
130764946|NCT03515629|470762069|FG002|Overall Study|Progressive disease|0|||
130764947|NCT01273155|470762074|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
130764948|NCT01273155|470762075|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
130764949|NCT01273155|470762076|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
130764950|NCT01273155|470762077|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
130764951|NCT01273155|470762078|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
130764952|NCT01273155|470762079|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
130764953|NCT01273155|470762080|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
130764954|NCT01273155|470762074|FG000|Overall Study|Change in liver function/no longer eval.|0|||
130764955|NCT01273155|470762075|FG001|Overall Study|Change in liver function/no longer eval.|1|||
130764956|NCT01273155|470762076|FG002|Overall Study|Change in liver function/no longer eval.|0|||
130764957|NCT01273155|470762077|FG003|Overall Study|Change in liver function/no longer eval.|0|||
130764958|NCT01273155|470762078|FG004|Overall Study|Change in liver function/no longer eval.|1|||
130764959|NCT01273155|470762079|FG005|Overall Study|Change in liver function/no longer eval.|0|||
130764960|NCT01273155|470762080|FG006|Overall Study|Change in liver function/no longer eval.|0|||
130764961|NCT01273155|470762074|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
130764962|NCT01273155|470762075|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
130764963|NCT01273155|470762076|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
130764964|NCT01273155|470762077|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
130764965|NCT01273155|470762078|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
130764966|NCT01273155|470762079|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
130764967|NCT01273155|470762080|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
130764968|NCT01273155|470762074|FG000|Overall Study|Died during Cycle 1|0|||
130764969|NCT01273155|470762075|FG001|Overall Study|Died during Cycle 1|0|||
130764970|NCT01273155|470762076|FG002|Overall Study|Died during Cycle 1|1|||
130764971|NCT01273155|470762077|FG003|Overall Study|Died during Cycle 1|1|||
130764972|NCT01273155|470762078|FG004|Overall Study|Died during Cycle 1|0|||
130764973|NCT01273155|470762079|FG005|Overall Study|Died during Cycle 1|2|||
130764974|NCT01273155|470762080|FG006|Overall Study|Died during Cycle 1|2|||
130764975|NCT01273155|470762074|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
130764976|NCT01273155|470762075|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
130764977|NCT01273155|470762076|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
130764978|NCT01273155|470762077|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
130764979|NCT01273155|470762078|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
130764980|NCT01273155|470762079|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
130764981|NCT01273155|470762080|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
130878126|NCT01691794|471185934|FG000|Overall Study|Adverse Event|0|||
130878127|NCT01691794|471185935|FG001|Overall Study|Adverse Event|1|||
130878128|NCT01691794|471185936|FG002|Overall Study|Adverse Event|1|||
130878129|NCT01691794|471185934|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
130878130|NCT01691794|471185935|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
130878131|NCT01691794|471185936|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
130764982|NCT01438814|470762081|FG000|Overall Study|Adverse Event|3|||
130764983|NCT01438814|470762082|FG001|Overall Study|Adverse Event|3|||
130764984|NCT01438814|470762081|FG000|Overall Study|Protocol Violation|1|||
130764985|NCT01438814|470762082|FG001|Overall Study|Protocol Violation|2|||
130764986|NCT01438814|470762081|FG000|Overall Study|Lost to Follow-up|4|||
130764987|NCT01438814|470762082|FG001|Overall Study|Lost to Follow-up|3|||
130764988|NCT01438814|470762081|FG000|Overall Study|Withdrawal by Subject|4|||
130764989|NCT01438814|470762082|FG001|Overall Study|Withdrawal by Subject|2|||
130764990|NCT01438814|470762081|FG000|Overall Study|Other|2|||
130764991|NCT01438814|470762082|FG001|Overall Study|Other|4|||
130764992|NCT00990665|470762088|FG000|Overall Study|Unsuccessful Implant|8|||
130764993|NCT00990665|470762088|FG000|Overall Study|Death|29|||
130764994|NCT00990665|470762088|FG000|Overall Study|Heart Transplant|1|||
130764995|NCT00990665|470762088|FG000|Overall Study|Withdrawal by Subject|6|||
130764996|NCT00990665|470762088|FG000|Overall Study|Lost to Follow-up|1|||
130764997|NCT00990665|470762088|FG000|Overall Study|System Explant|3|||
130764998|NCT00672841|470762089|FG000|Overall Study|Comfort care|1|||
130764999|NCT00672841|470762090|FG001|Overall Study|Comfort care|4|||
130765000|NCT00672841|470762089|FG000|Overall Study|icteric specimens|0|||
130765001|NCT00672841|470762090|FG001|Overall Study|icteric specimens|3|||
130765002|NCT00672841|470762089|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
130765003|NCT00672841|470762090|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
130765004|NCT00672841|470762089|FG000|Overall Study|Adverse Event|0|||
130765005|NCT00672841|470762090|FG001|Overall Study|Adverse Event|3|||
130765006|NCT00672841|470762089|FG000|Overall Study|Pregnancy|0|||
130765007|NCT00672841|470762090|FG001|Overall Study|Pregnancy|1|||
130765008|NCT03578146|470762091|FG000|Overall Study|Did Not Receive Treatment|1|||
130765009|NCT03578146|470762092|FG001|Overall Study|Did Not Receive Treatment|0|||
130765010|NCT03578146|470762093|FG002|Overall Study|Did Not Receive Treatment|0|||
130765011|NCT03578146|470762094|FG003|Overall Study|Did Not Receive Treatment|0|||
130765012|NCT03578146|470762095|FG004|Overall Study|Did Not Receive Treatment|0|||
130765013|NCT03578146|470762096|FG005|Overall Study|Did Not Receive Treatment|2|||
130765014|NCT03578146|470762091|FG000|Overall Study|Lost to Follow-up|0|||
130765015|NCT03578146|470762092|FG001|Overall Study|Lost to Follow-up|1|||
130765016|NCT03578146|470762093|FG002|Overall Study|Lost to Follow-up|1|||
130765017|NCT03578146|470762094|FG003|Overall Study|Lost to Follow-up|0|||
130765018|NCT03578146|470762095|FG004|Overall Study|Lost to Follow-up|0|||
130765019|NCT03578146|470762096|FG005|Overall Study|Lost to Follow-up|1|||
130765020|NCT01717391|470762097|FG000|Overall Study|Withdrawal by Subject|5|||
130765021|NCT01717391|470762097|FG000|Overall Study|Physician Decision|1|||
130765022|NCT01717391|470762097|FG000|Overall Study|FLT technical failure|3|||
130765023|NCT03677934|470762098|FG000|Overall Study|Adverse Event|1|||
130765024|NCT03677934|470762099|FG001|Overall Study|Adverse Event|1|||
130765025|NCT03677934|470762098|FG000|Overall Study|Death|8|||
130765026|NCT03677934|470762099|FG001|Overall Study|Death|4|||
130765027|NCT03677934|470762098|FG000|Overall Study|Lost to Follow-up|3|||
130765028|NCT03677934|470762099|FG001|Overall Study|Lost to Follow-up|0|||
130765029|NCT03677934|470762098|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130765030|NCT03677934|470762099|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130765031|NCT03677934|470762098|FG000|Overall Study|Physician Decision|0|||
130765032|NCT03677934|470762099|FG001|Overall Study|Physician Decision|1|||
130765033|NCT03677934|470762098|FG000|Overall Study|Withdrawal by Subject|1|||
130765034|NCT03677934|470762099|FG001|Overall Study|Withdrawal by Subject|7|||
130765035|NCT01731470|470762101|FG000|Overall Study|Withdrawal by Subject|1|||
130765036|NCT01731470|470762101|FG000|Overall Study|Did not meet study criteria|1|||
130765037|NCT00335959|470762102|FG000|Overall Study|Adverse Event|2|||
130765038|NCT00335959|470762102|FG000|Overall Study|Ineligible|1|||
130765039|NCT02450552|470762106|FG000|Overall Study|Withdrawal by Subject|4|||
130765040|NCT02450552|470762107|FG001|Overall Study|Withdrawal by Subject|0|||
130765041|NCT02450552|470762108|FG002|Overall Study|Withdrawal by Subject|4|||
130765042|NCT02450552|470762106|FG000|Overall Study|Physician Decision|1|||
130765043|NCT02450552|470762107|FG001|Overall Study|Physician Decision|0|||
130878132|NCT01691794|471185934|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
130765044|NCT02450552|470762108|FG002|Overall Study|Physician Decision|1|||
130765045|NCT01876979|470762114|FG000|Overall Study|Physician Decision|2|||
130989853|NCT01576367|471591511|FG000|Overall Study|Moved to commercial use after 6 months|1|||
130765046|NCT01876979|470762115|FG001|Overall Study|Physician Decision|3|||
130765047|NCT00948506|470762116|FG000|Overall Study|Withdrawal by Subject|3|||
130765048|NCT00948506|470762117|FG001|Overall Study|Withdrawal by Subject|1|||
130765049|NCT00824382|470762118|FG000|Overall Study|Adverse Event|4|||
130765050|NCT00824382|470762119|FG001|Overall Study|Adverse Event|1|||
130765051|NCT00824382|470762120|FG002|Overall Study|Adverse Event|1|||
130765052|NCT00824382|470762121|FG003|Overall Study|Adverse Event|4|||
130765053|NCT00824382|470762118|FG000|Overall Study|Protocol Violation|1|||
130765054|NCT00824382|470762119|FG001|Overall Study|Protocol Violation|0|||
130765055|NCT00824382|470762120|FG002|Overall Study|Protocol Violation|0|||
130765056|NCT00824382|470762121|FG003|Overall Study|Protocol Violation|1|||
130765057|NCT00824382|470762118|FG000|Overall Study|Investigator's decision|0|||
130765058|NCT00824382|470762119|FG001|Overall Study|Investigator's decision|1|||
130878133|NCT01691794|471185935|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
130878134|NCT01691794|471185936|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
130878135|NCT03962491|471187642|FG000|Overall Study|Lost to Follow-up|4|||
130878136|NCT03962491|471187643|FG001|Overall Study|Lost to Follow-up|5|||
130878137|NCT03882021|471187646|FG000|Enrollment|Procedure aborted/cancelled|2|||
130878138|NCT03882021|471187646|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
130878139|NCT03882021|471187646|FG000|Enrollment to 3-Month|Death|1|||
130878140|NCT03882021|471187646|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
130878141|NCT03882021|471187646|FG000|Enrollment to 3-Month|Missed Visit|4|||
130878142|NCT03882021|471187646|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
130878143|NCT03882021|471187646|FG000|6-Month to 12-Month Visit|Death|1|||
130878144|NCT03882021|471187646|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
130878145|NCT03796728|471187650|FG000|Overall Study|Lost to Follow-up|8|||
130878146|NCT03796728|471187650|FG000|Overall Study|Reason not Specified|16|||
130878147|NCT00333775|471187651|FG000|Overall Study|Death|144|||
130878148|NCT00333775|471187652|FG001|Overall Study|Death|149|||
130878149|NCT00333775|471187653|FG002|Overall Study|Death|143|||
130878150|NCT00333775|471187651|FG000|Overall Study|In Follow-up When Study Stopped|87|||
130878151|NCT00333775|471187652|FG001|Overall Study|In Follow-up When Study Stopped|92|||
130878152|NCT00333775|471187653|FG002|Overall Study|In Follow-up When Study Stopped|96|||
130878153|NCT00333775|471187651|FG000|Overall Study|Lost to Follow-up|10|||
130878154|NCT00333775|471187652|FG001|Overall Study|Lost to Follow-up|7|||
130878155|NCT00333775|471187653|FG002|Overall Study|Lost to Follow-up|8|||
130878156|NCT02476617|471187657|FG000|Overall Study|Adverse Event|1|||
130878157|NCT02476617|471187657|FG000|Overall Study|Lost to Follow-up|1|||
130878158|NCT03486912|471187658|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
130878159|NCT03486912|471187659|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
130878160|NCT03486912|471187660|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
130878161|NCT03486912|471187661|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
130878162|NCT03486912|471187658|FG000|Treatment Period|Withdrawal by Subject|3|||
130878163|NCT03486912|471187659|FG001|Treatment Period|Withdrawal by Subject|3|||
130878164|NCT03486912|471187660|FG002|Treatment Period|Withdrawal by Subject|3|||
130878165|NCT03486912|471187661|FG003|Treatment Period|Withdrawal by Subject|2|||
130878166|NCT03486912|471187658|FG000|Treatment Period|Other Reasons|0|||
130878167|NCT03486912|471187659|FG001|Treatment Period|Other Reasons|2|||
130878168|NCT03486912|471187660|FG002|Treatment Period|Other Reasons|1|||
130878169|NCT03486912|471187661|FG003|Treatment Period|Other Reasons|1|||
130878170|NCT03486912|471187658|FG000|Treatment Period|Adverse Event|0|||
130878171|NCT03486912|471187659|FG001|Treatment Period|Adverse Event|1|||
130878172|NCT03486912|471187660|FG002|Treatment Period|Adverse Event|1|||
130878173|NCT03486912|471187661|FG003|Treatment Period|Adverse Event|0|||
130878174|NCT03486912|471187658|FG000|Treatment Period|Lost to Follow-up|1|||
130878175|NCT03486912|471187659|FG001|Treatment Period|Lost to Follow-up|0|||
130878176|NCT03486912|471187660|FG002|Treatment Period|Lost to Follow-up|0|||
130878177|NCT03486912|471187661|FG003|Treatment Period|Lost to Follow-up|2|||
130878178|NCT02491684|471187662|FG000|Treatment Phase|Adverse Event|2|||
130878179|NCT02491684|471187663|FG001|Treatment Phase|Adverse Event|2|||
130878180|NCT02491684|471187662|FG000|Treatment Phase|Incorrect randomisation|1|||
130765059|NCT00824382|470762120|FG002|Overall Study|Investigator's decision|2|||
130765060|NCT00824382|470762121|FG003|Overall Study|Investigator's decision|0|||
130765061|NCT00721279|470762122|FG000|Overall Study|Lack of Efficacy|6|||
130765062|NCT00721279|470762123|FG001|Overall Study|Lack of Efficacy|3|||
130765063|NCT00721279|470762122|FG000|Overall Study|Tolerability insufficient|5|||
130765064|NCT00721279|470762123|FG001|Overall Study|Tolerability insufficient|2|||
130765065|NCT00721279|470762122|FG000|Overall Study|Withdrawal by Subject|13|||
130878181|NCT02491684|471187663|FG001|Treatment Phase|Incorrect randomisation|0|||
130878182|NCT02491684|471187662|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
130878183|NCT02491684|471187663|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
130878184|NCT01263769|471187666|FG000|Overall Study|Non-Compliant with treatment|1|||
130878185|NCT04842747|471187671|FG000|Overall Study|Withdrawal by Subject|6|||
130878186|NCT04842747|471187672|FG001|Overall Study|Withdrawal by Subject|2|||
130878187|NCT04842747|471187671|FG000|Overall Study|Lost to Follow-up|1|||
130878188|NCT04842747|471187672|FG001|Overall Study|Lost to Follow-up|2|||
130878189|NCT04842747|471187671|FG000|Overall Study|Physician Decision|1|||
130878190|NCT04842747|471187672|FG001|Overall Study|Physician Decision|0|||
130878191|NCT04842747|471187671|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
130878192|NCT04842747|471187672|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
130878193|NCT02559622|471187673|FG000|Overall Study|Progressive disease|0|||
130878194|NCT02559622|471187674|FG001|Overall Study|Progressive disease|1|||
130878195|NCT02559622|471187675|FG002|Overall Study|Progressive disease|0|||
130878196|NCT02559622|471187676|FG003|Overall Study|Progressive disease|0|||
130878197|NCT02559622|471187673|FG000|Overall Study|Adverse Event|0|||
130765066|NCT00721279|470762123|FG001|Overall Study|Withdrawal by Subject|3|||
130765067|NCT00721279|470762122|FG000|Overall Study|Other|12|||
130765068|NCT00721279|470762123|FG001|Overall Study|Other|16|||
130765069|NCT03467763|470762124|FG000|Overall Study|Lost to Follow-up|1|||
130765070|NCT03467763|470762124|FG000|Overall Study|Protocol Violation|2|||
130765071|NCT00131365|470762125|FG000|Overall Study|Withdrawal by Subject|1|||
130765072|NCT00131365|470762125|FG000|Overall Study|Alternative treatment|3|||
130765073|NCT04608344|470762126|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
130765074|NCT04608344|470762127|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
130765075|NCT04608344|470762126|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
130765076|NCT04608344|470762127|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
130765077|NCT00415597|470762128|FG000|Enrollment|Withdrawal by Subject|1|||
130765078|NCT00415597|470762128|FG000|Enrollment|Protocol Violation|1|||
130765079|NCT00415597|470762128|FG000|Treatment|Adverse Event|110|||
130765080|NCT00415597|470762128|FG000|Treatment|Lack of Efficacy|39|||
130765081|NCT00415597|470762128|FG000|Treatment|Protocol Violation|67|||
130765082|NCT00415597|470762128|FG000|Treatment|Physician Decision|3|||
130765083|NCT00415597|470762128|FG000|Treatment|Withdrawal by Subject|51|||
130765084|NCT00415597|470762128|FG000|Treatment|Lost to Follow-up|28|||
130765085|NCT00415597|470762128|FG000|Treatment|Drug Screen|2|||
130765086|NCT00415597|470762128|FG000|Treatment|Administrative|3|||
130765087|NCT00415597|470762128|FG000|Treatment|Sponsor Decision|1|||
130765088|NCT00415597|470762128|FG000|Treatment|Multiple Reasons|1|||
130765089|NCT01764997|470762129|FG000|Run-in Period|Adverse Event|15|||
130765090|NCT01764997|470762130|FG001|Run-in Period|Adverse Event|0|||
130765091|NCT01764997|470762131|FG002|Run-in Period|Adverse Event|0|||
130765092|NCT01764997|470762132|FG003|Run-in Period|Adverse Event|0|||
130765093|NCT01764997|470762133|FG004|Run-in Period|Adverse Event|0|||
130765094|NCT01764997|470762129|FG000|Run-in Period|Lack of Efficacy|5|||
130765095|NCT01764997|470762130|FG001|Run-in Period|Lack of Efficacy|0|||
130765096|NCT01764997|470762131|FG002|Run-in Period|Lack of Efficacy|0|||
130765097|NCT01764997|470762132|FG003|Run-in Period|Lack of Efficacy|0|||
130765098|NCT01764997|470762133|FG004|Run-in Period|Lack of Efficacy|0|||
130765099|NCT01764997|470762129|FG000|Run-in Period|Poor compliance to protocol|1|||
130765100|NCT01764997|470762130|FG001|Run-in Period|Poor compliance to protocol|0|||
130765101|NCT01764997|470762131|FG002|Run-in Period|Poor compliance to protocol|0|||
130765102|NCT01764997|470762132|FG003|Run-in Period|Poor compliance to protocol|0|||
130765103|NCT01764997|470762133|FG004|Run-in Period|Poor compliance to protocol|0|||
130765104|NCT01764997|470762129|FG000|Run-in Period|Other than specified above|17|||
130765105|NCT01764997|470762130|FG001|Run-in Period|Other than specified above|0|||
130765106|NCT01764997|470762131|FG002|Run-in Period|Other than specified above|0|||
130765107|NCT01764997|470762132|FG003|Run-in Period|Other than specified above|0|||
130765108|NCT01764997|470762133|FG004|Run-in Period|Other than specified above|0|||
130765109|NCT01764997|470762129|FG000|Study Drug Treatment Period|Adverse Event|0|||
130765110|NCT01764997|470762130|FG001|Study Drug Treatment Period|Adverse Event|1|||
130765111|NCT01764997|470762131|FG002|Study Drug Treatment Period|Adverse Event|0|||
130765112|NCT01764997|470762132|FG003|Study Drug Treatment Period|Adverse Event|0|||
130765113|NCT01764997|470762133|FG004|Study Drug Treatment Period|Adverse Event|24|||
130765114|NCT01764997|470762129|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
130765115|NCT01764997|470762130|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
130765116|NCT01764997|470762131|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
130765117|NCT01764997|470762132|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
130765118|NCT01764997|470762133|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
130765119|NCT01764997|470762129|FG000|Study Drug Treatment Period|Other than specified above|0|||
130765120|NCT01764997|470762130|FG001|Study Drug Treatment Period|Other than specified above|0|||
130765121|NCT01764997|470762131|FG002|Study Drug Treatment Period|Other than specified above|0|||
130765122|NCT01764997|470762132|FG003|Study Drug Treatment Period|Other than specified above|0|||
130765123|NCT01764997|470762133|FG004|Study Drug Treatment Period|Other than specified above|10|||
130765124|NCT04438499|470762142|FG000|Overall Study|Lack of Efficacy|3|||
130765125|NCT04918355|470762143|FG000|Overall Study|no qualifying health encounter|497|||
130765126|NCT04918355|470762144|FG001|Overall Study|no qualifying health encounter|192|||
130765127|NCT04918355|470762145|FG002|Overall Study|no qualifying health encounter|438|||
130765128|NCT04918355|470762146|FG003|Overall Study|no qualifying health encounter|424|||
130778860|NCT03428100|470817457|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778861|NCT03428100|470817458|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778862|NCT03428100|470817459|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778863|NCT03428100|470817441|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
130778864|NCT03428100|470817442|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778865|NCT03428100|470817443|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778866|NCT03428100|470817444|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778867|NCT03428100|470817445|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778868|NCT03428100|470817446|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778869|NCT03428100|470817447|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778870|NCT03428100|470817448|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778871|NCT03428100|470817449|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130878198|NCT02559622|471187674|FG001|Overall Study|Adverse Event|2|||
130878199|NCT02559622|471187675|FG002|Overall Study|Adverse Event|2|||
130989854|NCT04359771|471591512|FG000|Overall Study|Lack of Efficacy|2|||
130765129|NCT02000882|470764109|FG000|Overall Study|Adverse Event|3|||
130765130|NCT02000882|470764109|FG000|Overall Study|Physician Decision|2|||
130765131|NCT02000882|470764109|FG000|Overall Study|Withdrawal by Subject|1|||
130765132|NCT00549601|470764110|FG000|Randomized|Protocol Violation|0|||
130765133|NCT00549601|470764111|FG001|Randomized|Protocol Violation|0|||
130765134|NCT00549601|470764112|FG002|Randomized|Protocol Violation|1|||
130765135|NCT00549601|470764110|FG000|Randomized|Withdrawal by Subject|0|||
130765136|NCT00549601|470764111|FG001|Randomized|Withdrawal by Subject|1|||
130765137|NCT00549601|470764112|FG002|Randomized|Withdrawal by Subject|1|||
130765138|NCT00549601|470764110|FG000|Received Study Drug|Adverse Event|2|||
130765139|NCT00549601|470764111|FG001|Received Study Drug|Adverse Event|5|||
130765140|NCT00549601|470764112|FG002|Received Study Drug|Adverse Event|1|||
130765141|NCT00549601|470764110|FG000|Received Study Drug|Death|0|||
130765142|NCT00549601|470764111|FG001|Received Study Drug|Death|1|||
130765143|NCT00549601|470764112|FG002|Received Study Drug|Death|0|||
130765144|NCT00549601|470764110|FG000|Received Study Drug|Lost to Follow-up|0|||
130765145|NCT00549601|470764111|FG001|Received Study Drug|Lost to Follow-up|1|||
130765146|NCT00549601|470764112|FG002|Received Study Drug|Lost to Follow-up|1|||
130765147|NCT00549601|470764110|FG000|Received Study Drug|Protocol Violation|3|||
130765148|NCT00549601|470764111|FG001|Received Study Drug|Protocol Violation|4|||
130765149|NCT00549601|470764112|FG002|Received Study Drug|Protocol Violation|1|||
130765150|NCT00549601|470764110|FG000|Received Study Drug|Withdrawal by Subject|2|||
130765151|NCT00549601|470764111|FG001|Received Study Drug|Withdrawal by Subject|0|||
130765152|NCT00549601|470764112|FG002|Received Study Drug|Withdrawal by Subject|1|||
130765153|NCT00908596|470764116|FG000|Overall Study|Other reasons|46|||
130765154|NCT00908596|470764117|FG001|Overall Study|Other reasons|6|||
130765155|NCT00908596|470764118|FG002|Overall Study|Other reasons|2|||
130878200|NCT02559622|471187676|FG003|Overall Study|Adverse Event|2|||
130878201|NCT02559622|471187673|FG000|Overall Study|Patient/guardian decision|1|||
130878202|NCT02559622|471187674|FG001|Overall Study|Patient/guardian decision|2|||
130878203|NCT02559622|471187675|FG002|Overall Study|Patient/guardian decision|0|||
130878204|NCT02559622|471187676|FG003|Overall Study|Patient/guardian decision|1|||
130878205|NCT04011540|471187682|FG000|Overall Study|Lost to Follow-up|9|||
130878206|NCT04011540|471187683|FG001|Overall Study|Lost to Follow-up|6|||
130878207|NCT03019406|471187684|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
130878208|NCT03019406|471187685|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
130878209|NCT03019406|471187686|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
130878210|NCT03019406|471187687|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
130878211|NCT02954536|471187692|FG000|Overall Study|Adverse Event|2|||
130878212|NCT02954536|471187692|FG000|Overall Study|Death|12|||
130878213|NCT05498649|471187693|FG000|Overall Study|Lost to Follow-up|1|||
130878214|NCT02946580|471187697|FG000|Overall Study|Withdrawal by Subject|1|||
130878215|NCT02946580|471187698|FG001|Overall Study|Withdrawal by Subject|2|||
130878216|NCT02946580|471187697|FG000|Overall Study|Adverse Event|0|||
130878217|NCT02946580|471187698|FG001|Overall Study|Adverse Event|2|||
130878218|NCT02946580|471187697|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
130878219|NCT02946580|471187698|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
130878220|NCT02761330|471187699|FG000|Treatment Week 1|Withdrawal by Subject|0|||
130878221|NCT02761330|471187700|FG001|Treatment Week 1|Withdrawal by Subject|0|||
130878222|NCT02761330|471187701|FG002|Treatment Week 1|Withdrawal by Subject|0|||
130878223|NCT02761330|471187702|FG003|Treatment Week 1|Withdrawal by Subject|1|||
130878224|NCT02761330|471187703|FG004|Treatment Week 1|Withdrawal by Subject|0|||
130878225|NCT02761330|471187704|FG005|Treatment Week 1|Withdrawal by Subject|1|||
130878226|NCT03043313|471187707|FG000|Overall Study|Withdrawal by Subject|5|||
130878227|NCT03043313|471187708|FG001|Overall Study|Withdrawal by Subject|1|||
130878228|NCT03043313|471187709|FG002|Overall Study|Withdrawal by Subject|1|||
130878229|NCT03043313|471187707|FG000|Overall Study|Lost to Follow-up|1|||
130878230|NCT03043313|471187708|FG001|Overall Study|Lost to Follow-up|1|||
130878231|NCT03043313|471187709|FG002|Overall Study|Lost to Follow-up|0|||
130878232|NCT03043313|471187707|FG000|Overall Study|Death|28|||
130878233|NCT03043313|471187708|FG001|Overall Study|Death|26|||
130878234|NCT03043313|471187709|FG002|Overall Study|Death|17|||
130878235|NCT03043313|471187707|FG000|Overall Study|Participation terminated by sponsor|11|||
130878236|NCT03043313|471187708|FG001|Overall Study|Participation terminated by sponsor|13|||
130878237|NCT03043313|471187709|FG002|Overall Study|Participation terminated by sponsor|13|||
130878238|NCT02657889|471187710|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
130878239|NCT02657889|471187711|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
130878240|NCT02657889|471187712|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
130878241|NCT02657889|471187713|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
130989855|NCT04359771|471591513|FG001|Overall Study|Lack of Efficacy|2|||
130765156|NCT00908596|470764119|FG003|Overall Study|Other reasons|0|||
130878242|NCT02657889|471187710|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
130878243|NCT02657889|471187711|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
130765157|NCT00908596|470764116|FG000|Overall Study|Lost to Follow-up|0|||
130989856|NCT03592277|471591514|FG000|Overall Study|Withdrawal by Subject|6|||
130989857|NCT03592277|471591515|FG001|Overall Study|Withdrawal by Subject|8|||
130765158|NCT00908596|470764117|FG001|Overall Study|Lost to Follow-up|1|||
130765159|NCT00908596|470764118|FG002|Overall Study|Lost to Follow-up|12|||
130765160|NCT00908596|470764119|FG003|Overall Study|Lost to Follow-up|4|||
130765161|NCT00908596|470764116|FG000|Overall Study|Death|0|||
130765162|NCT00908596|470764117|FG001|Overall Study|Death|5|||
130765163|NCT00908596|470764118|FG002|Overall Study|Death|57|||
130765164|NCT00908596|470764119|FG003|Overall Study|Death|32|||
130765165|NCT00908596|470764116|FG000|Overall Study|Protocol Violation|1|||
130765166|NCT00908596|470764117|FG001|Overall Study|Protocol Violation|0|||
130765167|NCT00908596|470764118|FG002|Overall Study|Protocol Violation|0|||
130765168|NCT00908596|470764119|FG003|Overall Study|Protocol Violation|0|||
130765169|NCT00908596|470764116|FG000|Overall Study|Withdrawal by Subject|0|||
130765170|NCT00908596|470764117|FG001|Overall Study|Withdrawal by Subject|1|||
130765171|NCT00908596|470764118|FG002|Overall Study|Withdrawal by Subject|3|||
130765172|NCT00908596|470764119|FG003|Overall Study|Withdrawal by Subject|1|||
130765173|NCT01472939|470764121|FG000|Overall Study|Adverse Event|3|||
130765174|NCT01472939|470764122|FG001|Overall Study|Adverse Event|7|||
130765175|NCT01472939|470764123|FG002|Overall Study|Adverse Event|7|||
130765176|NCT01472939|470764124|FG003|Overall Study|Adverse Event|14|||
130765177|NCT01472939|470764121|FG000|Overall Study|Lack of Efficacy|1|||
130765178|NCT01472939|470764122|FG001|Overall Study|Lack of Efficacy|0|||
130765179|NCT01472939|470764123|FG002|Overall Study|Lack of Efficacy|0|||
130765180|NCT01472939|470764124|FG003|Overall Study|Lack of Efficacy|1|||
130765181|NCT01472939|470764121|FG000|Overall Study|Lost to Follow-up|3|||
130765182|NCT01472939|470764122|FG001|Overall Study|Lost to Follow-up|0|||
130765183|NCT01472939|470764123|FG002|Overall Study|Lost to Follow-up|2|||
130765184|NCT01472939|470764124|FG003|Overall Study|Lost to Follow-up|0|||
130765185|NCT01472939|470764121|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
130765186|NCT01472939|470764122|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
130765187|NCT01472939|470764123|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
130765188|NCT01472939|470764124|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
130765189|NCT01472939|470764121|FG000|Overall Study|Prohibited Medication|0|||
130765190|NCT01472939|470764122|FG001|Overall Study|Prohibited Medication|1|||
130765191|NCT01472939|470764123|FG002|Overall Study|Prohibited Medication|0|||
130765192|NCT01472939|470764124|FG003|Overall Study|Prohibited Medication|0|||
130765193|NCT01472939|470764121|FG000|Overall Study|Withdrawal By PI|1|||
130765194|NCT01472939|470764122|FG001|Overall Study|Withdrawal By PI|0|||
130765195|NCT01472939|470764123|FG002|Overall Study|Withdrawal By PI|0|||
130765196|NCT01472939|470764124|FG003|Overall Study|Withdrawal By PI|0|||
130765197|NCT01472939|470764121|FG000|Overall Study|Protocol Violation|3|||
130765198|NCT01472939|470764122|FG001|Overall Study|Protocol Violation|3|||
130765199|NCT01472939|470764123|FG002|Overall Study|Protocol Violation|0|||
130765200|NCT01472939|470764124|FG003|Overall Study|Protocol Violation|1|||
130765201|NCT01472939|470764121|FG000|Overall Study|Withdrawal by Subject|9|||
130765202|NCT01472939|470764122|FG001|Overall Study|Withdrawal by Subject|3|||
130765203|NCT01472939|470764123|FG002|Overall Study|Withdrawal by Subject|1|||
130765204|NCT01472939|470764124|FG003|Overall Study|Withdrawal by Subject|4|||
130765205|NCT00388297|470764125|FG000|Overall Study|Lost to Follow-up|16|||
130765206|NCT00388297|470764126|FG001|Overall Study|Lost to Follow-up|12|||
130765207|NCT00388297|470764127|FG002|Overall Study|Lost to Follow-up|11|||
130765208|NCT00388297|470764128|FG003|Overall Study|Lost to Follow-up|8|||
130765209|NCT02607280|470764129|FG000|Overall Study|Adverse Event|4|||
130765210|NCT02607280|470764130|FG001|Overall Study|Adverse Event|0|||
130765211|NCT02607280|470764129|FG000|Overall Study|Decrease in CrCl <15|0|||
130765212|NCT02607280|470764130|FG001|Overall Study|Decrease in CrCl <15|1|||
130765213|NCT03435224|470764136|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
130765214|NCT04472026|470764137|FG000|Overall Study|Lost to Follow-up|5|||
130765215|NCT01777295|470764138|FG000|Overall Study|Withdrawal by Subject|2|||
130765216|NCT01777295|470764139|FG001|Overall Study|Withdrawal by Subject|2|||
130765217|NCT01777295|470764138|FG000|Overall Study|Pregnancy|0|||
130765218|NCT01777295|470764139|FG001|Overall Study|Pregnancy|1|||
130765219|NCT01777295|470764138|FG000|Overall Study|Personal problem|1|||
130765220|NCT01777295|470764139|FG001|Overall Study|Personal problem|0|||
130765221|NCT01777295|470764138|FG000|Overall Study|Investigator call for AEs check|1|||
130765222|NCT01777295|470764139|FG001|Overall Study|Investigator call for AEs check|0|||
130765223|NCT01069419|470764140|FG000|Overall Study|Adverse Event|233|||
130765224|NCT01069419|470764140|FG000|Overall Study|Lack of Efficacy|332|||
130765225|NCT01069419|470764140|FG000|Overall Study|Lost to Follow-up|49|||
130765226|NCT01069419|470764140|FG000|Overall Study|Remission of disease|11|||
130765227|NCT01069419|470764140|FG000|Overall Study|Withdrawal by Subject|34|||
130989858|NCT01462162|471591516|FG000|Overall Study|Adverse Event|5|||
130765228|NCT01069419|470764140|FG000|Overall Study|Other Reason|43|||
130765229|NCT01069419|470764140|FG000|Overall Study|Missing termination information|13|||
130765230|NCT04526574|470764141|FG000|Overall Study|Protocol Violation|3|||
130765231|NCT04526574|470764142|FG001|Overall Study|Protocol Violation|1|||
130765232|NCT04526574|470764141|FG000|Overall Study|Withdrawal by Subject|12|||
130765233|NCT04526574|470764142|FG001|Overall Study|Withdrawal by Subject|9|||
130765234|NCT04526574|470764141|FG000|Overall Study|Other|1|||
130989859|NCT01462162|471591516|FG000|Overall Study|Lack of Efficacy|4|||
130989860|NCT01462162|471591516|FG000|Overall Study|Abnormal laboratory parameters|1|||
130989861|NCT01462162|471591516|FG000|Overall Study|Other|2|||
130989862|NCT01346514|471591517|FG000|Overall Study|Lost to Follow-up|19|||
130989863|NCT01346514|471591518|FG001|Overall Study|Lost to Follow-up|30|||
130989864|NCT01346514|471591517|FG000|Overall Study|Withdrawal by Subject|7|||
130989865|NCT01346514|471591518|FG001|Overall Study|Withdrawal by Subject|3|||
130989866|NCT01346514|471591517|FG000|Overall Study|Death|3|||
130989867|NCT01346514|471591518|FG001|Overall Study|Death|4|||
130989868|NCT01215357|471591519|FG000|Overall Study|Withdrawal by Subject|3|||
130989869|NCT01215357|471591519|FG000|Overall Study|Protocol Violation|9|||
130989870|NCT00909480|471591523|FG000|Overall Study|Adverse Event|5|||
130989871|NCT00909480|471591524|FG001|Overall Study|Adverse Event|3|||
130989872|NCT00909480|471591523|FG000|Overall Study|Protocol Violation|6|||
130989873|NCT00909480|471591524|FG001|Overall Study|Protocol Violation|8|||
130989874|NCT00909480|471591523|FG000|Overall Study|Withdrawal criteria|9|||
130989875|NCT00909480|471591524|FG001|Overall Study|Withdrawal criteria|11|||
130989876|NCT00909480|471591523|FG000|Overall Study|Unclassified|18|||
130989877|NCT00909480|471591524|FG001|Overall Study|Unclassified|19|||
130989878|NCT01859793|471591534|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
130989879|NCT01859793|471591535|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
130989880|NCT01859793|471591534|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
130989881|NCT01859793|471591535|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
130989882|NCT01859793|471591534|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130989883|NCT01859793|471591535|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130989884|NCT01859793|471591534|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
130989885|NCT01859793|471591535|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
130989886|NCT02002182|471591538|FG000|Overall Study|Withdraw from study|3|||
130989887|NCT02002182|471591539|FG001|Overall Study|Withdraw from study|1|||
130989888|NCT02002182|471591538|FG000|Overall Study|Health Reasons|1|||
130989889|NCT02002182|471591539|FG001|Overall Study|Health Reasons|0|||
130989890|NCT02002182|471591538|FG000|Overall Study|Death|1|||
130989891|NCT02002182|471591539|FG001|Overall Study|Death|0|||
130989892|NCT04772053|471591544|FG000|Overall Study|Physician Decision|2|||
130989893|NCT04772053|471591544|FG000|Overall Study|Withdrawal by Subject|3|||
130989894|NCT04772053|471591544|FG000|Overall Study|Study Terminated by Sponsor|1|||
130989895|NCT04599101|471591545|FG000|Overall Study|Lost to Follow-up|5|||
130989896|NCT04599101|471591546|FG001|Overall Study|Lost to Follow-up|5|||
130989897|NCT04146896|471591549|FG000|Overall Study|Adverse Event|5|||
130989898|NCT04146896|471591550|FG001|Overall Study|Adverse Event|8|||
130989899|NCT04146896|471591549|FG000|Overall Study|Lack of Efficacy|3|||
130989900|NCT04146896|471591550|FG001|Overall Study|Lack of Efficacy|2|||
130989901|NCT04146896|471591549|FG000|Overall Study|Lost to Follow-up|0|||
130989902|NCT04146896|471591550|FG001|Overall Study|Lost to Follow-up|1|||
130989903|NCT04146896|471591549|FG000|Overall Study|Non-compliance|5|||
130765235|NCT04526574|470764142|FG001|Overall Study|Other|2|||
130765236|NCT04526574|470764141|FG000|Overall Study|Adverse Event|1|||
130765237|NCT04526574|470764142|FG001|Overall Study|Adverse Event|1|||
130765238|NCT04526574|470764141|FG000|Overall Study|Death|2|||
130765239|NCT04526574|470764142|FG001|Overall Study|Death|3|||
130765240|NCT04526574|470764141|FG000|Overall Study|Lost to Follow-up|9|||
130765241|NCT04526574|470764142|FG001|Overall Study|Lost to Follow-up|9|||
130765242|NCT04526574|470764141|FG000|Overall Study|No longer meets eligibility criteria|8|||
130765243|NCT04526574|470764142|FG001|Overall Study|No longer meets eligibility criteria|8|||
130765244|NCT02248974|470764145|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
130765245|NCT02248974|470764146|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
130765246|NCT02248974|470764145|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
130765247|NCT02248974|470764146|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
130765248|NCT02248974|470764145|FG000|1-Day Follow-Up|Enrolled in another study|1|||
130765249|NCT02248974|470764146|FG001|1-Day Follow-Up|Enrolled in another study|0|||
130765250|NCT02248974|470764145|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
130765251|NCT02248974|470764146|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
130765252|NCT02248974|470764145|FG000|1-Week Follow-Up|Enrolled in another study|1|||
130765253|NCT02248974|470764146|FG001|1-Week Follow-Up|Enrolled in another study|1|||
130765254|NCT02248974|470764145|FG000|1-Week Follow-Up|Transferred to another facility|1|||
130765255|NCT02248974|470764146|FG001|1-Week Follow-Up|Transferred to another facility|0|||
130989904|NCT04146896|471591550|FG001|Overall Study|Non-compliance|4|||
130989905|NCT04146896|471591549|FG000|Overall Study|Withdrawal by Subject|3|||
130989906|NCT04146896|471591550|FG001|Overall Study|Withdrawal by Subject|5|||
130989907|NCT04146896|471591549|FG000|Overall Study|Randomized in error|1|||
130989908|NCT04146896|471591550|FG001|Overall Study|Randomized in error|2|||
130989909|NCT02118337|471591551|FG000|Overall Study|Other|1|||
130765256|NCT02248974|470764145|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
130765257|NCT02248974|470764146|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
130989910|NCT02118337|471591552|FG001|Overall Study|Other|0|||
130989911|NCT02118337|471591553|FG002|Overall Study|Other|0|||
130989912|NCT02118337|471591554|FG003|Overall Study|Other|0|||
130989913|NCT02118337|471591555|FG004|Overall Study|Other|2|||
130765258|NCT02248974|470764145|FG000|1-Week Follow-Up|Death|1|||
130765259|NCT02248974|470764146|FG001|1-Week Follow-Up|Death|1|||
130765260|NCT02248974|470764145|FG000|1-Week Follow-Up|Excluded because of age|0|||
130765261|NCT02248974|470764146|FG001|1-Week Follow-Up|Excluded because of age|1|||
130765262|NCT02248974|470764145|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
130765263|NCT02248974|470764146|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
130765264|NCT02248974|470764145|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
130765265|NCT02248974|470764146|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
130765266|NCT02248974|470764145|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
130765267|NCT02248974|470764146|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
130765268|NCT02248974|470764145|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
130765269|NCT02248974|470764146|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
130765270|NCT02248974|470764145|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
130765271|NCT02248974|470764146|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
130765272|NCT02332239|470764147|FG000|Overall Study|Lost to Follow-up|4|||
130765273|NCT02332239|470764148|FG001|Overall Study|Lost to Follow-up|6|||
130765274|NCT00115037|470764149|FG000|Phase1|Lost to Follow-up|16|||
130765275|NCT00115037|470764150|FG001|Phase1|Lost to Follow-up|23|||
130765276|NCT00115037|470764151|FG002|Phase1|Lost to Follow-up|0|||
130765277|NCT00115037|470764152|FG003|Phase1|Lost to Follow-up|0|||
130765278|NCT00115037|470764153|FG004|Phase1|Lost to Follow-up|0|||
130765279|NCT00115037|470764154|FG005|Phase1|Lost to Follow-up|0|||
130765280|NCT00115037|470764149|FG000|Phase1|Withdrawal by Subject|9|||
130765281|NCT00115037|470764150|FG001|Phase1|Withdrawal by Subject|4|||
130765282|NCT00115037|470764151|FG002|Phase1|Withdrawal by Subject|0|||
130765283|NCT00115037|470764152|FG003|Phase1|Withdrawal by Subject|0|||
130765284|NCT00115037|470764153|FG004|Phase1|Withdrawal by Subject|0|||
130765285|NCT00115037|470764154|FG005|Phase1|Withdrawal by Subject|0|||
130765286|NCT00115037|470764149|FG000|Phase2|Death|0|||
130765287|NCT00115037|470764150|FG001|Phase2|Death|0|||
130765288|NCT00115037|470764151|FG002|Phase2|Death|1|||
130765289|NCT00115037|470764152|FG003|Phase2|Death|0|||
130765290|NCT00115037|470764153|FG004|Phase2|Death|0|||
130765291|NCT00115037|470764154|FG005|Phase2|Death|1|||
130765292|NCT00115037|470764149|FG000|Phase2|Withdrawal by Subject|0|||
130765293|NCT00115037|470764150|FG001|Phase2|Withdrawal by Subject|0|||
130765294|NCT00115037|470764151|FG002|Phase2|Withdrawal by Subject|2|||
130765295|NCT00115037|470764152|FG003|Phase2|Withdrawal by Subject|1|||
130765296|NCT00115037|470764153|FG004|Phase2|Withdrawal by Subject|2|||
130765297|NCT00115037|470764154|FG005|Phase2|Withdrawal by Subject|1|||
130765298|NCT00115037|470764149|FG000|Phase2|Lost to Follow-up|0|||
130765299|NCT00115037|470764150|FG001|Phase2|Lost to Follow-up|0|||
130765300|NCT00115037|470764151|FG002|Phase2|Lost to Follow-up|12|||
130765301|NCT00115037|470764152|FG003|Phase2|Lost to Follow-up|14|||
130765302|NCT00115037|470764153|FG004|Phase2|Lost to Follow-up|4|||
130765303|NCT00115037|470764154|FG005|Phase2|Lost to Follow-up|10|||
130765304|NCT00396877|470764155|FG000|Overall Study|Lost to Follow-up|2|||
130765305|NCT00396877|470764156|FG001|Overall Study|Lost to Follow-up|1|||
130765306|NCT00396877|470764155|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
130765307|NCT00396877|470764156|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
130765308|NCT00334802|470764157|FG000|Overall Study|Progressive Disease|2|||
130765309|NCT00334802|470764158|FG001|Overall Study|Progressive Disease|24|||
130765310|NCT00334802|470764157|FG000|Overall Study|Toxicity|1|||
130765311|NCT00334802|470764158|FG001|Overall Study|Toxicity|5|||
130878244|NCT02657889|471187712|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
130878245|NCT02657889|471187713|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
130878246|NCT02657889|471187710|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
130878247|NCT02657889|471187711|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
130878248|NCT02657889|471187712|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
130878249|NCT02657889|471187713|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
130878250|NCT02657889|471187710|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
130878251|NCT02657889|471187711|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
130878252|NCT02657889|471187712|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
130878253|NCT02657889|471187713|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
130878254|NCT02657889|471187710|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
130878255|NCT02657889|471187711|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
130878256|NCT02657889|471187712|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
130878257|NCT02657889|471187713|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
130878258|NCT02657889|471187710|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
130878259|NCT02657889|471187711|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
130765312|NCT00334802|470764157|FG000|Overall Study|Lack of Efficacy|1|||
130765313|NCT00334802|470764158|FG001|Overall Study|Lack of Efficacy|3|||
130765314|NCT00334802|470764157|FG000|Overall Study|Patient Condition Aggrevated|1|||
130765315|NCT00334802|470764158|FG001|Overall Study|Patient Condition Aggrevated|0|||
130765316|NCT00334802|470764157|FG000|Overall Study|Physician Decision|1|||
130765317|NCT00334802|470764158|FG001|Overall Study|Physician Decision|0|||
130765318|NCT00334802|470764157|FG000|Overall Study|Withdrawal by Subject|0|||
130878260|NCT02657889|471187712|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
130878261|NCT02657889|471187713|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
130878262|NCT02657889|471187710|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
130878263|NCT02657889|471187711|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
130878264|NCT02657889|471187712|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
130878265|NCT02657889|471187713|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
130878266|NCT02657889|471187710|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
130878267|NCT02657889|471187711|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
130878268|NCT02657889|471187712|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
130878269|NCT02657889|471187713|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
130878270|NCT02657889|471187710|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
130878271|NCT02657889|471187711|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
130878272|NCT02657889|471187712|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
130878273|NCT02657889|471187713|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
130878274|NCT02657889|471187710|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
130878275|NCT02657889|471187711|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
130878276|NCT02657889|471187712|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
130878277|NCT02657889|471187713|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
130878278|NCT02657889|471187710|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
130878279|NCT02657889|471187711|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
130878280|NCT02657889|471187712|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
130878281|NCT02657889|471187713|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
130989914|NCT02118337|471591556|FG005|Overall Study|Other|3|||
130989915|NCT02118337|471591557|FG006|Overall Study|Other|1|||
130989916|NCT02118337|471591558|FG007|Overall Study|Other|28|||
130989917|NCT02118337|471591559|FG008|Overall Study|Other|15|||
130989918|NCT02118337|471591551|FG000|Overall Study|Lost to Follow-up|0|||
130989919|NCT02118337|471591552|FG001|Overall Study|Lost to Follow-up|0|||
130989920|NCT02118337|471591553|FG002|Overall Study|Lost to Follow-up|0|||
130989921|NCT02118337|471591554|FG003|Overall Study|Lost to Follow-up|0|||
130989922|NCT02118337|471591555|FG004|Overall Study|Lost to Follow-up|0|||
130989923|NCT02118337|471591556|FG005|Overall Study|Lost to Follow-up|0|||
130989924|NCT02118337|471591557|FG006|Overall Study|Lost to Follow-up|0|||
130989925|NCT02118337|471591558|FG007|Overall Study|Lost to Follow-up|1|||
130989926|NCT02118337|471591559|FG008|Overall Study|Lost to Follow-up|0|||
130989927|NCT02118337|471591551|FG000|Overall Study|Withdrawal by Subject|1|||
130989928|NCT02118337|471591552|FG001|Overall Study|Withdrawal by Subject|3|||
130989929|NCT02118337|471591553|FG002|Overall Study|Withdrawal by Subject|2|||
130878282|NCT02657889|471187710|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
130878283|NCT02657889|471187711|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
130878284|NCT02657889|471187712|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
130878285|NCT02657889|471187713|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
130878286|NCT01576341|471187714|FG000|Overall Study|Withdrawal by Subject|24|||
130878287|NCT01576341|471187714|FG000|Overall Study|Adverse Event|10|||
130878288|NCT01576341|471187714|FG000|Overall Study|Death|21|||
130878289|NCT01576341|471187714|FG000|Overall Study|Physician Decision|2|||
130878290|NCT01576341|471187714|FG000|Overall Study|Lost to Follow-up|2|||
130878291|NCT01576341|471187714|FG000|Overall Study|Kidney transplantation|10|||
130878292|NCT01576341|471187714|FG000|Overall Study|Protocol Violation|12|||
130878293|NCT01576341|471187714|FG000|Overall Study|Other|12|||
130878294|NCT00604565|471187722|FG000|Overall Study|Study terminated|0|||
130878295|NCT00604565|471187723|FG001|Overall Study|Study terminated|3|||
130878296|NCT04292535|471187725|FG000|Overall Study|Withdrawal by Subject|0|||
130878297|NCT04292535|471187726|FG001|Overall Study|Withdrawal by Subject|0|||
130878298|NCT04292535|471187727|FG002|Overall Study|Withdrawal by Subject|0|||
130989930|NCT02118337|471591554|FG003|Overall Study|Withdrawal by Subject|1|||
130989931|NCT02118337|471591555|FG004|Overall Study|Withdrawal by Subject|2|||
130989932|NCT02118337|471591556|FG005|Overall Study|Withdrawal by Subject|2|||
130989933|NCT02118337|471591557|FG006|Overall Study|Withdrawal by Subject|1|||
130989934|NCT02118337|471591558|FG007|Overall Study|Withdrawal by Subject|4|||
130989935|NCT02118337|471591559|FG008|Overall Study|Withdrawal by Subject|2|||
130989936|NCT02118337|471591551|FG000|Overall Study|Death|2|||
130989937|NCT02118337|471591552|FG001|Overall Study|Death|2|||
130989938|NCT02118337|471591553|FG002|Overall Study|Death|1|||
130989939|NCT02118337|471591554|FG003|Overall Study|Death|2|||
130878299|NCT04292535|471187728|FG003|Overall Study|Withdrawal by Subject|0|||
130878300|NCT04292535|471187729|FG004|Overall Study|Withdrawal by Subject|0|||
130989940|NCT02118337|471591555|FG004|Overall Study|Death|5|||
130989941|NCT02118337|471591556|FG005|Overall Study|Death|1|||
130989942|NCT02118337|471591557|FG006|Overall Study|Death|2|||
130989943|NCT02118337|471591558|FG007|Overall Study|Death|9|||
131213192|NCT03110107|472405301|FG009|Treatment Period|Study drug toxicity|2|||
130878301|NCT04292535|471187730|FG005|Overall Study|Withdrawal by Subject|0|||
130878302|NCT04292535|471187731|FG006|Overall Study|Withdrawal by Subject|0|||
130878303|NCT04292535|471187732|FG007|Overall Study|Withdrawal by Subject|1|||
130878304|NCT04292535|471187733|FG008|Overall Study|Withdrawal by Subject|0|||
130878305|NCT04292535|471187734|FG009|Overall Study|Withdrawal by Subject|0|||
130878306|NCT04292535|471187735|FG010|Overall Study|Withdrawal by Subject|0|||
130878307|NCT04292535|471187736|FG011|Overall Study|Withdrawal by Subject|0|||
130878308|NCT04292535|471187737|FG012|Overall Study|Withdrawal by Subject|0|||
130878309|NCT04292535|471187738|FG013|Overall Study|Withdrawal by Subject|0|||
130878310|NCT04292535|471187725|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130878311|NCT04292535|471187726|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130878312|NCT04292535|471187727|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130878313|NCT04292535|471187728|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130878314|NCT04292535|471187729|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130989944|NCT02118337|471591559|FG008|Overall Study|Death|4|||
130989945|NCT04296890|471591561|FG000|Overall Study|Withdrawal by Subject|1|||
130989946|NCT04296890|471591561|FG000|Overall Study|Death|62|||
130989947|NCT04296890|471591561|FG000|Overall Study|Lost to Follow-up|3|||
130989948|NCT04296890|471591561|FG000|Overall Study|Other than specified|2|||
130989949|NCT05400746|471591562|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
130989950|NCT05400746|471591563|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
130989951|NCT05400746|471591564|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
130989952|NCT02277743|471591565|FG000|Overall Study|Protocol Violation|1|||
130989953|NCT02277743|471591566|FG001|Overall Study|Protocol Violation|1|||
130989954|NCT02277743|471591567|FG002|Overall Study|Protocol Violation|1|||
130989955|NCT02277743|471591565|FG000|Overall Study|Adverse Event|10|||
130989956|NCT02277743|471591566|FG001|Overall Study|Adverse Event|6|||
130989957|NCT02277743|471591567|FG002|Overall Study|Adverse Event|6|||
130989958|NCT02277743|471591565|FG000|Overall Study|Lack of Efficacy|11|||
130989959|NCT02277743|471591566|FG001|Overall Study|Lack of Efficacy|4|||
130989960|NCT02277743|471591567|FG002|Overall Study|Lack of Efficacy|3|||
130989961|NCT02277743|471591565|FG000|Overall Study|Other than specified above|18|||
130989962|NCT02277743|471591566|FG001|Overall Study|Other than specified above|5|||
130989963|NCT02277743|471591567|FG002|Overall Study|Other than specified above|16|||
130989964|NCT02055157|471591571|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
130989965|NCT02055157|471591572|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
130989966|NCT02055157|471591573|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
130989967|NCT02055157|471591574|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
130989968|NCT02055157|471591571|FG000|Initial 6 Months|Adverse Event|0|||
130989969|NCT02055157|471591572|FG001|Initial 6 Months|Adverse Event|0|||
130989970|NCT02055157|471591573|FG002|Initial 6 Months|Adverse Event|0|||
130989971|NCT02055157|471591574|FG003|Initial 6 Months|Adverse Event|1|||
130989972|NCT02055157|471591571|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
130989973|NCT02055157|471591572|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
130989974|NCT02055157|471591573|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
130989975|NCT02055157|471591574|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
130989976|NCT02055157|471591571|FG000|18-month Extension|Investigator decision|0|||
130989977|NCT02055157|471591572|FG001|18-month Extension|Investigator decision|1|||
130989978|NCT02055157|471591573|FG002|18-month Extension|Investigator decision|0|||
130989979|NCT02055157|471591574|FG003|18-month Extension|Investigator decision|0|||
130989980|NCT02055157|471591571|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
130989981|NCT02055157|471591572|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
130989982|NCT02055157|471591573|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
130989983|NCT02055157|471591574|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
130989984|NCT03976466|471591575|FG000|Overall Study|Lost to Follow-up|1|||
130989985|NCT03976466|471591576|FG001|Overall Study|Lost to Follow-up|3|||
130989986|NCT00943306|471591579|FG000|Overall Study|Physician Decision|1|||
130989987|NCT00943306|471591579|FG000|Overall Study|Death|1|||
130989988|NCT00943306|471591579|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
130989989|NCT02739347|471591580|FG000|Overall Study|Adverse Event|3|||
130989990|NCT02739347|471591581|FG001|Overall Study|Adverse Event|0|||
130989991|NCT02739347|471591580|FG000|Overall Study|Protocol Violation|0|||
130878315|NCT04292535|471187730|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130989992|NCT02739347|471591581|FG001|Overall Study|Protocol Violation|1|||
130989993|NCT02739347|471591580|FG000|Overall Study|Lost to Follow-up|0|||
130989994|NCT02739347|471591581|FG001|Overall Study|Lost to Follow-up|2|||
130989995|NCT03929562|471591582|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
130989996|NCT03929562|471591583|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
130989997|NCT03929562|471591582|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
130989998|NCT03929562|471591583|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
130878316|NCT04292535|471187731|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130878317|NCT04292535|471187732|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
130878318|NCT04292535|471187733|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130878319|NCT04292535|471187734|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130878320|NCT04292535|471187735|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130878321|NCT04292535|471187736|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130878322|NCT04292535|471187737|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
130878323|NCT04292535|471187738|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
130878324|NCT04292535|471187725|FG000|Overall Study|Report of Dizziness|0|||
130989999|NCT03929562|471591582|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
130990000|NCT03929562|471591583|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
130990001|NCT00576732|471591592|FG000|DOUBLE BLIND|Adverse Event|0|||
130990002|NCT00576732|471591593|FG001|DOUBLE BLIND|Adverse Event|0|||
130990003|NCT00576732|471591594|FG002|DOUBLE BLIND|Adverse Event|1|||
130990004|NCT00576732|471591595|FG003|DOUBLE BLIND|Adverse Event|0|||
130990005|NCT00576732|471591596|FG004|DOUBLE BLIND|Adverse Event|0|||
130990006|NCT00576732|471591597|FG005|DOUBLE BLIND|Adverse Event|0|||
130990007|NCT00576732|471591592|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
130990008|NCT00576732|471591593|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
130990009|NCT00576732|471591594|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
130990010|NCT00576732|471591595|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
130990011|NCT00576732|471591596|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
130990012|NCT00576732|471591597|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
130990013|NCT00576732|471591592|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
130990014|NCT00576732|471591593|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
130990015|NCT00576732|471591594|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
130990016|NCT00576732|471591595|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
130990017|NCT00576732|471591596|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
130990018|NCT00576732|471591597|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
130990019|NCT00576732|471591592|FG000|DOUBLE BLIND|OTHER|0|||
130990020|NCT00576732|471591593|FG001|DOUBLE BLIND|OTHER|2|||
130990021|NCT00576732|471591594|FG002|DOUBLE BLIND|OTHER|1|||
130990022|NCT00576732|471591595|FG003|DOUBLE BLIND|OTHER|0|||
130990023|NCT00576732|471591596|FG004|DOUBLE BLIND|OTHER|0|||
130990024|NCT00576732|471591597|FG005|DOUBLE BLIND|OTHER|0|||
130990025|NCT00576732|471591592|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
130990026|NCT00576732|471591593|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
130990027|NCT00576732|471591594|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
130990028|NCT00576732|471591595|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
130990029|NCT00576732|471591596|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
130990030|NCT00576732|471591597|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
130990031|NCT00576732|471591592|FG000|DOUBLE BLIND|Protocol Violation|1|||
130990032|NCT00576732|471591593|FG001|DOUBLE BLIND|Protocol Violation|0|||
130990033|NCT00576732|471591594|FG002|DOUBLE BLIND|Protocol Violation|0|||
130990034|NCT00576732|471591595|FG003|DOUBLE BLIND|Protocol Violation|0|||
130990035|NCT00576732|471591596|FG004|DOUBLE BLIND|Protocol Violation|0|||
130990036|NCT00576732|471591597|FG005|DOUBLE BLIND|Protocol Violation|0|||
130990037|NCT00576732|471591592|FG000|OPEN LABEL|Adverse Event|0|||
130990038|NCT00576732|471591593|FG001|OPEN LABEL|Adverse Event|0|||
130990039|NCT00576732|471591594|FG002|OPEN LABEL|Adverse Event|0|||
130990040|NCT00576732|471591595|FG003|OPEN LABEL|Adverse Event|4|||
130990041|NCT00576732|471591596|FG004|OPEN LABEL|Adverse Event|0|||
130990042|NCT00576732|471591597|FG005|OPEN LABEL|Adverse Event|1|||
130990043|NCT00576732|471591592|FG000|OPEN LABEL|Lost to Follow-up|0|||
130990044|NCT00576732|471591593|FG001|OPEN LABEL|Lost to Follow-up|0|||
130878325|NCT04292535|471187726|FG001|Overall Study|Report of Dizziness|0|||
130878326|NCT04292535|471187727|FG002|Overall Study|Report of Dizziness|0|||
130878327|NCT04292535|471187728|FG003|Overall Study|Report of Dizziness|0|||
130878328|NCT04292535|471187729|FG004|Overall Study|Report of Dizziness|0|||
130878329|NCT04292535|471187730|FG005|Overall Study|Report of Dizziness|0|||
130878330|NCT04292535|471187731|FG006|Overall Study|Report of Dizziness|0|||
130878331|NCT04292535|471187732|FG007|Overall Study|Report of Dizziness|0|||
130878332|NCT04292535|471187733|FG008|Overall Study|Report of Dizziness|0|||
130990045|NCT00576732|471591594|FG002|OPEN LABEL|Lost to Follow-up|0|||
130990046|NCT00576732|471591595|FG003|OPEN LABEL|Lost to Follow-up|2|||
130990047|NCT00576732|471591596|FG004|OPEN LABEL|Lost to Follow-up|1|||
130990048|NCT00576732|471591597|FG005|OPEN LABEL|Lost to Follow-up|1|||
130990049|NCT00576732|471591592|FG000|OPEN LABEL|Withdrawal by Subject|0|||
130990050|NCT00576732|471591593|FG001|OPEN LABEL|Withdrawal by Subject|0|||
130990051|NCT00576732|471591594|FG002|OPEN LABEL|Withdrawal by Subject|0|||
130990052|NCT00576732|471591595|FG003|OPEN LABEL|Withdrawal by Subject|1|||
131098655|NCT01290315|471991008|FG002|Overall Study|Withdrawal by Subject|0|||
131098656|NCT01290315|471991009|FG003|Overall Study|Withdrawal by Subject|0|||
131098657|NCT00591721|471991010|FG000|Overall Study|Withdrawal by Subject|10|||
131098658|NCT00591721|471991011|FG001|Overall Study|Withdrawal by Subject|10|||
130878333|NCT04292535|471187734|FG009|Overall Study|Report of Dizziness|0|||
130990053|NCT00576732|471591596|FG004|OPEN LABEL|Withdrawal by Subject|0|||
131098659|NCT00591721|471991010|FG000|Overall Study|Lost to Follow-up|1|||
130990054|NCT00576732|471591597|FG005|OPEN LABEL|Withdrawal by Subject|1|||
130990055|NCT00576732|471591592|FG000|OPEN LABEL|OTHER|0|||
130878334|NCT04292535|471187735|FG010|Overall Study|Report of Dizziness|0|||
130878335|NCT04292535|471187736|FG011|Overall Study|Report of Dizziness|0|||
130878336|NCT04292535|471187737|FG012|Overall Study|Report of Dizziness|0|||
130878337|NCT04292535|471187738|FG013|Overall Study|Report of Dizziness|1|||
130878338|NCT04292535|471187725|FG000|Overall Study|Equipment Failure|0|||
130878339|NCT04292535|471187726|FG001|Overall Study|Equipment Failure|0|||
130878340|NCT04292535|471187727|FG002|Overall Study|Equipment Failure|0|||
130878341|NCT04292535|471187728|FG003|Overall Study|Equipment Failure|0|||
130878342|NCT04292535|471187729|FG004|Overall Study|Equipment Failure|0|||
130878343|NCT04292535|471187730|FG005|Overall Study|Equipment Failure|0|||
130878344|NCT04292535|471187731|FG006|Overall Study|Equipment Failure|0|||
130878345|NCT04292535|471187732|FG007|Overall Study|Equipment Failure|0|||
130878346|NCT04292535|471187733|FG008|Overall Study|Equipment Failure|0|||
130878347|NCT04292535|471187734|FG009|Overall Study|Equipment Failure|0|||
130878348|NCT04292535|471187735|FG010|Overall Study|Equipment Failure|0|||
130878349|NCT04292535|471187736|FG011|Overall Study|Equipment Failure|1|||
130878350|NCT04292535|471187737|FG012|Overall Study|Equipment Failure|0|||
130878351|NCT04292535|471187738|FG013|Overall Study|Equipment Failure|0|||
130878352|NCT00517296|471187739|FG000|Overall Study|Withdrawal by Subject|1|||
130878353|NCT00517296|471187740|FG001|Overall Study|Withdrawal by Subject|0|||
130878354|NCT00791934|471187742|FG000|Overall Study|Withdrawal by Subject|2|||
130878355|NCT00791934|471187742|FG000|Overall Study|Did not consent for extended follow-up|13|||
130878356|NCT02018562|471187744|FG000|Overall Study|Withdrawal by Subject|2|||
130878357|NCT02018562|471187745|FG001|Overall Study|Withdrawal by Subject|0|||
130878358|NCT02018562|471187744|FG000|Overall Study|Discharged prior to study completion|1|||
130878359|NCT02018562|471187745|FG001|Overall Study|Discharged prior to study completion|0|||
130878360|NCT03642873|471187747|FG000|Third Intervention (1 Day)|Screen failure|0|||
130878361|NCT03642873|471187748|FG001|Third Intervention (1 Day)|Screen failure|0|||
130878362|NCT03642873|471187749|FG002|Third Intervention (1 Day)|Screen failure|0|||
130878363|NCT03642873|471187750|FG003|Third Intervention (1 Day)|Screen failure|0|||
130878364|NCT03642873|471187751|FG004|Third Intervention (1 Day)|Screen failure|1|||
130878365|NCT03642873|471187752|FG005|Third Intervention (1 Day)|Screen failure|0|||
130878366|NCT04609319|471187753|FG000|Overall Study|Death|64|||
130878367|NCT04609319|471187754|FG001|Overall Study|Death|49|||
130878368|NCT04609319|471187755|FG002|Overall Study|Death|1|||
130878369|NCT04609319|471187753|FG000|Overall Study|Withdrawal of consent|15|||
130878370|NCT04609319|471187754|FG001|Overall Study|Withdrawal of consent|3|||
130878371|NCT04609319|471187755|FG002|Overall Study|Withdrawal of consent|0|||
130878372|NCT04609319|471187753|FG000|Overall Study|Lost to Follow-up|20|||
130878373|NCT04609319|471187754|FG001|Overall Study|Lost to Follow-up|33|||
130878374|NCT04609319|471187755|FG002|Overall Study|Lost to Follow-up|0|||
130878375|NCT04609319|471187753|FG000|Overall Study|Alive until end of follow-up|60|||
130878376|NCT04609319|471187754|FG001|Overall Study|Alive until end of follow-up|53|||
130878377|NCT04609319|471187755|FG002|Overall Study|Alive until end of follow-up|1|||
130878378|NCT01253291|471187758|FG000|Overall Study|Withdrawal by Subject|1|||
130878379|NCT01253291|471187759|FG001|Overall Study|Withdrawal by Subject|1|||
130878380|NCT01253291|471187760|FG002|Overall Study|Withdrawal by Subject|0|||
130878381|NCT01253291|471187761|FG003|Overall Study|Withdrawal by Subject|0|||
130878382|NCT01253291|471187762|FG004|Overall Study|Withdrawal by Subject|0|||
130878383|NCT01253291|471187758|FG000|Overall Study|Adverse Event|0|||
130878384|NCT01253291|471187759|FG001|Overall Study|Adverse Event|1|||
130878385|NCT01253291|471187760|FG002|Overall Study|Adverse Event|0|||
130878386|NCT01253291|471187761|FG003|Overall Study|Adverse Event|0|||
130878387|NCT01253291|471187762|FG004|Overall Study|Adverse Event|0|||
130878388|NCT01253291|471187758|FG000|Overall Study|Lack of Efficacy|1|||
130878389|NCT01253291|471187759|FG001|Overall Study|Lack of Efficacy|0|||
130878390|NCT01253291|471187760|FG002|Overall Study|Lack of Efficacy|0|||
130878391|NCT01253291|471187761|FG003|Overall Study|Lack of Efficacy|0|||
130878392|NCT01253291|471187762|FG004|Overall Study|Lack of Efficacy|0|||
130878393|NCT01253291|471187758|FG000|Overall Study|Physician Decision|2|||
130878394|NCT01253291|471187759|FG001|Overall Study|Physician Decision|0|||
130878395|NCT01253291|471187760|FG002|Overall Study|Physician Decision|0|||
130878396|NCT01253291|471187761|FG003|Overall Study|Physician Decision|0|||
130878397|NCT01253291|471187762|FG004|Overall Study|Physician Decision|2|||
130878398|NCT02234843|471187771|FG000|Overall Study|Death|1|||
130878399|NCT02234843|471187772|FG001|Overall Study|Death|0|||
130878400|NCT02234843|471187773|FG002|Overall Study|Death|0|||
130878401|NCT02234843|471187774|FG003|Overall Study|Death|0|||
130878402|NCT02234843|471187775|FG004|Overall Study|Death|0|||
130878403|NCT02234843|471187776|FG005|Overall Study|Death|0|||
130878404|NCT02234843|471187777|FG006|Overall Study|Death|0|||
130878405|NCT02234843|471187778|FG007|Overall Study|Death|0|||
130878406|NCT02234843|471187779|FG008|Overall Study|Death|0|||
130878407|NCT02234843|471187780|FG009|Overall Study|Death|0|||
130878408|NCT02234843|471187771|FG000|Overall Study|Protocol Violation|1|||
130878409|NCT02234843|471187772|FG001|Overall Study|Protocol Violation|0|||
130878410|NCT02234843|471187773|FG002|Overall Study|Protocol Violation|1|||
130878411|NCT02234843|471187774|FG003|Overall Study|Protocol Violation|0|||
130878412|NCT02234843|471187775|FG004|Overall Study|Protocol Violation|0|||
130878413|NCT02234843|471187776|FG005|Overall Study|Protocol Violation|0|||
131098660|NCT00591721|471991011|FG001|Overall Study|Lost to Follow-up|4|||
131098661|NCT00591721|471991010|FG000|Overall Study|Intervention not received|10|||
131098662|NCT00591721|471991011|FG001|Overall Study|Intervention not received|8|||
131098663|NCT03809429|471991014|FG000|Overall Study|Withdrawal by Subject|7|||
130990056|NCT00576732|471591593|FG001|OPEN LABEL|OTHER|0|||
130990057|NCT00576732|471591594|FG002|OPEN LABEL|OTHER|0|||
130990058|NCT00576732|471591595|FG003|OPEN LABEL|OTHER|0|||
130990059|NCT00576732|471591596|FG004|OPEN LABEL|OTHER|0|||
131098664|NCT03809429|471991015|FG001|Overall Study|Withdrawal by Subject|3|||
131098665|NCT03809429|471991014|FG000|Overall Study|Adverse Event|6|||
131098666|NCT03809429|471991015|FG001|Overall Study|Adverse Event|9|||
131098667|NCT03809429|471991014|FG000|Overall Study|COVID-19|3|||
131098668|NCT03809429|471991015|FG001|Overall Study|COVID-19|1|||
131098669|NCT03809429|471991014|FG000|Overall Study|Participant was discontinued by investigator|12|||
131098670|NCT03809429|471991015|FG001|Overall Study|Participant was discontinued by investigator|7|||
131098671|NCT03828747|471991016|FG000|Double-Blind Treatment Period|Adverse Event|6|||
131098672|NCT03828747|471991017|FG001|Double-Blind Treatment Period|Adverse Event|6|||
131098673|NCT03828747|471991016|FG000|Double-Blind Treatment Period|Death|1|||
131098674|NCT03828747|471991017|FG001|Double-Blind Treatment Period|Death|1|||
131098675|NCT03828747|471991016|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131098676|NCT03828747|471991017|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
131098677|NCT03828747|471991016|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
131098678|NCT03828747|471991017|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
131098679|NCT03828747|471991016|FG000|Double-Blind Treatment Period|Physician Decision|1|||
131098680|NCT03828747|471991017|FG001|Double-Blind Treatment Period|Physician Decision|4|||
131098681|NCT03828747|471991016|FG000|Double-Blind Treatment Period|Various reasons|5|||
131098682|NCT03828747|471991017|FG001|Double-Blind Treatment Period|Various reasons|3|||
131098683|NCT03828747|471991016|FG000|Open-Label Extension|Adverse Event|9|||
130990060|NCT00576732|471591597|FG005|OPEN LABEL|OTHER|2|||
130990061|NCT00576732|471591592|FG000|OPEN LABEL|Lack of Efficacy|0|||
130990062|NCT00576732|471591593|FG001|OPEN LABEL|Lack of Efficacy|0|||
130990063|NCT00576732|471591594|FG002|OPEN LABEL|Lack of Efficacy|0|||
130990064|NCT00576732|471591595|FG003|OPEN LABEL|Lack of Efficacy|2|||
130990065|NCT00576732|471591596|FG004|OPEN LABEL|Lack of Efficacy|2|||
130990066|NCT00576732|471591597|FG005|OPEN LABEL|Lack of Efficacy|3|||
130990067|NCT00576732|471591592|FG000|OPEN LABEL|Protocol Violation|0|||
130990068|NCT00576732|471591593|FG001|OPEN LABEL|Protocol Violation|0|||
130990069|NCT00576732|471591594|FG002|OPEN LABEL|Protocol Violation|0|||
131098684|NCT03828747|471991017|FG001|Open-Label Extension|Adverse Event|7|||
131098685|NCT03828747|471991016|FG000|Open-Label Extension|Death|0|||
131098686|NCT03828747|471991017|FG001|Open-Label Extension|Death|2|||
130990070|NCT00576732|471591595|FG003|OPEN LABEL|Protocol Violation|2|||
130990071|NCT00576732|471591596|FG004|OPEN LABEL|Protocol Violation|1|||
130990072|NCT00576732|471591597|FG005|OPEN LABEL|Protocol Violation|0|||
130990073|NCT03188120|471591598|FG000|Overall Study|Adverse Event|4|||
130990074|NCT03188120|471591598|FG000|Overall Study|Insufficient Effectiveness|8|||
130990075|NCT03188120|471591598|FG000|Overall Study|Improved|12|||
130990076|NCT03188120|471591598|FG000|Overall Study|Lost to Follow-up|7|||
130990077|NCT03188120|471591598|FG000|Overall Study|Other than specified|3|||
130990078|NCT03188120|471591598|FG000|Overall Study|No visit after the first visit|13|||
130990079|NCT02978443|471591600|FG000|Overall Study|Withdrawal by Subject|1|||
130990080|NCT02978443|471591600|FG000|Overall Study|Adverse Event|3|||
130990081|NCT02978443|471591600|FG000|Overall Study|Disease Progression on study|6|||
130990082|NCT02978443|471591600|FG000|Overall Study|Death|1|||
130990083|NCT02978443|471591600|FG000|Overall Study|Physician Decision|1|||
130990084|NCT02978443|471591600|FG000|Overall Study|Switch to alternative therapy|1|||
130990085|NCT02978443|471591600|FG000|Overall Study|Refused further treatment|1|||
130990086|NCT00717314|471591602|FG000|Overall Study|Adverse Event|3|||
130990087|NCT00717314|471591603|FG001|Overall Study|Adverse Event|2|||
130990088|NCT00717314|471591602|FG000|Overall Study|Protocol Violation|1|||
130990089|NCT00717314|471591603|FG001|Overall Study|Protocol Violation|0|||
130990090|NCT00717314|471591602|FG000|Overall Study|Lost to Follow-up|1|||
130990091|NCT00717314|471591603|FG001|Overall Study|Lost to Follow-up|5|||
130990092|NCT00717314|471591602|FG000|Overall Study|Withdrawal by Subject|1|||
130990093|NCT00717314|471591603|FG001|Overall Study|Withdrawal by Subject|3|||
130990094|NCT04043962|471591605|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
130990095|NCT04043962|471591605|FG000|Post-Treatment|Withdrawal by Subject|5|||
130990096|NCT04043962|471591605|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
130990097|NCT01336621|471591606|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
130990098|NCT01336621|471591606|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
130720913|NCT00620555|470601559|FG000|Overall Study|Visit failure against planned|1|||
130878414|NCT02234843|471187777|FG006|Overall Study|Protocol Violation|0|||
130990099|NCT01336621|471591606|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
130990100|NCT01336621|471591606|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
130990101|NCT01336621|471591606|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
130878415|NCT02234843|471187778|FG007|Overall Study|Protocol Violation|0|||
130878416|NCT02234843|471187779|FG008|Overall Study|Protocol Violation|0|||
130878417|NCT02234843|471187780|FG009|Overall Study|Protocol Violation|0|||
130878418|NCT02234843|471187771|FG000|Overall Study|Efficacy outcome reached|2|||
130878419|NCT02234843|471187772|FG001|Overall Study|Efficacy outcome reached|0|||
130878420|NCT02234843|471187773|FG002|Overall Study|Efficacy outcome reached|0|||
130878421|NCT02234843|471187774|FG003|Overall Study|Efficacy outcome reached|0|||
130878422|NCT02234843|471187775|FG004|Overall Study|Efficacy outcome reached|0|||
130878423|NCT02234843|471187776|FG005|Overall Study|Efficacy outcome reached|2|||
130878424|NCT02234843|471187777|FG006|Overall Study|Efficacy outcome reached|0|||
130878425|NCT02234843|471187778|FG007|Overall Study|Efficacy outcome reached|0|||
130878426|NCT02234843|471187779|FG008|Overall Study|Efficacy outcome reached|0|||
130878427|NCT02234843|471187780|FG009|Overall Study|Efficacy outcome reached|0|||
130878428|NCT02234843|471187771|FG000|Overall Study|Patient convenience|2|||
130878429|NCT02234843|471187772|FG001|Overall Study|Patient convenience|0|||
130878430|NCT02234843|471187773|FG002|Overall Study|Patient convenience|0|||
130878431|NCT02234843|471187774|FG003|Overall Study|Patient convenience|0|||
130878432|NCT02234843|471187775|FG004|Overall Study|Patient convenience|0|||
130878433|NCT02234843|471187776|FG005|Overall Study|Patient convenience|1|||
130878434|NCT02234843|471187777|FG006|Overall Study|Patient convenience|0|||
130990102|NCT01336621|471591606|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
130990103|NCT01336621|471591606|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
130990104|NCT01336621|471591606|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
130990105|NCT01336621|471591606|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
130990106|NCT01336621|471591606|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
130990107|NCT01336621|471591606|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
130990108|NCT01336621|471591606|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
130990109|NCT01336621|471591606|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
130990110|NCT01336621|471591606|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
130990111|NCT01126060|471591609|FG000|Overall Study|Protocol Violation|0|||
130990112|NCT01126060|471591610|FG001|Overall Study|Protocol Violation|2|||
130990113|NCT01874145|471591611|FG000|Core Period|Non-compliance|1|||
130990114|NCT01874145|471591612|FG001|Core Period|Non-compliance|0|||
130990115|NCT01874145|471591611|FG000|Core Period|Protocol Violation|1|||
130990116|NCT01874145|471591612|FG001|Core Period|Protocol Violation|1|||
130990117|NCT01874145|471591611|FG000|Core Period|Physician Decision|1|||
130990118|NCT01874145|471591612|FG001|Core Period|Physician Decision|1|||
130990119|NCT01874145|471591611|FG000|Core Period|Adverse Event|0|||
130990120|NCT01874145|471591612|FG001|Core Period|Adverse Event|1|||
130990121|NCT01874145|471591611|FG000|Core Period|Withdrawal by Subject|0|||
130990122|NCT01874145|471591612|FG001|Core Period|Withdrawal by Subject|4|||
130990123|NCT01874145|471591611|FG000|Extension Period|Adverse Event|3|||
130990124|NCT01874145|471591612|FG001|Extension Period|Adverse Event|2|||
130990125|NCT01874145|471591611|FG000|Extension Period|Withdrawal by Subject|2|||
130990126|NCT01874145|471591612|FG001|Extension Period|Withdrawal by Subject|1|||
130990127|NCT01874145|471591611|FG000|Extension Period|Lost to Follow-up|1|||
130990128|NCT01874145|471591612|FG001|Extension Period|Lost to Follow-up|1|||
130990129|NCT01521884|471591618|FG000|Overall Study|Non Responders|10|||
130990130|NCT01521884|471591618|FG000|Overall Study|Adverse Event|5|||
130990131|NCT01521884|471591618|FG000|Overall Study|Pregnancy|1|||
130990132|NCT01521884|471591618|FG000|Overall Study|Withdrawal by Subject|1|||
130990133|NCT01521884|471591618|FG000|Overall Study|Physician Decision|2|||
130990134|NCT01521884|471591618|FG000|Overall Study|Protocol Violation|3|||
130990135|NCT01521884|471591618|FG000|Overall Study|Participant non-eligible|1|||
130990136|NCT01521884|471591618|FG000|Overall Study|Lost to Follow-up|4|||
130990137|NCT02821819|471591619|FG000|Overall Study|Protocol Violation|1|||
130990138|NCT03565068|471591620|FG000|Overall Study|Protocol Violation|0|||
130990139|NCT03565068|471591621|FG001|Overall Study|Protocol Violation|0|||
130990140|NCT03565068|471591622|FG002|Overall Study|Protocol Violation|0|||
130990141|NCT03565068|471591623|FG003|Overall Study|Protocol Violation|0|||
130990142|NCT03565068|471591624|FG004|Overall Study|Protocol Violation|1|||
130990143|NCT03565068|471591625|FG005|Overall Study|Protocol Violation|0|||
130990144|NCT03565068|471591626|FG006|Overall Study|Protocol Violation|0|||
130990145|NCT03565068|471591627|FG007|Overall Study|Protocol Violation|1|||
130990146|NCT03565068|471591628|FG008|Overall Study|Protocol Violation|0|||
130990147|NCT03565068|471591620|FG000|Overall Study|Sponsor decision|0|||
130878435|NCT02234843|471187778|FG007|Overall Study|Patient convenience|0|||
130878436|NCT02234843|471187779|FG008|Overall Study|Patient convenience|0|||
130990148|NCT03565068|471591621|FG001|Overall Study|Sponsor decision|0|||
130990149|NCT03565068|471591622|FG002|Overall Study|Sponsor decision|0|||
130990150|NCT03565068|471591623|FG003|Overall Study|Sponsor decision|0|||
130878437|NCT02234843|471187780|FG009|Overall Study|Patient convenience|0|||
130878438|NCT02234843|471187771|FG000|Overall Study|Withdrawal by Subject|5|||
130878439|NCT02234843|471187772|FG001|Overall Study|Withdrawal by Subject|1|||
130878440|NCT02234843|471187773|FG002|Overall Study|Withdrawal by Subject|1|||
130878441|NCT02234843|471187774|FG003|Overall Study|Withdrawal by Subject|0|||
130990151|NCT03565068|471591624|FG004|Overall Study|Sponsor decision|1|||
130990152|NCT03565068|471591625|FG005|Overall Study|Sponsor decision|1|||
130990153|NCT03565068|471591626|FG006|Overall Study|Sponsor decision|0|||
130990154|NCT03565068|471591627|FG007|Overall Study|Sponsor decision|0|||
130990155|NCT03565068|471591628|FG008|Overall Study|Sponsor decision|0|||
130990156|NCT03565068|471591620|FG000|Overall Study|Withdrawal by Subject|0|||
130990157|NCT03565068|471591621|FG001|Overall Study|Withdrawal by Subject|0|||
130990158|NCT03565068|471591622|FG002|Overall Study|Withdrawal by Subject|1|||
130990159|NCT03565068|471591623|FG003|Overall Study|Withdrawal by Subject|0|||
130990160|NCT03565068|471591624|FG004|Overall Study|Withdrawal by Subject|2|||
130990161|NCT03565068|471591625|FG005|Overall Study|Withdrawal by Subject|0|||
130990162|NCT03565068|471591626|FG006|Overall Study|Withdrawal by Subject|1|||
130990163|NCT03565068|471591627|FG007|Overall Study|Withdrawal by Subject|5|||
130990164|NCT03565068|471591628|FG008|Overall Study|Withdrawal by Subject|1|||
130990165|NCT03565068|471591620|FG000|Overall Study|Physician Decision|0|||
130990166|NCT03565068|471591621|FG001|Overall Study|Physician Decision|0|||
130990167|NCT03565068|471591622|FG002|Overall Study|Physician Decision|0|||
130990168|NCT03565068|471591623|FG003|Overall Study|Physician Decision|0|||
130990169|NCT03565068|471591624|FG004|Overall Study|Physician Decision|0|||
130990170|NCT03565068|471591625|FG005|Overall Study|Physician Decision|0|||
130990171|NCT03565068|471591626|FG006|Overall Study|Physician Decision|0|||
130990172|NCT03565068|471591627|FG007|Overall Study|Physician Decision|1|||
130990173|NCT03565068|471591628|FG008|Overall Study|Physician Decision|0|||
130990174|NCT03565068|471591620|FG000|Overall Study|Lost to Follow-up|0|||
130990175|NCT03565068|471591621|FG001|Overall Study|Lost to Follow-up|0|||
130990176|NCT03565068|471591622|FG002|Overall Study|Lost to Follow-up|0|||
130990177|NCT03565068|471591623|FG003|Overall Study|Lost to Follow-up|0|||
130990178|NCT03565068|471591624|FG004|Overall Study|Lost to Follow-up|0|||
130990179|NCT03565068|471591625|FG005|Overall Study|Lost to Follow-up|0|||
130990180|NCT03565068|471591626|FG006|Overall Study|Lost to Follow-up|0|||
130990181|NCT03565068|471591627|FG007|Overall Study|Lost to Follow-up|1|||
130990182|NCT03565068|471591628|FG008|Overall Study|Lost to Follow-up|0|||
130990183|NCT03238300|471591632|FG000|Baseline (Before Intervention)|Physician Decision|0|||
130990184|NCT03238300|471591633|FG001|Baseline (Before Intervention)|Physician Decision|1|||
130990185|NCT03238300|471591632|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
130990186|NCT03238300|471591633|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
130990187|NCT03238300|471591632|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
130990188|NCT03238300|471591633|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
130990189|NCT03238300|471591632|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
130990190|NCT03238300|471591633|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
130990191|NCT01893827|471591636|FG000|Overall Study|Lost to Follow-up|19|||
130990192|NCT01893827|471591637|FG001|Overall Study|Lost to Follow-up|26|||
130990193|NCT02089230|471591639|FG000|Overall Study|Death|0|||
130990194|NCT02089230|471591640|FG001|Overall Study|Death|0|||
130990195|NCT02089230|471591641|FG002|Overall Study|Death|2|||
130765319|NCT00334802|470764158|FG001|Overall Study|Withdrawal by Subject|4|||
130765320|NCT00334802|470764157|FG000|Overall Study|Adverse Event|0|||
130765321|NCT00334802|470764158|FG001|Overall Study|Adverse Event|3|||
130765322|NCT00334802|470764157|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
130765323|NCT00334802|470764158|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
130765324|NCT03436199|470764159|FG000|Overall Study|Adverse Event|15|||
130765325|NCT03436199|470764160|FG001|Overall Study|Adverse Event|40|||
130765326|NCT03436199|470764161|FG002|Overall Study|Adverse Event|7|||
130765327|NCT03436199|470764159|FG000|Overall Study|Withdrawal by Subject|4|||
130765328|NCT03436199|470764160|FG001|Overall Study|Withdrawal by Subject|10|||
130765329|NCT03436199|470764161|FG002|Overall Study|Withdrawal by Subject|3|||
130765330|NCT03436199|470764159|FG000|Overall Study|Lost to Follow-up|1|||
130765331|NCT03436199|470764160|FG001|Overall Study|Lost to Follow-up|0|||
130765332|NCT03436199|470764161|FG002|Overall Study|Lost to Follow-up|2|||
130765333|NCT03436199|470764159|FG000|Overall Study|Protocol Violation|1|||
130765334|NCT03436199|470764160|FG001|Overall Study|Protocol Violation|1|||
130765335|NCT03436199|470764161|FG002|Overall Study|Protocol Violation|0|||
130765336|NCT03436199|470764159|FG000|Overall Study|Physician Decision|0|||
130765337|NCT03436199|470764160|FG001|Overall Study|Physician Decision|1|||
130765338|NCT03436199|470764161|FG002|Overall Study|Physician Decision|0|||
130765339|NCT03436199|470764159|FG000|Overall Study|Could not return to clinic|1|||
130765340|NCT03436199|470764160|FG001|Overall Study|Could not return to clinic|0|||
130765341|NCT03436199|470764161|FG002|Overall Study|Could not return to clinic|0|||
130765342|NCT03436199|470764159|FG000|Overall Study|Withdrawn per physician|0|||
130765343|NCT03436199|470764160|FG001|Overall Study|Withdrawn per physician|1|||
130765344|NCT03436199|470764161|FG002|Overall Study|Withdrawn per physician|0|||
130765345|NCT00085098|470764162|FG000|Overall Study|Withdrawal by Subject|0|||
130765346|NCT00085098|470764163|FG001|Overall Study|Withdrawal by Subject|1|||
130765347|NCT00085098|470764162|FG000|Overall Study|Ineligible|1|||
130765348|NCT00085098|470764163|FG001|Overall Study|Ineligible|1|||
130765349|NCT01886781|470764164|FG000|Overall Study|Protocol Violation|5|||
130765350|NCT01886781|470764165|FG001|Overall Study|Protocol Violation|0|||
130765351|NCT01886781|470764164|FG000|Overall Study|Adverse Event|1|||
130765352|NCT01886781|470764165|FG001|Overall Study|Adverse Event|0|||
130990196|NCT02089230|471591639|FG000|Overall Study|Seeking Alternative Therapy|0|||
130765353|NCT01886781|470764164|FG000|Overall Study|Lost to Follow-up|5|||
130765354|NCT01886781|470764165|FG001|Overall Study|Lost to Follow-up|0|||
130765355|NCT01886781|470764164|FG000|Overall Study|Withdrawal by Subject|2|||
130765356|NCT01886781|470764165|FG001|Overall Study|Withdrawal by Subject|1|||
130765357|NCT01886781|470764164|FG000|Overall Study|Worsening of symptoms|1|||
130765358|NCT01886781|470764165|FG001|Overall Study|Worsening of symptoms|1|||
130765359|NCT00424021|470764166|FG000|NCT00046319 Study Period|Adverse Event|1|||
130765360|NCT00424021|470764167|FG001|NCT00046319 Study Period|Adverse Event|0|||
130990197|NCT02089230|471591640|FG001|Overall Study|Seeking Alternative Therapy|0|||
130990198|NCT02089230|471591641|FG002|Overall Study|Seeking Alternative Therapy|4|||
130990199|NCT02392611|471593109|FG000|Overall Study|Adverse Event|0|||
130990200|NCT02392611|471593110|FG001|Overall Study|Adverse Event|0|||
130990201|NCT02392611|471593111|FG002|Overall Study|Adverse Event|0|||
130990202|NCT02392611|471593112|FG003|Overall Study|Adverse Event|1|||
130990203|NCT02392611|471593113|FG004|Overall Study|Adverse Event|0|||
130990204|NCT02392611|471593114|FG005|Overall Study|Adverse Event|0|||
130990205|NCT02392611|471593115|FG006|Overall Study|Adverse Event|0|||
130990206|NCT02392611|471593116|FG007|Overall Study|Adverse Event|0|||
130990207|NCT02392611|471593117|FG008|Overall Study|Adverse Event|0|||
130990208|NCT02392611|471593109|FG000|Overall Study|Progressive disease|0|||
130990209|NCT02392611|471593110|FG001|Overall Study|Progressive disease|0|||
130990210|NCT02392611|471593111|FG002|Overall Study|Progressive disease|0|||
130990211|NCT02392611|471593112|FG003|Overall Study|Progressive disease|2|||
130990212|NCT02392611|471593113|FG004|Overall Study|Progressive disease|1|||
130990213|NCT02392611|471593114|FG005|Overall Study|Progressive disease|0|||
130990214|NCT02392611|471593115|FG006|Overall Study|Progressive disease|0|||
130990215|NCT02392611|471593116|FG007|Overall Study|Progressive disease|0|||
130990216|NCT02392611|471593117|FG008|Overall Study|Progressive disease|0|||
130990217|NCT02392611|471593109|FG000|Overall Study|Death|1|||
130990218|NCT02392611|471593110|FG001|Overall Study|Death|0|||
130990219|NCT02392611|471593111|FG002|Overall Study|Death|0|||
130990220|NCT02392611|471593112|FG003|Overall Study|Death|0|||
130990221|NCT02392611|471593113|FG004|Overall Study|Death|0|||
130990222|NCT02392611|471593114|FG005|Overall Study|Death|1|||
130990223|NCT02392611|471593115|FG006|Overall Study|Death|0|||
130990224|NCT02392611|471593116|FG007|Overall Study|Death|0|||
130990225|NCT02392611|471593117|FG008|Overall Study|Death|0|||
130990226|NCT02392611|471593109|FG000|Overall Study|Withdrawal by Subject|0|||
130990227|NCT02392611|471593110|FG001|Overall Study|Withdrawal by Subject|0|||
130990228|NCT02392611|471593111|FG002|Overall Study|Withdrawal by Subject|0|||
130990229|NCT02392611|471593112|FG003|Overall Study|Withdrawal by Subject|1|||
130990230|NCT02392611|471593113|FG004|Overall Study|Withdrawal by Subject|0|||
130990231|NCT02392611|471593114|FG005|Overall Study|Withdrawal by Subject|0|||
130990232|NCT02392611|471593115|FG006|Overall Study|Withdrawal by Subject|0|||
130990233|NCT02392611|471593116|FG007|Overall Study|Withdrawal by Subject|0|||
130990234|NCT02392611|471593117|FG008|Overall Study|Withdrawal by Subject|0|||
130990235|NCT02392611|471593109|FG000|Overall Study|Lost to Follow-up|0|||
130990236|NCT02392611|471593110|FG001|Overall Study|Lost to Follow-up|0|||
130990237|NCT02392611|471593111|FG002|Overall Study|Lost to Follow-up|0|||
130990238|NCT02392611|471593112|FG003|Overall Study|Lost to Follow-up|0|||
130990239|NCT02392611|471593113|FG004|Overall Study|Lost to Follow-up|0|||
130990240|NCT02392611|471593114|FG005|Overall Study|Lost to Follow-up|0|||
130990241|NCT02392611|471593115|FG006|Overall Study|Lost to Follow-up|1|||
130990242|NCT02392611|471593116|FG007|Overall Study|Lost to Follow-up|0|||
130990243|NCT02392611|471593117|FG008|Overall Study|Lost to Follow-up|0|||
130990244|NCT02392611|471593109|FG000|Overall Study|Enrolled, not treated|0|||
130990245|NCT02392611|471593110|FG001|Overall Study|Enrolled, not treated|0|||
130990246|NCT02392611|471593111|FG002|Overall Study|Enrolled, not treated|0|||
130990247|NCT02392611|471593112|FG003|Overall Study|Enrolled, not treated|2|||
130990248|NCT02392611|471593113|FG004|Overall Study|Enrolled, not treated|0|||
130990249|NCT02392611|471593114|FG005|Overall Study|Enrolled, not treated|0|||
130990250|NCT02392611|471593115|FG006|Overall Study|Enrolled, not treated|0|||
130990251|NCT02392611|471593116|FG007|Overall Study|Enrolled, not treated|0|||
130990252|NCT02392611|471593117|FG008|Overall Study|Enrolled, not treated|0|||
130990253|NCT00462670|471593126|FG000|Overall Study|Adverse Event|3|||
130765361|NCT00424021|470764168|FG002|NCT00046319 Study Period|Adverse Event|1|||
130765362|NCT00424021|470764169|FG003|NCT00046319 Study Period|Adverse Event|1|||
130990254|NCT00462670|471593127|FG001|Overall Study|Adverse Event|5|||
130990255|NCT00462670|471593126|FG000|Overall Study|Lack of Efficacy|1|||
130990256|NCT00462670|471593127|FG001|Overall Study|Lack of Efficacy|0|||
130990257|NCT00462670|471593126|FG000|Overall Study|Protocol Violation|1|||
130765363|NCT00424021|470764166|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
130765364|NCT00424021|470764167|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
130765365|NCT00424021|470764168|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
130990258|NCT00462670|471593127|FG001|Overall Study|Protocol Violation|0|||
130990259|NCT00462670|471593126|FG000|Overall Study|Resolution of signs and symptoms|0|||
130990260|NCT00462670|471593127|FG001|Overall Study|Resolution of signs and symptoms|2|||
130990261|NCT02110732|471593128|FG000|Overall Study|Physician Decision|5|||
130990262|NCT02110732|471593129|FG001|Overall Study|Physician Decision|2|||
130765366|NCT00424021|470764169|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
130765367|NCT00424021|470764166|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
130765368|NCT00424021|470764167|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
130765369|NCT00424021|470764168|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
130765370|NCT00424021|470764169|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
130765371|NCT00424021|470764166|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
130765372|NCT00424021|470764167|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
130765373|NCT00424021|470764168|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
130990263|NCT02110732|471593128|FG000|Overall Study|Lost to Follow-up|1|||
130990264|NCT02110732|471593129|FG001|Overall Study|Lost to Follow-up|1|||
130990265|NCT00633932|471593130|FG000|Overall Study|Adverse Event|1|||
130990266|NCT00633932|471593131|FG001|Overall Study|Adverse Event|3|||
130990267|NCT00633932|471593132|FG002|Overall Study|Adverse Event|4|||
130765374|NCT00424021|470764169|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
130765375|NCT00424021|470764166|FG000|AMB-220-E Study Period|Adverse Event|1|||
130765376|NCT00424021|470764167|FG001|AMB-220-E Study Period|Adverse Event|1|||
130765377|NCT00424021|470764168|FG002|AMB-220-E Study Period|Adverse Event|3|||
130765378|NCT00424021|470764169|FG003|AMB-220-E Study Period|Adverse Event|7|||
130765379|NCT00424021|470764166|FG000|AMB-220-E Study Period|Death|0|||
130765380|NCT00424021|470764167|FG001|AMB-220-E Study Period|Death|0|||
130765381|NCT00424021|470764168|FG002|AMB-220-E Study Period|Death|1|||
130765382|NCT00424021|470764169|FG003|AMB-220-E Study Period|Death|1|||
130765383|NCT00424021|470764166|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
130765384|NCT00424021|470764167|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
130765385|NCT00424021|470764168|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
130765386|NCT00424021|470764169|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
130765387|NCT00424021|470764166|FG000|AMB-220-E Study Period|Physician Decision|0|||
130765388|NCT00424021|470764167|FG001|AMB-220-E Study Period|Physician Decision|0|||
130765389|NCT00424021|470764168|FG002|AMB-220-E Study Period|Physician Decision|0|||
130765390|NCT00424021|470764169|FG003|AMB-220-E Study Period|Physician Decision|1|||
130765391|NCT03769194|470764170|FG000|Overall Study|Withdrawal by Subject|0|||
130765392|NCT03769194|470764171|FG001|Overall Study|Withdrawal by Subject|7|||
130765393|NCT03769194|470764172|FG002|Overall Study|Withdrawal by Subject|4|||
130765394|NCT03769194|470764173|FG003|Overall Study|Withdrawal by Subject|1|||
130765395|NCT03769194|470764170|FG000|Overall Study|moved from study area|0|||
130765396|NCT03769194|470764171|FG001|Overall Study|moved from study area|2|||
130765397|NCT03769194|470764172|FG002|Overall Study|moved from study area|1|||
130765398|NCT03769194|470764173|FG003|Overall Study|moved from study area|1|||
130765399|NCT03769194|470764170|FG000|Overall Study|Lost to Follow-up|3|||
130765400|NCT03769194|470764171|FG001|Overall Study|Lost to Follow-up|6|||
130765401|NCT03769194|470764172|FG002|Overall Study|Lost to Follow-up|3|||
130765402|NCT03769194|470764173|FG003|Overall Study|Lost to Follow-up|6|||
130765403|NCT03769194|470764170|FG000|Overall Study|other|1|||
130765404|NCT03769194|470764171|FG001|Overall Study|other|3|||
130765405|NCT03769194|470764172|FG002|Overall Study|other|0|||
130765406|NCT03769194|470764173|FG003|Overall Study|other|1|||
130765407|NCT03597022|470764176|FG000|Overall Study|Premature termination of the study|7|||
130765408|NCT03597022|470764177|FG001|Overall Study|Premature termination of the study|7|||
130765409|NCT03597022|470764178|FG002|Overall Study|Premature termination of the study|8|||
130765410|NCT03597022|470764176|FG000|Overall Study|Serious adverse event|1|||
130765411|NCT03597022|470764177|FG001|Overall Study|Serious adverse event|1|||
130765412|NCT03597022|470764178|FG002|Overall Study|Serious adverse event|0|||
130765413|NCT01672294|470764180|FG000|Overall Study|Withdrawal by Subject|4|||
130765414|NCT01672294|470764181|FG001|Overall Study|Withdrawal by Subject|4|||
130765415|NCT01672294|470764182|FG002|Overall Study|Withdrawal by Subject|4|||
130765416|NCT01672294|470764183|FG003|Overall Study|Withdrawal by Subject|4|||
130765417|NCT01672294|470764180|FG000|Overall Study|Excluded by study|1|||
130765418|NCT01672294|470764181|FG001|Overall Study|Excluded by study|1|||
130765419|NCT01672294|470764182|FG002|Overall Study|Excluded by study|0|||
130765420|NCT01672294|470764183|FG003|Overall Study|Excluded by study|0|||
130765421|NCT01672294|470764180|FG000|Overall Study|Lost to Follow-up|1|||
130765422|NCT01672294|470764181|FG001|Overall Study|Lost to Follow-up|16|||
130765423|NCT01672294|470764182|FG002|Overall Study|Lost to Follow-up|7|||
130765424|NCT01672294|470764183|FG003|Overall Study|Lost to Follow-up|9|||
130765425|NCT03887117|470764184|FG000|Overall Study|Discontinued prematurely|0|||
130765426|NCT03887117|470764185|FG001|Overall Study|Discontinued prematurely|1|||
130765427|NCT03887117|470764186|FG002|Overall Study|Discontinued prematurely|1|||
130765428|NCT03887117|470764187|FG003|Overall Study|Discontinued prematurely|2|||
130765429|NCT01739764|470764188|FG000|Overall Study|Adverse Event|0|||
130765430|NCT01739764|470764189|FG001|Overall Study|Adverse Event|3|||
130765431|NCT01739764|470764190|FG002|Overall Study|Adverse Event|4|||
130765432|NCT01739764|470764188|FG000|Overall Study|Death|4|||
130765433|NCT01739764|470764189|FG001|Overall Study|Death|6|||
130765434|NCT01739764|470764190|FG002|Overall Study|Death|38|||
130765435|NCT01739764|470764188|FG000|Overall Study|Lost to Follow-up|0|||
130765436|NCT01739764|470764189|FG001|Overall Study|Lost to Follow-up|0|||
130765437|NCT01739764|470764190|FG002|Overall Study|Lost to Follow-up|5|||
130878442|NCT02234843|471187775|FG004|Overall Study|Withdrawal by Subject|0|||
130878443|NCT02234843|471187776|FG005|Overall Study|Withdrawal by Subject|7|||
130878444|NCT02234843|471187777|FG006|Overall Study|Withdrawal by Subject|0|||
130878445|NCT02234843|471187778|FG007|Overall Study|Withdrawal by Subject|0|||
130878446|NCT02234843|471187779|FG008|Overall Study|Withdrawal by Subject|0|||
130878447|NCT02234843|471187780|FG009|Overall Study|Withdrawal by Subject|0|||
130878448|NCT02234843|471187771|FG000|Overall Study|Recovery|1|||
130878449|NCT02234843|471187772|FG001|Overall Study|Recovery|0|||
130878450|NCT02234843|471187773|FG002|Overall Study|Recovery|0|||
130878451|NCT02234843|471187774|FG003|Overall Study|Recovery|0|||
130878452|NCT02234843|471187775|FG004|Overall Study|Recovery|0|||
130878453|NCT02234843|471187776|FG005|Overall Study|Recovery|0|||
130878454|NCT02234843|471187777|FG006|Overall Study|Recovery|0|||
130878455|NCT02234843|471187778|FG007|Overall Study|Recovery|0|||
130878456|NCT02234843|471187779|FG008|Overall Study|Recovery|0|||
130878457|NCT02234843|471187780|FG009|Overall Study|Recovery|0|||
130878458|NCT02234843|471187771|FG000|Overall Study|Other|0|||
130878459|NCT02234843|471187772|FG001|Overall Study|Other|2|||
130878460|NCT02234843|471187773|FG002|Overall Study|Other|0|||
130878461|NCT02234843|471187774|FG003|Overall Study|Other|1|||
130878462|NCT02234843|471187775|FG004|Overall Study|Other|0|||
130878463|NCT02234843|471187776|FG005|Overall Study|Other|1|||
130878464|NCT02234843|471187777|FG006|Overall Study|Other|0|||
130878465|NCT02234843|471187778|FG007|Overall Study|Other|1|||
130878466|NCT02234843|471187779|FG008|Overall Study|Other|0|||
130878467|NCT02234843|471187780|FG009|Overall Study|Other|0|||
130878468|NCT02234843|471187771|FG000|Overall Study|Physician Decision|4|||
130878469|NCT02234843|471187772|FG001|Overall Study|Physician Decision|1|||
130878470|NCT02234843|471187773|FG002|Overall Study|Physician Decision|0|||
130878471|NCT02234843|471187774|FG003|Overall Study|Physician Decision|1|||
130878472|NCT02234843|471187775|FG004|Overall Study|Physician Decision|0|||
130878473|NCT02234843|471187776|FG005|Overall Study|Physician Decision|0|||
130878474|NCT02234843|471187777|FG006|Overall Study|Physician Decision|0|||
130878475|NCT02234843|471187778|FG007|Overall Study|Physician Decision|1|||
130878476|NCT02234843|471187779|FG008|Overall Study|Physician Decision|0|||
130878477|NCT02234843|471187780|FG009|Overall Study|Physician Decision|0|||
130878478|NCT02234843|471187771|FG000|Overall Study|Adverse Event|5|||
130878479|NCT02234843|471187772|FG001|Overall Study|Adverse Event|1|||
130878480|NCT02234843|471187773|FG002|Overall Study|Adverse Event|1|||
130878481|NCT02234843|471187774|FG003|Overall Study|Adverse Event|3|||
130878482|NCT02234843|471187775|FG004|Overall Study|Adverse Event|2|||
130878483|NCT02234843|471187776|FG005|Overall Study|Adverse Event|1|||
130878484|NCT02234843|471187777|FG006|Overall Study|Adverse Event|0|||
130878485|NCT02234843|471187778|FG007|Overall Study|Adverse Event|0|||
130878486|NCT02234843|471187779|FG008|Overall Study|Adverse Event|1|||
130878487|NCT02234843|471187780|FG009|Overall Study|Adverse Event|0|||
130878488|NCT02234843|471187771|FG000|Overall Study|Non-compliance with study drug|1|||
130878489|NCT02234843|471187772|FG001|Overall Study|Non-compliance with study drug|0|||
130878490|NCT02234843|471187773|FG002|Overall Study|Non-compliance with study drug|0|||
130878491|NCT02234843|471187774|FG003|Overall Study|Non-compliance with study drug|0|||
130878492|NCT02234843|471187775|FG004|Overall Study|Non-compliance with study drug|0|||
130878493|NCT02234843|471187776|FG005|Overall Study|Non-compliance with study drug|1|||
130765438|NCT01739764|470764188|FG000|Overall Study|Non-Compliance|0|||
130765439|NCT01739764|470764189|FG001|Overall Study|Non-Compliance|0|||
130765440|NCT01739764|470764190|FG002|Overall Study|Non-Compliance|1|||
130765441|NCT01739764|470764188|FG000|Overall Study|Multiple Reasons|3|||
130765442|NCT01739764|470764189|FG001|Overall Study|Multiple Reasons|2|||
130765443|NCT01739764|470764190|FG002|Overall Study|Multiple Reasons|3|||
130765444|NCT01739764|470764188|FG000|Overall Study|Physician Decision|2|||
130765445|NCT01739764|470764189|FG001|Overall Study|Physician Decision|2|||
130765446|NCT01739764|470764190|FG002|Overall Study|Physician Decision|4|||
130765447|NCT01739764|470764188|FG000|Overall Study|Progressive Disease|3|||
130765448|NCT01739764|470764189|FG001|Overall Study|Progressive Disease|5|||
130765449|NCT01739764|470764190|FG002|Overall Study|Progressive Disease|16|||
130765450|NCT01739764|470764188|FG000|Overall Study|Protocol Violation|0|||
130765451|NCT01739764|470764189|FG001|Overall Study|Protocol Violation|0|||
130765452|NCT01739764|470764190|FG002|Overall Study|Protocol Violation|2|||
130765453|NCT01739764|470764188|FG000|Overall Study|Study Terminated by Sponsor|8|||
130765454|NCT01739764|470764189|FG001|Overall Study|Study Terminated by Sponsor|13|||
130765455|NCT01739764|470764190|FG002|Overall Study|Study Terminated by Sponsor|26|||
130765456|NCT01739764|470764188|FG000|Overall Study|Withdrawal by Subject|6|||
130765457|NCT01739764|470764189|FG001|Overall Study|Withdrawal by Subject|5|||
130765458|NCT01739764|470764190|FG002|Overall Study|Withdrawal by Subject|27|||
130765459|NCT01389258|470764191|FG000|Overall Study|Lost to Follow-up|5|||
130765460|NCT00926536|470764192|FG000|Overall Study|Physician Decision|1|||
130765461|NCT00926536|470764193|FG001|Overall Study|Physician Decision|2|||
130765462|NCT03013985|470764194|FG000|Overall Study|Protocol Violation|2|||
130878494|NCT02234843|471187777|FG006|Overall Study|Non-compliance with study drug|1|||
130878495|NCT02234843|471187778|FG007|Overall Study|Non-compliance with study drug|0|||
130878496|NCT02234843|471187779|FG008|Overall Study|Non-compliance with study drug|0|||
130765463|NCT03013985|470764195|FG001|Overall Study|Protocol Violation|2|||
130765464|NCT03013985|470764194|FG000|Overall Study|Withdrawal by Subject|14|||
130765465|NCT03013985|470764195|FG001|Overall Study|Withdrawal by Subject|17|||
130765466|NCT01080391|470764196|FG000|Overall Study|Randomized but not treated|7|||
130765467|NCT01080391|470764197|FG001|Overall Study|Randomized but not treated|4|||
130765468|NCT01534208|470764198|FG000|Overall Study|Lost to Follow-up|19|||
130765469|NCT01534208|470764199|FG001|Overall Study|Lost to Follow-up|14|||
130765470|NCT01534208|470764198|FG000|Overall Study|Withdrawal by Subject|6|||
130765471|NCT01534208|470764199|FG001|Overall Study|Withdrawal by Subject|20|||
130765472|NCT01534208|470764198|FG000|Overall Study|Adverse Event|15|||
130765473|NCT01534208|470764199|FG001|Overall Study|Adverse Event|8|||
130765474|NCT01534208|470764198|FG000|Overall Study|Physician Decision|2|||
130765475|NCT01534208|470764199|FG001|Overall Study|Physician Decision|0|||
130765476|NCT01534208|470764198|FG000|Overall Study|Lack of Efficacy|0|||
130765477|NCT01534208|470764199|FG001|Overall Study|Lack of Efficacy|3|||
130765478|NCT01534208|470764198|FG000|Overall Study|Protocol Violation|2|||
130765479|NCT01534208|470764199|FG001|Overall Study|Protocol Violation|2|||
130765480|NCT01534208|470764198|FG000|Overall Study|Sponsor decision|4|||
130765481|NCT01534208|470764199|FG001|Overall Study|Sponsor decision|1|||
130765482|NCT01534208|470764198|FG000|Overall Study|Subject relocation|2|||
130765483|NCT01534208|470764199|FG001|Overall Study|Subject relocation|0|||
130765484|NCT01534208|470764198|FG000|Overall Study|Lab assessment|2|||
130765485|NCT01534208|470764199|FG001|Overall Study|Lab assessment|1|||
130765486|NCT01534208|470764198|FG000|Overall Study|Eligibility error|3|||
130765487|NCT01534208|470764199|FG001|Overall Study|Eligibility error|0|||
130765488|NCT01534208|470764198|FG000|Overall Study|PCP decision|1|||
130765489|NCT01534208|470764199|FG001|Overall Study|PCP decision|0|||
130765490|NCT01534208|470764198|FG000|Overall Study|Needed prohibited meds|1|||
130765491|NCT01534208|470764199|FG001|Overall Study|Needed prohibited meds|0|||
130765492|NCT01904903|470764200|FG000|Overall Study|Withdrawal by Subject|1|||
130765493|NCT01260584|470764201|FG000|Period 1|Protocol Violation|0|||
130765494|NCT01260584|470764202|FG001|Period 1|Protocol Violation|0|||
130765495|NCT01260584|470764203|FG002|Period 1|Protocol Violation|1|||
130765496|NCT01260584|470764204|FG003|Period 1|Protocol Violation|1|||
130765497|NCT01260584|470764201|FG000|Period 1|Adverse Event|0|||
130765498|NCT01260584|470764202|FG001|Period 1|Adverse Event|0|||
130765499|NCT01260584|470764203|FG002|Period 1|Adverse Event|1|||
130765500|NCT01260584|470764204|FG003|Period 1|Adverse Event|0|||
130765501|NCT01260584|470764201|FG000|Period 2|Protocol Violation|0|||
130765502|NCT01260584|470764202|FG001|Period 2|Protocol Violation|2|||
130765503|NCT01260584|470764203|FG002|Period 2|Protocol Violation|3|||
130765504|NCT01260584|470764204|FG003|Period 2|Protocol Violation|1|||
130765505|NCT01260584|470764201|FG000|Period 2|Adverse Event|1|||
130765506|NCT01260584|470764202|FG001|Period 2|Adverse Event|0|||
130765507|NCT01260584|470764203|FG002|Period 2|Adverse Event|2|||
130765508|NCT01260584|470764204|FG003|Period 2|Adverse Event|0|||
130765509|NCT01260584|470764201|FG000|Period 2|Withdrawal by Subject|0|||
130765510|NCT01260584|470764202|FG001|Period 2|Withdrawal by Subject|1|||
130765511|NCT01260584|470764203|FG002|Period 2|Withdrawal by Subject|0|||
130765512|NCT01260584|470764204|FG003|Period 2|Withdrawal by Subject|0|||
130765513|NCT00045734|470764205|FG000|Overall Study|Protocol Violation|1|||
130765514|NCT00586508|470764210|FG000|Overall Study|Progressive disease|52|||
130765515|NCT00586508|470764211|FG001|Overall Study|Progressive disease|8|||
130765516|NCT00586508|470764210|FG000|Overall Study|Death|0|||
130765517|NCT00586508|470764211|FG001|Overall Study|Death|1|||
130765518|NCT00586508|470764210|FG000|Overall Study|Adverse Event|12|||
130765519|NCT00586508|470764211|FG001|Overall Study|Adverse Event|4|||
130765520|NCT00586508|470764210|FG000|Overall Study|Withdrawal by Subject|4|||
130765521|NCT00586508|470764211|FG001|Overall Study|Withdrawal by Subject|0|||
130765522|NCT00561470|470764212|FG000|Overall Study|Adverse Event|74|||
130765523|NCT00561470|470764213|FG001|Overall Study|Adverse Event|163|||
130765524|NCT00561470|470764212|FG000|Overall Study|Disease progression|437|||
130765525|NCT00561470|470764213|FG001|Overall Study|Disease progression|305|||
130765526|NCT00561470|470764212|FG000|Overall Study|poor compliance to protocol|4|||
130765527|NCT00561470|470764213|FG001|Overall Study|poor compliance to protocol|4|||
130765528|NCT00561470|470764212|FG000|Overall Study|Lost to Follow-up|2|||
130765529|NCT00561470|470764213|FG001|Overall Study|Lost to Follow-up|0|||
130765530|NCT00561470|470764212|FG000|Overall Study|Physician Decision|21|||
130765531|NCT00561470|470764213|FG001|Overall Study|Physician Decision|20|||
130765532|NCT00561470|470764212|FG000|Overall Study|Consent Withdrawn|2|||
130765533|NCT00561470|470764213|FG001|Overall Study|Consent Withdrawn|6|||
130765534|NCT00561470|470764212|FG000|Overall Study|Subject request|43|||
130765535|NCT00561470|470764213|FG001|Overall Study|Subject request|77|||
130765536|NCT00561470|470764212|FG000|Overall Study|Metastatic surgery|10|||
130765537|NCT00561470|470764213|FG001|Overall Study|Metastatic surgery|12|||
130765538|NCT00561470|470764212|FG000|Overall Study|Unauthorized procedure|3|||
130765539|NCT00561470|470764213|FG001|Overall Study|Unauthorized procedure|1|||
130765540|NCT00561470|470764212|FG000|Overall Study|Randomized but not treated|5|||
130765541|NCT00561470|470764213|FG001|Overall Study|Randomized but not treated|5|||
130765542|NCT00561470|470764212|FG000|Overall Study|Missed visit window|1|||
130765543|NCT00561470|470764213|FG001|Overall Study|Missed visit window|4|||
130765544|NCT00561470|470764212|FG000|Overall Study|Planning surgery|1|||
130765545|NCT00561470|470764213|FG001|Overall Study|Planning surgery|1|||
130765546|NCT00561470|470764212|FG000|Overall Study|Ongoing Treatment|11|||
130765547|NCT00561470|470764213|FG001|Overall Study|Ongoing Treatment|14|||
130765548|NCT03434249|470764214|FG000|Overall Study|Adverse Event|1|||
130765549|NCT03434249|470764215|FG001|Overall Study|Adverse Event|0|||
130765550|NCT03434249|470764214|FG000|Overall Study|Lost to Follow-up|0|||
130765551|NCT03434249|470764215|FG001|Overall Study|Lost to Follow-up|1|||
130765552|NCT03434249|470764214|FG000|Overall Study|Non-compliance of family|2|||
130765553|NCT03434249|470764215|FG001|Overall Study|Non-compliance of family|1|||
130765554|NCT03434249|470764214|FG000|Overall Study|Difficulties in completing daily diary|2|||
130765555|NCT03434249|470764215|FG001|Overall Study|Difficulties in completing daily diary|1|||
130765556|NCT02918552|470764216|FG000|Overall Study|Failed Pharmacokinetics|1|||
130765557|NCT02918552|470764217|FG001|Overall Study|Failed Pharmacokinetics|0|||
130765558|NCT02918552|470764216|FG000|Overall Study|Withdrawal by Subject|0|||
130765559|NCT02918552|470764217|FG001|Overall Study|Withdrawal by Subject|1|||
130765560|NCT02918552|470764216|FG000|Overall Study|Lost to Follow-up|0|||
130765561|NCT02918552|470764217|FG001|Overall Study|Lost to Follow-up|1|||
130765562|NCT04395274|470764218|FG000|Overall Study|Lost to Follow-up|20|||
130765563|NCT04395274|470764219|FG001|Overall Study|Lost to Follow-up|11|||
130765564|NCT04395274|470764218|FG000|Overall Study|Withdrawal by Subject|13|||
130765565|NCT04395274|470764219|FG001|Overall Study|Withdrawal by Subject|10|||
130765566|NCT04395274|470764218|FG000|Overall Study|Moved Abroad|0|||
130765567|NCT04395274|470764219|FG001|Overall Study|Moved Abroad|1|||
130765568|NCT03325894|470764220|FG000|Overall Study|Adverse Event|2|||
130765569|NCT03325894|470764221|FG001|Overall Study|Adverse Event|3|||
130765570|NCT03325894|470764220|FG000|Overall Study|Protocol Violation|1|||
130765571|NCT03325894|470764221|FG001|Overall Study|Protocol Violation|2|||
130765572|NCT03325894|470764220|FG000|Overall Study|Withdrawal by Subject|10|||
130765573|NCT03325894|470764221|FG001|Overall Study|Withdrawal by Subject|6|||
130765574|NCT03325894|470764220|FG000|Overall Study|Lost to Follow-up|4|||
130765575|NCT03325894|470764221|FG001|Overall Study|Lost to Follow-up|9|||
130765576|NCT03325894|470764220|FG000|Overall Study|Lack of Efficacy|8|||
130765577|NCT03325894|470764221|FG001|Overall Study|Lack of Efficacy|14|||
130765578|NCT03325894|470764220|FG000|Overall Study|Study Terminated by Sponsor|38|||
130765579|NCT03325894|470764221|FG001|Overall Study|Study Terminated by Sponsor|43|||
130765580|NCT03325894|470764220|FG000|Overall Study|Other (Not received Treatment)|1|||
130765581|NCT03325894|470764221|FG001|Overall Study|Other (Not received Treatment)|0|||
130765582|NCT01001598|470764225|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
130765583|NCT01001598|470764225|FG000|Overall Study|Adverse Event|1|||
130765584|NCT02920177|470764236|FG000|Overall Study|Withdrawal by Subject|1|||
130765585|NCT02920177|470764237|FG001|Overall Study|Withdrawal by Subject|1|||
130765586|NCT02920177|470764236|FG000|Overall Study|Physician Decision|1|||
130765587|NCT02920177|470764237|FG001|Overall Study|Physician Decision|0|||
130765588|NCT02920177|470764236|FG000|Overall Study|Lost to Follow-up|0|||
130765589|NCT02920177|470764237|FG001|Overall Study|Lost to Follow-up|1|||
130765590|NCT02054910|470764238|FG000|Overall Study|Lost to Follow-up|4|||
130765591|NCT02054910|470764239|FG001|Overall Study|Lost to Follow-up|1|||
130765592|NCT01096589|470764241|FG000|Overall Study|Adverse Event|2|||
130765593|NCT01096589|470764242|FG001|Overall Study|Adverse Event|1|||
130765594|NCT01096589|470764243|FG002|Overall Study|Adverse Event|2|||
130765595|NCT01096589|470764244|FG003|Overall Study|Adverse Event|1|||
130765596|NCT01096589|470764241|FG000|Overall Study|Withdrawal by Subject|2|||
130765597|NCT01096589|470764242|FG001|Overall Study|Withdrawal by Subject|1|||
130765598|NCT01096589|470764243|FG002|Overall Study|Withdrawal by Subject|1|||
130765599|NCT01096589|470764244|FG003|Overall Study|Withdrawal by Subject|1|||
130765600|NCT01096589|470764241|FG000|Overall Study|Compliance with protocol|0|||
130990268|NCT00633932|471593130|FG000|Overall Study|Withdrawal by Subject|3|||
130990269|NCT00633932|471593131|FG001|Overall Study|Withdrawal by Subject|9|||
130765601|NCT01096589|470764242|FG001|Overall Study|Compliance with protocol|0|||
130765602|NCT01096589|470764243|FG002|Overall Study|Compliance with protocol|1|||
130765603|NCT01096589|470764244|FG003|Overall Study|Compliance with protocol|0|||
130765604|NCT01096589|470764241|FG000|Overall Study|found treatment exhausting|0|||
130765605|NCT01096589|470764242|FG001|Overall Study|found treatment exhausting|0|||
130765606|NCT01096589|470764243|FG002|Overall Study|found treatment exhausting|0|||
130765607|NCT01096589|470764244|FG003|Overall Study|found treatment exhausting|1|||
130765608|NCT03673345|470764245|FG000|Overall Study|Lost to Follow-up|1|||
130765609|NCT03673345|470764246|FG001|Overall Study|Lost to Follow-up|0|||
130765610|NCT03673345|470764247|FG002|Overall Study|Lost to Follow-up|3|||
130990270|NCT00633932|471593132|FG002|Overall Study|Withdrawal by Subject|1|||
130765611|NCT03673345|470764248|FG003|Overall Study|Lost to Follow-up|3|||
130765612|NCT03673345|470764249|FG004|Overall Study|Lost to Follow-up|2|||
130765613|NCT03673345|470764250|FG005|Overall Study|Lost to Follow-up|1|||
130765614|NCT03673345|470764251|FG006|Overall Study|Lost to Follow-up|0|||
130765615|NCT03673345|470764252|FG007|Overall Study|Lost to Follow-up|0|||
130765616|NCT03673345|470764245|FG000|Overall Study|Withdrawal by Subject|1|||
130765617|NCT03673345|470764246|FG001|Overall Study|Withdrawal by Subject|0|||
130765618|NCT03673345|470764247|FG002|Overall Study|Withdrawal by Subject|4|||
130765619|NCT03673345|470764248|FG003|Overall Study|Withdrawal by Subject|2|||
130765620|NCT03673345|470764249|FG004|Overall Study|Withdrawal by Subject|0|||
130765621|NCT03673345|470764250|FG005|Overall Study|Withdrawal by Subject|0|||
130765622|NCT03673345|470764251|FG006|Overall Study|Withdrawal by Subject|0|||
130765623|NCT03673345|470764252|FG007|Overall Study|Withdrawal by Subject|0|||
130765624|NCT03673345|470764245|FG000|Overall Study|Physician Decision|0|||
130765625|NCT03673345|470764246|FG001|Overall Study|Physician Decision|0|||
130765626|NCT03673345|470764247|FG002|Overall Study|Physician Decision|2|||
130765627|NCT03673345|470764248|FG003|Overall Study|Physician Decision|0|||
130878497|NCT02234843|471187780|FG009|Overall Study|Non-compliance with study drug|0|||
130878498|NCT02234843|471187771|FG000|Overall Study|Lost to Follow-up|0|||
130878499|NCT02234843|471187772|FG001|Overall Study|Lost to Follow-up|1|||
130878500|NCT02234843|471187773|FG002|Overall Study|Lost to Follow-up|0|||
130878501|NCT02234843|471187774|FG003|Overall Study|Lost to Follow-up|0|||
130878502|NCT02234843|471187775|FG004|Overall Study|Lost to Follow-up|0|||
130878503|NCT02234843|471187776|FG005|Overall Study|Lost to Follow-up|0|||
130878504|NCT02234843|471187777|FG006|Overall Study|Lost to Follow-up|1|||
130878505|NCT02234843|471187778|FG007|Overall Study|Lost to Follow-up|0|||
130878506|NCT02234843|471187779|FG008|Overall Study|Lost to Follow-up|0|||
130878507|NCT02234843|471187780|FG009|Overall Study|Lost to Follow-up|0|||
130878508|NCT01607957|471187783|FG000|Overall Study|Not treated|1|||
130878509|NCT01607957|471187784|FG001|Overall Study|Not treated|1|||
130878510|NCT01607957|471187783|FG000|Overall Study|Death|367|||
130878511|NCT01607957|471187784|FG001|Overall Study|Death|211|||
130878512|NCT01607957|471187783|FG000|Overall Study|Lost to Follow-up|3|||
130878513|NCT01607957|471187784|FG001|Overall Study|Lost to Follow-up|3|||
130878514|NCT01607957|471187783|FG000|Overall Study|Participant refusal|1|||
130878515|NCT01607957|471187784|FG001|Overall Study|Participant refusal|0|||
130878516|NCT00945009|471187791|FG000|Overall Study|Lack of Efficacy|10|||
130878517|NCT00945009|471187792|FG001|Overall Study|Lack of Efficacy|0|||
130878518|NCT00945009|471187793|FG002|Overall Study|Lack of Efficacy|0|||
130878519|NCT00945009|471187791|FG000|Overall Study|Physician Decision|21|||
130878520|NCT00945009|471187792|FG001|Overall Study|Physician Decision|4|||
130878521|NCT00945009|471187793|FG002|Overall Study|Physician Decision|3|||
130878522|NCT00945009|471187791|FG000|Overall Study|Protocol Violation|6|||
130878523|NCT00945009|471187792|FG001|Overall Study|Protocol Violation|1|||
130878524|NCT00945009|471187793|FG002|Overall Study|Protocol Violation|0|||
130878525|NCT00945009|471187791|FG000|Overall Study|Withdrawal by Subject|1|||
130878526|NCT00945009|471187792|FG001|Overall Study|Withdrawal by Subject|0|||
130878527|NCT00945009|471187793|FG002|Overall Study|Withdrawal by Subject|0|||
130878528|NCT00945009|471187791|FG000|Overall Study|Ineligible|6|||
130878529|NCT00945009|471187792|FG001|Overall Study|Ineligible|1|||
130878530|NCT00945009|471187793|FG002|Overall Study|Ineligible|0|||
130878531|NCT00945009|471187791|FG000|Overall Study|Inevaluable|0|||
130878532|NCT00945009|471187792|FG001|Overall Study|Inevaluable|1|||
130878533|NCT00945009|471187793|FG002|Overall Study|Inevaluable|0|||
130878534|NCT00945009|471187791|FG000|Overall Study|Refusal of further protocol|1|||
130878535|NCT00945009|471187792|FG001|Overall Study|Refusal of further protocol|0|||
130878536|NCT00945009|471187793|FG002|Overall Study|Refusal of further protocol|0|||
130878537|NCT03919773|471187794|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
130878538|NCT03919773|471187795|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
130878539|NCT03919773|471187794|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
130878540|NCT03919773|471187795|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
130878541|NCT04659044|471187796|FG000|Induction|Physician Decision|1|||
130878542|NCT04659044|471187796|FG000|Induction|Adverse Event|2|||
130878543|NCT03589859|471187797|FG000|Overall Study|Withdrawal by Subject|0|||
130878544|NCT03589859|471187798|FG001|Overall Study|Withdrawal by Subject|6|||
130878545|NCT04966013|471187799|FG000|Overall Study|Withdrawal by Subject|0|||
130878546|NCT04966013|471187800|FG001|Overall Study|Withdrawal by Subject|2|||
130878547|NCT04966013|471187801|FG002|Overall Study|Withdrawal by Subject|1|||
130878548|NCT04966013|471187799|FG000|Overall Study|Adverse Event|2|||
130878549|NCT04966013|471187800|FG001|Overall Study|Adverse Event|1|||
130878550|NCT04966013|471187801|FG002|Overall Study|Adverse Event|1|||
130878551|NCT03518086|471187805|FG000|Overall Study|Adverse Event|23|||
130878552|NCT03518086|471187806|FG001|Overall Study|Adverse Event|15|||
130878553|NCT03518086|471187807|FG002|Overall Study|Adverse Event|3|||
130878554|NCT03518086|471187808|FG003|Overall Study|Adverse Event|2|||
130878555|NCT03518086|471187805|FG000|Overall Study|Withdrawal by Subject|8|||
130878556|NCT03518086|471187806|FG001|Overall Study|Withdrawal by Subject|5|||
130878557|NCT03518086|471187807|FG002|Overall Study|Withdrawal by Subject|1|||
130878558|NCT03518086|471187808|FG003|Overall Study|Withdrawal by Subject|0|||
130878559|NCT03518086|471187805|FG000|Overall Study|Lack of Efficacy|5|||
130878560|NCT03518086|471187806|FG001|Overall Study|Lack of Efficacy|5|||
130878561|NCT03518086|471187807|FG002|Overall Study|Lack of Efficacy|0|||
130878562|NCT03518086|471187808|FG003|Overall Study|Lack of Efficacy|2|||
130878563|NCT03518086|471187805|FG000|Overall Study|Protocol Violation|1|||
130878564|NCT03518086|471187806|FG001|Overall Study|Protocol Violation|5|||
130878565|NCT03518086|471187807|FG002|Overall Study|Protocol Violation|1|||
130878566|NCT03518086|471187808|FG003|Overall Study|Protocol Violation|3|||
130878567|NCT03518086|471187805|FG000|Overall Study|Lost to Follow-up|0|||
130878568|NCT03518086|471187806|FG001|Overall Study|Lost to Follow-up|3|||
130878569|NCT03518086|471187807|FG002|Overall Study|Lost to Follow-up|0|||
130878570|NCT03518086|471187808|FG003|Overall Study|Lost to Follow-up|0|||
130878571|NCT03518086|471187805|FG000|Overall Study|Insufficient Diary Data|0|||
130878572|NCT03518086|471187806|FG001|Overall Study|Insufficient Diary Data|2|||
130878573|NCT03518086|471187807|FG002|Overall Study|Insufficient Diary Data|0|||
130878574|NCT03518086|471187808|FG003|Overall Study|Insufficient Diary Data|0|||
130878575|NCT03518086|471187805|FG000|Overall Study|Non- compliance to Protocol|0|||
130878576|NCT03518086|471187806|FG001|Overall Study|Non- compliance to Protocol|1|||
130878577|NCT03518086|471187807|FG002|Overall Study|Non- compliance to Protocol|0|||
130878578|NCT03518086|471187808|FG003|Overall Study|Non- compliance to Protocol|0|||
130878579|NCT03518086|471187805|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
130878580|NCT03518086|471187806|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
130878581|NCT03518086|471187807|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
130878582|NCT03518086|471187808|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
130878583|NCT03518086|471187805|FG000|Overall Study|Site Terminated by Sponsor|0|||
130878584|NCT03518086|471187806|FG001|Overall Study|Site Terminated by Sponsor|1|||
130878585|NCT03518086|471187807|FG002|Overall Study|Site Terminated by Sponsor|0|||
130878586|NCT03518086|471187808|FG003|Overall Study|Site Terminated by Sponsor|0|||
130878587|NCT03518086|471187805|FG000|Overall Study|Pregnancy|0|||
130878588|NCT03518086|471187806|FG001|Overall Study|Pregnancy|0|||
130878589|NCT03518086|471187807|FG002|Overall Study|Pregnancy|0|||
130878590|NCT03518086|471187808|FG003|Overall Study|Pregnancy|2|||
130878591|NCT05967260|471187809|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
130878592|NCT05967260|471187810|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
130878593|NCT02994108|471189475|FG000|Intervention Messages|Withdrawal by Subject|2|||
130878594|NCT02994108|471189476|FG001|Intervention Messages|Withdrawal by Subject|0|||
130878595|NCT02994108|471189475|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
130878596|NCT02994108|471189476|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
130878597|NCT02994108|471189475|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
130878598|NCT02994108|471189476|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
130878599|NCT02994108|471189475|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
130878600|NCT02994108|471189476|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
130878601|NCT02081677|471189477|FG000|Overall Study|Adverse Event|0|||
130878602|NCT02081677|471189478|FG001|Overall Study|Adverse Event|0|||
130878603|NCT02081677|471189479|FG002|Overall Study|Adverse Event|1|||
130878604|NCT02081677|471189480|FG003|Overall Study|Adverse Event|0|||
130878605|NCT02081677|471189477|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130878606|NCT02081677|471189478|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130878607|NCT02081677|471189479|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
130878608|NCT02081677|471189480|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130878609|NCT02081677|471189477|FG000|Overall Study|Not comfortable with lens care system|1|||
130878610|NCT02081677|471189478|FG001|Overall Study|Not comfortable with lens care system|0|||
130878611|NCT02081677|471189479|FG002|Overall Study|Not comfortable with lens care system|0|||
130878612|NCT02081677|471189480|FG003|Overall Study|Not comfortable with lens care system|0|||
130878613|NCT02081677|471189477|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
130878614|NCT02081677|471189478|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
130878615|NCT02081677|471189479|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
130878616|NCT02081677|471189480|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
130878617|NCT01097668|471189481|FG000|Overall Study|Withdrawal by Subject|1|||
130878618|NCT01097668|471189482|FG001|Overall Study|Withdrawal by Subject|2|||
130878619|NCT01097668|471189481|FG000|Overall Study|Lost to Follow-up|1|||
130878620|NCT01097668|471189482|FG001|Overall Study|Lost to Follow-up|0|||
130878621|NCT04607668|471189487|FG000|Overall Study|Death|49|||
130878622|NCT04607668|471189488|FG001|Overall Study|Death|26|||
130878623|NCT04607668|471189487|FG000|Overall Study|Lost to Follow-up|3|||
130878624|NCT04607668|471189488|FG001|Overall Study|Lost to Follow-up|4|||
130878625|NCT04607668|471189487|FG000|Overall Study|Study terminated by Sponsor|92|||
130878626|NCT04607668|471189488|FG001|Overall Study|Study terminated by Sponsor|114|||
130878627|NCT04607668|471189487|FG000|Overall Study|Withdrawal by Subject|12|||
130878628|NCT04607668|471189488|FG001|Overall Study|Withdrawal by Subject|11|||
130878629|NCT04607668|471189487|FG000|Overall Study|Other, unspecified|8|||
130878630|NCT04607668|471189488|FG001|Overall Study|Other, unspecified|7|||
130878631|NCT00474487|471189489|FG000|Overall Study|Withdrawal by Subject|6|||
130878632|NCT00474487|471189490|FG001|Overall Study|Withdrawal by Subject|0|||
130878633|NCT00474487|471189491|FG002|Overall Study|Withdrawal by Subject|0|||
130878634|NCT00474487|471189492|FG003|Overall Study|Withdrawal by Subject|0|||
130878635|NCT00474487|471189489|FG000|Overall Study|Lost to Follow-up|20|||
130878636|NCT00474487|471189490|FG001|Overall Study|Lost to Follow-up|1|||
130878637|NCT00474487|471189491|FG002|Overall Study|Lost to Follow-up|7|||
130878638|NCT00474487|471189492|FG003|Overall Study|Lost to Follow-up|0|||
130878639|NCT00474487|471189489|FG000|Overall Study|Inappropriate enrollment|4|||
130878640|NCT00474487|471189490|FG001|Overall Study|Inappropriate enrollment|0|||
130878641|NCT00474487|471189491|FG002|Overall Study|Inappropriate enrollment|7|||
130878642|NCT00474487|471189492|FG003|Overall Study|Inappropriate enrollment|0|||
130878643|NCT00474487|471189489|FG000|Overall Study|Death|0|||
130878644|NCT00474487|471189490|FG001|Overall Study|Death|1|||
130878645|NCT00474487|471189491|FG002|Overall Study|Death|0|||
130878646|NCT00474487|471189492|FG003|Overall Study|Death|0|||
130878647|NCT01428258|471189493|FG000|Intervention 1|Withdrawal by Subject|2|||
130878648|NCT01428258|471189494|FG001|Intervention 1|Withdrawal by Subject|0|||
130878649|NCT00616759|471189495|FG000|Overall Study|Physician Decision|2|||
130878650|NCT00616759|471189496|FG001|Overall Study|Physician Decision|0|||
130878651|NCT00616759|471189495|FG000|Overall Study|Withdrawal by Subject|1|||
130878652|NCT00616759|471189496|FG001|Overall Study|Withdrawal by Subject|2|||
130878653|NCT00726063|471189500|FG000|Overall Study|Adverse Event|9|||
130878654|NCT00726063|471189501|FG001|Overall Study|Adverse Event|7|||
130878655|NCT02007096|471189502|FG000|Overall Study|medication not available|2|||
130878656|NCT02007096|471189503|FG001|Overall Study|medication not available|0|||
130878657|NCT02007096|471189502|FG000|Overall Study|did not inject saline|0|||
130878658|NCT02007096|471189503|FG001|Overall Study|did not inject saline|3|||
130878659|NCT02007096|471189502|FG000|Overall Study|did not follow postoperative protocol|8|||
130878660|NCT02007096|471189503|FG001|Overall Study|did not follow postoperative protocol|11|||
130878661|NCT02007096|471189502|FG000|Overall Study|converted to open surgery|1|||
130878662|NCT02007096|471189503|FG001|Overall Study|converted to open surgery|1|||
130878663|NCT02007096|471189502|FG000|Overall Study|no mesh placed|0|||
130878664|NCT02007096|471189503|FG001|Overall Study|no mesh placed|1|||
130878665|NCT05176314|471189505|FG000|Overall Study|Lost to Follow-up|2|||
130878666|NCT05176314|471189505|FG000|Overall Study|Physician Decision|1|||
130878667|NCT05176314|471189505|FG000|Overall Study|Adverse Event|1|||
130878668|NCT01231984|471189506|FG000|Study Period 1|Withdrawal by Subject|0|||
130878669|NCT01231984|471189507|FG001|Study Period 1|Withdrawal by Subject|0|||
130878670|NCT01231984|471189508|FG002|Study Period 1|Withdrawal by Subject|0|||
130878671|NCT01231984|471189509|FG003|Study Period 1|Withdrawal by Subject|1|||
130878672|NCT01231984|471189506|FG000|Study Period 1|Lost to Follow-up|1|||
130878673|NCT01231984|471189507|FG001|Study Period 1|Lost to Follow-up|1|||
130878674|NCT01231984|471189508|FG002|Study Period 1|Lost to Follow-up|1|||
130878675|NCT01231984|471189509|FG003|Study Period 1|Lost to Follow-up|0|||
130878676|NCT01231984|471189506|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
130878677|NCT01231984|471189507|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
130878678|NCT01231984|471189508|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
130878679|NCT01231984|471189509|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
130878680|NCT01231984|471189506|FG000|Study Period 1|Screen Failure|0|||
130878681|NCT01231984|471189507|FG001|Study Period 1|Screen Failure|0|||
130878682|NCT01231984|471189508|FG002|Study Period 1|Screen Failure|0|||
130878683|NCT01231984|471189509|FG003|Study Period 1|Screen Failure|1|||
130878684|NCT01231984|471189506|FG000|Study Period 1|Non-compliance with study requirements|5|||
130878685|NCT01231984|471189507|FG001|Study Period 1|Non-compliance with study requirements|0|||
130878686|NCT01231984|471189508|FG002|Study Period 1|Non-compliance with study requirements|2|||
130878687|NCT01231984|471189509|FG003|Study Period 1|Non-compliance with study requirements|1|||
130878688|NCT01231984|471189506|FG000|Study Period 1|Protocol Violation|3|||
130878689|NCT01231984|471189507|FG001|Study Period 1|Protocol Violation|4|||
130878690|NCT01231984|471189508|FG002|Study Period 1|Protocol Violation|2|||
130878691|NCT01231984|471189509|FG003|Study Period 1|Protocol Violation|3|||
130878692|NCT01231984|471189506|FG000|Study Period 1|Adverse Event|1|||
130878693|NCT01231984|471189507|FG001|Study Period 1|Adverse Event|0|||
130878694|NCT01231984|471189508|FG002|Study Period 1|Adverse Event|0|||
130878695|NCT01231984|471189509|FG003|Study Period 1|Adverse Event|0|||
130878696|NCT01231984|471189506|FG000|Study Period 1|Other|0|||
130878697|NCT01231984|471189507|FG001|Study Period 1|Other|0|||
130878698|NCT01231984|471189508|FG002|Study Period 1|Other|0|||
130878699|NCT01231984|471189509|FG003|Study Period 1|Other|1|||
130878700|NCT01231984|471189506|FG000|Study Period 2|Withdrawal by Subject|1|||
130878701|NCT01231984|471189507|FG001|Study Period 2|Withdrawal by Subject|1|||
130878702|NCT01231984|471189508|FG002|Study Period 2|Withdrawal by Subject|0|||
130878703|NCT01231984|471189509|FG003|Study Period 2|Withdrawal by Subject|0|||
130878704|NCT01231984|471189506|FG000|Study Period 2|Lost to Follow-up|1|||
130878705|NCT01231984|471189507|FG001|Study Period 2|Lost to Follow-up|0|||
130878706|NCT01231984|471189508|FG002|Study Period 2|Lost to Follow-up|0|||
130878707|NCT01231984|471189509|FG003|Study Period 2|Lost to Follow-up|3|||
130990271|NCT00633932|471593130|FG000|Overall Study|Lost to Follow-up|1|||
130990272|NCT00633932|471593131|FG001|Overall Study|Lost to Follow-up|0|||
130990273|NCT00633932|471593132|FG002|Overall Study|Lost to Follow-up|2|||
130990274|NCT00633932|471593130|FG000|Overall Study|Protocol Violation|5|||
130878708|NCT01231984|471189506|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
130878709|NCT01231984|471189507|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
130878710|NCT01231984|471189508|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
130878711|NCT01231984|471189509|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
130990275|NCT00633932|471593131|FG001|Overall Study|Protocol Violation|2|||
130878712|NCT02766023|471189512|FG000|Overall Study|Lost to Follow-up|23|||
130990276|NCT00633932|471593132|FG002|Overall Study|Protocol Violation|3|||
130990277|NCT00633932|471593130|FG000|Overall Study|Physician Decision|0|||
130990278|NCT00633932|471593131|FG001|Overall Study|Physician Decision|0|||
130765628|NCT03673345|470764249|FG004|Overall Study|Physician Decision|0|||
130765629|NCT03673345|470764250|FG005|Overall Study|Physician Decision|0|||
130765630|NCT03673345|470764251|FG006|Overall Study|Physician Decision|0|||
130765631|NCT03673345|470764252|FG007|Overall Study|Physician Decision|0|||
130765632|NCT01362244|470764253|FG000|Overall Study|Adverse Event|3|||
130765633|NCT01362244|470764254|FG001|Overall Study|Adverse Event|5|||
130765634|NCT01362244|470764253|FG000|Overall Study|Lack of Efficacy|5|||
130765635|NCT01362244|470764254|FG001|Overall Study|Lack of Efficacy|11|||
130765636|NCT01362244|470764253|FG000|Overall Study|Lost to Follow-up|0|||
130765637|NCT01362244|470764254|FG001|Overall Study|Lost to Follow-up|2|||
130765638|NCT01362244|470764253|FG000|Overall Study|Protocol Violation|5|||
130765639|NCT01362244|470764254|FG001|Overall Study|Protocol Violation|1|||
130765640|NCT01362244|470764253|FG000|Overall Study|Withdrawal by Subject|2|||
130765641|NCT01362244|470764254|FG001|Overall Study|Withdrawal by Subject|1|||
130765642|NCT01362244|470764253|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
130765643|NCT01362244|470764254|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
130765644|NCT01362244|470764253|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
130765645|NCT01362244|470764254|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
130765646|NCT02093390|470764255|FG000|Overall Study|Withdrawal by Subject|0|||
130765647|NCT02093390|470764256|FG001|Overall Study|Withdrawal by Subject|1|||
130765648|NCT01709864|470765769|FG000|Overall Study|Physician Decision|0|||
130765649|NCT01709864|470765770|FG001|Overall Study|Physician Decision|1|||
130765650|NCT01709864|470765769|FG000|Overall Study|subject/guardian decision|5|||
130765651|NCT01709864|470765770|FG001|Overall Study|subject/guardian decision|6|||
130765652|NCT01709864|470765769|FG000|Overall Study|Lost to Follow-up|1|||
130765653|NCT01709864|470765770|FG001|Overall Study|Lost to Follow-up|0|||
130765654|NCT01709864|470765769|FG000|Overall Study|non-compliance with study treatment|1|||
130765655|NCT01709864|470765770|FG001|Overall Study|non-compliance with study treatment|1|||
130765656|NCT01709864|470765769|FG000|Overall Study|Adverse Event|0|||
130765657|NCT01709864|470765770|FG001|Overall Study|Adverse Event|2|||
130765658|NCT01709864|470765769|FG000|Overall Study|Death|0|||
130765659|NCT01709864|470765770|FG001|Overall Study|Death|1|||
130765660|NCT02661061|470765773|FG000|Overall Study|Lack of Efficacy|1|||
130765661|NCT02661061|470765774|FG001|Overall Study|Lack of Efficacy|1|||
130765662|NCT02661061|470765773|FG000|Overall Study|Withdrawal by Subject|1|||
130765663|NCT02661061|470765774|FG001|Overall Study|Withdrawal by Subject|1|||
130765664|NCT01492101|470765777|FG000|Overall Study|Death|323|||
130765665|NCT01492101|470765778|FG001|Overall Study|Death|322|||
130765666|NCT01492101|470765777|FG000|Overall Study|Withdrawal by Subject|14|||
130765667|NCT01492101|470765778|FG001|Overall Study|Withdrawal by Subject|18|||
130765668|NCT01492101|470765777|FG000|Overall Study|Lost to Follow-up|0|||
130765669|NCT01492101|470765778|FG001|Overall Study|Lost to Follow-up|2|||
130765670|NCT02696434|470765779|FG000|Overall Study|Adverse Event|3|||
130765671|NCT02696434|470765780|FG001|Overall Study|Adverse Event|1|||
130765672|NCT02696434|470765779|FG000|Overall Study|Lost to Follow-up|5|||
130765673|NCT02696434|470765780|FG001|Overall Study|Lost to Follow-up|4|||
130765674|NCT02696434|470765779|FG000|Overall Study|Withdrawal by Subject|14|||
130765675|NCT02696434|470765780|FG001|Overall Study|Withdrawal by Subject|12|||
130765676|NCT02696434|470765779|FG000|Overall Study|Physician Decision|0|||
130765677|NCT02696434|470765780|FG001|Overall Study|Physician Decision|1|||
130765678|NCT00316914|470765799|FG000|Overall Study|Withdrawal by Subject|5|||
130765679|NCT00316914|470765800|FG001|Overall Study|Withdrawal by Subject|3|||
130765680|NCT00316914|470765799|FG000|Overall Study|Adverse Event|8|||
130765681|NCT00316914|470765800|FG001|Overall Study|Adverse Event|7|||
130765682|NCT00316914|470765799|FG000|Overall Study|Other Problems|6|||
130765683|NCT00316914|470765800|FG001|Overall Study|Other Problems|11|||
130765684|NCT00316914|470765799|FG000|Overall Study|Missing end of treatment documentation|14|||
130765685|NCT00316914|470765800|FG001|Overall Study|Missing end of treatment documentation|15|||
130765686|NCT04105010|470765801|FG000|Overall Study|Death|3|||
130765687|NCT04105010|470765802|FG001|Overall Study|Death|1|||
130765688|NCT04105010|470765803|FG002|Overall Study|Death|1|||
130765689|NCT04105010|470765804|FG003|Overall Study|Death|54|||
130765690|NCT04105010|470765801|FG000|Overall Study|Lost to Follow-up|0|||
130765691|NCT04105010|470765802|FG001|Overall Study|Lost to Follow-up|0|||
130765692|NCT04105010|470765803|FG002|Overall Study|Lost to Follow-up|0|||
130765693|NCT04105010|470765804|FG003|Overall Study|Lost to Follow-up|4|||
130765694|NCT04105010|470765801|FG000|Overall Study|Withdrawal by Subject|8|||
130765695|NCT04105010|470765802|FG001|Overall Study|Withdrawal by Subject|1|||
130765696|NCT04105010|470765803|FG002|Overall Study|Withdrawal by Subject|1|||
130765697|NCT04105010|470765804|FG003|Overall Study|Withdrawal by Subject|4|||
130765698|NCT04105010|470765801|FG000|Overall Study|Other reason|4|||
130765699|NCT04105010|470765802|FG001|Overall Study|Other reason|7|||
130765700|NCT04105010|470765803|FG002|Overall Study|Other reason|0|||
130765701|NCT04105010|470765804|FG003|Overall Study|Other reason|19|||
130765702|NCT01675154|470765805|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
130878713|NCT02766023|471189513|FG001|Overall Study|Lost to Follow-up|11|||
130990279|NCT00633932|471593132|FG002|Overall Study|Physician Decision|1|||
130990280|NCT00633932|471593130|FG000|Overall Study|Doctor's judgement|1|||
130990281|NCT00633932|471593131|FG001|Overall Study|Doctor's judgement|0|||
130990282|NCT00633932|471593132|FG002|Overall Study|Doctor's judgement|0|||
130990283|NCT00633932|471593130|FG000|Overall Study|Moved Away|1|||
130990284|NCT00633932|471593131|FG001|Overall Study|Moved Away|0|||
130990285|NCT00633932|471593132|FG002|Overall Study|Moved Away|0|||
130990286|NCT00482274|471593134|FG000|Overall Study|Adverse Event|1|||
130990287|NCT00597714|471593137|FG000|Overall Study|Death|56|||
130990288|NCT00597714|471593138|FG001|Overall Study|Death|46|||
130990289|NCT00597714|471593139|FG002|Overall Study|Death|0|||
130990290|NCT00597714|471593137|FG000|Overall Study|Recipient death|0|||
130990291|NCT00597714|471593138|FG001|Overall Study|Recipient death|0|||
130990292|NCT00597714|471593139|FG002|Overall Study|Recipient death|10|||
130990293|NCT01350141|471593140|FG000|Overall Study|Lost to Follow-up|1|||
130990294|NCT01350141|471593141|FG001|Overall Study|Lost to Follow-up|0|||
130990295|NCT01350141|471593142|FG002|Overall Study|Lost to Follow-up|1|||
130990296|NCT01350141|471593140|FG000|Overall Study|Withdrawal by Subject|1|||
130990297|NCT01350141|471593141|FG001|Overall Study|Withdrawal by Subject|0|||
130990298|NCT01350141|471593142|FG002|Overall Study|Withdrawal by Subject|0|||
130990299|NCT01350141|471593140|FG000|Overall Study|Randomized but not treated|1|||
130990300|NCT01350141|471593141|FG001|Overall Study|Randomized but not treated|0|||
130990301|NCT01350141|471593142|FG002|Overall Study|Randomized but not treated|0|||
130990302|NCT00810082|471593143|FG000|Overall Study|Lost to Follow-up|0|||
130990303|NCT00810082|471593144|FG001|Overall Study|Lost to Follow-up|4|||
130990304|NCT01588990|471593145|FG000|Phase A|Withdrawal by Subject|5|||
130990305|NCT01588990|471593145|FG000|Phase A|Physician Decision|11|||
130990306|NCT01588990|471593145|FG000|Phase A|Other|14|||
130990307|NCT01588990|471593145|FG000|Phase A|Lost to Follow-up|1|||
130990308|NCT01588990|471593145|FG000|Phase A|Death|5|||
130990309|NCT01588990|471593145|FG000|Phase A|Adverse Event|28|||
130990310|NCT01588990|471593145|FG000|Phase A|Still on therapy at end of study|6|||
130990311|NCT01588990|471593145|FG000|Phase B|Adverse Event|2|||
130990312|NCT01588990|471593145|FG000|Phase B|Still on therapy at end of study|5|||
131098687|NCT03828747|471991016|FG000|Open-Label Extension|Lost to Follow-up|4|||
131098688|NCT03828747|471991017|FG001|Open-Label Extension|Lost to Follow-up|0|||
131098689|NCT03828747|471991016|FG000|Open-Label Extension|Withdrawal by Subject|31|||
131098690|NCT03828747|471991017|FG001|Open-Label Extension|Withdrawal by Subject|30|||
131098691|NCT03828747|471991016|FG000|Open-Label Extension|Various reasons|4|||
131098692|NCT03828747|471991017|FG001|Open-Label Extension|Various reasons|4|||
131098693|NCT03828747|471991016|FG000|Open-Label Extension|Physician Decision|6|||
131098694|NCT03828747|471991017|FG001|Open-Label Extension|Physician Decision|2|||
131098695|NCT01144052|471991018|FG000|Overall Study|Withdrawal by Subject|1|||
131098696|NCT01144052|471991019|FG001|Overall Study|Withdrawal by Subject|1|||
130990313|NCT01588990|471593145|FG000|Phase B|Withdrawal by Subject|3|||
130990314|NCT01588990|471593145|FG000|Phase B|Physician Decision|4|||
130990315|NCT01588990|471593145|FG000|Phase B|Other|2|||
131098697|NCT00424385|471991020|FG000|Cohort 0|Withdrawal by Subject|5|||
131098698|NCT00424385|471991020|FG000|Cohort 0|Physician Decision|1|||
131098699|NCT00424385|471991020|FG000|Cohort 1|Withdrawal by Subject|1|||
131098700|NCT02683876|471991021|FG000|Overall Study|samples damaged during shipping|2|||
131098701|NCT02683876|471991022|FG001|Overall Study|samples damaged during shipping|0|||
131098702|NCT03980808|471991045|FG000|Overall Study|Lost to Follow-up|2|||
131098703|NCT03980808|471991046|FG001|Overall Study|Lost to Follow-up|2|||
131098704|NCT01655693|471991047|FG000|Overall Study|Progression of Disease|92|||
131098705|NCT01655693|471991048|FG001|Overall Study|Progression of Disease|76|||
131098706|NCT01655693|471991049|FG002|Overall Study|Progression of Disease|58|||
131098707|NCT01655693|471991047|FG000|Overall Study|Death|8|||
131098708|NCT01655693|471991048|FG001|Overall Study|Death|9|||
131098709|NCT01655693|471991049|FG002|Overall Study|Death|12|||
131098710|NCT01655693|471991047|FG000|Overall Study|Serious Adverse Event|3|||
131098711|NCT01655693|471991048|FG001|Overall Study|Serious Adverse Event|15|||
131098712|NCT01655693|471991049|FG002|Overall Study|Serious Adverse Event|11|||
131098713|NCT01655693|471991047|FG000|Overall Study|Withdrawal by Subject|3|||
131098714|NCT01655693|471991048|FG001|Overall Study|Withdrawal by Subject|2|||
130990316|NCT02508532|471593150|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130990317|NCT02508532|471593151|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130990318|NCT02508532|471593152|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130990319|NCT02508532|471593153|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130990320|NCT02508532|471593154|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130990321|NCT02508532|471593155|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130990322|NCT02508532|471593156|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
130990323|NCT02508532|471593157|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130990324|NCT02508532|471593158|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
131098715|NCT01655693|471991049|FG002|Overall Study|Withdrawal by Subject|20|||
131098716|NCT01655693|471991047|FG000|Overall Study|Adverse Event|3|||
130878714|NCT02766023|471189512|FG000|Overall Study|Pregnancy|1|||
130878715|NCT02766023|471189513|FG001|Overall Study|Pregnancy|0|||
130878716|NCT02766023|471189512|FG000|Overall Study|Adverse Event|1|||
130878717|NCT02766023|471189513|FG001|Overall Study|Adverse Event|0|||
130878718|NCT02766023|471189512|FG000|Overall Study|Withdrawal by Subject|4|||
130878719|NCT02766023|471189513|FG001|Overall Study|Withdrawal by Subject|5|||
130878720|NCT02766023|471189512|FG000|Overall Study|Physician Decision|1|||
130878721|NCT02766023|471189513|FG001|Overall Study|Physician Decision|0|||
130878722|NCT02766023|471189512|FG000|Overall Study|Not Eligible at Enrollment|0|||
130878723|NCT02766023|471189513|FG001|Overall Study|Not Eligible at Enrollment|1|||
130878724|NCT02923726|471189516|FG000|Overall Study|Death|196|||
130878725|NCT02923726|471189517|FG001|Overall Study|Death|175|||
130878726|NCT02923726|471189516|FG000|Overall Study|Withdrawal by Subject|337|||
130878727|NCT02923726|471189517|FG001|Overall Study|Withdrawal by Subject|307|||
130878728|NCT01488045|471189518|FG000|Overall Study|Withdrawal by Subject|6|||
130878729|NCT01488045|471189519|FG001|Overall Study|Withdrawal by Subject|11|||
130878730|NCT01488045|471189518|FG000|Overall Study|Failure to present for colonoscopy|3|||
130878731|NCT01488045|471189519|FG001|Overall Study|Failure to present for colonoscopy|6|||
130878732|NCT01488045|471189518|FG000|Overall Study|Failure to report exclusion criteria|0|||
130878733|NCT01488045|471189519|FG001|Overall Study|Failure to report exclusion criteria|1|||
130878734|NCT05365217|471189522|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130878735|NCT05365217|471189523|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130878736|NCT00656513|471189527|FG000|Overall Study|Protocol Violation|1|||
130878737|NCT00656513|471189528|FG001|Overall Study|Protocol Violation|0|||
130878738|NCT00656513|471189529|FG002|Overall Study|Protocol Violation|2|||
130878739|NCT00656513|471189527|FG000|Overall Study|Withdrawal by Subject|0|||
130878740|NCT00656513|471189528|FG001|Overall Study|Withdrawal by Subject|11|||
130878741|NCT00656513|471189529|FG002|Overall Study|Withdrawal by Subject|4|||
130878742|NCT00656513|471189527|FG000|Overall Study|Death|0|||
130878743|NCT00656513|471189528|FG001|Overall Study|Death|0|||
130878744|NCT00656513|471189529|FG002|Overall Study|Death|1|||
130878745|NCT00656513|471189527|FG000|Overall Study|Missing data|0|||
130878746|NCT00656513|471189528|FG001|Overall Study|Missing data|11|||
130878747|NCT00656513|471189529|FG002|Overall Study|Missing data|9|||
130878748|NCT00656513|471189527|FG000|Overall Study|Incomplete treatment|3|||
130878749|NCT00656513|471189528|FG001|Overall Study|Incomplete treatment|0|||
130878750|NCT00656513|471189529|FG002|Overall Study|Incomplete treatment|0|||
130878751|NCT00656513|471189527|FG000|Overall Study|Treatment completed outside of timeframe|0|||
130878752|NCT00656513|471189528|FG001|Overall Study|Treatment completed outside of timeframe|3|||
130878753|NCT00656513|471189529|FG002|Overall Study|Treatment completed outside of timeframe|1|||
130878754|NCT00656513|471189527|FG000|Overall Study|Missing baseline form|0|||
130878755|NCT00656513|471189528|FG001|Overall Study|Missing baseline form|5|||
130878756|NCT00656513|471189529|FG002|Overall Study|Missing baseline form|5|||
130878757|NCT03405792|471189530|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
130878758|NCT03405792|471189531|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
130878759|NCT03405792|471189530|FG000|Overall Study|o Did not receive pembrolizumab|1|||
130878760|NCT03405792|471189531|FG001|Overall Study|o Did not receive pembrolizumab|0|||
130878761|NCT02285855|471189532|FG000|Overall Study|Withdrawal by Subject|2|||
130878762|NCT02285855|471189533|FG001|Overall Study|Withdrawal by Subject|1|||
130878763|NCT02718898|471189534|FG000|Blinded Treatment Period|Adverse Event|5|||
130878764|NCT02718898|471189535|FG001|Blinded Treatment Period|Adverse Event|1|||
130878765|NCT02718898|471189536|FG002|Blinded Treatment Period|Adverse Event|0|||
130878766|NCT02718898|471189537|FG003|Blinded Treatment Period|Adverse Event|0|||
130878767|NCT02718898|471189538|FG004|Blinded Treatment Period|Adverse Event|0|||
130878768|NCT02718898|471189539|FG005|Blinded Treatment Period|Adverse Event|0|||
130878769|NCT02718898|471189540|FG006|Blinded Treatment Period|Adverse Event|0|||
130878770|NCT02718898|471189534|FG000|Blinded Treatment Period|Physician Decision|1|||
130878771|NCT02718898|471189535|FG001|Blinded Treatment Period|Physician Decision|0|||
130878772|NCT02718898|471189536|FG002|Blinded Treatment Period|Physician Decision|0|||
130878773|NCT02718898|471189537|FG003|Blinded Treatment Period|Physician Decision|0|||
130878774|NCT02718898|471189538|FG004|Blinded Treatment Period|Physician Decision|0|||
130878775|NCT02718898|471189539|FG005|Blinded Treatment Period|Physician Decision|0|||
130878776|NCT02718898|471189540|FG006|Blinded Treatment Period|Physician Decision|0|||
130878777|NCT02718898|471189534|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
130878778|NCT02718898|471189535|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
130878779|NCT02718898|471189536|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
130878780|NCT02718898|471189537|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
130878781|NCT02718898|471189538|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
130878782|NCT02718898|471189539|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
130878783|NCT02718898|471189540|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
130878784|NCT02718898|471189534|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
130878785|NCT02718898|471189535|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
130878786|NCT02718898|471189536|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
130990325|NCT02508532|471593150|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
130878787|NCT02718898|471189537|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
130878788|NCT02718898|471189538|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
130878789|NCT02718898|471189539|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
130878790|NCT02718898|471189540|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
130878791|NCT02718898|471189534|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130878792|NCT02718898|471189535|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130878793|NCT02718898|471189536|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
130878794|NCT02718898|471189537|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
130878795|NCT02718898|471189538|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130878796|NCT02718898|471189539|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130878797|NCT02718898|471189540|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130878798|NCT02718898|471189534|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130878799|NCT02718898|471189535|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130878800|NCT02718898|471189536|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130878801|NCT02718898|471189537|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
130878802|NCT02718898|471189538|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130878803|NCT02718898|471189539|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130878804|NCT02718898|471189540|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130878805|NCT02718898|471189534|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130878806|NCT02718898|471189535|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130878807|NCT02718898|471189536|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
130878808|NCT02718898|471189537|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
130878809|NCT02718898|471189538|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130878810|NCT02718898|471189539|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130878811|NCT02718898|471189540|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130878812|NCT02718898|471189534|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130878813|NCT02718898|471189535|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130878814|NCT02718898|471189536|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
130878815|NCT02718898|471189537|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
130878816|NCT02718898|471189538|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130878817|NCT02718898|471189539|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130878818|NCT02718898|471189540|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130878819|NCT02718898|471189534|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130878820|NCT02718898|471189535|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130878821|NCT02718898|471189536|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130878822|NCT02718898|471189537|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
130878823|NCT02718898|471189538|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130878824|NCT02718898|471189539|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130878825|NCT02718898|471189540|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130878826|NCT02718898|471189534|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130878827|NCT02718898|471189535|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130878828|NCT02718898|471189536|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130878829|NCT02718898|471189537|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
130878830|NCT02718898|471189538|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130878831|NCT02718898|471189539|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130878832|NCT02718898|471189540|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130878833|NCT02718898|471189534|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
130878834|NCT02718898|471189535|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
130878835|NCT02718898|471189536|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
130878836|NCT02718898|471189537|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
130878837|NCT02718898|471189538|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
130878838|NCT02718898|471189539|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
130878839|NCT02718898|471189540|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
130878840|NCT02718898|471189534|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130878841|NCT02718898|471189535|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130878842|NCT02718898|471189536|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130878843|NCT02718898|471189537|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130878844|NCT02718898|471189538|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
130878845|NCT02718898|471189539|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
130878846|NCT02718898|471189540|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
130878847|NCT02718898|471189534|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130878848|NCT02718898|471189535|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130878849|NCT02718898|471189536|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130878850|NCT02718898|471189537|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130990326|NCT02508532|471593151|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
130990327|NCT02508532|471593152|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
131213193|NCT03110107|472405302|FG010|Treatment Period|Study drug toxicity|0|||
131213194|NCT03110107|472405303|FG011|Treatment Period|Study drug toxicity|2|||
131213195|NCT03110107|472405304|FG012|Treatment Period|Study drug toxicity|0|||
131213196|NCT03110107|472405305|FG013|Treatment Period|Study drug toxicity|0|||
131213197|NCT03110107|472405306|FG014|Treatment Period|Study drug toxicity|2|||
131213198|NCT03110107|472405307|FG015|Treatment Period|Study drug toxicity|3|||
131213199|NCT03110107|472405308|FG016|Treatment Period|Study drug toxicity|3|||
131213200|NCT03110107|472405309|FG017|Treatment Period|Study drug toxicity|3|||
131213201|NCT03110107|472405310|FG018|Treatment Period|Study drug toxicity|1|||
131213202|NCT03110107|472405311|FG019|Treatment Period|Study drug toxicity|2|||
131213203|NCT03110107|472405312|FG020|Treatment Period|Study drug toxicity|2|||
131213204|NCT03110107|472405313|FG021|Treatment Period|Study drug toxicity|0|||
131213205|NCT03110107|472405314|FG022|Treatment Period|Study drug toxicity|2|||
131213206|NCT03110107|472405315|FG023|Treatment Period|Study drug toxicity|6|||
131213207|NCT03110107|472405316|FG024|Treatment Period|Study drug toxicity|7|||
131213208|NCT03110107|472405317|FG025|Treatment Period|Study drug toxicity|6|||
131213209|NCT03110107|472405292|FG000|Treatment Period|Death|0|||
131213210|NCT03110107|472405293|FG001|Treatment Period|Death|0|||
131213211|NCT03110107|472405294|FG002|Treatment Period|Death|0|||
131213212|NCT03110107|472405295|FG003|Treatment Period|Death|0|||
131213213|NCT03110107|472405296|FG004|Treatment Period|Death|0|||
131213214|NCT03110107|472405297|FG005|Treatment Period|Death|0|||
131213215|NCT03110107|472405298|FG006|Treatment Period|Death|0|||
131213216|NCT03110107|472405299|FG007|Treatment Period|Death|0|||
131213217|NCT03110107|472405300|FG008|Treatment Period|Death|0|||
131213218|NCT03110107|472405301|FG009|Treatment Period|Death|0|||
131213219|NCT03110107|472405302|FG010|Treatment Period|Death|0|||
131213220|NCT03110107|472405303|FG011|Treatment Period|Death|0|||
131213221|NCT03110107|472405304|FG012|Treatment Period|Death|1|||
131213222|NCT03110107|472405305|FG013|Treatment Period|Death|0|||
131213223|NCT03110107|472405306|FG014|Treatment Period|Death|0|||
131213224|NCT03110107|472405307|FG015|Treatment Period|Death|0|||
131213225|NCT03110107|472405308|FG016|Treatment Period|Death|0|||
131213226|NCT03110107|472405309|FG017|Treatment Period|Death|0|||
131213227|NCT03110107|472405310|FG018|Treatment Period|Death|0|||
131213228|NCT03110107|472405311|FG019|Treatment Period|Death|0|||
131213229|NCT03110107|472405312|FG020|Treatment Period|Death|0|||
131213230|NCT03110107|472405313|FG021|Treatment Period|Death|0|||
131213231|NCT03110107|472405314|FG022|Treatment Period|Death|0|||
131213232|NCT03110107|472405315|FG023|Treatment Period|Death|0|||
131213233|NCT03110107|472405316|FG024|Treatment Period|Death|0|||
131213234|NCT03110107|472405317|FG025|Treatment Period|Death|0|||
131213235|NCT03110107|472405292|FG000|Treatment Period|Adverse Event|0|||
131213236|NCT03110107|472405293|FG001|Treatment Period|Adverse Event|0|||
131213237|NCT03110107|472405294|FG002|Treatment Period|Adverse Event|1|||
131213238|NCT03110107|472405295|FG003|Treatment Period|Adverse Event|0|||
131213239|NCT03110107|472405296|FG004|Treatment Period|Adverse Event|0|||
131213240|NCT03110107|472405297|FG005|Treatment Period|Adverse Event|2|||
131213241|NCT03110107|472405298|FG006|Treatment Period|Adverse Event|0|||
131213242|NCT03110107|472405299|FG007|Treatment Period|Adverse Event|2|||
131213243|NCT03110107|472405300|FG008|Treatment Period|Adverse Event|0|||
131213244|NCT03110107|472405301|FG009|Treatment Period|Adverse Event|1|||
131213245|NCT03110107|472405302|FG010|Treatment Period|Adverse Event|0|||
131213246|NCT03110107|472405303|FG011|Treatment Period|Adverse Event|0|||
131213247|NCT03110107|472405304|FG012|Treatment Period|Adverse Event|0|||
131213248|NCT03110107|472405305|FG013|Treatment Period|Adverse Event|0|||
131213249|NCT03110107|472405306|FG014|Treatment Period|Adverse Event|0|||
131213250|NCT03110107|472405307|FG015|Treatment Period|Adverse Event|2|||
131213251|NCT03110107|472405308|FG016|Treatment Period|Adverse Event|0|||
131213252|NCT03110107|472405309|FG017|Treatment Period|Adverse Event|1|||
131213253|NCT03110107|472405310|FG018|Treatment Period|Adverse Event|2|||
131213254|NCT03110107|472405311|FG019|Treatment Period|Adverse Event|1|||
131213255|NCT03110107|472405312|FG020|Treatment Period|Adverse Event|4|||
131213256|NCT03110107|472405313|FG021|Treatment Period|Adverse Event|2|||
131213257|NCT03110107|472405314|FG022|Treatment Period|Adverse Event|2|||
131213258|NCT03110107|472405315|FG023|Treatment Period|Adverse Event|2|||
131213259|NCT03110107|472405316|FG024|Treatment Period|Adverse Event|2|||
131213260|NCT03110107|472405317|FG025|Treatment Period|Adverse Event|4|||
131213261|NCT03110107|472405292|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
131213262|NCT03110107|472405293|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
131213263|NCT03110107|472405294|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
131213264|NCT03110107|472405295|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
131213265|NCT03110107|472405296|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
131213266|NCT03110107|472405297|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
131098717|NCT01655693|471991048|FG001|Overall Study|Adverse Event|11|||
131213267|NCT03110107|472405298|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
131229206|NCT01360632|472465872|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
130765703|NCT01675154|470765806|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
130765704|NCT01675154|470765807|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
130765705|NCT01675154|470765808|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
130765706|NCT00427999|470765809|FG000|Overall Study|Adverse Event|6|||
130765707|NCT00427999|470765809|FG000|Overall Study|Abnormal laboratory values|1|||
130765708|NCT00427999|470765809|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
130765709|NCT00427999|470765809|FG000|Overall Study|Protocol Violation|2|||
130765710|NCT00427999|470765809|FG000|Overall Study|Withdrawal by Subject|9|||
130765711|NCT00427999|470765809|FG000|Overall Study|Death|1|||
130765712|NCT02380859|470765810|FG000|Overall Study|Withdrawal by Subject|2|||
130765713|NCT02380859|470765811|FG001|Overall Study|Withdrawal by Subject|0|||
130765714|NCT02284568|470765812|FG000|Overall Study|Adverse Event|2|||
130765715|NCT02284568|470765813|FG001|Overall Study|Adverse Event|9|||
130765716|NCT02284568|470765814|FG002|Overall Study|Adverse Event|4|||
130765717|NCT02284568|470765812|FG000|Overall Study|Withdrawal by Subject|22|||
130765718|NCT02284568|470765813|FG001|Overall Study|Withdrawal by Subject|21|||
130765719|NCT02284568|470765814|FG002|Overall Study|Withdrawal by Subject|1|||
130765720|NCT02284568|470765812|FG000|Overall Study|Noncompliance with study drug admin|1|||
130765721|NCT02284568|470765813|FG001|Overall Study|Noncompliance with study drug admin|2|||
130765722|NCT02284568|470765814|FG002|Overall Study|Noncompliance with study drug admin|0|||
130765723|NCT02284568|470765812|FG000|Overall Study|Noncompliance|1|||
130765724|NCT02284568|470765813|FG001|Overall Study|Noncompliance|0|||
130765725|NCT02284568|470765814|FG002|Overall Study|Noncompliance|0|||
130765726|NCT02284568|470765812|FG000|Overall Study|Protocol Violation|0|||
130765727|NCT02284568|470765813|FG001|Overall Study|Protocol Violation|1|||
130765728|NCT02284568|470765814|FG002|Overall Study|Protocol Violation|0|||
130765729|NCT02284568|470765812|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
130765730|NCT02284568|470765813|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
130765731|NCT02284568|470765814|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
130765732|NCT02284568|470765812|FG000|Overall Study|Lost to Follow-up|0|||
130765733|NCT02284568|470765813|FG001|Overall Study|Lost to Follow-up|3|||
130765734|NCT02284568|470765814|FG002|Overall Study|Lost to Follow-up|0|||
130765735|NCT02284568|470765812|FG000|Overall Study|Lack of Efficacy|4|||
130765736|NCT02284568|470765813|FG001|Overall Study|Lack of Efficacy|7|||
130765737|NCT02284568|470765814|FG002|Overall Study|Lack of Efficacy|0|||
130765738|NCT02284568|470765812|FG000|Overall Study|Other|1|||
130765739|NCT02284568|470765813|FG001|Overall Study|Other|2|||
130765740|NCT02284568|470765814|FG002|Overall Study|Other|0|||
130765741|NCT02284568|470765812|FG000|Overall Study|Withdrew before taking study drug|0|||
130765742|NCT02284568|470765813|FG001|Overall Study|Withdrew before taking study drug|1|||
130765743|NCT02284568|470765814|FG002|Overall Study|Withdrew before taking study drug|0|||
130765744|NCT05323994|470765815|FG000|Overall Study|Protocol Violation|1|||
130765745|NCT01420679|470765821|FG000|Overall Study|Disease Progression|3|||
130765746|NCT01420679|470765822|FG001|Overall Study|Disease Progression|2|||
130765747|NCT01420679|470765821|FG000|Overall Study|Adverse Event|4|||
130765748|NCT01420679|470765822|FG001|Overall Study|Adverse Event|0|||
130765749|NCT01420679|470765821|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
130765750|NCT01420679|470765822|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
130765751|NCT01420679|470765821|FG000|Overall Study|Patient Decision|1|||
130765752|NCT01420679|470765822|FG001|Overall Study|Patient Decision|0|||
130765753|NCT01420679|470765821|FG000|Overall Study|Investigator Decision|1|||
130765754|NCT01420679|470765822|FG001|Overall Study|Investigator Decision|2|||
130765755|NCT01420679|470765821|FG000|Overall Study|Sponsor Decision|3|||
130765756|NCT01420679|470765822|FG001|Overall Study|Sponsor Decision|3|||
130765757|NCT01420679|470765821|FG000|Overall Study|Other|1|||
130765758|NCT01420679|470765822|FG001|Overall Study|Other|0|||
130765759|NCT00943670|470765823|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
130765760|NCT00943670|470765823|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
130765761|NCT00943670|470765823|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
130765762|NCT00943670|470765823|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
130765763|NCT00943670|470765823|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
130765764|NCT00943670|470765823|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
130765765|NCT00943670|470765823|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
130765766|NCT00943670|470765823|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
130765767|NCT00943670|470765823|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
130765768|NCT00943670|470765823|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
130765769|NCT03956615|470765824|FG000|Overall Study|No multiple myeloma confirmed|2|||
130765770|NCT03956615|470765824|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
130765771|NCT03956615|470765824|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
130765772|NCT03956615|470765824|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
130765773|NCT04245202|470765830|FG000|Overall Study|Lack of Efficacy|10|||
130765774|NCT04245202|470765831|FG001|Overall Study|Lack of Efficacy|1|||
130765775|NCT03329248|470765835|FG000|Overall Study|Progressive Disease|6|||
130765776|NCT01254721|470765836|FG000|Overall Study|Lost to Follow-up|0|||
130878851|NCT02718898|471189538|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130878852|NCT02718898|471189539|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
130878853|NCT02718898|471189540|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
130878854|NCT04484961|471189541|FG000|Overall Study|Lost to Follow-up|9|||
130878855|NCT04484961|471189542|FG001|Overall Study|Lost to Follow-up|9|||
130878856|NCT01667900|471189543|FG000|Part B|Death|0|||
130878857|NCT01667900|471189544|FG001|Part B|Death|0|||
130878858|NCT01667900|471189545|FG002|Part B|Death|0|||
130878859|NCT01667900|471189546|FG003|Part B|Death|0|||
130878860|NCT01667900|471189547|FG004|Part B|Death|0|||
130878861|NCT01667900|471189548|FG005|Part B|Death|0|||
130878862|NCT01667900|471189549|FG006|Part B|Death|0|||
130878863|NCT01667900|471189550|FG007|Part B|Death|0|||
130878864|NCT01667900|471189551|FG008|Part B|Death|0|||
130878865|NCT01667900|471189552|FG009|Part B|Death|0|||
130878866|NCT01667900|471189553|FG010|Part B|Death|0|||
130878867|NCT01667900|471189554|FG011|Part B|Death|0|||
130878868|NCT01667900|471189555|FG012|Part B|Death|0|||
130878869|NCT01667900|471189556|FG013|Part B|Death|0|||
130878870|NCT01667900|471189557|FG014|Part B|Death|0|||
130878871|NCT01667900|471189558|FG015|Part B|Death|0|||
130878872|NCT01667900|471189559|FG016|Part B|Death|1|||
130878873|NCT01667900|471189560|FG017|Part B|Death|0|||
130878874|NCT01667900|471189561|FG018|Part B|Death|0|||
130878875|NCT01667900|471189562|FG019|Part B|Death|0|||
130878876|NCT01339832|471189564|FG000|Overall Study|Lost to Follow-up|3|||
130878877|NCT01339832|471189564|FG000|Overall Study|Death|11|||
130878878|NCT00231816|471189565|FG000|Overall Study|Adverse Event|1|||
130878879|NCT00231816|471189566|FG001|Overall Study|Adverse Event|0|||
130878880|NCT00231816|471189565|FG000|Overall Study|Lost to Follow-up|8|||
130878881|NCT00231816|471189566|FG001|Overall Study|Lost to Follow-up|5|||
130878882|NCT00231816|471189565|FG000|Overall Study|Protocol Violation|2|||
130878883|NCT00231816|471189566|FG001|Overall Study|Protocol Violation|3|||
130878884|NCT00231816|471189565|FG000|Overall Study|Withdrawal by Subject|3|||
130878885|NCT00231816|471189566|FG001|Overall Study|Withdrawal by Subject|3|||
130878886|NCT00231816|471189565|FG000|Overall Study|Other|2|||
130878887|NCT00231816|471189566|FG001|Overall Study|Other|1|||
130878888|NCT00468169|471189567|FG000|Overall Study|Withdrawal by Subject|1|||
130878889|NCT00468169|471189568|FG001|Overall Study|Withdrawal by Subject|0|||
130878890|NCT01126749|471189573|FG000|Phase 1b|Other|0|||
130878891|NCT01126749|471189574|FG001|Phase 1b|Other|1|||
130878892|NCT01126749|471189575|FG002|Phase 1b|Other|0|||
130878893|NCT01126749|471189576|FG003|Phase 1b|Other|0|||
130878894|NCT01126749|471189573|FG000|Phase 1b|Withdrawal by Subject|0|||
130878895|NCT01126749|471189574|FG001|Phase 1b|Withdrawal by Subject|1|||
130878896|NCT01126749|471189575|FG002|Phase 1b|Withdrawal by Subject|0|||
130878897|NCT01126749|471189576|FG003|Phase 1b|Withdrawal by Subject|0|||
130878898|NCT01126749|471189573|FG000|Phase 1b|Death|3|||
130878899|NCT01126749|471189574|FG001|Phase 1b|Death|4|||
130878900|NCT01126749|471189575|FG002|Phase 1b|Death|0|||
130878901|NCT01126749|471189576|FG003|Phase 1b|Death|0|||
130878902|NCT01126749|471189573|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
130878903|NCT01126749|471189574|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
130878904|NCT01126749|471189575|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
130878905|NCT01126749|471189576|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
130878906|NCT01126749|471189573|FG000|Phase 2|Study Termination by Sponsor|0|||
130878907|NCT01126749|471189574|FG001|Phase 2|Study Termination by Sponsor|0|||
130878908|NCT01126749|471189575|FG002|Phase 2|Study Termination by Sponsor|12|||
130878909|NCT01126749|471189576|FG003|Phase 2|Study Termination by Sponsor|6|||
130878910|NCT01126749|471189573|FG000|Phase 2|Other|0|||
130878911|NCT01126749|471189574|FG001|Phase 2|Other|0|||
130878912|NCT01126749|471189575|FG002|Phase 2|Other|4|||
130878913|NCT01126749|471189576|FG003|Phase 2|Other|2|||
130878914|NCT01126749|471189573|FG000|Phase 2|Withdrawal by Subject|0|||
130878915|NCT01126749|471189574|FG001|Phase 2|Withdrawal by Subject|0|||
130878916|NCT01126749|471189575|FG002|Phase 2|Withdrawal by Subject|0|||
130878917|NCT01126749|471189576|FG003|Phase 2|Withdrawal by Subject|2|||
130878918|NCT01126749|471189573|FG000|Phase 2|Lost to Follow-up|0|||
130878919|NCT01126749|471189574|FG001|Phase 2|Lost to Follow-up|0|||
130878920|NCT01126749|471189575|FG002|Phase 2|Lost to Follow-up|0|||
130878921|NCT01126749|471189576|FG003|Phase 2|Lost to Follow-up|1|||
130878922|NCT01126749|471189573|FG000|Phase 2|Death|0|||
130878923|NCT01126749|471189574|FG001|Phase 2|Death|0|||
130878924|NCT01126749|471189575|FG002|Phase 2|Death|22|||
130878925|NCT01126749|471189576|FG003|Phase 2|Death|22|||
130878926|NCT01126749|471189573|FG000|Phase 2|Adverse Event|0|||
130878927|NCT01126749|471189574|FG001|Phase 2|Adverse Event|0|||
130878928|NCT01126749|471189575|FG002|Phase 2|Adverse Event|0|||
130878929|NCT01126749|471189576|FG003|Phase 2|Adverse Event|1|||
130878930|NCT00976274|471189578|FG000|Overall Study|Lost to Follow-up|5|||
130878931|NCT00976274|471189579|FG001|Overall Study|Lost to Follow-up|5|||
130878932|NCT00976274|471189578|FG000|Overall Study|Withdrawal by Subject|1|||
130878933|NCT00976274|471189579|FG001|Overall Study|Withdrawal by Subject|1|||
130878934|NCT00976274|471189578|FG000|Overall Study|Physician Decision|1|||
130878935|NCT00976274|471189579|FG001|Overall Study|Physician Decision|2|||
131098718|NCT01655693|471991049|FG002|Overall Study|Adverse Event|3|||
130878936|NCT00627393|471189582|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
130878937|NCT00627393|471189583|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
130878938|NCT00627393|471189582|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
130878939|NCT00627393|471189583|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
130878940|NCT00627393|471189582|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
130878941|NCT00627393|471189583|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
130878942|NCT00627393|471189582|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
130878943|NCT00627393|471189583|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
130878944|NCT02183675|471189584|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
130878945|NCT02183675|471189585|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
130878946|NCT02183675|471189586|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
130878947|NCT02183675|471189587|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
130878948|NCT02183675|471189588|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
130878949|NCT02183675|471189589|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
130878950|NCT00004563|471189590|FG000|Overall Study|Withdrawal by Subject|20|||
130878951|NCT00004563|471189591|FG001|Overall Study|Withdrawal by Subject|16|||
130878952|NCT00004563|471189590|FG000|Overall Study|Lack of Efficacy|3|||
130878953|NCT00004563|471189591|FG001|Overall Study|Lack of Efficacy|5|||
130878954|NCT00004563|471189590|FG000|Overall Study|Death|2|||
130878955|NCT00004563|471189591|FG001|Overall Study|Death|3|||
130878956|NCT03337308|471189592|FG000|Overall Study|Adverse Event|2|||
130878957|NCT03337308|471189593|FG001|Overall Study|Adverse Event|3|||
130878958|NCT03337308|471189594|FG002|Overall Study|Adverse Event|3|||
130878959|NCT03337308|471189595|FG003|Overall Study|Adverse Event|1|||
130878960|NCT03337308|471189592|FG000|Overall Study|Lost to Follow-up|1|||
130878961|NCT03337308|471189593|FG001|Overall Study|Lost to Follow-up|2|||
130878962|NCT03337308|471189594|FG002|Overall Study|Lost to Follow-up|0|||
130878963|NCT03337308|471189595|FG003|Overall Study|Lost to Follow-up|0|||
130878964|NCT03337308|471189592|FG000|Overall Study|Withdrawal by Subject|2|||
130878965|NCT03337308|471189593|FG001|Overall Study|Withdrawal by Subject|1|||
130878966|NCT03337308|471189594|FG002|Overall Study|Withdrawal by Subject|2|||
130878967|NCT03337308|471189595|FG003|Overall Study|Withdrawal by Subject|1|||
130878968|NCT03337308|471189592|FG000|Overall Study|Protocol Violation|0|||
130878969|NCT03337308|471189593|FG001|Overall Study|Protocol Violation|1|||
130878970|NCT03337308|471189594|FG002|Overall Study|Protocol Violation|0|||
130878971|NCT03337308|471189595|FG003|Overall Study|Protocol Violation|0|||
130878972|NCT01056822|471189596|FG000|Overall Study|Adverse Event|0|||
130878973|NCT01056822|471189597|FG001|Overall Study|Adverse Event|1|||
130878974|NCT01056822|471189596|FG000|Overall Study|Protocol Violation|6|||
130878975|NCT01056822|471189597|FG001|Overall Study|Protocol Violation|5|||
130878976|NCT01056822|471189596|FG000|Overall Study|Withdrawal by Subject|1|||
130878977|NCT01056822|471189597|FG001|Overall Study|Withdrawal by Subject|1|||
130878978|NCT01056822|471189596|FG000|Overall Study|Lost to Follow-up|1|||
130878979|NCT01056822|471189597|FG001|Overall Study|Lost to Follow-up|0|||
130878980|NCT01614249|471189602|FG000|Overall Study|Lost to Follow-up|11|||
130878981|NCT01614249|471189603|FG001|Overall Study|Lost to Follow-up|23|||
130878982|NCT04528641|471189604|FG000|Overall Study|Withdrawal by Subject|0|||
130878983|NCT04528641|471189605|FG001|Overall Study|Withdrawal by Subject|0|||
130878984|NCT04528641|471189606|FG002|Overall Study|Withdrawal by Subject|0|||
130878985|NCT04528641|471189607|FG003|Overall Study|Withdrawal by Subject|1|||
130878986|NCT04528641|471189608|FG004|Overall Study|Withdrawal by Subject|0|||
130878987|NCT04528641|471189609|FG005|Overall Study|Withdrawal by Subject|1|||
130878988|NCT04366349|471189610|FG000|Overall Study|Withdrawal by Subject|1|||
130878989|NCT04366349|471189611|FG001|Overall Study|Withdrawal by Subject|0|||
130878990|NCT04366349|471189612|FG002|Overall Study|Withdrawal by Subject|0|||
130878991|NCT04366349|471189613|FG003|Overall Study|Withdrawal by Subject|0|||
130878992|NCT04366349|471189614|FG004|Overall Study|Withdrawal by Subject|0|||
130878993|NCT04366349|471189615|FG005|Overall Study|Withdrawal by Subject|0|||
130878994|NCT03341299|471189619|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
130878995|NCT03341299|471189620|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
130878996|NCT03341299|471189621|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
130878997|NCT03341299|471189622|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
130878998|NCT05194124|471189625|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130878999|NCT05194124|471189626|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130879000|NCT05194124|471189627|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130879001|NCT05194124|471189628|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
130879002|NCT05194124|471189629|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130879003|NCT05194124|471189630|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
130879004|NCT05194124|471189631|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130879005|NCT05194124|471189632|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130879006|NCT05194124|471189633|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130879007|NCT05194124|471189634|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130879008|NCT05194124|471189625|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130879009|NCT05194124|471189626|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130879010|NCT05194124|471189627|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130879011|NCT05194124|471189628|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130879012|NCT05194124|471189629|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130879013|NCT05194124|471189630|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130879014|NCT05194124|471189631|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130879015|NCT05194124|471189632|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130879016|NCT05194124|471189633|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130879017|NCT05194124|471189634|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
130879018|NCT02783690|471189635|FG000|Overall Study|Withdrawal by Subject|3|||
130879019|NCT02783690|471189636|FG001|Overall Study|Withdrawal by Subject|3|||
130879020|NCT03474588|471189637|FG000|Overall Study|Withdrawal by Subject|4|||
130879021|NCT03474588|471189638|FG001|Overall Study|Withdrawal by Subject|3|||
130879022|NCT03474588|471189637|FG000|Overall Study|Death|0|||
130879023|NCT03474588|471189638|FG001|Overall Study|Death|1|||
130879024|NCT00626106|471189641|FG000|Overall Study|Withdrawal by Subject|2|||
130879025|NCT00626106|471189642|FG001|Overall Study|Withdrawal by Subject|1|||
130879026|NCT00626106|471189641|FG000|Overall Study|Lost to Follow-up|1|||
130879027|NCT00626106|471189642|FG001|Overall Study|Lost to Follow-up|4|||
130879028|NCT00626106|471189641|FG000|Overall Study|Death|64|||
130879029|NCT00626106|471189642|FG001|Overall Study|Death|19|||
130879030|NCT02702492|471189643|FG000|Overall Study|Disease progression|3|||
130879031|NCT02702492|471189644|FG001|Overall Study|Disease progression|3|||
130879032|NCT02702492|471189645|FG002|Overall Study|Disease progression|2|||
130879033|NCT02702492|471189646|FG003|Overall Study|Disease progression|4|||
130879034|NCT02702492|471189647|FG004|Overall Study|Disease progression|4|||
130879035|NCT02702492|471189648|FG005|Overall Study|Disease progression|1|||
130879036|NCT02702492|471189649|FG006|Overall Study|Disease progression|2|||
130879037|NCT02702492|471189650|FG007|Overall Study|Disease progression|8|||
130879038|NCT02702492|471189651|FG008|Overall Study|Disease progression|5|||
130879039|NCT02702492|471189652|FG009|Overall Study|Disease progression|1|||
130879040|NCT02702492|471189653|FG010|Overall Study|Disease progression|0|||
130879041|NCT02702492|471189654|FG011|Overall Study|Disease progression|3|||
130765777|NCT01254721|470765837|FG001|Overall Study|Lost to Follow-up|4|||
130765778|NCT01254721|470765836|FG000|Overall Study|Lack of Efficacy|4|||
130765779|NCT01254721|470765837|FG001|Overall Study|Lack of Efficacy|2|||
130765780|NCT01254721|470765836|FG000|Overall Study|Death|0|||
130765781|NCT01254721|470765837|FG001|Overall Study|Death|1|||
130765782|NCT01254721|470765836|FG000|Overall Study|technical problum|1|||
130765783|NCT01254721|470765837|FG001|Overall Study|technical problum|0|||
130765784|NCT01254721|470765836|FG000|Overall Study|Adverse Event|2|||
130765785|NCT01254721|470765837|FG001|Overall Study|Adverse Event|3|||
130765786|NCT01254721|470765836|FG000|Overall Study|Withdrawal by Subject|8|||
130765787|NCT01254721|470765837|FG001|Overall Study|Withdrawal by Subject|11|||
130765788|NCT01254721|470765836|FG000|Overall Study|Wrongly randomization|0|||
130765789|NCT01254721|470765837|FG001|Overall Study|Wrongly randomization|1|||
130765790|NCT00987402|470765838|FG000|Overall Study|Insufficient data entry|86|||
130765791|NCT00987402|470765839|FG001|Overall Study|Insufficient data entry|98|||
130765792|NCT03000530|470765840|FG000|Overall Study|Adverse Event|0|||
130765793|NCT03000530|470765841|FG001|Overall Study|Adverse Event|0|||
130765794|NCT03000530|470765842|FG002|Overall Study|Adverse Event|2|||
130765795|NCT03000530|470765840|FG000|Overall Study|Lost to Follow-up|0|||
130765796|NCT03000530|470765841|FG001|Overall Study|Lost to Follow-up|3|||
130765797|NCT03000530|470765842|FG002|Overall Study|Lost to Follow-up|1|||
130765798|NCT03000530|470765840|FG000|Overall Study|Withdrawal by Subject|0|||
130765799|NCT03000530|470765841|FG001|Overall Study|Withdrawal by Subject|2|||
130765800|NCT03000530|470765842|FG002|Overall Study|Withdrawal by Subject|1|||
130765801|NCT00312572|470765846|FG000|Overall Study|Adverse Event|10|||
130765802|NCT00312572|470765847|FG001|Overall Study|Adverse Event|16|||
130765803|NCT00312572|470765846|FG000|Overall Study|Lost to Follow-up|1|||
130765804|NCT00312572|470765847|FG001|Overall Study|Lost to Follow-up|1|||
130765805|NCT00312572|470765846|FG000|Overall Study|Administrative|4|||
130765806|NCT00312572|470765847|FG001|Overall Study|Administrative|2|||
130765807|NCT00312572|470765846|FG000|Overall Study|Lack of Efficacy|1|||
130765808|NCT00312572|470765847|FG001|Overall Study|Lack of Efficacy|2|||
130765809|NCT01430624|470765848|FG000|Overall Study|Lost to Follow-up|23|||
130765810|NCT01430624|470765849|FG001|Overall Study|Lost to Follow-up|29|||
130765811|NCT01430624|470765850|FG002|Overall Study|Lost to Follow-up|27|||
130765812|NCT01430624|470765848|FG000|Overall Study|technical or eligibility|5|||
130765813|NCT01430624|470765849|FG001|Overall Study|technical or eligibility|5|||
130879042|NCT02702492|471189655|FG012|Overall Study|Disease progression|2|||
130879043|NCT02702492|471189643|FG000|Overall Study|Clinical progression|0|||
130879044|NCT02702492|471189644|FG001|Overall Study|Clinical progression|0|||
130879045|NCT02702492|471189645|FG002|Overall Study|Clinical progression|2|||
130879046|NCT02702492|471189646|FG003|Overall Study|Clinical progression|1|||
130879047|NCT02702492|471189647|FG004|Overall Study|Clinical progression|0|||
130879048|NCT02702492|471189648|FG005|Overall Study|Clinical progression|2|||
130879049|NCT02702492|471189649|FG006|Overall Study|Clinical progression|1|||
130879050|NCT02702492|471189650|FG007|Overall Study|Clinical progression|4|||
130879051|NCT02702492|471189651|FG008|Overall Study|Clinical progression|0|||
130879052|NCT02702492|471189652|FG009|Overall Study|Clinical progression|0|||
130879053|NCT02702492|471189653|FG010|Overall Study|Clinical progression|1|||
130879054|NCT02702492|471189654|FG011|Overall Study|Clinical progression|2|||
130879055|NCT02702492|471189655|FG012|Overall Study|Clinical progression|0|||
130879056|NCT02702492|471189643|FG000|Overall Study|Adverse Event|0|||
130879057|NCT02702492|471189644|FG001|Overall Study|Adverse Event|0|||
130879058|NCT02702492|471189645|FG002|Overall Study|Adverse Event|1|||
130879059|NCT02702492|471189646|FG003|Overall Study|Adverse Event|2|||
130879060|NCT02702492|471189647|FG004|Overall Study|Adverse Event|1|||
130879061|NCT02702492|471189648|FG005|Overall Study|Adverse Event|0|||
130879062|NCT02702492|471189649|FG006|Overall Study|Adverse Event|1|||
130879063|NCT02702492|471189650|FG007|Overall Study|Adverse Event|0|||
130879064|NCT02702492|471189651|FG008|Overall Study|Adverse Event|2|||
130879065|NCT02702492|471189652|FG009|Overall Study|Adverse Event|0|||
130879066|NCT02702492|471189653|FG010|Overall Study|Adverse Event|0|||
130879067|NCT02702492|471189654|FG011|Overall Study|Adverse Event|0|||
130879068|NCT02702492|471189655|FG012|Overall Study|Adverse Event|1|||
130879069|NCT02702492|471189643|FG000|Overall Study|Other|0|||
130879070|NCT02702492|471189644|FG001|Overall Study|Other|0|||
130879071|NCT02702492|471189645|FG002|Overall Study|Other|0|||
130879072|NCT02702492|471189646|FG003|Overall Study|Other|0|||
130879073|NCT02702492|471189647|FG004|Overall Study|Other|0|||
130879074|NCT02702492|471189648|FG005|Overall Study|Other|0|||
130879075|NCT02702492|471189649|FG006|Overall Study|Other|0|||
130879076|NCT02702492|471189650|FG007|Overall Study|Other|0|||
130879077|NCT02702492|471189651|FG008|Overall Study|Other|0|||
130879078|NCT02702492|471189652|FG009|Overall Study|Other|0|||
130879079|NCT02702492|471189653|FG010|Overall Study|Other|0|||
130879080|NCT02702492|471189654|FG011|Overall Study|Other|0|||
130879081|NCT02702492|471189655|FG012|Overall Study|Other|1|||
130879082|NCT03253393|471189657|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
130879083|NCT03253393|471189658|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
130879084|NCT03253393|471189659|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
130879085|NCT00781768|471191212|FG000|Overall Study|Not transplanted.|0|||
130879086|NCT00781768|471191213|FG001|Overall Study|Not transplanted.|2|||
130879087|NCT00079417|471191222|FG000|Overall Study|Physician Decision|2|||
130879088|NCT00079417|471191222|FG000|Overall Study|Ineligible|7|||
130879089|NCT02458313|471191223|FG000|Overall Study|Withdrawal by Subject|6|||
130879090|NCT02458313|471191224|FG001|Overall Study|Withdrawal by Subject|8|||
130879091|NCT02458313|471191223|FG000|Overall Study|Excluded for motion during MRI|1|||
130879092|NCT02458313|471191224|FG001|Overall Study|Excluded for motion during MRI|2|||
130879093|NCT00904969|471191225|FG000|Overall Study|Lost to Follow-up|4|||
130879094|NCT00904969|471191225|FG000|Overall Study|Withdrawal by Subject|3|||
130879095|NCT00904969|471191225|FG000|Overall Study|Additional Treatments|11|||
130879096|NCT00904969|471191225|FG000|Overall Study|Case Aborted; Subject Exited|1|||
130879097|NCT00199381|471191232|FG000|Overall Study|Withdrawal by Subject|38|||
130879098|NCT00199381|471191232|FG000|Overall Study|Adverse Event|73|||
130879099|NCT00199381|471191232|FG000|Overall Study|Protocol Violation|6|||
130879100|NCT00199381|471191232|FG000|Overall Study|Lack of Efficacy|27|||
130879101|NCT00199381|471191232|FG000|Overall Study|Not including due to early termination|37|||
130879102|NCT00199381|471191232|FG000|Overall Study|Study termination by Sponsor|323|||
130879103|NCT00385671|471191234|FG000|Overall Study|Adverse Event|14|||
130879104|NCT00385671|471191235|FG001|Overall Study|Adverse Event|27|||
130879105|NCT00385671|471191236|FG002|Overall Study|Adverse Event|18|||
130879106|NCT00385671|471191234|FG000|Overall Study|Lack of Efficacy|5|||
130879107|NCT00385671|471191235|FG001|Overall Study|Lack of Efficacy|9|||
130879108|NCT00385671|471191236|FG002|Overall Study|Lack of Efficacy|5|||
130879109|NCT00385671|471191234|FG000|Overall Study|Lost to Follow-up|6|||
130879110|NCT00385671|471191235|FG001|Overall Study|Lost to Follow-up|6|||
130879111|NCT00385671|471191236|FG002|Overall Study|Lost to Follow-up|5|||
130879112|NCT00385671|471191234|FG000|Overall Study|Physician Decision|2|||
130879113|NCT00385671|471191235|FG001|Overall Study|Physician Decision|1|||
130879114|NCT00385671|471191236|FG002|Overall Study|Physician Decision|2|||
130879115|NCT00385671|471191234|FG000|Overall Study|Protocol Violation|5|||
130879116|NCT00385671|471191235|FG001|Overall Study|Protocol Violation|2|||
130879117|NCT00385671|471191236|FG002|Overall Study|Protocol Violation|1|||
130879118|NCT00385671|471191234|FG000|Overall Study|Sponsor Decision|2|||
130879119|NCT00385671|471191235|FG001|Overall Study|Sponsor Decision|2|||
130879120|NCT00385671|471191236|FG002|Overall Study|Sponsor Decision|1|||
130879121|NCT00385671|471191234|FG000|Overall Study|Withdrawal by Subject|4|||
130879122|NCT00385671|471191235|FG001|Overall Study|Withdrawal by Subject|4|||
130879123|NCT00385671|471191236|FG002|Overall Study|Withdrawal by Subject|4|||
130879124|NCT00303069|471191237|FG000|Overall Study|Lost to Follow-up|1|||
130879125|NCT00303069|471191238|FG001|Overall Study|Lost to Follow-up|0|||
130879126|NCT00303069|471191239|FG002|Overall Study|Lost to Follow-up|0|||
130879127|NCT00303069|471191240|FG003|Overall Study|Lost to Follow-up|2|||
130879128|NCT00303069|471191237|FG000|Overall Study|subject moved|1|||
130879129|NCT00303069|471191238|FG001|Overall Study|subject moved|0|||
130879130|NCT00303069|471191239|FG002|Overall Study|subject moved|0|||
130879131|NCT00303069|471191240|FG003|Overall Study|subject moved|0|||
130879132|NCT00303069|471191237|FG000|Overall Study|Recruitment into Army Reserves|0|||
130879133|NCT00303069|471191238|FG001|Overall Study|Recruitment into Army Reserves|0|||
130879134|NCT00303069|471191239|FG002|Overall Study|Recruitment into Army Reserves|1|||
130879135|NCT00303069|471191240|FG003|Overall Study|Recruitment into Army Reserves|0|||
130879136|NCT00751296|471191241|FG000|Overall Study|Adverse Event|2|||
130879137|NCT01775501|471191242|FG000|Overall Study|Discontinued prior to treatment|1|||
130879138|NCT01280903|471191246|FG000|Overall Study|Lost to Follow-up|23|||
130879139|NCT01280903|471191247|FG001|Overall Study|Lost to Follow-up|16|||
130879140|NCT03453164|471191248|FG000|Overall Study|Lack of Efficacy|16|||
130879141|NCT03453164|471191248|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
130879142|NCT03007966|471191251|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
130879143|NCT03007966|471191252|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
130879144|NCT00248625|471191253|FG000|Overall Study|Withdrawal by Subject|0|||
130879145|NCT00248625|471191254|FG001|Overall Study|Withdrawal by Subject|2|||
130879146|NCT02443688|471191257|FG000|Overall Study|Adverse Event|2|||
130879147|NCT02443688|471191258|FG001|Overall Study|Adverse Event|3|||
130879148|NCT02443688|471191259|FG002|Overall Study|Adverse Event|2|||
130879149|NCT02443688|471191257|FG000|Overall Study|Lost to Follow-up|1|||
130879150|NCT02443688|471191258|FG001|Overall Study|Lost to Follow-up|0|||
130879151|NCT02443688|471191259|FG002|Overall Study|Lost to Follow-up|0|||
130879152|NCT02443688|471191257|FG000|Overall Study|Physician Decision|3|||
130879153|NCT02443688|471191258|FG001|Overall Study|Physician Decision|0|||
130879154|NCT02443688|471191259|FG002|Overall Study|Physician Decision|1|||
130879155|NCT02443688|471191257|FG000|Overall Study|Pregnancy|0|||
130879156|NCT02443688|471191258|FG001|Overall Study|Pregnancy|0|||
130879157|NCT02443688|471191259|FG002|Overall Study|Pregnancy|1|||
130879158|NCT02443688|471191257|FG000|Overall Study|Withdrawal by Subject|3|||
130879159|NCT02443688|471191258|FG001|Overall Study|Withdrawal by Subject|3|||
130879160|NCT02443688|471191259|FG002|Overall Study|Withdrawal by Subject|4|||
130879161|NCT02443688|471191257|FG000|Overall Study|Non-compliance with study drug|1|||
130879162|NCT02443688|471191258|FG001|Overall Study|Non-compliance with study drug|2|||
130879163|NCT02443688|471191259|FG002|Overall Study|Non-compliance with study drug|4|||
130879164|NCT02443688|471191257|FG000|Overall Study|Sponsor Request|2|||
130879165|NCT02443688|471191258|FG001|Overall Study|Sponsor Request|1|||
130879166|NCT02443688|471191259|FG002|Overall Study|Sponsor Request|0|||
130879167|NCT03182374|471191260|FG000|Overall Study|Lost to Follow-up|3|||
130879168|NCT03182374|471191261|FG001|Overall Study|Lost to Follow-up|2|||
130879169|NCT03182374|471191260|FG000|Overall Study|Lack of Efficacy|8|||
130879170|NCT03182374|471191261|FG001|Overall Study|Lack of Efficacy|14|||
130879171|NCT03182374|471191260|FG000|Overall Study|Withdrawal by Subject|1|||
130879172|NCT03182374|471191261|FG001|Overall Study|Withdrawal by Subject|1|||
130879173|NCT03182374|471191260|FG000|Overall Study|exit for non-compliance|1|||
130879174|NCT03182374|471191261|FG001|Overall Study|exit for non-compliance|1|||
130879175|NCT03182374|471191260|FG000|Overall Study|one subject was randomized but not treated|1|||
130879176|NCT03182374|471191261|FG001|Overall Study|one subject was randomized but not treated|0|||
130879177|NCT03182374|471191260|FG000|Overall Study|Other reasons|0|||
130879178|NCT03182374|471191261|FG001|Overall Study|Other reasons|3|||
130879179|NCT03085095|471191262|FG000|Overall Study|Adverse Event|23|||
130879180|NCT03085095|471191263|FG001|Overall Study|Adverse Event|8|||
130879181|NCT03085095|471191262|FG000|Overall Study|Protocol Violation|0|||
130879182|NCT03085095|471191263|FG001|Overall Study|Protocol Violation|1|||
130879183|NCT03085095|471191262|FG000|Overall Study|Lost to Follow-up|2|||
130879184|NCT03085095|471191263|FG001|Overall Study|Lost to Follow-up|1|||
130879185|NCT03085095|471191262|FG000|Overall Study|Withdrawal by Subject|17|||
130879186|NCT03085095|471191263|FG001|Overall Study|Withdrawal by Subject|6|||
130879187|NCT03085095|471191262|FG000|Overall Study|Physician Decision|9|||
130879188|NCT03085095|471191263|FG001|Overall Study|Physician Decision|3|||
130879189|NCT03085095|471191262|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
130879190|NCT03085095|471191263|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
130879191|NCT03085095|471191262|FG000|Overall Study|Did not Receive Study Drug|2|||
130879192|NCT03085095|471191263|FG001|Overall Study|Did not Receive Study Drug|2|||
130879193|NCT03085095|471191262|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
130879194|NCT03085095|471191263|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
130879195|NCT00408317|471191264|FG000|First Intervention Period|Adverse Event|0|||
130879196|NCT00408317|471191265|FG001|First Intervention Period|Adverse Event|1|||
130879197|NCT00408317|471191264|FG000|Second Intervention Period|Adverse Event|2|||
130879198|NCT00408317|471191265|FG001|Second Intervention Period|Adverse Event|0|||
130879199|NCT00408317|471191264|FG000|Second Intervention Period|Protocol Violation|0|||
130879200|NCT00408317|471191265|FG001|Second Intervention Period|Protocol Violation|1|||
130990328|NCT02508532|471593153|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
130879201|NCT00408317|471191264|FG000|Second Intervention Period|Withdrawal of consent|0|||
130879202|NCT00408317|471191265|FG001|Second Intervention Period|Withdrawal of consent|1|||
130879203|NCT03822117|471191266|FG000|Overall Study|Death|18|||
130879204|NCT03822117|471191267|FG001|Overall Study|Death|17|||
130879205|NCT03822117|471191268|FG002|Overall Study|Death|12|||
130879206|NCT03822117|471191269|FG003|Overall Study|Death|4|||
130879207|NCT03822117|471191266|FG000|Overall Study|Lost to Follow-up|1|||
130879208|NCT03822117|471191267|FG001|Overall Study|Lost to Follow-up|2|||
130879209|NCT03822117|471191268|FG002|Overall Study|Lost to Follow-up|3|||
130879210|NCT03822117|471191269|FG003|Overall Study|Lost to Follow-up|0|||
130879211|NCT03822117|471191266|FG000|Overall Study|Study Terminated by Sponsor|25|||
130879212|NCT03822117|471191267|FG001|Overall Study|Study Terminated by Sponsor|11|||
130879213|NCT03822117|471191268|FG002|Overall Study|Study Terminated by Sponsor|6|||
130879214|NCT03822117|471191269|FG003|Overall Study|Study Terminated by Sponsor|0|||
130879215|NCT03822117|471191266|FG000|Overall Study|Withdrawal by Subject|4|||
130879216|NCT03822117|471191267|FG001|Overall Study|Withdrawal by Subject|0|||
130879217|NCT03822117|471191268|FG002|Overall Study|Withdrawal by Subject|3|||
130879218|NCT03822117|471191269|FG003|Overall Study|Withdrawal by Subject|0|||
130879219|NCT03822117|471191266|FG000|Overall Study|Disease Progression|1|||
130879220|NCT03822117|471191267|FG001|Overall Study|Disease Progression|2|||
130879221|NCT03822117|471191268|FG002|Overall Study|Disease Progression|1|||
130879222|NCT03822117|471191269|FG003|Overall Study|Disease Progression|0|||
130879223|NCT03822117|471191266|FG000|Overall Study|Never Returned to Hospital|0|||
130879224|NCT03822117|471191267|FG001|Overall Study|Never Returned to Hospital|0|||
130879225|NCT03822117|471191268|FG002|Overall Study|Never Returned to Hospital|1|||
130879226|NCT03822117|471191269|FG003|Overall Study|Never Returned to Hospital|0|||
130879227|NCT01074502|471191270|FG000|Overall Study|Withdrawal by Subject|1|||
130879228|NCT03459079|471191271|FG000|Overall Study|Adverse Event|4|||
130879229|NCT03459079|471191272|FG001|Overall Study|Adverse Event|2|||
130879230|NCT03459079|471191273|FG002|Overall Study|Adverse Event|0|||
130879231|NCT03459079|471191271|FG000|Overall Study|Withdrawal by Subject|2|||
130879232|NCT03459079|471191272|FG001|Overall Study|Withdrawal by Subject|2|||
130879233|NCT03459079|471191273|FG002|Overall Study|Withdrawal by Subject|0|||
130879234|NCT03198715|471191274|FG000|Overall Study|Death|0|||
130879235|NCT03198715|471191275|FG001|Overall Study|Death|0|||
130879236|NCT03198715|471191276|FG002|Overall Study|Death|1|||
130879237|NCT03198715|471191277|FG003|Overall Study|Death|0|||
130879238|NCT03198715|471191278|FG004|Overall Study|Death|2|||
130879239|NCT03198715|471191274|FG000|Overall Study|Other|0|||
130879240|NCT03198715|471191275|FG001|Overall Study|Other|1|||
130879241|NCT03198715|471191276|FG002|Overall Study|Other|1|||
130879242|NCT03198715|471191277|FG003|Overall Study|Other|0|||
130879243|NCT03198715|471191278|FG004|Overall Study|Other|0|||
130879244|NCT02118584|471191280|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
130879245|NCT02118584|471191281|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
130879246|NCT02118584|471191282|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
130879247|NCT02118584|471191280|FG000|Part 1: Open Label Extension Period|Death|9|||
130879248|NCT02118584|471191281|FG001|Part 1: Open Label Extension Period|Death|0|||
130879249|NCT02118584|471191282|FG002|Part 1: Open Label Extension Period|Death|0|||
130879250|NCT02118584|471191280|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
130879251|NCT02118584|471191281|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
130879252|NCT02118584|471191282|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
130879253|NCT02118584|471191280|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
130879254|NCT02118584|471191281|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
130879255|NCT02118584|471191282|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
130879256|NCT02118584|471191280|FG000|Part 1: Open Label Extension Period|Other|135|||
130879257|NCT02118584|471191281|FG001|Part 1: Open Label Extension Period|Other|0|||
130879258|NCT02118584|471191282|FG002|Part 1: Open Label Extension Period|Other|0|||
130879259|NCT02118584|471191280|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
130879260|NCT02118584|471191281|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
130879261|NCT02118584|471191282|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
130879262|NCT02118584|471191280|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
130879263|NCT02118584|471191281|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
130879264|NCT02118584|471191282|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
130879265|NCT02118584|471191280|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
130879266|NCT02118584|471191281|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
130879267|NCT02118584|471191282|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
130879268|NCT02118584|471191280|FG000|Part 1: Open Label Extension Period|Other|3|||
130879269|NCT02118584|471191281|FG001|Part 1: Open Label Extension Period|Other|0|||
130879270|NCT02118584|471191282|FG002|Part 1: Open Label Extension Period|Other|0|||
130879271|NCT02118584|471191280|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
130879272|NCT02118584|471191281|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
130879273|NCT02118584|471191282|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
130879274|NCT02118584|471191280|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
131213268|NCT03110107|472405299|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
131213269|NCT03110107|472405300|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
131213270|NCT03110107|472405301|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
131213271|NCT03110107|472405302|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
131213272|NCT03110107|472405303|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
131213273|NCT03110107|472405304|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
131213274|NCT03110107|472405305|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
131213275|NCT03110107|472405306|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
131213276|NCT03110107|472405307|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
131213277|NCT03110107|472405308|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
131213278|NCT03110107|472405309|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
131213279|NCT03110107|472405310|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
131213280|NCT03110107|472405311|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
131213281|NCT03110107|472405312|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
131213282|NCT03110107|472405313|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
131213283|NCT03110107|472405314|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
131213284|NCT03110107|472405315|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
131213285|NCT03110107|472405316|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
131213286|NCT03110107|472405317|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
131213287|NCT03110107|472405292|FG000|Treatment Period|Participant withdrew consent|0|||
131213288|NCT03110107|472405293|FG001|Treatment Period|Participant withdrew consent|0|||
131213289|NCT03110107|472405294|FG002|Treatment Period|Participant withdrew consent|1|||
131213290|NCT03110107|472405295|FG003|Treatment Period|Participant withdrew consent|0|||
131213291|NCT03110107|472405296|FG004|Treatment Period|Participant withdrew consent|4|||
131213292|NCT03110107|472405297|FG005|Treatment Period|Participant withdrew consent|3|||
131213293|NCT03110107|472405298|FG006|Treatment Period|Participant withdrew consent|0|||
131213294|NCT03110107|472405299|FG007|Treatment Period|Participant withdrew consent|0|||
131213295|NCT03110107|472405300|FG008|Treatment Period|Participant withdrew consent|0|||
131213296|NCT03110107|472405301|FG009|Treatment Period|Participant withdrew consent|1|||
131213297|NCT03110107|472405302|FG010|Treatment Period|Participant withdrew consent|0|||
131213298|NCT03110107|472405303|FG011|Treatment Period|Participant withdrew consent|0|||
131213299|NCT03110107|472405304|FG012|Treatment Period|Participant withdrew consent|0|||
131213300|NCT03110107|472405305|FG013|Treatment Period|Participant withdrew consent|0|||
131213301|NCT03110107|472405306|FG014|Treatment Period|Participant withdrew consent|0|||
131213302|NCT03110107|472405307|FG015|Treatment Period|Participant withdrew consent|0|||
131213303|NCT03110107|472405308|FG016|Treatment Period|Participant withdrew consent|0|||
131213304|NCT03110107|472405309|FG017|Treatment Period|Participant withdrew consent|0|||
131213305|NCT03110107|472405310|FG018|Treatment Period|Participant withdrew consent|0|||
131213306|NCT03110107|472405311|FG019|Treatment Period|Participant withdrew consent|1|||
131213307|NCT03110107|472405312|FG020|Treatment Period|Participant withdrew consent|0|||
131213308|NCT03110107|472405313|FG021|Treatment Period|Participant withdrew consent|2|||
131213309|NCT03110107|472405314|FG022|Treatment Period|Participant withdrew consent|0|||
131213310|NCT03110107|472405315|FG023|Treatment Period|Participant withdrew consent|0|||
131213311|NCT03110107|472405316|FG024|Treatment Period|Participant withdrew consent|0|||
131213312|NCT03110107|472405317|FG025|Treatment Period|Participant withdrew consent|2|||
131213313|NCT03110107|472405292|FG000|Treatment Period|Participants no longer meets study criteria|0|||
131213314|NCT03110107|472405293|FG001|Treatment Period|Participants no longer meets study criteria|0|||
131213315|NCT03110107|472405294|FG002|Treatment Period|Participants no longer meets study criteria|0|||
131213316|NCT03110107|472405295|FG003|Treatment Period|Participants no longer meets study criteria|0|||
131213317|NCT03110107|472405296|FG004|Treatment Period|Participants no longer meets study criteria|0|||
131213318|NCT03110107|472405297|FG005|Treatment Period|Participants no longer meets study criteria|0|||
131213319|NCT03110107|472405298|FG006|Treatment Period|Participants no longer meets study criteria|0|||
131213320|NCT03110107|472405299|FG007|Treatment Period|Participants no longer meets study criteria|0|||
131213321|NCT03110107|472405300|FG008|Treatment Period|Participants no longer meets study criteria|0|||
131213322|NCT03110107|472405301|FG009|Treatment Period|Participants no longer meets study criteria|0|||
131213323|NCT03110107|472405302|FG010|Treatment Period|Participants no longer meets study criteria|0|||
130879275|NCT02118584|471191281|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
130879276|NCT02118584|471191282|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
130879277|NCT02118584|471191280|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
130879278|NCT02118584|471191281|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
130879279|NCT02118584|471191282|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
130879280|NCT02118584|471191280|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
130879281|NCT02118584|471191281|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
130879282|NCT02118584|471191282|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
130879283|NCT02118584|471191280|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
130879284|NCT02118584|471191281|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
130879285|NCT02118584|471191282|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
130879286|NCT02118584|471191280|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
130879287|NCT02118584|471191281|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
130879288|NCT02118584|471191282|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
130879289|NCT02118584|471191280|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
130879290|NCT02118584|471191281|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
130879291|NCT02118584|471191282|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
130879292|NCT02118584|471191280|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
130879293|NCT02118584|471191281|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
130879294|NCT02118584|471191282|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
130879295|NCT02118584|471191280|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
130879296|NCT02118584|471191281|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
130879297|NCT02118584|471191282|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
130879298|NCT04026113|471191286|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
130879299|NCT04026113|471191287|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
130879300|NCT04026113|471191288|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130879301|NCT04026113|471191289|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
130879302|NCT04026113|471191286|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
130879303|NCT04026113|471191287|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
130879304|NCT04026113|471191288|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130879305|NCT04026113|471191289|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
130879306|NCT04026113|471191286|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
130879307|NCT04026113|471191287|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130879308|NCT04026113|471191288|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130879309|NCT04026113|471191289|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130879310|NCT04026113|471191286|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
130879311|NCT04026113|471191287|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
130879312|NCT04026113|471191288|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
130879313|NCT04026113|471191289|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
130879314|NCT04026113|471191286|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
130879315|NCT04026113|471191287|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
130879316|NCT04026113|471191288|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
130879317|NCT04026113|471191289|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
130879318|NCT04026113|471191286|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
130879319|NCT04026113|471191287|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
130879320|NCT04026113|471191288|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130879321|NCT04026113|471191289|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130879322|NCT04026113|471191286|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
130879323|NCT04026113|471191287|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
130879324|NCT04026113|471191288|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
130879325|NCT04026113|471191289|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
130879326|NCT04026113|471191286|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130879327|NCT04026113|471191287|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
130879328|NCT04026113|471191288|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130879329|NCT04026113|471191289|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130879330|NCT04026113|471191286|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
130879331|NCT04026113|471191287|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
130879332|NCT04026113|471191288|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
130879333|NCT04026113|471191289|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
130879334|NCT04613362|471191290|FG000|3 Month Follow-up|Lost to Follow-up|1|||
130879335|NCT04613362|471191291|FG001|3 Month Follow-up|Lost to Follow-up|2|||
130879336|NCT04613362|471191290|FG000|6 Month Follow-up|Lost to Follow-up|0|||
130879337|NCT04613362|471191291|FG001|6 Month Follow-up|Lost to Follow-up|1|||
130879338|NCT02218372|471191292|FG000|Overall Study|Adverse Event|1|||
130879339|NCT02218372|471191293|FG001|Overall Study|Adverse Event|1|||
130879340|NCT02218372|471191292|FG000|Overall Study|Miscellaneous|2|||
130879341|NCT02218372|471191293|FG001|Overall Study|Miscellaneous|1|||
130879342|NCT02218372|471191292|FG000|Overall Study|Randomized but did not receive treatment|2|||
130879343|NCT02218372|471191293|FG001|Overall Study|Randomized but did not receive treatment|3|||
130879344|NCT02218372|471191292|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130879345|NCT02218372|471191293|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130879346|NCT00074711|471191302|FG000|Overall Study|Withdrawal by Subject|1|||
130879347|NCT00074711|471191303|FG001|Overall Study|Withdrawal by Subject|1|||
130879348|NCT00074711|471191302|FG000|Overall Study|Lost to Follow-up|10|||
130879349|NCT00074711|471191303|FG001|Overall Study|Lost to Follow-up|8|||
130879350|NCT00074711|471191302|FG000|Overall Study|Participant stopped study drug|4|||
130879351|NCT00074711|471191303|FG001|Overall Study|Participant stopped study drug|6|||
130879352|NCT00671658|471191304|FG000|Overall Study|Physician Decision|5|||
130879353|NCT01921205|471191305|FG000|Overall Study|Adverse Event|12|||
130879354|NCT01921205|471191306|FG001|Overall Study|Adverse Event|7|||
130879355|NCT01921205|471191305|FG000|Overall Study|Lack of Efficacy|1|||
130879356|NCT01921205|471191306|FG001|Overall Study|Lack of Efficacy|0|||
130879357|NCT01921205|471191305|FG000|Overall Study|Protocol Violation|1|||
130879358|NCT01921205|471191306|FG001|Overall Study|Protocol Violation|3|||
130879359|NCT01921205|471191305|FG000|Overall Study|Lost to Follow-up|1|||
130879360|NCT01921205|471191306|FG001|Overall Study|Lost to Follow-up|1|||
130879361|NCT01921205|471191305|FG000|Overall Study|Withdrawal by Subject|6|||
130879362|NCT01921205|471191306|FG001|Overall Study|Withdrawal by Subject|5|||
130879363|NCT01921205|471191305|FG000|Overall Study|Use Of Prohibited Medication|0|||
130879364|NCT01921205|471191306|FG001|Overall Study|Use Of Prohibited Medication|1|||
130879365|NCT01921205|471191305|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
130879366|NCT01921205|471191306|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
130879367|NCT01921205|471191305|FG000|Overall Study|Non Compliance Of The Parent|0|||
130879368|NCT01921205|471191306|FG001|Overall Study|Non Compliance Of The Parent|1|||
130879369|NCT01921205|471191305|FG000|Overall Study|Non Compliance Of Child|0|||
130879370|NCT01921205|471191306|FG001|Overall Study|Non Compliance Of Child|1|||
130879371|NCT01527149|471191308|FG000|Overall Study|Death|2|||
130879372|NCT01680341|471191310|FG000|Overall Study|Adverse Event|3|||
130879373|NCT01680341|471191311|FG001|Overall Study|Adverse Event|2|||
130879374|NCT01680341|471191310|FG000|Overall Study|Unclassified|18|||
130879375|NCT01680341|471191311|FG001|Overall Study|Unclassified|15|||
130879376|NCT00481832|471191312|FG000|Enrollment|Physician Decision|8|||
130879377|NCT00481832|471191312|FG000|Enrollment|Unable to collect enough stem cells|2|||
130879378|NCT00481832|471191312|FG000|Inter-transplant Period|Adverse Event|4|||
130879379|NCT00481832|471191312|FG000|Inter-transplant Period|Death|3|||
130879380|NCT00481832|471191312|FG000|Inter-transplant Period|Physician Decision|4|||
130879381|NCT00481832|471191312|FG000|Inter-transplant Period|Disease relapse|11|||
130879382|NCT00481832|471191312|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
130879383|NCT02558894|471191315|FG000|Overall Study|Death; any cause, entire study duration|28|||
130879384|NCT02558894|471191316|FG001|Overall Study|Death; any cause, entire study duration|31|||
130879385|NCT02558894|471191315|FG000|Overall Study|Withdrawal by Subject|2|||
130879386|NCT02558894|471191316|FG001|Overall Study|Withdrawal by Subject|1|||
130879387|NCT02558894|471191315|FG000|Overall Study|Closure of Part A|2|||
130879388|NCT02558894|471191316|FG001|Overall Study|Closure of Part A|1|||
130879389|NCT02992288|471191317|FG000|Overall Study|Adverse Event|8|||
130879390|NCT02992288|471191318|FG001|Overall Study|Adverse Event|2|||
130879391|NCT02992288|471191319|FG002|Overall Study|Adverse Event|2|||
130879392|NCT02992288|471191320|FG003|Overall Study|Adverse Event|2|||
130879393|NCT02992288|471191321|FG004|Overall Study|Adverse Event|2|||
130879394|NCT02992288|471191322|FG005|Overall Study|Adverse Event|7|||
130879395|NCT02992288|471191317|FG000|Overall Study|Non-compliance with study drug|0|||
130879396|NCT02992288|471191318|FG001|Overall Study|Non-compliance with study drug|1|||
130879397|NCT02992288|471191319|FG002|Overall Study|Non-compliance with study drug|1|||
130879398|NCT02992288|471191320|FG003|Overall Study|Non-compliance with study drug|0|||
130879399|NCT02992288|471191321|FG004|Overall Study|Non-compliance with study drug|1|||
130879400|NCT02992288|471191322|FG005|Overall Study|Non-compliance with study drug|0|||
130990329|NCT02508532|471593154|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
130990330|NCT02508532|471593155|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
130990331|NCT02508532|471593156|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
130879401|NCT02992288|471191317|FG000|Overall Study|Physician Decision|3|||
130879402|NCT02992288|471191318|FG001|Overall Study|Physician Decision|0|||
130990332|NCT02508532|471593157|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
130990333|NCT02508532|471593158|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
130879403|NCT02992288|471191319|FG002|Overall Study|Physician Decision|1|||
130879404|NCT02992288|471191320|FG003|Overall Study|Physician Decision|0|||
130879405|NCT02992288|471191321|FG004|Overall Study|Physician Decision|0|||
130879406|NCT02992288|471191322|FG005|Overall Study|Physician Decision|1|||
130879407|NCT02992288|471191317|FG000|Overall Study|Death|2|||
130879408|NCT02992288|471191318|FG001|Overall Study|Death|0|||
130990334|NCT02508532|471593150|FG000|Part 2 - Treatment|Disease Progression|0|||
130879409|NCT02992288|471191319|FG002|Overall Study|Death|2|||
130879410|NCT02992288|471191320|FG003|Overall Study|Death|1|||
130879411|NCT02992288|471191321|FG004|Overall Study|Death|2|||
130879412|NCT02992288|471191322|FG005|Overall Study|Death|0|||
130879413|NCT02992288|471191317|FG000|Overall Study|Lost to Follow-up|0|||
130879414|NCT02992288|471191318|FG001|Overall Study|Lost to Follow-up|0|||
130879415|NCT02992288|471191319|FG002|Overall Study|Lost to Follow-up|0|||
130879416|NCT02992288|471191320|FG003|Overall Study|Lost to Follow-up|1|||
130879417|NCT02992288|471191321|FG004|Overall Study|Lost to Follow-up|0|||
130879418|NCT02992288|471191322|FG005|Overall Study|Lost to Follow-up|0|||
130879419|NCT02992288|471191317|FG000|Overall Study|Protocol Violation|0|||
130879420|NCT02992288|471191318|FG001|Overall Study|Protocol Violation|0|||
130879421|NCT02992288|471191319|FG002|Overall Study|Protocol Violation|0|||
130879422|NCT02992288|471191320|FG003|Overall Study|Protocol Violation|0|||
130879423|NCT02992288|471191321|FG004|Overall Study|Protocol Violation|0|||
130879424|NCT02992288|471191322|FG005|Overall Study|Protocol Violation|1|||
130879425|NCT02992288|471191317|FG000|Overall Study|Withdrawal by Subject|4|||
130879426|NCT02992288|471191318|FG001|Overall Study|Withdrawal by Subject|2|||
130879427|NCT02992288|471191319|FG002|Overall Study|Withdrawal by Subject|1|||
130879428|NCT02992288|471191320|FG003|Overall Study|Withdrawal by Subject|5|||
130879429|NCT02992288|471191321|FG004|Overall Study|Withdrawal by Subject|3|||
130879430|NCT02992288|471191322|FG005|Overall Study|Withdrawal by Subject|4|||
130879431|NCT02006472|471191326|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
130879432|NCT02006472|471191327|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
130879433|NCT02006472|471191328|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
130879434|NCT02006472|471191329|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
130879435|NCT02006472|471191330|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
130879436|NCT02006472|471191326|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130879437|NCT02006472|471191327|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130879438|NCT02006472|471191328|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
130879439|NCT02006472|471191329|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130879440|NCT02006472|471191330|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130879441|NCT02006472|471191326|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
130879442|NCT02006472|471191327|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
130879443|NCT02006472|471191328|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
130879444|NCT02006472|471191329|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
130879445|NCT02006472|471191330|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
130879446|NCT02006472|471191326|FG000|Period 1 (Through Week 26)|Other|1|||
130879447|NCT02006472|471191327|FG001|Period 1 (Through Week 26)|Other|5|||
130879448|NCT02006472|471191328|FG002|Period 1 (Through Week 26)|Other|0|||
130879449|NCT02006472|471191329|FG003|Period 1 (Through Week 26)|Other|2|||
130879450|NCT02006472|471191330|FG004|Period 1 (Through Week 26)|Other|3|||
130879451|NCT02006472|471191326|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
130879452|NCT02006472|471191327|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
130879453|NCT02006472|471191328|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
130879454|NCT02006472|471191329|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
130879455|NCT02006472|471191330|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
130879456|NCT02006472|471191326|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
130879457|NCT02006472|471191327|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
130879458|NCT02006472|471191328|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
130879459|NCT02006472|471191329|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
130879460|NCT02006472|471191330|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
130879461|NCT02006472|471191326|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
130879462|NCT02006472|471191327|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
130879463|NCT02006472|471191328|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
130879464|NCT02006472|471191329|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
130879465|NCT02006472|471191330|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
130879466|NCT02006472|471191326|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
130879467|NCT02006472|471191327|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
130879468|NCT02006472|471191328|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
130879469|NCT02006472|471191329|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
130879470|NCT02006472|471191330|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
130879471|NCT02006472|471191326|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
130879472|NCT02006472|471191327|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
130879473|NCT02006472|471191328|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
130879474|NCT02006472|471191329|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
130879475|NCT02006472|471191330|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
130879476|NCT02006472|471191326|FG000|Period 2 (Through Week 52)|Other|0|||
130879477|NCT02006472|471191327|FG001|Period 2 (Through Week 52)|Other|1|||
130879478|NCT02006472|471191328|FG002|Period 2 (Through Week 52)|Other|0|||
130879479|NCT02006472|471191329|FG003|Period 2 (Through Week 52)|Other|1|||
130879480|NCT02006472|471191330|FG004|Period 2 (Through Week 52)|Other|0|||
130879481|NCT02006472|471191326|FG000|Period 2 (Through Week 52)|Not treated|0|||
130879482|NCT02006472|471191327|FG001|Period 2 (Through Week 52)|Not treated|0|||
130879483|NCT02006472|471191328|FG002|Period 2 (Through Week 52)|Not treated|2|||
130879484|NCT02006472|471191329|FG003|Period 2 (Through Week 52)|Not treated|0|||
130879485|NCT02006472|471191330|FG004|Period 2 (Through Week 52)|Not treated|0|||
130879486|NCT02006472|471191326|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
130879487|NCT02006472|471191327|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
130879488|NCT02006472|471191328|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
130879489|NCT02006472|471191329|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
130879490|NCT02006472|471191330|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
130879491|NCT02006472|471191326|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
130879492|NCT02006472|471191327|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
130879493|NCT02006472|471191328|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
130879494|NCT02006472|471191329|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
130879495|NCT02006472|471191330|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
130879496|NCT00499486|471191331|FG000|Overall Study|Withdrawal by Subject|16|||
130879497|NCT00087152|471191332|FG000|Overall Study|Ineligible|6|||
130879498|NCT03125395|471191334|FG000|Overall Study|Adverse Event|2|||
130879499|NCT03125395|471191334|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130879500|NCT03125395|471191334|FG000|Overall Study|Physician Decision|2|||
130879501|NCT03125395|471191334|FG000|Overall Study|Commercial drug is available|5|||
130879502|NCT01780506|471191335|FG000|Double-Blind Phase|Randomized but not Treated|3|||
130879503|NCT01780506|471191336|FG001|Double-Blind Phase|Randomized but not Treated|2|||
130879504|NCT01780506|471191335|FG000|Double-Blind Phase|Adverse Event|4|||
130879505|NCT01780506|471191336|FG001|Double-Blind Phase|Adverse Event|14|||
130879506|NCT01780506|471191335|FG000|Double-Blind Phase|Death|1|||
130879507|NCT01780506|471191336|FG001|Double-Blind Phase|Death|2|||
130879508|NCT01780506|471191335|FG000|Double-Blind Phase|Pregnancy|2|||
130879509|NCT01780506|471191336|FG001|Double-Blind Phase|Pregnancy|1|||
130879510|NCT01780506|471191335|FG000|Double-Blind Phase|Lack of Efficacy|1|||
130879511|NCT01780506|471191336|FG001|Double-Blind Phase|Lack of Efficacy|1|||
130879512|NCT01780506|471191335|FG000|Double-Blind Phase|Investigator's Discretion|5|||
130879513|NCT01780506|471191336|FG001|Double-Blind Phase|Investigator's Discretion|2|||
130879514|NCT01780506|471191335|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
130879515|NCT01780506|471191336|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
130879516|NCT01780506|471191335|FG000|Double-Blind Phase|Protocol Violation|4|||
130879517|NCT01780506|471191336|FG001|Double-Blind Phase|Protocol Violation|3|||
130879518|NCT01780506|471191335|FG000|Double-Blind Phase|Withdrew Consent|23|||
130879519|NCT01780506|471191336|FG001|Double-Blind Phase|Withdrew Consent|24|||
130879520|NCT01780506|471191335|FG000|Double-Blind Phase|Lost to Follow-up|23|||
130879521|NCT01780506|471191336|FG001|Double-Blind Phase|Lost to Follow-up|26|||
130879522|NCT01780506|471191335|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
130879523|NCT01780506|471191336|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
130879524|NCT05236270|471191337|FG000|Overall Study|Lost to Follow-up|3|||
130879525|NCT05236270|471191338|FG001|Overall Study|Lost to Follow-up|2|||
130879526|NCT05236270|471191339|FG002|Overall Study|Lost to Follow-up|0|||
130879527|NCT05236270|471191340|FG003|Overall Study|Lost to Follow-up|0|||
130879528|NCT05236270|471191341|FG004|Overall Study|Lost to Follow-up|2|||
130879529|NCT05236270|471191342|FG005|Overall Study|Lost to Follow-up|0|||
130879530|NCT05236270|471191343|FG006|Overall Study|Lost to Follow-up|1|||
130879531|NCT05236270|471191344|FG007|Overall Study|Lost to Follow-up|3|||
130879532|NCT01499940|471191345|FG000|Overall Study|Study was withdrawn before completion.|9|||
130879533|NCT01436149|471191346|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
130879534|NCT01436149|471191347|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
130879535|NCT01436149|471191348|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
130879536|NCT01436149|471191346|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
130879537|NCT01436149|471191347|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
130879538|NCT01436149|471191348|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
130879539|NCT01436149|471191346|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
130879540|NCT01436149|471191347|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130879541|NCT01436149|471191348|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130879542|NCT01436149|471191346|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
130879543|NCT01436149|471191347|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130879544|NCT01436149|471191348|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130879545|NCT01436149|471191346|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
130879546|NCT01436149|471191347|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
130879547|NCT01436149|471191348|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
130879548|NCT01436149|471191346|FG000|Antidepressant Lead-in Phase|Other|119|||
130879549|NCT01436149|471191347|FG001|Antidepressant Lead-in Phase|Other|0|||
130879550|NCT01436149|471191348|FG002|Antidepressant Lead-in Phase|Other|0|||
130879551|NCT01436149|471191346|FG000|Randomized Phase|Adverse Event|9|||
130879552|NCT01436149|471191347|FG001|Randomized Phase|Adverse Event|10|||
130879553|NCT01436149|471191348|FG002|Randomized Phase|Adverse Event|11|||
130879554|NCT01436149|471191346|FG000|Randomized Phase|Protocol Violation|4|||
130879555|NCT01436149|471191347|FG001|Randomized Phase|Protocol Violation|5|||
130879556|NCT01436149|471191348|FG002|Randomized Phase|Protocol Violation|0|||
130879557|NCT01436149|471191346|FG000|Randomized Phase|Withdrawal by Subject|16|||
130879558|NCT01436149|471191347|FG001|Randomized Phase|Withdrawal by Subject|10|||
130879559|NCT01436149|471191348|FG002|Randomized Phase|Withdrawal by Subject|10|||
130879560|NCT01436149|471191346|FG000|Randomized Phase|Lost to Follow-up|34|||
130879561|NCT01436149|471191347|FG001|Randomized Phase|Lost to Follow-up|5|||
130879562|NCT01436149|471191348|FG002|Randomized Phase|Lost to Follow-up|6|||
130879563|NCT01436149|471191346|FG000|Randomized Phase|Lack of Efficacy|0|||
130879564|NCT01436149|471191347|FG001|Randomized Phase|Lack of Efficacy|0|||
130879565|NCT01436149|471191348|FG002|Randomized Phase|Lack of Efficacy|1|||
130879566|NCT01436149|471191346|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
130879567|NCT01436149|471191347|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
130879568|NCT01436149|471191348|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
130879569|NCT01436149|471191346|FG000|Randomized Phase|Other|12|||
130879570|NCT01436149|471191347|FG001|Randomized Phase|Other|5|||
130879571|NCT01436149|471191348|FG002|Randomized Phase|Other|11|||
130879572|NCT01643668|471191352|FG000|Overall Study|Death|1|||
130879573|NCT00322881|471191353|FG000|Overall Study|Death|2|||
130879574|NCT00322881|471191353|FG000|Overall Study|Adverse Event|1|||
130879575|NCT00322881|471191353|FG000|Overall Study|Disease Progression|2|||
130879576|NCT00561652|471191354|FG000|Overall Study|Withdrawal by Subject|0|||
130879577|NCT00561652|471191355|FG001|Overall Study|Withdrawal by Subject|1|||
130879578|NCT05417438|471191361|FG000|Overall Study|Withdrawal by Subject|3|||
130879579|NCT03780244|471193031|FG000|Overall Study|Lost to Follow-up|1|||
130879580|NCT03780244|471193032|FG001|Overall Study|Lost to Follow-up|0|||
130879581|NCT00804908|471193035|FG000|Overall Study|Other|115|||
130879582|NCT00804908|471193036|FG001|Overall Study|Other|116|||
130879583|NCT00804908|471193037|FG002|Overall Study|Other|114|||
130879584|NCT03181932|471193038|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
130879585|NCT03181932|471193039|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
130879586|NCT03181932|471193038|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
130879587|NCT03181932|471193039|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
130879588|NCT03181932|471193038|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
130879589|NCT03181932|471193039|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
130879590|NCT03181932|471193038|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
130879591|NCT03181932|471193039|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
130879592|NCT03181932|471193038|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
130879593|NCT03181932|471193039|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
130879594|NCT03181932|471193038|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
130879595|NCT03181932|471193039|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
130879596|NCT03181932|471193038|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
130879597|NCT03181932|471193039|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
130879598|NCT03181932|471193038|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
130879599|NCT03181932|471193039|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
130879600|NCT03181932|471193038|FG000|Period 2 (Open-label Period)|Reason missing|2|||
130879601|NCT03181932|471193039|FG001|Period 2 (Open-label Period)|Reason missing|0|||
130879602|NCT02220920|471193041|FG000|Overall Study|Adverse Event|1|||
130879603|NCT02220920|471193042|FG001|Overall Study|Adverse Event|0|||
130879604|NCT02220920|471193041|FG000|Overall Study|Lack of Efficacy|0|||
130879605|NCT02220920|471193042|FG001|Overall Study|Lack of Efficacy|1|||
130879606|NCT02220920|471193041|FG000|Overall Study|Withdrawal by Subject|1|||
130879607|NCT02220920|471193042|FG001|Overall Study|Withdrawal by Subject|0|||
130879608|NCT02220920|471193041|FG000|Overall Study|Conflict with the stopping criteria|1|||
130879609|NCT02220920|471193042|FG001|Overall Study|Conflict with the stopping criteria|2|||
130879610|NCT02177123|471193043|FG000|Overall Study|Lost to Follow-up|6|||
130879611|NCT02177123|471193043|FG000|Overall Study|Withdrawal by Subject|4|||
130879612|NCT02177123|471193043|FG000|Overall Study|Adverse Event|4|||
130879613|NCT02177123|471193043|FG000|Overall Study|Physician Decision|3|||
130879614|NCT02177123|471193043|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
130879615|NCT02177123|471193043|FG000|Overall Study|Excluded for medical reasons|2|||
130879616|NCT02177123|471193043|FG000|Overall Study|Death|1|||
130879617|NCT02177123|471193043|FG000|Overall Study|Other|1|||
130879618|NCT02177123|471193043|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
130879619|NCT06271993|471193044|FG000|Overall Study|Not reactive to histamine|5|||
130879620|NCT06271993|471193045|FG001|Overall Study|Not reactive to histamine|5|||
130879621|NCT06271993|471193046|FG002|Overall Study|Not reactive to histamine|5|||
130879622|NCT03103542|471193047|FG000|Overall Study|Physician Decision|2|||
130879623|NCT03103542|471193047|FG000|Overall Study|Adverse Event|2|||
130879624|NCT03103542|471193047|FG000|Overall Study|Other|2|||
130879625|NCT03103542|471193047|FG000|Overall Study|Withdrawal by Subject|1|||
130879626|NCT03566511|471193048|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
130879627|NCT03566511|471193049|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
130879628|NCT02939287|471193051|FG000|Overall Study|met exclusion criteria|1|||
130879629|NCT02939287|471193052|FG001|Overall Study|met exclusion criteria|1|||
130879630|NCT02939287|471193053|FG002|Overall Study|met exclusion criteria|1|||
130879631|NCT02939287|471193051|FG000|Overall Study|Did not complete survey|2|||
131213324|NCT03110107|472405303|FG011|Treatment Period|Participants no longer meets study criteria|0|||
131213325|NCT03110107|472405304|FG012|Treatment Period|Participants no longer meets study criteria|0|||
131213326|NCT03110107|472405305|FG013|Treatment Period|Participants no longer meets study criteria|0|||
131213327|NCT03110107|472405306|FG014|Treatment Period|Participants no longer meets study criteria|0|||
131213328|NCT03110107|472405307|FG015|Treatment Period|Participants no longer meets study criteria|0|||
131213329|NCT03110107|472405308|FG016|Treatment Period|Participants no longer meets study criteria|0|||
131213330|NCT03110107|472405309|FG017|Treatment Period|Participants no longer meets study criteria|0|||
131213331|NCT03110107|472405310|FG018|Treatment Period|Participants no longer meets study criteria|0|||
131213332|NCT03110107|472405311|FG019|Treatment Period|Participants no longer meets study criteria|0|||
131213333|NCT03110107|472405312|FG020|Treatment Period|Participants no longer meets study criteria|0|||
131213334|NCT03110107|472405313|FG021|Treatment Period|Participants no longer meets study criteria|0|||
131213335|NCT03110107|472405314|FG022|Treatment Period|Participants no longer meets study criteria|0|||
131213336|NCT03110107|472405315|FG023|Treatment Period|Participants no longer meets study criteria|1|||
131213337|NCT03110107|472405316|FG024|Treatment Period|Participants no longer meets study criteria|0|||
131213338|NCT03110107|472405317|FG025|Treatment Period|Participants no longer meets study criteria|0|||
131213339|NCT03110107|472405292|FG000|Treatment Period|Other Reasons|0|||
131213340|NCT03110107|472405293|FG001|Treatment Period|Other Reasons|0|||
131213341|NCT03110107|472405294|FG002|Treatment Period|Other Reasons|1|||
131213342|NCT03110107|472405295|FG003|Treatment Period|Other Reasons|1|||
131213343|NCT03110107|472405296|FG004|Treatment Period|Other Reasons|0|||
131213344|NCT03110107|472405297|FG005|Treatment Period|Other Reasons|1|||
131213345|NCT03110107|472405298|FG006|Treatment Period|Other Reasons|0|||
131213346|NCT03110107|472405299|FG007|Treatment Period|Other Reasons|0|||
131213347|NCT03110107|472405300|FG008|Treatment Period|Other Reasons|0|||
131213348|NCT03110107|472405301|FG009|Treatment Period|Other Reasons|0|||
131213349|NCT03110107|472405302|FG010|Treatment Period|Other Reasons|0|||
131213350|NCT03110107|472405303|FG011|Treatment Period|Other Reasons|0|||
131213351|NCT03110107|472405304|FG012|Treatment Period|Other Reasons|0|||
131213352|NCT03110107|472405305|FG013|Treatment Period|Other Reasons|0|||
131213353|NCT03110107|472405306|FG014|Treatment Period|Other Reasons|0|||
131213354|NCT03110107|472405307|FG015|Treatment Period|Other Reasons|0|||
131213355|NCT03110107|472405308|FG016|Treatment Period|Other Reasons|0|||
131213356|NCT03110107|472405309|FG017|Treatment Period|Other Reasons|0|||
131213357|NCT03110107|472405310|FG018|Treatment Period|Other Reasons|0|||
131213358|NCT03110107|472405311|FG019|Treatment Period|Other Reasons|0|||
131213359|NCT03110107|472405312|FG020|Treatment Period|Other Reasons|0|||
131213360|NCT03110107|472405313|FG021|Treatment Period|Other Reasons|0|||
131213361|NCT03110107|472405314|FG022|Treatment Period|Other Reasons|0|||
131213362|NCT03110107|472405315|FG023|Treatment Period|Other Reasons|0|||
131213363|NCT03110107|472405316|FG024|Treatment Period|Other Reasons|1|||
131213364|NCT03110107|472405317|FG025|Treatment Period|Other Reasons|0|||
131213365|NCT03586427|472405326|FG000|Overall Study|Lost to Follow-up|0|||
131213366|NCT03586427|472405327|FG001|Overall Study|Lost to Follow-up|3|||
131213367|NCT03586427|472405328|FG002|Overall Study|Lost to Follow-up|1|||
131213368|NCT03586427|472405329|FG003|Overall Study|Lost to Follow-up|3|||
131213369|NCT03586427|472405330|FG004|Overall Study|Lost to Follow-up|3|||
131213370|NCT03586427|472405326|FG000|Overall Study|Withdrawal by Subject|0|||
131213371|NCT03586427|472405327|FG001|Overall Study|Withdrawal by Subject|1|||
131213372|NCT03586427|472405328|FG002|Overall Study|Withdrawal by Subject|2|||
131213373|NCT03586427|472405329|FG003|Overall Study|Withdrawal by Subject|1|||
131213374|NCT03586427|472405330|FG004|Overall Study|Withdrawal by Subject|1|||
131213375|NCT03586427|472405326|FG000|Overall Study|Adverse Event|0|||
131213376|NCT03586427|472405327|FG001|Overall Study|Adverse Event|0|||
131213377|NCT03586427|472405328|FG002|Overall Study|Adverse Event|1|||
131213378|NCT03586427|472405329|FG003|Overall Study|Adverse Event|0|||
131213379|NCT03586427|472405330|FG004|Overall Study|Adverse Event|0|||
131213380|NCT03586427|472405326|FG000|Overall Study|Protocol Violation|0|||
131213381|NCT03586427|472405327|FG001|Overall Study|Protocol Violation|0|||
131213382|NCT03586427|472405328|FG002|Overall Study|Protocol Violation|1|||
131213383|NCT03586427|472405329|FG003|Overall Study|Protocol Violation|0|||
131213384|NCT03586427|472405330|FG004|Overall Study|Protocol Violation|1|||
131213385|NCT03586427|472405326|FG000|Overall Study|Noncompliance with study drug|0|||
131213386|NCT03586427|472405327|FG001|Overall Study|Noncompliance with study drug|0|||
131213387|NCT03586427|472405328|FG002|Overall Study|Noncompliance with study drug|1|||
131213388|NCT03586427|472405329|FG003|Overall Study|Noncompliance with study drug|0|||
131213389|NCT03586427|472405330|FG004|Overall Study|Noncompliance with study drug|0|||
131213390|NCT03193996|472405331|FG000|Overall Study|Withdrawal by Subject|4|||
131213391|NCT03193996|472405331|FG000|Overall Study|Lost to Follow-up|4|||
131213392|NCT03193996|472405331|FG000|Overall Study|Physician Decision|2|||
131213393|NCT03193996|472405331|FG000|Overall Study|Pregnancy|1|||
131213394|NCT03193996|472405331|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
131213395|NCT03193996|472405331|FG000|Overall Study|Complicating disease|1|||
131213396|NCT00494234|472405332|FG000|Overall Study|Withdrawal by Subject|1|||
131213397|NCT00494234|472405333|FG001|Overall Study|Withdrawal by Subject|0|||
131213398|NCT00494234|472405332|FG000|Overall Study|Disease progression|11|||
130990335|NCT02508532|471593151|FG001|Part 2 - Treatment|Disease Progression|0|||
130990336|NCT02508532|471593152|FG002|Part 2 - Treatment|Disease Progression|0|||
130990337|NCT02508532|471593153|FG003|Part 2 - Treatment|Disease Progression|0|||
130990338|NCT02508532|471593154|FG004|Part 2 - Treatment|Disease Progression|0|||
130990339|NCT02508532|471593155|FG005|Part 2 - Treatment|Disease Progression|0|||
130879632|NCT02939287|471193052|FG001|Overall Study|Did not complete survey|2|||
130879633|NCT02939287|471193053|FG002|Overall Study|Did not complete survey|0|||
130879634|NCT02939287|471193051|FG000|Overall Study|Withdrawal by Subject|1|||
130879635|NCT02939287|471193052|FG001|Overall Study|Withdrawal by Subject|1|||
130879636|NCT02939287|471193053|FG002|Overall Study|Withdrawal by Subject|0|||
130879637|NCT03406780|471193054|FG000|Overall Study|Withdrawal by Subject|1|||
130879638|NCT03406780|471193055|FG001|Overall Study|Withdrawal by Subject|1|||
130879639|NCT03406780|471193054|FG000|Overall Study|Other|0|||
130879640|NCT03406780|471193055|FG001|Overall Study|Other|2|||
130879641|NCT03466658|471193056|FG000|Overall Study|Withdrawal by Subject|3|||
130879642|NCT00129402|471193057|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130879643|NCT00129402|471193058|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
130879644|NCT00129402|471193059|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
130879645|NCT00129402|471193060|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130879646|NCT00129402|471193061|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130879647|NCT00129402|471193062|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
130879648|NCT00129402|471193063|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130879649|NCT00129402|471193057|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130879650|NCT00129402|471193058|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130879651|NCT00129402|471193059|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130879652|NCT00129402|471193060|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130879653|NCT00129402|471193061|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130879654|NCT00129402|471193062|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
130879655|NCT00129402|471193063|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130879656|NCT00129402|471193057|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130879657|NCT00129402|471193058|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130879658|NCT00129402|471193059|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130879659|NCT00129402|471193060|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
130879660|NCT00129402|471193061|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130879661|NCT00129402|471193062|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130879662|NCT00129402|471193063|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130879663|NCT00129402|471193057|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130879664|NCT00129402|471193058|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130879665|NCT00129402|471193059|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
130879666|NCT00129402|471193060|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130879667|NCT00129402|471193061|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
130879668|NCT00129402|471193062|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130879669|NCT00129402|471193063|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130879670|NCT00129402|471193057|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130879671|NCT00129402|471193058|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130879672|NCT00129402|471193059|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
130879673|NCT00129402|471193060|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130879674|NCT00129402|471193061|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130879675|NCT00129402|471193062|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130879676|NCT00129402|471193063|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130879677|NCT00129402|471193057|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130879678|NCT00129402|471193058|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130879679|NCT00129402|471193059|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
130879680|NCT00129402|471193060|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130879681|NCT00129402|471193061|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130879682|NCT00129402|471193062|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
130879683|NCT00129402|471193063|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130879684|NCT00129402|471193057|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130879685|NCT00129402|471193058|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130879686|NCT00129402|471193059|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
130879687|NCT00129402|471193060|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130879688|NCT00129402|471193061|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130879689|NCT00129402|471193062|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130879690|NCT00129402|471193063|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130990340|NCT02508532|471593156|FG006|Part 2 - Treatment|Disease Progression|0|||
130990341|NCT02508532|471593157|FG007|Part 2 - Treatment|Disease Progression|0|||
130879691|NCT00129402|471193057|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130879692|NCT00129402|471193058|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130879693|NCT00129402|471193059|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
130879694|NCT00129402|471193060|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130879695|NCT00129402|471193061|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130879696|NCT00129402|471193062|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
130879697|NCT00129402|471193063|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130879698|NCT00129402|471193057|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130879699|NCT00129402|471193058|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130879700|NCT00129402|471193059|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
130879701|NCT00129402|471193060|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130879702|NCT00129402|471193061|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130879703|NCT00129402|471193062|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
130879704|NCT00129402|471193063|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130879705|NCT00129402|471193057|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130879706|NCT00129402|471193058|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130879707|NCT00129402|471193059|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130879708|NCT00129402|471193060|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130879709|NCT00129402|471193061|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130879710|NCT00129402|471193062|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130879711|NCT00129402|471193063|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
130879712|NCT00129402|471193057|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130879713|NCT00129402|471193058|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130879714|NCT00129402|471193059|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130879715|NCT00129402|471193060|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130879716|NCT00129402|471193061|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130879717|NCT00129402|471193062|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130879718|NCT00129402|471193063|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
130879719|NCT00129402|471193057|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130879720|NCT00129402|471193058|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130879721|NCT00129402|471193059|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130879722|NCT00129402|471193060|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130879723|NCT00129402|471193061|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130879724|NCT00129402|471193062|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130879725|NCT00129402|471193063|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
130879726|NCT00129402|471193057|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130879727|NCT00129402|471193058|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130879728|NCT00129402|471193059|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130879729|NCT00129402|471193060|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130879730|NCT00129402|471193061|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130879731|NCT00129402|471193062|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130879732|NCT00129402|471193063|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
130879733|NCT03044106|471193064|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
130879734|NCT03044106|471193065|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
130879735|NCT03199976|471193067|FG000|Overall Study|Lack of Efficacy|3|||
130879736|NCT03199976|471193068|FG001|Overall Study|Lack of Efficacy|6|||
130879737|NCT03199976|471193069|FG002|Overall Study|Lack of Efficacy|13|||
130879738|NCT03199976|471193067|FG000|Overall Study|Withdrawal by Subject|1|||
130879739|NCT03199976|471193068|FG001|Overall Study|Withdrawal by Subject|0|||
130879740|NCT03199976|471193069|FG002|Overall Study|Withdrawal by Subject|0|||
130879741|NCT03199976|471193067|FG000|Overall Study|Lost to Follow-up|0|||
130879742|NCT03199976|471193068|FG001|Overall Study|Lost to Follow-up|1|||
130879743|NCT03199976|471193069|FG002|Overall Study|Lost to Follow-up|1|||
130879744|NCT04030143|471193070|FG000|Overall Study|Adverse Event|5|||
130879745|NCT04030143|471193071|FG001|Overall Study|Adverse Event|10|||
130879746|NCT04030143|471193070|FG000|Overall Study|Lost to Follow-up|3|||
130879747|NCT04030143|471193071|FG001|Overall Study|Lost to Follow-up|7|||
130879748|NCT04030143|471193070|FG000|Overall Study|Protocol Deviation|2|||
130879749|NCT04030143|471193071|FG001|Overall Study|Protocol Deviation|2|||
130879750|NCT04030143|471193070|FG000|Overall Study|Withdrawal by Subject|16|||
130879751|NCT04030143|471193071|FG001|Overall Study|Withdrawal by Subject|18|||
130879752|NCT04030143|471193070|FG000|Overall Study|Physician Decision|1|||
130879753|NCT04030143|471193071|FG001|Overall Study|Physician Decision|1|||
130879754|NCT04030143|471193070|FG000|Overall Study|Due to Covid-19|2|||
130879755|NCT04030143|471193071|FG001|Overall Study|Due to Covid-19|3|||
130879756|NCT04030143|471193070|FG000|Overall Study|Not Due to Covid-19|1|||
130879757|NCT04030143|471193071|FG001|Overall Study|Not Due to Covid-19|1|||
130879758|NCT04914364|471193073|FG000|Overall Study|No longer eligible for study|1|||
130879759|NCT04914364|471193073|FG000|Overall Study|Lost to Follow-up|2|||
130879760|NCT04097678|471193074|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
130879761|NCT04097678|471193075|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
130879762|NCT02435212|471193076|FG000|Core Phase|Adverse Event|8|||
130879763|NCT02435212|471193077|FG001|Core Phase|Adverse Event|5|||
130879764|NCT02435212|471193076|FG000|Core Phase|Withdrawal by Subject|3|||
130879765|NCT02435212|471193077|FG001|Core Phase|Withdrawal by Subject|0|||
130879766|NCT02435212|471193076|FG000|Core Phase|Withdrawal by parent/guardian|9|||
130879767|NCT02435212|471193077|FG001|Core Phase|Withdrawal by parent/guardian|4|||
130879768|NCT02435212|471193076|FG000|Core Phase|Protocol Violation|1|||
130879769|NCT02435212|471193077|FG001|Core Phase|Protocol Violation|2|||
130879770|NCT02435212|471193076|FG000|Core Phase|Physician Decision|3|||
130879771|NCT02435212|471193077|FG001|Core Phase|Physician Decision|0|||
130879772|NCT02435212|471193076|FG000|Core Phase|Lost to Follow-up|0|||
130879773|NCT02435212|471193077|FG001|Core Phase|Lost to Follow-up|1|||
130879774|NCT02435212|471193076|FG000|Core Phase|Lack of Efficacy|0|||
130879775|NCT02435212|471193077|FG001|Core Phase|Lack of Efficacy|1|||
130879776|NCT02435212|471193076|FG000|Core Phase|Recovery|1|||
130879777|NCT02435212|471193077|FG001|Core Phase|Recovery|0|||
130879778|NCT02435212|471193076|FG000|Optional Extension Phase|Adverse Event|3|||
130879779|NCT02435212|471193077|FG001|Optional Extension Phase|Adverse Event|9|||
130879780|NCT02435212|471193076|FG000|Optional Extension Phase|Physician Decision|6|||
130879781|NCT02435212|471193077|FG001|Optional Extension Phase|Physician Decision|8|||
130879782|NCT02435212|471193076|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
130879783|NCT02435212|471193077|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
130879784|NCT02435212|471193076|FG000|Optional Extension Phase|Lack of Efficacy|2|||
130879785|NCT02435212|471193077|FG001|Optional Extension Phase|Lack of Efficacy|3|||
130879786|NCT02435212|471193076|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
130879787|NCT02435212|471193077|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
130879788|NCT02435212|471193076|FG000|Optional Extension Phase|Protocol Violation|0|||
130879789|NCT02435212|471193077|FG001|Optional Extension Phase|Protocol Violation|1|||
130879790|NCT02435212|471193076|FG000|Optional Extension Phase|Recovery|1|||
130879791|NCT02435212|471193077|FG001|Optional Extension Phase|Recovery|1|||
130879792|NCT02435212|471193076|FG000|Optional Extension Phase|Death|1|||
130879793|NCT02435212|471193077|FG001|Optional Extension Phase|Death|0|||
130879794|NCT02435212|471193076|FG000|Optional Extension Phase|Technical problems|2|||
130879795|NCT02435212|471193077|FG001|Optional Extension Phase|Technical problems|0|||
130879796|NCT04852302|471193083|FG000|Overall Study|Withdrawal by Subject|2|||
130879797|NCT04852302|471193083|FG000|Overall Study|Did not complete CALM therapy.|2|||
130879798|NCT04711850|471193084|FG000|Overall Study|Graft loss|2|||
130879799|NCT04711850|471193085|FG001|Overall Study|Graft loss|1|||
130879800|NCT04711850|471193084|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
130879801|NCT04711850|471193085|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
130879802|NCT04711850|471193084|FG000|Overall Study|Study terminated by sponsor|5|||
130879803|NCT04711850|471193085|FG001|Overall Study|Study terminated by sponsor|3|||
130879804|NCT04711850|471193084|FG000|Overall Study|Sponsor decision|0|||
130879805|NCT04711850|471193085|FG001|Overall Study|Sponsor decision|2|||
130879806|NCT03267277|471193086|FG000|Overall Study|Withdrawal by Subject|1|||
130879807|NCT04849364|471193087|FG000|Overall Study|Eligibility criteria not meet|0|||
130879808|NCT04849364|471193088|FG001|Overall Study|Eligibility criteria not meet|1|||
130990342|NCT02508532|471593158|FG008|Part 2 - Treatment|Disease Progression|118|||
130990343|NCT02508532|471593150|FG000|Part 2 - Treatment|Adverse Event|0|||
130990344|NCT02508532|471593151|FG001|Part 2 - Treatment|Adverse Event|0|||
130990345|NCT02508532|471593152|FG002|Part 2 - Treatment|Adverse Event|0|||
130990346|NCT02508532|471593153|FG003|Part 2 - Treatment|Adverse Event|0|||
130990347|NCT02508532|471593154|FG004|Part 2 - Treatment|Adverse Event|0|||
130990348|NCT02508532|471593155|FG005|Part 2 - Treatment|Adverse Event|0|||
130990349|NCT02508532|471593156|FG006|Part 2 - Treatment|Adverse Event|0|||
130990350|NCT02508532|471593157|FG007|Part 2 - Treatment|Adverse Event|0|||
130990351|NCT02508532|471593158|FG008|Part 2 - Treatment|Adverse Event|49|||
130990352|NCT02508532|471593150|FG000|Part 2 - Treatment|Physician Decision|0|||
130990353|NCT02508532|471593151|FG001|Part 2 - Treatment|Physician Decision|0|||
130990354|NCT02508532|471593152|FG002|Part 2 - Treatment|Physician Decision|0|||
130990355|NCT02508532|471593153|FG003|Part 2 - Treatment|Physician Decision|0|||
130990356|NCT02508532|471593154|FG004|Part 2 - Treatment|Physician Decision|0|||
131213399|NCT00494234|472405333|FG001|Overall Study|Disease progression|8|||
130879809|NCT04849364|471193089|FG002|Overall Study|Eligibility criteria not meet|0|||
130879810|NCT03521570|471193101|FG000|Overall Study|Not eligible|11|||
130879811|NCT03279081|471193102|FG000|Overall Study|Withdrawal by Subject|12|||
130879812|NCT03279081|471193103|FG001|Overall Study|Withdrawal by Subject|20|||
130879813|NCT03279081|471193102|FG000|Overall Study|Physician Decision|4|||
130879814|NCT03279081|471193103|FG001|Overall Study|Physician Decision|1|||
130879815|NCT03279081|471193102|FG000|Overall Study|Lost to Follow-up|8|||
130879816|NCT03279081|471193103|FG001|Overall Study|Lost to Follow-up|8|||
130990357|NCT02508532|471593155|FG005|Part 2 - Treatment|Physician Decision|0|||
130990358|NCT02508532|471593156|FG006|Part 2 - Treatment|Physician Decision|0|||
131213400|NCT00494234|472405332|FG000|Overall Study|Death|2|||
130990359|NCT02508532|471593157|FG007|Part 2 - Treatment|Physician Decision|0|||
130990360|NCT02508532|471593158|FG008|Part 2 - Treatment|Physician Decision|12|||
130990361|NCT02508532|471593150|FG000|Part 2 - Treatment|Administrative|0|||
130990362|NCT02508532|471593151|FG001|Part 2 - Treatment|Administrative|0|||
130990363|NCT02508532|471593152|FG002|Part 2 - Treatment|Administrative|0|||
130990364|NCT02508532|471593153|FG003|Part 2 - Treatment|Administrative|0|||
130990365|NCT02508532|471593154|FG004|Part 2 - Treatment|Administrative|0|||
130879817|NCT03279081|471193102|FG000|Overall Study|Death|0|||
130990366|NCT02508532|471593155|FG005|Part 2 - Treatment|Administrative|0|||
130990367|NCT02508532|471593156|FG006|Part 2 - Treatment|Administrative|0|||
130990368|NCT02508532|471593157|FG007|Part 2 - Treatment|Administrative|0|||
130990369|NCT02508532|471593158|FG008|Part 2 - Treatment|Administrative|3|||
130990370|NCT02508532|471593150|FG000|Part 2 - Treatment|Sponsor Decision|0|||
130990371|NCT02508532|471593151|FG001|Part 2 - Treatment|Sponsor Decision|0|||
130990372|NCT02508532|471593152|FG002|Part 2 - Treatment|Sponsor Decision|0|||
130990373|NCT02508532|471593153|FG003|Part 2 - Treatment|Sponsor Decision|0|||
130990374|NCT02508532|471593154|FG004|Part 2 - Treatment|Sponsor Decision|0|||
130990375|NCT02508532|471593155|FG005|Part 2 - Treatment|Sponsor Decision|0|||
130990376|NCT02508532|471593156|FG006|Part 2 - Treatment|Sponsor Decision|0|||
130990377|NCT02508532|471593157|FG007|Part 2 - Treatment|Sponsor Decision|0|||
130990378|NCT02508532|471593158|FG008|Part 2 - Treatment|Sponsor Decision|28|||
130990379|NCT02508532|471593150|FG000|Part 2 - Treatment|Death|0|||
130990380|NCT02508532|471593151|FG001|Part 2 - Treatment|Death|0|||
130990381|NCT02508532|471593152|FG002|Part 2 - Treatment|Death|0|||
130990382|NCT02508532|471593153|FG003|Part 2 - Treatment|Death|0|||
130990383|NCT02508532|471593154|FG004|Part 2 - Treatment|Death|0|||
130990384|NCT02508532|471593155|FG005|Part 2 - Treatment|Death|0|||
130990385|NCT02508532|471593156|FG006|Part 2 - Treatment|Death|0|||
130990386|NCT02508532|471593157|FG007|Part 2 - Treatment|Death|0|||
130990387|NCT02508532|471593158|FG008|Part 2 - Treatment|Death|1|||
130990388|NCT02508532|471593150|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
130990389|NCT02508532|471593151|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
130990390|NCT02508532|471593152|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
130990391|NCT02508532|471593153|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
130990392|NCT02508532|471593154|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
130990393|NCT02508532|471593155|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
130990394|NCT02508532|471593156|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
130990395|NCT02508532|471593157|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
130990396|NCT02508532|471593158|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
130990397|NCT02508532|471593150|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
130990398|NCT02508532|471593151|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
130990399|NCT02508532|471593152|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
130990400|NCT02508532|471593153|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
130990401|NCT02508532|471593154|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
130990402|NCT02508532|471593155|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
130990403|NCT02508532|471593156|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
130990404|NCT02508532|471593157|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
130990405|NCT02508532|471593158|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
130990406|NCT02508532|471593150|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
130990407|NCT02508532|471593151|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
130990408|NCT02508532|471593152|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
130990409|NCT02508532|471593153|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
130990410|NCT02508532|471593154|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
130990411|NCT02508532|471593155|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
130990412|NCT02508532|471593156|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
130990413|NCT02508532|471593157|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
130990414|NCT02508532|471593158|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
130990415|NCT02508532|471593150|FG000|Part 1 and Part 2 End of Study|Death|0|||
130990416|NCT02508532|471593151|FG001|Part 1 and Part 2 End of Study|Death|4|||
130990417|NCT02508532|471593152|FG002|Part 1 and Part 2 End of Study|Death|2|||
130990418|NCT02508532|471593153|FG003|Part 1 and Part 2 End of Study|Death|4|||
130990419|NCT02508532|471593154|FG004|Part 1 and Part 2 End of Study|Death|3|||
130990420|NCT02508532|471593155|FG005|Part 1 and Part 2 End of Study|Death|0|||
130990421|NCT02508532|471593156|FG006|Part 1 and Part 2 End of Study|Death|0|||
130990422|NCT02508532|471593157|FG007|Part 1 and Part 2 End of Study|Death|1|||
130990423|NCT02508532|471593158|FG008|Part 1 and Part 2 End of Study|Death|111|||
130990424|NCT02508532|471593150|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
130990425|NCT02508532|471593151|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
130990426|NCT02508532|471593152|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
130990427|NCT02508532|471593153|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
130990428|NCT02508532|471593154|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
130990429|NCT02508532|471593155|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
131098719|NCT01655693|471991047|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
131098720|NCT01655693|471991048|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
131098721|NCT01655693|471991049|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
131098722|NCT01655693|471991047|FG000|Overall Study|Non-Compliance|0|||
131098723|NCT01655693|471991048|FG001|Overall Study|Non-Compliance|0|||
131098724|NCT01655693|471991049|FG002|Overall Study|Non-Compliance|7|||
131098725|NCT01655693|471991047|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
131098726|NCT01655693|471991048|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
131098727|NCT01655693|471991049|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
131098728|NCT01655693|471991047|FG000|Overall Study|Protocol Violation|1|||
131098729|NCT01655693|471991048|FG001|Overall Study|Protocol Violation|0|||
131098730|NCT01655693|471991049|FG002|Overall Study|Protocol Violation|3|||
131098731|NCT01655693|471991047|FG000|Overall Study|Lost to Follow-up|1|||
131098732|NCT01655693|471991048|FG001|Overall Study|Lost to Follow-up|0|||
131098733|NCT01655693|471991049|FG002|Overall Study|Lost to Follow-up|1|||
131098734|NCT01655693|471991047|FG000|Overall Study|Screening Failure|1|||
131098735|NCT01655693|471991048|FG001|Overall Study|Screening Failure|0|||
131098736|NCT01655693|471991049|FG002|Overall Study|Screening Failure|0|||
131098737|NCT01655693|471991047|FG000|Overall Study|Other|8|||
131098738|NCT01655693|471991048|FG001|Overall Study|Other|6|||
131098739|NCT01655693|471991049|FG002|Overall Study|Other|15|||
131098740|NCT00929110|471991050|FG000|Overall Study|Adverse Event|40|||
131098741|NCT00929110|471991051|FG001|Overall Study|Adverse Event|29|||
131098742|NCT00929110|471991052|FG002|Overall Study|Adverse Event|18|||
131098743|NCT00929110|471991050|FG000|Overall Study|Subject withdrew consent|40|||
131098744|NCT00929110|471991051|FG001|Overall Study|Subject withdrew consent|23|||
131098745|NCT00929110|471991052|FG002|Overall Study|Subject withdrew consent|26|||
131098746|NCT00929110|471991050|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
131098747|NCT00929110|471991051|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
131098748|NCT00929110|471991052|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
131098749|NCT00929110|471991050|FG000|Overall Study|Lost to Follow-up|7|||
131098750|NCT00929110|471991051|FG001|Overall Study|Lost to Follow-up|7|||
131098751|NCT00929110|471991052|FG002|Overall Study|Lost to Follow-up|3|||
131098752|NCT00929110|471991050|FG000|Overall Study|Protocol deviation|5|||
131098753|NCT00929110|471991051|FG001|Overall Study|Protocol deviation|2|||
131098754|NCT00929110|471991052|FG002|Overall Study|Protocol deviation|4|||
131098755|NCT00929110|471991050|FG000|Overall Study|Administrative problems|4|||
131098756|NCT00929110|471991051|FG001|Overall Study|Administrative problems|1|||
131098757|NCT00929110|471991052|FG002|Overall Study|Administrative problems|2|||
131098758|NCT00929110|471991050|FG000|Overall Study|Death|2|||
131098759|NCT00929110|471991051|FG001|Overall Study|Death|2|||
131098760|NCT00929110|471991052|FG002|Overall Study|Death|2|||
131098761|NCT00929110|471991050|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131098762|NCT00929110|471991051|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131098763|NCT00929110|471991052|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131098764|NCT00929110|471991050|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131098765|NCT00929110|471991051|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131098766|NCT00929110|471991052|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131098767|NCT00929110|471991050|FG000|Overall Study|Patient inability to use the device|0|||
131098768|NCT00929110|471991051|FG001|Overall Study|Patient inability to use the device|1|||
131098769|NCT00929110|471991052|FG002|Overall Study|Patient inability to use the device|0|||
131098770|NCT02285153|471991053|FG000|Overall Study|Adverse Event|1|||
131098771|NCT02285153|471991054|FG001|Overall Study|Adverse Event|0|||
131098772|NCT00548262|471991055|FG000|Overall Study|Death|21|||
131098773|NCT00548262|471991055|FG000|Overall Study|Adverse Event|2|||
131098774|NCT00548262|471991055|FG000|Overall Study|Lack of Efficacy|4|||
131098775|NCT00548262|471991055|FG000|Overall Study|Lost to Follow-up|1|||
131098776|NCT00548262|471991055|FG000|Overall Study|Other|3|||
131098777|NCT00548262|471991055|FG000|Overall Study|Withdrawal by Subject|1|||
131098778|NCT01712659|471991056|FG000|Dose Escalation|Physician Decision|0|||
131098779|NCT01712659|471991057|FG001|Dose Escalation|Physician Decision|1|||
131098780|NCT01712659|471991058|FG002|Dose Escalation|Physician Decision|0|||
131098781|NCT01712659|471991059|FG003|Dose Escalation|Physician Decision|0|||
131098782|NCT01712659|471991060|FG004|Dose Escalation|Physician Decision|0|||
131098783|NCT01712659|471991056|FG000|Dose Escalation|Unable to take study drug|0|||
131098784|NCT01712659|471991057|FG001|Dose Escalation|Unable to take study drug|1|||
131098785|NCT01712659|471991058|FG002|Dose Escalation|Unable to take study drug|0|||
131098786|NCT01712659|471991059|FG003|Dose Escalation|Unable to take study drug|0|||
131098787|NCT01712659|471991060|FG004|Dose Escalation|Unable to take study drug|0|||
131098788|NCT01712659|471991056|FG000|Dose Expansion|Early disease progression|1|||
131098789|NCT01712659|471991057|FG001|Dose Expansion|Early disease progression|0|||
131098790|NCT01712659|471991058|FG002|Dose Expansion|Early disease progression|0|||
131098791|NCT01712659|471991059|FG003|Dose Expansion|Early disease progression|0|||
131098792|NCT01712659|471991060|FG004|Dose Expansion|Early disease progression|0|||
131098793|NCT01712659|471991056|FG000|Dose Expansion|Physician Decision|1|||
131098794|NCT01712659|471991057|FG001|Dose Expansion|Physician Decision|0|||
131098795|NCT01712659|471991058|FG002|Dose Expansion|Physician Decision|0|||
131098796|NCT01712659|471991059|FG003|Dose Expansion|Physician Decision|0|||
131098797|NCT01712659|471991060|FG004|Dose Expansion|Physician Decision|0|||
131098798|NCT00948766|471991062|FG000|Core Study|Adverse Event|73|||
131098799|NCT00948766|471991063|FG001|Core Study|Adverse Event|51|||
131098800|NCT00948766|471991062|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
131098801|NCT00948766|471991063|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
131098802|NCT00948766|471991062|FG000|Core Study|Patient Withdrew Consent|27|||
131098803|NCT00948766|471991063|FG001|Core Study|Patient Withdrew Consent|46|||
131098804|NCT00948766|471991062|FG000|Core Study|Lost to Follow-up|3|||
131098805|NCT00948766|471991063|FG001|Core Study|Lost to Follow-up|2|||
131098806|NCT00948766|471991062|FG000|Core Study|Administrative Problems|2|||
131098807|NCT00948766|471991063|FG001|Core Study|Administrative Problems|2|||
131098808|NCT00948766|471991062|FG000|Core Study|Death|1|||
131098809|NCT00948766|471991063|FG001|Core Study|Death|1|||
131098810|NCT00948766|471991062|FG000|Core Study|Protocol Deviation|8|||
131098811|NCT00948766|471991063|FG001|Core Study|Protocol Deviation|10|||
131098812|NCT00948766|471991062|FG000|Extension Study|Adverse Event|43|||
131098813|NCT00948766|471991063|FG001|Extension Study|Adverse Event|0|||
131098814|NCT00948766|471991062|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
131098815|NCT00948766|471991063|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
131098816|NCT00948766|471991062|FG000|Extension Study|Study Drug No Longer Required|1|||
131098817|NCT00948766|471991063|FG001|Extension Study|Study Drug No Longer Required|0|||
131098818|NCT00948766|471991062|FG000|Extension Study|Patient Withdrew Consent|32|||
131098819|NCT00948766|471991063|FG001|Extension Study|Patient Withdrew Consent|0|||
131098820|NCT00948766|471991062|FG000|Extension Study|Lost to Follow-up|8|||
131098821|NCT00948766|471991063|FG001|Extension Study|Lost to Follow-up|0|||
131098822|NCT00948766|471991062|FG000|Extension Study|Administrative Problems|1|||
131098823|NCT00948766|471991063|FG001|Extension Study|Administrative Problems|0|||
131098824|NCT00948766|471991062|FG000|Extension Study|Death|4|||
131098825|NCT00948766|471991063|FG001|Extension Study|Death|0|||
131098826|NCT02153073|471991067|FG000|Overall Study|Case Report Forms Uncollected|230|||
131098827|NCT02153073|471991067|FG000|Overall Study|Protocol Deviation|68|||
131098828|NCT03592745|471991068|FG000|Overall Study|Adverse Event|0|||
131098829|NCT03592745|471991069|FG001|Overall Study|Adverse Event|2|||
131098830|NCT03592745|471991068|FG000|Overall Study|Lost to Follow-up|2|||
131098831|NCT03592745|471991069|FG001|Overall Study|Lost to Follow-up|0|||
131098832|NCT03592745|471991068|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
131098833|NCT03592745|471991069|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
131098834|NCT00738894|471991070|FG000|Overall Study|Lost to Follow-up|23|||
131098835|NCT00738894|471991071|FG001|Overall Study|Lost to Follow-up|13|||
131098836|NCT00738894|471991070|FG000|Overall Study|Withdrawal by Subject|10|||
131098837|NCT00738894|471991071|FG001|Overall Study|Withdrawal by Subject|15|||
131098838|NCT00738894|471991070|FG000|Overall Study|Physician Decision|4|||
131098839|NCT00738894|471991071|FG001|Overall Study|Physician Decision|5|||
131098840|NCT00738894|471991070|FG000|Overall Study|Death|2|||
131098841|NCT00738894|471991071|FG001|Overall Study|Death|0|||
131098842|NCT01081665|471991072|FG000|Overall Study|Death|41|||
131098843|NCT01081665|471991072|FG000|Overall Study|Lost to Follow-up|18|||
131098844|NCT01081665|471991072|FG000|Overall Study|Withdrawal by Subject|17|||
131098845|NCT01081665|471991072|FG000|Overall Study|Change of dialysis unit|10|||
131098846|NCT01081665|471991072|FG000|Overall Study|Regulation of iPTH|5|||
131098847|NCT01081665|471991072|FG000|Overall Study|Change in renal replacement therapy|2|||
131098848|NCT01081665|471991072|FG000|Overall Study|Adverse Event|1|||
131098849|NCT01081665|471991072|FG000|Overall Study|Lack of Efficacy|1|||
131098850|NCT02546921|471991081|FG000|Overall Study|Adverse Event|0|||
131098851|NCT02546921|471991082|FG001|Overall Study|Adverse Event|5|||
131098852|NCT02546921|471991083|FG002|Overall Study|Adverse Event|2|||
131098853|NCT02546921|471991084|FG003|Overall Study|Adverse Event|0|||
131098854|NCT02546921|471991085|FG004|Overall Study|Adverse Event|0|||
131098855|NCT02546921|471991086|FG005|Overall Study|Adverse Event|0|||
131098856|NCT02546921|471991087|FG006|Overall Study|Adverse Event|0|||
131098857|NCT02546921|471991081|FG000|Overall Study|Evidence of Disease Progression|1|||
131098858|NCT02546921|471991082|FG001|Overall Study|Evidence of Disease Progression|0|||
131098859|NCT02546921|471991083|FG002|Overall Study|Evidence of Disease Progression|0|||
131098860|NCT02546921|471991084|FG003|Overall Study|Evidence of Disease Progression|0|||
131098861|NCT02546921|471991085|FG004|Overall Study|Evidence of Disease Progression|1|||
131098862|NCT02546921|471991086|FG005|Overall Study|Evidence of Disease Progression|0|||
131098863|NCT02546921|471991087|FG006|Overall Study|Evidence of Disease Progression|0|||
131098864|NCT02546921|471991081|FG000|Overall Study|Patient Choice|0|||
131098865|NCT02546921|471991082|FG001|Overall Study|Patient Choice|1|||
131098866|NCT02546921|471991083|FG002|Overall Study|Patient Choice|0|||
131098867|NCT02546921|471991084|FG003|Overall Study|Patient Choice|0|||
131098868|NCT02546921|471991085|FG004|Overall Study|Patient Choice|0|||
131098869|NCT02546921|471991086|FG005|Overall Study|Patient Choice|1|||
131098870|NCT02546921|471991087|FG006|Overall Study|Patient Choice|0|||
131098871|NCT01413503|471991088|FG000|Overall Study|Lost to Follow-up|1|||
131098872|NCT01373151|471991089|FG000|Period 1|Lack of Efficacy|3|||
131098873|NCT01373151|471991090|FG001|Period 1|Lack of Efficacy|0|||
131098874|NCT01373151|471991091|FG002|Period 1|Lack of Efficacy|0|||
131098875|NCT01373151|471991092|FG003|Period 1|Lack of Efficacy|0|||
131098876|NCT01373151|471991093|FG004|Period 1|Lack of Efficacy|1|||
131098877|NCT01373151|471991094|FG005|Period 1|Lack of Efficacy|0|||
131098878|NCT01373151|471991095|FG006|Period 1|Lack of Efficacy|0|||
131098879|NCT01373151|471991089|FG000|Period 1|Adverse Event|0|||
131098880|NCT01373151|471991090|FG001|Period 1|Adverse Event|0|||
131098881|NCT01373151|471991091|FG002|Period 1|Adverse Event|1|||
131098882|NCT01373151|471991092|FG003|Period 1|Adverse Event|0|||
131098883|NCT01373151|471991093|FG004|Period 1|Adverse Event|4|||
131098884|NCT01373151|471991094|FG005|Period 1|Adverse Event|3|||
131098885|NCT01373151|471991095|FG006|Period 1|Adverse Event|0|||
131098886|NCT01373151|471991089|FG000|Period 1|Withdrawal by Subject|2|||
131098887|NCT01373151|471991090|FG001|Period 1|Withdrawal by Subject|0|||
131098888|NCT01373151|471991091|FG002|Period 1|Withdrawal by Subject|3|||
131098889|NCT01373151|471991092|FG003|Period 1|Withdrawal by Subject|1|||
131098890|NCT01373151|471991093|FG004|Period 1|Withdrawal by Subject|0|||
131098891|NCT01373151|471991094|FG005|Period 1|Withdrawal by Subject|1|||
131098892|NCT01373151|471991095|FG006|Period 1|Withdrawal by Subject|0|||
131098893|NCT01373151|471991089|FG000|Period 2|Lack of Efficacy|9|||
131098894|NCT01373151|471991090|FG001|Period 2|Lack of Efficacy|0|||
131098895|NCT01373151|471991091|FG002|Period 2|Lack of Efficacy|0|||
131098896|NCT01373151|471991092|FG003|Period 2|Lack of Efficacy|1|||
131098897|NCT01373151|471991093|FG004|Period 2|Lack of Efficacy|2|||
131098898|NCT01373151|471991094|FG005|Period 2|Lack of Efficacy|0|||
131098899|NCT01373151|471991095|FG006|Period 2|Lack of Efficacy|3|||
131098900|NCT01373151|471991089|FG000|Period 2|Adverse Event|0|||
131098901|NCT01373151|471991090|FG001|Period 2|Adverse Event|0|||
131098902|NCT01373151|471991091|FG002|Period 2|Adverse Event|3|||
131098903|NCT01373151|471991092|FG003|Period 2|Adverse Event|3|||
131098904|NCT01373151|471991093|FG004|Period 2|Adverse Event|0|||
131098905|NCT01373151|471991094|FG005|Period 2|Adverse Event|0|||
131098906|NCT01373151|471991095|FG006|Period 2|Adverse Event|1|||
131098907|NCT01373151|471991089|FG000|Period 2|subject request to discontinue|0|||
131098908|NCT01373151|471991090|FG001|Period 2|subject request to discontinue|1|||
131098909|NCT01373151|471991091|FG002|Period 2|subject request to discontinue|0|||
131098910|NCT01373151|471991092|FG003|Period 2|subject request to discontinue|0|||
131098911|NCT01373151|471991093|FG004|Period 2|subject request to discontinue|0|||
131098912|NCT01373151|471991094|FG005|Period 2|subject request to discontinue|0|||
131098913|NCT01373151|471991095|FG006|Period 2|subject request to discontinue|0|||
131098914|NCT01373151|471991089|FG000|Period 2|Withdrawal by Subject|0|||
131098915|NCT01373151|471991090|FG001|Period 2|Withdrawal by Subject|0|||
131098916|NCT01373151|471991091|FG002|Period 2|Withdrawal by Subject|0|||
131098917|NCT01373151|471991092|FG003|Period 2|Withdrawal by Subject|1|||
131098918|NCT01373151|471991093|FG004|Period 2|Withdrawal by Subject|0|||
131098919|NCT01373151|471991094|FG005|Period 2|Withdrawal by Subject|0|||
131098920|NCT01373151|471991095|FG006|Period 2|Withdrawal by Subject|0|||
131098921|NCT01373151|471991089|FG000|Period 2|Other|0|||
131098922|NCT01373151|471991090|FG001|Period 2|Other|0|||
131098923|NCT01373151|471991091|FG002|Period 2|Other|1|||
131098924|NCT01373151|471991092|FG003|Period 2|Other|0|||
131098925|NCT01373151|471991093|FG004|Period 2|Other|0|||
131098926|NCT01373151|471991094|FG005|Period 2|Other|0|||
131098927|NCT01373151|471991095|FG006|Period 2|Other|1|||
131098928|NCT03026075|471991099|FG000|Overall Study|Physician Decision|1|||
131098929|NCT03381339|471991100|FG000|Overall Study|Protocol Violation|4|||
131098930|NCT03381339|471991101|FG001|Overall Study|Protocol Violation|3|||
131098931|NCT03381339|471991100|FG000|Overall Study|Lost to Follow-up|0|||
131098932|NCT03381339|471991101|FG001|Overall Study|Lost to Follow-up|1|||
131098933|NCT00293059|471991103|FG000|Overall Study|Adverse Event|12|||
131098934|NCT00293059|471991104|FG001|Overall Study|Adverse Event|4|||
131098935|NCT00293059|471991103|FG000|Overall Study|Lack of Efficacy|2|||
131098936|NCT00293059|471991104|FG001|Overall Study|Lack of Efficacy|0|||
131098937|NCT00293059|471991103|FG000|Overall Study|Lost to Follow-up|2|||
131098938|NCT00293059|471991104|FG001|Overall Study|Lost to Follow-up|3|||
131098939|NCT00293059|471991103|FG000|Overall Study|Pregnancy|1|||
131098940|NCT00293059|471991104|FG001|Overall Study|Pregnancy|1|||
131098941|NCT00293059|471991103|FG000|Overall Study|Protocol Violation|2|||
131098942|NCT00293059|471991104|FG001|Overall Study|Protocol Violation|0|||
131098943|NCT00293059|471991103|FG000|Overall Study|Withdrawal by Subject|11|||
131098944|NCT00293059|471991104|FG001|Overall Study|Withdrawal by Subject|5|||
131098945|NCT00293059|471991103|FG000|Overall Study|Participant moved out of state|1|||
131098946|NCT00293059|471991104|FG001|Overall Study|Participant moved out of state|0|||
131098947|NCT00293059|471991103|FG000|Overall Study|Participant stopped study drug|1|||
131098948|NCT00293059|471991104|FG001|Overall Study|Participant stopped study drug|0|||
131098949|NCT00293059|471991103|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
131098950|NCT00293059|471991104|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
131098951|NCT00293059|471991103|FG000|Overall Study|missing|3|||
131098952|NCT00293059|471991104|FG001|Overall Study|missing|5|||
131098953|NCT02227199|471991108|FG000|Overall Study|Physician Decision|0|||
131098954|NCT02227199|471991109|FG001|Overall Study|Physician Decision|0|||
131098955|NCT02227199|471991110|FG002|Overall Study|Physician Decision|1|||
131098956|NCT02227199|471991108|FG000|Overall Study|Adverse Event|0|||
131098957|NCT02227199|471991109|FG001|Overall Study|Adverse Event|0|||
131098958|NCT02227199|471991110|FG002|Overall Study|Adverse Event|3|||
131098959|NCT01934790|471991111|FG000|Treatment|Adverse Event|3|||
131098960|NCT01934790|471991111|FG000|Treatment|Clinical progression|6|||
131098961|NCT01934790|471991111|FG000|Treatment|Radiological progression|4|||
131098962|NCT01934790|471991111|FG000|Treatment|Withdrawal by Subject|2|||
131098963|NCT01934790|471991111|FG000|Treatment|Study drug never administered|1|||
131098964|NCT01934790|471991111|FG000|Active Follow up|Death|20|||
131098965|NCT01934790|471991111|FG000|Active Follow up|Physician Decision|2|||
131098966|NCT01934790|471991111|FG000|Active Follow up|Progressive disease|1|||
131098967|NCT01934790|471991111|FG000|Active Follow up|Other reason|1|||
131098968|NCT00552929|471991114|FG000|Overall Study|Lost to Follow-up|0|||
131098969|NCT00552929|471991115|FG001|Overall Study|Lost to Follow-up|0|||
131098970|NCT00552929|471991116|FG002|Overall Study|Lost to Follow-up|0|||
131098971|NCT00552929|471991117|FG003|Overall Study|Lost to Follow-up|0|||
131098972|NCT00552929|471991118|FG004|Overall Study|Lost to Follow-up|0|||
131098973|NCT00552929|471991119|FG005|Overall Study|Lost to Follow-up|0|||
131098974|NCT00552929|471991120|FG006|Overall Study|Lost to Follow-up|0|||
131098975|NCT00552929|471991121|FG007|Overall Study|Lost to Follow-up|0|||
131098976|NCT00552929|471991122|FG008|Overall Study|Lost to Follow-up|1|||
131098977|NCT00552929|471991123|FG009|Overall Study|Lost to Follow-up|0|||
131098978|NCT00552929|471991114|FG000|Overall Study|Not Eligible|0|||
131098979|NCT00552929|471991115|FG001|Overall Study|Not Eligible|0|||
131098980|NCT00552929|471991116|FG002|Overall Study|Not Eligible|0|||
131098981|NCT00552929|471991117|FG003|Overall Study|Not Eligible|0|||
131098982|NCT00552929|471991118|FG004|Overall Study|Not Eligible|0|||
131098983|NCT00552929|471991119|FG005|Overall Study|Not Eligible|1|||
131098984|NCT00552929|471991120|FG006|Overall Study|Not Eligible|0|||
131098985|NCT00552929|471991121|FG007|Overall Study|Not Eligible|0|||
131098986|NCT00552929|471991122|FG008|Overall Study|Not Eligible|0|||
131098987|NCT00552929|471991123|FG009|Overall Study|Not Eligible|0|||
131098988|NCT01147536|471991129|FG000|Overall Study|Administrative study close|2|||
131098989|NCT01147536|471991129|FG000|Overall Study|Death|1|||
131098990|NCT04577001|471991133|FG000|Overall Study|Subject became ineligible|0|||
131098991|NCT04577001|471991134|FG001|Overall Study|Subject became ineligible|1|||
131098992|NCT01241604|471991135|FG000|Screening Period|Screen Failure|3|||
131098993|NCT01241604|471991136|FG001|Screening Period|Screen Failure|0|||
131098994|NCT01241604|471991137|FG002|Screening Period|Screen Failure|0|||
131098995|NCT05110690|471991138|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
131098996|NCT05110690|471991138|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
131098997|NCT05110690|471991138|FG000|Completion of Intervention|Lost to Follow-up|1|||
131098998|NCT05110690|471991138|FG000|Completion of Intervention|Death|1|||
131098999|NCT05110690|471991138|FG000|Completion of Intervention|Withdrawal by Subject|2|||
131099000|NCT03973931|471991141|FG000|Overall Study|Lost to Follow-up|47|||
131099001|NCT03973931|471991142|FG001|Overall Study|Lost to Follow-up|63|||
131099002|NCT03973931|471991143|FG002|Overall Study|Lost to Follow-up|51|||
131099003|NCT03973931|471991144|FG003|Overall Study|Lost to Follow-up|54|||
131099004|NCT03973931|471991141|FG000|Overall Study|opted out|6|||
131099005|NCT03973931|471991142|FG001|Overall Study|opted out|5|||
131099006|NCT03973931|471991143|FG002|Overall Study|opted out|5|||
131099007|NCT03973931|471991144|FG003|Overall Study|opted out|1|||
131099008|NCT00925353|471991145|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
131133616|NCT01687712|472115381|FG001|Cycle 2|Not Biochemically Pregnant|77|||
131133617|NCT01687712|472115380|FG000|Cycle 2|Early Pregnancy Loss|18|||
131133618|NCT01687712|472115381|FG001|Cycle 2|Early Pregnancy Loss|16|||
131133619|NCT01687712|472115380|FG000|Cycle 2|Ectopic Pregnancy|0|||
131133620|NCT01687712|472115381|FG001|Cycle 2|Ectopic Pregnancy|1|||
131133621|NCT01687712|472115380|FG000|Cycle 2|Still Birth|1|||
131133622|NCT01687712|472115381|FG001|Cycle 2|Still Birth|0|||
131133623|NCT01687712|472115380|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
131133624|NCT01687712|472115381|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
131133625|NCT01687712|472115380|FG000|Cycle 3|Not Biochemically Pregnant|21|||
131133626|NCT01687712|472115381|FG001|Cycle 3|Not Biochemically Pregnant|22|||
131133627|NCT01687712|472115380|FG000|Cycle 3|Early Pregnancy Loss|1|||
131133628|NCT01687712|472115381|FG001|Cycle 3|Early Pregnancy Loss|2|||
131133629|NCT01687712|472115380|FG000|Cycle 3|Ectopic Pregnancy|1|||
131133630|NCT01687712|472115381|FG001|Cycle 3|Ectopic Pregnancy|0|||
131133631|NCT01687712|472115380|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
131133632|NCT01687712|472115381|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
131133633|NCT03074474|472115384|FG000|Overall Study|Lost to Follow-up|10|||
131133634|NCT03074474|472115384|FG000|Overall Study|Withdrawal by Subject|10|||
131133635|NCT03074474|472115384|FG000|Overall Study|Death|4|||
131133636|NCT03074474|472115384|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
131133637|NCT01035905|472115387|FG000|Overall Study|Lack of Efficacy|1|||
130879818|NCT03279081|471193103|FG001|Overall Study|Death|1|||
131133638|NCT01035905|472115388|FG001|Overall Study|Lack of Efficacy|1|||
131133639|NCT03368170|472117160|FG000|Overall Study|Adverse Event|2|||
131133640|NCT03368170|472117161|FG001|Overall Study|Adverse Event|1|||
131133641|NCT01662440|472117162|FG000|Overall Study|Adverse Event|1|||
131133642|NCT01662440|472117163|FG001|Overall Study|Adverse Event|0|||
131099009|NCT03507777|471992568|FG000|Overall Study|Lost to Follow-up|5|||
131099010|NCT03507777|471992569|FG001|Overall Study|Lost to Follow-up|7|||
131099011|NCT03507777|471992568|FG000|Overall Study|Withdrawal by Subject|6|||
131099012|NCT03507777|471992569|FG001|Overall Study|Withdrawal by Subject|11|||
131099013|NCT03507777|471992568|FG000|Overall Study|Death|30|||
131099014|NCT03507777|471992569|FG001|Overall Study|Death|44|||
131099015|NCT03507777|471992568|FG000|Overall Study|Other Reasons|3|||
131099016|NCT03507777|471992569|FG001|Overall Study|Other Reasons|8|||
131099017|NCT01879722|471992570|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131099018|NCT01879722|471992571|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
131099019|NCT01879722|471992572|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131099020|NCT01879722|471992573|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
131099021|NCT01879722|471992574|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
131099022|NCT01879722|471992575|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
131099023|NCT01879722|471992576|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
131099024|NCT01879722|471992577|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
131099025|NCT01879722|471992578|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
131099026|NCT01879722|471992579|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
131099027|NCT01879722|471992570|FG000|Overall Study|Voluntary Withdrawal|0|||
131099028|NCT01879722|471992571|FG001|Overall Study|Voluntary Withdrawal|0|||
131099029|NCT01879722|471992572|FG002|Overall Study|Voluntary Withdrawal|0|||
131099030|NCT01879722|471992573|FG003|Overall Study|Voluntary Withdrawal|0|||
131099031|NCT01879722|471992574|FG004|Overall Study|Voluntary Withdrawal|0|||
131099032|NCT01879722|471992575|FG005|Overall Study|Voluntary Withdrawal|0|||
131099033|NCT01879722|471992576|FG006|Overall Study|Voluntary Withdrawal|0|||
131099034|NCT01879722|471992577|FG007|Overall Study|Voluntary Withdrawal|0|||
131099035|NCT01879722|471992578|FG008|Overall Study|Voluntary Withdrawal|1|||
131099036|NCT01879722|471992579|FG009|Overall Study|Voluntary Withdrawal|0|||
131099037|NCT01253304|471992580|FG000|Overall Study|Adverse Event|0|||
131099038|NCT01253304|471992581|FG001|Overall Study|Adverse Event|0|||
131099039|NCT01253304|471992582|FG002|Overall Study|Adverse Event|0|||
131099040|NCT01253304|471992583|FG003|Overall Study|Adverse Event|1|||
131099041|NCT01327495|471992584|FG000|Overall Study|Adverse Event|2|||
131099042|NCT01327495|471992585|FG001|Overall Study|Adverse Event|1|||
131099043|NCT01327495|471992586|FG002|Overall Study|Adverse Event|1|||
131099044|NCT01327495|471992587|FG003|Overall Study|Adverse Event|0|||
131099045|NCT01327495|471992588|FG004|Overall Study|Adverse Event|0|||
131099046|NCT01327495|471992589|FG005|Overall Study|Adverse Event|2|||
131099047|NCT01327495|471992584|FG000|Overall Study|Withdrawal by Subject|0|||
131099048|NCT01327495|471992585|FG001|Overall Study|Withdrawal by Subject|1|||
131099049|NCT01327495|471992586|FG002|Overall Study|Withdrawal by Subject|1|||
131099050|NCT01327495|471992587|FG003|Overall Study|Withdrawal by Subject|0|||
131099051|NCT01327495|471992588|FG004|Overall Study|Withdrawal by Subject|1|||
131099052|NCT01327495|471992589|FG005|Overall Study|Withdrawal by Subject|0|||
131099053|NCT01327495|471992584|FG000|Overall Study|Physician Decision|0|||
131099054|NCT01327495|471992585|FG001|Overall Study|Physician Decision|0|||
131099055|NCT01327495|471992586|FG002|Overall Study|Physician Decision|0|||
131099056|NCT01327495|471992587|FG003|Overall Study|Physician Decision|0|||
131099057|NCT01327495|471992588|FG004|Overall Study|Physician Decision|2|||
131099058|NCT01327495|471992589|FG005|Overall Study|Physician Decision|0|||
131099059|NCT00006011|471992590|FG000|Overall Study|Disease progression|13|||
131099060|NCT00006011|471992591|FG001|Overall Study|Disease progression|6|||
131099061|NCT00006011|471992592|FG002|Overall Study|Disease progression|26|||
131099062|NCT00006011|471992590|FG000|Overall Study|Refused further treatment|15|||
131099063|NCT00006011|471992591|FG001|Overall Study|Refused further treatment|13|||
131099064|NCT00006011|471992592|FG002|Overall Study|Refused further treatment|26|||
131099065|NCT00006011|471992590|FG000|Overall Study|Adverse Event|15|||
131099066|NCT00006011|471992591|FG001|Overall Study|Adverse Event|39|||
131099067|NCT00006011|471992592|FG002|Overall Study|Adverse Event|5|||
131099068|NCT00006011|471992590|FG000|Overall Study|Death|0|||
131099069|NCT00006011|471992591|FG001|Overall Study|Death|1|||
131099070|NCT00006011|471992592|FG002|Overall Study|Death|2|||
131099071|NCT00006011|471992590|FG000|Overall Study|Other|4|||
131099072|NCT00006011|471992591|FG001|Overall Study|Other|2|||
131099073|NCT00006011|471992592|FG002|Overall Study|Other|5|||
131099074|NCT00006011|471992590|FG000|Overall Study|Ineligible|18|||
131099075|NCT00006011|471992591|FG001|Overall Study|Ineligible|16|||
131099076|NCT00006011|471992592|FG002|Overall Study|Ineligible|9|||
131099077|NCT03212989|471992594|FG000|Overall Study|Physician Decision|8|||
131099078|NCT03047395|471992597|FG000|Overall Study|Adverse Event|142|||
131099079|NCT03047395|471992597|FG000|Overall Study|Withdrawal by Subject|155|||
131099080|NCT03047395|471992597|FG000|Overall Study|Lost to Follow-up|144|||
131099081|NCT03047395|471992597|FG000|Overall Study|COVID-19 Infection|2|||
131099082|NCT03047395|471992597|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
131099083|NCT03047395|471992597|FG000|Overall Study|Other, Not Specified|117|||
131099084|NCT00560066|471992600|FG000|Overall Study|Death|2|||
131099085|NCT00560066|471992601|FG001|Overall Study|Death|1|||
131099086|NCT00560066|471992600|FG000|Overall Study|Withdrawal by Subject|0|||
131133643|NCT01662440|472117164|FG002|Overall Study|Adverse Event|0|||
131099087|NCT00560066|471992601|FG001|Overall Study|Withdrawal by Subject|3|||
131099088|NCT00560066|471992600|FG000|Overall Study|Lost to Follow-up|4|||
131099089|NCT00560066|471992601|FG001|Overall Study|Lost to Follow-up|10|||
131099090|NCT00560066|471992600|FG000|Overall Study|Protocol Violation|0|||
131099091|NCT00560066|471992601|FG001|Overall Study|Protocol Violation|1|||
131099092|NCT00560066|471992600|FG000|Overall Study|Administrative reason|0|||
131099093|NCT00560066|471992601|FG001|Overall Study|Administrative reason|5|||
131099094|NCT00560066|471992600|FG000|Overall Study|Missing primary reason|0|||
131099095|NCT00560066|471992601|FG001|Overall Study|Missing primary reason|2|||
131099096|NCT00620282|471992608|FG000|Overall Study|Adverse Event|0|||
131099097|NCT00620282|471992609|FG001|Overall Study|Adverse Event|1|||
131099098|NCT00620282|471992610|FG002|Overall Study|Adverse Event|0|||
131099099|NCT00620282|471992608|FG000|Overall Study|Arterial line unable to be placed|0|||
131099100|NCT00620282|471992609|FG001|Overall Study|Arterial line unable to be placed|0|||
131099101|NCT00620282|471992610|FG002|Overall Study|Arterial line unable to be placed|1|||
131099102|NCT00620282|471992608|FG000|Overall Study|Withdrawal by Subject|0|||
131099103|NCT00620282|471992609|FG001|Overall Study|Withdrawal by Subject|1|||
131099104|NCT00620282|471992610|FG002|Overall Study|Withdrawal by Subject|0|||
131099105|NCT01258595|471992611|FG000|Overall Study|Lost to Follow-up|1|||
131099106|NCT01258595|471992612|FG001|Overall Study|Lost to Follow-up|0|||
131099107|NCT01258595|471992611|FG000|Overall Study|Withdrawal by Subject|0|||
131099108|NCT01258595|471992612|FG001|Overall Study|Withdrawal by Subject|1|||
131099109|NCT02703259|471992613|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
131099110|NCT02703259|471992614|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
131099111|NCT02703259|471992613|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
131099112|NCT02703259|471992614|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
131099113|NCT02703259|471992613|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
131099114|NCT02703259|471992614|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
131099115|NCT04738292|471992619|FG000|Overall Study|Death|1|||
131099116|NCT03122223|471992620|FG000|Overall Study|Withdrawal by Subject|2|||
131099117|NCT03122223|471992621|FG001|Overall Study|Withdrawal by Subject|2|||
131099118|NCT03122223|471992622|FG002|Overall Study|Withdrawal by Subject|1|||
131099119|NCT03122223|471992623|FG003|Overall Study|Withdrawal by Subject|0|||
131099120|NCT03122223|471992620|FG000|Overall Study|Lost to Follow-up|0|||
131099121|NCT03122223|471992621|FG001|Overall Study|Lost to Follow-up|2|||
131099122|NCT03122223|471992622|FG002|Overall Study|Lost to Follow-up|2|||
131099123|NCT03122223|471992623|FG003|Overall Study|Lost to Follow-up|0|||
131099124|NCT03122223|471992620|FG000|Overall Study|Participant unable to adhere|1|||
131099125|NCT03122223|471992621|FG001|Overall Study|Participant unable to adhere|1|||
131099126|NCT03122223|471992622|FG002|Overall Study|Participant unable to adhere|1|||
131099127|NCT03122223|471992623|FG003|Overall Study|Participant unable to adhere|0|||
131099128|NCT01820585|471992625|FG000|Overall Study|Adverse Event|9|||
131099129|NCT01820585|471992626|FG001|Overall Study|Adverse Event|13|||
131099130|NCT01820585|471992627|FG002|Overall Study|Adverse Event|23|||
131099131|NCT01820585|471992628|FG003|Overall Study|Adverse Event|34|||
131099132|NCT01820585|471992625|FG000|Overall Study|Lack of Efficacy|9|||
131099133|NCT01820585|471992626|FG001|Overall Study|Lack of Efficacy|7|||
131099134|NCT01820585|471992627|FG002|Overall Study|Lack of Efficacy|5|||
131099135|NCT01820585|471992628|FG003|Overall Study|Lack of Efficacy|1|||
131099136|NCT01820585|471992625|FG000|Overall Study|Withdrawal by Subject|3|||
131099137|NCT01820585|471992626|FG001|Overall Study|Withdrawal by Subject|7|||
131099138|NCT01820585|471992627|FG002|Overall Study|Withdrawal by Subject|3|||
131099139|NCT01820585|471992628|FG003|Overall Study|Withdrawal by Subject|8|||
131099140|NCT01820585|471992625|FG000|Overall Study|Lost to Follow-up|3|||
131099141|NCT01820585|471992626|FG001|Overall Study|Lost to Follow-up|3|||
131099142|NCT01820585|471992627|FG002|Overall Study|Lost to Follow-up|0|||
131099143|NCT01820585|471992628|FG003|Overall Study|Lost to Follow-up|3|||
131099144|NCT01820585|471992625|FG000|Overall Study|Protocol Violation|3|||
131099145|NCT01820585|471992626|FG001|Overall Study|Protocol Violation|1|||
131099146|NCT01820585|471992627|FG002|Overall Study|Protocol Violation|1|||
131099147|NCT01820585|471992628|FG003|Overall Study|Protocol Violation|1|||
131099148|NCT01820585|471992625|FG000|Overall Study|Subject non-compliance|0|||
131099149|NCT01820585|471992626|FG001|Overall Study|Subject non-compliance|0|||
131099150|NCT01820585|471992627|FG002|Overall Study|Subject non-compliance|1|||
131099151|NCT01820585|471992628|FG003|Overall Study|Subject non-compliance|2|||
131099152|NCT01820585|471992625|FG000|Overall Study|at sponsor request|0|||
131099153|NCT01820585|471992626|FG001|Overall Study|at sponsor request|0|||
131099154|NCT01820585|471992627|FG002|Overall Study|at sponsor request|1|||
131099155|NCT01820585|471992628|FG003|Overall Study|at sponsor request|0|||
131099156|NCT01820585|471992625|FG000|Overall Study|Pregnancy|0|||
131099157|NCT01820585|471992626|FG001|Overall Study|Pregnancy|1|||
131099158|NCT01820585|471992627|FG002|Overall Study|Pregnancy|0|||
131099159|NCT01820585|471992628|FG003|Overall Study|Pregnancy|0|||
131099160|NCT02544451|471992629|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
131099161|NCT02544451|471992630|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
131099162|NCT02544451|471992631|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
131099163|NCT02544451|471992632|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
131099164|NCT02544451|471992629|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
131099165|NCT02544451|471992630|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
131099166|NCT02544451|471992631|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
131099167|NCT02544451|471992632|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
131099168|NCT02544451|471992629|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
131099169|NCT02544451|471992630|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
131099170|NCT02544451|471992631|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
131099171|NCT02544451|471992632|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
131099172|NCT02544451|471992629|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
131099173|NCT02544451|471992630|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
131099174|NCT02544451|471992631|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
131099175|NCT02544451|471992632|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
131099176|NCT02544451|471992629|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
131099177|NCT02544451|471992630|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
131099178|NCT02544451|471992631|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
131099179|NCT02544451|471992632|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
131099180|NCT02544451|471992629|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
131099181|NCT02544451|471992630|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
131099182|NCT02544451|471992631|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
131099183|NCT02544451|471992632|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
131099184|NCT01489891|471992633|FG000|Overall Study|Endoscopy failure|1|||
131099185|NCT01489891|471992634|FG001|Overall Study|Endoscopy failure|0|||
131099186|NCT00998790|471992635|FG000|Overall Study|Withdrawal by Subject|21|||
131099187|NCT03001076|471992636|FG000|Overall Study|Withdrawal by patient|2|||
131099188|NCT03001076|471992637|FG001|Overall Study|Withdrawal by patient|0|||
131099189|NCT03001076|471992636|FG000|Overall Study|Other|1|||
131099190|NCT03001076|471992637|FG001|Overall Study|Other|0|||
131099191|NCT03001076|471992636|FG000|Overall Study|Adverse Event|3|||
131099192|NCT03001076|471992637|FG001|Overall Study|Adverse Event|3|||
131099193|NCT03001076|471992636|FG000|Overall Study|Sponsor decision|1|||
131099194|NCT03001076|471992637|FG001|Overall Study|Sponsor decision|0|||
131099195|NCT03001076|471992636|FG000|Overall Study|Lost to Follow-up|0|||
131099196|NCT03001076|471992637|FG001|Overall Study|Lost to Follow-up|2|||
131099197|NCT03189745|471992638|FG000|Overall Study|Conflict in work schedule of participant|1|||
131099198|NCT03189745|471992639|FG001|Overall Study|Conflict in work schedule of participant|1|||
131099199|NCT00895154|471992640|FG000|Overall Study|Lost to Follow-up|1|||
131099200|NCT00895154|471992641|FG001|Overall Study|Lost to Follow-up|1|||
131099201|NCT00895154|471992640|FG000|Overall Study|Withdrawal by Subject|0|||
131099202|NCT00895154|471992641|FG001|Overall Study|Withdrawal by Subject|1|||
131099203|NCT01993927|471992642|FG000|Overall Study|Case Report Forms Uncollected|18|||
131099204|NCT01993927|471992642|FG000|Overall Study|Protocol Violation|11|||
131099205|NCT00777088|471992643|FG000|Overall Study|PED Treatment not attempted|1|||
131099206|NCT02729831|471992645|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
131099207|NCT02729831|471992646|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
131099208|NCT02729831|471992647|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
131099209|NCT02729831|471992648|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
131099210|NCT02729831|471992645|FG000|1 Week Post-visit|Lost to Follow-up|43|||
131099211|NCT02729831|471992646|FG001|1 Week Post-visit|Lost to Follow-up|40|||
131099212|NCT02729831|471992647|FG002|1 Week Post-visit|Lost to Follow-up|38|||
131099213|NCT02729831|471992648|FG003|1 Week Post-visit|Lost to Follow-up|36|||
131099214|NCT02729831|471992645|FG000|6 Month Follow-up|Lost to Follow-up|54|||
131099215|NCT02729831|471992646|FG001|6 Month Follow-up|Lost to Follow-up|51|||
131099216|NCT02729831|471992647|FG002|6 Month Follow-up|Lost to Follow-up|48|||
131099217|NCT02729831|471992648|FG003|6 Month Follow-up|Lost to Follow-up|42|||
131099218|NCT02729831|471992645|FG000|6 Month Follow-up|Death|1|||
131099219|NCT02729831|471992646|FG001|6 Month Follow-up|Death|3|||
131099220|NCT02729831|471992647|FG002|6 Month Follow-up|Death|0|||
131099221|NCT02729831|471992648|FG003|6 Month Follow-up|Death|1|||
131099222|NCT03117998|471992649|FG000|Overall Study|Adverse Event|1|||
131099223|NCT03117998|471992650|FG001|Overall Study|Adverse Event|0|||
131099224|NCT03117998|471992651|FG002|Overall Study|Adverse Event|0|||
131099225|NCT03117998|471992652|FG003|Overall Study|Adverse Event|0|||
131099226|NCT03117998|471992653|FG004|Overall Study|Adverse Event|0|||
131099227|NCT03117998|471992654|FG005|Overall Study|Adverse Event|0|||
131099228|NCT03117998|471992649|FG000|Overall Study|Withdrawal by Subject|0|||
131099229|NCT03117998|471992650|FG001|Overall Study|Withdrawal by Subject|0|||
131099230|NCT03117998|471992651|FG002|Overall Study|Withdrawal by Subject|2|||
131213401|NCT00494234|472405333|FG001|Overall Study|Death|1|||
131213402|NCT00423137|472405334|FG000|Overall Study|Lost to Follow-up|0|||
130879819|NCT03279081|471193102|FG000|Overall Study|Adverse Event|1|||
130879820|NCT03279081|471193103|FG001|Overall Study|Adverse Event|0|||
130879821|NCT03279081|471193102|FG000|Overall Study|Reason not Specified|14|||
131099231|NCT03117998|471992652|FG003|Overall Study|Withdrawal by Subject|3|||
131099232|NCT03117998|471992653|FG004|Overall Study|Withdrawal by Subject|3|||
131099233|NCT03117998|471992654|FG005|Overall Study|Withdrawal by Subject|0|||
131099234|NCT03117998|471992649|FG000|Overall Study|Physician Decision|0|||
131099235|NCT03117998|471992650|FG001|Overall Study|Physician Decision|1|||
131099236|NCT03117998|471992651|FG002|Overall Study|Physician Decision|1|||
131099237|NCT03117998|471992652|FG003|Overall Study|Physician Decision|0|||
131099238|NCT03117998|471992653|FG004|Overall Study|Physician Decision|0|||
131099239|NCT03117998|471992654|FG005|Overall Study|Physician Decision|0|||
131099240|NCT03117998|471992649|FG000|Overall Study|Lost to Follow-up|0|||
131099241|NCT03117998|471992650|FG001|Overall Study|Lost to Follow-up|0|||
131099242|NCT03117998|471992651|FG002|Overall Study|Lost to Follow-up|0|||
131099243|NCT03117998|471992652|FG003|Overall Study|Lost to Follow-up|1|||
131099244|NCT03117998|471992653|FG004|Overall Study|Lost to Follow-up|4|||
131099245|NCT03117998|471992654|FG005|Overall Study|Lost to Follow-up|0|||
131099246|NCT03117998|471992649|FG000|Overall Study|Subject noncompliance|0|||
131099247|NCT03117998|471992650|FG001|Overall Study|Subject noncompliance|0|||
131099248|NCT03117998|471992651|FG002|Overall Study|Subject noncompliance|1|||
131099249|NCT03117998|471992652|FG003|Overall Study|Subject noncompliance|0|||
131099250|NCT03117998|471992653|FG004|Overall Study|Subject noncompliance|0|||
131099251|NCT03117998|471992654|FG005|Overall Study|Subject noncompliance|2|||
131099252|NCT03117998|471992649|FG000|Overall Study|Protocol Violation|0|||
131099253|NCT03117998|471992650|FG001|Overall Study|Protocol Violation|0|||
131099254|NCT03117998|471992651|FG002|Overall Study|Protocol Violation|0|||
131099255|NCT03117998|471992652|FG003|Overall Study|Protocol Violation|0|||
131099256|NCT03117998|471992653|FG004|Overall Study|Protocol Violation|0|||
131099257|NCT03117998|471992654|FG005|Overall Study|Protocol Violation|1|||
131099258|NCT00438672|471992655|FG000|Overall Study|Lost to Follow-up|7|||
131099259|NCT00438672|471992656|FG001|Overall Study|Lost to Follow-up|9|||
131099260|NCT01468181|471992657|FG000|Overall Study|Adverse Event|8|||
131099261|NCT01468181|471992658|FG001|Overall Study|Adverse Event|1|||
131099262|NCT01468181|471992659|FG002|Overall Study|Adverse Event|6|||
131099263|NCT01468181|471992660|FG003|Overall Study|Adverse Event|2|||
131099264|NCT01468181|471992661|FG004|Overall Study|Adverse Event|2|||
131099265|NCT01468181|471992657|FG000|Overall Study|Protocol Violation|2|||
131099266|NCT01468181|471992658|FG001|Overall Study|Protocol Violation|0|||
131099267|NCT01468181|471992659|FG002|Overall Study|Protocol Violation|1|||
131099268|NCT01468181|471992660|FG003|Overall Study|Protocol Violation|0|||
131099269|NCT01468181|471992661|FG004|Overall Study|Protocol Violation|1|||
131099270|NCT01468181|471992657|FG000|Overall Study|Physician Decision|0|||
131099271|NCT01468181|471992658|FG001|Overall Study|Physician Decision|0|||
131099272|NCT01468181|471992659|FG002|Overall Study|Physician Decision|0|||
131099273|NCT01468181|471992660|FG003|Overall Study|Physician Decision|1|||
131099274|NCT01468181|471992661|FG004|Overall Study|Physician Decision|1|||
131099275|NCT01468181|471992657|FG000|Overall Study|Lost to Follow-up|0|||
131099276|NCT01468181|471992658|FG001|Overall Study|Lost to Follow-up|0|||
131099277|NCT01468181|471992659|FG002|Overall Study|Lost to Follow-up|1|||
131099278|NCT01468181|471992660|FG003|Overall Study|Lost to Follow-up|0|||
131099279|NCT01468181|471992661|FG004|Overall Study|Lost to Follow-up|1|||
131099280|NCT01468181|471992657|FG000|Overall Study|Withdrawal by Subject|0|||
131099281|NCT01468181|471992658|FG001|Overall Study|Withdrawal by Subject|1|||
131099282|NCT01468181|471992659|FG002|Overall Study|Withdrawal by Subject|0|||
131099283|NCT01468181|471992660|FG003|Overall Study|Withdrawal by Subject|0|||
131099284|NCT01468181|471992661|FG004|Overall Study|Withdrawal by Subject|0|||
131099285|NCT04828837|471992665|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
131099286|NCT04828837|471992666|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
131099287|NCT04828837|471992665|FG000|Overall Study|Lost to Follow-up|2|||
131099288|NCT04828837|471992666|FG001|Overall Study|Lost to Follow-up|6|||
131099289|NCT04828837|471992665|FG000|Overall Study|Lack of Efficacy|1|||
131099290|NCT04828837|471992666|FG001|Overall Study|Lack of Efficacy|0|||
131099291|NCT04828837|471992665|FG000|Overall Study|Admitted due to pneumothorax.|1|||
131099292|NCT04828837|471992666|FG001|Overall Study|Admitted due to pneumothorax.|0|||
131099293|NCT04828837|471992665|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
131099294|NCT04828837|471992666|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
131099295|NCT00320528|471992667|FG000|Study Period II|Adverse Event|3|||
131099296|NCT00320528|471992668|FG001|Study Period II|Adverse Event|4|||
131099297|NCT00320528|471992669|FG002|Study Period II|Adverse Event|8|||
131099298|NCT00320528|471992667|FG000|Study Period II|Parent/Caregiver Decision|8|||
131099299|NCT00320528|471992668|FG001|Study Period II|Parent/Caregiver Decision|3|||
131099300|NCT00320528|471992669|FG002|Study Period II|Parent/Caregiver Decision|11|||
131099301|NCT00320528|471992667|FG000|Study Period II|Withdrawal by Subject|0|||
131099302|NCT00320528|471992668|FG001|Study Period II|Withdrawal by Subject|1|||
131099303|NCT00320528|471992669|FG002|Study Period II|Withdrawal by Subject|1|||
131099304|NCT00320528|471992667|FG000|Study Period II|Entry Criteria Exclusion|0|||
131099305|NCT00320528|471992668|FG001|Study Period II|Entry Criteria Exclusion|2|||
131099306|NCT00320528|471992669|FG002|Study Period II|Entry Criteria Exclusion|2|||
131099307|NCT00320528|471992667|FG000|Study Period III|Adverse Event|1|||
131099308|NCT00320528|471992668|FG001|Study Period III|Adverse Event|0|||
131099309|NCT00320528|471992669|FG002|Study Period III|Adverse Event|0|||
131099310|NCT00320528|471992667|FG000|Study Period III|Lost to Follow-up|1|||
131099311|NCT00320528|471992668|FG001|Study Period III|Lost to Follow-up|0|||
131099312|NCT00320528|471992669|FG002|Study Period III|Lost to Follow-up|0|||
131099313|NCT00320528|471992667|FG000|Study Period III|Withdrawal by Subject|1|||
131099314|NCT00320528|471992668|FG001|Study Period III|Withdrawal by Subject|1|||
131099315|NCT00320528|471992669|FG002|Study Period III|Withdrawal by Subject|2|||
131099316|NCT00320528|471992667|FG000|Study Period III|Lack of Efficacy|2|||
131099317|NCT00320528|471992668|FG001|Study Period III|Lack of Efficacy|0|||
131099318|NCT00320528|471992669|FG002|Study Period III|Lack of Efficacy|0|||
131099319|NCT00320528|471992667|FG000|Study Period III|Parent/Caregiver Decision|14|||
131099320|NCT00320528|471992668|FG001|Study Period III|Parent/Caregiver Decision|3|||
131099321|NCT00320528|471992669|FG002|Study Period III|Parent/Caregiver Decision|11|||
131099322|NCT00320528|471992667|FG000|Study Period III|Protocol Violation|0|||
131099323|NCT00320528|471992668|FG001|Study Period III|Protocol Violation|1|||
131099324|NCT00320528|471992669|FG002|Study Period III|Protocol Violation|0|||
131099325|NCT00320528|471992667|FG000|Study Period III|Physician Decision|0|||
131099326|NCT00320528|471992668|FG001|Study Period III|Physician Decision|1|||
131099327|NCT00320528|471992669|FG002|Study Period III|Physician Decision|2|||
131099328|NCT00320528|471992667|FG000|Study Period III|Sponsor Decision|0|||
131099329|NCT00320528|471992668|FG001|Study Period III|Sponsor Decision|0|||
131099330|NCT00320528|471992669|FG002|Study Period III|Sponsor Decision|1|||
131099331|NCT00320528|471992667|FG000|Study Period III|Atomoxetine Commercially Available|68|||
131099332|NCT00320528|471992668|FG001|Study Period III|Atomoxetine Commercially Available|25|||
131099333|NCT00320528|471992669|FG002|Study Period III|Atomoxetine Commercially Available|90|||
131099334|NCT00545753|471992670|FG000|Overall Study|Withdrawal by Subject|0|||
131099335|NCT00545753|471992671|FG001|Overall Study|Withdrawal by Subject|1|||
131099336|NCT00545753|471992672|FG002|Overall Study|Withdrawal by Subject|10|||
131099337|NCT00545753|471992670|FG000|Overall Study|Lost to Follow-up|13|||
131099338|NCT00545753|471992671|FG001|Overall Study|Lost to Follow-up|3|||
131099339|NCT00545753|471992672|FG002|Overall Study|Lost to Follow-up|12|||
131099340|NCT00545753|471992670|FG000|Overall Study|Protocol Violation|3|||
131099341|NCT00545753|471992671|FG001|Overall Study|Protocol Violation|1|||
131099342|NCT00545753|471992672|FG002|Overall Study|Protocol Violation|4|||
131099343|NCT02297139|471992679|FG000|Overall Study|Disease progression|0|||
131099344|NCT02297139|471992680|FG001|Overall Study|Disease progression|1|||
131099345|NCT02297139|471992679|FG000|Overall Study|Study drug toxicity|0|||
131099346|NCT02297139|471992680|FG001|Overall Study|Study drug toxicity|4|||
131099347|NCT02297139|471992679|FG000|Overall Study|Participant request to discontinue study treatment|0|||
131099348|NCT02297139|471992680|FG001|Overall Study|Participant request to discontinue study treatment|1|||
131099349|NCT02297139|471992679|FG000|Overall Study|Maximum clinical benefit|1|||
131099350|NCT02297139|471992680|FG001|Overall Study|Maximum clinical benefit|0|||
131099351|NCT02297139|471992679|FG000|Overall Study|Administrative reason by sponsor|0|||
131099352|NCT02297139|471992680|FG001|Overall Study|Administrative reason by sponsor|2|||
131099353|NCT02297139|471992679|FG000|Overall Study|Other reasons|0|||
131099354|NCT02297139|471992680|FG001|Overall Study|Other reasons|8|||
131099355|NCT02101385|471992681|FG000|Study Treatment|Disease Progression|9|||
131099356|NCT02101385|471992682|FG001|Study Treatment|Disease Progression|3|||
131099357|NCT02101385|471992681|FG000|Study Treatment|Alternative therapy|0|||
131099358|NCT02101385|471992682|FG001|Study Treatment|Alternative therapy|1|||
131099359|NCT02101385|471992681|FG000|Study Treatment|No treatment, per protocol criteria|0|||
131099360|NCT02101385|471992682|FG001|Study Treatment|No treatment, per protocol criteria|4|||
131099361|NCT02101385|471992681|FG000|Study Treatment|Patient Non compliance|0|||
131099362|NCT02101385|471992682|FG001|Study Treatment|Patient Non compliance|2|||
131099363|NCT02101385|471992681|FG000|Study Treatment|Withdrawal by Subject|5|||
131099364|NCT02101385|471992682|FG001|Study Treatment|Withdrawal by Subject|2|||
131099365|NCT02101385|471992681|FG000|Study Treatment|screen failure|1|||
131099366|NCT02101385|471992682|FG001|Study Treatment|screen failure|0|||
131099367|NCT02101385|471992681|FG000|Study Treatment|AE/Side Effects/Complications|8|||
131099368|NCT02101385|471992682|FG001|Study Treatment|AE/Side Effects/Complications|0|||
131099369|NCT02101385|471992681|FG000|Study Treatment|Lost to Follow-up|1|||
131099370|NCT02101385|471992682|FG001|Study Treatment|Lost to Follow-up|0|||
131099371|NCT02101385|471992681|FG000|Study Treatment|Disease Progression before treatment|1|||
131099372|NCT02101385|471992682|FG001|Study Treatment|Disease Progression before treatment|0|||
131099373|NCT02101385|471992681|FG000|Study Treatment|Death|1|||
131099374|NCT02101385|471992682|FG001|Study Treatment|Death|0|||
131099375|NCT02101385|471992681|FG000|Follow up|Lost to Follow-up|4|||
131213403|NCT00423137|472405335|FG001|Overall Study|Lost to Follow-up|0|||
131099376|NCT02101385|471992682|FG001|Follow up|Lost to Follow-up|9|||
131099377|NCT02101385|471992681|FG000|Follow up|Refused to follow up|5|||
131099378|NCT02101385|471992682|FG001|Follow up|Refused to follow up|4|||
131099379|NCT02101385|471992681|FG000|Follow up|Death|21|||
131099380|NCT02101385|471992682|FG001|Follow up|Death|39|||
131099381|NCT02101385|471992681|FG000|Follow up|study completed|33|||
131099382|NCT02101385|471992682|FG001|Follow up|study completed|52|||
131099383|NCT02101385|471992681|FG000|Follow up|screen failure|2|||
131099384|NCT02101385|471992682|FG001|Follow up|screen failure|0|||
131099385|NCT02101385|471992681|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
131099386|NCT02101385|471992682|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
131099387|NCT02101385|471992681|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
131099388|NCT02101385|471992682|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
131099389|NCT02101385|471992681|FG000|Follow up|Withdrawal by Subject|2|||
131099390|NCT02101385|471992682|FG001|Follow up|Withdrawal by Subject|2|||
131099391|NCT02101385|471992681|FG000|Follow up|PI requested closure of site|0|||
131099392|NCT02101385|471992682|FG001|Follow up|PI requested closure of site|5|||
131099393|NCT02432196|471992683|FG000|Overall Study|Exit - did not receive study device|1|||
131099394|NCT02432196|471992683|FG000|Overall Study|Death|2|||
131099395|NCT02432196|471992683|FG000|Overall Study|Reoperation|3|||
131099396|NCT01942785|471992684|FG000|Overall Study|Adverse Event|2|||
131099397|NCT01942785|471992684|FG000|Overall Study|Withdrawal by Subject|1|||
131099398|NCT01942785|471992684|FG000|Overall Study|Protocol Violation|1|||
131099399|NCT01905150|471992685|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
131099400|NCT01905150|471992686|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
131099401|NCT03762200|471992691|FG000|Overall Study|Death|2|||
131099402|NCT02631577|471992692|FG000|Overall Study|Death|1|||
131099403|NCT02631577|471992693|FG001|Overall Study|Death|7|||
131099404|NCT02631577|471992692|FG000|Overall Study|Withdrawal by Subject|0|||
131099405|NCT02631577|471992693|FG001|Overall Study|Withdrawal by Subject|3|||
131099406|NCT01593787|471992694|FG000|Overall Study|Adverse Event|1|||
131099407|NCT01593787|471992695|FG001|Overall Study|Adverse Event|0|||
131099408|NCT01593787|471992696|FG002|Overall Study|Adverse Event|0|||
131099409|NCT03981861|471992702|FG000|Overall Study|Withdrawal by Subject|3|||
131099410|NCT05618912|471992703|FG000|Overall Study|Lost to Follow-up|14|||
131099411|NCT05618912|471992704|FG001|Overall Study|Lost to Follow-up|19|||
131099412|NCT01022112|471992705|FG000|Overall Study|Adverse Event|1|||
131099413|NCT01022112|471992706|FG001|Overall Study|Adverse Event|2|||
131099414|NCT01022112|471992707|FG002|Overall Study|Adverse Event|0|||
131099415|NCT01022112|471992708|FG003|Overall Study|Adverse Event|1|||
131099416|NCT01022112|471992709|FG004|Overall Study|Adverse Event|0|||
131099417|NCT01022112|471992705|FG000|Overall Study|Lack of Efficacy|1|||
131099418|NCT01022112|471992706|FG001|Overall Study|Lack of Efficacy|0|||
131099419|NCT01022112|471992707|FG002|Overall Study|Lack of Efficacy|0|||
131099420|NCT01022112|471992708|FG003|Overall Study|Lack of Efficacy|0|||
131099421|NCT01022112|471992709|FG004|Overall Study|Lack of Efficacy|1|||
131099422|NCT01022112|471992705|FG000|Overall Study|Physician Decision|0|||
131099423|NCT01022112|471992706|FG001|Overall Study|Physician Decision|0|||
131099424|NCT01022112|471992707|FG002|Overall Study|Physician Decision|1|||
131099425|NCT01022112|471992708|FG003|Overall Study|Physician Decision|0|||
131099426|NCT01022112|471992709|FG004|Overall Study|Physician Decision|1|||
131099427|NCT01022112|471992705|FG000|Overall Study|Withdrawal by Subject|0|||
131099428|NCT01022112|471992706|FG001|Overall Study|Withdrawal by Subject|1|||
131099429|NCT01022112|471992707|FG002|Overall Study|Withdrawal by Subject|2|||
131099430|NCT01022112|471992708|FG003|Overall Study|Withdrawal by Subject|2|||
131099431|NCT01022112|471992709|FG004|Overall Study|Withdrawal by Subject|1|||
131099432|NCT01022112|471992705|FG000|Overall Study|Fasting plasma glucose level increased|1|||
131099433|NCT01022112|471992706|FG001|Overall Study|Fasting plasma glucose level increased|0|||
131099434|NCT01022112|471992707|FG002|Overall Study|Fasting plasma glucose level increased|0|||
131099435|NCT01022112|471992708|FG003|Overall Study|Fasting plasma glucose level increased|0|||
131099436|NCT01022112|471992709|FG004|Overall Study|Fasting plasma glucose level increased|7|||
131099437|NCT00978627|471994505|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
131099438|NCT00978627|471994506|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
131099439|NCT00978627|471994505|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
131099440|NCT00978627|471994506|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
131099441|NCT00978627|471994505|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
131099442|NCT00978627|471994506|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
131099443|NCT00978627|471994505|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
131099444|NCT00978627|471994506|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
131099445|NCT00978627|471994505|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
131099446|NCT00978627|471994506|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
131099447|NCT00978627|471994505|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
131099448|NCT00978627|471994506|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
131099449|NCT00978627|471994505|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
131099450|NCT00978627|471994506|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
131099451|NCT00978627|471994505|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
131133644|NCT01662440|472117165|FG003|Overall Study|Adverse Event|1|||
131133645|NCT01662440|472117162|FG000|Overall Study|Death|0|||
131133646|NCT01662440|472117163|FG001|Overall Study|Death|1|||
131133647|NCT01662440|472117164|FG002|Overall Study|Death|0|||
131099452|NCT00978627|471994506|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
131099453|NCT00978627|471994505|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
131099454|NCT00978627|471994506|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
131099455|NCT02516332|471994507|FG000|Overall Study|Withdrawal by Subject|2|||
131099456|NCT02516332|471994508|FG001|Overall Study|Withdrawal by Subject|1|||
131099457|NCT02516332|471994509|FG002|Overall Study|Withdrawal by Subject|2|||
131099458|NCT03037931|471994510|FG000|Overall Study|Death|354|||
131099459|NCT03037931|471994511|FG001|Overall Study|Death|367|||
131099460|NCT03037931|471994510|FG000|Overall Study|Lost to Follow-up|7|||
131099461|NCT03037931|471994511|FG001|Overall Study|Lost to Follow-up|4|||
131099462|NCT03037931|471994510|FG000|Overall Study|Withdrawal by Subject|48|||
131099463|NCT03037931|471994511|FG001|Overall Study|Withdrawal by Subject|41|||
131099464|NCT00605215|471994512|FG000|Overall Study|Death|0|||
131099465|NCT00605215|471994513|FG001|Overall Study|Death|0|||
131099466|NCT00605215|471994514|FG002|Overall Study|Death|1|||
131099467|NCT00605215|471994512|FG000|Overall Study|Adverse Event|19|||
131099468|NCT00605215|471994513|FG001|Overall Study|Adverse Event|21|||
131099469|NCT00605215|471994514|FG002|Overall Study|Adverse Event|26|||
131099470|NCT00605215|471994512|FG000|Overall Study|Refusal to sign the re-consent form|8|||
131099471|NCT00605215|471994513|FG001|Overall Study|Refusal to sign the re-consent form|3|||
131099472|NCT00605215|471994514|FG002|Overall Study|Refusal to sign the re-consent form|3|||
131099473|NCT00605215|471994512|FG000|Overall Study|Withdrawal by Subject|39|||
131099474|NCT00605215|471994513|FG001|Overall Study|Withdrawal by Subject|37|||
131099475|NCT00605215|471994514|FG002|Overall Study|Withdrawal by Subject|27|||
131099476|NCT00605215|471994512|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
131099477|NCT00605215|471994513|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
131099478|NCT00605215|471994514|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
131099479|NCT00605215|471994512|FG000|Overall Study|Protocol Violation|3|||
131099480|NCT00605215|471994513|FG001|Overall Study|Protocol Violation|4|||
131099481|NCT00605215|471994514|FG002|Overall Study|Protocol Violation|1|||
131099482|NCT00605215|471994512|FG000|Overall Study|Pregnancy|8|||
131099483|NCT00605215|471994513|FG001|Overall Study|Pregnancy|5|||
131099484|NCT00605215|471994514|FG002|Overall Study|Pregnancy|4|||
131099485|NCT00605215|471994512|FG000|Overall Study|Lost to Follow-up|8|||
131099486|NCT00605215|471994513|FG001|Overall Study|Lost to Follow-up|5|||
131099487|NCT00605215|471994514|FG002|Overall Study|Lost to Follow-up|2|||
131099488|NCT00605215|471994512|FG000|Overall Study|Other than specified|0|||
131099489|NCT00605215|471994513|FG001|Overall Study|Other than specified|2|||
131099490|NCT00605215|471994514|FG002|Overall Study|Other than specified|1|||
131099491|NCT02704754|471994518|FG000|Overall Study|Lost to Follow-up|1|||
131099492|NCT02704754|471994519|FG001|Overall Study|Lost to Follow-up|1|||
131099493|NCT02704754|471994518|FG000|Overall Study|Lack of Efficacy|1|||
131099494|NCT02704754|471994519|FG001|Overall Study|Lack of Efficacy|0|||
131099495|NCT02704754|471994518|FG000|Overall Study|Withdrawal by Subject|1|||
131099496|NCT02704754|471994519|FG001|Overall Study|Withdrawal by Subject|0|||
131099497|NCT00657020|471994520|FG000|PERIOD 1|Adverse Event|0|||
131099498|NCT00657020|471994521|FG001|PERIOD 1|Adverse Event|1|||
131099499|NCT00774930|471994525|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
131099500|NCT00774930|471994526|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
131099501|NCT00774930|471994525|FG000|DB Phase|Adverse Event|1|||
131099502|NCT00774930|471994526|FG001|DB Phase|Adverse Event|2|||
131099503|NCT00774930|471994525|FG000|DB Phase|Subject Decision|1|||
131099504|NCT00774930|471994526|FG001|DB Phase|Subject Decision|5|||
131099505|NCT00774930|471994525|FG000|DB Phase|Sponsor Decision|0|||
131099506|NCT00774930|471994526|FG001|DB Phase|Sponsor Decision|1|||
131099507|NCT00774930|471994525|FG000|DB Phase|Disease Progression|1|||
131099508|NCT00774930|471994526|FG001|DB Phase|Disease Progression|1|||
131099509|NCT00774930|471994525|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
131099510|NCT00774930|471994526|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
131099511|NCT00774930|471994525|FG000|IOL Phase|Adverse Event|1|||
131099512|NCT00774930|471994526|FG001|IOL Phase|Adverse Event|1|||
131099513|NCT00774930|471994525|FG000|IOL Phase|Subject Decision|4|||
131099514|NCT00774930|471994526|FG001|IOL Phase|Subject Decision|3|||
131099515|NCT00774930|471994525|FG000|IOL Phase|Physician Decision|3|||
131099516|NCT00774930|471994526|FG001|IOL Phase|Physician Decision|2|||
131099517|NCT00774930|471994525|FG000|IOL Phase|Sponsor Decision|1|||
131099518|NCT00774930|471994526|FG001|IOL Phase|Sponsor Decision|0|||
131213404|NCT00423137|472405336|FG002|Overall Study|Lost to Follow-up|1|||
131099519|NCT00774930|471994525|FG000|IOL Phase|Disease Progression|2|||
131213405|NCT00423137|472405337|FG003|Overall Study|Lost to Follow-up|0|||
131213406|NCT00423137|472405334|FG000|Overall Study|Protocol Violation|0|||
131099520|NCT00774930|471994526|FG001|IOL Phase|Disease Progression|1|||
131099521|NCT00774930|471994525|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
131099522|NCT00774930|471994526|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
131099523|NCT00774930|471994525|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
131099524|NCT00774930|471994526|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
131099525|NCT00774930|471994525|FG000|IOL Phase|Other|1|||
131099526|NCT00774930|471994526|FG001|IOL Phase|Other|0|||
131099527|NCT00774930|471994525|FG000|IOL Phase|Brain radiation|0|||
131099528|NCT00774930|471994526|FG001|IOL Phase|Brain radiation|1|||
131099529|NCT00774930|471994525|FG000|LTOLE Phase|Adverse Event|7|||
131099530|NCT00774930|471994526|FG001|LTOLE Phase|Adverse Event|3|||
131099531|NCT00774930|471994525|FG000|LTOLE Phase|Subject decision|0|||
131099532|NCT00774930|471994526|FG001|LTOLE Phase|Subject decision|5|||
131099533|NCT00774930|471994525|FG000|LTOLE Phase|Physician Decision|4|||
131099534|NCT00774930|471994526|FG001|LTOLE Phase|Physician Decision|1|||
131099535|NCT00774930|471994525|FG000|LTOLE Phase|Sponsor decision|2|||
131099536|NCT00774930|471994526|FG001|LTOLE Phase|Sponsor decision|1|||
131099537|NCT00774930|471994525|FG000|LTOLE Phase|Disease Progression|2|||
131099538|NCT00774930|471994526|FG001|LTOLE Phase|Disease Progression|5|||
131099539|NCT00774930|471994525|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
131099540|NCT00774930|471994526|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
131099541|NCT00774930|471994525|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
131099542|NCT00774930|471994526|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
131099543|NCT00766363|471994527|FG000|Overall Study|Withdrawal by Subject|1|||
131099544|NCT00766363|471994528|FG001|Overall Study|Withdrawal by Subject|0|||
131099545|NCT00766363|471994529|FG002|Overall Study|Withdrawal by Subject|0|||
131099546|NCT00766363|471994530|FG003|Overall Study|Withdrawal by Subject|0|||
131099547|NCT00766363|471994527|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
131099548|NCT00766363|471994528|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
131099549|NCT00766363|471994529|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
131099550|NCT00766363|471994530|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
131099551|NCT01153321|471994535|FG000|Overall Study|Development of study withdrawal criteria|0|||
131099552|NCT01153321|471994536|FG001|Overall Study|Development of study withdrawal criteria|1|||
131099553|NCT01153321|471994535|FG000|Overall Study|Withdrawal by Subject|0|||
131099554|NCT01153321|471994536|FG001|Overall Study|Withdrawal by Subject|1|||
131099555|NCT01153321|471994535|FG000|Overall Study|Adverse Event|1|||
131099556|NCT01153321|471994536|FG001|Overall Study|Adverse Event|1|||
131099557|NCT03020576|471994537|FG000|Overall Study|Withdrawal by Subject|1|||
131099558|NCT03020576|471994538|FG001|Overall Study|Withdrawal by Subject|2|||
131099559|NCT01177800|471994540|FG000|Overall Study|Adverse Event|9|||
131099560|NCT01177800|471994541|FG001|Overall Study|Adverse Event|3|||
131099561|NCT01177800|471994540|FG000|Overall Study|Protocol Violation|0|||
131099562|NCT01177800|471994541|FG001|Overall Study|Protocol Violation|1|||
131099563|NCT01177800|471994540|FG000|Overall Study|Physician Decision|1|||
131099564|NCT01177800|471994541|FG001|Overall Study|Physician Decision|0|||
131099565|NCT01177800|471994540|FG000|Overall Study|Withdrawal of informed consent|0|||
131099566|NCT01177800|471994541|FG001|Overall Study|Withdrawal of informed consent|1|||
131099567|NCT03527550|471994542|FG000|Overall Study|Lost to Follow-up|4|||
131099568|NCT03527550|471994543|FG001|Overall Study|Lost to Follow-up|2|||
131099569|NCT03527550|471994542|FG000|Overall Study|Withdrawal by Subject|4|||
131099570|NCT03527550|471994543|FG001|Overall Study|Withdrawal by Subject|1|||
131099571|NCT03527550|471994542|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
131099572|NCT03527550|471994543|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
131099573|NCT00911937|471994544|FG000|Overall Study|Death|1|||
131099574|NCT00911937|471994545|FG001|Overall Study|Death|0|||
131099575|NCT00911937|471994544|FG000|Overall Study|Lost to Follow-up|8|||
131099576|NCT00911937|471994545|FG001|Overall Study|Lost to Follow-up|5|||
131099577|NCT00911937|471994544|FG000|Overall Study|Withdrawal by Subject|10|||
131099578|NCT00911937|471994545|FG001|Overall Study|Withdrawal by Subject|7|||
131099579|NCT00911937|471994544|FG000|Overall Study|Withdrawn due to pregnancy|1|||
131099580|NCT00911937|471994545|FG001|Overall Study|Withdrawn due to pregnancy|0|||
131099581|NCT00911937|471994544|FG000|Overall Study|Adverse Event|11|||
131099582|NCT00911937|471994545|FG001|Overall Study|Adverse Event|25|||
131099583|NCT00911937|471994544|FG000|Overall Study|Lack of Efficacy|11|||
131099584|NCT00911937|471994545|FG001|Overall Study|Lack of Efficacy|6|||
131099585|NCT00911937|471994544|FG000|Overall Study|Did not meet inclusion criteria|9|||
131099586|NCT00911937|471994545|FG001|Overall Study|Did not meet inclusion criteria|11|||
131099587|NCT00911937|471994544|FG000|Overall Study|Protocol Violation|14|||
131099588|NCT00911937|471994545|FG001|Overall Study|Protocol Violation|23|||
131099589|NCT00911937|471994544|FG000|Overall Study|Randomized but not treated|13|||
131099590|NCT00911937|471994545|FG001|Overall Study|Randomized but not treated|13|||
131099591|NCT00911937|471994544|FG000|Overall Study|Other|9|||
131099592|NCT00911937|471994545|FG001|Overall Study|Other|5|||
131099593|NCT01498679|471994546|FG000|Overall Study|Adverse Event|1|||
131099594|NCT01498679|471994547|FG001|Overall Study|Adverse Event|4|||
131099595|NCT01498679|471994546|FG000|Overall Study|Lack of Efficacy|72|||
131099596|NCT01498679|471994547|FG001|Overall Study|Lack of Efficacy|12|||
131099597|NCT01498679|471994546|FG000|Overall Study|Protocol Violation|4|||
131099598|NCT01498679|471994547|FG001|Overall Study|Protocol Violation|0|||
131099599|NCT01498679|471994546|FG000|Overall Study|Physician Decision|0|||
131099600|NCT01498679|471994547|FG001|Overall Study|Physician Decision|2|||
131099601|NCT01498679|471994546|FG000|Overall Study|Withdrawal by Subject|12|||
131099602|NCT01498679|471994547|FG001|Overall Study|Withdrawal by Subject|4|||
131099603|NCT01844687|471994552|FG000|Visit 1|Protocol Violation|3|||
131099604|NCT01844687|471994552|FG000|Visit 1|Lost to Follow-up|5|||
131099605|NCT01844687|471994552|FG000|Visit 2|Withdrawal by Subject|1|||
131099606|NCT01844687|471994552|FG000|Visit 2|Protocol Violation|1|||
131099607|NCT01844687|471994552|FG000|Visit 3|Lost to Follow-up|1|||
131099608|NCT01844687|471994552|FG000|Visit 3|Withdrawal by Subject|3|||
131099609|NCT01844687|471994552|FG000|Visit 3|child care problems|1|||
131099610|NCT01844687|471994552|FG000|Visit 4|Pregnancy|1|||
131099611|NCT01844687|471994552|FG000|Visit 4|Lost to Follow-up|1|||
131099612|NCT01844687|471994552|FG000|Visit 4|Withdrawal by Subject|2|||
131099613|NCT03484273|471994559|FG000|Overall Study|Equipment Malfunction|1|||
131099614|NCT03484273|471994559|FG000|Overall Study|Data excluded from analysis|1|||
131099615|NCT02706899|471994562|FG000|Overall Study|Withdrawal by Subject|1|||
131099616|NCT02706899|471994563|FG001|Overall Study|Withdrawal by Subject|0|||
131099617|NCT02706899|471994562|FG000|Overall Study|Death|8|||
131099618|NCT02706899|471994563|FG001|Overall Study|Death|0|||
131099619|NCT02706899|471994562|FG000|Overall Study|Study Termination by Sponsor|4|||
131099620|NCT02706899|471994563|FG001|Overall Study|Study Termination by Sponsor|6|||
131099621|NCT02442336|471994567|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
131099622|NCT02442336|471994567|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
131099623|NCT02442336|471994567|FG000|Overall Study|Lost to Follow-up|11|||
131099624|NCT00844532|471994569|FG000|Overall Study|Death|16|||
131099625|NCT00844532|471994569|FG000|Overall Study|Withdrawal by Subject|16|||
131099626|NCT00844532|471994569|FG000|Overall Study|Lost to Follow-up|7|||
131099627|NCT01056718|471994570|FG000|Overall Study|Withdrawal by Subject|2|||
131099628|NCT01056718|471994570|FG000|Overall Study|Ischemia on baseline stress test|1|||
131099629|NCT00287690|471994571|FG000|Overall Study|Protocol Violation|20|||
131099630|NCT00287690|471994572|FG001|Overall Study|Protocol Violation|26|||
131099631|NCT02270515|471994573|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
131099632|NCT02270515|471994573|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
131099633|NCT02270515|471994573|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
131099634|NCT02270515|471994573|FG000|Intervention Period 1: 0-6 Months|Death|7|||
131099635|NCT02270515|471994573|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
131099636|NCT02270515|471994573|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
131099637|NCT02270515|471994573|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
131099638|NCT02270515|471994573|FG000|Intervention Period 2: 6-12 Months|Death|5|||
131099639|NCT02270515|471994573|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
131099640|NCT02270515|471994573|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
131099641|NCT02270515|471994573|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
131099642|NCT02270515|471994573|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
131099643|NCT02270515|471994573|FG000|Intervention Period 3: 12-18 Months|Death|3|||
131099644|NCT02270515|471994573|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
131099645|NCT01237587|471994576|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
131099646|NCT01237587|471994577|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
131099647|NCT01237587|471994576|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
131099648|NCT01237587|471994577|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
131099649|NCT01237587|471994576|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
131099650|NCT01237587|471994577|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
131099651|NCT01237587|471994576|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
131099652|NCT01237587|471994577|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
131099653|NCT01237587|471994576|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
131099654|NCT01237587|471994577|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
131099655|NCT01237587|471994576|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
131099656|NCT01237587|471994577|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
131099657|NCT01237587|471994576|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
131099658|NCT01237587|471994577|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
131099659|NCT01237587|471994576|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
131099660|NCT01237587|471994577|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
131099661|NCT01237587|471994576|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
131099662|NCT01237587|471994577|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
131099663|NCT01237587|471994576|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
131099664|NCT01237587|471994577|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
131099665|NCT01237587|471994576|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
131099666|NCT01237587|471994577|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
131099667|NCT01237587|471994576|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
131099668|NCT01237587|471994577|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
131099669|NCT01237587|471994576|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
131099670|NCT01237587|471994577|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
131099671|NCT01237587|471994576|FG000|Taper Phase|Adverse Event|0|||
131099672|NCT01237587|471994577|FG001|Taper Phase|Adverse Event|2|||
131099673|NCT01237587|471994576|FG000|Taper Phase|Protocol Violation|2|||
131099674|NCT01237587|471994577|FG001|Taper Phase|Protocol Violation|0|||
131099675|NCT01237587|471994576|FG000|Taper Phase|Lack of Efficacy|2|||
131099676|NCT01237587|471994577|FG001|Taper Phase|Lack of Efficacy|5|||
131099677|NCT01237587|471994576|FG000|Taper Phase|Parent/Guardian Decision|0|||
131099678|NCT01237587|471994577|FG001|Taper Phase|Parent/Guardian Decision|2|||
131099679|NCT01237587|471994576|FG000|Taper Phase|Sponsor Decision|1|||
131099680|NCT01237587|471994577|FG001|Taper Phase|Sponsor Decision|0|||
131099681|NCT01237587|471994576|FG000|Taper Phase|Withdrawal by Subject|0|||
131099682|NCT01237587|471994577|FG001|Taper Phase|Withdrawal by Subject|1|||
131099683|NCT05017103|471994578|FG000|Overall Study|Death|2|||
131099684|NCT01747551|471994583|FG000|Overall Study|Progressive Disease|24|||
131099685|NCT01747551|471994584|FG001|Overall Study|Progressive Disease|17|||
131099686|NCT01747551|471994583|FG000|Overall Study|Death|3|||
131099687|NCT01747551|471994584|FG001|Overall Study|Death|1|||
131099688|NCT01747551|471994583|FG000|Overall Study|Adverse Event|7|||
131099689|NCT01747551|471994584|FG001|Overall Study|Adverse Event|1|||
131099690|NCT01747551|471994583|FG000|Overall Study|Prolonged Treatment Delay|2|||
131099691|NCT01747551|471994584|FG001|Overall Study|Prolonged Treatment Delay|0|||
131099692|NCT01747551|471994583|FG000|Overall Study|Withdrawal by Subject|3|||
131099693|NCT01747551|471994584|FG001|Overall Study|Withdrawal by Subject|1|||
131099694|NCT01747551|471994583|FG000|Overall Study|Physician Decision|2|||
130879822|NCT03279081|471193103|FG001|Overall Study|Reason not Specified|4|||
130879823|NCT04531176|471193114|FG000|Overall Study|Study was stopped early|24|||
130879824|NCT04531176|471193115|FG001|Overall Study|Study was stopped early|26|||
130879825|NCT04531176|471193116|FG002|Overall Study|Study was stopped early|24|||
130879826|NCT03253796|471193117|FG000|Period 1: Run-In|Adverse Event|4|||
130879827|NCT03253796|471193118|FG001|Period 1: Run-In|Adverse Event|0|||
130879828|NCT03253796|471193119|FG002|Period 1: Run-In|Adverse Event|0|||
130879829|NCT03253796|471193120|FG003|Period 1: Run-In|Adverse Event|0|||
130879830|NCT03253796|471193121|FG004|Period 1: Run-In|Adverse Event|0|||
130879831|NCT03253796|471193117|FG000|Period 1: Run-In|Lack of Efficacy|1|||
130879832|NCT03253796|471193118|FG001|Period 1: Run-In|Lack of Efficacy|0|||
130879833|NCT03253796|471193119|FG002|Period 1: Run-In|Lack of Efficacy|0|||
130879834|NCT03253796|471193120|FG003|Period 1: Run-In|Lack of Efficacy|0|||
130879835|NCT03253796|471193121|FG004|Period 1: Run-In|Lack of Efficacy|0|||
130879836|NCT03253796|471193117|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
130879837|NCT03253796|471193118|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
130879838|NCT03253796|471193119|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
130879839|NCT03253796|471193120|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
130879840|NCT03253796|471193121|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
130879841|NCT03253796|471193117|FG000|Period 1: Run-In|Protocol Violation|5|||
130879842|NCT03253796|471193118|FG001|Period 1: Run-In|Protocol Violation|0|||
130879843|NCT03253796|471193119|FG002|Period 1: Run-In|Protocol Violation|0|||
130879844|NCT03253796|471193120|FG003|Period 1: Run-In|Protocol Violation|0|||
130879845|NCT03253796|471193121|FG004|Period 1: Run-In|Protocol Violation|0|||
130879846|NCT03253796|471193117|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
130879847|NCT03253796|471193118|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
130879848|NCT03253796|471193119|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
130879849|NCT03253796|471193120|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
130879850|NCT03253796|471193121|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
130879851|NCT03253796|471193117|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130879852|NCT03253796|471193118|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130879853|NCT03253796|471193119|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
130879854|NCT03253796|471193120|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130879855|NCT03253796|471193121|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130879856|NCT03253796|471193117|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130879857|NCT03253796|471193118|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130879858|NCT03253796|471193119|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
130879859|NCT03253796|471193120|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130879860|NCT03253796|471193121|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130879861|NCT03253796|471193117|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
130879862|NCT03253796|471193118|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
130879863|NCT03253796|471193119|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
130879864|NCT03253796|471193120|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
130879865|NCT03253796|471193121|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
130879866|NCT03253796|471193117|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
131099695|NCT01747551|471994584|FG001|Overall Study|Physician Decision|1|||
131099696|NCT01747551|471994583|FG000|Overall Study|Other|2|||
131099697|NCT01747551|471994584|FG001|Overall Study|Other|0|||
131099698|NCT01142115|471994585|FG000|First Intervention|Lack of Efficacy|1|||
131099699|NCT01142115|471994586|FG001|First Intervention|Lack of Efficacy|1|||
131099700|NCT01142115|471994585|FG000|First Intervention|Adverse Event|1|||
131099701|NCT01142115|471994586|FG001|First Intervention|Adverse Event|0|||
131099702|NCT00633880|471994587|FG000|Open Label Titration|Lack of Efficacy|1|||
131099703|NCT00633880|471994588|FG001|Open Label Titration|Lack of Efficacy|0|||
131099704|NCT00633880|471994589|FG002|Open Label Titration|Lack of Efficacy|0|||
131099705|NCT00633880|471994587|FG000|Open Label Titration|Adverse Event|13|||
131099706|NCT00633880|471994588|FG001|Open Label Titration|Adverse Event|0|||
131099707|NCT00633880|471994589|FG002|Open Label Titration|Adverse Event|0|||
131099708|NCT00633880|471994587|FG000|Open Label Titration|Treatment Failure|55|||
131099709|NCT00633880|471994588|FG001|Open Label Titration|Treatment Failure|0|||
131099710|NCT00633880|471994589|FG002|Open Label Titration|Treatment Failure|0|||
131099711|NCT00633880|471994587|FG000|Open Label Titration|Protocol Violation|6|||
131099712|NCT00633880|471994588|FG001|Open Label Titration|Protocol Violation|0|||
131099713|NCT00633880|471994589|FG002|Open Label Titration|Protocol Violation|0|||
131099714|NCT00633880|471994587|FG000|Open Label Titration|Physician Decision|1|||
131099715|NCT00633880|471994588|FG001|Open Label Titration|Physician Decision|0|||
131099716|NCT00633880|471994589|FG002|Open Label Titration|Physician Decision|0|||
131099717|NCT00633880|471994587|FG000|Open Label Titration|Withdrawal by Subject|4|||
131099718|NCT00633880|471994588|FG001|Open Label Titration|Withdrawal by Subject|0|||
131099719|NCT00633880|471994589|FG002|Open Label Titration|Withdrawal by Subject|0|||
131099720|NCT03208036|471994590|FG000|Baseline Assessment|Withdrawal by Subject|1|||
131099721|NCT03208036|471994591|FG001|Baseline Assessment|Withdrawal by Subject|1|||
131099722|NCT03208036|471994590|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
131099723|NCT03208036|471994591|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
131099724|NCT03208036|471994590|FG000|Intervention|Withdrawal by Subject|3|||
131099725|NCT03208036|471994591|FG001|Intervention|Withdrawal by Subject|2|||
131099726|NCT03208036|471994590|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
131099727|NCT03208036|471994591|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
131099728|NCT03406078|471994592|FG000|Overall Study|Death|1|||
131099729|NCT03406078|471994593|FG001|Overall Study|Death|0|||
131099730|NCT03406078|471994592|FG000|Overall Study|Lost to Follow-up|0|||
131099731|NCT03406078|471994593|FG001|Overall Study|Lost to Follow-up|1|||
131099732|NCT03406078|471994592|FG000|Overall Study|Withdrawal by Subject|5|||
131099733|NCT03406078|471994593|FG001|Overall Study|Withdrawal by Subject|2|||
131099734|NCT02091206|471994594|FG000|Treatment Period|Adverse Event|0|||
131099735|NCT02091206|471994595|FG001|Treatment Period|Adverse Event|1|||
131099736|NCT02091206|471994596|FG002|Treatment Period|Adverse Event|0|||
131099737|NCT02091206|471994597|FG003|Treatment Period|Adverse Event|0|||
131099738|NCT02091206|471994594|FG000|Treatment Period|Met withdrawal criteria|0|||
131099739|NCT02091206|471994595|FG001|Treatment Period|Met withdrawal criteria|0|||
131099740|NCT02091206|471994596|FG002|Treatment Period|Met withdrawal criteria|1|||
131099741|NCT02091206|471994597|FG003|Treatment Period|Met withdrawal criteria|0|||
131099742|NCT02091206|471994594|FG000|Taper Period|Participant refused study drug|1|||
131099743|NCT02091206|471994595|FG001|Taper Period|Participant refused study drug|0|||
131099744|NCT02091206|471994596|FG002|Taper Period|Participant refused study drug|0|||
131099745|NCT02091206|471994597|FG003|Taper Period|Participant refused study drug|1|||
131099746|NCT02091206|471994594|FG000|Taper Period|Lost to Follow-up|0|||
131099747|NCT02091206|471994595|FG001|Taper Period|Lost to Follow-up|0|||
131099748|NCT02091206|471994596|FG002|Taper Period|Lost to Follow-up|0|||
131099749|NCT02091206|471994597|FG003|Taper Period|Lost to Follow-up|1|||
131099750|NCT00700778|471994598|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
131099751|NCT00350103|471994602|FG000|Overall Study|Adverse Event|12|||
131099752|NCT00350103|471994603|FG001|Overall Study|Adverse Event|29|||
131099753|NCT00350103|471994604|FG002|Overall Study|Adverse Event|17|||
131099754|NCT00350103|471994602|FG000|Overall Study|Lack of Efficacy|5|||
131099755|NCT00350103|471994603|FG001|Overall Study|Lack of Efficacy|1|||
131099756|NCT00350103|471994604|FG002|Overall Study|Lack of Efficacy|3|||
131099757|NCT00350103|471994602|FG000|Overall Study|Withdrawal by Subject|6|||
131099758|NCT00350103|471994603|FG001|Overall Study|Withdrawal by Subject|6|||
131099759|NCT00350103|471994604|FG002|Overall Study|Withdrawal by Subject|8|||
131099760|NCT00350103|471994602|FG000|Overall Study|Protocol Violation|0|||
131099761|NCT00350103|471994603|FG001|Overall Study|Protocol Violation|0|||
131099762|NCT00350103|471994604|FG002|Overall Study|Protocol Violation|1|||
131099763|NCT00350103|471994602|FG000|Overall Study|Unsatisfactory Compliance|2|||
131099764|NCT00350103|471994603|FG001|Overall Study|Unsatisfactory Compliance|2|||
131099765|NCT00350103|471994604|FG002|Overall Study|Unsatisfactory Compliance|1|||
131099766|NCT00350103|471994602|FG000|Overall Study|Investigator´s decision|1|||
131099767|NCT00350103|471994603|FG001|Overall Study|Investigator´s decision|1|||
131099768|NCT00350103|471994604|FG002|Overall Study|Investigator´s decision|0|||
131099769|NCT00350103|471994602|FG000|Overall Study|Exclusion criteria met|0|||
131099770|NCT00350103|471994603|FG001|Overall Study|Exclusion criteria met|0|||
131099771|NCT00350103|471994604|FG002|Overall Study|Exclusion criteria met|1|||
131099772|NCT00350103|471994602|FG000|Overall Study|Patient relocated|0|||
131099773|NCT00350103|471994603|FG001|Overall Study|Patient relocated|0|||
131099774|NCT00350103|471994604|FG002|Overall Study|Patient relocated|1|||
131099775|NCT00350103|471994602|FG000|Overall Study|Need for prohibited medication|1|||
131099776|NCT00350103|471994603|FG001|Overall Study|Need for prohibited medication|0|||
131099777|NCT00350103|471994604|FG002|Overall Study|Need for prohibited medication|0|||
131099778|NCT00350103|471994602|FG000|Overall Study|Personal reasons|0|||
131099779|NCT00350103|471994603|FG001|Overall Study|Personal reasons|0|||
131099780|NCT00350103|471994604|FG002|Overall Study|Personal reasons|1|||
131099781|NCT00350103|471994602|FG000|Overall Study|Patient stopped feeling pain|1|||
131099782|NCT00350103|471994603|FG001|Overall Study|Patient stopped feeling pain|0|||
131099783|NCT00350103|471994604|FG002|Overall Study|Patient stopped feeling pain|0|||
131099784|NCT00350103|471994602|FG000|Overall Study|PR greater than 250ms|0|||
131099785|NCT00350103|471994603|FG001|Overall Study|PR greater than 250ms|0|||
131099786|NCT00350103|471994604|FG002|Overall Study|PR greater than 250ms|1|||
131099787|NCT00350103|471994602|FG000|Overall Study|Wrong calculation of QT interval|0|||
131099788|NCT00350103|471994603|FG001|Overall Study|Wrong calculation of QT interval|0|||
131099789|NCT00350103|471994604|FG002|Overall Study|Wrong calculation of QT interval|1|||
131099790|NCT00350103|471994602|FG000|Overall Study|Sponsor mistake|1|||
131099791|NCT00350103|471994603|FG001|Overall Study|Sponsor mistake|0|||
131099792|NCT00350103|471994604|FG002|Overall Study|Sponsor mistake|0|||
131099793|NCT00350103|471994602|FG000|Overall Study|Randomization mistake|0|||
131099794|NCT00350103|471994603|FG001|Overall Study|Randomization mistake|1|||
131099795|NCT00350103|471994604|FG002|Overall Study|Randomization mistake|1|||
131099796|NCT00350103|471994602|FG000|Overall Study|Sponsor´s decision|0|||
131099797|NCT00350103|471994603|FG001|Overall Study|Sponsor´s decision|1|||
131099798|NCT00350103|471994604|FG002|Overall Study|Sponsor´s decision|0|||
131099799|NCT00350103|471994602|FG000|Overall Study|Lost, Reason unknown|1|||
131099800|NCT00350103|471994603|FG001|Overall Study|Lost, Reason unknown|1|||
131099801|NCT00350103|471994604|FG002|Overall Study|Lost, Reason unknown|0|||
131099802|NCT01879553|471994605|FG000|Overall Study|Withdrawal by Subject|1|||
131099803|NCT01879553|471994606|FG001|Overall Study|Withdrawal by Subject|0|||
131099804|NCT02712905|471994607|FG000|Monotherapy|Death|2|||
131099805|NCT02712905|471994608|FG001|Monotherapy|Death|5|||
131099806|NCT02712905|471994609|FG002|Monotherapy|Death|0|||
131099807|NCT02712905|471994610|FG003|Monotherapy|Death|3|||
131099808|NCT02712905|471994611|FG004|Monotherapy|Death|15|||
131099809|NCT02712905|471994612|FG005|Monotherapy|Death|1|||
131099810|NCT02712905|471994613|FG006|Monotherapy|Death|3|||
131099811|NCT02712905|471994614|FG007|Monotherapy|Death|3|||
131099812|NCT02712905|471994615|FG008|Monotherapy|Death|0|||
131099813|NCT02712905|471994616|FG009|Monotherapy|Death|27|||
131099814|NCT02712905|471994617|FG010|Monotherapy|Death|2|||
131099815|NCT02712905|471994618|FG011|Monotherapy|Death|5|||
131099816|NCT02712905|471994619|FG012|Monotherapy|Death|0|||
131099817|NCT02712905|471994620|FG013|Monotherapy|Death|0|||
131099818|NCT02712905|471994621|FG014|Monotherapy|Death|0|||
131099819|NCT02712905|471994622|FG015|Monotherapy|Death|0|||
131099820|NCT02712905|471994623|FG016|Monotherapy|Death|0|||
131099821|NCT02712905|471994624|FG017|Monotherapy|Death|0|||
131099822|NCT02712905|471994607|FG000|Monotherapy|Lost to Follow-up|0|||
131099823|NCT02712905|471994608|FG001|Monotherapy|Lost to Follow-up|1|||
131099824|NCT02712905|471994609|FG002|Monotherapy|Lost to Follow-up|0|||
131099825|NCT02712905|471994610|FG003|Monotherapy|Lost to Follow-up|1|||
131099826|NCT02712905|471994611|FG004|Monotherapy|Lost to Follow-up|0|||
131099827|NCT02712905|471994612|FG005|Monotherapy|Lost to Follow-up|0|||
131099828|NCT02712905|471994613|FG006|Monotherapy|Lost to Follow-up|0|||
131099829|NCT02712905|471994614|FG007|Monotherapy|Lost to Follow-up|0|||
131099830|NCT02712905|471994615|FG008|Monotherapy|Lost to Follow-up|0|||
131099831|NCT02712905|471994616|FG009|Monotherapy|Lost to Follow-up|2|||
131099832|NCT02712905|471994617|FG010|Monotherapy|Lost to Follow-up|0|||
131099833|NCT02712905|471994618|FG011|Monotherapy|Lost to Follow-up|0|||
131099834|NCT02712905|471994619|FG012|Monotherapy|Lost to Follow-up|0|||
131099835|NCT02712905|471994620|FG013|Monotherapy|Lost to Follow-up|0|||
131099836|NCT02712905|471994621|FG014|Monotherapy|Lost to Follow-up|0|||
131099837|NCT02712905|471994622|FG015|Monotherapy|Lost to Follow-up|0|||
131099838|NCT02712905|471994623|FG016|Monotherapy|Lost to Follow-up|0|||
131099839|NCT02712905|471994624|FG017|Monotherapy|Lost to Follow-up|0|||
131099840|NCT02712905|471994607|FG000|Monotherapy|Physician Decision|1|||
131099841|NCT02712905|471994608|FG001|Monotherapy|Physician Decision|0|||
131099842|NCT02712905|471994609|FG002|Monotherapy|Physician Decision|0|||
131099843|NCT02712905|471994610|FG003|Monotherapy|Physician Decision|1|||
131099844|NCT02712905|471994611|FG004|Monotherapy|Physician Decision|0|||
131099845|NCT02712905|471994612|FG005|Monotherapy|Physician Decision|0|||
131099846|NCT02712905|471994613|FG006|Monotherapy|Physician Decision|0|||
131099847|NCT02712905|471994614|FG007|Monotherapy|Physician Decision|0|||
131099848|NCT02712905|471994615|FG008|Monotherapy|Physician Decision|0|||
131099849|NCT02712905|471994616|FG009|Monotherapy|Physician Decision|1|||
131099850|NCT02712905|471994617|FG010|Monotherapy|Physician Decision|0|||
131099851|NCT02712905|471994618|FG011|Monotherapy|Physician Decision|0|||
131099852|NCT02712905|471994619|FG012|Monotherapy|Physician Decision|0|||
131099853|NCT02712905|471994620|FG013|Monotherapy|Physician Decision|0|||
131099854|NCT02712905|471994621|FG014|Monotherapy|Physician Decision|0|||
131099855|NCT02712905|471994622|FG015|Monotherapy|Physician Decision|0|||
131099856|NCT02712905|471994623|FG016|Monotherapy|Physician Decision|0|||
131099857|NCT02712905|471994624|FG017|Monotherapy|Physician Decision|0|||
131099858|NCT02712905|471994607|FG000|Monotherapy|Study Terminated by Sponsor|0|||
131099859|NCT02712905|471994608|FG001|Monotherapy|Study Terminated by Sponsor|0|||
131099860|NCT02712905|471994609|FG002|Monotherapy|Study Terminated by Sponsor|0|||
131099861|NCT02712905|471994610|FG003|Monotherapy|Study Terminated by Sponsor|0|||
131099862|NCT02712905|471994611|FG004|Monotherapy|Study Terminated by Sponsor|1|||
131099863|NCT02712905|471994612|FG005|Monotherapy|Study Terminated by Sponsor|0|||
131099864|NCT02712905|471994613|FG006|Monotherapy|Study Terminated by Sponsor|0|||
131099865|NCT02712905|471994614|FG007|Monotherapy|Study Terminated by Sponsor|0|||
131099866|NCT02712905|471994615|FG008|Monotherapy|Study Terminated by Sponsor|0|||
131099867|NCT02712905|471994616|FG009|Monotherapy|Study Terminated by Sponsor|2|||
131099868|NCT02712905|471994617|FG010|Monotherapy|Study Terminated by Sponsor|0|||
131099869|NCT02712905|471994618|FG011|Monotherapy|Study Terminated by Sponsor|0|||
131099870|NCT02712905|471994619|FG012|Monotherapy|Study Terminated by Sponsor|0|||
131099871|NCT02712905|471994620|FG013|Monotherapy|Study Terminated by Sponsor|0|||
131099872|NCT02712905|471994621|FG014|Monotherapy|Study Terminated by Sponsor|0|||
131099873|NCT02712905|471994622|FG015|Monotherapy|Study Terminated by Sponsor|0|||
131099874|NCT02712905|471994623|FG016|Monotherapy|Study Terminated by Sponsor|0|||
131099875|NCT02712905|471994624|FG017|Monotherapy|Study Terminated by Sponsor|0|||
131099876|NCT02712905|471994607|FG000|Monotherapy|Withdrawal by Subject|0|||
131099877|NCT02712905|471994608|FG001|Monotherapy|Withdrawal by Subject|0|||
131099878|NCT02712905|471994609|FG002|Monotherapy|Withdrawal by Subject|1|||
131099879|NCT02712905|471994610|FG003|Monotherapy|Withdrawal by Subject|0|||
131099880|NCT02712905|471994611|FG004|Monotherapy|Withdrawal by Subject|2|||
131099881|NCT02712905|471994612|FG005|Monotherapy|Withdrawal by Subject|0|||
131099882|NCT02712905|471994613|FG006|Monotherapy|Withdrawal by Subject|0|||
131099883|NCT02712905|471994614|FG007|Monotherapy|Withdrawal by Subject|0|||
131099884|NCT02712905|471994615|FG008|Monotherapy|Withdrawal by Subject|0|||
131099885|NCT02712905|471994616|FG009|Monotherapy|Withdrawal by Subject|4|||
131099886|NCT02712905|471994617|FG010|Monotherapy|Withdrawal by Subject|1|||
131099887|NCT02712905|471994618|FG011|Monotherapy|Withdrawal by Subject|2|||
131099888|NCT02712905|471994619|FG012|Monotherapy|Withdrawal by Subject|0|||
131099889|NCT02712905|471994620|FG013|Monotherapy|Withdrawal by Subject|0|||
131099890|NCT02712905|471994621|FG014|Monotherapy|Withdrawal by Subject|0|||
131099891|NCT02712905|471994622|FG015|Monotherapy|Withdrawal by Subject|0|||
131099892|NCT02712905|471994623|FG016|Monotherapy|Withdrawal by Subject|0|||
131099893|NCT02712905|471994624|FG017|Monotherapy|Withdrawal by Subject|0|||
131099894|NCT02712905|471994607|FG000|Monotherapy|Started New Cancer Drug|0|||
131099895|NCT02712905|471994608|FG001|Monotherapy|Started New Cancer Drug|0|||
131099896|NCT02712905|471994609|FG002|Monotherapy|Started New Cancer Drug|0|||
131099897|NCT02712905|471994610|FG003|Monotherapy|Started New Cancer Drug|0|||
131099898|NCT02712905|471994611|FG004|Monotherapy|Started New Cancer Drug|0|||
131099899|NCT02712905|471994612|FG005|Monotherapy|Started New Cancer Drug|1|||
131099900|NCT02712905|471994613|FG006|Monotherapy|Started New Cancer Drug|0|||
131099901|NCT02712905|471994614|FG007|Monotherapy|Started New Cancer Drug|0|||
131099902|NCT02712905|471994615|FG008|Monotherapy|Started New Cancer Drug|0|||
131099903|NCT02712905|471994616|FG009|Monotherapy|Started New Cancer Drug|0|||
131099904|NCT02712905|471994617|FG010|Monotherapy|Started New Cancer Drug|0|||
131099905|NCT02712905|471994618|FG011|Monotherapy|Started New Cancer Drug|0|||
131099906|NCT02712905|471994619|FG012|Monotherapy|Started New Cancer Drug|0|||
131099907|NCT02712905|471994620|FG013|Monotherapy|Started New Cancer Drug|0|||
131099908|NCT02712905|471994621|FG014|Monotherapy|Started New Cancer Drug|0|||
131099909|NCT02712905|471994622|FG015|Monotherapy|Started New Cancer Drug|0|||
131099910|NCT02712905|471994623|FG016|Monotherapy|Started New Cancer Drug|0|||
131099911|NCT02712905|471994624|FG017|Monotherapy|Started New Cancer Drug|0|||
131099912|NCT02712905|471994607|FG000|Monotherapy|Adverse Event|0|||
131099913|NCT02712905|471994608|FG001|Monotherapy|Adverse Event|0|||
131099914|NCT02712905|471994609|FG002|Monotherapy|Adverse Event|0|||
131099915|NCT02712905|471994610|FG003|Monotherapy|Adverse Event|0|||
131099916|NCT02712905|471994611|FG004|Monotherapy|Adverse Event|0|||
131099917|NCT02712905|471994612|FG005|Monotherapy|Adverse Event|0|||
131099918|NCT02712905|471994613|FG006|Monotherapy|Adverse Event|0|||
131099919|NCT02712905|471994614|FG007|Monotherapy|Adverse Event|0|||
131099920|NCT02712905|471994615|FG008|Monotherapy|Adverse Event|1|||
131099921|NCT02712905|471994616|FG009|Monotherapy|Adverse Event|0|||
131099922|NCT02712905|471994617|FG010|Monotherapy|Adverse Event|0|||
131099923|NCT02712905|471994618|FG011|Monotherapy|Adverse Event|0|||
131099924|NCT02712905|471994619|FG012|Monotherapy|Adverse Event|0|||
131099925|NCT02712905|471994620|FG013|Monotherapy|Adverse Event|0|||
131099926|NCT02712905|471994621|FG014|Monotherapy|Adverse Event|0|||
131099927|NCT02712905|471994622|FG015|Monotherapy|Adverse Event|0|||
131099928|NCT02712905|471994623|FG016|Monotherapy|Adverse Event|0|||
131099929|NCT02712905|471994624|FG017|Monotherapy|Adverse Event|0|||
131099930|NCT02712905|471994607|FG000|Combination Therapy|Death|0|||
131099931|NCT02712905|471994608|FG001|Combination Therapy|Death|0|||
131099932|NCT02712905|471994609|FG002|Combination Therapy|Death|0|||
131099933|NCT02712905|471994610|FG003|Combination Therapy|Death|0|||
131213407|NCT00423137|472405335|FG001|Overall Study|Protocol Violation|0|||
131099934|NCT02712905|471994611|FG004|Combination Therapy|Death|0|||
131099935|NCT02712905|471994612|FG005|Combination Therapy|Death|0|||
131099936|NCT02712905|471994613|FG006|Combination Therapy|Death|0|||
131099937|NCT02712905|471994614|FG007|Combination Therapy|Death|0|||
131099938|NCT02712905|471994615|FG008|Combination Therapy|Death|0|||
131099939|NCT02712905|471994616|FG009|Combination Therapy|Death|0|||
131099940|NCT02712905|471994617|FG010|Combination Therapy|Death|0|||
131099941|NCT02712905|471994618|FG011|Combination Therapy|Death|0|||
131099942|NCT02712905|471994619|FG012|Combination Therapy|Death|5|||
131099943|NCT02712905|471994620|FG013|Combination Therapy|Death|6|||
131099944|NCT02712905|471994621|FG014|Combination Therapy|Death|1|||
131099945|NCT02712905|471994622|FG015|Combination Therapy|Death|3|||
131099946|NCT02712905|471994623|FG016|Combination Therapy|Death|1|||
131099947|NCT02712905|471994624|FG017|Combination Therapy|Death|3|||
131099948|NCT02712905|471994607|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
131099949|NCT02712905|471994608|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
131099950|NCT02712905|471994609|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
131099951|NCT02712905|471994610|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
131099952|NCT02712905|471994611|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
131099953|NCT02712905|471994612|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
131099954|NCT02712905|471994613|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
131099955|NCT02712905|471994614|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
131099956|NCT02712905|471994615|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
131099957|NCT02712905|471994616|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
131099958|NCT02712905|471994617|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
131099959|NCT02712905|471994618|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
131099960|NCT02712905|471994619|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
131099961|NCT02712905|471994620|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
131099962|NCT02712905|471994621|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
131099963|NCT02712905|471994622|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
131099964|NCT02712905|471994623|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
131099965|NCT02712905|471994624|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
131099966|NCT02712905|471994607|FG000|Combination Therapy|Withdrawal by Subject|0|||
131099967|NCT02712905|471994608|FG001|Combination Therapy|Withdrawal by Subject|0|||
131099968|NCT02712905|471994609|FG002|Combination Therapy|Withdrawal by Subject|0|||
131099969|NCT02712905|471994610|FG003|Combination Therapy|Withdrawal by Subject|0|||
131099970|NCT02712905|471994611|FG004|Combination Therapy|Withdrawal by Subject|0|||
131099971|NCT02712905|471994612|FG005|Combination Therapy|Withdrawal by Subject|0|||
131099972|NCT02712905|471994613|FG006|Combination Therapy|Withdrawal by Subject|0|||
131099973|NCT02712905|471994614|FG007|Combination Therapy|Withdrawal by Subject|0|||
131099974|NCT02712905|471994615|FG008|Combination Therapy|Withdrawal by Subject|0|||
131099975|NCT02712905|471994616|FG009|Combination Therapy|Withdrawal by Subject|0|||
131099976|NCT02712905|471994617|FG010|Combination Therapy|Withdrawal by Subject|0|||
131099977|NCT02712905|471994618|FG011|Combination Therapy|Withdrawal by Subject|0|||
131099978|NCT02712905|471994619|FG012|Combination Therapy|Withdrawal by Subject|0|||
131099979|NCT02712905|471994620|FG013|Combination Therapy|Withdrawal by Subject|0|||
131099980|NCT02712905|471994621|FG014|Combination Therapy|Withdrawal by Subject|0|||
131099981|NCT02712905|471994622|FG015|Combination Therapy|Withdrawal by Subject|1|||
131099982|NCT02712905|471994623|FG016|Combination Therapy|Withdrawal by Subject|0|||
131099983|NCT02712905|471994624|FG017|Combination Therapy|Withdrawal by Subject|2|||
131099984|NCT02712905|471994607|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099985|NCT02712905|471994608|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099986|NCT02712905|471994609|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099987|NCT02712905|471994610|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099988|NCT02712905|471994611|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099989|NCT02712905|471994612|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099990|NCT02712905|471994613|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099991|NCT02712905|471994614|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099992|NCT02712905|471994615|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099993|NCT02712905|471994616|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099994|NCT02712905|471994617|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099995|NCT02712905|471994618|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099996|NCT02712905|471994619|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099997|NCT02712905|471994620|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099998|NCT02712905|471994621|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131099999|NCT02712905|471994622|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
131100000|NCT02712905|471994623|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131100001|NCT02712905|471994624|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
131100002|NCT04664400|471994627|FG000|Overall Study|Withdrawal by Subject|2|||
131100003|NCT01011153|471994628|FG000|Overall Study|Less than 78 cases completed|8|||
131213408|NCT00423137|472405336|FG002|Overall Study|Protocol Violation|0|||
131213409|NCT00423137|472405337|FG003|Overall Study|Protocol Violation|1|||
131100004|NCT01011153|471994629|FG001|Overall Study|Less than 78 cases completed|11|||
131100005|NCT01011153|471994630|FG002|Overall Study|Less than 78 cases completed|9|||
131100006|NCT03014479|471994631|FG000|Overall Study|Adverse Event|0|||
131100007|NCT03014479|471994632|FG001|Overall Study|Adverse Event|1|||
131100008|NCT03014479|471994631|FG000|Overall Study|Voluntary Withdrawal|0|||
131100009|NCT03014479|471994632|FG001|Overall Study|Voluntary Withdrawal|2|||
131100010|NCT03014479|471994631|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
131100011|NCT03014479|471994632|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
131100012|NCT01394978|471994636|FG000|Overall Study|Withdrawal by Subject|2|||
131100013|NCT01394978|471994637|FG001|Overall Study|Withdrawal by Subject|4|||
131100014|NCT01394978|471994636|FG000|Overall Study|Lost to Follow-up|13|||
131100015|NCT01394978|471994637|FG001|Overall Study|Lost to Follow-up|20|||
131100016|NCT01394978|471994636|FG000|Overall Study|Death|6|||
131100017|NCT01394978|471994637|FG001|Overall Study|Death|7|||
131100018|NCT01081132|471994638|FG000|Overall Study|Lack of Efficacy|25|||
131100019|NCT01081132|471994639|FG001|Overall Study|Lack of Efficacy|9|||
131100020|NCT01081132|471994638|FG000|Overall Study|Withdrawal by Subject|13|||
131100021|NCT01081132|471994639|FG001|Overall Study|Withdrawal by Subject|16|||
131100022|NCT01081132|471994638|FG000|Overall Study|Lost to Follow-up|4|||
131100023|NCT01081132|471994639|FG001|Overall Study|Lost to Follow-up|11|||
131100024|NCT01081132|471994638|FG000|Overall Study|Adverse Event|3|||
131100025|NCT01081132|471994639|FG001|Overall Study|Adverse Event|9|||
131100026|NCT01081132|471994638|FG000|Overall Study|Non Compliance|4|||
131100027|NCT01081132|471994639|FG001|Overall Study|Non Compliance|2|||
131100028|NCT01081132|471994638|FG000|Overall Study|Lack Of Compliance|0|||
131100029|NCT01081132|471994639|FG001|Overall Study|Lack Of Compliance|1|||
131100030|NCT01081132|471994638|FG000|Overall Study|Missed Visits|1|||
131100031|NCT01081132|471994639|FG001|Overall Study|Missed Visits|1|||
131100032|NCT01081132|471994638|FG000|Overall Study|Stopped Taking Meds|2|||
131100033|NCT01081132|471994639|FG001|Overall Study|Stopped Taking Meds|0|||
131100034|NCT01081132|471994638|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
131100035|NCT01081132|471994639|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
131100036|NCT01081132|471994638|FG000|Overall Study|Declined Taper Phase|0|||
131100037|NCT01081132|471994639|FG001|Overall Study|Declined Taper Phase|1|||
131100038|NCT01081132|471994638|FG000|Overall Study|Protocol Violation|3|||
131100039|NCT01081132|471994639|FG001|Overall Study|Protocol Violation|1|||
131100040|NCT02019667|471994640|FG000|First Intervention (6 Months)|Adverse Event|0|||
131100041|NCT02019667|471994641|FG001|First Intervention (6 Months)|Adverse Event|1|||
131100042|NCT02019667|471994640|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
131100043|NCT02019667|471994641|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
131100044|NCT02019667|471994640|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
131100045|NCT02019667|471994641|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
131100046|NCT05038163|471994644|FG000|Stage 1|Did not complete survey|374|||
131100047|NCT05038163|471994645|FG001|Stage 1|Did not complete survey|0|||
131100048|NCT05038163|471994646|FG002|Stage 1|Did not complete survey|0|||
131100049|NCT05038163|471994647|FG003|Stage 1|Did not complete survey|0|||
131100050|NCT05038163|471994648|FG004|Stage 1|Did not complete survey|0|||
131100051|NCT05038163|471994649|FG005|Stage 1|Did not complete survey|0|||
131100052|NCT05038163|471994644|FG000|Stage 2|Did not complete Stage 2 survey|0|||
131100053|NCT05038163|471994645|FG001|Stage 2|Did not complete Stage 2 survey|29|||
131100054|NCT05038163|471994646|FG002|Stage 2|Did not complete Stage 2 survey|30|||
131100055|NCT05038163|471994647|FG003|Stage 2|Did not complete Stage 2 survey|24|||
131100056|NCT05038163|471994648|FG004|Stage 2|Did not complete Stage 2 survey|21|||
131100057|NCT05038163|471994649|FG005|Stage 2|Did not complete Stage 2 survey|100|||
131100058|NCT00432666|471996221|FG000|Main Period|Adverse Event|1|||
131100059|NCT00432666|471996222|FG001|Main Period|Adverse Event|1|||
131100060|NCT00432666|471996221|FG000|Main Period|Consent Withdrawn|1|||
131100061|NCT00432666|471996222|FG001|Main Period|Consent Withdrawn|0|||
131100062|NCT00432666|471996221|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
131100063|NCT00432666|471996222|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
131100064|NCT00432666|471996221|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
131100065|NCT00432666|471996222|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
131100066|NCT00432666|471996221|FG000|Open-Label Extension Period|Adverse Event|5|||
131100067|NCT00432666|471996222|FG001|Open-Label Extension Period|Adverse Event|0|||
131100068|NCT00432666|471996221|FG000|Open-Label Extension Period|Consent withdrawn|10|||
131100069|NCT00432666|471996222|FG001|Open-Label Extension Period|Consent withdrawn|0|||
131100070|NCT00432666|471996221|FG000|Open-Label Extension Period|Physician Decision|3|||
131100071|NCT00432666|471996222|FG001|Open-Label Extension Period|Physician Decision|0|||
131100072|NCT00565851|471996223|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
131100073|NCT00565851|471996224|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
131100074|NCT00565851|471996225|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
131100075|NCT00565851|471996226|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
131100076|NCT00565851|471996227|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
131100077|NCT00565851|471996228|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
131213410|NCT00423137|472405334|FG000|Overall Study|Adverse Event Study disease worse|1|||
131213411|NCT00423137|472405335|FG001|Overall Study|Adverse Event Study disease worse|0|||
130765814|NCT01430624|470765850|FG002|Overall Study|technical or eligibility|2|||
130990430|NCT02508532|471593156|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
130990431|NCT02508532|471593157|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
130990432|NCT02508532|471593158|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
130990433|NCT02508532|471593150|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130990434|NCT02508532|471593151|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130990435|NCT02508532|471593152|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130990436|NCT02508532|471593153|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130990437|NCT02508532|471593154|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130990438|NCT02508532|471593155|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130990439|NCT02508532|471593156|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130990440|NCT02508532|471593157|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
130990441|NCT02508532|471593158|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
130990442|NCT02508532|471593150|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
130990443|NCT02508532|471593151|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
130990444|NCT02508532|471593152|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
130990445|NCT02508532|471593153|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
130990446|NCT02508532|471593154|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
130990447|NCT02508532|471593155|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
130990448|NCT02508532|471593156|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
130990449|NCT02508532|471593157|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
130990450|NCT02508532|471593158|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
130990451|NCT02508532|471593150|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130990452|NCT02508532|471593151|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130990453|NCT02508532|471593152|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130990454|NCT02508532|471593153|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130990455|NCT02508532|471593154|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130990456|NCT02508532|471593155|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130990457|NCT02508532|471593156|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130990458|NCT02508532|471593157|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
130990459|NCT02508532|471593158|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
130990460|NCT02508532|471593150|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
130990461|NCT02508532|471593151|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
130990462|NCT02508532|471593152|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
130990463|NCT02508532|471593153|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
130990464|NCT02508532|471593154|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
130990465|NCT02508532|471593155|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
130990466|NCT02508532|471593156|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
130990467|NCT02508532|471593157|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
130990468|NCT02508532|471593158|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
130990469|NCT03097861|471593161|FG000|Overall Study|Adverse Event|3|||
130990470|NCT03097861|471593162|FG001|Overall Study|Adverse Event|8|||
130990471|NCT03097861|471593163|FG002|Overall Study|Adverse Event|4|||
130990472|NCT03097861|471593161|FG000|Overall Study|Investigator Decision|0|||
130990473|NCT03097861|471593162|FG001|Overall Study|Investigator Decision|1|||
130990474|NCT03097861|471593163|FG002|Overall Study|Investigator Decision|0|||
130990475|NCT03097861|471593161|FG000|Overall Study|Lost to Follow-up|0|||
130990476|NCT03097861|471593162|FG001|Overall Study|Lost to Follow-up|7|||
130990477|NCT03097861|471593163|FG002|Overall Study|Lost to Follow-up|1|||
130990478|NCT03097861|471593161|FG000|Overall Study|Withdrawal by Subject|1|||
130990479|NCT03097861|471593162|FG001|Overall Study|Withdrawal by Subject|5|||
130990480|NCT03097861|471593163|FG002|Overall Study|Withdrawal by Subject|3|||
130990481|NCT03097861|471593161|FG000|Overall Study|Reason not provided|3|||
130990482|NCT03097861|471593162|FG001|Overall Study|Reason not provided|1|||
130990483|NCT03097861|471593163|FG002|Overall Study|Reason not provided|1|||
130990484|NCT04251065|471593165|FG000|Overall Study|Death|2|||
130990485|NCT04251065|471593165|FG000|Overall Study|Lack of Efficacy|3|||
130990486|NCT04251065|471593165|FG000|Overall Study|Death|1|||
130990487|NCT03812536|471593166|FG000|Overall Study|Protocol Violation|2|||
130990488|NCT03812536|471593167|FG001|Overall Study|Protocol Violation|0|||
130990489|NCT03812536|471593166|FG000|Overall Study|Withdrawal by Subject|1|||
130990490|NCT03812536|471593167|FG001|Overall Study|Withdrawal by Subject|1|||
130990491|NCT00152009|471593168|FG000|Overall Study|Adverse Event|9|||
130990492|NCT00152009|471593169|FG001|Overall Study|Adverse Event|13|||
130990493|NCT00152009|471593170|FG002|Overall Study|Adverse Event|20|||
130990494|NCT00152009|471593171|FG003|Overall Study|Adverse Event|1|||
130990495|NCT00152009|471593168|FG000|Overall Study|Protocol Violation|3|||
130990496|NCT00152009|471593169|FG001|Overall Study|Protocol Violation|0|||
130990497|NCT00152009|471593170|FG002|Overall Study|Protocol Violation|0|||
130990498|NCT00152009|471593171|FG003|Overall Study|Protocol Violation|1|||
130990499|NCT00152009|471593168|FG000|Overall Study|Withdrawal by Subject|2|||
131100078|NCT00565851|471996229|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
131100079|NCT00565851|471996230|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
131100080|NCT00565851|471996223|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
131100081|NCT00565851|471996224|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
131100082|NCT00565851|471996225|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
131100083|NCT00565851|471996226|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
131100084|NCT00565851|471996227|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
131100085|NCT00565851|471996228|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
131100086|NCT00565851|471996229|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
131100087|NCT00565851|471996230|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
131100088|NCT00969709|471996235|FG000|Overall Study|Adverse Event|3|||
131100089|NCT00969709|471996236|FG001|Overall Study|Adverse Event|13|||
131100090|NCT00969709|471996237|FG002|Overall Study|Adverse Event|26|||
131100091|NCT00969709|471996238|FG003|Overall Study|Adverse Event|12|||
131100092|NCT00969709|471996235|FG000|Overall Study|Lack of Efficacy|7|||
131100093|NCT00969709|471996236|FG001|Overall Study|Lack of Efficacy|4|||
131100094|NCT00969709|471996237|FG002|Overall Study|Lack of Efficacy|1|||
131100095|NCT00969709|471996238|FG003|Overall Study|Lack of Efficacy|3|||
131100096|NCT00969709|471996235|FG000|Overall Study|Protocol Violation|9|||
131100097|NCT00969709|471996236|FG001|Overall Study|Protocol Violation|5|||
131100098|NCT00969709|471996237|FG002|Overall Study|Protocol Violation|9|||
131100099|NCT00969709|471996238|FG003|Overall Study|Protocol Violation|10|||
131100100|NCT00969709|471996235|FG000|Overall Study|Withdrawal by Subject|9|||
131100101|NCT00969709|471996236|FG001|Overall Study|Withdrawal by Subject|12|||
131100102|NCT00969709|471996237|FG002|Overall Study|Withdrawal by Subject|11|||
131100103|NCT00969709|471996238|FG003|Overall Study|Withdrawal by Subject|23|||
131100104|NCT00969709|471996235|FG000|Overall Study|Lost to Follow-up|10|||
131100105|NCT00969709|471996236|FG001|Overall Study|Lost to Follow-up|14|||
131100106|NCT00969709|471996237|FG002|Overall Study|Lost to Follow-up|8|||
131100107|NCT00969709|471996238|FG003|Overall Study|Lost to Follow-up|15|||
131100108|NCT00969709|471996235|FG000|Overall Study|Other reasons|0|||
131100109|NCT00969709|471996236|FG001|Overall Study|Other reasons|0|||
131100110|NCT00969709|471996237|FG002|Overall Study|Other reasons|3|||
131100111|NCT00969709|471996238|FG003|Overall Study|Other reasons|0|||
131100112|NCT03695237|471996239|FG000|Overall Study|Withdrawal by Subject|1|||
131100113|NCT03695237|471996240|FG001|Overall Study|Withdrawal by Subject|3|||
131100114|NCT03695237|471996239|FG000|Overall Study|Lost to Follow-up|1|||
131100115|NCT03695237|471996240|FG001|Overall Study|Lost to Follow-up|2|||
131100116|NCT03695237|471996239|FG000|Overall Study|Other, Not Specified|8|||
131100117|NCT03695237|471996240|FG001|Overall Study|Other, Not Specified|2|||
131100118|NCT01342341|471996243|FG000|Overall Study|Lost to Follow-up|4|||
131100119|NCT01342341|471996244|FG001|Overall Study|Lost to Follow-up|4|||
131100120|NCT01789567|471996245|FG000|Overall Study|Death|6|||
131100121|NCT02914275|471996246|FG000|Overall Study|Lost to Follow-up|84|||
131100122|NCT02914275|471996247|FG001|Overall Study|Lost to Follow-up|29|||
131100123|NCT02914275|471996246|FG000|Overall Study|Withdrawal by Subject|26|||
131100124|NCT02914275|471996247|FG001|Overall Study|Withdrawal by Subject|10|||
131100125|NCT02914275|471996246|FG000|Overall Study|Protocol Violation|1|||
131100126|NCT02914275|471996247|FG001|Overall Study|Protocol Violation|1|||
131100127|NCT02914275|471996246|FG000|Overall Study|Physician Decision|3|||
131100128|NCT02914275|471996247|FG001|Overall Study|Physician Decision|1|||
131100129|NCT02914275|471996246|FG000|Overall Study|Other|4|||
131100130|NCT02914275|471996247|FG001|Overall Study|Other|1|||
131100131|NCT02914275|471996246|FG000|Overall Study|Excluded due to invalid informed consent|3|||
131100132|NCT02914275|471996247|FG001|Overall Study|Excluded due to invalid informed consent|0|||
131100133|NCT00091169|471996248|FG000|Overall Study|Disease progression|3|||
131100134|NCT00091169|471996249|FG001|Overall Study|Disease progression|1|||
131100135|NCT00091169|471996248|FG000|Overall Study|Adverse Event|11|||
131100136|NCT00091169|471996249|FG001|Overall Study|Adverse Event|17|||
131100137|NCT00091169|471996248|FG000|Overall Study|Death|4|||
131100138|NCT00091169|471996249|FG001|Overall Study|Death|1|||
131100139|NCT00091169|471996248|FG000|Overall Study|Withdrawal by Subject|10|||
131100140|NCT00091169|471996249|FG001|Overall Study|Withdrawal by Subject|13|||
131100141|NCT00091169|471996248|FG000|Overall Study|Other|3|||
131100142|NCT00091169|471996249|FG001|Overall Study|Other|4|||
131100143|NCT00091169|471996248|FG000|Overall Study|Not start protocol therapy|26|||
131100144|NCT00091169|471996249|FG001|Overall Study|Not start protocol therapy|17|||
131100145|NCT00872989|471996250|FG000|Overall Study|Adverse Event|7|||
131100146|NCT00872989|471996251|FG001|Overall Study|Adverse Event|15|||
131100147|NCT00872989|471996250|FG000|Overall Study|Withdrawal by Subject|8|||
131100148|NCT00872989|471996251|FG001|Overall Study|Withdrawal by Subject|5|||
131213412|NCT00423137|472405336|FG002|Overall Study|Adverse Event Study disease worse|3|||
131213413|NCT00423137|472405337|FG003|Overall Study|Adverse Event Study disease worse|1|||
131213414|NCT00423137|472405334|FG000|Overall Study|Adverse Event Other|0|||
131213415|NCT00423137|472405335|FG001|Overall Study|Adverse Event Other|0|||
131100149|NCT00872989|471996250|FG000|Overall Study|Progression/relapse|47|||
131100150|NCT00872989|471996251|FG001|Overall Study|Progression/relapse|35|||
131100151|NCT00872989|471996250|FG000|Overall Study|Not protocol specified|3|||
131100152|NCT00872989|471996251|FG001|Overall Study|Not protocol specified|8|||
131100153|NCT01302067|471996258|FG000|Overall Study|Death|0|||
131100154|NCT01302067|471996259|FG001|Overall Study|Death|0|||
131100155|NCT01302067|471996260|FG002|Overall Study|Death|1|||
131100156|NCT01302067|471996258|FG000|Overall Study|Physician Decision|9|||
131100157|NCT01302067|471996259|FG001|Overall Study|Physician Decision|5|||
131100158|NCT01302067|471996260|FG002|Overall Study|Physician Decision|14|||
131100159|NCT01302067|471996258|FG000|Overall Study|Lack of Efficacy|8|||
131100160|NCT01302067|471996259|FG001|Overall Study|Lack of Efficacy|4|||
131100161|NCT01302067|471996260|FG002|Overall Study|Lack of Efficacy|2|||
131100162|NCT01302067|471996258|FG000|Overall Study|Lost to Follow-up|9|||
131100163|NCT01302067|471996259|FG001|Overall Study|Lost to Follow-up|4|||
131100164|NCT01302067|471996260|FG002|Overall Study|Lost to Follow-up|15|||
131100165|NCT01302067|471996258|FG000|Overall Study|Withdrawal by Subject|13|||
131100166|NCT01302067|471996259|FG001|Overall Study|Withdrawal by Subject|6|||
131100167|NCT01302067|471996260|FG002|Overall Study|Withdrawal by Subject|10|||
131100168|NCT01302067|471996258|FG000|Overall Study|Other|1|||
131100169|NCT01302067|471996259|FG001|Overall Study|Other|1|||
131100170|NCT01302067|471996260|FG002|Overall Study|Other|3|||
131100171|NCT01302067|471996258|FG000|Overall Study|Protocol Violation|11|||
131100172|NCT01302067|471996259|FG001|Overall Study|Protocol Violation|0|||
131100173|NCT01302067|471996260|FG002|Overall Study|Protocol Violation|8|||
131100174|NCT01302067|471996258|FG000|Overall Study|Adverse Event|27|||
131100175|NCT01302067|471996259|FG001|Overall Study|Adverse Event|14|||
131100176|NCT01302067|471996260|FG002|Overall Study|Adverse Event|45|||
131100177|NCT02738203|471996261|FG000|Overall Study|Failed IUD Insertion|2|||
131100178|NCT02738203|471996262|FG001|Overall Study|Failed IUD Insertion|2|||
131100179|NCT02738203|471996261|FG000|Overall Study|Protocol Violation|0|||
131100180|NCT02738203|471996262|FG001|Overall Study|Protocol Violation|1|||
131100181|NCT00266227|471996263|FG000|Initial Treatment|Adverse Event|0|||
130879867|NCT03253796|471193118|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130879868|NCT03253796|471193119|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
130879869|NCT03253796|471193120|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130879870|NCT03253796|471193121|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130879871|NCT03253796|471193117|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
130879872|NCT03253796|471193118|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
130879873|NCT03253796|471193119|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
130879874|NCT03253796|471193120|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
130879875|NCT03253796|471193121|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
130879876|NCT03253796|471193117|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
130879877|NCT03253796|471193118|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
130879878|NCT03253796|471193119|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
130879879|NCT03253796|471193120|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
130879880|NCT03253796|471193121|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
131100182|NCT00266227|471996264|FG001|Initial Treatment|Adverse Event|0|||
131100183|NCT00266227|471996265|FG002|Initial Treatment|Adverse Event|13|||
131100184|NCT00266227|471996263|FG000|Initial Treatment|Lost to Follow-up|0|||
131100185|NCT00266227|471996264|FG001|Initial Treatment|Lost to Follow-up|0|||
131100186|NCT00266227|471996265|FG002|Initial Treatment|Lost to Follow-up|6|||
131100187|NCT00266227|471996263|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
131100188|NCT00266227|471996264|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
131100189|NCT00266227|471996265|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
131100190|NCT00266227|471996263|FG000|Initial Treatment|Physician decision to withdraw|0|||
131100191|NCT00266227|471996264|FG001|Initial Treatment|Physician decision to withdraw|0|||
131100192|NCT00266227|471996265|FG002|Initial Treatment|Physician decision to withdraw|12|||
131100193|NCT00266227|471996263|FG000|Initial Treatment|Pregnancy|0|||
131100194|NCT00266227|471996264|FG001|Initial Treatment|Pregnancy|0|||
131213416|NCT00423137|472405336|FG002|Overall Study|Adverse Event Other|2|||
131213417|NCT00423137|472405337|FG003|Overall Study|Adverse Event Other|0|||
131213418|NCT00593385|472405342|FG000|Overall Study|Death|14|||
131213419|NCT00593385|472405342|FG000|Overall Study|Lost to Follow-up|17|||
131213420|NCT00593385|472405342|FG000|Overall Study|Withdrawal by Subject|9|||
131213421|NCT00924313|472405343|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
131213422|NCT00762073|472405346|FG000|Overall Study|Lack of Efficacy|1|||
131213423|NCT00762073|472405347|FG001|Overall Study|Lack of Efficacy|1|||
131213424|NCT00762073|472405348|FG002|Overall Study|Lack of Efficacy|0|||
131213425|NCT00762073|472405349|FG003|Overall Study|Lack of Efficacy|0|||
131213426|NCT00762073|472405346|FG000|Overall Study|Adverse Event|1|||
131213427|NCT00762073|472405347|FG001|Overall Study|Adverse Event|0|||
131213428|NCT00762073|472405348|FG002|Overall Study|Adverse Event|1|||
131213429|NCT00762073|472405349|FG003|Overall Study|Adverse Event|1|||
131213430|NCT00762073|472405346|FG000|Overall Study|Significant Subject Noncompliance|0|||
131213431|NCT00762073|472405347|FG001|Overall Study|Significant Subject Noncompliance|1|||
130879881|NCT00528112|471193122|FG000|Treatment up to 3 Years|Adverse Event|313|||
130879882|NCT00528112|471193123|FG001|Treatment up to 3 Years|Adverse Event|278|||
130879883|NCT00528112|471193122|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
130879884|NCT00528112|471193123|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
130879885|NCT00528112|471193122|FG000|Treatment up to 3 Years|Protocol Violation|16|||
130879886|NCT00528112|471193123|FG001|Treatment up to 3 Years|Protocol Violation|16|||
130879887|NCT00528112|471193122|FG000|Treatment up to 3 Years|Death|0|||
130879888|NCT00528112|471193123|FG001|Treatment up to 3 Years|Death|1|||
130879889|NCT00528112|471193122|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
130879890|NCT00528112|471193123|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
130879891|NCT00528112|471193122|FG000|Treatment up to 3 Years|Pregnancy|9|||
130879892|NCT00528112|471193123|FG001|Treatment up to 3 Years|Pregnancy|10|||
130879893|NCT00528112|471193122|FG000|Treatment up to 3 Years|Other reasons|186|||
130879894|NCT00528112|471193123|FG001|Treatment up to 3 Years|Other reasons|186|||
130879895|NCT00528112|471193122|FG000|Extension Phase|Withdrawal by Subject|0|||
130879896|NCT00528112|471193123|FG001|Extension Phase|Withdrawal by Subject|3|||
130879897|NCT00528112|471193122|FG000|Extension Phase|Other reasons|0|||
130879898|NCT00528112|471193123|FG001|Extension Phase|Other reasons|100|||
130879899|NCT00528112|471193122|FG000|Extension Phase|Pregnancy|0|||
130879900|NCT00528112|471193123|FG001|Extension Phase|Pregnancy|3|||
130879901|NCT00528112|471193122|FG000|Extension Phase|Lost to Follow-up|0|||
130879902|NCT00528112|471193123|FG001|Extension Phase|Lost to Follow-up|12|||
130879903|NCT00528112|471193122|FG000|Extension Phase|Death|0|||
130879904|NCT00528112|471193123|FG001|Extension Phase|Death|1|||
130879905|NCT00528112|471193122|FG000|Extension Phase|Adverse Event|0|||
130879906|NCT00528112|471193123|FG001|Extension Phase|Adverse Event|36|||
130879907|NCT00528112|471193122|FG000|Extension Phase|Protocol Violation|0|||
130879908|NCT00528112|471193123|FG001|Extension Phase|Protocol Violation|2|||
130879909|NCT00894803|471193124|FG000|Overall Study|Death|20|||
130879910|NCT00894803|471193125|FG001|Overall Study|Death|4|||
130879911|NCT00894803|471193124|FG000|Overall Study|Lost to Follow-up|0|||
130879912|NCT00894803|471193125|FG001|Overall Study|Lost to Follow-up|1|||
130879913|NCT01345240|471193127|FG000|Overall Study|Adverse Event|3|||
130879914|NCT01345240|471193128|FG001|Overall Study|Adverse Event|5|||
130879915|NCT01345240|471193129|FG002|Overall Study|Adverse Event|4|||
130879916|NCT01345240|471193130|FG003|Overall Study|Adverse Event|2|||
130879917|NCT01345240|471193131|FG004|Overall Study|Adverse Event|1|||
130879918|NCT01345240|471193127|FG000|Overall Study|Lost to Follow-up|8|||
130879919|NCT01345240|471193128|FG001|Overall Study|Lost to Follow-up|9|||
130879920|NCT01345240|471193129|FG002|Overall Study|Lost to Follow-up|14|||
130879921|NCT01345240|471193130|FG003|Overall Study|Lost to Follow-up|7|||
130879922|NCT01345240|471193131|FG004|Overall Study|Lost to Follow-up|9|||
130879923|NCT01502293|471193134|FG000|Overall Study|Progressive Disease|20|||
130879924|NCT01502293|471193135|FG001|Overall Study|Progressive Disease|12|||
130879925|NCT01502293|471193136|FG002|Overall Study|Progressive Disease|2|||
130879926|NCT01502293|471193134|FG000|Overall Study|Withdrawal by Subject|3|||
130879927|NCT01502293|471193135|FG001|Overall Study|Withdrawal by Subject|3|||
130879928|NCT01502293|471193136|FG002|Overall Study|Withdrawal by Subject|1|||
130879929|NCT01502293|471193134|FG000|Overall Study|Adverse Event|0|||
130879930|NCT01502293|471193135|FG001|Overall Study|Adverse Event|2|||
130879931|NCT01502293|471193136|FG002|Overall Study|Adverse Event|0|||
130879932|NCT01502293|471193134|FG000|Overall Study|Reason Not Specified|2|||
130879933|NCT01502293|471193135|FG001|Overall Study|Reason Not Specified|0|||
130879934|NCT01502293|471193136|FG002|Overall Study|Reason Not Specified|0|||
130879935|NCT01502293|471193134|FG000|Overall Study|Physician Decision|0|||
130879936|NCT01502293|471193135|FG001|Overall Study|Physician Decision|0|||
130879937|NCT01502293|471193136|FG002|Overall Study|Physician Decision|1|||
130879938|NCT00774046|471193140|FG000|Screening|Not eligible|56|||
130879939|NCT00774046|471193140|FG000|Enrollment|Desired other therapy/refused|28|||
130879940|NCT00774046|471193140|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
130879941|NCT01075243|471193141|FG000|Overall Study|Lost to Follow-up|5|||
131100195|NCT00266227|471996265|FG002|Initial Treatment|Pregnancy|1|||
131100196|NCT00266227|471996263|FG000|Retreatment: Up to Week 48|Death|1|||
131100197|NCT00266227|471996264|FG001|Retreatment: Up to Week 48|Death|0|||
130879942|NCT01075243|471193142|FG001|Overall Study|Lost to Follow-up|2|||
131100198|NCT00266227|471996265|FG002|Retreatment: Up to Week 48|Death|0|||
131100199|NCT00266227|471996263|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
130879943|NCT01075243|471193143|FG002|Overall Study|Lost to Follow-up|0|||
130879944|NCT01075243|471193141|FG000|Overall Study|Withdrawal by Subject|1|||
130879945|NCT01075243|471193142|FG001|Overall Study|Withdrawal by Subject|1|||
130879946|NCT01075243|471193143|FG002|Overall Study|Withdrawal by Subject|0|||
130879947|NCT03094416|471193146|FG000|Run-in|Screening failure|8|||
130879948|NCT03094416|471193146|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
130879949|NCT03094416|471193146|FG000|Run-in|Withdrawal by Subject|3|||
130879950|NCT03094416|471193146|FG000|Treatment Period|Withdrawal by Subject|2|||
130879951|NCT01668784|471193147|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
130879952|NCT01668784|471193148|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
130879953|NCT01668784|471193147|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
130879954|NCT01668784|471193148|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
130879955|NCT01668784|471193147|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
130879956|NCT01668784|471193148|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
130879957|NCT01668784|471193147|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
130879958|NCT01668784|471193148|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
130879959|NCT01668784|471193147|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
130879960|NCT01668784|471193148|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
130879961|NCT01668784|471193147|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
130879962|NCT01668784|471193148|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
130879963|NCT01668784|471193147|FG000|Treatment Period|Disease Progression|316|||
130879964|NCT01668784|471193148|FG001|Treatment Period|Disease Progression|293|||
130879965|NCT01668784|471193147|FG000|Treatment Period|Study Drug Toxicity|46|||
130879966|NCT01668784|471193148|FG001|Treatment Period|Study Drug Toxicity|53|||
130879967|NCT01668784|471193147|FG000|Treatment Period|Death|1|||
130879968|NCT01668784|471193148|FG001|Treatment Period|Death|1|||
130879969|NCT01668784|471193147|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
130879970|NCT01668784|471193148|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
130879971|NCT01668784|471193147|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
130879972|NCT01668784|471193148|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
130879973|NCT01668784|471193147|FG000|Treatment Period|Withdrawal by Subject|5|||
130879974|NCT01668784|471193148|FG001|Treatment Period|Withdrawal by Subject|3|||
130879975|NCT01668784|471193147|FG000|Treatment Period|Maximal Clinical Benefit|3|||
130879976|NCT01668784|471193148|FG001|Treatment Period|Maximal Clinical Benefit|3|||
130879977|NCT01668784|471193147|FG000|Treatment Period|Other|2|||
130879978|NCT01668784|471193148|FG001|Treatment Period|Other|8|||
130879979|NCT01668784|471193147|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
130879980|NCT01668784|471193148|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
130879981|NCT03804528|471193156|FG000|Overall Study|Time Commitment|18|||
130879982|NCT03804528|471193156|FG000|Overall Study|Health Reasons|5|||
130879983|NCT04607005|471193157|FG000|Overall Study|Adverse Event|0|||
130879984|NCT04607005|471193158|FG001|Overall Study|Adverse Event|1|||
130879985|NCT04607005|471193157|FG000|Overall Study|Lack of Efficacy|1|||
130879986|NCT04607005|471193158|FG001|Overall Study|Lack of Efficacy|6|||
130879987|NCT04607005|471193157|FG000|Overall Study|Withdrawal by Subject|4|||
130879988|NCT04607005|471193158|FG001|Overall Study|Withdrawal by Subject|9|||
130879989|NCT04607005|471193157|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
130879990|NCT04607005|471193158|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
130879991|NCT02331134|471193159|FG000|Overall Study|Withdrawal by Subject|1|||
130879992|NCT04825574|471193161|FG000|Overall Study|Commercial treatment became available|1|||
130879993|NCT04825574|471193161|FG000|Overall Study|Disease progression|1|||
130879994|NCT04272242|471193164|FG000|Overall Study|Withdrawal by Subject|3|||
130879995|NCT04272242|471193164|FG000|Overall Study|Lost to Follow-up|1|||
130879996|NCT04272242|471193164|FG000|Overall Study|Adverse Event|1|||
130879997|NCT04944992|471194988|FG000|Overall Study|Lost to Follow-up|1|||
130879998|NCT04944992|471194989|FG001|Overall Study|Lost to Follow-up|1|||
130879999|NCT04944992|471194988|FG000|Overall Study|Physician Decision|1|||
130880000|NCT04944992|471194989|FG001|Overall Study|Physician Decision|0|||
130880001|NCT04944992|471194988|FG000|Overall Study|Withdrawal by Subject|6|||
130880002|NCT04944992|471194989|FG001|Overall Study|Withdrawal by Subject|1|||
130880003|NCT01295814|471194990|FG000|Overall Study|Lack of Efficacy|0|||
130880004|NCT01295814|471194991|FG001|Overall Study|Lack of Efficacy|2|||
130880005|NCT01295814|471194990|FG000|Overall Study|Withdrawal by Subject|2|||
130880006|NCT01295814|471194991|FG001|Overall Study|Withdrawal by Subject|0|||
130880007|NCT03414983|471194992|FG000|Pre-Treatment|Other reasons|1|||
130880008|NCT03414983|471194993|FG001|Pre-Treatment|Other reasons|0|||
130880009|NCT03414983|471194992|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
130880010|NCT03414983|471194993|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
130880011|NCT03414983|471194992|FG000|Pre-Treatment|Participant withdrew consent|1|||
130880012|NCT03414983|471194993|FG001|Pre-Treatment|Participant withdrew consent|3|||
130880013|NCT03414983|471194992|FG000|Treatment|Participant withdrew consent|4|||
130880014|NCT03414983|471194993|FG001|Treatment|Participant withdrew consent|3|||
130880015|NCT03414983|471194992|FG000|Treatment|Participant request to discontinue study treatment|8|||
130880016|NCT03414983|471194993|FG001|Treatment|Participant request to discontinue study treatment|10|||
130880017|NCT03414983|471194992|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
130880018|NCT03414983|471194993|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
130880019|NCT03414983|471194992|FG000|Treatment|Death|0|||
130880020|NCT03414983|471194993|FG001|Treatment|Death|1|||
130880021|NCT03414983|471194992|FG000|Treatment|Study Drug Toxicity|10|||
130880022|NCT03414983|471194993|FG001|Treatment|Study Drug Toxicity|5|||
130880023|NCT03414983|471194992|FG000|Treatment|Disease Progression|75|||
131100200|NCT00266227|471996264|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
130880024|NCT03414983|471194993|FG001|Treatment|Disease Progression|29|||
130880025|NCT03414983|471194992|FG000|Treatment|Not reported|1|||
130880026|NCT03414983|471194993|FG001|Treatment|Not reported|0|||
130880027|NCT03414983|471194992|FG000|Treatment|Other reasons|3|||
130880028|NCT03414983|471194993|FG001|Treatment|Other reasons|2|||
130880029|NCT03414983|471194992|FG000|Treatment|Poor/non-compliance|2|||
130880030|NCT03414983|471194993|FG001|Treatment|Poor/non-compliance|0|||
130880031|NCT03414983|471194992|FG000|Treatment|Maximum clinical benefit|5|||
130880032|NCT03414983|471194993|FG001|Treatment|Maximum clinical benefit|9|||
130880033|NCT03414983|471194992|FG000|Treatment|Lost to Follow-up|0|||
130880034|NCT03414983|471194993|FG001|Treatment|Lost to Follow-up|1|||
130880035|NCT03414983|471194992|FG000|Treatment|Administrative reasons by sponsor|1|||
130880036|NCT03414983|471194993|FG001|Treatment|Administrative reasons by sponsor|0|||
130880037|NCT00092417|471194994|FG000|Overall Study|Lost to Follow-up|2|||
130880038|NCT00092417|471194995|FG001|Overall Study|Lost to Follow-up|0|||
130880039|NCT00092417|471194994|FG000|Overall Study|Withdrawal by Subject|2|||
130880040|NCT00092417|471194995|FG001|Overall Study|Withdrawal by Subject|1|||
130880041|NCT00092417|471194994|FG000|Overall Study|Other|1|||
130880042|NCT00092417|471194995|FG001|Overall Study|Other|0|||
130880043|NCT02318706|471195001|FG000|Double-blind Phase|Adverse Event|7|||
130880044|NCT02318706|471195002|FG001|Double-blind Phase|Adverse Event|4|||
130880045|NCT02318706|471195003|FG002|Double-blind Phase|Adverse Event|3|||
130880046|NCT02318706|471195004|FG003|Double-blind Phase|Adverse Event|10|||
130880047|NCT02318706|471195005|FG004|Double-blind Phase|Adverse Event|0|||
130880048|NCT02318706|471195001|FG000|Double-blind Phase|Lost to Follow-up|1|||
130880049|NCT02318706|471195002|FG001|Double-blind Phase|Lost to Follow-up|0|||
130880050|NCT02318706|471195003|FG002|Double-blind Phase|Lost to Follow-up|0|||
130880051|NCT02318706|471195004|FG003|Double-blind Phase|Lost to Follow-up|0|||
130880052|NCT02318706|471195005|FG004|Double-blind Phase|Lost to Follow-up|0|||
130880053|NCT02318706|471195001|FG000|Double-blind Phase|Protocol Violation|4|||
130880054|NCT02318706|471195002|FG001|Double-blind Phase|Protocol Violation|2|||
130880055|NCT02318706|471195003|FG002|Double-blind Phase|Protocol Violation|4|||
130880056|NCT02318706|471195004|FG003|Double-blind Phase|Protocol Violation|3|||
130880057|NCT02318706|471195005|FG004|Double-blind Phase|Protocol Violation|0|||
130880058|NCT02318706|471195001|FG000|Double-blind Phase|Withdrawal by Subject|9|||
130880059|NCT02318706|471195002|FG001|Double-blind Phase|Withdrawal by Subject|5|||
130880060|NCT02318706|471195003|FG002|Double-blind Phase|Withdrawal by Subject|7|||
130880061|NCT02318706|471195004|FG003|Double-blind Phase|Withdrawal by Subject|10|||
130880062|NCT02318706|471195005|FG004|Double-blind Phase|Withdrawal by Subject|0|||
130880063|NCT02318706|471195001|FG000|Double-blind Phase|Other|4|||
130880064|NCT02318706|471195002|FG001|Double-blind Phase|Other|1|||
130880065|NCT02318706|471195003|FG002|Double-blind Phase|Other|2|||
130880066|NCT02318706|471195004|FG003|Double-blind Phase|Other|1|||
130880067|NCT02318706|471195005|FG004|Double-blind Phase|Other|0|||
130880068|NCT02318706|471195001|FG000|Double-blind Phase|Death|0|||
130880069|NCT02318706|471195002|FG001|Double-blind Phase|Death|0|||
130880070|NCT02318706|471195003|FG002|Double-blind Phase|Death|2|||
130880071|NCT02318706|471195004|FG003|Double-blind Phase|Death|0|||
130880072|NCT02318706|471195005|FG004|Double-blind Phase|Death|0|||
130880073|NCT02318706|471195001|FG000|Open-label Extension Phase|Adverse Event|0|||
130880074|NCT02318706|471195002|FG001|Open-label Extension Phase|Adverse Event|0|||
130880075|NCT02318706|471195003|FG002|Open-label Extension Phase|Adverse Event|0|||
130880076|NCT02318706|471195004|FG003|Open-label Extension Phase|Adverse Event|0|||
130880077|NCT02318706|471195005|FG004|Open-label Extension Phase|Adverse Event|21|||
130880078|NCT02318706|471195001|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
130880079|NCT02318706|471195002|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
130880080|NCT02318706|471195003|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
130880081|NCT02318706|471195004|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
130880082|NCT02318706|471195005|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
130880083|NCT02318706|471195001|FG000|Open-label Extension Phase|Death|0|||
130880084|NCT02318706|471195002|FG001|Open-label Extension Phase|Death|0|||
130880085|NCT02318706|471195003|FG002|Open-label Extension Phase|Death|0|||
130880086|NCT02318706|471195004|FG003|Open-label Extension Phase|Death|0|||
130880087|NCT02318706|471195005|FG004|Open-label Extension Phase|Death|1|||
130880088|NCT02318706|471195001|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
130880089|NCT02318706|471195002|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
130880090|NCT02318706|471195003|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
130880091|NCT02318706|471195004|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
130880092|NCT02318706|471195005|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
130880093|NCT00755183|471195008|FG000|Overall Study|Adverse Event|5|||
130880094|NCT00755183|471195009|FG001|Overall Study|Adverse Event|2|||
130880095|NCT00755183|471195008|FG000|Overall Study|Protocol Violation|0|||
130880096|NCT00755183|471195009|FG001|Overall Study|Protocol Violation|1|||
130990500|NCT00152009|471593169|FG001|Overall Study|Withdrawal by Subject|3|||
130990501|NCT00152009|471593170|FG002|Overall Study|Withdrawal by Subject|4|||
130990502|NCT00152009|471593171|FG003|Overall Study|Withdrawal by Subject|9|||
130990503|NCT00152009|471593168|FG000|Overall Study|Lost to Follow-up|2|||
130990504|NCT00152009|471593169|FG001|Overall Study|Lost to Follow-up|4|||
130990505|NCT00152009|471593170|FG002|Overall Study|Lost to Follow-up|3|||
130880097|NCT00755183|471195008|FG000|Overall Study|Withdrawal by Subject|0|||
130880098|NCT00755183|471195009|FG001|Overall Study|Withdrawal by Subject|2|||
130880099|NCT00755183|471195008|FG000|Overall Study|Administrative|2|||
130880100|NCT00755183|471195009|FG001|Overall Study|Administrative|1|||
130880101|NCT00148317|471195010|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
130880102|NCT00148317|471195010|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
130880103|NCT00148317|471195010|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
130880104|NCT00992108|471195014|FG000|Overall Study|Lost to Follow-up|0|||
130880105|NCT00992108|471195015|FG001|Overall Study|Lost to Follow-up|1|||
130880106|NCT04639245|471195020|FG000|Overall Study|Death|1|||
130880107|NCT01702311|471195021|FG000|Overall Study|Withdrawal by Subject|3|||
130880108|NCT01702311|471195022|FG001|Overall Study|Withdrawal by Subject|2|||
130880109|NCT01702311|471195021|FG000|Overall Study|Discharge less than 24 hours|10|||
130880110|NCT01702311|471195022|FG001|Overall Study|Discharge less than 24 hours|7|||
130880111|NCT01702311|471195021|FG000|Overall Study|Physician Decision|3|||
130880112|NCT01702311|471195022|FG001|Overall Study|Physician Decision|4|||
130880113|NCT04106557|471195031|FG000|Overall Study|Physician Decision|0|||
130880114|NCT04106557|471195032|FG001|Overall Study|Physician Decision|1|||
130880115|NCT04106557|471195033|FG002|Overall Study|Physician Decision|0|||
130880116|NCT04106557|471195031|FG000|Overall Study|Protocol Violation|0|||
130880117|NCT04106557|471195032|FG001|Overall Study|Protocol Violation|1|||
130880118|NCT04106557|471195033|FG002|Overall Study|Protocol Violation|0|||
130880119|NCT01209689|471195034|FG000|Overall Study|Insufficient Therapeutic Response|7|||
130880120|NCT01209689|471195035|FG001|Overall Study|Insufficient Therapeutic Response|2|||
130880121|NCT01209689|471195034|FG000|Overall Study|Refused Treatment|8|||
130880122|NCT01209689|471195035|FG001|Overall Study|Refused Treatment|3|||
130880123|NCT01209689|471195034|FG000|Overall Study|Adverse Event|4|||
130880124|NCT01209689|471195035|FG001|Overall Study|Adverse Event|0|||
130880125|NCT01209689|471195034|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130880126|NCT01209689|471195035|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
130880127|NCT01209689|471195034|FG000|Overall Study|Failure to Return|3|||
130880128|NCT01209689|471195035|FG001|Overall Study|Failure to Return|0|||
130880129|NCT01209689|471195034|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
130880130|NCT01209689|471195035|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
130880131|NCT03175367|471195036|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
130880132|NCT03175367|471195037|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
130880133|NCT03175367|471195038|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
130880134|NCT03175367|471195039|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
130880135|NCT03175367|471195040|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
130880136|NCT03175367|471195041|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
130880137|NCT03175367|471195042|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
130880138|NCT03175367|471195036|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130880139|NCT03175367|471195037|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130880140|NCT03175367|471195038|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
130880141|NCT03175367|471195039|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
130880142|NCT03175367|471195040|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
130880143|NCT03175367|471195041|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130880144|NCT03175367|471195042|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130880145|NCT03175367|471195036|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130880146|NCT03175367|471195037|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130880147|NCT03175367|471195038|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
130880148|NCT03175367|471195039|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
130880149|NCT03175367|471195040|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130880150|NCT03175367|471195041|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130880151|NCT03175367|471195042|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130880152|NCT03175367|471195036|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
130880153|NCT03175367|471195037|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
130880154|NCT03175367|471195038|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
130880155|NCT03175367|471195039|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
130880156|NCT03175367|471195040|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
130880157|NCT03175367|471195041|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
130880158|NCT03175367|471195042|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
130880159|NCT03175367|471195036|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130880160|NCT03175367|471195037|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130880161|NCT03175367|471195038|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
130880162|NCT03175367|471195039|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130880163|NCT03175367|471195040|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
130880164|NCT03175367|471195041|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130880165|NCT03175367|471195042|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130880166|NCT03175367|471195036|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130880167|NCT03175367|471195037|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130880168|NCT03175367|471195038|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130880169|NCT03175367|471195039|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130880170|NCT03175367|471195040|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130880171|NCT03175367|471195041|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130880172|NCT03175367|471195042|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
130880173|NCT03175367|471195036|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130880174|NCT03175367|471195037|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130880175|NCT03175367|471195038|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130880176|NCT03175367|471195039|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130880177|NCT03175367|471195040|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130880178|NCT03175367|471195041|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
130880179|NCT03175367|471195042|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
130880180|NCT02151058|471195044|FG000|Overall Study|Withdrawal by Subject|1|||
130880181|NCT02151058|471195045|FG001|Overall Study|Withdrawal by Subject|1|||
130880182|NCT02151058|471195046|FG002|Overall Study|Withdrawal by Subject|3|||
130880183|NCT02151058|471195044|FG000|Overall Study|Lost to Follow-up|1|||
130880184|NCT02151058|471195045|FG001|Overall Study|Lost to Follow-up|0|||
130880185|NCT02151058|471195046|FG002|Overall Study|Lost to Follow-up|2|||
130880186|NCT03829228|471195047|FG000|Overall Study|Protocol Violation|1|||
130880187|NCT03337477|471195048|FG000|Overall Study|not categorized into the listed ones|11|||
130880188|NCT03337477|471195049|FG001|Overall Study|not categorized into the listed ones|9|||
130880189|NCT03337477|471195048|FG000|Overall Study|Withdrawal by Subject|0|||
130880190|NCT03337477|471195049|FG001|Overall Study|Withdrawal by Subject|1|||
130880191|NCT03337477|471195048|FG000|Overall Study|Death|0|||
130880192|NCT03337477|471195049|FG001|Overall Study|Death|1|||
130880193|NCT03337477|471195048|FG000|Overall Study|Lost to Follow-up|0|||
130880194|NCT03337477|471195049|FG001|Overall Study|Lost to Follow-up|2|||
130880195|NCT00853307|471195050|FG000|Overall Study|Adverse Event|1|||
130880196|NCT00853307|471195051|FG001|Overall Study|Adverse Event|2|||
130880197|NCT00853307|471195050|FG000|Overall Study|Withdrawal by Subject|1|||
130880198|NCT00853307|471195051|FG001|Overall Study|Withdrawal by Subject|2|||
130880199|NCT00853307|471195050|FG000|Overall Study|Reason Not Specified|0|||
130880200|NCT00853307|471195051|FG001|Overall Study|Reason Not Specified|1|||
130880201|NCT01112917|471195052|FG000|Overall Study|Death|2|||
130880202|NCT01112917|471195053|FG001|Overall Study|Death|11|||
130880203|NCT01112917|471195052|FG000|Overall Study|Lost to Follow-up|1|||
130880204|NCT01112917|471195053|FG001|Overall Study|Lost to Follow-up|1|||
130880205|NCT01112917|471195052|FG000|Overall Study|Withdrawal by Subject|1|||
130880206|NCT01112917|471195053|FG001|Overall Study|Withdrawal by Subject|3|||
130880207|NCT01112917|471195052|FG000|Overall Study|Unable to Convert Filter|3|||
130880208|NCT01112917|471195053|FG001|Overall Study|Unable to Convert Filter|0|||
130880209|NCT00981656|471195064|FG000|Overall Study|Protocol Violation|1|||
130880210|NCT00981656|471195064|FG000|Overall Study|Did not start protocol treatment|2|||
130880211|NCT00687596|471195065|FG000|Overall Study|Adverse Event (AE)|10|||
130880212|NCT00687596|471195066|FG001|Overall Study|Adverse Event (AE)|3|||
130880213|NCT00687596|471195065|FG000|Overall Study|Radiological Disease Progression|6|||
130880214|NCT00687596|471195066|FG001|Overall Study|Radiological Disease Progression|2|||
130880215|NCT00687596|471195065|FG000|Overall Study|Clinical Disease Progression|1|||
130880216|NCT00687596|471195066|FG001|Overall Study|Clinical Disease Progression|3|||
130880217|NCT00687596|471195065|FG000|Overall Study|Investigator Discretion|3|||
130880218|NCT00687596|471195066|FG001|Overall Study|Investigator Discretion|1|||
130880219|NCT00687596|471195065|FG000|Overall Study|Sponsor Terminated Study|6|||
130880220|NCT00687596|471195066|FG001|Overall Study|Sponsor Terminated Study|17|||
130880221|NCT00837434|471195069|FG000|Overall Study|Physician Decision|3|||
130880222|NCT00837434|471195070|FG001|Overall Study|Physician Decision|0|||
130880223|NCT00837434|471195069|FG000|Overall Study|Lost to Follow-up|1|||
130880224|NCT00837434|471195070|FG001|Overall Study|Lost to Follow-up|1|||
130880225|NCT00837434|471195069|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
130880226|NCT00837434|471195070|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
130880227|NCT00837434|471195069|FG000|Overall Study|Noncompliant|2|||
130880228|NCT00837434|471195070|FG001|Overall Study|Noncompliant|0|||
130880229|NCT00837434|471195069|FG000|Overall Study|Baseline assessments not done in time|1|||
130880230|NCT00837434|471195070|FG001|Overall Study|Baseline assessments not done in time|0|||
130880231|NCT00837434|471195069|FG000|Overall Study|Unable to obtain study drug|1|||
130880232|NCT00837434|471195070|FG001|Overall Study|Unable to obtain study drug|0|||
130880233|NCT00456846|471195071|FG000|Overall Study|Adverse Event|2|||
130880234|NCT00456846|471195072|FG001|Overall Study|Adverse Event|15|||
130880235|NCT00456846|471195071|FG000|Overall Study|Physician Decision|11|||
130880236|NCT00456846|471195072|FG001|Overall Study|Physician Decision|6|||
130880237|NCT00456846|471195071|FG000|Overall Study|Protocol Deviation|2|||
130880238|NCT00456846|471195072|FG001|Overall Study|Protocol Deviation|0|||
130880239|NCT00456846|471195071|FG000|Overall Study|Participant Discretion|1|||
130880240|NCT00456846|471195072|FG001|Overall Study|Participant Discretion|5|||
130880241|NCT00456846|471195071|FG000|Overall Study|Other|0|||
130880242|NCT00456846|471195072|FG001|Overall Study|Other|2|||
130880243|NCT01207414|471195073|FG000|Overall Study|Adverse Event|25|||
130880244|NCT01207414|471195074|FG001|Overall Study|Adverse Event|39|||
130880245|NCT01207414|471195073|FG000|Overall Study|Abnormal test procedure results|0|||
130880246|NCT01207414|471195074|FG001|Overall Study|Abnormal test procedure results|1|||
130880247|NCT01207414|471195073|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130880248|NCT01207414|471195074|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130880249|NCT01207414|471195073|FG000|Overall Study|Patient withdrew consent|14|||
130880250|NCT01207414|471195074|FG001|Overall Study|Patient withdrew consent|11|||
130880251|NCT01207414|471195073|FG000|Overall Study|Lost to Follow-up|15|||
130880252|NCT01207414|471195074|FG001|Overall Study|Lost to Follow-up|17|||
130880253|NCT01207414|471195073|FG000|Overall Study|Administrative problems|1|||
130880254|NCT01207414|471195074|FG001|Overall Study|Administrative problems|1|||
130880255|NCT01207414|471195073|FG000|Overall Study|Protocol deviation|12|||
130880256|NCT01207414|471195074|FG001|Overall Study|Protocol deviation|9|||
130880257|NCT01207414|471195073|FG000|Overall Study|Randomized in error|1|||
130880258|NCT01207414|471195074|FG001|Overall Study|Randomized in error|0|||
130880259|NCT01748292|471195075|FG000|Overall Study|Adverse Event|2|||
130880260|NCT01748292|471195076|FG001|Overall Study|Adverse Event|4|||
130880261|NCT01748292|471195075|FG000|Overall Study|Lost to Follow-up|0|||
130880262|NCT01748292|471195076|FG001|Overall Study|Lost to Follow-up|3|||
130880263|NCT01748292|471195075|FG000|Overall Study|Death|0|||
130880264|NCT01748292|471195076|FG001|Overall Study|Death|3|||
130880265|NCT01748292|471195075|FG000|Overall Study|Withdrawal by Subject|0|||
130880266|NCT01748292|471195076|FG001|Overall Study|Withdrawal by Subject|2|||
130880267|NCT03379818|471195079|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
130880268|NCT03379818|471195080|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
130880269|NCT03379818|471195079|FG000|Overall Study|Withdrawal by Subject|2|||
130880270|NCT03379818|471195080|FG001|Overall Study|Withdrawal by Subject|3|||
130880271|NCT03379818|471195079|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
130880272|NCT03379818|471195080|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
130880273|NCT00412984|471195088|FG000|Overall Study|Death|331|||
130880274|NCT00412984|471195089|FG001|Overall Study|Death|349|||
130880275|NCT00412984|471195088|FG000|Overall Study|Adverse Event|679|||
130880276|NCT00412984|471195089|FG001|Overall Study|Adverse Event|738|||
130880277|NCT00412984|471195088|FG000|Overall Study|Withdrawal by Subject|921|||
130880278|NCT00412984|471195089|FG001|Overall Study|Withdrawal by Subject|989|||
130880279|NCT00412984|471195088|FG000|Overall Study|Lost to Follow-up|51|||
130880280|NCT00412984|471195089|FG001|Overall Study|Lost to Follow-up|39|||
130880281|NCT00412984|471195088|FG000|Overall Study|Poor/Noncompliance|57|||
130880282|NCT00412984|471195089|FG001|Overall Study|Poor/Noncompliance|77|||
130880283|NCT00412984|471195088|FG000|Overall Study|Pregnancy|1|||
130880284|NCT00412984|471195089|FG001|Overall Study|Pregnancy|0|||
130880285|NCT00412984|471195088|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
130880286|NCT00412984|471195089|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
130880287|NCT00412984|471195088|FG000|Overall Study|Administrative Reason by Sponsor|11|||
130880288|NCT00412984|471195089|FG001|Overall Study|Administrative Reason by Sponsor|8|||
130880289|NCT00412984|471195088|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
130880290|NCT00412984|471195089|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
130880291|NCT00412984|471195088|FG000|Overall Study|Other Reason|80|||
130880292|NCT00412984|471195089|FG001|Overall Study|Other Reason|92|||
130880293|NCT00412984|471195088|FG000|Overall Study|Not Reported|11|||
130880294|NCT00412984|471195089|FG001|Overall Study|Not Reported|12|||
130880295|NCT02383576|471195090|FG000|Overall Study|Death|53|||
130880296|NCT02383576|471195091|FG001|Overall Study|Death|33|||
130880297|NCT02383576|471195090|FG000|Overall Study|Lost to Follow-up|7|||
130880298|NCT02383576|471195091|FG001|Overall Study|Lost to Follow-up|1|||
130880299|NCT02383576|471195090|FG000|Overall Study|Withdrew Consent|1|||
130880300|NCT02383576|471195091|FG001|Overall Study|Withdrew Consent|6|||
130880301|NCT02383576|471195090|FG000|Overall Study|Investigator's Decision|0|||
130880302|NCT02383576|471195091|FG001|Overall Study|Investigator's Decision|1|||
130880303|NCT02383576|471195090|FG000|Overall Study|Administrative/Other|2|||
130880304|NCT02383576|471195091|FG001|Overall Study|Administrative/Other|4|||
130880305|NCT04218240|471195092|FG000|Overall Study|Withdrawal by Subject|6|||
130880306|NCT04218240|471195093|FG001|Overall Study|Withdrawal by Subject|0|||
130880307|NCT04218240|471195092|FG000|Overall Study|Lack of Efficacy|24|||
130880308|NCT04218240|471195093|FG001|Overall Study|Lack of Efficacy|19|||
130880309|NCT04218240|471195092|FG000|Overall Study|Physician Decision|0|||
130880310|NCT04218240|471195093|FG001|Overall Study|Physician Decision|1|||
130880311|NCT04218240|471195092|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
130880312|NCT04218240|471195093|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
130880313|NCT03694678|471195094|FG000|Overall Study|Withdrawal by Subject|2|||
130880314|NCT03694678|471195095|FG001|Overall Study|Withdrawal by Subject|0|||
130880315|NCT03694678|471195094|FG000|Overall Study|Lost to Follow-up|2|||
130880316|NCT03694678|471195095|FG001|Overall Study|Lost to Follow-up|3|||
130880317|NCT05966142|471195105|FG000|Overall Study|Death|3|||
130880318|NCT05966142|471195106|FG001|Overall Study|Death|3|||
130880319|NCT05966142|471195105|FG000|Overall Study|Lost to Follow-up|55|||
130880320|NCT05966142|471195106|FG001|Overall Study|Lost to Follow-up|52|||
130880321|NCT05966142|471195105|FG000|Overall Study|Physician Decision|1|||
130880322|NCT05966142|471195106|FG001|Overall Study|Physician Decision|0|||
130880323|NCT05966142|471195105|FG000|Overall Study|Withdrawal by Subject|9|||
130880324|NCT05966142|471195106|FG001|Overall Study|Withdrawal by Subject|8|||
130880325|NCT05966142|471195105|FG000|Overall Study|Duplicate Enrollment|1|||
130880326|NCT05966142|471195106|FG001|Overall Study|Duplicate Enrollment|0|||
130880327|NCT05966142|471195105|FG000|Overall Study|Study Logistical Reason|1|||
130880328|NCT05966142|471195106|FG001|Overall Study|Study Logistical Reason|0|||
130880329|NCT05966142|471195105|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
130880330|NCT05966142|471195106|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
130880331|NCT02340026|471195107|FG000|Treatment Phase|Withdrawal by Subject|2|||
130880332|NCT02340026|471195108|FG001|Treatment Phase|Withdrawal by Subject|2|||
130880333|NCT02340026|471195107|FG000|Follow-up Phase|Lost to Follow-up|1|||
130880334|NCT02340026|471195108|FG001|Follow-up Phase|Lost to Follow-up|0|||
130880335|NCT02246530|471195110|FG000|Overall Study|Lost to Follow-up|4|||
130880336|NCT02246530|471195111|FG001|Overall Study|Lost to Follow-up|0|||
130880337|NCT05135767|471195112|FG000|Baseline|Lost to Follow-up|1|||
130880338|NCT05135767|471195113|FG001|Baseline|Lost to Follow-up|1|||
130880339|NCT05135767|471195112|FG000|Baseline|Withdrawal by Subject|0|||
130880340|NCT05135767|471195113|FG001|Baseline|Withdrawal by Subject|2|||
130880341|NCT05135767|471195112|FG000|Active Study Phase|Lost to Follow-up|2|||
130880342|NCT05135767|471195113|FG001|Active Study Phase|Lost to Follow-up|0|||
130880343|NCT02260934|471195119|FG000|Overall Study|Lost to Follow-up|2|||
130880344|NCT02260934|471195120|FG001|Overall Study|Lost to Follow-up|1|||
130880345|NCT02260934|471195119|FG000|Overall Study|Withdrawal by Subject|0|||
130880346|NCT02260934|471195120|FG001|Overall Study|Withdrawal by Subject|2|||
130880347|NCT02260934|471195119|FG000|Overall Study|Participant Relocated|1|||
130880348|NCT02260934|471195120|FG001|Overall Study|Participant Relocated|0|||
130880349|NCT02260934|471195119|FG000|Overall Study|Site error|0|||
130880350|NCT02260934|471195120|FG001|Overall Study|Site error|1|||
130880351|NCT03605667|471195123|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
130880352|NCT03605667|471195124|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
130880353|NCT03605667|471195123|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
130880354|NCT03605667|471195124|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
130880355|NCT03605667|471195123|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
130880356|NCT03605667|471195124|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
130880357|NCT03605667|471195123|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
130880358|NCT03605667|471195124|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
130880359|NCT03605667|471195123|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
130880360|NCT03605667|471195124|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
130880361|NCT03605667|471195123|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
130880362|NCT03605667|471195124|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
130880363|NCT03605667|471195123|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
130880364|NCT03605667|471195124|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
130880365|NCT03605667|471195123|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
130880366|NCT03605667|471195124|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
130880367|NCT03605667|471195123|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
130880368|NCT03605667|471195124|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
130880369|NCT03605667|471195123|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
130880370|NCT03605667|471195124|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
130880371|NCT03605667|471195123|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
130880372|NCT03605667|471195124|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
130880373|NCT03605667|471195123|FG000|OLE Phase (48 Weeks)|Other|6|||
130880374|NCT03605667|471195124|FG001|OLE Phase (48 Weeks)|Other|8|||
130880375|NCT03605667|471195123|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
130880376|NCT03605667|471195124|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
130880377|NCT03605667|471195123|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
130880378|NCT03605667|471195124|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
130880379|NCT03605667|471195123|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
130880380|NCT03605667|471195124|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
131100201|NCT00266227|471996265|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
131100202|NCT00266227|471996263|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
131100203|NCT00266227|471996264|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
130880381|NCT03605667|471195123|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
130880382|NCT03605667|471195124|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
130880383|NCT03605667|471195123|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
130880384|NCT03605667|471195124|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
130880385|NCT03605667|471195123|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
130880386|NCT03605667|471195124|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
131100204|NCT00266227|471996265|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
131100205|NCT00266227|471996263|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
130880387|NCT03605667|471195123|FG000|OLE Phase (48 Weeks)|Death|0|||
130880388|NCT03605667|471195124|FG001|OLE Phase (48 Weeks)|Death|2|||
130880389|NCT03605667|471195123|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
130880390|NCT03605667|471195124|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
130880391|NCT03597347|471195127|FG000|Overall Study|Withdrawal by Subject|1|||
130880392|NCT03597347|471195128|FG001|Overall Study|Withdrawal by Subject|1|||
130880393|NCT03597347|471195129|FG002|Overall Study|Withdrawal by Subject|0|||
130880394|NCT03597347|471195127|FG000|Overall Study|Withdrawal due to Covid-19|3|||
130880395|NCT03597347|471195128|FG001|Overall Study|Withdrawal due to Covid-19|0|||
130880396|NCT03597347|471195129|FG002|Overall Study|Withdrawal due to Covid-19|0|||
130880397|NCT03597347|471195127|FG000|Overall Study|Sponsor decision to terminate study|3|||
130880398|NCT03597347|471195128|FG001|Overall Study|Sponsor decision to terminate study|2|||
130880399|NCT03597347|471195129|FG002|Overall Study|Sponsor decision to terminate study|4|||
130880400|NCT00107653|471195130|FG000|Overall Study|Adverse Event|24|||
130880401|NCT00107653|471195131|FG001|Overall Study|Adverse Event|43|||
130880402|NCT00107653|471195130|FG000|Overall Study|Insufficient Therapeutic Response|25|||
130880403|NCT00107653|471195131|FG001|Overall Study|Insufficient Therapeutic Response|11|||
130880404|NCT00107653|471195130|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130880405|NCT00107653|471195131|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130880406|NCT00107653|471195130|FG000|Overall Study|Protocol Violation|1|||
130880407|NCT00107653|471195131|FG001|Overall Study|Protocol Violation|0|||
130880408|NCT00107653|471195130|FG000|Overall Study|Withdrawal by Subject|12|||
130880409|NCT00107653|471195131|FG001|Overall Study|Withdrawal by Subject|13|||
130880410|NCT00107653|471195130|FG000|Overall Study|Lost to Follow-up|13|||
130880411|NCT00107653|471195131|FG001|Overall Study|Lost to Follow-up|5|||
130880412|NCT00107653|471195130|FG000|Overall Study|Administrative Reasons|3|||
130880413|NCT00107653|471195131|FG001|Overall Study|Administrative Reasons|3|||
130880414|NCT02532517|471195135|FG000|Overall Study|Did not complete 24-Month visit|4|||
130880415|NCT02532517|471195135|FG000|Overall Study|Failed Angiographic eligibility|1|||
130880416|NCT02532517|471195135|FG000|Overall Study|Lost to Follow-up|4|||
130880417|NCT02532517|471195135|FG000|Overall Study|Withdrawal by Subject|4|||
130880418|NCT02532517|471195135|FG000|Overall Study|Death|4|||
130880419|NCT03312231|471195136|FG000|Overall Study|Lost to Follow-up|2|||
130880420|NCT03312231|471195137|FG001|Overall Study|Lost to Follow-up|6|||
130880421|NCT03312231|471195138|FG002|Overall Study|Lost to Follow-up|1|||
130880422|NCT03312231|471195139|FG003|Overall Study|Lost to Follow-up|3|||
130880423|NCT03312231|471195140|FG004|Overall Study|Lost to Follow-up|1|||
130880424|NCT03312231|471195136|FG000|Overall Study|Withdrawal by Subject|0|||
130880425|NCT03312231|471195137|FG001|Overall Study|Withdrawal by Subject|3|||
130880426|NCT03312231|471195138|FG002|Overall Study|Withdrawal by Subject|1|||
130880427|NCT03312231|471195139|FG003|Overall Study|Withdrawal by Subject|0|||
130880428|NCT03312231|471195140|FG004|Overall Study|Withdrawal by Subject|0|||
130880429|NCT03312231|471195136|FG000|Overall Study|Death|0|||
130880430|NCT03312231|471195137|FG001|Overall Study|Death|1|||
130880431|NCT03312231|471195138|FG002|Overall Study|Death|1|||
130880432|NCT03312231|471195139|FG003|Overall Study|Death|0|||
130880433|NCT03312231|471195140|FG004|Overall Study|Death|0|||
130880434|NCT03312231|471195136|FG000|Overall Study|Study Vaccination not Received|1|||
130880435|NCT03312231|471195137|FG001|Overall Study|Study Vaccination not Received|1|||
130880436|NCT03312231|471195138|FG002|Overall Study|Study Vaccination not Received|1|||
130880437|NCT03312231|471195139|FG003|Overall Study|Study Vaccination not Received|0|||
130880438|NCT03312231|471195140|FG004|Overall Study|Study Vaccination not Received|0|||
130880439|NCT03157830|471195141|FG000|Overall Study|Lost to Follow-up|1|||
130880440|NCT03157830|471195141|FG000|Overall Study|Withdrawal by Subject|1|||
130880441|NCT03694353|471195143|FG000|Overall Study|Withdrawal by Subject|1|||
130880442|NCT03694353|471195143|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
130880443|NCT05720897|471195144|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
130880444|NCT05720897|471195145|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
130880445|NCT00400179|471195146|FG000|Overall Study|Adverse Event|2|||
130880446|NCT00400179|471195147|FG001|Overall Study|Adverse Event|2|||
130880447|NCT00400179|471195146|FG000|Overall Study|Death|1|||
130880448|NCT00400179|471195147|FG001|Overall Study|Death|2|||
130880449|NCT00400179|471195146|FG000|Overall Study|Withdrew Consent|1|||
130880450|NCT00400179|471195147|FG001|Overall Study|Withdrew Consent|5|||
130880451|NCT00400179|471195146|FG000|Overall Study|Disease progression|1|||
131100206|NCT00266227|471996264|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
130880452|NCT00400179|471195147|FG001|Overall Study|Disease progression|1|||
130880453|NCT00400179|471195146|FG000|Overall Study|Intercurrent illness|0|||
130880454|NCT00400179|471195147|FG001|Overall Study|Intercurrent illness|1|||
130880455|NCT00400179|471195146|FG000|Overall Study|Investigator judgment|0|||
130880456|NCT00400179|471195147|FG001|Overall Study|Investigator judgment|1|||
130880457|NCT00400179|471195146|FG000|Overall Study|Randomization error/patient ineligible|1|||
130880458|NCT00400179|471195147|FG001|Overall Study|Randomization error/patient ineligible|6|||
131100207|NCT00266227|471996265|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
131100208|NCT00266227|471996263|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
131100209|NCT00266227|471996264|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
131100210|NCT00266227|471996265|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
131100211|NCT00266227|471996263|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
131100212|NCT00266227|471996264|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
131100213|NCT00266227|471996265|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
131100214|NCT00266227|471996263|FG000|Retreatment: Week 48 to Week 72|Death|1|||
131100215|NCT00266227|471996264|FG001|Retreatment: Week 48 to Week 72|Death|1|||
131100216|NCT00266227|471996265|FG002|Retreatment: Week 48 to Week 72|Death|0|||
131100217|NCT00266227|471996263|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
131100218|NCT00266227|471996264|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
131100219|NCT00266227|471996265|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
131100220|NCT00266227|471996263|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
131100221|NCT00266227|471996264|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
131100222|NCT00266227|471996265|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
131100223|NCT00266227|471996263|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
131100224|NCT00266227|471996264|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
131100225|NCT00266227|471996265|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
131100226|NCT00266227|471996263|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
131100227|NCT00266227|471996264|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
131100228|NCT00266227|471996265|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
131100229|NCT03241927|471996266|FG000|Overall Study|study terminated|1|||
131100230|NCT03241927|471996267|FG001|Overall Study|study terminated|0|||
131100231|NCT03725085|471996272|FG000|Overall Study|Lost to Follow-up|2|||
131100232|NCT00423943|471996273|FG000|Overall Study|Withdrawal by Subject|3|||
131100233|NCT00423943|471996274|FG001|Overall Study|Withdrawal by Subject|1|||
131100234|NCT02383056|471996278|FG000|Overall Study|Adverse Event|1|||
131100235|NCT02383056|471996279|FG001|Overall Study|Adverse Event|0|||
131100236|NCT02383056|471996278|FG000|Overall Study|Lost to Follow-up|0|||
131100237|NCT02383056|471996279|FG001|Overall Study|Lost to Follow-up|2|||
131100238|NCT04214600|471996280|FG000|Overall Study|Lost to Follow-up|9|||
131100239|NCT04214600|471996281|FG001|Overall Study|Lost to Follow-up|14|||
131100240|NCT03245151|471996287|FG000|Overall Study|Withdrawal by Subject|2|||
131100241|NCT03245151|471996288|FG001|Overall Study|Withdrawal by Subject|0|||
131100242|NCT03245151|471996289|FG002|Overall Study|Withdrawal by Subject|0|||
131100243|NCT03245151|471996290|FG003|Overall Study|Withdrawal by Subject|2|||
131100244|NCT03245151|471996291|FG004|Overall Study|Withdrawal by Subject|1|||
131100245|NCT03245151|471996287|FG000|Overall Study|Death|3|||
131100246|NCT03245151|471996288|FG001|Overall Study|Death|14|||
131100247|NCT03245151|471996289|FG002|Overall Study|Death|9|||
131100248|NCT03245151|471996290|FG003|Overall Study|Death|16|||
131100249|NCT03245151|471996291|FG004|Overall Study|Death|7|||
131100250|NCT03245151|471996287|FG000|Overall Study|Sponsor's decision|0|||
131100251|NCT03245151|471996288|FG001|Overall Study|Sponsor's decision|1|||
131100252|NCT03245151|471996289|FG002|Overall Study|Sponsor's decision|0|||
131100253|NCT03245151|471996290|FG003|Overall Study|Sponsor's decision|0|||
131100254|NCT03245151|471996291|FG004|Overall Study|Sponsor's decision|0|||
131100255|NCT02245737|471996292|FG000|Overall Study|Adverse Event|23|||
131100256|NCT02245737|471996293|FG001|Overall Study|Adverse Event|26|||
131100257|NCT02245737|471996294|FG002|Overall Study|Adverse Event|33|||
131100258|NCT02245737|471996292|FG000|Overall Study|Condition Worsened|9|||
131100259|NCT02245737|471996293|FG001|Overall Study|Condition Worsened|10|||
131100260|NCT02245737|471996294|FG002|Overall Study|Condition Worsened|9|||
131100261|NCT02245737|471996292|FG000|Overall Study|Death|2|||
131100262|NCT02245737|471996293|FG001|Overall Study|Death|4|||
131100263|NCT02245737|471996294|FG002|Overall Study|Death|4|||
131100264|NCT02245737|471996292|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
131100265|NCT02245737|471996293|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
131100266|NCT02245737|471996294|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
131100267|NCT02245737|471996292|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
131100268|NCT02245737|471996293|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
131100269|NCT02245737|471996294|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
131100270|NCT02245737|471996292|FG000|Overall Study|Lost to Follow-up|2|||
131100271|NCT02245737|471996293|FG001|Overall Study|Lost to Follow-up|5|||
131100272|NCT02245737|471996294|FG002|Overall Study|Lost to Follow-up|4|||
131100273|NCT02245737|471996292|FG000|Overall Study|Other-determined by Investigator|9|||
131100274|NCT02245737|471996293|FG001|Overall Study|Other-determined by Investigator|10|||
131100275|NCT02245737|471996294|FG002|Overall Study|Other-determined by Investigator|10|||
131100276|NCT02245737|471996292|FG000|Overall Study|Physician Decision|6|||
131100277|NCT02245737|471996293|FG001|Overall Study|Physician Decision|3|||
131100278|NCT02245737|471996294|FG002|Overall Study|Physician Decision|6|||
131100279|NCT02245737|471996292|FG000|Overall Study|Protocol Violation|3|||
131100280|NCT02245737|471996293|FG001|Overall Study|Protocol Violation|2|||
131100281|NCT02245737|471996294|FG002|Overall Study|Protocol Violation|3|||
130880459|NCT04780061|471195148|FG000|Overall Study|Withdrawal by Subject|5|||
130880460|NCT04780061|471195149|FG001|Overall Study|Withdrawal by Subject|8|||
130880461|NCT04780061|471195148|FG000|Overall Study|Adverse Event|2|||
130880462|NCT04780061|471195149|FG001|Overall Study|Adverse Event|2|||
130880463|NCT04780061|471195148|FG000|Overall Study|Lost to Follow-up|1|||
130880464|NCT04780061|471195149|FG001|Overall Study|Lost to Follow-up|5|||
130880465|NCT05138653|471195150|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
130880466|NCT05138653|471195151|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880467|NCT05138653|471195152|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880468|NCT05138653|471195153|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880469|NCT05138653|471195154|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880470|NCT05138653|471195155|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880471|NCT05138653|471195156|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880472|NCT05138653|471195157|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880473|NCT05138653|471195158|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880474|NCT05138653|471195159|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880475|NCT05138653|471195160|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880476|NCT05138653|471195161|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880477|NCT05138653|471195162|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880478|NCT05138653|471195163|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880479|NCT05138653|471195164|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880480|NCT05138653|471195165|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130880481|NCT05138653|471195150|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880482|NCT05138653|471195151|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
130880483|NCT05138653|471195152|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880484|NCT05138653|471195153|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880485|NCT05138653|471195154|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880486|NCT05138653|471195155|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880487|NCT05138653|471195156|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880488|NCT05138653|471195157|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880489|NCT05138653|471195158|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
130880490|NCT05138653|471195159|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880491|NCT05138653|471195160|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880492|NCT05138653|471195161|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880493|NCT05138653|471195162|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880494|NCT05138653|471195163|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880495|NCT05138653|471195164|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880496|NCT05138653|471195165|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130880497|NCT05138653|471195150|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880498|NCT05138653|471195151|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
130880499|NCT05138653|471195152|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880500|NCT05138653|471195153|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880501|NCT05138653|471195154|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
130880502|NCT05138653|471195155|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880503|NCT05138653|471195156|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880504|NCT05138653|471195157|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880505|NCT05138653|471195158|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880506|NCT05138653|471195159|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880507|NCT05138653|471195160|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880508|NCT05138653|471195161|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880509|NCT05138653|471195162|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880510|NCT05138653|471195163|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880511|NCT05138653|471195164|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880512|NCT05138653|471195165|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130880513|NCT05138653|471195150|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880514|NCT05138653|471195151|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880515|NCT05138653|471195152|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880516|NCT05138653|471195153|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880517|NCT05138653|471195154|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880518|NCT05138653|471195155|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880519|NCT05138653|471195156|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
130880520|NCT05138653|471195157|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880521|NCT05138653|471195158|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
131213432|NCT00762073|472405348|FG002|Overall Study|Significant Subject Noncompliance|0|||
131213433|NCT00762073|472405349|FG003|Overall Study|Significant Subject Noncompliance|1|||
130880522|NCT05138653|471195159|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880523|NCT05138653|471195160|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880524|NCT05138653|471195161|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880525|NCT05138653|471195162|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880526|NCT05138653|471195163|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880527|NCT05138653|471195164|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880528|NCT05138653|471195165|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130880529|NCT05138653|471195150|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880530|NCT05138653|471195151|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880531|NCT05138653|471195152|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880532|NCT05138653|471195153|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880533|NCT05138653|471195154|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880534|NCT05138653|471195155|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880535|NCT05138653|471195156|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880536|NCT05138653|471195157|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880537|NCT05138653|471195158|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880538|NCT05138653|471195159|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880539|NCT05138653|471195160|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
130880540|NCT05138653|471195161|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880541|NCT05138653|471195162|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
130880542|NCT05138653|471195163|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880543|NCT05138653|471195164|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
130880544|NCT05138653|471195165|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130880545|NCT05138653|471195150|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880546|NCT05138653|471195151|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880547|NCT05138653|471195152|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880548|NCT05138653|471195153|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880549|NCT05138653|471195154|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880550|NCT05138653|471195155|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880551|NCT05138653|471195156|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880552|NCT05138653|471195157|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880553|NCT05138653|471195158|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880554|NCT05138653|471195159|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880555|NCT05138653|471195160|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880556|NCT05138653|471195161|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880557|NCT05138653|471195162|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880558|NCT05138653|471195163|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880559|NCT05138653|471195164|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130880560|NCT05138653|471195165|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
130880561|NCT05138653|471195150|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880562|NCT05138653|471195151|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880563|NCT05138653|471195152|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880564|NCT05138653|471195153|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880565|NCT05138653|471195154|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880566|NCT05138653|471195155|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880567|NCT05138653|471195156|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880568|NCT05138653|471195157|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880569|NCT05138653|471195158|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880570|NCT05138653|471195159|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880571|NCT05138653|471195160|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880572|NCT05138653|471195161|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880573|NCT05138653|471195162|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130990506|NCT00152009|471593171|FG003|Overall Study|Lost to Follow-up|3|||
130990507|NCT00152009|471593168|FG000|Overall Study|Lack of Efficacy|8|||
130990508|NCT00152009|471593169|FG001|Overall Study|Lack of Efficacy|6|||
130990509|NCT00152009|471593170|FG002|Overall Study|Lack of Efficacy|7|||
130990510|NCT00152009|471593171|FG003|Overall Study|Lack of Efficacy|15|||
130990511|NCT00152009|471593168|FG000|Overall Study|ECG abnormalities|2|||
130990512|NCT00152009|471593169|FG001|Overall Study|ECG abnormalities|2|||
130990513|NCT00152009|471593170|FG002|Overall Study|ECG abnormalities|2|||
130990514|NCT00152009|471593171|FG003|Overall Study|ECG abnormalities|1|||
130990515|NCT00152009|471593168|FG000|Overall Study|Sponsor's decision|3|||
130990516|NCT00152009|471593169|FG001|Overall Study|Sponsor's decision|3|||
130990517|NCT00152009|471593170|FG002|Overall Study|Sponsor's decision|1|||
130990518|NCT00152009|471593171|FG003|Overall Study|Sponsor's decision|3|||
130990519|NCT00098254|471593177|FG000|Overall Study|Adverse Event|2|||
130880574|NCT05138653|471195163|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
130880575|NCT05138653|471195164|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880576|NCT05138653|471195165|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130880577|NCT01824836|471195166|FG000|Overall Study|Adverse Event|48|||
130880578|NCT01824836|471195166|FG000|Overall Study|Withdrawal by Subject|63|||
130880579|NCT01824836|471195166|FG000|Overall Study|Other complicating disease|116|||
130880580|NCT01824836|471195166|FG000|Overall Study|Disease progression|5|||
130880581|NCT01824836|471195166|FG000|Overall Study|Alternative therapy|2|||
130880582|NCT01824836|471195166|FG000|Overall Study|Depression|1|||
130880583|NCT01824836|471195166|FG000|Overall Study|Non-compliance|3|||
130880584|NCT01824836|471195166|FG000|Overall Study|Patient regained ovarian function|3|||
130880585|NCT01824836|471195166|FG000|Overall Study|Lost to Follow-up|8|||
130880586|NCT01824836|471195166|FG000|Overall Study|Physician Decision|2|||
130880587|NCT01824836|471195166|FG000|Overall Study|Research office was closed|3|||
130880588|NCT01824836|471195166|FG000|Overall Study|Relocation|3|||
130880589|NCT01824836|471195166|FG000|Overall Study|Insurance-related issue|1|||
130880590|NCT01824836|471195166|FG000|Overall Study|Transportation issue|1|||
130880591|NCT01824836|471195166|FG000|Overall Study|Patient transferred care|1|||
130880592|NCT01824836|471195166|FG000|Overall Study|Unknown reasons|4|||
130880593|NCT01824836|471195166|FG000|Overall Study|Never started treatment|16|||
130880594|NCT02608684|471197288|FG000|Overall Study|Physician Decision|2|||
130880595|NCT02608684|471197288|FG000|Overall Study|Withdrawal by Subject|1|||
130880596|NCT01972217|471197289|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
130880597|NCT01972217|471197290|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
130880598|NCT01972217|471197291|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
130880599|NCT01972217|471197292|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
130880600|NCT01972217|471197289|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
130880601|NCT01972217|471197290|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
130880602|NCT01972217|471197291|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
130880603|NCT01972217|471197292|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
130880604|NCT01972217|471197289|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
130880605|NCT01972217|471197290|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
130880606|NCT01972217|471197291|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
130880607|NCT01972217|471197292|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
130880608|NCT01972217|471197289|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
130880609|NCT01972217|471197290|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
130880610|NCT01972217|471197291|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
130880611|NCT01972217|471197292|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
130880612|NCT01972217|471197289|FG000|Part B Double-blind, Randomised Period|Death|0|||
130880613|NCT01972217|471197290|FG001|Part B Double-blind, Randomised Period|Death|0|||
130880614|NCT01972217|471197291|FG002|Part B Double-blind, Randomised Period|Death|43|||
130880615|NCT01972217|471197292|FG003|Part B Double-blind, Randomised Period|Death|44|||
130880616|NCT01972217|471197289|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
130880617|NCT01972217|471197290|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
130880618|NCT01972217|471197291|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
130880619|NCT01972217|471197292|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
130880620|NCT01972217|471197289|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
130880621|NCT01972217|471197290|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
130880622|NCT01972217|471197291|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
130880623|NCT01972217|471197292|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
130880624|NCT01972217|471197289|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
130880625|NCT01972217|471197290|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
130880626|NCT01972217|471197291|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
130880627|NCT01972217|471197292|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
130880628|NCT01972217|471197289|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
130880629|NCT01972217|471197290|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
130880630|NCT01972217|471197291|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
130880631|NCT01972217|471197292|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
130880632|NCT01456039|471197293|FG000|Phase 1 (First Step)|Disease Progression|1|||
131100282|NCT02245737|471996292|FG000|Overall Study|Withdrawal by Subject|40|||
131100283|NCT02245737|471996293|FG001|Overall Study|Withdrawal by Subject|41|||
131100284|NCT02245737|471996294|FG002|Overall Study|Withdrawal by Subject|44|||
130880633|NCT01456039|471197294|FG001|Phase 1 (First Step)|Disease Progression|1|||
130880634|NCT01456039|471197295|FG002|Phase 1 (First Step)|Disease Progression|0|||
130880635|NCT01456039|471197293|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
130880636|NCT01456039|471197294|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
130880637|NCT01456039|471197295|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
131100285|NCT02245737|471996292|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
130880638|NCT01456039|471197293|FG000|Phase 1 (First Step)|Adverse Event|0|||
130880639|NCT01456039|471197294|FG001|Phase 1 (First Step)|Adverse Event|3|||
130880640|NCT01456039|471197295|FG002|Phase 1 (First Step)|Adverse Event|0|||
130880641|NCT01456039|471197293|FG000|Phase 1 (First Step)|Other|0|||
130880642|NCT01456039|471197294|FG001|Phase 1 (First Step)|Other|1|||
130880643|NCT01456039|471197295|FG002|Phase 1 (First Step)|Other|0|||
130880644|NCT01456039|471197293|FG000|Phase 2 (Second Step)|Disease Progression|0|||
130880645|NCT01456039|471197294|FG001|Phase 2 (Second Step)|Disease Progression|0|||
130880646|NCT01456039|471197295|FG002|Phase 2 (Second Step)|Disease Progression|17|||
130880647|NCT01456039|471197293|FG000|Phase 2 (Second Step)|Adverse Event|0|||
130880648|NCT01456039|471197294|FG001|Phase 2 (Second Step)|Adverse Event|0|||
130880649|NCT01456039|471197295|FG002|Phase 2 (Second Step)|Adverse Event|10|||
130880650|NCT01456039|471197293|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
130880651|NCT01456039|471197294|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
130880652|NCT01456039|471197295|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
130880653|NCT01456039|471197293|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
130880654|NCT01456039|471197294|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
130880655|NCT01456039|471197295|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
130880656|NCT01456039|471197293|FG000|Phase 2 (Second Step)|Other|0|||
130880657|NCT01456039|471197294|FG001|Phase 2 (Second Step)|Other|0|||
130880658|NCT01456039|471197295|FG002|Phase 2 (Second Step)|Other|1|||
130880659|NCT00321620|471197296|FG000|Overall Study|Death|269|||
130880660|NCT00321620|471197297|FG001|Overall Study|Death|294|||
130880661|NCT00321620|471197296|FG000|Overall Study|Withdrawal by Subject|164|||
130880662|NCT00321620|471197297|FG001|Overall Study|Withdrawal by Subject|147|||
130880663|NCT00321620|471197296|FG000|Overall Study|Disease progression|113|||
130880664|NCT00321620|471197297|FG001|Overall Study|Disease progression|117|||
130880665|NCT00321620|471197296|FG000|Overall Study|Adverse Event|43|||
130880666|NCT00321620|471197297|FG001|Overall Study|Adverse Event|56|||
130880667|NCT00321620|471197296|FG000|Overall Study|Lost to Follow-up|13|||
130880668|NCT00321620|471197297|FG001|Overall Study|Lost to Follow-up|9|||
130880669|NCT00321620|471197296|FG000|Overall Study|Physician Decision|4|||
130880670|NCT00321620|471197297|FG001|Overall Study|Physician Decision|1|||
130880671|NCT00321620|471197296|FG000|Overall Study|Noncompliance|14|||
130880672|NCT00321620|471197297|FG001|Overall Study|Noncompliance|7|||
130880673|NCT00321620|471197296|FG000|Overall Study|Protocol deviation|4|||
130880674|NCT00321620|471197297|FG001|Overall Study|Protocol deviation|3|||
130880675|NCT00321620|471197296|FG000|Overall Study|Ineligibility determined|2|||
130880676|NCT00321620|471197297|FG001|Overall Study|Ineligibility determined|3|||
130880677|NCT00321620|471197296|FG000|Overall Study|Participant request|75|||
130880678|NCT00321620|471197297|FG001|Overall Study|Participant request|52|||
130880679|NCT00321620|471197296|FG000|Overall Study|Other|42|||
130880680|NCT00321620|471197297|FG001|Overall Study|Other|33|||
130880681|NCT01462370|471197304|FG000|Overall Study|Lack of Qualifying Event|1|||
130880682|NCT01462370|471197305|FG001|Overall Study|Lack of Qualifying Event|1|||
130880683|NCT01462370|471197304|FG000|Overall Study|Physician Decision|0|||
130880684|NCT01462370|471197305|FG001|Overall Study|Physician Decision|1|||
130880685|NCT01462370|471197304|FG000|Overall Study|Withdrawal by Subject|0|||
130880686|NCT01462370|471197305|FG001|Overall Study|Withdrawal by Subject|3|||
130880687|NCT00473564|471197306|FG000|Overall Study|robot surgery aborted in OR|23|||
130880688|NCT00674817|471197307|FG000|Period 1|Withdrawal by Subject|2|||
130880689|NCT00674817|471197307|FG000|Period 1|Protocol Violation|1|||
130880690|NCT00674817|471197307|FG000|Period 3|Adverse Event|1|||
130880691|NCT00674817|471197307|FG000|Period 3|Protocol Violation|1|||
130880692|NCT00674817|471197307|FG000|Period 4|Adverse Event|1|||
130880693|NCT04385277|471197309|FG000|Overall Study|Physician Decision|2|||
130880694|NCT04385277|471197309|FG000|Overall Study|Ineligible|1|||
130880695|NCT04385277|471197309|FG000|Overall Study|Patient/Parent Refusal|2|||
130880696|NCT02903771|471197314|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
130880697|NCT02903771|471197315|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
130880698|NCT02903771|471197316|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
130880699|NCT02903771|471197317|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
130880700|NCT02903771|471197318|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
130880701|NCT02903771|471197319|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
130880702|NCT02903771|471197320|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
130880703|NCT02903771|471197314|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
130880704|NCT02903771|471197315|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
131100286|NCT02245737|471996293|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
130880705|NCT02903771|471197316|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
130880706|NCT02903771|471197317|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
130880707|NCT02903771|471197318|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
130880708|NCT02903771|471197319|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
130880709|NCT02903771|471197320|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
130880710|NCT02903771|471197314|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130880711|NCT02903771|471197315|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130880712|NCT02903771|471197316|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
130880713|NCT02903771|471197317|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130880714|NCT02903771|471197318|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130880715|NCT02903771|471197319|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
130880716|NCT02903771|471197320|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130880717|NCT02903771|471197314|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130880718|NCT02903771|471197315|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130880719|NCT02903771|471197316|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130880720|NCT02903771|471197317|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130880721|NCT02903771|471197318|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
130880722|NCT02903771|471197319|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130880723|NCT02903771|471197320|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130880724|NCT02903771|471197314|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
130880725|NCT02903771|471197315|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
130880726|NCT02903771|471197316|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
130880727|NCT02903771|471197317|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
130880728|NCT02903771|471197318|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
130880729|NCT02903771|471197319|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
130880730|NCT02903771|471197320|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
130880731|NCT02903771|471197314|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130880732|NCT02903771|471197315|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130880733|NCT02903771|471197316|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130880734|NCT02903771|471197317|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130880735|NCT02903771|471197318|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
130880736|NCT02903771|471197319|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130880737|NCT02903771|471197320|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130880738|NCT02903771|471197314|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130880739|NCT02903771|471197315|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130880740|NCT02903771|471197316|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130880741|NCT02903771|471197317|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130880742|NCT02903771|471197318|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
130880743|NCT02903771|471197319|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130880744|NCT02903771|471197320|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130880745|NCT02903771|471197314|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130880746|NCT02903771|471197315|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130880747|NCT02903771|471197316|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130880748|NCT02903771|471197317|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130880749|NCT02903771|471197318|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
130880750|NCT02903771|471197319|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130880751|NCT02903771|471197320|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130880752|NCT02903771|471197314|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130880753|NCT02903771|471197315|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130880754|NCT02903771|471197316|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130880755|NCT02903771|471197317|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130880756|NCT02903771|471197318|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
130880757|NCT02903771|471197319|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130880758|NCT02903771|471197320|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130880759|NCT02903771|471197314|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130880760|NCT02903771|471197315|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130880761|NCT02903771|471197316|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130880762|NCT02903771|471197317|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130880763|NCT02903771|471197318|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
130880764|NCT02903771|471197319|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130880765|NCT02903771|471197320|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130880766|NCT02903771|471197314|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130880767|NCT02903771|471197315|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130880768|NCT02903771|471197316|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130880769|NCT02903771|471197317|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130880770|NCT02903771|471197318|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
130880771|NCT02903771|471197319|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130880772|NCT02903771|471197320|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130880773|NCT03041038|471197344|FG000|Overall Study|Withdrawal by Subject|4|||
130880774|NCT03041038|471197345|FG001|Overall Study|Withdrawal by Subject|0|||
130880775|NCT03041038|471197344|FG000|Overall Study|Lost to Follow-up|1|||
130880776|NCT03041038|471197345|FG001|Overall Study|Lost to Follow-up|1|||
130880777|NCT03041038|471197344|FG000|Overall Study|Protocol Violation|1|||
130880778|NCT03041038|471197345|FG001|Overall Study|Protocol Violation|1|||
130880779|NCT03331315|471197346|FG000|Overall Study|Physician Decision|18|||
130880780|NCT03331315|471197347|FG001|Overall Study|Physician Decision|14|||
130880781|NCT01709721|471197348|FG000|Open Label Phase|Withdrawal by Subject|0|||
130880782|NCT01709721|471197349|FG001|Open Label Phase|Withdrawal by Subject|0|||
130880783|NCT01709721|471197350|FG002|Open Label Phase|Withdrawal by Subject|5|||
130880784|NCT01709721|471197348|FG000|Open Label Phase|Adverse Event|0|||
130880785|NCT01709721|471197349|FG001|Open Label Phase|Adverse Event|0|||
130880786|NCT01709721|471197350|FG002|Open Label Phase|Adverse Event|8|||
130880787|NCT01709721|471197348|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
130880788|NCT01709721|471197349|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
130880789|NCT01709721|471197350|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
130880790|NCT01709721|471197348|FG000|Open Label Phase|Investigator Decision|0|||
130880791|NCT01709721|471197349|FG001|Open Label Phase|Investigator Decision|0|||
130880792|NCT01709721|471197350|FG002|Open Label Phase|Investigator Decision|1|||
130880793|NCT01709721|471197348|FG000|Open Label Phase|Sponsor Decision|0|||
130880794|NCT01709721|471197349|FG001|Open Label Phase|Sponsor Decision|0|||
130880795|NCT01709721|471197350|FG002|Open Label Phase|Sponsor Decision|2|||
130880796|NCT01709721|471197348|FG000|Open Label Phase|Protocol Violation|0|||
130880797|NCT01709721|471197349|FG001|Open Label Phase|Protocol Violation|0|||
130880798|NCT01709721|471197350|FG002|Open Label Phase|Protocol Violation|1|||
130880799|NCT01709721|471197348|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
130880800|NCT01709721|471197349|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
130880801|NCT01709721|471197350|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
130880802|NCT01709721|471197348|FG000|Open Label Phase|Inadequate Pain Control|0|||
130880803|NCT01709721|471197349|FG001|Open Label Phase|Inadequate Pain Control|0|||
130880804|NCT01709721|471197350|FG002|Open Label Phase|Inadequate Pain Control|37|||
130880805|NCT01709721|471197348|FG000|Open Label Phase|Other, Specify in text field in database|0|||
130880806|NCT01709721|471197349|FG001|Open Label Phase|Other, Specify in text field in database|0|||
130880807|NCT01709721|471197350|FG002|Open Label Phase|Other, Specify in text field in database|14|||
130880808|NCT01709721|471197348|FG000|Randomized Phase|Adverse Event|0|||
130880809|NCT01709721|471197349|FG001|Randomized Phase|Adverse Event|1|||
130880810|NCT01709721|471197350|FG002|Randomized Phase|Adverse Event|0|||
130880811|NCT01709721|471197348|FG000|Randomized Phase|Lost to Follow-up|1|||
130880812|NCT01709721|471197349|FG001|Randomized Phase|Lost to Follow-up|0|||
130880813|NCT01709721|471197350|FG002|Randomized Phase|Lost to Follow-up|0|||
130880814|NCT01709721|471197348|FG000|Randomized Phase|Inadequate Pain Control|1|||
130880815|NCT01709721|471197349|FG001|Randomized Phase|Inadequate Pain Control|2|||
130880816|NCT01709721|471197350|FG002|Randomized Phase|Inadequate Pain Control|0|||
130880817|NCT01709721|471197348|FG000|Randomized Phase|Other, Specify text field in database|1|||
130880818|NCT01709721|471197349|FG001|Randomized Phase|Other, Specify text field in database|3|||
130880819|NCT01709721|471197350|FG002|Randomized Phase|Other, Specify text field in database|0|||
130880820|NCT00360230|471197353|FG000|Overall Study|Withdrawal by Subject|1|||
130880821|NCT00360230|471197354|FG001|Overall Study|Withdrawal by Subject|1|||
130880822|NCT00360230|471197355|FG002|Overall Study|Withdrawal by Subject|0|||
130880823|NCT00360230|471197356|FG003|Overall Study|Withdrawal by Subject|1|||
130880824|NCT00360230|471197357|FG004|Overall Study|Withdrawal by Subject|1|||
130880825|NCT00360230|471197358|FG005|Overall Study|Withdrawal by Subject|1|||
130880826|NCT00360230|471197359|FG006|Overall Study|Withdrawal by Subject|0|||
130880827|NCT00360230|471197353|FG000|Overall Study|Migrated|4|||
130880828|NCT00360230|471197354|FG001|Overall Study|Migrated|1|||
130880829|NCT00360230|471197355|FG002|Overall Study|Migrated|3|||
130880830|NCT00360230|471197356|FG003|Overall Study|Migrated|1|||
130880831|NCT00360230|471197357|FG004|Overall Study|Migrated|4|||
130880832|NCT00360230|471197358|FG005|Overall Study|Migrated|1|||
130880833|NCT00360230|471197359|FG006|Overall Study|Migrated|1|||
130880834|NCT00360230|471197353|FG000|Overall Study|Other|1|||
130880835|NCT00360230|471197354|FG001|Overall Study|Other|0|||
130880836|NCT00360230|471197355|FG002|Overall Study|Other|0|||
130880837|NCT00360230|471197356|FG003|Overall Study|Other|0|||
130880838|NCT00360230|471197357|FG004|Overall Study|Other|0|||
130880839|NCT00360230|471197358|FG005|Overall Study|Other|0|||
130880840|NCT00360230|471197359|FG006|Overall Study|Other|0|||
130880841|NCT00360230|471197353|FG000|Overall Study|Protocol Violation|0|||
130880842|NCT00360230|471197354|FG001|Overall Study|Protocol Violation|0|||
130880843|NCT00360230|471197355|FG002|Overall Study|Protocol Violation|0|||
130880844|NCT00360230|471197356|FG003|Overall Study|Protocol Violation|0|||
130880845|NCT00360230|471197357|FG004|Overall Study|Protocol Violation|0|||
130880846|NCT00360230|471197358|FG005|Overall Study|Protocol Violation|1|||
130880847|NCT00360230|471197359|FG006|Overall Study|Protocol Violation|0|||
130880848|NCT00360230|471197353|FG000|Overall Study|Death|0|||
130880849|NCT00360230|471197354|FG001|Overall Study|Death|1|||
130880850|NCT00360230|471197355|FG002|Overall Study|Death|0|||
130880851|NCT00360230|471197356|FG003|Overall Study|Death|0|||
130880852|NCT00360230|471197357|FG004|Overall Study|Death|0|||
130880853|NCT00360230|471197358|FG005|Overall Study|Death|1|||
130990520|NCT00098254|471593177|FG000|Overall Study|Death|1|||
130880854|NCT00360230|471197359|FG006|Overall Study|Death|1|||
130880855|NCT00581308|471197360|FG000|Pre Discharge|Lost to Follow-up|1|||
130880856|NCT00581308|471197360|FG000|Pre Discharge|Device Removed|1|||
130880857|NCT00581308|471197360|FG000|Month 1|Lost to Follow-up|3|||
130880858|NCT00581308|471197360|FG000|Month 1|Withdrawal by Subject|2|||
130880859|NCT00581308|471197360|FG000|Month 1|Device Removed|2|||
130880860|NCT00581308|471197360|FG000|Month 1|Uknown|1|||
130880861|NCT00581308|471197360|FG000|Month 6|Lost to Follow-up|1|||
130880862|NCT00581308|471197360|FG000|Month 6|Withdrawal by Subject|2|||
130880863|NCT00581308|471197360|FG000|Month 12|Death|1|||
130880864|NCT00581308|471197360|FG000|Month 12|Lost to Follow-up|14|||
130880865|NCT00581308|471197360|FG000|Month 12|Withdrawal by Subject|3|||
130880866|NCT00581308|471197360|FG000|Month 12|Device Removed|1|||
130880867|NCT00581308|471197360|FG000|Month 12|Other|1|||
130880868|NCT03219723|471197361|FG000|Overall Study|Case Report Forms Uncollected|6|||
130880869|NCT03219723|471197361|FG000|Overall Study|Protocol Deviation|4|||
130880870|NCT00459316|471197362|FG000|Steps 1 & 2|Other eligibility failure|1|||
130880871|NCT00459316|471197363|FG001|Steps 1 & 2|Other eligibility failure|1|||
130880872|NCT00459316|471197364|FG002|Steps 1 & 2|Other eligibility failure|0|||
130880873|NCT00459316|471197362|FG000|Steps 1 & 2|Death|1|||
130880874|NCT00459316|471197363|FG001|Steps 1 & 2|Death|1|||
130880875|NCT00459316|471197364|FG002|Steps 1 & 2|Death|0|||
130880876|NCT00459316|471197362|FG000|Steps 1 & 2|Not able to get to clinic|7|||
130880877|NCT00459316|471197363|FG001|Steps 1 & 2|Not able to get to clinic|4|||
130880878|NCT00459316|471197364|FG002|Steps 1 & 2|Not able to get to clinic|0|||
130880879|NCT00459316|471197362|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
130880880|NCT00459316|471197363|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
130880881|NCT00459316|471197364|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
130880882|NCT00459316|471197362|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
130880883|NCT00459316|471197363|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
130880884|NCT00459316|471197364|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
130880885|NCT00459316|471197362|FG000|Steps 1 & 2|Lost to Follow-up|5|||
130880886|NCT00459316|471197363|FG001|Steps 1 & 2|Lost to Follow-up|0|||
130880887|NCT00459316|471197364|FG002|Steps 1 & 2|Lost to Follow-up|2|||
130880888|NCT00459316|471197362|FG000|Step 3|Withdrawal by Subject|3|||
130880889|NCT00459316|471197363|FG001|Step 3|Withdrawal by Subject|0|||
130880890|NCT00459316|471197364|FG002|Step 3|Withdrawal by Subject|1|||
130880891|NCT01614886|471197365|FG000|Overall Study|Adverse Event|15|||
130880892|NCT01614886|471197366|FG001|Overall Study|Adverse Event|20|||
130880893|NCT01614886|471197365|FG000|Overall Study|Withdrawal by Subject|4|||
130880894|NCT01614886|471197366|FG001|Overall Study|Withdrawal by Subject|4|||
130880895|NCT01614886|471197365|FG000|Overall Study|Death|1|||
130880896|NCT01614886|471197366|FG001|Overall Study|Death|0|||
130880897|NCT01614886|471197365|FG000|Overall Study|Protocol deviation|0|||
130880898|NCT01614886|471197366|FG001|Overall Study|Protocol deviation|2|||
130880899|NCT01527370|471197368|FG000|Overall Study|Withdrawal by Subject|4|||
130880900|NCT01527370|471197368|FG000|Overall Study|Physician Decision|1|||
130880901|NCT01527370|471197368|FG000|Overall Study|Death|1|||
130880902|NCT02057250|471197371|FG000|AID Assessment Phase|Adverse Event|3|||
130880903|NCT02057250|471197372|FG001|AID Assessment Phase|Adverse Event|2|||
130880904|NCT02057250|471197373|FG002|AID Assessment Phase|Adverse Event|6|||
130880905|NCT02057250|471197374|FG003|AID Assessment Phase|Adverse Event|1|||
130880906|NCT02057250|471197375|FG004|AID Assessment Phase|Adverse Event|0|||
130880907|NCT02057250|471197371|FG000|AID Assessment Phase|Other than specified above|1|||
130880908|NCT02057250|471197372|FG001|AID Assessment Phase|Other than specified above|1|||
130880909|NCT02057250|471197373|FG002|AID Assessment Phase|Other than specified above|1|||
130880910|NCT02057250|471197374|FG003|AID Assessment Phase|Other than specified above|1|||
130880911|NCT02057250|471197375|FG004|AID Assessment Phase|Other than specified above|0|||
130880912|NCT02057250|471197371|FG000|Extension Phase|Adverse Event|0|||
130880913|NCT02057250|471197372|FG001|Extension Phase|Adverse Event|0|||
130880914|NCT02057250|471197373|FG002|Extension Phase|Adverse Event|0|||
130880915|NCT02057250|471197374|FG003|Extension Phase|Adverse Event|0|||
130880916|NCT02057250|471197375|FG004|Extension Phase|Adverse Event|15|||
130880917|NCT02057250|471197371|FG000|Extension Phase|Lack of Efficacy|0|||
130880918|NCT02057250|471197372|FG001|Extension Phase|Lack of Efficacy|0|||
130880919|NCT02057250|471197373|FG002|Extension Phase|Lack of Efficacy|0|||
130880920|NCT02057250|471197374|FG003|Extension Phase|Lack of Efficacy|0|||
130880921|NCT02057250|471197375|FG004|Extension Phase|Lack of Efficacy|10|||
130880922|NCT02057250|471197371|FG000|Extension Phase|Entered in this period but not treated|0|||
130880923|NCT02057250|471197372|FG001|Extension Phase|Entered in this period but not treated|0|||
130880924|NCT02057250|471197373|FG002|Extension Phase|Entered in this period but not treated|0|||
130880925|NCT02057250|471197374|FG003|Extension Phase|Entered in this period but not treated|0|||
130880926|NCT02057250|471197375|FG004|Extension Phase|Entered in this period but not treated|4|||
130880927|NCT02057250|471197371|FG000|Extension Phase|Other than specified above|0|||
130880928|NCT02057250|471197372|FG001|Extension Phase|Other than specified above|0|||
130880929|NCT02057250|471197373|FG002|Extension Phase|Other than specified above|0|||
130880930|NCT02057250|471197374|FG003|Extension Phase|Other than specified above|0|||
130880931|NCT02057250|471197375|FG004|Extension Phase|Other than specified above|7|||
130880932|NCT01435382|471197377|FG000|Overall Study|Lost to Follow-up|1|||
130880933|NCT01435382|471197378|FG001|Overall Study|Lost to Follow-up|0|||
130880934|NCT01435382|471197379|FG002|Overall Study|Lost to Follow-up|1|||
130880935|NCT01435382|471197380|FG003|Overall Study|Lost to Follow-up|0|||
130880936|NCT01435382|471197377|FG000|Overall Study|Withdrawal by Subject|0|||
130880937|NCT01435382|471197378|FG001|Overall Study|Withdrawal by Subject|2|||
130880938|NCT01435382|471197379|FG002|Overall Study|Withdrawal by Subject|0|||
130880939|NCT01435382|471197380|FG003|Overall Study|Withdrawal by Subject|1|||
130880940|NCT02435992|471197381|FG000|Overall Study|non compliance with protocol|2|||
130880941|NCT02435992|471197382|FG001|Overall Study|non compliance with protocol|0|||
130880942|NCT02435992|471197383|FG002|Overall Study|non compliance with protocol|1|||
130880943|NCT02435992|471197384|FG003|Overall Study|non compliance with protocol|0|||
130880944|NCT02435992|471197385|FG004|Overall Study|non compliance with protocol|0|||
130880945|NCT02435992|471197381|FG000|Overall Study|Adverse Event|11|||
130880946|NCT02435992|471197382|FG001|Overall Study|Adverse Event|6|||
130880947|NCT02435992|471197383|FG002|Overall Study|Adverse Event|12|||
130880948|NCT02435992|471197384|FG003|Overall Study|Adverse Event|0|||
130880949|NCT02435992|471197385|FG004|Overall Study|Adverse Event|0|||
130880950|NCT02435992|471197381|FG000|Overall Study|Lack of Efficacy|4|||
130880951|NCT02435992|471197382|FG001|Overall Study|Lack of Efficacy|10|||
130880952|NCT02435992|471197383|FG002|Overall Study|Lack of Efficacy|9|||
130880953|NCT02435992|471197384|FG003|Overall Study|Lack of Efficacy|0|||
130880954|NCT02435992|471197385|FG004|Overall Study|Lack of Efficacy|0|||
130880955|NCT02435992|471197381|FG000|Overall Study|Withdrawal by Subject|10|||
130880956|NCT02435992|471197382|FG001|Overall Study|Withdrawal by Subject|8|||
130880957|NCT02435992|471197383|FG002|Overall Study|Withdrawal by Subject|20|||
130880958|NCT02435992|471197384|FG003|Overall Study|Withdrawal by Subject|0|||
130880959|NCT02435992|471197385|FG004|Overall Study|Withdrawal by Subject|0|||
130880960|NCT02435992|471197381|FG000|Overall Study|Other Reason|1|||
130880961|NCT02435992|471197382|FG001|Overall Study|Other Reason|0|||
130880962|NCT02435992|471197383|FG002|Overall Study|Other Reason|0|||
130880963|NCT02435992|471197384|FG003|Overall Study|Other Reason|0|||
130880964|NCT02435992|471197385|FG004|Overall Study|Other Reason|0|||
130880965|NCT02435992|471197381|FG000|Overall Study|Physician Decision|0|||
130880966|NCT02435992|471197382|FG001|Overall Study|Physician Decision|0|||
130880967|NCT02435992|471197383|FG002|Overall Study|Physician Decision|1|||
130880968|NCT02435992|471197384|FG003|Overall Study|Physician Decision|0|||
130880969|NCT02435992|471197385|FG004|Overall Study|Physician Decision|0|||
130880970|NCT00260533|471197386|FG000|Overall Study|Other|3|||
130880971|NCT00260533|471197387|FG001|Overall Study|Other|3|||
130880972|NCT01761877|471197388|FG000|Overall Study|Adverse Event|7|||
130880973|NCT01761877|471197389|FG001|Overall Study|Adverse Event|0|||
130880974|NCT01761877|471197388|FG000|Overall Study|Withdrawal by Subject|6|||
130880975|NCT01761877|471197389|FG001|Overall Study|Withdrawal by Subject|4|||
130880976|NCT01761877|471197388|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
130880977|NCT01761877|471197389|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
130880978|NCT01761877|471197388|FG000|Overall Study|Death|0|||
130880979|NCT01761877|471197389|FG001|Overall Study|Death|1|||
130880980|NCT01761877|471197388|FG000|Overall Study|MRI intolerant|1|||
130880981|NCT01761877|471197389|FG001|Overall Study|MRI intolerant|6|||
130880982|NCT01310777|471197391|FG000|Overall Study|Adverse Event|23|||
130880983|NCT01310777|471197392|FG001|Overall Study|Adverse Event|1|||
130880984|NCT01310777|471197393|FG002|Overall Study|Adverse Event|15|||
130880985|NCT01310777|471197391|FG000|Overall Study|Lost to Follow-up|0|||
130880986|NCT01310777|471197392|FG001|Overall Study|Lost to Follow-up|4|||
130880987|NCT01310777|471197393|FG002|Overall Study|Lost to Follow-up|1|||
130880988|NCT01310777|471197391|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
130880989|NCT01310777|471197392|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
130880990|NCT01310777|471197393|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
130880991|NCT01310777|471197391|FG000|Overall Study|Inadequate Control of IOP|5|||
130880992|NCT01310777|471197392|FG001|Overall Study|Inadequate Control of IOP|7|||
130880993|NCT01310777|471197393|FG002|Overall Study|Inadequate Control of IOP|10|||
130880994|NCT01310777|471197391|FG000|Overall Study|Other|4|||
130880995|NCT01310777|471197392|FG001|Overall Study|Other|1|||
130880996|NCT01310777|471197393|FG002|Overall Study|Other|2|||
130880997|NCT03697252|471197394|FG000|Overall Study|Adverse Event|3|||
130880998|NCT03697252|471197395|FG001|Overall Study|Adverse Event|2|||
130880999|NCT03697252|471197394|FG000|Overall Study|Withdrawal by Subject|14|||
130881000|NCT03697252|471197395|FG001|Overall Study|Withdrawal by Subject|14|||
131100287|NCT02245737|471996294|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
131100288|NCT02245737|471996292|FG000|Overall Study|Sponsor Decision|445|||
131100289|NCT02245737|471996293|FG001|Overall Study|Sponsor Decision|430|||
131100290|NCT02245737|471996294|FG002|Overall Study|Sponsor Decision|432|||
131100291|NCT02366468|471996296|FG000|Overall Study|Adverse Event|2|||
130881001|NCT03697252|471197394|FG000|Overall Study|Lost to Follow-up|0|||
130881002|NCT03697252|471197395|FG001|Overall Study|Lost to Follow-up|1|||
130881003|NCT03697252|471197394|FG000|Overall Study|Physician Decision|1|||
130881004|NCT03697252|471197395|FG001|Overall Study|Physician Decision|1|||
130881005|NCT03697252|471197394|FG000|Overall Study|Other|0|||
130881006|NCT03697252|471197395|FG001|Overall Study|Other|1|||
130881007|NCT02461758|471197396|FG000|Overall Study|Lost to Follow-up|0|||
130881008|NCT02461758|471197397|FG001|Overall Study|Lost to Follow-up|1|||
130881009|NCT02461758|471197398|FG002|Overall Study|Lost to Follow-up|1|||
130881010|NCT02461758|471197399|FG003|Overall Study|Lost to Follow-up|0|||
130881011|NCT02738801|471197412|FG000|Overall Study|Adverse Event|1|||
130881012|NCT02738801|471197413|FG001|Overall Study|Adverse Event|1|||
130881013|NCT02738801|471197412|FG000|Overall Study|Withdrawal by Subject|0|||
130881014|NCT02738801|471197413|FG001|Overall Study|Withdrawal by Subject|1|||
130881015|NCT00888134|471197429|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
130881016|NCT00888134|471197429|FG000|Follow-up|being followed for long-term survival|1|||
130881017|NCT01506596|471197433|FG000|Overall Study|ineligible pathology|1|||
130881018|NCT00888173|471197434|FG000|Overall Study|Wrong Primary|1|||
130881019|NCT00888173|471197434|FG000|Overall Study|Ineligible: required test not done|1|||
130881020|NCT01488890|471197437|FG000|Overall Study|Serious adverse event|2|||
130881021|NCT01488890|471197438|FG001|Overall Study|Serious adverse event|0|||
130881022|NCT01488890|471197439|FG002|Overall Study|Serious adverse event|0|||
130881023|NCT01488890|471197440|FG003|Overall Study|Serious adverse event|0|||
130881024|NCT01488890|471197437|FG000|Overall Study|Protocol Violation|3|||
130881025|NCT01488890|471197438|FG001|Overall Study|Protocol Violation|0|||
130881026|NCT01488890|471197439|FG002|Overall Study|Protocol Violation|4|||
130881027|NCT01488890|471197440|FG003|Overall Study|Protocol Violation|0|||
130881028|NCT01488890|471197437|FG000|Overall Study|Lost to Follow-up|13|||
130881029|NCT01488890|471197438|FG001|Overall Study|Lost to Follow-up|10|||
130881030|NCT01488890|471197439|FG002|Overall Study|Lost to Follow-up|20|||
130881031|NCT01488890|471197440|FG003|Overall Study|Lost to Follow-up|3|||
130881032|NCT01488890|471197437|FG000|Overall Study|Withdrawal by Subject|14|||
130881033|NCT01488890|471197438|FG001|Overall Study|Withdrawal by Subject|10|||
130881034|NCT01488890|471197439|FG002|Overall Study|Withdrawal by Subject|11|||
130881035|NCT01488890|471197440|FG003|Overall Study|Withdrawal by Subject|2|||
130881036|NCT05712460|471197441|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881037|NCT05712460|471197442|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881038|NCT05712460|471197443|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881039|NCT05712460|471197444|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881040|NCT05712460|471197445|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881041|NCT05712460|471197446|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881042|NCT05712460|471197447|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881043|NCT05712460|471197448|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
130881044|NCT05712460|471197449|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881045|NCT05712460|471197450|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881046|NCT05712460|471197451|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881047|NCT05712460|471197452|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130881048|NCT00829426|471197457|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130881049|NCT00829426|471197458|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
131100292|NCT02366468|471996297|FG001|Overall Study|Adverse Event|0|||
131100293|NCT02366468|471996296|FG000|Overall Study|Withdrawal by Subject|1|||
131100294|NCT02366468|471996297|FG001|Overall Study|Withdrawal by Subject|5|||
131100295|NCT02366468|471996296|FG000|Overall Study|Lost to Follow-up|2|||
130881054|NCT00651742|471197474|FG000|Overall Study|Objective Disease Progression|22|||
130881055|NCT00651742|471197474|FG000|Overall Study|Toxicity|3|||
130881056|NCT00651742|471197474|FG000|Overall Study|Investigator Judgment|1|||
130881057|NCT00651742|471197474|FG000|Overall Study|Withdrawal of Consent|1|||
130881058|NCT00651742|471197474|FG000|Overall Study|Enrolled but not treated|1|||
130881059|NCT04050553|471197475|FG000|Period 1|Physician Decision|2|||
130881060|NCT04050553|471197476|FG001|Period 1|Physician Decision|2|||
130881061|NCT04050553|471197475|FG000|Period 1|Adverse Event|1|||
130881062|NCT04050553|471197476|FG001|Period 1|Adverse Event|1|||
130881063|NCT04050553|471197475|FG000|Period 1|Withdrawal by Subject|0|||
130881064|NCT04050553|471197476|FG001|Period 1|Withdrawal by Subject|1|||
130881065|NCT04050553|471197475|FG000|Wash-out|Adverse Event|0|||
130881066|NCT04050553|471197476|FG001|Wash-out|Adverse Event|1|||
130881067|NCT04050553|471197475|FG000|Wash-out|Withdrawal by Subject|0|||
130881068|NCT04050553|471197476|FG001|Wash-out|Withdrawal by Subject|1|||
130881069|NCT05523089|471197477|FG000|Overall Study|Withdrawal by Subject|1|||
130881070|NCT05523089|471197478|FG001|Overall Study|Withdrawal by Subject|0|||
130881071|NCT05523089|471197479|FG002|Overall Study|Withdrawal by Subject|0|||
130881072|NCT05523089|471197477|FG000|Overall Study|Lost to Follow-up|1|||
130881073|NCT05523089|471197478|FG001|Overall Study|Lost to Follow-up|0|||
130881074|NCT05523089|471197479|FG002|Overall Study|Lost to Follow-up|0|||
130881075|NCT02681523|471197480|FG000|Overall Study|Adverse Event|1|||
130881076|NCT02681523|471197480|FG000|Overall Study|Patient Non-compliance|1|||
130881077|NCT03204188|471197485|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
130881078|NCT03204188|471197485|FG000|Immunotherapy Phase (1 Year)|Death|1|||
130881079|NCT03204188|471197485|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
130881080|NCT03204188|471197485|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
130881081|NCT01520506|471199348|FG000|Overall Study|Missed Visit|4|||
130881082|NCT01520506|471199348|FG000|Overall Study|Lost to Follow-up|1|||
131100296|NCT02366468|471996297|FG001|Overall Study|Lost to Follow-up|0|||
130881083|NCT01520506|471199348|FG000|Overall Study|Withdrawal by Subject|1|||
130881084|NCT00425269|471199349|FG000|Overall Study|Pregnancy|5|||
130881085|NCT00425269|471199350|FG001|Overall Study|Pregnancy|7|||
130881086|NCT00425269|471199349|FG000|Overall Study|Lost to Follow-up|9|||
130881087|NCT00425269|471199350|FG001|Overall Study|Lost to Follow-up|9|||
130881088|NCT00425269|471199349|FG000|Overall Study|moved or medical reason|5|||
130881089|NCT00425269|471199350|FG001|Overall Study|moved or medical reason|4|||
130881090|NCT01084655|471199355|FG000|Overall Study|Radiographic disease progression|3|||
130881091|NCT01084655|471199356|FG001|Overall Study|Radiographic disease progression|2|||
130881092|NCT01084655|471199357|FG002|Overall Study|Radiographic disease progression|8|||
130881093|NCT01084655|471199355|FG000|Overall Study|Withdrawal by Subject|1|||
130881094|NCT01084655|471199356|FG001|Overall Study|Withdrawal by Subject|0|||
130881095|NCT01084655|471199357|FG002|Overall Study|Withdrawal by Subject|4|||
130881096|NCT01084655|471199355|FG000|Overall Study|Adverse Event|2|||
130881097|NCT01084655|471199356|FG001|Overall Study|Adverse Event|1|||
130881098|NCT01084655|471199357|FG002|Overall Study|Adverse Event|2|||
130881099|NCT01084655|471199355|FG000|Overall Study|Other|0|||
130881100|NCT01084655|471199356|FG001|Overall Study|Other|3|||
130881101|NCT01084655|471199357|FG002|Overall Study|Other|2|||
130881102|NCT01084655|471199355|FG000|Overall Study|Symptomatic deterioration|0|||
130881103|NCT01084655|471199356|FG001|Overall Study|Symptomatic deterioration|0|||
130881104|NCT01084655|471199357|FG002|Overall Study|Symptomatic deterioration|2|||
130881105|NCT01084655|471199355|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
130881106|NCT01084655|471199356|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
130881107|NCT01084655|471199357|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
130881108|NCT00335777|471199359|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
130881109|NCT00335777|471199359|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
130881110|NCT00335777|471199359|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
130881111|NCT00335777|471199359|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
130881112|NCT00335777|471199359|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
130881113|NCT00535496|471199360|FG000|Overall Study|Lost to Follow-up|0|||
130881114|NCT00535496|471199361|FG001|Overall Study|Lost to Follow-up|1|||
130881115|NCT00535496|471199362|FG002|Overall Study|Lost to Follow-up|0|||
130881116|NCT00535496|471199363|FG003|Overall Study|Lost to Follow-up|0|||
130881117|NCT00535496|471199360|FG000|Overall Study|Not treated with sugammadex|0|||
130881118|NCT00535496|471199361|FG001|Overall Study|Not treated with sugammadex|1|||
130881119|NCT00535496|471199362|FG002|Overall Study|Not treated with sugammadex|0|||
130881120|NCT00535496|471199363|FG003|Overall Study|Not treated with sugammadex|0|||
130881121|NCT02326155|471199364|FG000|Overall Study|Adverse Event|21|||
130881122|NCT02326155|471199365|FG001|Overall Study|Adverse Event|5|||
130881123|NCT02326155|471199364|FG000|Overall Study|Death|3|||
130881124|NCT02326155|471199365|FG001|Overall Study|Death|0|||
130881125|NCT02326155|471199364|FG000|Overall Study|Lack of Efficacy|49|||
130881126|NCT02326155|471199365|FG001|Overall Study|Lack of Efficacy|5|||
130881127|NCT02326155|471199364|FG000|Overall Study|Lost to Follow-up|14|||
130881128|NCT02326155|471199365|FG001|Overall Study|Lost to Follow-up|3|||
130881129|NCT02326155|471199364|FG000|Overall Study|Protocol Violation|2|||
130881130|NCT02326155|471199365|FG001|Overall Study|Protocol Violation|0|||
130881131|NCT02326155|471199364|FG000|Overall Study|Withdrawal by Subject|34|||
130881132|NCT02326155|471199365|FG001|Overall Study|Withdrawal by Subject|11|||
130881133|NCT02326155|471199364|FG000|Overall Study|Disease progression|37|||
130881134|NCT02326155|471199365|FG001|Overall Study|Disease progression|4|||
130881135|NCT02326155|471199364|FG000|Overall Study|Study close|188|||
130881136|NCT02326155|471199365|FG001|Overall Study|Study close|21|||
130881137|NCT02326155|471199364|FG000|Overall Study|except for study close|46|||
130881138|NCT02326155|471199365|FG001|Overall Study|except for study close|13|||
130881139|NCT05024032|471199366|FG000|Overall Study|Withdrawal by Subject|0|||
130881140|NCT05024032|471199367|FG001|Overall Study|Withdrawal by Subject|3|||
130881141|NCT05024032|471199368|FG002|Overall Study|Withdrawal by Subject|4|||
130881142|NCT05024032|471199366|FG000|Overall Study|Adverse Event|0|||
130881143|NCT05024032|471199367|FG001|Overall Study|Adverse Event|1|||
130881144|NCT05024032|471199368|FG002|Overall Study|Adverse Event|0|||
130881145|NCT05024032|471199366|FG000|Overall Study|Protocol Deviation|1|||
130881146|NCT05024032|471199367|FG001|Overall Study|Protocol Deviation|0|||
130881147|NCT05024032|471199368|FG002|Overall Study|Protocol Deviation|0|||
130881148|NCT00371150|471199373|FG000|Overall Study|Lost to Follow-up|3|||
130881149|NCT00371150|471199374|FG001|Overall Study|Lost to Follow-up|2|||
130881150|NCT03714672|471199375|FG000|Overall Study|Adverse Event|0|||
130881151|NCT03714672|471199376|FG001|Overall Study|Adverse Event|0|||
130881152|NCT03714672|471199377|FG002|Overall Study|Adverse Event|3|||
130881153|NCT03714672|471199378|FG003|Overall Study|Adverse Event|0|||
130881154|NCT03714672|471199375|FG000|Overall Study|Physician Decision|0|||
130881155|NCT03714672|471199376|FG001|Overall Study|Physician Decision|1|||
130881156|NCT03714672|471199377|FG002|Overall Study|Physician Decision|0|||
130881157|NCT03714672|471199378|FG003|Overall Study|Physician Decision|0|||
130881158|NCT03714672|471199375|FG000|Overall Study|Other Reason|1|||
130881159|NCT03714672|471199376|FG001|Overall Study|Other Reason|2|||
130881160|NCT03714672|471199377|FG002|Overall Study|Other Reason|1|||
130881161|NCT03714672|471199378|FG003|Overall Study|Other Reason|1|||
130881162|NCT03714672|471199375|FG000|Overall Study|Lost to Follow-up|1|||
130881163|NCT03714672|471199376|FG001|Overall Study|Lost to Follow-up|1|||
130881164|NCT03714672|471199377|FG002|Overall Study|Lost to Follow-up|0|||
130881165|NCT03714672|471199378|FG003|Overall Study|Lost to Follow-up|0|||
130881166|NCT02345070|471199379|FG000|Overall Study|Adverse Event|12|||
130881167|NCT02345070|471199380|FG001|Overall Study|Adverse Event|8|||
130881168|NCT02345070|471199381|FG002|Overall Study|Adverse Event|16|||
130881169|NCT02345070|471199379|FG000|Overall Study|Poor compliance to protocol|2|||
130881170|NCT02345070|471199380|FG001|Overall Study|Poor compliance to protocol|0|||
130881171|NCT02345070|471199381|FG002|Overall Study|Poor compliance to protocol|0|||
130881172|NCT02345070|471199379|FG000|Overall Study|Other than specified above|6|||
130881173|NCT02345070|471199380|FG001|Overall Study|Other than specified above|3|||
130881174|NCT02345070|471199381|FG002|Overall Study|Other than specified above|7|||
130881175|NCT00124943|471199384|FG000|Phase II|Adverse Event|0|||
130881176|NCT00124943|471199385|FG001|Phase II|Adverse Event|2|||
130881177|NCT00124943|471199386|FG002|Phase II|Adverse Event|0|||
130881178|NCT00124943|471199387|FG003|Phase II|Adverse Event|1|||
130881179|NCT00124943|471199384|FG000|Phase II|Protocol Violation|0|||
130881180|NCT00124943|471199385|FG001|Phase II|Protocol Violation|0|||
130881181|NCT00124943|471199386|FG002|Phase II|Protocol Violation|0|||
130881182|NCT00124943|471199387|FG003|Phase II|Protocol Violation|1|||
130881183|NCT00124943|471199384|FG000|Phase II|Lost to Follow-up|0|||
130881184|NCT00124943|471199385|FG001|Phase II|Lost to Follow-up|0|||
130881185|NCT00124943|471199386|FG002|Phase II|Lost to Follow-up|0|||
130881186|NCT00124943|471199387|FG003|Phase II|Lost to Follow-up|1|||
130881187|NCT00124943|471199384|FG000|Phase II|Withdrawal by Subject|0|||
130881188|NCT00124943|471199385|FG001|Phase II|Withdrawal by Subject|0|||
130881189|NCT00124943|471199386|FG002|Phase II|Withdrawal by Subject|0|||
130881190|NCT00124943|471199387|FG003|Phase II|Withdrawal by Subject|2|||
130881191|NCT03304626|471199390|FG000|Overall Study|Adverse Event|1|||
130881192|NCT03304626|471199391|FG001|Overall Study|Adverse Event|0|||
130881193|NCT03304626|471199390|FG000|Overall Study|Lack of Efficacy|1|||
130881194|NCT03304626|471199391|FG001|Overall Study|Lack of Efficacy|1|||
130881195|NCT02379728|471199392|FG000|Overall Study|Lost to Follow-up|1|||
130881196|NCT02379728|471199393|FG001|Overall Study|Lost to Follow-up|0|||
130881197|NCT02379728|471199394|FG002|Overall Study|Lost to Follow-up|3|||
130881198|NCT02379728|471199395|FG003|Overall Study|Lost to Follow-up|0|||
130881199|NCT02379728|471199392|FG000|Overall Study|Withdrawal by Subject|5|||
130881200|NCT02379728|471199393|FG001|Overall Study|Withdrawal by Subject|0|||
130881201|NCT02379728|471199394|FG002|Overall Study|Withdrawal by Subject|5|||
130881202|NCT02379728|471199395|FG003|Overall Study|Withdrawal by Subject|3|||
130881203|NCT02379728|471199392|FG000|Overall Study|Protocol Violation|0|||
130881204|NCT02379728|471199393|FG001|Overall Study|Protocol Violation|0|||
130881205|NCT02379728|471199394|FG002|Overall Study|Protocol Violation|2|||
130881206|NCT02379728|471199395|FG003|Overall Study|Protocol Violation|0|||
130881207|NCT05101122|471199396|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
130881208|NCT05101122|471199396|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
130881209|NCT05101122|471199396|FG000|AD313 80/5|Withdrawal by Subject|1|||
130881210|NCT05101122|471199396|FG000|AD313 80/10|Physician Decision|1|||
130881211|NCT04945733|471199399|FG000|Overall Study|Physician Decision|1|||
130881212|NCT04945733|471199400|FG001|Overall Study|Physician Decision|3|||
130881213|NCT04945733|471199401|FG002|Overall Study|Physician Decision|0|||
130881214|NCT04945733|471199399|FG000|Overall Study|Withdrawal by Subject|3|||
130881215|NCT04945733|471199400|FG001|Overall Study|Withdrawal by Subject|3|||
130881216|NCT04945733|471199401|FG002|Overall Study|Withdrawal by Subject|0|||
130881217|NCT05660577|471199404|FG000|Overall Study|Discontinued|9|||
130881218|NCT03363841|471199407|FG000|Overall Study|Adverse Event|1|||
130881219|NCT03363841|471199407|FG000|Overall Study|Withdrawal by Subject|1|||
130881220|NCT03363841|471199407|FG000|Overall Study|Death|7|||
130881221|NCT03363841|471199407|FG000|Overall Study|Physician Decision|1|||
130881222|NCT00886379|471199410|FG000|Overall Study|Transferred Schools|0|||
131100297|NCT02366468|471996296|FG000|Overall Study|Death|1|||
130881223|NCT00886379|471199411|FG001|Overall Study|Transferred Schools|0|||
130881224|NCT00886379|471199412|FG002|Overall Study|Transferred Schools|2|||
130881225|NCT00886379|471199413|FG003|Overall Study|Transferred Schools|1|||
130881226|NCT00886379|471199414|FG004|Overall Study|Transferred Schools|1|||
130881227|NCT00886379|471199410|FG000|Overall Study|Final blood draw not obtained|3|||
130881228|NCT00886379|471199411|FG001|Overall Study|Final blood draw not obtained|3|||
130881229|NCT00886379|471199412|FG002|Overall Study|Final blood draw not obtained|4|||
130881230|NCT00886379|471199413|FG003|Overall Study|Final blood draw not obtained|2|||
130881231|NCT00886379|471199414|FG004|Overall Study|Final blood draw not obtained|2|||
130881232|NCT04558125|471199415|FG000|Overall Study|Death|1|||
130881233|NCT03137381|471199416|FG000|Overall Study|Adverse Event|3|||
130881234|NCT03137381|471199417|FG001|Overall Study|Adverse Event|0|||
130881235|NCT03137381|471199418|FG002|Overall Study|Adverse Event|2|||
130881236|NCT03137381|471199419|FG003|Overall Study|Adverse Event|0|||
130881237|NCT03137381|471199416|FG000|Overall Study|Lost to Follow-up|2|||
130881238|NCT03137381|471199417|FG001|Overall Study|Lost to Follow-up|1|||
130881239|NCT03137381|471199418|FG002|Overall Study|Lost to Follow-up|1|||
130881240|NCT03137381|471199419|FG003|Overall Study|Lost to Follow-up|0|||
130881241|NCT03137381|471199416|FG000|Overall Study|Protocol deviation|1|||
130881242|NCT03137381|471199417|FG001|Overall Study|Protocol deviation|1|||
130881243|NCT03137381|471199418|FG002|Overall Study|Protocol deviation|0|||
130881244|NCT03137381|471199419|FG003|Overall Study|Protocol deviation|1|||
130881245|NCT03137381|471199416|FG000|Overall Study|Withdrawal by Investigator|0|||
130881246|NCT03137381|471199417|FG001|Overall Study|Withdrawal by Investigator|1|||
130881247|NCT03137381|471199418|FG002|Overall Study|Withdrawal by Investigator|1|||
130881248|NCT03137381|471199419|FG003|Overall Study|Withdrawal by Investigator|0|||
130881249|NCT03137381|471199416|FG000|Overall Study|Withdrawal by Subject|3|||
130881250|NCT03137381|471199417|FG001|Overall Study|Withdrawal by Subject|4|||
130881251|NCT03137381|471199418|FG002|Overall Study|Withdrawal by Subject|3|||
130881252|NCT03137381|471199419|FG003|Overall Study|Withdrawal by Subject|0|||
130881253|NCT03137381|471199416|FG000|Overall Study|Pregnancy|0|||
130881254|NCT03137381|471199417|FG001|Overall Study|Pregnancy|0|||
130881255|NCT03137381|471199418|FG002|Overall Study|Pregnancy|1|||
130881256|NCT03137381|471199419|FG003|Overall Study|Pregnancy|0|||
130881257|NCT01980017|471199424|FG000|Overall Study|Lost to Follow-up|30|||
130881258|NCT01980017|471199425|FG001|Overall Study|Lost to Follow-up|21|||
130881259|NCT01980017|471199424|FG000|Overall Study|Death|0|||
130881260|NCT01980017|471199425|FG001|Overall Study|Death|1|||
130881261|NCT00910650|471199426|FG000|Overall Study|Death|2|||
130881262|NCT03367793|471199427|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130881263|NCT03367793|471199428|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130881264|NCT03367793|471199429|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
130881265|NCT03367793|471199430|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130881266|NCT03367793|471199431|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130881267|NCT03367793|471199432|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130881268|NCT00423579|471199433|FG000|Overall Study|Lost to Follow-up|3|||
130881269|NCT00423579|471199434|FG001|Overall Study|Lost to Follow-up|0|||
130881270|NCT00423579|471199433|FG000|Overall Study|Protocol Violation|1|||
130881271|NCT00423579|471199434|FG001|Overall Study|Protocol Violation|3|||
130881272|NCT00423579|471199433|FG000|Overall Study|Diagnosis of diabetes|0|||
130881273|NCT00423579|471199434|FG001|Overall Study|Diagnosis of diabetes|1|||
130881274|NCT00106704|471199437|FG000|Overall Study|Adverse Event|10|||
130881275|NCT00106704|471199438|FG001|Overall Study|Adverse Event|7|||
130881276|NCT00106704|471199437|FG000|Overall Study|Death|2|||
130881277|NCT00106704|471199438|FG001|Overall Study|Death|1|||
130881278|NCT00106704|471199437|FG000|Overall Study|Lack of Efficacy|67|||
130881279|NCT00106704|471199438|FG001|Overall Study|Lack of Efficacy|69|||
130881280|NCT00106704|471199437|FG000|Overall Study|Lost to Follow-up|7|||
130881281|NCT00106704|471199438|FG001|Overall Study|Lost to Follow-up|3|||
130881282|NCT00106704|471199437|FG000|Overall Study|Pregnancy|1|||
130881283|NCT00106704|471199438|FG001|Overall Study|Pregnancy|0|||
130881284|NCT00106704|471199437|FG000|Overall Study|Protocol Violation|4|||
130881285|NCT00106704|471199438|FG001|Overall Study|Protocol Violation|7|||
130881286|NCT00106704|471199437|FG000|Overall Study|Withdrawal by Subject|14|||
130881287|NCT00106704|471199438|FG001|Overall Study|Withdrawal by Subject|21|||
130881288|NCT00106704|471199437|FG000|Overall Study|Patient moved|1|||
130881289|NCT00106704|471199438|FG001|Overall Study|Patient moved|0|||
130881290|NCT00106704|471199437|FG000|Overall Study|Site terminated|0|||
130881291|NCT00106704|471199438|FG001|Overall Study|Site terminated|1|||
130881292|NCT00106704|471199437|FG000|Overall Study|Planned major surgery|1|||
130881293|NCT00106704|471199438|FG001|Overall Study|Planned major surgery|0|||
130881294|NCT00106704|471199437|FG000|Overall Study|Patient Received Glycemic Medication|22|||
130881295|NCT00106704|471199438|FG001|Overall Study|Patient Received Glycemic Medication|41|||
130881296|NCT00106704|471199437|FG000|Overall Study|Unable to re-enter US|1|||
130881297|NCT00106704|471199438|FG001|Overall Study|Unable to re-enter US|0|||
130881298|NCT00106704|471199437|FG000|Overall Study|Laboratory test|1|||
130881299|NCT00106704|471199438|FG001|Overall Study|Laboratory test|1|||
130881300|NCT02224560|471199440|FG000|Overall Study|Protocol Deviation|1|||
130881301|NCT02224560|471199441|FG001|Overall Study|Protocol Deviation|0|||
130881302|NCT02224560|471199442|FG002|Overall Study|Protocol Deviation|0|||
130881303|NCT02224560|471199440|FG000|Overall Study|Withdrawal by Subject|2|||
130881304|NCT02224560|471199441|FG001|Overall Study|Withdrawal by Subject|0|||
131100298|NCT02366468|471996297|FG001|Overall Study|Death|2|||
130881305|NCT02224560|471199442|FG002|Overall Study|Withdrawal by Subject|1|||
130881306|NCT02224560|471199440|FG000|Overall Study|Met Withdrawal Criteria|1|||
130881307|NCT02224560|471199441|FG001|Overall Study|Met Withdrawal Criteria|0|||
130881308|NCT02224560|471199442|FG002|Overall Study|Met Withdrawal Criteria|0|||
130881309|NCT02224560|471199440|FG000|Overall Study|Adverse Event|4|||
130881310|NCT02224560|471199441|FG001|Overall Study|Adverse Event|1|||
130881311|NCT02224560|471199442|FG002|Overall Study|Adverse Event|1|||
130881312|NCT02224560|471199440|FG000|Overall Study|Withdrawn by Investigator|1|||
131100299|NCT02366468|471996296|FG000|Overall Study|Other|0|||
130881313|NCT02224560|471199441|FG001|Overall Study|Withdrawn by Investigator|1|||
130881314|NCT02224560|471199442|FG002|Overall Study|Withdrawn by Investigator|0|||
130881315|NCT01210313|471199447|FG000|Overall Study|Withdrawal by Subject|3|||
130881316|NCT01210313|471199447|FG000|Overall Study|Adverse Event|2|||
130881317|NCT01210313|471199447|FG000|Overall Study|Distant recurrence|4|||
130881318|NCT01210313|471199447|FG000|Overall Study|Non-compliance|7|||
130881319|NCT03773978|471199450|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
130881320|NCT03773978|471199451|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
130881321|NCT03773978|471199450|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
130881322|NCT03773978|471199451|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
130881323|NCT03773978|471199450|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
130881324|NCT03773978|471199451|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
130881325|NCT03773978|471199450|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
130881326|NCT03773978|471199451|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
130881327|NCT03773978|471199450|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
130881328|NCT03773978|471199451|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
131100300|NCT02366468|471996297|FG001|Overall Study|Other|2|||
131100301|NCT01552603|471996298|FG000|Overall Study|Physician Decision|1|||
131100302|NCT04797650|471996303|FG000|Overall Study|Reason Not Specified|5|||
131100303|NCT04797650|471996304|FG001|Overall Study|Reason Not Specified|12|||
131100304|NCT04797650|471996305|FG002|Overall Study|Reason Not Specified|5|||
131100305|NCT04797650|471996303|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
131100306|NCT04797650|471996304|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
131100307|NCT04797650|471996305|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
131100308|NCT04797650|471996303|FG000|Overall Study|Lack of Efficacy|1|||
131100309|NCT04797650|471996304|FG001|Overall Study|Lack of Efficacy|0|||
131100310|NCT04797650|471996305|FG002|Overall Study|Lack of Efficacy|1|||
130881329|NCT03773978|471199450|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
130881330|NCT03773978|471199451|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
130881331|NCT03773978|471199450|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
130881332|NCT03773978|471199451|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
130881333|NCT03773978|471199450|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
130881334|NCT03773978|471199451|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
130881335|NCT03773978|471199450|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
130881336|NCT03773978|471199451|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
130881337|NCT03773978|471199450|FG000|DBW Period|Adverse Event|2|||
130881338|NCT03773978|471199451|FG001|DBW Period|Adverse Event|2|||
130881339|NCT03773978|471199450|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
130881340|NCT03773978|471199451|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
130881341|NCT03773978|471199450|FG000|DBW Period|Withdrawal by Subject|2|||
130881342|NCT03773978|471199451|FG001|DBW Period|Withdrawal by Subject|1|||
130881343|NCT03773978|471199450|FG000|DBW Period|Due to epidemic or pandemic|5|||
130881344|NCT03773978|471199451|FG001|DBW Period|Due to epidemic or pandemic|6|||
130881345|NCT03773978|471199450|FG000|DBW Period|Study team decision|1|||
130881346|NCT03773978|471199451|FG001|DBW Period|Study team decision|0|||
130881347|NCT01710345|471199460|FG000|Overall Study|Adverse Event|0|||
130881348|NCT01710345|471199461|FG001|Overall Study|Adverse Event|2|||
130881349|NCT01710345|471199462|FG002|Overall Study|Adverse Event|0|||
130881350|NCT01710345|471199460|FG000|Overall Study|Lack of Efficacy|2|||
130881351|NCT01710345|471199461|FG001|Overall Study|Lack of Efficacy|3|||
130881352|NCT01710345|471199462|FG002|Overall Study|Lack of Efficacy|1|||
130881353|NCT01710345|471199460|FG000|Overall Study|Drug Dosing Error|1|||
130881354|NCT01710345|471199461|FG001|Overall Study|Drug Dosing Error|0|||
130881355|NCT01710345|471199462|FG002|Overall Study|Drug Dosing Error|0|||
130881356|NCT04298697|471199465|FG000|Overall Study|Lost to Follow-up|5|||
130881357|NCT04298697|471199466|FG001|Overall Study|Lost to Follow-up|5|||
130881358|NCT04298697|471199467|FG002|Overall Study|Lost to Follow-up|1|||
130881359|NCT04298697|471199468|FG003|Overall Study|Lost to Follow-up|0|||
130881360|NCT04298697|471199465|FG000|Overall Study|Withdrawal by Subject|0|||
130881361|NCT04298697|471199466|FG001|Overall Study|Withdrawal by Subject|3|||
130881362|NCT04298697|471199467|FG002|Overall Study|Withdrawal by Subject|2|||
130881363|NCT04298697|471199468|FG003|Overall Study|Withdrawal by Subject|3|||
130881364|NCT00449696|471199469|FG000|Overall Study|Other Treatment Required|6|||
130881365|NCT00449696|471199470|FG001|Overall Study|Other Treatment Required|1|||
130881366|NCT00449696|471199469|FG000|Overall Study|Withdrawal by Subject|5|||
130881367|NCT00449696|471199470|FG001|Overall Study|Withdrawal by Subject|5|||
131100311|NCT04797650|471996303|FG000|Overall Study|Non-compliance with Study Drug|0|||
130881368|NCT00449696|471199469|FG000|Overall Study|Lost to Follow-up|2|||
130881369|NCT00449696|471199470|FG001|Overall Study|Lost to Follow-up|3|||
130881370|NCT00449696|471199469|FG000|Overall Study|Others|7|||
130881371|NCT00449696|471199470|FG001|Overall Study|Others|0|||
130881372|NCT01033019|471199474|FG000|Overall Study|Withdrawal by Subject|1|||
130881373|NCT01033019|471199475|FG001|Overall Study|Withdrawal by Subject|0|||
130881374|NCT03224819|471199478|FG000|Overall Study|Withdrawal by Subject|0|||
131100312|NCT04797650|471996304|FG001|Overall Study|Non-compliance with Study Drug|0|||
131100313|NCT04797650|471996305|FG002|Overall Study|Non-compliance with Study Drug|2|||
130881375|NCT03224819|471199479|FG001|Overall Study|Withdrawal by Subject|0|||
130881376|NCT03224819|471199480|FG002|Overall Study|Withdrawal by Subject|0|||
130881377|NCT03224819|471199481|FG003|Overall Study|Withdrawal by Subject|0|||
130881378|NCT03224819|471199482|FG004|Overall Study|Withdrawal by Subject|0|||
130881379|NCT03224819|471199483|FG005|Overall Study|Withdrawal by Subject|0|||
130881380|NCT03224819|471199484|FG006|Overall Study|Withdrawal by Subject|0|||
130881381|NCT03224819|471199485|FG007|Overall Study|Withdrawal by Subject|0|||
130881382|NCT03224819|471199486|FG008|Overall Study|Withdrawal by Subject|0|||
130881383|NCT03224819|471199487|FG009|Overall Study|Withdrawal by Subject|0|||
130881384|NCT03224819|471199488|FG010|Overall Study|Withdrawal by Subject|0|||
130881385|NCT03224819|471199489|FG011|Overall Study|Withdrawal by Subject|0|||
130881386|NCT03224819|471199490|FG012|Overall Study|Withdrawal by Subject|1|||
130881387|NCT03224819|471199491|FG013|Overall Study|Withdrawal by Subject|0|||
130881388|NCT03224819|471199478|FG000|Overall Study|Sponsor Decision|0|||
130881389|NCT03224819|471199479|FG001|Overall Study|Sponsor Decision|0|||
130881390|NCT03224819|471199480|FG002|Overall Study|Sponsor Decision|0|||
130881391|NCT03224819|471199481|FG003|Overall Study|Sponsor Decision|1|||
130881392|NCT03224819|471199482|FG004|Overall Study|Sponsor Decision|1|||
130881393|NCT03224819|471199483|FG005|Overall Study|Sponsor Decision|2|||
130881394|NCT03224819|471199484|FG006|Overall Study|Sponsor Decision|1|||
130881395|NCT03224819|471199485|FG007|Overall Study|Sponsor Decision|1|||
130881396|NCT03224819|471199486|FG008|Overall Study|Sponsor Decision|1|||
130881397|NCT03224819|471199487|FG009|Overall Study|Sponsor Decision|2|||
130881398|NCT03224819|471199488|FG010|Overall Study|Sponsor Decision|1|||
130881399|NCT03224819|471199489|FG011|Overall Study|Sponsor Decision|1|||
130881400|NCT03224819|471199490|FG012|Overall Study|Sponsor Decision|1|||
130881401|NCT03224819|471199491|FG013|Overall Study|Sponsor Decision|0|||
130881402|NCT03224819|471199478|FG000|Overall Study|Lost to Follow-up|0|||
130881403|NCT03224819|471199479|FG001|Overall Study|Lost to Follow-up|0|||
130881404|NCT03224819|471199480|FG002|Overall Study|Lost to Follow-up|0|||
130881405|NCT03224819|471199481|FG003|Overall Study|Lost to Follow-up|0|||
130881406|NCT03224819|471199482|FG004|Overall Study|Lost to Follow-up|0|||
130881407|NCT03224819|471199483|FG005|Overall Study|Lost to Follow-up|0|||
130881408|NCT03224819|471199484|FG006|Overall Study|Lost to Follow-up|0|||
130881409|NCT03224819|471199485|FG007|Overall Study|Lost to Follow-up|0|||
130881410|NCT03224819|471199486|FG008|Overall Study|Lost to Follow-up|1|||
130881411|NCT03224819|471199487|FG009|Overall Study|Lost to Follow-up|0|||
130881412|NCT03224819|471199488|FG010|Overall Study|Lost to Follow-up|0|||
130881413|NCT03224819|471199489|FG011|Overall Study|Lost to Follow-up|0|||
130881414|NCT03224819|471199490|FG012|Overall Study|Lost to Follow-up|0|||
130881415|NCT03224819|471199491|FG013|Overall Study|Lost to Follow-up|0|||
130881416|NCT03224819|471199478|FG000|Overall Study|Death|0|||
130881417|NCT03224819|471199479|FG001|Overall Study|Death|1|||
130881418|NCT03224819|471199480|FG002|Overall Study|Death|0|||
130881419|NCT03224819|471199481|FG003|Overall Study|Death|0|||
130881420|NCT03224819|471199482|FG004|Overall Study|Death|0|||
130881421|NCT03224819|471199483|FG005|Overall Study|Death|0|||
130881422|NCT03224819|471199484|FG006|Overall Study|Death|0|||
130881423|NCT03224819|471199485|FG007|Overall Study|Death|1|||
130881424|NCT03224819|471199486|FG008|Overall Study|Death|0|||
130881425|NCT03224819|471199487|FG009|Overall Study|Death|0|||
130881426|NCT03224819|471199488|FG010|Overall Study|Death|0|||
130881427|NCT03224819|471199489|FG011|Overall Study|Death|1|||
130881428|NCT03224819|471199490|FG012|Overall Study|Death|0|||
130881429|NCT03224819|471199491|FG013|Overall Study|Death|0|||
130881430|NCT01903460|471199496|FG000|Overall Study|Adverse Event|0|||
130881431|NCT01903460|471199497|FG001|Overall Study|Adverse Event|0|||
130881432|NCT01903460|471199498|FG002|Overall Study|Adverse Event|0|||
130881433|NCT01903460|471199499|FG003|Overall Study|Adverse Event|1|||
130881434|NCT04973449|471199500|FG000|Overall Study|Withdrawal by Subject|3|||
130881435|NCT04973449|471199501|FG001|Overall Study|Withdrawal by Subject|3|||
130881436|NCT04973449|471199502|FG002|Overall Study|Withdrawal by Subject|2|||
130881437|NCT04973449|471199503|FG003|Overall Study|Withdrawal by Subject|5|||
130881438|NCT04973449|471199504|FG004|Overall Study|Withdrawal by Subject|5|||
130881439|NCT04973449|471199505|FG005|Overall Study|Withdrawal by Subject|4|||
130881440|NCT04973449|471199506|FG006|Overall Study|Withdrawal by Subject|7|||
130881441|NCT04973449|471199507|FG007|Overall Study|Withdrawal by Subject|5|||
130881442|NCT04973449|471199500|FG000|Overall Study|Lost to Follow-up|15|||
130881443|NCT04973449|471199501|FG001|Overall Study|Lost to Follow-up|16|||
130881444|NCT04973449|471199502|FG002|Overall Study|Lost to Follow-up|16|||
130881445|NCT04973449|471199503|FG003|Overall Study|Lost to Follow-up|13|||
130881446|NCT04973449|471199504|FG004|Overall Study|Lost to Follow-up|5|||
130881447|NCT04973449|471199505|FG005|Overall Study|Lost to Follow-up|6|||
130881448|NCT04973449|471199506|FG006|Overall Study|Lost to Follow-up|10|||
130881449|NCT04973449|471199507|FG007|Overall Study|Lost to Follow-up|6|||
130881450|NCT04973449|471199500|FG000|Overall Study|Death|1|||
130881451|NCT04973449|471199501|FG001|Overall Study|Death|0|||
130881452|NCT04973449|471199502|FG002|Overall Study|Death|0|||
130881453|NCT04973449|471199503|FG003|Overall Study|Death|0|||
130881454|NCT04973449|471199504|FG004|Overall Study|Death|0|||
130881455|NCT04973449|471199505|FG005|Overall Study|Death|1|||
130881456|NCT04973449|471199506|FG006|Overall Study|Death|0|||
130881457|NCT04973449|471199507|FG007|Overall Study|Death|0|||
130881458|NCT04973449|471199500|FG000|Overall Study|Other|1|||
130881459|NCT04973449|471199501|FG001|Overall Study|Other|1|||
130881460|NCT04973449|471199502|FG002|Overall Study|Other|2|||
130881461|NCT04973449|471199503|FG003|Overall Study|Other|1|||
130881462|NCT04973449|471199504|FG004|Overall Study|Other|4|||
130881463|NCT04973449|471199505|FG005|Overall Study|Other|0|||
130881464|NCT04973449|471199506|FG006|Overall Study|Other|2|||
130881465|NCT04973449|471199507|FG007|Overall Study|Other|2|||
130881466|NCT00521079|471199508|FG000|Overall Study|Adverse Event|7|||
130881467|NCT00521079|471199509|FG001|Overall Study|Adverse Event|1|||
130881468|NCT00521079|471199508|FG000|Overall Study|Lost to Follow-up|2|||
130881469|NCT00521079|471199509|FG001|Overall Study|Lost to Follow-up|1|||
130881470|NCT00521079|471199508|FG000|Overall Study|Withdrawal by Subject|5|||
130881471|NCT00521079|471199509|FG001|Overall Study|Withdrawal by Subject|3|||
130881472|NCT02638220|471199512|FG000|Overall Study|Lost to Follow-up|6|||
130881473|NCT02638220|471199512|FG000|Overall Study|Withdrawal by Subject|3|||
130881474|NCT02638220|471199512|FG000|Overall Study|Physician Decision|1|||
130881475|NCT02638220|471199512|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
130881476|NCT04323124|471199516|FG000|Overall Study|Adverse Event|0|||
130881477|NCT04323124|471199517|FG001|Overall Study|Adverse Event|0|||
130881478|NCT04323124|471199518|FG002|Overall Study|Adverse Event|0|||
130881479|NCT04323124|471199519|FG003|Overall Study|Adverse Event|0|||
130881480|NCT04323124|471199520|FG004|Overall Study|Adverse Event|0|||
130881481|NCT04323124|471199521|FG005|Overall Study|Adverse Event|1|||
130881482|NCT04323124|471199522|FG006|Overall Study|Adverse Event|0|||
130881483|NCT04323124|471199523|FG007|Overall Study|Adverse Event|1|||
130881484|NCT04323124|471199524|FG008|Overall Study|Adverse Event|1|||
130881485|NCT04323124|471199525|FG009|Overall Study|Adverse Event|0|||
130881486|NCT04323124|471199526|FG010|Overall Study|Adverse Event|0|||
130881487|NCT04323124|471199527|FG011|Overall Study|Adverse Event|0|||
130881488|NCT04323124|471199528|FG012|Overall Study|Adverse Event|0|||
130881489|NCT04323124|471199529|FG013|Overall Study|Adverse Event|0|||
130881490|NCT04323124|471199530|FG014|Overall Study|Adverse Event|0|||
130881491|NCT04323124|471199516|FG000|Overall Study|Other|0|||
130881492|NCT04323124|471199517|FG001|Overall Study|Other|0|||
130881493|NCT04323124|471199518|FG002|Overall Study|Other|0|||
130881494|NCT04323124|471199519|FG003|Overall Study|Other|0|||
130881495|NCT04323124|471199520|FG004|Overall Study|Other|1|||
130881496|NCT04323124|471199521|FG005|Overall Study|Other|0|||
130881497|NCT04323124|471199522|FG006|Overall Study|Other|0|||
130881498|NCT04323124|471199523|FG007|Overall Study|Other|0|||
130881499|NCT04323124|471199524|FG008|Overall Study|Other|1|||
130881500|NCT04323124|471199525|FG009|Overall Study|Other|0|||
130881501|NCT04323124|471199526|FG010|Overall Study|Other|0|||
130881502|NCT04323124|471199527|FG011|Overall Study|Other|0|||
130881503|NCT04323124|471199528|FG012|Overall Study|Other|0|||
130881504|NCT04323124|471199529|FG013|Overall Study|Other|0|||
130881505|NCT04323124|471199530|FG014|Overall Study|Other|0|||
130881506|NCT04323124|471199516|FG000|Overall Study|Coming from a red zone (COVID)|0|||
130881507|NCT04323124|471199517|FG001|Overall Study|Coming from a red zone (COVID)|0|||
130881508|NCT04323124|471199518|FG002|Overall Study|Coming from a red zone (COVID)|0|||
130881509|NCT04323124|471199519|FG003|Overall Study|Coming from a red zone (COVID)|0|||
130881510|NCT04323124|471199520|FG004|Overall Study|Coming from a red zone (COVID)|1|||
130881511|NCT04323124|471199521|FG005|Overall Study|Coming from a red zone (COVID)|1|||
130881512|NCT04323124|471199522|FG006|Overall Study|Coming from a red zone (COVID)|0|||
130881513|NCT04323124|471199523|FG007|Overall Study|Coming from a red zone (COVID)|0|||
130881514|NCT04323124|471199524|FG008|Overall Study|Coming from a red zone (COVID)|0|||
130881515|NCT04323124|471199525|FG009|Overall Study|Coming from a red zone (COVID)|0|||
130881516|NCT04323124|471199526|FG010|Overall Study|Coming from a red zone (COVID)|0|||
131100314|NCT04797650|471996303|FG000|Overall Study|Lost to Follow-up|4|||
131100315|NCT04797650|471996304|FG001|Overall Study|Lost to Follow-up|6|||
130881517|NCT04323124|471199527|FG011|Overall Study|Coming from a red zone (COVID)|0|||
130881518|NCT04323124|471199528|FG012|Overall Study|Coming from a red zone (COVID)|0|||
130881519|NCT04323124|471199529|FG013|Overall Study|Coming from a red zone (COVID)|0|||
130881520|NCT04323124|471199530|FG014|Overall Study|Coming from a red zone (COVID)|0|||
130881521|NCT04323124|471199516|FG000|Overall Study|No longer meets eligibility criteria|0|||
130881522|NCT04323124|471199517|FG001|Overall Study|No longer meets eligibility criteria|0|||
130881523|NCT04323124|471199518|FG002|Overall Study|No longer meets eligibility criteria|0|||
130881524|NCT04323124|471199519|FG003|Overall Study|No longer meets eligibility criteria|0|||
130881525|NCT04323124|471199520|FG004|Overall Study|No longer meets eligibility criteria|0|||
130881526|NCT04323124|471199521|FG005|Overall Study|No longer meets eligibility criteria|0|||
130881527|NCT04323124|471199522|FG006|Overall Study|No longer meets eligibility criteria|0|||
130881528|NCT04323124|471199523|FG007|Overall Study|No longer meets eligibility criteria|1|||
130881529|NCT04323124|471199524|FG008|Overall Study|No longer meets eligibility criteria|0|||
130881530|NCT04323124|471199525|FG009|Overall Study|No longer meets eligibility criteria|0|||
131100316|NCT04797650|471996305|FG002|Overall Study|Lost to Follow-up|1|||
130881531|NCT04323124|471199526|FG010|Overall Study|No longer meets eligibility criteria|0|||
130881532|NCT04323124|471199527|FG011|Overall Study|No longer meets eligibility criteria|0|||
130881533|NCT04323124|471199528|FG012|Overall Study|No longer meets eligibility criteria|0|||
130881534|NCT04323124|471199529|FG013|Overall Study|No longer meets eligibility criteria|1|||
130881535|NCT04323124|471199530|FG014|Overall Study|No longer meets eligibility criteria|1|||
130881536|NCT04323124|471199516|FG000|Overall Study|Study terminated by sponsor|0|||
130881537|NCT04323124|471199517|FG001|Overall Study|Study terminated by sponsor|0|||
130881538|NCT04323124|471199518|FG002|Overall Study|Study terminated by sponsor|0|||
130881539|NCT04323124|471199519|FG003|Overall Study|Study terminated by sponsor|0|||
130881540|NCT04323124|471199520|FG004|Overall Study|Study terminated by sponsor|0|||
130881541|NCT04323124|471199521|FG005|Overall Study|Study terminated by sponsor|0|||
130881542|NCT04323124|471199522|FG006|Overall Study|Study terminated by sponsor|0|||
130881543|NCT04323124|471199523|FG007|Overall Study|Study terminated by sponsor|0|||
130881544|NCT04323124|471199524|FG008|Overall Study|Study terminated by sponsor|0|||
130881545|NCT04323124|471199525|FG009|Overall Study|Study terminated by sponsor|0|||
130881546|NCT04323124|471199526|FG010|Overall Study|Study terminated by sponsor|0|||
130881547|NCT04323124|471199527|FG011|Overall Study|Study terminated by sponsor|2|||
130881548|NCT04323124|471199528|FG012|Overall Study|Study terminated by sponsor|1|||
130881549|NCT04323124|471199529|FG013|Overall Study|Study terminated by sponsor|0|||
130881550|NCT04323124|471199530|FG014|Overall Study|Study terminated by sponsor|0|||
130881551|NCT00489307|471199531|FG000|Overall Study|Death|1|||
130881552|NCT00489307|471199532|FG001|Overall Study|Death|1|||
130881553|NCT00489307|471199531|FG000|Overall Study|Lost to Follow-up|2|||
130881554|NCT00489307|471199532|FG001|Overall Study|Lost to Follow-up|2|||
130881555|NCT00489307|471199531|FG000|Overall Study|Physician Decision|1|||
130881556|NCT00489307|471199532|FG001|Overall Study|Physician Decision|0|||
130881557|NCT00489307|471199531|FG000|Overall Study|Withdrawal by Subject|2|||
130881558|NCT00489307|471199532|FG001|Overall Study|Withdrawal by Subject|4|||
130881559|NCT00489307|471199531|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
130881560|NCT00489307|471199532|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
130881561|NCT00489307|471199531|FG000|Overall Study|Surgery after assignment|1|||
130881562|NCT00489307|471199532|FG001|Overall Study|Surgery after assignment|0|||
130881563|NCT00489307|471199531|FG000|Overall Study|Did not fill up the forms|2|||
130881564|NCT00489307|471199532|FG001|Overall Study|Did not fill up the forms|1|||
130881565|NCT00489307|471199531|FG000|Overall Study|Patient or family refusal|5|||
130881566|NCT00489307|471199532|FG001|Overall Study|Patient or family refusal|9|||
130881567|NCT01615939|471200565|FG000|Overall Study|Lost to Follow-up|5|||
130881568|NCT01615939|471200566|FG001|Overall Study|Lost to Follow-up|0|||
130881569|NCT02892344|471200570|FG000|Overall Study|Protocol deviation|3|||
130881570|NCT02892344|471200571|FG001|Overall Study|Protocol deviation|4|||
130881571|NCT02892344|471200570|FG000|Overall Study|Adverse Event|1|||
130881572|NCT02892344|471200571|FG001|Overall Study|Adverse Event|8|||
130881573|NCT02892344|471200570|FG000|Overall Study|Lost to Follow-up|0|||
130881574|NCT02892344|471200571|FG001|Overall Study|Lost to Follow-up|1|||
130881575|NCT02892344|471200570|FG000|Overall Study|Non-compliance with study treatment|0|||
130881576|NCT02892344|471200571|FG001|Overall Study|Non-compliance with study treatment|1|||
130881577|NCT02892344|471200570|FG000|Overall Study|Physician Decision|0|||
130881578|NCT02892344|471200571|FG001|Overall Study|Physician Decision|2|||
130881579|NCT02892344|471200570|FG000|Overall Study|Subject/guardian decision|0|||
130881580|NCT02892344|471200571|FG001|Overall Study|Subject/guardian decision|4|||
130881581|NCT02892344|471200570|FG000|Overall Study|Technical problems|0|||
130881582|NCT02892344|471200571|FG001|Overall Study|Technical problems|1|||
130881583|NCT00939393|471200574|FG000|Overall Study|Withdrawal by Subject|1|||
130881584|NCT00939393|471200575|FG001|Overall Study|Withdrawal by Subject|0|||
130881585|NCT00939393|471200574|FG000|Overall Study|Lost to Follow-up|3|||
130881586|NCT00939393|471200575|FG001|Overall Study|Lost to Follow-up|0|||
130881587|NCT01747876|471200578|FG000|Overall Study|Adverse Event|1|||
130881588|NCT01747876|471200579|FG001|Overall Study|Adverse Event|0|||
130881589|NCT01747876|471200580|FG002|Overall Study|Adverse Event|2|||
130881590|NCT01747876|471200578|FG000|Overall Study|Withdrawal by Subject|0|||
130881591|NCT01747876|471200579|FG001|Overall Study|Withdrawal by Subject|1|||
130881592|NCT01747876|471200580|FG002|Overall Study|Withdrawal by Subject|1|||
130881593|NCT01747876|471200578|FG000|Overall Study|Disease progression|4|||
130881594|NCT01747876|471200579|FG001|Overall Study|Disease progression|13|||
130881595|NCT01747876|471200580|FG002|Overall Study|Disease progression|8|||
130881596|NCT01747876|471200578|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
130881597|NCT01747876|471200579|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
130881598|NCT01747876|471200580|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
130881599|NCT05386329|471200583|FG000|Overall Study|Lost to Follow-up|3|||
130881600|NCT03041181|471200585|FG000|Overall Study|Disease Progression|1|||
130881601|NCT03041181|471200586|FG001|Overall Study|Disease Progression|2|||
130881602|NCT03104868|471200587|FG000|6 Week Follow up|Lost to Follow-up|5|||
130881603|NCT03104868|471200588|FG001|6 Week Follow up|Lost to Follow-up|8|||
130881604|NCT03104868|471200587|FG000|6 Week Follow up|Death|1|||
131213434|NCT00762073|472405346|FG000|Overall Study|Withdrawal by Subject|1|||
131213435|NCT00762073|472405347|FG001|Overall Study|Withdrawal by Subject|2|||
130881605|NCT03104868|471200588|FG001|6 Week Follow up|Death|1|||
130881606|NCT03104868|471200587|FG000|6 Week Follow up|Withdrawal by Subject|7|||
130881607|NCT03104868|471200588|FG001|6 Week Follow up|Withdrawal by Subject|6|||
130881608|NCT03104868|471200587|FG000|6 Week Follow up|Completed Later Timepoint|24|||
130881609|NCT03104868|471200588|FG001|6 Week Follow up|Completed Later Timepoint|22|||
130881610|NCT03104868|471200587|FG000|6 Month Follow up|Lost to Follow-up|2|||
130881611|NCT03104868|471200588|FG001|6 Month Follow up|Lost to Follow-up|2|||
130881612|NCT03104868|471200587|FG000|6 Month Follow up|Death|0|||
130881613|NCT03104868|471200588|FG001|6 Month Follow up|Death|1|||
130881614|NCT03104868|471200587|FG000|6 Month Follow up|Completed Later Timepoint|22|||
130881615|NCT03104868|471200588|FG001|6 Month Follow up|Completed Later Timepoint|32|||
130881616|NCT03104868|471200587|FG000|12 Month Follow up|Lost to Follow-up|1|||
130881617|NCT03104868|471200588|FG001|12 Month Follow up|Lost to Follow-up|2|||
130881618|NCT03104868|471200587|FG000|12 Month Follow up|Death|0|||
130881619|NCT03104868|471200588|FG001|12 Month Follow up|Death|1|||
130881620|NCT03104868|471200587|FG000|12 Month Follow up|Withdrawal by Subject|0|||
130881621|NCT03104868|471200588|FG001|12 Month Follow up|Withdrawal by Subject|3|||
130881622|NCT03104868|471200587|FG000|12 Month Follow up|Completed Later Timepoint|32|||
130881623|NCT03104868|471200588|FG001|12 Month Follow up|Completed Later Timepoint|29|||
130881624|NCT03104868|471200587|FG000|18 Month Follow up|Lost to Follow-up|7|||
130881625|NCT03104868|471200588|FG001|18 Month Follow up|Lost to Follow-up|11|||
130881626|NCT03104868|471200587|FG000|18 Month Follow up|Death|2|||
130881627|NCT03104868|471200588|FG001|18 Month Follow up|Death|1|||
130881628|NCT03104868|471200587|FG000|18 Month Follow up|Withdrawal by Subject|1|||
130881629|NCT03104868|471200588|FG001|18 Month Follow up|Withdrawal by Subject|2|||
130881630|NCT03104868|471200587|FG000|18 Month Follow up|Graft Loss|1|||
130881631|NCT03104868|471200588|FG001|18 Month Follow up|Graft Loss|1|||
130881632|NCT03104868|471200587|FG000|18 Month Follow up|Completed Later Timepoint|19|||
130881633|NCT03104868|471200588|FG001|18 Month Follow up|Completed Later Timepoint|20|||
130881634|NCT03104868|471200587|FG000|24 Month Follow up|Lost to Follow-up|15|||
130881635|NCT03104868|471200588|FG001|24 Month Follow up|Lost to Follow-up|16|||
130881636|NCT03104868|471200587|FG000|24 Month Follow up|Death|3|||
130881637|NCT03104868|471200588|FG001|24 Month Follow up|Death|2|||
130881638|NCT03104868|471200587|FG000|24 Month Follow up|Withdrawal by Subject|1|||
130881639|NCT03104868|471200588|FG001|24 Month Follow up|Withdrawal by Subject|0|||
130881640|NCT03104868|471200587|FG000|24 Month Follow up|Graft Loss|2|||
130881641|NCT03104868|471200588|FG001|24 Month Follow up|Graft Loss|0|||
130881642|NCT03050801|471200591|FG000|Experiment 1|Lost to Follow-up|0|||
130881643|NCT03050801|471200592|FG001|Experiment 1|Lost to Follow-up|1|||
130881644|NCT03050801|471200593|FG002|Experiment 1|Lost to Follow-up|0|||
130881645|NCT03050801|471200594|FG003|Experiment 1|Lost to Follow-up|0|||
130881646|NCT03050801|471200595|FG004|Experiment 1|Lost to Follow-up|0|||
130881647|NCT03050801|471200596|FG005|Experiment 1|Lost to Follow-up|0|||
130881648|NCT03050801|471200591|FG000|Experiment 1|Physician Decision|0|||
130881649|NCT03050801|471200592|FG001|Experiment 1|Physician Decision|3|||
130881650|NCT03050801|471200593|FG002|Experiment 1|Physician Decision|0|||
130881651|NCT03050801|471200594|FG003|Experiment 1|Physician Decision|0|||
130881652|NCT03050801|471200595|FG004|Experiment 1|Physician Decision|0|||
130881653|NCT03050801|471200596|FG005|Experiment 1|Physician Decision|0|||
130881654|NCT03050801|471200591|FG000|Experiment 1|Change of experimental design|0|||
130881655|NCT03050801|471200592|FG001|Experiment 1|Change of experimental design|3|||
130881656|NCT03050801|471200593|FG002|Experiment 1|Change of experimental design|0|||
130881657|NCT03050801|471200594|FG003|Experiment 1|Change of experimental design|0|||
130881658|NCT03050801|471200595|FG004|Experiment 1|Change of experimental design|0|||
130881659|NCT03050801|471200596|FG005|Experiment 1|Change of experimental design|0|||
130881660|NCT03050801|471200591|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
130881661|NCT03050801|471200592|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
130881662|NCT03050801|471200593|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
130881663|NCT03050801|471200594|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
130881664|NCT03050801|471200595|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
130881665|NCT03050801|471200596|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
130881666|NCT03050801|471200591|FG000|Experiment 2|Lost to Follow-up|0|||
130881667|NCT03050801|471200592|FG001|Experiment 2|Lost to Follow-up|0|||
130881668|NCT03050801|471200593|FG002|Experiment 2|Lost to Follow-up|0|||
130881669|NCT03050801|471200594|FG003|Experiment 2|Lost to Follow-up|1|||
130881670|NCT03050801|471200595|FG004|Experiment 2|Lost to Follow-up|1|||
130881671|NCT03050801|471200596|FG005|Experiment 2|Lost to Follow-up|0|||
130881672|NCT03050801|471200591|FG000|Experiment 2|Physician Decision|0|||
130881673|NCT03050801|471200592|FG001|Experiment 2|Physician Decision|0|||
130881674|NCT03050801|471200593|FG002|Experiment 2|Physician Decision|0|||
130881675|NCT03050801|471200594|FG003|Experiment 2|Physician Decision|0|||
130881676|NCT03050801|471200595|FG004|Experiment 2|Physician Decision|1|||
130881677|NCT03050801|471200596|FG005|Experiment 2|Physician Decision|0|||
130881678|NCT03050801|471200591|FG000|Experiment 2|Pregnancy|0|||
130881679|NCT03050801|471200592|FG001|Experiment 2|Pregnancy|0|||
130881680|NCT03050801|471200593|FG002|Experiment 2|Pregnancy|0|||
130881681|NCT03050801|471200594|FG003|Experiment 2|Pregnancy|0|||
130881682|NCT03050801|471200595|FG004|Experiment 2|Pregnancy|1|||
130881683|NCT03050801|471200596|FG005|Experiment 2|Pregnancy|0|||
130881684|NCT03050801|471200591|FG000|Experiment 2|Withdrawal by Subject|0|||
130881685|NCT03050801|471200592|FG001|Experiment 2|Withdrawal by Subject|0|||
130881686|NCT03050801|471200593|FG002|Experiment 2|Withdrawal by Subject|0|||
130881687|NCT03050801|471200594|FG003|Experiment 2|Withdrawal by Subject|1|||
130881688|NCT03050801|471200595|FG004|Experiment 2|Withdrawal by Subject|0|||
130881689|NCT03050801|471200596|FG005|Experiment 2|Withdrawal by Subject|0|||
130881690|NCT03050801|471200591|FG000|Experiment 2|Poor data quality|0|||
131100317|NCT00446043|471996306|FG000|Overall Study|Adverse Event|9|||
131100318|NCT00446043|471996306|FG000|Overall Study|Withdrawal by Subject|70|||
131100319|NCT00446043|471996306|FG000|Overall Study|Protocol Violation|2|||
131100320|NCT00446043|471996306|FG000|Overall Study|Lost to Follow-up|42|||
130881691|NCT03050801|471200592|FG001|Experiment 2|Poor data quality|0|||
130881692|NCT03050801|471200593|FG002|Experiment 2|Poor data quality|0|||
130881693|NCT03050801|471200594|FG003|Experiment 2|Poor data quality|4|||
130881694|NCT03050801|471200595|FG004|Experiment 2|Poor data quality|1|||
130881695|NCT03050801|471200596|FG005|Experiment 2|Poor data quality|0|||
130881696|NCT03050801|471200591|FG000|Experiment 2|Discomfort during stimulation|0|||
130881697|NCT03050801|471200592|FG001|Experiment 2|Discomfort during stimulation|0|||
130881698|NCT03050801|471200593|FG002|Experiment 2|Discomfort during stimulation|0|||
130881699|NCT03050801|471200594|FG003|Experiment 2|Discomfort during stimulation|0|||
130881700|NCT03050801|471200595|FG004|Experiment 2|Discomfort during stimulation|0|||
130881701|NCT03050801|471200596|FG005|Experiment 2|Discomfort during stimulation|2|||
130881702|NCT00005780|471200597|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
130881703|NCT03600909|471200598|FG000|Overall Study|Not treated|0|||
130881704|NCT03600909|471200599|FG001|Overall Study|Not treated|3|||
130881705|NCT03600909|471200600|FG002|Overall Study|Not treated|0|||
130881706|NCT02651675|471200601|FG000|Overall Study|Death|0|||
130881707|NCT02651675|471200602|FG001|Overall Study|Death|0|||
130881708|NCT02651675|471200603|FG002|Overall Study|Death|1|||
130881709|NCT03674411|471200604|FG000|Overall Study|Non-treatment|4|||
130881710|NCT04408989|471200605|FG000|Overall Study|Lost to Follow-up|0|||
130881711|NCT04408989|471200606|FG001|Overall Study|Lost to Follow-up|0|||
130881712|NCT04408989|471200607|FG002|Overall Study|Lost to Follow-up|1|||
130881713|NCT04408989|471200605|FG000|Overall Study|Withdrawal by Subject|0|||
130881714|NCT04408989|471200606|FG001|Overall Study|Withdrawal by Subject|0|||
130881715|NCT04408989|471200607|FG002|Overall Study|Withdrawal by Subject|2|||
130881716|NCT02694185|471200608|FG000|Overall Study|Withdrawal by Subject|45|||
130881717|NCT02694185|471200609|FG001|Overall Study|Withdrawal by Subject|0|||
130881718|NCT05082857|471200610|FG000|Overall Study|participants relocated and could not continue|2|||
130881719|NCT05082857|471200611|FG001|Overall Study|participants relocated and could not continue|1|||
130881720|NCT05082857|471200610|FG000|Overall Study|Lost to Follow-up|1|||
130881721|NCT05082857|471200611|FG001|Overall Study|Lost to Follow-up|3|||
130881722|NCT04363320|471200612|FG000|Overall Study|Lost to Follow-up|43|||
130881723|NCT04363320|471200613|FG001|Overall Study|Lost to Follow-up|42|||
130881724|NCT04363320|471200614|FG002|Overall Study|Lost to Follow-up|24|||
130881725|NCT04363320|471200615|FG003|Overall Study|Lost to Follow-up|29|||
130881726|NCT04363320|471200612|FG000|Overall Study|Death|0|||
130881727|NCT04363320|471200613|FG001|Overall Study|Death|0|||
130881728|NCT04363320|471200614|FG002|Overall Study|Death|1|||
130881729|NCT04363320|471200615|FG003|Overall Study|Death|0|||
130881730|NCT05632211|471200616|FG000|Overall Study|Withdrawal by Subject|2|||
130881731|NCT05632211|471200617|FG001|Overall Study|Withdrawal by Subject|0|||
130881732|NCT05632211|471200618|FG002|Overall Study|Withdrawal by Subject|2|||
130881733|NCT05632211|471200616|FG000|Overall Study|Other reasons|1|||
130881734|NCT05632211|471200617|FG001|Overall Study|Other reasons|1|||
130881735|NCT05632211|471200618|FG002|Overall Study|Other reasons|1|||
130881736|NCT04672239|471200619|FG000|Week 2 Survey|Failed survey check items|1|||
130881737|NCT04672239|471200620|FG001|Week 2 Survey|Failed survey check items|2|||
130881738|NCT04672239|471200621|FG002|Week 2 Survey|Failed survey check items|3|||
130881739|NCT04672239|471200619|FG000|Week 2 Survey|Partially completed survey|7|||
130881740|NCT04672239|471200620|FG001|Week 2 Survey|Partially completed survey|1|||
130881741|NCT04672239|471200621|FG002|Week 2 Survey|Partially completed survey|4|||
130881742|NCT04672239|471200619|FG000|Week 2 Survey|Withdrawal by Subject|0|||
130881743|NCT04672239|471200620|FG001|Week 2 Survey|Withdrawal by Subject|1|||
130881744|NCT04672239|471200621|FG002|Week 2 Survey|Withdrawal by Subject|0|||
130881745|NCT04672239|471200619|FG000|Week 2 Survey|Lost to Follow-up|3|||
130881746|NCT04672239|471200620|FG001|Week 2 Survey|Lost to Follow-up|2|||
130881747|NCT04672239|471200621|FG002|Week 2 Survey|Lost to Follow-up|5|||
130881748|NCT04672239|471200619|FG000|Week 6 Survey|Failed survey check items|2|||
130881749|NCT04672239|471200620|FG001|Week 6 Survey|Failed survey check items|2|||
130881750|NCT04672239|471200621|FG002|Week 6 Survey|Failed survey check items|2|||
130881751|NCT04672239|471200619|FG000|Week 6 Survey|Partially completed survey|3|||
130881752|NCT04672239|471200620|FG001|Week 6 Survey|Partially completed survey|3|||
131100321|NCT00446043|471996306|FG000|Overall Study|Pregnancy|2|||
131100322|NCT04772898|471996309|FG000|Overall Study|Withdrawal by Subject|0|||
130881753|NCT04672239|471200621|FG002|Week 6 Survey|Partially completed survey|2|||
130881754|NCT04672239|471200619|FG000|Week 6 Survey|Withdrawal by Subject|1|||
130881755|NCT04672239|471200620|FG001|Week 6 Survey|Withdrawal by Subject|1|||
130881756|NCT04672239|471200621|FG002|Week 6 Survey|Withdrawal by Subject|1|||
130881757|NCT04672239|471200619|FG000|Week 6 Survey|Withdrawn by PI|0|||
130881758|NCT04672239|471200620|FG001|Week 6 Survey|Withdrawn by PI|1|||
130881759|NCT04672239|471200621|FG002|Week 6 Survey|Withdrawn by PI|0|||
130881760|NCT04672239|471200619|FG000|Week 6 Survey|Lost to Follow-up|12|||
130881761|NCT04672239|471200620|FG001|Week 6 Survey|Lost to Follow-up|2|||
130881762|NCT04672239|471200621|FG002|Week 6 Survey|Lost to Follow-up|5|||
130881763|NCT04672239|471200619|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
130881764|NCT04672239|471200620|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
130881765|NCT04672239|471200621|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
130881766|NCT04672239|471200619|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
130881767|NCT04672239|471200620|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
130881768|NCT04672239|471200621|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
130881769|NCT04672239|471200619|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
130881770|NCT04672239|471200620|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
130881771|NCT04672239|471200621|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
130881772|NCT04672239|471200619|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
130881773|NCT04672239|471200620|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
130881774|NCT04672239|471200621|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
130881775|NCT04672239|471200619|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
130881776|NCT04672239|471200620|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
130881777|NCT04672239|471200621|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
130881778|NCT04672239|471200619|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
130881779|NCT04672239|471200620|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
130881780|NCT04672239|471200621|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
130881781|NCT04672239|471200619|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
130881782|NCT04672239|471200620|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
130881783|NCT04672239|471200621|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
130881784|NCT04606134|471200622|FG000|Overall Study|Adverse Event|0|||
130881785|NCT04606134|471200623|FG001|Overall Study|Adverse Event|1|||
130881786|NCT01099267|471200625|FG000|MDS-003 Study|Adverse Event|37|||
130881787|NCT01099267|471200625|FG000|MDS-003 Study|Lack of Efficacy|52|||
130881788|NCT01099267|471200625|FG000|MDS-003 Study|Withdrawal by Subject|8|||
130881789|NCT01099267|471200625|FG000|MDS-003 Study|Lost to Follow-up|1|||
130881790|NCT01099267|471200625|FG000|MDS-003 Study|Death|11|||
130881791|NCT01099267|471200625|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
130881792|NCT01099267|471200625|FG000|MDS-003 Study|Disease Progression|7|||
130881793|NCT01099267|471200625|FG000|MDS-003 Study|Investigator Decision|2|||
130881794|NCT01099267|471200625|FG000|MDS-003 Study|Non-Compliance|2|||
130881795|NCT01099267|471200625|FG000|MDS-003 Study|Loss of Response|1|||
130881796|NCT01099267|471200625|FG000|MDS-003 Study|Secondary Malign Disease|1|||
130881797|NCT01838395|471200633|FG000|Overall Study|Withdrawal by Subject|0|||
130881798|NCT01838395|471200634|FG001|Overall Study|Withdrawal by Subject|0|||
130881799|NCT01838395|471200635|FG002|Overall Study|Withdrawal by Subject|0|||
130881800|NCT01838395|471200636|FG003|Overall Study|Withdrawal by Subject|0|||
130881801|NCT01838395|471200637|FG004|Overall Study|Withdrawal by Subject|1|||
130881802|NCT01838395|471200638|FG005|Overall Study|Withdrawal by Subject|0|||
130881803|NCT01838395|471200633|FG000|Overall Study|Death|0|||
130881804|NCT01838395|471200634|FG001|Overall Study|Death|0|||
130881805|NCT01838395|471200635|FG002|Overall Study|Death|1|||
130881806|NCT01838395|471200636|FG003|Overall Study|Death|0|||
130881807|NCT01838395|471200637|FG004|Overall Study|Death|0|||
130881808|NCT01838395|471200638|FG005|Overall Study|Death|0|||
130881809|NCT01838395|471200633|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130881810|NCT01838395|471200634|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
130881811|NCT01838395|471200635|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130881812|NCT01838395|471200636|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130881813|NCT01838395|471200637|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130881814|NCT01838395|471200638|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130881815|NCT01535040|471200639|FG000|Overall Study|Physician Decision|0|||
130881816|NCT01535040|471200640|FG001|Overall Study|Physician Decision|1|||
130881817|NCT01535040|471200639|FG000|Overall Study|Withdrawal by Subject|13|||
130881818|NCT01535040|471200640|FG001|Overall Study|Withdrawal by Subject|10|||
130881819|NCT01535040|471200639|FG000|Overall Study|Never Started|9|||
130881820|NCT01535040|471200640|FG001|Overall Study|Never Started|4|||
130881821|NCT01535040|471200639|FG000|Overall Study|Toxicity|7|||
130881822|NCT01535040|471200640|FG001|Overall Study|Toxicity|5|||
130881823|NCT01535040|471200639|FG000|Overall Study|Multiple Reasons|1|||
130881824|NCT01535040|471200640|FG001|Overall Study|Multiple Reasons|1|||
130990521|NCT05672680|471593178|FG000|Overall Study|Patient Did Not Complete the Form|5|||
130881825|NCT01074970|471200642|FG000|Overall Study|Never Treated|0|||
130881826|NCT01074970|471200643|FG001|Overall Study|Never Treated|0|||
130881827|NCT01074970|471200644|FG002|Overall Study|Never Treated|8|||
130881828|NCT01074970|471200645|FG003|Overall Study|Never Treated|1|||
130881829|NCT01074970|471200642|FG000|Overall Study|Adverse Event|1|||
130881830|NCT01074970|471200643|FG001|Overall Study|Adverse Event|0|||
130881831|NCT01074970|471200644|FG002|Overall Study|Adverse Event|4|||
130881832|NCT01074970|471200645|FG003|Overall Study|Adverse Event|3|||
130881833|NCT01074970|471200642|FG000|Overall Study|Disease progression during treatment|3|||
130881834|NCT01074970|471200643|FG001|Overall Study|Disease progression during treatment|1|||
130881835|NCT01074970|471200644|FG002|Overall Study|Disease progression during treatment|2|||
130881836|NCT01074970|471200645|FG003|Overall Study|Disease progression during treatment|9|||
130881837|NCT01074970|471200642|FG000|Overall Study|Lost to Follow-up|0|||
130881838|NCT01074970|471200643|FG001|Overall Study|Lost to Follow-up|0|||
130881839|NCT01074970|471200644|FG002|Overall Study|Lost to Follow-up|1|||
130881840|NCT01074970|471200645|FG003|Overall Study|Lost to Follow-up|0|||
130881841|NCT01074970|471200642|FG000|Overall Study|Withdrawal by Subject|0|||
130881842|NCT01074970|471200643|FG001|Overall Study|Withdrawal by Subject|0|||
130881843|NCT01074970|471200644|FG002|Overall Study|Withdrawal by Subject|6|||
130881844|NCT01074970|471200645|FG003|Overall Study|Withdrawal by Subject|4|||
130881845|NCT00734149|471200646|FG000|Overall Study|Withdrawal by Subject|1|||
130881846|NCT05430854|471200647|FG000|Overall Study|Trial terminated by Sponsor|39|||
130881847|NCT05430854|471200648|FG001|Overall Study|Trial terminated by Sponsor|50|||
130881848|NCT05430854|471200649|FG002|Overall Study|Trial terminated by Sponsor|46|||
130881849|NCT05430854|471200647|FG000|Overall Study|Withdrawal by Subject|0|||
130881850|NCT05430854|471200648|FG001|Overall Study|Withdrawal by Subject|3|||
130881851|NCT05430854|471200649|FG002|Overall Study|Withdrawal by Subject|0|||
130881852|NCT04314284|471200650|FG000|Overall Study|Withdrawal by Subject|4|||
130881853|NCT04314284|471200651|FG001|Overall Study|Withdrawal by Subject|7|||
130881854|NCT04314284|471200650|FG000|Overall Study|Consented but did not complete survey|0|||
130881855|NCT04314284|471200651|FG001|Overall Study|Consented but did not complete survey|6|||
130881856|NCT01652235|471200654|FG000|Overall Study|Death|9|||
130881857|NCT01652235|471200654|FG000|Overall Study|Lost to Follow-up|5|||
130881858|NCT01652235|471200654|FG000|Overall Study|Withdrawal by Subject|2|||
130881859|NCT02023086|471200657|FG000|Overall Study|Withdrawal by Subject|2|||
130881860|NCT02023086|471200658|FG001|Overall Study|Withdrawal by Subject|0|||
130881861|NCT05565742|471200661|FG000|Overall Study|Withdrawal by Subject|0|||
130881862|NCT05565742|471200662|FG001|Overall Study|Withdrawal by Subject|0|||
130881863|NCT05565742|471200663|FG002|Overall Study|Withdrawal by Subject|2|||
130881864|NCT05565742|471200664|FG003|Overall Study|Withdrawal by Subject|2|||
130881865|NCT05565742|471200665|FG004|Overall Study|Withdrawal by Subject|2|||
130881866|NCT05565742|471200661|FG000|Overall Study|Death|1|||
130881867|NCT05565742|471200662|FG001|Overall Study|Death|0|||
130881868|NCT05565742|471200663|FG002|Overall Study|Death|0|||
130881869|NCT05565742|471200664|FG003|Overall Study|Death|0|||
130881870|NCT05565742|471200665|FG004|Overall Study|Death|0|||
130881871|NCT05565742|471200661|FG000|Overall Study|Participant Travelled Abroad|0|||
130881872|NCT05565742|471200662|FG001|Overall Study|Participant Travelled Abroad|0|||
130881873|NCT05565742|471200663|FG002|Overall Study|Participant Travelled Abroad|0|||
130881874|NCT05565742|471200664|FG003|Overall Study|Participant Travelled Abroad|0|||
130881875|NCT05565742|471200665|FG004|Overall Study|Participant Travelled Abroad|1|||
130881876|NCT04163341|471200666|FG000|Overall Study|Withdrawal by Subject|2|||
130881877|NCT04163341|471200667|FG001|Overall Study|Withdrawal by Subject|0|||
130881878|NCT04163341|471200666|FG000|Overall Study|Lost to Follow-up|3|||
130881879|NCT04163341|471200667|FG001|Overall Study|Lost to Follow-up|4|||
130881880|NCT03472885|471200668|FG000|24-Week Treatment Period|Adverse Event|1|||
130881881|NCT02201953|471200671|FG000|Overall Study|Randomized but Never Treated|1|||
130881882|NCT02201953|471200672|FG001|Overall Study|Randomized but Never Treated|5|||
130881883|NCT02201953|471200671|FG000|Overall Study|Lack of Efficacy|9|||
130881884|NCT02201953|471200672|FG001|Overall Study|Lack of Efficacy|30|||
130881885|NCT02201953|471200671|FG000|Overall Study|Lost to Follow-up|8|||
130881886|NCT02201953|471200672|FG001|Overall Study|Lost to Follow-up|8|||
130881887|NCT02201953|471200671|FG000|Overall Study|Withdrew Consent|2|||
130881888|NCT02201953|471200672|FG001|Overall Study|Withdrew Consent|5|||
130881889|NCT02201953|471200671|FG000|Overall Study|Adverse Event|0|||
130881890|NCT02201953|471200672|FG001|Overall Study|Adverse Event|5|||
130881891|NCT02201953|471200671|FG000|Overall Study|Death|0|||
130881892|NCT02201953|471200672|FG001|Overall Study|Death|3|||
130881893|NCT04586205|471200676|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
130881894|NCT04586205|471200677|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
130881895|NCT02121535|471202419|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
130881896|NCT02121535|471202420|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
130881897|NCT02121535|471202419|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
130881898|NCT02121535|471202420|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
130881899|NCT04328077|471202421|FG000|Overall Study|Lost to Follow-up|0|||
130881900|NCT04328077|471202422|FG001|Overall Study|Lost to Follow-up|1|||
130881901|NCT04328077|471202423|FG002|Overall Study|Lost to Follow-up|0|||
130881902|NCT04328077|471202424|FG003|Overall Study|Lost to Follow-up|0|||
130881903|NCT04328077|471202421|FG000|Overall Study|Withdrawal by Subject|0|||
130881904|NCT04328077|471202422|FG001|Overall Study|Withdrawal by Subject|1|||
130881905|NCT04328077|471202423|FG002|Overall Study|Withdrawal by Subject|1|||
130881906|NCT04328077|471202424|FG003|Overall Study|Withdrawal by Subject|3|||
130881907|NCT03591406|471202426|FG000|Overall Study|Adverse Event|5|||
130881908|NCT03591406|471202427|FG001|Overall Study|Adverse Event|3|||
130881909|NCT03591406|471202426|FG000|Overall Study|Protocol Violation|2|||
130881910|NCT03591406|471202427|FG001|Overall Study|Protocol Violation|1|||
130881911|NCT03591406|471202426|FG000|Overall Study|Withdrawal by Subject|0|||
130881912|NCT03591406|471202427|FG001|Overall Study|Withdrawal by Subject|5|||
130881913|NCT01083771|471202428|FG000|Overall Study|non-compliant|2|||
130881914|NCT01083771|471202428|FG000|Overall Study|Withdrawal by Subject|3|||
130881915|NCT02066181|471202429|FG000|Overall Study|Withdrawal by Subject|1|||
130881916|NCT02066181|471202430|FG001|Overall Study|Withdrawal by Subject|1|||
130881917|NCT02851615|471202431|FG000|Overall Study|Cognitive Issue|1|||
130881918|NCT02851615|471202432|FG001|Overall Study|Cognitive Issue|0|||
130881919|NCT02851615|471202431|FG000|Overall Study|Lost to Follow-up|0|||
130881920|NCT02851615|471202432|FG001|Overall Study|Lost to Follow-up|4|||
130881921|NCT03131219|471202443|FG000|Initial Evaluation Period|Adverse Event|2|||
130881922|NCT03131219|471202444|FG001|Initial Evaluation Period|Adverse Event|0|||
130881923|NCT03131219|471202443|FG000|Initial Evaluation Period|Protocol Violation|1|||
130881924|NCT03131219|471202444|FG001|Initial Evaluation Period|Protocol Violation|0|||
130881925|NCT03131219|471202443|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
130881926|NCT03131219|471202444|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
130881927|NCT03131219|471202443|FG000|Initial Evaluation Period|Physician Decision|1|||
130881928|NCT03131219|471202444|FG001|Initial Evaluation Period|Physician Decision|0|||
130881929|NCT03131219|471202443|FG000|Extension Period|Physician Decision|1|||
130881930|NCT03131219|471202444|FG001|Extension Period|Physician Decision|0|||
130881931|NCT01391546|471202447|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
130881932|NCT01391546|471202448|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
130881933|NCT01744977|471202449|FG000|Overall Study|Withdrawal by Subject|1|||
130881934|NCT01744977|471202450|FG001|Overall Study|Withdrawal by Subject|2|||
130881935|NCT01744977|471202449|FG000|Overall Study|Death|2|||
130881936|NCT01744977|471202450|FG001|Overall Study|Death|3|||
130881937|NCT01744977|471202449|FG000|Overall Study|Lost to Follow-up|2|||
130881938|NCT01744977|471202450|FG001|Overall Study|Lost to Follow-up|0|||
130881939|NCT01744977|471202449|FG000|Overall Study|No longer meets inclusion|6|||
130881940|NCT01744977|471202450|FG001|Overall Study|No longer meets inclusion|0|||
130881941|NCT02156076|471202453|FG000|Treatment Period|no longer meets study criteria|0|||
130881942|NCT02156076|471202454|FG001|Treatment Period|no longer meets study criteria|0|||
130881943|NCT02156076|471202455|FG002|Treatment Period|no longer meets study criteria|1|||
130881944|NCT02156076|471202456|FG003|Treatment Period|no longer meets study criteria|0|||
130881945|NCT02156076|471202453|FG000|Treatment Period|Poor/non-compliance|0|||
130881946|NCT02156076|471202454|FG001|Treatment Period|Poor/non-compliance|1|||
130881947|NCT02156076|471202455|FG002|Treatment Period|Poor/non-compliance|0|||
130881948|NCT02156076|471202456|FG003|Treatment Period|Poor/non-compliance|0|||
130881949|NCT02156076|471202453|FG000|Treatment Period|Lost to Follow-up|0|||
130881950|NCT02156076|471202454|FG001|Treatment Period|Lost to Follow-up|0|||
130881951|NCT02156076|471202455|FG002|Treatment Period|Lost to Follow-up|0|||
130881952|NCT02156076|471202456|FG003|Treatment Period|Lost to Follow-up|1|||
130881953|NCT02156076|471202453|FG000|Treatment Period|Withdrawal by Subject|0|||
130881954|NCT02156076|471202454|FG001|Treatment Period|Withdrawal by Subject|0|||
130881955|NCT02156076|471202455|FG002|Treatment Period|Withdrawal by Subject|1|||
130881956|NCT02156076|471202456|FG003|Treatment Period|Withdrawal by Subject|0|||
130881957|NCT02156076|471202453|FG000|Treatment Period|Subject request to discontinue treatment|0|||
130881958|NCT02156076|471202454|FG001|Treatment Period|Subject request to discontinue treatment|1|||
130881959|NCT02156076|471202455|FG002|Treatment Period|Subject request to discontinue treatment|0|||
130881960|NCT02156076|471202456|FG003|Treatment Period|Subject request to discontinue treatment|0|||
130881961|NCT02156076|471202453|FG000|Treatment Period|Adverse Event|0|||
130881962|NCT02156076|471202454|FG001|Treatment Period|Adverse Event|0|||
130881963|NCT02156076|471202455|FG002|Treatment Period|Adverse Event|0|||
130881964|NCT02156076|471202456|FG003|Treatment Period|Adverse Event|1|||
130881965|NCT02156076|471202453|FG000|Follow-up Period|Withdrawal by Subject|1|||
130881966|NCT02156076|471202454|FG001|Follow-up Period|Withdrawal by Subject|0|||
130881967|NCT02156076|471202455|FG002|Follow-up Period|Withdrawal by Subject|0|||
130881968|NCT02156076|471202456|FG003|Follow-up Period|Withdrawal by Subject|0|||
130881969|NCT04225897|471202462|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130881970|NCT04225897|471202463|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
130881971|NCT04225897|471202464|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130881972|NCT04225897|471202465|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130881973|NCT04225897|471202466|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130990522|NCT05672680|471593179|FG001|Overall Study|Patient Did Not Complete the Form|4|||
130990523|NCT05672680|471593178|FG000|Overall Study|Procedure Aborted|1|||
130881974|NCT04225897|471202467|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130881975|NCT04225897|471202468|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130881976|NCT04225897|471202469|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130881977|NCT04225897|471202470|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130881978|NCT04225897|471202471|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130881979|NCT04225897|471202472|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130881980|NCT04225897|471202473|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130881981|NCT04225897|471202462|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130881982|NCT04225897|471202463|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130881983|NCT04225897|471202464|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
130881984|NCT04225897|471202465|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130881985|NCT04225897|471202466|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130881986|NCT04225897|471202467|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130881987|NCT04225897|471202468|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130881988|NCT04225897|471202469|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130881989|NCT04225897|471202470|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130881990|NCT04225897|471202471|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130881991|NCT04225897|471202472|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130881992|NCT04225897|471202473|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130990524|NCT05672680|471593179|FG001|Overall Study|Procedure Aborted|0|||
130990525|NCT01395823|471593184|FG000|Overall Study|Death|4|||
130990526|NCT01395823|471593185|FG001|Overall Study|Death|4|||
130990527|NCT01395823|471593184|FG000|Overall Study|Physician Decision|3|||
130990528|NCT01395823|471593185|FG001|Overall Study|Physician Decision|1|||
130990529|NCT01395823|471593184|FG000|Overall Study|Lost to Follow-up|1|||
130990530|NCT01395823|471593185|FG001|Overall Study|Lost to Follow-up|0|||
130990531|NCT01395823|471593184|FG000|Overall Study|Transplant|1|||
130990532|NCT01395823|471593185|FG001|Overall Study|Transplant|0|||
130990533|NCT01395823|471593184|FG000|Overall Study|GI symptoms|1|||
130990534|NCT01395823|471593185|FG001|Overall Study|GI symptoms|0|||
130990535|NCT01395823|471593184|FG000|Overall Study|Withdrawal by Subject|5|||
130990536|NCT01395823|471593185|FG001|Overall Study|Withdrawal by Subject|4|||
130990537|NCT01036022|471593186|FG000|Overall Study|Adverse Event|1|||
130990538|NCT01036022|471593187|FG001|Overall Study|Adverse Event|3|||
130990539|NCT01036022|471593188|FG002|Overall Study|Adverse Event|2|||
130990540|NCT01036022|471593189|FG003|Overall Study|Adverse Event|1|||
130990541|NCT01036022|471593190|FG004|Overall Study|Adverse Event|0|||
130990542|NCT01036022|471593191|FG005|Overall Study|Adverse Event|2|||
130990543|NCT01036022|471593186|FG000|Overall Study|Lack of Efficacy|1|||
130990544|NCT01036022|471593187|FG001|Overall Study|Lack of Efficacy|1|||
130990545|NCT01036022|471593188|FG002|Overall Study|Lack of Efficacy|1|||
130990546|NCT01036022|471593189|FG003|Overall Study|Lack of Efficacy|0|||
130990547|NCT01036022|471593190|FG004|Overall Study|Lack of Efficacy|1|||
130990548|NCT01036022|471593191|FG005|Overall Study|Lack of Efficacy|1|||
130990549|NCT01036022|471593186|FG000|Overall Study|Physician Decision|0|||
130990550|NCT01036022|471593187|FG001|Overall Study|Physician Decision|0|||
130990551|NCT01036022|471593188|FG002|Overall Study|Physician Decision|1|||
130990552|NCT01036022|471593189|FG003|Overall Study|Physician Decision|0|||
130990553|NCT01036022|471593190|FG004|Overall Study|Physician Decision|0|||
130990554|NCT01036022|471593191|FG005|Overall Study|Physician Decision|0|||
130990555|NCT01036022|471593186|FG000|Overall Study|Withdrawal by Subject|0|||
130990556|NCT01036022|471593187|FG001|Overall Study|Withdrawal by Subject|0|||
130990557|NCT01036022|471593188|FG002|Overall Study|Withdrawal by Subject|0|||
130990558|NCT01036022|471593189|FG003|Overall Study|Withdrawal by Subject|1|||
130990559|NCT01036022|471593190|FG004|Overall Study|Withdrawal by Subject|2|||
130990560|NCT01036022|471593191|FG005|Overall Study|Withdrawal by Subject|0|||
130990561|NCT03300570|471593192|FG000|Overall Study|Adverse Event|0|||
130990562|NCT03300570|471593193|FG001|Overall Study|Adverse Event|1|||
130990563|NCT03300570|471593192|FG000|Overall Study|Withdrawal by Subject|1|||
130990564|NCT03300570|471593193|FG001|Overall Study|Withdrawal by Subject|0|||
130990565|NCT03300570|471593192|FG000|Overall Study|Inadequate bowel prep|1|||
130990566|NCT03300570|471593193|FG001|Overall Study|Inadequate bowel prep|0|||
130990567|NCT05076149|471593196|FG000|Overall Study|Adverse Event|3|||
130990568|NCT05076149|471593197|FG001|Overall Study|Adverse Event|9|||
130990569|NCT05076149|471593196|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130990570|NCT05076149|471593197|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
130990571|NCT05076149|471593196|FG000|Overall Study|Lost to Follow-up|0|||
130990572|NCT05076149|471593197|FG001|Overall Study|Lost to Follow-up|1|||
130990573|NCT05076149|471593196|FG000|Overall Study|Commercial drug is available for participant|0|||
130990574|NCT05076149|471593197|FG001|Overall Study|Commercial drug is available for participant|1|||
130990575|NCT05076149|471593196|FG000|Overall Study|Other non compliance|1|||
130990576|NCT05076149|471593197|FG001|Overall Study|Other non compliance|1|||
130990577|NCT05076149|471593196|FG000|Overall Study|Physician Decision|0|||
131100323|NCT04772898|471996310|FG001|Overall Study|Withdrawal by Subject|1|||
131100324|NCT02947087|471996311|FG000|Overall Study|Withdrawal by Subject|3|||
131100325|NCT02947087|471996312|FG001|Overall Study|Withdrawal by Subject|2|||
131100326|NCT01983254|471996316|FG000|Overall Study|Death|6|||
131100327|NCT01983254|471996317|FG001|Overall Study|Death|6|||
131100328|NCT01983254|471996316|FG000|Overall Study|Lost to Follow-up|17|||
131100329|NCT01983254|471996317|FG001|Overall Study|Lost to Follow-up|16|||
131100330|NCT01983254|471996316|FG000|Overall Study|too ill|11|||
131100331|NCT01983254|471996317|FG001|Overall Study|too ill|8|||
131100332|NCT04988867|471996322|FG000|Overall Study|Study terminated by Sponsor|12|||
131100333|NCT04988867|471996322|FG000|Overall Study|Adverse Event|2|||
131100334|NCT04988867|471996322|FG000|Overall Study|Study drug noncompliance|1|||
131100335|NCT01699503|471996325|FG000|Overall Study|Death|31|||
131100336|NCT01699503|471996326|FG001|Overall Study|Death|40|||
131100337|NCT01699503|471996325|FG000|Overall Study|Withdrawal by Subject|65|||
131100338|NCT01699503|471996326|FG001|Overall Study|Withdrawal by Subject|57|||
131100339|NCT01699503|471996325|FG000|Overall Study|Lost to Follow-up|121|||
131100340|NCT01699503|471996326|FG001|Overall Study|Lost to Follow-up|117|||
131100341|NCT01699503|471996325|FG000|Overall Study|Excluded due to quality|783|||
131100342|NCT01699503|471996326|FG001|Overall Study|Excluded due to quality|791|||
131100343|NCT00635427|471996333|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
131100344|NCT00635427|471996334|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
131100345|NCT00635427|471996335|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
131100346|NCT00635427|471996336|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
131100347|NCT00635427|471996337|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
131100348|NCT00635427|471996333|FG000|Overall Study|Death|0|||
131100349|NCT00635427|471996334|FG001|Overall Study|Death|0|||
131100350|NCT00635427|471996335|FG002|Overall Study|Death|0|||
131100351|NCT00635427|471996336|FG003|Overall Study|Death|1|||
131100352|NCT00635427|471996337|FG004|Overall Study|Death|0|||
131100353|NCT00635427|471996333|FG000|Overall Study|Termination Of Study By Sponsor|12|||
131100354|NCT00635427|471996334|FG001|Overall Study|Termination Of Study By Sponsor|6|||
131100355|NCT00635427|471996335|FG002|Overall Study|Termination Of Study By Sponsor|10|||
131100356|NCT00635427|471996336|FG003|Overall Study|Termination Of Study By Sponsor|6|||
131100357|NCT00635427|471996337|FG004|Overall Study|Termination Of Study By Sponsor|6|||
131100358|NCT00635427|471996333|FG000|Overall Study|Withdrawal Of Consent|0|||
131100359|NCT00635427|471996334|FG001|Overall Study|Withdrawal Of Consent|0|||
131100360|NCT00635427|471996335|FG002|Overall Study|Withdrawal Of Consent|0|||
131100361|NCT00635427|471996336|FG003|Overall Study|Withdrawal Of Consent|2|||
131100362|NCT00635427|471996337|FG004|Overall Study|Withdrawal Of Consent|2|||
131100363|NCT03412747|471996340|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
131100364|NCT03412747|471996341|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
131100365|NCT03412747|471996342|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
131100366|NCT03412747|471996340|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
131100367|NCT03412747|471996341|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
131100368|NCT03412747|471996342|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
131100369|NCT03412747|471996340|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
131100370|NCT03412747|471996341|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
131100371|NCT03412747|471996342|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
131100372|NCT03412747|471996340|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
131100373|NCT03412747|471996341|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
131100374|NCT03412747|471996342|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
131100375|NCT03412747|471996340|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
131100376|NCT03412747|471996341|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
131100377|NCT03412747|471996342|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
131100378|NCT03412747|471996340|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
131100379|NCT03412747|471996341|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
131100380|NCT03412747|471996342|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
131100381|NCT03412747|471996340|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
131100382|NCT03412747|471996341|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
131100383|NCT03412747|471996342|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
131100384|NCT03412747|471996340|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
131100385|NCT03412747|471996341|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
131100386|NCT03412747|471996342|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
131100387|NCT03412747|471996340|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
131100388|NCT03412747|471996341|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
131100389|NCT03412747|471996342|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
131100390|NCT03412747|471996340|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
131100391|NCT03412747|471996341|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
131100392|NCT03412747|471996342|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
131100393|NCT03412747|471996340|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
131100394|NCT03412747|471996341|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
131100395|NCT03412747|471996342|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
131100396|NCT03412747|471996340|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
131100397|NCT03412747|471996341|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
131100398|NCT03412747|471996342|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
131100399|NCT03412747|471996340|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
131100400|NCT03412747|471996341|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
131100401|NCT03412747|471996342|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
131100402|NCT03412747|471996340|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
131100403|NCT03412747|471996341|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
131100404|NCT03412747|471996342|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
131100405|NCT03412747|471996340|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
131100406|NCT03412747|471996341|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
131100407|NCT03412747|471996342|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
131100408|NCT03412747|471996340|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
131100409|NCT03412747|471996341|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
131100410|NCT03412747|471996342|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
131100411|NCT02081417|471996343|FG000|Overall Study|Lost to Follow-up|26|||
131100412|NCT02081417|471996344|FG001|Overall Study|Lost to Follow-up|23|||
131100413|NCT02081417|471996343|FG000|Overall Study|Moved Away|1|||
131100414|NCT02081417|471996344|FG001|Overall Study|Moved Away|2|||
131100415|NCT02081417|471996343|FG000|Overall Study|Incarcerated|2|||
131100416|NCT02081417|471996344|FG001|Overall Study|Incarcerated|2|||
131100417|NCT02081417|471996343|FG000|Overall Study|Death|4|||
131100418|NCT02081417|471996344|FG001|Overall Study|Death|3|||
131100419|NCT02081417|471996343|FG000|Overall Study|Withdrawal by Subject|4|||
131100420|NCT02081417|471996344|FG001|Overall Study|Withdrawal by Subject|0|||
131100421|NCT02081417|471996343|FG000|Overall Study|Admitted to Residential Treatment|2|||
131100422|NCT02081417|471996344|FG001|Overall Study|Admitted to Residential Treatment|0|||
131100423|NCT02081417|471996343|FG000|Overall Study|Did not start treatment|17|||
131100424|NCT02081417|471996344|FG001|Overall Study|Did not start treatment|21|||
131100425|NCT01263665|471996348|FG000|Overall Study|Withdrew Consent|1|||
131100426|NCT01263665|471996348|FG000|Overall Study|Lost to Follow-up|3|||
131100427|NCT01263665|471996348|FG000|Overall Study|Death|2|||
131100428|NCT01263665|471996348|FG000|Overall Study|Amputation above the ankle|1|||
131100429|NCT01263665|471996348|FG000|Overall Study|Surgical Bypass|2|||
131100430|NCT00324675|471996350|FG000|Overall Study|Adverse Event|1|||
131100431|NCT00324675|471996351|FG001|Overall Study|Adverse Event|0|||
131100432|NCT00381615|471996352|FG000|Overall Study|Withdrawal by Subject|1|||
131100433|NCT00381615|471996353|FG001|Overall Study|Withdrawal by Subject|3|||
131100434|NCT00381615|471996354|FG002|Overall Study|Withdrawal by Subject|0|||
131100435|NCT00381615|471996355|FG003|Overall Study|Withdrawal by Subject|1|||
131100436|NCT00381615|471996352|FG000|Overall Study|Lost to Follow-up|3|||
131100437|NCT00381615|471996353|FG001|Overall Study|Lost to Follow-up|2|||
131100438|NCT00381615|471996354|FG002|Overall Study|Lost to Follow-up|0|||
131100439|NCT00381615|471996355|FG003|Overall Study|Lost to Follow-up|1|||
131100440|NCT00381615|471996352|FG000|Overall Study|Protocol Violation|0|||
131100441|NCT00381615|471996353|FG001|Overall Study|Protocol Violation|0|||
131100442|NCT00381615|471996354|FG002|Overall Study|Protocol Violation|1|||
131100443|NCT00381615|471996355|FG003|Overall Study|Protocol Violation|0|||
131100444|NCT01801735|471996358|FG000|Overall Study|Adverse Event|79|||
131100445|NCT01801735|471996358|FG000|Overall Study|Lack of Efficacy|28|||
131100446|NCT01801735|471996358|FG000|Overall Study|Withdrawal by Subject|27|||
130881993|NCT04225897|471202462|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130881994|NCT04225897|471202463|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130881995|NCT04225897|471202464|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
130881996|NCT04225897|471202465|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130881997|NCT04225897|471202466|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130881998|NCT04225897|471202467|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130881999|NCT04225897|471202468|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130882000|NCT04225897|471202469|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130882001|NCT04225897|471202470|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130882002|NCT04225897|471202471|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130882003|NCT04225897|471202472|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130882004|NCT04225897|471202473|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
131100447|NCT01801735|471996358|FG000|Overall Study|Protocol Violation|25|||
131100448|NCT01801735|471996358|FG000|Overall Study|Lost to Follow-up|15|||
131100449|NCT01801735|471996358|FG000|Overall Study|Non-compliance with Trial Drug|13|||
131100450|NCT01801735|471996358|FG000|Overall Study|Physician Decision|3|||
131100451|NCT01801735|471996358|FG000|Overall Study|Death|1|||
131100452|NCT01801735|471996358|FG000|Overall Study|Other, including site closure|19|||
131100453|NCT01435616|471996359|FG000|Overall Study|Adverse Event|39|||
131100454|NCT01435616|471996360|FG001|Overall Study|Adverse Event|21|||
130882005|NCT04225897|471202462|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130882006|NCT04225897|471202463|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130882007|NCT04225897|471202464|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
131100455|NCT01435616|471996359|FG000|Overall Study|Death|7|||
131100456|NCT01435616|471996360|FG001|Overall Study|Death|2|||
131100457|NCT01435616|471996359|FG000|Overall Study|Lost to Follow-up|22|||
131100458|NCT01435616|471996360|FG001|Overall Study|Lost to Follow-up|13|||
131100459|NCT01435616|471996359|FG000|Overall Study|Protocol Violation|16|||
131100460|NCT01435616|471996360|FG001|Overall Study|Protocol Violation|13|||
131100461|NCT01435616|471996359|FG000|Overall Study|Withdrawal by Subject|66|||
131100462|NCT01435616|471996360|FG001|Overall Study|Withdrawal by Subject|24|||
131100463|NCT01435616|471996359|FG000|Overall Study|Physician Decision|20|||
131213436|NCT00762073|472405348|FG002|Overall Study|Withdrawal by Subject|1|||
131213437|NCT00762073|472405349|FG003|Overall Study|Withdrawal by Subject|1|||
131213438|NCT00762073|472405346|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
131213439|NCT00762073|472405347|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
131213440|NCT00762073|472405348|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
131213441|NCT00762073|472405349|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
131213442|NCT00491322|472405351|FG000|Overall Study|Protocol Violation|1|||
131213443|NCT00491322|472405352|FG001|Overall Study|Protocol Violation|0|||
131213444|NCT00491322|472405351|FG000|Overall Study|Pregnancy|0|||
131213445|NCT00491322|472405352|FG001|Overall Study|Pregnancy|1|||
131213446|NCT00455923|472405353|FG000|Overall Study|Pregnancy|0|||
131213447|NCT00455923|472405354|FG001|Overall Study|Pregnancy|2|||
131213448|NCT00455923|472405353|FG000|Overall Study|Other|3|||
131213449|NCT00455923|472405354|FG001|Overall Study|Other|1|||
131213450|NCT03426995|472405355|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213451|NCT03426995|472405356|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213452|NCT03426995|472405357|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
131213453|NCT03426995|472405358|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213454|NCT03426995|472405359|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213455|NCT03426995|472405360|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213456|NCT03426995|472405361|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213457|NCT03426995|472405362|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213458|NCT03426995|472405363|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213459|NCT03426995|472405364|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213460|NCT03426995|472405365|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213461|NCT03426995|472405366|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213462|NCT03426995|472405367|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213463|NCT03426995|472405368|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213464|NCT03426995|472405369|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213465|NCT03426995|472405370|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213466|NCT03426995|472405371|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213467|NCT03426995|472405372|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
131213468|NCT03426995|472405373|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130882008|NCT04225897|471202465|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130882009|NCT04225897|471202466|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130882010|NCT04225897|471202467|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130882011|NCT04225897|471202468|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130882012|NCT04225897|471202469|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
130882013|NCT04225897|471202470|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130882014|NCT04225897|471202471|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130882015|NCT04225897|471202472|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130882016|NCT04225897|471202473|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130882017|NCT02703597|471202474|FG000|Assignment to Baseline|Lost to Follow-up|17|||
130882018|NCT02703597|471202475|FG001|Assignment to Baseline|Lost to Follow-up|16|||
130882019|NCT02703597|471202474|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
130882020|NCT02703597|471202475|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
130882021|NCT02703597|471202474|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
130882022|NCT02703597|471202475|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
130882023|NCT02703597|471202474|FG000|First Post-test to First Follow-up|Site drop out|0|||
130882024|NCT02703597|471202475|FG001|First Post-test to First Follow-up|Site drop out|58|||
130882025|NCT02703597|471202474|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
131213469|NCT03426995|472405355|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131100464|NCT01435616|471996360|FG001|Overall Study|Physician Decision|7|||
131100465|NCT01435616|471996359|FG000|Overall Study|Sponsor Decision|1|||
131100466|NCT01435616|471996360|FG001|Overall Study|Sponsor Decision|0|||
131213470|NCT03426995|472405356|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213471|NCT03426995|472405357|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213472|NCT03426995|472405358|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213473|NCT03426995|472405359|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213474|NCT03426995|472405360|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
131213475|NCT03426995|472405361|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213476|NCT03426995|472405362|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213477|NCT03426995|472405363|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130882026|NCT02703597|471202475|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
130882027|NCT02703597|471202474|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
130882028|NCT02703597|471202475|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
130882029|NCT02703597|471202474|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
130882030|NCT02703597|471202475|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
130882031|NCT02131259|471202476|FG000|Overall Study|Progressive disease|751|||
130882032|NCT02131259|471202476|FG000|Overall Study|Adverse Event|341|||
130882033|NCT02131259|471202476|FG000|Overall Study|Lost to Follow-up|7|||
130882034|NCT02131259|471202476|FG000|Overall Study|Relocation|32|||
130882035|NCT02131259|471202476|FG000|Overall Study|Other|63|||
130882036|NCT02131259|471202476|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
130882037|NCT02131259|471202476|FG000|Overall Study|Progressive disease/relocation|1|||
130882038|NCT02131259|471202476|FG000|Overall Study|Progressive disease/other|2|||
130882039|NCT02131259|471202476|FG000|Overall Study|AE/lost to follow-up|1|||
130882040|NCT02131259|471202476|FG000|Overall Study|AE/other|1|||
130882041|NCT02131259|471202476|FG000|Overall Study|Progressive disease/AE/other|1|||
130882042|NCT02131259|471202476|FG000|Overall Study|Missing|3|||
130882043|NCT02796170|471202477|FG000|Overall Study|Lost to Follow-up|3|||
130882044|NCT02796170|471202478|FG001|Overall Study|Lost to Follow-up|0|||
130882045|NCT00003475|471202481|FG000|Overall Study|Not evaluable|13|||
130882046|NCT03818321|471202482|FG000|Overall Study|Withdrawal by Subject|1|||
130882047|NCT03818321|471202483|FG001|Overall Study|Withdrawal by Subject|2|||
130882048|NCT01867671|471202487|FG000|Overall Study|Adverse Event|5|||
130882049|NCT01867671|471202488|FG001|Overall Study|Adverse Event|3|||
130882050|NCT01867671|471202487|FG000|Overall Study|Anaphylaxis|0|||
130882051|NCT01867671|471202488|FG001|Overall Study|Anaphylaxis|1|||
130882052|NCT01867671|471202487|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
130882053|NCT01867671|471202488|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
130882054|NCT01867671|471202487|FG000|Overall Study|Lost to Follow-up|0|||
130882055|NCT01867671|471202488|FG001|Overall Study|Lost to Follow-up|1|||
130882056|NCT01867671|471202487|FG000|Overall Study|Non-compliance with Study Drug|1|||
130882057|NCT01867671|471202488|FG001|Overall Study|Non-compliance with Study Drug|2|||
130882058|NCT01867671|471202487|FG000|Overall Study|Withdrawal by Subject|21|||
130882059|NCT01867671|471202488|FG001|Overall Study|Withdrawal by Subject|21|||
130882060|NCT01523366|471202489|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130882061|NCT01523366|471202490|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130882062|NCT01523366|471202489|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
130882063|NCT01523366|471202490|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
130882064|NCT04543279|471202495|FG000|Overall Study|Withdrawal by Subject|1|||
130882065|NCT04543279|471202496|FG001|Overall Study|Withdrawal by Subject|0|||
130882066|NCT04543279|471202495|FG000|Overall Study|Adverse Event|1|||
130882067|NCT04543279|471202496|FG001|Overall Study|Adverse Event|0|||
130882068|NCT04543279|471202495|FG000|Overall Study|Physician Decision|1|||
130882069|NCT04543279|471202496|FG001|Overall Study|Physician Decision|0|||
130882070|NCT05249582|471202500|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
130882071|NCT05249582|471202501|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
130882072|NCT05249582|471202500|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
130882073|NCT05249582|471202501|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
130882074|NCT05249582|471202500|FG000|Overall Study|Declined to use virtual reality headset|1|||
130882075|NCT05249582|471202501|FG001|Overall Study|Declined to use virtual reality headset|0|||
130882076|NCT03675126|471202502|FG000|Overall Study|Study Terminated by Sponsor|9|||
130882077|NCT03675126|471202502|FG000|Overall Study|Death|2|||
130882078|NCT03675126|471202502|FG000|Overall Study|Withdrawal by Subject|4|||
130882079|NCT00001959|471202503|FG000|Overall Study|newly diagnosed colon cancer|1|||
130882080|NCT00001959|471202503|FG000|Overall Study|disabling sedation|1|||
130882081|NCT00001959|471202503|FG000|Overall Study|non-compliance|1|||
130882082|NCT04189952|471202505|FG000|Follow-up Period|Death|1|||
130882083|NCT04189952|471202505|FG000|Follow-up Period|Withdrawal by Subject|1|||
130882084|NCT01052493|471202506|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
130882085|NCT01052493|471202507|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
130882086|NCT01052493|471202508|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
130882087|NCT01498068|471202509|FG000|Overall Study|Withdrawal by Subject|1|||
130882088|NCT01498068|471202510|FG001|Overall Study|Withdrawal by Subject|1|||
131213478|NCT03426995|472405364|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213479|NCT03426995|472405365|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213480|NCT03426995|472405366|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213481|NCT03426995|472405367|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213482|NCT03426995|472405368|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213483|NCT03426995|472405369|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213484|NCT03426995|472405370|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213485|NCT03426995|472405371|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213486|NCT03426995|472405372|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213487|NCT03426995|472405373|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
131213488|NCT03426995|472405355|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213489|NCT03426995|472405356|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213490|NCT03426995|472405357|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213491|NCT03426995|472405358|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213492|NCT03426995|472405359|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
131213493|NCT03426995|472405360|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
131213494|NCT03426995|472405361|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213495|NCT03426995|472405362|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213496|NCT03426995|472405363|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213497|NCT03426995|472405364|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213498|NCT03426995|472405365|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213499|NCT03426995|472405366|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213500|NCT03426995|472405367|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213501|NCT03426995|472405368|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213502|NCT03426995|472405369|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213503|NCT03426995|472405370|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213504|NCT03426995|472405371|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213505|NCT03426995|472405372|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213506|NCT03426995|472405373|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
131213507|NCT03426995|472405355|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213508|NCT03426995|472405356|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213509|NCT03426995|472405357|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213510|NCT03426995|472405358|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213511|NCT03426995|472405359|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213512|NCT03426995|472405360|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213513|NCT03426995|472405361|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213514|NCT03426995|472405362|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213515|NCT03426995|472405363|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213516|NCT03426995|472405364|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213517|NCT03426995|472405365|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
131213518|NCT03426995|472405366|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130882089|NCT00283296|471202513|FG000|Overall Study|in-home trial not completed|5|||
130882090|NCT01353898|471202514|FG000|Overall Study|Study site terminated|0|||
130882091|NCT01353898|471202515|FG001|Overall Study|Study site terminated|0|||
130882092|NCT01353898|471202516|FG002|Overall Study|Study site terminated|0|||
130882093|NCT01353898|471202517|FG003|Overall Study|Study site terminated|0|||
130882094|NCT01353898|471202518|FG004|Overall Study|Study site terminated|0|||
130882095|NCT01353898|471202519|FG005|Overall Study|Study site terminated|1|||
130882096|NCT03558737|471202522|FG000|Overall Study|Death|1|||
130882097|NCT03558737|471202523|FG001|Overall Study|Death|1|||
130882098|NCT02158442|471202524|FG000|Overall Study|Withdrawal by Subject|1|||
130882099|NCT02158442|471202525|FG001|Overall Study|Withdrawal by Subject|0|||
130882100|NCT02158442|471202524|FG000|Overall Study|Perfusion staff not available|1|||
130882101|NCT02158442|471202525|FG001|Overall Study|Perfusion staff not available|0|||
130882102|NCT01318915|471202526|FG000|Overall Study|Lost to Follow-up|1|||
130882103|NCT00453206|471202528|FG000|Overall Study|Death|1|||
130882104|NCT03866577|471202530|FG000|Overall Study|Protocol Violation|0|||
130882105|NCT03866577|471202531|FG001|Overall Study|Protocol Violation|0|||
130882106|NCT03866577|471202532|FG002|Overall Study|Protocol Violation|0|||
130882107|NCT03866577|471202533|FG003|Overall Study|Protocol Violation|0|||
130882108|NCT03866577|471202534|FG004|Overall Study|Protocol Violation|0|||
130882109|NCT03866577|471202535|FG005|Overall Study|Protocol Violation|0|||
130882110|NCT03866577|471202536|FG006|Overall Study|Protocol Violation|0|||
130882111|NCT03866577|471202537|FG007|Overall Study|Protocol Violation|0|||
130882112|NCT03866577|471202538|FG008|Overall Study|Protocol Violation|0|||
131213519|NCT03426995|472405367|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213520|NCT03426995|472405368|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213521|NCT03426995|472405369|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130882113|NCT03866577|471202539|FG009|Overall Study|Protocol Violation|0|||
130882114|NCT03866577|471202540|FG010|Overall Study|Protocol Violation|0|||
130882115|NCT03866577|471202541|FG011|Overall Study|Protocol Violation|1|||
131213522|NCT03426995|472405370|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213523|NCT03426995|472405371|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213524|NCT03426995|472405372|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213525|NCT03426995|472405373|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
131213526|NCT03426995|472405355|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213527|NCT03426995|472405356|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213528|NCT03426995|472405357|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213529|NCT03426995|472405358|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213530|NCT03426995|472405359|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213531|NCT03426995|472405360|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213532|NCT03426995|472405361|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213533|NCT03426995|472405362|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
131213534|NCT03426995|472405363|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213535|NCT03426995|472405364|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213536|NCT03426995|472405365|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213537|NCT03426995|472405366|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213538|NCT03426995|472405367|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213539|NCT03426995|472405368|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213540|NCT03426995|472405369|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213541|NCT03426995|472405370|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213542|NCT03426995|472405371|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213543|NCT03426995|472405372|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213544|NCT03426995|472405373|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
131213545|NCT03426995|472405355|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213546|NCT03426995|472405356|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213547|NCT03426995|472405357|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213548|NCT03426995|472405358|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213549|NCT03426995|472405359|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213550|NCT03426995|472405360|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213551|NCT03426995|472405361|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213552|NCT03426995|472405362|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213553|NCT03426995|472405363|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213554|NCT03426995|472405364|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213555|NCT03426995|472405365|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213556|NCT03426995|472405366|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213557|NCT03426995|472405367|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213558|NCT03426995|472405368|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213559|NCT03426995|472405369|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
131213560|NCT03426995|472405370|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
131213561|NCT03426995|472405371|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213562|NCT03426995|472405372|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213563|NCT03426995|472405373|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
131213564|NCT03426995|472405355|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213565|NCT03426995|472405356|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213566|NCT03426995|472405357|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213567|NCT03426995|472405358|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213568|NCT03426995|472405359|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213569|NCT03426995|472405360|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213570|NCT03426995|472405361|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213571|NCT03426995|472405362|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213572|NCT03426995|472405363|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213573|NCT03426995|472405364|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213574|NCT03426995|472405365|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213575|NCT03426995|472405366|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213576|NCT03426995|472405367|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213577|NCT03426995|472405368|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213578|NCT03426995|472405369|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
131213579|NCT03426995|472405370|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
131213580|NCT03426995|472405371|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213581|NCT03426995|472405372|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130765815|NCT02614131|470765855|FG000|Overall Study|Withdrawal by Subject|1|||
131213582|NCT03426995|472405373|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
131213583|NCT04410978|472405379|FG000|Overall Study|Poor compliance to protocol|2|||
131213584|NCT04410978|472405380|FG001|Overall Study|Poor compliance to protocol|4|||
130765816|NCT02614131|470765856|FG001|Overall Study|Withdrawal by Subject|0|||
130765817|NCT02614131|470765857|FG002|Overall Study|Withdrawal by Subject|0|||
130882116|NCT03866577|471202542|FG012|Overall Study|Protocol Violation|0|||
131100467|NCT01528345|471996361|FG000|Overall Study|Adverse Event|10|||
131100468|NCT01528345|471996362|FG001|Overall Study|Adverse Event|1|||
131100469|NCT01528345|471996361|FG000|Overall Study|Death|1|||
131100470|NCT01528345|471996362|FG001|Overall Study|Death|1|||
131100471|NCT01528345|471996361|FG000|Overall Study|Non-compliance with study treatment|1|||
131100472|NCT01528345|471996362|FG001|Overall Study|Non-compliance with study treatment|0|||
131100473|NCT01528345|471996361|FG000|Overall Study|Progressive Disease|26|||
131100474|NCT01528345|471996362|FG001|Overall Study|Progressive Disease|40|||
131100475|NCT01528345|471996361|FG000|Overall Study|Study Terminated by Sponsor|4|||
131100476|NCT01528345|471996362|FG001|Overall Study|Study Terminated by Sponsor|8|||
131100477|NCT01528345|471996361|FG000|Overall Study|Subject/Guardian Decision|5|||
131100478|NCT01528345|471996362|FG001|Overall Study|Subject/Guardian Decision|0|||
131100479|NCT01151410|471996364|FG000|Overall Study|Withdrawal by Subject|3|||
131100480|NCT01151410|471996365|FG001|Overall Study|Withdrawal by Subject|5|||
131100481|NCT01151410|471996364|FG000|Overall Study|Lost to Follow-up|3|||
131100482|NCT01151410|471996365|FG001|Overall Study|Lost to Follow-up|4|||
131100483|NCT01151410|471996364|FG000|Overall Study|Adverse Event|1|||
131100484|NCT01151410|471996365|FG001|Overall Study|Adverse Event|2|||
131100485|NCT01151410|471996364|FG000|Overall Study|Protocol deviation|2|||
131100486|NCT01151410|471996365|FG001|Overall Study|Protocol deviation|1|||
131100487|NCT01151410|471996364|FG000|Overall Study|Administrative problems|1|||
131100488|NCT01151410|471996365|FG001|Overall Study|Administrative problems|1|||
131100489|NCT01151410|471996364|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131100490|NCT01151410|471996365|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131100491|NCT01151410|471996364|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131100492|NCT01151410|471996365|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131100493|NCT00735475|471996366|FG000|Overall Study|Adverse Event|0|||
131100494|NCT00735475|471996367|FG001|Overall Study|Adverse Event|1|||
131100495|NCT00735475|471996366|FG000|Overall Study|Death|1|||
131100496|NCT00735475|471996367|FG001|Overall Study|Death|1|||
131100497|NCT00735475|471996366|FG000|Overall Study|Lost to Follow-up|3|||
131100498|NCT00735475|471996367|FG001|Overall Study|Lost to Follow-up|3|||
131100499|NCT00735475|471996366|FG000|Overall Study|Physician Decision|0|||
131100500|NCT00735475|471996367|FG001|Overall Study|Physician Decision|1|||
131100501|NCT00735475|471996366|FG000|Overall Study|Withdrawal by Subject|4|||
131100502|NCT00735475|471996367|FG001|Overall Study|Withdrawal by Subject|5|||
131100503|NCT01080716|471996369|FG000|Part 1|Physician Decision|1|||
131100504|NCT01080716|471996370|FG001|Part 1|Physician Decision|0|||
131100505|NCT01080716|471996371|FG002|Part 1|Physician Decision|0|||
131100506|NCT01080716|471996372|FG003|Part 1|Physician Decision|0|||
131100507|NCT05086276|471996373|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
131100508|NCT05086276|471996374|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
131100509|NCT00760474|471996381|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
131100510|NCT00760474|471996382|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
131100511|NCT00760474|471996381|FG000|Placebo Washout Period|Other|0|||
131100512|NCT00760474|471996382|FG001|Placebo Washout Period|Other|1|||
131100513|NCT00760474|471996381|FG000|Period 2 (P2)|Lost to Follow-up|1|||
131100514|NCT00760474|471996382|FG001|Period 2 (P2)|Lost to Follow-up|0|||
131100515|NCT00760474|471996381|FG000|Period 2 (P2)|Adverse Event|0|||
131100516|NCT00760474|471996382|FG001|Period 2 (P2)|Adverse Event|1|||
131100517|NCT02217501|471996388|FG000|Overall Study|Death|3|||
131100518|NCT02217501|471996389|FG001|Overall Study|Death|4|||
131100519|NCT00775463|471998011|FG000|Overall Study|Withdrawal by Subject|0|||
131100520|NCT00775463|471998012|FG001|Overall Study|Withdrawal by Subject|1|||
131100521|NCT00775463|471998011|FG000|Overall Study|Adverse Event|7|||
131100522|NCT00775463|471998012|FG001|Overall Study|Adverse Event|9|||
131100523|NCT00775463|471998011|FG000|Overall Study|Protocol Violation|2|||
131100524|NCT00775463|471998012|FG001|Overall Study|Protocol Violation|2|||
131100525|NCT00775463|471998011|FG000|Overall Study|Lost to Follow-up|1|||
131100526|NCT00775463|471998012|FG001|Overall Study|Lost to Follow-up|0|||
131100527|NCT00775463|471998011|FG000|Overall Study|Lack of Efficacy|1|||
131100528|NCT00775463|471998012|FG001|Overall Study|Lack of Efficacy|1|||
131100529|NCT01238900|471998013|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
131100530|NCT01238900|471998013|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
131100531|NCT03836716|471998017|FG000|Overall Study|Adverse Event|3|||
131100532|NCT03836716|471998017|FG000|Overall Study|Death|22|||
131100533|NCT03836716|471998017|FG000|Overall Study|Withdrawal by Subject|8|||
131100534|NCT03836716|471998017|FG000|Overall Study|Study terminated by sponsor|87|||
131100535|NCT00434213|471998018|FG000|Overall Study|Adverse Event|12|||
131100536|NCT00434213|471998018|FG000|Overall Study|Lack of Efficacy|9|||
131100537|NCT00434213|471998018|FG000|Overall Study|Lost to Follow-up|14|||
131100538|NCT00434213|471998018|FG000|Overall Study|Withdrawal by Subject|7|||
131100539|NCT00434213|471998018|FG000|Overall Study|Protocol Violation|3|||
131100540|NCT00434213|471998018|FG000|Overall Study|Unable to comply with study visit window|2|||
131100541|NCT00434213|471998018|FG000|Overall Study|Application site reaction|1|||
131100542|NCT00434213|471998018|FG000|Overall Study|Non-compliant to study schedule|1|||
131100543|NCT01631227|471998024|FG000|Overall Study|withdrawn consent|27|||
130882117|NCT03866577|471202530|FG000|Overall Study|Withdrawal by Subject|0|||
130882118|NCT03866577|471202531|FG001|Overall Study|Withdrawal by Subject|0|||
130882119|NCT03866577|471202532|FG002|Overall Study|Withdrawal by Subject|0|||
130882120|NCT03866577|471202533|FG003|Overall Study|Withdrawal by Subject|0|||
130882121|NCT03866577|471202534|FG004|Overall Study|Withdrawal by Subject|0|||
130882122|NCT03866577|471202535|FG005|Overall Study|Withdrawal by Subject|0|||
130882123|NCT03866577|471202536|FG006|Overall Study|Withdrawal by Subject|0|||
130882124|NCT03866577|471202537|FG007|Overall Study|Withdrawal by Subject|0|||
130882125|NCT03866577|471202538|FG008|Overall Study|Withdrawal by Subject|1|||
130882126|NCT03866577|471202539|FG009|Overall Study|Withdrawal by Subject|1|||
130882127|NCT03866577|471202540|FG010|Overall Study|Withdrawal by Subject|0|||
130882128|NCT03866577|471202541|FG011|Overall Study|Withdrawal by Subject|0|||
130882129|NCT03866577|471202542|FG012|Overall Study|Withdrawal by Subject|0|||
130882130|NCT03866577|471202530|FG000|Overall Study|Not qualified for IVIg infusion|0|||
130882131|NCT03866577|471202531|FG001|Overall Study|Not qualified for IVIg infusion|0|||
130882132|NCT03866577|471202532|FG002|Overall Study|Not qualified for IVIg infusion|0|||
130882133|NCT03866577|471202533|FG003|Overall Study|Not qualified for IVIg infusion|0|||
130882134|NCT03866577|471202534|FG004|Overall Study|Not qualified for IVIg infusion|0|||
130882135|NCT03866577|471202535|FG005|Overall Study|Not qualified for IVIg infusion|0|||
130882136|NCT03866577|471202536|FG006|Overall Study|Not qualified for IVIg infusion|0|||
130882137|NCT03866577|471202537|FG007|Overall Study|Not qualified for IVIg infusion|0|||
130882138|NCT03866577|471202538|FG008|Overall Study|Not qualified for IVIg infusion|0|||
130882139|NCT03866577|471202539|FG009|Overall Study|Not qualified for IVIg infusion|1|||
130882140|NCT03866577|471202540|FG010|Overall Study|Not qualified for IVIg infusion|0|||
130882141|NCT03866577|471202541|FG011|Overall Study|Not qualified for IVIg infusion|0|||
130882142|NCT03866577|471202542|FG012|Overall Study|Not qualified for IVIg infusion|0|||
130990578|NCT05076149|471593197|FG001|Overall Study|Physician Decision|1|||
130990579|NCT05076149|471593196|FG000|Overall Study|Other|5|||
130990580|NCT05076149|471593197|FG001|Overall Study|Other|4|||
130990581|NCT05096208|471593198|FG000|Overall Study|Lost to Follow-up|3|||
130990582|NCT05096208|471593199|FG001|Overall Study|Lost to Follow-up|5|||
130990583|NCT05096208|471593200|FG002|Overall Study|Lost to Follow-up|5|||
130990584|NCT05096208|471593201|FG003|Overall Study|Lost to Follow-up|2|||
130990585|NCT05096208|471593198|FG000|Overall Study|Withdrawal by Subject|0|||
130990586|NCT05096208|471593199|FG001|Overall Study|Withdrawal by Subject|1|||
130990587|NCT05096208|471593200|FG002|Overall Study|Withdrawal by Subject|2|||
130990588|NCT05096208|471593201|FG003|Overall Study|Withdrawal by Subject|3|||
130990589|NCT05096208|471593198|FG000|Overall Study|No longer met eligibility criteria|1|||
130990590|NCT05096208|471593199|FG001|Overall Study|No longer met eligibility criteria|0|||
130990591|NCT05096208|471593200|FG002|Overall Study|No longer met eligibility criteria|0|||
130990592|NCT05096208|471593201|FG003|Overall Study|No longer met eligibility criteria|0|||
130990593|NCT05096208|471593198|FG000|Overall Study|Other|0|||
130990594|NCT05096208|471593199|FG001|Overall Study|Other|0|||
130990595|NCT05096208|471593200|FG002|Overall Study|Other|1|||
130990596|NCT05096208|471593201|FG003|Overall Study|Other|0|||
130990597|NCT02087501|471593202|FG000|Overall Study|Death|7|||
130990598|NCT02087501|471593202|FG000|Overall Study|Open repair of aneurysm|1|||
130990599|NCT02087501|471593202|FG000|Overall Study|Lost to Follow-up|2|||
130990600|NCT00094328|471593203|FG000|Overall Study|Lost to Follow-up|1|||
130990601|NCT01483937|471593204|FG000|Overall Study|Withdrawal by Subject|4|||
130990602|NCT01483937|471593205|FG001|Overall Study|Withdrawal by Subject|3|||
130990603|NCT01875185|471593207|FG000|Overall Study|study was terminated|52|||
130990604|NCT01875185|471593208|FG001|Overall Study|study was terminated|48|||
130990613|NCT01686581|471593211|FG000|Overall Study|Side-effects or Health Problems|15|||
130990614|NCT01686581|471593211|FG000|Overall Study|Lack of Efficacy|90|||
130990615|NCT01686581|471593211|FG000|Overall Study|Participant Concerned about Risks|6|||
130990616|NCT01686581|471593211|FG000|Overall Study|Thinks Injections Too Painful|8|||
130990617|NCT01686581|471593211|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
130990618|NCT01686581|471593211|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
130990619|NCT01686581|471593211|FG000|Overall Study|Thinks it is Inconvenient|17|||
130990620|NCT01686581|471593211|FG000|Overall Study|Other Miscellaneous Reasons|36|||
130990621|NCT01686581|471593211|FG000|Overall Study|Reason Missing|1|||
130990622|NCT00399763|471593212|FG000|Overall Study|Lost to Follow-up|2|||
130990623|NCT00399763|471593213|FG001|Overall Study|Lost to Follow-up|3|||
130990624|NCT04182880|471593214|FG000|Overall Study|Pregnancy|1|||
130990625|NCT04182880|471593215|FG001|Overall Study|Pregnancy|0|||
130990626|NCT03389477|471593216|FG000|Step 1|Withdrawal by Subject|1|||
130990627|NCT03389477|471593217|FG001|Step 1|Withdrawal by Subject|0|||
131100544|NCT01631227|471998025|FG001|Overall Study|withdrawn consent|21|||
131100545|NCT01631227|471998024|FG000|Overall Study|Adverse Event|1|||
131100546|NCT01631227|471998025|FG001|Overall Study|Adverse Event|0|||
131100547|NCT01631227|471998024|FG000|Overall Study|administrative|2|||
131100548|NCT01631227|471998025|FG001|Overall Study|administrative|1|||
131100549|NCT00768079|471998026|FG000|Overall Study|Lost to Follow-up|2|||
131100550|NCT00768079|471998027|FG001|Overall Study|Lost to Follow-up|0|||
131100551|NCT00768079|471998028|FG002|Overall Study|Lost to Follow-up|4|||
131100552|NCT00768079|471998026|FG000|Overall Study|Participant incarcerated|0|||
131100553|NCT00768079|471998027|FG001|Overall Study|Participant incarcerated|1|||
131100554|NCT00768079|471998028|FG002|Overall Study|Participant incarcerated|0|||
131100555|NCT01097707|471998029|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131100556|NCT01097707|471998030|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131100557|NCT01097707|471998031|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131100558|NCT01097707|471998032|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131100559|NCT01097707|471998033|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131100560|NCT01097707|471998029|FG000|Overall Study|Adverse Event|4|||
131100561|NCT01097707|471998030|FG001|Overall Study|Adverse Event|2|||
131100562|NCT01097707|471998031|FG002|Overall Study|Adverse Event|3|||
131100563|NCT01097707|471998032|FG003|Overall Study|Adverse Event|1|||
131100564|NCT01097707|471998033|FG004|Overall Study|Adverse Event|3|||
131100565|NCT01097707|471998029|FG000|Overall Study|Entry Criteria Not Met|2|||
131100566|NCT01097707|471998030|FG001|Overall Study|Entry Criteria Not Met|1|||
131100567|NCT01097707|471998031|FG002|Overall Study|Entry Criteria Not Met|1|||
131100568|NCT01097707|471998032|FG003|Overall Study|Entry Criteria Not Met|0|||
131100569|NCT01097707|471998033|FG004|Overall Study|Entry Criteria Not Met|1|||
131100570|NCT01097707|471998029|FG000|Overall Study|Lack of Efficacy|1|||
131100571|NCT01097707|471998030|FG001|Overall Study|Lack of Efficacy|0|||
131100572|NCT01097707|471998031|FG002|Overall Study|Lack of Efficacy|0|||
131100573|NCT01097707|471998032|FG003|Overall Study|Lack of Efficacy|1|||
131100574|NCT01097707|471998033|FG004|Overall Study|Lack of Efficacy|0|||
131100575|NCT01097707|471998029|FG000|Overall Study|Lost to Follow-up|1|||
131100576|NCT01097707|471998030|FG001|Overall Study|Lost to Follow-up|1|||
131100577|NCT01097707|471998031|FG002|Overall Study|Lost to Follow-up|2|||
131100578|NCT01097707|471998032|FG003|Overall Study|Lost to Follow-up|0|||
131100579|NCT01097707|471998033|FG004|Overall Study|Lost to Follow-up|3|||
131100580|NCT01097707|471998029|FG000|Overall Study|Protocol Violation|2|||
131100581|NCT01097707|471998030|FG001|Overall Study|Protocol Violation|2|||
131100582|NCT01097707|471998031|FG002|Overall Study|Protocol Violation|3|||
131100583|NCT01097707|471998032|FG003|Overall Study|Protocol Violation|2|||
131100584|NCT01097707|471998033|FG004|Overall Study|Protocol Violation|2|||
131100585|NCT01097707|471998029|FG000|Overall Study|Sponsor Decision|31|||
131100586|NCT01097707|471998030|FG001|Overall Study|Sponsor Decision|31|||
131100587|NCT01097707|471998031|FG002|Overall Study|Sponsor Decision|34|||
131100588|NCT01097707|471998032|FG003|Overall Study|Sponsor Decision|35|||
131100589|NCT01097707|471998033|FG004|Overall Study|Sponsor Decision|36|||
131100590|NCT01097707|471998029|FG000|Overall Study|Withdrawal by Subject|3|||
131100591|NCT01097707|471998030|FG001|Overall Study|Withdrawal by Subject|6|||
131100592|NCT01097707|471998031|FG002|Overall Study|Withdrawal by Subject|1|||
131100593|NCT01097707|471998032|FG003|Overall Study|Withdrawal by Subject|4|||
131100594|NCT01097707|471998033|FG004|Overall Study|Withdrawal by Subject|3|||
131100595|NCT01097707|471998029|FG000|Overall Study|Reason unknown|0|||
131100596|NCT01097707|471998030|FG001|Overall Study|Reason unknown|0|||
131100597|NCT01097707|471998031|FG002|Overall Study|Reason unknown|0|||
131100598|NCT01097707|471998032|FG003|Overall Study|Reason unknown|0|||
131100599|NCT01097707|471998033|FG004|Overall Study|Reason unknown|1|||
131100600|NCT02207569|471998036|FG000|1-Month|Death|6|||
131100601|NCT02207569|471998036|FG000|1-Month|Withdrawal by Subject|2|||
131100602|NCT02207569|471998036|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
131100603|NCT02207569|471998036|FG000|6-Month|Death|8|||
131100604|NCT02207569|471998036|FG000|6-Month|Withdrawal by Subject|2|||
131100605|NCT02207569|471998036|FG000|12-Month|Death|14|||
131100606|NCT02207569|471998036|FG000|12-Month|Withdrawal by Subject|2|||
131100607|NCT02207569|471998036|FG000|24-Month|Death|23|||
131100608|NCT02207569|471998036|FG000|24-Month|Withdrawal by Subject|3|||
131100609|NCT02207569|471998036|FG000|36-Month|Death|23|||
131100610|NCT02207569|471998036|FG000|36-Month|Withdrawal by Subject|4|||
131100611|NCT02207569|471998036|FG000|48-Month|Death|25|||
131100612|NCT02207569|471998036|FG000|48-Month|Withdrawal by Subject|2|||
131100613|NCT02207569|471998036|FG000|48-Month|Lost to Follow-up|4|||
131100614|NCT02207569|471998036|FG000|60-Month|Death|1|||
131100615|NCT02207569|471998036|FG000|60-Month|Lost to Follow-up|1|||
131100616|NCT02207569|471998036|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
131100617|NCT02207569|471998036|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
131100618|NCT01236534|471998039|FG000|Overall Study|Adverse Event|3|||
131100619|NCT01236534|471998040|FG001|Overall Study|Adverse Event|0|||
131100620|NCT05383508|471998051|FG000|Overall Study|Withdrawal by Subject|1|||
131100621|NCT05383508|471998052|FG001|Overall Study|Withdrawal by Subject|0|||
131100622|NCT05383508|471998053|FG002|Overall Study|Withdrawal by Subject|1|||
131213585|NCT04410978|472405379|FG000|Overall Study|Withdrawal by Subject|64|||
131213586|NCT04410978|472405380|FG001|Overall Study|Withdrawal by Subject|66|||
131213587|NCT04410978|472405379|FG000|Overall Study|Other|6|||
131213588|NCT04410978|472405380|FG001|Overall Study|Other|7|||
131213589|NCT04410978|472405379|FG000|Overall Study|Missing study status|1|||
131213590|NCT04410978|472405380|FG001|Overall Study|Missing study status|0|||
131213591|NCT05153629|472405382|FG000|Overall Study|Withdrawal by Subject|0|||
131213592|NCT05153629|472405383|FG001|Overall Study|Withdrawal by Subject|2|||
131213593|NCT03743571|472405389|FG000|Overall Study|Withdrawal by Subject|1|||
131213594|NCT03743571|472405390|FG001|Overall Study|Withdrawal by Subject|1|||
131213595|NCT03743571|472405389|FG000|Overall Study|Lost to Follow-up|1|||
131213596|NCT03743571|472405390|FG001|Overall Study|Lost to Follow-up|2|||
131213597|NCT04115488|472405391|FG000|Overall Study|Adverse Event|8|||
131213598|NCT04115488|472405392|FG001|Overall Study|Adverse Event|4|||
131213599|NCT04115488|472405391|FG000|Overall Study|Withdrawal by Subject|3|||
131213600|NCT04115488|472405392|FG001|Overall Study|Withdrawal by Subject|6|||
131213601|NCT04115488|472405391|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
131213602|NCT04115488|472405392|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
131213603|NCT04115488|472405391|FG000|Overall Study|Patient 's location change|1|||
131213604|NCT04115488|472405392|FG001|Overall Study|Patient 's location change|0|||
131213605|NCT04115488|472405391|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
131213606|NCT04115488|472405392|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
131213607|NCT00885677|472405393|FG000|Overall Study|Death|40|||
131213608|NCT00885677|472405394|FG001|Overall Study|Death|34|||
131213609|NCT00885677|472405393|FG000|Overall Study|Lost to Follow-up|15|||
131213610|NCT00885677|472405394|FG001|Overall Study|Lost to Follow-up|13|||
131213611|NCT00885677|472405393|FG000|Overall Study|Protocol Violation|54|||
131213612|NCT00885677|472405394|FG001|Overall Study|Protocol Violation|54|||
131213613|NCT00885677|472405393|FG000|Overall Study|premature study closure|41|||
131213614|NCT00885677|472405394|FG001|Overall Study|premature study closure|44|||
131213615|NCT00885677|472405393|FG000|Overall Study|device/lead revision or replacement|7|||
131213616|NCT00885677|472405394|FG001|Overall Study|device/lead revision or replacement|6|||
131213617|NCT00885677|472405393|FG000|Overall Study|Heart transplantation|1|||
131213618|NCT00885677|472405394|FG001|Overall Study|Heart transplantation|0|||
131213619|NCT00885677|472405393|FG000|Overall Study|Inclusion/exclusion not met|25|||
131213620|NCT00885677|472405394|FG001|Overall Study|Inclusion/exclusion not met|27|||
131213621|NCT00972309|472405395|FG000|Overall Study|Switched to alternative treatment|0|||
131213622|NCT00972309|472405396|FG001|Overall Study|Switched to alternative treatment|2|||
131213623|NCT00972309|472405395|FG000|Overall Study|Refused further treatment|0|||
131213624|NCT00972309|472405396|FG001|Overall Study|Refused further treatment|1|||
131213625|NCT00972309|472405395|FG000|Overall Study|Late determination of ineligibility|0|||
131213626|NCT00972309|472405396|FG001|Overall Study|Late determination of ineligibility|1|||
131213627|NCT00972309|472405395|FG000|Overall Study|Second malignancy|1|||
131213628|NCT00972309|472405396|FG001|Overall Study|Second malignancy|1|||
131213629|NCT00972309|472405395|FG000|Overall Study|Visa issues|0|||
131213630|NCT00972309|472405396|FG001|Overall Study|Visa issues|1|||
131213631|NCT00972309|472405395|FG000|Overall Study|Secondary cancer (SCC)|0|||
131213632|NCT00972309|472405396|FG001|Overall Study|Secondary cancer (SCC)|1|||
131213633|NCT00972309|472405395|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
131213634|NCT00972309|472405396|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
131213635|NCT00972309|472405395|FG000|Overall Study|Lost to Follow-up|1|||
131213636|NCT00972309|472405396|FG001|Overall Study|Lost to Follow-up|1|||
131213637|NCT00972309|472405395|FG000|Overall Study|Disease progression on study|10|||
131213638|NCT00972309|472405396|FG001|Overall Study|Disease progression on study|4|||
131213639|NCT01593761|472405402|FG000|Overall Study|Lost to Follow-up|1|||
131213640|NCT01593761|472405402|FG000|Overall Study|culture negative for MRSA at baseline|5|||
131213641|NCT01593761|472405402|FG000|Overall Study|positive for hepatitis C virus|1|||
131213642|NCT01593761|472405402|FG000|Overall Study|secondary cellulitis|1|||
131213643|NCT00828009|472405404|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
131213644|NCT00828009|472405404|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
131213645|NCT00828009|472405404|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
131213646|NCT00828009|472405404|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
131213647|NCT00828009|472405404|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
131213648|NCT00828009|472405404|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
131213649|NCT00828009|472405404|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
131213650|NCT00828009|472405404|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
131213651|NCT00828009|472405404|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
131213652|NCT00828009|472405404|FG000|Step 2 - Maintenance Therapy|Death|1|||
131213653|NCT00828009|472405404|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
131213654|NCT00828009|472405404|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
131213655|NCT00828009|472405404|FG000|Step 2 - Maintenance Therapy|Other|1|||
131213656|NCT02576951|472405410|FG000|Overall Study|Lost to Follow-up|0|||
131213657|NCT02576951|472405411|FG001|Overall Study|Lost to Follow-up|0|||
130882143|NCT05530252|471202543|FG000|Overall Study|Lost to Follow-up|1|||
130882144|NCT05530252|471202544|FG001|Overall Study|Lost to Follow-up|1|||
130882145|NCT05530252|471202545|FG002|Overall Study|Lost to Follow-up|1|||
130882146|NCT04825678|471202546|FG000|Overall Study|Decision by Sponsor|2|||
130882147|NCT04825678|471202547|FG001|Overall Study|Decision by Sponsor|3|||
130882148|NCT04825678|471202546|FG000|Overall Study|Withdrawal of Consent From Study|7|||
130882149|NCT04825678|471202547|FG001|Overall Study|Withdrawal of Consent From Study|9|||
130882150|NCT04825678|471202546|FG000|Overall Study|Lost to Follow-up|3|||
130882151|NCT04825678|471202547|FG001|Overall Study|Lost to Follow-up|4|||
130882152|NCT04825678|471202546|FG000|Overall Study|Never Received Investigational Product|1|||
130882153|NCT04825678|471202547|FG001|Overall Study|Never Received Investigational Product|1|||
130882154|NCT03818256|471202548|FG000|Overall Study|Withdrawal by Subject|2|||
130882155|NCT03818256|471202549|FG001|Overall Study|Withdrawal by Subject|2|||
130882156|NCT03818256|471202548|FG000|Overall Study|Adverse Event|3|||
130882157|NCT03818256|471202549|FG001|Overall Study|Adverse Event|1|||
130882158|NCT03818256|471202548|FG000|Overall Study|Lost to Follow-up|0|||
130882159|NCT03818256|471202549|FG001|Overall Study|Lost to Follow-up|5|||
130882160|NCT03818256|471202548|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
130882161|NCT03818256|471202549|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
130882162|NCT03818256|471202548|FG000|Overall Study|Not reporting for scheduled visits|1|||
130882163|NCT03818256|471202549|FG001|Overall Study|Not reporting for scheduled visits|0|||
130882164|NCT03818256|471202548|FG000|Overall Study|Non-compliant with investigational product|1|||
130882165|NCT03818256|471202549|FG001|Overall Study|Non-compliant with investigational product|0|||
130882166|NCT03043794|471202553|FG000|Overall Study|Lost to Follow-up|1|||
130882167|NCT02855125|471202554|FG000|Overall Study|Withdrawal by Subject|2|||
130882168|NCT02855125|471202555|FG001|Overall Study|Withdrawal by Subject|2|||
130882169|NCT02855125|471202554|FG000|Overall Study|Clinical Disease Progression|5|||
130882170|NCT02855125|471202555|FG001|Overall Study|Clinical Disease Progression|4|||
130882171|NCT02855125|471202554|FG000|Overall Study|Radiologic Disease Progression|36|||
130882172|NCT02855125|471202555|FG001|Overall Study|Radiologic Disease Progression|39|||
130882173|NCT02855125|471202554|FG000|Overall Study|Adverse Event|11|||
130882174|NCT02855125|471202555|FG001|Overall Study|Adverse Event|7|||
130882175|NCT02855125|471202554|FG000|Overall Study|Physician Decision|1|||
130882176|NCT02855125|471202555|FG001|Overall Study|Physician Decision|0|||
130882177|NCT02855125|471202554|FG000|Overall Study|On Treatment|9|||
130882178|NCT02855125|471202555|FG001|Overall Study|On Treatment|11|||
130882179|NCT02855125|471202554|FG000|Overall Study|Randomized but not treated|0|||
130882180|NCT02855125|471202555|FG001|Overall Study|Randomized but not treated|1|||
130882181|NCT04467905|471202556|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
130882182|NCT04467905|471202557|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
130882183|NCT04467905|471202558|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
130882184|NCT04467905|471202556|FG000|Overall Study|Conversion to SR|0|||
130882185|NCT04467905|471202557|FG001|Overall Study|Conversion to SR|0|||
130882186|NCT04467905|471202558|FG002|Overall Study|Conversion to SR|3|||
130882187|NCT04467905|471202556|FG000|Overall Study|Technical issue with Holter ECG|0|||
130882188|NCT04467905|471202557|FG001|Overall Study|Technical issue with Holter ECG|0|||
130882189|NCT04467905|471202558|FG002|Overall Study|Technical issue with Holter ECG|3|||
130882190|NCT04467905|471202556|FG000|Overall Study|Hemodynamic instability|0|||
130882191|NCT04467905|471202557|FG001|Overall Study|Hemodynamic instability|0|||
130882192|NCT04467905|471202558|FG002|Overall Study|Hemodynamic instability|1|||
130882193|NCT04467905|471202556|FG000|Overall Study|Site misinterpretation of protocol|0|||
130882194|NCT04467905|471202557|FG001|Overall Study|Site misinterpretation of protocol|0|||
130882195|NCT04467905|471202558|FG002|Overall Study|Site misinterpretation of protocol|1|||
130882196|NCT02514083|471202559|FG000|Overall Study|Adverse Event|1|||
130882197|NCT01586364|471205387|FG000|Overall Study|Withdrawal by Subject|40|||
130882198|NCT01586364|471205387|FG000|Overall Study|Adverse Event|37|||
130882199|NCT01586364|471205387|FG000|Overall Study|Lost to Follow-up|17|||
130882200|NCT01586364|471205387|FG000|Overall Study|Protocol Violation|16|||
130882201|NCT01586364|471205387|FG000|Overall Study|Lack of Efficacy|1|||
130882202|NCT01586364|471205387|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
130882203|NCT01586364|471205387|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
130882204|NCT01586364|471205387|FG000|Overall Study|Other-Site closure due to PI illness|1|||
130882205|NCT01586364|471205387|FG000|Overall Study|Other-PI discretion, site closing|2|||
130882206|NCT01586364|471205387|FG000|Overall Study|Other-Not specified|1|||
130882207|NCT00091949|471205388|FG000|Overall Study|Withdrawal by Subject|117|||
130882208|NCT00091949|471205389|FG001|Overall Study|Withdrawal by Subject|110|||
130882209|NCT00091949|471205388|FG000|Overall Study|Lost to Follow-up|58|||
130882210|NCT00091949|471205389|FG001|Overall Study|Lost to Follow-up|41|||
130882211|NCT02083354|471205390|FG000|Overall Study|Withdrawal by Subject|9|||
130882212|NCT02083354|471205390|FG000|Overall Study|Lost to Follow-up|1|||
130882213|NCT02083354|471205390|FG000|Overall Study|Adverse Event|3|||
130882214|NCT02083354|471205390|FG000|Overall Study|Disease progression|46|||
130882215|NCT02083354|471205390|FG000|Overall Study|Study closed/terminated|5|||
130882216|NCT02419001|471205401|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
131213658|NCT02576951|472405412|FG002|Overall Study|Lost to Follow-up|2|||
131213659|NCT02576951|472405413|FG003|Overall Study|Lost to Follow-up|2|||
131213660|NCT02576951|472405410|FG000|Overall Study|Withdrawal by Subject|1|||
131213661|NCT02576951|472405411|FG001|Overall Study|Withdrawal by Subject|0|||
131213662|NCT02576951|472405412|FG002|Overall Study|Withdrawal by Subject|0|||
131213663|NCT02576951|472405413|FG003|Overall Study|Withdrawal by Subject|2|||
131213664|NCT02576951|472405410|FG000|Overall Study|Protocol Violation|0|||
131213665|NCT02576951|472405411|FG001|Overall Study|Protocol Violation|0|||
131213666|NCT02576951|472405412|FG002|Overall Study|Protocol Violation|0|||
131213667|NCT02576951|472405413|FG003|Overall Study|Protocol Violation|1|||
131213668|NCT00563706|472407113|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
131213669|NCT00563706|472407114|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
131213670|NCT00563706|472407115|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
131213671|NCT00563706|472407116|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
131213672|NCT00563706|472407117|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
131213673|NCT00563706|472407118|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
131213674|NCT00563706|472407119|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
131213675|NCT00563706|472407120|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
131213676|NCT00563706|472407121|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
131213677|NCT00563706|472407113|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
131213678|NCT00563706|472407114|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
131213679|NCT00563706|472407115|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
131213680|NCT00563706|472407116|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
131213681|NCT00563706|472407117|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
131213682|NCT00563706|472407118|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
131213683|NCT00563706|472407119|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
131213684|NCT00563706|472407120|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
131213685|NCT00563706|472407121|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
131213686|NCT00563706|472407113|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
131213687|NCT00563706|472407114|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
131213688|NCT00563706|472407115|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
131213689|NCT00563706|472407116|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
131213690|NCT00563706|472407117|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
131213691|NCT00563706|472407118|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
131213692|NCT00563706|472407119|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
131213693|NCT00563706|472407120|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
131213694|NCT00563706|472407121|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
131213695|NCT00563706|472407113|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
131213696|NCT00563706|472407114|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131213697|NCT00563706|472407115|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131213698|NCT00563706|472407116|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131213699|NCT00563706|472407117|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131213700|NCT00563706|472407118|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131213701|NCT00563706|472407119|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131213702|NCT00563706|472407120|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
131213703|NCT00563706|472407121|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
131213704|NCT00563706|472407113|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131213705|NCT00563706|472407114|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131213706|NCT00563706|472407115|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131213707|NCT00563706|472407116|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131213708|NCT00563706|472407117|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131213709|NCT00563706|472407118|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131213710|NCT00563706|472407119|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
131213711|NCT00563706|472407120|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
131213712|NCT00563706|472407121|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
131213713|NCT03280628|472407122|FG000|Overall Study|Lost to Follow-up|8|||
131213714|NCT03280628|472407123|FG001|Overall Study|Lost to Follow-up|6|||
131213715|NCT03280628|472407124|FG002|Overall Study|Lost to Follow-up|11|||
131213716|NCT01361308|472407127|FG000|Overall Study|Withdrawal by Subject|9|||
131213717|NCT01361308|472407128|FG001|Overall Study|Withdrawal by Subject|13|||
131213718|NCT01361308|472407127|FG000|Overall Study|Physician Decision|3|||
131213719|NCT01361308|472407128|FG001|Overall Study|Physician Decision|3|||
131213720|NCT01361308|472407127|FG000|Overall Study|Lack of Efficacy|2|||
131213721|NCT01361308|472407128|FG001|Overall Study|Lack of Efficacy|0|||
131213722|NCT01361308|472407127|FG000|Overall Study|Protocol Violation|1|||
131213723|NCT01361308|472407128|FG001|Overall Study|Protocol Violation|0|||
131213724|NCT01361308|472407127|FG000|Overall Study|Lost to Follow-up|5|||
131213725|NCT01361308|472407128|FG001|Overall Study|Lost to Follow-up|4|||
131213726|NCT01361308|472407127|FG000|Overall Study|Adverse Event|8|||
131213727|NCT01361308|472407128|FG001|Overall Study|Adverse Event|4|||
131213728|NCT01361308|472407127|FG000|Overall Study|Eligibility Criteria Not Met|2|||
131213729|NCT01361308|472407128|FG001|Overall Study|Eligibility Criteria Not Met|3|||
131213730|NCT01361308|472407127|FG000|Overall Study|Failed C-SSRS|5|||
131213731|NCT01361308|472407128|FG001|Overall Study|Failed C-SSRS|2|||
131213732|NCT01361308|472407127|FG000|Overall Study|Other|0|||
131213733|NCT01361308|472407128|FG001|Overall Study|Other|1|||
131213734|NCT03839693|472407133|FG000|Overall Study|Lost to Follow-up|0|||
131213735|NCT03839693|472407134|FG001|Overall Study|Lost to Follow-up|2|||
131213736|NCT03839693|472407135|FG002|Overall Study|Lost to Follow-up|2|||
131213737|NCT03839693|472407133|FG000|Overall Study|Withdrawal by Subject|1|||
131213738|NCT03839693|472407134|FG001|Overall Study|Withdrawal by Subject|0|||
131213739|NCT03839693|472407135|FG002|Overall Study|Withdrawal by Subject|2|||
131213740|NCT03839693|472407133|FG000|Overall Study|subject moved out of the area|1|||
131213741|NCT03839693|472407134|FG001|Overall Study|subject moved out of the area|0|||
131213742|NCT03839693|472407135|FG002|Overall Study|subject moved out of the area|0|||
131213743|NCT00700115|472407144|FG000|Overall Study|Withdrawal by Subject|1|||
131213744|NCT00700115|472407145|FG001|Overall Study|Withdrawal by Subject|0|||
131213745|NCT00700115|472407144|FG000|Overall Study|Lost to Follow-up|0|||
131213746|NCT00700115|472407145|FG001|Overall Study|Lost to Follow-up|1|||
131213747|NCT02503215|472407146|FG000|Overall Study|Unable to wear compression stockings|1|||
131213748|NCT02503215|472407146|FG000|Overall Study|Unable to use positive airway pressure|2|||
131213749|NCT02983305|472407151|FG000|Overall Study|incomplete data|2|||
131213750|NCT02983305|472407152|FG001|Overall Study|incomplete data|0|||
131213751|NCT00822237|472407153|FG000|Dose 1 Vaccination|Not vaccinated|3|||
131213752|NCT00822237|472407154|FG001|Dose 1 Vaccination|Not vaccinated|0|||
131213753|NCT00822237|472407153|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
131213754|NCT00822237|472407154|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
131213755|NCT00822237|472407153|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
131213756|NCT00822237|472407154|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
131213757|NCT00822237|472407153|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
131213758|NCT00822237|472407154|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
131213759|NCT00822237|472407153|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
131213760|NCT00822237|472407154|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
131213761|NCT03433482|472407155|FG000|Overall Study|Lost to Follow-up|1|||
131213762|NCT03433482|472407156|FG001|Overall Study|Lost to Follow-up|0|||
131213763|NCT03433482|472407157|FG002|Overall Study|Lost to Follow-up|1|||
131213764|NCT03433482|472407158|FG003|Overall Study|Lost to Follow-up|1|||
131213765|NCT03433482|472407155|FG000|Overall Study|Withdrawal by Subject|0|||
131213766|NCT03433482|472407156|FG001|Overall Study|Withdrawal by Subject|0|||
131213767|NCT03433482|472407157|FG002|Overall Study|Withdrawal by Subject|1|||
131213768|NCT03433482|472407158|FG003|Overall Study|Withdrawal by Subject|0|||
131213769|NCT03433482|472407155|FG000|Overall Study|Unknown reason|0|||
131213770|NCT03433482|472407156|FG001|Overall Study|Unknown reason|0|||
131213771|NCT03433482|472407157|FG002|Overall Study|Unknown reason|2|||
131213772|NCT03433482|472407158|FG003|Overall Study|Unknown reason|0|||
131213773|NCT01646268|472407159|FG000|Overall Study|Adverse Event|6|||
131213774|NCT01646268|472407160|FG001|Overall Study|Adverse Event|7|||
131213775|NCT01646268|472407159|FG000|Overall Study|Lack of Efficacy|1|||
131213776|NCT01646268|472407160|FG001|Overall Study|Lack of Efficacy|3|||
131213777|NCT01646268|472407159|FG000|Overall Study|Protocol Violation|0|||
131213778|NCT01646268|472407160|FG001|Overall Study|Protocol Violation|1|||
131213779|NCT01646268|472407159|FG000|Overall Study|Withdrawal by Subject|2|||
131213780|NCT01646268|472407160|FG001|Overall Study|Withdrawal by Subject|5|||
131213781|NCT01646268|472407159|FG000|Overall Study|Other|2|||
131213782|NCT01646268|472407160|FG001|Overall Study|Other|0|||
131213783|NCT01519635|472407165|FG000|Overall Study|Withdrawal by Subject|0|||
131213784|NCT01519635|472407166|FG001|Overall Study|Withdrawal by Subject|1|||
131213785|NCT01519635|472407165|FG000|Overall Study|No possibility to put a catheter|1|||
131213786|NCT01519635|472407166|FG001|Overall Study|No possibility to put a catheter|2|||
131213787|NCT02325414|472407167|FG000|Overall Study|Withdrawal by Subject|3|||
131213788|NCT02325414|472407168|FG001|Overall Study|Withdrawal by Subject|1|||
131213789|NCT02325414|472407167|FG000|Overall Study|Lost to Follow-up|5|||
131213790|NCT02325414|472407168|FG001|Overall Study|Lost to Follow-up|5|||
131213791|NCT00347776|472407169|FG000|1.5 Month Follow-up|Death|2|||
131213792|NCT00347776|472407170|FG001|1.5 Month Follow-up|Death|0|||
131213793|NCT00347776|472407171|FG002|1.5 Month Follow-up|Death|0|||
131213794|NCT00347776|472407169|FG000|1.5 Month Follow-up|reached the endpoint|12|||
131213795|NCT00347776|472407170|FG001|1.5 Month Follow-up|reached the endpoint|8|||
131213796|NCT00347776|472407171|FG002|1.5 Month Follow-up|reached the endpoint|12|||
131213797|NCT00347776|472407169|FG000|6 Month Follow-up|Death|2|||
131213798|NCT00347776|472407170|FG001|6 Month Follow-up|Death|1|||
131213799|NCT00347776|472407171|FG002|6 Month Follow-up|Death|3|||
131213800|NCT00347776|472407169|FG000|6 Month Follow-up|reached endpont|20|||
131213801|NCT00347776|472407170|FG001|6 Month Follow-up|reached endpont|12|||
131213802|NCT00347776|472407171|FG002|6 Month Follow-up|reached endpont|15|||
131213803|NCT00347776|472407169|FG000|12 Month Follow-up|Lost to Follow-up|7|||
131213804|NCT00347776|472407170|FG001|12 Month Follow-up|Lost to Follow-up|6|||
131213805|NCT00347776|472407171|FG002|12 Month Follow-up|Lost to Follow-up|6|||
131213806|NCT00347776|472407169|FG000|12 Month Follow-up|Death|3|||
131213807|NCT00347776|472407170|FG001|12 Month Follow-up|Death|4|||
131213808|NCT00347776|472407171|FG002|12 Month Follow-up|Death|4|||
131213809|NCT00347776|472407169|FG000|12 Month Follow-up|Reached endpoint|13|||
131213810|NCT00347776|472407170|FG001|12 Month Follow-up|Reached endpoint|6|||
131213811|NCT00347776|472407171|FG002|12 Month Follow-up|Reached endpoint|9|||
131213812|NCT00594568|472407172|FG000|Initial Treatment|Adverse Event|51|||
131213813|NCT00594568|472407173|FG001|Initial Treatment|Adverse Event|121|||
131213814|NCT00594568|472407174|FG002|Initial Treatment|Adverse Event|144|||
131213815|NCT00594568|472407172|FG000|Initial Treatment|Death|6|||
131213816|NCT00594568|472407173|FG001|Initial Treatment|Death|11|||
131213817|NCT00594568|472407174|FG002|Initial Treatment|Death|15|||
131213818|NCT00594568|472407172|FG000|Initial Treatment|Lost to Follow-up|4|||
131213819|NCT00594568|472407173|FG001|Initial Treatment|Lost to Follow-up|1|||
131213820|NCT00594568|472407174|FG002|Initial Treatment|Lost to Follow-up|4|||
131213821|NCT00594568|472407172|FG000|Initial Treatment|Physician Decision|3|||
131213822|NCT00594568|472407173|FG001|Initial Treatment|Physician Decision|2|||
131213823|NCT00594568|472407174|FG002|Initial Treatment|Physician Decision|4|||
131213824|NCT00594568|472407172|FG000|Initial Treatment|Protocol Violation|2|||
131213825|NCT00594568|472407173|FG001|Initial Treatment|Protocol Violation|2|||
131213826|NCT00594568|472407174|FG002|Initial Treatment|Protocol Violation|5|||
131213827|NCT00594568|472407172|FG000|Initial Treatment|Withdrawal by Subject|25|||
131213828|NCT00594568|472407173|FG001|Initial Treatment|Withdrawal by Subject|31|||
131213829|NCT00594568|472407174|FG002|Initial Treatment|Withdrawal by Subject|46|||
131213830|NCT00594568|472407172|FG000|Initial Treatment|Sponsor decision|193|||
131213831|NCT00594568|472407173|FG001|Initial Treatment|Sponsor decision|142|||
131213832|NCT00594568|472407174|FG002|Initial Treatment|Sponsor decision|147|||
131213833|NCT00594568|472407172|FG000|Initial Treatment|Caregiver decision|21|||
131213834|NCT00594568|472407173|FG001|Initial Treatment|Caregiver decision|36|||
131213835|NCT00594568|472407174|FG002|Initial Treatment|Caregiver decision|36|||
131213836|NCT00594568|472407172|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
131213837|NCT00594568|472407173|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
131213838|NCT00594568|472407174|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
131213839|NCT00594568|472407172|FG000|Initial Treatment|Entry criteria exclusion|0|||
131213840|NCT00594568|472407173|FG001|Initial Treatment|Entry criteria exclusion|1|||
131213841|NCT00594568|472407174|FG002|Initial Treatment|Entry criteria exclusion|1|||
131213842|NCT00594568|472407172|FG000|Delayed Start|Death|0|||
131213843|NCT00594568|472407173|FG001|Delayed Start|Death|0|||
131213844|NCT00594568|472407174|FG002|Delayed Start|Death|1|||
131213845|NCT00594568|472407172|FG000|Delayed Start|Adverse Event|12|||
131213846|NCT00594568|472407173|FG001|Delayed Start|Adverse Event|2|||
131213847|NCT00594568|472407174|FG002|Delayed Start|Adverse Event|2|||
131213848|NCT00594568|472407172|FG000|Delayed Start|Withdrawal by Subject|4|||
131213849|NCT00594568|472407173|FG001|Delayed Start|Withdrawal by Subject|3|||
131213850|NCT00594568|472407174|FG002|Delayed Start|Withdrawal by Subject|0|||
131213851|NCT00594568|472407172|FG000|Delayed Start|Physician Decision|0|||
131213852|NCT00594568|472407173|FG001|Delayed Start|Physician Decision|0|||
131213853|NCT00594568|472407174|FG002|Delayed Start|Physician Decision|1|||
130990628|NCT03389477|471593216|FG000|Step 2|Withdrawal by Subject|1|||
131213854|NCT00594568|472407172|FG000|Delayed Start|Lost to Follow-up|0|||
131213855|NCT00594568|472407173|FG001|Delayed Start|Lost to Follow-up|0|||
131213856|NCT00594568|472407174|FG002|Delayed Start|Lost to Follow-up|1|||
131213857|NCT00594568|472407172|FG000|Delayed Start|Caregiver Decision|5|||
131213858|NCT00594568|472407173|FG001|Delayed Start|Caregiver Decision|6|||
131213859|NCT00594568|472407174|FG002|Delayed Start|Caregiver Decision|2|||
131213860|NCT00594568|472407172|FG000|Delayed Start|Sponsor Decision|77|||
131213861|NCT00594568|472407173|FG001|Delayed Start|Sponsor Decision|66|||
131213862|NCT00594568|472407174|FG002|Delayed Start|Sponsor Decision|59|||
130990629|NCT03389477|471593217|FG001|Step 2|Withdrawal by Subject|2|||
130990630|NCT03389477|471593216|FG000|Step 2|Disease progression|1|||
130990631|NCT03389477|471593217|FG001|Step 2|Disease progression|0|||
131213863|NCT00594568|472407172|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
131213864|NCT00594568|472407173|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
131213865|NCT00594568|472407174|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
131213866|NCT00594568|472407172|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
131213867|NCT00594568|472407173|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
131213868|NCT00594568|472407174|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
131213869|NCT00594568|472407172|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
131213870|NCT00594568|472407173|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
131213871|NCT00594568|472407174|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
131213872|NCT00594568|472407172|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
131213873|NCT00594568|472407173|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
131213874|NCT00594568|472407174|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
131213875|NCT00594568|472407172|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
130990632|NCT03389477|471593216|FG000|Step 2|Death|0|||
131213876|NCT00594568|472407173|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
131213877|NCT00594568|472407174|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
131213878|NCT00594568|472407172|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
131213879|NCT00594568|472407173|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
131213880|NCT00594568|472407174|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
131213881|NCT00299546|472407175|FG000|Overall Study|Death|3|||
131213882|NCT00299546|472407176|FG001|Overall Study|Death|2|||
131213883|NCT00299546|472407177|FG002|Overall Study|Death|0|||
131213884|NCT00299546|472407175|FG000|Overall Study|Lost to Follow-up|2|||
131213885|NCT00299546|472407176|FG001|Overall Study|Lost to Follow-up|2|||
131213886|NCT00299546|472407177|FG002|Overall Study|Lost to Follow-up|5|||
131213887|NCT00299546|472407175|FG000|Overall Study|Adverse Event|37|||
131213888|NCT00299546|472407176|FG001|Overall Study|Adverse Event|22|||
131213889|NCT00299546|472407177|FG002|Overall Study|Adverse Event|27|||
131213890|NCT00299546|472407175|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
131213891|NCT00299546|472407176|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
131213892|NCT00299546|472407177|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
131213893|NCT00299546|472407175|FG000|Overall Study|Other|24|||
131213894|NCT00299546|472407176|FG001|Overall Study|Other|26|||
131213895|NCT00299546|472407177|FG002|Overall Study|Other|19|||
131213896|NCT00299546|472407175|FG000|Overall Study|Not treated|0|||
131213897|NCT00299546|472407176|FG001|Overall Study|Not treated|1|||
131213898|NCT00299546|472407177|FG002|Overall Study|Not treated|1|||
131213899|NCT03099265|472407178|FG000|Overall Study|Adverse Event|1|||
131213900|NCT00518531|472407182|FG000|Treatment Period 1|Adverse Event|5|||
131213901|NCT00518531|472407183|FG001|Treatment Period 1|Adverse Event|0|||
131213902|NCT00518531|472407182|FG000|Treatment Period 1|Lost to Follow-up|5|||
131213903|NCT00518531|472407183|FG001|Treatment Period 1|Lost to Follow-up|3|||
131213904|NCT00518531|472407182|FG000|Treatment Period 1|Physician Decision|1|||
131213905|NCT00518531|472407183|FG001|Treatment Period 1|Physician Decision|0|||
131213906|NCT00518531|472407182|FG000|Treatment Period 1|Protocol Violation|2|||
131213907|NCT00518531|472407183|FG001|Treatment Period 1|Protocol Violation|0|||
131213908|NCT00518531|472407182|FG000|Treatment Period 1|Withdrawal by Subject|4|||
131213909|NCT00518531|472407183|FG001|Treatment Period 1|Withdrawal by Subject|6|||
131213910|NCT00518531|472407182|FG000|Treatment Period 1|Early crossover|1|||
131213911|NCT00518531|472407183|FG001|Treatment Period 1|Early crossover|3|||
131213912|NCT00518531|472407182|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131213913|NCT00518531|472407183|FG001|Treatment Period 2|Withdrawal by Subject|8|||
131213914|NCT00518531|472407182|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
131213915|NCT00518531|472407183|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
131213916|NCT00518531|472407182|FG000|Treatment Period 2|Adverse Event|1|||
131213917|NCT00518531|472407183|FG001|Treatment Period 2|Adverse Event|7|||
131213918|NCT00518531|472407182|FG000|Treatment Period 2|Protocol-specified criteria|0|||
131213919|NCT00518531|472407183|FG001|Treatment Period 2|Protocol-specified criteria|1|||
131213920|NCT00518531|472407182|FG000|Treatment Period 2|Non-compliance|1|||
131213921|NCT00518531|472407183|FG001|Treatment Period 2|Non-compliance|2|||
131213922|NCT00602927|472407186|FG000|Period 1: 13 Days|Protocol Violation|2|||
131213923|NCT00602927|472407187|FG001|Period 1: 13 Days|Protocol Violation|4|||
131213924|NCT00602927|472407186|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
131213925|NCT00602927|472407187|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
131213926|NCT00602927|472407186|FG000|Period 1: 13 Days|Time|1|||
131213927|NCT00602927|472407187|FG001|Period 1: 13 Days|Time|0|||
131213928|NCT00602927|472407186|FG000|Period 1: 13 Days|Claustrophobia|0|||
131213929|NCT00602927|472407187|FG001|Period 1: 13 Days|Claustrophobia|1|||
131213930|NCT00602927|472407186|FG000|Period 2: 14 Days|Protocol Violation|0|||
131213931|NCT00602927|472407187|FG001|Period 2: 14 Days|Protocol Violation|2|||
131213932|NCT00602927|472407186|FG000|Period 3: 13 Days|Protocol Violation|0|||
131213933|NCT00602927|472407187|FG001|Period 3: 13 Days|Protocol Violation|1|||
131213934|NCT00602927|472407186|FG000|Period 3: 13 Days|MRI data quality|2|||
131213935|NCT00602927|472407187|FG001|Period 3: 13 Days|MRI data quality|2|||
131213936|NCT02856282|472407193|FG000|Overall Study|Withdrawal by Subject|1|||
131213937|NCT00057330|472407194|FG000|Overall Study|Adverse Event|9|||
131213938|NCT00057330|472407195|FG001|Overall Study|Adverse Event|12|||
131213939|NCT00057330|472407194|FG000|Overall Study|Death|1|||
131213940|NCT00057330|472407195|FG001|Overall Study|Death|0|||
131213941|NCT00057330|472407194|FG000|Overall Study|Protocol Violation|1|||
131213942|NCT00057330|472407195|FG001|Overall Study|Protocol Violation|1|||
131213943|NCT00057330|472407194|FG000|Overall Study|Withdrawal by Subject|115|||
131213944|NCT00057330|472407195|FG001|Overall Study|Withdrawal by Subject|84|||
131213945|NCT00057330|472407194|FG000|Overall Study|Lost to Follow-up|745|||
131213946|NCT00057330|472407195|FG001|Overall Study|Lost to Follow-up|617|||
131213947|NCT00057330|472407194|FG000|Overall Study|Physician Decision|1|||
131213948|NCT00057330|472407195|FG001|Overall Study|Physician Decision|0|||
131213949|NCT00057330|472407194|FG000|Overall Study|Other|260|||
131213950|NCT00057330|472407195|FG001|Overall Study|Other|206|||
131213951|NCT02074982|472407196|FG000|Overall Study|Adverse Event|15|||
131213952|NCT02074982|472407197|FG001|Overall Study|Adverse Event|7|||
131213953|NCT02074982|472407196|FG000|Overall Study|Lack of Efficacy|6|||
131213954|NCT02074982|472407197|FG001|Overall Study|Lack of Efficacy|1|||
131213955|NCT02074982|472407196|FG000|Overall Study|Lost to Follow-up|9|||
131213956|NCT02074982|472407197|FG001|Overall Study|Lost to Follow-up|10|||
131213957|NCT02074982|472407196|FG000|Overall Study|Non-compliance with study treatment|0|||
131213958|NCT02074982|472407197|FG001|Overall Study|Non-compliance with study treatment|2|||
131213959|NCT02074982|472407196|FG000|Overall Study|Physician Decision|1|||
131213960|NCT02074982|472407197|FG001|Overall Study|Physician Decision|1|||
131213961|NCT02074982|472407196|FG000|Overall Study|Pregnancy|1|||
131213962|NCT02074982|472407197|FG001|Overall Study|Pregnancy|2|||
131213963|NCT02074982|472407196|FG000|Overall Study|Protocol deviation|4|||
131213964|NCT02074982|472407197|FG001|Overall Study|Protocol deviation|3|||
131213965|NCT02074982|472407196|FG000|Overall Study|Technical problems|0|||
131213966|NCT02074982|472407197|FG001|Overall Study|Technical problems|2|||
131213967|NCT02074982|472407196|FG000|Overall Study|Subject/guardian decision|15|||
131213968|NCT02074982|472407197|FG001|Overall Study|Subject/guardian decision|24|||
131213969|NCT02074982|472407196|FG000|Overall Study|Death|0|||
131213970|NCT02074982|472407197|FG001|Overall Study|Death|2|||
131213971|NCT03722849|472407200|FG000|Overall Study|Withdrawal by Subject|1|||
131213972|NCT03722849|472407201|FG001|Overall Study|Withdrawal by Subject|1|||
131213973|NCT05993299|472407202|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
131213974|NCT05993299|472407202|FG000|Overall Study|Ongoing|4|||
131213975|NCT03985982|472407203|FG000|Double-Blind Phase|Lost to Follow-up|4|||
131213976|NCT03985982|472407204|FG001|Double-Blind Phase|Lost to Follow-up|3|||
131213977|NCT03985982|472407205|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131213978|NCT03985982|472407203|FG000|Double-Blind Phase|Physician Decision|1|||
131213979|NCT03985982|472407204|FG001|Double-Blind Phase|Physician Decision|0|||
131213980|NCT03985982|472407205|FG002|Double-Blind Phase|Physician Decision|0|||
131213981|NCT03985982|472407203|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
131213982|NCT03985982|472407204|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
131213983|NCT03985982|472407205|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
131213984|NCT03985982|472407203|FG000|Double-Blind Phase|COVID-19|1|||
131213985|NCT03985982|472407204|FG001|Double-Blind Phase|COVID-19|0|||
131213986|NCT03985982|472407205|FG002|Double-Blind Phase|COVID-19|0|||
131213987|NCT03985982|472407203|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
131213988|NCT03985982|472407204|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
131213989|NCT03985982|472407205|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
131213990|NCT03985982|472407203|FG000|Open-Label Phase|Lost to Follow-up|0|||
131213991|NCT03985982|472407204|FG001|Open-Label Phase|Lost to Follow-up|0|||
131213992|NCT03985982|472407205|FG002|Open-Label Phase|Lost to Follow-up|13|||
131213993|NCT03985982|472407203|FG000|Open-Label Phase|Physician Decision|0|||
131213994|NCT03985982|472407204|FG001|Open-Label Phase|Physician Decision|0|||
131213995|NCT03985982|472407205|FG002|Open-Label Phase|Physician Decision|2|||
131213996|NCT03985982|472407203|FG000|Open-Label Phase|Withdrawal by Subject|0|||
131213997|NCT03985982|472407204|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131213998|NCT03985982|472407205|FG002|Open-Label Phase|Withdrawal by Subject|11|||
131213999|NCT00478933|472407206|FG000|Overall Study|Protocol Violation|22|||
131214000|NCT00478933|472407206|FG000|Overall Study|Informed consent not verified|3|||
131214001|NCT00478933|472407206|FG000|Overall Study|Inadequate data available|53|||
131214002|NCT03772574|472407207|FG000|Overall Study|Protocol Violation|2|||
131214003|NCT03772574|472407208|FG001|Overall Study|Protocol Violation|0|||
131214004|NCT03772574|472407209|FG002|Overall Study|Protocol Violation|0|||
131214005|NCT03772574|472407207|FG000|Overall Study|Discomfort|0|||
131214006|NCT03772574|472407208|FG001|Overall Study|Discomfort|5|||
131214007|NCT03772574|472407209|FG002|Overall Study|Discomfort|4|||
131214008|NCT00348348|472407212|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
131214009|NCT00348348|472407213|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
131214010|NCT00348348|472407212|FG000|Overall Study|Lack of Efficacy|1|||
131214011|NCT00348348|472407213|FG001|Overall Study|Lack of Efficacy|1|||
131214012|NCT00348348|472407212|FG000|Overall Study|Lost to Follow-up|8|||
131214013|NCT00348348|472407213|FG001|Overall Study|Lost to Follow-up|10|||
131214014|NCT00348348|472407212|FG000|Overall Study|Withdrawal by Subject|4|||
131214015|NCT00348348|472407213|FG001|Overall Study|Withdrawal by Subject|1|||
131214016|NCT00348348|472407212|FG000|Overall Study|Other|7|||
131214017|NCT00348348|472407213|FG001|Overall Study|Other|4|||
131214018|NCT00348348|472407212|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
131214019|NCT00348348|472407213|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
131214020|NCT00348348|472407212|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
131214021|NCT00348348|472407213|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
131214022|NCT00348348|472407212|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
131214023|NCT00348348|472407213|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
131214024|NCT00348348|472407212|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
131214025|NCT00348348|472407213|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
131214026|NCT00348348|472407212|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
131214027|NCT00348348|472407213|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
131214028|NCT00348348|472407212|FG000|Overall Study|Adverse event probably related to study|1|||
131214029|NCT00348348|472407213|FG001|Overall Study|Adverse event probably related to study|0|||
131214030|NCT01298362|472407217|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
131214031|NCT01298362|472407218|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
131214032|NCT01012609|472407229|FG000|Overall Study|Withdrawal by Subject|1|||
131214033|NCT01012609|472407230|FG001|Overall Study|Withdrawal by Subject|1|||
131214034|NCT00183170|472407234|FG000|First Intervention|Did not complete study|1|||
131214035|NCT00183170|472407235|FG001|First Intervention|Did not complete study|0|||
131214036|NCT00183170|472407234|FG000|First Intervention|Did not meet targeted BrAC|1|||
131214037|NCT00183170|472407235|FG001|First Intervention|Did not meet targeted BrAC|0|||
131214038|NCT00183170|472407234|FG000|Washout 1 Week|Did not complete study|6|||
131214039|NCT00183170|472407235|FG001|Washout 1 Week|Did not complete study|8|||
131214040|NCT00183170|472407234|FG000|Second Intervention|Did not complete study|1|||
131214041|NCT00183170|472407235|FG001|Second Intervention|Did not complete study|0|||
131214042|NCT00183170|472407234|FG000|Second Intervention|Did not meet targeted BrAC|0|||
131214043|NCT00183170|472407235|FG001|Second Intervention|Did not meet targeted BrAC|2|||
131214044|NCT04983589|472407236|FG000|Overall Study|Withdrawal by Subject|0|||
131214045|NCT04983589|472407237|FG001|Overall Study|Withdrawal by Subject|3|||
131214046|NCT04983589|472407236|FG000|Overall Study|COVID-19 Infection|1|||
131214047|NCT04983589|472407237|FG001|Overall Study|COVID-19 Infection|0|||
131214048|NCT04983589|472407236|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
131214049|NCT04983589|472407237|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
131214050|NCT00924820|472407238|FG000|Overall Study|Death|2|||
131214051|NCT00924820|472407238|FG000|Overall Study|Ineligible, Screen Failure|5|||
131214052|NCT00761969|472407239|FG000|Overall Study|Death|112|||
131214053|NCT00761969|472407240|FG001|Overall Study|Death|47|||
131214054|NCT00761969|472407239|FG000|Overall Study|Lost to Follow-up|88|||
131214055|NCT00761969|472407240|FG001|Overall Study|Lost to Follow-up|93|||
131214056|NCT00585468|472407241|FG000|First Intervention|Withdrawal by Subject|1|||
131214057|NCT00585468|472407242|FG001|First Intervention|Withdrawal by Subject|1|||
131214058|NCT01353586|472407243|FG000|Overall Study|Procedure terminated prior to ablation|3|||
131214059|NCT01353586|472407244|FG001|Overall Study|Procedure terminated prior to ablation|0|||
131214060|NCT01353586|472407243|FG000|Overall Study|Never had insertion of study catheter|4|||
131214061|NCT01353586|472407244|FG001|Overall Study|Never had insertion of study catheter|1|||
131214062|NCT01353586|472407243|FG000|Overall Study|Neurological exam not done|0|||
131214063|NCT01353586|472407244|FG001|Overall Study|Neurological exam not done|1|||
131214064|NCT00978120|472407247|FG000|Overall Study|Death|0|||
131214065|NCT00978120|472407248|FG001|Overall Study|Death|0|||
131214066|NCT00978120|472407249|FG002|Overall Study|Death|0|||
131214067|NCT00978120|472407250|FG003|Overall Study|Death|1|||
131214068|NCT00978120|472407247|FG000|Overall Study|Lost to Follow-up|0|||
131214069|NCT00978120|472407248|FG001|Overall Study|Lost to Follow-up|0|||
131214070|NCT00978120|472407249|FG002|Overall Study|Lost to Follow-up|3|||
131214071|NCT00978120|472407250|FG003|Overall Study|Lost to Follow-up|0|||
131214072|NCT00978120|472407247|FG000|Overall Study|Withdrawal by Subject|2|||
131214073|NCT00978120|472407248|FG001|Overall Study|Withdrawal by Subject|0|||
131214074|NCT00978120|472407249|FG002|Overall Study|Withdrawal by Subject|0|||
131214075|NCT00978120|472407250|FG003|Overall Study|Withdrawal by Subject|0|||
131214076|NCT00978120|472407247|FG000|Overall Study|Moved out of state|0|||
131214077|NCT00978120|472407248|FG001|Overall Study|Moved out of state|0|||
131214078|NCT00978120|472407249|FG002|Overall Study|Moved out of state|0|||
131214079|NCT00978120|472407250|FG003|Overall Study|Moved out of state|1|||
131214080|NCT01068418|472407259|FG000|Overall Study|Physician Decision|12|||
131214081|NCT03155269|472407260|FG000|Overall Study|Withdrawal by Subject|4|||
131214082|NCT03155269|472407261|FG001|Overall Study|Withdrawal by Subject|5|||
131214083|NCT03155269|472407260|FG000|Overall Study|Lost to Follow-up|1|||
131214084|NCT03155269|472407261|FG001|Overall Study|Lost to Follow-up|2|||
131214085|NCT00483119|472407262|FG000|Overall Study|Adverse Event|0|||
131214086|NCT00483119|472407263|FG001|Overall Study|Adverse Event|1|||
131214087|NCT00483119|472407262|FG000|Overall Study|Physician Decision|1|||
131214088|NCT00483119|472407263|FG001|Overall Study|Physician Decision|0|||
131214089|NCT02279888|472407264|FG000|Overall Study|Death|326|||
131214090|NCT02279888|472407264|FG000|Overall Study|Withdrawal by Subject|38|||
131214091|NCT02279888|472407264|FG000|Overall Study|Lost to Follow-up|21|||
131214092|NCT02279888|472407264|FG000|Overall Study|Physician Decision|62|||
131214093|NCT02279888|472407264|FG000|Overall Study|Subject Non-compliance|43|||
131214094|NCT02279888|472407264|FG000|Overall Study|Not implanted|14|||
131214095|NCT02279888|472407264|FG000|Overall Study|Visit not performed|26|||
131214096|NCT05939388|472407266|FG000|Overall Study|Lost to Follow-up|1|||
131214097|NCT00602667|472407267|FG000|Overall Study|Still on Therapy|0|||
131214098|NCT00602667|472407268|FG001|Overall Study|Still on Therapy|2|||
131214099|NCT00602667|472407269|FG002|Overall Study|Still on Therapy|2|||
131214100|NCT00602667|472407267|FG000|Overall Study|Death|0|||
131214101|NCT00602667|472407268|FG001|Overall Study|Death|1|||
131214102|NCT00602667|472407269|FG002|Overall Study|Death|1|||
131214103|NCT00602667|472407267|FG000|Overall Study|Family request|3|||
131214104|NCT00602667|472407268|FG001|Overall Study|Family request|25|||
131214105|NCT00602667|472407269|FG002|Overall Study|Family request|6|||
131214106|NCT00602667|472407267|FG000|Overall Study|Excessive toxicity|1|||
131214107|NCT00602667|472407268|FG001|Overall Study|Excessive toxicity|1|||
131214108|NCT00602667|472407269|FG002|Overall Study|Excessive toxicity|0|||
131214109|NCT00602667|472407267|FG000|Overall Study|Second malignancy|0|||
131214110|NCT00602667|472407268|FG001|Overall Study|Second malignancy|1|||
131214111|NCT00602667|472407269|FG002|Overall Study|Second malignancy|0|||
131214112|NCT00602667|472407267|FG000|Overall Study|Physician Decision|2|||
131214113|NCT00602667|472407268|FG001|Overall Study|Physician Decision|3|||
131214114|NCT00602667|472407269|FG002|Overall Study|Physician Decision|8|||
131214115|NCT00602667|472407267|FG000|Overall Study|Progressive disease|13|||
131214116|NCT00602667|472407268|FG001|Overall Study|Progressive disease|48|||
131214117|NCT00602667|472407269|FG002|Overall Study|Progressive disease|45|||
131214118|NCT00602667|472407267|FG000|Overall Study|Progressive disease prior to therapy|0|||
131214119|NCT00602667|472407268|FG001|Overall Study|Progressive disease prior to therapy|0|||
131214120|NCT00602667|472407269|FG002|Overall Study|Progressive disease prior to therapy|1|||
131214121|NCT04637815|472408312|FG000|Overall Study|Death|1|||
131214122|NCT04637815|472408313|FG001|Overall Study|Death|0|||
131214123|NCT04637815|472408312|FG000|Overall Study|Lost to Follow-up|5|||
131214124|NCT04637815|472408313|FG001|Overall Study|Lost to Follow-up|2|||
131214125|NCT00943826|472408314|FG000|Concurrent Phase|Adverse Event|50|||
131214126|NCT00943826|472408315|FG001|Concurrent Phase|Adverse Event|27|||
131214127|NCT00943826|472408314|FG000|Concurrent Phase|Withdrew consent|3|||
131214128|NCT00943826|472408315|FG001|Concurrent Phase|Withdrew consent|7|||
131214129|NCT00943826|472408314|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
131214130|NCT00943826|472408315|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
131214131|NCT00943826|472408314|FG000|Concurrent Phase|Administrative reasons|2|||
131214132|NCT00943826|472408315|FG001|Concurrent Phase|Administrative reasons|1|||
131214133|NCT00943826|472408314|FG000|Concurrent Phase|Protocol Violation|1|||
131214134|NCT00943826|472408315|FG001|Concurrent Phase|Protocol Violation|0|||
131214135|NCT00943826|472408314|FG000|Maintenance Phase|Adverse Event|31|||
131214136|NCT00943826|472408315|FG001|Maintenance Phase|Adverse Event|30|||
131214137|NCT00943826|472408314|FG000|Maintenance Phase|Withdrew consent|2|||
131214138|NCT00943826|472408315|FG001|Maintenance Phase|Withdrew consent|4|||
131214139|NCT00943826|472408314|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
131214140|NCT00943826|472408315|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
131214141|NCT00943826|472408314|FG000|Maintenance Phase|Administrative reasons|4|||
131214142|NCT00943826|472408315|FG001|Maintenance Phase|Administrative reasons|1|||
131214143|NCT00943826|472408314|FG000|Maintenance Phase|Failure to return|0|||
131214144|NCT00943826|472408315|FG001|Maintenance Phase|Failure to return|1|||
131214145|NCT00943826|472408314|FG000|Monotherapy Phase|Adverse Event|42|||
131214146|NCT00943826|472408315|FG001|Monotherapy Phase|Adverse Event|5|||
131214147|NCT00943826|472408314|FG000|Monotherapy Phase|Administrative reasons|11|||
131214148|NCT00943826|472408315|FG001|Monotherapy Phase|Administrative reasons|5|||
131214149|NCT00943826|472408314|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
131214150|NCT00943826|472408315|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
131214151|NCT00943826|472408314|FG000|Monotherapy Phase|Withdrew Consent|2|||
131214152|NCT00943826|472408315|FG001|Monotherapy Phase|Withdrew Consent|3|||
131214153|NCT00943826|472408314|FG000|Monotherapy Phase|Failure to return|2|||
131214154|NCT00943826|472408315|FG001|Monotherapy Phase|Failure to return|1|||
131214155|NCT00943826|472408314|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
131214156|NCT00943826|472408315|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
131214157|NCT00943826|472408314|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
131214158|NCT00943826|472408315|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
131214159|NCT00943826|472408314|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
131214160|NCT00943826|472408315|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
131214161|NCT00943826|472408314|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
131214162|NCT00943826|472408315|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
131214163|NCT00326625|472408316|FG000|Overall Study|Adverse Event|20|||
131214164|NCT00326625|472408317|FG001|Overall Study|Adverse Event|9|||
131214165|NCT00326625|472408316|FG000|Overall Study|Withdrawal by Subject|15|||
131214166|NCT00326625|472408317|FG001|Overall Study|Withdrawal by Subject|12|||
131214167|NCT00326625|472408316|FG000|Overall Study|Death|18|||
131214168|NCT00326625|472408317|FG001|Overall Study|Death|16|||
131214169|NCT00326625|472408316|FG000|Overall Study|Lost to Follow-up|1|||
131214170|NCT00326625|472408317|FG001|Overall Study|Lost to Follow-up|0|||
131214171|NCT00326625|472408316|FG000|Overall Study|prescheduled medical intervention|0|||
131214172|NCT00326625|472408317|FG001|Overall Study|prescheduled medical intervention|1|||
131214173|NCT04054011|472408322|FG000|Overall Study|COVID|3|||
131214174|NCT00669110|472408324|FG000|Overall Study|Adverse Event|4|||
131214175|NCT00669110|472408325|FG001|Overall Study|Adverse Event|3|||
131214176|NCT00669110|472408324|FG000|Overall Study|Caregiver request|3|||
131214177|NCT00669110|472408325|FG001|Overall Study|Caregiver request|2|||
131214178|NCT00669110|472408324|FG000|Overall Study|Physician Decision|0|||
131214179|NCT00669110|472408325|FG001|Overall Study|Physician Decision|1|||
131214180|NCT00669110|472408324|FG000|Overall Study|Lost to Follow-up|1|||
130990633|NCT03389477|471593217|FG001|Step 2|Death|1|||
130990634|NCT03389477|471593216|FG000|Step 2|Poor performance status and nutrition|0|||
130990635|NCT03389477|471593217|FG001|Step 2|Poor performance status and nutrition|1|||
130990636|NCT03389477|471593216|FG000|Step 3|Withdrawal after 3 cycles|0|||
130990637|NCT03389477|471593217|FG001|Step 3|Withdrawal after 3 cycles|1|||
130990638|NCT03389477|471593216|FG000|Step 3|Still receiving active treatment|4|||
130990639|NCT03389477|471593217|FG001|Step 3|Still receiving active treatment|0|||
130990640|NCT03389477|471593216|FG000|Step 3|Progressive disease after 2 cycles|1|||
130990641|NCT03389477|471593217|FG001|Step 3|Progressive disease after 2 cycles|0|||
130990642|NCT03403426|471593220|FG000|Overall Study|Death|1|||
130990643|NCT03403426|471593220|FG000|Overall Study|Lost to Follow-up|2|||
130990644|NCT01657266|471593223|FG000|Overall Study|Lost to Follow-up|2|||
130990645|NCT01657266|471593224|FG001|Overall Study|Lost to Follow-up|2|||
130990646|NCT01657266|471593223|FG000|Overall Study|Adverse Event|2|||
130990647|NCT01657266|471593224|FG001|Overall Study|Adverse Event|3|||
130990648|NCT02217280|471593227|FG000|Overall Study|Withdrawal by Subject|2|||
130990649|NCT02217280|471593227|FG000|Overall Study|Post-consent sceen fail|2|||
130990650|NCT00116844|471593228|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
130990651|NCT00116844|471593229|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
130990652|NCT00116844|471593228|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
130990653|NCT00116844|471593229|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
130990654|NCT00116844|471593228|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
130990655|NCT00116844|471593229|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
130990656|NCT00116844|471593228|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
130990657|NCT00116844|471593229|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
130990658|NCT00116844|471593228|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
130990659|NCT00116844|471593229|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
130990660|NCT00116844|471593228|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
130990661|NCT00116844|471593229|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
130990662|NCT00116844|471593228|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
130990663|NCT00116844|471593229|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
130990664|NCT00116844|471593228|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
130990665|NCT00116844|471593229|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
130990666|NCT00116844|471593228|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
130990667|NCT00116844|471593229|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
130990668|NCT01933880|471593230|FG000|Overall Study|Withdrawal by Subject|5|||
130990669|NCT01933880|471593231|FG001|Overall Study|Withdrawal by Subject|0|||
130990670|NCT01933880|471593230|FG000|Overall Study|Lack of Efficacy|1|||
130990671|NCT01933880|471593231|FG001|Overall Study|Lack of Efficacy|0|||
130990672|NCT01933880|471593230|FG000|Overall Study|Concomitant medication Interference|0|||
130990673|NCT01933880|471593231|FG001|Overall Study|Concomitant medication Interference|1|||
131214181|NCT00669110|472408325|FG001|Overall Study|Lost to Follow-up|0|||
131214182|NCT00669110|472408324|FG000|Overall Study|Protocol Violation|0|||
131214183|NCT00669110|472408325|FG001|Overall Study|Protocol Violation|5|||
131214184|NCT00669110|472408324|FG000|Overall Study|Withdrawal by Subject|0|||
130990674|NCT01933880|471593230|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
130990675|NCT01933880|471593231|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
130990676|NCT01933880|471593230|FG000|Overall Study|Other|4|||
130990677|NCT01933880|471593231|FG001|Overall Study|Other|0|||
130990678|NCT01933880|471593230|FG000|Overall Study|Protocol Violation|1|||
130990679|NCT01933880|471593231|FG001|Overall Study|Protocol Violation|0|||
130990680|NCT02395133|471593232|FG000|Overall Study|Adverse Event|4|||
130990681|NCT02395133|471593233|FG001|Overall Study|Adverse Event|1|||
130990682|NCT02395133|471593234|FG002|Overall Study|Adverse Event|3|||
130990683|NCT02395133|471593235|FG003|Overall Study|Adverse Event|0|||
130990684|NCT02395133|471593232|FG000|Overall Study|Lack of Efficacy|1|||
130990685|NCT02395133|471593233|FG001|Overall Study|Lack of Efficacy|0|||
130990686|NCT02395133|471593234|FG002|Overall Study|Lack of Efficacy|1|||
130990687|NCT02395133|471593235|FG003|Overall Study|Lack of Efficacy|1|||
130990688|NCT02395133|471593232|FG000|Overall Study|Protocol Violation|1|||
130990689|NCT02395133|471593233|FG001|Overall Study|Protocol Violation|1|||
130990690|NCT02395133|471593234|FG002|Overall Study|Protocol Violation|0|||
130990691|NCT02395133|471593235|FG003|Overall Study|Protocol Violation|3|||
130990692|NCT02395133|471593232|FG000|Overall Study|Lost to Follow-up|0|||
131214185|NCT00669110|472408325|FG001|Overall Study|Withdrawal by Subject|2|||
131214186|NCT01870921|472408326|FG000|Overall Study|Subject decision|80|||
131214187|NCT01870921|472408326|FG000|Overall Study|Severe non-compliance to protocol|7|||
131214188|NCT01870921|472408326|FG000|Overall Study|Subject Lost to Follow up|2|||
131214189|NCT01870921|472408326|FG000|Overall Study|Other|1|||
130990693|NCT02395133|471593233|FG001|Overall Study|Lost to Follow-up|1|||
130990694|NCT02395133|471593234|FG002|Overall Study|Lost to Follow-up|1|||
130990695|NCT02395133|471593235|FG003|Overall Study|Lost to Follow-up|0|||
130990696|NCT02395133|471593232|FG000|Overall Study|Pregnancy|0|||
130990697|NCT02395133|471593233|FG001|Overall Study|Pregnancy|0|||
130990698|NCT02395133|471593234|FG002|Overall Study|Pregnancy|3|||
131214190|NCT01265875|472408329|FG000|Overall Study|Uncooperative/unreliable|1|||
131214191|NCT05275673|472408330|FG000|Overall Study|Study Termination by Sponsor|2|||
131214192|NCT05275673|472408331|FG001|Overall Study|Study Termination by Sponsor|3|||
131214193|NCT05275673|472408330|FG000|Overall Study|Death|1|||
131214194|NCT05275673|472408331|FG001|Overall Study|Death|0|||
131214195|NCT05275673|472408330|FG000|Overall Study|Withdrawal by Subject|1|||
131214196|NCT05275673|472408331|FG001|Overall Study|Withdrawal by Subject|0|||
131214197|NCT04409509|472408332|FG000|Overall Study|Failure to meet randomization requirement|1|||
131214198|NCT04409509|472408333|FG001|Overall Study|Failure to meet randomization requirement|0|||
131214199|NCT04409509|472408332|FG000|Overall Study|Adverse Event|0|||
131214200|NCT04409509|472408333|FG001|Overall Study|Adverse Event|1|||
131214201|NCT04409509|472408332|FG000|Overall Study|Death|11|||
131214202|NCT04409509|472408333|FG001|Overall Study|Death|10|||
131214203|NCT04409509|472408332|FG000|Overall Study|Non-compliance with study drug|0|||
131214204|NCT04409509|472408333|FG001|Overall Study|Non-compliance with study drug|1|||
131214205|NCT04409509|472408332|FG000|Overall Study|Lost to Follow-up|0|||
131214206|NCT04409509|472408333|FG001|Overall Study|Lost to Follow-up|3|||
131214207|NCT04409509|472408332|FG000|Overall Study|Withdrawal by Subject|0|||
131214208|NCT04409509|472408333|FG001|Overall Study|Withdrawal by Subject|3|||
131214209|NCT04409509|472408332|FG000|Overall Study|Randomized by mistake|0|||
131214210|NCT04409509|472408333|FG001|Overall Study|Randomized by mistake|1|||
131214211|NCT04409509|472408332|FG000|Overall Study|Other|1|||
131214212|NCT04409509|472408333|FG001|Overall Study|Other|1|||
131214213|NCT02331680|472408336|FG000|Overall Study|Adverse Event|3|||
131214214|NCT02331680|472408337|FG001|Overall Study|Adverse Event|0|||
131214215|NCT02331680|472408338|FG002|Overall Study|Adverse Event|2|||
131214216|NCT02331680|472408336|FG000|Overall Study|Physician Decision|1|||
131214217|NCT02331680|472408337|FG001|Overall Study|Physician Decision|1|||
131214218|NCT02331680|472408338|FG002|Overall Study|Physician Decision|2|||
131214219|NCT02331680|472408336|FG000|Overall Study|Withdrawal by Subject|0|||
131214220|NCT02331680|472408337|FG001|Overall Study|Withdrawal by Subject|1|||
131214221|NCT02331680|472408338|FG002|Overall Study|Withdrawal by Subject|2|||
131214222|NCT02331680|472408336|FG000|Overall Study|Met withdrawal criteria|2|||
131214223|NCT02331680|472408337|FG001|Overall Study|Met withdrawal criteria|2|||
131214224|NCT02331680|472408338|FG002|Overall Study|Met withdrawal criteria|5|||
131214225|NCT02331680|472408336|FG000|Overall Study|Non-compliance with study drug|0|||
131214226|NCT02331680|472408337|FG001|Overall Study|Non-compliance with study drug|0|||
131214227|NCT02331680|472408338|FG002|Overall Study|Non-compliance with study drug|1|||
131214228|NCT02331680|472408336|FG000|Overall Study|Protocol Violation|0|||
131214229|NCT02331680|472408337|FG001|Overall Study|Protocol Violation|0|||
131214230|NCT02331680|472408338|FG002|Overall Study|Protocol Violation|3|||
131214231|NCT02335411|472408339|FG000|Overall Study|Death|223|||
131214232|NCT02335411|472408340|FG001|Overall Study|Death|22|||
131214233|NCT02335411|472408341|FG002|Overall Study|Death|26|||
131214234|NCT02335411|472408339|FG000|Overall Study|Physician Decision|3|||
131214235|NCT02335411|472408340|FG001|Overall Study|Physician Decision|0|||
131214236|NCT02335411|472408341|FG002|Overall Study|Physician Decision|0|||
131214237|NCT02335411|472408339|FG000|Overall Study|Protocol Violation|1|||
131214238|NCT02335411|472408340|FG001|Overall Study|Protocol Violation|0|||
131214239|NCT02335411|472408341|FG002|Overall Study|Protocol Violation|0|||
131214240|NCT02335411|472408339|FG000|Overall Study|Withdrawal by Subject|11|||
131214241|NCT02335411|472408340|FG001|Overall Study|Withdrawal by Subject|0|||
131214242|NCT02335411|472408341|FG002|Overall Study|Withdrawal by Subject|3|||
131214243|NCT02335411|472408339|FG000|Overall Study|Sponsor Decision|12|||
131214244|NCT02335411|472408340|FG001|Overall Study|Sponsor Decision|3|||
131214245|NCT02335411|472408341|FG002|Overall Study|Sponsor Decision|2|||
131214246|NCT02335411|472408339|FG000|Overall Study|Adverse Event|9|||
131214247|NCT02335411|472408340|FG001|Overall Study|Adverse Event|0|||
131214248|NCT02335411|472408341|FG002|Overall Study|Adverse Event|0|||
131214249|NCT01891669|472408342|FG000|Overall Study|Death|0|||
131214250|NCT01891669|472408343|FG001|Overall Study|Death|0|||
131214251|NCT01891669|472408344|FG002|Overall Study|Death|0|||
131214252|NCT01891669|472408345|FG003|Overall Study|Death|0|||
131214253|NCT01891669|472408346|FG004|Overall Study|Death|0|||
131214254|NCT01891669|472408347|FG005|Overall Study|Death|0|||
131214255|NCT01891669|472408348|FG006|Overall Study|Death|0|||
131214256|NCT01891669|472408349|FG007|Overall Study|Death|1|||
131214257|NCT01891669|472408350|FG008|Overall Study|Death|0|||
131214258|NCT01891669|472408351|FG009|Overall Study|Death|1|||
131214259|NCT01891669|472408342|FG000|Overall Study|Withdrawal by Subject|1|||
131214260|NCT01891669|472408343|FG001|Overall Study|Withdrawal by Subject|1|||
131214261|NCT01891669|472408344|FG002|Overall Study|Withdrawal by Subject|0|||
131214262|NCT01891669|472408345|FG003|Overall Study|Withdrawal by Subject|0|||
131214263|NCT01891669|472408346|FG004|Overall Study|Withdrawal by Subject|0|||
131214264|NCT01891669|472408347|FG005|Overall Study|Withdrawal by Subject|0|||
131214265|NCT01891669|472408348|FG006|Overall Study|Withdrawal by Subject|1|||
131214266|NCT01891669|472408349|FG007|Overall Study|Withdrawal by Subject|2|||
131214267|NCT01891669|472408350|FG008|Overall Study|Withdrawal by Subject|1|||
131214268|NCT01891669|472408351|FG009|Overall Study|Withdrawal by Subject|1|||
131214269|NCT01891669|472408342|FG000|Overall Study|Other|1|||
131214270|NCT01891669|472408343|FG001|Overall Study|Other|0|||
131214271|NCT01891669|472408344|FG002|Overall Study|Other|0|||
131214272|NCT01891669|472408345|FG003|Overall Study|Other|0|||
131214273|NCT01891669|472408346|FG004|Overall Study|Other|0|||
131214274|NCT01891669|472408347|FG005|Overall Study|Other|0|||
131214275|NCT01891669|472408348|FG006|Overall Study|Other|0|||
131214276|NCT01891669|472408349|FG007|Overall Study|Other|1|||
131214277|NCT01891669|472408350|FG008|Overall Study|Other|0|||
131214278|NCT01891669|472408351|FG009|Overall Study|Other|0|||
131214279|NCT03075826|472408352|FG000|Overall Study|Withdrawal by Subject|1|||
131214280|NCT03075826|472408352|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
131214281|NCT00650806|472408353|FG000|Overall Study|Adverse Event|0|||
131214282|NCT00650806|472408354|FG001|Overall Study|Adverse Event|5|||
131214283|NCT00650806|472408355|FG002|Overall Study|Adverse Event|3|||
131214284|NCT00650806|472408356|FG003|Overall Study|Adverse Event|4|||
131214285|NCT00650806|472408353|FG000|Overall Study|Lost to Follow-up|7|||
131214286|NCT00650806|472408354|FG001|Overall Study|Lost to Follow-up|6|||
131214287|NCT00650806|472408355|FG002|Overall Study|Lost to Follow-up|11|||
131214288|NCT00650806|472408356|FG003|Overall Study|Lost to Follow-up|10|||
131214289|NCT00650806|472408353|FG000|Overall Study|Protocol Violation|0|||
131214290|NCT00650806|472408354|FG001|Overall Study|Protocol Violation|0|||
131214291|NCT00650806|472408355|FG002|Overall Study|Protocol Violation|0|||
131214292|NCT00650806|472408356|FG003|Overall Study|Protocol Violation|1|||
131214293|NCT00650806|472408353|FG000|Overall Study|Pregnancy|0|||
131214294|NCT00650806|472408354|FG001|Overall Study|Pregnancy|0|||
131214295|NCT00650806|472408355|FG002|Overall Study|Pregnancy|0|||
131214296|NCT00650806|472408356|FG003|Overall Study|Pregnancy|1|||
131214297|NCT00650806|472408353|FG000|Overall Study|Withdrawal by Subject|7|||
131214298|NCT00650806|472408354|FG001|Overall Study|Withdrawal by Subject|5|||
131214299|NCT00650806|472408355|FG002|Overall Study|Withdrawal by Subject|8|||
131214300|NCT00650806|472408356|FG003|Overall Study|Withdrawal by Subject|6|||
131214301|NCT00650806|472408353|FG000|Overall Study|Noncompliance with study drug regimen|1|||
131214302|NCT00650806|472408354|FG001|Overall Study|Noncompliance with study drug regimen|1|||
131214303|NCT00650806|472408355|FG002|Overall Study|Noncompliance with study drug regimen|0|||
131214304|NCT00650806|472408356|FG003|Overall Study|Noncompliance with study drug regimen|0|||
131214305|NCT00650806|472408353|FG000|Overall Study|Study terminated by sponsor|2|||
131214306|NCT00650806|472408354|FG001|Overall Study|Study terminated by sponsor|3|||
131214307|NCT00650806|472408355|FG002|Overall Study|Study terminated by sponsor|5|||
131214308|NCT00650806|472408356|FG003|Overall Study|Study terminated by sponsor|4|||
131214309|NCT00650806|472408353|FG000|Overall Study|Other|1|||
131214310|NCT00650806|472408354|FG001|Overall Study|Other|1|||
131214311|NCT00650806|472408355|FG002|Overall Study|Other|2|||
131214312|NCT00650806|472408356|FG003|Overall Study|Other|0|||
131214313|NCT04456998|472408357|FG000|Overall Study|Adverse Event|0|||
131214314|NCT04456998|472408358|FG001|Overall Study|Adverse Event|4|||
131214315|NCT04456998|472408357|FG000|Overall Study|Protocol Deviation|0|||
131214316|NCT04456998|472408358|FG001|Overall Study|Protocol Deviation|1|||
131214317|NCT04456998|472408357|FG000|Overall Study|Withdrawal by Subject|0|||
131214318|NCT04456998|472408358|FG001|Overall Study|Withdrawal by Subject|1|||
131214319|NCT03707145|472408362|FG000|Overall Study|Lost to Follow-up|0|||
131214320|NCT03707145|472408363|FG001|Overall Study|Lost to Follow-up|1|||
131214321|NCT03707145|472408364|FG002|Overall Study|Lost to Follow-up|1|||
131214322|NCT03707145|472408365|FG003|Overall Study|Lost to Follow-up|0|||
131214323|NCT04882085|472408366|FG000|Overall Study|Death|6|||
131214324|NCT04882085|472408367|FG001|Overall Study|Death|9|||
131214325|NCT04882085|472408366|FG000|Overall Study|Withdrawal by Subject|0|||
131214326|NCT04882085|472408367|FG001|Overall Study|Withdrawal by Subject|3|||
131214327|NCT04882085|472408366|FG000|Overall Study|Randomized not treated|1|||
131214328|NCT04882085|472408367|FG001|Overall Study|Randomized not treated|0|||
131214329|NCT04455620|472408371|FG000|Overall Study|Withdrawal by Subject|0|||
131214330|NCT04455620|472408372|FG001|Overall Study|Withdrawal by Subject|0|||
131214331|NCT04455620|472408373|FG002|Overall Study|Withdrawal by Subject|2|||
131214332|NCT04455620|472408374|FG003|Overall Study|Withdrawal by Subject|0|||
131214333|NCT04455620|472408375|FG004|Overall Study|Withdrawal by Subject|1|||
131214334|NCT04455620|472408371|FG000|Overall Study|Lost to Follow-up|0|||
131214335|NCT04455620|472408372|FG001|Overall Study|Lost to Follow-up|0|||
131214336|NCT04455620|472408373|FG002|Overall Study|Lost to Follow-up|1|||
131214337|NCT04455620|472408374|FG003|Overall Study|Lost to Follow-up|1|||
131214338|NCT04455620|472408375|FG004|Overall Study|Lost to Follow-up|0|||
131214339|NCT04455620|472408371|FG000|Overall Study|Death|1|||
131214340|NCT04455620|472408372|FG001|Overall Study|Death|6|||
130990699|NCT02395133|471593235|FG003|Overall Study|Pregnancy|0|||
131214341|NCT04455620|472408373|FG002|Overall Study|Death|20|||
131214342|NCT04455620|472408374|FG003|Overall Study|Death|1|||
131214343|NCT04455620|472408375|FG004|Overall Study|Death|7|||
131214344|NCT04455620|472408371|FG000|Overall Study|Study Termination|0|||
131214345|NCT04455620|472408372|FG001|Overall Study|Study Termination|2|||
131214346|NCT04455620|472408373|FG002|Overall Study|Study Termination|1|||
131214347|NCT04455620|472408374|FG003|Overall Study|Study Termination|0|||
131214348|NCT04455620|472408375|FG004|Overall Study|Study Termination|6|||
131214349|NCT00400985|472408376|FG000|Overall Study|Withdrawal by Subject|5|||
131214350|NCT00400985|472408376|FG000|Overall Study|system modification|8|||
131214351|NCT00400985|472408376|FG000|Overall Study|Death|30|||
131214352|NCT00400985|472408376|FG000|Overall Study|Lost to Follow-up|9|||
131214353|NCT00965562|472408377|FG000|Overall Study|Lost to Follow-up|1|||
131214354|NCT00965562|472408378|FG001|Overall Study|Lost to Follow-up|2|||
131214355|NCT00965562|472408379|FG002|Overall Study|Lost to Follow-up|3|||
131214356|NCT00965562|472408377|FG000|Overall Study|Withdrawal by Subject|2|||
131214357|NCT00965562|472408378|FG001|Overall Study|Withdrawal by Subject|2|||
131214358|NCT00965562|472408379|FG002|Overall Study|Withdrawal by Subject|0|||
131214359|NCT03792633|472408384|FG000|Overall Study|Alternative Treatment|17|||
131214360|NCT03792633|472408385|FG001|Overall Study|Alternative Treatment|19|||
131214361|NCT03792633|472408384|FG000|Overall Study|Death|2|||
131214362|NCT03792633|472408385|FG001|Overall Study|Death|0|||
131214363|NCT03792633|472408384|FG000|Overall Study|Disease progression|8|||
131214364|NCT03792633|472408385|FG001|Overall Study|Disease progression|9|||
131214365|NCT03792633|472408384|FG000|Overall Study|Lost to Follow-up|1|||
131214366|NCT03792633|472408385|FG001|Overall Study|Lost to Follow-up|1|||
131214367|NCT03792633|472408384|FG000|Overall Study|Screen fail|1|||
131214368|NCT03792633|472408385|FG001|Overall Study|Screen fail|0|||
131214369|NCT03792633|472408384|FG000|Overall Study|Second malignancy|0|||
131214370|NCT03792633|472408385|FG001|Overall Study|Second malignancy|1|||
131214371|NCT03179462|472408387|FG000|Overall Study|screening failure|1|||
131214372|NCT03179462|472408388|FG001|Overall Study|screening failure|2|||
131214373|NCT03179462|472408389|FG002|Overall Study|screening failure|0|||
131214374|NCT00816166|472408390|FG000|Overall Study|Lost to Follow-up|6|||
131214375|NCT00816166|472408391|FG001|Overall Study|Lost to Follow-up|10|||
131214376|NCT00816166|472408390|FG000|Overall Study|Death|4|||
131214377|NCT00816166|472408391|FG001|Overall Study|Death|2|||
131214378|NCT01843660|472408397|FG000|Overall Study|Other|30|||
131214379|NCT00209560|472408398|FG000|Overall Study|Lack of Efficacy|1|||
131214380|NCT00209560|472408399|FG001|Overall Study|Lack of Efficacy|0|||
131214381|NCT00795886|472408400|FG000|Overall Study|Death|10|||
131214382|NCT00526227|472408413|FG000|Overall Study|Device not implanted|1|||
131214383|NCT00526227|472408413|FG000|Overall Study|Death|1|||
131214384|NCT03222856|472408416|FG000|Overall Study|Adverse Event|6|||
131214385|NCT03222856|472408416|FG000|Overall Study|Death|1|||
131214386|NCT01721369|472408417|FG000|Overall Study|Not initial etiological diagnosis|12|||
131214387|NCT04478994|472410221|FG000|Overall Study|Withdrawal by Subject|1|||
131214388|NCT04478994|472410222|FG001|Overall Study|Withdrawal by Subject|1|||
131214389|NCT01100073|472410223|FG000|Overall Study|Lack of Efficacy|4|||
131214390|NCT01100073|472410223|FG000|Overall Study|Insufficient Tolerability|21|||
131214391|NCT01100073|472410223|FG000|Overall Study|Withdrawal by Subject|13|||
131214392|NCT01100073|472410223|FG000|Overall Study|Lost to Follow-up|39|||
131214393|NCT01100073|472410223|FG000|Overall Study|Lack of effect + patient's wish|2|||
131214394|NCT01100073|472410223|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
131214395|NCT01100073|472410223|FG000|Overall Study|Other|8|||
131214396|NCT01100073|472410223|FG000|Overall Study|Missing|5|||
131214397|NCT01656850|472410224|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
131214398|NCT01656850|472410225|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
131214399|NCT03255226|472410229|FG000|Overall Study|Adverse Event|2|||
131214400|NCT03255226|472410229|FG000|Overall Study|Physician Decision|3|||
131214401|NCT03255226|472410229|FG000|Overall Study|Withdrawal by Subject|1|||
131214402|NCT03255226|472410229|FG000|Overall Study|Serum or blood sodium increased|4|||
131214403|NCT03255226|472410229|FG000|Overall Study|Serum or blood potassium increased|4|||
131214404|NCT00685763|472410236|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
131214405|NCT00685763|472410236|FG000|Overall Study|Protocol Violation|1|||
131214406|NCT01741259|472410237|FG000|Overall Study|Protocol Violation|6|||
131214407|NCT01741259|472410238|FG001|Overall Study|Protocol Violation|4|||
131214408|NCT01741259|472410237|FG000|Overall Study|Withdrawal by Subject|0|||
131214409|NCT01741259|472410238|FG001|Overall Study|Withdrawal by Subject|2|||
131214410|NCT00698009|472410239|FG000|Overall Study|Withdrawal by Subject|1|||
131214411|NCT02094573|472410240|FG000|Overall Study|Adverse Event|4|||
131214412|NCT02094573|472410241|FG001|Overall Study|Adverse Event|14|||
131214413|NCT02094573|472410240|FG000|Overall Study|Clinical Progressive Disease|9|||
131214414|NCT02094573|472410241|FG001|Overall Study|Clinical Progressive Disease|13|||
131214415|NCT02094573|472410240|FG000|Overall Study|Death|11|||
131214416|NCT02094573|472410241|FG001|Overall Study|Death|3|||
131214417|NCT02094573|472410240|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
131214418|NCT02094573|472410241|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
131214419|NCT02094573|472410240|FG000|Overall Study|Non-compliance with Study Drug|1|||
131214420|NCT02094573|472410241|FG001|Overall Study|Non-compliance with Study Drug|1|||
131214421|NCT02094573|472410240|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
131214422|NCT02094573|472410241|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
131214423|NCT02094573|472410240|FG000|Overall Study|Physician Decision|4|||
131214424|NCT02094573|472410241|FG001|Overall Study|Physician Decision|4|||
131214425|NCT02094573|472410240|FG000|Overall Study|Site Terminated by Sponsor|10|||
130990700|NCT02395133|471593232|FG000|Overall Study|Consent withdrawn with no reason given|1|||
130990701|NCT02395133|471593233|FG001|Overall Study|Consent withdrawn with no reason given|3|||
131133648|NCT01662440|472117165|FG003|Overall Study|Death|0|||
131133649|NCT01662440|472117162|FG000|Overall Study|Lost to Follow-up|2|||
131133650|NCT01662440|472117163|FG001|Overall Study|Lost to Follow-up|2|||
131133651|NCT01662440|472117164|FG002|Overall Study|Lost to Follow-up|4|||
131133652|NCT01662440|472117165|FG003|Overall Study|Lost to Follow-up|1|||
131133653|NCT01662440|472117162|FG000|Overall Study|Subject moved to another country.|0|||
131133654|NCT01662440|472117163|FG001|Overall Study|Subject moved to another country.|1|||
131133655|NCT01662440|472117164|FG002|Overall Study|Subject moved to another country.|0|||
131133656|NCT01662440|472117165|FG003|Overall Study|Subject moved to another country.|0|||
131133657|NCT01662440|472117162|FG000|Overall Study|Protocol Violation|1|||
131133658|NCT01662440|472117163|FG001|Overall Study|Protocol Violation|0|||
131133659|NCT01662440|472117164|FG002|Overall Study|Protocol Violation|0|||
131133660|NCT01662440|472117165|FG003|Overall Study|Protocol Violation|0|||
131133661|NCT01662440|472117162|FG000|Overall Study|Withdrawal by Subject|5|||
131133662|NCT01662440|472117163|FG001|Overall Study|Withdrawal by Subject|2|||
131133663|NCT01662440|472117164|FG002|Overall Study|Withdrawal by Subject|2|||
131133664|NCT01662440|472117165|FG003|Overall Study|Withdrawal by Subject|2|||
131133665|NCT02229552|472117166|FG000|Baseline|Withdrawal by Subject|6|||
131133666|NCT02229552|472117166|FG000|1-year Follow up|Withdrawal by Subject|7|||
131133667|NCT02229552|472117166|FG000|1-year Follow up|Lost to Follow-up|18|||
131133668|NCT02229552|472117166|FG000|2-Year Follow up|Withdrawal by Subject|9|||
131133669|NCT02229552|472117166|FG000|2-Year Follow up|Lost to Follow-up|17|||
131133670|NCT04872101|472117167|FG000|Overall Study|Withdrawal by Subject|10|||
131133671|NCT04872101|472117168|FG001|Overall Study|Withdrawal by Subject|16|||
131133672|NCT04872101|472117167|FG000|Overall Study|Lack of Efficacy|6|||
131133673|NCT04872101|472117168|FG001|Overall Study|Lack of Efficacy|14|||
131133674|NCT04872101|472117167|FG000|Overall Study|Adverse Event|1|||
131133675|NCT04872101|472117168|FG001|Overall Study|Adverse Event|6|||
131133676|NCT04872101|472117167|FG000|Overall Study|Lost to Follow-up|2|||
131133677|NCT04872101|472117168|FG001|Overall Study|Lost to Follow-up|1|||
131133678|NCT04872101|472117167|FG000|Overall Study|Pregnancy|2|||
131133679|NCT04872101|472117168|FG001|Overall Study|Pregnancy|0|||
131133680|NCT04872101|472117167|FG000|Overall Study|Prohibited Medication|1|||
131133681|NCT04872101|472117168|FG001|Overall Study|Prohibited Medication|0|||
131133682|NCT04872101|472117167|FG000|Overall Study|Not dosed|1|||
131133683|NCT04872101|472117168|FG001|Overall Study|Not dosed|0|||
131133684|NCT00971945|472117169|FG000|Overall Study|Progressive Disease|3|||
131133685|NCT00971945|472117169|FG000|Overall Study|Change in treatment policy|1|||
131133686|NCT00971945|472117169|FG000|Overall Study|Other reasons|2|||
131133687|NCT03354663|472117170|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
131133688|NCT03354663|472117170|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
131133689|NCT03354663|472117170|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
131133690|NCT03354663|472117170|FG000|Completed 30-day Visit|Missed Visit|1|||
131133691|NCT03691974|472117171|FG000|Overall Study|Physician Decision|1|||
131133692|NCT03691974|472117172|FG001|Overall Study|Physician Decision|0|||
131133693|NCT03691974|472117171|FG000|Overall Study|Adverse Event|1|||
131133694|NCT03691974|472117172|FG001|Overall Study|Adverse Event|0|||
131133695|NCT03691974|472117171|FG000|Overall Study|Withdrawal by Subject|11|||
131133696|NCT03691974|472117172|FG001|Overall Study|Withdrawal by Subject|9|||
131133697|NCT03691974|472117171|FG000|Overall Study|Protocol Violation|1|||
131133698|NCT03691974|472117172|FG001|Overall Study|Protocol Violation|0|||
131133699|NCT03691974|472117171|FG000|Overall Study|Lost to Follow-up|8|||
131133700|NCT03691974|472117172|FG001|Overall Study|Lost to Follow-up|7|||
131133701|NCT01661140|472117173|FG000|Open-Label Period|Adverse Event|44|||
131133702|NCT01661140|472117174|FG001|Open-Label Period|Adverse Event|0|||
131133703|NCT01661140|472117175|FG002|Open-Label Period|Adverse Event|0|||
131133704|NCT01661140|472117173|FG000|Open-Label Period|Protocol Violation|3|||
131133705|NCT01661140|472117174|FG001|Open-Label Period|Protocol Violation|0|||
131133706|NCT01661140|472117175|FG002|Open-Label Period|Protocol Violation|0|||
131133707|NCT01661140|472117173|FG000|Open-Label Period|Withdrawal by Subject|5|||
131133708|NCT01661140|472117174|FG001|Open-Label Period|Withdrawal by Subject|0|||
131133709|NCT01661140|472117175|FG002|Open-Label Period|Withdrawal by Subject|0|||
131133710|NCT01661140|472117173|FG000|Open-Label Period|Investigator Decision|3|||
131133711|NCT01661140|472117174|FG001|Open-Label Period|Investigator Decision|0|||
131133712|NCT01661140|472117175|FG002|Open-Label Period|Investigator Decision|0|||
131133713|NCT01661140|472117173|FG000|Open-Label Period|Death|1|||
131133714|NCT01661140|472117174|FG001|Open-Label Period|Death|0|||
131133715|NCT01661140|472117175|FG002|Open-Label Period|Death|0|||
131133716|NCT01661140|472117173|FG000|Open-Label Period|Administrative/Other|1|||
131133717|NCT01661140|472117174|FG001|Open-Label Period|Administrative/Other|0|||
131133718|NCT01661140|472117175|FG002|Open-Label Period|Administrative/Other|0|||
131133719|NCT01661140|472117173|FG000|Open-Label Period|Sponsor termination|16|||
131133720|NCT01661140|472117174|FG001|Open-Label Period|Sponsor termination|0|||
131214426|NCT02094573|472410241|FG001|Overall Study|Site Terminated by Sponsor|17|||
131214427|NCT02094573|472410240|FG000|Overall Study|Withdrawal by Subject|6|||
131214428|NCT02094573|472410241|FG001|Overall Study|Withdrawal by Subject|8|||
131214429|NCT02094573|472410240|FG000|Overall Study|Randomized but not Treated|3|||
131214430|NCT02094573|472410241|FG001|Overall Study|Randomized but not Treated|0|||
131214431|NCT00929201|472410242|FG000|Period 1|Withdrawal by Subject|0|||
131214432|NCT00929201|472410243|FG001|Period 1|Withdrawal by Subject|1|||
131214433|NCT04633434|472410250|FG000|Overall Study|Lost to Follow-up|32|||
131214434|NCT04633434|472410251|FG001|Overall Study|Lost to Follow-up|32|||
131214435|NCT04242264|472410255|FG000|Overall Study|Lost to Follow-up|2|||
131214436|NCT04242264|472410256|FG001|Overall Study|Lost to Follow-up|2|||
131214437|NCT04242264|472410257|FG002|Overall Study|Lost to Follow-up|1|||
131214438|NCT04242264|472410258|FG003|Overall Study|Lost to Follow-up|1|||
131214439|NCT04242264|472410255|FG000|Overall Study|Withdrawal by Subject|1|||
131214440|NCT04242264|472410256|FG001|Overall Study|Withdrawal by Subject|0|||
131214441|NCT04242264|472410257|FG002|Overall Study|Withdrawal by Subject|0|||
131214442|NCT04242264|472410258|FG003|Overall Study|Withdrawal by Subject|0|||
131214443|NCT00471237|472410262|FG000|Overall Study|Adverse Event|6|||
131214444|NCT00471237|472410263|FG001|Overall Study|Adverse Event|5|||
131214445|NCT00471237|472410264|FG002|Overall Study|Adverse Event|4|||
131214446|NCT00471237|472410265|FG003|Overall Study|Adverse Event|8|||
131214447|NCT00471237|472410266|FG004|Overall Study|Adverse Event|7|||
131214448|NCT00471237|472410267|FG005|Overall Study|Adverse Event|5|||
131214449|NCT00471237|472410268|FG006|Overall Study|Adverse Event|0|||
131214450|NCT00471237|472410262|FG000|Overall Study|Lost to Follow-up|1|||
131214451|NCT00471237|472410263|FG001|Overall Study|Lost to Follow-up|1|||
131214452|NCT00471237|472410264|FG002|Overall Study|Lost to Follow-up|0|||
131214453|NCT00471237|472410265|FG003|Overall Study|Lost to Follow-up|2|||
131214454|NCT00471237|472410266|FG004|Overall Study|Lost to Follow-up|3|||
131214455|NCT00471237|472410267|FG005|Overall Study|Lost to Follow-up|0|||
131214456|NCT00471237|472410268|FG006|Overall Study|Lost to Follow-up|0|||
131214457|NCT00471237|472410262|FG000|Overall Study|Protocol Violation|3|||
131214458|NCT00471237|472410263|FG001|Overall Study|Protocol Violation|6|||
131214459|NCT00471237|472410264|FG002|Overall Study|Protocol Violation|3|||
131214460|NCT00471237|472410265|FG003|Overall Study|Protocol Violation|2|||
131214461|NCT00471237|472410266|FG004|Overall Study|Protocol Violation|2|||
131214462|NCT00471237|472410267|FG005|Overall Study|Protocol Violation|4|||
131214463|NCT00471237|472410268|FG006|Overall Study|Protocol Violation|1|||
131214464|NCT00471237|472410262|FG000|Overall Study|Withdrawal by Subject|8|||
131214465|NCT00471237|472410263|FG001|Overall Study|Withdrawal by Subject|6|||
131214466|NCT00471237|472410264|FG002|Overall Study|Withdrawal by Subject|5|||
131214467|NCT00471237|472410265|FG003|Overall Study|Withdrawal by Subject|8|||
131214468|NCT00471237|472410266|FG004|Overall Study|Withdrawal by Subject|7|||
131214469|NCT00471237|472410267|FG005|Overall Study|Withdrawal by Subject|4|||
131214470|NCT00471237|472410268|FG006|Overall Study|Withdrawal by Subject|2|||
131214471|NCT00471237|472410262|FG000|Overall Study|Sponsor terminated study|20|||
131214472|NCT00471237|472410263|FG001|Overall Study|Sponsor terminated study|23|||
131214473|NCT00471237|472410264|FG002|Overall Study|Sponsor terminated study|19|||
131214474|NCT00471237|472410265|FG003|Overall Study|Sponsor terminated study|22|||
131214475|NCT00471237|472410266|FG004|Overall Study|Sponsor terminated study|18|||
131214476|NCT00471237|472410267|FG005|Overall Study|Sponsor terminated study|24|||
131214477|NCT00471237|472410268|FG006|Overall Study|Sponsor terminated study|0|||
131214478|NCT00471237|472410262|FG000|Overall Study|Non-compliance|0|||
131214479|NCT00471237|472410263|FG001|Overall Study|Non-compliance|1|||
131214480|NCT00471237|472410264|FG002|Overall Study|Non-compliance|0|||
131214481|NCT00471237|472410265|FG003|Overall Study|Non-compliance|1|||
131214482|NCT00471237|472410266|FG004|Overall Study|Non-compliance|0|||
131214483|NCT00471237|472410267|FG005|Overall Study|Non-compliance|0|||
131214484|NCT00471237|472410268|FG006|Overall Study|Non-compliance|0|||
131214485|NCT00471237|472410262|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
131214486|NCT00471237|472410263|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
131214487|NCT00471237|472410264|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
131214488|NCT00471237|472410265|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
131214489|NCT00471237|472410266|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
130990702|NCT02395133|471593234|FG002|Overall Study|Consent withdrawn with no reason given|0|||
131214490|NCT00471237|472410267|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
131214491|NCT00471237|472410268|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
131214492|NCT00471237|472410262|FG000|Overall Study|Early stopping due to non-efficacy|1|||
131214493|NCT00471237|472410263|FG001|Overall Study|Early stopping due to non-efficacy|0|||
131214494|NCT00471237|472410264|FG002|Overall Study|Early stopping due to non-efficacy|0|||
131214495|NCT00471237|472410265|FG003|Overall Study|Early stopping due to non-efficacy|0|||
131214496|NCT00471237|472410266|FG004|Overall Study|Early stopping due to non-efficacy|1|||
131214497|NCT00471237|472410267|FG005|Overall Study|Early stopping due to non-efficacy|0|||
131214498|NCT00471237|472410268|FG006|Overall Study|Early stopping due to non-efficacy|0|||
131214499|NCT00471237|472410262|FG000|Overall Study|Participant planned to travel to abraod|1|||
131214500|NCT00471237|472410263|FG001|Overall Study|Participant planned to travel to abraod|0|||
131214501|NCT00471237|472410264|FG002|Overall Study|Participant planned to travel to abraod|0|||
131214502|NCT00471237|472410265|FG003|Overall Study|Participant planned to travel to abraod|0|||
131214503|NCT00471237|472410266|FG004|Overall Study|Participant planned to travel to abraod|0|||
131214504|NCT00471237|472410267|FG005|Overall Study|Participant planned to travel to abraod|1|||
131214505|NCT00471237|472410268|FG006|Overall Study|Participant planned to travel to abraod|0|||
131214506|NCT00471237|472410262|FG000|Overall Study|High parathyroid hormone|0|||
131214507|NCT00471237|472410263|FG001|Overall Study|High parathyroid hormone|0|||
131214508|NCT00471237|472410264|FG002|Overall Study|High parathyroid hormone|1|||
131214509|NCT00471237|472410265|FG003|Overall Study|High parathyroid hormone|0|||
131214510|NCT00471237|472410266|FG004|Overall Study|High parathyroid hormone|0|||
131214511|NCT00471237|472410267|FG005|Overall Study|High parathyroid hormone|0|||
131214512|NCT00471237|472410268|FG006|Overall Study|High parathyroid hormone|0|||
131214513|NCT00471237|472410262|FG000|Overall Study|Participant lost medication|0|||
131214514|NCT00471237|472410263|FG001|Overall Study|Participant lost medication|0|||
131214515|NCT00471237|472410264|FG002|Overall Study|Participant lost medication|0|||
131214516|NCT00471237|472410265|FG003|Overall Study|Participant lost medication|0|||
131214517|NCT00471237|472410266|FG004|Overall Study|Participant lost medication|1|||
131214518|NCT00471237|472410267|FG005|Overall Study|Participant lost medication|0|||
131214519|NCT00471237|472410268|FG006|Overall Study|Participant lost medication|0|||
131214520|NCT00471237|472410262|FG000|Overall Study|Administration of prohibited medicine|0|||
131214521|NCT00471237|472410263|FG001|Overall Study|Administration of prohibited medicine|0|||
131214522|NCT00471237|472410264|FG002|Overall Study|Administration of prohibited medicine|0|||
131214523|NCT00471237|472410265|FG003|Overall Study|Administration of prohibited medicine|0|||
131214524|NCT00471237|472410266|FG004|Overall Study|Administration of prohibited medicine|1|||
131214525|NCT00471237|472410267|FG005|Overall Study|Administration of prohibited medicine|0|||
131214526|NCT00471237|472410268|FG006|Overall Study|Administration of prohibited medicine|0|||
131214527|NCT00471237|472410262|FG000|Overall Study|Participant shifted residence|0|||
131214528|NCT00471237|472410263|FG001|Overall Study|Participant shifted residence|0|||
131214529|NCT00471237|472410264|FG002|Overall Study|Participant shifted residence|0|||
131214530|NCT00471237|472410265|FG003|Overall Study|Participant shifted residence|0|||
131214531|NCT00471237|472410266|FG004|Overall Study|Participant shifted residence|1|||
131214532|NCT00471237|472410267|FG005|Overall Study|Participant shifted residence|0|||
131214533|NCT00471237|472410268|FG006|Overall Study|Participant shifted residence|0|||
131214534|NCT00471237|472410262|FG000|Overall Study|Participant's decision|0|||
131214535|NCT00471237|472410263|FG001|Overall Study|Participant's decision|0|||
131214536|NCT00471237|472410264|FG002|Overall Study|Participant's decision|0|||
131214537|NCT00471237|472410265|FG003|Overall Study|Participant's decision|0|||
131214538|NCT00471237|472410266|FG004|Overall Study|Participant's decision|0|||
131214539|NCT00471237|472410267|FG005|Overall Study|Participant's decision|1|||
131214540|NCT00471237|472410268|FG006|Overall Study|Participant's decision|0|||
131214541|NCT01301625|472410279|FG000|Overall Study|Death|5|||
131214542|NCT01301625|472410279|FG000|Overall Study|Not Due|21|||
131214543|NCT01301625|472410279|FG000|Overall Study|Expected|8|||
131214544|NCT01301625|472410279|FG000|Overall Study|Lost to Follow-up|1|||
131214545|NCT00627094|472410286|FG000|Overall Study|Adverse Event|8|||
131214546|NCT00627094|472410287|FG001|Overall Study|Adverse Event|7|||
131214547|NCT00627094|472410286|FG000|Overall Study|Lost to Follow-up|1|||
131214548|NCT00627094|472410287|FG001|Overall Study|Lost to Follow-up|0|||
131214549|NCT00627094|472410286|FG000|Overall Study|Withdrawal by Subject|1|||
131214550|NCT00627094|472410287|FG001|Overall Study|Withdrawal by Subject|1|||
131214551|NCT00627094|472410286|FG000|Overall Study|ulcer healed|1|||
131214552|NCT00627094|472410287|FG001|Overall Study|ulcer healed|7|||
131214553|NCT00627094|472410286|FG000|Overall Study|Other reason|1|||
131214554|NCT00627094|472410287|FG001|Overall Study|Other reason|0|||
131214555|NCT00877799|472410297|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
131214556|NCT00877799|472410298|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
131214557|NCT00877799|472410299|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
131214558|NCT00877799|472410300|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
131214559|NCT00877799|472410301|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
131214560|NCT00877799|472410297|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
131214561|NCT00877799|472410298|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
131214562|NCT00877799|472410299|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
131214563|NCT00877799|472410300|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
131214564|NCT00877799|472410301|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
131214565|NCT00877799|472410297|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
131214566|NCT00877799|472410298|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
131214567|NCT00877799|472410299|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
131214568|NCT00877799|472410300|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
131214569|NCT00877799|472410301|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
131214570|NCT00877799|472410297|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
131214571|NCT00877799|472410298|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
131214572|NCT00877799|472410299|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
131214573|NCT00877799|472410300|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
131214574|NCT00877799|472410301|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
131214575|NCT00877799|472410297|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
131214576|NCT00877799|472410298|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
131214577|NCT00877799|472410299|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
131214578|NCT00877799|472410300|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
131214579|NCT00877799|472410301|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
131214580|NCT04636437|472410304|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
131214581|NCT04636437|472410305|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
131214582|NCT04636437|472410306|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
131214583|NCT04636437|472410304|FG000|Overall Study|Started weight loss drug/program|2|||
131214584|NCT04636437|472410305|FG001|Overall Study|Started weight loss drug/program|1|||
131214585|NCT04636437|472410306|FG002|Overall Study|Started weight loss drug/program|1|||
131214586|NCT04636437|472410304|FG000|Overall Study|Lost to Follow-up|3|||
131214587|NCT04636437|472410305|FG001|Overall Study|Lost to Follow-up|1|||
131214588|NCT04636437|472410306|FG002|Overall Study|Lost to Follow-up|4|||
131214589|NCT04636437|472410304|FG000|Overall Study|Participant or physician decision|3|||
131214590|NCT04636437|472410305|FG001|Overall Study|Participant or physician decision|1|||
131214591|NCT04636437|472410306|FG002|Overall Study|Participant or physician decision|1|||
131214592|NCT02851069|472410307|FG000|Overall Study|Failure to Return|3|||
131214593|NCT02851069|472410307|FG000|Overall Study|Other|3|||
131214594|NCT00352664|472410314|FG000|Overall Study|Withdrawal by Subject|7|||
131214595|NCT00352664|472410315|FG001|Overall Study|Withdrawal by Subject|0|||
131214596|NCT03539952|472410318|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
131214597|NCT03539952|472410319|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
131214598|NCT03539952|472410318|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
131214599|NCT03539952|472410319|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
131214600|NCT03539952|472410318|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
131214601|NCT03539952|472410319|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
131214602|NCT03539952|472410318|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
131214603|NCT03539952|472410319|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
131214604|NCT03539952|472410318|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
131214605|NCT03539952|472410319|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
131214606|NCT03539952|472410318|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
131214607|NCT03539952|472410319|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
131214608|NCT03539952|472410318|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
131214609|NCT03539952|472410319|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
131214610|NCT03075215|472410320|FG000|12-Month Primary Endpoint|Death|152|||
131214611|NCT03075215|472410320|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
131214612|NCT03075215|472410320|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
131214613|NCT03075215|472410320|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
131214614|NCT01233284|472410321|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
131214615|NCT01233284|472410322|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131214616|NCT01233284|472410323|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131214617|NCT01233284|472410324|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131214618|NCT01233284|472410325|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131214619|NCT01233284|472410321|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131214620|NCT01233284|472410322|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
131214621|NCT01233284|472410323|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131214622|NCT01233284|472410324|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131214623|NCT01233284|472410325|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131214624|NCT01233284|472410321|FG000|Period 1 (4 Weeks)|Other|0|||
131214625|NCT01233284|472410322|FG001|Period 1 (4 Weeks)|Other|0|||
131214626|NCT01233284|472410323|FG002|Period 1 (4 Weeks)|Other|1|||
131214627|NCT01233284|472410324|FG003|Period 1 (4 Weeks)|Other|0|||
131214628|NCT01233284|472410325|FG004|Period 1 (4 Weeks)|Other|0|||
131214629|NCT01233284|472410321|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131214630|NCT01233284|472410322|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131214631|NCT01233284|472410323|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
131214632|NCT01233284|472410324|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131214633|NCT01233284|472410325|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
131214634|NCT01233284|472410321|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131214635|NCT01233284|472410322|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131214636|NCT01233284|472410323|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
131214637|NCT01233284|472410324|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131214638|NCT01233284|472410325|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
131214639|NCT01233284|472410321|FG000|Period 3 (4 Weeks)|Other|0|||
131214640|NCT01233284|472410322|FG001|Period 3 (4 Weeks)|Other|0|||
131214641|NCT01233284|472410323|FG002|Period 3 (4 Weeks)|Other|0|||
130882217|NCT02419001|471205402|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
130882218|NCT00313014|471205403|FG000|Overall Study|Withdrawal by Subject|11|||
131214642|NCT01233284|472410324|FG003|Period 3 (4 Weeks)|Other|1|||
131214643|NCT01233284|472410325|FG004|Period 3 (4 Weeks)|Other|0|||
131214644|NCT01233284|472410321|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
131214645|NCT01233284|472410322|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
131214646|NCT01233284|472410323|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
131214647|NCT01233284|472410324|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
131214648|NCT01233284|472410325|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
131214649|NCT01233284|472410321|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
131214650|NCT01233284|472410322|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
131214651|NCT01233284|472410323|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
131214652|NCT01233284|472410324|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
131214653|NCT01233284|472410325|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
131214654|NCT02756182|472410326|FG000|Overall Study|StudyTechnical Difficulties|4|||
131214655|NCT01058707|472410327|FG000|Overall Study|Disease Progression|15|||
131214656|NCT01058707|472410328|FG001|Overall Study|Disease Progression|20|||
131214657|NCT01058707|472410329|FG002|Overall Study|Disease Progression|20|||
131214658|NCT01058707|472410330|FG003|Overall Study|Disease Progression|15|||
131214659|NCT01058707|472410331|FG004|Overall Study|Disease Progression|23|||
131214660|NCT01058707|472410332|FG005|Overall Study|Disease Progression|10|||
131214661|NCT01058707|472410333|FG006|Overall Study|Disease Progression|12|||
131214662|NCT01058707|472410327|FG000|Overall Study|Adverse Event|11|||
131214663|NCT01058707|472410328|FG001|Overall Study|Adverse Event|4|||
131214664|NCT01058707|472410329|FG002|Overall Study|Adverse Event|7|||
131214665|NCT01058707|472410330|FG003|Overall Study|Adverse Event|6|||
131214666|NCT01058707|472410331|FG004|Overall Study|Adverse Event|7|||
131214667|NCT01058707|472410332|FG005|Overall Study|Adverse Event|3|||
131214668|NCT01058707|472410333|FG006|Overall Study|Adverse Event|1|||
131214669|NCT01058707|472410327|FG000|Overall Study|Subject Decision|5|||
131214670|NCT01058707|472410328|FG001|Overall Study|Subject Decision|3|||
131214671|NCT01058707|472410329|FG002|Overall Study|Subject Decision|3|||
131214672|NCT01058707|472410330|FG003|Overall Study|Subject Decision|1|||
131214673|NCT01058707|472410331|FG004|Overall Study|Subject Decision|2|||
131214674|NCT01058707|472410332|FG005|Overall Study|Subject Decision|3|||
131214675|NCT01058707|472410333|FG006|Overall Study|Subject Decision|6|||
131214676|NCT01058707|472410327|FG000|Overall Study|Lost to Follow-up|0|||
131214677|NCT01058707|472410328|FG001|Overall Study|Lost to Follow-up|0|||
131214678|NCT01058707|472410329|FG002|Overall Study|Lost to Follow-up|1|||
131214679|NCT01058707|472410330|FG003|Overall Study|Lost to Follow-up|0|||
131214680|NCT01058707|472410331|FG004|Overall Study|Lost to Follow-up|0|||
131214681|NCT01058707|472410332|FG005|Overall Study|Lost to Follow-up|0|||
131214682|NCT01058707|472410333|FG006|Overall Study|Lost to Follow-up|0|||
131214683|NCT01058707|472410327|FG000|Overall Study|Reason Not Specified|0|||
131214684|NCT01058707|472410328|FG001|Overall Study|Reason Not Specified|3|||
131214685|NCT01058707|472410329|FG002|Overall Study|Reason Not Specified|2|||
131214686|NCT01058707|472410330|FG003|Overall Study|Reason Not Specified|0|||
131214687|NCT01058707|472410331|FG004|Overall Study|Reason Not Specified|7|||
131214688|NCT01058707|472410332|FG005|Overall Study|Reason Not Specified|1|||
131214689|NCT01058707|472410333|FG006|Overall Study|Reason Not Specified|7|||
131214690|NCT01821391|472410334|FG000|Overall Study|Adverse Event|1|||
131214691|NCT01821391|472410335|FG001|Overall Study|Adverse Event|0|||
131214692|NCT02146365|472410336|FG000|Overall Study|Lost to Follow-up|2|||
131214693|NCT02146365|472410337|FG001|Overall Study|Lost to Follow-up|1|||
131214694|NCT02146365|472410338|FG002|Overall Study|Lost to Follow-up|3|||
131214695|NCT02146365|472410339|FG003|Overall Study|Lost to Follow-up|3|||
131214696|NCT02146365|472410340|FG004|Overall Study|Lost to Follow-up|1|||
131214697|NCT02146365|472410341|FG005|Overall Study|Lost to Follow-up|1|||
131214698|NCT02146365|472410342|FG006|Overall Study|Lost to Follow-up|0|||
131214699|NCT02146365|472410343|FG007|Overall Study|Lost to Follow-up|1|||
131214700|NCT02146365|472410336|FG000|Overall Study|Withdrawal by Subject|1|||
131214701|NCT02146365|472410337|FG001|Overall Study|Withdrawal by Subject|2|||
131214702|NCT02146365|472410338|FG002|Overall Study|Withdrawal by Subject|1|||
131214703|NCT02146365|472410339|FG003|Overall Study|Withdrawal by Subject|5|||
131214704|NCT02146365|472410340|FG004|Overall Study|Withdrawal by Subject|1|||
131214705|NCT02146365|472410341|FG005|Overall Study|Withdrawal by Subject|0|||
131214706|NCT02146365|472410342|FG006|Overall Study|Withdrawal by Subject|0|||
131214707|NCT02146365|472410343|FG007|Overall Study|Withdrawal by Subject|0|||
131214708|NCT02146365|472410336|FG000|Overall Study|Unable to Comply with Protocol|0|||
131214709|NCT02146365|472410337|FG001|Overall Study|Unable to Comply with Protocol|1|||
131214710|NCT02146365|472410338|FG002|Overall Study|Unable to Comply with Protocol|1|||
131214711|NCT02146365|472410339|FG003|Overall Study|Unable to Comply with Protocol|0|||
130882219|NCT00313014|471205404|FG001|Overall Study|Withdrawal by Subject|7|||
130882220|NCT00313014|471205405|FG002|Overall Study|Withdrawal by Subject|5|||
130882221|NCT00313014|471205403|FG000|Overall Study|Adverse Event|14|||
130882222|NCT00313014|471205404|FG001|Overall Study|Adverse Event|29|||
130882223|NCT00313014|471205405|FG002|Overall Study|Adverse Event|16|||
130882224|NCT00313014|471205403|FG000|Overall Study|Lost to Follow-up|7|||
130882225|NCT00313014|471205404|FG001|Overall Study|Lost to Follow-up|6|||
130882226|NCT00313014|471205405|FG002|Overall Study|Lost to Follow-up|10|||
130882227|NCT00313014|471205403|FG000|Overall Study|Administrative|9|||
131214712|NCT02146365|472410340|FG004|Overall Study|Unable to Comply with Protocol|0|||
131214713|NCT02146365|472410341|FG005|Overall Study|Unable to Comply with Protocol|0|||
131214714|NCT02146365|472410342|FG006|Overall Study|Unable to Comply with Protocol|0|||
130990703|NCT02395133|471593235|FG003|Overall Study|Consent withdrawn with no reason given|2|||
130990704|NCT02395133|471593232|FG000|Overall Study|Consent withdrawn with personal reason|0|||
130990705|NCT02395133|471593233|FG001|Overall Study|Consent withdrawn with personal reason|1|||
130990706|NCT02395133|471593234|FG002|Overall Study|Consent withdrawn with personal reason|0|||
130990707|NCT02395133|471593235|FG003|Overall Study|Consent withdrawn with personal reason|3|||
130990708|NCT02395133|471593232|FG000|Overall Study|Sponsor decision|2|||
130990709|NCT02395133|471593233|FG001|Overall Study|Sponsor decision|0|||
130990710|NCT02395133|471593234|FG002|Overall Study|Sponsor decision|0|||
130990711|NCT02395133|471593235|FG003|Overall Study|Sponsor decision|1|||
130990712|NCT02395133|471593232|FG000|Overall Study|Other than specified above|5|||
130990713|NCT02395133|471593233|FG001|Overall Study|Other than specified above|2|||
130990714|NCT02395133|471593234|FG002|Overall Study|Other than specified above|2|||
130990715|NCT02395133|471593235|FG003|Overall Study|Other than specified above|4|||
130990716|NCT00962247|471593236|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
130990717|NCT00962247|471593236|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
130990718|NCT00709059|471593246|FG000|Overall Study|Lost to Follow-up|34|||
130990719|NCT00709059|471593246|FG000|Overall Study|Withdrawal by Subject|19|||
130990720|NCT00709059|471593246|FG000|Overall Study|Physician Decision|7|||
130882228|NCT00313014|471205404|FG001|Overall Study|Administrative|6|||
130882229|NCT00313014|471205405|FG002|Overall Study|Administrative|14|||
130882230|NCT00313014|471205403|FG000|Overall Study|Lack of Efficacy|52|||
130882231|NCT00313014|471205404|FG001|Overall Study|Lack of Efficacy|25|||
130882232|NCT00313014|471205405|FG002|Overall Study|Lack of Efficacy|16|||
130882233|NCT01198795|471205407|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
130882234|NCT01198795|471205407|FG000|Overall Study|Withdrawal by Subject|17|||
130882235|NCT01198795|471205407|FG000|Overall Study|Lost to Follow-up|15|||
130882236|NCT01198795|471205407|FG000|Overall Study|Adverse Event|9|||
130882237|NCT01198795|471205407|FG000|Overall Study|Lack of Efficacy|5|||
130882238|NCT01198795|471205407|FG000|Overall Study|Protocol Violation|2|||
130882239|NCT01198795|471205407|FG000|Overall Study|Other Reason|4|||
130882240|NCT00744497|471205408|FG000|Overall Study|Withdrawal by Subject|21|||
131214715|NCT02146365|472410343|FG007|Overall Study|Unable to Comply with Protocol|0|||
131214716|NCT02146365|472410336|FG000|Overall Study|Other|1|||
131214717|NCT02146365|472410337|FG001|Overall Study|Other|0|||
131214718|NCT02146365|472410338|FG002|Overall Study|Other|2|||
131214719|NCT02146365|472410339|FG003|Overall Study|Other|1|||
131214720|NCT02146365|472410340|FG004|Overall Study|Other|0|||
131214721|NCT02146365|472410341|FG005|Overall Study|Other|0|||
131214722|NCT02146365|472410342|FG006|Overall Study|Other|0|||
131214723|NCT02146365|472410343|FG007|Overall Study|Other|0|||
130882241|NCT00744497|471205409|FG001|Overall Study|Withdrawal by Subject|18|||
130882242|NCT00744497|471205408|FG000|Overall Study|Death|11|||
130882243|NCT00744497|471205409|FG001|Overall Study|Death|9|||
130882244|NCT00744497|471205408|FG000|Overall Study|Lost to Follow-up|4|||
130882245|NCT00744497|471205409|FG001|Overall Study|Lost to Follow-up|2|||
130882246|NCT00744497|471205408|FG000|Overall Study|Poor compliance/noncompliance|9|||
130882247|NCT00744497|471205409|FG001|Overall Study|Poor compliance/noncompliance|5|||
130882248|NCT00744497|471205408|FG000|Overall Study|No longer meets study criteria|7|||
130882249|NCT00744497|471205409|FG001|Overall Study|No longer meets study criteria|3|||
130882250|NCT00744497|471205408|FG000|Overall Study|Administrative Reason By Sponsor|25|||
130882251|NCT00744497|471205409|FG001|Overall Study|Administrative Reason By Sponsor|8|||
130882252|NCT00744497|471205408|FG000|Overall Study|Disease progression|312|||
130882253|NCT00744497|471205409|FG001|Overall Study|Disease progression|219|||
130882254|NCT00744497|471205408|FG000|Overall Study|Study drug toxicity|68|||
130882255|NCT00744497|471205409|FG001|Overall Study|Study drug toxicity|141|||
130882256|NCT00744497|471205408|FG000|Overall Study|Adverse event unrelated to study drug|78|||
130882257|NCT00744497|471205409|FG001|Overall Study|Adverse event unrelated to study drug|122|||
130882258|NCT00744497|471205408|FG000|Overall Study|Patient requested to stop study drug|65|||
130882259|NCT00744497|471205409|FG001|Overall Study|Patient requested to stop study drug|80|||
131214724|NCT01977482|472410345|FG000|Overall Study|Adverse Event|0|||
131214725|NCT01977482|472410346|FG001|Overall Study|Adverse Event|1|||
130882260|NCT00744497|471205408|FG000|Overall Study|Maximum clinical benefit|141|||
130882261|NCT00744497|471205409|FG001|Overall Study|Maximum clinical benefit|142|||
130882262|NCT00744497|471205408|FG000|Overall Study|Not defined|19|||
130882263|NCT00744497|471205409|FG001|Overall Study|Not defined|13|||
130882264|NCT04154904|471205442|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
130882265|NCT04154904|471205443|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
130882266|NCT04154904|471205444|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
130882267|NCT00936715|471205445|FG000|Overall Study|Investigators Discretion|1|||
130990721|NCT00709059|471593246|FG000|Overall Study|Disease complication|3|||
131214726|NCT01977482|472410347|FG002|Overall Study|Adverse Event|1|||
131214727|NCT01977482|472410348|FG003|Overall Study|Adverse Event|0|||
131214728|NCT01977482|472410349|FG004|Overall Study|Adverse Event|2|||
130882268|NCT00936715|471205445|FG000|Overall Study|Protocol Violation|1|||
130882269|NCT00936715|471205445|FG000|Overall Study|Safety or Tolerability Reasons|4|||
130882270|NCT03819114|471205446|FG000|Overall Study|Protocol Violation|0|||
130882271|NCT03819114|471205447|FG001|Overall Study|Protocol Violation|1|||
130882272|NCT03819114|471205448|FG002|Overall Study|Protocol Violation|1|||
130882273|NCT03819114|471205449|FG003|Overall Study|Protocol Violation|0|||
130882274|NCT03819114|471205446|FG000|Overall Study|Lost to Follow-up|0|||
130882275|NCT03819114|471205447|FG001|Overall Study|Lost to Follow-up|0|||
130882276|NCT03819114|471205448|FG002|Overall Study|Lost to Follow-up|1|||
130882277|NCT03819114|471205449|FG003|Overall Study|Lost to Follow-up|0|||
130882278|NCT00914316|471205453|FG000|Phase 1|Physician Decision|4|||
130882279|NCT00914316|471205454|FG001|Phase 1|Physician Decision|0|||
130882280|NCT00914316|471205455|FG002|Phase 1|Physician Decision|1|||
130882281|NCT00914316|471205456|FG003|Phase 1|Physician Decision|2|||
130882282|NCT00914316|471205453|FG000|Phase 1|Withdrawal by Subject|0|||
130882283|NCT00914316|471205454|FG001|Phase 1|Withdrawal by Subject|2|||
130882284|NCT00914316|471205455|FG002|Phase 1|Withdrawal by Subject|4|||
130882285|NCT00914316|471205456|FG003|Phase 1|Withdrawal by Subject|0|||
130882286|NCT00914316|471205453|FG000|Phase 1|Adverse Event|1|||
130882287|NCT00914316|471205454|FG001|Phase 1|Adverse Event|0|||
130882288|NCT00914316|471205455|FG002|Phase 1|Adverse Event|0|||
130882289|NCT00914316|471205456|FG003|Phase 1|Adverse Event|0|||
130882290|NCT00914316|471205453|FG000|Phase 2|Withdrawal by Subject|1|||
130882291|NCT00914316|471205454|FG001|Phase 2|Withdrawal by Subject|0|||
130882292|NCT00914316|471205455|FG002|Phase 2|Withdrawal by Subject|1|||
130882293|NCT00914316|471205456|FG003|Phase 2|Withdrawal by Subject|0|||
130882294|NCT01759446|471205458|FG000|Overall Study|Protocol Violation|1|||
130882295|NCT01759446|471205459|FG001|Overall Study|Protocol Violation|0|||
130882296|NCT01759446|471205460|FG002|Overall Study|Protocol Violation|1|||
130882297|NCT01759446|471205461|FG003|Overall Study|Protocol Violation|0|||
130882298|NCT01759446|471205462|FG004|Overall Study|Protocol Violation|0|||
130882299|NCT01759446|471205458|FG000|Overall Study|Withdrawal by Subject|0|||
130882300|NCT01759446|471205459|FG001|Overall Study|Withdrawal by Subject|1|||
130882301|NCT01759446|471205460|FG002|Overall Study|Withdrawal by Subject|0|||
130882302|NCT01759446|471205461|FG003|Overall Study|Withdrawal by Subject|1|||
130882303|NCT01759446|471205462|FG004|Overall Study|Withdrawal by Subject|0|||
130882304|NCT01213472|471205468|FG000|Overall Study|Recurrence/Progressive disease|25|||
130882305|NCT01213472|471205468|FG000|Overall Study|Withdrawal by Subject|1|||
130882306|NCT01213472|471205468|FG000|Overall Study|Physician Decision|1|||
130882307|NCT01472289|471205471|FG000|Overall Study|Death|2|||
130882308|NCT03879772|471205472|FG000|Overall Study|Adverse Event|2|||
130882309|NCT03879772|471205473|FG001|Overall Study|Adverse Event|2|||
130882310|NCT03879772|471205474|FG002|Overall Study|Adverse Event|3|||
130882311|NCT03879772|471205475|FG003|Overall Study|Adverse Event|4|||
130882312|NCT03879772|471205476|FG004|Overall Study|Adverse Event|3|||
130882313|NCT03879772|471205472|FG000|Overall Study|Treatment Failure|1|||
130990722|NCT00709059|471593246|FG000|Overall Study|Side effects|20|||
130990723|NCT00709059|471593246|FG000|Overall Study|Serious side effects|11|||
130990724|NCT01786330|471593247|FG000|Overall Study|Withdrawal by Subject|0|||
130882314|NCT03879772|471205473|FG001|Overall Study|Treatment Failure|0|||
130882315|NCT03879772|471205474|FG002|Overall Study|Treatment Failure|0|||
130882316|NCT03879772|471205475|FG003|Overall Study|Treatment Failure|2|||
130882317|NCT03879772|471205476|FG004|Overall Study|Treatment Failure|1|||
130882318|NCT03879772|471205472|FG000|Overall Study|Lost to Follow-up|0|||
130882319|NCT03879772|471205473|FG001|Overall Study|Lost to Follow-up|0|||
130990725|NCT01786330|471593248|FG001|Overall Study|Withdrawal by Subject|1|||
130990726|NCT01786330|471593247|FG000|Overall Study|Lost to Follow-up|0|||
130990727|NCT01786330|471593248|FG001|Overall Study|Lost to Follow-up|1|||
130990728|NCT01786330|471593247|FG000|Overall Study|Excluded intraoperatively|0|||
130990729|NCT01786330|471593248|FG001|Overall Study|Excluded intraoperatively|1|||
130990730|NCT01786330|471593247|FG000|Overall Study|Protocol Violation|1|||
130990731|NCT01786330|471593248|FG001|Overall Study|Protocol Violation|0|||
131214729|NCT01977482|472410350|FG005|Overall Study|Adverse Event|0|||
130990732|NCT02172625|471593253|FG000|Overall Study|Adverse Event|0|||
131214730|NCT01977482|472410345|FG000|Overall Study|Lost to Follow-up|1|||
130990733|NCT02172625|471593254|FG001|Overall Study|Adverse Event|1|||
130990734|NCT02172625|471593253|FG000|Overall Study|Pregnancy|0|||
130990735|NCT02172625|471593254|FG001|Overall Study|Pregnancy|1|||
130882320|NCT03879772|471205474|FG002|Overall Study|Lost to Follow-up|0|||
130882321|NCT03879772|471205475|FG003|Overall Study|Lost to Follow-up|0|||
130882322|NCT03879772|471205476|FG004|Overall Study|Lost to Follow-up|1|||
130882323|NCT03879772|471205472|FG000|Overall Study|Withdrawal by Subject|0|||
130882324|NCT03879772|471205473|FG001|Overall Study|Withdrawal by Subject|1|||
130882325|NCT03879772|471205474|FG002|Overall Study|Withdrawal by Subject|3|||
130882326|NCT03879772|471205475|FG003|Overall Study|Withdrawal by Subject|1|||
130882327|NCT03879772|471205476|FG004|Overall Study|Withdrawal by Subject|1|||
130882328|NCT03879772|471205472|FG000|Overall Study|Protocol Violation|0|||
130882329|NCT03879772|471205473|FG001|Overall Study|Protocol Violation|0|||
130990736|NCT02172625|471593253|FG000|Overall Study|car accident|0|||
130990737|NCT02172625|471593254|FG001|Overall Study|car accident|1|||
130990738|NCT00524030|471593255|FG000|Overall Study|Lack of Efficacy|10|||
130990739|NCT00524030|471593256|FG001|Overall Study|Lack of Efficacy|24|||
130990740|NCT00524030|471593255|FG000|Overall Study|Lost to Follow-up|0|||
130990741|NCT00524030|471593256|FG001|Overall Study|Lost to Follow-up|2|||
130990742|NCT00524030|471593255|FG000|Overall Study|Withdrawal by Subject|3|||
130990743|NCT00524030|471593256|FG001|Overall Study|Withdrawal by Subject|8|||
130990744|NCT00524030|471593255|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
130990745|NCT00524030|471593256|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
130990746|NCT00524030|471593255|FG000|Overall Study|Protocol Violation|0|||
130990747|NCT00524030|471593256|FG001|Overall Study|Protocol Violation|1|||
130990748|NCT00524030|471593255|FG000|Overall Study|Pregnancy|1|||
130990749|NCT00524030|471593256|FG001|Overall Study|Pregnancy|0|||
130990750|NCT00524030|471593255|FG000|Overall Study|Adverse Event|3|||
130990751|NCT00524030|471593256|FG001|Overall Study|Adverse Event|21|||
130990752|NCT00524030|471593255|FG000|Overall Study|Death|0|||
130990753|NCT00524030|471593256|FG001|Overall Study|Death|1|||
130990754|NCT03315130|471593257|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
130990755|NCT03315130|471593258|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
130990756|NCT03315130|471593259|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
130990757|NCT03315130|471593260|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
130990758|NCT03315130|471593257|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
130990759|NCT03315130|471593258|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
130990760|NCT03315130|471593259|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
130990761|NCT03315130|471593260|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
130990762|NCT03315130|471593257|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
130990763|NCT03315130|471593258|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
130990764|NCT03315130|471593259|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
130990765|NCT03315130|471593260|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
130990766|NCT03315130|471593257|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
130990767|NCT03315130|471593258|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
130990768|NCT03315130|471593259|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
130990769|NCT03315130|471593260|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
130990770|NCT03315130|471593257|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
130990771|NCT03315130|471593258|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
130990772|NCT03315130|471593259|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
130990773|NCT03315130|471593260|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
130990774|NCT03315130|471593257|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
130990775|NCT03315130|471593258|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
130990776|NCT03315130|471593259|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
130990777|NCT03315130|471593260|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
130990778|NCT00118898|471593261|FG000|Overall Study|Death|6|||
130990779|NCT00118898|471593262|FG001|Overall Study|Death|11|||
130990780|NCT00118898|471593263|FG002|Overall Study|Death|6|||
130990781|NCT00118898|471593264|FG003|Overall Study|Death|8|||
130990782|NCT00118898|471593261|FG000|Overall Study|Lost to Follow-up|26|||
130990783|NCT00118898|471593262|FG001|Overall Study|Lost to Follow-up|34|||
130990784|NCT00118898|471593263|FG002|Overall Study|Lost to Follow-up|33|||
130990785|NCT00118898|471593264|FG003|Overall Study|Lost to Follow-up|33|||
130990786|NCT00118898|471593261|FG000|Overall Study|Withdrawal by Subject|10|||
130990787|NCT00118898|471593262|FG001|Overall Study|Withdrawal by Subject|5|||
130990788|NCT00118898|471593263|FG002|Overall Study|Withdrawal by Subject|8|||
130990789|NCT00118898|471593264|FG003|Overall Study|Withdrawal by Subject|8|||
130990790|NCT00118898|471593261|FG000|Overall Study|Site Closure|33|||
130990791|NCT00118898|471593262|FG001|Overall Study|Site Closure|31|||
130990792|NCT00118898|471593263|FG002|Overall Study|Site Closure|28|||
130990793|NCT00118898|471593264|FG003|Overall Study|Site Closure|37|||
130990794|NCT00118898|471593261|FG000|Overall Study|Severe debilitation|1|||
130990795|NCT00118898|471593262|FG001|Overall Study|Severe debilitation|4|||
130990796|NCT00118898|471593263|FG002|Overall Study|Severe debilitation|6|||
130990797|NCT00118898|471593264|FG003|Overall Study|Severe debilitation|4|||
130990798|NCT00118898|471593261|FG000|Overall Study|Not compliant with requirements|11|||
130990799|NCT00118898|471593262|FG001|Overall Study|Not compliant with requirements|13|||
130990800|NCT00118898|471593263|FG002|Overall Study|Not compliant with requirements|11|||
130990801|NCT00118898|471593264|FG003|Overall Study|Not compliant with requirements|11|||
130990802|NCT00118898|471593261|FG000|Overall Study|Not able to get to clinic|34|||
130990803|NCT00118898|471593262|FG001|Overall Study|Not able to get to clinic|43|||
130990804|NCT00118898|471593263|FG002|Overall Study|Not able to get to clinic|31|||
130990805|NCT00118898|471593264|FG003|Overall Study|Not able to get to clinic|40|||
130990806|NCT00976703|471594522|FG000|Overall Study|Physician Decision|1|||
130990807|NCT00976703|471594523|FG001|Overall Study|Physician Decision|1|||
130990808|NCT00976703|471594522|FG000|Overall Study|ineligible for study|2|||
130990809|NCT00976703|471594523|FG001|Overall Study|ineligible for study|2|||
130990810|NCT03075501|471594526|FG000|Overall Study|Scheduling difficulties|15|||
130990811|NCT03075501|471594527|FG001|Overall Study|Scheduling difficulties|9|||
130990812|NCT00957931|471594530|FG000|Overall Study|Death|4|||
130990813|NCT00857805|471594531|FG000|Overall Study|Withdrawal by Subject|1|||
130990814|NCT00857805|471594532|FG001|Overall Study|Withdrawal by Subject|1|||
130990815|NCT04867785|471594533|FG000|Overall Study|Adverse Event|1|||
130990816|NCT04867785|471594534|FG001|Overall Study|Adverse Event|0|||
130990817|NCT04867785|471594535|FG002|Overall Study|Adverse Event|1|||
130990818|NCT04867785|471594536|FG003|Overall Study|Adverse Event|0|||
130990819|NCT04867785|471594537|FG004|Overall Study|Adverse Event|0|||
130990820|NCT04867785|471594538|FG005|Overall Study|Adverse Event|0|||
130990821|NCT04867785|471594539|FG006|Overall Study|Adverse Event|0|||
130990822|NCT04867785|471594540|FG007|Overall Study|Adverse Event|2|||
130990823|NCT04867785|471594533|FG000|Overall Study|Lost to Follow-up|4|||
130990824|NCT04867785|471594534|FG001|Overall Study|Lost to Follow-up|4|||
130990825|NCT04867785|471594535|FG002|Overall Study|Lost to Follow-up|3|||
130990826|NCT04867785|471594536|FG003|Overall Study|Lost to Follow-up|2|||
130990827|NCT04867785|471594537|FG004|Overall Study|Lost to Follow-up|0|||
130990828|NCT04867785|471594538|FG005|Overall Study|Lost to Follow-up|1|||
130990829|NCT04867785|471594539|FG006|Overall Study|Lost to Follow-up|0|||
130990830|NCT04867785|471594540|FG007|Overall Study|Lost to Follow-up|1|||
130990831|NCT04867785|471594533|FG000|Overall Study|Withdrawal by Subject|6|||
130990832|NCT04867785|471594534|FG001|Overall Study|Withdrawal by Subject|2|||
130990833|NCT04867785|471594535|FG002|Overall Study|Withdrawal by Subject|2|||
130990834|NCT04867785|471594536|FG003|Overall Study|Withdrawal by Subject|1|||
130990835|NCT04867785|471594537|FG004|Overall Study|Withdrawal by Subject|2|||
130990836|NCT04867785|471594538|FG005|Overall Study|Withdrawal by Subject|0|||
130990837|NCT04867785|471594539|FG006|Overall Study|Withdrawal by Subject|2|||
130990838|NCT04867785|471594540|FG007|Overall Study|Withdrawal by Subject|5|||
130990839|NCT04867785|471594533|FG000|Overall Study|Physician Decision|0|||
130990840|NCT04867785|471594534|FG001|Overall Study|Physician Decision|0|||
130990841|NCT04867785|471594535|FG002|Overall Study|Physician Decision|0|||
130990842|NCT04867785|471594536|FG003|Overall Study|Physician Decision|0|||
130990843|NCT04867785|471594537|FG004|Overall Study|Physician Decision|0|||
130990844|NCT04867785|471594538|FG005|Overall Study|Physician Decision|0|||
130990845|NCT04867785|471594539|FG006|Overall Study|Physician Decision|0|||
130990846|NCT04867785|471594540|FG007|Overall Study|Physician Decision|1|||
130990847|NCT04867785|471594533|FG000|Overall Study|Inadvertent Enrollment|0|||
130990848|NCT04867785|471594534|FG001|Overall Study|Inadvertent Enrollment|0|||
130990849|NCT04867785|471594535|FG002|Overall Study|Inadvertent Enrollment|0|||
130990850|NCT04867785|471594536|FG003|Overall Study|Inadvertent Enrollment|1|||
130990851|NCT04867785|471594537|FG004|Overall Study|Inadvertent Enrollment|1|||
130990852|NCT04867785|471594538|FG005|Overall Study|Inadvertent Enrollment|0|||
130990853|NCT04867785|471594539|FG006|Overall Study|Inadvertent Enrollment|0|||
130990854|NCT04867785|471594540|FG007|Overall Study|Inadvertent Enrollment|1|||
130990855|NCT04867785|471594533|FG000|Overall Study|Eligibility Criteria Not Met|0|||
130990856|NCT04867785|471594534|FG001|Overall Study|Eligibility Criteria Not Met|0|||
130990857|NCT04867785|471594535|FG002|Overall Study|Eligibility Criteria Not Met|0|||
130990858|NCT04867785|471594536|FG003|Overall Study|Eligibility Criteria Not Met|0|||
130990859|NCT04867785|471594537|FG004|Overall Study|Eligibility Criteria Not Met|0|||
130990860|NCT04867785|471594538|FG005|Overall Study|Eligibility Criteria Not Met|0|||
130990861|NCT04867785|471594539|FG006|Overall Study|Eligibility Criteria Not Met|0|||
130990862|NCT04867785|471594540|FG007|Overall Study|Eligibility Criteria Not Met|1|||
130990863|NCT01289041|471594541|FG000|Overall Study|Adverse Event|24|||
130990864|NCT01289041|471594541|FG000|Overall Study|Physician Decision|1|||
130990865|NCT01289041|471594541|FG000|Overall Study|Progressive Disease|41|||
130990866|NCT01289041|471594541|FG000|Overall Study|Withdrawal by Subject|3|||
130990867|NCT01289041|471594541|FG000|Overall Study|Death|1|||
130990868|NCT01062763|471594542|FG000|Overall Study|Adverse Event|3|||
130990869|NCT01062763|471594543|FG001|Overall Study|Adverse Event|4|||
130990870|NCT02494921|471594545|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
130990871|NCT02494921|471594546|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
130990872|NCT02494921|471594547|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
130990873|NCT02494921|471594548|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
131214731|NCT01977482|472410346|FG001|Overall Study|Lost to Follow-up|0|||
131214732|NCT01977482|472410347|FG002|Overall Study|Lost to Follow-up|0|||
130990874|NCT02494921|471594549|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
130990875|NCT02494921|471594545|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
130990876|NCT02494921|471594546|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
131214733|NCT01977482|472410348|FG003|Overall Study|Lost to Follow-up|0|||
130990877|NCT02494921|471594547|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
130990878|NCT02494921|471594548|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
130990879|NCT02494921|471594549|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
130990880|NCT02494921|471594545|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
130990881|NCT02494921|471594546|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
130990882|NCT02494921|471594547|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
130990883|NCT02494921|471594548|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
130990884|NCT02494921|471594549|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
131214734|NCT01977482|472410349|FG004|Overall Study|Lost to Follow-up|0|||
130990885|NCT02714868|471594557|FG000|Overall Study|Withdrawal by Subject|3|||
130990886|NCT02714868|471594558|FG001|Overall Study|Withdrawal by Subject|0|||
130990887|NCT02714868|471594557|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
130990888|NCT02714868|471594558|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
130990889|NCT02714868|471594557|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
130990890|NCT02714868|471594558|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
130990891|NCT00255346|471594562|FG000|Overall Study|Adverse Event|1|||
130990892|NCT00255346|471594563|FG001|Overall Study|Adverse Event|0|||
130990893|NCT00255346|471594564|FG002|Overall Study|Adverse Event|0|||
130990894|NCT00255346|471594565|FG003|Overall Study|Adverse Event|0|||
130990895|NCT00255346|471594566|FG004|Overall Study|Adverse Event|0|||
130990896|NCT00674323|471594567|FG000|Overall Study|Adverse Event|0|||
130990897|NCT00674323|471594568|FG001|Overall Study|Adverse Event|1|||
130990898|NCT00674323|471594569|FG002|Overall Study|Adverse Event|0|||
130990899|NCT00674323|471594567|FG000|Overall Study|Protocol Violation|1|||
130990900|NCT00674323|471594568|FG001|Overall Study|Protocol Violation|0|||
130990901|NCT00674323|471594569|FG002|Overall Study|Protocol Violation|0|||
130990902|NCT02045433|471594579|FG000|Overall Study|Withdrawal by Subject|1|||
130990903|NCT03585296|471594580|FG000|Overall Study|Adverse Event|1|||
130990904|NCT03585296|471594580|FG000|Overall Study|Lost to Follow-up|2|||
130990905|NCT03585296|471594580|FG000|Overall Study|Withdrawal by Subject|2|||
130990906|NCT04836858|471594582|FG000|Overall Study|Adverse Event|0|||
130990907|NCT04836858|471594583|FG001|Overall Study|Adverse Event|0|||
130990908|NCT04836858|471594584|FG002|Overall Study|Adverse Event|0|||
130990909|NCT04836858|471594585|FG003|Overall Study|Adverse Event|1|||
130990910|NCT04836858|471594582|FG000|Overall Study|Lost to Follow-up|1|||
130990911|NCT04836858|471594583|FG001|Overall Study|Lost to Follow-up|0|||
130990912|NCT04836858|471594584|FG002|Overall Study|Lost to Follow-up|0|||
130990913|NCT04836858|471594585|FG003|Overall Study|Lost to Follow-up|0|||
130990914|NCT04836858|471594582|FG000|Overall Study|Subject/Guardian decision|3|||
130990915|NCT04836858|471594583|FG001|Overall Study|Subject/Guardian decision|0|||
130990916|NCT04836858|471594584|FG002|Overall Study|Subject/Guardian decision|0|||
130990917|NCT04836858|471594585|FG003|Overall Study|Subject/Guardian decision|1|||
130990918|NCT04836858|471594582|FG000|Overall Study|Randomized but not treated|4|||
130990919|NCT04836858|471594583|FG001|Overall Study|Randomized but not treated|0|||
130990920|NCT04836858|471594584|FG002|Overall Study|Randomized but not treated|0|||
130990921|NCT04836858|471594585|FG003|Overall Study|Randomized but not treated|0|||
130990922|NCT02948959|471594586|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
130990923|NCT02948959|471594587|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
130990924|NCT02948959|471594586|FG000|52 Weeks Treatment Period|Adverse Event|2|||
130990925|NCT02948959|471594587|FG001|52 Weeks Treatment Period|Adverse Event|5|||
130990926|NCT02948959|471594586|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
130990927|NCT02948959|471594587|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
130990928|NCT02948959|471594586|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
130990929|NCT02948959|471594587|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
130990930|NCT02948959|471594586|FG000|52 Weeks Treatment Period|Randomized by error|0|||
130990931|NCT02948959|471594587|FG001|52 Weeks Treatment Period|Randomized by error|5|||
130990932|NCT02948959|471594586|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
130990933|NCT02948959|471594587|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
130990934|NCT02948959|471594586|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
130990935|NCT02948959|471594587|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
130990936|NCT02948959|471594586|FG000|52 Weeks Treatment Period|Change of residence location|0|||
130990937|NCT02948959|471594587|FG001|52 Weeks Treatment Period|Change of residence location|1|||
130990938|NCT02948959|471594586|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
130990939|NCT02948959|471594587|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
130990940|NCT02948959|471594586|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
130990941|NCT02948959|471594587|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
130990942|NCT02948959|471594586|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
130990943|NCT02948959|471594587|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
130990944|NCT02948959|471594586|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
130990945|NCT02948959|471594587|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
130990946|NCT02948959|471594586|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
130990947|NCT02948959|471594587|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
130990948|NCT02948959|471594586|FG000|12 Weeks Follow-up Period|Study site closure|1|||
130990949|NCT02948959|471594587|FG001|12 Weeks Follow-up Period|Study site closure|0|||
130990950|NCT04399356|471594588|FG000|Overall Study|Lost to Follow-up|1|||
130990951|NCT04399356|471594589|FG001|Overall Study|Lost to Follow-up|1|||
130990952|NCT04399356|471594588|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
130990953|NCT04399356|471594589|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
130990954|NCT04399356|471594588|FG000|Overall Study|Withdrawal by Subject|1|||
130990955|NCT04399356|471594589|FG001|Overall Study|Withdrawal by Subject|0|||
130990956|NCT00154310|471594590|FG000|Overall Study|Adverse Event|19|||
130990957|NCT00154310|471594591|FG001|Overall Study|Adverse Event|9|||
130990958|NCT00154310|471594590|FG000|Overall Study|Lack of Efficacy|5|||
130990959|NCT00154310|471594591|FG001|Overall Study|Lack of Efficacy|4|||
130990960|NCT00154310|471594590|FG000|Overall Study|Protocol Violation|4|||
130990961|NCT00154310|471594591|FG001|Overall Study|Protocol Violation|2|||
130990962|NCT00154310|471594590|FG000|Overall Study|Withdrawal by Subject|9|||
130990963|NCT00154310|471594591|FG001|Overall Study|Withdrawal by Subject|3|||
130990964|NCT00154310|471594590|FG000|Overall Study|Lost to Follow-up|0|||
130990965|NCT00154310|471594591|FG001|Overall Study|Lost to Follow-up|8|||
130990966|NCT00154310|471594590|FG000|Overall Study|Administrative problems|0|||
130990967|NCT00154310|471594591|FG001|Overall Study|Administrative problems|1|||
130990968|NCT00154310|471594590|FG000|Overall Study|Death|0|||
130990969|NCT00154310|471594591|FG001|Overall Study|Death|1|||
130990970|NCT01678820|471594592|FG000|Overall Study|Study Terminated by Sponsor|45|||
130990971|NCT01678820|471594593|FG001|Overall Study|Study Terminated by Sponsor|43|||
130990972|NCT01678820|471594594|FG002|Overall Study|Study Terminated by Sponsor|43|||
130990973|NCT01678820|471594592|FG000|Overall Study|Withdrawal by Subject|2|||
130990974|NCT01678820|471594593|FG001|Overall Study|Withdrawal by Subject|5|||
130990975|NCT01678820|471594594|FG002|Overall Study|Withdrawal by Subject|2|||
130990976|NCT01678820|471594592|FG000|Overall Study|Protocol Specified Criteria|2|||
130990977|NCT01678820|471594593|FG001|Overall Study|Protocol Specified Criteria|3|||
130990978|NCT01678820|471594594|FG002|Overall Study|Protocol Specified Criteria|1|||
130990979|NCT01678820|471594592|FG000|Overall Study|Adverse Event|2|||
130990980|NCT01678820|471594593|FG001|Overall Study|Adverse Event|2|||
130990981|NCT01678820|471594594|FG002|Overall Study|Adverse Event|2|||
130990982|NCT01678820|471594592|FG000|Overall Study|Lost to Follow-up|7|||
130990983|NCT01678820|471594593|FG001|Overall Study|Lost to Follow-up|2|||
130990984|NCT01678820|471594594|FG002|Overall Study|Lost to Follow-up|2|||
130990985|NCT01678820|471594592|FG000|Overall Study|Non-compliance with study drug|0|||
130990986|NCT01678820|471594593|FG001|Overall Study|Non-compliance with study drug|1|||
130990987|NCT01678820|471594594|FG002|Overall Study|Non-compliance with study drug|0|||
130990988|NCT01678820|471594592|FG000|Overall Study|Physician Decision|0|||
130990989|NCT01678820|471594593|FG001|Overall Study|Physician Decision|0|||
130990990|NCT01678820|471594594|FG002|Overall Study|Physician Decision|1|||
130990991|NCT01678820|471594592|FG000|Overall Study|Protocol Violation|4|||
130990992|NCT01678820|471594593|FG001|Overall Study|Protocol Violation|5|||
130990993|NCT01678820|471594594|FG002|Overall Study|Protocol Violation|4|||
130990994|NCT01678820|471594592|FG000|Overall Study|Not treated with double-blind study drug|0|||
130990995|NCT01678820|471594593|FG001|Overall Study|Not treated with double-blind study drug|2|||
130990996|NCT01678820|471594594|FG002|Overall Study|Not treated with double-blind study drug|2|||
130990997|NCT03447730|471594595|FG000|Overall Study|Adverse Event|0|||
130990998|NCT03447730|471594596|FG001|Overall Study|Adverse Event|2|||
130990999|NCT03447730|471594597|FG002|Overall Study|Adverse Event|0|||
130991000|NCT01350505|471594603|FG000|Overall Study|Lost to Follow-up|4|||
130991001|NCT01834222|471594607|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
130991002|NCT01054573|471594608|FG000|Overall Study|Adverse Event|1|||
130991003|NCT01054573|471594609|FG001|Overall Study|Adverse Event|0|||
130991004|NCT01054573|471594610|FG002|Overall Study|Adverse Event|1|||
130991005|NCT01054573|471594611|FG003|Overall Study|Adverse Event|1|||
130991006|NCT01054573|471594608|FG000|Overall Study|Lost to Follow-up|0|||
130991007|NCT01054573|471594609|FG001|Overall Study|Lost to Follow-up|2|||
130991008|NCT01054573|471594610|FG002|Overall Study|Lost to Follow-up|0|||
130991009|NCT01054573|471594611|FG003|Overall Study|Lost to Follow-up|0|||
130991010|NCT01054573|471594608|FG000|Overall Study|Withdrawal by Subject|0|||
130991011|NCT01054573|471594609|FG001|Overall Study|Withdrawal by Subject|2|||
130991012|NCT01054573|471594610|FG002|Overall Study|Withdrawal by Subject|2|||
130991013|NCT01054573|471594611|FG003|Overall Study|Withdrawal by Subject|1|||
130991014|NCT05266963|471594615|FG000|Drug Period A|Withdrawal by Subject|0|||
130991015|NCT05266963|471594616|FG001|Drug Period A|Withdrawal by Subject|1|||
130991016|NCT01725386|471594617|FG000|Overall Study|Death|84|||
130991017|NCT01725386|471594618|FG001|Overall Study|Death|40|||
130991018|NCT01725386|471594617|FG000|Overall Study|Lost to Follow-up|81|||
130991019|NCT01725386|471594618|FG001|Overall Study|Lost to Follow-up|6|||
130991020|NCT01725386|471594617|FG000|Overall Study|Withdrawal by Subject|10|||
130991021|NCT01725386|471594618|FG001|Overall Study|Withdrawal by Subject|0|||
130991022|NCT01306201|471594619|FG000|Overall Study|Arrhythmia|4|||
130991023|NCT01306201|471594619|FG000|Overall Study|Files could not be processed|3|||
130991024|NCT01306201|471594619|FG000|Overall Study|Files unreadable|3|||
130991025|NCT00393523|471594620|FG000|Overall Study|Lost to Follow-up|0|||
130991026|NCT00393523|471594621|FG001|Overall Study|Lost to Follow-up|0|||
130991027|NCT00393523|471594622|FG002|Overall Study|Lost to Follow-up|0|||
130991028|NCT00393523|471594623|FG003|Overall Study|Lost to Follow-up|2|||
130991029|NCT00393523|471594624|FG004|Overall Study|Lost to Follow-up|1|||
130991030|NCT00393523|471594620|FG000|Overall Study|Protocol Violation|6|||
131100623|NCT05383508|471998054|FG003|Overall Study|Withdrawal by Subject|1|||
130991031|NCT00393523|471594621|FG001|Overall Study|Protocol Violation|2|||
130991032|NCT00393523|471594622|FG002|Overall Study|Protocol Violation|0|||
130991033|NCT00393523|471594623|FG003|Overall Study|Protocol Violation|1|||
130991034|NCT00393523|471594624|FG004|Overall Study|Protocol Violation|0|||
130991035|NCT00393523|471594620|FG000|Overall Study|Withdrawal by Subject|6|||
130991036|NCT00393523|471594621|FG001|Overall Study|Withdrawal by Subject|7|||
130991037|NCT00393523|471594622|FG002|Overall Study|Withdrawal by Subject|2|||
131214735|NCT01977482|472410350|FG005|Overall Study|Lost to Follow-up|0|||
131214736|NCT01977482|472410345|FG000|Overall Study|Physician Decision|0|||
131214737|NCT01977482|472410346|FG001|Overall Study|Physician Decision|1|||
131214738|NCT01977482|472410347|FG002|Overall Study|Physician Decision|0|||
131214739|NCT01977482|472410348|FG003|Overall Study|Physician Decision|0|||
131214740|NCT01977482|472410349|FG004|Overall Study|Physician Decision|0|||
131214741|NCT01977482|472410350|FG005|Overall Study|Physician Decision|0|||
131214742|NCT01977482|472410345|FG000|Overall Study|Protocol Violation|0|||
131214743|NCT01977482|472410346|FG001|Overall Study|Protocol Violation|0|||
131214744|NCT01977482|472410347|FG002|Overall Study|Protocol Violation|1|||
131214745|NCT01977482|472410348|FG003|Overall Study|Protocol Violation|0|||
131214746|NCT01977482|472410349|FG004|Overall Study|Protocol Violation|0|||
130882330|NCT03879772|471205474|FG002|Overall Study|Protocol Violation|3|||
130882331|NCT03879772|471205475|FG003|Overall Study|Protocol Violation|1|||
130882332|NCT03879772|471205476|FG004|Overall Study|Protocol Violation|2|||
130882333|NCT03879772|471205472|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
130882334|NCT03879772|471205473|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
130882335|NCT03879772|471205474|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
130882336|NCT03879772|471205475|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
130882337|NCT03879772|471205476|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
130882338|NCT00930046|471205477|FG000|Overall Study|Wound catheter malfunctioned|1|||
130882339|NCT00930046|471205478|FG001|Overall Study|Wound catheter malfunctioned|2|||
130882340|NCT02531802|471205479|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
130882341|NCT02531802|471205480|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
130882342|NCT02531802|471205481|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
130882343|NCT02531802|471205482|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
130882344|NCT02531802|471205483|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
130882345|NCT02531802|471205484|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
130882346|NCT02531802|471205485|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
130882347|NCT02531802|471205486|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
130882348|NCT02531802|471205487|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
130882349|NCT02531802|471205488|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
130882350|NCT02531802|471205489|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
130882351|NCT02531802|471205490|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
130882352|NCT02531802|471205491|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
130882353|NCT02531802|471205492|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
130882354|NCT02531802|471205493|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
130882355|NCT02531802|471205494|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
130882356|NCT02531802|471205495|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
130882357|NCT02531802|471205496|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
130882358|NCT02531802|471205497|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
130882359|NCT02531802|471205498|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
130882360|NCT02531802|471205499|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
130882361|NCT02531802|471205479|FG000|Received Vaccination 2|Physician Decision|0|||
130882362|NCT02531802|471205480|FG001|Received Vaccination 2|Physician Decision|0|||
130882363|NCT02531802|471205481|FG002|Received Vaccination 2|Physician Decision|0|||
130882364|NCT02531802|471205482|FG003|Received Vaccination 2|Physician Decision|0|||
130882365|NCT02531802|471205483|FG004|Received Vaccination 2|Physician Decision|0|||
130882366|NCT02531802|471205484|FG005|Received Vaccination 2|Physician Decision|1|||
130882367|NCT02531802|471205485|FG006|Received Vaccination 2|Physician Decision|0|||
130882368|NCT02531802|471205486|FG007|Received Vaccination 2|Physician Decision|0|||
130882369|NCT02531802|471205487|FG008|Received Vaccination 2|Physician Decision|0|||
130882370|NCT02531802|471205488|FG009|Received Vaccination 2|Physician Decision|2|||
130882371|NCT02531802|471205489|FG010|Received Vaccination 2|Physician Decision|0|||
130882372|NCT02531802|471205490|FG011|Received Vaccination 2|Physician Decision|0|||
130882373|NCT02531802|471205491|FG012|Received Vaccination 2|Physician Decision|0|||
130882374|NCT02531802|471205492|FG013|Received Vaccination 2|Physician Decision|1|||
130882375|NCT02531802|471205493|FG014|Received Vaccination 2|Physician Decision|0|||
130882376|NCT02531802|471205494|FG015|Received Vaccination 2|Physician Decision|0|||
130882377|NCT02531802|471205495|FG016|Received Vaccination 2|Physician Decision|0|||
130882378|NCT02531802|471205496|FG017|Received Vaccination 2|Physician Decision|1|||
130882379|NCT02531802|471205497|FG018|Received Vaccination 2|Physician Decision|0|||
130882380|NCT02531802|471205498|FG019|Received Vaccination 2|Physician Decision|0|||
130882381|NCT02531802|471205499|FG020|Received Vaccination 2|Physician Decision|0|||
130882382|NCT02531802|471205479|FG000|Received Vaccination 2|Adverse Event|0|||
130882383|NCT02531802|471205480|FG001|Received Vaccination 2|Adverse Event|0|||
130882384|NCT02531802|471205481|FG002|Received Vaccination 2|Adverse Event|0|||
130882385|NCT02531802|471205482|FG003|Received Vaccination 2|Adverse Event|0|||
131214747|NCT01977482|472410350|FG005|Overall Study|Protocol Violation|0|||
131214748|NCT01977482|472410345|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
131214749|NCT01977482|472410346|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
131214750|NCT01977482|472410347|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
131214751|NCT01977482|472410348|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
131214752|NCT01977482|472410349|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
131214753|NCT01977482|472410350|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
131214754|NCT01977482|472410345|FG000|Overall Study|Withdrawal by Subject|2|||
130991038|NCT00393523|471594623|FG003|Overall Study|Withdrawal by Subject|3|||
130991039|NCT00393523|471594624|FG004|Overall Study|Withdrawal by Subject|0|||
130991040|NCT00393523|471594620|FG000|Overall Study|Difficulties in specimen collection|0|||
130991041|NCT00393523|471594621|FG001|Overall Study|Difficulties in specimen collection|0|||
130991042|NCT00393523|471594622|FG002|Overall Study|Difficulties in specimen collection|1|||
130991043|NCT00393523|471594623|FG003|Overall Study|Difficulties in specimen collection|0|||
130991044|NCT00393523|471594624|FG004|Overall Study|Difficulties in specimen collection|0|||
130991045|NCT00393523|471594620|FG000|Overall Study|Vaccine supply issue|0|||
130991046|NCT00393523|471594621|FG001|Overall Study|Vaccine supply issue|0|||
131214755|NCT01977482|472410346|FG001|Overall Study|Withdrawal by Subject|4|||
131214756|NCT01977482|472410347|FG002|Overall Study|Withdrawal by Subject|1|||
131214757|NCT01977482|472410348|FG003|Overall Study|Withdrawal by Subject|3|||
131214758|NCT01977482|472410349|FG004|Overall Study|Withdrawal by Subject|1|||
130991047|NCT00393523|471594622|FG002|Overall Study|Vaccine supply issue|1|||
130991048|NCT00393523|471594623|FG003|Overall Study|Vaccine supply issue|0|||
130991049|NCT00393523|471594624|FG004|Overall Study|Vaccine supply issue|0|||
130991050|NCT00423852|471594625|FG000|Overall Study|Removed pior to the high-dose portion|3|||
130991051|NCT00744263|471594626|FG000|Overall Study|Death|3006|||
130991052|NCT00744263|471594627|FG001|Overall Study|Death|3005|||
130991053|NCT00744263|471594626|FG000|Overall Study|Lost to Follow-up|2038|||
130991054|NCT00744263|471594627|FG001|Overall Study|Lost to Follow-up|2135|||
130991055|NCT00744263|471594626|FG000|Overall Study|Withdrawal by Subject|166|||
130991056|NCT00744263|471594627|FG001|Overall Study|Withdrawal by Subject|150|||
130991057|NCT00744263|471594626|FG000|Overall Study|Physician Decision|20|||
130991058|NCT00744263|471594627|FG001|Overall Study|Physician Decision|23|||
130991059|NCT00744263|471594626|FG000|Overall Study|Protocol Violation|3|||
130991060|NCT00744263|471594627|FG001|Overall Study|Protocol Violation|5|||
130991061|NCT00744263|471594626|FG000|Overall Study|Adverse Event|1|||
130991062|NCT00744263|471594627|FG001|Overall Study|Adverse Event|0|||
130991063|NCT00744263|471594626|FG000|Overall Study|Other|2|||
130991064|NCT00744263|471594627|FG001|Overall Study|Other|2|||
130991065|NCT01515189|471594629|FG000|Induction|Disease Progression|109|||
130991066|NCT01515189|471594630|FG001|Induction|Disease Progression|155|||
130991067|NCT01515189|471594629|FG000|Induction|Study drug toxicity|86|||
130991068|NCT01515189|471594630|FG001|Induction|Study drug toxicity|36|||
130991069|NCT01515189|471594629|FG000|Induction|Death|24|||
130991070|NCT01515189|471594630|FG001|Induction|Death|17|||
130991071|NCT01515189|471594629|FG000|Induction|Adverse Event|14|||
130991072|NCT01515189|471594630|FG001|Induction|Adverse Event|9|||
130991073|NCT01515189|471594629|FG000|Induction|Withdrawal by Subject|3|||
130991074|NCT01515189|471594630|FG001|Induction|Withdrawal by Subject|9|||
130991075|NCT01515189|471594629|FG000|Induction|No longer meets study criteria|0|||
130991076|NCT01515189|471594630|FG001|Induction|No longer meets study criteria|2|||
130991077|NCT01515189|471594629|FG000|Induction|Lost to Follow-up|1|||
130991078|NCT01515189|471594630|FG001|Induction|Lost to Follow-up|0|||
130991079|NCT01515189|471594629|FG000|Induction|Other|0|||
130991080|NCT01515189|471594630|FG001|Induction|Other|4|||
130991081|NCT01515189|471594629|FG000|First Re-Induction Phase|Disease progression|6|||
130991082|NCT01515189|471594630|FG001|First Re-Induction Phase|Disease progression|14|||
130991083|NCT01515189|471594629|FG000|First Re-Induction Phase|Study drug toxicity|5|||
130991084|NCT01515189|471594630|FG001|First Re-Induction Phase|Study drug toxicity|0|||
130991085|NCT01515189|471594629|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
130991086|NCT01515189|471594630|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
131214759|NCT01977482|472410350|FG005|Overall Study|Withdrawal by Subject|5|||
131214760|NCT05554471|472410351|FG000|Overall Study|Physician Decision|2|||
131214761|NCT05554471|472410352|FG001|Overall Study|Physician Decision|1|||
130991087|NCT01515189|471594629|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
130991088|NCT01515189|471594630|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
130991089|NCT01515189|471594629|FG000|First Re-Induction Phase|Other|1|||
131214762|NCT05554471|472410351|FG000|Overall Study|Lost to Follow-up|2|||
131214763|NCT05554471|472410352|FG001|Overall Study|Lost to Follow-up|1|||
131214764|NCT05554471|472410351|FG000|Overall Study|Death|0|||
130991090|NCT01515189|471594630|FG001|First Re-Induction Phase|Other|0|||
130991091|NCT03787680|471594631|FG000|Overall Study|Physician Decision|2|||
130991092|NCT03787680|471594632|FG001|Overall Study|Physician Decision|3|||
130991093|NCT03787680|471594631|FG000|Overall Study|Adverse Event|7|||
130991094|NCT03787680|471594632|FG001|Overall Study|Adverse Event|3|||
130991095|NCT03787680|471594631|FG000|Overall Study|Withdrawal by Subject|2|||
130991096|NCT03787680|471594632|FG001|Overall Study|Withdrawal by Subject|1|||
130991097|NCT05458024|471594633|FG000|Overall Study|Withdrawal by Subject|1|||
130991098|NCT05458024|471594634|FG001|Overall Study|Withdrawal by Subject|1|||
130991099|NCT00909428|471594635|FG000|Overall Study|Lost to Follow-up|13|||
130991100|NCT00909428|471594636|FG001|Overall Study|Lost to Follow-up|10|||
130991101|NCT00909428|471594637|FG002|Overall Study|Lost to Follow-up|9|||
130991102|NCT03021668|471594638|FG000|Overall Study|Physician Decision|0|||
130991103|NCT03021668|471594639|FG001|Overall Study|Physician Decision|1|||
130991104|NCT01122381|471594640|FG000|Overall Study|study terminated early|0|||
130991105|NCT01122381|471594641|FG001|Overall Study|study terminated early|1|||
130991106|NCT01125722|471594642|FG000|Overall Study|Withdrawal by Subject|2|||
130991107|NCT01125722|471594643|FG001|Overall Study|Withdrawal by Subject|1|||
130991108|NCT01125722|471594642|FG000|Overall Study|Lost to Follow-up|1|||
130991109|NCT01125722|471594643|FG001|Overall Study|Lost to Follow-up|0|||
130991110|NCT03474549|471594644|FG000|Overall Study|Death|31|||
130991111|NCT03474549|471594644|FG000|Overall Study|Lost to Follow-up|4|||
130991112|NCT03474549|471594644|FG000|Overall Study|Withdrawal by Subject|2|||
130991113|NCT00738101|471594646|FG000|Overall Study|Physician Decision|5|||
130991114|NCT00738101|471594646|FG000|Overall Study|Death|1|||
130991115|NCT00738101|471594646|FG000|Overall Study|Repeat enrollment|1|||
130991116|NCT02969525|471594647|FG000|Double-Blind Period|Adverse Event|0|||
130991117|NCT02969525|471594648|FG001|Double-Blind Period|Adverse Event|0|||
130991118|NCT02969525|471594649|FG002|Double-Blind Period|Adverse Event|1|||
130991119|NCT02969525|471594650|FG003|Double-Blind Period|Adverse Event|1|||
130991120|NCT02969525|471594651|FG004|Double-Blind Period|Adverse Event|0|||
130991121|NCT02969525|471594652|FG005|Double-Blind Period|Adverse Event|0|||
130991122|NCT02969525|471594653|FG006|Double-Blind Period|Adverse Event|0|||
130991123|NCT02969525|471594654|FG007|Double-Blind Period|Adverse Event|0|||
130991124|NCT02969525|471594655|FG008|Double-Blind Period|Adverse Event|0|||
130991125|NCT02969525|471594656|FG009|Double-Blind Period|Adverse Event|0|||
130991126|NCT02969525|471594657|FG010|Double-Blind Period|Adverse Event|0|||
130991127|NCT02969525|471594658|FG011|Double-Blind Period|Adverse Event|0|||
130991128|NCT02969525|471594647|FG000|Double-Blind Period|LOW EGFR|0|||
130991129|NCT02969525|471594648|FG001|Double-Blind Period|LOW EGFR|0|||
130991130|NCT02969525|471594649|FG002|Double-Blind Period|LOW EGFR|0|||
130991131|NCT02969525|471594650|FG003|Double-Blind Period|LOW EGFR|1|||
130991132|NCT02969525|471594651|FG004|Double-Blind Period|LOW EGFR|0|||
130991133|NCT02969525|471594652|FG005|Double-Blind Period|LOW EGFR|0|||
130991134|NCT02969525|471594653|FG006|Double-Blind Period|LOW EGFR|0|||
130991135|NCT02969525|471594654|FG007|Double-Blind Period|LOW EGFR|0|||
130991136|NCT02969525|471594655|FG008|Double-Blind Period|LOW EGFR|0|||
130991137|NCT02969525|471594656|FG009|Double-Blind Period|LOW EGFR|0|||
130991138|NCT02969525|471594657|FG010|Double-Blind Period|LOW EGFR|0|||
130991139|NCT02969525|471594658|FG011|Double-Blind Period|LOW EGFR|0|||
130991140|NCT02969525|471594647|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
130991141|NCT02969525|471594648|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130991142|NCT02969525|471594649|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130991143|NCT02969525|471594650|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
130991144|NCT02969525|471594651|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130991145|NCT02969525|471594652|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130991146|NCT02969525|471594653|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130991147|NCT02969525|471594654|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130991148|NCT02969525|471594655|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130991149|NCT02969525|471594656|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130991150|NCT02969525|471594657|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130991151|NCT02969525|471594658|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
130991152|NCT02969525|471594647|FG000|Dose-Blind Period|Adverse Event|0|||
130991153|NCT02969525|471594648|FG001|Dose-Blind Period|Adverse Event|0|||
130991154|NCT02969525|471594649|FG002|Dose-Blind Period|Adverse Event|0|||
130991155|NCT02969525|471594650|FG003|Dose-Blind Period|Adverse Event|0|||
130991156|NCT02969525|471594651|FG004|Dose-Blind Period|Adverse Event|0|||
130991157|NCT02969525|471594652|FG005|Dose-Blind Period|Adverse Event|0|||
130991158|NCT02969525|471594653|FG006|Dose-Blind Period|Adverse Event|0|||
130991159|NCT02969525|471594654|FG007|Dose-Blind Period|Adverse Event|0|||
130991160|NCT02969525|471594655|FG008|Dose-Blind Period|Adverse Event|0|||
130991161|NCT02969525|471594656|FG009|Dose-Blind Period|Adverse Event|1|||
130991162|NCT02969525|471594657|FG010|Dose-Blind Period|Adverse Event|1|||
130991163|NCT02969525|471594658|FG011|Dose-Blind Period|Adverse Event|1|||
130991164|NCT02969525|471594647|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
130991165|NCT02969525|471594648|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
130991166|NCT02969525|471594649|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
130991167|NCT02969525|471594650|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
130991168|NCT02969525|471594651|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
130991169|NCT02969525|471594652|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
130991170|NCT02969525|471594653|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
130991171|NCT02969525|471594654|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
130991172|NCT02969525|471594655|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
130991173|NCT02969525|471594656|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
130991174|NCT02969525|471594657|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
130991175|NCT02969525|471594658|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
130991176|NCT02969525|471594647|FG000|Dose-Blind Period|Non-cooperating patient|0|||
130991177|NCT02969525|471594648|FG001|Dose-Blind Period|Non-cooperating patient|0|||
130991178|NCT02969525|471594649|FG002|Dose-Blind Period|Non-cooperating patient|0|||
130991179|NCT02969525|471594650|FG003|Dose-Blind Period|Non-cooperating patient|0|||
130991180|NCT02969525|471594651|FG004|Dose-Blind Period|Non-cooperating patient|0|||
130991181|NCT02969525|471594652|FG005|Dose-Blind Period|Non-cooperating patient|0|||
130991182|NCT02969525|471594653|FG006|Dose-Blind Period|Non-cooperating patient|0|||
130991183|NCT02969525|471594654|FG007|Dose-Blind Period|Non-cooperating patient|0|||
130991184|NCT02969525|471594655|FG008|Dose-Blind Period|Non-cooperating patient|0|||
130991185|NCT02969525|471594656|FG009|Dose-Blind Period|Non-cooperating patient|0|||
130991186|NCT02969525|471594657|FG010|Dose-Blind Period|Non-cooperating patient|0|||
130991187|NCT02969525|471594658|FG011|Dose-Blind Period|Non-cooperating patient|1|||
130991188|NCT02969525|471594647|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991189|NCT02969525|471594648|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991190|NCT02969525|471594649|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991191|NCT02969525|471594650|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991192|NCT02969525|471594651|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991193|NCT02969525|471594652|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991194|NCT02969525|471594653|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991195|NCT02969525|471594654|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991196|NCT02969525|471594655|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991197|NCT02969525|471594656|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991198|NCT02969525|471594657|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
130991199|NCT02969525|471594658|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
130991200|NCT03445065|471594659|FG000|Overall Study|Withdrawal by Subject|3|||
130991201|NCT03445065|471594660|FG001|Overall Study|Withdrawal by Subject|6|||
130991202|NCT03445065|471594661|FG002|Overall Study|Withdrawal by Subject|2|||
130991203|NCT03445065|471594662|FG003|Overall Study|Withdrawal by Subject|2|||
130991204|NCT03445065|471594659|FG000|Overall Study|Other|4|||
130991205|NCT03445065|471594660|FG001|Overall Study|Other|3|||
130991206|NCT03445065|471594661|FG002|Overall Study|Other|3|||
130991207|NCT03445065|471594662|FG003|Overall Study|Other|1|||
130991208|NCT01816763|471596386|FG000|Overall Study|The main reason for an incomplete survey|4|||
130991209|NCT01816763|471596387|FG001|Overall Study|The main reason for an incomplete survey|15|||
130991210|NCT01816763|471596388|FG002|Overall Study|The main reason for an incomplete survey|11|||
130991211|NCT00311155|471596389|FG000|Overall Study|Adverse Event|21|||
130991212|NCT00311155|471596389|FG000|Overall Study|Withdrawal by Subject|17|||
130991213|NCT00311155|471596389|FG000|Overall Study|Did not meet entry criteria|55|||
130991214|NCT00429494|471596390|FG000|Overall Study|Withdrawal by Subject|9|||
130991215|NCT00429494|471596390|FG000|Overall Study|Death|6|||
130991216|NCT00409786|471596394|FG000|Overall Study|Withdrawal by Subject|3|||
130991217|NCT02341456|471596395|FG000|Overall Study|Disease progression|2|||
130991218|NCT02341456|471596396|FG001|Overall Study|Disease progression|3|||
130991219|NCT02341456|471596397|FG002|Overall Study|Disease progression|1|||
130991220|NCT02341456|471596395|FG000|Overall Study|Death|1|||
130991221|NCT02341456|471596396|FG001|Overall Study|Death|1|||
130991222|NCT02341456|471596397|FG002|Overall Study|Death|1|||
130991223|NCT02341456|471596395|FG000|Overall Study|Withdrawal by Subject|0|||
130991224|NCT02341456|471596396|FG001|Overall Study|Withdrawal by Subject|1|||
130991225|NCT02341456|471596397|FG002|Overall Study|Withdrawal by Subject|1|||
130991226|NCT02341456|471596395|FG000|Overall Study|Moved to local access programme.|0|||
130991227|NCT02341456|471596396|FG001|Overall Study|Moved to local access programme.|1|||
130991228|NCT02341456|471596397|FG002|Overall Study|Moved to local access programme.|1|||
130991229|NCT02341456|471596395|FG000|Overall Study|Physician Decision|1|||
130991230|NCT02341456|471596396|FG001|Overall Study|Physician Decision|0|||
130991231|NCT02341456|471596397|FG002|Overall Study|Physician Decision|0|||
130991232|NCT02306265|471596398|FG000|Overall Study|Withdrawal by Subject|1|||
130991233|NCT04702568|471596399|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
130991234|NCT04702568|471596400|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
130991235|NCT04702568|471596399|FG000|Overall Study|Pregnancy|1|||
130991236|NCT04702568|471596400|FG001|Overall Study|Pregnancy|0|||
130991237|NCT04702568|471596399|FG000|Overall Study|Bone marrow transplant|1|||
130991238|NCT04702568|471596400|FG001|Overall Study|Bone marrow transplant|0|||
130991239|NCT04702568|471596399|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
130991240|NCT04702568|471596400|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
130991241|NCT04702568|471596399|FG000|Overall Study|Withdrawal by Subject|0|||
130991242|NCT04702568|471596400|FG001|Overall Study|Withdrawal by Subject|2|||
130991243|NCT04091360|471596401|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130991244|NCT04091360|471596402|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130991245|NCT04091360|471596403|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
131214765|NCT05554471|472410352|FG001|Overall Study|Death|1|||
130991246|NCT04091360|471596404|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130991247|NCT04091360|471596405|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130991248|NCT04091360|471596406|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130991249|NCT04091360|471596407|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130991250|NCT04091360|471596408|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
130991251|NCT04091360|471596409|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
130991252|NCT04091360|471596410|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
130991253|NCT04091360|471596401|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130991254|NCT04091360|471596402|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130991255|NCT04091360|471596403|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130991256|NCT04091360|471596404|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130991257|NCT04091360|471596405|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130991258|NCT04091360|471596406|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130991259|NCT04091360|471596407|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
130991260|NCT04091360|471596408|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
130991261|NCT04091360|471596409|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130991262|NCT04091360|471596410|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130991263|NCT04091360|471596401|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130991264|NCT04091360|471596402|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130991265|NCT04091360|471596403|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130991266|NCT04091360|471596404|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130991267|NCT04091360|471596405|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130991268|NCT04091360|471596406|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130991269|NCT04091360|471596407|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
130991270|NCT04091360|471596408|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130991271|NCT04091360|471596409|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
130991272|NCT04091360|471596410|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
130991273|NCT00572624|471596411|FG000|Overall Study|Lost to Follow-up|10|||
130991274|NCT00572624|471596412|FG001|Overall Study|Lost to Follow-up|4|||
130991275|NCT00572624|471596411|FG000|Overall Study|Wanted to do a different diet program|1|||
130991276|NCT00572624|471596412|FG001|Overall Study|Wanted to do a different diet program|0|||
130991277|NCT00572624|471596411|FG000|Overall Study|Medication change|1|||
130991278|NCT00572624|471596412|FG001|Overall Study|Medication change|0|||
130991279|NCT00572624|471596411|FG000|Overall Study|Started a new job-- no time for study|1|||
130991280|NCT00572624|471596412|FG001|Overall Study|Started a new job-- no time for study|0|||
130991281|NCT00572624|471596411|FG000|Overall Study|Admitted to being a smoker|1|||
130991282|NCT00572624|471596412|FG001|Overall Study|Admitted to being a smoker|0|||
130991283|NCT00572624|471596411|FG000|Overall Study|Refused to do the stress test|1|||
130991284|NCT00572624|471596412|FG001|Overall Study|Refused to do the stress test|0|||
130991285|NCT00572624|471596411|FG000|Overall Study|Problem with vascular access|1|||
130991286|NCT00572624|471596412|FG001|Overall Study|Problem with vascular access|0|||
130991287|NCT00572624|471596411|FG000|Overall Study|Health issues unrelated to the study|1|||
130991288|NCT00572624|471596412|FG001|Overall Study|Health issues unrelated to the study|0|||
130991289|NCT00130793|471596415|FG000|Overall Study|Lost to Follow-up|1|||
130991290|NCT00130793|471596416|FG001|Overall Study|Lost to Follow-up|4|||
130991291|NCT00130793|471596415|FG000|Overall Study|Withdrew consent|2|||
130991292|NCT00130793|471596416|FG001|Overall Study|Withdrew consent|0|||
130991293|NCT00453102|471596419|FG000|Overall Study|Withdrawal by Subject|2|||
130991294|NCT03500640|471596427|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
130991295|NCT03500640|471596428|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
130991296|NCT03500640|471596429|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
130991297|NCT03500640|471596427|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
130991298|NCT03500640|471596428|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
130991299|NCT03500640|471596429|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
130991300|NCT03500640|471596427|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
130991301|NCT03500640|471596428|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
130991302|NCT03500640|471596429|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
130991303|NCT03500640|471596427|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
130991304|NCT03500640|471596428|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
130991305|NCT03500640|471596429|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
130991306|NCT03500640|471596427|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
130991307|NCT03500640|471596428|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
130991308|NCT03500640|471596429|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
131214766|NCT04880850|472410355|FG000|Overall Study|Death|2|||
131214767|NCT04880850|472410356|FG001|Overall Study|Death|1|||
131214768|NCT04880850|472410355|FG000|Overall Study|Lost to Follow-up|3|||
131214769|NCT04880850|472410356|FG001|Overall Study|Lost to Follow-up|6|||
130991309|NCT03500640|471596427|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
130991310|NCT03500640|471596428|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
130991311|NCT03500640|471596429|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
130991312|NCT03500640|471596427|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
130991313|NCT03500640|471596428|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
130991314|NCT03500640|471596429|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
130991315|NCT03500640|471596427|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
130991316|NCT03500640|471596428|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
130991317|NCT03500640|471596429|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
130991318|NCT03500640|471596427|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
130991319|NCT03500640|471596428|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
130991320|NCT03500640|471596429|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
130991321|NCT03500640|471596427|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
130991322|NCT03500640|471596428|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
130991323|NCT03500640|471596429|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
130991324|NCT01650519|471596430|FG000|Overall Study|Withdrawal by Subject|1|||
130991325|NCT01650519|471596431|FG001|Overall Study|Withdrawal by Subject|0|||
130991326|NCT05229653|471596437|FG000|Overall Study|Lost to Follow-up|1|||
130991327|NCT05229653|471596438|FG001|Overall Study|Lost to Follow-up|0|||
130991328|NCT02667886|471596439|FG000|Dose Escalation (Part A)|Adverse Event|1|||
130991329|NCT02667886|471596440|FG001|Dose Escalation (Part A)|Adverse Event|3|||
130991330|NCT02667886|471596441|FG002|Dose Escalation (Part A)|Adverse Event|1|||
130991331|NCT02667886|471596442|FG003|Dose Escalation (Part A)|Adverse Event|0|||
130991332|NCT02667886|471596443|FG004|Dose Escalation (Part A)|Adverse Event|0|||
130991333|NCT02667886|471596439|FG000|Dose Escalation (Part A)|Disease Progression|1|||
130991334|NCT02667886|471596440|FG001|Dose Escalation (Part A)|Disease Progression|4|||
130991335|NCT02667886|471596441|FG002|Dose Escalation (Part A)|Disease Progression|3|||
130991336|NCT02667886|471596442|FG003|Dose Escalation (Part A)|Disease Progression|0|||
130991337|NCT02667886|471596443|FG004|Dose Escalation (Part A)|Disease Progression|0|||
130991338|NCT02667886|471596439|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
130991339|NCT02667886|471596440|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
130991340|NCT02667886|471596441|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
130991341|NCT02667886|471596442|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
130991342|NCT02667886|471596443|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
130991343|NCT02667886|471596439|FG000|Dose Expansion (Part B)|Adverse Event|0|||
130991344|NCT02667886|471596440|FG001|Dose Expansion (Part B)|Adverse Event|0|||
130991345|NCT02667886|471596441|FG002|Dose Expansion (Part B)|Adverse Event|0|||
130991346|NCT02667886|471596442|FG003|Dose Expansion (Part B)|Adverse Event|9|||
130991347|NCT02667886|471596443|FG004|Dose Expansion (Part B)|Adverse Event|0|||
130991348|NCT02667886|471596439|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
130991349|NCT02667886|471596440|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
130991350|NCT02667886|471596441|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
130991351|NCT02667886|471596442|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
130991352|NCT02667886|471596443|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
130991353|NCT02667886|471596439|FG000|Dose Expansion (Part B)|Disease Progression|0|||
130991354|NCT02667886|471596440|FG001|Dose Expansion (Part B)|Disease Progression|0|||
130991355|NCT02667886|471596441|FG002|Dose Expansion (Part B)|Disease Progression|0|||
130991356|NCT02667886|471596442|FG003|Dose Expansion (Part B)|Disease Progression|38|||
130991357|NCT02667886|471596443|FG004|Dose Expansion (Part B)|Disease Progression|0|||
130991358|NCT02667886|471596439|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
130991359|NCT02667886|471596440|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
130991360|NCT02667886|471596441|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
130991361|NCT02667886|471596442|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
130991362|NCT02667886|471596443|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
130991363|NCT02667886|471596439|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
130991364|NCT02667886|471596440|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
130991365|NCT02667886|471596441|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
130991366|NCT02667886|471596442|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
130991367|NCT02667886|471596443|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
130991368|NCT02667886|471596439|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
130991369|NCT02667886|471596440|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
130991370|NCT02667886|471596441|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
130991371|NCT02667886|471596442|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
131214770|NCT04880850|472410355|FG000|Overall Study|Physician Decision|2|||
131214771|NCT04880850|472410356|FG001|Overall Study|Physician Decision|1|||
130991372|NCT02667886|471596443|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
130991373|NCT00594217|471596444|FG000|Overall Study|Withdrawal by Subject|1|||
130991374|NCT00594217|471596445|FG001|Overall Study|Withdrawal by Subject|3|||
130991375|NCT00747123|471596446|FG000|Overall Study|Investigator's request|0|||
131214772|NCT04880850|472410355|FG000|Overall Study|Withdrawal by Subject|9|||
130991376|NCT00747123|471596447|FG001|Overall Study|Investigator's request|0|||
130991377|NCT00747123|471596448|FG002|Overall Study|Investigator's request|1|||
130991378|NCT00747123|471596449|FG003|Overall Study|Investigator's request|0|||
130991379|NCT00747123|471596446|FG000|Overall Study|Withdrew consent|0|||
130991380|NCT00747123|471596447|FG001|Overall Study|Withdrew consent|1|||
130991381|NCT00747123|471596448|FG002|Overall Study|Withdrew consent|0|||
130991382|NCT00747123|471596449|FG003|Overall Study|Withdrew consent|0|||
130991383|NCT00747123|471596446|FG000|Overall Study|Adverse Event|0|||
130991384|NCT00747123|471596447|FG001|Overall Study|Adverse Event|1|||
130991385|NCT00747123|471596448|FG002|Overall Study|Adverse Event|0|||
130991386|NCT00747123|471596449|FG003|Overall Study|Adverse Event|1|||
130991387|NCT03635489|471596450|FG000|Overall Study|Death|19|||
130991388|NCT03635489|471596451|FG001|Overall Study|Death|13|||
130991389|NCT03635489|471596450|FG000|Overall Study|Lost to Follow-up|1|||
130991390|NCT03635489|471596451|FG001|Overall Study|Lost to Follow-up|2|||
130991391|NCT03635489|471596450|FG000|Overall Study|Withdrawal by Subject|1|||
130991392|NCT03635489|471596451|FG001|Overall Study|Withdrawal by Subject|2|||
130991393|NCT03635489|471596450|FG000|Overall Study|Study Ended by Sponsor|28|||
130991394|NCT03635489|471596451|FG001|Overall Study|Study Ended by Sponsor|34|||
130991395|NCT02213328|471596453|FG000|Overall Study|Withdrawal by Subject|10|||
130991396|NCT02213328|471596453|FG000|Overall Study|Physician Decision|2|||
130991397|NCT02213328|471596453|FG000|Overall Study|Lost to Follow-up|16|||
130991398|NCT02487095|471596459|FG000|Dose Expansion|Unable to scan/restage participant|0|||
130991399|NCT02487095|471596460|FG001|Dose Expansion|Unable to scan/restage participant|0|||
130991400|NCT02487095|471596461|FG002|Dose Expansion|Unable to scan/restage participant|0|||
130991401|NCT02487095|471596462|FG003|Dose Expansion|Unable to scan/restage participant|0|||
130991402|NCT02487095|471596463|FG004|Dose Expansion|Unable to scan/restage participant|1|||
130991403|NCT05778526|471596466|FG000|Overall Study|Lost to Follow-up|0|||
130991404|NCT05778526|471596467|FG001|Overall Study|Lost to Follow-up|1|||
130991405|NCT05778526|471596468|FG002|Overall Study|Lost to Follow-up|3|||
130991406|NCT05778526|471596466|FG000|Overall Study|Protocol Violation|0|||
130991407|NCT05778526|471596467|FG001|Overall Study|Protocol Violation|0|||
130991408|NCT05778526|471596468|FG002|Overall Study|Protocol Violation|8|||
130991409|NCT03108157|471596469|FG000|Overall Study|Protocol Violation|15|||
130991410|NCT03108157|471596470|FG001|Overall Study|Protocol Violation|4|||
130991411|NCT01279343|471596473|FG000|Overall Study|Did not receive treatment|2|||
130991412|NCT01279343|471596474|FG001|Overall Study|Did not receive treatment|6|||
130991413|NCT04534114|471596475|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
130991414|NCT04534114|471596476|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
130991415|NCT04534114|471596477|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
130991416|NCT04534114|471596478|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
130991417|NCT04534114|471596475|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
130991418|NCT04534114|471596476|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
130991419|NCT04534114|471596477|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
130991420|NCT04534114|471596478|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
130991421|NCT04534114|471596475|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
130991422|NCT04534114|471596476|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
130991423|NCT04534114|471596477|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
130991424|NCT04534114|471596478|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
130991425|NCT04534114|471596475|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
130991426|NCT04534114|471596476|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
130991427|NCT04534114|471596477|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
130991428|NCT04534114|471596478|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
130991429|NCT04534114|471596475|FG000|Main Treatment Period|Physician Decision|0|||
130991430|NCT04534114|471596476|FG001|Main Treatment Period|Physician Decision|0|||
130991431|NCT04534114|471596477|FG002|Main Treatment Period|Physician Decision|0|||
130991432|NCT04534114|471596478|FG003|Main Treatment Period|Physician Decision|1|||
130991433|NCT04534114|471596475|FG000|Main Treatment Period|Death|1|||
130991434|NCT04534114|471596476|FG001|Main Treatment Period|Death|0|||
130991435|NCT04534114|471596477|FG002|Main Treatment Period|Death|0|||
130991436|NCT04534114|471596478|FG003|Main Treatment Period|Death|1|||
130991437|NCT04534114|471596475|FG000|Main Treatment Period|Other reason|1|||
130991438|NCT04534114|471596476|FG001|Main Treatment Period|Other reason|1|||
130991439|NCT04534114|471596477|FG002|Main Treatment Period|Other reason|0|||
130991440|NCT04534114|471596478|FG003|Main Treatment Period|Other reason|0|||
131214773|NCT04880850|472410356|FG001|Overall Study|Withdrawal by Subject|10|||
130991441|NCT04534114|471596475|FG000|Main Treatment Period|Participant decision|1|||
130991442|NCT04534114|471596476|FG001|Main Treatment Period|Participant decision|3|||
130991443|NCT04534114|471596477|FG002|Main Treatment Period|Participant decision|3|||
130991444|NCT04534114|471596478|FG003|Main Treatment Period|Participant decision|1|||
130991445|NCT04534114|471596475|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
130991446|NCT04534114|471596476|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
130991447|NCT04534114|471596477|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
130991448|NCT04534114|471596478|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
130991449|NCT04534114|471596475|FG000|Main Treatment Period|Adverse Event|4|||
130991450|NCT04534114|471596476|FG001|Main Treatment Period|Adverse Event|2|||
130991451|NCT04534114|471596477|FG002|Main Treatment Period|Adverse Event|1|||
130991452|NCT04534114|471596478|FG003|Main Treatment Period|Adverse Event|2|||
130991453|NCT04534114|471596475|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
130991454|NCT04534114|471596476|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
130991455|NCT04534114|471596477|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
130991456|NCT04534114|471596478|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
130991457|NCT04534114|471596475|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
130991458|NCT04534114|471596476|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
130991459|NCT04534114|471596477|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
130991460|NCT04534114|471596478|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
130991461|NCT04534114|471596475|FG000|Extension Treatment Period|Other reason|0|||
130991462|NCT04534114|471596476|FG001|Extension Treatment Period|Other reason|1|||
130991463|NCT04534114|471596477|FG002|Extension Treatment Period|Other reason|0|||
130991464|NCT04534114|471596478|FG003|Extension Treatment Period|Other reason|0|||
130991465|NCT04534114|471596475|FG000|Extension Treatment Period|Death|0|||
130991466|NCT04534114|471596476|FG001|Extension Treatment Period|Death|0|||
130991467|NCT04534114|471596477|FG002|Extension Treatment Period|Death|1|||
130991468|NCT04534114|471596478|FG003|Extension Treatment Period|Death|2|||
130991469|NCT04534114|471596475|FG000|Extension Treatment Period|Adverse Event|0|||
130991470|NCT04534114|471596476|FG001|Extension Treatment Period|Adverse Event|1|||
130991471|NCT04534114|471596477|FG002|Extension Treatment Period|Adverse Event|0|||
130991472|NCT04534114|471596478|FG003|Extension Treatment Period|Adverse Event|1|||
130991473|NCT04534114|471596475|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
130991474|NCT04534114|471596476|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
130991475|NCT04534114|471596477|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
130991476|NCT04534114|471596478|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
130991477|NCT03287414|471596479|FG000|Treatment Epoch|Adverse Event|0|||
130991478|NCT03287414|471596480|FG001|Treatment Epoch|Adverse Event|1|||
130991479|NCT03287414|471596479|FG000|Treatment Epoch|Study terminated by sponsor|2|||
130991480|NCT03287414|471596480|FG001|Treatment Epoch|Study terminated by sponsor|2|||
130991481|NCT03287414|471596479|FG000|Treatment Epoch|Subject/Guardian decision|4|||
130991482|NCT03287414|471596480|FG001|Treatment Epoch|Subject/Guardian decision|0|||
130991483|NCT03287414|471596479|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
130991484|NCT03287414|471596480|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
130991485|NCT03287414|471596479|FG000|Treatment Epoch|Withdrawal by Subject|1|||
130991486|NCT03287414|471596480|FG001|Treatment Epoch|Withdrawal by Subject|0|||
130991487|NCT03287414|471596479|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
130991488|NCT03287414|471596480|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
130991489|NCT03287414|471596479|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
130991490|NCT03287414|471596480|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
130991491|NCT02759185|471596481|FG000|Stage 1|Adverse Event|0|||
130991492|NCT02759185|471596482|FG001|Stage 1|Adverse Event|1|||
130991493|NCT02759185|471596483|FG002|Stage 1|Adverse Event|3|||
130991494|NCT02759185|471596484|FG003|Stage 1|Adverse Event|0|||
130991495|NCT02759185|471596485|FG004|Stage 1|Adverse Event|0|||
130991496|NCT02759185|471596486|FG005|Stage 1|Adverse Event|0|||
130991497|NCT02759185|471596487|FG006|Stage 1|Adverse Event|0|||
130991498|NCT02759185|471596481|FG000|Stage 1|Withdrawal by Subject|1|||
130991499|NCT02759185|471596482|FG001|Stage 1|Withdrawal by Subject|0|||
130991500|NCT02759185|471596483|FG002|Stage 1|Withdrawal by Subject|0|||
130991501|NCT02759185|471596484|FG003|Stage 1|Withdrawal by Subject|0|||
130991502|NCT02759185|471596485|FG004|Stage 1|Withdrawal by Subject|0|||
130991503|NCT02759185|471596486|FG005|Stage 1|Withdrawal by Subject|0|||
130991504|NCT02759185|471596487|FG006|Stage 1|Withdrawal by Subject|0|||
130991505|NCT02759185|471596481|FG000|Stage 2|Adverse Event|0|||
130991506|NCT02759185|471596482|FG001|Stage 2|Adverse Event|0|||
130991507|NCT02759185|471596483|FG002|Stage 2|Adverse Event|0|||
130991508|NCT02759185|471596484|FG003|Stage 2|Adverse Event|0|||
130991509|NCT02759185|471596485|FG004|Stage 2|Adverse Event|1|||
130991510|NCT02759185|471596486|FG005|Stage 2|Adverse Event|2|||
130991511|NCT02759185|471596487|FG006|Stage 2|Adverse Event|0|||
131214774|NCT01608321|472410357|FG000|Overall Study|Withdrawal by Subject|1|||
131214775|NCT01608321|472410358|FG001|Overall Study|Withdrawal by Subject|0|||
131214776|NCT03417102|472410359|FG000|Overall Study|Adverse Event|0|||
130991512|NCT02759185|471596481|FG000|Stage 2|Withdrawal by Subject|0|||
130991513|NCT02759185|471596482|FG001|Stage 2|Withdrawal by Subject|0|||
130991514|NCT02759185|471596483|FG002|Stage 2|Withdrawal by Subject|0|||
130991515|NCT02759185|471596484|FG003|Stage 2|Withdrawal by Subject|0|||
130991516|NCT02759185|471596485|FG004|Stage 2|Withdrawal by Subject|1|||
130991517|NCT02759185|471596486|FG005|Stage 2|Withdrawal by Subject|1|||
130991518|NCT02759185|471596487|FG006|Stage 2|Withdrawal by Subject|1|||
130991519|NCT02613221|471596493|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
130991520|NCT02613221|471596493|FG000|Overall Study|Adverse Event|2|||
130991521|NCT02613221|471596493|FG000|Overall Study|Voluntary Discontinuation|1|||
130991522|NCT02613221|471596493|FG000|Overall Study|Delayed Treatment|1|||
130991523|NCT02613221|471596493|FG000|Overall Study|Enrolled but Not Treated|1|||
130991524|NCT01008475|471596496|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
130991525|NCT01008475|471596497|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
130991526|NCT01008475|471596498|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
130991527|NCT01008475|471596499|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
130991528|NCT01008475|471596500|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
130991529|NCT01008475|471596501|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
130991530|NCT01008475|471596502|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
130991531|NCT02668016|471596503|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
130991532|NCT02668016|471596503|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
130991533|NCT02668016|471596503|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
130991534|NCT02668016|471596503|FG000|Month 4|Withdrawal due to severe symptoms|1|||
130991535|NCT02668016|471596503|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
130991536|NCT02668016|471596503|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
130991537|NCT02668016|471596503|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
130991538|NCT02668016|471596503|FG000|Month 6|Withdrawal due to severe symptoms|2|||
130991539|NCT02668016|471596503|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
130991540|NCT02668016|471596503|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
130991541|NCT02668016|471596503|FG000|Month 8|Withdrawal due to severe symptoms|1|||
130991542|NCT02668016|471596503|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
130991543|NCT02668016|471596503|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
130991544|NCT02668016|471596503|FG000|Month 10|Withdrawal due to severe symptoms|1|||
130991545|NCT02668016|471596503|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
130991546|NCT02917941|471596505|FG000|Treatment Period|Adverse Event|11|||
130991547|NCT02917941|471596505|FG000|Treatment Period|Progressive Disease|11|||
130991548|NCT02917941|471596505|FG000|Treatment Period|Reason not Specified|2|||
130991549|NCT02917941|471596505|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
130991550|NCT02917941|471596505|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
130991551|NCT05067933|471596516|FG000|Overall Study|Withdrawal by Subject|2|||
130991552|NCT05067933|471596517|FG001|Overall Study|Withdrawal by Subject|0|||
130991553|NCT05067933|471596518|FG002|Overall Study|Withdrawal by Subject|0|||
130991554|NCT05067933|471596519|FG003|Overall Study|Withdrawal by Subject|0|||
130991555|NCT05067933|471596520|FG004|Overall Study|Withdrawal by Subject|0|||
130991556|NCT05067933|471596521|FG005|Overall Study|Withdrawal by Subject|0|||
130991557|NCT05067933|471596516|FG000|Overall Study|Lost to Follow-up|1|||
130991558|NCT05067933|471596517|FG001|Overall Study|Lost to Follow-up|1|||
130991559|NCT05067933|471596518|FG002|Overall Study|Lost to Follow-up|1|||
130991560|NCT05067933|471596519|FG003|Overall Study|Lost to Follow-up|2|||
130991561|NCT05067933|471596520|FG004|Overall Study|Lost to Follow-up|1|||
130991562|NCT05067933|471596521|FG005|Overall Study|Lost to Follow-up|0|||
130991563|NCT05067933|471596516|FG000|Overall Study|Miscellaneous|1|||
130991564|NCT05067933|471596517|FG001|Overall Study|Miscellaneous|0|||
130991565|NCT05067933|471596518|FG002|Overall Study|Miscellaneous|0|||
130991566|NCT05067933|471596519|FG003|Overall Study|Miscellaneous|0|||
130991567|NCT05067933|471596520|FG004|Overall Study|Miscellaneous|0|||
130991568|NCT05067933|471596521|FG005|Overall Study|Miscellaneous|0|||
130991569|NCT05067933|471596516|FG000|Overall Study|Death|0|||
130991570|NCT05067933|471596517|FG001|Overall Study|Death|0|||
130991571|NCT05067933|471596518|FG002|Overall Study|Death|0|||
130991572|NCT05067933|471596519|FG003|Overall Study|Death|1|||
130991573|NCT05067933|471596520|FG004|Overall Study|Death|0|||
130991574|NCT05067933|471596521|FG005|Overall Study|Death|0|||
130991575|NCT01807650|471596530|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
130991576|NCT01807650|471596530|FG000|Overall Study|Adverse Event|5|||
130991577|NCT01807650|471596530|FG000|Overall Study|Other|2|||
130991578|NCT00736489|471596533|FG000|Period 1|Lost to Follow-up|1|||
130991579|NCT00736489|471596534|FG001|Period 1|Lost to Follow-up|0|||
130991580|NCT00736489|471596535|FG002|Period 1|Lost to Follow-up|0|||
130991581|NCT00736489|471596536|FG003|Period 1|Lost to Follow-up|0|||
130991582|NCT00736489|471596537|FG004|Period 1|Lost to Follow-up|0|||
130991583|NCT00736489|471596538|FG005|Period 1|Lost to Follow-up|0|||
130991584|NCT00736489|471596533|FG000|Period 1|Withdrawal by Subject|0|||
130991585|NCT00736489|471596534|FG001|Period 1|Withdrawal by Subject|0|||
130991586|NCT00736489|471596535|FG002|Period 1|Withdrawal by Subject|0|||
130991587|NCT00736489|471596536|FG003|Period 1|Withdrawal by Subject|0|||
130991588|NCT00736489|471596537|FG004|Period 1|Withdrawal by Subject|0|||
130765818|NCT02614131|470765858|FG003|Overall Study|Withdrawal by Subject|0|||
130765819|NCT02614131|470765859|FG004|Overall Study|Withdrawal by Subject|0|||
130991589|NCT00736489|471596538|FG005|Period 1|Withdrawal by Subject|1|||
130991590|NCT02946918|471596541|FG000|Overall Study|Patient unblinded himself|1|||
130991591|NCT02946918|471596542|FG001|Overall Study|Patient unblinded himself|0|||
130991592|NCT02946918|471596541|FG000|Overall Study|Physician Decision|0|||
130991593|NCT02946918|471596542|FG001|Overall Study|Physician Decision|2|||
130991594|NCT02946918|471596541|FG000|Overall Study|Ran out of study medication|0|||
130991595|NCT02946918|471596542|FG001|Overall Study|Ran out of study medication|1|||
130991596|NCT00069784|471596543|FG000|Overall Study|Adverse Event|105|||
130991597|NCT00069784|471596544|FG001|Overall Study|Adverse Event|0|||
130991598|NCT00069784|471596543|FG000|Overall Study|Withdrawal by Subject|1090|||
130991599|NCT00069784|471596544|FG001|Overall Study|Withdrawal by Subject|0|||
130991600|NCT00069784|471596543|FG000|Overall Study|Other|17|||
130991601|NCT00069784|471596544|FG001|Overall Study|Other|0|||
130991602|NCT01672853|471596549|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
130991603|NCT01672853|471596550|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
130991604|NCT01672853|471596551|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
130991605|NCT01672853|471596549|FG000|Overall Study|Pregnancy|0|||
130991606|NCT01672853|471596550|FG001|Overall Study|Pregnancy|1|||
130991607|NCT01672853|471596551|FG002|Overall Study|Pregnancy|0|||
130991608|NCT01672853|471596549|FG000|Overall Study|Investigator's Discretion|1|||
130991609|NCT01672853|471596550|FG001|Overall Study|Investigator's Discretion|0|||
130991610|NCT01672853|471596551|FG002|Overall Study|Investigator's Discretion|0|||
130991611|NCT01672853|471596549|FG000|Overall Study|Withdrew Consent|5|||
130991612|NCT01672853|471596550|FG001|Overall Study|Withdrew Consent|5|||
130991613|NCT01672853|471596551|FG002|Overall Study|Withdrew Consent|5|||
130991614|NCT01672853|471596549|FG000|Overall Study|Adverse Event|4|||
131214777|NCT03417102|472410360|FG001|Overall Study|Adverse Event|1|||
131214778|NCT03417102|472410359|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
131214779|NCT03417102|472410360|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
131214780|NCT03417102|472410359|FG000|Overall Study|Other|0|||
131214781|NCT03417102|472410360|FG001|Overall Study|Other|1|||
131214782|NCT02062385|472410361|FG000|Overall Study|Adverse Event|19|||
131214783|NCT02062385|472410362|FG001|Overall Study|Adverse Event|13|||
131214784|NCT02062385|472410363|FG002|Overall Study|Adverse Event|1|||
131214785|NCT02062385|472410364|FG003|Overall Study|Adverse Event|0|||
131214786|NCT02062385|472410361|FG000|Overall Study|Protocol Violation|1|||
131214787|NCT02062385|472410362|FG001|Overall Study|Protocol Violation|0|||
131214788|NCT02062385|472410363|FG002|Overall Study|Protocol Violation|0|||
131214789|NCT02062385|472410364|FG003|Overall Study|Protocol Violation|0|||
130765820|NCT02614131|470765860|FG005|Overall Study|Withdrawal by Subject|0|||
130765821|NCT02614131|470765861|FG006|Overall Study|Withdrawal by Subject|0|||
130765822|NCT02614131|470765855|FG000|Overall Study|Adverse Event|0|||
130765823|NCT02614131|470765856|FG001|Overall Study|Adverse Event|0|||
130765824|NCT02614131|470765857|FG002|Overall Study|Adverse Event|0|||
130765825|NCT02614131|470765858|FG003|Overall Study|Adverse Event|0|||
130765826|NCT02614131|470765859|FG004|Overall Study|Adverse Event|0|||
130765827|NCT02614131|470765860|FG005|Overall Study|Adverse Event|0|||
130765828|NCT02614131|470765861|FG006|Overall Study|Adverse Event|1|||
130765829|NCT01285492|470765866|FG000|Overall Study|Adverse Event|11|||
130765830|NCT01285492|470765867|FG001|Overall Study|Adverse Event|0|||
130765831|NCT01285492|470765866|FG000|Overall Study|Protocol Violation|3|||
130765832|NCT01285492|470765867|FG001|Overall Study|Protocol Violation|0|||
130765833|NCT01285492|470765866|FG000|Overall Study|Withdrawal by Subject|2|||
130765834|NCT01285492|470765867|FG001|Overall Study|Withdrawal by Subject|1|||
130765835|NCT01285492|470765866|FG000|Overall Study|Death|1|||
130765836|NCT01285492|470765867|FG001|Overall Study|Death|0|||
130765837|NCT01797094|470765868|FG000|Overall Study|Adverse Event|1|||
130765838|NCT01797094|470765869|FG001|Overall Study|Adverse Event|1|||
130765839|NCT01797094|470765868|FG000|Overall Study|Personal Reasons|4|||
130765840|NCT01797094|470765869|FG001|Overall Study|Personal Reasons|0|||
130765841|NCT01797094|470765868|FG000|Overall Study|Protocol Violation|0|||
130765842|NCT01797094|470765869|FG001|Overall Study|Protocol Violation|1|||
130765843|NCT01797094|470765868|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130765844|NCT01797094|470765869|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130765845|NCT03217968|470765872|FG000|Overall Study|Withdrawal by Subject|4|||
130765846|NCT03217968|470765872|FG000|Overall Study|Lost to Follow-up|1|||
130765847|NCT03217968|470765872|FG000|Overall Study|Protocol Violation|6|||
130765848|NCT00634049|470765884|FG000|Overall Study|Never received study drug|1|||
130765849|NCT00634049|470765884|FG000|Overall Study|Died prior to receiving study drug|1|||
130765850|NCT00634049|470765884|FG000|Overall Study|Screening failure|1|||
130991615|NCT01672853|471596550|FG001|Overall Study|Adverse Event|6|||
130991616|NCT01672853|471596551|FG002|Overall Study|Adverse Event|8|||
130991617|NCT01672853|471596549|FG000|Overall Study|Lost to Follow-up|0|||
130991618|NCT01672853|471596550|FG001|Overall Study|Lost to Follow-up|1|||
130991619|NCT01672853|471596551|FG002|Overall Study|Lost to Follow-up|0|||
130991620|NCT01672853|471596549|FG000|Overall Study|Randomized but Never Treated|0|||
131214790|NCT02062385|472410361|FG000|Overall Study|Incomplete EPI by database lock|2|||
131214791|NCT02062385|472410362|FG001|Overall Study|Incomplete EPI by database lock|0|||
131214792|NCT02062385|472410363|FG002|Overall Study|Incomplete EPI by database lock|0|||
130991621|NCT01672853|471596550|FG001|Overall Study|Randomized but Never Treated|0|||
130991622|NCT01672853|471596551|FG002|Overall Study|Randomized but Never Treated|1|||
130991623|NCT00663117|471598094|FG000|Overall Study|Lack of Efficacy|1|||
130991624|NCT00663117|471598095|FG001|Overall Study|Lack of Efficacy|0|||
130991625|NCT02243631|471598099|FG000|Overall Study|no synovial fluid on second aspirate|0|||
130991626|NCT02243631|471598100|FG001|Overall Study|no synovial fluid on second aspirate|1|||
130991627|NCT01992549|471598107|FG000|Overall Study|Lost to Follow-up|2|||
130991628|NCT01992549|471598107|FG000|Overall Study|Serious Adverse Event|1|||
130991629|NCT01992549|471598107|FG000|Overall Study|Product Switch to Extend Half Life|1|||
130991630|NCT01590771|471598108|FG000|Overall Study|Other Protocol Specified Criteria|5|||
130991631|NCT01590771|471598109|FG001|Overall Study|Other Protocol Specified Criteria|14|||
130991632|NCT01590771|471598108|FG000|Overall Study|Withdrawal by Subject|8|||
130991633|NCT01590771|471598109|FG001|Overall Study|Withdrawal by Subject|15|||
130991634|NCT01590771|471598108|FG000|Overall Study|Protocol Violation|1|||
130991635|NCT01590771|471598109|FG001|Overall Study|Protocol Violation|2|||
130991636|NCT01590771|471598108|FG000|Overall Study|Lost to Follow-up|1|||
130991637|NCT01590771|471598109|FG001|Overall Study|Lost to Follow-up|1|||
130991638|NCT01590771|471598108|FG000|Overall Study|Lack of Efficacy|1|||
130991639|NCT01590771|471598109|FG001|Overall Study|Lack of Efficacy|0|||
130991640|NCT01590771|471598108|FG000|Overall Study|Adverse Event|3|||
130991641|NCT01590771|471598109|FG001|Overall Study|Adverse Event|7|||
130991642|NCT01785628|471598113|FG000|Overall Study|Lost to Follow-up|2|||
130991643|NCT01785628|471598114|FG001|Overall Study|Lost to Follow-up|3|||
130991644|NCT00767104|471598117|FG000|Overall Study|Lost to Follow-up|1|||
130991645|NCT00767104|471598118|FG001|Overall Study|Lost to Follow-up|2|||
130991646|NCT00840996|471598119|FG000|Overall Study|Withdrawal by Subject|1|||
130991647|NCT00840996|471598120|FG001|Overall Study|Withdrawal by Subject|0|||
130991648|NCT01900054|471598128|FG000|Overall Study|Physician Decision|1|||
130991649|NCT01900054|471598128|FG000|Overall Study|Withdrawal by Subject|1|||
130991650|NCT01186328|471598129|FG000|Overall Study|Death|1|||
130991651|NCT01186328|471598130|FG001|Overall Study|Death|0|||
130991652|NCT01186328|471598131|FG002|Overall Study|Death|0|||
130991653|NCT03285295|471598136|FG000|Alinity s HBsAg|Protocol Violation|11|||
130991654|NCT03285295|471598137|FG001|Alinity s HBsAg|Protocol Violation|0|||
130991655|NCT03285295|471598138|FG002|Alinity s HBsAg|Protocol Violation|0|||
130991656|NCT03285295|471598139|FG003|Alinity s HBsAg|Protocol Violation|0|||
130991657|NCT03285295|471598140|FG004|Alinity s HBsAg|Protocol Violation|0|||
130991658|NCT03285295|471598136|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
130991659|NCT03285295|471598137|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
130991660|NCT03285295|471598138|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
130991661|NCT03285295|471598139|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
130991662|NCT03285295|471598140|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
130991663|NCT03285295|471598136|FG000|Alinity s HBsAg|No Results Generated|74|||
130991664|NCT03285295|471598137|FG001|Alinity s HBsAg|No Results Generated|6|||
130991665|NCT03285295|471598138|FG002|Alinity s HBsAg|No Results Generated|0|||
130991666|NCT03285295|471598139|FG003|Alinity s HBsAg|No Results Generated|0|||
130991667|NCT03285295|471598140|FG004|Alinity s HBsAg|No Results Generated|0|||
130991668|NCT03285295|471598136|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
130991669|NCT03285295|471598137|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
130991670|NCT03285295|471598138|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
130991671|NCT03285295|471598139|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
130991672|NCT03285295|471598140|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
130991673|NCT03285295|471598136|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
130991674|NCT03285295|471598137|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
130991675|NCT03285295|471598138|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
130991676|NCT03285295|471598139|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
130991677|NCT03285295|471598140|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
130991678|NCT03285295|471598136|FG000|Alinity s HTLV I/II|No Results Generated|70|||
130991679|NCT03285295|471598137|FG001|Alinity s HTLV I/II|No Results Generated|0|||
130991680|NCT03285295|471598138|FG002|Alinity s HTLV I/II|No Results Generated|0|||
131214793|NCT02062385|472410364|FG003|Overall Study|Incomplete EPI by database lock|0|||
131214794|NCT02062385|472410361|FG000|Overall Study|Moved|10|||
131214795|NCT02062385|472410362|FG001|Overall Study|Moved|11|||
131214796|NCT02062385|472410363|FG002|Overall Study|Moved|1|||
131214797|NCT02062385|472410364|FG003|Overall Study|Moved|0|||
131214798|NCT02062385|472410361|FG000|Overall Study|Withdrawn by parent/guardian|46|||
130765851|NCT00314132|470765885|FG000|Overall Study|Lost to Follow-up|3|||
130991681|NCT03285295|471598139|FG003|Alinity s HTLV I/II|No Results Generated|0|||
130991682|NCT03285295|471598140|FG004|Alinity s HTLV I/II|No Results Generated|0|||
130991683|NCT03285295|471598136|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
130991684|NCT03285295|471598137|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
130991685|NCT03285295|471598138|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
130991686|NCT03285295|471598139|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
130991687|NCT03285295|471598140|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
130991688|NCT03285295|471598136|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
130991689|NCT03285295|471598137|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
130991690|NCT03285295|471598138|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
130991691|NCT03285295|471598139|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
130991692|NCT03285295|471598140|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
130991693|NCT03285295|471598136|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
130991694|NCT03285295|471598137|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
130991695|NCT03285295|471598138|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
130991696|NCT03285295|471598139|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
130991697|NCT03285295|471598140|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
130991698|NCT03285295|471598136|FG000|Alinity s Anti-HCV|No Results Generated|71|||
130991699|NCT03285295|471598137|FG001|Alinity s Anti-HCV|No Results Generated|0|||
130991700|NCT03285295|471598138|FG002|Alinity s Anti-HCV|No Results Generated|0|||
130991701|NCT03285295|471598139|FG003|Alinity s Anti-HCV|No Results Generated|0|||
130991702|NCT03285295|471598140|FG004|Alinity s Anti-HCV|No Results Generated|0|||
130991703|NCT03285295|471598136|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
130991704|NCT03285295|471598137|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
130991705|NCT03285295|471598138|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
130991706|NCT03285295|471598139|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
130991707|NCT03285295|471598140|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
130991708|NCT03285295|471598136|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
130991709|NCT03285295|471598137|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
130991710|NCT03285295|471598138|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
130882386|NCT02531802|471205483|FG004|Received Vaccination 2|Adverse Event|0|||
130882387|NCT02531802|471205484|FG005|Received Vaccination 2|Adverse Event|2|||
130882388|NCT02531802|471205485|FG006|Received Vaccination 2|Adverse Event|0|||
130882389|NCT02531802|471205486|FG007|Received Vaccination 2|Adverse Event|0|||
130882390|NCT02531802|471205487|FG008|Received Vaccination 2|Adverse Event|0|||
130882391|NCT02531802|471205488|FG009|Received Vaccination 2|Adverse Event|0|||
130882392|NCT02531802|471205489|FG010|Received Vaccination 2|Adverse Event|0|||
130882393|NCT02531802|471205490|FG011|Received Vaccination 2|Adverse Event|0|||
130882394|NCT02531802|471205491|FG012|Received Vaccination 2|Adverse Event|0|||
130882395|NCT02531802|471205492|FG013|Received Vaccination 2|Adverse Event|0|||
130882396|NCT02531802|471205493|FG014|Received Vaccination 2|Adverse Event|0|||
130882397|NCT02531802|471205494|FG015|Received Vaccination 2|Adverse Event|0|||
130882398|NCT02531802|471205495|FG016|Received Vaccination 2|Adverse Event|0|||
130882399|NCT02531802|471205496|FG017|Received Vaccination 2|Adverse Event|2|||
130882400|NCT02531802|471205497|FG018|Received Vaccination 2|Adverse Event|1|||
130882401|NCT02531802|471205498|FG019|Received Vaccination 2|Adverse Event|0|||
130882402|NCT02531802|471205499|FG020|Received Vaccination 2|Adverse Event|1|||
130882403|NCT02531802|471205479|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
130882404|NCT02531802|471205480|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
130882405|NCT02531802|471205481|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
130882406|NCT02531802|471205482|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
130882407|NCT02531802|471205483|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
130882408|NCT02531802|471205484|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
130882409|NCT02531802|471205485|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
130882410|NCT02531802|471205486|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
130882411|NCT02531802|471205487|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
130991711|NCT03285295|471598139|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
130991712|NCT03285295|471598140|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
130991713|NCT03285295|471598136|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
131100624|NCT05383508|471998055|FG004|Overall Study|Withdrawal by Subject|2|||
131100625|NCT05383508|471998056|FG005|Overall Study|Withdrawal by Subject|0|||
131100626|NCT01871805|471998059|FG000|Phase I|Death|7|||
131100627|NCT01871805|471998060|FG001|Phase I|Death|4|||
131100628|NCT01871805|471998061|FG002|Phase I|Death|6|||
131100629|NCT01871805|471998062|FG003|Phase I|Death|2|||
131100630|NCT01871805|471998063|FG004|Phase I|Death|9|||
131100631|NCT01871805|471998064|FG005|Phase I|Death|0|||
131100632|NCT01871805|471998059|FG000|Phase I|Alive in Survival Follow-up|0|||
131100633|NCT01871805|471998060|FG001|Phase I|Alive in Survival Follow-up|2|||
131100634|NCT01871805|471998061|FG002|Phase I|Alive in Survival Follow-up|4|||
131100635|NCT01871805|471998062|FG003|Phase I|Alive in Survival Follow-up|5|||
131100636|NCT01871805|471998063|FG004|Phase I|Alive in Survival Follow-up|4|||
131100637|NCT01871805|471998064|FG005|Phase I|Alive in Survival Follow-up|0|||
131100638|NCT01871805|471998059|FG000|Phase I|Lost to Follow-up|0|||
131100639|NCT01871805|471998060|FG001|Phase I|Lost to Follow-up|1|||
131100640|NCT01871805|471998061|FG002|Phase I|Lost to Follow-up|3|||
131100641|NCT01871805|471998062|FG003|Phase I|Lost to Follow-up|0|||
131100642|NCT01871805|471998063|FG004|Phase I|Lost to Follow-up|0|||
131100643|NCT01871805|471998064|FG005|Phase I|Lost to Follow-up|0|||
130882412|NCT02531802|471205488|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
130882413|NCT02531802|471205489|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
130882414|NCT02531802|471205490|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
131100644|NCT01871805|471998059|FG000|Phase II|Death|0|||
131100645|NCT01871805|471998060|FG001|Phase II|Death|0|||
130991714|NCT03285295|471598137|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
130991715|NCT03285295|471598138|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
130991716|NCT03285295|471598139|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
130991717|NCT03285295|471598140|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
130991718|NCT03285295|471598136|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
130991719|NCT03285295|471598137|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
130991720|NCT03285295|471598138|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
130991721|NCT03285295|471598139|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
130991722|NCT03285295|471598140|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
130991723|NCT03285295|471598136|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
130991724|NCT03285295|471598137|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
131214799|NCT02062385|472410362|FG001|Overall Study|Withdrawn by parent/guardian|41|||
131214800|NCT02062385|472410363|FG002|Overall Study|Withdrawn by parent/guardian|9|||
131214801|NCT02062385|472410364|FG003|Overall Study|Withdrawn by parent/guardian|8|||
131214802|NCT02062385|472410361|FG000|Overall Study|Death|0|||
131214803|NCT02062385|472410362|FG001|Overall Study|Death|0|||
131214804|NCT02062385|472410363|FG002|Overall Study|Death|0|||
131214805|NCT02062385|472410364|FG003|Overall Study|Death|1|||
131214806|NCT02062385|472410361|FG000|Overall Study|Lost to Follow-up|0|||
131214807|NCT02062385|472410362|FG001|Overall Study|Lost to Follow-up|0|||
131214808|NCT02062385|472410363|FG002|Overall Study|Lost to Follow-up|1|||
131214809|NCT02062385|472410364|FG003|Overall Study|Lost to Follow-up|0|||
131214810|NCT00706901|472412009|FG000|Overall Study|Lost to Follow-up|2|||
131214811|NCT00706901|472412010|FG001|Overall Study|Lost to Follow-up|3|||
131214812|NCT00706901|472412011|FG002|Overall Study|Lost to Follow-up|2|||
131214813|NCT00706901|472412009|FG000|Overall Study|Withdrawal by Subject|4|||
131214814|NCT00706901|472412010|FG001|Overall Study|Withdrawal by Subject|2|||
131214815|NCT00706901|472412011|FG002|Overall Study|Withdrawal by Subject|5|||
131214816|NCT00706901|472412009|FG000|Overall Study|In Jail|1|||
131214817|NCT00706901|472412010|FG001|Overall Study|In Jail|0|||
131214818|NCT00706901|472412011|FG002|Overall Study|In Jail|1|||
131214819|NCT00706901|472412009|FG000|Overall Study|Death|1|||
131214820|NCT00706901|472412010|FG001|Overall Study|Death|0|||
131214821|NCT00706901|472412011|FG002|Overall Study|Death|0|||
131214822|NCT01118949|472412014|FG000|Overall Study|Adverse Event|5|||
131214823|NCT01118949|472412014|FG000|Overall Study|Withdrawal by Subject|4|||
131214824|NCT00798707|472412015|FG000|Overall Study|Adverse Event|6|||
131214825|NCT00798707|472412016|FG001|Overall Study|Adverse Event|8|||
131214826|NCT00798707|472412017|FG002|Overall Study|Adverse Event|8|||
131214827|NCT00798707|472412015|FG000|Overall Study|Failed to return|2|||
131214828|NCT00798707|472412016|FG001|Overall Study|Failed to return|2|||
131214829|NCT00798707|472412017|FG002|Overall Study|Failed to return|0|||
131214830|NCT00798707|472412015|FG000|Overall Study|Investigator|0|||
131214831|NCT00798707|472412016|FG001|Overall Study|Investigator|1|||
131214832|NCT00798707|472412017|FG002|Overall Study|Investigator|2|||
131214833|NCT00798707|472412015|FG000|Overall Study|Lack of Efficacy|2|||
131214834|NCT00798707|472412016|FG001|Overall Study|Lack of Efficacy|2|||
131214835|NCT00798707|472412017|FG002|Overall Study|Lack of Efficacy|1|||
131214836|NCT00798707|472412015|FG000|Overall Study|Lost to Follow-up|5|||
131214837|NCT00798707|472412016|FG001|Overall Study|Lost to Follow-up|6|||
131214838|NCT00798707|472412017|FG002|Overall Study|Lost to Follow-up|6|||
131214839|NCT00798707|472412015|FG000|Overall Study|Other|0|||
131214840|NCT00798707|472412016|FG001|Overall Study|Other|1|||
131214841|NCT00798707|472412017|FG002|Overall Study|Other|0|||
131214842|NCT00798707|472412015|FG000|Overall Study|Protocol Violation|4|||
131214843|NCT00798707|472412016|FG001|Overall Study|Protocol Violation|0|||
131214844|NCT00798707|472412017|FG002|Overall Study|Protocol Violation|2|||
131214845|NCT00798707|472412015|FG000|Overall Study|Withdrawal by Subject|3|||
131214846|NCT00798707|472412016|FG001|Overall Study|Withdrawal by Subject|8|||
131214847|NCT00798707|472412017|FG002|Overall Study|Withdrawal by Subject|2|||
131214848|NCT00798707|472412015|FG000|Overall Study|Randomized not treated|4|||
131214849|NCT00798707|472412016|FG001|Overall Study|Randomized not treated|5|||
131214850|NCT00798707|472412017|FG002|Overall Study|Randomized not treated|1|||
130991725|NCT03285295|471598138|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
130991726|NCT03285295|471598139|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
130991727|NCT03285295|471598140|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
131214851|NCT02875340|472412018|FG000|Overall Study|Death|2|||
131214852|NCT02875340|472412018|FG000|Overall Study|Withdrawal by Subject|2|||
131214853|NCT02875340|472412018|FG000|Overall Study|Physician Decision|3|||
131214854|NCT02875340|472412018|FG000|Overall Study|Adverse Event|1|||
131214855|NCT01160770|472412019|FG000|Overall Study|Adverse Event|10|||
131214856|NCT01160770|472412019|FG000|Overall Study|Protocol Violation|2|||
131214857|NCT01160770|472412019|FG000|Overall Study|Subject/parent/caregiver request|33|||
131214858|NCT01160770|472412019|FG000|Overall Study|Physician Decision|1|||
131214859|NCT01160770|472412019|FG000|Overall Study|Lost to Follow-up|7|||
131214860|NCT01160770|472412019|FG000|Overall Study|Study termination or sponsor request|1|||
131214861|NCT01160770|472412019|FG000|Overall Study|Death|9|||
131214862|NCT01160770|472412019|FG000|Overall Study|Lack of Efficacy|15|||
131214863|NCT01160770|472412019|FG000|Overall Study|Other Reasons|1|||
131214864|NCT03457727|472412020|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
131214865|NCT03457727|472412021|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
131214866|NCT03457727|472412022|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
131214867|NCT03457727|472412023|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
131214868|NCT01299272|472412029|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
131214869|NCT01299272|472412030|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
131214870|NCT01299272|472412031|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
130991728|NCT03285295|471598136|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
130991729|NCT03285295|471598137|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
130991730|NCT03285295|471598138|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
130991731|NCT03285295|471598139|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
130991732|NCT03285295|471598140|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
130991733|NCT03285295|471598136|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
130991734|NCT03285295|471598137|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
130991735|NCT03285295|471598138|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
130991736|NCT03285295|471598139|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
130991737|NCT03285295|471598140|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
130991738|NCT03285295|471598136|FG000|Alinity s Anti-HBc|No Results Generated|70|||
130991739|NCT03285295|471598137|FG001|Alinity s Anti-HBc|No Results Generated|0|||
130991740|NCT03285295|471598138|FG002|Alinity s Anti-HBc|No Results Generated|0|||
130991741|NCT03285295|471598139|FG003|Alinity s Anti-HBc|No Results Generated|0|||
130991742|NCT03285295|471598140|FG004|Alinity s Anti-HBc|No Results Generated|0|||
130991743|NCT03285295|471598136|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
130991744|NCT03285295|471598137|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
130991745|NCT03285295|471598138|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
130991746|NCT03285295|471598139|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
130991747|NCT03285295|471598140|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
130991748|NCT03285295|471598136|FG000|Alinity s Chagas|Protocol Violation|76|||
130991749|NCT03285295|471598137|FG001|Alinity s Chagas|Protocol Violation|0|||
130991750|NCT03285295|471598138|FG002|Alinity s Chagas|Protocol Violation|0|||
130991751|NCT03285295|471598139|FG003|Alinity s Chagas|Protocol Violation|0|||
130991752|NCT03285295|471598140|FG004|Alinity s Chagas|Protocol Violation|0|||
130991753|NCT03285295|471598136|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
130991754|NCT03285295|471598137|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
130991755|NCT03285295|471598138|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
130991756|NCT03285295|471598139|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
130991757|NCT03285295|471598140|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
130991758|NCT03285295|471598136|FG000|Alinity s Chagas|No Results Generated|105|||
130991759|NCT03285295|471598137|FG001|Alinity s Chagas|No Results Generated|0|||
130991760|NCT03285295|471598138|FG002|Alinity s Chagas|No Results Generated|0|||
130991761|NCT03285295|471598139|FG003|Alinity s Chagas|No Results Generated|0|||
130991762|NCT03285295|471598140|FG004|Alinity s Chagas|No Results Generated|0|||
130991763|NCT03285295|471598136|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
130991764|NCT03285295|471598137|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
130991765|NCT03285295|471598138|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
130991766|NCT03285295|471598139|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
130991767|NCT03285295|471598140|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
130991768|NCT03015116|471598141|FG000|Overall Study|Lost to Follow-up|3|||
130991769|NCT03015116|471598142|FG001|Overall Study|Lost to Follow-up|0|||
130991770|NCT03015116|471598143|FG002|Overall Study|Lost to Follow-up|2|||
130991771|NCT03015116|471598141|FG000|Overall Study|Withdrawal by Subject|3|||
130991772|NCT03015116|471598142|FG001|Overall Study|Withdrawal by Subject|1|||
130991773|NCT03015116|471598143|FG002|Overall Study|Withdrawal by Subject|0|||
130991774|NCT03015116|471598141|FG000|Overall Study|Subject has New Medical Status|1|||
130991775|NCT03015116|471598142|FG001|Overall Study|Subject has New Medical Status|0|||
130991776|NCT03015116|471598143|FG002|Overall Study|Subject has New Medical Status|0|||
130991777|NCT03015116|471598141|FG000|Overall Study|Physician Decision|0|||
130991778|NCT03015116|471598142|FG001|Overall Study|Physician Decision|1|||
130991779|NCT03015116|471598143|FG002|Overall Study|Physician Decision|0|||
130991780|NCT02200939|471598148|FG000|Overall Study|Participant withdrew consent|0|||
130991781|NCT02200939|471598149|FG001|Overall Study|Participant withdrew consent|1|||
130991782|NCT02200939|471598148|FG000|Overall Study|Lost to Follow-up|2|||
130991783|NCT02200939|471598149|FG001|Overall Study|Lost to Follow-up|9|||
130991784|NCT02200939|471598148|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
130991785|NCT02200939|471598149|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
130991786|NCT02746575|471598150|FG000|Overall Study|Surgery cancelled or time chaned|13|||
130991787|NCT02746575|471598150|FG000|Overall Study|Received epidural|10|||
130991788|NCT02746575|471598150|FG000|Overall Study|Withdrawal by Subject|3|||
130991789|NCT02746575|471598150|FG000|Overall Study|Bradycardia/hypotension|9|||
130991790|NCT02746575|471598150|FG000|Overall Study|Study paused|8|||
130991791|NCT02746575|471598150|FG000|Overall Study|put on beta-blocker|3|||
130991792|NCT02746575|471598150|FG000|Overall Study|type of surgery|1|||
130991793|NCT02746575|471598150|FG000|Overall Study|typ of surgery|1|||
130991794|NCT02746575|471598150|FG000|Overall Study|PI unavailable|1|||
130991795|NCT02746575|471598150|FG000|Overall Study|Unknown history of CVA|1|||
130991796|NCT02762981|471598151|FG000|Overall Study|Adverse Event|2|||
130991797|NCT02762981|471598152|FG001|Overall Study|Adverse Event|3|||
130991798|NCT02762981|471598153|FG002|Overall Study|Adverse Event|1|||
130991799|NCT02762981|471598154|FG003|Overall Study|Adverse Event|1|||
130991800|NCT02762981|471598155|FG004|Overall Study|Adverse Event|3|||
130991801|NCT02762981|471598151|FG000|Overall Study|Physician Decision|0|||
130991802|NCT02762981|471598152|FG001|Overall Study|Physician Decision|1|||
130991803|NCT02762981|471598153|FG002|Overall Study|Physician Decision|0|||
130991804|NCT02762981|471598154|FG003|Overall Study|Physician Decision|0|||
130991805|NCT02762981|471598155|FG004|Overall Study|Physician Decision|1|||
130991806|NCT02762981|471598151|FG000|Overall Study|Disease progression|11|||
130991807|NCT02762981|471598152|FG001|Overall Study|Disease progression|23|||
130991808|NCT02762981|471598153|FG002|Overall Study|Disease progression|4|||
130991809|NCT02762981|471598154|FG003|Overall Study|Disease progression|10|||
130991810|NCT02762981|471598155|FG004|Overall Study|Disease progression|1|||
130991811|NCT02762981|471598151|FG000|Overall Study|Enrolled not treated|1|||
130991812|NCT02762981|471598152|FG001|Overall Study|Enrolled not treated|5|||
130991813|NCT02762981|471598153|FG002|Overall Study|Enrolled not treated|0|||
130991814|NCT02762981|471598154|FG003|Overall Study|Enrolled not treated|2|||
130991815|NCT02762981|471598155|FG004|Overall Study|Enrolled not treated|0|||
130991816|NCT02762981|471598151|FG000|Overall Study|Other|2|||
130991817|NCT02762981|471598152|FG001|Overall Study|Other|3|||
130991818|NCT02762981|471598153|FG002|Overall Study|Other|1|||
130991819|NCT02762981|471598154|FG003|Overall Study|Other|0|||
130991820|NCT02762981|471598155|FG004|Overall Study|Other|0|||
130991821|NCT02762981|471598151|FG000|Overall Study|Missing|1|||
130991822|NCT02762981|471598152|FG001|Overall Study|Missing|0|||
130991823|NCT02762981|471598153|FG002|Overall Study|Missing|0|||
130991824|NCT02762981|471598154|FG003|Overall Study|Missing|0|||
130991825|NCT02762981|471598155|FG004|Overall Study|Missing|0|||
130991826|NCT02762981|471598151|FG000|Overall Study|Withdrawal by Subject|0|||
130991827|NCT02762981|471598152|FG001|Overall Study|Withdrawal by Subject|5|||
130991828|NCT02762981|471598153|FG002|Overall Study|Withdrawal by Subject|1|||
130991829|NCT02762981|471598154|FG003|Overall Study|Withdrawal by Subject|3|||
130991830|NCT02762981|471598155|FG004|Overall Study|Withdrawal by Subject|0|||
130991831|NCT03239873|471598156|FG000|Overall Study|Lost to Follow-up|15|||
130991832|NCT03239873|471598157|FG001|Overall Study|Lost to Follow-up|16|||
130991833|NCT03239873|471598156|FG000|Overall Study|Physician Decision|1|||
130991834|NCT03239873|471598157|FG001|Overall Study|Physician Decision|0|||
130991835|NCT03239873|471598156|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
131214871|NCT01299272|472412032|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
131214872|NCT01299272|472412029|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
131214873|NCT01299272|472412030|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
131214874|NCT01299272|472412031|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
131214875|NCT01299272|472412032|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
131214876|NCT01299272|472412029|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
131214877|NCT01299272|472412030|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
131214878|NCT01299272|472412031|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
131214879|NCT01299272|472412032|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
131214880|NCT01299272|472412029|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
131214881|NCT01299272|472412030|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
131214882|NCT01299272|472412031|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
131214883|NCT01299272|472412032|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
131214884|NCT01299272|472412029|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
130991836|NCT03239873|471598157|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
130991837|NCT03239873|471598156|FG000|Overall Study|Withdrawal by Subject|2|||
130991838|NCT03239873|471598157|FG001|Overall Study|Withdrawal by Subject|0|||
130991839|NCT03239873|471598156|FG000|Overall Study|Contraindication to study medication|1|||
131214885|NCT01299272|472412030|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
130991840|NCT03239873|471598157|FG001|Overall Study|Contraindication to study medication|0|||
130991841|NCT03239873|471598156|FG000|Overall Study|Protocol Violation|1|||
130991842|NCT03239873|471598157|FG001|Overall Study|Protocol Violation|0|||
130991843|NCT00605319|471598162|FG000|Overall Study|Adverse Event|6|||
130991844|NCT01250119|471598163|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
130991845|NCT01250119|471598164|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
130991846|NCT01250119|471598163|FG000|Diagnostic Phase|Participants Not Tested|44|||
130991847|NCT01250119|471598164|FG001|Diagnostic Phase|Participants Not Tested|0|||
130991848|NCT01250119|471598163|FG000|Treatment Phase|Progressive Disease|0|||
131214886|NCT01299272|472412031|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
131214887|NCT01299272|472412032|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
130991849|NCT01250119|471598164|FG001|Treatment Phase|Progressive Disease|32|||
130991850|NCT01250119|471598163|FG000|Treatment Phase|Death|0|||
130991851|NCT01250119|471598164|FG001|Treatment Phase|Death|2|||
130991852|NCT01250119|471598163|FG000|Treatment Phase|Withdrawal by Subject|0|||
130991853|NCT01250119|471598164|FG001|Treatment Phase|Withdrawal by Subject|1|||
130991854|NCT01250119|471598163|FG000|Treatment Phase|Adverse Event|0|||
131214888|NCT01299272|472412029|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
131214889|NCT01299272|472412030|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
131214890|NCT01299272|472412031|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
131214891|NCT01299272|472412032|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
130991855|NCT01250119|471598164|FG001|Treatment Phase|Adverse Event|2|||
130991856|NCT01250119|471598163|FG000|Treatment Phase|Unknown reason|0|||
130991857|NCT01250119|471598164|FG001|Treatment Phase|Unknown reason|4|||
130991858|NCT02670538|471598165|FG000|Overall Study|Withdrawal of Consent|8|||
130991859|NCT02670538|471598166|FG001|Overall Study|Withdrawal of Consent|6|||
130991860|NCT02670538|471598167|FG002|Overall Study|Withdrawal of Consent|5|||
130991861|NCT02670538|471598165|FG000|Overall Study|Lost to Follow-up|8|||
130991862|NCT02670538|471598166|FG001|Overall Study|Lost to Follow-up|12|||
130991863|NCT02670538|471598167|FG002|Overall Study|Lost to Follow-up|7|||
130991864|NCT02670538|471598165|FG000|Overall Study|Adverse Event|5|||
130991865|NCT02670538|471598166|FG001|Overall Study|Adverse Event|5|||
130991866|NCT02670538|471598167|FG002|Overall Study|Adverse Event|11|||
130991867|NCT02670538|471598165|FG000|Overall Study|Lack of Efficacy|7|||
130991868|NCT02670538|471598166|FG001|Overall Study|Lack of Efficacy|1|||
130991869|NCT02670538|471598167|FG002|Overall Study|Lack of Efficacy|2|||
130991870|NCT02670538|471598165|FG000|Overall Study|Protocol Violation|3|||
130991871|NCT02670538|471598166|FG001|Overall Study|Protocol Violation|4|||
130991872|NCT02670538|471598167|FG002|Overall Study|Protocol Violation|1|||
131214892|NCT01299272|472412029|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
131214893|NCT01299272|472412030|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
131214894|NCT01299272|472412031|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
131214895|NCT01299272|472412032|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
131214896|NCT01299272|472412029|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
131214897|NCT01299272|472412030|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
131214898|NCT01299272|472412031|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
131214899|NCT01299272|472412032|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
131214900|NCT01299272|472412029|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
131214901|NCT01299272|472412030|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
131214902|NCT01299272|472412031|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
131214903|NCT01299272|472412032|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
131214904|NCT01299272|472412029|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
131214905|NCT01299272|472412030|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
131214906|NCT01299272|472412031|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
131214907|NCT01299272|472412032|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
131214908|NCT01299272|472412029|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
131214909|NCT01299272|472412030|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
131214910|NCT01299272|472412031|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
131214911|NCT01299272|472412032|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
131214912|NCT01299272|472412029|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
131214913|NCT01299272|472412030|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
131214914|NCT01299272|472412031|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
131214915|NCT01299272|472412032|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
131214916|NCT01299272|472412029|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
131214917|NCT01299272|472412030|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
131214918|NCT01299272|472412031|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
131214919|NCT01299272|472412032|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
131214920|NCT01299272|472412029|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
131214921|NCT01299272|472412030|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
131214922|NCT01299272|472412031|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
131214923|NCT01299272|472412032|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
131214924|NCT01299272|472412029|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
131214925|NCT01299272|472412030|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
131214926|NCT01299272|472412031|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
131214927|NCT01299272|472412032|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
131214928|NCT01299272|472412029|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
131214929|NCT01299272|472412030|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
130991873|NCT02670538|471598165|FG000|Overall Study|Noncompliance with Study Drug|1|||
130991874|NCT02670538|471598166|FG001|Overall Study|Noncompliance with Study Drug|3|||
130991875|NCT02670538|471598167|FG002|Overall Study|Noncompliance with Study Drug|2|||
130991876|NCT02670538|471598165|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130991877|NCT02670538|471598166|FG001|Overall Study|Other Miscellaneous Reasons|1|||
131214930|NCT01299272|472412031|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
131214931|NCT01299272|472412032|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
131214932|NCT01299272|472412029|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
131214933|NCT01299272|472412030|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
131214934|NCT01299272|472412031|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
131214935|NCT01299272|472412032|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
131214936|NCT01299272|472412029|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
131214937|NCT01299272|472412030|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
131214938|NCT01299272|472412031|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
131214939|NCT01299272|472412032|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
131214940|NCT01299272|472412029|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
131214941|NCT01299272|472412030|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
130991878|NCT02670538|471598167|FG002|Overall Study|Other Miscellaneous Reasons|2|||
130991879|NCT02887989|471598168|FG000|Overall Study|Withdrawal by Subject|8|||
130991880|NCT02887989|471598169|FG001|Overall Study|Withdrawal by Subject|11|||
130991881|NCT02887989|471598168|FG000|Overall Study|Death|1|||
130991882|NCT02887989|471598169|FG001|Overall Study|Death|0|||
130991883|NCT05648357|471598173|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
130991884|NCT02176421|471598174|FG000|Overall Study|Lost to Follow-up|4|||
130991885|NCT02176421|471598174|FG000|Overall Study|Adverse Event|1|||
130991886|NCT00584805|471598177|FG000|Overall Study|No longer at risk of exposure|39|||
131214942|NCT01299272|472412031|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
131214943|NCT01299272|472412032|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
130991887|NCT00584805|471598177|FG000|Overall Study|Relocation|36|||
131214944|NCT01299272|472412029|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
131214945|NCT01299272|472412030|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
130991888|NCT00584805|471598177|FG000|Overall Study|Withdrawal by Subject|18|||
130991889|NCT00584805|471598177|FG000|Overall Study|Non-compliance|1|||
130991890|NCT00584805|471598177|FG000|Overall Study|Lost to follow up|3|||
130991891|NCT00584805|471598177|FG000|Overall Study|Screen failures|2|||
130991892|NCT01077362|471598181|FG000|Overall Study|Lack of Efficacy|13|||
130991893|NCT01077362|471598182|FG001|Overall Study|Lack of Efficacy|8|||
130991894|NCT01077362|471598183|FG002|Overall Study|Lack of Efficacy|10|||
130991895|NCT01077362|471598181|FG000|Overall Study|Lost to Follow-up|1|||
130991896|NCT01077362|471598182|FG001|Overall Study|Lost to Follow-up|0|||
130991897|NCT01077362|471598183|FG002|Overall Study|Lost to Follow-up|3|||
130991898|NCT01077362|471598181|FG000|Overall Study|Adverse Event|12|||
130991899|NCT01077362|471598182|FG001|Overall Study|Adverse Event|7|||
130991900|NCT01077362|471598183|FG002|Overall Study|Adverse Event|4|||
130991901|NCT01077362|471598181|FG000|Overall Study|Withdrawal by Subject|5|||
130991902|NCT01077362|471598182|FG001|Overall Study|Withdrawal by Subject|3|||
130991903|NCT01077362|471598183|FG002|Overall Study|Withdrawal by Subject|5|||
131214946|NCT01299272|472412031|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
131214947|NCT01299272|472412032|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
131214948|NCT01299272|472412029|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
131214949|NCT01299272|472412030|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
130991904|NCT01077362|471598181|FG000|Overall Study|Other|0|||
130991905|NCT01077362|471598182|FG001|Overall Study|Other|1|||
130991906|NCT01077362|471598183|FG002|Overall Study|Other|2|||
130991907|NCT00301080|471598184|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
130991908|NCT00301080|471598185|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
130991909|NCT00301080|471598186|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
131214950|NCT01299272|472412031|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
131214951|NCT01299272|472412032|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
131214952|NCT01299272|472412029|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
131214953|NCT01299272|472412030|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
131214954|NCT01299272|472412031|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
131214955|NCT01299272|472412032|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
131214956|NCT01299272|472412029|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
131214957|NCT01299272|472412030|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
131214958|NCT01299272|472412031|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
131214959|NCT01299272|472412032|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
130991910|NCT00301080|471598187|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
130991911|NCT00301080|471598188|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
130991912|NCT01641926|471598189|FG000|Overall Study|Adverse Event|5|||
130991913|NCT01641926|471598190|FG001|Overall Study|Adverse Event|2|||
130991914|NCT01641926|471598191|FG002|Overall Study|Adverse Event|3|||
130991915|NCT01641926|471598192|FG003|Overall Study|Adverse Event|1|||
130991916|NCT01641926|471598189|FG000|Overall Study|Lost to Follow-up|2|||
130991917|NCT01641926|471598190|FG001|Overall Study|Lost to Follow-up|2|||
130991918|NCT01641926|471598191|FG002|Overall Study|Lost to Follow-up|1|||
131214960|NCT01299272|472412029|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
131214961|NCT01299272|472412030|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
131214962|NCT01299272|472412031|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
131214963|NCT01299272|472412032|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
131214964|NCT01299272|472412029|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
131214965|NCT01299272|472412030|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
130991919|NCT01641926|471598192|FG003|Overall Study|Lost to Follow-up|0|||
130991920|NCT01641926|471598189|FG000|Overall Study|Physician Decision|6|||
131214966|NCT01299272|472412031|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
131214967|NCT01299272|472412032|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
131214968|NCT00464308|472412033|FG000|Overall Study|Adverse Event|22|||
131214969|NCT00464308|472412034|FG001|Overall Study|Adverse Event|27|||
130991921|NCT01641926|471598190|FG001|Overall Study|Physician Decision|5|||
130991922|NCT01641926|471598191|FG002|Overall Study|Physician Decision|0|||
130991923|NCT01641926|471598192|FG003|Overall Study|Physician Decision|1|||
130991924|NCT01641926|471598189|FG000|Overall Study|Protocol Violation|1|||
130991925|NCT01641926|471598190|FG001|Overall Study|Protocol Violation|0|||
130991926|NCT01641926|471598191|FG002|Overall Study|Protocol Violation|0|||
130991927|NCT01641926|471598192|FG003|Overall Study|Protocol Violation|1|||
130991928|NCT01641926|471598189|FG000|Overall Study|Withdrawal by Subject|13|||
130991929|NCT01641926|471598190|FG001|Overall Study|Withdrawal by Subject|5|||
130991930|NCT01641926|471598191|FG002|Overall Study|Withdrawal by Subject|6|||
130991931|NCT01641926|471598192|FG003|Overall Study|Withdrawal by Subject|1|||
130991932|NCT01641926|471598189|FG000|Overall Study|Not Treated|1|||
130991933|NCT01641926|471598190|FG001|Overall Study|Not Treated|1|||
130991934|NCT01641926|471598191|FG002|Overall Study|Not Treated|1|||
130991935|NCT01641926|471598192|FG003|Overall Study|Not Treated|0|||
130991936|NCT02567825|471598199|FG000|Overall Study|No follow-up post-randomization|5|||
130991937|NCT02567825|471598200|FG001|Overall Study|No follow-up post-randomization|1|||
130991938|NCT02567825|471598199|FG000|Overall Study|Follow-up less than 23 months|16|||
130991939|NCT02567825|471598200|FG001|Overall Study|Follow-up less than 23 months|20|||
130991940|NCT01540565|471598202|FG000|Overall Study|Ineligible|2|||
130991941|NCT04041440|471598203|FG000|Overall Study|Withdrawal by Subject|0|||
130991942|NCT04041440|471598204|FG001|Overall Study|Withdrawal by Subject|1|||
130991943|NCT04041440|471598203|FG000|Overall Study|Lost to Follow-up|0|||
131214970|NCT00464308|472412035|FG002|Overall Study|Adverse Event|16|||
131214971|NCT00464308|472412033|FG000|Overall Study|Lost to Follow-up|29|||
131214972|NCT00464308|472412034|FG001|Overall Study|Lost to Follow-up|19|||
131214973|NCT00464308|472412035|FG002|Overall Study|Lost to Follow-up|20|||
131214974|NCT00464308|472412033|FG000|Overall Study|Patient discontinued and other reasons|17|||
131214975|NCT00464308|472412034|FG001|Overall Study|Patient discontinued and other reasons|17|||
131214976|NCT00464308|472412035|FG002|Overall Study|Patient discontinued and other reasons|23|||
131214977|NCT00464308|472412033|FG000|Overall Study|Physician Decision|1|||
131214978|NCT00464308|472412034|FG001|Overall Study|Physician Decision|0|||
131214979|NCT00464308|472412035|FG002|Overall Study|Physician Decision|0|||
131214980|NCT01513759|472412036|FG000|Overall Study|Protocol Violation|4|||
131214981|NCT01513759|472412036|FG000|Overall Study|Death during catheter placement|1|||
131214982|NCT03606109|472412037|FG000|Overall Study|Lost to Follow-up|2|||
131214983|NCT03606109|472412038|FG001|Overall Study|Lost to Follow-up|1|||
131214984|NCT00630994|472412039|FG000|Overall Study|Adverse Event|1|||
131214985|NCT00630994|472412039|FG000|Overall Study|Disease Progression|1|||
131214986|NCT00630994|472412039|FG000|Overall Study|Lack of Efficacy|1|||
131214987|NCT00630994|472412039|FG000|Overall Study|Other|1|||
131214988|NCT03669640|472412040|FG000|Overall Study|Study Terminated by Sponsor|0|||
131214989|NCT03669640|472412041|FG001|Overall Study|Study Terminated by Sponsor|0|||
130991944|NCT04041440|471598204|FG001|Overall Study|Lost to Follow-up|1|||
130991945|NCT02247804|471598205|FG000|Treatment Period 1|Adverse Event|9|||
130991946|NCT02247804|471598206|FG001|Treatment Period 1|Adverse Event|2|||
130991947|NCT02247804|471598207|FG002|Treatment Period 1|Adverse Event|0|||
130991948|NCT02247804|471598205|FG000|Treatment Period 1|Lack of Efficacy|0|||
130991949|NCT02247804|471598206|FG001|Treatment Period 1|Lack of Efficacy|0|||
131214990|NCT03669640|472412042|FG002|Overall Study|Study Terminated by Sponsor|0|||
131214991|NCT03669640|472412043|FG003|Overall Study|Study Terminated by Sponsor|0|||
131214992|NCT03669640|472412044|FG004|Overall Study|Study Terminated by Sponsor|1|||
130991950|NCT02247804|471598207|FG002|Treatment Period 1|Lack of Efficacy|2|||
130991951|NCT02247804|471598205|FG000|Treatment Period 1|Lost to Follow-up|1|||
130991952|NCT02247804|471598206|FG001|Treatment Period 1|Lost to Follow-up|0|||
130991953|NCT02247804|471598207|FG002|Treatment Period 1|Lost to Follow-up|2|||
131214993|NCT03669640|472412045|FG005|Overall Study|Study Terminated by Sponsor|0|||
131214994|NCT03669640|472412040|FG000|Overall Study|Lost to Follow-up|0|||
130991954|NCT02247804|471598205|FG000|Treatment Period 1|Personal Reasons|7|||
130991955|NCT02247804|471598206|FG001|Treatment Period 1|Personal Reasons|1|||
131214995|NCT03669640|472412041|FG001|Overall Study|Lost to Follow-up|0|||
131214996|NCT03669640|472412042|FG002|Overall Study|Lost to Follow-up|2|||
130991956|NCT02247804|471598207|FG002|Treatment Period 1|Personal Reasons|2|||
130991957|NCT02247804|471598205|FG000|Treatment Period 1|Protocol Deviation|0|||
130991958|NCT02247804|471598206|FG001|Treatment Period 1|Protocol Deviation|0|||
130991959|NCT02247804|471598207|FG002|Treatment Period 1|Protocol Deviation|1|||
130991960|NCT02247804|471598205|FG000|Treatment Period 1|Randomized but not Treated|5|||
130991961|NCT02247804|471598206|FG001|Treatment Period 1|Randomized but not Treated|1|||
130991962|NCT02247804|471598207|FG002|Treatment Period 1|Randomized but not Treated|1|||
130991963|NCT02247804|471598205|FG000|Treatment Period 2|Adverse Event|6|||
130991964|NCT02247804|471598206|FG001|Treatment Period 2|Adverse Event|3|||
130991965|NCT02247804|471598207|FG002|Treatment Period 2|Adverse Event|3|||
130991966|NCT02247804|471598205|FG000|Treatment Period 2|Lack of Efficacy|0|||
130991967|NCT02247804|471598206|FG001|Treatment Period 2|Lack of Efficacy|0|||
130991968|NCT02247804|471598207|FG002|Treatment Period 2|Lack of Efficacy|1|||
130991969|NCT02247804|471598205|FG000|Treatment Period 2|Lost to Follow-up|0|||
130991970|NCT02247804|471598206|FG001|Treatment Period 2|Lost to Follow-up|1|||
130991971|NCT02247804|471598207|FG002|Treatment Period 2|Lost to Follow-up|1|||
130991972|NCT02247804|471598205|FG000|Treatment Period 2|Personal Reasons|2|||
130991973|NCT02247804|471598206|FG001|Treatment Period 2|Personal Reasons|1|||
130991974|NCT02247804|471598207|FG002|Treatment Period 2|Personal Reasons|1|||
130991975|NCT02247804|471598205|FG000|Treatment Period 2|Reason not Specified|0|||
130991976|NCT02247804|471598206|FG001|Treatment Period 2|Reason not Specified|0|||
130991977|NCT02247804|471598207|FG002|Treatment Period 2|Reason not Specified|2|||
130991978|NCT02247804|471598205|FG000|Treatment Period 3|Adverse Event|4|||
130991979|NCT02247804|471598206|FG001|Treatment Period 3|Adverse Event|3|||
130991980|NCT02247804|471598207|FG002|Treatment Period 3|Adverse Event|3|||
130991981|NCT02247804|471598205|FG000|Treatment Period 3|Lack of Efficacy|0|||
130991982|NCT02247804|471598206|FG001|Treatment Period 3|Lack of Efficacy|1|||
130991983|NCT02247804|471598207|FG002|Treatment Period 3|Lack of Efficacy|0|||
130991984|NCT02247804|471598205|FG000|Treatment Period 3|Lost to Follow-up|1|||
130991985|NCT02247804|471598206|FG001|Treatment Period 3|Lost to Follow-up|2|||
130991986|NCT02247804|471598207|FG002|Treatment Period 3|Lost to Follow-up|2|||
130991987|NCT02247804|471598205|FG000|Treatment Period 3|Personal Reasons|4|||
130991988|NCT02247804|471598206|FG001|Treatment Period 3|Personal Reasons|3|||
130991989|NCT02247804|471598207|FG002|Treatment Period 3|Personal Reasons|2|||
130991990|NCT02247804|471598205|FG000|Treatment Period 3|Reason not Specified|2|||
130991991|NCT02247804|471598206|FG001|Treatment Period 3|Reason not Specified|1|||
130991992|NCT02247804|471598207|FG002|Treatment Period 3|Reason not Specified|3|||
130991993|NCT04488003|471598212|FG000|Assessed for Eligibility|Screen Failure|24|||
130991994|NCT04488003|471598213|FG001|Assessed for Eligibility|Screen Failure|0|||
130991995|NCT04488003|471598214|FG002|Assessed for Eligibility|Screen Failure|0|||
130991996|NCT04488003|471598212|FG000|Assessed for Eligibility|Adverse Event|1|||
130991997|NCT04488003|471598213|FG001|Assessed for Eligibility|Adverse Event|0|||
130991998|NCT04488003|471598214|FG002|Assessed for Eligibility|Adverse Event|0|||
130991999|NCT04488003|471598212|FG000|Assessed for Eligibility|Death|1|||
130992000|NCT04488003|471598213|FG001|Assessed for Eligibility|Death|0|||
130992001|NCT04488003|471598214|FG002|Assessed for Eligibility|Death|0|||
130992002|NCT04488003|471598212|FG000|Assessed for Eligibility|Physician Decision|1|||
130992003|NCT04488003|471598213|FG001|Assessed for Eligibility|Physician Decision|0|||
130992004|NCT04488003|471598214|FG002|Assessed for Eligibility|Physician Decision|0|||
130992005|NCT04488003|471598212|FG000|Allocated to Treatment|Progressive Disease|51|||
130992006|NCT04488003|471598213|FG001|Allocated to Treatment|Progressive Disease|0|||
130992007|NCT04488003|471598214|FG002|Allocated to Treatment|Progressive Disease|0|||
130992008|NCT04488003|471598212|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
130992009|NCT04488003|471598213|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
130992010|NCT04488003|471598214|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
130992011|NCT04488003|471598212|FG000|Allocated to Treatment|Adverse Event|6|||
130992012|NCT04488003|471598213|FG001|Allocated to Treatment|Adverse Event|0|||
130992013|NCT04488003|471598214|FG002|Allocated to Treatment|Adverse Event|0|||
130992014|NCT04488003|471598212|FG000|Allocated to Treatment|Other|5|||
130992015|NCT04488003|471598213|FG001|Allocated to Treatment|Other|0|||
130992016|NCT04488003|471598214|FG002|Allocated to Treatment|Other|0|||
130992017|NCT04488003|471598212|FG000|Allocated to Treatment|Physician Decision|4|||
130992018|NCT04488003|471598213|FG001|Allocated to Treatment|Physician Decision|0|||
130992019|NCT04488003|471598214|FG002|Allocated to Treatment|Physician Decision|0|||
130992020|NCT04488003|471598212|FG000|Allocated to Treatment|Death|4|||
130992021|NCT04488003|471598213|FG001|Allocated to Treatment|Death|0|||
130992022|NCT04488003|471598214|FG002|Allocated to Treatment|Death|0|||
130992023|NCT02917265|471598215|FG000|Overall Study|Physician Decision|1|||
130992024|NCT02917265|471598216|FG001|Overall Study|Physician Decision|0|||
130992025|NCT02917265|471598215|FG000|Overall Study|Withdrawal by Subject|1|||
130992026|NCT02917265|471598216|FG001|Overall Study|Withdrawal by Subject|0|||
130992027|NCT00980005|471598222|FG000|Overall Study|Withdrawal by Subject|6|||
130992028|NCT00980005|471598223|FG001|Overall Study|Withdrawal by Subject|17|||
130992029|NCT00980005|471598222|FG000|Overall Study|Lost to Follow-up|37|||
130992030|NCT00980005|471598223|FG001|Overall Study|Lost to Follow-up|43|||
130992031|NCT00980005|471598222|FG000|Overall Study|Other|4|||
130992032|NCT00980005|471598223|FG001|Overall Study|Other|3|||
130992033|NCT00692406|471598224|FG000|Overall Study|PI dropped, bad data|57|||
130992034|NCT01617005|471598225|FG000|Overall Study|Pregnancy|1|||
130992035|NCT01617005|471598225|FG000|Overall Study|Lack of motivation for treatment|1|||
130992036|NCT04145037|471598229|FG000|Overall Study|Study terminated|2|||
130992037|NCT04145037|471598230|FG001|Overall Study|Study terminated|0|||
130992038|NCT04145037|471598229|FG000|Overall Study|Withdrawal by Subject|1|||
130992039|NCT04145037|471598230|FG001|Overall Study|Withdrawal by Subject|0|||
130992040|NCT04145037|471598229|FG000|Overall Study|Lost to Follow-up|1|||
130992041|NCT04145037|471598230|FG001|Overall Study|Lost to Follow-up|0|||
130992042|NCT02307513|471598233|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
130992043|NCT02307513|471598234|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
130992044|NCT02307513|471598233|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
130992045|NCT02307513|471598234|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
130992046|NCT02307513|471598233|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
130992047|NCT02307513|471598234|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
130992048|NCT02307513|471598233|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
130992049|NCT02307513|471598234|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
130992050|NCT02307513|471598233|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
130992051|NCT02307513|471598234|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
130992052|NCT02307513|471598233|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
130992053|NCT02307513|471598234|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
130992054|NCT02307513|471598233|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
130992055|NCT02307513|471598234|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
130992056|NCT02307513|471598233|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
130992057|NCT02307513|471598234|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
130992058|NCT02307513|471598233|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
130992059|NCT02307513|471598234|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
130992060|NCT02307513|471598233|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
130992061|NCT02307513|471598234|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
130992062|NCT02307513|471598233|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
130992063|NCT02307513|471598234|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
130992064|NCT02307513|471598233|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
130992065|NCT02307513|471598234|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
130992066|NCT02307513|471598233|FG000|Long-term Extension|Physician Decision|1|||
130992067|NCT02307513|471598234|FG001|Long-term Extension|Physician Decision|0|||
130992068|NCT02954458|471598239|FG000|Overall Study|Adverse Event|0|||
130992069|NCT02954458|471598240|FG001|Overall Study|Adverse Event|0|||
130992070|NCT02954458|471598241|FG002|Overall Study|Adverse Event|0|||
130992071|NCT02954458|471598242|FG003|Overall Study|Adverse Event|1|||
130992072|NCT02954458|471598239|FG000|Overall Study|Withdrawal by Subject|0|||
130992073|NCT02954458|471598240|FG001|Overall Study|Withdrawal by Subject|0|||
130992074|NCT02954458|471598241|FG002|Overall Study|Withdrawal by Subject|0|||
130992075|NCT02954458|471598242|FG003|Overall Study|Withdrawal by Subject|1|||
130992076|NCT02954458|471598239|FG000|Overall Study|Physician Decision|0|||
130992077|NCT02954458|471598240|FG001|Overall Study|Physician Decision|0|||
130992078|NCT02954458|471598241|FG002|Overall Study|Physician Decision|1|||
130992079|NCT02954458|471598242|FG003|Overall Study|Physician Decision|1|||
130992080|NCT02954458|471598239|FG000|Overall Study|Lost to Follow-up|1|||
130992081|NCT02954458|471598240|FG001|Overall Study|Lost to Follow-up|0|||
130992082|NCT02954458|471598241|FG002|Overall Study|Lost to Follow-up|0|||
130992083|NCT02954458|471598242|FG003|Overall Study|Lost to Follow-up|1|||
130992084|NCT02954458|471598239|FG000|Overall Study|Death|0|||
130992085|NCT02954458|471598240|FG001|Overall Study|Death|0|||
130992086|NCT02954458|471598241|FG002|Overall Study|Death|0|||
130992087|NCT02954458|471598242|FG003|Overall Study|Death|1|||
130992088|NCT02954458|471598239|FG000|Overall Study|Other|0|||
130992089|NCT02954458|471598240|FG001|Overall Study|Other|0|||
130992090|NCT02954458|471598241|FG002|Overall Study|Other|0|||
130992091|NCT02954458|471598242|FG003|Overall Study|Other|7|||
130992092|NCT01845974|471598243|FG000|Overall Study|screen failure|1|||
130992093|NCT01845974|471598244|FG001|Overall Study|screen failure|0|||
130992094|NCT04186403|471598245|FG000|Overall Study|Adverse Event|1|||
130992095|NCT04186403|471598246|FG001|Overall Study|Adverse Event|8|||
130992096|NCT04186403|471598245|FG000|Overall Study|Lost to Follow-up|7|||
131214997|NCT03669640|472412043|FG003|Overall Study|Lost to Follow-up|0|||
131214998|NCT03669640|472412044|FG004|Overall Study|Lost to Follow-up|0|||
130992097|NCT04186403|471598246|FG001|Overall Study|Lost to Follow-up|3|||
131214999|NCT03669640|472412045|FG005|Overall Study|Lost to Follow-up|0|||
130992098|NCT04186403|471598245|FG000|Overall Study|Physician Decision|1|||
130992099|NCT04186403|471598246|FG001|Overall Study|Physician Decision|0|||
130992100|NCT04186403|471598245|FG000|Overall Study|Withdrawal by Subject|7|||
130992101|NCT04186403|471598246|FG001|Overall Study|Withdrawal by Subject|8|||
130992102|NCT04186403|471598245|FG000|Overall Study|Other: Not Related to Covid-19|3|||
130992103|NCT04186403|471598246|FG001|Overall Study|Other: Not Related to Covid-19|0|||
130992104|NCT00405639|471598247|FG000|Overall Study|Withdrawal by Subject|1|||
130992105|NCT00405639|471598248|FG001|Overall Study|Withdrawal by Subject|0|||
130992106|NCT00405639|471598247|FG000|Overall Study|Adverse Event|1|||
130992107|NCT00405639|471598248|FG001|Overall Study|Adverse Event|0|||
130992108|NCT00405639|471598247|FG000|Overall Study|Seizure prior to receiving BNP|1|||
130992109|NCT00405639|471598248|FG001|Overall Study|Seizure prior to receiving BNP|0|||
130992110|NCT00265330|471598249|FG000|Overall Study|Adverse Event|41|||
130992111|NCT00265330|471598249|FG000|Overall Study|Lost to Follow-up|8|||
130992112|NCT00265330|471598249|FG000|Overall Study|Withdrawal by Subject|34|||
130992113|NCT00265330|471598249|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
130992114|NCT00265330|471598249|FG000|Overall Study|Lack of Efficacy|4|||
130992115|NCT00265330|471598249|FG000|Overall Study|Family Scheduling Conflicts|1|||
130992116|NCT00265330|471598249|FG000|Overall Study|Began Taking Formulary Geodon|1|||
130992117|NCT00265330|471598249|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
130992118|NCT00265330|471598249|FG000|Overall Study|Site Closed by Sponsor|1|||
130992119|NCT00265330|471598249|FG000|Overall Study|Principal Investigators Request|1|||
130992120|NCT00265330|471598249|FG000|Overall Study|Withdrew Consent|1|||
130992121|NCT00265330|471598249|FG000|Overall Study|Protocol Violation|1|||
130992122|NCT01396317|471598254|FG000|Overall Study|Adverse Event|1|||
130992123|NCT01396317|471598255|FG001|Overall Study|Adverse Event|0|||
130992124|NCT02294474|471598256|FG000|Overall Study|Adverse Event|7|||
130992125|NCT02294474|471598257|FG001|Overall Study|Adverse Event|7|||
130992126|NCT02294474|471598256|FG000|Overall Study|Lack of Efficacy|2|||
130992127|NCT02294474|471598257|FG001|Overall Study|Lack of Efficacy|1|||
130992128|NCT02294474|471598256|FG000|Overall Study|Protocol Violation|4|||
130992129|NCT02294474|471598257|FG001|Overall Study|Protocol Violation|2|||
130992130|NCT02294474|471598256|FG000|Overall Study|Other than specified above|12|||
130992131|NCT02294474|471598257|FG001|Overall Study|Other than specified above|12|||
130992132|NCT03443713|471598258|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
130992133|NCT03443713|471598259|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
130992134|NCT03443713|471598260|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
130992135|NCT02944656|471598262|FG000|Overall Study|No longer eligible|3|||
130992136|NCT02944656|471598263|FG001|Overall Study|No longer eligible|0|||
130992137|NCT02944656|471598262|FG000|Overall Study|Lost to Follow-up|7|||
130992138|NCT02944656|471598263|FG001|Overall Study|Lost to Follow-up|10|||
130992139|NCT05879198|471598266|FG000|Overall Study|Lost to Follow-up|1|||
130992140|NCT02073097|471598267|FG000|Overall Study|Adverse Event|0|||
130992141|NCT02073097|471598268|FG001|Overall Study|Adverse Event|0|||
130992142|NCT02073097|471598269|FG002|Overall Study|Adverse Event|0|||
130992143|NCT02073097|471598270|FG003|Overall Study|Adverse Event|0|||
130992144|NCT02073097|471598271|FG004|Overall Study|Adverse Event|0|||
130992145|NCT02073097|471598272|FG005|Overall Study|Adverse Event|0|||
130992146|NCT02073097|471598273|FG006|Overall Study|Adverse Event|0|||
130992147|NCT02073097|471598274|FG007|Overall Study|Adverse Event|2|||
130992148|NCT02073097|471598267|FG000|Overall Study|Withdrawal by Subject|0|||
130992149|NCT02073097|471598268|FG001|Overall Study|Withdrawal by Subject|0|||
130992150|NCT02073097|471598269|FG002|Overall Study|Withdrawal by Subject|0|||
130992151|NCT02073097|471598270|FG003|Overall Study|Withdrawal by Subject|0|||
130992152|NCT02073097|471598271|FG004|Overall Study|Withdrawal by Subject|0|||
130992153|NCT02073097|471598272|FG005|Overall Study|Withdrawal by Subject|0|||
130992154|NCT02073097|471598273|FG006|Overall Study|Withdrawal by Subject|0|||
130992155|NCT02073097|471598274|FG007|Overall Study|Withdrawal by Subject|2|||
130992156|NCT02073097|471598267|FG000|Overall Study|Death|0|||
130992157|NCT02073097|471598268|FG001|Overall Study|Death|0|||
130992158|NCT02073097|471598269|FG002|Overall Study|Death|0|||
130992159|NCT02073097|471598270|FG003|Overall Study|Death|0|||
130992160|NCT02073097|471598271|FG004|Overall Study|Death|0|||
130992161|NCT02073097|471598272|FG005|Overall Study|Death|0|||
130992162|NCT02073097|471598273|FG006|Overall Study|Death|0|||
130992163|NCT02073097|471598274|FG007|Overall Study|Death|1|||
130992164|NCT02073097|471598267|FG000|Overall Study|Physician Decision|0|||
130992165|NCT02073097|471598268|FG001|Overall Study|Physician Decision|0|||
130992166|NCT02073097|471598269|FG002|Overall Study|Physician Decision|0|||
131215000|NCT03669640|472412040|FG000|Overall Study|Death|0|||
130992167|NCT02073097|471598270|FG003|Overall Study|Physician Decision|0|||
130992168|NCT02073097|471598271|FG004|Overall Study|Physician Decision|0|||
130992169|NCT02073097|471598272|FG005|Overall Study|Physician Decision|0|||
130992170|NCT02073097|471598273|FG006|Overall Study|Physician Decision|0|||
130992171|NCT02073097|471598274|FG007|Overall Study|Physician Decision|1|||
130992172|NCT04741802|471599698|FG000|Overall Study|Death|1|||
130992173|NCT04741802|471599698|FG000|Overall Study|Lost to Follow-up|11|||
130992174|NCT01785563|471599700|FG000|Overall Study|Physician Decision|10|||
130992175|NCT01785563|471599700|FG000|Overall Study|Withdrawal by Subject|1|||
131215001|NCT03669640|472412041|FG001|Overall Study|Death|0|||
130992176|NCT01785563|471599700|FG000|Overall Study|Protocol Violation|2|||
130992177|NCT01872910|471599701|FG000|Overall Study|Lost to Follow-up|2|||
130992178|NCT01872910|471599702|FG001|Overall Study|Lost to Follow-up|0|||
130992179|NCT01872910|471599703|FG002|Overall Study|Lost to Follow-up|2|||
130992180|NCT01872910|471599704|FG003|Overall Study|Lost to Follow-up|0|||
130992181|NCT01872910|471599705|FG004|Overall Study|Lost to Follow-up|0|||
130992182|NCT01872910|471599706|FG005|Overall Study|Lost to Follow-up|0|||
130992183|NCT01616771|471599707|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
131215002|NCT03669640|472412042|FG002|Overall Study|Death|1|||
131215003|NCT03669640|472412043|FG003|Overall Study|Death|0|||
131215004|NCT03669640|472412044|FG004|Overall Study|Death|0|||
131215005|NCT03669640|472412045|FG005|Overall Study|Death|0|||
131215006|NCT03669640|472412040|FG000|Overall Study|Withdrawal by Subject|1|||
131215007|NCT03669640|472412041|FG001|Overall Study|Withdrawal by Subject|2|||
131215008|NCT03669640|472412042|FG002|Overall Study|Withdrawal by Subject|1|||
131215009|NCT03669640|472412043|FG003|Overall Study|Withdrawal by Subject|0|||
131215010|NCT03669640|472412044|FG004|Overall Study|Withdrawal by Subject|1|||
131215011|NCT03669640|472412045|FG005|Overall Study|Withdrawal by Subject|3|||
131215012|NCT03669640|472412040|FG000|Overall Study|Protocol Violation|1|||
131215013|NCT03669640|472412041|FG001|Overall Study|Protocol Violation|0|||
131215014|NCT03669640|472412042|FG002|Overall Study|Protocol Violation|0|||
131215015|NCT03669640|472412043|FG003|Overall Study|Protocol Violation|0|||
130992184|NCT00100932|471599708|FG000|Overall Study|Adverse Event|11|||
130992185|NCT00100932|471599709|FG001|Overall Study|Adverse Event|2|||
130992186|NCT00100932|471599708|FG000|Overall Study|Withdrawal by Subject|6|||
130992187|NCT00100932|471599709|FG001|Overall Study|Withdrawal by Subject|0|||
130992188|NCT00100932|471599708|FG000|Overall Study|Progressive Disease|44|||
130992189|NCT00100932|471599709|FG001|Overall Study|Progressive Disease|18|||
130992190|NCT00100932|471599708|FG000|Overall Study|Physician Decision|7|||
130992191|NCT00100932|471599709|FG001|Overall Study|Physician Decision|5|||
130992192|NCT00100932|471599708|FG000|Overall Study|Other|5|||
130992193|NCT00100932|471599709|FG001|Overall Study|Other|2|||
130992194|NCT00744328|471599710|FG000|Overall Study|Lost to Follow-up|2|||
130992195|NCT00744328|471599711|FG001|Overall Study|Lost to Follow-up|5|||
130992196|NCT00744328|471599712|FG002|Overall Study|Lost to Follow-up|3|||
130992197|NCT00744328|471599710|FG000|Overall Study|Withdrawal by Subject|5|||
130992198|NCT00744328|471599711|FG001|Overall Study|Withdrawal by Subject|3|||
130992199|NCT00744328|471599712|FG002|Overall Study|Withdrawal by Subject|4|||
130992200|NCT00744328|471599710|FG000|Overall Study|Found ineligible after randomization|0|||
130992201|NCT00744328|471599711|FG001|Overall Study|Found ineligible after randomization|0|||
130992202|NCT00744328|471599712|FG002|Overall Study|Found ineligible after randomization|1|||
130992203|NCT02387216|471599717|FG000|Overall Study|Progressive disease|2|||
130992204|NCT02387216|471599718|FG001|Overall Study|Progressive disease|0|||
130992205|NCT02387216|471599717|FG000|Overall Study|Withdrawal by Subject|3|||
130992206|NCT02387216|471599718|FG001|Overall Study|Withdrawal by Subject|5|||
130992207|NCT02387216|471599717|FG000|Overall Study|Physician Decision|2|||
130992208|NCT02387216|471599718|FG001|Overall Study|Physician Decision|0|||
130992209|NCT02387216|471599717|FG000|Overall Study|Sponsor Decision|28|||
130992210|NCT02387216|471599718|FG001|Overall Study|Sponsor Decision|12|||
130992211|NCT02387216|471599717|FG000|Overall Study|Death|60|||
130992212|NCT02387216|471599718|FG001|Overall Study|Death|23|||
130992213|NCT02387216|471599717|FG000|Overall Study|Other|5|||
130992214|NCT02387216|471599718|FG001|Overall Study|Other|4|||
130992215|NCT02387216|471599717|FG000|Overall Study|Lost to Follow-up|0|||
130992216|NCT02387216|471599718|FG001|Overall Study|Lost to Follow-up|3|||
130992217|NCT05952297|471599720|FG000|Overall Study|Withdrawal by Subject|1|||
130992218|NCT05952297|471599721|FG001|Overall Study|Withdrawal by Subject|0|||
130992219|NCT00525265|471599724|FG000|Overall Study|Protocol Violation|1|||
130992220|NCT00525265|471599725|FG001|Overall Study|Protocol Violation|0|||
131215016|NCT03669640|472412044|FG004|Overall Study|Protocol Violation|0|||
131215017|NCT03669640|472412045|FG005|Overall Study|Protocol Violation|0|||
131215018|NCT03669640|472412040|FG000|Overall Study|Physician Decision|0|||
131215019|NCT03669640|472412041|FG001|Overall Study|Physician Decision|2|||
131215020|NCT03669640|472412042|FG002|Overall Study|Physician Decision|0|||
131215021|NCT03669640|472412043|FG003|Overall Study|Physician Decision|0|||
131215022|NCT03669640|472412044|FG004|Overall Study|Physician Decision|0|||
131215023|NCT03669640|472412045|FG005|Overall Study|Physician Decision|0|||
131215024|NCT03669640|472412040|FG000|Overall Study|Disease Relapse|1|||
131215025|NCT03669640|472412041|FG001|Overall Study|Disease Relapse|0|||
131215026|NCT03669640|472412042|FG002|Overall Study|Disease Relapse|0|||
131215027|NCT03669640|472412043|FG003|Overall Study|Disease Relapse|0|||
131215028|NCT03669640|472412044|FG004|Overall Study|Disease Relapse|0|||
130992221|NCT03107377|471599726|FG000|Overall Study|Adverse Event|3|||
130992222|NCT03107377|471599727|FG001|Overall Study|Adverse Event|3|||
130992223|NCT03107377|471599726|FG000|Overall Study|Protocol Violation|9|||
130992224|NCT03107377|471599727|FG001|Overall Study|Protocol Violation|12|||
131215029|NCT03669640|472412045|FG005|Overall Study|Disease Relapse|0|||
131215030|NCT03669640|472412040|FG000|Overall Study|Adverse Event|2|||
131215031|NCT03669640|472412041|FG001|Overall Study|Adverse Event|1|||
131215032|NCT03669640|472412042|FG002|Overall Study|Adverse Event|0|||
130992225|NCT03107377|471599726|FG000|Overall Study|Physician Decision|3|||
130992226|NCT03107377|471599727|FG001|Overall Study|Physician Decision|6|||
130992227|NCT03107377|471599726|FG000|Overall Study|Pregnancy|7|||
130992228|NCT03107377|471599727|FG001|Overall Study|Pregnancy|7|||
130992229|NCT03107377|471599726|FG000|Overall Study|Withdrawal by Subject|16|||
131215033|NCT03669640|472412043|FG003|Overall Study|Adverse Event|0|||
130992230|NCT03107377|471599727|FG001|Overall Study|Withdrawal by Subject|22|||
130992231|NCT03107377|471599726|FG000|Overall Study|Lost to Follow-up|37|||
130992232|NCT03107377|471599727|FG001|Overall Study|Lost to Follow-up|34|||
130992233|NCT03107377|471599726|FG000|Overall Study|Other reason not specified|16|||
130992234|NCT03107377|471599727|FG001|Overall Study|Other reason not specified|15|||
130992235|NCT00211237|471599728|FG000|Baseline|Withdrew|1|||
130992236|NCT00211237|471599729|FG001|Baseline|Withdrew|3|||
130992237|NCT00211237|471599730|FG002|Baseline|Withdrew|0|||
130992238|NCT00211237|471599728|FG000|Baseline|Refused random assignment|1|||
130992239|NCT00211237|471599729|FG001|Baseline|Refused random assignment|0|||
130992240|NCT00211237|471599730|FG002|Baseline|Refused random assignment|0|||
130992241|NCT00211237|471599728|FG000|1 Month|Death|2|||
130992242|NCT00211237|471599729|FG001|1 Month|Death|1|||
130992243|NCT00211237|471599730|FG002|1 Month|Death|0|||
130992244|NCT00211237|471599728|FG000|1 Month|Lost to Follow-up|0|||
130992245|NCT00211237|471599729|FG001|1 Month|Lost to Follow-up|2|||
130992246|NCT00211237|471599730|FG002|1 Month|Lost to Follow-up|0|||
130992247|NCT00211237|471599728|FG000|1 Month|Withdrew|0|||
130992248|NCT00211237|471599729|FG001|1 Month|Withdrew|4|||
130992249|NCT00211237|471599730|FG002|1 Month|Withdrew|0|||
130992250|NCT00211237|471599728|FG000|1 Month|Additional surgery needed|1|||
130992251|NCT00211237|471599729|FG001|1 Month|Additional surgery needed|0|||
130992252|NCT00211237|471599730|FG002|1 Month|Additional surgery needed|0|||
130992253|NCT00211237|471599728|FG000|1 Month|Non-medical problem|0|||
130992254|NCT00211237|471599729|FG001|1 Month|Non-medical problem|2|||
130992255|NCT00211237|471599730|FG002|1 Month|Non-medical problem|0|||
130992256|NCT00211237|471599728|FG000|3 Months|Death|7|||
130992257|NCT00211237|471599729|FG001|3 Months|Death|3|||
130992258|NCT00211237|471599730|FG002|3 Months|Death|0|||
130992259|NCT00211237|471599728|FG000|3 Months|Could not comply with protocol|1|||
130992260|NCT00211237|471599729|FG001|3 Months|Could not comply with protocol|0|||
130992261|NCT00211237|471599730|FG002|3 Months|Could not comply with protocol|0|||
130992262|NCT00211237|471599728|FG000|3 Months|Withdrew|0|||
130992263|NCT00211237|471599729|FG001|3 Months|Withdrew|1|||
130992264|NCT00211237|471599730|FG002|3 Months|Withdrew|0|||
130992265|NCT00211237|471599728|FG000|3 Months|Non-medical problem|0|||
130992266|NCT00211237|471599729|FG001|3 Months|Non-medical problem|0|||
130992267|NCT00211237|471599730|FG002|3 Months|Non-medical problem|1|||
130992268|NCT00211237|471599728|FG000|6 Months|Death|6|||
130992269|NCT00211237|471599729|FG001|6 Months|Death|0|||
130992270|NCT00211237|471599730|FG002|6 Months|Death|3|||
130992271|NCT00211237|471599728|FG000|6 Months|Lost to Follow-up|2|||
130992272|NCT00211237|471599729|FG001|6 Months|Lost to Follow-up|0|||
130992273|NCT00211237|471599730|FG002|6 Months|Lost to Follow-up|0|||
130992274|NCT00211237|471599728|FG000|6 Months|Could not comply with protocol|0|||
130992275|NCT00211237|471599729|FG001|6 Months|Could not comply with protocol|2|||
130992276|NCT00211237|471599730|FG002|6 Months|Could not comply with protocol|0|||
130992277|NCT00211237|471599728|FG000|12 Months|Death|8|||
130992278|NCT00211237|471599729|FG001|12 Months|Death|2|||
130992279|NCT00211237|471599730|FG002|12 Months|Death|3|||
130992280|NCT00211237|471599728|FG000|12 Months|Lost to Follow-up|1|||
130992281|NCT00211237|471599729|FG001|12 Months|Lost to Follow-up|0|||
130992282|NCT00211237|471599730|FG002|12 Months|Lost to Follow-up|1|||
130992283|NCT00211237|471599728|FG000|12 Months|Withdrew|0|||
130992284|NCT00211237|471599729|FG001|12 Months|Withdrew|0|||
130992285|NCT00211237|471599730|FG002|12 Months|Withdrew|1|||
130992286|NCT00211237|471599728|FG000|12 Months|unrelated medical problem|0|||
130992287|NCT00211237|471599729|FG001|12 Months|unrelated medical problem|0|||
130992288|NCT00211237|471599730|FG002|12 Months|unrelated medical problem|1|||
130992289|NCT04078035|471599731|FG000|Session 2|Lost to Follow-up|3|||
130992290|NCT04078035|471599732|FG001|Session 2|Lost to Follow-up|1|||
130992291|NCT04078035|471599731|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
130992292|NCT04078035|471599732|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
130992293|NCT01013792|471599733|FG000|Overall Study|Study suspended|2|||
131215034|NCT03669640|472412044|FG004|Overall Study|Adverse Event|1|||
130992294|NCT01013792|471599734|FG001|Overall Study|Study suspended|1|||
130992295|NCT01013792|471599733|FG000|Overall Study|Adverse Event|0|||
130992296|NCT01013792|471599734|FG001|Overall Study|Adverse Event|3|||
130992297|NCT01013792|471599733|FG000|Overall Study|Lost to Follow-up|0|||
130992298|NCT01013792|471599734|FG001|Overall Study|Lost to Follow-up|1|||
130992299|NCT02100722|471599735|FG000|Overall Study|Withdrawal pre-procedure|4|||
131215035|NCT03669640|472412045|FG005|Overall Study|Adverse Event|0|||
130992300|NCT02100722|471599736|FG001|Overall Study|Withdrawal pre-procedure|9|||
130992301|NCT02100722|471599735|FG000|Overall Study|Withdrawal post-procedure|0|||
130992302|NCT02100722|471599736|FG001|Overall Study|Withdrawal post-procedure|3|||
130992303|NCT02100722|471599735|FG000|Overall Study|Lost to Follow-up|2|||
130992304|NCT02100722|471599736|FG001|Overall Study|Lost to Follow-up|2|||
130992305|NCT02100722|471599735|FG000|Overall Study|Continuing on study|751|||
130992306|NCT02100722|471599736|FG001|Overall Study|Continuing on study|729|||
130992307|NCT02541383|471599740|FG000|Overall Study|Death|50|||
130992308|NCT02541383|471599741|FG001|Overall Study|Death|37|||
130992309|NCT02541383|471599742|FG002|Overall Study|Death|48|||
130992310|NCT02541383|471599743|FG003|Overall Study|Death|41|||
130992311|NCT02541383|471599744|FG004|Overall Study|Death|21|||
130992312|NCT02541383|471599745|FG005|Overall Study|Death|25|||
130992313|NCT02541383|471599740|FG000|Overall Study|Lost to Follow-up|5|||
130992314|NCT02541383|471599741|FG001|Overall Study|Lost to Follow-up|3|||
130992315|NCT02541383|471599742|FG002|Overall Study|Lost to Follow-up|1|||
130992316|NCT02541383|471599743|FG003|Overall Study|Lost to Follow-up|1|||
130992317|NCT02541383|471599744|FG004|Overall Study|Lost to Follow-up|3|||
130992318|NCT02541383|471599745|FG005|Overall Study|Lost to Follow-up|0|||
130992319|NCT02541383|471599740|FG000|Overall Study|Consent withdrawn|5|||
130992320|NCT02541383|471599741|FG001|Overall Study|Consent withdrawn|6|||
130992321|NCT02541383|471599742|FG002|Overall Study|Consent withdrawn|1|||
130992322|NCT02541383|471599743|FG003|Overall Study|Consent withdrawn|1|||
130992323|NCT02541383|471599744|FG004|Overall Study|Consent withdrawn|0|||
130992324|NCT02541383|471599745|FG005|Overall Study|Consent withdrawn|0|||
130992325|NCT02541383|471599740|FG000|Overall Study|Sponsor's decision|1|||
130992326|NCT02541383|471599741|FG001|Overall Study|Sponsor's decision|1|||
130992327|NCT02541383|471599742|FG002|Overall Study|Sponsor's decision|0|||
130992328|NCT02541383|471599743|FG003|Overall Study|Sponsor's decision|0|||
130992329|NCT02541383|471599744|FG004|Overall Study|Sponsor's decision|0|||
130992330|NCT02541383|471599745|FG005|Overall Study|Sponsor's decision|0|||
130992331|NCT05796518|471599746|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
130992332|NCT02690077|471599747|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
130992333|NCT02690077|471599748|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
130992334|NCT02690077|471599747|FG000|Overall Study|Withdrawal by Subject|0|||
130992335|NCT02690077|471599748|FG001|Overall Study|Withdrawal by Subject|5|||
130992336|NCT02690077|471599747|FG000|Overall Study|Excluded by IRB|0|||
130992337|NCT02690077|471599748|FG001|Overall Study|Excluded by IRB|2|||
130992338|NCT05408468|471599749|FG000|Overall Study|Lost to Follow-up|3|||
130992339|NCT05408468|471599750|FG001|Overall Study|Lost to Follow-up|1|||
130992340|NCT05408468|471599749|FG000|Overall Study|Physician Decision|1|||
130992341|NCT05408468|471599750|FG001|Overall Study|Physician Decision|0|||
130992342|NCT05408468|471599749|FG000|Overall Study|Overwhelmed by clinical situation|3|||
130992343|NCT05408468|471599750|FG001|Overall Study|Overwhelmed by clinical situation|0|||
130992344|NCT05408468|471599749|FG000|Overall Study|Personal illness precluding participation|1|||
130992345|NCT05408468|471599750|FG001|Overall Study|Personal illness precluding participation|0|||
130992346|NCT05408468|471599749|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
130992347|NCT05408468|471599750|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
130992348|NCT00612534|471599753|FG000|Overall Study|Adverse Event|0|||
130992349|NCT00612534|471599754|FG001|Overall Study|Adverse Event|4|||
130992350|NCT00612534|471599755|FG002|Overall Study|Adverse Event|2|||
130992351|NCT00612534|471599756|FG003|Overall Study|Adverse Event|1|||
130992352|NCT00612534|471599753|FG000|Overall Study|Lack of Efficacy|13|||
130992353|NCT00612534|471599754|FG001|Overall Study|Lack of Efficacy|12|||
130992354|NCT00612534|471599755|FG002|Overall Study|Lack of Efficacy|5|||
130992355|NCT00612534|471599756|FG003|Overall Study|Lack of Efficacy|16|||
130992356|NCT00612534|471599753|FG000|Overall Study|Other Reason|0|||
130992357|NCT00612534|471599754|FG001|Overall Study|Other Reason|1|||
130992358|NCT00612534|471599755|FG002|Overall Study|Other Reason|0|||
130992359|NCT00612534|471599756|FG003|Overall Study|Other Reason|0|||
130992360|NCT01065350|471599761|FG000|Overall Study|Received incorrect drug allocation|0|||
130992361|NCT01065350|471599762|FG001|Overall Study|Received incorrect drug allocation|1|||
130992362|NCT02234063|471599775|FG000|Overall Study|Lost to Follow-up|235|||
130992363|NCT02234063|471599776|FG001|Overall Study|Lost to Follow-up|42|||
130992364|NCT02234063|471599775|FG000|Overall Study|Withdrawal by Subject|20|||
130992365|NCT02234063|471599776|FG001|Overall Study|Withdrawal by Subject|1|||
130992366|NCT00510458|471599777|FG000|Overall Study|5 year not evaluable/missed|21|||
130992367|NCT00510458|471599777|FG000|Overall Study|Death|1|||
130992368|NCT00510458|471599777|FG000|Overall Study|Terminated|14|||
130992369|NCT00510458|471599777|FG000|Overall Study|Lost to Follow-up|6|||
130992370|NCT00510458|471599777|FG000|Overall Study|Withdrawal by Subject|3|||
130992371|NCT00510458|471599777|FG000|Overall Study|Revision|2|||
130992372|NCT02569710|471599778|FG000|Overall Study|Adverse Event|1|||
130992373|NCT02569710|471599779|FG001|Overall Study|Adverse Event|0|||
130992374|NCT02569710|471599780|FG002|Overall Study|Adverse Event|0|||
130992375|NCT02569710|471599781|FG003|Overall Study|Adverse Event|0|||
130992376|NCT02569710|471599782|FG004|Overall Study|Adverse Event|0|||
130992377|NCT02569710|471599783|FG005|Overall Study|Adverse Event|0|||
130992378|NCT02569710|471599784|FG006|Overall Study|Adverse Event|0|||
130992379|NCT02569710|471599785|FG007|Overall Study|Adverse Event|0|||
130992380|NCT02569710|471599786|FG008|Overall Study|Adverse Event|0|||
130992381|NCT02569710|471599787|FG009|Overall Study|Adverse Event|0|||
130992382|NCT02569710|471599778|FG000|Overall Study|Lost to Follow-up|0|||
130992383|NCT02569710|471599779|FG001|Overall Study|Lost to Follow-up|0|||
130992384|NCT02569710|471599780|FG002|Overall Study|Lost to Follow-up|0|||
130992385|NCT02569710|471599781|FG003|Overall Study|Lost to Follow-up|0|||
130992386|NCT02569710|471599782|FG004|Overall Study|Lost to Follow-up|0|||
130992387|NCT02569710|471599783|FG005|Overall Study|Lost to Follow-up|0|||
130992388|NCT02569710|471599784|FG006|Overall Study|Lost to Follow-up|1|||
130992389|NCT02569710|471599785|FG007|Overall Study|Lost to Follow-up|0|||
130992390|NCT02569710|471599786|FG008|Overall Study|Lost to Follow-up|1|||
130992391|NCT02569710|471599787|FG009|Overall Study|Lost to Follow-up|0|||
131215036|NCT03533608|472412046|FG000|Overall Study|Withdrawal by Subject|3|||
131215037|NCT03533608|472412046|FG000|Overall Study|Physician Decision|2|||
131215038|NCT03286426|472412047|FG000|Overall Study|Physician Decision|3|||
131215039|NCT03514121|472412048|FG000|Overall Study|Withdrawal by Subject|0|||
131215040|NCT03514121|472412049|FG001|Overall Study|Withdrawal by Subject|0|||
131215041|NCT03514121|472412050|FG002|Overall Study|Withdrawal by Subject|0|||
131215042|NCT03514121|472412051|FG003|Overall Study|Withdrawal by Subject|0|||
131215043|NCT03514121|472412052|FG004|Overall Study|Withdrawal by Subject|1|||
131215044|NCT03514121|472412053|FG005|Overall Study|Withdrawal by Subject|2|||
131215045|NCT03514121|472412054|FG006|Overall Study|Withdrawal by Subject|1|||
131215046|NCT03514121|472412055|FG007|Overall Study|Withdrawal by Subject|1|||
131215047|NCT03514121|472412056|FG008|Overall Study|Withdrawal by Subject|7|||
130992392|NCT02569710|471599778|FG000|Overall Study|Virologic failure|0|||
130992393|NCT02569710|471599779|FG001|Overall Study|Virologic failure|0|||
130992394|NCT02569710|471599780|FG002|Overall Study|Virologic failure|0|||
130992395|NCT02569710|471599781|FG003|Overall Study|Virologic failure|0|||
130992396|NCT02569710|471599782|FG004|Overall Study|Virologic failure|1|||
130992397|NCT02569710|471599783|FG005|Overall Study|Virologic failure|0|||
130992398|NCT02569710|471599784|FG006|Overall Study|Virologic failure|1|||
130992399|NCT02569710|471599785|FG007|Overall Study|Virologic failure|0|||
130992400|NCT02569710|471599786|FG008|Overall Study|Virologic failure|0|||
130992401|NCT02569710|471599787|FG009|Overall Study|Virologic failure|0|||
130992402|NCT02569710|471599778|FG000|Overall Study|Withdrawal by Subject|0|||
130992403|NCT02569710|471599779|FG001|Overall Study|Withdrawal by Subject|0|||
130992404|NCT02569710|471599780|FG002|Overall Study|Withdrawal by Subject|0|||
130992405|NCT02569710|471599781|FG003|Overall Study|Withdrawal by Subject|0|||
130992406|NCT02569710|471599782|FG004|Overall Study|Withdrawal by Subject|0|||
130992407|NCT02569710|471599783|FG005|Overall Study|Withdrawal by Subject|1|||
130992408|NCT02569710|471599784|FG006|Overall Study|Withdrawal by Subject|0|||
130992409|NCT02569710|471599785|FG007|Overall Study|Withdrawal by Subject|0|||
130992410|NCT02569710|471599786|FG008|Overall Study|Withdrawal by Subject|0|||
130992411|NCT02569710|471599787|FG009|Overall Study|Withdrawal by Subject|0|||
130992412|NCT02716038|471599788|FG000|Overall Study|Not evaluable|1|||
130992413|NCT02716038|471599788|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
130992414|NCT02716038|471599788|FG000|Overall Study|Unresectable|3|||
130992415|NCT03573908|471599789|FG000|Treatment Period|Adverse Event|4|||
130992416|NCT03573908|471599790|FG001|Treatment Period|Adverse Event|9|||
130992417|NCT03573908|471599791|FG002|Treatment Period|Adverse Event|0|||
130992418|NCT03573908|471599792|FG003|Treatment Period|Adverse Event|0|||
130992419|NCT03573908|471599793|FG004|Treatment Period|Adverse Event|0|||
130992420|NCT03573908|471599789|FG000|Treatment Period|Protocol Violation|1|||
130992421|NCT03573908|471599790|FG001|Treatment Period|Protocol Violation|0|||
130992422|NCT03573908|471599791|FG002|Treatment Period|Protocol Violation|0|||
130992423|NCT03573908|471599792|FG003|Treatment Period|Protocol Violation|0|||
130992424|NCT03573908|471599793|FG004|Treatment Period|Protocol Violation|0|||
130992425|NCT03573908|471599789|FG000|Treatment Period|Withdrawal by Subject|7|||
130992426|NCT03573908|471599790|FG001|Treatment Period|Withdrawal by Subject|5|||
130992427|NCT03573908|471599791|FG002|Treatment Period|Withdrawal by Subject|0|||
130992428|NCT03573908|471599792|FG003|Treatment Period|Withdrawal by Subject|0|||
130992429|NCT03573908|471599793|FG004|Treatment Period|Withdrawal by Subject|0|||
130992430|NCT03573908|471599789|FG000|Treatment Period|Lost to Follow-up|7|||
130992431|NCT03573908|471599790|FG001|Treatment Period|Lost to Follow-up|6|||
130992432|NCT03573908|471599791|FG002|Treatment Period|Lost to Follow-up|0|||
130992433|NCT03573908|471599792|FG003|Treatment Period|Lost to Follow-up|0|||
130992434|NCT03573908|471599793|FG004|Treatment Period|Lost to Follow-up|0|||
131215048|NCT03514121|472412057|FG009|Overall Study|Withdrawal by Subject|2|||
130992435|NCT03573908|471599789|FG000|Treatment Period|Pregnancy|1|||
131215049|NCT03514121|472412048|FG000|Overall Study|Death|0|||
131215050|NCT03514121|472412049|FG001|Overall Study|Death|0|||
131215051|NCT03514121|472412050|FG002|Overall Study|Death|0|||
131215052|NCT03514121|472412051|FG003|Overall Study|Death|0|||
130992436|NCT03573908|471599790|FG001|Treatment Period|Pregnancy|0|||
130992437|NCT03573908|471599791|FG002|Treatment Period|Pregnancy|0|||
130992438|NCT03573908|471599792|FG003|Treatment Period|Pregnancy|0|||
130992439|NCT03573908|471599793|FG004|Treatment Period|Pregnancy|0|||
130992440|NCT03573908|471599789|FG000|Treatment Period|Other, Not Specified|4|||
130992441|NCT03573908|471599790|FG001|Treatment Period|Other, Not Specified|6|||
130992442|NCT03573908|471599791|FG002|Treatment Period|Other, Not Specified|0|||
130992443|NCT03573908|471599792|FG003|Treatment Period|Other, Not Specified|0|||
130992444|NCT03573908|471599793|FG004|Treatment Period|Other, Not Specified|0|||
130992445|NCT03573908|471599789|FG000|Randomized Withdrawal Period|Adverse Event|0|||
130992446|NCT03573908|471599790|FG001|Randomized Withdrawal Period|Adverse Event|0|||
131215053|NCT03514121|472412052|FG004|Overall Study|Death|0|||
131215054|NCT03514121|472412053|FG005|Overall Study|Death|3|||
130882415|NCT02531802|471205491|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
130882416|NCT02531802|471205492|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
130882417|NCT02531802|471205493|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
130882418|NCT02531802|471205494|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
130882419|NCT02531802|471205495|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
130882420|NCT02531802|471205496|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
130882421|NCT02531802|471205497|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
130882422|NCT02531802|471205498|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
130882423|NCT02531802|471205499|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
130882424|NCT03345784|471205502|FG000|Overall Study|Withdrawal by Subject|2|||
130882425|NCT03345784|471205503|FG001|Overall Study|Withdrawal by Subject|1|||
130882426|NCT04798196|471205504|FG000|Overall Study|Lost to Follow-up|3|||
130882427|NCT04798196|471205505|FG001|Overall Study|Lost to Follow-up|1|||
130882428|NCT04798196|471205506|FG002|Overall Study|Lost to Follow-up|3|||
130882429|NCT00728689|471205515|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
130882430|NCT00728689|471205516|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
130882431|NCT00929695|471205517|FG000|Overall Study|Death|2|||
130882432|NCT00929695|471205518|FG001|Overall Study|Death|1|||
130882433|NCT00929695|471205517|FG000|Overall Study|Withdrawal by Subject|0|||
130882434|NCT00929695|471205518|FG001|Overall Study|Withdrawal by Subject|2|||
130882435|NCT00929695|471205517|FG000|Overall Study|discharge home|4|||
130882436|NCT00929695|471205518|FG001|Overall Study|discharge home|3|||
130882437|NCT00929695|471205517|FG000|Overall Study|incorrect stratification|2|||
130882438|NCT00929695|471205518|FG001|Overall Study|incorrect stratification|0|||
130882439|NCT03216226|471205519|FG000|Overall Study|Adverse Event|3|||
130882440|NCT03216226|471205520|FG001|Overall Study|Adverse Event|0|||
130882441|NCT03216226|471205519|FG000|Overall Study|Protocol Violation|1|||
130882442|NCT03216226|471205520|FG001|Overall Study|Protocol Violation|3|||
130882443|NCT03216226|471205519|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
130882444|NCT03216226|471205520|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
130882445|NCT03216226|471205519|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
130882446|NCT03216226|471205520|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
130882447|NCT03216226|471205519|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
130882448|NCT03216226|471205520|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
130882449|NCT00887809|471205521|FG000|Overall Study|Patient Not Treated|3|||
130882450|NCT00887809|471205522|FG001|Overall Study|Patient Not Treated|0|||
130882451|NCT00887809|471205521|FG000|Overall Study|Death|1|||
130882452|NCT00887809|471205522|FG001|Overall Study|Death|0|||
130882453|NCT01352715|471205525|FG000|Overall Study|Death|3|||
130882454|NCT01352715|471205526|FG001|Overall Study|Death|3|||
130882455|NCT01352715|471205525|FG000|Overall Study|Lost to Follow-up|5|||
130882456|NCT01352715|471205526|FG001|Overall Study|Lost to Follow-up|7|||
130882457|NCT01352715|471205525|FG000|Overall Study|Withdrawal by Subject|4|||
130882458|NCT01352715|471205526|FG001|Overall Study|Withdrawal by Subject|8|||
130882459|NCT01352715|471205525|FG000|Overall Study|site closure|16|||
130882460|NCT01352715|471205526|FG001|Overall Study|site closure|15|||
130882461|NCT01352715|471205525|FG000|Overall Study|no final visit in closeout period|15|||
130882462|NCT01352715|471205526|FG001|Overall Study|no final visit in closeout period|12|||
130882463|NCT01352715|471205525|FG000|Overall Study|major ineligibility|2|||
130882464|NCT01352715|471205526|FG001|Overall Study|major ineligibility|1|||
130882465|NCT04596267|471205527|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
130882466|NCT04596267|471205528|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
130882467|NCT04596267|471205527|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
130882468|NCT04596267|471205528|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
130882469|NCT00071058|471205529|FG000|Overall Study|brain tumor-removed from study|1|||
130882470|NCT04109547|471205530|FG000|Overall Study|Withdrawal by Subject|3|||
130882471|NCT04109547|471205531|FG001|Overall Study|Withdrawal by Subject|2|||
130882472|NCT04109547|471205532|FG002|Overall Study|Withdrawal by Subject|6|||
130882473|NCT04109547|471205533|FG003|Overall Study|Withdrawal by Subject|6|||
130882474|NCT04109547|471205530|FG000|Overall Study|Lost to Follow-up|0|||
130882475|NCT04109547|471205531|FG001|Overall Study|Lost to Follow-up|0|||
130882476|NCT04109547|471205532|FG002|Overall Study|Lost to Follow-up|0|||
130882477|NCT04109547|471205533|FG003|Overall Study|Lost to Follow-up|1|||
130882478|NCT04109547|471205530|FG000|Overall Study|Physician Decision|1|||
130882479|NCT04109547|471205531|FG001|Overall Study|Physician Decision|2|||
130882480|NCT04109547|471205532|FG002|Overall Study|Physician Decision|0|||
131100646|NCT01871805|471998061|FG002|Phase II|Death|0|||
130882481|NCT04109547|471205533|FG003|Overall Study|Physician Decision|0|||
130882482|NCT01550003|471205534|FG000|Overall Study|Adverse Event|0|||
130882483|NCT01550003|471205535|FG001|Overall Study|Adverse Event|9|||
130882484|NCT01550003|471205536|FG002|Overall Study|Adverse Event|15|||
130882485|NCT01550003|471205534|FG000|Overall Study|Lack of Efficacy|4|||
130882486|NCT01550003|471205535|FG001|Overall Study|Lack of Efficacy|11|||
130882487|NCT01550003|471205536|FG002|Overall Study|Lack of Efficacy|15|||
130992447|NCT03573908|471599791|FG002|Randomized Withdrawal Period|Adverse Event|3|||
130992448|NCT03573908|471599792|FG003|Randomized Withdrawal Period|Adverse Event|0|||
130992449|NCT03573908|471599793|FG004|Randomized Withdrawal Period|Adverse Event|0|||
130992450|NCT03573908|471599789|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130992451|NCT03573908|471599790|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130992452|NCT03573908|471599791|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130992453|NCT03573908|471599792|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130992454|NCT03573908|471599793|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
130992455|NCT03573908|471599789|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
130992456|NCT03573908|471599790|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
130992457|NCT03573908|471599791|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
130992458|NCT03573908|471599792|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
130992459|NCT03573908|471599793|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
130992460|NCT03573908|471599789|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
130992461|NCT03573908|471599790|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
130992462|NCT03573908|471599791|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
130992463|NCT03573908|471599792|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
130992464|NCT03573908|471599793|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
130992465|NCT04006925|471599794|FG000|Overall Study|Side effects|2|||
130992466|NCT04006925|471599795|FG001|Overall Study|Side effects|0|||
130992467|NCT02669095|471599800|FG000|Overall Study|Adverse Event|1|||
130992468|NCT02669095|471599801|FG001|Overall Study|Adverse Event|0|||
130992469|NCT02669095|471599800|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
130992470|NCT02669095|471599801|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
130992471|NCT02669095|471599800|FG000|Overall Study|Torn Lens|0|||
130992472|NCT02669095|471599801|FG001|Overall Study|Torn Lens|1|||
130992473|NCT02669095|471599800|FG000|Overall Study|Visit 5 assessments not completed|0|||
130992474|NCT02669095|471599801|FG001|Overall Study|Visit 5 assessments not completed|1|||
130992475|NCT01555164|471599803|FG000|Overall Study|Adverse Event|5|||
130992476|NCT01555164|471599804|FG001|Overall Study|Adverse Event|7|||
130992477|NCT01555164|471599803|FG000|Overall Study|Hyperglycemia|0|||
130992478|NCT01555164|471599804|FG001|Overall Study|Hyperglycemia|1|||
130992479|NCT01555164|471599803|FG000|Overall Study|Investigator's Discretion|2|||
130992480|NCT01555164|471599804|FG001|Overall Study|Investigator's Discretion|2|||
130992481|NCT01555164|471599803|FG000|Overall Study|Lost to Follow-up|4|||
131215055|NCT03514121|472412054|FG006|Overall Study|Death|2|||
131215056|NCT03514121|472412055|FG007|Overall Study|Death|1|||
131215057|NCT03514121|472412056|FG008|Overall Study|Death|26|||
131215058|NCT03514121|472412057|FG009|Overall Study|Death|3|||
131215059|NCT03514121|472412048|FG000|Overall Study|Lost to Follow-up|0|||
131215060|NCT03514121|472412049|FG001|Overall Study|Lost to Follow-up|0|||
131215061|NCT03514121|472412050|FG002|Overall Study|Lost to Follow-up|1|||
131215062|NCT03514121|472412051|FG003|Overall Study|Lost to Follow-up|0|||
131215063|NCT03514121|472412052|FG004|Overall Study|Lost to Follow-up|0|||
131215064|NCT03514121|472412053|FG005|Overall Study|Lost to Follow-up|0|||
131215065|NCT03514121|472412054|FG006|Overall Study|Lost to Follow-up|0|||
131215066|NCT03514121|472412055|FG007|Overall Study|Lost to Follow-up|0|||
131215067|NCT03514121|472412056|FG008|Overall Study|Lost to Follow-up|1|||
131215068|NCT03514121|472412057|FG009|Overall Study|Lost to Follow-up|0|||
131215069|NCT03514121|472412048|FG000|Overall Study|Adverse Event|0|||
131215070|NCT03514121|472412049|FG001|Overall Study|Adverse Event|0|||
131215071|NCT03514121|472412050|FG002|Overall Study|Adverse Event|0|||
131215072|NCT03514121|472412051|FG003|Overall Study|Adverse Event|0|||
131215073|NCT03514121|472412052|FG004|Overall Study|Adverse Event|0|||
131215074|NCT03514121|472412053|FG005|Overall Study|Adverse Event|0|||
131215075|NCT03514121|472412054|FG006|Overall Study|Adverse Event|1|||
131215076|NCT03514121|472412055|FG007|Overall Study|Adverse Event|0|||
131215077|NCT03514121|472412056|FG008|Overall Study|Adverse Event|0|||
131215078|NCT03514121|472412057|FG009|Overall Study|Adverse Event|0|||
131215079|NCT03514121|472412048|FG000|Overall Study|Other|0|||
131215080|NCT03514121|472412049|FG001|Overall Study|Other|1|||
131215081|NCT03514121|472412050|FG002|Overall Study|Other|1|||
131215082|NCT03514121|472412051|FG003|Overall Study|Other|0|||
131215083|NCT03514121|472412052|FG004|Overall Study|Other|1|||
131215084|NCT03514121|472412053|FG005|Overall Study|Other|2|||
130992482|NCT01555164|471599804|FG001|Overall Study|Lost to Follow-up|3|||
130992483|NCT01555164|471599803|FG000|Overall Study|Protocol Violation|9|||
130992484|NCT01555164|471599804|FG001|Overall Study|Protocol Violation|5|||
130992485|NCT01555164|471599803|FG000|Overall Study|Subject Non-compliance|14|||
130992486|NCT01555164|471599804|FG001|Overall Study|Subject Non-compliance|6|||
130992487|NCT01555164|471599803|FG000|Overall Study|Subject Withdrew Consent|6|||
130992488|NCT01555164|471599804|FG001|Overall Study|Subject Withdrew Consent|11|||
131215085|NCT03514121|472412054|FG006|Overall Study|Other|3|||
131215086|NCT03514121|472412055|FG007|Overall Study|Other|2|||
131215087|NCT03514121|472412056|FG008|Overall Study|Other|7|||
131215088|NCT03514121|472412057|FG009|Overall Study|Other|3|||
131215089|NCT03514121|472412048|FG000|Overall Study|Study termination by Sponsor|0|||
131215090|NCT03514121|472412049|FG001|Overall Study|Study termination by Sponsor|0|||
131215091|NCT03514121|472412050|FG002|Overall Study|Study termination by Sponsor|0|||
131215092|NCT03514121|472412051|FG003|Overall Study|Study termination by Sponsor|0|||
131215093|NCT03514121|472412052|FG004|Overall Study|Study termination by Sponsor|0|||
131215094|NCT03514121|472412053|FG005|Overall Study|Study termination by Sponsor|0|||
131215095|NCT03514121|472412054|FG006|Overall Study|Study termination by Sponsor|0|||
131215096|NCT03514121|472412055|FG007|Overall Study|Study termination by Sponsor|0|||
131215097|NCT03514121|472412056|FG008|Overall Study|Study termination by Sponsor|11|||
131215098|NCT03514121|472412057|FG009|Overall Study|Study termination by Sponsor|3|||
131215099|NCT03514121|472412048|FG000|Overall Study|Investigator decision|0|||
131215100|NCT03514121|472412049|FG001|Overall Study|Investigator decision|0|||
131215101|NCT03514121|472412050|FG002|Overall Study|Investigator decision|0|||
131215102|NCT03514121|472412051|FG003|Overall Study|Investigator decision|0|||
131215103|NCT03514121|472412052|FG004|Overall Study|Investigator decision|0|||
131215104|NCT03514121|472412053|FG005|Overall Study|Investigator decision|0|||
131215105|NCT03514121|472412054|FG006|Overall Study|Investigator decision|0|||
131215106|NCT03514121|472412055|FG007|Overall Study|Investigator decision|0|||
131215107|NCT03514121|472412056|FG008|Overall Study|Investigator decision|1|||
131215108|NCT03514121|472412057|FG009|Overall Study|Investigator decision|0|||
131215109|NCT05553600|472412058|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
131215110|NCT05553600|472412059|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
131215111|NCT05553600|472412060|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
131215112|NCT05553600|472412061|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
131215113|NCT05553600|472412058|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
131215114|NCT05553600|472412059|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
131215115|NCT05553600|472412060|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
131215116|NCT05553600|472412061|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
131215117|NCT05553600|472412058|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
131215118|NCT05553600|472412059|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
131215119|NCT05553600|472412060|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
131215120|NCT05553600|472412061|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
131215121|NCT05553600|472412058|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
131215122|NCT05553600|472412059|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
131215123|NCT05553600|472412060|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
131215124|NCT05553600|472412061|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
131215125|NCT05553600|472412058|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
131215126|NCT05553600|472412059|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
130882488|NCT01550003|471205534|FG000|Overall Study|Protocol Violation|0|||
130882489|NCT01550003|471205535|FG001|Overall Study|Protocol Violation|3|||
130882490|NCT01550003|471205536|FG002|Overall Study|Protocol Violation|2|||
130882491|NCT01550003|471205534|FG000|Overall Study|Lost to Follow-up|1|||
130882492|NCT01550003|471205535|FG001|Overall Study|Lost to Follow-up|4|||
130882493|NCT01550003|471205536|FG002|Overall Study|Lost to Follow-up|8|||
130882494|NCT01550003|471205534|FG000|Overall Study|Consent withdrawn|2|||
130882495|NCT01550003|471205535|FG001|Overall Study|Consent withdrawn|11|||
130882496|NCT01550003|471205536|FG002|Overall Study|Consent withdrawn|23|||
130882497|NCT01550003|471205534|FG000|Overall Study|Missing|1|||
130882498|NCT01550003|471205535|FG001|Overall Study|Missing|0|||
130882499|NCT01550003|471205536|FG002|Overall Study|Missing|2|||
130882500|NCT01550003|471205534|FG000|Overall Study|Study closure as announced by sponsor|7|||
130882501|NCT01550003|471205535|FG001|Overall Study|Study closure as announced by sponsor|6|||
130882502|NCT01550003|471205536|FG002|Overall Study|Study closure as announced by sponsor|24|||
130882503|NCT01550003|471205534|FG000|Overall Study|Protocol Noncompliance|1|||
130882504|NCT01550003|471205535|FG001|Overall Study|Protocol Noncompliance|0|||
130882505|NCT01550003|471205536|FG002|Overall Study|Protocol Noncompliance|0|||
130882506|NCT01550003|471205534|FG000|Overall Study|Study closure|0|||
130882507|NCT01550003|471205535|FG001|Overall Study|Study closure|1|||
130882508|NCT01550003|471205536|FG002|Overall Study|Study closure|1|||
130882509|NCT01550003|471205534|FG000|Overall Study|Patient reached adulthood|0|||
130882510|NCT01550003|471205535|FG001|Overall Study|Patient reached adulthood|1|||
130882511|NCT01550003|471205536|FG002|Overall Study|Patient reached adulthood|0|||
130882512|NCT01550003|471205534|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
130882513|NCT01550003|471205535|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
130882514|NCT01550003|471205536|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
130882515|NCT01550003|471205534|FG000|Overall Study|Sponsor's order|0|||
130882516|NCT01550003|471205535|FG001|Overall Study|Sponsor's order|3|||
130882517|NCT01550003|471205536|FG002|Overall Study|Sponsor's order|3|||
130882518|NCT01550003|471205534|FG000|Overall Study|Sponsor's decision|1|||
130882519|NCT01550003|471205535|FG001|Overall Study|Sponsor's decision|5|||
130882520|NCT01550003|471205536|FG002|Overall Study|Sponsor's decision|4|||
130882521|NCT01550003|471205534|FG000|Overall Study|Subject mother passed away|0|||
130882522|NCT01550003|471205535|FG001|Overall Study|Subject mother passed away|1|||
130992489|NCT00926003|471599805|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
130992490|NCT00926003|471599806|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
130992491|NCT00926003|471599807|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
130992492|NCT00926003|471599805|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
130992493|NCT00926003|471599806|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
130992494|NCT00926003|471599807|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
130992495|NCT01709305|471599812|FG000|Phase 1|Clinical Adverse Event|80|||
130992496|NCT01709305|471599813|FG001|Phase 1|Clinical Adverse Event|0|||
130992497|NCT01709305|471599814|FG002|Phase 1|Clinical Adverse Event|0|||
130992498|NCT01709305|471599815|FG003|Phase 1|Clinical Adverse Event|0|||
130992499|NCT01709305|471599816|FG004|Phase 1|Clinical Adverse Event|0|||
130992500|NCT01709305|471599812|FG000|Phase 1|Death|2|||
130992501|NCT01709305|471599813|FG001|Phase 1|Death|0|||
130992502|NCT01709305|471599814|FG002|Phase 1|Death|0|||
130992503|NCT01709305|471599815|FG003|Phase 1|Death|0|||
130992504|NCT01709305|471599816|FG004|Phase 1|Death|0|||
130992505|NCT01709305|471599812|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
130992506|NCT01709305|471599813|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
130992507|NCT01709305|471599814|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
130992508|NCT01709305|471599815|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
130992509|NCT01709305|471599816|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
130992510|NCT01709305|471599812|FG000|Phase 1|Laboratory Adverse Event|16|||
130992511|NCT01709305|471599813|FG001|Phase 1|Laboratory Adverse Event|0|||
130992512|NCT01709305|471599814|FG002|Phase 1|Laboratory Adverse Event|0|||
130992513|NCT01709305|471599815|FG003|Phase 1|Laboratory Adverse Event|0|||
130992514|NCT01709305|471599816|FG004|Phase 1|Laboratory Adverse Event|0|||
130992515|NCT01709305|471599812|FG000|Phase 1|Lost to Follow-up|147|||
130992516|NCT01709305|471599813|FG001|Phase 1|Lost to Follow-up|0|||
130992517|NCT01709305|471599814|FG002|Phase 1|Lost to Follow-up|0|||
130992518|NCT01709305|471599815|FG003|Phase 1|Lost to Follow-up|0|||
130992519|NCT01709305|471599816|FG004|Phase 1|Lost to Follow-up|0|||
130992520|NCT01709305|471599812|FG000|Phase 1|Travel, moving, etc.|30|||
130992521|NCT01709305|471599813|FG001|Phase 1|Travel, moving, etc.|0|||
130992522|NCT01709305|471599814|FG002|Phase 1|Travel, moving, etc.|0|||
130992523|NCT01709305|471599815|FG003|Phase 1|Travel, moving, etc.|0|||
130992524|NCT01709305|471599816|FG004|Phase 1|Travel, moving, etc.|0|||
130992525|NCT01709305|471599812|FG000|Phase 1|Physician Decision|13|||
130992526|NCT01709305|471599813|FG001|Phase 1|Physician Decision|0|||
130992527|NCT01709305|471599814|FG002|Phase 1|Physician Decision|0|||
130992528|NCT01709305|471599815|FG003|Phase 1|Physician Decision|0|||
130992529|NCT01709305|471599816|FG004|Phase 1|Physician Decision|0|||
130992530|NCT01709305|471599812|FG000|Phase 1|Protocol Violation|118|||
130992531|NCT01709305|471599813|FG001|Phase 1|Protocol Violation|0|||
130992532|NCT01709305|471599814|FG002|Phase 1|Protocol Violation|0|||
130992533|NCT01709305|471599815|FG003|Phase 1|Protocol Violation|0|||
130992534|NCT01709305|471599816|FG004|Phase 1|Protocol Violation|0|||
130992535|NCT01709305|471599812|FG000|Phase 1|Withdrawal by Subject|218|||
130992536|NCT01709305|471599813|FG001|Phase 1|Withdrawal by Subject|0|||
130992537|NCT01709305|471599814|FG002|Phase 1|Withdrawal by Subject|0|||
130992538|NCT01709305|471599815|FG003|Phase 1|Withdrawal by Subject|0|||
130992539|NCT01709305|471599816|FG004|Phase 1|Withdrawal by Subject|0|||
130992540|NCT01709305|471599812|FG000|Phase 2|Clinical Adverse Event|0|||
130992541|NCT01709305|471599813|FG001|Phase 2|Clinical Adverse Event|10|||
130992542|NCT01709305|471599814|FG002|Phase 2|Clinical Adverse Event|10|||
130992543|NCT01709305|471599815|FG003|Phase 2|Clinical Adverse Event|6|||
130992544|NCT01709305|471599816|FG004|Phase 2|Clinical Adverse Event|11|||
130992545|NCT01709305|471599812|FG000|Phase 2|Death|0|||
130992546|NCT01709305|471599813|FG001|Phase 2|Death|0|||
130992547|NCT01709305|471599814|FG002|Phase 2|Death|1|||
130992548|NCT01709305|471599815|FG003|Phase 2|Death|0|||
130992549|NCT01709305|471599816|FG004|Phase 2|Death|0|||
130992550|NCT01709305|471599812|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
130992551|NCT01709305|471599813|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
130992552|NCT01709305|471599814|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
130992553|NCT01709305|471599815|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
130992554|NCT01709305|471599816|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
130992555|NCT01709305|471599812|FG000|Phase 2|Laboratory Adverse Event|0|||
130992556|NCT01709305|471599813|FG001|Phase 2|Laboratory Adverse Event|1|||
130992557|NCT01709305|471599814|FG002|Phase 2|Laboratory Adverse Event|0|||
130992558|NCT01709305|471599815|FG003|Phase 2|Laboratory Adverse Event|1|||
130992559|NCT01709305|471599816|FG004|Phase 2|Laboratory Adverse Event|1|||
130992560|NCT01709305|471599812|FG000|Phase 2|Lost to Follow-up|0|||
130992561|NCT01709305|471599813|FG001|Phase 2|Lost to Follow-up|10|||
130992562|NCT01709305|471599814|FG002|Phase 2|Lost to Follow-up|6|||
130992563|NCT01709305|471599815|FG003|Phase 2|Lost to Follow-up|9|||
130992564|NCT01709305|471599816|FG004|Phase 2|Lost to Follow-up|5|||
130992565|NCT01709305|471599812|FG000|Phase 2|Travel, moving, etc.|0|||
130992566|NCT01709305|471599813|FG001|Phase 2|Travel, moving, etc.|2|||
130992567|NCT01709305|471599814|FG002|Phase 2|Travel, moving, etc.|3|||
130992568|NCT01709305|471599815|FG003|Phase 2|Travel, moving, etc.|3|||
130992569|NCT01709305|471599816|FG004|Phase 2|Travel, moving, etc.|5|||
130992570|NCT01709305|471599812|FG000|Phase 2|Physician Decision|0|||
130992571|NCT01709305|471599813|FG001|Phase 2|Physician Decision|2|||
130992572|NCT01709305|471599814|FG002|Phase 2|Physician Decision|0|||
130992573|NCT01709305|471599815|FG003|Phase 2|Physician Decision|1|||
130992574|NCT01709305|471599816|FG004|Phase 2|Physician Decision|2|||
131215127|NCT05553600|472412060|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
130882523|NCT01550003|471205536|FG002|Overall Study|Subject mother passed away|0|||
130882524|NCT01550003|471205534|FG000|Overall Study|Discontinuation|0|||
130882525|NCT01550003|471205535|FG001|Overall Study|Discontinuation|1|||
130882526|NCT01550003|471205536|FG002|Overall Study|Discontinuation|0|||
130882527|NCT01550003|471205534|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
130882528|NCT01550003|471205535|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
130882529|NCT01550003|471205536|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
130882530|NCT01550003|471205534|FG000|Overall Study|Site closure|0|||
130882531|NCT01550003|471205535|FG001|Overall Study|Site closure|2|||
130882532|NCT01550003|471205536|FG002|Overall Study|Site closure|0|||
130882533|NCT01550003|471205534|FG000|Overall Study|Pregnancy|0|||
130882534|NCT01550003|471205535|FG001|Overall Study|Pregnancy|1|||
130882535|NCT01550003|471205536|FG002|Overall Study|Pregnancy|0|||
130882536|NCT01550003|471205534|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
130882537|NCT01550003|471205535|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
130882538|NCT01550003|471205536|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
130882539|NCT01550003|471205534|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
130882540|NCT01550003|471205535|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
130882541|NCT01550003|471205536|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
130882542|NCT01550003|471205534|FG000|Overall Study|Switching to adult rheumatologist|0|||
130882543|NCT01550003|471205535|FG001|Overall Study|Switching to adult rheumatologist|0|||
130882544|NCT01550003|471205536|FG002|Overall Study|Switching to adult rheumatologist|1|||
130882545|NCT01550003|471205534|FG000|Overall Study|Patient transition to adult care|0|||
130882546|NCT01550003|471205535|FG001|Overall Study|Patient transition to adult care|0|||
130882547|NCT01550003|471205536|FG002|Overall Study|Patient transition to adult care|1|||
130882548|NCT01550003|471205534|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
130882549|NCT01550003|471205535|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
130882550|NCT01550003|471205536|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
130882551|NCT01550003|471205534|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
130882552|NCT01550003|471205535|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
130882553|NCT01550003|471205536|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
130882554|NCT01550003|471205534|FG000|Overall Study|Per Sponsor request|1|||
130882555|NCT01550003|471205535|FG001|Overall Study|Per Sponsor request|0|||
130882556|NCT01550003|471205536|FG002|Overall Study|Per Sponsor request|1|||
130882557|NCT01550003|471205534|FG000|Overall Study|Patient not compliance|0|||
130882558|NCT01550003|471205535|FG001|Overall Study|Patient not compliance|0|||
130882559|NCT01550003|471205536|FG002|Overall Study|Patient not compliance|1|||
130882560|NCT01550003|471205534|FG000|Overall Study|Non-compliance|0|||
130882561|NCT01550003|471205535|FG001|Overall Study|Non-compliance|0|||
130882562|NCT01550003|471205536|FG002|Overall Study|Non-compliance|1|||
130882563|NCT01550003|471205534|FG000|Overall Study|Study closed|0|||
130882564|NCT01550003|471205535|FG001|Overall Study|Study closed|1|||
130882565|NCT01550003|471205536|FG002|Overall Study|Study closed|0|||
130882566|NCT01550003|471205534|FG000|Overall Study|Transitioned to adult rheumatology|0|||
130882567|NCT01550003|471205535|FG001|Overall Study|Transitioned to adult rheumatology|0|||
130882568|NCT01550003|471205536|FG002|Overall Study|Transitioned to adult rheumatology|1|||
130882569|NCT01656408|471205537|FG000|Overall Study|Adverse Event|0|||
130882570|NCT01656408|471205538|FG001|Overall Study|Adverse Event|0|||
130882571|NCT01656408|471205539|FG002|Overall Study|Adverse Event|1|||
130882572|NCT01656408|471205540|FG003|Overall Study|Adverse Event|0|||
130882573|NCT01656408|471205541|FG004|Overall Study|Adverse Event|0|||
130882574|NCT01656408|471205542|FG005|Overall Study|Adverse Event|1|||
130882575|NCT01656408|471205543|FG006|Overall Study|Adverse Event|1|||
130882576|NCT01656408|471205544|FG007|Overall Study|Adverse Event|0|||
130882577|NCT01656408|471205545|FG008|Overall Study|Adverse Event|1|||
130882578|NCT01656408|471205546|FG009|Overall Study|Adverse Event|0|||
130882579|NCT01656408|471205537|FG000|Overall Study|Physician Decision|1|||
130882580|NCT01656408|471205538|FG001|Overall Study|Physician Decision|0|||
130882581|NCT01656408|471205539|FG002|Overall Study|Physician Decision|1|||
130882582|NCT01656408|471205540|FG003|Overall Study|Physician Decision|0|||
130882583|NCT01656408|471205541|FG004|Overall Study|Physician Decision|1|||
130882584|NCT01656408|471205542|FG005|Overall Study|Physician Decision|1|||
130882585|NCT01656408|471205543|FG006|Overall Study|Physician Decision|0|||
130882586|NCT01656408|471205544|FG007|Overall Study|Physician Decision|1|||
130882587|NCT01656408|471205545|FG008|Overall Study|Physician Decision|1|||
130882588|NCT01656408|471205546|FG009|Overall Study|Physician Decision|3|||
130882589|NCT00871975|471205547|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
130992575|NCT01709305|471599812|FG000|Phase 2|Protocol Violation|0|||
130992576|NCT01709305|471599813|FG001|Phase 2|Protocol Violation|19|||
130992577|NCT01709305|471599814|FG002|Phase 2|Protocol Violation|19|||
130992578|NCT01709305|471599815|FG003|Phase 2|Protocol Violation|13|||
130992579|NCT01709305|471599816|FG004|Phase 2|Protocol Violation|9|||
130992580|NCT01709305|471599812|FG000|Phase 2|Withdrawal by Subject|0|||
130992581|NCT01709305|471599813|FG001|Phase 2|Withdrawal by Subject|8|||
130992582|NCT01709305|471599814|FG002|Phase 2|Withdrawal by Subject|6|||
130992583|NCT01709305|471599815|FG003|Phase 2|Withdrawal by Subject|15|||
131215128|NCT05553600|472412061|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
131215129|NCT05553600|472412058|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
131215130|NCT05553600|472412059|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
131215131|NCT05553600|472412060|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
131215132|NCT05553600|472412061|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
131215133|NCT05553600|472412058|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
131215134|NCT05553600|472412059|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
131215135|NCT05553600|472412060|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
131215136|NCT05553600|472412061|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
131215137|NCT05553600|472412058|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
131215138|NCT05553600|472412059|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
131215139|NCT05553600|472412060|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
131215140|NCT05553600|472412061|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
131215141|NCT05553600|472412058|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
131215142|NCT05553600|472412059|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
131215143|NCT05553600|472412060|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
131215144|NCT05553600|472412061|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
131215145|NCT05553600|472412058|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
131215146|NCT05553600|472412059|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
131215147|NCT05553600|472412060|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
131215148|NCT05553600|472412061|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
131215149|NCT05553600|472412058|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
131215150|NCT05553600|472412059|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
131215151|NCT05553600|472412060|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
131215152|NCT05553600|472412061|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
131215153|NCT05553600|472412058|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
131215154|NCT05553600|472412059|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
131215155|NCT05553600|472412060|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
131215156|NCT05553600|472412061|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
131215157|NCT04930536|472412062|FG000|Overall Study|Adverse Event|1|||
131215158|NCT04930536|472412063|FG001|Overall Study|Adverse Event|0|||
131215159|NCT04930536|472412062|FG000|Overall Study|Disease Progression|2|||
131215160|NCT04930536|472412063|FG001|Overall Study|Disease Progression|0|||
131215161|NCT04930536|472412062|FG000|Overall Study|Patient Decision|4|||
131215162|NCT04930536|472412063|FG001|Overall Study|Patient Decision|2|||
131215163|NCT04930536|472412062|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
131215164|NCT04930536|472412063|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
131215165|NCT01432600|472412064|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
131215166|NCT01432600|472412065|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
131215167|NCT01432600|472412066|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
131215168|NCT01605370|472412070|FG000|Overall Study|Adverse Event|1|||
131215169|NCT01605370|472412071|FG001|Overall Study|Adverse Event|0|||
131215170|NCT00578448|472412072|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
131215171|NCT00578448|472412072|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
131215172|NCT00578448|472412072|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
130992584|NCT01709305|471599816|FG004|Phase 2|Withdrawal by Subject|12|||
130992585|NCT00171873|471599821|FG000|Overall Study|Withdrawal by Subject|4|||
130992586|NCT00171873|471599822|FG001|Overall Study|Withdrawal by Subject|2|||
130992587|NCT00171873|471599821|FG000|Overall Study|Adverse Event|5|||
130992588|NCT00171873|471599822|FG001|Overall Study|Adverse Event|0|||
130992589|NCT00171873|471599821|FG000|Overall Study|Switched to Octreotide|0|||
130992590|NCT00171873|471599822|FG001|Overall Study|Switched to Octreotide|1|||
131215173|NCT00578448|472412072|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
131215174|NCT01976104|472412073|FG000|Overall Study|Adverse Event|0|||
131215175|NCT01976104|472412074|FG001|Overall Study|Adverse Event|0|||
131215176|NCT01976104|472412075|FG002|Overall Study|Adverse Event|1|||
130992591|NCT05200936|471599823|FG000|Overall Study|Withdrawal by Subject|2|||
130992592|NCT05200936|471599824|FG001|Overall Study|Withdrawal by Subject|2|||
130992593|NCT05200936|471599823|FG000|Overall Study|Lost to Follow-up|2|||
130992594|NCT05200936|471599824|FG001|Overall Study|Lost to Follow-up|0|||
130992595|NCT05200936|471599823|FG000|Overall Study|Pregnancy|0|||
130992596|NCT05200936|471599824|FG001|Overall Study|Pregnancy|1|||
130992597|NCT00539279|471599825|FG000|Treatment|Withdrawal by Subject|10|||
131215177|NCT01976104|472412076|FG003|Overall Study|Adverse Event|0|||
131215178|NCT01976104|472412073|FG000|Overall Study|Lost to Follow-up|3|||
131215179|NCT01976104|472412074|FG001|Overall Study|Lost to Follow-up|0|||
131215180|NCT01976104|472412075|FG002|Overall Study|Lost to Follow-up|1|||
131215181|NCT01976104|472412076|FG003|Overall Study|Lost to Follow-up|1|||
131215182|NCT01976104|472412073|FG000|Overall Study|Subject Choice|0|||
131215183|NCT01976104|472412074|FG001|Overall Study|Subject Choice|1|||
131215184|NCT01976104|472412075|FG002|Overall Study|Subject Choice|0|||
131215185|NCT01976104|472412076|FG003|Overall Study|Subject Choice|1|||
131215186|NCT01976104|472412073|FG000|Overall Study|Withdrawal by Subject|3|||
131215187|NCT01976104|472412074|FG001|Overall Study|Withdrawal by Subject|0|||
131215188|NCT01976104|472412075|FG002|Overall Study|Withdrawal by Subject|0|||
131215189|NCT01976104|472412076|FG003|Overall Study|Withdrawal by Subject|1|||
131215190|NCT01976104|472412073|FG000|Overall Study|Other|0|||
131215191|NCT01976104|472412074|FG001|Overall Study|Other|1|||
131215192|NCT01976104|472412075|FG002|Overall Study|Other|0|||
131215193|NCT01976104|472412076|FG003|Overall Study|Other|0|||
131215194|NCT01317199|472412077|FG000|Dose-escalation Phase 1|Physician Decision|5|||
131215195|NCT01317199|472412078|FG001|Dose-escalation Phase 1|Physician Decision|0|||
131215196|NCT01317199|472412079|FG002|Dose-escalation Phase 1|Physician Decision|0|||
131215197|NCT01317199|472412080|FG003|Dose-escalation Phase 1|Physician Decision|0|||
131215198|NCT01317199|472412077|FG000|Dose-escalation Phase 1|Disease progression|1|||
131215199|NCT01317199|472412078|FG001|Dose-escalation Phase 1|Disease progression|0|||
131215200|NCT01317199|472412079|FG002|Dose-escalation Phase 1|Disease progression|0|||
131215201|NCT01317199|472412080|FG003|Dose-escalation Phase 1|Disease progression|0|||
131215202|NCT01317199|472412077|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
131215203|NCT01317199|472412078|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
131215204|NCT01317199|472412079|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
131215205|NCT01317199|472412080|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
131215206|NCT01317199|472412077|FG000|Randomized Phase 2|Disease progression|0|||
131215207|NCT01317199|472412078|FG001|Randomized Phase 2|Disease progression|3|||
131215208|NCT01317199|472412079|FG002|Randomized Phase 2|Disease progression|7|||
131215209|NCT01317199|472412080|FG003|Randomized Phase 2|Disease progression|5|||
131215210|NCT01317199|472412077|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
131215211|NCT01317199|472412078|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
131215212|NCT01317199|472412079|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
131215213|NCT01317199|472412080|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
131215214|NCT01317199|472412077|FG000|Randomized Phase 2|Adverse Event|0|||
131215215|NCT01317199|472412078|FG001|Randomized Phase 2|Adverse Event|0|||
131215216|NCT01317199|472412079|FG002|Randomized Phase 2|Adverse Event|0|||
131215217|NCT01317199|472412080|FG003|Randomized Phase 2|Adverse Event|1|||
131215218|NCT01317199|472412077|FG000|Randomized Phase 2|Comorbidities|0|||
131215219|NCT01317199|472412078|FG001|Randomized Phase 2|Comorbidities|2|||
131215220|NCT01317199|472412079|FG002|Randomized Phase 2|Comorbidities|2|||
131215221|NCT01317199|472412080|FG003|Randomized Phase 2|Comorbidities|2|||
131215222|NCT01317199|472412077|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
131215223|NCT01317199|472412078|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
131215224|NCT01317199|472412079|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
131215225|NCT01317199|472412080|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
131215226|NCT01317199|472412077|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
131215227|NCT01317199|472412078|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
131215228|NCT01317199|472412079|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
131215229|NCT01317199|472412080|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
131215230|NCT01317199|472412077|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
131215231|NCT01317199|472412078|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
131215232|NCT01317199|472412079|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
131215233|NCT01317199|472412080|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
131215234|NCT01317199|472412077|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
131215235|NCT01317199|472412078|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
131215236|NCT01317199|472412079|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
131215237|NCT01317199|472412080|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
131215238|NCT01353209|472412081|FG000|Overall Study|Adverse Event|1|||
130882590|NCT00871975|471205547|FG000|Overall Study|Catheters could not be inserted|1|||
130882591|NCT00871975|471205547|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
131215239|NCT01353209|472412082|FG001|Overall Study|Adverse Event|1|||
131215240|NCT03237325|472412083|FG000|Overall Study|Lost to Follow-up|3|||
131215241|NCT03237325|472412084|FG001|Overall Study|Lost to Follow-up|5|||
131215242|NCT03237325|472412083|FG000|Overall Study|Physician Decision|2|||
131215243|NCT03237325|472412084|FG001|Overall Study|Physician Decision|4|||
131215244|NCT03237325|472412083|FG000|Overall Study|Withdrawal by Subject|9|||
131215245|NCT03237325|472412084|FG001|Overall Study|Withdrawal by Subject|12|||
131215246|NCT03237325|472412083|FG000|Overall Study|Noncompliance with Study Procedures|1|||
131215247|NCT03237325|472412084|FG001|Overall Study|Noncompliance with Study Procedures|1|||
130882592|NCT00871975|471205547|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
131215248|NCT03237325|472412083|FG000|Overall Study|Termination by Sponsor|0|||
131215249|NCT03237325|472412084|FG001|Overall Study|Termination by Sponsor|1|||
131215250|NCT03237325|472412083|FG000|Overall Study|Reason other than described|0|||
131215251|NCT03237325|472412084|FG001|Overall Study|Reason other than described|2|||
131215252|NCT02684370|472412086|FG000|Part A|Adverse Event|2|||
131215253|NCT02684370|472412087|FG001|Part A|Adverse Event|0|||
131215254|NCT02684370|472412088|FG002|Part A|Adverse Event|1|||
131215255|NCT02684370|472412089|FG003|Part A|Adverse Event|0|||
131215256|NCT02684370|472412090|FG004|Part A|Adverse Event|0|||
131215257|NCT02684370|472412091|FG005|Part A|Adverse Event|0|||
131215258|NCT02684370|472412086|FG000|Part A|Lost to Follow-up|1|||
131215259|NCT02684370|472412087|FG001|Part A|Lost to Follow-up|1|||
131215260|NCT02684370|472412088|FG002|Part A|Lost to Follow-up|0|||
131215261|NCT02684370|472412089|FG003|Part A|Lost to Follow-up|0|||
131215262|NCT02684370|472412090|FG004|Part A|Lost to Follow-up|0|||
131215263|NCT02684370|472412091|FG005|Part A|Lost to Follow-up|0|||
131215264|NCT02684370|472412086|FG000|Part A|Subject Withdrawal|1|||
131215265|NCT02684370|472412087|FG001|Part A|Subject Withdrawal|0|||
131215266|NCT02684370|472412088|FG002|Part A|Subject Withdrawal|3|||
131215267|NCT02684370|472412089|FG003|Part A|Subject Withdrawal|0|||
131215268|NCT02684370|472412090|FG004|Part A|Subject Withdrawal|0|||
131215269|NCT02684370|472412091|FG005|Part A|Subject Withdrawal|0|||
131215270|NCT02684370|472412086|FG000|Part A|Other|0|||
131215271|NCT02684370|472412087|FG001|Part A|Other|0|||
131215272|NCT02684370|472412088|FG002|Part A|Other|1|||
131215273|NCT02684370|472412089|FG003|Part A|Other|0|||
131215274|NCT02684370|472412090|FG004|Part A|Other|0|||
131215275|NCT02684370|472412091|FG005|Part A|Other|0|||
131215276|NCT02684370|472412086|FG000|Part B|Adverse Event|0|||
131215277|NCT02684370|472412087|FG001|Part B|Adverse Event|0|||
131215278|NCT02684370|472412088|FG002|Part B|Adverse Event|0|||
131215279|NCT02684370|472412089|FG003|Part B|Adverse Event|0|||
131215280|NCT02684370|472412090|FG004|Part B|Adverse Event|2|||
131215281|NCT02684370|472412091|FG005|Part B|Adverse Event|1|||
131215282|NCT02684370|472412086|FG000|Part B|Lost to Follow-up|0|||
131215283|NCT02684370|472412087|FG001|Part B|Lost to Follow-up|0|||
131215284|NCT02684370|472412088|FG002|Part B|Lost to Follow-up|0|||
131215285|NCT02684370|472412089|FG003|Part B|Lost to Follow-up|1|||
131215286|NCT02684370|472412090|FG004|Part B|Lost to Follow-up|2|||
131215287|NCT02684370|472412091|FG005|Part B|Lost to Follow-up|5|||
131215288|NCT02684370|472412086|FG000|Part B|Subject Withdrawal|0|||
131215289|NCT02684370|472412087|FG001|Part B|Subject Withdrawal|0|||
131215290|NCT02684370|472412088|FG002|Part B|Subject Withdrawal|0|||
131215291|NCT02684370|472412089|FG003|Part B|Subject Withdrawal|1|||
131215292|NCT02684370|472412090|FG004|Part B|Subject Withdrawal|1|||
131215293|NCT02684370|472412091|FG005|Part B|Subject Withdrawal|2|||
131215294|NCT04221373|472412092|FG000|Overall Study|Physician Decision|4|||
131215295|NCT04221373|472412093|FG001|Overall Study|Physician Decision|0|||
131215296|NCT01165424|472412096|FG000|Overall Study|Clinical adverse experiences|1|||
131215297|NCT01165424|472412096|FG000|Overall Study|Laboratory adverse experiences|1|||
131215298|NCT01165424|472412096|FG000|Overall Study|Did not meet entry criteria|1|||
131215299|NCT01165424|472412096|FG000|Overall Study|Participant moved (relocated)|1|||
131215300|NCT02181673|472412097|FG000|Up to Week 24|Adverse Event|2|||
131215301|NCT02181673|472412098|FG001|Up to Week 24|Adverse Event|0|||
131215302|NCT02181673|472412099|FG002|Up to Week 24|Adverse Event|3|||
131215303|NCT02181673|472412097|FG000|Up to Week 24|Death|1|||
131215304|NCT02181673|472412098|FG001|Up to Week 24|Death|0|||
131215305|NCT02181673|472412099|FG002|Up to Week 24|Death|0|||
131215306|NCT02181673|472412097|FG000|Up to Week 24|Lack of Efficacy|1|||
131215307|NCT02181673|472412098|FG001|Up to Week 24|Lack of Efficacy|0|||
131215308|NCT02181673|472412099|FG002|Up to Week 24|Lack of Efficacy|0|||
131215309|NCT02181673|472412097|FG000|Up to Week 24|Lost to Follow-up|1|||
131215310|NCT02181673|472412098|FG001|Up to Week 24|Lost to Follow-up|0|||
131215311|NCT02181673|472412099|FG002|Up to Week 24|Lost to Follow-up|0|||
131215312|NCT02181673|472412097|FG000|Up to Week 24|Physician Decision|0|||
131215313|NCT02181673|472412098|FG001|Up to Week 24|Physician Decision|0|||
131215314|NCT02181673|472412099|FG002|Up to Week 24|Physician Decision|3|||
130992598|NCT00539279|471599826|FG001|Treatment|Withdrawal by Subject|8|||
131215315|NCT02181673|472412097|FG000|Up to Week 24|Withdrawal by Subject|10|||
131215316|NCT02181673|472412098|FG001|Up to Week 24|Withdrawal by Subject|0|||
131215317|NCT02181673|472412099|FG002|Up to Week 24|Withdrawal by Subject|1|||
131215318|NCT02181673|472412097|FG000|Up to Week 24|Other|2|||
131215319|NCT02181673|472412098|FG001|Up to Week 24|Other|0|||
131215320|NCT02181673|472412099|FG002|Up to Week 24|Other|3|||
131215321|NCT02181673|472412097|FG000|Up to Week 24|Randomized not Treated|0|||
131215322|NCT02181673|472412098|FG001|Up to Week 24|Randomized not Treated|0|||
131215323|NCT02181673|472412099|FG002|Up to Week 24|Randomized not Treated|1|||
131215324|NCT02181673|472412097|FG000|Week 24-Week 60|Adverse Event|0|||
130992599|NCT00539279|471599825|FG000|Treatment|Death|1|||
131215325|NCT02181673|472412098|FG001|Week 24-Week 60|Adverse Event|4|||
130992600|NCT00539279|471599826|FG001|Treatment|Death|0|||
131215326|NCT02181673|472412099|FG002|Week 24-Week 60|Adverse Event|10|||
131215327|NCT02181673|472412097|FG000|Week 24-Week 60|Other|0|||
131215328|NCT02181673|472412098|FG001|Week 24-Week 60|Other|2|||
131215329|NCT02181673|472412099|FG002|Week 24-Week 60|Other|1|||
131215330|NCT02181673|472412097|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
131215331|NCT02181673|472412098|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
131215332|NCT02181673|472412099|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
131215333|NCT02181673|472412097|FG000|Week 24-Week 60|Pregnancy|0|||
131215334|NCT02181673|472412098|FG001|Week 24-Week 60|Pregnancy|0|||
131215335|NCT02181673|472412099|FG002|Week 24-Week 60|Pregnancy|1|||
131215336|NCT02181673|472412097|FG000|Week 24-Week 60|Lack of Efficacy|0|||
131215337|NCT02181673|472412098|FG001|Week 24-Week 60|Lack of Efficacy|0|||
131215338|NCT02181673|472412099|FG002|Week 24-Week 60|Lack of Efficacy|1|||
131215339|NCT02181673|472412097|FG000|Week 24-Week 60|Lost to Follow-up|0|||
131215340|NCT02181673|472412098|FG001|Week 24-Week 60|Lost to Follow-up|0|||
131215341|NCT02181673|472412099|FG002|Week 24-Week 60|Lost to Follow-up|1|||
131215342|NCT02181673|472412097|FG000|Week 24-Week 60|Physician Decision|0|||
131215343|NCT02181673|472412098|FG001|Week 24-Week 60|Physician Decision|0|||
131215344|NCT02181673|472412099|FG002|Week 24-Week 60|Physician Decision|1|||
131215345|NCT00138658|472412100|FG000|Overall Study|Adverse Event|23|||
131215346|NCT00138658|472412100|FG000|Overall Study|Death|1|||
131215347|NCT00138658|472412100|FG000|Overall Study|Disease Progression|21|||
131215348|NCT00138658|472412100|FG000|Overall Study|Physician Decision|11|||
131215349|NCT00138658|472412100|FG000|Overall Study|Withdrawal by Subject|5|||
131215350|NCT03733301|472412103|FG000|Overall Study|Screen Fail|1|||
131215351|NCT03733301|472412104|FG001|Overall Study|Screen Fail|0|||
131215352|NCT03733301|472412105|FG002|Overall Study|Screen Fail|0|||
131215353|NCT03733301|472412103|FG000|Overall Study|Non-compliance|1|||
131215354|NCT03733301|472412104|FG001|Overall Study|Non-compliance|0|||
131215355|NCT03733301|472412105|FG002|Overall Study|Non-compliance|0|||
131215356|NCT03733301|472412103|FG000|Overall Study|Lack of Efficacy|2|||
131215357|NCT03733301|472412104|FG001|Overall Study|Lack of Efficacy|3|||
131215358|NCT03733301|472412105|FG002|Overall Study|Lack of Efficacy|0|||
131215359|NCT03733301|472412103|FG000|Overall Study|Adverse Event|0|||
131215360|NCT03733301|472412104|FG001|Overall Study|Adverse Event|1|||
131215361|NCT03733301|472412105|FG002|Overall Study|Adverse Event|3|||
131215362|NCT03733301|472412103|FG000|Overall Study|Withdrawal by Subject|3|||
131215363|NCT03733301|472412104|FG001|Overall Study|Withdrawal by Subject|5|||
131215364|NCT03733301|472412105|FG002|Overall Study|Withdrawal by Subject|1|||
131215365|NCT00320801|472412108|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
131215366|NCT00320801|472412109|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
131215367|NCT00320801|472412110|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
131215368|NCT00320801|472412111|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
131215369|NCT00320801|472412108|FG000|Open-label Run-in Period|Adverse Event|33|||
131215370|NCT00320801|472412109|FG001|Open-label Run-in Period|Adverse Event|0|||
131215371|NCT00320801|472412110|FG002|Open-label Run-in Period|Adverse Event|0|||
131215372|NCT00320801|472412111|FG003|Open-label Run-in Period|Adverse Event|0|||
131215373|NCT00320801|472412108|FG000|Open-label Run-in Period|Administrative|10|||
131215374|NCT00320801|472412109|FG001|Open-label Run-in Period|Administrative|0|||
131215375|NCT00320801|472412110|FG002|Open-label Run-in Period|Administrative|0|||
131215376|NCT00320801|472412111|FG003|Open-label Run-in Period|Administrative|0|||
131215377|NCT00320801|472412108|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
131215378|NCT00320801|472412109|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
131215379|NCT00320801|472412110|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
131215380|NCT00320801|472412111|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
131215381|NCT00320801|472412108|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
131215382|NCT00320801|472412109|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
131215383|NCT00320801|472412110|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
131215384|NCT00320801|472412111|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
131215385|NCT00320801|472412108|FG000|Open-label Run-in Period|Did not qualify|1|||
131215386|NCT00320801|472412109|FG001|Open-label Run-in Period|Did not qualify|0|||
131215387|NCT00320801|472412110|FG002|Open-label Run-in Period|Did not qualify|0|||
131215388|NCT00320801|472412111|FG003|Open-label Run-in Period|Did not qualify|0|||
131215389|NCT00320801|472412108|FG000|Double-blind Phase|Withdrawal by Subject|0|||
131215390|NCT00320801|472412109|FG001|Double-blind Phase|Withdrawal by Subject|0|||
131215391|NCT00320801|472412110|FG002|Double-blind Phase|Withdrawal by Subject|1|||
131215392|NCT00320801|472412111|FG003|Double-blind Phase|Withdrawal by Subject|0|||
131215393|NCT00320801|472412108|FG000|Double-blind Phase|Adverse Event|0|||
131215394|NCT00320801|472412109|FG001|Double-blind Phase|Adverse Event|2|||
131215395|NCT00320801|472412110|FG002|Double-blind Phase|Adverse Event|8|||
131215396|NCT00320801|472412111|FG003|Double-blind Phase|Adverse Event|0|||
131215397|NCT00320801|472412108|FG000|Double-blind Phase|Administrative|0|||
131215398|NCT00320801|472412109|FG001|Double-blind Phase|Administrative|0|||
131215399|NCT00320801|472412110|FG002|Double-blind Phase|Administrative|4|||
131215400|NCT00320801|472412111|FG003|Double-blind Phase|Administrative|0|||
131215401|NCT00320801|472412108|FG000|Double-blind Phase|Lack of Efficacy|0|||
131215402|NCT00320801|472412109|FG001|Double-blind Phase|Lack of Efficacy|9|||
131215403|NCT00320801|472412110|FG002|Double-blind Phase|Lack of Efficacy|1|||
131215404|NCT00320801|472412111|FG003|Double-blind Phase|Lack of Efficacy|0|||
131215405|NCT00320801|472412108|FG000|Extension Phase|Withdrawal by Subject|0|||
131215406|NCT00320801|472412109|FG001|Extension Phase|Withdrawal by Subject|0|||
131215407|NCT00320801|472412110|FG002|Extension Phase|Withdrawal by Subject|0|||
131215408|NCT00320801|472412111|FG003|Extension Phase|Withdrawal by Subject|6|||
131215409|NCT00320801|472412108|FG000|Extension Phase|Adverse Event|0|||
131215410|NCT00320801|472412109|FG001|Extension Phase|Adverse Event|0|||
131215411|NCT00320801|472412110|FG002|Extension Phase|Adverse Event|0|||
131215412|NCT00320801|472412111|FG003|Extension Phase|Adverse Event|8|||
131215413|NCT00320801|472412108|FG000|Extension Phase|Administrative|0|||
131215414|NCT00320801|472412109|FG001|Extension Phase|Administrative|0|||
131215415|NCT00320801|472412110|FG002|Extension Phase|Administrative|0|||
131215416|NCT00320801|472412111|FG003|Extension Phase|Administrative|29|||
131215417|NCT00320801|472412108|FG000|Extension Phase|Lack of Efficacy|0|||
131215418|NCT00320801|472412109|FG001|Extension Phase|Lack of Efficacy|0|||
131215419|NCT00320801|472412110|FG002|Extension Phase|Lack of Efficacy|0|||
131215420|NCT00320801|472412111|FG003|Extension Phase|Lack of Efficacy|2|||
131215421|NCT00320801|472412108|FG000|Extension Phase|Lost to Follow-up|0|||
131215422|NCT00320801|472412109|FG001|Extension Phase|Lost to Follow-up|0|||
131215423|NCT00320801|472412110|FG002|Extension Phase|Lost to Follow-up|0|||
131215424|NCT00320801|472412111|FG003|Extension Phase|Lost to Follow-up|3|||
131215425|NCT00337727|472412112|FG000|Overall Study|Adverse Event|5|||
131215426|NCT00337727|472412113|FG001|Overall Study|Adverse Event|3|||
131215427|NCT00337727|472412112|FG000|Overall Study|Lost to Follow-up|5|||
131215428|NCT00337727|472412113|FG001|Overall Study|Lost to Follow-up|4|||
131215429|NCT00337727|472412112|FG000|Overall Study|Physician Decision|1|||
131215430|NCT00337727|472412113|FG001|Overall Study|Physician Decision|0|||
131215431|NCT00337727|472412112|FG000|Overall Study|Protocol Violation|4|||
131215432|NCT00337727|472412113|FG001|Overall Study|Protocol Violation|0|||
131215433|NCT00337727|472412112|FG000|Overall Study|Withdrawal by Subject|3|||
131215434|NCT00337727|472412113|FG001|Overall Study|Withdrawal by Subject|5|||
131215435|NCT00577031|472412114|FG000|Overall Study|Adverse Event|52|||
131215436|NCT00577031|472412114|FG000|Overall Study|Progression of disease|93|||
131215437|NCT00577031|472412114|FG000|Overall Study|Protocol Violation|5|||
131215438|NCT00577031|472412114|FG000|Overall Study|Participant withdrew consent|13|||
131215439|NCT00577031|472412114|FG000|Overall Study|Participant non-compliance|5|||
131215440|NCT00577031|472412114|FG000|Overall Study|Need for surgery|17|||
131215441|NCT00577031|472412114|FG000|Overall Study|Medical decision|14|||
131215442|NCT00577031|472412114|FG000|Overall Study|Death|6|||
131215443|NCT06067191|472412116|FG000|Overall Study|Withdrawal by Subject|0|||
131215444|NCT06067191|472412117|FG001|Overall Study|Withdrawal by Subject|1|||
131215445|NCT04764669|472412118|FG000|Overall Study|Adverse Event|1|||
131215446|NCT04764669|472412119|FG001|Overall Study|Adverse Event|0|||
131215447|NCT04764669|472412120|FG002|Overall Study|Adverse Event|1|||
131215448|NCT04764669|472412121|FG003|Overall Study|Adverse Event|0|||
131215449|NCT04764669|472412118|FG000|Overall Study|Subject Choice|0|||
131215450|NCT04764669|472412119|FG001|Overall Study|Subject Choice|0|||
131215451|NCT04764669|472412120|FG002|Overall Study|Subject Choice|1|||
131215452|NCT04764669|472412121|FG003|Overall Study|Subject Choice|0|||
131215453|NCT04764669|472412118|FG000|Overall Study|Withdrawal by Subject|2|||
131215454|NCT04764669|472412119|FG001|Overall Study|Withdrawal by Subject|0|||
131215455|NCT04764669|472412120|FG002|Overall Study|Withdrawal by Subject|0|||
131215456|NCT04764669|472412121|FG003|Overall Study|Withdrawal by Subject|0|||
131215457|NCT00807040|472412122|FG000|Overall Study|Death|24|||
131215458|NCT00807040|472412123|FG001|Overall Study|Death|29|||
131215459|NCT00807040|472412122|FG000|Overall Study|Withdrawal by Subject|8|||
131215460|NCT00807040|472412123|FG001|Overall Study|Withdrawal by Subject|6|||
131215461|NCT00807040|472412122|FG000|Overall Study|Lost to Follow-up|4|||
131215462|NCT00807040|472412123|FG001|Overall Study|Lost to Follow-up|6|||
131215463|NCT00625846|472412124|FG000|Overall Study|Withdrawal by Subject|2|||
131215464|NCT00625846|472412125|FG001|Overall Study|Withdrawal by Subject|0|||
131215465|NCT00625846|472412126|FG002|Overall Study|Withdrawal by Subject|1|||
131215466|NCT00625846|472412127|FG003|Overall Study|Withdrawal by Subject|2|||
130882593|NCT00870740|471205548|FG000|Overall Study|Adverse Event|2|||
130882594|NCT00870740|471205549|FG001|Overall Study|Adverse Event|1|||
130882595|NCT00870740|471205550|FG002|Overall Study|Adverse Event|3|||
130882596|NCT00870740|471205551|FG003|Overall Study|Adverse Event|2|||
130882597|NCT00870740|471205552|FG004|Overall Study|Adverse Event|1|||
130882598|NCT00870740|471205553|FG005|Overall Study|Adverse Event|6|||
130882599|NCT00870740|471205548|FG000|Overall Study|Consent Withdrawn|6|||
131215467|NCT00890409|472412134|FG000|Overall Study|Lost to Follow-up|20|||
131215468|NCT00890409|472412135|FG001|Overall Study|Lost to Follow-up|21|||
130882600|NCT00870740|471205549|FG001|Overall Study|Consent Withdrawn|3|||
131215469|NCT01067339|472412136|FG000|Overall Study|Withdrawal by Subject|6|||
131215470|NCT01067339|472412137|FG001|Overall Study|Withdrawal by Subject|5|||
131215471|NCT00769132|472412139|FG000|Period 1|Adverse Event|1|||
131215472|NCT00769132|472412140|FG001|Period 1|Adverse Event|0|||
131215473|NCT00769132|472412141|FG002|Period 1|Adverse Event|0|||
131215474|NCT00769132|472412142|FG003|Period 1|Adverse Event|1|||
131215475|NCT00769132|472412139|FG000|Period 2|Withdrawal by Subject|0|||
130882601|NCT00870740|471205550|FG002|Overall Study|Consent Withdrawn|4|||
130882602|NCT00870740|471205551|FG003|Overall Study|Consent Withdrawn|6|||
131215476|NCT00769132|472412140|FG001|Period 2|Withdrawal by Subject|0|||
131215477|NCT00769132|472412141|FG002|Period 2|Withdrawal by Subject|0|||
131215478|NCT00769132|472412142|FG003|Period 2|Withdrawal by Subject|1|||
131215479|NCT00769132|472412139|FG000|Period 3|Withdrawal by Subject|1|||
131215480|NCT00769132|472412140|FG001|Period 3|Withdrawal by Subject|0|||
131215481|NCT00769132|472412141|FG002|Period 3|Withdrawal by Subject|0|||
131215482|NCT00769132|472412142|FG003|Period 3|Withdrawal by Subject|0|||
131215483|NCT00769132|472412139|FG000|Period 4|Withdrawal by Subject|0|||
131215484|NCT00769132|472412140|FG001|Period 4|Withdrawal by Subject|1|||
131215485|NCT00769132|472412141|FG002|Period 4|Withdrawal by Subject|0|||
131215486|NCT00769132|472412142|FG003|Period 4|Withdrawal by Subject|0|||
131215487|NCT00557830|472412146|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
131215488|NCT00557830|472412147|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
131215489|NCT00557830|472412148|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
131215490|NCT00557830|472412146|FG000|Screening Treatment Phase|Adverse Event|2|||
131215491|NCT00557830|472412147|FG001|Screening Treatment Phase|Adverse Event|0|||
131215492|NCT00557830|472412148|FG002|Screening Treatment Phase|Adverse Event|0|||
131215493|NCT00557830|472412146|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
131215494|NCT00557830|472412147|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
131215495|NCT00557830|472412148|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
131215496|NCT00538473|472412149|FG000|Overall Study|Adverse Event|1|||
131215497|NCT00538473|472412150|FG001|Overall Study|Adverse Event|0|||
131215498|NCT01833897|472412151|FG000|Overall Study|Lack of Efficacy|1|||
131215499|NCT00127192|472412152|FG000|Overall Study|Adverse Event|0|||
131215500|NCT00127192|472412153|FG001|Overall Study|Adverse Event|1|||
131215501|NCT00127192|472412154|FG002|Overall Study|Adverse Event|1|||
131215502|NCT00127192|472412155|FG003|Overall Study|Adverse Event|1|||
131215503|NCT00127192|472412156|FG004|Overall Study|Adverse Event|0|||
131215504|NCT00127192|472412152|FG000|Overall Study|Lack of Efficacy|2|||
131215505|NCT00127192|472412153|FG001|Overall Study|Lack of Efficacy|0|||
131215506|NCT00127192|472412154|FG002|Overall Study|Lack of Efficacy|0|||
131215507|NCT00127192|472412155|FG003|Overall Study|Lack of Efficacy|0|||
131215508|NCT00127192|472412156|FG004|Overall Study|Lack of Efficacy|2|||
131215509|NCT00127192|472412152|FG000|Overall Study|Withdrawal by Subject|0|||
131215510|NCT00127192|472412153|FG001|Overall Study|Withdrawal by Subject|0|||
131215511|NCT00127192|472412154|FG002|Overall Study|Withdrawal by Subject|1|||
131215512|NCT00127192|472412155|FG003|Overall Study|Withdrawal by Subject|0|||
131215513|NCT00127192|472412156|FG004|Overall Study|Withdrawal by Subject|3|||
131215514|NCT00127192|472412152|FG000|Overall Study|Adverse event in pre-treatment period|1|||
131215515|NCT00127192|472412153|FG001|Overall Study|Adverse event in pre-treatment period|0|||
131215516|NCT00127192|472412154|FG002|Overall Study|Adverse event in pre-treatment period|0|||
131215517|NCT00127192|472412155|FG003|Overall Study|Adverse event in pre-treatment period|0|||
131215518|NCT00127192|472412156|FG004|Overall Study|Adverse event in pre-treatment period|0|||
131215519|NCT03664024|472412161|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
131215520|NCT03664024|472412161|FG000|Overall Study|Lost to Follow-up|2|||
131215521|NCT03664024|472412161|FG000|Overall Study|Withdrawal by Subject|2|||
131215522|NCT03664024|472412161|FG000|Overall Study|Death|80|||
131215523|NCT00077766|472412162|FG000|Overall Study|Adverse Event|1|||
131215524|NCT00077766|472412163|FG001|Overall Study|Adverse Event|1|||
131215525|NCT00077766|472412162|FG000|Overall Study|Withdrawal by Subject|4|||
131215526|NCT00077766|472412163|FG001|Overall Study|Withdrawal by Subject|3|||
131215527|NCT00077766|472412162|FG000|Overall Study|Death|12|||
131215528|NCT00077766|472412163|FG001|Overall Study|Death|10|||
131215529|NCT00077766|472412162|FG000|Overall Study|Lost to Follow-up|2|||
131215530|NCT00077766|472412163|FG001|Overall Study|Lost to Follow-up|0|||
131215531|NCT00077766|472412162|FG000|Overall Study|Protocol Violation|1|||
131215532|NCT00077766|472412163|FG001|Overall Study|Protocol Violation|0|||
131215533|NCT00077766|472412162|FG000|Overall Study|Kidney Transplantation|9|||
131215534|NCT00077766|472412163|FG001|Overall Study|Kidney Transplantation|5|||
131215535|NCT00077766|472412162|FG000|Overall Study|Transplantation|5|||
131215536|NCT00077766|472412163|FG001|Overall Study|Transplantation|1|||
131215537|NCT00077766|472412162|FG000|Overall Study|Investigators Discretion|1|||
131215538|NCT00077766|472412163|FG001|Overall Study|Investigators Discretion|0|||
131215539|NCT00077766|472412162|FG000|Overall Study|Participant's decision|1|||
131215540|NCT00077766|472412163|FG001|Overall Study|Participant's decision|0|||
131215541|NCT00077766|472412162|FG000|Overall Study|Dialysis Discontinued|1|||
131215542|NCT00077766|472412163|FG001|Overall Study|Dialysis Discontinued|0|||
131215543|NCT00077766|472412162|FG000|Overall Study|Dialysis|0|||
131100647|NCT01871805|471998062|FG003|Phase II|Death|0|||
131215544|NCT00077766|472412163|FG001|Overall Study|Dialysis|1|||
131215545|NCT00077766|472412162|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
131215546|NCT00077766|472412163|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
131215547|NCT00077766|472412162|FG000|Overall Study|Started Nocturnal Dialysis|0|||
131215548|NCT00077766|472412163|FG001|Overall Study|Started Nocturnal Dialysis|1|||
131215549|NCT00077766|472412162|FG000|Overall Study|Stop Dialysis|0|||
131215550|NCT00077766|472412163|FG001|Overall Study|Stop Dialysis|1|||
131215551|NCT00077766|472412162|FG000|Overall Study|Participants Vacation|2|||
131215552|NCT00077766|472412163|FG001|Overall Study|Participants Vacation|1|||
131215553|NCT01886105|472412164|FG000|Overall Study|Lack of Efficacy|3|||
131215554|NCT03843775|472412165|FG000|Overall Study|Adverse Event|1|||
131215555|NCT03843775|472412166|FG001|Overall Study|Adverse Event|1|||
131215556|NCT03843775|472412165|FG000|Overall Study|Lack of Efficacy|2|||
131215557|NCT03843775|472412166|FG001|Overall Study|Lack of Efficacy|6|||
131215558|NCT03843775|472412165|FG000|Overall Study|Withdrawal by Subject|0|||
131215559|NCT03843775|472412166|FG001|Overall Study|Withdrawal by Subject|1|||
131215560|NCT04150107|472412169|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
131215561|NCT04150107|472412170|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
131215562|NCT04150107|472412169|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
131215563|NCT04150107|472412170|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
131215564|NCT02184988|472412175|FG000|Overall Study|Pregnancy|2|||
131215565|NCT02184988|472412175|FG000|Overall Study|Adverse Event|2|||
131215566|NCT02184988|472412175|FG000|Overall Study|moving away/travelling/unable to complet|6|||
131215567|NCT02184988|472412175|FG000|Overall Study|work scheduling issues|4|||
131215568|NCT02184988|472412175|FG000|Overall Study|various other reasons|9|||
131215569|NCT02184988|472412175|FG000|Overall Study|Lost to Follow-up|32|||
131215570|NCT03188991|472412176|FG000|Overall Study|Withdrawal by Subject|0|||
131215571|NCT03188991|472412177|FG001|Overall Study|Withdrawal by Subject|0|||
131215572|NCT03188991|472412178|FG002|Overall Study|Withdrawal by Subject|0|||
131215573|NCT03188991|472412179|FG003|Overall Study|Withdrawal by Subject|1|||
131215574|NCT01319994|472413071|FG000|Overall Study|Protocol Violation|7|||
131215575|NCT01319994|472413072|FG001|Overall Study|Protocol Violation|6|||
131215576|NCT01340794|472413073|FG000|Overall Study|Withdrawal by Subject|0|||
131215577|NCT01340794|472413074|FG001|Overall Study|Withdrawal by Subject|1|||
131215578|NCT01035229|472413082|FG000|Overall Study|Adverse Event|61|||
131215579|NCT01035229|472413083|FG001|Overall Study|Adverse Event|14|||
131215580|NCT01035229|472413082|FG000|Overall Study|Withdrawal by Subject|20|||
131215581|NCT01035229|472413083|FG001|Overall Study|Withdrawal by Subject|7|||
131215582|NCT01035229|472413082|FG000|Overall Study|Lost to Follow-up|1|||
131215583|NCT01035229|472413083|FG001|Overall Study|Lost to Follow-up|0|||
131215584|NCT01035229|472413082|FG000|Overall Study|Administrative problems|1|||
131215585|NCT01035229|472413083|FG001|Overall Study|Administrative problems|1|||
131215586|NCT01035229|472413082|FG000|Overall Study|Death|13|||
131215587|NCT01035229|472413083|FG001|Overall Study|Death|5|||
131215588|NCT01035229|472413082|FG000|Overall Study|New cancer therapy|2|||
131215589|NCT01035229|472413083|FG001|Overall Study|New cancer therapy|0|||
131215590|NCT01035229|472413082|FG000|Overall Study|Protocol Violation|0|||
131215591|NCT01035229|472413083|FG001|Overall Study|Protocol Violation|2|||
131215592|NCT01035229|472413082|FG000|Overall Study|Sponsor's decision to end study|3|||
131215593|NCT01035229|472413083|FG001|Overall Study|Sponsor's decision to end study|3|||
131215594|NCT01035229|472413082|FG000|Overall Study|Disease Progression|261|||
131215595|NCT01035229|472413083|FG001|Overall Study|Disease Progression|152|||
131215596|NCT02525627|472413087|FG000|Overall Study|Revision|1|||
131215597|NCT02525627|472413088|FG001|Overall Study|Revision|1|||
131215598|NCT02525627|472413087|FG000|Overall Study|Withdrawal by Subject|1|||
131215599|NCT02525627|472413088|FG001|Overall Study|Withdrawal by Subject|2|||
131215600|NCT02525627|472413087|FG000|Overall Study|Death|1|||
131215601|NCT02525627|472413088|FG001|Overall Study|Death|0|||
131215602|NCT02525627|472413087|FG000|Overall Study|Site terminated|11|||
131215603|NCT02525627|472413088|FG001|Overall Study|Site terminated|10|||
131215604|NCT03746080|472413089|FG000|Overall Study|In follow up|2|||
131215605|NCT03746080|472413089|FG000|Overall Study|Death|15|||
131215606|NCT01473589|472413090|FG000|Overall Study|Adverse Event|1|||
131215607|NCT01473589|472413091|FG001|Overall Study|Adverse Event|1|||
131215608|NCT01473589|472413090|FG000|Overall Study|Death|2|||
131215609|NCT01473589|472413091|FG001|Overall Study|Death|0|||
131215610|NCT01473589|472413090|FG000|Overall Study|Lost to Follow-up|2|||
131215611|NCT01473589|472413091|FG001|Overall Study|Lost to Follow-up|2|||
131215612|NCT01473589|472413090|FG000|Overall Study|Protocol Violation|1|||
131215613|NCT01473589|472413091|FG001|Overall Study|Protocol Violation|0|||
131215614|NCT01473589|472413090|FG000|Overall Study|Withdrawal by Subject|5|||
131215615|NCT01473589|472413091|FG001|Overall Study|Withdrawal by Subject|11|||
131215616|NCT01473589|472413090|FG000|Overall Study|Physician Decision|0|||
131215617|NCT01473589|472413091|FG001|Overall Study|Physician Decision|1|||
130992601|NCT00539279|471599825|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
130992602|NCT00539279|471599826|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
131215618|NCT01473589|472413090|FG000|Overall Study|Entry criteria not met|0|||
131215619|NCT01473589|472413091|FG001|Overall Study|Entry criteria not met|1|||
131215620|NCT03256526|472413093|FG000|Overall Study|Adverse Event|1|||
131215621|NCT03256526|472413094|FG001|Overall Study|Adverse Event|0|||
131215622|NCT03256526|472413095|FG002|Overall Study|Adverse Event|1|||
131215623|NCT03256526|472413093|FG000|Overall Study|Lost to Follow-up|1|||
131215624|NCT03256526|472413094|FG001|Overall Study|Lost to Follow-up|0|||
131215625|NCT03256526|472413095|FG002|Overall Study|Lost to Follow-up|2|||
131215626|NCT03286400|472413106|FG000|Overall Study|Death|10|||
131215627|NCT03286400|472413106|FG000|Overall Study|Lost to Follow-up|10|||
131215628|NCT03286400|472413106|FG000|Overall Study|Physician Decision|1|||
131215629|NCT03286400|472413106|FG000|Overall Study|Scheduling difficulty|4|||
131215630|NCT00826176|472413109|FG000|Overall Study|Lost to Follow-up|1|||
131215631|NCT00826176|472413110|FG001|Overall Study|Lost to Follow-up|0|||
131215632|NCT00826176|472413109|FG000|Overall Study|Subject Withdrew Consent|3|||
131215633|NCT00826176|472413110|FG001|Overall Study|Subject Withdrew Consent|0|||
131215634|NCT00826176|472413109|FG000|Overall Study|Administrative|9|||
131215635|NCT00826176|472413110|FG001|Overall Study|Administrative|0|||
131215636|NCT00297882|472413116|FG000|Day 14|Lack of Efficacy|12|||
131215637|NCT00297882|472413117|FG001|Day 14|Lack of Efficacy|49|||
131215638|NCT00297882|472413116|FG000|Day 28|Lost to Follow-up|13|||
131215639|NCT00297882|472413117|FG001|Day 28|Lost to Follow-up|23|||
131215640|NCT00297882|472413116|FG000|Day 28|Lack of Efficacy|3|||
131215641|NCT00297882|472413117|FG001|Day 28|Lack of Efficacy|0|||
131215642|NCT04484805|472413118|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
131215643|NCT04484805|472413119|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
131215644|NCT04484805|472413118|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
131215645|NCT04484805|472413119|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
131215646|NCT02116309|472413121|FG000|Overall Study|Lost to Follow-up|0|||
131215647|NCT02116309|472413122|FG001|Overall Study|Lost to Follow-up|1|||
131215648|NCT00848965|472413123|FG000|Overall Study|Adverse Event|1|||
131215649|NCT00848965|472413123|FG000|Overall Study|Withdrawal by Subject|1|||
131215650|NCT03710824|472413124|FG000|Overall Study|Withdrawal by Subject|1|||
131215651|NCT03710824|472413124|FG000|Overall Study|Lost to Follow-up|3|||
131215652|NCT03710824|472413124|FG000|Overall Study|Adverse Event|25|||
131215653|NCT03710824|472413124|FG000|Overall Study|Treatment discontinuation|2|||
131215654|NCT02329834|472413125|FG000|Overall Study|Physician Decision|1|||
131215655|NCT02329834|472413126|FG001|Overall Study|Physician Decision|0|||
131215656|NCT05102162|472413134|FG000|Overall Study|Withdrawal by Subject|3|||
131215657|NCT05102162|472413135|FG001|Overall Study|Withdrawal by Subject|0|||
131215658|NCT05102162|472413134|FG000|Overall Study|Baseline cultures negative|4|||
131215659|NCT05102162|472413135|FG001|Overall Study|Baseline cultures negative|2|||
131215660|NCT05102162|472413134|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
131215661|NCT05102162|472413135|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
131215662|NCT05102162|472413134|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
131215663|NCT05102162|472413135|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
131215664|NCT00433771|472413136|FG000|Overall Study|screen fail|14|||
131215665|NCT00433771|472413136|FG000|Overall Study|Treated and later found to be ineligible|2|||
131215666|NCT00433771|472413136|FG000|Overall Study|Death|2|||
131215667|NCT00433771|472413136|FG000|Overall Study|Failure to deploy stent|1|||
131215668|NCT02353572|472413137|FG000|Overall Study|Withdrawal by Subject|1|||
131215669|NCT02353572|472413137|FG000|Overall Study|Study terminated|2|||
131215670|NCT02230332|472413141|FG000|Overall Study|Adverse Event|2|||
131215671|NCT02230332|472413142|FG001|Overall Study|Adverse Event|1|||
131215672|NCT02230332|472413141|FG000|Overall Study|Lost to Follow-up|1|||
131215673|NCT02230332|472413142|FG001|Overall Study|Lost to Follow-up|0|||
131215674|NCT02230332|472413141|FG000|Overall Study|Protocol Violation|1|||
131215675|NCT02230332|472413142|FG001|Overall Study|Protocol Violation|0|||
131215676|NCT01036594|472413144|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
131215677|NCT01036594|472413145|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
131215678|NCT01036594|472413144|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
131215679|NCT01036594|472413145|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
131215680|NCT01036594|472413144|FG000|Week 12 Evaluation|Adverse Event|5|||
131215681|NCT01036594|472413145|FG001|Week 12 Evaluation|Adverse Event|0|||
131215682|NCT01036594|472413144|FG000|Week 12 Evaluation|Physician Decision|1|||
131215683|NCT01036594|472413145|FG001|Week 12 Evaluation|Physician Decision|0|||
131215684|NCT01036594|472413144|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
131215685|NCT01036594|472413145|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
131215686|NCT01036594|472413144|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
131215687|NCT01036594|472413145|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
131215688|NCT01036594|472413144|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
131215689|NCT01036594|472413145|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
131215690|NCT01036594|472413144|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
131215691|NCT01036594|472413145|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
131215692|NCT01036594|472413144|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
131215693|NCT01036594|472413145|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
131215694|NCT00227591|472413146|FG000|Overall Study|Withdrawal by Subject|1|||
131215695|NCT02057549|472413148|FG000|Overall Study|Lost to Follow-up|1|||
131215696|NCT02057549|472413149|FG001|Overall Study|Lost to Follow-up|0|||
131215697|NCT02057549|472413148|FG000|Overall Study|Physician Decision|1|||
131215698|NCT02057549|472413149|FG001|Overall Study|Physician Decision|0|||
131215699|NCT02057549|472413148|FG000|Overall Study|Withdrawal by Subject|1|||
131215700|NCT02057549|472413149|FG001|Overall Study|Withdrawal by Subject|0|||
131215701|NCT01418365|472413152|FG000|First Intervention|Withdrawal by Subject|0|||
131215702|NCT01418365|472413153|FG001|First Intervention|Withdrawal by Subject|1|||
130765852|NCT00314132|470765886|FG001|Overall Study|Lost to Follow-up|13|||
131215703|NCT01418365|472413152|FG000|First Intervention|Non-compliance|1|||
131215704|NCT01418365|472413153|FG001|First Intervention|Non-compliance|0|||
131215705|NCT01418365|472413152|FG000|Second Intervention|Withdrawal by Subject|0|||
131215706|NCT01418365|472413153|FG001|Second Intervention|Withdrawal by Subject|1|||
131215707|NCT04502862|472413157|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
131215708|NCT04502862|472413158|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
131215709|NCT04502862|472413157|FG000|Overall Study|Withdrawal by Subject|1|||
131215710|NCT04502862|472413158|FG001|Overall Study|Withdrawal by Subject|0|||
131215711|NCT04502862|472413157|FG000|Overall Study|Adverse Event|1|||
131215712|NCT04502862|472413158|FG001|Overall Study|Adverse Event|1|||
131215713|NCT03505606|472414883|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
131215714|NCT03505606|472414884|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
131215715|NCT03505606|472414885|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
131215716|NCT03505606|472414883|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
131215717|NCT03505606|472414884|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
131215718|NCT03505606|472414885|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
131215719|NCT03505606|472414883|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
131215720|NCT03505606|472414884|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
131215721|NCT03505606|472414885|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
131215722|NCT03505606|472414883|FG000|Overall Study|Poor compliance with refractive correction|0|||
131215723|NCT03505606|472414884|FG001|Overall Study|Poor compliance with refractive correction|0|||
131215724|NCT03505606|472414885|FG002|Overall Study|Poor compliance with refractive correction|1|||
131215725|NCT03505606|472414883|FG000|Overall Study|Insufficient anisometropia|0|||
131215726|NCT03505606|472414884|FG001|Overall Study|Insufficient anisometropia|0|||
131215727|NCT03505606|472414885|FG002|Overall Study|Insufficient anisometropia|2|||
131215728|NCT03505606|472414883|FG000|Overall Study|Ectopia Lentis|0|||
131215729|NCT03505606|472414884|FG001|Overall Study|Ectopia Lentis|0|||
131215730|NCT03505606|472414885|FG002|Overall Study|Ectopia Lentis|1|||
131215731|NCT03505606|472414883|FG000|Overall Study|alternation of amblyopic eye|0|||
131215732|NCT03505606|472414884|FG001|Overall Study|alternation of amblyopic eye|1|||
131215733|NCT03505606|472414885|FG002|Overall Study|alternation of amblyopic eye|0|||
131215734|NCT02087865|472414887|FG000|Overall Study|Withdrawal by Subject|6|||
131215735|NCT02087865|472414888|FG001|Overall Study|Withdrawal by Subject|0|||
131215736|NCT02087865|472414889|FG002|Overall Study|Withdrawal by Subject|1|||
131215737|NCT02087865|472414887|FG000|Overall Study|Lost to Follow-up|0|||
131215738|NCT02087865|472414888|FG001|Overall Study|Lost to Follow-up|0|||
131215739|NCT02087865|472414889|FG002|Overall Study|Lost to Follow-up|1|||
131215740|NCT02087865|472414887|FG000|Overall Study|Drug Non-compliance|0|||
131215741|NCT02087865|472414888|FG001|Overall Study|Drug Non-compliance|2|||
131215742|NCT02087865|472414889|FG002|Overall Study|Drug Non-compliance|0|||
131215743|NCT02087865|472414887|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
131215744|NCT02087865|472414888|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
131215745|NCT02087865|472414889|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
131215746|NCT01392469|472414892|FG000|Overall Study|Adverse Event|2|||
131215747|NCT01392469|472414892|FG000|Overall Study|Withdrawal by Subject|1|||
131215748|NCT01392469|472414892|FG000|Overall Study|Protocol Violation|1|||
131215749|NCT00648739|472414895|FG000|Overall Study|Adverse Event|1|||
131215750|NCT00648739|472414896|FG001|Overall Study|Adverse Event|0|||
131215751|NCT00648739|472414897|FG002|Overall Study|Adverse Event|1|||
131215752|NCT00648739|472414898|FG003|Overall Study|Adverse Event|2|||
131215753|NCT00648739|472414899|FG004|Overall Study|Adverse Event|1|||
131215754|NCT00648739|472414900|FG005|Overall Study|Adverse Event|0|||
131215755|NCT00648739|472414901|FG006|Overall Study|Adverse Event|0|||
131215756|NCT00648739|472414895|FG000|Overall Study|Withdrawal by Subject|1|||
131215757|NCT00648739|472414896|FG001|Overall Study|Withdrawal by Subject|0|||
131215758|NCT00648739|472414897|FG002|Overall Study|Withdrawal by Subject|1|||
131215759|NCT00648739|472414898|FG003|Overall Study|Withdrawal by Subject|0|||
131215760|NCT00648739|472414899|FG004|Overall Study|Withdrawal by Subject|0|||
131215761|NCT00648739|472414900|FG005|Overall Study|Withdrawal by Subject|2|||
131215762|NCT00648739|472414901|FG006|Overall Study|Withdrawal by Subject|0|||
131215763|NCT00648739|472414895|FG000|Overall Study|Lack of Efficacy|0|||
131215764|NCT00648739|472414896|FG001|Overall Study|Lack of Efficacy|0|||
131215765|NCT00648739|472414897|FG002|Overall Study|Lack of Efficacy|0|||
131215766|NCT00648739|472414898|FG003|Overall Study|Lack of Efficacy|0|||
131215767|NCT00648739|472414899|FG004|Overall Study|Lack of Efficacy|1|||
131215768|NCT00648739|472414900|FG005|Overall Study|Lack of Efficacy|2|||
131215769|NCT00648739|472414901|FG006|Overall Study|Lack of Efficacy|0|||
131215770|NCT00648739|472414895|FG000|Overall Study|Investigator Considered it Advisable|0|||
131215771|NCT00648739|472414896|FG001|Overall Study|Investigator Considered it Advisable|0|||
131215772|NCT00648739|472414897|FG002|Overall Study|Investigator Considered it Advisable|0|||
131215773|NCT00648739|472414898|FG003|Overall Study|Investigator Considered it Advisable|0|||
131215774|NCT00648739|472414899|FG004|Overall Study|Investigator Considered it Advisable|0|||
131215775|NCT00648739|472414900|FG005|Overall Study|Investigator Considered it Advisable|1|||
131215776|NCT00648739|472414901|FG006|Overall Study|Investigator Considered it Advisable|1|||
131215777|NCT00648739|472414895|FG000|Overall Study|Death|0|||
131215778|NCT00648739|472414896|FG001|Overall Study|Death|1|||
131215779|NCT00648739|472414897|FG002|Overall Study|Death|0|||
131215780|NCT00648739|472414898|FG003|Overall Study|Death|0|||
131215781|NCT00648739|472414899|FG004|Overall Study|Death|0|||
131215782|NCT00648739|472414900|FG005|Overall Study|Death|0|||
131215783|NCT00648739|472414901|FG006|Overall Study|Death|0|||
131215784|NCT00648739|472414895|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
131215785|NCT00648739|472414896|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
131215786|NCT00648739|472414897|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
131215787|NCT00648739|472414898|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
131215788|NCT00648739|472414899|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
131215789|NCT00648739|472414900|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
131215790|NCT00648739|472414901|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
131215791|NCT00648739|472414895|FG000|Overall Study|Follow-up Visits Not Completed|0|||
131215792|NCT00648739|472414896|FG001|Overall Study|Follow-up Visits Not Completed|1|||
131215793|NCT00648739|472414897|FG002|Overall Study|Follow-up Visits Not Completed|0|||
131215794|NCT00648739|472414898|FG003|Overall Study|Follow-up Visits Not Completed|0|||
131215795|NCT00648739|472414899|FG004|Overall Study|Follow-up Visits Not Completed|0|||
131215796|NCT00648739|472414900|FG005|Overall Study|Follow-up Visits Not Completed|0|||
131215797|NCT00648739|472414901|FG006|Overall Study|Follow-up Visits Not Completed|0|||
131215798|NCT00564486|472414906|FG000|Overall Study|Adverse Event|0|||
131215799|NCT00564486|472414907|FG001|Overall Study|Adverse Event|1|||
131215800|NCT00564486|472414908|FG002|Overall Study|Adverse Event|0|||
131215801|NCT00564486|472414909|FG003|Overall Study|Adverse Event|0|||
131215802|NCT00564486|472414906|FG000|Overall Study|Withdrawal by Subject|4|||
131215803|NCT00564486|472414907|FG001|Overall Study|Withdrawal by Subject|0|||
131215804|NCT00564486|472414908|FG002|Overall Study|Withdrawal by Subject|0|||
131215805|NCT00564486|472414909|FG003|Overall Study|Withdrawal by Subject|5|||
131215806|NCT00564486|472414906|FG000|Overall Study|Subject refused to have blood drawn|0|||
131215807|NCT00564486|472414907|FG001|Overall Study|Subject refused to have blood drawn|0|||
131215808|NCT00564486|472414908|FG002|Overall Study|Subject refused to have blood drawn|1|||
131215809|NCT00564486|472414909|FG003|Overall Study|Subject refused to have blood drawn|0|||
131215810|NCT00564486|472414906|FG000|Overall Study|Lost to Follow-up|3|||
131215811|NCT00564486|472414907|FG001|Overall Study|Lost to Follow-up|0|||
131215812|NCT00564486|472414908|FG002|Overall Study|Lost to Follow-up|2|||
131215813|NCT00564486|472414909|FG003|Overall Study|Lost to Follow-up|2|||
131215814|NCT03862807|472414914|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
131215815|NCT04362761|472414915|FG000|Part A (48 Weeks)|Adverse Event|2|||
131215816|NCT04362761|472414915|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
131215817|NCT04362761|472414915|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
131215818|NCT04362761|472414915|FG000|Part A (48 Weeks)|Other|5|||
131215819|NCT04362761|472414915|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
131215820|NCT04362761|472414915|FG000|Part B (86 Weeks)|Other|4|||
131215821|NCT00684645|472414916|FG000|Overall Study|Death|2|||
131215822|NCT00684645|472414916|FG000|Overall Study|Progressive disease|67|||
131215823|NCT00684645|472414916|FG000|Overall Study|Adverse Event|27|||
131215824|NCT00684645|472414916|FG000|Overall Study|Lost to Follow-up|3|||
131215825|NCT00684645|472414916|FG000|Overall Study|Other|15|||
131215826|NCT01819467|472414930|FG000|Overall Study|Physician Decision|20|||
131215827|NCT01819467|472414931|FG001|Overall Study|Physician Decision|9|||
131215828|NCT01607398|472414934|FG000|Overall Study|Adverse Event|0|||
131215829|NCT01607398|472414935|FG001|Overall Study|Adverse Event|2|||
131215830|NCT01607398|472414934|FG000|Overall Study|Severe COPD|2|||
131215831|NCT01607398|472414935|FG001|Overall Study|Severe COPD|0|||
131215832|NCT04139642|472414936|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
131215833|NCT04139642|472414937|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
131215834|NCT02871921|472414941|FG000|Overall Study|Withdrawal by Subject|34|||
131215835|NCT02871921|472414942|FG001|Overall Study|Withdrawal by Subject|27|||
131215836|NCT02871921|472414943|FG002|Overall Study|Withdrawal by Subject|27|||
131215837|NCT02871921|472414944|FG003|Overall Study|Withdrawal by Subject|30|||
131215838|NCT00244881|472414951|FG000|Overall Study|Withdrawal by Subject|3|||
131215839|NCT01102972|472414952|FG000|Overall Study|Adverse Event|8|||
131215840|NCT01102972|472414953|FG001|Overall Study|Adverse Event|2|||
131215841|NCT01102972|472414952|FG000|Overall Study|Lack of Efficacy|2|||
131215842|NCT01102972|472414953|FG001|Overall Study|Lack of Efficacy|1|||
131215843|NCT01102972|472414952|FG000|Overall Study|Protocol Violation|1|||
131215844|NCT01102972|472414953|FG001|Overall Study|Protocol Violation|0|||
131215845|NCT01102972|472414952|FG000|Overall Study|Lost to Follow-up|10|||
131215846|NCT01102972|472414953|FG001|Overall Study|Lost to Follow-up|5|||
131215847|NCT01102972|472414952|FG000|Overall Study|Investigator Discretion|2|||
131215848|NCT01102972|472414953|FG001|Overall Study|Investigator Discretion|0|||
131215849|NCT01102972|472414952|FG000|Overall Study|Withdrawal by Subject|6|||
131215850|NCT01102972|472414953|FG001|Overall Study|Withdrawal by Subject|6|||
131215851|NCT01856257|472414954|FG000|Overall Study|Death|2|||
131215852|NCT01856257|472414955|FG001|Overall Study|Death|0|||
131215853|NCT01856257|472414956|FG002|Overall Study|Death|0|||
131215854|NCT01856257|472414957|FG003|Overall Study|Death|0|||
131215855|NCT01856257|472414954|FG000|Overall Study|Physician Decision|0|||
131215856|NCT01856257|472414955|FG001|Overall Study|Physician Decision|0|||
131215857|NCT01856257|472414956|FG002|Overall Study|Physician Decision|0|||
131215858|NCT01856257|472414957|FG003|Overall Study|Physician Decision|1|||
131215859|NCT01856257|472414954|FG000|Overall Study|Withdrawal by Subject|1|||
131215860|NCT01856257|472414955|FG001|Overall Study|Withdrawal by Subject|1|||
131215861|NCT01856257|472414956|FG002|Overall Study|Withdrawal by Subject|0|||
131215862|NCT01856257|472414957|FG003|Overall Study|Withdrawal by Subject|0|||
131215863|NCT01856257|472414954|FG000|Overall Study|Donor complication|0|||
131215864|NCT01856257|472414955|FG001|Overall Study|Donor complication|0|||
131215865|NCT01856257|472414956|FG002|Overall Study|Donor complication|0|||
131215866|NCT01856257|472414957|FG003|Overall Study|Donor complication|1|||
131215867|NCT04527549|472414961|FG000|Overall Study|Withdrawal by Subject|1|||
131215868|NCT04527549|472414962|FG001|Overall Study|Withdrawal by Subject|1|||
131215869|NCT03159611|472414963|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
131215870|NCT03159611|472414964|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
131215871|NCT03159611|472414963|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
131215872|NCT03159611|472414964|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
131215873|NCT03159611|472414963|FG000|Overall Study|Protocol Violation|7|||
131215874|NCT03159611|472414964|FG001|Overall Study|Protocol Violation|4|||
131215875|NCT03159611|472414963|FG000|Overall Study|Adverse Event|1|||
131215876|NCT03159611|472414964|FG001|Overall Study|Adverse Event|0|||
131215877|NCT03159611|472414963|FG000|Overall Study|Withdrawal by Subject|1|||
131215878|NCT03159611|472414964|FG001|Overall Study|Withdrawal by Subject|1|||
131215879|NCT03159611|472414963|FG000|Overall Study|Non-compliance with protocol requirement|3|||
131215880|NCT03159611|472414964|FG001|Overall Study|Non-compliance with protocol requirement|2|||
131215881|NCT03159611|472414963|FG000|Overall Study|Inability to perform procedures|1|||
131215882|NCT03159611|472414964|FG001|Overall Study|Inability to perform procedures|0|||
131215883|NCT02325739|472414965|FG000|Phase I Part|Adverse Event|1|||
131215884|NCT02325739|472414966|FG001|Phase I Part|Adverse Event|0|||
131215885|NCT02325739|472414967|FG002|Phase I Part|Adverse Event|1|||
131215886|NCT02325739|472414968|FG003|Phase I Part|Adverse Event|2|||
131215887|NCT02325739|472414969|FG004|Phase I Part|Adverse Event|3|||
131215888|NCT02325739|472414970|FG005|Phase I Part|Adverse Event|1|||
131215889|NCT02325739|472414971|FG006|Phase I Part|Adverse Event|0|||
131215890|NCT02325739|472414972|FG007|Phase I Part|Adverse Event|2|||
131215891|NCT02325739|472414973|FG008|Phase I Part|Adverse Event|0|||
131215892|NCT02325739|472414974|FG009|Phase I Part|Adverse Event|0|||
131215893|NCT02325739|472414975|FG010|Phase I Part|Adverse Event|0|||
131215894|NCT02325739|472414965|FG000|Phase I Part|Progressive disease|9|||
131215895|NCT02325739|472414966|FG001|Phase I Part|Progressive disease|6|||
131215896|NCT02325739|472414967|FG002|Phase I Part|Progressive disease|3|||
131215897|NCT02325739|472414968|FG003|Phase I Part|Progressive disease|23|||
131215898|NCT02325739|472414969|FG004|Phase I Part|Progressive disease|14|||
131215899|NCT02325739|472414970|FG005|Phase I Part|Progressive disease|6|||
131215900|NCT02325739|472414971|FG006|Phase I Part|Progressive disease|6|||
131215901|NCT02325739|472414972|FG007|Phase I Part|Progressive disease|3|||
130882603|NCT00870740|471205552|FG004|Overall Study|Consent Withdrawn|6|||
130882604|NCT00870740|471205553|FG005|Overall Study|Consent Withdrawn|5|||
130882605|NCT00870740|471205548|FG000|Overall Study|Investigator Decision|2|||
130882606|NCT00870740|471205549|FG001|Overall Study|Investigator Decision|0|||
130882607|NCT00870740|471205550|FG002|Overall Study|Investigator Decision|1|||
130882608|NCT00870740|471205551|FG003|Overall Study|Investigator Decision|0|||
130882609|NCT00870740|471205552|FG004|Overall Study|Investigator Decision|0|||
130882610|NCT00870740|471205553|FG005|Overall Study|Investigator Decision|0|||
130882611|NCT00870740|471205548|FG000|Overall Study|Subject Non-compliance|0|||
130882612|NCT00870740|471205549|FG001|Overall Study|Subject Non-compliance|0|||
130882613|NCT00870740|471205550|FG002|Overall Study|Subject Non-compliance|0|||
130882614|NCT00870740|471205551|FG003|Overall Study|Subject Non-compliance|0|||
130992603|NCT00539279|471599825|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
131215902|NCT02325739|472414973|FG008|Phase I Part|Progressive disease|0|||
131215903|NCT02325739|472414974|FG009|Phase I Part|Progressive disease|0|||
131215904|NCT02325739|472414975|FG010|Phase I Part|Progressive disease|0|||
131215905|NCT02325739|472414965|FG000|Phase I Part|Subject/guardian decision|1|||
131215906|NCT02325739|472414966|FG001|Phase I Part|Subject/guardian decision|0|||
131215907|NCT02325739|472414967|FG002|Phase I Part|Subject/guardian decision|1|||
131215908|NCT02325739|472414968|FG003|Phase I Part|Subject/guardian decision|1|||
131215909|NCT02325739|472414969|FG004|Phase I Part|Subject/guardian decision|0|||
131215910|NCT02325739|472414970|FG005|Phase I Part|Subject/guardian decision|0|||
131215911|NCT02325739|472414971|FG006|Phase I Part|Subject/guardian decision|0|||
131215912|NCT02325739|472414972|FG007|Phase I Part|Subject/guardian decision|1|||
130882615|NCT00870740|471205552|FG004|Overall Study|Subject Non-compliance|0|||
130882616|NCT00870740|471205553|FG005|Overall Study|Subject Non-compliance|1|||
130882617|NCT00870740|471205548|FG000|Overall Study|Death|0|||
131215913|NCT02325739|472414973|FG008|Phase I Part|Subject/guardian decision|0|||
131215914|NCT02325739|472414974|FG009|Phase I Part|Subject/guardian decision|0|||
131215915|NCT02325739|472414975|FG010|Phase I Part|Subject/guardian decision|0|||
131215916|NCT02325739|472414965|FG000|Phase I Part|Death|0|||
131215917|NCT02325739|472414966|FG001|Phase I Part|Death|0|||
131215918|NCT02325739|472414967|FG002|Phase I Part|Death|0|||
131215919|NCT02325739|472414968|FG003|Phase I Part|Death|0|||
131215920|NCT02325739|472414969|FG004|Phase I Part|Death|2|||
131215921|NCT02325739|472414970|FG005|Phase I Part|Death|0|||
131215922|NCT02325739|472414971|FG006|Phase I Part|Death|0|||
131215923|NCT02325739|472414972|FG007|Phase I Part|Death|0|||
131215924|NCT02325739|472414973|FG008|Phase I Part|Death|0|||
131215925|NCT02325739|472414974|FG009|Phase I Part|Death|0|||
131215926|NCT02325739|472414975|FG010|Phase I Part|Death|0|||
131215927|NCT02325739|472414965|FG000|Phase II Part|Adverse Event|0|||
131215928|NCT02325739|472414966|FG001|Phase II Part|Adverse Event|0|||
131215929|NCT02325739|472414967|FG002|Phase II Part|Adverse Event|0|||
131215930|NCT02325739|472414968|FG003|Phase II Part|Adverse Event|0|||
131215931|NCT02325739|472414969|FG004|Phase II Part|Adverse Event|0|||
131215932|NCT02325739|472414970|FG005|Phase II Part|Adverse Event|0|||
131215933|NCT02325739|472414971|FG006|Phase II Part|Adverse Event|0|||
131215934|NCT02325739|472414972|FG007|Phase II Part|Adverse Event|0|||
131215935|NCT02325739|472414973|FG008|Phase II Part|Adverse Event|4|||
131215936|NCT02325739|472414974|FG009|Phase II Part|Adverse Event|5|||
131215937|NCT02325739|472414975|FG010|Phase II Part|Adverse Event|1|||
131215938|NCT02325739|472414965|FG000|Phase II Part|Physician Decision|0|||
131215939|NCT02325739|472414966|FG001|Phase II Part|Physician Decision|0|||
131215940|NCT02325739|472414967|FG002|Phase II Part|Physician Decision|0|||
131215941|NCT02325739|472414968|FG003|Phase II Part|Physician Decision|0|||
131215942|NCT02325739|472414969|FG004|Phase II Part|Physician Decision|0|||
131215943|NCT02325739|472414970|FG005|Phase II Part|Physician Decision|0|||
131215944|NCT02325739|472414971|FG006|Phase II Part|Physician Decision|0|||
131215945|NCT02325739|472414972|FG007|Phase II Part|Physician Decision|0|||
131215946|NCT02325739|472414973|FG008|Phase II Part|Physician Decision|0|||
131215947|NCT02325739|472414974|FG009|Phase II Part|Physician Decision|1|||
131215948|NCT02325739|472414975|FG010|Phase II Part|Physician Decision|0|||
131215949|NCT02325739|472414965|FG000|Phase II Part|Progressive disease|0|||
131215950|NCT02325739|472414966|FG001|Phase II Part|Progressive disease|0|||
131215951|NCT02325739|472414967|FG002|Phase II Part|Progressive disease|0|||
131215952|NCT02325739|472414968|FG003|Phase II Part|Progressive disease|0|||
131215953|NCT02325739|472414969|FG004|Phase II Part|Progressive disease|0|||
131215954|NCT02325739|472414970|FG005|Phase II Part|Progressive disease|0|||
131215955|NCT02325739|472414971|FG006|Phase II Part|Progressive disease|0|||
131215956|NCT02325739|472414972|FG007|Phase II Part|Progressive disease|0|||
131215957|NCT02325739|472414973|FG008|Phase II Part|Progressive disease|22|||
131215958|NCT02325739|472414974|FG009|Phase II Part|Progressive disease|29|||
131215959|NCT02325739|472414975|FG010|Phase II Part|Progressive disease|18|||
131215960|NCT02325739|472414965|FG000|Phase II Part|Subject/guardian decision|0|||
131215961|NCT02325739|472414966|FG001|Phase II Part|Subject/guardian decision|0|||
131215962|NCT02325739|472414967|FG002|Phase II Part|Subject/guardian decision|0|||
131215963|NCT02325739|472414968|FG003|Phase II Part|Subject/guardian decision|0|||
131215964|NCT02325739|472414969|FG004|Phase II Part|Subject/guardian decision|0|||
131215965|NCT02325739|472414970|FG005|Phase II Part|Subject/guardian decision|0|||
131215966|NCT02325739|472414971|FG006|Phase II Part|Subject/guardian decision|0|||
131215967|NCT02325739|472414972|FG007|Phase II Part|Subject/guardian decision|0|||
131215968|NCT02325739|472414973|FG008|Phase II Part|Subject/guardian decision|4|||
131215969|NCT02325739|472414974|FG009|Phase II Part|Subject/guardian decision|1|||
131215970|NCT02325739|472414975|FG010|Phase II Part|Subject/guardian decision|1|||
131215971|NCT00530621|472414984|FG000|Overall Study|Adverse Event|11|||
131215972|NCT00530621|472414985|FG001|Overall Study|Adverse Event|8|||
131215973|NCT00530621|472414984|FG000|Overall Study|Physician Decision|2|||
131215974|NCT00530621|472414985|FG001|Overall Study|Physician Decision|4|||
131215975|NCT00530621|472414984|FG000|Overall Study|Progressive Disease (PD)|47|||
131215976|NCT00530621|472414985|FG001|Overall Study|Progressive Disease (PD)|40|||
131215977|NCT00530621|472414984|FG000|Overall Study|Sponsor Decision|12|||
131215978|NCT00530621|472414985|FG001|Overall Study|Sponsor Decision|15|||
131215979|NCT00530621|472414984|FG000|Overall Study|Subject Decision|4|||
131215980|NCT00530621|472414985|FG001|Overall Study|Subject Decision|7|||
131215981|NCT00530621|472414984|FG000|Overall Study|Death|3|||
131215982|NCT00530621|472414985|FG001|Overall Study|Death|6|||
131215983|NCT00530621|472414984|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
131215984|NCT00530621|472414985|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
131215985|NCT02596009|472414986|FG000|Overall Study|Administrative problems|0|||
130765853|NCT00314132|470765885|FG000|Overall Study|Withdrawal by Subject|3|||
130882618|NCT00870740|471205549|FG001|Overall Study|Death|0|||
130882619|NCT00870740|471205550|FG002|Overall Study|Death|0|||
130882620|NCT00870740|471205551|FG003|Overall Study|Death|0|||
131215986|NCT02596009|472414987|FG001|Overall Study|Administrative problems|1|||
131215987|NCT02596009|472414988|FG002|Overall Study|Administrative problems|0|||
131215988|NCT02596009|472414989|FG003|Overall Study|Administrative problems|0|||
131215989|NCT02596009|472414990|FG004|Overall Study|Administrative problems|0|||
131215990|NCT02596009|472414991|FG005|Overall Study|Administrative problems|0|||
131215991|NCT00518011|472414992|FG000|Overall Study|Death|1|||
131215992|NCT00518011|472414993|FG001|Overall Study|Death|1|||
131215993|NCT00518011|472414992|FG000|Overall Study|Adverse Event|2|||
131215994|NCT00518011|472414993|FG001|Overall Study|Adverse Event|3|||
131215995|NCT00518011|472414992|FG000|Overall Study|Disease Progression|2|||
131215996|NCT00518011|472414993|FG001|Overall Study|Disease Progression|2|||
131215997|NCT00518011|472414992|FG000|Overall Study|Other Reasons|3|||
131215998|NCT00518011|472414993|FG001|Overall Study|Other Reasons|2|||
131215999|NCT00518011|472414992|FG000|Overall Study|Withdrawal by Subject|1|||
131216000|NCT00518011|472414993|FG001|Overall Study|Withdrawal by Subject|0|||
131216001|NCT03409328|472414994|FG000|Overall Study|Lost to Follow-up|6|||
131216002|NCT03409328|472414995|FG001|Overall Study|Lost to Follow-up|3|||
131216003|NCT02998645|472414996|FG000|Treatment Period 1|Adverse Event|6|||
131216004|NCT02998645|472414996|FG000|Treatment Period 1|Death|5|||
131216005|NCT02998645|472414996|FG000|Treatment Period 1|Technical Problems|4|||
131216006|NCT02998645|472414996|FG000|Treatment Period 1|Lack of Efficacy|2|||
131216007|NCT02998645|472414996|FG000|Treatment Period 1|Progressive disease|1|||
131216008|NCT02998645|472414996|FG000|Treatment Period 1|Subject/guardian decision|1|||
131216009|NCT02998645|472414996|FG000|Treatment Period 2|Lack of Efficacy|5|||
131216010|NCT02998645|472414996|FG000|Treatment Period 2|Adverse Event|2|||
131216011|NCT02998645|472414996|FG000|Treatment Period 2|Progressive disease|2|||
131216012|NCT02998645|472414996|FG000|Treatment Period 2|Physician Decision|1|||
131216013|NCT03930615|472415000|FG000|Overall Study|Death|9|||
131216014|NCT03930615|472415001|FG001|Overall Study|Death|3|||
131216015|NCT03930615|472415000|FG000|Overall Study|Lost to Follow-up|1|||
131216016|NCT03930615|472415001|FG001|Overall Study|Lost to Follow-up|2|||
131216017|NCT03930615|472415000|FG000|Overall Study|Physician Decision|3|||
131216018|NCT03930615|472415001|FG001|Overall Study|Physician Decision|4|||
131216019|NCT03930615|472415000|FG000|Overall Study|Withdrawal by Subject|13|||
131216020|NCT03930615|472415001|FG001|Overall Study|Withdrawal by Subject|2|||
131216021|NCT03930615|472415000|FG000|Overall Study|Not treated|1|||
131216022|NCT03930615|472415001|FG001|Overall Study|Not treated|1|||
131216023|NCT04611152|472415004|FG000|Overall Study|Adverse Event|9|||
131216024|NCT04611152|472415005|FG001|Overall Study|Adverse Event|8|||
131216025|NCT04611152|472415004|FG000|Overall Study|Non-compliance with study schedule|1|||
131216026|NCT04611152|472415005|FG001|Overall Study|Non-compliance with study schedule|3|||
131216027|NCT04611152|472415004|FG000|Overall Study|Withdrawal by Subject|5|||
131216028|NCT04611152|472415005|FG001|Overall Study|Withdrawal by Subject|6|||
131216029|NCT04611152|472415004|FG000|Overall Study|Lost to Follow-up|11|||
131216030|NCT04611152|472415005|FG001|Overall Study|Lost to Follow-up|2|||
131216031|NCT03644927|472415008|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
131216032|NCT03644927|472415009|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
131216033|NCT00956813|472415013|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
131216034|NCT00956813|472415014|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
131216035|NCT00956813|472415013|FG000|Flaxseed and Placebo|Ineligible|3|||
131216036|NCT00956813|472415014|FG001|Flaxseed and Placebo|Ineligible|1|||
131216037|NCT04797637|472415015|FG000|Overall Study|Lost to Follow-up|23|||
131216038|NCT04797637|472415016|FG001|Overall Study|Lost to Follow-up|32|||
131216039|NCT04797637|472415015|FG000|Overall Study|Withdrawal by Subject|0|||
131216040|NCT04797637|472415016|FG001|Overall Study|Withdrawal by Subject|1|||
131216041|NCT00605839|472415021|FG000|Overall Study|Protocol Violation|1|||
131216042|NCT00605839|472415022|FG001|Overall Study|Protocol Violation|0|||
131216043|NCT00605839|472415023|FG002|Overall Study|Protocol Violation|0|||
131216044|NCT01023022|472415026|FG000|Overall Study|Death|5|||
131216045|NCT01023022|472415026|FG000|Overall Study|Lost to Follow-up|7|||
131216046|NCT01023022|472415026|FG000|Overall Study|due to technical issues|2|||
131216047|NCT03917654|472415027|FG000|Year 1|Withdrawal by Subject|1|||
131216048|NCT03917654|472415028|FG001|Year 1|Withdrawal by Subject|0|||
131216049|NCT03917654|472415029|FG002|Year 1|Withdrawal by Subject|0|||
131216050|NCT03917654|472415030|FG003|Year 1|Withdrawal by Subject|0|||
131216051|NCT03917654|472415031|FG004|Year 1|Withdrawal by Subject|0|||
131216052|NCT03917654|472415032|FG005|Year 1|Withdrawal by Subject|1|||
131216053|NCT03917654|472415033|FG006|Year 1|Withdrawal by Subject|6|||
131216054|NCT03917654|472415034|FG007|Year 1|Withdrawal by Subject|2|||
131216055|NCT03917654|472415035|FG008|Year 1|Withdrawal by Subject|5|||
131216056|NCT03917654|472415036|FG009|Year 1|Withdrawal by Subject|3|||
131216057|NCT03917654|472415037|FG010|Year 1|Withdrawal by Subject|1|||
131216058|NCT03917654|472415038|FG011|Year 1|Withdrawal by Subject|0|||
131216059|NCT03917654|472415027|FG000|Year 1|Travel|0|||
131216060|NCT03917654|472415028|FG001|Year 1|Travel|1|||
131216061|NCT03917654|472415029|FG002|Year 1|Travel|1|||
131216062|NCT03917654|472415030|FG003|Year 1|Travel|0|||
131216063|NCT03917654|472415031|FG004|Year 1|Travel|4|||
131216064|NCT03917654|472415032|FG005|Year 1|Travel|4|||
131216065|NCT03917654|472415033|FG006|Year 1|Travel|10|||
131216066|NCT03917654|472415034|FG007|Year 1|Travel|8|||
131216067|NCT03917654|472415035|FG008|Year 1|Travel|2|||
131216068|NCT03917654|472415036|FG009|Year 1|Travel|5|||
131216069|NCT03917654|472415037|FG010|Year 1|Travel|3|||
131216070|NCT03917654|472415038|FG011|Year 1|Travel|3|||
131216071|NCT03917654|472415027|FG000|Year 1|Subject moved away from site|0|||
131216072|NCT03917654|472415028|FG001|Year 1|Subject moved away from site|1|||
131216073|NCT03917654|472415029|FG002|Year 1|Subject moved away from site|0|||
131216074|NCT03917654|472415030|FG003|Year 1|Subject moved away from site|0|||
131216075|NCT03917654|472415031|FG004|Year 1|Subject moved away from site|0|||
131216076|NCT03917654|472415032|FG005|Year 1|Subject moved away from site|0|||
131216077|NCT03917654|472415033|FG006|Year 1|Subject moved away from site|1|||
131216078|NCT03917654|472415034|FG007|Year 1|Subject moved away from site|2|||
131216079|NCT03917654|472415035|FG008|Year 1|Subject moved away from site|1|||
131216080|NCT03917654|472415036|FG009|Year 1|Subject moved away from site|0|||
130992604|NCT00539279|471599826|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
131216081|NCT03917654|472415037|FG010|Year 1|Subject moved away from site|0|||
131216082|NCT03917654|472415038|FG011|Year 1|Subject moved away from site|3|||
131216083|NCT03917654|472415027|FG000|Year 1|Spouse/Family member request|0|||
131216084|NCT03917654|472415028|FG001|Year 1|Spouse/Family member request|0|||
131216085|NCT03917654|472415029|FG002|Year 1|Spouse/Family member request|1|||
131216086|NCT03917654|472415030|FG003|Year 1|Spouse/Family member request|0|||
131216087|NCT03917654|472415031|FG004|Year 1|Spouse/Family member request|1|||
131216088|NCT03917654|472415032|FG005|Year 1|Spouse/Family member request|0|||
131216089|NCT03917654|472415033|FG006|Year 1|Spouse/Family member request|0|||
131216090|NCT03917654|472415034|FG007|Year 1|Spouse/Family member request|2|||
131216091|NCT03917654|472415035|FG008|Year 1|Spouse/Family member request|0|||
131216092|NCT03917654|472415036|FG009|Year 1|Spouse/Family member request|0|||
131216093|NCT03917654|472415037|FG010|Year 1|Spouse/Family member request|0|||
131216094|NCT03917654|472415038|FG011|Year 1|Spouse/Family member request|1|||
131216095|NCT03917654|472415027|FG000|Year 1|Death|0|||
131216096|NCT03917654|472415028|FG001|Year 1|Death|0|||
131216097|NCT03917654|472415029|FG002|Year 1|Death|0|||
131216098|NCT03917654|472415030|FG003|Year 1|Death|0|||
131216099|NCT03917654|472415031|FG004|Year 1|Death|0|||
131216100|NCT03917654|472415032|FG005|Year 1|Death|0|||
131216101|NCT03917654|472415033|FG006|Year 1|Death|0|||
131216102|NCT03917654|472415034|FG007|Year 1|Death|0|||
131216103|NCT03917654|472415035|FG008|Year 1|Death|1|||
131216104|NCT03917654|472415036|FG009|Year 1|Death|1|||
131216105|NCT03917654|472415037|FG010|Year 1|Death|0|||
131216106|NCT03917654|472415038|FG011|Year 1|Death|0|||
131216107|NCT03917654|472415027|FG000|Year 1|Lost to Follow-up|0|||
131216108|NCT03917654|472415028|FG001|Year 1|Lost to Follow-up|0|||
131216109|NCT03917654|472415029|FG002|Year 1|Lost to Follow-up|0|||
131216110|NCT03917654|472415030|FG003|Year 1|Lost to Follow-up|0|||
131216111|NCT03917654|472415031|FG004|Year 1|Lost to Follow-up|0|||
131216112|NCT03917654|472415032|FG005|Year 1|Lost to Follow-up|0|||
131216113|NCT03917654|472415033|FG006|Year 1|Lost to Follow-up|2|||
131216114|NCT03917654|472415034|FG007|Year 1|Lost to Follow-up|0|||
131216115|NCT03917654|472415035|FG008|Year 1|Lost to Follow-up|0|||
131216116|NCT03917654|472415036|FG009|Year 1|Lost to Follow-up|0|||
131216117|NCT03917654|472415037|FG010|Year 1|Lost to Follow-up|0|||
131216118|NCT03917654|472415038|FG011|Year 1|Lost to Follow-up|0|||
131216119|NCT03917654|472415027|FG000|Year 1|Missed visits|0|||
131216120|NCT03917654|472415028|FG001|Year 1|Missed visits|0|||
131216121|NCT03917654|472415029|FG002|Year 1|Missed visits|0|||
131216122|NCT03917654|472415030|FG003|Year 1|Missed visits|0|||
131216123|NCT03917654|472415031|FG004|Year 1|Missed visits|0|||
131216124|NCT03917654|472415032|FG005|Year 1|Missed visits|0|||
131216125|NCT03917654|472415033|FG006|Year 1|Missed visits|0|||
131216126|NCT03917654|472415034|FG007|Year 1|Missed visits|0|||
131216127|NCT03917654|472415035|FG008|Year 1|Missed visits|0|||
131216128|NCT03917654|472415036|FG009|Year 1|Missed visits|0|||
131216129|NCT03917654|472415037|FG010|Year 1|Missed visits|1|||
131216130|NCT03917654|472415038|FG011|Year 1|Missed visits|1|||
131216131|NCT03917654|472415027|FG000|Year 1|Pregnancy|0|||
131216132|NCT03917654|472415028|FG001|Year 1|Pregnancy|0|||
131216133|NCT03917654|472415029|FG002|Year 1|Pregnancy|0|||
131216134|NCT03917654|472415030|FG003|Year 1|Pregnancy|0|||
131216135|NCT03917654|472415031|FG004|Year 1|Pregnancy|0|||
131216136|NCT03917654|472415032|FG005|Year 1|Pregnancy|0|||
131216137|NCT03917654|472415033|FG006|Year 1|Pregnancy|0|||
131216138|NCT03917654|472415034|FG007|Year 1|Pregnancy|1|||
131216139|NCT03917654|472415035|FG008|Year 1|Pregnancy|0|||
130992605|NCT01338012|471599829|FG000|Overall Study|Death|4|||
131216140|NCT03917654|472415036|FG009|Year 1|Pregnancy|1|||
131216141|NCT03917654|472415037|FG010|Year 1|Pregnancy|0|||
131216142|NCT03917654|472415038|FG011|Year 1|Pregnancy|0|||
131216143|NCT03917654|472415027|FG000|Year 2|Travel|1|||
131216144|NCT03917654|472415028|FG001|Year 2|Travel|0|||
131216145|NCT03917654|472415029|FG002|Year 2|Travel|0|||
131216146|NCT03917654|472415030|FG003|Year 2|Travel|0|||
131216147|NCT03917654|472415031|FG004|Year 2|Travel|1|||
131216148|NCT03917654|472415032|FG005|Year 2|Travel|1|||
131216149|NCT03917654|472415033|FG006|Year 2|Travel|2|||
131216150|NCT03917654|472415034|FG007|Year 2|Travel|1|||
131216151|NCT03917654|472415035|FG008|Year 2|Travel|0|||
131216152|NCT03917654|472415036|FG009|Year 2|Travel|1|||
131216153|NCT03917654|472415037|FG010|Year 2|Travel|0|||
131216154|NCT03917654|472415038|FG011|Year 2|Travel|1|||
131216155|NCT03917654|472415027|FG000|Year 2|Married|1|||
131216156|NCT03917654|472415028|FG001|Year 2|Married|0|||
131216157|NCT03917654|472415029|FG002|Year 2|Married|0|||
131216158|NCT03917654|472415030|FG003|Year 2|Married|0|||
131216159|NCT03917654|472415031|FG004|Year 2|Married|0|||
131216160|NCT03917654|472415032|FG005|Year 2|Married|0|||
131216161|NCT03917654|472415033|FG006|Year 2|Married|1|||
131216162|NCT03917654|472415034|FG007|Year 2|Married|1|||
131216163|NCT03917654|472415035|FG008|Year 2|Married|0|||
131216164|NCT03917654|472415036|FG009|Year 2|Married|0|||
131216165|NCT03917654|472415037|FG010|Year 2|Married|0|||
131216166|NCT03917654|472415038|FG011|Year 2|Married|0|||
131216167|NCT03917654|472415027|FG000|Year 2|Subject moved away from site|1|||
131216168|NCT03917654|472415028|FG001|Year 2|Subject moved away from site|0|||
131216169|NCT03917654|472415029|FG002|Year 2|Subject moved away from site|0|||
131216170|NCT03917654|472415030|FG003|Year 2|Subject moved away from site|0|||
131216171|NCT03917654|472415031|FG004|Year 2|Subject moved away from site|1|||
131216172|NCT03917654|472415032|FG005|Year 2|Subject moved away from site|0|||
131216173|NCT03917654|472415033|FG006|Year 2|Subject moved away from site|2|||
131216174|NCT03917654|472415034|FG007|Year 2|Subject moved away from site|3|||
131216175|NCT03917654|472415035|FG008|Year 2|Subject moved away from site|0|||
131216176|NCT03917654|472415036|FG009|Year 2|Subject moved away from site|2|||
131216177|NCT03917654|472415037|FG010|Year 2|Subject moved away from site|0|||
131216178|NCT03917654|472415038|FG011|Year 2|Subject moved away from site|1|||
131216179|NCT03917654|472415027|FG000|Year 2|Year 2 Screening failure|0|||
131216180|NCT03917654|472415028|FG001|Year 2|Year 2 Screening failure|1|||
131216181|NCT03917654|472415029|FG002|Year 2|Year 2 Screening failure|0|||
131216182|NCT03917654|472415030|FG003|Year 2|Year 2 Screening failure|0|||
131216183|NCT03917654|472415031|FG004|Year 2|Year 2 Screening failure|2|||
131216184|NCT03917654|472415032|FG005|Year 2|Year 2 Screening failure|0|||
131216185|NCT03917654|472415033|FG006|Year 2|Year 2 Screening failure|4|||
131216186|NCT03917654|472415034|FG007|Year 2|Year 2 Screening failure|3|||
131216187|NCT03917654|472415035|FG008|Year 2|Year 2 Screening failure|10|||
131216188|NCT03917654|472415036|FG009|Year 2|Year 2 Screening failure|2|||
131216189|NCT03917654|472415037|FG010|Year 2|Year 2 Screening failure|1|||
131216190|NCT03917654|472415038|FG011|Year 2|Year 2 Screening failure|1|||
131216191|NCT03917654|472415027|FG000|Year 2|Death|0|||
131216192|NCT03917654|472415028|FG001|Year 2|Death|0|||
131216193|NCT03917654|472415029|FG002|Year 2|Death|0|||
131216194|NCT03917654|472415030|FG003|Year 2|Death|0|||
131216195|NCT03917654|472415031|FG004|Year 2|Death|0|||
131216196|NCT03917654|472415032|FG005|Year 2|Death|1|||
131216197|NCT03917654|472415033|FG006|Year 2|Death|0|||
131216198|NCT03917654|472415034|FG007|Year 2|Death|0|||
131216199|NCT03917654|472415035|FG008|Year 2|Death|1|||
131216200|NCT03917654|472415036|FG009|Year 2|Death|1|||
131216201|NCT03917654|472415037|FG010|Year 2|Death|0|||
131216202|NCT03917654|472415038|FG011|Year 2|Death|0|||
131216203|NCT03917654|472415027|FG000|Year 2|Withdrawal by Subject|0|||
131216204|NCT03917654|472415028|FG001|Year 2|Withdrawal by Subject|0|||
131216205|NCT03917654|472415029|FG002|Year 2|Withdrawal by Subject|0|||
131216206|NCT03917654|472415030|FG003|Year 2|Withdrawal by Subject|0|||
131216207|NCT03917654|472415031|FG004|Year 2|Withdrawal by Subject|0|||
131216208|NCT03917654|472415032|FG005|Year 2|Withdrawal by Subject|0|||
131216209|NCT03917654|472415033|FG006|Year 2|Withdrawal by Subject|3|||
131216210|NCT03917654|472415034|FG007|Year 2|Withdrawal by Subject|0|||
131216211|NCT03917654|472415035|FG008|Year 2|Withdrawal by Subject|2|||
131216212|NCT03917654|472415036|FG009|Year 2|Withdrawal by Subject|5|||
131216213|NCT03917654|472415037|FG010|Year 2|Withdrawal by Subject|0|||
131216214|NCT03917654|472415038|FG011|Year 2|Withdrawal by Subject|0|||
131216215|NCT03917654|472415027|FG000|Year 2|Spouse/family member request|0|||
131216216|NCT03917654|472415028|FG001|Year 2|Spouse/family member request|0|||
131216217|NCT03917654|472415029|FG002|Year 2|Spouse/family member request|0|||
131216218|NCT03917654|472415030|FG003|Year 2|Spouse/family member request|0|||
131216219|NCT03917654|472415031|FG004|Year 2|Spouse/family member request|0|||
131216220|NCT03917654|472415032|FG005|Year 2|Spouse/family member request|0|||
131216221|NCT03917654|472415033|FG006|Year 2|Spouse/family member request|1|||
131216222|NCT03917654|472415034|FG007|Year 2|Spouse/family member request|0|||
131216223|NCT03917654|472415035|FG008|Year 2|Spouse/family member request|0|||
131216224|NCT03917654|472415036|FG009|Year 2|Spouse/family member request|0|||
131216225|NCT03917654|472415037|FG010|Year 2|Spouse/family member request|0|||
131216226|NCT03917654|472415038|FG011|Year 2|Spouse/family member request|0|||
131216227|NCT03917654|472415027|FG000|Year 2|Lost to Follow-up|0|||
131216228|NCT03917654|472415028|FG001|Year 2|Lost to Follow-up|0|||
131216229|NCT03917654|472415029|FG002|Year 2|Lost to Follow-up|0|||
131216230|NCT03917654|472415030|FG003|Year 2|Lost to Follow-up|0|||
131216231|NCT03917654|472415031|FG004|Year 2|Lost to Follow-up|0|||
131216232|NCT03917654|472415032|FG005|Year 2|Lost to Follow-up|0|||
131216233|NCT03917654|472415033|FG006|Year 2|Lost to Follow-up|1|||
131216234|NCT03917654|472415034|FG007|Year 2|Lost to Follow-up|0|||
131216235|NCT03917654|472415035|FG008|Year 2|Lost to Follow-up|1|||
131216236|NCT03917654|472415036|FG009|Year 2|Lost to Follow-up|0|||
131216237|NCT03917654|472415037|FG010|Year 2|Lost to Follow-up|0|||
130992606|NCT01338012|471599829|FG000|Overall Study|Study terminated|4|||
130992607|NCT02714205|471599830|FG000|Overall Study|Cannot tolerate medication|1|||
130992608|NCT02714205|471599831|FG001|Overall Study|Cannot tolerate medication|0|||
130992609|NCT02714205|471599830|FG000|Overall Study|Adverse Event|2|||
130992610|NCT02714205|471599831|FG001|Overall Study|Adverse Event|0|||
130992611|NCT02714205|471599830|FG000|Overall Study|Too busy|1|||
130992612|NCT02714205|471599831|FG001|Overall Study|Too busy|0|||
130992613|NCT02714205|471599830|FG000|Overall Study|Incomplete outcome data|0|||
130992614|NCT02714205|471599831|FG001|Overall Study|Incomplete outcome data|1|||
130992615|NCT02769065|471601556|FG000|Overall Study|Voluntary Withdrawal|1|||
130992616|NCT02769065|471601557|FG001|Overall Study|Voluntary Withdrawal|0|||
130992617|NCT02769065|471601558|FG002|Overall Study|Voluntary Withdrawal|0|||
130992618|NCT02769065|471601559|FG003|Overall Study|Voluntary Withdrawal|0|||
130992619|NCT02769065|471601560|FG004|Overall Study|Voluntary Withdrawal|0|||
130992620|NCT02769065|471601561|FG005|Overall Study|Voluntary Withdrawal|0|||
130992621|NCT02769065|471601562|FG006|Overall Study|Voluntary Withdrawal|0|||
130992622|NCT02769065|471601563|FG007|Overall Study|Voluntary Withdrawal|0|||
130992623|NCT02769065|471601564|FG008|Overall Study|Voluntary Withdrawal|0|||
130992624|NCT02769065|471601565|FG009|Overall Study|Voluntary Withdrawal|0|||
130992625|NCT02769065|471601566|FG010|Overall Study|Voluntary Withdrawal|0|||
130992626|NCT02769065|471601567|FG011|Overall Study|Voluntary Withdrawal|0|||
130992627|NCT02769065|471601568|FG012|Overall Study|Voluntary Withdrawal|0|||
130992628|NCT02769065|471601569|FG013|Overall Study|Voluntary Withdrawal|0|||
130992629|NCT02769065|471601570|FG014|Overall Study|Voluntary Withdrawal|0|||
130992630|NCT02769065|471601571|FG015|Overall Study|Voluntary Withdrawal|0|||
130992631|NCT02769065|471601572|FG016|Overall Study|Voluntary Withdrawal|0|||
130992632|NCT02769065|471601573|FG017|Overall Study|Voluntary Withdrawal|0|||
130992633|NCT02769065|471601574|FG018|Overall Study|Voluntary Withdrawal|0|||
130992634|NCT02769065|471601575|FG019|Overall Study|Voluntary Withdrawal|0|||
130992635|NCT02769065|471601576|FG020|Overall Study|Voluntary Withdrawal|0|||
130992636|NCT02769065|471601577|FG021|Overall Study|Voluntary Withdrawal|0|||
130992637|NCT02769065|471601578|FG022|Overall Study|Voluntary Withdrawal|0|||
130992638|NCT02769065|471601579|FG023|Overall Study|Voluntary Withdrawal|0|||
130992639|NCT02769065|471601580|FG024|Overall Study|Voluntary Withdrawal|0|||
130992640|NCT02769065|471601581|FG025|Overall Study|Voluntary Withdrawal|0|||
130992641|NCT02769065|471601582|FG026|Overall Study|Voluntary Withdrawal|0|||
130992642|NCT02769065|471601583|FG027|Overall Study|Voluntary Withdrawal|0|||
130992643|NCT02769065|471601584|FG028|Overall Study|Voluntary Withdrawal|0|||
130992644|NCT02769065|471601585|FG029|Overall Study|Voluntary Withdrawal|0|||
130992645|NCT02769065|471601556|FG000|Overall Study|Reason Not Specified|0|||
130992646|NCT02769065|471601557|FG001|Overall Study|Reason Not Specified|0|||
130992647|NCT02769065|471601558|FG002|Overall Study|Reason Not Specified|0|||
130992648|NCT02769065|471601559|FG003|Overall Study|Reason Not Specified|0|||
130992649|NCT02769065|471601560|FG004|Overall Study|Reason Not Specified|0|||
130992650|NCT02769065|471601561|FG005|Overall Study|Reason Not Specified|0|||
130992651|NCT02769065|471601562|FG006|Overall Study|Reason Not Specified|1|||
130992652|NCT02769065|471601563|FG007|Overall Study|Reason Not Specified|0|||
130992653|NCT02769065|471601564|FG008|Overall Study|Reason Not Specified|0|||
130992654|NCT02769065|471601565|FG009|Overall Study|Reason Not Specified|0|||
130992655|NCT02769065|471601566|FG010|Overall Study|Reason Not Specified|0|||
130992656|NCT02769065|471601567|FG011|Overall Study|Reason Not Specified|0|||
130992657|NCT02769065|471601568|FG012|Overall Study|Reason Not Specified|0|||
130992658|NCT02769065|471601569|FG013|Overall Study|Reason Not Specified|0|||
130992659|NCT02769065|471601570|FG014|Overall Study|Reason Not Specified|0|||
130992660|NCT02769065|471601571|FG015|Overall Study|Reason Not Specified|0|||
130992661|NCT02769065|471601572|FG016|Overall Study|Reason Not Specified|0|||
130992662|NCT02769065|471601573|FG017|Overall Study|Reason Not Specified|0|||
130992663|NCT02769065|471601574|FG018|Overall Study|Reason Not Specified|0|||
130992664|NCT02769065|471601575|FG019|Overall Study|Reason Not Specified|0|||
130992665|NCT02769065|471601576|FG020|Overall Study|Reason Not Specified|0|||
130992666|NCT02769065|471601577|FG021|Overall Study|Reason Not Specified|0|||
130992667|NCT02769065|471601578|FG022|Overall Study|Reason Not Specified|0|||
130992668|NCT02769065|471601579|FG023|Overall Study|Reason Not Specified|0|||
130992669|NCT02769065|471601580|FG024|Overall Study|Reason Not Specified|0|||
130992670|NCT02769065|471601581|FG025|Overall Study|Reason Not Specified|0|||
130992671|NCT02769065|471601582|FG026|Overall Study|Reason Not Specified|0|||
130992672|NCT02769065|471601583|FG027|Overall Study|Reason Not Specified|0|||
130992673|NCT02769065|471601584|FG028|Overall Study|Reason Not Specified|0|||
130992674|NCT02769065|471601585|FG029|Overall Study|Reason Not Specified|0|||
131216238|NCT03917654|472415038|FG011|Year 2|Lost to Follow-up|1|||
131216239|NCT03917654|472415027|FG000|Year 2|Adverse Event|0|||
131216240|NCT03917654|472415028|FG001|Year 2|Adverse Event|0|||
131216241|NCT03917654|472415029|FG002|Year 2|Adverse Event|0|||
130992675|NCT02769065|471601556|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992676|NCT02769065|471601557|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
131216242|NCT03917654|472415030|FG003|Year 2|Adverse Event|0|||
131216243|NCT03917654|472415031|FG004|Year 2|Adverse Event|0|||
131216244|NCT03917654|472415032|FG005|Year 2|Adverse Event|0|||
131216245|NCT03917654|472415033|FG006|Year 2|Adverse Event|0|||
131216246|NCT03917654|472415034|FG007|Year 2|Adverse Event|0|||
131216247|NCT03917654|472415035|FG008|Year 2|Adverse Event|0|||
131216248|NCT03917654|472415036|FG009|Year 2|Adverse Event|1|||
131216249|NCT03917654|472415037|FG010|Year 2|Adverse Event|0|||
131216250|NCT03917654|472415038|FG011|Year 2|Adverse Event|0|||
131216251|NCT03728257|472415039|FG000|Overall Study|Death|3|||
131216252|NCT03728257|472415040|FG001|Overall Study|Death|0|||
131216253|NCT00905437|472415043|FG000|Overall Study|Adverse Event|3|||
131216254|NCT00905437|472415044|FG001|Overall Study|Adverse Event|2|||
131216255|NCT00905437|472415043|FG000|Overall Study|Lost to Follow-up|0|||
131216256|NCT00905437|472415044|FG001|Overall Study|Lost to Follow-up|1|||
131216257|NCT00905437|472415043|FG000|Overall Study|Withdrawal by Subject|0|||
131216258|NCT00905437|472415044|FG001|Overall Study|Withdrawal by Subject|1|||
131216259|NCT00905437|472415043|FG000|Overall Study|Other|5|||
131216260|NCT00905437|472415044|FG001|Overall Study|Other|6|||
131216261|NCT01306968|472415047|FG000|Overall Study|Lost to Follow-up|1|||
131216262|NCT01306968|472415048|FG001|Overall Study|Lost to Follow-up|1|||
131216263|NCT01306968|472415049|FG002|Overall Study|Lost to Follow-up|0|||
131216264|NCT01306968|472415050|FG003|Overall Study|Lost to Follow-up|0|||
131216265|NCT01306968|472415047|FG000|Overall Study|Physician Decision|0|||
131216266|NCT01306968|472415048|FG001|Overall Study|Physician Decision|1|||
131216267|NCT01306968|472415049|FG002|Overall Study|Physician Decision|0|||
131216268|NCT01306968|472415050|FG003|Overall Study|Physician Decision|0|||
131216269|NCT01306968|472415047|FG000|Overall Study|Relocated and left active duty|0|||
131216270|NCT01306968|472415048|FG001|Overall Study|Relocated and left active duty|1|||
131216271|NCT01306968|472415049|FG002|Overall Study|Relocated and left active duty|1|||
131216272|NCT01306968|472415050|FG003|Overall Study|Relocated and left active duty|1|||
131216273|NCT01306968|472415047|FG000|Overall Study|Withdrew - time commitment|0|||
131216274|NCT01306968|472415048|FG001|Overall Study|Withdrew - time commitment|0|||
131216275|NCT01306968|472415049|FG002|Overall Study|Withdrew - time commitment|0|||
131216276|NCT01306968|472415050|FG003|Overall Study|Withdrew - time commitment|2|||
131216277|NCT01306968|472415047|FG000|Overall Study|Withdrew over privacy concerns|0|||
131216278|NCT01306968|472415048|FG001|Overall Study|Withdrew over privacy concerns|0|||
131216279|NCT01306968|472415049|FG002|Overall Study|Withdrew over privacy concerns|0|||
131216280|NCT01306968|472415050|FG003|Overall Study|Withdrew over privacy concerns|1|||
131216281|NCT03252015|472415053|FG000|Overall Study|Withdrawal by Subject|0|||
131216282|NCT03252015|472415054|FG001|Overall Study|Withdrawal by Subject|1|||
131216283|NCT03252015|472415055|FG002|Overall Study|Withdrawal by Subject|1|||
131216284|NCT03252015|472415056|FG003|Overall Study|Withdrawal by Subject|0|||
131216285|NCT03252015|472415053|FG000|Overall Study|Adverse Event|1|||
131216286|NCT03252015|472415054|FG001|Overall Study|Adverse Event|0|||
131216287|NCT03252015|472415055|FG002|Overall Study|Adverse Event|0|||
131216288|NCT03252015|472415056|FG003|Overall Study|Adverse Event|1|||
131216289|NCT01329562|472415057|FG000|Overall Study|Protocol Violation|5|||
131216290|NCT01329562|472415058|FG001|Overall Study|Protocol Violation|3|||
131216291|NCT01329562|472415057|FG000|Overall Study|Lost to Follow-up|1|||
131216292|NCT01329562|472415058|FG001|Overall Study|Lost to Follow-up|1|||
131216293|NCT01329562|472415057|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
131216294|NCT01329562|472415058|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
131216295|NCT01329562|472415057|FG000|Overall Study|Physician Decision|0|||
131216296|NCT01329562|472415058|FG001|Overall Study|Physician Decision|1|||
131216297|NCT03128931|472415059|FG000|Overall Study|Physician Decision|1|||
131216298|NCT03128931|472415059|FG000|Overall Study|Equipment Issues|3|||
131216299|NCT04993339|472415060|FG000|Overall Study|Lost to Follow-up|0|||
131216300|NCT04993339|472415061|FG001|Overall Study|Lost to Follow-up|1|||
131216301|NCT04993339|472415060|FG000|Overall Study|no MRI scan|3|||
131216302|NCT04993339|472415061|FG001|Overall Study|no MRI scan|1|||
131216303|NCT00690573|472415073|FG000|Overall Study|Lack of Efficacy|8|||
131216304|NCT00690573|472415073|FG000|Overall Study|Withdrawal by Subject|1|||
131216305|NCT01808508|472416765|FG000|Overall Study|Lost to Follow-up|1|||
131216306|NCT01808508|472416766|FG001|Overall Study|Lost to Follow-up|0|||
131216307|NCT01808508|472416767|FG002|Overall Study|Lost to Follow-up|0|||
131216308|NCT01017731|472416768|FG000|Overall Study|Lost to Follow-up|2|||
131216309|NCT01017731|472416768|FG000|Overall Study|Withdrawal by Subject|3|||
131216310|NCT01017731|472416768|FG000|Overall Study|Physician Decision|2|||
131216311|NCT01017731|472416768|FG000|Overall Study|Adverse Event|1|||
131216312|NCT05378269|472416769|FG000|Overall Study|Protocol Violation|1|||
131216313|NCT05378269|472416770|FG001|Overall Study|Protocol Violation|0|||
131216314|NCT05378269|472416771|FG002|Overall Study|Protocol Violation|2|||
131216315|NCT05378269|472416772|FG003|Overall Study|Protocol Violation|0|||
131216316|NCT05378269|472416773|FG004|Overall Study|Protocol Violation|0|||
131216317|NCT00242567|472416776|FG000|Overall Study|Adverse Event|70|||
131216318|NCT00242567|472416777|FG001|Overall Study|Adverse Event|43|||
131216319|NCT00242567|472416776|FG000|Overall Study|Disease Progression|17|||
131216320|NCT00242567|472416777|FG001|Overall Study|Disease Progression|22|||
131216321|NCT00242567|472416776|FG000|Overall Study|Symptomatic deterioration|9|||
131216322|NCT00242567|472416777|FG001|Overall Study|Symptomatic deterioration|3|||
131216323|NCT00242567|472416776|FG000|Overall Study|Lack of Efficacy|2|||
131216324|NCT00242567|472416777|FG001|Overall Study|Lack of Efficacy|2|||
131216325|NCT00242567|472416776|FG000|Overall Study|Lost to Follow-up|9|||
131216326|NCT00242567|472416777|FG001|Overall Study|Lost to Follow-up|19|||
131216327|NCT00242567|472416776|FG000|Overall Study|Withdrawal by Subject|33|||
131216328|NCT00242567|472416777|FG001|Overall Study|Withdrawal by Subject|28|||
131216329|NCT00242567|472416776|FG000|Overall Study|Protocol Violation|12|||
131216330|NCT00242567|472416777|FG001|Overall Study|Protocol Violation|12|||
131216331|NCT00242567|472416776|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
131216332|NCT00242567|472416777|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
131216333|NCT00242567|472416776|FG000|Overall Study|Other|14|||
131216334|NCT00242567|472416777|FG001|Overall Study|Other|9|||
131216335|NCT01721200|472416778|FG000|Overall Study|Lost to Follow-up|3|||
131216336|NCT01721200|472416779|FG001|Overall Study|Lost to Follow-up|5|||
131216337|NCT03926728|472416780|FG000|Overall Study|Withdrawal by Subject|0|||
131216338|NCT03926728|472416781|FG001|Overall Study|Withdrawal by Subject|1|||
131216339|NCT03926728|472416782|FG002|Overall Study|Withdrawal by Subject|1|||
131216340|NCT03926728|472416783|FG003|Overall Study|Withdrawal by Subject|0|||
131216341|NCT03926728|472416784|FG004|Overall Study|Withdrawal by Subject|0|||
131216342|NCT03926728|472416785|FG005|Overall Study|Withdrawal by Subject|1|||
131216343|NCT03926728|472416786|FG006|Overall Study|Withdrawal by Subject|1|||
131216344|NCT03926728|472416787|FG007|Overall Study|Withdrawal by Subject|0|||
131216345|NCT03926728|472416788|FG008|Overall Study|Withdrawal by Subject|0|||
131216346|NCT03926728|472416789|FG009|Overall Study|Withdrawal by Subject|1|||
131216347|NCT03926728|472416790|FG010|Overall Study|Withdrawal by Subject|0|||
131216348|NCT03926728|472416791|FG011|Overall Study|Withdrawal by Subject|0|||
131216349|NCT02729545|472416792|FG000|Overall Study|Pregnancy|1|||
131216350|NCT02729545|472416793|FG001|Overall Study|Pregnancy|1|||
131216351|NCT02729545|472416792|FG000|Overall Study|Lost to Follow-up|0|||
131216352|NCT02729545|472416793|FG001|Overall Study|Lost to Follow-up|1|||
131216353|NCT02729545|472416792|FG000|Overall Study|Withdrawal by Subject|2|||
131216354|NCT02729545|472416793|FG001|Overall Study|Withdrawal by Subject|3|||
131216355|NCT00398632|472416794|FG000|Overall Study|Withdrawal by Subject|1|||
131216356|NCT00398632|472416794|FG000|Overall Study|Lack of Efficacy|1|||
131216357|NCT00366678|472416797|FG000|Infant Series|Withdrawal by Subject|8|||
131216358|NCT00366678|472416798|FG001|Infant Series|Withdrawal by Subject|6|||
131216359|NCT00366678|472416799|FG002|Infant Series|Withdrawal by Subject|0|||
131216360|NCT00366678|472416797|FG000|Infant Series|Protocol Violation|4|||
131216361|NCT00366678|472416798|FG001|Infant Series|Protocol Violation|3|||
131216362|NCT00366678|472416799|FG002|Infant Series|Protocol Violation|0|||
131216363|NCT00366678|472416797|FG000|Infant Series|Failed to return|1|||
131216364|NCT00366678|472416798|FG001|Infant Series|Failed to return|1|||
131216365|NCT00366678|472416799|FG002|Infant Series|Failed to return|0|||
131216366|NCT00366678|472416797|FG000|Infant Series|Adverse Event|1|||
131216367|NCT00366678|472416798|FG001|Infant Series|Adverse Event|0|||
131216368|NCT00366678|472416799|FG002|Infant Series|Adverse Event|0|||
131216369|NCT00366678|472416797|FG000|After Infant|Withdrawal by Subject|8|||
131216370|NCT00366678|472416798|FG001|After Infant|Withdrawal by Subject|4|||
131216371|NCT00366678|472416799|FG002|After Infant|Withdrawal by Subject|0|||
131216372|NCT00366678|472416797|FG000|After Infant|Lost to Follow-up|2|||
131216373|NCT00366678|472416798|FG001|After Infant|Lost to Follow-up|1|||
131216374|NCT00366678|472416799|FG002|After Infant|Lost to Follow-up|0|||
131216375|NCT00366678|472416797|FG000|After Infant|Failed to return|5|||
131216376|NCT00366678|472416798|FG001|After Infant|Failed to return|5|||
131216377|NCT00366678|472416799|FG002|After Infant|Failed to return|0|||
131216378|NCT00366678|472416797|FG000|After Infant|Adverse Event|1|||
131216379|NCT00366678|472416798|FG001|After Infant|Adverse Event|0|||
131216380|NCT00366678|472416799|FG002|After Infant|Adverse Event|0|||
131216381|NCT00366678|472416797|FG000|After Infant|Protocol Violation|1|||
131216382|NCT00366678|472416798|FG001|After Infant|Protocol Violation|0|||
131216383|NCT00366678|472416799|FG002|After Infant|Protocol Violation|0|||
131216384|NCT00366678|472416797|FG000|Toddler Dose|Protocol Violation|2|||
131216385|NCT00366678|472416798|FG001|Toddler Dose|Protocol Violation|1|||
131216386|NCT00366678|472416799|FG002|Toddler Dose|Protocol Violation|0|||
131216387|NCT00366678|472416797|FG000|Toddler Dose|Failed to return|1|||
131216388|NCT00366678|472416798|FG001|Toddler Dose|Failed to return|0|||
131216389|NCT00366678|472416799|FG002|Toddler Dose|Failed to return|0|||
131216390|NCT00366678|472416797|FG000|Toddler Dose|Withdrawal by Subject|1|||
131216391|NCT00366678|472416798|FG001|Toddler Dose|Withdrawal by Subject|0|||
131216392|NCT00366678|472416799|FG002|Toddler Dose|Withdrawal by Subject|0|||
131216393|NCT00366678|472416797|FG000|Toddler Dose|protocol deviation|1|||
131216394|NCT00366678|472416798|FG001|Toddler Dose|protocol deviation|0|||
131216395|NCT00366678|472416799|FG002|Toddler Dose|protocol deviation|0|||
131216396|NCT04292171|472416800|FG000|Overall Study|Pharmacy error|2|||
131216397|NCT04292171|472416801|FG001|Overall Study|Pharmacy error|0|||
131216398|NCT04292171|472416800|FG000|Overall Study|Delivered prior to procedure|0|||
131216399|NCT04292171|472416801|FG001|Overall Study|Delivered prior to procedure|1|||
131216400|NCT03079869|472416804|FG000|Overall Study|Adverse Event|6|||
131216401|NCT03079869|472416805|FG001|Overall Study|Adverse Event|8|||
131216402|NCT03079869|472416804|FG000|Overall Study|Withdrawal by Subject|4|||
131216403|NCT03079869|472416805|FG001|Overall Study|Withdrawal by Subject|1|||
131216404|NCT03079869|472416804|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
131216405|NCT03079869|472416805|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
131216406|NCT02411110|472416806|FG000|Treatment Period 1|Adverse Event|4|||
131216407|NCT02411110|472416807|FG001|Treatment Period 1|Adverse Event|2|||
131216408|NCT02411110|472416806|FG000|Treatment Period 1|Lost to Follow-up|1|||
131216409|NCT02411110|472416807|FG001|Treatment Period 1|Lost to Follow-up|0|||
131216410|NCT02411110|472416806|FG000|Treatment Period 1|Personal Reasons|2|||
131216411|NCT02411110|472416807|FG001|Treatment Period 1|Personal Reasons|5|||
131216412|NCT02411110|472416806|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
131216413|NCT02411110|472416807|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
131216414|NCT02411110|472416806|FG000|Treatment Period 2|Adverse Event|1|||
131216415|NCT02411110|472416807|FG001|Treatment Period 2|Adverse Event|0|||
131216416|NCT02411110|472416806|FG000|Treatment Period 2|Lost to Follow-up|0|||
131216417|NCT02411110|472416807|FG001|Treatment Period 2|Lost to Follow-up|2|||
131216418|NCT02411110|472416806|FG000|Treatment Period 2|Personal Reasons|0|||
131216419|NCT02411110|472416807|FG001|Treatment Period 2|Personal Reasons|2|||
131216420|NCT03292731|472416808|FG000|Overall Study|Protocol Violation|4|||
131216421|NCT03292731|472416809|FG001|Overall Study|Protocol Violation|11|||
131216422|NCT03292731|472416810|FG002|Overall Study|Protocol Violation|1|||
131216423|NCT00539006|472416819|FG000|Pre-treatment|Other|0|||
131216424|NCT00539006|472416820|FG001|Pre-treatment|Other|1|||
131216425|NCT00539006|472416821|FG002|Pre-treatment|Other|0|||
131216426|NCT00539006|472416822|FG003|Pre-treatment|Other|0|||
131216427|NCT00539006|472416819|FG000|Treatment Period 1|Lost to Follow-up|0|||
131216428|NCT00539006|472416820|FG001|Treatment Period 1|Lost to Follow-up|0|||
131216429|NCT00539006|472416821|FG002|Treatment Period 1|Lost to Follow-up|1|||
131216430|NCT00539006|472416822|FG003|Treatment Period 1|Lost to Follow-up|0|||
131216431|NCT00539006|472416819|FG000|Treatment Period 1|Protocol Violation|0|||
131216432|NCT00539006|472416820|FG001|Treatment Period 1|Protocol Violation|0|||
131216433|NCT00539006|472416821|FG002|Treatment Period 1|Protocol Violation|1|||
131216434|NCT00539006|472416822|FG003|Treatment Period 1|Protocol Violation|0|||
131216435|NCT00539006|472416819|FG000|Treatment Period 1|Lack of Efficacy|0|||
131216436|NCT00539006|472416820|FG001|Treatment Period 1|Lack of Efficacy|0|||
131216437|NCT00539006|472416821|FG002|Treatment Period 1|Lack of Efficacy|0|||
131216438|NCT00539006|472416822|FG003|Treatment Period 1|Lack of Efficacy|1|||
131216439|NCT00539006|472416819|FG000|Washout|Adverse Event|2|||
131216440|NCT00539006|472416820|FG001|Washout|Adverse Event|1|||
131216441|NCT00539006|472416821|FG002|Washout|Adverse Event|0|||
131216442|NCT00539006|472416822|FG003|Washout|Adverse Event|0|||
131216443|NCT00539006|472416819|FG000|Washout|Protocol Violation|1|||
131216444|NCT00539006|472416820|FG001|Washout|Protocol Violation|1|||
131216445|NCT00539006|472416821|FG002|Washout|Protocol Violation|0|||
131216446|NCT00539006|472416822|FG003|Washout|Protocol Violation|0|||
131216447|NCT00539006|472416819|FG000|Washout|Withdrawal by Subject|0|||
131216448|NCT00539006|472416820|FG001|Washout|Withdrawal by Subject|2|||
131216449|NCT00539006|472416821|FG002|Washout|Withdrawal by Subject|0|||
131216450|NCT00539006|472416822|FG003|Washout|Withdrawal by Subject|0|||
131216451|NCT00539006|472416819|FG000|Washout|Failed to meet continuation criteria|16|||
131216452|NCT00539006|472416820|FG001|Washout|Failed to meet continuation criteria|5|||
131216453|NCT00539006|472416821|FG002|Washout|Failed to meet continuation criteria|14|||
131216454|NCT00539006|472416822|FG003|Washout|Failed to meet continuation criteria|6|||
131216455|NCT00539006|472416819|FG000|Washout|Other|1|||
131216456|NCT00539006|472416820|FG001|Washout|Other|1|||
131216457|NCT00539006|472416821|FG002|Washout|Other|2|||
131216458|NCT00539006|472416822|FG003|Washout|Other|3|||
131216459|NCT00539006|472416819|FG000|Treatment Period 2|Protocol Violation|1|||
131216460|NCT00539006|472416820|FG001|Treatment Period 2|Protocol Violation|0|||
131216461|NCT00539006|472416821|FG002|Treatment Period 2|Protocol Violation|0|||
131216462|NCT00539006|472416822|FG003|Treatment Period 2|Protocol Violation|0|||
131216463|NCT00539006|472416819|FG000|Treatment Period 2|Other|0|||
131216464|NCT00539006|472416820|FG001|Treatment Period 2|Other|1|||
130882621|NCT00870740|471205552|FG004|Overall Study|Death|1|||
130882622|NCT00870740|471205553|FG005|Overall Study|Death|0|||
130882623|NCT00870740|471205548|FG000|Overall Study|Other|2|||
130882624|NCT00870740|471205549|FG001|Overall Study|Other|5|||
130882625|NCT00870740|471205550|FG002|Overall Study|Other|2|||
130882626|NCT00870740|471205551|FG003|Overall Study|Other|4|||
130882627|NCT00870740|471205552|FG004|Overall Study|Other|3|||
131216465|NCT00539006|472416821|FG002|Treatment Period 2|Other|0|||
131216466|NCT00539006|472416822|FG003|Treatment Period 2|Other|0|||
131216467|NCT01965431|472416823|FG000|Overall Study|Adverse Event|0|||
131216468|NCT01965431|472416824|FG001|Overall Study|Adverse Event|1|||
130882628|NCT00870740|471205553|FG005|Overall Study|Other|5|||
130882629|NCT03592186|471205554|FG000|Overall Study|Withdrawal by Subject|1|||
130882630|NCT03592186|471205555|FG001|Overall Study|Withdrawal by Subject|0|||
131216469|NCT01965431|472416825|FG002|Overall Study|Adverse Event|0|||
131216470|NCT01965431|472416826|FG003|Overall Study|Adverse Event|0|||
131216471|NCT01965431|472416827|FG004|Overall Study|Adverse Event|0|||
131216472|NCT01965431|472416828|FG005|Overall Study|Adverse Event|0|||
131216473|NCT01965431|472416823|FG000|Overall Study|Other than stated above|6|||
131216474|NCT01965431|472416824|FG001|Overall Study|Other than stated above|5|||
131216475|NCT01965431|472416825|FG002|Overall Study|Other than stated above|6|||
131216476|NCT01965431|472416826|FG003|Overall Study|Other than stated above|6|||
131216477|NCT01965431|472416827|FG004|Overall Study|Other than stated above|6|||
131216478|NCT01965431|472416828|FG005|Overall Study|Other than stated above|6|||
131216479|NCT01803464|472416829|FG000|Overall Study|Incomplete data|0|||
131216480|NCT01803464|472416830|FG001|Overall Study|Incomplete data|0|||
131216481|NCT01803464|472416831|FG002|Overall Study|Incomplete data|4|||
131216482|NCT01803464|472416832|FG003|Overall Study|Incomplete data|0|||
131216483|NCT01803464|472416829|FG000|Overall Study|Withdrawal by Subject|1|||
131216484|NCT01803464|472416830|FG001|Overall Study|Withdrawal by Subject|0|||
131216485|NCT01803464|472416831|FG002|Overall Study|Withdrawal by Subject|0|||
131216486|NCT01803464|472416832|FG003|Overall Study|Withdrawal by Subject|0|||
131216487|NCT02860039|472416833|FG000|Overall Study|Death|4|||
131216488|NCT02860039|472416834|FG001|Overall Study|Death|0|||
131216489|NCT02860039|472416833|FG000|Overall Study|Lost to Follow-up|2|||
131216490|NCT02860039|472416834|FG001|Overall Study|Lost to Follow-up|2|||
131216491|NCT02860039|472416833|FG000|Overall Study|Protocol Violation|3|||
131216492|NCT02860039|472416834|FG001|Overall Study|Protocol Violation|1|||
131216493|NCT02860039|472416833|FG000|Overall Study|Withdrawal by Subject|1|||
131216494|NCT02860039|472416834|FG001|Overall Study|Withdrawal by Subject|0|||
131216495|NCT02860039|472416833|FG000|Overall Study|Not otherwise eligible|1|||
131216496|NCT02860039|472416834|FG001|Overall Study|Not otherwise eligible|1|||
131216497|NCT03319368|472416838|FG000|Overall Study|Discharge swabs not collected from resident|57|||
131216498|NCT03319368|472416839|FG001|Overall Study|Discharge swabs not collected from resident|46|||
131216499|NCT03000075|472416840|FG000|Part A|Adverse Event|4|||
131216500|NCT03000075|472416841|FG001|Part A|Adverse Event|0|||
131216501|NCT03000075|472416842|FG002|Part A|Adverse Event|0|||
131216502|NCT03000075|472416843|FG003|Part A|Adverse Event|0|||
131216503|NCT03000075|472416844|FG004|Part A|Adverse Event|0|||
131216504|NCT03000075|472416845|FG005|Part A|Adverse Event|0|||
131216505|NCT03000075|472416846|FG006|Part A|Adverse Event|0|||
131216506|NCT03000075|472416840|FG000|Part B|Not dosed due to AE|0|||
131216507|NCT03000075|472416841|FG001|Part B|Not dosed due to AE|0|||
131216508|NCT03000075|472416842|FG002|Part B|Not dosed due to AE|0|||
131216509|NCT03000075|472416843|FG003|Part B|Not dosed due to AE|0|||
131216510|NCT03000075|472416844|FG004|Part B|Not dosed due to AE|0|||
131216511|NCT03000075|472416845|FG005|Part B|Not dosed due to AE|2|||
131216512|NCT03000075|472416846|FG006|Part B|Not dosed due to AE|1|||
131216513|NCT03000075|472416840|FG000|Part B|Adverse Event|0|||
131216514|NCT03000075|472416841|FG001|Part B|Adverse Event|0|||
131216515|NCT03000075|472416842|FG002|Part B|Adverse Event|0|||
131216516|NCT03000075|472416843|FG003|Part B|Adverse Event|0|||
131216517|NCT03000075|472416844|FG004|Part B|Adverse Event|1|||
131216518|NCT03000075|472416845|FG005|Part B|Adverse Event|0|||
131216519|NCT03000075|472416846|FG006|Part B|Adverse Event|0|||
131216520|NCT00111007|472416847|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
131216521|NCT00111007|472416848|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
131216522|NCT00111007|472416847|FG000|Double-blind (DB) Treatment|Death|5|||
131216523|NCT00111007|472416848|FG001|Double-blind (DB) Treatment|Death|2|||
131216524|NCT00111007|472416847|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
131216525|NCT00111007|472416848|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
131216526|NCT00111007|472416847|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
131216527|NCT00111007|472416848|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
131216528|NCT00111007|472416847|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
131216529|NCT00111007|472416848|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
131216530|NCT00111007|472416847|FG000|Double-blind (DB) Treatment|Relapse|1|||
131216531|NCT00111007|472416848|FG001|Double-blind (DB) Treatment|Relapse|0|||
131216532|NCT00111007|472416847|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
131216533|NCT00111007|472416848|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
131216534|NCT00111007|472416847|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
131216535|NCT00111007|472416848|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
131216536|NCT00111007|472416847|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
131216537|NCT00111007|472416848|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
131216538|NCT00111007|472416847|FG000|Active Follow-up|Adverse Event|1|||
131216539|NCT00111007|472416848|FG001|Active Follow-up|Adverse Event|0|||
131216540|NCT00111007|472416847|FG000|Active Follow-up|Death|2|||
131216541|NCT00111007|472416848|FG001|Active Follow-up|Death|0|||
131216542|NCT00111007|472416847|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
131216543|NCT00111007|472416848|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
131216544|NCT00111007|472416847|FG000|Long Term Follow-up|Death|34|||
131216545|NCT00111007|472416848|FG001|Long Term Follow-up|Death|39|||
131216546|NCT00111007|472416847|FG000|Long Term Follow-up|Lost to Follow-up|1|||
131216547|NCT00111007|472416848|FG001|Long Term Follow-up|Lost to Follow-up|1|||
131216548|NCT00111007|472416847|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
131216549|NCT00111007|472416848|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
131216550|NCT00111007|472416847|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
131216551|NCT00111007|472416848|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
131216552|NCT00111007|472416847|FG000|Long Term Follow-up|Missing|10|||
131216553|NCT00111007|472416848|FG001|Long Term Follow-up|Missing|3|||
131216554|NCT00440193|472416849|FG000|Treatment Period|Adverse Event|74|||
131216555|NCT00440193|472416850|FG001|Treatment Period|Adverse Event|67|||
131216556|NCT00440193|472416849|FG000|Treatment Period|Death|19|||
131216557|NCT00440193|472416850|FG001|Treatment Period|Death|22|||
131216558|NCT00440193|472416849|FG000|Treatment Period|Lack of Efficacy|0|||
131216559|NCT00440193|472416850|FG001|Treatment Period|Lack of Efficacy|1|||
131216560|NCT00440193|472416849|FG000|Treatment Period|Lost to Follow-up|12|||
131216561|NCT00440193|472416850|FG001|Treatment Period|Lost to Follow-up|18|||
131216562|NCT00440193|472416849|FG000|Treatment Period|Physician Decision|3|||
131216563|NCT00440193|472416850|FG001|Treatment Period|Physician Decision|6|||
131216564|NCT00440193|472416849|FG000|Treatment Period|Protocol Violation|16|||
131216565|NCT00440193|472416850|FG001|Treatment Period|Protocol Violation|19|||
131216566|NCT00440193|472416849|FG000|Treatment Period|Withdrawal by Subject|36|||
131216567|NCT00440193|472416850|FG001|Treatment Period|Withdrawal by Subject|77|||
131216568|NCT00440193|472416849|FG000|Treatment Period|Clinical endpoint reached|28|||
131216569|NCT00440193|472416850|FG001|Treatment Period|Clinical endpoint reached|25|||
131216570|NCT00440193|472416849|FG000|Treatment Period|Study terminated by sponsor|102|||
131216571|NCT00440193|472416850|FG001|Treatment Period|Study terminated by sponsor|94|||
131216572|NCT00440193|472416849|FG000|Treatment Period|Protocol driven decision point|2|||
131216573|NCT00440193|472416850|FG001|Treatment Period|Protocol driven decision point|2|||
131216574|NCT00440193|472416849|FG000|Treatment Period|Switch to commercial drug|0|||
131216575|NCT00440193|472416850|FG001|Treatment Period|Switch to commercial drug|2|||
131216576|NCT00440193|472416849|FG000|Treatment Period|Technical problems|1|||
131216577|NCT00440193|472416850|FG001|Treatment Period|Technical problems|1|||
131216578|NCT00440193|472416849|FG000|Treatment Period|Participant convenience|5|||
131216579|NCT00440193|472416850|FG001|Treatment Period|Participant convenience|2|||
131216580|NCT00440193|472416849|FG000|Treatment Period|Participant did not receive treatment|7|||
131216581|NCT00440193|472416850|FG001|Treatment Period|Participant did not receive treatment|13|||
131216582|NCT00440193|472416849|FG000|Treatment Period|Site closed by investigator|0|||
131216583|NCT00440193|472416850|FG001|Treatment Period|Site closed by investigator|2|||
131216584|NCT00440193|472416849|FG000|Observational Period|Adverse Event|2|||
131216585|NCT00440193|472416850|FG001|Observational Period|Adverse Event|2|||
131216586|NCT00440193|472416849|FG000|Observational Period|Death|15|||
131216587|NCT00440193|472416850|FG001|Observational Period|Death|20|||
131216588|NCT00440193|472416849|FG000|Observational Period|Lost to Follow-up|12|||
131216589|NCT00440193|472416850|FG001|Observational Period|Lost to Follow-up|8|||
131216590|NCT00440193|472416849|FG000|Observational Period|Protocol Violation|1|||
131216591|NCT00440193|472416850|FG001|Observational Period|Protocol Violation|0|||
131216592|NCT00440193|472416849|FG000|Observational Period|Withdrawal by Subject|11|||
131216593|NCT00440193|472416850|FG001|Observational Period|Withdrawal by Subject|8|||
131216594|NCT00440193|472416849|FG000|Observational Period|Physician Decision|1|||
131216595|NCT00440193|472416850|FG001|Observational Period|Physician Decision|0|||
131216596|NCT00440193|472416849|FG000|Observational Period|Clinical endpoint reached|1|||
131216597|NCT00440193|472416850|FG001|Observational Period|Clinical endpoint reached|0|||
131216598|NCT00440193|472416849|FG000|Observational Period|Participant convenience|2|||
131216599|NCT00440193|472416850|FG001|Observational Period|Participant convenience|0|||
131216600|NCT00824993|472416851|FG000|Overall Study|Withdrawal by Subject|1|||
131216601|NCT00824993|472416852|FG001|Overall Study|Withdrawal by Subject|1|||
131216602|NCT00824993|472416851|FG000|Overall Study|Malignancy Relapse|9|||
131216603|NCT00824993|472416852|FG001|Overall Study|Malignancy Relapse|10|||
131216604|NCT00824993|472416851|FG000|Overall Study|Rapid Bone Loss|0|||
131216605|NCT00824993|472416852|FG001|Overall Study|Rapid Bone Loss|1|||
131216606|NCT00824993|472416851|FG000|Overall Study|Non-Compliant|2|||
131216607|NCT00824993|472416852|FG001|Overall Study|Non-Compliant|1|||
131216608|NCT00824993|472416851|FG000|Overall Study|Insurance Issue|2|||
131216609|NCT00824993|472416852|FG001|Overall Study|Insurance Issue|1|||
131216610|NCT00824993|472416851|FG000|Overall Study|Death|0|||
131216611|NCT00824993|472416852|FG001|Overall Study|Death|3|||
131216612|NCT00061568|472416855|FG000|Overall Study|Lost to Follow-up|12|||
131216613|NCT00061568|472416856|FG001|Overall Study|Lost to Follow-up|0|||
131216614|NCT00061568|472416855|FG000|Overall Study|Death|6|||
131216615|NCT00061568|472416856|FG001|Overall Study|Death|0|||
131216616|NCT00061568|472416855|FG000|Overall Study|Withdrawal by Subject|1|||
131216617|NCT00061568|472416856|FG001|Overall Study|Withdrawal by Subject|0|||
131216618|NCT01381068|472416857|FG000|Overall Study|Death|1|||
131216619|NCT01381068|472416858|FG001|Overall Study|Death|0|||
131216620|NCT01071278|472416862|FG000|Overall Study|Premature Discontinuation|254|||
131216621|NCT01071278|472416862|FG000|Overall Study|Completion Status Unknown|459|||
131216622|NCT00903409|472416863|FG000|Overall Study|Adverse Event|11|||
131216623|NCT00903409|472416864|FG001|Overall Study|Adverse Event|9|||
131216624|NCT00903409|472416863|FG000|Overall Study|Non-compliance with Protocol|1|||
131216625|NCT00903409|472416864|FG001|Overall Study|Non-compliance with Protocol|1|||
131216626|NCT00903409|472416863|FG000|Overall Study|Laboratory Abnormality|2|||
131216627|NCT00903409|472416864|FG001|Overall Study|Laboratory Abnormality|0|||
131216628|NCT00903409|472416863|FG000|Overall Study|Withdrawal by Subject|8|||
131216629|NCT00903409|472416864|FG001|Overall Study|Withdrawal by Subject|8|||
131216630|NCT00903409|472416863|FG000|Overall Study|Other|2|||
131216631|NCT00903409|472416864|FG001|Overall Study|Other|3|||
131216632|NCT00903409|472416863|FG000|Overall Study|Lost to Follow-up|2|||
131216633|NCT00903409|472416864|FG001|Overall Study|Lost to Follow-up|6|||
131216634|NCT00797316|472416865|FG000|Overall Study|Administrative problems|1|||
131216635|NCT00797316|472416866|FG001|Overall Study|Administrative problems|0|||
131216636|NCT00797316|472416865|FG000|Overall Study|Adverse Event|5|||
131216637|NCT00797316|472416866|FG001|Overall Study|Adverse Event|3|||
131216638|NCT00797316|472416865|FG000|Overall Study|Lost to Follow-up|4|||
131216639|NCT00797316|472416866|FG001|Overall Study|Lost to Follow-up|8|||
131216640|NCT00797316|472416865|FG000|Overall Study|Protocol Deviation|1|||
131216641|NCT00797316|472416866|FG001|Overall Study|Protocol Deviation|2|||
131216642|NCT00797316|472416865|FG000|Overall Study|Patient withdrew consent|12|||
131216643|NCT00797316|472416866|FG001|Overall Study|Patient withdrew consent|6|||
131216644|NCT00797316|472416865|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131216645|NCT00797316|472416866|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
131216646|NCT03239340|472416873|FG000|Overall Study|Other|26|||
131216647|NCT03239340|472416873|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
131216648|NCT03239340|472416873|FG000|Overall Study|Death|40|||
131216649|NCT03239340|472416873|FG000|Overall Study|Lost to Follow-up|2|||
131216650|NCT03239340|472416873|FG000|Overall Study|Physician Decision|16|||
131216651|NCT03239340|472416873|FG000|Overall Study|Withdrawal by Subject|27|||
131216652|NCT03868059|472416875|FG000|Overall Study|Adverse Event|3|||
131216653|NCT03868059|472416875|FG000|Overall Study|Lost to Follow-up|3|||
131216654|NCT03868059|472416875|FG000|Overall Study|Withdrawal by Subject|6|||
131216655|NCT02061293|472416876|FG000|Overall Study|Elevated Blood Pressure|1|||
131216656|NCT02061293|472416877|FG001|Overall Study|Elevated Blood Pressure|1|||
131216657|NCT04066894|472416878|FG000|Overall Study|Lack of Efficacy|1|||
131216658|NCT04066894|472416878|FG000|Overall Study|Screen Failure|1|||
131216659|NCT03494816|472416880|FG000|Overall Study|Protocol Violation|2|||
131216660|NCT03494816|472416880|FG000|Overall Study|Physician Decision|2|||
131216661|NCT03494816|472416880|FG000|Overall Study|Did not start trial treatment|1|||
131216662|NCT03494816|472416880|FG000|Overall Study|Adverse Event|1|||
131216663|NCT01283282|472416887|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
131216664|NCT01283282|472416888|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
131216665|NCT01283282|472416887|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
131216666|NCT01283282|472416888|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
131216667|NCT01283282|472416887|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
131216668|NCT01283282|472416888|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
131216669|NCT00777920|472416889|FG000|Overall Study|Adverse Event|39|||
131216670|NCT00777920|472416889|FG000|Overall Study|Withdrawal of Consent|4|||
131216671|NCT00777920|472416889|FG000|Overall Study|Lost to Follow-up|1|||
131216672|NCT00777920|472416889|FG000|Overall Study|Investigator's discretion|1|||
131216673|NCT00777920|472416889|FG000|Overall Study|Clinical status did not improve|1|||
131216674|NCT00777920|472416889|FG000|Overall Study|Other, not specified|4|||
131216675|NCT00483717|472416890|FG000|Overall Study|Protocol Violation|5|||
131216676|NCT00483717|472416891|FG001|Overall Study|Protocol Violation|7|||
131216677|NCT00483717|472416890|FG000|Overall Study|Time of dosing missing|1|||
131216678|NCT00483717|472416891|FG001|Overall Study|Time of dosing missing|1|||
131216679|NCT00483717|472416890|FG000|Overall Study|No treatment for migraine|16|||
131216680|NCT00483717|472416891|FG001|Overall Study|No treatment for migraine|13|||
131216681|NCT00483717|472416890|FG000|Overall Study|Lost to Follow-up|1|||
131216682|NCT00483717|472416891|FG001|Overall Study|Lost to Follow-up|0|||
131216683|NCT00483717|472416890|FG000|Overall Study|Withdrawal by Subject|1|||
131216684|NCT00483717|472416891|FG001|Overall Study|Withdrawal by Subject|0|||
131216685|NCT00909857|472416892|FG000|Overall Study|Withdrawal by Subject|6|||
131216686|NCT00909857|472416893|FG001|Overall Study|Withdrawal by Subject|10|||
131216687|NCT00909857|472416892|FG000|Overall Study|Adverse Event|5|||
131216688|NCT00909857|472416893|FG001|Overall Study|Adverse Event|5|||
131216689|NCT00909857|472416892|FG000|Overall Study|Lost to Follow-up|2|||
131216690|NCT00909857|472416893|FG001|Overall Study|Lost to Follow-up|5|||
131216691|NCT00909857|472416892|FG000|Overall Study|Protocol Violation|2|||
131216692|NCT00909857|472416893|FG001|Overall Study|Protocol Violation|1|||
131216693|NCT00909857|472416892|FG000|Overall Study|Pregnancy|1|||
131216694|NCT00909857|472416893|FG001|Overall Study|Pregnancy|0|||
131216695|NCT00909857|472416892|FG000|Overall Study|Other|1|||
131216696|NCT00909857|472416893|FG001|Overall Study|Other|0|||
131216697|NCT00909857|472416892|FG000|Overall Study|Did not receive study medication|19|||
131216698|NCT00909857|472416893|FG001|Overall Study|Did not receive study medication|24|||
131216699|NCT03878108|472416894|FG000|Overall Study|Adverse Event|1|||
131216700|NCT03878108|472416895|FG001|Overall Study|Adverse Event|0|||
131216701|NCT01682681|472416896|FG000|Overall Study|Lack of Efficacy|62|||
131216702|NCT01682681|472416896|FG000|Overall Study|Withdrawal by Subject|1|||
131216703|NCT01682681|472416896|FG000|Overall Study|Moved to other hospital|10|||
131216704|NCT01682681|472416896|FG000|Overall Study|Lost to Follow-up|174|||
131216705|NCT01682681|472416896|FG000|Overall Study|Adverse Event|46|||
131216706|NCT01682681|472416896|FG000|Overall Study|tapering of topiramate|5|||
131216707|NCT01682681|472416896|FG000|Overall Study|Other|21|||
131216708|NCT01682681|472416896|FG000|Overall Study|Low compliance|13|||
131216709|NCT00975000|472416897|FG000|Overall Study|Other|1|||
131216710|NCT00975000|472416898|FG001|Overall Study|Other|0|||
131216711|NCT00975000|472416897|FG000|Overall Study|Adverse Event|1|||
131216712|NCT00975000|472416898|FG001|Overall Study|Adverse Event|1|||
131216713|NCT00975000|472416897|FG000|Overall Study|Withdrawal by Subject|2|||
131216714|NCT00975000|472416898|FG001|Overall Study|Withdrawal by Subject|2|||
130992677|NCT02769065|471601558|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992678|NCT02769065|471601559|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992679|NCT02769065|471601560|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992680|NCT02769065|471601561|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992681|NCT02769065|471601562|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992682|NCT02769065|471601563|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992683|NCT02769065|471601564|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
131216715|NCT00975000|472416897|FG000|Overall Study|Lost to Follow-up|0|||
131216716|NCT00975000|472416898|FG001|Overall Study|Lost to Follow-up|1|||
131216717|NCT00975000|472416897|FG000|Overall Study|Protocol-specified Criteria|1|||
131216718|NCT00975000|472416898|FG001|Overall Study|Protocol-specified Criteria|0|||
131216719|NCT00975000|472416897|FG000|Overall Study|Non-compliance|0|||
131216720|NCT00975000|472416898|FG001|Overall Study|Non-compliance|1|||
131216721|NCT01126359|472416899|FG000|First Intervention (20-minutes)|Physician Decision|0|||
131216722|NCT01126359|472416900|FG001|First Intervention (20-minutes)|Physician Decision|1|||
131216723|NCT00902486|472416901|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
131216724|NCT00902486|472416902|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
131216725|NCT00902486|472416903|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
131216726|NCT00902486|472416904|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
131216727|NCT00902486|472416905|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
131216728|NCT00902486|472416906|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
131216729|NCT00902486|472416901|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
131216730|NCT00902486|472416902|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
131216731|NCT00902486|472416903|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
131216732|NCT00902486|472416904|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
131216733|NCT00902486|472416905|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
131216734|NCT00902486|472416906|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
131216735|NCT00902486|472416901|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
131216736|NCT00902486|472416902|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
131216737|NCT00902486|472416903|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
131216738|NCT00902486|472416904|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
131216739|NCT00902486|472416905|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
131216740|NCT00902486|472416906|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
131216741|NCT00902486|472416901|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
131216742|NCT00902486|472416902|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
131216743|NCT00902486|472416903|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
131216744|NCT00902486|472416904|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
131216745|NCT00902486|472416905|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
131216746|NCT00902486|472416906|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
131216747|NCT00902486|472416901|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
131216748|NCT00902486|472416902|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
131216749|NCT00902486|472416903|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
131216750|NCT00902486|472416904|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
131216751|NCT00902486|472416905|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
131216752|NCT00902486|472416906|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
131216753|NCT00902486|472416901|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
131216754|NCT00902486|472416902|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
131216755|NCT00902486|472416903|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
131216756|NCT00902486|472416904|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
131216757|NCT00902486|472416905|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
131216758|NCT00902486|472416906|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
130992684|NCT02769065|471601565|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992685|NCT02769065|471601566|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
130765854|NCT00314132|470765886|FG001|Overall Study|Withdrawal by Subject|5|||
130992686|NCT02769065|471601567|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
131216759|NCT00902486|472416901|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
131216760|NCT00902486|472416902|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
131216761|NCT00902486|472416903|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
131216762|NCT00902486|472416904|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
131216763|NCT00902486|472416905|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
131216764|NCT00902486|472416906|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
131216765|NCT00902486|472416901|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
131216766|NCT00902486|472416902|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
131216767|NCT00902486|472416903|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
131216768|NCT00902486|472416904|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
131216769|NCT00902486|472416905|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
131216770|NCT00902486|472416906|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
131216771|NCT00902486|472416901|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
131216772|NCT00902486|472416902|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
131216773|NCT00902486|472416903|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
131216774|NCT00902486|472416904|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
131216775|NCT00902486|472416905|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
131216776|NCT00902486|472416906|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
131216777|NCT00902486|472416901|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
131216778|NCT00902486|472416902|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
131216779|NCT00902486|472416903|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
131216780|NCT00902486|472416904|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
131216781|NCT00902486|472416905|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
131216782|NCT00902486|472416906|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
131216783|NCT00902486|472416901|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
131216784|NCT00902486|472416902|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
131216785|NCT00902486|472416903|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
131216786|NCT00902486|472416904|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
131216787|NCT00902486|472416905|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
131216788|NCT00902486|472416906|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
131216789|NCT02332655|472416907|FG000|Overall Study|Lack of Efficacy|1|||
131216790|NCT01298661|472416908|FG000|Overall Study|Withdrawal by Subject|2|||
131216791|NCT01298661|472416909|FG001|Overall Study|Withdrawal by Subject|0|||
131216792|NCT01298661|472416910|FG002|Overall Study|Withdrawal by Subject|2|||
131216793|NCT01525407|472416911|FG000|Overall Study|Change in recipient treatment plan|2|||
131216794|NCT01525407|472416912|FG001|Overall Study|Change in recipient treatment plan|2|||
131216795|NCT01525407|472416911|FG000|Overall Study|Withdrawal by Subject|0|||
131216796|NCT01525407|472416912|FG001|Overall Study|Withdrawal by Subject|1|||
131216797|NCT01525407|472416911|FG000|Overall Study|Transplant was delayed|0|||
131216798|NCT01525407|472416912|FG001|Overall Study|Transplant was delayed|1|||
131216799|NCT01525407|472416911|FG000|Overall Study|Delay in Transplant|1|||
131216800|NCT01525407|472416912|FG001|Overall Study|Delay in Transplant|0|||
131216801|NCT03976076|472418669|FG000|Overall Study|Withdrawal by Subject|2|||
131216802|NCT00568776|472418672|FG000|Overall Study|Adverse Event|8|||
131216803|NCT00568776|472418673|FG001|Overall Study|Adverse Event|8|||
131216804|NCT00568776|472418674|FG002|Overall Study|Adverse Event|10|||
131216805|NCT00568776|472418675|FG003|Overall Study|Adverse Event|8|||
131216806|NCT00568776|472418672|FG000|Overall Study|Death|0|||
131216807|NCT00568776|472418673|FG001|Overall Study|Death|1|||
131216808|NCT00568776|472418674|FG002|Overall Study|Death|4|||
131216809|NCT00568776|472418675|FG003|Overall Study|Death|3|||
131216810|NCT00568776|472418672|FG000|Overall Study|Physician Decision|0|||
131216811|NCT00568776|472418673|FG001|Overall Study|Physician Decision|2|||
131216812|NCT00568776|472418674|FG002|Overall Study|Physician Decision|0|||
131216813|NCT00568776|472418675|FG003|Overall Study|Physician Decision|0|||
131216814|NCT00568776|472418672|FG000|Overall Study|Lack of Efficacy|2|||
131216815|NCT00568776|472418673|FG001|Overall Study|Lack of Efficacy|2|||
131216816|NCT00568776|472418674|FG002|Overall Study|Lack of Efficacy|2|||
131216817|NCT00568776|472418675|FG003|Overall Study|Lack of Efficacy|4|||
131216818|NCT00568776|472418672|FG000|Overall Study|Lost to Follow-up|1|||
130992687|NCT02769065|471601568|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992688|NCT02769065|471601569|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992689|NCT02769065|471601570|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992690|NCT02769065|471601571|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
131216819|NCT00568776|472418673|FG001|Overall Study|Lost to Follow-up|1|||
131216820|NCT00568776|472418674|FG002|Overall Study|Lost to Follow-up|1|||
130992691|NCT02769065|471601572|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992692|NCT02769065|471601573|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
131216821|NCT00568776|472418675|FG003|Overall Study|Lost to Follow-up|1|||
131216822|NCT00568776|472418672|FG000|Overall Study|Protocol Violation|1|||
131216823|NCT00568776|472418673|FG001|Overall Study|Protocol Violation|0|||
131216824|NCT00568776|472418674|FG002|Overall Study|Protocol Violation|1|||
131216825|NCT00568776|472418675|FG003|Overall Study|Protocol Violation|1|||
131216826|NCT00568776|472418672|FG000|Overall Study|Withdrawal by Subject|13|||
131216827|NCT00568776|472418673|FG001|Overall Study|Withdrawal by Subject|15|||
131216828|NCT00568776|472418674|FG002|Overall Study|Withdrawal by Subject|13|||
131216829|NCT00568776|472418675|FG003|Overall Study|Withdrawal by Subject|7|||
131216830|NCT00568776|472418672|FG000|Overall Study|Loss of Caregiver|0|||
131216831|NCT00568776|472418673|FG001|Overall Study|Loss of Caregiver|2|||
131216832|NCT00568776|472418674|FG002|Overall Study|Loss of Caregiver|1|||
131216833|NCT00568776|472418675|FG003|Overall Study|Loss of Caregiver|2|||
131216834|NCT00568776|472418672|FG000|Overall Study|Sponsor Decision|2|||
131216835|NCT00568776|472418673|FG001|Overall Study|Sponsor Decision|2|||
131216836|NCT00568776|472418674|FG002|Overall Study|Sponsor Decision|41|||
131216837|NCT00568776|472418675|FG003|Overall Study|Sponsor Decision|42|||
131216838|NCT00568776|472418672|FG000|Overall Study|Miscellaeneous|3|||
131216839|NCT00568776|472418673|FG001|Overall Study|Miscellaeneous|3|||
131216840|NCT00568776|472418674|FG002|Overall Study|Miscellaeneous|1|||
131216841|NCT00568776|472418675|FG003|Overall Study|Miscellaeneous|4|||
131216842|NCT01005680|472418676|FG000|Overall Study|Lost to Follow-up|4|||
131216843|NCT01005680|472418677|FG001|Overall Study|Lost to Follow-up|6|||
131216844|NCT01005680|472418676|FG000|Overall Study|Withdrawal by Subject|1|||
131216845|NCT01005680|472418677|FG001|Overall Study|Withdrawal by Subject|4|||
131216846|NCT01005680|472418676|FG000|Overall Study|Physician Decision|1|||
131216847|NCT01005680|472418677|FG001|Overall Study|Physician Decision|1|||
131216848|NCT02118896|472418690|FG000|Overall Study|Death|4|||
131216849|NCT02118896|472418691|FG001|Overall Study|Death|0|||
131216850|NCT02118896|472418692|FG002|Overall Study|Death|4|||
131216851|NCT02118896|472418693|FG003|Overall Study|Death|6|||
131216852|NCT02118896|472418694|FG004|Overall Study|Death|3|||
131216853|NCT02118896|472418695|FG005|Overall Study|Death|1|||
131216854|NCT02118896|472418696|FG006|Overall Study|Death|0|||
131216855|NCT02118896|472418697|FG007|Overall Study|Death|0|||
131216856|NCT02118896|472418698|FG008|Overall Study|Death|0|||
131216857|NCT02118896|472418699|FG009|Overall Study|Death|0|||
131216858|NCT02118896|472418690|FG000|Overall Study|Adverse Event|5|||
131216859|NCT02118896|472418691|FG001|Overall Study|Adverse Event|4|||
131216860|NCT02118896|472418692|FG002|Overall Study|Adverse Event|4|||
131216861|NCT02118896|472418693|FG003|Overall Study|Adverse Event|5|||
131216862|NCT02118896|472418694|FG004|Overall Study|Adverse Event|5|||
131216863|NCT02118896|472418695|FG005|Overall Study|Adverse Event|9|||
131216864|NCT02118896|472418696|FG006|Overall Study|Adverse Event|1|||
131216865|NCT02118896|472418697|FG007|Overall Study|Adverse Event|1|||
131216866|NCT02118896|472418698|FG008|Overall Study|Adverse Event|4|||
131216867|NCT02118896|472418699|FG009|Overall Study|Adverse Event|0|||
131216868|NCT02118896|472418690|FG000|Overall Study|Consent withdrawn|2|||
131216869|NCT02118896|472418691|FG001|Overall Study|Consent withdrawn|0|||
131216870|NCT02118896|472418692|FG002|Overall Study|Consent withdrawn|3|||
131216871|NCT02118896|472418693|FG003|Overall Study|Consent withdrawn|4|||
131216872|NCT02118896|472418694|FG004|Overall Study|Consent withdrawn|1|||
131216873|NCT02118896|472418695|FG005|Overall Study|Consent withdrawn|4|||
131216874|NCT02118896|472418696|FG006|Overall Study|Consent withdrawn|0|||
131216875|NCT02118896|472418697|FG007|Overall Study|Consent withdrawn|0|||
131216876|NCT02118896|472418698|FG008|Overall Study|Consent withdrawn|0|||
131216877|NCT02118896|472418699|FG009|Overall Study|Consent withdrawn|0|||
131216878|NCT02118896|472418690|FG000|Overall Study|Non-compliance|2|||
131216879|NCT02118896|472418691|FG001|Overall Study|Non-compliance|1|||
131216880|NCT02118896|472418692|FG002|Overall Study|Non-compliance|1|||
131216881|NCT02118896|472418693|FG003|Overall Study|Non-compliance|5|||
131216882|NCT02118896|472418694|FG004|Overall Study|Non-compliance|0|||
131216883|NCT02118896|472418695|FG005|Overall Study|Non-compliance|1|||
131216884|NCT02118896|472418696|FG006|Overall Study|Non-compliance|0|||
131216885|NCT02118896|472418697|FG007|Overall Study|Non-compliance|1|||
131216886|NCT02118896|472418698|FG008|Overall Study|Non-compliance|0|||
131216887|NCT02118896|472418699|FG009|Overall Study|Non-compliance|0|||
131216888|NCT02118896|472418690|FG000|Overall Study|Pregnancy|1|||
131216889|NCT02118896|472418691|FG001|Overall Study|Pregnancy|1|||
131216890|NCT02118896|472418692|FG002|Overall Study|Pregnancy|0|||
131216891|NCT02118896|472418693|FG003|Overall Study|Pregnancy|0|||
131216892|NCT02118896|472418694|FG004|Overall Study|Pregnancy|1|||
131216893|NCT02118896|472418695|FG005|Overall Study|Pregnancy|3|||
131216894|NCT02118896|472418696|FG006|Overall Study|Pregnancy|1|||
131216895|NCT02118896|472418697|FG007|Overall Study|Pregnancy|0|||
131216896|NCT02118896|472418698|FG008|Overall Study|Pregnancy|0|||
131216897|NCT02118896|472418699|FG009|Overall Study|Pregnancy|0|||
131216898|NCT02118896|472418690|FG000|Overall Study|Lost to Follow-up|1|||
131216899|NCT02118896|472418691|FG001|Overall Study|Lost to Follow-up|2|||
131216900|NCT02118896|472418692|FG002|Overall Study|Lost to Follow-up|1|||
131216901|NCT02118896|472418693|FG003|Overall Study|Lost to Follow-up|0|||
131216902|NCT02118896|472418694|FG004|Overall Study|Lost to Follow-up|2|||
131216903|NCT02118896|472418695|FG005|Overall Study|Lost to Follow-up|1|||
131216904|NCT02118896|472418696|FG006|Overall Study|Lost to Follow-up|0|||
131216905|NCT02118896|472418697|FG007|Overall Study|Lost to Follow-up|0|||
131216906|NCT02118896|472418698|FG008|Overall Study|Lost to Follow-up|0|||
131216907|NCT02118896|472418699|FG009|Overall Study|Lost to Follow-up|0|||
131216908|NCT02118896|472418690|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
131216909|NCT02118896|472418691|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
131216910|NCT02118896|472418692|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
131216911|NCT02118896|472418693|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
131216912|NCT02118896|472418694|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
131216913|NCT02118896|472418695|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
131216914|NCT02118896|472418696|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
131216915|NCT02118896|472418697|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
131216916|NCT02118896|472418698|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
131216917|NCT02118896|472418699|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
131216918|NCT02118896|472418690|FG000|Overall Study|Prohibited medication|0|||
131216919|NCT02118896|472418691|FG001|Overall Study|Prohibited medication|0|||
131216920|NCT02118896|472418692|FG002|Overall Study|Prohibited medication|0|||
131216921|NCT02118896|472418693|FG003|Overall Study|Prohibited medication|0|||
131216922|NCT02118896|472418694|FG004|Overall Study|Prohibited medication|1|||
131216923|NCT02118896|472418695|FG005|Overall Study|Prohibited medication|3|||
131216924|NCT02118896|472418696|FG006|Overall Study|Prohibited medication|0|||
131216925|NCT02118896|472418697|FG007|Overall Study|Prohibited medication|0|||
131216926|NCT02118896|472418698|FG008|Overall Study|Prohibited medication|0|||
131216927|NCT02118896|472418699|FG009|Overall Study|Prohibited medication|0|||
131216928|NCT02118896|472418690|FG000|Overall Study|Miscellaneous|1|||
131216929|NCT02118896|472418691|FG001|Overall Study|Miscellaneous|2|||
131216930|NCT02118896|472418692|FG002|Overall Study|Miscellaneous|0|||
131216931|NCT02118896|472418693|FG003|Overall Study|Miscellaneous|2|||
131216932|NCT02118896|472418694|FG004|Overall Study|Miscellaneous|0|||
131216933|NCT02118896|472418695|FG005|Overall Study|Miscellaneous|4|||
131216934|NCT02118896|472418696|FG006|Overall Study|Miscellaneous|0|||
131216935|NCT02118896|472418697|FG007|Overall Study|Miscellaneous|0|||
131216936|NCT02118896|472418698|FG008|Overall Study|Miscellaneous|0|||
131216937|NCT02118896|472418699|FG009|Overall Study|Miscellaneous|0|||
131216938|NCT03901352|472418700|FG000|Double-blind Phase|Adverse Event|6|||
131216939|NCT03901352|472418701|FG001|Double-blind Phase|Adverse Event|4|||
131216940|NCT03901352|472418700|FG000|Double-blind Phase|Death|1|||
131216941|NCT03901352|472418701|FG001|Double-blind Phase|Death|0|||
131216942|NCT03901352|472418700|FG000|Double-blind Phase|Lack of Efficacy|0|||
131216943|NCT03901352|472418701|FG001|Double-blind Phase|Lack of Efficacy|1|||
131216944|NCT03901352|472418700|FG000|Double-blind Phase|Protocol Violation|0|||
131216945|NCT03901352|472418701|FG001|Double-blind Phase|Protocol Violation|1|||
131216946|NCT03901352|472418700|FG000|Double-blind Phase|Withdrawal by Subject|10|||
131216947|NCT03901352|472418701|FG001|Double-blind Phase|Withdrawal by Subject|8|||
131216948|NCT03901352|472418700|FG000|Open-label Extension Phase|Adverse Event|24|||
131216949|NCT03901352|472418701|FG001|Open-label Extension Phase|Adverse Event|0|||
131216950|NCT03901352|472418700|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
131216951|NCT03901352|472418701|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
131216952|NCT03901352|472418700|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
131216953|NCT03901352|472418701|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
131216954|NCT03901352|472418700|FG000|Open-label Extension Phase|Other|1|||
131216955|NCT03901352|472418701|FG001|Open-label Extension Phase|Other|0|||
131216956|NCT04635631|472418702|FG000|Overall Study|Adverse Event|1|||
131216957|NCT04635631|472418702|FG000|Overall Study|Progressive disease|13|||
131216958|NCT04635631|472418702|FG000|Overall Study|Withdrawal by Subject|1|||
131216959|NCT02050373|472418703|FG000|Overall Study|Adverse Event|4|||
131216960|NCT02050373|472418704|FG001|Overall Study|Adverse Event|7|||
131216961|NCT02050373|472418703|FG000|Overall Study|Death|3|||
131216962|NCT02050373|472418704|FG001|Overall Study|Death|3|||
131216963|NCT01360021|472418715|FG000|Overall Study|Eligibility criteria + other|2|||
131216964|NCT01360021|472418716|FG001|Overall Study|Eligibility criteria + other|1|||
131216965|NCT01360021|472418717|FG002|Overall Study|Eligibility criteria + other|1|||
131216966|NCT01360021|472418715|FG000|Overall Study|Protocol Violation|0|||
131216967|NCT01360021|472418716|FG001|Overall Study|Protocol Violation|0|||
131216968|NCT01360021|472418717|FG002|Overall Study|Protocol Violation|1|||
131216969|NCT01360021|472418715|FG000|Overall Study|Withdrawal by Subject|4|||
131216970|NCT01360021|472418716|FG001|Overall Study|Withdrawal by Subject|0|||
131216971|NCT01360021|472418717|FG002|Overall Study|Withdrawal by Subject|2|||
131216972|NCT01360021|472418715|FG000|Overall Study|Adverse Event|2|||
131216973|NCT01360021|472418716|FG001|Overall Study|Adverse Event|3|||
131216974|NCT01360021|472418717|FG002|Overall Study|Adverse Event|3|||
131216975|NCT01257737|472418719|FG000|Overall Study|Lost to Follow-up|1|||
131216976|NCT01257737|472418720|FG001|Overall Study|Lost to Follow-up|2|||
131216977|NCT01257737|472418719|FG000|Overall Study|Liver transplant|1|||
131216978|NCT01257737|472418720|FG001|Overall Study|Liver transplant|0|||
131216979|NCT01257737|472418719|FG000|Overall Study|Relocation out of the country|0|||
131216980|NCT01257737|472418720|FG001|Overall Study|Relocation out of the country|1|||
131216981|NCT01257737|472418719|FG000|Overall Study|Withdrew from study|0|||
131216982|NCT01257737|472418720|FG001|Overall Study|Withdrew from study|1|||
131216983|NCT03170271|472418724|FG000|Overall Study|Adverse Event|7|||
131216984|NCT03170271|472418725|FG001|Overall Study|Adverse Event|2|||
131216985|NCT03170271|472418724|FG000|Overall Study|Lost to Follow-up|0|||
131216986|NCT03170271|472418725|FG001|Overall Study|Lost to Follow-up|1|||
131216987|NCT03170271|472418724|FG000|Overall Study|Physician Decision|1|||
131216988|NCT03170271|472418725|FG001|Overall Study|Physician Decision|0|||
131216989|NCT03170271|472418724|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
131216990|NCT03170271|472418725|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
131216991|NCT03170271|472418724|FG000|Overall Study|Withdrawal by Subject|17|||
131216992|NCT03170271|472418725|FG001|Overall Study|Withdrawal by Subject|5|||
131216993|NCT03170271|472418724|FG000|Overall Study|Other|2|||
131216994|NCT03170271|472418725|FG001|Overall Study|Other|2|||
131216995|NCT03170271|472418724|FG000|Overall Study|Randomized in error|4|||
131216996|NCT03170271|472418725|FG001|Overall Study|Randomized in error|0|||
131216997|NCT00203892|472418727|FG000|Overall Study|Physician Decision|1|||
131216998|NCT00203892|472418728|FG001|Overall Study|Physician Decision|2|||
131216999|NCT00203892|472418729|FG002|Overall Study|Physician Decision|0|||
131217000|NCT00203892|472418727|FG000|Overall Study|Death|1|||
131217001|NCT00203892|472418728|FG001|Overall Study|Death|0|||
131217002|NCT00203892|472418729|FG002|Overall Study|Death|0|||
131217003|NCT00806416|472418730|FG000|Period 1 - Part I|Adverse Event|0|||
131217004|NCT00806416|472418731|FG001|Period 1 - Part I|Adverse Event|1|||
131217005|NCT00806416|472418732|FG002|Period 1 - Part I|Adverse Event|0|||
131217006|NCT00806416|472418733|FG003|Period 1 - Part I|Adverse Event|0|||
131217007|NCT00806416|472418730|FG000|Period 1 - Part I|Lost to Follow-up|0|||
131217008|NCT00806416|472418731|FG001|Period 1 - Part I|Lost to Follow-up|2|||
131217009|NCT00806416|472418732|FG002|Period 1 - Part I|Lost to Follow-up|0|||
131217010|NCT00806416|472418733|FG003|Period 1 - Part I|Lost to Follow-up|0|||
131217011|NCT00806416|472418730|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
131217012|NCT00806416|472418731|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
131217013|NCT00806416|472418732|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
131217014|NCT00806416|472418733|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
131217015|NCT00806416|472418730|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
131217016|NCT00806416|472418731|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
131217017|NCT00806416|472418732|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
131217018|NCT00806416|472418733|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
131217019|NCT01244516|472418737|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
131217020|NCT01244516|472418738|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
131217021|NCT01244516|472418739|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
131217022|NCT01244516|472418737|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
131217023|NCT01244516|472418738|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
131217024|NCT01244516|472418739|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
131217025|NCT01244516|472418737|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
131217026|NCT01244516|472418738|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
131217027|NCT01244516|472418739|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
131217028|NCT01244516|472418737|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
131217029|NCT01244516|472418738|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
131217030|NCT01244516|472418739|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
131217031|NCT01244516|472418737|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
131217032|NCT01244516|472418738|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
131217033|NCT01244516|472418739|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
131217034|NCT01244516|472418737|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
131217035|NCT01244516|472418738|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
131217036|NCT01244516|472418739|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
131217037|NCT01244516|472418737|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
131217038|NCT01244516|472418738|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
131217039|NCT01244516|472418739|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
131217040|NCT03345485|472418742|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
131217041|NCT03345485|472418743|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
131217042|NCT03345485|472418744|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
131217043|NCT03345485|472418745|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
131217044|NCT03345485|472418746|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
131217045|NCT03345485|472418747|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
131217046|NCT03345485|472418748|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
131217047|NCT03345485|472418749|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
131217048|NCT03345485|472418750|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
131217049|NCT03345485|472418751|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
131217050|NCT03345485|472418752|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
130765855|NCT00314132|470765885|FG000|Overall Study|Adverse Event|1|||
131217051|NCT03345485|472418753|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
131217052|NCT03345485|472418754|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
131217053|NCT03359473|472418755|FG000|Overall Study|Adverse Event|0|||
131217054|NCT03359473|472418756|FG001|Overall Study|Adverse Event|2|||
131217055|NCT03359473|472418757|FG002|Overall Study|Adverse Event|5|||
131217056|NCT03359473|472418758|FG003|Overall Study|Adverse Event|3|||
131217057|NCT03359473|472418755|FG000|Overall Study|Lost to Follow-up|0|||
131217058|NCT03359473|472418756|FG001|Overall Study|Lost to Follow-up|1|||
131217059|NCT03359473|472418757|FG002|Overall Study|Lost to Follow-up|0|||
131217060|NCT03359473|472418758|FG003|Overall Study|Lost to Follow-up|0|||
131217061|NCT03359473|472418755|FG000|Overall Study|Physician Decision|0|||
131217062|NCT03359473|472418756|FG001|Overall Study|Physician Decision|1|||
131217063|NCT03359473|472418757|FG002|Overall Study|Physician Decision|0|||
131217064|NCT03359473|472418758|FG003|Overall Study|Physician Decision|1|||
131217065|NCT03359473|472418755|FG000|Overall Study|Withdrawal by Subject|1|||
131217066|NCT03359473|472418756|FG001|Overall Study|Withdrawal by Subject|2|||
131217067|NCT03359473|472418757|FG002|Overall Study|Withdrawal by Subject|1|||
131217068|NCT03359473|472418758|FG003|Overall Study|Withdrawal by Subject|0|||
131217069|NCT03359473|472418755|FG000|Overall Study|Protocol-defined stopping criteria|1|||
131217070|NCT03359473|472418756|FG001|Overall Study|Protocol-defined stopping criteria|0|||
131217071|NCT03359473|472418757|FG002|Overall Study|Protocol-defined stopping criteria|0|||
131217072|NCT03359473|472418758|FG003|Overall Study|Protocol-defined stopping criteria|1|||
131217073|NCT05302414|472418759|FG000|Pretest to Posttest|Lost to Follow-up|12|||
131217074|NCT05302414|472418760|FG001|Pretest to Posttest|Lost to Follow-up|8|||
131217075|NCT05302414|472418761|FG002|Pretest to Posttest|Lost to Follow-up|8|||
131217076|NCT05302414|472418759|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
131217077|NCT05302414|472418760|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
131217078|NCT05302414|472418761|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
131217079|NCT01610284|472418762|FG000|Randomization Phase|Adverse Event|1|||
131217080|NCT01610284|472418763|FG001|Randomization Phase|Adverse Event|0|||
131217081|NCT01610284|472418762|FG000|Randomization Phase|Physician Decision|1|||
131217082|NCT01610284|472418763|FG001|Randomization Phase|Physician Decision|1|||
131217083|NCT01610284|472418762|FG000|Randomization Phase|Death|0|||
131217084|NCT01610284|472418763|FG001|Randomization Phase|Death|1|||
131217085|NCT01610284|472418762|FG000|Treatment Phase|Adverse Event|80|||
131217086|NCT01610284|472418763|FG001|Treatment Phase|Adverse Event|12|||
131217087|NCT01610284|472418762|FG000|Treatment Phase|Lost to Follow-up|1|||
131217088|NCT01610284|472418763|FG001|Treatment Phase|Lost to Follow-up|0|||
131217089|NCT01610284|472418762|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
131217090|NCT01610284|472418763|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
131217091|NCT01610284|472418762|FG000|Treatment Phase|Physician Decision|27|||
131217092|NCT01610284|472418763|FG001|Treatment Phase|Physician Decision|24|||
131217093|NCT01610284|472418762|FG000|Treatment Phase|Progressive Disease|377|||
131217094|NCT01610284|472418763|FG001|Treatment Phase|Progressive Disease|486|||
131217095|NCT01610284|472418762|FG000|Treatment Phase|Protocol Deviation|2|||
131217096|NCT01610284|472418763|FG001|Treatment Phase|Protocol Deviation|3|||
131217097|NCT01610284|472418762|FG000|Treatment Phase|Study terminated by Sponsor|18|||
131217098|NCT01610284|472418763|FG001|Treatment Phase|Study terminated by Sponsor|15|||
131217099|NCT01610284|472418762|FG000|Treatment Phase|Subject/Guardian Decision|55|||
131217100|NCT01610284|472418763|FG001|Treatment Phase|Subject/Guardian Decision|23|||
131217101|NCT01610284|472418762|FG000|Treatment Phase|Death|6|||
131217102|NCT01610284|472418763|FG001|Treatment Phase|Death|5|||
131217103|NCT01610284|472418762|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
131217104|NCT01610284|472418763|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
131217105|NCT01610284|472418762|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
131217106|NCT01610284|472418763|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
131217107|NCT01610284|472418762|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
131217108|NCT01610284|472418763|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
131217109|NCT01610284|472418762|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
131217110|NCT01610284|472418763|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
131217111|NCT01610284|472418762|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
131217112|NCT01610284|472418763|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
131217113|NCT01610284|472418762|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
131217114|NCT01610284|472418763|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
131217115|NCT01125358|472418769|FG000|Overall Study|Adverse Event|3|||
131217116|NCT01125358|472418770|FG001|Overall Study|Adverse Event|0|||
131217117|NCT01125358|472418771|FG002|Overall Study|Adverse Event|0|||
131217118|NCT01125358|472418772|FG003|Overall Study|Adverse Event|2|||
131217119|NCT01125358|472418769|FG000|Overall Study|Perceived Lack of Efficacy|6|||
131217120|NCT01125358|472418770|FG001|Overall Study|Perceived Lack of Efficacy|3|||
131217121|NCT01125358|472418771|FG002|Overall Study|Perceived Lack of Efficacy|7|||
131217122|NCT01125358|472418772|FG003|Overall Study|Perceived Lack of Efficacy|4|||
131217123|NCT01125358|472418769|FG000|Overall Study|Protocol Violation|1|||
131217124|NCT01125358|472418770|FG001|Overall Study|Protocol Violation|0|||
131217125|NCT01125358|472418771|FG002|Overall Study|Protocol Violation|0|||
131217126|NCT01125358|472418772|FG003|Overall Study|Protocol Violation|0|||
131217127|NCT01125358|472418769|FG000|Overall Study|Sponsor Decision|0|||
131217128|NCT01125358|472418770|FG001|Overall Study|Sponsor Decision|0|||
131217129|NCT01125358|472418771|FG002|Overall Study|Sponsor Decision|1|||
131217130|NCT01125358|472418772|FG003|Overall Study|Sponsor Decision|1|||
131217131|NCT01125358|472418769|FG000|Overall Study|Withdrawal by Subject|2|||
131217132|NCT01125358|472418770|FG001|Overall Study|Withdrawal by Subject|1|||
131217133|NCT01125358|472418771|FG002|Overall Study|Withdrawal by Subject|1|||
131217134|NCT01125358|472418772|FG003|Overall Study|Withdrawal by Subject|1|||
131217135|NCT01157065|472418773|FG000|Overall Study|Death|0|||
131217136|NCT01157065|472418774|FG001|Overall Study|Death|1|||
131217137|NCT01060007|472418775|FG000|Overall Study|Withdrawal by Subject|1|||
131217138|NCT01060007|472418775|FG000|Overall Study|Inevaluable for response at surgery|3|||
131217139|NCT05168657|472418778|FG000|Overall Study|Adverse Event|0|||
131217140|NCT05168657|472418779|FG001|Overall Study|Adverse Event|0|||
131217141|NCT05168657|472418780|FG002|Overall Study|Adverse Event|1|||
131217142|NCT05168657|472418781|FG003|Overall Study|Adverse Event|0|||
131217143|NCT05168657|472418782|FG004|Overall Study|Adverse Event|0|||
131217144|NCT05168657|472418783|FG005|Overall Study|Adverse Event|0|||
131217145|NCT05168657|472418784|FG006|Overall Study|Adverse Event|0|||
131217146|NCT05168657|472418785|FG007|Overall Study|Adverse Event|0|||
131217147|NCT04935931|472418786|FG000|Overall Study|Withdrawal by Subject|1|||
131217148|NCT00962013|472418789|FG000|Overall Study|Did not have surgery|1|||
131217149|NCT00962013|472418789|FG000|Overall Study|Death|8|||
131217150|NCT00962013|472418789|FG000|Overall Study|Lost to Follow-up|12|||
131217151|NCT00962013|472418789|FG000|Overall Study|Unable/Unwilling to return|6|||
131217152|NCT00962013|472418789|FG000|Overall Study|Withdrawal by Subject|8|||
131217153|NCT00962013|472418789|FG000|Overall Study|Removal of study device|3|||
131217154|NCT00962013|472418789|FG000|Overall Study|Site Termination|24|||
131217155|NCT00962013|472418789|FG000|Overall Study|No 5 year evaluation|6|||
131217156|NCT00424632|472418790|FG000|Overall Study|Death|0|||
131217157|NCT00424632|472418791|FG001|Overall Study|Death|0|||
131217158|NCT00424632|472418792|FG002|Overall Study|Death|0|||
131217159|NCT00424632|472418793|FG003|Overall Study|Death|0|||
131217160|NCT00424632|472418794|FG004|Overall Study|Death|0|||
131217161|NCT00424632|472418795|FG005|Overall Study|Death|2|||
131217162|NCT00424632|472418796|FG006|Overall Study|Death|0|||
131217163|NCT00424632|472418797|FG007|Overall Study|Death|0|||
131217164|NCT00424632|472418798|FG008|Overall Study|Death|0|||
131217165|NCT00424632|472418799|FG009|Overall Study|Death|0|||
131217166|NCT00424632|472418790|FG000|Overall Study|Adverse Event|0|||
131217167|NCT00424632|472418791|FG001|Overall Study|Adverse Event|0|||
131217168|NCT00424632|472418792|FG002|Overall Study|Adverse Event|0|||
131217169|NCT00424632|472418793|FG003|Overall Study|Adverse Event|0|||
131217170|NCT00424632|472418794|FG004|Overall Study|Adverse Event|0|||
131217171|NCT00424632|472418795|FG005|Overall Study|Adverse Event|0|||
131217172|NCT00424632|472418796|FG006|Overall Study|Adverse Event|0|||
131217173|NCT00424632|472418797|FG007|Overall Study|Adverse Event|0|||
131217174|NCT00424632|472418798|FG008|Overall Study|Adverse Event|3|||
131217175|NCT00424632|472418799|FG009|Overall Study|Adverse Event|2|||
131217176|NCT00424632|472418790|FG000|Overall Study|Global deterioration of health status|0|||
131217177|NCT00424632|472418791|FG001|Overall Study|Global deterioration of health status|0|||
131217178|NCT00424632|472418792|FG002|Overall Study|Global deterioration of health status|0|||
131217179|NCT00424632|472418793|FG003|Overall Study|Global deterioration of health status|1|||
131217180|NCT00424632|472418794|FG004|Overall Study|Global deterioration of health status|1|||
131217181|NCT00424632|472418795|FG005|Overall Study|Global deterioration of health status|0|||
131217182|NCT00424632|472418796|FG006|Overall Study|Global deterioration of health status|0|||
131217183|NCT00424632|472418797|FG007|Overall Study|Global deterioration of health status|0|||
131217184|NCT00424632|472418798|FG008|Overall Study|Global deterioration of health status|0|||
131217185|NCT00424632|472418799|FG009|Overall Study|Global deterioration of health status|0|||
131217186|NCT00424632|472418790|FG000|Overall Study|Objective progression or relapse|1|||
131217187|NCT00424632|472418791|FG001|Overall Study|Objective progression or relapse|1|||
131217188|NCT00424632|472418792|FG002|Overall Study|Objective progression or relapse|1|||
131217189|NCT00424632|472418793|FG003|Overall Study|Objective progression or relapse|2|||
131217190|NCT00424632|472418794|FG004|Overall Study|Objective progression or relapse|2|||
131217191|NCT00424632|472418795|FG005|Overall Study|Objective progression or relapse|13|||
131217192|NCT00424632|472418796|FG006|Overall Study|Objective progression or relapse|7|||
131217193|NCT00424632|472418797|FG007|Overall Study|Objective progression or relapse|3|||
131217194|NCT00424632|472418798|FG008|Overall Study|Objective progression or relapse|12|||
131217195|NCT00424632|472418799|FG009|Overall Study|Objective progression or relapse|4|||
131217196|NCT00424632|472418790|FG000|Overall Study|Other|0|||
131217197|NCT00424632|472418791|FG001|Overall Study|Other|0|||
131217198|NCT00424632|472418792|FG002|Overall Study|Other|0|||
131217199|NCT00424632|472418793|FG003|Overall Study|Other|1|||
131217200|NCT00424632|472418794|FG004|Overall Study|Other|0|||
131217201|NCT00424632|472418795|FG005|Overall Study|Other|0|||
131217202|NCT00424632|472418796|FG006|Overall Study|Other|0|||
131217203|NCT00424632|472418797|FG007|Overall Study|Other|0|||
131217204|NCT00424632|472418798|FG008|Overall Study|Other|1|||
131217205|NCT00424632|472418799|FG009|Overall Study|Other|0|||
131217206|NCT00445458|472418810|FG000|Overall Study|Disease Progression|3|||
131217207|NCT00445458|472418811|FG001|Overall Study|Disease Progression|4|||
131217208|NCT00445458|472418812|FG002|Overall Study|Disease Progression|54|||
131217209|NCT00445458|472418813|FG003|Overall Study|Disease Progression|27|||
131217210|NCT00445458|472418810|FG000|Overall Study|Withdrawal by Subject|0|||
131217211|NCT00445458|472418811|FG001|Overall Study|Withdrawal by Subject|0|||
131217212|NCT00445458|472418812|FG002|Overall Study|Withdrawal by Subject|7|||
131217213|NCT00445458|472418813|FG003|Overall Study|Withdrawal by Subject|0|||
131217214|NCT00445458|472418810|FG000|Overall Study|Adverse Event|0|||
131217215|NCT00445458|472418811|FG001|Overall Study|Adverse Event|0|||
131217216|NCT00445458|472418812|FG002|Overall Study|Adverse Event|3|||
131217217|NCT00445458|472418813|FG003|Overall Study|Adverse Event|0|||
131217218|NCT00445458|472418810|FG000|Overall Study|Death|0|||
131217219|NCT00445458|472418811|FG001|Overall Study|Death|1|||
131217220|NCT00445458|472418812|FG002|Overall Study|Death|2|||
131217221|NCT00445458|472418813|FG003|Overall Study|Death|0|||
131217222|NCT00445458|472418810|FG000|Overall Study|Physician Decision|0|||
131217223|NCT00445458|472418811|FG001|Overall Study|Physician Decision|0|||
131217224|NCT00445458|472418812|FG002|Overall Study|Physician Decision|1|||
131217225|NCT00445458|472418813|FG003|Overall Study|Physician Decision|1|||
131217226|NCT00445458|472418810|FG000|Overall Study|Surgery|0|||
131217227|NCT00445458|472418811|FG001|Overall Study|Surgery|0|||
131217228|NCT00445458|472418812|FG002|Overall Study|Surgery|1|||
131217229|NCT00445458|472418813|FG003|Overall Study|Surgery|0|||
131217230|NCT01071083|472418816|FG000|Overall Study|Adverse Event|1|||
131217231|NCT01071083|472418817|FG001|Overall Study|Adverse Event|0|||
131217232|NCT01071083|472418818|FG002|Overall Study|Adverse Event|1|||
131217233|NCT01071083|472418819|FG003|Overall Study|Adverse Event|0|||
131217234|NCT01071083|472418820|FG004|Overall Study|Adverse Event|1|||
131217235|NCT01071083|472418816|FG000|Overall Study|Withdrawal by Subject|3|||
131217236|NCT01071083|472418817|FG001|Overall Study|Withdrawal by Subject|0|||
131217237|NCT01071083|472418818|FG002|Overall Study|Withdrawal by Subject|2|||
131217238|NCT01071083|472418819|FG003|Overall Study|Withdrawal by Subject|0|||
131217239|NCT01071083|472418820|FG004|Overall Study|Withdrawal by Subject|3|||
131217240|NCT01071083|472418816|FG000|Overall Study|Physician Decision|1|||
131217241|NCT01071083|472418817|FG001|Overall Study|Physician Decision|0|||
131217242|NCT01071083|472418818|FG002|Overall Study|Physician Decision|0|||
131217243|NCT01071083|472418819|FG003|Overall Study|Physician Decision|1|||
131217244|NCT01071083|472418820|FG004|Overall Study|Physician Decision|1|||
131217245|NCT01071083|472418816|FG000|Overall Study|Early Rescue|1|||
131217246|NCT01071083|472418817|FG001|Overall Study|Early Rescue|0|||
131217247|NCT01071083|472418818|FG002|Overall Study|Early Rescue|0|||
131217248|NCT01071083|472418819|FG003|Overall Study|Early Rescue|0|||
131217249|NCT01071083|472418820|FG004|Overall Study|Early Rescue|1|||
131217250|NCT01071083|472418816|FG000|Overall Study|Subject Moved|0|||
131217251|NCT01071083|472418817|FG001|Overall Study|Subject Moved|1|||
131217252|NCT01071083|472418818|FG002|Overall Study|Subject Moved|0|||
131217253|NCT01071083|472418819|FG003|Overall Study|Subject Moved|0|||
131217254|NCT01071083|472418820|FG004|Overall Study|Subject Moved|0|||
131217255|NCT01071083|472418816|FG000|Overall Study|Images Not Usable (Motion)|0|||
131217256|NCT01071083|472418817|FG001|Overall Study|Images Not Usable (Motion)|1|||
131217257|NCT01071083|472418818|FG002|Overall Study|Images Not Usable (Motion)|0|||
131217258|NCT01071083|472418819|FG003|Overall Study|Images Not Usable (Motion)|0|||
131217259|NCT01071083|472418820|FG004|Overall Study|Images Not Usable (Motion)|0|||
131217260|NCT01071083|472418816|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
131217261|NCT01071083|472418817|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
131217262|NCT01071083|472418818|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
131217263|NCT01071083|472418819|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
131217264|NCT01071083|472418820|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
131217265|NCT01071083|472418816|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
131217266|NCT01071083|472418817|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
131217267|NCT01071083|472418818|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
131217268|NCT01071083|472418819|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
131217269|NCT01071083|472418820|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
131217270|NCT01071083|472418816|FG000|Overall Study|Subject Refused to Continue|1|||
131217271|NCT01071083|472418817|FG001|Overall Study|Subject Refused to Continue|0|||
131217272|NCT01071083|472418818|FG002|Overall Study|Subject Refused to Continue|0|||
131100648|NCT01871805|471998063|FG004|Phase II|Death|0|||
131217273|NCT01071083|472418819|FG003|Overall Study|Subject Refused to Continue|0|||
131217274|NCT01071083|472418820|FG004|Overall Study|Subject Refused to Continue|0|||
131217275|NCT00728988|472418821|FG000|Overall Study|Not Treated|2|||
131217276|NCT00728988|472418822|FG001|Overall Study|Not Treated|2|||
131217277|NCT00728988|472418821|FG000|Overall Study|Death|1|||
131217278|NCT00728988|472418822|FG001|Overall Study|Death|1|||
131217279|NCT00728988|472418821|FG000|Overall Study|Adverse Event|3|||
131217280|NCT00728988|472418822|FG001|Overall Study|Adverse Event|2|||
131217281|NCT00728988|472418821|FG000|Overall Study|Other|85|||
131217282|NCT00728988|472418822|FG001|Overall Study|Other|77|||
131217283|NCT00728988|472418821|FG000|Overall Study|Withdrawal by Subject|2|||
131217284|NCT00728988|472418822|FG001|Overall Study|Withdrawal by Subject|6|||
131217285|NCT03186794|472418827|FG000|Overall Study|Physician Decision|2|||
131217286|NCT03186794|472418827|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
131217287|NCT02864953|472418831|FG000|Overall Study|Adverse Event|22|||
131217288|NCT02864953|472418832|FG001|Overall Study|Adverse Event|19|||
131217289|NCT02864953|472418831|FG000|Overall Study|Withdrawal by Subject|1|||
131217290|NCT02864953|472418832|FG001|Overall Study|Withdrawal by Subject|0|||
131217291|NCT02864953|472418831|FG000|Overall Study|Physician Decision|4|||
131217292|NCT02864953|472418832|FG001|Overall Study|Physician Decision|2|||
131217293|NCT02864953|472418831|FG000|Overall Study|Death|3|||
131217294|NCT02864953|472418832|FG001|Overall Study|Death|13|||
131217295|NCT02864953|472418831|FG000|Overall Study|Reason not specified|14|||
131217296|NCT02864953|472418832|FG001|Overall Study|Reason not specified|12|||
131217297|NCT02864953|472418831|FG000|Overall Study|Withdrew Prior to Dosing|9|||
131217298|NCT02864953|472418832|FG001|Overall Study|Withdrew Prior to Dosing|8|||
131217299|NCT00621309|472418833|FG000|Overall Study|Withdrawal by Subject|2|||
131217300|NCT00621309|472418834|FG001|Overall Study|Withdrawal by Subject|0|||
131217301|NCT00621309|472418835|FG002|Overall Study|Withdrawal by Subject|1|||
131217302|NCT00621309|472418836|FG003|Overall Study|Withdrawal by Subject|1|||
131217303|NCT00621309|472418837|FG004|Overall Study|Withdrawal by Subject|1|||
131217304|NCT00621309|472418838|FG005|Overall Study|Withdrawal by Subject|1|||
131217305|NCT02949219|472418841|FG000|Overall Study|Withdrawal by Subject|1|||
131217306|NCT02392377|472418842|FG000|Overall Study|Withdrawal by Subject|0|||
131217307|NCT02392377|472418843|FG001|Overall Study|Withdrawal by Subject|1|||
131217308|NCT03205163|472418846|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
131217309|NCT03205163|472418847|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
131217310|NCT03993288|472420662|FG000|Overall Study|Lost to Follow-up|2|||
131217311|NCT03993288|472420663|FG001|Overall Study|Lost to Follow-up|1|||
131217312|NCT03993288|472420662|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
131217313|NCT03993288|472420663|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
131217314|NCT03993288|472420662|FG000|Overall Study|wrong randomization|0|||
131217315|NCT03993288|472420663|FG001|Overall Study|wrong randomization|1|||
131217316|NCT03993288|472420662|FG000|Overall Study|improper enrollment|0|||
131217317|NCT03993288|472420663|FG001|Overall Study|improper enrollment|1|||
131217318|NCT03993288|472420662|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
131217319|NCT03993288|472420663|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
131217320|NCT03993288|472420662|FG000|Overall Study|developed SAE|2|||
131217321|NCT03993288|472420663|FG001|Overall Study|developed SAE|0|||
131217322|NCT03993288|472420662|FG000|Overall Study|consent withdrawal|1|||
131217323|NCT03993288|472420663|FG001|Overall Study|consent withdrawal|0|||
131217324|NCT03993288|472420662|FG000|Overall Study|did not follow the treatment schedule|1|||
131217325|NCT03993288|472420663|FG001|Overall Study|did not follow the treatment schedule|0|||
131217326|NCT03993288|472420662|FG000|Overall Study|did not follow the treatment regimen|1|||
131217327|NCT03993288|472420663|FG001|Overall Study|did not follow the treatment regimen|0|||
131217328|NCT03993288|472420662|FG000|Overall Study|Adverse Event|1|||
131217329|NCT03993288|472420663|FG001|Overall Study|Adverse Event|0|||
131217330|NCT03993288|472420662|FG000|Overall Study|Withdrawal by Subject|1|||
131217331|NCT03993288|472420663|FG001|Overall Study|Withdrawal by Subject|1|||
131217332|NCT00915473|472420664|FG000|Screening|Withdrawal by Subject|1|||
131217333|NCT00915473|472420665|FG001|Screening|Withdrawal by Subject|0|||
131217334|NCT00915473|472420664|FG000|4-week Follow Up|Lost to Follow-up|1|||
131217335|NCT00915473|472420665|FG001|4-week Follow Up|Lost to Follow-up|5|||
131217336|NCT03526679|472420666|FG000|Overall Study|still under treatment|2|||
131217337|NCT03443973|472420667|FG000|Double-blind Treatment Period|Adverse Event|5|||
131217338|NCT03443973|472420668|FG001|Double-blind Treatment Period|Adverse Event|19|||
131217339|NCT03443973|472420669|FG002|Double-blind Treatment Period|Adverse Event|0|||
131217340|NCT03443973|472420670|FG003|Double-blind Treatment Period|Adverse Event|0|||
131217341|NCT03443973|472420667|FG000|Double-blind Treatment Period|Death|5|||
131217342|NCT03443973|472420668|FG001|Double-blind Treatment Period|Death|7|||
131217343|NCT03443973|472420669|FG002|Double-blind Treatment Period|Death|0|||
131217344|NCT03443973|472420670|FG003|Double-blind Treatment Period|Death|0|||
131217345|NCT03443973|472420667|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
131217346|NCT03443973|472420668|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
131217347|NCT03443973|472420669|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
131217348|NCT03443973|472420670|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
131217349|NCT03443973|472420667|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
131217350|NCT03443973|472420668|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
131217351|NCT03443973|472420669|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
131217352|NCT03443973|472420670|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
131217353|NCT03443973|472420667|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
131217354|NCT03443973|472420668|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
131217355|NCT03443973|472420669|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
131217356|NCT03443973|472420670|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
131217357|NCT03443973|472420667|FG000|Double-blind Treatment Period|Physician Decision|5|||
131217358|NCT03443973|472420668|FG001|Double-blind Treatment Period|Physician Decision|6|||
131217359|NCT03443973|472420669|FG002|Double-blind Treatment Period|Physician Decision|0|||
131217360|NCT03443973|472420670|FG003|Double-blind Treatment Period|Physician Decision|0|||
131217361|NCT03443973|472420667|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
131217362|NCT03443973|472420668|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
131217363|NCT03443973|472420669|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
131217364|NCT03443973|472420670|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
131217365|NCT03443973|472420667|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
131217366|NCT03443973|472420668|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
131217367|NCT03443973|472420669|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131217368|NCT03443973|472420670|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
131217369|NCT03443973|472420667|FG000|Open-label Extension Period|Reason Not Specified|0|||
131217370|NCT03443973|472420668|FG001|Open-label Extension Period|Reason Not Specified|0|||
131217371|NCT03443973|472420669|FG002|Open-label Extension Period|Reason Not Specified|3|||
131217372|NCT03443973|472420670|FG003|Open-label Extension Period|Reason Not Specified|0|||
131217373|NCT03443973|472420667|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
131217374|NCT03443973|472420668|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
131217375|NCT03443973|472420669|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
131217376|NCT03443973|472420670|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
131217377|NCT01956123|472420671|FG000|COS Cycle 2|Protocol Violation|8|||
131217378|NCT01956123|472420672|FG001|COS Cycle 2|Protocol Violation|3|||
131217379|NCT01956123|472420673|FG002|COS Cycle 2|Protocol Violation|0|||
131217380|NCT01956123|472420674|FG003|COS Cycle 2|Protocol Violation|0|||
131217381|NCT01956123|472420671|FG000|COS Cycle 2|Adverse Event|3|||
131217382|NCT01956123|472420672|FG001|COS Cycle 2|Adverse Event|4|||
131217383|NCT01956123|472420673|FG002|COS Cycle 2|Adverse Event|0|||
131217384|NCT01956123|472420674|FG003|COS Cycle 2|Adverse Event|0|||
131217385|NCT01956123|472420671|FG000|COS Cycle 2|Personal Reasons|2|||
131217386|NCT01956123|472420672|FG001|COS Cycle 2|Personal Reasons|0|||
131217387|NCT01956123|472420673|FG002|COS Cycle 2|Personal Reasons|0|||
131217388|NCT01956123|472420674|FG003|COS Cycle 2|Personal Reasons|0|||
131217389|NCT01956123|472420671|FG000|COS Cycle 2|Withdrawal by Subject|1|||
131217390|NCT01956123|472420672|FG001|COS Cycle 2|Withdrawal by Subject|0|||
131217391|NCT01956123|472420673|FG002|COS Cycle 2|Withdrawal by Subject|0|||
131217392|NCT01956123|472420674|FG003|COS Cycle 2|Withdrawal by Subject|0|||
131217393|NCT01956123|472420671|FG000|COS Cycle 3|Protocol Violation|0|||
131217394|NCT01956123|472420672|FG001|COS Cycle 3|Protocol Violation|0|||
131217395|NCT01956123|472420673|FG002|COS Cycle 3|Protocol Violation|2|||
131217396|NCT01956123|472420674|FG003|COS Cycle 3|Protocol Violation|1|||
131217397|NCT01956123|472420671|FG000|COS Cycle 3|Adverse Event|0|||
131217398|NCT01956123|472420672|FG001|COS Cycle 3|Adverse Event|0|||
131217399|NCT01956123|472420673|FG002|COS Cycle 3|Adverse Event|3|||
131217400|NCT01956123|472420674|FG003|COS Cycle 3|Adverse Event|0|||
131217401|NCT01956123|472420671|FG000|COS Cycle 3|Personal Reasons|0|||
131217402|NCT01956123|472420672|FG001|COS Cycle 3|Personal Reasons|0|||
131217403|NCT01956123|472420673|FG002|COS Cycle 3|Personal Reasons|1|||
131217404|NCT01956123|472420674|FG003|COS Cycle 3|Personal Reasons|0|||
131217405|NCT01956123|472420671|FG000|COS Cycle 3|Withdrawal by Subject|0|||
131217406|NCT01956123|472420672|FG001|COS Cycle 3|Withdrawal by Subject|0|||
131217407|NCT01956123|472420673|FG002|COS Cycle 3|Withdrawal by Subject|0|||
131217408|NCT01956123|472420674|FG003|COS Cycle 3|Withdrawal by Subject|1|||
131217409|NCT02545868|472420679|FG000|Overall Study|Lack of Efficacy|1|||
131217410|NCT02545868|472420680|FG001|Overall Study|Lack of Efficacy|1|||
131217411|NCT02545868|472420681|FG002|Overall Study|Lack of Efficacy|0|||
131217412|NCT02545868|472420679|FG000|Overall Study|Lost to Follow-up|1|||
131217413|NCT02545868|472420680|FG001|Overall Study|Lost to Follow-up|5|||
131217414|NCT02545868|472420681|FG002|Overall Study|Lost to Follow-up|1|||
131217415|NCT02545868|472420679|FG000|Overall Study|Non-compliance|1|||
131217416|NCT02545868|472420680|FG001|Overall Study|Non-compliance|1|||
131217417|NCT02545868|472420681|FG002|Overall Study|Non-compliance|1|||
131217418|NCT02545868|472420679|FG000|Overall Study|Treatment change|21|||
131217419|NCT02545868|472420680|FG001|Overall Study|Treatment change|19|||
131217420|NCT02545868|472420681|FG002|Overall Study|Treatment change|22|||
131217421|NCT02545868|472420679|FG000|Overall Study|Physician Decision|1|||
131217422|NCT02545868|472420680|FG001|Overall Study|Physician Decision|1|||
131217423|NCT02545868|472420681|FG002|Overall Study|Physician Decision|1|||
131217424|NCT02545868|472420679|FG000|Overall Study|Withdrawal by Subject|6|||
131217425|NCT02545868|472420680|FG001|Overall Study|Withdrawal by Subject|7|||
131217426|NCT02545868|472420681|FG002|Overall Study|Withdrawal by Subject|9|||
131217427|NCT01777191|472420682|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
131217428|NCT01777191|472420683|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
131217429|NCT01777191|472420682|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
131217430|NCT01777191|472420683|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
131217431|NCT01777191|472420682|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
131217432|NCT01777191|472420683|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
131217433|NCT01777191|472420682|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
130765856|NCT00314132|470765886|FG001|Overall Study|Adverse Event|0|||
131217434|NCT01777191|472420683|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
131217435|NCT01777191|472420682|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
131217436|NCT01777191|472420683|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
131217437|NCT01777191|472420682|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
131217438|NCT01777191|472420683|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
131217439|NCT01777191|472420682|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
131217440|NCT01777191|472420683|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
131217441|NCT01777191|472420682|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
131217442|NCT01777191|472420683|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
131217443|NCT01777191|472420682|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
131217444|NCT01777191|472420683|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
131217445|NCT01777191|472420682|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
131217446|NCT01777191|472420683|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
131217447|NCT01777191|472420682|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
131217448|NCT01777191|472420683|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
131217449|NCT04465916|472420688|FG000|Overall Study|Withdrawal by Subject|0|||
131217450|NCT04465916|472420689|FG001|Overall Study|Withdrawal by Subject|1|||
131217451|NCT01325701|472420695|FG000|Overall Study|Adverse Event|12|||
131217452|NCT01325701|472420696|FG001|Overall Study|Adverse Event|0|||
131217453|NCT01325701|472420695|FG000|Overall Study|Protocol Violation|1|||
131217454|NCT01325701|472420696|FG001|Overall Study|Protocol Violation|0|||
131217455|NCT01325701|472420695|FG000|Overall Study|Physician Decision|2|||
131217456|NCT01325701|472420696|FG001|Overall Study|Physician Decision|2|||
131217457|NCT01325701|472420695|FG000|Overall Study|Withdrawal by Subject|2|||
131217458|NCT01325701|472420696|FG001|Overall Study|Withdrawal by Subject|1|||
131217459|NCT01325701|472420695|FG000|Overall Study|Rollerover Extension Study|4|||
131217460|NCT01325701|472420696|FG001|Overall Study|Rollerover Extension Study|0|||
131217461|NCT00388674|472420704|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
131217462|NCT00388674|472420705|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
131217463|NCT00388674|472420704|FG000|Initial Treatment|Adverse Event|22|||
131217464|NCT00388674|472420705|FG001|Initial Treatment|Adverse Event|87|||
131217465|NCT00388674|472420704|FG000|Initial Treatment|Death|215|||
131217466|NCT00388674|472420705|FG001|Initial Treatment|Death|216|||
131217467|NCT00388674|472420704|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
131217468|NCT00388674|472420705|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
131217469|NCT00388674|472420704|FG000|Initial Treatment|HCC|12|||
131217470|NCT00388674|472420705|FG001|Initial Treatment|HCC|20|||
131217471|NCT00388674|472420704|FG000|Initial Treatment|Lost to Follow-up|526|||
131217472|NCT00388674|472420705|FG001|Initial Treatment|Lost to Follow-up|624|||
131217473|NCT00388674|472420704|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
131217474|NCT00388674|472420705|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
131217475|NCT00388674|472420704|FG000|Initial Treatment|Never Treated with Study Medication|1|||
131217476|NCT00388674|472420705|FG001|Initial Treatment|Never Treated with Study Medication|7|||
131217477|NCT00388674|472420704|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
131217478|NCT00388674|472420705|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
131217479|NCT00388674|472420704|FG000|Initial Treatment|Not Defined|125|||
131217480|NCT00388674|472420705|FG001|Initial Treatment|Not Defined|172|||
131217481|NCT00388674|472420704|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
131217482|NCT00388674|472420705|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
131217483|NCT00388674|472420704|FG000|Initial Treatment|Pregnancy|26|||
131217484|NCT00388674|472420705|FG001|Initial Treatment|Pregnancy|16|||
131217485|NCT00388674|472420704|FG000|Initial Treatment|Study Drug Toxicity|5|||
131217486|NCT00388674|472420705|FG001|Initial Treatment|Study Drug Toxicity|92|||
131217487|NCT00388674|472420704|FG000|Initial Treatment|Participant Request|501|||
131217488|NCT00388674|472420705|FG001|Initial Treatment|Participant Request|673|||
131217489|NCT00388674|472420704|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
131217490|NCT00388674|472420705|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
131217491|NCT00388674|472420704|FG000|Initial Treatment|Not Reported|10|||
131217492|NCT00388674|472420705|FG001|Initial Treatment|Not Reported|12|||
131217493|NCT00388674|472420704|FG000|End of Study|Administrative Reason By Sponsor|299|||
131217494|NCT00388674|472420705|FG001|End of Study|Administrative Reason By Sponsor|253|||
131217495|NCT00388674|472420704|FG000|End of Study|Death|239|||
131217496|NCT00388674|472420705|FG001|End of Study|Death|262|||
131217497|NCT00388674|472420704|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
130765857|NCT00314132|470765885|FG000|Overall Study|Physician Decision|1|||
131217498|NCT00388674|472420705|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
131217499|NCT00388674|472420704|FG000|End of Study|HCC|8|||
131217500|NCT00388674|472420705|FG001|End of Study|HCC|7|||
131217501|NCT00388674|472420704|FG000|End of Study|Lost to Follow-up|587|||
131217502|NCT00388674|472420705|FG001|End of Study|Lost to Follow-up|715|||
131217503|NCT00388674|472420704|FG000|End of Study|Malignancy (Non-HCC)|1|||
131217504|NCT00388674|472420705|FG001|End of Study|Malignancy (Non-HCC)|1|||
131217505|NCT00388674|472420704|FG000|End of Study|Non-Study Related Comorbidities|3|||
131217506|NCT00388674|472420705|FG001|End of Study|Non-Study Related Comorbidities|4|||
131217507|NCT00388674|472420704|FG000|End of Study|Not Defined|135|||
131217508|NCT00388674|472420705|FG001|End of Study|Not Defined|214|||
131217509|NCT00388674|472420704|FG000|End of Study|Participant Withdrew Consent|437|||
131217510|NCT00388674|472420705|FG001|End of Study|Participant Withdrew Consent|673|||
131217511|NCT00388674|472420704|FG000|End of Study|No Off-Treatment Status Data|22|||
131217512|NCT00388674|472420705|FG001|End of Study|No Off-Treatment Status Data|30|||
131217513|NCT00388674|472420704|FG000|End of Study|Not Reported|0|||
131217514|NCT00388674|472420705|FG001|End of Study|Not Reported|1|||
131217515|NCT03576131|472420708|FG000|Overall Study|Investigator decision|0|||
131217516|NCT03576131|472420709|FG001|Overall Study|Investigator decision|0|||
131217517|NCT03576131|472420710|FG002|Overall Study|Investigator decision|0|||
131217518|NCT03576131|472420711|FG003|Overall Study|Investigator decision|1|||
131217519|NCT03576131|472420712|FG004|Overall Study|Investigator decision|0|||
131217520|NCT03576131|472420713|FG005|Overall Study|Investigator decision|1|||
131217521|NCT03576131|472420714|FG006|Overall Study|Investigator decision|0|||
131217522|NCT03576131|472420715|FG007|Overall Study|Investigator decision|0|||
131217523|NCT03576131|472420708|FG000|Overall Study|Withdrawal by Subject|1|||
131217524|NCT03576131|472420709|FG001|Overall Study|Withdrawal by Subject|1|||
131217525|NCT03576131|472420710|FG002|Overall Study|Withdrawal by Subject|0|||
131217526|NCT03576131|472420711|FG003|Overall Study|Withdrawal by Subject|1|||
131217527|NCT03576131|472420712|FG004|Overall Study|Withdrawal by Subject|2|||
131217528|NCT03576131|472420713|FG005|Overall Study|Withdrawal by Subject|3|||
131217529|NCT03576131|472420714|FG006|Overall Study|Withdrawal by Subject|1|||
131217530|NCT03576131|472420715|FG007|Overall Study|Withdrawal by Subject|0|||
131217531|NCT03576131|472420708|FG000|Overall Study|Death|3|||
131217532|NCT03576131|472420709|FG001|Overall Study|Death|3|||
131217533|NCT03576131|472420710|FG002|Overall Study|Death|1|||
131217534|NCT03576131|472420711|FG003|Overall Study|Death|5|||
131217535|NCT03576131|472420712|FG004|Overall Study|Death|4|||
131217536|NCT03576131|472420713|FG005|Overall Study|Death|1|||
131217537|NCT03576131|472420714|FG006|Overall Study|Death|0|||
131217538|NCT03576131|472420715|FG007|Overall Study|Death|1|||
131217539|NCT03576131|472420708|FG000|Overall Study|New anti-cancer treatment|5|||
131217540|NCT03576131|472420709|FG001|Overall Study|New anti-cancer treatment|1|||
131217541|NCT03576131|472420710|FG002|Overall Study|New anti-cancer treatment|2|||
131217542|NCT03576131|472420711|FG003|Overall Study|New anti-cancer treatment|3|||
131217543|NCT03576131|472420712|FG004|Overall Study|New anti-cancer treatment|0|||
131217544|NCT03576131|472420713|FG005|Overall Study|New anti-cancer treatment|0|||
131217545|NCT03576131|472420714|FG006|Overall Study|New anti-cancer treatment|0|||
131217546|NCT03576131|472420715|FG007|Overall Study|New anti-cancer treatment|0|||
131217547|NCT03576131|472420708|FG000|Overall Study|Unspecified reason|0|||
131217548|NCT03576131|472420709|FG001|Overall Study|Unspecified reason|0|||
131217549|NCT03576131|472420710|FG002|Overall Study|Unspecified reason|1|||
131217550|NCT03576131|472420711|FG003|Overall Study|Unspecified reason|1|||
131217551|NCT03576131|472420712|FG004|Overall Study|Unspecified reason|1|||
131217552|NCT03576131|472420713|FG005|Overall Study|Unspecified reason|1|||
131217553|NCT03576131|472420714|FG006|Overall Study|Unspecified reason|0|||
131217554|NCT03576131|472420715|FG007|Overall Study|Unspecified reason|0|||
131217555|NCT03576131|472420708|FG000|Overall Study|Subject non-compliance|0|||
131217556|NCT03576131|472420709|FG001|Overall Study|Subject non-compliance|0|||
131217557|NCT03576131|472420710|FG002|Overall Study|Subject non-compliance|0|||
131217558|NCT03576131|472420711|FG003|Overall Study|Subject non-compliance|0|||
131217559|NCT03576131|472420712|FG004|Overall Study|Subject non-compliance|0|||
131217560|NCT03576131|472420713|FG005|Overall Study|Subject non-compliance|1|||
131217561|NCT03576131|472420714|FG006|Overall Study|Subject non-compliance|0|||
131217562|NCT03576131|472420715|FG007|Overall Study|Subject non-compliance|0|||
130992693|NCT02769065|471601574|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992694|NCT02769065|471601575|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992695|NCT02769065|471601576|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992696|NCT02769065|471601577|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992697|NCT02769065|471601578|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992698|NCT02769065|471601579|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
131217563|NCT00996632|472420720|FG000|Overall Study|Physician Decision|0|||
131217564|NCT00996632|472420721|FG001|Overall Study|Physician Decision|0|||
131217565|NCT03069365|472420726|FG000|Overall Study|Adverse Event|1|||
131217566|NCT03901339|472420727|FG000|Overall Study|Death|220|||
131217567|NCT03901339|472420728|FG001|Overall Study|Death|192|||
131217568|NCT03901339|472420727|FG000|Overall Study|Informed consent withdrawn|13|||
131217569|NCT03901339|472420728|FG001|Overall Study|Informed consent withdrawn|40|||
131217570|NCT03901339|472420727|FG000|Overall Study|Sponsor request|30|||
131217571|NCT03901339|472420728|FG001|Overall Study|Sponsor request|23|||
130992699|NCT02769065|471601580|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
131217572|NCT03901339|472420727|FG000|Overall Study|Reason not specified|5|||
131217573|NCT03901339|472420728|FG001|Overall Study|Reason not specified|7|||
131217574|NCT03901339|472420727|FG000|Overall Study|Lost to Follow-up|4|||
131217575|NCT03901339|472420728|FG001|Overall Study|Lost to Follow-up|7|||
131217576|NCT03901339|472420727|FG000|Overall Study|Covid19|0|||
131217577|NCT03901339|472420728|FG001|Overall Study|Covid19|2|||
131217578|NCT02886494|472420729|FG000|Overall Study|Adverse Event|1|||
131217579|NCT02886494|472420730|FG001|Overall Study|Adverse Event|0|||
131217580|NCT02886494|472420729|FG000|Overall Study|Withdrawal by Subject|12|||
131217581|NCT02886494|472420730|FG001|Overall Study|Withdrawal by Subject|3|||
131217582|NCT02886494|472420729|FG000|Overall Study|Protocol Violation|4|||
131217583|NCT02886494|472420730|FG001|Overall Study|Protocol Violation|1|||
131217584|NCT02780115|472420731|FG000|Overall Study|Withdrawal by Subject|0|||
131217585|NCT02780115|472420732|FG001|Overall Study|Withdrawal by Subject|1|||
131217586|NCT02780115|472420733|FG002|Overall Study|Withdrawal by Subject|1|||
131217587|NCT02780115|472420734|FG003|Overall Study|Withdrawal by Subject|0|||
131217588|NCT02780115|472420735|FG004|Overall Study|Withdrawal by Subject|0|||
131217589|NCT02780115|472420731|FG000|Overall Study|Adverse Event|0|||
131217590|NCT02780115|472420732|FG001|Overall Study|Adverse Event|0|||
131217591|NCT02780115|472420733|FG002|Overall Study|Adverse Event|0|||
131217592|NCT02780115|472420734|FG003|Overall Study|Adverse Event|1|||
131217593|NCT02780115|472420735|FG004|Overall Study|Adverse Event|1|||
131217594|NCT01179191|472420736|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
131217595|NCT01179191|472420736|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
131217596|NCT01179191|472420736|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
131217597|NCT01179191|472420736|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
131217598|NCT01179191|472420736|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
131217599|NCT01179191|472420736|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
131217600|NCT01179191|472420736|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
131217601|NCT01179191|472420736|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
131217602|NCT01179191|472420736|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
131217603|NCT01179191|472420736|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
131217604|NCT01179191|472420736|FG000|Maintenance Phase (8 Weeks)|Other|66|||
131217605|NCT00572910|472420740|FG000|Overall Study|Adverse Event|1|||
131217606|NCT00572910|472420741|FG001|Overall Study|Adverse Event|2|||
131217607|NCT00572910|472420742|FG002|Overall Study|Adverse Event|0|||
131217608|NCT00572910|472420743|FG003|Overall Study|Adverse Event|2|||
131217609|NCT00572910|472420744|FG004|Overall Study|Adverse Event|0|||
131217610|NCT00572910|472420745|FG005|Overall Study|Adverse Event|0|||
131217611|NCT00572910|472420746|FG006|Overall Study|Adverse Event|4|||
131217612|NCT00572910|472420747|FG007|Overall Study|Adverse Event|2|||
131217613|NCT00572910|472420748|FG008|Overall Study|Adverse Event|1|||
131217614|NCT00572910|472420749|FG009|Overall Study|Adverse Event|3|||
131217615|NCT00572910|472420750|FG010|Overall Study|Adverse Event|2|||
131217616|NCT00572910|472420740|FG000|Overall Study|Lost to Follow-up|0|||
131217617|NCT00572910|472420741|FG001|Overall Study|Lost to Follow-up|1|||
131217618|NCT00572910|472420742|FG002|Overall Study|Lost to Follow-up|1|||
131217619|NCT00572910|472420743|FG003|Overall Study|Lost to Follow-up|2|||
131217620|NCT00572910|472420744|FG004|Overall Study|Lost to Follow-up|1|||
131217621|NCT00572910|472420745|FG005|Overall Study|Lost to Follow-up|0|||
131217622|NCT00572910|472420746|FG006|Overall Study|Lost to Follow-up|0|||
131217623|NCT00572910|472420747|FG007|Overall Study|Lost to Follow-up|0|||
131217624|NCT00572910|472420748|FG008|Overall Study|Lost to Follow-up|0|||
131217625|NCT00572910|472420749|FG009|Overall Study|Lost to Follow-up|1|||
131217626|NCT00572910|472420750|FG010|Overall Study|Lost to Follow-up|0|||
131217627|NCT00572910|472420740|FG000|Overall Study|Withdrawal by Subject|3|||
131217628|NCT00572910|472420741|FG001|Overall Study|Withdrawal by Subject|0|||
131217629|NCT00572910|472420742|FG002|Overall Study|Withdrawal by Subject|1|||
131217630|NCT00572910|472420743|FG003|Overall Study|Withdrawal by Subject|0|||
131217631|NCT00572910|472420744|FG004|Overall Study|Withdrawal by Subject|1|||
131217632|NCT00572910|472420745|FG005|Overall Study|Withdrawal by Subject|3|||
131217633|NCT00572910|472420746|FG006|Overall Study|Withdrawal by Subject|0|||
131217634|NCT00572910|472420747|FG007|Overall Study|Withdrawal by Subject|2|||
131217635|NCT00572910|472420748|FG008|Overall Study|Withdrawal by Subject|2|||
131217636|NCT00572910|472420749|FG009|Overall Study|Withdrawal by Subject|2|||
131217637|NCT00572910|472420750|FG010|Overall Study|Withdrawal by Subject|1|||
131217638|NCT00457418|472420755|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
131217639|NCT00457418|472420755|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
131217640|NCT00457418|472420755|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
131217641|NCT00457418|472420755|FG000|Post PK Maintenance|Adverse Event|10|||
131217642|NCT00457418|472420755|FG000|Post PK Maintenance|Progression of Disease|6|||
131100649|NCT01871805|471998064|FG005|Phase II|Death|45|||
131217643|NCT00457418|472420755|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
130765858|NCT00314132|470765886|FG001|Overall Study|Physician Decision|0|||
131217644|NCT00457418|472420755|FG000|Post PK Maintenance|Lost to Follow-up|1|||
131217645|NCT00592007|472420756|FG000|Overall Study|Withdrawal by Subject|1|||
131217646|NCT00592007|472420756|FG000|Overall Study|patient ineligible (out of lab range)|1|||
131217647|NCT00595127|472420757|FG000|Overall Study|Death|6|||
131217648|NCT00595127|472420757|FG000|Overall Study|Relapsed|3|||
131217649|NCT00595127|472420757|FG000|Overall Study|joined another trial|1|||
131217650|NCT01785472|472420758|FG000|Overall Study|Adverse Event|5|||
131217651|NCT01785472|472420759|FG001|Overall Study|Adverse Event|4|||
131217652|NCT01785472|472420760|FG002|Overall Study|Adverse Event|6|||
131217653|NCT01785472|472420758|FG000|Overall Study|Lack of Efficacy|2|||
131217654|NCT01785472|472420759|FG001|Overall Study|Lack of Efficacy|0|||
131217655|NCT01785472|472420760|FG002|Overall Study|Lack of Efficacy|1|||
131217656|NCT01785472|472420758|FG000|Overall Study|Lost to Follow-up|1|||
131217657|NCT01785472|472420759|FG001|Overall Study|Lost to Follow-up|2|||
131217658|NCT01785472|472420760|FG002|Overall Study|Lost to Follow-up|0|||
131217659|NCT01785472|472420758|FG000|Overall Study|Physician Decision|1|||
131217660|NCT01785472|472420759|FG001|Overall Study|Physician Decision|1|||
131217661|NCT01785472|472420760|FG002|Overall Study|Physician Decision|1|||
131217662|NCT01785472|472420758|FG000|Overall Study|Protocol deviation|0|||
131217663|NCT01785472|472420759|FG001|Overall Study|Protocol deviation|2|||
131217664|NCT01785472|472420760|FG002|Overall Study|Protocol deviation|2|||
131217665|NCT01785472|472420758|FG000|Overall Study|Subject/guardian decision|15|||
131217666|NCT01785472|472420759|FG001|Overall Study|Subject/guardian decision|10|||
131217667|NCT01785472|472420760|FG002|Overall Study|Subject/guardian decision|11|||
131217668|NCT01785472|472420758|FG000|Overall Study|Technical problems|0|||
131217669|NCT01785472|472420759|FG001|Overall Study|Technical problems|0|||
131217670|NCT01785472|472420760|FG002|Overall Study|Technical problems|1|||
131217671|NCT02086968|472420762|FG000|Overall Study|Adverse Event|1|||
131217672|NCT02086968|472420763|FG001|Overall Study|Adverse Event|5|||
131217673|NCT02086968|472420762|FG000|Overall Study|Lost to Follow-up|2|||
131217674|NCT02086968|472420763|FG001|Overall Study|Lost to Follow-up|3|||
131217675|NCT02086968|472420762|FG000|Overall Study|Study drug received outside protocol|0|||
131217676|NCT02086968|472420763|FG001|Overall Study|Study drug received outside protocol|1|||
131217677|NCT02086968|472420762|FG000|Overall Study|Physician Decision|4|||
131217678|NCT02086968|472420763|FG001|Overall Study|Physician Decision|0|||
131217679|NCT02086968|472420762|FG000|Overall Study|Withdrawal by Subject|1|||
131217680|NCT02086968|472420763|FG001|Overall Study|Withdrawal by Subject|4|||
131217681|NCT01569074|472420767|FG000|Overall Study|Study stopped|6|||
131217682|NCT01569074|472420768|FG001|Overall Study|Study stopped|6|||
131217683|NCT01569074|472420769|FG002|Overall Study|Study stopped|8|||
131217684|NCT01569074|472420770|FG003|Overall Study|Study stopped|7|||
131217685|NCT01569074|472420771|FG004|Overall Study|Study stopped|7|||
131217686|NCT01569074|472420767|FG000|Overall Study|Study-specific discontinuation criteria|0|||
131217687|NCT01569074|472420768|FG001|Overall Study|Study-specific discontinuation criteria|1|||
131217688|NCT01569074|472420769|FG002|Overall Study|Study-specific discontinuation criteria|0|||
131217689|NCT01569074|472420770|FG003|Overall Study|Study-specific discontinuation criteria|0|||
131217690|NCT01569074|472420771|FG004|Overall Study|Study-specific discontinuation criteria|0|||
131217691|NCT01569074|472420767|FG000|Overall Study|Severe non-compliance to protocol|0|||
131217692|NCT01569074|472420768|FG001|Overall Study|Severe non-compliance to protocol|0|||
131217693|NCT01569074|472420769|FG002|Overall Study|Severe non-compliance to protocol|1|||
131217694|NCT01569074|472420770|FG003|Overall Study|Severe non-compliance to protocol|0|||
131217695|NCT01569074|472420771|FG004|Overall Study|Severe non-compliance to protocol|0|||
131217696|NCT01569074|472420767|FG000|Overall Study|eg change in circumstances|0|||
131217697|NCT01569074|472420768|FG001|Overall Study|eg change in circumstances|2|||
131217698|NCT01569074|472420769|FG002|Overall Study|eg change in circumstances|0|||
131217699|NCT01569074|472420770|FG003|Overall Study|eg change in circumstances|1|||
131217700|NCT01569074|472420771|FG004|Overall Study|eg change in circumstances|1|||
131217701|NCT01569074|472420767|FG000|Overall Study|Adverse Event|1|||
131217702|NCT01569074|472420768|FG001|Overall Study|Adverse Event|0|||
131217703|NCT01569074|472420769|FG002|Overall Study|Adverse Event|3|||
131217704|NCT01569074|472420770|FG003|Overall Study|Adverse Event|0|||
131217705|NCT01569074|472420771|FG004|Overall Study|Adverse Event|0|||
131217706|NCT03099161|472420772|FG000|Overall Study|Adverse Event|0|||
131217707|NCT03099161|472420773|FG001|Overall Study|Adverse Event|0|||
131217708|NCT03099161|472420774|FG002|Overall Study|Adverse Event|2|||
131217709|NCT03099161|472420772|FG000|Overall Study|Physician Decision|2|||
131217710|NCT03099161|472420773|FG001|Overall Study|Physician Decision|0|||
131217711|NCT03099161|472420774|FG002|Overall Study|Physician Decision|0|||
131217712|NCT03099161|472420772|FG000|Overall Study|Progressive Disease|1|||
131217713|NCT03099161|472420773|FG001|Overall Study|Progressive Disease|4|||
131217714|NCT03099161|472420774|FG002|Overall Study|Progressive Disease|1|||
131217715|NCT02723786|472420776|FG000|Overall Study|Lost to Follow-up|1|||
130765859|NCT03482167|470765887|FG000|Allocated to Intervention|Physician Decision|1|||
131217716|NCT00556166|472420788|FG000|Overall Study|Withdrawal by Subject|1|||
131217717|NCT02985515|472420791|FG000|Olfaction Testing|Lost to Follow-up|0|||
131217718|NCT02985515|472420792|FG001|Olfaction Testing|Lost to Follow-up|5|||
131217719|NCT02985515|472420791|FG000|Olfaction Testing|Protocol Violation|0|||
131217720|NCT02985515|472420792|FG001|Olfaction Testing|Protocol Violation|3|||
131217721|NCT00742859|472420799|FG000|Overall Study|Adverse Event|5|||
131217722|NCT00742859|472420800|FG001|Overall Study|Adverse Event|6|||
131217723|NCT00742859|472420801|FG002|Overall Study|Adverse Event|3|||
131217724|NCT00742859|472420802|FG003|Overall Study|Adverse Event|1|||
131217725|NCT00742859|472420799|FG000|Overall Study|Death|1|||
131217726|NCT00742859|472420800|FG001|Overall Study|Death|0|||
131217727|NCT00742859|472420801|FG002|Overall Study|Death|0|||
131217728|NCT00742859|472420802|FG003|Overall Study|Death|1|||
131217729|NCT00742859|472420799|FG000|Overall Study|Physician Decision|1|||
131217730|NCT00742859|472420800|FG001|Overall Study|Physician Decision|2|||
131217731|NCT00742859|472420801|FG002|Overall Study|Physician Decision|0|||
131217732|NCT00742859|472420802|FG003|Overall Study|Physician Decision|0|||
131217733|NCT00742859|472420799|FG000|Overall Study|Withdrawal by Subject|4|||
131217734|NCT00742859|472420800|FG001|Overall Study|Withdrawal by Subject|2|||
131217735|NCT00742859|472420801|FG002|Overall Study|Withdrawal by Subject|4|||
131217736|NCT00742859|472420802|FG003|Overall Study|Withdrawal by Subject|1|||
131217737|NCT00742859|472420799|FG000|Overall Study|Endpoint|0|||
131217738|NCT00742859|472420800|FG001|Overall Study|Endpoint|1|||
131217739|NCT00742859|472420801|FG002|Overall Study|Endpoint|1|||
131217740|NCT00742859|472420802|FG003|Overall Study|Endpoint|2|||
131217741|NCT00742859|472420799|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
131217742|NCT00742859|472420800|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
131217743|NCT00742859|472420801|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
131217744|NCT00742859|472420802|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
131217745|NCT00742859|472420799|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
131217746|NCT00742859|472420800|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
131217747|NCT00742859|472420801|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
131217748|NCT00742859|472420802|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
131217749|NCT00742859|472420799|FG000|Overall Study|Sponsor request patient out of town|0|||
131217750|NCT00742859|472420800|FG001|Overall Study|Sponsor request patient out of town|0|||
131217751|NCT00742859|472420801|FG002|Overall Study|Sponsor request patient out of town|1|||
131217752|NCT00742859|472420802|FG003|Overall Study|Sponsor request patient out of town|1|||
131217753|NCT00742859|472420799|FG000|Overall Study|Site error|0|||
131217754|NCT00742859|472420800|FG001|Overall Study|Site error|0|||
131217755|NCT00742859|472420801|FG002|Overall Study|Site error|1|||
131217756|NCT00742859|472420802|FG003|Overall Study|Site error|1|||
131217757|NCT01984229|472420805|FG000|Safety Follow-up Period|Adverse Event|1|||
131217758|NCT01984229|472420806|FG001|Safety Follow-up Period|Adverse Event|1|||
131217759|NCT01984229|472420805|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
131217760|NCT01984229|472420806|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
130992700|NCT02769065|471601581|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
131217761|NCT00834366|472420808|FG000|Treatment Period 1|Adverse Event|1|||
131217762|NCT00834366|472420809|FG001|Treatment Period 1|Adverse Event|1|||
131217763|NCT02380248|472420811|FG000|Overall Study|Lost to Follow-up|11|||
131217764|NCT02380248|472420811|FG000|Overall Study|Withdrawal by Subject|3|||
131217765|NCT01275170|472420812|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
131217766|NCT01275170|472420813|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
131217767|NCT01275170|472420814|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
131217768|NCT01275170|472420815|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
131217769|NCT01275170|472420816|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
131217770|NCT01275170|472420817|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
131217771|NCT01275170|472420818|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
131217772|NCT01275170|472420819|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
131217773|NCT00314262|472420825|FG000|Overall Study|Adverse Event|2|||
131217774|NCT00314262|472420825|FG000|Overall Study|Withdrawal by Subject|2|||
131217775|NCT00314262|472420825|FG000|Overall Study|Physician Decision|1|||
131217776|NCT00083226|472420826|FG000|Overall Study|Lack of Efficacy|19|||
131217777|NCT00083226|472420826|FG000|Overall Study|Adverse Event|9|||
131217778|NCT00083226|472420826|FG000|Overall Study|Death|4|||
131217779|NCT00083226|472420826|FG000|Overall Study|Withdrawal by Subject|4|||
131217780|NCT00083226|472420826|FG000|Overall Study|Other|2|||
131217781|NCT00083226|472420826|FG000|Overall Study|ineligible or not receiving treatment|4|||
131217782|NCT00604175|472420833|FG000|Entry Through Week 28|Death|2|||
131217783|NCT00604175|472420834|FG001|Entry Through Week 28|Death|0|||
131217784|NCT00604175|472420835|FG002|Entry Through Week 28|Death|0|||
131217785|NCT00604175|472420833|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
131217786|NCT00604175|472420834|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
131217787|NCT00604175|472420835|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
131217788|NCT00604175|472420833|FG000|Entry Through Week 28|Lost to Follow-up|4|||
131217789|NCT00604175|472420834|FG001|Entry Through Week 28|Lost to Follow-up|3|||
131217790|NCT00604175|472420835|FG002|Entry Through Week 28|Lost to Follow-up|0|||
131217791|NCT00604175|472420833|FG000|Entry Through Week 28|Ineligible|1|||
131217792|NCT00604175|472420834|FG001|Entry Through Week 28|Ineligible|0|||
131217793|NCT00604175|472420835|FG002|Entry Through Week 28|Ineligible|0|||
131217794|NCT00604175|472420833|FG000|Entry Through Week 28|Did not start intervention|2|||
131217795|NCT00604175|472420834|FG001|Entry Through Week 28|Did not start intervention|0|||
131217796|NCT00604175|472420835|FG002|Entry Through Week 28|Did not start intervention|1|||
131217797|NCT00604175|472420833|FG000|Week 29 Through Week 72|Death|0|||
131217798|NCT00604175|472420834|FG001|Week 29 Through Week 72|Death|0|||
131217799|NCT00604175|472420835|FG002|Week 29 Through Week 72|Death|1|||
131217800|NCT00604175|472420833|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
131217801|NCT00604175|472420834|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
131217802|NCT00604175|472420835|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
131217803|NCT00604175|472420833|FG000|Week 29 Through Week 72|Site closure|0|||
131217804|NCT00604175|472420834|FG001|Week 29 Through Week 72|Site closure|1|||
131217805|NCT00604175|472420835|FG002|Week 29 Through Week 72|Site closure|0|||
131217806|NCT00604175|472420833|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
131217807|NCT00604175|472420834|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
131217808|NCT00604175|472420835|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
131217809|NCT02044094|472420836|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
131217810|NCT02044094|472420836|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
131217811|NCT02044094|472420836|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
131217812|NCT02044094|472420836|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
131217813|NCT02044094|472420836|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
131217814|NCT02044094|472420836|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
131217815|NCT02044094|472420836|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
131217816|NCT02044094|472420836|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
131217817|NCT03387423|472422270|FG000|Overall Study|Lost to Follow-up|16|||
131217818|NCT03387423|472422271|FG001|Overall Study|Lost to Follow-up|12|||
131217819|NCT03387423|472422272|FG002|Overall Study|Lost to Follow-up|1|||
131217820|NCT03387423|472422273|FG003|Overall Study|Lost to Follow-up|0|||
131217821|NCT03387423|472422270|FG000|Overall Study|Other|0|||
131217822|NCT03387423|472422271|FG001|Overall Study|Other|3|||
131217823|NCT03387423|472422272|FG002|Overall Study|Other|0|||
131217824|NCT03387423|472422273|FG003|Overall Study|Other|0|||
131217825|NCT03387423|472422270|FG000|Overall Study|Administrative Reason|166|||
131217826|NCT03387423|472422271|FG001|Overall Study|Administrative Reason|89|||
131217827|NCT03387423|472422272|FG002|Overall Study|Administrative Reason|17|||
131217828|NCT03387423|472422273|FG003|Overall Study|Administrative Reason|19|||
131217829|NCT03387423|472422270|FG000|Overall Study|Revocation Consent|76|||
131217830|NCT03387423|472422271|FG001|Overall Study|Revocation Consent|32|||
131217831|NCT03387423|472422272|FG002|Overall Study|Revocation Consent|3|||
131217832|NCT03387423|472422273|FG003|Overall Study|Revocation Consent|5|||
131217833|NCT00602979|472422274|FG000|Overall Study|Lost to Follow-up|3|||
131217834|NCT00602979|472422275|FG001|Overall Study|Lost to Follow-up|2|||
131217835|NCT00602979|472422276|FG002|Overall Study|Lost to Follow-up|3|||
131217836|NCT00602979|472422277|FG003|Overall Study|Lost to Follow-up|2|||
131217837|NCT00602979|472422278|FG004|Overall Study|Lost to Follow-up|3|||
131217838|NCT00602979|472422274|FG000|Overall Study|Failed Intubation|0|||
131217839|NCT00602979|472422275|FG001|Overall Study|Failed Intubation|1|||
131217840|NCT00602979|472422276|FG002|Overall Study|Failed Intubation|0|||
131217841|NCT00602979|472422277|FG003|Overall Study|Failed Intubation|1|||
131217842|NCT00602979|472422278|FG004|Overall Study|Failed Intubation|0|||
131217843|NCT01052038|472422279|FG000|Overall Study|Lost to Follow-up|2|||
131217844|NCT01052038|472422280|FG001|Overall Study|Lost to Follow-up|3|||
131217845|NCT01052038|472422281|FG002|Overall Study|Lost to Follow-up|1|||
131217846|NCT01052038|472422279|FG000|Overall Study|Protocol Violation|2|||
131217847|NCT01052038|472422280|FG001|Overall Study|Protocol Violation|3|||
131217848|NCT01052038|472422281|FG002|Overall Study|Protocol Violation|3|||
131217849|NCT03349437|472422282|FG000|Screening|Screen Fail|4|||
131217850|NCT03349437|472422283|FG001|Screening|Screen Fail|0|||
131217851|NCT03349437|472422284|FG002|Screening|Screen Fail|0|||
131217852|NCT03349437|472422282|FG000|Screening|Withdrawn|1|||
131217853|NCT03349437|472422283|FG001|Screening|Withdrawn|0|||
131217854|NCT03349437|472422284|FG002|Screening|Withdrawn|0|||
131217855|NCT01461369|472422285|FG000|Overall Study|Lack of Efficacy|2|||
131217856|NCT01461369|472422286|FG001|Overall Study|Lack of Efficacy|0|||
131217857|NCT01461369|472422287|FG002|Overall Study|Lack of Efficacy|6|||
131217858|NCT01461369|472422285|FG000|Overall Study|Lost to Follow-up|0|||
131217859|NCT01461369|472422286|FG001|Overall Study|Lost to Follow-up|0|||
131217860|NCT01461369|472422287|FG002|Overall Study|Lost to Follow-up|3|||
131217861|NCT01461369|472422285|FG000|Overall Study|Adverse Event|9|||
131217862|NCT01461369|472422286|FG001|Overall Study|Adverse Event|12|||
131217863|NCT01461369|472422287|FG002|Overall Study|Adverse Event|4|||
131217864|NCT01461369|472422285|FG000|Overall Study|Protocol Violation|1|||
131217865|NCT01461369|472422286|FG001|Overall Study|Protocol Violation|2|||
131217866|NCT01461369|472422287|FG002|Overall Study|Protocol Violation|2|||
131217867|NCT01461369|472422285|FG000|Overall Study|Withdrawal by Subject|1|||
131217868|NCT01461369|472422286|FG001|Overall Study|Withdrawal by Subject|3|||
131217869|NCT01461369|472422287|FG002|Overall Study|Withdrawal by Subject|2|||
131217870|NCT01563029|472422290|FG000|Overall Study|Adverse Event|1|||
131217871|NCT01563029|472422291|FG001|Overall Study|Adverse Event|0|||
131217872|NCT01563029|472422292|FG002|Overall Study|Adverse Event|1|||
131217873|NCT01563029|472422293|FG003|Overall Study|Adverse Event|2|||
131217874|NCT01563029|472422294|FG004|Overall Study|Adverse Event|1|||
131217875|NCT01563029|472422290|FG000|Overall Study|Lack of Efficacy|42|||
131217876|NCT01563029|472422291|FG001|Overall Study|Lack of Efficacy|16|||
131217877|NCT01563029|472422292|FG002|Overall Study|Lack of Efficacy|23|||
131217878|NCT01563029|472422293|FG003|Overall Study|Lack of Efficacy|21|||
131217879|NCT01563029|472422294|FG004|Overall Study|Lack of Efficacy|19|||
131217880|NCT01563029|472422290|FG000|Overall Study|Protocol Violation|1|||
131217881|NCT01563029|472422291|FG001|Overall Study|Protocol Violation|2|||
131217882|NCT01563029|472422292|FG002|Overall Study|Protocol Violation|3|||
131217883|NCT01563029|472422293|FG003|Overall Study|Protocol Violation|1|||
131217884|NCT01563029|472422294|FG004|Overall Study|Protocol Violation|3|||
131217885|NCT01563029|472422290|FG000|Overall Study|Protocol defined stopping criteria|1|||
131217886|NCT01563029|472422291|FG001|Overall Study|Protocol defined stopping criteria|0|||
131217887|NCT01563029|472422292|FG002|Overall Study|Protocol defined stopping criteria|0|||
131217888|NCT01563029|472422293|FG003|Overall Study|Protocol defined stopping criteria|0|||
131217889|NCT01563029|472422294|FG004|Overall Study|Protocol defined stopping criteria|0|||
131217890|NCT01563029|472422290|FG000|Overall Study|Lost to Follow-up|1|||
131217891|NCT01563029|472422291|FG001|Overall Study|Lost to Follow-up|0|||
131217892|NCT01563029|472422292|FG002|Overall Study|Lost to Follow-up|1|||
131217893|NCT01563029|472422293|FG003|Overall Study|Lost to Follow-up|1|||
131217894|NCT01563029|472422294|FG004|Overall Study|Lost to Follow-up|1|||
131217895|NCT01563029|472422290|FG000|Overall Study|Physician Decision|3|||
131217896|NCT01563029|472422291|FG001|Overall Study|Physician Decision|5|||
131217897|NCT01563029|472422292|FG002|Overall Study|Physician Decision|2|||
131217898|NCT01563029|472422293|FG003|Overall Study|Physician Decision|4|||
131217899|NCT01563029|472422294|FG004|Overall Study|Physician Decision|2|||
131217900|NCT01563029|472422290|FG000|Overall Study|Withdrawal by Subject|4|||
131217901|NCT01563029|472422291|FG001|Overall Study|Withdrawal by Subject|1|||
131217902|NCT01563029|472422292|FG002|Overall Study|Withdrawal by Subject|3|||
131217903|NCT01563029|472422293|FG003|Overall Study|Withdrawal by Subject|4|||
131217904|NCT01563029|472422294|FG004|Overall Study|Withdrawal by Subject|3|||
131217905|NCT01569594|472422295|FG000|Overall Study|Physician Decision|4|||
131217906|NCT01569594|472422295|FG000|Overall Study|Death|13|||
131217907|NCT01569594|472422295|FG000|Overall Study|Lost to Follow-up|22|||
131217908|NCT01569594|472422295|FG000|Overall Study|Adverse Event|2|||
131217909|NCT01569594|472422295|FG000|Overall Study|Withdrawal by Subject|13|||
131217910|NCT01569594|472422295|FG000|Overall Study|Other|4|||
131217911|NCT01569594|472422295|FG000|Overall Study|No ECM used|9|||
131217912|NCT01826201|472422298|FG000|Overall Study|Non compliance with protocol|4|||
131217913|NCT01615822|472422299|FG000|Period 1|Withdrawal by Subject|0|||
131217914|NCT01615822|472422300|FG001|Period 1|Withdrawal by Subject|1|||
131217915|NCT01615822|472422301|FG002|Period 1|Withdrawal by Subject|0|||
131217916|NCT01615822|472422299|FG000|Period 1|Adverse Event|1|||
131217917|NCT01615822|472422300|FG001|Period 1|Adverse Event|1|||
131217918|NCT01615822|472422301|FG002|Period 1|Adverse Event|0|||
131217919|NCT01615822|472422299|FG000|Period 2|Lost to Follow-up|0|||
131217920|NCT01615822|472422300|FG001|Period 2|Lost to Follow-up|1|||
131217921|NCT01615822|472422301|FG002|Period 2|Lost to Follow-up|2|||
131217922|NCT02861534|472422302|FG000|Overall Study|Death|541|||
131217923|NCT02861534|472422303|FG001|Overall Study|Death|552|||
131217924|NCT02861534|472422302|FG000|Overall Study|Lost to Follow-up|14|||
131217925|NCT02861534|472422303|FG001|Overall Study|Lost to Follow-up|14|||
131217926|NCT02861534|472422302|FG000|Overall Study|Site Terminated by Sponsor|4|||
131217927|NCT02861534|472422303|FG001|Overall Study|Site Terminated by Sponsor|3|||
131217928|NCT02861534|472422302|FG000|Overall Study|Withdrawal by Subject|15|||
131217929|NCT02861534|472422303|FG001|Overall Study|Withdrawal by Subject|18|||
131217930|NCT00916617|472422306|FG000|Overall Study|Adverse Event|3|||
131217931|NCT00916617|472422307|FG001|Overall Study|Adverse Event|2|||
131217932|NCT00916617|472422308|FG002|Overall Study|Adverse Event|6|||
131217933|NCT00916617|472422309|FG003|Overall Study|Adverse Event|3|||
131217934|NCT00916617|472422306|FG000|Overall Study|Withdrawal by Subject|3|||
131217935|NCT00916617|472422307|FG001|Overall Study|Withdrawal by Subject|2|||
131217936|NCT00916617|472422308|FG002|Overall Study|Withdrawal by Subject|0|||
131217937|NCT00916617|472422309|FG003|Overall Study|Withdrawal by Subject|1|||
131217938|NCT00916617|472422306|FG000|Overall Study|Caregiver Request|3|||
131217939|NCT00916617|472422307|FG001|Overall Study|Caregiver Request|2|||
131217940|NCT00916617|472422308|FG002|Overall Study|Caregiver Request|1|||
131217941|NCT00916617|472422309|FG003|Overall Study|Caregiver Request|0|||
131217942|NCT00916617|472422306|FG000|Overall Study|Physician Decision|1|||
131217943|NCT00916617|472422307|FG001|Overall Study|Physician Decision|1|||
131217944|NCT00916617|472422308|FG002|Overall Study|Physician Decision|0|||
131217945|NCT00916617|472422309|FG003|Overall Study|Physician Decision|0|||
131217946|NCT00916617|472422306|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
131217947|NCT00916617|472422307|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
131217948|NCT00916617|472422308|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
131217949|NCT00916617|472422309|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
131217950|NCT00916617|472422306|FG000|Overall Study|Lost to Follow-up|2|||
131217951|NCT00916617|472422307|FG001|Overall Study|Lost to Follow-up|1|||
131217952|NCT00916617|472422308|FG002|Overall Study|Lost to Follow-up|0|||
131217953|NCT00916617|472422309|FG003|Overall Study|Lost to Follow-up|0|||
131217954|NCT00916617|472422306|FG000|Overall Study|Lack of Efficacy|1|||
131217955|NCT00916617|472422307|FG001|Overall Study|Lack of Efficacy|0|||
131217956|NCT00916617|472422308|FG002|Overall Study|Lack of Efficacy|0|||
131217957|NCT00916617|472422309|FG003|Overall Study|Lack of Efficacy|0|||
131217958|NCT00916617|472422306|FG000|Overall Study|Other|2|||
131217959|NCT00916617|472422307|FG001|Overall Study|Other|0|||
131217960|NCT00916617|472422308|FG002|Overall Study|Other|0|||
131217961|NCT00916617|472422309|FG003|Overall Study|Other|2|||
131217962|NCT01988337|472422312|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
131217963|NCT02742818|472422313|FG000|Overall Study|Adverse Event|0|||
131217964|NCT02742818|472422314|FG001|Overall Study|Adverse Event|1|||
131217965|NCT02742818|472422313|FG000|Overall Study|Protocol Violation|0|||
131217966|NCT02742818|472422314|FG001|Overall Study|Protocol Violation|1|||
131217967|NCT01260194|472422316|FG000|Overall Study|Withdrawal of Consent|1|||
131217968|NCT03972709|472422320|FG000|Overall Study|Withdrawal by Subject|18|||
131217969|NCT03972709|472422321|FG001|Overall Study|Withdrawal by Subject|7|||
131217970|NCT03972709|472422322|FG002|Overall Study|Withdrawal by Subject|14|||
131217971|NCT03972709|472422320|FG000|Overall Study|Study Terminated by Sponsor|48|||
131217972|NCT03972709|472422321|FG001|Overall Study|Study Terminated by Sponsor|25|||
131217973|NCT03972709|472422322|FG002|Overall Study|Study Terminated by Sponsor|50|||
131217974|NCT03972709|472422320|FG000|Overall Study|Physician Decision|1|||
131217975|NCT03972709|472422321|FG001|Overall Study|Physician Decision|0|||
131217976|NCT03972709|472422322|FG002|Overall Study|Physician Decision|0|||
131217977|NCT03972709|472422320|FG000|Overall Study|COVID-19|0|||
131217978|NCT03972709|472422321|FG001|Overall Study|COVID-19|1|||
131217979|NCT03972709|472422322|FG002|Overall Study|COVID-19|1|||
131217980|NCT03972709|472422320|FG000|Overall Study|Lost to Follow-up|6|||
131217981|NCT03972709|472422321|FG001|Overall Study|Lost to Follow-up|1|||
131217982|NCT03972709|472422322|FG002|Overall Study|Lost to Follow-up|2|||
131217983|NCT03972709|472422320|FG000|Overall Study|Death|5|||
131217984|NCT03972709|472422321|FG001|Overall Study|Death|1|||
131217985|NCT03972709|472422322|FG002|Overall Study|Death|4|||
131217986|NCT03972709|472422320|FG000|Overall Study|Adverse Event|3|||
131217987|NCT03972709|472422321|FG001|Overall Study|Adverse Event|1|||
131217988|NCT03972709|472422322|FG002|Overall Study|Adverse Event|4|||
131217989|NCT03972709|472422320|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
131217990|NCT03972709|472422321|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
131217991|NCT03972709|472422322|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
131217992|NCT03972709|472422320|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
131217993|NCT03972709|472422321|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
131217994|NCT03972709|472422322|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
131217995|NCT03972709|472422320|FG000|Overall Study|Subject Unable to be Contacted|0|||
131217996|NCT03972709|472422321|FG001|Overall Study|Subject Unable to be Contacted|1|||
131217997|NCT03972709|472422322|FG002|Overall Study|Subject Unable to be Contacted|0|||
131217998|NCT03972709|472422320|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
131217999|NCT03972709|472422321|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
131218000|NCT03972709|472422322|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
131218001|NCT03972709|472422320|FG000|Overall Study|Subject Moved|0|||
131218002|NCT03972709|472422321|FG001|Overall Study|Subject Moved|1|||
131218003|NCT03972709|472422322|FG002|Overall Study|Subject Moved|0|||
131218004|NCT03972709|472422320|FG000|Overall Study|Missed Study Visits|1|||
131218005|NCT03972709|472422321|FG001|Overall Study|Missed Study Visits|0|||
131218006|NCT03972709|472422322|FG002|Overall Study|Missed Study Visits|0|||
131218007|NCT02072174|472422323|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
131218008|NCT02072174|472422324|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
131218009|NCT02072174|472422323|FG000|Overall Study|Protocol Violation|16|||
131218010|NCT02072174|472422324|FG001|Overall Study|Protocol Violation|23|||
131218011|NCT02072174|472422323|FG000|Overall Study|Physician Decision|0|||
131218012|NCT02072174|472422324|FG001|Overall Study|Physician Decision|1|||
131218013|NCT02072174|472422323|FG000|Overall Study|Non-compliance with protocol requirement|2|||
131218014|NCT02072174|472422324|FG001|Overall Study|Non-compliance with protocol requirement|0|||
131218015|NCT05674721|472422326|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
131218016|NCT05674721|472422327|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
131218017|NCT05674721|472422326|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
131218018|NCT05674721|472422327|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
131218019|NCT05013749|472422341|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
131218020|NCT05013749|472422342|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
131218021|NCT05013749|472422341|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
130992701|NCT02769065|471601582|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
131218022|NCT05013749|472422342|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
131218023|NCT02017535|472422345|FG000|Overall Study|Withdrawal by Subject|1|||
131218024|NCT02017535|472422346|FG001|Overall Study|Withdrawal by Subject|0|||
131218025|NCT02017535|472422347|FG002|Overall Study|Withdrawal by Subject|0|||
131218026|NCT02017535|472422348|FG003|Overall Study|Withdrawal by Subject|0|||
131218027|NCT01393626|472422349|FG000|Overall Study|Adverse Event|2|||
131218028|NCT01393626|472422350|FG001|Overall Study|Adverse Event|1|||
130992702|NCT02769065|471601583|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992703|NCT02769065|471601584|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
131218029|NCT01393626|472422351|FG002|Overall Study|Adverse Event|5|||
131218030|NCT01393626|472422352|FG003|Overall Study|Adverse Event|0|||
131218031|NCT01393626|472422349|FG000|Overall Study|Did not meet entrance criteria|1|||
131218032|NCT01393626|472422350|FG001|Overall Study|Did not meet entrance criteria|0|||
131218033|NCT01393626|472422351|FG002|Overall Study|Did not meet entrance criteria|0|||
131218034|NCT01393626|472422352|FG003|Overall Study|Did not meet entrance criteria|0|||
131218035|NCT01393626|472422349|FG000|Overall Study|Lack of Efficacy|6|||
131218036|NCT01393626|472422350|FG001|Overall Study|Lack of Efficacy|6|||
131218037|NCT01393626|472422351|FG002|Overall Study|Lack of Efficacy|4|||
131218038|NCT01393626|472422352|FG003|Overall Study|Lack of Efficacy|1|||
131218039|NCT01393626|472422349|FG000|Overall Study|Lost to Follow-up|1|||
131218040|NCT01393626|472422350|FG001|Overall Study|Lost to Follow-up|1|||
131218041|NCT01393626|472422351|FG002|Overall Study|Lost to Follow-up|1|||
131218042|NCT01393626|472422352|FG003|Overall Study|Lost to Follow-up|0|||
131218043|NCT01393626|472422349|FG000|Overall Study|Withdrawal by Subject|6|||
131218044|NCT01393626|472422350|FG001|Overall Study|Withdrawal by Subject|4|||
131218045|NCT01393626|472422351|FG002|Overall Study|Withdrawal by Subject|0|||
131218046|NCT01393626|472422352|FG003|Overall Study|Withdrawal by Subject|0|||
131218047|NCT01393626|472422349|FG000|Overall Study|Other|1|||
131218048|NCT01393626|472422350|FG001|Overall Study|Other|0|||
131218049|NCT01393626|472422351|FG002|Overall Study|Other|0|||
131218050|NCT01393626|472422352|FG003|Overall Study|Other|0|||
131218051|NCT01393626|472422349|FG000|Overall Study|Protocol Violation|1|||
131218052|NCT01393626|472422350|FG001|Overall Study|Protocol Violation|0|||
131218053|NCT01393626|472422351|FG002|Overall Study|Protocol Violation|2|||
131218054|NCT01393626|472422352|FG003|Overall Study|Protocol Violation|0|||
131218055|NCT02426125|472422353|FG000|Overall Study|Lost to Follow-up|14|||
131218056|NCT02426125|472422354|FG001|Overall Study|Lost to Follow-up|12|||
131218057|NCT02426125|472422353|FG000|Overall Study|Withdrawal by Subject|13|||
131218058|NCT02426125|472422354|FG001|Overall Study|Withdrawal by Subject|14|||
131218059|NCT02426125|472422353|FG000|Overall Study|Death|185|||
131218060|NCT02426125|472422354|FG001|Overall Study|Death|200|||
131218061|NCT02426125|472422353|FG000|Overall Study|Randomized, But Never Treated|5|||
131218062|NCT02426125|472422354|FG001|Overall Study|Randomized, But Never Treated|2|||
131218063|NCT02858076|472422355|FG000|Overall Study|Death|6|||
131218064|NCT02858076|472422356|FG001|Overall Study|Death|3|||
131218065|NCT02858076|472422355|FG000|Overall Study|Withdrawal by Subject|1|||
131218066|NCT02858076|472422356|FG001|Overall Study|Withdrawal by Subject|5|||
131218067|NCT02858076|472422355|FG000|Overall Study|Lost to Follow-up|2|||
131218068|NCT02858076|472422356|FG001|Overall Study|Lost to Follow-up|7|||
131218069|NCT02858076|472422355|FG000|Overall Study|Completed Out of Window|1|||
131218070|NCT02858076|472422356|FG001|Overall Study|Completed Out of Window|3|||
131218071|NCT03506425|472422357|FG000|Overall Study|Adverse Event|1|||
131218072|NCT03506425|472422358|FG001|Overall Study|Adverse Event|3|||
131218073|NCT03506425|472422359|FG002|Overall Study|Adverse Event|0|||
131218074|NCT03506425|472422357|FG000|Overall Study|Death|1|||
131218075|NCT03506425|472422358|FG001|Overall Study|Death|0|||
131218076|NCT03506425|472422359|FG002|Overall Study|Death|0|||
131218077|NCT03506425|472422357|FG000|Overall Study|Withdrawal by Subject|0|||
131218078|NCT03506425|472422358|FG001|Overall Study|Withdrawal by Subject|0|||
131218079|NCT03506425|472422359|FG002|Overall Study|Withdrawal by Subject|1|||
131218080|NCT02643394|472422362|FG000|Overall Study|Protocol Violation|4|||
131218081|NCT02643394|472422363|FG001|Overall Study|Protocol Violation|5|||
131218082|NCT04088734|472422364|FG000|Overall Study|Other, Not Specified|5|||
131218083|NCT00096200|472422365|FG000|Overall Study|Adverse Event|0|||
131218084|NCT00096200|472422366|FG001|Overall Study|Adverse Event|4|||
131218085|NCT00096200|472422367|FG002|Overall Study|Adverse Event|0|||
131218086|NCT00096200|472422365|FG000|Overall Study|Withdrawal by Subject|1|||
131218087|NCT00096200|472422366|FG001|Overall Study|Withdrawal by Subject|2|||
131218088|NCT00096200|472422367|FG002|Overall Study|Withdrawal by Subject|0|||
131218089|NCT00096200|472422365|FG000|Overall Study|Ineligible pathology|0|||
131218090|NCT00096200|472422366|FG001|Overall Study|Ineligible pathology|1|||
131218091|NCT00096200|472422367|FG002|Overall Study|Ineligible pathology|0|||
131218092|NCT00938015|472422371|FG000|Overall Study|Death|2|||
131218093|NCT00938015|472422371|FG000|Overall Study|Lost to Follow-up|32|||
131218094|NCT00938015|472422371|FG000|Overall Study|Adverse Event|32|||
131218095|NCT00938015|472422371|FG000|Overall Study|Non-responder|52|||
131218096|NCT00938015|472422371|FG000|Overall Study|Reason not related to Etanercept|29|||
131218097|NCT02341482|472422372|FG000|Overall Study|Adverse Event|1|||
131218098|NCT00090259|472422378|FG000|Overall Study|Lost to Follow-up|30|||
131218099|NCT00090259|472422379|FG001|Overall Study|Lost to Follow-up|26|||
131218100|NCT00090259|472422378|FG000|Overall Study|Withdrawal by Subject|21|||
131218101|NCT00090259|472422379|FG001|Overall Study|Withdrawal by Subject|15|||
131218102|NCT00090259|472422378|FG000|Overall Study|Investigator site closed|11|||
131218103|NCT00090259|472422379|FG001|Overall Study|Investigator site closed|7|||
131218104|NCT00358670|472422382|FG000|Overall Study|Adverse Event|26|||
131218105|NCT00358670|472422383|FG001|Overall Study|Adverse Event|29|||
131218106|NCT00358670|472422382|FG000|Overall Study|Lack of Efficacy|20|||
131218107|NCT00358670|472422383|FG001|Overall Study|Lack of Efficacy|23|||
131218108|NCT00358670|472422382|FG000|Overall Study|Protocol Violation|6|||
131218109|NCT00358670|472422383|FG001|Overall Study|Protocol Violation|9|||
131218110|NCT00358670|472422382|FG000|Overall Study|Lost to Follow-up|4|||
131218111|NCT00358670|472422383|FG001|Overall Study|Lost to Follow-up|5|||
131218112|NCT00358670|472422382|FG000|Overall Study|Withdrawal by Subject|13|||
131218113|NCT00358670|472422383|FG001|Overall Study|Withdrawal by Subject|24|||
131218114|NCT00358670|472422382|FG000|Overall Study|Protocol Defined Clinical Event|0|||
131218115|NCT00358670|472422383|FG001|Overall Study|Protocol Defined Clinical Event|1|||
131218116|NCT00358670|472422382|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
131218117|NCT00358670|472422383|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
131218118|NCT00358670|472422382|FG000|Overall Study|Administrative|153|||
131218119|NCT00358670|472422383|FG001|Overall Study|Administrative|125|||
131218120|NCT00981019|472422384|FG000|Overall Study|Did not respond|65|||
131218121|NCT00981019|472422384|FG000|Overall Study|Did not match target population|94|||
131218122|NCT00981019|472422384|FG000|Overall Study|Inadvertent exclusion|239|||
131218123|NCT00981019|472422384|FG000|Overall Study|Hit the survey after closure|79|||
131218124|NCT00960687|472422385|FG000|Washout Period of 7 Days|Adverse Event|3|||
131218125|NCT00960687|472422386|FG001|Washout Period of 7 Days|Adverse Event|2|||
131218126|NCT00960687|472422385|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
131218127|NCT00960687|472422386|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131218128|NCT02704130|472422387|FG000|Overall Study|Physician Decision|5|||
131218129|NCT02704130|472422388|FG001|Overall Study|Physician Decision|3|||
131218130|NCT02666768|472422389|FG000|Overall Study|Withdrawal by Subject|4|||
131218131|NCT03940742|472422390|FG000|Overall Study|Lost to Follow-up|0|||
131218132|NCT03940742|472422391|FG001|Overall Study|Lost to Follow-up|0|||
131218133|NCT03940742|472422392|FG002|Overall Study|Lost to Follow-up|0|||
131218134|NCT03940742|472422393|FG003|Overall Study|Lost to Follow-up|1|||
131218135|NCT02032823|472422396|FG000|Overall Study|Death|75|||
131218136|NCT02032823|472422397|FG001|Overall Study|Death|109|||
131218137|NCT02032823|472422396|FG000|Overall Study|Lost to Follow-up|18|||
131218138|NCT02032823|472422397|FG001|Overall Study|Lost to Follow-up|17|||
131218139|NCT02032823|472422396|FG000|Overall Study|Withdrawal by Subject|70|||
131218140|NCT02032823|472422397|FG001|Overall Study|Withdrawal by Subject|53|||
131218141|NCT02032823|472422396|FG000|Overall Study|Ongoing study at data cut-off|755|||
131218142|NCT02032823|472422397|FG001|Overall Study|Ongoing study at data cut-off|731|||
131218143|NCT02032823|472422396|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
131218144|NCT02032823|472422397|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
131218145|NCT00285012|472422398|FG000|Assigned to Study Treatment (Tx)|Other|2|||
131218146|NCT00285012|472422399|FG001|Assigned to Study Treatment (Tx)|Other|3|||
131218147|NCT00285012|472422398|FG000|Received Study Tx|Death|2|||
131218148|NCT00285012|472422399|FG001|Received Study Tx|Death|1|||
131218149|NCT00285012|472422398|FG000|Received Study Tx|Adverse Event|5|||
131218150|NCT00285012|472422399|FG001|Received Study Tx|Adverse Event|11|||
131218151|NCT00285012|472422398|FG000|Received Study Tx|Lack of Efficacy|0|||
131218152|NCT00285012|472422399|FG001|Received Study Tx|Lack of Efficacy|3|||
131218153|NCT00285012|472422398|FG000|Received Study Tx|Lost to Follow-up|29|||
131218154|NCT00285012|472422399|FG001|Received Study Tx|Lost to Follow-up|31|||
131218155|NCT00285012|472422398|FG000|Received Study Tx|Withdrawal by Subject|31|||
131218156|NCT00285012|472422399|FG001|Received Study Tx|Withdrawal by Subject|43|||
131218157|NCT00285012|472422398|FG000|Received Study Tx|Other|5|||
131218158|NCT00285012|472422399|FG001|Received Study Tx|Other|5|||
131218159|NCT02873195|472422402|FG000|Overall Study|Ineligible|5|||
131218160|NCT02873195|472422403|FG001|Overall Study|Ineligible|0|||
131218161|NCT05004181|472422404|FG000|Overall Study|Withdrawal of consent|0|||
131218162|NCT05004181|472422405|FG001|Overall Study|Withdrawal of consent|0|||
131218163|NCT05004181|472422406|FG002|Overall Study|Withdrawal of consent|1|||
131218164|NCT05004181|472422407|FG003|Overall Study|Withdrawal of consent|3|||
131218165|NCT05004181|472422408|FG004|Overall Study|Withdrawal of consent|3|||
131218166|NCT05004181|472422409|FG005|Overall Study|Withdrawal of consent|0|||
131218167|NCT05004181|472422410|FG006|Overall Study|Withdrawal of consent|30|||
131218168|NCT05004181|472422411|FG007|Overall Study|Withdrawal of consent|9|||
131218169|NCT05004181|472422412|FG008|Overall Study|Withdrawal of consent|3|||
131218170|NCT05004181|472422413|FG009|Overall Study|Withdrawal of consent|2|||
131218171|NCT05004181|472422414|FG010|Overall Study|Withdrawal of consent|5|||
131218172|NCT05004181|472422415|FG011|Overall Study|Withdrawal of consent|1|||
131218173|NCT05004181|472422404|FG000|Overall Study|Lost to Follow-up|2|||
131218174|NCT05004181|472422405|FG001|Overall Study|Lost to Follow-up|4|||
131218175|NCT05004181|472422406|FG002|Overall Study|Lost to Follow-up|2|||
131218176|NCT05004181|472422407|FG003|Overall Study|Lost to Follow-up|3|||
131218177|NCT05004181|472422408|FG004|Overall Study|Lost to Follow-up|5|||
131218178|NCT05004181|472422409|FG005|Overall Study|Lost to Follow-up|2|||
131218179|NCT05004181|472422410|FG006|Overall Study|Lost to Follow-up|15|||
131218180|NCT05004181|472422411|FG007|Overall Study|Lost to Follow-up|12|||
131218181|NCT05004181|472422412|FG008|Overall Study|Lost to Follow-up|38|||
131218182|NCT05004181|472422413|FG009|Overall Study|Lost to Follow-up|6|||
131218183|NCT05004181|472422414|FG010|Overall Study|Lost to Follow-up|6|||
131218184|NCT05004181|472422415|FG011|Overall Study|Lost to Follow-up|0|||
131218185|NCT05004181|472422404|FG000|Overall Study|Death|0|||
131218186|NCT05004181|472422405|FG001|Overall Study|Death|0|||
131218187|NCT05004181|472422406|FG002|Overall Study|Death|0|||
131218188|NCT05004181|472422407|FG003|Overall Study|Death|0|||
131218189|NCT05004181|472422408|FG004|Overall Study|Death|0|||
131218190|NCT05004181|472422409|FG005|Overall Study|Death|0|||
131218191|NCT05004181|472422410|FG006|Overall Study|Death|1|||
131218192|NCT05004181|472422411|FG007|Overall Study|Death|0|||
131218193|NCT05004181|472422412|FG008|Overall Study|Death|2|||
131218194|NCT05004181|472422413|FG009|Overall Study|Death|0|||
131218195|NCT05004181|472422414|FG010|Overall Study|Death|0|||
131218196|NCT05004181|472422415|FG011|Overall Study|Death|0|||
131218197|NCT05004181|472422404|FG000|Overall Study|Physician Decision|0|||
131218198|NCT05004181|472422405|FG001|Overall Study|Physician Decision|0|||
131218199|NCT05004181|472422406|FG002|Overall Study|Physician Decision|0|||
131218200|NCT05004181|472422407|FG003|Overall Study|Physician Decision|0|||
131218201|NCT05004181|472422408|FG004|Overall Study|Physician Decision|0|||
131218202|NCT05004181|472422409|FG005|Overall Study|Physician Decision|0|||
131218203|NCT05004181|472422410|FG006|Overall Study|Physician Decision|2|||
131218204|NCT05004181|472422411|FG007|Overall Study|Physician Decision|0|||
131218205|NCT05004181|472422412|FG008|Overall Study|Physician Decision|7|||
131218206|NCT05004181|472422413|FG009|Overall Study|Physician Decision|0|||
131218207|NCT05004181|472422414|FG010|Overall Study|Physician Decision|0|||
131218208|NCT05004181|472422415|FG011|Overall Study|Physician Decision|0|||
131218209|NCT05004181|472422404|FG000|Overall Study|Withdrawal by Subject|2|||
131218210|NCT05004181|472422405|FG001|Overall Study|Withdrawal by Subject|3|||
130992704|NCT02769065|471601585|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
130992705|NCT02764775|471601588|FG000|Overall Study|Death|1|||
130992706|NCT02764775|471601588|FG000|Overall Study|Lost to Follow-up|2|||
130992707|NCT02764775|471601588|FG000|Overall Study|Withdrawal by Subject|3|||
130992708|NCT04022889|471601591|FG000|Stage 1: Period 1|Adverse Event|1|||
130992709|NCT04022889|471601592|FG001|Stage 1: Period 1|Adverse Event|0|||
131218211|NCT05004181|472422406|FG002|Overall Study|Withdrawal by Subject|2|||
131218212|NCT05004181|472422407|FG003|Overall Study|Withdrawal by Subject|2|||
131218213|NCT05004181|472422408|FG004|Overall Study|Withdrawal by Subject|4|||
131218214|NCT05004181|472422409|FG005|Overall Study|Withdrawal by Subject|2|||
131218215|NCT05004181|472422410|FG006|Overall Study|Withdrawal by Subject|4|||
131218216|NCT05004181|472422411|FG007|Overall Study|Withdrawal by Subject|22|||
131218217|NCT05004181|472422412|FG008|Overall Study|Withdrawal by Subject|8|||
131218218|NCT05004181|472422413|FG009|Overall Study|Withdrawal by Subject|1|||
131218219|NCT05004181|472422414|FG010|Overall Study|Withdrawal by Subject|3|||
131218220|NCT05004181|472422415|FG011|Overall Study|Withdrawal by Subject|2|||
131218221|NCT05004181|472422404|FG000|Overall Study|Protocol Violation|2|||
131218222|NCT05004181|472422405|FG001|Overall Study|Protocol Violation|3|||
131218223|NCT05004181|472422406|FG002|Overall Study|Protocol Violation|0|||
131218224|NCT05004181|472422407|FG003|Overall Study|Protocol Violation|0|||
131218225|NCT05004181|472422408|FG004|Overall Study|Protocol Violation|1|||
131218226|NCT05004181|472422409|FG005|Overall Study|Protocol Violation|0|||
131218227|NCT05004181|472422410|FG006|Overall Study|Protocol Violation|16|||
131218228|NCT05004181|472422411|FG007|Overall Study|Protocol Violation|18|||
131218229|NCT05004181|472422412|FG008|Overall Study|Protocol Violation|2|||
131218230|NCT05004181|472422413|FG009|Overall Study|Protocol Violation|2|||
131218231|NCT05004181|472422414|FG010|Overall Study|Protocol Violation|2|||
131218232|NCT05004181|472422415|FG011|Overall Study|Protocol Violation|1|||
131218233|NCT05004181|472422404|FG000|Overall Study|Not further specified|1|||
131218234|NCT05004181|472422405|FG001|Overall Study|Not further specified|0|||
131218235|NCT05004181|472422406|FG002|Overall Study|Not further specified|0|||
131218236|NCT05004181|472422407|FG003|Overall Study|Not further specified|0|||
131218237|NCT05004181|472422408|FG004|Overall Study|Not further specified|0|||
131218238|NCT05004181|472422409|FG005|Overall Study|Not further specified|0|||
131218239|NCT05004181|472422410|FG006|Overall Study|Not further specified|1|||
131218240|NCT05004181|472422411|FG007|Overall Study|Not further specified|0|||
131218241|NCT05004181|472422412|FG008|Overall Study|Not further specified|2|||
131218242|NCT05004181|472422413|FG009|Overall Study|Not further specified|1|||
131218243|NCT05004181|472422414|FG010|Overall Study|Not further specified|0|||
131218244|NCT05004181|472422415|FG011|Overall Study|Not further specified|1|||
131218245|NCT04278872|472422416|FG000|Overall Study|Adverse Event|1|||
131218246|NCT04278872|472422417|FG001|Overall Study|Adverse Event|0|||
130992710|NCT04022889|471601593|FG002|Stage 1: Period 1|Adverse Event|0|||
130992711|NCT04022889|471601591|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
130992712|NCT04022889|471601592|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
130992713|NCT04022889|471601593|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
131218247|NCT04278872|472422416|FG000|Overall Study|Protocol Violation|0|||
131218248|NCT04278872|472422417|FG001|Overall Study|Protocol Violation|1|||
131218249|NCT04278872|472422416|FG000|Overall Study|Study Termination|2|||
131218250|NCT04278872|472422417|FG001|Overall Study|Study Termination|0|||
131218251|NCT00752895|472422418|FG000|Overall Study|Withdrawal by Subject|8|||
131218252|NCT00752895|472422419|FG001|Overall Study|Withdrawal by Subject|3|||
131218253|NCT00096031|472422420|FG000|Overall Study|Adverse Event|3|||
131218254|NCT00096031|472422420|FG000|Overall Study|Lack of Efficacy|42|||
131218255|NCT00096031|472422420|FG000|Overall Study|Death|4|||
131218256|NCT00096031|472422420|FG000|Overall Study|Withdrawal by Subject|1|||
131218257|NCT00096031|472422420|FG000|Overall Study|Ineligible|8|||
131218258|NCT00096031|472422420|FG000|Overall Study|Not protocol specified|5|||
131218259|NCT03353415|472422423|FG000|Masked CGM Wear|Lost to Follow-up|2|||
131218260|NCT03353415|472422423|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
131218261|NCT05257109|472422424|FG000|Overall Study|Withdrawal by Subject|1|||
131218262|NCT05257109|472422425|FG001|Overall Study|Withdrawal by Subject|0|||
131218263|NCT05257109|472422426|FG002|Overall Study|Withdrawal by Subject|0|||
131218264|NCT05257109|472422427|FG003|Overall Study|Withdrawal by Subject|0|||
131218265|NCT00359073|472424484|FG000|Overall Study|Withdrawal by Subject|1|||
131218266|NCT00359073|472424485|FG001|Overall Study|Withdrawal by Subject|1|||
131218267|NCT00359073|472424484|FG000|Overall Study|Eligibility criteria no longer met|3|||
131218268|NCT00359073|472424485|FG001|Overall Study|Eligibility criteria no longer met|0|||
131218269|NCT00359073|472424484|FG000|Overall Study|developed RV16 antibody|0|||
131218270|NCT00359073|472424485|FG001|Overall Study|developed RV16 antibody|1|||
131218271|NCT01371006|472424486|FG000|Overall Study|Adverse Event|1|||
131218272|NCT01371006|472424487|FG001|Overall Study|Adverse Event|0|||
131218273|NCT02038959|472424489|FG000|Overall Study|Withdrawal by Subject|6|||
131218274|NCT02038959|472424490|FG001|Overall Study|Withdrawal by Subject|8|||
131218275|NCT03515837|472424497|FG000|Overall Study|Death|219|||
131218276|NCT03515837|472424498|FG001|Overall Study|Death|227|||
131218277|NCT03515837|472424497|FG000|Overall Study|Lost to Follow-up|0|||
131218278|NCT03515837|472424498|FG001|Overall Study|Lost to Follow-up|1|||
131218279|NCT03515837|472424497|FG000|Overall Study|Withdrawal by Subject|0|||
131218280|NCT03515837|472424498|FG001|Overall Study|Withdrawal by Subject|4|||
131218281|NCT03515837|472424497|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
131218282|NCT03515837|472424498|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
131218283|NCT01964898|472424499|FG000|Overall Study|ineligible post-randomization|1|||
131218284|NCT01964898|472424500|FG001|Overall Study|ineligible post-randomization|1|||
131218285|NCT01964898|472424499|FG000|Overall Study|did not receive the allocated interventi|2|||
131218286|NCT01964898|472424500|FG001|Overall Study|did not receive the allocated interventi|1|||
131218287|NCT01964898|472424499|FG000|Overall Study|Lost to Follow-up|3|||
131218288|NCT01964898|472424500|FG001|Overall Study|Lost to Follow-up|5|||
131218289|NCT01964898|472424499|FG000|Overall Study|Withdrawal by Subject|1|||
131218290|NCT01964898|472424500|FG001|Overall Study|Withdrawal by Subject|0|||
131218291|NCT00819091|472424501|FG000|Overall Study|Adverse Event|3|||
131218292|NCT00819091|472424502|FG001|Overall Study|Adverse Event|5|||
131218293|NCT00819091|472424501|FG000|Overall Study|Protocol Violation|0|||
131218294|NCT00819091|472424502|FG001|Overall Study|Protocol Violation|1|||
131218295|NCT00819091|472424501|FG000|Overall Study|Lost to Follow-up|2|||
131218296|NCT00819091|472424502|FG001|Overall Study|Lost to Follow-up|0|||
131218297|NCT00819091|472424501|FG000|Overall Study|Withdrawal by Subject|1|||
131218298|NCT00819091|472424502|FG001|Overall Study|Withdrawal by Subject|2|||
131218299|NCT00819091|472424501|FG000|Overall Study|Other|1|||
131218300|NCT00819091|472424502|FG001|Overall Study|Other|2|||
131218301|NCT02325401|472424505|FG000|Overall Study|Withdrawal by Subject|0|||
131218302|NCT02325401|472424506|FG001|Overall Study|Withdrawal by Subject|1|||
131218303|NCT02325401|472424507|FG002|Overall Study|Withdrawal by Subject|1|||
131218304|NCT02209454|472424514|FG000|Second Period|Adverse Event|1|||
131218305|NCT02209454|472424515|FG001|Second Period|Adverse Event|0|||
131218306|NCT01652573|472424516|FG000|Overall Study|Adverse Event|0|||
131218307|NCT01652573|472424517|FG001|Overall Study|Adverse Event|1|||
131218308|NCT00740480|472424518|FG000|Overall Study|Adverse Event|1|||
131218309|NCT00740480|472424518|FG000|Overall Study|Physician Decision|1|||
131218310|NCT00934622|472424519|FG000|Overall Study|Lost to Follow-up|7|||
131218311|NCT00934622|472424519|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
131218312|NCT01856686|472424523|FG000|Overall Study|Lost to Follow-up|5|||
131218313|NCT01856686|472424524|FG001|Overall Study|Lost to Follow-up|11|||
131218314|NCT00468312|472424527|FG000|Overall Study|Adverse Event|2|||
131218315|NCT00468312|472424528|FG001|Overall Study|Adverse Event|1|||
131218316|NCT00468312|472424527|FG000|Overall Study|Lack of Efficacy|0|||
131218317|NCT00468312|472424528|FG001|Overall Study|Lack of Efficacy|1|||
131218318|NCT00468312|472424527|FG000|Overall Study|Withdrawal by Subject|0|||
131218319|NCT00468312|472424528|FG001|Overall Study|Withdrawal by Subject|1|||
131218320|NCT00468312|472424527|FG000|Overall Study|Protocol Violation|2|||
131218321|NCT00468312|472424528|FG001|Overall Study|Protocol Violation|1|||
131218322|NCT00468312|472424527|FG000|Overall Study|Did not meet protocol eligibility|0|||
131218323|NCT00468312|472424528|FG001|Overall Study|Did not meet protocol eligibility|1|||
131218324|NCT02962739|472424531|FG000|Overall Study|Withdrawal by Subject|0|||
131218325|NCT02962739|472424532|FG001|Overall Study|Withdrawal by Subject|1|||
131218326|NCT02962739|472424533|FG002|Overall Study|Withdrawal by Subject|0|||
131218327|NCT02962739|472424534|FG003|Overall Study|Withdrawal by Subject|0|||
131218328|NCT02962739|472424535|FG004|Overall Study|Withdrawal by Subject|0|||
131218329|NCT02962739|472424536|FG005|Overall Study|Withdrawal by Subject|0|||
131218330|NCT02962739|472424531|FG000|Overall Study|Protocol Violation|0|||
131218331|NCT02962739|472424532|FG001|Overall Study|Protocol Violation|0|||
131218332|NCT02962739|472424533|FG002|Overall Study|Protocol Violation|1|||
131218333|NCT02962739|472424534|FG003|Overall Study|Protocol Violation|0|||
131218334|NCT02962739|472424535|FG004|Overall Study|Protocol Violation|1|||
131218335|NCT02962739|472424536|FG005|Overall Study|Protocol Violation|0|||
131218336|NCT00734617|472424537|FG000|Overall Study|Adverse Event|4|||
131218337|NCT00734617|472424538|FG001|Overall Study|Adverse Event|7|||
131218338|NCT00734617|472424537|FG000|Overall Study|Withdrawal by Subject|103|||
131218339|NCT00734617|472424538|FG001|Overall Study|Withdrawal by Subject|95|||
131218340|NCT02406742|472424539|FG000|Overall Study|Progression of Disease|5|||
131218341|NCT02406742|472424540|FG001|Overall Study|Progression of Disease|1|||
131218342|NCT02406742|472424541|FG002|Overall Study|Progression of Disease|6|||
131218343|NCT02406742|472424539|FG000|Overall Study|Adverse Event|3|||
131218344|NCT02406742|472424540|FG001|Overall Study|Adverse Event|0|||
131218345|NCT02406742|472424541|FG002|Overall Study|Adverse Event|2|||
131218346|NCT02406742|472424539|FG000|Overall Study|Death|1|||
131218347|NCT02406742|472424540|FG001|Overall Study|Death|0|||
131218348|NCT02406742|472424541|FG002|Overall Study|Death|0|||
131218349|NCT02406742|472424539|FG000|Overall Study|Lack of Efficacy|0|||
131218350|NCT02406742|472424540|FG001|Overall Study|Lack of Efficacy|0|||
131218351|NCT02406742|472424541|FG002|Overall Study|Lack of Efficacy|1|||
131218352|NCT02406742|472424539|FG000|Overall Study|Withdrawal by Participant|1|||
131218353|NCT02406742|472424540|FG001|Overall Study|Withdrawal by Participant|2|||
131218354|NCT02406742|472424541|FG002|Overall Study|Withdrawal by Participant|0|||
131218355|NCT02406742|472424539|FG000|Overall Study|Physician Decision|1|||
131218356|NCT02406742|472424540|FG001|Overall Study|Physician Decision|2|||
131218357|NCT02406742|472424541|FG002|Overall Study|Physician Decision|1|||
131218358|NCT02406742|472424539|FG000|Overall Study|Transition to other treatment|2|||
131218359|NCT02406742|472424540|FG001|Overall Study|Transition to other treatment|0|||
131218360|NCT02406742|472424541|FG002|Overall Study|Transition to other treatment|1|||
131218361|NCT02406742|472424539|FG000|Overall Study|Other Reasons|1|||
131218362|NCT02406742|472424540|FG001|Overall Study|Other Reasons|11|||
131218363|NCT02406742|472424541|FG002|Overall Study|Other Reasons|5|||
131218364|NCT02367729|472424542|FG000|Overall Study|Organic disorder diagnosed|2|||
131218365|NCT02367729|472424543|FG001|Overall Study|Organic disorder diagnosed|1|||
131218366|NCT02367729|472424542|FG000|Overall Study|Adverse Event|1|||
131218367|NCT02367729|472424543|FG001|Overall Study|Adverse Event|2|||
131218368|NCT02367729|472424542|FG000|Overall Study|Withdrawal by Subject|0|||
131218369|NCT02367729|472424543|FG001|Overall Study|Withdrawal by Subject|5|||
131218370|NCT00759174|472424548|FG000|Overall Study|Other|0|||
131218371|NCT00759174|472424549|FG001|Overall Study|Other|2|||
131218372|NCT01890109|472424550|FG000|Overall Study|Withdrawal by Subject|0|||
131218373|NCT01890109|472424551|FG001|Overall Study|Withdrawal by Subject|3|||
131218374|NCT01890109|472424550|FG000|Overall Study|Lost to Follow-up|1|||
131218375|NCT01890109|472424551|FG001|Overall Study|Lost to Follow-up|2|||
131218376|NCT01643928|472424552|FG000|Overall Study|Lost to Follow-up|1|||
131218377|NCT01643928|472424553|FG001|Overall Study|Lost to Follow-up|0|||
131218378|NCT01643928|472424554|FG002|Overall Study|Lost to Follow-up|2|||
131218379|NCT01643928|472424555|FG003|Overall Study|Lost to Follow-up|0|||
131218380|NCT01643928|472424556|FG004|Overall Study|Lost to Follow-up|0|||
131218381|NCT01643928|472424552|FG000|Overall Study|Withdrawal by Subject|2|||
131218382|NCT01643928|472424553|FG001|Overall Study|Withdrawal by Subject|0|||
131218383|NCT01643928|472424554|FG002|Overall Study|Withdrawal by Subject|0|||
131218384|NCT01643928|472424555|FG003|Overall Study|Withdrawal by Subject|1|||
131218385|NCT01643928|472424556|FG004|Overall Study|Withdrawal by Subject|0|||
131218386|NCT01643928|472424552|FG000|Overall Study|Pregnancy|0|||
131218387|NCT01643928|472424553|FG001|Overall Study|Pregnancy|0|||
131218388|NCT01643928|472424554|FG002|Overall Study|Pregnancy|0|||
131218389|NCT01643928|472424555|FG003|Overall Study|Pregnancy|1|||
131218390|NCT01643928|472424556|FG004|Overall Study|Pregnancy|0|||
131218391|NCT01643928|472424552|FG000|Overall Study|Other|5|||
131218392|NCT01643928|472424553|FG001|Overall Study|Other|1|||
131218393|NCT01643928|472424554|FG002|Overall Study|Other|1|||
131218394|NCT01643928|472424555|FG003|Overall Study|Other|0|||
131218395|NCT01643928|472424556|FG004|Overall Study|Other|0|||
131218396|NCT01643928|472424552|FG000|Overall Study|Adverse Event|2|||
131218397|NCT01643928|472424553|FG001|Overall Study|Adverse Event|1|||
131218398|NCT01643928|472424554|FG002|Overall Study|Adverse Event|0|||
131218399|NCT01643928|472424555|FG003|Overall Study|Adverse Event|1|||
131218400|NCT01643928|472424556|FG004|Overall Study|Adverse Event|2|||
131218401|NCT03692078|472424557|FG000|Overall Study|Adverse Event|0|||
131218402|NCT03692078|472424558|FG001|Overall Study|Adverse Event|0|||
131218403|NCT03692078|472424559|FG002|Overall Study|Adverse Event|0|||
131218404|NCT03692078|472424560|FG003|Overall Study|Adverse Event|0|||
131218405|NCT03692078|472424561|FG004|Overall Study|Adverse Event|0|||
131218406|NCT03692078|472424562|FG005|Overall Study|Adverse Event|1|||
131218407|NCT03692078|472424563|FG006|Overall Study|Adverse Event|0|||
131218408|NCT03692078|472424557|FG000|Overall Study|Enrollment Closed|5|||
131218409|NCT03692078|472424558|FG001|Overall Study|Enrollment Closed|0|||
131218410|NCT03692078|472424559|FG002|Overall Study|Enrollment Closed|0|||
131218411|NCT03692078|472424560|FG003|Overall Study|Enrollment Closed|0|||
131218412|NCT03692078|472424561|FG004|Overall Study|Enrollment Closed|0|||
131218413|NCT03692078|472424562|FG005|Overall Study|Enrollment Closed|0|||
131218414|NCT03692078|472424563|FG006|Overall Study|Enrollment Closed|0|||
131218415|NCT03692078|472424557|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
131218416|NCT03692078|472424558|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
131218417|NCT03692078|472424559|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
131218418|NCT03692078|472424560|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
131218419|NCT03692078|472424561|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
131218420|NCT03692078|472424562|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
131218421|NCT03692078|472424563|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
131218422|NCT03692078|472424557|FG000|Overall Study|Withdrawal by Subject|0|||
131218423|NCT03692078|472424558|FG001|Overall Study|Withdrawal by Subject|2|||
131218424|NCT03692078|472424559|FG002|Overall Study|Withdrawal by Subject|0|||
131218425|NCT03692078|472424560|FG003|Overall Study|Withdrawal by Subject|1|||
131218426|NCT03692078|472424561|FG004|Overall Study|Withdrawal by Subject|5|||
131218427|NCT03692078|472424562|FG005|Overall Study|Withdrawal by Subject|3|||
131218428|NCT03692078|472424563|FG006|Overall Study|Withdrawal by Subject|3|||
131218429|NCT04854707|472424566|FG000|Overall Study|Lack of Efficacy|78|||
131218430|NCT04854707|472424567|FG001|Overall Study|Lack of Efficacy|59|||
131218431|NCT04854707|472424568|FG002|Overall Study|Lack of Efficacy|30|||
131218432|NCT03466060|472424574|FG000|Period 1|Test Lens Damage|0|||
131218433|NCT03466060|472424575|FG001|Period 1|Test Lens Damage|2|||
131218434|NCT03466060|472424576|FG002|Period 1|Test Lens Damage|0|||
131218435|NCT03466060|472424577|FG003|Period 1|Test Lens Damage|0|||
131218436|NCT03466060|472424578|FG004|Period 1|Test Lens Damage|0|||
131218437|NCT03466060|472424579|FG005|Period 1|Test Lens Damage|0|||
131218438|NCT03466060|472424574|FG000|Period 1|Withdrawal by Subject|0|||
131218439|NCT03466060|472424575|FG001|Period 1|Withdrawal by Subject|0|||
131218440|NCT03466060|472424576|FG002|Period 1|Withdrawal by Subject|2|||
131218441|NCT03466060|472424577|FG003|Period 1|Withdrawal by Subject|0|||
131218442|NCT03466060|472424578|FG004|Period 1|Withdrawal by Subject|0|||
131218443|NCT03466060|472424579|FG005|Period 1|Withdrawal by Subject|0|||
131218444|NCT03466060|472424574|FG000|Period 1|Lost to Follow-up|0|||
131218445|NCT03466060|472424575|FG001|Period 1|Lost to Follow-up|0|||
131218446|NCT03466060|472424576|FG002|Period 1|Lost to Follow-up|0|||
131218447|NCT03466060|472424577|FG003|Period 1|Lost to Follow-up|1|||
131218448|NCT03466060|472424578|FG004|Period 1|Lost to Follow-up|0|||
131218449|NCT03466060|472424579|FG005|Period 1|Lost to Follow-up|0|||
131218450|NCT03466060|472424574|FG000|Period 1|Grade 2 Conjunctivitis|0|||
131218451|NCT03466060|472424575|FG001|Period 1|Grade 2 Conjunctivitis|0|||
131218452|NCT03466060|472424576|FG002|Period 1|Grade 2 Conjunctivitis|1|||
131218453|NCT03466060|472424577|FG003|Period 1|Grade 2 Conjunctivitis|0|||
131218454|NCT03466060|472424578|FG004|Period 1|Grade 2 Conjunctivitis|0|||
131218455|NCT03466060|472424579|FG005|Period 1|Grade 2 Conjunctivitis|0|||
131218456|NCT03466060|472424574|FG000|Period 2|Lens Handling Difficulties|0|||
131218457|NCT03466060|472424575|FG001|Period 2|Lens Handling Difficulties|0|||
131218458|NCT03466060|472424576|FG002|Period 2|Lens Handling Difficulties|1|||
131218459|NCT03466060|472424577|FG003|Period 2|Lens Handling Difficulties|0|||
131218460|NCT03466060|472424578|FG004|Period 2|Lens Handling Difficulties|0|||
131218461|NCT03466060|472424579|FG005|Period 2|Lens Handling Difficulties|0|||
131218462|NCT01612780|472424580|FG000|Overall Study|Treatment not completed|1|||
131218463|NCT01612780|472424580|FG000|Overall Study|Withdrawal by Subject|5|||
131218464|NCT04732728|472424584|FG000|Overall Study|Death|12|||
131218465|NCT04732728|472424584|FG000|Overall Study|Withdrawn|136|||
131218466|NCT01339000|472424587|FG000|Overall Study|study closed due to lack of drug supply|1|||
131218467|NCT01339000|472424588|FG001|Overall Study|study closed due to lack of drug supply|0|||
131218468|NCT00664066|472424589|FG000|Overall Study|Study terminated|3|||
131218469|NCT03701516|472424590|FG000|Period 1|Lost to Follow-up|0|||
131218470|NCT03701516|472424591|FG001|Period 1|Lost to Follow-up|1|||
131218471|NCT03701516|472424590|FG000|Period 1|Adverse Event|0|||
131218472|NCT03701516|472424591|FG001|Period 1|Adverse Event|2|||
131218473|NCT03701516|472424590|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
131218474|NCT03701516|472424591|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
131218475|NCT03701516|472424590|FG000|Period 1|Non Compliance to Protocol|2|||
131218476|NCT03701516|472424591|FG001|Period 1|Non Compliance to Protocol|1|||
131218477|NCT03701516|472424590|FG000|Period 1|Withdrawal by Subject|0|||
131218478|NCT03701516|472424591|FG001|Period 1|Withdrawal by Subject|1|||
131218479|NCT03701516|472424590|FG000|Period 2|failed to meet all eligibility creiteria|1|||
131218480|NCT03701516|472424591|FG001|Period 2|failed to meet all eligibility creiteria|0|||
131218481|NCT03701516|472424590|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
131218482|NCT03701516|472424591|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
131218483|NCT03083639|472424592|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
131218484|NCT03083639|472424593|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
131218485|NCT03083639|472424592|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
131218486|NCT03083639|472424593|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
131218487|NCT01591499|472424594|FG000|Baseline Visit|Withdrawal by Subject|0|||
131218488|NCT01591499|472424595|FG001|Baseline Visit|Withdrawal by Subject|2|||
131218489|NCT01591499|472424596|FG002|Baseline Visit|Withdrawal by Subject|0|||
131218490|NCT01591499|472424597|FG003|Baseline Visit|Withdrawal by Subject|2|||
131218491|NCT01591499|472424594|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
131218492|NCT01591499|472424595|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
131218493|NCT01591499|472424596|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
131218494|NCT01591499|472424597|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
131218495|NCT01591499|472424594|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
131218496|NCT01591499|472424595|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
131218497|NCT01591499|472424596|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
131218498|NCT01591499|472424597|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
131218499|NCT05083559|472424598|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
131218500|NCT05083559|472424599|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
131218501|NCT05083559|472424598|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
131218502|NCT05083559|472424599|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
131218503|NCT05083559|472424598|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
131218504|NCT05083559|472424599|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
131218505|NCT03428217|472424601|FG000|Overall Study|Death|89|||
131218506|NCT03428217|472424602|FG001|Overall Study|Death|93|||
131218507|NCT03428217|472424601|FG000|Overall Study|Withdrawal by Subject|8|||
131218508|NCT03428217|472424602|FG001|Overall Study|Withdrawal by Subject|7|||
131218509|NCT03428217|472424601|FG000|Overall Study|Lost to Follow-up|1|||
131218510|NCT03428217|472424602|FG001|Overall Study|Lost to Follow-up|3|||
131218511|NCT03428217|472424601|FG000|Overall Study|Study terminated by sponsor|124|||
131218512|NCT03428217|472424602|FG001|Overall Study|Study terminated by sponsor|118|||
131218513|NCT03428217|472424601|FG000|Overall Study|Other, Not Specified|1|||
131218514|NCT03428217|472424602|FG001|Overall Study|Other, Not Specified|0|||
131218515|NCT03889197|472424603|FG000|Overall Study|Withdrawal by Subject|1|||
131218516|NCT03889197|472424604|FG001|Overall Study|Withdrawal by Subject|0|||
131218517|NCT03889197|472424603|FG000|Overall Study|Physician Decision|0|||
131218518|NCT03889197|472424604|FG001|Overall Study|Physician Decision|1|||
131218519|NCT03889197|472424603|FG000|Overall Study|met exclusion criteria|0|||
131218520|NCT03889197|472424604|FG001|Overall Study|met exclusion criteria|1|||
131218521|NCT03889197|472424603|FG000|Overall Study|Protocol Violation|1|||
131218522|NCT03889197|472424604|FG001|Overall Study|Protocol Violation|0|||
131218523|NCT05899218|472424605|FG000|Overall Study|Lost to Follow-up|2|||
131218524|NCT05899218|472424606|FG001|Overall Study|Lost to Follow-up|2|||
131218525|NCT05899218|472424605|FG000|Overall Study|deemed ineligible out of country|1|||
131218526|NCT05899218|472424606|FG001|Overall Study|deemed ineligible out of country|0|||
131218527|NCT05246111|472424607|FG000|Period 01|NOT ELIGIBLE IC5|1|||
131218528|NCT05246111|472424608|FG001|Period 01|NOT ELIGIBLE IC5|0|||
131218529|NCT03151226|472424609|FG000|Overall Study|Withdrawal by Subject|2|||
131218530|NCT03151226|472424609|FG000|Overall Study|not wear device correctly|1|||
131218531|NCT00633217|472424612|FG000|Overall Study|Adverse Event|5|||
131218532|NCT00633217|472424613|FG001|Overall Study|Adverse Event|9|||
131218533|NCT00633217|472424612|FG000|Overall Study|Lack of Efficacy|0|||
131218534|NCT00633217|472424613|FG001|Overall Study|Lack of Efficacy|2|||
131218535|NCT00633217|472424612|FG000|Overall Study|Protocol Violation|3|||
131218536|NCT00633217|472424613|FG001|Overall Study|Protocol Violation|7|||
131218537|NCT00633217|472424612|FG000|Overall Study|Lost to Follow-up|2|||
131218538|NCT00633217|472424613|FG001|Overall Study|Lost to Follow-up|2|||
131218539|NCT00633217|472424612|FG000|Overall Study|Investigator Discretion|2|||
131218540|NCT00633217|472424613|FG001|Overall Study|Investigator Discretion|0|||
131218541|NCT00633217|472424612|FG000|Overall Study|Withdrew Consent|3|||
131218542|NCT00633217|472424613|FG001|Overall Study|Withdrew Consent|3|||
131218543|NCT04881448|472424614|FG000|Overall Study|Study cancelled by sponsor|220|||
131218544|NCT04881448|472424614|FG000|Overall Study|Withdrawal by Subject|2|||
131218545|NCT04881448|472424614|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
131218546|NCT00005879|472424619|FG000|Overall Study|Withdrawal by Subject|8|||
131218547|NCT00005879|472424620|FG001|Overall Study|Withdrawal by Subject|10|||
131218548|NCT00689273|472424621|FG000|Overall Study|Adverse Event|3|||
131218549|NCT00689273|472424622|FG001|Overall Study|Adverse Event|1|||
131218550|NCT00689273|472424621|FG000|Overall Study|Lack of Efficacy|3|||
130992714|NCT04022889|471601591|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
131218551|NCT00689273|472424622|FG001|Overall Study|Lack of Efficacy|0|||
130992715|NCT04022889|471601592|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
131218552|NCT00689273|472424621|FG000|Overall Study|Lost to Follow-up|0|||
131218553|NCT00689273|472424622|FG001|Overall Study|Lost to Follow-up|2|||
131218554|NCT00689273|472424621|FG000|Overall Study|Other|6|||
131218555|NCT00689273|472424622|FG001|Overall Study|Other|2|||
131218556|NCT00689273|472424621|FG000|Overall Study|Randomized but not Treated|1|||
131218557|NCT00689273|472424622|FG001|Overall Study|Randomized but not Treated|0|||
131218558|NCT01238172|472424624|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
131218559|NCT01238172|472424625|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
131218560|NCT01238172|472424624|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
131218561|NCT01238172|472424625|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
131218562|NCT05022121|472424628|FG000|Overall Study|Lack of Efficacy|1|||
131218563|NCT05022121|472424629|FG001|Overall Study|Lack of Efficacy|0|||
131218564|NCT05022121|472424628|FG000|Overall Study|Lost to Follow-up|0|||
131218565|NCT05022121|472424629|FG001|Overall Study|Lost to Follow-up|2|||
131218566|NCT02531698|472424631|FG000|Overall Study|Adverse Event|2|||
131218567|NCT02531698|472424632|FG001|Overall Study|Adverse Event|1|||
131218568|NCT02531698|472424631|FG000|Overall Study|Withdrawal by Subject|6|||
131218569|NCT02531698|472424632|FG001|Overall Study|Withdrawal by Subject|1|||
131218570|NCT02531698|472424631|FG000|Overall Study|Protocol Violation|2|||
131218571|NCT02531698|472424632|FG001|Overall Study|Protocol Violation|0|||
131218572|NCT02531698|472424631|FG000|Overall Study|Lost to Follow-up|1|||
131218573|NCT02531698|472424632|FG001|Overall Study|Lost to Follow-up|0|||
131218574|NCT02237118|472426605|FG000|Overall Study|Protocol Violation|0|||
131218575|NCT02237118|472426606|FG001|Overall Study|Protocol Violation|1|||
131218576|NCT02237118|472426605|FG000|Overall Study|consent withdrawn|1|||
131218577|NCT02237118|472426606|FG001|Overall Study|consent withdrawn|0|||
131218578|NCT02953262|472426607|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
131218579|NCT02953262|472426608|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
131218580|NCT02953262|472426609|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
131218581|NCT02953262|472426610|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
131218582|NCT03284424|472426612|FG000|Overall Study|Death|70|||
131218583|NCT03284424|472426613|FG001|Overall Study|Death|24|||
131218584|NCT03284424|472426612|FG000|Overall Study|Lost to Follow-up|3|||
131218585|NCT03284424|472426613|FG001|Overall Study|Lost to Follow-up|1|||
131218586|NCT03284424|472426612|FG000|Overall Study|Physician Decision|1|||
131218587|NCT03284424|472426613|FG001|Overall Study|Physician Decision|2|||
131218588|NCT03284424|472426612|FG000|Overall Study|Withdrawal by Subject|4|||
131218589|NCT03284424|472426613|FG001|Overall Study|Withdrawal by Subject|5|||
131218590|NCT03284424|472426612|FG000|Overall Study|Sponsor's decision|27|||
131218591|NCT03284424|472426613|FG001|Overall Study|Sponsor's decision|22|||
131218592|NCT00765999|472426614|FG000|Overall Study|Adverse Event|203|||
131218593|NCT00765999|472426614|FG000|Overall Study|Insufficient Therapeutic Response|100|||
131218594|NCT00765999|472426614|FG000|Overall Study|Protocol Violation|95|||
131218595|NCT00765999|472426614|FG000|Overall Study|Consent Withdrawn|202|||
131218596|NCT00765999|472426614|FG000|Overall Study|Lost to Follow-up|131|||
131218597|NCT00765999|472426614|FG000|Overall Study|Study Terminated by Sponsor|2|||
131218598|NCT00765999|472426614|FG000|Overall Study|Other Miscellaneous Reasons|51|||
131218599|NCT03981614|472426618|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
131218600|NCT03981614|472426619|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
131218601|NCT03981614|472426620|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
131218602|NCT00499252|472426621|FG000|Overall Study|Adverse Event|3|||
131218603|NCT00499252|472426621|FG000|Overall Study|Refused further treatment|2|||
131218604|NCT00499252|472426621|FG000|Overall Study|Ineligible|4|||
131218605|NCT00499252|472426621|FG000|Overall Study|<no further label>|3|||
131218606|NCT00566631|472426622|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
131218607|NCT00566631|472426622|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
131218608|NCT00566631|472426622|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
131218609|NCT00566631|472426622|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
131218610|NCT00566631|472426622|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
131218611|NCT00566631|472426622|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
131218612|NCT00566631|472426622|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
131218613|NCT00566631|472426622|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
131218614|NCT00566631|472426622|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
131218615|NCT00566631|472426622|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
131218616|NCT00566631|472426622|FG000|Part 2: Extension Phase|Adverse Event|11|||
131218617|NCT00566631|472426622|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
131218618|NCT00566631|472426622|FG000|Part 2: Extension Phase|Death|1|||
131218619|NCT00566631|472426622|FG000|Part 2: Extension Phase|Other|5|||
131218620|NCT03387735|472426623|FG000|Overall Study|Lost to Follow-up|4|||
131218621|NCT03387735|472426624|FG001|Overall Study|Lost to Follow-up|8|||
131218622|NCT03387735|472426623|FG000|Overall Study|Death|4|||
131218623|NCT03387735|472426624|FG001|Overall Study|Death|8|||
131218624|NCT00110084|472426625|FG000|Overall Study|Adverse Event|9|||
131218625|NCT00110084|472426625|FG000|Overall Study|Death|1|||
131218626|NCT00110084|472426625|FG000|Overall Study|Patient Refusal|10|||
131218627|NCT00110084|472426625|FG000|Overall Study|Alternate Therapy|5|||
131218628|NCT00110084|472426625|FG000|Overall Study|Intercurrent Illness|1|||
131218629|NCT00110084|472426625|FG000|Overall Study|Other|2|||
131218630|NCT00537056|472426626|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
131218631|NCT03020966|472426630|FG000|Overall Study|Withdrawal by Subject|2|||
131218632|NCT03020966|472426631|FG001|Overall Study|Withdrawal by Subject|0|||
131218633|NCT01346501|472426636|FG000|Overall Study|Initiated Other Biological Agents|3|||
130992716|NCT04022889|471601593|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
130992717|NCT04022889|471601591|FG000|Stage 2|Screen Failure|0|||
130992718|NCT04022889|471601592|FG001|Stage 2|Screen Failure|0|||
130992719|NCT04022889|471601593|FG002|Stage 2|Screen Failure|3|||
130992720|NCT04022889|471601591|FG000|Stage 2|Ineligible for apheresis donation|0|||
130992721|NCT04022889|471601592|FG001|Stage 2|Ineligible for apheresis donation|0|||
130992722|NCT04022889|471601593|FG002|Stage 2|Ineligible for apheresis donation|2|||
130992723|NCT04022889|471601591|FG000|Stage 2|Adverse Event|0|||
130992724|NCT04022889|471601592|FG001|Stage 2|Adverse Event|0|||
130992725|NCT04022889|471601593|FG002|Stage 2|Adverse Event|2|||
131218634|NCT01346501|472426637|FG001|Overall Study|Initiated Other Biological Agents|1|||
130992726|NCT04022889|471601591|FG000|Stage 2|Protocol Violation|0|||
130992727|NCT04022889|471601592|FG001|Stage 2|Protocol Violation|0|||
130992728|NCT04022889|471601593|FG002|Stage 2|Protocol Violation|1|||
130992729|NCT04022889|471601591|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
130992730|NCT04022889|471601592|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
130992731|NCT04022889|471601593|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
130992732|NCT01382940|471601594|FG000|Overall Study|Adverse Event|19|||
130992733|NCT01382940|471601594|FG000|Overall Study|Lost to Follow-up|4|||
130992734|NCT01382940|471601594|FG000|Overall Study|Physician Decision|7|||
130992735|NCT01382940|471601594|FG000|Overall Study|Withdrawal by Subject|23|||
130992736|NCT01382940|471601594|FG000|Overall Study|Protocol Violation|20|||
130992737|NCT00976482|471601597|FG000|Overall Study|Death|208|||
130992738|NCT00976482|471601597|FG000|Overall Study|Withdrawal by Subject|45|||
130992739|NCT00976482|471601597|FG000|Overall Study|Center terminated|1|||
130992740|NCT00976482|471601597|FG000|Overall Study|Protocol Violation|5|||
130992741|NCT00720902|471601600|FG000|Overall Study|Withdrawal by Subject|1|||
130992742|NCT00720902|471601601|FG001|Overall Study|Withdrawal by Subject|0|||
130992743|NCT00720902|471601600|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
130992744|NCT00720902|471601601|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
130992745|NCT01486758|471601602|FG000|Overall Study|Lost to Follow-up|0|||
130992746|NCT01486758|471601603|FG001|Overall Study|Lost to Follow-up|1|||
130992747|NCT02254408|471601613|FG000|Overall Study|Randomized But Not Treated|1|||
130992748|NCT02254408|471601614|FG001|Overall Study|Randomized But Not Treated|3|||
130992749|NCT02254408|471601613|FG000|Overall Study|Adverse Event|1|||
130992750|NCT02254408|471601614|FG001|Overall Study|Adverse Event|0|||
130992751|NCT02254408|471601613|FG000|Overall Study|Death|2|||
130992752|NCT02254408|471601614|FG001|Overall Study|Death|3|||
130992753|NCT02254408|471601613|FG000|Overall Study|Investigator's Discretion|0|||
130992754|NCT02254408|471601614|FG001|Overall Study|Investigator's Discretion|1|||
130992755|NCT02254408|471601613|FG000|Overall Study|Withdrawal by Subject|3|||
130992756|NCT02254408|471601614|FG001|Overall Study|Withdrawal by Subject|3|||
130992757|NCT02254408|471601613|FG000|Overall Study|Lost to Follow-up|1|||
130992758|NCT02254408|471601614|FG001|Overall Study|Lost to Follow-up|0|||
130992759|NCT02914184|471601616|FG000|Overall Study|Lost to Follow-up|7|||
130992760|NCT02914184|471601617|FG001|Overall Study|Lost to Follow-up|10|||
130992761|NCT02914184|471601618|FG002|Overall Study|Lost to Follow-up|8|||
130992762|NCT02914184|471601619|FG003|Overall Study|Lost to Follow-up|7|||
130992763|NCT02914184|471601616|FG000|Overall Study|Withdrawal by Subject|4|||
130992764|NCT02914184|471601617|FG001|Overall Study|Withdrawal by Subject|2|||
130992765|NCT02914184|471601618|FG002|Overall Study|Withdrawal by Subject|7|||
130992766|NCT02914184|471601619|FG003|Overall Study|Withdrawal by Subject|3|||
130992767|NCT02914184|471601616|FG000|Overall Study|Other|1|||
130992768|NCT02914184|471601617|FG001|Overall Study|Other|0|||
130992769|NCT02914184|471601618|FG002|Overall Study|Other|0|||
130992770|NCT02914184|471601619|FG003|Overall Study|Other|0|||
131218635|NCT01346501|472426636|FG000|Overall Study|Other|8|||
131218636|NCT01346501|472426637|FG001|Overall Study|Other|12|||
131218637|NCT02628418|472426638|FG000|Overall Study|Lost to Follow-up|1|||
131218638|NCT02628418|472426639|FG001|Overall Study|Lost to Follow-up|2|||
131218639|NCT03747939|472426640|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
131218640|NCT03747939|472426641|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
131218641|NCT03747939|472426642|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
131218642|NCT03747939|472426643|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
131218643|NCT03747939|472426640|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
131218644|NCT03747939|472426641|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
131218645|NCT03747939|472426642|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
130992771|NCT02914184|471601616|FG000|Overall Study|Migrated/moved from the study area|2|||
130992772|NCT02914184|471601617|FG001|Overall Study|Migrated/moved from the study area|1|||
131218646|NCT03747939|472426643|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
130992773|NCT02914184|471601618|FG002|Overall Study|Migrated/moved from the study area|2|||
130992774|NCT02914184|471601619|FG003|Overall Study|Migrated/moved from the study area|1|||
130992775|NCT00798174|471601620|FG000|Overall Study|inability to implant azygos coil|3|||
130992776|NCT00798174|471601621|FG001|Overall Study|inability to implant azygos coil|3|||
130992777|NCT00798174|471601620|FG000|Overall Study|Inability to sedate for DFT testing|1|||
130992778|NCT00798174|471601621|FG001|Overall Study|Inability to sedate for DFT testing|0|||
131218647|NCT03747939|472426640|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
131218648|NCT03747939|472426641|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
131218649|NCT03747939|472426642|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
131218650|NCT03747939|472426643|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
131218651|NCT03747939|472426640|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
131218652|NCT03747939|472426641|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
131218653|NCT03747939|472426642|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
131218654|NCT03747939|472426643|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
131218655|NCT03747939|472426640|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
131218656|NCT03747939|472426641|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
131218657|NCT03747939|472426642|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
131218658|NCT03747939|472426643|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
131218659|NCT03747939|472426640|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
131218660|NCT03747939|472426641|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
131218661|NCT03747939|472426642|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
131218662|NCT03747939|472426643|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
131218663|NCT03747939|472426640|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
131218664|NCT03747939|472426641|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
131218665|NCT03747939|472426642|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
131218666|NCT03747939|472426643|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
131218667|NCT03747939|472426640|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
131218668|NCT03747939|472426641|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
131218669|NCT03747939|472426642|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
131218670|NCT03747939|472426643|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
131218671|NCT03747939|472426640|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
131218672|NCT03747939|472426641|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
131218673|NCT03747939|472426642|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
131218674|NCT03747939|472426643|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
131218675|NCT03747939|472426640|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
131218676|NCT03747939|472426641|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
131218677|NCT03747939|472426642|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
131218678|NCT03747939|472426643|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
131218679|NCT03747939|472426640|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
131218680|NCT03747939|472426641|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
131218681|NCT03747939|472426642|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
131218682|NCT03747939|472426643|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
131218683|NCT03747939|472426640|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
131218684|NCT03747939|472426641|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
131218685|NCT03747939|472426642|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
131218686|NCT03747939|472426643|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
131218687|NCT03747939|472426640|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
131218688|NCT03747939|472426641|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
131218689|NCT03747939|472426642|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
131218690|NCT03747939|472426643|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
131218691|NCT03747939|472426640|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
131218692|NCT03747939|472426641|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
131218693|NCT03747939|472426642|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
131218694|NCT03747939|472426643|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
131218695|NCT01215955|472426644|FG000|Overall Study|Adverse Event|1|||
131218696|NCT01215955|472426645|FG001|Overall Study|Adverse Event|4|||
131218697|NCT01215955|472426646|FG002|Overall Study|Adverse Event|2|||
131218698|NCT01215955|472426647|FG003|Overall Study|Adverse Event|3|||
131218699|NCT01215955|472426644|FG000|Overall Study|Death|2|||
131218700|NCT01215955|472426645|FG001|Overall Study|Death|0|||
131218701|NCT01215955|472426646|FG002|Overall Study|Death|1|||
131218702|NCT01215955|472426647|FG003|Overall Study|Death|3|||
131218703|NCT01215955|472426644|FG000|Overall Study|Entry Criteria Not Met|1|||
131218704|NCT01215955|472426645|FG001|Overall Study|Entry Criteria Not Met|3|||
131218705|NCT01215955|472426646|FG002|Overall Study|Entry Criteria Not Met|4|||
131218706|NCT01215955|472426647|FG003|Overall Study|Entry Criteria Not Met|7|||
131218707|NCT01215955|472426644|FG000|Overall Study|Lack of Efficacy|1|||
131218708|NCT01215955|472426645|FG001|Overall Study|Lack of Efficacy|2|||
131218709|NCT01215955|472426646|FG002|Overall Study|Lack of Efficacy|1|||
131218710|NCT01215955|472426647|FG003|Overall Study|Lack of Efficacy|0|||
131218711|NCT01215955|472426644|FG000|Overall Study|Lost to Follow-up|4|||
131218712|NCT01215955|472426645|FG001|Overall Study|Lost to Follow-up|4|||
131218713|NCT01215955|472426646|FG002|Overall Study|Lost to Follow-up|8|||
131218714|NCT01215955|472426647|FG003|Overall Study|Lost to Follow-up|9|||
131218715|NCT01215955|472426644|FG000|Overall Study|Physician Decision|4|||
131218716|NCT01215955|472426645|FG001|Overall Study|Physician Decision|10|||
131218717|NCT01215955|472426646|FG002|Overall Study|Physician Decision|8|||
131218718|NCT01215955|472426647|FG003|Overall Study|Physician Decision|11|||
131218719|NCT01215955|472426644|FG000|Overall Study|Protocol Violation|17|||
131218720|NCT01215955|472426645|FG001|Overall Study|Protocol Violation|13|||
131218721|NCT01215955|472426646|FG002|Overall Study|Protocol Violation|8|||
131218722|NCT01215955|472426647|FG003|Overall Study|Protocol Violation|8|||
131218723|NCT01215955|472426644|FG000|Overall Study|Sponsor Decision|1|||
130992779|NCT01478113|471601625|FG000|Overall Study|Withdrawal by Subject|0|||
130992780|NCT01478113|471601626|FG001|Overall Study|Withdrawal by Subject|1|||
130992781|NCT01478113|471601625|FG000|Overall Study|Physician Decision|1|||
130992782|NCT01478113|471601626|FG001|Overall Study|Physician Decision|0|||
130992783|NCT03093428|471601629|FG000|Overall Study|Not eligible for treatment|2|||
130992784|NCT03093428|471601630|FG001|Overall Study|Not eligible for treatment|1|||
130992785|NCT03093428|471601629|FG000|Overall Study|Progression|14|||
130992786|NCT03093428|471601630|FG001|Overall Study|Progression|4|||
130992787|NCT03093428|471601629|FG000|Overall Study|Death|1|||
130992788|NCT03093428|471601630|FG001|Overall Study|Death|0|||
130992789|NCT03093428|471601629|FG000|Overall Study|Adverse Event|1|||
130992790|NCT03093428|471601630|FG001|Overall Study|Adverse Event|0|||
130992791|NCT03093428|471601629|FG000|Overall Study|Withdrawal by Subject|1|||
130992792|NCT03093428|471601630|FG001|Overall Study|Withdrawal by Subject|1|||
130992793|NCT00041756|471601631|FG000|Overall Study|Adverse Event|4|||
130992794|NCT00041756|471601632|FG001|Overall Study|Adverse Event|10|||
130992795|NCT00041756|471601633|FG002|Overall Study|Adverse Event|6|||
130992796|NCT00041756|471601634|FG003|Overall Study|Adverse Event|11|||
130992797|NCT00041756|471601635|FG004|Overall Study|Adverse Event|34|||
130992798|NCT00041756|471601631|FG000|Overall Study|Protocol Violation|1|||
130992799|NCT00041756|471601632|FG001|Overall Study|Protocol Violation|1|||
130992800|NCT00041756|471601633|FG002|Overall Study|Protocol Violation|2|||
130992801|NCT00041756|471601634|FG003|Overall Study|Protocol Violation|2|||
130992802|NCT00041756|471601635|FG004|Overall Study|Protocol Violation|1|||
130992803|NCT00041756|471601631|FG000|Overall Study|Withdrawal by Subject|3|||
130992804|NCT00041756|471601632|FG001|Overall Study|Withdrawal by Subject|3|||
130992805|NCT00041756|471601633|FG002|Overall Study|Withdrawal by Subject|4|||
130992806|NCT00041756|471601634|FG003|Overall Study|Withdrawal by Subject|2|||
130992807|NCT00041756|471601635|FG004|Overall Study|Withdrawal by Subject|3|||
130992808|NCT00041756|471601631|FG000|Overall Study|Lost to Follow-up|0|||
130992809|NCT00041756|471601632|FG001|Overall Study|Lost to Follow-up|1|||
130992810|NCT00041756|471601633|FG002|Overall Study|Lost to Follow-up|0|||
130992811|NCT00041756|471601634|FG003|Overall Study|Lost to Follow-up|1|||
130992812|NCT00041756|471601635|FG004|Overall Study|Lost to Follow-up|0|||
130992813|NCT00041756|471601631|FG000|Overall Study|Unable to meet protocol criteria|0|||
130992814|NCT00041756|471601632|FG001|Overall Study|Unable to meet protocol criteria|0|||
130992815|NCT00041756|471601633|FG002|Overall Study|Unable to meet protocol criteria|1|||
130992816|NCT00041756|471601634|FG003|Overall Study|Unable to meet protocol criteria|0|||
130992817|NCT00041756|471601635|FG004|Overall Study|Unable to meet protocol criteria|1|||
130992818|NCT00041756|471601631|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
130992819|NCT00041756|471601632|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
130992820|NCT00041756|471601633|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
130992821|NCT00041756|471601634|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
130992822|NCT00041756|471601635|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
130992823|NCT03980184|471601636|FG000|Overall Study|Dropped out before treatment|2|||
131218724|NCT01215955|472426645|FG001|Overall Study|Sponsor Decision|2|||
131218725|NCT01215955|472426646|FG002|Overall Study|Sponsor Decision|0|||
131218726|NCT01215955|472426647|FG003|Overall Study|Sponsor Decision|1|||
131218727|NCT01215955|472426644|FG000|Overall Study|Withdrawal by Subject|14|||
131218728|NCT01215955|472426645|FG001|Overall Study|Withdrawal by Subject|15|||
131218729|NCT01215955|472426646|FG002|Overall Study|Withdrawal by Subject|13|||
131218730|NCT01215955|472426647|FG003|Overall Study|Withdrawal by Subject|9|||
131218731|NCT01215955|472426644|FG000|Overall Study|Quality Issues|0|||
131218732|NCT01215955|472426645|FG001|Overall Study|Quality Issues|0|||
131218733|NCT01215955|472426646|FG002|Overall Study|Quality Issues|3|||
131218734|NCT01215955|472426647|FG003|Overall Study|Quality Issues|2|||
131218735|NCT01787188|472426648|FG000|Overall Study|Adverse Event|2|||
131218736|NCT01787188|472426649|FG001|Overall Study|Adverse Event|4|||
131218737|NCT01787188|472426650|FG002|Overall Study|Adverse Event|6|||
131218738|NCT01787188|472426648|FG000|Overall Study|Lack of Efficacy|7|||
130992824|NCT03980184|471601637|FG001|Overall Study|Dropped out before treatment|2|||
130992825|NCT03980184|471601636|FG000|Overall Study|Lost to Follow-up|11|||
130992826|NCT03980184|471601637|FG001|Overall Study|Lost to Follow-up|13|||
130992827|NCT00603265|471601638|FG000|Overall Study|Adverse Event|2|||
130992828|NCT00603265|471601639|FG001|Overall Study|Adverse Event|11|||
130992829|NCT00603265|471601640|FG002|Overall Study|Adverse Event|1|||
130992830|NCT00603265|471601638|FG000|Overall Study|Withdrawal by Subject|1|||
130992831|NCT00603265|471601639|FG001|Overall Study|Withdrawal by Subject|2|||
131218739|NCT01787188|472426649|FG001|Overall Study|Lack of Efficacy|3|||
131218740|NCT01787188|472426650|FG002|Overall Study|Lack of Efficacy|5|||
131218741|NCT01787188|472426648|FG000|Overall Study|Non-compliance with Study Drug|0|||
131218742|NCT01787188|472426649|FG001|Overall Study|Non-compliance with Study Drug|1|||
131218743|NCT01787188|472426650|FG002|Overall Study|Non-compliance with Study Drug|0|||
131218744|NCT01787188|472426648|FG000|Overall Study|Withdrawal by Subject|4|||
131218745|NCT01787188|472426649|FG001|Overall Study|Withdrawal by Subject|3|||
131218746|NCT01787188|472426650|FG002|Overall Study|Withdrawal by Subject|2|||
131218747|NCT01787188|472426648|FG000|Overall Study|Protocol Violation|3|||
131218748|NCT01787188|472426649|FG001|Overall Study|Protocol Violation|2|||
131218749|NCT01787188|472426650|FG002|Overall Study|Protocol Violation|3|||
131218750|NCT01787188|472426648|FG000|Overall Study|Lost to Follow-up|1|||
131218751|NCT01787188|472426649|FG001|Overall Study|Lost to Follow-up|2|||
131218752|NCT01787188|472426650|FG002|Overall Study|Lost to Follow-up|2|||
131218753|NCT01787188|472426648|FG000|Overall Study|Other, including patient moved|0|||
131218754|NCT01787188|472426649|FG001|Overall Study|Other, including patient moved|3|||
131218755|NCT01787188|472426650|FG002|Overall Study|Other, including patient moved|0|||
131218756|NCT02756078|472426653|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
131218757|NCT02756078|472426654|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
131218758|NCT02756078|472426653|FG000|Period 1|Lost to Follow-up|0|||
131218759|NCT02756078|472426654|FG001|Period 1|Lost to Follow-up|2|||
131218760|NCT02756078|472426653|FG000|Period 1|Protocol Violation|0|||
131218761|NCT02756078|472426654|FG001|Period 1|Protocol Violation|1|||
131218762|NCT02756078|472426653|FG000|Period 1|Adverse Event|1|||
131218763|NCT02756078|472426654|FG001|Period 1|Adverse Event|10|||
131218764|NCT02756078|472426653|FG000|Period 1|Withdrawal by Subject|6|||
131218765|NCT02756078|472426654|FG001|Period 1|Withdrawal by Subject|6|||
131218766|NCT02756078|472426653|FG000|Period 1|Lens Discomfort|2|||
131218767|NCT02756078|472426654|FG001|Period 1|Lens Discomfort|2|||
131218768|NCT02756078|472426653|FG000|Period 2|Adverse Event|3|||
131218769|NCT02756078|472426654|FG001|Period 2|Adverse Event|5|||
131218770|NCT02756078|472426653|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
131218771|NCT02756078|472426654|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
131218772|NCT02756078|472426653|FG000|Period 2|Withdrawal by Subject|3|||
131218773|NCT02756078|472426654|FG001|Period 2|Withdrawal by Subject|1|||
131218774|NCT05349188|472426655|FG000|Overall Study|Withdrawal by Subject|1|||
131218775|NCT05349188|472426656|FG001|Overall Study|Withdrawal by Subject|0|||
131218776|NCT00835068|472426659|FG000|Overall Study|Death|1|||
131218777|NCT00835068|472426660|FG001|Overall Study|Death|0|||
131218778|NCT00835068|472426659|FG000|Overall Study|Adverse Event|0|||
131218779|NCT00835068|472426660|FG001|Overall Study|Adverse Event|1|||
131218780|NCT00835068|472426659|FG000|Overall Study|Other|8|||
131218781|NCT00835068|472426660|FG001|Overall Study|Other|0|||
131218782|NCT00835068|472426659|FG000|Overall Study|Withdrawal by Subject|1|||
131218783|NCT00835068|472426660|FG001|Overall Study|Withdrawal by Subject|0|||
131218784|NCT02575807|472426661|FG000|Overall Study|Death|8|||
131218785|NCT02575807|472426662|FG001|Overall Study|Death|3|||
131218786|NCT02575807|472426663|FG002|Overall Study|Death|7|||
131218787|NCT02575807|472426664|FG003|Overall Study|Death|0|||
131218788|NCT02575807|472426665|FG004|Overall Study|Death|1|||
131218789|NCT02575807|472426661|FG000|Overall Study|Study terminated by Sponsor|0|||
131218790|NCT02575807|472426662|FG001|Overall Study|Study terminated by Sponsor|1|||
131218791|NCT02575807|472426663|FG002|Overall Study|Study terminated by Sponsor|7|||
131218792|NCT02575807|472426664|FG003|Overall Study|Study terminated by Sponsor|0|||
131218793|NCT02575807|472426665|FG004|Overall Study|Study terminated by Sponsor|1|||
131218794|NCT02575807|472426661|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
131218795|NCT02575807|472426662|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
131218796|NCT02575807|472426663|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
131218797|NCT02575807|472426664|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
131218798|NCT02575807|472426665|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
131218799|NCT02575807|472426661|FG000|Overall Study|Terminated due to physician decision|0|||
131218800|NCT02575807|472426662|FG001|Overall Study|Terminated due to physician decision|0|||
131218801|NCT02575807|472426663|FG002|Overall Study|Terminated due to physician decision|1|||
131218802|NCT02575807|472426664|FG003|Overall Study|Terminated due to physician decision|0|||
131218803|NCT02575807|472426665|FG004|Overall Study|Terminated due to physician decision|0|||
131218804|NCT02575807|472426661|FG000|Overall Study|Subject ineligible - medical implant|0|||
131218805|NCT02575807|472426662|FG001|Overall Study|Subject ineligible - medical implant|0|||
131218806|NCT02575807|472426663|FG002|Overall Study|Subject ineligible - medical implant|0|||
131218807|NCT02575807|472426664|FG003|Overall Study|Subject ineligible - medical implant|1|||
131218808|NCT02575807|472426665|FG004|Overall Study|Subject ineligible - medical implant|0|||
131218809|NCT02575807|472426661|FG000|Overall Study|Withdrawal by Subject|0|||
131218810|NCT02575807|472426662|FG001|Overall Study|Withdrawal by Subject|0|||
131218811|NCT02575807|472426663|FG002|Overall Study|Withdrawal by Subject|1|||
131218812|NCT02575807|472426664|FG003|Overall Study|Withdrawal by Subject|1|||
131218813|NCT02575807|472426665|FG004|Overall Study|Withdrawal by Subject|2|||
131218814|NCT02180659|472426666|FG000|Overall Study|Adverse Event|1|||
131218815|NCT02180659|472426667|FG001|Overall Study|Adverse Event|0|||
131218816|NCT02180659|472426666|FG000|Overall Study|Lost to Follow-up|4|||
130882631|NCT03592186|471205554|FG000|Overall Study|Lost to Follow-up|16|||
131218817|NCT02180659|472426667|FG001|Overall Study|Lost to Follow-up|2|||
131218818|NCT02180659|472426666|FG000|Overall Study|Subject incarcerated during conduct|1|||
131218819|NCT02180659|472426667|FG001|Overall Study|Subject incarcerated during conduct|0|||
131218820|NCT02180659|472426666|FG000|Overall Study|Withdrawal by Subject|0|||
131218821|NCT02180659|472426667|FG001|Overall Study|Withdrawal by Subject|2|||
131218822|NCT02180659|472426666|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
131218823|NCT02180659|472426667|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
131218824|NCT01495793|472426668|FG000|Overall Study|Lost to Follow-up|1|||
131218825|NCT01495793|472426668|FG000|Overall Study|Violation of inclusion criteria|1|||
131218826|NCT03014570|472426671|FG000|Overall Study|COVID-19 Restrictions|38|||
131218827|NCT03014570|472426672|FG001|Overall Study|COVID-19 Restrictions|24|||
131218828|NCT03014570|472426671|FG000|Overall Study|Death|70|||
131218829|NCT03014570|472426672|FG001|Overall Study|Death|79|||
131218830|NCT03014570|472426671|FG000|Overall Study|Transfer from facility|11|||
131218831|NCT03014570|472426672|FG001|Overall Study|Transfer from facility|14|||
131218832|NCT03014570|472426671|FG000|Overall Study|Hospitalized|5|||
131218833|NCT03014570|472426672|FG001|Overall Study|Hospitalized|3|||
131218834|NCT03014570|472426671|FG000|Overall Study|Transfer within facility|1|||
131218835|NCT03014570|472426672|FG001|Overall Study|Transfer within facility|0|||
131218836|NCT03014570|472426671|FG000|Overall Study|Site refusal|0|||
131218837|NCT03014570|472426672|FG001|Overall Study|Site refusal|11|||
131218838|NCT00478673|472426678|FG000|30-Days Post-Procedure|Death|2|||
131218839|NCT00478673|472426678|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
131218840|NCT00478673|472426678|FG000|30-Days Post-Procedure|Missed Visit|7|||
131218841|NCT00478673|472426678|FG000|12-Months Post-Procedure|Death|23|||
131218842|NCT00478673|472426678|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
131218843|NCT00478673|472426678|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
131218844|NCT00478673|472426678|FG000|12-Months Post-Procedure|Missed Visit|25|||
131218845|NCT00478673|472426678|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
131218846|NCT03332212|472426679|FG000|Overall Study|Not treated|0|||
131218847|NCT03332212|472426680|FG001|Overall Study|Not treated|1|||
131218848|NCT03332212|472426681|FG002|Overall Study|Not treated|0|||
131218849|NCT03332212|472426682|FG003|Overall Study|Not treated|0|||
131218850|NCT03332212|472426679|FG000|Overall Study|Adverse Event|0|||
131218851|NCT03332212|472426680|FG001|Overall Study|Adverse Event|0|||
131218852|NCT03332212|472426681|FG002|Overall Study|Adverse Event|0|||
131218853|NCT03332212|472426682|FG003|Overall Study|Adverse Event|1|||
131218854|NCT03332212|472426679|FG000|Overall Study|worsening of disease under study|1|||
131218855|NCT03332212|472426680|FG001|Overall Study|worsening of disease under study|1|||
131218856|NCT03332212|472426681|FG002|Overall Study|worsening of disease under study|0|||
131218857|NCT03332212|472426682|FG003|Overall Study|worsening of disease under study|0|||
131218858|NCT02125734|472426686|FG000|Period 2|Adverse Event|0|||
131218859|NCT02125734|472426687|FG001|Period 2|Adverse Event|1|||
131218860|NCT01308762|472426688|FG000|Overall Study|Protocol Violation|0|||
131218861|NCT01308762|472426689|FG001|Overall Study|Protocol Violation|1|||
131218862|NCT01308762|472426690|FG002|Overall Study|Protocol Violation|0|||
131218863|NCT01216319|472426696|FG000|Overall Study|Lost to Follow-up|2|||
131218864|NCT01216319|472426696|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
131218865|NCT00929864|472426700|FG000|Overall Study|Death|1|||
131218866|NCT00929864|472426701|FG001|Overall Study|Death|1|||
131218867|NCT00929864|472426700|FG000|Overall Study|Adverse Event|11|||
131218868|NCT00929864|472426701|FG001|Overall Study|Adverse Event|30|||
131218869|NCT00929864|472426700|FG000|Overall Study|Lack of Efficacy|19|||
131218870|NCT00929864|472426701|FG001|Overall Study|Lack of Efficacy|16|||
131218871|NCT00929864|472426700|FG000|Overall Study|Lost to Follow-up|7|||
131218872|NCT00929864|472426701|FG001|Overall Study|Lost to Follow-up|12|||
131218873|NCT00929864|472426700|FG000|Overall Study|Withdrawal by Subject|20|||
131218874|NCT00929864|472426701|FG001|Overall Study|Withdrawal by Subject|9|||
131218875|NCT00929864|472426700|FG000|Overall Study|No longer met criteria|2|||
131218876|NCT00929864|472426701|FG001|Overall Study|No longer met criteria|1|||
131218877|NCT00929864|472426700|FG000|Overall Study|Poor or non-compliance|3|||
131218878|NCT00929864|472426701|FG001|Overall Study|Poor or non-compliance|3|||
131218879|NCT00929864|472426700|FG000|Overall Study|Pregnancy|0|||
131218880|NCT00929864|472426701|FG001|Overall Study|Pregnancy|3|||
131218881|NCT00929864|472426700|FG000|Overall Study|Administrative reason by Sponsor|1|||
131218882|NCT00929864|472426701|FG001|Overall Study|Administrative reason by Sponsor|1|||
131218883|NCT00929864|472426700|FG000|Overall Study|Non-specified|2|||
131218884|NCT00929864|472426701|FG001|Overall Study|Non-specified|7|||
131218885|NCT02304302|472426706|FG000|Overall Study|Adverse Event|2|||
131218886|NCT02304302|472426707|FG001|Overall Study|Adverse Event|3|||
131218887|NCT02304302|472426706|FG000|Overall Study|Lost to Follow-up|1|||
131218888|NCT02304302|472426707|FG001|Overall Study|Lost to Follow-up|4|||
131218889|NCT02304302|472426706|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
131218890|NCT02304302|472426707|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
131218891|NCT00391118|472426708|FG000|Overall Study|Adverse Event|3|||
131218892|NCT00391118|472426709|FG001|Overall Study|Adverse Event|10|||
131218893|NCT00391118|472426710|FG002|Overall Study|Adverse Event|7|||
131218894|NCT00391118|472426708|FG000|Overall Study|Lost to Follow-up|0|||
131218895|NCT00391118|472426709|FG001|Overall Study|Lost to Follow-up|2|||
131218896|NCT00391118|472426710|FG002|Overall Study|Lost to Follow-up|3|||
131218897|NCT00391118|472426708|FG000|Overall Study|Withdrawal by Subject|0|||
131218898|NCT00391118|472426709|FG001|Overall Study|Withdrawal by Subject|9|||
131218899|NCT00391118|472426710|FG002|Overall Study|Withdrawal by Subject|1|||
131218900|NCT00391118|472426708|FG000|Overall Study|Death|0|||
131218901|NCT00391118|472426709|FG001|Overall Study|Death|1|||
131218902|NCT00391118|472426710|FG002|Overall Study|Death|0|||
131218903|NCT00391118|472426708|FG000|Overall Study|Physician Decision|0|||
131218904|NCT00391118|472426709|FG001|Overall Study|Physician Decision|3|||
131218905|NCT00391118|472426710|FG002|Overall Study|Physician Decision|0|||
131218906|NCT00391118|472426708|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
131218907|NCT00391118|472426709|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
131218908|NCT00391118|472426710|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
131218909|NCT00391118|472426708|FG000|Overall Study|Progressive Disease|7|||
131218910|NCT00391118|472426709|FG001|Overall Study|Progressive Disease|26|||
131218911|NCT00391118|472426710|FG002|Overall Study|Progressive Disease|43|||
131218912|NCT00391118|472426708|FG000|Overall Study|Sponsor Decision|0|||
131218913|NCT00391118|472426709|FG001|Overall Study|Sponsor Decision|1|||
131218914|NCT00391118|472426710|FG002|Overall Study|Sponsor Decision|3|||
131218915|NCT00391118|472426708|FG000|Overall Study|Protocol Violation|1|||
131218916|NCT00391118|472426709|FG001|Overall Study|Protocol Violation|0|||
131218917|NCT00391118|472426710|FG002|Overall Study|Protocol Violation|0|||
131218918|NCT05473247|472426711|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
131218919|NCT02392559|472426712|FG000|Overall Study|Withdrawal by Subject|0|||
131218920|NCT02392559|472426713|FG001|Overall Study|Withdrawal by Subject|1|||
131218921|NCT03078192|472426715|FG000|Overall Study|Withdrawal by Subject|2|||
131218922|NCT03078192|472426716|FG001|Overall Study|Withdrawal by Subject|1|||
131218923|NCT03078192|472426715|FG000|Overall Study|screen failure|0|||
131218924|NCT03078192|472426716|FG001|Overall Study|screen failure|3|||
131218925|NCT00402779|472426717|FG000|Overall Study|Screen Failure|77|||
131218926|NCT00402779|472426718|FG001|Overall Study|Screen Failure|76|||
131218927|NCT02508649|472426721|FG000|Overall Study|Withdrawal by Subject|4|||
131218928|NCT02508649|472426722|FG001|Overall Study|Withdrawal by Subject|6|||
131218929|NCT02508649|472426723|FG002|Overall Study|Withdrawal by Subject|5|||
131218930|NCT02508649|472426724|FG003|Overall Study|Withdrawal by Subject|6|||
131218931|NCT02508649|472426721|FG000|Overall Study|Investigator withdrew the subject|1|||
131218932|NCT02508649|472426722|FG001|Overall Study|Investigator withdrew the subject|2|||
131218933|NCT02508649|472426723|FG002|Overall Study|Investigator withdrew the subject|1|||
131218934|NCT02508649|472426724|FG003|Overall Study|Investigator withdrew the subject|0|||
131218935|NCT02508649|472426721|FG000|Overall Study|Post randomization screening failure|12|||
131218936|NCT02508649|472426722|FG001|Overall Study|Post randomization screening failure|4|||
131218937|NCT02508649|472426723|FG002|Overall Study|Post randomization screening failure|9|||
131218938|NCT02508649|472426724|FG003|Overall Study|Post randomization screening failure|3|||
131218939|NCT02508649|472426721|FG000|Overall Study|Lost to Follow-up|1|||
131218940|NCT02508649|472426722|FG001|Overall Study|Lost to Follow-up|1|||
131218941|NCT02508649|472426723|FG002|Overall Study|Lost to Follow-up|0|||
131218942|NCT02508649|472426724|FG003|Overall Study|Lost to Follow-up|1|||
131218943|NCT03107715|472426725|FG000|Overall Study|did not deliver at the home hospital|4|||
131218944|NCT03107715|472426726|FG001|Overall Study|did not deliver at the home hospital|6|||
131218945|NCT03107715|472426725|FG000|Overall Study|infant stillborn|0|||
131218946|NCT03107715|472426726|FG001|Overall Study|infant stillborn|1|||
131218947|NCT02149199|472426733|FG000|Overall Study|Study specific withdrawal criteria|4|||
131218948|NCT02149199|472426734|FG001|Overall Study|Study specific withdrawal criteria|21|||
131218949|NCT02149199|472426735|FG002|Overall Study|Study specific withdrawal criteria|6|||
131218950|NCT02149199|472426733|FG000|Overall Study|Other|20|||
131218951|NCT02149199|472426734|FG001|Overall Study|Other|25|||
131218952|NCT02149199|472426735|FG002|Overall Study|Other|20|||
131218953|NCT02149199|472426733|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
131218954|NCT02149199|472426734|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
131218955|NCT02149199|472426735|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
131218956|NCT02149199|472426733|FG000|Overall Study|Withdrawal by Subject|75|||
131218957|NCT02149199|472426734|FG001|Overall Study|Withdrawal by Subject|93|||
131218958|NCT02149199|472426735|FG002|Overall Study|Withdrawal by Subject|77|||
131218959|NCT02149199|472426733|FG000|Overall Study|Protocol Violation|16|||
131218960|NCT02149199|472426734|FG001|Overall Study|Protocol Violation|13|||
131218961|NCT02149199|472426735|FG002|Overall Study|Protocol Violation|15|||
131218962|NCT02149199|472426733|FG000|Overall Study|Lost to Follow-up|3|||
131218963|NCT02149199|472426734|FG001|Overall Study|Lost to Follow-up|12|||
131218964|NCT02149199|472426735|FG002|Overall Study|Lost to Follow-up|11|||
131218965|NCT02149199|472426733|FG000|Overall Study|Death|0|||
131218966|NCT02149199|472426734|FG001|Overall Study|Death|0|||
131218967|NCT02149199|472426735|FG002|Overall Study|Death|1|||
131218968|NCT02149199|472426733|FG000|Overall Study|Adverse Event|6|||
131218969|NCT02149199|472426734|FG001|Overall Study|Adverse Event|15|||
131218970|NCT02149199|472426735|FG002|Overall Study|Adverse Event|9|||
131218971|NCT03594175|472426737|FG000|Overall Study|Not treated|8|||
131218972|NCT03594175|472426738|FG001|Overall Study|Not treated|1|||
131218973|NCT03594175|472426739|FG002|Overall Study|Not treated|5|||
130992832|NCT00603265|471601640|FG002|Overall Study|Withdrawal by Subject|1|||
130992833|NCT00603265|471601638|FG000|Overall Study|Lack of Efficacy|3|||
130992834|NCT00603265|471601639|FG001|Overall Study|Lack of Efficacy|0|||
130992835|NCT00603265|471601640|FG002|Overall Study|Lack of Efficacy|3|||
130992836|NCT00603265|471601638|FG000|Overall Study|Lost to Follow-up|0|||
130992837|NCT00603265|471601639|FG001|Overall Study|Lost to Follow-up|1|||
130992838|NCT00603265|471601640|FG002|Overall Study|Lost to Follow-up|0|||
130992839|NCT00603265|471601638|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
130992840|NCT00603265|471601639|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
130992841|NCT00603265|471601640|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
130992842|NCT00603265|471601638|FG000|Overall Study|Participant Left Country, No Responses|0|||
130992843|NCT00603265|471601639|FG001|Overall Study|Participant Left Country, No Responses|1|||
130992844|NCT00603265|471601640|FG002|Overall Study|Participant Left Country, No Responses|0|||
130992845|NCT00603265|471601638|FG000|Overall Study|Protocol Violation|1|||
130992846|NCT00603265|471601639|FG001|Overall Study|Protocol Violation|0|||
130992847|NCT00603265|471601640|FG002|Overall Study|Protocol Violation|0|||
130992848|NCT02966002|471601641|FG000|Overall Study|Withdrawal by Subject|2|||
130992849|NCT02966002|471601641|FG000|Overall Study|Adverse Event|1|||
130992850|NCT02966002|471601641|FG000|Overall Study|Lost to Follow-up|1|||
130992851|NCT02291432|471601644|FG000|Overall Study|Withdrawal by Subject|2|||
130992852|NCT03377790|471601645|FG000|Overall Study|Withdrawal by Subject|1|||
130992853|NCT03377790|471601646|FG001|Overall Study|Withdrawal by Subject|0|||
130992854|NCT03377790|471601645|FG000|Overall Study|Adverse Event|1|||
130992855|NCT03377790|471601646|FG001|Overall Study|Adverse Event|0|||
130992856|NCT03377790|471601645|FG000|Overall Study|Lost to Follow-up|0|||
130992857|NCT03377790|471601646|FG001|Overall Study|Lost to Follow-up|2|||
130992858|NCT03377790|471601645|FG000|Overall Study|Randomized but not treated|1|||
130992859|NCT03377790|471601646|FG001|Overall Study|Randomized but not treated|0|||
130992860|NCT03377790|471601645|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
130992861|NCT03377790|471601646|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
130992862|NCT02145078|471601647|FG000|Overall Study|Death|1|||
130992863|NCT02145078|471601647|FG000|Overall Study|Reason not given|3|||
130992864|NCT03327402|471601648|FG000|Overall Study|Withdrawal by Subject|1|||
130992865|NCT03327402|471601648|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
130992866|NCT02440594|471601652|FG000|Overall Study|Lost to Follow-up|34|||
130992867|NCT02440594|471601653|FG001|Overall Study|Lost to Follow-up|33|||
130992868|NCT02440594|471601654|FG002|Overall Study|Lost to Follow-up|54|||
130992869|NCT02440594|471601655|FG003|Overall Study|Lost to Follow-up|47|||
130992870|NCT02440594|471601656|FG004|Overall Study|Lost to Follow-up|5|||
131218974|NCT03594175|472426737|FG000|Overall Study|Adverse Event|3|||
131218975|NCT03594175|472426738|FG001|Overall Study|Adverse Event|0|||
130882632|NCT03592186|471205555|FG001|Overall Study|Lost to Follow-up|11|||
130882633|NCT00307801|471205558|FG000|Overall Study|Adverse Event|12|||
130882634|NCT00307801|471205559|FG001|Overall Study|Adverse Event|4|||
130882635|NCT00307801|471205558|FG000|Overall Study|Withdrawal by Subject|9|||
130882636|NCT00307801|471205559|FG001|Overall Study|Withdrawal by Subject|4|||
130882637|NCT00307801|471205558|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
130882638|NCT00307801|471205559|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
130882639|NCT00307801|471205558|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
130882640|NCT00307801|471205559|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
130882641|NCT00307801|471205558|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
130882642|NCT00307801|471205559|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
130882643|NCT00307801|471205558|FG000|Overall Study|Wrong Randomization|1|||
130882644|NCT00307801|471205559|FG001|Overall Study|Wrong Randomization|0|||
130882645|NCT00307801|471205558|FG000|Overall Study|Lack of Efficacy|0|||
130882646|NCT00307801|471205559|FG001|Overall Study|Lack of Efficacy|2|||
130882647|NCT00307801|471205558|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
130882648|NCT00307801|471205559|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
130882649|NCT00307801|471205558|FG000|Overall Study|Frustration with e-diary|1|||
130882650|NCT00307801|471205559|FG001|Overall Study|Frustration with e-diary|0|||
130882651|NCT00307801|471205558|FG000|Overall Study|Protocol Violation|3|||
130882652|NCT00307801|471205559|FG001|Overall Study|Protocol Violation|2|||
130882653|NCT00307801|471205558|FG000|Overall Study|No reason specified|2|||
130882654|NCT00307801|471205559|FG001|Overall Study|No reason specified|0|||
130992871|NCT02440594|471601657|FG005|Overall Study|Lost to Follow-up|4|||
130992872|NCT02440594|471601658|FG006|Overall Study|Lost to Follow-up|28|||
130992873|NCT02440594|471601659|FG007|Overall Study|Lost to Follow-up|48|||
130992874|NCT02440594|471601652|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
130992875|NCT02440594|471601653|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
130992876|NCT02440594|471601654|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
130992877|NCT02440594|471601655|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
130992878|NCT02440594|471601656|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
130992879|NCT02440594|471601657|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
131218976|NCT03594175|472426739|FG002|Overall Study|Adverse Event|0|||
130992880|NCT02440594|471601658|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
130992881|NCT02440594|471601659|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
130992882|NCT02440594|471601652|FG000|Overall Study|Withdrawal by Subject|81|||
130992883|NCT02440594|471601653|FG001|Overall Study|Withdrawal by Subject|67|||
130992884|NCT02440594|471601654|FG002|Overall Study|Withdrawal by Subject|59|||
130992885|NCT02440594|471601655|FG003|Overall Study|Withdrawal by Subject|38|||
130992886|NCT02440594|471601656|FG004|Overall Study|Withdrawal by Subject|2|||
130992887|NCT02440594|471601657|FG005|Overall Study|Withdrawal by Subject|2|||
130992888|NCT02440594|471601658|FG006|Overall Study|Withdrawal by Subject|7|||
130992889|NCT02440594|471601659|FG007|Overall Study|Withdrawal by Subject|7|||
130992890|NCT02440594|471601652|FG000|Overall Study|Administratively w/drawn|3|||
130992891|NCT02440594|471601653|FG001|Overall Study|Administratively w/drawn|2|||
130992892|NCT02440594|471601654|FG002|Overall Study|Administratively w/drawn|0|||
130992893|NCT02440594|471601655|FG003|Overall Study|Administratively w/drawn|0|||
130992894|NCT02440594|471601656|FG004|Overall Study|Administratively w/drawn|0|||
130992895|NCT02440594|471601657|FG005|Overall Study|Administratively w/drawn|0|||
130992896|NCT02440594|471601658|FG006|Overall Study|Administratively w/drawn|2|||
130992897|NCT02440594|471601659|FG007|Overall Study|Administratively w/drawn|1|||
130992898|NCT03810313|471601660|FG000|Overall Study|Study terminated by sponsor|164|||
130992899|NCT03810313|471601661|FG001|Overall Study|Study terminated by sponsor|159|||
130992900|NCT03810313|471601660|FG000|Overall Study|Subject decision|10|||
130992901|NCT03810313|471601661|FG001|Overall Study|Subject decision|11|||
130992902|NCT03810313|471601660|FG000|Overall Study|Lost to Follow-up|3|||
130992903|NCT03810313|471601661|FG001|Overall Study|Lost to Follow-up|3|||
130992904|NCT03810313|471601660|FG000|Overall Study|Adverse Event|2|||
130992905|NCT03810313|471601661|FG001|Overall Study|Adverse Event|1|||
130992906|NCT03810313|471601660|FG000|Overall Study|Death|2|||
130992907|NCT03810313|471601661|FG001|Overall Study|Death|1|||
130992908|NCT03810313|471601660|FG000|Overall Study|Physician Decision|0|||
130992909|NCT03810313|471601661|FG001|Overall Study|Physician Decision|1|||
130992910|NCT03029780|471601666|FG000|Overall Study|Disease Progression|20|||
130992911|NCT03029780|471601667|FG001|Overall Study|Disease Progression|22|||
130992912|NCT03029780|471601666|FG000|Overall Study|Study Drug Toxicity|15|||
130992913|NCT03029780|471601667|FG001|Overall Study|Study Drug Toxicity|11|||
130992914|NCT03029780|471601666|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
130992915|NCT03029780|471601667|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130992916|NCT03029780|471601666|FG000|Overall Study|Participant request to discontinue study treatment|4|||
130992917|NCT03029780|471601667|FG001|Overall Study|Participant request to discontinue study treatment|1|||
130992918|NCT03029780|471601666|FG000|Overall Study|Maximum clinical benefit|1|||
130992919|NCT03029780|471601667|FG001|Overall Study|Maximum clinical benefit|0|||
130992920|NCT03029780|471601666|FG000|Overall Study|Participant no longer meets study criteria|0|||
130992921|NCT03029780|471601667|FG001|Overall Study|Participant no longer meets study criteria|1|||
130992922|NCT03029780|471601666|FG000|Overall Study|Other reasons|6|||
130992923|NCT03029780|471601667|FG001|Overall Study|Other reasons|6|||
130992924|NCT03029780|471601666|FG000|Overall Study|Not reported|1|||
130992925|NCT03029780|471601667|FG001|Overall Study|Not reported|1|||
130992926|NCT03029780|471601666|FG000|Overall Study|Death|2|||
130992927|NCT03029780|471601667|FG001|Overall Study|Death|6|||
130992928|NCT03066622|471601668|FG000|Overall Study|Lost to Follow-up|24|||
130992929|NCT03066622|471601669|FG001|Overall Study|Lost to Follow-up|25|||
130992930|NCT03066622|471601668|FG000|Overall Study|Withdrawal by Subject|2|||
130992931|NCT03066622|471601669|FG001|Overall Study|Withdrawal by Subject|1|||
130992932|NCT01111838|471601670|FG000|Overall Study|Patient Ineligible|2|||
130992933|NCT01111838|471601670|FG000|Overall Study|Not Treated|3|||
130992934|NCT01111838|471601670|FG000|Overall Study|Clinical deterioration|1|||
130992935|NCT01111838|471601670|FG000|Overall Study|Other Complicating Disease|1|||
130992936|NCT00641719|471601671|FG000|Overall Study|Lack of Efficacy|1|||
130992937|NCT00641719|471601672|FG001|Overall Study|Lack of Efficacy|2|||
130992938|NCT00641719|471601671|FG000|Overall Study|Adverse Event|24|||
130992939|NCT00641719|471601672|FG001|Overall Study|Adverse Event|29|||
130992940|NCT00641719|471601671|FG000|Overall Study|Withdrawal by Subject|4|||
130992941|NCT00641719|471601672|FG001|Overall Study|Withdrawal by Subject|4|||
130992942|NCT00641719|471601671|FG000|Overall Study|Reason Not Specified|1|||
130992943|NCT00641719|471601672|FG001|Overall Study|Reason Not Specified|2|||
130992944|NCT03303469|471601673|FG000|Overall Study|Lost to Follow-up|2|||
130992945|NCT03101241|471601676|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
130992946|NCT03101241|471601677|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
130992947|NCT03101241|471601676|FG000|Overall Study|Participant withdrew consent|3|||
130992948|NCT03101241|471601677|FG001|Overall Study|Participant withdrew consent|1|||
130992949|NCT03101241|471601676|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
130992950|NCT03101241|471601677|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
130992951|NCT03101241|471601676|FG000|Overall Study|Lost to Follow-up|2|||
130992952|NCT03101241|471601677|FG001|Overall Study|Lost to Follow-up|0|||
130992953|NCT03101241|471601676|FG000|Overall Study|Lack of Efficacy|0|||
130992954|NCT03101241|471601677|FG001|Overall Study|Lack of Efficacy|1|||
130992955|NCT03101241|471601676|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
130992956|NCT03101241|471601677|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
130992957|NCT04498247|471601678|FG000|Overall Study|Lost to Follow-up|0|||
130992958|NCT04498247|471601679|FG001|Overall Study|Lost to Follow-up|0|||
130992959|NCT04498247|471601680|FG002|Overall Study|Lost to Follow-up|0|||
130992960|NCT04498247|471601681|FG003|Overall Study|Lost to Follow-up|1|||
130992961|NCT04498247|471601682|FG004|Overall Study|Lost to Follow-up|0|||
130992962|NCT04498247|471601683|FG005|Overall Study|Lost to Follow-up|0|||
130992963|NCT04498247|471601684|FG006|Overall Study|Lost to Follow-up|0|||
130992964|NCT04498247|471601685|FG007|Overall Study|Lost to Follow-up|0|||
130992965|NCT04498247|471601678|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
130992966|NCT04498247|471601679|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
130992967|NCT04498247|471601680|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
130992968|NCT04498247|471601681|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
130992969|NCT04498247|471601682|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
130992970|NCT04498247|471601683|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
130992971|NCT04498247|471601684|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
130992972|NCT04498247|471601685|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
130992973|NCT04498247|471601678|FG000|Overall Study|Withdrawal by Subject|0|||
130992974|NCT04498247|471601679|FG001|Overall Study|Withdrawal by Subject|8|||
130992975|NCT04498247|471601680|FG002|Overall Study|Withdrawal by Subject|0|||
130992976|NCT04498247|471601681|FG003|Overall Study|Withdrawal by Subject|7|||
130992977|NCT04498247|471601682|FG004|Overall Study|Withdrawal by Subject|0|||
130992978|NCT04498247|471601683|FG005|Overall Study|Withdrawal by Subject|0|||
130992979|NCT04498247|471601684|FG006|Overall Study|Withdrawal by Subject|1|||
130992980|NCT04498247|471601685|FG007|Overall Study|Withdrawal by Subject|0|||
130992981|NCT04498247|471601678|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
130992982|NCT04498247|471601679|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
130992983|NCT04498247|471601680|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
130992984|NCT04498247|471601681|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
130992985|NCT04498247|471601682|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
130992986|NCT04498247|471601683|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
130992987|NCT04498247|471601684|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
130992988|NCT04498247|471601685|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
130992989|NCT03469349|471601686|FG000|Overall Study|Withdrawal by Subject|1|||
130992990|NCT03469349|471601687|FG001|Overall Study|Withdrawal by Subject|3|||
130992991|NCT03469349|471601686|FG000|Overall Study|Progressive Disease|0|||
130992992|NCT03469349|471601687|FG001|Overall Study|Progressive Disease|1|||
130992993|NCT03469349|471601686|FG000|Overall Study|Lost to Follow-up|2|||
130992994|NCT03469349|471601687|FG001|Overall Study|Lost to Follow-up|2|||
130992995|NCT03469349|471601686|FG000|Overall Study|Adverse Event|2|||
130992996|NCT03469349|471601687|FG001|Overall Study|Adverse Event|4|||
130992997|NCT00879996|471601689|FG000|Overall Study|Lost to Follow-up|7|||
130992998|NCT00879996|471601690|FG001|Overall Study|Lost to Follow-up|6|||
130992999|NCT00879996|471601689|FG000|Overall Study|non-compliance|6|||
130993000|NCT00879996|471601690|FG001|Overall Study|non-compliance|4|||
130993001|NCT00879996|471601689|FG000|Overall Study|Physician Decision|1|||
130993002|NCT00879996|471601690|FG001|Overall Study|Physician Decision|2|||
130993003|NCT00879996|471601689|FG000|Overall Study|psychiatric problem|0|||
131218977|NCT03594175|472426737|FG000|Overall Study|Withdrawal by Subject|3|||
131218978|NCT03594175|472426738|FG001|Overall Study|Withdrawal by Subject|0|||
131218979|NCT03594175|472426739|FG002|Overall Study|Withdrawal by Subject|0|||
131218980|NCT03594175|472426737|FG000|Overall Study|Protocol Violation|2|||
131218981|NCT03594175|472426738|FG001|Overall Study|Protocol Violation|2|||
131218982|NCT03594175|472426739|FG002|Overall Study|Protocol Violation|2|||
131218983|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131218984|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131218985|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131218986|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
131218987|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
131218988|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131218989|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131218990|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131218991|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131218992|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
131218993|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131218994|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131218995|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
131218996|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
131218997|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130993004|NCT00879996|471601690|FG001|Overall Study|psychiatric problem|1|||
130993005|NCT00879996|471601689|FG000|Overall Study|put on parole|1|||
130993006|NCT00879996|471601690|FG001|Overall Study|put on parole|0|||
130993007|NCT02912468|471601695|FG000|Overall Study|Adverse Event|3|||
130993008|NCT02912468|471601696|FG001|Overall Study|Adverse Event|2|||
130993009|NCT02912468|471601695|FG000|Overall Study|Withdrawal by Subject|6|||
130993010|NCT02912468|471601696|FG001|Overall Study|Withdrawal by Subject|2|||
130993011|NCT02912468|471601695|FG000|Overall Study|Randomized and not treated|0|||
130993012|NCT02912468|471601696|FG001|Overall Study|Randomized and not treated|1|||
130993013|NCT02597933|471601698|FG000|Overall Study|Withdrawal by Subject|7|||
130993014|NCT02597933|471601699|FG001|Overall Study|Withdrawal by Subject|5|||
130993015|NCT02597933|471601698|FG000|Overall Study|Protocol Violation|2|||
130993016|NCT02597933|471601699|FG001|Overall Study|Protocol Violation|2|||
130993017|NCT02597933|471601698|FG000|Overall Study|Adverse Event|20|||
130993018|NCT02597933|471601699|FG001|Overall Study|Adverse Event|28|||
130993019|NCT02597933|471601698|FG000|Overall Study|Not treated|2|||
130993020|NCT02597933|471601699|FG001|Overall Study|Not treated|2|||
130993021|NCT02597933|471601698|FG000|Overall Study|Other than stated above|7|||
130993022|NCT02597933|471601699|FG001|Overall Study|Other than stated above|14|||
130993023|NCT01320735|471601702|FG000|Overall Study|Adverse Event|3|||
130993024|NCT01320735|471601702|FG000|Overall Study|Withdrawal by Subject|3|||
130993025|NCT01320735|471601702|FG000|Overall Study|Lost to Follow-up|13|||
130993026|NCT01320735|471601702|FG000|Overall Study|Administrative Reason|6|||
130993027|NCT01320735|471601702|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
130993028|NCT01320735|471601702|FG000|Overall Study|Protocol Violation|1|||
130993029|NCT01320735|471601702|FG000|Overall Study|Other|1|||
130993030|NCT01320735|471601702|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
130993031|NCT01320735|471601702|FG000|Overall Study|Investigator Unable to be Contacted|17|||
130993032|NCT01913639|471601705|FG000|Overall Study|Not Eligible|3|||
130993033|NCT01225822|471601715|FG000|Overall Study|Adverse Event|13|||
130993034|NCT01225822|471601716|FG001|Overall Study|Adverse Event|31|||
130993035|NCT01225822|471601717|FG002|Overall Study|Adverse Event|18|||
130993036|NCT01225822|471601718|FG003|Overall Study|Adverse Event|23|||
130993037|NCT01225822|471601719|FG004|Overall Study|Adverse Event|14|||
130993038|NCT01225822|471601715|FG000|Overall Study|Protocol Violation|6|||
130993039|NCT01225822|471601716|FG001|Overall Study|Protocol Violation|8|||
130993040|NCT01225822|471601717|FG002|Overall Study|Protocol Violation|6|||
130993041|NCT01225822|471601718|FG003|Overall Study|Protocol Violation|7|||
130993042|NCT01225822|471601719|FG004|Overall Study|Protocol Violation|4|||
131218998|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
131218999|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
131219000|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
131219001|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
131219002|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219003|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219004|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219005|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219006|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219007|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
131219008|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219009|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219010|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219011|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
131219012|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219013|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219014|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
131219015|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
131219016|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
131219017|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
131219018|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
131219019|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
131219020|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130993043|NCT01225822|471601715|FG000|Overall Study|Lost to Follow-up|0|||
130993044|NCT01225822|471601716|FG001|Overall Study|Lost to Follow-up|0|||
130993045|NCT01225822|471601717|FG002|Overall Study|Lost to Follow-up|0|||
130993046|NCT01225822|471601718|FG003|Overall Study|Lost to Follow-up|1|||
130993047|NCT01225822|471601719|FG004|Overall Study|Lost to Follow-up|0|||
131219021|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
130993048|NCT01225822|471601715|FG000|Overall Study|Withdrawal by Subject|6|||
130993049|NCT01225822|471601716|FG001|Overall Study|Withdrawal by Subject|7|||
130993050|NCT01225822|471601717|FG002|Overall Study|Withdrawal by Subject|7|||
130993051|NCT01225822|471601718|FG003|Overall Study|Withdrawal by Subject|11|||
130993052|NCT01225822|471601719|FG004|Overall Study|Withdrawal by Subject|6|||
130993053|NCT01225822|471601715|FG000|Overall Study|Other|13|||
130993054|NCT01225822|471601716|FG001|Overall Study|Other|10|||
130993055|NCT01225822|471601717|FG002|Overall Study|Other|7|||
130993056|NCT01225822|471601718|FG003|Overall Study|Other|10|||
130993057|NCT01225822|471601719|FG004|Overall Study|Other|7|||
130993058|NCT01290822|471601720|FG000|Overall Study|Withdrawal by Subject|1|||
130993059|NCT01290822|471601720|FG000|Overall Study|Physician Decision|10|||
130993060|NCT02223754|471601724|FG000|Period 1|Adverse Event|1|||
130993061|NCT02223754|471601725|FG001|Period 1|Adverse Event|0|||
130993062|NCT02223754|471601724|FG000|Period 1|Lost to Follow-up|0|||
130993063|NCT02223754|471601725|FG001|Period 1|Lost to Follow-up|1|||
130993064|NCT02223754|471601724|FG000|Period 1|Protocol Violation|2|||
130993065|NCT02223754|471601725|FG001|Period 1|Protocol Violation|4|||
130993066|NCT02223754|471601724|FG000|Period 1|Withdrawal by Subject|0|||
130993067|NCT02223754|471601725|FG001|Period 1|Withdrawal by Subject|4|||
130993068|NCT02223754|471601724|FG000|Period 1|Test Article No Longer Available|1|||
130993069|NCT02223754|471601725|FG001|Period 1|Test Article No Longer Available|5|||
130993070|NCT02223754|471601724|FG000|Period 1|Unsatisfactory Visual Response|0|||
130993071|NCT02223754|471601725|FG001|Period 1|Unsatisfactory Visual Response|1|||
130993072|NCT02223754|471601724|FG000|Period 2|Adverse Event|0|||
130993073|NCT02223754|471601725|FG001|Period 2|Adverse Event|1|||
130993074|NCT02223754|471601724|FG000|Period 2|Protocol Violation|1|||
130993075|NCT02223754|471601725|FG001|Period 2|Protocol Violation|0|||
130993076|NCT02223754|471601724|FG000|Period 2|Lens Discomfort|1|||
130993077|NCT02223754|471601725|FG001|Period 2|Lens Discomfort|1|||
130993078|NCT02223754|471601724|FG000|Period 2|Lost to Follow-up|1|||
130993079|NCT02223754|471601725|FG001|Period 2|Lost to Follow-up|0|||
130993080|NCT02223754|471601724|FG000|Period 2|Test Article No Longer Available|0|||
130993081|NCT02223754|471601725|FG001|Period 2|Test Article No Longer Available|1|||
130993082|NCT04395183|471601726|FG000|Overall Study|Withdrawal by Subject|1|||
130993083|NCT04395183|471601727|FG001|Overall Study|Withdrawal by Subject|0|||
130993084|NCT04395183|471601728|FG002|Overall Study|Withdrawal by Subject|2|||
130993085|NCT04395183|471601729|FG003|Overall Study|Withdrawal by Subject|2|||
130993086|NCT01693692|471601733|FG000|Overall Study|Withdrawal by Subject|12|||
130993087|NCT01693692|471601734|FG001|Overall Study|Withdrawal by Subject|10|||
130993088|NCT01693692|471601735|FG002|Overall Study|Withdrawal by Subject|11|||
130993089|NCT01693692|471601733|FG000|Overall Study|Adverse Event|7|||
130993090|NCT01693692|471601734|FG001|Overall Study|Adverse Event|14|||
130993091|NCT01693692|471601735|FG002|Overall Study|Adverse Event|9|||
130993092|NCT01693692|471601733|FG000|Overall Study|Physician Decision|0|||
130993093|NCT01693692|471601734|FG001|Overall Study|Physician Decision|0|||
130993094|NCT01693692|471601735|FG002|Overall Study|Physician Decision|1|||
130993095|NCT01693692|471601733|FG000|Overall Study|Protocol Violation|5|||
130993096|NCT01693692|471601734|FG001|Overall Study|Protocol Violation|4|||
130993097|NCT01693692|471601735|FG002|Overall Study|Protocol Violation|6|||
130993098|NCT01693692|471601733|FG000|Overall Study|Lost to Follow-up|2|||
130993099|NCT01693692|471601734|FG001|Overall Study|Lost to Follow-up|2|||
130993100|NCT01693692|471601735|FG002|Overall Study|Lost to Follow-up|3|||
130993101|NCT01693692|471601733|FG000|Overall Study|Other|4|||
130993102|NCT01693692|471601734|FG001|Overall Study|Other|4|||
130993103|NCT01693692|471601735|FG002|Overall Study|Other|6|||
130993104|NCT04567693|471603682|FG000|Overall Study|Death|0|||
130993105|NCT04567693|471603683|FG001|Overall Study|Death|0|||
130993106|NCT04567693|471603684|FG002|Overall Study|Death|2|||
130993107|NCT04567693|471603682|FG000|Overall Study|Lost to Follow-up|1|||
130993108|NCT04567693|471603683|FG001|Overall Study|Lost to Follow-up|0|||
130993109|NCT04567693|471603684|FG002|Overall Study|Lost to Follow-up|2|||
130993110|NCT04567693|471603682|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
130993111|NCT04567693|471603683|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
130993112|NCT04567693|471603684|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
130993113|NCT03722264|471603685|FG000|Overall Study|Physician Decision|3|||
130993114|NCT02959671|471603686|FG000|Overall Study|Adverse Event|2|||
130993115|NCT02959671|471603686|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
130993116|NCT03462706|471603689|FG000|Overall Study|Polyp was pedunculated|1|||
130993117|NCT03462706|471603690|FG001|Overall Study|Polyp was pedunculated|0|||
130993118|NCT03462706|471603691|FG002|Overall Study|Polyp was pedunculated|1|||
130993119|NCT03462706|471603692|FG003|Overall Study|Polyp was pedunculated|0|||
130993120|NCT03462706|471603689|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
130993121|NCT03462706|471603690|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
130993122|NCT03462706|471603691|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
130993123|NCT03462706|471603692|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
130993124|NCT04105972|471603697|FG000|Overall Study|Adverse Event|2|||
130993125|NCT04105972|471603698|FG001|Overall Study|Adverse Event|1|||
130993126|NCT00553202|471603703|FG000|Overall Study|Death|16|||
130993127|NCT00553202|471603703|FG000|Overall Study|Lost to Follow-up|1|||
130993128|NCT00553202|471603703|FG000|Overall Study|Physician Decision|28|||
130993129|NCT00553202|471603703|FG000|Overall Study|Withdrawal by Subject|1|||
130993130|NCT00553202|471603703|FG000|Overall Study|No donor identified|16|||
130993131|NCT00553202|471603703|FG000|Overall Study|Fails to meet organ function|6|||
130993132|NCT02593305|471603706|FG000|Post 1|Comparison only group. No intervention.|0|||
130993133|NCT02593305|471603707|FG001|Post 1|Comparison only group. No intervention.|0|||
130993134|NCT02593305|471603708|FG002|Post 1|Comparison only group. No intervention.|10|||
130993135|NCT01190215|471603709|FG000|Up to Month 6|Lost to Follow-up|2|||
130993136|NCT01190215|471603710|FG001|Up to Month 6|Lost to Follow-up|0|||
130993137|NCT01161472|471603712|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
130993138|NCT01161472|471603713|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
130993139|NCT01161472|471603714|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
130993140|NCT01161472|471603715|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
130993141|NCT00768430|471603735|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
130993142|NCT00768430|471603736|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
130993143|NCT02002884|471603743|FG000|Main Period (MP)|Other|0|||
130993144|NCT02002884|471603744|FG001|Main Period (MP)|Other|3|||
130993145|NCT02002884|471603745|FG002|Main Period (MP)|Other|3|||
130993146|NCT02002884|471603746|FG003|Main Period (MP)|Other|0|||
130993147|NCT02002884|471603743|FG000|Main Period (MP)|Adverse Event|0|||
130993148|NCT02002884|471603744|FG001|Main Period (MP)|Adverse Event|1|||
130993149|NCT02002884|471603745|FG002|Main Period (MP)|Adverse Event|1|||
130993150|NCT02002884|471603746|FG003|Main Period (MP)|Adverse Event|0|||
130993151|NCT02002884|471603743|FG000|Main Period (MP)|Withdrawal by Subject|6|||
130993152|NCT02002884|471603744|FG001|Main Period (MP)|Withdrawal by Subject|2|||
130993153|NCT02002884|471603745|FG002|Main Period (MP)|Withdrawal by Subject|2|||
130993154|NCT02002884|471603746|FG003|Main Period (MP)|Withdrawal by Subject|0|||
130993155|NCT02002884|471603743|FG000|Main Period (MP)|Lost to Follow-up|0|||
130993156|NCT02002884|471603744|FG001|Main Period (MP)|Lost to Follow-up|0|||
130993157|NCT02002884|471603745|FG002|Main Period (MP)|Lost to Follow-up|2|||
130993158|NCT02002884|471603746|FG003|Main Period (MP)|Lost to Follow-up|0|||
130993159|NCT02002884|471603743|FG000|Open-Label Extension Period (OLEX)|Other|0|||
130993160|NCT02002884|471603744|FG001|Open-Label Extension Period (OLEX)|Other|0|||
130993161|NCT02002884|471603745|FG002|Open-Label Extension Period (OLEX)|Other|0|||
130993162|NCT02002884|471603746|FG003|Open-Label Extension Period (OLEX)|Other|24|||
130993163|NCT02002884|471603743|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
130993164|NCT02002884|471603744|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
130993165|NCT02002884|471603745|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
130993166|NCT02002884|471603746|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
130993167|NCT02002884|471603743|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
130993168|NCT02002884|471603744|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
130993169|NCT02002884|471603745|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
130993170|NCT02002884|471603746|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
130993171|NCT02002884|471603743|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
130993172|NCT02002884|471603744|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
130993173|NCT02002884|471603745|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
130993174|NCT02002884|471603746|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
130993175|NCT02002884|471603743|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
130993176|NCT02002884|471603744|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
130993177|NCT02002884|471603745|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
130993178|NCT02002884|471603746|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
130993179|NCT01642602|471603747|FG000|Overall Study|Adverse Event|2|||
130993180|NCT02632786|471603748|FG000|Overall Study|Adverse Event|2|||
130993181|NCT02632786|471603749|FG001|Overall Study|Adverse Event|1|||
130993182|NCT02632786|471603748|FG000|Overall Study|Death|3|||
130993183|NCT02632786|471603749|FG001|Overall Study|Death|2|||
130993184|NCT02632786|471603748|FG000|Overall Study|Physician Decision|5|||
130993185|NCT02632786|471603749|FG001|Overall Study|Physician Decision|4|||
130993186|NCT02632786|471603748|FG000|Overall Study|Withdrawal by Subject|1|||
130993187|NCT02632786|471603749|FG001|Overall Study|Withdrawal by Subject|0|||
130993188|NCT01928225|471603750|FG000|Overall Study|Pregnancy|1|||
130993189|NCT01928225|471603751|FG001|Overall Study|Pregnancy|0|||
130993190|NCT01928225|471603750|FG000|Overall Study|basaloid cervical cancer|1|||
130993191|NCT01928225|471603751|FG001|Overall Study|basaloid cervical cancer|0|||
130993192|NCT01928225|471603750|FG000|Overall Study|Lost to Follow-up|1|||
131219022|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219023|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130765860|NCT03482167|470765888|FG001|Allocated to Intervention|Physician Decision|2|||
130993193|NCT01928225|471603751|FG001|Overall Study|Lost to Follow-up|3|||
130993194|NCT00474175|471603753|FG000|Overall Study|Lack of Efficacy|0|||
130993195|NCT00474175|471603754|FG001|Overall Study|Lack of Efficacy|0|||
130993196|NCT00474175|471603755|FG002|Overall Study|Lack of Efficacy|1|||
130993197|NCT00474175|471603753|FG000|Overall Study|Withdrawal by Subject|0|||
130993198|NCT00474175|471603754|FG001|Overall Study|Withdrawal by Subject|1|||
130993199|NCT00474175|471603755|FG002|Overall Study|Withdrawal by Subject|1|||
130993200|NCT00474175|471603753|FG000|Overall Study|Ineligible|1|||
130993201|NCT00474175|471603754|FG001|Overall Study|Ineligible|3|||
130993202|NCT00474175|471603755|FG002|Overall Study|Ineligible|1|||
130993203|NCT00474175|471603753|FG000|Overall Study|Protocol Violation|0|||
130993204|NCT00474175|471603754|FG001|Overall Study|Protocol Violation|2|||
130993205|NCT00474175|471603755|FG002|Overall Study|Protocol Violation|1|||
130993206|NCT00474175|471603753|FG000|Overall Study|Administrative|0|||
130993207|NCT00474175|471603754|FG001|Overall Study|Administrative|1|||
130993208|NCT00474175|471603755|FG002|Overall Study|Administrative|0|||
130993209|NCT01460160|471603757|FG000|Treatment Phase|Lack of Efficacy|3|||
130993210|NCT01460160|471603757|FG000|Treatment Phase|Study Drug Toxicity|2|||
130993211|NCT01460160|471603757|FG000|Treatment Phase|Adverse Event|8|||
130993212|NCT01460160|471603757|FG000|Treatment Phase|Withdrawal by Subject|4|||
130993213|NCT01460160|471603757|FG000|Treatment Phase|Death|2|||
130993214|NCT01460160|471603757|FG000|Treatment Phase|Other reasons|9|||
130993215|NCT01460160|471603757|FG000|Follow-up Phase|Withdrawal by Subject|4|||
130993216|NCT01460160|471603757|FG000|Follow-up Phase|Death|14|||
130993217|NCT01460160|471603757|FG000|Follow-up Phase|Lost to Follow-up|7|||
130993218|NCT01460160|471603757|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
130993219|NCT01460160|471603757|FG000|Follow-up Phase|Other and not reported reasons|5|||
130993220|NCT02091739|471603759|FG000|MP: 16 Weeks|Adverse Event|1|||
130993221|NCT02091739|471603760|FG001|MP: 16 Weeks|Adverse Event|1|||
130993222|NCT02091739|471603761|FG002|MP: 16 Weeks|Adverse Event|1|||
130993223|NCT02091739|471603762|FG003|MP: 16 Weeks|Adverse Event|0|||
130993224|NCT02091739|471603763|FG004|MP: 16 Weeks|Adverse Event|0|||
130993225|NCT02091739|471603759|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
130993226|NCT02091739|471603760|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
130993227|NCT02091739|471603761|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
130993228|NCT02091739|471603762|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
130993229|NCT02091739|471603763|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
130993230|NCT02091739|471603759|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
130993231|NCT02091739|471603760|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
130993232|NCT02091739|471603761|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
130993233|NCT02091739|471603762|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
130993234|NCT02091739|471603763|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
130993235|NCT02091739|471603759|FG000|EP: 48 Weeks|Other|0|||
130993236|NCT02091739|471603760|FG001|EP: 48 Weeks|Other|0|||
130993237|NCT02091739|471603761|FG002|EP: 48 Weeks|Other|0|||
130993238|NCT02091739|471603762|FG003|EP: 48 Weeks|Other|1|||
130993239|NCT02091739|471603763|FG004|EP: 48 Weeks|Other|0|||
130993240|NCT02091739|471603759|FG000|EP: 48 Weeks|Death|0|||
130993241|NCT02091739|471603760|FG001|EP: 48 Weeks|Death|0|||
130993242|NCT02091739|471603761|FG002|EP: 48 Weeks|Death|0|||
130993243|NCT02091739|471603762|FG003|EP: 48 Weeks|Death|3|||
130993244|NCT02091739|471603763|FG004|EP: 48 Weeks|Death|2|||
130993245|NCT02091739|471603759|FG000|EP: 48 Weeks|Adverse Event|0|||
130993246|NCT02091739|471603760|FG001|EP: 48 Weeks|Adverse Event|0|||
130993247|NCT02091739|471603761|FG002|EP: 48 Weeks|Adverse Event|0|||
130993248|NCT02091739|471603762|FG003|EP: 48 Weeks|Adverse Event|2|||
130993249|NCT02091739|471603763|FG004|EP: 48 Weeks|Adverse Event|6|||
130993250|NCT02091739|471603759|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
130993251|NCT02091739|471603760|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
130993252|NCT02091739|471603761|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
130993253|NCT02091739|471603762|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
130993254|NCT02091739|471603763|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
130993255|NCT00192023|471603764|FG000|Period III - Double-Blind|Adverse Event|3|||
130993256|NCT00192023|471603765|FG001|Period III - Double-Blind|Adverse Event|0|||
130993257|NCT00192023|471603764|FG000|Period III - Double-Blind|Physician Decision|2|||
130993258|NCT00192023|471603765|FG001|Period III - Double-Blind|Physician Decision|0|||
130993259|NCT00192023|471603764|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
131219024|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219025|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219026|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
131219027|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219028|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219029|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219030|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219031|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219032|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219033|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130993260|NCT00192023|471603765|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
130993261|NCT00192023|471603764|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
130993262|NCT00192023|471603765|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
130993263|NCT00192023|471603764|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
130993264|NCT00192023|471603765|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
130993265|NCT00192023|471603764|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
130993266|NCT00192023|471603765|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
130993267|NCT00192023|471603764|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
130993268|NCT00192023|471603765|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
131219034|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219035|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
131219036|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219037|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219038|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
131219039|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
131219040|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219041|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219042|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219043|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219044|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219045|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219046|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219047|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219048|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219049|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219050|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
131219051|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219052|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219053|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
131219054|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219055|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219056|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
131219057|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
131219058|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
131219059|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
131219060|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
131219061|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131219062|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
131219063|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131219064|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131219065|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
131219066|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131219067|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131219068|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131219069|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
131219070|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
131219071|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
131219072|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
131219073|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
131219074|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
131219075|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
131219076|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
131219077|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130882655|NCT00307801|471205558|FG000|Overall Study|Pregnancy|0|||
130882656|NCT00307801|471205559|FG001|Overall Study|Pregnancy|1|||
131219078|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131219079|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131219080|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
131219081|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131219082|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131219083|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131219084|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131219085|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131219086|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131219087|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131219088|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131219089|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130882657|NCT00551642|471205562|FG000|Treatment Period|Protocol Deviation|6|||
131219090|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131219091|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131219092|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131219093|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
131219094|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
131219095|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
131219096|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
131219097|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219098|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219099|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219100|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219101|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
131219102|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219103|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219104|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219105|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219106|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
131219107|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219108|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219109|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219110|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219111|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219112|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219113|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219114|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219115|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
131219116|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
131219117|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131219118|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131219119|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131219120|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131219121|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
131219122|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131219123|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131219124|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131219125|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131219126|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
131219127|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131219128|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131219129|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
131219130|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
131219131|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
131219132|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
131219133|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
131219134|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
131219135|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219136|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219137|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219138|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219139|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219140|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219141|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219142|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219143|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219144|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219145|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
131219146|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219147|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219148|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219149|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219150|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219151|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219152|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219153|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
131219154|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
131219155|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
131219156|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130993269|NCT00192023|471603764|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
130993270|NCT00192023|471603765|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
130993271|NCT00192023|471603764|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
130993272|NCT00192023|471603765|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
130993273|NCT00192023|471603764|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
130993274|NCT00192023|471603765|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
131219157|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131219158|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
131219159|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
131219160|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131219161|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
131219162|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131219163|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
131219164|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131219165|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131219166|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
131219167|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
131219168|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
131219169|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
131219170|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
131219171|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
131219172|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
131219173|NCT01915498|472426740|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
131219174|NCT01915498|472426741|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
131219175|NCT01915498|472426742|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
131219176|NCT01915498|472426743|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
131219177|NCT01915498|472426744|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
131219178|NCT01915498|472426745|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
131219179|NCT01915498|472426746|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
131219180|NCT01915498|472426747|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
131219181|NCT01915498|472426748|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
131219182|NCT01915498|472426749|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
131219183|NCT01915498|472426750|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
131219184|NCT01915498|472426751|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
131219185|NCT01915498|472426752|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
131219186|NCT01915498|472426753|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
131219187|NCT01915498|472426754|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
131219188|NCT01915498|472426755|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
131219189|NCT01915498|472426756|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
131219190|NCT01915498|472426757|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
131219191|NCT01915498|472426758|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
131219192|NCT01915498|472426740|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219193|NCT01915498|472426741|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219194|NCT01915498|472426742|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219195|NCT01915498|472426743|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219196|NCT01915498|472426744|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219197|NCT01915498|472426745|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219198|NCT01915498|472426746|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219199|NCT01915498|472426747|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219200|NCT01915498|472426748|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219201|NCT01915498|472426749|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219202|NCT01915498|472426750|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219203|NCT01915498|472426751|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219204|NCT01915498|472426752|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219205|NCT01915498|472426753|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219206|NCT01915498|472426754|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219207|NCT01915498|472426755|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219208|NCT01915498|472426756|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219209|NCT01915498|472426757|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
131219210|NCT01915498|472426758|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
131219211|NCT01915498|472426740|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219212|NCT01915498|472426741|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219213|NCT01915498|472426742|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130993275|NCT01381874|471603766|FG000|Overall Study|Lost to Follow-up|1|||
131219214|NCT01915498|472426743|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219215|NCT01915498|472426744|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219216|NCT01915498|472426745|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219217|NCT01915498|472426746|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219218|NCT01915498|472426747|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219219|NCT01915498|472426748|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219220|NCT01915498|472426749|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219221|NCT01915498|472426750|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219222|NCT01915498|472426751|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219223|NCT01915498|472426752|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219224|NCT01915498|472426753|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219225|NCT01915498|472426754|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219226|NCT01915498|472426755|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219227|NCT01915498|472426756|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219228|NCT01915498|472426757|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
131219229|NCT01915498|472426758|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
131219230|NCT01915498|472426740|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219231|NCT01915498|472426741|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219232|NCT01915498|472426742|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219233|NCT01915498|472426743|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219234|NCT01915498|472426744|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219235|NCT01915498|472426745|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219236|NCT01915498|472426746|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219237|NCT01915498|472426747|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219238|NCT01915498|472426748|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219239|NCT01915498|472426749|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219240|NCT01915498|472426750|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219241|NCT01915498|472426751|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219242|NCT01915498|472426752|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219243|NCT01915498|472426753|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219244|NCT01915498|472426754|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219245|NCT01915498|472426755|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219246|NCT01915498|472426756|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219247|NCT01915498|472426757|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
131219248|NCT01915498|472426758|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
131219249|NCT01907516|472426759|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
131219250|NCT01907516|472426760|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
131219251|NCT01907516|472426759|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
130993276|NCT01381874|471603767|FG001|Overall Study|Lost to Follow-up|1|||
130993277|NCT01381874|471603768|FG002|Overall Study|Lost to Follow-up|0|||
130993278|NCT01381874|471603766|FG000|Overall Study|Withdrawal by Subject|9|||
131219252|NCT01907516|472426760|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
131219253|NCT01907516|472426759|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
130993279|NCT01381874|471603767|FG001|Overall Study|Withdrawal by Subject|10|||
130993280|NCT01381874|471603768|FG002|Overall Study|Withdrawal by Subject|9|||
131219254|NCT01907516|472426760|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
131219255|NCT01907516|472426759|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
131219256|NCT01907516|472426760|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
131219257|NCT02395536|472426764|FG000|Overall Study|Lost to Follow-up|4|||
131219258|NCT02395536|472426765|FG001|Overall Study|Lost to Follow-up|4|||
131219259|NCT02395536|472426764|FG000|Overall Study|Death|2|||
131219260|NCT02395536|472426765|FG001|Overall Study|Death|0|||
131219261|NCT02395536|472426764|FG000|Overall Study|Physician Decision|4|||
131219262|NCT02395536|472426765|FG001|Overall Study|Physician Decision|6|||
131219263|NCT02395536|472426764|FG000|Overall Study|Withdrawal by Subject|9|||
131219264|NCT02395536|472426765|FG001|Overall Study|Withdrawal by Subject|17|||
130993281|NCT01381874|471603766|FG000|Overall Study|Other|67|||
130993282|NCT01381874|471603767|FG001|Overall Study|Other|52|||
130993283|NCT01381874|471603768|FG002|Overall Study|Other|67|||
130993284|NCT01737996|471603775|FG000|Overall Study|Adverse Event|0|||
130993285|NCT01737996|471603776|FG001|Overall Study|Adverse Event|1|||
130993286|NCT01737996|471603777|FG002|Overall Study|Adverse Event|1|||
131219265|NCT02395536|472426764|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
130765861|NCT03482167|470765887|FG000|Received Intervention|Adverse Event|3|||
130765862|NCT03482167|470765888|FG001|Received Intervention|Adverse Event|1|||
130993287|NCT01737996|471603775|FG000|Overall Study|Withdrawal by Subject|0|||
130993288|NCT01737996|471603776|FG001|Overall Study|Withdrawal by Subject|0|||
130993289|NCT01737996|471603777|FG002|Overall Study|Withdrawal by Subject|1|||
131219266|NCT02395536|472426765|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
131219267|NCT02395536|472426764|FG000|Overall Study|Insurance issue|0|||
131219268|NCT02395536|472426765|FG001|Overall Study|Insurance issue|1|||
131219269|NCT00891527|472429011|FG000|Overall Study|Withdrawal by Subject|2|||
131219270|NCT01186744|472429012|FG000|Overall Study|Lack of Efficacy|156|||
131219271|NCT01186744|472429013|FG001|Overall Study|Lack of Efficacy|99|||
131219272|NCT01186744|472429014|FG002|Overall Study|Lack of Efficacy|0|||
131219273|NCT01186744|472429015|FG003|Overall Study|Lack of Efficacy|2|||
131219274|NCT01186744|472429016|FG004|Overall Study|Lack of Efficacy|2|||
131219275|NCT01186744|472429017|FG005|Overall Study|Lack of Efficacy|5|||
131219276|NCT01186744|472429012|FG000|Overall Study|Protocol Violation|1|||
131219277|NCT01186744|472429013|FG001|Overall Study|Protocol Violation|2|||
131219278|NCT01186744|472429014|FG002|Overall Study|Protocol Violation|0|||
131219279|NCT01186744|472429015|FG003|Overall Study|Protocol Violation|1|||
131219280|NCT01186744|472429016|FG004|Overall Study|Protocol Violation|1|||
131219281|NCT01186744|472429017|FG005|Overall Study|Protocol Violation|2|||
131219282|NCT01186744|472429012|FG000|Overall Study|Lost to Follow-up|15|||
131219283|NCT01186744|472429013|FG001|Overall Study|Lost to Follow-up|16|||
131219284|NCT01186744|472429014|FG002|Overall Study|Lost to Follow-up|2|||
131219285|NCT01186744|472429015|FG003|Overall Study|Lost to Follow-up|1|||
131219286|NCT01186744|472429016|FG004|Overall Study|Lost to Follow-up|1|||
131219287|NCT01186744|472429017|FG005|Overall Study|Lost to Follow-up|4|||
131219288|NCT01186744|472429012|FG000|Overall Study|Screen failure|1|||
131219289|NCT01186744|472429013|FG001|Overall Study|Screen failure|1|||
131219290|NCT01186744|472429014|FG002|Overall Study|Screen failure|0|||
131219291|NCT01186744|472429015|FG003|Overall Study|Screen failure|1|||
131219292|NCT01186744|472429016|FG004|Overall Study|Screen failure|0|||
131219293|NCT01186744|472429017|FG005|Overall Study|Screen failure|0|||
130882658|NCT00551642|471205563|FG001|Treatment Period|Protocol Deviation|11|||
130882659|NCT00551642|471205562|FG000|Treatment Period|Delivery device failure|1|||
130882660|NCT00551642|471205563|FG001|Treatment Period|Delivery device failure|3|||
130882661|NCT00551642|471205562|FG000|Treatment Period|Physician Decision|0|||
130882662|NCT00551642|471205563|FG001|Treatment Period|Physician Decision|1|||
130882663|NCT00551642|471205562|FG000|Treatment Period|Death|33|||
130882664|NCT00551642|471205563|FG001|Treatment Period|Death|31|||
130882665|NCT00551642|471205562|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
130882666|NCT00551642|471205563|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
130882667|NCT00551642|471205562|FG000|Treatment Period|Adverse Event|15|||
130882668|NCT00551642|471205563|FG001|Treatment Period|Adverse Event|12|||
130882669|NCT00551642|471205562|FG000|Treatment Period|Withdrawal by Subject|2|||
130882670|NCT00551642|471205563|FG001|Treatment Period|Withdrawal by Subject|1|||
130882671|NCT03011099|471205565|FG000|Overall Study|Withdrawal by Subject|0|||
130882672|NCT03011099|471205566|FG001|Overall Study|Withdrawal by Subject|2|||
130882673|NCT00926237|471205573|FG000|Overall Study|Withdrawal by Subject|2|||
130882674|NCT00926237|471205574|FG001|Overall Study|Withdrawal by Subject|1|||
130882675|NCT00632229|471205580|FG000|Overall Study|Adverse Event|6|||
130882676|NCT00632229|471205581|FG001|Overall Study|Adverse Event|0|||
130882677|NCT00632229|471205580|FG000|Overall Study|Lost to Follow-up|0|||
130882678|NCT00632229|471205581|FG001|Overall Study|Lost to Follow-up|3|||
130882679|NCT00632229|471205580|FG000|Overall Study|Lack of Efficacy|0|||
130882680|NCT00632229|471205581|FG001|Overall Study|Lack of Efficacy|2|||
130882681|NCT00632229|471205580|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
130882682|NCT00632229|471205581|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
130882683|NCT02667119|471205586|FG000|Overall Study|Lost to Follow-up|3|||
130882684|NCT02667119|471205587|FG001|Overall Study|Lost to Follow-up|0|||
130882685|NCT03783078|471205588|FG000|Overall Study|Death|31|||
130882686|NCT03783078|471205588|FG000|Overall Study|Sponsor Decision|23|||
130882687|NCT03783078|471205588|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130882688|NCT00474812|471205591|FG000|Overall Study|Withdrawal by Subject|5|||
130882689|NCT00474812|471205591|FG000|Overall Study|No Initiation of treatment|2|||
130882690|NCT00737672|471205598|FG000|Overall Study|Graft Abandonment|48|||
130882691|NCT00737672|471205599|FG001|Overall Study|Graft Abandonment|56|||
131219294|NCT01186744|472429012|FG000|Overall Study|Withdrawal by Subject|14|||
130765863|NCT03482167|470765887|FG000|Received Intervention|Physician Decision|1|||
130765864|NCT03482167|470765888|FG001|Received Intervention|Physician Decision|1|||
130882692|NCT00737672|471205598|FG000|Overall Study|Death|23|||
130882693|NCT00737672|471205599|FG001|Overall Study|Death|22|||
130882694|NCT00737672|471205598|FG000|Overall Study|Withdrawal by Subject|1|||
130882695|NCT00737672|471205599|FG001|Overall Study|Withdrawal by Subject|2|||
130882696|NCT00737672|471205598|FG000|Overall Study|Lost to Follow-up|1|||
130882697|NCT00737672|471205599|FG001|Overall Study|Lost to Follow-up|0|||
130882698|NCT00737672|471205598|FG000|Overall Study|Miscellaneous|7|||
130882699|NCT00737672|471205599|FG001|Overall Study|Miscellaneous|1|||
131219295|NCT01186744|472429013|FG001|Overall Study|Withdrawal by Subject|10|||
131219296|NCT01186744|472429014|FG002|Overall Study|Withdrawal by Subject|2|||
131219297|NCT01186744|472429015|FG003|Overall Study|Withdrawal by Subject|5|||
131219298|NCT01186744|472429016|FG004|Overall Study|Withdrawal by Subject|0|||
131219299|NCT01186744|472429017|FG005|Overall Study|Withdrawal by Subject|6|||
131219300|NCT01186744|472429012|FG000|Overall Study|Study terminated by Sponsor|1|||
131219301|NCT01186744|472429013|FG001|Overall Study|Study terminated by Sponsor|0|||
131219302|NCT01186744|472429014|FG002|Overall Study|Study terminated by Sponsor|0|||
131219303|NCT01186744|472429015|FG003|Overall Study|Study terminated by Sponsor|0|||
131219304|NCT01186744|472429016|FG004|Overall Study|Study terminated by Sponsor|0|||
131219305|NCT01186744|472429017|FG005|Overall Study|Study terminated by Sponsor|0|||
131219306|NCT01186744|472429012|FG000|Overall Study|Other|9|||
131219307|NCT01186744|472429013|FG001|Overall Study|Other|10|||
131219308|NCT01186744|472429014|FG002|Overall Study|Other|1|||
131219309|NCT01186744|472429015|FG003|Overall Study|Other|2|||
131219310|NCT01186744|472429016|FG004|Overall Study|Other|1|||
131219311|NCT01186744|472429017|FG005|Overall Study|Other|5|||
131219312|NCT01186744|472429012|FG000|Overall Study|Adverse Event|10|||
131219313|NCT01186744|472429013|FG001|Overall Study|Adverse Event|14|||
131219314|NCT01186744|472429014|FG002|Overall Study|Adverse Event|1|||
131219315|NCT01186744|472429015|FG003|Overall Study|Adverse Event|0|||
131219316|NCT01186744|472429016|FG004|Overall Study|Adverse Event|1|||
131219317|NCT01186744|472429017|FG005|Overall Study|Adverse Event|4|||
131219318|NCT01186744|472429012|FG000|Overall Study|Death|1|||
131219319|NCT01186744|472429013|FG001|Overall Study|Death|0|||
131219320|NCT01186744|472429014|FG002|Overall Study|Death|0|||
131219321|NCT01186744|472429015|FG003|Overall Study|Death|0|||
131219322|NCT01186744|472429016|FG004|Overall Study|Death|0|||
131219323|NCT01186744|472429017|FG005|Overall Study|Death|0|||
131219324|NCT01020773|472429020|FG000|Overall Study|Withdrawal by Subject|4|||
131219325|NCT01020773|472429021|FG001|Overall Study|Withdrawal by Subject|3|||
131219326|NCT01389024|472429022|FG000|Overall Study|Withdrawal by Subject|0|||
131219327|NCT01389024|472429023|FG001|Overall Study|Withdrawal by Subject|1|||
131219328|NCT01389024|472429022|FG000|Overall Study|Lost to Follow-up|1|||
131219329|NCT01389024|472429023|FG001|Overall Study|Lost to Follow-up|0|||
131219330|NCT01788163|472429027|FG000|Overall Study|Other|53|||
131219331|NCT01788163|472429028|FG001|Overall Study|Other|0|||
131219332|NCT01788163|472429029|FG002|Overall Study|Other|0|||
131219333|NCT01788163|472429030|FG003|Overall Study|Other|0|||
131219334|NCT01788163|472429031|FG004|Overall Study|Other|0|||
131219335|NCT01788163|472429032|FG005|Overall Study|Other|7|||
131219336|NCT01788163|472429033|FG006|Overall Study|Other|1|||
131219337|NCT01788163|472429034|FG007|Overall Study|Other|48|||
131219338|NCT01788163|472429035|FG008|Overall Study|Other|15|||
131219339|NCT01788163|472429027|FG000|Overall Study|Withdrawal by Subject|2|||
131219340|NCT01788163|472429028|FG001|Overall Study|Withdrawal by Subject|0|||
131219341|NCT01788163|472429029|FG002|Overall Study|Withdrawal by Subject|0|||
131219342|NCT01788163|472429030|FG003|Overall Study|Withdrawal by Subject|0|||
131219343|NCT01788163|472429031|FG004|Overall Study|Withdrawal by Subject|0|||
131219344|NCT01788163|472429032|FG005|Overall Study|Withdrawal by Subject|0|||
131219345|NCT01788163|472429033|FG006|Overall Study|Withdrawal by Subject|0|||
131219346|NCT01788163|472429034|FG007|Overall Study|Withdrawal by Subject|0|||
131219347|NCT01788163|472429035|FG008|Overall Study|Withdrawal by Subject|1|||
131219348|NCT00545441|472429036|FG000|Overall Study|Fistula draining at 6 months|2|||
131219349|NCT00545441|472429037|FG001|Overall Study|Fistula draining at 6 months|4|||
131219350|NCT00545441|472429036|FG000|Overall Study|Lost to Follow-up|9|||
131219351|NCT00545441|472429037|FG001|Overall Study|Lost to Follow-up|5|||
131219352|NCT00545441|472429036|FG000|Overall Study|Technical failure|0|||
131219353|NCT00545441|472429037|FG001|Overall Study|Technical failure|1|||
131219354|NCT00545441|472429036|FG000|Overall Study|Withdrawal by Subject|1|||
131219355|NCT00545441|472429037|FG001|Overall Study|Withdrawal by Subject|1|||
131219356|NCT00545441|472429036|FG000|Overall Study|Persistence or recurrence of fistula|5|||
131219357|NCT00545441|472429037|FG001|Overall Study|Persistence or recurrence of fistula|2|||
131219358|NCT00545441|472429036|FG000|Overall Study|Patients were not treated|1|||
131219359|NCT00545441|472429037|FG001|Overall Study|Patients were not treated|3|||
131219360|NCT00265239|472429038|FG000|Overall Study|Adverse Event|2|||
131219361|NCT00265239|472429039|FG001|Overall Study|Adverse Event|1|||
131219362|NCT02803138|472429042|FG000|Overall Study|Failure to return|38|||
131219363|NCT02803138|472429042|FG000|Overall Study|Insufficient virological response|2|||
131219364|NCT02803138|472429042|FG000|Overall Study|Withdrawn consent|1|||
131219365|NCT02803138|472429042|FG000|Overall Study|Death|1|||
131219366|NCT02803138|472429042|FG000|Overall Study|Other, not specified|28|||
131219367|NCT00424515|472429043|FG000|Overall Study|Progressive Disease|10|||
131219368|NCT00424515|472429044|FG001|Overall Study|Progressive Disease|11|||
131219369|NCT00424515|472429043|FG000|Overall Study|Adverse Event|0|||
131219370|NCT00424515|472429044|FG001|Overall Study|Adverse Event|1|||
131219371|NCT00424515|472429043|FG000|Overall Study|Intercurrent Illness|0|||
131219372|NCT00424515|472429044|FG001|Overall Study|Intercurrent Illness|1|||
130882700|NCT00737672|471205598|FG000|Overall Study|Physician Decision|0|||
131219373|NCT00424515|472429043|FG000|Overall Study|Withdrawal by Subject|1|||
131219374|NCT00424515|472429044|FG001|Overall Study|Withdrawal by Subject|0|||
131219375|NCT00267020|472429045|FG000|Overall Study|Adverse Event|22|||
131219376|NCT00267020|472429046|FG001|Overall Study|Adverse Event|5|||
131219377|NCT00267020|472429045|FG000|Overall Study|Death|2|||
131219378|NCT00267020|472429046|FG001|Overall Study|Death|1|||
131219379|NCT00267020|472429045|FG000|Overall Study|Withdrawal by Subject|17|||
131219380|NCT00267020|472429046|FG001|Overall Study|Withdrawal by Subject|7|||
131219381|NCT00267020|472429045|FG000|Overall Study|Physician Decision|3|||
131219382|NCT00267020|472429046|FG001|Overall Study|Physician Decision|2|||
131219383|NCT00267020|472429045|FG000|Overall Study|Disease Progression|39|||
131219384|NCT00267020|472429046|FG001|Overall Study|Disease Progression|25|||
131219385|NCT00267020|472429045|FG000|Overall Study|Unrelated Complication|1|||
131219386|NCT00267020|472429046|FG001|Overall Study|Unrelated Complication|1|||
131219387|NCT00267020|472429045|FG000|Overall Study|Sponsor Request|1|||
131219388|NCT00267020|472429046|FG001|Overall Study|Sponsor Request|0|||
131219389|NCT00267020|472429045|FG000|Overall Study|Other|1|||
131219390|NCT00267020|472429046|FG001|Overall Study|Other|2|||
131219391|NCT04071366|472429047|FG000|Part 1: Open-label (29 Days)|Death|4|||
131219392|NCT04071366|472429048|FG001|Part 1: Open-label (29 Days)|Death|2|||
131219393|NCT04071366|472429049|FG002|Part 1: Open-label (29 Days)|Death|8|||
131219394|NCT04071366|472429050|FG003|Part 1: Open-label (29 Days)|Death|0|||
131219395|NCT04071366|472429051|FG004|Part 1: Open-label (29 Days)|Death|0|||
131219396|NCT04071366|472429047|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
131219397|NCT04071366|472429048|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
131219398|NCT04071366|472429049|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
131219399|NCT04071366|472429050|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
131219400|NCT04071366|472429051|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
131219401|NCT04071366|472429047|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
131219402|NCT04071366|472429048|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
131219403|NCT04071366|472429049|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
131219404|NCT04071366|472429050|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
131219405|NCT04071366|472429051|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
131219406|NCT04071366|472429047|FG000|Part 2: Randomized (29 Days)|Death|0|||
131219407|NCT04071366|472429048|FG001|Part 2: Randomized (29 Days)|Death|0|||
131219408|NCT04071366|472429049|FG002|Part 2: Randomized (29 Days)|Death|0|||
131219409|NCT04071366|472429050|FG003|Part 2: Randomized (29 Days)|Death|2|||
131219410|NCT04071366|472429051|FG004|Part 2: Randomized (29 Days)|Death|2|||
131219411|NCT04071366|472429047|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
131219412|NCT04071366|472429048|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
131219413|NCT04071366|472429049|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
131219414|NCT04071366|472429050|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
131219415|NCT04071366|472429051|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
131219416|NCT04071366|472429047|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
131219417|NCT04071366|472429048|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
131219418|NCT04071366|472429049|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
131219419|NCT04071366|472429050|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
131219420|NCT04071366|472429051|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
131219421|NCT04071366|472429047|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
131219422|NCT04071366|472429048|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
131219423|NCT04071366|472429049|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
131219424|NCT04071366|472429050|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
131219425|NCT04071366|472429051|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
131219426|NCT04071366|472429047|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
131219427|NCT04071366|472429048|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
131219428|NCT04071366|472429049|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
131219429|NCT04071366|472429050|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
131219430|NCT04071366|472429051|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
131219431|NCT04071366|472429047|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
131219432|NCT04071366|472429048|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
131219433|NCT04071366|472429049|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
131219434|NCT04071366|472429050|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
131219435|NCT04071366|472429051|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
131219436|NCT04071366|472429047|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
131219437|NCT04071366|472429048|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
131219438|NCT04071366|472429049|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
131219439|NCT04071366|472429050|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
131219440|NCT04071366|472429051|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
131219441|NCT00858234|472429052|FG000|Overall Study|Adverse Event|6|||
131219442|NCT00858234|472429052|FG000|Overall Study|Progressive disease|2|||
131219443|NCT00858234|472429052|FG000|Overall Study|Status unknown|1|||
131219444|NCT00640614|472429054|FG000|Overall Study|Lost to Follow-up|1|||
131219445|NCT00640614|472429055|FG001|Overall Study|Lost to Follow-up|0|||
131219446|NCT00529802|472429056|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
131219447|NCT00529802|472429056|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
131219448|NCT00529802|472429056|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
131219449|NCT00529802|472429056|FG000|Evaluable for Primary Endpoint|Death|1|||
130993290|NCT00452413|471603778|FG000|Overall Study|Progressive Disease|4|||
131219450|NCT00529802|472429056|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
131219451|NCT00529802|472429056|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
131219452|NCT00529802|472429056|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
131219453|NCT02675426|472429057|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
131219454|NCT02675426|472429058|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
131219455|NCT02675426|472429059|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
131219456|NCT02675426|472429060|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
131219457|NCT02675426|472429057|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
131219458|NCT02675426|472429058|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
131219459|NCT02675426|472429059|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
131219460|NCT02675426|472429060|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
131219461|NCT02675426|472429057|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
131219462|NCT02675426|472429058|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
131219463|NCT02675426|472429059|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
131219464|NCT02675426|472429060|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
131219465|NCT02675426|472429057|FG000|Period 1: Week 1 to Week 12|Other|2|||
131219466|NCT02675426|472429058|FG001|Period 1: Week 1 to Week 12|Other|1|||
131219467|NCT02675426|472429059|FG002|Period 1: Week 1 to Week 12|Other|0|||
131219468|NCT02675426|472429060|FG003|Period 1: Week 1 to Week 12|Other|2|||
131219469|NCT02675426|472429057|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
131219470|NCT02675426|472429058|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
131219471|NCT02675426|472429059|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
131219472|NCT02675426|472429060|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
131219473|NCT02675426|472429057|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
131219474|NCT02675426|472429058|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
131219475|NCT02675426|472429059|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
131219476|NCT02675426|472429060|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
131219477|NCT02675426|472429057|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
131219478|NCT02675426|472429058|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
131219479|NCT02675426|472429059|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
131219480|NCT02675426|472429060|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
131219481|NCT02675426|472429057|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
131219482|NCT02675426|472429058|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
131219483|NCT02675426|472429059|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
131219484|NCT02675426|472429060|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
131219485|NCT02675426|472429057|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
131219486|NCT02675426|472429058|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
131219487|NCT02675426|472429059|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
131219488|NCT02675426|472429060|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
131219489|NCT02675426|472429057|FG000|Period 2: Week 12 to Week 260|Other|8|||
131219490|NCT02675426|472429058|FG001|Period 2: Week 12 to Week 260|Other|12|||
131219491|NCT02675426|472429059|FG002|Period 2: Week 12 to Week 260|Other|23|||
131219492|NCT02675426|472429060|FG003|Period 2: Week 12 to Week 260|Other|15|||
131219493|NCT02156466|472429063|FG000|Overall Study|Adverse Event|0|||
131219494|NCT02156466|472429064|FG001|Overall Study|Adverse Event|0|||
131219495|NCT02156466|472429065|FG002|Overall Study|Adverse Event|1|||
131219496|NCT02156466|472429066|FG003|Overall Study|Adverse Event|1|||
131219497|NCT02156466|472429067|FG004|Overall Study|Adverse Event|0|||
131219498|NCT02156466|472429063|FG000|Overall Study|Quantiferon Positivity|0|||
131219499|NCT02156466|472429064|FG001|Overall Study|Quantiferon Positivity|0|||
131219500|NCT02156466|472429065|FG002|Overall Study|Quantiferon Positivity|0|||
131219501|NCT02156466|472429066|FG003|Overall Study|Quantiferon Positivity|1|||
131219502|NCT02156466|472429067|FG004|Overall Study|Quantiferon Positivity|0|||
131219503|NCT00080288|472429068|FG000|Overall Study|Adverse Event|7|||
131219504|NCT00080288|472429069|FG001|Overall Study|Adverse Event|4|||
131219505|NCT00080288|472429068|FG000|Overall Study|Lost to Follow-up|3|||
131219506|NCT00080288|472429069|FG001|Overall Study|Lost to Follow-up|5|||
131219507|NCT00080288|472429068|FG000|Overall Study|Physician Decision|6|||
130993291|NCT00452413|471603779|FG001|Overall Study|Progressive Disease|11|||
130993292|NCT00452413|471603780|FG002|Overall Study|Progressive Disease|30|||
130993293|NCT00452413|471603778|FG000|Overall Study|Withdrawal by Subject|0|||
131219508|NCT00080288|472429069|FG001|Overall Study|Physician Decision|2|||
130993294|NCT00452413|471603779|FG001|Overall Study|Withdrawal by Subject|1|||
131219509|NCT00080288|472429068|FG000|Overall Study|Withdrawal by Subject|3|||
131219510|NCT00080288|472429069|FG001|Overall Study|Withdrawal by Subject|16|||
131219511|NCT00080288|472429068|FG000|Overall Study|Miscellaneous|11|||
131219512|NCT00080288|472429069|FG001|Overall Study|Miscellaneous|11|||
131219513|NCT04470622|472429070|FG000|Overall Study|Withdrawal by Subject|0|||
131219514|NCT04470622|472429071|FG001|Overall Study|Withdrawal by Subject|1|||
131219515|NCT04470622|472429070|FG000|Overall Study|Screen Failure|0|||
130993295|NCT00452413|471603780|FG002|Overall Study|Withdrawal by Subject|4|||
131219516|NCT04470622|472429071|FG001|Overall Study|Screen Failure|1|||
131219517|NCT04470622|472429070|FG000|Overall Study|Death|0|||
131219518|NCT04470622|472429071|FG001|Overall Study|Death|1|||
131219519|NCT01268683|472429080|FG000|Overall Study|Lost to Follow-up|1|||
131219520|NCT01268683|472429080|FG000|Overall Study|Death|1|||
131219521|NCT02216214|472429081|FG000|Overall Study|Randomized Never Received Study Drug|1|||
131219522|NCT02216214|472429082|FG001|Overall Study|Randomized Never Received Study Drug|0|||
131219523|NCT02216214|472429081|FG000|Overall Study|Adverse Event|10|||
131219524|NCT02216214|472429082|FG001|Overall Study|Adverse Event|8|||
131219525|NCT02216214|472429081|FG000|Overall Study|Lack of Efficacy|2|||
131219526|NCT02216214|472429082|FG001|Overall Study|Lack of Efficacy|2|||
131219527|NCT02216214|472429081|FG000|Overall Study|Lost to Follow-up|3|||
131219528|NCT02216214|472429082|FG001|Overall Study|Lost to Follow-up|2|||
131219529|NCT02216214|472429081|FG000|Overall Study|Protocol Violation|4|||
131219530|NCT02216214|472429082|FG001|Overall Study|Protocol Violation|2|||
131219531|NCT02216214|472429081|FG000|Overall Study|Withdrawal by Subject|22|||
131219532|NCT02216214|472429082|FG001|Overall Study|Withdrawal by Subject|20|||
131219533|NCT02216214|472429081|FG000|Overall Study|Study Terminated By Sponsor|0|||
131219534|NCT02216214|472429082|FG001|Overall Study|Study Terminated By Sponsor|1|||
131219535|NCT02216214|472429081|FG000|Overall Study|Miscellaneous|1|||
131219536|NCT02216214|472429082|FG001|Overall Study|Miscellaneous|1|||
131219537|NCT05354206|472429083|FG000|Overall Study|Withdrawal by Subject|1|||
131219538|NCT05354206|472429084|FG001|Overall Study|Withdrawal by Subject|0|||
131219539|NCT00713830|472429085|FG000|Overall Study|Adverse Event|23|||
131219540|NCT00713830|472429086|FG001|Overall Study|Adverse Event|71|||
131219541|NCT00713830|472429085|FG000|Overall Study|Lack of Efficacy|24|||
131219542|NCT00713830|472429086|FG001|Overall Study|Lack of Efficacy|16|||
131219543|NCT00713830|472429085|FG000|Overall Study|Lost to Follow-up|2|||
131219544|NCT00713830|472429086|FG001|Overall Study|Lost to Follow-up|9|||
131219545|NCT00713830|472429085|FG000|Overall Study|Withdrawal by Subject|13|||
131219546|NCT00713830|472429086|FG001|Overall Study|Withdrawal by Subject|23|||
131219547|NCT00713830|472429085|FG000|Overall Study|Poor Compliance to Protocol|7|||
131219548|NCT00713830|472429086|FG001|Overall Study|Poor Compliance to Protocol|14|||
131219549|NCT00713830|472429085|FG000|Overall Study|Familial and Personal Reasons|9|||
131219550|NCT00713830|472429086|FG001|Overall Study|Familial and Personal Reasons|34|||
131219551|NCT00713830|472429085|FG000|Overall Study|Sponsor Decision|4|||
131219552|NCT00713830|472429086|FG001|Overall Study|Sponsor Decision|10|||
131219553|NCT04701658|472429087|FG000|Overall Study|Lost to Follow-up|6|||
131219554|NCT04101721|472429090|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
131219555|NCT04101721|472429091|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
131219556|NCT04101721|472429090|FG000|Overall Study|Death|0|||
131219557|NCT04101721|472429091|FG001|Overall Study|Death|1|||
131219558|NCT04101721|472429090|FG000|Overall Study|Lost to Follow-up|0|||
131219559|NCT04101721|472429091|FG001|Overall Study|Lost to Follow-up|3|||
131219560|NCT01523301|472429092|FG000|Overall Study|Adverse Event|25|||
131219561|NCT01523301|472429093|FG001|Overall Study|Adverse Event|16|||
131219562|NCT01523301|472429092|FG000|Overall Study|Lack of Efficacy|0|||
131219563|NCT01523301|472429093|FG001|Overall Study|Lack of Efficacy|2|||
131219564|NCT01523301|472429092|FG000|Overall Study|Protocol Violation|3|||
131219565|NCT01523301|472429093|FG001|Overall Study|Protocol Violation|4|||
131219566|NCT01523301|472429092|FG000|Overall Study|Lost to Follow-up|1|||
131219567|NCT01523301|472429093|FG001|Overall Study|Lost to Follow-up|0|||
131219568|NCT01523301|472429092|FG000|Overall Study|Withdrawal by Subject|6|||
131219569|NCT01523301|472429093|FG001|Overall Study|Withdrawal by Subject|8|||
131219570|NCT01523301|472429092|FG000|Overall Study|Other Reason|0|||
131219571|NCT01523301|472429093|FG001|Overall Study|Other Reason|2|||
131219572|NCT01447628|472429094|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
131219573|NCT01447628|472429095|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
131219574|NCT01447628|472429096|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
131219575|NCT01447628|472429097|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
131219576|NCT03087773|472429098|FG000|Overall Study|Withdrawal by Subject|8|||
131219577|NCT03087773|472429099|FG001|Overall Study|Withdrawal by Subject|4|||
131219578|NCT03087773|472429098|FG000|Overall Study|Lost to Follow-up|12|||
131219579|NCT03087773|472429099|FG001|Overall Study|Lost to Follow-up|8|||
131219580|NCT00185731|472429100|FG000|Overall Study|Withdrawal by Subject|1|||
131219581|NCT00185731|472429100|FG000|Overall Study|Not Eligible|1|||
131219582|NCT03891875|472429107|FG000|Overall Study|Withdrawal by Subject|20|||
131219583|NCT03891875|472429108|FG001|Overall Study|Withdrawal by Subject|3|||
131219584|NCT03891875|472429107|FG000|Overall Study|Adverse Event|10|||
131219585|NCT03891875|472429108|FG001|Overall Study|Adverse Event|4|||
131219586|NCT03891875|472429107|FG000|Overall Study|Physician Decision|1|||
131219587|NCT03891875|472429108|FG001|Overall Study|Physician Decision|1|||
131219588|NCT03891875|472429107|FG000|Overall Study|Protocol Violation|1|||
131219589|NCT03891875|472429108|FG001|Overall Study|Protocol Violation|0|||
131219590|NCT03891875|472429107|FG000|Overall Study|Lost to Follow-up|1|||
131219591|NCT03891875|472429108|FG001|Overall Study|Lost to Follow-up|0|||
131219592|NCT03891875|472429107|FG000|Overall Study|COVID-19 infection|1|||
131219593|NCT03891875|472429108|FG001|Overall Study|COVID-19 infection|0|||
131219594|NCT00943384|472429109|FG000|Overall Study|Dispositioned prior to treatment|23|||
131219595|NCT00943384|472429109|FG000|Overall Study|Treated off protocol-protocol violation|5|||
131219596|NCT00943384|472429109|FG000|Overall Study|Lost to Follow-up|16|||
131219597|NCT00943384|472429109|FG000|Overall Study|Withdrawal by Subject|5|||
131219598|NCT00481871|472429110|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
131219599|NCT00481871|472429111|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
131219600|NCT00481871|472429112|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
131219601|NCT00481871|472429113|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
131219602|NCT00481871|472429114|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
131219603|NCT02362646|472429118|FG000|Overall Study|Death|15|||
131219604|NCT02362646|472429119|FG001|Overall Study|Death|8|||
131219605|NCT02362646|472429118|FG000|Overall Study|Withdrawal by Subject|2|||
131219606|NCT02362646|472429119|FG001|Overall Study|Withdrawal by Subject|2|||
131219607|NCT02362646|472429118|FG000|Overall Study|received transplant|21|||
131219608|NCT02362646|472429119|FG001|Overall Study|received transplant|14|||
131219609|NCT00865306|472429120|FG000|Controlled Trial|Lost to Follow-up|1|||
131219610|NCT00865306|472429121|FG001|Controlled Trial|Lost to Follow-up|1|||
131219611|NCT00865306|472429120|FG000|Controlled Trial|Difficulty commuting|2|||
131219612|NCT00865306|472429121|FG001|Controlled Trial|Difficulty commuting|0|||
131219613|NCT00865306|472429120|FG000|Controlled Trial|Improved btw baseline and first session|1|||
131219614|NCT00865306|472429121|FG001|Controlled Trial|Improved btw baseline and first session|0|||
131219615|NCT00865306|472429120|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
131219616|NCT00865306|472429121|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
130993296|NCT00452413|471603778|FG000|Overall Study|Adverse Event|0|||
131219617|NCT00865306|472429120|FG000|Controlled Trial|Withdrawal by Subject|0|||
131219618|NCT00865306|472429121|FG001|Controlled Trial|Withdrawal by Subject|1|||
131219619|NCT02058368|472429123|FG000|Overall Study|Adverse Event|15|||
131219620|NCT02058368|472429124|FG001|Overall Study|Adverse Event|20|||
131219621|NCT02058368|472429123|FG000|Overall Study|Lack of Efficacy|0|||
131219622|NCT02058368|472429124|FG001|Overall Study|Lack of Efficacy|1|||
131219623|NCT02058368|472429123|FG000|Overall Study|Protocol Violation|0|||
131219624|NCT02058368|472429124|FG001|Overall Study|Protocol Violation|4|||
131219625|NCT02058368|472429123|FG000|Overall Study|Lost to Follow-up|2|||
131219626|NCT02058368|472429124|FG001|Overall Study|Lost to Follow-up|0|||
131219627|NCT02058368|472429123|FG000|Overall Study|Physician Decision|2|||
131219628|NCT02058368|472429124|FG001|Overall Study|Physician Decision|3|||
131219629|NCT02058368|472429123|FG000|Overall Study|Withdrawal by Subject|22|||
131219630|NCT02058368|472429124|FG001|Overall Study|Withdrawal by Subject|26|||
131219631|NCT01652872|472429125|FG000|Overall Study|Death|36|||
131219632|NCT01652872|472429126|FG001|Overall Study|Death|39|||
131219633|NCT01652872|472429125|FG000|Overall Study|Lost to Follow-up|28|||
131219634|NCT01652872|472429126|FG001|Overall Study|Lost to Follow-up|23|||
131219635|NCT01652872|472429125|FG000|Overall Study|Decision by sponsor|5|||
131219636|NCT01652872|472429126|FG001|Overall Study|Decision by sponsor|7|||
131219637|NCT01652872|472429125|FG000|Overall Study|Withdrawal by Subject|76|||
131219638|NCT01652872|472429126|FG001|Overall Study|Withdrawal by Subject|84|||
131219639|NCT03454672|472429127|FG000|Overall Study|Adverse Event|1|||
131219640|NCT03454672|472429128|FG001|Overall Study|Adverse Event|1|||
131219641|NCT03454672|472429127|FG000|Overall Study|Lost to Follow-up|1|||
131219642|NCT03454672|472429128|FG001|Overall Study|Lost to Follow-up|3|||
131219643|NCT03454672|472429127|FG000|Overall Study|painful|1|||
131219644|NCT03454672|472429128|FG001|Overall Study|painful|2|||
131219645|NCT03454672|472429127|FG000|Overall Study|Non-compliance|2|||
131219646|NCT03454672|472429128|FG001|Overall Study|Non-compliance|4|||
131219647|NCT03454672|472429127|FG000|Overall Study|personal reasons|3|||
131219648|NCT03454672|472429128|FG001|Overall Study|personal reasons|2|||
131219649|NCT03454672|472429127|FG000|Overall Study|Withdrawal by Subject|1|||
131219650|NCT03454672|472429128|FG001|Overall Study|Withdrawal by Subject|0|||
131219651|NCT03252756|472429130|FG000|Overall Study|Protocol Violation|2|||
131219652|NCT03252756|472429131|FG001|Overall Study|Protocol Violation|4|||
131219653|NCT03252756|472429130|FG000|Overall Study|COVID-19 Pandemic|1|||
131219654|NCT03252756|472429131|FG001|Overall Study|COVID-19 Pandemic|1|||
131219655|NCT03252756|472429130|FG000|Overall Study|Study Drug Expiration|0|||
131219656|NCT03252756|472429131|FG001|Overall Study|Study Drug Expiration|1|||
131219657|NCT01500434|472429134|FG000|Overall Study|Death|1|||
131219658|NCT01500434|472429134|FG000|Overall Study|Withdrawal by Subject|1|||
131219659|NCT01500434|472429134|FG000|Overall Study|Missed 12-month follow-up|5|||
131219660|NCT01966107|472429138|FG000|Overall Study|excluded from FAS|21|||
131219661|NCT01966107|472429139|FG001|Overall Study|excluded from FAS|20|||
131219662|NCT01966107|472429138|FG000|Overall Study|discontinued treatment|345|||
131219663|NCT01966107|472429139|FG001|Overall Study|discontinued treatment|372|||
131219664|NCT01966107|472429138|FG000|Overall Study|due to study closure|164|||
131219665|NCT01966107|472429139|FG001|Overall Study|due to study closure|186|||
131219666|NCT01966107|472429138|FG000|Overall Study|withdrew from the study|272|||
131219667|NCT01966107|472429139|FG001|Overall Study|withdrew from the study|303|||
130993297|NCT00452413|471603779|FG001|Overall Study|Adverse Event|0|||
131219668|NCT00532779|472429140|FG000|Overall Study|Adverse Event|122|||
131219669|NCT00532779|472429141|FG001|Overall Study|Adverse Event|112|||
131219670|NCT00532779|472429142|FG002|Overall Study|Adverse Event|56|||
131219671|NCT00532779|472429140|FG000|Overall Study|Lost to Follow-up|76|||
131219672|NCT00532779|472429141|FG001|Overall Study|Lost to Follow-up|65|||
131219673|NCT00532779|472429142|FG002|Overall Study|Lost to Follow-up|66|||
131219674|NCT00532779|472429140|FG000|Overall Study|Withdrawal by Subject|63|||
131219675|NCT00532779|472429141|FG001|Overall Study|Withdrawal by Subject|60|||
131219676|NCT00532779|472429142|FG002|Overall Study|Withdrawal by Subject|90|||
131219677|NCT00532779|472429140|FG000|Overall Study|Lack of Efficacy|12|||
131219678|NCT00532779|472429141|FG001|Overall Study|Lack of Efficacy|12|||
131219679|NCT00532779|472429142|FG002|Overall Study|Lack of Efficacy|40|||
131219680|NCT00532779|472429140|FG000|Overall Study|Protocol Violation|5|||
131219681|NCT00532779|472429141|FG001|Overall Study|Protocol Violation|9|||
131219682|NCT00532779|472429142|FG002|Overall Study|Protocol Violation|7|||
131219683|NCT00532779|472429140|FG000|Overall Study|Pregnancy|2|||
131219684|NCT00532779|472429141|FG001|Overall Study|Pregnancy|5|||
131219685|NCT00532779|472429142|FG002|Overall Study|Pregnancy|3|||
131219686|NCT00532779|472429140|FG000|Overall Study|Death|0|||
131219687|NCT00532779|472429141|FG001|Overall Study|Death|1|||
131219688|NCT00532779|472429142|FG002|Overall Study|Death|0|||
131219689|NCT00532779|472429140|FG000|Overall Study|Drug noncompliance, moved, other|14|||
131219690|NCT00532779|472429141|FG001|Overall Study|Drug noncompliance, moved, other|23|||
131219691|NCT00532779|472429142|FG002|Overall Study|Drug noncompliance, moved, other|29|||
131219692|NCT02662556|472429143|FG000|Overall Study|Adverse Event|4|||
131219693|NCT02662556|472429143|FG000|Overall Study|Lack of Efficacy|4|||
131219694|NCT01556165|472429144|FG000|Overall Study|Adverse Event|5|||
131219695|NCT01556165|472429145|FG001|Overall Study|Adverse Event|3|||
131219696|NCT01556165|472429144|FG000|Overall Study|Protocol Violation|0|||
131219697|NCT01556165|472429145|FG001|Overall Study|Protocol Violation|3|||
131219698|NCT01556165|472429144|FG000|Overall Study|Withdrawal of Consent|7|||
131219699|NCT01556165|472429145|FG001|Overall Study|Withdrawal of Consent|1|||
131219700|NCT00701558|472429146|FG000|Overall Study|Death|7|||
131219701|NCT00701558|472429146|FG000|Overall Study|Lost to Follow-up|8|||
131219702|NCT00131937|472429147|FG000|Overall Study|Adverse Event|3|||
131219703|NCT00131937|472429147|FG000|Overall Study|Withdrawal by Subject|2|||
131219704|NCT00131937|472429147|FG000|Overall Study|Physician Decision|1|||
131219705|NCT00131937|472429147|FG000|Overall Study|Disease Progression|7|||
131219706|NCT00131937|472429147|FG000|Overall Study|Alternative therapy|1|||
131219707|NCT01640964|472429148|FG000|Overall Study|Lost to Follow-up|0|||
131219708|NCT01640964|472429149|FG001|Overall Study|Lost to Follow-up|0|||
131219709|NCT01640964|472429150|FG002|Overall Study|Lost to Follow-up|1|||
131219710|NCT01640964|472429148|FG000|Overall Study|Protocol Deviation|1|||
131219711|NCT01640964|472429149|FG001|Overall Study|Protocol Deviation|1|||
131219712|NCT01640964|472429150|FG002|Overall Study|Protocol Deviation|2|||
131219713|NCT02787746|472429151|FG000|Overall Study|Adverse Event|42|||
131219714|NCT02787746|472429151|FG000|Overall Study|Withdrawal by Subject|65|||
131219715|NCT02787746|472429151|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
131219716|NCT01678924|472430620|FG000|Overall Study|Adverse Event|1|||
131219717|NCT01678924|472430621|FG001|Overall Study|Adverse Event|1|||
131219718|NCT01678924|472430622|FG002|Overall Study|Adverse Event|0|||
131219719|NCT01678924|472430623|FG003|Overall Study|Adverse Event|1|||
131219720|NCT01678924|472430620|FG000|Overall Study|Lack of Efficacy|7|||
131219721|NCT01678924|472430621|FG001|Overall Study|Lack of Efficacy|2|||
131219722|NCT01678924|472430622|FG002|Overall Study|Lack of Efficacy|0|||
131219723|NCT01678924|472430623|FG003|Overall Study|Lack of Efficacy|5|||
131219724|NCT01678924|472430620|FG000|Overall Study|Lost to Follow-up|0|||
131219725|NCT01678924|472430621|FG001|Overall Study|Lost to Follow-up|4|||
131219726|NCT01678924|472430622|FG002|Overall Study|Lost to Follow-up|0|||
131219727|NCT01678924|472430623|FG003|Overall Study|Lost to Follow-up|2|||
131219728|NCT01678924|472430620|FG000|Overall Study|Personal Reasons|2|||
131219729|NCT01678924|472430621|FG001|Overall Study|Personal Reasons|2|||
131219730|NCT01678924|472430622|FG002|Overall Study|Personal Reasons|2|||
131219731|NCT01678924|472430623|FG003|Overall Study|Personal Reasons|7|||
131219732|NCT01678924|472430620|FG000|Overall Study|Withdrawal by Subject|0|||
131219733|NCT01678924|472430621|FG001|Overall Study|Withdrawal by Subject|3|||
131219734|NCT01678924|472430622|FG002|Overall Study|Withdrawal by Subject|0|||
131219735|NCT01678924|472430623|FG003|Overall Study|Withdrawal by Subject|2|||
131219736|NCT01678924|472430620|FG000|Overall Study|Unable to attend scheduled visits|0|||
131219737|NCT01678924|472430621|FG001|Overall Study|Unable to attend scheduled visits|0|||
131219738|NCT01678924|472430622|FG002|Overall Study|Unable to attend scheduled visits|0|||
131219739|NCT01678924|472430623|FG003|Overall Study|Unable to attend scheduled visits|1|||
131219740|NCT00021229|472430626|FG000|Overall Study|Adverse Event|10|||
131219741|NCT00021229|472430627|FG001|Overall Study|Adverse Event|5|||
131219742|NCT00021229|472430628|FG002|Overall Study|Adverse Event|2|||
131219743|NCT00021229|472430626|FG000|Overall Study|Death|0|||
131219744|NCT00021229|472430627|FG001|Overall Study|Death|1|||
131219745|NCT00021229|472430628|FG002|Overall Study|Death|0|||
131219746|NCT00021229|472430626|FG000|Overall Study|Withdrawal by Subject|7|||
131219747|NCT00021229|472430627|FG001|Overall Study|Withdrawal by Subject|7|||
131219748|NCT00021229|472430628|FG002|Overall Study|Withdrawal by Subject|1|||
130993298|NCT00452413|471603780|FG002|Overall Study|Adverse Event|5|||
130993299|NCT00452413|471603778|FG000|Overall Study|Physician Decision|0|||
130993300|NCT00452413|471603779|FG001|Overall Study|Physician Decision|0|||
130993301|NCT00452413|471603780|FG002|Overall Study|Physician Decision|4|||
130993302|NCT00452413|471603778|FG000|Overall Study|Death due to study disease|0|||
130993303|NCT00452413|471603779|FG001|Overall Study|Death due to study disease|0|||
130993304|NCT00452413|471603780|FG002|Overall Study|Death due to study disease|2|||
130993305|NCT00452413|471603778|FG000|Overall Study|Death due to adverse event (AE)|0|||
130993306|NCT00452413|471603779|FG001|Overall Study|Death due to adverse event (AE)|0|||
130993307|NCT00452413|471603780|FG002|Overall Study|Death due to adverse event (AE)|1|||
130993308|NCT00452413|471603778|FG000|Overall Study|On treatment|0|||
130993309|NCT00452413|471603779|FG001|Overall Study|On treatment|0|||
130993310|NCT00452413|471603780|FG002|Overall Study|On treatment|3|||
130993311|NCT01027364|471603781|FG000|Overall Study|Adverse Event|1|||
131219749|NCT00021229|472430626|FG000|Overall Study|Progressive Disease|15|||
131219750|NCT00021229|472430627|FG001|Overall Study|Progressive Disease|19|||
131219751|NCT00021229|472430628|FG002|Overall Study|Progressive Disease|12|||
131219752|NCT00021229|472430626|FG000|Overall Study|Protocol Violation|1|||
131219753|NCT00021229|472430627|FG001|Overall Study|Protocol Violation|1|||
131219754|NCT00021229|472430628|FG002|Overall Study|Protocol Violation|0|||
131219755|NCT00021229|472430626|FG000|Overall Study|Physician Decision|0|||
131219756|NCT00021229|472430627|FG001|Overall Study|Physician Decision|0|||
131219757|NCT00021229|472430628|FG002|Overall Study|Physician Decision|1|||
131219758|NCT00021229|472430626|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
131219759|NCT00021229|472430627|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
131219760|NCT00021229|472430628|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
131219761|NCT02428231|472430634|FG000|Overall Study|Other|10|||
131219762|NCT02428231|472430635|FG001|Overall Study|Other|16|||
131219763|NCT02428231|472430634|FG000|Overall Study|Required Symptomatic Therapy|0|||
131219764|NCT02428231|472430635|FG001|Overall Study|Required Symptomatic Therapy|1|||
131219765|NCT02428231|472430634|FG000|Overall Study|Adverse Event|3|||
131219766|NCT02428231|472430635|FG001|Overall Study|Adverse Event|0|||
131219767|NCT01784419|472430636|FG000|Overall Study|Adverse Event|3|||
131219768|NCT01336608|472430637|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
131219769|NCT01336608|472430638|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131219770|NCT01336608|472430639|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131219771|NCT01336608|472430640|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
131219772|NCT01336608|472430637|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
131219773|NCT01336608|472430638|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130765865|NCT03482167|470765887|FG000|Received Intervention|Withdrawal by Subject|1|||
130882701|NCT00737672|471205599|FG001|Overall Study|Physician Decision|2|||
130882702|NCT00541658|471205601|FG000|Overall Study|Adverse Event|28|||
130882703|NCT00541658|471205602|FG001|Overall Study|Adverse Event|37|||
130882704|NCT00541658|471205603|FG002|Overall Study|Adverse Event|25|||
130882705|NCT00541658|471205601|FG000|Overall Study|Physician Decision|0|||
130882706|NCT00541658|471205602|FG001|Overall Study|Physician Decision|0|||
130882707|NCT00541658|471205603|FG002|Overall Study|Physician Decision|4|||
130882708|NCT00541658|471205601|FG000|Overall Study|Lost to Follow-up|3|||
130882709|NCT00541658|471205602|FG001|Overall Study|Lost to Follow-up|3|||
130882710|NCT00541658|471205603|FG002|Overall Study|Lost to Follow-up|6|||
130882711|NCT00541658|471205601|FG000|Overall Study|Protocol Violation|0|||
130882712|NCT00541658|471205602|FG001|Overall Study|Protocol Violation|1|||
130882713|NCT00541658|471205603|FG002|Overall Study|Protocol Violation|1|||
130882714|NCT00541658|471205601|FG000|Overall Study|Withdrawal by Subject|28|||
130882715|NCT00541658|471205602|FG001|Overall Study|Withdrawal by Subject|32|||
130882716|NCT00541658|471205603|FG002|Overall Study|Withdrawal by Subject|32|||
130882717|NCT00541658|471205601|FG000|Overall Study|Took No Study Drug|1|||
130882718|NCT00541658|471205602|FG001|Overall Study|Took No Study Drug|0|||
130882719|NCT00541658|471205603|FG002|Overall Study|Took No Study Drug|0|||
130882720|NCT04123470|471205604|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
130882721|NCT04123470|471205605|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
130882722|NCT04123470|471205604|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
130882723|NCT04123470|471205605|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
130882724|NCT04123470|471205604|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
130882725|NCT04123470|471205605|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
130882726|NCT04123470|471205604|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
130882727|NCT04123470|471205605|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
130882728|NCT05408429|471205617|FG000|Overall Study|Lost to Follow-up|1|||
130882729|NCT05408429|471205618|FG001|Overall Study|Lost to Follow-up|1|||
130882730|NCT05408429|471205619|FG002|Overall Study|Lost to Follow-up|0|||
130882731|NCT05408429|471205617|FG000|Overall Study|Withdrawal by Subject|5|||
130882732|NCT05408429|471205618|FG001|Overall Study|Withdrawal by Subject|0|||
130882733|NCT05408429|471205619|FG002|Overall Study|Withdrawal by Subject|1|||
130882734|NCT05972993|471205620|FG000|Overall Study|Lost to Follow-up|2|||
131219774|NCT01336608|472430639|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131219775|NCT01336608|472430640|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131219776|NCT01336608|472430637|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
131219777|NCT01336608|472430638|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
131219778|NCT01336608|472430639|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
131219779|NCT01336608|472430640|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
131219780|NCT01336608|472430637|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
131219781|NCT01336608|472430638|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
131219782|NCT01336608|472430639|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
131219783|NCT01336608|472430640|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
131219784|NCT01336608|472430637|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
131219785|NCT01336608|472430638|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131219786|NCT01336608|472430639|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131219787|NCT01336608|472430640|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
131219788|NCT01336608|472430637|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
131219789|NCT01336608|472430638|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
131219790|NCT01336608|472430639|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
131219791|NCT01336608|472430640|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
131219792|NCT01336608|472430637|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131219793|NCT01336608|472430638|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
131219794|NCT01336608|472430639|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131219795|NCT01336608|472430640|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
131219796|NCT01336608|472430637|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
131219797|NCT01336608|472430638|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
131219798|NCT01336608|472430639|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
131219799|NCT01336608|472430640|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
131219800|NCT01336608|472430637|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
131219801|NCT01336608|472430638|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
131219802|NCT01336608|472430639|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
131219803|NCT01336608|472430640|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
131219804|NCT01336608|472430637|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
131219805|NCT01336608|472430638|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
131219806|NCT01336608|472430639|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
131219807|NCT01336608|472430640|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
131219808|NCT01336608|472430637|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130882735|NCT05972993|471205621|FG001|Overall Study|Lost to Follow-up|0|||
130882736|NCT05972993|471205622|FG002|Overall Study|Lost to Follow-up|1|||
130882737|NCT05972993|471205623|FG003|Overall Study|Lost to Follow-up|0|||
130882738|NCT05972993|471205624|FG004|Overall Study|Lost to Follow-up|0|||
130882739|NCT05972993|471205625|FG005|Overall Study|Lost to Follow-up|0|||
130882740|NCT05972993|471205626|FG006|Overall Study|Lost to Follow-up|0|||
130882741|NCT05972993|471205627|FG007|Overall Study|Lost to Follow-up|2|||
130882742|NCT05972993|471205628|FG008|Overall Study|Lost to Follow-up|0|||
130882743|NCT04482647|471205635|FG000|Overall Study|Time constraints|2|||
130882744|NCT04482647|471205635|FG000|Overall Study|Health issues|1|||
130882745|NCT04482647|471205635|FG000|Overall Study|Death in the family|1|||
130882746|NCT04482647|471205635|FG000|Overall Study|Disliked the intervention|1|||
130882747|NCT04482647|471205635|FG000|Overall Study|No reasons specified|7|||
130882748|NCT02484391|471205636|FG000|Overall Study|Lack of Efficacy|15|||
130882749|NCT02484391|471205637|FG001|Overall Study|Lack of Efficacy|14|||
130882750|NCT02484391|471205638|FG002|Overall Study|Lack of Efficacy|3|||
130882751|NCT02484391|471205636|FG000|Overall Study|Lost to Follow-up|0|||
130882752|NCT02484391|471205637|FG001|Overall Study|Lost to Follow-up|0|||
130882753|NCT02484391|471205638|FG002|Overall Study|Lost to Follow-up|2|||
130882754|NCT02484391|471205636|FG000|Overall Study|Physician Decision|1|||
130882755|NCT02484391|471205637|FG001|Overall Study|Physician Decision|3|||
130882756|NCT02484391|471205638|FG002|Overall Study|Physician Decision|0|||
130882757|NCT02484391|471205636|FG000|Overall Study|Went to Transplant|5|||
130882758|NCT02484391|471205637|FG001|Overall Study|Went to Transplant|3|||
130882759|NCT02484391|471205638|FG002|Overall Study|Went to Transplant|2|||
130882760|NCT00911170|471205639|FG000|Treatment Period|Randomized in error|1|||
130882761|NCT00911170|471205640|FG001|Treatment Period|Randomized in error|1|||
130882762|NCT00911170|471205639|FG000|Treatment Period|Ineligibility determined|1|||
130882763|NCT00911170|471205640|FG001|Treatment Period|Ineligibility determined|3|||
130882764|NCT00911170|471205639|FG000|Treatment Period|Protocol deviation|1|||
130882765|NCT00911170|471205640|FG001|Treatment Period|Protocol deviation|2|||
130882766|NCT00911170|471205639|FG000|Treatment Period|Adverse Event|9|||
130882767|NCT00911170|471205640|FG001|Treatment Period|Adverse Event|10|||
130882768|NCT00911170|471205639|FG000|Treatment Period|Withdrawal by Subject|4|||
130882769|NCT00911170|471205640|FG001|Treatment Period|Withdrawal by Subject|4|||
131219809|NCT01336608|472430638|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
131219810|NCT01336608|472430639|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131219811|NCT01336608|472430640|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131219812|NCT01336608|472430637|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
131219813|NCT01336608|472430638|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
131219814|NCT01336608|472430639|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
131219815|NCT01336608|472430640|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
131219816|NCT01336608|472430637|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131219817|NCT01336608|472430638|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
131219818|NCT01336608|472430639|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
131219819|NCT01336608|472430640|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
131219820|NCT02253654|472430641|FG000|Overall Study|Withdrawal by Subject|12|||
131219821|NCT02253654|472430642|FG001|Overall Study|Withdrawal by Subject|4|||
131219822|NCT02253654|472430641|FG000|Overall Study|Decision by Sponsor|1|||
131219823|NCT02253654|472430642|FG001|Overall Study|Decision by Sponsor|1|||
131219824|NCT02253654|472430641|FG000|Overall Study|Lost to Follow-up|2|||
131219825|NCT02253654|472430642|FG001|Overall Study|Lost to Follow-up|5|||
131219826|NCT02253654|472430641|FG000|Overall Study|Death|4|||
131219827|NCT02253654|472430642|FG001|Overall Study|Death|7|||
131219828|NCT02253654|472430641|FG000|Overall Study|Did Not Receive Study Treatment|4|||
131219829|NCT02253654|472430642|FG001|Overall Study|Did Not Receive Study Treatment|1|||
131219830|NCT03044431|472430645|FG000|Overall Study|Lost to Follow-up|59|||
131219831|NCT03456726|472430646|FG000|Overall Study|Disease Progression|6|||
131219832|NCT03456726|472430647|FG001|Overall Study|Disease Progression|1|||
131219833|NCT03456726|472430646|FG000|Overall Study|Adverse Event|4|||
131219834|NCT03456726|472430647|FG001|Overall Study|Adverse Event|2|||
131219835|NCT03456726|472430646|FG000|Overall Study|Withdrawal by Subject|1|||
131219836|NCT03456726|472430647|FG001|Overall Study|Withdrawal by Subject|0|||
131219837|NCT03456726|472430646|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
131219838|NCT03456726|472430647|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
131219839|NCT00399490|472430648|FG000|Overall Study|Adverse Event|19|||
131219840|NCT00399490|472430648|FG000|Overall Study|Lack of Efficacy|31|||
131219841|NCT00399490|472430648|FG000|Overall Study|Lost to Follow-up|5|||
131219842|NCT00399490|472430648|FG000|Overall Study|Withdrawal by Subject|18|||
131219843|NCT00399490|472430648|FG000|Overall Study|Other|25|||
131219844|NCT02328547|472430649|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
131219845|NCT02328547|472430650|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
131219846|NCT02328547|472430649|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
131219847|NCT02328547|472430650|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
131219848|NCT02576054|472430651|FG000|Overall Study|Withdrawal by Subject|1|||
131219849|NCT01190098|472430655|FG000|Overall Study|Adverse Event|2|||
131219850|NCT01190098|472430656|FG001|Overall Study|Adverse Event|0|||
131219851|NCT01190098|472430655|FG000|Overall Study|Patient coomorbidity|0|||
131219852|NCT01190098|472430656|FG001|Overall Study|Patient coomorbidity|1|||
131219853|NCT01190098|472430655|FG000|Overall Study|Lack of transportation|1|||
131219854|NCT01190098|472430656|FG001|Overall Study|Lack of transportation|0|||
131219855|NCT01190098|472430655|FG000|Overall Study|Other|0|||
131219856|NCT01190098|472430656|FG001|Overall Study|Other|1|||
131219857|NCT00344305|472430657|FG000|Overall Study|Lost to Follow-up|2|||
131219858|NCT00344305|472430658|FG001|Overall Study|Lost to Follow-up|0|||
131219859|NCT00344305|472430657|FG000|Overall Study|Participant was not contacted in window|0|||
131219860|NCT00344305|472430658|FG001|Overall Study|Participant was not contacted in window|1|||
131219861|NCT02957682|472430659|FG000|Overall Study|Adverse Event|64|||
131219862|NCT02957682|472430660|FG001|Overall Study|Adverse Event|67|||
131219863|NCT02957682|472430659|FG000|Overall Study|Poor Compliance to Protocol|30|||
131219864|NCT02957682|472430660|FG001|Overall Study|Poor Compliance to Protocol|26|||
131219865|NCT02957682|472430659|FG000|Overall Study|Physician Decision|4|||
131219866|NCT02957682|472430660|FG001|Overall Study|Physician Decision|4|||
131219867|NCT02957682|472430659|FG000|Overall Study|Study Terminated by Sponsor|4|||
131219868|NCT02957682|472430660|FG001|Overall Study|Study Terminated by Sponsor|3|||
131219869|NCT02957682|472430659|FG000|Overall Study|Subject Moved|10|||
131219870|NCT02957682|472430660|FG001|Overall Study|Subject Moved|16|||
131219871|NCT02957682|472430659|FG000|Overall Study|Withdrawal by Subject|64|||
131219872|NCT02957682|472430660|FG001|Overall Study|Withdrawal by Subject|33|||
130993312|NCT01027364|471603782|FG001|Overall Study|Adverse Event|0|||
131219873|NCT02957682|472430659|FG000|Overall Study|Related to IMP Administration|3|||
131219874|NCT02957682|472430660|FG001|Overall Study|Related to IMP Administration|6|||
131219875|NCT02957682|472430659|FG000|Overall Study|Non-disclosed|16|||
131219876|NCT02957682|472430660|FG001|Overall Study|Non-disclosed|12|||
131219877|NCT02957682|472430659|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
131219878|NCT02957682|472430660|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
131219879|NCT00791154|472430669|FG000|Overall Study|Noncompliance|0|||
131219880|NCT00791154|472430670|FG001|Overall Study|Noncompliance|1|||
131219881|NCT00791154|472430671|FG002|Overall Study|Noncompliance|0|||
131219882|NCT00791154|472430672|FG003|Overall Study|Noncompliance|0|||
131219883|NCT00791154|472430673|FG004|Overall Study|Noncompliance|1|||
131219884|NCT00791154|472430674|FG005|Overall Study|Noncompliance|1|||
131219885|NCT00791154|472430675|FG006|Overall Study|Noncompliance|1|||
131219886|NCT00791154|472430669|FG000|Overall Study|Adverse Event|0|||
131219887|NCT00791154|472430670|FG001|Overall Study|Adverse Event|0|||
131219888|NCT00791154|472430671|FG002|Overall Study|Adverse Event|0|||
131219889|NCT00791154|472430672|FG003|Overall Study|Adverse Event|0|||
131219890|NCT00791154|472430673|FG004|Overall Study|Adverse Event|2|||
131219891|NCT00791154|472430674|FG005|Overall Study|Adverse Event|0|||
131219892|NCT00791154|472430675|FG006|Overall Study|Adverse Event|1|||
131219893|NCT00791154|472430669|FG000|Overall Study|Full Consent withdrawn|1|||
131219894|NCT00791154|472430670|FG001|Overall Study|Full Consent withdrawn|3|||
131219895|NCT00791154|472430671|FG002|Overall Study|Full Consent withdrawn|0|||
131219896|NCT00791154|472430672|FG003|Overall Study|Full Consent withdrawn|0|||
131219897|NCT00791154|472430673|FG004|Overall Study|Full Consent withdrawn|1|||
131219898|NCT00791154|472430674|FG005|Overall Study|Full Consent withdrawn|3|||
130993313|NCT01027364|471603783|FG002|Overall Study|Adverse Event|1|||
131219899|NCT00791154|472430675|FG006|Overall Study|Full Consent withdrawn|1|||
131219900|NCT00791154|472430669|FG000|Overall Study|Lost to Follow-up|0|||
131219901|NCT00791154|472430670|FG001|Overall Study|Lost to Follow-up|0|||
131219902|NCT00791154|472430671|FG002|Overall Study|Lost to Follow-up|0|||
131219903|NCT00791154|472430672|FG003|Overall Study|Lost to Follow-up|1|||
131219904|NCT00791154|472430673|FG004|Overall Study|Lost to Follow-up|2|||
131219905|NCT00791154|472430674|FG005|Overall Study|Lost to Follow-up|0|||
131219906|NCT00791154|472430675|FG006|Overall Study|Lost to Follow-up|4|||
131219907|NCT00791154|472430669|FG000|Overall Study|Death|5|||
131219908|NCT00791154|472430670|FG001|Overall Study|Death|4|||
131219909|NCT00791154|472430671|FG002|Overall Study|Death|4|||
131219910|NCT00791154|472430672|FG003|Overall Study|Death|7|||
131219911|NCT00791154|472430673|FG004|Overall Study|Death|54|||
131219912|NCT00791154|472430674|FG005|Overall Study|Death|54|||
131219913|NCT00791154|472430675|FG006|Overall Study|Death|52|||
131219914|NCT00791154|472430669|FG000|Overall Study|Other event|0|||
131219915|NCT00791154|472430670|FG001|Overall Study|Other event|0|||
131219916|NCT00791154|472430671|FG002|Overall Study|Other event|2|||
131219917|NCT00791154|472430672|FG003|Overall Study|Other event|0|||
131219918|NCT00791154|472430673|FG004|Overall Study|Other event|2|||
131219919|NCT00791154|472430674|FG005|Overall Study|Other event|4|||
131219920|NCT00791154|472430675|FG006|Overall Study|Other event|2|||
131219921|NCT00953927|472430676|FG000|Overall Study|Lost to Follow-up|61|||
131219922|NCT00953927|472430677|FG001|Overall Study|Lost to Follow-up|65|||
131219923|NCT00953927|472430676|FG000|Overall Study|Withdrawal by Subject|36|||
131219924|NCT00953927|472430677|FG001|Overall Study|Withdrawal by Subject|25|||
131219925|NCT00953927|472430676|FG000|Overall Study|Death|7|||
131219926|NCT00953927|472430677|FG001|Overall Study|Death|4|||
131219927|NCT00953927|472430676|FG000|Overall Study|Other study discontinuation|1|||
131219928|NCT00953927|472430677|FG001|Overall Study|Other study discontinuation|1|||
131219929|NCT01396161|472430678|FG000|Overall Study|Withdrawal by Subject|0|||
130993314|NCT01027364|471603784|FG003|Overall Study|Adverse Event|0|||
130993315|NCT01027364|471603781|FG000|Overall Study|Lost to Follow-up|1|||
130993316|NCT01027364|471603782|FG001|Overall Study|Lost to Follow-up|0|||
130993317|NCT01027364|471603783|FG002|Overall Study|Lost to Follow-up|0|||
130993318|NCT01027364|471603784|FG003|Overall Study|Lost to Follow-up|0|||
130993319|NCT01027364|471603781|FG000|Overall Study|Protocol Violation|1|||
130993320|NCT01027364|471603782|FG001|Overall Study|Protocol Violation|0|||
130993321|NCT01027364|471603783|FG002|Overall Study|Protocol Violation|0|||
130993322|NCT01027364|471603784|FG003|Overall Study|Protocol Violation|1|||
130993323|NCT01027364|471603781|FG000|Overall Study|Withdrawal by Subject|1|||
130993324|NCT01027364|471603782|FG001|Overall Study|Withdrawal by Subject|2|||
130993325|NCT01027364|471603783|FG002|Overall Study|Withdrawal by Subject|0|||
130993326|NCT01027364|471603784|FG003|Overall Study|Withdrawal by Subject|0|||
131219930|NCT01396161|472430679|FG001|Overall Study|Withdrawal by Subject|0|||
131219931|NCT01396161|472430680|FG002|Overall Study|Withdrawal by Subject|0|||
131219932|NCT01396161|472430681|FG003|Overall Study|Withdrawal by Subject|0|||
131219933|NCT01396161|472430682|FG004|Overall Study|Withdrawal by Subject|1|||
131219934|NCT01396161|472430683|FG005|Overall Study|Withdrawal by Subject|0|||
131219935|NCT01396161|472430684|FG006|Overall Study|Withdrawal by Subject|0|||
131219936|NCT01396161|472430678|FG000|Overall Study|Other|0|||
131219937|NCT01396161|472430679|FG001|Overall Study|Other|0|||
131219938|NCT01396161|472430680|FG002|Overall Study|Other|0|||
130765866|NCT03482167|470765888|FG001|Received Intervention|Withdrawal by Subject|0|||
130993327|NCT01248962|471603785|FG000|Overall Study|Withdrawal by Subject|1|||
130993328|NCT01248962|471603786|FG001|Overall Study|Withdrawal by Subject|1|||
131219939|NCT01396161|472430681|FG003|Overall Study|Other|0|||
131219940|NCT01396161|472430682|FG004|Overall Study|Other|0|||
131219941|NCT01396161|472430683|FG005|Overall Study|Other|0|||
131219942|NCT01396161|472430684|FG006|Overall Study|Other|1|||
131219943|NCT03578276|472430687|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
130993329|NCT01248962|471603785|FG000|Overall Study|Adverse Event|2|||
131219944|NCT03578276|472430688|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
131219945|NCT00981409|472430689|FG000|Overall Study|Adverse Event|4|||
131219946|NCT00981409|472430690|FG001|Overall Study|Adverse Event|0|||
131219947|NCT00981409|472430689|FG000|Overall Study|Protocol Violation|0|||
131219948|NCT00981409|472430690|FG001|Overall Study|Protocol Violation|1|||
131219949|NCT00981409|472430689|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
131219950|NCT00981409|472430690|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
131219951|NCT00078312|472430701|FG000|Overall Study|Adverse Event|43|||
131219952|NCT00078312|472430701|FG000|Overall Study|Lack of Efficacy|15|||
131219953|NCT00078312|472430701|FG000|Overall Study|Lost to Follow-up|41|||
131219954|NCT00078312|472430701|FG000|Overall Study|Physician Decision|9|||
131219955|NCT00078312|472430701|FG000|Overall Study|Protocol Violation|3|||
131219956|NCT00078312|472430701|FG000|Overall Study|Withdrawal by Subject|33|||
131219957|NCT00078312|472430701|FG000|Overall Study|Miscellaneous|33|||
131219958|NCT04840901|472430702|FG000|Overall Study|Lost to Follow-up|3|||
131219959|NCT04840901|472430703|FG001|Overall Study|Lost to Follow-up|1|||
131219960|NCT04840901|472430702|FG000|Overall Study|Moved|1|||
131219961|NCT04840901|472430703|FG001|Overall Study|Moved|0|||
131219962|NCT04840901|472430702|FG000|Overall Study|Unable to comply with study schedule|0|||
131219963|NCT04840901|472430703|FG001|Overall Study|Unable to comply with study schedule|1|||
131219964|NCT04840901|472430702|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
131219965|NCT04840901|472430703|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
131219966|NCT00902265|472430704|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
131219967|NCT00902265|472430704|FG000|Overall Study|Adverse Event|2|||
131219968|NCT00902265|472430704|FG000|Overall Study|Lack of Efficacy|2|||
131219969|NCT00902265|472430704|FG000|Overall Study|Protocol Violation|1|||
131219970|NCT05016765|472430705|FG000|Overall Study|Lost to Follow-up|4|||
130993330|NCT01248962|471603786|FG001|Overall Study|Adverse Event|1|||
130993331|NCT01248962|471603785|FG000|Overall Study|Complete Response after 4 Cycles|1|||
130993332|NCT01248962|471603786|FG001|Overall Study|Complete Response after 4 Cycles|0|||
130993333|NCT01248962|471603785|FG000|Overall Study|Complete Response after 3 Cycles|0|||
130993334|NCT01248962|471603786|FG001|Overall Study|Complete Response after 3 Cycles|1|||
130993335|NCT01248962|471603785|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
130993336|NCT01248962|471603786|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
130993337|NCT03119610|471603788|FG000|Overall Study|Adverse Event|1|||
130993338|NCT03119610|471603789|FG001|Overall Study|Adverse Event|0|||
130993339|NCT03119610|471603788|FG000|Overall Study|Lost to Follow-up|0|||
131219971|NCT02494583|472430708|FG000|Overall Study|Death|224|||
131219972|NCT02494583|472430709|FG001|Overall Study|Death|214|||
131219973|NCT02494583|472430710|FG002|Overall Study|Death|225|||
131219974|NCT02494583|472430708|FG000|Overall Study|Lost to Follow-up|1|||
131219975|NCT02494583|472430709|FG001|Overall Study|Lost to Follow-up|0|||
131219976|NCT02494583|472430710|FG002|Overall Study|Lost to Follow-up|0|||
131219977|NCT02494583|472430708|FG000|Overall Study|Protocol Violation|1|||
131219978|NCT02494583|472430709|FG001|Overall Study|Protocol Violation|2|||
131219979|NCT02494583|472430710|FG002|Overall Study|Protocol Violation|0|||
131219980|NCT02494583|472430708|FG000|Overall Study|Screen Failure|0|||
131219981|NCT02494583|472430709|FG001|Overall Study|Screen Failure|1|||
131219982|NCT02494583|472430710|FG002|Overall Study|Screen Failure|0|||
131219983|NCT02494583|472430708|FG000|Overall Study|Transferred to Extension Study|15|||
131219984|NCT02494583|472430709|FG001|Overall Study|Transferred to Extension Study|15|||
131219985|NCT02494583|472430710|FG002|Overall Study|Transferred to Extension Study|6|||
131219986|NCT02494583|472430708|FG000|Overall Study|Did Not Continue on Extension Study|8|||
131219987|NCT02494583|472430709|FG001|Overall Study|Did Not Continue on Extension Study|10|||
131219988|NCT02494583|472430710|FG002|Overall Study|Did Not Continue on Extension Study|4|||
131219989|NCT02494583|472430708|FG000|Overall Study|Withdrawal by Subject|7|||
131219990|NCT02494583|472430709|FG001|Overall Study|Withdrawal by Subject|15|||
131219991|NCT02494583|472430710|FG002|Overall Study|Withdrawal by Subject|15|||
131219992|NCT03151707|472430713|FG000|Overall Study|Lost to Follow-up|6|||
131219993|NCT02181842|472430714|FG000|Overall Study|Case Report Forms Uncollected|2|||
131219994|NCT04529096|472430715|FG000|Overall Study|Adverse Event|6|||
131219995|NCT04529096|472430716|FG001|Overall Study|Adverse Event|1|||
131219996|NCT04529096|472430715|FG000|Overall Study|Lack of Efficacy|1|||
131219997|NCT04529096|472430716|FG001|Overall Study|Lack of Efficacy|0|||
131219998|NCT04529096|472430715|FG000|Overall Study|Lost to Follow-up|1|||
131219999|NCT04529096|472430716|FG001|Overall Study|Lost to Follow-up|1|||
131220000|NCT04529096|472430715|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131220001|NCT04529096|472430716|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131220002|NCT04529096|472430715|FG000|Overall Study|Physician Decision|1|||
130993340|NCT03119610|471603789|FG001|Overall Study|Lost to Follow-up|1|||
130993341|NCT00114634|471603790|FG000|Overall Study|failure to return forms|3|||
130993342|NCT03283696|471603791|FG000|Overall Study|Physician Decision|5|||
131220003|NCT04529096|472430716|FG001|Overall Study|Physician Decision|3|||
130993343|NCT03283696|471603792|FG001|Overall Study|Physician Decision|6|||
131220004|NCT04529096|472430715|FG000|Overall Study|Withdrawal by Subject|5|||
131220005|NCT04529096|472430716|FG001|Overall Study|Withdrawal by Subject|0|||
130993344|NCT03283696|471603791|FG000|Overall Study|Withdrawal by Subject|2|||
130993345|NCT03283696|471603792|FG001|Overall Study|Withdrawal by Subject|0|||
130993346|NCT01539863|471603796|FG000|Overall Study|Lost to Follow-up|5|||
130993347|NCT01539863|471603797|FG001|Overall Study|Lost to Follow-up|4|||
130993348|NCT00557622|471603798|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
130993349|NCT00557622|471603799|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
130993350|NCT00557622|471603798|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
130993351|NCT00557622|471603799|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
130993352|NCT00557622|471603798|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
130993353|NCT00557622|471603799|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
130993354|NCT02765490|471603802|FG000|Overall Study|Lost to Follow-up|1|||
130993355|NCT02765490|471603803|FG001|Overall Study|Lost to Follow-up|1|||
130993356|NCT02765490|471603802|FG000|Overall Study|Other|0|||
130993357|NCT02765490|471603803|FG001|Overall Study|Other|1|||
130993358|NCT02765490|471603802|FG000|Overall Study|Death|0|||
130993359|NCT02765490|471603803|FG001|Overall Study|Death|1|||
130993360|NCT01468922|471603804|FG000|Overall Study|Screening failure|0|||
130993361|NCT01468922|471603805|FG001|Overall Study|Screening failure|0|||
130993362|NCT01468922|471603806|FG002|Overall Study|Screening failure|0|||
131220006|NCT03985293|472430727|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
131220007|NCT03985293|472430728|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
131220008|NCT03985293|472430729|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
131220009|NCT03985293|472430730|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
131220010|NCT03985293|472430731|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
131220011|NCT03985293|472430732|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
131220012|NCT03985293|472430727|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
131220013|NCT03985293|472430728|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
131220014|NCT03985293|472430729|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
131220015|NCT03985293|472430730|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
131220016|NCT03985293|472430731|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
131220017|NCT03985293|472430732|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
131220018|NCT03985293|472430727|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
131220019|NCT03985293|472430728|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
131220020|NCT03985293|472430729|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
131220021|NCT03985293|472430730|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
131220022|NCT03985293|472430731|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
131220023|NCT03985293|472430732|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
131220024|NCT03985293|472430727|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
131220025|NCT03985293|472430728|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
131220026|NCT03985293|472430729|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
131220027|NCT03985293|472430730|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
131220028|NCT03985293|472430731|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
131220029|NCT03985293|472430732|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
131220030|NCT03985293|472430727|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
131220031|NCT03985293|472430728|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
131220032|NCT03985293|472430729|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
131220033|NCT03985293|472430730|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
131220034|NCT03985293|472430731|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
131220035|NCT03985293|472430732|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
131220036|NCT03985293|472430727|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
131220037|NCT03985293|472430728|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
131220038|NCT03985293|472430729|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
131220039|NCT03985293|472430730|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
131220040|NCT03985293|472430731|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
131220041|NCT03985293|472430732|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
131220042|NCT03985293|472430727|FG000|FOLLOW-UP|Lost to Follow-up|0|||
131220043|NCT03985293|472430728|FG001|FOLLOW-UP|Lost to Follow-up|0|||
131220044|NCT03985293|472430729|FG002|FOLLOW-UP|Lost to Follow-up|1|||
131220045|NCT03985293|472430730|FG003|FOLLOW-UP|Lost to Follow-up|0|||
131220046|NCT03985293|472430731|FG004|FOLLOW-UP|Lost to Follow-up|0|||
131220047|NCT03985293|472430732|FG005|FOLLOW-UP|Lost to Follow-up|0|||
131220048|NCT00390572|472430733|FG000|Overall Study|Lost to Follow-up|8|||
131220049|NCT00390572|472430734|FG001|Overall Study|Lost to Follow-up|4|||
131220050|NCT00390572|472430733|FG000|Overall Study|health condition|0|||
130765867|NCT05079230|470765892|FG000|Overall Study|Study Terminated by Sponsor|101|||
130993363|NCT01468922|471603807|FG003|Overall Study|Screening failure|0|||
130993364|NCT01468922|471603808|FG004|Overall Study|Screening failure|0|||
130993365|NCT01468922|471603809|FG005|Overall Study|Screening failure|0|||
131220051|NCT00390572|472430734|FG001|Overall Study|health condition|1|||
131220052|NCT01345058|472430741|FG000|Overall Study|Withdrawal by Subject|1|||
131220053|NCT01345058|472430742|FG001|Overall Study|Withdrawal by Subject|0|||
131220054|NCT01345058|472430741|FG000|Overall Study|Participant Reported Increase in Events|1|||
131220055|NCT01345058|472430742|FG001|Overall Study|Participant Reported Increase in Events|0|||
130993366|NCT01468922|471603810|FG006|Overall Study|Screening failure|0|||
130993367|NCT01468922|471603811|FG007|Overall Study|Screening failure|0|||
130993368|NCT01468922|471603812|FG008|Overall Study|Screening failure|1|||
130993369|NCT01468922|471603804|FG000|Overall Study|Per patient choice|1|||
130993370|NCT01468922|471603805|FG001|Overall Study|Per patient choice|0|||
130993371|NCT01468922|471603806|FG002|Overall Study|Per patient choice|0|||
130993372|NCT01468922|471603807|FG003|Overall Study|Per patient choice|0|||
130993373|NCT01468922|471603808|FG004|Overall Study|Per patient choice|0|||
130993374|NCT01468922|471603809|FG005|Overall Study|Per patient choice|0|||
130993375|NCT01468922|471603810|FG006|Overall Study|Per patient choice|0|||
130993376|NCT01468922|471603811|FG007|Overall Study|Per patient choice|0|||
130993377|NCT01468922|471603812|FG008|Overall Study|Per patient choice|0|||
130993378|NCT01468922|471603804|FG000|Overall Study|Switched to alternative treatment|1|||
130993379|NCT01468922|471603805|FG001|Overall Study|Switched to alternative treatment|0|||
130993380|NCT01468922|471603806|FG002|Overall Study|Switched to alternative treatment|0|||
130993381|NCT01468922|471603807|FG003|Overall Study|Switched to alternative treatment|0|||
130993382|NCT01468922|471603808|FG004|Overall Study|Switched to alternative treatment|1|||
130993383|NCT01468922|471603809|FG005|Overall Study|Switched to alternative treatment|0|||
130993384|NCT01468922|471603810|FG006|Overall Study|Switched to alternative treatment|0|||
130993385|NCT01468922|471603811|FG007|Overall Study|Switched to alternative treatment|0|||
130993386|NCT01468922|471603812|FG008|Overall Study|Switched to alternative treatment|0|||
130993387|NCT01468922|471603804|FG000|Overall Study|Enrolled on new protocol|0|||
130993388|NCT01468922|471603805|FG001|Overall Study|Enrolled on new protocol|0|||
130993389|NCT01468922|471603806|FG002|Overall Study|Enrolled on new protocol|0|||
130993390|NCT01468922|471603807|FG003|Overall Study|Enrolled on new protocol|0|||
130993391|NCT01468922|471603808|FG004|Overall Study|Enrolled on new protocol|1|||
130993392|NCT01468922|471603809|FG005|Overall Study|Enrolled on new protocol|0|||
130993393|NCT01468922|471603810|FG006|Overall Study|Enrolled on new protocol|0|||
130993394|NCT01468922|471603811|FG007|Overall Study|Enrolled on new protocol|0|||
130993395|NCT01468922|471603812|FG008|Overall Study|Enrolled on new protocol|0|||
130993396|NCT01468922|471603804|FG000|Overall Study|Adverse Event|0|||
130993397|NCT01468922|471603805|FG001|Overall Study|Adverse Event|0|||
130993398|NCT01468922|471603806|FG002|Overall Study|Adverse Event|0|||
130993399|NCT01468922|471603807|FG003|Overall Study|Adverse Event|0|||
130993400|NCT01468922|471603808|FG004|Overall Study|Adverse Event|0|||
130993401|NCT01468922|471603809|FG005|Overall Study|Adverse Event|0|||
130993402|NCT01468922|471603810|FG006|Overall Study|Adverse Event|0|||
130993403|NCT01468922|471603811|FG007|Overall Study|Adverse Event|1|||
130993404|NCT01468922|471603812|FG008|Overall Study|Adverse Event|0|||
130993405|NCT01468922|471603804|FG000|Overall Study|Infection of blood|0|||
130993406|NCT01468922|471603805|FG001|Overall Study|Infection of blood|0|||
130993407|NCT01468922|471603806|FG002|Overall Study|Infection of blood|0|||
130993408|NCT01468922|471603807|FG003|Overall Study|Infection of blood|0|||
130993409|NCT01468922|471603808|FG004|Overall Study|Infection of blood|0|||
130993410|NCT01468922|471603809|FG005|Overall Study|Infection of blood|0|||
130993411|NCT01468922|471603810|FG006|Overall Study|Infection of blood|0|||
130993412|NCT01468922|471603811|FG007|Overall Study|Infection of blood|1|||
130993413|NCT01468922|471603812|FG008|Overall Study|Infection of blood|0|||
130993414|NCT01468922|471603804|FG000|Overall Study|Patient choice - surgery|0|||
130993415|NCT01468922|471603805|FG001|Overall Study|Patient choice - surgery|0|||
130993416|NCT01468922|471603806|FG002|Overall Study|Patient choice - surgery|0|||
130993417|NCT01468922|471603807|FG003|Overall Study|Patient choice - surgery|0|||
130993418|NCT01468922|471603808|FG004|Overall Study|Patient choice - surgery|0|||
130993419|NCT01468922|471603809|FG005|Overall Study|Patient choice - surgery|0|||
130993420|NCT01468922|471603810|FG006|Overall Study|Patient choice - surgery|0|||
130993421|NCT01468922|471603811|FG007|Overall Study|Patient choice - surgery|1|||
130993422|NCT01468922|471603812|FG008|Overall Study|Patient choice - surgery|0|||
130993423|NCT01468922|471603804|FG000|Overall Study|Refused further treatment|0|||
130993424|NCT01468922|471603805|FG001|Overall Study|Refused further treatment|0|||
130993425|NCT01468922|471603806|FG002|Overall Study|Refused further treatment|0|||
130993426|NCT01468922|471603807|FG003|Overall Study|Refused further treatment|0|||
130993427|NCT01468922|471603808|FG004|Overall Study|Refused further treatment|0|||
130993428|NCT01468922|471603809|FG005|Overall Study|Refused further treatment|0|||
130993429|NCT01468922|471603810|FG006|Overall Study|Refused further treatment|0|||
130993430|NCT01468922|471603811|FG007|Overall Study|Refused further treatment|1|||
130993431|NCT01468922|471603812|FG008|Overall Study|Refused further treatment|0|||
130993432|NCT03662997|471603819|FG000|Overall Study|Adverse Event|0|||
130993433|NCT03662997|471603820|FG001|Overall Study|Adverse Event|2|||
130993434|NCT03662997|471603821|FG002|Overall Study|Adverse Event|0|||
130993435|NCT03662997|471603822|FG003|Overall Study|Adverse Event|0|||
130993436|NCT00007475|471603823|FG000|Overall Study|Withdrawal by Subject|1|||
130993437|NCT00007475|471603824|FG001|Overall Study|Withdrawal by Subject|0|||
130993438|NCT00007475|471603825|FG002|Overall Study|Withdrawal by Subject|0|||
130993439|NCT00007475|471603826|FG003|Overall Study|Withdrawal by Subject|0|||
130993440|NCT00007475|471603823|FG000|Overall Study|Adverse Event|3|||
130993441|NCT00007475|471603824|FG001|Overall Study|Adverse Event|0|||
130993442|NCT00007475|471603825|FG002|Overall Study|Adverse Event|0|||
130993443|NCT00007475|471603826|FG003|Overall Study|Adverse Event|0|||
130993444|NCT01719224|471603827|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
131220056|NCT01345058|472430741|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
131220057|NCT01345058|472430742|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
131220058|NCT01345058|472430741|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
131220059|NCT01345058|472430742|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
131220060|NCT01345058|472430741|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
131220061|NCT01345058|472430742|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
131220062|NCT01892020|472430749|FG000|Period 1|Adverse Event|1|||
131220063|NCT01892020|472430750|FG001|Period 1|Adverse Event|1|||
131220064|NCT01892020|472430749|FG000|Period 1|Protocol Violation|2|||
131220065|NCT01892020|472430750|FG001|Period 1|Protocol Violation|4|||
131220066|NCT01892020|472430749|FG000|Period 1|Unclassified|0|||
131220067|NCT01892020|472430750|FG001|Period 1|Unclassified|1|||
131220068|NCT01892020|472430749|FG000|Period 2|Protocol Violation|1|||
131220069|NCT01892020|472430750|FG001|Period 2|Protocol Violation|0|||
131220070|NCT01796860|472432155|FG000|Overall Study|Withdrawal by Subject|3|||
131220071|NCT02703454|472432160|FG000|Overall Study|Not treated|1|||
131220072|NCT02703454|472432161|FG001|Overall Study|Not treated|3|||
131220073|NCT02703454|472432160|FG000|Overall Study|Withdrawal by Subject|4|||
131220074|NCT02703454|472432161|FG001|Overall Study|Withdrawal by Subject|3|||
131220075|NCT02703454|472432160|FG000|Overall Study|Lost to Follow-up|1|||
131220076|NCT02703454|472432161|FG001|Overall Study|Lost to Follow-up|2|||
131220077|NCT02703454|472432160|FG000|Overall Study|Study discontinuation|5|||
131220078|NCT02703454|472432161|FG001|Overall Study|Study discontinuation|8|||
131220079|NCT02284373|472432162|FG000|Overall Study|Withdrawal by Subject|0|||
131220080|NCT02284373|472432163|FG001|Overall Study|Withdrawal by Subject|1|||
131220081|NCT02284373|472432164|FG002|Overall Study|Withdrawal by Subject|0|||
131220082|NCT02284373|472432162|FG000|Overall Study|Other|0|||
131220083|NCT02284373|472432163|FG001|Overall Study|Other|1|||
131220084|NCT02284373|472432164|FG002|Overall Study|Other|0|||
131220085|NCT02284373|472432162|FG000|Overall Study|Lost to Follow-up|0|||
131220086|NCT02284373|472432163|FG001|Overall Study|Lost to Follow-up|1|||
131220087|NCT02284373|472432164|FG002|Overall Study|Lost to Follow-up|0|||
131220088|NCT02016755|472432165|FG000|Overall Study|Major amputation of index limb|2|||
131220089|NCT02016755|472432165|FG000|Overall Study|Adverse Event|2|||
131220090|NCT02016755|472432165|FG000|Overall Study|Physician Decision|1|||
131220091|NCT02016755|472432165|FG000|Overall Study|Death|2|||
131220092|NCT02499406|472432166|FG000|Overall Study|missed 3 treatment sessions|4|||
131220093|NCT04651218|472432170|FG000|Overall Study|Withdrawal by Subject|0|||
131220094|NCT04651218|472432171|FG001|Overall Study|Withdrawal by Subject|2|||
131220095|NCT00414011|472432172|FG000|Overall Study|Physician Decision|3|||
131220096|NCT00414011|472432172|FG000|Overall Study|Withdrawal by Subject|2|||
131220097|NCT02476851|472432173|FG000|Overall Study|Protocol Violation|1|||
131220098|NCT02476851|472432174|FG001|Overall Study|Protocol Violation|1|||
131220099|NCT01399125|472432177|FG000|Overall Study|Adverse Event|32|||
131220100|NCT01399125|472432178|FG001|Overall Study|Adverse Event|30|||
130882770|NCT00911170|471205639|FG000|Treatment Period|Disease progression|0|||
130882771|NCT00911170|471205640|FG001|Treatment Period|Disease progression|2|||
130882772|NCT00911170|471205639|FG000|Treatment Period|Physician Decision|5|||
130882773|NCT00911170|471205640|FG001|Treatment Period|Physician Decision|5|||
130882774|NCT00911170|471205639|FG000|Treatment Period|Lost to Follow-up|0|||
130882775|NCT00911170|471205640|FG001|Treatment Period|Lost to Follow-up|1|||
130882776|NCT00911170|471205639|FG000|Treatment Period|Death|6|||
130882777|NCT00911170|471205640|FG001|Treatment Period|Death|9|||
130882778|NCT00911170|471205639|FG000|Long Term Follow-Up|Continuing in study|274|||
130882779|NCT00911170|471205640|FG001|Long Term Follow-Up|Continuing in study|269|||
130882780|NCT00911170|471205639|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
130882781|NCT00911170|471205640|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
130882782|NCT00911170|471205639|FG000|Long Term Follow-Up|Physician Decision|5|||
130882783|NCT00911170|471205640|FG001|Long Term Follow-Up|Physician Decision|4|||
130882784|NCT00911170|471205639|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
130882785|NCT00911170|471205640|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
130882786|NCT00911170|471205639|FG000|Long Term Follow-Up|Death|116|||
130882787|NCT00911170|471205640|FG001|Long Term Follow-Up|Death|121|||
130993445|NCT01719224|471603828|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
131220101|NCT01399125|472432177|FG000|Overall Study|Abnormal Lab values|0|||
131220102|NCT01399125|472432178|FG001|Overall Study|Abnormal Lab values|1|||
131220103|NCT01399125|472432177|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131220104|NCT01399125|472432178|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
131220105|NCT01399125|472432177|FG000|Overall Study|Withdrawal by Subject|5|||
131220106|NCT01399125|472432178|FG001|Overall Study|Withdrawal by Subject|8|||
131220107|NCT01399125|472432177|FG000|Overall Study|Lost to Follow-up|2|||
131220108|NCT01399125|472432178|FG001|Overall Study|Lost to Follow-up|3|||
131220109|NCT01399125|472432177|FG000|Overall Study|Administrative Problems|7|||
131220110|NCT01399125|472432178|FG001|Overall Study|Administrative Problems|11|||
130882788|NCT01899040|471205641|FG000|Overall Study|Randomized in error|0|||
130882789|NCT01899040|471205642|FG001|Overall Study|Randomized in error|1|||
130882790|NCT01899040|471205643|FG002|Overall Study|Randomized in error|1|||
131220111|NCT01399125|472432177|FG000|Overall Study|Death|0|||
131220112|NCT01399125|472432178|FG001|Overall Study|Death|1|||
130993446|NCT03000673|471603829|FG000|Overall Study|Withdrawal by Subject|1|||
130993447|NCT03000673|471603830|FG001|Overall Study|Withdrawal by Subject|0|||
130993448|NCT03000673|471603831|FG002|Overall Study|Withdrawal by Subject|0|||
130993449|NCT03000673|471603832|FG003|Overall Study|Withdrawal by Subject|0|||
131220113|NCT01399125|472432177|FG000|Overall Study|Protocol Deviation|5|||
131220114|NCT01399125|472432178|FG001|Overall Study|Protocol Deviation|2|||
131220115|NCT00647426|472432179|FG000|Overall Study|Withdrawal by Subject|2|||
131220116|NCT00306852|472432184|FG000|Overall Study|Death|14|||
131220117|NCT00306852|472432185|FG001|Overall Study|Death|14|||
131220118|NCT00306852|472432184|FG000|Overall Study|Lost to Follow-up|15|||
131220119|NCT00306852|472432185|FG001|Overall Study|Lost to Follow-up|24|||
131220120|NCT00883740|472432186|FG000|First Intervention|Lost to Follow-up|1|||
131220121|NCT00883740|472432187|FG001|First Intervention|Lost to Follow-up|0|||
131220122|NCT00883740|472432186|FG000|First Intervention|No longer willing to participate|2|||
131220123|NCT00883740|472432187|FG001|First Intervention|No longer willing to participate|0|||
131220124|NCT00883740|472432186|FG000|First Intervention|Protocol Violation|3|||
131220125|NCT00883740|472432187|FG001|First Intervention|Protocol Violation|6|||
131220126|NCT00883740|472432186|FG000|First Intervention|Adverse Event|1|||
131220127|NCT00883740|472432187|FG001|First Intervention|Adverse Event|2|||
131220128|NCT00883740|472432186|FG000|Second Intervention|Protocol Violation|1|||
131220129|NCT00883740|472432187|FG001|Second Intervention|Protocol Violation|0|||
131220130|NCT00883740|472432186|FG000|Second Intervention|No longer willing to participate|0|||
131220131|NCT00883740|472432187|FG001|Second Intervention|No longer willing to participate|1|||
131220132|NCT03543046|472432192|FG000|Overall Study|Adverse Event|1|||
131220133|NCT03543046|472432193|FG001|Overall Study|Adverse Event|1|||
131220134|NCT03543046|472432192|FG000|Overall Study|Physician Decision|1|||
131220135|NCT03543046|472432193|FG001|Overall Study|Physician Decision|1|||
131220136|NCT03543046|472432192|FG000|Overall Study|Protocol Violation|1|||
131220137|NCT03543046|472432193|FG001|Overall Study|Protocol Violation|0|||
131220138|NCT03869684|472432194|FG000|Overall Study|Adverse Event|0|||
131220139|NCT03869684|472432195|FG001|Overall Study|Adverse Event|3|||
131220140|NCT03869684|472432196|FG002|Overall Study|Adverse Event|1|||
131220141|NCT03869684|472432194|FG000|Overall Study|Withdrawal by Subject|1|||
131220142|NCT03869684|472432195|FG001|Overall Study|Withdrawal by Subject|0|||
131220143|NCT03869684|472432196|FG002|Overall Study|Withdrawal by Subject|0|||
131220144|NCT03869684|472432194|FG000|Overall Study|Lost to Follow-up|1|||
131220145|NCT03869684|472432195|FG001|Overall Study|Lost to Follow-up|0|||
131220146|NCT03869684|472432196|FG002|Overall Study|Lost to Follow-up|0|||
131220147|NCT03869684|472432194|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
131220148|NCT03869684|472432195|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
131220149|NCT03869684|472432196|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
131220150|NCT04056299|472432197|FG000|Overall Study|Sponsor discontinued study|3|||
131220151|NCT04056299|472432198|FG001|Overall Study|Sponsor discontinued study|3|||
131220152|NCT01227954|472432203|FG000|Overall Study|Protocol Violation|6|||
131220153|NCT01227954|472432203|FG000|Overall Study|No protocol treatment|7|||
131220154|NCT01296152|472432204|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
131220155|NCT01414062|472432209|FG000|Overall Study|Lost to Follow-up|3|||
131220156|NCT01414062|472432210|FG001|Overall Study|Lost to Follow-up|2|||
131220157|NCT01414062|472432209|FG000|Overall Study|Left Country|1|||
131220158|NCT01414062|472432210|FG001|Overall Study|Left Country|1|||
131220159|NCT01414062|472432209|FG000|Overall Study|Family Disapproval|1|||
130993450|NCT01121484|471603834|FG000|Overall Study|Adverse Event|12|||
130993451|NCT01121484|471603835|FG001|Overall Study|Adverse Event|5|||
130993452|NCT01121484|471603834|FG000|Overall Study|Lack of Efficacy|3|||
130993453|NCT01121484|471603835|FG001|Overall Study|Lack of Efficacy|11|||
130993454|NCT01121484|471603834|FG000|Overall Study|Lost to Follow-up|5|||
130993455|NCT01121484|471603835|FG001|Overall Study|Lost to Follow-up|9|||
130993456|NCT01121484|471603834|FG000|Overall Study|Physician Decision|0|||
130993457|NCT01121484|471603835|FG001|Overall Study|Physician Decision|3|||
130993458|NCT01121484|471603834|FG000|Overall Study|Protocol Violation|1|||
130993459|NCT01121484|471603835|FG001|Overall Study|Protocol Violation|0|||
130993460|NCT01121484|471603834|FG000|Overall Study|Withdrawal by Subject|8|||
130993461|NCT01121484|471603835|FG001|Overall Study|Withdrawal by Subject|7|||
130993462|NCT01121484|471603834|FG000|Overall Study|Discontinuation of study by sponsor|0|||
130993463|NCT01121484|471603835|FG001|Overall Study|Discontinuation of study by sponsor|1|||
131220160|NCT01414062|472432210|FG001|Overall Study|Family Disapproval|0|||
131220161|NCT01414062|472432209|FG000|Overall Study|Withdrawal by Subject|0|||
131220162|NCT01414062|472432210|FG001|Overall Study|Withdrawal by Subject|1|||
131220163|NCT04285983|472432211|FG000|Overall Study|Protocol Violation|6|||
131220164|NCT04936334|472432212|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
131220165|NCT00422058|472432213|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
131220166|NCT00422058|472432214|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
130993464|NCT01121484|471603834|FG000|Overall Study|Other|3|||
130993465|NCT01121484|471603835|FG001|Overall Study|Other|3|||
131220167|NCT00422058|472432215|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
131220168|NCT00422058|472432216|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
130993466|NCT01121484|471603834|FG000|Overall Study|Randomized, not treated|1|||
130993467|NCT01121484|471603835|FG001|Overall Study|Randomized, not treated|4|||
130993468|NCT01512745|471603836|FG000|Overall Study|Adverse Event|22|||
130993469|NCT01512745|471603837|FG001|Overall Study|Adverse Event|3|||
130993470|NCT01512745|471603836|FG000|Overall Study|Death|9|||
130993471|NCT01512745|471603837|FG001|Overall Study|Death|13|||
130993472|NCT01512745|471603836|FG000|Overall Study|Withdrawal by Subject|2|||
130993473|NCT01512745|471603837|FG001|Overall Study|Withdrawal by Subject|2|||
130993474|NCT01512745|471603836|FG000|Overall Study|Lost to Follow-up|4|||
130993475|NCT01512745|471603837|FG001|Overall Study|Lost to Follow-up|0|||
130993476|NCT01512745|471603836|FG000|Overall Study|Lack of Efficacy|2|||
130993477|NCT01512745|471603837|FG001|Overall Study|Lack of Efficacy|2|||
130993478|NCT01512745|471603836|FG000|Overall Study|Protocol Violation|1|||
130993479|NCT01512745|471603837|FG001|Overall Study|Protocol Violation|0|||
130993480|NCT02357810|471603838|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
130993481|NCT02357810|471603838|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
130993482|NCT02357810|471603838|FG000|Reached 12 Weeks Response|Adverse Event|5|||
130993483|NCT02357810|471603838|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
130993484|NCT02357810|471603838|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
130993485|NCT02357810|471603838|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
130993486|NCT02357810|471603838|FG000|Reached 12 Weeks Response|Death|1|||
130993487|NCT02357810|471603838|FG000|Reached 12 Weeks Response|Physician Decision|1|||
130993488|NCT02357810|471603838|FG000|Reached 12 Weeks Response|Other|1|||
130993489|NCT02357810|471603838|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
130993490|NCT02357810|471603838|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
130993491|NCT02357810|471603838|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
130993492|NCT02357810|471603838|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
131220169|NCT00422058|472432217|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
131220170|NCT00422058|472432218|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
131220171|NCT00422058|472432213|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
131220172|NCT00422058|472432214|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
131220173|NCT00422058|472432215|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
131220174|NCT00422058|472432216|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
131220175|NCT00422058|472432217|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
131220176|NCT00422058|472432218|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
131220177|NCT00422058|472432213|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
131220178|NCT00422058|472432214|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
131220179|NCT00422058|472432215|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
131220180|NCT00422058|472432216|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
131220181|NCT00422058|472432217|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
131220182|NCT00422058|472432218|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
131220183|NCT00422058|472432213|FG000|Double-Blind, Week 0-20|Other|11|||
131220184|NCT00422058|472432214|FG001|Double-Blind, Week 0-20|Other|3|||
131220185|NCT00422058|472432215|FG002|Double-Blind, Week 0-20|Other|8|||
131220186|NCT00422058|472432216|FG003|Double-Blind, Week 0-20|Other|8|||
131220187|NCT00422058|472432217|FG004|Double-Blind, Week 0-20|Other|4|||
131220188|NCT00422058|472432218|FG005|Double-Blind, Week 0-20|Other|10|||
131220189|NCT00422058|472432213|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
131220190|NCT00422058|472432214|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
131220191|NCT00422058|472432215|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
131220192|NCT00422058|472432216|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
131220193|NCT00422058|472432217|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
131220194|NCT00422058|472432218|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
131220195|NCT00422058|472432213|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
130882791|NCT01899040|471205641|FG000|Overall Study|Adverse Event|3|||
130882792|NCT01899040|471205642|FG001|Overall Study|Adverse Event|1|||
130882793|NCT01899040|471205643|FG002|Overall Study|Adverse Event|2|||
130882794|NCT01899040|471205641|FG000|Overall Study|Unspecified reasons|4|||
130882795|NCT01899040|471205642|FG001|Overall Study|Unspecified reasons|4|||
130882796|NCT01899040|471205643|FG002|Overall Study|Unspecified reasons|0|||
130882797|NCT01899040|471205641|FG000|Overall Study|Compliance issues|1|||
130882798|NCT01899040|471205642|FG001|Overall Study|Compliance issues|2|||
130882799|NCT01899040|471205643|FG002|Overall Study|Compliance issues|0|||
130882800|NCT00905164|471205644|FG000|Period 1|Protocol Violation|0|||
130882801|NCT00905164|471205645|FG001|Period 1|Protocol Violation|1|||
130882802|NCT01256788|471207792|FG000|Overall Study|Lost to Follow-up|5|||
130882803|NCT01256788|471207793|FG001|Overall Study|Lost to Follow-up|8|||
130882804|NCT01256788|471207794|FG002|Overall Study|Lost to Follow-up|3|||
130882805|NCT05366738|471207795|FG000|Overall Study|Adverse Event|0|||
130882806|NCT05366738|471207796|FG001|Overall Study|Adverse Event|1|||
130882807|NCT05366738|471207797|FG002|Overall Study|Adverse Event|0|||
130882808|NCT00906204|471207798|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
130882809|NCT00906204|471207799|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
131220196|NCT00422058|472432214|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
131220197|NCT00422058|472432215|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
131220198|NCT00422058|472432216|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
131220199|NCT00422058|472432217|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
131220200|NCT00422058|472432218|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
131220201|NCT00422058|472432213|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
131220202|NCT00422058|472432214|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
131220203|NCT00422058|472432215|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
131220204|NCT00422058|472432216|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
131220205|NCT00422058|472432217|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
131220206|NCT00422058|472432218|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
131220207|NCT00422058|472432213|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
131220208|NCT00422058|472432214|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
131220209|NCT00422058|472432215|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
131220210|NCT00422058|472432216|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
131220211|NCT00422058|472432217|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
131220212|NCT00422058|472432218|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
131220213|NCT00422058|472432213|FG000|Open-Label Extension, Week 20-104|Other|13|||
131220214|NCT00422058|472432214|FG001|Open-Label Extension, Week 20-104|Other|14|||
131220215|NCT00422058|472432215|FG002|Open-Label Extension, Week 20-104|Other|6|||
131220216|NCT00422058|472432216|FG003|Open-Label Extension, Week 20-104|Other|13|||
131220217|NCT00422058|472432217|FG004|Open-Label Extension, Week 20-104|Other|16|||
131220218|NCT00422058|472432218|FG005|Open-Label Extension, Week 20-104|Other|18|||
131220219|NCT02787785|472432221|FG000|Overall Study|Death|3|||
131220220|NCT02787785|472432222|FG001|Overall Study|Death|4|||
131220221|NCT02787785|472432221|FG000|Overall Study|Lost to Follow-up|1|||
131220222|NCT02787785|472432222|FG001|Overall Study|Lost to Follow-up|1|||
131220223|NCT02787785|472432221|FG000|Overall Study|Withdrawal by Subject|0|||
131220224|NCT02787785|472432222|FG001|Overall Study|Withdrawal by Subject|5|||
131220225|NCT00103259|472432226|FG000|Overall Study|Death|3|||
131220226|NCT00103259|472432227|FG001|Overall Study|Death|2|||
131220227|NCT00103259|472432226|FG000|Overall Study|Withdrawal by Subject|2|||
131220228|NCT00103259|472432227|FG001|Overall Study|Withdrawal by Subject|3|||
131220229|NCT00103259|472432226|FG000|Overall Study|alternative therapy|1|||
131220230|NCT00103259|472432227|FG001|Overall Study|alternative therapy|0|||
131220231|NCT00103259|472432226|FG000|Overall Study|other (reasons were not specified)|2|||
131220232|NCT00103259|472432227|FG001|Overall Study|other (reasons were not specified)|1|||
131220233|NCT00103259|472432226|FG000|Overall Study|ineligible/no protocol therapy|4|||
131220234|NCT00103259|472432227|FG001|Overall Study|ineligible/no protocol therapy|6|||
131220235|NCT02866695|472432232|FG000|Overall Study|Adverse Event|1|||
131220236|NCT02866695|472432232|FG000|Overall Study|Lost to Follow-up|1|||
131220237|NCT03224234|472432233|FG000|Main Study|Lost to Follow-up|5|||
131220238|NCT03224234|472432234|FG001|Main Study|Lost to Follow-up|5|||
131220239|NCT02564952|472432235|FG000|Overall Study|Adverse Event|6|||
131220240|NCT02564952|472432235|FG000|Overall Study|Lost to Follow-up|1|||
131220241|NCT02564952|472432235|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
131220242|NCT02564952|472432235|FG000|Overall Study|Withdrawal by Subject|1|||
131220243|NCT02564952|472432235|FG000|Overall Study|Low Efficacy|1|||
131220244|NCT02564952|472432235|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
131220245|NCT00756652|472432236|FG000|Original Phase|Withdrawal by Subject|864|||
131220246|NCT00756652|472432237|FG001|Original Phase|Withdrawal by Subject|23|||
131220247|NCT00756652|472432236|FG000|Original Phase|Lost to Follow-up|601|||
131220248|NCT00756652|472432237|FG001|Original Phase|Lost to Follow-up|0|||
131220249|NCT00756652|472432236|FG000|Original Phase|Other Discontinuation|797|||
131220250|NCT00756652|472432237|FG001|Original Phase|Other Discontinuation|5|||
131220251|NCT00756652|472432236|FG000|Original Phase|Participant Noncompliance|18622|||
131220252|NCT00756652|472432237|FG001|Original Phase|Participant Noncompliance|424|||
131220253|NCT00756652|472432236|FG000|Original Phase|Unknown Discontinuation Reason|2|||
131220254|NCT00756652|472432237|FG001|Original Phase|Unknown Discontinuation Reason|0|||
131220255|NCT00756652|472432236|FG000|Original Phase|Participants without data|3259|||
131220256|NCT00756652|472432237|FG001|Original Phase|Participants without data|466|||
131220257|NCT00756652|472432236|FG000|Original Phase|Death|168|||
131220258|NCT00756652|472432237|FG001|Original Phase|Death|1|||
131220259|NCT00756652|472432236|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
131220260|NCT00756652|472432237|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
131220261|NCT00756652|472432236|FG000|Re-Op Phase|Withdrawal by Subject|62|||
131220262|NCT00756652|472432237|FG001|Re-Op Phase|Withdrawal by Subject|0|||
131220263|NCT00756652|472432236|FG000|Re-Op Phase|Death|6|||
131220264|NCT00756652|472432237|FG001|Re-Op Phase|Death|0|||
131220265|NCT00756652|472432236|FG000|Re-Op Phase|Lost to Follow-up|340|||
131220266|NCT00756652|472432237|FG001|Re-Op Phase|Lost to Follow-up|0|||
131220267|NCT00756652|472432236|FG000|Re-Op Phase|Site Closed|2454|||
131220268|NCT00756652|472432237|FG001|Re-Op Phase|Site Closed|0|||
131220269|NCT00756652|472432236|FG000|Re-Op Phase|Withdrawn after explant|14|||
131220270|NCT00756652|472432237|FG001|Re-Op Phase|Withdrawn after explant|0|||
131220271|NCT02610842|472432238|FG000|Overall Study|Lost to Follow-up|5|||
131220272|NCT01850108|472432239|FG000|Overall Study|Lost to Follow-up|4|||
131220273|NCT01850108|472432239|FG000|Overall Study|Not eligible|1|||
131220274|NCT01850108|472432239|FG000|Overall Study|Failed engraftment|2|||
131220275|NCT01850108|472432239|FG000|Overall Study|Physician Decision|1|||
131220276|NCT00038467|472432240|FG000|Overall Study|Adverse Event|170|||
131220277|NCT00038467|472432241|FG001|Overall Study|Adverse Event|145|||
131220278|NCT00038467|472432240|FG000|Overall Study|Withdrawal by Subject|150|||
130993493|NCT02357810|471603838|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
130993494|NCT02357810|471603838|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
130993495|NCT00675506|471603842|FG000|Overall Study|Lost to Follow-up|1|||
130993496|NCT00675506|471603843|FG001|Overall Study|Lost to Follow-up|5|||
130993497|NCT00675506|471603842|FG000|Overall Study|Lost interest|3|||
130993498|NCT00675506|471603843|FG001|Overall Study|Lost interest|5|||
130993499|NCT00675506|471603842|FG000|Overall Study|Elevated fasting glucose|2|||
130993500|NCT00675506|471603843|FG001|Overall Study|Elevated fasting glucose|1|||
130993501|NCT00675506|471603842|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
130993502|NCT00675506|471603843|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
130993503|NCT00675506|471603842|FG000|Overall Study|Elevated IGF-1|2|||
130993504|NCT00675506|471603843|FG001|Overall Study|Elevated IGF-1|0|||
130993505|NCT00675506|471603842|FG000|Overall Study|Hypersensitivity Reaction|1|||
130993506|NCT00675506|471603843|FG001|Overall Study|Hypersensitivity Reaction|0|||
130993507|NCT00675506|471603842|FG000|Overall Study|Disclosed history of cancer|1|||
130993508|NCT00675506|471603843|FG001|Overall Study|Disclosed history of cancer|0|||
130993509|NCT00675506|471603842|FG000|Overall Study|Declined participation|1|||
130993510|NCT00675506|471603843|FG001|Overall Study|Declined participation|0|||
130993511|NCT00675506|471603842|FG000|Overall Study|Schedule conflict|0|||
130993512|NCT00675506|471603843|FG001|Overall Study|Schedule conflict|1|||
130993513|NCT00936221|471603844|FG000|Overall Study|Withdrawal by Subject|1|||
130993514|NCT00936221|471603845|FG001|Overall Study|Withdrawal by Subject|1|||
130993515|NCT03820323|471603846|FG000|Overall Study|Lost to Follow-up|2|||
130993516|NCT03820323|471603847|FG001|Overall Study|Lost to Follow-up|1|||
130993517|NCT03820323|471603846|FG000|Overall Study|Missed 12-month visit|22|||
130993518|NCT03820323|471603847|FG001|Overall Study|Missed 12-month visit|14|||
130993519|NCT03820323|471603846|FG000|Overall Study|Death|2|||
130993520|NCT03820323|471603847|FG001|Overall Study|Death|1|||
130993521|NCT03820323|471603846|FG000|Overall Study|Transferred out|13|||
130993522|NCT03820323|471603847|FG001|Overall Study|Transferred out|11|||
130993523|NCT03820323|471603846|FG000|Overall Study|Terminated|0|||
130993524|NCT03820323|471603847|FG001|Overall Study|Terminated|3|||
130993525|NCT03820323|471603846|FG000|Overall Study|Withdrawal by Subject|1|||
130993526|NCT03820323|471603847|FG001|Overall Study|Withdrawal by Subject|6|||
130993527|NCT03151395|471603848|FG000|Overall Study|Adverse Event|2|||
130993528|NCT03151395|471603848|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
130993529|NCT03151395|471603848|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
130993530|NCT03151395|471603848|FG000|Overall Study|Unspecified reason|4|||
130993531|NCT05644353|471603849|FG000|Overall Study|Physician Decision|1|||
130993532|NCT05644353|471603850|FG001|Overall Study|Physician Decision|0|||
130993533|NCT05644353|471603851|FG002|Overall Study|Physician Decision|0|||
130993534|NCT05644353|471603852|FG003|Overall Study|Physician Decision|0|||
130993535|NCT05644353|471603853|FG004|Overall Study|Physician Decision|0|||
130993536|NCT05644353|471603854|FG005|Overall Study|Physician Decision|0|||
130993537|NCT05644353|471603849|FG000|Overall Study|Protocol Violation|1|||
130993538|NCT05644353|471603850|FG001|Overall Study|Protocol Violation|0|||
130993539|NCT05644353|471603851|FG002|Overall Study|Protocol Violation|0|||
130993540|NCT05644353|471603852|FG003|Overall Study|Protocol Violation|0|||
130993541|NCT05644353|471603853|FG004|Overall Study|Protocol Violation|0|||
130993542|NCT05644353|471603854|FG005|Overall Study|Protocol Violation|0|||
130993543|NCT05644353|471603849|FG000|Overall Study|Withdrawal by Subject|0|||
130993544|NCT05644353|471603850|FG001|Overall Study|Withdrawal by Subject|2|||
130993545|NCT05644353|471603851|FG002|Overall Study|Withdrawal by Subject|0|||
131220279|NCT00038467|472432241|FG001|Overall Study|Withdrawal by Subject|107|||
131220280|NCT00038467|472432240|FG000|Overall Study|Protocol Violation|19|||
130993546|NCT05644353|471603852|FG003|Overall Study|Withdrawal by Subject|0|||
130993547|NCT05644353|471603853|FG004|Overall Study|Withdrawal by Subject|1|||
130993548|NCT05644353|471603854|FG005|Overall Study|Withdrawal by Subject|0|||
130993549|NCT05644353|471603849|FG000|Overall Study|Lost to Follow-up|0|||
130993550|NCT05644353|471603850|FG001|Overall Study|Lost to Follow-up|0|||
131220281|NCT00038467|472432241|FG001|Overall Study|Protocol Violation|22|||
130993551|NCT05644353|471603851|FG002|Overall Study|Lost to Follow-up|1|||
130993552|NCT05644353|471603852|FG003|Overall Study|Lost to Follow-up|0|||
130993553|NCT05644353|471603853|FG004|Overall Study|Lost to Follow-up|0|||
130993554|NCT05644353|471603854|FG005|Overall Study|Lost to Follow-up|0|||
130993555|NCT01535274|471603855|FG000|Overall Study|Determined to be ineligible|0|||
130993556|NCT01535274|471603856|FG001|Overall Study|Determined to be ineligible|1|||
131220282|NCT00038467|472432240|FG000|Overall Study|Death|22|||
131220283|NCT00038467|472432241|FG001|Overall Study|Death|16|||
131220284|NCT00038467|472432240|FG000|Overall Study|Lost to Follow-up|15|||
131220285|NCT00038467|472432241|FG001|Overall Study|Lost to Follow-up|10|||
131220286|NCT00038467|472432240|FG000|Overall Study|Recurrence|109|||
131220287|NCT00038467|472432241|FG001|Overall Study|Recurrence|179|||
131220288|NCT00038467|472432240|FG000|Overall Study|Randomized, but not treated|31|||
131220289|NCT00038467|472432241|FG001|Overall Study|Randomized, but not treated|35|||
131220290|NCT00038467|472432240|FG000|Overall Study|Other|26|||
131220291|NCT00038467|472432241|FG001|Overall Study|Other|28|||
131220292|NCT01988493|472432242|FG000|Overall Study|Randomized but not treated|0|||
131220293|NCT01988493|472432243|FG001|Overall Study|Randomized but not treated|0|||
131220294|NCT01988493|472432244|FG002|Overall Study|Randomized but not treated|0|||
131220295|NCT01988493|472432245|FG003|Overall Study|Randomized but not treated|0|||
131220296|NCT01988493|472432246|FG004|Overall Study|Randomized but not treated|1|||
131220297|NCT00627458|472432247|FG000|Overall Study|Migrated from study area|1|||
131220298|NCT00627458|472432248|FG001|Overall Study|Migrated from study area|0|||
131220299|NCT00627458|472432249|FG002|Overall Study|Migrated from study area|1|||
131220300|NCT00627458|472432247|FG000|Overall Study|Withdrawal by Subject|2|||
131220301|NCT00627458|472432248|FG001|Overall Study|Withdrawal by Subject|6|||
131220302|NCT00627458|472432249|FG002|Overall Study|Withdrawal by Subject|5|||
131220303|NCT00627458|472432247|FG000|Overall Study|Lost to Follow-up|1|||
131220304|NCT00627458|472432248|FG001|Overall Study|Lost to Follow-up|1|||
131220305|NCT00627458|472432249|FG002|Overall Study|Lost to Follow-up|0|||
131220306|NCT02268045|472432251|FG000|Overall Study|Death|4|||
131220307|NCT02268045|472432252|FG001|Overall Study|Death|4|||
131220308|NCT02268045|472432251|FG000|Overall Study|Disease Progression|2|||
131220309|NCT02268045|472432252|FG001|Overall Study|Disease Progression|1|||
131220310|NCT02268045|472432251|FG000|Overall Study|Adverse Event|7|||
131220311|NCT02268045|472432252|FG001|Overall Study|Adverse Event|7|||
131220312|NCT02268045|472432251|FG000|Overall Study|Withdrawal by Subject|2|||
131220313|NCT02268045|472432252|FG001|Overall Study|Withdrawal by Subject|6|||
131220314|NCT02268045|472432251|FG000|Overall Study|Physician Decision|0|||
131220315|NCT02268045|472432252|FG001|Overall Study|Physician Decision|1|||
131220316|NCT02268045|472432251|FG000|Overall Study|Protocol Violation|1|||
131220317|NCT02268045|472432252|FG001|Overall Study|Protocol Violation|1|||
131220318|NCT01766310|472432253|FG000|Overall Study|Lost to Follow-up|1|||
131220319|NCT01766310|472432254|FG001|Overall Study|Lost to Follow-up|3|||
131220320|NCT01154673|472432255|FG000|Overall Study|Lost to Follow-up|1|||
131220321|NCT01154673|472432256|FG001|Overall Study|Lost to Follow-up|0|||
131220322|NCT01154673|472432255|FG000|Overall Study|moved out of province|1|||
131220323|NCT01154673|472432256|FG001|Overall Study|moved out of province|0|||
131220324|NCT00646282|472432259|FG000|Overall Study|Protocol terminated|4|||
131220325|NCT00646282|472432260|FG001|Overall Study|Protocol terminated|4|||
131220326|NCT02617446|472432261|FG000|Overall Study|Withdrawal by Subject|0|||
130882810|NCT00906204|471207798|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
130882811|NCT00906204|471207799|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
130882812|NCT00906204|471207798|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
130882813|NCT00906204|471207799|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
130882814|NCT00906204|471207798|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
130882815|NCT00906204|471207799|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
130882816|NCT00906204|471207798|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
130882817|NCT00906204|471207799|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
130882818|NCT00696072|471207800|FG000|Overall Study|continuing active treatment|10|||
130882819|NCT00696072|471207801|FG001|Overall Study|continuing active treatment|13|||
130882820|NCT00696072|471207800|FG000|Overall Study|Adverse Event|10|||
130882821|NCT00696072|471207801|FG001|Overall Study|Adverse Event|6|||
130882822|NCT00696072|471207800|FG000|Overall Study|Patient Request|3|||
130882823|NCT00696072|471207801|FG001|Overall Study|Patient Request|7|||
130882824|NCT00696072|471207800|FG000|Overall Study|Investigator Request|1|||
130882825|NCT00696072|471207801|FG001|Overall Study|Investigator Request|4|||
130882826|NCT00696072|471207800|FG000|Overall Study|Sponsor Request|0|||
130882827|NCT00696072|471207801|FG001|Overall Study|Sponsor Request|1|||
130882828|NCT00696072|471207800|FG000|Overall Study|Disease Progression|32|||
130882829|NCT00696072|471207801|FG001|Overall Study|Disease Progression|30|||
130882830|NCT00696072|471207800|FG000|Overall Study|Non-specified|1|||
130882831|NCT00696072|471207801|FG001|Overall Study|Non-specified|2|||
130882832|NCT01597596|471207802|FG000|Overall Study|Study terminated by sponsor|1|||
130882833|NCT01597596|471207803|FG001|Overall Study|Study terminated by sponsor|0|||
130882834|NCT01597596|471207802|FG000|Overall Study|Physician Decision|0|||
130993557|NCT01535274|471603855|FG000|Overall Study|Misallocated to propofol intervention|0|||
131220327|NCT02617446|472432262|FG001|Overall Study|Withdrawal by Subject|2|||
131220328|NCT02617446|472432263|FG002|Overall Study|Withdrawal by Subject|0|||
131220329|NCT02617446|472432261|FG000|Overall Study|Adverse Event|1|||
131220330|NCT02617446|472432262|FG001|Overall Study|Adverse Event|0|||
131220331|NCT02617446|472432263|FG002|Overall Study|Adverse Event|5|||
131220332|NCT02617446|472432261|FG000|Overall Study|Lost to Follow-up|3|||
131220333|NCT02617446|472432262|FG001|Overall Study|Lost to Follow-up|0|||
131220334|NCT02617446|472432263|FG002|Overall Study|Lost to Follow-up|0|||
131220335|NCT02617446|472432261|FG000|Overall Study|Death|0|||
131220336|NCT02617446|472432262|FG001|Overall Study|Death|0|||
131220337|NCT02617446|472432263|FG002|Overall Study|Death|2|||
131220338|NCT01556490|472432272|FG000|Randomized Patients Summary|Protocol Violation|22|||
131220339|NCT01556490|472432273|FG001|Randomized Patients Summary|Protocol Violation|23|||
131220340|NCT01556490|472432272|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
131220341|NCT01556490|472432273|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
131220342|NCT00530088|472432274|FG000|Overall Study|Disease Progression|4|||
131220343|NCT00530088|472432274|FG000|Overall Study|Physician Decision|4|||
131220344|NCT00530088|472432274|FG000|Overall Study|Other Not Specified|2|||
131220345|NCT00902278|472432275|FG000|Overall Study|Physician Decision|1|||
131220346|NCT00902278|472432276|FG001|Overall Study|Physician Decision|0|||
131220347|NCT00902278|472432277|FG002|Overall Study|Physician Decision|2|||
131220348|NCT00902278|472432278|FG003|Overall Study|Physician Decision|0|||
131220349|NCT00902278|472432279|FG004|Overall Study|Physician Decision|1|||
131220350|NCT00902278|472432275|FG000|Overall Study|Lost to Follow-up|3|||
131220351|NCT00902278|472432276|FG001|Overall Study|Lost to Follow-up|2|||
131220352|NCT00902278|472432277|FG002|Overall Study|Lost to Follow-up|3|||
131220353|NCT00902278|472432278|FG003|Overall Study|Lost to Follow-up|0|||
131220354|NCT00902278|472432279|FG004|Overall Study|Lost to Follow-up|1|||
130993558|NCT01535274|471603856|FG001|Overall Study|Misallocated to propofol intervention|1|||
130993559|NCT03679767|471603857|FG000|Overall Study|Death|16|||
130993560|NCT03679767|471603858|FG001|Overall Study|Death|11|||
130993561|NCT03679767|471603859|FG002|Overall Study|Death|17|||
130993562|NCT03679767|471603860|FG003|Overall Study|Death|10|||
130993563|NCT03679767|471603857|FG000|Overall Study|Lost to Follow-up|1|||
130993564|NCT03679767|471603858|FG001|Overall Study|Lost to Follow-up|1|||
130993565|NCT03679767|471603859|FG002|Overall Study|Lost to Follow-up|1|||
130993566|NCT03679767|471603860|FG003|Overall Study|Lost to Follow-up|1|||
130993567|NCT03679767|471603857|FG000|Overall Study|Withdrawal by Subject|0|||
130993568|NCT03679767|471603858|FG001|Overall Study|Withdrawal by Subject|0|||
130993569|NCT03679767|471603859|FG002|Overall Study|Withdrawal by Subject|0|||
130993570|NCT03679767|471603860|FG003|Overall Study|Withdrawal by Subject|1|||
130993571|NCT03679767|471603857|FG000|Overall Study|Follow-up Completed|18|||
130993572|NCT03679767|471603858|FG001|Overall Study|Follow-up Completed|11|||
130993573|NCT03679767|471603859|FG002|Overall Study|Follow-up Completed|11|||
130993574|NCT03679767|471603860|FG003|Overall Study|Follow-up Completed|20|||
130993575|NCT03679767|471603857|FG000|Overall Study|Entered Hospice Care|0|||
130993576|NCT03679767|471603858|FG001|Overall Study|Entered Hospice Care|0|||
130993577|NCT03679767|471603859|FG002|Overall Study|Entered Hospice Care|0|||
130993578|NCT03679767|471603860|FG003|Overall Study|Entered Hospice Care|1|||
130993579|NCT03679767|471603857|FG000|Overall Study|Progressive Disease|0|||
130993580|NCT03679767|471603858|FG001|Overall Study|Progressive Disease|0|||
130993581|NCT03679767|471603859|FG002|Overall Study|Progressive Disease|0|||
130993582|NCT03679767|471603860|FG003|Overall Study|Progressive Disease|1|||
130993583|NCT01407354|471603862|FG000|First Intervention|Withdrawal by Subject|0|||
130993584|NCT01407354|471603863|FG001|First Intervention|Withdrawal by Subject|2|||
130993585|NCT01407354|471603862|FG000|First Intervention|Adverse Event|1|||
130993586|NCT01407354|471603863|FG001|First Intervention|Adverse Event|0|||
130993587|NCT01407354|471603862|FG000|First Intervention|Physician Decision|1|||
130993588|NCT01407354|471603863|FG001|First Intervention|Physician Decision|0|||
130993589|NCT02204579|471603864|FG000|Overall Study|Screen failures|2|||
130993590|NCT02778399|471603865|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
130993591|NCT02778399|471603866|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
130993592|NCT02778399|471603867|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
130993593|NCT02778399|471603868|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
130993594|NCT02778399|471603869|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
130993595|NCT02778399|471603870|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
130993596|NCT02778399|471603865|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
130993597|NCT02778399|471603866|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
130993598|NCT02778399|471603867|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
130993599|NCT02778399|471603868|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
130993600|NCT02778399|471603869|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
130993601|NCT02778399|471603870|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
130993602|NCT02778399|471603865|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
130993603|NCT02778399|471603866|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
130993604|NCT02778399|471603867|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
130993605|NCT02778399|471603868|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
130993606|NCT02778399|471603869|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
131220355|NCT04822701|472432281|FG000|Overall Study|Not treated|2|||
131220356|NCT04822701|472432282|FG001|Overall Study|Not treated|0|||
131220357|NCT04822701|472432281|FG000|Overall Study|Lost to Follow-up|1|||
131220358|NCT04822701|472432282|FG001|Overall Study|Lost to Follow-up|0|||
131220359|NCT04822701|472432281|FG000|Overall Study|Withdrawal by Subject|1|||
130993607|NCT02778399|471603870|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
130993608|NCT02778399|471603865|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
130993609|NCT02778399|471603866|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
131220360|NCT04822701|472432282|FG001|Overall Study|Withdrawal by Subject|0|||
131220361|NCT00391092|472434412|FG000|Overall Study|Death|78|||
131220362|NCT00391092|472434413|FG001|Overall Study|Death|81|||
131220363|NCT00391092|472434412|FG000|Overall Study|Lost to Follow-up|13|||
131220364|NCT00391092|472434413|FG001|Overall Study|Lost to Follow-up|18|||
131220365|NCT00391092|472434412|FG000|Overall Study|Alive on treatment|29|||
131220366|NCT00391092|472434413|FG001|Overall Study|Alive on treatment|33|||
131220367|NCT00391092|472434412|FG000|Overall Study|Alive in follow-up|88|||
131220368|NCT00391092|472434413|FG001|Overall Study|Alive in follow-up|84|||
131220369|NCT00303316|472434418|FG000|Overall Study|Protocol Violation|1|||
131220370|NCT00303316|472434419|FG001|Overall Study|Protocol Violation|0|||
131220371|NCT00303316|472434418|FG000|Overall Study|Lost to Follow-up|0|||
131220372|NCT00303316|472434419|FG001|Overall Study|Lost to Follow-up|1|||
131220373|NCT00303316|472434418|FG000|Overall Study|Withdrawal by Subject|1|||
131220374|NCT00303316|472434419|FG001|Overall Study|Withdrawal by Subject|2|||
131220375|NCT01726335|472434420|FG000|Overall Study|Lost to Follow-up|2|||
131220376|NCT01726335|472434420|FG000|Overall Study|Withdrawal by Subject|15|||
131220377|NCT01726335|472434420|FG000|Overall Study|Adverse Event|4|||
131220378|NCT01726335|472434420|FG000|Overall Study|Lost to Follow-up|2|||
131220379|NCT01726335|472434420|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
131220380|NCT01586624|472434421|FG000|Overall Study|Adverse Event|3|||
131220381|NCT01586624|472434422|FG001|Overall Study|Adverse Event|0|||
131220382|NCT01586624|472434423|FG002|Overall Study|Adverse Event|2|||
131220383|NCT01586624|472434424|FG003|Overall Study|Adverse Event|1|||
131220384|NCT01586624|472434425|FG004|Overall Study|Adverse Event|3|||
131220385|NCT01586624|472434426|FG005|Overall Study|Adverse Event|3|||
131220386|NCT01586624|472434427|FG006|Overall Study|Adverse Event|2|||
131220387|NCT01586624|472434428|FG007|Overall Study|Adverse Event|3|||
131220388|NCT01586624|472434421|FG000|Overall Study|Physician Decision|0|||
131220389|NCT01586624|472434422|FG001|Overall Study|Physician Decision|1|||
131220390|NCT01586624|472434423|FG002|Overall Study|Physician Decision|1|||
131220391|NCT01586624|472434424|FG003|Overall Study|Physician Decision|0|||
131220392|NCT01586624|472434425|FG004|Overall Study|Physician Decision|2|||
131220393|NCT01586624|472434426|FG005|Overall Study|Physician Decision|0|||
131220394|NCT01586624|472434427|FG006|Overall Study|Physician Decision|1|||
131220395|NCT01586624|472434428|FG007|Overall Study|Physician Decision|1|||
131220396|NCT01586624|472434421|FG000|Overall Study|Withdrawal by Subject|0|||
131220397|NCT01586624|472434422|FG001|Overall Study|Withdrawal by Subject|0|||
131220398|NCT01586624|472434423|FG002|Overall Study|Withdrawal by Subject|0|||
131220399|NCT01586624|472434424|FG003|Overall Study|Withdrawal by Subject|1|||
131220400|NCT01586624|472434425|FG004|Overall Study|Withdrawal by Subject|0|||
131220401|NCT01586624|472434426|FG005|Overall Study|Withdrawal by Subject|0|||
131220402|NCT01586624|472434427|FG006|Overall Study|Withdrawal by Subject|0|||
131220403|NCT01586624|472434428|FG007|Overall Study|Withdrawal by Subject|0|||
131220404|NCT01586624|472434421|FG000|Overall Study|Evidence of disease progression|1|||
131220405|NCT01586624|472434422|FG001|Overall Study|Evidence of disease progression|3|||
131220406|NCT01586624|472434423|FG002|Overall Study|Evidence of disease progression|2|||
131220407|NCT01586624|472434424|FG003|Overall Study|Evidence of disease progression|5|||
131220408|NCT01586624|472434425|FG004|Overall Study|Evidence of disease progression|3|||
131220409|NCT01586624|472434426|FG005|Overall Study|Evidence of disease progression|5|||
131220410|NCT01586624|472434427|FG006|Overall Study|Evidence of disease progression|4|||
131220411|NCT01586624|472434428|FG007|Overall Study|Evidence of disease progression|6|||
131220412|NCT01586624|472434421|FG000|Overall Study|Screen failure (no treatment received)|0|||
131220413|NCT01586624|472434422|FG001|Overall Study|Screen failure (no treatment received)|0|||
131220414|NCT01586624|472434423|FG002|Overall Study|Screen failure (no treatment received)|0|||
130882835|NCT01597596|471207803|FG001|Overall Study|Physician Decision|1|||
130882836|NCT02141295|471207818|FG000|Overall Study|Adverse Event|1|||
130882837|NCT02141295|471207819|FG001|Overall Study|Adverse Event|18|||
131220415|NCT01586624|472434424|FG003|Overall Study|Screen failure (no treatment received)|0|||
131220416|NCT01586624|472434425|FG004|Overall Study|Screen failure (no treatment received)|0|||
130882838|NCT02141295|471207820|FG002|Overall Study|Adverse Event|11|||
130882839|NCT02141295|471207818|FG000|Overall Study|Physician Decision|2|||
130882840|NCT02141295|471207819|FG001|Overall Study|Physician Decision|19|||
130882841|NCT02141295|471207820|FG002|Overall Study|Physician Decision|14|||
130882842|NCT02141295|471207818|FG000|Overall Study|Study terminated by sponsor|0|||
130882843|NCT02141295|471207819|FG001|Overall Study|Study terminated by sponsor|6|||
130882844|NCT02141295|471207820|FG002|Overall Study|Study terminated by sponsor|6|||
130882845|NCT02141295|471207818|FG000|Overall Study|Non-compliance|0|||
130882846|NCT02141295|471207819|FG001|Overall Study|Non-compliance|1|||
130882847|NCT02141295|471207820|FG002|Overall Study|Non-compliance|0|||
130882848|NCT02141295|471207818|FG000|Overall Study|Progressive disease|3|||
130882849|NCT02141295|471207819|FG001|Overall Study|Progressive disease|32|||
130882850|NCT02141295|471207820|FG002|Overall Study|Progressive disease|50|||
131220417|NCT01586624|472434426|FG005|Overall Study|Screen failure (no treatment received)|0|||
131220418|NCT01586624|472434427|FG006|Overall Study|Screen failure (no treatment received)|1|||
131220419|NCT01586624|472434428|FG007|Overall Study|Screen failure (no treatment received)|0|||
131220420|NCT04330482|472434439|FG000|Overall Study|Lost to Follow-up|2|||
131220421|NCT04330482|472434440|FG001|Overall Study|Lost to Follow-up|1|||
131220422|NCT04330482|472434439|FG000|Overall Study|Withdrawal by Subject|0|||
130882851|NCT02141295|471207818|FG000|Overall Study|Reason not specified|0|||
130882852|NCT02141295|471207819|FG001|Overall Study|Reason not specified|9|||
130882853|NCT02141295|471207820|FG002|Overall Study|Reason not specified|10|||
130882854|NCT02141295|471207818|FG000|Overall Study|Withdrawal by Subject|0|||
130882855|NCT02141295|471207819|FG001|Overall Study|Withdrawal by Subject|9|||
130882856|NCT02141295|471207820|FG002|Overall Study|Withdrawal by Subject|4|||
130882857|NCT01710501|471207821|FG000|Overall Study|Lost to Follow-up|2|||
130882858|NCT01710501|471207822|FG001|Overall Study|Lost to Follow-up|0|||
130882859|NCT01710501|471207823|FG002|Overall Study|Lost to Follow-up|0|||
130882860|NCT02536976|471207824|FG000|Overall Study|Physician Decision|0|||
130882861|NCT02536976|471207825|FG001|Overall Study|Physician Decision|1|||
130882862|NCT01389596|471207828|FG000|Overall Study|Protocol Violation|3|||
130882863|NCT01389596|471207829|FG001|Overall Study|Protocol Violation|4|||
130882864|NCT01389596|471207830|FG002|Overall Study|Protocol Violation|3|||
130882865|NCT01389596|471207828|FG000|Overall Study|Withdrawal by Subject|1|||
130882866|NCT01389596|471207829|FG001|Overall Study|Withdrawal by Subject|2|||
130882867|NCT01389596|471207830|FG002|Overall Study|Withdrawal by Subject|2|||
130882868|NCT01389596|471207828|FG000|Overall Study|Insufficient Clinical Response|3|||
130882869|NCT01389596|471207829|FG001|Overall Study|Insufficient Clinical Response|4|||
130882870|NCT01389596|471207830|FG002|Overall Study|Insufficient Clinical Response|5|||
130882871|NCT01389596|471207828|FG000|Overall Study|Adverse Event|1|||
130882872|NCT01389596|471207829|FG001|Overall Study|Adverse Event|4|||
130882873|NCT01389596|471207830|FG002|Overall Study|Adverse Event|0|||
130882874|NCT01389596|471207828|FG000|Overall Study|Death|0|||
130882875|NCT01389596|471207829|FG001|Overall Study|Death|1|||
130882876|NCT01389596|471207830|FG002|Overall Study|Death|0|||
130882877|NCT01389596|471207828|FG000|Overall Study|Other Unspecified|2|||
130882878|NCT01389596|471207829|FG001|Overall Study|Other Unspecified|1|||
130882879|NCT01389596|471207830|FG002|Overall Study|Other Unspecified|0|||
130882880|NCT01671319|471207831|FG000|Overall Study|Withdrawal by Subject|1|||
130882881|NCT01709084|471207832|FG000|Overall Study|Lost to Follow-up|4|||
130882882|NCT01709084|471207833|FG001|Overall Study|Lost to Follow-up|7|||
130882883|NCT01709084|471207832|FG000|Overall Study|Withdrawal by Subject|2|||
130882884|NCT01709084|471207833|FG001|Overall Study|Withdrawal by Subject|2|||
130882885|NCT01709084|471207832|FG000|Overall Study|Adverse Event|5|||
130882886|NCT01709084|471207833|FG001|Overall Study|Adverse Event|0|||
130882887|NCT01709084|471207832|FG000|Overall Study|Other|5|||
130882888|NCT01709084|471207833|FG001|Overall Study|Other|3|||
130882889|NCT01709084|471207832|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
130882890|NCT01709084|471207833|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
130882891|NCT01709084|471207832|FG000|Overall Study|Not Treated|0|||
130882892|NCT01709084|471207833|FG001|Overall Study|Not Treated|2|||
130882893|NCT02144610|471207834|FG000|Overall Study|Physician Decision|1|||
130882894|NCT02144610|471207835|FG001|Overall Study|Physician Decision|0|||
130882895|NCT02144610|471207834|FG000|Overall Study|Withdrawal by Subject|1|||
130882896|NCT02144610|471207835|FG001|Overall Study|Withdrawal by Subject|5|||
130882897|NCT02144610|471207834|FG000|Overall Study|Death|2|||
130882898|NCT02144610|471207835|FG001|Overall Study|Death|2|||
130882899|NCT02144610|471207834|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
130882900|NCT02144610|471207835|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
130882901|NCT02144610|471207834|FG000|Overall Study|Other|0|||
130882902|NCT02144610|471207835|FG001|Overall Study|Other|1|||
130882903|NCT01054885|471207836|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
130882904|NCT01054885|471207837|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130882905|NCT01054885|471207838|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130882906|NCT01054885|471207839|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130882907|NCT01054885|471207840|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130882908|NCT01054885|471207841|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130882909|NCT01054885|471207842|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130882910|NCT01054885|471207836|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
130882911|NCT01054885|471207837|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
130882912|NCT01054885|471207838|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
130882913|NCT01054885|471207839|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
130882914|NCT01054885|471207840|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
130882915|NCT01054885|471207841|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
130882916|NCT01054885|471207842|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
130882917|NCT01054885|471207836|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
130882918|NCT01054885|471207837|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130882919|NCT01054885|471207838|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130882920|NCT01054885|471207839|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130882921|NCT01054885|471207840|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130882922|NCT01054885|471207841|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130993610|NCT02778399|471603867|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
130993611|NCT02778399|471603868|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
130993612|NCT02778399|471603869|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
130993613|NCT02778399|471603870|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
130993614|NCT02778399|471603865|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
130993615|NCT02778399|471603866|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
130993616|NCT02778399|471603867|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
130993617|NCT02778399|471603868|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
130993618|NCT02778399|471603869|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
130993619|NCT02778399|471603870|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
130993620|NCT02778399|471603865|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
130993621|NCT02778399|471603866|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
130993622|NCT02778399|471603867|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
130993623|NCT02778399|471603868|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
130993624|NCT02778399|471603869|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
130993625|NCT02778399|471603870|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
130993626|NCT02778399|471603865|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
130993627|NCT02778399|471603866|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
130993628|NCT02778399|471603867|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
130993629|NCT02778399|471603868|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
130993630|NCT02778399|471603869|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
130993631|NCT02778399|471603870|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
130993632|NCT02778399|471603865|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
130993633|NCT02778399|471603866|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
130993634|NCT02778399|471603867|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
130993635|NCT02778399|471603868|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
130993636|NCT02778399|471603869|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
130993637|NCT02778399|471603870|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
130993638|NCT02778399|471603865|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
130993639|NCT02778399|471603866|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
130993640|NCT02778399|471603867|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
130993641|NCT02778399|471603868|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
130993642|NCT02778399|471603869|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
130993643|NCT02778399|471603870|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
130993644|NCT02778399|471603865|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
130993645|NCT02778399|471603866|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
130993646|NCT02778399|471603867|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
130993647|NCT02778399|471603868|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
130993648|NCT02778399|471603869|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
130993649|NCT02778399|471603870|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
130993650|NCT02778399|471603865|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
130993651|NCT02778399|471603866|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
130993652|NCT02778399|471603867|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
130993653|NCT02778399|471603868|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
130993654|NCT02778399|471603869|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
130993655|NCT02778399|471603870|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
130993656|NCT00447954|471603875|FG000|Overall Study|Adverse Event|0|||
130993657|NCT00447954|471603876|FG001|Overall Study|Adverse Event|2|||
130993658|NCT00447954|471603877|FG002|Overall Study|Adverse Event|0|||
130993659|NCT00447954|471603875|FG000|Overall Study|Withdrawal by Subject|0|||
130993660|NCT00447954|471603876|FG001|Overall Study|Withdrawal by Subject|1|||
130993661|NCT00447954|471603877|FG002|Overall Study|Withdrawal by Subject|1|||
130993662|NCT00447954|471603875|FG000|Overall Study|Lost to Follow-up|0|||
130993663|NCT00447954|471603876|FG001|Overall Study|Lost to Follow-up|1|||
130993664|NCT00447954|471603877|FG002|Overall Study|Lost to Follow-up|0|||
130993665|NCT00447954|471603875|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
130993666|NCT00447954|471603876|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
130993667|NCT00447954|471603877|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
130993668|NCT03556358|471603880|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
130993669|NCT03556358|471603881|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
130993670|NCT03556358|471603880|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
130993671|NCT03556358|471603881|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
130993672|NCT03556358|471603880|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
131220423|NCT04330482|472434440|FG001|Overall Study|Withdrawal by Subject|3|||
130993673|NCT03556358|471603881|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
130993674|NCT03556358|471603880|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
130993675|NCT03556358|471603881|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
131220424|NCT05144477|472434442|FG000|Overall Study|Withdrawal by Subject|1|||
131220425|NCT05144477|472434443|FG001|Overall Study|Withdrawal by Subject|1|||
131220426|NCT04333199|472434446|FG000|Evaluated Patients|Lost to Follow-up|0|||
131220427|NCT04333199|472434447|FG001|Evaluated Patients|Lost to Follow-up|1|||
131220428|NCT04333199|472434448|FG002|Evaluated Patients|Lost to Follow-up|2|||
131220429|NCT01155284|472434457|FG000|Overall Study|Withdrawal by Subject|4|||
131220430|NCT01155284|472434458|FG001|Overall Study|Withdrawal by Subject|3|||
131220431|NCT01155284|472434457|FG000|Overall Study|Lost to Follow-up|1|||
131220432|NCT01155284|472434458|FG001|Overall Study|Lost to Follow-up|2|||
131220433|NCT01155284|472434457|FG000|Overall Study|Physician Decision|1|||
131220434|NCT01155284|472434458|FG001|Overall Study|Physician Decision|0|||
131220435|NCT01155284|472434457|FG000|Overall Study|Adverse Event|1|||
131220436|NCT01155284|472434458|FG001|Overall Study|Adverse Event|0|||
131220437|NCT01289990|472434464|FG000|Overall Study|Death|0|||
131220438|NCT01289990|472434465|FG001|Overall Study|Death|0|||
130993676|NCT03556358|471603880|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
130993677|NCT03556358|471603881|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
130993678|NCT03556358|471603880|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
131220439|NCT01289990|472434466|FG002|Overall Study|Death|0|||
131220440|NCT01289990|472434467|FG003|Overall Study|Death|1|||
131220441|NCT01289990|472434468|FG004|Overall Study|Death|2|||
131220442|NCT01289990|472434469|FG005|Overall Study|Death|1|||
131220443|NCT01289990|472434470|FG006|Overall Study|Death|0|||
131220444|NCT01289990|472434471|FG007|Overall Study|Death|0|||
131220445|NCT01289990|472434472|FG008|Overall Study|Death|0|||
131220446|NCT01289990|472434473|FG009|Overall Study|Death|0|||
131220447|NCT01289990|472434474|FG010|Overall Study|Death|0|||
131220448|NCT01289990|472434475|FG011|Overall Study|Death|1|||
131220449|NCT01289990|472434476|FG012|Overall Study|Death|0|||
131220450|NCT01289990|472434464|FG000|Overall Study|Lost to Follow-up|3|||
131220451|NCT01289990|472434465|FG001|Overall Study|Lost to Follow-up|2|||
131220452|NCT01289990|472434466|FG002|Overall Study|Lost to Follow-up|5|||
131220453|NCT01289990|472434467|FG003|Overall Study|Lost to Follow-up|5|||
131220454|NCT01289990|472434468|FG004|Overall Study|Lost to Follow-up|3|||
131220455|NCT01289990|472434469|FG005|Overall Study|Lost to Follow-up|4|||
131220456|NCT01289990|472434470|FG006|Overall Study|Lost to Follow-up|2|||
131220457|NCT01289990|472434471|FG007|Overall Study|Lost to Follow-up|2|||
131220458|NCT01289990|472434472|FG008|Overall Study|Lost to Follow-up|1|||
131220459|NCT01289990|472434473|FG009|Overall Study|Lost to Follow-up|4|||
131220460|NCT01289990|472434474|FG010|Overall Study|Lost to Follow-up|2|||
131220461|NCT01289990|472434475|FG011|Overall Study|Lost to Follow-up|1|||
131220462|NCT01289990|472434476|FG012|Overall Study|Lost to Follow-up|2|||
131220463|NCT01289990|472434464|FG000|Overall Study|Withdrawal by Subject|15|||
131220464|NCT01289990|472434465|FG001|Overall Study|Withdrawal by Subject|14|||
131220465|NCT01289990|472434466|FG002|Overall Study|Withdrawal by Subject|12|||
131220466|NCT01289990|472434467|FG003|Overall Study|Withdrawal by Subject|13|||
131220467|NCT01289990|472434468|FG004|Overall Study|Withdrawal by Subject|8|||
131220468|NCT01289990|472434469|FG005|Overall Study|Withdrawal by Subject|7|||
130765868|NCT05079230|470765893|FG001|Overall Study|Study Terminated by Sponsor|102|||
130765869|NCT05079230|470765892|FG000|Overall Study|Death|72|||
130993679|NCT03556358|471603881|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
130993680|NCT03556358|471603880|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
130993681|NCT03556358|471603881|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
130993682|NCT01351025|471603882|FG000|Week 0 - 20|Lost to Follow-up|2|||
130993683|NCT01351025|471603883|FG001|Week 0 - 20|Lost to Follow-up|1|||
130993684|NCT01351025|471603882|FG000|Week 0 - 20|Withdrawal by Subject|1|||
130993685|NCT01351025|471603883|FG001|Week 0 - 20|Withdrawal by Subject|0|||
130993686|NCT01351025|471603882|FG000|Week 24 - 44|Lost to Follow-up|0|||
130993687|NCT01351025|471603883|FG001|Week 24 - 44|Lost to Follow-up|2|||
130993688|NCT01351025|471603882|FG000|Week 24 - 44|Site closed|0|||
130993689|NCT01351025|471603883|FG001|Week 24 - 44|Site closed|1|||
130993690|NCT01351025|471603882|FG000|Week 24 - 44|unable to get to clinic|1|||
130993691|NCT01351025|471603883|FG001|Week 24 - 44|unable to get to clinic|1|||
130993692|NCT01861522|471603888|FG000|Overall Study|Adverse Event|1|||
131220469|NCT01289990|472434470|FG006|Overall Study|Withdrawal by Subject|13|||
131220470|NCT01289990|472434471|FG007|Overall Study|Withdrawal by Subject|9|||
131220471|NCT01289990|472434472|FG008|Overall Study|Withdrawal by Subject|12|||
131220472|NCT01289990|472434473|FG009|Overall Study|Withdrawal by Subject|13|||
131220473|NCT01289990|472434474|FG010|Overall Study|Withdrawal by Subject|11|||
131220474|NCT01289990|472434475|FG011|Overall Study|Withdrawal by Subject|13|||
131220475|NCT01289990|472434476|FG012|Overall Study|Withdrawal by Subject|16|||
131220476|NCT01289990|472434464|FG000|Overall Study|discontinued in preceding trial|18|||
131220477|NCT01289990|472434465|FG001|Overall Study|discontinued in preceding trial|20|||
131220478|NCT01289990|472434466|FG002|Overall Study|discontinued in preceding trial|41|||
131220479|NCT01289990|472434467|FG003|Overall Study|discontinued in preceding trial|17|||
131220480|NCT01289990|472434468|FG004|Overall Study|discontinued in preceding trial|11|||
130765870|NCT05079230|470765893|FG001|Overall Study|Death|66|||
131220481|NCT01289990|472434469|FG005|Overall Study|discontinued in preceding trial|12|||
131220482|NCT01289990|472434470|FG006|Overall Study|discontinued in preceding trial|18|||
131220483|NCT01289990|472434471|FG007|Overall Study|discontinued in preceding trial|8|||
131220484|NCT01289990|472434472|FG008|Overall Study|discontinued in preceding trial|17|||
131220485|NCT01289990|472434473|FG009|Overall Study|discontinued in preceding trial|21|||
131220486|NCT01289990|472434474|FG010|Overall Study|discontinued in preceding trial|17|||
131220487|NCT01289990|472434475|FG011|Overall Study|discontinued in preceding trial|17|||
131220488|NCT01289990|472434476|FG012|Overall Study|discontinued in preceding trial|24|||
131220489|NCT01289990|472434464|FG000|Overall Study|did not continue in extension|41|||
131220490|NCT01289990|472434465|FG001|Overall Study|did not continue in extension|45|||
131220491|NCT01289990|472434466|FG002|Overall Study|did not continue in extension|51|||
131220492|NCT01289990|472434467|FG003|Overall Study|did not continue in extension|51|||
131220493|NCT01289990|472434468|FG004|Overall Study|did not continue in extension|48|||
131220494|NCT01289990|472434469|FG005|Overall Study|did not continue in extension|50|||
131220495|NCT01289990|472434470|FG006|Overall Study|did not continue in extension|54|||
131220496|NCT01289990|472434471|FG007|Overall Study|did not continue in extension|36|||
131220497|NCT01289990|472434472|FG008|Overall Study|did not continue in extension|44|||
131220498|NCT01289990|472434473|FG009|Overall Study|did not continue in extension|48|||
131220499|NCT01289990|472434474|FG010|Overall Study|did not continue in extension|45|||
131220500|NCT01289990|472434475|FG011|Overall Study|did not continue in extension|34|||
131220501|NCT01289990|472434476|FG012|Overall Study|did not continue in extension|56|||
131220502|NCT01289990|472434464|FG000|Overall Study|Not treated|0|||
131220503|NCT01289990|472434465|FG001|Overall Study|Not treated|0|||
131220504|NCT01289990|472434466|FG002|Overall Study|Not treated|0|||
131220505|NCT01289990|472434467|FG003|Overall Study|Not treated|0|||
131220506|NCT01289990|472434468|FG004|Overall Study|Not treated|0|||
131220507|NCT01289990|472434469|FG005|Overall Study|Not treated|0|||
131220508|NCT01289990|472434470|FG006|Overall Study|Not treated|1|||
131220509|NCT01289990|472434471|FG007|Overall Study|Not treated|0|||
131220510|NCT01289990|472434472|FG008|Overall Study|Not treated|1|||
131220511|NCT01289990|472434473|FG009|Overall Study|Not treated|0|||
131220512|NCT01289990|472434474|FG010|Overall Study|Not treated|1|||
131220513|NCT01289990|472434475|FG011|Overall Study|Not treated|2|||
131220514|NCT01289990|472434476|FG012|Overall Study|Not treated|0|||
131220515|NCT04529499|472434477|FG000|Overall Study|Withdrawal by Subject|9|||
131220516|NCT04529499|472434478|FG001|Overall Study|Withdrawal by Subject|11|||
131220517|NCT04529499|472434477|FG000|Overall Study|Physician Decision|1|||
131220518|NCT04529499|472434478|FG001|Overall Study|Physician Decision|2|||
131220519|NCT04529499|472434477|FG000|Overall Study|Adverse Event|4|||
131220520|NCT04529499|472434478|FG001|Overall Study|Adverse Event|4|||
131220521|NCT04529499|472434477|FG000|Overall Study|Death|14|||
131220522|NCT04529499|472434478|FG001|Overall Study|Death|11|||
131220523|NCT04529499|472434477|FG000|Overall Study|Lost to Follow-up|1|||
131220524|NCT04529499|472434478|FG001|Overall Study|Lost to Follow-up|1|||
131220525|NCT04529499|472434477|FG000|Overall Study|Others|7|||
131220526|NCT04529499|472434478|FG001|Overall Study|Others|11|||
131220527|NCT00683904|472434479|FG000|Dose Level 1|Disease progression|2|||
131220528|NCT00683904|472434480|FG001|Dose Level 1|Disease progression|0|||
131220529|NCT00683904|472434479|FG000|Dose Level 1|Adverse Event|1|||
131220530|NCT00683904|472434480|FG001|Dose Level 1|Adverse Event|0|||
131220531|NCT00683904|472434479|FG000|Dose Level 2|Adverse Event|0|||
131220532|NCT00683904|472434480|FG001|Dose Level 2|Adverse Event|2|||
131220533|NCT00758706|472434481|FG000|Overall Study|Adverse Event|4|||
131220534|NCT00758706|472434482|FG001|Overall Study|Adverse Event|4|||
131220535|NCT03611751|472434483|FG000|Pre-treatment|Randomized but not treated|1|||
131220536|NCT03611751|472434484|FG001|Pre-treatment|Randomized but not treated|1|||
131220537|NCT03611751|472434485|FG002|Pre-treatment|Randomized but not treated|0|||
131220538|NCT03611751|472434483|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
131220539|NCT03611751|472434484|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
131220540|NCT03611751|472434485|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
131220541|NCT03611751|472434483|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
131220542|NCT03611751|472434484|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
131220543|NCT03611751|472434485|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
131220544|NCT03611751|472434483|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
131220545|NCT03611751|472434484|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
131220546|NCT03611751|472434485|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
131220547|NCT03611751|472434483|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
131220548|NCT03611751|472434484|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
131220549|NCT03611751|472434485|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
131220550|NCT03611751|472434483|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
131220551|NCT03611751|472434484|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
131220552|NCT03611751|472434485|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
131220553|NCT03611751|472434483|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
131220554|NCT03611751|472434484|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
131220555|NCT03611751|472434485|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
130882923|NCT01054885|471207842|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
131220556|NCT03611751|472434483|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
131220557|NCT03611751|472434484|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
131220558|NCT03611751|472434485|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
131220559|NCT03611751|472434483|FG000|Treatment Week 0 - Week 16|Death|0|||
131220560|NCT03611751|472434484|FG001|Treatment Week 0 - Week 16|Death|0|||
131220561|NCT03611751|472434485|FG002|Treatment Week 0 - Week 16|Death|1|||
131220562|NCT03611751|472434483|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
131220563|NCT03611751|472434484|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
131220564|NCT03611751|472434485|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
131220565|NCT03611751|472434483|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
131220566|NCT03611751|472434484|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
131220567|NCT03611751|472434485|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
131220568|NCT03611751|472434483|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
131220569|NCT03611751|472434484|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
131220570|NCT03611751|472434485|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
131220571|NCT03611751|472434483|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
131220572|NCT03611751|472434484|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
131220573|NCT03611751|472434485|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
131220574|NCT03611751|472434483|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
131220575|NCT03611751|472434484|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
131220576|NCT03611751|472434485|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
131220577|NCT03611751|472434483|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
131220578|NCT03611751|472434484|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
131220579|NCT03611751|472434485|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
131220580|NCT03611751|472434483|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
131220581|NCT03611751|472434484|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
131220582|NCT03611751|472434485|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
131220583|NCT03611751|472434483|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
131220584|NCT03611751|472434484|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
131220585|NCT03611751|472434485|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
131220586|NCT03611751|472434483|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
131220587|NCT03611751|472434484|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
131220588|NCT03611751|472434485|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
131220589|NCT03611751|472434483|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
131220590|NCT03611751|472434484|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
131220591|NCT03611751|472434485|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
131220592|NCT03611751|472434483|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
131220593|NCT03611751|472434484|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
131220594|NCT03611751|472434485|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
131220595|NCT03611751|472434483|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
131220596|NCT03611751|472434484|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
131220597|NCT03611751|472434485|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
131220598|NCT03611751|472434483|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
131220599|NCT03611751|472434484|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
131220600|NCT03611751|472434485|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
131220601|NCT03611751|472434483|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
131220602|NCT03611751|472434484|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
131220603|NCT03611751|472434485|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
131220604|NCT03467971|472434486|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131220605|NCT03467971|472434487|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130882924|NCT01054885|471207836|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
130882925|NCT01054885|471207837|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130882926|NCT01054885|471207838|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130882927|NCT01054885|471207839|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130882928|NCT01054885|471207840|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130882929|NCT01054885|471207841|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130882930|NCT01054885|471207842|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130882931|NCT01054885|471207836|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
130882932|NCT01054885|471207837|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
130882933|NCT01054885|471207838|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
130882934|NCT01054885|471207839|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
130882935|NCT01054885|471207840|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
130882936|NCT01054885|471207841|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
130882937|NCT01054885|471207842|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
130882938|NCT01054885|471207836|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
130882939|NCT01054885|471207837|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130882940|NCT01054885|471207838|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130882941|NCT01054885|471207839|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130882942|NCT01054885|471207840|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130993693|NCT01861522|471603889|FG001|Overall Study|Adverse Event|0|||
131220606|NCT01488071|472434492|FG000|Overall Study|Adverse Event|15|||
131220607|NCT01488071|472434493|FG001|Overall Study|Adverse Event|23|||
131220608|NCT01488071|472434492|FG000|Overall Study|Lack of Efficacy|11|||
131220609|NCT01488071|472434493|FG001|Overall Study|Lack of Efficacy|17|||
131220610|NCT01488071|472434492|FG000|Overall Study|Non-compliance with study drug|2|||
131220611|NCT01488071|472434493|FG001|Overall Study|Non-compliance with study drug|0|||
131220612|NCT01488071|472434492|FG000|Overall Study|Protocol Violation|5|||
131220613|NCT01488071|472434493|FG001|Overall Study|Protocol Violation|7|||
131220614|NCT01488071|472434492|FG000|Overall Study|Withdrawal of Consent|14|||
131220615|NCT01488071|472434493|FG001|Overall Study|Withdrawal of Consent|12|||
131220616|NCT01488071|472434492|FG000|Overall Study|Lost to Follow-up|1|||
131220617|NCT01488071|472434493|FG001|Overall Study|Lost to Follow-up|0|||
131220618|NCT01488071|472434492|FG000|Overall Study|Administrative or Other Reason(s)|5|||
131220619|NCT01488071|472434493|FG001|Overall Study|Administrative or Other Reason(s)|4|||
131220620|NCT02139306|472434494|FG000|Overall Study|Withdrawal by Subject|4|||
131220621|NCT02139306|472434495|FG001|Overall Study|Withdrawal by Subject|6|||
131220622|NCT02139306|472434494|FG000|Overall Study|Adverse Event|3|||
131220623|NCT02139306|472434495|FG001|Overall Study|Adverse Event|4|||
131220624|NCT02139306|472434494|FG000|Overall Study|Physician Decision|0|||
131220625|NCT02139306|472434495|FG001|Overall Study|Physician Decision|1|||
131220626|NCT02139306|472434494|FG000|Overall Study|Other Unspecified|2|||
131220627|NCT02139306|472434495|FG001|Overall Study|Other Unspecified|3|||
131220628|NCT02139306|472434494|FG000|Overall Study|Protocol Violation|4|||
131220629|NCT02139306|472434495|FG001|Overall Study|Protocol Violation|0|||
131220630|NCT04449354|472434496|FG000|Overall Study|Withdrawal by Subject|1|||
131220631|NCT05789420|472434497|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
131220632|NCT05789420|472434497|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
131220633|NCT02587325|472434498|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
131220634|NCT02587325|472434499|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
131220635|NCT02587325|472434500|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
131220636|NCT02587325|472434501|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
131220637|NCT02587325|472434502|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
131220638|NCT02587325|472434498|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
131220639|NCT02587325|472434499|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
131220640|NCT02587325|472434500|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
131220641|NCT02587325|472434501|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
131220642|NCT02587325|472434502|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
131220643|NCT02587325|472434498|FG000|32-Week Optional Extension Part|Adverse Event|0|||
131220644|NCT02587325|472434499|FG001|32-Week Optional Extension Part|Adverse Event|0|||
131220645|NCT02587325|472434500|FG002|32-Week Optional Extension Part|Adverse Event|1|||
131220646|NCT02587325|472434501|FG003|32-Week Optional Extension Part|Adverse Event|0|||
131220647|NCT02587325|472434502|FG004|32-Week Optional Extension Part|Adverse Event|0|||
131220648|NCT02587325|472434498|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
131220649|NCT02587325|472434499|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
131220650|NCT02587325|472434500|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
131220651|NCT02587325|472434501|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
131220652|NCT02587325|472434502|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
131220653|NCT01220128|472434503|FG000|Overall Study|Progressive disease|0|||
131220654|NCT01220128|472434504|FG001|Overall Study|Progressive disease|0|||
131220655|NCT01220128|472434505|FG002|Overall Study|Progressive disease|2|||
131220656|NCT01220128|472434506|FG003|Overall Study|Progressive disease|0|||
131220657|NCT01220128|472434507|FG004|Overall Study|Progressive disease|0|||
131220658|NCT01220128|472434508|FG005|Overall Study|Progressive disease|0|||
131220659|NCT01220128|472434509|FG006|Overall Study|Progressive disease|0|||
130882943|NCT01054885|471207841|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130882944|NCT01054885|471207842|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130882945|NCT01054885|471207836|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
130882946|NCT01054885|471207837|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
130882947|NCT01054885|471207838|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
130882948|NCT01054885|471207839|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
130882949|NCT01054885|471207840|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
130882950|NCT01054885|471207841|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
131220660|NCT01220128|472434503|FG000|Overall Study|Sponsor study termination|0|||
131220661|NCT01220128|472434504|FG001|Overall Study|Sponsor study termination|1|||
131220662|NCT01220128|472434505|FG002|Overall Study|Sponsor study termination|0|||
131220663|NCT01220128|472434506|FG003|Overall Study|Sponsor study termination|0|||
131220664|NCT01220128|472434507|FG004|Overall Study|Sponsor study termination|0|||
131220665|NCT01220128|472434508|FG005|Overall Study|Sponsor study termination|0|||
131220666|NCT01220128|472434509|FG006|Overall Study|Sponsor study termination|1|||
131220667|NCT01220128|472434503|FG000|Overall Study|Adverse event, serious fatal|2|||
131220668|NCT01220128|472434504|FG001|Overall Study|Adverse event, serious fatal|0|||
131220669|NCT01220128|472434505|FG002|Overall Study|Adverse event, serious fatal|0|||
131220670|NCT01220128|472434506|FG003|Overall Study|Adverse event, serious fatal|0|||
131220671|NCT01220128|472434507|FG004|Overall Study|Adverse event, serious fatal|0|||
131220672|NCT01220128|472434508|FG005|Overall Study|Adverse event, serious fatal|0|||
131220673|NCT01220128|472434509|FG006|Overall Study|Adverse event, serious fatal|1|||
131220674|NCT01220128|472434503|FG000|Overall Study|Adverse event, non-fatal|1|||
131220675|NCT01220128|472434504|FG001|Overall Study|Adverse event, non-fatal|0|||
131220676|NCT01220128|472434505|FG002|Overall Study|Adverse event, non-fatal|0|||
131220677|NCT01220128|472434506|FG003|Overall Study|Adverse event, non-fatal|0|||
131220678|NCT01220128|472434507|FG004|Overall Study|Adverse event, non-fatal|0|||
131220679|NCT01220128|472434508|FG005|Overall Study|Adverse event, non-fatal|0|||
131220680|NCT01220128|472434509|FG006|Overall Study|Adverse event, non-fatal|3|||
131220681|NCT01220128|472434503|FG000|Overall Study|Other|0|||
131220682|NCT01220128|472434504|FG001|Overall Study|Other|0|||
131220683|NCT01220128|472434505|FG002|Overall Study|Other|1|||
131220684|NCT01220128|472434506|FG003|Overall Study|Other|0|||
131220685|NCT01220128|472434507|FG004|Overall Study|Other|0|||
131220686|NCT01220128|472434508|FG005|Overall Study|Other|0|||
131220687|NCT01220128|472434509|FG006|Overall Study|Other|0|||
131220688|NCT01220128|472434503|FG000|Overall Study|Consent withdrawn by subject|1|||
131220689|NCT01220128|472434504|FG001|Overall Study|Consent withdrawn by subject|0|||
131220690|NCT01220128|472434505|FG002|Overall Study|Consent withdrawn by subject|0|||
131220691|NCT01220128|472434506|FG003|Overall Study|Consent withdrawn by subject|0|||
131220692|NCT01220128|472434507|FG004|Overall Study|Consent withdrawn by subject|0|||
131220693|NCT01220128|472434508|FG005|Overall Study|Consent withdrawn by subject|0|||
131220694|NCT01220128|472434509|FG006|Overall Study|Consent withdrawn by subject|0|||
131220695|NCT02913261|472434510|FG000|Overall Study|Technical problems|0|||
131220696|NCT02913261|472434511|FG001|Overall Study|Technical problems|1|||
131220697|NCT02913261|472434510|FG000|Overall Study|Lack of Efficacy|32|||
131220698|NCT02913261|472434511|FG001|Overall Study|Lack of Efficacy|69|||
131220699|NCT02913261|472434510|FG000|Overall Study|Adverse Event|27|||
131220700|NCT02913261|472434511|FG001|Overall Study|Adverse Event|5|||
131220701|NCT02913261|472434510|FG000|Overall Study|Death|25|||
131220702|NCT02913261|472434511|FG001|Overall Study|Death|22|||
131220703|NCT02913261|472434510|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
131220704|NCT02913261|472434511|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
131220705|NCT02913261|472434510|FG000|Overall Study|Disease relapse|8|||
131220706|NCT02913261|472434511|FG001|Overall Study|Disease relapse|13|||
131220707|NCT02913261|472434510|FG000|Overall Study|Physician Decision|8|||
131220708|NCT02913261|472434511|FG001|Overall Study|Physician Decision|9|||
131220709|NCT02913261|472434510|FG000|Overall Study|Subject/guardian decision|4|||
131220710|NCT02913261|472434511|FG001|Overall Study|Subject/guardian decision|6|||
131220711|NCT02913261|472434510|FG000|Overall Study|Graft loss|2|||
131220712|NCT02913261|472434511|FG001|Overall Study|Graft loss|0|||
131220713|NCT00000135|472434534|FG000|Overall Study|Death|27|||
131220714|NCT00000135|472434535|FG001|Overall Study|Death|14|||
131220715|NCT02340078|472434536|FG000|Overall Study|Protocol Violation|1|||
131220716|NCT01311505|472434537|FG000|First Intervention Period|Protocol Violation|0|||
131220717|NCT01311505|472434538|FG001|First Intervention Period|Protocol Violation|1|||
131220718|NCT00567996|472434539|FG000|Overall Study|Adverse Event|18|||
131220719|NCT00567996|472434540|FG001|Overall Study|Adverse Event|16|||
131220720|NCT00567996|472434541|FG002|Overall Study|Adverse Event|13|||
131220721|NCT00567996|472434539|FG000|Overall Study|Protocol Deviation|9|||
131220722|NCT00567996|472434540|FG001|Overall Study|Protocol Deviation|11|||
131220723|NCT00567996|472434541|FG002|Overall Study|Protocol Deviation|13|||
131220724|NCT00567996|472434539|FG000|Overall Study|Withdrawal by Subject|8|||
131220725|NCT00567996|472434540|FG001|Overall Study|Withdrawal by Subject|12|||
131220726|NCT00567996|472434541|FG002|Overall Study|Withdrawal by Subject|22|||
131220727|NCT00567996|472434539|FG000|Overall Study|Abnormal Lab value(s)|2|||
131220728|NCT00567996|472434540|FG001|Overall Study|Abnormal Lab value(s)|1|||
131220729|NCT00567996|472434541|FG002|Overall Study|Abnormal Lab value(s)|2|||
131220730|NCT00567996|472434539|FG000|Overall Study|Abnormal test procedure result(s)|2|||
131220731|NCT00567996|472434540|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131220732|NCT00567996|472434541|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131220733|NCT00567996|472434539|FG000|Overall Study|Lost to Follow-up|2|||
131220734|NCT00567996|472434540|FG001|Overall Study|Lost to Follow-up|5|||
131220735|NCT00567996|472434541|FG002|Overall Study|Lost to Follow-up|2|||
131220736|NCT00567996|472434539|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131220737|NCT00567996|472434540|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131220738|NCT00567996|472434541|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
131220739|NCT00567996|472434539|FG000|Overall Study|Administrative problems|1|||
131220740|NCT00567996|472434540|FG001|Overall Study|Administrative problems|1|||
131220741|NCT00567996|472434541|FG002|Overall Study|Administrative problems|0|||
131220742|NCT00567996|472434539|FG000|Overall Study|Death|1|||
131220743|NCT00567996|472434540|FG001|Overall Study|Death|0|||
131220744|NCT00567996|472434541|FG002|Overall Study|Death|2|||
131220745|NCT00567996|472434539|FG000|Overall Study|Patient's inability to use the device|0|||
131220746|NCT00567996|472434540|FG001|Overall Study|Patient's inability to use the device|1|||
131220747|NCT00567996|472434541|FG002|Overall Study|Patient's inability to use the device|0|||
131220748|NCT02524665|472434544|FG000|Overall Study|Lost to Follow-up|1|||
131220749|NCT03022799|472434547|FG000|Overall Study|Adverse Event|0|||
131220750|NCT03022799|472434548|FG001|Overall Study|Adverse Event|0|||
131220751|NCT03022799|472434549|FG002|Overall Study|Adverse Event|0|||
131220752|NCT03022799|472434550|FG003|Overall Study|Adverse Event|0|||
131220753|NCT03022799|472434551|FG004|Overall Study|Adverse Event|0|||
131220754|NCT03022799|472434552|FG005|Overall Study|Adverse Event|0|||
131220755|NCT03022799|472434553|FG006|Overall Study|Adverse Event|0|||
131220756|NCT03022799|472434554|FG007|Overall Study|Adverse Event|0|||
131220757|NCT03022799|472434555|FG008|Overall Study|Adverse Event|0|||
131220758|NCT03022799|472434556|FG009|Overall Study|Adverse Event|1|||
131220759|NCT03022799|472434557|FG010|Overall Study|Adverse Event|1|||
131220760|NCT03022799|472434558|FG011|Overall Study|Adverse Event|0|||
131220761|NCT03022799|472434559|FG012|Overall Study|Adverse Event|0|||
131220762|NCT01185639|472434563|FG000|Overall Study|Progressed and didn't receive therapy|2|||
131220763|NCT02200614|472434564|FG000|Double Blind Treatment|Adverse Event|86|||
131220764|NCT02200614|472434565|FG001|Double Blind Treatment|Adverse Event|48|||
131220765|NCT02200614|472434564|FG000|Double Blind Treatment|Confirmed metastasis|120|||
131220766|NCT02200614|472434565|FG001|Double Blind Treatment|Confirmed metastasis|140|||
131220767|NCT02200614|472434564|FG000|Double Blind Treatment|Judgment of the investigator|59|||
131220768|NCT02200614|472434565|FG001|Double Blind Treatment|Judgment of the investigator|99|||
131220769|NCT02200614|472434564|FG000|Double Blind Treatment|Metastasis by local reading|1|||
131220770|NCT02200614|472434565|FG001|Double Blind Treatment|Metastasis by local reading|3|||
131220771|NCT02200614|472434564|FG000|Double Blind Treatment|Other reason|6|||
131220772|NCT02200614|472434565|FG001|Double Blind Treatment|Other reason|2|||
131220773|NCT02200614|472434564|FG000|Double Blind Treatment|Personal reason|77|||
131220774|NCT02200614|472434565|FG001|Double Blind Treatment|Personal reason|85|||
131220775|NCT02200614|472434564|FG000|Double Blind Treatment|Protocol deviation|14|||
131220776|NCT02200614|472434565|FG001|Double Blind Treatment|Protocol deviation|7|||
131220777|NCT02200614|472434564|FG000|Double Blind Treatment|Not treated|1|||
131220778|NCT02200614|472434565|FG001|Double Blind Treatment|Not treated|0|||
131220779|NCT02200614|472434564|FG000|Open Label|Adverse Event|41|||
131220780|NCT02200614|472434565|FG001|Open Label|Adverse Event|11|||
131220781|NCT02200614|472434564|FG000|Open Label|Confirmed metastasis|1|||
131220782|NCT02200614|472434565|FG001|Open Label|Confirmed metastasis|0|||
131220783|NCT02200614|472434564|FG000|Open Label|Judgment of the investigator|29|||
131220784|NCT02200614|472434565|FG001|Open Label|Judgment of the investigator|2|||
131220785|NCT02200614|472434564|FG000|Open Label|Metastasis by local reading|138|||
131220786|NCT02200614|472434565|FG001|Open Label|Metastasis by local reading|27|||
131220787|NCT02200614|472434564|FG000|Open Label|Other reason|22|||
131220788|NCT02200614|472434565|FG001|Open Label|Other reason|4|||
131220789|NCT02200614|472434564|FG000|Open Label|Personal reason|60|||
131220790|NCT02200614|472434565|FG001|Open Label|Personal reason|8|||
131220791|NCT02200614|472434564|FG000|Open Label|Protocol deviation|3|||
131220792|NCT02200614|472434565|FG001|Open Label|Protocol deviation|2|||
131220793|NCT02200614|472434564|FG000|Open Label|Missing|2|||
131220794|NCT02200614|472434565|FG001|Open Label|Missing|2|||
131220795|NCT01898884|472434566|FG000|Multiple Dose Period|Adverse Event|0|||
131220796|NCT01898884|472434567|FG001|Multiple Dose Period|Adverse Event|0|||
131220797|NCT01898884|472434568|FG002|Multiple Dose Period|Adverse Event|0|||
131220798|NCT01898884|472434569|FG003|Multiple Dose Period|Adverse Event|0|||
131220799|NCT01898884|472434570|FG004|Multiple Dose Period|Adverse Event|0|||
131220800|NCT01898884|472434571|FG005|Multiple Dose Period|Adverse Event|0|||
131220801|NCT01898884|472434572|FG006|Multiple Dose Period|Adverse Event|1|||
131220802|NCT01898884|472434573|FG007|Multiple Dose Period|Adverse Event|0|||
131220803|NCT01898884|472434574|FG008|Multiple Dose Period|Adverse Event|0|||
131220804|NCT01898884|472434566|FG000|Multiple Dose Period|Randomized Not Treated|0|||
131220805|NCT01898884|472434567|FG001|Multiple Dose Period|Randomized Not Treated|0|||
131220806|NCT01898884|472434568|FG002|Multiple Dose Period|Randomized Not Treated|0|||
131220807|NCT01898884|472434569|FG003|Multiple Dose Period|Randomized Not Treated|0|||
131220808|NCT01898884|472434570|FG004|Multiple Dose Period|Randomized Not Treated|0|||
131220809|NCT01898884|472434571|FG005|Multiple Dose Period|Randomized Not Treated|0|||
131220810|NCT01898884|472434572|FG006|Multiple Dose Period|Randomized Not Treated|0|||
131220811|NCT01898884|472434573|FG007|Multiple Dose Period|Randomized Not Treated|0|||
131220812|NCT01898884|472434574|FG008|Multiple Dose Period|Randomized Not Treated|1|||
131220813|NCT00759759|472434575|FG000|Overall Study|didn't return for period 2|1|||
131220814|NCT00759759|472434576|FG001|Overall Study|didn't return for period 2|0|||
131220815|NCT00759759|472434575|FG000|Overall Study|Didn't receive drug in period 2|1|||
131220816|NCT00759759|472434576|FG001|Overall Study|Didn't receive drug in period 2|0|||
131220817|NCT00759759|472434575|FG000|Overall Study|Withdrawal by Subject|2|||
131220818|NCT00759759|472434576|FG001|Overall Study|Withdrawal by Subject|1|||
131220819|NCT03853213|472436000|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
131220820|NCT03853213|472436001|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
131220821|NCT03853213|472436000|FG000|Overall Study|Other (e.g., too busy)|0|||
131220822|NCT03853213|472436001|FG001|Overall Study|Other (e.g., too busy)|2|||
131220823|NCT03302299|472436002|FG000|Overall Study|Protocol Violation|1|||
131220824|NCT03911960|472436003|FG000|Overall Study|Lost to Follow-up|5|||
131220825|NCT03911960|472436004|FG001|Overall Study|Lost to Follow-up|3|||
131220826|NCT02239692|472436005|FG000|Overall Study|Incomplete colonoscopy|1|||
131220827|NCT02239692|472436006|FG001|Overall Study|Incomplete colonoscopy|2|||
131220828|NCT02239692|472436005|FG000|Overall Study|Adverse Event|0|||
131220829|NCT02239692|472436006|FG001|Overall Study|Adverse Event|1|||
131220830|NCT02239692|472436005|FG000|Overall Study|Physician Decision|0|||
131220831|NCT02239692|472436006|FG001|Overall Study|Physician Decision|1|||
131220832|NCT02239692|472436005|FG000|Overall Study|Lost to Follow-up|1|||
131220833|NCT02239692|472436006|FG001|Overall Study|Lost to Follow-up|4|||
131220834|NCT02239692|472436005|FG000|Overall Study|Withdrawal by Subject|3|||
131220835|NCT02239692|472436006|FG001|Overall Study|Withdrawal by Subject|5|||
131220836|NCT02239692|472436005|FG000|Overall Study|Other reason|1|||
131220837|NCT02239692|472436006|FG001|Overall Study|Other reason|0|||
131220838|NCT04318535|472436007|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
131220839|NCT04318535|472436008|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
131220840|NCT04318535|472436009|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
131220841|NCT01901146|472436011|FG000|Neoadjuvant Phase|Death|1|||
131220842|NCT01901146|472436012|FG001|Neoadjuvant Phase|Death|2|||
131220843|NCT01901146|472436013|FG002|Neoadjuvant Phase|Death|0|||
131220844|NCT01901146|472436014|FG003|Neoadjuvant Phase|Death|0|||
131220845|NCT01901146|472436015|FG004|Neoadjuvant Phase|Death|0|||
131220846|NCT01901146|472436011|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
131220847|NCT01901146|472436012|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
131220848|NCT01901146|472436013|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
131220849|NCT01901146|472436014|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
131220850|NCT01901146|472436015|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
131220851|NCT01901146|472436011|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
131220852|NCT01901146|472436012|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
131220853|NCT01901146|472436013|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
131220854|NCT01901146|472436014|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
131220855|NCT01901146|472436015|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
131220856|NCT01901146|472436011|FG000|Neoadjuvant Phase|Physician Decision|1|||
131220857|NCT01901146|472436012|FG001|Neoadjuvant Phase|Physician Decision|2|||
131220858|NCT01901146|472436013|FG002|Neoadjuvant Phase|Physician Decision|0|||
131220859|NCT01901146|472436014|FG003|Neoadjuvant Phase|Physician Decision|0|||
131220860|NCT01901146|472436015|FG004|Neoadjuvant Phase|Physician Decision|0|||
131220861|NCT01901146|472436011|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
131220862|NCT01901146|472436012|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
131220863|NCT01901146|472436013|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
131220864|NCT01901146|472436014|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
131220865|NCT01901146|472436015|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
131220866|NCT01901146|472436011|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
131220867|NCT01901146|472436012|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
131220868|NCT01901146|472436013|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
131220869|NCT01901146|472436014|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
131220870|NCT01901146|472436015|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
131220871|NCT01901146|472436011|FG000|Adjuvant Phase|Other|0|||
131220872|NCT01901146|472436012|FG001|Adjuvant Phase|Other|0|||
131220873|NCT01901146|472436013|FG002|Adjuvant Phase|Other|1|||
131220874|NCT01901146|472436014|FG003|Adjuvant Phase|Other|0|||
131220875|NCT01901146|472436015|FG004|Adjuvant Phase|Other|0|||
131220876|NCT01901146|472436011|FG000|Adjuvant Phase|Death|0|||
131220877|NCT01901146|472436012|FG001|Adjuvant Phase|Death|0|||
131220878|NCT01901146|472436013|FG002|Adjuvant Phase|Death|0|||
131220879|NCT01901146|472436014|FG003|Adjuvant Phase|Death|0|||
131220880|NCT01901146|472436015|FG004|Adjuvant Phase|Death|3|||
131220881|NCT01901146|472436011|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
131220882|NCT01901146|472436012|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
131220883|NCT01901146|472436013|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
131220884|NCT01901146|472436014|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
131220885|NCT01901146|472436015|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
131220886|NCT01901146|472436011|FG000|Adjuvant Phase|Physician Decision|0|||
131220887|NCT01901146|472436012|FG001|Adjuvant Phase|Physician Decision|0|||
131220888|NCT01901146|472436013|FG002|Adjuvant Phase|Physician Decision|9|||
131220889|NCT01901146|472436014|FG003|Adjuvant Phase|Physician Decision|2|||
131220890|NCT01901146|472436015|FG004|Adjuvant Phase|Physician Decision|4|||
131220891|NCT01901146|472436011|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
131220892|NCT01901146|472436012|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
131220893|NCT01901146|472436013|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
131220894|NCT01901146|472436014|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
131220895|NCT01901146|472436015|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
131220896|NCT01614925|472436016|FG000|Overall Study|Withdrawal by Subject|1|||
131220897|NCT01614925|472436017|FG001|Overall Study|Withdrawal by Subject|0|||
131220898|NCT01614925|472436016|FG000|Overall Study|Protocol Violation|3|||
131220899|NCT01614925|472436017|FG001|Overall Study|Protocol Violation|2|||
131220900|NCT04723173|472436018|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
131220901|NCT02996448|472436019|FG000|Overall Study|Study terminated due to adverse effects|3|||
131220902|NCT01422720|472436020|FG000|Overall Study|Adverse Event|16|||
131220903|NCT01422720|472436020|FG000|Overall Study|Lack of Efficacy|1|||
131220904|NCT01422720|472436020|FG000|Overall Study|Withdrawal by Subject|4|||
131220905|NCT01422720|472436020|FG000|Overall Study|Ineligibility|1|||
131220906|NCT00606801|472436021|FG000|Intervention|Protocol Violation|3|||
131220907|NCT00606801|472436022|FG001|Intervention|Protocol Violation|3|||
131220908|NCT01160198|472436030|FG000|Overall Study|Withdrawal by Subject|2|||
131220909|NCT01160198|472436031|FG001|Overall Study|Withdrawal by Subject|1|||
131220910|NCT01160198|472436032|FG002|Overall Study|Withdrawal by Subject|0|||
131220911|NCT01160198|472436030|FG000|Overall Study|Adverse Event|0|||
131220912|NCT01160198|472436031|FG001|Overall Study|Adverse Event|1|||
131220913|NCT01160198|472436032|FG002|Overall Study|Adverse Event|0|||
131220914|NCT01160198|472436030|FG000|Overall Study|Lost to Follow-up|0|||
131220915|NCT01160198|472436031|FG001|Overall Study|Lost to Follow-up|1|||
131220916|NCT01160198|472436032|FG002|Overall Study|Lost to Follow-up|0|||
131220917|NCT01160198|472436030|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
131220918|NCT01160198|472436031|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
131220919|NCT01160198|472436032|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
131220920|NCT03343054|472436034|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
131220921|NCT03343054|472436035|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
131220922|NCT03343054|472436036|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
131220923|NCT03343054|472436034|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
131220924|NCT03343054|472436035|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
131220925|NCT03343054|472436036|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
131220926|NCT03343054|472436034|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
131220927|NCT03343054|472436035|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
131220928|NCT03343054|472436036|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
131220929|NCT03343054|472436034|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
131220930|NCT03343054|472436035|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
130882951|NCT01054885|471207842|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
130882952|NCT01054885|471207836|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130882953|NCT01054885|471207837|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130882954|NCT01054885|471207838|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
130882955|NCT01054885|471207839|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
130882956|NCT01054885|471207840|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130882957|NCT01054885|471207841|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
130882958|NCT01054885|471207842|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130882959|NCT01054885|471207836|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
130882960|NCT01054885|471207837|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
130882961|NCT01054885|471207838|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
130882962|NCT01054885|471207839|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
130882963|NCT01054885|471207840|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
130882964|NCT01054885|471207841|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
130882965|NCT01054885|471207842|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
130882966|NCT01054885|471207836|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130882967|NCT01054885|471207837|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
130882968|NCT01054885|471207838|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
130882969|NCT01054885|471207839|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
130882970|NCT01054885|471207840|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
130882971|NCT01054885|471207841|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
130882972|NCT01054885|471207842|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130882973|NCT01054885|471207836|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
130882974|NCT01054885|471207837|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
130882975|NCT01054885|471207838|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
130882976|NCT01054885|471207839|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
130882977|NCT01054885|471207840|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
130882978|NCT01054885|471207841|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
131220931|NCT03343054|472436036|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
131220932|NCT01467570|472436037|FG000|Overall Study|Lost to Follow-up|8|||
131220933|NCT01467570|472436038|FG001|Overall Study|Lost to Follow-up|9|||
131220934|NCT02626182|472436039|FG000|Overall Study|Adverse Event|2|||
131220935|NCT02626182|472436040|FG001|Overall Study|Adverse Event|0|||
131220936|NCT01222715|472436043|FG000|Overall Study|Adverse Event|0|||
131220937|NCT01222715|472436044|FG001|Overall Study|Adverse Event|4|||
131220938|NCT01222715|472436043|FG000|Overall Study|Death|0|||
131220939|NCT01222715|472436044|FG001|Overall Study|Death|1|||
131220940|NCT01222715|472436043|FG000|Overall Study|Lack of Efficacy|22|||
131220941|NCT01222715|472436044|FG001|Overall Study|Lack of Efficacy|14|||
131220942|NCT01222715|472436043|FG000|Overall Study|Physician Decision|12|||
131220943|NCT01222715|472436044|FG001|Overall Study|Physician Decision|2|||
131220944|NCT01222715|472436043|FG000|Overall Study|Refusal of further protocol therapy|0|||
131220945|NCT01222715|472436044|FG001|Overall Study|Refusal of further protocol therapy|4|||
131220946|NCT01222715|472436043|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
131220947|NCT01222715|472436044|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
131220948|NCT01222715|472436043|FG000|Overall Study|Ineligible|0|||
131220949|NCT01222715|472436044|FG001|Overall Study|Ineligible|1|||
131220950|NCT01222715|472436043|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
131220951|NCT01222715|472436044|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
131220952|NCT02360397|472436045|FG000|Overall Study|Incomplete screening|3|||
131220953|NCT02360397|472436045|FG000|Overall Study|Adverse Event|1|||
131220954|NCT01537549|472436046|FG000|Overall Study|Lost to Follow-up|1|||
131220955|NCT01537549|472436046|FG000|Overall Study|Withdrawal by Subject|2|||
131220956|NCT03555890|472436049|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131220957|NCT03555890|472436050|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131220958|NCT03555890|472436051|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131220959|NCT03555890|472436052|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
131220960|NCT03372369|472436053|FG000|Qualification Period|Withdrawal by Subject|16|||
131220961|NCT03372369|472436054|FG001|Qualification Period|Withdrawal by Subject|13|||
131220962|NCT03372369|472436053|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
131220963|NCT03372369|472436054|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
131220964|NCT03372369|472436053|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
131220965|NCT03372369|472436054|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
131220966|NCT02239601|472436055|FG000|Overall Study|Withdrawal by Subject|3|||
131220967|NCT02239601|472436056|FG001|Overall Study|Withdrawal by Subject|4|||
131220968|NCT02239601|472436055|FG000|Overall Study|Protocol Violation|4|||
131220969|NCT02239601|472436056|FG001|Overall Study|Protocol Violation|2|||
131220970|NCT01508325|472436057|FG000|Overall Study|Withdrawal by Subject|8|||
131220971|NCT01508325|472436058|FG001|Overall Study|Withdrawal by Subject|9|||
131220972|NCT01508325|472436057|FG000|Overall Study|Protocol Violation|0|||
131220973|NCT01508325|472436058|FG001|Overall Study|Protocol Violation|3|||
131220974|NCT01508325|472436057|FG000|Overall Study|Physician Decision|2|||
131220975|NCT01508325|472436058|FG001|Overall Study|Physician Decision|1|||
131220976|NCT01508325|472436057|FG000|Overall Study|Adverse Event|1|||
131220977|NCT01508325|472436058|FG001|Overall Study|Adverse Event|0|||
131220978|NCT01508325|472436057|FG000|Overall Study|Lost to Follow-up|5|||
131220979|NCT01508325|472436058|FG001|Overall Study|Lost to Follow-up|6|||
131220980|NCT01508325|472436057|FG000|Overall Study|Other|2|||
131220981|NCT01508325|472436058|FG001|Overall Study|Other|2|||
131220982|NCT04682639|472436059|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
131220983|NCT04682639|472436060|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
131220984|NCT04682639|472436061|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
131220985|NCT04682639|472436062|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
131220986|NCT04682639|472436063|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
131220987|NCT04682639|472436059|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
131220988|NCT04682639|472436060|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
131220989|NCT04682639|472436061|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
131220990|NCT04682639|472436062|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131220991|NCT04682639|472436063|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131220992|NCT04682639|472436059|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
131220993|NCT04682639|472436060|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131220994|NCT04682639|472436061|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131220995|NCT04682639|472436062|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131220996|NCT04682639|472436063|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131220997|NCT04682639|472436059|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
131220998|NCT04682639|472436060|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
131220999|NCT04682639|472436061|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
131221000|NCT04682639|472436062|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
131221001|NCT04682639|472436063|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
131221002|NCT04682639|472436059|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
131221003|NCT04682639|472436060|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
131221004|NCT04682639|472436061|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
131221005|NCT04682639|472436062|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
131221006|NCT04682639|472436063|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
131221007|NCT04682639|472436059|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
131221008|NCT04682639|472436060|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
131221009|NCT04682639|472436061|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
131221010|NCT04682639|472436062|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131221011|NCT04682639|472436063|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131221012|NCT04682639|472436059|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
131221013|NCT04682639|472436060|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
131221014|NCT04682639|472436061|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
131221015|NCT04682639|472436062|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
131221016|NCT04682639|472436063|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
131221017|NCT04682639|472436059|FG000|OLE Period (28 Weeks)|Other|1|||
131221018|NCT04682639|472436060|FG001|OLE Period (28 Weeks)|Other|2|||
131221019|NCT04682639|472436061|FG002|OLE Period (28 Weeks)|Other|0|||
131221020|NCT04682639|472436062|FG003|OLE Period (28 Weeks)|Other|0|||
131221021|NCT04682639|472436063|FG004|OLE Period (28 Weeks)|Other|1|||
131221022|NCT04682639|472436059|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
131221023|NCT04682639|472436060|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
131221024|NCT04682639|472436061|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
131221025|NCT04682639|472436062|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
131221026|NCT04682639|472436063|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
131221027|NCT04682639|472436059|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
131221028|NCT04682639|472436060|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
131221029|NCT04682639|472436061|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131221030|NCT04682639|472436062|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131221031|NCT04682639|472436063|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131221032|NCT04682639|472436059|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
131221033|NCT04682639|472436060|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
131221034|NCT04682639|472436061|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
131221035|NCT04682639|472436062|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
131221036|NCT04682639|472436063|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
131221037|NCT04682639|472436059|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
131221038|NCT04682639|472436060|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
131221039|NCT04682639|472436061|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
131221040|NCT04682639|472436062|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
131221041|NCT04682639|472436063|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
131221042|NCT01392170|472436064|FG000|Overall Study|Withdrawal by Subject|1|||
131221043|NCT01392170|472436064|FG000|Overall Study|Ineligible|1|||
131221044|NCT01286207|472436065|FG000|Overall Study|Adverse Event|27|||
131221045|NCT01286207|472436066|FG001|Overall Study|Adverse Event|41|||
131221046|NCT01286207|472436067|FG002|Overall Study|Adverse Event|8|||
131221047|NCT01286207|472436065|FG000|Overall Study|Lost to Follow-up|49|||
131221048|NCT01286207|472436066|FG001|Overall Study|Lost to Follow-up|43|||
131221049|NCT01286207|472436067|FG002|Overall Study|Lost to Follow-up|20|||
131221050|NCT01286207|472436065|FG000|Overall Study|Withdrawal by Subject|93|||
131221051|NCT01286207|472436066|FG001|Overall Study|Withdrawal by Subject|79|||
131221052|NCT01286207|472436067|FG002|Overall Study|Withdrawal by Subject|41|||
131221053|NCT01286207|472436065|FG000|Overall Study|Lack of Response|92|||
131221054|NCT01286207|472436066|FG001|Overall Study|Lack of Response|38|||
131221055|NCT01286207|472436067|FG002|Overall Study|Lack of Response|8|||
131221056|NCT01286207|472436065|FG000|Overall Study|Other|37|||
131221057|NCT01286207|472436066|FG001|Overall Study|Other|47|||
131221058|NCT01286207|472436067|FG002|Overall Study|Other|13|||
131221059|NCT00450177|472436069|FG000|Overall Study|Adverse Event|7|||
131221060|NCT00450177|472436070|FG001|Overall Study|Adverse Event|4|||
131221061|NCT00450177|472436069|FG000|Overall Study|Withdrawal by Subject|1|||
131221062|NCT00450177|472436070|FG001|Overall Study|Withdrawal by Subject|6|||
131221063|NCT00450177|472436069|FG000|Overall Study|Withdrawal by Primary Team|1|||
131221064|NCT00450177|472436070|FG001|Overall Study|Withdrawal by Primary Team|1|||
131221065|NCT03174925|472436082|FG000|Overall Study|Elastographic images not retrievable|2|||
131221066|NCT03174925|472436082|FG000|Overall Study|Elastography image not interpretable|1|||
131221067|NCT01791127|472436083|FG000|Overall Study|Death|356|||
131221068|NCT01791127|472436083|FG000|Overall Study|Patient has withdrawn from study|293|||
131221069|NCT01791127|472436083|FG000|Overall Study|Lost to Follow-up|42|||
131221070|NCT01791127|472436083|FG000|Overall Study|All Siello leads are explanted|31|||
131221071|NCT01791127|472436083|FG000|Overall Study|Completion of 30 day safety registry|1|||
131221072|NCT01791127|472436083|FG000|Overall Study|Study terminated for EP Passion|749|||
131221073|NCT04247594|472436086|FG000|Overall Study|Withdrawal by Subject|4|||
131221074|NCT02748616|472436092|FG000|Overall Study|Lost to Follow-up|1|||
131221075|NCT02748616|472436092|FG000|Overall Study|Withdrawal by Subject|2|||
131221076|NCT02748616|472436092|FG000|Overall Study|Physician Decision|2|||
131221077|NCT02748616|472436092|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
131221078|NCT00589693|472436094|FG000|Overall Study|randomized in error|12|||
131221079|NCT00589693|472436095|FG001|Overall Study|randomized in error|6|||
131221080|NCT00589693|472436094|FG000|Overall Study|Adverse Event|4|||
131221081|NCT00589693|472436095|FG001|Overall Study|Adverse Event|4|||
130765871|NCT05079230|470765892|FG000|Overall Study|Withdrew Consent|16|||
130882979|NCT01054885|471207842|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
130882980|NCT01054885|471207836|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130882981|NCT01054885|471207837|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130882982|NCT01054885|471207838|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
130882983|NCT01054885|471207839|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
131221082|NCT00589693|472436094|FG000|Overall Study|Death|26|||
130882984|NCT01054885|471207840|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130882985|NCT01054885|471207841|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130882986|NCT01054885|471207842|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
130882987|NCT01054885|471207836|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130882988|NCT01054885|471207837|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
130882989|NCT01054885|471207838|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130882990|NCT01054885|471207839|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130882991|NCT01054885|471207840|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130882992|NCT01054885|471207841|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130882993|NCT01054885|471207842|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
130882994|NCT01054885|471207836|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
130882995|NCT01054885|471207837|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
130882996|NCT01054885|471207838|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
130882997|NCT01054885|471207839|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
130882998|NCT01054885|471207840|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
130882999|NCT01054885|471207841|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
130883000|NCT01054885|471207842|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
130883001|NCT01054885|471207836|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130883002|NCT01054885|471207837|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
130883003|NCT01054885|471207838|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130883004|NCT01054885|471207839|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
130883005|NCT01054885|471207840|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
130883006|NCT01054885|471207841|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130883007|NCT01054885|471207842|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
130883008|NCT00214201|471207844|FG000|Overall Study|Withdrawal by Subject|2|||
130883009|NCT00214201|471207845|FG001|Overall Study|Withdrawal by Subject|0|||
130883010|NCT00214201|471207844|FG000|Overall Study|Death|0|||
130883011|NCT00214201|471207845|FG001|Overall Study|Death|2|||
130883012|NCT04226742|471207849|FG000|Overall Study|Lost to Follow-up|16|||
130883013|NCT04226742|471207850|FG001|Overall Study|Lost to Follow-up|13|||
130883014|NCT04226742|471207849|FG000|Overall Study|Withdrawal by Subject|5|||
130883015|NCT04226742|471207850|FG001|Overall Study|Withdrawal by Subject|3|||
130883016|NCT02492763|471207851|FG000|Overall Study|Withdrawal by Subject|0|||
130883017|NCT02492763|471207852|FG001|Overall Study|Withdrawal by Subject|2|||
130883018|NCT02492763|471207853|FG002|Overall Study|Withdrawal by Subject|1|||
130883019|NCT02492763|471207854|FG003|Overall Study|Withdrawal by Subject|0|||
130883020|NCT02492763|471207851|FG000|Overall Study|Adverse Event|3|||
130883021|NCT02492763|471207852|FG001|Overall Study|Adverse Event|1|||
130883022|NCT02492763|471207853|FG002|Overall Study|Adverse Event|1|||
130883023|NCT02492763|471207854|FG003|Overall Study|Adverse Event|2|||
130883024|NCT02492763|471207851|FG000|Overall Study|Death|0|||
130883025|NCT02492763|471207852|FG001|Overall Study|Death|0|||
130883026|NCT02492763|471207853|FG002|Overall Study|Death|1|||
130883027|NCT02492763|471207854|FG003|Overall Study|Death|0|||
130883028|NCT02492763|471207851|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
130883029|NCT02492763|471207852|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
130883030|NCT02492763|471207853|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
130883031|NCT02492763|471207854|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
130883032|NCT02492763|471207851|FG000|Overall Study|Lost to Follow-up|0|||
130883033|NCT02492763|471207852|FG001|Overall Study|Lost to Follow-up|0|||
130883034|NCT02492763|471207853|FG002|Overall Study|Lost to Follow-up|1|||
130883035|NCT02492763|471207854|FG003|Overall Study|Lost to Follow-up|0|||
130883036|NCT02492763|471207851|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130883037|NCT02492763|471207852|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130883038|NCT02492763|471207853|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130883039|NCT02492763|471207854|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130883040|NCT02492763|471207851|FG000|Overall Study|Screen Failure|0|||
131221083|NCT00589693|472436095|FG001|Overall Study|Death|16|||
131221084|NCT00589693|472436094|FG000|Overall Study|Lack of Efficacy|0|||
131221085|NCT00589693|472436095|FG001|Overall Study|Lack of Efficacy|1|||
131221086|NCT00589693|472436094|FG000|Overall Study|Lost to Follow-up|1|||
131221087|NCT00589693|472436095|FG001|Overall Study|Lost to Follow-up|0|||
131221088|NCT00589693|472436094|FG000|Overall Study|Physician Decision|0|||
131221089|NCT00589693|472436095|FG001|Overall Study|Physician Decision|1|||
131221090|NCT00589693|472436094|FG000|Overall Study|Protocol Violation|1|||
131221091|NCT00589693|472436095|FG001|Overall Study|Protocol Violation|1|||
131221092|NCT03231709|472436096|FG000|Treatment Period 1|Reason not Specified|0|||
131221093|NCT03231709|472436097|FG001|Treatment Period 1|Reason not Specified|1|||
131221094|NCT03231709|472436096|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
131221095|NCT03231709|472436097|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
131221096|NCT04057118|472436098|FG000|Overall Study|Adverse Event|1|||
131221097|NCT04057118|472436099|FG001|Overall Study|Adverse Event|0|||
131221098|NCT04057118|472436100|FG002|Overall Study|Adverse Event|1|||
131221099|NCT04057118|472436101|FG003|Overall Study|Adverse Event|1|||
131221100|NCT04057118|472436098|FG000|Overall Study|Physician Decision|0|||
131221101|NCT04057118|472436099|FG001|Overall Study|Physician Decision|0|||
131221102|NCT04057118|472436100|FG002|Overall Study|Physician Decision|1|||
131221103|NCT04057118|472436101|FG003|Overall Study|Physician Decision|1|||
131221104|NCT04057118|472436098|FG000|Overall Study|Withdrawal by Subject|2|||
131221105|NCT04057118|472436099|FG001|Overall Study|Withdrawal by Subject|2|||
131221106|NCT04057118|472436100|FG002|Overall Study|Withdrawal by Subject|0|||
131221107|NCT04057118|472436101|FG003|Overall Study|Withdrawal by Subject|2|||
131221108|NCT04057118|472436098|FG000|Overall Study|Not Specific|0|||
131221109|NCT04057118|472436099|FG001|Overall Study|Not Specific|0|||
131221110|NCT04057118|472436100|FG002|Overall Study|Not Specific|1|||
131221111|NCT04057118|472436101|FG003|Overall Study|Not Specific|1|||
131221112|NCT03273712|472436102|FG000|Overall Study|Death|5|||
131221113|NCT03273712|472436102|FG000|Overall Study|Adverse Event|1|||
131221114|NCT03273712|472436102|FG000|Overall Study|Disease Progression|1|||
130883041|NCT02492763|471207852|FG001|Overall Study|Screen Failure|0|||
130883042|NCT02492763|471207853|FG002|Overall Study|Screen Failure|0|||
130883043|NCT02492763|471207854|FG003|Overall Study|Screen Failure|1|||
130883044|NCT02492763|471207851|FG000|Overall Study|Study Terminated by Sponsor|13|||
130883045|NCT02492763|471207852|FG001|Overall Study|Study Terminated by Sponsor|10|||
130883046|NCT02492763|471207853|FG002|Overall Study|Study Terminated by Sponsor|6|||
130883047|NCT02492763|471207854|FG003|Overall Study|Study Terminated by Sponsor|10|||
130883048|NCT01337960|471207855|FG000|Overall Study|Lost to Follow-up|1|||
130883049|NCT01337960|471207856|FG001|Overall Study|Lost to Follow-up|0|||
130883050|NCT01337960|471207857|FG002|Overall Study|Lost to Follow-up|0|||
130883051|NCT01337960|471207855|FG000|Overall Study|Withdrawal by Subject|1|||
130883052|NCT01337960|471207856|FG001|Overall Study|Withdrawal by Subject|0|||
130883053|NCT01337960|471207857|FG002|Overall Study|Withdrawal by Subject|0|||
130883054|NCT01772316|471207858|FG000|Overall Study|Serious adverse event|1|||
130883055|NCT01772316|471207858|FG000|Overall Study|Inform consent withdrawn|1|||
130883056|NCT01772316|471207858|FG000|Overall Study|Withdrawn by sponsor decision|5|||
130883057|NCT01907854|471207859|FG000|Overall Study|Protocol Violation|1|||
130883058|NCT01907854|471207860|FG001|Overall Study|Protocol Violation|1|||
130883059|NCT01907854|471207859|FG000|Overall Study|Withdrawal by Subject|9|||
130883060|NCT01907854|471207860|FG001|Overall Study|Withdrawal by Subject|7|||
130883061|NCT01907854|471207859|FG000|Overall Study|Lost to Follow-up|2|||
130883062|NCT01907854|471207860|FG001|Overall Study|Lost to Follow-up|2|||
130883063|NCT01907854|471207859|FG000|Overall Study|Unclassified|4|||
130883064|NCT01907854|471207860|FG001|Overall Study|Unclassified|3|||
130883065|NCT02215252|471207861|FG000|Overall Study|Adverse Event|1|||
130883066|NCT02215252|471207862|FG001|Overall Study|Adverse Event|5|||
130883067|NCT02215252|471207863|FG002|Overall Study|Adverse Event|2|||
130883068|NCT02215252|471207861|FG000|Overall Study|Lost to Follow-up|0|||
130883069|NCT02215252|471207862|FG001|Overall Study|Lost to Follow-up|0|||
130883070|NCT02215252|471207863|FG002|Overall Study|Lost to Follow-up|1|||
130883071|NCT02215252|471207861|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
130883072|NCT02215252|471207862|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
130883073|NCT02215252|471207863|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
130883074|NCT02215252|471207861|FG000|Overall Study|Protocol Violation|0|||
130883075|NCT02215252|471207862|FG001|Overall Study|Protocol Violation|1|||
130883076|NCT02215252|471207863|FG002|Overall Study|Protocol Violation|0|||
130883077|NCT02215252|471207861|FG000|Overall Study|Withdrawal by Subject|1|||
130883078|NCT02215252|471207862|FG001|Overall Study|Withdrawal by Subject|0|||
130883079|NCT02215252|471207863|FG002|Overall Study|Withdrawal by Subject|0|||
130883080|NCT02215252|471207861|FG000|Overall Study|Other|0|||
130883081|NCT02215252|471207862|FG001|Overall Study|Other|1|||
130883082|NCT02215252|471207863|FG002|Overall Study|Other|1|||
130883083|NCT02633306|471207864|FG000|Overall Study|Withdrawal by Subject|3|||
130883084|NCT03910244|471207865|FG000|Overall Study|Adverse Event|14|||
131221115|NCT03959137|472436105|FG000|Overall Study|Protocol Violation|6|||
131221116|NCT00190684|472436106|FG000|Overall Study|Adverse Event|86|||
131221117|NCT00190684|472436106|FG000|Overall Study|Satisfactory response|80|||
130883085|NCT03910244|471207866|FG001|Overall Study|Adverse Event|0|||
130883086|NCT03910244|471207865|FG000|Overall Study|Death|1|||
130883087|NCT03910244|471207866|FG001|Overall Study|Death|0|||
131221118|NCT00190684|472436106|FG000|Overall Study|Lack of efficacy|204|||
131221119|NCT00190684|472436106|FG000|Overall Study|Lost to Follow-up|232|||
131221120|NCT00190684|472436106|FG000|Overall Study|Patient moved|60|||
130883088|NCT03910244|471207865|FG000|Overall Study|Lost to Follow-up|0|||
131221121|NCT00190684|472436106|FG000|Overall Study|Patient Decision|432|||
131221122|NCT00190684|472436106|FG000|Overall Study|Clinical relapse|67|||
131221123|NCT00190684|472436106|FG000|Overall Study|Sponsor's decision|17|||
131221124|NCT00190684|472436106|FG000|Overall Study|Physician Decision|84|||
131221125|NCT00190684|472436106|FG000|Overall Study|Protocol Violation|123|||
131221126|NCT00190684|472436106|FG000|Overall Study|Study Period III Completed|103|||
131221127|NCT00190684|472436106|FG000|Overall Study|Study Period V Completed|1|||
131221128|NCT00995488|472436112|FG000|Overall Study|Withdrawal by Subject|1|||
131221129|NCT02702271|472436113|FG000|Overall Study|Death|36|||
131221130|NCT02702271|472436114|FG001|Overall Study|Death|7|||
131221131|NCT02702271|472436113|FG000|Overall Study|Lost to Follow-up|12|||
131221132|NCT02702271|472436114|FG001|Overall Study|Lost to Follow-up|0|||
131221133|NCT02702271|472436113|FG000|Overall Study|Withdrawal by Subject|8|||
131221134|NCT02702271|472436114|FG001|Overall Study|Withdrawal by Subject|1|||
131221135|NCT02702271|472436113|FG000|Overall Study|Physician Decision|2|||
131221136|NCT02702271|472436114|FG001|Overall Study|Physician Decision|0|||
131221137|NCT02702271|472436113|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
131221138|NCT02702271|472436114|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
131221139|NCT01494649|472436115|FG000|Overall Study|Lost to Follow-up|0|||
131221140|NCT01494649|472436116|FG001|Overall Study|Lost to Follow-up|1|||
131221141|NCT01174368|472436117|FG000|Overall Study|Withdrawal by Subject|1|||
131221142|NCT05166512|472436120|FG000|Randomized|Lost to Follow-up|2|||
131221143|NCT05166512|472436121|FG001|Randomized|Lost to Follow-up|0|||
131221144|NCT05166512|472436120|FG000|Randomized|Withdrawal by Subject|1|||
131221145|NCT05166512|472436121|FG001|Randomized|Withdrawal by Subject|0|||
131221146|NCT05166512|472436120|FG000|Baseline Data Collection|Lost to Follow-up|0|||
131221147|NCT05166512|472436121|FG001|Baseline Data Collection|Lost to Follow-up|3|||
131221148|NCT05166512|472436120|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
131221149|NCT05166512|472436121|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
131221150|NCT05166512|472436120|FG000|Baseline Data Collection|Protocol Violation|2|||
131221151|NCT05166512|472436121|FG001|Baseline Data Collection|Protocol Violation|0|||
131221152|NCT05166512|472436120|FG000|4 Month Data Collection|Lost to Follow-up|1|||
131221153|NCT05166512|472436121|FG001|4 Month Data Collection|Lost to Follow-up|0|||
131221154|NCT05166512|472436120|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
131221155|NCT05166512|472436121|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
131221156|NCT05166512|472436120|FG000|12 Month Data Collection|Lost to Follow-up|3|||
131221157|NCT05166512|472436121|FG001|12 Month Data Collection|Lost to Follow-up|1|||
131221158|NCT05166512|472436120|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
131221159|NCT05166512|472436121|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
131221160|NCT01831596|472436122|FG000|Overall Study|Other|8|||
131221161|NCT02956005|472436126|FG000|Overall Study|Not eligible|1|||
131221162|NCT02956005|472436126|FG000|Overall Study|Withdrawal by Subject|3|||
130765872|NCT05079230|470765893|FG001|Overall Study|Withdrew Consent|18|||
130883089|NCT03910244|471207866|FG001|Overall Study|Lost to Follow-up|2|||
130883090|NCT03910244|471207865|FG000|Overall Study|Joint withdrawal decision|1|||
130883091|NCT03910244|471207866|FG001|Overall Study|Joint withdrawal decision|0|||
130883092|NCT03910244|471207865|FG000|Overall Study|Study Terminated by Sponsor|7|||
130883093|NCT03910244|471207866|FG001|Overall Study|Study Terminated by Sponsor|4|||
130883094|NCT03910244|471207865|FG000|Overall Study|Physician Decision|1|||
131221163|NCT02956005|472436126|FG000|Overall Study|Physician Decision|12|||
131221164|NCT02602080|472436127|FG000|Overall Study|Protocol Violation|6|||
131221165|NCT02602080|472436128|FG001|Overall Study|Protocol Violation|1|||
131221166|NCT02602080|472436129|FG002|Overall Study|Protocol Violation|3|||
131221167|NCT00883129|472436130|FG000|Overall Study|Adverse Event|7|||
131221168|NCT00883129|472436131|FG001|Overall Study|Adverse Event|15|||
131221169|NCT00883129|472436130|FG000|Overall Study|Withdrawal by Subject|8|||
131221170|NCT00883129|472436131|FG001|Overall Study|Withdrawal by Subject|9|||
131221171|NCT00883129|472436130|FG000|Overall Study|Non-compliance|3|||
131221172|NCT00883129|472436131|FG001|Overall Study|Non-compliance|6|||
131221173|NCT00883129|472436130|FG000|Overall Study|Lost to Follow-up|1|||
131221174|NCT00883129|472436131|FG001|Overall Study|Lost to Follow-up|2|||
131221175|NCT00883129|472436130|FG000|Overall Study|Death|1|||
131221176|NCT00883129|472436131|FG001|Overall Study|Death|2|||
131221177|NCT00883129|472436130|FG000|Overall Study|Defined Treatment Failure|0|||
131221178|NCT00883129|472436131|FG001|Overall Study|Defined Treatment Failure|2|||
131221179|NCT03273257|472436132|FG000|Overall Study|Death|0|||
131221180|NCT03273257|472436133|FG001|Overall Study|Death|1|||
131221181|NCT03273257|472436132|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
131221182|NCT03273257|472436133|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
131221183|NCT03273257|472436132|FG000|Overall Study|Study terminated|3|||
131221184|NCT03273257|472436133|FG001|Overall Study|Study terminated|2|||
131221185|NCT04355767|472436135|FG000|Overall Study|Withdrawal by Subject|2|||
131221186|NCT04355767|472436136|FG001|Overall Study|Withdrawal by Subject|2|||
131221187|NCT04355767|472436135|FG000|Overall Study|Death|5|||
131221188|NCT04355767|472436136|FG001|Overall Study|Death|1|||
131221189|NCT01999322|472436137|FG000|Overall Study|Adverse Event|1|||
131221190|NCT01999322|472436138|FG001|Overall Study|Adverse Event|0|||
131221191|NCT01211613|472437838|FG000|Overall Study|Lost to Follow-up|2|||
131221192|NCT01211613|472437839|FG001|Overall Study|Lost to Follow-up|2|||
131221193|NCT01211613|472437840|FG002|Overall Study|Lost to Follow-up|2|||
131221194|NCT01211613|472437838|FG000|Overall Study|Withdrawal by Subject|1|||
131221195|NCT01211613|472437839|FG001|Overall Study|Withdrawal by Subject|0|||
131221196|NCT01211613|472437840|FG002|Overall Study|Withdrawal by Subject|0|||
131221197|NCT01458132|472437841|FG000|Overall Study|Other|15|||
131221198|NCT01458132|472437842|FG001|Overall Study|Other|3|||
131221199|NCT00833976|472437847|FG000|Overall Study|Withdrawal by Subject|5|||
131221200|NCT00833976|472437847|FG000|Overall Study|Lost to Follow-up|4|||
131221201|NCT00833976|472437847|FG000|Overall Study|Did not meet eligibility criteria|41|||
131221202|NCT00833976|472437847|FG000|Overall Study|Physician Decision|1|||
131221203|NCT00297492|472437848|FG000|Set Quit Date|Lost to Follow-up|7|||
131221204|NCT00297492|472437849|FG001|Set Quit Date|Lost to Follow-up|13|||
131221205|NCT00297492|472437850|FG002|Set Quit Date|Lost to Follow-up|5|||
131221206|NCT00297492|472437848|FG000|6 Month Follow-up|Lost to Follow-up|63|||
131221207|NCT00297492|472437849|FG001|6 Month Follow-up|Lost to Follow-up|49|||
131221208|NCT00297492|472437850|FG002|6 Month Follow-up|Lost to Follow-up|27|||
131221209|NCT02437890|472437855|FG000|Overall Study|Non-compliance to study drug|0|||
131221210|NCT02437890|472437856|FG001|Overall Study|Non-compliance to study drug|1|||
131221211|NCT02437890|472437857|FG002|Overall Study|Non-compliance to study drug|0|||
131221212|NCT02437890|472437858|FG003|Overall Study|Non-compliance to study drug|0|||
131221213|NCT02437890|472437859|FG004|Overall Study|Non-compliance to study drug|1|||
131221214|NCT02437890|472437855|FG000|Overall Study|Sponsor's decision|1|||
131221215|NCT02437890|472437856|FG001|Overall Study|Sponsor's decision|1|||
131221216|NCT02437890|472437857|FG002|Overall Study|Sponsor's decision|4|||
131221217|NCT02437890|472437858|FG003|Overall Study|Sponsor's decision|0|||
131221218|NCT02437890|472437859|FG004|Overall Study|Sponsor's decision|2|||
131221219|NCT02437890|472437855|FG000|Overall Study|Physician Decision|0|||
131221220|NCT02437890|472437856|FG001|Overall Study|Physician Decision|0|||
131221221|NCT02437890|472437857|FG002|Overall Study|Physician Decision|0|||
131221222|NCT02437890|472437858|FG003|Overall Study|Physician Decision|1|||
131221223|NCT02437890|472437859|FG004|Overall Study|Physician Decision|0|||
131221224|NCT02437890|472437855|FG000|Overall Study|Unable to attend visit(s)|1|||
131221225|NCT02437890|472437856|FG001|Overall Study|Unable to attend visit(s)|0|||
131221226|NCT02437890|472437857|FG002|Overall Study|Unable to attend visit(s)|0|||
131221227|NCT02437890|472437858|FG003|Overall Study|Unable to attend visit(s)|0|||
131221228|NCT02437890|472437859|FG004|Overall Study|Unable to attend visit(s)|0|||
131221229|NCT02437890|472437855|FG000|Overall Study|Lack of Efficacy|1|||
131221230|NCT02437890|472437856|FG001|Overall Study|Lack of Efficacy|3|||
131221231|NCT02437890|472437857|FG002|Overall Study|Lack of Efficacy|0|||
131221232|NCT02437890|472437858|FG003|Overall Study|Lack of Efficacy|3|||
131221233|NCT02437890|472437859|FG004|Overall Study|Lack of Efficacy|1|||
131221234|NCT02437890|472437855|FG000|Overall Study|Adverse Event|4|||
131221235|NCT02437890|472437856|FG001|Overall Study|Adverse Event|9|||
131221236|NCT02437890|472437857|FG002|Overall Study|Adverse Event|5|||
131221237|NCT02437890|472437858|FG003|Overall Study|Adverse Event|11|||
131221238|NCT02437890|472437859|FG004|Overall Study|Adverse Event|7|||
131221239|NCT02437890|472437855|FG000|Overall Study|Withdrawal by Subject|1|||
131221240|NCT02437890|472437856|FG001|Overall Study|Withdrawal by Subject|2|||
131221241|NCT02437890|472437857|FG002|Overall Study|Withdrawal by Subject|6|||
131221242|NCT02437890|472437858|FG003|Overall Study|Withdrawal by Subject|5|||
131221243|NCT02437890|472437859|FG004|Overall Study|Withdrawal by Subject|5|||
131221244|NCT02437890|472437855|FG000|Overall Study|Death|0|||
130993694|NCT01861522|471603888|FG000|Overall Study|Withdrawal by Subject|2|||
130993695|NCT01861522|471603889|FG001|Overall Study|Withdrawal by Subject|0|||
130993696|NCT00550550|471603890|FG000|Overall Study|Adverse Event|13|||
130993697|NCT00550550|471603891|FG001|Overall Study|Adverse Event|5|||
130993698|NCT00550550|471603890|FG000|Overall Study|Treatment Failure|0|||
130993699|NCT00550550|471603891|FG001|Overall Study|Treatment Failure|1|||
130993700|NCT00550550|471603890|FG000|Overall Study|Lost to Follow-up|4|||
130993701|NCT00550550|471603891|FG001|Overall Study|Lost to Follow-up|0|||
130993702|NCT00550550|471603890|FG000|Overall Study|Withdrawal by Subject|10|||
130993703|NCT00550550|471603891|FG001|Overall Study|Withdrawal by Subject|8|||
130993704|NCT00550550|471603890|FG000|Overall Study|Protocol Violation|5|||
130993705|NCT00550550|471603891|FG001|Overall Study|Protocol Violation|14|||
130993706|NCT00550550|471603890|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
130993707|NCT00550550|471603891|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
130993708|NCT00550550|471603890|FG000|Overall Study|Randomized But Not Treated|1|||
130993709|NCT00550550|471603891|FG001|Overall Study|Randomized But Not Treated|0|||
130993710|NCT00381641|471603894|FG000|Overall Study|Withdrawal by Subject|0|||
130993711|NCT00381641|471603895|FG001|Overall Study|Withdrawal by Subject|2|||
130993712|NCT01598298|471603896|FG000|Overall Study|Not eligible|5|||
130993713|NCT01598298|471603897|FG001|Overall Study|Not eligible|5|||
130993714|NCT01598298|471603896|FG000|Overall Study|Adverse Event|21|||
130993715|NCT01598298|471603897|FG001|Overall Study|Adverse Event|19|||
131221245|NCT02437890|472437856|FG001|Overall Study|Death|0|||
131221246|NCT02437890|472437857|FG002|Overall Study|Death|0|||
131221247|NCT02437890|472437858|FG003|Overall Study|Death|2|||
131221248|NCT02437890|472437859|FG004|Overall Study|Death|0|||
130993716|NCT01598298|471603896|FG000|Overall Study|Progression/relapse|0|||
130993717|NCT01598298|471603897|FG001|Overall Study|Progression/relapse|2|||
130993718|NCT01598298|471603896|FG000|Overall Study|Withdrawal by Subject|10|||
130993719|NCT01598298|471603897|FG001|Overall Study|Withdrawal by Subject|15|||
130993720|NCT01598298|471603896|FG000|Overall Study|Other reason (not protocol specified)|4|||
131221249|NCT02414854|472437860|FG000|Overall Study|Adverse Event|9|||
131221250|NCT02414854|472437861|FG001|Overall Study|Adverse Event|7|||
131221251|NCT02414854|472437862|FG002|Overall Study|Adverse Event|1|||
131221252|NCT02414854|472437863|FG003|Overall Study|Adverse Event|12|||
131221253|NCT02414854|472437860|FG000|Overall Study|Poor compliance to protocol|1|||
131221254|NCT02414854|472437861|FG001|Overall Study|Poor compliance to protocol|1|||
131221255|NCT02414854|472437862|FG002|Overall Study|Poor compliance to protocol|2|||
131221256|NCT02414854|472437863|FG003|Overall Study|Poor compliance to protocol|2|||
131221257|NCT02414854|472437860|FG000|Overall Study|Other than specified above|12|||
131221258|NCT02414854|472437861|FG001|Overall Study|Other than specified above|37|||
131221259|NCT02414854|472437862|FG002|Overall Study|Other than specified above|17|||
131221260|NCT02414854|472437863|FG003|Overall Study|Other than specified above|37|||
131221261|NCT02082262|472437864|FG000|Overall Study|Withdrawal by Subject|3|||
131221262|NCT02082262|472437864|FG000|Overall Study|Adverse Event|48|||
131221263|NCT01074307|472437865|FG000|Overall Study|No primary endpoint evaluation|14|||
131221264|NCT01074307|472437866|FG001|Overall Study|No primary endpoint evaluation|6|||
131221265|NCT01074307|472437865|FG000|Overall Study|Exclusion criterion|0|||
130993721|NCT01598298|471603897|FG001|Overall Study|Other reason (not protocol specified)|0|||
131221266|NCT01074307|472437866|FG001|Overall Study|Exclusion criterion|1|||
131221267|NCT01074307|472437865|FG000|Overall Study|Protocol Violation|8|||
131221268|NCT01074307|472437866|FG001|Overall Study|Protocol Violation|5|||
131221269|NCT02162511|472437867|FG000|Overall Study|Lack of Efficacy|0|||
131221270|NCT02162511|472437868|FG001|Overall Study|Lack of Efficacy|0|||
131221271|NCT02162511|472437869|FG002|Overall Study|Lack of Efficacy|2|||
131221272|NCT01408576|472437870|FG000|Overall Study|Lack of Efficacy|17|||
131221273|NCT01408576|472437871|FG001|Overall Study|Lack of Efficacy|30|||
131221274|NCT01408576|472437872|FG002|Overall Study|Lack of Efficacy|48|||
131221275|NCT01408576|472437870|FG000|Overall Study|Protocol Violation|1|||
131221276|NCT01408576|472437871|FG001|Overall Study|Protocol Violation|2|||
131221277|NCT01408576|472437872|FG002|Overall Study|Protocol Violation|2|||
131221278|NCT01408576|472437870|FG000|Overall Study|Lost to Follow-up|10|||
131221279|NCT01408576|472437871|FG001|Overall Study|Lost to Follow-up|9|||
131221280|NCT01408576|472437872|FG002|Overall Study|Lost to Follow-up|17|||
131221281|NCT01408576|472437870|FG000|Overall Study|Withdrawal by Subject|34|||
130993722|NCT03813147|471603898|FG000|Overall Study|Lack of Efficacy|4|||
130993723|NCT03813147|471603899|FG001|Overall Study|Lack of Efficacy|4|||
130993724|NCT03813147|471603898|FG000|Overall Study|Physician Decision|2|||
130993725|NCT03813147|471603899|FG001|Overall Study|Physician Decision|1|||
130883095|NCT03910244|471207866|FG001|Overall Study|Physician Decision|0|||
130883096|NCT03910244|471207865|FG000|Overall Study|Protocol Violation|1|||
130883097|NCT03910244|471207866|FG001|Overall Study|Protocol Violation|0|||
130883098|NCT03910244|471207865|FG000|Overall Study|Withdrawal by Subject|7|||
130883099|NCT03910244|471207866|FG001|Overall Study|Withdrawal by Subject|2|||
130883100|NCT02085460|471207870|FG000|Overall Study|Adverse Event|2|||
130883101|NCT02085460|471207871|FG001|Overall Study|Adverse Event|2|||
130883102|NCT02085460|471207872|FG002|Overall Study|Adverse Event|1|||
130883103|NCT02085460|471207870|FG000|Overall Study|Physician Decision|1|||
130883104|NCT02085460|471207871|FG001|Overall Study|Physician Decision|1|||
130883105|NCT02085460|471207872|FG002|Overall Study|Physician Decision|2|||
130883106|NCT02085460|471207870|FG000|Overall Study|Withdrawal by Subject|11|||
130883107|NCT02085460|471207871|FG001|Overall Study|Withdrawal by Subject|5|||
130883108|NCT02085460|471207872|FG002|Overall Study|Withdrawal by Subject|7|||
130883109|NCT01285323|471207873|FG000|Overall Study|Adverse Event|9|||
130883110|NCT01285323|471207874|FG001|Overall Study|Adverse Event|8|||
130883111|NCT01285323|471207873|FG000|Overall Study|Lack of Efficacy|4|||
130993726|NCT04666922|471605861|FG000|Overall Study|Withdrawal by Subject|1|||
130883112|NCT01285323|471207874|FG001|Overall Study|Lack of Efficacy|2|||
130883113|NCT01285323|471207873|FG000|Overall Study|Withdrawal by Subject|15|||
130883114|NCT01285323|471207874|FG001|Overall Study|Withdrawal by Subject|11|||
130883115|NCT01285323|471207873|FG000|Overall Study|Protocol Violation|1|||
130883116|NCT01285323|471207874|FG001|Overall Study|Protocol Violation|2|||
130883117|NCT01285323|471207873|FG000|Overall Study|Non-compliance with study procedures|2|||
130883118|NCT01285323|471207874|FG001|Overall Study|Non-compliance with study procedures|3|||
130883119|NCT01285323|471207873|FG000|Overall Study|Lost to Follow-up|1|||
130883120|NCT01285323|471207874|FG001|Overall Study|Lost to Follow-up|1|||
130883121|NCT01285323|471207873|FG000|Overall Study|Other|1|||
130883122|NCT01285323|471207874|FG001|Overall Study|Other|3|||
130883123|NCT00763035|471207875|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
130883124|NCT00763035|471207876|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
130883125|NCT00763035|471207875|FG000|First Intervention|Adverse Event|0|||
130883126|NCT00763035|471207876|FG001|First Intervention|Adverse Event|1|||
130883127|NCT00763035|471207875|FG000|Second Intervention|Adverse Event|1|||
130883128|NCT00763035|471207876|FG001|Second Intervention|Adverse Event|0|||
130883129|NCT00763035|471207875|FG000|Second Intervention|Physician Decision|2|||
130883130|NCT00763035|471207876|FG001|Second Intervention|Physician Decision|0|||
130883131|NCT02606643|471207877|FG000|Overall Study|did not meet inclusion criteria|1|||
130883132|NCT02606643|471207878|FG001|Overall Study|did not meet inclusion criteria|3|||
130883133|NCT00803569|471207880|FG000|Overall Study|Progressive Disease|3|||
130883134|NCT00803569|471207880|FG000|Overall Study|Noncompliance|1|||
130883135|NCT04313244|471207885|FG000|Overall Study|Withdrawal of Consent|3|||
130883136|NCT04313244|471207886|FG001|Overall Study|Withdrawal of Consent|3|||
130883137|NCT04313244|471207885|FG000|Overall Study|Met Exclusion Criteria|1|||
130883138|NCT04313244|471207886|FG001|Overall Study|Met Exclusion Criteria|0|||
130883139|NCT04313244|471207885|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
130883140|NCT04313244|471207886|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
130883141|NCT00907335|471207887|FG000|Overall Study|Withdrawal by Subject|2|||
130883142|NCT00907335|471207888|FG001|Overall Study|Withdrawal by Subject|0|||
130883143|NCT00907335|471207887|FG000|Overall Study|Adverse Event|4|||
130883144|NCT00907335|471207888|FG001|Overall Study|Adverse Event|1|||
130883145|NCT00907335|471207887|FG000|Overall Study|Lost to Follow-up|2|||
130883146|NCT00907335|471207888|FG001|Overall Study|Lost to Follow-up|0|||
130883147|NCT04004988|471207889|FG000|Period 1|Physician Decision|2|||
130883148|NCT04004988|471207890|FG001|Period 1|Physician Decision|0|||
130883149|NCT04004988|471207889|FG000|Period 1|Withdrawal by Subject|0|||
130883150|NCT04004988|471207890|FG001|Period 1|Withdrawal by Subject|1|||
130883151|NCT04004988|471207889|FG000|Period 1|Adverse Event|1|||
130883152|NCT04004988|471207890|FG001|Period 1|Adverse Event|2|||
130883153|NCT01598532|471207891|FG000|Overall Study|Lost to Follow-up|3|||
130883154|NCT01598532|471207891|FG000|Overall Study|Did not meet inclusion criteria|8|||
130883155|NCT02161016|471207892|FG000|Overall Study|withdrawn by IRB|1|||
130883156|NCT03873116|471207893|FG000|Part 1|Study drug discontinuation due to rash|0|||
130883157|NCT03873116|471207894|FG001|Part 1|Study drug discontinuation due to rash|0|||
130883158|NCT03873116|471207895|FG002|Part 1|Study drug discontinuation due to rash|0|||
130883159|NCT03873116|471207896|FG003|Part 1|Study drug discontinuation due to rash|0|||
130883160|NCT03873116|471207897|FG004|Part 1|Study drug discontinuation due to rash|0|||
130883161|NCT03873116|471207898|FG005|Part 1|Study drug discontinuation due to rash|1|||
130883162|NCT03873116|471207893|FG000|Part 2|Withdrawal by Subject|0|||
130883163|NCT03873116|471207894|FG001|Part 2|Withdrawal by Subject|0|||
130883164|NCT03873116|471207895|FG002|Part 2|Withdrawal by Subject|1|||
130883165|NCT03873116|471207896|FG003|Part 2|Withdrawal by Subject|0|||
130883166|NCT03873116|471207897|FG004|Part 2|Withdrawal by Subject|0|||
130883167|NCT03873116|471207898|FG005|Part 2|Withdrawal by Subject|0|||
130883168|NCT03873116|471207893|FG000|Part 2|Lab abnormality or AE|0|||
130883169|NCT03873116|471207894|FG001|Part 2|Lab abnormality or AE|0|||
130883170|NCT03873116|471207895|FG002|Part 2|Lab abnormality or AE|0|||
130883171|NCT03873116|471207896|FG003|Part 2|Lab abnormality or AE|0|||
130883172|NCT03873116|471207897|FG004|Part 2|Lab abnormality or AE|1|||
130883173|NCT03873116|471207898|FG005|Part 2|Lab abnormality or AE|0|||
130883174|NCT03873116|471207893|FG000|Part 3|Withdrawal by Subject|0|||
130883175|NCT03873116|471207894|FG001|Part 3|Withdrawal by Subject|0|||
130765873|NCT05079230|470765892|FG000|Overall Study|Lost to Follow-up|0|||
130883176|NCT03873116|471207895|FG002|Part 3|Withdrawal by Subject|0|||
130883177|NCT03873116|471207896|FG003|Part 3|Withdrawal by Subject|0|||
130883178|NCT03873116|471207897|FG004|Part 3|Withdrawal by Subject|1|||
130883179|NCT03873116|471207898|FG005|Part 3|Withdrawal by Subject|0|||
130883180|NCT00912808|471207899|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
130883181|NCT00912808|471207900|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
130883182|NCT00912808|471207899|FG000|Washout|Withdrawal by Subject|0|||
130883183|NCT00912808|471207900|FG001|Washout|Withdrawal by Subject|1|||
130883184|NCT00912808|471207899|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
130883185|NCT00912808|471207900|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
130883186|NCT00912808|471207899|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
130883187|NCT00912808|471207900|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
130883188|NCT04682366|471207901|FG000|Overall Study|Lost to Follow-up|1|||
130883189|NCT04682366|471207902|FG001|Overall Study|Lost to Follow-up|1|||
130883190|NCT00702221|471207903|FG000|Overall Study|Adverse Event|4|||
130883191|NCT00702221|471207904|FG001|Overall Study|Adverse Event|3|||
130883192|NCT02000440|471207909|FG000|Overall Study|Adverse Event|3|||
130883193|NCT02000440|471207909|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
130883194|NCT03995368|471207910|FG000|Overall Study|Lost to Follow-up|1|||
130883195|NCT03995368|471207911|FG001|Overall Study|Lost to Follow-up|4|||
130883196|NCT03995368|471207912|FG002|Overall Study|Lost to Follow-up|1|||
130883197|NCT03995368|471207910|FG000|Overall Study|Did not meet inclusion criteria|1|||
130883198|NCT03995368|471207911|FG001|Overall Study|Did not meet inclusion criteria|6|||
130883199|NCT03995368|471207912|FG002|Overall Study|Did not meet inclusion criteria|3|||
130883200|NCT03995368|471207910|FG000|Overall Study|Withdrawal by Subject|0|||
130883201|NCT03995368|471207911|FG001|Overall Study|Withdrawal by Subject|1|||
130883202|NCT03995368|471207912|FG002|Overall Study|Withdrawal by Subject|1|||
130883203|NCT03755934|471207913|FG000|Overall Study|Adverse Event|4|||
130883204|NCT03755934|471207914|FG001|Overall Study|Adverse Event|1|||
130883205|NCT03755934|471207915|FG002|Overall Study|Adverse Event|1|||
130883206|NCT03755934|471207916|FG003|Overall Study|Adverse Event|3|||
130883207|NCT03755934|471207913|FG000|Overall Study|Physician Decision|2|||
130883208|NCT03755934|471207914|FG001|Overall Study|Physician Decision|0|||
130883209|NCT03755934|471207915|FG002|Overall Study|Physician Decision|0|||
130883210|NCT03755934|471207916|FG003|Overall Study|Physician Decision|1|||
130883211|NCT03755934|471207913|FG000|Overall Study|Withdrawal by Subject|5|||
130883212|NCT03755934|471207914|FG001|Overall Study|Withdrawal by Subject|0|||
130883213|NCT03755934|471207915|FG002|Overall Study|Withdrawal by Subject|0|||
130883214|NCT03755934|471207916|FG003|Overall Study|Withdrawal by Subject|1|||
130883215|NCT03755934|471207913|FG000|Overall Study|Other|3|||
130883216|NCT03755934|471207914|FG001|Overall Study|Other|1|||
130883217|NCT03755934|471207915|FG002|Overall Study|Other|3|||
130883218|NCT03755934|471207916|FG003|Overall Study|Other|1|||
130883219|NCT00361296|471207920|FG000|Overall Study|Physician Decision|1|||
130883220|NCT00361296|471207920|FG000|Overall Study|Lack of Efficacy|2|||
130883221|NCT00198822|471207921|FG000|Overall Study|Lost to Follow-up|14|||
130883222|NCT00198822|471207922|FG001|Overall Study|Lost to Follow-up|20|||
130883223|NCT00198822|471207923|FG002|Overall Study|Lost to Follow-up|21|||
130883224|NCT02668653|471207925|FG000|Overall Study|Refractory disease|41|||
130883225|NCT02668653|471207926|FG001|Overall Study|Refractory disease|70|||
130883226|NCT02668653|471207925|FG000|Overall Study|Relapse|44|||
130883227|NCT02668653|471207926|FG001|Overall Study|Relapse|65|||
130883228|NCT02668653|471207925|FG000|Overall Study|Adverse Event|58|||
130883229|NCT02668653|471207926|FG001|Overall Study|Adverse Event|23|||
130883230|NCT02668653|471207925|FG000|Overall Study|Subject decision to stop study drug|25|||
130883231|NCT02668653|471207926|FG001|Overall Study|Subject decision to stop study drug|23|||
130883232|NCT02668653|471207925|FG000|Overall Study|Other reasons not specified|16|||
130883233|NCT02668653|471207926|FG001|Overall Study|Other reasons not specified|11|||
130765874|NCT05079230|470765893|FG001|Overall Study|Lost to Follow-up|3|||
130993727|NCT04666922|471605862|FG001|Overall Study|Withdrawal by Subject|0|||
130993728|NCT04666922|471605863|FG002|Overall Study|Withdrawal by Subject|0|||
130993729|NCT04666922|471605864|FG003|Overall Study|Withdrawal by Subject|0|||
130993730|NCT04666922|471605865|FG004|Overall Study|Withdrawal by Subject|0|||
130993731|NCT04666922|471605866|FG005|Overall Study|Withdrawal by Subject|0|||
130993732|NCT04666922|471605867|FG006|Overall Study|Withdrawal by Subject|0|||
130993733|NCT00244374|471605868|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
130993734|NCT00244374|471605869|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
130993735|NCT00244374|471605870|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
130993736|NCT00244374|471605871|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
130993737|NCT00244374|471605872|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
130993738|NCT00244374|471605868|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
130993739|NCT00244374|471605869|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
130993740|NCT00244374|471605870|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
130993741|NCT00244374|471605871|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
130993742|NCT00244374|471605872|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
130993743|NCT00244374|471605868|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
130993744|NCT00244374|471605869|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
130993745|NCT00244374|471605870|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
130993746|NCT00244374|471605871|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
130993747|NCT00244374|471605872|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
130993748|NCT00244374|471605868|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
130993749|NCT00244374|471605869|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
130993750|NCT00244374|471605870|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
130993751|NCT00244374|471605871|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
130993752|NCT00244374|471605872|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
130993753|NCT00244374|471605868|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
130883234|NCT02668653|471207925|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
130883235|NCT02668653|471207926|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
130883236|NCT02668653|471207925|FG000|Overall Study|Investigator decision|10|||
130883237|NCT02668653|471207926|FG001|Overall Study|Investigator decision|7|||
130883238|NCT02668653|471207925|FG000|Overall Study|Failure to meet continuation criteria|5|||
130883239|NCT02668653|471207926|FG001|Overall Study|Failure to meet continuation criteria|12|||
130883240|NCT02668653|471207925|FG000|Overall Study|Lost to Follow-up|1|||
130883241|NCT02668653|471207926|FG001|Overall Study|Lost to Follow-up|0|||
130883242|NCT02668653|471207925|FG000|Overall Study|Pregnancy|0|||
130883243|NCT02668653|471207926|FG001|Overall Study|Pregnancy|1|||
130883244|NCT02668653|471207925|FG000|Overall Study|Death|0|||
130883245|NCT02668653|471207926|FG001|Overall Study|Death|1|||
130883246|NCT02420821|471207927|FG000|Overall Study|Lost to Follow-up|6|||
130883247|NCT02420821|471207928|FG001|Overall Study|Lost to Follow-up|6|||
130883248|NCT02420821|471207927|FG000|Overall Study|Non-compliance|0|||
130883249|NCT02420821|471207928|FG001|Overall Study|Non-compliance|2|||
130883250|NCT02420821|471207927|FG000|Overall Study|Physician Decision|6|||
130883251|NCT02420821|471207928|FG001|Overall Study|Physician Decision|2|||
130883252|NCT02420821|471207927|FG000|Overall Study|Withdrawal by Subject|32|||
130883253|NCT02420821|471207928|FG001|Overall Study|Withdrawal by Subject|25|||
130883254|NCT02420821|471207927|FG000|Overall Study|Death|270|||
130883255|NCT02420821|471207928|FG001|Overall Study|Death|263|||
130883256|NCT02420821|471207927|FG000|Overall Study|Study Terminated By Sponsor|145|||
130883257|NCT02420821|471207928|FG001|Overall Study|Study Terminated By Sponsor|149|||
130883258|NCT02420821|471207927|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
130883259|NCT02420821|471207928|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
130883260|NCT02420821|471207927|FG000|Overall Study|Adverse Event|0|||
130883261|NCT02420821|471207928|FG001|Overall Study|Adverse Event|1|||
130883262|NCT02420821|471207927|FG000|Overall Study|Protinuria|0|||
130883263|NCT02420821|471207928|FG001|Overall Study|Protinuria|1|||
130883264|NCT02420821|471207927|FG000|Overall Study|Progressive Disease|1|||
130883265|NCT02420821|471207928|FG001|Overall Study|Progressive Disease|1|||
130883266|NCT02420821|471207927|FG000|Overall Study|Disease Progression|0|||
130883267|NCT02420821|471207928|FG001|Overall Study|Disease Progression|1|||
130883268|NCT02420821|471207927|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
130883269|NCT02420821|471207928|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
130883270|NCT01294553|471207929|FG000|Overall Study|Duplicated Participants|1|||
130883271|NCT01294553|471207929|FG000|Overall Study|Protocol Violation|268|||
130883272|NCT01217229|471207930|FG000|Overall Study|Adverse Event|1|||
130883273|NCT01217229|471207930|FG000|Overall Study|Disease progression, deterioration|2|||
130883274|NCT01217229|471207930|FG000|Overall Study|Disease progression, Cheson criteria|14|||
130883275|NCT01217229|471207930|FG000|Overall Study|Protocol Violation|1|||
130883276|NCT01217229|471207930|FG000|Overall Study|Disease progression not confirmed|2|||
130883277|NCT00577889|471207932|FG000|Overall Study|Withdrawal by Subject|1|||
130883278|NCT00577889|471207933|FG001|Overall Study|Withdrawal by Subject|0|||
130883279|NCT00577889|471207934|FG002|Overall Study|Withdrawal by Subject|0|||
130883280|NCT04322526|471207935|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
130883281|NCT04322526|471207936|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
130883282|NCT04322526|471207935|FG000|Washout (1 Week)|Lost to Follow-up|1|||
130883283|NCT04322526|471207936|FG001|Washout (1 Week)|Lost to Follow-up|2|||
130883284|NCT00993967|471207937|FG000|Overall Study|Adverse Event|8|||
130883285|NCT00993967|471207937|FG000|Overall Study|Death|1|||
130883286|NCT00993967|471207937|FG000|Overall Study|Lost to Follow-up|14|||
130883287|NCT00993967|471207937|FG000|Overall Study|Withdrawal by Subject|36|||
130883288|NCT00993967|471207937|FG000|Overall Study|Protocol Violation|2|||
130883289|NCT02760498|471207940|FG000|Overall Study|Adverse Event|3|||
130883290|NCT02760498|471207941|FG001|Overall Study|Adverse Event|3|||
130883291|NCT02760498|471207942|FG002|Overall Study|Adverse Event|1|||
130883292|NCT02760498|471207943|FG003|Overall Study|Adverse Event|1|||
130883293|NCT02760498|471207944|FG004|Overall Study|Adverse Event|0|||
130883294|NCT02760498|471207945|FG005|Overall Study|Adverse Event|6|||
130883295|NCT02760498|471207940|FG000|Overall Study|Death|7|||
130883296|NCT02760498|471207941|FG001|Overall Study|Death|5|||
130883297|NCT02760498|471207942|FG002|Overall Study|Death|5|||
130883298|NCT02760498|471207943|FG003|Overall Study|Death|7|||
130883299|NCT02760498|471207944|FG004|Overall Study|Death|0|||
130883300|NCT02760498|471207945|FG005|Overall Study|Death|23|||
130883301|NCT02760498|471207940|FG000|Overall Study|Lost to Follow-up|0|||
130883302|NCT02760498|471207941|FG001|Overall Study|Lost to Follow-up|0|||
130883303|NCT02760498|471207942|FG002|Overall Study|Lost to Follow-up|0|||
130883304|NCT02760498|471207943|FG003|Overall Study|Lost to Follow-up|0|||
130883305|NCT02760498|471207944|FG004|Overall Study|Lost to Follow-up|0|||
130883306|NCT02760498|471207945|FG005|Overall Study|Lost to Follow-up|3|||
131221282|NCT01408576|472437871|FG001|Overall Study|Withdrawal by Subject|60|||
131221283|NCT01408576|472437872|FG002|Overall Study|Withdrawal by Subject|66|||
131221284|NCT01408576|472437870|FG000|Overall Study|Sponsor terminated study|89|||
131221285|NCT01408576|472437871|FG001|Overall Study|Sponsor terminated study|333|||
131221286|NCT01408576|472437872|FG002|Overall Study|Sponsor terminated study|330|||
130993754|NCT00244374|471605869|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
130993755|NCT00244374|471605870|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
130993756|NCT00244374|471605871|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
130993757|NCT00244374|471605872|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
130993758|NCT00244374|471605868|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
130993759|NCT00244374|471605869|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
130993760|NCT00244374|471605870|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
130993761|NCT00244374|471605871|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
131221287|NCT01408576|472437870|FG000|Overall Study|AE, serious fatal|4|||
131221288|NCT01408576|472437871|FG001|Overall Study|AE, serious fatal|4|||
131221289|NCT01408576|472437872|FG002|Overall Study|AE, serious fatal|1|||
131221290|NCT01408576|472437870|FG000|Overall Study|SAE, non-fatal|11|||
131221291|NCT01408576|472437871|FG001|Overall Study|SAE, non-fatal|23|||
131221292|NCT01408576|472437872|FG002|Overall Study|SAE, non-fatal|14|||
131221293|NCT01408576|472437870|FG000|Overall Study|AE, non-serious non-fatal|12|||
131221294|NCT01408576|472437871|FG001|Overall Study|AE, non-serious non-fatal|19|||
131221295|NCT01408576|472437872|FG002|Overall Study|AE, non-serious non-fatal|11|||
131221296|NCT01408576|472437870|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
131221297|NCT01408576|472437871|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131221298|NCT01408576|472437872|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131221299|NCT01408576|472437870|FG000|Overall Study|AE, unknown type|0|||
131221300|NCT01408576|472437871|FG001|Overall Study|AE, unknown type|1|||
131221301|NCT01408576|472437872|FG002|Overall Study|AE, unknown type|0|||
131221302|NCT01408576|472437870|FG000|Overall Study|Other|10|||
131221303|NCT01408576|472437871|FG001|Overall Study|Other|16|||
131221304|NCT01408576|472437872|FG002|Overall Study|Other|18|||
131221305|NCT00802529|472437873|FG000|Overall Study|Lost to Follow-up|0|||
131221306|NCT00802529|472437874|FG001|Overall Study|Lost to Follow-up|1|||
131221307|NCT00552617|472437876|FG000|Overall Study|Not Treated|0|||
131221308|NCT00552617|472437877|FG001|Overall Study|Not Treated|0|||
131221309|NCT00552617|472437878|FG002|Overall Study|Not Treated|1|||
131221310|NCT00552617|472437879|FG003|Overall Study|Not Treated|0|||
131221311|NCT00552617|472437880|FG004|Overall Study|Not Treated|0|||
131221312|NCT00552617|472437881|FG005|Overall Study|Not Treated|0|||
131221313|NCT00552617|472437882|FG006|Overall Study|Not Treated|0|||
131221314|NCT00552617|472437883|FG007|Overall Study|Not Treated|0|||
131221315|NCT00552617|472437884|FG008|Overall Study|Not Treated|0|||
131221316|NCT00552617|472437885|FG009|Overall Study|Not Treated|1|||
131221317|NCT00552617|472437876|FG000|Overall Study|Lost to Follow-up|0|||
131221318|NCT00552617|472437877|FG001|Overall Study|Lost to Follow-up|0|||
131221319|NCT00552617|472437878|FG002|Overall Study|Lost to Follow-up|0|||
131221320|NCT00552617|472437879|FG003|Overall Study|Lost to Follow-up|1|||
131221321|NCT00552617|472437880|FG004|Overall Study|Lost to Follow-up|0|||
131221322|NCT00552617|472437881|FG005|Overall Study|Lost to Follow-up|2|||
131221323|NCT00552617|472437882|FG006|Overall Study|Lost to Follow-up|0|||
131221324|NCT00552617|472437883|FG007|Overall Study|Lost to Follow-up|0|||
131221325|NCT00552617|472437884|FG008|Overall Study|Lost to Follow-up|2|||
131221326|NCT00552617|472437885|FG009|Overall Study|Lost to Follow-up|0|||
131221327|NCT00337129|472437893|FG000|Overall Study|Adverse Event|4|||
131221328|NCT00337129|472437893|FG000|Overall Study|Withdrawal by Subject|1|||
131221329|NCT00337129|472437893|FG000|Overall Study|Lack of Efficacy|32|||
131221330|NCT00337129|472437893|FG000|Overall Study|Death|2|||
131221331|NCT00337129|472437893|FG000|Overall Study|not protocol specified|1|||
131221332|NCT00563524|472437896|FG000|Overall Study|Adverse Event|0|||
131221333|NCT00563524|472437897|FG001|Overall Study|Adverse Event|1|||
131221334|NCT00563524|472437898|FG002|Overall Study|Adverse Event|0|||
131221335|NCT00563524|472437899|FG003|Overall Study|Adverse Event|0|||
131221336|NCT00563524|472437900|FG004|Overall Study|Adverse Event|2|||
131221337|NCT00563524|472437901|FG005|Overall Study|Adverse Event|0|||
131221338|NCT00563524|472437896|FG000|Overall Study|Lost to Follow-up|1|||
131221339|NCT00563524|472437897|FG001|Overall Study|Lost to Follow-up|0|||
131221340|NCT00563524|472437898|FG002|Overall Study|Lost to Follow-up|0|||
131221341|NCT00563524|472437899|FG003|Overall Study|Lost to Follow-up|0|||
131221342|NCT00563524|472437900|FG004|Overall Study|Lost to Follow-up|0|||
131221343|NCT00563524|472437901|FG005|Overall Study|Lost to Follow-up|0|||
131221344|NCT00563524|472437896|FG000|Overall Study|Protocol Violation|0|||
131221345|NCT00563524|472437897|FG001|Overall Study|Protocol Violation|1|||
131221346|NCT00563524|472437898|FG002|Overall Study|Protocol Violation|0|||
131221347|NCT00563524|472437899|FG003|Overall Study|Protocol Violation|0|||
131221348|NCT00563524|472437900|FG004|Overall Study|Protocol Violation|0|||
131221349|NCT00563524|472437901|FG005|Overall Study|Protocol Violation|0|||
131221350|NCT00563524|472437896|FG000|Overall Study|Withdrawal by Subject|1|||
131221351|NCT00563524|472437897|FG001|Overall Study|Withdrawal by Subject|1|||
131221352|NCT00563524|472437898|FG002|Overall Study|Withdrawal by Subject|3|||
131221353|NCT00563524|472437899|FG003|Overall Study|Withdrawal by Subject|0|||
130993762|NCT00244374|471605872|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
130993763|NCT00244374|471605868|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
130993764|NCT00244374|471605869|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
130993765|NCT00244374|471605870|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
130993766|NCT00244374|471605871|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
131045795|NCT03582033|471802282|FG004|Part B|Study terminated by sponsor|0|||
130765875|NCT01524783|470765894|FG000|Blinded Period|Adverse Event|64|||
130765876|NCT01524783|470765895|FG001|Blinded Period|Adverse Event|7|||
130765877|NCT01524783|470765896|FG002|Blinded Period|Adverse Event|0|||
130765878|NCT01524783|470765894|FG000|Blinded Period|Disease Progression|89|||
130765879|NCT01524783|470765895|FG001|Blinded Period|Disease Progression|75|||
130765880|NCT01524783|470765896|FG002|Blinded Period|Disease Progression|0|||
130765881|NCT01524783|470765894|FG000|Blinded Period|Withdrawal by Subject|19|||
130765882|NCT01524783|470765895|FG001|Blinded Period|Withdrawal by Subject|6|||
130765883|NCT01524783|470765896|FG002|Blinded Period|Withdrawal by Subject|0|||
130765884|NCT01524783|470765894|FG000|Blinded Period|Protocol deviation|2|||
130765885|NCT01524783|470765895|FG001|Blinded Period|Protocol deviation|1|||
130993767|NCT00244374|471605872|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
130993768|NCT00244374|471605868|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
130765886|NCT01524783|470765896|FG002|Blinded Period|Protocol deviation|0|||
130765887|NCT01524783|470765894|FG000|Blinded Period|Death|5|||
130765888|NCT01524783|470765895|FG001|Blinded Period|Death|2|||
130765889|NCT01524783|470765896|FG002|Blinded Period|Death|0|||
130765890|NCT01524783|470765894|FG000|Open-label Period|Disease progression|13|||
130765891|NCT01524783|470765895|FG001|Open-label Period|Disease progression|0|||
130765892|NCT01524783|470765896|FG002|Open-label Period|Disease progression|2|||
130993769|NCT00244374|471605869|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
130993770|NCT00244374|471605870|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
130993771|NCT00244374|471605871|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
130993772|NCT00244374|471605872|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
130993773|NCT00244374|471605868|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
130993774|NCT00244374|471605869|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
130993775|NCT00244374|471605870|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
130993776|NCT00244374|471605871|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
130993777|NCT00244374|471605872|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
130993778|NCT04651114|471605875|FG000|Overall Study|Withdrawal by Subject|8|||
130993779|NCT01923896|471605880|FG000|Overall Study|Adverse Event|1|||
130993780|NCT01923896|471605881|FG001|Overall Study|Adverse Event|0|||
130993781|NCT00474929|471605884|FG000|Overall Study|Withdrawal by Subject|0|||
130993782|NCT00474929|471605885|FG001|Overall Study|Withdrawal by Subject|1|||
130993783|NCT00474929|471605886|FG002|Overall Study|Withdrawal by Subject|0|||
130993784|NCT00474929|471605887|FG003|Overall Study|Withdrawal by Subject|0|||
130993785|NCT00474929|471605888|FG004|Overall Study|Withdrawal by Subject|0|||
130993786|NCT00474929|471605884|FG000|Overall Study|Unrelated medical condition|0|||
130993787|NCT00474929|471605885|FG001|Overall Study|Unrelated medical condition|0|||
130993788|NCT00474929|471605886|FG002|Overall Study|Unrelated medical condition|1|||
130993789|NCT00474929|471605887|FG003|Overall Study|Unrelated medical condition|0|||
130993790|NCT00474929|471605888|FG004|Overall Study|Unrelated medical condition|0|||
130993791|NCT00474929|471605884|FG000|Overall Study|Physician Decision|0|||
130993792|NCT00474929|471605885|FG001|Overall Study|Physician Decision|0|||
130993793|NCT00474929|471605886|FG002|Overall Study|Physician Decision|1|||
130993794|NCT00474929|471605887|FG003|Overall Study|Physician Decision|2|||
130993795|NCT00474929|471605888|FG004|Overall Study|Physician Decision|0|||
130993796|NCT03661996|471605891|FG000|Overall Study|Adverse Event|0|||
130993797|NCT03661996|471605892|FG001|Overall Study|Adverse Event|0|||
130993798|NCT03661996|471605893|FG002|Overall Study|Adverse Event|1|||
130993799|NCT03661996|471605894|FG003|Overall Study|Adverse Event|1|||
130993800|NCT03661996|471605895|FG004|Overall Study|Adverse Event|0|||
130993801|NCT03661996|471605891|FG000|Overall Study|Lost to Follow-up|5|||
130993802|NCT03661996|471605892|FG001|Overall Study|Lost to Follow-up|1|||
130993803|NCT03661996|471605893|FG002|Overall Study|Lost to Follow-up|2|||
130993804|NCT03661996|471605894|FG003|Overall Study|Lost to Follow-up|2|||
130993805|NCT03661996|471605895|FG004|Overall Study|Lost to Follow-up|6|||
130993806|NCT03661996|471605891|FG000|Overall Study|Physician Decision|1|||
130993807|NCT03661996|471605892|FG001|Overall Study|Physician Decision|1|||
130993808|NCT03661996|471605893|FG002|Overall Study|Physician Decision|1|||
130993809|NCT03661996|471605894|FG003|Overall Study|Physician Decision|2|||
130993810|NCT03661996|471605895|FG004|Overall Study|Physician Decision|0|||
130993811|NCT03661996|471605891|FG000|Overall Study|Protocol Violation|0|||
130993812|NCT03661996|471605892|FG001|Overall Study|Protocol Violation|0|||
130993813|NCT03661996|471605893|FG002|Overall Study|Protocol Violation|0|||
130993814|NCT03661996|471605894|FG003|Overall Study|Protocol Violation|0|||
130993815|NCT03661996|471605895|FG004|Overall Study|Protocol Violation|1|||
130993816|NCT03661996|471605891|FG000|Overall Study|Withdrawal by Subject|3|||
130993817|NCT03661996|471605892|FG001|Overall Study|Withdrawal by Subject|5|||
130993818|NCT03661996|471605893|FG002|Overall Study|Withdrawal by Subject|1|||
130993819|NCT03661996|471605894|FG003|Overall Study|Withdrawal by Subject|7|||
130993820|NCT03661996|471605895|FG004|Overall Study|Withdrawal by Subject|7|||
130993821|NCT03661996|471605891|FG000|Overall Study|Sponsors Decision|2|||
130993822|NCT03661996|471605892|FG001|Overall Study|Sponsors Decision|0|||
130993823|NCT03661996|471605893|FG002|Overall Study|Sponsors Decision|0|||
130993824|NCT03661996|471605894|FG003|Overall Study|Sponsors Decision|0|||
130993825|NCT03661996|471605895|FG004|Overall Study|Sponsors Decision|0|||
130993826|NCT03661996|471605891|FG000|Overall Study|Other|1|||
130993827|NCT03661996|471605892|FG001|Overall Study|Other|1|||
130883307|NCT02760498|471207940|FG000|Overall Study|Non-compliance with study drug|0|||
130883308|NCT02760498|471207941|FG001|Overall Study|Non-compliance with study drug|2|||
130883309|NCT02760498|471207942|FG002|Overall Study|Non-compliance with study drug|0|||
130883310|NCT02760498|471207943|FG003|Overall Study|Non-compliance with study drug|0|||
130883311|NCT02760498|471207944|FG004|Overall Study|Non-compliance with study drug|0|||
130883312|NCT02760498|471207945|FG005|Overall Study|Non-compliance with study drug|0|||
130883313|NCT02760498|471207940|FG000|Overall Study|Participant decision|1|||
130883314|NCT02760498|471207941|FG001|Overall Study|Participant decision|4|||
130883315|NCT02760498|471207942|FG002|Overall Study|Participant decision|2|||
130883316|NCT02760498|471207943|FG003|Overall Study|Participant decision|2|||
130883317|NCT02760498|471207944|FG004|Overall Study|Participant decision|1|||
130883318|NCT02760498|471207945|FG005|Overall Study|Participant decision|6|||
130883319|NCT02760498|471207940|FG000|Overall Study|Sponsor decision|0|||
130883320|NCT02760498|471207941|FG001|Overall Study|Sponsor decision|0|||
130883321|NCT02760498|471207942|FG002|Overall Study|Sponsor decision|0|||
130883322|NCT02760498|471207943|FG003|Overall Study|Sponsor decision|3|||
130883323|NCT02760498|471207944|FG004|Overall Study|Sponsor decision|0|||
130883324|NCT02760498|471207945|FG005|Overall Study|Sponsor decision|0|||
130883325|NCT02760498|471207940|FG000|Overall Study|Physician Decision|3|||
130883326|NCT02760498|471207941|FG001|Overall Study|Physician Decision|4|||
130883327|NCT02760498|471207942|FG002|Overall Study|Physician Decision|1|||
130883328|NCT02760498|471207943|FG003|Overall Study|Physician Decision|4|||
130883329|NCT02760498|471207944|FG004|Overall Study|Physician Decision|0|||
130883330|NCT02760498|471207945|FG005|Overall Study|Physician Decision|2|||
130883331|NCT02760498|471207940|FG000|Overall Study|Disease progression|21|||
130883332|NCT02760498|471207941|FG001|Overall Study|Disease progression|19|||
130883333|NCT02760498|471207942|FG002|Overall Study|Disease progression|20|||
130883334|NCT02760498|471207943|FG003|Overall Study|Disease progression|18|||
130883335|NCT02760498|471207944|FG004|Overall Study|Disease progression|4|||
130883336|NCT02760498|471207945|FG005|Overall Study|Disease progression|55|||
130883337|NCT02760498|471207940|FG000|Overall Study|Withdrawal by Subject|4|||
130883338|NCT02760498|471207941|FG001|Overall Study|Withdrawal by Subject|7|||
130883339|NCT02760498|471207942|FG002|Overall Study|Withdrawal by Subject|5|||
130993828|NCT03661996|471605893|FG002|Overall Study|Other|1|||
130993829|NCT03661996|471605894|FG003|Overall Study|Other|1|||
130993830|NCT03661996|471605895|FG004|Overall Study|Other|0|||
130993831|NCT00068380|471605896|FG000|Overall Study|Withdrawal by Subject|3|||
130993832|NCT00068380|471605896|FG000|Overall Study|Adverse Event|2|||
130993833|NCT00067990|471605913|FG000|Overall Study|Death|5|||
130993834|NCT00067990|471605914|FG001|Overall Study|Death|7|||
130993835|NCT00067990|471605913|FG000|Overall Study|ESRD, Non IF/TA|1|||
130993836|NCT00067990|471605914|FG001|Overall Study|ESRD, Non IF/TA|3|||
130993837|NCT00067990|471605913|FG000|Overall Study|Withdrawal by Subject|4|||
130993838|NCT00067990|471605914|FG001|Overall Study|Withdrawal by Subject|12|||
130993839|NCT01112514|471605915|FG000|Overall Study|Lost to Follow-up|1|||
130993840|NCT01118455|471605916|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
130993841|NCT01118455|471605917|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
130993842|NCT01973491|471605918|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
130993843|NCT01973491|471605918|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
130993844|NCT01973491|471605918|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
130993845|NCT01454830|471605931|FG000|Overall Study|Withdrawal by Subject|4|||
130993846|NCT01454830|471605932|FG001|Overall Study|Withdrawal by Subject|4|||
130993847|NCT01454830|471605931|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
130993848|NCT01454830|471605932|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
130993849|NCT01454830|471605931|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
130993850|NCT01454830|471605932|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
130993851|NCT01454830|471605931|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
130993852|NCT01454830|471605932|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
130993853|NCT01454830|471605931|FG000|Overall Study|Withdrawal - no polysomnography|3|||
130993854|NCT01454830|471605932|FG001|Overall Study|Withdrawal - no polysomnography|2|||
130993855|NCT00152763|471605933|FG000|Overall Study|Death|4|||
130993856|NCT00152763|471605934|FG001|Overall Study|Death|1|||
130993857|NCT00152763|471605935|FG002|Overall Study|Death|2|||
130993858|NCT00152763|471605936|FG003|Overall Study|Death|1|||
130993859|NCT00152763|471605933|FG000|Overall Study|Lost to Follow-up|6|||
130993860|NCT00152763|471605934|FG001|Overall Study|Lost to Follow-up|4|||
130993861|NCT00152763|471605935|FG002|Overall Study|Lost to Follow-up|2|||
130993862|NCT00152763|471605936|FG003|Overall Study|Lost to Follow-up|13|||
130993863|NCT00569803|471605939|FG000|Overall Study|Lost to Follow-up|1|||
130993864|NCT00569803|471605940|FG001|Overall Study|Lost to Follow-up|0|||
130993865|NCT00569803|471605941|FG002|Overall Study|Lost to Follow-up|0|||
130993866|NCT00569803|471605942|FG003|Overall Study|Lost to Follow-up|0|||
130993867|NCT00569803|471605943|FG004|Overall Study|Lost to Follow-up|0|||
130993868|NCT00569803|471605944|FG005|Overall Study|Lost to Follow-up|0|||
130993869|NCT00569803|471605945|FG006|Overall Study|Lost to Follow-up|0|||
130993870|NCT00569803|471605946|FG007|Overall Study|Lost to Follow-up|0|||
130993871|NCT00569803|471605939|FG000|Overall Study|injection syringe leaked during dosing|0|||
130993872|NCT00569803|471605940|FG001|Overall Study|injection syringe leaked during dosing|0|||
130993873|NCT00569803|471605941|FG002|Overall Study|injection syringe leaked during dosing|0|||
130993874|NCT00569803|471605942|FG003|Overall Study|injection syringe leaked during dosing|1|||
130993875|NCT00569803|471605943|FG004|Overall Study|injection syringe leaked during dosing|0|||
130993876|NCT00569803|471605944|FG005|Overall Study|injection syringe leaked during dosing|0|||
130993877|NCT00569803|471605945|FG006|Overall Study|injection syringe leaked during dosing|0|||
130993878|NCT00569803|471605946|FG007|Overall Study|injection syringe leaked during dosing|0|||
130993879|NCT00569803|471605939|FG000|Overall Study|Withdrawal by Subject|0|||
130993880|NCT00569803|471605940|FG001|Overall Study|Withdrawal by Subject|0|||
130993881|NCT00569803|471605941|FG002|Overall Study|Withdrawal by Subject|0|||
130993882|NCT00569803|471605942|FG003|Overall Study|Withdrawal by Subject|0|||
130993883|NCT00569803|471605943|FG004|Overall Study|Withdrawal by Subject|0|||
130993884|NCT00569803|471605944|FG005|Overall Study|Withdrawal by Subject|0|||
130993885|NCT00569803|471605945|FG006|Overall Study|Withdrawal by Subject|0|||
130993886|NCT00569803|471605946|FG007|Overall Study|Withdrawal by Subject|1|||
130993887|NCT01993823|471605947|FG000|Overall Study|Requested by the patient|6|||
130993888|NCT01993823|471605948|FG001|Overall Study|Requested by the patient|11|||
130993889|NCT01993823|471605947|FG000|Overall Study|Protocol Violation|0|||
130993890|NCT01993823|471605948|FG001|Overall Study|Protocol Violation|1|||
130993891|NCT01993823|471605947|FG000|Overall Study|Lost to Follow-up|1|||
130993892|NCT01993823|471605948|FG001|Overall Study|Lost to Follow-up|4|||
130993893|NCT01235975|471605951|FG000|Overall Study|Serious Adverse Event|0|||
130993894|NCT01235975|471605952|FG001|Overall Study|Serious Adverse Event|1|||
130993895|NCT01235975|471605951|FG000|Overall Study|Withdrawal by Subject|8|||
130993896|NCT01235975|471605952|FG001|Overall Study|Withdrawal by Subject|2|||
130993897|NCT01235975|471605951|FG000|Overall Study|Migrated/moved from study area|2|||
130993898|NCT01235975|471605952|FG001|Overall Study|Migrated/moved from study area|1|||
130993899|NCT01235975|471605951|FG000|Overall Study|Lost to Follow-up|7|||
130993900|NCT01235975|471605952|FG001|Overall Study|Lost to Follow-up|3|||
130993901|NCT00791921|471605953|FG000|Overall Study|Protocol planed|24|||
130993902|NCT00791921|471605954|FG001|Overall Study|Protocol planed|88|||
130993903|NCT00791921|471605953|FG000|Overall Study|Withdrawal by Subject|1|||
130993904|NCT00791921|471605954|FG001|Overall Study|Withdrawal by Subject|2|||
130993905|NCT00791921|471605953|FG000|Overall Study|Adverse Event|8|||
130993906|NCT00791921|471605954|FG001|Overall Study|Adverse Event|2|||
130993907|NCT00791921|471605953|FG000|Overall Study|Lack of Efficacy|0|||
130993908|NCT00791921|471605954|FG001|Overall Study|Lack of Efficacy|2|||
130993909|NCT00791921|471605953|FG000|Overall Study|Lack of study drug administration|1|||
130993910|NCT00791921|471605954|FG001|Overall Study|Lack of study drug administration|1|||
130993911|NCT00791921|471605953|FG000|Overall Study|Reason other than those above|0|||
130993912|NCT00791921|471605954|FG001|Overall Study|Reason other than those above|1|||
130993913|NCT00422799|471605956|FG000|Overall Study|Withdrawal by Subject|6|||
130993914|NCT00422799|471605956|FG000|Overall Study|Adverse Event|7|||
130993915|NCT01965158|471605957|FG000|Overall Study|Adverse Event|14|||
130993916|NCT01965158|471605958|FG001|Overall Study|Adverse Event|5|||
130993917|NCT01965158|471605957|FG000|Overall Study|Withdrawal by Subject|16|||
130993918|NCT01965158|471605958|FG001|Overall Study|Withdrawal by Subject|24|||
130993919|NCT01965158|471605957|FG000|Overall Study|Lost to Follow-up|7|||
130993920|NCT01965158|471605958|FG001|Overall Study|Lost to Follow-up|5|||
130993921|NCT01965158|471605957|FG000|Overall Study|Protocol Violation|1|||
130993922|NCT01965158|471605958|FG001|Overall Study|Protocol Violation|1|||
130993923|NCT01965158|471605957|FG000|Overall Study|Other - Miscellaneous|3|||
130993924|NCT01965158|471605958|FG001|Overall Study|Other - Miscellaneous|0|||
130993925|NCT01619787|471605959|FG000|Overall Study|Lost to Follow-up|5|||
130993926|NCT02086162|471605960|FG000|Overall Study|Withdrawal by Subject|4|||
130993927|NCT02086162|471605961|FG001|Overall Study|Withdrawal by Subject|4|||
130993928|NCT02086162|471605960|FG000|Overall Study|moved|1|||
130993929|NCT02086162|471605961|FG001|Overall Study|moved|1|||
130993930|NCT02086162|471605960|FG000|Overall Study|Lost to Follow-up|4|||
130993931|NCT02086162|471605961|FG001|Overall Study|Lost to Follow-up|2|||
130993932|NCT02086162|471605960|FG000|Overall Study|Death|1|||
130993933|NCT02086162|471605961|FG001|Overall Study|Death|0|||
130993934|NCT01107743|471605970|FG000|Overall Study|Protocol Violation|46|||
130993935|NCT00308737|471605971|FG000|Overall Study|Adverse Event|104|||
130993936|NCT00308737|471605972|FG001|Overall Study|Adverse Event|9|||
130993937|NCT00308737|471605973|FG002|Overall Study|Adverse Event|0|||
130993938|NCT00308737|471605971|FG000|Overall Study|Death|4|||
130993939|NCT00308737|471605972|FG001|Overall Study|Death|3|||
130993940|NCT00308737|471605973|FG002|Overall Study|Death|0|||
130993941|NCT00308737|471605971|FG000|Overall Study|Lost to Follow-up|56|||
130993942|NCT00308737|471605972|FG001|Overall Study|Lost to Follow-up|80|||
130993943|NCT00308737|471605973|FG002|Overall Study|Lost to Follow-up|5|||
130993944|NCT00308737|471605971|FG000|Overall Study|Physician Decision|15|||
130993945|NCT00308737|471605972|FG001|Overall Study|Physician Decision|2|||
130993946|NCT00308737|471605973|FG002|Overall Study|Physician Decision|1|||
130993947|NCT00308737|471605971|FG000|Overall Study|Protocol Violation|34|||
130993948|NCT00308737|471605972|FG001|Overall Study|Protocol Violation|9|||
130993949|NCT00308737|471605973|FG002|Overall Study|Protocol Violation|5|||
130993950|NCT00308737|471605971|FG000|Overall Study|Withdrawal by Subject|218|||
130993951|NCT00308737|471605972|FG001|Overall Study|Withdrawal by Subject|166|||
130993952|NCT00308737|471605973|FG002|Overall Study|Withdrawal by Subject|18|||
130993953|NCT00308737|471605971|FG000|Overall Study|Various|32|||
130993954|NCT00308737|471605972|FG001|Overall Study|Various|20|||
130993955|NCT00308737|471605973|FG002|Overall Study|Various|8|||
130993956|NCT00089895|471605974|FG000|Overall Study|Consent Withdrawn|11|||
130993957|NCT00089895|471605975|FG001|Overall Study|Consent Withdrawn|14|||
130993958|NCT00089895|471605974|FG000|Overall Study|Technical reason|7|||
130993959|NCT00089895|471605975|FG001|Overall Study|Technical reason|2|||
130993960|NCT00089895|471605974|FG000|Overall Study|Surgery|0|||
130993961|NCT00089895|471605975|FG001|Overall Study|Surgery|1|||
130993962|NCT00089895|471605974|FG000|Overall Study|Bleeding|0|||
130993963|NCT00089895|471605975|FG001|Overall Study|Bleeding|2|||
130993964|NCT00089895|471605974|FG000|Overall Study|Physician Decision|3|||
130993965|NCT00089895|471605975|FG001|Overall Study|Physician Decision|7|||
130993966|NCT00089895|471605974|FG000|Overall Study|Exclusion criteria met|6|||
130993967|NCT00089895|471605975|FG001|Overall Study|Exclusion criteria met|6|||
130993968|NCT00089895|471605974|FG000|Overall Study|Not otherwise specified|4|||
130993969|NCT00089895|471605975|FG001|Overall Study|Not otherwise specified|8|||
130993970|NCT00089895|471605974|FG000|Overall Study|Missing|4|||
130993971|NCT00089895|471605975|FG001|Overall Study|Missing|2|||
130993972|NCT02494206|471605989|FG000|Overall Study|Adverse Event|1|||
130993973|NCT02494206|471605989|FG000|Overall Study|Disease Progression|1|||
130993974|NCT04986982|471605991|FG000|Overall Study|Withdrawal by Subject|3|||
130993975|NCT04986982|471605992|FG001|Overall Study|Withdrawal by Subject|1|||
130993976|NCT04986982|471605991|FG000|Overall Study|Lack of Efficacy|0|||
130993977|NCT04986982|471605992|FG001|Overall Study|Lack of Efficacy|2|||
130993978|NCT04986982|471605991|FG000|Overall Study|Ineligibility|3|||
130993979|NCT04986982|471605992|FG001|Overall Study|Ineligibility|0|||
130993980|NCT04986982|471605991|FG000|Overall Study|Adverse Event|4|||
130993981|NCT04986982|471605992|FG001|Overall Study|Adverse Event|4|||
130993982|NCT04986982|471605991|FG000|Overall Study|Lost to Follow-up|0|||
130993983|NCT04986982|471605992|FG001|Overall Study|Lost to Follow-up|1|||
130993984|NCT04986982|471605991|FG000|Overall Study|Sponsor's discretion|1|||
130993985|NCT04986982|471605992|FG001|Overall Study|Sponsor's discretion|0|||
130993986|NCT01155661|471605993|FG000|Overall Study|Adverse Event|101|||
130993987|NCT01155661|471605993|FG000|Overall Study|Death|1|||
130993988|NCT01155661|471605993|FG000|Overall Study|Lack of Efficacy|32|||
130993989|NCT01155661|471605993|FG000|Overall Study|Lost to Follow-up|22|||
130993990|NCT01155661|471605993|FG000|Overall Study|Physician Decision|3|||
130993991|NCT01155661|471605993|FG000|Overall Study|Protocol Violation|35|||
130993992|NCT01155661|471605993|FG000|Overall Study|Withdrawal by Subject|73|||
130993993|NCT01155661|471605993|FG000|Overall Study|Sponsor Decision|13|||
130993994|NCT01396395|471605997|FG000|Overall Study|Withdrawal by Subject|10|||
130993995|NCT01396395|471605998|FG001|Overall Study|Withdrawal by Subject|12|||
130993996|NCT01396395|471605997|FG000|Overall Study|Protocol Violation|3|||
130993997|NCT01396395|471605998|FG001|Overall Study|Protocol Violation|1|||
130993998|NCT01396395|471605997|FG000|Overall Study|Adverse Event|10|||
130993999|NCT01396395|471605998|FG001|Overall Study|Adverse Event|2|||
130994000|NCT01396395|471605997|FG000|Overall Study|Lost to Follow-up|17|||
130994001|NCT01396395|471605998|FG001|Overall Study|Lost to Follow-up|11|||
130994002|NCT01396395|471605997|FG000|Overall Study|Other|0|||
130994003|NCT01396395|471605998|FG001|Overall Study|Other|1|||
130994004|NCT00882921|471606003|FG000|Overall Study|Death|2|||
130994005|NCT00882921|471606003|FG000|Overall Study|Other|3|||
130994006|NCT00882921|471606003|FG000|Overall Study|Lost to Follow-up|2|||
130994007|NCT00882921|471606003|FG000|Overall Study|Termination By Investigator|3|||
130994008|NCT00882921|471606003|FG000|Overall Study|Withdrawal Of Consent|1|||
130994009|NCT01370005|471606004|FG000|Overall Study|Not treated|1|||
131221354|NCT00563524|472437900|FG004|Overall Study|Withdrawal by Subject|0|||
131221355|NCT00563524|472437901|FG005|Overall Study|Withdrawal by Subject|1|||
131221356|NCT02766088|472437907|FG000|Overall Study|Sponsor study termination|498|||
131221357|NCT02766088|472437907|FG000|Overall Study|Migrated/moved from the study area|1|||
131221358|NCT02766088|472437907|FG000|Overall Study|Lost to Follow-up|5|||
131221359|NCT02766088|472437907|FG000|Overall Study|Other|1|||
131221360|NCT02766088|472437907|FG000|Overall Study|Death|1|||
131221361|NCT01383954|472437916|FG000|Overall Study|Lack of Efficacy|2|||
130994010|NCT01370005|471606005|FG001|Overall Study|Not treated|0|||
130994011|NCT01370005|471606006|FG002|Overall Study|Not treated|0|||
130994012|NCT01370005|471606004|FG000|Overall Study|Adverse Event|5|||
130994013|NCT01370005|471606005|FG001|Overall Study|Adverse Event|5|||
130994014|NCT01370005|471606006|FG002|Overall Study|Adverse Event|6|||
130994015|NCT01370005|471606004|FG000|Overall Study|Lack of Efficacy|1|||
130994016|NCT01370005|471606005|FG001|Overall Study|Lack of Efficacy|0|||
130994017|NCT01370005|471606006|FG002|Overall Study|Lack of Efficacy|0|||
130994018|NCT01370005|471606004|FG000|Overall Study|Non compliant with protocol|0|||
130994019|NCT01370005|471606005|FG001|Overall Study|Non compliant with protocol|1|||
130994020|NCT01370005|471606006|FG002|Overall Study|Non compliant with protocol|2|||
130994021|NCT01370005|471606004|FG000|Overall Study|Lost to Follow-up|1|||
130994022|NCT01370005|471606005|FG001|Overall Study|Lost to Follow-up|1|||
130994023|NCT01370005|471606006|FG002|Overall Study|Lost to Follow-up|1|||
130994024|NCT01370005|471606004|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
130994025|NCT01370005|471606005|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
130994026|NCT01370005|471606006|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
130994027|NCT01370005|471606004|FG000|Overall Study|Other reason not defined above|3|||
131221362|NCT01383954|472437916|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
131221363|NCT01383954|472437916|FG000|Overall Study|Adverse Event|1|||
131221364|NCT01383954|472437916|FG000|Overall Study|Reason Not Specified|9|||
130883340|NCT02760498|471207943|FG003|Overall Study|Withdrawal by Subject|1|||
130883341|NCT02760498|471207944|FG004|Overall Study|Withdrawal by Subject|0|||
130883342|NCT02760498|471207945|FG005|Overall Study|Withdrawal by Subject|6|||
130883343|NCT02760498|471207940|FG000|Overall Study|Other than specified|1|||
130883344|NCT02760498|471207941|FG001|Overall Study|Other than specified|6|||
130883345|NCT02760498|471207942|FG002|Overall Study|Other than specified|0|||
130883346|NCT02760498|471207943|FG003|Overall Study|Other than specified|3|||
130883347|NCT02760498|471207944|FG004|Overall Study|Other than specified|1|||
130883348|NCT02760498|471207945|FG005|Overall Study|Other than specified|0|||
130883349|NCT02760498|471207940|FG000|Overall Study|Not treated|0|||
130883350|NCT02760498|471207941|FG001|Overall Study|Not treated|0|||
130883351|NCT02760498|471207942|FG002|Overall Study|Not treated|0|||
130994028|NCT01370005|471606005|FG001|Overall Study|Other reason not defined above|0|||
130994029|NCT01370005|471606006|FG002|Overall Study|Other reason not defined above|2|||
131100650|NCT01871805|471998059|FG000|Phase II|Alive in Survival Follow-up|0|||
131100651|NCT01871805|471998060|FG001|Phase II|Alive in Survival Follow-up|0|||
131100652|NCT01871805|471998061|FG002|Phase II|Alive in Survival Follow-up|0|||
131100653|NCT01871805|471998062|FG003|Phase II|Alive in Survival Follow-up|0|||
131100654|NCT01871805|471998063|FG004|Phase II|Alive in Survival Follow-up|0|||
131100655|NCT01871805|471998064|FG005|Phase II|Alive in Survival Follow-up|29|||
131100656|NCT01871805|471998059|FG000|Phase II|Lost to Follow-up|0|||
131100657|NCT01871805|471998060|FG001|Phase II|Lost to Follow-up|0|||
131100658|NCT01871805|471998061|FG002|Phase II|Lost to Follow-up|0|||
131100659|NCT01871805|471998062|FG003|Phase II|Lost to Follow-up|0|||
131100660|NCT01871805|471998063|FG004|Phase II|Lost to Follow-up|0|||
131100661|NCT01871805|471998064|FG005|Phase II|Lost to Follow-up|13|||
131100662|NCT01157676|471998067|FG000|Randomization|Death|1|||
131100663|NCT01157676|471998068|FG001|Randomization|Death|1|||
131100664|NCT01157676|471998067|FG000|Randomization|unresectable|2|||
131100665|NCT01157676|471998068|FG001|Randomization|unresectable|3|||
131100666|NCT01157676|471998067|FG000|Randomization|Withdrawal by Subject|17|||
131100667|NCT01157676|471998068|FG001|Randomization|Withdrawal by Subject|13|||
131100668|NCT01157676|471998067|FG000|Randomization|Physician Decision|1|||
131100669|NCT01157676|471998068|FG001|Randomization|Physician Decision|0|||
130994050|NCT02009696|471606011|FG000|Overall Study|Withdrawal by Subject|2|||
130994051|NCT00856661|471606012|FG000|Overall Study|Death|15|||
130994052|NCT00856661|471606013|FG001|Overall Study|Death|18|||
130994053|NCT00856661|471606012|FG000|Overall Study|Protocol Violation|2|||
130994054|NCT00856661|471606013|FG001|Overall Study|Protocol Violation|1|||
130994055|NCT00856661|471606012|FG000|Overall Study|Withdrawal by Subject|1|||
130994056|NCT00856661|471606013|FG001|Overall Study|Withdrawal by Subject|2|||
130994057|NCT00856661|471606012|FG000|Overall Study|Lost to Follow-up|1|||
130994058|NCT00856661|471606013|FG001|Overall Study|Lost to Follow-up|3|||
130994059|NCT00856661|471606012|FG000|Overall Study|Physician Judgement|8|||
130994060|NCT00856661|471606013|FG001|Overall Study|Physician Judgement|5|||
130994061|NCT02120664|471606014|FG000|Overall Study|Withdrawal by Subject|0|||
130994062|NCT02120664|471606015|FG001|Overall Study|Withdrawal by Subject|0|||
130994063|NCT02120664|471606016|FG002|Overall Study|Withdrawal by Subject|0|||
130994064|NCT02120664|471606017|FG003|Overall Study|Withdrawal by Subject|1|||
130994065|NCT02120664|471606018|FG004|Overall Study|Withdrawal by Subject|0|||
130994066|NCT03916744|471606019|FG000|Overall Study|Withdrawal by Subject|0|||
130994067|NCT03916744|471606020|FG001|Overall Study|Withdrawal by Subject|1|||
130994068|NCT03916744|471606021|FG002|Overall Study|Withdrawal by Subject|2|||
130994069|NCT02460263|471606022|FG000|Transition Period|Withdrawal by Subject|1|||
130994070|NCT02460263|471606022|FG000|Transition Period|Death|1|||
130994071|NCT03176238|471606023|FG000|Overall Study|Unacceptable AEs|15|||
130994072|NCT03176238|471606024|FG001|Overall Study|Unacceptable AEs|8|||
131100670|NCT01157676|471998067|FG000|Surgery|underwent open cystectomy|0|||
130994073|NCT03176238|471606023|FG000|Overall Study|Abnormal lab value(s)|2|||
131100671|NCT01157676|471998068|FG001|Surgery|underwent open cystectomy|4|||
130994074|NCT03176238|471606024|FG001|Overall Study|Abnormal lab value(s)|0|||
130994075|NCT03176238|471606023|FG000|Overall Study|Inter-current illness|0|||
130994076|NCT03176238|471606024|FG001|Overall Study|Inter-current illness|1|||
130994077|NCT03176238|471606023|FG000|Overall Study|Consent withdrawal|14|||
130994078|NCT03176238|471606024|FG001|Overall Study|Consent withdrawal|2|||
130994079|NCT03176238|471606023|FG000|Overall Study|Lost to Follow-up|3|||
130994080|NCT03176238|471606024|FG001|Overall Study|Lost to Follow-up|0|||
130994081|NCT03176238|471606023|FG000|Overall Study|Administrative problems|1|||
130994082|NCT03176238|471606024|FG001|Overall Study|Administrative problems|0|||
130994083|NCT03176238|471606023|FG000|Overall Study|Death|3|||
130994084|NCT03176238|471606024|FG001|Overall Study|Death|0|||
130994085|NCT03176238|471606023|FG000|Overall Study|Disease Progression|133|||
130994086|NCT03176238|471606024|FG001|Overall Study|Disease Progression|22|||
130994087|NCT03176238|471606023|FG000|Overall Study|Tx duration completed per EAP|0|||
130994088|NCT03176238|471606024|FG001|Overall Study|Tx duration completed per EAP|1|||
130994089|NCT03176238|471606023|FG000|Overall Study|Patient is switched to commercial drug|16|||
130994090|NCT03176238|471606024|FG001|Overall Study|Patient is switched to commercial drug|1|||
130994091|NCT03176238|471606023|FG000|Overall Study|Protocol Violation|1|||
130994092|NCT03176238|471606024|FG001|Overall Study|Protocol Violation|0|||
130994093|NCT03176238|471606023|FG000|Overall Study|Changes in the patient's condition|2|||
130994094|NCT03176238|471606024|FG001|Overall Study|Changes in the patient's condition|1|||
130994095|NCT03176238|471606023|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
130994096|NCT03176238|471606024|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
130994097|NCT04524598|471606025|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
130994098|NCT04524598|471606026|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
130994099|NCT04524598|471606027|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
130994100|NCT04524598|471606028|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
130994101|NCT04524598|471606029|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
130994102|NCT04524598|471606025|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
130994103|NCT04524598|471606026|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
130994104|NCT04524598|471606027|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
130994105|NCT04524598|471606028|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
130994106|NCT04524598|471606029|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
130994107|NCT04524598|471606025|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
130994108|NCT04524598|471606026|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
130994109|NCT04524598|471606027|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
130994110|NCT04524598|471606028|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
130994111|NCT04524598|471606029|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
130994112|NCT04524598|471606025|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
130994113|NCT04524598|471606026|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
130994114|NCT04524598|471606027|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
130994115|NCT04524598|471606028|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
130994116|NCT04524598|471606029|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
130994117|NCT04524598|471606025|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
130994118|NCT04524598|471606026|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
130994119|NCT04524598|471606027|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
130994120|NCT04524598|471606028|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
130994121|NCT04524598|471606029|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
130994122|NCT04524598|471606025|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
130994123|NCT04524598|471606026|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
130994124|NCT04524598|471606027|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
130994125|NCT04524598|471606028|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
130994126|NCT04524598|471606029|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
130994127|NCT04524598|471606025|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
130994128|NCT04524598|471606026|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
130994129|NCT04524598|471606027|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
130994130|NCT04524598|471606028|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
130994131|NCT04524598|471606029|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
130994132|NCT02301156|471606030|FG000|Overall Study|Adverse Event|13|||
130994133|NCT02301156|471606031|FG001|Overall Study|Adverse Event|14|||
130994134|NCT02301156|471606030|FG000|Overall Study|Death|1|||
130994135|NCT02301156|471606031|FG001|Overall Study|Death|5|||
131221365|NCT00763269|472437918|FG000|Overall Study|Lost to Follow-up|12|||
131221366|NCT00763269|472437919|FG001|Overall Study|Lost to Follow-up|13|||
131221367|NCT02609178|472437921|FG000|First Crown|Withdrawal by Subject|0|||
131221368|NCT02609178|472437922|FG001|First Crown|Withdrawal by Subject|0|||
131221369|NCT02609178|472437923|FG002|First Crown|Withdrawal by Subject|1|||
131221370|NCT02609178|472437924|FG003|First Crown|Withdrawal by Subject|1|||
131221371|NCT02609178|472437925|FG004|First Crown|Withdrawal by Subject|0|||
131221372|NCT02609178|472437926|FG005|First Crown|Withdrawal by Subject|0|||
131221373|NCT01128153|472437927|FG000|Overall Study|Adverse Event|1|||
131221374|NCT01128153|472437928|FG001|Overall Study|Adverse Event|3|||
131221375|NCT01128153|472437927|FG000|Overall Study|Condition under investigation worsened|8|||
131221376|NCT01128153|472437928|FG001|Overall Study|Condition under investigation worsened|7|||
131221377|NCT01128153|472437927|FG000|Overall Study|Withdrawal by Subject|2|||
131221378|NCT01128153|472437928|FG001|Overall Study|Withdrawal by Subject|3|||
131221379|NCT01128153|472437927|FG000|Overall Study|Incorrect enrolment to study|2|||
130994136|NCT02301156|471606030|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
130994137|NCT02301156|471606031|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
130994138|NCT02301156|471606030|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
130994139|NCT02301156|471606031|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
130994140|NCT02301156|471606030|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
130994141|NCT02301156|471606031|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
130994142|NCT02301156|471606030|FG000|Overall Study|Reason not Specified|6|||
130994143|NCT02301156|471606031|FG001|Overall Study|Reason not Specified|3|||
130994144|NCT00886639|471606032|FG000|Overall Study|acute exacerbation|14|||
130994145|NCT00886639|471606032|FG000|Overall Study|non-compliance|2|||
130994146|NCT01871558|471606033|FG000|Overall Study|Other reason|0|||
130994147|NCT01871558|471606034|FG001|Overall Study|Other reason|1|||
130994148|NCT01871558|471606033|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
130994149|NCT01871558|471606034|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
130994150|NCT01871558|471606033|FG000|Overall Study|Withdrawal by Subject|2|||
130994151|NCT01871558|471606034|FG001|Overall Study|Withdrawal by Subject|0|||
130994152|NCT03203694|471606035|FG000|Overall Study|Withdrawal by Subject|2|||
130994153|NCT03203694|471606036|FG001|Overall Study|Withdrawal by Subject|0|||
130994154|NCT03203694|471606037|FG002|Overall Study|Withdrawal by Subject|0|||
130994155|NCT03203694|471606038|FG003|Overall Study|Withdrawal by Subject|0|||
130994156|NCT03203694|471606039|FG004|Overall Study|Withdrawal by Subject|0|||
130994157|NCT03203694|471606040|FG005|Overall Study|Withdrawal by Subject|0|||
130994158|NCT01103960|471606046|FG000|Overall Study|Adverse Event|2|||
130994159|NCT01103960|471606047|FG001|Overall Study|Adverse Event|1|||
130994160|NCT01103960|471606046|FG000|Overall Study|Withdrawal by Subject|2|||
130994161|NCT01103960|471606047|FG001|Overall Study|Withdrawal by Subject|1|||
130994162|NCT01103960|471606046|FG000|Overall Study|Other|1|||
130994163|NCT01103960|471606047|FG001|Overall Study|Other|0|||
130994164|NCT04287868|471606054|FG000|Overall Study|Screening fail|1|||
130994165|NCT04287868|471606055|FG001|Overall Study|Screening fail|0|||
130994166|NCT01167179|471607853|FG000|Overall Study|disease recurrence|4|||
130994167|NCT01167179|471607854|FG001|Overall Study|disease recurrence|4|||
130994168|NCT01167179|471607853|FG000|Overall Study|Death|4|||
130994169|NCT01167179|471607854|FG001|Overall Study|Death|10|||
130994170|NCT01167179|471607853|FG000|Overall Study|Withdrawal by Subject|1|||
130994171|NCT01167179|471607854|FG001|Overall Study|Withdrawal by Subject|2|||
130994172|NCT01167179|471607853|FG000|Overall Study|diverse|6|||
130994173|NCT01167179|471607854|FG001|Overall Study|diverse|5|||
130994174|NCT02781506|471607855|FG000|Overall Study|Adverse Event|5|||
130994175|NCT01158378|471607856|FG000|Overall Study|Death|4|||
130994176|NCT01158378|471607857|FG001|Overall Study|Death|5|||
130994177|NCT01158378|471607856|FG000|Overall Study|Lost to Follow-up|2|||
130994178|NCT01158378|471607857|FG001|Overall Study|Lost to Follow-up|4|||
130994179|NCT01158378|471607856|FG000|Overall Study|Withdrawal by Subject|4|||
130994180|NCT01158378|471607857|FG001|Overall Study|Withdrawal by Subject|0|||
130994181|NCT03017235|471607858|FG000|Overall Study|Withdrawal by Subject|4|||
130994182|NCT03017235|471607859|FG001|Overall Study|Withdrawal by Subject|3|||
130994183|NCT03017235|471607858|FG000|Overall Study|Lost to Follow-up|2|||
130994184|NCT03017235|471607859|FG001|Overall Study|Lost to Follow-up|7|||
130994185|NCT03017235|471607858|FG000|Overall Study|Adverse Event|0|||
130994186|NCT03017235|471607859|FG001|Overall Study|Adverse Event|1|||
130994187|NCT03017235|471607858|FG000|Overall Study|Protocol Violation|2|||
130994188|NCT03017235|471607859|FG001|Overall Study|Protocol Violation|1|||
130994189|NCT03017235|471607858|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
130994190|NCT03017235|471607859|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
130994191|NCT02936037|471607863|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
130994192|NCT02936037|471607864|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
130994193|NCT02936037|471607863|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
130994194|NCT02936037|471607864|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
130994195|NCT02936037|471607863|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
130994196|NCT02936037|471607864|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
130994197|NCT02936037|471607863|FG000|Double-Blind Treatment Period|Death|0|||
130994198|NCT02936037|471607864|FG001|Double-Blind Treatment Period|Death|1|||
130994199|NCT02936037|471607863|FG000|Double-Blind Treatment Period|Adverse Event|11|||
130994200|NCT02936037|471607864|FG001|Double-Blind Treatment Period|Adverse Event|11|||
130994201|NCT02936037|471607863|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
130994202|NCT02936037|471607864|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
130994203|NCT02936037|471607863|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130994204|NCT02936037|471607864|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130994205|NCT02936037|471607863|FG000|Open Label Extension|Adverse Event|0|||
130994206|NCT02936037|471607864|FG001|Open Label Extension|Adverse Event|3|||
130994207|NCT02936037|471607863|FG000|Open Label Extension|Other|0|||
130994208|NCT02936037|471607864|FG001|Open Label Extension|Other|3|||
130994209|NCT02936037|471607863|FG000|Open Label Extension|Withdrawal by Subject|0|||
130994210|NCT02936037|471607864|FG001|Open Label Extension|Withdrawal by Subject|4|||
130994211|NCT02105636|471607869|FG000|Pre-Treatment|Disease Progression|1|||
130994212|NCT02105636|471607870|FG001|Pre-Treatment|Disease Progression|0|||
130994213|NCT02105636|471607869|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
130994214|NCT02105636|471607870|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
130994215|NCT02105636|471607869|FG000|Pre-Treatment|Participant withdrew consent|0|||
130994216|NCT02105636|471607870|FG001|Pre-Treatment|Participant withdrew consent|6|||
130994217|NCT02105636|471607869|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
130994218|NCT02105636|471607870|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
130883352|NCT02760498|471207943|FG003|Overall Study|Not treated|0|||
130883353|NCT02760498|471207944|FG004|Overall Study|Not treated|0|||
130883354|NCT02760498|471207945|FG005|Overall Study|Not treated|2|||
130883355|NCT02059278|471207947|FG000|Overall Study|Adverse Event|1|||
130883356|NCT02059278|471207948|FG001|Overall Study|Adverse Event|1|||
130883357|NCT02059278|471207947|FG000|Overall Study|Lost to Follow-up|1|||
130883358|NCT02059278|471207948|FG001|Overall Study|Lost to Follow-up|0|||
130883359|NCT02059278|471207947|FG000|Overall Study|Withdrawal by Subject|0|||
130883360|NCT02059278|471207948|FG001|Overall Study|Withdrawal by Subject|3|||
130883361|NCT02059278|471207947|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
130883362|NCT02059278|471207948|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
130883363|NCT03955146|471207951|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
130883364|NCT03955146|471207952|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
130883365|NCT03955146|471207953|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
130883366|NCT03955146|471207954|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
130883367|NCT03955146|471207951|FG000|DB Period (48 Weeks)|Adverse Event|2|||
130883368|NCT03955146|471207952|FG001|DB Period (48 Weeks)|Adverse Event|5|||
130883369|NCT03955146|471207953|FG002|DB Period (48 Weeks)|Adverse Event|1|||
130883370|NCT03955146|471207954|FG003|DB Period (48 Weeks)|Adverse Event|2|||
130883371|NCT03955146|471207951|FG000|DB Period (48 Weeks)|Death|13|||
130883372|NCT03955146|471207952|FG001|DB Period (48 Weeks)|Death|17|||
130883373|NCT03955146|471207953|FG002|DB Period (48 Weeks)|Death|1|||
130883374|NCT03955146|471207954|FG003|DB Period (48 Weeks)|Death|0|||
130883375|NCT03955146|471207951|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
130883376|NCT03955146|471207952|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
130883377|NCT03955146|471207953|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
130883378|NCT03955146|471207954|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
130883379|NCT03955146|471207951|FG000|DB Period (48 Weeks)|Disease Progression|2|||
130883380|NCT03955146|471207952|FG001|DB Period (48 Weeks)|Disease Progression|0|||
130883381|NCT03955146|471207953|FG002|DB Period (48 Weeks)|Disease Progression|0|||
130883382|NCT03955146|471207954|FG003|DB Period (48 Weeks)|Disease Progression|0|||
130883383|NCT03955146|471207951|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
130883384|NCT03955146|471207952|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
130883385|NCT03955146|471207953|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
130883386|NCT03955146|471207954|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
130883387|NCT03955146|471207951|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
130883388|NCT03955146|471207952|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
130883389|NCT03955146|471207953|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
130883390|NCT03955146|471207954|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
130883391|NCT03955146|471207951|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
130883392|NCT03955146|471207952|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
130883393|NCT03955146|471207953|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
130883394|NCT03955146|471207954|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
130883395|NCT03955146|471207951|FG000|DB Period (48 Weeks)|Participant Decision|9|||
130883396|NCT03955146|471207952|FG001|DB Period (48 Weeks)|Participant Decision|12|||
130883397|NCT03955146|471207953|FG002|DB Period (48 Weeks)|Participant Decision|1|||
130883398|NCT03955146|471207954|FG003|DB Period (48 Weeks)|Participant Decision|1|||
130883399|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
130883400|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
130883401|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
130883402|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
130883403|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
130883404|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
130883405|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
130994219|NCT02105636|471607869|FG000|Treatment|Study Drug Toxicity|14|||
130994220|NCT02105636|471607870|FG001|Treatment|Study Drug Toxicity|10|||
130994221|NCT02105636|471607869|FG000|Treatment|Adverse event unrelated to study drug|19|||
130994222|NCT02105636|471607870|FG001|Treatment|Adverse event unrelated to study drug|3|||
130994223|NCT02105636|471607869|FG000|Treatment|Participant request to discontinue study treatment|8|||
130994224|NCT02105636|471607870|FG001|Treatment|Participant request to discontinue study treatment|6|||
130994225|NCT02105636|471607869|FG000|Treatment|Participant withdrew consent|5|||
130994226|NCT02105636|471607870|FG001|Treatment|Participant withdrew consent|1|||
130994227|NCT02105636|471607869|FG000|Treatment|Lost to Follow-up|1|||
130994228|NCT02105636|471607870|FG001|Treatment|Lost to Follow-up|0|||
130994229|NCT02105636|471607869|FG000|Treatment|Maximum Clinical Benefit|1|||
130994230|NCT02105636|471607870|FG001|Treatment|Maximum Clinical Benefit|3|||
130994231|NCT02105636|471607869|FG000|Treatment|Poor/Non-compliance|0|||
130994232|NCT02105636|471607870|FG001|Treatment|Poor/Non-compliance|1|||
130994233|NCT02105636|471607869|FG000|Treatment|Participant no longer meets study criteria|1|||
130994234|NCT02105636|471607870|FG001|Treatment|Participant no longer meets study criteria|0|||
130994235|NCT02105636|471607869|FG000|Treatment|Other reasons|1|||
130994236|NCT02105636|471607870|FG001|Treatment|Other reasons|0|||
130994237|NCT02105636|471607869|FG000|Treatment|Disease Progression|185|||
130994238|NCT02105636|471607870|FG001|Treatment|Disease Progression|87|||
130994239|NCT00235443|471607872|FG000|Overall Study|Adverse Event|4|||
130994240|NCT00235443|471607873|FG001|Overall Study|Adverse Event|12|||
130994241|NCT00235443|471607874|FG002|Overall Study|Adverse Event|17|||
130994242|NCT00235443|471607875|FG003|Overall Study|Adverse Event|44|||
130994243|NCT00235443|471607876|FG004|Overall Study|Adverse Event|10|||
130994244|NCT00235443|471607877|FG005|Overall Study|Adverse Event|15|||
130994245|NCT00235443|471607872|FG000|Overall Study|Lack of Efficacy|0|||
130994246|NCT00235443|471607873|FG001|Overall Study|Lack of Efficacy|1|||
131221380|NCT01128153|472437928|FG001|Overall Study|Incorrect enrolment to study|1|||
131221381|NCT01128153|472437927|FG000|Overall Study|Protocol Violation|2|||
131221382|NCT01128153|472437928|FG001|Overall Study|Protocol Violation|0|||
131221383|NCT01128153|472437927|FG000|Overall Study|Developed discontinuation criteria|1|||
131221384|NCT01128153|472437928|FG001|Overall Study|Developed discontinuation criteria|1|||
131221385|NCT01875991|472437929|FG000|Overall Study|Withdrawal by Subject|6|||
131221386|NCT01875991|472437930|FG001|Overall Study|Withdrawal by Subject|6|||
131221387|NCT01875991|472437929|FG000|Overall Study|Sponsor Decision|1|||
131221388|NCT01875991|472437930|FG001|Overall Study|Sponsor Decision|0|||
131221389|NCT02419469|472437931|FG000|Overall Study|Withdrawal by Subject|1|||
131221390|NCT01682512|472437932|FG000|Overall Study|Adverse Event|6|||
131221391|NCT01682512|472437933|FG001|Overall Study|Adverse Event|5|||
131221392|NCT01682512|472437934|FG002|Overall Study|Adverse Event|2|||
131221393|NCT01682512|472437932|FG000|Overall Study|Withdrawal by Subject|2|||
131221394|NCT01682512|472437933|FG001|Overall Study|Withdrawal by Subject|6|||
131221395|NCT01682512|472437934|FG002|Overall Study|Withdrawal by Subject|3|||
131221396|NCT01682512|472437932|FG000|Overall Study|Physician Decision|0|||
130994247|NCT00235443|471607874|FG002|Overall Study|Lack of Efficacy|5|||
131221397|NCT01682512|472437933|FG001|Overall Study|Physician Decision|2|||
131221398|NCT01682512|472437934|FG002|Overall Study|Physician Decision|0|||
130994248|NCT00235443|471607875|FG003|Overall Study|Lack of Efficacy|12|||
131221399|NCT01682512|472437932|FG000|Overall Study|Study terminated by sponsor|46|||
131221400|NCT01682512|472437933|FG001|Overall Study|Study terminated by sponsor|43|||
131221401|NCT01682512|472437934|FG002|Overall Study|Study terminated by sponsor|0|||
131221402|NCT01682512|472437932|FG000|Overall Study|Lost to Follow-up|3|||
130994249|NCT00235443|471607876|FG004|Overall Study|Lack of Efficacy|2|||
130994250|NCT00235443|471607877|FG005|Overall Study|Lack of Efficacy|9|||
130994251|NCT00235443|471607872|FG000|Overall Study|Withdrawal by Subject|3|||
130994252|NCT00235443|471607873|FG001|Overall Study|Withdrawal by Subject|9|||
130994253|NCT00235443|471607874|FG002|Overall Study|Withdrawal by Subject|25|||
130994254|NCT00235443|471607875|FG003|Overall Study|Withdrawal by Subject|24|||
130994255|NCT00235443|471607876|FG004|Overall Study|Withdrawal by Subject|10|||
130994256|NCT00235443|471607877|FG005|Overall Study|Withdrawal by Subject|12|||
130994257|NCT00235443|471607872|FG000|Overall Study|Lost to Follow-up|0|||
130994258|NCT00235443|471607873|FG001|Overall Study|Lost to Follow-up|8|||
130994259|NCT00235443|471607874|FG002|Overall Study|Lost to Follow-up|6|||
130994260|NCT00235443|471607875|FG003|Overall Study|Lost to Follow-up|6|||
130994261|NCT00235443|471607876|FG004|Overall Study|Lost to Follow-up|4|||
130994262|NCT00235443|471607877|FG005|Overall Study|Lost to Follow-up|3|||
130994263|NCT00235443|471607872|FG000|Overall Study|Unsatisfactory compliance|0|||
130994264|NCT00235443|471607873|FG001|Overall Study|Unsatisfactory compliance|2|||
130994265|NCT00235443|471607874|FG002|Overall Study|Unsatisfactory compliance|3|||
130994266|NCT00235443|471607875|FG003|Overall Study|Unsatisfactory compliance|4|||
130994267|NCT00235443|471607876|FG004|Overall Study|Unsatisfactory compliance|1|||
130994268|NCT00235443|471607877|FG005|Overall Study|Unsatisfactory compliance|0|||
130994269|NCT00235443|471607872|FG000|Overall Study|Other reasons for premature termination|1|||
130994270|NCT00235443|471607873|FG001|Overall Study|Other reasons for premature termination|6|||
130994271|NCT00235443|471607874|FG002|Overall Study|Other reasons for premature termination|6|||
130994272|NCT00235443|471607875|FG003|Overall Study|Other reasons for premature termination|7|||
130994273|NCT00235443|471607876|FG004|Overall Study|Other reasons for premature termination|3|||
130994274|NCT00235443|471607877|FG005|Overall Study|Other reasons for premature termination|6|||
130994275|NCT03029247|471607878|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
130994276|NCT03029247|471607879|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
130994277|NCT03029247|471607878|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
130994278|NCT03029247|471607879|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
130994279|NCT03029247|471607878|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
130994280|NCT03029247|471607879|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
130994281|NCT03029247|471607878|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
130994282|NCT03029247|471607879|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
130994283|NCT01976364|471607882|FG000|Main Study (36 Months)|Adverse Event|63|||
130994284|NCT01976364|471607883|FG001|Main Study (36 Months)|Adverse Event|0|||
130994285|NCT01976364|471607884|FG002|Main Study (36 Months)|Adverse Event|0|||
130994286|NCT01976364|471607882|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
130994287|NCT01976364|471607883|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
130994288|NCT01976364|471607884|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
130994289|NCT01976364|471607882|FG000|Main Study (36 Months)|Other|13|||
130994290|NCT01976364|471607883|FG001|Main Study (36 Months)|Other|0|||
130994291|NCT01976364|471607884|FG002|Main Study (36 Months)|Other|0|||
130994292|NCT01976364|471607882|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
130994293|NCT01976364|471607883|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
130994294|NCT01976364|471607884|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
130994295|NCT01976364|471607882|FG000|Main Study (36 Months)|Medication error|1|||
130994296|NCT01976364|471607883|FG001|Main Study (36 Months)|Medication error|0|||
130994297|NCT01976364|471607884|FG002|Main Study (36 Months)|Medication error|0|||
130994298|NCT01976364|471607882|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
130994299|NCT01976364|471607883|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
130994300|NCT01976364|471607884|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
130994301|NCT01976364|471607882|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
130994302|NCT01976364|471607883|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
130994303|NCT01976364|471607884|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
130994304|NCT01976364|471607882|FG000|Main Study (36 Months)|Protocol Violation|13|||
130994305|NCT01976364|471607883|FG001|Main Study (36 Months)|Protocol Violation|0|||
130994306|NCT01976364|471607884|FG002|Main Study (36 Months)|Protocol Violation|0|||
130994307|NCT01976364|471607882|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
130994308|NCT01976364|471607883|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
130994309|NCT01976364|471607884|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
130994310|NCT01976364|471607882|FG000|Main Study (36 Months)|Death|5|||
130994311|NCT01976364|471607883|FG001|Main Study (36 Months)|Death|0|||
130994312|NCT01976364|471607884|FG002|Main Study (36 Months)|Death|0|||
130994313|NCT01976364|471607882|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
130994314|NCT01976364|471607883|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
130994315|NCT01976364|471607884|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
130994316|NCT01976364|471607882|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
130994317|NCT01976364|471607883|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
130994318|NCT01976364|471607884|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
130994319|NCT01976364|471607882|FG000|Sub-study (12 Months)|Protocol Violation|0|||
130994320|NCT01976364|471607883|FG001|Sub-study (12 Months)|Protocol Violation|1|||
130994321|NCT01976364|471607884|FG002|Sub-study (12 Months)|Protocol Violation|1|||
130994322|NCT01976364|471607882|FG000|Sub-study (12 Months)|Adverse Event|0|||
130994323|NCT01976364|471607883|FG001|Sub-study (12 Months)|Adverse Event|4|||
130994324|NCT01976364|471607884|FG002|Sub-study (12 Months)|Adverse Event|3|||
130994325|NCT02318719|471607886|FG000|Double-blind Phase|Adverse Event|7|||
130994326|NCT02318719|471607887|FG001|Double-blind Phase|Adverse Event|6|||
130994327|NCT02318719|471607888|FG002|Double-blind Phase|Adverse Event|12|||
130994328|NCT02318719|471607889|FG003|Double-blind Phase|Adverse Event|4|||
130994329|NCT02318719|471607890|FG004|Double-blind Phase|Adverse Event|0|||
130994330|NCT02318719|471607886|FG000|Double-blind Phase|Lack of Efficacy|5|||
130994331|NCT02318719|471607887|FG001|Double-blind Phase|Lack of Efficacy|0|||
130994332|NCT02318719|471607888|FG002|Double-blind Phase|Lack of Efficacy|1|||
130994333|NCT02318719|471607889|FG003|Double-blind Phase|Lack of Efficacy|1|||
130994334|NCT02318719|471607890|FG004|Double-blind Phase|Lack of Efficacy|0|||
130994335|NCT02318719|471607886|FG000|Double-blind Phase|Protocol Violation|0|||
130994336|NCT02318719|471607887|FG001|Double-blind Phase|Protocol Violation|1|||
130994337|NCT02318719|471607888|FG002|Double-blind Phase|Protocol Violation|3|||
130994338|NCT02318719|471607889|FG003|Double-blind Phase|Protocol Violation|0|||
130994339|NCT02318719|471607890|FG004|Double-blind Phase|Protocol Violation|0|||
130994340|NCT02318719|471607886|FG000|Double-blind Phase|Withdrawal by Subject|25|||
130994341|NCT02318719|471607887|FG001|Double-blind Phase|Withdrawal by Subject|7|||
130994342|NCT02318719|471607888|FG002|Double-blind Phase|Withdrawal by Subject|9|||
130994343|NCT02318719|471607889|FG003|Double-blind Phase|Withdrawal by Subject|10|||
130994344|NCT02318719|471607890|FG004|Double-blind Phase|Withdrawal by Subject|0|||
130994345|NCT02318719|471607886|FG000|Double-blind Phase|Other|1|||
130994346|NCT02318719|471607887|FG001|Double-blind Phase|Other|2|||
130994347|NCT02318719|471607888|FG002|Double-blind Phase|Other|0|||
130994348|NCT02318719|471607889|FG003|Double-blind Phase|Other|0|||
130994349|NCT02318719|471607890|FG004|Double-blind Phase|Other|0|||
130994350|NCT02318719|471607886|FG000|Open-label Extension Phase|Adverse Event|0|||
130994351|NCT02318719|471607887|FG001|Open-label Extension Phase|Adverse Event|0|||
130994352|NCT02318719|471607888|FG002|Open-label Extension Phase|Adverse Event|0|||
130994353|NCT02318719|471607889|FG003|Open-label Extension Phase|Adverse Event|0|||
130994354|NCT02318719|471607890|FG004|Open-label Extension Phase|Adverse Event|15|||
130994355|NCT02318719|471607886|FG000|Open-label Extension Phase|Death|0|||
130994356|NCT02318719|471607887|FG001|Open-label Extension Phase|Death|0|||
130994357|NCT02318719|471607888|FG002|Open-label Extension Phase|Death|0|||
130994358|NCT02318719|471607889|FG003|Open-label Extension Phase|Death|0|||
130994359|NCT02318719|471607890|FG004|Open-label Extension Phase|Death|1|||
130994360|NCT02318719|471607886|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
130994361|NCT02318719|471607887|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
130994362|NCT02318719|471607888|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
130994363|NCT02318719|471607889|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
130994364|NCT02318719|471607890|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
130994365|NCT02318719|471607886|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
130994366|NCT02318719|471607887|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
130994367|NCT02318719|471607888|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
130994368|NCT02318719|471607889|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
130994369|NCT02318719|471607890|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
130994370|NCT02318719|471607886|FG000|Open-label Extension Phase|Other|0|||
130994371|NCT02318719|471607887|FG001|Open-label Extension Phase|Other|0|||
130994372|NCT02318719|471607888|FG002|Open-label Extension Phase|Other|0|||
130994373|NCT02318719|471607889|FG003|Open-label Extension Phase|Other|0|||
130994374|NCT02318719|471607890|FG004|Open-label Extension Phase|Other|7|||
130994375|NCT01868035|471607891|FG000|Overall Study|Lost to Follow-up|3|||
130994376|NCT01868035|471607891|FG000|Overall Study|Withdrawal by Subject|1|||
130994377|NCT01868035|471607891|FG000|Overall Study|Progressive Disease|2|||
130994378|NCT01868035|471607891|FG000|Overall Study|Non-compliance|1|||
130994379|NCT00432835|471607892|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
130994380|NCT00432835|471607893|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
130994381|NCT00423293|471607894|FG000|Overall Study|Ineligible / No protocol treatment|11|||
130994382|NCT01912222|471607895|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
130994383|NCT01912222|471607896|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
130994384|NCT01912222|471607897|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
131221403|NCT01682512|472437933|FG001|Overall Study|Lost to Follow-up|0|||
131221404|NCT01682512|472437934|FG002|Overall Study|Lost to Follow-up|2|||
131221405|NCT01682512|472437932|FG000|Overall Study|Protocol Violation|2|||
130994385|NCT01912222|471607895|FG000|Part B: Treatment Period|Progressive disease|10|||
130994386|NCT01912222|471607896|FG001|Part B: Treatment Period|Progressive disease|12|||
130994387|NCT01912222|471607897|FG002|Part B: Treatment Period|Progressive disease|15|||
130994388|NCT01912222|471607895|FG000|Part B: Treatment Period|Adverse Event|1|||
130994389|NCT01912222|471607896|FG001|Part B: Treatment Period|Adverse Event|2|||
130994390|NCT01912222|471607897|FG002|Part B: Treatment Period|Adverse Event|3|||
130994391|NCT01912222|471607895|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
130994392|NCT01912222|471607896|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
130994393|NCT01912222|471607897|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
130994394|NCT03154359|471607898|FG000|Overall Study|Adverse Event|1|||
130994395|NCT03154359|471607898|FG000|Overall Study|Lack of Efficacy|2|||
130994396|NCT03154359|471607898|FG000|Overall Study|Lost to Follow-up|3|||
130994397|NCT03154359|471607898|FG000|Overall Study|Physician Decision|3|||
130994398|NCT03154359|471607898|FG000|Overall Study|Protocol Violation|4|||
130994399|NCT03154359|471607898|FG000|Overall Study|Withdrawal by Subject|5|||
130994400|NCT03154359|471607898|FG000|Overall Study|Disruption of study due to COVID-19|4|||
130994401|NCT03321006|471607901|FG000|Overall Study|Death|1|||
130994402|NCT03321006|471607902|FG001|Overall Study|Death|0|||
130994403|NCT03321006|471607901|FG000|Overall Study|Lack of Efficacy|1|||
130994404|NCT03321006|471607902|FG001|Overall Study|Lack of Efficacy|0|||
130994405|NCT00885352|471607903|FG000|Overall Study|Adverse Event|2|||
130994406|NCT00885352|471607904|FG001|Overall Study|Adverse Event|3|||
130994407|NCT00885352|471607903|FG000|Overall Study|Lost to Follow-up|2|||
130994408|NCT00885352|471607904|FG001|Overall Study|Lost to Follow-up|2|||
130994409|NCT00885352|471607903|FG000|Overall Study|Physician Decision|0|||
130994410|NCT00885352|471607904|FG001|Overall Study|Physician Decision|3|||
130994411|NCT00885352|471607903|FG000|Overall Study|Protocol Violation|0|||
130994412|NCT00885352|471607904|FG001|Overall Study|Protocol Violation|2|||
130994413|NCT00885352|471607903|FG000|Overall Study|Withdrawal by Subject|1|||
130994414|NCT00885352|471607904|FG001|Overall Study|Withdrawal by Subject|5|||
130994415|NCT00885352|471607903|FG000|Overall Study|Contradiction to study medication|0|||
130994416|NCT00885352|471607904|FG001|Overall Study|Contradiction to study medication|2|||
130994417|NCT00885352|471607903|FG000|Overall Study|Excluded medication|2|||
130994418|NCT00885352|471607904|FG001|Overall Study|Excluded medication|2|||
130994419|NCT00885352|471607903|FG000|Overall Study|Lab abnormalities|1|||
130994420|NCT00885352|471607904|FG001|Overall Study|Lab abnormalities|1|||
130994421|NCT00365378|471607905|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
130994422|NCT00365378|471607906|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
130994423|NCT00365378|471607907|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130994424|NCT00365378|471607905|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
130994425|NCT00365378|471607906|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
130994426|NCT00365378|471607907|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
130994427|NCT00365378|471607905|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
130994428|NCT00365378|471607906|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
130994429|NCT00365378|471607907|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
130994430|NCT00365378|471607905|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
130994431|NCT00365378|471607906|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
130994432|NCT00365378|471607907|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
130994433|NCT00365378|471607905|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
130994434|NCT00365378|471607906|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
130994435|NCT00365378|471607907|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
130994436|NCT00365378|471607905|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
130994437|NCT00365378|471607906|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
130994438|NCT00365378|471607907|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
130994439|NCT00365378|471607905|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
130994440|NCT00365378|471607906|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
130994441|NCT00365378|471607907|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
130994442|NCT00365378|471607905|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
130994443|NCT00365378|471607906|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
130994444|NCT00365378|471607907|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
130994445|NCT00365378|471607905|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
130994446|NCT00365378|471607906|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
130994447|NCT00365378|471607907|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
130994448|NCT00365378|471607905|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
130994449|NCT00365378|471607906|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
130994450|NCT00365378|471607907|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
130994451|NCT00365378|471607905|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
130994452|NCT00365378|471607906|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
130994453|NCT00365378|471607907|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
130994454|NCT00365378|471607905|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
130994455|NCT00365378|471607906|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
130994456|NCT00365378|471607907|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
130994457|NCT00365378|471607905|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
130994458|NCT00365378|471607906|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
130994459|NCT00365378|471607907|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
130994460|NCT00365378|471607905|FG000|Extension|Adverse Event|0|||
130994461|NCT00365378|471607906|FG001|Extension|Adverse Event|0|||
130994462|NCT00365378|471607907|FG002|Extension|Adverse Event|1|||
130994463|NCT00365378|471607905|FG000|Extension|Moved|0|||
130994464|NCT00365378|471607906|FG001|Extension|Moved|0|||
130994465|NCT00365378|471607907|FG002|Extension|Moved|8|||
130994466|NCT00365378|471607905|FG000|Extension|Lost to Follow-up|0|||
130994467|NCT00365378|471607906|FG001|Extension|Lost to Follow-up|0|||
130994468|NCT00365378|471607907|FG002|Extension|Lost to Follow-up|57|||
130994469|NCT00365378|471607905|FG000|Extension|Protocol Violation|0|||
130994470|NCT00365378|471607906|FG001|Extension|Protocol Violation|0|||
130994471|NCT00365378|471607907|FG002|Extension|Protocol Violation|2|||
130994472|NCT00365378|471607905|FG000|Extension|Withdrawal by Subject|0|||
130994473|NCT00365378|471607906|FG001|Extension|Withdrawal by Subject|0|||
130994474|NCT00365378|471607907|FG002|Extension|Withdrawal by Subject|98|||
130994475|NCT00365378|471607905|FG000|Extension|Other|0|||
130994476|NCT00365378|471607906|FG001|Extension|Other|0|||
130994477|NCT00365378|471607907|FG002|Extension|Other|31|||
130994478|NCT03560258|471607910|FG000|Overall Study|Lost to Follow-up|3|||
130994479|NCT03560258|471607911|FG001|Overall Study|Lost to Follow-up|0|||
130994480|NCT03560258|471607912|FG002|Overall Study|Lost to Follow-up|0|||
130994481|NCT03560258|471607910|FG000|Overall Study|Protocol Violation|0|||
130994482|NCT03560258|471607911|FG001|Overall Study|Protocol Violation|1|||
130994483|NCT03560258|471607912|FG002|Overall Study|Protocol Violation|0|||
130994484|NCT03560258|471607910|FG000|Overall Study|Withdrawal by Subject|0|||
130994485|NCT03560258|471607911|FG001|Overall Study|Withdrawal by Subject|0|||
130994486|NCT03560258|471607912|FG002|Overall Study|Withdrawal by Subject|1|||
130994487|NCT04161807|471607916|FG000|Overall Study|Withdrawal by Subject|2|||
130994488|NCT04161807|471607916|FG000|Overall Study|Performed only 1 treatment|2|||
130994489|NCT02006121|471607917|FG000|Double Blind Phase|Adverse Event|6|||
130994490|NCT02006121|471607918|FG001|Double Blind Phase|Adverse Event|0|||
130994491|NCT02006121|471607917|FG000|Double Blind Phase|Lack of Efficacy|1|||
130994492|NCT02006121|471607918|FG001|Double Blind Phase|Lack of Efficacy|16|||
130994493|NCT02006121|471607917|FG000|Double Blind Phase|Withdrawal by Subject|3|||
130994494|NCT02006121|471607918|FG001|Double Blind Phase|Withdrawal by Subject|4|||
130994495|NCT02006121|471607917|FG000|Double Blind Phase|Non-compliance with study drug|1|||
130994496|NCT02006121|471607918|FG001|Double Blind Phase|Non-compliance with study drug|3|||
130994497|NCT02006121|471607917|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
130994498|NCT02006121|471607918|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
130994499|NCT02006121|471607917|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
130994500|NCT02006121|471607918|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
130994501|NCT02006121|471607917|FG000|Open Label Phase|Adverse Event|15|||
130994502|NCT02006121|471607918|FG001|Open Label Phase|Adverse Event|0|||
130994503|NCT02006121|471607917|FG000|Open Label Phase|Lack of Efficacy|2|||
130994504|NCT02006121|471607918|FG001|Open Label Phase|Lack of Efficacy|0|||
130994505|NCT02006121|471607917|FG000|Open Label Phase|Protocol Violation|2|||
130994506|NCT02006121|471607918|FG001|Open Label Phase|Protocol Violation|0|||
130994507|NCT02006121|471607917|FG000|Open Label Phase|Withdrawal by Subject|3|||
130994508|NCT02006121|471607918|FG001|Open Label Phase|Withdrawal by Subject|0|||
130994509|NCT02006121|471607917|FG000|Open Label Phase|Non-compliance with study drug|3|||
130994510|NCT02006121|471607918|FG001|Open Label Phase|Non-compliance with study drug|0|||
130994511|NCT00669903|471607929|FG000|Overall Study|Adverse Event|0|||
130765893|NCT01524783|470765894|FG000|Open-label Period|Administrative problems|5|||
130994512|NCT00669903|471607930|FG001|Overall Study|Adverse Event|1|||
130994513|NCT00669903|471607931|FG002|Overall Study|Adverse Event|3|||
130994514|NCT00669903|471607932|FG003|Overall Study|Adverse Event|1|||
130994515|NCT00669903|471607929|FG000|Overall Study|Withdrawal by Subject|0|||
130994516|NCT00669903|471607930|FG001|Overall Study|Withdrawal by Subject|2|||
130994517|NCT00669903|471607931|FG002|Overall Study|Withdrawal by Subject|2|||
130994518|NCT00669903|471607932|FG003|Overall Study|Withdrawal by Subject|2|||
130994519|NCT00669903|471607929|FG000|Overall Study|Lost to Follow-up|1|||
130994520|NCT00669903|471607930|FG001|Overall Study|Lost to Follow-up|1|||
130994521|NCT00669903|471607931|FG002|Overall Study|Lost to Follow-up|0|||
130994522|NCT00669903|471607932|FG003|Overall Study|Lost to Follow-up|1|||
130994523|NCT00669903|471607929|FG000|Overall Study|Protocol Violation|0|||
130994524|NCT00669903|471607930|FG001|Overall Study|Protocol Violation|1|||
130994525|NCT00669903|471607931|FG002|Overall Study|Protocol Violation|0|||
130994526|NCT00669903|471607932|FG003|Overall Study|Protocol Violation|0|||
130994527|NCT04789577|471607936|FG000|Overall Study|Withdrawal by Subject|1|||
130994528|NCT04789577|471607937|FG001|Overall Study|Withdrawal by Subject|1|||
130994529|NCT04789577|471607938|FG002|Overall Study|Withdrawal by Subject|1|||
130994530|NCT04789577|471607939|FG003|Overall Study|Withdrawal by Subject|3|||
130994531|NCT04789577|471607940|FG004|Overall Study|Withdrawal by Subject|1|||
130994532|NCT04789577|471607941|FG005|Overall Study|Withdrawal by Subject|7|||
130994533|NCT04789577|471607942|FG006|Overall Study|Withdrawal by Subject|1|||
130994534|NCT04789577|471607936|FG000|Overall Study|Lost to Follow-up|7|||
130994535|NCT04789577|471607937|FG001|Overall Study|Lost to Follow-up|12|||
130994536|NCT04789577|471607938|FG002|Overall Study|Lost to Follow-up|7|||
130994537|NCT04789577|471607939|FG003|Overall Study|Lost to Follow-up|10|||
130994538|NCT04789577|471607940|FG004|Overall Study|Lost to Follow-up|8|||
130994539|NCT04789577|471607941|FG005|Overall Study|Lost to Follow-up|6|||
130994540|NCT04789577|471607942|FG006|Overall Study|Lost to Follow-up|10|||
130994541|NCT04789577|471607936|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
130994542|NCT04789577|471607937|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
130994543|NCT04789577|471607938|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
130994544|NCT04789577|471607939|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
130994545|NCT04789577|471607940|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
130994546|NCT04789577|471607941|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
130994547|NCT04789577|471607942|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
130994548|NCT04789577|471607936|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
130994549|NCT04789577|471607937|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
130994550|NCT04789577|471607938|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
130994551|NCT04789577|471607939|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
130994552|NCT04789577|471607940|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
130994553|NCT04789577|471607941|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
130994554|NCT04789577|471607942|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
130994555|NCT01827254|471607943|FG000|Overall Study|Death|10|||
130994556|NCT01827254|471607943|FG000|Overall Study|Case report form not completed|4|||
130994557|NCT01827254|471607943|FG000|Overall Study|Invalidated centre|3|||
130994558|NCT01827254|471607943|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
130994559|NCT01827254|471607943|FG000|Overall Study|Did not complete re-challenge|1|||
130994560|NCT01827254|471607943|FG000|Overall Study|Disease progression|36|||
130994561|NCT01827254|471607943|FG000|Overall Study|Intolerance to treatment|4|||
130994562|NCT00245856|471607951|FG000|Period Two|Withdrawal by Subject|0|||
130994563|NCT00245856|471607952|FG001|Period Two|Withdrawal by Subject|1|||
130994564|NCT01003184|471607954|FG000|Overall Study|Adverse Event|12|||
130994565|NCT01003184|471607955|FG001|Overall Study|Adverse Event|5|||
130994566|NCT01003184|471607954|FG000|Overall Study|Lost to Follow-up|1|||
130994567|NCT01003184|471607955|FG001|Overall Study|Lost to Follow-up|0|||
130994568|NCT01003184|471607954|FG000|Overall Study|Loss of glucose control|1|||
130994569|NCT01003184|471607955|FG001|Overall Study|Loss of glucose control|1|||
130994570|NCT01003184|471607954|FG000|Overall Study|Protocol Violation|3|||
130994571|NCT01003184|471607955|FG001|Overall Study|Protocol Violation|0|||
130994572|NCT01003184|471607954|FG000|Overall Study|Withdrawal by Subject|1|||
130994573|NCT01003184|471607955|FG001|Overall Study|Withdrawal by Subject|6|||
130994574|NCT01003184|471607954|FG000|Overall Study|Physician Decision|1|||
131221406|NCT01682512|472437933|FG001|Overall Study|Protocol Violation|3|||
131221407|NCT01682512|472437934|FG002|Overall Study|Protocol Violation|2|||
131221408|NCT01682512|472437932|FG000|Overall Study|Primary lack of efficacy|10|||
131221409|NCT01682512|472437933|FG001|Overall Study|Primary lack of efficacy|7|||
131221410|NCT01682512|472437934|FG002|Overall Study|Primary lack of efficacy|7|||
131221411|NCT01682512|472437932|FG000|Overall Study|Secondary lack of efficacy|1|||
131221412|NCT01682512|472437933|FG001|Overall Study|Secondary lack of efficacy|1|||
131221413|NCT01682512|472437934|FG002|Overall Study|Secondary lack of efficacy|0|||
131221414|NCT01682512|472437932|FG000|Overall Study|Other than stated above|2|||
131221415|NCT01682512|472437933|FG001|Overall Study|Other than stated above|4|||
131221416|NCT01682512|472437934|FG002|Overall Study|Other than stated above|2|||
131221417|NCT00054275|472437937|FG000|Overall Study|Withdrawal by Subject|4|||
130994575|NCT01003184|471607955|FG001|Overall Study|Physician Decision|0|||
130994576|NCT02693834|471607956|FG000|Baseline Measurement|Withdrawal by Subject|1|||
130994577|NCT02693834|471607957|FG001|Baseline Measurement|Withdrawal by Subject|0|||
130994578|NCT02693834|471607956|FG000|Baseline Measurement|Adverse Event|1|||
130994579|NCT02693834|471607957|FG001|Baseline Measurement|Adverse Event|0|||
130994580|NCT02693834|471607956|FG000|Week 2 Practice|Adverse Event|0|||
130994581|NCT02693834|471607957|FG001|Week 2 Practice|Adverse Event|1|||
130994582|NCT04848662|471607958|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
130994583|NCT04848662|471607959|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
130994584|NCT00562978|471607960|FG000|Overall Study|Patient had imaging dose only|1|||
130994585|NCT00562978|471607961|FG001|Overall Study|Patient had imaging dose only|11|||
130994586|NCT00152971|471607963|FG000|Overall Study|Adverse Event|12|||
130994587|NCT00152971|471607964|FG001|Overall Study|Adverse Event|10|||
130994588|NCT00152971|471607965|FG002|Overall Study|Adverse Event|9|||
130994589|NCT00152971|471607963|FG000|Overall Study|Protocol Violation|10|||
130994590|NCT00152971|471607964|FG001|Overall Study|Protocol Violation|11|||
130994591|NCT00152971|471607965|FG002|Overall Study|Protocol Violation|8|||
130994592|NCT00152971|471607963|FG000|Overall Study|Lost to Follow-up|17|||
130994593|NCT00152971|471607964|FG001|Overall Study|Lost to Follow-up|14|||
130994594|NCT00152971|471607965|FG002|Overall Study|Lost to Follow-up|13|||
130994595|NCT00152971|471607963|FG000|Overall Study|Withdrawal by Subject|9|||
130994596|NCT00152971|471607964|FG001|Overall Study|Withdrawal by Subject|8|||
130994597|NCT00152971|471607965|FG002|Overall Study|Withdrawal by Subject|14|||
130994598|NCT00152971|471607963|FG000|Overall Study|Other|3|||
130994599|NCT00152971|471607964|FG001|Overall Study|Other|5|||
130994600|NCT00152971|471607965|FG002|Overall Study|Other|5|||
130994601|NCT00152971|471607963|FG000|Treatment|Adverse Event|49|||
130994602|NCT00152971|471607964|FG001|Treatment|Adverse Event|40|||
130994603|NCT00152971|471607965|FG002|Treatment|Adverse Event|54|||
130994604|NCT00152971|471607963|FG000|Treatment|Protocol Violation|8|||
130994605|NCT00152971|471607964|FG001|Treatment|Protocol Violation|6|||
130994606|NCT00152971|471607965|FG002|Treatment|Protocol Violation|10|||
130994607|NCT00152971|471607963|FG000|Treatment|Lost to Follow-up|1|||
130994608|NCT00152971|471607964|FG001|Treatment|Lost to Follow-up|2|||
130994609|NCT00152971|471607965|FG002|Treatment|Lost to Follow-up|1|||
130994610|NCT00152971|471607963|FG000|Treatment|Withdrawal by Subject|4|||
130994611|NCT00152971|471607964|FG001|Treatment|Withdrawal by Subject|4|||
130994612|NCT00152971|471607965|FG002|Treatment|Withdrawal by Subject|5|||
130994613|NCT00152971|471607963|FG000|Treatment|Other|9|||
130994614|NCT00152971|471607964|FG001|Treatment|Other|11|||
130994615|NCT00152971|471607965|FG002|Treatment|Other|10|||
130994616|NCT03125941|471607972|FG000|Overall Study|did not receive intervention|1|||
130994617|NCT03125941|471607973|FG001|Overall Study|did not receive intervention|2|||
130994618|NCT03853317|471607974|FG000|Overall Study|Progressive Disease|5|||
130994619|NCT03853317|471607974|FG000|Overall Study|Adverse Event|1|||
130994620|NCT03853317|471607974|FG000|Overall Study|Death|1|||
130994621|NCT03853317|471607974|FG000|Overall Study|other event|2|||
130994622|NCT00779584|471607975|FG000|Overall Study|Protocol Violation|0|||
130994623|NCT00779584|471607976|FG001|Overall Study|Protocol Violation|0|||
130994624|NCT00779584|471607977|FG002|Overall Study|Protocol Violation|0|||
130994625|NCT00779584|471607978|FG003|Overall Study|Protocol Violation|0|||
130994626|NCT00779584|471607979|FG004|Overall Study|Protocol Violation|0|||
130994627|NCT00779584|471607980|FG005|Overall Study|Protocol Violation|1|||
130994628|NCT00779584|471607981|FG006|Overall Study|Protocol Violation|0|||
130994629|NCT00779584|471607982|FG007|Overall Study|Protocol Violation|0|||
130994630|NCT00779584|471607983|FG008|Overall Study|Protocol Violation|0|||
130994631|NCT00779584|471607975|FG000|Overall Study|Withdrawal by Subject|1|||
130994632|NCT00779584|471607976|FG001|Overall Study|Withdrawal by Subject|1|||
130994633|NCT00779584|471607977|FG002|Overall Study|Withdrawal by Subject|2|||
130994634|NCT00779584|471607978|FG003|Overall Study|Withdrawal by Subject|0|||
130994635|NCT00779584|471607979|FG004|Overall Study|Withdrawal by Subject|0|||
130994636|NCT00779584|471607980|FG005|Overall Study|Withdrawal by Subject|2|||
130994637|NCT00779584|471607981|FG006|Overall Study|Withdrawal by Subject|1|||
130994638|NCT00779584|471607982|FG007|Overall Study|Withdrawal by Subject|0|||
130994639|NCT00779584|471607983|FG008|Overall Study|Withdrawal by Subject|0|||
130994640|NCT00779584|471607975|FG000|Overall Study|Lost to Follow-up|0|||
130994641|NCT00779584|471607976|FG001|Overall Study|Lost to Follow-up|0|||
130994642|NCT00779584|471607977|FG002|Overall Study|Lost to Follow-up|0|||
130994643|NCT00779584|471607978|FG003|Overall Study|Lost to Follow-up|0|||
130994644|NCT00779584|471607979|FG004|Overall Study|Lost to Follow-up|1|||
130994645|NCT00779584|471607980|FG005|Overall Study|Lost to Follow-up|0|||
130994646|NCT00779584|471607981|FG006|Overall Study|Lost to Follow-up|0|||
130994647|NCT00779584|471607982|FG007|Overall Study|Lost to Follow-up|0|||
130994648|NCT00779584|471607983|FG008|Overall Study|Lost to Follow-up|0|||
130994649|NCT00779584|471607975|FG000|Overall Study|Progression of Disease|0|||
130994650|NCT00779584|471607976|FG001|Overall Study|Progression of Disease|1|||
130994651|NCT00779584|471607977|FG002|Overall Study|Progression of Disease|2|||
130994652|NCT00779584|471607978|FG003|Overall Study|Progression of Disease|6|||
130994653|NCT00779584|471607979|FG004|Overall Study|Progression of Disease|5|||
130994654|NCT00779584|471607980|FG005|Overall Study|Progression of Disease|1|||
130994655|NCT00779584|471607981|FG006|Overall Study|Progression of Disease|4|||
130994656|NCT00779584|471607982|FG007|Overall Study|Progression of Disease|2|||
130994657|NCT00779584|471607983|FG008|Overall Study|Progression of Disease|1|||
130994658|NCT00779584|471607975|FG000|Overall Study|Adverse Event|1|||
130994659|NCT00779584|471607976|FG001|Overall Study|Adverse Event|0|||
130994660|NCT00779584|471607977|FG002|Overall Study|Adverse Event|2|||
130994661|NCT00779584|471607978|FG003|Overall Study|Adverse Event|0|||
130994662|NCT00779584|471607979|FG004|Overall Study|Adverse Event|0|||
130994663|NCT00779584|471607980|FG005|Overall Study|Adverse Event|0|||
130994664|NCT00779584|471607981|FG006|Overall Study|Adverse Event|2|||
130994665|NCT00779584|471607982|FG007|Overall Study|Adverse Event|1|||
130994666|NCT00779584|471607983|FG008|Overall Study|Adverse Event|1|||
130994667|NCT00779584|471607975|FG000|Overall Study|Symptomatic Deterioration|1|||
130994668|NCT00779584|471607976|FG001|Overall Study|Symptomatic Deterioration|1|||
130994669|NCT00779584|471607977|FG002|Overall Study|Symptomatic Deterioration|1|||
130994670|NCT00779584|471607978|FG003|Overall Study|Symptomatic Deterioration|0|||
130994671|NCT00779584|471607979|FG004|Overall Study|Symptomatic Deterioration|0|||
130994672|NCT00779584|471607980|FG005|Overall Study|Symptomatic Deterioration|1|||
130994673|NCT00779584|471607981|FG006|Overall Study|Symptomatic Deterioration|1|||
130994674|NCT00779584|471607982|FG007|Overall Study|Symptomatic Deterioration|0|||
130994675|NCT00779584|471607983|FG008|Overall Study|Symptomatic Deterioration|0|||
130994676|NCT00779584|471607975|FG000|Overall Study|Ongoing in Study|0|||
130994677|NCT00779584|471607976|FG001|Overall Study|Ongoing in Study|0|||
131221418|NCT00054275|472437937|FG000|Overall Study|Adverse Event|5|||
131221419|NCT00054275|472437937|FG000|Overall Study|Progressive disease in cycle 1|1|||
131221420|NCT00054275|472437937|FG000|Overall Study|Physician Decision|1|||
131221421|NCT02030834|472437940|FG000|Overall Study|Death|4|||
131221422|NCT02030834|472437941|FG001|Overall Study|Death|0|||
130994678|NCT00779584|471607977|FG002|Overall Study|Ongoing in Study|0|||
130994679|NCT00779584|471607978|FG003|Overall Study|Ongoing in Study|0|||
130994680|NCT00779584|471607979|FG004|Overall Study|Ongoing in Study|1|||
130994681|NCT00779584|471607980|FG005|Overall Study|Ongoing in Study|1|||
130994682|NCT00779584|471607981|FG006|Overall Study|Ongoing in Study|0|||
130994683|NCT00779584|471607982|FG007|Overall Study|Ongoing in Study|0|||
131221423|NCT02030834|472437942|FG002|Overall Study|Death|0|||
130994684|NCT00779584|471607983|FG008|Overall Study|Ongoing in Study|0|||
130994685|NCT00406419|471607986|FG000|Overall Study|Death|3|||
130994686|NCT00406419|471607987|FG001|Overall Study|Death|1|||
130994687|NCT00406419|471607988|FG002|Overall Study|Death|4|||
130994688|NCT00406419|471607986|FG000|Overall Study|Protocol Violation|6|||
130994689|NCT00406419|471607987|FG001|Overall Study|Protocol Violation|2|||
130994690|NCT00406419|471607988|FG002|Overall Study|Protocol Violation|5|||
130994691|NCT00406419|471607986|FG000|Overall Study|Study Terminated by Sponsor|260|||
130994692|NCT00406419|471607987|FG001|Overall Study|Study Terminated by Sponsor|288|||
130994693|NCT00406419|471607988|FG002|Overall Study|Study Terminated by Sponsor|282|||
130994694|NCT00406419|471607986|FG000|Overall Study|Withdrawal by Subject|17|||
130994695|NCT00406419|471607987|FG001|Overall Study|Withdrawal by Subject|24|||
130994696|NCT00406419|471607988|FG002|Overall Study|Withdrawal by Subject|26|||
130994697|NCT00406419|471607986|FG000|Overall Study|Lack of Efficacy|12|||
130994698|NCT00406419|471607987|FG001|Overall Study|Lack of Efficacy|1|||
130994699|NCT00406419|471607988|FG002|Overall Study|Lack of Efficacy|6|||
130994700|NCT00406419|471607986|FG000|Overall Study|Non-Compliance with Study Drug|5|||
130994701|NCT00406419|471607987|FG001|Overall Study|Non-Compliance with Study Drug|6|||
130994702|NCT00406419|471607988|FG002|Overall Study|Non-Compliance with Study Drug|3|||
130994703|NCT00406419|471607986|FG000|Overall Study|Adverse Event|10|||
130994704|NCT00406419|471607987|FG001|Overall Study|Adverse Event|12|||
130994705|NCT00406419|471607988|FG002|Overall Study|Adverse Event|16|||
130994706|NCT00406419|471607986|FG000|Overall Study|Lost to Follow-up|11|||
130994707|NCT00406419|471607987|FG001|Overall Study|Lost to Follow-up|10|||
130994708|NCT00406419|471607988|FG002|Overall Study|Lost to Follow-up|5|||
130994709|NCT02878213|471607989|FG000|Overall Study|Withdrawal by Subject|2|||
130994710|NCT02878213|471607989|FG000|Overall Study|Adverse Event|1|||
130994711|NCT05490329|471607992|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
130994712|NCT05490329|471607993|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
130994713|NCT05490329|471607992|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
130994714|NCT05490329|471607993|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
130994715|NCT05490329|471607992|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
130994716|NCT05490329|471607993|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
130994717|NCT02638623|471607995|FG000|Overall Study|Surgery timing|5|||
130994718|NCT02638623|471607996|FG001|Overall Study|Surgery timing|6|||
130994719|NCT02638623|471607995|FG000|Overall Study|Not given intervention|2|||
130994720|NCT02638623|471607996|FG001|Overall Study|Not given intervention|0|||
130994721|NCT04152343|471607997|FG000|Overall Study|Transplanted|5|||
130994722|NCT04152343|471607997|FG000|Overall Study|Death|20|||
130994723|NCT04152343|471607997|FG000|Overall Study|Lost to Follow-up|3|||
130994724|NCT01965938|471608002|FG000|Overall Study|Withdrawal by Subject|1|||
130994725|NCT01965938|471608003|FG001|Overall Study|Withdrawal by Subject|0|||
130994726|NCT02090634|471608004|FG000|Overall Study|Lost to Follow-up|0|||
130994727|NCT02090634|471608005|FG001|Overall Study|Lost to Follow-up|1|||
130994728|NCT02090634|471608004|FG000|Overall Study|Death|0|||
130994729|NCT02090634|471608005|FG001|Overall Study|Death|1|||
130994730|NCT02090634|471608004|FG000|Overall Study|Protocol Violation|3|||
130994731|NCT02090634|471608005|FG001|Overall Study|Protocol Violation|1|||
130994732|NCT02090634|471608004|FG000|Overall Study|Adverse Event|2|||
130994733|NCT02090634|471608005|FG001|Overall Study|Adverse Event|0|||
130994734|NCT01164228|471608006|FG000|Overall Study|Progression|24|||
130994735|NCT01164228|471608007|FG001|Overall Study|Progression|25|||
130994736|NCT01164228|471608006|FG000|Overall Study|Adverse Event|13|||
130994737|NCT01164228|471608007|FG001|Overall Study|Adverse Event|7|||
130994738|NCT01164228|471608006|FG000|Overall Study|Death|1|||
130994739|NCT01164228|471608007|FG001|Overall Study|Death|1|||
130994740|NCT01164228|471608006|FG000|Overall Study|Withdrawal by Subject|2|||
130994741|NCT01164228|471608007|FG001|Overall Study|Withdrawal by Subject|0|||
130994742|NCT01164228|471608006|FG000|Overall Study|Physician Decision|1|||
130994743|NCT01164228|471608007|FG001|Overall Study|Physician Decision|2|||
130994744|NCT01164228|471608006|FG000|Overall Study|Symptomatic deterioration|1|||
130994745|NCT01164228|471608007|FG001|Overall Study|Symptomatic deterioration|0|||
130994746|NCT01164228|471608006|FG000|Overall Study|Never started treatment|1|||
130994747|NCT01164228|471608007|FG001|Overall Study|Never started treatment|3|||
130994748|NCT01164228|471608006|FG000|Overall Study|Ineligible|1|||
130994749|NCT01164228|471608007|FG001|Overall Study|Ineligible|0|||
130994750|NCT03757234|471608008|FG000|Overall Study|Adverse Event|0|||
131221424|NCT02030834|472437940|FG000|Overall Study|Manufacturing failure|2|||
131221425|NCT02030834|472437941|FG001|Overall Study|Manufacturing failure|0|||
131221426|NCT02030834|472437942|FG002|Overall Study|Manufacturing failure|1|||
131221427|NCT02030834|472437940|FG000|Overall Study|Disease progression|2|||
131221428|NCT02030834|472437941|FG001|Overall Study|Disease progression|0|||
131221429|NCT02030834|472437942|FG002|Overall Study|Disease progression|2|||
131221430|NCT02030834|472437940|FG000|Overall Study|Lost to Follow-up|1|||
130994751|NCT03757234|471608009|FG001|Overall Study|Adverse Event|0|||
131221431|NCT02030834|472437941|FG001|Overall Study|Lost to Follow-up|0|||
130994752|NCT03757234|471608010|FG002|Overall Study|Adverse Event|0|||
130994753|NCT03757234|471608011|FG003|Overall Study|Adverse Event|0|||
130994754|NCT03757234|471608012|FG004|Overall Study|Adverse Event|1|||
131221432|NCT02030834|472437942|FG002|Overall Study|Lost to Follow-up|0|||
130994755|NCT03757234|471608008|FG000|Overall Study|Lost to Follow-up|1|||
130994756|NCT03757234|471608009|FG001|Overall Study|Lost to Follow-up|0|||
130994757|NCT03757234|471608010|FG002|Overall Study|Lost to Follow-up|0|||
130994758|NCT03757234|471608011|FG003|Overall Study|Lost to Follow-up|0|||
130994759|NCT03757234|471608012|FG004|Overall Study|Lost to Follow-up|1|||
130994760|NCT03757234|471608008|FG000|Overall Study|Withdrawal by Subject|1|||
130994761|NCT03757234|471608009|FG001|Overall Study|Withdrawal by Subject|1|||
130994762|NCT03757234|471608010|FG002|Overall Study|Withdrawal by Subject|0|||
130994763|NCT03757234|471608011|FG003|Overall Study|Withdrawal by Subject|1|||
130994764|NCT03757234|471608012|FG004|Overall Study|Withdrawal by Subject|2|||
130994765|NCT03757234|471608008|FG000|Overall Study|Other|1|||
130994766|NCT03757234|471608009|FG001|Overall Study|Other|1|||
130994767|NCT03757234|471608010|FG002|Overall Study|Other|0|||
130994768|NCT03757234|471608011|FG003|Overall Study|Other|0|||
130994769|NCT03757234|471608012|FG004|Overall Study|Other|0|||
130994770|NCT00917267|471609662|FG000|Overall Study|Adverse Event|15|||
130994771|NCT00917267|471609663|FG001|Overall Study|Adverse Event|36|||
130994772|NCT00917267|471609662|FG000|Overall Study|Physician Decision|2|||
130994773|NCT00917267|471609663|FG001|Overall Study|Physician Decision|4|||
130994774|NCT00917267|471609662|FG000|Overall Study|Protocol Violation|9|||
130994775|NCT00917267|471609663|FG001|Overall Study|Protocol Violation|18|||
131221433|NCT02030834|472437940|FG000|Overall Study|Withdrawal by Subject|1|||
131221434|NCT02030834|472437941|FG001|Overall Study|Withdrawal by Subject|0|||
131221435|NCT02030834|472437942|FG002|Overall Study|Withdrawal by Subject|0|||
131221436|NCT02030834|472437940|FG000|Overall Study|Lack of funding|1|||
131221437|NCT02030834|472437941|FG001|Overall Study|Lack of funding|0|||
131221438|NCT02030834|472437942|FG002|Overall Study|Lack of funding|0|||
131221439|NCT01440595|472437943|FG000|Overall Study|Lost to Follow-up|0|||
131221440|NCT01440595|472437944|FG001|Overall Study|Lost to Follow-up|1|||
131221441|NCT01440595|472437945|FG002|Overall Study|Lost to Follow-up|0|||
131221442|NCT01440595|472437943|FG000|Overall Study|Study terminated by sponsor.|1|||
131221443|NCT01440595|472437944|FG001|Overall Study|Study terminated by sponsor.|2|||
131221444|NCT01440595|472437945|FG002|Overall Study|Study terminated by sponsor.|1|||
131221445|NCT01347879|472437946|FG000|Overall Study|Adverse Event|0|||
131221446|NCT01347879|472437947|FG001|Overall Study|Adverse Event|12|||
131221447|NCT01347879|472437946|FG000|Overall Study|Lost to Follow-up|2|||
131221448|NCT01347879|472437947|FG001|Overall Study|Lost to Follow-up|0|||
131221449|NCT01347879|472437946|FG000|Overall Study|Withdrawal by Subject|3|||
131221450|NCT01347879|472437947|FG001|Overall Study|Withdrawal by Subject|2|||
131221451|NCT01347879|472437946|FG000|Overall Study|Other|2|||
131221452|NCT01347879|472437947|FG001|Overall Study|Other|3|||
131221453|NCT01238822|472437948|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
131221454|NCT04736576|472437949|FG000|Overall Study|Progressive disease|3|||
131221455|NCT04736576|472437950|FG001|Overall Study|Progressive disease|1|||
131221456|NCT04736576|472437949|FG000|Overall Study|Death|1|||
131221457|NCT04736576|472437950|FG001|Overall Study|Death|0|||
131221458|NCT00965263|472437965|FG000|Overall Study|Physician Decision|2|||
131221459|NCT00965263|472437966|FG001|Overall Study|Physician Decision|0|||
131221460|NCT00965263|472437965|FG000|Overall Study|Family emergency|0|||
131221461|NCT00965263|472437966|FG001|Overall Study|Family emergency|1|||
131221462|NCT00965263|472437965|FG000|Overall Study|Protocol Violation|0|||
131221463|NCT00965263|472437966|FG001|Overall Study|Protocol Violation|2|||
131221464|NCT00829439|472437967|FG000|Overall Study|Adverse Event|0|||
131221465|NCT00829439|472437968|FG001|Overall Study|Adverse Event|0|||
131221466|NCT00829439|472437969|FG002|Overall Study|Adverse Event|1|||
131221467|NCT00829439|472437970|FG003|Overall Study|Adverse Event|0|||
131221468|NCT00123487|472437971|FG000|Randomized|Death prior to starting treatment|0|||
131221469|NCT00123487|472437972|FG001|Randomized|Death prior to starting treatment|1|||
131221470|NCT00123487|472437971|FG000|Randomized|SAE prior to starting treatment|1|||
131221471|NCT00123487|472437972|FG001|Randomized|SAE prior to starting treatment|0|||
131221472|NCT00123487|472437971|FG000|Treated With Study Drug|Adverse Event|23|||
131221473|NCT00123487|472437972|FG001|Treated With Study Drug|Adverse Event|22|||
131221474|NCT00123487|472437971|FG000|Treated With Study Drug|Disease Progression|141|||
131221475|NCT00123487|472437972|FG001|Treated With Study Drug|Disease Progression|122|||
131221476|NCT00123487|472437971|FG000|Treated With Study Drug|Physician Decision|8|||
131221477|NCT00123487|472437972|FG001|Treated With Study Drug|Physician Decision|9|||
131221478|NCT00123487|472437971|FG000|Treated With Study Drug|Other|59|||
131221479|NCT00123487|472437972|FG001|Treated With Study Drug|Other|58|||
130994776|NCT00917267|471609662|FG000|Overall Study|Withdrawal by Subject|5|||
131221480|NCT00123487|472437971|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
131221481|NCT00123487|472437972|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
130994777|NCT00917267|471609663|FG001|Overall Study|Withdrawal by Subject|12|||
131221482|NCT00123487|472437971|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
131221483|NCT00123487|472437972|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
131221484|NCT00123487|472437971|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
131221485|NCT00123487|472437972|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
130994778|NCT00917267|471609662|FG000|Overall Study|Lost to follow up|0|||
130994779|NCT00917267|471609663|FG001|Overall Study|Lost to follow up|2|||
131221486|NCT03835975|472437973|FG000|Overall Study|Lost to Follow-up|1|||
131221487|NCT03835975|472437974|FG001|Overall Study|Lost to Follow-up|1|||
130994780|NCT00917267|471609662|FG000|Overall Study|Entry Criteria Not Met|1|||
130994781|NCT00917267|471609663|FG001|Overall Study|Entry Criteria Not Met|0|||
130994782|NCT00917267|471609662|FG000|Overall Study|Sponsor Decision|5|||
130994783|NCT00917267|471609663|FG001|Overall Study|Sponsor Decision|5|||
130994784|NCT00917267|471609662|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
130994785|NCT00917267|471609663|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
130994786|NCT02960763|471609665|FG000|Step 1|Withdrawal by Subject|10|||
130994787|NCT02960763|471609666|FG001|Step 1|Withdrawal by Subject|8|||
130994788|NCT02960763|471609667|FG002|Step 1|Withdrawal by Subject|13|||
130994789|NCT02960763|471609668|FG003|Step 1|Withdrawal by Subject|0|||
130994790|NCT02960763|471609669|FG004|Step 1|Withdrawal by Subject|0|||
130994791|NCT02960763|471609665|FG000|Step 1|Lost to Follow-up|7|||
130994792|NCT02960763|471609666|FG001|Step 1|Lost to Follow-up|9|||
130994793|NCT02960763|471609667|FG002|Step 1|Lost to Follow-up|12|||
130994794|NCT02960763|471609668|FG003|Step 1|Lost to Follow-up|0|||
130994795|NCT02960763|471609669|FG004|Step 1|Lost to Follow-up|0|||
130994796|NCT02960763|471609665|FG000|Step 1|Death|1|||
130994797|NCT02960763|471609666|FG001|Step 1|Death|1|||
130994798|NCT02960763|471609667|FG002|Step 1|Death|1|||
130994799|NCT02960763|471609668|FG003|Step 1|Death|0|||
130994800|NCT02960763|471609669|FG004|Step 1|Death|0|||
130994801|NCT02960763|471609665|FG000|Step 1|Investigator discretion|1|||
130994802|NCT02960763|471609666|FG001|Step 1|Investigator discretion|0|||
130994803|NCT02960763|471609667|FG002|Step 1|Investigator discretion|1|||
130994804|NCT02960763|471609668|FG003|Step 1|Investigator discretion|0|||
130994805|NCT02960763|471609669|FG004|Step 1|Investigator discretion|0|||
130994806|NCT02960763|471609665|FG000|Step 1|Other|0|||
130994807|NCT02960763|471609666|FG001|Step 1|Other|0|||
130994808|NCT02960763|471609667|FG002|Step 1|Other|1|||
130994809|NCT02960763|471609668|FG003|Step 1|Other|0|||
130994810|NCT02960763|471609669|FG004|Step 1|Other|0|||
130994811|NCT02960763|471609665|FG000|Step 2|Withdrawal by Subject|0|||
130994812|NCT02960763|471609666|FG001|Step 2|Withdrawal by Subject|0|||
130994813|NCT02960763|471609667|FG002|Step 2|Withdrawal by Subject|0|||
130994814|NCT02960763|471609668|FG003|Step 2|Withdrawal by Subject|7|||
130994815|NCT02960763|471609669|FG004|Step 2|Withdrawal by Subject|3|||
130994816|NCT02960763|471609665|FG000|Step 2|Lost to Follow-up|0|||
130994817|NCT02960763|471609666|FG001|Step 2|Lost to Follow-up|0|||
130994818|NCT02960763|471609667|FG002|Step 2|Lost to Follow-up|0|||
130994819|NCT02960763|471609668|FG003|Step 2|Lost to Follow-up|4|||
130994820|NCT02960763|471609669|FG004|Step 2|Lost to Follow-up|1|||
130994821|NCT02960763|471609665|FG000|Step 2|Investigator discretion|0|||
130994822|NCT02960763|471609666|FG001|Step 2|Investigator discretion|0|||
130994823|NCT02960763|471609667|FG002|Step 2|Investigator discretion|0|||
130994824|NCT02960763|471609668|FG003|Step 2|Investigator discretion|0|||
130994825|NCT02960763|471609669|FG004|Step 2|Investigator discretion|1|||
130994826|NCT00312858|471609672|FG000|Overall Study|Adverse Event|0|||
130994827|NCT00312858|471609673|FG001|Overall Study|Adverse Event|1|||
130994828|NCT00312858|471609672|FG000|Overall Study|Lost to Follow-up|25|||
130994829|NCT00312858|471609673|FG001|Overall Study|Lost to Follow-up|42|||
130994830|NCT00312858|471609672|FG000|Overall Study|Protocol Violation|3|||
130994831|NCT00312858|471609673|FG001|Overall Study|Protocol Violation|8|||
130994832|NCT00312858|471609672|FG000|Overall Study|Withdraw by Participant|20|||
130994833|NCT00312858|471609673|FG001|Overall Study|Withdraw by Participant|20|||
130994834|NCT00312858|471609672|FG000|Overall Study|Participant Moved|11|||
130994835|NCT00312858|471609673|FG001|Overall Study|Participant Moved|10|||
130994836|NCT00312858|471609672|FG000|Overall Study|Other|9|||
130994837|NCT00312858|471609673|FG001|Overall Study|Other|12|||
130994838|NCT03638635|471609675|FG000|Initial Hospitalization|Study terminated prematurely|0|||
130994839|NCT03638635|471609676|FG001|Initial Hospitalization|Study terminated prematurely|1|||
130994840|NCT03638635|471609675|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
130994841|NCT03638635|471609676|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
130994842|NCT03638635|471609675|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
130994843|NCT03638635|471609676|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
130994844|NCT00802659|471609682|FG000|Overall Study|Physician Decision|0|||
130994845|NCT00802659|471609683|FG001|Overall Study|Physician Decision|1|||
130994846|NCT00802659|471609684|FG002|Overall Study|Physician Decision|0|||
130994847|NCT00802659|471609685|FG003|Overall Study|Physician Decision|0|||
130994848|NCT00289770|471609686|FG000|Year 15|Withdrawal by Subject|1|||
130994849|NCT05340751|471609692|FG000|Overall Study|Physician Decision|3|||
130994850|NCT04399551|471609693|FG000|Overall Study|Adverse Event|15|||
130994851|NCT04399551|471609693|FG000|Overall Study|Withdrawal by Subject|6|||
130994852|NCT04399551|471609693|FG000|Overall Study|Physician Decision|3|||
130994853|NCT04399551|471609693|FG000|Overall Study|Lost to Follow-up|2|||
130994854|NCT04399551|471609693|FG000|Overall Study|Protocol Deviation|2|||
130994855|NCT01014975|471609694|FG000|Overall Study|Withdrawal by Subject|1|||
130994856|NCT01014975|471609695|FG001|Overall Study|Withdrawal by Subject|0|||
130994857|NCT01014975|471609696|FG002|Overall Study|Withdrawal by Subject|1|||
130994858|NCT01014975|471609694|FG000|Overall Study|Death|3|||
130994859|NCT01014975|471609695|FG001|Overall Study|Death|3|||
130994860|NCT01014975|471609696|FG002|Overall Study|Death|4|||
131221488|NCT03835975|472437975|FG002|Overall Study|Lost to Follow-up|0|||
130883406|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
130883407|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
130883408|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
130883409|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
130883410|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
130883411|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
130883412|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
130883413|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
130883414|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
130883415|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
130883416|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
130883417|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
130883418|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
130883419|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
130883420|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
130883421|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
130883422|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
130883423|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
130883424|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
130883425|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
130883426|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
130883427|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
130883428|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
130883429|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
130883430|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
130883431|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
130883432|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
130883433|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
130883434|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
130883435|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
130883436|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
130883437|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
130883438|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
130883439|NCT03955146|471207951|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
130883440|NCT03955146|471207952|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
130883441|NCT03955146|471207953|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
130883442|NCT03955146|471207954|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
130883443|NCT02002598|471207957|FG000|Dose Level 1|Withdrawal by Subject|1|||
130883444|NCT02002598|471207958|FG001|Dose Level 1|Withdrawal by Subject|0|||
130883445|NCT02002598|471207959|FG002|Dose Level 1|Withdrawal by Subject|0|||
130883446|NCT02002598|471207960|FG003|Dose Level 1|Withdrawal by Subject|0|||
130883447|NCT02002598|471207961|FG004|Dose Level 1|Withdrawal by Subject|0|||
130883448|NCT02628873|471207962|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
130883449|NCT02628873|471207963|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
130883450|NCT02628873|471207962|FG000|Second Test (1 Hour)|Physician Decision|1|||
130883451|NCT02628873|471207963|FG001|Second Test (1 Hour)|Physician Decision|0|||
130883452|NCT02594124|471207965|FG000|Overall Study|Adverse Event|0|||
130883453|NCT02594124|471207966|FG001|Overall Study|Adverse Event|5|||
130883454|NCT02594124|471207967|FG002|Overall Study|Adverse Event|8|||
130883455|NCT02594124|471207968|FG003|Overall Study|Adverse Event|1|||
130883456|NCT02594124|471207969|FG004|Overall Study|Adverse Event|0|||
130883457|NCT02594124|471207970|FG005|Overall Study|Adverse Event|0|||
130883458|NCT02594124|471207971|FG006|Overall Study|Adverse Event|2|||
130883459|NCT02594124|471207972|FG007|Overall Study|Adverse Event|2|||
130883460|NCT02594124|471207973|FG008|Overall Study|Adverse Event|0|||
130883461|NCT02594124|471207965|FG000|Overall Study|Withdrawal by Subject|2|||
130883462|NCT02594124|471207966|FG001|Overall Study|Withdrawal by Subject|3|||
130883463|NCT02594124|471207967|FG002|Overall Study|Withdrawal by Subject|5|||
130883464|NCT02594124|471207968|FG003|Overall Study|Withdrawal by Subject|1|||
130883465|NCT02594124|471207969|FG004|Overall Study|Withdrawal by Subject|8|||
131221489|NCT03835975|472437976|FG003|Overall Study|Lost to Follow-up|0|||
130883466|NCT02594124|471207970|FG005|Overall Study|Withdrawal by Subject|4|||
130883467|NCT02594124|471207971|FG006|Overall Study|Withdrawal by Subject|13|||
130883468|NCT02594124|471207972|FG007|Overall Study|Withdrawal by Subject|19|||
130883469|NCT02594124|471207973|FG008|Overall Study|Withdrawal by Subject|0|||
130883470|NCT02594124|471207965|FG000|Overall Study|Physician Decision|0|||
130883471|NCT02594124|471207966|FG001|Overall Study|Physician Decision|2|||
130883472|NCT02594124|471207967|FG002|Overall Study|Physician Decision|0|||
130883473|NCT02594124|471207968|FG003|Overall Study|Physician Decision|0|||
131221490|NCT03835975|472437977|FG004|Overall Study|Lost to Follow-up|0|||
130994861|NCT01014975|471609694|FG000|Overall Study|Lost to Follow-up|0|||
130994862|NCT01014975|471609695|FG001|Overall Study|Lost to Follow-up|0|||
130994863|NCT01014975|471609696|FG002|Overall Study|Lost to Follow-up|1|||
130994864|NCT01336634|471609699|FG000|Overall Study|Study closed/terminated|5|||
130994865|NCT01336634|471609700|FG001|Overall Study|Study closed/terminated|6|||
130994866|NCT01336634|471609701|FG002|Overall Study|Study closed/terminated|6|||
130994867|NCT01336634|471609699|FG000|Overall Study|Lost to Follow-up|2|||
130994868|NCT01336634|471609700|FG001|Overall Study|Lost to Follow-up|1|||
130994869|NCT01336634|471609701|FG002|Overall Study|Lost to Follow-up|1|||
131221491|NCT03835975|472437973|FG000|Overall Study|No longer met eligibility criteria|0|||
131221492|NCT03835975|472437974|FG001|Overall Study|No longer met eligibility criteria|1|||
131221493|NCT03835975|472437975|FG002|Overall Study|No longer met eligibility criteria|0|||
131221494|NCT03835975|472437976|FG003|Overall Study|No longer met eligibility criteria|0|||
131221495|NCT03835975|472437977|FG004|Overall Study|No longer met eligibility criteria|0|||
131221496|NCT03835975|472437973|FG000|Overall Study|Protocol Violation|1|||
131221497|NCT03835975|472437974|FG001|Overall Study|Protocol Violation|1|||
131221498|NCT03835975|472437975|FG002|Overall Study|Protocol Violation|2|||
131221499|NCT03835975|472437976|FG003|Overall Study|Protocol Violation|0|||
130883474|NCT02594124|471207969|FG004|Overall Study|Physician Decision|0|||
130883475|NCT02594124|471207970|FG005|Overall Study|Physician Decision|0|||
130883476|NCT02594124|471207971|FG006|Overall Study|Physician Decision|0|||
130883477|NCT02594124|471207972|FG007|Overall Study|Physician Decision|1|||
130883478|NCT02594124|471207973|FG008|Overall Study|Physician Decision|0|||
130883479|NCT02594124|471207965|FG000|Overall Study|Commercial drug|0|||
130883480|NCT02594124|471207966|FG001|Overall Study|Commercial drug|1|||
130883481|NCT02594124|471207967|FG002|Overall Study|Commercial drug|6|||
130883482|NCT02594124|471207968|FG003|Overall Study|Commercial drug|3|||
130883483|NCT02594124|471207969|FG004|Overall Study|Commercial drug|0|||
130883484|NCT02594124|471207970|FG005|Overall Study|Commercial drug|0|||
130883485|NCT02594124|471207971|FG006|Overall Study|Commercial drug|7|||
130883486|NCT02594124|471207972|FG007|Overall Study|Commercial drug|11|||
130883487|NCT02594124|471207973|FG008|Overall Study|Commercial drug|2|||
130883488|NCT02594124|471207965|FG000|Overall Study|Reason Not Specified|1|||
130883489|NCT02594124|471207966|FG001|Overall Study|Reason Not Specified|3|||
130883490|NCT02594124|471207967|FG002|Overall Study|Reason Not Specified|4|||
130883491|NCT02594124|471207968|FG003|Overall Study|Reason Not Specified|0|||
130883492|NCT02594124|471207969|FG004|Overall Study|Reason Not Specified|0|||
130883493|NCT02594124|471207970|FG005|Overall Study|Reason Not Specified|1|||
130883494|NCT02594124|471207971|FG006|Overall Study|Reason Not Specified|1|||
130883495|NCT02594124|471207972|FG007|Overall Study|Reason Not Specified|6|||
130883496|NCT02594124|471207973|FG008|Overall Study|Reason Not Specified|1|||
130883497|NCT03312634|471209373|FG000|Overall Study|Adverse Event|11|||
130883498|NCT03312634|471209374|FG001|Overall Study|Adverse Event|0|||
130883499|NCT03312634|471209373|FG000|Overall Study|Sponsor request|2|||
130883500|NCT03312634|471209374|FG001|Overall Study|Sponsor request|0|||
130883501|NCT03312634|471209373|FG000|Overall Study|Withdrawal by Subject|31|||
130883502|NCT03312634|471209374|FG001|Overall Study|Withdrawal by Subject|9|||
130883503|NCT03312634|471209373|FG000|Overall Study|Enrolled in an interventional study|0|||
130883504|NCT03312634|471209374|FG001|Overall Study|Enrolled in an interventional study|52|||
130883505|NCT03312634|471209373|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
130883506|NCT03312634|471209374|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
130883507|NCT03312634|471209373|FG000|Overall Study|Death|0|||
130883508|NCT03312634|471209374|FG001|Overall Study|Death|1|||
130883509|NCT03312634|471209373|FG000|Overall Study|Non-compliance|0|||
130883510|NCT03312634|471209374|FG001|Overall Study|Non-compliance|2|||
130883511|NCT03312634|471209373|FG000|Overall Study|Lost to Follow-up|0|||
130883512|NCT03312634|471209374|FG001|Overall Study|Lost to Follow-up|1|||
130883513|NCT03312634|471209373|FG000|Overall Study|Enrolled into non-interventional study|0|||
130883514|NCT03312634|471209374|FG001|Overall Study|Enrolled into non-interventional study|5|||
130883515|NCT03312634|471209373|FG000|Overall Study|Worsening clinical condition|0|||
130994870|NCT01336634|471609699|FG000|Overall Study|Physician Decision|1|||
130994871|NCT01336634|471609700|FG001|Overall Study|Physician Decision|1|||
130883516|NCT03312634|471209374|FG001|Overall Study|Worsening clinical condition|1|||
130883517|NCT03312634|471209373|FG000|Overall Study|Participant did not want to travel|0|||
130883518|NCT03312634|471209374|FG001|Overall Study|Participant did not want to travel|1|||
130883519|NCT03312634|471209373|FG000|Overall Study|Physician Decision|1|||
130883520|NCT03312634|471209374|FG001|Overall Study|Physician Decision|0|||
130883521|NCT03312634|471209373|FG000|Overall Study|Other|13|||
130883522|NCT03312634|471209374|FG001|Overall Study|Other|0|||
130994872|NCT01336634|471609701|FG002|Overall Study|Physician Decision|0|||
130994873|NCT01336634|471609699|FG000|Overall Study|Withdrawal by Subject|6|||
130994874|NCT01336634|471609700|FG001|Overall Study|Withdrawal by Subject|0|||
130994875|NCT01336634|471609701|FG002|Overall Study|Withdrawal by Subject|2|||
130994876|NCT02961881|471609702|FG000|Overall Study|Adverse Event|1|||
130994877|NCT02961881|471609703|FG001|Overall Study|Adverse Event|2|||
130994878|NCT02961881|471609704|FG002|Overall Study|Adverse Event|2|||
130994879|NCT02961881|471609705|FG003|Overall Study|Adverse Event|0|||
130994880|NCT02961881|471609706|FG004|Overall Study|Adverse Event|1|||
130994881|NCT02961881|471609702|FG000|Overall Study|Participant request|0|||
130994882|NCT02961881|471609703|FG001|Overall Study|Participant request|2|||
130994883|NCT02961881|471609704|FG002|Overall Study|Participant request|0|||
130994884|NCT02961881|471609705|FG003|Overall Study|Participant request|0|||
130994885|NCT02961881|471609706|FG004|Overall Study|Participant request|0|||
130994886|NCT02961881|471609702|FG000|Overall Study|Disease progression|1|||
130994887|NCT02961881|471609703|FG001|Overall Study|Disease progression|0|||
130994888|NCT02961881|471609704|FG002|Overall Study|Disease progression|1|||
130994889|NCT02961881|471609705|FG003|Overall Study|Disease progression|0|||
130994890|NCT02961881|471609706|FG004|Overall Study|Disease progression|0|||
130994891|NCT01863043|471609708|FG000|Overall Study|Death|6|||
130994892|NCT01863043|471609709|FG001|Overall Study|Death|1|||
130994893|NCT01863043|471609708|FG000|Overall Study|Withdrawal by Subject|0|||
130994894|NCT01863043|471609709|FG001|Overall Study|Withdrawal by Subject|2|||
130994895|NCT01863043|471609708|FG000|Overall Study|Adverse Event|7|||
130994896|NCT01863043|471609709|FG001|Overall Study|Adverse Event|8|||
130994897|NCT01863043|471609708|FG000|Overall Study|exclusion criteria found after enrollment|0|||
130994898|NCT01863043|471609709|FG001|Overall Study|exclusion criteria found after enrollment|1|||
130994899|NCT00313911|471609710|FG000|Overall Study|Serious adverse event|6|||
130994900|NCT00313911|471609711|FG001|Overall Study|Serious adverse event|1|||
130994901|NCT00313911|471609710|FG000|Overall Study|Adverse Event|2|||
130994902|NCT00313911|471609711|FG001|Overall Study|Adverse Event|3|||
130994903|NCT00313911|471609710|FG000|Overall Study|Protocol Violation|19|||
130994904|NCT00313911|471609711|FG001|Overall Study|Protocol Violation|10|||
130994905|NCT00313911|471609710|FG000|Overall Study|Lost to Follow-up|27|||
130994906|NCT00313911|471609711|FG001|Overall Study|Lost to Follow-up|14|||
130994907|NCT00313911|471609710|FG000|Overall Study|Withdrawal by Subject|39|||
130994908|NCT00313911|471609711|FG001|Overall Study|Withdrawal by Subject|12|||
130994909|NCT00313911|471609710|FG000|Overall Study|Did not meet age criteria|1|||
130994910|NCT00313911|471609711|FG001|Overall Study|Did not meet age criteria|1|||
131100672|NCT01157676|471998067|FG000|Surgery|converted to open procedure|0|||
131100673|NCT01157676|471998068|FG001|Surgery|converted to open procedure|5|||
131100674|NCT01157676|471998067|FG000|Surgery|underwent robotic cystectomy|1|||
131100675|NCT01157676|471998068|FG001|Surgery|underwent robotic cystectomy|0|||
131100676|NCT00468104|471998069|FG000|First Intervention|Protocol Violation|2|||
131100677|NCT00468104|471998070|FG001|First Intervention|Protocol Violation|1|||
131100678|NCT00468104|471998069|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
131100679|NCT00468104|471998070|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
131100680|NCT00468104|471998069|FG000|First Intervention|died within 3 weeks|1|||
131100681|NCT00468104|471998070|FG001|First Intervention|died within 3 weeks|0|||
131100682|NCT00468104|471998069|FG000|First Intervention|malposition/blocked chest tube tube|2|||
131100683|NCT00468104|471998070|FG001|First Intervention|malposition/blocked chest tube tube|0|||
131100684|NCT00468104|471998069|FG000|First Intervention|large lung mass with minimal effusion|1|||
131100685|NCT00468104|471998070|FG001|First Intervention|large lung mass with minimal effusion|0|||
131100686|NCT00468104|471998069|FG000|First Intervention|associated prolonged pneumothorax|1|||
131221500|NCT03835975|472437977|FG004|Overall Study|Protocol Violation|0|||
131221501|NCT03835975|472437973|FG000|Overall Study|Withdrawal by Subject|1|||
131221502|NCT03835975|472437974|FG001|Overall Study|Withdrawal by Subject|0|||
131221503|NCT03835975|472437975|FG002|Overall Study|Withdrawal by Subject|1|||
131100687|NCT00468104|471998070|FG001|First Intervention|associated prolonged pneumothorax|0|||
131221504|NCT03835975|472437976|FG003|Overall Study|Withdrawal by Subject|1|||
131221505|NCT03835975|472437977|FG004|Overall Study|Withdrawal by Subject|0|||
131221506|NCT00975884|472437978|FG000|Overall Study|Adverse Event|1|||
130994911|NCT01912781|471609714|FG000|Overall Study|Withdrawal by Subject|2|||
131221507|NCT00975884|472437979|FG001|Overall Study|Adverse Event|0|||
131221508|NCT00975884|472437978|FG000|Overall Study|Lost to Follow-up|5|||
130883523|NCT05291520|471209377|FG000|Overall Study|Lost to Follow-up|0|||
130883524|NCT05291520|471209378|FG001|Overall Study|Lost to Follow-up|0|||
130883525|NCT05291520|471209379|FG002|Overall Study|Lost to Follow-up|1|||
130883526|NCT01347112|471209380|FG000|Overall Study|Withdrawal by Subject|1|||
130883527|NCT01347112|471209381|FG001|Overall Study|Withdrawal by Subject|7|||
130883528|NCT01347112|471209380|FG000|Overall Study|Lost to Follow-up|3|||
130883529|NCT01347112|471209381|FG001|Overall Study|Lost to Follow-up|5|||
130883530|NCT01399372|471209384|FG000|Overall Study|Protocol Violation|3|||
130883531|NCT01399372|471209385|FG001|Overall Study|Protocol Violation|1|||
130883532|NCT01432730|471209386|FG000|Period 1|Adverse Event|2|||
130883533|NCT01432730|471209387|FG001|Period 1|Adverse Event|0|||
130883534|NCT01432730|471209386|FG000|Period 2|Adverse Event|0|||
130883535|NCT01432730|471209387|FG001|Period 2|Adverse Event|4|||
130883536|NCT01421719|471209392|FG000|Overall Study|Withdrawal by Subject|4|||
130883537|NCT01124006|471209393|FG000|Overall Study|Withdrawal by Subject|2|||
130883538|NCT01124006|471209394|FG001|Overall Study|Withdrawal by Subject|2|||
130883539|NCT01124006|471209395|FG002|Overall Study|Withdrawal by Subject|0|||
130883540|NCT01124006|471209393|FG000|Overall Study|Lost to Follow-up|1|||
130883541|NCT01124006|471209394|FG001|Overall Study|Lost to Follow-up|0|||
130883542|NCT01124006|471209395|FG002|Overall Study|Lost to Follow-up|1|||
130883543|NCT01124006|471209393|FG000|Overall Study|Other|0|||
130883544|NCT01124006|471209394|FG001|Overall Study|Other|0|||
130883545|NCT01124006|471209395|FG002|Overall Study|Other|1|||
130883546|NCT01712399|471209401|FG000|Overall Study|Lost to Follow-up|1|||
130883547|NCT01712399|471209401|FG000|Overall Study|Withdrawal by Subject|39|||
130883548|NCT01712399|471209401|FG000|Overall Study|Death|1|||
130883549|NCT01712399|471209401|FG000|Overall Study|Adverse Event|11|||
130883550|NCT01712399|471209401|FG000|Overall Study|Study closure|345|||
130883551|NCT01942837|471209402|FG000|Overall Study|Death|1|||
130883552|NCT01942837|471209402|FG000|Overall Study|Symptomatic or radiographic progression|49|||
130883553|NCT01942837|471209402|FG000|Overall Study|Adverse Event|6|||
130883554|NCT01942837|471209402|FG000|Overall Study|Physician Decision|3|||
130883555|NCT01942837|471209402|FG000|Overall Study|Withdrawal by Subject|2|||
130883556|NCT01942837|471209402|FG000|Overall Study|Intercurrent Illness|1|||
130883557|NCT01942837|471209402|FG000|Overall Study|On treatment|3|||
130883558|NCT01942837|471209402|FG000|Overall Study|Never initiate the treatment|2|||
130883559|NCT01298648|471209403|FG000|Overall Study|Withdrawal by Subject|2|||
130883560|NCT01298648|471209403|FG000|Overall Study|Lost to Follow-up|21|||
130883561|NCT01803607|471209406|FG000|Overall Study|Adverse Event|5|||
130883562|NCT01803607|471209407|FG001|Overall Study|Adverse Event|3|||
130883563|NCT01803607|471209406|FG000|Overall Study|Lack of Efficacy|0|||
130883564|NCT01803607|471209407|FG001|Overall Study|Lack of Efficacy|1|||
130883565|NCT01803607|471209406|FG000|Overall Study|Protocol Violation|3|||
130883566|NCT01803607|471209407|FG001|Overall Study|Protocol Violation|2|||
130883567|NCT01803607|471209406|FG000|Overall Study|Study terminated by sponsor|54|||
130883568|NCT01803607|471209407|FG001|Overall Study|Study terminated by sponsor|56|||
130883569|NCT01803607|471209406|FG000|Overall Study|Withdrawal by Subject|6|||
130883570|NCT01803607|471209407|FG001|Overall Study|Withdrawal by Subject|5|||
130883571|NCT01281124|471209426|FG000|Overall Study|Death|1|||
130883572|NCT03038100|471209427|FG000|Overall Study|Death|289|||
130883573|NCT03038100|471209428|FG001|Overall Study|Death|272|||
130883574|NCT03038100|471209427|FG000|Overall Study|Lost to Follow-up|9|||
130883575|NCT03038100|471209428|FG001|Overall Study|Lost to Follow-up|10|||
130883576|NCT03038100|471209427|FG000|Overall Study|Protocol Deviation|1|||
130883577|NCT03038100|471209428|FG001|Overall Study|Protocol Deviation|4|||
130883578|NCT03038100|471209427|FG000|Overall Study|Withdrawal by Subject|45|||
130883579|NCT03038100|471209428|FG001|Overall Study|Withdrawal by Subject|51|||
130883580|NCT03038100|471209427|FG000|Overall Study|Study Terminated By Sponsor|305|||
130883581|NCT03038100|471209428|FG001|Overall Study|Study Terminated By Sponsor|311|||
130883582|NCT03038100|471209427|FG000|Overall Study|Physician Decision|1|||
130883583|NCT03038100|471209428|FG001|Overall Study|Physician Decision|3|||
130883584|NCT02038933|471209429|FG000|Overall Study|Disease progression|104|||
130883585|NCT02038933|471209429|FG000|Overall Study|Study drug toxicity|6|||
130883586|NCT02038933|471209429|FG000|Overall Study|Adverse event unrelated to study drug|6|||
130883587|NCT02038933|471209429|FG000|Overall Study|Participant request to discontinue treatment|2|||
130883588|NCT02038933|471209429|FG000|Overall Study|Lost to Follow-up|1|||
130883589|NCT02038933|471209429|FG000|Overall Study|Other reasons|2|||
130883590|NCT03250273|471209430|FG000|Overall Study|Disease Progression|2|||
130883591|NCT03250273|471209431|FG001|Overall Study|Disease Progression|11|||
130883592|NCT03250273|471209430|FG000|Overall Study|Death|0|||
130883593|NCT03250273|471209431|FG001|Overall Study|Death|1|||
130883594|NCT02392624|471209432|FG000|Overall Study|Withdrawal by Subject|15|||
130883595|NCT02392624|471209433|FG001|Overall Study|Withdrawal by Subject|12|||
130883596|NCT02392624|471209434|FG002|Overall Study|Withdrawal by Subject|9|||
130883597|NCT02392624|471209432|FG000|Overall Study|Adverse Event|4|||
130883598|NCT02392624|471209433|FG001|Overall Study|Adverse Event|1|||
130883599|NCT02392624|471209434|FG002|Overall Study|Adverse Event|2|||
130883600|NCT02392624|471209432|FG000|Overall Study|Pregnancy|1|||
130883601|NCT02392624|471209433|FG001|Overall Study|Pregnancy|0|||
130883602|NCT02392624|471209434|FG002|Overall Study|Pregnancy|0|||
130883603|NCT02392624|471209432|FG000|Overall Study|Protocol Violation|0|||
130883604|NCT02392624|471209433|FG001|Overall Study|Protocol Violation|0|||
130883605|NCT02392624|471209434|FG002|Overall Study|Protocol Violation|1|||
130883606|NCT02392624|471209432|FG000|Overall Study|Sponsor/Investigator Decision|2|||
130883607|NCT02392624|471209433|FG001|Overall Study|Sponsor/Investigator Decision|1|||
130883608|NCT02392624|471209434|FG002|Overall Study|Sponsor/Investigator Decision|0|||
130883609|NCT02392624|471209432|FG000|Overall Study|Other|49|||
130883610|NCT02392624|471209433|FG001|Overall Study|Other|1|||
130883611|NCT02392624|471209434|FG002|Overall Study|Other|1|||
130883612|NCT00706238|471209435|FG000|Overall Study|Disease progression|4|||
130883613|NCT00706238|471209435|FG000|Overall Study|Other|1|||
130883614|NCT03841604|471209440|FG000|Overall Study|Withdrawal by Subject|3|||
130994912|NCT01912781|471609715|FG001|Overall Study|Withdrawal by Subject|0|||
130994913|NCT00854295|471609718|FG000|Overall Study|Death|7|||
130994914|NCT00854295|471609719|FG001|Overall Study|Death|0|||
130994915|NCT00854295|471609720|FG002|Overall Study|Death|1|||
130994916|NCT00854295|471609721|FG003|Overall Study|Death|1|||
130994917|NCT00854295|471609718|FG000|Overall Study|Adverse Event|6|||
130994918|NCT00854295|471609719|FG001|Overall Study|Adverse Event|1|||
130994919|NCT00854295|471609720|FG002|Overall Study|Adverse Event|1|||
130994920|NCT00854295|471609721|FG003|Overall Study|Adverse Event|3|||
130994921|NCT00854295|471609718|FG000|Overall Study|Lost to Follow-up|18|||
130994922|NCT00854295|471609719|FG001|Overall Study|Lost to Follow-up|5|||
130994923|NCT00854295|471609720|FG002|Overall Study|Lost to Follow-up|21|||
130994924|NCT00854295|471609721|FG003|Overall Study|Lost to Follow-up|21|||
130994925|NCT00854295|471609718|FG000|Overall Study|Physician Decision|10|||
130994926|NCT00854295|471609719|FG001|Overall Study|Physician Decision|0|||
130994927|NCT00854295|471609720|FG002|Overall Study|Physician Decision|0|||
130994928|NCT00854295|471609721|FG003|Overall Study|Physician Decision|0|||
130994929|NCT04250337|471609722|FG000|Overall Study|Adverse Event|0|||
130994930|NCT04250337|471609723|FG001|Overall Study|Adverse Event|3|||
130994931|NCT04250337|471609722|FG000|Overall Study|Lack of Efficacy|1|||
130994932|NCT04250337|471609723|FG001|Overall Study|Lack of Efficacy|3|||
130994933|NCT04250337|471609722|FG000|Overall Study|Physician Decision|1|||
130994934|NCT04250337|471609723|FG001|Overall Study|Physician Decision|0|||
130994935|NCT04250337|471609722|FG000|Overall Study|Protocol Deviation|2|||
130994936|NCT04250337|471609723|FG001|Overall Study|Protocol Deviation|2|||
130994937|NCT04250337|471609722|FG000|Overall Study|Withdrawal by Subject|4|||
130994938|NCT04250337|471609723|FG001|Overall Study|Withdrawal by Subject|3|||
130994939|NCT05033743|471609729|FG000|Overall Study|Lost to Follow-up|1|||
130994940|NCT05033743|471609729|FG000|Overall Study|Protocol Violation|2|||
130994941|NCT05033743|471609729|FG000|Overall Study|Withdrawal by Subject|1|||
130994942|NCT04537897|471609730|FG000|Overall Study|Other than listed|0|||
130994943|NCT04537897|471609731|FG001|Overall Study|Other than listed|0|||
130994944|NCT04537897|471609732|FG002|Overall Study|Other than listed|0|||
130994945|NCT04537897|471609733|FG003|Overall Study|Other than listed|0|||
130994946|NCT04537897|471609734|FG004|Overall Study|Other than listed|0|||
130994947|NCT04537897|471609735|FG005|Overall Study|Other than listed|0|||
130994948|NCT04537897|471609736|FG006|Overall Study|Other than listed|1|||
130994949|NCT04537897|471609737|FG007|Overall Study|Other than listed|0|||
130994950|NCT04537897|471609738|FG008|Overall Study|Other than listed|0|||
130994951|NCT04537897|471609730|FG000|Overall Study|Adverse Event|0|||
130994952|NCT04537897|471609731|FG001|Overall Study|Adverse Event|0|||
130994953|NCT04537897|471609732|FG002|Overall Study|Adverse Event|0|||
130994954|NCT04537897|471609733|FG003|Overall Study|Adverse Event|1|||
130994955|NCT04537897|471609734|FG004|Overall Study|Adverse Event|0|||
130994956|NCT04537897|471609735|FG005|Overall Study|Adverse Event|0|||
130994957|NCT04537897|471609736|FG006|Overall Study|Adverse Event|0|||
130994958|NCT04537897|471609737|FG007|Overall Study|Adverse Event|0|||
130994959|NCT04537897|471609738|FG008|Overall Study|Adverse Event|0|||
130994960|NCT04537897|471609730|FG000|Overall Study|Withdrawal by Subject|0|||
130994961|NCT04537897|471609731|FG001|Overall Study|Withdrawal by Subject|1|||
130994962|NCT04537897|471609732|FG002|Overall Study|Withdrawal by Subject|0|||
130994963|NCT04537897|471609733|FG003|Overall Study|Withdrawal by Subject|0|||
130994964|NCT04537897|471609734|FG004|Overall Study|Withdrawal by Subject|0|||
130994965|NCT04537897|471609735|FG005|Overall Study|Withdrawal by Subject|0|||
130994966|NCT04537897|471609736|FG006|Overall Study|Withdrawal by Subject|0|||
130994967|NCT04537897|471609737|FG007|Overall Study|Withdrawal by Subject|0|||
130994968|NCT04537897|471609738|FG008|Overall Study|Withdrawal by Subject|0|||
130994969|NCT00197028|471609742|FG000|Overall Study|Adverse Event|2|||
130994970|NCT00197028|471609743|FG001|Overall Study|Adverse Event|2|||
130994971|NCT00197028|471609742|FG000|Overall Study|Protocol Violation|2|||
130994972|NCT00197028|471609743|FG001|Overall Study|Protocol Violation|1|||
130994973|NCT00197028|471609742|FG000|Overall Study|Withdrawal by Subject|8|||
131221509|NCT00975884|472437979|FG001|Overall Study|Lost to Follow-up|3|||
130994974|NCT00197028|471609743|FG001|Overall Study|Withdrawal by Subject|12|||
130994975|NCT00197028|471609742|FG000|Overall Study|Lost to Follow-up|1|||
130994976|NCT00197028|471609743|FG001|Overall Study|Lost to Follow-up|0|||
130994977|NCT00197028|471609742|FG000|Overall Study|Other|3|||
130994978|NCT00197028|471609743|FG001|Overall Study|Other|6|||
130994979|NCT01923389|471609755|FG000|Overall Study|Protocol Violation|1|||
130994980|NCT01923389|471609756|FG001|Overall Study|Protocol Violation|0|||
130994981|NCT03292146|471609762|FG000|Baseline to 12 Months|Relocation|1|||
130994982|NCT03292146|471609763|FG001|Baseline to 12 Months|Relocation|0|||
130994983|NCT03292146|471609762|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
130994984|NCT03292146|471609763|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
130994985|NCT03292146|471609762|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
130994986|NCT03292146|471609763|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
130994987|NCT03292146|471609762|FG000|12 Months to 24 Months|Planning pregnancy|2|||
130994988|NCT03292146|471609763|FG001|12 Months to 24 Months|Planning pregnancy|2|||
131221510|NCT00975884|472437978|FG000|Overall Study|Withdrawal by Subject|9|||
130994989|NCT03292146|471609762|FG000|12 Months to 24 Months|Personal reasons|1|||
130994990|NCT03292146|471609763|FG001|12 Months to 24 Months|Personal reasons|0|||
130994991|NCT03292146|471609762|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
130994992|NCT03292146|471609763|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
130994993|NCT00545363|471609766|FG000|Overall Study|Adverse Event|6|||
130994994|NCT00545363|471609767|FG001|Overall Study|Adverse Event|7|||
130994995|NCT00545363|471609766|FG000|Overall Study|Withdrawal by Subject|6|||
130994996|NCT00545363|471609767|FG001|Overall Study|Withdrawal by Subject|5|||
130994997|NCT00545363|471609766|FG000|Overall Study|Non-compliance|3|||
130994998|NCT00545363|471609767|FG001|Overall Study|Non-compliance|1|||
130994999|NCT00545363|471609766|FG000|Overall Study|Did not meet entry criteria|1|||
130995000|NCT00545363|471609767|FG001|Overall Study|Did not meet entry criteria|1|||
130995001|NCT00545363|471609766|FG000|Overall Study|Lost to Follow-up|2|||
130995002|NCT00545363|471609767|FG001|Overall Study|Lost to Follow-up|0|||
130995003|NCT00545363|471609766|FG000|Overall Study|Other|1|||
130995004|NCT00545363|471609767|FG001|Overall Study|Other|1|||
130995005|NCT00366301|471609768|FG000|Overall Study|Lost to Follow-up|4|||
130995006|NCT00366301|471609769|FG001|Overall Study|Lost to Follow-up|4|||
130995007|NCT00366301|471609770|FG002|Overall Study|Lost to Follow-up|3|||
130995008|NCT00366301|471609771|FG003|Overall Study|Lost to Follow-up|7|||
130995009|NCT00366301|471609768|FG000|Overall Study|Withdrawal by Subject|4|||
130995010|NCT00366301|471609769|FG001|Overall Study|Withdrawal by Subject|2|||
130995011|NCT00366301|471609770|FG002|Overall Study|Withdrawal by Subject|1|||
130995012|NCT00366301|471609771|FG003|Overall Study|Withdrawal by Subject|1|||
130995013|NCT01348776|471609776|FG000|Overall Study|Lost to Follow-up|3|||
130995014|NCT01372605|471609777|FG000|Overall Study|Death|1|||
130995015|NCT01372605|471609778|FG001|Overall Study|Death|2|||
130995016|NCT01372605|471609777|FG000|Overall Study|Lost to Follow-up|2|||
130995017|NCT01372605|471609778|FG001|Overall Study|Lost to Follow-up|1|||
130995018|NCT01372605|471609777|FG000|Overall Study|Withdrawal by Subject|4|||
130995019|NCT01372605|471609778|FG001|Overall Study|Withdrawal by Subject|7|||
130995020|NCT01372605|471609777|FG000|Overall Study|Moved|3|||
130995021|NCT01372605|471609778|FG001|Overall Study|Moved|0|||
130995022|NCT01372605|471609777|FG000|Overall Study|Changed medical home|2|||
130995023|NCT01372605|471609778|FG001|Overall Study|Changed medical home|0|||
130995024|NCT01463293|471609779|FG000|Overall Study|Lost to Follow-up|1|||
130995025|NCT01463293|471609780|FG001|Overall Study|Lost to Follow-up|4|||
130995026|NCT01463293|471609781|FG002|Overall Study|Lost to Follow-up|5|||
130995027|NCT01463293|471609779|FG000|Overall Study|Adverse Event|1|||
130995028|NCT01463293|471609780|FG001|Overall Study|Adverse Event|2|||
130995029|NCT01463293|471609781|FG002|Overall Study|Adverse Event|0|||
130995030|NCT01463293|471609779|FG000|Overall Study|Withdrawal by Subject|4|||
130995031|NCT01463293|471609780|FG001|Overall Study|Withdrawal by Subject|10|||
130995032|NCT01463293|471609781|FG002|Overall Study|Withdrawal by Subject|5|||
130995033|NCT01463293|471609779|FG000|Overall Study|Other|0|||
130995034|NCT01463293|471609780|FG001|Overall Study|Other|0|||
130995035|NCT01463293|471609781|FG002|Overall Study|Other|2|||
130995036|NCT00951509|471609782|FG000|Overall Study|Withdrawal by Subject|2|||
130995037|NCT02302066|471609783|FG000|Overall Study|Adverse Event|1|||
130995038|NCT02302066|471609784|FG001|Overall Study|Adverse Event|1|||
130995039|NCT02302066|471609785|FG002|Overall Study|Adverse Event|3|||
130995040|NCT02302066|471609786|FG003|Overall Study|Adverse Event|0|||
130995041|NCT02302066|471609783|FG000|Overall Study|Lost to Follow-up|4|||
130995042|NCT02302066|471609784|FG001|Overall Study|Lost to Follow-up|5|||
130995043|NCT02302066|471609785|FG002|Overall Study|Lost to Follow-up|24|||
130995044|NCT02302066|471609786|FG003|Overall Study|Lost to Follow-up|7|||
130765894|NCT01524783|470765895|FG001|Open-label Period|Administrative problems|0|||
130765895|NCT01524783|470765896|FG002|Open-label Period|Administrative problems|2|||
130883615|NCT03841604|471209441|FG001|Overall Study|Withdrawal by Subject|1|||
130883616|NCT03841604|471209440|FG000|Overall Study|Adverse Event|4|||
130883617|NCT03841604|471209441|FG001|Overall Study|Adverse Event|2|||
130883618|NCT03841604|471209440|FG000|Overall Study|Physician Decision|1|||
130883619|NCT03841604|471209441|FG001|Overall Study|Physician Decision|0|||
130883620|NCT03877510|471209444|FG000|Overall Study|Death|6|||
130883621|NCT03877510|471209444|FG000|Overall Study|Lost to Follow-up|2|||
130883622|NCT03877510|471209444|FG000|Overall Study|Non-compliance with study drug|2|||
130883623|NCT03877510|471209444|FG000|Overall Study|Lack of Efficacy|14|||
130883624|NCT03877510|471209444|FG000|Overall Study|Adverse Event|20|||
130883625|NCT03877510|471209444|FG000|Overall Study|Withdrawal by Subject|22|||
130883626|NCT03877510|471209444|FG000|Overall Study|Miscellaneous|1|||
130883627|NCT01417377|471209445|FG000|Overall Study|Lost to Follow-up|12|||
130995045|NCT02302066|471609783|FG000|Overall Study|Withdrawal by Subject|25|||
130995046|NCT02302066|471609784|FG001|Overall Study|Withdrawal by Subject|58|||
130995047|NCT02302066|471609785|FG002|Overall Study|Withdrawal by Subject|124|||
130995048|NCT02302066|471609786|FG003|Overall Study|Withdrawal by Subject|33|||
130995049|NCT02302066|471609783|FG000|Overall Study|Pregnancy|2|||
130995050|NCT02302066|471609784|FG001|Overall Study|Pregnancy|10|||
130995051|NCT02302066|471609785|FG002|Overall Study|Pregnancy|12|||
130995052|NCT02302066|471609786|FG003|Overall Study|Pregnancy|0|||
130995053|NCT02302066|471609783|FG000|Overall Study|Reason Not Specified|1|||
130995054|NCT02302066|471609784|FG001|Overall Study|Reason Not Specified|1|||
130995055|NCT02302066|471609785|FG002|Overall Study|Reason Not Specified|9|||
130995056|NCT02302066|471609786|FG003|Overall Study|Reason Not Specified|1|||
130995057|NCT02875834|471609787|FG000|Open-label Phase|Withdrawal by Subject|3|||
130995058|NCT02875834|471609788|FG001|Open-label Phase|Withdrawal by Subject|0|||
130995059|NCT02875834|471609789|FG002|Open-label Phase|Withdrawal by Subject|0|||
130995060|NCT02875834|471609790|FG003|Open-label Phase|Withdrawal by Subject|0|||
130995061|NCT02875834|471609787|FG000|Open-label Phase|(Not collected)|4|||
130995062|NCT02875834|471609788|FG001|Open-label Phase|(Not collected)|0|||
130995063|NCT02875834|471609789|FG002|Open-label Phase|(Not collected)|0|||
130995064|NCT02875834|471609790|FG003|Open-label Phase|(Not collected)|0|||
130995065|NCT02875834|471609787|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
130995066|NCT02875834|471609788|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
130995067|NCT02875834|471609789|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
130995068|NCT02875834|471609790|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
130995069|NCT02875834|471609787|FG000|Randomized Treatment Phase|Protocol Violation|0|||
130995070|NCT02875834|471609788|FG001|Randomized Treatment Phase|Protocol Violation|2|||
130995071|NCT02875834|471609789|FG002|Randomized Treatment Phase|Protocol Violation|0|||
130995072|NCT02875834|471609790|FG003|Randomized Treatment Phase|Protocol Violation|0|||
130995073|NCT02875834|471609787|FG000|Randomized Treatment Phase|(Not collected)|0|||
130995074|NCT02875834|471609788|FG001|Randomized Treatment Phase|(Not collected)|9|||
130995075|NCT02875834|471609789|FG002|Randomized Treatment Phase|(Not collected)|10|||
130995076|NCT02875834|471609790|FG003|Randomized Treatment Phase|(Not collected)|9|||
130995077|NCT01032044|471609791|FG000|Overall Study|Protocol Violation|14|||
130995078|NCT01032044|471609792|FG001|Overall Study|Protocol Violation|8|||
130995079|NCT01032044|471609791|FG000|Overall Study|Adverse Event|0|||
130995080|NCT01032044|471609792|FG001|Overall Study|Adverse Event|1|||
130995081|NCT01032044|471609791|FG000|Overall Study|Lost to Follow-up|11|||
130995082|NCT01032044|471609792|FG001|Overall Study|Lost to Follow-up|11|||
130995083|NCT03311230|471609793|FG000|Overall Study|Withdrawal by Subject|1|||
130995084|NCT03311230|471609794|FG001|Overall Study|Withdrawal by Subject|4|||
130995085|NCT03311230|471609795|FG002|Overall Study|Withdrawal by Subject|2|||
130995086|NCT03311230|471609796|FG003|Overall Study|Withdrawal by Subject|7|||
130995087|NCT03311230|471609793|FG000|Overall Study|Unrelated injury|0|||
130995088|NCT03311230|471609794|FG001|Overall Study|Unrelated injury|1|||
130995089|NCT03311230|471609795|FG002|Overall Study|Unrelated injury|0|||
130995090|NCT03311230|471609796|FG003|Overall Study|Unrelated injury|0|||
130995091|NCT03342053|471609797|FG000|Overall Study|Adverse Event|2|||
130995092|NCT03342053|471609798|FG001|Overall Study|Adverse Event|0|||
130995093|NCT03342053|471609797|FG000|Overall Study|Withdrawal by Subject|0|||
130995094|NCT03342053|471609798|FG001|Overall Study|Withdrawal by Subject|1|||
130995095|NCT01302938|471609799|FG000|Overall Study|Withdrawal by Subject|1|||
130995096|NCT01302938|471609800|FG001|Overall Study|Withdrawal by Subject|0|||
130995097|NCT01302938|471609799|FG000|Overall Study|Adverse Event|1|||
130765896|NCT01524783|470765894|FG000|Open-label Period|Adverse Event|5|||
130883628|NCT01417377|471209445|FG000|Overall Study|Enrolled, but not treated|1|||
130883629|NCT02113982|471209446|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
130883630|NCT02113982|471209447|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
130883631|NCT02113982|471209448|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
130883632|NCT02113982|471209449|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
130883633|NCT02113982|471209450|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
130883634|NCT02113982|471209451|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
130883635|NCT02113982|471209452|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
130883636|NCT02113982|471209453|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
130883637|NCT02113982|471209454|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
130883638|NCT02113982|471209455|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
130883639|NCT02113982|471209456|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
130883640|NCT02113982|471209457|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
130883641|NCT02113982|471209458|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
130883642|NCT02113982|471209459|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
130883643|NCT02113982|471209446|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
130883644|NCT02113982|471209447|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
130883645|NCT02113982|471209448|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
130883646|NCT02113982|471209449|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
130883647|NCT02113982|471209450|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
130883648|NCT02113982|471209451|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
130883649|NCT02113982|471209452|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
130883650|NCT02113982|471209453|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
130883651|NCT02113982|471209454|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
130883652|NCT02113982|471209455|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
130883653|NCT02113982|471209456|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
130995098|NCT01302938|471609800|FG001|Overall Study|Adverse Event|0|||
130995099|NCT01233609|471609801|FG000|Overall Study|Death|1|||
130995100|NCT01233609|471609802|FG001|Overall Study|Death|0|||
130995101|NCT01233609|471609801|FG000|Overall Study|Lost to Follow-up|3|||
130995102|NCT01233609|471609802|FG001|Overall Study|Lost to Follow-up|1|||
130995103|NCT01233609|471609801|FG000|Overall Study|Adverse Event|2|||
130995104|NCT01233609|471609802|FG001|Overall Study|Adverse Event|1|||
130995105|NCT01233609|471609801|FG000|Overall Study|Withdrawal by Subject|3|||
130995106|NCT01233609|471609802|FG001|Overall Study|Withdrawal by Subject|0|||
130995107|NCT00735644|471609803|FG000|Overall Study|Did not receive study vaccine|0|||
130995108|NCT00735644|471609804|FG001|Overall Study|Did not receive study vaccine|1|||
130995109|NCT00735644|471609805|FG002|Overall Study|Did not receive study vaccine|0|||
130995110|NCT00735644|471609806|FG003|Overall Study|Did not receive study vaccine|0|||
130995111|NCT00735644|471609807|FG004|Overall Study|Did not receive study vaccine|0|||
130995112|NCT00735644|471609803|FG000|Overall Study|Withdrawal by Subject|0|||
130995113|NCT00735644|471609804|FG001|Overall Study|Withdrawal by Subject|1|||
130995114|NCT00735644|471609805|FG002|Overall Study|Withdrawal by Subject|1|||
130995115|NCT00735644|471609806|FG003|Overall Study|Withdrawal by Subject|1|||
130995116|NCT00735644|471609807|FG004|Overall Study|Withdrawal by Subject|0|||
130995117|NCT02961374|471609808|FG000|Overall Study|Adverse Event|4|||
130995118|NCT02041923|471609811|FG000|Overall Study|Lost to Follow-up|26|||
130995119|NCT02041923|471609812|FG001|Overall Study|Lost to Follow-up|30|||
130995120|NCT00309608|471609819|FG000|Overall Study|Adverse Event|1|||
130995121|NCT00309608|471609820|FG001|Overall Study|Adverse Event|5|||
130995122|NCT00309608|471609821|FG002|Overall Study|Adverse Event|3|||
130995123|NCT00309608|471609822|FG003|Overall Study|Adverse Event|2|||
130995124|NCT00309608|471609823|FG004|Overall Study|Adverse Event|3|||
130995125|NCT00309608|471609819|FG000|Overall Study|Protocol Violation|2|||
130995126|NCT00309608|471609820|FG001|Overall Study|Protocol Violation|0|||
130995127|NCT00309608|471609821|FG002|Overall Study|Protocol Violation|0|||
130995128|NCT00309608|471609822|FG003|Overall Study|Protocol Violation|0|||
130995129|NCT00309608|471609823|FG004|Overall Study|Protocol Violation|0|||
130995130|NCT00309608|471609819|FG000|Overall Study|Lost to Follow-up|0|||
130995131|NCT00309608|471609820|FG001|Overall Study|Lost to Follow-up|0|||
130995132|NCT00309608|471609821|FG002|Overall Study|Lost to Follow-up|2|||
130995133|NCT00309608|471609822|FG003|Overall Study|Lost to Follow-up|0|||
130995134|NCT00309608|471609823|FG004|Overall Study|Lost to Follow-up|1|||
130995135|NCT00309608|471609819|FG000|Overall Study|Withdrawal by Subject|1|||
130995136|NCT00309608|471609820|FG001|Overall Study|Withdrawal by Subject|4|||
130995137|NCT00309608|471609821|FG002|Overall Study|Withdrawal by Subject|2|||
130995138|NCT00309608|471609822|FG003|Overall Study|Withdrawal by Subject|0|||
130995139|NCT00309608|471609823|FG004|Overall Study|Withdrawal by Subject|0|||
130995140|NCT00309608|471609819|FG000|Overall Study|Other incl. Lack of efficacy|10|||
130995141|NCT00309608|471609820|FG001|Overall Study|Other incl. Lack of efficacy|4|||
130995142|NCT00309608|471609821|FG002|Overall Study|Other incl. Lack of efficacy|3|||
130765897|NCT01524783|470765895|FG001|Open-label Period|Adverse Event|0|||
130883654|NCT02113982|471209457|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
130883655|NCT02113982|471209458|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
130883656|NCT02113982|471209459|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
130883657|NCT02113982|471209446|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883658|NCT02113982|471209447|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883659|NCT02113982|471209448|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883660|NCT02113982|471209449|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883661|NCT02113982|471209450|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883662|NCT02113982|471209451|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883663|NCT02113982|471209452|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
130883664|NCT02113982|471209453|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883665|NCT02113982|471209454|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883666|NCT02113982|471209455|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883667|NCT02113982|471209456|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883668|NCT02113982|471209457|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883669|NCT02113982|471209458|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883670|NCT02113982|471209459|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130883671|NCT02113982|471209446|FG000|Stage 1: Dose Escalation|Transplant|0|||
130883672|NCT02113982|471209447|FG001|Stage 1: Dose Escalation|Transplant|1|||
130883673|NCT02113982|471209448|FG002|Stage 1: Dose Escalation|Transplant|0|||
130883674|NCT02113982|471209449|FG003|Stage 1: Dose Escalation|Transplant|0|||
130883675|NCT02113982|471209450|FG004|Stage 1: Dose Escalation|Transplant|0|||
130883676|NCT02113982|471209451|FG005|Stage 1: Dose Escalation|Transplant|1|||
130883677|NCT02113982|471209452|FG006|Stage 1: Dose Escalation|Transplant|0|||
130883678|NCT02113982|471209453|FG007|Stage 1: Dose Escalation|Transplant|0|||
130883679|NCT02113982|471209454|FG008|Stage 1: Dose Escalation|Transplant|0|||
130883680|NCT02113982|471209455|FG009|Stage 1: Dose Escalation|Transplant|0|||
130883681|NCT02113982|471209456|FG010|Stage 1: Dose Escalation|Transplant|0|||
130883682|NCT02113982|471209457|FG011|Stage 1: Dose Escalation|Transplant|0|||
130883683|NCT02113982|471209458|FG012|Stage 1: Dose Escalation|Transplant|0|||
130995143|NCT00309608|471609822|FG003|Overall Study|Other incl. Lack of efficacy|4|||
130995144|NCT00309608|471609823|FG004|Overall Study|Other incl. Lack of efficacy|0|||
130995145|NCT00621296|471609830|FG000|Overall Study|Adverse Event|2|||
130995146|NCT00621296|471609830|FG000|Overall Study|Lack of Efficacy|1|||
130995147|NCT00621296|471609830|FG000|Overall Study|Physician Decision|7|||
130995148|NCT00621296|471609830|FG000|Overall Study|Unmatch Criteria|1|||
130995149|NCT00621296|471609830|FG000|Overall Study|Stopping Criteria|3|||
130995150|NCT02049710|471609831|FG000|Overall Study|Lost to Follow-up|319|||
130995151|NCT02049710|471609832|FG001|Overall Study|Lost to Follow-up|324|||
130995152|NCT00874432|471609834|FG000|Overall Study|Withdrawal by Subject|1|||
130995153|NCT00874432|471609835|FG001|Overall Study|Withdrawal by Subject|0|||
130995154|NCT00874432|471609836|FG002|Overall Study|Withdrawal by Subject|0|||
130995155|NCT00874432|471609837|FG003|Overall Study|Withdrawal by Subject|0|||
130995156|NCT00874432|471609834|FG000|Overall Study|Physician Decision|1|||
130995157|NCT00874432|471609835|FG001|Overall Study|Physician Decision|0|||
130995158|NCT00874432|471609836|FG002|Overall Study|Physician Decision|0|||
130995159|NCT00874432|471609837|FG003|Overall Study|Physician Decision|0|||
130995160|NCT00874432|471609834|FG000|Overall Study|Other|1|||
130995161|NCT00874432|471609835|FG001|Overall Study|Other|2|||
130995162|NCT00874432|471609836|FG002|Overall Study|Other|8|||
130995163|NCT00874432|471609837|FG003|Overall Study|Other|3|||
130995164|NCT01518946|471609838|FG000|Open-label Phase|Other|4|||
130995165|NCT01518946|471609839|FG001|Open-label Phase|Other|0|||
130995166|NCT01518946|471609840|FG002|Open-label Phase|Other|0|||
130995167|NCT01518946|471609838|FG000|Randomized Phase (First Intervention)|Other|0|||
130995168|NCT01518946|471609839|FG001|Randomized Phase (First Intervention)|Other|1|||
130995169|NCT01518946|471609840|FG002|Randomized Phase (First Intervention)|Other|0|||
130995170|NCT00384059|471609841|FG000|Infant Series|Not consented|2|||
130995171|NCT00384059|471609842|FG001|Infant Series|Not consented|6|||
130995172|NCT00384059|471609841|FG000|Infant Series|Withdrawal by Subject|2|||
130995173|NCT00384059|471609842|FG001|Infant Series|Withdrawal by Subject|2|||
130995174|NCT00384059|471609841|FG000|Infant Series|Adverse Event|1|||
130995175|NCT00384059|471609842|FG001|Infant Series|Adverse Event|2|||
130995176|NCT00384059|471609841|FG000|Infant Series|Protocol Violation|1|||
130995177|NCT00384059|471609842|FG001|Infant Series|Protocol Violation|2|||
130995178|NCT00384059|471609841|FG000|Infant Series|Lost to Follow-up|0|||
130995179|NCT00384059|471609842|FG001|Infant Series|Lost to Follow-up|1|||
130995180|NCT00384059|471609841|FG000|After Infant Series|Protocol Violation|2|||
130995181|NCT00384059|471609842|FG001|After Infant Series|Protocol Violation|3|||
130995182|NCT00384059|471609841|FG000|After Infant Series|Withdrawal by Subject|2|||
130995183|NCT00384059|471609842|FG001|After Infant Series|Withdrawal by Subject|2|||
130995184|NCT00384059|471609841|FG000|After Infant Series|Failed to Return|0|||
130995185|NCT00384059|471609842|FG001|After Infant Series|Failed to Return|2|||
130995186|NCT00384059|471609841|FG000|After Infant Series|Adverse Event|0|||
130995187|NCT00384059|471609842|FG001|After Infant Series|Adverse Event|1|||
130995188|NCT00384059|471609841|FG000|After Infant Series|Physician Decision|0|||
130995189|NCT00384059|471609842|FG001|After Infant Series|Physician Decision|1|||
130995190|NCT00384059|471609841|FG000|After Infant Series|Lost to Follow-up|0|||
130995191|NCT00384059|471609842|FG001|After Infant Series|Lost to Follow-up|1|||
130995192|NCT00384059|471609841|FG000|Toddler Dose|Lost to Follow-up|1|||
130995193|NCT00384059|471609842|FG001|Toddler Dose|Lost to Follow-up|1|||
130995194|NCT00384059|471609841|FG000|Toddler Dose|Failed to return|0|||
130995195|NCT00384059|471609842|FG001|Toddler Dose|Failed to return|1|||
130995196|NCT00386308|471611043|FG000|Overall Study|Adverse Event|3|||
130995197|NCT00386308|471611044|FG001|Overall Study|Adverse Event|3|||
130995198|NCT00386308|471611043|FG000|Overall Study|Protocol Violation|2|||
130995199|NCT00386308|471611044|FG001|Overall Study|Protocol Violation|5|||
130995200|NCT00386308|471611043|FG000|Overall Study|Lack of Efficacy|0|||
130995201|NCT00386308|471611044|FG001|Overall Study|Lack of Efficacy|2|||
130995202|NCT00386308|471611043|FG000|Overall Study|Lost to Follow-up|10|||
130995203|NCT00386308|471611044|FG001|Overall Study|Lost to Follow-up|6|||
130995204|NCT00386308|471611043|FG000|Overall Study|Withdrawal by Subject|6|||
130995205|NCT00386308|471611044|FG001|Overall Study|Withdrawal by Subject|2|||
130995206|NCT00386308|471611043|FG000|Overall Study|Other Event|8|||
130995207|NCT00386308|471611044|FG001|Overall Study|Other Event|1|||
130995208|NCT02906683|471611045|FG000|Overall Study|Adverse Event|0|||
130995209|NCT02906683|471611046|FG001|Overall Study|Adverse Event|1|||
130995210|NCT02906683|471611047|FG002|Overall Study|Adverse Event|0|||
130995211|NCT02906683|471611045|FG000|Overall Study|Physician Decision|0|||
130995212|NCT02906683|471611046|FG001|Overall Study|Physician Decision|1|||
130995213|NCT02906683|471611047|FG002|Overall Study|Physician Decision|1|||
130995214|NCT02906683|471611045|FG000|Overall Study|Withdrawal by Subject|0|||
130995215|NCT02906683|471611046|FG001|Overall Study|Withdrawal by Subject|2|||
130995216|NCT02906683|471611047|FG002|Overall Study|Withdrawal by Subject|1|||
130995217|NCT02906683|471611045|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
130995218|NCT02906683|471611046|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
130995219|NCT02906683|471611047|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
130995220|NCT02906683|471611045|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
130995221|NCT02906683|471611046|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
130995222|NCT02906683|471611047|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
130995223|NCT01340482|471611048|FG000|Overall Study|Adverse Event|2|||
130995224|NCT01340482|471611049|FG001|Overall Study|Adverse Event|0|||
130995225|NCT01340482|471611050|FG002|Overall Study|Adverse Event|0|||
130995226|NCT02593539|471611051|FG000|Overall Study|Adverse Event|1|||
130995227|NCT01282476|471611052|FG000|Overall Study|Death|11|||
130995228|NCT00437125|471611055|FG000|Overall Study|Adverse Event|12|||
130995229|NCT00437125|471611055|FG000|Overall Study|Death|1|||
130995230|NCT00437125|471611055|FG000|Overall Study|Clinical Relapse|1|||
130995231|NCT00437125|471611055|FG000|Overall Study|Lack of Efficacy|1|||
130995232|NCT00437125|471611055|FG000|Overall Study|Lost to Follow-up|1|||
130995233|NCT00437125|471611055|FG000|Overall Study|Withdrawal by Subject|13|||
130995234|NCT00437125|471611055|FG000|Overall Study|Withdrawal by Caregiver|2|||
130995235|NCT00437125|471611055|FG000|Overall Study|Physician Decision|1|||
130995236|NCT02248961|471611056|FG000|Overall Study|Adverse Event|1|||
130995237|NCT02248961|471611057|FG001|Overall Study|Adverse Event|0|||
130995238|NCT02248961|471611056|FG000|Overall Study|Withdrawal by Subject|1|||
130995239|NCT02248961|471611057|FG001|Overall Study|Withdrawal by Subject|2|||
130995240|NCT02248961|471611056|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
130995241|NCT02248961|471611057|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
130995242|NCT00649389|471611058|FG000|Overall Study|Adverse Event|22|||
130995243|NCT00649389|471611059|FG001|Overall Study|Adverse Event|46|||
130995244|NCT00649389|471611060|FG002|Overall Study|Adverse Event|38|||
130995245|NCT00649389|471611061|FG003|Overall Study|Adverse Event|48|||
130995246|NCT00649389|471611058|FG000|Overall Study|Lost to Follow-up|15|||
130995247|NCT00649389|471611059|FG001|Overall Study|Lost to Follow-up|17|||
130995248|NCT00649389|471611060|FG002|Overall Study|Lost to Follow-up|21|||
130995249|NCT00649389|471611061|FG003|Overall Study|Lost to Follow-up|26|||
130995250|NCT00649389|471611058|FG000|Overall Study|Protocol Violation|11|||
130995251|NCT00649389|471611059|FG001|Overall Study|Protocol Violation|13|||
130995252|NCT00649389|471611060|FG002|Overall Study|Protocol Violation|9|||
130995253|NCT00649389|471611061|FG003|Overall Study|Protocol Violation|8|||
130995254|NCT00649389|471611058|FG000|Overall Study|Withdrawal by Subject|20|||
130995255|NCT00649389|471611059|FG001|Overall Study|Withdrawal by Subject|21|||
130995256|NCT00649389|471611060|FG002|Overall Study|Withdrawal by Subject|19|||
130995257|NCT00649389|471611061|FG003|Overall Study|Withdrawal by Subject|23|||
130995258|NCT00649389|471611058|FG000|Overall Study|Other|3|||
130995259|NCT00649389|471611059|FG001|Overall Study|Other|9|||
130995260|NCT00649389|471611060|FG002|Overall Study|Other|1|||
130995261|NCT00649389|471611061|FG003|Overall Study|Other|6|||
130995262|NCT00453310|471611066|FG000|Overall Study|Progression of Disease|10|||
130995263|NCT01267825|471611067|FG000|Overall Study|study terminated. no data collected.|1|||
130995264|NCT01267825|471611068|FG001|Overall Study|study terminated. no data collected.|0|||
130995265|NCT01806740|471611069|FG000|Overall Study|Withdrawal by Subject|4|||
130995266|NCT01806740|471611069|FG000|Overall Study|Physician Decision|1|||
130995267|NCT01806740|471611069|FG000|Overall Study|Patient's refusal of treatment|1|||
130995268|NCT00871351|471611074|FG000|Overall Study|Withdrawal by Subject|1|||
130995269|NCT00871351|471611075|FG001|Overall Study|Withdrawal by Subject|0|||
130995270|NCT00871351|471611076|FG002|Overall Study|Withdrawal by Subject|0|||
130995271|NCT00871351|471611074|FG000|Overall Study|Adverse Event|3|||
130995272|NCT00871351|471611075|FG001|Overall Study|Adverse Event|1|||
130995273|NCT00871351|471611076|FG002|Overall Study|Adverse Event|0|||
130995274|NCT00744237|471611077|FG000|Overall Study|Lack of Efficacy|1|||
130995275|NCT00744237|471611078|FG001|Overall Study|Lack of Efficacy|1|||
130995276|NCT00744237|471611079|FG002|Overall Study|Lack of Efficacy|0|||
130995277|NCT00744237|471611077|FG000|Overall Study|Withdrawal by Subject|9|||
130995278|NCT00744237|471611078|FG001|Overall Study|Withdrawal by Subject|5|||
130995279|NCT00744237|471611079|FG002|Overall Study|Withdrawal by Subject|3|||
130995280|NCT00744237|471611077|FG000|Overall Study|Lost to Follow-up|1|||
130995281|NCT00744237|471611078|FG001|Overall Study|Lost to Follow-up|1|||
130995282|NCT00744237|471611079|FG002|Overall Study|Lost to Follow-up|1|||
130995283|NCT00744237|471611077|FG000|Overall Study|Protocol Violation|3|||
130995284|NCT00744237|471611078|FG001|Overall Study|Protocol Violation|4|||
130883684|NCT02113982|471209459|FG013|Stage 1: Dose Escalation|Transplant|0|||
130883685|NCT02113982|471209446|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
130883686|NCT02113982|471209447|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
130883687|NCT02113982|471209448|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
130883688|NCT02113982|471209449|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
130883689|NCT02113982|471209450|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
130883690|NCT02113982|471209451|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
130883691|NCT02113982|471209452|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
130883692|NCT02113982|471209453|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
130883693|NCT02113982|471209454|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
130883694|NCT02113982|471209455|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
130883695|NCT02113982|471209456|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
130883696|NCT02113982|471209457|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
130883697|NCT02113982|471209458|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
130883698|NCT02113982|471209459|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
130883699|NCT02113982|471209446|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
130883700|NCT02113982|471209447|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
130883701|NCT02113982|471209448|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
130883702|NCT02113982|471209449|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
130883703|NCT02113982|471209450|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
130883704|NCT02113982|471209451|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
130883705|NCT02113982|471209452|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
130883706|NCT02113982|471209453|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
130883707|NCT02113982|471209454|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
130883708|NCT02113982|471209455|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
130883709|NCT02113982|471209456|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
130883710|NCT02113982|471209457|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
130883711|NCT02113982|471209458|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
130883712|NCT02113982|471209459|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
130883713|NCT02113982|471209446|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
130883714|NCT02113982|471209447|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
130883715|NCT02113982|471209448|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
130883716|NCT02113982|471209449|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
130883717|NCT02113982|471209450|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
130883718|NCT02113982|471209451|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
130883719|NCT02113982|471209452|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
130883720|NCT02113982|471209453|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
130883721|NCT02113982|471209454|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
130883722|NCT02113982|471209455|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
130883723|NCT02113982|471209456|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
130883724|NCT02113982|471209457|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
130883725|NCT02113982|471209458|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
130883726|NCT02113982|471209459|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
130883727|NCT02113982|471209446|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
130883728|NCT02113982|471209447|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
130883729|NCT02113982|471209448|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
130883730|NCT02113982|471209449|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
130883731|NCT02113982|471209450|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
130883732|NCT02113982|471209451|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
130883733|NCT02113982|471209452|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
130883734|NCT02113982|471209453|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
130883735|NCT02113982|471209454|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
130883736|NCT02113982|471209455|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
130995285|NCT00744237|471611079|FG002|Overall Study|Protocol Violation|3|||
130995286|NCT00744237|471611077|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
130883737|NCT02113982|471209456|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
130883738|NCT02113982|471209457|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
130883739|NCT02113982|471209458|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
130883740|NCT02113982|471209459|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
130883741|NCT02113982|471209446|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
130883742|NCT02113982|471209447|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
130995287|NCT00744237|471611078|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
130995288|NCT00744237|471611079|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
130995289|NCT00744237|471611077|FG000|Overall Study|Dosing Error|1|||
130995290|NCT00744237|471611078|FG001|Overall Study|Dosing Error|0|||
130995291|NCT00744237|471611079|FG002|Overall Study|Dosing Error|1|||
130995292|NCT00744237|471611077|FG000|Overall Study|Study Drug Error|1|||
130995293|NCT00744237|471611078|FG001|Overall Study|Study Drug Error|0|||
130995294|NCT00744237|471611079|FG002|Overall Study|Study Drug Error|0|||
130995295|NCT00744237|471611077|FG000|Overall Study|Prohibited Concomitant Medication|0|||
130995296|NCT00744237|471611078|FG001|Overall Study|Prohibited Concomitant Medication|0|||
130995297|NCT00744237|471611079|FG002|Overall Study|Prohibited Concomitant Medication|1|||
130995298|NCT00744237|471611077|FG000|Overall Study|Poor Compliance|0|||
130995299|NCT00744237|471611078|FG001|Overall Study|Poor Compliance|2|||
130995300|NCT00744237|471611079|FG002|Overall Study|Poor Compliance|0|||
130995301|NCT00744237|471611077|FG000|Overall Study|Administrative. Site Closed|1|||
130995302|NCT00744237|471611078|FG001|Overall Study|Administrative. Site Closed|1|||
130995303|NCT00744237|471611079|FG002|Overall Study|Administrative. Site Closed|1|||
130995304|NCT00744237|471611077|FG000|Overall Study|Adverse Event|9|||
130995305|NCT00744237|471611078|FG001|Overall Study|Adverse Event|13|||
130995306|NCT00744237|471611079|FG002|Overall Study|Adverse Event|5|||
130995307|NCT02791490|471611081|FG000|Overall Study|Lost to Follow-up|1|||
130995308|NCT02791490|471611082|FG001|Overall Study|Lost to Follow-up|2|||
130995309|NCT02791490|471611081|FG000|Overall Study|Withdrawal by Subject|2|||
130995310|NCT02791490|471611082|FG001|Overall Study|Withdrawal by Subject|6|||
130995311|NCT01984424|471611083|FG000|Overall Study|Withdrawal by Subject|3|||
130995312|NCT01984424|471611084|FG001|Overall Study|Withdrawal by Subject|5|||
130995313|NCT01984424|471611083|FG000|Overall Study|Sponsor Decision|0|||
130995314|NCT01984424|471611084|FG001|Overall Study|Sponsor Decision|1|||
130995315|NCT01984424|471611083|FG000|Overall Study|Lost to Follow-up|0|||
130995316|NCT01984424|471611084|FG001|Overall Study|Lost to Follow-up|1|||
130995317|NCT02802319|471611085|FG000|Overall Study|Physician Decision|2|||
130995318|NCT02802319|471611086|FG001|Overall Study|Physician Decision|1|||
130995319|NCT02802319|471611085|FG000|Overall Study|Lost to Follow-up|0|||
130995320|NCT02802319|471611086|FG001|Overall Study|Lost to Follow-up|4|||
130995321|NCT00077636|471611087|FG000|Overall Study|Refused Treatment|9|||
130995322|NCT00077636|471611088|FG001|Overall Study|Refused Treatment|31|||
130995323|NCT00077636|471611087|FG000|Overall Study|Admin|3|||
130995324|NCT00077636|471611088|FG001|Overall Study|Admin|3|||
130995325|NCT00077636|471611087|FG000|Overall Study|Withdrawal by Subject|2|||
130995326|NCT00077636|471611088|FG001|Overall Study|Withdrawal by Subject|2|||
130995327|NCT00077636|471611087|FG000|Overall Study|Adverse Event|17|||
130995328|NCT00077636|471611088|FG001|Overall Study|Adverse Event|34|||
130995329|NCT00077636|471611087|FG000|Overall Study|Protocol Violation|0|||
130995330|NCT00077636|471611088|FG001|Overall Study|Protocol Violation|2|||
130995331|NCT00077636|471611087|FG000|Overall Study|Lost to Follow-up|10|||
130995332|NCT00077636|471611088|FG001|Overall Study|Lost to Follow-up|18|||
130995333|NCT00077636|471611087|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
130995334|NCT00077636|471611088|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
130995335|NCT00592319|471611089|FG000|Overall Study|Lost to Follow-up|0|||
130995336|NCT00592319|471611090|FG001|Overall Study|Lost to Follow-up|3|||
130995337|NCT02032173|471611091|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
130995338|NCT03321513|471611097|FG000|Overall Study|Death|11|||
130995339|NCT03321513|471611098|FG001|Overall Study|Death|5|||
130995340|NCT03321513|471611097|FG000|Overall Study|Withdrawal by Subject|5|||
130995341|NCT03321513|471611098|FG001|Overall Study|Withdrawal by Subject|10|||
130995342|NCT03321513|471611097|FG000|Overall Study|Lost to Follow-up|10|||
130995343|NCT03321513|471611098|FG001|Overall Study|Lost to Follow-up|11|||
130995344|NCT01993017|471611099|FG000|Overall Study|Death|23|||
130995345|NCT01993017|471611100|FG001|Overall Study|Death|26|||
130995346|NCT01993017|471611101|FG002|Overall Study|Death|18|||
130995347|NCT01993017|471611099|FG000|Overall Study|Could not be contacted|43|||
130995348|NCT01993017|471611100|FG001|Overall Study|Could not be contacted|42|||
130995349|NCT01993017|471611101|FG002|Overall Study|Could not be contacted|38|||
130995350|NCT01993017|471611099|FG000|Overall Study|Dropped out|19|||
130995351|NCT01993017|471611100|FG001|Overall Study|Dropped out|6|||
130995352|NCT01993017|471611101|FG002|Overall Study|Dropped out|11|||
130995353|NCT01993017|471611099|FG000|Overall Study|Other reasons|17|||
130995354|NCT01993017|471611100|FG001|Overall Study|Other reasons|11|||
130995355|NCT01993017|471611101|FG002|Overall Study|Other reasons|7|||
130995356|NCT01993017|471611099|FG000|Overall Study|Ineligible after randomization|4|||
130995357|NCT01993017|471611100|FG001|Overall Study|Ineligible after randomization|5|||
130995358|NCT01993017|471611101|FG002|Overall Study|Ineligible after randomization|5|||
130995359|NCT02757521|471611102|FG000|Overall Study|Adverse Event|1|||
130995360|NCT02757521|471611103|FG001|Overall Study|Adverse Event|0|||
130995361|NCT00003511|471611104|FG000|Overall Study|Not evaluable|4|||
130995362|NCT01683994|471611111|FG000|Overall Study|Withdrawal by Subject|1|||
130995363|NCT01683994|471611112|FG001|Overall Study|Withdrawal by Subject|0|||
130995364|NCT01683994|471611113|FG002|Overall Study|Withdrawal by Subject|0|||
130995365|NCT01683994|471611114|FG003|Overall Study|Withdrawal by Subject|1|||
130995366|NCT01683994|471611115|FG004|Overall Study|Withdrawal by Subject|0|||
130995367|NCT01683994|471611111|FG000|Overall Study|Intercurrent illness|0|||
130995368|NCT01683994|471611112|FG001|Overall Study|Intercurrent illness|0|||
130995369|NCT01683994|471611113|FG002|Overall Study|Intercurrent illness|0|||
130995370|NCT01683994|471611114|FG003|Overall Study|Intercurrent illness|2|||
130995371|NCT01683994|471611115|FG004|Overall Study|Intercurrent illness|1|||
130995372|NCT00999661|471611120|FG000|Overall Study|Lost to Follow-up|59|||
130995373|NCT00999661|471611120|FG000|Overall Study|Adverse Event|1|||
130995374|NCT00999661|471611120|FG000|Overall Study|Withdrawal by Subject|1|||
130995375|NCT00999661|471611120|FG000|Overall Study|Not meeting eligibility criteria|9|||
130995376|NCT00582491|471611121|FG000|Overall Study|Withdrawal by Subject|1|||
130995377|NCT00582491|471611122|FG001|Overall Study|Withdrawal by Subject|0|||
130995378|NCT01775930|471611129|FG000|Overall Study|Futility stopping boundary met|1|||
130995379|NCT01794117|471611130|FG000|Overall Study|Adverse Event|1|||
130995380|NCT01794117|471611131|FG001|Overall Study|Adverse Event|0|||
130995381|NCT01794117|471611132|FG002|Overall Study|Adverse Event|0|||
130995382|NCT01794117|471611133|FG003|Overall Study|Adverse Event|0|||
130995383|NCT01794117|471611130|FG000|Overall Study|Participant noncompliance|0|||
130995384|NCT01794117|471611131|FG001|Overall Study|Participant noncompliance|1|||
130995385|NCT01794117|471611132|FG002|Overall Study|Participant noncompliance|0|||
130995386|NCT01794117|471611133|FG003|Overall Study|Participant noncompliance|0|||
130995387|NCT01794117|471611130|FG000|Overall Study|Refused further treatment|0|||
130995388|NCT01794117|471611131|FG001|Overall Study|Refused further treatment|2|||
130995389|NCT01794117|471611132|FG002|Overall Study|Refused further treatment|0|||
130995390|NCT01794117|471611133|FG003|Overall Study|Refused further treatment|0|||
130995391|NCT03734991|471611134|FG000|Overall Study|Adverse Event|4|||
130995392|NCT03734991|471611135|FG001|Overall Study|Adverse Event|0|||
130995393|NCT03734991|471611134|FG000|Overall Study|Lost to Follow-up|4|||
130995394|NCT03734991|471611135|FG001|Overall Study|Lost to Follow-up|0|||
130995395|NCT03734991|471611134|FG000|Overall Study|Physician Decision|0|||
130995396|NCT03734991|471611135|FG001|Overall Study|Physician Decision|1|||
130995397|NCT03734991|471611134|FG000|Overall Study|Pregnancy|1|||
130995398|NCT03734991|471611135|FG001|Overall Study|Pregnancy|0|||
130995399|NCT03734991|471611134|FG000|Overall Study|Withdrawal by Subject|6|||
130995400|NCT03734991|471611135|FG001|Overall Study|Withdrawal by Subject|3|||
130995401|NCT03734991|471611134|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
130883743|NCT02113982|471209448|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
130883744|NCT02113982|471209449|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
130883745|NCT02113982|471209450|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
130883746|NCT02113982|471209451|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
130883747|NCT02113982|471209452|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
130883748|NCT02113982|471209453|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
130883749|NCT02113982|471209454|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
130883750|NCT02113982|471209455|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
130883751|NCT02113982|471209456|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
130883752|NCT02113982|471209457|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
130883753|NCT02113982|471209458|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
130883754|NCT02113982|471209459|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
130883755|NCT02113982|471209446|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883756|NCT02113982|471209447|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883757|NCT02113982|471209448|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883758|NCT02113982|471209449|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883759|NCT02113982|471209450|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883760|NCT02113982|471209451|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883761|NCT02113982|471209452|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883762|NCT02113982|471209453|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
130883763|NCT02113982|471209454|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883764|NCT02113982|471209455|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
130883765|NCT02113982|471209456|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883766|NCT02113982|471209457|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883767|NCT02113982|471209458|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883768|NCT02113982|471209459|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130883769|NCT02113982|471209446|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130995402|NCT03734991|471611135|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
130995403|NCT03734991|471611134|FG000|Overall Study|Other|2|||
130995404|NCT03734991|471611135|FG001|Overall Study|Other|2|||
130995405|NCT02322814|471611138|FG000|Overall Study|Death|7|||
130995406|NCT02322814|471611139|FG001|Overall Study|Death|29|||
131221511|NCT00975884|472437979|FG001|Overall Study|Withdrawal by Subject|9|||
131221512|NCT00975884|472437978|FG000|Overall Study|Other|1|||
130883770|NCT02113982|471209447|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883771|NCT02113982|471209448|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883772|NCT02113982|471209449|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883773|NCT02113982|471209450|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883774|NCT02113982|471209451|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883775|NCT02113982|471209452|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883776|NCT02113982|471209453|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
130883777|NCT02113982|471209454|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883778|NCT02113982|471209455|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883779|NCT02113982|471209456|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883780|NCT02113982|471209457|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883781|NCT02113982|471209458|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883782|NCT02113982|471209459|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130883783|NCT02113982|471209446|FG000|Stage 2: Cohort Expansion|Transplant|0|||
130883784|NCT02113982|471209447|FG001|Stage 2: Cohort Expansion|Transplant|0|||
130883785|NCT02113982|471209448|FG002|Stage 2: Cohort Expansion|Transplant|0|||
130883786|NCT02113982|471209449|FG003|Stage 2: Cohort Expansion|Transplant|0|||
130883787|NCT02113982|471209450|FG004|Stage 2: Cohort Expansion|Transplant|0|||
130883788|NCT02113982|471209451|FG005|Stage 2: Cohort Expansion|Transplant|0|||
130883789|NCT02113982|471209452|FG006|Stage 2: Cohort Expansion|Transplant|0|||
130883790|NCT02113982|471209453|FG007|Stage 2: Cohort Expansion|Transplant|0|||
130883791|NCT02113982|471209454|FG008|Stage 2: Cohort Expansion|Transplant|0|||
130883792|NCT02113982|471209455|FG009|Stage 2: Cohort Expansion|Transplant|4|||
130883793|NCT02113982|471209456|FG010|Stage 2: Cohort Expansion|Transplant|2|||
130883794|NCT02113982|471209457|FG011|Stage 2: Cohort Expansion|Transplant|0|||
130883795|NCT02113982|471209458|FG012|Stage 2: Cohort Expansion|Transplant|0|||
130883796|NCT02113982|471209459|FG013|Stage 2: Cohort Expansion|Transplant|0|||
130883797|NCT02113982|471209446|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
130883798|NCT02113982|471209447|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
130883799|NCT02113982|471209448|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
130883800|NCT02113982|471209449|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
130883801|NCT02113982|471209450|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
130883802|NCT02113982|471209451|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
130883803|NCT02113982|471209452|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
130883804|NCT02113982|471209453|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
130883805|NCT02113982|471209454|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
130883806|NCT02113982|471209455|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
130883807|NCT02113982|471209456|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
130883808|NCT02113982|471209457|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
130883809|NCT02113982|471209458|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
130883810|NCT02113982|471209459|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
130883811|NCT02113982|471209446|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
130883812|NCT02113982|471209447|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
130883813|NCT02113982|471209448|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
130883814|NCT02113982|471209449|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
130883815|NCT02113982|471209450|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
130883816|NCT02113982|471209451|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
130883817|NCT02113982|471209452|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
130883818|NCT02113982|471209453|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
130883819|NCT02113982|471209454|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
130883820|NCT02113982|471209455|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
130883821|NCT02113982|471209456|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
130883822|NCT02113982|471209457|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
130883823|NCT02113982|471209458|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
130883824|NCT02113982|471209459|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
130883825|NCT02113982|471209446|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883826|NCT02113982|471209447|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883827|NCT02113982|471209448|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883828|NCT02113982|471209449|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883829|NCT02113982|471209450|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883830|NCT02113982|471209451|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883831|NCT02113982|471209452|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883832|NCT02113982|471209453|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883833|NCT02113982|471209454|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883834|NCT02113982|471209455|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883835|NCT02113982|471209456|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883836|NCT02113982|471209457|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
130883837|NCT02113982|471209458|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883838|NCT02113982|471209459|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
130883839|NCT02113982|471209446|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883840|NCT02113982|471209447|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
130995407|NCT02322814|471611140|FG002|Overall Study|Death|32|||
130995408|NCT02322814|471611141|FG003|Overall Study|Death|23|||
130995409|NCT02322814|471611142|FG004|Overall Study|Death|14|||
130995410|NCT02322814|471611138|FG000|Overall Study|Lost to Follow-up|1|||
130995411|NCT02322814|471611139|FG001|Overall Study|Lost to Follow-up|3|||
130995412|NCT02322814|471611140|FG002|Overall Study|Lost to Follow-up|3|||
130995413|NCT02322814|471611141|FG003|Overall Study|Lost to Follow-up|1|||
130995414|NCT02322814|471611142|FG004|Overall Study|Lost to Follow-up|0|||
130995415|NCT02322814|471611138|FG000|Overall Study|Various Reasons|2|||
130995416|NCT02322814|471611139|FG001|Overall Study|Various Reasons|0|||
130995417|NCT02322814|471611140|FG002|Overall Study|Various Reasons|1|||
130995418|NCT02322814|471611141|FG003|Overall Study|Various Reasons|1|||
130995419|NCT02322814|471611142|FG004|Overall Study|Various Reasons|0|||
130995420|NCT02322814|471611138|FG000|Overall Study|Progressive Disease|0|||
130995421|NCT02322814|471611139|FG001|Overall Study|Progressive Disease|0|||
130995422|NCT02322814|471611140|FG002|Overall Study|Progressive Disease|0|||
130995423|NCT02322814|471611141|FG003|Overall Study|Progressive Disease|1|||
130995424|NCT02322814|471611142|FG004|Overall Study|Progressive Disease|1|||
130995425|NCT02322814|471611138|FG000|Overall Study|Protocol Violation|1|||
130995426|NCT02322814|471611139|FG001|Overall Study|Protocol Violation|0|||
130995427|NCT02322814|471611140|FG002|Overall Study|Protocol Violation|0|||
130995428|NCT02322814|471611141|FG003|Overall Study|Protocol Violation|0|||
130995429|NCT02322814|471611142|FG004|Overall Study|Protocol Violation|0|||
130995430|NCT02322814|471611138|FG000|Overall Study|Study Terminated by Sponsor|0|||
130995431|NCT02322814|471611139|FG001|Overall Study|Study Terminated by Sponsor|7|||
130995432|NCT02322814|471611140|FG002|Overall Study|Study Terminated by Sponsor|9|||
130995433|NCT02322814|471611141|FG003|Overall Study|Study Terminated by Sponsor|5|||
130995434|NCT02322814|471611142|FG004|Overall Study|Study Terminated by Sponsor|13|||
130995435|NCT02322814|471611138|FG000|Overall Study|Withdrawal by Subject|5|||
130995436|NCT02322814|471611139|FG001|Overall Study|Withdrawal by Subject|4|||
130995437|NCT02322814|471611140|FG002|Overall Study|Withdrawal by Subject|2|||
130995438|NCT02322814|471611141|FG003|Overall Study|Withdrawal by Subject|1|||
130995439|NCT02322814|471611142|FG004|Overall Study|Withdrawal by Subject|3|||
130995440|NCT00118092|471611143|FG000|Overall Study|Withdrawal by Subject|1|||
130995441|NCT00118092|471611143|FG000|Overall Study|Protocol Violation|1|||
130995442|NCT00591864|471611144|FG000|Overall Study|Incomplete Imaging|5|||
130995443|NCT02459093|471611145|FG000|Overall Study|Protocol Violation|6|||
130995444|NCT02459093|471611146|FG001|Overall Study|Protocol Violation|11|||
130995445|NCT02459093|471611145|FG000|Overall Study|Lost to Follow-up|6|||
130995446|NCT02459093|471611146|FG001|Overall Study|Lost to Follow-up|7|||
130995447|NCT02401308|471611158|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
130995448|NCT02401308|471611159|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
130995449|NCT02736968|471611160|FG000|Overall Study|Lost to Follow-up|0|||
130995450|NCT02736968|471611161|FG001|Overall Study|Lost to Follow-up|0|||
130995451|NCT02736968|471611162|FG002|Overall Study|Lost to Follow-up|0|||
130995452|NCT02736968|471611163|FG003|Overall Study|Lost to Follow-up|0|||
130995453|NCT02736968|471611164|FG004|Overall Study|Lost to Follow-up|0|||
130995454|NCT02736968|471611165|FG005|Overall Study|Lost to Follow-up|0|||
130995455|NCT02736968|471611166|FG006|Overall Study|Lost to Follow-up|5|||
130995456|NCT02736968|471611167|FG007|Overall Study|Lost to Follow-up|2|||
130995457|NCT02736968|471611160|FG000|Overall Study|COVID-19 Pandemic|0|||
130995458|NCT02736968|471611161|FG001|Overall Study|COVID-19 Pandemic|0|||
130995459|NCT02736968|471611162|FG002|Overall Study|COVID-19 Pandemic|0|||
130995460|NCT02736968|471611163|FG003|Overall Study|COVID-19 Pandemic|0|||
130995461|NCT02736968|471611164|FG004|Overall Study|COVID-19 Pandemic|0|||
130995462|NCT02736968|471611165|FG005|Overall Study|COVID-19 Pandemic|0|||
130995463|NCT02736968|471611166|FG006|Overall Study|COVID-19 Pandemic|2|||
130995464|NCT02736968|471611167|FG007|Overall Study|COVID-19 Pandemic|0|||
130995465|NCT02736968|471611160|FG000|Overall Study|Withdrawal by Subject|0|||
130995466|NCT02736968|471611161|FG001|Overall Study|Withdrawal by Subject|0|||
130995467|NCT02736968|471611162|FG002|Overall Study|Withdrawal by Subject|0|||
130995468|NCT02736968|471611163|FG003|Overall Study|Withdrawal by Subject|0|||
130995469|NCT02736968|471611164|FG004|Overall Study|Withdrawal by Subject|0|||
130995470|NCT02736968|471611165|FG005|Overall Study|Withdrawal by Subject|0|||
130995471|NCT02736968|471611166|FG006|Overall Study|Withdrawal by Subject|1|||
130995472|NCT02736968|471611167|FG007|Overall Study|Withdrawal by Subject|0|||
130995473|NCT00147225|471611168|FG000|Overall Study|Withdrawal by Subject|1|||
130995474|NCT00147225|471611169|FG001|Overall Study|Withdrawal by Subject|0|||
130995475|NCT00147225|471611170|FG002|Overall Study|Withdrawal by Subject|1|||
130995476|NCT00147225|471611171|FG003|Overall Study|Withdrawal by Subject|0|||
130995477|NCT00147225|471611172|FG004|Overall Study|Withdrawal by Subject|0|||
130995478|NCT00147225|471611173|FG005|Overall Study|Withdrawal by Subject|1|||
130995479|NCT00147225|471611168|FG000|Overall Study|Adverse Event|0|||
130995480|NCT00147225|471611169|FG001|Overall Study|Adverse Event|0|||
130995481|NCT00147225|471611170|FG002|Overall Study|Adverse Event|1|||
130995482|NCT00147225|471611171|FG003|Overall Study|Adverse Event|1|||
130995483|NCT00147225|471611172|FG004|Overall Study|Adverse Event|0|||
130995484|NCT00147225|471611173|FG005|Overall Study|Adverse Event|0|||
130995485|NCT00147225|471611168|FG000|Overall Study|Screen Failure|0|||
130995486|NCT00147225|471611169|FG001|Overall Study|Screen Failure|0|||
130995487|NCT00147225|471611170|FG002|Overall Study|Screen Failure|0|||
130995488|NCT00147225|471611171|FG003|Overall Study|Screen Failure|0|||
130995489|NCT00147225|471611172|FG004|Overall Study|Screen Failure|1|||
130995490|NCT00147225|471611173|FG005|Overall Study|Screen Failure|0|||
130995491|NCT00147225|471611168|FG000|Overall Study|Chemotherapy Changed|0|||
130995492|NCT00147225|471611169|FG001|Overall Study|Chemotherapy Changed|0|||
130995493|NCT00147225|471611170|FG002|Overall Study|Chemotherapy Changed|0|||
130995494|NCT00147225|471611171|FG003|Overall Study|Chemotherapy Changed|0|||
130995495|NCT00147225|471611172|FG004|Overall Study|Chemotherapy Changed|0|||
130995496|NCT00147225|471611173|FG005|Overall Study|Chemotherapy Changed|1|||
130995497|NCT02998021|471611174|FG000|Overall Study|Withdrawal by Subject|3|||
130995498|NCT02998021|471611175|FG001|Overall Study|Withdrawal by Subject|1|||
130995499|NCT02998021|471611174|FG000|Overall Study|unsafe home|0|||
130995500|NCT02998021|471611175|FG001|Overall Study|unsafe home|1|||
130995501|NCT00655551|471611176|FG000|All Periods Combined|Adverse Event|0|||
130995502|NCT00655551|471611177|FG001|All Periods Combined|Adverse Event|3|||
130995503|NCT00655551|471611178|FG002|All Periods Combined|Adverse Event|4|||
130995504|NCT00655551|471611176|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
130995505|NCT00655551|471611177|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
130995506|NCT00655551|471611178|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
130995507|NCT00655551|471611176|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
130995508|NCT00655551|471611177|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
130995509|NCT00655551|471611178|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
130995510|NCT00655551|471611176|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
130995511|NCT00655551|471611177|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
130995512|NCT00655551|471611178|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
130995513|NCT01734434|471611181|FG000|Overall Study|Death Infant|3|||
130995514|NCT01734434|471611182|FG001|Overall Study|Death Infant|1|||
130995515|NCT01734434|471611183|FG002|Overall Study|Death Infant|17|||
130995516|NCT01734434|471611184|FG003|Overall Study|Death Infant|5|||
130995517|NCT01734434|471611181|FG000|Overall Study|Lost to Follow-up|2|||
130995518|NCT01734434|471611182|FG001|Overall Study|Lost to Follow-up|9|||
130995519|NCT01734434|471611183|FG002|Overall Study|Lost to Follow-up|67|||
130995520|NCT01734434|471611184|FG003|Overall Study|Lost to Follow-up|11|||
130995521|NCT01734434|471611181|FG000|Overall Study|No Live Birth|1|||
130995522|NCT01734434|471611182|FG001|Overall Study|No Live Birth|2|||
130995523|NCT01734434|471611183|FG002|Overall Study|No Live Birth|32|||
130995524|NCT01734434|471611184|FG003|Overall Study|No Live Birth|6|||
130995525|NCT01734434|471611181|FG000|Overall Study|Withdrawal by Subject|4|||
130995526|NCT01734434|471611182|FG001|Overall Study|Withdrawal by Subject|0|||
130995527|NCT01734434|471611183|FG002|Overall Study|Withdrawal by Subject|8|||
130995528|NCT01734434|471611184|FG003|Overall Study|Withdrawal by Subject|1|||
130995529|NCT01734434|471611181|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
130995530|NCT01734434|471611182|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
130995531|NCT01734434|471611183|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
130995532|NCT01734434|471611184|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
130995533|NCT01734434|471611181|FG000|Overall Study|Subject Not Reachable|0|||
130995534|NCT01734434|471611182|FG001|Overall Study|Subject Not Reachable|0|||
130995535|NCT01734434|471611183|FG002|Overall Study|Subject Not Reachable|1|||
130995536|NCT01734434|471611184|FG003|Overall Study|Subject Not Reachable|0|||
130995537|NCT01734434|471611181|FG000|Overall Study|Treatment Defaulter|0|||
130995538|NCT01734434|471611182|FG001|Overall Study|Treatment Defaulter|0|||
130995539|NCT01734434|471611183|FG002|Overall Study|Treatment Defaulter|1|||
130995540|NCT01734434|471611184|FG003|Overall Study|Treatment Defaulter|0|||
130995541|NCT01734434|471611181|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
130995542|NCT01734434|471611182|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
130995543|NCT01734434|471611183|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
130995544|NCT01734434|471611184|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
130995545|NCT01734434|471611181|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
130995546|NCT01734434|471611182|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
130995547|NCT01734434|471611183|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
130995548|NCT01734434|471611184|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
130995549|NCT03713021|471611189|FG000|Overall Study|Did not have CT sim scan available|6|||
130995550|NCT03713021|471611189|FG000|Overall Study|Not eligible|4|||
130995551|NCT03713021|471611189|FG000|Overall Study|Issues with TraceIT markers|5|||
130995552|NCT03391960|471611192|FG000|Overall Study|Protocol Violation|0|||
130995553|NCT03391960|471611193|FG001|Overall Study|Protocol Violation|0|||
130995554|NCT03545113|471613085|FG000|Overall Study|Surgery Cancelled|1|||
130995555|NCT03545113|471613086|FG001|Overall Study|Surgery Cancelled|0|||
130765898|NCT01524783|470765896|FG002|Open-label Period|Adverse Event|1|||
130995556|NCT03545113|471613085|FG000|Overall Study|Death|1|||
130883841|NCT02113982|471209448|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883842|NCT02113982|471209449|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883843|NCT02113982|471209450|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883844|NCT02113982|471209451|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883845|NCT02113982|471209452|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883846|NCT02113982|471209453|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883847|NCT02113982|471209454|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883848|NCT02113982|471209455|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883849|NCT02113982|471209456|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883850|NCT02113982|471209457|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
130883851|NCT02113982|471209458|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883852|NCT02113982|471209459|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
130883853|NCT02113982|471209446|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883854|NCT02113982|471209447|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883855|NCT02113982|471209448|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883856|NCT02113982|471209449|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883857|NCT02113982|471209450|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883858|NCT02113982|471209451|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883859|NCT02113982|471209452|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883860|NCT02113982|471209453|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883861|NCT02113982|471209454|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883862|NCT02113982|471209455|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883863|NCT02113982|471209456|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883864|NCT02113982|471209457|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
130883865|NCT02113982|471209458|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883866|NCT02113982|471209459|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130883867|NCT02113982|471209446|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
130883868|NCT02113982|471209447|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
130883869|NCT02113982|471209448|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
130883870|NCT02113982|471209449|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
130883871|NCT02113982|471209450|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
130883872|NCT02113982|471209451|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
130883873|NCT02113982|471209452|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
130883874|NCT02113982|471209453|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
130883875|NCT02113982|471209454|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
130883876|NCT02113982|471209455|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
130883877|NCT02113982|471209456|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
130883878|NCT02113982|471209457|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
130883879|NCT02113982|471209458|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
130883880|NCT02113982|471209459|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
130883881|NCT02113982|471209446|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883882|NCT02113982|471209447|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883883|NCT02113982|471209448|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883884|NCT02113982|471209449|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883885|NCT02113982|471209450|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883886|NCT02113982|471209451|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883887|NCT02113982|471209452|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883888|NCT02113982|471209453|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883889|NCT02113982|471209454|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883890|NCT02113982|471209455|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883891|NCT02113982|471209456|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883892|NCT02113982|471209457|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883893|NCT02113982|471209458|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
130883894|NCT02113982|471209459|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130883895|NCT02113982|471209446|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883896|NCT02113982|471209447|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883897|NCT02113982|471209448|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883898|NCT02113982|471209449|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883899|NCT02113982|471209450|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883900|NCT02113982|471209451|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883901|NCT02113982|471209452|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883902|NCT02113982|471209453|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883903|NCT02113982|471209454|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883904|NCT02113982|471209455|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883905|NCT02113982|471209456|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883906|NCT02113982|471209457|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130883907|NCT02113982|471209458|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
130995557|NCT03545113|471613086|FG001|Overall Study|Death|0|||
130995558|NCT03545113|471613085|FG000|Overall Study|Adverse Event|2|||
130995559|NCT03545113|471613086|FG001|Overall Study|Adverse Event|0|||
130995560|NCT03545113|471613085|FG000|Overall Study|Received different surgery|1|||
130995561|NCT03545113|471613086|FG001|Overall Study|Received different surgery|0|||
130995562|NCT01804673|471613087|FG000|Overall Study|Adverse Event|4|||
130995563|NCT01804673|471613087|FG000|Overall Study|Withdrawal by Subject|1|||
130995564|NCT01804673|471613087|FG000|Overall Study|Lack of Efficacy|9|||
130995565|NCT01804673|471613087|FG000|Overall Study|Change to Oral Therapy|37|||
130995566|NCT01804673|471613087|FG000|Overall Study|No Further Therapy Required|84|||
130995567|NCT01804673|471613087|FG000|Overall Study|Use of Prohibited Medication|1|||
130995568|NCT01804673|471613087|FG000|Overall Study|Other|4|||
130995569|NCT01533714|471613088|FG000|Overall Study|Adverse Event|0|||
130995570|NCT01533714|471613089|FG001|Overall Study|Adverse Event|1|||
130995571|NCT01533714|471613090|FG002|Overall Study|Adverse Event|2|||
130995572|NCT01533714|471613091|FG003|Overall Study|Adverse Event|2|||
130995573|NCT01533714|471613092|FG004|Overall Study|Adverse Event|2|||
130995574|NCT01533714|471613093|FG005|Overall Study|Adverse Event|1|||
130995575|NCT01533714|471613088|FG000|Overall Study|Lack of Efficacy|0|||
130995576|NCT01533714|471613089|FG001|Overall Study|Lack of Efficacy|0|||
130995577|NCT01533714|471613090|FG002|Overall Study|Lack of Efficacy|0|||
130995578|NCT01533714|471613091|FG003|Overall Study|Lack of Efficacy|0|||
130995579|NCT01533714|471613092|FG004|Overall Study|Lack of Efficacy|0|||
130995580|NCT01533714|471613093|FG005|Overall Study|Lack of Efficacy|1|||
130995581|NCT01533714|471613088|FG000|Overall Study|Withdrawal by Subject|0|||
130995582|NCT01533714|471613089|FG001|Overall Study|Withdrawal by Subject|1|||
130995583|NCT01533714|471613090|FG002|Overall Study|Withdrawal by Subject|0|||
130995584|NCT01533714|471613091|FG003|Overall Study|Withdrawal by Subject|1|||
130995585|NCT01533714|471613092|FG004|Overall Study|Withdrawal by Subject|1|||
130995586|NCT01533714|471613093|FG005|Overall Study|Withdrawal by Subject|0|||
130995587|NCT01533714|471613088|FG000|Overall Study|Exclusion criteria|0|||
130995588|NCT01533714|471613089|FG001|Overall Study|Exclusion criteria|1|||
130995589|NCT01533714|471613090|FG002|Overall Study|Exclusion criteria|0|||
130995590|NCT01533714|471613091|FG003|Overall Study|Exclusion criteria|0|||
130995591|NCT01533714|471613092|FG004|Overall Study|Exclusion criteria|0|||
130995592|NCT01533714|471613093|FG005|Overall Study|Exclusion criteria|0|||
130995593|NCT01533714|471613088|FG000|Overall Study|Positive for purified protein derivative|0|||
130995594|NCT01533714|471613089|FG001|Overall Study|Positive for purified protein derivative|0|||
130995595|NCT01533714|471613090|FG002|Overall Study|Positive for purified protein derivative|1|||
130995596|NCT01533714|471613091|FG003|Overall Study|Positive for purified protein derivative|0|||
130995597|NCT01533714|471613092|FG004|Overall Study|Positive for purified protein derivative|1|||
130995598|NCT01533714|471613093|FG005|Overall Study|Positive for purified protein derivative|0|||
130995599|NCT01533714|471613088|FG000|Overall Study|Withdrawal criteria|0|||
130995600|NCT01533714|471613089|FG001|Overall Study|Withdrawal criteria|0|||
130995601|NCT01533714|471613090|FG002|Overall Study|Withdrawal criteria|1|||
130995602|NCT01533714|471613091|FG003|Overall Study|Withdrawal criteria|0|||
130995603|NCT01533714|471613092|FG004|Overall Study|Withdrawal criteria|3|||
130995604|NCT01533714|471613093|FG005|Overall Study|Withdrawal criteria|1|||
130995605|NCT01533714|471613088|FG000|Overall Study|Ineligibility reason|0|||
130995606|NCT01533714|471613089|FG001|Overall Study|Ineligibility reason|0|||
130995607|NCT01533714|471613090|FG002|Overall Study|Ineligibility reason|0|||
130995608|NCT01533714|471613091|FG003|Overall Study|Ineligibility reason|1|||
130995609|NCT01533714|471613092|FG004|Overall Study|Ineligibility reason|0|||
130995610|NCT01533714|471613093|FG005|Overall Study|Ineligibility reason|0|||
130995611|NCT01844115|471613097|FG000|Overall Study|Adverse Event|4|||
130995612|NCT01844115|471613098|FG001|Overall Study|Adverse Event|22|||
130995613|NCT01844115|471613097|FG000|Overall Study|Lack of Efficacy|1|||
130995614|NCT01844115|471613098|FG001|Overall Study|Lack of Efficacy|4|||
130995615|NCT01844115|471613097|FG000|Overall Study|Protocol Violation|12|||
130995616|NCT01844115|471613098|FG001|Overall Study|Protocol Violation|10|||
130995617|NCT01844115|471613097|FG000|Overall Study|Withdrawal by Subject|11|||
130995618|NCT01844115|471613098|FG001|Overall Study|Withdrawal by Subject|11|||
130995619|NCT01844115|471613097|FG000|Overall Study|Lost to Follow-up|11|||
130995620|NCT01844115|471613098|FG001|Overall Study|Lost to Follow-up|10|||
130995621|NCT01844115|471613097|FG000|Overall Study|Pregnancy|0|||
130995622|NCT01844115|471613098|FG001|Overall Study|Pregnancy|1|||
130995623|NCT00758160|471613099|FG000|Overall Study|No Longer Requires Study Medication|4|||
130995624|NCT00758160|471613099|FG000|Overall Study|Administration Problems|3|||
130995625|NCT00758160|471613099|FG000|Overall Study|Adverse Event|15|||
130995626|NCT00758160|471613099|FG000|Overall Study|Lack of Efficacy|10|||
130995627|NCT00758160|471613099|FG000|Overall Study|Lost to Follow-up|14|||
130995628|NCT00758160|471613099|FG000|Overall Study|Protocol Violation|12|||
130995629|NCT00758160|471613099|FG000|Overall Study|Withdrawal by Subject|8|||
130995630|NCT01613027|471613100|FG000|Overall Study|Lost to Follow-up|5|||
130995631|NCT01613027|471613100|FG000|Overall Study|Switched Physician|1|||
130995632|NCT01613027|471613100|FG000|Overall Study|Lack of Efficacy|1|||
130995633|NCT01613027|471613100|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
130995634|NCT00993317|471613101|FG000|Overall Study|Adverse Event|2|||
130995635|NCT00993317|471613102|FG001|Overall Study|Adverse Event|4|||
130995636|NCT00993317|471613101|FG000|Overall Study|Lack of Efficacy|18|||
130995637|NCT00993317|471613102|FG001|Overall Study|Lack of Efficacy|18|||
130995638|NCT00993317|471613101|FG000|Overall Study|Withdrawal by Subject|0|||
130995639|NCT00993317|471613102|FG001|Overall Study|Withdrawal by Subject|2|||
130995640|NCT00993317|471613101|FG000|Overall Study|Investigator's opinion|0|||
130995641|NCT00993317|471613102|FG001|Overall Study|Investigator's opinion|1|||
130995642|NCT00993317|471613101|FG000|Overall Study|Early study termination at the site|1|||
130995643|NCT00993317|471613102|FG001|Overall Study|Early study termination at the site|0|||
130995644|NCT02153359|471613103|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
130995645|NCT02153359|471613104|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
130995646|NCT04422639|471613105|FG000|Overall Study|Death|1|||
130995647|NCT04422639|471613106|FG001|Overall Study|Death|0|||
130995648|NCT04422639|471613105|FG000|Overall Study|study closed prior to completion of FU visits|0|||
130995649|NCT04422639|471613106|FG001|Overall Study|study closed prior to completion of FU visits|2|||
130995650|NCT01964521|471613107|FG000|Overall Study|Lost to Follow-up|4|||
130995651|NCT01108510|471613108|FG000|Overall Study|Randomized but Not Treated|5|||
130995652|NCT01108510|471613109|FG001|Overall Study|Randomized but Not Treated|1|||
130995653|NCT01108510|471613108|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
130995654|NCT01108510|471613109|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
130995655|NCT01108510|471613108|FG000|Overall Study|Adverse Event|26|||
130995656|NCT01108510|471613109|FG001|Overall Study|Adverse Event|19|||
130995657|NCT01108510|471613108|FG000|Overall Study|Lost to Follow-up|20|||
130995658|NCT01108510|471613109|FG001|Overall Study|Lost to Follow-up|17|||
130995659|NCT01108510|471613108|FG000|Overall Study|Withdrew Consent|21|||
130995660|NCT01108510|471613109|FG001|Overall Study|Withdrew Consent|15|||
130995661|NCT01108510|471613108|FG000|Overall Study|Investigator's Discretion|12|||
130995662|NCT01108510|471613109|FG001|Overall Study|Investigator's Discretion|10|||
130995663|NCT01108510|471613108|FG000|Overall Study|Participant Noncompliance|5|||
130995664|NCT01108510|471613109|FG001|Overall Study|Participant Noncompliance|7|||
130995665|NCT01108510|471613108|FG000|Overall Study|Lack of Efficacy|3|||
130995666|NCT01108510|471613109|FG001|Overall Study|Lack of Efficacy|0|||
130995667|NCT01108510|471613108|FG000|Overall Study|Pregnancy|0|||
130995668|NCT01108510|471613109|FG001|Overall Study|Pregnancy|3|||
130995669|NCT01108510|471613108|FG000|Overall Study|Death|1|||
130995670|NCT01108510|471613109|FG001|Overall Study|Death|1|||
130995671|NCT02796963|471613110|FG000|Overall Study|Lost to Follow-up|89|||
130995672|NCT02796963|471613111|FG001|Overall Study|Lost to Follow-up|76|||
130995673|NCT02796963|471613112|FG002|Overall Study|Lost to Follow-up|69|||
130995674|NCT02796963|471613113|FG003|Overall Study|Lost to Follow-up|72|||
130995675|NCT01258660|471613115|FG000|Overall Study|Adverse Event|2|||
130883908|NCT02113982|471209459|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
130883909|NCT02113982|471209446|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883910|NCT02113982|471209447|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883911|NCT02113982|471209448|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883912|NCT02113982|471209449|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883913|NCT02113982|471209450|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883914|NCT02113982|471209451|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883915|NCT02113982|471209452|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883916|NCT02113982|471209453|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883917|NCT02113982|471209454|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883918|NCT02113982|471209455|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883919|NCT02113982|471209456|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883920|NCT02113982|471209457|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130883921|NCT02113982|471209458|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
130883922|NCT02113982|471209459|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
130883923|NCT02113982|471209446|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130995676|NCT01258660|471613116|FG001|Overall Study|Adverse Event|4|||
130995677|NCT01258660|471613115|FG000|Overall Study|Withdrawal by Subject|3|||
130995678|NCT01258660|471613116|FG001|Overall Study|Withdrawal by Subject|0|||
130995679|NCT01258660|471613115|FG000|Overall Study|due to relocation|2|||
130995680|NCT01258660|471613116|FG001|Overall Study|due to relocation|0|||
130995681|NCT01258660|471613115|FG000|Overall Study|Protocol Violation|0|||
130995682|NCT01258660|471613116|FG001|Overall Study|Protocol Violation|1|||
130995683|NCT01258660|471613115|FG000|Overall Study|Invalid for primary analysis data set|4|||
130995684|NCT01258660|471613116|FG001|Overall Study|Invalid for primary analysis data set|6|||
130995685|NCT04192630|471613117|FG000|Overall Study|Discontinued before surgery|2|||
130995686|NCT04192630|471613118|FG001|Overall Study|Discontinued before surgery|0|||
130995687|NCT04192630|471613117|FG000|Overall Study|Discontinued after surgery|5|||
130995688|NCT04192630|471613118|FG001|Overall Study|Discontinued after surgery|3|||
130995689|NCT01193582|471613119|FG000|Vaccination Series|Withdrawal by Subject|11|||
130995690|NCT01193582|471613120|FG001|Vaccination Series|Withdrawal by Subject|13|||
130995691|NCT01193582|471613121|FG002|Vaccination Series|Withdrawal by Subject|8|||
130995692|NCT01193582|471613122|FG003|Vaccination Series|Withdrawal by Subject|3|||
130995693|NCT01193582|471613119|FG000|12 Month Follow-up|Death|0|||
130995694|NCT01193582|471613120|FG001|12 Month Follow-up|Death|0|||
130995695|NCT01193582|471613121|FG002|12 Month Follow-up|Death|1|||
130995696|NCT01193582|471613122|FG003|12 Month Follow-up|Death|0|||
130995697|NCT01193582|471613119|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
130995698|NCT01193582|471613120|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
130995699|NCT01193582|471613121|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
130995700|NCT01193582|471613122|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
130995701|NCT01425632|471613123|FG000|Overall Study|Adverse Event|0|||
130995702|NCT01425632|471613124|FG001|Overall Study|Adverse Event|1|||
130995703|NCT01425632|471613125|FG002|Overall Study|Adverse Event|1|||
130995704|NCT01425632|471613123|FG000|Overall Study|Physician Decision|1|||
130995705|NCT01425632|471613124|FG001|Overall Study|Physician Decision|0|||
130995706|NCT01425632|471613125|FG002|Overall Study|Physician Decision|0|||
130995707|NCT01425632|471613123|FG000|Overall Study|Protocol Violation|0|||
130995708|NCT01425632|471613124|FG001|Overall Study|Protocol Violation|0|||
130995709|NCT01425632|471613125|FG002|Overall Study|Protocol Violation|2|||
130995710|NCT01425632|471613123|FG000|Overall Study|Withdrawal by Subject|0|||
130995711|NCT01425632|471613124|FG001|Overall Study|Withdrawal by Subject|0|||
130995712|NCT01425632|471613125|FG002|Overall Study|Withdrawal by Subject|1|||
130995713|NCT01208415|471613128|FG000|Overall Study|Death|1|||
130995714|NCT01208415|471613128|FG000|Overall Study|Lost to Follow-up|2|||
130995715|NCT01208415|471613128|FG000|Overall Study|Withdrawal by Subject|3|||
130995716|NCT01208415|471613128|FG000|Overall Study|Device not placed|1|||
130995717|NCT01208415|471613128|FG000|Overall Study|Still be eligible for follow-up|33|||
130995718|NCT01115491|471613129|FG000|Overall Study|Death|22|||
130995719|NCT01115491|471613129|FG000|Overall Study|Adverse Event|3|||
130995720|NCT01115491|471613129|FG000|Overall Study|Lost to Follow-up|3|||
130995721|NCT01115491|471613129|FG000|Overall Study|Withdrawal by Subject|1|||
130995722|NCT01115491|471613129|FG000|Overall Study|Physician Decision|1|||
130995723|NCT04297241|471613130|FG000|Overall Study|Withdrawal by Subject|1|||
130995724|NCT04297241|471613130|FG000|Overall Study|Adverse Event|1|||
130995725|NCT04297241|471613130|FG000|Overall Study|Physician Decision|3|||
130995726|NCT03856996|471613134|FG000|Overall Study|Withdrawal by Subject|1|||
130995727|NCT03856996|471613135|FG001|Overall Study|Withdrawal by Subject|0|||
130995728|NCT03856996|471613134|FG000|Overall Study|Lost to Follow-up|0|||
130995729|NCT03856996|471613135|FG001|Overall Study|Lost to Follow-up|1|||
130995730|NCT03856996|471613134|FG000|Overall Study|Adverse Event|1|||
130995731|NCT03856996|471613135|FG001|Overall Study|Adverse Event|1|||
130995732|NCT03856996|471613134|FG000|Overall Study|Other|1|||
130995733|NCT03856996|471613135|FG001|Overall Study|Other|0|||
130995734|NCT02340520|471613138|FG000|Overall Study|Lost to Follow-up|1|||
130995735|NCT02340520|471613138|FG000|Overall Study|Patient did not take drug as specified|1|||
130995736|NCT02340520|471613138|FG000|Overall Study|Withdrawal by Subject|1|||
130995737|NCT01003639|471613139|FG000|Overall Study|Lost to Follow-up|6|||
130995738|NCT01003639|471613140|FG001|Overall Study|Lost to Follow-up|9|||
130995739|NCT01003639|471613139|FG000|Overall Study|Withdrawal by Subject|9|||
130995740|NCT01003639|471613140|FG001|Overall Study|Withdrawal by Subject|5|||
130995741|NCT01003639|471613139|FG000|Overall Study|Lack of Efficacy|1|||
130995742|NCT01003639|471613140|FG001|Overall Study|Lack of Efficacy|6|||
130995743|NCT01003639|471613139|FG000|Overall Study|Adverse Event|0|||
130995744|NCT01003639|471613140|FG001|Overall Study|Adverse Event|1|||
130995745|NCT01003639|471613139|FG000|Overall Study|Protocol Violation|0|||
130995746|NCT01003639|471613140|FG001|Overall Study|Protocol Violation|1|||
130995747|NCT01003639|471613139|FG000|Overall Study|Physician Decision|1|||
130995748|NCT01003639|471613140|FG001|Overall Study|Physician Decision|0|||
130995749|NCT01464255|471613141|FG000|Overall Study|unresolve corneal staining|0|||
130995750|NCT01464255|471613142|FG001|Overall Study|unresolve corneal staining|1|||
130995751|NCT01231503|471613144|FG000|Overall Study|Adverse Event|0|||
130995752|NCT01231503|471613145|FG001|Overall Study|Adverse Event|0|||
130995753|NCT01231503|471613146|FG002|Overall Study|Adverse Event|0|||
130995754|NCT01231503|471613147|FG003|Overall Study|Adverse Event|0|||
130995755|NCT01231503|471613148|FG004|Overall Study|Adverse Event|0|||
130995756|NCT01231503|471613149|FG005|Overall Study|Adverse Event|1|||
130995757|NCT01231503|471613150|FG006|Overall Study|Adverse Event|0|||
130995758|NCT01231503|471613151|FG007|Overall Study|Adverse Event|0|||
130995759|NCT01231503|471613144|FG000|Overall Study|Adverse event, serious fatal|0|||
130995760|NCT01231503|471613145|FG001|Overall Study|Adverse event, serious fatal|0|||
130995761|NCT01231503|471613146|FG002|Overall Study|Adverse event, serious fatal|1|||
130995762|NCT01231503|471613147|FG003|Overall Study|Adverse event, serious fatal|1|||
130995763|NCT01231503|471613148|FG004|Overall Study|Adverse event, serious fatal|0|||
130995764|NCT01231503|471613149|FG005|Overall Study|Adverse event, serious fatal|1|||
130995765|NCT01231503|471613150|FG006|Overall Study|Adverse event, serious fatal|0|||
130995766|NCT01231503|471613151|FG007|Overall Study|Adverse event, serious fatal|0|||
130995767|NCT01231503|471613144|FG000|Overall Study|Withdrawal by Subject|6|||
130995768|NCT01231503|471613145|FG001|Overall Study|Withdrawal by Subject|3|||
130995769|NCT01231503|471613146|FG002|Overall Study|Withdrawal by Subject|3|||
130995770|NCT01231503|471613147|FG003|Overall Study|Withdrawal by Subject|1|||
130995771|NCT01231503|471613148|FG004|Overall Study|Withdrawal by Subject|3|||
130995772|NCT01231503|471613149|FG005|Overall Study|Withdrawal by Subject|5|||
130995773|NCT01231503|471613150|FG006|Overall Study|Withdrawal by Subject|1|||
130995774|NCT01231503|471613151|FG007|Overall Study|Withdrawal by Subject|2|||
130995775|NCT01231503|471613144|FG000|Overall Study|Lost to Follow-up|8|||
130995776|NCT01231503|471613145|FG001|Overall Study|Lost to Follow-up|10|||
130995777|NCT01231503|471613146|FG002|Overall Study|Lost to Follow-up|8|||
130995778|NCT01231503|471613147|FG003|Overall Study|Lost to Follow-up|5|||
130995779|NCT01231503|471613148|FG004|Overall Study|Lost to Follow-up|7|||
130995780|NCT01231503|471613149|FG005|Overall Study|Lost to Follow-up|9|||
130995781|NCT01231503|471613150|FG006|Overall Study|Lost to Follow-up|6|||
130995782|NCT01231503|471613151|FG007|Overall Study|Lost to Follow-up|6|||
130995783|NCT01231503|471613144|FG000|Overall Study|Protocol Violation|0|||
130995784|NCT01231503|471613145|FG001|Overall Study|Protocol Violation|0|||
130995785|NCT01231503|471613146|FG002|Overall Study|Protocol Violation|0|||
130995786|NCT01231503|471613147|FG003|Overall Study|Protocol Violation|1|||
130995787|NCT01231503|471613148|FG004|Overall Study|Protocol Violation|0|||
130995788|NCT01231503|471613149|FG005|Overall Study|Protocol Violation|0|||
130995789|NCT01231503|471613150|FG006|Overall Study|Protocol Violation|0|||
130883924|NCT02113982|471209447|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883925|NCT02113982|471209448|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883926|NCT02113982|471209449|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883927|NCT02113982|471209450|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883928|NCT02113982|471209451|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883929|NCT02113982|471209452|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883930|NCT02113982|471209453|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883931|NCT02113982|471209454|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883932|NCT02113982|471209455|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883933|NCT02113982|471209456|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883934|NCT02113982|471209457|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130883935|NCT02113982|471209458|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
130883936|NCT02113982|471209459|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
130883937|NCT02113982|471209446|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883938|NCT02113982|471209447|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883939|NCT02113982|471209448|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883940|NCT02113982|471209449|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883941|NCT02113982|471209450|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883942|NCT02113982|471209451|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883943|NCT02113982|471209452|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883944|NCT02113982|471209453|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883945|NCT02113982|471209454|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883946|NCT02113982|471209455|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883947|NCT02113982|471209456|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883948|NCT02113982|471209457|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883949|NCT02113982|471209458|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
130883950|NCT02113982|471209459|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130883951|NCT02113982|471209446|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883952|NCT02113982|471209447|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883953|NCT02113982|471209448|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883954|NCT02113982|471209449|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883955|NCT02113982|471209450|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883956|NCT02113982|471209451|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883957|NCT02113982|471209452|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883958|NCT02113982|471209453|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883959|NCT02113982|471209454|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883960|NCT02113982|471209455|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883961|NCT02113982|471209456|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130995790|NCT01231503|471613151|FG007|Overall Study|Protocol Violation|0|||
130995791|NCT01586338|471613152|FG000|Overall Study|Adverse Event|3|||
130995792|NCT01586338|471613152|FG000|Overall Study|Lost to Follow-up|1|||
130995793|NCT01586338|471613152|FG000|Overall Study|Withdrawal by participant|3|||
130995794|NCT01586338|471613152|FG000|Overall Study|Other|1|||
130995795|NCT00284089|471613153|FG000|Multiple Dose Phase|Adverse Event|1|||
130995796|NCT00284089|471613154|FG001|Multiple Dose Phase|Adverse Event|0|||
130995797|NCT00284089|471613155|FG002|Multiple Dose Phase|Adverse Event|1|||
130995798|NCT00284089|471613156|FG003|Multiple Dose Phase|Adverse Event|1|||
130995799|NCT00284089|471613153|FG000|Multiple Dose Phase|Protocol Violation|0|||
130995800|NCT00284089|471613154|FG001|Multiple Dose Phase|Protocol Violation|0|||
130995801|NCT00284089|471613155|FG002|Multiple Dose Phase|Protocol Violation|1|||
130995802|NCT00284089|471613156|FG003|Multiple Dose Phase|Protocol Violation|0|||
130995803|NCT00284089|471613153|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
130995804|NCT00284089|471613154|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
130995805|NCT00284089|471613155|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
130995806|NCT00284089|471613156|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
130995807|NCT00284089|471613153|FG000|Multiple Dose Phase|Death|0|||
130995808|NCT00284089|471613154|FG001|Multiple Dose Phase|Death|0|||
130995809|NCT00284089|471613155|FG002|Multiple Dose Phase|Death|1|||
130995810|NCT00284089|471613156|FG003|Multiple Dose Phase|Death|1|||
130995811|NCT00284089|471613153|FG000|Extension Phase|Adverse Event|0|||
130995812|NCT00284089|471613154|FG001|Extension Phase|Adverse Event|0|||
130995813|NCT00284089|471613155|FG002|Extension Phase|Adverse Event|2|||
130995814|NCT00284089|471613156|FG003|Extension Phase|Adverse Event|2|||
130995815|NCT00284089|471613153|FG000|Extension Phase|condition no longer requires study drug|2|||
130995816|NCT00284089|471613154|FG001|Extension Phase|condition no longer requires study drug|0|||
130995817|NCT00284089|471613155|FG002|Extension Phase|condition no longer requires study drug|2|||
130995818|NCT00284089|471613156|FG003|Extension Phase|condition no longer requires study drug|7|||
130995819|NCT00284089|471613153|FG000|Extension Phase|Protocol Violation|0|||
130995820|NCT00284089|471613154|FG001|Extension Phase|Protocol Violation|0|||
130995821|NCT00284089|471613155|FG002|Extension Phase|Protocol Violation|1|||
130995822|NCT00284089|471613156|FG003|Extension Phase|Protocol Violation|0|||
130995823|NCT00284089|471613153|FG000|Extension Phase|Withdrawal by Subject|0|||
130995824|NCT00284089|471613154|FG001|Extension Phase|Withdrawal by Subject|0|||
130995825|NCT00284089|471613155|FG002|Extension Phase|Withdrawal by Subject|1|||
130995826|NCT00284089|471613156|FG003|Extension Phase|Withdrawal by Subject|3|||
130995827|NCT04362137|471613161|FG000|Overall Study|Death|9|||
130995828|NCT04362137|471613162|FG001|Overall Study|Death|3|||
130995829|NCT04362137|471613161|FG000|Overall Study|Patient decision|6|||
130995830|NCT04362137|471613162|FG001|Overall Study|Patient decision|3|||
130995831|NCT04362137|471613161|FG000|Overall Study|Adverse Event|1|||
130995832|NCT04362137|471613162|FG001|Overall Study|Adverse Event|0|||
130995833|NCT04362137|471613161|FG000|Overall Study|Lost to Follow-up|1|||
130995834|NCT04362137|471613162|FG001|Overall Study|Lost to Follow-up|0|||
130995835|NCT04362137|471613161|FG000|Overall Study|Protocol deviation|1|||
130995836|NCT04362137|471613162|FG001|Overall Study|Protocol deviation|0|||
130995837|NCT01868074|471613163|FG000|Overall Study|Lost to Follow-up|3|||
130995838|NCT01868074|471613164|FG001|Overall Study|Lost to Follow-up|2|||
130995839|NCT01868074|471613163|FG000|Overall Study|Withdrawal by Subject|4|||
130995840|NCT01868074|471613164|FG001|Overall Study|Withdrawal by Subject|2|||
130995841|NCT03306043|471613168|FG000|Overall Study|Adverse Event|1|||
130995842|NCT03306043|471613168|FG000|Overall Study|Lost to Follow-up|1|||
130995843|NCT03306043|471613168|FG000|Overall Study|Withdrawal by Subject|2|||
130995844|NCT00785538|471613169|FG000|Treatment Period|Adverse Event|1|||
130995845|NCT00785538|471613170|FG001|Treatment Period|Adverse Event|2|||
130995846|NCT00785538|471613171|FG002|Treatment Period|Adverse Event|2|||
130995847|NCT00785538|471613172|FG003|Treatment Period|Adverse Event|0|||
130995848|NCT00785538|471613169|FG000|Treatment Period|Withdrawal by Subject|0|||
130995849|NCT00785538|471613170|FG001|Treatment Period|Withdrawal by Subject|0|||
130995850|NCT00785538|471613171|FG002|Treatment Period|Withdrawal by Subject|0|||
130995851|NCT00785538|471613172|FG003|Treatment Period|Withdrawal by Subject|1|||
130995852|NCT01799720|471613173|FG000|Overall Study|Withdrawal by Subject|3|||
130995853|NCT01799720|471613174|FG001|Overall Study|Withdrawal by Subject|0|||
130995854|NCT01799720|471613175|FG002|Overall Study|Withdrawal by Subject|0|||
130995855|NCT01799720|471613173|FG000|Overall Study|Protocol Violation|0|||
130995856|NCT01799720|471613174|FG001|Overall Study|Protocol Violation|1|||
130995857|NCT01799720|471613175|FG002|Overall Study|Protocol Violation|0|||
130995858|NCT01799720|471613173|FG000|Overall Study|Pregnancy|0|||
130995859|NCT01799720|471613174|FG001|Overall Study|Pregnancy|0|||
130995860|NCT01799720|471613175|FG002|Overall Study|Pregnancy|1|||
130995861|NCT04276090|471613176|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
130995862|NCT04276090|471613177|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
130995863|NCT01234649|471613178|FG000|Overall Study|Withdrawal by Subject|32|||
130995864|NCT01234649|471613179|FG001|Overall Study|Withdrawal by Subject|26|||
130995865|NCT01234649|471613178|FG000|Overall Study|Pregnancy|6|||
130995866|NCT01234649|471613179|FG001|Overall Study|Pregnancy|6|||
130995867|NCT01234649|471613178|FG000|Overall Study|intolerant to side effects|4|||
130995868|NCT01234649|471613179|FG001|Overall Study|intolerant to side effects|3|||
130995869|NCT01234649|471613178|FG000|Overall Study|Allergic reaction|1|||
130995870|NCT01234649|471613179|FG001|Overall Study|Allergic reaction|0|||
130995871|NCT01234649|471613178|FG000|Overall Study|Lack of Efficacy|0|||
130995872|NCT01234649|471613179|FG001|Overall Study|Lack of Efficacy|3|||
130995873|NCT00318149|471613183|FG000|Overall Study|Adverse Event|0|||
130995874|NCT00318149|471613184|FG001|Overall Study|Adverse Event|0|||
130995875|NCT00318149|471613185|FG002|Overall Study|Adverse Event|0|||
130995876|NCT00318149|471613186|FG003|Overall Study|Adverse Event|0|||
130995877|NCT00318149|471613187|FG004|Overall Study|Adverse Event|0|||
130995878|NCT00318149|471613188|FG005|Overall Study|Adverse Event|2|||
130995879|NCT04642469|471613190|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
130995880|NCT04642469|471613191|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
130995881|NCT04642469|471613190|FG000|Overall Study|Death|1|||
130995882|NCT04642469|471613191|FG001|Overall Study|Death|2|||
130995883|NCT04642469|471613190|FG000|Overall Study|Study/site closed following amendment 1|11|||
130995884|NCT04642469|471613191|FG001|Overall Study|Study/site closed following amendment 1|11|||
130995885|NCT04642469|471613190|FG000|Overall Study|Other|1|||
130995886|NCT04642469|471613191|FG001|Overall Study|Other|1|||
130995887|NCT04642469|471613190|FG000|Overall Study|Withdrawal by Subject|1|||
130995888|NCT04642469|471613191|FG001|Overall Study|Withdrawal by Subject|0|||
130995889|NCT01461993|471613192|FG000|Overall Study|Withdrawal by Subject|60|||
130995890|NCT01461993|471613193|FG001|Overall Study|Withdrawal by Subject|53|||
130995891|NCT01461993|471613194|FG002|Overall Study|Withdrawal by Subject|16|||
130995892|NCT01461993|471613192|FG000|Overall Study|Lost to Follow-up|44|||
130995893|NCT01461993|471613193|FG001|Overall Study|Lost to Follow-up|48|||
130995894|NCT01461993|471613194|FG002|Overall Study|Lost to Follow-up|22|||
130995895|NCT01461993|471613192|FG000|Overall Study|Protocol Violation|10|||
130995896|NCT01461993|471613193|FG001|Overall Study|Protocol Violation|9|||
130995897|NCT01461993|471613194|FG002|Overall Study|Protocol Violation|7|||
130995898|NCT01461993|471613192|FG000|Overall Study|Adverse Event|9|||
130995899|NCT01461993|471613193|FG001|Overall Study|Adverse Event|11|||
130995900|NCT01461993|471613194|FG002|Overall Study|Adverse Event|3|||
130995901|NCT01461993|471613192|FG000|Overall Study|No longer met eligibility criteria|13|||
130995902|NCT01461993|471613193|FG001|Overall Study|No longer met eligibility criteria|18|||
130995903|NCT01461993|471613194|FG002|Overall Study|No longer met eligibility criteria|10|||
130995904|NCT01461993|471613192|FG000|Overall Study|Did not meet entrance criteria|2|||
130995905|NCT01461993|471613193|FG001|Overall Study|Did not meet entrance criteria|3|||
130995906|NCT01461993|471613194|FG002|Overall Study|Did not meet entrance criteria|0|||
130995907|NCT01461993|471613192|FG000|Overall Study|Other|13|||
130995908|NCT01461993|471613193|FG001|Overall Study|Other|15|||
130995909|NCT01461993|471613194|FG002|Overall Study|Other|6|||
130995910|NCT00680056|471613196|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
130995911|NCT00680056|471613197|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
130995912|NCT00680056|471613196|FG000|Second Intervention|Protocol Violation|3|||
130995913|NCT00680056|471613197|FG001|Second Intervention|Protocol Violation|1|||
130995914|NCT00219141|471613203|FG000|Overall Study|Adverse Event|4|||
130995915|NCT00219141|471613204|FG001|Overall Study|Adverse Event|10|||
130995916|NCT00219141|471613205|FG002|Overall Study|Adverse Event|5|||
130995917|NCT00219141|471613203|FG000|Overall Study|Lack of Efficacy|3|||
130995918|NCT00219141|471613204|FG001|Overall Study|Lack of Efficacy|2|||
130995919|NCT00219141|471613205|FG002|Overall Study|Lack of Efficacy|0|||
130995920|NCT00219141|471613203|FG000|Overall Study|Administrative problems|0|||
130995921|NCT00219141|471613204|FG001|Overall Study|Administrative problems|1|||
130995922|NCT00219141|471613205|FG002|Overall Study|Administrative problems|0|||
130995923|NCT00219141|471613203|FG000|Overall Study|Lost to Follow-up|2|||
130995924|NCT00219141|471613204|FG001|Overall Study|Lost to Follow-up|4|||
130995925|NCT00219141|471613205|FG002|Overall Study|Lost to Follow-up|1|||
130995926|NCT00219141|471613203|FG000|Overall Study|Protocol Violation|3|||
130995927|NCT00219141|471613204|FG001|Overall Study|Protocol Violation|1|||
130995928|NCT00219141|471613205|FG002|Overall Study|Protocol Violation|1|||
130995929|NCT00219141|471613203|FG000|Overall Study|Withdrawal by Subject|1|||
130995930|NCT00219141|471613204|FG001|Overall Study|Withdrawal by Subject|3|||
130995931|NCT00219141|471613205|FG002|Overall Study|Withdrawal by Subject|5|||
130995932|NCT00219141|471613203|FG000|Overall Study|Condition no longer requires study drug|1|||
130995933|NCT00219141|471613204|FG001|Overall Study|Condition no longer requires study drug|0|||
130995934|NCT00219141|471613205|FG002|Overall Study|Condition no longer requires study drug|0|||
130995935|NCT02838628|471613206|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
130995936|NCT02838628|471613207|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
130995937|NCT02838628|471613206|FG000|Recurrence Follow-up Period|Adverse Event|1|||
130995938|NCT02838628|471613207|FG001|Recurrence Follow-up Period|Adverse Event|0|||
130995939|NCT02838628|471613206|FG000|Recurrence Follow-up Period|Non-compliance|0|||
130995940|NCT02838628|471613207|FG001|Recurrence Follow-up Period|Non-compliance|1|||
130995941|NCT02838628|471613206|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
130995942|NCT02838628|471613207|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
130995943|NCT02838628|471613206|FG000|Recurrence Follow-up Period|Other un-specified|1|||
130995944|NCT02838628|471613207|FG001|Recurrence Follow-up Period|Other un-specified|1|||
130995945|NCT02066532|471613208|FG000|Phase II|Withdrawal by Subject|1|||
130995946|NCT02066532|471613209|FG001|Phase II|Withdrawal by Subject|0|||
130995947|NCT02066532|471613210|FG002|Phase II|Withdrawal by Subject|0|||
130995948|NCT02066532|471613211|FG003|Phase II|Withdrawal by Subject|0|||
130995949|NCT01265823|471613212|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
130995950|NCT01265823|471613212|FG000|Overall Study|Failure to Return|4|||
130995951|NCT01265823|471613212|FG000|Overall Study|Protocol Violation|1|||
130995952|NCT01265823|471613212|FG000|Overall Study|Participant Request|1|||
130995953|NCT01018563|471613217|FG000|Overall Study|Termination of the study by Sponsor|2|||
130995954|NCT01018563|471613218|FG001|Overall Study|Termination of the study by Sponsor|1|||
130995955|NCT02344537|471613221|FG000|Overall Study|Protocol Violation|1|||
130995956|NCT02344537|471613222|FG001|Overall Study|Protocol Violation|1|||
130995957|NCT02344537|471613221|FG000|Overall Study|Subject started another treatment after wk 6|1|||
130995958|NCT02344537|471613222|FG001|Overall Study|Subject started another treatment after wk 6|0|||
130995959|NCT02344537|471613221|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
130995960|NCT02344537|471613222|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
130995961|NCT00960752|471613224|FG000|Overall Study|Adverse Event|0|||
130995962|NCT00960752|471613225|FG001|Overall Study|Adverse Event|0|||
130995963|NCT00960752|471613226|FG002|Overall Study|Adverse Event|1|||
130995964|NCT00960752|471613224|FG000|Overall Study|Progression|0|||
130995965|NCT00960752|471613225|FG001|Overall Study|Progression|0|||
130995966|NCT00960752|471613226|FG002|Overall Study|Progression|1|||
130995967|NCT02180438|471613232|FG000|Overall Study|Lost to Follow-up|1|||
130995968|NCT00785707|471613234|FG000|Overall Study|Lost to Follow-up|7|||
130995969|NCT00105586|471613235|FG000|Overall Study|Adverse Event|4|||
130995970|NCT00105586|471613236|FG001|Overall Study|Adverse Event|3|||
130995971|NCT00105586|471613235|FG000|Overall Study|Physician Decision|13|||
130995972|NCT00105586|471613236|FG001|Overall Study|Physician Decision|13|||
130995973|NCT02306122|471613237|FG000|Initial Physician Randomization|Physician Decision|0|||
130995974|NCT02306122|471613238|FG001|Initial Physician Randomization|Physician Decision|0|||
130995975|NCT02306122|471613239|FG002|Initial Physician Randomization|Physician Decision|0|||
130995976|NCT02306122|471613240|FG003|Initial Physician Randomization|Physician Decision|0|||
130995977|NCT02306122|471613241|FG004|Initial Physician Randomization|Physician Decision|0|||
130995978|NCT02306122|471613242|FG005|Initial Physician Randomization|Physician Decision|0|||
130995979|NCT02306122|471613243|FG006|Initial Physician Randomization|Physician Decision|0|||
130995980|NCT02306122|471613244|FG007|Initial Physician Randomization|Physician Decision|0|||
130995981|NCT02306122|471613245|FG008|Initial Physician Randomization|Physician Decision|1|||
130995982|NCT02306122|471613246|FG009|Initial Physician Randomization|Physician Decision|0|||
130995983|NCT02306122|471613247|FG010|Initial Physician Randomization|Physician Decision|0|||
130995984|NCT02262260|471613248|FG000|Overall Study|Adverse Event|4|||
130995985|NCT02262260|471613249|FG001|Overall Study|Adverse Event|1|||
130995986|NCT02262260|471613248|FG000|Overall Study|Withdrawal of consent|4|||
130995987|NCT02262260|471613249|FG001|Overall Study|Withdrawal of consent|2|||
130995988|NCT02262260|471613248|FG000|Overall Study|Lost to Follow-up|1|||
130995989|NCT02262260|471613249|FG001|Overall Study|Lost to Follow-up|2|||
130995990|NCT02262260|471613248|FG000|Overall Study|Protocol deviation|2|||
130995991|NCT02262260|471613249|FG001|Overall Study|Protocol deviation|5|||
130995992|NCT00180713|471613255|FG000|Overall Study|Withdrawal by Subject|2|||
130995993|NCT00180713|471613256|FG001|Overall Study|Withdrawal by Subject|0|||
130995994|NCT00180713|471613255|FG000|Overall Study|Adverse Event|3|||
130995995|NCT00180713|471613256|FG001|Overall Study|Adverse Event|3|||
130995996|NCT01567865|471613258|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
130995997|NCT01567865|471613259|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
130995998|NCT01567865|471613260|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
130995999|NCT01567865|471613261|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
130996000|NCT01567865|471613258|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
130996001|NCT01567865|471613259|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
130996002|NCT01567865|471613260|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
130996003|NCT01567865|471613261|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
130996004|NCT01051063|471613266|FG000|Overall Study|Death|2|||
130996005|NCT01051063|471613267|FG001|Overall Study|Death|2|||
130996006|NCT01051063|471613266|FG000|Overall Study|Withdrawal by Subject|1|||
130996007|NCT01051063|471613267|FG001|Overall Study|Withdrawal by Subject|1|||
130883962|NCT02113982|471209457|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883963|NCT02113982|471209458|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
130883964|NCT02113982|471209459|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130883965|NCT02113982|471209446|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883966|NCT02113982|471209447|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883967|NCT02113982|471209448|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883968|NCT02113982|471209449|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883969|NCT02113982|471209450|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883970|NCT02113982|471209451|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883971|NCT02113982|471209452|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883972|NCT02113982|471209453|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883973|NCT02113982|471209454|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883974|NCT02113982|471209455|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883975|NCT02113982|471209456|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883976|NCT02113982|471209457|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883977|NCT02113982|471209458|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
130883978|NCT02113982|471209459|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130883979|NCT02085161|471209461|FG000|Overall Study|Not Treated|1|||
130883980|NCT02085161|471209462|FG001|Overall Study|Not Treated|0|||
130883981|NCT02085161|471209463|FG002|Overall Study|Not Treated|0|||
130883982|NCT02085161|471209464|FG003|Overall Study|Not Treated|0|||
130883983|NCT02085161|471209461|FG000|Overall Study|Adverse Event|8|||
130883984|NCT02085161|471209462|FG001|Overall Study|Adverse Event|5|||
130883985|NCT02085161|471209463|FG002|Overall Study|Adverse Event|4|||
130883986|NCT02085161|471209464|FG003|Overall Study|Adverse Event|5|||
130883987|NCT02085161|471209461|FG000|Overall Study|Protocol Violation|0|||
130883988|NCT02085161|471209462|FG001|Overall Study|Protocol Violation|1|||
130883989|NCT02085161|471209463|FG002|Overall Study|Protocol Violation|0|||
130883990|NCT02085161|471209464|FG003|Overall Study|Protocol Violation|1|||
130883991|NCT02085161|471209461|FG000|Overall Study|Withdrawal by Subject|2|||
130883992|NCT02085161|471209462|FG001|Overall Study|Withdrawal by Subject|4|||
130883993|NCT02085161|471209463|FG002|Overall Study|Withdrawal by Subject|0|||
130883994|NCT02085161|471209464|FG003|Overall Study|Withdrawal by Subject|3|||
130883995|NCT02085161|471209461|FG000|Overall Study|Other Reason|1|||
130883996|NCT02085161|471209462|FG001|Overall Study|Other Reason|0|||
130883997|NCT02085161|471209463|FG002|Overall Study|Other Reason|1|||
130883998|NCT02085161|471209464|FG003|Overall Study|Other Reason|1|||
130883999|NCT01774721|471209469|FG000|Overall Study|Death|133|||
130884000|NCT01774721|471209470|FG001|Overall Study|Death|152|||
130884001|NCT01774721|471209469|FG000|Overall Study|Withdrawal by Subject|20|||
130884002|NCT01774721|471209470|FG001|Overall Study|Withdrawal by Subject|14|||
130884003|NCT01774721|471209469|FG000|Overall Study|Lost to Follow-up|6|||
130884004|NCT01774721|471209470|FG001|Overall Study|Lost to Follow-up|7|||
130884005|NCT01774721|471209469|FG000|Overall Study|Did not meet eligibility criteria|0|||
130884006|NCT01774721|471209470|FG001|Overall Study|Did not meet eligibility criteria|3|||
130884007|NCT01774721|471209469|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
130884008|NCT01774721|471209470|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
130884009|NCT01774721|471209469|FG000|Overall Study|Study terminated by sponsor|5|||
130884010|NCT01774721|471209470|FG001|Overall Study|Study terminated by sponsor|0|||
130884011|NCT01774721|471209469|FG000|Overall Study|Disease progression|5|||
130884012|NCT01774721|471209470|FG001|Overall Study|Disease progression|0|||
130884013|NCT01936870|471209471|FG000|Overall Study|No Visit After Treatment|176|||
130884014|NCT01936870|471209471|FG000|Overall Study|Protocol Violation|12|||
130884015|NCT01936870|471209471|FG000|Overall Study|No Drug Administration|1|||
130884016|NCT00628108|471209481|FG000|Overall Study|Adverse Event|0|||
130884017|NCT00628108|471209482|FG001|Overall Study|Adverse Event|3|||
130884018|NCT00628108|471209481|FG000|Overall Study|Withdrawal by Subject|1|||
130884019|NCT00628108|471209482|FG001|Overall Study|Withdrawal by Subject|0|||
130884020|NCT02399163|471209485|FG000|Overall Study|Adverse Event|2|||
130884021|NCT02399163|471209485|FG000|Overall Study|Protocol Deviation|2|||
130884022|NCT02399163|471209485|FG000|Overall Study|Withdrawal by Participant|5|||
130884023|NCT04646044|471209487|FG000|Overall Study|Lost to Follow-up|0|||
130884024|NCT04646044|471209488|FG001|Overall Study|Lost to Follow-up|0|||
130884025|NCT04646044|471209489|FG002|Overall Study|Lost to Follow-up|1|||
130884026|NCT04646044|471209490|FG003|Overall Study|Lost to Follow-up|0|||
130884027|NCT04646044|471209487|FG000|Overall Study|Withdrawal by Subject|0|||
130884028|NCT04646044|471209488|FG001|Overall Study|Withdrawal by Subject|1|||
130996008|NCT01051063|471613266|FG000|Overall Study|Termination of the study|5|||
131100688|NCT00468104|471998069|FG000|First Intervention|trapped lung|1|||
130996009|NCT01051063|471613267|FG001|Overall Study|Termination of the study|0|||
130996010|NCT01051063|471613266|FG000|Overall Study|Moved from the study site area|1|||
130996011|NCT01051063|471613267|FG001|Overall Study|Moved from the study site area|0|||
130996012|NCT01051063|471613266|FG000|Overall Study|Other|1|||
130996013|NCT01051063|471613267|FG001|Overall Study|Other|0|||
130996014|NCT01051063|471613266|FG000|Overall Study|Lost to Follow-up|0|||
130996015|NCT01051063|471613267|FG001|Overall Study|Lost to Follow-up|1|||
130996016|NCT03857841|471613269|FG000|Overall Study|Death|1|||
130996017|NCT03857841|471613270|FG001|Overall Study|Death|0|||
130996018|NCT03857841|471613271|FG002|Overall Study|Death|0|||
130996019|NCT03857841|471613272|FG003|Overall Study|Death|0|||
130996020|NCT03857841|471613269|FG000|Overall Study|Study Terminated by Sponsor|1|||
130996021|NCT03857841|471613270|FG001|Overall Study|Study Terminated by Sponsor|0|||
130996022|NCT03857841|471613271|FG002|Overall Study|Study Terminated by Sponsor|0|||
130996023|NCT03857841|471613272|FG003|Overall Study|Study Terminated by Sponsor|0|||
130996024|NCT04921969|471613273|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
130996025|NCT04921969|471613274|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
130996026|NCT04921969|471613275|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
130996027|NCT04921969|471613276|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
130996028|NCT04921969|471613277|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
130996029|NCT04921969|471613278|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
130996030|NCT04921969|471613279|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
130996031|NCT04921969|471613273|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
130996032|NCT04921969|471613274|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130996033|NCT04921969|471613275|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130996034|NCT04921969|471613276|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130996035|NCT04921969|471613277|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130996036|NCT04921969|471613278|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130996037|NCT04921969|471613279|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130996038|NCT04921969|471613273|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
130996039|NCT04921969|471613274|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
130996040|NCT04921969|471613275|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
130996041|NCT04921969|471613276|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130996042|NCT04921969|471613277|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130996043|NCT04921969|471613278|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130996044|NCT04921969|471613279|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130996045|NCT04921969|471613273|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
130996046|NCT04921969|471613274|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
130996047|NCT04921969|471613275|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
130996048|NCT04921969|471613276|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
130996049|NCT04921969|471613277|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
130996050|NCT04921969|471613278|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
130996051|NCT04921969|471613279|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
130996052|NCT04921969|471613273|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130996053|NCT04921969|471613274|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130996054|NCT04921969|471613275|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
130996055|NCT04921969|471613276|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130996056|NCT04921969|471613277|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130996057|NCT04921969|471613278|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130996058|NCT04921969|471613279|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
130996059|NCT04921969|471613273|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
130996060|NCT04921969|471613274|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
130996061|NCT04921969|471613275|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
130996062|NCT04921969|471613276|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130996063|NCT04921969|471613277|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130996064|NCT04921969|471613278|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130996065|NCT04921969|471613279|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130996066|NCT04921969|471613273|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
130996067|NCT04921969|471613274|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
130996068|NCT04921969|471613275|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
130996069|NCT04921969|471613276|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
130996070|NCT04921969|471613277|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
130996071|NCT04921969|471613278|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
130996072|NCT04921969|471613279|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
130996073|NCT04921969|471613273|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130996074|NCT04921969|471613274|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130996075|NCT04921969|471613275|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130996076|NCT04921969|471613276|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130996077|NCT04921969|471613277|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130996078|NCT04921969|471613278|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
130996079|NCT04921969|471613279|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
131221513|NCT00975884|472437979|FG001|Overall Study|Other|3|||
130884029|NCT04646044|471209489|FG002|Overall Study|Withdrawal by Subject|0|||
130884030|NCT04646044|471209490|FG003|Overall Study|Withdrawal by Subject|0|||
130884031|NCT01409707|471209491|FG000|Overall Study|Withdrawal by Subject|5|||
130884032|NCT01409707|471209492|FG001|Overall Study|Withdrawal by Subject|17|||
130884033|NCT01409707|471209493|FG002|Overall Study|Withdrawal by Subject|16|||
130884034|NCT01929317|471209494|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
130884035|NCT01929317|471209495|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
130884036|NCT01929317|471209494|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
130884037|NCT01929317|471209495|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
130884038|NCT01929317|471209494|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
130884039|NCT01929317|471209495|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
130884040|NCT01929317|471209494|FG000|Long-term Phase|Adverse Event|5|||
130884041|NCT01929317|471209495|FG001|Long-term Phase|Adverse Event|1|||
130884042|NCT01929317|471209494|FG000|Long-term Phase|Physician Decision|3|||
130884043|NCT01929317|471209495|FG001|Long-term Phase|Physician Decision|0|||
130884044|NCT01929317|471209494|FG000|Long-term Phase|Withdrawal by Subject|4|||
130884045|NCT01929317|471209495|FG001|Long-term Phase|Withdrawal by Subject|0|||
130884046|NCT01929317|471209494|FG000|Long-term Phase|Protocol Violation|1|||
130884047|NCT01929317|471209495|FG001|Long-term Phase|Protocol Violation|0|||
130884048|NCT01929317|471209494|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
130884049|NCT01929317|471209495|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
130884050|NCT01929317|471209494|FG000|Long-term Phase|Study Closed/Terminated|5|||
130884051|NCT01929317|471209495|FG001|Long-term Phase|Study Closed/Terminated|3|||
130884052|NCT01523756|471209496|FG000|Baseline Period|Adverse Event|0|||
130884053|NCT01523756|471209497|FG001|Baseline Period|Adverse Event|1|||
130884054|NCT01523756|471209496|FG000|Test Period 1|Adverse Event|1|||
130884055|NCT01523756|471209497|FG001|Test Period 1|Adverse Event|0|||
130884056|NCT01523756|471209496|FG000|Test Period 2|Withdrawal by Subject|0|||
130884057|NCT01523756|471209497|FG001|Test Period 2|Withdrawal by Subject|1|||
130884058|NCT02195518|471209498|FG000|Overall Study|Adverse Event|1|||
130884059|NCT02195518|471209498|FG000|Overall Study|Protocol Violation|4|||
130884060|NCT02195518|471209498|FG000|Overall Study|Pregnancy|2|||
130884061|NCT02195518|471209498|FG000|Overall Study|Withdrawal by Subject|1|||
130884062|NCT02195518|471209498|FG000|Overall Study|Lost to Follow-up|1|||
130884063|NCT04949490|471209499|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130884064|NCT04949490|471209500|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130884065|NCT04949490|471209501|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130884066|NCT04949490|471209502|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
130884067|NCT04949490|471209503|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130884068|NCT04949490|471209504|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130884069|NCT04949490|471209499|FG000|Group A and Group B|Withdrawal by Subject|0|||
130884070|NCT04949490|471209500|FG001|Group A and Group B|Withdrawal by Subject|0|||
130884071|NCT04949490|471209501|FG002|Group A and Group B|Withdrawal by Subject|1|||
130884072|NCT04949490|471209502|FG003|Group A and Group B|Withdrawal by Subject|0|||
130884073|NCT04949490|471209503|FG004|Group A and Group B|Withdrawal by Subject|0|||
130884074|NCT04949490|471209504|FG005|Group A and Group B|Withdrawal by Subject|0|||
130884075|NCT04949490|471209499|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130884076|NCT04949490|471209500|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130884077|NCT04949490|471209501|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130884078|NCT04949490|471209502|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130884079|NCT04949490|471209503|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130884080|NCT04949490|471209504|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
130884081|NCT04949490|471209499|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130884082|NCT04949490|471209500|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130884083|NCT04949490|471209501|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130884084|NCT04949490|471209502|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130884085|NCT04949490|471209503|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
130884086|NCT04949490|471209504|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130884087|NCT02017405|471209505|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130884088|NCT02017405|471209506|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130884089|NCT02017405|471209507|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130884090|NCT02017405|471209508|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130884091|NCT02017405|471209509|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130884092|NCT02017405|471209510|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
130884093|NCT02017405|471209505|FG000|Open-label Phase|Adverse Event|1|||
130884094|NCT02017405|471209506|FG001|Open-label Phase|Adverse Event|1|||
130884095|NCT02017405|471209507|FG002|Open-label Phase|Adverse Event|0|||
130884096|NCT02017405|471209508|FG003|Open-label Phase|Adverse Event|0|||
131221514|NCT01656967|472437980|FG000|Overall Study|faulty monitor|1|||
130996080|NCT04921969|471613273|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130996081|NCT04921969|471613274|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130996082|NCT04921969|471613275|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130996083|NCT04921969|471613276|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
130996084|NCT04921969|471613277|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130996085|NCT04921969|471613278|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
130996086|NCT04921969|471613279|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
130996087|NCT04921969|471613273|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130996088|NCT04921969|471613274|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130996089|NCT04921969|471613275|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130996090|NCT04921969|471613276|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
130996091|NCT04921969|471613277|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
130996092|NCT04921969|471613278|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
130996093|NCT04921969|471613279|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
130996094|NCT04921969|471613273|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
130996095|NCT04921969|471613274|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
130996096|NCT04921969|471613275|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
130996097|NCT04921969|471613276|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
130996098|NCT04921969|471613277|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
130996099|NCT04921969|471613278|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
130996100|NCT04921969|471613279|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
130996101|NCT04921969|471613273|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130996102|NCT04921969|471613274|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130996103|NCT04921969|471613275|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130996104|NCT04921969|471613276|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
130996105|NCT04921969|471613277|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
130996106|NCT04921969|471613278|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
130996107|NCT04921969|471613279|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
130996108|NCT04921969|471613273|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130996109|NCT04921969|471613274|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130996110|NCT04921969|471613275|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130996111|NCT04921969|471613276|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
130996112|NCT04921969|471613277|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130996113|NCT04921969|471613278|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
130996114|NCT04921969|471613279|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
130996115|NCT04921969|471613273|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130996116|NCT04921969|471613274|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130996117|NCT04921969|471613275|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130996118|NCT04921969|471613276|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
130996119|NCT04921969|471613277|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130996120|NCT04921969|471613278|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130996121|NCT04921969|471613279|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
130996122|NCT04921969|471613273|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
130996123|NCT04921969|471613274|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
130996124|NCT04921969|471613275|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
130996125|NCT04921969|471613276|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
130996126|NCT04921969|471613277|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
130996127|NCT04921969|471613278|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
130996128|NCT04921969|471613279|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
130996129|NCT03518658|471614903|FG000|Overall Study|Other|51|||
130996130|NCT03518658|471614904|FG001|Overall Study|Other|0|||
130996131|NCT02531295|471614905|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
130996132|NCT02531295|471614906|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
130996133|NCT02531295|471614907|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
130996134|NCT02531295|471614908|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
130996135|NCT02531295|471614909|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
130996136|NCT02531295|471614910|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
130996137|NCT03884231|471614913|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
130996138|NCT03884231|471614913|FG000|Overall Study|Subject Withdrew Consent|1|||
130996139|NCT03884231|471614913|FG000|Overall Study|MRI Scan Not Performed|1|||
130996140|NCT01853254|471614914|FG000|Overall Study|Abnormal Laboratory Test|1|||
130996141|NCT01853254|471614914|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
130996142|NCT01853254|471614914|FG000|Overall Study|Death|1|||
130996143|NCT01853254|471614914|FG000|Overall Study|Failure to Return|43|||
130996144|NCT01853254|471614914|FG000|Overall Study|Insufficient Therapeutic Response|22|||
130996145|NCT01853254|471614914|FG000|Overall Study|Refusal of Treatment|1|||
130996146|NCT01853254|471614914|FG000|Overall Study|Other Protocol Violation|1|||
130996147|NCT01853254|471614914|FG000|Overall Study|Withdrawal of Consent|16|||
130996148|NCT01853254|471614914|FG000|Overall Study|Administrative/Other|16|||
130996149|NCT01017120|471614920|FG000|Overall Study|Adverse Event|9|||
130996150|NCT01017120|471614921|FG001|Overall Study|Adverse Event|0|||
130996151|NCT01017120|471614920|FG000|Overall Study|Lost to Follow-up|13|||
130996152|NCT01017120|471614921|FG001|Overall Study|Lost to Follow-up|11|||
130996153|NCT01017120|471614920|FG000|Overall Study|Lack of Efficacy|1|||
130996154|NCT01017120|471614921|FG001|Overall Study|Lack of Efficacy|0|||
130996155|NCT01017120|471614920|FG000|Overall Study|Withdrawal by Subject|39|||
130996156|NCT01017120|471614921|FG001|Overall Study|Withdrawal by Subject|21|||
130996157|NCT01017120|471614920|FG000|Overall Study|Pregnancy|1|||
130996158|NCT01017120|471614921|FG001|Overall Study|Pregnancy|1|||
130996159|NCT01017120|471614920|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
130996160|NCT01017120|471614921|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
130996161|NCT01017120|471614920|FG000|Overall Study|Relocated Out of Town|0|||
130996162|NCT01017120|471614921|FG001|Overall Study|Relocated Out of Town|2|||
130996163|NCT01017120|471614920|FG000|Overall Study|Protocol Violation|1|||
130996164|NCT01017120|471614921|FG001|Overall Study|Protocol Violation|0|||
130996165|NCT01017120|471614920|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
130996166|NCT01017120|471614921|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
130996167|NCT01087723|471614922|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
130996168|NCT01087723|471614923|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
130996169|NCT01087723|471614922|FG000|Overall Study|Withdrawal by Subject|10|||
130996170|NCT01087723|471614923|FG001|Overall Study|Withdrawal by Subject|13|||
130996171|NCT01087723|471614922|FG000|Overall Study|Physician Decision|2|||
130996172|NCT01087723|471614923|FG001|Overall Study|Physician Decision|0|||
130996173|NCT01087723|471614922|FG000|Overall Study|Lost to Follow-up|1|||
130996174|NCT01087723|471614923|FG001|Overall Study|Lost to Follow-up|4|||
130996175|NCT01087723|471614922|FG000|Overall Study|Reason Not Specified|1|||
130996176|NCT01087723|471614923|FG001|Overall Study|Reason Not Specified|2|||
130996177|NCT00806624|471614924|FG000|Overall Study|Adverse Event|2|||
130996178|NCT00806624|471614925|FG001|Overall Study|Adverse Event|8|||
130996179|NCT00806624|471614926|FG002|Overall Study|Adverse Event|0|||
130996180|NCT00806624|471614924|FG000|Overall Study|Death|0|||
130996181|NCT00806624|471614925|FG001|Overall Study|Death|1|||
130996182|NCT00806624|471614926|FG002|Overall Study|Death|1|||
130996183|NCT00806624|471614924|FG000|Overall Study|Lost to Follow-up|1|||
130996184|NCT00806624|471614925|FG001|Overall Study|Lost to Follow-up|0|||
130996185|NCT00806624|471614926|FG002|Overall Study|Lost to Follow-up|1|||
130996186|NCT00806624|471614924|FG000|Overall Study|Withdrawal by Subject|6|||
130996187|NCT00806624|471614925|FG001|Overall Study|Withdrawal by Subject|3|||
130996188|NCT00806624|471614926|FG002|Overall Study|Withdrawal by Subject|3|||
130996189|NCT00806624|471614924|FG000|Overall Study|discontinued before start of treatment|0|||
130996190|NCT00806624|471614925|FG001|Overall Study|discontinued before start of treatment|0|||
130996191|NCT00806624|471614926|FG002|Overall Study|discontinued before start of treatment|1|||
130996192|NCT01702428|471614928|FG000|Overall Study|Adverse Event|2|||
130996193|NCT01702428|471614929|FG001|Overall Study|Adverse Event|0|||
130996194|NCT01702428|471614930|FG002|Overall Study|Adverse Event|0|||
130996195|NCT01702428|471614931|FG003|Overall Study|Adverse Event|0|||
130996196|NCT01702428|471614928|FG000|Overall Study|Lost to Follow-up|33|||
130996197|NCT01702428|471614929|FG001|Overall Study|Lost to Follow-up|41|||
130996198|NCT01702428|471614930|FG002|Overall Study|Lost to Follow-up|37|||
130996199|NCT01702428|471614931|FG003|Overall Study|Lost to Follow-up|44|||
130996200|NCT01702428|471614928|FG000|Overall Study|Parents cannot assist to site|1|||
130996201|NCT01702428|471614929|FG001|Overall Study|Parents cannot assist to site|0|||
130996202|NCT01702428|471614930|FG002|Overall Study|Parents cannot assist to site|1|||
130996203|NCT01702428|471614931|FG003|Overall Study|Parents cannot assist to site|0|||
130996204|NCT01702428|471614928|FG000|Overall Study|Lost Coverage|0|||
130996205|NCT01702428|471614929|FG001|Overall Study|Lost Coverage|0|||
130996206|NCT01702428|471614930|FG002|Overall Study|Lost Coverage|0|||
130996207|NCT01702428|471614931|FG003|Overall Study|Lost Coverage|1|||
130996208|NCT01702428|471614928|FG000|Overall Study|Lost Health Plan|3|||
130996209|NCT01702428|471614929|FG001|Overall Study|Lost Health Plan|5|||
130996210|NCT01702428|471614930|FG002|Overall Study|Lost Health Plan|0|||
130996211|NCT01702428|471614931|FG003|Overall Study|Lost Health Plan|2|||
130996212|NCT01702428|471614928|FG000|Overall Study|Mother transferred care|0|||
130996213|NCT01702428|471614929|FG001|Overall Study|Mother transferred care|1|||
130996214|NCT01702428|471614930|FG002|Overall Study|Mother transferred care|0|||
131221515|NCT01656967|472437981|FG001|Overall Study|faulty monitor|0|||
131221516|NCT01656967|472437980|FG000|Overall Study|unsuccessful ETT insertion|3|||
131221517|NCT01656967|472437981|FG001|Overall Study|unsuccessful ETT insertion|2|||
131221518|NCT00479765|472437982|FG000|Overall Study|study terminated|4|||
131221519|NCT00420849|472437983|FG000|Overall Study|Lack of Efficacy|154|||
131100689|NCT00468104|471998070|FG001|First Intervention|trapped lung|0|||
130996215|NCT01702428|471614931|FG003|Overall Study|Mother transferred care|0|||
130996216|NCT01702428|471614928|FG000|Overall Study|Parents too busy|1|||
130996217|NCT01702428|471614929|FG001|Overall Study|Parents too busy|0|||
130996218|NCT01702428|471614930|FG002|Overall Study|Parents too busy|0|||
130996219|NCT01702428|471614931|FG003|Overall Study|Parents too busy|0|||
130996220|NCT01702428|471614928|FG000|Overall Study|Protocol Violation|3|||
130996221|NCT01702428|471614929|FG001|Overall Study|Protocol Violation|0|||
130996222|NCT01702428|471614930|FG002|Overall Study|Protocol Violation|1|||
130996223|NCT01702428|471614931|FG003|Overall Study|Protocol Violation|0|||
130996224|NCT01702428|471614928|FG000|Overall Study|Withdrawal by Subject|21|||
130996225|NCT01702428|471614929|FG001|Overall Study|Withdrawal by Subject|23|||
130996226|NCT01702428|471614930|FG002|Overall Study|Withdrawal by Subject|14|||
130996227|NCT01702428|471614931|FG003|Overall Study|Withdrawal by Subject|10|||
130996228|NCT00154063|471614934|FG000|Overall Study|Adverse Event|4|||
130996229|NCT00154063|471614935|FG001|Overall Study|Adverse Event|8|||
130996230|NCT00154063|471614934|FG000|Overall Study|Protocol Violation|1|||
130996231|NCT00154063|471614935|FG001|Overall Study|Protocol Violation|1|||
130996232|NCT00154063|471614934|FG000|Overall Study|Investigator or Sponsor Request|0|||
130996233|NCT00154063|471614935|FG001|Overall Study|Investigator or Sponsor Request|1|||
130996234|NCT00154063|471614934|FG000|Overall Study|Withdrawal by Subject|4|||
130996235|NCT00154063|471614935|FG001|Overall Study|Withdrawal by Subject|9|||
130996236|NCT00154063|471614934|FG000|Overall Study|Other|3|||
130996237|NCT00154063|471614935|FG001|Overall Study|Other|3|||
130996238|NCT02091869|471614936|FG000|Overall Study|Withdrawal by Subject|0|||
130996239|NCT02091869|471614937|FG001|Overall Study|Withdrawal by Subject|3|||
130996240|NCT00451217|471614946|FG000|Overall Study|Lost to Follow-up|0|||
130996241|NCT00451217|471614947|FG001|Overall Study|Lost to Follow-up|1|||
130996242|NCT00451217|471614948|FG002|Overall Study|Lost to Follow-up|1|||
130996243|NCT00451217|471614949|FG003|Overall Study|Lost to Follow-up|1|||
130996244|NCT00451217|471614946|FG000|Overall Study|Withdrawal by Subject|1|||
130996245|NCT00451217|471614947|FG001|Overall Study|Withdrawal by Subject|0|||
130996246|NCT00451217|471614948|FG002|Overall Study|Withdrawal by Subject|0|||
130996247|NCT00451217|471614949|FG003|Overall Study|Withdrawal by Subject|0|||
130996248|NCT00451217|471614946|FG000|Overall Study|Not Treated|1|||
130996249|NCT00451217|471614947|FG001|Overall Study|Not Treated|1|||
130996250|NCT00451217|471614948|FG002|Overall Study|Not Treated|3|||
130996251|NCT00451217|471614949|FG003|Overall Study|Not Treated|4|||
130996252|NCT04668989|471614950|FG000|First Intervention|Covid-19 related self-isolation|0|||
130996253|NCT04668989|471614951|FG001|First Intervention|Covid-19 related self-isolation|1|||
130996254|NCT04668989|471614950|FG000|Second Intervention|Adverse Event|0|||
130996255|NCT04668989|471614951|FG001|Second Intervention|Adverse Event|1|||
130996256|NCT01622348|471614956|FG000|Overall Study|Withdrawal by Subject|1|||
130996257|NCT01622348|471614957|FG001|Overall Study|Withdrawal by Subject|0|||
130996258|NCT01622348|471614958|FG002|Overall Study|Withdrawal by Subject|1|||
130996259|NCT01592695|471614965|FG000|Overall Study|Lost to Follow-up|8|||
130996260|NCT01592695|471614966|FG001|Overall Study|Lost to Follow-up|4|||
130996261|NCT00467142|471614967|FG000|Overall Study|Withdrawal by Subject|1|||
130996262|NCT00467142|471614967|FG000|Overall Study|Adverse Event|1|||
130996263|NCT00467142|471614967|FG000|Overall Study|Protocol Violation|1|||
130996264|NCT00919893|471614968|FG000|Overall Study|Protocol Violation|19|||
130996265|NCT00919893|471614969|FG001|Overall Study|Protocol Violation|9|||
130996266|NCT03893825|471614974|FG000|Overall Study|Death|2|||
130996267|NCT03893825|471614975|FG001|Overall Study|Death|1|||
130996268|NCT03893825|471614974|FG000|Overall Study|Adverse Event|0|||
130996269|NCT03893825|471614975|FG001|Overall Study|Adverse Event|2|||
130996270|NCT03893825|471614974|FG000|Overall Study|Withdrawal by Subject|19|||
130996271|NCT03893825|471614975|FG001|Overall Study|Withdrawal by Subject|21|||
130996272|NCT03893825|471614974|FG000|Overall Study|Protocol deviation|1|||
130996273|NCT03893825|471614975|FG001|Overall Study|Protocol deviation|0|||
130996274|NCT03893825|471614974|FG000|Overall Study|Lost to Follow-up|10|||
130996275|NCT03893825|471614975|FG001|Overall Study|Lost to Follow-up|10|||
130996276|NCT03893825|471614974|FG000|Overall Study|Other than specified|7|||
130996277|NCT03893825|471614975|FG001|Overall Study|Other than specified|6|||
130996278|NCT00251927|471614978|FG000|Overall Study|Adverse Event|3|||
130996279|NCT00251927|471614979|FG001|Overall Study|Adverse Event|15|||
130996280|NCT00251927|471614978|FG000|Overall Study|Lack of Efficacy|22|||
130996281|NCT00251927|471614979|FG001|Overall Study|Lack of Efficacy|16|||
130996282|NCT00251927|471614978|FG000|Overall Study|Lost to Follow-up|22|||
130996283|NCT00251927|471614979|FG001|Overall Study|Lost to Follow-up|8|||
130996284|NCT00251927|471614978|FG000|Overall Study|Protocol Violation|1|||
130996285|NCT00251927|471614979|FG001|Overall Study|Protocol Violation|2|||
130996286|NCT00251927|471614978|FG000|Overall Study|Pregnancy|2|||
130996287|NCT00251927|471614979|FG001|Overall Study|Pregnancy|0|||
130996288|NCT00251927|471614978|FG000|Overall Study|Withdrawal by Subject|40|||
130996289|NCT00251927|471614979|FG001|Overall Study|Withdrawal by Subject|25|||
130996290|NCT00251927|471614978|FG000|Overall Study|Study-specific discont. achieved|13|||
130996291|NCT00251927|471614979|FG001|Overall Study|Study-specific discont. achieved|2|||
130996292|NCT00251927|471614978|FG000|Overall Study|Study procedure non-compliance|5|||
130884097|NCT02017405|471209509|FG004|Open-label Phase|Adverse Event|0|||
130884098|NCT02017405|471209510|FG005|Open-label Phase|Adverse Event|0|||
130884099|NCT02864394|471209512|FG000|Overall Study|Death|184|||
130884100|NCT02864394|471209513|FG001|Overall Study|Death|189|||
130884101|NCT02864394|471209512|FG000|Overall Study|Lost to Follow-up|0|||
130884102|NCT02864394|471209513|FG001|Overall Study|Lost to Follow-up|2|||
130884103|NCT02864394|471209512|FG000|Overall Study|Sponsor Decision|26|||
130884104|NCT02864394|471209513|FG001|Overall Study|Sponsor Decision|11|||
130884105|NCT02864394|471209512|FG000|Overall Study|Withdrawal by Subject|3|||
130884106|NCT02864394|471209513|FG001|Overall Study|Withdrawal by Subject|10|||
130884107|NCT04730804|471209518|FG000|Overall Study|Physician Decision|0|||
130884108|NCT04730804|471209519|FG001|Overall Study|Physician Decision|0|||
130884109|NCT04730804|471209520|FG002|Overall Study|Physician Decision|0|||
130884110|NCT04730804|471209521|FG003|Overall Study|Physician Decision|0|||
130884111|NCT04730804|471209522|FG004|Overall Study|Physician Decision|0|||
130884112|NCT04730804|471209523|FG005|Overall Study|Physician Decision|1|||
130884113|NCT04730804|471209518|FG000|Overall Study|Withdrawal by Subject|0|||
130884114|NCT04730804|471209519|FG001|Overall Study|Withdrawal by Subject|0|||
130884115|NCT04730804|471209520|FG002|Overall Study|Withdrawal by Subject|0|||
130884116|NCT04730804|471209521|FG003|Overall Study|Withdrawal by Subject|0|||
130884117|NCT04730804|471209522|FG004|Overall Study|Withdrawal by Subject|1|||
130884118|NCT04730804|471209523|FG005|Overall Study|Withdrawal by Subject|2|||
130884119|NCT00463567|471211428|FG000|Overall Study|Adverse Event|29|||
130884120|NCT00463567|471211429|FG001|Overall Study|Adverse Event|26|||
130884121|NCT00463567|471211430|FG002|Overall Study|Adverse Event|17|||
130884122|NCT00463567|471211431|FG003|Overall Study|Adverse Event|46|||
130884123|NCT00463567|471211432|FG004|Overall Study|Adverse Event|10|||
130884124|NCT00463567|471211433|FG005|Overall Study|Adverse Event|10|||
130884125|NCT00463567|471211434|FG006|Overall Study|Adverse Event|4|||
130884126|NCT00463567|471211428|FG000|Overall Study|Withdrawal by Subject|29|||
130884127|NCT00463567|471211429|FG001|Overall Study|Withdrawal by Subject|22|||
130884128|NCT00463567|471211430|FG002|Overall Study|Withdrawal by Subject|20|||
130884129|NCT00463567|471211431|FG003|Overall Study|Withdrawal by Subject|37|||
130884130|NCT00463567|471211432|FG004|Overall Study|Withdrawal by Subject|6|||
130884131|NCT00463567|471211433|FG005|Overall Study|Withdrawal by Subject|5|||
130884132|NCT00463567|471211434|FG006|Overall Study|Withdrawal by Subject|1|||
130884133|NCT00463567|471211428|FG000|Overall Study|Protocol Deviation|13|||
130884134|NCT00463567|471211429|FG001|Overall Study|Protocol Deviation|9|||
130884135|NCT00463567|471211430|FG002|Overall Study|Protocol Deviation|14|||
130884136|NCT00463567|471211431|FG003|Overall Study|Protocol Deviation|11|||
130884137|NCT00463567|471211432|FG004|Overall Study|Protocol Deviation|1|||
130884138|NCT00463567|471211433|FG005|Overall Study|Protocol Deviation|1|||
130884139|NCT00463567|471211434|FG006|Overall Study|Protocol Deviation|2|||
130884140|NCT00463567|471211428|FG000|Overall Study|Lost to Follow-up|12|||
130884141|NCT00463567|471211429|FG001|Overall Study|Lost to Follow-up|6|||
130884142|NCT00463567|471211430|FG002|Overall Study|Lost to Follow-up|13|||
130884143|NCT00463567|471211431|FG003|Overall Study|Lost to Follow-up|8|||
130884144|NCT00463567|471211432|FG004|Overall Study|Lost to Follow-up|1|||
130884145|NCT00463567|471211433|FG005|Overall Study|Lost to Follow-up|1|||
130884146|NCT00463567|471211434|FG006|Overall Study|Lost to Follow-up|1|||
130884147|NCT00463567|471211428|FG000|Overall Study|Administrative problems|5|||
130884148|NCT00463567|471211429|FG001|Overall Study|Administrative problems|3|||
130884149|NCT00463567|471211430|FG002|Overall Study|Administrative problems|6|||
130884150|NCT00463567|471211431|FG003|Overall Study|Administrative problems|9|||
130884151|NCT00463567|471211432|FG004|Overall Study|Administrative problems|3|||
130884152|NCT00463567|471211433|FG005|Overall Study|Administrative problems|2|||
130884153|NCT00463567|471211434|FG006|Overall Study|Administrative problems|2|||
130884154|NCT00463567|471211428|FG000|Overall Study|Lack of Efficacy|4|||
130884155|NCT00463567|471211429|FG001|Overall Study|Lack of Efficacy|9|||
130884156|NCT00463567|471211430|FG002|Overall Study|Lack of Efficacy|9|||
130884157|NCT00463567|471211431|FG003|Overall Study|Lack of Efficacy|17|||
130996293|NCT00251927|471614979|FG001|Overall Study|Study procedure non-compliance|6|||
130996294|NCT04012814|471614986|FG000|Overall Study|Lost to Follow-up|4|||
131221520|NCT00420849|472437983|FG000|Overall Study|Adverse Event|107|||
130884158|NCT00463567|471211432|FG004|Overall Study|Lack of Efficacy|1|||
130884159|NCT00463567|471211433|FG005|Overall Study|Lack of Efficacy|0|||
130884160|NCT00463567|471211434|FG006|Overall Study|Lack of Efficacy|1|||
130884161|NCT00463567|471211428|FG000|Overall Study|Abnormal lab value(s)|1|||
130884162|NCT00463567|471211429|FG001|Overall Study|Abnormal lab value(s)|1|||
130884163|NCT00463567|471211430|FG002|Overall Study|Abnormal lab value(s)|2|||
130884164|NCT00463567|471211431|FG003|Overall Study|Abnormal lab value(s)|1|||
130884165|NCT00463567|471211432|FG004|Overall Study|Abnormal lab value(s)|1|||
131221521|NCT00420849|472437983|FG000|Overall Study|Withdrawal by Subject|28|||
131221522|NCT00420849|472437983|FG000|Overall Study|Death|18|||
131221523|NCT00420849|472437983|FG000|Overall Study|Other|14|||
131221524|NCT00420849|472437983|FG000|Overall Study|Transplant|8|||
131221525|NCT00420849|472437983|FG000|Overall Study|Protocol Violation|1|||
131221526|NCT00420849|472437983|FG000|Overall Study|Lost to Follow-up|1|||
131221527|NCT00944125|472437984|FG000|3 to 6 Months|Withdrawal by Subject|0|||
130996295|NCT04012814|471614986|FG000|Overall Study|Withdrawal by Subject|2|||
130996296|NCT04012814|471614986|FG000|Overall Study|Protocol Violation|1|||
130996297|NCT04012814|471614986|FG000|Overall Study|Adverse Event|1|||
130996298|NCT01275196|471614992|FG000|Overall Study|Adverse Event|3|||
130996299|NCT01275196|471614993|FG001|Overall Study|Adverse Event|5|||
130996300|NCT01275196|471614992|FG000|Overall Study|Withdrawal by Subject|4|||
130996301|NCT01275196|471614993|FG001|Overall Study|Withdrawal by Subject|5|||
130996302|NCT01275196|471614992|FG000|Overall Study|Lost to Follow-up|1|||
130996303|NCT01275196|471614993|FG001|Overall Study|Lost to Follow-up|0|||
130996304|NCT01275196|471614992|FG000|Overall Study|Disease Progression|6|||
130996305|NCT01275196|471614993|FG001|Overall Study|Disease Progression|5|||
130996306|NCT01275196|471614992|FG000|Overall Study|Protocol Violation|1|||
130996307|NCT01275196|471614993|FG001|Overall Study|Protocol Violation|0|||
130996308|NCT01275196|471614992|FG000|Overall Study|Suboptimal response/treatment failure|5|||
130996309|NCT01275196|471614993|FG001|Overall Study|Suboptimal response/treatment failure|6|||
130996310|NCT02406261|471614994|FG000|Period 1|Lost to Follow-up|2|||
130996311|NCT02406261|471614995|FG001|Period 1|Lost to Follow-up|0|||
130996312|NCT02406261|471614994|FG000|Period 1|Adverse Event|1|||
130996313|NCT02406261|471614995|FG001|Period 1|Adverse Event|0|||
130996314|NCT02406261|471614994|FG000|Period 2|Physician Decision|0|||
130996315|NCT02406261|471614995|FG001|Period 2|Physician Decision|1|||
130996316|NCT02406261|471614994|FG000|Period 2|Protocol Violation|0|||
130996317|NCT02406261|471614995|FG001|Period 2|Protocol Violation|1|||
130996318|NCT02406261|471614994|FG000|Period 2|Withdrawal by Subject|0|||
130996319|NCT02406261|471614995|FG001|Period 2|Withdrawal by Subject|1|||
130996320|NCT02572817|471614996|FG000|Overall Study|Death|6|||
130996321|NCT02572817|471614997|FG001|Overall Study|Death|3|||
130996322|NCT02572817|471614996|FG000|Overall Study|Lost to Follow-up|3|||
130996323|NCT02572817|471614997|FG001|Overall Study|Lost to Follow-up|3|||
130996324|NCT02222896|471615000|FG000|Abdomen|Did not qualify|34|||
130996325|NCT02222896|471615001|FG001|Abdomen|Did not qualify|10|||
130996326|NCT02222896|471615002|FG002|Abdomen|Did not qualify|32|||
130996327|NCT02222896|471615000|FG000|Groin|Did not qualify|43|||
130996328|NCT02222896|471615001|FG001|Groin|Did not qualify|9|||
130996329|NCT02222896|471615002|FG002|Groin|Did not qualify|40|||
130996330|NCT02226172|471615007|FG000|Overall Study|Participant refused further follow-up|4|||
130996331|NCT02226172|471615007|FG000|Overall Study|Other|5|||
130996332|NCT02226172|471615007|FG000|Overall Study|Death|1|||
130996333|NCT02226172|471615007|FG000|Overall Study|Study terminated by sponsor|1|||
130996334|NCT02226172|471615007|FG000|Overall Study|Adverse Event|6|||
130996335|NCT01865617|471615008|FG000|Overall Study|Death|27|||
130996336|NCT01865617|471615009|FG001|Overall Study|Death|3|||
130996337|NCT01865617|471615010|FG002|Overall Study|Death|1|||
130996338|NCT01865617|471615011|FG003|Overall Study|Death|1|||
130996339|NCT01865617|471615012|FG004|Overall Study|Death|5|||
130996340|NCT01865617|471615013|FG005|Overall Study|Death|1|||
130996341|NCT01865617|471615014|FG006|Overall Study|Death|11|||
130996342|NCT01865617|471615015|FG007|Overall Study|Death|1|||
130996343|NCT01865617|471615016|FG008|Overall Study|Death|11|||
130996344|NCT01865617|471615017|FG009|Overall Study|Death|3|||
130996345|NCT01865617|471615018|FG010|Overall Study|Death|32|||
130996346|NCT01865617|471615019|FG011|Overall Study|Death|6|||
130996347|NCT01865617|471615020|FG012|Overall Study|Death|13|||
130996348|NCT01865617|471615008|FG000|Overall Study|Lost to Follow-up|2|||
130996349|NCT01865617|471615009|FG001|Overall Study|Lost to Follow-up|0|||
130996350|NCT01865617|471615010|FG002|Overall Study|Lost to Follow-up|0|||
130996351|NCT01865617|471615011|FG003|Overall Study|Lost to Follow-up|0|||
130996352|NCT01865617|471615012|FG004|Overall Study|Lost to Follow-up|0|||
130996353|NCT01865617|471615013|FG005|Overall Study|Lost to Follow-up|0|||
130996354|NCT01865617|471615014|FG006|Overall Study|Lost to Follow-up|0|||
130996355|NCT01865617|471615015|FG007|Overall Study|Lost to Follow-up|0|||
130996356|NCT01865617|471615016|FG008|Overall Study|Lost to Follow-up|0|||
130996357|NCT01865617|471615017|FG009|Overall Study|Lost to Follow-up|0|||
130996358|NCT01865617|471615018|FG010|Overall Study|Lost to Follow-up|0|||
130996359|NCT01865617|471615019|FG011|Overall Study|Lost to Follow-up|0|||
130996360|NCT01865617|471615020|FG012|Overall Study|Lost to Follow-up|0|||
130996361|NCT01865617|471615008|FG000|Overall Study|Withdrawal by Subject|1|||
130996362|NCT01865617|471615009|FG001|Overall Study|Withdrawal by Subject|0|||
130996363|NCT01865617|471615010|FG002|Overall Study|Withdrawal by Subject|0|||
130996364|NCT01865617|471615011|FG003|Overall Study|Withdrawal by Subject|0|||
130996365|NCT01865617|471615012|FG004|Overall Study|Withdrawal by Subject|0|||
130996366|NCT01865617|471615013|FG005|Overall Study|Withdrawal by Subject|0|||
130996367|NCT01865617|471615014|FG006|Overall Study|Withdrawal by Subject|0|||
130996368|NCT01865617|471615015|FG007|Overall Study|Withdrawal by Subject|0|||
130996369|NCT01865617|471615016|FG008|Overall Study|Withdrawal by Subject|0|||
130996370|NCT01865617|471615017|FG009|Overall Study|Withdrawal by Subject|0|||
130996371|NCT01865617|471615018|FG010|Overall Study|Withdrawal by Subject|0|||
130996372|NCT01865617|471615019|FG011|Overall Study|Withdrawal by Subject|0|||
130996373|NCT01865617|471615020|FG012|Overall Study|Withdrawal by Subject|0|||
130996374|NCT01865617|471615008|FG000|Overall Study|Patient proceeded to new therapy|0|||
130996375|NCT01865617|471615009|FG001|Overall Study|Patient proceeded to new therapy|0|||
130996376|NCT01865617|471615010|FG002|Overall Study|Patient proceeded to new therapy|0|||
130996377|NCT01865617|471615011|FG003|Overall Study|Patient proceeded to new therapy|0|||
130996378|NCT01865617|471615012|FG004|Overall Study|Patient proceeded to new therapy|2|||
130996379|NCT01865617|471615013|FG005|Overall Study|Patient proceeded to new therapy|0|||
130996380|NCT01865617|471615014|FG006|Overall Study|Patient proceeded to new therapy|0|||
130996381|NCT01865617|471615015|FG007|Overall Study|Patient proceeded to new therapy|0|||
130996382|NCT01865617|471615016|FG008|Overall Study|Patient proceeded to new therapy|0|||
130996383|NCT01865617|471615017|FG009|Overall Study|Patient proceeded to new therapy|0|||
130996384|NCT01865617|471615018|FG010|Overall Study|Patient proceeded to new therapy|0|||
130996385|NCT01865617|471615019|FG011|Overall Study|Patient proceeded to new therapy|0|||
130996386|NCT01865617|471615020|FG012|Overall Study|Patient proceeded to new therapy|0|||
130996387|NCT01865617|471615008|FG000|Overall Study|Other|0|||
130996388|NCT01865617|471615009|FG001|Overall Study|Other|0|||
130996389|NCT01865617|471615010|FG002|Overall Study|Other|0|||
130996390|NCT01865617|471615011|FG003|Overall Study|Other|0|||
130996391|NCT01865617|471615012|FG004|Overall Study|Other|0|||
130996392|NCT01865617|471615013|FG005|Overall Study|Other|0|||
130996393|NCT01865617|471615014|FG006|Overall Study|Other|1|||
130996394|NCT01865617|471615015|FG007|Overall Study|Other|0|||
130996395|NCT01865617|471615016|FG008|Overall Study|Other|0|||
130996396|NCT01865617|471615017|FG009|Overall Study|Other|0|||
130996397|NCT01865617|471615018|FG010|Overall Study|Other|0|||
130996398|NCT01865617|471615019|FG011|Overall Study|Other|0|||
130996399|NCT01865617|471615020|FG012|Overall Study|Other|0|||
130996400|NCT00258440|471615024|FG000|Overall Study|Withdrawal by Subject|0|||
130996401|NCT00258440|471615025|FG001|Overall Study|Withdrawal by Subject|0|||
130996402|NCT00258440|471615026|FG002|Overall Study|Withdrawal by Subject|1|||
130996403|NCT00737061|471615027|FG000|Waiting Period|Lost to Follow-up|6|||
130996404|NCT00737061|471615027|FG000|Waiting Period|Withdrawal by Subject|1|||
130996405|NCT00737061|471615027|FG000|Waiting Period|Bilateral placement failure|34|||
130996406|NCT00737061|471615027|FG000|Waiting Period|Deemed patent following HSG|26|||
130996407|NCT00737061|471615027|FG000|Waiting Period|Alternative contraception failure|3|||
130996408|NCT00737061|471615027|FG000|Waiting Period|Elected surgical tubal ligation|5|||
130996409|NCT00737061|471615027|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
130996410|NCT00737061|471615027|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
130996411|NCT00737061|471615027|FG000|1 Year Wearing Period|Discontinued reilance|3|||
130996412|NCT00737061|471615027|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
130996413|NCT00439179|471615029|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
130996414|NCT00439179|471615030|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
130996415|NCT00439179|471615031|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
130996416|NCT00439179|471615032|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
130996417|NCT03632434|471615035|FG000|Overall Study|Withdrawal by Subject|2|||
130996418|NCT01821898|471615038|FG000|Overall Study|Withdrawal by Subject|2|||
130996419|NCT01821898|471615039|FG001|Overall Study|Withdrawal by Subject|1|||
130996420|NCT00337662|471615044|FG000|Study Period II|Lost to Follow-up|0|||
130996421|NCT00337662|471615045|FG001|Study Period II|Lost to Follow-up|0|||
130996422|NCT00337662|471615046|FG002|Study Period II|Lost to Follow-up|0|||
130996423|NCT00337662|471615047|FG003|Study Period II|Lost to Follow-up|35|||
130996424|NCT00337662|471615044|FG000|Study Period II|Withdrawal by Subject|0|||
130996425|NCT00337662|471615045|FG001|Study Period II|Withdrawal by Subject|0|||
130996426|NCT00337662|471615046|FG002|Study Period II|Withdrawal by Subject|0|||
130996427|NCT00337662|471615047|FG003|Study Period II|Withdrawal by Subject|20|||
130996428|NCT00337662|471615044|FG000|Study Period II|Adverse Event|0|||
130996429|NCT00337662|471615045|FG001|Study Period II|Adverse Event|0|||
130996430|NCT00337662|471615046|FG002|Study Period II|Adverse Event|0|||
130996431|NCT00337662|471615047|FG003|Study Period II|Adverse Event|16|||
130996432|NCT00337662|471615044|FG000|Study Period II|Physician Decision|0|||
130996433|NCT00337662|471615045|FG001|Study Period II|Physician Decision|0|||
130996434|NCT00337662|471615046|FG002|Study Period II|Physician Decision|0|||
130996435|NCT00337662|471615047|FG003|Study Period II|Physician Decision|13|||
130996436|NCT00337662|471615044|FG000|Study Period II|Entry Criteria Not Met|0|||
130996437|NCT00337662|471615045|FG001|Study Period II|Entry Criteria Not Met|0|||
130996438|NCT00337662|471615046|FG002|Study Period II|Entry Criteria Not Met|0|||
130996439|NCT00337662|471615047|FG003|Study Period II|Entry Criteria Not Met|6|||
130996440|NCT00337662|471615044|FG000|Study Period II|Protocol Violation|0|||
130996441|NCT00337662|471615045|FG001|Study Period II|Protocol Violation|0|||
130996442|NCT00337662|471615046|FG002|Study Period II|Protocol Violation|0|||
130996443|NCT00337662|471615047|FG003|Study Period II|Protocol Violation|6|||
130996444|NCT00337662|471615044|FG000|Study Period II|Lack of Efficacy|0|||
130996445|NCT00337662|471615045|FG001|Study Period II|Lack of Efficacy|0|||
130996446|NCT00337662|471615046|FG002|Study Period II|Lack of Efficacy|0|||
130996447|NCT00337662|471615047|FG003|Study Period II|Lack of Efficacy|7|||
130996448|NCT00337662|471615044|FG000|Study Period II|Sponsor Decision|0|||
130996449|NCT00337662|471615045|FG001|Study Period II|Sponsor Decision|0|||
130996450|NCT00337662|471615046|FG002|Study Period II|Sponsor Decision|0|||
130996451|NCT00337662|471615047|FG003|Study Period II|Sponsor Decision|2|||
130996452|NCT00337662|471615044|FG000|Study Period II|Parent/Caregiver Decision|0|||
130996453|NCT00337662|471615045|FG001|Study Period II|Parent/Caregiver Decision|0|||
130996454|NCT00337662|471615046|FG002|Study Period II|Parent/Caregiver Decision|0|||
131221528|NCT00944125|472437985|FG001|3 to 6 Months|Withdrawal by Subject|2|||
131221529|NCT00944125|472437984|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
131221530|NCT00944125|472437985|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
131221531|NCT00446134|472437986|FG000|Overall Study|Adverse Event|7|||
131221532|NCT00446134|472437987|FG001|Overall Study|Adverse Event|17|||
131221533|NCT00446134|472437988|FG002|Overall Study|Adverse Event|13|||
131221534|NCT00446134|472437989|FG003|Overall Study|Adverse Event|18|||
131221535|NCT00446134|472437986|FG000|Overall Study|Lack of Efficacy|19|||
131221536|NCT00446134|472437987|FG001|Overall Study|Lack of Efficacy|19|||
131221537|NCT00446134|472437988|FG002|Overall Study|Lack of Efficacy|24|||
131221538|NCT00446134|472437989|FG003|Overall Study|Lack of Efficacy|19|||
131221539|NCT00446134|472437986|FG000|Overall Study|Protocol Violation|0|||
131221540|NCT00446134|472437987|FG001|Overall Study|Protocol Violation|2|||
131221541|NCT00446134|472437988|FG002|Overall Study|Protocol Violation|1|||
131221542|NCT00446134|472437989|FG003|Overall Study|Protocol Violation|0|||
131221543|NCT00446134|472437986|FG000|Overall Study|Lost to Follow-up|1|||
131221544|NCT00446134|472437987|FG001|Overall Study|Lost to Follow-up|3|||
131221545|NCT00446134|472437988|FG002|Overall Study|Lost to Follow-up|1|||
131221546|NCT00446134|472437989|FG003|Overall Study|Lost to Follow-up|1|||
131221547|NCT00446134|472437986|FG000|Overall Study|Withdrawal by Subject|3|||
131221548|NCT00446134|472437987|FG001|Overall Study|Withdrawal by Subject|3|||
131221549|NCT00446134|472437988|FG002|Overall Study|Withdrawal by Subject|1|||
131221550|NCT00446134|472437989|FG003|Overall Study|Withdrawal by Subject|3|||
131221551|NCT00446134|472437986|FG000|Overall Study|Physician Decision|0|||
131221552|NCT00446134|472437987|FG001|Overall Study|Physician Decision|0|||
131221553|NCT00446134|472437988|FG002|Overall Study|Physician Decision|0|||
131221554|NCT00446134|472437989|FG003|Overall Study|Physician Decision|2|||
131221555|NCT00446134|472437986|FG000|Overall Study|Adverse Event-Diarrhea|1|||
131221556|NCT00446134|472437987|FG001|Overall Study|Adverse Event-Diarrhea|1|||
131221557|NCT00446134|472437988|FG002|Overall Study|Adverse Event-Diarrhea|2|||
130996455|NCT00337662|471615047|FG003|Study Period II|Parent/Caregiver Decision|1|||
130996456|NCT00337662|471615044|FG000|Study Period III|Lost to Follow-up|14|||
130996457|NCT00337662|471615045|FG001|Study Period III|Lost to Follow-up|16|||
131221558|NCT00446134|472437989|FG003|Overall Study|Adverse Event-Diarrhea|0|||
131221559|NCT00446134|472437986|FG000|Overall Study|Reason Not Completed|3|||
131221560|NCT00446134|472437987|FG001|Overall Study|Reason Not Completed|0|||
131221561|NCT00446134|472437988|FG002|Overall Study|Reason Not Completed|1|||
130996458|NCT00337662|471615046|FG002|Study Period III|Lost to Follow-up|14|||
130996459|NCT00337662|471615047|FG003|Study Period III|Lost to Follow-up|0|||
130996460|NCT00337662|471615044|FG000|Study Period III|Withdrawal by Subject|18|||
130996461|NCT00337662|471615045|FG001|Study Period III|Withdrawal by Subject|14|||
130996462|NCT00337662|471615046|FG002|Study Period III|Withdrawal by Subject|12|||
130996463|NCT00337662|471615047|FG003|Study Period III|Withdrawal by Subject|0|||
130996464|NCT00337662|471615044|FG000|Study Period III|Adverse Event|9|||
130996465|NCT00337662|471615045|FG001|Study Period III|Adverse Event|10|||
130996466|NCT00337662|471615046|FG002|Study Period III|Adverse Event|8|||
130996467|NCT00337662|471615047|FG003|Study Period III|Adverse Event|0|||
130996468|NCT00337662|471615044|FG000|Study Period III|Protocol Violation|3|||
130996469|NCT00337662|471615045|FG001|Study Period III|Protocol Violation|8|||
130996470|NCT00337662|471615046|FG002|Study Period III|Protocol Violation|2|||
130996471|NCT00337662|471615047|FG003|Study Period III|Protocol Violation|0|||
130996472|NCT00337662|471615044|FG000|Study Period III|Physician Decision|6|||
130996473|NCT00337662|471615045|FG001|Study Period III|Physician Decision|5|||
130996474|NCT00337662|471615046|FG002|Study Period III|Physician Decision|0|||
130996475|NCT00337662|471615047|FG003|Study Period III|Physician Decision|0|||
130996476|NCT00337662|471615044|FG000|Study Period III|Entry Criteria Not Met|4|||
130996477|NCT00337662|471615045|FG001|Study Period III|Entry Criteria Not Met|1|||
130996478|NCT00337662|471615046|FG002|Study Period III|Entry Criteria Not Met|3|||
130996479|NCT00337662|471615047|FG003|Study Period III|Entry Criteria Not Met|0|||
130996480|NCT00337662|471615044|FG000|Study Period III|Lack of Efficacy|4|||
130996481|NCT00337662|471615045|FG001|Study Period III|Lack of Efficacy|4|||
130996482|NCT00337662|471615046|FG002|Study Period III|Lack of Efficacy|2|||
130996483|NCT00337662|471615047|FG003|Study Period III|Lack of Efficacy|0|||
130996484|NCT00337662|471615044|FG000|Study Period III|Parent/Caregiver Decision|0|||
130996485|NCT00337662|471615045|FG001|Study Period III|Parent/Caregiver Decision|0|||
130996486|NCT00337662|471615046|FG002|Study Period III|Parent/Caregiver Decision|2|||
130996487|NCT00337662|471615047|FG003|Study Period III|Parent/Caregiver Decision|0|||
130996488|NCT00337662|471615044|FG000|Study Period III|Sponsor Decision|1|||
130996489|NCT00337662|471615045|FG001|Study Period III|Sponsor Decision|0|||
130996490|NCT00337662|471615046|FG002|Study Period III|Sponsor Decision|1|||
130996491|NCT00337662|471615047|FG003|Study Period III|Sponsor Decision|0|||
130996492|NCT00337662|471615044|FG000|Study Period III|Clinical Relapse|1|||
130996493|NCT00337662|471615045|FG001|Study Period III|Clinical Relapse|0|||
130996494|NCT00337662|471615046|FG002|Study Period III|Clinical Relapse|0|||
130996495|NCT00337662|471615047|FG003|Study Period III|Clinical Relapse|0|||
130996496|NCT03691948|471615048|FG000|Overall Study|Lost to Follow-up|1|||
130996497|NCT03691948|471615049|FG001|Overall Study|Lost to Follow-up|3|||
130996498|NCT03012061|471615059|FG000|Overall Study|Withdrawal by Subject|1|||
130996499|NCT03012061|471615060|FG001|Overall Study|Withdrawal by Subject|5|||
130996500|NCT03012061|471615061|FG002|Overall Study|Withdrawal by Subject|4|||
130996501|NCT03012061|471615059|FG000|Overall Study|Investigator Site Closed|1|||
130996502|NCT03012061|471615060|FG001|Overall Study|Investigator Site Closed|2|||
130996503|NCT03012061|471615061|FG002|Overall Study|Investigator Site Closed|0|||
130996504|NCT03012061|471615059|FG000|Overall Study|Lost to Follow-up|2|||
130996505|NCT03012061|471615060|FG001|Overall Study|Lost to Follow-up|1|||
130996506|NCT03012061|471615061|FG002|Overall Study|Lost to Follow-up|0|||
130996507|NCT03012061|471615059|FG000|Overall Study|Study closed/ Terminated|0|||
130996508|NCT03012061|471615060|FG001|Overall Study|Study closed/ Terminated|0|||
130996509|NCT03012061|471615061|FG002|Overall Study|Study closed/ Terminated|1|||
130996510|NCT03012061|471615059|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
130996511|NCT03012061|471615060|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
130996512|NCT03012061|471615061|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
130996513|NCT03012061|471615059|FG000|Overall Study|Protocol Violation|0|||
130996514|NCT03012061|471615060|FG001|Overall Study|Protocol Violation|0|||
130884166|NCT00463567|471211433|FG005|Overall Study|Abnormal lab value(s)|0|||
130884167|NCT00463567|471211434|FG006|Overall Study|Abnormal lab value(s)|0|||
130884168|NCT00463567|471211428|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130884169|NCT00463567|471211429|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130884170|NCT00463567|471211430|FG002|Overall Study|Abnormal test procedure result(s)|6|||
130884171|NCT00463567|471211431|FG003|Overall Study|Abnormal test procedure result(s)|2|||
130884172|NCT00463567|471211432|FG004|Overall Study|Abnormal test procedure result(s)|0|||
130884173|NCT00463567|471211433|FG005|Overall Study|Abnormal test procedure result(s)|2|||
130884174|NCT00463567|471211434|FG006|Overall Study|Abnormal test procedure result(s)|0|||
130884175|NCT00463567|471211428|FG000|Overall Study|Death|1|||
130884176|NCT00463567|471211429|FG001|Overall Study|Death|0|||
130884177|NCT00463567|471211430|FG002|Overall Study|Death|2|||
130884178|NCT00463567|471211431|FG003|Overall Study|Death|0|||
130884179|NCT00463567|471211432|FG004|Overall Study|Death|0|||
130884180|NCT00463567|471211433|FG005|Overall Study|Death|0|||
130884181|NCT00463567|471211434|FG006|Overall Study|Death|0|||
130884182|NCT03848832|471211435|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
130884183|NCT03848832|471211436|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
130884184|NCT03848832|471211437|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
130884185|NCT03848832|471211435|FG000|Overall Study|Withdrawal by Subject|0|||
130884186|NCT03848832|471211436|FG001|Overall Study|Withdrawal by Subject|0|||
130884187|NCT03848832|471211437|FG002|Overall Study|Withdrawal by Subject|1|||
130884188|NCT03848832|471211435|FG000|Overall Study|Withdrawal (Covid-19)|0|||
130884189|NCT03848832|471211436|FG001|Overall Study|Withdrawal (Covid-19)|2|||
130884190|NCT03848832|471211437|FG002|Overall Study|Withdrawal (Covid-19)|0|||
130884191|NCT03848832|471211435|FG000|Overall Study|Physician Decision|2|||
130884192|NCT03848832|471211436|FG001|Overall Study|Physician Decision|1|||
130884193|NCT03848832|471211437|FG002|Overall Study|Physician Decision|3|||
130884194|NCT03848832|471211435|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
130884195|NCT03848832|471211436|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
130884196|NCT03848832|471211437|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
130884197|NCT03848832|471211435|FG000|Overall Study|Adverse Event|1|||
130884198|NCT03848832|471211436|FG001|Overall Study|Adverse Event|0|||
130884199|NCT03848832|471211437|FG002|Overall Study|Adverse Event|0|||
130884200|NCT01760733|471211439|FG000|Waiting List|Death|18|||
130884201|NCT01760733|471211439|FG000|Waiting List|Removed from waiting list|41|||
130884202|NCT01760733|471211439|FG000|Waiting List|Not received a transplant yet|13|||
130884203|NCT01760733|471211439|FG000|Transplanted|Not reached 10 years post transplant|184|||
130884204|NCT01760733|471211439|FG000|Transplanted|Death|26|||
130884205|NCT01760733|471211439|FG000|Transplanted|Graft loss|7|||
130884206|NCT02404025|471211441|FG000|Overall Study|Adverse Event|1|||
130884207|NCT02404025|471211441|FG000|Overall Study|Lack of Efficacy|3|||
130884208|NCT01524796|471211442|FG000|Overall Study|Adverse Event|13|||
130884209|NCT01524796|471211442|FG000|Overall Study|Lack of Efficacy|3|||
130884210|NCT01524796|471211442|FG000|Overall Study|Lost to Follow-up|1|||
130884211|NCT01524796|471211442|FG000|Overall Study|The price|1|||
130884212|NCT01524796|471211442|FG000|Overall Study|Withdrawal by Subject|4|||
130884213|NCT01524796|471211442|FG000|Overall Study|Move|1|||
130884214|NCT01524796|471211442|FG000|Overall Study|Deterioration of pains|1|||
130884215|NCT01524796|471211442|FG000|Overall Study|Gall stone surgery|1|||
130884216|NCT01524796|471211442|FG000|Overall Study|Nervous about confidentiality|1|||
130884217|NCT01524796|471211442|FG000|Overall Study|Switch to carbamazapine|1|||
130884218|NCT01524796|471211442|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
130884219|NCT03938259|471211446|FG000|Overall Study|unable to establish baseline for ventilation|1|||
130884220|NCT03938259|471211447|FG001|Overall Study|unable to establish baseline for ventilation|1|||
130884221|NCT00956007|471211450|FG000|Overall Study|Protocol Violation|27|||
130884222|NCT00956007|471211451|FG001|Overall Study|Protocol Violation|23|||
130884223|NCT03774576|471211452|FG000|Period 2|Adverse Event|1|||
130884224|NCT01746901|471211453|FG000|Naloxone Challenge Phase|Adverse Event|2|||
130884225|NCT01746901|471211454|FG001|Naloxone Challenge Phase|Adverse Event|0|||
130884226|NCT01746901|471211455|FG002|Naloxone Challenge Phase|Adverse Event|0|||
130884227|NCT01746901|471211456|FG003|Naloxone Challenge Phase|Adverse Event|0|||
130884228|NCT01746901|471211457|FG004|Naloxone Challenge Phase|Adverse Event|0|||
130884229|NCT01746901|471211458|FG005|Naloxone Challenge Phase|Adverse Event|0|||
130884230|NCT01746901|471211459|FG006|Naloxone Challenge Phase|Adverse Event|0|||
130884231|NCT01746901|471211460|FG007|Naloxone Challenge Phase|Adverse Event|0|||
130884232|NCT01746901|471211461|FG008|Naloxone Challenge Phase|Adverse Event|0|||
130884233|NCT01746901|471211453|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
130884234|NCT01746901|471211454|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130884235|NCT01746901|471211455|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130884236|NCT01746901|471211456|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130884237|NCT01746901|471211457|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130996515|NCT03012061|471615061|FG002|Overall Study|Protocol Violation|2|||
130996516|NCT03012061|471615059|FG000|Overall Study|Lack of Efficacy|0|||
130996517|NCT03012061|471615060|FG001|Overall Study|Lack of Efficacy|1|||
130996518|NCT03012061|471615061|FG002|Overall Study|Lack of Efficacy|0|||
130996519|NCT03012061|471615059|FG000|Overall Study|Adverse Event|2|||
130996520|NCT03012061|471615060|FG001|Overall Study|Adverse Event|0|||
130996521|NCT03012061|471615061|FG002|Overall Study|Adverse Event|0|||
130996522|NCT02696902|471615062|FG000|Overall Study|Lost to Follow-up|0|||
130996523|NCT02696902|471615063|FG001|Overall Study|Lost to Follow-up|1|||
130996524|NCT02696902|471615064|FG002|Overall Study|Lost to Follow-up|1|||
130996525|NCT02696902|471615062|FG000|Overall Study|Withdrawal by Subject|0|||
130996526|NCT02696902|471615063|FG001|Overall Study|Withdrawal by Subject|0|||
130996527|NCT02696902|471615064|FG002|Overall Study|Withdrawal by Subject|1|||
130996528|NCT02696902|471615062|FG000|Overall Study|Death|19|||
130996529|NCT02696902|471615063|FG001|Overall Study|Death|3|||
130996530|NCT02696902|471615064|FG002|Overall Study|Death|24|||
130996531|NCT02696902|471615062|FG000|Overall Study|Participant not fit post-randomization|0|||
130996532|NCT02696902|471615063|FG001|Overall Study|Participant not fit post-randomization|0|||
130996533|NCT02696902|471615064|FG002|Overall Study|Participant not fit post-randomization|1|||
130996534|NCT02696902|471615062|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
130996535|NCT02696902|471615063|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
130996536|NCT02696902|471615064|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
130996537|NCT02696902|471615062|FG000|Overall Study|Principal investigator's decision|1|||
130996538|NCT02696902|471615063|FG001|Overall Study|Principal investigator's decision|0|||
130996539|NCT02696902|471615064|FG002|Overall Study|Principal investigator's decision|0|||
130996540|NCT02696902|471615062|FG000|Overall Study|Sponsor's decision|1|||
130996541|NCT02696902|471615063|FG001|Overall Study|Sponsor's decision|0|||
130996542|NCT02696902|471615064|FG002|Overall Study|Sponsor's decision|0|||
130996543|NCT02696902|471615062|FG000|Overall Study|Transferred to other hospital|1|||
130996544|NCT02696902|471615063|FG001|Overall Study|Transferred to other hospital|0|||
130996545|NCT02696902|471615064|FG002|Overall Study|Transferred to other hospital|0|||
130996546|NCT00514046|471615065|FG000|Overall Study|transferred to another protocol|2|||
130996547|NCT00514046|471615066|FG001|Overall Study|transferred to another protocol|1|||
130996548|NCT00514046|471615067|FG002|Overall Study|transferred to another protocol|3|||
130996549|NCT00514046|471615068|FG003|Overall Study|transferred to another protocol|0|||
130996550|NCT00514046|471615069|FG004|Overall Study|transferred to another protocol|1|||
130996551|NCT00514046|471615070|FG005|Overall Study|transferred to another protocol|0|||
130996552|NCT00514046|471615071|FG006|Overall Study|transferred to another protocol|0|||
130996553|NCT00514046|471615072|FG007|Overall Study|transferred to another protocol|0|||
130996554|NCT00514046|471615073|FG008|Overall Study|transferred to another protocol|0|||
130996555|NCT00514046|471615065|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
130996556|NCT00514046|471615066|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
130996557|NCT00514046|471615067|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
130996558|NCT00514046|471615068|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
130996559|NCT00514046|471615069|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
130996560|NCT00514046|471615070|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
130996561|NCT00514046|471615071|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
130996562|NCT00514046|471615072|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
130996563|NCT00514046|471615073|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
130996564|NCT00514046|471615065|FG000|Overall Study|Disease progression on study|0|||
130996565|NCT00514046|471615066|FG001|Overall Study|Disease progression on study|0|||
130996566|NCT00514046|471615067|FG002|Overall Study|Disease progression on study|2|||
130996567|NCT00514046|471615068|FG003|Overall Study|Disease progression on study|0|||
130996568|NCT00514046|471615069|FG004|Overall Study|Disease progression on study|0|||
130996569|NCT00514046|471615070|FG005|Overall Study|Disease progression on study|1|||
130996570|NCT00514046|471615071|FG006|Overall Study|Disease progression on study|0|||
130996571|NCT00514046|471615072|FG007|Overall Study|Disease progression on study|0|||
130996572|NCT00514046|471615073|FG008|Overall Study|Disease progression on study|0|||
130996573|NCT00383240|471615075|FG000|Overall Study|Adverse Event|4|||
130996574|NCT00383240|471615076|FG001|Overall Study|Adverse Event|6|||
130996575|NCT00383240|471615077|FG002|Overall Study|Adverse Event|9|||
130996576|NCT00383240|471615078|FG003|Overall Study|Adverse Event|7|||
130996577|NCT00383240|471615075|FG000|Overall Study|Treatment Failure|8|||
130996578|NCT00383240|471615076|FG001|Overall Study|Treatment Failure|13|||
130996579|NCT00383240|471615077|FG002|Overall Study|Treatment Failure|47|||
130996580|NCT00383240|471615078|FG003|Overall Study|Treatment Failure|46|||
130996581|NCT00383240|471615075|FG000|Overall Study|Lost to Follow-up|3|||
130996582|NCT00383240|471615076|FG001|Overall Study|Lost to Follow-up|0|||
130996583|NCT00383240|471615077|FG002|Overall Study|Lost to Follow-up|0|||
130996584|NCT00383240|471615078|FG003|Overall Study|Lost to Follow-up|2|||
130996585|NCT00383240|471615075|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
130996586|NCT00383240|471615076|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
130996587|NCT00383240|471615077|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
130996588|NCT00383240|471615078|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
130996589|NCT00383240|471615075|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
130996590|NCT00383240|471615076|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
130996591|NCT00383240|471615077|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
130996592|NCT00383240|471615078|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
130996593|NCT00383240|471615075|FG000|Overall Study|Protocol Violation|4|||
130996594|NCT00383240|471615076|FG001|Overall Study|Protocol Violation|5|||
130996595|NCT00383240|471615077|FG002|Overall Study|Protocol Violation|9|||
130996596|NCT00383240|471615078|FG003|Overall Study|Protocol Violation|6|||
130996597|NCT00383240|471615075|FG000|Overall Study|Did not meet protocol eligibility|9|||
130996598|NCT00383240|471615076|FG001|Overall Study|Did not meet protocol eligibility|4|||
130996599|NCT00383240|471615077|FG002|Overall Study|Did not meet protocol eligibility|9|||
130996600|NCT00383240|471615078|FG003|Overall Study|Did not meet protocol eligibility|3|||
130996601|NCT00383240|471615075|FG000|Overall Study|Administrative|1|||
131221562|NCT00446134|472437989|FG003|Overall Study|Reason Not Completed|2|||
131221563|NCT01858558|472439351|FG000|Overall Study|Death|1|||
131221564|NCT01858558|472439352|FG001|Overall Study|Death|1|||
131221565|NCT01858558|472439351|FG000|Overall Study|Lost to Follow-up|1|||
131221566|NCT01858558|472439352|FG001|Overall Study|Lost to Follow-up|0|||
131221567|NCT01858558|472439351|FG000|Overall Study|Disease progression|3|||
131221568|NCT01858558|472439352|FG001|Overall Study|Disease progression|1|||
131221569|NCT01858558|472439351|FG000|Overall Study|Product contamination|2|||
131221570|NCT01858558|472439352|FG001|Overall Study|Product contamination|0|||
130996602|NCT00383240|471615076|FG001|Overall Study|Administrative|1|||
130996603|NCT00383240|471615077|FG002|Overall Study|Administrative|0|||
131221571|NCT01858558|472439351|FG000|Overall Study|Failed expansion of cell product|2|||
130996604|NCT00383240|471615078|FG003|Overall Study|Administrative|0|||
131221572|NCT01858558|472439352|FG001|Overall Study|Failed expansion of cell product|0|||
131221573|NCT01142466|472439353|FG000|Overall Study|Adverse Event|2|||
130884238|NCT01746901|471211458|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130884239|NCT01746901|471211459|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130884240|NCT01746901|471211460|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130884241|NCT01746901|471211461|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130884242|NCT01746901|471211453|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130884243|NCT01746901|471211454|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
130884244|NCT01746901|471211455|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130884245|NCT01746901|471211456|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130884246|NCT01746901|471211457|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130884247|NCT01746901|471211458|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130884248|NCT01746901|471211459|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130884249|NCT01746901|471211460|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130884250|NCT01746901|471211461|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130884251|NCT01746901|471211453|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130884252|NCT01746901|471211454|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
130884253|NCT01746901|471211455|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
130884254|NCT01746901|471211456|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130884255|NCT01746901|471211457|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130884256|NCT01746901|471211458|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130884257|NCT01746901|471211459|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130884258|NCT01746901|471211460|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130884259|NCT01746901|471211461|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130884260|NCT01746901|471211453|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130884261|NCT01746901|471211454|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
130884262|NCT01746901|471211455|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
130884263|NCT01746901|471211456|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130884264|NCT01746901|471211457|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130884265|NCT01746901|471211458|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130884266|NCT01746901|471211459|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130884267|NCT01746901|471211460|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130884268|NCT01746901|471211461|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130884269|NCT01746901|471211453|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130884270|NCT01746901|471211454|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
130884271|NCT01746901|471211455|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
130884272|NCT01746901|471211456|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130884273|NCT01746901|471211457|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130884274|NCT01746901|471211458|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130884275|NCT01746901|471211459|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130884276|NCT01746901|471211460|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130884277|NCT01746901|471211461|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130884278|NCT01746901|471211453|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
130884279|NCT01746901|471211454|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
130884280|NCT01746901|471211455|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
130884281|NCT01746901|471211456|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
130996605|NCT02023879|471615082|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
130996606|NCT02023879|471615083|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
130996607|NCT02023879|471615084|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
130996608|NCT02023879|471615082|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
130996609|NCT02023879|471615083|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
130996610|NCT02023879|471615084|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
130996611|NCT02023879|471615082|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
130996612|NCT02023879|471615083|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
130996613|NCT02023879|471615084|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
130996614|NCT02023879|471615082|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
130996615|NCT02023879|471615083|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
131221574|NCT01142466|472439354|FG001|Overall Study|Adverse Event|1|||
131221575|NCT01142466|472439353|FG000|Overall Study|Withdrawal by Subject|1|||
131221576|NCT01142466|472439354|FG001|Overall Study|Withdrawal by Subject|1|||
131221577|NCT00569231|472439355|FG000|Overall Study|Study unrelated surgery|1|||
131221578|NCT00569231|472439355|FG000|Overall Study|Airfare expense|2|||
131221579|NCT00569231|472439355|FG000|Overall Study|Withdrawal by Subject|1|||
131221580|NCT00569231|472439355|FG000|Overall Study|Car accident injury|1|||
131221581|NCT00569231|472439355|FG000|Overall Study|Non-compliance|2|||
131221582|NCT00817778|472439368|FG000|Overall Study|Adverse Event|1|||
131221583|NCT00817778|472439369|FG001|Overall Study|Adverse Event|0|||
131221584|NCT00817778|472439368|FG000|Overall Study|Withdrawal by Subject|1|||
131221585|NCT00817778|472439369|FG001|Overall Study|Withdrawal by Subject|1|||
131221586|NCT00817778|472439368|FG000|Overall Study|Protocol Violation|0|||
131221587|NCT00817778|472439369|FG001|Overall Study|Protocol Violation|1|||
131221588|NCT00817778|472439368|FG000|Overall Study|Study-specific discontinuation criteria|0|||
131221589|NCT00817778|472439369|FG001|Overall Study|Study-specific discontinuation criteria|1|||
131221590|NCT00817778|472439368|FG000|Overall Study|Poor venous access|1|||
131221591|NCT00817778|472439369|FG001|Overall Study|Poor venous access|0|||
131221592|NCT02923115|472439373|FG000|Overall Study|Lost to Follow-up|0|||
131221593|NCT02923115|472439374|FG001|Overall Study|Lost to Follow-up|0|||
131221594|NCT02923115|472439375|FG002|Overall Study|Lost to Follow-up|0|||
131221595|NCT02923115|472439376|FG003|Overall Study|Lost to Follow-up|1|||
131221596|NCT02923115|472439377|FG004|Overall Study|Lost to Follow-up|0|||
131221597|NCT02923115|472439378|FG005|Overall Study|Lost to Follow-up|0|||
131221598|NCT02923115|472439373|FG000|Overall Study|Withdrawal by Subject|0|||
131221599|NCT02923115|472439374|FG001|Overall Study|Withdrawal by Subject|1|||
131221600|NCT02923115|472439375|FG002|Overall Study|Withdrawal by Subject|0|||
131221601|NCT02923115|472439376|FG003|Overall Study|Withdrawal by Subject|0|||
131221602|NCT02923115|472439377|FG004|Overall Study|Withdrawal by Subject|0|||
131221603|NCT02923115|472439378|FG005|Overall Study|Withdrawal by Subject|0|||
131221604|NCT02923115|472439373|FG000|Overall Study|Randomized, but not dosed|0|||
131221605|NCT02923115|472439374|FG001|Overall Study|Randomized, but not dosed|0|||
131221606|NCT02923115|472439375|FG002|Overall Study|Randomized, but not dosed|3|||
131221607|NCT02923115|472439376|FG003|Overall Study|Randomized, but not dosed|1|||
131221608|NCT02923115|472439377|FG004|Overall Study|Randomized, but not dosed|5|||
131221609|NCT02923115|472439378|FG005|Overall Study|Randomized, but not dosed|0|||
131221610|NCT04388527|472439379|FG000|Overall Study|Death|14|||
131221611|NCT04388527|472439379|FG000|Overall Study|Withdrawal by Subject|2|||
131221612|NCT04388527|472439379|FG000|Overall Study|Lost to Follow-up|1|||
131221613|NCT00520494|472439380|FG000|Overall Study|Withdrawal by Subject|1|||
131221614|NCT03471182|472439383|FG000|Overall Study|Withdrawal by Subject|1|||
131221615|NCT03471182|472439384|FG001|Overall Study|Withdrawal by Subject|1|||
131221616|NCT03471182|472439385|FG002|Overall Study|Withdrawal by Subject|0|||
131221617|NCT03471182|472439383|FG000|Overall Study|Technical failure|2|||
131221618|NCT03471182|472439384|FG001|Overall Study|Technical failure|0|||
131221619|NCT03471182|472439385|FG002|Overall Study|Technical failure|0|||
131221620|NCT00068406|472439388|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
131221621|NCT00068406|472439388|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
131221622|NCT02018042|472439389|FG000|Overall Study|Withdrawal by Subject|1|||
131221623|NCT01954082|472439390|FG000|Overall Study|Study Suspension|42|||
131221624|NCT01954082|472439391|FG001|Overall Study|Study Suspension|36|||
131221625|NCT01954082|472439390|FG000|Overall Study|Adverse Event|10|||
131221626|NCT01954082|472439391|FG001|Overall Study|Adverse Event|4|||
131221627|NCT01954082|472439390|FG000|Overall Study|Intolerance|0|||
131221628|NCT01954082|472439391|FG001|Overall Study|Intolerance|1|||
131221629|NCT01954082|472439390|FG000|Overall Study|Non-compliance|6|||
131221630|NCT01954082|472439391|FG001|Overall Study|Non-compliance|4|||
131221631|NCT01954082|472439390|FG000|Overall Study|Physician Decision|2|||
131221632|NCT01954082|472439391|FG001|Overall Study|Physician Decision|0|||
131221633|NCT01954082|472439390|FG000|Overall Study|Parent Decision|1|||
131221634|NCT01954082|472439391|FG001|Overall Study|Parent Decision|0|||
131221635|NCT01954082|472439390|FG000|Overall Study|Withdrawal by Subject|0|||
131221636|NCT01954082|472439391|FG001|Overall Study|Withdrawal by Subject|1|||
131221637|NCT01954082|472439390|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
131221638|NCT01954082|472439391|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
131221639|NCT01954082|472439390|FG000|Overall Study|Redirection of Care|0|||
131221640|NCT01954082|472439391|FG001|Overall Study|Redirection of Care|2|||
131221641|NCT01954082|472439390|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
131221642|NCT01954082|472439391|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
131221643|NCT01954082|472439390|FG000|Overall Study|Comfort Care|0|||
131221644|NCT01954082|472439391|FG001|Overall Study|Comfort Care|1|||
131221645|NCT01954082|472439390|FG000|Overall Study|Infant Moved|0|||
131221646|NCT01954082|472439391|FG001|Overall Study|Infant Moved|1|||
131221647|NCT01954082|472439390|FG000|Overall Study|Randomized not Treated|4|||
131221648|NCT01954082|472439391|FG001|Overall Study|Randomized not Treated|2|||
131221649|NCT03451331|472439392|FG000|Overall Study|Withdrawal by Subject|1|||
131221650|NCT03451331|472439393|FG001|Overall Study|Withdrawal by Subject|0|||
131221651|NCT03451331|472439392|FG000|Overall Study|Unable to start treatment.|1|||
131221652|NCT03451331|472439393|FG001|Overall Study|Unable to start treatment.|1|||
131221653|NCT02454972|472439394|FG000|Overall Study|Progressive disease|17|||
131221654|NCT02454972|472439395|FG001|Overall Study|Progressive disease|16|||
131221655|NCT02454972|472439396|FG002|Overall Study|Progressive disease|59|||
131221656|NCT02454972|472439397|FG003|Overall Study|Progressive disease|23|||
131221657|NCT02454972|472439398|FG004|Overall Study|Progressive disease|16|||
131221658|NCT02454972|472439399|FG005|Overall Study|Progressive disease|12|||
131221659|NCT02454972|472439400|FG006|Overall Study|Progressive disease|19|||
131221660|NCT02454972|472439401|FG007|Overall Study|Progressive disease|27|||
131221661|NCT02454972|472439402|FG008|Overall Study|Progressive disease|0|||
131221662|NCT02454972|472439394|FG000|Overall Study|Death|0|||
131221663|NCT02454972|472439395|FG001|Overall Study|Death|0|||
131221664|NCT02454972|472439396|FG002|Overall Study|Death|5|||
131221665|NCT02454972|472439397|FG003|Overall Study|Death|1|||
131221666|NCT02454972|472439398|FG004|Overall Study|Death|0|||
131221667|NCT02454972|472439399|FG005|Overall Study|Death|0|||
131221668|NCT02454972|472439400|FG006|Overall Study|Death|0|||
131221669|NCT02454972|472439401|FG007|Overall Study|Death|0|||
131221670|NCT02454972|472439402|FG008|Overall Study|Death|95|||
131221671|NCT02454972|472439394|FG000|Overall Study|Physician Decision|0|||
131221672|NCT02454972|472439395|FG001|Overall Study|Physician Decision|1|||
130996616|NCT02023879|471615084|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
130996617|NCT02023879|471615082|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
130996618|NCT02023879|471615083|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
130996619|NCT02023879|471615084|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
130996620|NCT02023879|471615082|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
130996621|NCT02023879|471615083|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
130996622|NCT02023879|471615084|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
130996623|NCT02023879|471615082|FG000|Extension Open Label Treatment|Adverse Event|1|||
130996624|NCT02023879|471615083|FG001|Extension Open Label Treatment|Adverse Event|7|||
130996625|NCT02023879|471615084|FG002|Extension Open Label Treatment|Adverse Event|3|||
130996626|NCT02023879|471615082|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
130996627|NCT02023879|471615083|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
130996628|NCT02023879|471615084|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
130996629|NCT02023879|471615082|FG000|Extension Open Label Treatment|Participant moved|1|||
130996630|NCT02023879|471615083|FG001|Extension Open Label Treatment|Participant moved|2|||
130996631|NCT02023879|471615084|FG002|Extension Open Label Treatment|Participant moved|0|||
130996632|NCT02023879|471615082|FG000|Extension Open Label Treatment|Other than specified above|2|||
130996633|NCT02023879|471615083|FG001|Extension Open Label Treatment|Other than specified above|7|||
130996634|NCT02023879|471615084|FG002|Extension Open Label Treatment|Other than specified above|2|||
130996635|NCT02924389|471615085|FG000|Overall Study|Lost to Follow-up|1|||
130996636|NCT02924389|471615086|FG001|Overall Study|Lost to Follow-up|0|||
130996637|NCT02924389|471615085|FG000|Overall Study|Physician Decision|2|||
130996638|NCT02924389|471615086|FG001|Overall Study|Physician Decision|0|||
130996639|NCT02924389|471615085|FG000|Overall Study|Withdrawal by Subject|3|||
130996640|NCT02924389|471615086|FG001|Overall Study|Withdrawal by Subject|0|||
130996641|NCT02924389|471615085|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
130996642|NCT02924389|471615086|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
130996643|NCT01091428|471617492|FG000|Phase 1|Progressive Disease|24|||
130996644|NCT01091428|471617493|FG001|Phase 1|Progressive Disease|8|||
130996645|NCT01091428|471617494|FG002|Phase 1|Progressive Disease|0|||
130996646|NCT01091428|471617495|FG003|Phase 1|Progressive Disease|0|||
130996647|NCT01091428|471617492|FG000|Phase 1|Symptomatic Deterioration|3|||
130996648|NCT01091428|471617493|FG001|Phase 1|Symptomatic Deterioration|2|||
130996649|NCT01091428|471617494|FG002|Phase 1|Symptomatic Deterioration|0|||
130996650|NCT01091428|471617495|FG003|Phase 1|Symptomatic Deterioration|0|||
130996651|NCT01091428|471617492|FG000|Phase 1|Adverse Event|2|||
130996652|NCT01091428|471617493|FG001|Phase 1|Adverse Event|0|||
130996653|NCT01091428|471617494|FG002|Phase 1|Adverse Event|0|||
130996654|NCT01091428|471617495|FG003|Phase 1|Adverse Event|0|||
130996655|NCT01091428|471617492|FG000|Phase 1|Withdrawal by Subject|7|||
130996656|NCT01091428|471617493|FG001|Phase 1|Withdrawal by Subject|0|||
130996657|NCT01091428|471617494|FG002|Phase 1|Withdrawal by Subject|0|||
130996658|NCT01091428|471617495|FG003|Phase 1|Withdrawal by Subject|0|||
130996659|NCT01091428|471617492|FG000|Phase 1|Reason not specified|0|||
130996660|NCT01091428|471617493|FG001|Phase 1|Reason not specified|1|||
130996661|NCT01091428|471617494|FG002|Phase 1|Reason not specified|0|||
130996662|NCT01091428|471617495|FG003|Phase 1|Reason not specified|0|||
130996663|NCT01091428|471617492|FG000|Phase 1|Single-Patient IND|2|||
130996664|NCT01091428|471617493|FG001|Phase 1|Single-Patient IND|0|||
131221673|NCT02454972|472439396|FG002|Overall Study|Physician Decision|2|||
131221674|NCT02454972|472439397|FG003|Overall Study|Physician Decision|1|||
131221675|NCT02454972|472439398|FG004|Overall Study|Physician Decision|2|||
131221676|NCT02454972|472439399|FG005|Overall Study|Physician Decision|0|||
131221677|NCT02454972|472439400|FG006|Overall Study|Physician Decision|0|||
131221678|NCT02454972|472439401|FG007|Overall Study|Physician Decision|1|||
131221679|NCT02454972|472439402|FG008|Overall Study|Physician Decision|0|||
131221680|NCT02454972|472439394|FG000|Overall Study|Non treatment-related adverse event|2|||
131221681|NCT02454972|472439395|FG001|Overall Study|Non treatment-related adverse event|0|||
131221682|NCT02454972|472439396|FG002|Overall Study|Non treatment-related adverse event|1|||
131221683|NCT02454972|472439397|FG003|Overall Study|Non treatment-related adverse event|0|||
131221684|NCT02454972|472439398|FG004|Overall Study|Non treatment-related adverse event|0|||
131221685|NCT02454972|472439399|FG005|Overall Study|Non treatment-related adverse event|1|||
131221686|NCT02454972|472439400|FG006|Overall Study|Non treatment-related adverse event|0|||
131221687|NCT02454972|472439401|FG007|Overall Study|Non treatment-related adverse event|1|||
131221688|NCT02454972|472439402|FG008|Overall Study|Non treatment-related adverse event|0|||
131221689|NCT02454972|472439394|FG000|Overall Study|Treatment-related adverse events|0|||
130996665|NCT01091428|471617494|FG002|Phase 1|Single-Patient IND|0|||
130996666|NCT01091428|471617495|FG003|Phase 1|Single-Patient IND|0|||
130996667|NCT01091428|471617492|FG000|Phase 2|Progressive Disease|0|||
130996668|NCT01091428|471617493|FG001|Phase 2|Progressive Disease|0|||
130996669|NCT01091428|471617494|FG002|Phase 2|Progressive Disease|44|||
130996670|NCT01091428|471617495|FG003|Phase 2|Progressive Disease|46|||
130996671|NCT01091428|471617492|FG000|Phase 2|Symptomatic Deterioration|0|||
130996672|NCT01091428|471617493|FG001|Phase 2|Symptomatic Deterioration|0|||
130996673|NCT01091428|471617494|FG002|Phase 2|Symptomatic Deterioration|1|||
130996674|NCT01091428|471617495|FG003|Phase 2|Symptomatic Deterioration|6|||
130996675|NCT01091428|471617492|FG000|Phase 2|Adverse Event|0|||
130996676|NCT01091428|471617493|FG001|Phase 2|Adverse Event|0|||
130996677|NCT01091428|471617494|FG002|Phase 2|Adverse Event|12|||
130996678|NCT01091428|471617495|FG003|Phase 2|Adverse Event|5|||
130996679|NCT01091428|471617492|FG000|Phase 2|Withdrawal by Subject|0|||
130996680|NCT01091428|471617493|FG001|Phase 2|Withdrawal by Subject|0|||
130996681|NCT01091428|471617494|FG002|Phase 2|Withdrawal by Subject|9|||
130996682|NCT01091428|471617495|FG003|Phase 2|Withdrawal by Subject|8|||
130996683|NCT01091428|471617492|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
130996684|NCT01091428|471617493|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
130996685|NCT01091428|471617494|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
130996686|NCT01091428|471617495|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
130996687|NCT01091428|471617492|FG000|Phase 2|Reason not specified|0|||
130996688|NCT01091428|471617493|FG001|Phase 2|Reason not specified|0|||
130996689|NCT01091428|471617494|FG002|Phase 2|Reason not specified|4|||
130996690|NCT01091428|471617495|FG003|Phase 2|Reason not specified|3|||
130996691|NCT01091428|471617492|FG000|Phase 2|Physician Decision|0|||
130996692|NCT01091428|471617493|FG001|Phase 2|Physician Decision|0|||
130996693|NCT01091428|471617494|FG002|Phase 2|Physician Decision|2|||
130996694|NCT01091428|471617495|FG003|Phase 2|Physician Decision|0|||
130996695|NCT00636792|471617496|FG000|Overall Study|Adverse Event|16|||
130996696|NCT00636792|471617496|FG000|Overall Study|Physician Decision|7|||
130996697|NCT00636792|471617496|FG000|Overall Study|Progressive Disease|4|||
130996698|NCT00636792|471617496|FG000|Overall Study|Withdrawal by Subject|3|||
130996699|NCT00636792|471617496|FG000|Overall Study|Other|3|||
130996700|NCT01987596|471617499|FG000|Overall Study|Physician Decision|1|||
130996701|NCT01987596|471617500|FG001|Overall Study|Physician Decision|0|||
130996702|NCT01987596|471617499|FG000|Overall Study|Progressive Disease; missing all period|0|||
130996703|NCT01987596|471617500|FG001|Overall Study|Progressive Disease; missing all period|1|||
130996704|NCT00709592|471617501|FG000|Overall Study|Unable to proceed to transplant|0|||
130996705|NCT00709592|471617502|FG001|Overall Study|Unable to proceed to transplant|1|||
130996706|NCT00179010|471617503|FG000|Overall Study|Muscle probe defective|1|||
130996707|NCT00179010|471617504|FG001|Overall Study|Muscle probe defective|1|||
130996708|NCT00179010|471617503|FG000|Overall Study|Failure to place arterial line|0|||
130996709|NCT00179010|471617504|FG001|Overall Study|Failure to place arterial line|1|||
130996710|NCT01375959|471617510|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
130996711|NCT01375959|471617511|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
130996712|NCT01375959|471617510|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
130996713|NCT01375959|471617511|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
130996714|NCT01375959|471617510|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
130996715|NCT01375959|471617511|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
130996716|NCT00178256|471617512|FG000|Overall Study|Adverse Event|2|||
130996717|NCT00178256|471617513|FG001|Overall Study|Adverse Event|0|||
130996718|NCT00178256|471617514|FG002|Overall Study|Adverse Event|0|||
130996719|NCT00178256|471617515|FG003|Overall Study|Adverse Event|0|||
130996720|NCT00178256|471617512|FG000|Overall Study|Death|0|||
130996721|NCT00178256|471617513|FG001|Overall Study|Death|1|||
130996722|NCT00178256|471617514|FG002|Overall Study|Death|0|||
130996723|NCT00178256|471617515|FG003|Overall Study|Death|1|||
130996724|NCT00178256|471617512|FG000|Overall Study|Cancer progression|2|||
130996725|NCT00178256|471617513|FG001|Overall Study|Cancer progression|0|||
130996726|NCT00178256|471617514|FG002|Overall Study|Cancer progression|0|||
130996727|NCT00178256|471617515|FG003|Overall Study|Cancer progression|1|||
130996728|NCT01763788|471617516|FG000|Overall Study|Lost to Follow-up|0|||
130996729|NCT01763788|471617517|FG001|Overall Study|Lost to Follow-up|0|||
130996730|NCT01763788|471617518|FG002|Overall Study|Lost to Follow-up|1|||
130996731|NCT01763788|471617519|FG003|Overall Study|Lost to Follow-up|0|||
130996732|NCT00708305|471617522|FG000|Period 1|Protocol Violation|1|||
130996733|NCT00708305|471617523|FG001|Period 1|Protocol Violation|0|||
130996734|NCT00708305|471617524|FG002|Period 1|Protocol Violation|1|||
130996735|NCT00708305|471617525|FG003|Period 1|Protocol Violation|0|||
130996736|NCT00708305|471617522|FG000|Period 1|Other Reason|0|||
130996737|NCT00708305|471617523|FG001|Period 1|Other Reason|0|||
130996738|NCT00708305|471617524|FG002|Period 1|Other Reason|0|||
130996739|NCT00708305|471617525|FG003|Period 1|Other Reason|2|||
130996740|NCT00708305|471617522|FG000|Period 2|Lost to Follow-up|0|||
130996741|NCT00708305|471617523|FG001|Period 2|Lost to Follow-up|1|||
130996742|NCT00708305|471617524|FG002|Period 2|Lost to Follow-up|0|||
130996743|NCT00708305|471617525|FG003|Period 2|Lost to Follow-up|0|||
130996744|NCT00708305|471617522|FG000|Period 2|Protocol Violation|0|||
130996745|NCT00708305|471617523|FG001|Period 2|Protocol Violation|1|||
130996746|NCT00708305|471617524|FG002|Period 2|Protocol Violation|0|||
130996747|NCT00708305|471617525|FG003|Period 2|Protocol Violation|0|||
130996748|NCT00708305|471617522|FG000|Period 2|Other Reason|1|||
130996749|NCT00708305|471617523|FG001|Period 2|Other Reason|0|||
130996750|NCT00708305|471617524|FG002|Period 2|Other Reason|0|||
130996751|NCT00708305|471617525|FG003|Period 2|Other Reason|1|||
130996752|NCT00708305|471617522|FG000|Period 3|Protocol Violation|0|||
130996753|NCT00708305|471617523|FG001|Period 3|Protocol Violation|2|||
130996754|NCT00708305|471617524|FG002|Period 3|Protocol Violation|0|||
130996755|NCT00708305|471617525|FG003|Period 3|Protocol Violation|0|||
130996756|NCT00708305|471617522|FG000|Period 3|Other Reason|1|||
130996757|NCT00708305|471617523|FG001|Period 3|Other Reason|0|||
130996758|NCT00708305|471617524|FG002|Period 3|Other Reason|0|||
130996759|NCT00708305|471617525|FG003|Period 3|Other Reason|0|||
130996760|NCT02771210|471617526|FG000|Period 1|Adverse Event|5|||
130996761|NCT02771210|471617527|FG001|Period 1|Adverse Event|3|||
130996762|NCT02771210|471617526|FG000|Period 1|Lack of Efficacy|3|||
130996763|NCT02771210|471617527|FG001|Period 1|Lack of Efficacy|6|||
130996764|NCT02771210|471617526|FG000|Period 1|Lost to Follow-up|2|||
130996765|NCT02771210|471617527|FG001|Period 1|Lost to Follow-up|0|||
130996766|NCT02771210|471617526|FG000|Period 1|Physician Decision|0|||
130996767|NCT02771210|471617527|FG001|Period 1|Physician Decision|1|||
130996768|NCT02771210|471617526|FG000|Period 1|Withdrawal by Subject|0|||
130996769|NCT02771210|471617527|FG001|Period 1|Withdrawal by Subject|3|||
130996770|NCT02771210|471617526|FG000|Period 1|Withdrawal of informed consent|1|||
130996771|NCT02771210|471617527|FG001|Period 1|Withdrawal of informed consent|5|||
130996772|NCT02771210|471617526|FG000|Period 2|Adverse Event|1|||
130996773|NCT02771210|471617527|FG001|Period 2|Adverse Event|0|||
130996774|NCT02771210|471617526|FG000|Period 2|Lack of Efficacy|0|||
130996775|NCT02771210|471617527|FG001|Period 2|Lack of Efficacy|1|||
130996776|NCT02771210|471617526|FG000|Period 2|Withdrawal by Subject|1|||
130996777|NCT02771210|471617527|FG001|Period 2|Withdrawal by Subject|0|||
130996778|NCT02771210|471617526|FG000|Period 2|Withdrawal of informed consent|0|||
130996779|NCT02771210|471617527|FG001|Period 2|Withdrawal of informed consent|2|||
130996780|NCT02310126|471617530|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
130996781|NCT02310126|471617531|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
130996782|NCT02310126|471617530|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
130996783|NCT02310126|471617531|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
130996784|NCT02441946|471617537|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
130996785|NCT02441946|471617538|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
130996786|NCT02441946|471617539|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
130996787|NCT02441946|471617537|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
130996788|NCT02441946|471617538|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
130996789|NCT02441946|471617539|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
130996790|NCT02441946|471617537|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130996791|NCT02441946|471617538|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
130996792|NCT02441946|471617539|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130996793|NCT02441946|471617537|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
130996794|NCT02441946|471617538|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
130996795|NCT02441946|471617539|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
130996796|NCT02441946|471617537|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
130996797|NCT02441946|471617538|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
130996798|NCT02441946|471617539|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
130996799|NCT02441946|471617537|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
130996800|NCT02441946|471617538|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
130996801|NCT02441946|471617539|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
130996802|NCT02441946|471617537|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
130996803|NCT02441946|471617538|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
130996804|NCT02441946|471617539|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
130996805|NCT02441946|471617537|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
130996806|NCT02441946|471617538|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
130996807|NCT02441946|471617539|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
130996808|NCT02441946|471617537|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
130996809|NCT02441946|471617538|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
130996810|NCT02441946|471617539|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
130996811|NCT02441946|471617537|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
130996812|NCT02441946|471617538|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
130996813|NCT02441946|471617539|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
130996814|NCT02441946|471617537|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
130996815|NCT02441946|471617538|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130996816|NCT02441946|471617539|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130996817|NCT02111213|471617540|FG000|Overall Study|Withdrawal by Subject|3|||
130996818|NCT02111213|471617541|FG001|Overall Study|Withdrawal by Subject|2|||
130996819|NCT02111213|471617540|FG000|Overall Study|Lost to Follow-up|3|||
130996820|NCT02111213|471617541|FG001|Overall Study|Lost to Follow-up|4|||
130996821|NCT03237013|471617542|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
130996822|NCT03237013|471617543|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
130996823|NCT03237013|471617544|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
130996824|NCT02761629|471617547|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
130996825|NCT02761629|471617548|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
130996826|NCT02761629|471617547|FG000|Overall Study|Insufficient Therapeutic Response|2|||
130996827|NCT02761629|471617548|FG001|Overall Study|Insufficient Therapeutic Response|7|||
130996828|NCT02761629|471617547|FG000|Overall Study|Failure to Return|2|||
130996829|NCT02761629|471617548|FG001|Overall Study|Failure to Return|4|||
130996830|NCT02761629|471617547|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
130996831|NCT02761629|471617548|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
130996832|NCT02761629|471617547|FG000|Overall Study|Protocol Violation|2|||
130996833|NCT02761629|471617548|FG001|Overall Study|Protocol Violation|2|||
130996834|NCT02761629|471617547|FG000|Overall Study|Withdrawal by Subject|0|||
130996835|NCT02761629|471617548|FG001|Overall Study|Withdrawal by Subject|3|||
130996836|NCT02761629|471617547|FG000|Overall Study|Other|0|||
130996837|NCT02761629|471617548|FG001|Overall Study|Other|2|||
130996838|NCT02761629|471617547|FG000|Overall Study|Lost to Follow-up|4|||
130996839|NCT02761629|471617548|FG001|Overall Study|Lost to Follow-up|1|||
130996840|NCT02761629|471617547|FG000|Overall Study|Randomized But Not Treated|8|||
130996841|NCT02761629|471617548|FG001|Overall Study|Randomized But Not Treated|4|||
130996842|NCT02001974|471617549|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
130996843|NCT02001974|471617550|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
130996844|NCT02001974|471617551|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
130996845|NCT02001974|471617549|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
130996846|NCT02001974|471617550|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
130996847|NCT02001974|471617551|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
130996848|NCT02001974|471617549|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
130996849|NCT02001974|471617550|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
130996850|NCT02001974|471617551|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
130996851|NCT02001974|471617549|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
130996852|NCT02001974|471617550|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
130996853|NCT02001974|471617551|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
130996854|NCT00210119|471617552|FG000|Overall Study|Protocol Violation|1|||
130996855|NCT00210119|471617552|FG000|Overall Study|Withdrawal by Subject|1|||
130996856|NCT01830881|471617553|FG000|Overall Study|Changed decision to have an abortion|0|||
130996857|NCT01830881|471617554|FG001|Overall Study|Changed decision to have an abortion|1|||
130996858|NCT00988351|471617555|FG000|Overall Study|Withdrawal by Subject|8|||
130996859|NCT00988351|471617556|FG001|Overall Study|Withdrawal by Subject|0|||
130996860|NCT00988351|471617555|FG000|Overall Study|Lost to Follow-up|6|||
130996861|NCT00988351|471617556|FG001|Overall Study|Lost to Follow-up|9|||
130996862|NCT00988351|471617555|FG000|Overall Study|not using CPAP|5|||
130996863|NCT00988351|471617556|FG001|Overall Study|not using CPAP|3|||
130996864|NCT00119262|471617557|FG000|Overall Study|Lack of Efficacy|0|||
130996865|NCT00119262|471617558|FG001|Overall Study|Lack of Efficacy|3|||
130996866|NCT00119262|471617557|FG000|Overall Study|Withdrawal by Subject|12|||
130996867|NCT00119262|471617558|FG001|Overall Study|Withdrawal by Subject|11|||
130996868|NCT00119262|471617557|FG000|Overall Study|Adverse Event|33|||
130996869|NCT00119262|471617558|FG001|Overall Study|Adverse Event|35|||
130996870|NCT00119262|471617557|FG000|Overall Study|other disease|0|||
130996871|NCT00119262|471617558|FG001|Overall Study|other disease|2|||
130996872|NCT00119262|471617557|FG000|Overall Study|ineligble|1|||
130996873|NCT00119262|471617558|FG001|Overall Study|ineligble|2|||
130996874|NCT00119262|471617557|FG000|Overall Study|others|0|||
130996875|NCT00119262|471617558|FG001|Overall Study|others|5|||
130996876|NCT00734214|471617559|FG000|Overall Study|Withdrawal by Subject|3|||
130996877|NCT00734214|471617560|FG001|Overall Study|Withdrawal by Subject|4|||
130996878|NCT00734214|471617559|FG000|Overall Study|MD withdrawal|1|||
130996879|NCT00734214|471617560|FG001|Overall Study|MD withdrawal|0|||
130996880|NCT02038764|471617561|FG000|Overall Study|Adverse Event|0|||
130996881|NCT02038764|471617562|FG001|Overall Study|Adverse Event|0|||
130996882|NCT02038764|471617563|FG002|Overall Study|Adverse Event|1|||
130996883|NCT02038764|471617564|FG003|Overall Study|Adverse Event|0|||
130996884|NCT02038764|471617565|FG004|Overall Study|Adverse Event|0|||
130996885|NCT02038764|471617561|FG000|Overall Study|Lost to Follow-up|0|||
130996886|NCT02038764|471617562|FG001|Overall Study|Lost to Follow-up|1|||
130996887|NCT02038764|471617563|FG002|Overall Study|Lost to Follow-up|0|||
130996888|NCT02038764|471617564|FG003|Overall Study|Lost to Follow-up|0|||
130996889|NCT02038764|471617565|FG004|Overall Study|Lost to Follow-up|0|||
130996890|NCT02038764|471617561|FG000|Overall Study|Withdrawal by Subject|0|||
130996891|NCT02038764|471617562|FG001|Overall Study|Withdrawal by Subject|0|||
130996892|NCT02038764|471617563|FG002|Overall Study|Withdrawal by Subject|0|||
130996893|NCT02038764|471617564|FG003|Overall Study|Withdrawal by Subject|0|||
130996894|NCT02038764|471617565|FG004|Overall Study|Withdrawal by Subject|1|||
130996895|NCT02038764|471617561|FG000|Overall Study|Other|1|||
130996896|NCT02038764|471617562|FG001|Overall Study|Other|0|||
130996897|NCT02038764|471617563|FG002|Overall Study|Other|1|||
130996898|NCT02038764|471617564|FG003|Overall Study|Other|0|||
130996899|NCT02038764|471617565|FG004|Overall Study|Other|0|||
130996900|NCT04844918|471617568|FG000|Overall Study|Adverse Event|7|||
130996901|NCT04844918|471617569|FG001|Overall Study|Adverse Event|8|||
130996902|NCT04844918|471617570|FG002|Overall Study|Adverse Event|5|||
130996903|NCT04844918|471617568|FG000|Overall Study|Physician Decision|0|||
130996904|NCT04844918|471617569|FG001|Overall Study|Physician Decision|1|||
130996905|NCT04844918|471617570|FG002|Overall Study|Physician Decision|0|||
130996906|NCT04844918|471617568|FG000|Overall Study|Withdrawal by Subject|6|||
130996907|NCT04844918|471617569|FG001|Overall Study|Withdrawal by Subject|3|||
130996908|NCT04844918|471617570|FG002|Overall Study|Withdrawal by Subject|3|||
130996909|NCT04844918|471617568|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
130996910|NCT04844918|471617569|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
130996911|NCT04844918|471617570|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
130996912|NCT01751113|471617582|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130996913|NCT01751113|471617583|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130996914|NCT01751113|471617584|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130996915|NCT01751113|471617585|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
130996916|NCT01751113|471617586|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
130996917|NCT01751113|471617587|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130996918|NCT01751113|471617582|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
130996919|NCT01751113|471617583|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
130996920|NCT01751113|471617584|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
130996921|NCT01751113|471617585|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
130996922|NCT01751113|471617586|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
130996923|NCT01751113|471617587|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
130996924|NCT01551303|471617588|FG000|Overall Study|failed awareness check on vision test|4|||
130996925|NCT01551303|471617589|FG001|Overall Study|failed awareness check on vision test|7|||
130996926|NCT00363896|471617590|FG000|Overall Study|Withdrawal by Subject|29|||
130996927|NCT00363896|471617591|FG001|Overall Study|Withdrawal by Subject|16|||
130996928|NCT00363896|471617590|FG000|Overall Study|Adverse Event|24|||
130996929|NCT00363896|471617591|FG001|Overall Study|Adverse Event|13|||
130996930|NCT00363896|471617590|FG000|Overall Study|COPD exacerbation|13|||
130996931|NCT00363896|471617591|FG001|Overall Study|COPD exacerbation|7|||
130996932|NCT00363896|471617590|FG000|Overall Study|Lack of Efficacy|12|||
130996933|NCT00363896|471617591|FG001|Overall Study|Lack of Efficacy|8|||
130996934|NCT00363896|471617590|FG000|Overall Study|Protocol Violation|6|||
130996935|NCT00363896|471617591|FG001|Overall Study|Protocol Violation|1|||
130996936|NCT00363896|471617590|FG000|Overall Study|Lost to Follow-up|3|||
130996937|NCT00363896|471617591|FG001|Overall Study|Lost to Follow-up|0|||
130996938|NCT00363896|471617590|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
130996939|NCT00363896|471617591|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
130996940|NCT00363896|471617590|FG000|Overall Study|Other|1|||
130996941|NCT00363896|471617591|FG001|Overall Study|Other|2|||
130996942|NCT00924469|471617596|FG000|Overall Study|Adverse Event|2|||
130996943|NCT00924469|471617597|FG001|Overall Study|Adverse Event|0|||
130996944|NCT00924469|471617596|FG000|Overall Study|Withdrawal by Subject|0|||
130996945|NCT00924469|471617597|FG001|Overall Study|Withdrawal by Subject|1|||
130996946|NCT00924469|471617596|FG000|Overall Study|Lost to Follow-up|0|||
130996947|NCT00924469|471617597|FG001|Overall Study|Lost to Follow-up|1|||
130996948|NCT00630058|471617598|FG000|Overall Study|Adverse Event|1|||
130996949|NCT00630058|471617599|FG001|Overall Study|Adverse Event|1|||
130996950|NCT00630058|471617598|FG000|Overall Study|Withdrawal by Subject|0|||
130996951|NCT00630058|471617599|FG001|Overall Study|Withdrawal by Subject|1|||
130996952|NCT00630058|471617598|FG000|Overall Study|stopping criteria|3|||
130996953|NCT00630058|471617599|FG001|Overall Study|stopping criteria|2|||
130996954|NCT01651936|471617600|FG000|Base Study|Adverse Event|3|||
130996955|NCT01651936|471617601|FG001|Base Study|Adverse Event|0|||
130996956|NCT01651936|471617602|FG002|Base Study|Adverse Event|0|||
130996957|NCT01651936|471617600|FG000|Base Study|Withdrawal by Subject|1|||
130996958|NCT01651936|471617601|FG001|Base Study|Withdrawal by Subject|1|||
130996959|NCT01651936|471617602|FG002|Base Study|Withdrawal by Subject|0|||
130996960|NCT01651936|471617600|FG000|Base Study|Early Escape|2|||
130996961|NCT01651936|471617601|FG001|Base Study|Early Escape|8|||
130996962|NCT01651936|471617602|FG002|Base Study|Early Escape|0|||
130996963|NCT01651936|471617600|FG000|Base Study|Study terminated by sponsor|21|||
130996964|NCT01651936|471617601|FG001|Base Study|Study terminated by sponsor|16|||
130996965|NCT01651936|471617602|FG002|Base Study|Study terminated by sponsor|0|||
130996966|NCT01651936|471617600|FG000|Extension Study|Lack of Efficacy|0|||
130996967|NCT01651936|471617601|FG001|Extension Study|Lack of Efficacy|0|||
130996968|NCT01651936|471617602|FG002|Extension Study|Lack of Efficacy|1|||
130996969|NCT01651936|471617600|FG000|Extension Study|Study terminated by sponsor|0|||
130996970|NCT01651936|471617601|FG001|Extension Study|Study terminated by sponsor|0|||
130996971|NCT01651936|471617602|FG002|Extension Study|Study terminated by sponsor|13|||
130996972|NCT03044353|471617603|FG000|Overall Study|Adverse Event|0|||
130996973|NCT03044353|471617604|FG001|Overall Study|Adverse Event|1|||
130996974|NCT03044353|471617605|FG002|Overall Study|Adverse Event|0|||
130996975|NCT02141659|471617612|FG000|Overall Study|Major Protocol Deviation|0|||
130996976|NCT02141659|471617613|FG001|Overall Study|Major Protocol Deviation|1|||
130996977|NCT02141659|471617614|FG002|Overall Study|Major Protocol Deviation|0|||
130996978|NCT02141659|471617615|FG003|Overall Study|Major Protocol Deviation|0|||
130996979|NCT02141659|471617616|FG004|Overall Study|Major Protocol Deviation|0|||
130996980|NCT02141659|471617617|FG005|Overall Study|Major Protocol Deviation|0|||
130996981|NCT02141659|471617612|FG000|Overall Study|Lack of Efficacy|0|||
130996982|NCT02141659|471617613|FG001|Overall Study|Lack of Efficacy|0|||
130996983|NCT02141659|471617614|FG002|Overall Study|Lack of Efficacy|0|||
130996984|NCT02141659|471617615|FG003|Overall Study|Lack of Efficacy|0|||
130996985|NCT02141659|471617616|FG004|Overall Study|Lack of Efficacy|0|||
130996986|NCT02141659|471617617|FG005|Overall Study|Lack of Efficacy|1|||
130996987|NCT02141659|471617612|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
130996988|NCT02141659|471617613|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
130996989|NCT02141659|471617614|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
130996990|NCT02141659|471617615|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
130996991|NCT02141659|471617616|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
130996992|NCT02141659|471617617|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
130996993|NCT01927731|471617625|FG000|Overall Study|Graft Failure|1|||
130996994|NCT01927731|471617626|FG001|Overall Study|Graft Failure|2|||
130996995|NCT01927731|471617625|FG000|Overall Study|Physician Decision|2|||
130996996|NCT01927731|471617626|FG001|Overall Study|Physician Decision|3|||
130996997|NCT01927731|471617625|FG000|Overall Study|Withdrawal by Subject|0|||
130996998|NCT01927731|471617626|FG001|Overall Study|Withdrawal by Subject|2|||
130996999|NCT01927731|471617625|FG000|Overall Study|Death|0|||
130997000|NCT01927731|471617626|FG001|Overall Study|Death|3|||
130997001|NCT01388530|471617631|FG000|Overall Study|Lost to Follow-up|5|||
130997002|NCT00305864|471617632|FG000|Overall Study|Ineligible / No protocol treatment|0|||
130997003|NCT00305864|471617633|FG001|Overall Study|Ineligible / No protocol treatment|1|||
130997004|NCT00305864|471617634|FG002|Overall Study|Ineligible / No protocol treatment|1|||
130997005|NCT00305864|471617635|FG003|Overall Study|Ineligible / No protocol treatment|13|||
130997006|NCT02836613|471617638|FG000|Overall Study|Accidental drowning|1|||
130997007|NCT02836613|471617639|FG001|Overall Study|Accidental drowning|0|||
130997008|NCT02836613|471617638|FG000|Overall Study|Lost to Follow-up|0|||
130997009|NCT02836613|471617639|FG001|Overall Study|Lost to Follow-up|1|||
130997010|NCT02836613|471617638|FG000|Overall Study|Withdrawal by Subject|0|||
130997011|NCT02836613|471617639|FG001|Overall Study|Withdrawal by Subject|2|||
130997012|NCT03881059|471617640|FG000|Treatment Period - Part A|Adverse Event|1|||
130997013|NCT03881059|471617641|FG001|Treatment Period - Part A|Adverse Event|3|||
130997014|NCT03881059|471617642|FG002|Treatment Period - Part A|Adverse Event|4|||
130997015|NCT03881059|471617640|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
130997016|NCT03881059|471617641|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
130997017|NCT03881059|471617642|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
130997018|NCT03881059|471617640|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
130997019|NCT03881059|471617641|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
131221690|NCT02454972|472439395|FG001|Overall Study|Treatment-related adverse events|1|||
131221691|NCT02454972|472439396|FG002|Overall Study|Treatment-related adverse events|1|||
131221692|NCT02454972|472439397|FG003|Overall Study|Treatment-related adverse events|0|||
131221693|NCT02454972|472439398|FG004|Overall Study|Treatment-related adverse events|2|||
131221694|NCT02454972|472439399|FG005|Overall Study|Treatment-related adverse events|0|||
131221695|NCT02454972|472439400|FG006|Overall Study|Treatment-related adverse events|0|||
131221696|NCT02454972|472439401|FG007|Overall Study|Treatment-related adverse events|2|||
130997020|NCT03881059|471617642|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
130997021|NCT03881059|471617640|FG000|Treatment Period - Part A|Other reasons|2|||
130997022|NCT03881059|471617641|FG001|Treatment Period - Part A|Other reasons|1|||
130997023|NCT03881059|471617642|FG002|Treatment Period - Part A|Other reasons|0|||
130997024|NCT03881059|471617640|FG000|Treatment Period - Part B|Adverse Event|0|||
130997025|NCT03881059|471617641|FG001|Treatment Period - Part B|Adverse Event|0|||
130997026|NCT03881059|471617642|FG002|Treatment Period - Part B|Adverse Event|3|||
130997027|NCT03881059|471617640|FG000|Treatment Period - Part B|Death|0|||
130997028|NCT03881059|471617641|FG001|Treatment Period - Part B|Death|1|||
130997029|NCT03881059|471617642|FG002|Treatment Period - Part B|Death|1|||
130997030|NCT03881059|471617640|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
130997031|NCT03881059|471617641|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
130997032|NCT03881059|471617642|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
130997033|NCT03881059|471617640|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
130997034|NCT03881059|471617641|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
130997035|NCT03881059|471617642|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
130997036|NCT03881059|471617640|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
130997037|NCT03881059|471617641|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
130997038|NCT03881059|471617642|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
130997039|NCT03881059|471617640|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
130997040|NCT03881059|471617641|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
130997041|NCT03881059|471617642|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
130997042|NCT03881059|471617640|FG000|Treatment Period - Part B|Other reasons|4|||
130997043|NCT03881059|471617641|FG001|Treatment Period - Part B|Other reasons|3|||
130997044|NCT03881059|471617642|FG002|Treatment Period - Part B|Other reasons|3|||
130997045|NCT05284019|471617643|FG000|Overall Study|Study terminated|2|||
130997046|NCT05284019|471617644|FG001|Overall Study|Study terminated|2|||
130997047|NCT05284019|471617645|FG002|Overall Study|Study terminated|2|||
130997048|NCT05284019|471617646|FG003|Overall Study|Study terminated|5|||
130997049|NCT05284019|471617647|FG004|Overall Study|Study terminated|15|||
130997050|NCT05284019|471617643|FG000|Overall Study|Withdrawal by Subject|0|||
130997051|NCT05284019|471617644|FG001|Overall Study|Withdrawal by Subject|0|||
130997052|NCT05284019|471617645|FG002|Overall Study|Withdrawal by Subject|0|||
130997053|NCT05284019|471617646|FG003|Overall Study|Withdrawal by Subject|1|||
130997054|NCT05284019|471617647|FG004|Overall Study|Withdrawal by Subject|1|||
130997055|NCT05284019|471617643|FG000|Overall Study|Lost to Follow-up|1|||
130997056|NCT05284019|471617644|FG001|Overall Study|Lost to Follow-up|0|||
130997057|NCT05284019|471617645|FG002|Overall Study|Lost to Follow-up|0|||
130997058|NCT05284019|471617646|FG003|Overall Study|Lost to Follow-up|2|||
130997059|NCT05284019|471617647|FG004|Overall Study|Lost to Follow-up|1|||
130997060|NCT02065570|471617648|FG000|Induction Study|Adverse Event|5|||
130997061|NCT02065570|471617649|FG001|Induction Study|Adverse Event|12|||
130997062|NCT02065570|471617650|FG002|Induction Study|Adverse Event|0|||
130997063|NCT02065570|471617651|FG003|Induction Study|Adverse Event|0|||
130997064|NCT02065570|471617648|FG000|Induction Study|Withdrawal by Subject|2|||
130997065|NCT02065570|471617649|FG001|Induction Study|Withdrawal by Subject|3|||
130997066|NCT02065570|471617650|FG002|Induction Study|Withdrawal by Subject|0|||
130997067|NCT02065570|471617651|FG003|Induction Study|Withdrawal by Subject|0|||
130997068|NCT02065570|471617648|FG000|Induction Study|Lost to Follow-up|1|||
130997069|NCT02065570|471617649|FG001|Induction Study|Lost to Follow-up|1|||
130997070|NCT02065570|471617650|FG002|Induction Study|Lost to Follow-up|0|||
130997071|NCT02065570|471617651|FG003|Induction Study|Lost to Follow-up|0|||
130997072|NCT02065570|471617648|FG000|Induction Study|Other, Not Specified|6|||
130997073|NCT02065570|471617649|FG001|Induction Study|Other, Not Specified|5|||
130997074|NCT02065570|471617650|FG002|Induction Study|Other, Not Specified|0|||
130997075|NCT02065570|471617651|FG003|Induction Study|Other, Not Specified|0|||
130997076|NCT02065570|471617648|FG000|Maintenance Study|Adverse Event|0|||
130997077|NCT02065570|471617649|FG001|Maintenance Study|Adverse Event|0|||
130997078|NCT02065570|471617650|FG002|Maintenance Study|Adverse Event|8|||
130997079|NCT02065570|471617651|FG003|Maintenance Study|Adverse Event|8|||
130997080|NCT02065570|471617648|FG000|Maintenance Study|Withdrawal by Subject|0|||
130997081|NCT02065570|471617649|FG001|Maintenance Study|Withdrawal by Subject|0|||
130997082|NCT02065570|471617650|FG002|Maintenance Study|Withdrawal by Subject|1|||
130997083|NCT02065570|471617651|FG003|Maintenance Study|Withdrawal by Subject|4|||
130997084|NCT02065570|471617648|FG000|Maintenance Study|Lost to Follow-up|0|||
130997085|NCT02065570|471617649|FG001|Maintenance Study|Lost to Follow-up|0|||
130997086|NCT02065570|471617650|FG002|Maintenance Study|Lost to Follow-up|2|||
130997087|NCT02065570|471617651|FG003|Maintenance Study|Lost to Follow-up|2|||
130997088|NCT02065570|471617648|FG000|Maintenance Study|Other, Not Specified|0|||
130997089|NCT02065570|471617649|FG001|Maintenance Study|Other, Not Specified|0|||
130997090|NCT02065570|471617650|FG002|Maintenance Study|Other, Not Specified|11|||
130997091|NCT02065570|471617651|FG003|Maintenance Study|Other, Not Specified|5|||
130997092|NCT02743793|471617652|FG000|Overall Study|Death|1|||
130997093|NCT02743793|471617653|FG001|Overall Study|Death|1|||
130997094|NCT02743793|471617652|FG000|Overall Study|Withdrawal by Subject|0|||
130997095|NCT02743793|471617653|FG001|Overall Study|Withdrawal by Subject|1|||
130997096|NCT02743793|471617652|FG000|Overall Study|Screen Failure|4|||
130997097|NCT02743793|471617653|FG001|Overall Study|Screen Failure|0|||
130997098|NCT02743793|471617652|FG000|Overall Study|No Primary Care Physician|0|||
130997099|NCT02743793|471617653|FG001|Overall Study|No Primary Care Physician|1|||
130997100|NCT02743793|471617652|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
130997101|NCT02743793|471617653|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
130997102|NCT02743793|471617652|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
130997103|NCT02743793|471617653|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
130997104|NCT01146574|471617658|FG000|Overall Study|Death|0|||
130997105|NCT01146574|471617659|FG001|Overall Study|Death|1|||
130997106|NCT01146574|471617660|FG002|Overall Study|Death|1|||
130997107|NCT01146574|471617661|FG003|Overall Study|Death|0|||
130997108|NCT01146574|471617662|FG004|Overall Study|Death|0|||
130997109|NCT01146574|471617663|FG005|Overall Study|Death|0|||
130997110|NCT01146574|471617664|FG006|Overall Study|Death|0|||
130997111|NCT01146574|471617658|FG000|Overall Study|Other reasons|0|||
130997112|NCT01146574|471617659|FG001|Overall Study|Other reasons|0|||
130997113|NCT01146574|471617660|FG002|Overall Study|Other reasons|3|||
130997114|NCT01146574|471617661|FG003|Overall Study|Other reasons|0|||
130997115|NCT01146574|471617662|FG004|Overall Study|Other reasons|0|||
130997116|NCT01146574|471617663|FG005|Overall Study|Other reasons|0|||
130997117|NCT01146574|471617664|FG006|Overall Study|Other reasons|0|||
130997118|NCT01146574|471617658|FG000|Overall Study|Kidney transplant|0|||
130997119|NCT01146574|471617659|FG001|Overall Study|Kidney transplant|0|||
130997120|NCT01146574|471617660|FG002|Overall Study|Kidney transplant|1|||
130997121|NCT01146574|471617661|FG003|Overall Study|Kidney transplant|1|||
130997122|NCT01146574|471617662|FG004|Overall Study|Kidney transplant|0|||
130997123|NCT01146574|471617663|FG005|Overall Study|Kidney transplant|0|||
130997124|NCT01146574|471617664|FG006|Overall Study|Kidney transplant|0|||
130997125|NCT01146574|471617658|FG000|Overall Study|Withdrew consent|0|||
130997126|NCT01146574|471617659|FG001|Overall Study|Withdrew consent|0|||
130997127|NCT01146574|471617660|FG002|Overall Study|Withdrew consent|1|||
130997128|NCT01146574|471617661|FG003|Overall Study|Withdrew consent|1|||
130997129|NCT01146574|471617662|FG004|Overall Study|Withdrew consent|2|||
130997130|NCT01146574|471617663|FG005|Overall Study|Withdrew consent|1|||
130997131|NCT01146574|471617664|FG006|Overall Study|Withdrew consent|1|||
130997132|NCT01266993|471617665|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
130997133|NCT01266993|471617666|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
130997134|NCT01266993|471617665|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
130997135|NCT01266993|471617666|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
130997136|NCT03051659|471617669|FG000|Treatment Period|Withdrawal by Subject|0|||
130997137|NCT03051659|471617670|FG001|Treatment Period|Withdrawal by Subject|2|||
130997138|NCT03051659|471617669|FG000|Survival Follow-up|Lost to Follow-up|23|||
130997139|NCT03051659|471617670|FG001|Survival Follow-up|Lost to Follow-up|22|||
130997140|NCT02293837|471617671|FG000|Overall Study|Lost to Follow-up|0|||
130997141|NCT02293837|471617672|FG001|Overall Study|Lost to Follow-up|2|||
130997142|NCT02293837|471617673|FG002|Overall Study|Lost to Follow-up|1|||
130997143|NCT02293837|471617674|FG003|Overall Study|Lost to Follow-up|0|||
130997144|NCT02293837|471617671|FG000|Overall Study|Withdrawal by Subject|2|||
130997145|NCT02293837|471617672|FG001|Overall Study|Withdrawal by Subject|1|||
130997146|NCT02293837|471617673|FG002|Overall Study|Withdrawal by Subject|2|||
130997147|NCT02293837|471617674|FG003|Overall Study|Withdrawal by Subject|1|||
130997148|NCT02293837|471617671|FG000|Overall Study|COVID-19 Related|1|||
130997149|NCT02293837|471617672|FG001|Overall Study|COVID-19 Related|1|||
130997150|NCT02293837|471617673|FG002|Overall Study|COVID-19 Related|0|||
130997151|NCT02293837|471617674|FG003|Overall Study|COVID-19 Related|0|||
130997152|NCT02293837|471617671|FG000|Overall Study|Participant ill and could not be infused|0|||
130997153|NCT02293837|471617672|FG001|Overall Study|Participant ill and could not be infused|0|||
130997154|NCT02293837|471617673|FG002|Overall Study|Participant ill and could not be infused|1|||
130997155|NCT02293837|471617674|FG003|Overall Study|Participant ill and could not be infused|0|||
130997156|NCT04779242|471617675|FG000|Overall Study|Adverse Event|1|||
130997157|NCT04779242|471617676|FG001|Overall Study|Adverse Event|1|||
130997158|NCT04779242|471617675|FG000|Overall Study|Lost to Follow-up|2|||
130997159|NCT04779242|471617676|FG001|Overall Study|Lost to Follow-up|4|||
130997160|NCT04779242|471617675|FG000|Overall Study|Withdrawal by Subject|7|||
130997161|NCT04779242|471617676|FG001|Overall Study|Withdrawal by Subject|9|||
130997162|NCT04779242|471617675|FG000|Overall Study|Death|6|||
130997163|NCT04779242|471617676|FG001|Overall Study|Death|6|||
130997164|NCT04779242|471617675|FG000|Overall Study|COVID-19 related reasons|2|||
130997165|NCT04779242|471617676|FG001|Overall Study|COVID-19 related reasons|1|||
130997166|NCT04779242|471617675|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
130997167|NCT04779242|471617676|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
130997168|NCT04779242|471617675|FG000|Overall Study|Martial Law in Ukraine|2|||
130997169|NCT04779242|471617676|FG001|Overall Study|Martial Law in Ukraine|3|||
130997170|NCT01076088|471617677|FG000|Overall Study|Adverse Event|1|||
130997171|NCT01076088|471617678|FG001|Overall Study|Adverse Event|6|||
130997172|NCT01076088|471617679|FG002|Overall Study|Adverse Event|3|||
130997173|NCT01076088|471617680|FG003|Overall Study|Adverse Event|2|||
130997174|NCT01076088|471617681|FG004|Overall Study|Adverse Event|3|||
130997175|NCT01076088|471617682|FG005|Overall Study|Adverse Event|3|||
130997176|NCT01076088|471617677|FG000|Overall Study|Lost to Follow-up|1|||
130997177|NCT01076088|471617678|FG001|Overall Study|Lost to Follow-up|1|||
130997178|NCT01076088|471617679|FG002|Overall Study|Lost to Follow-up|0|||
130997179|NCT01076088|471617680|FG003|Overall Study|Lost to Follow-up|1|||
130997180|NCT01076088|471617681|FG004|Overall Study|Lost to Follow-up|1|||
130997181|NCT01076088|471617682|FG005|Overall Study|Lost to Follow-up|2|||
130997182|NCT01076088|471617677|FG000|Overall Study|Non-compliance with study drug|0|||
130997183|NCT01076088|471617678|FG001|Overall Study|Non-compliance with study drug|0|||
130997184|NCT01076088|471617679|FG002|Overall Study|Non-compliance with study drug|0|||
130997185|NCT01076088|471617680|FG003|Overall Study|Non-compliance with study drug|1|||
130997186|NCT01076088|471617681|FG004|Overall Study|Non-compliance with study drug|0|||
130997187|NCT01076088|471617682|FG005|Overall Study|Non-compliance with study drug|0|||
130997188|NCT01076088|471617677|FG000|Overall Study|Physician Decision|1|||
130997189|NCT01076088|471617678|FG001|Overall Study|Physician Decision|3|||
130997190|NCT01076088|471617679|FG002|Overall Study|Physician Decision|0|||
130997191|NCT01076088|471617680|FG003|Overall Study|Physician Decision|1|||
130997192|NCT01076088|471617681|FG004|Overall Study|Physician Decision|1|||
130997193|NCT01076088|471617682|FG005|Overall Study|Physician Decision|0|||
130997194|NCT01076088|471617677|FG000|Overall Study|Withdrawal by Subject|8|||
130997195|NCT01076088|471617678|FG001|Overall Study|Withdrawal by Subject|8|||
130997196|NCT01076088|471617679|FG002|Overall Study|Withdrawal by Subject|14|||
130997197|NCT01076088|471617680|FG003|Overall Study|Withdrawal by Subject|10|||
130997198|NCT01076088|471617681|FG004|Overall Study|Withdrawal by Subject|11|||
130997199|NCT01076088|471617682|FG005|Overall Study|Withdrawal by Subject|17|||
130997200|NCT01076088|471617677|FG000|Overall Study|Other protocol specified criteria|0|||
130997201|NCT01076088|471617678|FG001|Overall Study|Other protocol specified criteria|0|||
130997202|NCT01076088|471617679|FG002|Overall Study|Other protocol specified criteria|0|||
130997203|NCT01076088|471617680|FG003|Overall Study|Other protocol specified criteria|0|||
130997204|NCT01076088|471617681|FG004|Overall Study|Other protocol specified criteria|0|||
130997205|NCT01076088|471617682|FG005|Overall Study|Other protocol specified criteria|1|||
130997206|NCT00786474|471617683|FG000|Overall Study|Death|5|||
130997207|NCT00786474|471617684|FG001|Overall Study|Death|4|||
130997208|NCT00786474|471617683|FG000|Overall Study|Withdrawal by Subject|23|||
130997209|NCT00786474|471617684|FG001|Overall Study|Withdrawal by Subject|31|||
130997210|NCT00786474|471617683|FG000|Overall Study|Lost to Follow-up|3|||
130997211|NCT00786474|471617684|FG001|Overall Study|Lost to Follow-up|3|||
130997212|NCT00786474|471617683|FG000|Overall Study|Physician Decision|2|||
130997213|NCT00786474|471617684|FG001|Overall Study|Physician Decision|1|||
130997214|NCT00786474|471617683|FG000|Overall Study|Other|4|||
130997215|NCT00786474|471617684|FG001|Overall Study|Other|4|||
130997216|NCT03053492|471617685|FG000|Overall Study|Adverse Event|1|||
130997217|NCT03053492|471617686|FG001|Overall Study|Adverse Event|1|||
130997218|NCT03053492|471617685|FG000|Overall Study|Withdrawal by Subject|7|||
130997219|NCT03053492|471617686|FG001|Overall Study|Withdrawal by Subject|5|||
130997220|NCT01544491|471617687|FG000|Overall Study|Withdrawal by Subject|3|||
130997221|NCT01544491|471617688|FG001|Overall Study|Withdrawal by Subject|2|||
130997222|NCT01544491|471617687|FG000|Overall Study|Lost to Follow-up|0|||
130997223|NCT01544491|471617688|FG001|Overall Study|Lost to Follow-up|1|||
130997224|NCT01544491|471617687|FG000|Overall Study|administrative problems|2|||
130997225|NCT01544491|471617688|FG001|Overall Study|administrative problems|0|||
130997226|NCT00967018|471617689|FG000|Overall Study|Adverse Event|2|||
130997227|NCT00967018|471617689|FG000|Overall Study|Physician Decision|7|||
130997228|NCT00967018|471617689|FG000|Overall Study|Lost to Follow-up|2|||
130997229|NCT00967018|471617689|FG000|Overall Study|Withdrawal by Subject|1|||
130997230|NCT00967018|471617689|FG000|Overall Study|Miscellaneous Reasons|9|||
130997231|NCT02733042|471617693|FG000|Overall Study|Adverse Event|1|||
130997232|NCT02733042|471617694|FG001|Overall Study|Adverse Event|0|||
130997233|NCT02733042|471617695|FG002|Overall Study|Adverse Event|1|||
130997234|NCT02733042|471617696|FG003|Overall Study|Adverse Event|1|||
130997235|NCT02733042|471617697|FG004|Overall Study|Adverse Event|0|||
130997236|NCT02733042|471617698|FG005|Overall Study|Adverse Event|0|||
130997237|NCT02733042|471617699|FG006|Overall Study|Adverse Event|0|||
130997238|NCT02733042|471617700|FG007|Overall Study|Adverse Event|0|||
130997239|NCT02733042|471617701|FG008|Overall Study|Adverse Event|0|||
130997240|NCT02733042|471617702|FG009|Overall Study|Adverse Event|0|||
130997241|NCT02733042|471617703|FG010|Overall Study|Adverse Event|2|||
130997242|NCT02733042|471617704|FG011|Overall Study|Adverse Event|2|||
130997243|NCT02733042|471617705|FG012|Overall Study|Adverse Event|0|||
130997244|NCT02733042|471617706|FG013|Overall Study|Adverse Event|2|||
130997245|NCT02733042|471617707|FG014|Overall Study|Adverse Event|0|||
130997246|NCT02733042|471617708|FG015|Overall Study|Adverse Event|0|||
130997247|NCT02733042|471617709|FG016|Overall Study|Adverse Event|0|||
130997248|NCT02733042|471617710|FG017|Overall Study|Adverse Event|1|||
130997249|NCT02733042|471617711|FG018|Overall Study|Adverse Event|0|||
130997250|NCT02733042|471617693|FG000|Overall Study|Progressive Disease|2|||
130997251|NCT02733042|471617694|FG001|Overall Study|Progressive Disease|1|||
130997252|NCT02733042|471617695|FG002|Overall Study|Progressive Disease|3|||
130997253|NCT02733042|471617696|FG003|Overall Study|Progressive Disease|1|||
130997254|NCT02733042|471617697|FG004|Overall Study|Progressive Disease|2|||
130997255|NCT02733042|471617698|FG005|Overall Study|Progressive Disease|3|||
130997256|NCT02733042|471617699|FG006|Overall Study|Progressive Disease|0|||
130997257|NCT02733042|471617700|FG007|Overall Study|Progressive Disease|3|||
130997258|NCT02733042|471617701|FG008|Overall Study|Progressive Disease|3|||
130997259|NCT02733042|471617702|FG009|Overall Study|Progressive Disease|2|||
130997260|NCT02733042|471617703|FG010|Overall Study|Progressive Disease|2|||
130997261|NCT02733042|471617704|FG011|Overall Study|Progressive Disease|2|||
130997262|NCT02733042|471617705|FG012|Overall Study|Progressive Disease|8|||
130884282|NCT01746901|471211457|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
130884283|NCT01746901|471211458|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
130884284|NCT01746901|471211459|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
130884285|NCT01746901|471211460|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
130884286|NCT01746901|471211461|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
130884287|NCT01746901|471211453|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130884288|NCT01746901|471211454|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130884289|NCT01746901|471211455|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130884290|NCT01746901|471211456|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130884291|NCT01746901|471211457|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130884292|NCT01746901|471211458|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130884293|NCT01746901|471211459|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130884294|NCT01746901|471211460|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
130884295|NCT01746901|471211461|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130884296|NCT01746901|471211453|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
130884297|NCT01746901|471211454|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
130884298|NCT01746901|471211455|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
130884299|NCT01746901|471211456|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
130884300|NCT01746901|471211457|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
130884301|NCT01746901|471211458|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
130884302|NCT01746901|471211459|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
130884303|NCT01746901|471211460|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
130884304|NCT01746901|471211461|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
130884305|NCT01746901|471211453|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130884306|NCT01746901|471211454|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130884307|NCT01746901|471211455|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130884308|NCT01746901|471211456|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
130884309|NCT01746901|471211457|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130884310|NCT01746901|471211458|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130884311|NCT01746901|471211459|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130884312|NCT01746901|471211460|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130884313|NCT01746901|471211461|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130884314|NCT01746901|471211453|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130884315|NCT01746901|471211454|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130884316|NCT01746901|471211455|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130884317|NCT01746901|471211456|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130884318|NCT01746901|471211457|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130884319|NCT01746901|471211458|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
130884320|NCT01746901|471211459|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130884321|NCT01746901|471211460|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130884322|NCT01746901|471211461|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
130884323|NCT01746901|471211453|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130884324|NCT01746901|471211454|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130884325|NCT01746901|471211455|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130884326|NCT01746901|471211456|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130884327|NCT01746901|471211457|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130884328|NCT01746901|471211458|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130884329|NCT01746901|471211459|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
130884330|NCT01746901|471211460|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130884331|NCT01746901|471211461|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
130884332|NCT03594110|471211465|FG000|Interventional Part|Participant concerned about study treatment|23|||
130884333|NCT03594110|471211466|FG001|Interventional Part|Participant concerned about study treatment|28|||
130884334|NCT03594110|471211465|FG000|Interventional Part|Doctor advice|38|||
130884335|NCT03594110|471211466|FG001|Interventional Part|Doctor advice|40|||
130884336|NCT03594110|471211465|FG000|Interventional Part|Participants' wish|89|||
130884337|NCT03594110|471211466|FG001|Interventional Part|Participants' wish|68|||
130884338|NCT03594110|471211465|FG000|Interventional Part|Adverse event-non-fatal events|119|||
130884339|NCT03594110|471211466|FG001|Interventional Part|Adverse event-non-fatal events|116|||
130884340|NCT03594110|471211465|FG000|Interventional Part|Study drug stopped, reason missing|336|||
130884341|NCT03594110|471211466|FG001|Interventional Part|Study drug stopped, reason missing|294|||
130884342|NCT03594110|471211465|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
130884343|NCT03594110|471211466|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
130884344|NCT03594110|471211465|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
130884345|NCT03594110|471211466|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
130884346|NCT03594110|471211465|FG000|Interventional Part|Contraindicated drug started|32|||
130997263|NCT02733042|471617706|FG013|Overall Study|Progressive Disease|1|||
130997264|NCT02733042|471617707|FG014|Overall Study|Progressive Disease|4|||
130997265|NCT02733042|471617708|FG015|Overall Study|Progressive Disease|7|||
130997266|NCT02733042|471617709|FG016|Overall Study|Progressive Disease|2|||
130997267|NCT02733042|471617710|FG017|Overall Study|Progressive Disease|3|||
130997268|NCT02733042|471617711|FG018|Overall Study|Progressive Disease|4|||
130997269|NCT02733042|471617693|FG000|Overall Study|Withdrawal by Subject|0|||
130997270|NCT02733042|471617694|FG001|Overall Study|Withdrawal by Subject|1|||
130997271|NCT02733042|471617695|FG002|Overall Study|Withdrawal by Subject|2|||
130997272|NCT02733042|471617696|FG003|Overall Study|Withdrawal by Subject|1|||
130997273|NCT02733042|471617697|FG004|Overall Study|Withdrawal by Subject|1|||
130997274|NCT02733042|471617698|FG005|Overall Study|Withdrawal by Subject|0|||
130997275|NCT02733042|471617699|FG006|Overall Study|Withdrawal by Subject|0|||
130997276|NCT02733042|471617700|FG007|Overall Study|Withdrawal by Subject|0|||
130997277|NCT02733042|471617701|FG008|Overall Study|Withdrawal by Subject|1|||
130997278|NCT02733042|471617702|FG009|Overall Study|Withdrawal by Subject|1|||
130997279|NCT02733042|471617703|FG010|Overall Study|Withdrawal by Subject|0|||
130997280|NCT02733042|471617704|FG011|Overall Study|Withdrawal by Subject|2|||
130997281|NCT02733042|471617705|FG012|Overall Study|Withdrawal by Subject|1|||
130997282|NCT02733042|471617706|FG013|Overall Study|Withdrawal by Subject|1|||
130997283|NCT02733042|471617707|FG014|Overall Study|Withdrawal by Subject|0|||
130997284|NCT02733042|471617708|FG015|Overall Study|Withdrawal by Subject|0|||
130997285|NCT02733042|471617709|FG016|Overall Study|Withdrawal by Subject|0|||
130997286|NCT02733042|471617710|FG017|Overall Study|Withdrawal by Subject|0|||
130997287|NCT02733042|471617711|FG018|Overall Study|Withdrawal by Subject|0|||
130997288|NCT02733042|471617693|FG000|Overall Study|Other Reasons|0|||
130997289|NCT02733042|471617694|FG001|Overall Study|Other Reasons|0|||
130997290|NCT02733042|471617695|FG002|Overall Study|Other Reasons|1|||
130997291|NCT02733042|471617696|FG003|Overall Study|Other Reasons|0|||
130997292|NCT02733042|471617697|FG004|Overall Study|Other Reasons|0|||
130997293|NCT02733042|471617698|FG005|Overall Study|Other Reasons|0|||
130997294|NCT02733042|471617699|FG006|Overall Study|Other Reasons|0|||
130997295|NCT02733042|471617700|FG007|Overall Study|Other Reasons|0|||
130997296|NCT02733042|471617701|FG008|Overall Study|Other Reasons|0|||
130997297|NCT02733042|471617702|FG009|Overall Study|Other Reasons|1|||
130997298|NCT02733042|471617703|FG010|Overall Study|Other Reasons|1|||
130997299|NCT02733042|471617704|FG011|Overall Study|Other Reasons|0|||
130997300|NCT02733042|471617705|FG012|Overall Study|Other Reasons|0|||
130997301|NCT02733042|471617706|FG013|Overall Study|Other Reasons|0|||
130997302|NCT02733042|471617707|FG014|Overall Study|Other Reasons|0|||
130997303|NCT02733042|471617708|FG015|Overall Study|Other Reasons|1|||
130997304|NCT02733042|471617709|FG016|Overall Study|Other Reasons|0|||
130997305|NCT02733042|471617710|FG017|Overall Study|Other Reasons|1|||
130997306|NCT02733042|471617711|FG018|Overall Study|Other Reasons|0|||
130997307|NCT02733042|471617693|FG000|Overall Study|Death|0|||
130997308|NCT02733042|471617694|FG001|Overall Study|Death|0|||
130997309|NCT02733042|471617695|FG002|Overall Study|Death|0|||
130997310|NCT02733042|471617696|FG003|Overall Study|Death|0|||
130997311|NCT02733042|471617697|FG004|Overall Study|Death|0|||
130997312|NCT02733042|471617698|FG005|Overall Study|Death|0|||
130997313|NCT02733042|471617699|FG006|Overall Study|Death|1|||
130997314|NCT02733042|471617700|FG007|Overall Study|Death|0|||
130997315|NCT02733042|471617701|FG008|Overall Study|Death|1|||
130997316|NCT02733042|471617702|FG009|Overall Study|Death|0|||
130997317|NCT02733042|471617703|FG010|Overall Study|Death|1|||
130997318|NCT02733042|471617704|FG011|Overall Study|Death|0|||
130997319|NCT02733042|471617705|FG012|Overall Study|Death|0|||
130997320|NCT02733042|471617706|FG013|Overall Study|Death|0|||
130997321|NCT02733042|471617707|FG014|Overall Study|Death|1|||
130997322|NCT02733042|471617708|FG015|Overall Study|Death|2|||
130997323|NCT02733042|471617709|FG016|Overall Study|Death|0|||
130997324|NCT02733042|471617710|FG017|Overall Study|Death|0|||
130997325|NCT02733042|471617711|FG018|Overall Study|Death|0|||
130997326|NCT01088529|471617713|FG000|Overall Study|Did not receive study treatment|0|||
130997327|NCT01088529|471617714|FG001|Overall Study|Did not receive study treatment|1|||
130997328|NCT01680458|471617718|FG000|Overall Study|Protocol Violation|3|||
130997329|NCT03864926|471619498|FG000|Overall Study|Death|0|||
130997330|NCT03864926|471619499|FG001|Overall Study|Death|2|||
130997331|NCT00445601|471619500|FG000|Overall Study|Withdrawal by Subject|11|||
130997332|NCT00445601|471619501|FG001|Overall Study|Withdrawal by Subject|11|||
130997333|NCT00445601|471619500|FG000|Overall Study|TURBT Complication|12|||
130997334|NCT00445601|471619501|FG001|Overall Study|TURBT Complication|8|||
130997335|NCT00445601|471619500|FG000|Overall Study|Incorrect Disease Status|6|||
130997336|NCT00445601|471619501|FG001|Overall Study|Incorrect Disease Status|6|||
130997337|NCT00445601|471619500|FG000|Overall Study|Drug Delivery Issue|2|||
130997338|NCT00445601|471619501|FG001|Overall Study|Drug Delivery Issue|2|||
130997339|NCT00445601|471619500|FG000|Overall Study|Adverse Event|2|||
130997340|NCT00445601|471619501|FG001|Overall Study|Adverse Event|0|||
130997341|NCT00445601|471619500|FG000|Overall Study|Death prior to TURBT|0|||
130997342|NCT00445601|471619501|FG001|Overall Study|Death prior to TURBT|1|||
130997343|NCT02391038|471619508|FG000|Overall Study|Progressive disease|3|||
130997344|NCT02391038|471619509|FG001|Overall Study|Progressive disease|3|||
130997345|NCT02391038|471619510|FG002|Overall Study|Progressive disease|6|||
130997346|NCT04424290|471619516|FG000|Overall Study|Not treated|0|||
130997347|NCT04424290|471619517|FG001|Overall Study|Not treated|0|||
130997348|NCT04424290|471619518|FG002|Overall Study|Not treated|1|||
130997349|NCT04424290|471619519|FG003|Overall Study|Not treated|0|||
130997350|NCT04424290|471619520|FG004|Overall Study|Not treated|1|||
130997351|NCT04424290|471619516|FG000|Overall Study|Adverse Event|0|||
130997352|NCT04424290|471619517|FG001|Overall Study|Adverse Event|0|||
130997353|NCT04424290|471619518|FG002|Overall Study|Adverse Event|0|||
130997354|NCT04424290|471619519|FG003|Overall Study|Adverse Event|2|||
130997355|NCT04424290|471619520|FG004|Overall Study|Adverse Event|0|||
130997356|NCT04424290|471619516|FG000|Overall Study|Withdrawal by Subject|0|||
130997357|NCT04424290|471619517|FG001|Overall Study|Withdrawal by Subject|0|||
130997358|NCT04424290|471619518|FG002|Overall Study|Withdrawal by Subject|0|||
130997359|NCT04424290|471619519|FG003|Overall Study|Withdrawal by Subject|0|||
130997360|NCT04424290|471619520|FG004|Overall Study|Withdrawal by Subject|1|||
130997361|NCT04424290|471619516|FG000|Overall Study|Other than listed|0|||
130997362|NCT04424290|471619517|FG001|Overall Study|Other than listed|0|||
130997363|NCT04424290|471619518|FG002|Overall Study|Other than listed|0|||
130997364|NCT04424290|471619519|FG003|Overall Study|Other than listed|1|||
130997365|NCT04424290|471619520|FG004|Overall Study|Other than listed|0|||
130997366|NCT03918239|471619521|FG000|Overall Study|Lost to Follow-up|3|||
130997367|NCT03918239|471619522|FG001|Overall Study|Lost to Follow-up|1|||
130997368|NCT03918239|471619521|FG000|Overall Study|Pregnancy|0|||
130997369|NCT03918239|471619522|FG001|Overall Study|Pregnancy|2|||
130997370|NCT03918239|471619521|FG000|Overall Study|Withdrawal by Subject|3|||
130997371|NCT03918239|471619522|FG001|Overall Study|Withdrawal by Subject|3|||
130997372|NCT03918239|471619521|FG000|Overall Study|positive urine drug screening results|4|||
130997373|NCT03918239|471619522|FG001|Overall Study|positive urine drug screening results|1|||
130997374|NCT04249336|471619525|FG000|Overall Study|Lost to Follow-up|3|||
130997375|NCT04249336|471619526|FG001|Overall Study|Lost to Follow-up|3|||
130997376|NCT04249336|471619527|FG002|Overall Study|Lost to Follow-up|3|||
130997377|NCT04249336|471619528|FG003|Overall Study|Lost to Follow-up|3|||
130997378|NCT01242176|471619529|FG000|Washout Period of 7 Days|Adverse Event|0|||
130997379|NCT01242176|471619530|FG001|Washout Period of 7 Days|Adverse Event|2|||
130997380|NCT01242176|471619529|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
130997381|NCT01242176|471619530|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
130997382|NCT03390036|471619531|FG000|Overall Study|Lost to Follow-up|1|||
130997383|NCT03390036|471619532|FG001|Overall Study|Lost to Follow-up|0|||
130997384|NCT03390036|471619533|FG002|Overall Study|Lost to Follow-up|0|||
130997385|NCT03390036|471619531|FG000|Overall Study|Lack of Efficacy|1|||
130997386|NCT03390036|471619532|FG001|Overall Study|Lack of Efficacy|0|||
130997387|NCT03390036|471619533|FG002|Overall Study|Lack of Efficacy|0|||
130997388|NCT00358215|471619536|FG000|Overall Study|Ineligibility determined|4|||
130997389|NCT00358215|471619537|FG001|Overall Study|Ineligibility determined|3|||
130997390|NCT00358215|471619536|FG000|Overall Study|Adverse Event|83|||
130997391|NCT00358215|471619537|FG001|Overall Study|Adverse Event|65|||
130997392|NCT00358215|471619536|FG000|Overall Study|Withdrawal by Subject|111|||
130997393|NCT00358215|471619537|FG001|Overall Study|Withdrawal by Subject|102|||
130997394|NCT00358215|471619536|FG000|Overall Study|Participant request|65|||
130997395|NCT00358215|471619537|FG001|Overall Study|Participant request|64|||
130997396|NCT00358215|471619536|FG000|Overall Study|Physician Decision|47|||
130997397|NCT00358215|471619537|FG001|Overall Study|Physician Decision|39|||
130997398|NCT00358215|471619536|FG000|Overall Study|Lost to Follow-up|16|||
130997399|NCT00358215|471619537|FG001|Overall Study|Lost to Follow-up|22|||
130997400|NCT00358215|471619536|FG000|Overall Study|Death|265|||
130997401|NCT00358215|471619537|FG001|Overall Study|Death|281|||
130997402|NCT00358215|471619536|FG000|Overall Study|Protocol Violation|64|||
130997403|NCT00358215|471619537|FG001|Overall Study|Protocol Violation|59|||
130997404|NCT00358215|471619536|FG000|Overall Study|Pregnancy|1|||
130997405|NCT00358215|471619537|FG001|Overall Study|Pregnancy|0|||
130997406|NCT00358215|471619536|FG000|Overall Study|Other|21|||
130997407|NCT00358215|471619537|FG001|Overall Study|Other|14|||
130997408|NCT00358215|471619536|FG000|Overall Study|Did not receive investigational product|2|||
130997409|NCT00358215|471619537|FG001|Overall Study|Did not receive investigational product|3|||
130997410|NCT01189890|471619540|FG000|Overall Study|Adverse Event|3|||
130997411|NCT01189890|471619541|FG001|Overall Study|Adverse Event|4|||
130997412|NCT01189890|471619540|FG000|Overall Study|Lack of Efficacy|7|||
130997413|NCT01189890|471619541|FG001|Overall Study|Lack of Efficacy|2|||
130997414|NCT01189890|471619540|FG000|Overall Study|Lost to Follow-up|1|||
130997415|NCT01189890|471619541|FG001|Overall Study|Lost to Follow-up|7|||
130997416|NCT01189890|471619540|FG000|Overall Study|Protocol Violation|1|||
130997417|NCT01189890|471619541|FG001|Overall Study|Protocol Violation|5|||
130997418|NCT01189890|471619540|FG000|Overall Study|Withdrawal by Subject|15|||
130997419|NCT01189890|471619541|FG001|Overall Study|Withdrawal by Subject|11|||
130997420|NCT01189890|471619540|FG000|Overall Study|Non Compliance|0|||
130997421|NCT01189890|471619541|FG001|Overall Study|Non Compliance|1|||
130997422|NCT01189890|471619540|FG000|Overall Study|Physician Decision|5|||
130997423|NCT01189890|471619541|FG001|Overall Study|Physician Decision|4|||
130997424|NCT01189890|471619540|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
130997425|NCT01189890|471619541|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
130997426|NCT01807221|471619544|FG000|Overall Study|Progressive disease|1|||
130997427|NCT01807221|471619545|FG001|Overall Study|Progressive disease|0|||
130997428|NCT01807221|471619546|FG002|Overall Study|Progressive disease|1|||
130997429|NCT01807221|471619547|FG003|Overall Study|Progressive disease|0|||
130997430|NCT01807221|471619548|FG004|Overall Study|Progressive disease|0|||
130997431|NCT01807221|471619549|FG005|Overall Study|Progressive disease|0|||
130997432|NCT01807221|471619544|FG000|Overall Study|Death|7|||
130997433|NCT01807221|471619545|FG001|Overall Study|Death|9|||
130997434|NCT01807221|471619546|FG002|Overall Study|Death|4|||
130997435|NCT01807221|471619547|FG003|Overall Study|Death|2|||
130997436|NCT01807221|471619548|FG004|Overall Study|Death|1|||
130997437|NCT01807221|471619549|FG005|Overall Study|Death|6|||
130997438|NCT01807221|471619544|FG000|Overall Study|Physician Decision|2|||
130997439|NCT01807221|471619545|FG001|Overall Study|Physician Decision|1|||
130997440|NCT01807221|471619546|FG002|Overall Study|Physician Decision|0|||
130997441|NCT01807221|471619547|FG003|Overall Study|Physician Decision|0|||
130997442|NCT01807221|471619548|FG004|Overall Study|Physician Decision|0|||
130997443|NCT01807221|471619549|FG005|Overall Study|Physician Decision|0|||
130997444|NCT01807221|471619544|FG000|Overall Study|Adverse Event|33|||
130997445|NCT01807221|471619545|FG001|Overall Study|Adverse Event|22|||
130997446|NCT01807221|471619546|FG002|Overall Study|Adverse Event|26|||
130997447|NCT01807221|471619547|FG003|Overall Study|Adverse Event|25|||
130997448|NCT01807221|471619548|FG004|Overall Study|Adverse Event|18|||
130997449|NCT01807221|471619549|FG005|Overall Study|Adverse Event|21|||
130997450|NCT01807221|471619544|FG000|Overall Study|Protocol Violation|0|||
130997451|NCT01807221|471619545|FG001|Overall Study|Protocol Violation|2|||
130997452|NCT01807221|471619546|FG002|Overall Study|Protocol Violation|1|||
130997453|NCT01807221|471619547|FG003|Overall Study|Protocol Violation|2|||
130997454|NCT01807221|471619548|FG004|Overall Study|Protocol Violation|0|||
130997455|NCT01807221|471619549|FG005|Overall Study|Protocol Violation|1|||
130997456|NCT01807221|471619544|FG000|Overall Study|Non-compliance|1|||
130997457|NCT01807221|471619545|FG001|Overall Study|Non-compliance|2|||
130997458|NCT01807221|471619546|FG002|Overall Study|Non-compliance|0|||
130997459|NCT01807221|471619547|FG003|Overall Study|Non-compliance|1|||
130997460|NCT01807221|471619548|FG004|Overall Study|Non-compliance|0|||
130997461|NCT01807221|471619549|FG005|Overall Study|Non-compliance|0|||
130997462|NCT01807221|471619544|FG000|Overall Study|Logistical difficulties|0|||
130997463|NCT01807221|471619545|FG001|Overall Study|Logistical difficulties|1|||
130997464|NCT01807221|471619546|FG002|Overall Study|Logistical difficulties|0|||
130997465|NCT01807221|471619547|FG003|Overall Study|Logistical difficulties|0|||
130997466|NCT01807221|471619548|FG004|Overall Study|Logistical difficulties|1|||
130997467|NCT01807221|471619549|FG005|Overall Study|Logistical difficulties|0|||
130997468|NCT01807221|471619544|FG000|Overall Study|Withdrawal by Subject|33|||
130997469|NCT01807221|471619545|FG001|Overall Study|Withdrawal by Subject|15|||
130997470|NCT01807221|471619546|FG002|Overall Study|Withdrawal by Subject|8|||
130997471|NCT01807221|471619547|FG003|Overall Study|Withdrawal by Subject|14|||
130997472|NCT01807221|471619548|FG004|Overall Study|Withdrawal by Subject|16|||
130997473|NCT01807221|471619549|FG005|Overall Study|Withdrawal by Subject|13|||
130997474|NCT01807221|471619544|FG000|Overall Study|Sponsor decision|2|||
130997475|NCT01807221|471619545|FG001|Overall Study|Sponsor decision|0|||
130997476|NCT01807221|471619546|FG002|Overall Study|Sponsor decision|1|||
130997477|NCT01807221|471619547|FG003|Overall Study|Sponsor decision|1|||
130997478|NCT01807221|471619548|FG004|Overall Study|Sponsor decision|0|||
130997479|NCT01807221|471619549|FG005|Overall Study|Sponsor decision|0|||
130997480|NCT01807221|471619544|FG000|Overall Study|Lost to Follow-up|1|||
130997481|NCT01807221|471619545|FG001|Overall Study|Lost to Follow-up|0|||
130997482|NCT01807221|471619546|FG002|Overall Study|Lost to Follow-up|2|||
130997483|NCT01807221|471619547|FG003|Overall Study|Lost to Follow-up|1|||
130997484|NCT01807221|471619548|FG004|Overall Study|Lost to Follow-up|0|||
130997485|NCT01807221|471619549|FG005|Overall Study|Lost to Follow-up|0|||
130997486|NCT02609659|471619550|FG000|Overall Study|Adverse Event|1|||
130997487|NCT02609659|471619550|FG000|Overall Study|Lost to Follow-up|6|||
130997488|NCT02609659|471619550|FG000|Overall Study|Other|1|||
130997489|NCT04329104|471619553|FG000|Efficacy Study|Withdrawal by Subject|0|||
130997490|NCT04329104|471619554|FG001|Efficacy Study|Withdrawal by Subject|0|||
130997491|NCT04329104|471619555|FG002|Efficacy Study|Withdrawal by Subject|0|||
130997492|NCT04329104|471619556|FG003|Efficacy Study|Withdrawal by Subject|5|||
130997493|NCT04329104|471619557|FG004|Efficacy Study|Withdrawal by Subject|6|||
130997494|NCT04329104|471619558|FG005|Efficacy Study|Withdrawal by Subject|8|||
130997495|NCT00593554|471619559|FG000|Overall Study|Death|1|||
130997496|NCT00593554|471619560|FG001|Overall Study|Death|2|||
130997497|NCT00593554|471619559|FG000|Overall Study|Physician Decision|0|||
130997498|NCT00593554|471619560|FG001|Overall Study|Physician Decision|1|||
130997499|NCT00593554|471619559|FG000|Overall Study|Withdrawal by Subject|1|||
130997500|NCT00593554|471619560|FG001|Overall Study|Withdrawal by Subject|0|||
130997501|NCT00593554|471619559|FG000|Overall Study|Disease Progression|1|||
130997502|NCT00593554|471619560|FG001|Overall Study|Disease Progression|2|||
130997503|NCT01024959|471619565|FG000|Overall Study|ineligible|12|||
130997504|NCT01024959|471619565|FG000|Overall Study|results not evaluable|12|||
130997505|NCT01024959|471619565|FG000|Overall Study|missing results required for analysis|17|||
130997506|NCT01129336|471619566|FG000|Overall Study|Protocol Violation|1|||
130997507|NCT01129336|471619567|FG001|Overall Study|Protocol Violation|0|||
130997508|NCT01129336|471619566|FG000|Overall Study|Disease Progression|1|||
130997509|NCT01129336|471619567|FG001|Overall Study|Disease Progression|4|||
130997510|NCT01129336|471619566|FG000|Overall Study|Lost to Follow-up|1|||
130997511|NCT01129336|471619567|FG001|Overall Study|Lost to Follow-up|0|||
130997512|NCT01129336|471619566|FG000|Overall Study|Withdrawal by Subject|7|||
130997513|NCT01129336|471619567|FG001|Overall Study|Withdrawal by Subject|4|||
130997514|NCT01129336|471619566|FG000|Overall Study|Adverse Event|0|||
130997515|NCT01129336|471619567|FG001|Overall Study|Adverse Event|1|||
130997516|NCT01129336|471619566|FG000|Overall Study|Missing Study Completion Status|2|||
130997517|NCT01129336|471619567|FG001|Overall Study|Missing Study Completion Status|3|||
130997518|NCT01129336|471619566|FG000|Overall Study|Death|0|||
130997519|NCT01129336|471619567|FG001|Overall Study|Death|4|||
130997520|NCT00358150|471619568|FG000|Overall Study|Adverse Event|3|||
130997521|NCT00358150|471619568|FG000|Overall Study|Withdrawal by Subject|1|||
130997522|NCT00358150|471619568|FG000|Overall Study|Undefined|3|||
130997523|NCT02086552|471619575|FG000|Overall Study|Withdrawal by Subject|1|||
130997524|NCT02080520|471619580|FG000|Overall Study|Self-reported symptoms|5|||
130997525|NCT02080520|471619581|FG001|Overall Study|Self-reported symptoms|6|||
130997526|NCT02080520|471619580|FG000|Overall Study|Unable to contact|2|||
130997527|NCT02080520|471619581|FG001|Overall Study|Unable to contact|1|||
130997528|NCT02080520|471619580|FG000|Overall Study|Initiated aspirin|2|||
130997529|NCT02080520|471619581|FG001|Overall Study|Initiated aspirin|0|||
130997530|NCT02080520|471619580|FG000|Overall Study|Atrial fibrillation|1|||
130997531|NCT02080520|471619581|FG001|Overall Study|Atrial fibrillation|1|||
130997532|NCT02080520|471619580|FG000|Overall Study|Cancer|1|||
130997533|NCT02080520|471619581|FG001|Overall Study|Cancer|2|||
130997534|NCT02080520|471619580|FG000|Overall Study|Not interested in study|1|||
130997535|NCT02080520|471619581|FG001|Overall Study|Not interested in study|3|||
130997536|NCT02080520|471619580|FG000|Overall Study|Too busy|1|||
130997537|NCT02080520|471619581|FG001|Overall Study|Too busy|1|||
130997538|NCT02080520|471619580|FG000|Overall Study|Work-related injury|1|||
130997539|NCT02080520|471619581|FG001|Overall Study|Work-related injury|0|||
130997540|NCT02080520|471619580|FG000|Overall Study|Personal reasons|0|||
130997541|NCT02080520|471619581|FG001|Overall Study|Personal reasons|3|||
130997542|NCT04397523|471619583|FG000|Overall Study|Lost to Follow-up|3|||
130997543|NCT04397523|471619583|FG000|Overall Study|Transfer from/to other hospital|8|||
130997544|NCT00684762|471619609|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
130997545|NCT00684762|471619610|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
130997546|NCT01394250|471619611|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
130997547|NCT01394250|471619612|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
130997548|NCT01394250|471619611|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
130997549|NCT01394250|471619612|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
130997550|NCT03537261|471619621|FG000|Overall Study|Lost to Follow-up|4|||
130997551|NCT03537261|471619622|FG001|Overall Study|Lost to Follow-up|5|||
130997552|NCT03537261|471619621|FG000|Overall Study|Withdrawal by Subject|4|||
130997553|NCT03537261|471619622|FG001|Overall Study|Withdrawal by Subject|6|||
130997554|NCT03537261|471619621|FG000|Overall Study|Did not return study questionnaires|0|||
130997555|NCT03537261|471619622|FG001|Overall Study|Did not return study questionnaires|1|||
130997556|NCT00502996|471619625|FG000|Overall Study|Lost to Follow-up|9|||
130997557|NCT00502996|471619625|FG000|Overall Study|Protocol Violation|2|||
130997558|NCT00502996|471619625|FG000|Overall Study|Treatment failure|25|||
130997559|NCT00502996|471619625|FG000|Overall Study|Withdrawal Informed Consent|6|||
130997560|NCT00502996|471619625|FG000|Overall Study|Adverse Event|2|||
130997561|NCT01729728|471619626|FG000|Overall Study|Adverse Event|0|||
130997562|NCT01729728|471619627|FG001|Overall Study|Adverse Event|6|||
130997563|NCT01729728|471619628|FG002|Overall Study|Adverse Event|0|||
130997564|NCT01729728|471619626|FG000|Overall Study|Protocol Violation|1|||
130997565|NCT01729728|471619627|FG001|Overall Study|Protocol Violation|0|||
130997566|NCT01729728|471619628|FG002|Overall Study|Protocol Violation|1|||
130997567|NCT04267614|471619629|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
130997568|NCT04267614|471619629|FG000|Overall Study|Lost to Follow-up|115|||
130997569|NCT03382600|471619639|FG000|Overall Study|Adverse Event|3|||
130997570|NCT03382600|471619640|FG001|Overall Study|Adverse Event|3|||
130997571|NCT03382600|471619639|FG000|Overall Study|Clinical Disease Progression|2|||
130997572|NCT03382600|471619640|FG001|Overall Study|Clinical Disease Progression|4|||
130997573|NCT03382600|471619639|FG000|Overall Study|Radiological Progression|40|||
130997574|NCT03382600|471619640|FG001|Overall Study|Radiological Progression|31|||
130997575|NCT03382600|471619639|FG000|Overall Study|Withdrawal by Subject|0|||
130997576|NCT03382600|471619640|FG001|Overall Study|Withdrawal by Subject|1|||
130997577|NCT03382600|471619639|FG000|Overall Study|Other|9|||
130997578|NCT03382600|471619640|FG001|Overall Study|Other|7|||
130997579|NCT01000376|471619641|FG000|Cycle 1 Day 1|Adverse Event|1|||
130997580|NCT01000376|471619642|FG001|Cycle 1 Day 1|Adverse Event|0|||
130997581|NCT01000376|471619641|FG000|Cycle 1 Day 1|Progressive Disease|1|||
130997582|NCT01000376|471619642|FG001|Cycle 1 Day 1|Progressive Disease|0|||
130997583|NCT00896454|471619643|FG000|Overall Study|Death|10|||
130997584|NCT00896454|471619643|FG000|Overall Study|Adverse Event|8|||
130997585|NCT00896454|471619643|FG000|Overall Study|Disease Progression|5|||
130997586|NCT00896454|471619643|FG000|Overall Study|Other|4|||
130997587|NCT00896454|471619643|FG000|Overall Study|Requirement for alternative therapy|3|||
130997588|NCT00896454|471619643|FG000|Overall Study|Ongoing in study|2|||
130997589|NCT00896454|471619643|FG000|Overall Study|Withdrawal by Subject|1|||
130997590|NCT03688711|471619644|FG000|Overall Study|Withdrawal by Subject|0|||
130997591|NCT03688711|471619645|FG001|Overall Study|Withdrawal by Subject|1|||
130997592|NCT05033080|471619654|FG000|Overall Study|Adverse Event|4|||
130997593|NCT05033080|471619655|FG001|Overall Study|Adverse Event|4|||
130997594|NCT05033080|471619654|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
130997595|NCT05033080|471619655|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
130997596|NCT05033080|471619654|FG000|Overall Study|Lost to Follow-up|1|||
130997597|NCT05033080|471619655|FG001|Overall Study|Lost to Follow-up|0|||
130997598|NCT05033080|471619654|FG000|Overall Study|Other non-compliance|0|||
130997599|NCT05033080|471619655|FG001|Overall Study|Other non-compliance|1|||
130997600|NCT05033080|471619654|FG000|Overall Study|Physician Decision|0|||
130997601|NCT05033080|471619655|FG001|Overall Study|Physician Decision|1|||
130997602|NCT05033080|471619654|FG000|Overall Study|Other|1|||
130997603|NCT05033080|471619655|FG001|Overall Study|Other|1|||
130997604|NCT03560245|471619656|FG000|Overall Study|Withdrawal by Subject|3|||
130997605|NCT03560245|471619657|FG001|Overall Study|Withdrawal by Subject|2|||
130997606|NCT03560245|471619656|FG000|Overall Study|Adverse Event|1|||
130997607|NCT03560245|471619657|FG001|Overall Study|Adverse Event|1|||
130997608|NCT03560245|471619656|FG000|Overall Study|Protocol Violation|1|||
130997609|NCT03560245|471619657|FG001|Overall Study|Protocol Violation|0|||
130997610|NCT03560245|471619656|FG000|Overall Study|Death|0|||
130997611|NCT03560245|471619657|FG001|Overall Study|Death|1|||
130997612|NCT03560245|471619656|FG000|Overall Study|Lost to Follow-up|0|||
130997613|NCT03560245|471619657|FG001|Overall Study|Lost to Follow-up|1|||
130997614|NCT03560245|471619656|FG000|Overall Study|Physician Decision|0|||
130997615|NCT03560245|471619657|FG001|Overall Study|Physician Decision|1|||
130997616|NCT03560245|471619656|FG000|Overall Study|Other|0|||
130997617|NCT03560245|471619657|FG001|Overall Study|Other|1|||
130997618|NCT01263106|471619658|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
130997619|NCT01263106|471619659|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
130997620|NCT01040780|471621371|FG000|Overall Study|Protocol Violation|1|||
130997621|NCT01040780|471621372|FG001|Overall Study|Protocol Violation|3|||
130997622|NCT00802737|471621373|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
130997623|NCT00802737|471621374|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
130997624|NCT00802737|471621375|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
130997625|NCT00802737|471621373|FG000|Overall Study|Death|6|||
130997626|NCT00802737|471621374|FG001|Overall Study|Death|5|||
130997627|NCT00802737|471621375|FG002|Overall Study|Death|1|||
130997628|NCT00802737|471621373|FG000|Overall Study|Adverse Event|1|||
130997629|NCT00802737|471621374|FG001|Overall Study|Adverse Event|0|||
130997630|NCT00802737|471621375|FG002|Overall Study|Adverse Event|0|||
130997631|NCT00802737|471621373|FG000|Overall Study|Received Prohibited Therapy|1|||
130997632|NCT00802737|471621374|FG001|Overall Study|Received Prohibited Therapy|0|||
130997633|NCT00802737|471621375|FG002|Overall Study|Received Prohibited Therapy|0|||
130997634|NCT00802737|471621373|FG000|Overall Study|Ongoing CLL-Treatment|0|||
130997635|NCT00802737|471621374|FG001|Overall Study|Ongoing CLL-Treatment|1|||
130997636|NCT00802737|471621375|FG002|Overall Study|Ongoing CLL-Treatment|0|||
130997637|NCT00802737|471621373|FG000|Overall Study|Participant too Unwell|0|||
130997638|NCT00802737|471621374|FG001|Overall Study|Participant too Unwell|2|||
130997639|NCT00802737|471621375|FG002|Overall Study|Participant too Unwell|0|||
130997640|NCT04213989|471621376|FG000|Overall Study|Withdrawal by Subject|3|||
130997641|NCT04213989|471621377|FG001|Overall Study|Withdrawal by Subject|2|||
130997642|NCT04213989|471621376|FG000|Overall Study|Physician Decision|1|||
130997643|NCT04213989|471621377|FG001|Overall Study|Physician Decision|0|||
130997644|NCT04213989|471621376|FG000|Overall Study|Lost to Follow-up|0|||
130997645|NCT04213989|471621377|FG001|Overall Study|Lost to Follow-up|4|||
130997646|NCT01811563|471621378|FG000|Overall Study|Lost to Follow-up|5|||
130997647|NCT01811563|471621379|FG001|Overall Study|Lost to Follow-up|2|||
130997648|NCT01811563|471621378|FG000|Overall Study|Incorrect Randomization procedure|0|||
130997649|NCT01811563|471621379|FG001|Overall Study|Incorrect Randomization procedure|1|||
130997650|NCT00329719|471621380|FG000|Overall Study|Lost to Follow-up|0|||
130997651|NCT00329719|471621381|FG001|Overall Study|Lost to Follow-up|0|||
130997652|NCT00329719|471621382|FG002|Overall Study|Lost to Follow-up|0|||
130997653|NCT00329719|471621383|FG003|Overall Study|Lost to Follow-up|1|||
130997654|NCT02930122|471621386|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
130997655|NCT02930122|471621387|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
130997656|NCT03943589|471621388|FG000|Overall Study|Death|1|||
130997657|NCT03943589|471621388|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
130997658|NCT00830947|471621389|FG000|Overall Study|Lost to Follow-up|4|||
130997659|NCT00830947|471621390|FG001|Overall Study|Lost to Follow-up|4|||
130997660|NCT02462083|471621391|FG000|Overall Study|Sponsor request|39|||
130997661|NCT02462083|471621391|FG000|Overall Study|Withdrawal by Subject|87|||
130997662|NCT02462083|471621391|FG000|Overall Study|Lost to Follow-up|41|||
130997663|NCT02462083|471621391|FG000|Overall Study|Lack of Efficacy|151|||
130997664|NCT02462083|471621391|FG000|Overall Study|Pregnancy|1|||
130997665|NCT02462083|471621391|FG000|Overall Study|Protocol Violation|6|||
130997666|NCT02462083|471621391|FG000|Overall Study|Adverse Event|33|||
130997667|NCT02462083|471621391|FG000|Overall Study|Worsening condition|16|||
130997668|NCT02462083|471621391|FG000|Overall Study|Other than specified|45|||
130997669|NCT02291289|471621392|FG000|Induction Treatment|Withdrawal by Subject|0|||
130997670|NCT02291289|471621393|FG001|Induction Treatment|Withdrawal by Subject|0|||
130997671|NCT02291289|471621394|FG002|Induction Treatment|Withdrawal by Subject|0|||
130997672|NCT02291289|471621395|FG003|Induction Treatment|Withdrawal by Subject|24|||
130997673|NCT02291289|471621396|FG004|Induction Treatment|Withdrawal by Subject|0|||
130997674|NCT02291289|471621397|FG005|Induction Treatment|Withdrawal by Subject|0|||
130997675|NCT02291289|471621398|FG006|Induction Treatment|Withdrawal by Subject|0|||
130997676|NCT02291289|471621399|FG007|Induction Treatment|Withdrawal by Subject|0|||
130997677|NCT02291289|471621400|FG008|Induction Treatment|Withdrawal by Subject|0|||
130997678|NCT02291289|471621401|FG009|Induction Treatment|Withdrawal by Subject|18|||
130997679|NCT02291289|471621402|FG010|Induction Treatment|Withdrawal by Subject|0|||
130997680|NCT02291289|471621403|FG011|Induction Treatment|Withdrawal by Subject|0|||
130997681|NCT02291289|471621404|FG012|Induction Treatment|Withdrawal by Subject|0|||
130997682|NCT02291289|471621392|FG000|Induction Treatment|Adverse Event|0|||
130997683|NCT02291289|471621393|FG001|Induction Treatment|Adverse Event|0|||
130997684|NCT02291289|471621394|FG002|Induction Treatment|Adverse Event|0|||
130997685|NCT02291289|471621395|FG003|Induction Treatment|Adverse Event|3|||
130997686|NCT02291289|471621396|FG004|Induction Treatment|Adverse Event|0|||
130997687|NCT02291289|471621397|FG005|Induction Treatment|Adverse Event|0|||
130997688|NCT02291289|471621398|FG006|Induction Treatment|Adverse Event|0|||
130997689|NCT02291289|471621399|FG007|Induction Treatment|Adverse Event|0|||
130997690|NCT02291289|471621400|FG008|Induction Treatment|Adverse Event|0|||
130997691|NCT02291289|471621401|FG009|Induction Treatment|Adverse Event|1|||
130997692|NCT02291289|471621402|FG010|Induction Treatment|Adverse Event|0|||
130997693|NCT02291289|471621403|FG011|Induction Treatment|Adverse Event|0|||
130997694|NCT02291289|471621404|FG012|Induction Treatment|Adverse Event|0|||
130997695|NCT02291289|471621392|FG000|Induction Treatment|Death|25|||
130997696|NCT02291289|471621393|FG001|Induction Treatment|Death|0|||
130997697|NCT02291289|471621394|FG002|Induction Treatment|Death|0|||
130997698|NCT02291289|471621395|FG003|Induction Treatment|Death|111|||
130997699|NCT02291289|471621396|FG004|Induction Treatment|Death|0|||
130997700|NCT02291289|471621397|FG005|Induction Treatment|Death|0|||
130997701|NCT02291289|471621398|FG006|Induction Treatment|Death|1|||
130997702|NCT02291289|471621399|FG007|Induction Treatment|Death|0|||
130997703|NCT02291289|471621400|FG008|Induction Treatment|Death|0|||
130997704|NCT02291289|471621401|FG009|Induction Treatment|Death|82|||
130997705|NCT02291289|471621402|FG010|Induction Treatment|Death|0|||
130997706|NCT02291289|471621403|FG011|Induction Treatment|Death|0|||
130997707|NCT02291289|471621404|FG012|Induction Treatment|Death|0|||
130997708|NCT02291289|471621392|FG000|Induction Treatment|Lost to Follow-up|1|||
130997709|NCT02291289|471621393|FG001|Induction Treatment|Lost to Follow-up|0|||
130997710|NCT02291289|471621394|FG002|Induction Treatment|Lost to Follow-up|0|||
130997711|NCT02291289|471621395|FG003|Induction Treatment|Lost to Follow-up|12|||
130997712|NCT02291289|471621396|FG004|Induction Treatment|Lost to Follow-up|0|||
130997713|NCT02291289|471621397|FG005|Induction Treatment|Lost to Follow-up|0|||
130997714|NCT02291289|471621398|FG006|Induction Treatment|Lost to Follow-up|0|||
130997715|NCT02291289|471621399|FG007|Induction Treatment|Lost to Follow-up|0|||
130997716|NCT02291289|471621400|FG008|Induction Treatment|Lost to Follow-up|0|||
130997717|NCT02291289|471621401|FG009|Induction Treatment|Lost to Follow-up|9|||
130997718|NCT02291289|471621402|FG010|Induction Treatment|Lost to Follow-up|0|||
130997719|NCT02291289|471621403|FG011|Induction Treatment|Lost to Follow-up|0|||
130997720|NCT02291289|471621404|FG012|Induction Treatment|Lost to Follow-up|0|||
130997721|NCT02291289|471621392|FG000|Induction Treatment|Non-Compliance|0|||
130997722|NCT02291289|471621393|FG001|Induction Treatment|Non-Compliance|0|||
130997723|NCT02291289|471621394|FG002|Induction Treatment|Non-Compliance|0|||
130997724|NCT02291289|471621395|FG003|Induction Treatment|Non-Compliance|1|||
130997725|NCT02291289|471621396|FG004|Induction Treatment|Non-Compliance|0|||
130997726|NCT02291289|471621397|FG005|Induction Treatment|Non-Compliance|0|||
130997727|NCT02291289|471621398|FG006|Induction Treatment|Non-Compliance|0|||
130884347|NCT03594110|471211466|FG001|Interventional Part|Contraindicated drug started|18|||
130884348|NCT03594110|471211465|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
130884349|NCT03594110|471211466|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
130997728|NCT02291289|471621399|FG007|Induction Treatment|Non-Compliance|0|||
130997729|NCT02291289|471621400|FG008|Induction Treatment|Non-Compliance|0|||
130997730|NCT02291289|471621401|FG009|Induction Treatment|Non-Compliance|1|||
130997731|NCT02291289|471621402|FG010|Induction Treatment|Non-Compliance|0|||
130997732|NCT02291289|471621403|FG011|Induction Treatment|Non-Compliance|0|||
130997733|NCT02291289|471621404|FG012|Induction Treatment|Non-Compliance|0|||
130997734|NCT02291289|471621392|FG000|Induction Treatment|Reason Not Specified|0|||
130884350|NCT03594110|471211465|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
130997735|NCT02291289|471621393|FG001|Induction Treatment|Reason Not Specified|0|||
130997736|NCT02291289|471621394|FG002|Induction Treatment|Reason Not Specified|0|||
130997737|NCT02291289|471621395|FG003|Induction Treatment|Reason Not Specified|4|||
130997738|NCT02291289|471621396|FG004|Induction Treatment|Reason Not Specified|0|||
130997739|NCT02291289|471621397|FG005|Induction Treatment|Reason Not Specified|0|||
130997740|NCT02291289|471621398|FG006|Induction Treatment|Reason Not Specified|0|||
130997741|NCT02291289|471621399|FG007|Induction Treatment|Reason Not Specified|0|||
130997742|NCT02291289|471621400|FG008|Induction Treatment|Reason Not Specified|0|||
130997743|NCT02291289|471621401|FG009|Induction Treatment|Reason Not Specified|7|||
130997744|NCT02291289|471621402|FG010|Induction Treatment|Reason Not Specified|0|||
130997745|NCT02291289|471621403|FG011|Induction Treatment|Reason Not Specified|0|||
130997746|NCT02291289|471621404|FG012|Induction Treatment|Reason Not Specified|0|||
130997747|NCT02291289|471621392|FG000|Induction Treatment|Physician Decision|0|||
130997748|NCT02291289|471621393|FG001|Induction Treatment|Physician Decision|0|||
130997749|NCT02291289|471621394|FG002|Induction Treatment|Physician Decision|0|||
130997750|NCT02291289|471621395|FG003|Induction Treatment|Physician Decision|3|||
130997751|NCT02291289|471621396|FG004|Induction Treatment|Physician Decision|0|||
130997752|NCT02291289|471621397|FG005|Induction Treatment|Physician Decision|0|||
130997753|NCT02291289|471621398|FG006|Induction Treatment|Physician Decision|0|||
130997754|NCT02291289|471621399|FG007|Induction Treatment|Physician Decision|0|||
130997755|NCT02291289|471621400|FG008|Induction Treatment|Physician Decision|0|||
130997756|NCT02291289|471621401|FG009|Induction Treatment|Physician Decision|1|||
130997757|NCT02291289|471621402|FG010|Induction Treatment|Physician Decision|0|||
130997758|NCT02291289|471621403|FG011|Induction Treatment|Physician Decision|0|||
130997759|NCT02291289|471621404|FG012|Induction Treatment|Physician Decision|0|||
130997760|NCT02291289|471621392|FG000|Induction Treatment|Protocol Violation|0|||
130997761|NCT02291289|471621393|FG001|Induction Treatment|Protocol Violation|0|||
130997762|NCT02291289|471621394|FG002|Induction Treatment|Protocol Violation|0|||
130997763|NCT02291289|471621395|FG003|Induction Treatment|Protocol Violation|3|||
130997764|NCT02291289|471621396|FG004|Induction Treatment|Protocol Violation|0|||
130997765|NCT02291289|471621397|FG005|Induction Treatment|Protocol Violation|0|||
130997766|NCT02291289|471621398|FG006|Induction Treatment|Protocol Violation|0|||
130997767|NCT02291289|471621399|FG007|Induction Treatment|Protocol Violation|0|||
130997768|NCT02291289|471621400|FG008|Induction Treatment|Protocol Violation|0|||
130997769|NCT02291289|471621401|FG009|Induction Treatment|Protocol Violation|2|||
130997770|NCT02291289|471621402|FG010|Induction Treatment|Protocol Violation|0|||
130997771|NCT02291289|471621403|FG011|Induction Treatment|Protocol Violation|0|||
130997772|NCT02291289|471621404|FG012|Induction Treatment|Protocol Violation|0|||
130997773|NCT02291289|471621392|FG000|Induction Treatment|Missing|4|||
130997774|NCT02291289|471621393|FG001|Induction Treatment|Missing|0|||
130997775|NCT02291289|471621394|FG002|Induction Treatment|Missing|0|||
130997776|NCT02291289|471621395|FG003|Induction Treatment|Missing|14|||
130997777|NCT02291289|471621396|FG004|Induction Treatment|Missing|0|||
130997778|NCT02291289|471621397|FG005|Induction Treatment|Missing|0|||
130997779|NCT02291289|471621398|FG006|Induction Treatment|Missing|0|||
130997780|NCT02291289|471621399|FG007|Induction Treatment|Missing|0|||
130997781|NCT02291289|471621400|FG008|Induction Treatment|Missing|0|||
130997782|NCT02291289|471621401|FG009|Induction Treatment|Missing|54|||
130997783|NCT02291289|471621402|FG010|Induction Treatment|Missing|0|||
130997784|NCT02291289|471621403|FG011|Induction Treatment|Missing|0|||
130997785|NCT02291289|471621404|FG012|Induction Treatment|Missing|0|||
130997786|NCT02291289|471621392|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130997787|NCT02291289|471621393|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130997788|NCT02291289|471621394|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130997789|NCT02291289|471621395|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130997790|NCT02291289|471621396|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
130997791|NCT02291289|471621397|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
130997792|NCT02291289|471621398|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130997793|NCT02291289|471621399|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130997794|NCT02291289|471621400|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130997795|NCT02291289|471621401|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130997796|NCT02291289|471621402|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
130997797|NCT02291289|471621403|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
130997798|NCT02291289|471621404|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130997799|NCT02291289|471621392|FG000|Maintenance Treatment Phase|Death|0|||
130997800|NCT02291289|471621393|FG001|Maintenance Treatment Phase|Death|29|||
130997801|NCT02291289|471621394|FG002|Maintenance Treatment Phase|Death|16|||
130997802|NCT02291289|471621395|FG003|Maintenance Treatment Phase|Death|0|||
130997803|NCT02291289|471621396|FG004|Maintenance Treatment Phase|Death|188|||
130997804|NCT02291289|471621397|FG005|Maintenance Treatment Phase|Death|107|||
130997805|NCT02291289|471621398|FG006|Maintenance Treatment Phase|Death|0|||
130997806|NCT02291289|471621399|FG007|Maintenance Treatment Phase|Death|1|||
130997807|NCT02291289|471621400|FG008|Maintenance Treatment Phase|Death|1|||
130997808|NCT02291289|471621401|FG009|Maintenance Treatment Phase|Death|0|||
130997809|NCT02291289|471621402|FG010|Maintenance Treatment Phase|Death|46|||
130997810|NCT02291289|471621403|FG011|Maintenance Treatment Phase|Death|19|||
130997811|NCT02291289|471621404|FG012|Maintenance Treatment Phase|Death|0|||
130997812|NCT02291289|471621392|FG000|Maintenance Treatment Phase|Adverse Event|0|||
130997813|NCT02291289|471621393|FG001|Maintenance Treatment Phase|Adverse Event|0|||
130997814|NCT02291289|471621394|FG002|Maintenance Treatment Phase|Adverse Event|0|||
130997815|NCT02291289|471621395|FG003|Maintenance Treatment Phase|Adverse Event|0|||
130997816|NCT02291289|471621396|FG004|Maintenance Treatment Phase|Adverse Event|1|||
130997817|NCT02291289|471621397|FG005|Maintenance Treatment Phase|Adverse Event|1|||
130997818|NCT02291289|471621398|FG006|Maintenance Treatment Phase|Adverse Event|0|||
130997819|NCT02291289|471621399|FG007|Maintenance Treatment Phase|Adverse Event|0|||
130997820|NCT02291289|471621400|FG008|Maintenance Treatment Phase|Adverse Event|0|||
130997821|NCT02291289|471621401|FG009|Maintenance Treatment Phase|Adverse Event|0|||
130997822|NCT02291289|471621402|FG010|Maintenance Treatment Phase|Adverse Event|0|||
130997823|NCT02291289|471621403|FG011|Maintenance Treatment Phase|Adverse Event|0|||
130997824|NCT02291289|471621404|FG012|Maintenance Treatment Phase|Adverse Event|0|||
130997825|NCT02291289|471621392|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
130997826|NCT02291289|471621393|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
130997827|NCT02291289|471621394|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
130997828|NCT02291289|471621395|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
130997829|NCT02291289|471621396|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
130997830|NCT02291289|471621397|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
130997831|NCT02291289|471621398|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
130997832|NCT02291289|471621399|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
130997833|NCT02291289|471621400|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
130997834|NCT02291289|471621401|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
130997835|NCT02291289|471621402|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
130997836|NCT02291289|471621403|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
130997837|NCT02291289|471621404|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
130997838|NCT02291289|471621392|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
130997839|NCT02291289|471621393|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
130997840|NCT02291289|471621394|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
130997841|NCT02291289|471621395|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
130997842|NCT02291289|471621396|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
130997843|NCT02291289|471621397|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
130997844|NCT02291289|471621398|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
130997845|NCT02291289|471621399|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
130997846|NCT02291289|471621400|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
130997847|NCT02291289|471621401|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
130997848|NCT02291289|471621402|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
130997849|NCT02291289|471621403|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
130997850|NCT02291289|471621404|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
130997851|NCT02291289|471621392|FG000|Maintenance Treatment Phase|Physician Decision|0|||
130997852|NCT02291289|471621393|FG001|Maintenance Treatment Phase|Physician Decision|2|||
130997853|NCT02291289|471621394|FG002|Maintenance Treatment Phase|Physician Decision|0|||
130997854|NCT02291289|471621395|FG003|Maintenance Treatment Phase|Physician Decision|0|||
130997855|NCT02291289|471621396|FG004|Maintenance Treatment Phase|Physician Decision|3|||
130997856|NCT02291289|471621397|FG005|Maintenance Treatment Phase|Physician Decision|0|||
130997857|NCT02291289|471621398|FG006|Maintenance Treatment Phase|Physician Decision|0|||
130997858|NCT02291289|471621399|FG007|Maintenance Treatment Phase|Physician Decision|0|||
130997859|NCT02291289|471621400|FG008|Maintenance Treatment Phase|Physician Decision|0|||
130997860|NCT02291289|471621401|FG009|Maintenance Treatment Phase|Physician Decision|0|||
130997861|NCT02291289|471621402|FG010|Maintenance Treatment Phase|Physician Decision|1|||
130997862|NCT02291289|471621403|FG011|Maintenance Treatment Phase|Physician Decision|3|||
130997863|NCT02291289|471621404|FG012|Maintenance Treatment Phase|Physician Decision|0|||
130997864|NCT02291289|471621392|FG000|Maintenance Treatment Phase|Not Treated|0|||
130997865|NCT02291289|471621393|FG001|Maintenance Treatment Phase|Not Treated|0|||
130997866|NCT02291289|471621394|FG002|Maintenance Treatment Phase|Not Treated|2|||
130997867|NCT02291289|471621395|FG003|Maintenance Treatment Phase|Not Treated|0|||
130997868|NCT02291289|471621396|FG004|Maintenance Treatment Phase|Not Treated|0|||
130997869|NCT02291289|471621397|FG005|Maintenance Treatment Phase|Not Treated|0|||
130997870|NCT02291289|471621398|FG006|Maintenance Treatment Phase|Not Treated|0|||
130997871|NCT02291289|471621399|FG007|Maintenance Treatment Phase|Not Treated|0|||
130997872|NCT02291289|471621400|FG008|Maintenance Treatment Phase|Not Treated|0|||
130997873|NCT02291289|471621401|FG009|Maintenance Treatment Phase|Not Treated|0|||
130997874|NCT02291289|471621402|FG010|Maintenance Treatment Phase|Not Treated|0|||
130997875|NCT02291289|471621403|FG011|Maintenance Treatment Phase|Not Treated|0|||
130997876|NCT02291289|471621404|FG012|Maintenance Treatment Phase|Not Treated|0|||
130997877|NCT02291289|471621392|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997878|NCT02291289|471621393|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
130997879|NCT02291289|471621394|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997880|NCT02291289|471621395|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997881|NCT02291289|471621396|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997882|NCT02291289|471621397|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997883|NCT02291289|471621398|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997884|NCT02291289|471621399|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997885|NCT02291289|471621400|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997886|NCT02291289|471621401|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997887|NCT02291289|471621402|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997888|NCT02291289|471621403|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997889|NCT02291289|471621404|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130997890|NCT02291289|471621392|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
130997891|NCT02291289|471621393|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
130997892|NCT02291289|471621394|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
130997893|NCT02291289|471621395|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
130997894|NCT02291289|471621396|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
130997895|NCT02291289|471621397|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
130997896|NCT02291289|471621398|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
130997897|NCT02291289|471621399|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
130997898|NCT02291289|471621400|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
130997899|NCT02291289|471621401|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
130997900|NCT02291289|471621402|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
130997901|NCT02291289|471621403|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
130997902|NCT02291289|471621404|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
130997903|NCT02291289|471621392|FG000|Early Disease Progression|Death|0|||
130997904|NCT02291289|471621393|FG001|Early Disease Progression|Death|0|||
130997905|NCT02291289|471621394|FG002|Early Disease Progression|Death|0|||
130997906|NCT02291289|471621395|FG003|Early Disease Progression|Death|0|||
130997907|NCT02291289|471621396|FG004|Early Disease Progression|Death|0|||
130997908|NCT02291289|471621397|FG005|Early Disease Progression|Death|0|||
130997909|NCT02291289|471621398|FG006|Early Disease Progression|Death|0|||
130997910|NCT02291289|471621399|FG007|Early Disease Progression|Death|0|||
130997911|NCT02291289|471621400|FG008|Early Disease Progression|Death|0|||
130997912|NCT02291289|471621401|FG009|Early Disease Progression|Death|0|||
130997913|NCT02291289|471621402|FG010|Early Disease Progression|Death|0|||
130997914|NCT02291289|471621403|FG011|Early Disease Progression|Death|0|||
130997915|NCT02291289|471621404|FG012|Early Disease Progression|Death|10|||
130997916|NCT02291289|471621392|FG000|Early Disease Progression|Lost to Follow-up|0|||
130997917|NCT02291289|471621393|FG001|Early Disease Progression|Lost to Follow-up|0|||
130997918|NCT02291289|471621394|FG002|Early Disease Progression|Lost to Follow-up|0|||
130997919|NCT02291289|471621395|FG003|Early Disease Progression|Lost to Follow-up|0|||
130997920|NCT02291289|471621396|FG004|Early Disease Progression|Lost to Follow-up|0|||
130997921|NCT02291289|471621397|FG005|Early Disease Progression|Lost to Follow-up|0|||
130997922|NCT02291289|471621398|FG006|Early Disease Progression|Lost to Follow-up|0|||
130997923|NCT02291289|471621399|FG007|Early Disease Progression|Lost to Follow-up|0|||
130997924|NCT02291289|471621400|FG008|Early Disease Progression|Lost to Follow-up|0|||
130997925|NCT02291289|471621401|FG009|Early Disease Progression|Lost to Follow-up|0|||
130997926|NCT02291289|471621402|FG010|Early Disease Progression|Lost to Follow-up|0|||
130997927|NCT02291289|471621403|FG011|Early Disease Progression|Lost to Follow-up|0|||
130997928|NCT02291289|471621404|FG012|Early Disease Progression|Lost to Follow-up|1|||
130997929|NCT00594906|471621409|FG000|Overall Study|Physician Decision|1|||
130997930|NCT00594906|471621410|FG001|Overall Study|Physician Decision|0|||
130997931|NCT00594906|471621409|FG000|Overall Study|Physician Decision|0|||
130997932|NCT00594906|471621410|FG001|Overall Study|Physician Decision|1|||
130997933|NCT00594906|471621409|FG000|Overall Study|Death|0|||
130997934|NCT00594906|471621410|FG001|Overall Study|Death|1|||
130997935|NCT01254565|471621411|FG000|Overall Study|Non-compliance to Study Procedures|0|||
130997936|NCT01254565|471621412|FG001|Overall Study|Non-compliance to Study Procedures|0|||
130997937|NCT01254565|471621413|FG002|Overall Study|Non-compliance to Study Procedures|0|||
130997938|NCT01254565|471621414|FG003|Overall Study|Non-compliance to Study Procedures|0|||
130997939|NCT01254565|471621415|FG004|Overall Study|Non-compliance to Study Procedures|1|||
130997940|NCT01254565|471621416|FG005|Overall Study|Non-compliance to Study Procedures|0|||
130997941|NCT01254565|471621411|FG000|Overall Study|Did not Receive Treatment|1|||
130997942|NCT01254565|471621412|FG001|Overall Study|Did not Receive Treatment|1|||
130997943|NCT01254565|471621413|FG002|Overall Study|Did not Receive Treatment|0|||
130997944|NCT01254565|471621414|FG003|Overall Study|Did not Receive Treatment|0|||
130997945|NCT01254565|471621415|FG004|Overall Study|Did not Receive Treatment|3|||
130997946|NCT01254565|471621416|FG005|Overall Study|Did not Receive Treatment|4|||
130997947|NCT01254565|471621411|FG000|Overall Study|Other|0|||
130997948|NCT01254565|471621412|FG001|Overall Study|Other|0|||
130997949|NCT01254565|471621413|FG002|Overall Study|Other|0|||
130997950|NCT01254565|471621414|FG003|Overall Study|Other|1|||
130997951|NCT01254565|471621415|FG004|Overall Study|Other|0|||
130997952|NCT01254565|471621416|FG005|Overall Study|Other|0|||
130997953|NCT02726399|471621417|FG000|Overall Study|Participant Non-Compliance|1|||
130997954|NCT02726399|471621417|FG000|Overall Study|Adverse Event|2|||
130997955|NCT02726399|471621417|FG000|Overall Study|Progression of disease|4|||
130997956|NCT04254679|471621439|FG000|Overall Study|Protocol Violation|1|||
130997957|NCT04254679|471621440|FG001|Overall Study|Protocol Violation|1|||
130997958|NCT04254679|471621439|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
130997959|NCT04254679|471621440|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
130997960|NCT02823964|471621441|FG000|Overall Study|Adverse Event|2|||
130884351|NCT03594110|471211466|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
130884352|NCT03594110|471211465|FG000|Non-interventional Part|Withdrawal by Subject|3|||
130884353|NCT03594110|471211466|FG001|Non-interventional Part|Withdrawal by Subject|4|||
130884354|NCT03594110|471211465|FG000|Non-interventional Part|Lost to Follow-up|45|||
130884355|NCT03594110|471211466|FG001|Non-interventional Part|Lost to Follow-up|41|||
130884356|NCT05029362|471211467|FG000|Overall Study|Lost to Follow-up|9|||
130884357|NCT00684021|471211473|FG000|Overall Study|MRI Contraindicated|1|||
130997961|NCT02823964|471621441|FG000|Overall Study|Physician Decision|1|||
130997962|NCT02823964|471621441|FG000|Overall Study|Lack of Efficacy|1|||
130997963|NCT02823964|471621441|FG000|Overall Study|Withdrawal by Subject|1|||
130997964|NCT00390455|471621447|FG000|Overall Study|Adverse Event|17|||
130997965|NCT00390455|471621448|FG001|Overall Study|Adverse Event|3|||
130997966|NCT00390455|471621447|FG000|Overall Study|Withdrawal by Subject|8|||
130997967|NCT00390455|471621448|FG001|Overall Study|Withdrawal by Subject|8|||
130997968|NCT00390455|471621447|FG000|Overall Study|Alternate Treatment|0|||
130997969|NCT00390455|471621448|FG001|Overall Study|Alternate Treatment|1|||
130997970|NCT00390455|471621447|FG000|Overall Study|Other Medical Reasons|7|||
130997971|NCT00390455|471621448|FG001|Overall Study|Other Medical Reasons|11|||
130997972|NCT00794820|471621454|FG000|Overall Study|Adverse Event|11|||
130997973|NCT00794820|471621454|FG000|Overall Study|Secondary Malignancies|2|||
130997974|NCT00794820|471621454|FG000|Overall Study|Resistant Disease|2|||
130997975|NCT00794820|471621454|FG000|Overall Study|Ineligible/Screen Failure|1|||
130997976|NCT04076020|471621455|FG000|Overall Study|Death|4|||
130997977|NCT04076020|471621456|FG001|Overall Study|Death|6|||
130997978|NCT04076020|471621455|FG000|Overall Study|Withdrawal by Subject|12|||
130997979|NCT04076020|471621456|FG001|Overall Study|Withdrawal by Subject|8|||
130997980|NCT02500979|471621458|FG000|Period 1|Hyperglycemia|1|||
130997981|NCT02500979|471621459|FG001|Period 1|Hyperglycemia|0|||
130997982|NCT02500979|471621458|FG000|Period 1|Severe non-compliance to protocol|0|||
130997983|NCT02500979|471621459|FG001|Period 1|Severe non-compliance to protocol|1|||
130997984|NCT02500979|471621458|FG000|Period 1|Adverse Event|1|||
130997985|NCT02500979|471621459|FG001|Period 1|Adverse Event|0|||
130997986|NCT02500979|471621458|FG000|Period 1|Subject decision|2|||
130997987|NCT02500979|471621459|FG001|Period 1|Subject decision|0|||
130997988|NCT02500979|471621458|FG000|Period 2|Change in risk|1|||
130997989|NCT02500979|471621459|FG001|Period 2|Change in risk|0|||
130997990|NCT00672958|471621462|FG000|Overall Study|Adverse Event|11|||
130997991|NCT00672958|471621463|FG001|Overall Study|Adverse Event|9|||
130997992|NCT00672958|471621462|FG000|Overall Study|Lack of Efficacy|6|||
130997993|NCT00672958|471621463|FG001|Overall Study|Lack of Efficacy|11|||
130997994|NCT00672958|471621462|FG000|Overall Study|Non-compliance with study drug|2|||
130997995|NCT00672958|471621463|FG001|Overall Study|Non-compliance with study drug|3|||
130997996|NCT00672958|471621462|FG000|Overall Study|Protocol deviations|11|||
130997997|NCT00672958|471621463|FG001|Overall Study|Protocol deviations|5|||
130997998|NCT00672958|471621462|FG000|Overall Study|Voluntary withdrawal|12|||
130997999|NCT00672958|471621463|FG001|Overall Study|Voluntary withdrawal|8|||
130998000|NCT00672958|471621462|FG000|Overall Study|Lost to Follow-up|22|||
130998001|NCT00672958|471621463|FG001|Overall Study|Lost to Follow-up|17|||
130998002|NCT00672958|471621462|FG000|Overall Study|Reason not specified|0|||
130998003|NCT00672958|471621463|FG001|Overall Study|Reason not specified|3|||
130998004|NCT01380990|471621464|FG000|Overall Study|Treatment Failure|1|||
130998005|NCT01380990|471621465|FG001|Overall Study|Treatment Failure|0|||
130998006|NCT01380990|471621464|FG000|Overall Study|Death|0|||
130998007|NCT01380990|471621465|FG001|Overall Study|Death|1|||
130998008|NCT01313923|471621471|FG000|Overall Study|Physician Decision|3|||
130998009|NCT02471404|471621472|FG000|Overall Study|Adverse Event|7|||
130998010|NCT02471404|471621473|FG001|Overall Study|Adverse Event|1|||
130998011|NCT02471404|471621474|FG002|Overall Study|Adverse Event|2|||
130998012|NCT02471404|471621472|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
130998013|NCT02471404|471621473|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
130998014|NCT02471404|471621474|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
130998015|NCT02471404|471621472|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
130998016|NCT02471404|471621473|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
130998017|NCT02471404|471621474|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
130998018|NCT02471404|471621472|FG000|Overall Study|Lost to Follow-up|1|||
130998019|NCT02471404|471621473|FG001|Overall Study|Lost to Follow-up|1|||
130998020|NCT02471404|471621474|FG002|Overall Study|Lost to Follow-up|3|||
130998021|NCT02471404|471621472|FG000|Overall Study|Protocol Violation|1|||
130998022|NCT02471404|471621473|FG001|Overall Study|Protocol Violation|0|||
130998023|NCT02471404|471621474|FG002|Overall Study|Protocol Violation|0|||
130998024|NCT02471404|471621472|FG000|Overall Study|Withdrawal by Subject|8|||
130998025|NCT02471404|471621473|FG001|Overall Study|Withdrawal by Subject|4|||
130998026|NCT02471404|471621474|FG002|Overall Study|Withdrawal by Subject|5|||
130998027|NCT02471404|471621472|FG000|Overall Study|Other reasons not specified|10|||
130998028|NCT02471404|471621473|FG001|Overall Study|Other reasons not specified|7|||
130998029|NCT02471404|471621474|FG002|Overall Study|Other reasons not specified|12|||
130998030|NCT03285113|471621475|FG000|Overall Study|Unable to implant leads|2|||
130998031|NCT00849680|471621478|FG000|Overall Study|Adverse Event|0|||
130998032|NCT00849680|471621479|FG001|Overall Study|Adverse Event|0|||
130998033|NCT00849680|471621480|FG002|Overall Study|Adverse Event|0|||
130998034|NCT00849680|471621481|FG003|Overall Study|Adverse Event|0|||
130998035|NCT00849680|471621482|FG004|Overall Study|Adverse Event|0|||
130998036|NCT00849680|471621483|FG005|Overall Study|Adverse Event|0|||
130998037|NCT00849680|471621484|FG006|Overall Study|Adverse Event|2|||
130998038|NCT00849680|471621485|FG007|Overall Study|Adverse Event|0|||
130998039|NCT00849680|471621478|FG000|Overall Study|Lost to Follow-up|7|||
130998040|NCT00849680|471621479|FG001|Overall Study|Lost to Follow-up|3|||
130998041|NCT00849680|471621480|FG002|Overall Study|Lost to Follow-up|12|||
130998042|NCT00849680|471621481|FG003|Overall Study|Lost to Follow-up|11|||
130998043|NCT00849680|471621482|FG004|Overall Study|Lost to Follow-up|8|||
130998044|NCT00849680|471621483|FG005|Overall Study|Lost to Follow-up|11|||
130998045|NCT00849680|471621484|FG006|Overall Study|Lost to Follow-up|12|||
130998046|NCT00849680|471621485|FG007|Overall Study|Lost to Follow-up|5|||
130998047|NCT00849680|471621478|FG000|Overall Study|Subject moved|1|||
130998048|NCT00849680|471621479|FG001|Overall Study|Subject moved|0|||
130998049|NCT00849680|471621480|FG002|Overall Study|Subject moved|3|||
130998050|NCT00849680|471621481|FG003|Overall Study|Subject moved|1|||
130998051|NCT00849680|471621482|FG004|Overall Study|Subject moved|0|||
130998052|NCT00849680|471621483|FG005|Overall Study|Subject moved|2|||
130998053|NCT00849680|471621484|FG006|Overall Study|Subject moved|2|||
130998054|NCT00849680|471621485|FG007|Overall Study|Subject moved|2|||
130998055|NCT00849680|471621478|FG000|Overall Study|Withdrawal by Subject|2|||
130998056|NCT00849680|471621479|FG001|Overall Study|Withdrawal by Subject|0|||
130998057|NCT00849680|471621480|FG002|Overall Study|Withdrawal by Subject|0|||
130998058|NCT00849680|471621481|FG003|Overall Study|Withdrawal by Subject|2|||
130998059|NCT00849680|471621482|FG004|Overall Study|Withdrawal by Subject|2|||
130998060|NCT00849680|471621483|FG005|Overall Study|Withdrawal by Subject|2|||
130998061|NCT00849680|471621484|FG006|Overall Study|Withdrawal by Subject|1|||
130998062|NCT00849680|471621485|FG007|Overall Study|Withdrawal by Subject|1|||
130998063|NCT00849680|471621478|FG000|Overall Study|Subject unable to comply with protocol|1|||
130998064|NCT00849680|471621479|FG001|Overall Study|Subject unable to comply with protocol|0|||
130998065|NCT00849680|471621480|FG002|Overall Study|Subject unable to comply with protocol|0|||
130998066|NCT00849680|471621481|FG003|Overall Study|Subject unable to comply with protocol|0|||
130998067|NCT00849680|471621482|FG004|Overall Study|Subject unable to comply with protocol|0|||
130998068|NCT00849680|471621483|FG005|Overall Study|Subject unable to comply with protocol|0|||
130998069|NCT00849680|471621484|FG006|Overall Study|Subject unable to comply with protocol|0|||
130998070|NCT00849680|471621485|FG007|Overall Study|Subject unable to comply with protocol|0|||
130998071|NCT02207374|471621488|FG000|Overall Study|Withdrawal by Subject|5|||
130998072|NCT02207374|471621489|FG001|Overall Study|Withdrawal by Subject|9|||
130998073|NCT02207374|471621490|FG002|Overall Study|Withdrawal by Subject|4|||
130998074|NCT02207374|471621488|FG000|Overall Study|Death|1|||
130998075|NCT02207374|471621489|FG001|Overall Study|Death|0|||
130998076|NCT02207374|471621490|FG002|Overall Study|Death|1|||
130998077|NCT02207374|471621488|FG000|Overall Study|Missing follow-up information|0|||
130998078|NCT02207374|471621489|FG001|Overall Study|Missing follow-up information|1|||
130998079|NCT02207374|471621490|FG002|Overall Study|Missing follow-up information|1|||
130998080|NCT02087150|471621491|FG000|Overall Study|Death|0|||
130998081|NCT02087150|471621492|FG001|Overall Study|Death|1|||
130998082|NCT02087150|471621493|FG002|Overall Study|Death|0|||
130998083|NCT02087150|471621491|FG000|Overall Study|Lost to Follow-up|6|||
130998084|NCT02087150|471621492|FG001|Overall Study|Lost to Follow-up|13|||
130998085|NCT02087150|471621493|FG002|Overall Study|Lost to Follow-up|7|||
130998086|NCT02087150|471621491|FG000|Overall Study|Withdrawal by Subject|2|||
130998087|NCT02087150|471621492|FG001|Overall Study|Withdrawal by Subject|5|||
130998088|NCT02087150|471621493|FG002|Overall Study|Withdrawal by Subject|3|||
130998089|NCT02087150|471621491|FG000|Overall Study|Physician Decision|0|||
130998090|NCT02087150|471621492|FG001|Overall Study|Physician Decision|1|||
130998091|NCT02087150|471621493|FG002|Overall Study|Physician Decision|0|||
130998092|NCT02087150|471621491|FG000|Overall Study|Procedure not done|1|||
130998093|NCT02087150|471621492|FG001|Overall Study|Procedure not done|13|||
130998094|NCT02087150|471621493|FG002|Overall Study|Procedure not done|0|||
130998095|NCT02087150|471621491|FG000|Overall Study|F/U not completed w/in study window|0|||
130998096|NCT02087150|471621492|FG001|Overall Study|F/U not completed w/in study window|0|||
130998097|NCT02087150|471621493|FG002|Overall Study|F/U not completed w/in study window|1|||
130998098|NCT02087150|471621491|FG000|Overall Study|Other|1|||
130998099|NCT02087150|471621492|FG001|Overall Study|Other|0|||
130998100|NCT02087150|471621493|FG002|Overall Study|Other|0|||
130998101|NCT02087150|471621491|FG000|Overall Study|Pt moved out of town|0|||
130998102|NCT02087150|471621492|FG001|Overall Study|Pt moved out of town|1|||
130998103|NCT02087150|471621493|FG002|Overall Study|Pt moved out of town|0|||
130998104|NCT01448044|471621494|FG000|Treatment Period|Adverse Event|4|||
130998105|NCT01448044|471621495|FG001|Treatment Period|Adverse Event|3|||
130998106|NCT01448044|471621494|FG000|Treatment Period|Lack of Efficacy|5|||
130998107|NCT01448044|471621495|FG001|Treatment Period|Lack of Efficacy|12|||
130998108|NCT01448044|471621494|FG000|Treatment Period|Subject requested discontinue study drug|1|||
130998109|NCT01448044|471621495|FG001|Treatment Period|Subject requested discontinue study drug|0|||
130998110|NCT01448044|471621494|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
130998111|NCT01448044|471621495|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
130998112|NCT01448044|471621494|FG000|Treatment Period|Participant does not meet study criteria|1|||
130998113|NCT01448044|471621495|FG001|Treatment Period|Participant does not meet study criteria|0|||
130998114|NCT01448044|471621494|FG000|Treatment Period|Lost to Follow-up|2|||
130998115|NCT01448044|471621495|FG001|Treatment Period|Lost to Follow-up|1|||
130998116|NCT01448044|471621494|FG000|Treatment Period|Other reason|2|||
130998117|NCT01448044|471621495|FG001|Treatment Period|Other reason|0|||
130998118|NCT01448044|471621494|FG000|Follow Up Period|Withdrawal by Subject|1|||
130998119|NCT01448044|471621495|FG001|Follow Up Period|Withdrawal by Subject|1|||
130998120|NCT01448044|471621494|FG000|Follow Up Period|Lost to Follow-up|6|||
130998121|NCT01448044|471621495|FG001|Follow Up Period|Lost to Follow-up|2|||
130998122|NCT01448044|471621494|FG000|Follow Up Period|Other|5|||
130998123|NCT01448044|471621495|FG001|Follow Up Period|Other|11|||
130998124|NCT02500316|471621498|FG000|Overall Study|Adverse Event|3|||
130998125|NCT02500316|471621498|FG000|Overall Study|Lost to Follow-up|2|||
130998126|NCT02500316|471621498|FG000|Overall Study|Protocol Violation|1|||
130998127|NCT02500316|471621498|FG000|Overall Study|Withdrawal by Subject|15|||
130998128|NCT02500316|471621498|FG000|Overall Study|Final height achieved|5|||
130998129|NCT02500316|471621498|FG000|Overall Study|Due to war activity|1|||
130998130|NCT02611830|471621508|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
130998131|NCT02611830|471621509|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
130998132|NCT02611830|471621510|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
130998133|NCT02611830|471621511|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
130998134|NCT02611830|471621508|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
130998135|NCT02611830|471621509|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
130998136|NCT02611830|471621510|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
130998137|NCT02611830|471621511|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
130998138|NCT02611830|471621508|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
130998139|NCT02611830|471621509|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
130998140|NCT02611830|471621510|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
130998141|NCT02611830|471621511|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
130998142|NCT02611830|471621508|FG000|OL Induction Phase|Lack of Efficacy|9|||
130998143|NCT02611830|471621509|FG001|OL Induction Phase|Lack of Efficacy|0|||
130998144|NCT02611830|471621510|FG002|OL Induction Phase|Lack of Efficacy|0|||
130998145|NCT02611830|471621511|FG003|OL Induction Phase|Lack of Efficacy|0|||
130998146|NCT02611830|471621508|FG000|OL Induction Phase|Reason not specified|3|||
130998147|NCT02611830|471621509|FG001|OL Induction Phase|Reason not specified|0|||
130998148|NCT02611830|471621510|FG002|OL Induction Phase|Reason not specified|0|||
130998149|NCT02611830|471621511|FG003|OL Induction Phase|Reason not specified|0|||
130998150|NCT02611830|471621508|FG000|Maintenance Phase|Lack of Efficacy|0|||
130998151|NCT02611830|471621509|FG001|Maintenance Phase|Lack of Efficacy|29|||
130998152|NCT02611830|471621510|FG002|Maintenance Phase|Lack of Efficacy|18|||
130998153|NCT02611830|471621511|FG003|Maintenance Phase|Lack of Efficacy|6|||
130998154|NCT02611830|471621508|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130998155|NCT02611830|471621509|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
130998156|NCT02611830|471621510|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
131221697|NCT02454972|472439402|FG008|Overall Study|Treatment-related adverse events|0|||
131221698|NCT02454972|472439394|FG000|Overall Study|Patient moves to compassionate use|0|||
131221699|NCT02454972|472439395|FG001|Overall Study|Patient moves to compassionate use|0|||
131221700|NCT02454972|472439396|FG002|Overall Study|Patient moves to compassionate use|0|||
131221701|NCT02454972|472439397|FG003|Overall Study|Patient moves to compassionate use|0|||
131221702|NCT02454972|472439398|FG004|Overall Study|Patient moves to compassionate use|0|||
131221703|NCT02454972|472439399|FG005|Overall Study|Patient moves to compassionate use|0|||
131221704|NCT02454972|472439400|FG006|Overall Study|Patient moves to compassionate use|2|||
131221705|NCT02454972|472439401|FG007|Overall Study|Patient moves to compassionate use|0|||
131221706|NCT02454972|472439402|FG008|Overall Study|Patient moves to compassionate use|0|||
131221707|NCT02454972|472439394|FG000|Overall Study|Withdrawal by Subject|0|||
131221708|NCT02454972|472439395|FG001|Overall Study|Withdrawal by Subject|1|||
131221709|NCT02454972|472439396|FG002|Overall Study|Withdrawal by Subject|5|||
131221710|NCT02454972|472439397|FG003|Overall Study|Withdrawal by Subject|2|||
131221711|NCT02454972|472439398|FG004|Overall Study|Withdrawal by Subject|3|||
131221712|NCT02454972|472439399|FG005|Overall Study|Withdrawal by Subject|2|||
131221713|NCT02454972|472439400|FG006|Overall Study|Withdrawal by Subject|0|||
131221714|NCT02454972|472439401|FG007|Overall Study|Withdrawal by Subject|1|||
131221715|NCT02454972|472439402|FG008|Overall Study|Withdrawal by Subject|2|||
131221716|NCT02454972|472439394|FG000|Overall Study|Multiple delay/holds on treatment|0|||
131221717|NCT02454972|472439395|FG001|Overall Study|Multiple delay/holds on treatment|0|||
131221718|NCT02454972|472439396|FG002|Overall Study|Multiple delay/holds on treatment|0|||
131221719|NCT02454972|472439397|FG003|Overall Study|Multiple delay/holds on treatment|1|||
131221720|NCT02454972|472439398|FG004|Overall Study|Multiple delay/holds on treatment|0|||
131221721|NCT02454972|472439399|FG005|Overall Study|Multiple delay/holds on treatment|0|||
131221722|NCT02454972|472439400|FG006|Overall Study|Multiple delay/holds on treatment|0|||
131221723|NCT02454972|472439401|FG007|Overall Study|Multiple delay/holds on treatment|0|||
131221724|NCT02454972|472439402|FG008|Overall Study|Multiple delay/holds on treatment|0|||
131221725|NCT02454972|472439394|FG000|Overall Study|Never treated|0|||
131221726|NCT02454972|472439395|FG001|Overall Study|Never treated|0|||
131221727|NCT02454972|472439396|FG002|Overall Study|Never treated|3|||
131221728|NCT02454972|472439397|FG003|Overall Study|Never treated|1|||
131221729|NCT02454972|472439398|FG004|Overall Study|Never treated|1|||
131221730|NCT02454972|472439399|FG005|Overall Study|Never treated|0|||
131221731|NCT02454972|472439400|FG006|Overall Study|Never treated|0|||
130884358|NCT00684021|471211474|FG001|Overall Study|MRI Contraindicated|1|||
130998157|NCT02611830|471621511|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
130998158|NCT02611830|471621508|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
131221732|NCT02454972|472439401|FG007|Overall Study|Never treated|0|||
131221733|NCT02454972|472439402|FG008|Overall Study|Never treated|5|||
131221734|NCT02454972|472439394|FG000|Overall Study|Lost to Follow-up|0|||
131221735|NCT02454972|472439395|FG001|Overall Study|Lost to Follow-up|0|||
131221736|NCT02454972|472439396|FG002|Overall Study|Lost to Follow-up|0|||
130998159|NCT02611830|471621509|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
130998160|NCT02611830|471621510|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
130998161|NCT02611830|471621511|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
130998162|NCT02611830|471621508|FG000|Maintenance Phase|Lost to Follow-up|0|||
130998163|NCT02611830|471621509|FG001|Maintenance Phase|Lost to Follow-up|0|||
130998164|NCT02611830|471621510|FG002|Maintenance Phase|Lost to Follow-up|0|||
130998165|NCT02611830|471621511|FG003|Maintenance Phase|Lost to Follow-up|1|||
130998166|NCT02611830|471621508|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
130998167|NCT02611830|471621509|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
130998168|NCT02611830|471621510|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
130998169|NCT02611830|471621511|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
130998170|NCT02611830|471621508|FG000|Maintenance Phase|Pregnancy|0|||
130998171|NCT02611830|471621509|FG001|Maintenance Phase|Pregnancy|0|||
130998172|NCT02611830|471621510|FG002|Maintenance Phase|Pregnancy|1|||
130998173|NCT02611830|471621511|FG003|Maintenance Phase|Pregnancy|0|||
130998174|NCT02611830|471621508|FG000|Maintenance Phase|Reason not specified|0|||
130998175|NCT02611830|471621509|FG001|Maintenance Phase|Reason not specified|1|||
130998176|NCT02611830|471621510|FG002|Maintenance Phase|Reason not specified|4|||
130998177|NCT02611830|471621511|FG003|Maintenance Phase|Reason not specified|0|||
130998178|NCT02058290|471621512|FG000|Overall Study|Protocol Violation|2|||
130998179|NCT02058290|471621513|FG001|Overall Study|Protocol Violation|1|||
130998180|NCT02058290|471621512|FG000|Overall Study|Physician Decision|1|||
130998181|NCT02058290|471621513|FG001|Overall Study|Physician Decision|0|||
130998182|NCT02058290|471621512|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
130998183|NCT02058290|471621513|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
130998184|NCT02058290|471621512|FG000|Overall Study|Withdrawal by Subject|0|||
130998185|NCT02058290|471621513|FG001|Overall Study|Withdrawal by Subject|1|||
130998186|NCT05822921|471621516|FG000|Overall Study|Lost to Follow-up|1|||
130998187|NCT05822921|471621517|FG001|Overall Study|Lost to Follow-up|1|||
130998188|NCT00544544|471621518|FG000|Overall Study|Withdrawal by Subject|1|||
130998189|NCT00544544|471621518|FG000|Overall Study|Adverse Event|1|||
130998190|NCT00544544|471621518|FG000|Overall Study|Lost to Follow-up|1|||
130998191|NCT03406702|471621519|FG000|Overall Study|Missed Day 27 Dosing|1|||
130998192|NCT01857622|471621524|FG000|Overall Study|Adverse Event|5|||
130998193|NCT01857622|471621525|FG001|Overall Study|Adverse Event|0|||
130998194|NCT01857622|471621526|FG002|Overall Study|Adverse Event|2|||
130998195|NCT01857622|471621524|FG000|Overall Study|Physician Decision|1|||
130998196|NCT01857622|471621525|FG001|Overall Study|Physician Decision|0|||
130998197|NCT01857622|471621526|FG002|Overall Study|Physician Decision|0|||
130998198|NCT01857622|471621524|FG000|Overall Study|Protocol Violation|4|||
130998199|NCT01857622|471621525|FG001|Overall Study|Protocol Violation|1|||
130998200|NCT01857622|471621526|FG002|Overall Study|Protocol Violation|0|||
130998201|NCT01857622|471621524|FG000|Overall Study|Withdrawal by Subject|1|||
130998202|NCT01857622|471621525|FG001|Overall Study|Withdrawal by Subject|0|||
130998203|NCT01857622|471621526|FG002|Overall Study|Withdrawal by Subject|0|||
130998204|NCT01291225|471621528|FG000|Overall Study|Lost to Follow-up|85|||
130998205|NCT01291225|471621529|FG001|Overall Study|Lost to Follow-up|39|||
130998206|NCT01267253|471621530|FG000|Overall Study|Ineligible - required test not done|1|||
130998207|NCT01267253|471621530|FG000|Overall Study|Inevaluable-never received study treatme|2|||
130998208|NCT04318093|471621531|FG000|Overall Study|Adverse Event|2|||
130998209|NCT04318093|471621532|FG001|Overall Study|Adverse Event|2|||
130998210|NCT04318093|471621531|FG000|Overall Study|Participant withdrew consent|1|||
130998211|NCT04318093|471621532|FG001|Overall Study|Participant withdrew consent|0|||
130998212|NCT04318093|471621531|FG000|Overall Study|Other reasons|0|||
130998213|NCT04318093|471621532|FG001|Overall Study|Other reasons|1|||
130998214|NCT02855164|471621535|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130998215|NCT02855164|471621536|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130998216|NCT02855164|471621537|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
130998217|NCT02855164|471621538|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
130998218|NCT02855164|471621539|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
130998219|NCT02855164|471621540|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130998220|NCT02855164|471621541|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130998221|NCT02855164|471621542|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130998222|NCT02855164|471621535|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
130998223|NCT02855164|471621536|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
130998224|NCT02855164|471621537|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
130998225|NCT02855164|471621538|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
130998226|NCT02855164|471621539|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
130998227|NCT02855164|471621540|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
130998228|NCT02855164|471621541|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
130998229|NCT02855164|471621542|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
130998230|NCT02855164|471621535|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
130998231|NCT02855164|471621536|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
130998232|NCT02855164|471621537|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
130998233|NCT02855164|471621538|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
130998234|NCT02855164|471621539|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
130998235|NCT02855164|471621540|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
130998236|NCT02855164|471621541|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
130998237|NCT02855164|471621542|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
130998238|NCT02855164|471621535|FG000|Part C (Randomized Set)|Adverse Event|0|||
130998239|NCT02855164|471621536|FG001|Part C (Randomized Set)|Adverse Event|0|||
130998240|NCT02855164|471621537|FG002|Part C (Randomized Set)|Adverse Event|0|||
130998241|NCT02855164|471621538|FG003|Part C (Randomized Set)|Adverse Event|0|||
130998242|NCT02855164|471621539|FG004|Part C (Randomized Set)|Adverse Event|0|||
130998243|NCT02855164|471621540|FG005|Part C (Randomized Set)|Adverse Event|5|||
130998244|NCT02855164|471621541|FG006|Part C (Randomized Set)|Adverse Event|9|||
130998245|NCT02855164|471621542|FG007|Part C (Randomized Set)|Adverse Event|2|||
130998246|NCT02855164|471621535|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
130998247|NCT02855164|471621536|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
130998248|NCT02855164|471621537|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
130998249|NCT02855164|471621538|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
130998250|NCT02855164|471621539|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
130998251|NCT02855164|471621540|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
130998252|NCT02855164|471621541|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
130998253|NCT02855164|471621542|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
130998254|NCT02855164|471621535|FG000|Part C (Randomized Set)|Physician Decision|0|||
130998255|NCT02855164|471621536|FG001|Part C (Randomized Set)|Physician Decision|0|||
130998256|NCT02855164|471621537|FG002|Part C (Randomized Set)|Physician Decision|0|||
130998257|NCT02855164|471621538|FG003|Part C (Randomized Set)|Physician Decision|0|||
130998258|NCT02855164|471621539|FG004|Part C (Randomized Set)|Physician Decision|0|||
130998259|NCT02855164|471621540|FG005|Part C (Randomized Set)|Physician Decision|1|||
130998260|NCT02855164|471621541|FG006|Part C (Randomized Set)|Physician Decision|0|||
130998261|NCT02855164|471621542|FG007|Part C (Randomized Set)|Physician Decision|1|||
130998262|NCT02855164|471621535|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
130998263|NCT02855164|471621536|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
130998264|NCT02855164|471621537|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
130998265|NCT02855164|471621538|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
130998266|NCT02855164|471621539|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
130998267|NCT02855164|471621540|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
130998268|NCT02855164|471621541|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
130998269|NCT02855164|471621542|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
130998270|NCT00876460|471621543|FG000|Combination Therapy Phase|Progressive disease|2|||
130998271|NCT00876460|471621544|FG001|Combination Therapy Phase|Progressive disease|3|||
130998272|NCT00876460|471621545|FG002|Combination Therapy Phase|Progressive disease|3|||
130998273|NCT00876460|471621546|FG003|Combination Therapy Phase|Progressive disease|3|||
130998274|NCT00876460|471621547|FG004|Combination Therapy Phase|Progressive disease|3|||
130998275|NCT00876460|471621548|FG005|Combination Therapy Phase|Progressive disease|1|||
130998276|NCT00876460|471621549|FG006|Combination Therapy Phase|Progressive disease|1|||
130998277|NCT00876460|471621550|FG007|Combination Therapy Phase|Progressive disease|1|||
130998278|NCT00876460|471621543|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
130998279|NCT00876460|471621544|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
130998280|NCT00876460|471621545|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
130998281|NCT00876460|471621546|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
130998282|NCT00876460|471621547|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
130998283|NCT00876460|471621548|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
130998284|NCT00876460|471621549|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
130998285|NCT00876460|471621550|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
130998286|NCT00876460|471621543|FG000|Combination Therapy Phase|Adverse Event|0|||
130998287|NCT00876460|471621544|FG001|Combination Therapy Phase|Adverse Event|2|||
130998288|NCT00876460|471621545|FG002|Combination Therapy Phase|Adverse Event|0|||
130998289|NCT00876460|471621546|FG003|Combination Therapy Phase|Adverse Event|2|||
130998290|NCT00876460|471621547|FG004|Combination Therapy Phase|Adverse Event|2|||
130998291|NCT00876460|471621548|FG005|Combination Therapy Phase|Adverse Event|0|||
130998292|NCT00876460|471621549|FG006|Combination Therapy Phase|Adverse Event|3|||
130998293|NCT00876460|471621550|FG007|Combination Therapy Phase|Adverse Event|2|||
130998294|NCT00876460|471621543|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
130998295|NCT00876460|471621544|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
130998296|NCT00876460|471621545|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
130884359|NCT00684021|471211475|FG002|Overall Study|MRI Contraindicated|1|||
130998297|NCT00876460|471621546|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
130998298|NCT00876460|471621547|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
130998299|NCT00876460|471621548|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
130998300|NCT00876460|471621549|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
130998301|NCT00876460|471621550|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
130998302|NCT00876460|471621543|FG000|Combination Therapy Phase|Other reason not defined above|0|||
130998303|NCT00876460|471621544|FG001|Combination Therapy Phase|Other reason not defined above|0|||
130998304|NCT00876460|471621545|FG002|Combination Therapy Phase|Other reason not defined above|0|||
130998305|NCT00876460|471621546|FG003|Combination Therapy Phase|Other reason not defined above|0|||
130998306|NCT00876460|471621547|FG004|Combination Therapy Phase|Other reason not defined above|0|||
130998307|NCT00876460|471621548|FG005|Combination Therapy Phase|Other reason not defined above|0|||
130998308|NCT00876460|471621549|FG006|Combination Therapy Phase|Other reason not defined above|1|||
130998309|NCT00876460|471621550|FG007|Combination Therapy Phase|Other reason not defined above|2|||
130998310|NCT00876460|471621543|FG000|Combination Therapy Phase|Not treated|0|||
130998311|NCT00876460|471621544|FG001|Combination Therapy Phase|Not treated|0|||
130998312|NCT00876460|471621545|FG002|Combination Therapy Phase|Not treated|0|||
130998313|NCT00876460|471621546|FG003|Combination Therapy Phase|Not treated|0|||
130998314|NCT00876460|471621547|FG004|Combination Therapy Phase|Not treated|0|||
130998315|NCT00876460|471621548|FG005|Combination Therapy Phase|Not treated|0|||
130998316|NCT00876460|471621549|FG006|Combination Therapy Phase|Not treated|1|||
130998317|NCT00876460|471621550|FG007|Combination Therapy Phase|Not treated|0|||
130998318|NCT00876460|471621543|FG000|Mono Therapy Phase|Progressive disease|0|||
130998319|NCT00876460|471621544|FG001|Mono Therapy Phase|Progressive disease|0|||
130998320|NCT00876460|471621545|FG002|Mono Therapy Phase|Progressive disease|0|||
130998321|NCT00876460|471621546|FG003|Mono Therapy Phase|Progressive disease|0|||
130998322|NCT00876460|471621547|FG004|Mono Therapy Phase|Progressive disease|2|||
130998323|NCT00876460|471621548|FG005|Mono Therapy Phase|Progressive disease|0|||
130998324|NCT00876460|471621549|FG006|Mono Therapy Phase|Progressive disease|1|||
130998325|NCT00876460|471621550|FG007|Mono Therapy Phase|Progressive disease|3|||
130998326|NCT00876460|471621543|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
130998327|NCT00876460|471621544|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
130998328|NCT00876460|471621545|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
130998329|NCT00876460|471621546|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
130998330|NCT00876460|471621547|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
131100690|NCT00468104|471998069|FG000|Second Intervention|Withdrawal by Subject|5|||
130998331|NCT00876460|471621548|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
130998332|NCT00876460|471621549|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
130998333|NCT00876460|471621550|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
130998334|NCT00876460|471621543|FG000|Mono Therapy Phase|Adverse Event|0|||
130998335|NCT00876460|471621544|FG001|Mono Therapy Phase|Adverse Event|0|||
130998336|NCT00876460|471621545|FG002|Mono Therapy Phase|Adverse Event|0|||
130998337|NCT00876460|471621546|FG003|Mono Therapy Phase|Adverse Event|1|||
130998338|NCT00876460|471621547|FG004|Mono Therapy Phase|Adverse Event|0|||
130998339|NCT00876460|471621548|FG005|Mono Therapy Phase|Adverse Event|0|||
130998340|NCT00876460|471621549|FG006|Mono Therapy Phase|Adverse Event|0|||
131100691|NCT00468104|471998070|FG001|Second Intervention|Withdrawal by Subject|2|||
131100692|NCT00468104|471998069|FG000|Second Intervention|discarded for malposition of chest tube|0|||
131221737|NCT02454972|472439397|FG003|Overall Study|Lost to Follow-up|0|||
130998341|NCT00876460|471621550|FG007|Mono Therapy Phase|Adverse Event|0|||
130998342|NCT00127413|471621552|FG000|Overall Study|Lost to Follow-up|6|||
130998343|NCT00127413|471621553|FG001|Overall Study|Lost to Follow-up|4|||
130998344|NCT00127413|471621554|FG002|Overall Study|Lost to Follow-up|8|||
130998345|NCT00127413|471621555|FG003|Overall Study|Lost to Follow-up|2|||
130998346|NCT00547911|471621556|FG000|Overall Study|Adverse Event|0|||
130998347|NCT00547911|471621557|FG001|Overall Study|Adverse Event|0|||
130998348|NCT00547911|471621558|FG002|Overall Study|Adverse Event|0|||
130998349|NCT00547911|471621559|FG003|Overall Study|Adverse Event|1|||
130998350|NCT00547911|471621560|FG004|Overall Study|Adverse Event|0|||
130998351|NCT00547911|471621561|FG005|Overall Study|Adverse Event|0|||
130998352|NCT01644474|471621563|FG000|Overall Study|Poor compliance to protocol|1|||
130998353|NCT01644474|471621564|FG001|Overall Study|Poor compliance to protocol|0|||
130998354|NCT01644474|471621563|FG000|Overall Study|Consent withdrawn by participant|0|||
130998355|NCT01644474|471621564|FG001|Overall Study|Consent withdrawn by participant|1|||
130998356|NCT01644474|471621563|FG000|Overall Study|Participant moved|0|||
131221738|NCT02454972|472439398|FG004|Overall Study|Lost to Follow-up|0|||
131221739|NCT02454972|472439399|FG005|Overall Study|Lost to Follow-up|0|||
131221740|NCT02454972|472439400|FG006|Overall Study|Lost to Follow-up|0|||
131221741|NCT02454972|472439401|FG007|Overall Study|Lost to Follow-up|0|||
131221742|NCT02454972|472439402|FG008|Overall Study|Lost to Follow-up|2|||
131221743|NCT02454972|472439394|FG000|Overall Study|Study termination|0|||
131221744|NCT02454972|472439395|FG001|Overall Study|Study termination|0|||
131221745|NCT02454972|472439396|FG002|Overall Study|Study termination|0|||
131221746|NCT02454972|472439397|FG003|Overall Study|Study termination|0|||
131221747|NCT02454972|472439398|FG004|Overall Study|Study termination|0|||
131221748|NCT02454972|472439399|FG005|Overall Study|Study termination|0|||
131221749|NCT02454972|472439400|FG006|Overall Study|Study termination|0|||
131221750|NCT02454972|472439401|FG007|Overall Study|Study termination|0|||
131221751|NCT02454972|472439402|FG008|Overall Study|Study termination|6|||
131221752|NCT01377233|472439405|FG000|Open-label|Adverse Event|1|||
131221753|NCT01377233|472439406|FG001|Open-label|Adverse Event|0|||
131221754|NCT01377233|472439407|FG002|Open-label|Adverse Event|0|||
131221755|NCT01377233|472439408|FG003|Open-label|Adverse Event|0|||
131221756|NCT01377233|472439409|FG004|Open-label|Adverse Event|0|||
131221757|NCT01377233|472439405|FG000|Open-label|Withdrawal by Subject|3|||
131221758|NCT01377233|472439406|FG001|Open-label|Withdrawal by Subject|0|||
131221759|NCT01377233|472439407|FG002|Open-label|Withdrawal by Subject|0|||
131221760|NCT01377233|472439408|FG003|Open-label|Withdrawal by Subject|0|||
131221761|NCT01377233|472439409|FG004|Open-label|Withdrawal by Subject|0|||
131221762|NCT01377233|472439405|FG000|Double-blind|Adverse Event|0|||
131221763|NCT01377233|472439406|FG001|Double-blind|Adverse Event|1|||
131221764|NCT01377233|472439407|FG002|Double-blind|Adverse Event|2|||
131221765|NCT01377233|472439408|FG003|Double-blind|Adverse Event|2|||
131221766|NCT01377233|472439409|FG004|Double-blind|Adverse Event|0|||
131221767|NCT01377233|472439405|FG000|Double-blind|Protocol Violation|0|||
131221768|NCT01377233|472439406|FG001|Double-blind|Protocol Violation|0|||
131221769|NCT01377233|472439407|FG002|Double-blind|Protocol Violation|0|||
131221770|NCT01377233|472439408|FG003|Double-blind|Protocol Violation|0|||
131221771|NCT01377233|472439409|FG004|Double-blind|Protocol Violation|1|||
131221772|NCT01377233|472439405|FG000|Double-blind|Withdrawal by Subject|0|||
131221773|NCT01377233|472439406|FG001|Double-blind|Withdrawal by Subject|0|||
130998357|NCT01644474|471621564|FG001|Overall Study|Participant moved|1|||
130998358|NCT01644474|471621563|FG000|Overall Study|Adverse Event|4|||
130998359|NCT01644474|471621564|FG001|Overall Study|Adverse Event|5|||
130998360|NCT01644474|471621563|FG000|Overall Study|Site scheduling error|1|||
130998361|NCT01644474|471621564|FG001|Overall Study|Site scheduling error|1|||
130998362|NCT01644474|471621563|FG000|Overall Study|Protocol Violation|1|||
130998363|NCT01644474|471621564|FG001|Overall Study|Protocol Violation|0|||
130998364|NCT02044458|471621568|FG000|Overall Study|Protocol Violation|3|||
130998365|NCT02044458|471621569|FG001|Overall Study|Protocol Violation|8|||
130998366|NCT02601937|471621570|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
130998367|NCT02601937|471621571|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
130998368|NCT02601937|471621572|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
130998369|NCT02601937|471621573|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
130998370|NCT02601937|471621574|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
130998371|NCT02601937|471621575|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
130998372|NCT02601937|471621576|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
130998373|NCT02601937|471621577|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
130998374|NCT02601937|471621578|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
130998375|NCT02601937|471621579|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
130998376|NCT02601937|471621580|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
130998377|NCT02601937|471621570|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
130998378|NCT02601937|471621571|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130998379|NCT02601937|471621572|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130998380|NCT02601937|471621573|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130998381|NCT02601937|471621574|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130998382|NCT02601937|471621575|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130998383|NCT02601937|471621576|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
130998384|NCT02601937|471621577|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130998385|NCT02601937|471621578|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130998386|NCT02601937|471621579|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130998387|NCT02601937|471621580|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
130998388|NCT02601937|471621570|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130998389|NCT02601937|471621571|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130998390|NCT02601937|471621572|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
130998391|NCT02601937|471621573|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130998392|NCT02601937|471621574|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130998393|NCT02601937|471621575|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130998394|NCT02601937|471621576|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130998395|NCT02601937|471621577|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130998396|NCT02601937|471621578|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130998397|NCT02601937|471621579|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130998398|NCT02601937|471621580|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
130998399|NCT02601937|471621570|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
130998400|NCT02601937|471621571|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
130998401|NCT02601937|471621572|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
130998402|NCT02601937|471621573|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
130998403|NCT02601937|471621574|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
130998404|NCT02601937|471621575|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
130998405|NCT02601937|471621576|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
130998406|NCT02601937|471621577|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
130998407|NCT02601937|471621578|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
130998408|NCT02601937|471621579|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
130998409|NCT02601937|471621580|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
130998410|NCT02601937|471621570|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130998411|NCT02601937|471621571|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130998412|NCT02601937|471621572|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130998413|NCT02601937|471621573|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130998414|NCT02601937|471621574|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130998415|NCT02601937|471621575|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130998416|NCT02601937|471621576|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130998417|NCT02601937|471621577|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130998418|NCT02601937|471621578|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130998419|NCT02601937|471621579|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
130998420|NCT02601937|471621580|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
130998421|NCT02601937|471621570|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130998422|NCT02601937|471621571|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130998423|NCT02601937|471621572|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130998424|NCT02601937|471621573|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130998425|NCT02601937|471621574|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130998426|NCT02601937|471621575|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130998427|NCT02601937|471621576|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130998428|NCT02601937|471621577|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
130998429|NCT02601937|471621578|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130998430|NCT02601937|471621579|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130998431|NCT02601937|471621580|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130998432|NCT02601937|471621570|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130998433|NCT02601937|471621571|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130998434|NCT02601937|471621572|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130998435|NCT02601937|471621573|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130998436|NCT02601937|471621574|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130998437|NCT02601937|471621575|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130998438|NCT02601937|471621576|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130998439|NCT02601937|471621577|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130998440|NCT02601937|471621578|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
130998441|NCT02601937|471621579|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
130998442|NCT02601937|471621580|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
130998443|NCT02601937|471621570|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130998444|NCT02601937|471621571|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130998445|NCT02601937|471621572|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130998446|NCT02601937|471621573|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130998447|NCT02601937|471621574|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130998448|NCT02601937|471621575|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130998449|NCT02601937|471621576|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130998450|NCT02601937|471621577|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
130998451|NCT02601937|471621578|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
130998452|NCT02601937|471621579|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
130998453|NCT02601937|471621580|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
130998454|NCT02601937|471621570|FG000|Period 2: Dose Expansion Cohort|Other|0|||
130998455|NCT02601937|471621571|FG001|Period 2: Dose Expansion Cohort|Other|0|||
130998456|NCT02601937|471621572|FG002|Period 2: Dose Expansion Cohort|Other|0|||
130998457|NCT02601937|471621573|FG003|Period 2: Dose Expansion Cohort|Other|0|||
130998458|NCT02601937|471621574|FG004|Period 2: Dose Expansion Cohort|Other|0|||
130998459|NCT02601937|471621575|FG005|Period 2: Dose Expansion Cohort|Other|0|||
130998460|NCT02601937|471621576|FG006|Period 2: Dose Expansion Cohort|Other|0|||
130998461|NCT02601937|471621577|FG007|Period 2: Dose Expansion Cohort|Other|0|||
130998462|NCT02601937|471621578|FG008|Period 2: Dose Expansion Cohort|Other|2|||
130998463|NCT02601937|471621579|FG009|Period 2: Dose Expansion Cohort|Other|2|||
130998464|NCT02601937|471621580|FG010|Period 2: Dose Expansion Cohort|Other|0|||
130998465|NCT02601937|471621570|FG000|Period 2: Dose Expansion Cohort|Death|0|||
130998466|NCT02601937|471621571|FG001|Period 2: Dose Expansion Cohort|Death|0|||
130998467|NCT02601937|471621572|FG002|Period 2: Dose Expansion Cohort|Death|0|||
131221774|NCT01377233|472439407|FG002|Double-blind|Withdrawal by Subject|0|||
131221775|NCT01377233|472439408|FG003|Double-blind|Withdrawal by Subject|1|||
131221776|NCT01377233|472439409|FG004|Double-blind|Withdrawal by Subject|0|||
131221777|NCT01377233|472439405|FG000|Double-blind|Administrative or other|0|||
131221778|NCT01377233|472439406|FG001|Double-blind|Administrative or other|0|||
131221779|NCT01377233|472439407|FG002|Double-blind|Administrative or other|0|||
131221780|NCT01377233|472439408|FG003|Double-blind|Administrative or other|1|||
131221781|NCT01377233|472439409|FG004|Double-blind|Administrative or other|1|||
131221782|NCT01785875|472439410|FG000|Overall Study|Withdrawal by Subject|41|||
131221783|NCT01785875|472439411|FG001|Overall Study|Withdrawal by Subject|34|||
131221784|NCT01785875|472439412|FG002|Overall Study|Withdrawal by Subject|36|||
131221785|NCT01785875|472439410|FG000|Overall Study|Lost to Follow-up|19|||
131221786|NCT01785875|472439411|FG001|Overall Study|Lost to Follow-up|22|||
131221787|NCT01785875|472439412|FG002|Overall Study|Lost to Follow-up|6|||
131221788|NCT01785875|472439410|FG000|Overall Study|Death|27|||
131221789|NCT01785875|472439411|FG001|Overall Study|Death|16|||
131221790|NCT01785875|472439412|FG002|Overall Study|Death|7|||
131221791|NCT01785875|472439410|FG000|Overall Study|Sponsor Decision|0|||
131221792|NCT01785875|472439411|FG001|Overall Study|Sponsor Decision|2|||
131221793|NCT01785875|472439412|FG002|Overall Study|Sponsor Decision|0|||
131221794|NCT01785875|472439410|FG000|Overall Study|Protocol Specified Criteria|207|||
131221795|NCT01785875|472439411|FG001|Overall Study|Protocol Specified Criteria|214|||
131221796|NCT01785875|472439412|FG002|Overall Study|Protocol Specified Criteria|55|||
131221797|NCT01785875|472439410|FG000|Overall Study|Missing|0|||
131221798|NCT01785875|472439411|FG001|Overall Study|Missing|1|||
131221799|NCT01785875|472439412|FG002|Overall Study|Missing|3|||
131221800|NCT00417027|472439415|FG000|Overall Study|Protocol Violation|0|||
131221801|NCT00417027|472439416|FG001|Overall Study|Protocol Violation|5|||
131221802|NCT00417027|472439417|FG002|Overall Study|Protocol Violation|5|||
131221803|NCT00707174|472439418|FG000|Overall Study|Adverse Event|1|||
131221804|NCT00707174|472439419|FG001|Overall Study|Adverse Event|6|||
131221805|NCT00707174|472439418|FG000|Overall Study|Withdrawal by Subject|4|||
131221806|NCT00707174|472439419|FG001|Overall Study|Withdrawal by Subject|1|||
131221807|NCT00618774|472439422|FG000|Overall Study|Adverse Event|5|||
131221808|NCT00618774|472439423|FG001|Overall Study|Adverse Event|3|||
131221809|NCT00618774|472439422|FG000|Overall Study|Withdrawal by Subject|1|||
131221810|NCT00618774|472439423|FG001|Overall Study|Withdrawal by Subject|0|||
131221811|NCT04991311|472439424|FG000|Overall Study|Adverse Event|1|||
131221812|NCT00996918|472439441|FG000|Overall Study|Lack of Efficacy|1|||
131221813|NCT00996918|472439442|FG001|Overall Study|Lack of Efficacy|1|||
131221814|NCT00996918|472439443|FG002|Overall Study|Lack of Efficacy|2|||
131221815|NCT00996918|472439444|FG003|Overall Study|Lack of Efficacy|2|||
131221816|NCT00996918|472439445|FG004|Overall Study|Lack of Efficacy|0|||
131221817|NCT00996918|472439441|FG000|Overall Study|Adverse Event|2|||
131221818|NCT00996918|472439442|FG001|Overall Study|Adverse Event|5|||
131221819|NCT00996918|472439443|FG002|Overall Study|Adverse Event|2|||
131221820|NCT00996918|472439444|FG003|Overall Study|Adverse Event|6|||
131221821|NCT00996918|472439445|FG004|Overall Study|Adverse Event|0|||
131221822|NCT00996918|472439441|FG000|Overall Study|Withdrawal by Subject|1|||
131221823|NCT00996918|472439442|FG001|Overall Study|Withdrawal by Subject|4|||
131221824|NCT00996918|472439443|FG002|Overall Study|Withdrawal by Subject|3|||
131221825|NCT00996918|472439444|FG003|Overall Study|Withdrawal by Subject|3|||
131221826|NCT00996918|472439445|FG004|Overall Study|Withdrawal by Subject|2|||
131221827|NCT00996918|472439441|FG000|Overall Study|Physician Decision|1|||
131221828|NCT00996918|472439442|FG001|Overall Study|Physician Decision|0|||
131221829|NCT00996918|472439443|FG002|Overall Study|Physician Decision|0|||
131221830|NCT00996918|472439444|FG003|Overall Study|Physician Decision|0|||
131221831|NCT00996918|472439445|FG004|Overall Study|Physician Decision|0|||
131221832|NCT00996918|472439441|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
131221833|NCT00996918|472439442|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
131221834|NCT00996918|472439443|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
131221835|NCT00996918|472439444|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
131221836|NCT00996918|472439445|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
131221837|NCT00996918|472439441|FG000|Overall Study|Loss of Caregiver|0|||
131221838|NCT00996918|472439442|FG001|Overall Study|Loss of Caregiver|1|||
131221839|NCT00996918|472439443|FG002|Overall Study|Loss of Caregiver|0|||
131221840|NCT00996918|472439444|FG003|Overall Study|Loss of Caregiver|0|||
131221841|NCT00996918|472439445|FG004|Overall Study|Loss of Caregiver|0|||
131221842|NCT00996918|472439441|FG000|Overall Study|Other|3|||
131221843|NCT00996918|472439442|FG001|Overall Study|Other|1|||
131221844|NCT00996918|472439443|FG002|Overall Study|Other|0|||
131221845|NCT00996918|472439444|FG003|Overall Study|Other|0|||
131221846|NCT00996918|472439445|FG004|Overall Study|Other|0|||
131221847|NCT04440007|472439446|FG000|Overall Study|Adverse Event|0|||
131221848|NCT04440007|472439447|FG001|Overall Study|Adverse Event|1|||
131221849|NCT04440007|472439446|FG000|Overall Study|Lost to Follow-up|1|||
131221850|NCT04440007|472439447|FG001|Overall Study|Lost to Follow-up|3|||
131221851|NCT04440007|472439446|FG000|Overall Study|Death|7|||
131221852|NCT04440007|472439447|FG001|Overall Study|Death|2|||
131221853|NCT04440007|472439446|FG000|Overall Study|Physician Decision|1|||
130884360|NCT00684021|471211476|FG003|Overall Study|MRI Contraindicated|0|||
130998468|NCT02601937|471621573|FG003|Period 2: Dose Expansion Cohort|Death|0|||
130998469|NCT02601937|471621574|FG004|Period 2: Dose Expansion Cohort|Death|0|||
130998470|NCT02601937|471621575|FG005|Period 2: Dose Expansion Cohort|Death|0|||
130998471|NCT02601937|471621576|FG006|Period 2: Dose Expansion Cohort|Death|0|||
131221854|NCT04440007|472439447|FG001|Overall Study|Physician Decision|1|||
131221855|NCT04440007|472439446|FG000|Overall Study|Withdrawal by Subject|2|||
131221856|NCT04440007|472439447|FG001|Overall Study|Withdrawal by Subject|1|||
131221857|NCT04440007|472439446|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
131221858|NCT04440007|472439447|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
131221859|NCT04440007|472439446|FG000|Overall Study|Discontinued prior to dosing|0|||
131221860|NCT04440007|472439447|FG001|Overall Study|Discontinued prior to dosing|2|||
131221861|NCT01466673|472439448|FG000|Overall Study|Non-compliance with study treatment|2|||
131221862|NCT01466673|472439449|FG001|Overall Study|Non-compliance with study treatment|0|||
131221863|NCT01466673|472439448|FG000|Overall Study|Lost to Follow-up|3|||
131221864|NCT01466673|472439449|FG001|Overall Study|Lost to Follow-up|5|||
131221865|NCT01466673|472439448|FG000|Overall Study|Adverse Event|2|||
131221866|NCT01466673|472439449|FG001|Overall Study|Adverse Event|1|||
131221867|NCT00854607|472439450|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
131221868|NCT02567266|472439451|FG000|Overall Study|Withdrawal by Subject|10|||
131221869|NCT02567266|472439452|FG001|Overall Study|Withdrawal by Subject|7|||
131221870|NCT02567266|472439453|FG002|Overall Study|Withdrawal by Subject|6|||
131221871|NCT02567266|472439451|FG000|Overall Study|Lost to Follow-up|13|||
131221872|NCT02567266|472439452|FG001|Overall Study|Lost to Follow-up|8|||
131221873|NCT02567266|472439453|FG002|Overall Study|Lost to Follow-up|10|||
131221874|NCT00061945|472439454|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
131221875|NCT00061945|472439455|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
131221876|NCT00061945|472439454|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
131221877|NCT00061945|472439455|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
131221878|NCT00061945|472439454|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
131221879|NCT00061945|472439455|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
131221880|NCT00061945|472439454|FG000|Course IV: Alemtuzumab|Early exits|6|||
131221881|NCT00061945|472439455|FG001|Course IV: Alemtuzumab|Early exits|15|||
131221882|NCT01039584|472439456|FG000|Overall Study|Withdrawal by Subject|4|||
131221883|NCT01039584|472439457|FG001|Overall Study|Withdrawal by Subject|2|||
131221884|NCT01039584|472439458|FG002|Overall Study|Withdrawal by Subject|1|||
131221885|NCT01039584|472439456|FG000|Overall Study|Protocol Violation|10|||
131221886|NCT01039584|472439457|FG001|Overall Study|Protocol Violation|4|||
131221887|NCT01039584|472439458|FG002|Overall Study|Protocol Violation|6|||
131221888|NCT01039584|472439456|FG000|Overall Study|Lost to Follow-up|5|||
131221889|NCT01039584|472439457|FG001|Overall Study|Lost to Follow-up|3|||
131221890|NCT01039584|472439458|FG002|Overall Study|Lost to Follow-up|4|||
131221891|NCT01039584|472439456|FG000|Overall Study|Negative Baseline culture for Candida|59|||
131221892|NCT01039584|472439457|FG001|Overall Study|Negative Baseline culture for Candida|59|||
131221893|NCT01039584|472439458|FG002|Overall Study|Negative Baseline culture for Candida|24|||
131221894|NCT01039584|472439456|FG000|Overall Study|Lack of Efficacy|7|||
131221895|NCT01039584|472439457|FG001|Overall Study|Lack of Efficacy|6|||
131221896|NCT01039584|472439458|FG002|Overall Study|Lack of Efficacy|10|||
131221897|NCT01039584|472439456|FG000|Overall Study|other|1|||
131221898|NCT01039584|472439457|FG001|Overall Study|other|3|||
131221899|NCT01039584|472439458|FG002|Overall Study|other|1|||
131221900|NCT01039584|472439456|FG000|Overall Study|Pap smear with significant pathology|10|||
131221901|NCT01039584|472439457|FG001|Overall Study|Pap smear with significant pathology|10|||
131221902|NCT01039584|472439458|FG002|Overall Study|Pap smear with significant pathology|3|||
131221903|NCT01039584|472439456|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
131221904|NCT01039584|472439457|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
131221905|NCT01039584|472439458|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
131221906|NCT03672396|472439459|FG000|Overall Study|Withdrawal by Subject|4|||
131221907|NCT03672396|472439459|FG000|Overall Study|Physician Decision|1|||
131221908|NCT03672396|472439459|FG000|Overall Study|Adverse Event|1|||
131221909|NCT04816877|472439461|FG000|Overall Study|Withdrawal by Subject|1|||
131221910|NCT04816877|472439462|FG001|Overall Study|Withdrawal by Subject|0|||
131221911|NCT01309828|472439463|FG000|Overall Study|Adverse Event|10|||
131221912|NCT01309828|472439464|FG001|Overall Study|Adverse Event|11|||
131221913|NCT01309828|472439463|FG000|Overall Study|Voluntary Withdrawal|5|||
130998472|NCT02601937|471621577|FG007|Period 2: Dose Expansion Cohort|Death|0|||
130998473|NCT02601937|471621578|FG008|Period 2: Dose Expansion Cohort|Death|1|||
130998474|NCT02601937|471621579|FG009|Period 2: Dose Expansion Cohort|Death|0|||
130998475|NCT02601937|471621580|FG010|Period 2: Dose Expansion Cohort|Death|0|||
130998476|NCT00581113|471623891|FG000|Overall Study|Withdrawal by Subject|0|||
130998477|NCT00581113|471623892|FG001|Overall Study|Withdrawal by Subject|1|||
130998478|NCT00619476|471623893|FG000|Overall Study|Adverse Event|12|||
130998479|NCT00619476|471623894|FG001|Overall Study|Adverse Event|6|||
130998480|NCT00619476|471623895|FG002|Overall Study|Adverse Event|12|||
130998481|NCT00619476|471623896|FG003|Overall Study|Adverse Event|16|||
130998482|NCT00619476|471623893|FG000|Overall Study|Lack of Efficacy|6|||
130998483|NCT00619476|471623894|FG001|Overall Study|Lack of Efficacy|1|||
130998484|NCT00619476|471623895|FG002|Overall Study|Lack of Efficacy|1|||
130998485|NCT00619476|471623896|FG003|Overall Study|Lack of Efficacy|4|||
130998486|NCT00619476|471623893|FG000|Overall Study|Protocol Violation|5|||
130998487|NCT00619476|471623894|FG001|Overall Study|Protocol Violation|4|||
130998488|NCT00619476|471623895|FG002|Overall Study|Protocol Violation|4|||
130998489|NCT00619476|471623896|FG003|Overall Study|Protocol Violation|9|||
130998490|NCT00619476|471623893|FG000|Overall Study|Lost to Follow-up|1|||
130998491|NCT00619476|471623894|FG001|Overall Study|Lost to Follow-up|2|||
130998492|NCT00619476|471623895|FG002|Overall Study|Lost to Follow-up|0|||
130998493|NCT00619476|471623896|FG003|Overall Study|Lost to Follow-up|1|||
130998494|NCT00619476|471623893|FG000|Overall Study|Investigator Discretion|2|||
130998495|NCT00619476|471623894|FG001|Overall Study|Investigator Discretion|2|||
130998496|NCT00619476|471623895|FG002|Overall Study|Investigator Discretion|2|||
130998497|NCT00619476|471623896|FG003|Overall Study|Investigator Discretion|0|||
130998498|NCT00619476|471623893|FG000|Overall Study|Withdrawal by Subject|5|||
130998499|NCT00619476|471623894|FG001|Overall Study|Withdrawal by Subject|7|||
130998500|NCT00619476|471623895|FG002|Overall Study|Withdrawal by Subject|5|||
130998501|NCT00619476|471623896|FG003|Overall Study|Withdrawal by Subject|4|||
130998502|NCT01625910|471623897|FG000|Overall Study|Lost to Follow-up|3|||
130998503|NCT01625910|471623898|FG001|Overall Study|Lost to Follow-up|4|||
130998504|NCT02959138|471623899|FG000|Overall Study|Enrolled but Never Treated|0|||
130998505|NCT02959138|471623900|FG001|Overall Study|Enrolled but Never Treated|1|||
130998506|NCT02959138|471623901|FG002|Overall Study|Enrolled but Never Treated|0|||
130998507|NCT01327547|471623902|FG000|Overall Study|Adverse Event|4|||
130998508|NCT01327547|471623903|FG001|Overall Study|Adverse Event|1|||
130998509|NCT01327547|471623902|FG000|Overall Study|Death|1|||
130998510|NCT01327547|471623903|FG001|Overall Study|Death|2|||
130998511|NCT01327547|471623902|FG000|Overall Study|Lost to Follow-up|6|||
130998512|NCT01327547|471623903|FG001|Overall Study|Lost to Follow-up|6|||
130998513|NCT01327547|471623902|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
130998514|NCT01327547|471623903|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
130998515|NCT01327547|471623902|FG000|Overall Study|Withdrawal by Subject|3|||
130998516|NCT01327547|471623903|FG001|Overall Study|Withdrawal by Subject|7|||
130998517|NCT01327547|471623902|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
130998518|NCT01327547|471623903|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
130998519|NCT01327547|471623902|FG000|Overall Study|Protocol Violation|1|||
130998520|NCT01327547|471623903|FG001|Overall Study|Protocol Violation|0|||
130998521|NCT01327547|471623902|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
130998522|NCT01327547|471623903|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
130998523|NCT01327547|471623902|FG000|Overall Study|Required prohibited medication|2|||
130998524|NCT01327547|471623903|FG001|Overall Study|Required prohibited medication|0|||
130998525|NCT01327547|471623902|FG000|Overall Study|Non-compliance with study procedures|1|||
130998526|NCT01327547|471623903|FG001|Overall Study|Non-compliance with study procedures|0|||
130998527|NCT01327547|471623902|FG000|Overall Study|By investigator in subject's interest|0|||
130998528|NCT01327547|471623903|FG001|Overall Study|By investigator in subject's interest|1|||
130998529|NCT01681368|471623907|FG000|Overall Study|Refused further treatment|1|||
130998530|NCT01681368|471623907|FG000|Overall Study|Refused further follow up|1|||
130998531|NCT01155388|471623910|FG000|Overall Study|Adverse Event|1|||
130998532|NCT01155388|471623911|FG001|Overall Study|Adverse Event|0|||
130998533|NCT01004250|471623912|FG000|Induction Therapy Period|Adverse Event|10|||
130998534|NCT01004250|471623912|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
130998535|NCT01004250|471623912|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
130998536|NCT01004250|471623912|FG000|Induction Therapy Period|Physician Decision|2|||
130998537|NCT01004250|471623912|FG000|Maintenance Therapy Period|Adverse Event|15|||
130998538|NCT01004250|471623912|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
130998539|NCT01004250|471623912|FG000|Maintenance Therapy Period|Protocol Violation|1|||
130998540|NCT01004250|471623912|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
130998541|NCT01004250|471623912|FG000|Maintenance Therapy Period|Physician Decision|4|||
130998542|NCT01004250|471623912|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
130998543|NCT00900627|471623913|FG000|Overall Study|Condition under investigation worsened|4|||
130998544|NCT00900627|471623914|FG001|Overall Study|Condition under investigation worsened|0|||
130998545|NCT00900627|471623915|FG002|Overall Study|Condition under investigation worsened|5|||
130998546|NCT00900627|471623916|FG003|Overall Study|Condition under investigation worsened|3|||
130998547|NCT00900627|471623917|FG004|Overall Study|Condition under investigation worsened|0|||
130998548|NCT00900627|471623918|FG005|Overall Study|Condition under investigation worsened|0|||
130998549|NCT00900627|471623913|FG000|Overall Study|Withdrawal by Subject|1|||
130998550|NCT00900627|471623914|FG001|Overall Study|Withdrawal by Subject|0|||
130998551|NCT00900627|471623915|FG002|Overall Study|Withdrawal by Subject|1|||
130998552|NCT00900627|471623916|FG003|Overall Study|Withdrawal by Subject|0|||
130998553|NCT00900627|471623917|FG004|Overall Study|Withdrawal by Subject|1|||
130998554|NCT00900627|471623918|FG005|Overall Study|Withdrawal by Subject|2|||
130998555|NCT00900627|471623913|FG000|Overall Study|Adverse Event|1|||
130998556|NCT00900627|471623914|FG001|Overall Study|Adverse Event|2|||
130998557|NCT00900627|471623915|FG002|Overall Study|Adverse Event|0|||
130998558|NCT00900627|471623916|FG003|Overall Study|Adverse Event|3|||
130998559|NCT00900627|471623917|FG004|Overall Study|Adverse Event|0|||
130998560|NCT00900627|471623918|FG005|Overall Study|Adverse Event|0|||
130998561|NCT00900627|471623913|FG000|Overall Study|Death|0|||
130998562|NCT00900627|471623914|FG001|Overall Study|Death|0|||
130998563|NCT00900627|471623915|FG002|Overall Study|Death|0|||
130998564|NCT00900627|471623916|FG003|Overall Study|Death|0|||
130998565|NCT00900627|471623917|FG004|Overall Study|Death|28|||
130998566|NCT00900627|471623918|FG005|Overall Study|Death|24|||
130998567|NCT00373295|471623919|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130998568|NCT00373295|471623920|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
130998569|NCT00373295|471623921|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130998570|NCT00373295|471623922|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130998571|NCT00373295|471623923|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
130998572|NCT00373295|471623924|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130998573|NCT01642186|471623925|FG000|Overall Study|Death|0|||
130998574|NCT01642186|471623926|FG001|Overall Study|Death|2|||
130998575|NCT01642186|471623927|FG002|Overall Study|Death|2|||
130998576|NCT01642186|471623925|FG000|Overall Study|Lost to Follow-up|0|||
130998577|NCT01642186|471623926|FG001|Overall Study|Lost to Follow-up|0|||
130998578|NCT01642186|471623927|FG002|Overall Study|Lost to Follow-up|1|||
130998579|NCT00506285|471623934|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
130998580|NCT00506285|471623935|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
130998581|NCT00506285|471623934|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
130998582|NCT00506285|471623935|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
130998583|NCT00506285|471623934|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
130998584|NCT00506285|471623935|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
130998585|NCT00506285|471623934|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
130998586|NCT00506285|471623935|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
130998587|NCT00506285|471623934|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
130998588|NCT00506285|471623935|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
130998589|NCT01089556|471623936|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
130998590|NCT01089556|471623937|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
130998591|NCT01089556|471623938|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
130998592|NCT01089556|471623939|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
130998593|NCT01089556|471623940|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
130998594|NCT01089556|471623941|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
130998595|NCT01089556|471623936|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
130998596|NCT01089556|471623937|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
130998597|NCT01089556|471623938|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
130998598|NCT01089556|471623939|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
130998599|NCT01089556|471623940|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
130998600|NCT01089556|471623941|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
130998601|NCT01089556|471623936|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
130998602|NCT01089556|471623937|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
130998603|NCT01089556|471623938|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
130998604|NCT01089556|471623939|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
130998605|NCT01089556|471623940|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
130998606|NCT01089556|471623941|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
130998607|NCT01089556|471623936|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
130998608|NCT01089556|471623937|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
130998609|NCT01089556|471623938|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
130998610|NCT01089556|471623939|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
130998611|NCT01089556|471623940|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
130884361|NCT00684021|471211473|FG000|Overall Study|MRI not performed|0|||
130884362|NCT00684021|471211474|FG001|Overall Study|MRI not performed|1|||
130998612|NCT01089556|471623941|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
130998613|NCT01089556|471623936|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
130998614|NCT01089556|471623937|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
130998615|NCT01089556|471623938|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
130884363|NCT00684021|471211475|FG002|Overall Study|MRI not performed|1|||
130884364|NCT00684021|471211476|FG003|Overall Study|MRI not performed|2|||
130998616|NCT01089556|471623939|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
130998617|NCT01089556|471623940|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
130998618|NCT01089556|471623941|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
130998619|NCT01089556|471623936|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
130998620|NCT01089556|471623937|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
130998621|NCT01089556|471623938|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
130998622|NCT01089556|471623939|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
130998623|NCT01089556|471623940|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
130998624|NCT01089556|471623941|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
130998625|NCT01089556|471623936|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
130998626|NCT01089556|471623937|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
130998627|NCT01089556|471623938|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
130998628|NCT01089556|471623939|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
130998629|NCT01089556|471623940|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
130998630|NCT01089556|471623941|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
130998631|NCT01089556|471623936|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
130998632|NCT01089556|471623937|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
130998633|NCT01089556|471623938|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
130998634|NCT01089556|471623939|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
130998635|NCT01089556|471623940|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
130998636|NCT01089556|471623941|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
130998637|NCT01089556|471623936|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
130998638|NCT01089556|471623937|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
130998639|NCT01089556|471623938|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
130998640|NCT01089556|471623939|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
130998641|NCT01089556|471623940|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
130998642|NCT01089556|471623941|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
130998643|NCT01089556|471623936|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
130998644|NCT01089556|471623937|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
130998645|NCT01089556|471623938|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
130998646|NCT01089556|471623939|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
130998647|NCT01089556|471623940|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
130998648|NCT01089556|471623941|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
130998649|NCT01089556|471623936|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
130998650|NCT01089556|471623937|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
130998651|NCT01089556|471623938|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
130998652|NCT01089556|471623939|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
130998653|NCT01089556|471623940|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
130998654|NCT01089556|471623941|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
130998655|NCT01089556|471623936|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
130998656|NCT01089556|471623937|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
130998657|NCT01089556|471623938|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
130998658|NCT01089556|471623939|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
130998659|NCT01089556|471623940|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
130998660|NCT01089556|471623941|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
130998661|NCT01089556|471623936|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
130998662|NCT01089556|471623937|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
130998663|NCT01089556|471623938|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
130998664|NCT01089556|471623939|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
130998665|NCT01089556|471623940|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
130998666|NCT01089556|471623941|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
130998667|NCT01089556|471623936|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
130998668|NCT01089556|471623937|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
130998669|NCT01089556|471623938|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
130998670|NCT01089556|471623939|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
130998671|NCT01089556|471623940|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
130998672|NCT01089556|471623941|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
130998673|NCT01089556|471623936|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
130998674|NCT01089556|471623937|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
130998675|NCT01089556|471623938|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
130998676|NCT01089556|471623939|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
130998677|NCT01089556|471623940|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
130998678|NCT01089556|471623941|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
130998679|NCT01238575|471623942|FG000|Overall Study|Lack of Efficacy|2|||
130998680|NCT01238575|471623943|FG001|Overall Study|Lack of Efficacy|4|||
130998681|NCT01238575|471623942|FG000|Overall Study|Adverse Event|2|||
130998682|NCT01238575|471623943|FG001|Overall Study|Adverse Event|0|||
130998683|NCT00962585|471623948|FG000|Overall Study|Adverse Event|0|||
130998684|NCT00962585|471623949|FG001|Overall Study|Adverse Event|2|||
130998685|NCT00962585|471623950|FG002|Overall Study|Adverse Event|1|||
130998686|NCT00962585|471623951|FG003|Overall Study|Adverse Event|0|||
130998687|NCT00962585|471623948|FG000|Overall Study|Lost to Follow-up|3|||
130998688|NCT00962585|471623949|FG001|Overall Study|Lost to Follow-up|0|||
130998689|NCT00962585|471623950|FG002|Overall Study|Lost to Follow-up|1|||
130998690|NCT00962585|471623951|FG003|Overall Study|Lost to Follow-up|0|||
130998691|NCT00962585|471623948|FG000|Overall Study|Protocol Violation|0|||
130998692|NCT00962585|471623949|FG001|Overall Study|Protocol Violation|0|||
130998693|NCT00962585|471623950|FG002|Overall Study|Protocol Violation|1|||
130998694|NCT00962585|471623951|FG003|Overall Study|Protocol Violation|0|||
130998695|NCT00962585|471623948|FG000|Overall Study|Withdrawal by Subject|1|||
130998696|NCT00962585|471623949|FG001|Overall Study|Withdrawal by Subject|0|||
130998697|NCT00962585|471623950|FG002|Overall Study|Withdrawal by Subject|0|||
130998698|NCT00962585|471623951|FG003|Overall Study|Withdrawal by Subject|0|||
130998699|NCT00962585|471623948|FG000|Overall Study|Withdrew Consent|2|||
130998700|NCT00962585|471623949|FG001|Overall Study|Withdrew Consent|0|||
130998701|NCT00962585|471623950|FG002|Overall Study|Withdrew Consent|0|||
130998702|NCT00962585|471623951|FG003|Overall Study|Withdrew Consent|0|||
130998703|NCT02254421|471623954|FG000|Overall Study|Randomized but Not Treated|1|||
130998704|NCT02254421|471623955|FG001|Overall Study|Randomized but Not Treated|0|||
130998705|NCT02254421|471623954|FG000|Overall Study|Death|0|||
130998706|NCT02254421|471623955|FG001|Overall Study|Death|2|||
130998707|NCT02254421|471623954|FG000|Overall Study|Withdrew Consent|1|||
130998708|NCT02254421|471623955|FG001|Overall Study|Withdrew Consent|1|||
130998709|NCT00839917|471623960|FG000|Overall Study|Lost to Follow-up|1|||
130998710|NCT00839917|471623961|FG001|Overall Study|Lost to Follow-up|0|||
130998711|NCT00839917|471623960|FG000|Overall Study|Did not receive vaccine|0|||
130998712|NCT00839917|471623961|FG001|Overall Study|Did not receive vaccine|1|||
130998713|NCT00867490|471623962|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
130998714|NCT00867490|471623962|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
130998715|NCT00867490|471623962|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
130998716|NCT00867490|471623962|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
130998717|NCT00867490|471623962|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
130998718|NCT01950273|471623963|FG000|Overall Study|Protocol Violation|1|||
130998719|NCT01950273|471623964|FG001|Overall Study|Protocol Violation|0|||
130998720|NCT01950273|471623963|FG000|Overall Study|Withdrawal by Subject|2|||
130998721|NCT01950273|471623964|FG001|Overall Study|Withdrawal by Subject|0|||
130998722|NCT01950273|471623963|FG000|Overall Study|Other not defined above|1|||
130998723|NCT01950273|471623964|FG001|Overall Study|Other not defined above|0|||
130998724|NCT00472186|471623965|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
130998725|NCT00472186|471623966|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
130998726|NCT03354637|471623971|FG000|Double-blind Period|Protocol Violation|2|||
130998727|NCT03354637|471623972|FG001|Double-blind Period|Protocol Violation|0|||
130998728|NCT03354637|471623973|FG002|Double-blind Period|Protocol Violation|0|||
130998729|NCT03354637|471623971|FG000|Double-blind Period|Adverse Event|1|||
130998730|NCT03354637|471623972|FG001|Double-blind Period|Adverse Event|2|||
130998731|NCT03354637|471623973|FG002|Double-blind Period|Adverse Event|0|||
130998732|NCT03354637|471623971|FG000|Double-blind Period|Lost to Follow-up|3|||
130998733|NCT03354637|471623972|FG001|Double-blind Period|Lost to Follow-up|4|||
130998734|NCT03354637|471623973|FG002|Double-blind Period|Lost to Follow-up|3|||
130998735|NCT03354637|471623971|FG000|Double-blind Period|Withdrawal by Subject|10|||
130998736|NCT03354637|471623972|FG001|Double-blind Period|Withdrawal by Subject|6|||
130998737|NCT03354637|471623973|FG002|Double-blind Period|Withdrawal by Subject|4|||
130998738|NCT03354637|471623971|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
130998739|NCT03354637|471623972|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
130998740|NCT03354637|471623973|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
130998741|NCT03354637|471623971|FG000|Open Label Extension|Adverse Event|0|||
130998742|NCT03354637|471623972|FG001|Open Label Extension|Adverse Event|0|||
130998743|NCT03354637|471623973|FG002|Open Label Extension|Adverse Event|1|||
130998744|NCT03354637|471623971|FG000|Open Label Extension|Lost to Follow-up|0|||
130998745|NCT03354637|471623972|FG001|Open Label Extension|Lost to Follow-up|0|||
130998746|NCT03354637|471623973|FG002|Open Label Extension|Lost to Follow-up|2|||
130998747|NCT03354637|471623971|FG000|Open Label Extension|Withdrawal by Subject|0|||
130998748|NCT03354637|471623972|FG001|Open Label Extension|Withdrawal by Subject|0|||
130998749|NCT03354637|471623973|FG002|Open Label Extension|Withdrawal by Subject|5|||
130998750|NCT03354637|471623971|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
130998751|NCT03354637|471623972|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
130998752|NCT03354637|471623973|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
130998753|NCT03354637|471623971|FG000|Open Label Extension|Subject Noncompliance|0|||
130998754|NCT03354637|471623972|FG001|Open Label Extension|Subject Noncompliance|0|||
130998755|NCT03354637|471623973|FG002|Open Label Extension|Subject Noncompliance|1|||
130998756|NCT03354637|471623971|FG000|Open Label Extension|Lack of Efficacy|0|||
130998757|NCT03354637|471623972|FG001|Open Label Extension|Lack of Efficacy|0|||
130998758|NCT03354637|471623973|FG002|Open Label Extension|Lack of Efficacy|1|||
130998759|NCT03354637|471623971|FG000|Open Label Extension|Physician Decision|0|||
130998760|NCT03354637|471623972|FG001|Open Label Extension|Physician Decision|0|||
130998761|NCT03354637|471623973|FG002|Open Label Extension|Physician Decision|1|||
130998762|NCT02564055|471623977|FG000|Overall Study|Adverse Event|1|||
130998763|NCT02564055|471623978|FG001|Overall Study|Adverse Event|0|||
130998764|NCT02564055|471623979|FG002|Overall Study|Adverse Event|4|||
130998765|NCT02564055|471623980|FG003|Overall Study|Adverse Event|1|||
130998766|NCT02564055|471623981|FG004|Overall Study|Adverse Event|4|||
130998767|NCT02564055|471623982|FG005|Overall Study|Adverse Event|1|||
130998768|NCT02564055|471623977|FG000|Overall Study|Protocol Violation|1|||
130998769|NCT02564055|471623978|FG001|Overall Study|Protocol Violation|0|||
130998770|NCT02564055|471623979|FG002|Overall Study|Protocol Violation|0|||
130998771|NCT02564055|471623980|FG003|Overall Study|Protocol Violation|0|||
130998772|NCT02564055|471623981|FG004|Overall Study|Protocol Violation|0|||
130998773|NCT02564055|471623982|FG005|Overall Study|Protocol Violation|0|||
130998774|NCT02564055|471623977|FG000|Overall Study|Reached stopping criteria|0|||
130998775|NCT02564055|471623978|FG001|Overall Study|Reached stopping criteria|0|||
130998776|NCT02564055|471623979|FG002|Overall Study|Reached stopping criteria|0|||
130998777|NCT02564055|471623980|FG003|Overall Study|Reached stopping criteria|0|||
130998778|NCT02564055|471623981|FG004|Overall Study|Reached stopping criteria|0|||
130998779|NCT02564055|471623982|FG005|Overall Study|Reached stopping criteria|1|||
130998780|NCT02564055|471623977|FG000|Overall Study|Lost to Follow-up|0|||
130998781|NCT02564055|471623978|FG001|Overall Study|Lost to Follow-up|1|||
130998782|NCT02564055|471623979|FG002|Overall Study|Lost to Follow-up|4|||
130998783|NCT02564055|471623980|FG003|Overall Study|Lost to Follow-up|2|||
130998784|NCT02564055|471623981|FG004|Overall Study|Lost to Follow-up|1|||
130998785|NCT02564055|471623982|FG005|Overall Study|Lost to Follow-up|0|||
130998786|NCT02564055|471623977|FG000|Overall Study|Physician Decision|0|||
130998787|NCT02564055|471623978|FG001|Overall Study|Physician Decision|0|||
130998788|NCT02564055|471623979|FG002|Overall Study|Physician Decision|1|||
130998789|NCT02564055|471623980|FG003|Overall Study|Physician Decision|0|||
130998790|NCT02564055|471623981|FG004|Overall Study|Physician Decision|0|||
130998791|NCT02564055|471623982|FG005|Overall Study|Physician Decision|0|||
130998792|NCT02564055|471623977|FG000|Overall Study|Withdrawal by Subject|4|||
130998793|NCT02564055|471623978|FG001|Overall Study|Withdrawal by Subject|4|||
130998794|NCT02564055|471623979|FG002|Overall Study|Withdrawal by Subject|3|||
130998795|NCT02564055|471623980|FG003|Overall Study|Withdrawal by Subject|3|||
130998796|NCT02564055|471623981|FG004|Overall Study|Withdrawal by Subject|10|||
130998797|NCT02564055|471623982|FG005|Overall Study|Withdrawal by Subject|10|||
130998798|NCT04747275|471623983|FG000|Overall Study|Study terminated|0|||
130998799|NCT04747275|471623984|FG001|Overall Study|Study terminated|1|||
130998800|NCT03268590|471623988|FG000|Overall Study|Previously unknown exclusion criteria|1|||
130998801|NCT00531011|471623989|FG000|Overall Study|Withdrawal by Subject|2|||
130998802|NCT00531011|471623990|FG001|Overall Study|Withdrawal by Subject|4|||
130998803|NCT00531011|471623989|FG000|Overall Study|Death|1|||
130998804|NCT00531011|471623990|FG001|Overall Study|Death|0|||
130998805|NCT00531011|471623989|FG000|Overall Study|Lost to Follow-up|1|||
130998806|NCT00531011|471623990|FG001|Overall Study|Lost to Follow-up|0|||
130998807|NCT00531011|471623989|FG000|Overall Study|Physician Decision|0|||
130998808|NCT00531011|471623990|FG001|Overall Study|Physician Decision|3|||
130998809|NCT02139982|471623993|FG000|Overall Study|Lack of Efficacy|0|||
130998810|NCT02139982|471623994|FG001|Overall Study|Lack of Efficacy|1|||
130998811|NCT02139982|471623995|FG002|Overall Study|Lack of Efficacy|0|||
130998812|NCT02139982|471623996|FG003|Overall Study|Lack of Efficacy|1|||
130998813|NCT02139982|471623997|FG004|Overall Study|Lack of Efficacy|0|||
130884365|NCT00684021|471211473|FG000|Overall Study|Death|1|||
130884366|NCT00684021|471211474|FG001|Overall Study|Death|0|||
130884367|NCT00684021|471211475|FG002|Overall Study|Death|0|||
130998814|NCT02139982|471623998|FG005|Overall Study|Lack of Efficacy|0|||
130998815|NCT02139982|471623999|FG006|Overall Study|Lack of Efficacy|0|||
130998816|NCT02139982|471624000|FG007|Overall Study|Lack of Efficacy|0|||
130998817|NCT02139982|471624001|FG008|Overall Study|Lack of Efficacy|0|||
130998818|NCT02139982|471624002|FG009|Overall Study|Lack of Efficacy|0|||
130998819|NCT02206152|471624025|FG000|Pre-Randomization|Withdrawal by Subject|2|||
130998820|NCT00478608|471624026|FG000|Overall Study|Adverse Event|1|||
130998821|NCT00478608|471624026|FG000|Overall Study|Serious Adverse Event|14|||
130884368|NCT00684021|471211476|FG003|Overall Study|Death|0|||
130998822|NCT00478608|471624026|FG000|Overall Study|Withdrawal by Subject|2|||
130998823|NCT00478608|471624026|FG000|Overall Study|Protocol Violation|3|||
130998824|NCT01591460|471624032|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
130998825|NCT01591460|471624032|FG000|Overall Study|Futility Rule (Week 12)|7|||
130998826|NCT01591460|471624032|FG000|Overall Study|Futility Rule (Week 24)|3|||
130998827|NCT01591460|471624032|FG000|Overall Study|Rebound or Breakthrough|3|||
130998828|NCT01591460|471624032|FG000|Overall Study|Treatment Discontinued by Error|1|||
130884369|NCT00927953|471211477|FG000|Overall Study|Death|2|||
130998829|NCT01591460|471624032|FG000|Overall Study|Lost to Follow-up|1|||
130884370|NCT00927953|471211478|FG001|Overall Study|Death|1|||
130998830|NCT01591460|471624032|FG000|Overall Study|Noncompliance|1|||
130884371|NCT04041414|471211479|FG000|Overall Study|Lost to Follow-up|1|||
130884372|NCT04041414|471211480|FG001|Overall Study|Lost to Follow-up|2|||
130884373|NCT02900378|471211481|FG000|Randomization (Visit 2)|Adverse Event|14|||
130884374|NCT02900378|471211482|FG001|Randomization (Visit 2)|Adverse Event|11|||
130884375|NCT02900378|471211481|FG000|Randomization (Visit 2)|Death|1|||
130884376|NCT02900378|471211482|FG001|Randomization (Visit 2)|Death|4|||
130884377|NCT02900378|471211481|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
130884378|NCT02900378|471211482|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
130884379|NCT02900378|471211481|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
130884380|NCT02900378|471211482|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
130884381|NCT02900378|471211481|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
130884382|NCT02900378|471211482|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
130884383|NCT02900378|471211481|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
130884384|NCT02900378|471211482|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
130884385|NCT02900378|471211481|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
130884386|NCT02900378|471211482|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
130884387|NCT01249261|471211496|FG000|Overall Study|Withdrawal by Subject|1|||
130884388|NCT01249261|471211497|FG001|Overall Study|Withdrawal by Subject|0|||
130884389|NCT00482053|471211501|FG000|Inter-treatment Period|Disease progression|1|||
130884390|NCT01690143|471211505|FG000|Overall Study|Withdrawal by Subject|1|||
130884391|NCT03113487|471211508|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
130884392|NCT00391586|471211511|FG000|Overall Study|Progressive disease|13|||
130884393|NCT00391586|471211511|FG000|Overall Study|Adverse Event|5|||
130884394|NCT00391586|471211511|FG000|Overall Study|Physician Decision|2|||
130884395|NCT00391586|471211511|FG000|Overall Study|Death|4|||
130884396|NCT02072668|471211516|FG000|Second Intervention|Lost to Follow-up|1|||
130884397|NCT02072668|471211517|FG001|Second Intervention|Lost to Follow-up|0|||
130884398|NCT01658436|471211522|FG000|Overall Study|Adverse Event|6|||
130884399|NCT01658436|471211523|FG001|Overall Study|Adverse Event|5|||
130884400|NCT01658436|471211522|FG000|Overall Study|Physician Decision|1|||
130884401|NCT01658436|471211523|FG001|Overall Study|Physician Decision|0|||
130884402|NCT01658436|471211522|FG000|Overall Study|Progressive disease|12|||
130884403|NCT01658436|471211523|FG001|Overall Study|Progressive disease|4|||
130884404|NCT01658436|471211522|FG000|Overall Study|Study terminated by sponsor|0|||
130884405|NCT01658436|471211523|FG001|Overall Study|Study terminated by sponsor|1|||
130884406|NCT01658436|471211522|FG000|Overall Study|Subject/guardian decision|0|||
130884407|NCT01658436|471211523|FG001|Overall Study|Subject/guardian decision|1|||
130884408|NCT01658436|471211522|FG000|Overall Study|Death|1|||
130884409|NCT01658436|471211523|FG001|Overall Study|Death|0|||
130884410|NCT00686712|471211524|FG000|Overall Study|Protocol Violation|8|||
130884411|NCT00686712|471211525|FG001|Overall Study|Protocol Violation|8|||
130884412|NCT00686712|471211526|FG002|Overall Study|Protocol Violation|10|||
130884413|NCT00686712|471211524|FG000|Overall Study|Lost to Follow-up|1|||
130884414|NCT00686712|471211525|FG001|Overall Study|Lost to Follow-up|2|||
130884415|NCT00686712|471211526|FG002|Overall Study|Lost to Follow-up|3|||
130884416|NCT00686712|471211524|FG000|Overall Study|Adverse Event|1|||
130884417|NCT00686712|471211525|FG001|Overall Study|Adverse Event|1|||
130884418|NCT00686712|471211526|FG002|Overall Study|Adverse Event|0|||
130884419|NCT03987503|471211527|FG000|Overall Study|Lost to Follow-up|20|||
130884420|NCT03987503|471211527|FG000|Overall Study|Withdrawal by Subject|2|||
130884421|NCT03058146|471211528|FG000|Overall Study|Withdrawal by Subject|4|||
130884422|NCT03058146|471211529|FG001|Overall Study|Withdrawal by Subject|1|||
130884423|NCT03058146|471211528|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
130884424|NCT03058146|471211529|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
130884425|NCT00515619|471211534|FG000|Overall Study|Adverse Event|34|||
130884426|NCT00515619|471211534|FG000|Overall Study|Lack of Efficacy|92|||
130884427|NCT00515619|471211534|FG000|Overall Study|Withdrawal by Subject|66|||
130884428|NCT00515619|471211534|FG000|Overall Study|Protocol Violation|3|||
130884429|NCT00515619|471211534|FG000|Overall Study|Lost to Follow-up|4|||
130884430|NCT00515619|471211534|FG000|Overall Study|Unsatisfactory compliance|6|||
130884431|NCT00515619|471211534|FG000|Overall Study|Other: Site discontinuing trials|2|||
130884432|NCT00515619|471211534|FG000|Overall Study|Other: Subject cannot attend visits|2|||
130884433|NCT00515619|471211534|FG000|Overall Study|Other: Subject required surgery|1|||
130884434|NCT00515619|471211534|FG000|Overall Study|Other: Subject moved to another country|1|||
130884435|NCT00515619|471211534|FG000|Overall Study|Other: Investigator decision|1|||
130884436|NCT00515619|471211534|FG000|Overall Study|Other: Subject became pregnant|1|||
130884437|NCT00515619|471211534|FG000|Overall Study|Other: Request from sponsor|1|||
130884438|NCT00515619|471211534|FG000|Overall Study|Other: Drug available on license|1|||
130884439|NCT00515619|471211534|FG000|Overall Study|Other: Subject interested in other AED|1|||
130884440|NCT01467960|471211535|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
130884441|NCT01467960|471211536|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
130998831|NCT01591460|471624032|FG000|Overall Study|Participant Refusal|3|||
130998832|NCT01591460|471624032|FG000|Overall Study|Withdrawal by Subject|1|||
130998833|NCT01591460|471624032|FG000|Overall Study|Protocol Violation|1|||
130998834|NCT03230864|471624033|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
130998835|NCT03230864|471624034|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
130998836|NCT03230864|471624035|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
130998837|NCT03230864|471624036|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
130998838|NCT03230864|471624033|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130998839|NCT03230864|471624034|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
130998840|NCT03230864|471624035|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130998841|NCT03230864|471624036|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130998842|NCT03230864|471624033|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
130998843|NCT03230864|471624034|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
130998844|NCT03230864|471624035|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130998845|NCT03230864|471624036|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130998846|NCT03230864|471624033|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
130998847|NCT03230864|471624034|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
130998848|NCT03230864|471624035|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130998849|NCT03230864|471624036|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130998850|NCT03230864|471624033|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
130998851|NCT03230864|471624034|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
130998852|NCT03230864|471624035|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
130998853|NCT03230864|471624036|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
130998854|NCT03230864|471624033|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
130998855|NCT03230864|471624034|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
130998856|NCT03230864|471624035|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
130998857|NCT03230864|471624036|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
130998858|NCT03230864|471624033|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
130998859|NCT03230864|471624034|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
130998860|NCT03230864|471624035|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
130998861|NCT03230864|471624036|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
130998862|NCT03230864|471624033|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
130998863|NCT03230864|471624034|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
130998864|NCT03230864|471624035|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
130998865|NCT03230864|471624036|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
130998866|NCT03230864|471624033|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130998867|NCT03230864|471624034|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130998868|NCT03230864|471624035|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
130998869|NCT03230864|471624036|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
130998870|NCT03230864|471624033|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
130998871|NCT03230864|471624034|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
130998872|NCT03230864|471624035|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
130998873|NCT03230864|471624036|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
130998874|NCT00432679|471624043|FG000|Overall Study|Adverse Event|2|||
130998875|NCT00432679|471624044|FG001|Overall Study|Adverse Event|1|||
130998876|NCT00432679|471624043|FG000|Overall Study|Withdrawal by Subject|3|||
130998877|NCT00432679|471624044|FG001|Overall Study|Withdrawal by Subject|2|||
130998878|NCT01744496|471624045|FG000|Titration Period|Adverse Event|2|||
130998879|NCT01744496|471624046|FG001|Titration Period|Adverse Event|1|||
130998880|NCT01744496|471624045|FG000|Titration Period|Personal reasons|0|||
130998881|NCT01744496|471624046|FG001|Titration Period|Personal reasons|1|||
130998882|NCT01744496|471624045|FG000|Maintenance Period|Adverse Event|1|||
130998883|NCT01744496|471624046|FG001|Maintenance Period|Adverse Event|3|||
130998884|NCT01744496|471624045|FG000|Maintenance Period|Protocol Violation|1|||
130998885|NCT01744496|471624046|FG001|Maintenance Period|Protocol Violation|0|||
130998886|NCT01744496|471624045|FG000|Maintenance Period|Withdrawal by Subject|1|||
130998887|NCT01744496|471624046|FG001|Maintenance Period|Withdrawal by Subject|1|||
130998888|NCT01744496|471624045|FG000|Maintenance Period|Subject left town|1|||
130998889|NCT01744496|471624046|FG001|Maintenance Period|Subject left town|0|||
130998890|NCT02374593|471624051|FG000|Overall Study|non-compliant|2|||
130998891|NCT02374593|471624052|FG001|Overall Study|non-compliant|0|||
130998892|NCT00579982|471624054|FG000|Overall Study|Adverse Event|4|||
130998893|NCT00579982|471624054|FG000|Overall Study|Protocol Violation|4|||
130998894|NCT04827134|471624055|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
130998895|NCT04827134|471624056|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
130998896|NCT04827134|471624057|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
130998897|NCT04827134|471624058|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
130998898|NCT00287469|471624065|FG000|Overall Study|serious adverse event|1|||
130998899|NCT00287469|471624066|FG001|Overall Study|serious adverse event|6|||
130998900|NCT00287469|471624065|FG000|Overall Study|Adverse Event|1|||
130998901|NCT00287469|471624066|FG001|Overall Study|Adverse Event|1|||
130998902|NCT00287469|471624065|FG000|Overall Study|moved from area|144|||
130998903|NCT00287469|471624066|FG001|Overall Study|moved from area|138|||
130998904|NCT00287469|471624065|FG000|Overall Study|Lost to Follow-up|74|||
130998905|NCT00287469|471624066|FG001|Overall Study|Lost to Follow-up|69|||
130998906|NCT00065468|471624067|FG000|Overall Study|Death|172|||
130998907|NCT00065468|471624068|FG001|Overall Study|Death|169|||
130998908|NCT00065468|471624069|FG002|Overall Study|Death|171|||
130998909|NCT00065468|471624067|FG000|Overall Study|Withdrawal by Subject|3|||
130998910|NCT00065468|471624068|FG001|Overall Study|Withdrawal by Subject|4|||
130998911|NCT00065468|471624069|FG002|Overall Study|Withdrawal by Subject|5|||
130998912|NCT00065468|471624067|FG000|Overall Study|Lost to Follow-up|5|||
130998913|NCT00065468|471624068|FG001|Overall Study|Lost to Follow-up|3|||
130998914|NCT00065468|471624069|FG002|Overall Study|Lost to Follow-up|2|||
130998915|NCT00065468|471624067|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
130998916|NCT00065468|471624068|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
130998917|NCT00065468|471624069|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
130998918|NCT00065468|471624067|FG000|Overall Study|Disease progression|0|||
130998919|NCT00065468|471624068|FG001|Overall Study|Disease progression|0|||
130998920|NCT00065468|471624069|FG002|Overall Study|Disease progression|1|||
130884442|NCT01467960|471211537|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
130998921|NCT00065468|471624067|FG000|Overall Study|Other|14|||
130998922|NCT00065468|471624068|FG001|Overall Study|Other|24|||
130998923|NCT00065468|471624069|FG002|Overall Study|Other|18|||
130998924|NCT01225835|471624070|FG000|Overall Study|Completed protocol|2|||
130998925|NCT01225835|471624071|FG001|Overall Study|Completed protocol|1|||
130998926|NCT01225835|471624070|FG000|Overall Study|Did not meet hCG criterion|2|||
130998927|NCT01225835|471624071|FG001|Overall Study|Did not meet hCG criterion|0|||
130998928|NCT01225835|471624070|FG000|Overall Study|Adverse Event|2|||
130998929|NCT01225835|471624071|FG001|Overall Study|Adverse Event|1|||
130998930|NCT01225835|471624070|FG000|Overall Study|Other|1|||
130998931|NCT01225835|471624071|FG001|Overall Study|Other|1|||
130998932|NCT00507026|471624077|FG000|Overall Study|Lack of Efficacy|6|||
130998933|NCT00507026|471624078|FG001|Overall Study|Lack of Efficacy|4|||
130998934|NCT00507026|471624079|FG002|Overall Study|Lack of Efficacy|21|||
130998935|NCT00507026|471624077|FG000|Overall Study|Withdrawal by Subject|2|||
130998936|NCT00507026|471624078|FG001|Overall Study|Withdrawal by Subject|0|||
130998937|NCT00507026|471624079|FG002|Overall Study|Withdrawal by Subject|0|||
130998938|NCT00507026|471624077|FG000|Overall Study|Investigator Decision|1|||
130998939|NCT00507026|471624078|FG001|Overall Study|Investigator Decision|0|||
130998940|NCT00507026|471624079|FG002|Overall Study|Investigator Decision|0|||
130998941|NCT00507026|471624077|FG000|Overall Study|Adverse Event|2|||
130998942|NCT00507026|471624078|FG001|Overall Study|Adverse Event|0|||
130998943|NCT00507026|471624079|FG002|Overall Study|Adverse Event|0|||
130998944|NCT00507026|471624077|FG000|Overall Study|Protocol Violation|1|||
130998945|NCT00507026|471624078|FG001|Overall Study|Protocol Violation|0|||
130998946|NCT00507026|471624079|FG002|Overall Study|Protocol Violation|0|||
130998947|NCT00507026|471624077|FG000|Overall Study|Other|1|||
130998948|NCT00507026|471624078|FG001|Overall Study|Other|0|||
130998949|NCT00507026|471624079|FG002|Overall Study|Other|0|||
130998950|NCT02372058|471624080|FG000|Overall Study|Withdrawal by Subject|3|||
130998951|NCT03523871|471624083|FG000|Overall Study|Death|1|||
130998952|NCT00972179|471624085|FG000|Overall Study|Noncompliance|1|||
130998953|NCT00972179|471624086|FG001|Overall Study|Noncompliance|0|||
130998954|NCT00972179|471624087|FG002|Overall Study|Noncompliance|0|||
130998955|NCT00972179|471624088|FG003|Overall Study|Noncompliance|0|||
130998956|NCT00972179|471624089|FG004|Overall Study|Noncompliance|1|||
130998957|NCT00972179|471624090|FG005|Overall Study|Noncompliance|0|||
130998958|NCT00972179|471624091|FG006|Overall Study|Noncompliance|1|||
130998959|NCT00972179|471624085|FG000|Overall Study|Withdrawal by Subject|0|||
130998960|NCT00972179|471624086|FG001|Overall Study|Withdrawal by Subject|3|||
130998961|NCT00972179|471624087|FG002|Overall Study|Withdrawal by Subject|0|||
130998962|NCT00972179|471624088|FG003|Overall Study|Withdrawal by Subject|1|||
130998963|NCT00972179|471624089|FG004|Overall Study|Withdrawal by Subject|0|||
130998964|NCT00972179|471624090|FG005|Overall Study|Withdrawal by Subject|0|||
130998965|NCT00972179|471624091|FG006|Overall Study|Withdrawal by Subject|2|||
130998966|NCT00972179|471624085|FG000|Overall Study|Administrative Decision|0|||
130998967|NCT00972179|471624086|FG001|Overall Study|Administrative Decision|0|||
130998968|NCT00972179|471624087|FG002|Overall Study|Administrative Decision|0|||
130998969|NCT00972179|471624088|FG003|Overall Study|Administrative Decision|0|||
130998970|NCT00972179|471624089|FG004|Overall Study|Administrative Decision|1|||
130998971|NCT00972179|471624090|FG005|Overall Study|Administrative Decision|0|||
130998972|NCT00972179|471624091|FG006|Overall Study|Administrative Decision|0|||
130998973|NCT00972179|471624085|FG000|Overall Study|Lost to Follow-up|0|||
130998974|NCT00972179|471624086|FG001|Overall Study|Lost to Follow-up|0|||
130998975|NCT00972179|471624087|FG002|Overall Study|Lost to Follow-up|1|||
130998976|NCT00972179|471624088|FG003|Overall Study|Lost to Follow-up|0|||
130998977|NCT00972179|471624089|FG004|Overall Study|Lost to Follow-up|0|||
130998978|NCT00972179|471624090|FG005|Overall Study|Lost to Follow-up|3|||
130998979|NCT00972179|471624091|FG006|Overall Study|Lost to Follow-up|1|||
130998980|NCT01994720|471624092|FG000|Overall Study|Withdrawal by Subject|46|||
130998981|NCT01994720|471624093|FG001|Overall Study|Withdrawal by Subject|56|||
130998982|NCT04285229|471624095|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130998983|NCT04285229|471624096|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130998984|NCT04285229|471624097|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130998985|NCT04285229|471624098|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130998986|NCT04285229|471624099|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130998987|NCT04285229|471624100|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130998988|NCT04285229|471624095|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
130998989|NCT04285229|471624096|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
130998990|NCT04285229|471624097|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
130998991|NCT04285229|471624098|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
130998992|NCT04285229|471624099|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
130998993|NCT04285229|471624100|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
130998994|NCT04285229|471624095|FG000|Extended Treatment Period|Adverse Event|0|||
130998995|NCT04285229|471624096|FG001|Extended Treatment Period|Adverse Event|0|||
130998996|NCT04285229|471624097|FG002|Extended Treatment Period|Adverse Event|0|||
130998997|NCT04285229|471624098|FG003|Extended Treatment Period|Adverse Event|1|||
130998998|NCT04285229|471624099|FG004|Extended Treatment Period|Adverse Event|0|||
130998999|NCT04285229|471624100|FG005|Extended Treatment Period|Adverse Event|0|||
130999000|NCT04285229|471624095|FG000|Extended Treatment Period|Physician Decision|0|||
130999001|NCT04285229|471624096|FG001|Extended Treatment Period|Physician Decision|0|||
130999002|NCT04285229|471624097|FG002|Extended Treatment Period|Physician Decision|1|||
130999003|NCT04285229|471624098|FG003|Extended Treatment Period|Physician Decision|0|||
130884443|NCT01467960|471211538|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
130884444|NCT01467960|471211539|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
130884445|NCT01467960|471211540|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
130884446|NCT03067077|471211541|FG000|Overall Study|Did not receive surgery|4|||
130884447|NCT03067077|471211542|FG001|Overall Study|Did not receive surgery|5|||
130884448|NCT03067077|471211541|FG000|Overall Study|Lost to Follow-up|3|||
130884449|NCT03067077|471211542|FG001|Overall Study|Lost to Follow-up|2|||
130884450|NCT04986904|471211543|FG000|Overall Study|Lost to Follow-up|11|||
130999004|NCT04285229|471624099|FG004|Extended Treatment Period|Physician Decision|0|||
130999005|NCT04285229|471624100|FG005|Extended Treatment Period|Physician Decision|0|||
130999006|NCT04285229|471624095|FG000|Follow-up Period|Adverse Event|0|||
130999007|NCT04285229|471624096|FG001|Follow-up Period|Adverse Event|0|||
130999008|NCT04285229|471624097|FG002|Follow-up Period|Adverse Event|0|||
130999009|NCT04285229|471624098|FG003|Follow-up Period|Adverse Event|0|||
130999010|NCT04285229|471624099|FG004|Follow-up Period|Adverse Event|1|||
130999011|NCT04285229|471624100|FG005|Follow-up Period|Adverse Event|4|||
130999012|NCT04285229|471624095|FG000|Follow-up Period|Withdrawal by Subject|0|||
130999013|NCT04285229|471624096|FG001|Follow-up Period|Withdrawal by Subject|0|||
130999014|NCT04285229|471624097|FG002|Follow-up Period|Withdrawal by Subject|0|||
130999015|NCT04285229|471624098|FG003|Follow-up Period|Withdrawal by Subject|0|||
130999016|NCT04285229|471624099|FG004|Follow-up Period|Withdrawal by Subject|0|||
130999017|NCT04285229|471624100|FG005|Follow-up Period|Withdrawal by Subject|5|||
130999018|NCT04285229|471624095|FG000|Follow-up Period|Covid-19|0|||
130999019|NCT04285229|471624096|FG001|Follow-up Period|Covid-19|0|||
130999020|NCT04285229|471624097|FG002|Follow-up Period|Covid-19|0|||
130999021|NCT04285229|471624098|FG003|Follow-up Period|Covid-19|0|||
130999022|NCT04285229|471624099|FG004|Follow-up Period|Covid-19|0|||
130999023|NCT04285229|471624100|FG005|Follow-up Period|Covid-19|2|||
130999024|NCT04285229|471624095|FG000|Follow-up Period|Physician Decision|0|||
130999025|NCT04285229|471624096|FG001|Follow-up Period|Physician Decision|0|||
130999026|NCT04285229|471624097|FG002|Follow-up Period|Physician Decision|0|||
130999027|NCT04285229|471624098|FG003|Follow-up Period|Physician Decision|0|||
130999028|NCT04285229|471624099|FG004|Follow-up Period|Physician Decision|0|||
130999029|NCT04285229|471624100|FG005|Follow-up Period|Physician Decision|1|||
130999030|NCT02061761|471624101|FG000|Overall Study|Disease progression|2|||
130999031|NCT02061761|471624102|FG001|Overall Study|Disease progression|8|||
130999032|NCT02061761|471624103|FG002|Overall Study|Disease progression|4|||
130999033|NCT02061761|471624104|FG003|Overall Study|Disease progression|5|||
130999034|NCT02061761|471624105|FG004|Overall Study|Disease progression|9|||
130999035|NCT02061761|471624106|FG005|Overall Study|Disease progression|3|||
130999036|NCT02061761|471624107|FG006|Overall Study|Disease progression|1|||
130999037|NCT02061761|471624108|FG007|Overall Study|Disease progression|2|||
130999038|NCT02061761|471624109|FG008|Overall Study|Disease progression|28|||
130999039|NCT02061761|471624101|FG000|Overall Study|Study Drug toxicity|0|||
130999040|NCT02061761|471624102|FG001|Overall Study|Study Drug toxicity|0|||
130999041|NCT02061761|471624103|FG002|Overall Study|Study Drug toxicity|0|||
130999042|NCT02061761|471624104|FG003|Overall Study|Study Drug toxicity|0|||
130999043|NCT02061761|471624105|FG004|Overall Study|Study Drug toxicity|0|||
130999044|NCT02061761|471624106|FG005|Overall Study|Study Drug toxicity|1|||
130999045|NCT02061761|471624107|FG006|Overall Study|Study Drug toxicity|0|||
130999046|NCT02061761|471624108|FG007|Overall Study|Study Drug toxicity|2|||
130999047|NCT02061761|471624109|FG008|Overall Study|Study Drug toxicity|6|||
130999048|NCT02061761|471624101|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
130999049|NCT02061761|471624102|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
130999050|NCT02061761|471624103|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
130999051|NCT02061761|471624104|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
130999052|NCT02061761|471624105|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
130999053|NCT02061761|471624106|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
130999054|NCT02061761|471624107|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
130999055|NCT02061761|471624108|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
130999056|NCT02061761|471624109|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
130999057|NCT02061761|471624101|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130999058|NCT02061761|471624102|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130999059|NCT02061761|471624103|FG002|Overall Study|Participant request to discontinue study treatment|2|||
130999060|NCT02061761|471624104|FG003|Overall Study|Participant request to discontinue study treatment|2|||
130999061|NCT02061761|471624105|FG004|Overall Study|Participant request to discontinue study treatment|0|||
130999062|NCT02061761|471624106|FG005|Overall Study|Participant request to discontinue study treatment|1|||
130999063|NCT02061761|471624107|FG006|Overall Study|Participant request to discontinue study treatment|0|||
130999064|NCT02061761|471624108|FG007|Overall Study|Participant request to discontinue study treatment|0|||
130999065|NCT02061761|471624109|FG008|Overall Study|Participant request to discontinue study treatment|2|||
130999066|NCT02061761|471624101|FG000|Overall Study|Withdrawal by Subject|0|||
130999067|NCT02061761|471624102|FG001|Overall Study|Withdrawal by Subject|0|||
130999068|NCT02061761|471624103|FG002|Overall Study|Withdrawal by Subject|0|||
130999069|NCT02061761|471624104|FG003|Overall Study|Withdrawal by Subject|0|||
130999070|NCT02061761|471624105|FG004|Overall Study|Withdrawal by Subject|0|||
130999071|NCT02061761|471624106|FG005|Overall Study|Withdrawal by Subject|0|||
130999072|NCT02061761|471624107|FG006|Overall Study|Withdrawal by Subject|0|||
130999073|NCT02061761|471624108|FG007|Overall Study|Withdrawal by Subject|0|||
130999074|NCT02061761|471624109|FG008|Overall Study|Withdrawal by Subject|2|||
130999075|NCT02061761|471624101|FG000|Overall Study|Maximum clinical benefit|0|||
130999076|NCT02061761|471624102|FG001|Overall Study|Maximum clinical benefit|0|||
130999077|NCT02061761|471624103|FG002|Overall Study|Maximum clinical benefit|0|||
130999078|NCT02061761|471624104|FG003|Overall Study|Maximum clinical benefit|1|||
130999079|NCT02061761|471624105|FG004|Overall Study|Maximum clinical benefit|0|||
130999080|NCT02061761|471624106|FG005|Overall Study|Maximum clinical benefit|0|||
130999081|NCT02061761|471624107|FG006|Overall Study|Maximum clinical benefit|0|||
130999082|NCT02061761|471624108|FG007|Overall Study|Maximum clinical benefit|0|||
130999083|NCT02061761|471624109|FG008|Overall Study|Maximum clinical benefit|6|||
130999084|NCT02061761|471624101|FG000|Overall Study|Participant no longer meets study criteria|0|||
130999085|NCT02061761|471624102|FG001|Overall Study|Participant no longer meets study criteria|0|||
130999086|NCT02061761|471624103|FG002|Overall Study|Participant no longer meets study criteria|0|||
130999087|NCT02061761|471624104|FG003|Overall Study|Participant no longer meets study criteria|0|||
130999088|NCT02061761|471624105|FG004|Overall Study|Participant no longer meets study criteria|0|||
130999089|NCT02061761|471624106|FG005|Overall Study|Participant no longer meets study criteria|0|||
130999090|NCT02061761|471624107|FG006|Overall Study|Participant no longer meets study criteria|0|||
130999091|NCT02061761|471624108|FG007|Overall Study|Participant no longer meets study criteria|0|||
130999092|NCT02061761|471624109|FG008|Overall Study|Participant no longer meets study criteria|1|||
130999093|NCT02061761|471624101|FG000|Overall Study|Other reasons|0|||
130999094|NCT02061761|471624102|FG001|Overall Study|Other reasons|0|||
130999095|NCT02061761|471624103|FG002|Overall Study|Other reasons|0|||
130999096|NCT02061761|471624104|FG003|Overall Study|Other reasons|0|||
130999097|NCT02061761|471624105|FG004|Overall Study|Other reasons|2|||
130999098|NCT02061761|471624106|FG005|Overall Study|Other reasons|0|||
130999099|NCT02061761|471624107|FG006|Overall Study|Other reasons|0|||
130999100|NCT02061761|471624108|FG007|Overall Study|Other reasons|0|||
130999101|NCT02061761|471624109|FG008|Overall Study|Other reasons|6|||
130999102|NCT03681639|471625940|FG000|Overall Study|Death|4|||
130999103|NCT03681639|471625940|FG000|Overall Study|Lost to Follow-up|2|||
130999104|NCT03681639|471625940|FG000|Overall Study|Withdrawal by Subject|1|||
130999105|NCT03681639|471625940|FG000|Overall Study|Adverse Event|2|||
130999106|NCT00654940|471625941|FG000|Period 1|Adverse Event|0|||
130999107|NCT00654940|471625942|FG001|Period 1|Adverse Event|1|||
130999108|NCT00654940|471625941|FG000|Period 1|Intolerable Pain Level|1|||
130999109|NCT00654940|471625942|FG001|Period 1|Intolerable Pain Level|0|||
130999110|NCT04714216|471625943|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
130999111|NCT04714216|471625943|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
130999112|NCT01818141|471625944|FG000|Overall Study|Withdrawal by Subject|2|||
130999113|NCT01818141|471625945|FG001|Overall Study|Withdrawal by Subject|0|||
130999114|NCT01818141|471625944|FG000|Overall Study|No baseline C.diff colonies|1|||
130999115|NCT01818141|471625945|FG001|Overall Study|No baseline C.diff colonies|1|||
130999116|NCT01818141|471625944|FG000|Overall Study|Lost to Follow-up|0|||
130999117|NCT01818141|471625945|FG001|Overall Study|Lost to Follow-up|2|||
130999118|NCT00742885|471625951|FG000|Overall Study|Lost to Follow-up|1|||
130999119|NCT00742885|471625952|FG001|Overall Study|Lost to Follow-up|0|||
130999120|NCT04781647|471625953|FG000|Overall Study|Study terminated by Sponsor|11|||
130999121|NCT04781647|471625954|FG001|Overall Study|Study terminated by Sponsor|9|||
130999122|NCT04781647|471625955|FG002|Overall Study|Study terminated by Sponsor|9|||
130999123|NCT04781647|471625953|FG000|Overall Study|Withdrawal by Subject|1|||
130999124|NCT04781647|471625954|FG001|Overall Study|Withdrawal by Subject|2|||
130999125|NCT04781647|471625955|FG002|Overall Study|Withdrawal by Subject|0|||
130999126|NCT04781647|471625953|FG000|Overall Study|Adverse Event|0|||
130999127|NCT04781647|471625954|FG001|Overall Study|Adverse Event|1|||
130999128|NCT04781647|471625955|FG002|Overall Study|Adverse Event|1|||
130999129|NCT04781647|471625953|FG000|Overall Study|Protocol Violation|1|||
130999130|NCT04781647|471625954|FG001|Overall Study|Protocol Violation|0|||
130999131|NCT04781647|471625955|FG002|Overall Study|Protocol Violation|0|||
130999132|NCT04781647|471625953|FG000|Overall Study|Pregnancy|0|||
130999133|NCT04781647|471625954|FG001|Overall Study|Pregnancy|0|||
130999134|NCT04781647|471625955|FG002|Overall Study|Pregnancy|1|||
130999135|NCT04781647|471625953|FG000|Overall Study|Virology rebounded|1|||
130999136|NCT04781647|471625954|FG001|Overall Study|Virology rebounded|0|||
130999137|NCT04781647|471625955|FG002|Overall Study|Virology rebounded|0|||
130999138|NCT01755689|471625956|FG000|Overall Study|Withdrawal by Subject|1|||
130999139|NCT01755689|471625957|FG001|Overall Study|Withdrawal by Subject|3|||
130999140|NCT01755689|471625958|FG002|Overall Study|Withdrawal by Subject|2|||
130999141|NCT01755689|471625959|FG003|Overall Study|Withdrawal by Subject|1|||
130999142|NCT01755689|471625960|FG004|Overall Study|Withdrawal by Subject|1|||
130999143|NCT01755689|471625956|FG000|Overall Study|Migrated/moved from study area|0|||
130999144|NCT01755689|471625957|FG001|Overall Study|Migrated/moved from study area|1|||
130999145|NCT01755689|471625958|FG002|Overall Study|Migrated/moved from study area|1|||
130999146|NCT01755689|471625959|FG003|Overall Study|Migrated/moved from study area|1|||
130999147|NCT01755689|471625960|FG004|Overall Study|Migrated/moved from study area|1|||
130999148|NCT01755689|471625956|FG000|Overall Study|Lost to Follow-up|1|||
130999149|NCT01755689|471625957|FG001|Overall Study|Lost to Follow-up|0|||
130999150|NCT01755689|471625958|FG002|Overall Study|Lost to Follow-up|1|||
130999151|NCT01755689|471625959|FG003|Overall Study|Lost to Follow-up|0|||
130999152|NCT01755689|471625960|FG004|Overall Study|Lost to Follow-up|2|||
130999153|NCT01755689|471625956|FG000|Overall Study|Pregnancy|1|||
130999154|NCT01755689|471625957|FG001|Overall Study|Pregnancy|1|||
130999155|NCT01755689|471625958|FG002|Overall Study|Pregnancy|2|||
130999156|NCT01755689|471625959|FG003|Overall Study|Pregnancy|4|||
130999157|NCT01755689|471625960|FG004|Overall Study|Pregnancy|2|||
130999158|NCT03772314|471625962|FG000|Overall Study|Adverse Event|7|||
130999159|NCT03772314|471625963|FG001|Overall Study|Adverse Event|2|||
130999160|NCT01284140|471625968|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
130999161|NCT01284140|471625969|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
130999162|NCT01284140|471625968|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
130999163|NCT01284140|471625969|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
130999164|NCT00088205|471625970|FG000|Overall Study|Adverse Event|4|||
130999165|NCT00088205|471625970|FG000|Overall Study|Progressive Disease|51|||
130999166|NCT00088205|471625970|FG000|Overall Study|Physician Decision|1|||
130999167|NCT00088205|471625970|FG000|Overall Study|Death Due to Study Disease|4|||
130999168|NCT03192215|471625971|FG000|Overall Study|Death|28|||
130999169|NCT03192215|471625972|FG001|Overall Study|Death|23|||
130999170|NCT03192215|471625971|FG000|Overall Study|Lost to Follow-up|10|||
130999171|NCT03192215|471625972|FG001|Overall Study|Lost to Follow-up|15|||
130999172|NCT03192215|471625971|FG000|Overall Study|Withdrawal by Subject|49|||
130999173|NCT03192215|471625972|FG001|Overall Study|Withdrawal by Subject|48|||
130999174|NCT03192215|471625971|FG000|Overall Study|Other as reported in analysis|4|||
130999175|NCT03192215|471625972|FG001|Overall Study|Other as reported in analysis|1|||
130999176|NCT05199233|471625975|FG000|Overall Study|Lack of Efficacy|1|||
130999177|NCT00322374|471625984|FG000|Starting Dose|Physician Decision|2|||
130999178|NCT00322374|471625985|FG001|Starting Dose|Physician Decision|0|||
130999179|NCT00322374|471625986|FG002|Starting Dose|Physician Decision|0|||
130999180|NCT00322374|471625987|FG003|Starting Dose|Physician Decision|0|||
130999181|NCT00322374|471625984|FG000|Starting Dose|Study Drug Toxicity|4|||
130999182|NCT00322374|471625985|FG001|Starting Dose|Study Drug Toxicity|0|||
130999183|NCT00322374|471625986|FG002|Starting Dose|Study Drug Toxicity|0|||
130999184|NCT00322374|471625987|FG003|Starting Dose|Study Drug Toxicity|0|||
130999185|NCT00322374|471625984|FG000|First Escalation|Documented Disease Progression|0|||
130999186|NCT00322374|471625985|FG001|First Escalation|Documented Disease Progression|6|||
130999187|NCT00322374|471625986|FG002|First Escalation|Documented Disease Progression|0|||
130999188|NCT00322374|471625987|FG003|First Escalation|Documented Disease Progression|0|||
130999189|NCT00322374|471625984|FG000|First Escalation|Physician Decision|0|||
130999190|NCT00322374|471625985|FG001|First Escalation|Physician Decision|12|||
130999191|NCT00322374|471625986|FG002|First Escalation|Physician Decision|0|||
130999192|NCT00322374|471625987|FG003|First Escalation|Physician Decision|0|||
130999193|NCT00322374|471625984|FG000|First Escalation|Study Drug Toxicity|0|||
130999194|NCT00322374|471625985|FG001|First Escalation|Study Drug Toxicity|11|||
130999195|NCT00322374|471625986|FG002|First Escalation|Study Drug Toxicity|0|||
130999196|NCT00322374|471625987|FG003|First Escalation|Study Drug Toxicity|0|||
130999197|NCT00322374|471625984|FG000|First Escalation|Participant Request|0|||
130999198|NCT00322374|471625985|FG001|First Escalation|Participant Request|1|||
130999199|NCT00322374|471625986|FG002|First Escalation|Participant Request|0|||
130999200|NCT00322374|471625987|FG003|First Escalation|Participant Request|0|||
130999201|NCT00322374|471625984|FG000|Second Escalation|Physician Decision|0|||
130999202|NCT00322374|471625985|FG001|Second Escalation|Physician Decision|0|||
130999203|NCT00322374|471625986|FG002|Second Escalation|Physician Decision|5|||
130999204|NCT00322374|471625987|FG003|Second Escalation|Physician Decision|0|||
130999205|NCT00322374|471625984|FG000|Second Escalation|Study Drug Toxicity|0|||
130999206|NCT00322374|471625985|FG001|Second Escalation|Study Drug Toxicity|0|||
130999207|NCT00322374|471625986|FG002|Second Escalation|Study Drug Toxicity|1|||
130999208|NCT00322374|471625987|FG003|Second Escalation|Study Drug Toxicity|0|||
130999209|NCT04230980|471625988|FG000|Overall Study|Lost to Follow-up|1|||
130999210|NCT04230980|471625989|FG001|Overall Study|Lost to Follow-up|2|||
130999211|NCT04230980|471625988|FG000|Overall Study|Adverse Event|0|||
130999212|NCT04230980|471625989|FG001|Overall Study|Adverse Event|1|||
130999213|NCT03257995|471625993|FG000|Overall Study|Adverse Event|0|||
130999214|NCT03257995|471625994|FG001|Overall Study|Adverse Event|1|||
130999215|NCT03257995|471625995|FG002|Overall Study|Adverse Event|0|||
130999216|NCT03257995|471625996|FG003|Overall Study|Adverse Event|0|||
130999217|NCT03257995|471625997|FG004|Overall Study|Adverse Event|0|||
130999218|NCT03257995|471625998|FG005|Overall Study|Adverse Event|0|||
130999219|NCT03257995|471625993|FG000|Overall Study|Protocol deviation|0|||
130999220|NCT03257995|471625994|FG001|Overall Study|Protocol deviation|0|||
130999221|NCT03257995|471625995|FG002|Overall Study|Protocol deviation|0|||
130999222|NCT03257995|471625996|FG003|Overall Study|Protocol deviation|0|||
130999223|NCT03257995|471625997|FG004|Overall Study|Protocol deviation|0|||
130999224|NCT03257995|471625998|FG005|Overall Study|Protocol deviation|2|||
130999225|NCT01556763|471626002|FG000|Overall Study|Withdrawal by Subject|0|||
130999226|NCT01556763|471626003|FG001|Overall Study|Withdrawal by Subject|1|||
130999227|NCT01556763|471626004|FG002|Overall Study|Withdrawal by Subject|0|||
130999228|NCT02258464|471626005|FG000|Overall Study|Progressive disease (PD)|9|||
130999229|NCT02258464|471626006|FG001|Overall Study|Progressive disease (PD)|17|||
130999230|NCT02258464|471626005|FG000|Overall Study|Study drug never administered|1|||
130999231|NCT02258464|471626006|FG001|Overall Study|Study drug never administered|1|||
130999232|NCT02258464|471626005|FG000|Overall Study|AE not related to clinical PD|1|||
130999233|NCT02258464|471626006|FG001|Overall Study|AE not related to clinical PD|3|||
130999234|NCT02258464|471626005|FG000|Overall Study|Withdrawal by Subject|5|||
130999235|NCT02258464|471626006|FG001|Overall Study|Withdrawal by Subject|4|||
130999236|NCT02258464|471626005|FG000|Overall Study|AE related to clinical PD|1|||
130999237|NCT02258464|471626006|FG001|Overall Study|AE related to clinical PD|0|||
130999238|NCT00932646|471626007|FG000|Overall Study|Adverse Event|2|||
130999239|NCT00932646|471626008|FG001|Overall Study|Adverse Event|1|||
130999240|NCT00932646|471626009|FG002|Overall Study|Adverse Event|1|||
130999241|NCT00932646|471626010|FG003|Overall Study|Adverse Event|1|||
130999242|NCT00932646|471626007|FG000|Overall Study|Lost to Follow-up|2|||
130999243|NCT00932646|471626008|FG001|Overall Study|Lost to Follow-up|1|||
130999244|NCT00932646|471626009|FG002|Overall Study|Lost to Follow-up|0|||
130999245|NCT00932646|471626010|FG003|Overall Study|Lost to Follow-up|0|||
130999246|NCT00932646|471626007|FG000|Overall Study|Withdrawal by Subject|1|||
130999247|NCT00932646|471626008|FG001|Overall Study|Withdrawal by Subject|1|||
130999248|NCT00932646|471626009|FG002|Overall Study|Withdrawal by Subject|3|||
130999249|NCT00932646|471626010|FG003|Overall Study|Withdrawal by Subject|0|||
130999250|NCT02138747|471626011|FG000|Treatment Period 1|Adverse Event|10|||
130999251|NCT02138747|471626012|FG001|Treatment Period 1|Adverse Event|14|||
130999252|NCT02138747|471626013|FG002|Treatment Period 1|Adverse Event|2|||
130999253|NCT02138747|471626014|FG003|Treatment Period 1|Adverse Event|1|||
131221914|NCT01309828|472439464|FG001|Overall Study|Voluntary Withdrawal|4|||
131221915|NCT01309828|472439463|FG000|Overall Study|Major Protocol Deviation|0|||
131221916|NCT01309828|472439464|FG001|Overall Study|Major Protocol Deviation|1|||
131221917|NCT01309828|472439463|FG000|Overall Study|Other|1|||
131221918|NCT01309828|472439464|FG001|Overall Study|Other|0|||
130999254|NCT02138747|471626011|FG000|Treatment Period 1|Lost to Follow-up|0|||
130999255|NCT02138747|471626012|FG001|Treatment Period 1|Lost to Follow-up|1|||
130999256|NCT02138747|471626013|FG002|Treatment Period 1|Lost to Follow-up|1|||
130999257|NCT02138747|471626014|FG003|Treatment Period 1|Lost to Follow-up|0|||
130999258|NCT02138747|471626011|FG000|Treatment Period 1|Protocol Violation|0|||
130999259|NCT02138747|471626012|FG001|Treatment Period 1|Protocol Violation|2|||
130999260|NCT02138747|471626013|FG002|Treatment Period 1|Protocol Violation|0|||
130999261|NCT02138747|471626014|FG003|Treatment Period 1|Protocol Violation|0|||
130999262|NCT02138747|471626011|FG000|Treatment Period 1|Withdrawal by Subject|8|||
130999263|NCT02138747|471626012|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130999264|NCT02138747|471626013|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130999265|NCT02138747|471626014|FG003|Treatment Period 1|Withdrawal by Subject|3|||
130999266|NCT02138747|471626011|FG000|Treatment Period 1|Other - Miscellaneous|2|||
130999267|NCT02138747|471626012|FG001|Treatment Period 1|Other - Miscellaneous|4|||
130999268|NCT02138747|471626013|FG002|Treatment Period 1|Other - Miscellaneous|0|||
130999269|NCT02138747|471626014|FG003|Treatment Period 1|Other - Miscellaneous|0|||
130999270|NCT02138747|471626011|FG000|Treatment Period 2|Adverse Event|6|||
130999271|NCT02138747|471626012|FG001|Treatment Period 2|Adverse Event|3|||
130884451|NCT04986904|471211543|FG000|Overall Study|Withdrawal by Subject|1|||
130884452|NCT03435211|471211544|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
130884453|NCT03863080|471211545|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
130884454|NCT03863080|471211546|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
130884455|NCT03863080|471211547|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
130884456|NCT03863080|471211548|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
130884457|NCT03863080|471211545|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
130884458|NCT03863080|471211546|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
130884459|NCT03863080|471211547|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
130884460|NCT03863080|471211548|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
130884461|NCT03863080|471211545|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
130884462|NCT03863080|471211546|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
130884463|NCT03863080|471211547|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
130884464|NCT03863080|471211548|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
130884465|NCT01342211|471211549|FG000|Overall Study|Lost to Follow-up|0|||
130884466|NCT01342211|471211550|FG001|Overall Study|Lost to Follow-up|0|||
130884467|NCT01342211|471211551|FG002|Overall Study|Lost to Follow-up|0|||
130884468|NCT01342211|471211552|FG003|Overall Study|Lost to Follow-up|1|||
130884469|NCT01342211|471211553|FG004|Overall Study|Lost to Follow-up|0|||
130884470|NCT01342211|471211549|FG000|Overall Study|Adverse Event|0|||
130884471|NCT01342211|471211550|FG001|Overall Study|Adverse Event|0|||
130884472|NCT01342211|471211551|FG002|Overall Study|Adverse Event|0|||
130884473|NCT01342211|471211552|FG003|Overall Study|Adverse Event|0|||
130884474|NCT01342211|471211553|FG004|Overall Study|Adverse Event|1|||
130884475|NCT01342211|471211549|FG000|Overall Study|Withdrawal by Subject|0|||
130884476|NCT01342211|471211550|FG001|Overall Study|Withdrawal by Subject|0|||
130884477|NCT01342211|471211551|FG002|Overall Study|Withdrawal by Subject|0|||
130884478|NCT01342211|471211552|FG003|Overall Study|Withdrawal by Subject|1|||
130884479|NCT01342211|471211553|FG004|Overall Study|Withdrawal by Subject|0|||
130884480|NCT01342211|471211549|FG000|Overall Study|Randomized, but not Treated|0|||
130884481|NCT01342211|471211550|FG001|Overall Study|Randomized, but not Treated|2|||
130884482|NCT01342211|471211551|FG002|Overall Study|Randomized, but not Treated|0|||
130884483|NCT01342211|471211552|FG003|Overall Study|Randomized, but not Treated|0|||
130884484|NCT01342211|471211553|FG004|Overall Study|Randomized, but not Treated|1|||
130884485|NCT01648751|471211571|FG000|Overall Study|Withdrawal by Subject|2|||
130884486|NCT01648751|471211572|FG001|Overall Study|Withdrawal by Subject|3|||
130884487|NCT01588522|471211575|FG000|Overall Study|Withdrawal by Subject|1|||
130884488|NCT01588522|471211576|FG001|Overall Study|Withdrawal by Subject|5|||
130884489|NCT01588522|471211577|FG002|Overall Study|Withdrawal by Subject|3|||
130884490|NCT01588522|471211578|FG003|Overall Study|Withdrawal by Subject|1|||
130884491|NCT01588522|471211579|FG004|Overall Study|Withdrawal by Subject|2|||
130884492|NCT01588522|471211580|FG005|Overall Study|Withdrawal by Subject|0|||
130884493|NCT01588522|471211575|FG000|Overall Study|Lack of Efficacy|0|||
130884494|NCT01588522|471211576|FG001|Overall Study|Lack of Efficacy|0|||
130884495|NCT01588522|471211577|FG002|Overall Study|Lack of Efficacy|0|||
130884496|NCT01588522|471211578|FG003|Overall Study|Lack of Efficacy|0|||
130884497|NCT01588522|471211579|FG004|Overall Study|Lack of Efficacy|1|||
130884498|NCT01588522|471211580|FG005|Overall Study|Lack of Efficacy|0|||
130884499|NCT01588522|471211575|FG000|Overall Study|Adverse Event|0|||
130884500|NCT01588522|471211576|FG001|Overall Study|Adverse Event|0|||
130884501|NCT01588522|471211577|FG002|Overall Study|Adverse Event|0|||
130884502|NCT01588522|471211578|FG003|Overall Study|Adverse Event|1|||
130884503|NCT01588522|471211579|FG004|Overall Study|Adverse Event|0|||
130884504|NCT01588522|471211580|FG005|Overall Study|Adverse Event|0|||
130884505|NCT01588522|471211575|FG000|Overall Study|Grade 2 alopecia|1|||
130884506|NCT01588522|471211576|FG001|Overall Study|Grade 2 alopecia|0|||
130884507|NCT01588522|471211577|FG002|Overall Study|Grade 2 alopecia|0|||
130884508|NCT01588522|471211578|FG003|Overall Study|Grade 2 alopecia|0|||
130884509|NCT01588522|471211579|FG004|Overall Study|Grade 2 alopecia|0|||
130884510|NCT01588522|471211580|FG005|Overall Study|Grade 2 alopecia|0|||
130884511|NCT01588522|471211575|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
130884512|NCT01588522|471211576|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
130884513|NCT01588522|471211577|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
130884514|NCT01588522|471211578|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
130884515|NCT01588522|471211579|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
130884516|NCT01588522|471211580|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
130884517|NCT01588522|471211575|FG000|Overall Study|Taken off taxane-based regimen|0|||
130884518|NCT01588522|471211576|FG001|Overall Study|Taken off taxane-based regimen|0|||
130884519|NCT01588522|471211577|FG002|Overall Study|Taken off taxane-based regimen|0|||
130884520|NCT01588522|471211578|FG003|Overall Study|Taken off taxane-based regimen|1|||
130884521|NCT01588522|471211579|FG004|Overall Study|Taken off taxane-based regimen|0|||
130884522|NCT01588522|471211580|FG005|Overall Study|Taken off taxane-based regimen|0|||
130884523|NCT01588522|471211575|FG000|Overall Study|Did not initiate chemotherapy|0|||
130884524|NCT01588522|471211576|FG001|Overall Study|Did not initiate chemotherapy|0|||
130884525|NCT01588522|471211577|FG002|Overall Study|Did not initiate chemotherapy|0|||
130884526|NCT01588522|471211578|FG003|Overall Study|Did not initiate chemotherapy|0|||
130884527|NCT01588522|471211579|FG004|Overall Study|Did not initiate chemotherapy|1|||
130884528|NCT01588522|471211580|FG005|Overall Study|Did not initiate chemotherapy|0|||
130884529|NCT05673876|471211581|FG000|Overall Study|Death|3|||
130884530|NCT05673876|471211582|FG001|Overall Study|Death|1|||
130884531|NCT05673876|471211581|FG000|Overall Study|Study Terminated by Sponsor|0|||
130884532|NCT05673876|471211582|FG001|Overall Study|Study Terminated by Sponsor|1|||
130884533|NCT05673876|471211581|FG000|Overall Study|Physician Decision|0|||
130884534|NCT05673876|471211582|FG001|Overall Study|Physician Decision|1|||
130884535|NCT03205423|471211587|FG000|Overall Study|Personal|1|||
130884536|NCT03205423|471211588|FG001|Overall Study|Personal|1|||
130884537|NCT03205423|471211587|FG000|Overall Study|Physician Decision|0|||
130884538|NCT03205423|471211588|FG001|Overall Study|Physician Decision|2|||
130884539|NCT02749422|471211591|FG000|Overall Study|Lost to Follow-up|0|||
130884540|NCT02749422|471211592|FG001|Overall Study|Lost to Follow-up|2|||
130884541|NCT02749422|471211591|FG000|Overall Study|Ineligible|0|||
130884542|NCT02749422|471211592|FG001|Overall Study|Ineligible|1|||
130884543|NCT05786651|471211595|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
131100693|NCT00468104|471998070|FG001|Second Intervention|discarded for malposition of chest tube|2|||
131100694|NCT04860297|471998075|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
131100695|NCT04860297|471998076|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
131100696|NCT04860297|471998077|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
131100697|NCT04860297|471998078|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
131100698|NCT04860297|471998079|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
131100699|NCT04860297|471998080|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
131100700|NCT04860297|471998081|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
131100701|NCT04860297|471998082|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
131100702|NCT04860297|471998075|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
131100703|NCT04860297|471998076|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
131100704|NCT04860297|471998077|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
131100705|NCT04860297|471998078|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
131100706|NCT04860297|471998079|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
131100707|NCT04860297|471998080|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
131100708|NCT04860297|471998081|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
131100709|NCT04860297|471998082|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
131100710|NCT04860297|471998075|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
131100711|NCT04860297|471998076|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
131100712|NCT04860297|471998077|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
131100713|NCT04860297|471998078|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
131100714|NCT04860297|471998079|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
131100715|NCT04860297|471998080|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
131100716|NCT04860297|471998081|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
131100717|NCT04860297|471998082|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
131100718|NCT04860297|471998075|FG000|Part B (Booster Dose)|Other Than Specified|0|||
131100719|NCT04860297|471998076|FG001|Part B (Booster Dose)|Other Than Specified|0|||
131100720|NCT04860297|471998077|FG002|Part B (Booster Dose)|Other Than Specified|0|||
131100721|NCT04860297|471998078|FG003|Part B (Booster Dose)|Other Than Specified|0|||
131100722|NCT04860297|471998079|FG004|Part B (Booster Dose)|Other Than Specified|0|||
131100723|NCT04860297|471998080|FG005|Part B (Booster Dose)|Other Than Specified|1|||
131100724|NCT04860297|471998081|FG006|Part B (Booster Dose)|Other Than Specified|1|||
131100725|NCT04860297|471998082|FG007|Part B (Booster Dose)|Other Than Specified|0|||
131100726|NCT04860297|471998075|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
131100727|NCT04860297|471998076|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
131100728|NCT04860297|471998077|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
131100729|NCT04860297|471998078|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
130884584|NCT00777153|471213172|FG000|Overall Study|Lost to Follow-up|1|||
130884585|NCT00777153|471213173|FG001|Overall Study|Lost to Follow-up|1|||
130884586|NCT00777153|471213174|FG002|Overall Study|Lost to Follow-up|0|||
130884587|NCT00777153|471213172|FG000|Overall Study|Death|85|||
130884588|NCT00777153|471213173|FG001|Overall Study|Death|73|||
130884589|NCT00777153|471213174|FG002|Overall Study|Death|33|||
130884590|NCT00777153|471213172|FG000|Overall Study|Withdrawal by Subject|3|||
130884591|NCT00777153|471213173|FG001|Overall Study|Withdrawal by Subject|4|||
130884592|NCT00777153|471213174|FG002|Overall Study|Withdrawal by Subject|3|||
130884593|NCT00777153|471213172|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
130884594|NCT00777153|471213173|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
130884595|NCT00777153|471213174|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
130884596|NCT00554216|471213176|FG000|Overall Study|Lost to Follow-up|92|||
130884597|NCT00554216|471213177|FG001|Overall Study|Lost to Follow-up|31|||
130884598|NCT00554216|471213178|FG002|Overall Study|Lost to Follow-up|63|||
130884599|NCT00554216|471213176|FG000|Overall Study|Adverse Event|16|||
130884600|NCT00554216|471213177|FG001|Overall Study|Adverse Event|16|||
130884601|NCT00554216|471213178|FG002|Overall Study|Adverse Event|36|||
130884602|NCT00554216|471213176|FG000|Overall Study|Withdrawal by Subject|92|||
130999272|NCT02138747|471626013|FG002|Treatment Period 2|Adverse Event|1|||
130999273|NCT02138747|471626014|FG003|Treatment Period 2|Adverse Event|1|||
130999274|NCT02138747|471626011|FG000|Treatment Period 2|Lost to Follow-up|2|||
130999275|NCT02138747|471626012|FG001|Treatment Period 2|Lost to Follow-up|0|||
130999276|NCT02138747|471626013|FG002|Treatment Period 2|Lost to Follow-up|0|||
130999277|NCT02138747|471626014|FG003|Treatment Period 2|Lost to Follow-up|0|||
130999278|NCT02138747|471626011|FG000|Treatment Period 2|Protocol Violation|1|||
130999279|NCT02138747|471626012|FG001|Treatment Period 2|Protocol Violation|0|||
130999280|NCT02138747|471626013|FG002|Treatment Period 2|Protocol Violation|0|||
130999281|NCT02138747|471626014|FG003|Treatment Period 2|Protocol Violation|0|||
130999282|NCT02138747|471626011|FG000|Treatment Period 2|Withdrawal by Subject|5|||
130999283|NCT02138747|471626012|FG001|Treatment Period 2|Withdrawal by Subject|4|||
130999284|NCT02138747|471626013|FG002|Treatment Period 2|Withdrawal by Subject|1|||
130999285|NCT02138747|471626014|FG003|Treatment Period 2|Withdrawal by Subject|2|||
130999286|NCT02138747|471626011|FG000|Treatment Period 2|Other - Miscellaneous|3|||
130999287|NCT02138747|471626012|FG001|Treatment Period 2|Other - Miscellaneous|0|||
130999288|NCT02138747|471626013|FG002|Treatment Period 2|Other - Miscellaneous|0|||
130999289|NCT02138747|471626014|FG003|Treatment Period 2|Other - Miscellaneous|0|||
130999290|NCT04170296|471626015|FG000|Overall Study|Adverse Event|1|||
130999291|NCT04170296|471626016|FG001|Overall Study|Adverse Event|0|||
130999292|NCT04170296|471626015|FG000|Overall Study|Withdrawal by Subject|3|||
130999293|NCT04170296|471626016|FG001|Overall Study|Withdrawal by Subject|2|||
130999294|NCT04170296|471626015|FG000|Overall Study|Lost to Follow-up|4|||
130999295|NCT04170296|471626016|FG001|Overall Study|Lost to Follow-up|2|||
130999296|NCT00653263|471626017|FG000|Overall Study|Withdrawal by Subject|1|||
130999297|NCT00653263|471626017|FG000|Overall Study|Physician Decision|1|||
130999298|NCT00776100|471626028|FG000|Overall Study|Disease Progression|1|||
130999299|NCT00776100|471626029|FG001|Overall Study|Disease Progression|0|||
130999300|NCT03567993|471626032|FG000|Overall Study|Lost to Follow-up|4|||
130999301|NCT03567993|471626033|FG001|Overall Study|Lost to Follow-up|2|||
130999302|NCT03567993|471626032|FG000|Overall Study|Death|1|||
130999303|NCT03567993|471626033|FG001|Overall Study|Death|1|||
130999304|NCT03567993|471626032|FG000|Overall Study|Withdrawal by Subject|1|||
130999305|NCT03567993|471626033|FG001|Overall Study|Withdrawal by Subject|0|||
130999306|NCT04793464|471626034|FG000|Overall Study|Lost to Follow-up|458|||
130999307|NCT04793464|471626035|FG001|Overall Study|Lost to Follow-up|168|||
130999308|NCT04793464|471626036|FG002|Overall Study|Lost to Follow-up|5|||
130999309|NCT04793464|471626034|FG000|Overall Study|Withdrawal by Subject|43|||
130999310|NCT04793464|471626035|FG001|Overall Study|Withdrawal by Subject|15|||
130999311|NCT04793464|471626036|FG002|Overall Study|Withdrawal by Subject|0|||
130999312|NCT00903786|471626040|FG000|Overall Study|Physician Decision|6|||
130999313|NCT00903786|471626040|FG000|Overall Study|Lack of Efficacy|5|||
130999314|NCT00903786|471626040|FG000|Overall Study|Reason other than lack of efficacy|4|||
130999315|NCT02285595|471626045|FG000|Overall Study|Lost to Follow-up|14|||
130999316|NCT02285595|471626045|FG000|Overall Study|Withdrawal by Subject|1|||
130999317|NCT00195715|471626046|FG000|Overall Study|Adverse Event|122|||
130999318|NCT00195715|471626046|FG000|Overall Study|Withdrawal by Subject|58|||
130999319|NCT00195715|471626046|FG000|Overall Study|Lost to Follow-up|27|||
130999320|NCT00195715|471626046|FG000|Overall Study|Protocol Violation|13|||
130999321|NCT00195715|471626046|FG000|Overall Study|Lack of Efficacy|93|||
130999322|NCT00195715|471626046|FG000|Overall Study|Pregnancy|14|||
130999323|NCT00195715|471626046|FG000|Overall Study|Investigative site closure|8|||
130999324|NCT00195715|471626046|FG000|Overall Study|Subject moved/relocated|7|||
130999325|NCT00195715|471626046|FG000|Overall Study|Subject non-compliance|6|||
130999326|NCT00195715|471626046|FG000|Overall Study|Subject started commercial Humira|5|||
130999327|NCT00195715|471626046|FG000|Overall Study|Subject choice|3|||
130999328|NCT00195715|471626046|FG000|Overall Study|Loss of response/no improvement|3|||
130999329|NCT00195715|471626046|FG000|Overall Study|Sponsor stopped study|1|||
130999330|NCT00195715|471626046|FG000|Overall Study|Administrative reasons|2|||
130999331|NCT00195715|471626046|FG000|Overall Study|Investigator's decision|2|||
130999332|NCT00195715|471626046|FG000|Overall Study|Subject wants to get pregnant|4|||
130999333|NCT00195715|471626046|FG000|Overall Study|Use of prohibited medication|2|||
130999334|NCT00195715|471626046|FG000|Overall Study|Planned surgery|2|||
130999335|NCT00195715|471626046|FG000|Overall Study|Increased infection rate|1|||
130999336|NCT00195715|471626046|FG000|Overall Study|Ineligible|1|||
130999337|NCT00195715|471626046|FG000|Overall Study|Colonic stricture|1|||
130999338|NCT00195715|471626046|FG000|Overall Study|Sponsor discontinued trial|1|||
130999339|NCT00195715|471626046|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
130999340|NCT00845871|471626051|FG000|Assessment Period|Adverse Event|2|||
130999341|NCT00845871|471626051|FG000|Assessment Period|Abnormal laboratory values|1|||
130999342|NCT00845871|471626051|FG000|Assessment Period|Abnormal test procedure results|1|||
130999343|NCT00845871|471626051|FG000|Assessment Period|Patient withdrew consent|3|||
130999344|NCT00064025|471626059|FG000|Overall Study|Ineligible|4|||
130999345|NCT00064025|471626059|FG000|Overall Study|Inevaluable|3|||
130999346|NCT02468934|471626060|FG000|Overall Study|Withdrawal by Subject|4|||
130999347|NCT02468934|471626060|FG000|Overall Study|Screen Failure|3|||
130999348|NCT05221749|471626065|FG000|Overall Study|Lost to Follow-up|2|||
130999349|NCT05221749|471626066|FG001|Overall Study|Lost to Follow-up|3|||
130999350|NCT02218489|471626067|FG000|Overall Study|Withdrawal by Subject|4|||
130999351|NCT02218489|471626068|FG001|Overall Study|Withdrawal by Subject|3|||
130999352|NCT02218489|471626067|FG000|Overall Study|Lost to Follow-up|1|||
130999353|NCT02218489|471626068|FG001|Overall Study|Lost to Follow-up|0|||
130999354|NCT02404493|471626069|FG000|Overall Study|Adverse Event|1|||
130999355|NCT02404493|471626070|FG001|Overall Study|Adverse Event|1|||
130999356|NCT01254890|471626071|FG000|Overall Study|Ineligible|0|||
130999357|NCT01254890|471626072|FG001|Overall Study|Ineligible|3|||
130999358|NCT01254890|471626071|FG000|Overall Study|Withdrawal by Subject|1|||
130999359|NCT01254890|471626072|FG001|Overall Study|Withdrawal by Subject|2|||
130999360|NCT01254890|471626071|FG000|Overall Study|Disease Progression|0|||
130999361|NCT01254890|471626072|FG001|Overall Study|Disease Progression|5|||
130999362|NCT04039503|471626077|FG000|Overall Study|Adverse Event|3|||
130999363|NCT04039503|471626078|FG001|Overall Study|Adverse Event|0|||
130999364|NCT04039503|471626079|FG002|Overall Study|Adverse Event|2|||
130999365|NCT04039503|471626080|FG003|Overall Study|Adverse Event|0|||
130999366|NCT04039503|471626077|FG000|Overall Study|Lost to Follow-up|0|||
130999367|NCT04039503|471626078|FG001|Overall Study|Lost to Follow-up|0|||
130999368|NCT04039503|471626079|FG002|Overall Study|Lost to Follow-up|1|||
130999369|NCT04039503|471626080|FG003|Overall Study|Lost to Follow-up|0|||
130999370|NCT04039503|471626077|FG000|Overall Study|Protocol Violation|0|||
130999371|NCT04039503|471626078|FG001|Overall Study|Protocol Violation|1|||
130999372|NCT04039503|471626079|FG002|Overall Study|Protocol Violation|2|||
130999373|NCT04039503|471626080|FG003|Overall Study|Protocol Violation|1|||
130999374|NCT04039503|471626077|FG000|Overall Study|Withdrawal by Subject|4|||
130999375|NCT04039503|471626078|FG001|Overall Study|Withdrawal by Subject|3|||
130999376|NCT04039503|471626079|FG002|Overall Study|Withdrawal by Subject|5|||
130999377|NCT04039503|471626080|FG003|Overall Study|Withdrawal by Subject|2|||
130999378|NCT01163747|471626082|FG000|Overall Study|Adverse Event|0|||
130999379|NCT01163747|471626083|FG001|Overall Study|Adverse Event|5|||
130999380|NCT01163747|471626082|FG000|Overall Study|Insufficient Therapeutic Response|0|||
130999381|NCT01163747|471626083|FG001|Overall Study|Insufficient Therapeutic Response|1|||
130999382|NCT01163747|471626082|FG000|Overall Study|Protocol Violation|0|||
130999383|NCT01163747|471626083|FG001|Overall Study|Protocol Violation|1|||
130999384|NCT01163747|471626082|FG000|Overall Study|Refused Treatment|6|||
130999385|NCT01163747|471626083|FG001|Overall Study|Refused Treatment|4|||
130999386|NCT03363659|471626084|FG000|Overall Study|Adverse Event|1|||
130999387|NCT03363659|471626084|FG000|Overall Study|Screen fail|1|||
130999388|NCT03363659|471626084|FG000|Overall Study|Withdrawal by Subject|1|||
130999389|NCT01216293|471626085|FG000|Main Study|Adverse Event|1|||
130999390|NCT01216293|471626086|FG001|Main Study|Adverse Event|4|||
130999391|NCT01216293|471626087|FG002|Main Study|Adverse Event|2|||
130999392|NCT01216293|471626085|FG000|Main Study|Major Protocol Deviation|1|||
130999393|NCT01216293|471626086|FG001|Main Study|Major Protocol Deviation|0|||
130999394|NCT01216293|471626087|FG002|Main Study|Major Protocol Deviation|1|||
130999395|NCT01216293|471626085|FG000|Main Study|Lost to Follow-up|3|||
130999396|NCT01216293|471626086|FG001|Main Study|Lost to Follow-up|1|||
130999397|NCT01216293|471626087|FG002|Main Study|Lost to Follow-up|0|||
130999398|NCT01216293|471626085|FG000|Main Study|Voluntary Withdrawal|2|||
130999399|NCT01216293|471626086|FG001|Main Study|Voluntary Withdrawal|2|||
130999400|NCT01216293|471626087|FG002|Main Study|Voluntary Withdrawal|2|||
130999401|NCT01216293|471626085|FG000|Main Study|Other Reason Not Specified|0|||
130999402|NCT01216293|471626086|FG001|Main Study|Other Reason Not Specified|1|||
130999403|NCT01216293|471626087|FG002|Main Study|Other Reason Not Specified|1|||
130999404|NCT01216293|471626085|FG000|Main Study|Randomized, Not Treated|1|||
130999405|NCT01216293|471626086|FG001|Main Study|Randomized, Not Treated|0|||
130999406|NCT01216293|471626087|FG002|Main Study|Randomized, Not Treated|0|||
130999407|NCT01216293|471626085|FG000|Calcium Absorption Substudy|Adverse Event|0|||
130999408|NCT01216293|471626086|FG001|Calcium Absorption Substudy|Adverse Event|2|||
130999409|NCT01216293|471626087|FG002|Calcium Absorption Substudy|Adverse Event|0|||
130999410|NCT01216293|471626085|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
130999411|NCT01216293|471626086|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
130999412|NCT01216293|471626087|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
130999413|NCT01216293|471626085|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
130999414|NCT01216293|471626086|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
130999415|NCT01216293|471626087|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
130999416|NCT01671748|471626088|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
130999417|NCT01671748|471626089|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
130999418|NCT01671748|471626088|FG000|4 Week run-in Phase|Adverse Event|1|||
130999419|NCT01671748|471626089|FG001|4 Week run-in Phase|Adverse Event|0|||
130999420|NCT01671748|471626088|FG000|4 Week run-in Phase|Not eligible|9|||
130999421|NCT01671748|471626089|FG001|4 Week run-in Phase|Not eligible|0|||
130999422|NCT03872388|471626090|FG000|Overall Study|Disease Progression|0|||
130999423|NCT03872388|471626091|FG001|Overall Study|Disease Progression|0|||
130999424|NCT03872388|471626092|FG002|Overall Study|Disease Progression|0|||
130999425|NCT03872388|471626093|FG003|Overall Study|Disease Progression|0|||
130999426|NCT03872388|471626094|FG004|Overall Study|Disease Progression|0|||
130999427|NCT03872388|471626095|FG005|Overall Study|Disease Progression|0|||
130999428|NCT03872388|471626096|FG006|Overall Study|Disease Progression|1|||
130999429|NCT03872388|471626097|FG007|Overall Study|Disease Progression|1|||
130999430|NCT02169830|471628075|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
130999431|NCT02169830|471628076|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
130999432|NCT02169830|471628077|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
130999433|NCT02169830|471628075|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
130999434|NCT02169830|471628076|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
130999435|NCT02169830|471628077|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
130999436|NCT02169830|471628075|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
130999437|NCT02169830|471628076|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
130999438|NCT02169830|471628077|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130999439|NCT02169830|471628075|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
130999440|NCT02169830|471628076|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
130999441|NCT02169830|471628077|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
130999442|NCT02169830|471628075|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
130999443|NCT02169830|471628076|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
130999444|NCT02169830|471628077|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
130999445|NCT03204695|471628078|FG000|Overall Study|Death|1|||
130999446|NCT03204695|471628078|FG000|Overall Study|Participant was treated with another device|1|||
130999447|NCT03204695|471628078|FG000|Overall Study|Physician Decision|2|||
130999448|NCT04834362|471628079|FG000|Overall Study|Death|1|||
130999449|NCT04834362|471628080|FG001|Overall Study|Death|2|||
130999450|NCT01349829|471628083|FG000|Overall Study|Lost to Follow-up|4|||
130999451|NCT01349829|471628084|FG001|Overall Study|Lost to Follow-up|8|||
130999452|NCT01349829|471628083|FG000|Overall Study|Consent withdrawal|3|||
130999453|NCT01349829|471628084|FG001|Overall Study|Consent withdrawal|8|||
130999454|NCT01349829|471628083|FG000|Overall Study|Migrated/moved|2|||
130999455|NCT01349829|471628084|FG001|Overall Study|Migrated/moved|7|||
130999456|NCT02555371|471628085|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
130999457|NCT02555371|471628086|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
130999458|NCT02555371|471628087|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
130999459|NCT02555371|471628088|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
130999460|NCT02555371|471628089|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
130999461|NCT02555371|471628085|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
130999462|NCT02555371|471628086|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
130999463|NCT02555371|471628087|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
130999464|NCT02555371|471628088|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
130999465|NCT02555371|471628089|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
130999466|NCT02555371|471628085|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
130999467|NCT02555371|471628086|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
130999468|NCT02555371|471628087|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
130884603|NCT00554216|471213177|FG001|Overall Study|Withdrawal by Subject|31|||
130884604|NCT00554216|471213178|FG002|Overall Study|Withdrawal by Subject|43|||
130884605|NCT00554216|471213176|FG000|Overall Study|Non compliance|10|||
130884606|NCT00554216|471213177|FG001|Overall Study|Non compliance|4|||
130884607|NCT00554216|471213178|FG002|Overall Study|Non compliance|5|||
130884608|NCT00554216|471213176|FG000|Overall Study|Pregnancy|2|||
130884609|NCT00554216|471213177|FG001|Overall Study|Pregnancy|1|||
130884610|NCT00554216|471213178|FG002|Overall Study|Pregnancy|14|||
130884611|NCT00554216|471213176|FG000|Overall Study|Restricted med|3|||
130884612|NCT00554216|471213177|FG001|Overall Study|Restricted med|1|||
130884613|NCT00554216|471213178|FG002|Overall Study|Restricted med|1|||
130884614|NCT00554216|471213176|FG000|Overall Study|Other|12|||
130884615|NCT00554216|471213177|FG001|Overall Study|Other|7|||
130884616|NCT00554216|471213178|FG002|Overall Study|Other|10|||
130884617|NCT00554216|471213176|FG000|Overall Study|Lack of Efficacy|15|||
130884618|NCT00554216|471213177|FG001|Overall Study|Lack of Efficacy|3|||
130884619|NCT00554216|471213178|FG002|Overall Study|Lack of Efficacy|0|||
130999469|NCT02555371|471628088|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
130999470|NCT02555371|471628089|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
130999471|NCT02555371|471628085|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
130999472|NCT02555371|471628086|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
130999473|NCT02555371|471628087|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
130999474|NCT02555371|471628088|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
130999475|NCT02555371|471628089|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
130999476|NCT02555371|471628085|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
130999477|NCT02555371|471628086|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
130999478|NCT02555371|471628087|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
130999479|NCT02555371|471628088|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
130999480|NCT02555371|471628089|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
130999481|NCT02555371|471628085|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
130999482|NCT02555371|471628086|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
130999483|NCT02555371|471628087|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
130999484|NCT02555371|471628088|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
130999485|NCT02555371|471628089|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
130999486|NCT02555371|471628085|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
130999487|NCT02555371|471628086|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
130999488|NCT02555371|471628087|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
130999489|NCT02555371|471628088|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
130999490|NCT02555371|471628089|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
130999491|NCT02555371|471628085|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
130999492|NCT02555371|471628086|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
130999493|NCT02555371|471628087|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
130999494|NCT02555371|471628088|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
130999495|NCT02555371|471628089|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
130999496|NCT02555371|471628085|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
130999497|NCT02555371|471628086|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
130999498|NCT02555371|471628087|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
130999499|NCT02555371|471628088|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
130999500|NCT02555371|471628089|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
130999501|NCT02555371|471628085|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
130999502|NCT02555371|471628086|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
130999503|NCT02555371|471628087|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
130999504|NCT02555371|471628088|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
130999505|NCT02555371|471628089|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
130999506|NCT02555371|471628085|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
130999507|NCT02555371|471628086|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
130999508|NCT02555371|471628087|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
130999509|NCT02555371|471628088|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
130999510|NCT02555371|471628089|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
130999511|NCT02555371|471628085|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
130999512|NCT02555371|471628086|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
130999513|NCT02555371|471628087|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
130999514|NCT02555371|471628088|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
130999515|NCT02555371|471628089|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
130999516|NCT02555371|471628085|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
130999517|NCT02555371|471628086|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
130999518|NCT02555371|471628087|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
130999519|NCT02555371|471628088|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
130999520|NCT02555371|471628089|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
130999521|NCT02555371|471628085|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130999522|NCT02555371|471628086|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130999523|NCT02555371|471628087|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130999524|NCT02555371|471628088|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
130999525|NCT02555371|471628089|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130999526|NCT03095599|471628090|FG000|Overall Study|Withdrawal by Subject|1|||
130999527|NCT03095599|471628091|FG001|Overall Study|Withdrawal by Subject|0|||
130999528|NCT03095599|471628090|FG000|Overall Study|Lost to Follow-up|1|||
130999529|NCT03095599|471628091|FG001|Overall Study|Lost to Follow-up|0|||
130999530|NCT03095599|471628090|FG000|Overall Study|Withdrawal prior to vaccination|1|||
130999531|NCT03095599|471628091|FG001|Overall Study|Withdrawal prior to vaccination|0|||
130999532|NCT00513019|471628093|FG000|Overall Study|Adverse Event|1|||
130999533|NCT00513019|471628094|FG001|Overall Study|Adverse Event|0|||
130999534|NCT00513019|471628093|FG000|Overall Study|Withdrawal by Subject|4|||
130999535|NCT00513019|471628094|FG001|Overall Study|Withdrawal by Subject|5|||
130999536|NCT01995357|471628095|FG000|Period 5|Lack of Efficacy|1|||
130999537|NCT01995357|471628096|FG001|Period 5|Lack of Efficacy|0|||
130999538|NCT01995357|471628097|FG002|Period 5|Lack of Efficacy|0|||
130999539|NCT01995357|471628098|FG003|Period 5|Lack of Efficacy|0|||
130999540|NCT01995357|471628099|FG004|Period 5|Lack of Efficacy|0|||
130999541|NCT01995357|471628100|FG005|Period 5|Lack of Efficacy|0|||
130999542|NCT01995357|471628095|FG000|Period 5|Adverse Event|1|||
130999543|NCT01995357|471628096|FG001|Period 5|Adverse Event|0|||
130999544|NCT01995357|471628097|FG002|Period 5|Adverse Event|1|||
130999545|NCT01995357|471628098|FG003|Period 5|Adverse Event|0|||
130999546|NCT01995357|471628099|FG004|Period 5|Adverse Event|0|||
130999547|NCT01995357|471628100|FG005|Period 5|Adverse Event|0|||
130999548|NCT03615482|471628101|FG000|Overall Study|Death|1|||
130999549|NCT03615482|471628102|FG001|Overall Study|Death|0|||
130999550|NCT03615482|471628101|FG000|Overall Study|Lost to Follow-up|7|||
130999551|NCT03615482|471628102|FG001|Overall Study|Lost to Follow-up|7|||
130999552|NCT03615482|471628101|FG000|Overall Study|Physician Decision|2|||
130999553|NCT03615482|471628102|FG001|Overall Study|Physician Decision|3|||
130999554|NCT03615482|471628101|FG000|Overall Study|Withdrawal by Subject|7|||
130999555|NCT03615482|471628102|FG001|Overall Study|Withdrawal by Subject|7|||
130999556|NCT01500226|471628105|FG000|Overall Study|Adverse Event|31|||
130999557|NCT01500226|471628106|FG001|Overall Study|Adverse Event|38|||
130999558|NCT01500226|471628105|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
130999559|NCT01500226|471628106|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
130999560|NCT01500226|471628105|FG000|Overall Study|Withdrawal by Subject|93|||
130999561|NCT01500226|471628106|FG001|Overall Study|Withdrawal by Subject|96|||
130999562|NCT01500226|471628105|FG000|Overall Study|Death|12|||
130999563|NCT01500226|471628106|FG001|Overall Study|Death|4|||
130999564|NCT01500226|471628105|FG000|Overall Study|Disease Progression|16|||
130999565|NCT01500226|471628106|FG001|Overall Study|Disease Progression|14|||
130999566|NCT01500226|471628105|FG000|Overall Study|Protocol Violation|53|||
130999567|NCT01500226|471628106|FG001|Overall Study|Protocol Violation|39|||
130999568|NCT01500226|471628105|FG000|Overall Study|Physician Decision|17|||
130999569|NCT01500226|471628106|FG001|Overall Study|Physician Decision|15|||
130999570|NCT01500226|471628105|FG000|Overall Study|Lack of Efficacy|14|||
130999571|NCT01500226|471628106|FG001|Overall Study|Lack of Efficacy|30|||
130999572|NCT01500226|471628105|FG000|Overall Study|Lost to Follow-up|9|||
130999573|NCT01500226|471628106|FG001|Overall Study|Lost to Follow-up|5|||
130999574|NCT01500226|471628105|FG000|Overall Study|Other Reasons|19|||
130999575|NCT01500226|471628106|FG001|Overall Study|Other Reasons|16|||
130999576|NCT02955277|471628107|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
130999577|NCT02955277|471628108|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
130999578|NCT02955277|471628107|FG000|Post to Follow-up|Lost to Follow-up|8|||
130999579|NCT02955277|471628108|FG001|Post to Follow-up|Lost to Follow-up|11|||
130765899|NCT01524783|470765894|FG000|Open-label Period|Withdrawal by Subject|2|||
130765900|NCT01524783|470765895|FG001|Open-label Period|Withdrawal by Subject|0|||
130765901|NCT01524783|470765896|FG002|Open-label Period|Withdrawal by Subject|1|||
130765902|NCT01524783|470765894|FG000|Open-label Period|Protocol deviation|1|||
130999580|NCT01809210|471628119|FG000|Overall Study|Withdrawal by Subject|0|||
130999581|NCT01809210|471628120|FG001|Overall Study|Withdrawal by Subject|0|||
130999582|NCT01809210|471628121|FG002|Overall Study|Withdrawal by Subject|1|||
130765903|NCT01524783|470765895|FG001|Open-label Period|Protocol deviation|0|||
130765904|NCT01524783|470765896|FG002|Open-label Period|Protocol deviation|0|||
130765905|NCT05153148|470765899|FG000|Overall Study|Adverse Event|1|||
130765906|NCT05153148|470765900|FG001|Overall Study|Adverse Event|0|||
130999583|NCT01809210|471628122|FG003|Overall Study|Withdrawal by Subject|1|||
130999584|NCT01809210|471628123|FG004|Overall Study|Withdrawal by Subject|1|||
130999585|NCT01809210|471628124|FG005|Overall Study|Withdrawal by Subject|0|||
130999586|NCT01809210|471628125|FG006|Overall Study|Withdrawal by Subject|4|||
130999587|NCT01809210|471628119|FG000|Overall Study|Death|1|||
130765907|NCT05153148|470765901|FG002|Overall Study|Adverse Event|3|||
130765908|NCT05153148|470765902|FG003|Overall Study|Adverse Event|5|||
130765909|NCT05153148|470765899|FG000|Overall Study|Lost to Follow-up|1|||
130999588|NCT01809210|471628120|FG001|Overall Study|Death|1|||
130999589|NCT01809210|471628121|FG002|Overall Study|Death|2|||
130999590|NCT01809210|471628122|FG003|Overall Study|Death|0|||
130999591|NCT01809210|471628123|FG004|Overall Study|Death|1|||
130999592|NCT01809210|471628124|FG005|Overall Study|Death|3|||
130999593|NCT01809210|471628125|FG006|Overall Study|Death|1|||
130999594|NCT01668147|471628126|FG000|Overall Study|Withdrawal by Subject|6|||
130999595|NCT00590980|471628127|FG000|Overall Study|Did not meet all inclusion criteria|10|||
130999596|NCT03699124|471628130|FG000|Overall Study|Adverse Event|6|||
130999597|NCT03699124|471628131|FG001|Overall Study|Adverse Event|5|||
130999598|NCT03699124|471628132|FG002|Overall Study|Adverse Event|2|||
130999599|NCT03699124|471628130|FG000|Overall Study|Death|0|||
130999600|NCT03699124|471628131|FG001|Overall Study|Death|2|||
130999601|NCT03699124|471628132|FG002|Overall Study|Death|0|||
130999602|NCT03699124|471628130|FG000|Overall Study|Lost to Follow-up|20|||
130999603|NCT03699124|471628131|FG001|Overall Study|Lost to Follow-up|16|||
130999604|NCT03699124|471628132|FG002|Overall Study|Lost to Follow-up|15|||
130999605|NCT03699124|471628130|FG000|Overall Study|Protocol Violation|1|||
130999606|NCT03699124|471628131|FG001|Overall Study|Protocol Violation|0|||
130999607|NCT03699124|471628132|FG002|Overall Study|Protocol Violation|0|||
130999608|NCT03699124|471628130|FG000|Overall Study|Withdrawal by Subject|13|||
130999609|NCT03699124|471628131|FG001|Overall Study|Withdrawal by Subject|14|||
130999610|NCT03699124|471628132|FG002|Overall Study|Withdrawal by Subject|13|||
130999611|NCT03699124|471628130|FG000|Overall Study|Other reasons|5|||
130999612|NCT03699124|471628131|FG001|Overall Study|Other reasons|3|||
130999613|NCT03699124|471628132|FG002|Overall Study|Other reasons|10|||
130999614|NCT01118962|471628135|FG000|Overall Study|Adverse Event|2|||
130999615|NCT01118962|471628135|FG000|Overall Study|Lack of Efficacy|1|||
130999616|NCT01118962|471628135|FG000|Overall Study|Protocol Violation|1|||
130999617|NCT01118962|471628135|FG000|Overall Study|Withdrawal by Subject|4|||
130999618|NCT01118962|471628135|FG000|Overall Study|Pregnancy|1|||
130999619|NCT01118962|471628135|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
130999620|NCT01567163|471628139|FG000|Overall Study|Progressive Disease|2|||
130999621|NCT01567163|471628139|FG000|Overall Study|Lost to Follow-up|2|||
130999622|NCT03405662|471628141|FG000|Overall Study|COVID-19 restriction|1|||
130999623|NCT03405662|471628142|FG001|Overall Study|COVID-19 restriction|0|||
130999624|NCT03405662|471628141|FG000|Overall Study|unblinding|0|||
130999625|NCT03405662|471628142|FG001|Overall Study|unblinding|1|||
130999626|NCT03405662|471628141|FG000|Overall Study|placement in memory care facility|0|||
130999627|NCT03405662|471628142|FG001|Overall Study|placement in memory care facility|2|||
130999628|NCT01177813|471628143|FG000|Overall Study|Adverse Event|8|||
130999629|NCT01177813|471628144|FG001|Overall Study|Adverse Event|2|||
130999630|NCT01177813|471628145|FG002|Overall Study|Adverse Event|4|||
130999631|NCT01177813|471628146|FG003|Overall Study|Adverse Event|6|||
130999632|NCT01177813|471628147|FG004|Overall Study|Adverse Event|3|||
130999633|NCT01177813|471628143|FG000|Overall Study|Lack of Efficacy|1|||
130999634|NCT01177813|471628144|FG001|Overall Study|Lack of Efficacy|0|||
130999635|NCT01177813|471628145|FG002|Overall Study|Lack of Efficacy|0|||
130999636|NCT01177813|471628146|FG003|Overall Study|Lack of Efficacy|0|||
130999637|NCT01177813|471628147|FG004|Overall Study|Lack of Efficacy|0|||
130999638|NCT01177813|471628143|FG000|Overall Study|Protocol Violation|3|||
130999639|NCT01177813|471628144|FG001|Overall Study|Protocol Violation|2|||
130999640|NCT01177813|471628145|FG002|Overall Study|Protocol Violation|2|||
130999641|NCT01177813|471628146|FG003|Overall Study|Protocol Violation|0|||
130999642|NCT01177813|471628147|FG004|Overall Study|Protocol Violation|1|||
130999643|NCT01177813|471628143|FG000|Overall Study|Lost to Follow-up|12|||
130999644|NCT01177813|471628144|FG001|Overall Study|Lost to Follow-up|5|||
130999645|NCT01177813|471628145|FG002|Overall Study|Lost to Follow-up|6|||
130999646|NCT01177813|471628146|FG003|Overall Study|Lost to Follow-up|3|||
130999647|NCT01177813|471628147|FG004|Overall Study|Lost to Follow-up|0|||
130999648|NCT01177813|471628143|FG000|Overall Study|Withdrawal by Subject|12|||
130999649|NCT01177813|471628144|FG001|Overall Study|Withdrawal by Subject|7|||
130999650|NCT01177813|471628145|FG002|Overall Study|Withdrawal by Subject|6|||
130999651|NCT01177813|471628146|FG003|Overall Study|Withdrawal by Subject|5|||
130999652|NCT01177813|471628147|FG004|Overall Study|Withdrawal by Subject|3|||
130999653|NCT01177813|471628143|FG000|Overall Study|Other reason not defined above|5|||
130999654|NCT01177813|471628144|FG001|Overall Study|Other reason not defined above|2|||
130999655|NCT01177813|471628145|FG002|Overall Study|Other reason not defined above|2|||
130999656|NCT01177813|471628146|FG003|Overall Study|Other reason not defined above|3|||
130999657|NCT01177813|471628147|FG004|Overall Study|Other reason not defined above|2|||
130999658|NCT00109928|471628150|FG000|Overall Study|Adverse Event|2|||
130999659|NCT00109928|471628150|FG000|Overall Study|Progression|6|||
130999660|NCT00109928|471628150|FG000|Overall Study|Death|2|||
130999661|NCT00109928|471628150|FG000|Overall Study|not protocol specified|2|||
130999662|NCT00109928|471628150|FG000|Overall Study|not eligible|1|||
130999663|NCT01196104|471628151|FG000|Overall Study|Lost to Follow-up|1|||
130999664|NCT01196104|471628152|FG001|Overall Study|Lost to Follow-up|0|||
130999665|NCT01196104|471628151|FG000|Overall Study|Physician Decision|0|||
130999666|NCT01196104|471628152|FG001|Overall Study|Physician Decision|1|||
130999667|NCT01196104|471628151|FG000|Overall Study|Withdrawal by Subject|3|||
130999668|NCT01196104|471628152|FG001|Overall Study|Withdrawal by Subject|3|||
130999669|NCT01196104|471628151|FG000|Overall Study|Various|0|||
130999670|NCT01196104|471628152|FG001|Overall Study|Various|1|||
130999671|NCT00610675|471628153|FG000|Overall Study|Untreated|4|||
130999672|NCT00610675|471628153|FG000|Overall Study|Adverse Event|67|||
130999673|NCT00610675|471628153|FG000|Overall Study|Insufficient Effect|31|||
130999674|NCT00610675|471628153|FG000|Overall Study|Withdrawal by Subject|28|||
130999675|NCT00610675|471628153|FG000|Overall Study|Reasons unrelated to trial|27|||
130999676|NCT00610675|471628153|FG000|Overall Study|Lack of Compliance|7|||
130999677|NCT00610675|471628153|FG000|Overall Study|Lost to Follow-up|31|||
130999678|NCT00610675|471628153|FG000|Overall Study|Other reason (not specified)|25|||
130999679|NCT01316692|471628158|FG000|Overall Study|Adverse Event|5|||
130999680|NCT01316692|471628158|FG000|Overall Study|Disease Progression|7|||
130999681|NCT00983619|471628162|FG000|Overall Study|Lost to Follow-up|0|||
130999682|NCT00983619|471628163|FG001|Overall Study|Lost to Follow-up|1|||
130999683|NCT00983619|471628164|FG002|Overall Study|Lost to Follow-up|0|||
130999684|NCT00983619|471628165|FG003|Overall Study|Lost to Follow-up|0|||
130999685|NCT00983619|471628166|FG004|Overall Study|Lost to Follow-up|0|||
130999686|NCT00983619|471628167|FG005|Overall Study|Lost to Follow-up|2|||
130999687|NCT00983619|471628168|FG006|Overall Study|Lost to Follow-up|0|||
130999688|NCT00983619|471628169|FG007|Overall Study|Lost to Follow-up|0|||
130999689|NCT00983619|471628170|FG008|Overall Study|Lost to Follow-up|0|||
130999690|NCT00983619|471628171|FG009|Overall Study|Lost to Follow-up|0|||
130999691|NCT00983619|471628172|FG010|Overall Study|Lost to Follow-up|0|||
130999692|NCT00983619|471628173|FG011|Overall Study|Lost to Follow-up|2|||
130999693|NCT00983619|471628162|FG000|Overall Study|Withdrawal by Subject|2|||
130999694|NCT00983619|471628163|FG001|Overall Study|Withdrawal by Subject|1|||
130999695|NCT00983619|471628164|FG002|Overall Study|Withdrawal by Subject|1|||
130999696|NCT00983619|471628165|FG003|Overall Study|Withdrawal by Subject|3|||
130999697|NCT00983619|471628166|FG004|Overall Study|Withdrawal by Subject|1|||
130999698|NCT00983619|471628167|FG005|Overall Study|Withdrawal by Subject|23|||
130999699|NCT00983619|471628168|FG006|Overall Study|Withdrawal by Subject|0|||
130999700|NCT00983619|471628169|FG007|Overall Study|Withdrawal by Subject|0|||
130999701|NCT00983619|471628170|FG008|Overall Study|Withdrawal by Subject|0|||
130999702|NCT00983619|471628171|FG009|Overall Study|Withdrawal by Subject|0|||
130999703|NCT00983619|471628172|FG010|Overall Study|Withdrawal by Subject|1|||
130999704|NCT00983619|471628173|FG011|Overall Study|Withdrawal by Subject|1|||
130999705|NCT00983619|471628162|FG000|Overall Study|Death|0|||
130999706|NCT00983619|471628163|FG001|Overall Study|Death|2|||
130999707|NCT00983619|471628164|FG002|Overall Study|Death|2|||
130999708|NCT00983619|471628165|FG003|Overall Study|Death|1|||
130999709|NCT00983619|471628166|FG004|Overall Study|Death|2|||
130999710|NCT00983619|471628167|FG005|Overall Study|Death|30|||
130999711|NCT00983619|471628168|FG006|Overall Study|Death|1|||
130999712|NCT00983619|471628169|FG007|Overall Study|Death|0|||
130999713|NCT00983619|471628170|FG008|Overall Study|Death|1|||
130999714|NCT00983619|471628171|FG009|Overall Study|Death|2|||
130999715|NCT00983619|471628172|FG010|Overall Study|Death|9|||
130999716|NCT00983619|471628173|FG011|Overall Study|Death|8|||
130999717|NCT00983619|471628162|FG000|Overall Study|Other|1|||
130999718|NCT00983619|471628163|FG001|Overall Study|Other|0|||
130999719|NCT00983619|471628164|FG002|Overall Study|Other|0|||
130999720|NCT00983619|471628165|FG003|Overall Study|Other|1|||
130999721|NCT00983619|471628166|FG004|Overall Study|Other|0|||
130999722|NCT00983619|471628167|FG005|Overall Study|Other|12|||
130999723|NCT00983619|471628168|FG006|Overall Study|Other|2|||
130999724|NCT00983619|471628169|FG007|Overall Study|Other|2|||
130999725|NCT00983619|471628170|FG008|Overall Study|Other|0|||
130999726|NCT00983619|471628171|FG009|Overall Study|Other|1|||
130999727|NCT00983619|471628172|FG010|Overall Study|Other|1|||
130999728|NCT00983619|471628173|FG011|Overall Study|Other|0|||
130999729|NCT04011384|471628182|FG000|Overall Study|Withdrawal by Subject|2|||
130999730|NCT04011384|471628183|FG001|Overall Study|Withdrawal by Subject|0|||
130999731|NCT01686932|471628184|FG000|Period 1|Adverse Event|1|||
130999732|NCT01686932|471628185|FG001|Period 1|Adverse Event|1|||
130999733|NCT01536145|471628186|FG000|Overall Study|Progressive disease|3|||
130999734|NCT01536145|471628187|FG001|Overall Study|Progressive disease|4|||
130999735|NCT01536145|471628188|FG002|Overall Study|Progressive disease|1|||
130999736|NCT01536145|471628189|FG003|Overall Study|Progressive disease|2|||
130999737|NCT01536145|471628190|FG004|Overall Study|Progressive disease|1|||
130999738|NCT01536145|471628191|FG005|Overall Study|Progressive disease|2|||
130999739|NCT01536145|471628192|FG006|Overall Study|Progressive disease|1|||
130999740|NCT01536145|471628193|FG007|Overall Study|Progressive disease|2|||
130999741|NCT01536145|471628194|FG008|Overall Study|Progressive disease|1|||
130999742|NCT01536145|471628195|FG009|Overall Study|Progressive disease|3|||
130999743|NCT01536145|471628196|FG010|Overall Study|Progressive disease|3|||
130999744|NCT01536145|471628186|FG000|Overall Study|Withdrawal by Subject|0|||
130999745|NCT01536145|471628187|FG001|Overall Study|Withdrawal by Subject|0|||
130999746|NCT01536145|471628188|FG002|Overall Study|Withdrawal by Subject|1|||
130999747|NCT01536145|471628189|FG003|Overall Study|Withdrawal by Subject|0|||
130999748|NCT01536145|471628190|FG004|Overall Study|Withdrawal by Subject|0|||
130999749|NCT01536145|471628191|FG005|Overall Study|Withdrawal by Subject|1|||
130999750|NCT01536145|471628192|FG006|Overall Study|Withdrawal by Subject|0|||
130999751|NCT01536145|471628193|FG007|Overall Study|Withdrawal by Subject|0|||
130999752|NCT01536145|471628194|FG008|Overall Study|Withdrawal by Subject|2|||
130999753|NCT01536145|471628195|FG009|Overall Study|Withdrawal by Subject|0|||
130999754|NCT01536145|471628196|FG010|Overall Study|Withdrawal by Subject|2|||
130999755|NCT01536145|471628186|FG000|Overall Study|Other|0|||
130999756|NCT01536145|471628187|FG001|Overall Study|Other|0|||
130999757|NCT01536145|471628188|FG002|Overall Study|Other|0|||
130999758|NCT01536145|471628189|FG003|Overall Study|Other|0|||
130999759|NCT01536145|471628190|FG004|Overall Study|Other|1|||
130999760|NCT01536145|471628191|FG005|Overall Study|Other|0|||
130999761|NCT01536145|471628192|FG006|Overall Study|Other|0|||
130999762|NCT01536145|471628193|FG007|Overall Study|Other|0|||
130999763|NCT01536145|471628194|FG008|Overall Study|Other|0|||
130999764|NCT01536145|471628195|FG009|Overall Study|Other|3|||
130999765|NCT01536145|471628196|FG010|Overall Study|Other|2|||
130999766|NCT01536145|471628186|FG000|Overall Study|Death|0|||
130999767|NCT01536145|471628187|FG001|Overall Study|Death|0|||
130999768|NCT01536145|471628188|FG002|Overall Study|Death|0|||
130999769|NCT01536145|471628189|FG003|Overall Study|Death|0|||
130999770|NCT01536145|471628190|FG004|Overall Study|Death|0|||
130999771|NCT01536145|471628191|FG005|Overall Study|Death|0|||
130999772|NCT01536145|471628192|FG006|Overall Study|Death|1|||
130999773|NCT01536145|471628193|FG007|Overall Study|Death|0|||
130999774|NCT01536145|471628194|FG008|Overall Study|Death|0|||
130999775|NCT01536145|471628195|FG009|Overall Study|Death|0|||
130999776|NCT01536145|471628196|FG010|Overall Study|Death|0|||
130999777|NCT01536145|471628186|FG000|Overall Study|Adverse Event|0|||
130999778|NCT01536145|471628187|FG001|Overall Study|Adverse Event|0|||
130999779|NCT01536145|471628188|FG002|Overall Study|Adverse Event|0|||
130999780|NCT01536145|471628189|FG003|Overall Study|Adverse Event|0|||
130999781|NCT01536145|471628190|FG004|Overall Study|Adverse Event|0|||
130999782|NCT01536145|471628191|FG005|Overall Study|Adverse Event|0|||
130999783|NCT01536145|471628192|FG006|Overall Study|Adverse Event|0|||
130999784|NCT01536145|471628193|FG007|Overall Study|Adverse Event|2|||
130999785|NCT01536145|471628194|FG008|Overall Study|Adverse Event|0|||
130999786|NCT01536145|471628195|FG009|Overall Study|Adverse Event|0|||
130999787|NCT01536145|471628196|FG010|Overall Study|Adverse Event|3|||
130999788|NCT01364727|471628199|FG000|Overall Study|Not Eligible|2|||
130999789|NCT04716881|471628200|FG000|Overall Study|Adverse Event|1|||
130999790|NCT04716881|471628200|FG000|Overall Study|Lost to Follow-up|1|||
130999791|NCT02443103|471628201|FG000|Overall Study|Adverse Event|2|||
130999792|NCT02443103|471628201|FG000|Overall Study|Noncompliance|1|||
130999793|NCT01630590|471628202|FG000|Overall Study|Adverse Event|9|||
130999794|NCT01630590|471628202|FG000|Overall Study|Lack of Efficacy|37|||
130999795|NCT01630590|471628202|FG000|Overall Study|Withdrawal by Subject|4|||
130999796|NCT01630590|471628202|FG000|Overall Study|2nd primary tumor|2|||
130999797|NCT01630590|471628202|FG000|Overall Study|Automobile accident|1|||
130999798|NCT01630590|471628202|FG000|Overall Study|Maximum benefit|4|||
130999799|NCT02366936|471628203|FG000|Overall Study|Withdrawal by Subject|2|||
130999800|NCT02366936|471628203|FG000|Overall Study|Lost to Follow-up|4|||
130999801|NCT02366936|471628203|FG000|Overall Study|Physician Decision|2|||
130999802|NCT01558674|471628206|FG000|Part 1|Study Terminated by Sponsor|10|||
130999803|NCT01558674|471628207|FG001|Part 1|Study Terminated by Sponsor|0|||
130999804|NCT01558674|471628206|FG000|Part 1|Withdrawal by Subject|1|||
130999805|NCT01558674|471628207|FG001|Part 1|Withdrawal by Subject|0|||
130999806|NCT04147260|471628208|FG000|Overall Study|Adverse Event|1|||
130999807|NCT04147260|471628209|FG001|Overall Study|Adverse Event|0|||
130999808|NCT04147260|471628210|FG002|Overall Study|Adverse Event|1|||
130999809|NCT04147260|471628211|FG003|Overall Study|Adverse Event|2|||
130999810|NCT04147260|471628212|FG004|Overall Study|Adverse Event|0|||
130999811|NCT04147260|471628208|FG000|Overall Study|Withdrawal by Subject|0|||
130999812|NCT04147260|471628209|FG001|Overall Study|Withdrawal by Subject|0|||
130999813|NCT04147260|471628210|FG002|Overall Study|Withdrawal by Subject|1|||
130999814|NCT04147260|471628211|FG003|Overall Study|Withdrawal by Subject|1|||
130999815|NCT04147260|471628212|FG004|Overall Study|Withdrawal by Subject|0|||
130999816|NCT01555021|471628213|FG000|Overall Study|Lost to Follow-up|1|||
130999817|NCT01555021|471628214|FG001|Overall Study|Lost to Follow-up|2|||
130999818|NCT03358329|471628217|FG000|Overall Study|Lost to Follow-up|2|||
130999819|NCT03358329|471628217|FG000|Overall Study|Withdrawal by Subject|2|||
130999820|NCT02982720|471628218|FG000|Overall Study|Adverse Event|3|||
130999821|NCT02982720|471628218|FG000|Overall Study|Death|1|||
130999822|NCT01734850|471628223|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
130999823|NCT01734850|471628224|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
130999824|NCT01734850|471628225|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
130999825|NCT01734850|471628223|FG000|Overall Study|Not infused due to manufacturing failure|0|||
130999826|NCT01734850|471628224|FG001|Overall Study|Not infused due to manufacturing failure|0|||
130999827|NCT01734850|471628225|FG002|Overall Study|Not infused due to manufacturing failure|1|||
130999828|NCT00750893|471628226|FG000|Overall Study|Adverse Event|5|||
130999829|NCT00750893|471628226|FG000|Overall Study|Withdrawal by Subject|10|||
130999830|NCT00750893|471628226|FG000|Overall Study|Lost to Follow-up|510|||
130999831|NCT00750893|471628226|FG000|Overall Study|Other|17|||
130999832|NCT02420327|471628227|FG000|Overall Study|Adverse Event|7|||
130999833|NCT02420327|471628227|FG000|Overall Study|Pregnancy|1|||
130999834|NCT02420327|471628227|FG000|Overall Study|Withdrawal by Subject|6|||
130999835|NCT02420327|471628227|FG000|Overall Study|Lost to Follow-up|1|||
130999836|NCT02420327|471628227|FG000|Overall Study|Protocol Violation|1|||
130999837|NCT02204293|471628228|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
130999838|NCT02204293|471628229|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
130999839|NCT02204293|471628230|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
130999840|NCT02204293|471628231|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
130999841|NCT02204293|471628232|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
130999842|NCT02204293|471628233|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
130999843|NCT02204293|471628228|FG000|Core Study Part I|Adverse Event|1|||
130999844|NCT02204293|471628229|FG001|Core Study Part I|Adverse Event|0|||
130999845|NCT02204293|471628230|FG002|Core Study Part I|Adverse Event|0|||
130999846|NCT02204293|471628231|FG003|Core Study Part I|Adverse Event|0|||
130999847|NCT02204293|471628232|FG004|Core Study Part I|Adverse Event|0|||
130999848|NCT02204293|471628233|FG005|Core Study Part I|Adverse Event|0|||
130999849|NCT02204293|471628228|FG000|Core Study Part I|Physician Decision|0|||
130999850|NCT02204293|471628229|FG001|Core Study Part I|Physician Decision|3|||
130999851|NCT02204293|471628230|FG002|Core Study Part I|Physician Decision|0|||
130999852|NCT02204293|471628231|FG003|Core Study Part I|Physician Decision|0|||
130999853|NCT02204293|471628232|FG004|Core Study Part I|Physician Decision|0|||
130999854|NCT02204293|471628233|FG005|Core Study Part I|Physician Decision|0|||
130999855|NCT02204293|471628228|FG000|LTE Phase|Study Suspended|0|||
130999856|NCT02204293|471628229|FG001|LTE Phase|Study Suspended|0|||
130999857|NCT02204293|471628230|FG002|LTE Phase|Study Suspended|0|||
130999858|NCT02204293|471628231|FG003|LTE Phase|Study Suspended|0|||
130999859|NCT02204293|471628232|FG004|LTE Phase|Study Suspended|0|||
130999860|NCT02204293|471628233|FG005|LTE Phase|Study Suspended|7|||
130999861|NCT02589392|471628235|FG000|Overall Study|Adverse Event|1|||
130999862|NCT02589392|471628236|FG001|Overall Study|Adverse Event|1|||
130999863|NCT02589392|471628235|FG000|Overall Study|Withdrawal by Subject|1|||
130999864|NCT02589392|471628236|FG001|Overall Study|Withdrawal by Subject|2|||
130999865|NCT02589392|471628235|FG000|Overall Study|Protocol Violation|1|||
130999866|NCT02589392|471628236|FG001|Overall Study|Protocol Violation|1|||
130999867|NCT02589392|471628235|FG000|Overall Study|Lost to Follow-up|2|||
130999868|NCT02589392|471628236|FG001|Overall Study|Lost to Follow-up|2|||
130999869|NCT02589392|471628235|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
130999870|NCT02589392|471628236|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
130999871|NCT00393094|471628241|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
130999872|NCT00393094|471628241|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
130999873|NCT02019602|471628242|FG000|Screening Period|Ineligibility|4|||
130999874|NCT02019602|471628243|FG001|Screening Period|Ineligibility|0|||
130999875|NCT02019602|471628242|FG000|Screening Period|Adverse Event|1|||
130999876|NCT02019602|471628243|FG001|Screening Period|Adverse Event|0|||
130999877|NCT01058863|471628244|FG000|Overall Study|Lost to Follow-up|1|||
130999878|NCT01058863|471628244|FG000|Overall Study|Withdrawal by Subject|1|||
130999879|NCT01058863|471628244|FG000|Overall Study|Sponsor requested withdrawal|1|||
130999880|NCT01058863|471628244|FG000|Overall Study|Randomized in error|1|||
130999881|NCT03653416|471628245|FG000|Overall Study|Protocol Violation|6|||
130999882|NCT03653416|471628246|FG001|Overall Study|Protocol Violation|1|||
130999883|NCT01370603|471628249|FG000|Period 1|Adverse Event|5|||
130999884|NCT01370603|471628250|FG001|Period 1|Adverse Event|3|||
130999885|NCT01370603|471628249|FG000|Period 1|Lost to Follow-up|2|||
130999886|NCT01370603|471628250|FG001|Period 1|Lost to Follow-up|0|||
130999887|NCT01370603|471628249|FG000|Period 1|Protocol Violation|2|||
130999888|NCT01370603|471628250|FG001|Period 1|Protocol Violation|2|||
130999889|NCT01370603|471628249|FG000|Period 1|Withdrawal by Subject|5|||
130999890|NCT01370603|471628250|FG001|Period 1|Withdrawal by Subject|5|||
130999891|NCT01370603|471628249|FG000|Crossover Washout|Adverse Event|2|||
130999892|NCT01370603|471628250|FG001|Crossover Washout|Adverse Event|1|||
130999893|NCT01370603|471628249|FG000|Crossover Washout|Lost to Follow-up|2|||
130999894|NCT01370603|471628250|FG001|Crossover Washout|Lost to Follow-up|0|||
130999895|NCT01370603|471628249|FG000|Crossover Washout|Protocol Violation|1|||
130999896|NCT01370603|471628250|FG001|Crossover Washout|Protocol Violation|0|||
130999897|NCT01370603|471628249|FG000|Crossover Washout|Withdrawal by Subject|4|||
130999898|NCT01370603|471628250|FG001|Crossover Washout|Withdrawal by Subject|1|||
130999899|NCT01370603|471628249|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
130999900|NCT01370603|471628250|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
130999901|NCT01370603|471628249|FG000|Period 2|Adverse Event|1|||
130999902|NCT01370603|471628250|FG001|Period 2|Adverse Event|4|||
130999903|NCT01370603|471628249|FG000|Period 2|Lost to Follow-up|1|||
130999904|NCT01370603|471628250|FG001|Period 2|Lost to Follow-up|0|||
130999905|NCT01370603|471628249|FG000|Period 2|Withdrawal by Subject|1|||
130999906|NCT01370603|471628250|FG001|Period 2|Withdrawal by Subject|0|||
130999907|NCT00641186|471628255|FG000|Overall Study|Adverse Event|3|||
130999908|NCT02388074|471628256|FG000|Overall Study|Lost in Transit|2|||
130999909|NCT02388074|471628256|FG000|Overall Study|Sample Not Returned|1|||
130999910|NCT00003458|471628259|FG000|Overall Study|Not evaluable|4|||
130999911|NCT02133924|471628260|FG000|Overall Study|Death|38|||
130999912|NCT02133924|471628260|FG000|Overall Study|Physician Decision|1|||
130999913|NCT02133924|471628260|FG000|Overall Study|Withdrawal by Subject|3|||
130999914|NCT04212169|471629866|FG000|Overall Study|Adverse Event|0|||
130999915|NCT04212169|471629867|FG001|Overall Study|Adverse Event|0|||
130999916|NCT04212169|471629868|FG002|Overall Study|Adverse Event|0|||
130999917|NCT04212169|471629869|FG003|Overall Study|Adverse Event|2|||
130999918|NCT04212169|471629866|FG000|Overall Study|Lost to Follow-up|1|||
130999919|NCT04212169|471629867|FG001|Overall Study|Lost to Follow-up|0|||
130999920|NCT04212169|471629868|FG002|Overall Study|Lost to Follow-up|0|||
130999921|NCT04212169|471629869|FG003|Overall Study|Lost to Follow-up|2|||
130999922|NCT04212169|471629866|FG000|Overall Study|Withdrawal by Subject|10|||
130999923|NCT04212169|471629867|FG001|Overall Study|Withdrawal by Subject|2|||
130999924|NCT04212169|471629868|FG002|Overall Study|Withdrawal by Subject|5|||
130999925|NCT04212169|471629869|FG003|Overall Study|Withdrawal by Subject|7|||
130999926|NCT04212169|471629866|FG000|Overall Study|Other reason, unspecified|3|||
130999927|NCT04212169|471629867|FG001|Overall Study|Other reason, unspecified|1|||
130999928|NCT04212169|471629868|FG002|Overall Study|Other reason, unspecified|0|||
130999929|NCT04212169|471629869|FG003|Overall Study|Other reason, unspecified|2|||
130999930|NCT02018861|471629872|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130999931|NCT02018861|471629873|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
130999932|NCT02018861|471629874|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
130999933|NCT02018861|471629875|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
130999934|NCT02018861|471629876|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
130999935|NCT02018861|471629877|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
130999936|NCT02018861|471629878|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130999937|NCT02018861|471629879|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130999938|NCT02018861|471629880|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130999939|NCT02018861|471629881|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130999940|NCT02018861|471629872|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130999941|NCT02018861|471629873|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130999942|NCT02018861|471629874|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130999943|NCT02018861|471629875|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
130999944|NCT02018861|471629876|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
130999945|NCT02018861|471629877|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130999946|NCT02018861|471629878|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130999947|NCT02018861|471629879|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130999948|NCT02018861|471629880|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130999949|NCT02018861|471629881|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
130999950|NCT02018861|471629872|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130999951|NCT02018861|471629873|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
130999952|NCT02018861|471629874|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
130999953|NCT02018861|471629875|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
130999954|NCT02018861|471629876|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
130999955|NCT02018861|471629877|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
130999956|NCT02018861|471629878|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130999957|NCT02018861|471629879|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130999958|NCT02018861|471629880|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130999959|NCT02018861|471629881|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130999960|NCT02018861|471629872|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
130999961|NCT02018861|471629873|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130999962|NCT02018861|471629874|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130999963|NCT02018861|471629875|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
130999964|NCT02018861|471629876|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
130999965|NCT02018861|471629877|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130999966|NCT02018861|471629878|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130999967|NCT02018861|471629879|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130999968|NCT02018861|471629880|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130999969|NCT02018861|471629881|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
130999970|NCT02018861|471629872|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130999971|NCT02018861|471629873|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130999972|NCT02018861|471629874|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
130999973|NCT02018861|471629875|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
130999974|NCT02018861|471629876|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130999975|NCT02018861|471629877|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130999976|NCT02018861|471629878|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130999977|NCT02018861|471629879|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130999978|NCT02018861|471629880|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130999979|NCT02018861|471629881|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130999980|NCT02018861|471629872|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130999981|NCT02018861|471629873|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130999982|NCT02018861|471629874|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130999983|NCT02018861|471629875|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130999984|NCT02018861|471629876|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
130999985|NCT02018861|471629877|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130999986|NCT02018861|471629878|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130999987|NCT02018861|471629879|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130999988|NCT02018861|471629880|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130999989|NCT02018861|471629881|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
130999990|NCT02018861|471629872|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130999991|NCT02018861|471629873|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130999992|NCT02018861|471629874|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130999993|NCT02018861|471629875|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
130999994|NCT02018861|471629876|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
130999995|NCT02018861|471629877|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
130999996|NCT02018861|471629878|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130999997|NCT02018861|471629879|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130999998|NCT02018861|471629880|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130999999|NCT02018861|471629881|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
131000000|NCT02018861|471629872|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131000001|NCT02018861|471629873|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131000002|NCT02018861|471629874|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131000003|NCT02018861|471629875|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
131000004|NCT02018861|471629876|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
131000005|NCT02018861|471629877|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131000006|NCT02018861|471629878|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131000007|NCT02018861|471629879|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131000008|NCT02018861|471629880|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131000009|NCT02018861|471629881|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
131000010|NCT02018861|471629872|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131000011|NCT02018861|471629873|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131000012|NCT02018861|471629874|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131000013|NCT02018861|471629875|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131000014|NCT02018861|471629876|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131000015|NCT02018861|471629877|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131000016|NCT02018861|471629878|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
131000017|NCT02018861|471629879|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
131000018|NCT02018861|471629880|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131000019|NCT02018861|471629881|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
131000020|NCT02018861|471629872|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131000021|NCT02018861|471629873|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131000022|NCT02018861|471629874|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131000023|NCT02018861|471629875|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131000024|NCT02018861|471629876|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131000025|NCT02018861|471629877|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131000026|NCT02018861|471629878|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
131000027|NCT02018861|471629879|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
131000028|NCT02018861|471629880|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131000029|NCT02018861|471629881|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
131000030|NCT02018861|471629872|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131000031|NCT02018861|471629873|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131000032|NCT02018861|471629874|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131000033|NCT02018861|471629875|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131000034|NCT02018861|471629876|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131000035|NCT02018861|471629877|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131000036|NCT02018861|471629878|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131000037|NCT02018861|471629879|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131000038|NCT02018861|471629880|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
131000039|NCT02018861|471629881|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
131000040|NCT02018861|471629872|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131000041|NCT02018861|471629873|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131000042|NCT02018861|471629874|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131000043|NCT02018861|471629875|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131000044|NCT02018861|471629876|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131000045|NCT02018861|471629877|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131000046|NCT02018861|471629878|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131000047|NCT02018861|471629879|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131000048|NCT02018861|471629880|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
131000049|NCT02018861|471629881|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
131000050|NCT02018861|471629872|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131000051|NCT02018861|471629873|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131000052|NCT02018861|471629874|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131000053|NCT02018861|471629875|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131000054|NCT02018861|471629876|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131000055|NCT02018861|471629877|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131000056|NCT02018861|471629878|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131000057|NCT02018861|471629879|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131000058|NCT02018861|471629880|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
131000059|NCT02018861|471629881|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
131000060|NCT00504348|471629882|FG000|Overall Study|Adverse Event|3|||
131000061|NCT00504348|471629882|FG000|Overall Study|Lack of Efficacy|4|||
131000062|NCT00504348|471629882|FG000|Overall Study|Physician Decision|1|||
131000063|NCT02718417|471629885|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
131000064|NCT02718417|471629886|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
131000065|NCT02718417|471629887|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
131000066|NCT02718417|471629885|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
131000067|NCT02718417|471629886|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
131000068|NCT02718417|471629887|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
131000069|NCT02718417|471629885|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
131000070|NCT02718417|471629886|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
131000071|NCT02718417|471629887|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
131000072|NCT02718417|471629885|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
131000073|NCT02718417|471629886|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
131000074|NCT02718417|471629887|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
131000075|NCT02718417|471629885|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
131000076|NCT02718417|471629886|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
131000077|NCT02718417|471629887|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
131000078|NCT02718417|471629885|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
131000079|NCT02718417|471629886|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
131000080|NCT02718417|471629887|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
131000081|NCT02718417|471629885|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
131000082|NCT02718417|471629886|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
131000083|NCT02718417|471629887|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
131000084|NCT02718417|471629885|FG000|Chemotherapy Phase (CP)|Other|2|||
131000085|NCT02718417|471629886|FG001|Chemotherapy Phase (CP)|Other|0|||
131000086|NCT02718417|471629887|FG002|Chemotherapy Phase (CP)|Other|1|||
131000087|NCT02718417|471629885|FG000|Maintenance Phase (MP)|Adverse Event|21|||
131000088|NCT02718417|471629886|FG001|Maintenance Phase (MP)|Adverse Event|26|||
131000089|NCT02718417|471629887|FG002|Maintenance Phase (MP)|Adverse Event|0|||
131000090|NCT02718417|471629885|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
131000091|NCT02718417|471629886|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
131000092|NCT02718417|471629887|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
131000093|NCT02718417|471629885|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
131000094|NCT02718417|471629886|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
131000095|NCT02718417|471629887|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
131000096|NCT02718417|471629885|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
131000097|NCT02718417|471629886|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
131000098|NCT02718417|471629887|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
131000099|NCT02718417|471629885|FG000|Maintenance Phase (MP)|Physician's decision|6|||
131000100|NCT02718417|471629886|FG001|Maintenance Phase (MP)|Physician's decision|7|||
131000101|NCT02718417|471629887|FG002|Maintenance Phase (MP)|Physician's decision|0|||
131000102|NCT02718417|471629885|FG000|Maintenance Phase (MP)|Progressive disease|100|||
131000103|NCT02718417|471629886|FG001|Maintenance Phase (MP)|Progressive disease|88|||
131000104|NCT02718417|471629887|FG002|Maintenance Phase (MP)|Progressive disease|0|||
131000105|NCT02718417|471629885|FG000|Maintenance Phase (MP)|Other|2|||
131000106|NCT02718417|471629886|FG001|Maintenance Phase (MP)|Other|1|||
131000107|NCT02718417|471629887|FG002|Maintenance Phase (MP)|Other|0|||
131000108|NCT02718417|471629885|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
131000109|NCT02718417|471629886|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
131000110|NCT02718417|471629887|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
131000111|NCT02718417|471629885|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
131000112|NCT02718417|471629886|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
131000113|NCT02718417|471629887|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
131000114|NCT02718417|471629885|FG000|Observation Phase (OP)|Adverse Event|0|||
131000115|NCT02718417|471629886|FG001|Observation Phase (OP)|Adverse Event|0|||
131000116|NCT02718417|471629887|FG002|Observation Phase (OP)|Adverse Event|1|||
131000117|NCT02718417|471629885|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
131000118|NCT02718417|471629886|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
131000119|NCT02718417|471629887|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
131000120|NCT02718417|471629885|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
131000121|NCT02718417|471629886|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
131000122|NCT02718417|471629887|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
131000123|NCT02718417|471629885|FG000|Observation Phase (OP)|Physician Decision|0|||
131000124|NCT02718417|471629886|FG001|Observation Phase (OP)|Physician Decision|0|||
131000125|NCT02718417|471629887|FG002|Observation Phase (OP)|Physician Decision|9|||
131000126|NCT02718417|471629885|FG000|Observation Phase (OP)|Progressive disease|0|||
131000127|NCT02718417|471629886|FG001|Observation Phase (OP)|Progressive disease|0|||
131000128|NCT02718417|471629887|FG002|Observation Phase (OP)|Progressive disease|92|||
131000129|NCT02718417|471629885|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
131000130|NCT02718417|471629886|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
131000131|NCT02718417|471629887|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
131000132|NCT02718417|471629885|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
131000133|NCT02718417|471629886|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
131000134|NCT02718417|471629887|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
131000135|NCT02718417|471629885|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
131000136|NCT02718417|471629886|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
131000137|NCT02718417|471629887|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
131000138|NCT02718417|471629885|FG000|Observation Phase (OP)|Other|0|||
131000139|NCT02718417|471629886|FG001|Observation Phase (OP)|Other|0|||
131000140|NCT02718417|471629887|FG002|Observation Phase (OP)|Other|7|||
131000141|NCT02718417|471629885|FG000|Follow-up Phase|Adverse Event|3|||
131000142|NCT02718417|471629886|FG001|Follow-up Phase|Adverse Event|1|||
131000143|NCT02718417|471629887|FG002|Follow-up Phase|Adverse Event|1|||
131000144|NCT02718417|471629885|FG000|Follow-up Phase|Other|4|||
131000145|NCT02718417|471629886|FG001|Follow-up Phase|Other|6|||
131000146|NCT02718417|471629887|FG002|Follow-up Phase|Other|4|||
131000147|NCT02718417|471629885|FG000|Follow-up Phase|Withdrawal by Subject|19|||
131000148|NCT02718417|471629886|FG001|Follow-up Phase|Withdrawal by Subject|17|||
131000149|NCT02718417|471629887|FG002|Follow-up Phase|Withdrawal by Subject|5|||
131000150|NCT02718417|471629885|FG000|Follow-up Phase|Study terminated by sponsor|100|||
131000151|NCT02718417|471629886|FG001|Follow-up Phase|Study terminated by sponsor|138|||
131000152|NCT02718417|471629887|FG002|Follow-up Phase|Study terminated by sponsor|6|||
131000153|NCT02718417|471629885|FG000|Follow-up Phase|Lost to Follow-up|2|||
131000154|NCT02718417|471629886|FG001|Follow-up Phase|Lost to Follow-up|3|||
131000155|NCT02718417|471629887|FG002|Follow-up Phase|Lost to Follow-up|0|||
131000156|NCT02718417|471629885|FG000|Follow-up Phase|Death leading to discontinuation|7|||
131221919|NCT00295620|472439465|FG000|Overall Study|Lost to Follow-up|9|||
131221920|NCT00295620|472439466|FG001|Overall Study|Lost to Follow-up|5|||
131221921|NCT00295620|472439465|FG000|Overall Study|Withdrawal by Subject|37|||
131000157|NCT02718417|471629886|FG001|Follow-up Phase|Death leading to discontinuation|7|||
131000158|NCT02718417|471629887|FG002|Follow-up Phase|Death leading to discontinuation|3|||
131000159|NCT02718417|471629885|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
131000160|NCT02718417|471629886|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
131000161|NCT02718417|471629887|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
131000162|NCT02718417|471629885|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
131000163|NCT02718417|471629886|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
131000164|NCT02718417|471629887|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
131000165|NCT02718417|471629885|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
131000166|NCT02718417|471629886|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
131000167|NCT02718417|471629887|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
131000168|NCT02718417|471629885|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
131000169|NCT02718417|471629886|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
131000170|NCT02718417|471629887|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
131000171|NCT02718417|471629885|FG000|Long-term Follow-up Phase|Other|0|||
131000172|NCT02718417|471629886|FG001|Long-term Follow-up Phase|Other|2|||
131000173|NCT02718417|471629887|FG002|Long-term Follow-up Phase|Other|0|||
131000174|NCT01474512|471629888|FG000|Induction Period|Adverse Event|6|||
131000175|NCT01474512|471629889|FG001|Induction Period|Adverse Event|10|||
131000176|NCT01474512|471629890|FG002|Induction Period|Adverse Event|10|||
131000177|NCT01474512|471629891|FG003|Induction Period|Adverse Event|0|||
131000178|NCT01474512|471629892|FG004|Induction Period|Adverse Event|0|||
131000179|NCT01474512|471629893|FG005|Induction Period|Adverse Event|0|||
131000180|NCT01474512|471629894|FG006|Induction Period|Adverse Event|0|||
131000181|NCT01474512|471629895|FG007|Induction Period|Adverse Event|0|||
131000182|NCT01474512|471629896|FG008|Induction Period|Adverse Event|0|||
131000183|NCT01474512|471629897|FG009|Induction Period|Adverse Event|0|||
131000184|NCT01474512|471629898|FG010|Induction Period|Adverse Event|0|||
131000185|NCT01474512|471629899|FG011|Induction Period|Adverse Event|0|||
131000186|NCT01474512|471629900|FG012|Induction Period|Adverse Event|0|||
131000187|NCT01474512|471629901|FG013|Induction Period|Adverse Event|0|||
131000188|NCT01474512|471629902|FG014|Induction Period|Adverse Event|0|||
131000189|NCT01474512|471629903|FG015|Induction Period|Adverse Event|0|||
131000190|NCT01474512|471629904|FG016|Induction Period|Adverse Event|0|||
131000191|NCT01474512|471629905|FG017|Induction Period|Adverse Event|0|||
131000192|NCT01474512|471629888|FG000|Induction Period|Lack of Efficacy|7|||
131000193|NCT01474512|471629889|FG001|Induction Period|Lack of Efficacy|1|||
131000194|NCT01474512|471629890|FG002|Induction Period|Lack of Efficacy|0|||
131000195|NCT01474512|471629891|FG003|Induction Period|Lack of Efficacy|0|||
131000196|NCT01474512|471629892|FG004|Induction Period|Lack of Efficacy|0|||
131000197|NCT01474512|471629893|FG005|Induction Period|Lack of Efficacy|0|||
131000198|NCT01474512|471629894|FG006|Induction Period|Lack of Efficacy|0|||
131000199|NCT01474512|471629895|FG007|Induction Period|Lack of Efficacy|0|||
131000200|NCT01474512|471629896|FG008|Induction Period|Lack of Efficacy|0|||
131000201|NCT01474512|471629897|FG009|Induction Period|Lack of Efficacy|0|||
131000202|NCT01474512|471629898|FG010|Induction Period|Lack of Efficacy|0|||
131000203|NCT01474512|471629899|FG011|Induction Period|Lack of Efficacy|0|||
131000204|NCT01474512|471629900|FG012|Induction Period|Lack of Efficacy|0|||
131000205|NCT01474512|471629901|FG013|Induction Period|Lack of Efficacy|0|||
131000206|NCT01474512|471629902|FG014|Induction Period|Lack of Efficacy|0|||
131000207|NCT01474512|471629903|FG015|Induction Period|Lack of Efficacy|0|||
131000208|NCT01474512|471629904|FG016|Induction Period|Lack of Efficacy|0|||
131000209|NCT01474512|471629905|FG017|Induction Period|Lack of Efficacy|0|||
131000210|NCT01474512|471629888|FG000|Induction Period|Withdrawal by Subject|6|||
131000211|NCT01474512|471629889|FG001|Induction Period|Withdrawal by Subject|6|||
131000212|NCT01474512|471629890|FG002|Induction Period|Withdrawal by Subject|5|||
131000213|NCT01474512|471629891|FG003|Induction Period|Withdrawal by Subject|0|||
131000214|NCT01474512|471629892|FG004|Induction Period|Withdrawal by Subject|0|||
131000215|NCT01474512|471629893|FG005|Induction Period|Withdrawal by Subject|0|||
131000216|NCT01474512|471629894|FG006|Induction Period|Withdrawal by Subject|0|||
131000217|NCT01474512|471629895|FG007|Induction Period|Withdrawal by Subject|0|||
131000218|NCT01474512|471629896|FG008|Induction Period|Withdrawal by Subject|0|||
131000219|NCT01474512|471629897|FG009|Induction Period|Withdrawal by Subject|0|||
131000220|NCT01474512|471629898|FG010|Induction Period|Withdrawal by Subject|0|||
131000221|NCT01474512|471629899|FG011|Induction Period|Withdrawal by Subject|0|||
131000222|NCT01474512|471629900|FG012|Induction Period|Withdrawal by Subject|0|||
131000223|NCT01474512|471629901|FG013|Induction Period|Withdrawal by Subject|0|||
131000224|NCT01474512|471629902|FG014|Induction Period|Withdrawal by Subject|0|||
131000225|NCT01474512|471629903|FG015|Induction Period|Withdrawal by Subject|0|||
131000226|NCT01474512|471629904|FG016|Induction Period|Withdrawal by Subject|0|||
131000227|NCT01474512|471629905|FG017|Induction Period|Withdrawal by Subject|0|||
131000228|NCT01474512|471629888|FG000|Induction Period|Protocol Violation|3|||
131000229|NCT01474512|471629889|FG001|Induction Period|Protocol Violation|6|||
131000230|NCT01474512|471629890|FG002|Induction Period|Protocol Violation|0|||
131000231|NCT01474512|471629891|FG003|Induction Period|Protocol Violation|0|||
131000232|NCT01474512|471629892|FG004|Induction Period|Protocol Violation|0|||
131000233|NCT01474512|471629893|FG005|Induction Period|Protocol Violation|0|||
131000234|NCT01474512|471629894|FG006|Induction Period|Protocol Violation|0|||
131000235|NCT01474512|471629895|FG007|Induction Period|Protocol Violation|0|||
131000236|NCT01474512|471629896|FG008|Induction Period|Protocol Violation|0|||
131000237|NCT01474512|471629897|FG009|Induction Period|Protocol Violation|0|||
131000238|NCT01474512|471629898|FG010|Induction Period|Protocol Violation|0|||
131000239|NCT01474512|471629899|FG011|Induction Period|Protocol Violation|0|||
131000240|NCT01474512|471629900|FG012|Induction Period|Protocol Violation|0|||
131000241|NCT01474512|471629901|FG013|Induction Period|Protocol Violation|0|||
131000242|NCT01474512|471629902|FG014|Induction Period|Protocol Violation|0|||
131000243|NCT01474512|471629903|FG015|Induction Period|Protocol Violation|0|||
131000244|NCT01474512|471629904|FG016|Induction Period|Protocol Violation|0|||
131000245|NCT01474512|471629905|FG017|Induction Period|Protocol Violation|0|||
131000246|NCT01474512|471629888|FG000|Induction Period|Sponsor Decision|1|||
131000247|NCT01474512|471629889|FG001|Induction Period|Sponsor Decision|1|||
131000248|NCT01474512|471629890|FG002|Induction Period|Sponsor Decision|1|||
131000249|NCT01474512|471629891|FG003|Induction Period|Sponsor Decision|0|||
131000250|NCT01474512|471629892|FG004|Induction Period|Sponsor Decision|0|||
131000251|NCT01474512|471629893|FG005|Induction Period|Sponsor Decision|0|||
131000252|NCT01474512|471629894|FG006|Induction Period|Sponsor Decision|0|||
131000253|NCT01474512|471629895|FG007|Induction Period|Sponsor Decision|0|||
131000254|NCT01474512|471629896|FG008|Induction Period|Sponsor Decision|0|||
131000255|NCT01474512|471629897|FG009|Induction Period|Sponsor Decision|0|||
131000256|NCT01474512|471629898|FG010|Induction Period|Sponsor Decision|0|||
131000257|NCT01474512|471629899|FG011|Induction Period|Sponsor Decision|0|||
131000258|NCT01474512|471629900|FG012|Induction Period|Sponsor Decision|0|||
131000259|NCT01474512|471629901|FG013|Induction Period|Sponsor Decision|0|||
131000260|NCT01474512|471629902|FG014|Induction Period|Sponsor Decision|0|||
131000261|NCT01474512|471629903|FG015|Induction Period|Sponsor Decision|0|||
131000262|NCT01474512|471629904|FG016|Induction Period|Sponsor Decision|0|||
131000263|NCT01474512|471629905|FG017|Induction Period|Sponsor Decision|0|||
131000264|NCT01474512|471629888|FG000|Induction Period|Lost to Follow-up|1|||
131000265|NCT01474512|471629889|FG001|Induction Period|Lost to Follow-up|0|||
131000266|NCT01474512|471629890|FG002|Induction Period|Lost to Follow-up|2|||
131000267|NCT01474512|471629891|FG003|Induction Period|Lost to Follow-up|0|||
131000268|NCT01474512|471629892|FG004|Induction Period|Lost to Follow-up|0|||
131000269|NCT01474512|471629893|FG005|Induction Period|Lost to Follow-up|0|||
131000270|NCT01474512|471629894|FG006|Induction Period|Lost to Follow-up|0|||
131000271|NCT01474512|471629895|FG007|Induction Period|Lost to Follow-up|0|||
131000272|NCT01474512|471629896|FG008|Induction Period|Lost to Follow-up|0|||
131000273|NCT01474512|471629897|FG009|Induction Period|Lost to Follow-up|0|||
131000274|NCT01474512|471629898|FG010|Induction Period|Lost to Follow-up|0|||
131000275|NCT01474512|471629899|FG011|Induction Period|Lost to Follow-up|0|||
131000276|NCT01474512|471629900|FG012|Induction Period|Lost to Follow-up|0|||
131000277|NCT01474512|471629901|FG013|Induction Period|Lost to Follow-up|0|||
131000278|NCT01474512|471629902|FG014|Induction Period|Lost to Follow-up|0|||
131000279|NCT01474512|471629903|FG015|Induction Period|Lost to Follow-up|0|||
131000280|NCT01474512|471629904|FG016|Induction Period|Lost to Follow-up|0|||
131000281|NCT01474512|471629905|FG017|Induction Period|Lost to Follow-up|0|||
131000282|NCT01474512|471629888|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000283|NCT01474512|471629889|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000284|NCT01474512|471629890|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000285|NCT01474512|471629891|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
131000286|NCT01474512|471629892|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
131000287|NCT01474512|471629893|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
131000288|NCT01474512|471629894|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
131000289|NCT01474512|471629895|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000290|NCT01474512|471629896|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000291|NCT01474512|471629897|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000292|NCT01474512|471629898|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000293|NCT01474512|471629899|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000294|NCT01474512|471629900|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000295|NCT01474512|471629901|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000296|NCT01474512|471629902|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000297|NCT01474512|471629903|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000298|NCT01474512|471629904|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000299|NCT01474512|471629905|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
131000300|NCT01474512|471629888|FG000|Maintenance Period|Adverse Event|0|||
131000301|NCT01474512|471629889|FG001|Maintenance Period|Adverse Event|0|||
131000302|NCT01474512|471629890|FG002|Maintenance Period|Adverse Event|0|||
131000303|NCT01474512|471629891|FG003|Maintenance Period|Adverse Event|4|||
131000304|NCT01474512|471629892|FG004|Maintenance Period|Adverse Event|2|||
131000305|NCT01474512|471629893|FG005|Maintenance Period|Adverse Event|7|||
131000306|NCT01474512|471629894|FG006|Maintenance Period|Adverse Event|0|||
131000307|NCT01474512|471629895|FG007|Maintenance Period|Adverse Event|19|||
131000308|NCT01474512|471629896|FG008|Maintenance Period|Adverse Event|1|||
131000309|NCT01474512|471629897|FG009|Maintenance Period|Adverse Event|3|||
131000310|NCT01474512|471629898|FG010|Maintenance Period|Adverse Event|0|||
131000311|NCT01474512|471629899|FG011|Maintenance Period|Adverse Event|0|||
131000312|NCT01474512|471629900|FG012|Maintenance Period|Adverse Event|0|||
131000313|NCT01474512|471629901|FG013|Maintenance Period|Adverse Event|0|||
131000314|NCT01474512|471629902|FG014|Maintenance Period|Adverse Event|0|||
131000315|NCT01474512|471629903|FG015|Maintenance Period|Adverse Event|0|||
131000316|NCT01474512|471629904|FG016|Maintenance Period|Adverse Event|0|||
131000317|NCT01474512|471629905|FG017|Maintenance Period|Adverse Event|0|||
131000318|NCT01474512|471629888|FG000|Maintenance Period|Withdrawal by Subject|0|||
131000319|NCT01474512|471629889|FG001|Maintenance Period|Withdrawal by Subject|0|||
131000320|NCT01474512|471629890|FG002|Maintenance Period|Withdrawal by Subject|0|||
131000321|NCT01474512|471629891|FG003|Maintenance Period|Withdrawal by Subject|6|||
131000322|NCT01474512|471629892|FG004|Maintenance Period|Withdrawal by Subject|2|||
131000323|NCT01474512|471629893|FG005|Maintenance Period|Withdrawal by Subject|3|||
131000324|NCT01474512|471629894|FG006|Maintenance Period|Withdrawal by Subject|1|||
131000325|NCT01474512|471629895|FG007|Maintenance Period|Withdrawal by Subject|6|||
131000326|NCT01474512|471629896|FG008|Maintenance Period|Withdrawal by Subject|3|||
131000327|NCT01474512|471629897|FG009|Maintenance Period|Withdrawal by Subject|1|||
131000328|NCT01474512|471629898|FG010|Maintenance Period|Withdrawal by Subject|0|||
131000329|NCT01474512|471629899|FG011|Maintenance Period|Withdrawal by Subject|0|||
131000330|NCT01474512|471629900|FG012|Maintenance Period|Withdrawal by Subject|0|||
131000331|NCT01474512|471629901|FG013|Maintenance Period|Withdrawal by Subject|0|||
131000332|NCT01474512|471629902|FG014|Maintenance Period|Withdrawal by Subject|0|||
131000333|NCT01474512|471629903|FG015|Maintenance Period|Withdrawal by Subject|0|||
131000334|NCT01474512|471629904|FG016|Maintenance Period|Withdrawal by Subject|0|||
131000335|NCT01474512|471629905|FG017|Maintenance Period|Withdrawal by Subject|0|||
131000336|NCT01474512|471629888|FG000|Maintenance Period|Lost to Follow-up|0|||
131000337|NCT01474512|471629889|FG001|Maintenance Period|Lost to Follow-up|0|||
131000338|NCT01474512|471629890|FG002|Maintenance Period|Lost to Follow-up|0|||
131000339|NCT01474512|471629891|FG003|Maintenance Period|Lost to Follow-up|3|||
131000340|NCT01474512|471629892|FG004|Maintenance Period|Lost to Follow-up|3|||
131000341|NCT01474512|471629893|FG005|Maintenance Period|Lost to Follow-up|0|||
131000342|NCT01474512|471629894|FG006|Maintenance Period|Lost to Follow-up|0|||
131000343|NCT01474512|471629895|FG007|Maintenance Period|Lost to Follow-up|2|||
131000344|NCT01474512|471629896|FG008|Maintenance Period|Lost to Follow-up|1|||
131000345|NCT01474512|471629897|FG009|Maintenance Period|Lost to Follow-up|1|||
131000346|NCT01474512|471629898|FG010|Maintenance Period|Lost to Follow-up|0|||
131000347|NCT01474512|471629899|FG011|Maintenance Period|Lost to Follow-up|0|||
131000348|NCT01474512|471629900|FG012|Maintenance Period|Lost to Follow-up|0|||
131000349|NCT01474512|471629901|FG013|Maintenance Period|Lost to Follow-up|0|||
131000350|NCT01474512|471629902|FG014|Maintenance Period|Lost to Follow-up|0|||
131000351|NCT01474512|471629903|FG015|Maintenance Period|Lost to Follow-up|0|||
131000352|NCT01474512|471629904|FG016|Maintenance Period|Lost to Follow-up|0|||
131000353|NCT01474512|471629905|FG017|Maintenance Period|Lost to Follow-up|0|||
131000354|NCT01474512|471629888|FG000|Maintenance Period|Death|0|||
131000355|NCT01474512|471629889|FG001|Maintenance Period|Death|0|||
131000356|NCT01474512|471629890|FG002|Maintenance Period|Death|0|||
131000357|NCT01474512|471629891|FG003|Maintenance Period|Death|0|||
131000358|NCT01474512|471629892|FG004|Maintenance Period|Death|0|||
131000359|NCT01474512|471629893|FG005|Maintenance Period|Death|2|||
131000360|NCT01474512|471629894|FG006|Maintenance Period|Death|0|||
131000361|NCT01474512|471629895|FG007|Maintenance Period|Death|0|||
131000362|NCT01474512|471629896|FG008|Maintenance Period|Death|0|||
131000363|NCT01474512|471629897|FG009|Maintenance Period|Death|0|||
131000364|NCT01474512|471629898|FG010|Maintenance Period|Death|0|||
131000365|NCT01474512|471629899|FG011|Maintenance Period|Death|0|||
131000366|NCT01474512|471629900|FG012|Maintenance Period|Death|0|||
131000367|NCT01474512|471629901|FG013|Maintenance Period|Death|0|||
131000368|NCT01474512|471629902|FG014|Maintenance Period|Death|0|||
131000369|NCT01474512|471629903|FG015|Maintenance Period|Death|0|||
131000370|NCT01474512|471629904|FG016|Maintenance Period|Death|0|||
131000371|NCT01474512|471629905|FG017|Maintenance Period|Death|0|||
131000372|NCT01474512|471629888|FG000|Maintenance Period|Physician Decision|0|||
131000373|NCT01474512|471629889|FG001|Maintenance Period|Physician Decision|0|||
131000374|NCT01474512|471629890|FG002|Maintenance Period|Physician Decision|0|||
131000375|NCT01474512|471629891|FG003|Maintenance Period|Physician Decision|0|||
131000376|NCT01474512|471629892|FG004|Maintenance Period|Physician Decision|0|||
131000377|NCT01474512|471629893|FG005|Maintenance Period|Physician Decision|1|||
131000378|NCT01474512|471629894|FG006|Maintenance Period|Physician Decision|0|||
131000379|NCT01474512|471629895|FG007|Maintenance Period|Physician Decision|2|||
131000380|NCT01474512|471629896|FG008|Maintenance Period|Physician Decision|0|||
131000381|NCT01474512|471629897|FG009|Maintenance Period|Physician Decision|0|||
131000382|NCT01474512|471629898|FG010|Maintenance Period|Physician Decision|0|||
131000383|NCT01474512|471629899|FG011|Maintenance Period|Physician Decision|0|||
131000384|NCT01474512|471629900|FG012|Maintenance Period|Physician Decision|0|||
131000385|NCT01474512|471629901|FG013|Maintenance Period|Physician Decision|0|||
131000386|NCT01474512|471629902|FG014|Maintenance Period|Physician Decision|0|||
131000387|NCT01474512|471629903|FG015|Maintenance Period|Physician Decision|0|||
131000388|NCT01474512|471629904|FG016|Maintenance Period|Physician Decision|0|||
131000389|NCT01474512|471629905|FG017|Maintenance Period|Physician Decision|0|||
131000390|NCT01474512|471629888|FG000|Maintenance Period|Clinical Relapse|0|||
131000391|NCT01474512|471629889|FG001|Maintenance Period|Clinical Relapse|0|||
131000392|NCT01474512|471629890|FG002|Maintenance Period|Clinical Relapse|0|||
131000393|NCT01474512|471629891|FG003|Maintenance Period|Clinical Relapse|1|||
131000394|NCT01474512|471629892|FG004|Maintenance Period|Clinical Relapse|0|||
131000395|NCT01474512|471629893|FG005|Maintenance Period|Clinical Relapse|0|||
131000396|NCT01474512|471629894|FG006|Maintenance Period|Clinical Relapse|0|||
131000397|NCT01474512|471629895|FG007|Maintenance Period|Clinical Relapse|0|||
131000398|NCT01474512|471629896|FG008|Maintenance Period|Clinical Relapse|0|||
131000399|NCT01474512|471629897|FG009|Maintenance Period|Clinical Relapse|0|||
131000400|NCT01474512|471629898|FG010|Maintenance Period|Clinical Relapse|0|||
131000401|NCT01474512|471629899|FG011|Maintenance Period|Clinical Relapse|0|||
131000402|NCT01474512|471629900|FG012|Maintenance Period|Clinical Relapse|0|||
131000403|NCT01474512|471629901|FG013|Maintenance Period|Clinical Relapse|0|||
131000404|NCT01474512|471629902|FG014|Maintenance Period|Clinical Relapse|0|||
131000405|NCT01474512|471629903|FG015|Maintenance Period|Clinical Relapse|0|||
131000406|NCT01474512|471629904|FG016|Maintenance Period|Clinical Relapse|0|||
131000407|NCT01474512|471629905|FG017|Maintenance Period|Clinical Relapse|0|||
131000408|NCT01474512|471629888|FG000|Maintenance Period|Lack of Efficacy|0|||
131000409|NCT01474512|471629889|FG001|Maintenance Period|Lack of Efficacy|0|||
131000410|NCT01474512|471629890|FG002|Maintenance Period|Lack of Efficacy|0|||
131000411|NCT01474512|471629891|FG003|Maintenance Period|Lack of Efficacy|1|||
131000412|NCT01474512|471629892|FG004|Maintenance Period|Lack of Efficacy|0|||
131000413|NCT01474512|471629893|FG005|Maintenance Period|Lack of Efficacy|0|||
131000414|NCT01474512|471629894|FG006|Maintenance Period|Lack of Efficacy|0|||
131000415|NCT01474512|471629895|FG007|Maintenance Period|Lack of Efficacy|11|||
131000416|NCT01474512|471629896|FG008|Maintenance Period|Lack of Efficacy|11|||
131000417|NCT01474512|471629897|FG009|Maintenance Period|Lack of Efficacy|12|||
131000418|NCT01474512|471629898|FG010|Maintenance Period|Lack of Efficacy|0|||
131000419|NCT01474512|471629899|FG011|Maintenance Period|Lack of Efficacy|0|||
131000420|NCT01474512|471629900|FG012|Maintenance Period|Lack of Efficacy|0|||
131000421|NCT01474512|471629901|FG013|Maintenance Period|Lack of Efficacy|0|||
131000422|NCT01474512|471629902|FG014|Maintenance Period|Lack of Efficacy|0|||
131000423|NCT01474512|471629903|FG015|Maintenance Period|Lack of Efficacy|0|||
131000424|NCT01474512|471629904|FG016|Maintenance Period|Lack of Efficacy|0|||
131000425|NCT01474512|471629905|FG017|Maintenance Period|Lack of Efficacy|0|||
131000426|NCT01474512|471629888|FG000|Maintenance Period|Protocol Violation|0|||
131000427|NCT01474512|471629889|FG001|Maintenance Period|Protocol Violation|0|||
131000428|NCT01474512|471629890|FG002|Maintenance Period|Protocol Violation|0|||
131000429|NCT01474512|471629891|FG003|Maintenance Period|Protocol Violation|1|||
131000430|NCT01474512|471629892|FG004|Maintenance Period|Protocol Violation|0|||
131000431|NCT01474512|471629893|FG005|Maintenance Period|Protocol Violation|0|||
131000432|NCT01474512|471629894|FG006|Maintenance Period|Protocol Violation|0|||
131000433|NCT01474512|471629895|FG007|Maintenance Period|Protocol Violation|1|||
131000434|NCT01474512|471629896|FG008|Maintenance Period|Protocol Violation|0|||
131000435|NCT01474512|471629897|FG009|Maintenance Period|Protocol Violation|1|||
131000436|NCT01474512|471629898|FG010|Maintenance Period|Protocol Violation|0|||
131000437|NCT01474512|471629899|FG011|Maintenance Period|Protocol Violation|0|||
131000438|NCT01474512|471629900|FG012|Maintenance Period|Protocol Violation|0|||
131000439|NCT01474512|471629901|FG013|Maintenance Period|Protocol Violation|0|||
131000440|NCT01474512|471629902|FG014|Maintenance Period|Protocol Violation|0|||
131000441|NCT01474512|471629903|FG015|Maintenance Period|Protocol Violation|0|||
131000442|NCT01474512|471629904|FG016|Maintenance Period|Protocol Violation|0|||
131000443|NCT01474512|471629905|FG017|Maintenance Period|Protocol Violation|0|||
131000444|NCT01474512|471629888|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
131000445|NCT01474512|471629889|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
131000446|NCT01474512|471629890|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
131000447|NCT01474512|471629891|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
131000448|NCT01474512|471629892|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
131000449|NCT01474512|471629893|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
131000450|NCT01474512|471629894|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
131000451|NCT01474512|471629895|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
131000452|NCT01474512|471629896|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
131000453|NCT01474512|471629897|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
131000454|NCT01474512|471629898|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
131000455|NCT01474512|471629899|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
131000456|NCT01474512|471629900|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
131000457|NCT01474512|471629901|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
131000458|NCT01474512|471629902|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
131000459|NCT01474512|471629903|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
131000460|NCT01474512|471629904|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
131000461|NCT01474512|471629905|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
131000462|NCT01474512|471629888|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
131000463|NCT01474512|471629889|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
131000464|NCT01474512|471629890|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
131000465|NCT01474512|471629891|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
131000466|NCT01474512|471629892|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
131000467|NCT01474512|471629893|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
131000468|NCT01474512|471629894|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
131000469|NCT01474512|471629895|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
131000470|NCT01474512|471629896|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
131000471|NCT01474512|471629897|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
131000472|NCT01474512|471629898|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
131000473|NCT01474512|471629899|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
131000474|NCT01474512|471629900|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
131000475|NCT01474512|471629901|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
131000476|NCT01474512|471629902|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
131000477|NCT01474512|471629903|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
131000478|NCT01474512|471629904|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
131000479|NCT01474512|471629905|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
131000480|NCT01474512|471629888|FG000|Long-Term Extension Period|Adverse Event|0|||
131000481|NCT01474512|471629889|FG001|Long-Term Extension Period|Adverse Event|0|||
131000482|NCT01474512|471629890|FG002|Long-Term Extension Period|Adverse Event|0|||
131000483|NCT01474512|471629891|FG003|Long-Term Extension Period|Adverse Event|0|||
131000484|NCT01474512|471629892|FG004|Long-Term Extension Period|Adverse Event|0|||
131000485|NCT01474512|471629893|FG005|Long-Term Extension Period|Adverse Event|0|||
131000486|NCT01474512|471629894|FG006|Long-Term Extension Period|Adverse Event|0|||
131000487|NCT01474512|471629895|FG007|Long-Term Extension Period|Adverse Event|0|||
131000488|NCT01474512|471629896|FG008|Long-Term Extension Period|Adverse Event|0|||
131000489|NCT01474512|471629897|FG009|Long-Term Extension Period|Adverse Event|0|||
131000490|NCT01474512|471629898|FG010|Long-Term Extension Period|Adverse Event|0|||
131000491|NCT01474512|471629899|FG011|Long-Term Extension Period|Adverse Event|1|||
131000492|NCT01474512|471629900|FG012|Long-Term Extension Period|Adverse Event|57|||
131000493|NCT01474512|471629901|FG013|Long-Term Extension Period|Adverse Event|58|||
131000494|NCT01474512|471629902|FG014|Long-Term Extension Period|Adverse Event|0|||
131000495|NCT01474512|471629903|FG015|Long-Term Extension Period|Adverse Event|0|||
131000496|NCT01474512|471629904|FG016|Long-Term Extension Period|Adverse Event|0|||
131000497|NCT01474512|471629905|FG017|Long-Term Extension Period|Adverse Event|0|||
131000498|NCT01474512|471629888|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
131000499|NCT01474512|471629889|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
131000500|NCT01474512|471629890|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
131000501|NCT01474512|471629891|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
131000502|NCT01474512|471629892|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
131000503|NCT01474512|471629893|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
131000504|NCT01474512|471629894|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
131000505|NCT01474512|471629895|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
131000506|NCT01474512|471629896|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
131000507|NCT01474512|471629897|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
131000508|NCT01474512|471629898|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
131000509|NCT01474512|471629899|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
131000510|NCT01474512|471629900|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
131000511|NCT01474512|471629901|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
131000512|NCT01474512|471629902|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
131000513|NCT01474512|471629903|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
131000514|NCT01474512|471629904|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
131000515|NCT01474512|471629905|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
131000516|NCT01474512|471629888|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
131000517|NCT01474512|471629889|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
131000518|NCT01474512|471629890|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
131000519|NCT01474512|471629891|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
131000520|NCT01474512|471629892|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
131000521|NCT01474512|471629893|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
131000522|NCT01474512|471629894|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
131000523|NCT01474512|471629895|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
131000524|NCT01474512|471629896|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
131000525|NCT01474512|471629897|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
131000526|NCT01474512|471629898|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
131000527|NCT01474512|471629899|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
131000528|NCT01474512|471629900|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
131000529|NCT01474512|471629901|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
131000530|NCT01474512|471629902|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
131000531|NCT01474512|471629903|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
131000532|NCT01474512|471629904|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
131000533|NCT01474512|471629905|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
131000534|NCT01474512|471629888|FG000|Long-Term Extension Period|Physician Decision|0|||
131000535|NCT01474512|471629889|FG001|Long-Term Extension Period|Physician Decision|0|||
131000536|NCT01474512|471629890|FG002|Long-Term Extension Period|Physician Decision|0|||
131000537|NCT01474512|471629891|FG003|Long-Term Extension Period|Physician Decision|0|||
131000538|NCT01474512|471629892|FG004|Long-Term Extension Period|Physician Decision|0|||
131000539|NCT01474512|471629893|FG005|Long-Term Extension Period|Physician Decision|0|||
131000540|NCT01474512|471629894|FG006|Long-Term Extension Period|Physician Decision|0|||
131000541|NCT01474512|471629895|FG007|Long-Term Extension Period|Physician Decision|0|||
131000542|NCT01474512|471629896|FG008|Long-Term Extension Period|Physician Decision|0|||
131000543|NCT01474512|471629897|FG009|Long-Term Extension Period|Physician Decision|0|||
131000544|NCT01474512|471629898|FG010|Long-Term Extension Period|Physician Decision|0|||
131000545|NCT01474512|471629899|FG011|Long-Term Extension Period|Physician Decision|0|||
131000546|NCT01474512|471629900|FG012|Long-Term Extension Period|Physician Decision|21|||
131000547|NCT01474512|471629901|FG013|Long-Term Extension Period|Physician Decision|21|||
131000548|NCT01474512|471629902|FG014|Long-Term Extension Period|Physician Decision|0|||
131000549|NCT01474512|471629903|FG015|Long-Term Extension Period|Physician Decision|0|||
131000550|NCT01474512|471629904|FG016|Long-Term Extension Period|Physician Decision|0|||
131000551|NCT01474512|471629905|FG017|Long-Term Extension Period|Physician Decision|0|||
131000552|NCT01474512|471629888|FG000|Long-Term Extension Period|Clinical Relapse|0|||
131000553|NCT01474512|471629889|FG001|Long-Term Extension Period|Clinical Relapse|0|||
131000554|NCT01474512|471629890|FG002|Long-Term Extension Period|Clinical Relapse|0|||
131000555|NCT01474512|471629891|FG003|Long-Term Extension Period|Clinical Relapse|0|||
131000556|NCT01474512|471629892|FG004|Long-Term Extension Period|Clinical Relapse|0|||
131000557|NCT01474512|471629893|FG005|Long-Term Extension Period|Clinical Relapse|0|||
131000558|NCT01474512|471629894|FG006|Long-Term Extension Period|Clinical Relapse|0|||
131000559|NCT01474512|471629895|FG007|Long-Term Extension Period|Clinical Relapse|0|||
131000560|NCT01474512|471629896|FG008|Long-Term Extension Period|Clinical Relapse|0|||
131000561|NCT01474512|471629897|FG009|Long-Term Extension Period|Clinical Relapse|0|||
131000562|NCT01474512|471629898|FG010|Long-Term Extension Period|Clinical Relapse|0|||
131000563|NCT01474512|471629899|FG011|Long-Term Extension Period|Clinical Relapse|0|||
131221922|NCT00295620|472439466|FG001|Overall Study|Withdrawal by Subject|50|||
131221923|NCT00295620|472439465|FG000|Overall Study|Death|206|||
131221924|NCT00295620|472439466|FG001|Overall Study|Death|207|||
131221925|NCT00295620|472439465|FG000|Overall Study|Other reasons|10|||
131221926|NCT00295620|472439466|FG001|Overall Study|Other reasons|9|||
131221927|NCT00295620|472439465|FG000|Overall Study|Discontinuation by sponsor|580|||
131221928|NCT00295620|472439466|FG001|Overall Study|Discontinuation by sponsor|593|||
131000564|NCT01474512|471629900|FG012|Long-Term Extension Period|Clinical Relapse|9|||
131000565|NCT01474512|471629901|FG013|Long-Term Extension Period|Clinical Relapse|9|||
131000566|NCT01474512|471629902|FG014|Long-Term Extension Period|Clinical Relapse|0|||
131000567|NCT01474512|471629903|FG015|Long-Term Extension Period|Clinical Relapse|0|||
131000568|NCT01474512|471629904|FG016|Long-Term Extension Period|Clinical Relapse|0|||
131000569|NCT01474512|471629905|FG017|Long-Term Extension Period|Clinical Relapse|0|||
131000570|NCT01474512|471629888|FG000|Long-Term Extension Period|Death|0|||
131000571|NCT01474512|471629889|FG001|Long-Term Extension Period|Death|0|||
131000572|NCT01474512|471629890|FG002|Long-Term Extension Period|Death|0|||
131000573|NCT01474512|471629891|FG003|Long-Term Extension Period|Death|0|||
131000574|NCT01474512|471629892|FG004|Long-Term Extension Period|Death|0|||
131000575|NCT01474512|471629893|FG005|Long-Term Extension Period|Death|0|||
131000576|NCT01474512|471629894|FG006|Long-Term Extension Period|Death|0|||
131000577|NCT01474512|471629895|FG007|Long-Term Extension Period|Death|0|||
131000578|NCT01474512|471629896|FG008|Long-Term Extension Period|Death|0|||
131000579|NCT01474512|471629897|FG009|Long-Term Extension Period|Death|0|||
131000580|NCT01474512|471629898|FG010|Long-Term Extension Period|Death|0|||
131000581|NCT01474512|471629899|FG011|Long-Term Extension Period|Death|0|||
131000582|NCT01474512|471629900|FG012|Long-Term Extension Period|Death|9|||
131000583|NCT01474512|471629901|FG013|Long-Term Extension Period|Death|9|||
131000584|NCT01474512|471629902|FG014|Long-Term Extension Period|Death|0|||
131000585|NCT01474512|471629903|FG015|Long-Term Extension Period|Death|0|||
131000586|NCT01474512|471629904|FG016|Long-Term Extension Period|Death|0|||
131000587|NCT01474512|471629905|FG017|Long-Term Extension Period|Death|0|||
131000588|NCT01474512|471629888|FG000|Long-Term Extension Period|Sponsor Decision|0|||
131000589|NCT01474512|471629889|FG001|Long-Term Extension Period|Sponsor Decision|0|||
131000590|NCT01474512|471629890|FG002|Long-Term Extension Period|Sponsor Decision|0|||
131000591|NCT01474512|471629891|FG003|Long-Term Extension Period|Sponsor Decision|0|||
131000592|NCT01474512|471629892|FG004|Long-Term Extension Period|Sponsor Decision|0|||
131000593|NCT01474512|471629893|FG005|Long-Term Extension Period|Sponsor Decision|0|||
131000594|NCT01474512|471629894|FG006|Long-Term Extension Period|Sponsor Decision|0|||
131000595|NCT01474512|471629895|FG007|Long-Term Extension Period|Sponsor Decision|0|||
131000596|NCT01474512|471629896|FG008|Long-Term Extension Period|Sponsor Decision|0|||
131000597|NCT01474512|471629897|FG009|Long-Term Extension Period|Sponsor Decision|0|||
131000598|NCT01474512|471629898|FG010|Long-Term Extension Period|Sponsor Decision|0|||
131000599|NCT01474512|471629899|FG011|Long-Term Extension Period|Sponsor Decision|0|||
131000600|NCT01474512|471629900|FG012|Long-Term Extension Period|Sponsor Decision|6|||
131000601|NCT01474512|471629901|FG013|Long-Term Extension Period|Sponsor Decision|6|||
131000602|NCT01474512|471629902|FG014|Long-Term Extension Period|Sponsor Decision|0|||
131000603|NCT01474512|471629903|FG015|Long-Term Extension Period|Sponsor Decision|0|||
131000604|NCT01474512|471629904|FG016|Long-Term Extension Period|Sponsor Decision|0|||
131000605|NCT01474512|471629905|FG017|Long-Term Extension Period|Sponsor Decision|0|||
131000606|NCT01474512|471629888|FG000|Long-Term Extension Period|Protocol Violation|0|||
131000607|NCT01474512|471629889|FG001|Long-Term Extension Period|Protocol Violation|0|||
131000608|NCT01474512|471629890|FG002|Long-Term Extension Period|Protocol Violation|0|||
131000609|NCT01474512|471629891|FG003|Long-Term Extension Period|Protocol Violation|0|||
131000610|NCT01474512|471629892|FG004|Long-Term Extension Period|Protocol Violation|0|||
131000611|NCT01474512|471629893|FG005|Long-Term Extension Period|Protocol Violation|0|||
131000612|NCT01474512|471629894|FG006|Long-Term Extension Period|Protocol Violation|0|||
131000613|NCT01474512|471629895|FG007|Long-Term Extension Period|Protocol Violation|0|||
131000614|NCT01474512|471629896|FG008|Long-Term Extension Period|Protocol Violation|0|||
131000615|NCT01474512|471629897|FG009|Long-Term Extension Period|Protocol Violation|0|||
131000616|NCT01474512|471629898|FG010|Long-Term Extension Period|Protocol Violation|0|||
131000617|NCT01474512|471629899|FG011|Long-Term Extension Period|Protocol Violation|0|||
131000618|NCT01474512|471629900|FG012|Long-Term Extension Period|Protocol Violation|5|||
131000619|NCT01474512|471629901|FG013|Long-Term Extension Period|Protocol Violation|5|||
131000620|NCT01474512|471629902|FG014|Long-Term Extension Period|Protocol Violation|0|||
131221929|NCT00295620|472439465|FG000|Overall Study|Protocol Violation|30|||
131221930|NCT00295620|472439466|FG001|Overall Study|Protocol Violation|32|||
131221931|NCT00928135|472439467|FG000|Overall Study|Withdrawal by Subject|1|||
131221932|NCT00928135|472439468|FG001|Overall Study|Withdrawal by Subject|0|||
131221933|NCT03338673|472439471|FG000|Overall Study|Lost to Follow-up|1|||
131221934|NCT03338673|472439472|FG001|Overall Study|Lost to Follow-up|1|||
131221935|NCT00434148|472439475|FG000|Overall Study|Adverse Event|18|||
131221936|NCT00434148|472439476|FG001|Overall Study|Adverse Event|18|||
131221937|NCT00434148|472439475|FG000|Overall Study|Lack of Efficacy|25|||
131221938|NCT00434148|472439476|FG001|Overall Study|Lack of Efficacy|28|||
131221939|NCT00434148|472439475|FG000|Overall Study|Withdrawal by Subject|15|||
131221940|NCT00434148|472439476|FG001|Overall Study|Withdrawal by Subject|15|||
131221941|NCT00434148|472439475|FG000|Overall Study|Protocol Violation|4|||
131221942|NCT00434148|472439476|FG001|Overall Study|Protocol Violation|0|||
131221943|NCT00434148|472439475|FG000|Overall Study|Administrative problems|6|||
131221944|NCT00434148|472439476|FG001|Overall Study|Administrative problems|10|||
131221945|NCT00434148|472439475|FG000|Overall Study|Lost to Follow-up|0|||
131000621|NCT01474512|471629903|FG015|Long-Term Extension Period|Protocol Violation|0|||
131000622|NCT01474512|471629904|FG016|Long-Term Extension Period|Protocol Violation|0|||
131000623|NCT01474512|471629905|FG017|Long-Term Extension Period|Protocol Violation|0|||
131000624|NCT01474512|471629888|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000625|NCT01474512|471629889|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000626|NCT01474512|471629890|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000627|NCT01474512|471629891|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000628|NCT01474512|471629892|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000629|NCT01474512|471629893|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000630|NCT01474512|471629894|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000631|NCT01474512|471629895|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000632|NCT01474512|471629896|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000633|NCT01474512|471629897|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000634|NCT01474512|471629898|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000635|NCT01474512|471629899|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000636|NCT01474512|471629900|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
131000637|NCT01474512|471629901|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
131000638|NCT01474512|471629902|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000639|NCT01474512|471629903|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000640|NCT01474512|471629904|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000641|NCT01474512|471629905|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
131000642|NCT01474512|471629888|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000643|NCT01474512|471629889|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000644|NCT01474512|471629890|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000645|NCT01474512|471629891|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000646|NCT01474512|471629892|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000647|NCT01474512|471629893|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000648|NCT01474512|471629894|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000649|NCT01474512|471629895|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000650|NCT01474512|471629896|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000651|NCT01474512|471629897|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000652|NCT01474512|471629898|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000653|NCT01474512|471629899|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
131000654|NCT01474512|471629900|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000655|NCT01474512|471629901|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000656|NCT01474512|471629902|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000657|NCT01474512|471629903|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000658|NCT01474512|471629904|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000659|NCT01474512|471629905|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
131000660|NCT01474512|471629888|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
131000661|NCT01474512|471629889|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
131000662|NCT01474512|471629890|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
131000663|NCT01474512|471629891|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
131000664|NCT01474512|471629892|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
131000665|NCT01474512|471629893|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
131000666|NCT01474512|471629894|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
131000667|NCT01474512|471629895|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
131000668|NCT01474512|471629896|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
131000669|NCT01474512|471629897|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
131000670|NCT01474512|471629898|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
131000671|NCT01474512|471629899|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
131000672|NCT01474512|471629900|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
131000673|NCT01474512|471629901|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
131000674|NCT01474512|471629902|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
131000675|NCT01474512|471629903|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
131000676|NCT01474512|471629904|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
131000677|NCT01474512|471629905|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
131000678|NCT01474512|471629888|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000679|NCT01474512|471629889|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000680|NCT01474512|471629890|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000681|NCT01474512|471629891|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000682|NCT01474512|471629892|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000683|NCT01474512|471629893|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000684|NCT01474512|471629894|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000685|NCT01474512|471629895|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000686|NCT01474512|471629896|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000687|NCT01474512|471629897|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000688|NCT01474512|471629898|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000689|NCT01474512|471629899|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000690|NCT01474512|471629900|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000691|NCT01474512|471629901|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
131000692|NCT01474512|471629902|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
131000693|NCT01474512|471629903|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
131000694|NCT01474512|471629904|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
131000695|NCT01474512|471629905|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
131000696|NCT01474512|471629888|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000697|NCT01474512|471629889|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000698|NCT01474512|471629890|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000699|NCT01474512|471629891|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000700|NCT01474512|471629892|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000701|NCT01474512|471629893|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000702|NCT01474512|471629894|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000703|NCT01474512|471629895|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000704|NCT01474512|471629896|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000705|NCT01474512|471629897|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000706|NCT01474512|471629898|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000707|NCT01474512|471629899|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000708|NCT01474512|471629900|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000709|NCT01474512|471629901|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
131000710|NCT01474512|471629902|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
131000711|NCT01474512|471629903|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
131000712|NCT01474512|471629904|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
131000713|NCT01474512|471629905|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
131000714|NCT01474512|471629888|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000715|NCT01474512|471629889|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000716|NCT01474512|471629890|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000717|NCT01474512|471629891|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130884620|NCT02079246|471213179|FG000|OLEX|Withdrawal before treatment|1|||
130884621|NCT02079246|471213180|FG001|OLEX|Withdrawal before treatment|0|||
130884622|NCT02079246|471213179|FG000|OLEX|Death|11|||
130884623|NCT02079246|471213180|FG001|OLEX|Death|0|||
130884624|NCT02079246|471213179|FG000|OLEX|Adverse Event|66|||
130884625|NCT02079246|471213180|FG001|OLEX|Adverse Event|0|||
130884626|NCT02079246|471213179|FG000|OLEX|Withdrawal by Subject|60|||
131000718|NCT01474512|471629892|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000719|NCT01474512|471629893|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000720|NCT01474512|471629894|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000721|NCT01474512|471629895|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000722|NCT01474512|471629896|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000723|NCT01474512|471629897|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000724|NCT01474512|471629898|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000725|NCT01474512|471629899|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130884627|NCT02079246|471213180|FG001|OLEX|Withdrawal by Subject|0|||
130884628|NCT02079246|471213179|FG000|OLEX|Lost to Follow-up|6|||
130884629|NCT02079246|471213180|FG001|OLEX|Lost to Follow-up|0|||
131000726|NCT01474512|471629900|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130884630|NCT02079246|471213179|FG000|OLEX|Protocol Violation|6|||
131000727|NCT01474512|471629901|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000728|NCT01474512|471629902|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000729|NCT01474512|471629903|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
131000730|NCT01474512|471629904|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
131000731|NCT01474512|471629905|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
131000732|NCT01474512|471629888|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
131000733|NCT01474512|471629889|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
131000734|NCT01474512|471629890|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
131000735|NCT01474512|471629891|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
131000736|NCT01474512|471629892|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
131000737|NCT01474512|471629893|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
131000738|NCT01474512|471629894|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
131000739|NCT01474512|471629895|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
131000740|NCT01474512|471629896|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
131000741|NCT01474512|471629897|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
131000742|NCT01474512|471629898|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
131000743|NCT01474512|471629899|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
131000744|NCT01474512|471629900|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
131000745|NCT01474512|471629901|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
131000746|NCT01474512|471629902|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
131000747|NCT01474512|471629903|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
131000748|NCT01474512|471629904|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
131000749|NCT01474512|471629905|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
131000750|NCT01474512|471629888|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000751|NCT01474512|471629889|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000752|NCT01474512|471629890|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000753|NCT01474512|471629891|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000754|NCT01474512|471629892|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000755|NCT01474512|471629893|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000756|NCT01474512|471629894|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000757|NCT01474512|471629895|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000758|NCT01474512|471629896|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000759|NCT01474512|471629897|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000760|NCT01474512|471629898|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000761|NCT01474512|471629899|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000762|NCT01474512|471629900|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000763|NCT01474512|471629901|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000764|NCT01474512|471629902|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000765|NCT01474512|471629903|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
131000766|NCT01474512|471629904|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
131000767|NCT01474512|471629905|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
131000768|NCT01474512|471629888|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
131000769|NCT01474512|471629889|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
131000770|NCT01474512|471629890|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
131000771|NCT01474512|471629891|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
131000772|NCT01474512|471629892|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
131000773|NCT01474512|471629893|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
131000774|NCT01474512|471629894|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
131000775|NCT01474512|471629895|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
131000776|NCT01474512|471629896|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
131000777|NCT01474512|471629897|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
131000778|NCT01474512|471629898|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
131000779|NCT01474512|471629899|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
131000780|NCT01474512|471629900|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
131000781|NCT01474512|471629901|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
131000782|NCT01474512|471629902|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
131000783|NCT01474512|471629903|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
131000784|NCT01474512|471629904|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
131000785|NCT01474512|471629905|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
131000786|NCT01474512|471629888|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000787|NCT01474512|471629889|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000788|NCT01474512|471629890|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000789|NCT01474512|471629891|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000790|NCT01474512|471629892|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000791|NCT01474512|471629893|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000792|NCT01474512|471629894|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000793|NCT01474512|471629895|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000794|NCT01474512|471629896|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000795|NCT01474512|471629897|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000796|NCT01474512|471629898|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000797|NCT01474512|471629899|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000798|NCT01474512|471629900|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000799|NCT01474512|471629901|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000800|NCT01474512|471629902|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
131000801|NCT01474512|471629903|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000802|NCT01474512|471629904|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
131000803|NCT01474512|471629905|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
131000804|NCT01474512|471629888|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000805|NCT01474512|471629889|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000806|NCT01474512|471629890|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000807|NCT01474512|471629891|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000808|NCT01474512|471629892|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000809|NCT01474512|471629893|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000810|NCT01474512|471629894|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000811|NCT01474512|471629895|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000812|NCT01474512|471629896|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000813|NCT01474512|471629897|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000814|NCT01474512|471629898|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000815|NCT01474512|471629899|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000816|NCT01474512|471629900|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000817|NCT01474512|471629901|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000818|NCT01474512|471629902|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
131000819|NCT01474512|471629903|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000820|NCT01474512|471629904|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
131000821|NCT01474512|471629905|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
131000822|NCT01474512|471629888|FG000|Post-Treatment Follow-Up|Death|0|||
131000823|NCT01474512|471629889|FG001|Post-Treatment Follow-Up|Death|0|||
131000824|NCT01474512|471629890|FG002|Post-Treatment Follow-Up|Death|0|||
131000825|NCT01474512|471629891|FG003|Post-Treatment Follow-Up|Death|0|||
131000826|NCT01474512|471629892|FG004|Post-Treatment Follow-Up|Death|0|||
131000827|NCT01474512|471629893|FG005|Post-Treatment Follow-Up|Death|0|||
131000828|NCT01474512|471629894|FG006|Post-Treatment Follow-Up|Death|0|||
131000829|NCT01474512|471629895|FG007|Post-Treatment Follow-Up|Death|0|||
131000830|NCT01474512|471629896|FG008|Post-Treatment Follow-Up|Death|0|||
131000831|NCT01474512|471629897|FG009|Post-Treatment Follow-Up|Death|0|||
131000832|NCT01474512|471629898|FG010|Post-Treatment Follow-Up|Death|0|||
131000833|NCT01474512|471629899|FG011|Post-Treatment Follow-Up|Death|0|||
131000834|NCT01474512|471629900|FG012|Post-Treatment Follow-Up|Death|0|||
131000835|NCT01474512|471629901|FG013|Post-Treatment Follow-Up|Death|0|||
131000836|NCT01474512|471629902|FG014|Post-Treatment Follow-Up|Death|0|||
131000837|NCT01474512|471629903|FG015|Post-Treatment Follow-Up|Death|0|||
131000838|NCT01474512|471629904|FG016|Post-Treatment Follow-Up|Death|1|||
131000839|NCT01474512|471629905|FG017|Post-Treatment Follow-Up|Death|0|||
131000840|NCT01023308|471629910|FG000|Overall Study|Abnormal test proceedure results|3|||
131000841|NCT01023308|471629911|FG001|Overall Study|Abnormal test proceedure results|8|||
131000842|NCT01023308|471629910|FG000|Overall Study|Administrative problems|2|||
131000843|NCT01023308|471629911|FG001|Overall Study|Administrative problems|1|||
131000844|NCT01023308|471629910|FG000|Overall Study|Adverse Event|130|||
131000845|NCT01023308|471629911|FG001|Overall Study|Adverse Event|66|||
131000846|NCT01023308|471629910|FG000|Overall Study|Death|21|||
131000847|NCT01023308|471629911|FG001|Overall Study|Death|17|||
131000848|NCT01023308|471629910|FG000|Overall Study|Disease progression|82|||
131000849|NCT01023308|471629911|FG001|Overall Study|Disease progression|153|||
131000850|NCT01023308|471629910|FG000|Overall Study|New Cancer therapy|4|||
131000851|NCT01023308|471629911|FG001|Overall Study|New Cancer therapy|7|||
131000852|NCT01023308|471629910|FG000|Overall Study|Protocol Violation|3|||
131000853|NCT01023308|471629911|FG001|Overall Study|Protocol Violation|4|||
131000854|NCT01023308|471629910|FG000|Overall Study|Untreated|5|||
131000855|NCT01023308|471629911|FG001|Overall Study|Untreated|5|||
131000856|NCT01023308|471629910|FG000|Overall Study|Lost to Follow-up|1|||
131000857|NCT01023308|471629911|FG001|Overall Study|Lost to Follow-up|0|||
131000858|NCT01023308|471629910|FG000|Overall Study|Withdrawal by Subject|34|||
131000859|NCT01023308|471629911|FG001|Overall Study|Withdrawal by Subject|18|||
131000860|NCT00551213|471629912|FG000|Overall Study|Adverse Event|6|||
131000861|NCT00551213|471629913|FG001|Overall Study|Adverse Event|3|||
131000862|NCT00551213|471629912|FG000|Overall Study|Progressive Disease|41|||
131000863|NCT00551213|471629913|FG001|Overall Study|Progressive Disease|12|||
131000864|NCT00551213|471629912|FG000|Overall Study|Withdrawal by Subject|2|||
131000865|NCT00551213|471629913|FG001|Overall Study|Withdrawal by Subject|0|||
131000866|NCT00551213|471629912|FG000|Overall Study|Not Treated|1|||
131000867|NCT00551213|471629913|FG001|Overall Study|Not Treated|2|||
131000868|NCT01890967|471629914|FG000|Overall Study|Adverse Event|3|||
131000869|NCT01890967|471629915|FG001|Overall Study|Adverse Event|3|||
131000870|NCT01890967|471629916|FG002|Overall Study|Adverse Event|3|||
131000871|NCT01890967|471629917|FG003|Overall Study|Adverse Event|2|||
131000872|NCT01890967|471629918|FG004|Overall Study|Adverse Event|1|||
131000873|NCT01890967|471629919|FG005|Overall Study|Adverse Event|7|||
131000874|NCT01890967|471629914|FG000|Overall Study|Death|1|||
131000875|NCT01890967|471629915|FG001|Overall Study|Death|0|||
131000876|NCT01890967|471629916|FG002|Overall Study|Death|0|||
131000877|NCT01890967|471629917|FG003|Overall Study|Death|0|||
131000878|NCT01890967|471629918|FG004|Overall Study|Death|0|||
131000879|NCT01890967|471629919|FG005|Overall Study|Death|0|||
131000880|NCT01890967|471629914|FG000|Overall Study|Lost to Follow-up|1|||
131000881|NCT01890967|471629915|FG001|Overall Study|Lost to Follow-up|1|||
131000882|NCT01890967|471629916|FG002|Overall Study|Lost to Follow-up|1|||
131000883|NCT01890967|471629917|FG003|Overall Study|Lost to Follow-up|1|||
131000884|NCT01890967|471629918|FG004|Overall Study|Lost to Follow-up|0|||
131000885|NCT01890967|471629919|FG005|Overall Study|Lost to Follow-up|1|||
131000886|NCT01890967|471629914|FG000|Overall Study|Protocol Violation|0|||
131000887|NCT01890967|471629915|FG001|Overall Study|Protocol Violation|3|||
131000888|NCT01890967|471629916|FG002|Overall Study|Protocol Violation|3|||
131000889|NCT01890967|471629917|FG003|Overall Study|Protocol Violation|2|||
131000890|NCT01890967|471629918|FG004|Overall Study|Protocol Violation|4|||
131000891|NCT01890967|471629919|FG005|Overall Study|Protocol Violation|1|||
131000892|NCT01890967|471629914|FG000|Overall Study|Sponsor Decision|2|||
131000893|NCT01890967|471629915|FG001|Overall Study|Sponsor Decision|0|||
131000894|NCT01890967|471629916|FG002|Overall Study|Sponsor Decision|1|||
131000895|NCT01890967|471629917|FG003|Overall Study|Sponsor Decision|3|||
131000896|NCT01890967|471629918|FG004|Overall Study|Sponsor Decision|2|||
131000897|NCT01890967|471629919|FG005|Overall Study|Sponsor Decision|3|||
130884631|NCT02079246|471213180|FG001|OLEX|Protocol Violation|0|||
131000898|NCT01890967|471629914|FG000|Overall Study|Withdrawal by Subject|3|||
131000899|NCT01890967|471629915|FG001|Overall Study|Withdrawal by Subject|4|||
131000900|NCT01890967|471629916|FG002|Overall Study|Withdrawal by Subject|2|||
131000901|NCT01890967|471629917|FG003|Overall Study|Withdrawal by Subject|3|||
131000902|NCT01890967|471629918|FG004|Overall Study|Withdrawal by Subject|3|||
131000903|NCT01890967|471629919|FG005|Overall Study|Withdrawal by Subject|1|||
131000904|NCT01383993|471629921|FG000|Overall Study|Adverse Event|1|||
131000905|NCT01383993|471629922|FG001|Overall Study|Adverse Event|1|||
131000906|NCT01383993|471629923|FG002|Overall Study|Adverse Event|0|||
131000907|NCT01383993|471629921|FG000|Overall Study|Withdrawal by Subject|0|||
131000908|NCT01383993|471629922|FG001|Overall Study|Withdrawal by Subject|0|||
131000909|NCT01383993|471629923|FG002|Overall Study|Withdrawal by Subject|1|||
131000910|NCT01383993|471629921|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
131000911|NCT01383993|471629922|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
131000912|NCT01383993|471629923|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
131000913|NCT00795132|471629927|FG000|Overall Study|Death|1|||
131000914|NCT00795132|471629927|FG000|Overall Study|Relapse|2|||
131000915|NCT02561455|471629928|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
131000916|NCT02561455|471629929|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
131000917|NCT02561455|471629930|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
131000918|NCT02561455|471629931|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
130765910|NCT05153148|470765900|FG001|Overall Study|Lost to Follow-up|1|||
131000919|NCT02561455|471629928|FG000|Overall Study|Withdrawal by Subject|1|||
131000920|NCT02561455|471629929|FG001|Overall Study|Withdrawal by Subject|0|||
131000921|NCT02561455|471629930|FG002|Overall Study|Withdrawal by Subject|1|||
131000922|NCT02561455|471629931|FG003|Overall Study|Withdrawal by Subject|0|||
131000923|NCT02561455|471629928|FG000|Overall Study|Disease Progression|0|||
131000924|NCT02561455|471629929|FG001|Overall Study|Disease Progression|1|||
131000925|NCT02561455|471629930|FG002|Overall Study|Disease Progression|0|||
131000926|NCT02561455|471629931|FG003|Overall Study|Disease Progression|0|||
131000927|NCT02451930|471629934|FG000|Overall Study|Death|0|||
131000928|NCT02451930|471629935|FG001|Overall Study|Death|15|||
131000929|NCT02451930|471629934|FG000|Overall Study|Lost to Follow-up|0|||
131000930|NCT02451930|471629935|FG001|Overall Study|Lost to Follow-up|3|||
131000931|NCT02451930|471629934|FG000|Overall Study|Sponsor Decision|2|||
131000932|NCT02451930|471629935|FG001|Overall Study|Sponsor Decision|10|||
131000933|NCT02451930|471629934|FG000|Overall Study|Withdrawal by Subject|0|||
131000934|NCT02451930|471629935|FG001|Overall Study|Withdrawal by Subject|1|||
131000935|NCT02451930|471629934|FG000|Overall Study|Other|0|||
131000936|NCT02451930|471629935|FG001|Overall Study|Other|1|||
131000937|NCT00262743|471629936|FG000|Overall Study|Adverse Event|0|||
131000938|NCT00262743|471629937|FG001|Overall Study|Adverse Event|9|||
131000939|NCT00262743|471629936|FG000|Overall Study|Disease progression|0|||
131000940|NCT00262743|471629937|FG001|Overall Study|Disease progression|3|||
131000941|NCT03685708|471629946|FG000|Overall Study|Withdrawal by Subject|0|||
131000942|NCT03685708|471629947|FG001|Overall Study|Withdrawal by Subject|0|||
131000943|NCT03685708|471629948|FG002|Overall Study|Withdrawal by Subject|1|||
131000944|NCT03685708|471629946|FG000|Overall Study|Screen Fail|0|||
131000945|NCT03685708|471629947|FG001|Overall Study|Screen Fail|1|||
131000946|NCT03685708|471629948|FG002|Overall Study|Screen Fail|1|||
131000947|NCT03685708|471629946|FG000|Overall Study|COVID 19 Pandemic|1|||
131000948|NCT03685708|471629947|FG001|Overall Study|COVID 19 Pandemic|1|||
131000949|NCT03685708|471629948|FG002|Overall Study|COVID 19 Pandemic|6|||
131000950|NCT03685708|471629946|FG000|Overall Study|Disease Progression|0|||
131000951|NCT03685708|471629947|FG001|Overall Study|Disease Progression|0|||
131000952|NCT03685708|471629948|FG002|Overall Study|Disease Progression|1|||
131000953|NCT04006366|471629949|FG000|Overall Study|Withdrawal by Subject|1|||
131000954|NCT04430335|471629951|FG000|Overall Study|Withdrawal by Subject|1|||
131000955|NCT03249376|471629957|FG000|Overall Study|Adverse Event|11|||
131000956|NCT03249376|471629958|FG001|Overall Study|Adverse Event|5|||
131000957|NCT03249376|471629957|FG000|Overall Study|Lack of Efficacy|2|||
130884632|NCT02079246|471213179|FG000|OLEX|Lack of Efficacy|3|||
131000958|NCT03249376|471629958|FG001|Overall Study|Lack of Efficacy|4|||
131000959|NCT03249376|471629957|FG000|Overall Study|Protocol Violation|3|||
131000960|NCT03249376|471629958|FG001|Overall Study|Protocol Violation|2|||
131000961|NCT03249376|471629957|FG000|Overall Study|Physician Decision|0|||
131000962|NCT03249376|471629958|FG001|Overall Study|Physician Decision|2|||
131000963|NCT03249376|471629957|FG000|Overall Study|Withdrawal by Subject|3|||
131000964|NCT03249376|471629958|FG001|Overall Study|Withdrawal by Subject|9|||
131000965|NCT03249376|471629957|FG000|Overall Study|LTFU|2|||
131000966|NCT03249376|471629958|FG001|Overall Study|LTFU|1|||
131000967|NCT00627042|471629959|FG000|Overall Study|Withdrawal by Subject|2|||
131000968|NCT01154036|471629960|FG000|Phase I|Physician Decision|0|||
131000969|NCT01154036|471629961|FG001|Phase I|Physician Decision|1|||
131000970|NCT01154036|471629962|FG002|Phase I|Physician Decision|0|||
131000971|NCT01154036|471629963|FG003|Phase I|Physician Decision|0|||
131000972|NCT01154036|471629964|FG004|Phase I|Physician Decision|0|||
131000973|NCT01154036|471629965|FG005|Phase I|Physician Decision|0|||
130884633|NCT02079246|471213180|FG001|OLEX|Lack of Efficacy|0|||
131000974|NCT01154036|471629966|FG006|Phase I|Physician Decision|0|||
130884634|NCT02079246|471213179|FG000|OLEX|Results of the lead-in studies|58|||
130884635|NCT02079246|471213180|FG001|OLEX|Results of the lead-in studies|0|||
130884636|NCT02079246|471213179|FG000|OLEX|Other: Disallowed medication|8|||
130884637|NCT02079246|471213180|FG001|OLEX|Other: Disallowed medication|0|||
130884638|NCT02079246|471213179|FG000|OLEX|Other: Insufficient compliance|2|||
130884639|NCT02079246|471213180|FG001|OLEX|Other: Insufficient compliance|0|||
130765911|NCT05153148|470765901|FG002|Overall Study|Lost to Follow-up|2|||
130884640|NCT02079246|471213179|FG000|OLEX|Other: Caregiver unavailable|3|||
130884641|NCT02079246|471213180|FG001|OLEX|Other: Caregiver unavailable|0|||
130884642|NCT02079246|471213179|FG000|OLEX|Other: Coordinator decision|1|||
130884643|NCT02079246|471213180|FG001|OLEX|Other: Coordinator decision|0|||
130884644|NCT02079246|471213179|FG000|OLEX|Other: Worsening of condition|1|||
131000975|NCT01154036|471629967|FG007|Phase I|Physician Decision|0|||
131000976|NCT01154036|471629960|FG000|Phase I|Lost to Follow-up|0|||
131000977|NCT01154036|471629961|FG001|Phase I|Lost to Follow-up|3|||
131000978|NCT01154036|471629962|FG002|Phase I|Lost to Follow-up|6|||
131000979|NCT01154036|471629963|FG003|Phase I|Lost to Follow-up|0|||
131000980|NCT01154036|471629964|FG004|Phase I|Lost to Follow-up|0|||
131000981|NCT01154036|471629965|FG005|Phase I|Lost to Follow-up|0|||
131000982|NCT01154036|471629966|FG006|Phase I|Lost to Follow-up|0|||
131000983|NCT01154036|471629967|FG007|Phase I|Lost to Follow-up|0|||
131000984|NCT01154036|471629960|FG000|Phase I|Protocol Violation|0|||
131000985|NCT01154036|471629961|FG001|Phase I|Protocol Violation|3|||
131000986|NCT01154036|471629962|FG002|Phase I|Protocol Violation|9|||
131000987|NCT01154036|471629963|FG003|Phase I|Protocol Violation|0|||
131000988|NCT01154036|471629964|FG004|Phase I|Protocol Violation|0|||
131000989|NCT01154036|471629965|FG005|Phase I|Protocol Violation|0|||
131100730|NCT04860297|471998079|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
131000990|NCT01154036|471629966|FG006|Phase I|Protocol Violation|0|||
131000991|NCT01154036|471629967|FG007|Phase I|Protocol Violation|0|||
131000992|NCT01154036|471629960|FG000|Phase I|Withdrawal by Subject|2|||
131000993|NCT01154036|471629961|FG001|Phase I|Withdrawal by Subject|10|||
131000994|NCT01154036|471629962|FG002|Phase I|Withdrawal by Subject|29|||
131000995|NCT01154036|471629963|FG003|Phase I|Withdrawal by Subject|0|||
131000996|NCT01154036|471629964|FG004|Phase I|Withdrawal by Subject|0|||
131000997|NCT01154036|471629965|FG005|Phase I|Withdrawal by Subject|0|||
131000998|NCT01154036|471629966|FG006|Phase I|Withdrawal by Subject|0|||
131000999|NCT01154036|471629967|FG007|Phase I|Withdrawal by Subject|0|||
131100731|NCT04860297|471998080|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
131100732|NCT04860297|471998081|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
131100733|NCT04860297|471998082|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
131100734|NCT04860297|471998075|FG000|Part B (Booster Dose)|Death|0|||
131100735|NCT04860297|471998076|FG001|Part B (Booster Dose)|Death|0|||
131100736|NCT04860297|471998077|FG002|Part B (Booster Dose)|Death|0|||
131100737|NCT04860297|471998078|FG003|Part B (Booster Dose)|Death|0|||
131100738|NCT04860297|471998079|FG004|Part B (Booster Dose)|Death|1|||
131100739|NCT04860297|471998080|FG005|Part B (Booster Dose)|Death|2|||
131100740|NCT04860297|471998081|FG006|Part B (Booster Dose)|Death|1|||
131100741|NCT04860297|471998082|FG007|Part B (Booster Dose)|Death|0|||
131100742|NCT04860297|471998075|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
131100743|NCT04860297|471998076|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
131001000|NCT01154036|471629960|FG000|Phase I|Adverse Event|1|||
131001001|NCT01154036|471629961|FG001|Phase I|Adverse Event|11|||
131001002|NCT01154036|471629962|FG002|Phase I|Adverse Event|12|||
131001003|NCT01154036|471629963|FG003|Phase I|Adverse Event|0|||
131001004|NCT01154036|471629964|FG004|Phase I|Adverse Event|0|||
131001005|NCT01154036|471629965|FG005|Phase I|Adverse Event|0|||
131001006|NCT01154036|471629966|FG006|Phase I|Adverse Event|0|||
131001007|NCT01154036|471629967|FG007|Phase I|Adverse Event|0|||
130765912|NCT05153148|470765902|FG003|Overall Study|Lost to Follow-up|0|||
131001008|NCT01154036|471629960|FG000|Phase II|Adverse Event|0|||
131001009|NCT01154036|471629961|FG001|Phase II|Adverse Event|0|||
131001010|NCT01154036|471629962|FG002|Phase II|Adverse Event|0|||
131001011|NCT01154036|471629963|FG003|Phase II|Adverse Event|0|||
131001012|NCT01154036|471629964|FG004|Phase II|Adverse Event|1|||
131001013|NCT01154036|471629965|FG005|Phase II|Adverse Event|1|||
131001014|NCT01154036|471629966|FG006|Phase II|Adverse Event|1|||
131001015|NCT01154036|471629967|FG007|Phase II|Adverse Event|1|||
131001016|NCT01154036|471629960|FG000|Phase II|Physician Decision|0|||
131001017|NCT01154036|471629961|FG001|Phase II|Physician Decision|0|||
131001018|NCT01154036|471629962|FG002|Phase II|Physician Decision|0|||
131001019|NCT01154036|471629963|FG003|Phase II|Physician Decision|0|||
131001020|NCT01154036|471629964|FG004|Phase II|Physician Decision|0|||
131001021|NCT01154036|471629965|FG005|Phase II|Physician Decision|0|||
131001022|NCT01154036|471629966|FG006|Phase II|Physician Decision|1|||
131001023|NCT01154036|471629967|FG007|Phase II|Physician Decision|0|||
131001024|NCT01154036|471629960|FG000|Phase II|Lost to Follow-up|0|||
131001025|NCT01154036|471629961|FG001|Phase II|Lost to Follow-up|0|||
131001026|NCT01154036|471629962|FG002|Phase II|Lost to Follow-up|0|||
131001027|NCT01154036|471629963|FG003|Phase II|Lost to Follow-up|1|||
130765913|NCT05153148|470765899|FG000|Overall Study|Withdrawal by Subject|6|||
130765914|NCT05153148|470765900|FG001|Overall Study|Withdrawal by Subject|8|||
130765915|NCT05153148|470765901|FG002|Overall Study|Withdrawal by Subject|6|||
130765916|NCT05153148|470765902|FG003|Overall Study|Withdrawal by Subject|8|||
130765917|NCT05153148|470765899|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
130765918|NCT05153148|470765900|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
130765919|NCT05153148|470765901|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
131001028|NCT01154036|471629964|FG004|Phase II|Lost to Follow-up|2|||
130765920|NCT05153148|470765902|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
130765921|NCT05153148|470765899|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
131001029|NCT01154036|471629965|FG005|Phase II|Lost to Follow-up|0|||
131001030|NCT01154036|471629966|FG006|Phase II|Lost to Follow-up|2|||
131001031|NCT01154036|471629967|FG007|Phase II|Lost to Follow-up|1|||
131001032|NCT01154036|471629960|FG000|Phase II|Protocol Violation|0|||
131001033|NCT01154036|471629961|FG001|Phase II|Protocol Violation|0|||
130884645|NCT02079246|471213180|FG001|OLEX|Other: Worsening of condition|0|||
130884646|NCT02079246|471213179|FG000|OLEX|Other: Moved to nursing home|1|||
131001034|NCT01154036|471629962|FG002|Phase II|Protocol Violation|0|||
131001035|NCT01154036|471629963|FG003|Phase II|Protocol Violation|0|||
131001036|NCT01154036|471629964|FG004|Phase II|Protocol Violation|1|||
131001037|NCT01154036|471629965|FG005|Phase II|Protocol Violation|2|||
131001038|NCT01154036|471629966|FG006|Phase II|Protocol Violation|0|||
131001039|NCT01154036|471629967|FG007|Phase II|Protocol Violation|0|||
131001040|NCT01154036|471629960|FG000|Phase II|Withdrawal by Subject|0|||
131001041|NCT01154036|471629961|FG001|Phase II|Withdrawal by Subject|0|||
131001042|NCT01154036|471629962|FG002|Phase II|Withdrawal by Subject|0|||
131001043|NCT01154036|471629963|FG003|Phase II|Withdrawal by Subject|0|||
131001044|NCT01154036|471629964|FG004|Phase II|Withdrawal by Subject|4|||
131001045|NCT01154036|471629965|FG005|Phase II|Withdrawal by Subject|2|||
131001046|NCT01154036|471629966|FG006|Phase II|Withdrawal by Subject|5|||
131001047|NCT01154036|471629967|FG007|Phase II|Withdrawal by Subject|4|||
131001048|NCT01094171|471629972|FG000|Overall Study|Lost to Follow-up|2|||
131001049|NCT01094171|471629972|FG000|Overall Study|Informed consent withdrawal|4|||
131001050|NCT01094171|471629972|FG000|Overall Study|Migration from the study area|3|||
131001051|NCT01094171|471629972|FG000|Overall Study|Other|1|||
131001052|NCT00594932|471629973|FG000|First 3 Months|Withdrawal by Subject|1|||
131001053|NCT00594932|471629974|FG001|First 3 Months|Withdrawal by Subject|3|||
131001054|NCT00594932|471629973|FG000|Final 3 Months|Withdrawal by Subject|4|||
131001055|NCT00594932|471629974|FG001|Final 3 Months|Withdrawal by Subject|3|||
131001056|NCT01009047|471629976|FG000|Overall Study|Adverse Event|5|||
131001057|NCT01009047|471629977|FG001|Overall Study|Adverse Event|0|||
131001058|NCT01009047|471629976|FG000|Overall Study|Lost to Follow-up|0|||
131001059|NCT01009047|471629977|FG001|Overall Study|Lost to Follow-up|2|||
131001060|NCT01009047|471629976|FG000|Overall Study|Lack of Efficacy|4|||
131001061|NCT01009047|471629977|FG001|Overall Study|Lack of Efficacy|11|||
131001062|NCT01009047|471629976|FG000|Overall Study|Withdrawal by consent|16|||
131001063|NCT01009047|471629977|FG001|Overall Study|Withdrawal by consent|11|||
131001064|NCT01009047|471629976|FG000|Overall Study|Other|3|||
131001065|NCT01009047|471629977|FG001|Overall Study|Other|2|||
131001066|NCT01676220|471629978|FG000|Overall Study|Randomized But Not Treated|4|||
131001067|NCT01676220|471629979|FG001|Overall Study|Randomized But Not Treated|1|||
131001068|NCT01676220|471629978|FG000|Overall Study|Adverse Event|10|||
131001069|NCT01676220|471629979|FG001|Overall Study|Adverse Event|8|||
131001070|NCT01676220|471629978|FG000|Overall Study|Lack of Efficacy|2|||
131001071|NCT01676220|471629979|FG001|Overall Study|Lack of Efficacy|5|||
131001072|NCT01676220|471629978|FG000|Overall Study|Protocol Violation|11|||
131001073|NCT01676220|471629979|FG001|Overall Study|Protocol Violation|12|||
131001074|NCT01676220|471629978|FG000|Overall Study|Received Rescue Therapy|14|||
131001075|NCT01676220|471629979|FG001|Overall Study|Received Rescue Therapy|22|||
131001076|NCT01676220|471629978|FG000|Overall Study|Personal Reason|34|||
131001077|NCT01676220|471629979|FG001|Overall Study|Personal Reason|45|||
131001078|NCT01676220|471629978|FG000|Overall Study|Lost to Follow-up|11|||
131001079|NCT01676220|471629979|FG001|Overall Study|Lost to Follow-up|18|||
131001080|NCT01676220|471629978|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
131001081|NCT01676220|471629979|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
131001082|NCT01676220|471629978|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
131001083|NCT01676220|471629979|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
131001084|NCT01676220|471629978|FG000|Overall Study|Perceived Lack of Efficacy|3|||
131001085|NCT01676220|471629979|FG001|Overall Study|Perceived Lack of Efficacy|1|||
131001086|NCT01676220|471629978|FG000|Overall Study|Non Serious Hypoglycemia|2|||
131001087|NCT01676220|471629979|FG001|Overall Study|Non Serious Hypoglycemia|0|||
131001088|NCT01676220|471629978|FG000|Overall Study|No More Need of Insulin|1|||
131001089|NCT01676220|471629979|FG001|Overall Study|No More Need of Insulin|0|||
131001090|NCT03875911|471629982|FG000|Overall Study|Lost to Follow-up|3|||
131001091|NCT03875911|471629983|FG001|Overall Study|Lost to Follow-up|6|||
131001092|NCT03875911|471629984|FG002|Overall Study|Lost to Follow-up|2|||
131001093|NCT03875911|471629982|FG000|Overall Study|Surgery cancelled|1|||
131001094|NCT03875911|471629983|FG001|Overall Study|Surgery cancelled|0|||
131001095|NCT03875911|471629984|FG002|Overall Study|Surgery cancelled|1|||
131001096|NCT03875911|471629982|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
131001097|NCT03875911|471629983|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
131001098|NCT03875911|471629984|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
131001099|NCT03824938|471629985|FG000|Overall Study|Withdrawal by Subject|2|||
131001100|NCT03824938|471629986|FG001|Overall Study|Withdrawal by Subject|1|||
131001101|NCT03824938|471629987|FG002|Overall Study|Withdrawal by Subject|0|||
131001102|NCT03824938|471629988|FG003|Overall Study|Withdrawal by Subject|2|||
131001103|NCT03824938|471629989|FG004|Overall Study|Withdrawal by Subject|0|||
131001104|NCT03824938|471629990|FG005|Overall Study|Withdrawal by Subject|1|||
131001105|NCT03824938|471629985|FG000|Overall Study|Lost to Follow-up|0|||
131001106|NCT03824938|471629986|FG001|Overall Study|Lost to Follow-up|1|||
131001107|NCT03824938|471629987|FG002|Overall Study|Lost to Follow-up|0|||
131001108|NCT03824938|471629988|FG003|Overall Study|Lost to Follow-up|0|||
131001109|NCT03824938|471629989|FG004|Overall Study|Lost to Follow-up|1|||
131001110|NCT03824938|471629990|FG005|Overall Study|Lost to Follow-up|0|||
131001111|NCT01990300|471629994|FG000|Overall Study|Case Report Forms Uncollected|89|||
131001112|NCT01990300|471629994|FG000|Overall Study|Protocol Deviation|53|||
131001113|NCT04496167|471629997|FG000|Overall Study|Adverse Event|6|||
131001114|NCT04496167|471629998|FG001|Overall Study|Adverse Event|2|||
131001115|NCT04496167|471629997|FG000|Overall Study|Withdrawal by Subject|7|||
131001116|NCT04496167|471629998|FG001|Overall Study|Withdrawal by Subject|6|||
131001117|NCT04496167|471629997|FG000|Overall Study|Lost to Follow-up|3|||
131001118|NCT04496167|471629998|FG001|Overall Study|Lost to Follow-up|5|||
131001119|NCT04496167|471629997|FG000|Overall Study|Not Treated|1|||
131001120|NCT04496167|471629998|FG001|Overall Study|Not Treated|2|||
131001121|NCT04496167|471629997|FG000|Overall Study|Other Than Specified|1|||
130884647|NCT02079246|471213180|FG001|OLEX|Other: Moved to nursing home|0|||
130884648|NCT02079246|471213179|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
131001122|NCT04496167|471629998|FG001|Overall Study|Other Than Specified|1|||
131001123|NCT00681187|471629999|FG000|Overall Study|Withdrawal by Subject|1|||
131001124|NCT00681187|471630000|FG001|Overall Study|Withdrawal by Subject|0|||
131001125|NCT00681187|471629999|FG000|Overall Study|Death|0|||
131001126|NCT00681187|471630000|FG001|Overall Study|Death|1|||
131001127|NCT00681187|471629999|FG000|Overall Study|Adverse Event|0|||
131001128|NCT00681187|471630000|FG001|Overall Study|Adverse Event|1|||
131001129|NCT02788006|471630002|FG000|Overall Study|Patient not treated|1|||
131001130|NCT02269943|471630005|FG000|Treatment Period|Death|0|||
131001131|NCT02269943|471630006|FG001|Treatment Period|Death|1|||
131001132|NCT02269943|471630005|FG000|Treatment Period|Adverse Event|1|||
131001133|NCT02269943|471630006|FG001|Treatment Period|Adverse Event|10|||
131001134|NCT02269943|471630005|FG000|Treatment Period|Progressive Disease|5|||
131001135|NCT02269943|471630006|FG001|Treatment Period|Progressive Disease|17|||
131001136|NCT02269943|471630005|FG000|Treatment Period|Symptomatic Deterioration|0|||
131001137|NCT02269943|471630006|FG001|Treatment Period|Symptomatic Deterioration|2|||
131001138|NCT02269943|471630005|FG000|Follow-Up Survival Period|Death|3|||
131001139|NCT02269943|471630006|FG001|Follow-Up Survival Period|Death|16|||
131001140|NCT02269943|471630005|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
131001141|NCT02269943|471630006|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
131001142|NCT02269943|471630005|FG000|Follow-Up Survival Period|Alive|2|||
131001143|NCT02269943|471630006|FG001|Follow-Up Survival Period|Alive|8|||
131001144|NCT03050398|471630007|FG000|Overall Study|Study terminated by sponsor|8|||
131001145|NCT00598481|471630008|FG000|Treatment|Physician Decision|1|||
131001146|NCT03018106|471630009|FG000|Overall Study|Lost to Follow-up|0|||
131001147|NCT03018106|471630010|FG001|Overall Study|Lost to Follow-up|1|||
131001148|NCT03055832|471630011|FG000|Week 2|Withdrawal by Subject|1|||
131001149|NCT03055832|471630012|FG001|Week 2|Withdrawal by Subject|0|||
131001150|NCT03619174|471630013|FG000|Overall Study|Lost to Follow-up|3|||
131001151|NCT03619174|471630014|FG001|Overall Study|Lost to Follow-up|0|||
131001152|NCT03619174|471630013|FG000|Overall Study|Withdrawal by Subject|4|||
131001153|NCT03619174|471630014|FG001|Overall Study|Withdrawal by Subject|3|||
131001154|NCT03619174|471630013|FG000|Overall Study|Pregnancy|1|||
131001155|NCT03619174|471630014|FG001|Overall Study|Pregnancy|1|||
131001156|NCT03619174|471630013|FG000|Overall Study|Discomfort during treatment|1|||
131001157|NCT03619174|471630014|FG001|Overall Study|Discomfort during treatment|0|||
131001158|NCT01991197|471630015|FG000|Overall Study|Lost to Follow-up|1|||
131001159|NCT01991197|471630016|FG001|Overall Study|Lost to Follow-up|1|||
131001160|NCT01991197|471630015|FG000|Overall Study|Physician Decision|0|||
131001161|NCT01991197|471630016|FG001|Overall Study|Physician Decision|2|||
131001162|NCT01991197|471630015|FG000|Overall Study|Withdrawal by Subject|2|||
131001163|NCT01991197|471630016|FG001|Overall Study|Withdrawal by Subject|0|||
131001164|NCT04157686|471630017|FG000|Overall Study|Adverse Event|1|||
131001165|NCT04157686|471630018|FG001|Overall Study|Adverse Event|0|||
131001166|NCT04157686|471630019|FG002|Overall Study|Adverse Event|1|||
131001167|NCT04157686|471630020|FG003|Overall Study|Adverse Event|0|||
131001168|NCT04157686|471630021|FG004|Overall Study|Adverse Event|1|||
131001169|NCT04157686|471630022|FG005|Overall Study|Adverse Event|0|||
131001170|NCT04157686|471630023|FG006|Overall Study|Adverse Event|0|||
131001171|NCT04157686|471630024|FG007|Overall Study|Adverse Event|0|||
131001172|NCT04157686|471630017|FG000|Overall Study|Pregnancy|0|||
131001173|NCT04157686|471630018|FG001|Overall Study|Pregnancy|1|||
131001174|NCT04157686|471630019|FG002|Overall Study|Pregnancy|3|||
131001175|NCT04157686|471630020|FG003|Overall Study|Pregnancy|0|||
131001176|NCT04157686|471630021|FG004|Overall Study|Pregnancy|0|||
131001177|NCT04157686|471630022|FG005|Overall Study|Pregnancy|0|||
131001178|NCT04157686|471630023|FG006|Overall Study|Pregnancy|3|||
131001179|NCT04157686|471630024|FG007|Overall Study|Pregnancy|0|||
131001180|NCT04157686|471630017|FG000|Overall Study|Lost to Follow-up|1|||
131001181|NCT04157686|471630018|FG001|Overall Study|Lost to Follow-up|2|||
131001182|NCT04157686|471630019|FG002|Overall Study|Lost to Follow-up|8|||
131001183|NCT04157686|471630020|FG003|Overall Study|Lost to Follow-up|6|||
131001184|NCT04157686|471630021|FG004|Overall Study|Lost to Follow-up|6|||
131001185|NCT04157686|471630022|FG005|Overall Study|Lost to Follow-up|3|||
131001186|NCT04157686|471630023|FG006|Overall Study|Lost to Follow-up|7|||
131001187|NCT04157686|471630024|FG007|Overall Study|Lost to Follow-up|9|||
131001188|NCT04157686|471630017|FG000|Overall Study|Lack of Efficacy|0|||
131001189|NCT04157686|471630018|FG001|Overall Study|Lack of Efficacy|0|||
131001190|NCT04157686|471630019|FG002|Overall Study|Lack of Efficacy|0|||
131001191|NCT04157686|471630020|FG003|Overall Study|Lack of Efficacy|0|||
131001192|NCT04157686|471630021|FG004|Overall Study|Lack of Efficacy|0|||
131001193|NCT04157686|471630022|FG005|Overall Study|Lack of Efficacy|2|||
131001194|NCT04157686|471630023|FG006|Overall Study|Lack of Efficacy|0|||
131001195|NCT04157686|471630024|FG007|Overall Study|Lack of Efficacy|1|||
131001196|NCT04157686|471630017|FG000|Overall Study|Withdrawal by Subject|10|||
131001197|NCT04157686|471630018|FG001|Overall Study|Withdrawal by Subject|10|||
131001198|NCT04157686|471630019|FG002|Overall Study|Withdrawal by Subject|12|||
131001199|NCT04157686|471630020|FG003|Overall Study|Withdrawal by Subject|20|||
131001200|NCT04157686|471630021|FG004|Overall Study|Withdrawal by Subject|12|||
131001201|NCT04157686|471630022|FG005|Overall Study|Withdrawal by Subject|11|||
131001202|NCT04157686|471630023|FG006|Overall Study|Withdrawal by Subject|18|||
131001203|NCT04157686|471630024|FG007|Overall Study|Withdrawal by Subject|24|||
131001204|NCT04157686|471630017|FG000|Overall Study|Physician Decision|0|||
131001205|NCT04157686|471630018|FG001|Overall Study|Physician Decision|0|||
131001206|NCT04157686|471630019|FG002|Overall Study|Physician Decision|1|||
131001207|NCT04157686|471630020|FG003|Overall Study|Physician Decision|0|||
131001208|NCT04157686|471630021|FG004|Overall Study|Physician Decision|1|||
131001209|NCT04157686|471630022|FG005|Overall Study|Physician Decision|0|||
131001210|NCT04157686|471630023|FG006|Overall Study|Physician Decision|3|||
131001211|NCT04157686|471630024|FG007|Overall Study|Physician Decision|0|||
131001212|NCT04157686|471630017|FG000|Overall Study|Death|0|||
131001213|NCT04157686|471630018|FG001|Overall Study|Death|0|||
131001214|NCT04157686|471630019|FG002|Overall Study|Death|0|||
131001215|NCT04157686|471630020|FG003|Overall Study|Death|2|||
131001216|NCT04157686|471630021|FG004|Overall Study|Death|0|||
131001217|NCT04157686|471630022|FG005|Overall Study|Death|0|||
131001218|NCT04157686|471630023|FG006|Overall Study|Death|0|||
131001219|NCT04157686|471630024|FG007|Overall Study|Death|0|||
131001220|NCT04157686|471630017|FG000|Overall Study|Protocol Violation|0|||
131001221|NCT04157686|471630018|FG001|Overall Study|Protocol Violation|0|||
131001222|NCT04157686|471630019|FG002|Overall Study|Protocol Violation|0|||
131001223|NCT04157686|471630020|FG003|Overall Study|Protocol Violation|0|||
131001224|NCT04157686|471630021|FG004|Overall Study|Protocol Violation|1|||
131001225|NCT04157686|471630022|FG005|Overall Study|Protocol Violation|0|||
131001226|NCT04157686|471630023|FG006|Overall Study|Protocol Violation|0|||
131001227|NCT04157686|471630024|FG007|Overall Study|Protocol Violation|0|||
131001228|NCT04157686|471630017|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
131001229|NCT04157686|471630018|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
131001230|NCT04157686|471630019|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
131001231|NCT04157686|471630020|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
131001232|NCT04157686|471630021|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
131001233|NCT04157686|471630022|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
131001234|NCT04157686|471630023|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
131001235|NCT04157686|471630024|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
131001236|NCT02268552|471631308|FG000|Part 1|Death|1|||
131001237|NCT02268552|471631309|FG001|Part 1|Death|1|||
131001238|NCT02268552|471631310|FG002|Part 1|Death|1|||
131001239|NCT02268552|471631311|FG003|Part 1|Death|2|||
131001240|NCT02268552|471631312|FG004|Part 1|Death|0|||
131001241|NCT02268552|471631313|FG005|Part 1|Death|0|||
131001242|NCT02268552|471631314|FG006|Part 1|Death|0|||
131001243|NCT02268552|471631308|FG000|Part 1|Subject/guardian decision|0|||
131001244|NCT02268552|471631309|FG001|Part 1|Subject/guardian decision|0|||
131001245|NCT02268552|471631310|FG002|Part 1|Subject/guardian decision|0|||
131001246|NCT02268552|471631311|FG003|Part 1|Subject/guardian decision|1|||
131001247|NCT02268552|471631312|FG004|Part 1|Subject/guardian decision|0|||
131001248|NCT02268552|471631313|FG005|Part 1|Subject/guardian decision|0|||
131001249|NCT02268552|471631314|FG006|Part 1|Subject/guardian decision|0|||
131001250|NCT02268552|471631308|FG000|Part 2|Death|0|||
131001251|NCT02268552|471631309|FG001|Part 2|Death|0|||
131001252|NCT02268552|471631310|FG002|Part 2|Death|0|||
131001253|NCT02268552|471631311|FG003|Part 2|Death|0|||
131001254|NCT02268552|471631312|FG004|Part 2|Death|0|||
131001255|NCT02268552|471631313|FG005|Part 2|Death|0|||
131001256|NCT02268552|471631314|FG006|Part 2|Death|2|||
131001257|NCT02268552|471631308|FG000|Part 2|Subject/guardian decision|0|||
131001258|NCT02268552|471631309|FG001|Part 2|Subject/guardian decision|0|||
131001259|NCT02268552|471631310|FG002|Part 2|Subject/guardian decision|0|||
131001260|NCT02268552|471631311|FG003|Part 2|Subject/guardian decision|0|||
131001261|NCT02268552|471631312|FG004|Part 2|Subject/guardian decision|0|||
131001262|NCT02268552|471631313|FG005|Part 2|Subject/guardian decision|0|||
131001263|NCT02268552|471631314|FG006|Part 2|Subject/guardian decision|1|||
131001264|NCT02268552|471631308|FG000|Part 3 Extension|Death|0|||
131001265|NCT02268552|471631309|FG001|Part 3 Extension|Death|1|||
131001266|NCT02268552|471631310|FG002|Part 3 Extension|Death|1|||
131001267|NCT02268552|471631311|FG003|Part 3 Extension|Death|1|||
131001268|NCT02268552|471631312|FG004|Part 3 Extension|Death|1|||
131001269|NCT02268552|471631313|FG005|Part 3 Extension|Death|1|||
131001270|NCT02268552|471631314|FG006|Part 3 Extension|Death|0|||
131001271|NCT02268552|471631308|FG000|Part 3 Extension|Early termination of trial|1|||
131001272|NCT02268552|471631309|FG001|Part 3 Extension|Early termination of trial|0|||
131001273|NCT02268552|471631310|FG002|Part 3 Extension|Early termination of trial|0|||
131001274|NCT02268552|471631311|FG003|Part 3 Extension|Early termination of trial|0|||
131001275|NCT02268552|471631312|FG004|Part 3 Extension|Early termination of trial|2|||
131001276|NCT02268552|471631313|FG005|Part 3 Extension|Early termination of trial|9|||
131001277|NCT02268552|471631314|FG006|Part 3 Extension|Early termination of trial|11|||
131001278|NCT02268552|471631308|FG000|Part 3 Extension|Subject/guardian decision|0|||
131001279|NCT02268552|471631309|FG001|Part 3 Extension|Subject/guardian decision|0|||
131001280|NCT02268552|471631310|FG002|Part 3 Extension|Subject/guardian decision|0|||
131001281|NCT02268552|471631311|FG003|Part 3 Extension|Subject/guardian decision|0|||
131001282|NCT02268552|471631312|FG004|Part 3 Extension|Subject/guardian decision|0|||
131001283|NCT02268552|471631313|FG005|Part 3 Extension|Subject/guardian decision|0|||
131001284|NCT02268552|471631314|FG006|Part 3 Extension|Subject/guardian decision|1|||
131001285|NCT00997243|471631315|FG000|Overall Study|Early termination of study by sponsor|7|||
131001286|NCT01349907|471631320|FG000|Overall Study|Adverse Event|37|||
131001287|NCT01349907|471631321|FG001|Overall Study|Adverse Event|11|||
131001288|NCT01349907|471631320|FG000|Overall Study|Treatment failure|13|||
131001289|NCT01349907|471631321|FG001|Overall Study|Treatment failure|4|||
131001290|NCT01349907|471631320|FG000|Overall Study|Lost to Follow-up|25|||
131001291|NCT01349907|471631321|FG001|Overall Study|Lost to Follow-up|6|||
131001292|NCT01349907|471631320|FG000|Overall Study|Withdrawal by Subject|30|||
131001293|NCT01349907|471631321|FG001|Overall Study|Withdrawal by Subject|8|||
131001294|NCT01349907|471631320|FG000|Overall Study|Protocol Violation|33|||
131001295|NCT01349907|471631321|FG001|Overall Study|Protocol Violation|13|||
131001296|NCT01349907|471631320|FG000|Overall Study|Administrative|1|||
131001297|NCT01349907|471631321|FG001|Overall Study|Administrative|1|||
131001298|NCT03583541|471631329|FG000|Overall Study|Lost to Follow-up|31|||
131001299|NCT03583541|471631330|FG001|Overall Study|Lost to Follow-up|65|||
131001300|NCT04102540|471631331|FG000|Overall Study|Withdrawn by PI|2|||
131001301|NCT04102540|471631331|FG000|Overall Study|Lost to Follow-up|6|||
131001302|NCT00280293|471631332|FG000|Overall Study|Protocol Violation|3|||
131001303|NCT00280293|471631333|FG001|Overall Study|Protocol Violation|0|||
131001304|NCT00280293|471631332|FG000|Overall Study|Physician Decision|5|||
131001305|NCT00280293|471631333|FG001|Overall Study|Physician Decision|4|||
131001306|NCT00280293|471631332|FG000|Overall Study|Lost to Follow-up|14|||
131001307|NCT00280293|471631333|FG001|Overall Study|Lost to Follow-up|12|||
131001308|NCT00280293|471631332|FG000|Overall Study|Withdrawal by Subject|3|||
131001309|NCT00280293|471631333|FG001|Overall Study|Withdrawal by Subject|5|||
131001310|NCT00280293|471631332|FG000|Overall Study|Incarceration/Legal Reasons|1|||
131001311|NCT00280293|471631333|FG001|Overall Study|Incarceration/Legal Reasons|1|||
131001312|NCT00280293|471631332|FG000|Overall Study|Adverse Event|0|||
131001313|NCT00280293|471631333|FG001|Overall Study|Adverse Event|1|||
131001314|NCT01458249|471631334|FG000|Overall Study|Not treated|1|||
131001315|NCT01458249|471631334|FG000|Overall Study|Adverse Event|4|||
131001316|NCT01458249|471631334|FG000|Overall Study|Other|2|||
131001317|NCT01458249|471631334|FG000|Overall Study|Ongoing|1|||
131001318|NCT01348854|471631335|FG000|Overall Study|Lost to Follow-up|2|||
131001319|NCT01348854|471631336|FG001|Overall Study|Lost to Follow-up|1|||
131001320|NCT01348854|471631335|FG000|Overall Study|Withdrawal by Subject|1|||
131001321|NCT01348854|471631336|FG001|Overall Study|Withdrawal by Subject|0|||
131001322|NCT01010217|471631337|FG000|Overall Study|Lost to Follow-up|4|||
131001323|NCT01010217|471631338|FG001|Overall Study|Lost to Follow-up|5|||
131001324|NCT01010217|471631339|FG002|Overall Study|Lost to Follow-up|1|||
131001325|NCT01010217|471631340|FG003|Overall Study|Lost to Follow-up|0|||
131001326|NCT01010217|471631341|FG004|Overall Study|Lost to Follow-up|0|||
131001327|NCT01010217|471631337|FG000|Overall Study|Withdrawal by Subject|1|||
131001328|NCT01010217|471631338|FG001|Overall Study|Withdrawal by Subject|0|||
131001329|NCT01010217|471631339|FG002|Overall Study|Withdrawal by Subject|0|||
131001330|NCT01010217|471631340|FG003|Overall Study|Withdrawal by Subject|0|||
131001331|NCT01010217|471631341|FG004|Overall Study|Withdrawal by Subject|0|||
131001332|NCT01010217|471631337|FG000|Overall Study|Physician Decision|0|||
131001333|NCT01010217|471631338|FG001|Overall Study|Physician Decision|0|||
131001334|NCT01010217|471631339|FG002|Overall Study|Physician Decision|0|||
131001335|NCT01010217|471631340|FG003|Overall Study|Physician Decision|6|||
131001336|NCT01010217|471631341|FG004|Overall Study|Physician Decision|3|||
131001337|NCT01439711|471631342|FG000|Overall Study|Ineligible|13|||
131001338|NCT01439711|471631342|FG000|Overall Study|Cancel|3|||
131001339|NCT01439711|471631342|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
131001340|NCT01439711|471631342|FG000|Overall Study|Adverse Event|5|||
131001341|NCT01439711|471631342|FG000|Overall Study|Withdrawal by Subject|3|||
131001342|NCT01439711|471631342|FG000|Overall Study|Progression During Active Tx|3|||
131001343|NCT01439711|471631342|FG000|Overall Study|Noncompliance|3|||
131001344|NCT01439711|471631342|FG000|Overall Study|No MRI|9|||
131001345|NCT04242875|471631343|FG000|Overall Study|Adverse Event|2|||
131001346|NCT02397460|471631344|FG000|Treatment Period 2|Adverse Event|0|||
131001347|NCT02397460|471631345|FG001|Treatment Period 2|Adverse Event|0|||
131001348|NCT02397460|471631346|FG002|Treatment Period 2|Adverse Event|0|||
131001349|NCT02397460|471631347|FG003|Treatment Period 2|Adverse Event|0|||
131001350|NCT02397460|471631348|FG004|Treatment Period 2|Adverse Event|0|||
131001351|NCT02397460|471631349|FG005|Treatment Period 2|Adverse Event|0|||
131001352|NCT02397460|471631350|FG006|Treatment Period 2|Adverse Event|0|||
131001353|NCT02397460|471631351|FG007|Treatment Period 2|Adverse Event|1|||
131001354|NCT02397460|471631344|FG000|Treatment Period 4|Adverse Event|0|||
131001355|NCT02397460|471631345|FG001|Treatment Period 4|Adverse Event|1|||
131001356|NCT02397460|471631346|FG002|Treatment Period 4|Adverse Event|0|||
131001357|NCT02397460|471631347|FG003|Treatment Period 4|Adverse Event|0|||
130884649|NCT02079246|471213180|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
131001358|NCT02397460|471631348|FG004|Treatment Period 4|Adverse Event|0|||
131001359|NCT02397460|471631349|FG005|Treatment Period 4|Adverse Event|0|||
131001360|NCT02397460|471631350|FG006|Treatment Period 4|Adverse Event|0|||
131001361|NCT02397460|471631351|FG007|Treatment Period 4|Adverse Event|0|||
131001362|NCT02397460|471631344|FG000|Treatment Period 4|Physician Decision|0|||
130884650|NCT02079246|471213179|FG000|OLEX-MEM|Adverse Event|0|||
131001363|NCT02397460|471631345|FG001|Treatment Period 4|Physician Decision|0|||
131001364|NCT02397460|471631346|FG002|Treatment Period 4|Physician Decision|0|||
131001365|NCT02397460|471631347|FG003|Treatment Period 4|Physician Decision|0|||
131001366|NCT02397460|471631348|FG004|Treatment Period 4|Physician Decision|1|||
131001367|NCT02397460|471631349|FG005|Treatment Period 4|Physician Decision|0|||
131001368|NCT02397460|471631350|FG006|Treatment Period 4|Physician Decision|0|||
131001369|NCT02397460|471631351|FG007|Treatment Period 4|Physician Decision|0|||
131001370|NCT01012973|471631352|FG000|Overall Study|Adverse Event|5|||
131001371|NCT01012973|471631353|FG001|Overall Study|Adverse Event|5|||
131001372|NCT01012973|471631352|FG000|Overall Study|Lack of Efficacy|0|||
131001373|NCT01012973|471631353|FG001|Overall Study|Lack of Efficacy|5|||
131001374|NCT01012973|471631352|FG000|Overall Study|Lost to Follow-up|1|||
131001375|NCT01012973|471631353|FG001|Overall Study|Lost to Follow-up|0|||
131001376|NCT01012973|471631352|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
131001377|NCT01012973|471631353|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
131001378|NCT01012973|471631352|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
131001379|NCT01012973|471631353|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
131001380|NCT01012973|471631352|FG000|Overall Study|Protocol Violation|5|||
131001381|NCT01012973|471631353|FG001|Overall Study|Protocol Violation|2|||
131001382|NCT01012973|471631352|FG000|Overall Study|Withdrawal by Subject|4|||
131001383|NCT01012973|471631353|FG001|Overall Study|Withdrawal by Subject|6|||
131001384|NCT02213055|471631355|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
131001385|NCT02213055|471631356|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
131001386|NCT02213055|471631355|FG000|Overall Study|Protocol was not Followed during Study|1|||
131001387|NCT02213055|471631356|FG001|Overall Study|Protocol was not Followed during Study|0|||
131001388|NCT02213055|471631355|FG000|Overall Study|Documentation Issue at Enrollment|1|||
131001389|NCT02213055|471631356|FG001|Overall Study|Documentation Issue at Enrollment|0|||
131001390|NCT02213055|471631355|FG000|Overall Study|Documentation Issue during Study|10|||
131001391|NCT02213055|471631356|FG001|Overall Study|Documentation Issue during Study|0|||
131001392|NCT02213055|471631355|FG000|Overall Study|Did not have Live Lice|8|||
131001393|NCT02213055|471631356|FG001|Overall Study|Did not have Live Lice|0|||
131001394|NCT02213055|471631355|FG000|Overall Study|Had another Treatment during the Study|3|||
131001395|NCT02213055|471631356|FG001|Overall Study|Had another Treatment during the Study|0|||
131001396|NCT02213055|471631355|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
131001397|NCT02213055|471631356|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
131001398|NCT02213055|471631355|FG000|Overall Study|Did not Return to School|5|||
131001399|NCT02213055|471631356|FG001|Overall Study|Did not Return to School|0|||
131001400|NCT00231894|471631357|FG000|Overall Study|Withdrawal by Subject|1|||
131001401|NCT00231894|471631358|FG001|Overall Study|Withdrawal by Subject|1|||
131001402|NCT02025205|471631360|FG000|Overall Study|Withdrawal by Subject|1|||
131001403|NCT02025205|471631361|FG001|Overall Study|Withdrawal by Subject|1|||
131001404|NCT02025205|471631360|FG000|Overall Study|Protocol Violation|2|||
131001405|NCT02025205|471631361|FG001|Overall Study|Protocol Violation|1|||
131001406|NCT02025205|471631360|FG000|Overall Study|Death|0|||
131001407|NCT02025205|471631361|FG001|Overall Study|Death|1|||
131001408|NCT04172987|471631363|FG000|Lead In Period|Adverse Event|1|||
131001409|NCT04172987|471631363|FG000|Lead In Period|Protocol Violation|1|||
131001410|NCT04172987|471631363|FG000|Period 1|Physician Decision|1|||
131001411|NCT04172987|471631363|FG000|Period 2|Adverse Event|5|||
131001412|NCT04172987|471631363|FG000|Period 2|Dosing Termination by Sponsor|4|||
131001413|NCT00738530|471631373|FG000|Overall Study|Death|220|||
131001414|NCT00738530|471631374|FG001|Overall Study|Death|224|||
131001415|NCT00738530|471631373|FG000|Overall Study|Lost to Follow-up|8|||
131001416|NCT00738530|471631374|FG001|Overall Study|Lost to Follow-up|6|||
131001417|NCT00738530|471631373|FG000|Overall Study|Withdrawal by Subject|6|||
131001418|NCT00738530|471631374|FG001|Overall Study|Withdrawal by Subject|8|||
131001419|NCT01628510|471631375|FG000|Overall Study|Withdrawal by Subject|0|||
131001420|NCT01628510|471631376|FG001|Overall Study|Withdrawal by Subject|4|||
131001421|NCT01628510|471631375|FG000|Overall Study|Death|3|||
131001422|NCT01628510|471631376|FG001|Overall Study|Death|1|||
131001423|NCT04179461|471631377|FG000|Overall Study|Lost to Follow-up|4|||
131001424|NCT01653847|471631378|FG000|Overall Study|Withdrawal by Subject|1|||
131001425|NCT01653847|471631379|FG001|Overall Study|Withdrawal by Subject|0|||
131001426|NCT04707391|471631380|FG000|Overall Study|Adverse Event|5|||
131001427|NCT04707391|471631381|FG001|Overall Study|Adverse Event|8|||
131001428|NCT04707391|471631380|FG000|Overall Study|Lost to Follow-up|44|||
131001429|NCT04707391|471631381|FG001|Overall Study|Lost to Follow-up|31|||
131001430|NCT04707391|471631380|FG000|Overall Study|Protocol Violation|1|||
131001431|NCT04707391|471631381|FG001|Overall Study|Protocol Violation|5|||
131001432|NCT04707391|471631380|FG000|Overall Study|Withdrawal by Subject|27|||
131001433|NCT04707391|471631381|FG001|Overall Study|Withdrawal by Subject|25|||
131001434|NCT04707391|471631380|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
131001435|NCT04707391|471631381|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
131001436|NCT04707391|471631380|FG000|Overall Study|Other|0|||
131001437|NCT04707391|471631381|FG001|Overall Study|Other|2|||
131001438|NCT03246672|471631382|FG000|Overall Study|Lost to Follow-up|2|||
131001439|NCT01406717|471631383|FG000|Overall Study|Subject non-compliance|4|||
131001440|NCT01406717|471631384|FG001|Overall Study|Subject non-compliance|3|||
131001441|NCT01406717|471631383|FG000|Overall Study|Protocol Violation|5|||
131001442|NCT01406717|471631384|FG001|Overall Study|Protocol Violation|1|||
131001443|NCT01406717|471631383|FG000|Overall Study|Lost to Follow-up|14|||
131001444|NCT01406717|471631384|FG001|Overall Study|Lost to Follow-up|8|||
131001445|NCT01406717|471631383|FG000|Overall Study|Withdrawal by Subject|19|||
131001446|NCT01406717|471631384|FG001|Overall Study|Withdrawal by Subject|15|||
131001447|NCT01406717|471631383|FG000|Overall Study|Adverse Event|1|||
131001448|NCT01406717|471631384|FG001|Overall Study|Adverse Event|2|||
131001449|NCT01406717|471631383|FG000|Overall Study|Lack of Efficacy|0|||
131001450|NCT01406717|471631384|FG001|Overall Study|Lack of Efficacy|1|||
131001451|NCT01406717|471631383|FG000|Overall Study|Non-completion of visit activity|0|||
131001452|NCT01406717|471631384|FG001|Overall Study|Non-completion of visit activity|1|||
131001453|NCT02040090|471631385|FG000|Overall Study|Adverse Event|2|||
131001454|NCT02040090|471631386|FG001|Overall Study|Adverse Event|0|||
131001455|NCT02040090|471631385|FG000|Overall Study|Physician Decision|1|||
131001456|NCT02040090|471631386|FG001|Overall Study|Physician Decision|0|||
131001457|NCT02040090|471631385|FG000|Overall Study|Withdrawal by Subject|0|||
131001458|NCT02040090|471631386|FG001|Overall Study|Withdrawal by Subject|1|||
131001459|NCT02040090|471631385|FG000|Overall Study|Lost to Follow-up|0|||
131001460|NCT02040090|471631386|FG001|Overall Study|Lost to Follow-up|1|||
131001461|NCT04894903|471631389|FG000|Overall Study|Death|1|||
131001462|NCT04894903|471631390|FG001|Overall Study|Death|0|||
131001463|NCT04894903|471631389|FG000|Overall Study|Pregnancy|1|||
131001464|NCT04894903|471631390|FG001|Overall Study|Pregnancy|0|||
131001465|NCT04894903|471631389|FG000|Overall Study|Withdrawal by Subject|1|||
131001466|NCT04894903|471631390|FG001|Overall Study|Withdrawal by Subject|1|||
131001467|NCT04894903|471631389|FG000|Overall Study|moved or exited health system|1|||
131001468|NCT04894903|471631390|FG001|Overall Study|moved or exited health system|3|||
131001469|NCT02584855|471631395|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
131001470|NCT02584855|471631396|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
131001471|NCT02584855|471631397|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
131001472|NCT02584855|471631398|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
131001473|NCT02584855|471631399|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
131001474|NCT02584855|471631400|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
131001475|NCT02584855|471631395|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
131001476|NCT02584855|471631396|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
131001477|NCT02584855|471631397|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
131001478|NCT02584855|471631398|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
131001479|NCT02584855|471631399|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
131001480|NCT02584855|471631400|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
131001481|NCT02584855|471631395|FG000|Open-Label Treatment Period|Adverse Event|14|||
131001482|NCT02584855|471631396|FG001|Open-Label Treatment Period|Adverse Event|0|||
131001483|NCT02584855|471631397|FG002|Open-Label Treatment Period|Adverse Event|0|||
131001484|NCT02584855|471631398|FG003|Open-Label Treatment Period|Adverse Event|0|||
131001485|NCT02584855|471631399|FG004|Open-Label Treatment Period|Adverse Event|0|||
131001486|NCT02584855|471631400|FG005|Open-Label Treatment Period|Adverse Event|0|||
131001487|NCT02584855|471631395|FG000|Open-Label Treatment Period|Death|2|||
131001488|NCT02584855|471631396|FG001|Open-Label Treatment Period|Death|0|||
131001489|NCT02584855|471631397|FG002|Open-Label Treatment Period|Death|0|||
131001490|NCT02584855|471631398|FG003|Open-Label Treatment Period|Death|0|||
131001491|NCT02584855|471631399|FG004|Open-Label Treatment Period|Death|0|||
131001492|NCT02584855|471631400|FG005|Open-Label Treatment Period|Death|0|||
131001493|NCT02584855|471631395|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
131001494|NCT02584855|471631396|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
131001495|NCT02584855|471631397|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
131001496|NCT02584855|471631398|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
131001497|NCT02584855|471631399|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
131001498|NCT02584855|471631400|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
131001499|NCT02584855|471631395|FG000|Open-Label Treatment Period|Protocol Violation|1|||
131001500|NCT02584855|471631396|FG001|Open-Label Treatment Period|Protocol Violation|0|||
131001501|NCT02584855|471631397|FG002|Open-Label Treatment Period|Protocol Violation|0|||
131001502|NCT02584855|471631398|FG003|Open-Label Treatment Period|Protocol Violation|0|||
131001503|NCT02584855|471631399|FG004|Open-Label Treatment Period|Protocol Violation|0|||
131001504|NCT02584855|471631400|FG005|Open-Label Treatment Period|Protocol Violation|0|||
131001505|NCT02584855|471631395|FG000|Open-Label Treatment Period|No PI Available|2|||
131001506|NCT02584855|471631396|FG001|Open-Label Treatment Period|No PI Available|0|||
130884651|NCT02079246|471213180|FG001|OLEX-MEM|Adverse Event|6|||
130884652|NCT02079246|471213179|FG000|OLEX-MEM|Withdrawal by Subject|0|||
130884653|NCT02079246|471213180|FG001|OLEX-MEM|Withdrawal by Subject|7|||
130884654|NCT02079246|471213179|FG000|OLEX-MEM|Protocol Violation|0|||
131001507|NCT02584855|471631397|FG002|Open-Label Treatment Period|No PI Available|0|||
131001508|NCT02584855|471631398|FG003|Open-Label Treatment Period|No PI Available|0|||
131001509|NCT02584855|471631399|FG004|Open-Label Treatment Period|No PI Available|0|||
131001510|NCT02584855|471631400|FG005|Open-Label Treatment Period|No PI Available|0|||
131001511|NCT02584855|471631395|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
131001512|NCT02584855|471631396|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
131001513|NCT02584855|471631397|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
131001514|NCT02584855|471631398|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
130884655|NCT02079246|471213180|FG001|OLEX-MEM|Protocol Violation|2|||
131001515|NCT02584855|471631399|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
130884656|NCT02079246|471213179|FG000|OLEX-MEM|Lost to Follow-up|0|||
131001516|NCT02584855|471631400|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
131001517|NCT02584855|471631395|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
131001518|NCT02584855|471631396|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
131001519|NCT02584855|471631397|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
131001520|NCT02584855|471631398|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
131001521|NCT02584855|471631399|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
131001522|NCT02584855|471631400|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
131001523|NCT02584855|471631395|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
131001524|NCT02584855|471631396|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
131001525|NCT02584855|471631397|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
131001526|NCT02584855|471631398|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
131001527|NCT02584855|471631399|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
131001528|NCT02584855|471631400|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
131001529|NCT02584855|471631395|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
131001530|NCT02584855|471631396|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
131001531|NCT02584855|471631397|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
131001532|NCT02584855|471631398|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
131001533|NCT02584855|471631399|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
131001534|NCT02584855|471631400|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
131001535|NCT02584855|471631395|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
131001536|NCT02584855|471631396|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
131001537|NCT02584855|471631397|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
131001538|NCT02584855|471631398|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
131001539|NCT02584855|471631399|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
131001540|NCT02584855|471631400|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
131001541|NCT02584855|471631395|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131001542|NCT02584855|471631396|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131001543|NCT02584855|471631397|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131001544|NCT02584855|471631398|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131001545|NCT02584855|471631399|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
131001546|NCT02584855|471631400|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
131001547|NCT02584855|471631395|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
131001548|NCT02584855|471631396|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
131001549|NCT02584855|471631397|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
131001550|NCT02584855|471631398|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
131001551|NCT02584855|471631399|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
131001552|NCT02584855|471631400|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
131001553|NCT02337478|471631401|FG000|Overall Study|Lack of Efficacy|5|||
131001554|NCT04963062|471631406|FG000|Overall Study|withdrew by the study team|4|||
131001555|NCT04963062|471631407|FG001|Overall Study|withdrew by the study team|2|||
131001556|NCT03873246|471631408|FG000|Overall Study|Adverse Event|1|||
131001557|NCT03873246|471631409|FG001|Overall Study|Adverse Event|3|||
131001558|NCT03873246|471631410|FG002|Overall Study|Adverse Event|3|||
131001559|NCT03873246|471631408|FG000|Overall Study|Lost to Follow-up|4|||
131001560|NCT03873246|471631409|FG001|Overall Study|Lost to Follow-up|4|||
131001561|NCT03873246|471631410|FG002|Overall Study|Lost to Follow-up|5|||
131001562|NCT03873246|471631408|FG000|Overall Study|Protocol Violation|0|||
131001563|NCT03873246|471631409|FG001|Overall Study|Protocol Violation|1|||
131001564|NCT03873246|471631410|FG002|Overall Study|Protocol Violation|0|||
131001565|NCT03873246|471631408|FG000|Overall Study|Withdrawal by Subject|0|||
131001566|NCT03873246|471631409|FG001|Overall Study|Withdrawal by Subject|4|||
131001567|NCT03873246|471631410|FG002|Overall Study|Withdrawal by Subject|1|||
131001568|NCT01857323|471631411|FG000|Overall Study|Adverse Event|1|||
131001569|NCT01857323|471631411|FG000|Overall Study|Withdrawal by Subject|3|||
131001570|NCT01857323|471631411|FG000|Overall Study|Non-compliance|1|||
131001571|NCT01857323|471631411|FG000|Overall Study|Protocol Violation|6|||
131001572|NCT01857323|471631411|FG000|Overall Study|Lost to Follow-up|1|||
131001573|NCT01857323|471631411|FG000|Overall Study|Other|4|||
131001574|NCT01857323|471631411|FG000|Overall Study|Did not complete 180 doses|48|||
131001575|NCT00885495|471631416|FG000|Overall Study|Adverse Event|1|||
131001576|NCT00885495|471631417|FG001|Overall Study|Adverse Event|2|||
131001577|NCT00885495|471631416|FG000|Overall Study|Protocol Violation|0|||
131001578|NCT00885495|471631417|FG001|Overall Study|Protocol Violation|1|||
131001579|NCT00885495|471631416|FG000|Overall Study|Withdrawal by Subject|1|||
131001580|NCT00885495|471631417|FG001|Overall Study|Withdrawal by Subject|0|||
131001581|NCT01400893|471631418|FG000|Overall Study|Death|27|||
131001582|NCT01400893|471631419|FG001|Overall Study|Death|21|||
131001583|NCT01400893|471631418|FG000|Overall Study|Lost to Follow-up|0|||
131001584|NCT01400893|471631419|FG001|Overall Study|Lost to Follow-up|6|||
131001585|NCT01368211|471631423|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
131001586|NCT01368211|471631424|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
131001587|NCT01349660|471631425|FG000|Overall Study|Still Receiving Study Treatment|0|||
131001588|NCT01349660|471631426|FG001|Overall Study|Still Receiving Study Treatment|0|||
131001589|NCT01349660|471631427|FG002|Overall Study|Still Receiving Study Treatment|1|||
131001590|NCT01349660|471631425|FG000|Overall Study|Disease Progression|2|||
131001591|NCT01349660|471631426|FG001|Overall Study|Disease Progression|4|||
131001592|NCT01349660|471631427|FG002|Overall Study|Disease Progression|50|||
131001593|NCT01349660|471631425|FG000|Overall Study|Adverse Event|1|||
131001594|NCT01349660|471631426|FG001|Overall Study|Adverse Event|1|||
131001595|NCT01349660|471631427|FG002|Overall Study|Adverse Event|12|||
131001596|NCT01349660|471631425|FG000|Overall Study|Withdrawal by Subject|2|||
131001597|NCT01349660|471631426|FG001|Overall Study|Withdrawal by Subject|0|||
131001598|NCT01349660|471631427|FG002|Overall Study|Withdrawal by Subject|9|||
131001599|NCT01349660|471631425|FG000|Overall Study|Death|1|||
131001600|NCT01349660|471631426|FG001|Overall Study|Death|1|||
131001601|NCT01349660|471631427|FG002|Overall Study|Death|0|||
131001602|NCT01349660|471631425|FG000|Overall Study|Non-Permitted Interventions|0|||
131001603|NCT01349660|471631426|FG001|Overall Study|Non-Permitted Interventions|0|||
131001604|NCT01349660|471631427|FG002|Overall Study|Non-Permitted Interventions|2|||
131001605|NCT01349660|471631425|FG000|Overall Study|Study Compliance|0|||
131001606|NCT01349660|471631426|FG001|Overall Study|Study Compliance|0|||
131001607|NCT01349660|471631427|FG002|Overall Study|Study Compliance|1|||
131001608|NCT01349660|471631425|FG000|Overall Study|Declining Performance Status|0|||
131001609|NCT01349660|471631426|FG001|Overall Study|Declining Performance Status|0|||
131001610|NCT01349660|471631427|FG002|Overall Study|Declining Performance Status|1|||
131001611|NCT00519636|471631428|FG000|Treatment Period 1|Adverse Event|1|||
131001612|NCT00519636|471631429|FG001|Treatment Period 1|Adverse Event|0|||
131001613|NCT00519636|471631430|FG002|Treatment Period 1|Adverse Event|1|||
131001614|NCT00519636|471631431|FG003|Treatment Period 1|Adverse Event|0|||
131001615|NCT00519636|471631428|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
131001616|NCT00519636|471631429|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
131001617|NCT00519636|471631430|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
131001618|NCT00519636|471631431|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
131001619|NCT00519636|471631428|FG000|Washout Period|Adverse Event|2|||
131001620|NCT00519636|471631429|FG001|Washout Period|Adverse Event|1|||
131001621|NCT00519636|471631430|FG002|Washout Period|Adverse Event|1|||
131001622|NCT00519636|471631431|FG003|Washout Period|Adverse Event|0|||
131001623|NCT00519636|471631428|FG000|Washout Period|Lost to Follow-up|1|||
131001624|NCT00519636|471631429|FG001|Washout Period|Lost to Follow-up|0|||
131001625|NCT00519636|471631430|FG002|Washout Period|Lost to Follow-up|0|||
131001626|NCT00519636|471631431|FG003|Washout Period|Lost to Follow-up|0|||
131001627|NCT00519636|471631428|FG000|Washout Period|Protocol Violation|0|||
131100744|NCT04860297|471998077|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
131100745|NCT04860297|471998078|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
131100746|NCT04860297|471998079|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
131100747|NCT04860297|471998080|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
131100748|NCT04860297|471998081|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
131100749|NCT04860297|471998082|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
131100750|NCT04811131|471998089|FG000|Overall Study|Adverse Event|0|||
131100751|NCT04811131|471998090|FG001|Overall Study|Adverse Event|0|||
131001628|NCT00519636|471631429|FG001|Washout Period|Protocol Violation|0|||
131001629|NCT00519636|471631430|FG002|Washout Period|Protocol Violation|1|||
131001630|NCT00519636|471631431|FG003|Washout Period|Protocol Violation|2|||
131001631|NCT00519636|471631428|FG000|Washout Period|Withdrawal by Subject|1|||
131100752|NCT04811131|471998091|FG002|Overall Study|Adverse Event|1|||
131100753|NCT04811131|471998092|FG003|Overall Study|Adverse Event|0|||
131100754|NCT04811131|471998089|FG000|Overall Study|Lack of Efficacy|0|||
131100755|NCT04811131|471998090|FG001|Overall Study|Lack of Efficacy|0|||
131001632|NCT00519636|471631429|FG001|Washout Period|Withdrawal by Subject|0|||
131001633|NCT00519636|471631430|FG002|Washout Period|Withdrawal by Subject|1|||
131001634|NCT00519636|471631431|FG003|Washout Period|Withdrawal by Subject|0|||
131001635|NCT00519636|471631428|FG000|Washout Period|Failed to meet continuation criteria|14|||
131001636|NCT00519636|471631429|FG001|Washout Period|Failed to meet continuation criteria|11|||
131100756|NCT04811131|471998091|FG002|Overall Study|Lack of Efficacy|0|||
131100757|NCT04811131|471998092|FG003|Overall Study|Lack of Efficacy|1|||
131001637|NCT00519636|471631430|FG002|Washout Period|Failed to meet continuation criteria|9|||
131001638|NCT00519636|471631431|FG003|Washout Period|Failed to meet continuation criteria|3|||
131001639|NCT00519636|471631428|FG000|Washout Period|Out of pollen area > 48 hours|1|||
131001640|NCT00519636|471631429|FG001|Washout Period|Out of pollen area > 48 hours|0|||
131001641|NCT00519636|471631430|FG002|Washout Period|Out of pollen area > 48 hours|0|||
131001642|NCT00519636|471631431|FG003|Washout Period|Out of pollen area > 48 hours|0|||
131001643|NCT00519636|471631428|FG000|Washout Period|Participating in study at another site|1|||
131001644|NCT00519636|471631429|FG001|Washout Period|Participating in study at another site|0|||
131001645|NCT00519636|471631430|FG002|Washout Period|Participating in study at another site|0|||
131001646|NCT00519636|471631431|FG003|Washout Period|Participating in study at another site|0|||
131001647|NCT00519636|471631428|FG000|Washout Period|Non-compliant|0|||
131001648|NCT00519636|471631429|FG001|Washout Period|Non-compliant|1|||
131001649|NCT00519636|471631430|FG002|Washout Period|Non-compliant|0|||
131001650|NCT00519636|471631431|FG003|Washout Period|Non-compliant|0|||
131001651|NCT00519636|471631428|FG000|Washout Period|Per doctors request|0|||
131001652|NCT00519636|471631429|FG001|Washout Period|Per doctors request|1|||
131001653|NCT00519636|471631430|FG002|Washout Period|Per doctors request|0|||
131001654|NCT00519636|471631431|FG003|Washout Period|Per doctors request|0|||
131001655|NCT00519636|471631428|FG000|Washout Period|Subject randomized in error|0|||
131001656|NCT00519636|471631429|FG001|Washout Period|Subject randomized in error|0|||
131001657|NCT00519636|471631430|FG002|Washout Period|Subject randomized in error|1|||
131001658|NCT00519636|471631431|FG003|Washout Period|Subject randomized in error|0|||
131001659|NCT00519636|471631428|FG000|Washout Period|Prohibited medications|0|||
131001660|NCT00519636|471631429|FG001|Washout Period|Prohibited medications|0|||
131001661|NCT00519636|471631430|FG002|Washout Period|Prohibited medications|1|||
131001662|NCT00519636|471631431|FG003|Washout Period|Prohibited medications|0|||
131001663|NCT00519636|471631428|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
131001664|NCT00519636|471631429|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
131001665|NCT00519636|471631430|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
131001666|NCT00519636|471631431|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
131001667|NCT00519636|471631428|FG000|Treatment Period 2|Subject randomized in error|0|||
131001668|NCT00519636|471631429|FG001|Treatment Period 2|Subject randomized in error|1|||
131001669|NCT00519636|471631430|FG002|Treatment Period 2|Subject randomized in error|0|||
131100758|NCT04811131|471998089|FG000|Overall Study|Lost to Follow-up|0|||
131100759|NCT04811131|471998090|FG001|Overall Study|Lost to Follow-up|1|||
131100760|NCT04811131|471998091|FG002|Overall Study|Lost to Follow-up|0|||
131001670|NCT00519636|471631431|FG003|Treatment Period 2|Subject randomized in error|0|||
131100761|NCT04811131|471998092|FG003|Overall Study|Lost to Follow-up|0|||
131001671|NCT00519636|471631428|FG000|Treatment Period 2|Per doctors request|0|||
131001672|NCT00519636|471631429|FG001|Treatment Period 2|Per doctors request|0|||
131001673|NCT00519636|471631430|FG002|Treatment Period 2|Per doctors request|1|||
131001674|NCT00519636|471631431|FG003|Treatment Period 2|Per doctors request|0|||
131001675|NCT00519636|471631428|FG000|Treatment Period 2|Subject misrandomized|0|||
131001676|NCT00519636|471631429|FG001|Treatment Period 2|Subject misrandomized|0|||
131001677|NCT00519636|471631430|FG002|Treatment Period 2|Subject misrandomized|0|||
131001678|NCT00519636|471631431|FG003|Treatment Period 2|Subject misrandomized|1|||
131001679|NCT00519636|471631428|FG000|Post Study Period|Subject randomized in error|0|||
131001680|NCT00519636|471631429|FG001|Post Study Period|Subject randomized in error|0|||
131001681|NCT00519636|471631430|FG002|Post Study Period|Subject randomized in error|0|||
131001682|NCT00519636|471631431|FG003|Post Study Period|Subject randomized in error|1|||
131001683|NCT02846558|471631436|FG000|Overall Study|Adverse Event|1|||
131001684|NCT02846558|471631437|FG001|Overall Study|Adverse Event|0|||
131001685|NCT02846558|471631438|FG002|Overall Study|Adverse Event|0|||
131001686|NCT02846558|471631439|FG003|Overall Study|Adverse Event|0|||
131001687|NCT02846558|471631436|FG000|Overall Study|Withdrawal by Subject|5|||
131001688|NCT02846558|471631437|FG001|Overall Study|Withdrawal by Subject|4|||
131001689|NCT02846558|471631438|FG002|Overall Study|Withdrawal by Subject|2|||
131001690|NCT02846558|471631439|FG003|Overall Study|Withdrawal by Subject|2|||
131001691|NCT02846558|471631436|FG000|Overall Study|Lost to Follow-up|2|||
131001692|NCT02846558|471631437|FG001|Overall Study|Lost to Follow-up|0|||
131001693|NCT02846558|471631438|FG002|Overall Study|Lost to Follow-up|0|||
131001694|NCT02846558|471631439|FG003|Overall Study|Lost to Follow-up|0|||
131001695|NCT00904150|471631449|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
131001696|NCT00904150|471631450|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
131001697|NCT00904150|471631449|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
131001698|NCT00904150|471631450|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
131001699|NCT04129580|471633211|FG000|Overall Study|Lost to Follow-up|14|||
131001700|NCT04129580|471633212|FG001|Overall Study|Lost to Follow-up|25|||
131001701|NCT00224133|471633215|FG000|Overall Study|Adverse Event|93|||
131001702|NCT00224133|471633215|FG000|Overall Study|Protocol Violation|6|||
131001703|NCT00224133|471633215|FG000|Overall Study|Withdrawal by Subject|33|||
131001704|NCT00224133|471633215|FG000|Overall Study|Lack of Efficacy|58|||
131001705|NCT00224133|471633215|FG000|Overall Study|Lost to Follow-up|21|||
131001706|NCT00224133|471633215|FG000|Overall Study|Physician Decision|1|||
131001707|NCT00224133|471633215|FG000|Overall Study|Other|14|||
131001708|NCT02056119|471633220|FG000|Overall Study|Death|1|||
131001709|NCT02056119|471633221|FG001|Overall Study|Death|2|||
131001710|NCT02056119|471633220|FG000|Overall Study|Intubated for less than 24 hrs|2|||
131001711|NCT02056119|471633221|FG001|Overall Study|Intubated for less than 24 hrs|7|||
131001712|NCT02056119|471633220|FG000|Overall Study|No aerosol treatments were given.|3|||
131001713|NCT02056119|471633221|FG001|Overall Study|No aerosol treatments were given.|2|||
131001714|NCT02056119|471633220|FG000|Overall Study|Received Metaneb treatment|0|||
131001715|NCT02056119|471633221|FG001|Overall Study|Received Metaneb treatment|2|||
131001716|NCT02056119|471633220|FG000|Overall Study|Protocol Violation|4|||
131001717|NCT02056119|471633221|FG001|Overall Study|Protocol Violation|7|||
131001718|NCT03220737|471633222|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
131001719|NCT03220737|471633223|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
131001720|NCT03220737|471633224|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
131001721|NCT03220737|471633225|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
131001722|NCT03220737|471633226|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
131001723|NCT03220737|471633227|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
131001724|NCT03220737|471633228|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
131001725|NCT03220737|471633222|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
131001726|NCT03220737|471633223|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
131001727|NCT03220737|471633224|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
131001728|NCT03220737|471633225|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
131001729|NCT03220737|471633226|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
131001730|NCT03220737|471633227|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
131001731|NCT03220737|471633228|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
131001732|NCT03220737|471633222|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
131001733|NCT03220737|471633223|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
131001734|NCT03220737|471633224|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
131001735|NCT03220737|471633225|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
131001736|NCT03220737|471633226|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
131001737|NCT03220737|471633227|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
131001738|NCT03220737|471633228|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
131001739|NCT03220737|471633222|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131001740|NCT03220737|471633223|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131001741|NCT03220737|471633224|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
131001742|NCT03220737|471633225|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131001743|NCT03220737|471633226|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131001744|NCT03220737|471633227|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131001745|NCT03220737|471633228|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
131001746|NCT03220737|471633222|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131001747|NCT03220737|471633223|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131001748|NCT03220737|471633224|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131001749|NCT03220737|471633225|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131001750|NCT03220737|471633226|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
131001751|NCT03220737|471633227|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131001752|NCT03220737|471633228|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
131001753|NCT03220737|471633222|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
131001754|NCT03220737|471633223|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131001755|NCT03220737|471633224|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131001756|NCT03220737|471633225|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131001757|NCT03220737|471633226|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131001758|NCT03220737|471633227|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131001759|NCT03220737|471633228|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
131001760|NCT03220737|471633222|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
131001761|NCT03220737|471633223|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131001762|NCT03220737|471633224|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131001763|NCT03220737|471633225|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131001764|NCT03220737|471633226|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131001765|NCT03220737|471633227|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
130884657|NCT02079246|471213180|FG001|OLEX-MEM|Lost to Follow-up|1|||
130884658|NCT02079246|471213179|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
130884659|NCT02079246|471213180|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
130884660|NCT03077412|471213185|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
130884661|NCT03077412|471213186|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
130884662|NCT03077412|471213187|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
130884663|NCT03077412|471213185|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
130884664|NCT03077412|471213186|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
130884665|NCT03077412|471213187|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
130884666|NCT03077412|471213185|FG000|Overall Study|Adverse Event|1|||
130884667|NCT03077412|471213186|FG001|Overall Study|Adverse Event|2|||
130884668|NCT03077412|471213187|FG002|Overall Study|Adverse Event|2|||
130884669|NCT03077412|471213185|FG000|Overall Study|Investigator's Discretion|0|||
130884670|NCT03077412|471213186|FG001|Overall Study|Investigator's Discretion|1|||
130884671|NCT03077412|471213187|FG002|Overall Study|Investigator's Discretion|1|||
130884672|NCT03077412|471213185|FG000|Overall Study|Withdrew Consent|0|||
130884673|NCT03077412|471213186|FG001|Overall Study|Withdrew Consent|2|||
130884674|NCT03077412|471213187|FG002|Overall Study|Withdrew Consent|0|||
130884675|NCT02266888|471213188|FG000|Overall Study|Death|2|||
130884676|NCT02266888|471213189|FG001|Overall Study|Death|2|||
130884677|NCT02266888|471213190|FG002|Overall Study|Death|4|||
130884678|NCT02266888|471213191|FG003|Overall Study|Death|2|||
130884679|NCT02266888|471213188|FG000|Overall Study|Physician Decision|0|||
130884680|NCT02266888|471213189|FG001|Overall Study|Physician Decision|1|||
130884681|NCT02266888|471213190|FG002|Overall Study|Physician Decision|2|||
130884682|NCT02266888|471213191|FG003|Overall Study|Physician Decision|2|||
130884683|NCT02266888|471213188|FG000|Overall Study|Study Terminated|5|||
130884684|NCT02266888|471213189|FG001|Overall Study|Study Terminated|1|||
130884685|NCT02266888|471213190|FG002|Overall Study|Study Terminated|0|||
130884686|NCT02266888|471213191|FG003|Overall Study|Study Terminated|0|||
130884687|NCT02266888|471213188|FG000|Overall Study|No Longer Eligible|0|||
130884688|NCT02266888|471213189|FG001|Overall Study|No Longer Eligible|0|||
130884689|NCT02266888|471213190|FG002|Overall Study|No Longer Eligible|0|||
130884690|NCT02266888|471213191|FG003|Overall Study|No Longer Eligible|2|||
130884691|NCT02266888|471213188|FG000|Overall Study|Randomization Closed|0|||
130884692|NCT02266888|471213189|FG001|Overall Study|Randomization Closed|0|||
130884693|NCT02266888|471213190|FG002|Overall Study|Randomization Closed|4|||
130884694|NCT02266888|471213191|FG003|Overall Study|Randomization Closed|0|||
130884695|NCT02266888|471213188|FG000|Overall Study|Personnel unavailable at transplant|0|||
130884696|NCT02266888|471213189|FG001|Overall Study|Personnel unavailable at transplant|0|||
130884697|NCT02266888|471213190|FG002|Overall Study|Personnel unavailable at transplant|0|||
130884698|NCT02266888|471213191|FG003|Overall Study|Personnel unavailable at transplant|1|||
130884699|NCT02266888|471213188|FG000|Overall Study|Transfer of care|0|||
131001766|NCT03220737|471633228|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
131100762|NCT04811131|471998089|FG000|Overall Study|Sponsor request|31|||
130884700|NCT02266888|471213189|FG001|Overall Study|Transfer of care|0|||
130884701|NCT02266888|471213190|FG002|Overall Study|Transfer of care|1|||
130884702|NCT02266888|471213191|FG003|Overall Study|Transfer of care|0|||
130884703|NCT02351856|471213192|FG000|Overall Study|Adverse Event|2|||
130884704|NCT02351856|471213192|FG000|Overall Study|Physician Decision|5|||
131001767|NCT03220737|471633222|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
131001768|NCT03220737|471633223|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131001769|NCT03220737|471633224|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131001770|NCT03220737|471633225|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131001771|NCT03220737|471633226|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131001772|NCT03220737|471633227|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131001773|NCT03220737|471633228|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
131001774|NCT01782326|471633231|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
131001775|NCT01782326|471633232|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
131001776|NCT01782326|471633231|FG000|Planned Treatment Epoch|Death|29|||
131001777|NCT01782326|471633232|FG001|Planned Treatment Epoch|Death|30|||
131001778|NCT01782326|471633231|FG000|Planned Treatment Epoch|Physician Decision|18|||
131001779|NCT01782326|471633232|FG001|Planned Treatment Epoch|Physician Decision|16|||
131001780|NCT01782326|471633231|FG000|Planned Treatment Epoch|Protocol deviation|2|||
131001781|NCT01782326|471633232|FG001|Planned Treatment Epoch|Protocol deviation|3|||
131001782|NCT01782326|471633231|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
131001783|NCT01782326|471633232|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
131001784|NCT01782326|471633231|FG000|Planned Treatment Epoch|Technical problems|0|||
131001785|NCT01782326|471633232|FG001|Planned Treatment Epoch|Technical problems|4|||
130884705|NCT02351856|471213192|FG000|Overall Study|Study terminated by sponsor|1|||
130884706|NCT01458392|471213193|FG000|Overall Study|Death|2|||
130884707|NCT01458392|471213194|FG001|Overall Study|Death|11|||
130884708|NCT01458392|471213195|FG002|Overall Study|Death|22|||
130884709|NCT01458392|471213193|FG000|Overall Study|At the discretion of the sponsor|0|||
130884710|NCT01458392|471213194|FG001|Overall Study|At the discretion of the sponsor|2|||
130884711|NCT01458392|471213195|FG002|Overall Study|At the discretion of the sponsor|7|||
130884712|NCT01458392|471213193|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
130884713|NCT01458392|471213194|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
130884714|NCT01458392|471213195|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
130884715|NCT01193244|471213198|FG000|Overall Study|Withdrawal by Subject|79|||
130884716|NCT01193244|471213199|FG001|Overall Study|Withdrawal by Subject|97|||
130884717|NCT01193244|471213198|FG000|Overall Study|Other|303|||
130884718|NCT01193244|471213199|FG001|Overall Study|Other|278|||
130884719|NCT01193244|471213198|FG000|Overall Study|Lost to Follow-up|6|||
130884720|NCT01193244|471213199|FG001|Overall Study|Lost to Follow-up|15|||
130884721|NCT00790842|471213216|FG000|Dose Level 1|Adverse Event|1|||
130884722|NCT00790842|471213217|FG001|Dose Level 1|Adverse Event|0|||
130884723|NCT00790842|471213218|FG002|Dose Level 1|Adverse Event|0|||
130884724|NCT00790842|471213219|FG003|Dose Level 1|Adverse Event|2|||
130884725|NCT00790842|471213220|FG004|Dose Level 1|Adverse Event|0|||
130884726|NCT00790842|471213221|FG005|Dose Level 1|Adverse Event|0|||
130884727|NCT00790842|471213222|FG006|Dose Level 1|Adverse Event|0|||
130884728|NCT00790842|471213223|FG007|Dose Level 1|Adverse Event|1|||
130884729|NCT00790842|471213224|FG008|Dose Level 1|Adverse Event|0|||
130884730|NCT00790842|471213225|FG009|Dose Level 1|Adverse Event|0|||
130884731|NCT00790842|471213226|FG010|Dose Level 1|Adverse Event|0|||
130884732|NCT00790842|471213216|FG000|Dose Level 1|Physician Decision|1|||
130884733|NCT00790842|471213217|FG001|Dose Level 1|Physician Decision|0|||
130884734|NCT00790842|471213218|FG002|Dose Level 1|Physician Decision|0|||
130884735|NCT00790842|471213219|FG003|Dose Level 1|Physician Decision|0|||
130884736|NCT00790842|471213220|FG004|Dose Level 1|Physician Decision|0|||
130884737|NCT00790842|471213221|FG005|Dose Level 1|Physician Decision|0|||
130884738|NCT00790842|471213222|FG006|Dose Level 1|Physician Decision|0|||
130884739|NCT00790842|471213223|FG007|Dose Level 1|Physician Decision|1|||
130884740|NCT00790842|471213224|FG008|Dose Level 1|Physician Decision|0|||
130884741|NCT00790842|471213225|FG009|Dose Level 1|Physician Decision|0|||
130884742|NCT00790842|471213226|FG010|Dose Level 1|Physician Decision|0|||
130884743|NCT00790842|471213216|FG000|Dose Level 1|Withdrawal by Subject|1|||
130884744|NCT00790842|471213217|FG001|Dose Level 1|Withdrawal by Subject|0|||
130884745|NCT00790842|471213218|FG002|Dose Level 1|Withdrawal by Subject|0|||
130884746|NCT00790842|471213219|FG003|Dose Level 1|Withdrawal by Subject|0|||
130884747|NCT00790842|471213220|FG004|Dose Level 1|Withdrawal by Subject|0|||
130884748|NCT00790842|471213221|FG005|Dose Level 1|Withdrawal by Subject|0|||
130884749|NCT00790842|471213222|FG006|Dose Level 1|Withdrawal by Subject|0|||
130884750|NCT00790842|471213223|FG007|Dose Level 1|Withdrawal by Subject|0|||
130884751|NCT00790842|471213224|FG008|Dose Level 1|Withdrawal by Subject|0|||
130884752|NCT00790842|471213225|FG009|Dose Level 1|Withdrawal by Subject|0|||
130884753|NCT00790842|471213226|FG010|Dose Level 1|Withdrawal by Subject|0|||
130884754|NCT00790842|471213216|FG000|Dose Level 2|Death|0|||
130884755|NCT00790842|471213217|FG001|Dose Level 2|Death|1|||
130884756|NCT00790842|471213218|FG002|Dose Level 2|Death|0|||
130884757|NCT00790842|471213219|FG003|Dose Level 2|Death|0|||
130884758|NCT00790842|471213220|FG004|Dose Level 2|Death|1|||
130884759|NCT00790842|471213221|FG005|Dose Level 2|Death|0|||
130884760|NCT00790842|471213222|FG006|Dose Level 2|Death|0|||
130884761|NCT00790842|471213223|FG007|Dose Level 2|Death|0|||
131001786|NCT01782326|471633231|FG000|Double-blind Treatment|Adverse Event|129|||
131001787|NCT01782326|471633232|FG001|Double-blind Treatment|Adverse Event|145|||
131001788|NCT01782326|471633231|FG000|Double-blind Treatment|Subject/guardian decision|111|||
131001789|NCT01782326|471633232|FG001|Double-blind Treatment|Subject/guardian decision|125|||
131001790|NCT01782326|471633231|FG000|Double-blind Treatment|Lack of Efficacy|17|||
131001791|NCT01782326|471633232|FG001|Double-blind Treatment|Lack of Efficacy|22|||
131001792|NCT01782326|471633231|FG000|Double-blind Treatment|Physician Decision|13|||
131001793|NCT01782326|471633232|FG001|Double-blind Treatment|Physician Decision|16|||
131001794|NCT01782326|471633231|FG000|Double-blind Treatment|Protocol deviation|8|||
131001795|NCT01782326|471633232|FG001|Double-blind Treatment|Protocol deviation|7|||
131001796|NCT01782326|471633231|FG000|Double-blind Treatment|Technical problems|0|||
131001797|NCT01782326|471633232|FG001|Double-blind Treatment|Technical problems|5|||
131001798|NCT01767129|471633233|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
131001799|NCT01767129|471633234|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
131001800|NCT03389893|471633235|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
131001801|NCT03389893|471633236|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
131001802|NCT03389893|471633237|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
131001803|NCT03389893|471633238|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
131001804|NCT03389893|471633235|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
131001805|NCT03389893|471633236|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
131001806|NCT03389893|471633237|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
131001807|NCT03389893|471633238|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
131001808|NCT03389893|471633235|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
131001809|NCT03389893|471633236|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
131001810|NCT03389893|471633237|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
131001811|NCT03389893|471633238|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
131001812|NCT03389893|471633235|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
131001813|NCT03389893|471633236|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
131001814|NCT03389893|471633237|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
131001815|NCT03389893|471633238|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
131001816|NCT01232556|471633241|FG000|Overall Study|Withdrawal by Subject|21|||
131001817|NCT01232556|471633242|FG001|Overall Study|Withdrawal by Subject|17|||
131001818|NCT01232556|471633241|FG000|Overall Study|Death|97|||
131001819|NCT01232556|471633242|FG001|Overall Study|Death|97|||
131001820|NCT01232556|471633241|FG000|Overall Study|Lost to Follow-up|0|||
131001821|NCT01232556|471633242|FG001|Overall Study|Lost to Follow-up|2|||
131001822|NCT01232556|471633241|FG000|Overall Study|Terminated by Sponsor|35|||
131001823|NCT01232556|471633242|FG001|Overall Study|Terminated by Sponsor|51|||
131001824|NCT01232556|471633241|FG000|Overall Study|Other|6|||
131001825|NCT01232556|471633242|FG001|Overall Study|Other|4|||
131001826|NCT01024751|471633243|FG000|Enrolled Participants|Ineligible at baseline|3|||
131001827|NCT01024751|471633244|FG001|Enrolled Participants|Ineligible at baseline|4|||
131001828|NCT01024751|471633243|FG000|Eligible Participants|Withdrawal by Subject|0|||
131001829|NCT01024751|471633244|FG001|Eligible Participants|Withdrawal by Subject|1|||
131001830|NCT01024751|471633243|FG000|Eligible Participants|Lost to Follow-up|0|||
131001831|NCT01024751|471633244|FG001|Eligible Participants|Lost to Follow-up|1|||
131001832|NCT01024751|471633243|FG000|Eligible Participants|Ineligible|0|||
131001833|NCT01024751|471633244|FG001|Eligible Participants|Ineligible|1|||
131001834|NCT02448719|471633245|FG000|Overall Study|Withdrawal by Subject|0|||
131001835|NCT02448719|471633246|FG001|Overall Study|Withdrawal by Subject|0|||
131001836|NCT02448719|471633247|FG002|Overall Study|Withdrawal by Subject|0|||
131001837|NCT02448719|471633248|FG003|Overall Study|Withdrawal by Subject|0|||
131001838|NCT02448719|471633249|FG004|Overall Study|Withdrawal by Subject|1|||
131001839|NCT02448719|471633250|FG005|Overall Study|Withdrawal by Subject|0|||
131001840|NCT02448719|471633251|FG006|Overall Study|Withdrawal by Subject|0|||
131001841|NCT02448719|471633252|FG007|Overall Study|Withdrawal by Subject|0|||
131001842|NCT02448719|471633253|FG008|Overall Study|Withdrawal by Subject|0|||
131001843|NCT02448719|471633254|FG009|Overall Study|Withdrawal by Subject|0|||
131001844|NCT02448719|471633255|FG010|Overall Study|Withdrawal by Subject|0|||
131001845|NCT01473420|471633257|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
131001846|NCT01473420|471633258|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
131001847|NCT01473420|471633257|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
131001848|NCT01473420|471633258|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
131001849|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
131001850|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
131001851|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
131001852|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
131001853|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
131001854|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
131001855|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
131001856|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
131001857|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
131001858|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
131001859|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
131001860|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
131001861|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
131001862|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
131001863|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
131001864|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
131001865|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
131001866|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
131001867|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
131001868|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
131001869|NCT01473420|471633257|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
131001870|NCT01473420|471633258|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
131001871|NCT01347645|471633259|FG000|Overall Study|Death|1|||
131001872|NCT01347645|471633260|FG001|Overall Study|Death|5|||
131001873|NCT01347645|471633261|FG002|Overall Study|Death|2|||
131001874|NCT01347645|471633262|FG003|Overall Study|Death|7|||
131001875|NCT01347645|471633263|FG004|Overall Study|Death|7|||
131001876|NCT01347645|471633259|FG000|Overall Study|Lost to Follow-up|1|||
131001877|NCT01347645|471633260|FG001|Overall Study|Lost to Follow-up|1|||
131001878|NCT01347645|471633261|FG002|Overall Study|Lost to Follow-up|0|||
131001879|NCT01347645|471633262|FG003|Overall Study|Lost to Follow-up|1|||
131001880|NCT01347645|471633263|FG004|Overall Study|Lost to Follow-up|1|||
131001881|NCT01347645|471633259|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
131001882|NCT01347645|471633260|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
131001883|NCT01347645|471633261|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
131001884|NCT01347645|471633262|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
131001885|NCT01347645|471633263|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
131001886|NCT01347645|471633259|FG000|Overall Study|Other|1|||
131001887|NCT01347645|471633260|FG001|Overall Study|Other|0|||
131001888|NCT01347645|471633261|FG002|Overall Study|Other|0|||
131001889|NCT01347645|471633262|FG003|Overall Study|Other|0|||
131001890|NCT01347645|471633263|FG004|Overall Study|Other|1|||
131001891|NCT01347645|471633259|FG000|Overall Study|Withdrawal by Subject|0|||
131001892|NCT01347645|471633260|FG001|Overall Study|Withdrawal by Subject|0|||
131001893|NCT01347645|471633261|FG002|Overall Study|Withdrawal by Subject|0|||
131001894|NCT01347645|471633262|FG003|Overall Study|Withdrawal by Subject|3|||
131001895|NCT01347645|471633263|FG004|Overall Study|Withdrawal by Subject|3|||
131001896|NCT01347645|471633259|FG000|Overall Study|Physician Decision|0|||
131001897|NCT01347645|471633260|FG001|Overall Study|Physician Decision|0|||
131001898|NCT01347645|471633261|FG002|Overall Study|Physician Decision|0|||
131001899|NCT01347645|471633262|FG003|Overall Study|Physician Decision|0|||
131001900|NCT01347645|471633263|FG004|Overall Study|Physician Decision|1|||
131001901|NCT01347645|471633259|FG000|Overall Study|Adverse Event|0|||
131001902|NCT01347645|471633260|FG001|Overall Study|Adverse Event|0|||
131001903|NCT01347645|471633261|FG002|Overall Study|Adverse Event|0|||
131001904|NCT01347645|471633262|FG003|Overall Study|Adverse Event|1|||
131001905|NCT01347645|471633263|FG004|Overall Study|Adverse Event|1|||
131001906|NCT00388362|471633264|FG000|Enrolled|Ineligible|1|||
131001907|NCT00388362|471633264|FG000|Enrolled|Adverse Event|9|||
131001908|NCT00388362|471633264|FG000|Enrolled|Death|1|||
131001909|NCT00388362|471633264|FG000|Enrolled|Loss insurance|1|||
131001910|NCT00388362|471633264|FG000|Enrolled|Withdrawal by Subject|1|||
131001911|NCT00388362|471633264|FG000|Remained on Study Median of 514 Days|Death|2|||
131001912|NCT01141660|471633265|FG000|Overall Study|Physician Decision|0|||
131001913|NCT01141660|471633266|FG001|Overall Study|Physician Decision|12|||
131001914|NCT00209027|471633268|FG000|Overall Study|study terminated|10|||
131001915|NCT00209027|471633269|FG001|Overall Study|study terminated|0|||
131001916|NCT01163149|471633270|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
131001917|NCT01163149|471633271|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
131001918|NCT01163149|471633272|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
131001919|NCT01163149|471633270|FG000|Extension Treatment Period|Adverse Event|0|||
131001920|NCT01163149|471633271|FG001|Extension Treatment Period|Adverse Event|1|||
131001921|NCT01163149|471633272|FG002|Extension Treatment Period|Adverse Event|0|||
131001922|NCT01163149|471633270|FG000|Extension Treatment Period|Noncompliance|0|||
131001923|NCT01163149|471633271|FG001|Extension Treatment Period|Noncompliance|0|||
131001924|NCT01163149|471633272|FG002|Extension Treatment Period|Noncompliance|1|||
131001925|NCT01932996|471633273|FG000|Overall Study|Protocol Violation|2|||
131001926|NCT01932996|471633274|FG001|Overall Study|Protocol Violation|0|||
131001927|NCT01848834|471633275|FG000|Overall Study|Adverse Event|3|||
131001928|NCT01848834|471633276|FG001|Overall Study|Adverse Event|11|||
131001929|NCT01848834|471633277|FG002|Overall Study|Adverse Event|3|||
131001930|NCT01848834|471633278|FG003|Overall Study|Adverse Event|5|||
131001931|NCT01848834|471633279|FG004|Overall Study|Adverse Event|9|||
131001932|NCT01848834|471633275|FG000|Overall Study|Death|2|||
131001933|NCT01848834|471633276|FG001|Overall Study|Death|11|||
131001934|NCT01848834|471633277|FG002|Overall Study|Death|1|||
131001935|NCT01848834|471633278|FG003|Overall Study|Death|8|||
131001936|NCT01848834|471633279|FG004|Overall Study|Death|27|||
131001937|NCT01848834|471633275|FG000|Overall Study|Excluded Medication|5|||
131001938|NCT01848834|471633276|FG001|Overall Study|Excluded Medication|4|||
131001939|NCT01848834|471633277|FG002|Overall Study|Excluded Medication|3|||
131001940|NCT01848834|471633278|FG003|Overall Study|Excluded Medication|6|||
131001941|NCT01848834|471633279|FG004|Overall Study|Excluded Medication|6|||
131001942|NCT01848834|471633275|FG000|Overall Study|Lost to Follow-up|5|||
131001943|NCT01848834|471633276|FG001|Overall Study|Lost to Follow-up|5|||
131001944|NCT01848834|471633277|FG002|Overall Study|Lost to Follow-up|3|||
131001945|NCT01848834|471633278|FG003|Overall Study|Lost to Follow-up|0|||
131001946|NCT01848834|471633279|FG004|Overall Study|Lost to Follow-up|3|||
131001947|NCT01848834|471633275|FG000|Overall Study|Physician Decision|1|||
131001948|NCT01848834|471633276|FG001|Overall Study|Physician Decision|3|||
131001949|NCT01848834|471633277|FG002|Overall Study|Physician Decision|4|||
131001950|NCT01848834|471633278|FG003|Overall Study|Physician Decision|0|||
131001951|NCT01848834|471633279|FG004|Overall Study|Physician Decision|11|||
131001952|NCT01848834|471633275|FG000|Overall Study|Protocol Violation|0|||
131001953|NCT01848834|471633276|FG001|Overall Study|Protocol Violation|0|||
131001954|NCT01848834|471633277|FG002|Overall Study|Protocol Violation|0|||
131001955|NCT01848834|471633278|FG003|Overall Study|Protocol Violation|0|||
131001956|NCT01848834|471633279|FG004|Overall Study|Protocol Violation|1|||
131001957|NCT01848834|471633275|FG000|Overall Study|Sponsor Decision|1|||
131001958|NCT01848834|471633276|FG001|Overall Study|Sponsor Decision|1|||
131001959|NCT01848834|471633277|FG002|Overall Study|Sponsor Decision|0|||
131001960|NCT01848834|471633278|FG003|Overall Study|Sponsor Decision|1|||
131001961|NCT01848834|471633279|FG004|Overall Study|Sponsor Decision|1|||
131001962|NCT01848834|471633275|FG000|Overall Study|Withdrawal by Subject|2|||
131001963|NCT01848834|471633276|FG001|Overall Study|Withdrawal by Subject|13|||
131001964|NCT01848834|471633277|FG002|Overall Study|Withdrawal by Subject|10|||
131001965|NCT01848834|471633278|FG003|Overall Study|Withdrawal by Subject|6|||
131001966|NCT01848834|471633279|FG004|Overall Study|Withdrawal by Subject|36|||
131001967|NCT03259373|471633291|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
131001968|NCT03259373|471633292|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
131001969|NCT03259373|471633291|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
131001970|NCT03259373|471633292|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
131001971|NCT03259373|471633291|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
131001972|NCT03259373|471633292|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
131001973|NCT03259373|471633291|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
131001974|NCT03259373|471633292|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
131001975|NCT03259373|471633291|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
131001976|NCT03259373|471633292|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
131001977|NCT03259373|471633291|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
131001978|NCT03259373|471633292|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
131001979|NCT01923428|471633295|FG000|Overall Study|Adverse Event|8|||
131001980|NCT01923428|471633296|FG001|Overall Study|Adverse Event|6|||
131001981|NCT01923428|471633297|FG002|Overall Study|Adverse Event|3|||
131001982|NCT01923428|471633298|FG003|Overall Study|Adverse Event|3|||
131001983|NCT01923428|471633295|FG000|Overall Study|Withdrawal by Subject|5|||
131001984|NCT01923428|471633296|FG001|Overall Study|Withdrawal by Subject|3|||
131001985|NCT01923428|471633297|FG002|Overall Study|Withdrawal by Subject|0|||
131001986|NCT01923428|471633298|FG003|Overall Study|Withdrawal by Subject|4|||
131001987|NCT01923428|471633295|FG000|Overall Study|Lost to Follow-up|2|||
131001988|NCT01923428|471633296|FG001|Overall Study|Lost to Follow-up|1|||
131001989|NCT01923428|471633297|FG002|Overall Study|Lost to Follow-up|5|||
131001990|NCT01923428|471633298|FG003|Overall Study|Lost to Follow-up|0|||
131001991|NCT01923428|471633295|FG000|Overall Study|Protocol Violation|3|||
131001992|NCT01923428|471633296|FG001|Overall Study|Protocol Violation|0|||
131001993|NCT01923428|471633297|FG002|Overall Study|Protocol Violation|2|||
131001994|NCT01923428|471633298|FG003|Overall Study|Protocol Violation|1|||
131001995|NCT01923428|471633295|FG000|Overall Study|Non Compliance to treatment|1|||
131001996|NCT01923428|471633296|FG001|Overall Study|Non Compliance to treatment|2|||
131001997|NCT01923428|471633297|FG002|Overall Study|Non Compliance to treatment|0|||
131001998|NCT01923428|471633298|FG003|Overall Study|Non Compliance to treatment|1|||
131001999|NCT01923428|471633295|FG000|Overall Study|Lack of Efficacy|0|||
131002000|NCT01923428|471633296|FG001|Overall Study|Lack of Efficacy|0|||
131002001|NCT01923428|471633297|FG002|Overall Study|Lack of Efficacy|1|||
131002002|NCT01923428|471633298|FG003|Overall Study|Lack of Efficacy|1|||
131002003|NCT02550873|471633299|FG000|Randomized Double Blind|Adverse Event|3|||
131002004|NCT02550873|471633300|FG001|Randomized Double Blind|Adverse Event|1|||
131002005|NCT02550873|471633301|FG002|Randomized Double Blind|Adverse Event|0|||
131002006|NCT02550873|471633299|FG000|Randomized Double Blind|Disease progression|1|||
131002007|NCT02550873|471633300|FG001|Randomized Double Blind|Disease progression|1|||
131002008|NCT02550873|471633301|FG002|Randomized Double Blind|Disease progression|0|||
131002009|NCT02550873|471633299|FG000|Open Label Extension|Study ongoing|0|||
131002010|NCT02550873|471633300|FG001|Open Label Extension|Study ongoing|0|||
131002011|NCT02550873|471633301|FG002|Open Label Extension|Study ongoing|111|||
131002012|NCT01822353|471633302|FG000|Overall Study|Adverse Event|1|||
131002013|NCT01822353|471633303|FG001|Overall Study|Adverse Event|3|||
131002014|NCT01822353|471633304|FG002|Overall Study|Adverse Event|1|||
131002015|NCT01822353|471633302|FG000|Overall Study|Pregnancy|0|||
131002016|NCT01822353|471633303|FG001|Overall Study|Pregnancy|1|||
131002017|NCT01822353|471633304|FG002|Overall Study|Pregnancy|0|||
131002018|NCT01822353|471633302|FG000|Overall Study|Withdrawal by Subject|3|||
131002019|NCT01822353|471633303|FG001|Overall Study|Withdrawal by Subject|1|||
131002020|NCT01822353|471633304|FG002|Overall Study|Withdrawal by Subject|0|||
131002021|NCT00895843|471633305|FG000|Overall Study|Protocol Violation|12|||
131002022|NCT00895843|471633306|FG001|Overall Study|Protocol Violation|12|||
131002023|NCT03658811|471633310|FG000|Overall Study|Lost to Follow-up|3|||
131002024|NCT00946647|471633311|FG000|Phase 1 Part|Adverse Event|2|||
131002025|NCT00946647|471633312|FG001|Phase 1 Part|Adverse Event|5|||
131002026|NCT00946647|471633313|FG002|Phase 1 Part|Adverse Event|3|||
131002027|NCT00946647|471633314|FG003|Phase 1 Part|Adverse Event|0|||
131002028|NCT00946647|471633315|FG004|Phase 1 Part|Adverse Event|0|||
131002029|NCT00946647|471633311|FG000|Phase 1 Part|Disease progression|3|||
131002030|NCT00946647|471633312|FG001|Phase 1 Part|Disease progression|6|||
131002031|NCT00946647|471633313|FG002|Phase 1 Part|Disease progression|1|||
131002032|NCT00946647|471633314|FG003|Phase 1 Part|Disease progression|0|||
131002033|NCT00946647|471633315|FG004|Phase 1 Part|Disease progression|0|||
131002034|NCT00946647|471633311|FG000|Phase 1 Part|Withdrawal by Subject|1|||
131002035|NCT00946647|471633312|FG001|Phase 1 Part|Withdrawal by Subject|4|||
131002036|NCT00946647|471633313|FG002|Phase 1 Part|Withdrawal by Subject|3|||
131002037|NCT00946647|471633314|FG003|Phase 1 Part|Withdrawal by Subject|0|||
131002038|NCT00946647|471633315|FG004|Phase 1 Part|Withdrawal by Subject|0|||
131002039|NCT00946647|471633311|FG000|Phase 1 Part|Abnormal values|0|||
131002040|NCT00946647|471633312|FG001|Phase 1 Part|Abnormal values|2|||
131002041|NCT00946647|471633313|FG002|Phase 1 Part|Abnormal values|0|||
131002042|NCT00946647|471633314|FG003|Phase 1 Part|Abnormal values|0|||
131002043|NCT00946647|471633315|FG004|Phase 1 Part|Abnormal values|0|||
131002044|NCT00946647|471633311|FG000|Phase 1 Part|Reason missing|0|||
131002045|NCT00946647|471633312|FG001|Phase 1 Part|Reason missing|1|||
131002046|NCT00946647|471633313|FG002|Phase 1 Part|Reason missing|0|||
131002047|NCT00946647|471633314|FG003|Phase 1 Part|Reason missing|0|||
131002048|NCT00946647|471633315|FG004|Phase 1 Part|Reason missing|0|||
131002049|NCT00946647|471633311|FG000|Phase ll Part|Untreated|0|||
131002050|NCT00946647|471633312|FG001|Phase ll Part|Untreated|0|||
131002051|NCT00946647|471633313|FG002|Phase ll Part|Untreated|0|||
131002052|NCT00946647|471633314|FG003|Phase ll Part|Untreated|0|||
131002053|NCT00946647|471633315|FG004|Phase ll Part|Untreated|2|||
131002054|NCT00946647|471633311|FG000|Phase ll Part|Adverse Event|0|||
131002055|NCT00946647|471633312|FG001|Phase ll Part|Adverse Event|0|||
131002056|NCT00946647|471633313|FG002|Phase ll Part|Adverse Event|0|||
131002057|NCT00946647|471633314|FG003|Phase ll Part|Adverse Event|10|||
131002058|NCT00946647|471633315|FG004|Phase ll Part|Adverse Event|6|||
131002059|NCT00946647|471633311|FG000|Phase ll Part|Withdrawal by Subject|0|||
131002060|NCT00946647|471633312|FG001|Phase ll Part|Withdrawal by Subject|0|||
131002061|NCT00946647|471633313|FG002|Phase ll Part|Withdrawal by Subject|0|||
131002062|NCT00946647|471633314|FG003|Phase ll Part|Withdrawal by Subject|8|||
131002063|NCT00946647|471633315|FG004|Phase ll Part|Withdrawal by Subject|6|||
131002064|NCT00946647|471633311|FG000|Phase ll Part|Administrative problems|0|||
131002065|NCT00946647|471633312|FG001|Phase ll Part|Administrative problems|0|||
130884762|NCT00790842|471213224|FG008|Dose Level 2|Death|0|||
131002066|NCT00946647|471633313|FG002|Phase ll Part|Administrative problems|0|||
131002067|NCT00946647|471633314|FG003|Phase ll Part|Administrative problems|3|||
131002068|NCT00946647|471633315|FG004|Phase ll Part|Administrative problems|8|||
131002069|NCT00946647|471633311|FG000|Phase ll Part|Death|0|||
131002070|NCT00946647|471633312|FG001|Phase ll Part|Death|0|||
131002071|NCT00946647|471633313|FG002|Phase ll Part|Death|0|||
131002072|NCT00946647|471633314|FG003|Phase ll Part|Death|7|||
131002073|NCT00946647|471633315|FG004|Phase ll Part|Death|4|||
131002074|NCT00946647|471633311|FG000|Phase ll Part|Disease progression|0|||
131002075|NCT00946647|471633312|FG001|Phase ll Part|Disease progression|0|||
131002076|NCT00946647|471633313|FG002|Phase ll Part|Disease progression|0|||
131002077|NCT00946647|471633314|FG003|Phase ll Part|Disease progression|6|||
131002078|NCT00946647|471633315|FG004|Phase ll Part|Disease progression|14|||
131002079|NCT00946647|471633311|FG000|Phase ll Part|Protocol Violation|0|||
131002080|NCT00946647|471633312|FG001|Phase ll Part|Protocol Violation|0|||
131002081|NCT00946647|471633313|FG002|Phase ll Part|Protocol Violation|0|||
131002082|NCT00946647|471633314|FG003|Phase ll Part|Protocol Violation|4|||
130884763|NCT00790842|471213225|FG009|Dose Level 2|Death|0|||
131002083|NCT00946647|471633315|FG004|Phase ll Part|Protocol Violation|2|||
131002084|NCT00946647|471633311|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
131002085|NCT00946647|471633312|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
131002086|NCT00946647|471633313|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
131002087|NCT00946647|471633314|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
131002088|NCT00946647|471633315|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
131002089|NCT01513967|471633326|FG000|Overall Study|Pregnancy|0|||
131002090|NCT01513967|471633327|FG001|Overall Study|Pregnancy|0|||
131002091|NCT01513967|471633328|FG002|Overall Study|Pregnancy|0|||
131002092|NCT01513967|471633329|FG003|Overall Study|Pregnancy|0|||
131002093|NCT01513967|471633330|FG004|Overall Study|Pregnancy|0|||
131002094|NCT01513967|471633331|FG005|Overall Study|Pregnancy|0|||
131002095|NCT01513967|471633332|FG006|Overall Study|Pregnancy|1|||
131002096|NCT01513967|471633333|FG007|Overall Study|Pregnancy|0|||
131002097|NCT01513967|471633326|FG000|Overall Study|missed a study visit|0|||
131002098|NCT01513967|471633327|FG001|Overall Study|missed a study visit|0|||
131002099|NCT01513967|471633328|FG002|Overall Study|missed a study visit|0|||
131002100|NCT01513967|471633329|FG003|Overall Study|missed a study visit|0|||
131002101|NCT01513967|471633330|FG004|Overall Study|missed a study visit|0|||
131002102|NCT01513967|471633331|FG005|Overall Study|missed a study visit|0|||
131002103|NCT01513967|471633332|FG006|Overall Study|missed a study visit|1|||
131002104|NCT01513967|471633333|FG007|Overall Study|missed a study visit|0|||
131002105|NCT01513967|471633326|FG000|Overall Study|excluded due to positive drug screen|0|||
131002106|NCT01513967|471633327|FG001|Overall Study|excluded due to positive drug screen|0|||
131002107|NCT01513967|471633328|FG002|Overall Study|excluded due to positive drug screen|0|||
131002108|NCT01513967|471633329|FG003|Overall Study|excluded due to positive drug screen|0|||
131002109|NCT01513967|471633330|FG004|Overall Study|excluded due to positive drug screen|0|||
131002110|NCT01513967|471633331|FG005|Overall Study|excluded due to positive drug screen|0|||
131002111|NCT01513967|471633332|FG006|Overall Study|excluded due to positive drug screen|0|||
131002112|NCT01513967|471633333|FG007|Overall Study|excluded due to positive drug screen|2|||
131002113|NCT01513967|471633326|FG000|Overall Study|Physician Decision|0|||
131002114|NCT01513967|471633327|FG001|Overall Study|Physician Decision|0|||
131002115|NCT01513967|471633328|FG002|Overall Study|Physician Decision|0|||
131002116|NCT01513967|471633329|FG003|Overall Study|Physician Decision|0|||
131002117|NCT01513967|471633330|FG004|Overall Study|Physician Decision|0|||
131002118|NCT01513967|471633331|FG005|Overall Study|Physician Decision|1|||
131002119|NCT01513967|471633332|FG006|Overall Study|Physician Decision|0|||
131002120|NCT01513967|471633333|FG007|Overall Study|Physician Decision|0|||
131002121|NCT02711826|471633334|FG000|Overall Study|Physician Decision|0|||
131002122|NCT02711826|471633335|FG001|Overall Study|Physician Decision|0|||
131002123|NCT02711826|471633336|FG002|Overall Study|Physician Decision|0|||
131002124|NCT02711826|471633337|FG003|Overall Study|Physician Decision|1|||
131002125|NCT02711826|471633338|FG004|Overall Study|Physician Decision|0|||
131002126|NCT02711826|471633334|FG000|Overall Study|Withdrawal by Subject|0|||
131002127|NCT02711826|471633335|FG001|Overall Study|Withdrawal by Subject|1|||
131002128|NCT02711826|471633336|FG002|Overall Study|Withdrawal by Subject|0|||
131002129|NCT02711826|471633337|FG003|Overall Study|Withdrawal by Subject|4|||
131002130|NCT02711826|471633338|FG004|Overall Study|Withdrawal by Subject|0|||
131002131|NCT02711826|471633334|FG000|Overall Study|Failure to manufacture cellular product|0|||
131002132|NCT02711826|471633335|FG001|Overall Study|Failure to manufacture cellular product|0|||
131002133|NCT02711826|471633336|FG002|Overall Study|Failure to manufacture cellular product|5|||
131002134|NCT02711826|471633337|FG003|Overall Study|Failure to manufacture cellular product|0|||
131002135|NCT02711826|471633338|FG004|Overall Study|Failure to manufacture cellular product|0|||
131002136|NCT02711826|471633334|FG000|Overall Study|Infusion canceled for active infection|0|||
131002137|NCT02711826|471633335|FG001|Overall Study|Infusion canceled for active infection|1|||
131002138|NCT02711826|471633336|FG002|Overall Study|Infusion canceled for active infection|0|||
131002139|NCT02711826|471633337|FG003|Overall Study|Infusion canceled for active infection|0|||
131002140|NCT02711826|471633338|FG004|Overall Study|Infusion canceled for active infection|0|||
131002141|NCT02711826|471633334|FG000|Overall Study|Screen failures|0|||
131002142|NCT02711826|471633335|FG001|Overall Study|Screen failures|0|||
131002143|NCT02711826|471633336|FG002|Overall Study|Screen failures|0|||
131002144|NCT02711826|471633337|FG003|Overall Study|Screen failures|4|||
131002145|NCT02711826|471633338|FG004|Overall Study|Screen failures|0|||
131002146|NCT02906202|471633339|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
131002147|NCT01960790|471633340|FG000|Overall Study|Survey forms could not be recovered|3|||
131002148|NCT01960790|471633340|FG000|Overall Study|Treat with Humira outside survey period|3|||
131002149|NCT01960790|471633340|FG000|Overall Study|Transferred to another hospital|4|||
131002150|NCT01960790|471633340|FG000|Overall Study|Unevaluable for safety|1|||
131002151|NCT01987830|471633341|FG000|Overall Study|Never received baseline scan|1|||
131002152|NCT03990363|471633342|FG000|Overall Study|Withdrawal by Subject|10|||
131002153|NCT03990363|471633343|FG001|Overall Study|Withdrawal by Subject|9|||
131002154|NCT03990363|471633344|FG002|Overall Study|Withdrawal by Subject|18|||
131002155|NCT03990363|471633345|FG003|Overall Study|Withdrawal by Subject|11|||
131002156|NCT03990363|471633346|FG004|Overall Study|Withdrawal by Subject|9|||
131002157|NCT03990363|471633342|FG000|Overall Study|Physician Decision|1|||
131002158|NCT03990363|471633343|FG001|Overall Study|Physician Decision|0|||
131002159|NCT03990363|471633344|FG002|Overall Study|Physician Decision|0|||
131002160|NCT03990363|471633345|FG003|Overall Study|Physician Decision|0|||
131002161|NCT03990363|471633346|FG004|Overall Study|Physician Decision|0|||
131002162|NCT03990363|471633342|FG000|Overall Study|Adverse Event|1|||
131002163|NCT03990363|471633343|FG001|Overall Study|Adverse Event|3|||
131002164|NCT03990363|471633344|FG002|Overall Study|Adverse Event|2|||
131002165|NCT03990363|471633345|FG003|Overall Study|Adverse Event|2|||
131002166|NCT03990363|471633346|FG004|Overall Study|Adverse Event|0|||
131002167|NCT03990363|471633342|FG000|Overall Study|Death|14|||
131002168|NCT03990363|471633343|FG001|Overall Study|Death|8|||
131002169|NCT03990363|471633344|FG002|Overall Study|Death|14|||
131002170|NCT03990363|471633345|FG003|Overall Study|Death|10|||
131002171|NCT03990363|471633346|FG004|Overall Study|Death|11|||
131002172|NCT03990363|471633342|FG000|Overall Study|Failure to meet randomization criteria|0|||
131002173|NCT03990363|471633343|FG001|Overall Study|Failure to meet randomization criteria|1|||
131002174|NCT03990363|471633344|FG002|Overall Study|Failure to meet randomization criteria|1|||
131002175|NCT03990363|471633345|FG003|Overall Study|Failure to meet randomization criteria|0|||
131002176|NCT03990363|471633346|FG004|Overall Study|Failure to meet randomization criteria|0|||
131002177|NCT03990363|471633342|FG000|Overall Study|Lost to Follow-up|0|||
131002178|NCT03990363|471633343|FG001|Overall Study|Lost to Follow-up|0|||
131002179|NCT03990363|471633344|FG002|Overall Study|Lost to Follow-up|0|||
131002180|NCT03990363|471633345|FG003|Overall Study|Lost to Follow-up|1|||
131002181|NCT03990363|471633346|FG004|Overall Study|Lost to Follow-up|2|||
131002182|NCT03990363|471633342|FG000|Overall Study|Non-compliance with study drug|2|||
131002183|NCT03990363|471633343|FG001|Overall Study|Non-compliance with study drug|1|||
131002184|NCT03990363|471633344|FG002|Overall Study|Non-compliance with study drug|2|||
131002185|NCT03990363|471633345|FG003|Overall Study|Non-compliance with study drug|0|||
131002186|NCT03990363|471633346|FG004|Overall Study|Non-compliance with study drug|0|||
131002187|NCT03990363|471633342|FG000|Overall Study|Study terminated by sponsor|0|||
131002188|NCT03990363|471633343|FG001|Overall Study|Study terminated by sponsor|1|||
131002189|NCT03990363|471633344|FG002|Overall Study|Study terminated by sponsor|0|||
131002190|NCT03990363|471633345|FG003|Overall Study|Study terminated by sponsor|0|||
131002191|NCT03990363|471633346|FG004|Overall Study|Study terminated by sponsor|0|||
131002192|NCT03990363|471633342|FG000|Overall Study|Site terminated by sponsor|2|||
131002193|NCT03990363|471633343|FG001|Overall Study|Site terminated by sponsor|1|||
131002194|NCT03990363|471633344|FG002|Overall Study|Site terminated by sponsor|2|||
131002195|NCT03990363|471633345|FG003|Overall Study|Site terminated by sponsor|0|||
131002196|NCT03990363|471633346|FG004|Overall Study|Site terminated by sponsor|2|||
131002197|NCT03990363|471633342|FG000|Overall Study|Not categorized|5|||
131002198|NCT03990363|471633343|FG001|Overall Study|Not categorized|5|||
131002199|NCT03990363|471633344|FG002|Overall Study|Not categorized|3|||
131002200|NCT03990363|471633345|FG003|Overall Study|Not categorized|2|||
131002201|NCT03990363|471633346|FG004|Overall Study|Not categorized|2|||
131002202|NCT00057811|471633356|FG000|Overall Study|Lack of Efficacy|1|||
131002203|NCT00057811|471633357|FG001|Overall Study|Lack of Efficacy|4|||
131002204|NCT00057811|471633356|FG000|Overall Study|Physician Decision|1|||
131002205|NCT00057811|471633357|FG001|Overall Study|Physician Decision|0|||
131002206|NCT00057811|471633356|FG000|Overall Study|Withdrawal by Subject|3|||
131002207|NCT00057811|471633357|FG001|Overall Study|Withdrawal by Subject|4|||
131002208|NCT00057811|471633356|FG000|Overall Study|Ineligible|4|||
131002209|NCT00057811|471633357|FG001|Overall Study|Ineligible|2|||
131002210|NCT00057811|471633356|FG000|Overall Study|Inevaluable|1|||
131002211|NCT00057811|471633357|FG001|Overall Study|Inevaluable|2|||
131002212|NCT00556374|471633358|FG000|Overall Study|Withdrawal by Subject|235|||
131002213|NCT00556374|471633359|FG001|Overall Study|Withdrawal by Subject|205|||
131002214|NCT00556374|471633358|FG000|Overall Study|Death|158|||
131002215|NCT00556374|471633359|FG001|Overall Study|Death|127|||
131002216|NCT00556374|471633358|FG000|Overall Study|Lost to Follow-up|24|||
131002217|NCT00556374|471633359|FG001|Overall Study|Lost to Follow-up|17|||
131002218|NCT00556374|471633358|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
131002219|NCT00556374|471633359|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
131002220|NCT02169219|471633360|FG000|Overall Study|Lack of Efficacy|6|||
131002221|NCT00238420|471633361|FG000|Overall Study|Protocol Violation|1|||
131002222|NCT00238420|471633362|FG001|Overall Study|Protocol Violation|1|||
131002223|NCT00442286|471633363|FG000|Overall Study|Death|2|||
131002224|NCT00442286|471633364|FG001|Overall Study|Death|2|||
131002225|NCT00442286|471633363|FG000|Overall Study|Lost to Follow-up|1|||
131002226|NCT00442286|471633364|FG001|Overall Study|Lost to Follow-up|0|||
131002227|NCT00442286|471633363|FG000|Overall Study|Withdrawal by Subject|2|||
131002228|NCT00442286|471633364|FG001|Overall Study|Withdrawal by Subject|0|||
131002229|NCT00442286|471633363|FG000|Overall Study|System explanted|1|||
131002230|NCT00442286|471633364|FG001|Overall Study|System explanted|0|||
131002231|NCT00442286|471633363|FG000|Overall Study|Patient Injury|1|||
131002232|NCT00442286|471633364|FG001|Overall Study|Patient Injury|0|||
131002233|NCT03317379|471633367|FG000|Overall Study|Lost to Follow-up|0|||
131002234|NCT03317379|471633368|FG001|Overall Study|Lost to Follow-up|3|||
131002235|NCT03317379|471633369|FG002|Overall Study|Lost to Follow-up|2|||
131002236|NCT03040687|471633370|FG000|Overall Study|Withdrawal by Subject|1|||
131002237|NCT03040687|471633371|FG001|Overall Study|Withdrawal by Subject|0|||
131002238|NCT03040687|471633372|FG002|Overall Study|Withdrawal by Subject|0|||
131002239|NCT00550173|471633373|FG000|Overall Study|Death|45|||
131002240|NCT00550173|471633374|FG001|Overall Study|Death|38|||
131002241|NCT00550173|471633375|FG002|Overall Study|Death|50|||
131002242|NCT00550173|471633373|FG000|Overall Study|Physician Decision|1|||
131002243|NCT00550173|471633374|FG001|Overall Study|Physician Decision|2|||
131002244|NCT00550173|471633375|FG002|Overall Study|Physician Decision|2|||
131002245|NCT00550173|471633373|FG000|Overall Study|Withdrawal by Subject|9|||
131002246|NCT00550173|471633374|FG001|Overall Study|Withdrawal by Subject|12|||
131002247|NCT00550173|471633375|FG002|Overall Study|Withdrawal by Subject|17|||
131002248|NCT00550173|471633373|FG000|Overall Study|Sponsor Decision|13|||
131002249|NCT00550173|471633374|FG001|Overall Study|Sponsor Decision|7|||
131002250|NCT00550173|471633375|FG002|Overall Study|Sponsor Decision|1|||
131002251|NCT00550173|471633373|FG000|Overall Study|Lost to Follow-up|4|||
131002252|NCT00550173|471633374|FG001|Overall Study|Lost to Follow-up|4|||
131002253|NCT00550173|471633375|FG002|Overall Study|Lost to Follow-up|3|||
131002254|NCT00810641|471633377|FG000|Overall Study|Withdrawal by Subject|0|||
131002255|NCT00810641|471633378|FG001|Overall Study|Withdrawal by Subject|1|||
131002256|NCT00810641|471633379|FG002|Overall Study|Withdrawal by Subject|2|||
131002257|NCT01556243|471633380|FG000|Overall Study|Ineligible|34|||
131002258|NCT01556243|471633380|FG000|Overall Study|Converted to mastectomy|14|||
131002259|NCT01556243|471633380|FG000|Overall Study|Unable to achieve negative margins|2|||
131002260|NCT01556243|471633380|FG000|Overall Study|Withdrawal by Subject|16|||
131002261|NCT02325713|471633383|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002262|NCT02325713|471633384|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002263|NCT02325713|471633385|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002264|NCT02325713|471633386|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002265|NCT02325713|471633387|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002266|NCT02325713|471633388|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002267|NCT02325713|471633389|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002268|NCT02325713|471633390|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002269|NCT02325713|471633391|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002270|NCT02325713|471633392|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002271|NCT02325713|471633393|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
131002272|NCT02325713|471633394|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002273|NCT02325713|471633395|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130884764|NCT00790842|471213226|FG010|Dose Level 2|Death|0|||
130884765|NCT00790842|471213216|FG000|Dose Level 2|Physician Decision|0|||
130884766|NCT00790842|471213217|FG001|Dose Level 2|Physician Decision|1|||
130884767|NCT00790842|471213218|FG002|Dose Level 2|Physician Decision|0|||
130884768|NCT00790842|471213219|FG003|Dose Level 2|Physician Decision|0|||
130884769|NCT00790842|471213220|FG004|Dose Level 2|Physician Decision|0|||
130884770|NCT00790842|471213221|FG005|Dose Level 2|Physician Decision|0|||
130884771|NCT00790842|471213222|FG006|Dose Level 2|Physician Decision|0|||
130884772|NCT00790842|471213223|FG007|Dose Level 2|Physician Decision|0|||
130884773|NCT00790842|471213224|FG008|Dose Level 2|Physician Decision|0|||
130884774|NCT00790842|471213225|FG009|Dose Level 2|Physician Decision|0|||
130884775|NCT00790842|471213226|FG010|Dose Level 2|Physician Decision|0|||
130884776|NCT00790842|471213216|FG000|Dose Level 2|Withdrawal by Subject|0|||
130884777|NCT00790842|471213217|FG001|Dose Level 2|Withdrawal by Subject|1|||
130884778|NCT00790842|471213218|FG002|Dose Level 2|Withdrawal by Subject|0|||
130884779|NCT00790842|471213219|FG003|Dose Level 2|Withdrawal by Subject|0|||
130884780|NCT00790842|471213220|FG004|Dose Level 2|Withdrawal by Subject|0|||
130884781|NCT00790842|471213221|FG005|Dose Level 2|Withdrawal by Subject|0|||
130884782|NCT00790842|471213222|FG006|Dose Level 2|Withdrawal by Subject|0|||
130884783|NCT00790842|471213223|FG007|Dose Level 2|Withdrawal by Subject|0|||
130884784|NCT00790842|471213224|FG008|Dose Level 2|Withdrawal by Subject|0|||
130884785|NCT00790842|471213225|FG009|Dose Level 2|Withdrawal by Subject|0|||
130884786|NCT00790842|471213226|FG010|Dose Level 2|Withdrawal by Subject|0|||
130884787|NCT00790842|471213216|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130884788|NCT00790842|471213217|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130884789|NCT00790842|471213218|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131002274|NCT02325713|471633396|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002275|NCT02325713|471633397|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002276|NCT02325713|471633398|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
131002277|NCT02325713|471633383|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
130884790|NCT00790842|471213219|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130884791|NCT00790842|471213220|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130884792|NCT00790842|471213221|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130884793|NCT00790842|471213222|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130884794|NCT00790842|471213223|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
131002278|NCT02325713|471633384|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002279|NCT02325713|471633385|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002280|NCT02325713|471633386|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002281|NCT02325713|471633387|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002282|NCT02325713|471633388|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002283|NCT02325713|471633389|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002284|NCT02325713|471633390|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002285|NCT02325713|471633391|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002286|NCT02325713|471633392|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002287|NCT02325713|471633393|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002288|NCT02325713|471633394|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002289|NCT02325713|471633395|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002290|NCT02325713|471633396|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002291|NCT02325713|471633397|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002292|NCT02325713|471633398|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
131002293|NCT02325713|471633383|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002294|NCT02325713|471633384|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002295|NCT02325713|471633385|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002296|NCT02325713|471633386|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002297|NCT02325713|471633387|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002298|NCT02325713|471633388|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002299|NCT02325713|471633389|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002300|NCT02325713|471633390|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002301|NCT02325713|471633391|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002302|NCT02325713|471633392|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
131002303|NCT02325713|471633393|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002304|NCT02325713|471633394|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002305|NCT02325713|471633395|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002306|NCT02325713|471633396|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002307|NCT02325713|471633397|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002308|NCT02325713|471633398|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
131002309|NCT00322868|471635253|FG000|Overall Study|disease progression|1|||
131002310|NCT02176928|471635254|FG000|Overall Study|Lost to Follow-up|2|||
131002311|NCT02176928|471635255|FG001|Overall Study|Lost to Follow-up|4|||
131002312|NCT01440049|471635259|FG000|Overall Study|Adverse Event|5|||
131002313|NCT00688259|471635266|FG000|Overall Study|Lost to Follow-up|2|||
131002314|NCT00688259|471635267|FG001|Overall Study|Lost to Follow-up|4|||
131002315|NCT00688259|471635266|FG000|Overall Study|Physician Decision|1|||
131002316|NCT00688259|471635267|FG001|Overall Study|Physician Decision|0|||
131002317|NCT00688259|471635266|FG000|Overall Study|Withdrawal by Subject|2|||
131002318|NCT00688259|471635267|FG001|Overall Study|Withdrawal by Subject|0|||
131002319|NCT00688259|471635266|FG000|Overall Study|Declined Interview|2|||
131002320|NCT00688259|471635267|FG001|Overall Study|Declined Interview|3|||
131002321|NCT00688259|471635266|FG000|Overall Study|Hospitalized at Follow-up|0|||
131002322|NCT00688259|471635267|FG001|Overall Study|Hospitalized at Follow-up|1|||
131002323|NCT01310868|471635269|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
131002324|NCT02411591|471635270|FG000|Overall Study|Adverse Event|0|||
131002325|NCT02411591|471635271|FG001|Overall Study|Adverse Event|4|||
131002326|NCT02411591|471635272|FG002|Overall Study|Adverse Event|2|||
131002327|NCT02411591|471635270|FG000|Overall Study|Withdrawal by Subject|0|||
131002328|NCT02411591|471635271|FG001|Overall Study|Withdrawal by Subject|3|||
131002329|NCT02411591|471635272|FG002|Overall Study|Withdrawal by Subject|0|||
131002330|NCT02411591|471635270|FG000|Overall Study|Physician Decision|0|||
131002331|NCT02411591|471635271|FG001|Overall Study|Physician Decision|3|||
131002332|NCT02411591|471635272|FG002|Overall Study|Physician Decision|1|||
131002333|NCT02491892|471635273|FG000|Overall Study|Adverse Event|1|||
131002334|NCT02491892|471635274|FG001|Overall Study|Adverse Event|1|||
131002335|NCT02491892|471635273|FG000|Overall Study|Death|1|||
131002336|NCT02491892|471635274|FG001|Overall Study|Death|1|||
131002337|NCT02491892|471635273|FG000|Overall Study|Lack of Efficacy|37|||
131002338|NCT02491892|471635274|FG001|Overall Study|Lack of Efficacy|36|||
131002339|NCT02491892|471635273|FG000|Overall Study|Refused Treatment|1|||
131002340|NCT02491892|471635274|FG001|Overall Study|Refused Treatment|0|||
131002341|NCT02491892|471635273|FG000|Overall Study|Lost to Follow-up|1|||
131002342|NCT02491892|471635274|FG001|Overall Study|Lost to Follow-up|0|||
131002343|NCT04227340|471635275|FG000|Overall Study|Withdrawal by Subject|3|||
131002344|NCT00661258|471635283|FG000|Overall Study|Death|1|||
131002345|NCT00661258|471635284|FG001|Overall Study|Death|0|||
131002346|NCT00661258|471635283|FG000|Overall Study|caught by police and in detox center|2|||
131002347|NCT00661258|471635284|FG001|Overall Study|caught by police and in detox center|1|||
131002348|NCT01628874|471635285|FG000|Overall Study|Physician Decision|1|||
131002349|NCT01628874|471635286|FG001|Overall Study|Physician Decision|1|||
131002350|NCT01628874|471635285|FG000|Overall Study|Age >4 months|4|||
131002351|NCT01628874|471635286|FG001|Overall Study|Age >4 months|2|||
131002352|NCT00683449|471635287|FG000|Overall Study|Lost to Follow-up|0|||
131002353|NCT00683449|471635288|FG001|Overall Study|Lost to Follow-up|1|||
131002354|NCT00683449|471635289|FG002|Overall Study|Lost to Follow-up|0|||
131002355|NCT00683449|471635290|FG003|Overall Study|Lost to Follow-up|0|||
131002356|NCT00683449|471635291|FG004|Overall Study|Lost to Follow-up|0|||
131002357|NCT03541642|471635294|FG000|Overall Study|Withdrawal by Subject|1|||
131002358|NCT03541642|471635295|FG001|Overall Study|Withdrawal by Subject|2|||
131002359|NCT03541642|471635294|FG000|Overall Study|Lost to Follow-up|16|||
131002360|NCT03541642|471635295|FG001|Overall Study|Lost to Follow-up|12|||
131002361|NCT03541642|471635294|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
131002362|NCT03541642|471635295|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
131002363|NCT01083160|471635300|FG000|Overall Study|Adverse Event|1|||
131002364|NCT00918749|471635303|FG000|Overall Study|Adverse Event|1|||
131002365|NCT00918749|471635304|FG001|Overall Study|Adverse Event|0|||
131002366|NCT00918749|471635305|FG002|Overall Study|Adverse Event|1|||
131002367|NCT00918749|471635303|FG000|Overall Study|Lost to Follow-up|0|||
131002368|NCT00918749|471635304|FG001|Overall Study|Lost to Follow-up|0|||
131002369|NCT00918749|471635305|FG002|Overall Study|Lost to Follow-up|1|||
131002370|NCT00918749|471635303|FG000|Overall Study|Withdrawal by Subject|5|||
131002371|NCT00918749|471635304|FG001|Overall Study|Withdrawal by Subject|3|||
131002372|NCT00918749|471635305|FG002|Overall Study|Withdrawal by Subject|5|||
131002373|NCT00918749|471635303|FG000|Overall Study|No Study Medication Taken|1|||
131002374|NCT00918749|471635304|FG001|Overall Study|No Study Medication Taken|0|||
131002375|NCT00918749|471635305|FG002|Overall Study|No Study Medication Taken|0|||
131002376|NCT01951092|471635306|FG000|Overall Study|Lost to Follow-up|10|||
131002377|NCT01951092|471635306|FG000|Overall Study|Incarceration|1|||
131002378|NCT01951092|471635306|FG000|Overall Study|Transfer of Care|1|||
131002379|NCT01712789|471635307|FG000|Overall Study|Lack of Efficacy|2|||
131002380|NCT01712789|471635307|FG000|Overall Study|Lost to Follow-up|1|||
131002381|NCT01712789|471635307|FG000|Overall Study|Progressive Disease|504|||
131002382|NCT01712789|471635307|FG000|Overall Study|Death|57|||
131002383|NCT01712789|471635307|FG000|Overall Study|Adverse Event|52|||
131002384|NCT01712789|471635307|FG000|Overall Study|Miscellaneous|31|||
131002385|NCT01712789|471635307|FG000|Overall Study|Withdrawal by Subject|21|||
131002386|NCT01712789|471635307|FG000|Overall Study|Transition to Commercial Treatment|8|||
131002387|NCT01712789|471635307|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
131002388|NCT00873093|471635308|FG000|Overall Study|Adverse Event|0|||
131002389|NCT00873093|471635309|FG001|Overall Study|Adverse Event|2|||
131002390|NCT00873093|471635310|FG002|Overall Study|Adverse Event|0|||
131002391|NCT00873093|471635311|FG003|Overall Study|Adverse Event|0|||
131002392|NCT00873093|471635312|FG004|Overall Study|Adverse Event|0|||
131002393|NCT00873093|471635308|FG000|Overall Study|Death|0|||
131002394|NCT00873093|471635309|FG001|Overall Study|Death|3|||
131002395|NCT00873093|471635310|FG002|Overall Study|Death|2|||
131002396|NCT00873093|471635311|FG003|Overall Study|Death|0|||
131002397|NCT00873093|471635312|FG004|Overall Study|Death|0|||
131002398|NCT00873093|471635308|FG000|Overall Study|Physician Decision|0|||
131002399|NCT00873093|471635309|FG001|Overall Study|Physician Decision|17|||
131002400|NCT00873093|471635310|FG002|Overall Study|Physician Decision|10|||
131002401|NCT00873093|471635311|FG003|Overall Study|Physician Decision|10|||
131002402|NCT00873093|471635312|FG004|Overall Study|Physician Decision|2|||
131002403|NCT00873093|471635308|FG000|Overall Study|Withdrawal by Subject|1|||
131002404|NCT00873093|471635309|FG001|Overall Study|Withdrawal by Subject|4|||
131002405|NCT00873093|471635310|FG002|Overall Study|Withdrawal by Subject|4|||
131002406|NCT00873093|471635311|FG003|Overall Study|Withdrawal by Subject|0|||
131002407|NCT00873093|471635312|FG004|Overall Study|Withdrawal by Subject|0|||
131002408|NCT00873093|471635308|FG000|Overall Study|Ineligible|0|||
131002409|NCT00873093|471635309|FG001|Overall Study|Ineligible|1|||
131002410|NCT00873093|471635310|FG002|Overall Study|Ineligible|0|||
131002411|NCT00873093|471635311|FG003|Overall Study|Ineligible|1|||
131002412|NCT00873093|471635312|FG004|Overall Study|Ineligible|0|||
131002413|NCT01708187|471635313|FG000|Overall Study|Lost to Follow-up|0|||
131002414|NCT01708187|471635314|FG001|Overall Study|Lost to Follow-up|1|||
131002415|NCT00136916|471635316|FG000|Overall Study|Never received study treatment|3|||
131002416|NCT00136916|471635317|FG001|Overall Study|Never received study treatment|5|||
131002417|NCT00136916|471635316|FG000|Overall Study|Death|1|||
131002418|NCT00136916|471635317|FG001|Overall Study|Death|3|||
131002419|NCT00136916|471635316|FG000|Overall Study|Adverse Event|27|||
131002420|NCT00136916|471635317|FG001|Overall Study|Adverse Event|8|||
131002421|NCT00136916|471635316|FG000|Overall Study|Laboratory abnormality|0|||
131002422|NCT00136916|471635317|FG001|Overall Study|Laboratory abnormality|1|||
131002423|NCT00136916|471635316|FG000|Overall Study|Lack of Efficacy|13|||
131002424|NCT00136916|471635317|FG001|Overall Study|Lack of Efficacy|3|||
131002425|NCT00136916|471635316|FG000|Overall Study|Lost to Follow-up|12|||
131002426|NCT00136916|471635317|FG001|Overall Study|Lost to Follow-up|14|||
131002427|NCT00136916|471635316|FG000|Overall Study|Withdrawal by Subject|44|||
131002428|NCT00136916|471635317|FG001|Overall Study|Withdrawal by Subject|46|||
131002429|NCT00136916|471635316|FG000|Overall Study|Other|22|||
131002430|NCT00136916|471635317|FG001|Overall Study|Other|24|||
131002431|NCT00136916|471635316|FG000|Overall Study|Discontinued in follow up period|3|||
131002432|NCT00136916|471635317|FG001|Overall Study|Discontinued in follow up period|0|||
131002433|NCT01152554|471635318|FG000|Overall Study|Withdrawal by Subject|73|||
131002434|NCT01152554|471635319|FG001|Overall Study|Withdrawal by Subject|28|||
131002435|NCT01152554|471635318|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
131002436|NCT01152554|471635319|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
131002437|NCT01152554|471635318|FG000|Overall Study|Adverse Event|67|||
131002438|NCT01152554|471635319|FG001|Overall Study|Adverse Event|14|||
131002439|NCT01152554|471635318|FG000|Overall Study|Severe non-compliance to protocol|36|||
131002440|NCT01152554|471635319|FG001|Overall Study|Severe non-compliance to protocol|14|||
131002441|NCT01152554|471635318|FG000|Overall Study|Condition under investigation worsened|5|||
131002442|NCT01152554|471635319|FG001|Overall Study|Condition under investigation worsened|2|||
131002443|NCT01152554|471635318|FG000|Overall Study|Lack of Efficacy|20|||
131002444|NCT01152554|471635319|FG001|Overall Study|Lack of Efficacy|3|||
131002445|NCT01152554|471635318|FG000|Overall Study|Study-specific withdrawal criteria|17|||
131002446|NCT01152554|471635319|FG001|Overall Study|Study-specific withdrawal criteria|8|||
131002447|NCT01152554|471635318|FG000|Overall Study|Lost to Follow-up|87|||
131002448|NCT01152554|471635319|FG001|Overall Study|Lost to Follow-up|32|||
131002449|NCT01152554|471635318|FG000|Overall Study|Other|28|||
131002450|NCT01152554|471635319|FG001|Overall Study|Other|8|||
131002451|NCT01152554|471635318|FG000|Overall Study|Death|1|||
131002452|NCT01152554|471635319|FG001|Overall Study|Death|1|||
131002453|NCT02117544|471635320|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
131002454|NCT02117544|471635321|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
131002455|NCT03486899|471635322|FG000|Overall Study|Lost to Follow-up|4|||
131002456|NCT03486899|471635323|FG001|Overall Study|Lost to Follow-up|1|||
131002457|NCT03486899|471635324|FG002|Overall Study|Lost to Follow-up|4|||
131002458|NCT03486899|471635325|FG003|Overall Study|Lost to Follow-up|3|||
131002459|NCT03486899|471635322|FG000|Overall Study|Death|1|||
131002460|NCT03486899|471635323|FG001|Overall Study|Death|0|||
131002461|NCT03486899|471635324|FG002|Overall Study|Death|0|||
131002462|NCT03486899|471635325|FG003|Overall Study|Death|1|||
131002463|NCT03486899|471635322|FG000|Overall Study|Adverse Event|0|||
131002464|NCT03486899|471635323|FG001|Overall Study|Adverse Event|2|||
131002465|NCT03486899|471635324|FG002|Overall Study|Adverse Event|0|||
131002466|NCT03486899|471635325|FG003|Overall Study|Adverse Event|2|||
131002467|NCT03486899|471635322|FG000|Overall Study|Withdrawal by Subject|3|||
131002468|NCT03486899|471635323|FG001|Overall Study|Withdrawal by Subject|7|||
131002469|NCT03486899|471635324|FG002|Overall Study|Withdrawal by Subject|4|||
131002470|NCT03486899|471635325|FG003|Overall Study|Withdrawal by Subject|3|||
131002471|NCT03486899|471635322|FG000|Overall Study|Other Reasons|0|||
131002472|NCT03486899|471635323|FG001|Overall Study|Other Reasons|1|||
131002473|NCT03486899|471635324|FG002|Overall Study|Other Reasons|0|||
131002474|NCT03486899|471635325|FG003|Overall Study|Other Reasons|1|||
131002475|NCT02559817|471635326|FG000|Treatment Period|Adverse Event|1|||
131002476|NCT02559817|471635327|FG001|Treatment Period|Adverse Event|0|||
131002477|NCT02559817|471635328|FG002|Treatment Period|Adverse Event|1|||
131002478|NCT02559817|471635329|FG003|Treatment Period|Adverse Event|0|||
131002479|NCT02559817|471635330|FG004|Treatment Period|Adverse Event|0|||
131002480|NCT02559817|471635326|FG000|Treatment Period|Lack of Efficacy|0|||
131002481|NCT02559817|471635327|FG001|Treatment Period|Lack of Efficacy|1|||
131002482|NCT02559817|471635328|FG002|Treatment Period|Lack of Efficacy|0|||
131002483|NCT02559817|471635329|FG003|Treatment Period|Lack of Efficacy|0|||
131002484|NCT02559817|471635330|FG004|Treatment Period|Lack of Efficacy|0|||
131002485|NCT02559817|471635326|FG000|Treatment Period|Lost to Follow-up|0|||
131002486|NCT02559817|471635327|FG001|Treatment Period|Lost to Follow-up|1|||
131002487|NCT02559817|471635328|FG002|Treatment Period|Lost to Follow-up|0|||
131002488|NCT02559817|471635329|FG003|Treatment Period|Lost to Follow-up|1|||
131002489|NCT02559817|471635330|FG004|Treatment Period|Lost to Follow-up|0|||
131002490|NCT02559817|471635326|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
131002491|NCT02559817|471635327|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
131002492|NCT02559817|471635328|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
131002493|NCT02559817|471635329|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
131002494|NCT02559817|471635330|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
131002495|NCT02559817|471635326|FG000|Treatment Period|Protocol Violation|0|||
131002496|NCT02559817|471635327|FG001|Treatment Period|Protocol Violation|0|||
131002497|NCT02559817|471635328|FG002|Treatment Period|Protocol Violation|0|||
131002498|NCT02559817|471635329|FG003|Treatment Period|Protocol Violation|1|||
131002499|NCT02559817|471635330|FG004|Treatment Period|Protocol Violation|0|||
131002500|NCT00577720|471635344|FG000|Overall Study|Adverse Event|2|||
131002501|NCT00577720|471635345|FG001|Overall Study|Adverse Event|1|||
131002502|NCT00577720|471635346|FG002|Overall Study|Adverse Event|0|||
131002503|NCT00577720|471635347|FG003|Overall Study|Adverse Event|4|||
131002504|NCT00577720|471635344|FG000|Overall Study|Lost to Follow-up|0|||
131002505|NCT00577720|471635345|FG001|Overall Study|Lost to Follow-up|0|||
131002506|NCT00577720|471635346|FG002|Overall Study|Lost to Follow-up|1|||
131002507|NCT00577720|471635347|FG003|Overall Study|Lost to Follow-up|0|||
131002508|NCT00577720|471635344|FG000|Overall Study|Protocol Violation|0|||
131002509|NCT00577720|471635345|FG001|Overall Study|Protocol Violation|0|||
131002510|NCT00577720|471635346|FG002|Overall Study|Protocol Violation|0|||
131002511|NCT00577720|471635347|FG003|Overall Study|Protocol Violation|1|||
131002512|NCT00577720|471635344|FG000|Overall Study|Withdrawal by Subject|2|||
131002513|NCT00577720|471635345|FG001|Overall Study|Withdrawal by Subject|0|||
131002514|NCT00577720|471635346|FG002|Overall Study|Withdrawal by Subject|0|||
131002515|NCT00577720|471635347|FG003|Overall Study|Withdrawal by Subject|2|||
131002516|NCT03100838|471635348|FG000|Overall Study|Adverse Event|1|||
131002517|NCT03100838|471635349|FG001|Overall Study|Adverse Event|0|||
131002518|NCT03100838|471635350|FG002|Overall Study|Adverse Event|0|||
131002519|NCT03100838|471635351|FG003|Overall Study|Adverse Event|0|||
131002520|NCT03100838|471635348|FG000|Overall Study|Physician Decision|1|||
131002521|NCT03100838|471635349|FG001|Overall Study|Physician Decision|1|||
131002522|NCT03100838|471635350|FG002|Overall Study|Physician Decision|1|||
131002523|NCT03100838|471635351|FG003|Overall Study|Physician Decision|1|||
131002524|NCT03100838|471635348|FG000|Overall Study|Pregnancy|0|||
131002525|NCT03100838|471635349|FG001|Overall Study|Pregnancy|1|||
131002526|NCT03100838|471635350|FG002|Overall Study|Pregnancy|0|||
131002527|NCT03100838|471635351|FG003|Overall Study|Pregnancy|0|||
131002528|NCT03100838|471635348|FG000|Overall Study|Lost to Follow-up|0|||
131002529|NCT03100838|471635349|FG001|Overall Study|Lost to Follow-up|0|||
131002530|NCT03100838|471635350|FG002|Overall Study|Lost to Follow-up|1|||
131002531|NCT03100838|471635351|FG003|Overall Study|Lost to Follow-up|0|||
131002532|NCT02806336|471635352|FG000|Overall Study|Physician Decision|1|||
131002533|NCT02806336|471635353|FG001|Overall Study|Physician Decision|0|||
131002534|NCT02806336|471635352|FG000|Overall Study|Withdrawal by Subject|2|||
131002535|NCT02806336|471635353|FG001|Overall Study|Withdrawal by Subject|4|||
131002536|NCT02806336|471635352|FG000|Overall Study|COVID-19 research shut down|3|||
131002537|NCT02806336|471635353|FG001|Overall Study|COVID-19 research shut down|4|||
131002538|NCT02806336|471635352|FG000|Overall Study|Lack of Efficacy|0|||
131002539|NCT02806336|471635353|FG001|Overall Study|Lack of Efficacy|1|||
131002540|NCT03077620|471635358|FG000|Overall Study|Unable to place lumbar catheter|1|||
131002541|NCT03077620|471635359|FG001|Overall Study|Unable to place lumbar catheter|0|||
131002542|NCT03077620|471635360|FG002|Overall Study|Unable to place lumbar catheter|1|||
131002543|NCT03077620|471635361|FG003|Overall Study|Unable to place lumbar catheter|0|||
131002544|NCT03077620|471635358|FG000|Overall Study|Withdrawal by Subject|0|||
131002545|NCT03077620|471635359|FG001|Overall Study|Withdrawal by Subject|1|||
131002546|NCT03077620|471635360|FG002|Overall Study|Withdrawal by Subject|0|||
131002547|NCT03077620|471635361|FG003|Overall Study|Withdrawal by Subject|0|||
131002548|NCT03077620|471635358|FG000|Overall Study|Physician Decision|0|||
131002549|NCT03077620|471635359|FG001|Overall Study|Physician Decision|0|||
131002550|NCT03077620|471635360|FG002|Overall Study|Physician Decision|1|||
131002551|NCT03077620|471635361|FG003|Overall Study|Physician Decision|0|||
131002552|NCT03225846|471635362|FG000|Overall Study|Adverse Event|0|||
131002553|NCT03225846|471635363|FG001|Overall Study|Adverse Event|0|||
131002554|NCT03225846|471635364|FG002|Overall Study|Adverse Event|0|||
131002555|NCT03225846|471635365|FG003|Overall Study|Adverse Event|0|||
131002556|NCT03225846|471635366|FG004|Overall Study|Adverse Event|0|||
131002557|NCT03225846|471635367|FG005|Overall Study|Adverse Event|0|||
131002558|NCT03225846|471635368|FG006|Overall Study|Adverse Event|6|||
131002559|NCT03225846|471635362|FG000|Overall Study|Withdrawal by Subject|0|||
131002560|NCT03225846|471635363|FG001|Overall Study|Withdrawal by Subject|1|||
131002561|NCT03225846|471635364|FG002|Overall Study|Withdrawal by Subject|0|||
131002562|NCT03225846|471635365|FG003|Overall Study|Withdrawal by Subject|0|||
131002563|NCT03225846|471635366|FG004|Overall Study|Withdrawal by Subject|0|||
131002564|NCT03225846|471635367|FG005|Overall Study|Withdrawal by Subject|0|||
131002565|NCT03225846|471635368|FG006|Overall Study|Withdrawal by Subject|0|||
131002566|NCT03225846|471635362|FG000|Overall Study|Death|0|||
131002567|NCT03225846|471635363|FG001|Overall Study|Death|1|||
131002568|NCT03225846|471635364|FG002|Overall Study|Death|0|||
131002569|NCT03225846|471635365|FG003|Overall Study|Death|0|||
131002570|NCT03225846|471635366|FG004|Overall Study|Death|0|||
131002571|NCT03225846|471635367|FG005|Overall Study|Death|0|||
131002572|NCT03225846|471635368|FG006|Overall Study|Death|0|||
131002573|NCT03225846|471635362|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
131002574|NCT03225846|471635363|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
131002575|NCT03225846|471635364|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
131002576|NCT03225846|471635365|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
131002577|NCT03225846|471635366|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
131002578|NCT03225846|471635367|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
131002579|NCT03225846|471635368|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
131002580|NCT03225846|471635362|FG000|Overall Study|Patient decision|0|||
131002581|NCT03225846|471635363|FG001|Overall Study|Patient decision|0|||
131002582|NCT03225846|471635364|FG002|Overall Study|Patient decision|0|||
131002583|NCT03225846|471635365|FG003|Overall Study|Patient decision|0|||
131002584|NCT03225846|471635366|FG004|Overall Study|Patient decision|0|||
131002585|NCT03225846|471635367|FG005|Overall Study|Patient decision|0|||
131002586|NCT03225846|471635368|FG006|Overall Study|Patient decision|1|||
131002587|NCT00996580|471635369|FG000|Overall Study|Adverse Event|466|||
131002588|NCT00996580|471635369|FG000|Overall Study|Lost to Follow-up|480|||
131002589|NCT00996580|471635369|FG000|Overall Study|Noncompliance with the protocol|137|||
131002590|NCT00996580|471635369|FG000|Overall Study|Physician Decision|5|||
131002591|NCT00996580|471635369|FG000|Overall Study|Pregnancy|68|||
131002592|NCT00996580|471635369|FG000|Overall Study|Protocol Violation|16|||
131002593|NCT00996580|471635369|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
131002594|NCT00996580|471635369|FG000|Overall Study|Withdrawal by Subject|217|||
131002595|NCT00996580|471635369|FG000|Overall Study|Other|29|||
131002596|NCT04248465|471635370|FG000|Randomized-Controlled Period|Death|12|||
131002597|NCT04248465|471635371|FG001|Randomized-Controlled Period|Death|5|||
131002598|NCT04248465|471635370|FG000|Randomized-Controlled Period|Adverse Event|2|||
131002599|NCT04248465|471635371|FG001|Randomized-Controlled Period|Adverse Event|0|||
131002600|NCT04248465|471635370|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
131002601|NCT04248465|471635371|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
131002602|NCT04248465|471635370|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
131002603|NCT04248465|471635371|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
131002604|NCT04248465|471635370|FG000|Randomized-Controlled Period|Physician Decision|1|||
131002605|NCT04248465|471635371|FG001|Randomized-Controlled Period|Physician Decision|1|||
131002606|NCT04248465|471635370|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
131002607|NCT04248465|471635371|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
131002608|NCT04248465|471635370|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
131002609|NCT04248465|471635371|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
131002610|NCT04248465|471635370|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
131002611|NCT04248465|471635371|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
131002612|NCT05708846|471635372|FG000|Overall Study|Death|5|||
131002613|NCT05708846|471635372|FG000|Overall Study|Withdrawal by Subject|20|||
131002614|NCT02036515|471635373|FG000|Overall Study|Adverse Event|1|||
131002615|NCT02036515|471635374|FG001|Overall Study|Adverse Event|1|||
131002616|NCT02036515|471635375|FG002|Overall Study|Adverse Event|2|||
131002617|NCT02036515|471635373|FG000|Overall Study|Lost to Follow-up|0|||
131002618|NCT02036515|471635374|FG001|Overall Study|Lost to Follow-up|2|||
131002619|NCT02036515|471635375|FG002|Overall Study|Lost to Follow-up|0|||
131002620|NCT02036515|471635373|FG000|Overall Study|Non-compliance with study drug|0|||
131002621|NCT02036515|471635374|FG001|Overall Study|Non-compliance with study drug|0|||
131002622|NCT02036515|471635375|FG002|Overall Study|Non-compliance with study drug|2|||
131002623|NCT02036515|471635373|FG000|Overall Study|Screen failure|0|||
131002624|NCT02036515|471635374|FG001|Overall Study|Screen failure|2|||
131002625|NCT02036515|471635375|FG002|Overall Study|Screen failure|0|||
131002626|NCT02036515|471635373|FG000|Overall Study|Withdrawal by Subject|4|||
131002627|NCT02036515|471635374|FG001|Overall Study|Withdrawal by Subject|7|||
131002628|NCT02036515|471635375|FG002|Overall Study|Withdrawal by Subject|9|||
131002629|NCT02036515|471635373|FG000|Overall Study|Hyperglycemia|0|||
131002630|NCT02036515|471635374|FG001|Overall Study|Hyperglycemia|0|||
131002631|NCT02036515|471635375|FG002|Overall Study|Hyperglycemia|1|||
131002632|NCT03621982|471635376|FG000|Overall Study|Withdrawal by Subject|1|||
131002633|NCT03621982|471635377|FG001|Overall Study|Withdrawal by Subject|0|||
131002634|NCT03621982|471635378|FG002|Overall Study|Withdrawal by Subject|0|||
131002635|NCT03621982|471635379|FG003|Overall Study|Withdrawal by Subject|1|||
131002636|NCT03621982|471635380|FG004|Overall Study|Withdrawal by Subject|0|||
131002637|NCT03621982|471635381|FG005|Overall Study|Withdrawal by Subject|1|||
131002638|NCT03621982|471635382|FG006|Overall Study|Withdrawal by Subject|1|||
131002639|NCT03621982|471635383|FG007|Overall Study|Withdrawal by Subject|0|||
131002640|NCT03621982|471635384|FG008|Overall Study|Withdrawal by Subject|1|||
131002641|NCT03621982|471635385|FG009|Overall Study|Withdrawal by Subject|0|||
131002642|NCT03621982|471635386|FG010|Overall Study|Withdrawal by Subject|2|||
131002643|NCT03621982|471635387|FG011|Overall Study|Withdrawal by Subject|1|||
131002644|NCT03621982|471635388|FG012|Overall Study|Withdrawal by Subject|2|||
131002645|NCT03621982|471635389|FG013|Overall Study|Withdrawal by Subject|2|||
131002646|NCT03621982|471635376|FG000|Overall Study|Investigator/Sponsor decision|0|||
131002647|NCT03621982|471635377|FG001|Overall Study|Investigator/Sponsor decision|0|||
131002648|NCT03621982|471635378|FG002|Overall Study|Investigator/Sponsor decision|0|||
131002649|NCT03621982|471635379|FG003|Overall Study|Investigator/Sponsor decision|0|||
131002650|NCT03621982|471635380|FG004|Overall Study|Investigator/Sponsor decision|0|||
131002651|NCT03621982|471635381|FG005|Overall Study|Investigator/Sponsor decision|0|||
131002652|NCT03621982|471635382|FG006|Overall Study|Investigator/Sponsor decision|0|||
131002653|NCT03621982|471635383|FG007|Overall Study|Investigator/Sponsor decision|0|||
131002654|NCT03621982|471635384|FG008|Overall Study|Investigator/Sponsor decision|0|||
131002655|NCT03621982|471635385|FG009|Overall Study|Investigator/Sponsor decision|0|||
131002656|NCT03621982|471635386|FG010|Overall Study|Investigator/Sponsor decision|0|||
131002657|NCT03621982|471635387|FG011|Overall Study|Investigator/Sponsor decision|4|||
131002658|NCT03621982|471635388|FG012|Overall Study|Investigator/Sponsor decision|0|||
131002659|NCT03621982|471635389|FG013|Overall Study|Investigator/Sponsor decision|2|||
131002660|NCT03621982|471635376|FG000|Overall Study|Death|2|||
131002661|NCT03621982|471635377|FG001|Overall Study|Death|4|||
131002662|NCT03621982|471635378|FG002|Overall Study|Death|4|||
131002663|NCT03621982|471635379|FG003|Overall Study|Death|3|||
131002664|NCT03621982|471635380|FG004|Overall Study|Death|8|||
131002665|NCT03621982|471635381|FG005|Overall Study|Death|4|||
131002666|NCT03621982|471635382|FG006|Overall Study|Death|6|||
131002667|NCT03621982|471635383|FG007|Overall Study|Death|3|||
131002668|NCT03621982|471635384|FG008|Overall Study|Death|0|||
130884795|NCT00790842|471213224|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
130884796|NCT00790842|471213225|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130884797|NCT00790842|471213226|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130884798|NCT00790842|471213216|FG000|Dose Level 3|Adverse Event|0|||
130884799|NCT00790842|471213217|FG001|Dose Level 3|Adverse Event|0|||
130884800|NCT00790842|471213218|FG002|Dose Level 3|Adverse Event|1|||
130884801|NCT00790842|471213219|FG003|Dose Level 3|Adverse Event|0|||
130884802|NCT00790842|471213220|FG004|Dose Level 3|Adverse Event|0|||
130884803|NCT00790842|471213221|FG005|Dose Level 3|Adverse Event|0|||
130884804|NCT00790842|471213222|FG006|Dose Level 3|Adverse Event|0|||
130884805|NCT00790842|471213223|FG007|Dose Level 3|Adverse Event|0|||
130884806|NCT00790842|471213224|FG008|Dose Level 3|Adverse Event|0|||
130884807|NCT00790842|471213225|FG009|Dose Level 3|Adverse Event|0|||
130884808|NCT00790842|471213226|FG010|Dose Level 3|Adverse Event|0|||
130884809|NCT00790842|471213216|FG000|Dose Level 3|Withdrawal by Subject|0|||
130884810|NCT00790842|471213217|FG001|Dose Level 3|Withdrawal by Subject|0|||
130884811|NCT00790842|471213218|FG002|Dose Level 3|Withdrawal by Subject|3|||
130884812|NCT00790842|471213219|FG003|Dose Level 3|Withdrawal by Subject|0|||
130884813|NCT00790842|471213220|FG004|Dose Level 3|Withdrawal by Subject|0|||
130884814|NCT00790842|471213221|FG005|Dose Level 3|Withdrawal by Subject|0|||
130884815|NCT00790842|471213222|FG006|Dose Level 3|Withdrawal by Subject|0|||
130884816|NCT00790842|471213223|FG007|Dose Level 3|Withdrawal by Subject|0|||
130884817|NCT00790842|471213224|FG008|Dose Level 3|Withdrawal by Subject|0|||
130884818|NCT00790842|471213225|FG009|Dose Level 3|Withdrawal by Subject|2|||
130884819|NCT00790842|471213226|FG010|Dose Level 3|Withdrawal by Subject|0|||
130884820|NCT00790842|471213216|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130884821|NCT00790842|471213217|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130884822|NCT00790842|471213218|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130884823|NCT00790842|471213219|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130884824|NCT00790842|471213220|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130884825|NCT00790842|471213221|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
130884826|NCT00790842|471213222|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130884827|NCT00790842|471213223|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130884828|NCT00790842|471213224|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130884829|NCT00790842|471213225|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130884830|NCT00790842|471213226|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130884831|NCT00790842|471213216|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130884832|NCT00790842|471213217|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130884833|NCT00790842|471213218|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
130884834|NCT00790842|471213219|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130884835|NCT00790842|471213220|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130884836|NCT00790842|471213221|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130884837|NCT00790842|471213222|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130884838|NCT00790842|471213223|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130884839|NCT00790842|471213224|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130884840|NCT00790842|471213225|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130884841|NCT00790842|471213226|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130884842|NCT00790842|471213216|FG000|Dose Level 4|Adverse Event|0|||
130884843|NCT00790842|471213217|FG001|Dose Level 4|Adverse Event|0|||
130884844|NCT00790842|471213218|FG002|Dose Level 4|Adverse Event|0|||
130884845|NCT00790842|471213219|FG003|Dose Level 4|Adverse Event|0|||
130884846|NCT00790842|471213220|FG004|Dose Level 4|Adverse Event|0|||
131002669|NCT03621982|471635385|FG009|Overall Study|Death|3|||
131221946|NCT00434148|472439476|FG001|Overall Study|Lost to Follow-up|1|||
130884847|NCT00790842|471213221|FG005|Dose Level 4|Adverse Event|0|||
130884848|NCT00790842|471213222|FG006|Dose Level 4|Adverse Event|1|||
130884849|NCT00790842|471213223|FG007|Dose Level 4|Adverse Event|0|||
130884850|NCT00790842|471213224|FG008|Dose Level 4|Adverse Event|0|||
130884851|NCT00790842|471213225|FG009|Dose Level 4|Adverse Event|0|||
130884852|NCT00790842|471213226|FG010|Dose Level 4|Adverse Event|0|||
130884853|NCT00790842|471213216|FG000|Dose Level 4|Physician Decision|0|||
130884854|NCT00790842|471213217|FG001|Dose Level 4|Physician Decision|0|||
130884855|NCT00790842|471213218|FG002|Dose Level 4|Physician Decision|0|||
131002670|NCT03621982|471635386|FG010|Overall Study|Death|8|||
131002671|NCT03621982|471635387|FG011|Overall Study|Death|4|||
131002672|NCT03621982|471635388|FG012|Overall Study|Death|2|||
131002673|NCT03621982|471635389|FG013|Overall Study|Death|2|||
131002674|NCT03621982|471635376|FG000|Overall Study|Lost to Follow-up|0|||
131002675|NCT03621982|471635377|FG001|Overall Study|Lost to Follow-up|0|||
131002676|NCT03621982|471635378|FG002|Overall Study|Lost to Follow-up|1|||
131002677|NCT03621982|471635379|FG003|Overall Study|Lost to Follow-up|0|||
131002678|NCT03621982|471635380|FG004|Overall Study|Lost to Follow-up|0|||
131002679|NCT03621982|471635381|FG005|Overall Study|Lost to Follow-up|0|||
131002680|NCT03621982|471635382|FG006|Overall Study|Lost to Follow-up|1|||
131002681|NCT03621982|471635383|FG007|Overall Study|Lost to Follow-up|0|||
131002682|NCT03621982|471635384|FG008|Overall Study|Lost to Follow-up|0|||
131002683|NCT03621982|471635385|FG009|Overall Study|Lost to Follow-up|1|||
131002684|NCT03621982|471635386|FG010|Overall Study|Lost to Follow-up|0|||
131002685|NCT03621982|471635387|FG011|Overall Study|Lost to Follow-up|0|||
131002686|NCT03621982|471635388|FG012|Overall Study|Lost to Follow-up|0|||
131002687|NCT03621982|471635389|FG013|Overall Study|Lost to Follow-up|0|||
131002688|NCT01544582|471635392|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
131002689|NCT01544582|471635393|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
131002690|NCT01544582|471635394|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
131002691|NCT01544582|471635395|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
131002692|NCT01544582|471635392|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
131002693|NCT01544582|471635393|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
131002694|NCT01544582|471635394|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
131002695|NCT01544582|471635395|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
131002696|NCT01544582|471635392|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
131002697|NCT01544582|471635393|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
131002698|NCT01544582|471635394|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
131002699|NCT01544582|471635395|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
131002700|NCT01544582|471635392|FG000|Analysis Population|Physician Decision|0|||
131002701|NCT01544582|471635393|FG001|Analysis Population|Physician Decision|13|||
131002702|NCT01544582|471635394|FG002|Analysis Population|Physician Decision|10|||
131002703|NCT01544582|471635395|FG003|Analysis Population|Physician Decision|9|||
131002704|NCT01544582|471635392|FG000|Analysis Population|Safety Reason|0|||
131002705|NCT01544582|471635393|FG001|Analysis Population|Safety Reason|33|||
131002706|NCT01544582|471635394|FG002|Analysis Population|Safety Reason|31|||
131002707|NCT01544582|471635395|FG003|Analysis Population|Safety Reason|8|||
131002708|NCT01544582|471635392|FG000|Analysis Population|Effectiveness Reason|0|||
131002709|NCT01544582|471635393|FG001|Analysis Population|Effectiveness Reason|48|||
131002710|NCT01544582|471635394|FG002|Analysis Population|Effectiveness Reason|29|||
131002711|NCT01544582|471635395|FG003|Analysis Population|Effectiveness Reason|12|||
131002712|NCT01544582|471635392|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
131002713|NCT01544582|471635393|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
131002714|NCT01544582|471635394|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
131002715|NCT01544582|471635395|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
131002716|NCT01544582|471635392|FG000|Analysis Population|Lost to Follow-up|0|||
131002717|NCT01544582|471635393|FG001|Analysis Population|Lost to Follow-up|6|||
131002718|NCT01544582|471635394|FG002|Analysis Population|Lost to Follow-up|6|||
131002719|NCT01544582|471635395|FG003|Analysis Population|Lost to Follow-up|5|||
131002720|NCT01544582|471635392|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
131002721|NCT01544582|471635393|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
131002722|NCT01544582|471635394|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
131002723|NCT01544582|471635395|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
131002724|NCT01544582|471635392|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
131002725|NCT01544582|471635393|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
131002726|NCT01544582|471635394|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
131002727|NCT01544582|471635395|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
131002728|NCT01544582|471635392|FG000|Analysis Population|Intolerance|0|||
131002729|NCT01544582|471635393|FG001|Analysis Population|Intolerance|1|||
131002730|NCT01544582|471635394|FG002|Analysis Population|Intolerance|0|||
131002731|NCT01544582|471635395|FG003|Analysis Population|Intolerance|0|||
131002732|NCT01544582|471635392|FG000|Analysis Population|Liver Transplantation|0|||
131002733|NCT01544582|471635393|FG001|Analysis Population|Liver Transplantation|0|||
131002734|NCT01544582|471635394|FG002|Analysis Population|Liver Transplantation|1|||
131002735|NCT01544582|471635395|FG003|Analysis Population|Liver Transplantation|0|||
131002736|NCT01544582|471635392|FG000|Analysis Population|No Social Insurance|0|||
131002737|NCT01544582|471635393|FG001|Analysis Population|No Social Insurance|0|||
131002738|NCT01544582|471635394|FG002|Analysis Population|No Social Insurance|1|||
131002739|NCT01544582|471635395|FG003|Analysis Population|No Social Insurance|0|||
131002740|NCT01544582|471635392|FG000|Analysis Population|Poor Adherence|0|||
131002741|NCT01544582|471635393|FG001|Analysis Population|Poor Adherence|0|||
131002742|NCT01544582|471635394|FG002|Analysis Population|Poor Adherence|1|||
131002743|NCT01544582|471635395|FG003|Analysis Population|Poor Adherence|0|||
131002744|NCT01544582|471635392|FG000|Analysis Population|Poor Participant Compliance|0|||
131002745|NCT01544582|471635393|FG001|Analysis Population|Poor Participant Compliance|1|||
131002746|NCT01544582|471635394|FG002|Analysis Population|Poor Participant Compliance|0|||
131002747|NCT01544582|471635395|FG003|Analysis Population|Poor Participant Compliance|0|||
131002748|NCT01544582|471635392|FG000|Analysis Population|Programmed Surgery|0|||
131002749|NCT01544582|471635393|FG001|Analysis Population|Programmed Surgery|1|||
131002750|NCT01544582|471635394|FG002|Analysis Population|Programmed Surgery|0|||
131002751|NCT01544582|471635395|FG003|Analysis Population|Programmed Surgery|0|||
131002752|NCT01544582|471635392|FG000|Analysis Population|Participant in Jail|0|||
131002753|NCT01544582|471635393|FG001|Analysis Population|Participant in Jail|0|||
131002754|NCT01544582|471635394|FG002|Analysis Population|Participant in Jail|1|||
131002755|NCT01544582|471635395|FG003|Analysis Population|Participant in Jail|0|||
131002756|NCT00663962|471635396|FG000|Overall Study|somnolence|1|||
131002757|NCT00663962|471635397|FG001|Overall Study|somnolence|0|||
131002758|NCT03428815|471635398|FG000|Overall Study|Lost to Follow-up|2|||
131002759|NCT03428815|471635399|FG001|Overall Study|Lost to Follow-up|2|||
131002760|NCT03428815|471635398|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
131002761|NCT03428815|471635399|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
131002762|NCT03428815|471635398|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
131002763|NCT03428815|471635399|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
131002764|NCT02102464|471635400|FG000|Randomized Study|Withdrawal by Subject|0|||
131002765|NCT02102464|471635401|FG001|Randomized Study|Withdrawal by Subject|1|||
131002766|NCT02102464|471635402|FG002|Randomized Study|Withdrawal by Subject|0|||
131002767|NCT04140890|471635403|FG000|Overall Study|Withdrawal by Subject|0|||
131002768|NCT04140890|471635404|FG001|Overall Study|Withdrawal by Subject|1|||
131002769|NCT01700348|471635405|FG000|Overall Study|Withdrawal by Subject|22|||
131002770|NCT01700348|471635405|FG000|Overall Study|Lost to Follow-up|1|||
131002771|NCT03958630|471635408|FG000|Overall Study|Withdrawal by Subject|0|||
131002772|NCT03958630|471635409|FG001|Overall Study|Withdrawal by Subject|0|||
131002773|NCT03958630|471635410|FG002|Overall Study|Withdrawal by Subject|1|||
131002774|NCT03958630|471635408|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
131002775|NCT03958630|471635409|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
131002776|NCT03958630|471635410|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
131002777|NCT01824472|471635415|FG000|Overall Study|Lost to Follow-up|0|||
131002778|NCT01824472|471635416|FG001|Overall Study|Lost to Follow-up|0|||
131002779|NCT01824472|471635417|FG002|Overall Study|Lost to Follow-up|1|||
131002780|NCT01824472|471635415|FG000|Overall Study|Withdrawal by Subject|1|||
131002781|NCT01824472|471635416|FG001|Overall Study|Withdrawal by Subject|5|||
131002782|NCT01824472|471635417|FG002|Overall Study|Withdrawal by Subject|3|||
131002783|NCT01824472|471635415|FG000|Overall Study|Ineligible post randomization&screening|0|||
131002784|NCT01824472|471635416|FG001|Overall Study|Ineligible post randomization&screening|2|||
131002785|NCT01824472|471635417|FG002|Overall Study|Ineligible post randomization&screening|0|||
131002786|NCT01815736|471635418|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
131002787|NCT01815736|471635419|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
131002788|NCT01815736|471635418|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
131002789|NCT01815736|471635419|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
131002790|NCT01815736|471635418|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
131002791|NCT01815736|471635419|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
131002792|NCT01815736|471635418|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
131002793|NCT01815736|471635419|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
131002794|NCT01815736|471635418|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
131002795|NCT01815736|471635419|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
131002796|NCT01815736|471635418|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
131002797|NCT01815736|471635419|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
131002798|NCT01815736|471635418|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
131002799|NCT01815736|471635419|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
131002800|NCT01815736|471635418|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
131002801|NCT01815736|471635419|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
131002802|NCT01815736|471635418|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
131002803|NCT01815736|471635419|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
131002804|NCT01815736|471635418|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
131002805|NCT01815736|471635419|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
131002806|NCT01815736|471635418|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
131002807|NCT01815736|471635419|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
131002808|NCT01815736|471635418|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
131002809|NCT01815736|471635419|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
131002810|NCT01815736|471635418|FG000|Extension Treatment Phase- After Week 96|Death|1|||
131002811|NCT01815736|471635419|FG001|Extension Treatment Phase- After Week 96|Death|0|||
131002812|NCT02684903|471635421|FG000|Overall Study|COVID-19 shutdown of lab|4|||
131002813|NCT02684903|471635422|FG001|Overall Study|COVID-19 shutdown of lab|6|||
131002814|NCT02684903|471635421|FG000|Overall Study|Lost to Follow-up|31|||
131002815|NCT02684903|471635422|FG001|Overall Study|Lost to Follow-up|41|||
131002816|NCT01354106|471635423|FG000|Overall Study|Withdrawal by Subject|2|||
131002817|NCT00107380|471636522|FG000|Overall Study|Adverse Event|7|||
131002818|NCT00107380|471636522|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
131002819|NCT00107380|471636522|FG000|Overall Study|Progression/relapse|4|||
131002820|NCT00107380|471636522|FG000|Overall Study|Death|3|||
131002821|NCT00107380|471636522|FG000|Overall Study|Other - not protocol specified|7|||
131002822|NCT00107380|471636522|FG000|Overall Study|Ineligible|2|||
131002823|NCT03673098|471636523|FG000|Overall Study|Lost to Follow-up|2|||
131002824|NCT03673098|471636524|FG001|Overall Study|Lost to Follow-up|3|||
131002825|NCT03673098|471636523|FG000|Overall Study|Withdrawal by Subject|6|||
131002826|NCT03673098|471636524|FG001|Overall Study|Withdrawal by Subject|1|||
131002827|NCT03673098|471636523|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
131002828|NCT03673098|471636524|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
131002829|NCT02485353|471636528|FG000|Overall Study|Death|1|||
131002830|NCT02485353|471636528|FG000|Overall Study|Disease Progression|1|||
131002831|NCT05343455|471636531|FG000|Overall Study|Withdrawal by Subject|4|||
131002832|NCT05343455|471636532|FG001|Overall Study|Withdrawal by Subject|9|||
131002833|NCT05343455|471636533|FG002|Overall Study|Withdrawal by Subject|7|||
131002834|NCT05343455|471636531|FG000|Overall Study|Adverse Event|2|||
131002835|NCT05343455|471636532|FG001|Overall Study|Adverse Event|1|||
131002836|NCT05343455|471636533|FG002|Overall Study|Adverse Event|2|||
131002837|NCT05343455|471636531|FG000|Overall Study|Lost to Follow-up|1|||
131002838|NCT05343455|471636532|FG001|Overall Study|Lost to Follow-up|1|||
131002839|NCT05343455|471636533|FG002|Overall Study|Lost to Follow-up|3|||
131002840|NCT05343455|471636531|FG000|Overall Study|Pregnancy|1|||
131002841|NCT05343455|471636532|FG001|Overall Study|Pregnancy|0|||
131002842|NCT05343455|471636533|FG002|Overall Study|Pregnancy|0|||
131002843|NCT05343455|471636531|FG000|Overall Study|Physician Decision|0|||
131002844|NCT05343455|471636532|FG001|Overall Study|Physician Decision|0|||
131002845|NCT05343455|471636533|FG002|Overall Study|Physician Decision|1|||
131002846|NCT05343455|471636531|FG000|Overall Study|Protocol Violation|0|||
131002847|NCT05343455|471636532|FG001|Overall Study|Protocol Violation|1|||
131002848|NCT05343455|471636533|FG002|Overall Study|Protocol Violation|1|||
131002849|NCT02748512|471636538|FG000|Overall Study|Lost to Follow-up|1|||
131002850|NCT02748512|471636539|FG001|Overall Study|Lost to Follow-up|1|||
131002851|NCT03930186|471636541|FG000|Weeks 0 to 16|Adverse Event|6|||
131002852|NCT03930186|471636541|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
131002853|NCT03930186|471636541|FG000|Weeks 16 to 32|Adverse Event|1|||
131002854|NCT03930186|471636541|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
131002855|NCT02264574|471636544|FG000|Overall Study|Death|21|||
131002856|NCT02264574|471636545|FG001|Overall Study|Death|21|||
131002857|NCT02264574|471636544|FG000|Overall Study|Withdrawal by Subject|8|||
131002858|NCT02264574|471636545|FG001|Overall Study|Withdrawal by Subject|6|||
131002859|NCT02264574|471636544|FG000|Overall Study|Other, Not Specified|0|||
131002860|NCT02264574|471636545|FG001|Overall Study|Other, Not Specified|3|||
131002861|NCT03415022|471636551|FG000|Overall Study|Withdrawal by Subject|1|||
131002862|NCT03415022|471636552|FG001|Overall Study|Withdrawal by Subject|2|||
131002863|NCT03415022|471636551|FG000|Overall Study|COVID-19 Suspension|2|||
131002864|NCT03415022|471636552|FG001|Overall Study|COVID-19 Suspension|3|||
131002865|NCT03415022|471636551|FG000|Overall Study|Lost to Follow-up|2|||
131002866|NCT03415022|471636552|FG001|Overall Study|Lost to Follow-up|0|||
131002867|NCT04466618|471636553|FG000|Overall Study|Withdrawal by Subject|0|||
131002868|NCT04466618|471636554|FG001|Overall Study|Withdrawal by Subject|1|||
131002869|NCT00884286|471636559|FG000|Overall Study|Progressive disease|21|||
131002870|NCT00884286|471636560|FG001|Overall Study|Progressive disease|28|||
131002871|NCT00884286|471636559|FG000|Overall Study|Toxicity|4|||
131002872|NCT00884286|471636560|FG001|Overall Study|Toxicity|1|||
131002873|NCT00884286|471636559|FG000|Overall Study|Death|2|||
131002874|NCT00884286|471636560|FG001|Overall Study|Death|2|||
131002875|NCT00884286|471636559|FG000|Overall Study|Physician Decision|1|||
131002876|NCT00884286|471636560|FG001|Overall Study|Physician Decision|0|||
131002877|NCT00884286|471636559|FG000|Overall Study|Septic shock|1|||
131002878|NCT00884286|471636560|FG001|Overall Study|Septic shock|0|||
131002879|NCT00884286|471636559|FG000|Overall Study|Thrombus in right auricle|1|||
131002880|NCT00884286|471636560|FG001|Overall Study|Thrombus in right auricle|0|||
131002881|NCT00884286|471636559|FG000|Overall Study|Not treated|2|||
131002882|NCT00884286|471636560|FG001|Overall Study|Not treated|1|||
131002883|NCT00884286|471636559|FG000|Overall Study|Comprised lung carcinoma|0|||
131002884|NCT00884286|471636560|FG001|Overall Study|Comprised lung carcinoma|1|||
131002885|NCT01720797|471636561|FG000|Overall Study|Withdrawal by Subject|3|||
131002886|NCT01720797|471636562|FG001|Overall Study|Withdrawal by Subject|0|||
131002887|NCT02724020|471636567|FG000|Overall Study|Death|16|||
131002888|NCT02724020|471636568|FG001|Overall Study|Death|18|||
131002889|NCT02724020|471636569|FG002|Overall Study|Death|19|||
131002890|NCT02724020|471636567|FG000|Overall Study|Lost to Follow-up|0|||
131002891|NCT02724020|471636568|FG001|Overall Study|Lost to Follow-up|3|||
131002892|NCT02724020|471636569|FG002|Overall Study|Lost to Follow-up|0|||
131002893|NCT02724020|471636567|FG000|Overall Study|Site Terminated by Sponsor|15|||
131002894|NCT02724020|471636568|FG001|Overall Study|Site Terminated by Sponsor|8|||
131002895|NCT02724020|471636569|FG002|Overall Study|Site Terminated by Sponsor|8|||
131002896|NCT02724020|471636567|FG000|Overall Study|Withdrawal by Subject|1|||
131002897|NCT02724020|471636568|FG001|Overall Study|Withdrawal by Subject|3|||
131002898|NCT02724020|471636569|FG002|Overall Study|Withdrawal by Subject|5|||
131002899|NCT02554513|471636570|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
131002900|NCT02554513|471636571|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
131002901|NCT00184028|471636572|FG000|Overall Study|Death|1|||
131002902|NCT00184028|471636572|FG000|Overall Study|Lack of Efficacy|4|||
131002903|NCT00184028|471636572|FG000|Overall Study|Adverse Event|2|||
131002904|NCT00184028|471636572|FG000|Overall Study|Withdrawal by Subject|1|||
131002905|NCT00184028|471636572|FG000|Overall Study|Non-compliance|2|||
131002906|NCT01354938|471636575|FG000|Overall Study|Lost to Follow-up|1|||
131002907|NCT01192295|471636579|FG000|Overall Study|Adverse Event|3|||
131002908|NCT01192295|471636580|FG001|Overall Study|Adverse Event|7|||
131002909|NCT01192295|471636579|FG000|Overall Study|Withdrawal by Subject|3|||
131002910|NCT01192295|471636580|FG001|Overall Study|Withdrawal by Subject|4|||
131002911|NCT01192295|471636579|FG000|Overall Study|Lost to Follow-up|0|||
131002912|NCT01192295|471636580|FG001|Overall Study|Lost to Follow-up|1|||
131002913|NCT01192295|471636579|FG000|Overall Study|Lack of Efficacy|0|||
131002914|NCT01192295|471636580|FG001|Overall Study|Lack of Efficacy|5|||
131002915|NCT01192295|471636579|FG000|Overall Study|Administrative|4|||
131002916|NCT01192295|471636580|FG001|Overall Study|Administrative|6|||
131002917|NCT03785340|471636583|FG000|Overall Study|Lost to Follow-up|2|||
131002918|NCT03785340|471636584|FG001|Overall Study|Lost to Follow-up|0|||
131002919|NCT03785340|471636583|FG000|Overall Study|Adverse Event|1|||
131002920|NCT03785340|471636584|FG001|Overall Study|Adverse Event|0|||
131002921|NCT01670500|471636591|FG000|Overall Study|Withdrawal by Subject|1|||
131002922|NCT01670500|471636592|FG001|Overall Study|Withdrawal by Subject|0|||
131002923|NCT04320615|471636593|FG000|Overall Study|Withdrawal by Subject|4|||
131002924|NCT04320615|471636594|FG001|Overall Study|Withdrawal by Subject|10|||
131002925|NCT04320615|471636593|FG000|Overall Study|Physician Decision|2|||
131002926|NCT04320615|471636594|FG001|Overall Study|Physician Decision|0|||
131002927|NCT04320615|471636593|FG000|Overall Study|Other|2|||
131002928|NCT04320615|471636594|FG001|Overall Study|Other|0|||
131002929|NCT04320615|471636593|FG000|Overall Study|Lost to Follow-up|5|||
131002930|NCT04320615|471636594|FG001|Overall Study|Lost to Follow-up|23|||
131002931|NCT04320615|471636593|FG000|Overall Study|Death|35|||
131002932|NCT04320615|471636594|FG001|Overall Study|Death|71|||
131002933|NCT01449721|471636595|FG000|Overall Study|Physician Decision|0|||
131002934|NCT01449721|471636596|FG001|Overall Study|Physician Decision|1|||
131002935|NCT01449721|471636595|FG000|Overall Study|Physician Decision|0|||
131002936|NCT01449721|471636596|FG001|Overall Study|Physician Decision|1|||
131002937|NCT00003509|471636597|FG000|Overall Study|Not evaluable|5|||
131002938|NCT03285711|471636598|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
131002939|NCT03285711|471636599|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
131002940|NCT03285711|471636600|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
131002941|NCT03285711|471636601|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
131002942|NCT03285711|471636598|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
131002943|NCT03285711|471636599|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
131002944|NCT03285711|471636600|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
131002945|NCT03285711|471636601|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
131002946|NCT03285711|471636598|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
131002947|NCT03285711|471636599|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
131002948|NCT03285711|471636600|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
131002949|NCT03285711|471636601|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
131002950|NCT03285711|471636598|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
131002951|NCT03285711|471636599|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
131002952|NCT03285711|471636600|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
131002953|NCT03285711|471636601|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
131002954|NCT02107443|471636602|FG000|Overall Study|Death|42|||
131002955|NCT02107443|471636603|FG001|Overall Study|Death|30|||
131002956|NCT02107443|471636602|FG000|Overall Study|Study Protocol Violation|3|||
131002957|NCT02107443|471636603|FG001|Overall Study|Study Protocol Violation|1|||
131002958|NCT02107443|471636602|FG000|Overall Study|Registered but Not Eligible|0|||
131002959|NCT02107443|471636603|FG001|Overall Study|Registered but Not Eligible|1|||
131002960|NCT02107443|471636602|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
131002961|NCT02107443|471636603|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
131002962|NCT02107443|471636602|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
131002963|NCT02107443|471636603|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
131002964|NCT02107443|471636602|FG000|Overall Study|Withdrawal: Changed Mind|2|||
131002965|NCT02107443|471636603|FG001|Overall Study|Withdrawal: Changed Mind|0|||
131002966|NCT02107443|471636602|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
131002967|NCT02107443|471636603|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
131002968|NCT02107443|471636602|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
131002969|NCT02107443|471636603|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
131002970|NCT02107443|471636602|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
131002971|NCT02107443|471636603|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
131002972|NCT02107443|471636602|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
131002973|NCT02107443|471636603|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
131002974|NCT02107443|471636602|FG000|Overall Study|Withdrawal: Other Medical|9|||
131002975|NCT02107443|471636603|FG001|Overall Study|Withdrawal: Other Medical|5|||
131002976|NCT02107443|471636602|FG000|Overall Study|Withdrawal: Disease Progression|4|||
131002977|NCT02107443|471636603|FG001|Overall Study|Withdrawal: Disease Progression|2|||
131002978|NCT02107443|471636602|FG000|Overall Study|Withdrawal: Personal Issues|0|||
131002979|NCT02107443|471636603|FG001|Overall Study|Withdrawal: Personal Issues|3|||
131002980|NCT00333788|471636604|FG000|Overall Study|Adverse Event|44|||
131002981|NCT00333788|471636604|FG000|Overall Study|Lack of Efficacy|80|||
131002982|NCT00333788|471636604|FG000|Overall Study|Lost to Follow-up|2|||
131002983|NCT00333788|471636604|FG000|Overall Study|Withdrawal by Subject|24|||
131002984|NCT00333788|471636604|FG000|Overall Study|Other: Non-compliance|2|||
131002985|NCT00333788|471636604|FG000|Overall Study|Other: Moved|2|||
131002986|NCT00333788|471636604|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
131002987|NCT00333788|471636604|FG000|Overall Study|Other: Investigator decision|1|||
131100763|NCT04811131|471998090|FG001|Overall Study|Sponsor request|35|||
131100764|NCT04811131|471998091|FG002|Overall Study|Sponsor request|27|||
131100765|NCT04811131|471998092|FG003|Overall Study|Sponsor request|10|||
131100766|NCT04811131|471998089|FG000|Overall Study|Withdrawal by Subject|3|||
131002988|NCT00333788|471636604|FG000|Overall Study|Other: Quality of life concern|1|||
131002989|NCT00333788|471636604|FG000|Overall Study|Other: Sponsor decision|1|||
131002990|NCT00333788|471636604|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
131002991|NCT00333788|471636604|FG000|Overall Study|Other: Medical monitor decision|1|||
131002992|NCT00333788|471636604|FG000|Overall Study|Other: Physician decision|1|||
131002993|NCT00333788|471636604|FG000|Overall Study|Other: Signed consent for another study|1|||
131002994|NCT01563978|471636605|FG000|Overall Study|Physician Decision|1|||
131002995|NCT01563978|471636606|FG001|Overall Study|Physician Decision|0|||
131002996|NCT01563978|471636605|FG000|Overall Study|Lost to Follow-up|1|||
131002997|NCT01563978|471636606|FG001|Overall Study|Lost to Follow-up|0|||
131002998|NCT01563978|471636605|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
131002999|NCT01563978|471636606|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
131003000|NCT01563978|471636605|FG000|Overall Study|Adverse Event|1|||
131003001|NCT01563978|471636606|FG001|Overall Study|Adverse Event|2|||
131003002|NCT05764239|471636607|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
131003003|NCT05764239|471636607|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
131003004|NCT05764239|471636607|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
131003005|NCT05764239|471636607|FG000|DEP (Part 1)|Adverse Event|1|||
131003006|NCT05764239|471636607|FG000|DEP (Part 1)|Lost to Follow-up|1|||
131003007|NCT05764239|471636607|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
131003008|NCT05764239|471636607|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
131003009|NCT05764239|471636607|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
131003010|NCT05764239|471636607|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
131003011|NCT04562779|471636611|FG000|Overall Study|Lost to Follow-up|7|||
131003012|NCT04562779|471636612|FG001|Overall Study|Lost to Follow-up|5|||
131003013|NCT04562779|471636613|FG002|Overall Study|Lost to Follow-up|10|||
131003014|NCT04562779|471636611|FG000|Overall Study|Protocol Violation|2|||
131003015|NCT04562779|471636612|FG001|Overall Study|Protocol Violation|2|||
131003016|NCT04562779|471636613|FG002|Overall Study|Protocol Violation|0|||
131003017|NCT00333138|471636614|FG000|Core Study (6 Months)|Adverse Event|4|||
131003018|NCT00333138|471636615|FG001|Core Study (6 Months)|Adverse Event|5|||
131003019|NCT00333138|471636616|FG002|Core Study (6 Months)|Adverse Event|8|||
131003020|NCT00333138|471636614|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
131003021|NCT00333138|471636615|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
131003022|NCT00333138|471636616|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
131003023|NCT00333138|471636614|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
131003024|NCT00333138|471636615|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
131003025|NCT00333138|471636616|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
131003026|NCT00333138|471636614|FG000|Core Study (6 Months)|Protocol Violation|1|||
131003027|NCT00333138|471636615|FG001|Core Study (6 Months)|Protocol Violation|0|||
131003028|NCT00333138|471636616|FG002|Core Study (6 Months)|Protocol Violation|1|||
131003029|NCT00333138|471636614|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
131003030|NCT00333138|471636615|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
131003031|NCT00333138|471636616|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
131003032|NCT00333138|471636614|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
131003033|NCT00333138|471636615|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
131003034|NCT00333138|471636616|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
131003035|NCT00333138|471636614|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
131003036|NCT00333138|471636615|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
131003037|NCT00333138|471636616|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
131003038|NCT00333138|471636614|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
131100767|NCT04811131|471998090|FG001|Overall Study|Withdrawal by Subject|1|||
131003039|NCT00333138|471636615|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
131003040|NCT00333138|471636616|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
131003041|NCT00333138|471636614|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
131003042|NCT00333138|471636615|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
131003043|NCT00333138|471636616|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
131003044|NCT00333138|471636614|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
131003045|NCT00333138|471636615|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
131003046|NCT00333138|471636616|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
131003047|NCT00333138|471636614|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
131003048|NCT00333138|471636615|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
131003049|NCT00333138|471636616|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
131003050|NCT00333138|471636614|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
131003051|NCT00333138|471636615|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
131003052|NCT00333138|471636616|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
131003053|NCT00333138|471636614|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
131003054|NCT00333138|471636615|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
131003055|NCT00333138|471636616|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
131003056|NCT00333138|471636614|FG000|Extension Study (Month6 to End of Study)|Death|0|||
131003057|NCT00333138|471636615|FG001|Extension Study (Month6 to End of Study)|Death|1|||
131003058|NCT00333138|471636616|FG002|Extension Study (Month6 to End of Study)|Death|0|||
131003059|NCT02320721|471636617|FG000|Overall Study|Adverse Event|6|||
131003060|NCT02320721|471636618|FG001|Overall Study|Adverse Event|6|||
131003061|NCT02320721|471636617|FG000|Overall Study|Lack of Efficacy|2|||
131003062|NCT02320721|471636618|FG001|Overall Study|Lack of Efficacy|0|||
131003063|NCT02320721|471636617|FG000|Overall Study|Poor compliance to protocol|3|||
131003064|NCT02320721|471636618|FG001|Overall Study|Poor compliance to protocol|7|||
131003065|NCT02320721|471636617|FG000|Overall Study|Randomized but not treated|0|||
131003066|NCT02320721|471636618|FG001|Overall Study|Randomized but not treated|1|||
131003067|NCT02320721|471636617|FG000|Overall Study|Hypoglycemia|1|||
131003068|NCT02320721|471636618|FG001|Overall Study|Hypoglycemia|0|||
131003069|NCT02320721|471636617|FG000|Overall Study|Other than specified above|15|||
131003070|NCT02320721|471636618|FG001|Overall Study|Other than specified above|20|||
131003071|NCT04630756|471636619|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
131003072|NCT04630756|471636620|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
131003073|NCT04630756|471636621|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
131003074|NCT04131907|471636622|FG000|Overall Study|Adverse Event|2|||
131003075|NCT04131907|471636623|FG001|Overall Study|Adverse Event|0|||
131003076|NCT04131907|471636624|FG002|Overall Study|Adverse Event|0|||
131003077|NCT04131907|471636622|FG000|Overall Study|Physician Decision|4|||
131003078|NCT04131907|471636623|FG001|Overall Study|Physician Decision|22|||
131003079|NCT04131907|471636624|FG002|Overall Study|Physician Decision|0|||
131003080|NCT04131907|471636622|FG000|Overall Study|Withdrawal by Subject|2|||
131003081|NCT04131907|471636623|FG001|Overall Study|Withdrawal by Subject|0|||
131003082|NCT04131907|471636624|FG002|Overall Study|Withdrawal by Subject|1|||
131003083|NCT04131907|471636622|FG000|Overall Study|Treatment failure|2|||
131003084|NCT04131907|471636623|FG001|Overall Study|Treatment failure|0|||
131003085|NCT04131907|471636624|FG002|Overall Study|Treatment failure|1|||
131003086|NCT00847301|471636625|FG000|Overall Study|Adverse Event|35|||
131003087|NCT00847301|471636625|FG000|Overall Study|Switch to other anticoagulants|16|||
131003088|NCT00847301|471636625|FG000|Overall Study|Lost to Follow-up|1|||
131003089|NCT00847301|471636625|FG000|Overall Study|No prescription after hospital discharge|1|||
131003090|NCT00847301|471636625|FG000|Overall Study|Other reason not defined above|1|||
131003091|NCT05593211|471636626|FG000|Overall Study|Withdrawal by Subject|1|||
131003092|NCT01778062|471636627|FG000|Overall Study|Adverse Event|1|||
131003093|NCT01778062|471636628|FG001|Overall Study|Adverse Event|3|||
131003094|NCT01778062|471636627|FG000|Overall Study|Consent Withdrawal|1|||
131003095|NCT01778062|471636628|FG001|Overall Study|Consent Withdrawal|5|||
131003096|NCT01778062|471636627|FG000|Overall Study|major protocol deviation|4|||
131003097|NCT01778062|471636628|FG001|Overall Study|major protocol deviation|3|||
131003098|NCT03387514|471636629|FG000|Overall Study|Withdrawal by Subject|2|||
131003099|NCT03387514|471636629|FG000|Overall Study|Physician Decision|1|||
131003100|NCT03387514|471636629|FG000|Overall Study|Lost to Follow-up|2|||
131003101|NCT04445155|471636637|FG000|Overall Study|Lost to Follow-up|11|||
131003102|NCT04445155|471636638|FG001|Overall Study|Lost to Follow-up|2|||
131003103|NCT04445155|471636639|FG002|Overall Study|Lost to Follow-up|3|||
131003104|NCT04445155|471636640|FG003|Overall Study|Lost to Follow-up|0|||
131003105|NCT04445155|471636637|FG000|Overall Study|Withdrawal by Subject|8|||
131003106|NCT04445155|471636638|FG001|Overall Study|Withdrawal by Subject|0|||
131003107|NCT04445155|471636639|FG002|Overall Study|Withdrawal by Subject|0|||
131003108|NCT04445155|471636640|FG003|Overall Study|Withdrawal by Subject|0|||
131003109|NCT04445155|471636637|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
131003110|NCT04445155|471636638|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
131003111|NCT04445155|471636639|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
131003112|NCT04445155|471636640|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
131003113|NCT04445155|471636637|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
131003114|NCT04445155|471636638|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
131003115|NCT04445155|471636639|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
131003116|NCT04445155|471636640|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
131003117|NCT01388543|471636646|FG000|Day 14|Adverse Event|1|||
131003118|NCT01388543|471636647|FG001|Day 14|Adverse Event|4|||
131003119|NCT00394095|471638365|FG000|Screening|Withdrawal by Subject|1|||
131003120|NCT00394095|471638366|FG001|Screening|Withdrawal by Subject|0|||
131003121|NCT00394095|471638365|FG000|Randomized|Withdrawal by Subject|5|||
131003122|NCT00394095|471638366|FG001|Randomized|Withdrawal by Subject|1|||
131003123|NCT00394095|471638365|FG000|Randomized|Adverse Event|1|||
131003124|NCT00394095|471638366|FG001|Randomized|Adverse Event|1|||
131003125|NCT00394095|471638365|FG000|Randomized|Overdose|1|||
131003126|NCT00394095|471638366|FG001|Randomized|Overdose|0|||
131003127|NCT00394095|471638365|FG000|Randomized|Lost to Follow-up|1|||
131003128|NCT00394095|471638366|FG001|Randomized|Lost to Follow-up|2|||
131003129|NCT04213846|471638367|FG000|Overall Study|Withdrawal by Subject|7|||
131003130|NCT04213846|471638368|FG001|Overall Study|Withdrawal by Subject|6|||
131003131|NCT04213846|471638367|FG000|Overall Study|Lost to Follow-up|15|||
131003132|NCT04213846|471638368|FG001|Overall Study|Lost to Follow-up|21|||
131003133|NCT00802841|471638369|FG000|Overall Study|Administrative problems|1|||
131003134|NCT00802841|471638370|FG001|Overall Study|Administrative problems|0|||
131003135|NCT00802841|471638369|FG000|Overall Study|Lost to Follow-up|2|||
131003136|NCT00802841|471638370|FG001|Overall Study|Lost to Follow-up|1|||
131003137|NCT00802841|471638369|FG000|Overall Study|Death|1|||
131003138|NCT00802841|471638370|FG001|Overall Study|Death|2|||
131003139|NCT00802841|471638369|FG000|Overall Study|Adverse Event|8|||
131003140|NCT00802841|471638370|FG001|Overall Study|Adverse Event|2|||
131003141|NCT00802841|471638369|FG000|Overall Study|Disease progression|7|||
131003142|NCT00802841|471638370|FG001|Overall Study|Disease progression|3|||
131003143|NCT00802841|471638369|FG000|Overall Study|Withdrawal by Subject|9|||
131003144|NCT00802841|471638370|FG001|Overall Study|Withdrawal by Subject|5|||
131003145|NCT00802841|471638369|FG000|Overall Study|Protocol deviation|2|||
131003146|NCT00802841|471638370|FG001|Overall Study|Protocol deviation|6|||
131003147|NCT00802841|471638369|FG000|Overall Study|Treatment duration completed|66|||
131003148|NCT00802841|471638370|FG001|Overall Study|Treatment duration completed|76|||
131003149|NCT01115998|471638376|FG000|Overall Study|Lost to Follow-up|6|||
131003150|NCT01115998|471638377|FG001|Overall Study|Lost to Follow-up|6|||
131003151|NCT02819479|471638378|FG000|Overall Study|Adverse Event|2|||
131003152|NCT03531905|471638379|FG000|Overall Study|Withdrawal by Subject|3|||
131003153|NCT03531905|471638380|FG001|Overall Study|Withdrawal by Subject|3|||
131003154|NCT03531905|471638381|FG002|Overall Study|Withdrawal by Subject|2|||
131003155|NCT03531905|471638379|FG000|Overall Study|Lost to Follow-up|2|||
131003156|NCT03531905|471638380|FG001|Overall Study|Lost to Follow-up|2|||
131003157|NCT03531905|471638381|FG002|Overall Study|Lost to Follow-up|1|||
131003158|NCT03531905|471638379|FG000|Overall Study|Participant was out of town|1|||
131003159|NCT03531905|471638380|FG001|Overall Study|Participant was out of town|0|||
131003160|NCT03531905|471638381|FG002|Overall Study|Participant was out of town|0|||
131003161|NCT03531905|471638379|FG000|Overall Study|Could not speak with the participant|1|||
131003162|NCT03531905|471638380|FG001|Overall Study|Could not speak with the participant|0|||
131003163|NCT03531905|471638381|FG002|Overall Study|Could not speak with the participant|0|||
131003164|NCT01155726|471638389|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
131003165|NCT01155726|471638390|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
131003166|NCT01155726|471638391|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
131003167|NCT01155726|471638392|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
131003168|NCT01646320|471638393|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
131003169|NCT01646320|471638394|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
131003170|NCT01646320|471638393|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
131003171|NCT01646320|471638394|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
131003172|NCT01646320|471638393|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
131003173|NCT01646320|471638394|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
131003174|NCT01646320|471638393|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
131003175|NCT01646320|471638394|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
131003176|NCT01646320|471638393|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
131003177|NCT01646320|471638394|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
131003178|NCT01646320|471638393|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
131003179|NCT01646320|471638394|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
131003180|NCT01646320|471638393|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
131003181|NCT01646320|471638394|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
131003182|NCT01646320|471638393|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
131003183|NCT01646320|471638394|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
131003184|NCT01646320|471638393|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
131003185|NCT01646320|471638394|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
131003186|NCT01646320|471638393|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
131003187|NCT01646320|471638394|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
131003188|NCT01646320|471638393|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
131003189|NCT01646320|471638394|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
131003190|NCT01489020|471638395|FG000|Overall Study|Withdrawal by Subject|1|||
131003191|NCT01489020|471638396|FG001|Overall Study|Withdrawal by Subject|0|||
131003192|NCT01489020|471638397|FG002|Overall Study|Withdrawal by Subject|0|||
131003193|NCT01489020|471638398|FG003|Overall Study|Withdrawal by Subject|0|||
131003194|NCT01489020|471638399|FG004|Overall Study|Withdrawal by Subject|0|||
131003195|NCT01489020|471638400|FG005|Overall Study|Withdrawal by Subject|0|||
131003196|NCT01489020|471638395|FG000|Overall Study|Adverse Event|0|||
131003197|NCT01489020|471638396|FG001|Overall Study|Adverse Event|0|||
131003198|NCT01489020|471638397|FG002|Overall Study|Adverse Event|3|||
131003199|NCT01489020|471638398|FG003|Overall Study|Adverse Event|0|||
131003200|NCT01489020|471638399|FG004|Overall Study|Adverse Event|3|||
131003201|NCT01489020|471638400|FG005|Overall Study|Adverse Event|0|||
131003202|NCT01489020|471638395|FG000|Overall Study|Concomitant disease|0|||
131003203|NCT01489020|471638396|FG001|Overall Study|Concomitant disease|0|||
131003204|NCT01489020|471638397|FG002|Overall Study|Concomitant disease|0|||
131003205|NCT01489020|471638398|FG003|Overall Study|Concomitant disease|0|||
131003206|NCT01489020|471638399|FG004|Overall Study|Concomitant disease|3|||
131003207|NCT01489020|471638400|FG005|Overall Study|Concomitant disease|0|||
131003208|NCT01174550|471638401|FG000|Overall Study|Death|75|||
131003209|NCT01174550|471638402|FG001|Overall Study|Death|74|||
131003210|NCT01174550|471638401|FG000|Overall Study|Lost to Follow-up|652|||
131003211|NCT01174550|471638402|FG001|Overall Study|Lost to Follow-up|510|||
131003212|NCT01174550|471638401|FG000|Overall Study|Withdrawal by Subject|543|||
131003213|NCT01174550|471638402|FG001|Overall Study|Withdrawal by Subject|289|||
131003214|NCT01536262|471638403|FG000|Overall Study|Adverse Event|6|||
131003215|NCT01536262|471638404|FG001|Overall Study|Adverse Event|1|||
131003216|NCT01536262|471638405|FG002|Overall Study|Adverse Event|2|||
131003217|NCT01536262|471638403|FG000|Overall Study|Withdrawal by Subject|1|||
131003218|NCT01536262|471638404|FG001|Overall Study|Withdrawal by Subject|1|||
131003219|NCT01536262|471638405|FG002|Overall Study|Withdrawal by Subject|0|||
131003220|NCT01536262|471638403|FG000|Overall Study|Other than stated above|1|||
131003221|NCT01536262|471638404|FG001|Overall Study|Other than stated above|0|||
131003222|NCT01536262|471638405|FG002|Overall Study|Other than stated above|0|||
131003223|NCT05257837|471638409|FG000|Overall Study|Excluded (did not find the guns)|4|||
131003224|NCT05257837|471638410|FG001|Overall Study|Excluded (did not find the guns)|2|||
131003225|NCT05257837|471638411|FG002|Overall Study|Excluded (did not find the guns)|4|||
131003226|NCT05257837|471638412|FG003|Overall Study|Excluded (did not find the guns)|0|||
131003227|NCT01625338|471638413|FG000|Overall Study|Enrolled but not Treated|0|||
131003228|NCT01625338|471638414|FG001|Overall Study|Enrolled but not Treated|0|||
131003229|NCT01625338|471638415|FG002|Overall Study|Enrolled but not Treated|1|||
131003230|NCT01625338|471638413|FG000|Overall Study|Efficacy Failure|27|||
131003231|NCT01625338|471638414|FG001|Overall Study|Efficacy Failure|39|||
131003232|NCT01625338|471638415|FG002|Overall Study|Efficacy Failure|31|||
131003233|NCT01625338|471638413|FG000|Overall Study|Lost to Follow-up|3|||
131003234|NCT01625338|471638414|FG001|Overall Study|Lost to Follow-up|3|||
131003235|NCT01625338|471638415|FG002|Overall Study|Lost to Follow-up|2|||
131003236|NCT01625338|471638413|FG000|Overall Study|Investigator Decision|0|||
131003237|NCT01625338|471638414|FG001|Overall Study|Investigator Decision|2|||
131003238|NCT01625338|471638415|FG002|Overall Study|Investigator Decision|1|||
131003239|NCT01625338|471638413|FG000|Overall Study|Subject Withdrew Consent|1|||
131003240|NCT01625338|471638414|FG001|Overall Study|Subject Withdrew Consent|0|||
131003241|NCT01625338|471638415|FG002|Overall Study|Subject Withdrew Consent|2|||
131003242|NCT01625338|471638413|FG000|Overall Study|Adverse Event|1|||
131003243|NCT01625338|471638414|FG001|Overall Study|Adverse Event|0|||
131003244|NCT01625338|471638415|FG002|Overall Study|Adverse Event|1|||
131003245|NCT01625338|471638413|FG000|Overall Study|Study Discontinued by Sponsor|0|||
131003246|NCT01625338|471638414|FG001|Overall Study|Study Discontinued by Sponsor|0|||
131003247|NCT01625338|471638415|FG002|Overall Study|Study Discontinued by Sponsor|1|||
131003248|NCT01781611|471638416|FG000|Overall Study|Adverse Event|4|||
131003249|NCT01781611|471638417|FG001|Overall Study|Adverse Event|0|||
131003250|NCT03639675|471638418|FG000|Overall Study|Withdrawal by Subject|1|||
131003251|NCT02459587|471638419|FG000|3-Month Follow-up Assessment|Death|0|||
131003252|NCT02459587|471638420|FG001|3-Month Follow-up Assessment|Death|2|||
131003253|NCT02459587|471638419|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
131003254|NCT02459587|471638420|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
131100768|NCT04811131|471998091|FG002|Overall Study|Withdrawal by Subject|3|||
131003255|NCT02459587|471638419|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
131100769|NCT04811131|471998092|FG003|Overall Study|Withdrawal by Subject|1|||
131003256|NCT02459587|471638420|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
131003257|NCT02459587|471638419|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
131003258|NCT02459587|471638420|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
131003259|NCT02459587|471638419|FG000|6-month Follow-up Assessment|Death|2|||
131003260|NCT02459587|471638420|FG001|6-month Follow-up Assessment|Death|1|||
131003261|NCT02459587|471638419|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
131003262|NCT02459587|471638420|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
131003263|NCT02459587|471638419|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
131003264|NCT02459587|471638420|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
131003265|NCT02459587|471638419|FG000|12-month Follow-up Assessment|Death|2|||
131003266|NCT02459587|471638420|FG001|12-month Follow-up Assessment|Death|0|||
131003267|NCT02459587|471638419|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
131003268|NCT02459587|471638420|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
131003269|NCT02459587|471638419|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
131003270|NCT02459587|471638420|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
131003271|NCT02459587|471638419|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
131003272|NCT02459587|471638420|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
131003273|NCT01021332|471638421|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
131003274|NCT01021332|471638421|FG000|Overall Study|Adverse Event|43|||
131003275|NCT01021332|471638421|FG000|Overall Study|Lack of Efficacy|19|||
131003276|NCT01021332|471638421|FG000|Overall Study|Withdrawal of Consent|23|||
131003277|NCT01021332|471638421|FG000|Overall Study|Lost to Follow-up|4|||
131003278|NCT01021332|471638421|FG000|Overall Study|Protocol Violation|9|||
131003279|NCT01021332|471638421|FG000|Overall Study|Miscellaneous|3|||
131003280|NCT03487666|471638424|FG000|Overall Study|Disease progression|4|||
131100770|NCT00371683|471998094|FG000|DB Treatment Period-Randomized Patients|Death|1|||
131100771|NCT00371683|471998095|FG001|DB Treatment Period-Randomized Patients|Death|1|||
131003281|NCT03487666|471638425|FG001|Overall Study|Disease progression|2|||
131003282|NCT03487666|471638426|FG002|Overall Study|Disease progression|0|||
131003283|NCT03487666|471638424|FG000|Overall Study|Adverse Event|0|||
131003284|NCT03487666|471638425|FG001|Overall Study|Adverse Event|0|||
131003285|NCT03487666|471638426|FG002|Overall Study|Adverse Event|1|||
131003286|NCT00031447|471638427|FG000|Overall Study|Lost to Follow-up|0|||
131003287|NCT00031447|471638428|FG001|Overall Study|Lost to Follow-up|1|||
131003288|NCT00031447|471638427|FG000|Overall Study|Non-compliant|1|||
131003289|NCT00031447|471638428|FG001|Overall Study|Non-compliant|1|||
131003290|NCT00031447|471638427|FG000|Overall Study|Re-activation of Disease|2|||
131003291|NCT00031447|471638428|FG001|Overall Study|Re-activation of Disease|1|||
131003292|NCT00031447|471638427|FG000|Overall Study|Disruption of blinded study drug supply|7|||
131003293|NCT00031447|471638428|FG001|Overall Study|Disruption of blinded study drug supply|4|||
131003294|NCT01636362|471638429|FG000|Overall Study|Physician Decision|6|||
131003295|NCT01636362|471638429|FG000|Overall Study|Subject healed, not returning|1|||
131003296|NCT01636362|471638429|FG000|Overall Study|Withdrawal by Subject|1|||
131003297|NCT03302910|471638431|FG000|Overall Study|Protocol Violation|1|||
131003298|NCT03302910|471638432|FG001|Overall Study|Protocol Violation|0|||
131003299|NCT01477749|471638433|FG000|Overall Study|Physician Decision|4|||
131003300|NCT02886728|471638435|FG000|Overall Study|Withdrew Consent|31|||
131003301|NCT02886728|471638436|FG001|Overall Study|Withdrew Consent|13|||
131003302|NCT02886728|471638437|FG002|Overall Study|Withdrew Consent|11|||
131003303|NCT02886728|471638438|FG003|Overall Study|Withdrew Consent|47|||
131003304|NCT02886728|471638435|FG000|Overall Study|Lost to Follow-up|12|||
131003305|NCT02886728|471638436|FG001|Overall Study|Lost to Follow-up|6|||
131003306|NCT02886728|471638437|FG002|Overall Study|Lost to Follow-up|13|||
131003307|NCT02886728|471638438|FG003|Overall Study|Lost to Follow-up|12|||
131003308|NCT02886728|471638435|FG000|Overall Study|Adverse Event|13|||
131003309|NCT02886728|471638436|FG001|Overall Study|Adverse Event|5|||
131003310|NCT02886728|471638437|FG002|Overall Study|Adverse Event|5|||
131003311|NCT02886728|471638438|FG003|Overall Study|Adverse Event|11|||
131003312|NCT02886728|471638435|FG000|Overall Study|Investigator's Discretion|11|||
131003313|NCT02886728|471638436|FG001|Overall Study|Investigator's Discretion|7|||
131003314|NCT02886728|471638437|FG002|Overall Study|Investigator's Discretion|5|||
131003315|NCT02886728|471638438|FG003|Overall Study|Investigator's Discretion|11|||
131003316|NCT02886728|471638435|FG000|Overall Study|Death|3|||
131003317|NCT02886728|471638436|FG001|Overall Study|Death|1|||
131003318|NCT02886728|471638437|FG002|Overall Study|Death|0|||
131003319|NCT02886728|471638438|FG003|Overall Study|Death|0|||
131003320|NCT02886728|471638435|FG000|Overall Study|Protocol Violation|0|||
131003321|NCT02886728|471638436|FG001|Overall Study|Protocol Violation|0|||
131003322|NCT02886728|471638437|FG002|Overall Study|Protocol Violation|0|||
131003323|NCT02886728|471638438|FG003|Overall Study|Protocol Violation|4|||
131003324|NCT02886728|471638435|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131003325|NCT02886728|471638436|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131003326|NCT02886728|471638437|FG002|Overall Study|Non-Compliance with Study Drug|1|||
131003327|NCT02886728|471638438|FG003|Overall Study|Non-Compliance with Study Drug|0|||
131003328|NCT02886728|471638435|FG000|Overall Study|Pregnancy|0|||
131003329|NCT02886728|471638436|FG001|Overall Study|Pregnancy|0|||
131003330|NCT02886728|471638437|FG002|Overall Study|Pregnancy|1|||
131003331|NCT02886728|471638438|FG003|Overall Study|Pregnancy|0|||
131003332|NCT02886728|471638435|FG000|Overall Study|Randomized but Not Dosed|1|||
131003333|NCT02886728|471638436|FG001|Overall Study|Randomized but Not Dosed|0|||
131003334|NCT02886728|471638437|FG002|Overall Study|Randomized but Not Dosed|0|||
131003335|NCT02886728|471638438|FG003|Overall Study|Randomized but Not Dosed|2|||
131003336|NCT04990440|471638449|FG000|Overall Study|Sponsor's Decision|0|||
131003337|NCT04990440|471638450|FG001|Overall Study|Sponsor's Decision|0|||
131003338|NCT04990440|471638451|FG002|Overall Study|Sponsor's Decision|1|||
131003339|NCT03712098|471638452|FG000|Overall Study|Lost to Follow-up|3|||
131003340|NCT03712098|471638453|FG001|Overall Study|Lost to Follow-up|7|||
131003341|NCT03712098|471638452|FG000|Overall Study|Withdrawal by Subject|9|||
131003342|NCT03712098|471638453|FG001|Overall Study|Withdrawal by Subject|4|||
131003343|NCT03712098|471638452|FG000|Overall Study|Protocol Violation|2|||
131003344|NCT03712098|471638453|FG001|Overall Study|Protocol Violation|1|||
131003345|NCT00724061|471638454|FG000|Dose Escalation Phase|Adverse Event|2|||
131003346|NCT00724061|471638454|FG000|Dose Escalation Phase|Disease Progression|3|||
131003347|NCT00953160|471638457|FG000|Overall Study|Lost to Follow-up|23|||
131003348|NCT00953160|471638457|FG000|Overall Study|Withdrawal by Subject|4|||
131003349|NCT00425503|471638460|FG000|Overall Study|Adverse Event|2|||
131003350|NCT00425503|471638460|FG000|Overall Study|Protocol Violation|1|||
131003351|NCT02118714|471638461|FG000|Overall Study|Lost to Follow-up|2|||
131003352|NCT02118714|471638461|FG000|Overall Study|Protocol Violation|1|||
131003353|NCT02954575|471638462|FG000|Overall Study|Withdrawal by Subject|2|||
131003354|NCT02954575|471638462|FG000|Overall Study|Adverse Event|1|||
131003355|NCT01066156|471638464|FG000|Overall Study|ineligible|2|||
131003356|NCT01066156|471638464|FG000|Overall Study|Lost to Follow-up|7|||
131003357|NCT01066156|471638464|FG000|Overall Study|Withdrawal by Subject|1|||
131003358|NCT03890120|471638468|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
131003359|NCT03890120|471638469|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
131003360|NCT03890120|471638470|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
131003361|NCT03890120|471638471|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
131003362|NCT03890120|471638468|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
131003363|NCT03890120|471638469|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
131003364|NCT03890120|471638470|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
131100772|NCT00371683|471998094|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
131100773|NCT00371683|471998095|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
131100774|NCT00371683|471998094|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
131100775|NCT00371683|471998095|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
131100776|NCT00371683|471998094|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
131003365|NCT03890120|471638471|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
131003366|NCT03890120|471638468|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
131003367|NCT03890120|471638469|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
131003368|NCT03890120|471638470|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
131003369|NCT03890120|471638471|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
131003370|NCT03890120|471638468|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
131003371|NCT03890120|471638469|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
131003372|NCT03890120|471638470|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
131003373|NCT03890120|471638471|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
131003374|NCT03890120|471638468|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
131003375|NCT03890120|471638469|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
131003376|NCT03890120|471638470|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
131003377|NCT03890120|471638471|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
131003378|NCT03890120|471638468|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
131003379|NCT03890120|471638469|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
131003380|NCT03890120|471638470|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
131003381|NCT03890120|471638471|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
131003382|NCT03890120|471638468|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
131003383|NCT03890120|471638469|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
131003384|NCT03890120|471638470|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
131003385|NCT03890120|471638471|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
131003386|NCT03890120|471638468|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
131003387|NCT03890120|471638469|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
131003388|NCT03890120|471638470|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
131003389|NCT03890120|471638471|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
131003390|NCT03890120|471638468|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
131003391|NCT03890120|471638469|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
131003392|NCT03890120|471638470|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
131003393|NCT03890120|471638471|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
131003394|NCT03890120|471638468|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
131003395|NCT03890120|471638469|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
131003396|NCT03890120|471638470|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
131003397|NCT03890120|471638471|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
131003398|NCT03890120|471638468|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
131003399|NCT03890120|471638469|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
131003400|NCT03890120|471638470|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
131003401|NCT03890120|471638471|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
131003402|NCT03890120|471638468|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
131003403|NCT03890120|471638469|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
131003404|NCT03890120|471638470|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
131003405|NCT03890120|471638471|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
131003406|NCT03890120|471638468|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
131003407|NCT03890120|471638469|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
131003408|NCT03890120|471638470|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
131003409|NCT03890120|471638471|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
131003410|NCT02400307|471638472|FG000|Overall Study|Enrolled and Never Dosed|1|||
131003411|NCT02400307|471638473|FG001|Overall Study|Enrolled and Never Dosed|0|||
131003412|NCT02015663|471638475|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
131003413|NCT02015663|471638476|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
131003414|NCT02015663|471638475|FG000|Overall Study|Withdrawal by Subject|1|||
131003415|NCT02015663|471638476|FG001|Overall Study|Withdrawal by Subject|0|||
131003416|NCT02015663|471638475|FG000|Overall Study|Protocol Violation|0|||
131003417|NCT02015663|471638476|FG001|Overall Study|Protocol Violation|1|||
131003418|NCT02015663|471638475|FG000|Overall Study|Adverse Event|3|||
131003419|NCT02015663|471638476|FG001|Overall Study|Adverse Event|0|||
131003420|NCT02015663|471638475|FG000|Overall Study|Administrative problems|10|||
131003421|NCT02015663|471638476|FG001|Overall Study|Administrative problems|11|||
131003422|NCT00479674|471638477|FG000|Overall Study|Adverse Event|18|||
131003423|NCT00479674|471638477|FG000|Overall Study|Withdrawal by Subject|6|||
131003424|NCT00479674|471638477|FG000|Overall Study|Physician Decision|14|||
131003425|NCT00479674|471638477|FG000|Overall Study|none provided|3|||
131003426|NCT00146640|471638481|FG000|Overall Study|Adverse Event|12|||
131003427|NCT00146640|471638482|FG001|Overall Study|Adverse Event|10|||
131003428|NCT00146640|471638481|FG000|Overall Study|Medical Reasons|3|||
131003429|NCT00146640|471638482|FG001|Overall Study|Medical Reasons|0|||
131003430|NCT00146640|471638481|FG000|Overall Study|Non-Medical Reasons|8|||
131003431|NCT00146640|471638482|FG001|Overall Study|Non-Medical Reasons|4|||
131003432|NCT02839681|471638485|FG000|Overall Study|Death|2|||
131003433|NCT02687919|471638486|FG000|Overall Study|Withdrawal by Subject|6|||
131003434|NCT02687919|471638487|FG001|Overall Study|Withdrawal by Subject|6|||
131003435|NCT02687919|471638486|FG000|Overall Study|Protocol Violation|2|||
131003436|NCT02687919|471638487|FG001|Overall Study|Protocol Violation|0|||
131003437|NCT01656759|471638488|FG000|Overall Study|Protocol Violation|2|||
131003438|NCT01656759|471638489|FG001|Overall Study|Protocol Violation|3|||
131003439|NCT00131911|471638497|FG000|Overall Study|Withdrawal by Subject|1|||
131003440|NCT00131911|471638498|FG001|Overall Study|Withdrawal by Subject|0|||
131003441|NCT00329303|471638499|FG000|Overall Study|Lack of Efficacy|1|||
131003442|NCT00329303|471638500|FG001|Overall Study|Lack of Efficacy|0|||
131003443|NCT00329303|471638499|FG000|Overall Study|Decision of the sponsor|0|||
131003444|NCT00329303|471638500|FG001|Overall Study|Decision of the sponsor|1|||
131003445|NCT00329303|471638499|FG000|Overall Study|Patient no longer available|1|||
131003446|NCT00329303|471638500|FG001|Overall Study|Patient no longer available|0|||
131003447|NCT00329303|471638499|FG000|Overall Study|Patient relocated|0|||
131003448|NCT00329303|471638500|FG001|Overall Study|Patient relocated|1|||
131003449|NCT02335268|471638505|FG000|Overall Study|Physician Decision|5|||
131003450|NCT02335268|471638506|FG001|Overall Study|Physician Decision|1|||
131003451|NCT02335268|471638505|FG000|Overall Study|Lack of Efficacy|2|||
131003452|NCT02335268|471638506|FG001|Overall Study|Lack of Efficacy|1|||
131003453|NCT02335268|471638505|FG000|Overall Study|Adverse Event|5|||
131003454|NCT02335268|471638506|FG001|Overall Study|Adverse Event|2|||
131003455|NCT02335268|471638505|FG000|Overall Study|increase blasts|2|||
131003456|NCT02335268|471638506|FG001|Overall Study|increase blasts|0|||
131003457|NCT02335268|471638505|FG000|Overall Study|Withdrawal by Subject|3|||
131003458|NCT02335268|471638506|FG001|Overall Study|Withdrawal by Subject|2|||
131003459|NCT02431533|471638507|FG000|Overall Study|Withdrawal by Subject|1|||
131003460|NCT02431533|471638508|FG001|Overall Study|Withdrawal by Subject|3|||
131003461|NCT02431533|471638507|FG000|Overall Study|Developed Exclusionary criteria|1|||
131003462|NCT02431533|471638508|FG001|Overall Study|Developed Exclusionary criteria|0|||
131003463|NCT04951479|471638510|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
131003464|NCT00729690|471638511|FG000|Overall Study|IT Catheter Malfunction|0|||
131003465|NCT00729690|471638512|FG001|Overall Study|IT Catheter Malfunction|2|||
131003466|NCT00729690|471638513|FG002|Overall Study|IT Catheter Malfunction|2|||
131003467|NCT02886936|471638519|FG000|Overall Study|Lost to Follow-up|4|||
131003468|NCT02886936|471638520|FG001|Overall Study|Lost to Follow-up|3|||
131003469|NCT02886936|471638521|FG002|Overall Study|Lost to Follow-up|0|||
131003470|NCT00245011|471638526|FG000|Overall Study|Lack of Efficacy|1|||
131003471|NCT02353832|471638531|FG000|Overall Study|Ineligible after enrollment|1|||
131003472|NCT02353832|471638531|FG000|Overall Study|Lost to Follow-up|1|||
131003473|NCT00777803|471640066|FG000|Overall Study|Lost to Follow-up|12|||
131003474|NCT00777803|471640067|FG001|Overall Study|Lost to Follow-up|5|||
131003475|NCT00777803|471640066|FG000|Overall Study|Adverse Event|1|||
131003476|NCT00777803|471640067|FG001|Overall Study|Adverse Event|0|||
131003477|NCT00777803|471640066|FG000|Overall Study|Non-compliance|2|||
131003478|NCT00777803|471640067|FG001|Overall Study|Non-compliance|2|||
131003479|NCT00731042|471640068|FG000|Second Intervention|Did not meet inclusion criteria|0|||
131003480|NCT00731042|471640069|FG001|Second Intervention|Did not meet inclusion criteria|2|||
131003481|NCT04423393|471640070|FG000|Overall Study|Withdrawal by Subject|0|||
131003482|NCT04423393|471640071|FG001|Overall Study|Withdrawal by Subject|0|||
131003483|NCT04423393|471640072|FG002|Overall Study|Withdrawal by Subject|0|||
131003484|NCT04423393|471640073|FG003|Overall Study|Withdrawal by Subject|0|||
131003485|NCT04423393|471640074|FG004|Overall Study|Withdrawal by Subject|0|||
131003486|NCT04423393|471640075|FG005|Overall Study|Withdrawal by Subject|1|||
131003487|NCT04423393|471640076|FG006|Overall Study|Withdrawal by Subject|0|||
131003488|NCT04423393|471640077|FG007|Overall Study|Withdrawal by Subject|0|||
131003489|NCT04423393|471640078|FG008|Overall Study|Withdrawal by Subject|0|||
131003490|NCT04423393|471640079|FG009|Overall Study|Withdrawal by Subject|0|||
131003491|NCT04423393|471640080|FG010|Overall Study|Withdrawal by Subject|0|||
131003492|NCT04423393|471640081|FG011|Overall Study|Withdrawal by Subject|0|||
131003493|NCT04423393|471640082|FG012|Overall Study|Withdrawal by Subject|0|||
131003494|NCT04423393|471640083|FG013|Overall Study|Withdrawal by Subject|1|||
131003495|NCT04423393|471640084|FG014|Overall Study|Withdrawal by Subject|0|||
131003496|NCT04423393|471640085|FG015|Overall Study|Withdrawal by Subject|0|||
131003497|NCT04423393|471640086|FG016|Overall Study|Withdrawal by Subject|0|||
131003498|NCT04423393|471640087|FG017|Overall Study|Withdrawal by Subject|0|||
131003499|NCT04423393|471640070|FG000|Overall Study|Sponsor Decision|0|||
131003500|NCT04423393|471640071|FG001|Overall Study|Sponsor Decision|0|||
131003501|NCT04423393|471640072|FG002|Overall Study|Sponsor Decision|0|||
131003502|NCT04423393|471640073|FG003|Overall Study|Sponsor Decision|0|||
131003503|NCT04423393|471640074|FG004|Overall Study|Sponsor Decision|0|||
131003504|NCT04423393|471640075|FG005|Overall Study|Sponsor Decision|0|||
131003505|NCT04423393|471640076|FG006|Overall Study|Sponsor Decision|0|||
131003506|NCT04423393|471640077|FG007|Overall Study|Sponsor Decision|0|||
131003507|NCT04423393|471640078|FG008|Overall Study|Sponsor Decision|0|||
131003508|NCT04423393|471640079|FG009|Overall Study|Sponsor Decision|0|||
131003509|NCT04423393|471640080|FG010|Overall Study|Sponsor Decision|0|||
131003510|NCT04423393|471640081|FG011|Overall Study|Sponsor Decision|0|||
131003511|NCT04423393|471640082|FG012|Overall Study|Sponsor Decision|0|||
131003512|NCT04423393|471640083|FG013|Overall Study|Sponsor Decision|1|||
131003513|NCT04423393|471640084|FG014|Overall Study|Sponsor Decision|0|||
131003514|NCT04423393|471640085|FG015|Overall Study|Sponsor Decision|0|||
131003515|NCT04423393|471640086|FG016|Overall Study|Sponsor Decision|0|||
131003516|NCT04423393|471640087|FG017|Overall Study|Sponsor Decision|0|||
131003517|NCT02692235|471640090|FG000|Overall Study|Withdrawal by Subject|2|||
131003518|NCT02692235|471640091|FG001|Overall Study|Withdrawal by Subject|1|||
131003519|NCT02692235|471640090|FG000|Overall Study|Adverse Event|1|||
131003520|NCT02692235|471640091|FG001|Overall Study|Adverse Event|2|||
131003521|NCT02711995|471640092|FG000|Washout (90 Days)|Conflicting medication|1|||
131003522|NCT01268059|471640096|FG000|Overall Study|Lost to Follow-up|0|||
131003523|NCT01268059|471640097|FG001|Overall Study|Lost to Follow-up|1|||
131003524|NCT01268059|471640098|FG002|Overall Study|Lost to Follow-up|0|||
131003525|NCT01268059|471640099|FG003|Overall Study|Lost to Follow-up|0|||
131003526|NCT01268059|471640096|FG000|Overall Study|Withdrawal by Subject|7|||
131003527|NCT01268059|471640097|FG001|Overall Study|Withdrawal by Subject|4|||
131003528|NCT01268059|471640098|FG002|Overall Study|Withdrawal by Subject|0|||
131003529|NCT01268059|471640099|FG003|Overall Study|Withdrawal by Subject|0|||
131003530|NCT01268059|471640096|FG000|Overall Study|Death|20|||
131003531|NCT01268059|471640097|FG001|Overall Study|Death|30|||
131003532|NCT01268059|471640098|FG002|Overall Study|Death|3|||
131003533|NCT01268059|471640099|FG003|Overall Study|Death|5|||
131003534|NCT01268059|471640096|FG000|Overall Study|Progression of disease|1|||
131003535|NCT01268059|471640097|FG001|Overall Study|Progression of disease|0|||
131003536|NCT01268059|471640098|FG002|Overall Study|Progression of disease|0|||
131003537|NCT01268059|471640099|FG003|Overall Study|Progression of disease|0|||
131003538|NCT03850444|471640100|FG000|Overall Study|Adverse Event|16|||
131003539|NCT03850444|471640101|FG001|Overall Study|Adverse Event|10|||
131003540|NCT03850444|471640100|FG000|Overall Study|Death|87|||
131003541|NCT03850444|471640101|FG001|Overall Study|Death|107|||
131003542|NCT03850444|471640100|FG000|Overall Study|Lost to Follow-up|1|||
131003543|NCT03850444|471640101|FG001|Overall Study|Lost to Follow-up|1|||
131003544|NCT03850444|471640100|FG000|Overall Study|Withdrawal by Subject|1|||
131003545|NCT03850444|471640101|FG001|Overall Study|Withdrawal by Subject|5|||
131003546|NCT03850444|471640100|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
131003547|NCT03850444|471640101|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
131003548|NCT01598987|471640102|FG000|Baseline to Month 12|Administrative problems|2|||
131003549|NCT01598987|471640102|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
131003550|NCT01598987|471640102|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
131003551|NCT01598987|471640102|FG000|Baseline to 24 Month|Administrative problems|2|||
131003552|NCT01598987|471640102|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
131003553|NCT02107274|471640103|FG000|Treatment vs. Placebo|Adverse Event|3|||
131003554|NCT02107274|471640104|FG001|Treatment vs. Placebo|Adverse Event|0|||
131003555|NCT02107274|471640103|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
131003556|NCT02107274|471640104|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
131003557|NCT02107274|471640103|FG000|Control Phase|Lost to Follow-up|1|||
131003558|NCT02107274|471640104|FG001|Control Phase|Lost to Follow-up|1|||
131003559|NCT02107274|471640103|FG000|Control Phase|Death|2|||
131003560|NCT02107274|471640104|FG001|Control Phase|Death|0|||
131003561|NCT02107274|471640103|FG000|Control Phase|Adverse Event|0|||
131003562|NCT02107274|471640104|FG001|Control Phase|Adverse Event|1|||
131100777|NCT00371683|471998095|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
131100778|NCT00371683|471998094|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
131100779|NCT00371683|471998095|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
131100780|NCT00371683|471998094|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
131100781|NCT00371683|471998095|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
131100782|NCT00371683|471998094|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
131100783|NCT00371683|471998095|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
131100784|NCT00371683|471998094|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
131100785|NCT00371683|471998095|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
131100786|NCT00371683|471998094|FG000|Follow-Up Period - Randomized Patients|Death|0|||
131100787|NCT00371683|471998095|FG001|Follow-Up Period - Randomized Patients|Death|2|||
131003563|NCT01036087|471640106|FG000|Overall Study|Adverse Event|2|||
131003564|NCT01036087|471640106|FG000|Overall Study|Lack of Efficacy|1|||
131003565|NCT01021878|471640110|FG000|Overall Study|Lost to Follow-up|4|||
131003566|NCT01021878|471640111|FG001|Overall Study|Lost to Follow-up|3|||
131003567|NCT01021878|471640110|FG000|Overall Study|Death|0|||
131003568|NCT01021878|471640111|FG001|Overall Study|Death|1|||
131003569|NCT01021878|471640110|FG000|Overall Study|Adverse Event|6|||
131003570|NCT01021878|471640111|FG001|Overall Study|Adverse Event|5|||
131003571|NCT01021878|471640110|FG000|Overall Study|Transplantation|6|||
131003572|NCT01021878|471640111|FG001|Overall Study|Transplantation|1|||
131003573|NCT02424344|471640112|FG000|Overall Study|Lack of Efficacy|0|||
131003574|NCT02424344|471640113|FG001|Overall Study|Lack of Efficacy|1|||
131003575|NCT02424344|471640112|FG000|Overall Study|Withdrawal by Subject|2|||
131003576|NCT02424344|471640113|FG001|Overall Study|Withdrawal by Subject|1|||
131003577|NCT02424344|471640112|FG000|Overall Study|Lost to Follow-up|1|||
131003578|NCT02424344|471640113|FG001|Overall Study|Lost to Follow-up|0|||
131003579|NCT02424344|471640112|FG000|Overall Study|Adverse Event|4|||
131003580|NCT02424344|471640113|FG001|Overall Study|Adverse Event|8|||
131100788|NCT00371683|471998094|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
131100789|NCT00371683|471998095|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
131100790|NCT00371683|471998094|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
131003581|NCT01460381|471640114|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
131100791|NCT00371683|471998095|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
131003582|NCT01460381|471640115|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
131003583|NCT00519779|471640117|FG000|Overall Study|Withdrawal by Subject|0|||
131003584|NCT00519779|471640118|FG001|Overall Study|Withdrawal by Subject|1|||
131003585|NCT02059161|471640127|FG000|Overall Study|Pregnancy|0|||
131003586|NCT02059161|471640128|FG001|Overall Study|Pregnancy|2|||
131003587|NCT02059161|471640127|FG000|Overall Study|Adverse Event|2|||
131003588|NCT02059161|471640128|FG001|Overall Study|Adverse Event|6|||
131003589|NCT02059161|471640127|FG000|Overall Study|Lost to Follow-up|20|||
131003590|NCT02059161|471640128|FG001|Overall Study|Lost to Follow-up|12|||
131003591|NCT02059161|471640127|FG000|Overall Study|Physician Decision|4|||
131003592|NCT02059161|471640128|FG001|Overall Study|Physician Decision|4|||
131003593|NCT02059161|471640127|FG000|Overall Study|Protocol Violation|1|||
131003594|NCT02059161|471640128|FG001|Overall Study|Protocol Violation|1|||
131003595|NCT02059161|471640127|FG000|Overall Study|Withdrawal by Subject|16|||
131003596|NCT02059161|471640128|FG001|Overall Study|Withdrawal by Subject|13|||
131100792|NCT03181789|471998096|FG000|Overall Study|Withdrawal by Subject|0|||
131100793|NCT03181789|471998097|FG001|Overall Study|Withdrawal by Subject|1|||
131100794|NCT03181789|471998098|FG002|Overall Study|Withdrawal by Subject|1|||
131100795|NCT03181789|471998099|FG003|Overall Study|Withdrawal by Subject|0|||
131100796|NCT03181789|471998096|FG000|Overall Study|Lost to Follow-up|7|||
131100797|NCT03181789|471998097|FG001|Overall Study|Lost to Follow-up|1|||
131100798|NCT03181789|471998098|FG002|Overall Study|Lost to Follow-up|0|||
131100799|NCT03181789|471998099|FG003|Overall Study|Lost to Follow-up|0|||
131100800|NCT03181789|471998096|FG000|Overall Study|Participant unable to adhere to visit|0|||
131003597|NCT02059161|471640127|FG000|Overall Study|Randomized in error, no study drug|0|||
131003598|NCT02059161|471640128|FG001|Overall Study|Randomized in error, no study drug|1|||
131003599|NCT02059161|471640127|FG000|Overall Study|Non-compliance with study drug|6|||
131003600|NCT02059161|471640128|FG001|Overall Study|Non-compliance with study drug|2|||
131003601|NCT03293485|471640130|FG000|Overall Study|Death|1|||
131003602|NCT03293485|471640130|FG000|Overall Study|Screen Failure|2|||
131003603|NCT03293485|471640130|FG000|Overall Study|Withdrawal by Subject|2|||
131003604|NCT01723826|471640134|FG000|Overall Study|Adverse Event|4|||
131003605|NCT01723826|471640135|FG001|Overall Study|Adverse Event|1|||
131003606|NCT01723826|471640136|FG002|Overall Study|Adverse Event|4|||
131003607|NCT01723826|471640137|FG003|Overall Study|Adverse Event|5|||
131003608|NCT01723826|471640134|FG000|Overall Study|Death according to AE eCRF|2|||
131003609|NCT01723826|471640135|FG001|Overall Study|Death according to AE eCRF|3|||
131003610|NCT01723826|471640136|FG002|Overall Study|Death according to AE eCRF|3|||
131003611|NCT01723826|471640137|FG003|Overall Study|Death according to AE eCRF|7|||
131003612|NCT01723826|471640134|FG000|Overall Study|Lost to Follow-up|1|||
131003613|NCT01723826|471640135|FG001|Overall Study|Lost to Follow-up|3|||
131003614|NCT01723826|471640136|FG002|Overall Study|Lost to Follow-up|1|||
131003615|NCT01723826|471640137|FG003|Overall Study|Lost to Follow-up|1|||
131003616|NCT01723826|471640134|FG000|Overall Study|Non-compliance|0|||
131003617|NCT01723826|471640135|FG001|Overall Study|Non-compliance|1|||
131003618|NCT01723826|471640136|FG002|Overall Study|Non-compliance|3|||
131003619|NCT01723826|471640137|FG003|Overall Study|Non-compliance|3|||
131003620|NCT01723826|471640134|FG000|Overall Study|Non-compliance With Study Drug|0|||
131003621|NCT01723826|471640135|FG001|Overall Study|Non-compliance With Study Drug|1|||
131003622|NCT01723826|471640136|FG002|Overall Study|Non-compliance With Study Drug|0|||
131003623|NCT01723826|471640137|FG003|Overall Study|Non-compliance With Study Drug|0|||
131003624|NCT01723826|471640134|FG000|Overall Study|Other Reason|8|||
131003625|NCT01723826|471640135|FG001|Overall Study|Other Reason|6|||
131003626|NCT01723826|471640136|FG002|Overall Study|Other Reason|12|||
131003627|NCT01723826|471640137|FG003|Overall Study|Other Reason|14|||
131003628|NCT01723826|471640134|FG000|Overall Study|Physician Decision|1|||
131003629|NCT01723826|471640135|FG001|Overall Study|Physician Decision|3|||
131003630|NCT01723826|471640136|FG002|Overall Study|Physician Decision|4|||
131003631|NCT01723826|471640137|FG003|Overall Study|Physician Decision|11|||
131003632|NCT01723826|471640134|FG000|Overall Study|Protocol Violation|1|||
131003633|NCT01723826|471640135|FG001|Overall Study|Protocol Violation|1|||
131003634|NCT01723826|471640136|FG002|Overall Study|Protocol Violation|3|||
131003635|NCT01723826|471640137|FG003|Overall Study|Protocol Violation|1|||
131003636|NCT01723826|471640134|FG000|Overall Study|Withdrawal by Subject|10|||
131003637|NCT01723826|471640135|FG001|Overall Study|Withdrawal by Subject|17|||
131003638|NCT01723826|471640136|FG002|Overall Study|Withdrawal by Subject|27|||
131003639|NCT01723826|471640137|FG003|Overall Study|Withdrawal by Subject|48|||
131003640|NCT02408549|471640140|FG000|Overall Study|Adverse Event|15|||
131003641|NCT02408549|471640140|FG000|Overall Study|Death|4|||
131003642|NCT02408549|471640140|FG000|Overall Study|Lack of Efficacy|17|||
131003643|NCT02408549|471640140|FG000|Overall Study|Protocol Violation|4|||
131003644|NCT02408549|471640140|FG000|Overall Study|Lost to Follow-up|6|||
131003645|NCT02408549|471640140|FG000|Overall Study|Consent withdrawn|30|||
131003646|NCT02408549|471640140|FG000|Overall Study|Neurology research program closing at site|1|||
131003647|NCT02408549|471640140|FG000|Overall Study|Site closure|1|||
131100801|NCT03181789|471998097|FG001|Overall Study|Participant unable to adhere to visit|1|||
131100802|NCT03181789|471998098|FG002|Overall Study|Participant unable to adhere to visit|0|||
131003648|NCT02408549|471640140|FG000|Overall Study|Pregnancy|1|||
131003649|NCT02408549|471640140|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
131003650|NCT02408549|471640140|FG000|Overall Study|Subject moved to another place, far from site|1|||
131003651|NCT02408549|471640140|FG000|Overall Study|Study terminated at site|1|||
131003652|NCT01272011|471640141|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
131003653|NCT01272011|471640142|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
131003654|NCT01272011|471640143|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
131003655|NCT01627340|471640144|FG000|Overall Study|Adverse Event|1|||
131003656|NCT01627340|471640145|FG001|Overall Study|Adverse Event|0|||
131003657|NCT01627340|471640144|FG000|Overall Study|Lost to Follow-up|8|||
131003658|NCT01627340|471640145|FG001|Overall Study|Lost to Follow-up|4|||
131003659|NCT01627340|471640144|FG000|Overall Study|Pregnancy|1|||
131003660|NCT01627340|471640145|FG001|Overall Study|Pregnancy|0|||
131100803|NCT03181789|471998099|FG003|Overall Study|Participant unable to adhere to visit|0|||
131003661|NCT01627340|471640144|FG000|Overall Study|Withdrawal by Subject|2|||
131003662|NCT01627340|471640145|FG001|Overall Study|Withdrawal by Subject|0|||
131003663|NCT01657032|471640146|FG000|Overall Study|Lost to Follow-up|0|||
131003664|NCT01657032|471640147|FG001|Overall Study|Lost to Follow-up|7|||
131003665|NCT03633903|471640148|FG000|Overall Study|Withdrawal by Subject|1|||
131003666|NCT03633903|471640149|FG001|Overall Study|Withdrawal by Subject|2|||
131003667|NCT03633903|471640148|FG000|Overall Study|Lost to Follow-up|5|||
131003668|NCT03633903|471640149|FG001|Overall Study|Lost to Follow-up|5|||
131100804|NCT02624791|471998100|FG000|Overall Study|Withdrawal by Subject|2|||
131100805|NCT02624791|471998101|FG001|Overall Study|Withdrawal by Subject|0|||
131100806|NCT02624791|471998102|FG002|Overall Study|Withdrawal by Subject|0|||
131100807|NCT02624791|471998103|FG003|Overall Study|Withdrawal by Subject|0|||
131100808|NCT02624791|471998104|FG004|Overall Study|Withdrawal by Subject|0|||
131100809|NCT02624791|471998105|FG005|Overall Study|Withdrawal by Subject|0|||
131100810|NCT01146782|471998111|FG000|Screening Cohort|Screen Failure|187|||
131100811|NCT01146782|471998111|FG000|Screening Cohort|Lost to Follow-up|4|||
131100812|NCT01146782|471998111|FG000|Screening Cohort|Physician Decision|1|||
131100813|NCT01146782|471998111|FG000|Screening Cohort|Withdrawal by Subject|29|||
131100814|NCT01146782|471998111|FG000|Safety Cohort|Screen Failure|61|||
131100815|NCT01146782|471998111|FG000|Safety Cohort|Withdrawal by Subject|4|||
131100816|NCT01146782|471998111|FG000|Safety Cohort|Control AHI <5|4|||
131100817|NCT01146782|471998111|FG000|Safety Cohort|TST <4 hrs|14|||
131100818|NCT01146782|471998111|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
131100819|NCT01146782|471998111|FG000|Primary Endpoint Cohort|Physician Decision|1|||
131100820|NCT02656329|471998112|FG000|Overall Study|Lost to Follow-up|2|||
131100821|NCT02656329|471998113|FG001|Overall Study|Lost to Follow-up|3|||
131100822|NCT02656329|471998112|FG000|Overall Study|Withdrawal by Subject|7|||
131100823|NCT02656329|471998113|FG001|Overall Study|Withdrawal by Subject|6|||
131100824|NCT02656329|471998112|FG000|Overall Study|Study termination by Sponsor|150|||
131100825|NCT02656329|471998113|FG001|Overall Study|Study termination by Sponsor|142|||
131100826|NCT02656329|471998112|FG000|Overall Study|Other than specified above|5|||
131100827|NCT02656329|471998113|FG001|Overall Study|Other than specified above|6|||
131100828|NCT01139580|471998114|FG000|Overall Study|Adverse Event|5|||
131100829|NCT01139580|471998115|FG001|Overall Study|Adverse Event|4|||
131003669|NCT01925170|471640151|FG000|Overall Study|Unverified cancer status|53|||
131003670|NCT01077024|471640152|FG000|Overall Study|Lost to Follow-up|20|||
131003671|NCT01077024|471640153|FG001|Overall Study|Lost to Follow-up|14|||
131003672|NCT01077024|471640152|FG000|Overall Study|Withdrawal by Subject|0|||
131003673|NCT01077024|471640153|FG001|Overall Study|Withdrawal by Subject|2|||
131003674|NCT01077024|471640152|FG000|Overall Study|Incarcerated|7|||
131003675|NCT01077024|471640153|FG001|Overall Study|Incarcerated|8|||
131003676|NCT01077024|471640152|FG000|Overall Study|Other|4|||
131003677|NCT01077024|471640153|FG001|Overall Study|Other|4|||
131003678|NCT03379233|471640154|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
131003679|NCT03379233|471640155|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
131003680|NCT01603121|471640156|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
131003681|NCT01603121|471640157|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
131003682|NCT02300311|471640160|FG000|Overall Study|Other than the reason specified|1|||
131003683|NCT02300311|471640161|FG001|Overall Study|Other than the reason specified|0|||
131003684|NCT02300311|471640160|FG000|Overall Study|Refused to continue taking medication|18|||
131003685|NCT02300311|471640161|FG001|Overall Study|Refused to continue taking medication|0|||
131003686|NCT00419003|471640162|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
131003687|NCT00419003|471640163|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
131003688|NCT00419003|471640162|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
131003689|NCT00419003|471640163|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
131003690|NCT02531438|471640164|FG000|Overall Study|Adverse Event|7|||
131003691|NCT02531438|471640165|FG001|Overall Study|Adverse Event|9|||
131003692|NCT02531438|471640164|FG000|Overall Study|Lost to Follow-up|0|||
131003693|NCT02531438|471640165|FG001|Overall Study|Lost to Follow-up|3|||
131003694|NCT02531438|471640164|FG000|Overall Study|Withdrawal by Subject|7|||
131003695|NCT02531438|471640165|FG001|Overall Study|Withdrawal by Subject|8|||
131003696|NCT02531438|471640164|FG000|Overall Study|Physician Decision|0|||
131003697|NCT02531438|471640165|FG001|Overall Study|Physician Decision|1|||
131003698|NCT02531438|471640164|FG000|Overall Study|Death|6|||
131003699|NCT02531438|471640165|FG001|Overall Study|Death|3|||
131003700|NCT02531438|471640164|FG000|Overall Study|Randomized, but Not Treated|4|||
131003701|NCT02531438|471640165|FG001|Overall Study|Randomized, but Not Treated|0|||
131003702|NCT02531438|471640164|FG000|Overall Study|Missed EOT/PTE Visit|5|||
131003703|NCT02531438|471640165|FG001|Overall Study|Missed EOT/PTE Visit|2|||
131003704|NCT02531438|471640164|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
131003705|NCT02531438|471640165|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
131003706|NCT00772928|471640166|FG000|Overall Study|Lost to Follow-up|9|||
131003707|NCT00772928|471640167|FG001|Overall Study|Lost to Follow-up|6|||
131003708|NCT00772928|471640166|FG000|Overall Study|Protocol Violation|10|||
131100830|NCT01139580|471998114|FG000|Overall Study|Lost to Follow-up|9|||
131100831|NCT01139580|471998115|FG001|Overall Study|Lost to Follow-up|1|||
131003709|NCT00772928|471640167|FG001|Overall Study|Protocol Violation|12|||
131003710|NCT00772928|471640166|FG000|Overall Study|Withdrawal by Subject|25|||
131003711|NCT00772928|471640167|FG001|Overall Study|Withdrawal by Subject|22|||
131003712|NCT00772928|471640166|FG000|Overall Study|Did not receive vaccine|0|||
131003713|NCT00772928|471640167|FG001|Overall Study|Did not receive vaccine|1|||
131003714|NCT00801242|471640168|FG000|Overall Study|Adverse Event|10|||
131003715|NCT00801242|471640168|FG000|Overall Study|Withdrawal by Subject|13|||
131003716|NCT00801242|471640168|FG000|Overall Study|Protocol Violation|5|||
131003717|NCT00801242|471640168|FG000|Overall Study|Physician Decision|3|||
131003718|NCT00801242|471640168|FG000|Overall Study|Lost to Follow-up|1|||
131003719|NCT00801242|471640168|FG000|Overall Study|Miscellaneous reasons|20|||
131003720|NCT02015195|471640169|FG000|Overall Study|Adverse Event|0|||
131003721|NCT02015195|471640170|FG001|Overall Study|Adverse Event|0|||
131003722|NCT02015195|471640171|FG002|Overall Study|Adverse Event|0|||
131003723|NCT02015195|471640172|FG003|Overall Study|Adverse Event|1|||
131003724|NCT02015195|471640173|FG004|Overall Study|Adverse Event|0|||
131003725|NCT02015195|471640174|FG005|Overall Study|Adverse Event|0|||
131003726|NCT02015195|471640175|FG006|Overall Study|Adverse Event|0|||
131003727|NCT01318811|471640176|FG000|Overall Study|Physician Decision|1|||
131003728|NCT01318811|471640177|FG001|Overall Study|Physician Decision|1|||
131003729|NCT01318811|471640176|FG000|Overall Study|CRRT stopped for head CT|0|||
131003730|NCT01318811|471640177|FG001|Overall Study|CRRT stopped for head CT|1|||
131003731|NCT01318811|471640176|FG000|Overall Study|Death|0|||
131003732|NCT01318811|471640177|FG001|Overall Study|Death|1|||
131003733|NCT01318811|471640176|FG000|Overall Study|CRRT stopped for head MRI|0|||
131003734|NCT01318811|471640177|FG001|Overall Study|CRRT stopped for head MRI|1|||
131003735|NCT00811187|471640178|FG000|Overall Study|Unable to place device / procedure abort|3|||
131003736|NCT00811187|471640179|FG001|Overall Study|Unable to place device / procedure abort|3|||
131003737|NCT00994279|471640182|FG000|Overall Study|Withdrawal by Subject|2|||
131003738|NCT00994279|471640183|FG001|Overall Study|Withdrawal by Subject|2|||
131003739|NCT00994279|471640182|FG000|Overall Study|Toxicity|1|||
131003740|NCT00994279|471640183|FG001|Overall Study|Toxicity|0|||
131003741|NCT00994279|471640182|FG000|Overall Study|Multiple reasons|1|||
131003742|NCT00994279|471640183|FG001|Overall Study|Multiple reasons|3|||
131003743|NCT01606189|471640184|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
131003744|NCT01606189|471640185|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
131003745|NCT01606189|471640186|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
131003746|NCT01606189|471640187|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
131003747|NCT01606189|471640188|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
131003748|NCT01606189|471640189|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
131003749|NCT01606189|471640184|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
131003750|NCT01606189|471640185|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
131003751|NCT01606189|471640186|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
131003752|NCT01606189|471640187|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
131003753|NCT01606189|471640188|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
131003754|NCT01606189|471640189|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
131003755|NCT00162942|471640190|FG000|Overall Study|Adverse Event|10|||
131003756|NCT00162942|471640191|FG001|Overall Study|Adverse Event|6|||
131003757|NCT00162942|471640190|FG000|Overall Study|Death|1|||
131003758|NCT00162942|471640191|FG001|Overall Study|Death|0|||
131003759|NCT00162942|471640190|FG000|Overall Study|Withdrawal by Subject|3|||
131003760|NCT00162942|471640191|FG001|Overall Study|Withdrawal by Subject|6|||
131003761|NCT00162942|471640190|FG000|Overall Study|Physician Decision|1|||
131003762|NCT00162942|471640191|FG001|Overall Study|Physician Decision|0|||
131100832|NCT01139580|471998114|FG000|Overall Study|Lack of Efficacy|0|||
131100833|NCT01139580|471998115|FG001|Overall Study|Lack of Efficacy|2|||
131100834|NCT01139580|471998114|FG000|Overall Study|Withdrawal by Subject|6|||
131003763|NCT00162942|471640190|FG000|Overall Study|Enter Open-Label Study|76|||
131003764|NCT00162942|471640191|FG001|Overall Study|Enter Open-Label Study|35|||
131003765|NCT00162942|471640190|FG000|Overall Study|Alternate Therapy|6|||
131003766|NCT00162942|471640191|FG001|Overall Study|Alternate Therapy|2|||
131003767|NCT00162942|471640190|FG000|Overall Study|Lack of Efficacy|1|||
131003768|NCT00162942|471640191|FG001|Overall Study|Lack of Efficacy|0|||
131003769|NCT00162942|471640190|FG000|Overall Study|Flare During Active Treatment|7|||
131100835|NCT01139580|471998115|FG001|Overall Study|Withdrawal by Subject|9|||
131003770|NCT00162942|471640191|FG001|Overall Study|Flare During Active Treatment|3|||
131003771|NCT00162942|471640190|FG000|Overall Study|2 or more consecutive treatments missed|1|||
131003772|NCT00162942|471640191|FG001|Overall Study|2 or more consecutive treatments missed|0|||
131003773|NCT02162732|471640192|FG000|Overall Study|Biopsy not performed.|18|||
131003774|NCT01167023|471640193|FG000|Overall Study|Lost to Follow-up|0|||
131003775|NCT01167023|471640194|FG001|Overall Study|Lost to Follow-up|1|||
131003776|NCT01167023|471640195|FG002|Overall Study|Lost to Follow-up|1|||
131003777|NCT01167023|471640193|FG000|Overall Study|Screen Failure|0|||
131003778|NCT01167023|471640194|FG001|Overall Study|Screen Failure|1|||
131003779|NCT01167023|471640195|FG002|Overall Study|Screen Failure|0|||
131100836|NCT01139580|471998114|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
131003780|NCT01167023|471640193|FG000|Overall Study|Sponsor Decision|0|||
131003781|NCT01167023|471640194|FG001|Overall Study|Sponsor Decision|1|||
131003782|NCT01167023|471640195|FG002|Overall Study|Sponsor Decision|0|||
131003783|NCT01167023|471640193|FG000|Overall Study|Withdrawal by Subject|0|||
131003784|NCT01167023|471640194|FG001|Overall Study|Withdrawal by Subject|0|||
131003785|NCT01167023|471640195|FG002|Overall Study|Withdrawal by Subject|1|||
131003786|NCT00410384|471640196|FG000|Overall Study|Withdrawal by Subject|28|||
131003787|NCT00410384|471640197|FG001|Overall Study|Withdrawal by Subject|17|||
131003788|NCT00410384|471640198|FG002|Overall Study|Withdrawal by Subject|20|||
131003789|NCT00410384|471640196|FG000|Overall Study|Adverse Event|23|||
131003790|NCT00410384|471640197|FG001|Overall Study|Adverse Event|18|||
131003791|NCT00410384|471640198|FG002|Overall Study|Adverse Event|23|||
131003792|NCT00410384|471640196|FG000|Overall Study|Lack of Efficacy|20|||
131003793|NCT00410384|471640197|FG001|Overall Study|Lack of Efficacy|12|||
131003794|NCT00410384|471640198|FG002|Overall Study|Lack of Efficacy|17|||
131003795|NCT00410384|471640196|FG000|Overall Study|Lack of Compliance|2|||
131003796|NCT00410384|471640197|FG001|Overall Study|Lack of Compliance|2|||
131003797|NCT00410384|471640198|FG002|Overall Study|Lack of Compliance|2|||
131003798|NCT00410384|471640196|FG000|Overall Study|Lost to Follow-up|4|||
131003799|NCT00410384|471640197|FG001|Overall Study|Lost to Follow-up|6|||
131003800|NCT00410384|471640198|FG002|Overall Study|Lost to Follow-up|6|||
131003801|NCT00410384|471640196|FG000|Overall Study|Protocol Violation|6|||
131003802|NCT00410384|471640197|FG001|Overall Study|Protocol Violation|6|||
131003803|NCT00410384|471640198|FG002|Overall Study|Protocol Violation|6|||
131003804|NCT00410384|471640196|FG000|Overall Study|Physician Decision|3|||
131003805|NCT00410384|471640197|FG001|Overall Study|Physician Decision|3|||
131003806|NCT00410384|471640198|FG002|Overall Study|Physician Decision|4|||
131003807|NCT00410384|471640196|FG000|Overall Study|Other|3|||
131003808|NCT00410384|471640197|FG001|Overall Study|Other|8|||
131003809|NCT00410384|471640198|FG002|Overall Study|Other|4|||
131003810|NCT01253200|471640201|FG000|Overall Study|Death|1|||
131003811|NCT01253200|471640202|FG001|Overall Study|Death|0|||
131003812|NCT01253200|471640203|FG002|Overall Study|Death|0|||
131003813|NCT01253200|471640204|FG003|Overall Study|Death|0|||
131003814|NCT01253200|471640205|FG004|Overall Study|Death|0|||
131003815|NCT01253200|471640201|FG000|Overall Study|Lost to Follow-up|1|||
131003816|NCT01253200|471640202|FG001|Overall Study|Lost to Follow-up|1|||
131003817|NCT01253200|471640203|FG002|Overall Study|Lost to Follow-up|0|||
131003818|NCT01253200|471640204|FG003|Overall Study|Lost to Follow-up|0|||
131003819|NCT01253200|471640205|FG004|Overall Study|Lost to Follow-up|0|||
131003820|NCT01253200|471640201|FG000|Overall Study|Withdrawal by Subject|2|||
131003821|NCT01253200|471640202|FG001|Overall Study|Withdrawal by Subject|0|||
131003822|NCT01253200|471640203|FG002|Overall Study|Withdrawal by Subject|0|||
131003823|NCT01253200|471640204|FG003|Overall Study|Withdrawal by Subject|0|||
131003824|NCT01253200|471640205|FG004|Overall Study|Withdrawal by Subject|0|||
131003825|NCT01253200|471640201|FG000|Overall Study|Protocol Violation|1|||
131003826|NCT01253200|471640202|FG001|Overall Study|Protocol Violation|4|||
131003827|NCT01253200|471640203|FG002|Overall Study|Protocol Violation|0|||
131003828|NCT01253200|471640204|FG003|Overall Study|Protocol Violation|0|||
131003829|NCT01253200|471640205|FG004|Overall Study|Protocol Violation|5|||
131003830|NCT01253200|471640201|FG000|Overall Study|intents|10|||
131003831|NCT01253200|471640202|FG001|Overall Study|intents|10|||
131003832|NCT01253200|471640203|FG002|Overall Study|intents|1|||
131003833|NCT01253200|471640204|FG003|Overall Study|intents|3|||
131003834|NCT01253200|471640205|FG004|Overall Study|intents|0|||
131003835|NCT01253200|471640201|FG000|Overall Study|Attempts|6|||
131003836|NCT01253200|471640202|FG001|Overall Study|Attempts|4|||
131003837|NCT01253200|471640203|FG002|Overall Study|Attempts|1|||
131003838|NCT01253200|471640204|FG003|Overall Study|Attempts|2|||
131003839|NCT01253200|471640205|FG004|Overall Study|Attempts|0|||
131003840|NCT02049437|471640206|FG000|Period 1|Adverse Event|1|||
131003841|NCT02049437|471640207|FG001|Period 1|Adverse Event|1|||
131003842|NCT02049437|471640206|FG000|Period 1|Adverse Event|1|||
131003843|NCT02049437|471640207|FG001|Period 1|Adverse Event|0|||
131003844|NCT04529538|471640208|FG000|Overall Study|Lost to Follow-up|3|||
131003845|NCT04529538|471640209|FG001|Overall Study|Lost to Follow-up|2|||
131003846|NCT04529538|471640210|FG002|Overall Study|Lost to Follow-up|1|||
131003847|NCT04529538|471640211|FG003|Overall Study|Lost to Follow-up|0|||
131003848|NCT04529538|471640212|FG004|Overall Study|Lost to Follow-up|1|||
131003849|NCT04529538|471640213|FG005|Overall Study|Lost to Follow-up|1|||
131003850|NCT04529538|471640214|FG006|Overall Study|Lost to Follow-up|2|||
131003851|NCT04529538|471640215|FG007|Overall Study|Lost to Follow-up|0|||
131003852|NCT04529538|471640208|FG000|Overall Study|Not eligible at enrollment|0|||
131003853|NCT04529538|471640209|FG001|Overall Study|Not eligible at enrollment|1|||
131003854|NCT04529538|471640210|FG002|Overall Study|Not eligible at enrollment|2|||
131003855|NCT04529538|471640211|FG003|Overall Study|Not eligible at enrollment|1|||
131003856|NCT04529538|471640212|FG004|Overall Study|Not eligible at enrollment|0|||
131003857|NCT04529538|471640213|FG005|Overall Study|Not eligible at enrollment|0|||
131003858|NCT04529538|471640214|FG006|Overall Study|Not eligible at enrollment|0|||
131003859|NCT04529538|471640215|FG007|Overall Study|Not eligible at enrollment|1|||
131003860|NCT04529538|471640208|FG000|Overall Study|Withdrawal by Subject|0|||
131003861|NCT04529538|471640209|FG001|Overall Study|Withdrawal by Subject|1|||
131003862|NCT04529538|471640210|FG002|Overall Study|Withdrawal by Subject|1|||
131003863|NCT04529538|471640211|FG003|Overall Study|Withdrawal by Subject|2|||
131003864|NCT04529538|471640212|FG004|Overall Study|Withdrawal by Subject|0|||
131003865|NCT04529538|471640213|FG005|Overall Study|Withdrawal by Subject|2|||
131003866|NCT04529538|471640214|FG006|Overall Study|Withdrawal by Subject|3|||
131003867|NCT04529538|471640215|FG007|Overall Study|Withdrawal by Subject|0|||
131003868|NCT04529538|471640208|FG000|Overall Study|Other|0|||
131003869|NCT04529538|471640209|FG001|Overall Study|Other|1|||
131003870|NCT04529538|471640210|FG002|Overall Study|Other|0|||
131003871|NCT04529538|471640211|FG003|Overall Study|Other|0|||
131100837|NCT01139580|471998115|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
131100838|NCT01139580|471998114|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
131100839|NCT01139580|471998115|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
131100840|NCT01139580|471998114|FG000|Overall Study|Misrandomized|1|||
131100841|NCT01139580|471998115|FG001|Overall Study|Misrandomized|0|||
131003872|NCT04529538|471640212|FG004|Overall Study|Other|0|||
131003873|NCT04529538|471640213|FG005|Overall Study|Other|0|||
131003874|NCT04529538|471640214|FG006|Overall Study|Other|0|||
131003875|NCT04529538|471640215|FG007|Overall Study|Other|0|||
131003876|NCT04529538|471640208|FG000|Overall Study|Adverse Event|0|||
131003877|NCT04529538|471640209|FG001|Overall Study|Adverse Event|0|||
131003878|NCT04529538|471640210|FG002|Overall Study|Adverse Event|0|||
131003879|NCT04529538|471640211|FG003|Overall Study|Adverse Event|1|||
131003880|NCT04529538|471640212|FG004|Overall Study|Adverse Event|0|||
131003881|NCT04529538|471640213|FG005|Overall Study|Adverse Event|0|||
131003882|NCT04529538|471640214|FG006|Overall Study|Adverse Event|0|||
131003883|NCT04529538|471640215|FG007|Overall Study|Adverse Event|0|||
131003884|NCT04529538|471640208|FG000|Overall Study|Protocol Deviation|0|||
131003885|NCT04529538|471640209|FG001|Overall Study|Protocol Deviation|0|||
131003886|NCT04529538|471640210|FG002|Overall Study|Protocol Deviation|0|||
131003887|NCT04529538|471640211|FG003|Overall Study|Protocol Deviation|1|||
131003888|NCT04529538|471640212|FG004|Overall Study|Protocol Deviation|0|||
131003889|NCT04529538|471640213|FG005|Overall Study|Protocol Deviation|0|||
131003890|NCT04529538|471640214|FG006|Overall Study|Protocol Deviation|0|||
131003891|NCT04529538|471640215|FG007|Overall Study|Protocol Deviation|0|||
131003892|NCT04529538|471640208|FG000|Overall Study|Physician Decision|0|||
131003893|NCT04529538|471640209|FG001|Overall Study|Physician Decision|0|||
131003894|NCT04529538|471640210|FG002|Overall Study|Physician Decision|0|||
131003895|NCT04529538|471640211|FG003|Overall Study|Physician Decision|0|||
131003896|NCT04529538|471640212|FG004|Overall Study|Physician Decision|0|||
131003897|NCT04529538|471640213|FG005|Overall Study|Physician Decision|1|||
131003898|NCT04529538|471640214|FG006|Overall Study|Physician Decision|0|||
131003899|NCT04529538|471640215|FG007|Overall Study|Physician Decision|1|||
131003900|NCT03473756|471640218|FG000|Overall Study|Withdrawal by Subject|1|||
131003901|NCT03473756|471640219|FG001|Overall Study|Withdrawal by Subject|4|||
131003902|NCT03473756|471640218|FG000|Overall Study|Adverse Event|6|||
131003903|NCT03473756|471640219|FG001|Overall Study|Adverse Event|7|||
131003904|NCT03473756|471640218|FG000|Overall Study|Lack of Efficacy|3|||
131003905|NCT03473756|471640219|FG001|Overall Study|Lack of Efficacy|10|||
131003906|NCT03473756|471640218|FG000|Overall Study|Physician Decision|0|||
131003907|NCT03473756|471640219|FG001|Overall Study|Physician Decision|2|||
131003908|NCT03473756|471640218|FG000|Overall Study|End of study treatment|0|||
131003909|NCT03473756|471640219|FG001|Overall Study|End of study treatment|2|||
131003910|NCT03473756|471640218|FG000|Overall Study|Lost to Follow-up|0|||
131003911|NCT03473756|471640219|FG001|Overall Study|Lost to Follow-up|1|||
131003912|NCT02148718|471640220|FG000|Overall Study|Protocol Violation|26|||
131003913|NCT02148718|471640220|FG000|Overall Study|Discontinued Study Prematurely|5|||
131003914|NCT02192359|471640225|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
131003915|NCT02192359|471640226|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
131003916|NCT02192359|471640227|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
131003917|NCT02192359|471640228|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
131003918|NCT02192359|471640225|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
131003919|NCT02192359|471640226|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
130884856|NCT00790842|471213219|FG003|Dose Level 4|Physician Decision|0|||
131003920|NCT02192359|471640227|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
131003921|NCT02192359|471640228|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
131003922|NCT02192359|471640225|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
131003923|NCT02192359|471640226|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
131003924|NCT02192359|471640227|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
131003925|NCT02192359|471640228|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
131003926|NCT01213173|471640229|FG000|Overall Study|Protocol Violation|2|||
131003927|NCT01213173|471640230|FG001|Overall Study|Protocol Violation|0|||
131003928|NCT01213173|471640229|FG000|Overall Study|Adverse Event|4|||
131003929|NCT01213173|471640230|FG001|Overall Study|Adverse Event|8|||
131003930|NCT01213173|471640229|FG000|Overall Study|Withdrawal by Subject|5|||
131003931|NCT01213173|471640230|FG001|Overall Study|Withdrawal by Subject|5|||
131003932|NCT01213173|471640229|FG000|Overall Study|Incorrect Enrollment|1|||
131003933|NCT01213173|471640230|FG001|Overall Study|Incorrect Enrollment|3|||
131003934|NCT04880161|471640231|FG000|Overall Study|Withdrawal by Subject|1|||
131003935|NCT04880161|471640232|FG001|Overall Study|Withdrawal by Subject|0|||
131003936|NCT04880161|471640231|FG000|Overall Study|Lack of Compliance|1|||
131003937|NCT04880161|471640232|FG001|Overall Study|Lack of Compliance|1|||
131003938|NCT04880161|471640231|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
131003939|NCT04880161|471640232|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
131003940|NCT04880161|471640231|FG000|Overall Study|Screen Failure|0|||
131003941|NCT04880161|471640232|FG001|Overall Study|Screen Failure|1|||
131003942|NCT02892409|471641809|FG000|Overall Study|Adverse Event|1|||
131003943|NCT02892409|471641810|FG001|Overall Study|Adverse Event|0|||
131003944|NCT02892409|471641809|FG000|Overall Study|Withdrawal by Subject|2|||
131003945|NCT02892409|471641810|FG001|Overall Study|Withdrawal by Subject|1|||
131003946|NCT02123966|471641813|FG000|Overall Study|Intercurrent Illness|1|||
131003947|NCT01333943|471641817|FG000|Overall Study|Known neuropathy|1|||
131003948|NCT01333943|471641818|FG001|Overall Study|Known neuropathy|0|||
131003949|NCT01511536|471641825|FG000|Phase 1|Other|0|||
131003950|NCT01511536|471641826|FG001|Phase 1|Other|1|||
131003951|NCT01511536|471641827|FG002|Phase 1|Other|0|||
131003952|NCT01511536|471641825|FG000|Phase 2|Other|0|||
131003953|NCT01511536|471641826|FG001|Phase 2|Other|0|||
131003954|NCT01511536|471641827|FG002|Phase 2|Other|9|||
131003955|NCT00765362|471641831|FG000|Overall Study|Death|9|||
131003956|NCT00765362|471641831|FG000|Overall Study|Adverse Event|2|||
131003957|NCT00765362|471641831|FG000|Overall Study|Protocol Violation|18|||
131003958|NCT00765362|471641831|FG000|Overall Study|Withdrawal by Subject|13|||
131003959|NCT00765362|471641831|FG000|Overall Study|Lost to Follow-up|95|||
131003960|NCT03019458|471641835|FG000|Overall Study|Death|0|||
131003961|NCT03019458|471641836|FG001|Overall Study|Death|1|||
131003962|NCT00557505|471641837|FG000|Overall Study|Death|0|||
131003963|NCT00557505|471641838|FG001|Overall Study|Death|0|||
131003964|NCT00557505|471641839|FG002|Overall Study|Death|0|||
131003965|NCT00557505|471641840|FG003|Overall Study|Death|0|||
131003966|NCT00557505|471641841|FG004|Overall Study|Death|0|||
131003967|NCT00557505|471641842|FG005|Overall Study|Death|0|||
131003968|NCT00557505|471641843|FG006|Overall Study|Death|0|||
131003969|NCT00557505|471641844|FG007|Overall Study|Death|0|||
131003970|NCT00557505|471641845|FG008|Overall Study|Death|1|||
131003971|NCT00557505|471641837|FG000|Overall Study|Adverse Event|0|||
131003972|NCT00557505|471641838|FG001|Overall Study|Adverse Event|0|||
131003973|NCT00557505|471641839|FG002|Overall Study|Adverse Event|1|||
131003974|NCT00557505|471641840|FG003|Overall Study|Adverse Event|0|||
131003975|NCT00557505|471641841|FG004|Overall Study|Adverse Event|0|||
131003976|NCT00557505|471641842|FG005|Overall Study|Adverse Event|0|||
131003977|NCT00557505|471641843|FG006|Overall Study|Adverse Event|1|||
131003978|NCT00557505|471641844|FG007|Overall Study|Adverse Event|0|||
131003979|NCT00557505|471641845|FG008|Overall Study|Adverse Event|0|||
131003980|NCT00557505|471641837|FG000|Overall Study|Global deterioration of health|1|||
131003981|NCT00557505|471641838|FG001|Overall Study|Global deterioration of health|0|||
131003982|NCT00557505|471641839|FG002|Overall Study|Global deterioration of health|0|||
131003983|NCT00557505|471641840|FG003|Overall Study|Global deterioration of health|0|||
131003984|NCT00557505|471641841|FG004|Overall Study|Global deterioration of health|0|||
131003985|NCT00557505|471641842|FG005|Overall Study|Global deterioration of health|0|||
131003986|NCT00557505|471641843|FG006|Overall Study|Global deterioration of health|0|||
131003987|NCT00557505|471641844|FG007|Overall Study|Global deterioration of health|0|||
131003988|NCT00557505|471641845|FG008|Overall Study|Global deterioration of health|0|||
131003989|NCT00557505|471641837|FG000|Overall Study|Objective progression or relapse|2|||
131003990|NCT00557505|471641838|FG001|Overall Study|Objective progression or relapse|3|||
131003991|NCT00557505|471641839|FG002|Overall Study|Objective progression or relapse|3|||
131003992|NCT00557505|471641840|FG003|Overall Study|Objective progression or relapse|2|||
131003993|NCT00557505|471641841|FG004|Overall Study|Objective progression or relapse|2|||
131003994|NCT00557505|471641842|FG005|Overall Study|Objective progression or relapse|3|||
131003995|NCT00557505|471641843|FG006|Overall Study|Objective progression or relapse|2|||
131003996|NCT00557505|471641844|FG007|Overall Study|Objective progression or relapse|5|||
131003997|NCT00557505|471641845|FG008|Overall Study|Objective progression or relapse|15|||
131003998|NCT00557505|471641837|FG000|Overall Study|Withdrawal by Subject|0|||
131003999|NCT00557505|471641838|FG001|Overall Study|Withdrawal by Subject|0|||
131004000|NCT00557505|471641839|FG002|Overall Study|Withdrawal by Subject|0|||
131004001|NCT00557505|471641840|FG003|Overall Study|Withdrawal by Subject|1|||
131004002|NCT00557505|471641841|FG004|Overall Study|Withdrawal by Subject|0|||
131004003|NCT00557505|471641842|FG005|Overall Study|Withdrawal by Subject|0|||
131004004|NCT00557505|471641843|FG006|Overall Study|Withdrawal by Subject|0|||
131004005|NCT00557505|471641844|FG007|Overall Study|Withdrawal by Subject|0|||
131004006|NCT00557505|471641845|FG008|Overall Study|Withdrawal by Subject|1|||
131004007|NCT01244763|471641846|FG000|Overall Study|Adverse Event|1|||
131004008|NCT01244763|471641847|FG001|Overall Study|Adverse Event|0|||
131004009|NCT01244763|471641848|FG002|Overall Study|Adverse Event|0|||
131004010|NCT01244763|471641849|FG003|Overall Study|Adverse Event|0|||
131004011|NCT01244763|471641850|FG004|Overall Study|Adverse Event|0|||
131004012|NCT01244763|471641851|FG005|Overall Study|Adverse Event|1|||
131004013|NCT01244763|471641846|FG000|Overall Study|Death|1|||
131004014|NCT01244763|471641847|FG001|Overall Study|Death|0|||
131004015|NCT01244763|471641848|FG002|Overall Study|Death|1|||
131004016|NCT01244763|471641849|FG003|Overall Study|Death|0|||
131004017|NCT01244763|471641850|FG004|Overall Study|Death|2|||
131004018|NCT01244763|471641851|FG005|Overall Study|Death|0|||
131004019|NCT01244763|471641846|FG000|Overall Study|Physician Decision|0|||
131004020|NCT01244763|471641847|FG001|Overall Study|Physician Decision|0|||
131004021|NCT01244763|471641848|FG002|Overall Study|Physician Decision|1|||
131004022|NCT01244763|471641849|FG003|Overall Study|Physician Decision|0|||
131004023|NCT01244763|471641850|FG004|Overall Study|Physician Decision|0|||
131004024|NCT01244763|471641851|FG005|Overall Study|Physician Decision|0|||
131004025|NCT01244763|471641846|FG000|Overall Study|Withdrawal by Subject|1|||
131004026|NCT01244763|471641847|FG001|Overall Study|Withdrawal by Subject|2|||
131004027|NCT01244763|471641848|FG002|Overall Study|Withdrawal by Subject|0|||
131004028|NCT01244763|471641849|FG003|Overall Study|Withdrawal by Subject|1|||
131004029|NCT01244763|471641850|FG004|Overall Study|Withdrawal by Subject|1|||
131004030|NCT01244763|471641851|FG005|Overall Study|Withdrawal by Subject|2|||
131004031|NCT01244763|471641846|FG000|Overall Study|Lost to Follow-up|0|||
131004032|NCT01244763|471641847|FG001|Overall Study|Lost to Follow-up|1|||
131004033|NCT01244763|471641848|FG002|Overall Study|Lost to Follow-up|0|||
131004034|NCT01244763|471641849|FG003|Overall Study|Lost to Follow-up|0|||
131004035|NCT01244763|471641850|FG004|Overall Study|Lost to Follow-up|0|||
131004036|NCT01244763|471641851|FG005|Overall Study|Lost to Follow-up|0|||
131004037|NCT01244763|471641846|FG000|Overall Study|Enrolled into the Extension Study|0|||
131004038|NCT01244763|471641847|FG001|Overall Study|Enrolled into the Extension Study|0|||
131004039|NCT01244763|471641848|FG002|Overall Study|Enrolled into the Extension Study|0|||
131004040|NCT01244763|471641849|FG003|Overall Study|Enrolled into the Extension Study|0|||
131004041|NCT01244763|471641850|FG004|Overall Study|Enrolled into the Extension Study|0|||
131004042|NCT01244763|471641851|FG005|Overall Study|Enrolled into the Extension Study|1|||
131004043|NCT01561079|471641852|FG000|Overall Study|Physician Decision|17|||
131004044|NCT01561079|471641852|FG000|Overall Study|Withdrawal by Subject|59|||
131004045|NCT01561079|471641852|FG000|Overall Study|Protocol Violation|2|||
131004046|NCT03330119|471641853|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
131004047|NCT03330119|471641854|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
131004048|NCT00664521|471641863|FG000|Overall Study|Adverse Event|4|||
131004049|NCT00664521|471641864|FG001|Overall Study|Adverse Event|1|||
131004050|NCT00664521|471641863|FG000|Overall Study|Lost to Follow-up|1|||
131004051|NCT00664521|471641864|FG001|Overall Study|Lost to Follow-up|0|||
131004052|NCT00664521|471641863|FG000|Overall Study|Other|1|||
131004053|NCT00664521|471641864|FG001|Overall Study|Other|0|||
131004054|NCT02459964|471641865|FG000|Overall Study|Withdrawal by Subject|0|||
131004055|NCT02459964|471641866|FG001|Overall Study|Withdrawal by Subject|0|||
131004056|NCT02459964|471641867|FG002|Overall Study|Withdrawal by Subject|1|||
131004057|NCT02459964|471641865|FG000|Overall Study|Abnormal EKG changes|0|||
131004058|NCT02459964|471641866|FG001|Overall Study|Abnormal EKG changes|0|||
131004059|NCT02459964|471641867|FG002|Overall Study|Abnormal EKG changes|1|||
131004060|NCT00367237|471641868|FG000|Overall Study|Adverse Event|7|||
131004061|NCT00367237|471641869|FG001|Overall Study|Adverse Event|2|||
131004062|NCT00367237|471641868|FG000|Overall Study|Lost to Follow-up|1|||
131004063|NCT00367237|471641869|FG001|Overall Study|Lost to Follow-up|0|||
131004064|NCT00367237|471641868|FG000|Overall Study|Withdrawal by Subject|0|||
131004065|NCT00367237|471641869|FG001|Overall Study|Withdrawal by Subject|4|||
131004066|NCT00367237|471641868|FG000|Overall Study|Protocol Violation|2|||
131004067|NCT00367237|471641869|FG001|Overall Study|Protocol Violation|5|||
131004068|NCT00550732|471641870|FG000|Overall Study|Death|4|||
131004069|NCT00550732|471641870|FG000|Overall Study|Withdrawal by Subject|2|||
131004070|NCT00550732|471641870|FG000|Overall Study|Physician Decision|2|||
131004071|NCT00550732|471641870|FG000|Overall Study|Lost to Follow-up|1|||
131004072|NCT00550732|471641870|FG000|Overall Study|Palliative care|1|||
131004073|NCT00550732|471641870|FG000|Overall Study|Adverse Event|1|||
131004074|NCT02800928|471641877|FG000|Overall Study|Withdrawal by Subject|1|||
131004075|NCT02800928|471641878|FG001|Overall Study|Withdrawal by Subject|1|||
131004076|NCT02800928|471641877|FG000|Overall Study|Protocol Violation|1|||
131004077|NCT02800928|471641878|FG001|Overall Study|Protocol Violation|1|||
131004078|NCT04004208|471641884|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131004079|NCT04004208|471641885|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131004080|NCT04004208|471641884|FG000|Overall Study|Death|3|||
131004081|NCT04004208|471641885|FG001|Overall Study|Death|0|||
131004082|NCT04004208|471641884|FG000|Overall Study|COVID-19 pandemic|1|||
131004083|NCT04004208|471641885|FG001|Overall Study|COVID-19 pandemic|0|||
131004084|NCT04004208|471641884|FG000|Overall Study|Physician Decision|1|||
131004085|NCT04004208|471641885|FG001|Overall Study|Physician Decision|0|||
131004086|NCT04004208|471641884|FG000|Overall Study|Adverse Event|1|||
131004087|NCT04004208|471641885|FG001|Overall Study|Adverse Event|1|||
131004088|NCT00570661|471641892|FG000|Overall Study|Disease worsening|5|||
131004089|NCT00570661|471641892|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
131004090|NCT00570661|471641892|FG000|Overall Study|Adverse Event|1|||
131004091|NCT01734382|471641893|FG000|Part 1|Adverse Event|2|||
131004092|NCT01734382|471641894|FG001|Part 1|Adverse Event|0|||
131004093|NCT01734382|471641895|FG002|Part 1|Adverse Event|0|||
131004094|NCT01734382|471641893|FG000|Part 2|Adverse Event|0|||
131004095|NCT01734382|471641894|FG001|Part 2|Adverse Event|0|||
131004096|NCT01734382|471641895|FG002|Part 2|Adverse Event|1|||
131004097|NCT01734382|471641893|FG000|Part 2|Lack of Efficacy|0|||
131004098|NCT01734382|471641894|FG001|Part 2|Lack of Efficacy|1|||
131004099|NCT01734382|471641895|FG002|Part 2|Lack of Efficacy|1|||
131004100|NCT01734382|471641893|FG000|Part 2|Other|0|||
131004101|NCT01734382|471641894|FG001|Part 2|Other|0|||
131004102|NCT01734382|471641895|FG002|Part 2|Other|1|||
131004103|NCT01734382|471641893|FG000|Part 2|Physician Decision|0|||
131004104|NCT01734382|471641894|FG001|Part 2|Physician Decision|0|||
131004105|NCT01734382|471641895|FG002|Part 2|Physician Decision|3|||
131004106|NCT01734382|471641893|FG000|Part 2|Protocol Violation|0|||
131004107|NCT01734382|471641894|FG001|Part 2|Protocol Violation|1|||
131004108|NCT01734382|471641895|FG002|Part 2|Protocol Violation|0|||
131004109|NCT01734382|471641893|FG000|Part 2|Withdrawal by Subject|0|||
131004110|NCT01734382|471641894|FG001|Part 2|Withdrawal by Subject|0|||
131004111|NCT01734382|471641895|FG002|Part 2|Withdrawal by Subject|1|||
131004112|NCT01052662|471641898|FG000|Overall Study|Lost to Follow-up|15|||
131004113|NCT01052662|471641899|FG001|Overall Study|Lost to Follow-up|13|||
131004114|NCT01052662|471641900|FG002|Overall Study|Lost to Follow-up|18|||
131004115|NCT01052662|471641898|FG000|Overall Study|Withdrawal by Subject|3|||
131004116|NCT01052662|471641899|FG001|Overall Study|Withdrawal by Subject|2|||
131004117|NCT01052662|471641900|FG002|Overall Study|Withdrawal by Subject|1|||
131004118|NCT01052662|471641898|FG000|Overall Study|Pharmacy issue|1|||
131004119|NCT01052662|471641899|FG001|Overall Study|Pharmacy issue|3|||
131004120|NCT01052662|471641900|FG002|Overall Study|Pharmacy issue|3|||
131004121|NCT01052662|471641898|FG000|Overall Study|Adverse Event|1|||
131004122|NCT01052662|471641899|FG001|Overall Study|Adverse Event|1|||
131004123|NCT01052662|471641900|FG002|Overall Study|Adverse Event|0|||
131004124|NCT01052662|471641898|FG000|Overall Study|Legal Problem|2|||
131004125|NCT01052662|471641899|FG001|Overall Study|Legal Problem|0|||
131004126|NCT01052662|471641900|FG002|Overall Study|Legal Problem|0|||
131004127|NCT01052662|471641898|FG000|Overall Study|Administrative|0|||
131004128|NCT01052662|471641899|FG001|Overall Study|Administrative|3|||
131004129|NCT01052662|471641900|FG002|Overall Study|Administrative|0|||
131004130|NCT02013687|471641901|FG000|Overall Study|Lost to Follow-up|0|||
131004131|NCT02013687|471641902|FG001|Overall Study|Lost to Follow-up|0|||
131004132|NCT02013687|471641903|FG002|Overall Study|Lost to Follow-up|1|||
131004133|NCT02013687|471641904|FG003|Overall Study|Lost to Follow-up|0|||
131004134|NCT02013687|471641901|FG000|Overall Study|Protocol Violation|0|||
131004135|NCT02013687|471641902|FG001|Overall Study|Protocol Violation|0|||
131004136|NCT02013687|471641903|FG002|Overall Study|Protocol Violation|0|||
131004137|NCT02013687|471641904|FG003|Overall Study|Protocol Violation|1|||
131004138|NCT02013687|471641901|FG000|Overall Study|Withdrawal by Subject|0|||
131004139|NCT02013687|471641902|FG001|Overall Study|Withdrawal by Subject|0|||
131004140|NCT02013687|471641903|FG002|Overall Study|Withdrawal by Subject|0|||
131004141|NCT02013687|471641904|FG003|Overall Study|Withdrawal by Subject|1|||
131004142|NCT02013687|471641901|FG000|Overall Study|Missed visits due to patient travel|0|||
131004143|NCT02013687|471641902|FG001|Overall Study|Missed visits due to patient travel|0|||
131004144|NCT02013687|471641903|FG002|Overall Study|Missed visits due to patient travel|1|||
131004145|NCT02013687|471641904|FG003|Overall Study|Missed visits due to patient travel|0|||
131004146|NCT05968482|471641905|FG000|First Crossover Period|Withdrawal by Subject|0|||
131004147|NCT05968482|471641906|FG001|First Crossover Period|Withdrawal by Subject|0|||
131004148|NCT05968482|471641907|FG002|First Crossover Period|Withdrawal by Subject|1|||
131004149|NCT05968482|471641908|FG003|First Crossover Period|Withdrawal by Subject|0|||
131004150|NCT05968482|471641909|FG004|First Crossover Period|Withdrawal by Subject|0|||
131004151|NCT05968482|471641910|FG005|First Crossover Period|Withdrawal by Subject|0|||
131004152|NCT05968482|471641905|FG000|First Crossover Period|Adverse Event|0|||
131004153|NCT05968482|471641906|FG001|First Crossover Period|Adverse Event|0|||
131004154|NCT05968482|471641907|FG002|First Crossover Period|Adverse Event|0|||
131004155|NCT05968482|471641908|FG003|First Crossover Period|Adverse Event|0|||
131004156|NCT05968482|471641909|FG004|First Crossover Period|Adverse Event|0|||
131004157|NCT05968482|471641910|FG005|First Crossover Period|Adverse Event|1|||
131004158|NCT05968482|471641905|FG000|Second Crossover Period|Withdrawal by Subject|0|||
131004159|NCT05968482|471641906|FG001|Second Crossover Period|Withdrawal by Subject|0|||
131004160|NCT05968482|471641907|FG002|Second Crossover Period|Withdrawal by Subject|0|||
131004161|NCT05968482|471641908|FG003|Second Crossover Period|Withdrawal by Subject|0|||
131004162|NCT05968482|471641909|FG004|Second Crossover Period|Withdrawal by Subject|1|||
131004163|NCT05968482|471641910|FG005|Second Crossover Period|Withdrawal by Subject|0|||
131004164|NCT05968482|471641905|FG000|Third Crossover Period|Adverse Event|0|||
131004165|NCT05968482|471641906|FG001|Third Crossover Period|Adverse Event|0|||
131004166|NCT05968482|471641907|FG002|Third Crossover Period|Adverse Event|0|||
131004167|NCT05968482|471641908|FG003|Third Crossover Period|Adverse Event|0|||
131004168|NCT05968482|471641909|FG004|Third Crossover Period|Adverse Event|1|||
131004169|NCT05968482|471641910|FG005|Third Crossover Period|Adverse Event|0|||
131004170|NCT05968482|471641905|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
131004171|NCT05968482|471641906|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
131004172|NCT05968482|471641907|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
131004173|NCT05968482|471641908|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
131004174|NCT05968482|471641909|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
131004175|NCT05968482|471641910|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
131004176|NCT00087490|471641911|FG000|Overall Study|Death|6|||
131004177|NCT00087490|471641912|FG001|Overall Study|Death|4|||
131004178|NCT00087490|471641911|FG000|Overall Study|Adverse Event|3|||
131004179|NCT00087490|471641912|FG001|Overall Study|Adverse Event|8|||
131004180|NCT00087490|471641911|FG000|Overall Study|Lack of Efficacy|0|||
131004181|NCT00087490|471641912|FG001|Overall Study|Lack of Efficacy|2|||
131004182|NCT00087490|471641911|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
131004183|NCT00087490|471641912|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
131004184|NCT00087490|471641911|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
131004185|NCT00087490|471641912|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
131004186|NCT00087490|471641911|FG000|Overall Study|Randomized but not treated|7|||
131004187|NCT00087490|471641912|FG001|Overall Study|Randomized but not treated|18|||
131004188|NCT00761774|471641915|FG000|Overall Study|Adverse Event|17|||
131004189|NCT00761774|471641915|FG000|Overall Study|Lack of Efficacy|37|||
131004190|NCT00761774|471641915|FG000|Overall Study|Lost to Follow-up|2|||
131004191|NCT00761774|471641915|FG000|Overall Study|Withdrawal by Subject|9|||
131004192|NCT00761774|471641915|FG000|Overall Study|Non-compliance|4|||
131004193|NCT00761774|471641915|FG000|Overall Study|End of study|2|||
131004194|NCT00761774|471641915|FG000|Overall Study|Reclassification of seizures|1|||
131004195|NCT00761774|471641915|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
131004196|NCT00761774|471641915|FG000|Overall Study|Sponsor decision|1|||
131004197|NCT00761774|471641915|FG000|Overall Study|Investigator clinical judgement|1|||
131004198|NCT00761774|471641915|FG000|Overall Study|Patient moved out of study area|1|||
131004199|NCT00761774|471641915|FG000|Overall Study|Coordinator leaving site|1|||
131004200|NCT00761774|471641915|FG000|Overall Study|Subject IP non-compliance|1|||
131004201|NCT00761774|471641915|FG000|Overall Study|IP stopped by hospital physician|1|||
131004202|NCT02034435|471641916|FG000|Overall Study|Withdrawal by Subject|1|||
131004203|NCT02034435|471641917|FG001|Overall Study|Withdrawal by Subject|0|||
131004204|NCT02034435|471641918|FG002|Overall Study|Withdrawal by Subject|0|||
131004205|NCT02034435|471641919|FG003|Overall Study|Withdrawal by Subject|0|||
131004206|NCT02034435|471641916|FG000|Overall Study|Illness|0|||
131004207|NCT02034435|471641917|FG001|Overall Study|Illness|2|||
131004208|NCT02034435|471641918|FG002|Overall Study|Illness|0|||
131004209|NCT02034435|471641919|FG003|Overall Study|Illness|0|||
131004210|NCT02034435|471641916|FG000|Overall Study|Inadequate IV access|1|||
131004211|NCT02034435|471641917|FG001|Overall Study|Inadequate IV access|0|||
131004212|NCT02034435|471641918|FG002|Overall Study|Inadequate IV access|0|||
131004213|NCT02034435|471641919|FG003|Overall Study|Inadequate IV access|1|||
131004214|NCT00630539|471641920|FG000|Overall Study|Adverse Event|1|||
131004215|NCT00630539|471641921|FG001|Overall Study|Adverse Event|3|||
131004216|NCT00630539|471641922|FG002|Overall Study|Adverse Event|1|||
131004217|NCT00630539|471641923|FG003|Overall Study|Adverse Event|2|||
131004218|NCT00630539|471641920|FG000|Overall Study|Withdrawal by Subject|0|||
131004219|NCT00630539|471641921|FG001|Overall Study|Withdrawal by Subject|1|||
131004220|NCT00630539|471641922|FG002|Overall Study|Withdrawal by Subject|0|||
131004221|NCT00630539|471641923|FG003|Overall Study|Withdrawal by Subject|1|||
131004222|NCT01700530|471641924|FG000|Overall Study|Withdrawal by Subject|0|||
131004223|NCT01700530|471641925|FG001|Overall Study|Withdrawal by Subject|3|||
131004224|NCT01700530|471641926|FG002|Overall Study|Withdrawal by Subject|1|||
131004225|NCT02223182|471641933|FG000|Double-Blind Period|Adverse Event|0|||
131004226|NCT02223182|471641934|FG001|Double-Blind Period|Adverse Event|2|||
131004227|NCT02223182|471641935|FG002|Double-Blind Period|Adverse Event|1|||
131004228|NCT02223182|471641936|FG003|Double-Blind Period|Adverse Event|0|||
131004229|NCT02223182|471641933|FG000|Double-Blind Period|Withdrawal by Subject|1|||
131004230|NCT02223182|471641934|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131004231|NCT02223182|471641935|FG002|Double-Blind Period|Withdrawal by Subject|1|||
131004232|NCT02223182|471641936|FG003|Double-Blind Period|Withdrawal by Subject|0|||
131004233|NCT02223182|471641933|FG000|Double-Blind Period|Lost to Follow-up|0|||
131004234|NCT02223182|471641934|FG001|Double-Blind Period|Lost to Follow-up|1|||
131004235|NCT02223182|471641935|FG002|Double-Blind Period|Lost to Follow-up|0|||
131004236|NCT02223182|471641936|FG003|Double-Blind Period|Lost to Follow-up|0|||
131004237|NCT02223182|471641933|FG000|Double-Blind Period|Non Compliance|0|||
131004238|NCT02223182|471641934|FG001|Double-Blind Period|Non Compliance|0|||
131004239|NCT02223182|471641935|FG002|Double-Blind Period|Non Compliance|0|||
131004240|NCT02223182|471641936|FG003|Double-Blind Period|Non Compliance|1|||
131004241|NCT02223182|471641933|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
131004242|NCT02223182|471641934|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
131004243|NCT02223182|471641935|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
131004244|NCT02223182|471641936|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
131004245|NCT02223182|471641933|FG000|Open-Label 500 Period|Adverse Event|1|||
131004246|NCT02223182|471641934|FG001|Open-Label 500 Period|Adverse Event|0|||
131004247|NCT02223182|471641935|FG002|Open-Label 500 Period|Adverse Event|2|||
131004248|NCT02223182|471641936|FG003|Open-Label 500 Period|Adverse Event|1|||
131004249|NCT02223182|471641933|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
131004250|NCT02223182|471641934|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
131004251|NCT02223182|471641935|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
131004252|NCT02223182|471641936|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
131004253|NCT02223182|471641933|FG000|Open-Label 500 Period|Physician Decision|0|||
131004254|NCT02223182|471641934|FG001|Open-Label 500 Period|Physician Decision|0|||
131004255|NCT02223182|471641935|FG002|Open-Label 500 Period|Physician Decision|0|||
131004256|NCT02223182|471641936|FG003|Open-Label 500 Period|Physician Decision|1|||
131004257|NCT02223182|471641933|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
131004258|NCT02223182|471641934|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
131004259|NCT02223182|471641935|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
131004260|NCT02223182|471641936|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
131004261|NCT02223182|471641933|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
131004262|NCT02223182|471641934|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
131004263|NCT02223182|471641935|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
131004264|NCT02223182|471641936|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
131004265|NCT02223182|471641933|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
131004266|NCT02223182|471641934|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
131004267|NCT02223182|471641935|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
131004268|NCT02223182|471641936|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
131004269|NCT02223182|471641933|FG000|Open-Label 300 Period|Non Compliance|0|||
131004270|NCT02223182|471641934|FG001|Open-Label 300 Period|Non Compliance|2|||
131004271|NCT02223182|471641935|FG002|Open-Label 300 Period|Non Compliance|1|||
131004272|NCT02223182|471641936|FG003|Open-Label 300 Period|Non Compliance|0|||
131004273|NCT03714022|471641937|FG000|Overall Study|Adverse Event|1|||
131004274|NCT03714022|471641938|FG001|Overall Study|Adverse Event|0|||
131004275|NCT03714022|471641937|FG000|Overall Study|Consent withdrawal|0|||
131004276|NCT03714022|471641938|FG001|Overall Study|Consent withdrawal|1|||
131004277|NCT03714022|471641937|FG000|Overall Study|Lost to Follow-up|3|||
131004278|NCT03714022|471641938|FG001|Overall Study|Lost to Follow-up|2|||
131004279|NCT00235495|471641947|FG000|Overall Study|Death|52|||
131004280|NCT00235495|471641948|FG001|Overall Study|Death|42|||
131004281|NCT00235495|471641947|FG000|Overall Study|Withdrawal by Subject|5|||
131004282|NCT00235495|471641948|FG001|Overall Study|Withdrawal by Subject|3|||
131004283|NCT00235495|471641947|FG000|Overall Study|Lost to Follow-up|11|||
131004284|NCT00235495|471641948|FG001|Overall Study|Lost to Follow-up|13|||
131004285|NCT00235495|471641947|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
131004286|NCT00235495|471641948|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
131004287|NCT03289455|471641949|FG000|Overall Study|Death|1|||
131004288|NCT03289455|471641950|FG001|Overall Study|Death|0|||
131004289|NCT03289455|471641951|FG002|Overall Study|Death|0|||
131004290|NCT03289455|471641949|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
131004291|NCT03289455|471641950|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
131004292|NCT03289455|471641951|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
131004293|NCT03289455|471641949|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
131004294|NCT03289455|471641950|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
131004295|NCT03289455|471641951|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
131004296|NCT03289455|471641949|FG000|Overall Study|Progressive disease|3|||
131004297|NCT03289455|471641950|FG001|Overall Study|Progressive disease|4|||
131004298|NCT03289455|471641951|FG002|Overall Study|Progressive disease|5|||
131004299|NCT00114959|471641952|FG000|Overall Study|Lack of Efficacy|6|||
131004300|NCT00114959|471641952|FG000|Overall Study|Physician Decision|1|||
131004301|NCT00114959|471641952|FG000|Overall Study|Death|1|||
131004302|NCT02337361|471641957|FG000|3-month Follow-up|Lost to Follow-up|19|||
131004303|NCT02337361|471641958|FG001|3-month Follow-up|Lost to Follow-up|14|||
131004304|NCT02337361|471641957|FG000|6-month Follow-up|Lost to Follow-up|2|||
131004305|NCT02337361|471641958|FG001|6-month Follow-up|Lost to Follow-up|4|||
131004306|NCT02419755|471641959|FG000|Overall Study|Death|1|||
131004307|NCT02419755|471641960|FG001|Overall Study|Death|3|||
131004308|NCT02419755|471641959|FG000|Overall Study|Relapse|0|||
131004309|NCT02419755|471641960|FG001|Overall Study|Relapse|1|||
131004310|NCT02419755|471641959|FG000|Overall Study|Ineligible|1|||
131004311|NCT02419755|471641960|FG001|Overall Study|Ineligible|0|||
131004312|NCT02419755|471641959|FG000|Overall Study|Withdrawal by Subject|1|||
131004313|NCT02419755|471641960|FG001|Overall Study|Withdrawal by Subject|0|||
131004314|NCT02427646|471641961|FG000|Overall Study|Lack of Efficacy|2|||
131004315|NCT02427646|471641962|FG001|Overall Study|Lack of Efficacy|3|||
131004316|NCT02427646|471641961|FG000|Overall Study|Physician Decision|1|||
131004317|NCT02427646|471641962|FG001|Overall Study|Physician Decision|4|||
131004318|NCT02427646|471641961|FG000|Overall Study|Protocol Violation|3|||
131004319|NCT02427646|471641962|FG001|Overall Study|Protocol Violation|3|||
131004320|NCT02427646|471641961|FG000|Overall Study|Bothersome hand weakness|2|||
131004321|NCT02427646|471641962|FG001|Overall Study|Bothersome hand weakness|4|||
131004322|NCT00901485|471641963|FG000|Overall Study|Lack of Efficacy|0|||
131004323|NCT00901485|471641964|FG001|Overall Study|Lack of Efficacy|2|||
131004324|NCT00901485|471641963|FG000|Overall Study|Withdrawal by Subject|1|||
131004325|NCT00901485|471641964|FG001|Overall Study|Withdrawal by Subject|2|||
131004326|NCT05567952|471644125|FG000|Overall Study|Lost to Follow-up|3|||
131004327|NCT05567952|471644126|FG001|Overall Study|Lost to Follow-up|2|||
131004328|NCT05567952|471644125|FG000|Overall Study|Withdrawal by Subject|6|||
131004329|NCT05567952|471644126|FG001|Overall Study|Withdrawal by Subject|3|||
131004330|NCT05567952|471644125|FG000|Overall Study|Other|3|||
131004331|NCT05567952|471644126|FG001|Overall Study|Other|1|||
131004332|NCT01929993|471644136|FG000|Overall Study|Protocol Violation|4|||
131004333|NCT01929993|471644137|FG001|Overall Study|Protocol Violation|6|||
131004334|NCT01929993|471644136|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
131004335|NCT01929993|471644137|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
131004336|NCT01852162|471644138|FG000|Overall Study|Adverse Event|1|||
131004337|NCT01852162|471644139|FG001|Overall Study|Adverse Event|0|||
131004338|NCT01852162|471644138|FG000|Overall Study|Withdrawal by Subject|3|||
131004339|NCT01852162|471644139|FG001|Overall Study|Withdrawal by Subject|1|||
131004340|NCT00163215|471644144|FG000|Overall Study|Lack of Efficacy|3|||
131004341|NCT00163215|471644144|FG000|Overall Study|Withdrawal by Subject|5|||
131004342|NCT00163215|471644144|FG000|Overall Study|Other|7|||
131004343|NCT03660943|471644147|FG000|Overall Study|Adverse Event|5|||
131004344|NCT03660943|471644148|FG001|Overall Study|Adverse Event|3|||
131004345|NCT03660943|471644147|FG000|Overall Study|Death|0|||
131004346|NCT03660943|471644148|FG001|Overall Study|Death|2|||
131004347|NCT03660943|471644147|FG000|Overall Study|Lost to Follow-up|7|||
131004348|NCT03660943|471644148|FG001|Overall Study|Lost to Follow-up|3|||
131004349|NCT03660943|471644147|FG000|Overall Study|Protocol Violation|3|||
131004350|NCT03660943|471644148|FG001|Overall Study|Protocol Violation|5|||
131004351|NCT03660943|471644147|FG000|Overall Study|Withdrawal by Subject|8|||
131004352|NCT03660943|471644148|FG001|Overall Study|Withdrawal by Subject|15|||
131100842|NCT01139580|471998114|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
131100843|NCT01139580|471998115|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
131100844|NCT01139580|471998114|FG000|Overall Study|Participant Randomization in Error|0|||
131100845|NCT01139580|471998115|FG001|Overall Study|Participant Randomization in Error|1|||
131100846|NCT00911768|471998116|FG000|Overall Study|Protocol Violation|5|||
131100847|NCT00911768|471998117|FG001|Overall Study|Protocol Violation|4|||
131100848|NCT00911768|471998116|FG000|Overall Study|Withdrawal by Subject|1|||
131100849|NCT00911768|471998117|FG001|Overall Study|Withdrawal by Subject|0|||
131100850|NCT02842151|471998120|FG000|Overall Study|Adverse Event|1|||
131100851|NCT02842151|471998120|FG000|Overall Study|Subject moved too far away|1|||
131100852|NCT00591851|471998121|FG000|Overall Study|Withdrawal by Subject|3|||
131100853|NCT00591851|471998121|FG000|Overall Study|Adverse Event|2|||
131004353|NCT03660943|471644147|FG000|Overall Study|Lack of Efficacy|9|||
131004354|NCT03660943|471644148|FG001|Overall Study|Lack of Efficacy|12|||
131004355|NCT03660943|471644147|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
131004356|NCT03660943|471644148|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
131004357|NCT04096365|471644149|FG000|Overall Study|Adverse Event|1|||
131004358|NCT05310084|471644150|FG000|Overall Study|Withdrawal by Subject|2|||
131004359|NCT05310084|471644151|FG001|Overall Study|Withdrawal by Subject|3|||
131004360|NCT05310084|471644150|FG000|Overall Study|Participant availability|0|||
131100854|NCT00591851|471998121|FG000|Overall Study|Progressive Disease|1|||
131004361|NCT05310084|471644151|FG001|Overall Study|Participant availability|4|||
131100855|NCT02559895|471998122|FG000|Overall Study|Adverse Event|3|||
131100856|NCT02559895|471998123|FG001|Overall Study|Adverse Event|3|||
131100857|NCT02559895|471998124|FG002|Overall Study|Adverse Event|2|||
131100858|NCT02559895|471998125|FG003|Overall Study|Adverse Event|1|||
131004362|NCT05310084|471644150|FG000|Overall Study|Lost to Follow-up|1|||
131004363|NCT05310084|471644151|FG001|Overall Study|Lost to Follow-up|1|||
131004364|NCT05310084|471644150|FG000|Overall Study|Adverse Event|1|||
131004365|NCT05310084|471644151|FG001|Overall Study|Adverse Event|1|||
131004366|NCT05310084|471644150|FG000|Overall Study|Randomized but not vaccinated|4|||
130884857|NCT00790842|471213220|FG004|Dose Level 4|Physician Decision|0|||
131004367|NCT05310084|471644151|FG001|Overall Study|Randomized but not vaccinated|2|||
131004368|NCT00751790|471644159|FG000|Overall Study|Lost to Follow-up|1|||
131004369|NCT00751790|471644159|FG000|Overall Study|Death|3|||
131004370|NCT00751790|471644159|FG000|Overall Study|Withdrawal by Subject|1|||
131004371|NCT01106976|471644160|FG000|Overall Study|Lost to Follow-up|8|||
131004372|NCT03836664|471644163|FG000|Overall Study|Didn't complete forms and lost drug|3|||
131004373|NCT03836664|471644164|FG001|Overall Study|Didn't complete forms and lost drug|3|||
131100859|NCT02559895|471998122|FG000|Overall Study|Lack of Efficacy|2|||
131100860|NCT02559895|471998123|FG001|Overall Study|Lack of Efficacy|3|||
131100861|NCT02559895|471998124|FG002|Overall Study|Lack of Efficacy|2|||
131100862|NCT02559895|471998125|FG003|Overall Study|Lack of Efficacy|8|||
131100863|NCT02559895|471998122|FG000|Overall Study|Lost to Follow-up|22|||
131004374|NCT01427907|471644165|FG000|Overall Study|Withdrawal by Subject|3|||
131004375|NCT01427907|471644166|FG001|Overall Study|Withdrawal by Subject|4|||
131100864|NCT02559895|471998123|FG001|Overall Study|Lost to Follow-up|16|||
131100865|NCT02559895|471998124|FG002|Overall Study|Lost to Follow-up|12|||
131100866|NCT02559895|471998125|FG003|Overall Study|Lost to Follow-up|17|||
131100867|NCT02559895|471998122|FG000|Overall Study|Physician Decision|1|||
131100868|NCT02559895|471998123|FG001|Overall Study|Physician Decision|1|||
131100869|NCT02559895|471998124|FG002|Overall Study|Physician Decision|3|||
131100870|NCT02559895|471998125|FG003|Overall Study|Physician Decision|0|||
131100871|NCT02559895|471998122|FG000|Overall Study|Withdrawal by Subject|16|||
131100872|NCT02559895|471998123|FG001|Overall Study|Withdrawal by Subject|9|||
131100873|NCT02559895|471998124|FG002|Overall Study|Withdrawal by Subject|20|||
131100874|NCT02559895|471998125|FG003|Overall Study|Withdrawal by Subject|9|||
131100875|NCT02559895|471998122|FG000|Overall Study|Study Burden|10|||
131100876|NCT02559895|471998123|FG001|Overall Study|Study Burden|16|||
131004376|NCT02179918|471644167|FG000|Overall Study|Death|0|||
131004377|NCT02179918|471644168|FG001|Overall Study|Death|0|||
131004378|NCT02179918|471644169|FG002|Overall Study|Death|0|||
131004379|NCT02179918|471644170|FG003|Overall Study|Death|1|||
131004380|NCT02179918|471644171|FG004|Overall Study|Death|0|||
131100877|NCT02559895|471998124|FG002|Overall Study|Study Burden|12|||
131100878|NCT02559895|471998125|FG003|Overall Study|Study Burden|22|||
131100879|NCT02559895|471998122|FG000|Overall Study|Other|1|||
131100880|NCT02559895|471998123|FG001|Overall Study|Other|5|||
131100881|NCT02559895|471998124|FG002|Overall Study|Other|3|||
131100882|NCT02559895|471998125|FG003|Overall Study|Other|3|||
131100883|NCT00867308|471998133|FG000|Overall Study|Death|1|||
131100884|NCT00867308|471998134|FG001|Overall Study|Death|0|||
131004381|NCT02179918|471644167|FG000|Overall Study|Lost to Follow-up|0|||
131100885|NCT00867308|471998133|FG000|Overall Study|Adverse Event|1|||
131100886|NCT00867308|471998134|FG001|Overall Study|Adverse Event|4|||
131100887|NCT00867308|471998133|FG000|Overall Study|Lack of Efficacy|6|||
131004382|NCT02179918|471644168|FG001|Overall Study|Lost to Follow-up|0|||
131004383|NCT02179918|471644169|FG002|Overall Study|Lost to Follow-up|1|||
131100888|NCT00867308|471998134|FG001|Overall Study|Lack of Efficacy|12|||
131100889|NCT00867308|471998133|FG000|Overall Study|Withdrawal by Subject|1|||
131100890|NCT00867308|471998134|FG001|Overall Study|Withdrawal by Subject|2|||
131004384|NCT02179918|471644170|FG003|Overall Study|Lost to Follow-up|0|||
131004385|NCT02179918|471644171|FG004|Overall Study|Lost to Follow-up|0|||
131004386|NCT02179918|471644167|FG000|Overall Study|Progressive Disease|4|||
131004387|NCT02179918|471644168|FG001|Overall Study|Progressive Disease|1|||
131004388|NCT02179918|471644169|FG002|Overall Study|Progressive Disease|1|||
131004389|NCT02179918|471644170|FG003|Overall Study|Progressive Disease|2|||
131004390|NCT02179918|471644171|FG004|Overall Study|Progressive Disease|6|||
131004391|NCT02179918|471644167|FG000|Overall Study|Other|0|||
131004392|NCT02179918|471644168|FG001|Overall Study|Other|1|||
131004393|NCT02179918|471644169|FG002|Overall Study|Other|0|||
131004394|NCT02179918|471644170|FG003|Overall Study|Other|0|||
131004395|NCT02179918|471644171|FG004|Overall Study|Other|1|||
131100891|NCT00604825|471998135|FG000|Overall Study|Adverse Event|2|||
131100892|NCT00604825|471998136|FG001|Overall Study|Adverse Event|6|||
131100893|NCT00604825|471998137|FG002|Overall Study|Adverse Event|7|||
131100894|NCT00604825|471998138|FG003|Overall Study|Adverse Event|4|||
131100895|NCT00604825|471998135|FG000|Overall Study|Lost to Follow-up|0|||
131100896|NCT00604825|471998136|FG001|Overall Study|Lost to Follow-up|3|||
131100897|NCT00604825|471998137|FG002|Overall Study|Lost to Follow-up|1|||
131100898|NCT00604825|471998138|FG003|Overall Study|Lost to Follow-up|0|||
131100899|NCT00604825|471998135|FG000|Overall Study|Protocol Violation|0|||
131100900|NCT00604825|471998136|FG001|Overall Study|Protocol Violation|1|||
131100901|NCT00604825|471998137|FG002|Overall Study|Protocol Violation|0|||
131100902|NCT00604825|471998138|FG003|Overall Study|Protocol Violation|0|||
131100903|NCT00604825|471998135|FG000|Overall Study|Withdrawal by Subject|4|||
131100904|NCT00604825|471998136|FG001|Overall Study|Withdrawal by Subject|3|||
131100905|NCT00604825|471998137|FG002|Overall Study|Withdrawal by Subject|5|||
131100906|NCT00604825|471998138|FG003|Overall Study|Withdrawal by Subject|5|||
131100907|NCT00604825|471998135|FG000|Overall Study|Lack of Efficacy|3|||
131004396|NCT02179918|471644167|FG000|Overall Study|Subject refused further follow-up|0|||
131004397|NCT02179918|471644168|FG001|Overall Study|Subject refused further follow-up|1|||
131004398|NCT02179918|471644169|FG002|Overall Study|Subject refused further follow-up|0|||
131100908|NCT00604825|471998136|FG001|Overall Study|Lack of Efficacy|2|||
131100909|NCT00604825|471998137|FG002|Overall Study|Lack of Efficacy|1|||
131100910|NCT00604825|471998138|FG003|Overall Study|Lack of Efficacy|0|||
131100911|NCT00604825|471998135|FG000|Overall Study|Did not meet eligibility criteria|0|||
131100912|NCT00604825|471998136|FG001|Overall Study|Did not meet eligibility criteria|0|||
131100913|NCT00604825|471998137|FG002|Overall Study|Did not meet eligibility criteria|2|||
131100914|NCT00604825|471998138|FG003|Overall Study|Did not meet eligibility criteria|0|||
131100915|NCT00604825|471998135|FG000|Overall Study|Physician Decision|0|||
131100916|NCT00604825|471998136|FG001|Overall Study|Physician Decision|0|||
131100917|NCT00604825|471998137|FG002|Overall Study|Physician Decision|0|||
131100918|NCT00604825|471998138|FG003|Overall Study|Physician Decision|1|||
131100919|NCT00604825|471998135|FG000|Overall Study|Exclusion criterion met|0|||
131100920|NCT00604825|471998136|FG001|Overall Study|Exclusion criterion met|0|||
131100921|NCT00604825|471998137|FG002|Overall Study|Exclusion criterion met|0|||
131100922|NCT00604825|471998138|FG003|Overall Study|Exclusion criterion met|1|||
131100923|NCT03647488|471999577|FG000|Overall Study|Progressive disease|10|||
131100924|NCT03647488|471999578|FG001|Overall Study|Progressive disease|0|||
131100925|NCT03647488|471999579|FG002|Overall Study|Progressive disease|0|||
131100926|NCT03647488|471999577|FG000|Overall Study|Adverse Event|5|||
131100927|NCT03647488|471999578|FG001|Overall Study|Adverse Event|0|||
131100928|NCT03647488|471999579|FG002|Overall Study|Adverse Event|0|||
131100929|NCT03647488|471999577|FG000|Overall Study|Clinical progression|2|||
131100930|NCT03647488|471999578|FG001|Overall Study|Clinical progression|0|||
131004399|NCT02179918|471644170|FG003|Overall Study|Subject refused further follow-up|0|||
131004400|NCT02179918|471644171|FG004|Overall Study|Subject refused further follow-up|1|||
131004401|NCT04337489|471644176|FG000|Overall Study|Withdrawal by Subject|1|||
131004402|NCT00972543|471644177|FG000|Overall Study|Adverse Event|1|||
131004403|NCT00972543|471644178|FG001|Overall Study|Adverse Event|0|||
131004404|NCT00972543|471644177|FG000|Overall Study|Early study termination by sponsor|4|||
131004405|NCT00972543|471644178|FG001|Overall Study|Early study termination by sponsor|1|||
131004406|NCT04833855|471644186|FG000|Overall Study|Decision by sponsor|0|||
131004407|NCT04833855|471644187|FG001|Overall Study|Decision by sponsor|1|||
131004408|NCT04833855|471644188|FG002|Overall Study|Decision by sponsor|0|||
131004409|NCT04833855|471644189|FG003|Overall Study|Decision by sponsor|0|||
131004410|NCT04833855|471644186|FG000|Overall Study|Withdrawal by Subject|4|||
131004411|NCT04833855|471644187|FG001|Overall Study|Withdrawal by Subject|1|||
131004412|NCT04833855|471644188|FG002|Overall Study|Withdrawal by Subject|3|||
131004413|NCT04833855|471644189|FG003|Overall Study|Withdrawal by Subject|1|||
131004414|NCT04833855|471644186|FG000|Overall Study|Lost to Follow-up|1|||
131004415|NCT04833855|471644187|FG001|Overall Study|Lost to Follow-up|0|||
131004416|NCT04833855|471644188|FG002|Overall Study|Lost to Follow-up|2|||
131004417|NCT04833855|471644189|FG003|Overall Study|Lost to Follow-up|2|||
131004418|NCT04833855|471644186|FG000|Overall Study|Protocol specified criteria|0|||
131004419|NCT04833855|471644187|FG001|Overall Study|Protocol specified criteria|0|||
131004420|NCT04833855|471644188|FG002|Overall Study|Protocol specified criteria|2|||
131004421|NCT04833855|471644189|FG003|Overall Study|Protocol specified criteria|1|||
131004422|NCT03682536|471644191|FG000|Randomization|Withdrawal by Subject|0|||
131004423|NCT03682536|471644192|FG001|Randomization|Withdrawal by Subject|2|||
131004424|NCT03682536|471644191|FG000|Treatment|Other Reasons|8|||
131004425|NCT03682536|471644192|FG001|Treatment|Other Reasons|7|||
131004426|NCT03682536|471644191|FG000|Treatment|Physician Decision|5|||
131004427|NCT03682536|471644192|FG001|Treatment|Physician Decision|5|||
131004428|NCT03682536|471644191|FG000|Treatment|Protocol Violation|1|||
131004429|NCT03682536|471644192|FG001|Treatment|Protocol Violation|0|||
131004430|NCT03682536|471644191|FG000|Treatment|Study Terminated by Sponsor|1|||
131004431|NCT03682536|471644192|FG001|Treatment|Study Terminated by Sponsor|2|||
131004432|NCT03682536|471644191|FG000|Treatment|Lost to Follow-up|0|||
131004433|NCT03682536|471644192|FG001|Treatment|Lost to Follow-up|1|||
131004434|NCT03682536|471644191|FG000|Treatment|Withdrawal by Subject|16|||
131004435|NCT03682536|471644192|FG001|Treatment|Withdrawal by Subject|18|||
131004436|NCT03682536|471644191|FG000|Treatment|Lack of Efficacy|41|||
131004437|NCT03682536|471644192|FG001|Treatment|Lack of Efficacy|68|||
131004438|NCT03682536|471644191|FG000|Treatment|Disease Progression|9|||
131004439|NCT03682536|471644192|FG001|Treatment|Disease Progression|7|||
131004440|NCT03682536|471644191|FG000|Treatment|Adverse Event|9|||
131004441|NCT03682536|471644192|FG001|Treatment|Adverse Event|5|||
131004442|NCT03682536|471644191|FG000|Treatment|Death|14|||
131004443|NCT03682536|471644192|FG001|Treatment|Death|13|||
131004444|NCT03008122|471644193|FG000|Overall Study|Physician Decision|3|||
131004445|NCT03008122|471644194|FG001|Overall Study|Physician Decision|2|||
131004446|NCT03008122|471644195|FG002|Overall Study|Physician Decision|0|||
131004447|NCT03008122|471644193|FG000|Overall Study|Withdrawal by Subject|1|||
131004448|NCT03008122|471644194|FG001|Overall Study|Withdrawal by Subject|3|||
131004449|NCT03008122|471644195|FG002|Overall Study|Withdrawal by Subject|0|||
131004450|NCT03008122|471644193|FG000|Overall Study|Lost to Follow-up|4|||
131004451|NCT03008122|471644194|FG001|Overall Study|Lost to Follow-up|8|||
131004452|NCT03008122|471644195|FG002|Overall Study|Lost to Follow-up|3|||
131004453|NCT03008122|471644193|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
131004454|NCT03008122|471644194|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
131004455|NCT03008122|471644195|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
131004456|NCT03008122|471644193|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
131004457|NCT03008122|471644194|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
131004458|NCT03008122|471644195|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
131004459|NCT03008122|471644193|FG000|Overall Study|Death|0|||
131004460|NCT03008122|471644194|FG001|Overall Study|Death|0|||
131004461|NCT03008122|471644195|FG002|Overall Study|Death|1|||
131004462|NCT02338609|471644196|FG000|Overall Study|Physician Decision|1|||
131004463|NCT02338609|471644196|FG000|Overall Study|Death|1|||
131004464|NCT02234310|471644199|FG000|Overall Study|Physician Decision|1|||
131004465|NCT02234310|471644199|FG000|Overall Study|Adverse Event|1|||
131004466|NCT02234310|471644199|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
131004467|NCT02234310|471644199|FG000|Overall Study|Withdrawal by Subject|2|||
131004468|NCT03251378|471644202|FG000|Overall Study|Death|3|||
131004469|NCT03251378|471644203|FG001|Overall Study|Death|2|||
131004470|NCT03251378|471644204|FG002|Overall Study|Death|3|||
131004471|NCT03251378|471644205|FG003|Overall Study|Death|30|||
131004472|NCT03251378|471644206|FG004|Overall Study|Death|24|||
131004473|NCT03251378|471644207|FG005|Overall Study|Death|12|||
131004474|NCT03251378|471644208|FG006|Overall Study|Death|12|||
131004475|NCT03251378|471644202|FG000|Overall Study|Lost to Follow-up|0|||
131004476|NCT03251378|471644203|FG001|Overall Study|Lost to Follow-up|0|||
131004477|NCT03251378|471644204|FG002|Overall Study|Lost to Follow-up|1|||
131004478|NCT03251378|471644205|FG003|Overall Study|Lost to Follow-up|3|||
131004479|NCT03251378|471644206|FG004|Overall Study|Lost to Follow-up|0|||
131004480|NCT03251378|471644207|FG005|Overall Study|Lost to Follow-up|0|||
131004481|NCT03251378|471644208|FG006|Overall Study|Lost to Follow-up|0|||
131004482|NCT03251378|471644202|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
131004483|NCT03251378|471644203|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
131004484|NCT03251378|471644204|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
131004485|NCT03251378|471644205|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
131004486|NCT03251378|471644206|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
131004487|NCT03251378|471644207|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
131004488|NCT03251378|471644208|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
131004489|NCT03251378|471644202|FG000|Overall Study|Progressive disease|2|||
131004490|NCT03251378|471644203|FG001|Overall Study|Progressive disease|0|||
131004491|NCT03251378|471644204|FG002|Overall Study|Progressive disease|0|||
131004492|NCT03251378|471644205|FG003|Overall Study|Progressive disease|1|||
131004493|NCT03251378|471644206|FG004|Overall Study|Progressive disease|0|||
131004494|NCT03251378|471644207|FG005|Overall Study|Progressive disease|0|||
131004495|NCT03251378|471644208|FG006|Overall Study|Progressive disease|0|||
131004496|NCT03251378|471644202|FG000|Overall Study|Physician Decision|0|||
130884858|NCT00790842|471213221|FG005|Dose Level 4|Physician Decision|0|||
130884859|NCT00790842|471213222|FG006|Dose Level 4|Physician Decision|1|||
130884860|NCT00790842|471213223|FG007|Dose Level 4|Physician Decision|0|||
130884861|NCT00790842|471213224|FG008|Dose Level 4|Physician Decision|0|||
130884862|NCT00790842|471213225|FG009|Dose Level 4|Physician Decision|0|||
131004497|NCT03251378|471644203|FG001|Overall Study|Physician Decision|2|||
131004498|NCT03251378|471644204|FG002|Overall Study|Physician Decision|0|||
131004499|NCT03251378|471644205|FG003|Overall Study|Physician Decision|0|||
130884863|NCT00790842|471213226|FG010|Dose Level 4|Physician Decision|1|||
130884864|NCT00790842|471213216|FG000|Dose Level 4|Withdrawal by Subject|0|||
130884865|NCT00790842|471213217|FG001|Dose Level 4|Withdrawal by Subject|0|||
131004500|NCT03251378|471644206|FG004|Overall Study|Physician Decision|0|||
131004501|NCT03251378|471644207|FG005|Overall Study|Physician Decision|0|||
131004502|NCT03251378|471644208|FG006|Overall Study|Physician Decision|0|||
131004503|NCT03251378|471644202|FG000|Overall Study|Other|2|||
131004504|NCT03251378|471644203|FG001|Overall Study|Other|3|||
131004505|NCT03251378|471644204|FG002|Overall Study|Other|2|||
131004506|NCT03251378|471644205|FG003|Overall Study|Other|0|||
131004507|NCT03251378|471644206|FG004|Overall Study|Other|1|||
131004508|NCT03251378|471644207|FG005|Overall Study|Other|1|||
130884866|NCT00790842|471213218|FG002|Dose Level 4|Withdrawal by Subject|0|||
130884867|NCT00790842|471213219|FG003|Dose Level 4|Withdrawal by Subject|0|||
130884868|NCT00790842|471213220|FG004|Dose Level 4|Withdrawal by Subject|0|||
130884869|NCT00790842|471213221|FG005|Dose Level 4|Withdrawal by Subject|0|||
130884870|NCT00790842|471213222|FG006|Dose Level 4|Withdrawal by Subject|0|||
130884871|NCT00790842|471213223|FG007|Dose Level 4|Withdrawal by Subject|0|||
130884872|NCT00790842|471213224|FG008|Dose Level 4|Withdrawal by Subject|0|||
130884873|NCT00790842|471213225|FG009|Dose Level 4|Withdrawal by Subject|0|||
130884874|NCT00790842|471213226|FG010|Dose Level 4|Withdrawal by Subject|1|||
130884875|NCT00790842|471213216|FG000|Expansion Cohort|Adverse Event|0|||
130884876|NCT00790842|471213217|FG001|Expansion Cohort|Adverse Event|0|||
130884877|NCT00790842|471213218|FG002|Expansion Cohort|Adverse Event|0|||
130884878|NCT00790842|471213219|FG003|Expansion Cohort|Adverse Event|0|||
130884879|NCT00790842|471213220|FG004|Expansion Cohort|Adverse Event|0|||
130765922|NCT05153148|470765900|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
130765923|NCT05153148|470765901|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
130765924|NCT05153148|470765902|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
130765925|NCT05153148|470765899|FG000|Overall Study|Reason not Specified|1|||
130765926|NCT05153148|470765900|FG001|Overall Study|Reason not Specified|1|||
130765927|NCT05153148|470765901|FG002|Overall Study|Reason not Specified|1|||
130884880|NCT00790842|471213221|FG005|Expansion Cohort|Adverse Event|0|||
130884881|NCT00790842|471213222|FG006|Expansion Cohort|Adverse Event|1|||
130884882|NCT00790842|471213223|FG007|Expansion Cohort|Adverse Event|0|||
131004509|NCT03251378|471644208|FG006|Overall Study|Other|1|||
131004510|NCT03251378|471644202|FG000|Overall Study|Other|0|||
131004511|NCT03251378|471644203|FG001|Overall Study|Other|0|||
131004512|NCT03251378|471644204|FG002|Overall Study|Other|0|||
131004513|NCT03251378|471644205|FG003|Overall Study|Other|4|||
131004514|NCT03251378|471644206|FG004|Overall Study|Other|13|||
131004515|NCT03251378|471644207|FG005|Overall Study|Other|0|||
131004516|NCT03251378|471644208|FG006|Overall Study|Other|0|||
131004517|NCT04060680|471644210|FG000|Overall Study|Unsuccessful implant|17|||
131004518|NCT04060680|471644211|FG001|Overall Study|Unsuccessful implant|2|||
131004519|NCT04060680|471644210|FG000|Overall Study|Adverse Event|3|||
131004520|NCT04060680|471644211|FG001|Overall Study|Adverse Event|0|||
131004521|NCT04060680|471644210|FG000|Overall Study|Death|2|||
131004522|NCT04060680|471644211|FG001|Overall Study|Death|0|||
131004523|NCT04060680|471644210|FG000|Overall Study|Study product no longer in use|1|||
131004524|NCT04060680|471644211|FG001|Overall Study|Study product no longer in use|0|||
131004525|NCT04060680|471644210|FG000|Overall Study|Withdrawal by Subject|1|||
131004526|NCT04060680|471644211|FG001|Overall Study|Withdrawal by Subject|0|||
131004527|NCT02322775|471644215|FG000|Overall Study|Adverse Event|1|||
131004528|NCT02322775|471644216|FG001|Overall Study|Adverse Event|0|||
131004529|NCT02322775|471644215|FG000|Overall Study|Lost to Follow-up|0|||
131004530|NCT02322775|471644216|FG001|Overall Study|Lost to Follow-up|1|||
131004531|NCT02322775|471644215|FG000|Overall Study|Protocol Violation|1|||
131004532|NCT02322775|471644216|FG001|Overall Study|Protocol Violation|0|||
131004533|NCT02322775|471644215|FG000|Overall Study|Withdrawal by Subject|3|||
131004534|NCT02322775|471644216|FG001|Overall Study|Withdrawal by Subject|4|||
131004535|NCT02322775|471644215|FG000|Overall Study|Not willing to perform all FU visits|0|||
131004536|NCT02322775|471644216|FG001|Overall Study|Not willing to perform all FU visits|1|||
131004537|NCT02956967|471644217|FG000|Overall Study|Adverse Event|3|||
131004538|NCT02956967|471644217|FG000|Overall Study|Reason non-related to neutropenia|10|||
131004539|NCT02956967|471644217|FG000|Overall Study|Lost to Follow-up|5|||
131004540|NCT02956967|471644217|FG000|Overall Study|Missing|1|||
131004541|NCT02956967|471644217|FG000|Overall Study|Termination of Nivestim administration|29|||
131004542|NCT04739423|471644218|FG000|Overall Study|Protocol Violation|0|||
131004543|NCT04739423|471644219|FG001|Overall Study|Protocol Violation|1|||
130884883|NCT00790842|471213224|FG008|Expansion Cohort|Adverse Event|0|||
131004544|NCT04739423|471644220|FG002|Overall Study|Protocol Violation|0|||
131004545|NCT04739423|471644221|FG003|Overall Study|Protocol Violation|0|||
131004546|NCT04739423|471644222|FG004|Overall Study|Protocol Violation|0|||
131004547|NCT04739423|471644223|FG005|Overall Study|Protocol Violation|0|||
131004548|NCT04739423|471644218|FG000|Overall Study|Adverse Event|0|||
131004549|NCT04739423|471644219|FG001|Overall Study|Adverse Event|0|||
131004550|NCT04739423|471644220|FG002|Overall Study|Adverse Event|1|||
131004551|NCT04739423|471644221|FG003|Overall Study|Adverse Event|0|||
131004552|NCT04739423|471644222|FG004|Overall Study|Adverse Event|1|||
130884884|NCT00790842|471213225|FG009|Expansion Cohort|Adverse Event|0|||
130884885|NCT00790842|471213226|FG010|Expansion Cohort|Adverse Event|0|||
130884886|NCT00790842|471213216|FG000|Expansion Cohort|Death|0|||
130884887|NCT00790842|471213217|FG001|Expansion Cohort|Death|0|||
131004553|NCT04739423|471644223|FG005|Overall Study|Adverse Event|0|||
131004554|NCT04739423|471644218|FG000|Overall Study|Withdrawal by Subject|0|||
131004555|NCT04739423|471644219|FG001|Overall Study|Withdrawal by Subject|0|||
131004556|NCT04739423|471644220|FG002|Overall Study|Withdrawal by Subject|0|||
131004557|NCT04739423|471644221|FG003|Overall Study|Withdrawal by Subject|0|||
131004558|NCT04739423|471644222|FG004|Overall Study|Withdrawal by Subject|0|||
131004559|NCT04739423|471644223|FG005|Overall Study|Withdrawal by Subject|1|||
131004560|NCT01007552|471644227|FG000|Overall Study|Withdrawal by Subject|1|||
131004561|NCT04482855|471644231|FG000|Overall Study|Lost to Follow-up|1|||
131004562|NCT04482855|471644232|FG001|Overall Study|Lost to Follow-up|0|||
131004563|NCT04482855|471644231|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
131004564|NCT04482855|471644232|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
131004565|NCT04482855|471644231|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
131004566|NCT04482855|471644232|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
131004567|NCT03212365|471644238|FG000|Overall Study|Discharged prior to Xa level|12|||
131004568|NCT03212365|471644239|FG001|Overall Study|Discharged prior to Xa level|8|||
131004569|NCT03212365|471644238|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
131004570|NCT03212365|471644239|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
131004571|NCT03212365|471644238|FG000|Overall Study|Refused study medication|3|||
131004572|NCT03212365|471644239|FG001|Overall Study|Refused study medication|0|||
130884888|NCT00790842|471213218|FG002|Expansion Cohort|Death|2|||
130884889|NCT00790842|471213219|FG003|Expansion Cohort|Death|0|||
130884890|NCT00790842|471213220|FG004|Expansion Cohort|Death|0|||
131004573|NCT03212365|471644238|FG000|Overall Study|Initiated heparin infusion on floor|1|||
131004574|NCT03212365|471644239|FG001|Overall Study|Initiated heparin infusion on floor|1|||
131004575|NCT03212365|471644238|FG000|Overall Study|Unexpected return to OR|1|||
131004576|NCT03212365|471644239|FG001|Overall Study|Unexpected return to OR|1|||
131004577|NCT03212365|471644238|FG000|Overall Study|Medication distribution error|1|||
131004578|NCT03212365|471644239|FG001|Overall Study|Medication distribution error|0|||
131004579|NCT03212365|471644238|FG000|Overall Study|Required epidural placement|1|||
131004580|NCT03212365|471644239|FG001|Overall Study|Required epidural placement|0|||
131004581|NCT03212365|471644238|FG000|Overall Study|Withdrawal by Subject|0|||
131004582|NCT03212365|471644239|FG001|Overall Study|Withdrawal by Subject|1|||
131004583|NCT03212365|471644238|FG000|Overall Study|developed acute renal failure|0|||
131004584|NCT03212365|471644239|FG001|Overall Study|developed acute renal failure|1|||
131004585|NCT02507219|471644240|FG000|Overall Study|Physician Decision|1|||
131004586|NCT02507219|471644241|FG001|Overall Study|Physician Decision|0|||
131004587|NCT02507219|471644242|FG002|Overall Study|Physician Decision|0|||
131004588|NCT02507219|471644243|FG003|Overall Study|Physician Decision|0|||
131004589|NCT02507219|471644244|FG004|Overall Study|Physician Decision|0|||
131004590|NCT02507219|471644245|FG005|Overall Study|Physician Decision|0|||
131004591|NCT02507219|471644240|FG000|Overall Study|Withdrawal by Subject|0|||
131004592|NCT02507219|471644241|FG001|Overall Study|Withdrawal by Subject|0|||
131004593|NCT02507219|471644242|FG002|Overall Study|Withdrawal by Subject|0|||
131004594|NCT02507219|471644243|FG003|Overall Study|Withdrawal by Subject|0|||
131004595|NCT02507219|471644244|FG004|Overall Study|Withdrawal by Subject|1|||
131221947|NCT00434148|472439475|FG000|Overall Study|Condition no longer requires study drug|1|||
131221948|NCT00434148|472439476|FG001|Overall Study|Condition no longer requires study drug|0|||
131221949|NCT00434148|472439475|FG000|Overall Study|Abnormal test procedure result|0|||
131221950|NCT00434148|472439476|FG001|Overall Study|Abnormal test procedure result|1|||
131221951|NCT01861717|472439484|FG000|Overall Study|Lost to Follow-up|1|||
131221952|NCT01861717|472439484|FG000|Overall Study|Withdrawal by Subject|1|||
131221953|NCT03033069|472439485|FG000|Overall Study|Adverse Event|6|||
131221954|NCT03033069|472439486|FG001|Overall Study|Adverse Event|7|||
131221955|NCT03033069|472439487|FG002|Overall Study|Adverse Event|4|||
131221956|NCT03033069|472439488|FG003|Overall Study|Adverse Event|6|||
131221957|NCT03033069|472439485|FG000|Overall Study|Lack of Efficacy|0|||
131221958|NCT03033069|472439486|FG001|Overall Study|Lack of Efficacy|0|||
131221959|NCT03033069|472439487|FG002|Overall Study|Lack of Efficacy|1|||
131221960|NCT03033069|472439488|FG003|Overall Study|Lack of Efficacy|0|||
131221961|NCT03033069|472439485|FG000|Overall Study|Lost to Follow-up|6|||
131221962|NCT03033069|472439486|FG001|Overall Study|Lost to Follow-up|5|||
131221963|NCT03033069|472439487|FG002|Overall Study|Lost to Follow-up|5|||
131221964|NCT03033069|472439488|FG003|Overall Study|Lost to Follow-up|6|||
131221965|NCT03033069|472439485|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131221966|NCT03033069|472439486|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131221967|NCT03033069|472439487|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131221968|NCT03033069|472439488|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131221969|NCT03033069|472439485|FG000|Overall Study|Protocol Deviation|0|||
131221970|NCT03033069|472439486|FG001|Overall Study|Protocol Deviation|1|||
131221971|NCT03033069|472439487|FG002|Overall Study|Protocol Deviation|0|||
131221972|NCT03033069|472439488|FG003|Overall Study|Protocol Deviation|0|||
131221973|NCT03033069|472439485|FG000|Overall Study|Withdrawal by Subject|10|||
131221974|NCT03033069|472439486|FG001|Overall Study|Withdrawal by Subject|10|||
131221975|NCT03033069|472439487|FG002|Overall Study|Withdrawal by Subject|11|||
131221976|NCT03033069|472439488|FG003|Overall Study|Withdrawal by Subject|6|||
131221977|NCT03033069|472439485|FG000|Overall Study|Withdrawal By Caregiver|1|||
131221978|NCT03033069|472439486|FG001|Overall Study|Withdrawal By Caregiver|0|||
131221979|NCT03033069|472439487|FG002|Overall Study|Withdrawal By Caregiver|0|||
131221980|NCT03033069|472439488|FG003|Overall Study|Withdrawal By Caregiver|0|||
131221981|NCT03033069|472439485|FG000|Overall Study|Reason not Specified|0|||
131221982|NCT03033069|472439486|FG001|Overall Study|Reason not Specified|1|||
131221983|NCT03033069|472439487|FG002|Overall Study|Reason not Specified|0|||
131221984|NCT03033069|472439488|FG003|Overall Study|Reason not Specified|1|||
131221985|NCT02623426|472439491|FG000|Overall Study|Lost to Follow-up|0|||
131221986|NCT02623426|472439492|FG001|Overall Study|Lost to Follow-up|0|||
131221987|NCT02623426|472439493|FG002|Overall Study|Lost to Follow-up|1|||
131221988|NCT02623426|472439491|FG000|Overall Study|Withdrawal by Subject|1|||
131221989|NCT02623426|472439492|FG001|Overall Study|Withdrawal by Subject|2|||
131221990|NCT02623426|472439493|FG002|Overall Study|Withdrawal by Subject|2|||
131221991|NCT05458895|472439499|FG000|Overall Study|Withdrawal by Subject|8|||
131221992|NCT05458895|472439499|FG000|Overall Study|Lost to Follow-up|17|||
131221993|NCT05458895|472439499|FG000|Overall Study|Pregnancy|2|||
131221994|NCT05458895|472439499|FG000|Overall Study|Withdrawal by Study Team|1|||
131221995|NCT04639310|472439500|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
131221996|NCT04639310|472439501|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
131221997|NCT03724968|472441352|FG000|Overall Study|Insurance issues|0|||
131221998|NCT03724968|472441353|FG001|Overall Study|Insurance issues|1|||
131221999|NCT03724968|472441352|FG000|Overall Study|Study closed|0|||
131222000|NCT03724968|472441353|FG001|Overall Study|Study closed|1|||
131222001|NCT00700310|472441358|FG000|Overall Study|Adverse Event|6|||
131222002|NCT00700310|472441359|FG001|Overall Study|Adverse Event|10|||
131222003|NCT00700310|472441360|FG002|Overall Study|Adverse Event|5|||
131004596|NCT02507219|471644245|FG005|Overall Study|Withdrawal by Subject|0|||
131004597|NCT00819234|471644250|FG000|Overall Study|Withdrawal by Subject|8|||
131222004|NCT00700310|472441361|FG003|Overall Study|Adverse Event|11|||
131222005|NCT00700310|472441358|FG000|Overall Study|Lost to Follow-up|4|||
131222006|NCT00700310|472441359|FG001|Overall Study|Lost to Follow-up|1|||
131222007|NCT00700310|472441360|FG002|Overall Study|Lost to Follow-up|0|||
131222008|NCT00700310|472441361|FG003|Overall Study|Lost to Follow-up|1|||
131222009|NCT00700310|472441358|FG000|Overall Study|Withdrawal by Subject|8|||
131222010|NCT00700310|472441359|FG001|Overall Study|Withdrawal by Subject|9|||
131222011|NCT00700310|472441360|FG002|Overall Study|Withdrawal by Subject|8|||
131222012|NCT00700310|472441361|FG003|Overall Study|Withdrawal by Subject|8|||
131222013|NCT00700310|472441358|FG000|Overall Study|Lack of Efficacy|0|||
131222014|NCT00700310|472441359|FG001|Overall Study|Lack of Efficacy|3|||
131222015|NCT00700310|472441360|FG002|Overall Study|Lack of Efficacy|0|||
131222016|NCT00700310|472441361|FG003|Overall Study|Lack of Efficacy|1|||
131222017|NCT00700310|472441358|FG000|Overall Study|Administrative/Other|1|||
131222018|NCT00700310|472441359|FG001|Overall Study|Administrative/Other|3|||
131222019|NCT00700310|472441360|FG002|Overall Study|Administrative/Other|1|||
131222020|NCT00700310|472441361|FG003|Overall Study|Administrative/Other|3|||
131004598|NCT00819234|471644251|FG001|Overall Study|Withdrawal by Subject|13|||
131004599|NCT00819234|471644252|FG002|Overall Study|Withdrawal by Subject|6|||
131004600|NCT00819234|471644253|FG003|Overall Study|Withdrawal by Subject|3|||
131004601|NCT00819234|471644254|FG004|Overall Study|Withdrawal by Subject|0|||
131004602|NCT00819234|471644255|FG005|Overall Study|Withdrawal by Subject|4|||
131004603|NCT00819234|471644256|FG006|Overall Study|Withdrawal by Subject|4|||
131004604|NCT00819234|471644257|FG007|Overall Study|Withdrawal by Subject|8|||
131004605|NCT00819234|471644258|FG008|Overall Study|Withdrawal by Subject|5|||
131004606|NCT00819234|471644259|FG009|Overall Study|Withdrawal by Subject|3|||
131004607|NCT00819234|471644250|FG000|Overall Study|Adverse Event|0|||
131004608|NCT00819234|471644251|FG001|Overall Study|Adverse Event|0|||
131004609|NCT00819234|471644252|FG002|Overall Study|Adverse Event|1|||
131004610|NCT00819234|471644253|FG003|Overall Study|Adverse Event|0|||
131004611|NCT00819234|471644254|FG004|Overall Study|Adverse Event|0|||
131004612|NCT00819234|471644255|FG005|Overall Study|Adverse Event|2|||
131004613|NCT00819234|471644256|FG006|Overall Study|Adverse Event|0|||
131004614|NCT00819234|471644257|FG007|Overall Study|Adverse Event|0|||
131004615|NCT00819234|471644258|FG008|Overall Study|Adverse Event|0|||
131004616|NCT00819234|471644259|FG009|Overall Study|Adverse Event|0|||
131004617|NCT00819234|471644250|FG000|Overall Study|Physician Decision|0|||
131004618|NCT00819234|471644251|FG001|Overall Study|Physician Decision|0|||
131004619|NCT00819234|471644252|FG002|Overall Study|Physician Decision|0|||
131004620|NCT00819234|471644253|FG003|Overall Study|Physician Decision|1|||
131004621|NCT00819234|471644254|FG004|Overall Study|Physician Decision|0|||
131004622|NCT00819234|471644255|FG005|Overall Study|Physician Decision|0|||
131004623|NCT00819234|471644256|FG006|Overall Study|Physician Decision|0|||
131222021|NCT00700310|472441358|FG000|Overall Study|Randomized, Not Treated|2|||
131004624|NCT00819234|471644257|FG007|Overall Study|Physician Decision|0|||
131004625|NCT00819234|471644258|FG008|Overall Study|Physician Decision|0|||
131004626|NCT00819234|471644259|FG009|Overall Study|Physician Decision|2|||
131222022|NCT00700310|472441359|FG001|Overall Study|Randomized, Not Treated|0|||
131004627|NCT00819234|471644250|FG000|Overall Study|Protocol Violation|0|||
131004628|NCT00819234|471644251|FG001|Overall Study|Protocol Violation|0|||
131004629|NCT00819234|471644252|FG002|Overall Study|Protocol Violation|1|||
130884891|NCT00790842|471213221|FG005|Expansion Cohort|Death|0|||
130884892|NCT00790842|471213222|FG006|Expansion Cohort|Death|0|||
131004630|NCT00819234|471644253|FG003|Overall Study|Protocol Violation|0|||
130884893|NCT00790842|471213223|FG007|Expansion Cohort|Death|0|||
131004631|NCT00819234|471644254|FG004|Overall Study|Protocol Violation|0|||
131004632|NCT00819234|471644255|FG005|Overall Study|Protocol Violation|0|||
131004633|NCT00819234|471644256|FG006|Overall Study|Protocol Violation|0|||
131004634|NCT00819234|471644257|FG007|Overall Study|Protocol Violation|0|||
131004635|NCT00819234|471644258|FG008|Overall Study|Protocol Violation|0|||
131222023|NCT00700310|472441360|FG002|Overall Study|Randomized, Not Treated|2|||
131222024|NCT00700310|472441361|FG003|Overall Study|Randomized, Not Treated|2|||
131222025|NCT00681824|472441362|FG000|Overall Study|withdrawn by investigator|0|||
131222026|NCT00681824|472441363|FG001|Overall Study|withdrawn by investigator|0|||
131222027|NCT00681824|472441364|FG002|Overall Study|withdrawn by investigator|1|||
131222028|NCT00681824|472441362|FG000|Overall Study|scheduling conflict|1|||
131222029|NCT00681824|472441363|FG001|Overall Study|scheduling conflict|0|||
131222030|NCT00681824|472441364|FG002|Overall Study|scheduling conflict|0|||
131222031|NCT00681824|472441362|FG000|Overall Study|Death|0|||
131222032|NCT00681824|472441363|FG001|Overall Study|Death|1|||
131222033|NCT00681824|472441364|FG002|Overall Study|Death|0|||
131222034|NCT03724916|472441365|FG000|Overall Study|Withdrawal by Subject|0|||
131222035|NCT03724916|472441366|FG001|Overall Study|Withdrawal by Subject|1|||
131222036|NCT03724916|472441367|FG002|Overall Study|Withdrawal by Subject|1|||
131222037|NCT03724916|472441368|FG003|Overall Study|Withdrawal by Subject|2|||
131222038|NCT03724916|472441365|FG000|Overall Study|Randomized but not Treated|1|||
131222039|NCT03724916|472441366|FG001|Overall Study|Randomized but not Treated|0|||
131222040|NCT03724916|472441367|FG002|Overall Study|Randomized but not Treated|0|||
131222041|NCT03724916|472441368|FG003|Overall Study|Randomized but not Treated|0|||
131222042|NCT04575038|472441369|FG000|Overall Study|Withdrawal by Subject|1|||
131222043|NCT04575038|472441370|FG001|Overall Study|Withdrawal by Subject|1|||
131222044|NCT00678379|472441373|FG000|Overall Study|Injection performed after tonsillectomy|2|||
131222045|NCT00678379|472441374|FG001|Overall Study|Injection performed after tonsillectomy|0|||
131222046|NCT00678379|472441375|FG002|Overall Study|Injection performed after tonsillectomy|1|||
131222047|NCT00678379|472441373|FG000|Overall Study|Incomplete Data|4|||
131222048|NCT00678379|472441374|FG001|Overall Study|Incomplete Data|3|||
131222049|NCT00678379|472441375|FG002|Overall Study|Incomplete Data|3|||
131222050|NCT04440163|472441382|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
131222051|NCT04440163|472441383|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
131222052|NCT04440163|472441384|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
131222053|NCT04440163|472441385|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
131222054|NCT04440163|472441386|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
131222055|NCT04440163|472441387|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
131222056|NCT04440163|472441388|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
131222057|NCT04440163|472441389|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
131222058|NCT04440163|472441382|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131222059|NCT04440163|472441383|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131229207|NCT01360632|472465873|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
131229208|NCT01360632|472465869|FG000|Phase A (8 Weeks)|Adverse Event|60|||
131229209|NCT01360632|472465870|FG001|Phase A (8 Weeks)|Adverse Event|0|||
131229210|NCT01360632|472465871|FG002|Phase A (8 Weeks)|Adverse Event|0|||
131229211|NCT01360632|472465872|FG003|Phase A (8 Weeks)|Adverse Event|0|||
131229212|NCT01360632|472465873|FG004|Phase A (8 Weeks)|Adverse Event|0|||
131229213|NCT01360632|472465869|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
131229214|NCT01360632|472465870|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
131229215|NCT01360632|472465871|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
131229216|NCT01360632|472465872|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
131229217|NCT01360632|472465873|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
131229218|NCT01360632|472465869|FG000|Phase A (8 Weeks)|Physician Decision|10|||
131229219|NCT01360632|472465870|FG001|Phase A (8 Weeks)|Physician Decision|0|||
131229220|NCT01360632|472465871|FG002|Phase A (8 Weeks)|Physician Decision|0|||
131229221|NCT01360632|472465872|FG003|Phase A (8 Weeks)|Physician Decision|0|||
131229222|NCT01360632|472465873|FG004|Phase A (8 Weeks)|Physician Decision|0|||
131229223|NCT01360632|472465869|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
131229224|NCT01360632|472465870|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
131229225|NCT01360632|472465871|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
131229226|NCT01360632|472465872|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
131229227|NCT01360632|472465873|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
131229228|NCT01360632|472465869|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
131229229|NCT01360632|472465870|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
131229230|NCT01360632|472465871|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
131229231|NCT01360632|472465872|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
131229232|NCT01360632|472465873|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
131229233|NCT01360632|472465869|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
131229234|NCT01360632|472465870|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
131229235|NCT01360632|472465871|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
131229236|NCT01360632|472465872|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
131229237|NCT01360632|472465873|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
131229238|NCT01360632|472465869|FG000|Phase B (6 Weeks)|Adverse Event|0|||
131229239|NCT01360632|472465870|FG001|Phase B (6 Weeks)|Adverse Event|3|||
131229240|NCT01360632|472465871|FG002|Phase B (6 Weeks)|Adverse Event|9|||
131229241|NCT01360632|472465872|FG003|Phase B (6 Weeks)|Adverse Event|3|||
131229242|NCT01360632|472465873|FG004|Phase B (6 Weeks)|Adverse Event|0|||
131229243|NCT01360632|472465869|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
131229244|NCT01360632|472465870|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
131229245|NCT01360632|472465871|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
131229246|NCT01360632|472465872|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
131229247|NCT01360632|472465873|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
131229248|NCT01360632|472465869|FG000|Phase B (6 Weeks)|Physician Decision|0|||
131229249|NCT01360632|472465870|FG001|Phase B (6 Weeks)|Physician Decision|0|||
131229250|NCT01360632|472465871|FG002|Phase B (6 Weeks)|Physician Decision|0|||
131229251|NCT01360632|472465872|FG003|Phase B (6 Weeks)|Physician Decision|1|||
131229252|NCT01360632|472465873|FG004|Phase B (6 Weeks)|Physician Decision|0|||
131229253|NCT01360632|472465869|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
131229254|NCT01360632|472465870|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
131229255|NCT01360632|472465871|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
131229256|NCT01360632|472465872|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
131229257|NCT01360632|472465873|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
131229258|NCT01360632|472465869|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
131229259|NCT01360632|472465870|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
131229260|NCT01360632|472465871|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
131229261|NCT01360632|472465872|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
131229262|NCT01360632|472465873|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
131229263|NCT01360632|472465869|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
131229264|NCT01360632|472465870|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
131229265|NCT01360632|472465871|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
131229266|NCT01360632|472465872|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
131229267|NCT01360632|472465873|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
131229268|NCT01360632|472465869|FG000|Phase A+|Lost to Follow-up|0|||
131222060|NCT04440163|472441384|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131222061|NCT04440163|472441385|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
131222062|NCT04440163|472441386|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
131222063|NCT04440163|472441387|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131222064|NCT04440163|472441388|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131222065|NCT04440163|472441389|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
131222066|NCT04440163|472441382|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
131222067|NCT04440163|472441383|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
131222068|NCT04440163|472441384|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
131222069|NCT04440163|472441385|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
131222070|NCT04440163|472441386|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
131222071|NCT04440163|472441387|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
131222072|NCT04440163|472441388|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
131222073|NCT04440163|472441389|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
131222074|NCT04440163|472441382|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
131222075|NCT04440163|472441383|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
131222076|NCT04440163|472441384|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
131222077|NCT04440163|472441385|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
131222078|NCT04440163|472441386|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
131222079|NCT04440163|472441387|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
131222080|NCT04440163|472441388|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
131222081|NCT04440163|472441389|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
131222082|NCT04440163|472441382|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
131222083|NCT04440163|472441383|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
131222084|NCT04440163|472441384|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
131222085|NCT04440163|472441385|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
131222086|NCT04440163|472441386|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
131222087|NCT04440163|472441387|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
131222088|NCT04440163|472441388|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
131222089|NCT04440163|472441389|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
131222090|NCT04440163|472441382|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
131222091|NCT04440163|472441383|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
131222092|NCT04440163|472441384|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
131222093|NCT04440163|472441385|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
131222094|NCT04440163|472441386|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
131222095|NCT04440163|472441387|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
131222096|NCT04440163|472441388|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
131222097|NCT04440163|472441389|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
131222098|NCT04440163|472441382|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
131222099|NCT04440163|472441383|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
131222100|NCT04440163|472441384|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
131222101|NCT04440163|472441385|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
131222102|NCT04440163|472441386|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
131222103|NCT04440163|472441387|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
131222104|NCT04440163|472441388|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
131222105|NCT04440163|472441389|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
131222106|NCT04440163|472441382|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
131222107|NCT04440163|472441383|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
131222108|NCT04440163|472441384|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
131222109|NCT04440163|472441385|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
131222110|NCT04440163|472441386|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
131222111|NCT04440163|472441387|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
131222112|NCT04440163|472441388|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
131222113|NCT04440163|472441389|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
131222114|NCT04440163|472441382|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
131222115|NCT04440163|472441383|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
131222116|NCT04440163|472441384|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
131222117|NCT04440163|472441385|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
131222118|NCT04440163|472441386|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
131222119|NCT04440163|472441387|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
131222120|NCT04440163|472441388|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
131222121|NCT04440163|472441389|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
131004636|NCT00819234|471644259|FG009|Overall Study|Protocol Violation|0|||
131004637|NCT00819234|471644250|FG000|Overall Study|Lost to Follow-up|2|||
131222122|NCT04440163|472441382|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
131222123|NCT04440163|472441383|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
131222124|NCT04440163|472441384|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
131222125|NCT04440163|472441385|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
131222126|NCT04440163|472441386|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
131222127|NCT04440163|472441387|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
131222128|NCT04440163|472441388|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
131222129|NCT04440163|472441389|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
131222130|NCT04440163|472441382|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
131222131|NCT04440163|472441383|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
131222132|NCT04440163|472441384|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
131222133|NCT04440163|472441385|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
131222134|NCT04440163|472441386|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
131222135|NCT04440163|472441387|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
131222136|NCT04440163|472441388|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
131222137|NCT04440163|472441389|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
131222138|NCT04440163|472441382|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131222139|NCT04440163|472441383|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131222140|NCT04440163|472441384|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131222141|NCT04440163|472441385|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
131222142|NCT04440163|472441386|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131222143|NCT04440163|472441387|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131222144|NCT04440163|472441388|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131222145|NCT04440163|472441389|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
131222146|NCT03137082|472441392|FG000|Overall Study|Withdrawal by Subject|1|||
131222147|NCT03137082|472441393|FG001|Overall Study|Withdrawal by Subject|1|||
131222148|NCT03137082|472441392|FG000|Overall Study|Lost to Follow-up|1|||
131222149|NCT03137082|472441393|FG001|Overall Study|Lost to Follow-up|0|||
131222150|NCT00544557|472441394|FG000|Overall Study|Adverse Event|140|||
131222151|NCT00544557|472441394|FG000|Overall Study|Lack of Efficacy|196|||
131222152|NCT00544557|472441394|FG000|Overall Study|Other|98|||
131222153|NCT01020305|472441400|FG000|Overall Study|Adverse Event|2|||
131222154|NCT00467818|472441401|FG000|Overall Study|Adverse Event|1|||
131222155|NCT00467818|472441402|FG001|Overall Study|Adverse Event|0|||
131222156|NCT00467818|472441401|FG000|Overall Study|Lost to Follow-up|2|||
131222157|NCT00467818|472441402|FG001|Overall Study|Lost to Follow-up|2|||
131222158|NCT02753400|472441403|FG000|Overall Study|Adverse Event|3|||
131222159|NCT02753400|472441404|FG001|Overall Study|Adverse Event|0|||
131222160|NCT02753400|472441403|FG000|Overall Study|Withdrawal by Subject|2|||
131222161|NCT02753400|472441404|FG001|Overall Study|Withdrawal by Subject|1|||
131222162|NCT01415921|472441405|FG000|Overall Study|Adverse Event|0|||
131222163|NCT01415921|472441406|FG001|Overall Study|Adverse Event|1|||
131222164|NCT01415921|472441405|FG000|Overall Study|Physician Decision|1|||
131222165|NCT01415921|472441406|FG001|Overall Study|Physician Decision|1|||
131222166|NCT01415921|472441405|FG000|Overall Study|Withdrawal by Subject|0|||
131222167|NCT01415921|472441406|FG001|Overall Study|Withdrawal by Subject|1|||
131222168|NCT01415921|472441405|FG000|Overall Study|Other|2|||
131222169|NCT01415921|472441406|FG001|Overall Study|Other|0|||
131222170|NCT01830920|472441409|FG000|Overall Study|Adverse Event|1|||
131222171|NCT01830920|472441410|FG001|Overall Study|Adverse Event|0|||
131222172|NCT01830920|472441411|FG002|Overall Study|Adverse Event|1|||
131222173|NCT01830920|472441412|FG003|Overall Study|Adverse Event|0|||
131222174|NCT01830920|472441413|FG004|Overall Study|Adverse Event|0|||
131222175|NCT01830920|472441409|FG000|Overall Study|Withdrawal by Subject|2|||
131222176|NCT01830920|472441410|FG001|Overall Study|Withdrawal by Subject|2|||
131222177|NCT01830920|472441411|FG002|Overall Study|Withdrawal by Subject|1|||
131222178|NCT01830920|472441412|FG003|Overall Study|Withdrawal by Subject|7|||
131222179|NCT01830920|472441413|FG004|Overall Study|Withdrawal by Subject|1|||
131222180|NCT01830920|472441409|FG000|Overall Study|Death|3|||
131222181|NCT01830920|472441410|FG001|Overall Study|Death|3|||
131222182|NCT01830920|472441411|FG002|Overall Study|Death|5|||
131222183|NCT01830920|472441412|FG003|Overall Study|Death|4|||
131222184|NCT01830920|472441413|FG004|Overall Study|Death|4|||
131222185|NCT01830920|472441409|FG000|Overall Study|Other|15|||
131222186|NCT01830920|472441410|FG001|Overall Study|Other|1|||
131222187|NCT01830920|472441411|FG002|Overall Study|Other|1|||
131222188|NCT01830920|472441412|FG003|Overall Study|Other|5|||
131222189|NCT01830920|472441413|FG004|Overall Study|Other|3|||
131222190|NCT01313728|472441414|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
131222191|NCT00755937|472441417|FG000|Recruitment|Unknown if infliximab received|164|||
131222192|NCT00755937|472441417|FG000|Observational Follow-up|Lost to Follow-up|148|||
131222193|NCT00572156|472441418|FG000|Overall Study|Adverse Event|3|||
131222194|NCT00572156|472441419|FG001|Overall Study|Adverse Event|1|||
131222195|NCT00572156|472441420|FG002|Overall Study|Adverse Event|5|||
131004638|NCT00819234|471644251|FG001|Overall Study|Lost to Follow-up|2|||
131004639|NCT00819234|471644252|FG002|Overall Study|Lost to Follow-up|0|||
131004640|NCT00819234|471644253|FG003|Overall Study|Lost to Follow-up|2|||
131004641|NCT00819234|471644254|FG004|Overall Study|Lost to Follow-up|1|||
131004642|NCT00819234|471644255|FG005|Overall Study|Lost to Follow-up|1|||
131004643|NCT00819234|471644256|FG006|Overall Study|Lost to Follow-up|1|||
131004644|NCT00819234|471644257|FG007|Overall Study|Lost to Follow-up|1|||
131004645|NCT00819234|471644258|FG008|Overall Study|Lost to Follow-up|1|||
131004646|NCT00819234|471644259|FG009|Overall Study|Lost to Follow-up|2|||
131004647|NCT05174065|471644260|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
131004648|NCT05174065|471644261|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
131004649|NCT05174065|471644262|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
131004650|NCT05174065|471644260|FG000|Placebo-controlled Period|Other|0|||
131004651|NCT05174065|471644261|FG001|Placebo-controlled Period|Other|1|||
131004652|NCT05174065|471644262|FG002|Placebo-controlled Period|Other|0|||
131004653|NCT05174065|471644260|FG000|Placebo-controlled Period|Adverse Event|1|||
131004654|NCT05174065|471644261|FG001|Placebo-controlled Period|Adverse Event|1|||
131004655|NCT05174065|471644262|FG002|Placebo-controlled Period|Adverse Event|0|||
131004656|NCT05174065|471644260|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
131004657|NCT05174065|471644261|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
131004658|NCT05174065|471644262|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
131004659|NCT05174065|471644260|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
131004660|NCT05174065|471644261|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
131004661|NCT05174065|471644262|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
131222196|NCT00572156|472441421|FG003|Overall Study|Adverse Event|1|||
131222197|NCT00572156|472441418|FG000|Overall Study|Lost to Follow-up|1|||
131222198|NCT00572156|472441419|FG001|Overall Study|Lost to Follow-up|1|||
131222199|NCT00572156|472441420|FG002|Overall Study|Lost to Follow-up|1|||
131222200|NCT00572156|472441421|FG003|Overall Study|Lost to Follow-up|0|||
131222201|NCT00572156|472441418|FG000|Overall Study|Protocol Violation|1|||
131222202|NCT00572156|472441419|FG001|Overall Study|Protocol Violation|2|||
131222203|NCT00572156|472441420|FG002|Overall Study|Protocol Violation|0|||
131222204|NCT00572156|472441421|FG003|Overall Study|Protocol Violation|2|||
131222205|NCT00572156|472441418|FG000|Overall Study|Patient/Parent Decision|1|||
131222206|NCT00572156|472441419|FG001|Overall Study|Patient/Parent Decision|6|||
131222207|NCT00572156|472441420|FG002|Overall Study|Patient/Parent Decision|4|||
131222208|NCT00572156|472441421|FG003|Overall Study|Patient/Parent Decision|3|||
131222209|NCT00572156|472441418|FG000|Overall Study|Sponsor Decision|20|||
131222210|NCT00572156|472441419|FG001|Overall Study|Sponsor Decision|16|||
131222211|NCT00572156|472441420|FG002|Overall Study|Sponsor Decision|17|||
131222212|NCT00572156|472441421|FG003|Overall Study|Sponsor Decision|19|||
131222213|NCT02261974|472441422|FG000|Overall Study|Withdrawal by Subject|3|||
131222214|NCT02261974|472441423|FG001|Overall Study|Withdrawal by Subject|2|||
131222215|NCT02261974|472441422|FG000|Overall Study|Pregnancy|0|||
131222216|NCT02261974|472441423|FG001|Overall Study|Pregnancy|1|||
131222217|NCT02261974|472441422|FG000|Overall Study|Missed treatment cut-off date|6|||
131222218|NCT02261974|472441423|FG001|Overall Study|Missed treatment cut-off date|3|||
131222219|NCT02261974|472441422|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
131222220|NCT02261974|472441423|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
131222221|NCT02261974|472441422|FG000|Overall Study|Lost to Follow-up|2|||
131222222|NCT02261974|472441423|FG001|Overall Study|Lost to Follow-up|0|||
131222223|NCT02261974|472441422|FG000|Overall Study|Adverse Event|1|||
131222224|NCT02261974|472441423|FG001|Overall Study|Adverse Event|0|||
131222225|NCT01223196|472441424|FG000|Overall Study|Lost to Follow-up|2|||
131222226|NCT01223196|472441425|FG001|Overall Study|Lost to Follow-up|0|||
131222227|NCT01223196|472441424|FG000|Overall Study|Physician Decision|1|||
131222228|NCT01223196|472441425|FG001|Overall Study|Physician Decision|0|||
131222229|NCT01223196|472441424|FG000|Overall Study|Withdrawal by Subject|1|||
131222230|NCT01223196|472441425|FG001|Overall Study|Withdrawal by Subject|0|||
131222231|NCT05180630|472441426|FG000|First Intervention|Physician Decision|0|||
131222232|NCT05180630|472441427|FG001|First Intervention|Physician Decision|0|||
131222233|NCT05180630|472441428|FG002|First Intervention|Physician Decision|3|||
131222234|NCT00709735|472441431|FG000|Overall Study|Lost to Follow-up|1|||
131222235|NCT00709735|472441432|FG001|Overall Study|Lost to Follow-up|1|||
131222236|NCT00709735|472441431|FG000|Overall Study|Relapse into Opioid Abuse|0|||
131222237|NCT00709735|472441432|FG001|Overall Study|Relapse into Opioid Abuse|1|||
131222238|NCT00709735|472441431|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
131222239|NCT00709735|472441432|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
131222240|NCT02725671|472441433|FG000|Overall Study|Lost to Follow-up|1|||
131222241|NCT00666718|472441434|FG000|Overall Study|Adverse Event|0|||
131222242|NCT00666718|472441435|FG001|Overall Study|Adverse Event|1|||
131222243|NCT00666718|472441434|FG000|Overall Study|Death|1|||
131222244|NCT00666718|472441435|FG001|Overall Study|Death|0|||
131222245|NCT00666718|472441434|FG000|Overall Study|Lost to Follow-up|1|||
131222246|NCT00666718|472441435|FG001|Overall Study|Lost to Follow-up|0|||
131222247|NCT00666718|472441434|FG000|Overall Study|Entry Criteria Not Met|2|||
131222248|NCT00666718|472441435|FG001|Overall Study|Entry Criteria Not Met|0|||
131222249|NCT00666718|472441434|FG000|Overall Study|Protocol Violation|1|||
131222250|NCT00666718|472441435|FG001|Overall Study|Protocol Violation|3|||
131222251|NCT00666718|472441434|FG000|Overall Study|Withdrawal by Subject|7|||
131222252|NCT00666718|472441435|FG001|Overall Study|Withdrawal by Subject|12|||
131222253|NCT00666718|472441434|FG000|Overall Study|Physician Decision|0|||
131004662|NCT05174065|471644260|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
131222254|NCT00666718|472441435|FG001|Overall Study|Physician Decision|2|||
131222255|NCT00963599|472441436|FG000|Overall Study|Adverse Event|2|||
131222256|NCT00963599|472441437|FG001|Overall Study|Adverse Event|0|||
131222257|NCT00963599|472441438|FG002|Overall Study|Adverse Event|1|||
131222258|NCT00963599|472441439|FG003|Overall Study|Adverse Event|2|||
130884894|NCT00790842|471213224|FG008|Expansion Cohort|Death|0|||
131004663|NCT05174065|471644261|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
131004664|NCT05174065|471644262|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
131004665|NCT01342887|471644268|FG000|Overall Study|Death|2|||
131004666|NCT00209274|471644269|FG000|Overall Study|Missed visit|3|||
131004667|NCT00209274|471644270|FG001|Overall Study|Missed visit|2|||
131004668|NCT00209274|471644269|FG000|Overall Study|Death|32|||
131004669|NCT00209274|471644270|FG001|Overall Study|Death|15|||
131004670|NCT00209274|471644269|FG000|Overall Study|Withdrawal by Subject|30|||
131004671|NCT00209274|471644270|FG001|Overall Study|Withdrawal by Subject|15|||
131004672|NCT00209274|471644269|FG000|Overall Study|Randomized not treated (RNT)|6|||
131004673|NCT00209274|471644270|FG001|Overall Study|Randomized not treated (RNT)|15|||
131004674|NCT02753530|471644271|FG000|Overall Study|Adverse Event|7|||
131222259|NCT00963599|472441436|FG000|Overall Study|Lack of Efficacy|0|||
131222260|NCT00963599|472441437|FG001|Overall Study|Lack of Efficacy|2|||
131222261|NCT00963599|472441438|FG002|Overall Study|Lack of Efficacy|1|||
131222262|NCT00963599|472441439|FG003|Overall Study|Lack of Efficacy|4|||
131222263|NCT00963599|472441436|FG000|Overall Study|Lost to Follow-up|0|||
131222264|NCT00963599|472441437|FG001|Overall Study|Lost to Follow-up|1|||
131222265|NCT00963599|472441438|FG002|Overall Study|Lost to Follow-up|1|||
131222266|NCT00963599|472441439|FG003|Overall Study|Lost to Follow-up|1|||
131222267|NCT00963599|472441436|FG000|Overall Study|Protocol Violation|2|||
131222268|NCT00963599|472441437|FG001|Overall Study|Protocol Violation|2|||
131222269|NCT00963599|472441438|FG002|Overall Study|Protocol Violation|3|||
131222270|NCT00963599|472441439|FG003|Overall Study|Protocol Violation|4|||
131222271|NCT00963599|472441436|FG000|Overall Study|Withdrawal by Subject|2|||
131222272|NCT00963599|472441437|FG001|Overall Study|Withdrawal by Subject|1|||
131222273|NCT00963599|472441438|FG002|Overall Study|Withdrawal by Subject|3|||
131222274|NCT00963599|472441439|FG003|Overall Study|Withdrawal by Subject|3|||
131222275|NCT03496207|472441442|FG000|Base Study|Adverse Event|0|||
131222276|NCT03496207|472441443|FG001|Base Study|Adverse Event|0|||
131222277|NCT03496207|472441444|FG002|Base Study|Adverse Event|1|||
131222278|NCT03496207|472441445|FG003|Base Study|Adverse Event|1|||
131222279|NCT03496207|472441446|FG004|Base Study|Adverse Event|4|||
131222280|NCT03496207|472441442|FG000|Base Study|Death|0|||
131222281|NCT03496207|472441443|FG001|Base Study|Death|0|||
131222282|NCT03496207|472441444|FG002|Base Study|Death|0|||
131222283|NCT03496207|472441445|FG003|Base Study|Death|0|||
131222284|NCT03496207|472441446|FG004|Base Study|Death|1|||
131222285|NCT03496207|472441442|FG000|Base Study|Withdrawal by Subject|0|||
131222286|NCT03496207|472441443|FG001|Base Study|Withdrawal by Subject|0|||
131222287|NCT03496207|472441444|FG002|Base Study|Withdrawal by Subject|1|||
131222288|NCT03496207|472441445|FG003|Base Study|Withdrawal by Subject|0|||
131222289|NCT03496207|472441446|FG004|Base Study|Withdrawal by Subject|1|||
131222290|NCT03496207|472441442|FG000|Extension Period|Adverse Event|0|||
131222291|NCT03496207|472441443|FG001|Extension Period|Adverse Event|0|||
131222292|NCT03496207|472441444|FG002|Extension Period|Adverse Event|0|||
131222293|NCT03496207|472441445|FG003|Extension Period|Adverse Event|1|||
131222294|NCT03496207|472441446|FG004|Extension Period|Adverse Event|1|||
131222295|NCT03496207|472441442|FG000|Extension Period|Death|1|||
131222296|NCT03496207|472441443|FG001|Extension Period|Death|0|||
131222297|NCT03496207|472441444|FG002|Extension Period|Death|0|||
131222298|NCT03496207|472441445|FG003|Extension Period|Death|1|||
131222299|NCT03496207|472441446|FG004|Extension Period|Death|2|||
131222300|NCT03496207|472441442|FG000|Extension Period|Withdrawal by Subject|1|||
131222301|NCT03496207|472441443|FG001|Extension Period|Withdrawal by Subject|0|||
131222302|NCT03496207|472441444|FG002|Extension Period|Withdrawal by Subject|0|||
131222303|NCT03496207|472441445|FG003|Extension Period|Withdrawal by Subject|1|||
131222304|NCT03496207|472441446|FG004|Extension Period|Withdrawal by Subject|1|||
131222305|NCT03496207|472441442|FG000|Extension Period|Elevated hemoglobin levels|0|||
131222306|NCT03496207|472441443|FG001|Extension Period|Elevated hemoglobin levels|0|||
131222307|NCT03496207|472441444|FG002|Extension Period|Elevated hemoglobin levels|0|||
131222308|NCT03496207|472441445|FG003|Extension Period|Elevated hemoglobin levels|0|||
131222309|NCT03496207|472441446|FG004|Extension Period|Elevated hemoglobin levels|1|||
131222310|NCT00810615|472441449|FG000|Overall Study|Withdrawal by Subject|1|||
131222311|NCT00810615|472441450|FG001|Overall Study|Withdrawal by Subject|1|||
131222312|NCT02525562|472441451|FG000|Overall Study|Death|9|||
131222313|NCT02525562|472441452|FG001|Overall Study|Death|0|||
131222314|NCT02525562|472441453|FG002|Overall Study|Death|0|||
131222315|NCT02525562|472441451|FG000|Overall Study|Lost to Follow-up|19|||
131222316|NCT02525562|472441452|FG001|Overall Study|Lost to Follow-up|0|||
131222317|NCT02525562|472441453|FG002|Overall Study|Lost to Follow-up|0|||
131222318|NCT02525562|472441451|FG000|Overall Study|Withdrawal by Subject|37|||
131222319|NCT02525562|472441452|FG001|Overall Study|Withdrawal by Subject|0|||
131222320|NCT02525562|472441453|FG002|Overall Study|Withdrawal by Subject|0|||
131222321|NCT02525562|472441451|FG000|Overall Study|Revision/Removal of Study Device|4|||
131222322|NCT02525562|472441452|FG001|Overall Study|Revision/Removal of Study Device|0|||
131222323|NCT02525562|472441453|FG002|Overall Study|Revision/Removal of Study Device|0|||
130884895|NCT00790842|471213225|FG009|Expansion Cohort|Death|0|||
131004675|NCT02753530|471644272|FG001|Overall Study|Adverse Event|1|||
131222324|NCT02525562|472441451|FG000|Overall Study|Study Closed by Sponsor|154|||
131222325|NCT02525562|472441452|FG001|Overall Study|Study Closed by Sponsor|0|||
131222326|NCT02525562|472441453|FG002|Overall Study|Study Closed by Sponsor|0|||
131222327|NCT01255722|472441454|FG000|Overall Study|Adverse Event|0|||
131222328|NCT01255722|472441455|FG001|Overall Study|Adverse Event|1|||
131004676|NCT02753530|471644271|FG000|Overall Study|Death|0|||
131004677|NCT02753530|471644272|FG001|Overall Study|Death|1|||
131004678|NCT02753530|471644271|FG000|Overall Study|Physician Decision|0|||
131004679|NCT02753530|471644272|FG001|Overall Study|Physician Decision|1|||
131004680|NCT02753530|471644271|FG000|Overall Study|Protocol Violation|1|||
131004681|NCT02753530|471644272|FG001|Overall Study|Protocol Violation|0|||
131004682|NCT02753530|471644271|FG000|Overall Study|Withdrawal by Subject|4|||
131004683|NCT02753530|471644272|FG001|Overall Study|Withdrawal by Subject|3|||
131004684|NCT00429793|471644281|FG000|Overall Study|Improper pre-protocol treatment|3|||
131004685|NCT00429793|471644281|FG000|Overall Study|Required test not done|1|||
131004686|NCT00429793|471644281|FG000|Overall Study|Never treated|1|||
131004687|NCT00429793|471644281|FG000|Overall Study|Non-measurable|1|||
131004688|NCT00097370|471644282|FG000|Stage 1|Adverse Event|3|||
131004689|NCT00097370|471644282|FG000|Stage 1|Withdrawal by Subject|1|||
131004690|NCT00097370|471644282|FG000|Stage 1|Lack of Efficacy|2|||
131004691|NCT00097370|471644282|FG000|Stage 2|Adverse Event|5|||
131004692|NCT00097370|471644282|FG000|Stage 2|Withdrawal by Subject|1|||
131004693|NCT00097370|471644282|FG000|Stage 2|Lack of Efficacy|3|||
131004694|NCT00097370|471644282|FG000|Stage 2|Pregnancy|1|||
131004695|NCT00097370|471644282|FG000|Stage 2|Sponsor Terminated Study|2|||
131004696|NCT00097370|471644282|FG000|Stage 2|Lost to Follow-up|1|||
131004697|NCT00097370|471644282|FG000|Stage 3|Adverse Event|2|||
131004698|NCT00097370|471644282|FG000|Stage 3|Withdrawal by Subject|3|||
131004699|NCT00097370|471644282|FG000|Stage 3|Lack of Efficacy|1|||
131004700|NCT00097370|471644282|FG000|Stage 3|Sponsor Terminated Study|52|||
131004701|NCT00097370|471644282|FG000|Stage 3|Lost to Follow-up|1|||
130765928|NCT05153148|470765902|FG003|Overall Study|Reason not Specified|1|||
130765929|NCT01732471|470765903|FG000|Overall Study|Withdrawal by Subject|1|||
131004702|NCT01641861|471644284|FG000|Overall Study|Lost to Follow-up|21|||
131004703|NCT01641861|471644285|FG001|Overall Study|Lost to Follow-up|16|||
131004704|NCT01641861|471644284|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
131004705|NCT01641861|471644285|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
131004706|NCT01641861|471644284|FG000|Overall Study|Died due to drowning|0|||
131004707|NCT01641861|471644285|FG001|Overall Study|Died due to drowning|1|||
131004708|NCT01101542|471644286|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
131004709|NCT01101542|471644286|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
131004710|NCT01101542|471644286|FG000|Year 4 Surveillance Period|Other|287|||
131004711|NCT01101542|471644286|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
131004712|NCT01101542|471644286|FG000|Year 5 Surveillance Period|Pregnancy|1|||
131004713|NCT01101542|471644286|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
131004714|NCT01101542|471644286|FG000|Year 6 Surveillance Period|Pregnancy|1|||
131004715|NCT01101542|471644286|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
131004716|NCT00432159|471646102|FG000|Overall Study|Death|0|||
131004717|NCT00432159|471646103|FG001|Overall Study|Death|1|||
131004718|NCT00432159|471646104|FG002|Overall Study|Death|0|||
131004719|NCT00432159|471646105|FG003|Overall Study|Death|0|||
131004720|NCT00432159|471646106|FG004|Overall Study|Death|0|||
131004721|NCT00432159|471646102|FG000|Overall Study|Failure|9|||
131004722|NCT00432159|471646103|FG001|Overall Study|Failure|5|||
131004723|NCT00432159|471646104|FG002|Overall Study|Failure|3|||
131004724|NCT00432159|471646105|FG003|Overall Study|Failure|2|||
131004725|NCT00432159|471646106|FG004|Overall Study|Failure|3|||
131004726|NCT00432159|471646102|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
131004727|NCT00432159|471646103|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
131004728|NCT00432159|471646104|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
131004729|NCT00432159|471646105|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
131004730|NCT00432159|471646106|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
131004731|NCT01256476|471646107|FG000|Overall Study|Adverse Event|2|||
131004732|NCT01256476|471646108|FG001|Overall Study|Adverse Event|1|||
131004733|NCT01256476|471646107|FG000|Overall Study|Withdrawal by Subject|2|||
131004734|NCT01256476|471646108|FG001|Overall Study|Withdrawal by Subject|1|||
131004735|NCT01256476|471646107|FG000|Overall Study|Lost to Follow-up|1|||
131004736|NCT01256476|471646108|FG001|Overall Study|Lost to Follow-up|2|||
131004737|NCT01256476|471646107|FG000|Overall Study|Persistent ALT or AST elevation|1|||
131004738|NCT01256476|471646108|FG001|Overall Study|Persistent ALT or AST elevation|0|||
131004739|NCT01256476|471646107|FG000|Overall Study|Physician Decision|0|||
131004740|NCT01256476|471646108|FG001|Overall Study|Physician Decision|1|||
131004741|NCT01256476|471646107|FG000|Overall Study|Subject non-compliance|0|||
131004742|NCT01256476|471646108|FG001|Overall Study|Subject non-compliance|1|||
131004743|NCT01256476|471646107|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
131004744|NCT01256476|471646108|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
131004745|NCT02491411|471646113|FG000|Overall Study|Physician Decision|4|||
131004746|NCT00924664|471646114|FG000|Overall Study|Adverse Event|23|||
131004747|NCT00924664|471646115|FG001|Overall Study|Adverse Event|39|||
131004748|NCT00924664|471646114|FG000|Overall Study|Lack of Efficacy|10|||
131004749|NCT00924664|471646115|FG001|Overall Study|Lack of Efficacy|15|||
131004750|NCT00924664|471646114|FG000|Overall Study|Lost to Follow-up|10|||
131004751|NCT00924664|471646115|FG001|Overall Study|Lost to Follow-up|12|||
131004752|NCT00924664|471646114|FG000|Overall Study|Withdrawal by Subject|47|||
131004753|NCT00924664|471646115|FG001|Overall Study|Withdrawal by Subject|71|||
131004754|NCT00924664|471646114|FG000|Overall Study|Protocol Violation|2|||
131004755|NCT00924664|471646115|FG001|Overall Study|Protocol Violation|5|||
131004756|NCT00924664|471646114|FG000|Overall Study|Pregnancy|1|||
131004757|NCT00924664|471646115|FG001|Overall Study|Pregnancy|1|||
131004758|NCT00924664|471646114|FG000|Overall Study|Death|0|||
131004759|NCT00924664|471646115|FG001|Overall Study|Death|2|||
131004760|NCT00924664|471646114|FG000|Overall Study|Study terminated by sponsor|199|||
131004761|NCT00924664|471646115|FG001|Overall Study|Study terminated by sponsor|330|||
131004762|NCT00924664|471646114|FG000|Overall Study|Other|29|||
131004763|NCT00924664|471646115|FG001|Overall Study|Other|52|||
131004764|NCT00924664|471646114|FG000|Overall Study|Randomized but not Treated|1|||
131004765|NCT00924664|471646115|FG001|Overall Study|Randomized but not Treated|0|||
131004766|NCT03158948|471646117|FG000|Overall Study|Death|1|||
131004767|NCT03158948|471646118|FG001|Overall Study|Death|1|||
131004768|NCT03158948|471646119|FG002|Overall Study|Death|3|||
131004769|NCT03158948|471646120|FG003|Overall Study|Death|2|||
131004770|NCT03158948|471646117|FG000|Overall Study|Physician Decision|0|||
131004771|NCT03158948|471646118|FG001|Overall Study|Physician Decision|0|||
131004772|NCT03158948|471646119|FG002|Overall Study|Physician Decision|0|||
131004773|NCT03158948|471646120|FG003|Overall Study|Physician Decision|1|||
131004774|NCT05305040|471646121|FG000|Overall Study|Not Dosed|37|||
131004775|NCT05305040|471646122|FG001|Overall Study|Not Dosed|37|||
131004776|NCT05305040|471646121|FG000|Overall Study|Study Closure|34|||
131004777|NCT05305040|471646122|FG001|Overall Study|Study Closure|46|||
131004778|NCT05305040|471646121|FG000|Overall Study|Death|14|||
131004779|NCT05305040|471646122|FG001|Overall Study|Death|13|||
131004780|NCT05305040|471646121|FG000|Overall Study|Withdrawal by Subject|15|||
131004781|NCT05305040|471646122|FG001|Overall Study|Withdrawal by Subject|10|||
131004782|NCT05305040|471646121|FG000|Overall Study|Other|13|||
131004783|NCT05305040|471646122|FG001|Overall Study|Other|10|||
131004784|NCT05305040|471646121|FG000|Overall Study|Primary Malignancy Relapse|3|||
131004785|NCT05305040|471646122|FG001|Overall Study|Primary Malignancy Relapse|4|||
131004786|NCT05305040|471646121|FG000|Overall Study|Adverse Event|3|||
131004787|NCT05305040|471646122|FG001|Overall Study|Adverse Event|3|||
131004788|NCT05305040|471646121|FG000|Overall Study|Lost to Follow-up|2|||
131004789|NCT05305040|471646122|FG001|Overall Study|Lost to Follow-up|1|||
131004790|NCT05305040|471646121|FG000|Overall Study|Graft versus host disease|2|||
131004791|NCT05305040|471646122|FG001|Overall Study|Graft versus host disease|0|||
131004792|NCT05305040|471646121|FG000|Overall Study|Investigator's Decision|1|||
131004793|NCT05305040|471646122|FG001|Overall Study|Investigator's Decision|1|||
131004794|NCT05305040|471646121|FG000|Overall Study|COVID-19 Reasons|1|||
131004795|NCT05305040|471646122|FG001|Overall Study|COVID-19 Reasons|0|||
131004796|NCT01876043|471646123|FG000|Overall Study|Death|1|||
131004797|NCT01876043|471646123|FG000|Overall Study|Withdrawal by Subject|1|||
131004798|NCT00079937|471646124|FG000|Overall Study|Adverse Event|2|||
131004799|NCT00079937|471646125|FG001|Overall Study|Adverse Event|1|||
131004800|NCT00079937|471646124|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131004801|NCT00079937|471646125|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131004802|NCT00079937|471646124|FG000|Overall Study|Subject no longer requires study drug|3|||
131004803|NCT00079937|471646125|FG001|Overall Study|Subject no longer requires study drug|0|||
131004804|NCT00079937|471646124|FG000|Overall Study|Protocol Violation|8|||
131004805|NCT00079937|471646125|FG001|Overall Study|Protocol Violation|6|||
131004806|NCT00079937|471646124|FG000|Overall Study|Withdrawal by Subject|21|||
131004807|NCT00079937|471646125|FG001|Overall Study|Withdrawal by Subject|7|||
131004808|NCT00079937|471646124|FG000|Overall Study|Lost to Follow-up|12|||
131004809|NCT00079937|471646125|FG001|Overall Study|Lost to Follow-up|5|||
131004810|NCT00079937|471646124|FG000|Overall Study|Administrative problems|22|||
131004811|NCT00079937|471646125|FG001|Overall Study|Administrative problems|11|||
131004812|NCT01616563|471646126|FG000|Overall Study|Lost to Follow-up|40|||
131004813|NCT01195675|471646130|FG000|Overall Study|Adverse Event|1|||
131004814|NCT01195675|471646130|FG000|Overall Study|Withdrawal by Subject|2|||
131004815|NCT01106287|471646131|FG000|Overall Study|Adverse Event|1|||
131004816|NCT01106287|471646132|FG001|Overall Study|Adverse Event|0|||
131004817|NCT01106287|471646133|FG002|Overall Study|Adverse Event|0|||
131004818|NCT01106287|471646134|FG003|Overall Study|Adverse Event|0|||
131004819|NCT00072475|471646135|FG000|Overall Study|Adverse Event|44|||
131004820|NCT00072475|471646135|FG000|Overall Study|Death|3|||
131004821|NCT00072475|471646135|FG000|Overall Study|Withdrawal by Subject|46|||
131004822|NCT00072475|471646135|FG000|Overall Study|Patient/Investigator Decision|4|||
131004823|NCT04730947|471646136|FG000|Overall Study|Withdrawal by Subject|0|||
131004824|NCT04730947|471646137|FG001|Overall Study|Withdrawal by Subject|1|||
131004825|NCT00940017|471646138|FG000|Overall Study|did not meet entrance criteria|3|||
131004826|NCT00940017|471646138|FG000|Overall Study|Adverse Event|1|||
131004827|NCT01450943|471646139|FG000|Overall Study|Screen failure, loss to follow-up|2|||
131004828|NCT01450943|471646140|FG001|Overall Study|Screen failure, loss to follow-up|7|||
131004829|NCT01450943|471646141|FG002|Overall Study|Screen failure, loss to follow-up|6|||
131004830|NCT01033643|471646146|FG000|Overall Study|Withdrew Consent|0|||
131004831|NCT01033643|471646147|FG001|Overall Study|Withdrew Consent|3|||
131004832|NCT01033643|471646148|FG002|Overall Study|Withdrew Consent|0|||
131004833|NCT01033643|471646149|FG003|Overall Study|Withdrew Consent|0|||
131004834|NCT01033643|471646150|FG004|Overall Study|Withdrew Consent|0|||
131004835|NCT01033643|471646151|FG005|Overall Study|Withdrew Consent|1|||
131004836|NCT00465361|471646152|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
131004837|NCT05406791|471646153|FG000|Overall Study|Lost to Follow-up|13|||
131004838|NCT05406791|471646154|FG001|Overall Study|Lost to Follow-up|10|||
131004839|NCT01789203|471646155|FG000|Overall Study|Adverse Event|2|||
131004840|NCT01789203|471646156|FG001|Overall Study|Adverse Event|2|||
131004841|NCT01789203|471646155|FG000|Overall Study|Withdrawal by Subject|1|||
131004842|NCT01789203|471646156|FG001|Overall Study|Withdrawal by Subject|0|||
131004843|NCT01789203|471646155|FG000|Overall Study|Death|1|||
131004844|NCT01789203|471646156|FG001|Overall Study|Death|0|||
131004845|NCT01789203|471646155|FG000|Overall Study|Protocol Violation|2|||
131004846|NCT01789203|471646156|FG001|Overall Study|Protocol Violation|1|||
131004847|NCT01789203|471646155|FG000|Overall Study|Other|1|||
131004848|NCT01789203|471646156|FG001|Overall Study|Other|1|||
131004849|NCT01789203|471646155|FG000|Overall Study|patient non-adherent|2|||
131004850|NCT01789203|471646156|FG001|Overall Study|patient non-adherent|0|||
131004851|NCT02652130|471646157|FG000|Overall Study|Death|1|||
131004852|NCT00354029|471646160|FG000|Overall Study|Protocol Violation|4|||
131004853|NCT00354029|471646161|FG001|Overall Study|Protocol Violation|2|||
131004854|NCT00826280|471646162|FG000|Overall Study|Randomized but drug not received|1|||
131004855|NCT00826280|471646163|FG001|Overall Study|Randomized but drug not received|0|||
131004856|NCT00826280|471646164|FG002|Overall Study|Randomized but drug not received|1|||
131004857|NCT00826280|471646162|FG000|Overall Study|Adverse Event|1|||
131004858|NCT00826280|471646163|FG001|Overall Study|Adverse Event|3|||
131004859|NCT00826280|471646164|FG002|Overall Study|Adverse Event|0|||
131004860|NCT00826280|471646162|FG000|Overall Study|Lost to Follow-up|0|||
131004861|NCT00826280|471646163|FG001|Overall Study|Lost to Follow-up|1|||
131004862|NCT00826280|471646164|FG002|Overall Study|Lost to Follow-up|0|||
131004863|NCT00826280|471646162|FG000|Overall Study|Sponsor discontinued subject or study|1|||
131004864|NCT00826280|471646163|FG001|Overall Study|Sponsor discontinued subject or study|0|||
131004865|NCT00826280|471646164|FG002|Overall Study|Sponsor discontinued subject or study|0|||
131004866|NCT00826280|471646162|FG000|Overall Study|Reversible ischemic defect not present|43|||
131004867|NCT00826280|471646163|FG001|Overall Study|Reversible ischemic defect not present|40|||
131004868|NCT00826280|471646164|FG002|Overall Study|Reversible ischemic defect not present|44|||
131004869|NCT00826280|471646162|FG000|Overall Study|Interpretation Failure|1|||
131004870|NCT00826280|471646163|FG001|Overall Study|Interpretation Failure|0|||
131004871|NCT00826280|471646164|FG002|Overall Study|Interpretation Failure|0|||
131004872|NCT00826280|471646162|FG000|Overall Study|Machine Failure|1|||
131004873|NCT00826280|471646163|FG001|Overall Study|Machine Failure|1|||
131004874|NCT00826280|471646164|FG002|Overall Study|Machine Failure|0|||
131004875|NCT00826280|471646162|FG000|Overall Study|One or more non-interpretable scan|0|||
131004876|NCT00826280|471646163|FG001|Overall Study|One or more non-interpretable scan|1|||
131004877|NCT00826280|471646164|FG002|Overall Study|One or more non-interpretable scan|1|||
131004878|NCT03201757|471646165|FG000|Overall Study|Withdrawal by Subject|133|||
131004879|NCT03201757|471646165|FG000|Overall Study|Adverse Event|44|||
131004880|NCT03201757|471646165|FG000|Overall Study|Lost to Follow-up|37|||
131004881|NCT03201757|471646165|FG000|Overall Study|Pregnancy|2|||
131004882|NCT03201757|471646165|FG000|Overall Study|Lack of Efficacy|1|||
131004883|NCT03201757|471646165|FG000|Overall Study|Protocol Violation|20|||
131004884|NCT03201757|471646165|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
131004885|NCT03201757|471646165|FG000|Overall Study|Not Yet Determined|5|||
131004886|NCT03201757|471646165|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
131004887|NCT03201757|471646165|FG000|Overall Study|Other|20|||
131004888|NCT02297503|471646166|FG000|Overall Study|Withdrawal by Subject|1|||
131004889|NCT02297503|471646167|FG001|Overall Study|Withdrawal by Subject|1|||
131004890|NCT02297503|471646166|FG000|Overall Study|Protocol Violation|1|||
131004891|NCT02297503|471646167|FG001|Overall Study|Protocol Violation|0|||
131004892|NCT02297503|471646166|FG000|Overall Study|Pregnancy|0|||
131004893|NCT02297503|471646167|FG001|Overall Study|Pregnancy|1|||
131004894|NCT02297503|471646166|FG000|Overall Study|Lost to Follow-up|0|||
131004895|NCT02297503|471646167|FG001|Overall Study|Lost to Follow-up|1|||
131004896|NCT02297503|471646166|FG000|Overall Study|Medical reason|0|||
131004897|NCT02297503|471646167|FG001|Overall Study|Medical reason|1|||
131004898|NCT02788656|471646169|FG000|Overall Study|Withdrawal by Subject|1|||
131004899|NCT02788656|471646170|FG001|Overall Study|Withdrawal by Subject|0|||
131004900|NCT01403987|471646174|FG000|Overall Study|Residents forgot their secret PIN|18|||
131004901|NCT01403987|471646175|FG001|Overall Study|Residents forgot their secret PIN|17|||
131004902|NCT01403987|471646176|FG002|Overall Study|Residents forgot their secret PIN|18|||
131004903|NCT00180674|471646178|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
131004904|NCT00180674|471646178|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
131004905|NCT04537949|471646180|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
131004906|NCT04537949|471646181|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
131004907|NCT04537949|471646182|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
131004908|NCT04537949|471646183|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
131004909|NCT04537949|471646184|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
131004910|NCT04537949|471646185|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
131004911|NCT04537949|471646186|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
131004912|NCT04537949|471646187|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
131004913|NCT04537949|471646180|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
131004914|NCT04537949|471646181|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
131004915|NCT04537949|471646182|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
131004916|NCT04537949|471646183|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
131004917|NCT04537949|471646184|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
131004918|NCT04537949|471646185|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
131004919|NCT04537949|471646186|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
131004920|NCT04537949|471646187|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
131004921|NCT04537949|471646180|FG000|Follow-up Phase|Lost to Follow-up|0|||
131004922|NCT04537949|471646181|FG001|Follow-up Phase|Lost to Follow-up|3|||
131004923|NCT04537949|471646182|FG002|Follow-up Phase|Lost to Follow-up|0|||
131004924|NCT04537949|471646183|FG003|Follow-up Phase|Lost to Follow-up|0|||
131004925|NCT04537949|471646184|FG004|Follow-up Phase|Lost to Follow-up|0|||
131004926|NCT04537949|471646185|FG005|Follow-up Phase|Lost to Follow-up|0|||
131004927|NCT04537949|471646186|FG006|Follow-up Phase|Lost to Follow-up|0|||
131004928|NCT04537949|471646187|FG007|Follow-up Phase|Lost to Follow-up|0|||
131004929|NCT04537949|471646180|FG000|Follow-up Phase|personal reasons|0|||
131004930|NCT04537949|471646181|FG001|Follow-up Phase|personal reasons|0|||
131004931|NCT04537949|471646182|FG002|Follow-up Phase|personal reasons|0|||
131004932|NCT04537949|471646183|FG003|Follow-up Phase|personal reasons|1|||
131004933|NCT04537949|471646184|FG004|Follow-up Phase|personal reasons|1|||
131004934|NCT04537949|471646185|FG005|Follow-up Phase|personal reasons|0|||
131004935|NCT04537949|471646186|FG006|Follow-up Phase|personal reasons|0|||
131004936|NCT04537949|471646187|FG007|Follow-up Phase|personal reasons|0|||
131004937|NCT04537949|471646180|FG000|Follow-up Phase|Withdrawal by Subject|0|||
131004938|NCT04537949|471646181|FG001|Follow-up Phase|Withdrawal by Subject|0|||
131004939|NCT04537949|471646182|FG002|Follow-up Phase|Withdrawal by Subject|0|||
131004940|NCT04537949|471646183|FG003|Follow-up Phase|Withdrawal by Subject|0|||
131004941|NCT04537949|471646184|FG004|Follow-up Phase|Withdrawal by Subject|1|||
131004942|NCT04537949|471646185|FG005|Follow-up Phase|Withdrawal by Subject|0|||
131004943|NCT04537949|471646186|FG006|Follow-up Phase|Withdrawal by Subject|0|||
131004944|NCT04537949|471646187|FG007|Follow-up Phase|Withdrawal by Subject|0|||
131004945|NCT04003974|471646189|FG000|Overall Study|Missing|1|||
131004946|NCT04003974|471646190|FG001|Overall Study|Missing|0|||
131004947|NCT04003974|471646189|FG000|Overall Study|Withdrawal by Subject|0|||
131004948|NCT04003974|471646190|FG001|Overall Study|Withdrawal by Subject|2|||
131004949|NCT04296942|471646191|FG000|Overall Study|Study closure by sponsor|1|||
131004950|NCT04296942|471646192|FG001|Overall Study|Study closure by sponsor|0|||
131004951|NCT04296942|471646193|FG002|Overall Study|Study closure by sponsor|0|||
131004952|NCT00335153|471646194|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
131004953|NCT00335153|471646194|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
131004954|NCT00335153|471646194|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
131004955|NCT00335153|471646194|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
131004956|NCT00335153|471646194|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
131004957|NCT00335153|471646194|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
131004958|NCT00335153|471646194|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
131004959|NCT00335153|471646194|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
131004960|NCT00335153|471646194|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
131004961|NCT00335153|471646194|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
131004962|NCT01113463|471646199|FG000|Overall Study|Physician Decision|5|||
131004963|NCT02478359|471646200|FG000|Overall Study|Disenrolled from health plan|106|||
131004964|NCT02478359|471646201|FG001|Overall Study|Disenrolled from health plan|65|||
131004965|NCT01237678|471646202|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
131004966|NCT01237678|471646203|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
131004967|NCT01237678|471646204|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
131004968|NCT01237678|471646202|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
131004969|NCT01237678|471646203|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
131004970|NCT01237678|471646204|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
131004971|NCT01237678|471646202|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
131004972|NCT01237678|471646203|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
131004973|NCT01237678|471646204|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
131004974|NCT01237678|471646202|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
131004975|NCT01237678|471646203|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
131004976|NCT01237678|471646204|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
131004977|NCT01237678|471646202|FG000|Phase II|Adverse Event|0|||
131004978|NCT01237678|471646203|FG001|Phase II|Adverse Event|39|||
131004979|NCT01237678|471646204|FG002|Phase II|Adverse Event|9|||
131004980|NCT01237678|471646202|FG000|Phase II|Death|0|||
131004981|NCT01237678|471646203|FG001|Phase II|Death|0|||
131004982|NCT01237678|471646204|FG002|Phase II|Death|2|||
131004983|NCT01237678|471646202|FG000|Phase II|Lack of Efficacy|0|||
131004984|NCT01237678|471646203|FG001|Phase II|Lack of Efficacy|25|||
131004985|NCT01237678|471646204|FG002|Phase II|Lack of Efficacy|3|||
131004986|NCT01237678|471646202|FG000|Phase II|Withdrawal by Subject|0|||
131004987|NCT01237678|471646203|FG001|Phase II|Withdrawal by Subject|1|||
131004988|NCT01237678|471646204|FG002|Phase II|Withdrawal by Subject|5|||
131004989|NCT01237678|471646202|FG000|Phase II|Completed Cycles 4-6|0|||
131004990|NCT01237678|471646203|FG001|Phase II|Completed Cycles 4-6|11|||
131004991|NCT01237678|471646204|FG002|Phase II|Completed Cycles 4-6|21|||
131004992|NCT01237678|471646202|FG000|Phase II|Sponsor Decision/Study Closed|0|||
131004993|NCT01237678|471646203|FG001|Phase II|Sponsor Decision/Study Closed|18|||
131004994|NCT01237678|471646204|FG002|Phase II|Sponsor Decision/Study Closed|7|||
131004995|NCT01237678|471646202|FG000|Phase II|Randomized but were not treated|0|||
131004996|NCT01237678|471646203|FG001|Phase II|Randomized but were not treated|4|||
131004997|NCT01237678|471646204|FG002|Phase II|Randomized but were not treated|3|||
131004998|NCT00372528|471646205|FG000|Overall Study|Lack of Efficacy|1|||
131004999|NCT00372528|471646205|FG000|Overall Study|Adverse Event|1|||
131005000|NCT00372528|471646205|FG000|Overall Study|Study Terminated by Sponsor|18|||
131005001|NCT00372528|471646205|FG000|Overall Study|Other|1|||
131222329|NCT01255722|472441456|FG002|Overall Study|Adverse Event|1|||
131222330|NCT01255722|472441454|FG000|Overall Study|asymptomatic patient|1|||
131222331|NCT01255722|472441455|FG001|Overall Study|asymptomatic patient|0|||
131222332|NCT01255722|472441456|FG002|Overall Study|asymptomatic patient|0|||
131222333|NCT01255722|472441454|FG000|Overall Study|beta-blocker contraindicated|2|||
131222334|NCT01255722|472441455|FG001|Overall Study|beta-blocker contraindicated|0|||
131222335|NCT01255722|472441456|FG002|Overall Study|beta-blocker contraindicated|0|||
131222336|NCT02164539|472441457|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
131222337|NCT02164539|472441458|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
131222338|NCT02164539|472441459|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
131222339|NCT02164539|472441460|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
131222340|NCT02164539|472441461|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
131222341|NCT02164539|472441462|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
131222342|NCT02164539|472441463|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
131222343|NCT02164539|472441457|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
131222344|NCT02164539|472441458|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
131222345|NCT02164539|472441459|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
131222346|NCT02164539|472441460|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
131222347|NCT02164539|472441461|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
131222348|NCT02164539|472441462|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
131222349|NCT02164539|472441463|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
131222350|NCT02164539|472441457|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
131222351|NCT02164539|472441458|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
131222352|NCT02164539|472441459|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
131222353|NCT02164539|472441460|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
131222354|NCT02164539|472441461|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
131222355|NCT02164539|472441462|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
131222356|NCT02164539|472441463|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
131222357|NCT02164539|472441457|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
131222358|NCT02164539|472441458|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131222359|NCT02164539|472441459|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131222360|NCT02164539|472441460|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131222361|NCT02164539|472441461|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131222362|NCT02164539|472441462|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131222363|NCT02164539|472441463|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
131222364|NCT02164539|472441457|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
131222365|NCT02164539|472441458|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
131222366|NCT02164539|472441459|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
131222367|NCT02164539|472441460|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
131222368|NCT02164539|472441461|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
131222369|NCT02164539|472441462|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
131222370|NCT02164539|472441463|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
131222371|NCT02164539|472441457|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
131222372|NCT02164539|472441458|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
131222373|NCT02164539|472441459|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
131222374|NCT02164539|472441460|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
131222375|NCT02164539|472441461|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
131222376|NCT02164539|472441462|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
131222377|NCT02164539|472441463|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
131222378|NCT02643966|472441464|FG000|First Screening Round|ineligible|1|||
131222379|NCT02643966|472441464|FG000|First Screening Round|excluded from analysis|2|||
131222380|NCT02643966|472441464|FG000|First Screening Round|Lost to Follow-up|56|||
131222381|NCT02643966|472441464|FG000|First Screening Round|Withdrawal by Subject|28|||
131222382|NCT02643966|472441464|FG000|First Screening Round|Death|1|||
131222383|NCT02643966|472441464|FG000|Between First and Second Screening|Lost to Follow-up|65|||
131222384|NCT02643966|472441464|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
131222385|NCT02643966|472441464|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
131222386|NCT02643966|472441464|FG000|Second Screening Round|Withdrawal by Subject|20|||
131222387|NCT02643966|472441464|FG000|Second Screening Round|Lost to Follow-up|57|||
131222388|NCT02643966|472441464|FG000|Second Screening Round|Physician Decision|2|||
131222389|NCT02643966|472441464|FG000|Second Screening Round|Death|4|||
131222390|NCT02643966|472441464|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
131222391|NCT02643966|472441464|FG000|Between Second and Third Screening|Death|1|||
131222392|NCT02643966|472441464|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
131222393|NCT02643966|472441464|FG000|Third Screening Round|PI excluded|2|||
131222394|NCT02643966|472441464|FG000|Third Screening Round|Lost to Follow-up|241|||
131222395|NCT01612702|472441467|FG000|Overall Study|Protocol Violation|11|||
131222396|NCT01612702|472441468|FG001|Overall Study|Protocol Violation|11|||
131222397|NCT01542736|472441469|FG000|Overall Study|Death|1|||
131222398|NCT02400905|472441470|FG000|Overall Study|Death|24|||
131222399|NCT02400905|472441470|FG000|Overall Study|Lost to Follow-up|18|||
131005002|NCT03023332|471646206|FG000|Overall Study|Withdrawal by Subject|10|||
131005003|NCT03023332|471646207|FG001|Overall Study|Withdrawal by Subject|5|||
131005004|NCT03023332|471646208|FG002|Overall Study|Withdrawal by Subject|4|||
131005005|NCT03023332|471646209|FG003|Overall Study|Withdrawal by Subject|7|||
131005006|NCT03023332|471646206|FG000|Overall Study|Lost to Follow-up|13|||
131005007|NCT03023332|471646207|FG001|Overall Study|Lost to Follow-up|16|||
131005008|NCT03023332|471646208|FG002|Overall Study|Lost to Follow-up|8|||
131005009|NCT03023332|471646209|FG003|Overall Study|Lost to Follow-up|13|||
131005010|NCT03023332|471646206|FG000|Overall Study|Death|1|||
131005011|NCT03023332|471646207|FG001|Overall Study|Death|0|||
131005012|NCT03023332|471646208|FG002|Overall Study|Death|0|||
131005013|NCT03023332|471646209|FG003|Overall Study|Death|0|||
131005014|NCT02412761|471646210|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131005015|NCT02412761|471646211|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131005016|NCT02412761|471646212|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131005017|NCT02412761|471646213|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131005018|NCT02412761|471646214|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131005019|NCT02412761|471646215|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131005020|NCT01818700|471646216|FG000|Overall Study|Adverse Event|67|||
131005021|NCT01818700|471646216|FG000|Overall Study|Lack of Efficacy|2|||
131005022|NCT01818700|471646216|FG000|Overall Study|Lost to Follow-up|5|||
131005023|NCT01818700|471646216|FG000|Overall Study|Withdrawal by Subject|27|||
131005024|NCT01818700|471646216|FG000|Overall Study|Protocol Violation|2|||
131005025|NCT01818700|471646216|FG000|Overall Study|Other|1|||
131005026|NCT02240680|471646217|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
131005027|NCT02240680|471646218|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
131222400|NCT02400905|472441470|FG000|Overall Study|Withdrawal by Subject|16|||
131222401|NCT02400905|472441470|FG000|Overall Study|Physician Decision|4|||
131222402|NCT02400905|472441470|FG000|Overall Study|Other|1|||
131222403|NCT02441179|472441477|FG000|Overall Study|Withdrawal by Subject|1|||
131222404|NCT02441179|472441478|FG001|Overall Study|Withdrawal by Subject|1|||
131222405|NCT03091400|472441479|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
131222406|NCT03091400|472441480|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
131222407|NCT00051636|472441481|FG000|Period 1 - Core|Adverse Event|2|||
131222408|NCT00051636|472441482|FG001|Period 1 - Core|Adverse Event|2|||
131222409|NCT00051636|472441481|FG000|Period 1 - Core|Protocol Violation|1|||
131222410|NCT00051636|472441482|FG001|Period 1 - Core|Protocol Violation|0|||
131222411|NCT00051636|472441481|FG000|Period 1 - Core|Withdrawal by Subject|1|||
131222412|NCT00051636|472441482|FG001|Period 1 - Core|Withdrawal by Subject|2|||
131222413|NCT00051636|472441481|FG000|Period 1 - Core|Lost to Follow-up|0|||
131222414|NCT00051636|472441482|FG001|Period 1 - Core|Lost to Follow-up|2|||
131222415|NCT00051636|472441481|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
131222416|NCT00051636|472441482|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
131222417|NCT00051636|472441481|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
131222418|NCT00051636|472441482|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
131222419|NCT00051636|472441481|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
131222420|NCT00051636|472441482|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
131222421|NCT00051636|472441481|FG000|Period 2- Extended Observation Period|Death|4|||
131222422|NCT00051636|472441482|FG001|Period 2- Extended Observation Period|Death|5|||
131222423|NCT00051636|472441481|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
131222424|NCT00051636|472441482|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
131222425|NCT00743119|472441487|FG000|Overall Study|unreliable|3|||
131222426|NCT00743119|472441487|FG000|Overall Study|Withdrawal by Subject|1|||
130884896|NCT00790842|471213226|FG010|Expansion Cohort|Death|0|||
130884897|NCT00790842|471213216|FG000|Expansion Cohort|Physician Decision|0|||
130884898|NCT00790842|471213217|FG001|Expansion Cohort|Physician Decision|0|||
130884899|NCT00790842|471213218|FG002|Expansion Cohort|Physician Decision|1|||
131005028|NCT02240680|471646219|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
131005029|NCT02240680|471646220|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
131005030|NCT02240680|471646217|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
131005031|NCT02240680|471646218|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
131100931|NCT03647488|471999579|FG002|Overall Study|Clinical progression|0|||
131100932|NCT03647488|471999577|FG000|Overall Study|Participant refused to take investigational product|1|||
131100933|NCT03647488|471999578|FG001|Overall Study|Participant refused to take investigational product|0|||
131100934|NCT03647488|471999579|FG002|Overall Study|Participant refused to take investigational product|0|||
131100935|NCT03694275|471999580|FG000|Overall Study|Adverse Event|0|||
131100936|NCT03694275|471999581|FG001|Overall Study|Adverse Event|1|||
131100937|NCT03694275|471999580|FG000|Overall Study|Reason not Specified|0|||
131100938|NCT03694275|471999581|FG001|Overall Study|Reason not Specified|1|||
131100939|NCT03541174|471999582|FG000|Part 1 Double-Blind|Adverse Event|6|||
131100940|NCT03541174|471999583|FG001|Part 1 Double-Blind|Adverse Event|5|||
131100941|NCT03541174|471999584|FG002|Part 1 Double-Blind|Adverse Event|2|||
131100942|NCT03541174|471999585|FG003|Part 1 Double-Blind|Adverse Event|0|||
131100943|NCT03541174|471999586|FG004|Part 1 Double-Blind|Adverse Event|0|||
131100944|NCT03541174|471999587|FG005|Part 1 Double-Blind|Adverse Event|0|||
131100945|NCT03541174|471999582|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
131100946|NCT03541174|471999583|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
131100947|NCT03541174|471999584|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
130884900|NCT00790842|471213219|FG003|Expansion Cohort|Physician Decision|0|||
130884901|NCT00790842|471213220|FG004|Expansion Cohort|Physician Decision|0|||
130884902|NCT00790842|471213221|FG005|Expansion Cohort|Physician Decision|0|||
130884903|NCT00790842|471213222|FG006|Expansion Cohort|Physician Decision|0|||
131229269|NCT01360632|472465870|FG001|Phase A+|Lost to Follow-up|0|||
131229270|NCT01360632|472465871|FG002|Phase A+|Lost to Follow-up|0|||
131229271|NCT01360632|472465872|FG003|Phase A+|Lost to Follow-up|0|||
131229272|NCT01360632|472465873|FG004|Phase A+|Lost to Follow-up|2|||
131229273|NCT01360632|472465869|FG000|Phase A+|Adverse Event|0|||
131229274|NCT01360632|472465870|FG001|Phase A+|Adverse Event|0|||
131229275|NCT01360632|472465871|FG002|Phase A+|Adverse Event|0|||
131229276|NCT01360632|472465872|FG003|Phase A+|Adverse Event|0|||
131229277|NCT01360632|472465873|FG004|Phase A+|Adverse Event|2|||
131229278|NCT01360632|472465869|FG000|Phase A+|Met Withdrawal Criteria|0|||
131229279|NCT01360632|472465870|FG001|Phase A+|Met Withdrawal Criteria|0|||
131229280|NCT01360632|472465871|FG002|Phase A+|Met Withdrawal Criteria|0|||
131229281|NCT01360632|472465872|FG003|Phase A+|Met Withdrawal Criteria|0|||
131005032|NCT02240680|471646219|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
131005033|NCT02240680|471646220|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
131005034|NCT02240680|471646217|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
131229282|NCT01360632|472465873|FG004|Phase A+|Met Withdrawal Criteria|7|||
131229283|NCT01360632|472465869|FG000|Phase A+|Physician Decision|0|||
131229284|NCT01360632|472465870|FG001|Phase A+|Physician Decision|0|||
131229285|NCT01360632|472465871|FG002|Phase A+|Physician Decision|0|||
131229286|NCT01360632|472465872|FG003|Phase A+|Physician Decision|0|||
131229287|NCT01360632|472465873|FG004|Phase A+|Physician Decision|3|||
131229288|NCT01360632|472465869|FG000|Phase A+|Withdrawal by Subject|0|||
131229289|NCT01360632|472465870|FG001|Phase A+|Withdrawal by Subject|0|||
131229290|NCT01360632|472465871|FG002|Phase A+|Withdrawal by Subject|0|||
131229291|NCT01360632|472465872|FG003|Phase A+|Withdrawal by Subject|0|||
131229292|NCT01360632|472465873|FG004|Phase A+|Withdrawal by Subject|8|||
131229293|NCT01360632|472465869|FG000|Phase A+|Protocol Deviation|0|||
131229294|NCT01360632|472465870|FG001|Phase A+|Protocol Deviation|0|||
131229295|NCT01360632|472465871|FG002|Phase A+|Protocol Deviation|0|||
131229296|NCT01360632|472465872|FG003|Phase A+|Protocol Deviation|0|||
131229297|NCT01360632|472465873|FG004|Phase A+|Protocol Deviation|3|||
131229298|NCT02173301|472465874|FG000|Overall Study|Adverse Event|7|||
131229299|NCT02173301|472465875|FG001|Overall Study|Adverse Event|8|||
131229300|NCT02173301|472465876|FG002|Overall Study|Adverse Event|13|||
131229301|NCT02173301|472465877|FG003|Overall Study|Adverse Event|5|||
131229302|NCT02173301|472465874|FG000|Overall Study|Withdrawal by Subject|8|||
131229303|NCT02173301|472465875|FG001|Overall Study|Withdrawal by Subject|10|||
131229304|NCT02173301|472465876|FG002|Overall Study|Withdrawal by Subject|4|||
131229305|NCT02173301|472465877|FG003|Overall Study|Withdrawal by Subject|8|||
131229306|NCT02173301|472465874|FG000|Overall Study|Lost to Follow-up|4|||
131229307|NCT02173301|472465875|FG001|Overall Study|Lost to Follow-up|4|||
131229308|NCT02173301|472465876|FG002|Overall Study|Lost to Follow-up|2|||
131229309|NCT02173301|472465877|FG003|Overall Study|Lost to Follow-up|2|||
131229310|NCT02173301|472465874|FG000|Overall Study|Protocol Violation|0|||
131229311|NCT02173301|472465875|FG001|Overall Study|Protocol Violation|1|||
131229312|NCT02173301|472465876|FG002|Overall Study|Protocol Violation|0|||
131229313|NCT02173301|472465877|FG003|Overall Study|Protocol Violation|0|||
131229314|NCT02173301|472465874|FG000|Overall Study|Physician Decision|0|||
131229315|NCT02173301|472465875|FG001|Overall Study|Physician Decision|0|||
131229316|NCT02173301|472465876|FG002|Overall Study|Physician Decision|1|||
131229317|NCT02173301|472465877|FG003|Overall Study|Physician Decision|0|||
131229318|NCT02173301|472465874|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
131229319|NCT02173301|472465875|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
131229320|NCT02173301|472465876|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
131229321|NCT02173301|472465877|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
131229322|NCT03016078|472465878|FG000|Overall Study|Protocol Violation|1|||
131229323|NCT03016078|472465878|FG000|Overall Study|Protocol Violation|1|||
131229324|NCT02123459|472465881|FG000|Washout Period (1 Day)|Adverse Event|1|||
131229325|NCT02123459|472465882|FG001|Washout Period (1 Day)|Adverse Event|0|||
131229326|NCT02196506|472465887|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
131229327|NCT02196506|472465888|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
131229328|NCT02196506|472465889|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
131229329|NCT02196506|472465890|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
131229330|NCT02196506|472465887|FG000|Phase A|Withdrawal by Subject|34|||
131229331|NCT02196506|472465888|FG001|Phase A|Withdrawal by Subject|0|||
131229332|NCT02196506|472465889|FG002|Phase A|Withdrawal by Subject|0|||
131229333|NCT02196506|472465890|FG003|Phase A|Withdrawal by Subject|0|||
131229334|NCT02196506|472465887|FG000|Phase A|Adverse Event|22|||
131229335|NCT02196506|472465888|FG001|Phase A|Adverse Event|0|||
131229336|NCT02196506|472465889|FG002|Phase A|Adverse Event|0|||
131229337|NCT02196506|472465890|FG003|Phase A|Adverse Event|0|||
131229338|NCT02196506|472465887|FG000|Phase A|Lost to Follow-up|9|||
131229339|NCT02196506|472465888|FG001|Phase A|Lost to Follow-up|0|||
131229340|NCT02196506|472465889|FG002|Phase A|Lost to Follow-up|0|||
131229341|NCT02196506|472465890|FG003|Phase A|Lost to Follow-up|0|||
131229342|NCT02196506|472465887|FG000|Phase A|Protocol deviation|12|||
131229343|NCT02196506|472465888|FG001|Phase A|Protocol deviation|0|||
131229344|NCT02196506|472465889|FG002|Phase A|Protocol deviation|0|||
131229345|NCT02196506|472465890|FG003|Phase A|Protocol deviation|0|||
131229346|NCT02196506|472465887|FG000|Phase A|Participant withdrawn by investigator|10|||
131229347|NCT02196506|472465888|FG001|Phase A|Participant withdrawn by investigator|0|||
131229348|NCT02196506|472465889|FG002|Phase A|Participant withdrawn by investigator|0|||
131229349|NCT02196506|472465890|FG003|Phase A|Participant withdrawn by investigator|0|||
131229350|NCT02196506|472465887|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
131229351|NCT02196506|472465888|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
131229352|NCT02196506|472465889|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
131229353|NCT02196506|472465890|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
131229354|NCT02196506|472465887|FG000|Phase B|Lack of Efficacy|0|||
131005035|NCT02240680|471646218|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
131005036|NCT02240680|471646219|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
131005037|NCT02240680|471646220|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
131005038|NCT02240680|471646217|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
131005039|NCT02240680|471646218|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
131005040|NCT02240680|471646219|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
131005041|NCT02240680|471646220|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
131005042|NCT02240680|471646217|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
131005043|NCT02240680|471646218|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
131005044|NCT02240680|471646219|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
131005045|NCT02240680|471646220|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
131005046|NCT02240680|471646217|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
131005047|NCT02240680|471646218|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
131005048|NCT02240680|471646219|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
131005049|NCT02240680|471646220|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
131005050|NCT02240680|471646217|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
131005051|NCT02240680|471646218|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
131005052|NCT02240680|471646219|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
131005053|NCT02240680|471646220|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
131005054|NCT02240680|471646217|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
131005055|NCT02240680|471646218|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
131005056|NCT02240680|471646219|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
131005057|NCT02240680|471646220|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
131005058|NCT01657682|471646221|FG000|Overall Study|Lost to Follow-up|1|||
131005059|NCT01657682|471646222|FG001|Overall Study|Lost to Follow-up|0|||
131005060|NCT01657682|471646223|FG002|Overall Study|Lost to Follow-up|0|||
131005061|NCT01657682|471646221|FG000|Overall Study|Withdrawal by Subject|0|||
131005062|NCT01657682|471646222|FG001|Overall Study|Withdrawal by Subject|1|||
131005063|NCT01657682|471646223|FG002|Overall Study|Withdrawal by Subject|1|||
131005064|NCT01657682|471646221|FG000|Overall Study|Adverse Event|0|||
131005065|NCT01657682|471646222|FG001|Overall Study|Adverse Event|1|||
131005066|NCT01657682|471646223|FG002|Overall Study|Adverse Event|0|||
131005067|NCT01719861|471646224|FG000|Cycle 1|Death|4|||
131005068|NCT01719861|471646224|FG000|Cycle 2|Death|1|||
131005069|NCT00965484|471646225|FG000|Overall Study|Protocol Violation|1|||
131005070|NCT00965484|471646225|FG000|Overall Study|Withdrawal by Subject|1|||
131005071|NCT00848211|471646226|FG000|Overall Study|Protocol Violation|0|||
131005072|NCT00848211|471646227|FG001|Overall Study|Protocol Violation|1|||
131005073|NCT00848211|471646228|FG002|Overall Study|Protocol Violation|1|||
131005074|NCT00848211|471646229|FG003|Overall Study|Protocol Violation|0|||
131005075|NCT00848211|471646226|FG000|Overall Study|Adverse Event|0|||
131005076|NCT00848211|471646227|FG001|Overall Study|Adverse Event|0|||
131005077|NCT00848211|471646228|FG002|Overall Study|Adverse Event|0|||
131005078|NCT00848211|471646229|FG003|Overall Study|Adverse Event|0|||
131229355|NCT02196506|472465888|FG001|Phase B|Lack of Efficacy|1|||
131229356|NCT02196506|472465889|FG002|Phase B|Lack of Efficacy|2|||
131229357|NCT02196506|472465890|FG003|Phase B|Lack of Efficacy|0|||
131229358|NCT02196506|472465887|FG000|Phase B|Withdrawal by Participant|0|||
131229359|NCT02196506|472465888|FG001|Phase B|Withdrawal by Participant|8|||
131229360|NCT02196506|472465889|FG002|Phase B|Withdrawal by Participant|1|||
131229361|NCT02196506|472465890|FG003|Phase B|Withdrawal by Participant|0|||
131229362|NCT02196506|472465887|FG000|Phase B|Adverse Event|0|||
131229363|NCT02196506|472465888|FG001|Phase B|Adverse Event|4|||
131229364|NCT02196506|472465889|FG002|Phase B|Adverse Event|1|||
131229365|NCT02196506|472465890|FG003|Phase B|Adverse Event|0|||
131229366|NCT02196506|472465887|FG000|Phase B|Lost to Follow-up|0|||
131229367|NCT02196506|472465888|FG001|Phase B|Lost to Follow-up|2|||
131005079|NCT00619151|471646230|FG000|Overall Study|Study terminated prior to followup|1|||
131005080|NCT00619151|471646231|FG001|Overall Study|Study terminated prior to followup|0|||
131005081|NCT02825043|471646232|FG000|Overall Study|Lost to Follow-up|4|||
131005082|NCT03582137|471646235|FG000|Overall Study|Adverse Event|1|||
131005083|NCT03582137|471646236|FG001|Overall Study|Adverse Event|0|||
131005084|NCT01982760|471646237|FG000|Overall Study|Physician Decision|1|||
131005085|NCT01982760|471646238|FG001|Overall Study|Physician Decision|0|||
131005086|NCT03704298|471646242|FG000|Overall Study|Death|3|||
131005087|NCT03704298|471646243|FG001|Overall Study|Death|1|||
131005088|NCT03704298|471646244|FG002|Overall Study|Death|1|||
131005089|NCT03704298|471646245|FG003|Overall Study|Death|0|||
131005090|NCT03704298|471646242|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
131005091|NCT03704298|471646243|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
131005092|NCT03704298|471646244|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
131005093|NCT03704298|471646245|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
131222427|NCT02176642|472441489|FG000|Overall Study|Withdrawal by Subject|0|||
131222428|NCT02176642|472441490|FG001|Overall Study|Withdrawal by Subject|1|||
131222429|NCT00217971|472441491|FG000|Overall Study|Adverse Event|1|||
131222430|NCT00217971|472441492|FG001|Overall Study|Adverse Event|1|||
131222431|NCT00217971|472441491|FG000|Overall Study|Lost to Follow-up|15|||
131222432|NCT00217971|472441492|FG001|Overall Study|Lost to Follow-up|19|||
131222433|NCT00217971|472441491|FG000|Overall Study|Physician Decision|0|||
131222434|NCT00217971|472441492|FG001|Overall Study|Physician Decision|1|||
131222435|NCT00217971|472441491|FG000|Overall Study|Withdrawal by Subject|7|||
131222436|NCT00217971|472441492|FG001|Overall Study|Withdrawal by Subject|12|||
131222437|NCT00217971|472441491|FG000|Overall Study|non compliant|1|||
131222438|NCT00217971|472441492|FG001|Overall Study|non compliant|0|||
131222439|NCT02989610|472441493|FG000|Overall Study|Withdrawal by Subject|20|||
131222440|NCT02989610|472441493|FG000|Overall Study|Departure of PI from Site|8|||
131222441|NCT02989610|472441493|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
131222442|NCT02989610|472441493|FG000|Overall Study|Lost to Follow-up|3|||
131222443|NCT02989610|472441493|FG000|Overall Study|Death|3|||
131222444|NCT02989610|472441493|FG000|Overall Study|System Explant|3|||
131222445|NCT02989610|472441493|FG000|Overall Study|Subject Non-Compliance|2|||
131222446|NCT02989610|472441493|FG000|Overall Study|System Revision|2|||
131222447|NCT02989610|472441493|FG000|Overall Study|PI Left, Study Closing|1|||
131222448|NCT02989610|472441493|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
131222449|NCT02989610|472441493|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
131222450|NCT02556632|472441498|FG000|Overall Study|Lost to Follow-up|1|||
131005094|NCT03704298|471646242|FG000|Overall Study|Withdrawal by Subject|1|||
131005095|NCT03704298|471646243|FG001|Overall Study|Withdrawal by Subject|0|||
131005096|NCT03704298|471646244|FG002|Overall Study|Withdrawal by Subject|0|||
131005097|NCT03704298|471646245|FG003|Overall Study|Withdrawal by Subject|0|||
131005098|NCT03704298|471646242|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
131005099|NCT03704298|471646243|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
131005100|NCT03704298|471646244|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
131005101|NCT03704298|471646245|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
131005102|NCT04796935|471646246|FG000|Overall Study|Withdrawal by Subject|0|||
131005103|NCT04796935|471646247|FG001|Overall Study|Withdrawal by Subject|1|||
131005104|NCT04796935|471646246|FG000|Overall Study|Physician Decision|0|||
131005105|NCT04796935|471646247|FG001|Overall Study|Physician Decision|1|||
131005106|NCT04796935|471646246|FG000|Overall Study|Device not available|1|||
131005107|NCT04796935|471646247|FG001|Overall Study|Device not available|0|||
131005108|NCT04796935|471646246|FG000|Overall Study|Trained provider not available|1|||
131005109|NCT04796935|471646247|FG001|Overall Study|Trained provider not available|0|||
131005110|NCT04159896|471646251|FG000|Overall Study|Lack of Efficacy|7|||
131005111|NCT04159896|471646251|FG000|Overall Study|Withdrawal by Subject|1|||
131222451|NCT02556632|472441499|FG001|Overall Study|Lost to Follow-up|0|||
131222452|NCT02556632|472441500|FG002|Overall Study|Lost to Follow-up|0|||
131005112|NCT04159896|471646251|FG000|Overall Study|Adverse Event|1|||
131005113|NCT04159896|471646251|FG000|Overall Study|A transient ischaemic attack|1|||
131005114|NCT02084082|471646252|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
131005115|NCT02084082|471646253|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
131005116|NCT02084082|471646254|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
131005117|NCT02084082|471646255|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
131005118|NCT02084082|471646252|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131005119|NCT02084082|471646253|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131005120|NCT02084082|471646254|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131005121|NCT02084082|471646255|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
131229368|NCT02196506|472465889|FG002|Phase B|Lost to Follow-up|1|||
131229369|NCT02196506|472465890|FG003|Phase B|Lost to Follow-up|0|||
131229370|NCT02196506|472465887|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
131229371|NCT02196506|472465888|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
131229372|NCT02196506|472465889|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
131229373|NCT02196506|472465890|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
131229374|NCT02196506|472465887|FG000|Phase A+|Withdrawal by Participant|0|||
131229375|NCT02196506|472465888|FG001|Phase A+|Withdrawal by Participant|0|||
131229376|NCT02196506|472465889|FG002|Phase A+|Withdrawal by Participant|0|||
131229377|NCT02196506|472465890|FG003|Phase A+|Withdrawal by Participant|5|||
131229378|NCT02196506|472465887|FG000|Phase A+|Adverse Event|0|||
131229379|NCT02196506|472465888|FG001|Phase A+|Adverse Event|0|||
131229380|NCT02196506|472465889|FG002|Phase A+|Adverse Event|0|||
131229381|NCT02196506|472465890|FG003|Phase A+|Adverse Event|1|||
131229382|NCT02196506|472465887|FG000|Phase A+|Lost to Follow-up|0|||
131229383|NCT02196506|472465888|FG001|Phase A+|Lost to Follow-up|0|||
131229384|NCT02196506|472465889|FG002|Phase A+|Lost to Follow-up|0|||
131229385|NCT02196506|472465890|FG003|Phase A+|Lost to Follow-up|6|||
131229386|NCT02196506|472465887|FG000|Phase A+|Participant withdrawn by investigator|0|||
131229387|NCT02196506|472465888|FG001|Phase A+|Participant withdrawn by investigator|0|||
131229388|NCT02196506|472465889|FG002|Phase A+|Participant withdrawn by investigator|0|||
131229389|NCT02196506|472465890|FG003|Phase A+|Participant withdrawn by investigator|1|||
131229390|NCT00254397|472465891|FG000|Overall Study|Disease Progression|4|||
131229391|NCT00254397|472465892|FG001|Overall Study|Disease Progression|1|||
131229392|NCT00254397|472465893|FG002|Overall Study|Disease Progression|16|||
131229393|NCT00254397|472465894|FG003|Overall Study|Disease Progression|23|||
131229394|NCT00254397|472465891|FG000|Overall Study|Non-Compliant|0|||
131229395|NCT00254397|472465892|FG001|Overall Study|Non-Compliant|0|||
131229396|NCT00254397|472465893|FG002|Overall Study|Non-Compliant|0|||
131229397|NCT00254397|472465894|FG003|Overall Study|Non-Compliant|1|||
131229398|NCT00254397|472465891|FG000|Overall Study|Adverse Event|2|||
131229399|NCT00254397|472465892|FG001|Overall Study|Adverse Event|0|||
131229400|NCT00254397|472465893|FG002|Overall Study|Adverse Event|3|||
131229401|NCT00254397|472465894|FG003|Overall Study|Adverse Event|1|||
131229402|NCT01715415|472465906|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
131229403|NCT01715415|472465907|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
131229404|NCT01715415|472465906|FG000|Double-blind Treatment|Adverse Event|3|||
131229405|NCT01715415|472465907|FG001|Double-blind Treatment|Adverse Event|0|||
131229406|NCT01715415|472465906|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
131229407|NCT01715415|472465907|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
131229408|NCT01715415|472465906|FG000|Double-blind Treatment|Other|1|||
131229409|NCT01715415|472465907|FG001|Double-blind Treatment|Other|0|||
131229410|NCT01715415|472465906|FG000|Open-label Treatment|Adverse Event|0|||
131229411|NCT01715415|472465907|FG001|Open-label Treatment|Adverse Event|1|||
131229412|NCT01715415|472465906|FG000|Open-label Treatment|Subject Noncompliant|0|||
131229413|NCT01715415|472465907|FG001|Open-label Treatment|Subject Noncompliant|1|||
131229414|NCT01015612|472465908|FG000|Overall Study|Death|113|||
131229415|NCT01015612|472465908|FG000|Overall Study|Withdrawal by Subject|40|||
131229416|NCT00066807|472465909|FG000|Overall Study|Study was terminated early|14|||
131229417|NCT00066807|472465910|FG001|Overall Study|Study was terminated early|15|||
131229418|NCT05028751|472465911|FG000|Overall Study|Study Terminated by Sponsor|3|||
131229419|NCT05028751|472465912|FG001|Overall Study|Study Terminated by Sponsor|0|||
131229420|NCT05028751|472465913|FG002|Overall Study|Study Terminated by Sponsor|0|||
131229421|NCT05028751|472465914|FG003|Overall Study|Study Terminated by Sponsor|0|||
131229422|NCT05028751|472465911|FG000|Overall Study|Death|9|||
131229423|NCT05028751|472465912|FG001|Overall Study|Death|3|||
131229424|NCT05028751|472465913|FG002|Overall Study|Death|2|||
131229425|NCT05028751|472465914|FG003|Overall Study|Death|4|||
131229426|NCT05028751|472465911|FG000|Overall Study|Withdrawal by Subject|0|||
131229427|NCT05028751|472465912|FG001|Overall Study|Withdrawal by Subject|0|||
131229428|NCT05028751|472465913|FG002|Overall Study|Withdrawal by Subject|1|||
131229429|NCT05028751|472465914|FG003|Overall Study|Withdrawal by Subject|0|||
131229430|NCT05028751|472465911|FG000|Overall Study|Miscellaneous|2|||
131229431|NCT05028751|472465912|FG001|Overall Study|Miscellaneous|0|||
131229432|NCT05028751|472465913|FG002|Overall Study|Miscellaneous|0|||
131005122|NCT05705167|471646256|FG000|Overall Study|Randomised but not Treated|0|||
131005123|NCT05705167|471646257|FG001|Overall Study|Randomised but not Treated|2|||
131005124|NCT05705167|471646258|FG002|Overall Study|Randomised but not Treated|0|||
131005125|NCT05705167|471646259|FG003|Overall Study|Randomised but not Treated|7|||
131222453|NCT02556632|472441498|FG000|Overall Study|Disliked Intervention|1|||
131005126|NCT05705167|471646260|FG004|Overall Study|Randomised but not Treated|0|||
131005127|NCT05705167|471646261|FG005|Overall Study|Randomised but not Treated|0|||
131005128|NCT05705167|471646262|FG006|Overall Study|Randomised but not Treated|0|||
131005129|NCT05705167|471646256|FG000|Overall Study|Death|0|||
131005130|NCT05705167|471646257|FG001|Overall Study|Death|0|||
131005131|NCT05705167|471646258|FG002|Overall Study|Death|3|||
131005132|NCT05705167|471646259|FG003|Overall Study|Death|0|||
131005133|NCT05705167|471646260|FG004|Overall Study|Death|1|||
131005134|NCT05705167|471646261|FG005|Overall Study|Death|1|||
131005135|NCT05705167|471646262|FG006|Overall Study|Death|1|||
131005136|NCT05705167|471646256|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
131005137|NCT05705167|471646257|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
131005138|NCT05705167|471646258|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
131005139|NCT05705167|471646259|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
131005140|NCT05705167|471646260|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
131005141|NCT05705167|471646261|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
131005142|NCT05705167|471646262|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
131005143|NCT02099539|471646265|FG000|Overall Study|Progressive Disease|3|||
131005144|NCT02099539|471646266|FG001|Overall Study|Progressive Disease|2|||
131005145|NCT02099539|471646267|FG002|Overall Study|Progressive Disease|2|||
131005146|NCT02099539|471646268|FG003|Overall Study|Progressive Disease|1|||
131005147|NCT02099539|471646269|FG004|Overall Study|Progressive Disease|4|||
131005148|NCT02099539|471646270|FG005|Overall Study|Progressive Disease|2|||
131005149|NCT02099539|471646271|FG006|Overall Study|Progressive Disease|0|||
131005150|NCT02099539|471646265|FG000|Overall Study|Adverse Event|0|||
131005151|NCT02099539|471646266|FG001|Overall Study|Adverse Event|0|||
131005152|NCT02099539|471646267|FG002|Overall Study|Adverse Event|1|||
131005153|NCT02099539|471646268|FG003|Overall Study|Adverse Event|1|||
131005154|NCT02099539|471646269|FG004|Overall Study|Adverse Event|0|||
131005155|NCT02099539|471646270|FG005|Overall Study|Adverse Event|0|||
131005156|NCT02099539|471646271|FG006|Overall Study|Adverse Event|0|||
131005157|NCT02099539|471646265|FG000|Overall Study|Physician Decision|0|||
131005158|NCT02099539|471646266|FG001|Overall Study|Physician Decision|0|||
131005159|NCT02099539|471646267|FG002|Overall Study|Physician Decision|0|||
131005160|NCT02099539|471646268|FG003|Overall Study|Physician Decision|0|||
131005161|NCT02099539|471646269|FG004|Overall Study|Physician Decision|0|||
131005162|NCT02099539|471646270|FG005|Overall Study|Physician Decision|1|||
131005163|NCT02099539|471646271|FG006|Overall Study|Physician Decision|0|||
131005164|NCT04091672|471648134|FG000|Overall Study|Death|6|||
131005165|NCT04091672|471648135|FG001|Overall Study|Death|6|||
131005166|NCT04091672|471648134|FG000|Overall Study|Lost to Follow-up|7|||
131005167|NCT04091672|471648135|FG001|Overall Study|Lost to Follow-up|7|||
131005168|NCT04091672|471648134|FG000|Overall Study|Withdrawal by Subject|3|||
131005169|NCT04091672|471648135|FG001|Overall Study|Withdrawal by Subject|3|||
131005170|NCT04091672|471648134|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
131005171|NCT04091672|471648135|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
131005172|NCT05296629|471648136|FG000|Overall Study|Withdrawal by Subject|3|||
131005173|NCT05296629|471648137|FG001|Overall Study|Withdrawal by Subject|10|||
131005174|NCT05296629|471648138|FG002|Overall Study|Withdrawal by Subject|4|||
131005175|NCT05296629|471648136|FG000|Overall Study|Lost to Follow-up|2|||
131005176|NCT05296629|471648137|FG001|Overall Study|Lost to Follow-up|7|||
131005177|NCT05296629|471648138|FG002|Overall Study|Lost to Follow-up|1|||
131005178|NCT05296629|471648136|FG000|Overall Study|Adverse Event|0|||
131005179|NCT05296629|471648137|FG001|Overall Study|Adverse Event|4|||
131005180|NCT05296629|471648138|FG002|Overall Study|Adverse Event|2|||
131005181|NCT05296629|471648136|FG000|Overall Study|Protocol Violation|0|||
131005182|NCT05296629|471648137|FG001|Overall Study|Protocol Violation|2|||
131005183|NCT05296629|471648138|FG002|Overall Study|Protocol Violation|0|||
131005184|NCT02268396|471648142|FG000|Overall Study|Adverse Event|3|||
131005185|NCT02268396|471648142|FG000|Overall Study|Administrative|2|||
131005186|NCT02268396|471648142|FG000|Overall Study|Withdrawal by Subject|1|||
131005187|NCT02268396|471648142|FG000|Overall Study|Lost to Follow-up|2|||
131005188|NCT02268396|471648142|FG000|Overall Study|Protocol-Specified Criteria|2|||
131005189|NCT02268396|471648142|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
131005190|NCT00231179|471648143|FG000|Overall Study|Lost to Follow-up|21|||
131005191|NCT00231179|471648144|FG001|Overall Study|Lost to Follow-up|21|||
131005192|NCT00231179|471648143|FG000|Overall Study|Withdrawal by Subject|3|||
131005193|NCT00231179|471648144|FG001|Overall Study|Withdrawal by Subject|3|||
131005194|NCT02401529|471648145|FG000|Overall Study|Lost to Follow-up|2|||
131005195|NCT02401529|471648146|FG001|Overall Study|Lost to Follow-up|1|||
131005196|NCT02401529|471648145|FG000|Overall Study|Physician Decision|2|||
131005197|NCT02401529|471648146|FG001|Overall Study|Physician Decision|6|||
131005198|NCT02401529|471648145|FG000|Overall Study|Protocol Violation|5|||
131005199|NCT02401529|471648146|FG001|Overall Study|Protocol Violation|0|||
131005200|NCT04034238|471648149|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
131005201|NCT04034238|471648150|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
131005202|NCT04034238|471648151|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
131005203|NCT04034238|471648152|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131005204|NCT04034238|471648149|FG000|Dose Escalation Phase|Screen failures|0|||
131005205|NCT04034238|471648150|FG001|Dose Escalation Phase|Screen failures|0|||
131005206|NCT04034238|471648151|FG002|Dose Escalation Phase|Screen failures|0|||
131005207|NCT04034238|471648152|FG003|Dose Escalation Phase|Screen failures|2|||
131005208|NCT04034238|471648149|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
131005209|NCT04034238|471648150|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
131005210|NCT04034238|471648151|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
131005211|NCT04034238|471648152|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
131005212|NCT04034238|471648149|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
131005213|NCT04034238|471648150|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
131005214|NCT04034238|471648151|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
131005215|NCT04034238|471648152|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
131005216|NCT02065245|471648155|FG000|Infusion 1|Lost to Follow-up|0|||
131005217|NCT02065245|471648156|FG001|Infusion 1|Lost to Follow-up|0|||
131005218|NCT02065245|471648157|FG002|Infusion 1|Lost to Follow-up|0|||
131005219|NCT02065245|471648158|FG003|Infusion 1|Lost to Follow-up|0|||
131005220|NCT02065245|471648159|FG004|Infusion 1|Lost to Follow-up|0|||
131005221|NCT02065245|471648160|FG005|Infusion 1|Lost to Follow-up|0|||
131222454|NCT02556632|472441499|FG001|Overall Study|Disliked Intervention|1|||
131222455|NCT02556632|472441500|FG002|Overall Study|Disliked Intervention|1|||
130884904|NCT00790842|471213223|FG007|Expansion Cohort|Physician Decision|0|||
131005222|NCT02065245|471648161|FG006|Infusion 1|Lost to Follow-up|1|||
131005223|NCT02065245|471648155|FG000|Infusion 1|Death|0|||
131005224|NCT02065245|471648156|FG001|Infusion 1|Death|0|||
131005225|NCT02065245|471648157|FG002|Infusion 1|Death|1|||
131005226|NCT02065245|471648158|FG003|Infusion 1|Death|0|||
131005227|NCT02065245|471648159|FG004|Infusion 1|Death|1|||
131005228|NCT02065245|471648160|FG005|Infusion 1|Death|0|||
131005229|NCT02065245|471648161|FG006|Infusion 1|Death|0|||
131005230|NCT02065245|471648155|FG000|Infusion 2|Death|0|||
131005231|NCT02065245|471648156|FG001|Infusion 2|Death|0|||
131005232|NCT02065245|471648157|FG002|Infusion 2|Death|0|||
131005233|NCT02065245|471648158|FG003|Infusion 2|Death|0|||
131005234|NCT02065245|471648159|FG004|Infusion 2|Death|0|||
131005235|NCT02065245|471648160|FG005|Infusion 2|Death|0|||
131005236|NCT02065245|471648161|FG006|Infusion 2|Death|1|||
131005237|NCT02065245|471648155|FG000|Infusion 3|Lost to Follow-up|1|||
131005238|NCT02065245|471648156|FG001|Infusion 3|Lost to Follow-up|1|||
131005239|NCT02065245|471648157|FG002|Infusion 3|Lost to Follow-up|0|||
131005240|NCT02065245|471648158|FG003|Infusion 3|Lost to Follow-up|0|||
131005241|NCT02065245|471648159|FG004|Infusion 3|Lost to Follow-up|0|||
131005242|NCT02065245|471648160|FG005|Infusion 3|Lost to Follow-up|0|||
131005243|NCT02065245|471648161|FG006|Infusion 3|Lost to Follow-up|0|||
131005244|NCT01518257|471648162|FG000|Overall Study|Lost to Follow-up|1|||
131005245|NCT01518257|471648163|FG001|Overall Study|Lost to Follow-up|0|||
131005246|NCT01518257|471648162|FG000|Overall Study|Other Miscellaneous Reason|1|||
131005247|NCT01518257|471648163|FG001|Overall Study|Other Miscellaneous Reason|0|||
131005248|NCT01304706|471648164|FG000|Overall Study|Adverse Event|2|||
131005249|NCT01304706|471648164|FG000|Overall Study|Lack of Efficacy|1|||
131005250|NCT01304706|471648164|FG000|Overall Study|Death|3|||
131005251|NCT01304706|471648164|FG000|Overall Study|Withdrawal by Subject|3|||
131005252|NCT01304706|471648164|FG000|Overall Study|Lost to Follow-up|7|||
131005253|NCT01304706|471648164|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
131005254|NCT02206685|471648165|FG000|Overall Study|Surgery cancelled/changed|2|||
131005255|NCT02206685|471648166|FG001|Overall Study|Surgery cancelled/changed|3|||
131005256|NCT02206685|471648165|FG000|Overall Study|Withdrawal by Subject|1|||
131005257|NCT02206685|471648166|FG001|Overall Study|Withdrawal by Subject|2|||
131005258|NCT02206685|471648165|FG000|Overall Study|Protocol Violation|2|||
131005259|NCT02206685|471648166|FG001|Overall Study|Protocol Violation|2|||
131005260|NCT01097655|471648167|FG000|Overall Study|Withdrawal by Subject|1|||
131005261|NCT01097655|471648167|FG000|Overall Study|Subject Documented Twice|1|||
131005262|NCT01097655|471648167|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
131005263|NCT01345292|471648168|FG000|Overall Study|Withdrawal by Subject|2|||
131005264|NCT01345292|471648169|FG001|Overall Study|Withdrawal by Subject|0|||
131005265|NCT01345292|471648170|FG002|Overall Study|Withdrawal by Subject|1|||
131005266|NCT03303105|471648172|FG000|Overall Study|Adverse Event|0|||
131005267|NCT03303105|471648173|FG001|Overall Study|Adverse Event|2|||
131005268|NCT03303105|471648172|FG000|Overall Study|Lack of Efficacy|1|||
131005269|NCT03303105|471648173|FG001|Overall Study|Lack of Efficacy|0|||
131005270|NCT03303105|471648172|FG000|Overall Study|Protocol Violation|1|||
131005271|NCT03303105|471648173|FG001|Overall Study|Protocol Violation|0|||
131005272|NCT03303105|471648172|FG000|Overall Study|Withdrawal by Subject|0|||
131005273|NCT03303105|471648173|FG001|Overall Study|Withdrawal by Subject|2|||
131005274|NCT04822298|471648174|FG000|Overall Study|Death|3|||
131222456|NCT02556632|472441498|FG000|Overall Study|No Reason|1|||
131222457|NCT02556632|472441499|FG001|Overall Study|No Reason|0|||
131005275|NCT00852475|471648183|FG000|Overall Study|Lost to Follow-up|3|||
131005276|NCT00852475|471648184|FG001|Overall Study|Lost to Follow-up|4|||
131005277|NCT00515086|471648185|FG000|Overall Study|Adverse Event|1|||
131005278|NCT00515086|471648186|FG001|Overall Study|Adverse Event|1|||
131005279|NCT00515086|471648187|FG002|Overall Study|Adverse Event|2|||
131005280|NCT00515086|471648188|FG003|Overall Study|Adverse Event|3|||
131005281|NCT00515086|471648185|FG000|Overall Study|Administrative|1|||
131005282|NCT00515086|471648186|FG001|Overall Study|Administrative|1|||
131005283|NCT00515086|471648187|FG002|Overall Study|Administrative|0|||
131005284|NCT00515086|471648188|FG003|Overall Study|Administrative|0|||
131005285|NCT00515086|471648185|FG000|Overall Study|Withdrawal by Subject|1|||
131005286|NCT00515086|471648186|FG001|Overall Study|Withdrawal by Subject|0|||
131005287|NCT00515086|471648187|FG002|Overall Study|Withdrawal by Subject|0|||
131005288|NCT00515086|471648188|FG003|Overall Study|Withdrawal by Subject|1|||
131005289|NCT00515086|471648185|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
131005290|NCT00515086|471648186|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131005291|NCT00515086|471648187|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
131005292|NCT00515086|471648188|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
131005293|NCT00515086|471648185|FG000|Overall Study|Lost to Follow-up|1|||
131005294|NCT00515086|471648186|FG001|Overall Study|Lost to Follow-up|0|||
131005295|NCT00515086|471648187|FG002|Overall Study|Lost to Follow-up|0|||
131005296|NCT00515086|471648188|FG003|Overall Study|Lost to Follow-up|0|||
131005297|NCT00515086|471648185|FG000|Overall Study|Study drug no longer required|0|||
131005298|NCT00515086|471648186|FG001|Overall Study|Study drug no longer required|1|||
131005299|NCT00515086|471648187|FG002|Overall Study|Study drug no longer required|0|||
131005300|NCT00515086|471648188|FG003|Overall Study|Study drug no longer required|0|||
131005301|NCT00515086|471648185|FG000|Overall Study|Death|2|||
131005302|NCT00515086|471648186|FG001|Overall Study|Death|0|||
131005303|NCT00515086|471648187|FG002|Overall Study|Death|0|||
131005304|NCT00515086|471648188|FG003|Overall Study|Death|0|||
131005305|NCT02028884|471648189|FG000|Double-blind Period|Adverse Event|5|||
131005306|NCT02028884|471648190|FG001|Double-blind Period|Adverse Event|3|||
131005307|NCT02028884|471648191|FG002|Double-blind Period|Adverse Event|0|||
131005308|NCT02028884|471648189|FG000|Double-blind Period|Eligibility Violation|1|||
131005309|NCT02028884|471648190|FG001|Double-blind Period|Eligibility Violation|0|||
131005310|NCT02028884|471648191|FG002|Double-blind Period|Eligibility Violation|0|||
131005311|NCT02028884|471648189|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
131005312|NCT02028884|471648190|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
131005313|NCT02028884|471648191|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
131005314|NCT02028884|471648189|FG000|Double-blind Period|Withdrawal by Subject|2|||
131005315|NCT02028884|471648190|FG001|Double-blind Period|Withdrawal by Subject|0|||
131005316|NCT02028884|471648191|FG002|Double-blind Period|Withdrawal by Subject|0|||
131005317|NCT02028884|471648189|FG000|Open-label Extension Period|Adverse Event|3|||
131005318|NCT02028884|471648190|FG001|Open-label Extension Period|Adverse Event|1|||
131005319|NCT02028884|471648191|FG002|Open-label Extension Period|Adverse Event|0|||
131005320|NCT02028884|471648189|FG000|Open-label Extension Period|Lack of Efficacy|3|||
131005321|NCT02028884|471648190|FG001|Open-label Extension Period|Lack of Efficacy|0|||
131005322|NCT02028884|471648191|FG002|Open-label Extension Period|Lack of Efficacy|0|||
131005323|NCT02028884|471648189|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
131005324|NCT02028884|471648190|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
131005325|NCT02028884|471648191|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
131005326|NCT02028884|471648189|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
131005327|NCT02028884|471648190|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
131005328|NCT02028884|471648191|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
131005329|NCT02028884|471648189|FG000|Open-label Extension Period|Switched to another treatment option|3|||
131222458|NCT02556632|472441500|FG002|Overall Study|No Reason|1|||
131222459|NCT02556632|472441498|FG000|Overall Study|Personal Issues|0|||
131005330|NCT02028884|471648190|FG001|Open-label Extension Period|Switched to another treatment option|0|||
131005331|NCT02028884|471648191|FG002|Open-label Extension Period|Switched to another treatment option|0|||
131005332|NCT02403674|471648192|FG000|Base Study|Death|1|||
131005333|NCT02403674|471648193|FG001|Base Study|Death|4|||
131005334|NCT02403674|471648192|FG000|Base Study|Adverse Event|11|||
131005335|NCT02403674|471648193|FG001|Base Study|Adverse Event|26|||
131005336|NCT02403674|471648192|FG000|Base Study|Lack of Efficacy|31|||
131005337|NCT02403674|471648193|FG001|Base Study|Lack of Efficacy|23|||
131005338|NCT02403674|471648192|FG000|Base Study|Lost to Follow-up|6|||
131005339|NCT02403674|471648193|FG001|Base Study|Lost to Follow-up|8|||
131005340|NCT02403674|471648192|FG000|Base Study|Withdrawal by Subject|10|||
131005341|NCT02403674|471648193|FG001|Base Study|Withdrawal by Subject|17|||
131005342|NCT02403674|471648192|FG000|Base Study|Physician Decision|2|||
131005343|NCT02403674|471648193|FG001|Base Study|Physician Decision|2|||
131005344|NCT02403674|471648192|FG000|Base Study|Pregnancy|2|||
131005345|NCT02403674|471648193|FG001|Base Study|Pregnancy|2|||
131005346|NCT02403674|471648192|FG000|Base Study|Protocol Violation|8|||
131005347|NCT02403674|471648193|FG001|Base Study|Protocol Violation|4|||
131005348|NCT02403674|471648192|FG000|Base Study|Non-Compliance with study drug|1|||
131005349|NCT02403674|471648193|FG001|Base Study|Non-Compliance with study drug|4|||
131005350|NCT02403674|471648192|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
131005351|NCT02403674|471648193|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
131005352|NCT02403674|471648192|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
131005353|NCT02403674|471648193|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
131005354|NCT02403674|471648192|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
131005355|NCT02403674|471648193|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
131005356|NCT02403674|471648192|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
131005357|NCT02403674|471648193|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
131005358|NCT02403674|471648192|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
131005359|NCT02403674|471648193|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
131005360|NCT02403674|471648192|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
131005361|NCT02403674|471648193|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
131005362|NCT02403674|471648192|FG000|Study Extension 1 (Open-Label)|Death|1|||
131005363|NCT02403674|471648193|FG001|Study Extension 1 (Open-Label)|Death|0|||
131005364|NCT02403674|471648192|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
131005365|NCT02403674|471648193|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
131005366|NCT02403674|471648192|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
131005367|NCT02403674|471648193|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
131005368|NCT02403674|471648192|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
131005369|NCT02403674|471648193|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
131005370|NCT02403674|471648192|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
131005371|NCT02403674|471648193|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
131005372|NCT02403674|471648192|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
131005373|NCT02403674|471648193|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
131005374|NCT02403674|471648192|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
131005375|NCT02403674|471648193|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
131005376|NCT02403674|471648192|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
131005377|NCT02403674|471648193|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
131005378|NCT02403674|471648192|FG000|Study Extension 2 (Open-Label)|Death|2|||
131005379|NCT02403674|471648193|FG001|Study Extension 2 (Open-Label)|Death|2|||
131005380|NCT02403674|471648192|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
131005381|NCT02403674|471648193|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
131005382|NCT02403674|471648192|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
131005383|NCT02403674|471648193|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
131005384|NCT02403674|471648192|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
131005385|NCT02403674|471648193|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
131005386|NCT02403674|471648192|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
131005387|NCT02403674|471648193|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
131005388|NCT02403674|471648192|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
131005389|NCT02403674|471648193|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
131005390|NCT02403674|471648192|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
131005391|NCT02403674|471648193|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
131005392|NCT02403674|471648192|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
131222460|NCT02556632|472441499|FG001|Overall Study|Personal Issues|1|||
131005393|NCT02403674|471648193|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
131005394|NCT01254305|471648195|FG000|Overall Study|Adverse Event|6|||
131005395|NCT01254305|471648196|FG001|Overall Study|Adverse Event|3|||
131005396|NCT01254305|471648197|FG002|Overall Study|Adverse Event|2|||
131005397|NCT01254305|471648195|FG000|Overall Study|Lack of Efficacy|1|||
131005398|NCT01254305|471648196|FG001|Overall Study|Lack of Efficacy|0|||
131005399|NCT01254305|471648197|FG002|Overall Study|Lack of Efficacy|1|||
131005400|NCT01254305|471648195|FG000|Overall Study|Protocol Violation|1|||
131005401|NCT01254305|471648196|FG001|Overall Study|Protocol Violation|7|||
131005402|NCT01254305|471648197|FG002|Overall Study|Protocol Violation|3|||
131005403|NCT01254305|471648195|FG000|Overall Study|Withdrawal by Subject|4|||
131005404|NCT01254305|471648196|FG001|Overall Study|Withdrawal by Subject|2|||
131005405|NCT01254305|471648197|FG002|Overall Study|Withdrawal by Subject|4|||
131005406|NCT01254305|471648195|FG000|Overall Study|Lost to Follow-up|10|||
131005407|NCT01254305|471648196|FG001|Overall Study|Lost to Follow-up|6|||
131005408|NCT01254305|471648197|FG002|Overall Study|Lost to Follow-up|5|||
131005409|NCT01254305|471648195|FG000|Overall Study|Other Reasons|0|||
131005410|NCT01254305|471648196|FG001|Overall Study|Other Reasons|0|||
131005411|NCT01254305|471648197|FG002|Overall Study|Other Reasons|2|||
131005412|NCT02263885|471648198|FG000|Overall Study|Withdrawal by Subject|7|||
131005413|NCT02263885|471648198|FG000|Overall Study|Alternative Treatment|3|||
130720914|NCT01140503|470601560|FG000|Overall Study|Withdrawal by Subject|1|||
131005414|NCT00088465|471648203|FG000|Overall Study|Withdrawal by Subject|290|||
131005415|NCT00088465|471648203|FG000|Overall Study|Adverse Event|77|||
131005416|NCT00088465|471648203|FG000|Overall Study|Lost to Follow-up|57|||
131005417|NCT00088465|471648203|FG000|Overall Study|Physician Decision|45|||
131005418|NCT00088465|471648203|FG000|Overall Study|Sponsor Decision|37|||
131005419|NCT00088465|471648203|FG000|Overall Study|Lack of Efficacy|27|||
131005420|NCT00088465|471648203|FG000|Overall Study|Protocol Violation|17|||
131005421|NCT00088465|471648203|FG000|Overall Study|Death|11|||
131005422|NCT04454567|471648204|FG000|Overall Study|Study Terminated by Sponsor|1|||
131005423|NCT04454567|471648205|FG001|Overall Study|Study Terminated by Sponsor|1|||
131005424|NCT01175707|471648209|FG000|Overall Study|Adverse Event|4|||
131005425|NCT01175707|471648210|FG001|Overall Study|Adverse Event|6|||
131005426|NCT03606460|471648213|FG000|Overall Study|Lost to Follow-up|1|||
131005427|NCT03606460|471648214|FG001|Overall Study|Lost to Follow-up|8|||
131005428|NCT04170023|471648215|FG000|LTE Period|Withdrawal by Subject|1|||
131005429|NCT04170023|471648216|FG001|LTE Period|Withdrawal by Subject|0|||
131005430|NCT04170023|471648217|FG002|LTE Period|Withdrawal by Subject|0|||
131005431|NCT04170023|471648215|FG000|LTE Period|Study Termination|11|||
131005432|NCT04170023|471648216|FG001|LTE Period|Study Termination|11|||
131005433|NCT04170023|471648217|FG002|LTE Period|Study Termination|5|||
131005434|NCT00562965|471648218|FG000|Overall Study|Withdrawal by Subject|0|||
131005435|NCT00562965|471648219|FG001|Overall Study|Withdrawal by Subject|1|||
131005436|NCT00562965|471648218|FG000|Overall Study|Death|2|||
131005437|NCT00562965|471648219|FG001|Overall Study|Death|4|||
131005438|NCT00562965|471648218|FG000|Overall Study|Lost to Follow-up|1|||
131005439|NCT00562965|471648219|FG001|Overall Study|Lost to Follow-up|0|||
131005440|NCT00562965|471648218|FG000|Overall Study|Other|0|||
131005441|NCT00562965|471648219|FG001|Overall Study|Other|1|||
131005442|NCT01124617|471648226|FG000|Overall Study|Adverse Event|5|||
131005443|NCT01124617|471648227|FG001|Overall Study|Adverse Event|2|||
131005444|NCT01124617|471648226|FG000|Overall Study|Lack of Efficacy|2|||
131005445|NCT01124617|471648227|FG001|Overall Study|Lack of Efficacy|1|||
131005446|NCT01124617|471648226|FG000|Overall Study|Protocol Violation|1|||
131005447|NCT01124617|471648227|FG001|Overall Study|Protocol Violation|1|||
131005448|NCT01124617|471648226|FG000|Overall Study|Withdrawal by Subject|9|||
131005449|NCT01124617|471648227|FG001|Overall Study|Withdrawal by Subject|1|||
131005450|NCT01124617|471648226|FG000|Overall Study|Other|2|||
131005451|NCT01124617|471648227|FG001|Overall Study|Other|1|||
131005452|NCT00945477|471648228|FG000|Overall Study|Adverse Event|3|||
131005453|NCT00945477|471648228|FG000|Overall Study|Lack of Efficacy|2|||
131005454|NCT00945477|471648228|FG000|Overall Study|Withdrawal by Subject|1|||
131005455|NCT02303574|471648232|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131005456|NCT02303574|471648233|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131005457|NCT02303574|471648234|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
131005458|NCT02303574|471648235|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131005459|NCT02303574|471648236|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131005460|NCT02303574|471648237|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131005461|NCT02303574|471648238|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131005462|NCT02303574|471648239|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131005463|NCT02303574|471648240|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131005464|NCT02303574|471648241|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
131005465|NCT02303574|471648232|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131005466|NCT02303574|471648233|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131005467|NCT02303574|471648234|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131005468|NCT02303574|471648235|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131005469|NCT02303574|471648236|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131005470|NCT02303574|471648237|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131005471|NCT02303574|471648238|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131005472|NCT02303574|471648239|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
131005473|NCT02303574|471648240|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131005474|NCT02303574|471648241|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
131005475|NCT00859014|471648242|FG000|Overall Study|Death|4|||
131005476|NCT00859014|471648242|FG000|Overall Study|Lost to Follow-up|1|||
131005477|NCT00783718|471648243|FG000|Induction Phase|Adverse Event|4|||
131005478|NCT00783718|471648244|FG001|Induction Phase|Adverse Event|0|||
131005479|NCT00783718|471648245|FG002|Induction Phase|Adverse Event|7|||
131005480|NCT00783718|471648246|FG003|Induction Phase|Adverse Event|0|||
131005481|NCT00783718|471648247|FG004|Induction Phase|Adverse Event|0|||
131005482|NCT00783718|471648248|FG005|Induction Phase|Adverse Event|0|||
131005483|NCT00783718|471648249|FG006|Induction Phase|Adverse Event|0|||
131005484|NCT00783718|471648243|FG000|Induction Phase|Protocol Violation|1|||
131005485|NCT00783718|471648244|FG001|Induction Phase|Protocol Violation|1|||
131005486|NCT00783718|471648245|FG002|Induction Phase|Protocol Violation|6|||
130720915|NCT00724048|470601561|FG000|Overall Study|Adverse Event|1|||
131005487|NCT00783718|471648246|FG003|Induction Phase|Protocol Violation|0|||
131005488|NCT00783718|471648247|FG004|Induction Phase|Protocol Violation|0|||
131005489|NCT00783718|471648248|FG005|Induction Phase|Protocol Violation|0|||
131005490|NCT00783718|471648249|FG006|Induction Phase|Protocol Violation|0|||
131005491|NCT00783718|471648243|FG000|Induction Phase|Lack of Efficacy|5|||
131005492|NCT00783718|471648244|FG001|Induction Phase|Lack of Efficacy|2|||
131005493|NCT00783718|471648245|FG002|Induction Phase|Lack of Efficacy|14|||
131005494|NCT00783718|471648246|FG003|Induction Phase|Lack of Efficacy|0|||
131005495|NCT00783718|471648247|FG004|Induction Phase|Lack of Efficacy|0|||
131005496|NCT00783718|471648248|FG005|Induction Phase|Lack of Efficacy|0|||
131005497|NCT00783718|471648249|FG006|Induction Phase|Lack of Efficacy|0|||
131005498|NCT00783718|471648243|FG000|Induction Phase|Withdrawal by Subject|3|||
131005499|NCT00783718|471648244|FG001|Induction Phase|Withdrawal by Subject|4|||
131005500|NCT00783718|471648245|FG002|Induction Phase|Withdrawal by Subject|8|||
131005501|NCT00783718|471648246|FG003|Induction Phase|Withdrawal by Subject|0|||
131005502|NCT00783718|471648247|FG004|Induction Phase|Withdrawal by Subject|0|||
131005503|NCT00783718|471648248|FG005|Induction Phase|Withdrawal by Subject|0|||
131005504|NCT00783718|471648249|FG006|Induction Phase|Withdrawal by Subject|0|||
131005505|NCT00783718|471648243|FG000|Induction Phase|Lost to Follow-up|1|||
131005506|NCT00783718|471648244|FG001|Induction Phase|Lost to Follow-up|0|||
131005507|NCT00783718|471648245|FG002|Induction Phase|Lost to Follow-up|1|||
131005508|NCT00783718|471648246|FG003|Induction Phase|Lost to Follow-up|0|||
131005509|NCT00783718|471648247|FG004|Induction Phase|Lost to Follow-up|0|||
131005510|NCT00783718|471648248|FG005|Induction Phase|Lost to Follow-up|0|||
131005511|NCT00783718|471648249|FG006|Induction Phase|Lost to Follow-up|0|||
131005512|NCT00783718|471648243|FG000|Maintenance Phase|Adverse Event|12|||
131005513|NCT00783718|471648244|FG001|Maintenance Phase|Adverse Event|0|||
131005514|NCT00783718|471648245|FG002|Maintenance Phase|Adverse Event|0|||
131005515|NCT00783718|471648246|FG003|Maintenance Phase|Adverse Event|15|||
131005516|NCT00783718|471648247|FG004|Maintenance Phase|Adverse Event|7|||
131005517|NCT00783718|471648248|FG005|Maintenance Phase|Adverse Event|6|||
131005518|NCT00783718|471648249|FG006|Maintenance Phase|Adverse Event|16|||
131005519|NCT00783718|471648243|FG000|Maintenance Phase|Protocol Violation|1|||
131005520|NCT00783718|471648244|FG001|Maintenance Phase|Protocol Violation|0|||
131005521|NCT00783718|471648245|FG002|Maintenance Phase|Protocol Violation|0|||
131005522|NCT00783718|471648246|FG003|Maintenance Phase|Protocol Violation|0|||
131005523|NCT00783718|471648247|FG004|Maintenance Phase|Protocol Violation|0|||
131005524|NCT00783718|471648248|FG005|Maintenance Phase|Protocol Violation|0|||
131005525|NCT00783718|471648249|FG006|Maintenance Phase|Protocol Violation|2|||
131005526|NCT00783718|471648243|FG000|Maintenance Phase|Lack of Efficacy|83|||
131005527|NCT00783718|471648244|FG001|Maintenance Phase|Lack of Efficacy|0|||
131005528|NCT00783718|471648245|FG002|Maintenance Phase|Lack of Efficacy|0|||
131005529|NCT00783718|471648246|FG003|Maintenance Phase|Lack of Efficacy|61|||
131005530|NCT00783718|471648247|FG004|Maintenance Phase|Lack of Efficacy|31|||
131005531|NCT00783718|471648248|FG005|Maintenance Phase|Lack of Efficacy|33|||
131005532|NCT00783718|471648249|FG006|Maintenance Phase|Lack of Efficacy|155|||
131005533|NCT00783718|471648243|FG000|Maintenance Phase|Withdrawal by Subject|6|||
131005534|NCT00783718|471648244|FG001|Maintenance Phase|Withdrawal by Subject|0|||
131005535|NCT00783718|471648245|FG002|Maintenance Phase|Withdrawal by Subject|0|||
131005536|NCT00783718|471648246|FG003|Maintenance Phase|Withdrawal by Subject|2|||
131005537|NCT00783718|471648247|FG004|Maintenance Phase|Withdrawal by Subject|5|||
131005538|NCT00783718|471648248|FG005|Maintenance Phase|Withdrawal by Subject|2|||
131005539|NCT00783718|471648249|FG006|Maintenance Phase|Withdrawal by Subject|20|||
131005540|NCT00783718|471648243|FG000|Maintenance Phase|Lost to Follow-up|3|||
131005541|NCT00783718|471648244|FG001|Maintenance Phase|Lost to Follow-up|0|||
131005542|NCT00783718|471648245|FG002|Maintenance Phase|Lost to Follow-up|0|||
131005543|NCT00783718|471648246|FG003|Maintenance Phase|Lost to Follow-up|0|||
131005544|NCT00783718|471648247|FG004|Maintenance Phase|Lost to Follow-up|2|||
131005545|NCT00783718|471648248|FG005|Maintenance Phase|Lost to Follow-up|0|||
131005546|NCT00783718|471648249|FG006|Maintenance Phase|Lost to Follow-up|2|||
131005547|NCT00578227|471648255|FG000|Overall Study|Lost to Follow-up|0|||
131005548|NCT00578227|471648256|FG001|Overall Study|Lost to Follow-up|1|||
131005549|NCT00578227|471648257|FG002|Overall Study|Lost to Follow-up|1|||
131005550|NCT00578227|471648255|FG000|Overall Study|Withdrawal by Subject|5|||
131005551|NCT00578227|471648256|FG001|Overall Study|Withdrawal by Subject|1|||
131005552|NCT00578227|471648257|FG002|Overall Study|Withdrawal by Subject|3|||
131005553|NCT00577629|471648258|FG000|Treatment Period|Death|1|||
131005554|NCT00577629|471648258|FG000|Long Term Follow-Up|Death|15|||
131005555|NCT00577629|471648258|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
131005556|NCT00577629|471648258|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
131005557|NCT00577629|471648258|FG000|Long Term Follow-Up|Physician Decision|1|||
131005558|NCT01027871|471648259|FG000|Overall Study|Physician Decision|1|||
131005559|NCT01027871|471648260|FG001|Overall Study|Physician Decision|5|||
131005560|NCT01027871|471648261|FG002|Overall Study|Physician Decision|0|||
131005561|NCT01027871|471648259|FG000|Overall Study|Protocol Violation|0|||
131005562|NCT01027871|471648260|FG001|Overall Study|Protocol Violation|2|||
131005563|NCT01027871|471648261|FG002|Overall Study|Protocol Violation|2|||
131005564|NCT01027871|471648259|FG000|Overall Study|Withdrawal by Subject|1|||
131005565|NCT01027871|471648260|FG001|Overall Study|Withdrawal by Subject|2|||
131005566|NCT01027871|471648261|FG002|Overall Study|Withdrawal by Subject|2|||
131005567|NCT01027871|471648259|FG000|Overall Study|Adverse Event|0|||
131005568|NCT01027871|471648260|FG001|Overall Study|Adverse Event|2|||
131005569|NCT01027871|471648261|FG002|Overall Study|Adverse Event|2|||
131005570|NCT01027871|471648259|FG000|Overall Study|Sponsor Decision|0|||
131005571|NCT01027871|471648260|FG001|Overall Study|Sponsor Decision|2|||
131005572|NCT01027871|471648261|FG002|Overall Study|Sponsor Decision|0|||
131005573|NCT01027871|471648259|FG000|Overall Study|Discontinued Prior to Treatment|0|||
131005574|NCT01027871|471648260|FG001|Overall Study|Discontinued Prior to Treatment|0|||
131005575|NCT01027871|471648261|FG002|Overall Study|Discontinued Prior to Treatment|1|||
131005576|NCT01414166|471648262|FG000|Overall Study|Adverse Event|10|||
131005577|NCT01414166|471648263|FG001|Overall Study|Adverse Event|2|||
131005578|NCT01414166|471648262|FG000|Overall Study|Lost to Follow-up|4|||
131005579|NCT01414166|471648263|FG001|Overall Study|Lost to Follow-up|1|||
131005580|NCT01414166|471648262|FG000|Overall Study|Non-compliance with study drug|2|||
131005581|NCT01414166|471648263|FG001|Overall Study|Non-compliance with study drug|0|||
131005582|NCT01414166|471648262|FG000|Overall Study|Physician Decision|2|||
131005583|NCT01414166|471648263|FG001|Overall Study|Physician Decision|0|||
131005584|NCT01414166|471648262|FG000|Overall Study|Protocol Violation|2|||
131005585|NCT01414166|471648263|FG001|Overall Study|Protocol Violation|0|||
131005586|NCT01414166|471648262|FG000|Overall Study|Study terminated by Sponsor|68|||
131005587|NCT01414166|471648263|FG001|Overall Study|Study terminated by Sponsor|75|||
131005588|NCT01414166|471648262|FG000|Overall Study|Withdrawal by Subject|3|||
131005589|NCT01414166|471648263|FG001|Overall Study|Withdrawal by Subject|5|||
131005590|NCT03782727|471648264|FG000|Overall Study|Lost to Follow-up|32|||
131005591|NCT04736056|471648267|FG000|Overall Study|Death|0|||
131005592|NCT04736056|471648268|FG001|Overall Study|Death|0|||
131005593|NCT04736056|471648269|FG002|Overall Study|Death|0|||
131005594|NCT04736056|471648270|FG003|Overall Study|Death|1|||
131005595|NCT04736056|471648267|FG000|Overall Study|Lost to Follow-up|1|||
131005596|NCT04736056|471648268|FG001|Overall Study|Lost to Follow-up|0|||
131005597|NCT04736056|471648269|FG002|Overall Study|Lost to Follow-up|1|||
131005598|NCT04736056|471648270|FG003|Overall Study|Lost to Follow-up|1|||
131005599|NCT04736056|471648267|FG000|Overall Study|Withdrawal by Subject|2|||
131005600|NCT04736056|471648268|FG001|Overall Study|Withdrawal by Subject|0|||
131005601|NCT04736056|471648269|FG002|Overall Study|Withdrawal by Subject|0|||
131005602|NCT04736056|471648270|FG003|Overall Study|Withdrawal by Subject|0|||
131005603|NCT04736056|471648267|FG000|Overall Study|Physician Decision|1|||
131005604|NCT04736056|471648268|FG001|Overall Study|Physician Decision|0|||
131005605|NCT04736056|471648269|FG002|Overall Study|Physician Decision|1|||
131005606|NCT04736056|471648270|FG003|Overall Study|Physician Decision|0|||
131005607|NCT00764868|471648273|FG000|Overall Study|Adverse Event|18|||
131005608|NCT00764868|471648273|FG000|Overall Study|Withdrawal by Subject|31|||
131005609|NCT00764868|471648273|FG000|Overall Study|Non-compliance|16|||
131005610|NCT00764868|471648273|FG000|Overall Study|Lost to Follow-up|25|||
131005611|NCT00764868|471648273|FG000|Overall Study|Lack of Efficacy|5|||
131005612|NCT00764868|471648273|FG000|Overall Study|Subject moved|7|||
131005613|NCT00764868|471648273|FG000|Overall Study|Pregnancy|3|||
131005614|NCT00764868|471648273|FG000|Overall Study|Prohibited medication|1|||
131005615|NCT00764868|471648273|FG000|Overall Study|Out of town|1|||
131005616|NCT00764868|471648273|FG000|Overall Study|Misuse and compliance of study drug|1|||
131005617|NCT00764868|471648273|FG000|Overall Study|Subject sent to boarding school|1|||
131005618|NCT00764868|471648273|FG000|Overall Study|Met an exclusion criteria|1|||
131005619|NCT00764868|471648273|FG000|Overall Study|Positive drug screen|2|||
131005620|NCT00764868|471648273|FG000|Overall Study|Sponsor requested withdrawal|1|||
131005621|NCT04438785|471648278|FG000|Overall Study|change of weight, give up intervention|2|||
131005622|NCT04438785|471648279|FG001|Overall Study|change of weight, give up intervention|10|||
131005623|NCT04011033|471648280|FG000|Overall Study|Physician Decision|2|||
131005624|NCT04011033|471648281|FG001|Overall Study|Physician Decision|3|||
131005625|NCT04011033|471648280|FG000|Overall Study|Withdrawal by Subject|1|||
131005626|NCT04011033|471648281|FG001|Overall Study|Withdrawal by Subject|0|||
131005627|NCT01823341|471648282|FG000|Overall Study|Failed run-in|7|||
131005628|NCT01823341|471648282|FG000|Overall Study|Withdrawal by Subject|7|||
131005629|NCT01823341|471648282|FG000|Overall Study|Adverse Event|1|||
131005630|NCT02027935|471648283|FG000|Overall Study|Death|1|||
131005631|NCT02027935|471648283|FG000|Overall Study|Lack of Efficacy|5|||
131005632|NCT02027935|471648283|FG000|Overall Study|Study Closure|1|||
131005633|NCT00689104|471648284|FG000|Overall Study|Eligibility criterion not met|5|||
131005634|NCT00689104|471648285|FG001|Overall Study|Eligibility criterion not met|8|||
131005635|NCT00689104|471648286|FG002|Overall Study|Eligibility criterion not met|0|||
131005636|NCT00689104|471648287|FG003|Overall Study|Eligibility criterion not met|4|||
131005637|NCT00689104|471648284|FG000|Overall Study|Adverse Event|13|||
131005638|NCT00689104|471648285|FG001|Overall Study|Adverse Event|25|||
131005639|NCT00689104|471648286|FG002|Overall Study|Adverse Event|16|||
131005640|NCT00689104|471648287|FG003|Overall Study|Adverse Event|24|||
131005641|NCT00689104|471648284|FG000|Overall Study|Lack of Efficacy|5|||
131005642|NCT00689104|471648285|FG001|Overall Study|Lack of Efficacy|6|||
131005643|NCT00689104|471648286|FG002|Overall Study|Lack of Efficacy|2|||
131005644|NCT00689104|471648287|FG003|Overall Study|Lack of Efficacy|3|||
131005645|NCT00689104|471648284|FG000|Overall Study|Withdrawal by Subject|12|||
131005646|NCT00689104|471648285|FG001|Overall Study|Withdrawal by Subject|11|||
131005647|NCT00689104|471648286|FG002|Overall Study|Withdrawal by Subject|18|||
131005648|NCT00689104|471648287|FG003|Overall Study|Withdrawal by Subject|11|||
131005649|NCT00689104|471648284|FG000|Overall Study|Lost to Follow-up|4|||
131005650|NCT00689104|471648285|FG001|Overall Study|Lost to Follow-up|3|||
131005651|NCT00689104|471648286|FG002|Overall Study|Lost to Follow-up|2|||
131005652|NCT00689104|471648287|FG003|Overall Study|Lost to Follow-up|5|||
131005653|NCT00689104|471648284|FG000|Overall Study|Protocol Violation|2|||
131005654|NCT00689104|471648285|FG001|Overall Study|Protocol Violation|3|||
131005655|NCT00689104|471648286|FG002|Overall Study|Protocol Violation|5|||
131005656|NCT00689104|471648287|FG003|Overall Study|Protocol Violation|3|||
131005657|NCT00689104|471648284|FG000|Overall Study|Randomized but never received study drug|2|||
131005658|NCT00689104|471648285|FG001|Overall Study|Randomized but never received study drug|1|||
131005659|NCT00689104|471648286|FG002|Overall Study|Randomized but never received study drug|1|||
131005660|NCT00689104|471648287|FG003|Overall Study|Randomized but never received study drug|0|||
131005661|NCT00689104|471648284|FG000|Overall Study|Physician Decision|1|||
131005662|NCT00689104|471648285|FG001|Overall Study|Physician Decision|0|||
131005663|NCT00689104|471648286|FG002|Overall Study|Physician Decision|0|||
131005664|NCT00689104|471648287|FG003|Overall Study|Physician Decision|0|||
131005665|NCT00689104|471648284|FG000|Overall Study|Non-compliance with study procedures|0|||
131005666|NCT00689104|471648285|FG001|Overall Study|Non-compliance with study procedures|0|||
131005667|NCT00689104|471648286|FG002|Overall Study|Non-compliance with study procedures|1|||
131005668|NCT00689104|471648287|FG003|Overall Study|Non-compliance with study procedures|0|||
131005669|NCT04873817|471648288|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
131005670|NCT04873817|471648288|FG000|Overall Study|Lost to Follow-up|4|||
131005671|NCT04873817|471648288|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
131005672|NCT04873817|471648288|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
131005673|NCT04873817|471648288|FG000|Overall Study|Other Reasons|3|||
131005674|NCT00924560|471648289|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
131005675|NCT00924560|471648290|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
131005676|NCT00924560|471648291|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
131005677|NCT00924560|471648289|FG000|Overall Study|Non Compliance with the Protocol|20|||
131005678|NCT00924560|471648290|FG001|Overall Study|Non Compliance with the Protocol|15|||
131005679|NCT00924560|471648291|FG002|Overall Study|Non Compliance with the Protocol|4|||
131005680|NCT00924560|471648289|FG000|Overall Study|Physician Decision|2|||
131005681|NCT00924560|471648290|FG001|Overall Study|Physician Decision|3|||
131005682|NCT00924560|471648291|FG002|Overall Study|Physician Decision|4|||
131005683|NCT00924560|471648289|FG000|Overall Study|Withdrawal by Subject|50|||
131005684|NCT00924560|471648290|FG001|Overall Study|Withdrawal by Subject|44|||
131005685|NCT00924560|471648291|FG002|Overall Study|Withdrawal by Subject|18|||
131005686|NCT00924560|471648289|FG000|Overall Study|Adverse Event|39|||
131005687|NCT00924560|471648290|FG001|Overall Study|Adverse Event|33|||
131005688|NCT00924560|471648291|FG002|Overall Study|Adverse Event|0|||
131005689|NCT00924560|471648289|FG000|Overall Study|Pregnancy|5|||
131005690|NCT00924560|471648290|FG001|Overall Study|Pregnancy|7|||
131005691|NCT00924560|471648291|FG002|Overall Study|Pregnancy|1|||
131005692|NCT00924560|471648289|FG000|Overall Study|Lost to Follow-up|78|||
131005693|NCT00924560|471648290|FG001|Overall Study|Lost to Follow-up|94|||
131005694|NCT00924560|471648291|FG002|Overall Study|Lost to Follow-up|45|||
131005695|NCT00924560|471648289|FG000|Overall Study|Miscellaneous Reasons|13|||
131005696|NCT00924560|471648290|FG001|Overall Study|Miscellaneous Reasons|10|||
131005697|NCT00924560|471648291|FG002|Overall Study|Miscellaneous Reasons|10|||
131005698|NCT02696226|471648295|FG000|Overall Study|Study terminated - lack of enrollment|1|||
131005699|NCT02696226|471648296|FG001|Overall Study|Study terminated - lack of enrollment|0|||
131005700|NCT02696226|471648297|FG002|Overall Study|Study terminated - lack of enrollment|2|||
131005701|NCT02696226|471648298|FG003|Overall Study|Study terminated - lack of enrollment|0|||
131005702|NCT02909101|471648306|FG000|Overall Study|Lost to Follow-up|1|||
131005703|NCT02909101|471648307|FG001|Overall Study|Lost to Follow-up|1|||
131005704|NCT01290094|471648308|FG000|Overall Study|Withdrawal by Subject|1|||
131005705|NCT01290094|471648308|FG000|Overall Study|Lost to Follow-up|5|||
131005706|NCT04949399|471648311|FG000|Overall Study|Lost to Follow-up|11|||
131005707|NCT04949399|471648312|FG001|Overall Study|Lost to Follow-up|6|||
131005708|NCT04949399|471648311|FG000|Overall Study|Withdrawal by Subject|2|||
131005709|NCT04949399|471648312|FG001|Overall Study|Withdrawal by Subject|3|||
131005710|NCT01939158|471650694|FG000|Overall Study|Adverse Event|1|||
131005711|NCT01939158|471650695|FG001|Overall Study|Adverse Event|0|||
131005712|NCT01939158|471650696|FG002|Overall Study|Adverse Event|0|||
131005713|NCT01939158|471650697|FG003|Overall Study|Adverse Event|0|||
131005714|NCT01939158|471650694|FG000|Overall Study|Withdrawal by Subject|22|||
131005715|NCT01939158|471650695|FG001|Overall Study|Withdrawal by Subject|25|||
131005716|NCT01939158|471650696|FG002|Overall Study|Withdrawal by Subject|15|||
131005717|NCT01939158|471650697|FG003|Overall Study|Withdrawal by Subject|17|||
131222461|NCT02556632|472441500|FG002|Overall Study|Personal Issues|1|||
131222462|NCT02556632|472441498|FG000|Overall Study|Changed Mind|0|||
131222463|NCT02556632|472441499|FG001|Overall Study|Changed Mind|1|||
131222464|NCT02556632|472441500|FG002|Overall Study|Changed Mind|0|||
131222465|NCT02556632|472441498|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
131222466|NCT02556632|472441499|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
131222467|NCT02556632|472441500|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
131222468|NCT02556632|472441498|FG000|Overall Study|Unrelated Adverse Event|1|||
131222469|NCT02556632|472441499|FG001|Overall Study|Unrelated Adverse Event|0|||
130720916|NCT00724048|470601562|FG001|Overall Study|Adverse Event|1|||
131005718|NCT01939158|471650694|FG000|Overall Study|Migrated/moved from study area|5|||
131005719|NCT01939158|471650695|FG001|Overall Study|Migrated/moved from study area|7|||
131005720|NCT01939158|471650696|FG002|Overall Study|Migrated/moved from study area|3|||
131005721|NCT01939158|471650697|FG003|Overall Study|Migrated/moved from study area|6|||
131005722|NCT01939158|471650694|FG000|Overall Study|Lost to Follow-up|18|||
131005723|NCT01939158|471650695|FG001|Overall Study|Lost to Follow-up|17|||
131005724|NCT01939158|471650696|FG002|Overall Study|Lost to Follow-up|17|||
131005725|NCT01939158|471650697|FG003|Overall Study|Lost to Follow-up|17|||
131005726|NCT01939158|471650694|FG000|Overall Study|Death|0|||
131005727|NCT01939158|471650695|FG001|Overall Study|Death|0|||
131005728|NCT01939158|471650696|FG002|Overall Study|Death|1|||
131005729|NCT01939158|471650697|FG003|Overall Study|Death|1|||
131005730|NCT01939158|471650694|FG000|Overall Study|No longer meets eligibility criteria|0|||
131005731|NCT01939158|471650695|FG001|Overall Study|No longer meets eligibility criteria|0|||
131005732|NCT01939158|471650696|FG002|Overall Study|No longer meets eligibility criteria|1|||
131005733|NCT01939158|471650697|FG003|Overall Study|No longer meets eligibility criteria|0|||
131005734|NCT01939158|471650694|FG000|Overall Study|Other|1|||
131005735|NCT01939158|471650695|FG001|Overall Study|Other|3|||
131005736|NCT01939158|471650696|FG002|Overall Study|Other|4|||
131005737|NCT01939158|471650697|FG003|Overall Study|Other|3|||
131005738|NCT02373813|471650701|FG000|Run-In Period|Other, Not Specified|5|||
131005739|NCT02373813|471650702|FG001|Run-In Period|Other, Not Specified|0|||
131005740|NCT02373813|471650703|FG002|Run-In Period|Other, Not Specified|0|||
131005741|NCT02373813|471650704|FG003|Run-In Period|Other, Not Specified|0|||
131005742|NCT02373813|471650701|FG000|Run-In Period|Withdrawal by Subject|16|||
131005743|NCT02373813|471650702|FG001|Run-In Period|Withdrawal by Subject|0|||
131005744|NCT02373813|471650703|FG002|Run-In Period|Withdrawal by Subject|0|||
131005745|NCT02373813|471650704|FG003|Run-In Period|Withdrawal by Subject|0|||
131222470|NCT02556632|472441500|FG002|Overall Study|Unrelated Adverse Event|3|||
131222471|NCT02556632|472441498|FG000|Overall Study|Related Adverse Event|0|||
131222472|NCT02556632|472441499|FG001|Overall Study|Related Adverse Event|1|||
131222473|NCT02556632|472441500|FG002|Overall Study|Related Adverse Event|0|||
131222474|NCT02556632|472441498|FG000|Overall Study|Possibly Related Adverse Event|0|||
131222475|NCT02556632|472441499|FG001|Overall Study|Possibly Related Adverse Event|0|||
131222476|NCT02556632|472441500|FG002|Overall Study|Possibly Related Adverse Event|1|||
131222477|NCT02556632|472441498|FG000|Overall Study|Did Not Start RT|0|||
131222478|NCT02556632|472441499|FG001|Overall Study|Did Not Start RT|1|||
131222479|NCT02556632|472441500|FG002|Overall Study|Did Not Start RT|0|||
131222480|NCT02556632|472441498|FG000|Overall Study|Ineligible|0|||
131222481|NCT02556632|472441499|FG001|Overall Study|Ineligible|1|||
131222482|NCT02556632|472441500|FG002|Overall Study|Ineligible|0|||
131005746|NCT02373813|471650701|FG000|Run-In Period|Decision by Sponsor|11|||
131005747|NCT02373813|471650702|FG001|Run-In Period|Decision by Sponsor|0|||
131005748|NCT02373813|471650703|FG002|Run-In Period|Decision by Sponsor|0|||
131005749|NCT02373813|471650704|FG003|Run-In Period|Decision by Sponsor|0|||
131005750|NCT02373813|471650701|FG000|Run-In Period|Protocol Violation|75|||
131005751|NCT02373813|471650702|FG001|Run-In Period|Protocol Violation|0|||
131005752|NCT02373813|471650703|FG002|Run-In Period|Protocol Violation|0|||
131005753|NCT02373813|471650704|FG003|Run-In Period|Protocol Violation|0|||
131005754|NCT02373813|471650701|FG000|Run-In Period|Lost to Follow-up|2|||
131005755|NCT02373813|471650702|FG001|Run-In Period|Lost to Follow-up|0|||
131005756|NCT02373813|471650703|FG002|Run-In Period|Lost to Follow-up|0|||
131005757|NCT02373813|471650704|FG003|Run-In Period|Lost to Follow-up|0|||
131005758|NCT02373813|471650701|FG000|Run-In Period|Adverse Event|3|||
131005759|NCT02373813|471650702|FG001|Run-In Period|Adverse Event|0|||
131005760|NCT02373813|471650703|FG002|Run-In Period|Adverse Event|0|||
131005761|NCT02373813|471650704|FG003|Run-In Period|Adverse Event|0|||
131005762|NCT02373813|471650701|FG000|Run-In Period|Noncompliance|1|||
131005763|NCT02373813|471650702|FG001|Run-In Period|Noncompliance|0|||
130720917|NCT00724048|470601563|FG002|Overall Study|Adverse Event|1|||
131005764|NCT02373813|471650703|FG002|Run-In Period|Noncompliance|0|||
131005765|NCT02373813|471650704|FG003|Run-In Period|Noncompliance|0|||
131005766|NCT02373813|471650701|FG000|Run-In Period|Ineligibility Determined|3|||
131005767|NCT02373813|471650702|FG001|Run-In Period|Ineligibility Determined|0|||
131005768|NCT02373813|471650703|FG002|Run-In Period|Ineligibility Determined|0|||
131005769|NCT02373813|471650704|FG003|Run-In Period|Ineligibility Determined|0|||
131005770|NCT02373813|471650701|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
131005771|NCT02373813|471650702|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
131005772|NCT02373813|471650703|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
131005773|NCT02373813|471650704|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
131005774|NCT02373813|471650701|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
131005775|NCT02373813|471650702|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
131005776|NCT02373813|471650703|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
131005777|NCT02373813|471650704|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
131005778|NCT02373813|471650701|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131005779|NCT02373813|471650702|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
131005780|NCT02373813|471650703|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
131005781|NCT02373813|471650704|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
131005782|NCT02373813|471650701|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131005783|NCT02373813|471650702|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
131005784|NCT02373813|471650703|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
131005785|NCT02373813|471650704|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
131005786|NCT02703532|471650710|FG000|Overall Study|Withdrawal by Subject|0|||
131005787|NCT02703532|471650711|FG001|Overall Study|Withdrawal by Subject|1|||
131005788|NCT02703532|471650712|FG002|Overall Study|Withdrawal by Subject|0|||
131005789|NCT02703532|471650713|FG003|Overall Study|Withdrawal by Subject|1|||
131005790|NCT02703532|471650710|FG000|Overall Study|Lost to Follow-up|2|||
131005791|NCT02703532|471650711|FG001|Overall Study|Lost to Follow-up|0|||
131005792|NCT02703532|471650712|FG002|Overall Study|Lost to Follow-up|2|||
131005793|NCT02703532|471650713|FG003|Overall Study|Lost to Follow-up|0|||
131005794|NCT03738241|471650719|FG000|Overall Study|Withdrawal by Subject|0|||
131005795|NCT03738241|471650720|FG001|Overall Study|Withdrawal by Subject|0|||
131005796|NCT03738241|471650721|FG002|Overall Study|Withdrawal by Subject|0|||
131005797|NCT03738241|471650722|FG003|Overall Study|Withdrawal by Subject|0|||
131005798|NCT03738241|471650723|FG004|Overall Study|Withdrawal by Subject|0|||
131005799|NCT03738241|471650724|FG005|Overall Study|Withdrawal by Subject|0|||
131005800|NCT03738241|471650725|FG006|Overall Study|Withdrawal by Subject|0|||
131005801|NCT03738241|471650726|FG007|Overall Study|Withdrawal by Subject|0|||
131005802|NCT03738241|471650727|FG008|Overall Study|Withdrawal by Subject|0|||
131005803|NCT03738241|471650728|FG009|Overall Study|Withdrawal by Subject|1|||
131005804|NCT03738241|471650719|FG000|Overall Study|Physician Decision|0|||
131005805|NCT03738241|471650720|FG001|Overall Study|Physician Decision|0|||
131005806|NCT03738241|471650721|FG002|Overall Study|Physician Decision|0|||
131005807|NCT03738241|471650722|FG003|Overall Study|Physician Decision|0|||
131005808|NCT03738241|471650723|FG004|Overall Study|Physician Decision|0|||
131005809|NCT03738241|471650724|FG005|Overall Study|Physician Decision|0|||
131005810|NCT03738241|471650725|FG006|Overall Study|Physician Decision|0|||
131005811|NCT03738241|471650726|FG007|Overall Study|Physician Decision|0|||
131005812|NCT03738241|471650727|FG008|Overall Study|Physician Decision|1|||
131005813|NCT03738241|471650728|FG009|Overall Study|Physician Decision|0|||
131005814|NCT03738241|471650719|FG000|Overall Study|Adverse Event|1|||
131005815|NCT03738241|471650720|FG001|Overall Study|Adverse Event|0|||
131005816|NCT03738241|471650721|FG002|Overall Study|Adverse Event|0|||
131005817|NCT03738241|471650722|FG003|Overall Study|Adverse Event|0|||
131005818|NCT03738241|471650723|FG004|Overall Study|Adverse Event|0|||
131005819|NCT03738241|471650724|FG005|Overall Study|Adverse Event|0|||
131005820|NCT03738241|471650725|FG006|Overall Study|Adverse Event|0|||
131005821|NCT03738241|471650726|FG007|Overall Study|Adverse Event|0|||
131005822|NCT03738241|471650727|FG008|Overall Study|Adverse Event|0|||
131005823|NCT03738241|471650728|FG009|Overall Study|Adverse Event|0|||
131005824|NCT03169361|471650729|FG000|Overall Study|Protocol Violation|32|||
131005825|NCT02271594|471650730|FG000|Overall Study|Study closed; recruiting failure|19|||
131005826|NCT02271594|471650731|FG001|Overall Study|Study closed; recruiting failure|12|||
131005827|NCT00495469|471650732|FG000|Overall Study|Adverse Event|0|||
131005828|NCT00495469|471650733|FG001|Overall Study|Adverse Event|1|||
131005829|NCT00495469|471650734|FG002|Overall Study|Adverse Event|3|||
131005830|NCT00495469|471650735|FG003|Overall Study|Adverse Event|0|||
131005831|NCT00495469|471650736|FG004|Overall Study|Adverse Event|1|||
131005832|NCT00495469|471650737|FG005|Overall Study|Adverse Event|1|||
131005833|NCT00495469|471650738|FG006|Overall Study|Adverse Event|1|||
131005834|NCT00495469|471650732|FG000|Overall Study|Lost to Follow-up|1|||
131005835|NCT00495469|471650733|FG001|Overall Study|Lost to Follow-up|1|||
131005836|NCT00495469|471650734|FG002|Overall Study|Lost to Follow-up|3|||
131005837|NCT00495469|471650735|FG003|Overall Study|Lost to Follow-up|1|||
131005838|NCT00495469|471650736|FG004|Overall Study|Lost to Follow-up|0|||
131005839|NCT00495469|471650737|FG005|Overall Study|Lost to Follow-up|0|||
131005840|NCT00495469|471650738|FG006|Overall Study|Lost to Follow-up|0|||
131005841|NCT00495469|471650732|FG000|Overall Study|Protocol Violation|0|||
131005842|NCT00495469|471650733|FG001|Overall Study|Protocol Violation|0|||
131005843|NCT00495469|471650734|FG002|Overall Study|Protocol Violation|0|||
131005844|NCT00495469|471650735|FG003|Overall Study|Protocol Violation|0|||
131005845|NCT00495469|471650736|FG004|Overall Study|Protocol Violation|1|||
131005846|NCT00495469|471650737|FG005|Overall Study|Protocol Violation|2|||
131005847|NCT00495469|471650738|FG006|Overall Study|Protocol Violation|0|||
131005848|NCT00495469|471650732|FG000|Overall Study|Withdrawal by Subject|5|||
131005849|NCT00495469|471650733|FG001|Overall Study|Withdrawal by Subject|3|||
131005850|NCT00495469|471650734|FG002|Overall Study|Withdrawal by Subject|1|||
131005851|NCT00495469|471650735|FG003|Overall Study|Withdrawal by Subject|3|||
131005852|NCT00495469|471650736|FG004|Overall Study|Withdrawal by Subject|3|||
131005853|NCT00495469|471650737|FG005|Overall Study|Withdrawal by Subject|2|||
131005854|NCT00495469|471650738|FG006|Overall Study|Withdrawal by Subject|3|||
131005855|NCT00495469|471650732|FG000|Overall Study|Lack of Efficacy|0|||
131005856|NCT00495469|471650733|FG001|Overall Study|Lack of Efficacy|0|||
131005857|NCT00495469|471650734|FG002|Overall Study|Lack of Efficacy|0|||
131005858|NCT00495469|471650735|FG003|Overall Study|Lack of Efficacy|0|||
131005859|NCT00495469|471650736|FG004|Overall Study|Lack of Efficacy|0|||
131005860|NCT00495469|471650737|FG005|Overall Study|Lack of Efficacy|0|||
131005861|NCT00495469|471650738|FG006|Overall Study|Lack of Efficacy|1|||
131005862|NCT00495469|471650732|FG000|Overall Study|Liver function test abnormality|0|||
131005863|NCT00495469|471650733|FG001|Overall Study|Liver function test abnormality|1|||
131005864|NCT00495469|471650734|FG002|Overall Study|Liver function test abnormality|0|||
131005865|NCT00495469|471650735|FG003|Overall Study|Liver function test abnormality|0|||
131005866|NCT00495469|471650736|FG004|Overall Study|Liver function test abnormality|0|||
131005867|NCT00495469|471650737|FG005|Overall Study|Liver function test abnormality|0|||
131005868|NCT00495469|471650738|FG006|Overall Study|Liver function test abnormality|0|||
131005869|NCT00495469|471650732|FG000|Overall Study|ST depression at randomisation in ECG|0|||
131005870|NCT00495469|471650733|FG001|Overall Study|ST depression at randomisation in ECG|1|||
131005871|NCT00495469|471650734|FG002|Overall Study|ST depression at randomisation in ECG|0|||
131005872|NCT00495469|471650735|FG003|Overall Study|ST depression at randomisation in ECG|0|||
131005873|NCT00495469|471650736|FG004|Overall Study|ST depression at randomisation in ECG|0|||
130884905|NCT00790842|471213224|FG008|Expansion Cohort|Physician Decision|0|||
131005874|NCT00495469|471650737|FG005|Overall Study|ST depression at randomisation in ECG|0|||
131005875|NCT00495469|471650738|FG006|Overall Study|ST depression at randomisation in ECG|0|||
131005876|NCT00448864|471650741|FG000|Overall Study|Death|1|||
131005877|NCT00448864|471650742|FG001|Overall Study|Death|0|||
131005878|NCT00448864|471650743|FG002|Overall Study|Death|0|||
131005879|NCT00448864|471650741|FG000|Overall Study|Lost to Follow-up|3|||
131005880|NCT00448864|471650742|FG001|Overall Study|Lost to Follow-up|1|||
131005881|NCT00448864|471650743|FG002|Overall Study|Lost to Follow-up|0|||
131005882|NCT00448864|471650741|FG000|Overall Study|Physician Decision|1|||
131005883|NCT00448864|471650742|FG001|Overall Study|Physician Decision|0|||
131005884|NCT00448864|471650743|FG002|Overall Study|Physician Decision|1|||
131005885|NCT00448864|471650741|FG000|Overall Study|Withdrawal by Subject|0|||
131005886|NCT00448864|471650742|FG001|Overall Study|Withdrawal by Subject|2|||
131005887|NCT00448864|471650743|FG002|Overall Study|Withdrawal by Subject|0|||
131005888|NCT00448864|471650741|FG000|Overall Study|Protocol Violation|0|||
131005889|NCT00448864|471650742|FG001|Overall Study|Protocol Violation|2|||
131005890|NCT00448864|471650743|FG002|Overall Study|Protocol Violation|0|||
131005891|NCT01323660|471650746|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
131005892|NCT01323660|471650747|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
131005893|NCT01323660|471650748|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
131005894|NCT01323660|471650749|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
131005895|NCT01323660|471650750|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
131005896|NCT01323660|471650751|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
131005897|NCT01323660|471650746|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
131005898|NCT01323660|471650747|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
131005899|NCT01323660|471650748|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
131005900|NCT01323660|471650749|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
131005901|NCT01323660|471650750|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
131005902|NCT01323660|471650751|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
131005903|NCT01323660|471650746|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
131005904|NCT01323660|471650747|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
131005905|NCT01323660|471650748|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
131005906|NCT01323660|471650749|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
131005907|NCT01323660|471650750|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
131005908|NCT01323660|471650751|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
131005909|NCT01323660|471650746|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131005910|NCT01323660|471650747|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131005911|NCT01323660|471650748|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131005912|NCT01323660|471650749|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131005913|NCT01323660|471650750|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
131005914|NCT01323660|471650751|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131005915|NCT01323660|471650746|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131005916|NCT01323660|471650747|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131005917|NCT01323660|471650748|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131005918|NCT01323660|471650749|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131005919|NCT01323660|471650750|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
131005920|NCT01323660|471650751|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131005921|NCT01323660|471650746|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
131005922|NCT01323660|471650747|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131005923|NCT01323660|471650748|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
131005924|NCT01323660|471650749|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
131005925|NCT01323660|471650750|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
131222483|NCT02556632|472441498|FG000|Overall Study|Disliked Study Procedures|0|||
131222484|NCT02556632|472441499|FG001|Overall Study|Disliked Study Procedures|0|||
131222485|NCT02556632|472441500|FG002|Overall Study|Disliked Study Procedures|1|||
131222486|NCT02556632|472441498|FG000|Overall Study|Treatment or Change Delay|0|||
131222487|NCT02556632|472441499|FG001|Overall Study|Treatment or Change Delay|0|||
131222488|NCT02556632|472441500|FG002|Overall Study|Treatment or Change Delay|1|||
131222489|NCT00808015|472441503|FG000|Overall Study|Death|1|||
131222490|NCT00808015|472441503|FG000|Overall Study|Lack of Efficacy|58|||
131222491|NCT00808015|472441503|FG000|Overall Study|Lost to Follow-up|76|||
131222492|NCT00808015|472441503|FG000|Overall Study|Participants not willing to participate|158|||
131222493|NCT00808015|472441503|FG000|Overall Study|Adverse Event|22|||
131222494|NCT00808015|472441503|FG000|Overall Study|Other|25|||
131222495|NCT00808015|472441503|FG000|Overall Study|Enrolled but not treated|4|||
131222496|NCT04508621|472441506|FG000|Overall Study|Adverse Event|39|||
131222497|NCT04508621|472441507|FG001|Overall Study|Adverse Event|16|||
131222498|NCT04508621|472441506|FG000|Overall Study|Lack of Efficacy|2|||
131222499|NCT04508621|472441507|FG001|Overall Study|Lack of Efficacy|8|||
131222500|NCT04508621|472441506|FG000|Overall Study|Physician Decision|0|||
131222501|NCT04508621|472441507|FG001|Overall Study|Physician Decision|1|||
131222502|NCT04508621|472441506|FG000|Overall Study|Withdrawal by Subject|10|||
131222503|NCT04508621|472441507|FG001|Overall Study|Withdrawal by Subject|14|||
131222504|NCT04508621|472441506|FG000|Overall Study|Lost to Follow-up|12|||
131222505|NCT04508621|472441507|FG001|Overall Study|Lost to Follow-up|9|||
131222506|NCT04508621|472441506|FG000|Overall Study|COVID-19 related crisis|3|||
131222507|NCT04508621|472441507|FG001|Overall Study|COVID-19 related crisis|0|||
131222508|NCT04508621|472441506|FG000|Overall Study|Subject non-compliance|1|||
131222509|NCT04508621|472441507|FG001|Overall Study|Subject non-compliance|0|||
131222510|NCT02574260|472441512|FG000|Overall Study|Disease Progression|1|||
131222511|NCT01066039|472441513|FG000|Overall Study|Adverse Event|6|||
131222512|NCT01066039|472441513|FG000|Overall Study|Withdrawal by Subject|17|||
131222513|NCT01066039|472441513|FG000|Overall Study|Protocol Violation|2|||
131222514|NCT01066039|472441513|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
131222515|NCT01066039|472441513|FG000|Overall Study|Investigator's Request|1|||
131222516|NCT01066039|472441513|FG000|Overall Study|Dropout due to Insulin Administration|1|||
131222517|NCT01066039|472441513|FG000|Overall Study|Additional Antihypertensive Required|4|||
131222518|NCT01066039|472441513|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
131222519|NCT01066039|472441513|FG000|Overall Study|Failure to Control Blood Pressure|1|||
131222520|NCT01066039|472441513|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
131222521|NCT00084617|472441523|FG000|Overall Study|Withdrawal by Subject|7|||
131222522|NCT00084617|472441523|FG000|Overall Study|Lack of Efficacy|1|||
131222523|NCT00084617|472441523|FG000|Overall Study|Protocol Violation|1|||
131222524|NCT01625286|472441524|FG000|Overall Study|Adverse Event|0|||
131222525|NCT01625286|472441525|FG001|Overall Study|Adverse Event|0|||
131222526|NCT01625286|472441526|FG002|Overall Study|Adverse Event|0|||
131222527|NCT01625286|472441527|FG003|Overall Study|Adverse Event|0|||
131222528|NCT01625286|472441528|FG004|Overall Study|Adverse Event|1|||
131222529|NCT01625286|472441529|FG005|Overall Study|Adverse Event|2|||
131222530|NCT01625286|472441530|FG006|Overall Study|Adverse Event|1|||
131222531|NCT01625286|472441524|FG000|Overall Study|Death|0|||
131222532|NCT01625286|472441525|FG001|Overall Study|Death|0|||
131222533|NCT01625286|472441526|FG002|Overall Study|Death|1|||
131222534|NCT01625286|472441527|FG003|Overall Study|Death|1|||
131222535|NCT01625286|472441528|FG004|Overall Study|Death|0|||
131222536|NCT01625286|472441529|FG005|Overall Study|Death|11|||
131222537|NCT01625286|472441530|FG006|Overall Study|Death|16|||
131222538|NCT01625286|472441524|FG000|Overall Study|Withdrawal by Subject|0|||
131222539|NCT01625286|472441525|FG001|Overall Study|Withdrawal by Subject|1|||
131222540|NCT01625286|472441526|FG002|Overall Study|Withdrawal by Subject|0|||
131222541|NCT01625286|472441527|FG003|Overall Study|Withdrawal by Subject|1|||
131222542|NCT01625286|472441528|FG004|Overall Study|Withdrawal by Subject|0|||
131005926|NCT01323660|471650751|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131005927|NCT01323660|471650746|FG000|Washout Period (14 Days)|Adverse Event|0|||
131005928|NCT01323660|471650747|FG001|Washout Period (14 Days)|Adverse Event|0|||
131005929|NCT01323660|471650748|FG002|Washout Period (14 Days)|Adverse Event|0|||
131005930|NCT01323660|471650749|FG003|Washout Period (14 Days)|Adverse Event|0|||
131005931|NCT01323660|471650750|FG004|Washout Period (14 Days)|Adverse Event|1|||
131005932|NCT01323660|471650751|FG005|Washout Period (14 Days)|Adverse Event|0|||
131005933|NCT01323660|471650746|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
131005934|NCT01323660|471650747|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
131005935|NCT01323660|471650748|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
131005936|NCT01323660|471650749|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
131005937|NCT01323660|471650750|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
131005938|NCT01323660|471650751|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
131005939|NCT01323660|471650746|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
131005940|NCT01323660|471650747|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
131005941|NCT01323660|471650748|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
131005942|NCT01323660|471650749|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
131005943|NCT01323660|471650750|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
131005944|NCT01323660|471650751|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
131005945|NCT01323660|471650746|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
131005946|NCT01323660|471650747|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
131005947|NCT01323660|471650748|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
131005948|NCT01323660|471650749|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
131005949|NCT01323660|471650750|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
131005950|NCT01323660|471650751|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
131005951|NCT01323660|471650746|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
131005952|NCT01323660|471650747|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
131005953|NCT01323660|471650748|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
131005954|NCT01323660|471650749|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
131005955|NCT01323660|471650750|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
131005956|NCT01323660|471650751|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
131005957|NCT01323660|471650746|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
131005958|NCT01323660|471650747|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
131005959|NCT01323660|471650748|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
131005960|NCT01323660|471650749|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
131005961|NCT01323660|471650750|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130720918|NCT00724048|470601564|FG003|Overall Study|Adverse Event|0|||
130720919|NCT00724048|470601561|FG000|Overall Study|Lost to Follow-up|0|||
131005962|NCT01323660|471650751|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
131005963|NCT01323660|471650746|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131005964|NCT01323660|471650747|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131005965|NCT01323660|471650748|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131005966|NCT01323660|471650749|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131222543|NCT01625286|472441529|FG005|Overall Study|Withdrawal by Subject|0|||
131005967|NCT01323660|471650750|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
131005968|NCT01323660|471650751|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131229433|NCT05028751|472465914|FG003|Overall Study|Miscellaneous|0|||
131229434|NCT03586830|472465916|FG000|Overall Study|Site terminated by Sponsor|1|||
131229435|NCT03586830|472465917|FG001|Overall Study|Site terminated by Sponsor|4|||
131229436|NCT03586830|472465918|FG002|Overall Study|Site terminated by Sponsor|3|||
131229437|NCT03586830|472465919|FG003|Overall Study|Site terminated by Sponsor|3|||
131229438|NCT03586830|472465916|FG000|Overall Study|Lost to Follow-up|0|||
131229439|NCT03586830|472465917|FG001|Overall Study|Lost to Follow-up|2|||
131229440|NCT03586830|472465918|FG002|Overall Study|Lost to Follow-up|2|||
131229441|NCT03586830|472465919|FG003|Overall Study|Lost to Follow-up|1|||
131229442|NCT03586830|472465916|FG000|Overall Study|Withdrawal by Subject|1|||
131229443|NCT03586830|472465917|FG001|Overall Study|Withdrawal by Subject|0|||
131229444|NCT03586830|472465918|FG002|Overall Study|Withdrawal by Subject|3|||
131229445|NCT03586830|472465919|FG003|Overall Study|Withdrawal by Subject|1|||
131229446|NCT04578548|472465920|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
131229447|NCT04578548|472465921|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
131229448|NCT04578548|472465920|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
131229449|NCT04578548|472465921|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
131229450|NCT04578548|472465920|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
131229451|NCT04578548|472465921|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
131229452|NCT04578548|472465920|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
131229453|NCT04578548|472465921|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
131229454|NCT04578548|472465920|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
131229455|NCT04578548|472465921|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
131229456|NCT04578548|472465920|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
131229457|NCT04578548|472465921|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
131229458|NCT00395083|472465924|FG000|Overall Study|Withdrawal by Subject|6|||
131229459|NCT00395083|472465925|FG001|Overall Study|Withdrawal by Subject|5|||
131229460|NCT00395083|472465924|FG000|Overall Study|Developed another disease|4|||
131229461|NCT00395083|472465925|FG001|Overall Study|Developed another disease|3|||
131229462|NCT00972153|472465926|FG000|Overall Study|Equipment malfunction during case|0|||
131229463|NCT00972153|472465927|FG001|Overall Study|Equipment malfunction during case|1|||
131229464|NCT00972153|472465928|FG002|Overall Study|Equipment malfunction during case|0|||
131005969|NCT05349084|471650753|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
131005970|NCT01004263|471650765|FG000|Overall Study|Adverse Event|15|||
131005971|NCT01004263|471650765|FG000|Overall Study|Withdrawal by Subject|58|||
131005972|NCT01004263|471650765|FG000|Overall Study|Protocol Violation|10|||
131005973|NCT01004263|471650765|FG000|Overall Study|Lost to Follow-up|64|||
131005974|NCT01004263|471650765|FG000|Overall Study|Lack of Efficacy|13|||
131005975|NCT01004263|471650765|FG000|Overall Study|Pregnancy|2|||
131005976|NCT01004263|471650765|FG000|Overall Study|Physician Decision|15|||
131005977|NCT01004263|471650765|FG000|Overall Study|Lack of Qualifying Event|2|||
131005978|NCT00958009|471650767|FG000|Overall Study|Adverse Event|1|||
130884906|NCT00790842|471213225|FG009|Expansion Cohort|Physician Decision|0|||
131222544|NCT01625286|472441530|FG006|Overall Study|Withdrawal by Subject|1|||
131005979|NCT00958009|471650767|FG000|Overall Study|Subject found device difficult to use|1|||
131005980|NCT01605136|471650768|FG000|Study Period|Withdrawal by Subject|2|||
131005981|NCT01605136|471650769|FG001|Study Period|Withdrawal by Subject|0|||
131005982|NCT01605136|471650768|FG000|Study Period|Physician Decision|1|||
131005983|NCT01605136|471650769|FG001|Study Period|Physician Decision|1|||
131005984|NCT01605136|471650768|FG000|Study Period|Lost to Follow-up|0|||
131005985|NCT01605136|471650769|FG001|Study Period|Lost to Follow-up|2|||
131005986|NCT01605136|471650768|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
131005987|NCT01605136|471650769|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
131005988|NCT01072929|471650770|FG000|Overall Study|Adverse Event|8|||
131005989|NCT01072929|471650771|FG001|Overall Study|Adverse Event|11|||
131005990|NCT01072929|471650772|FG002|Overall Study|Adverse Event|2|||
131005991|NCT01072929|471650770|FG000|Overall Study|Lack of Efficacy|7|||
131005992|NCT01072929|471650771|FG001|Overall Study|Lack of Efficacy|4|||
131005993|NCT01072929|471650772|FG002|Overall Study|Lack of Efficacy|0|||
131005994|NCT01072929|471650770|FG000|Overall Study|Withdrawal by Subject|7|||
131005995|NCT01072929|471650771|FG001|Overall Study|Withdrawal by Subject|15|||
131005996|NCT01072929|471650772|FG002|Overall Study|Withdrawal by Subject|3|||
131005997|NCT01072929|471650770|FG000|Overall Study|Protocol Violation|13|||
130765930|NCT01712334|470765904|FG000|Treatment Period 1|Randomized in Error|0|||
131005998|NCT01072929|471650771|FG001|Overall Study|Protocol Violation|11|||
131005999|NCT01072929|471650772|FG002|Overall Study|Protocol Violation|2|||
131006000|NCT01072929|471650770|FG000|Overall Study|Lost to Follow-up|8|||
131006001|NCT01072929|471650771|FG001|Overall Study|Lost to Follow-up|4|||
131222545|NCT01625286|472441524|FG000|Overall Study|Any reason not specifically recorded|0|||
131006002|NCT01072929|471650772|FG002|Overall Study|Lost to Follow-up|1|||
131006003|NCT01072929|471650770|FG000|Overall Study|Noncompliance with study medication|0|||
131006004|NCT01072929|471650771|FG001|Overall Study|Noncompliance with study medication|3|||
131006005|NCT01072929|471650772|FG002|Overall Study|Noncompliance with study medication|0|||
131006006|NCT01072929|471650770|FG000|Overall Study|Noncompliance with study procedures|1|||
131006007|NCT01072929|471650771|FG001|Overall Study|Noncompliance with study procedures|0|||
131006008|NCT01072929|471650772|FG002|Overall Study|Noncompliance with study procedures|1|||
131006009|NCT01072929|471650770|FG000|Overall Study|Other|0|||
131006010|NCT01072929|471650771|FG001|Overall Study|Other|3|||
131006011|NCT01072929|471650772|FG002|Overall Study|Other|0|||
131006012|NCT04824131|471650773|FG000|CAB LA Oral Phase|Adverse Event|1|||
131006013|NCT04824131|471650773|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
131006014|NCT04824131|471650773|FG000|Step 3|Withdrawal by Subject|2|||
131006015|NCT05489224|471650774|FG000|Treatment Period I|Withdrawal by Subject|6|||
131006016|NCT05489224|471650775|FG001|Treatment Period I|Withdrawal by Subject|5|||
131006017|NCT05489224|471650776|FG002|Treatment Period I|Withdrawal by Subject|0|||
131006018|NCT05489224|471650774|FG000|Treatment Period I|Adverse Event|3|||
131006019|NCT05489224|471650775|FG001|Treatment Period I|Adverse Event|11|||
131006020|NCT05489224|471650776|FG002|Treatment Period I|Adverse Event|0|||
131006021|NCT05489224|471650774|FG000|Treatment Period I|Lost to Follow-up|0|||
131006022|NCT05489224|471650775|FG001|Treatment Period I|Lost to Follow-up|1|||
131006023|NCT05489224|471650776|FG002|Treatment Period I|Lost to Follow-up|0|||
131006024|NCT05489224|471650774|FG000|Treatment Period I|Physician Decision|0|||
131006025|NCT05489224|471650775|FG001|Treatment Period I|Physician Decision|1|||
131006026|NCT05489224|471650776|FG002|Treatment Period I|Physician Decision|0|||
131006027|NCT05489224|471650774|FG000|Treatment Period II up to Week 32|Ongoing|222|||
131006028|NCT05489224|471650775|FG001|Treatment Period II up to Week 32|Ongoing|107|||
131006029|NCT05489224|471650776|FG002|Treatment Period II up to Week 32|Ongoing|107|||
131006030|NCT05489224|471650774|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
131006031|NCT05489224|471650775|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
131006032|NCT05489224|471650776|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
131006033|NCT05489224|471650774|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
131006034|NCT05489224|471650775|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
131006035|NCT05489224|471650776|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
131006036|NCT04887285|471650778|FG000|Overall Study|Lost to Follow-up|0|||
131006037|NCT04887285|471650779|FG001|Overall Study|Lost to Follow-up|2|||
131006038|NCT04887285|471650780|FG002|Overall Study|Lost to Follow-up|3|||
131006039|NCT04640571|471650781|FG000|Overall Study|Withdrawal by Subject|0|||
131006040|NCT04640571|471650782|FG001|Overall Study|Withdrawal by Subject|0|||
131006041|NCT04640571|471650783|FG002|Overall Study|Withdrawal by Subject|0|||
131006042|NCT04640571|471650784|FG003|Overall Study|Withdrawal by Subject|0|||
131006043|NCT04640571|471650785|FG004|Overall Study|Withdrawal by Subject|0|||
131006044|NCT04640571|471650786|FG005|Overall Study|Withdrawal by Subject|2|||
131006045|NCT01723774|471650791|FG000|Neoadjuvant|Ki67 > 10%|4|||
131006046|NCT01723774|471650792|FG001|Neoadjuvant|Ki67 > 10%|0|||
131006047|NCT01723774|471650793|FG002|Neoadjuvant|Ki67 > 10%|10|||
131006048|NCT01723774|471650794|FG003|Neoadjuvant|Ki67 > 10%|0|||
131006049|NCT01723774|471650791|FG000|Neoadjuvant|Withdrawal by Subject|3|||
131006050|NCT01723774|471650792|FG001|Neoadjuvant|Withdrawal by Subject|1|||
131006051|NCT01723774|471650793|FG002|Neoadjuvant|Withdrawal by Subject|0|||
131006052|NCT01723774|471650794|FG003|Neoadjuvant|Withdrawal by Subject|0|||
131006053|NCT01723774|471650791|FG000|Neoadjuvant|Disease progression|0|||
131006054|NCT01723774|471650792|FG001|Neoadjuvant|Disease progression|1|||
131006055|NCT01723774|471650793|FG002|Neoadjuvant|Disease progression|1|||
131006056|NCT01723774|471650794|FG003|Neoadjuvant|Disease progression|0|||
131006057|NCT01723774|471650791|FG000|Neoadjuvant|Adverse Event|0|||
131006058|NCT01723774|471650792|FG001|Neoadjuvant|Adverse Event|1|||
131006059|NCT01723774|471650793|FG002|Neoadjuvant|Adverse Event|2|||
131006060|NCT01723774|471650794|FG003|Neoadjuvant|Adverse Event|0|||
131006061|NCT01723774|471650791|FG000|Neoadjuvant|High estradiol|0|||
131006062|NCT01723774|471650792|FG001|Neoadjuvant|High estradiol|1|||
131006063|NCT01723774|471650793|FG002|Neoadjuvant|High estradiol|0|||
131006064|NCT01723774|471650794|FG003|Neoadjuvant|High estradiol|0|||
131006065|NCT02487446|471650800|FG000|Period 1|Physician Decision|0|||
131006066|NCT02487446|471650801|FG001|Period 1|Physician Decision|1|||
131006067|NCT02487446|471650800|FG000|Period 1|Lack of Efficacy|1|||
130720920|NCT00724048|470601562|FG001|Overall Study|Lost to Follow-up|1|||
131006068|NCT02487446|471650801|FG001|Period 1|Lack of Efficacy|0|||
131006069|NCT02487446|471650800|FG000|Period 1|Protocol deviation|3|||
131006070|NCT02487446|471650801|FG001|Period 1|Protocol deviation|2|||
131006071|NCT02487446|471650800|FG000|Period 1|Lost to Follow-up|2|||
131006072|NCT02487446|471650801|FG001|Period 1|Lost to Follow-up|0|||
131006073|NCT02487446|471650800|FG000|Period 1|Withdrawal by Subject|2|||
131006074|NCT02487446|471650801|FG001|Period 1|Withdrawal by Subject|0|||
131006075|NCT02487446|471650800|FG000|Period 1|Adverse Event|5|||
131006076|NCT02487446|471650801|FG001|Period 1|Adverse Event|5|||
131006077|NCT02487446|471650800|FG000|Washout|Lost to Follow-up|0|||
131006078|NCT02487446|471650801|FG001|Washout|Lost to Follow-up|2|||
131006079|NCT02487446|471650800|FG000|Washout|Withdrawal by Subject|1|||
131006080|NCT02487446|471650801|FG001|Washout|Withdrawal by Subject|4|||
131006081|NCT02487446|471650800|FG000|Washout|Adverse Event|2|||
131006082|NCT02487446|471650801|FG001|Washout|Adverse Event|2|||
131006083|NCT02487446|471650800|FG000|Period 2|Protocol deviation|0|||
131006084|NCT02487446|471650801|FG001|Period 2|Protocol deviation|1|||
131006085|NCT02487446|471650800|FG000|Period 2|Lost to Follow-up|1|||
131006086|NCT02487446|471650801|FG001|Period 2|Lost to Follow-up|1|||
131006087|NCT02487446|471650800|FG000|Period 2|Withdrawal by Subject|1|||
131006088|NCT02487446|471650801|FG001|Period 2|Withdrawal by Subject|1|||
131006089|NCT02487446|471650800|FG000|Period 2|Adverse Event|6|||
131006090|NCT02487446|471650801|FG001|Period 2|Adverse Event|2|||
131006091|NCT01822821|471650802|FG000|Overall Study|Eligible surgery cancelled|1|||
131006092|NCT01822821|471650803|FG001|Overall Study|Eligible surgery cancelled|1|||
131006093|NCT01822821|471650802|FG000|Overall Study|Other reasons|1|||
131006094|NCT01822821|471650803|FG001|Overall Study|Other reasons|0|||
131006095|NCT05780047|471650804|FG000|Overall Study|Did not submit baseline urine test kit|226|||
131006096|NCT05780047|471650804|FG000|Overall Study|Lost to Follow-up|34|||
131006097|NCT05780047|471650804|FG000|Overall Study|Did not submit second urine test kit|124|||
131006098|NCT03590743|471650807|FG000|Overall Study|Withdrawal by Subject|0|||
131006099|NCT03590743|471650808|FG001|Overall Study|Withdrawal by Subject|1|||
131006100|NCT00604786|471650809|FG000|Overall Study|Lost to Follow-up|2|||
131006101|NCT00604786|471650810|FG001|Overall Study|Lost to Follow-up|0|||
131006102|NCT01221181|471650811|FG000|Overall Study|Lost to Follow-up|1|||
131006103|NCT02698436|471650812|FG000|Overall Study|Adverse Event|1|||
131006104|NCT02698436|471650813|FG001|Overall Study|Adverse Event|0|||
131006105|NCT02698436|471650812|FG000|Overall Study|Withdrawal by Subject|3|||
131006106|NCT02698436|471650813|FG001|Overall Study|Withdrawal by Subject|3|||
131006107|NCT02698436|471650812|FG000|Overall Study|Lost to Follow-up|2|||
131006108|NCT02698436|471650813|FG001|Overall Study|Lost to Follow-up|4|||
131006109|NCT02698436|471650812|FG000|Overall Study|Non-compliance with study regimen|1|||
131006110|NCT02698436|471650813|FG001|Overall Study|Non-compliance with study regimen|0|||
131006111|NCT01394991|471650816|FG000|Overall Study|Adverse Event|0|||
131006112|NCT01394991|471650817|FG001|Overall Study|Adverse Event|4|||
131006113|NCT01394991|471650816|FG000|Overall Study|Lack of Efficacy|5|||
131006114|NCT01394991|471650817|FG001|Overall Study|Lack of Efficacy|7|||
131006115|NCT01394991|471650816|FG000|Overall Study|Lost to Follow-up|6|||
131006116|NCT01394991|471650817|FG001|Overall Study|Lost to Follow-up|8|||
131006117|NCT01394991|471650816|FG000|Overall Study|Physician Decision|1|||
131006118|NCT01394991|471650817|FG001|Overall Study|Physician Decision|3|||
131006119|NCT01394991|471650816|FG000|Overall Study|Protocol Violation|1|||
131006120|NCT01394991|471650817|FG001|Overall Study|Protocol Violation|1|||
131006121|NCT01394991|471650816|FG000|Overall Study|Withdrawal by Subject|20|||
131006122|NCT01394991|471650817|FG001|Overall Study|Withdrawal by Subject|17|||
131006123|NCT01394991|471650816|FG000|Overall Study|Chemotherapy Termination|10|||
131006124|NCT01394991|471650817|FG001|Overall Study|Chemotherapy Termination|15|||
131006125|NCT01394991|471650816|FG000|Overall Study|Disease Progression|7|||
131006126|NCT01394991|471650817|FG001|Overall Study|Disease Progression|7|||
131006127|NCT01394991|471650816|FG000|Overall Study|Prematurely Termination of Trial|9|||
131006128|NCT01394991|471650817|FG001|Overall Study|Prematurely Termination of Trial|10|||
131006129|NCT03073005|471650818|FG000|Overall Study|Death|6|||
131006130|NCT03073005|471650819|FG001|Overall Study|Death|0|||
131006131|NCT03073005|471650820|FG002|Overall Study|Death|7|||
131006132|NCT03073005|471650821|FG003|Overall Study|Death|0|||
131006133|NCT03073005|471650818|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
131006134|NCT03073005|471650819|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
131006135|NCT03073005|471650820|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
131006136|NCT03073005|471650821|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
131006137|NCT03073005|471650818|FG000|Overall Study|Lost to Follow-up|2|||
131006138|NCT03073005|471650819|FG001|Overall Study|Lost to Follow-up|2|||
131006139|NCT03073005|471650820|FG002|Overall Study|Lost to Follow-up|1|||
131006140|NCT03073005|471650821|FG003|Overall Study|Lost to Follow-up|2|||
131006141|NCT03073005|471650818|FG000|Overall Study|Withdrawal by Subject|0|||
131006142|NCT03073005|471650819|FG001|Overall Study|Withdrawal by Subject|4|||
131006143|NCT03073005|471650820|FG002|Overall Study|Withdrawal by Subject|4|||
131006144|NCT03073005|471650821|FG003|Overall Study|Withdrawal by Subject|4|||
131006145|NCT00062868|471650829|FG000|Dose Level 1|Death|2|||
131006146|NCT00062868|471650830|FG001|Dose Level 1|Death|0|||
131006147|NCT00062868|471650831|FG002|Dose Level 1|Death|0|||
131006148|NCT00062868|471650832|FG003|Dose Level 1|Death|2|||
131006149|NCT00062868|471650833|FG004|Dose Level 1|Death|0|||
131006150|NCT00062868|471650834|FG005|Dose Level 1|Death|0|||
131006151|NCT00062868|471650835|FG006|Dose Level 1|Death|3|||
131006152|NCT00062868|471650836|FG007|Dose Level 1|Death|0|||
131006153|NCT00062868|471650837|FG008|Dose Level 1|Death|0|||
131006154|NCT00062868|471650838|FG009|Dose Level 1|Death|0|||
131006155|NCT00062868|471650839|FG010|Dose Level 1|Death|0|||
131006156|NCT00062868|471650840|FG011|Dose Level 1|Death|0|||
131006157|NCT00062868|471650841|FG012|Dose Level 1|Death|0|||
131006158|NCT00062868|471650842|FG013|Dose Level 1|Death|0|||
131006159|NCT00062868|471650843|FG014|Dose Level 1|Death|0|||
131006160|NCT00062868|471650844|FG015|Dose Level 1|Death|0|||
131006161|NCT00062868|471650845|FG016|Dose Level 1|Death|0|||
131006162|NCT00062868|471650846|FG017|Dose Level 1|Death|0|||
131006163|NCT00062868|471650847|FG018|Dose Level 1|Death|7|||
131006164|NCT00062868|471650848|FG019|Dose Level 1|Death|0|||
131006165|NCT00062868|471650849|FG020|Dose Level 1|Death|1|||
131006166|NCT00062868|471650829|FG000|Dose Level 1|Lost to Follow-up|0|||
131006167|NCT00062868|471650830|FG001|Dose Level 1|Lost to Follow-up|0|||
131006168|NCT00062868|471650831|FG002|Dose Level 1|Lost to Follow-up|0|||
131006169|NCT00062868|471650832|FG003|Dose Level 1|Lost to Follow-up|0|||
131006170|NCT00062868|471650833|FG004|Dose Level 1|Lost to Follow-up|0|||
131006171|NCT00062868|471650834|FG005|Dose Level 1|Lost to Follow-up|0|||
131006172|NCT00062868|471650835|FG006|Dose Level 1|Lost to Follow-up|0|||
131006173|NCT00062868|471650836|FG007|Dose Level 1|Lost to Follow-up|0|||
131006174|NCT00062868|471650837|FG008|Dose Level 1|Lost to Follow-up|0|||
131006175|NCT00062868|471650838|FG009|Dose Level 1|Lost to Follow-up|0|||
131006176|NCT00062868|471650839|FG010|Dose Level 1|Lost to Follow-up|0|||
131006177|NCT00062868|471650840|FG011|Dose Level 1|Lost to Follow-up|0|||
131006178|NCT00062868|471650841|FG012|Dose Level 1|Lost to Follow-up|1|||
131006179|NCT00062868|471650842|FG013|Dose Level 1|Lost to Follow-up|0|||
131006180|NCT00062868|471650843|FG014|Dose Level 1|Lost to Follow-up|0|||
131006181|NCT00062868|471650844|FG015|Dose Level 1|Lost to Follow-up|0|||
131006182|NCT00062868|471650845|FG016|Dose Level 1|Lost to Follow-up|0|||
131006183|NCT00062868|471650846|FG017|Dose Level 1|Lost to Follow-up|0|||
131006184|NCT00062868|471650847|FG018|Dose Level 1|Lost to Follow-up|2|||
131006185|NCT00062868|471650848|FG019|Dose Level 1|Lost to Follow-up|0|||
131006186|NCT00062868|471650849|FG020|Dose Level 1|Lost to Follow-up|1|||
131006187|NCT00062868|471650829|FG000|Dose Level 2|Death|0|||
131006188|NCT00062868|471650830|FG001|Dose Level 2|Death|3|||
131006189|NCT00062868|471650831|FG002|Dose Level 2|Death|0|||
131006190|NCT00062868|471650832|FG003|Dose Level 2|Death|0|||
131006191|NCT00062868|471650833|FG004|Dose Level 2|Death|2|||
131006192|NCT00062868|471650834|FG005|Dose Level 2|Death|0|||
131006193|NCT00062868|471650835|FG006|Dose Level 2|Death|0|||
131006194|NCT00062868|471650836|FG007|Dose Level 2|Death|0|||
131006195|NCT00062868|471650837|FG008|Dose Level 2|Death|0|||
131006196|NCT00062868|471650838|FG009|Dose Level 2|Death|0|||
131006197|NCT00062868|471650839|FG010|Dose Level 2|Death|1|||
131006198|NCT00062868|471650840|FG011|Dose Level 2|Death|0|||
131006199|NCT00062868|471650841|FG012|Dose Level 2|Death|0|||
131006200|NCT00062868|471650842|FG013|Dose Level 2|Death|0|||
131006201|NCT00062868|471650843|FG014|Dose Level 2|Death|0|||
131006202|NCT00062868|471650844|FG015|Dose Level 2|Death|0|||
131006203|NCT00062868|471650845|FG016|Dose Level 2|Death|2|||
131006204|NCT00062868|471650846|FG017|Dose Level 2|Death|0|||
131006205|NCT00062868|471650847|FG018|Dose Level 2|Death|0|||
131222546|NCT01625286|472441525|FG001|Overall Study|Any reason not specifically recorded|0|||
131006206|NCT00062868|471650848|FG019|Dose Level 2|Death|0|||
131222547|NCT01625286|472441526|FG002|Overall Study|Any reason not specifically recorded|0|||
131006207|NCT00062868|471650849|FG020|Dose Level 2|Death|0|||
131006208|NCT00062868|471650829|FG000|Dose Level 2|Lost to Follow-up|0|||
131006209|NCT00062868|471650830|FG001|Dose Level 2|Lost to Follow-up|0|||
131006210|NCT00062868|471650831|FG002|Dose Level 2|Lost to Follow-up|0|||
131006211|NCT00062868|471650832|FG003|Dose Level 2|Lost to Follow-up|0|||
131006212|NCT00062868|471650833|FG004|Dose Level 2|Lost to Follow-up|0|||
131006213|NCT00062868|471650834|FG005|Dose Level 2|Lost to Follow-up|0|||
131006214|NCT00062868|471650835|FG006|Dose Level 2|Lost to Follow-up|0|||
131006215|NCT00062868|471650836|FG007|Dose Level 2|Lost to Follow-up|0|||
131006216|NCT00062868|471650837|FG008|Dose Level 2|Lost to Follow-up|0|||
131006217|NCT00062868|471650838|FG009|Dose Level 2|Lost to Follow-up|0|||
131006218|NCT00062868|471650839|FG010|Dose Level 2|Lost to Follow-up|0|||
131006219|NCT00062868|471650840|FG011|Dose Level 2|Lost to Follow-up|0|||
131006220|NCT00062868|471650841|FG012|Dose Level 2|Lost to Follow-up|0|||
131006221|NCT00062868|471650842|FG013|Dose Level 2|Lost to Follow-up|1|||
131006222|NCT00062868|471650843|FG014|Dose Level 2|Lost to Follow-up|0|||
131006223|NCT00062868|471650844|FG015|Dose Level 2|Lost to Follow-up|0|||
131006224|NCT00062868|471650845|FG016|Dose Level 2|Lost to Follow-up|1|||
131006225|NCT00062868|471650846|FG017|Dose Level 2|Lost to Follow-up|0|||
131006226|NCT00062868|471650847|FG018|Dose Level 2|Lost to Follow-up|0|||
131006227|NCT00062868|471650848|FG019|Dose Level 2|Lost to Follow-up|0|||
131006228|NCT00062868|471650849|FG020|Dose Level 2|Lost to Follow-up|0|||
131006229|NCT00062868|471650829|FG000|Dose Level 3|Death|0|||
131006230|NCT00062868|471650830|FG001|Dose Level 3|Death|0|||
131006231|NCT00062868|471650831|FG002|Dose Level 3|Death|0|||
131006232|NCT00062868|471650832|FG003|Dose Level 3|Death|0|||
131006233|NCT00062868|471650833|FG004|Dose Level 3|Death|0|||
131006234|NCT00062868|471650834|FG005|Dose Level 3|Death|0|||
131006235|NCT00062868|471650835|FG006|Dose Level 3|Death|0|||
131006236|NCT00062868|471650836|FG007|Dose Level 3|Death|0|||
131006237|NCT00062868|471650837|FG008|Dose Level 3|Death|0|||
131006238|NCT00062868|471650838|FG009|Dose Level 3|Death|0|||
131006239|NCT00062868|471650839|FG010|Dose Level 3|Death|0|||
131006240|NCT00062868|471650840|FG011|Dose Level 3|Death|1|||
131006241|NCT00062868|471650841|FG012|Dose Level 3|Death|0|||
131006242|NCT00062868|471650842|FG013|Dose Level 3|Death|0|||
131006243|NCT00062868|471650843|FG014|Dose Level 3|Death|0|||
131006244|NCT00062868|471650844|FG015|Dose Level 3|Death|0|||
131006245|NCT00062868|471650845|FG016|Dose Level 3|Death|0|||
131006246|NCT00062868|471650846|FG017|Dose Level 3|Death|1|||
131006247|NCT00062868|471650847|FG018|Dose Level 3|Death|0|||
131006248|NCT00062868|471650848|FG019|Dose Level 3|Death|0|||
131006249|NCT00062868|471650849|FG020|Dose Level 3|Death|0|||
131006250|NCT00062868|471650829|FG000|Dose Level 3|Lost to Follow-up|0|||
131006251|NCT00062868|471650830|FG001|Dose Level 3|Lost to Follow-up|0|||
131006252|NCT00062868|471650831|FG002|Dose Level 3|Lost to Follow-up|0|||
131006253|NCT00062868|471650832|FG003|Dose Level 3|Lost to Follow-up|0|||
131006254|NCT00062868|471650833|FG004|Dose Level 3|Lost to Follow-up|0|||
131006255|NCT00062868|471650834|FG005|Dose Level 3|Lost to Follow-up|0|||
131006256|NCT00062868|471650835|FG006|Dose Level 3|Lost to Follow-up|0|||
131006257|NCT00062868|471650836|FG007|Dose Level 3|Lost to Follow-up|0|||
131006258|NCT00062868|471650837|FG008|Dose Level 3|Lost to Follow-up|0|||
131006259|NCT00062868|471650838|FG009|Dose Level 3|Lost to Follow-up|0|||
131006260|NCT00062868|471650839|FG010|Dose Level 3|Lost to Follow-up|0|||
131006261|NCT00062868|471650840|FG011|Dose Level 3|Lost to Follow-up|0|||
131006262|NCT00062868|471650841|FG012|Dose Level 3|Lost to Follow-up|0|||
131006263|NCT00062868|471650842|FG013|Dose Level 3|Lost to Follow-up|0|||
131006264|NCT00062868|471650843|FG014|Dose Level 3|Lost to Follow-up|1|||
131006265|NCT00062868|471650844|FG015|Dose Level 3|Lost to Follow-up|0|||
131006266|NCT00062868|471650845|FG016|Dose Level 3|Lost to Follow-up|0|||
131006267|NCT00062868|471650846|FG017|Dose Level 3|Lost to Follow-up|0|||
131006268|NCT00062868|471650847|FG018|Dose Level 3|Lost to Follow-up|0|||
131006269|NCT00062868|471650848|FG019|Dose Level 3|Lost to Follow-up|0|||
131006270|NCT00062868|471650849|FG020|Dose Level 3|Lost to Follow-up|0|||
131006271|NCT00062868|471650829|FG000|Dose Level 3|Withdrew|0|||
131006272|NCT00062868|471650830|FG001|Dose Level 3|Withdrew|0|||
131006273|NCT00062868|471650831|FG002|Dose Level 3|Withdrew|2|||
131006274|NCT00062868|471650832|FG003|Dose Level 3|Withdrew|0|||
131006275|NCT00062868|471650833|FG004|Dose Level 3|Withdrew|0|||
131006276|NCT00062868|471650834|FG005|Dose Level 3|Withdrew|0|||
131006277|NCT00062868|471650835|FG006|Dose Level 3|Withdrew|0|||
131006278|NCT00062868|471650836|FG007|Dose Level 3|Withdrew|0|||
131006279|NCT00062868|471650837|FG008|Dose Level 3|Withdrew|0|||
131006280|NCT00062868|471650838|FG009|Dose Level 3|Withdrew|0|||
131006281|NCT00062868|471650839|FG010|Dose Level 3|Withdrew|0|||
131006282|NCT00062868|471650840|FG011|Dose Level 3|Withdrew|0|||
131006283|NCT00062868|471650841|FG012|Dose Level 3|Withdrew|0|||
131006284|NCT00062868|471650842|FG013|Dose Level 3|Withdrew|0|||
131006285|NCT00062868|471650843|FG014|Dose Level 3|Withdrew|0|||
131006286|NCT00062868|471650844|FG015|Dose Level 3|Withdrew|0|||
131006287|NCT00062868|471650845|FG016|Dose Level 3|Withdrew|0|||
131006288|NCT00062868|471650846|FG017|Dose Level 3|Withdrew|0|||
131006289|NCT00062868|471650847|FG018|Dose Level 3|Withdrew|0|||
131006290|NCT00062868|471650848|FG019|Dose Level 3|Withdrew|0|||
131006291|NCT00062868|471650849|FG020|Dose Level 3|Withdrew|0|||
131006292|NCT01734811|471650850|FG000|Overall Study|Lost to Follow-up|2|||
131006293|NCT01734811|471650851|FG001|Overall Study|Lost to Follow-up|3|||
131006294|NCT01734811|471650850|FG000|Overall Study|Withdrawal by Subject|2|||
131006295|NCT01734811|471650851|FG001|Overall Study|Withdrawal by Subject|0|||
131006296|NCT00725010|471650854|FG000|Overall Study|Toxicity|9|||
131006297|NCT00725010|471650854|FG000|Overall Study|Tumor Progression|7|||
131006298|NCT00725010|471650854|FG000|Overall Study|Withdrawal by Subject|2|||
131006299|NCT00725010|471650854|FG000|Overall Study|Death|1|||
131006300|NCT00725010|471650854|FG000|Overall Study|Lost to Follow-up|1|||
131006301|NCT00725010|471650854|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
131006302|NCT00725010|471650854|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
131006303|NCT00725010|471650854|FG000|Overall Study|No further documentation|1|||
131006304|NCT00725010|471650854|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
131006305|NCT02414828|471650855|FG000|Overall Study|Lost to Follow-up|0|||
131006306|NCT02414828|471650856|FG001|Overall Study|Lost to Follow-up|1|||
131006307|NCT02414828|471650857|FG002|Overall Study|Lost to Follow-up|1|||
131006308|NCT02414828|471650858|FG003|Overall Study|Lost to Follow-up|2|||
131006309|NCT00814489|471650859|FG000|Overall Study|Other|2|||
131006310|NCT00814489|471650860|FG001|Overall Study|Other|0|||
131006311|NCT00814489|471650861|FG002|Overall Study|Other|1|||
131006312|NCT01712685|471650887|FG000|Overall Study|pt declined to participate before trmt|1|||
131006313|NCT01866917|471650891|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
131006314|NCT01866917|471650892|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
131006315|NCT03253653|471650896|FG000|Overall Study|Withdrawal by Subject|4|||
131006316|NCT03253653|471650897|FG001|Overall Study|Withdrawal by Subject|1|||
131006317|NCT03253653|471650896|FG000|Overall Study|Protocol Violation|0|||
131006318|NCT03253653|471650897|FG001|Overall Study|Protocol Violation|5|||
131006319|NCT04610684|471652402|FG000|Study Treatment|Withdrawal by Subject|1|||
131006320|NCT04610684|471652402|FG000|Study Treatment|Disease Progression|2|||
131006321|NCT04610684|471652402|FG000|Follow up|Death|2|||
131006322|NCT04610684|471652402|FG000|Follow up|Withdrawal by Subject|1|||
131006323|NCT01251614|471652406|FG000|Overall Study|Adverse Event|1|||
131006324|NCT01251614|471652407|FG001|Overall Study|Adverse Event|0|||
131006325|NCT01251614|471652408|FG002|Overall Study|Adverse Event|1|||
131006326|NCT01251614|471652406|FG000|Overall Study|Lack of Efficacy|1|||
131006327|NCT01251614|471652407|FG001|Overall Study|Lack of Efficacy|9|||
131006328|NCT01251614|471652408|FG002|Overall Study|Lack of Efficacy|4|||
131006329|NCT01251614|471652406|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
131006330|NCT01251614|471652407|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
131006331|NCT01251614|471652408|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
131006332|NCT01251614|471652406|FG000|Overall Study|Pregnancy|0|||
131006333|NCT01251614|471652407|FG001|Overall Study|Pregnancy|0|||
131006334|NCT01251614|471652408|FG002|Overall Study|Pregnancy|2|||
131006335|NCT01251614|471652406|FG000|Overall Study|Loss of Disease Control|0|||
131006336|NCT01251614|471652407|FG001|Overall Study|Loss of Disease Control|1|||
131006337|NCT01251614|471652408|FG002|Overall Study|Loss of Disease Control|0|||
131006338|NCT01251614|471652406|FG000|Overall Study|Withdrawal by Subject|0|||
131006339|NCT01251614|471652407|FG001|Overall Study|Withdrawal by Subject|2|||
131006340|NCT01251614|471652408|FG002|Overall Study|Withdrawal by Subject|1|||
131006341|NCT01251614|471652406|FG000|Overall Study|Lost to Follow-up|0|||
131006342|NCT01251614|471652407|FG001|Overall Study|Lost to Follow-up|1|||
131006343|NCT01251614|471652408|FG002|Overall Study|Lost to Follow-up|0|||
131006344|NCT00093795|471652410|FG000|Overall Study|No follow up data|20|||
131006345|NCT00093795|471652411|FG001|Overall Study|No follow up data|16|||
131006346|NCT00093795|471652412|FG002|Overall Study|No follow up data|17|||
131006347|NCT02949271|471652415|FG000|Overall Study|Lack of Efficacy|5|||
131006348|NCT02949271|471652416|FG001|Overall Study|Lack of Efficacy|4|||
131006349|NCT02949271|471652415|FG000|Overall Study|Lost to Follow-up|3|||
131006350|NCT02949271|471652416|FG001|Overall Study|Lost to Follow-up|6|||
131006351|NCT02949271|471652415|FG000|Overall Study|Physician Decision|5|||
131006352|NCT02949271|471652416|FG001|Overall Study|Physician Decision|5|||
131006353|NCT02949271|471652415|FG000|Overall Study|Protocol Violation|6|||
131006354|NCT02949271|471652416|FG001|Overall Study|Protocol Violation|3|||
131006355|NCT02949271|471652415|FG000|Overall Study|Withdrawal by Subject|1|||
131006356|NCT02949271|471652416|FG001|Overall Study|Withdrawal by Subject|0|||
131006357|NCT02949271|471652415|FG000|Overall Study|Delivered prior to intervention|7|||
131006358|NCT02949271|471652416|FG001|Overall Study|Delivered prior to intervention|9|||
131006359|NCT02949271|471652415|FG000|Overall Study|Outside the window for cervical dilation|2|||
131006360|NCT02949271|471652416|FG001|Overall Study|Outside the window for cervical dilation|3|||
131006361|NCT05458102|471652417|FG000|Overall Study|Withdrew consent|2|||
131006362|NCT05458102|471652418|FG001|Overall Study|Withdrew consent|0|||
131006363|NCT05458102|471652417|FG000|Overall Study|Adverse Event|1|||
131006364|NCT05458102|471652418|FG001|Overall Study|Adverse Event|0|||
131006365|NCT05458102|471652417|FG000|Overall Study|Enrolled but never treated|1|||
131006366|NCT05458102|471652418|FG001|Overall Study|Enrolled but never treated|0|||
131006367|NCT05458102|471652417|FG000|Overall Study|Protocol Violation|1|||
131006368|NCT05458102|471652418|FG001|Overall Study|Protocol Violation|0|||
131006369|NCT00723294|471652419|FG000|Overall Study|Lobular histology|2|||
131006370|NCT00723294|471652419|FG000|Overall Study|>25% intraductal component|1|||
131006371|NCT00723294|471652419|FG000|Overall Study|No MRI tumor enhancement|1|||
131006372|NCT00723294|471652419|FG000|Overall Study|1.0-Tesla MRI|1|||
131006373|NCT00723294|471652419|FG000|Overall Study|No cryoabalation|2|||
131006374|NCT00723294|471652419|FG000|Overall Study|Did not undergo surgery|1|||
131006375|NCT00723294|471652419|FG000|Overall Study|Treated prior to registration|1|||
131006376|NCT00723294|471652419|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
131006377|NCT00723294|471652419|FG000|Overall Study|Benign lesion|1|||
131006378|NCT00723294|471652419|FG000|Overall Study|Withdrawal by Subject|1|||
131006379|NCT00723294|471652419|FG000|Overall Study|No treatment due to probe failure|1|||
131006380|NCT04531540|471652424|FG000|Overall Study|Adverse Event|1|||
131006381|NCT04531540|471652424|FG000|Overall Study|Protocol Violation|3|||
131006382|NCT04531540|471652424|FG000|Overall Study|Withdrawal by Subject|4|||
131006383|NCT04531540|471652424|FG000|Overall Study|Found to be Ineligible|1|||
131006384|NCT02688621|471652425|FG000|Overall Study|Pregnancy|1|||
131006385|NCT02688621|471652426|FG001|Overall Study|Pregnancy|3|||
131006386|NCT02688621|471652425|FG000|Overall Study|Lost to Follow-up|38|||
131006387|NCT02688621|471652426|FG001|Overall Study|Lost to Follow-up|15|||
131006388|NCT02688621|471652425|FG000|Overall Study|Withdrawal by Subject|1|||
131006389|NCT02688621|471652426|FG001|Overall Study|Withdrawal by Subject|0|||
131006390|NCT01575860|471652427|FG000|Overall Study|Withdrawal by Subject|1|||
131006391|NCT01575860|471652427|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
131006392|NCT00278564|471652429|FG000|Overall Study|Lack of Efficacy|4|||
131006393|NCT01094743|471652430|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
131006394|NCT02851511|471652431|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
131006395|NCT02851511|471652432|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
131006396|NCT02851511|471652433|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
131006397|NCT02851511|471652434|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
131006398|NCT02851511|471652431|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
131006399|NCT02851511|471652432|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
131006400|NCT02851511|471652433|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
131006401|NCT02851511|471652434|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
131006402|NCT02851511|471652431|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
131006403|NCT02851511|471652432|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
131006404|NCT02851511|471652433|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
131006405|NCT02851511|471652434|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
131006406|NCT02851511|471652431|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
131006407|NCT02851511|471652432|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
131006408|NCT02851511|471652433|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
131006409|NCT02851511|471652434|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
131006410|NCT02851511|471652431|FG000|Phase I|Physician Decision|0|||
131006411|NCT02851511|471652432|FG001|Phase I|Physician Decision|0|||
131006412|NCT02851511|471652433|FG002|Phase I|Physician Decision|0|||
131006413|NCT02851511|471652434|FG003|Phase I|Physician Decision|1|||
131006414|NCT02851511|471652431|FG000|Phase I|Withdrawal by Subject|2|||
131006415|NCT02851511|471652432|FG001|Phase I|Withdrawal by Subject|1|||
131006416|NCT02851511|471652433|FG002|Phase I|Withdrawal by Subject|0|||
131006417|NCT02851511|471652434|FG003|Phase I|Withdrawal by Subject|3|||
131006418|NCT02851511|471652431|FG000|Phase II|Physician Decision|18|||
131006419|NCT02851511|471652432|FG001|Phase II|Physician Decision|16|||
131006420|NCT02851511|471652433|FG002|Phase II|Physician Decision|0|||
131006421|NCT02851511|471652434|FG003|Phase II|Physician Decision|0|||
131006422|NCT02851511|471652431|FG000|Phase II|Withdrawal by Subject|18|||
131006423|NCT02851511|471652432|FG001|Phase II|Withdrawal by Subject|16|||
131006424|NCT02851511|471652433|FG002|Phase II|Withdrawal by Subject|0|||
131006425|NCT02851511|471652434|FG003|Phase II|Withdrawal by Subject|0|||
131006426|NCT02851511|471652431|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
131006427|NCT02851511|471652432|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
131006428|NCT02851511|471652433|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
131006429|NCT02851511|471652434|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
131006430|NCT02851511|471652431|FG000|Phase II|Lost to Follow-up|0|||
131006431|NCT02851511|471652432|FG001|Phase II|Lost to Follow-up|1|||
131006432|NCT02851511|471652433|FG002|Phase II|Lost to Follow-up|0|||
131006433|NCT02851511|471652434|FG003|Phase II|Lost to Follow-up|0|||
131006434|NCT00051311|471652435|FG000|Overall Study|Starting new study|0|||
131006435|NCT00051311|471652436|FG001|Overall Study|Starting new study|1|||
131006436|NCT00051311|471652435|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
131006437|NCT00051311|471652436|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
131006438|NCT00051311|471652435|FG000|Overall Study|Death of recipient|8|||
131006439|NCT00051311|471652436|FG001|Overall Study|Death of recipient|8|||
131006440|NCT00051311|471652435|FG000|Overall Study|Recipient taken off study|4|||
131006441|NCT00051311|471652436|FG001|Overall Study|Recipient taken off study|4|||
131006442|NCT00003377|471652437|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
131006443|NCT00003377|471652438|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
131006444|NCT00003377|471652439|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
131006445|NCT00003377|471652440|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
131006446|NCT00003377|471652441|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
131006447|NCT00003377|471652437|FG000|Period II|Ureteral stent complications|0|||
131006448|NCT00003377|471652438|FG001|Period II|Ureteral stent complications|0|||
131006449|NCT00003377|471652439|FG002|Period II|Ureteral stent complications|0|||
131006450|NCT00003377|471652440|FG003|Period II|Ureteral stent complications|0|||
131006451|NCT00003377|471652441|FG004|Period II|Ureteral stent complications|1|||
131006452|NCT02256969|471652449|FG000|Overall Study|Screenfailed or withdrew|2|||
131006453|NCT02256969|471652450|FG001|Overall Study|Screenfailed or withdrew|1|||
131006454|NCT02256969|471652451|FG002|Overall Study|Screenfailed or withdrew|1|||
131006455|NCT00372567|471652452|FG000|Phase 3 Study|Adverse Event|5|||
131006456|NCT00372567|471652453|FG001|Phase 3 Study|Adverse Event|1|||
131006457|NCT00372567|471652454|FG002|Phase 3 Study|Adverse Event|1|||
131006458|NCT00372567|471652452|FG000|Phase 3 Study|Death|1|||
131006459|NCT00372567|471652453|FG001|Phase 3 Study|Death|1|||
131006460|NCT00372567|471652454|FG002|Phase 3 Study|Death|0|||
131006461|NCT00372567|471652452|FG000|Phase 3 Study|Protocol Violation|0|||
131006462|NCT00372567|471652453|FG001|Phase 3 Study|Protocol Violation|0|||
131006463|NCT00372567|471652454|FG002|Phase 3 Study|Protocol Violation|1|||
131006464|NCT00372567|471652452|FG000|Phase 3 Study|Objective progression or relapse|10|||
131006465|NCT00372567|471652453|FG001|Phase 3 Study|Objective progression or relapse|13|||
131006466|NCT00372567|471652454|FG002|Phase 3 Study|Objective progression or relapse|4|||
131006467|NCT00372567|471652452|FG000|Phase 3 Study|Global deterioration of health status|0|||
131006468|NCT00372567|471652453|FG001|Phase 3 Study|Global deterioration of health status|1|||
131006469|NCT00372567|471652454|FG002|Phase 3 Study|Global deterioration of health status|0|||
131006470|NCT00372567|471652452|FG000|Phase 3 Study|Other|2|||
131006471|NCT00372567|471652453|FG001|Phase 3 Study|Other|2|||
131006472|NCT00372567|471652454|FG002|Phase 3 Study|Other|1|||
131006473|NCT00372567|471652452|FG000|Phase 3 Study|study terminated by sponsor|13|||
131006474|NCT00372567|471652453|FG001|Phase 3 Study|study terminated by sponsor|8|||
131006475|NCT00372567|471652454|FG002|Phase 3 Study|study terminated by sponsor|5|||
131006476|NCT02347943|471652457|FG000|Overall Study|Study was cancelled|140|||
131006477|NCT02347943|471652458|FG001|Overall Study|Study was cancelled|67|||
131006478|NCT02347943|471652459|FG002|Overall Study|Study was cancelled|45|||
131006479|NCT00303303|471652463|FG000|Overall Study|Withdrawal by Subject|0|||
131006480|NCT00303303|471652464|FG001|Overall Study|Withdrawal by Subject|0|||
131006481|NCT00303303|471652465|FG002|Overall Study|Withdrawal by Subject|1|||
131006482|NCT03566680|471652469|FG000|Overall Study|Pregnancy|1|||
131006483|NCT03566680|471652469|FG000|Overall Study|Lost to Follow-up|13|||
131006484|NCT03566680|471652469|FG000|Overall Study|Withdrawal by Subject|3|||
131006485|NCT00582790|471652472|FG000|Overall Study|Rapid progression of disease|1|||
131006486|NCT00480441|471652473|FG000|Screening|Not Eligible|37|||
131006487|NCT00480441|471652474|FG001|Screening|Not Eligible|0|||
131006488|NCT00480441|471652475|FG002|Screening|Not Eligible|0|||
131006489|NCT00480441|471652473|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
131006490|NCT00480441|471652474|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
131006491|NCT00480441|471652475|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
131006492|NCT00480441|471652473|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
131006493|NCT00480441|471652474|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
131006494|NCT00480441|471652475|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
131006495|NCT00480441|471652473|FG000|Baseline Functional MRI|physical contraindication|4|||
131006496|NCT00480441|471652474|FG001|Baseline Functional MRI|physical contraindication|0|||
131006497|NCT00480441|471652475|FG002|Baseline Functional MRI|physical contraindication|0|||
131006498|NCT00480441|471652473|FG000|Randomization|Lost to Follow-up|0|||
131006499|NCT00480441|471652474|FG001|Randomization|Lost to Follow-up|7|||
131006500|NCT00480441|471652475|FG002|Randomization|Lost to Follow-up|2|||
131006501|NCT02374957|471652476|FG000|Overall Study|Patient did not complete forms correctly|1|||
131006502|NCT02374957|471652477|FG001|Overall Study|Patient did not complete forms correctly|0|||
131006503|NCT01687270|471652478|FG000|Overall Study|Lack of Efficacy|11|||
131006504|NCT01687270|471652478|FG000|Overall Study|Lost to Follow-up|1|||
131006505|NCT01417000|471652479|FG000|Overall Study|Death|59|||
131006506|NCT01417000|471652480|FG001|Overall Study|Death|28|||
131006507|NCT01417000|471652479|FG000|Overall Study|Lost to Follow-up|1|||
131006508|NCT01417000|471652480|FG001|Overall Study|Lost to Follow-up|0|||
131006509|NCT01417000|471652479|FG000|Overall Study|Study Terminated by Sponsor|1|||
131006510|NCT01417000|471652480|FG001|Overall Study|Study Terminated by Sponsor|1|||
131006511|NCT00558753|471652482|FG000|Overall Study|Lost to Follow-up|5|||
131006512|NCT00558753|471652483|FG001|Overall Study|Lost to Follow-up|7|||
131006513|NCT01928940|471652484|FG000|Overall Study|Adverse Event|0|||
131006514|NCT01928940|471652485|FG001|Overall Study|Adverse Event|1|||
131006515|NCT04668144|471652492|FG000|Overall Study|Protocol Violation|0|||
131006516|NCT04668144|471652493|FG001|Overall Study|Protocol Violation|1|||
131006517|NCT04668144|471652494|FG002|Overall Study|Protocol Violation|2|||
131006518|NCT00916006|471652496|FG000|Overall Study|Adverse Event|1|||
131006519|NCT00916006|471652497|FG001|Overall Study|Adverse Event|1|||
131006520|NCT00916006|471652496|FG000|Overall Study|Withdrawal by Subject|2|||
131006521|NCT00916006|471652497|FG001|Overall Study|Withdrawal by Subject|5|||
131006522|NCT00916006|471652496|FG000|Overall Study|Protocol Violation|0|||
131006523|NCT00916006|471652497|FG001|Overall Study|Protocol Violation|1|||
131006524|NCT02929108|471652502|FG000|Overall Study|Hospice patient death|100|||
131006525|NCT02929108|471652503|FG001|Overall Study|Hospice patient death|64|||
131006526|NCT02929108|471652504|FG002|Overall Study|Hospice patient death|28|||
131006527|NCT02929108|471652505|FG003|Overall Study|Hospice patient death|46|||
131006528|NCT02929108|471652506|FG004|Overall Study|Hospice patient death|55|||
131006529|NCT02929108|471652507|FG005|Overall Study|Hospice patient death|28|||
131006530|NCT02929108|471652508|FG006|Overall Study|Hospice patient death|78|||
131006531|NCT00052962|471652509|FG000|Overall Study|Not evaluable|0|||
131006532|NCT00052962|471652510|FG001|Overall Study|Not evaluable|2|||
131006533|NCT00052962|471652509|FG000|Overall Study|Not randomized/not evaluable|1|||
131006534|NCT00052962|471652510|FG001|Overall Study|Not randomized/not evaluable|0|||
131006535|NCT04319094|471652516|FG000|Baseline|Lost to Follow-up|4|||
131006536|NCT04319094|471652517|FG001|Baseline|Lost to Follow-up|5|||
131006537|NCT04319094|471652516|FG000|Baseline|Protocol Violation|0|||
131006538|NCT04319094|471652517|FG001|Baseline|Protocol Violation|3|||
131006539|NCT04319094|471652516|FG000|Baseline|Withdrawal by Subject|2|||
131006540|NCT04319094|471652517|FG001|Baseline|Withdrawal by Subject|1|||
131006541|NCT04319094|471652516|FG000|Post-Intervention|Death|0|||
131006542|NCT04319094|471652517|FG001|Post-Intervention|Death|1|||
131006543|NCT04319094|471652516|FG000|Post-Intervention|Lost to Follow-up|4|||
131006544|NCT04319094|471652517|FG001|Post-Intervention|Lost to Follow-up|4|||
131006545|NCT04319094|471652516|FG000|Post-Intervention|Withdrawal by Subject|8|||
131006546|NCT04319094|471652517|FG001|Post-Intervention|Withdrawal by Subject|5|||
131006547|NCT04319094|471652516|FG000|Post-Intervention|Incomplete Data Collection|1|||
131006548|NCT04319094|471652517|FG001|Post-Intervention|Incomplete Data Collection|3|||
131006549|NCT04319094|471652516|FG000|3-month|Death|1|||
131006550|NCT04319094|471652517|FG001|3-month|Death|0|||
131006551|NCT04319094|471652516|FG000|3-month|Lost to Follow-up|2|||
131006552|NCT04319094|471652517|FG001|3-month|Lost to Follow-up|2|||
131006553|NCT04319094|471652516|FG000|3-month|Withdrawal by Subject|0|||
131006554|NCT04319094|471652517|FG001|3-month|Withdrawal by Subject|3|||
131006555|NCT04319094|471652516|FG000|3-month|Incomplete data collection|9|||
131006556|NCT04319094|471652517|FG001|3-month|Incomplete data collection|7|||
131006557|NCT04319094|471652516|FG000|6-month|Lost to Follow-up|1|||
131006558|NCT04319094|471652517|FG001|6-month|Lost to Follow-up|1|||
131006559|NCT04319094|471652516|FG000|6-month|Withdrawal by Subject|0|||
131006560|NCT04319094|471652517|FG001|6-month|Withdrawal by Subject|3|||
131006561|NCT04319094|471652516|FG000|6-month|Incomplete data collection|14|||
131006562|NCT04319094|471652517|FG001|6-month|Incomplete data collection|9|||
131006563|NCT04319094|471652516|FG000|9-month|Lost to Follow-up|8|||
131006564|NCT04319094|471652517|FG001|9-month|Lost to Follow-up|4|||
131006565|NCT04319094|471652516|FG000|9-month|Withdrawal by Subject|0|||
131006566|NCT04319094|471652517|FG001|9-month|Withdrawal by Subject|1|||
131006567|NCT04319094|471652516|FG000|9-month|Incomplete data collection|8|||
131006568|NCT04319094|471652517|FG001|9-month|Incomplete data collection|5|||
131006569|NCT04319094|471652516|FG000|12-month|Lost to Follow-up|11|||
131006570|NCT04319094|471652517|FG001|12-month|Lost to Follow-up|8|||
131006571|NCT00614744|471652518|FG000|Overall Study|Lost to Follow-up|5|||
131006572|NCT00614744|471652519|FG001|Overall Study|Lost to Follow-up|4|||
131006573|NCT00614744|471652518|FG000|Overall Study|Incomplete for Behavior Issues|0|||
131006574|NCT00614744|471652519|FG001|Overall Study|Incomplete for Behavior Issues|2|||
131006575|NCT00877851|471652520|FG000|Overall Study|Lost to Follow-up|5|||
131006576|NCT00877851|471652521|FG001|Overall Study|Lost to Follow-up|5|||
131006577|NCT00877851|471652520|FG000|Overall Study|computer problem|3|||
131006578|NCT00877851|471652521|FG001|Overall Study|computer problem|0|||
131006579|NCT00877851|471652520|FG000|Overall Study|no longer interested in participating|1|||
131006580|NCT00877851|471652521|FG001|Overall Study|no longer interested in participating|0|||
131006581|NCT00770211|471652529|FG000|Overall Study|Lost to Follow-up|1|||
131006582|NCT00770211|471652530|FG001|Overall Study|Lost to Follow-up|0|||
131006583|NCT00770211|471652529|FG000|Overall Study|Withdrawal by Subject|0|||
131006584|NCT00770211|471652530|FG001|Overall Study|Withdrawal by Subject|2|||
131006585|NCT03005288|471652532|FG000|Overall Study|Withdrawal by Subject|7|||
131006586|NCT03005288|471652533|FG001|Overall Study|Withdrawal by Subject|5|||
131006587|NCT03005288|471652532|FG000|Overall Study|Lost to Follow-up|0|||
131006588|NCT03005288|471652533|FG001|Overall Study|Lost to Follow-up|1|||
131006589|NCT03005288|471652532|FG000|Overall Study|Adverse Event|5|||
131006590|NCT03005288|471652533|FG001|Overall Study|Adverse Event|0|||
131006591|NCT03005288|471652532|FG000|Overall Study|Protocol deviation|0|||
131006592|NCT03005288|471652533|FG001|Overall Study|Protocol deviation|1|||
131006593|NCT03005288|471652532|FG000|Overall Study|Physician Decision|0|||
131006594|NCT03005288|471652533|FG001|Overall Study|Physician Decision|1|||
131006595|NCT00665561|471652534|FG000|Overall Study|Death recorded on subject summary pages|75|||
131006596|NCT00665561|471652535|FG001|Overall Study|Death recorded on subject summary pages|75|||
131006597|NCT00665561|471652534|FG000|Overall Study|Does not meet entrance criteria|19|||
131006598|NCT00665561|471652535|FG001|Overall Study|Does not meet entrance criteria|21|||
131006599|NCT00665561|471652534|FG000|Overall Study|Lost to Follow-up|203|||
131006600|NCT00665561|471652535|FG001|Overall Study|Lost to Follow-up|264|||
131006601|NCT00665561|471652534|FG000|Overall Study|Withdrawal by Subject|74|||
131006602|NCT00665561|471652535|FG001|Overall Study|Withdrawal by Subject|65|||
131006603|NCT00665561|471652534|FG000|Overall Study|Other|123|||
131006604|NCT00665561|471652535|FG001|Overall Study|Other|108|||
131006605|NCT00665561|471652534|FG000|Overall Study|Site closed|8|||
131006606|NCT00665561|471652535|FG001|Overall Study|Site closed|0|||
131006607|NCT00665561|471652534|FG000|Overall Study|Withdrawn due to pregnancy|0|||
131006608|NCT00665561|471652535|FG001|Overall Study|Withdrawn due to pregnancy|1|||
131006609|NCT03824236|471652536|FG000|Overall Study|Lost to Follow-up|0|||
131006610|NCT03824236|471652537|FG001|Overall Study|Lost to Follow-up|0|||
131006611|NCT03824236|471652538|FG002|Overall Study|Lost to Follow-up|1|||
131006612|NCT00701311|471652541|FG000|Overall Study|Lack of Efficacy|3|||
131006613|NCT00701311|471652541|FG000|Overall Study|Adverse Event|3|||
131006614|NCT00701311|471652541|FG000|Overall Study|Withdrawal by Subject|2|||
131006615|NCT00670540|471652542|FG000|Overall Study|ineligible|17|||
131006616|NCT00670540|471652542|FG000|Overall Study|not living in France|348|||
131006617|NCT00670540|471652542|FG000|Overall Study|refused to participate|189|||
131006618|NCT00670540|471652542|FG000|Overall Study|controls randomised for no follow up|2770|||
131006619|NCT00670540|471652542|FG000|Overall Study|missing information inclusion criteria|1|||
130720921|NCT00724048|470601563|FG002|Overall Study|Lost to Follow-up|0|||
131006620|NCT01140347|471652543|FG000|Overall Study|Lost to Follow-up|5|||
131006621|NCT01140347|471652544|FG001|Overall Study|Lost to Follow-up|6|||
131006622|NCT01140347|471652543|FG000|Overall Study|Withdrawal by Subject|13|||
131006623|NCT01140347|471652544|FG001|Overall Study|Withdrawal by Subject|8|||
131006624|NCT01515319|471652545|FG000|Overall Study|Withdrawal by Subject|0|||
131006625|NCT01515319|471652546|FG001|Overall Study|Withdrawal by Subject|0|||
131006626|NCT01515319|471652547|FG002|Overall Study|Withdrawal by Subject|0|||
131006627|NCT01515319|471652548|FG003|Overall Study|Withdrawal by Subject|0|||
131006628|NCT01515319|471652549|FG004|Overall Study|Withdrawal by Subject|0|||
131006629|NCT01515319|471652550|FG005|Overall Study|Withdrawal by Subject|0|||
131006630|NCT01515319|471652551|FG006|Overall Study|Withdrawal by Subject|1|||
131006631|NCT01515319|471652552|FG007|Overall Study|Withdrawal by Subject|0|||
131006632|NCT01515319|471652553|FG008|Overall Study|Withdrawal by Subject|0|||
131006633|NCT01515319|471652554|FG009|Overall Study|Withdrawal by Subject|0|||
131006634|NCT01515319|471652545|FG000|Overall Study|Adverse Event|0|||
131006635|NCT01515319|471652546|FG001|Overall Study|Adverse Event|0|||
131006636|NCT01515319|471652547|FG002|Overall Study|Adverse Event|0|||
131006637|NCT01515319|471652548|FG003|Overall Study|Adverse Event|0|||
131006638|NCT01515319|471652549|FG004|Overall Study|Adverse Event|0|||
131006639|NCT01515319|471652550|FG005|Overall Study|Adverse Event|0|||
131006640|NCT01515319|471652551|FG006|Overall Study|Adverse Event|0|||
131006641|NCT01515319|471652552|FG007|Overall Study|Adverse Event|0|||
131006642|NCT01515319|471652553|FG008|Overall Study|Adverse Event|3|||
131006643|NCT01515319|471652554|FG009|Overall Study|Adverse Event|0|||
131006644|NCT01515319|471652545|FG000|Overall Study|Protocol Violation|0|||
131006645|NCT01515319|471652546|FG001|Overall Study|Protocol Violation|0|||
131006646|NCT01515319|471652547|FG002|Overall Study|Protocol Violation|0|||
131006647|NCT01515319|471652548|FG003|Overall Study|Protocol Violation|0|||
131006648|NCT01515319|471652549|FG004|Overall Study|Protocol Violation|0|||
131006649|NCT01515319|471652550|FG005|Overall Study|Protocol Violation|0|||
131006650|NCT01515319|471652551|FG006|Overall Study|Protocol Violation|0|||
131006651|NCT01515319|471652552|FG007|Overall Study|Protocol Violation|0|||
131006652|NCT01515319|471652553|FG008|Overall Study|Protocol Violation|2|||
131006653|NCT01515319|471652554|FG009|Overall Study|Protocol Violation|0|||
131006654|NCT01449929|471652555|FG000|Randomization Phase 96 Week|Adverse Event|5|||
131006655|NCT01449929|471652556|FG001|Randomization Phase 96 Week|Adverse Event|13|||
131006656|NCT01449929|471652557|FG002|Randomization Phase 96 Week|Adverse Event|0|||
131006657|NCT01449929|471652555|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
131006658|NCT01449929|471652556|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
131006659|NCT01449929|471652557|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
131006660|NCT01449929|471652555|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
131006661|NCT01449929|471652556|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
131006662|NCT01449929|471652557|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
131006663|NCT01449929|471652555|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
131006664|NCT01449929|471652556|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
131006665|NCT01449929|471652557|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
131006666|NCT01449929|471652555|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
131006667|NCT01449929|471652556|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
131006668|NCT01449929|471652557|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
131006669|NCT01449929|471652555|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
131006670|NCT01449929|471652556|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
131006671|NCT01449929|471652557|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
131006672|NCT01449929|471652555|FG000|Randomization Phase 96 Week|Physician Decision|2|||
131006673|NCT01449929|471652556|FG001|Randomization Phase 96 Week|Physician Decision|3|||
131006674|NCT01449929|471652557|FG002|Randomization Phase 96 Week|Physician Decision|0|||
131006675|NCT01449929|471652555|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
131006676|NCT01449929|471652556|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
131006677|NCT01449929|471652557|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
131006678|NCT01449929|471652555|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
131006679|NCT01449929|471652556|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
131006680|NCT01449929|471652557|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
131006681|NCT01449929|471652555|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
131006682|NCT01449929|471652556|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
131006683|NCT01449929|471652557|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
131006684|NCT01449929|471652555|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
131006685|NCT01449929|471652556|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
131006686|NCT01449929|471652557|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
131006687|NCT01871285|471652558|FG000|First Intervention (1 Day)|Adverse Event|1|||
131006688|NCT01871285|471652559|FG001|First Intervention (1 Day)|Adverse Event|0|||
131006689|NCT01871285|471652560|FG002|First Intervention (1 Day)|Adverse Event|0|||
131006690|NCT01871285|471652561|FG003|First Intervention (1 Day)|Adverse Event|0|||
131006691|NCT01871285|471652558|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
131006692|NCT01871285|471652559|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
131006693|NCT01871285|471652560|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
131006694|NCT01871285|471652561|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
131006695|NCT01959880|471652562|FG000|Overall Study|Withdrawal by Subject|11|||
131006696|NCT01959880|471652563|FG001|Overall Study|Withdrawal by Subject|13|||
131006697|NCT01959880|471652564|FG002|Overall Study|Withdrawal by Subject|8|||
131006698|NCT01959880|471652565|FG003|Overall Study|Withdrawal by Subject|7|||
131006699|NCT01959880|471652562|FG000|Overall Study|Death|1|||
131006700|NCT01959880|471652563|FG001|Overall Study|Death|10|||
131006701|NCT01959880|471652564|FG002|Overall Study|Death|1|||
131006702|NCT01959880|471652565|FG003|Overall Study|Death|2|||
131006703|NCT01959880|471652562|FG000|Overall Study|Lost to Follow-up|95|||
131006704|NCT01959880|471652563|FG001|Overall Study|Lost to Follow-up|18|||
131006705|NCT01959880|471652564|FG002|Overall Study|Lost to Follow-up|15|||
131006706|NCT01959880|471652565|FG003|Overall Study|Lost to Follow-up|8|||
131006707|NCT01959880|471652562|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
131006708|NCT01959880|471652563|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
131006709|NCT01959880|471652564|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
131006710|NCT01959880|471652565|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
131006711|NCT01959880|471652562|FG000|Overall Study|Study completed early-FDA approved|1003|||
131006712|NCT01959880|471652563|FG001|Overall Study|Study completed early-FDA approved|311|||
131006713|NCT01959880|471652564|FG002|Overall Study|Study completed early-FDA approved|179|||
131006714|NCT01959880|471652565|FG003|Overall Study|Study completed early-FDA approved|152|||
131006715|NCT01919619|471652566|FG000|Overall Study|Physician Decision|1|||
131006716|NCT01919619|471652567|FG001|Overall Study|Physician Decision|1|||
131006717|NCT00662909|471652572|FG000|Overall Study|Adverse Event|17|||
131006718|NCT00662909|471652573|FG001|Overall Study|Adverse Event|18|||
131006719|NCT00662909|471652574|FG002|Overall Study|Adverse Event|19|||
131006720|NCT00662909|471652572|FG000|Overall Study|Lack of Efficacy|9|||
131006721|NCT00662909|471652573|FG001|Overall Study|Lack of Efficacy|1|||
131006722|NCT00662909|471652574|FG002|Overall Study|Lack of Efficacy|5|||
131006723|NCT00662909|471652572|FG000|Overall Study|Withdrawal by Subject|29|||
131006724|NCT00662909|471652573|FG001|Overall Study|Withdrawal by Subject|22|||
131006725|NCT00662909|471652574|FG002|Overall Study|Withdrawal by Subject|16|||
131006726|NCT00662909|471652572|FG000|Overall Study|Lost to Follow-up|2|||
131006727|NCT00662909|471652573|FG001|Overall Study|Lost to Follow-up|9|||
131006728|NCT00662909|471652574|FG002|Overall Study|Lost to Follow-up|3|||
131006729|NCT00662909|471652572|FG000|Overall Study|Protocol Violation|7|||
131006730|NCT00662909|471652573|FG001|Overall Study|Protocol Violation|4|||
131006731|NCT00662909|471652574|FG002|Overall Study|Protocol Violation|5|||
131006732|NCT00662909|471652572|FG000|Overall Study|Randomized- never received study drug|1|||
131006733|NCT00662909|471652573|FG001|Overall Study|Randomized- never received study drug|0|||
131006734|NCT00662909|471652574|FG002|Overall Study|Randomized- never received study drug|0|||
131006735|NCT00662909|471652572|FG000|Overall Study|Non-compliance with study procedures|3|||
131006736|NCT00662909|471652573|FG001|Overall Study|Non-compliance with study procedures|3|||
131006737|NCT00662909|471652574|FG002|Overall Study|Non-compliance with study procedures|2|||
131006738|NCT00662909|471652572|FG000|Overall Study|Physician Decision|1|||
131006739|NCT00662909|471652573|FG001|Overall Study|Physician Decision|1|||
131006740|NCT00662909|471652574|FG002|Overall Study|Physician Decision|2|||
131006741|NCT00662909|471652572|FG000|Overall Study|Eligibility criterion not met|0|||
131006742|NCT00662909|471652573|FG001|Overall Study|Eligibility criterion not met|1|||
131006743|NCT00662909|471652574|FG002|Overall Study|Eligibility criterion not met|1|||
131006744|NCT04978363|471654204|FG000|Overall Study|Other medical issues unrelated to the study|0|||
131006745|NCT04978363|471654205|FG001|Overall Study|Other medical issues unrelated to the study|0|||
131006746|NCT04978363|471654206|FG002|Overall Study|Other medical issues unrelated to the study|0|||
131006747|NCT04978363|471654207|FG003|Overall Study|Other medical issues unrelated to the study|0|||
131006748|NCT04978363|471654208|FG004|Overall Study|Other medical issues unrelated to the study|1|||
131006749|NCT04978363|471654209|FG005|Overall Study|Other medical issues unrelated to the study|0|||
131006750|NCT04978363|471654210|FG006|Overall Study|Other medical issues unrelated to the study|0|||
131006751|NCT04978363|471654211|FG007|Overall Study|Other medical issues unrelated to the study|0|||
131006752|NCT04978363|471654212|FG008|Overall Study|Other medical issues unrelated to the study|0|||
131006753|NCT04978363|471654213|FG009|Overall Study|Other medical issues unrelated to the study|0|||
131006754|NCT04978363|471654214|FG010|Overall Study|Other medical issues unrelated to the study|0|||
131006755|NCT04978363|471654204|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
131006756|NCT04978363|471654205|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
131006757|NCT04978363|471654206|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
131006758|NCT04978363|471654207|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
131006759|NCT04978363|471654208|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
131006760|NCT04978363|471654209|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
131006761|NCT04978363|471654210|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
131006762|NCT04978363|471654211|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
131006763|NCT04978363|471654212|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
131006764|NCT04978363|471654213|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
131006765|NCT04978363|471654214|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
131006766|NCT04978363|471654204|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131006767|NCT04978363|471654205|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
131006768|NCT04978363|471654206|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131006769|NCT04978363|471654207|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131006770|NCT04978363|471654208|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131006771|NCT04978363|471654209|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131006772|NCT04978363|471654210|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131006773|NCT04978363|471654211|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131006774|NCT04978363|471654212|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131006775|NCT04978363|471654213|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131006776|NCT04978363|471654214|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
131006777|NCT02153788|471654215|FG000|Overall Study|Physician Decision|2|||
131006778|NCT02153788|471654216|FG001|Overall Study|Physician Decision|1|||
131006779|NCT01684046|471654217|FG000|Period 1, First 30 Days|Adverse Event|0|||
131006780|NCT01684046|471654218|FG001|Period 1, First 30 Days|Adverse Event|2|||
131006781|NCT02790606|471654228|FG000|Overall Study|Death|27|||
131006782|NCT02790606|471654228|FG000|Overall Study|Lost to Follow-up|4|||
131006783|NCT02790606|471654228|FG000|Overall Study|Physician Decision|3|||
131006784|NCT02790606|471654228|FG000|Overall Study|Withdrawal by Subject|1|||
131006785|NCT02735915|471654229|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
131006786|NCT02735915|471654229|FG000|Overall Study|Withdrawal following SAE|2|||
131006787|NCT02735915|471654229|FG000|Overall Study|Withdrawal by Subject|1|||
131006788|NCT05328973|471654230|FG000|Overall Study|Withdrawal by Subject|0|||
131006789|NCT05328973|471654231|FG001|Overall Study|Withdrawal by Subject|1|||
131006790|NCT00946114|471654232|FG000|Overall Study|Death|5|||
131006791|NCT00946114|471654233|FG001|Overall Study|Death|2|||
131006792|NCT00946114|471654232|FG000|Overall Study|Other|1|||
131006793|NCT00946114|471654233|FG001|Overall Study|Other|0|||
131006794|NCT00946114|471654232|FG000|Overall Study|Withdrawal by Subject|2|||
131006795|NCT00946114|471654233|FG001|Overall Study|Withdrawal by Subject|0|||
131006796|NCT02757885|471654235|FG000|Overall Study|Screen Failures|4|||
131006797|NCT03239210|471654236|FG000|Overall Study|Lost to Follow-up|2|||
131006798|NCT03239210|471654237|FG001|Overall Study|Lost to Follow-up|2|||
131006799|NCT03239210|471654236|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
131006800|NCT03239210|471654237|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
131006801|NCT03239210|471654236|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
131006802|NCT03239210|471654237|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
131006803|NCT03681691|471654238|FG000|Overall Study|COVID|1|||
131006804|NCT03681691|471654239|FG001|Overall Study|COVID|0|||
131006805|NCT03681691|471654238|FG000|Overall Study|prolonged bleeding|1|||
131006806|NCT03681691|471654239|FG001|Overall Study|prolonged bleeding|0|||
131006807|NCT03681691|471654238|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
131006808|NCT03681691|471654239|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
131006809|NCT00748969|471654240|FG000|Overall Study|Withdrawal by Subject|1|||
131006810|NCT00748969|471654241|FG001|Overall Study|Withdrawal by Subject|0|||
131006811|NCT00748969|471654240|FG000|Overall Study|Withdrawal by Subject|0|||
131006812|NCT00748969|471654241|FG001|Overall Study|Withdrawal by Subject|1|||
131006813|NCT03613129|471654242|FG000|Pre-treatment Assessment|Protocol Violation|2|||
131006814|NCT03613129|471654243|FG001|Pre-treatment Assessment|Protocol Violation|0|||
131006815|NCT03613129|471654244|FG002|Pre-treatment Assessment|Protocol Violation|0|||
131006816|NCT03613129|471654245|FG003|Pre-treatment Assessment|Protocol Violation|0|||
131006817|NCT03613129|471654246|FG004|Pre-treatment Assessment|Protocol Violation|0|||
131006818|NCT03613129|471654242|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
131006819|NCT03613129|471654243|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
131006820|NCT03613129|471654244|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
131006821|NCT03613129|471654245|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
131006822|NCT03613129|471654246|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
131006823|NCT02334306|471654247|FG000|Double-blind Period|Adverse Event|0|||
131006824|NCT02334306|471654248|FG001|Double-blind Period|Adverse Event|1|||
131006825|NCT02334306|471654247|FG000|Double-blind Period|Withdrawal by Subject|1|||
131006826|NCT02334306|471654248|FG001|Double-blind Period|Withdrawal by Subject|1|||
131006827|NCT00465985|471654249|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
131006828|NCT00465985|471654250|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
131006829|NCT00465985|471654249|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
131006830|NCT00465985|471654250|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
131006831|NCT00465985|471654249|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
131006832|NCT00465985|471654250|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
131006833|NCT00465985|471654249|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
131006834|NCT00465985|471654250|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
131006835|NCT03532178|471654251|FG000|First Period|Withdrawal by Subject|1|||
131006836|NCT03532178|471654252|FG001|First Period|Withdrawal by Subject|3|||
131006837|NCT03532178|471654251|FG000|First Period|technical issues in data collection Technical issues|0|||
131006838|NCT03532178|471654252|FG001|First Period|technical issues in data collection Technical issues|1|||
131006839|NCT03532178|471654251|FG000|Second Period|Withdrawal by Subject|1|||
131006840|NCT03532178|471654252|FG001|Second Period|Withdrawal by Subject|1|||
131006841|NCT03532178|471654251|FG000|Second Period|Technical issues|0|||
131006842|NCT03532178|471654252|FG001|Second Period|Technical issues|1|||
131006843|NCT03302156|471654253|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
131006844|NCT03302156|471654254|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
131006845|NCT03302156|471654255|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
131006846|NCT02390557|471654256|FG000|Wave 2|Survey non-respondent|72|||
131006847|NCT02390557|471654257|FG001|Wave 2|Survey non-respondent|41|||
131006848|NCT02390557|471654258|FG002|Wave 2|Survey non-respondent|23|||
131006849|NCT03278028|471654261|FG000|Overall Study|Lost to Follow-up|1|||
131006850|NCT03278028|471654262|FG001|Overall Study|Lost to Follow-up|0|||
131006851|NCT03278028|471654261|FG000|Overall Study|Withdrawal by Subject|3|||
131006852|NCT03278028|471654262|FG001|Overall Study|Withdrawal by Subject|1|||
131006853|NCT03278028|471654261|FG000|Overall Study|Pregnancy|0|||
131006854|NCT03278028|471654262|FG001|Overall Study|Pregnancy|1|||
131006855|NCT00463151|471654264|FG000|Overall Study|Adverse Event|0|||
131006856|NCT00463151|471654265|FG001|Overall Study|Adverse Event|0|||
131006857|NCT00463151|471654266|FG002|Overall Study|Adverse Event|1|||
131006858|NCT00463151|471654267|FG003|Overall Study|Adverse Event|0|||
131006859|NCT00463151|471654264|FG000|Overall Study|Lack of Efficacy|2|||
131006860|NCT00463151|471654265|FG001|Overall Study|Lack of Efficacy|5|||
131006861|NCT00463151|471654266|FG002|Overall Study|Lack of Efficacy|2|||
131006862|NCT00463151|471654267|FG003|Overall Study|Lack of Efficacy|5|||
131006863|NCT00463151|471654264|FG000|Overall Study|Protocol Violation|0|||
131006864|NCT00463151|471654265|FG001|Overall Study|Protocol Violation|0|||
131006865|NCT00463151|471654266|FG002|Overall Study|Protocol Violation|0|||
131006866|NCT00463151|471654267|FG003|Overall Study|Protocol Violation|1|||
131006867|NCT00463151|471654264|FG000|Overall Study|Withdrawal by Subject|0|||
131006868|NCT00463151|471654265|FG001|Overall Study|Withdrawal by Subject|0|||
131006869|NCT00463151|471654266|FG002|Overall Study|Withdrawal by Subject|0|||
131006870|NCT00463151|471654267|FG003|Overall Study|Withdrawal by Subject|1|||
131006871|NCT00293462|471654268|FG000|Overall Study|Withdrawal by Subject|4|||
131006872|NCT00293462|471654269|FG001|Overall Study|Withdrawal by Subject|3|||
131006873|NCT00293462|471654270|FG002|Overall Study|Withdrawal by Subject|8|||
131006874|NCT00293462|471654268|FG000|Overall Study|Death|1|||
131006875|NCT00293462|471654269|FG001|Overall Study|Death|0|||
131006876|NCT00293462|471654270|FG002|Overall Study|Death|0|||
131006877|NCT00293462|471654268|FG000|Overall Study|Lost to Follow-up|0|||
131006878|NCT00293462|471654269|FG001|Overall Study|Lost to Follow-up|1|||
131006879|NCT00293462|471654270|FG002|Overall Study|Lost to Follow-up|0|||
131006880|NCT00293462|471654268|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
131006881|NCT00293462|471654269|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
131006882|NCT00293462|471654270|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
131006883|NCT00293462|471654268|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
131006884|NCT00293462|471654269|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
131006885|NCT00293462|471654270|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
131006886|NCT00293462|471654268|FG000|Overall Study|Refuse Radiation Treatment|1|||
131006887|NCT00293462|471654269|FG001|Overall Study|Refuse Radiation Treatment|0|||
131006888|NCT00293462|471654270|FG002|Overall Study|Refuse Radiation Treatment|0|||
131006889|NCT00293462|471654268|FG000|Overall Study|No Show|0|||
131006890|NCT00293462|471654269|FG001|Overall Study|No Show|0|||
131006891|NCT00293462|471654270|FG002|Overall Study|No Show|1|||
131006892|NCT00293462|471654268|FG000|Overall Study|Went back to his home country|0|||
131006893|NCT00293462|471654269|FG001|Overall Study|Went back to his home country|0|||
131006894|NCT00293462|471654270|FG002|Overall Study|Went back to his home country|1|||
131006895|NCT00293462|471654268|FG000|Overall Study|Blood clot after chemotherapy|0|||
131006896|NCT00293462|471654269|FG001|Overall Study|Blood clot after chemotherapy|0|||
131006897|NCT00293462|471654270|FG002|Overall Study|Blood clot after chemotherapy|1|||
131006898|NCT00293462|471654268|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
131006899|NCT00293462|471654269|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
131006900|NCT00293462|471654270|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
131006901|NCT00293462|471654268|FG000|Overall Study|Possible Tracheostomy leakage|0|||
131006902|NCT00293462|471654269|FG001|Overall Study|Possible Tracheostomy leakage|1|||
131006903|NCT00293462|471654270|FG002|Overall Study|Possible Tracheostomy leakage|0|||
131006904|NCT00293462|471654268|FG000|Overall Study|Low radiation dose in oral cavity|0|||
131006905|NCT00293462|471654269|FG001|Overall Study|Low radiation dose in oral cavity|1|||
131006906|NCT00293462|471654270|FG002|Overall Study|Low radiation dose in oral cavity|0|||
131006907|NCT00293462|471654268|FG000|Overall Study|Physician Decision|0|||
131006908|NCT00293462|471654269|FG001|Overall Study|Physician Decision|1|||
131006909|NCT00293462|471654270|FG002|Overall Study|Physician Decision|0|||
131006910|NCT00688688|471654271|FG000|Overall Study|Eligibility criterion not met|7|||
131006911|NCT00688688|471654272|FG001|Overall Study|Eligibility criterion not met|7|||
131006912|NCT00688688|471654273|FG002|Overall Study|Eligibility criterion not met|10|||
131006913|NCT00688688|471654271|FG000|Overall Study|Adverse Event|52|||
131006914|NCT00688688|471654272|FG001|Overall Study|Adverse Event|51|||
131006915|NCT00688688|471654273|FG002|Overall Study|Adverse Event|50|||
131006916|NCT00688688|471654271|FG000|Overall Study|Lack of Efficacy|34|||
131006917|NCT00688688|471654272|FG001|Overall Study|Lack of Efficacy|25|||
131006918|NCT00688688|471654273|FG002|Overall Study|Lack of Efficacy|45|||
131006919|NCT00688688|471654271|FG000|Overall Study|Withdrawal by Subject|66|||
131006920|NCT00688688|471654272|FG001|Overall Study|Withdrawal by Subject|75|||
131006921|NCT00688688|471654273|FG002|Overall Study|Withdrawal by Subject|65|||
131006922|NCT00688688|471654271|FG000|Overall Study|Lost to Follow-up|14|||
131006923|NCT00688688|471654272|FG001|Overall Study|Lost to Follow-up|7|||
131006924|NCT00688688|471654273|FG002|Overall Study|Lost to Follow-up|7|||
131006925|NCT00688688|471654271|FG000|Overall Study|Protocol Violation|6|||
131006926|NCT00688688|471654272|FG001|Overall Study|Protocol Violation|9|||
131006927|NCT00688688|471654273|FG002|Overall Study|Protocol Violation|11|||
131006928|NCT00688688|471654271|FG000|Overall Study|Randomized but never received study drug|1|||
131006929|NCT00688688|471654272|FG001|Overall Study|Randomized but never received study drug|0|||
131006930|NCT00688688|471654273|FG002|Overall Study|Randomized but never received study drug|0|||
131006931|NCT00688688|471654271|FG000|Overall Study|Non-compliance with study procedures|5|||
131006932|NCT00688688|471654272|FG001|Overall Study|Non-compliance with study procedures|3|||
131006933|NCT00688688|471654273|FG002|Overall Study|Non-compliance with study procedures|4|||
131006934|NCT00688688|471654271|FG000|Overall Study|Taking exclusionary medications|1|||
131006935|NCT00688688|471654272|FG001|Overall Study|Taking exclusionary medications|0|||
131006936|NCT00688688|471654273|FG002|Overall Study|Taking exclusionary medications|0|||
131006937|NCT00688688|471654271|FG000|Overall Study|Site closure|0|||
131006938|NCT00688688|471654272|FG001|Overall Study|Site closure|1|||
131006939|NCT00688688|471654273|FG002|Overall Study|Site closure|0|||
131006940|NCT00688688|471654271|FG000|Overall Study|Violation of exclusion criterion|0|||
131006941|NCT00688688|471654272|FG001|Overall Study|Violation of exclusion criterion|1|||
131006942|NCT00688688|471654273|FG002|Overall Study|Violation of exclusion criterion|0|||
131006943|NCT03283553|471654276|FG000|Patient Participant Flow|Death|5|||
131006944|NCT03283553|471654277|FG001|Patient Participant Flow|Death|10|||
131006945|NCT03283553|471654276|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
131006946|NCT03283553|471654277|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
131006947|NCT03283553|471654276|FG000|Patient Participant Flow|Lost to Follow-up|1|||
131006948|NCT03283553|471654277|FG001|Patient Participant Flow|Lost to Follow-up|1|||
131006949|NCT03283553|471654276|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
131006950|NCT03283553|471654277|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
131006951|NCT03283553|471654276|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
131006952|NCT03283553|471654277|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
131006953|NCT03283553|471654276|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
131006954|NCT03283553|471654277|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
131006955|NCT03686683|471654278|FG000|Overall Study|Withdrawal by Subject|52|||
131006956|NCT03686683|471654279|FG001|Overall Study|Withdrawal by Subject|32|||
131006957|NCT03686683|471654278|FG000|Overall Study|Lost to Follow-up|23|||
131006958|NCT03686683|471654279|FG001|Overall Study|Lost to Follow-up|19|||
131006959|NCT03686683|471654278|FG000|Overall Study|Adverse Event|1|||
131006960|NCT03686683|471654279|FG001|Overall Study|Adverse Event|0|||
131006961|NCT03686683|471654278|FG000|Overall Study|Death|10|||
131006962|NCT03686683|471654279|FG001|Overall Study|Death|5|||
131006963|NCT03686683|471654278|FG000|Overall Study|Progressive Disease|1|||
131006964|NCT03686683|471654279|FG001|Overall Study|Progressive Disease|1|||
131006965|NCT03686683|471654278|FG000|Overall Study|Noncompliance|1|||
131006966|NCT03686683|471654279|FG001|Overall Study|Noncompliance|0|||
131006967|NCT03686683|471654278|FG000|Overall Study|Physician Decision|1|||
131006968|NCT03686683|471654279|FG001|Overall Study|Physician Decision|1|||
131006969|NCT03686683|471654278|FG000|Overall Study|Screen fail post-randomization|1|||
131006970|NCT03686683|471654279|FG001|Overall Study|Screen fail post-randomization|0|||
131006971|NCT03686683|471654278|FG000|Overall Study|Protocol Violation|3|||
131006972|NCT03686683|471654279|FG001|Overall Study|Protocol Violation|0|||
131006973|NCT03686683|471654278|FG000|Overall Study|No data available|1|||
131006974|NCT03686683|471654279|FG001|Overall Study|No data available|0|||
131006975|NCT03255941|471654280|FG000|Overall Study|Not eligible or refused injection|37|||
131006976|NCT03255941|471654281|FG001|Overall Study|Not eligible or refused injection|44|||
131006977|NCT03255941|471654282|FG002|Overall Study|Not eligible or refused injection|5|||
131006978|NCT03255941|471654283|FG003|Overall Study|Not eligible or refused injection|6|||
131006979|NCT03255941|471654280|FG000|Overall Study|Did not complete exit interview|1|||
131006980|NCT03255941|471654281|FG001|Overall Study|Did not complete exit interview|2|||
131006981|NCT03255941|471654282|FG002|Overall Study|Did not complete exit interview|0|||
131006982|NCT03255941|471654283|FG003|Overall Study|Did not complete exit interview|0|||
131006983|NCT00372060|471654284|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
131006984|NCT00372060|471654285|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
131006985|NCT00372060|471654284|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
131006986|NCT00372060|471654285|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
131006987|NCT00372060|471654284|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
131006988|NCT00372060|471654285|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
131006989|NCT00372060|471654284|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
131006990|NCT00372060|471654285|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
131006991|NCT00372060|471654284|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
131006992|NCT00372060|471654285|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
131006993|NCT00372060|471654284|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
131006994|NCT00372060|471654285|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
131006995|NCT01579578|471654286|FG000|Overall Study|Death|4|||
131006996|NCT01579578|471654287|FG001|Overall Study|Death|1|||
131006997|NCT01579578|471654286|FG000|Overall Study|Lost to Follow-up|1|||
131006998|NCT01579578|471654287|FG001|Overall Study|Lost to Follow-up|1|||
131006999|NCT01579578|471654286|FG000|Overall Study|Withdrawal by Subject|2|||
131007000|NCT01579578|471654287|FG001|Overall Study|Withdrawal by Subject|1|||
131007001|NCT01579578|471654286|FG000|Overall Study|Eligibility criteria|3|||
131007002|NCT01579578|471654287|FG001|Overall Study|Eligibility criteria|9|||
131007003|NCT01579578|471654286|FG000|Overall Study|Ongoing|3|||
131007004|NCT01579578|471654287|FG001|Overall Study|Ongoing|0|||
131007005|NCT01528709|471654288|FG000|Overall Study|Death|2|||
131007006|NCT01528709|471654289|FG001|Overall Study|Death|0|||
131007007|NCT01528709|471654288|FG000|Overall Study|Withdrawal by Subject|10|||
131007008|NCT01528709|471654289|FG001|Overall Study|Withdrawal by Subject|15|||
131007009|NCT01528709|471654288|FG000|Overall Study|allergy|1|||
131007010|NCT01528709|471654289|FG001|Overall Study|allergy|0|||
131007011|NCT00647348|471654292|FG000|Overall Study|Lost to Follow-up|3|||
131007012|NCT00647348|471654293|FG001|Overall Study|Lost to Follow-up|6|||
131007013|NCT04889118|471654298|FG000|Overall Study|Death|33|||
131007014|NCT04889118|471654299|FG001|Overall Study|Death|37|||
131007015|NCT04889118|471654298|FG000|Overall Study|Ongoing in Study|31|||
131007016|NCT04889118|471654299|FG001|Overall Study|Ongoing in Study|30|||
131007017|NCT00821236|471654304|FG000|Overall Study|Lost to Follow-up|3|||
131007018|NCT01582243|471654305|FG000|Overall Study|Withdrawal by Subject|1|||
131007019|NCT01582243|471654305|FG000|Overall Study|Adverse Event|1|||
131007020|NCT01582243|471654305|FG000|Overall Study|Lost to Follow-up|1|||
131007021|NCT02397889|471654307|FG000|Overall Study|Physician Decision|1|||
131007022|NCT02397889|471654308|FG001|Overall Study|Physician Decision|0|||
131007023|NCT02954055|471654318|FG000|Overall Study|Did not initiate therapy|6|||
131007024|NCT02954055|471654319|FG001|Overall Study|Did not initiate therapy|1|||
131007025|NCT02096003|471654320|FG000|Overall Study|Protocol Violation|0|||
131007026|NCT02096003|471654321|FG001|Overall Study|Protocol Violation|2|||
131007027|NCT02096003|471654320|FG000|Overall Study|additional surgery|2|||
131007028|NCT02096003|471654321|FG001|Overall Study|additional surgery|1|||
131007029|NCT01511250|471654322|FG000|Overall Study|Withdrawal of Consent|1|||
131007030|NCT01511250|471654323|FG001|Overall Study|Withdrawal of Consent|0|||
131007031|NCT01511250|471654324|FG002|Overall Study|Withdrawal of Consent|0|||
131007032|NCT01511250|471654325|FG003|Overall Study|Withdrawal of Consent|0|||
131007033|NCT01511250|471654326|FG004|Overall Study|Withdrawal of Consent|0|||
131007034|NCT01511250|471654327|FG005|Overall Study|Withdrawal of Consent|0|||
131007035|NCT01511250|471654328|FG006|Overall Study|Withdrawal of Consent|0|||
131007036|NCT01511250|471654329|FG007|Overall Study|Withdrawal of Consent|1|||
131007037|NCT01511250|471654330|FG008|Overall Study|Withdrawal of Consent|1|||
131007038|NCT01511250|471654331|FG009|Overall Study|Withdrawal of Consent|0|||
131007039|NCT01511250|471654322|FG000|Overall Study|Sponsor/Investigator Decision|1|||
131007040|NCT01511250|471654323|FG001|Overall Study|Sponsor/Investigator Decision|0|||
131007041|NCT01511250|471654324|FG002|Overall Study|Sponsor/Investigator Decision|0|||
131007042|NCT01511250|471654325|FG003|Overall Study|Sponsor/Investigator Decision|0|||
131007043|NCT01511250|471654326|FG004|Overall Study|Sponsor/Investigator Decision|0|||
131007044|NCT01511250|471654327|FG005|Overall Study|Sponsor/Investigator Decision|0|||
131007045|NCT01511250|471654328|FG006|Overall Study|Sponsor/Investigator Decision|0|||
131007046|NCT01511250|471654329|FG007|Overall Study|Sponsor/Investigator Decision|0|||
131007047|NCT01511250|471654330|FG008|Overall Study|Sponsor/Investigator Decision|0|||
131007048|NCT01511250|471654331|FG009|Overall Study|Sponsor/Investigator Decision|0|||
131007049|NCT01511250|471654322|FG000|Overall Study|Lost to Follow-up|7|||
131007050|NCT01511250|471654323|FG001|Overall Study|Lost to Follow-up|3|||
131007051|NCT01511250|471654324|FG002|Overall Study|Lost to Follow-up|3|||
131007052|NCT01511250|471654325|FG003|Overall Study|Lost to Follow-up|3|||
131007053|NCT01511250|471654326|FG004|Overall Study|Lost to Follow-up|0|||
131007054|NCT01511250|471654327|FG005|Overall Study|Lost to Follow-up|0|||
131007055|NCT01511250|471654328|FG006|Overall Study|Lost to Follow-up|2|||
131007056|NCT01511250|471654329|FG007|Overall Study|Lost to Follow-up|3|||
131007057|NCT01511250|471654330|FG008|Overall Study|Lost to Follow-up|13|||
131007058|NCT01511250|471654331|FG009|Overall Study|Lost to Follow-up|5|||
131007059|NCT01511250|471654322|FG000|Overall Study|Protocol Violation|0|||
131007060|NCT01511250|471654323|FG001|Overall Study|Protocol Violation|2|||
131007061|NCT01511250|471654324|FG002|Overall Study|Protocol Violation|1|||
131007062|NCT01511250|471654325|FG003|Overall Study|Protocol Violation|0|||
131007063|NCT01511250|471654326|FG004|Overall Study|Protocol Violation|0|||
131007064|NCT01511250|471654327|FG005|Overall Study|Protocol Violation|0|||
131007065|NCT01511250|471654328|FG006|Overall Study|Protocol Violation|0|||
131007066|NCT01511250|471654329|FG007|Overall Study|Protocol Violation|0|||
131007067|NCT01511250|471654330|FG008|Overall Study|Protocol Violation|0|||
131007068|NCT01511250|471654331|FG009|Overall Study|Protocol Violation|0|||
131007069|NCT05487703|471654332|FG000|Overall Study|Other|19|||
131007070|NCT05487703|471654332|FG000|Overall Study|Participant not well|5|||
131007071|NCT05487703|471654332|FG000|Overall Study|Insurance Reasons|6|||
131007072|NCT05487703|471654332|FG000|Overall Study|Physician Decision|19|||
131007073|NCT05487703|471654332|FG000|Overall Study|Lack of Efficacy|60|||
131007074|NCT03686384|471654333|FG000|Overall Study|Lack of Efficacy|4|||
131007075|NCT03686384|471654334|FG001|Overall Study|Lack of Efficacy|13|||
131007076|NCT03686384|471654333|FG000|Overall Study|Lost to Follow-up|3|||
131007077|NCT03686384|471654334|FG001|Overall Study|Lost to Follow-up|0|||
131007078|NCT03686384|471654333|FG000|Overall Study|Physician Decision|0|||
131007079|NCT03686384|471654334|FG001|Overall Study|Physician Decision|1|||
131007080|NCT03686384|471654333|FG000|Overall Study|Took prohibited medication|0|||
131007081|NCT03686384|471654334|FG001|Overall Study|Took prohibited medication|1|||
131007082|NCT02820051|471654337|FG000|Overall Study|Lost to Follow-up|7|||
131007083|NCT02820051|471654338|FG001|Overall Study|Lost to Follow-up|4|||
131007084|NCT01222247|471654342|FG000|Overall Study|Lost to Follow-up|2|||
131007085|NCT01222247|471654343|FG001|Overall Study|Lost to Follow-up|2|||
131007086|NCT00832780|471654344|FG000|Overall Study|Death|16|||
131007087|NCT00832780|471654344|FG000|Overall Study|Lost to Follow-up|4|||
131007088|NCT00832780|471654344|FG000|Overall Study|no reason given|2|||
131007089|NCT00832780|471654344|FG000|Overall Study|other complicating condition|2|||
131007090|NCT00832780|471654344|FG000|Overall Study|Physician Decision|1|||
131007091|NCT01767909|471654347|FG000|Overall Study|Withdrawal by Subject|4|||
131007092|NCT01767909|471654348|FG001|Overall Study|Withdrawal by Subject|7|||
131007093|NCT01767909|471654347|FG000|Overall Study|Adverse Event|3|||
131007094|NCT01767909|471654348|FG001|Overall Study|Adverse Event|1|||
131007095|NCT01767909|471654347|FG000|Overall Study|Withdrawal by Study Partner|3|||
131007096|NCT01767909|471654348|FG001|Overall Study|Withdrawal by Study Partner|1|||
131007097|NCT01767909|471654347|FG000|Overall Study|Non-Compliance|2|||
131007098|NCT01767909|471654348|FG001|Overall Study|Non-Compliance|0|||
131007099|NCT01767909|471654347|FG000|Overall Study|Perceived Lack of Efficacy|1|||
131007100|NCT01767909|471654348|FG001|Overall Study|Perceived Lack of Efficacy|0|||
131007101|NCT01767909|471654347|FG000|Overall Study|Investigator Recommendation|0|||
131007102|NCT01767909|471654348|FG001|Overall Study|Investigator Recommendation|1|||
131007103|NCT01767909|471654347|FG000|Overall Study|Lost to Follow-up|0|||
131007104|NCT01767909|471654348|FG001|Overall Study|Lost to Follow-up|1|||
131007105|NCT01767909|471654347|FG000|Overall Study|LP uncessessful|0|||
131007106|NCT01767909|471654348|FG001|Overall Study|LP uncessessful|1|||
131007107|NCT04939428|471654349|FG000|Overall Study|Death|0|||
131007108|NCT04939428|471654350|FG001|Overall Study|Death|1|||
131007109|NCT04939428|471654351|FG002|Overall Study|Death|0|||
131007110|NCT04939428|471654349|FG000|Overall Study|Lost to Follow-up|0|||
131007111|NCT04939428|471654350|FG001|Overall Study|Lost to Follow-up|5|||
131007112|NCT04939428|471654351|FG002|Overall Study|Lost to Follow-up|0|||
131007113|NCT04939428|471654349|FG000|Overall Study|Physician Decision|1|||
131007114|NCT04939428|471654350|FG001|Overall Study|Physician Decision|0|||
131007115|NCT04939428|471654351|FG002|Overall Study|Physician Decision|0|||
131007116|NCT04939428|471654349|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131007117|NCT04939428|471654350|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131007118|NCT04939428|471654351|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131007119|NCT04939428|471654349|FG000|Overall Study|Withdrawal by Subject|10|||
131007120|NCT04939428|471654350|FG001|Overall Study|Withdrawal by Subject|11|||
131007121|NCT04939428|471654351|FG002|Overall Study|Withdrawal by Subject|0|||
131007122|NCT04939428|471654349|FG000|Overall Study|Unkown|6|||
131007123|NCT04939428|471654350|FG001|Overall Study|Unkown|3|||
131007124|NCT04939428|471654351|FG002|Overall Study|Unkown|0|||
131007125|NCT04939428|471654349|FG000|Overall Study|Discotinued per protocol|0|||
131007126|NCT04939428|471654350|FG001|Overall Study|Discotinued per protocol|0|||
131007127|NCT04939428|471654351|FG002|Overall Study|Discotinued per protocol|902|||
131007128|NCT04956692|471654353|FG000|Overall Study|Death|115|||
131007129|NCT04956692|471654354|FG001|Overall Study|Death|47|||
131007130|NCT04956692|471654353|FG000|Overall Study|Lost to Follow-up|0|||
131007131|NCT04956692|471654354|FG001|Overall Study|Lost to Follow-up|1|||
131007132|NCT04956692|471654353|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
131007133|NCT04956692|471654354|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131007134|NCT04956692|471654353|FG000|Overall Study|Withdrawal by Subject|5|||
131007135|NCT04956692|471654354|FG001|Overall Study|Withdrawal by Subject|2|||
131007136|NCT04956692|471654353|FG000|Overall Study|Ongoing in Study|236|||
131007137|NCT04956692|471654354|FG001|Overall Study|Ongoing in Study|123|||
131007138|NCT04639947|471654355|FG000|Overall Study|Screen fail|1|||
131007139|NCT02696785|471654358|FG000|Blinded Treatment Period|Adverse Event|0|||
131007140|NCT02696785|471654359|FG001|Blinded Treatment Period|Adverse Event|1|||
131007141|NCT02696785|471654360|FG002|Blinded Treatment Period|Adverse Event|3|||
131007142|NCT02696785|471654361|FG003|Blinded Treatment Period|Adverse Event|0|||
131007143|NCT02696785|471654358|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
131007144|NCT02696785|471654359|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
131007145|NCT02696785|471654360|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
131007146|NCT02696785|471654361|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
131007147|NCT02696785|471654358|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
131007148|NCT02696785|471654359|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
131007149|NCT02696785|471654360|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
131007150|NCT02696785|471654361|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
131007151|NCT02696785|471654358|FG000|Blinded Treatment Period|Screen Failure|1|||
131007152|NCT02696785|471654359|FG001|Blinded Treatment Period|Screen Failure|0|||
131007153|NCT02696785|471654360|FG002|Blinded Treatment Period|Screen Failure|0|||
131007154|NCT02696785|471654361|FG003|Blinded Treatment Period|Screen Failure|0|||
131007155|NCT02696785|471654358|FG000|Washout Period|Withdrawal by Subject|0|||
131007156|NCT02696785|471654359|FG001|Washout Period|Withdrawal by Subject|1|||
131007157|NCT02696785|471654360|FG002|Washout Period|Withdrawal by Subject|0|||
131007158|NCT02696785|471654361|FG003|Washout Period|Withdrawal by Subject|0|||
131007159|NCT02696785|471654358|FG000|Washout Period|Lack of Efficacy|0|||
131007160|NCT02696785|471654359|FG001|Washout Period|Lack of Efficacy|1|||
131007161|NCT02696785|471654360|FG002|Washout Period|Lack of Efficacy|0|||
131007162|NCT02696785|471654361|FG003|Washout Period|Lack of Efficacy|0|||
131007163|NCT02696785|471654358|FG000|Extended Treatment Period|Adverse Event|2|||
131007164|NCT02696785|471654359|FG001|Extended Treatment Period|Adverse Event|3|||
131007165|NCT02696785|471654360|FG002|Extended Treatment Period|Adverse Event|2|||
131007166|NCT02696785|471654361|FG003|Extended Treatment Period|Adverse Event|1|||
131007167|NCT02696785|471654358|FG000|Extended Treatment Period|Lack of Efficacy|0|||
131007168|NCT02696785|471654359|FG001|Extended Treatment Period|Lack of Efficacy|1|||
131007169|NCT02696785|471654360|FG002|Extended Treatment Period|Lack of Efficacy|0|||
131007170|NCT02696785|471654361|FG003|Extended Treatment Period|Lack of Efficacy|0|||
131007171|NCT02696785|471654358|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
131007172|NCT02696785|471654359|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
131007173|NCT02696785|471654360|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
131007174|NCT02696785|471654361|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
131007175|NCT02696785|471654358|FG000|Follow-up Period|Adverse Event|0|||
131007176|NCT02696785|471654359|FG001|Follow-up Period|Adverse Event|0|||
131007177|NCT02696785|471654360|FG002|Follow-up Period|Adverse Event|8|||
131007178|NCT02696785|471654361|FG003|Follow-up Period|Adverse Event|2|||
131007179|NCT02696785|471654358|FG000|Follow-up Period|Lost to Follow-up|0|||
131007180|NCT02696785|471654359|FG001|Follow-up Period|Lost to Follow-up|0|||
131007181|NCT02696785|471654360|FG002|Follow-up Period|Lost to Follow-up|0|||
131007182|NCT02696785|471654361|FG003|Follow-up Period|Lost to Follow-up|1|||
131007183|NCT02696785|471654358|FG000|Follow-up Period|Lack of Efficacy|0|||
131007184|NCT02696785|471654359|FG001|Follow-up Period|Lack of Efficacy|0|||
131007185|NCT02696785|471654360|FG002|Follow-up Period|Lack of Efficacy|0|||
131007186|NCT02696785|471654361|FG003|Follow-up Period|Lack of Efficacy|1|||
131007187|NCT02696785|471654358|FG000|Follow-up Period|Withdrawal by Subject|1|||
131007188|NCT02696785|471654359|FG001|Follow-up Period|Withdrawal by Subject|0|||
131007189|NCT02696785|471654360|FG002|Follow-up Period|Withdrawal by Subject|5|||
131007190|NCT02696785|471654361|FG003|Follow-up Period|Withdrawal by Subject|4|||
131007191|NCT04863898|471654362|FG000|Overall Study|Away from study clinic during intervention training period|2|||
131007192|NCT04863898|471654362|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
131007193|NCT04863898|471654362|FG000|Overall Study|Lost to Follow-up|3|||
131007194|NCT04863898|471654362|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
131007195|NCT04863898|471654362|FG000|Overall Study|No longer employed at clinic|3|||
131007196|NCT02320253|471654363|FG000|Overall Study|Withdrawal by Subject|3|||
131007197|NCT02320253|471654364|FG001|Overall Study|Withdrawal by Subject|0|||
131007198|NCT02320253|471654365|FG002|Overall Study|Withdrawal by Subject|0|||
131007199|NCT02320253|471654363|FG000|Overall Study|Lost to Follow-up|2|||
131007200|NCT02320253|471654364|FG001|Overall Study|Lost to Follow-up|2|||
131007201|NCT02320253|471654365|FG002|Overall Study|Lost to Follow-up|1|||
131007202|NCT02320253|471654363|FG000|Overall Study|Death|1|||
131007203|NCT02320253|471654364|FG001|Overall Study|Death|0|||
131007204|NCT02320253|471654365|FG002|Overall Study|Death|1|||
131007205|NCT00603538|471654366|FG000|Overall Study|Adverse Event|0|||
131007206|NCT00603538|471654367|FG001|Overall Study|Adverse Event|4|||
131007207|NCT00603538|471654368|FG002|Overall Study|Adverse Event|2|||
130720922|NCT00724048|470601564|FG003|Overall Study|Lost to Follow-up|0|||
131007208|NCT00603538|471654366|FG000|Overall Study|Objective progression or relapse|3|||
131007209|NCT00603538|471654367|FG001|Overall Study|Objective progression or relapse|0|||
131007210|NCT00603538|471654368|FG002|Overall Study|Objective progression or relapse|0|||
131007211|NCT01764386|471655779|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
131007212|NCT01764386|471655780|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
131007213|NCT01764386|471655779|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
131007214|NCT01764386|471655780|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
131007215|NCT01764386|471655779|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
131007216|NCT01764386|471655780|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
131007217|NCT01764386|471655779|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
131007218|NCT01764386|471655780|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
131007219|NCT01764386|471655779|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
131007220|NCT01764386|471655780|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
131007221|NCT01764386|471655779|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
131007222|NCT01764386|471655780|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
131007223|NCT01764386|471655779|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
131007224|NCT01764386|471655780|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
131007225|NCT01764386|471655779|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
131007226|NCT01764386|471655780|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
131007227|NCT00498186|471655781|FG000|Overall Study|Protocol Violation|10|||
131007228|NCT00498186|471655781|FG000|Overall Study|Lack of Efficacy|31|||
131007229|NCT00498186|471655781|FG000|Overall Study|Adverse Event|89|||
131007230|NCT00498186|471655781|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
131007231|NCT00498186|471655781|FG000|Overall Study|Withdrawal by Subject|18|||
131007232|NCT00498186|471655781|FG000|Overall Study|Lost to Follow-up|3|||
131007233|NCT00498186|471655781|FG000|Overall Study|Other|10|||
131007234|NCT03929302|471655782|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
131007235|NCT03929302|471655783|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
131007236|NCT03929302|471655784|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
131007237|NCT03929302|471655782|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
131007238|NCT03929302|471655783|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
131007239|NCT03929302|471655784|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
131007240|NCT03929302|471655782|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
131007241|NCT03929302|471655783|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
131007242|NCT03929302|471655784|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
131007243|NCT00886613|471655786|FG000|Overall Study|Protocol deviation (Part B)|1|||
131007244|NCT00886613|471655787|FG001|Overall Study|Protocol deviation (Part B)|0|||
131007245|NCT00886613|471655788|FG002|Overall Study|Protocol deviation (Part B)|0|||
131007246|NCT00886613|471655786|FG000|Overall Study|Lost to follow-up (Part B)|1|||
131007247|NCT00886613|471655787|FG001|Overall Study|Lost to follow-up (Part B)|0|||
131007248|NCT00886613|471655788|FG002|Overall Study|Lost to follow-up (Part B)|1|||
131007249|NCT00886613|471655786|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
131007250|NCT00886613|471655787|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
131007251|NCT00886613|471655788|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
131007252|NCT04541186|471655791|FG000|Main Study|Adverse Event|0|||
131007253|NCT04541186|471655792|FG001|Main Study|Adverse Event|0|||
131007254|NCT04541186|471655793|FG002|Main Study|Adverse Event|4|||
131007255|NCT04541186|471655794|FG003|Main Study|Adverse Event|0|||
131007256|NCT04541186|471655795|FG004|Main Study|Adverse Event|0|||
131007257|NCT04541186|471655791|FG000|Main Study|Investigator Decision|0|||
131007258|NCT04541186|471655792|FG001|Main Study|Investigator Decision|0|||
131007259|NCT04541186|471655793|FG002|Main Study|Investigator Decision|1|||
131007260|NCT04541186|471655794|FG003|Main Study|Investigator Decision|1|||
131007261|NCT04541186|471655795|FG004|Main Study|Investigator Decision|0|||
131007262|NCT04541186|471655791|FG000|Main Study|Withdrawal by Subject|1|||
131007263|NCT04541186|471655792|FG001|Main Study|Withdrawal by Subject|1|||
131007264|NCT04541186|471655793|FG002|Main Study|Withdrawal by Subject|0|||
131007265|NCT04541186|471655794|FG003|Main Study|Withdrawal by Subject|0|||
131007266|NCT04541186|471655795|FG004|Main Study|Withdrawal by Subject|0|||
131007267|NCT04541186|471655791|FG000|Main Study|COVID-19-related Dose Interruption|0|||
131007268|NCT04541186|471655792|FG001|Main Study|COVID-19-related Dose Interruption|0|||
131007269|NCT04541186|471655793|FG002|Main Study|COVID-19-related Dose Interruption|0|||
131007270|NCT04541186|471655794|FG003|Main Study|COVID-19-related Dose Interruption|0|||
131007271|NCT04541186|471655795|FG004|Main Study|COVID-19-related Dose Interruption|1|||
131007272|NCT04541186|471655791|FG000|Main Study|Randomized in Error Not Treated|0|||
131007273|NCT04541186|471655792|FG001|Main Study|Randomized in Error Not Treated|0|||
131007274|NCT04541186|471655793|FG002|Main Study|Randomized in Error Not Treated|1|||
131007275|NCT04541186|471655794|FG003|Main Study|Randomized in Error Not Treated|0|||
131007276|NCT04541186|471655795|FG004|Main Study|Randomized in Error Not Treated|0|||
131007277|NCT04541186|471655791|FG000|Fibrate Expansion Study|Other than Specified|0|||
131007278|NCT04541186|471655792|FG001|Fibrate Expansion Study|Other than Specified|0|||
131007279|NCT04541186|471655793|FG002|Fibrate Expansion Study|Other than Specified|0|||
131007280|NCT04541186|471655794|FG003|Fibrate Expansion Study|Other than Specified|0|||
131007281|NCT04541186|471655795|FG004|Fibrate Expansion Study|Other than Specified|1|||
131007282|NCT00691028|471655796|FG000|Open-label Period|Adverse Event|0|||
131007283|NCT00691028|471655797|FG001|Open-label Period|Adverse Event|0|||
131007284|NCT00691028|471655798|FG002|Open-label Period|Adverse Event|0|||
131007285|NCT00691028|471655799|FG003|Open-label Period|Adverse Event|16|||
131007286|NCT00691028|471655796|FG000|Open-label Period|Withdrawal by Subject|0|||
131007287|NCT00691028|471655797|FG001|Open-label Period|Withdrawal by Subject|0|||
131007288|NCT00691028|471655798|FG002|Open-label Period|Withdrawal by Subject|0|||
131007289|NCT00691028|471655799|FG003|Open-label Period|Withdrawal by Subject|3|||
131007290|NCT00691028|471655796|FG000|Open-label Period|not come to a hospital|0|||
131007291|NCT00691028|471655797|FG001|Open-label Period|not come to a hospital|0|||
131007292|NCT00691028|471655798|FG002|Open-label Period|not come to a hospital|0|||
131007293|NCT00691028|471655799|FG003|Open-label Period|not come to a hospital|1|||
131007294|NCT00691028|471655796|FG000|Double-blind Period|Adverse Event|8|||
131007295|NCT00691028|471655797|FG001|Double-blind Period|Adverse Event|9|||
131007296|NCT00691028|471655798|FG002|Double-blind Period|Adverse Event|6|||
131007297|NCT00691028|471655799|FG003|Double-blind Period|Adverse Event|0|||
131007298|NCT00691028|471655796|FG000|Double-blind Period|Lack of Efficacy|4|||
131007299|NCT00691028|471655797|FG001|Double-blind Period|Lack of Efficacy|3|||
131007300|NCT00691028|471655798|FG002|Double-blind Period|Lack of Efficacy|2|||
131007301|NCT00691028|471655799|FG003|Double-blind Period|Lack of Efficacy|0|||
131007302|NCT00691028|471655796|FG000|Double-blind Period|Withdrawal by Subject|1|||
131007303|NCT00691028|471655797|FG001|Double-blind Period|Withdrawal by Subject|0|||
131007304|NCT00691028|471655798|FG002|Double-blind Period|Withdrawal by Subject|1|||
131007305|NCT00691028|471655799|FG003|Double-blind Period|Withdrawal by Subject|0|||
131007306|NCT00691028|471655796|FG000|Double-blind Period|not come to a hospital.|0|||
131007307|NCT00691028|471655797|FG001|Double-blind Period|not come to a hospital.|1|||
131007308|NCT00691028|471655798|FG002|Double-blind Period|not come to a hospital.|0|||
131007309|NCT00691028|471655799|FG003|Double-blind Period|not come to a hospital.|0|||
131007310|NCT03085017|471655807|FG000|Overall Study|Death|0|||
131007311|NCT03085017|471655808|FG001|Overall Study|Death|3|||
131007312|NCT00058058|471655809|FG000|Overall Study|Withdrawal by Subject|4|||
131007313|NCT00058058|471655809|FG000|Overall Study|Ineligible|20|||
131007314|NCT00058058|471655809|FG000|Overall Study|Claustrophobic|5|||
131007315|NCT00058058|471655809|FG000|Overall Study|technical issues|6|||
131007316|NCT00058058|471655809|FG000|Overall Study|Poor positioning, illness,pain|3|||
131007317|NCT03255018|471655817|FG000|Overall Study|Death on study|0|||
131007318|NCT03255018|471655818|FG001|Overall Study|Death on study|5|||
131007319|NCT03255018|471655817|FG000|Overall Study|Withdrawal by Subject|0|||
131007320|NCT03255018|471655818|FG001|Overall Study|Withdrawal by Subject|2|||
131007321|NCT01360840|471655825|FG000|Overall Study|Ongoing at data cut-off|10|||
131007322|NCT01360840|471655826|FG001|Overall Study|Ongoing at data cut-off|10|||
131007323|NCT01360840|471655827|FG002|Overall Study|Ongoing at data cut-off|9|||
131007324|NCT05124899|471655829|FG000|Overall Study|Lost to Follow-up|3|||
131007325|NCT01813422|471655840|FG000|Overall Study|Withdrawal by Subject|14|||
131007326|NCT01813422|471655841|FG001|Overall Study|Withdrawal by Subject|8|||
131007327|NCT01813422|471655840|FG000|Overall Study|Death|2|||
131007328|NCT01813422|471655841|FG001|Overall Study|Death|3|||
131007329|NCT01813422|471655840|FG000|Overall Study|Sponsor Decision|2|||
131007330|NCT01813422|471655841|FG001|Overall Study|Sponsor Decision|1|||
131007331|NCT01813422|471655840|FG000|Overall Study|Lost to Follow-up|2|||
131007332|NCT01813422|471655841|FG001|Overall Study|Lost to Follow-up|4|||
131007333|NCT01653743|471655842|FG000|Overall Study|Withdrawal by Subject|1|||
131007334|NCT01653743|471655843|FG001|Overall Study|Withdrawal by Subject|0|||
131007335|NCT01653743|471655842|FG000|Overall Study|Investigator discretion|3|||
131007336|NCT01653743|471655843|FG001|Overall Study|Investigator discretion|0|||
131007337|NCT00797225|471655850|FG000|Weeks 1 to 12|Adverse Event|0|||
131007338|NCT00797225|471655851|FG001|Weeks 1 to 12|Adverse Event|0|||
131007339|NCT00797225|471655852|FG002|Weeks 1 to 12|Adverse Event|1|||
131007340|NCT00797225|471655853|FG003|Weeks 1 to 12|Adverse Event|0|||
131007341|NCT00797225|471655854|FG004|Weeks 1 to 12|Adverse Event|0|||
131007342|NCT00797225|471655855|FG005|Weeks 1 to 12|Adverse Event|0|||
131007343|NCT00797225|471655856|FG006|Weeks 1 to 12|Adverse Event|0|||
131007344|NCT00797225|471655857|FG007|Weeks 1 to 12|Adverse Event|0|||
131007345|NCT00797225|471655850|FG000|Weeks 1 to 12|Non-compliance|0|||
131007346|NCT00797225|471655851|FG001|Weeks 1 to 12|Non-compliance|1|||
131007347|NCT00797225|471655852|FG002|Weeks 1 to 12|Non-compliance|0|||
131007348|NCT00797225|471655853|FG003|Weeks 1 to 12|Non-compliance|0|||
131007349|NCT00797225|471655854|FG004|Weeks 1 to 12|Non-compliance|0|||
131007350|NCT00797225|471655855|FG005|Weeks 1 to 12|Non-compliance|0|||
131007351|NCT00797225|471655856|FG006|Weeks 1 to 12|Non-compliance|0|||
131007352|NCT00797225|471655857|FG007|Weeks 1 to 12|Non-compliance|0|||
131007353|NCT00797225|471655850|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
131007354|NCT00797225|471655851|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
131007355|NCT00797225|471655852|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
131007356|NCT00797225|471655853|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
131007357|NCT00797225|471655854|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
131007358|NCT00797225|471655855|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
131007359|NCT00797225|471655856|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
131007360|NCT00797225|471655857|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
131007361|NCT00797225|471655850|FG000|Weeks 1 to 12|Sponsor Decision|1|||
131007362|NCT00797225|471655851|FG001|Weeks 1 to 12|Sponsor Decision|0|||
131007363|NCT00797225|471655852|FG002|Weeks 1 to 12|Sponsor Decision|0|||
131007364|NCT00797225|471655853|FG003|Weeks 1 to 12|Sponsor Decision|0|||
131007365|NCT00797225|471655854|FG004|Weeks 1 to 12|Sponsor Decision|0|||
131007366|NCT00797225|471655855|FG005|Weeks 1 to 12|Sponsor Decision|0|||
131007367|NCT00797225|471655856|FG006|Weeks 1 to 12|Sponsor Decision|0|||
131007368|NCT00797225|471655857|FG007|Weeks 1 to 12|Sponsor Decision|0|||
131007369|NCT00797225|471655850|FG000|Weeks 13 to 24|Non-compliance|0|||
131007370|NCT00797225|471655851|FG001|Weeks 13 to 24|Non-compliance|2|||
131007371|NCT00797225|471655852|FG002|Weeks 13 to 24|Non-compliance|0|||
131007372|NCT00797225|471655853|FG003|Weeks 13 to 24|Non-compliance|0|||
131007373|NCT00797225|471655854|FG004|Weeks 13 to 24|Non-compliance|0|||
131007374|NCT00797225|471655855|FG005|Weeks 13 to 24|Non-compliance|0|||
131007375|NCT00797225|471655856|FG006|Weeks 13 to 24|Non-compliance|0|||
131007376|NCT00797225|471655857|FG007|Weeks 13 to 24|Non-compliance|0|||
131007377|NCT00797225|471655850|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
131007378|NCT00797225|471655851|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
131007379|NCT00797225|471655852|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
131007380|NCT00797225|471655853|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
131007381|NCT00797225|471655854|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
131007382|NCT00797225|471655855|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
131007383|NCT00797225|471655856|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
131007384|NCT00797225|471655857|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
131007385|NCT00797225|471655850|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
131007386|NCT00797225|471655851|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
131007387|NCT00797225|471655852|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
131007388|NCT00797225|471655853|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
131007389|NCT00797225|471655854|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
131007390|NCT00797225|471655855|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
131007391|NCT00797225|471655856|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
131007392|NCT00797225|471655857|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
131007393|NCT00797225|471655850|FG000|Weeks 13 to 24|Adverse Event|0|||
131007394|NCT00797225|471655851|FG001|Weeks 13 to 24|Adverse Event|1|||
131007395|NCT00797225|471655852|FG002|Weeks 13 to 24|Adverse Event|0|||
131007396|NCT00797225|471655853|FG003|Weeks 13 to 24|Adverse Event|0|||
131007397|NCT00797225|471655854|FG004|Weeks 13 to 24|Adverse Event|0|||
131007398|NCT00797225|471655855|FG005|Weeks 13 to 24|Adverse Event|0|||
131007399|NCT00797225|471655856|FG006|Weeks 13 to 24|Adverse Event|1|||
131007400|NCT00797225|471655857|FG007|Weeks 13 to 24|Adverse Event|0|||
131007401|NCT00797225|471655850|FG000|Weeks 13 to 24|Sponsor Decision|0|||
131007402|NCT00797225|471655851|FG001|Weeks 13 to 24|Sponsor Decision|0|||
131007403|NCT00797225|471655852|FG002|Weeks 13 to 24|Sponsor Decision|0|||
131007404|NCT00797225|471655853|FG003|Weeks 13 to 24|Sponsor Decision|0|||
131007405|NCT00797225|471655854|FG004|Weeks 13 to 24|Sponsor Decision|0|||
131007406|NCT00797225|471655855|FG005|Weeks 13 to 24|Sponsor Decision|0|||
131007407|NCT00797225|471655856|FG006|Weeks 13 to 24|Sponsor Decision|1|||
131007408|NCT00797225|471655857|FG007|Weeks 13 to 24|Sponsor Decision|0|||
131007409|NCT01352507|471655860|FG000|Treatment Period 1|Adverse Event|3|||
131007410|NCT01352507|471655861|FG001|Treatment Period 1|Adverse Event|0|||
131007411|NCT01352507|471655860|FG000|Treatment Period 1|Lost to Follow-up|3|||
131007412|NCT01352507|471655861|FG001|Treatment Period 1|Lost to Follow-up|4|||
131007413|NCT01352507|471655860|FG000|Treatment Period 1|Withdrawal by Subject|7|||
131007414|NCT01352507|471655861|FG001|Treatment Period 1|Withdrawal by Subject|5|||
131007415|NCT01352507|471655860|FG000|Treatment Period 1|Physician Decision|1|||
131007416|NCT01352507|471655861|FG001|Treatment Period 1|Physician Decision|0|||
131007417|NCT01352507|471655860|FG000|Washout Period|Withdrawal by Subject|0|||
131007418|NCT01352507|471655861|FG001|Washout Period|Withdrawal by Subject|1|||
131007419|NCT01352507|471655860|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
131007420|NCT01352507|471655861|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
131007421|NCT01352507|471655860|FG000|Treatment Period 2|Withdrawal by Subject|4|||
131007422|NCT01352507|471655861|FG001|Treatment Period 2|Withdrawal by Subject|3|||
131007423|NCT01352507|471655860|FG000|Treatment Period 2|Lack of Efficacy|1|||
131007424|NCT01352507|471655861|FG001|Treatment Period 2|Lack of Efficacy|0|||
131007425|NCT01119703|471655862|FG000|Overall Study|Adverse Event|0|||
131007426|NCT01119703|471655863|FG001|Overall Study|Adverse Event|1|||
131007427|NCT03178201|471655864|FG000|Overall Study|Off study|5|||
131007428|NCT01763047|471655865|FG000|Period 1|Test Article Not Available|4|||
131007429|NCT01763047|471655866|FG001|Period 1|Test Article Not Available|1|||
131007430|NCT01763047|471655865|FG000|Period 1|Protocol Violation|4|||
131007431|NCT01763047|471655866|FG001|Period 1|Protocol Violation|4|||
131007432|NCT01763047|471655865|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
131007433|NCT01763047|471655866|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
131007434|NCT01763047|471655865|FG000|Period 1|Adverse Event|0|||
131007435|NCT01763047|471655866|FG001|Period 1|Adverse Event|1|||
131007436|NCT01763047|471655865|FG000|Period 1|Unsatisfactory Visual Response|0|||
131007437|NCT01763047|471655866|FG001|Period 1|Unsatisfactory Visual Response|3|||
131007438|NCT01763047|471655865|FG000|Period 1|Lens Power Not Available|0|||
131007439|NCT01763047|471655866|FG001|Period 1|Lens Power Not Available|1|||
131007440|NCT01763047|471655865|FG000|Period 1|Study Site office Closed|0|||
131007441|NCT01763047|471655866|FG001|Period 1|Study Site office Closed|1|||
131007442|NCT01763047|471655865|FG000|Period 2|Lens Discomfort|1|||
131007443|NCT01763047|471655866|FG001|Period 2|Lens Discomfort|0|||
131007444|NCT01763047|471655865|FG000|Period 2|No longer meets Eligibility Criteria|1|||
131007445|NCT01763047|471655866|FG001|Period 2|No longer meets Eligibility Criteria|0|||
131007446|NCT01763047|471655865|FG000|Period 2|Study Site office Closed|1|||
131007447|NCT01763047|471655866|FG001|Period 2|Study Site office Closed|1|||
131007448|NCT01763047|471655865|FG000|Period 2|Unsatisfactory Visual Response|1|||
131007449|NCT01763047|471655866|FG001|Period 2|Unsatisfactory Visual Response|1|||
131007450|NCT01763047|471655865|FG000|Period 2|Protocol Violation|0|||
131007451|NCT01763047|471655866|FG001|Period 2|Protocol Violation|2|||
131007452|NCT01763047|471655865|FG000|Period 2|Unsatisfactory lens Fitting|0|||
131007453|NCT01763047|471655866|FG001|Period 2|Unsatisfactory lens Fitting|1|||
131007454|NCT02095158|471655872|FG000|Overall Study|Adverse Event|14|||
131007455|NCT02095158|471655872|FG000|Overall Study|Lack of Efficacy|3|||
131007456|NCT02095158|471655872|FG000|Overall Study|Pregnancy|1|||
131007457|NCT02095158|471655872|FG000|Overall Study|Lost to Follow-up|20|||
131007458|NCT02095158|471655872|FG000|Overall Study|Personal Reasons|35|||
131007459|NCT02095158|471655872|FG000|Overall Study|Protocol Violation|1|||
131007460|NCT02095158|471655872|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131007461|NCT02282527|471655873|FG000|Overall Study|Lost to Follow-up|0|||
131007462|NCT02282527|471655874|FG001|Overall Study|Lost to Follow-up|1|||
131007463|NCT02282527|471655873|FG000|Overall Study|Lack of home health aid|1|||
131007464|NCT02282527|471655874|FG001|Overall Study|Lack of home health aid|0|||
131007465|NCT00941031|471655875|FG000|Induction Period|Lack of Efficacy|2|||
131007466|NCT00941031|471655876|FG001|Induction Period|Lack of Efficacy|1|||
131007467|NCT00941031|471655877|FG002|Induction Period|Lack of Efficacy|0|||
131007468|NCT00941031|471655878|FG003|Induction Period|Lack of Efficacy|5|||
131007469|NCT00941031|471655879|FG004|Induction Period|Lack of Efficacy|0|||
131007470|NCT00941031|471655880|FG005|Induction Period|Lack of Efficacy|0|||
131007471|NCT00941031|471655881|FG006|Induction Period|Lack of Efficacy|0|||
131007472|NCT00941031|471655875|FG000|Induction Period|Withdrawal by Subject|1|||
131007473|NCT00941031|471655876|FG001|Induction Period|Withdrawal by Subject|2|||
131007474|NCT00941031|471655877|FG002|Induction Period|Withdrawal by Subject|2|||
131007475|NCT00941031|471655878|FG003|Induction Period|Withdrawal by Subject|2|||
131007476|NCT00941031|471655879|FG004|Induction Period|Withdrawal by Subject|0|||
131007477|NCT00941031|471655880|FG005|Induction Period|Withdrawal by Subject|0|||
131007478|NCT00941031|471655881|FG006|Induction Period|Withdrawal by Subject|0|||
131007479|NCT00941031|471655875|FG000|Induction Period|Adminstative Problems|1|||
131007480|NCT00941031|471655876|FG001|Induction Period|Adminstative Problems|1|||
131007481|NCT00941031|471655877|FG002|Induction Period|Adminstative Problems|1|||
131007482|NCT00941031|471655878|FG003|Induction Period|Adminstative Problems|0|||
131007483|NCT00941031|471655879|FG004|Induction Period|Adminstative Problems|0|||
131007484|NCT00941031|471655880|FG005|Induction Period|Adminstative Problems|0|||
131007485|NCT00941031|471655881|FG006|Induction Period|Adminstative Problems|0|||
131007486|NCT00941031|471655875|FG000|Induction Period|Adverse Event|1|||
131007487|NCT00941031|471655876|FG001|Induction Period|Adverse Event|0|||
131007488|NCT00941031|471655877|FG002|Induction Period|Adverse Event|3|||
131007489|NCT00941031|471655878|FG003|Induction Period|Adverse Event|2|||
131007490|NCT00941031|471655879|FG004|Induction Period|Adverse Event|0|||
131007491|NCT00941031|471655880|FG005|Induction Period|Adverse Event|0|||
131007492|NCT00941031|471655881|FG006|Induction Period|Adverse Event|0|||
131007493|NCT00941031|471655875|FG000|Maintenance Period|Withdrawal by Subject|0|||
131007494|NCT00941031|471655876|FG001|Maintenance Period|Withdrawal by Subject|0|||
131007495|NCT00941031|471655877|FG002|Maintenance Period|Withdrawal by Subject|0|||
131007496|NCT00941031|471655878|FG003|Maintenance Period|Withdrawal by Subject|0|||
131007497|NCT00941031|471655879|FG004|Maintenance Period|Withdrawal by Subject|6|||
131007498|NCT00941031|471655880|FG005|Maintenance Period|Withdrawal by Subject|2|||
131007499|NCT00941031|471655881|FG006|Maintenance Period|Withdrawal by Subject|13|||
131007500|NCT00941031|471655875|FG000|Maintenance Period|Administrative Problems|0|||
131007501|NCT00941031|471655876|FG001|Maintenance Period|Administrative Problems|0|||
131007502|NCT00941031|471655877|FG002|Maintenance Period|Administrative Problems|0|||
131007503|NCT00941031|471655878|FG003|Maintenance Period|Administrative Problems|0|||
131007504|NCT00941031|471655879|FG004|Maintenance Period|Administrative Problems|1|||
131007505|NCT00941031|471655880|FG005|Maintenance Period|Administrative Problems|0|||
131007506|NCT00941031|471655881|FG006|Maintenance Period|Administrative Problems|1|||
131007507|NCT00941031|471655875|FG000|Maintenance Period|Protocol Violation|0|||
131007508|NCT00941031|471655876|FG001|Maintenance Period|Protocol Violation|0|||
131007509|NCT00941031|471655877|FG002|Maintenance Period|Protocol Violation|0|||
131007510|NCT00941031|471655878|FG003|Maintenance Period|Protocol Violation|0|||
131007511|NCT00941031|471655879|FG004|Maintenance Period|Protocol Violation|0|||
131007512|NCT00941031|471655880|FG005|Maintenance Period|Protocol Violation|0|||
131007513|NCT00941031|471655881|FG006|Maintenance Period|Protocol Violation|1|||
131007514|NCT00941031|471655875|FG000|Maintenance Period|Adverse Event|0|||
131007515|NCT00941031|471655876|FG001|Maintenance Period|Adverse Event|0|||
131007516|NCT00941031|471655877|FG002|Maintenance Period|Adverse Event|0|||
131007517|NCT00941031|471655878|FG003|Maintenance Period|Adverse Event|0|||
131007518|NCT00941031|471655879|FG004|Maintenance Period|Adverse Event|0|||
131007519|NCT00941031|471655880|FG005|Maintenance Period|Adverse Event|2|||
131007520|NCT00941031|471655881|FG006|Maintenance Period|Adverse Event|8|||
131007521|NCT00941031|471655875|FG000|Maintenance Period|Lost to Follow-up|0|||
131007522|NCT00941031|471655876|FG001|Maintenance Period|Lost to Follow-up|0|||
131007523|NCT00941031|471655877|FG002|Maintenance Period|Lost to Follow-up|0|||
131007524|NCT00941031|471655878|FG003|Maintenance Period|Lost to Follow-up|0|||
131007525|NCT00941031|471655879|FG004|Maintenance Period|Lost to Follow-up|2|||
131007526|NCT00941031|471655880|FG005|Maintenance Period|Lost to Follow-up|2|||
131007527|NCT00941031|471655881|FG006|Maintenance Period|Lost to Follow-up|7|||
131007528|NCT00941031|471655875|FG000|Maintenance Period|Lack of Efficacy|0|||
131007529|NCT00941031|471655876|FG001|Maintenance Period|Lack of Efficacy|0|||
131007530|NCT00941031|471655877|FG002|Maintenance Period|Lack of Efficacy|0|||
131007531|NCT00941031|471655878|FG003|Maintenance Period|Lack of Efficacy|0|||
131007532|NCT00941031|471655879|FG004|Maintenance Period|Lack of Efficacy|0|||
131007533|NCT00941031|471655880|FG005|Maintenance Period|Lack of Efficacy|0|||
131007534|NCT00941031|471655881|FG006|Maintenance Period|Lack of Efficacy|13|||
131007535|NCT01872611|471655882|FG000|Overall Study|Adverse Event|3|||
131007536|NCT01872611|471655883|FG001|Overall Study|Adverse Event|1|||
131007537|NCT01872611|471655882|FG000|Overall Study|Adverse Event, prior to treatment|0|||
131007538|NCT01872611|471655883|FG001|Overall Study|Adverse Event, prior to treatment|1|||
131007539|NCT01872611|471655882|FG000|Overall Study|Death|0|||
131007540|NCT01872611|471655883|FG001|Overall Study|Death|1|||
131007541|NCT01872611|471655882|FG000|Overall Study|Death, prior to treatment|0|||
131007542|NCT01872611|471655883|FG001|Overall Study|Death, prior to treatment|1|||
131007543|NCT01872611|471655882|FG000|Overall Study|Lost to Follow-up|8|||
131007544|NCT01872611|471655883|FG001|Overall Study|Lost to Follow-up|1|||
131007545|NCT01872611|471655882|FG000|Overall Study|Physician Decision|1|||
131007546|NCT01872611|471655883|FG001|Overall Study|Physician Decision|0|||
131007547|NCT01872611|471655882|FG000|Overall Study|Withdrawal by Subject|6|||
131007548|NCT01872611|471655883|FG001|Overall Study|Withdrawal by Subject|1|||
131007549|NCT01872611|471655882|FG000|Overall Study|Reason not provided|6|||
131007550|NCT01872611|471655883|FG001|Overall Study|Reason not provided|6|||
131007551|NCT03124108|471655884|FG000|Overall Study|Adverse Event|0|||
131007552|NCT03124108|471655885|FG001|Overall Study|Adverse Event|1|||
131007553|NCT03124108|471655886|FG002|Overall Study|Adverse Event|0|||
131007554|NCT00631917|471655887|FG000|Overall Study|Adverse Event|34|||
131007555|NCT00631917|471655888|FG001|Overall Study|Adverse Event|45|||
131007556|NCT00631917|471655887|FG000|Overall Study|Abnormal laboratory value(s)|2|||
131007557|NCT00631917|471655888|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131007558|NCT00631917|471655887|FG000|Overall Study|Abnormal test procedure result(s)|3|||
131007559|NCT00631917|471655888|FG001|Overall Study|Abnormal test procedure result(s)|2|||
131007560|NCT00631917|471655887|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
131007561|NCT00631917|471655888|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
131007562|NCT00631917|471655887|FG000|Overall Study|No longer required study drug|0|||
131007563|NCT00631917|471655888|FG001|Overall Study|No longer required study drug|1|||
131007564|NCT00631917|471655887|FG000|Overall Study|Protocol deviation|6|||
131007565|NCT00631917|471655888|FG001|Overall Study|Protocol deviation|5|||
131007566|NCT00631917|471655887|FG000|Overall Study|Subject withdrew consent|25|||
131007567|NCT00631917|471655888|FG001|Overall Study|Subject withdrew consent|33|||
131007568|NCT00631917|471655887|FG000|Overall Study|Lost to Follow-up|7|||
131007569|NCT00631917|471655888|FG001|Overall Study|Lost to Follow-up|7|||
131007570|NCT00631917|471655887|FG000|Overall Study|Administrative problems|2|||
131007571|NCT00631917|471655888|FG001|Overall Study|Administrative problems|0|||
131007572|NCT00631917|471655887|FG000|Overall Study|Death|1|||
131007573|NCT00631917|471655888|FG001|Overall Study|Death|0|||
131007574|NCT05650333|471655889|FG000|Treatment Period (7 Days)|Adverse Event|1|||
131007575|NCT02616263|471655890|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
131007576|NCT02616263|471655891|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
131007577|NCT02616263|471655890|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
131007578|NCT02616263|471655891|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
131007579|NCT02616263|471655890|FG000|6 Month to 1.5 Year|Death|1|||
131007580|NCT02616263|471655891|FG001|6 Month to 1.5 Year|Death|0|||
131007581|NCT02616263|471655890|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
131007582|NCT02616263|471655891|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
131007583|NCT02616263|471655890|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
131007584|NCT02616263|471655891|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
131007585|NCT02616263|471655890|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
131007586|NCT02616263|471655891|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
131007587|NCT02939183|471655894|FG000|Overall Study|Death|0|||
131007588|NCT02939183|471655895|FG001|Overall Study|Death|0|||
131007589|NCT02939183|471655896|FG002|Overall Study|Death|1|||
131007590|NCT02939183|471655897|FG003|Overall Study|Death|0|||
131007591|NCT02939183|471655898|FG004|Overall Study|Death|0|||
131007592|NCT02939183|471655899|FG005|Overall Study|Death|2|||
131007593|NCT02939183|471655900|FG006|Overall Study|Death|1|||
131007594|NCT02939183|471655901|FG007|Overall Study|Death|0|||
131007595|NCT02939183|471655902|FG008|Overall Study|Death|0|||
131007596|NCT02939183|471655894|FG000|Overall Study|Sponsor decision|0|||
131007597|NCT02939183|471655895|FG001|Overall Study|Sponsor decision|1|||
131007598|NCT02939183|471655896|FG002|Overall Study|Sponsor decision|0|||
131007599|NCT02939183|471655897|FG003|Overall Study|Sponsor decision|1|||
131007600|NCT02939183|471655898|FG004|Overall Study|Sponsor decision|2|||
131007601|NCT02939183|471655899|FG005|Overall Study|Sponsor decision|0|||
131007602|NCT02939183|471655900|FG006|Overall Study|Sponsor decision|3|||
131007603|NCT02939183|471655901|FG007|Overall Study|Sponsor decision|1|||
131007604|NCT02939183|471655902|FG008|Overall Study|Sponsor decision|4|||
131007605|NCT02939183|471655894|FG000|Overall Study|Withdrawal by Subject|0|||
131007606|NCT02939183|471655895|FG001|Overall Study|Withdrawal by Subject|2|||
131007607|NCT02939183|471655896|FG002|Overall Study|Withdrawal by Subject|0|||
131007608|NCT02939183|471655897|FG003|Overall Study|Withdrawal by Subject|1|||
131007609|NCT02939183|471655898|FG004|Overall Study|Withdrawal by Subject|0|||
131007610|NCT02939183|471655899|FG005|Overall Study|Withdrawal by Subject|0|||
131007611|NCT02939183|471655900|FG006|Overall Study|Withdrawal by Subject|2|||
131007612|NCT02939183|471655901|FG007|Overall Study|Withdrawal by Subject|2|||
131007613|NCT02939183|471655902|FG008|Overall Study|Withdrawal by Subject|2|||
131007614|NCT02939183|471655894|FG000|Overall Study|Not treated due to adverse event|0|||
131007615|NCT02939183|471655895|FG001|Overall Study|Not treated due to adverse event|0|||
131007616|NCT02939183|471655896|FG002|Overall Study|Not treated due to adverse event|0|||
131007617|NCT02939183|471655897|FG003|Overall Study|Not treated due to adverse event|1|||
131007618|NCT02939183|471655898|FG004|Overall Study|Not treated due to adverse event|0|||
131007619|NCT02939183|471655899|FG005|Overall Study|Not treated due to adverse event|0|||
131007620|NCT02939183|471655900|FG006|Overall Study|Not treated due to adverse event|1|||
131007621|NCT02939183|471655901|FG007|Overall Study|Not treated due to adverse event|0|||
131007622|NCT02939183|471655902|FG008|Overall Study|Not treated due to adverse event|0|||
131007623|NCT00783692|471655907|FG000|Induction Phase|Adverse Event|7|||
131007624|NCT00783692|471655908|FG001|Induction Phase|Adverse Event|9|||
131007625|NCT00783692|471655909|FG002|Induction Phase|Adverse Event|24|||
131007626|NCT00783692|471655910|FG003|Induction Phase|Adverse Event|0|||
131007627|NCT00783692|471655911|FG004|Induction Phase|Adverse Event|0|||
131007628|NCT00783692|471655912|FG005|Induction Phase|Adverse Event|0|||
131007629|NCT00783692|471655913|FG006|Induction Phase|Adverse Event|0|||
131007630|NCT00783692|471655907|FG000|Induction Phase|Protocol Violation|0|||
131007631|NCT00783692|471655908|FG001|Induction Phase|Protocol Violation|0|||
131007632|NCT00783692|471655909|FG002|Induction Phase|Protocol Violation|1|||
131007633|NCT00783692|471655910|FG003|Induction Phase|Protocol Violation|0|||
131007634|NCT00783692|471655911|FG004|Induction Phase|Protocol Violation|0|||
131007635|NCT00783692|471655912|FG005|Induction Phase|Protocol Violation|0|||
131007636|NCT00783692|471655913|FG006|Induction Phase|Protocol Violation|0|||
131007637|NCT00783692|471655907|FG000|Induction Phase|Lack of Efficacy|1|||
131007638|NCT00783692|471655908|FG001|Induction Phase|Lack of Efficacy|3|||
131007639|NCT00783692|471655909|FG002|Induction Phase|Lack of Efficacy|28|||
131007640|NCT00783692|471655910|FG003|Induction Phase|Lack of Efficacy|0|||
131007641|NCT00783692|471655911|FG004|Induction Phase|Lack of Efficacy|0|||
131007642|NCT00783692|471655912|FG005|Induction Phase|Lack of Efficacy|0|||
131007643|NCT00783692|471655913|FG006|Induction Phase|Lack of Efficacy|0|||
131007644|NCT00783692|471655907|FG000|Induction Phase|Withdrawal by Subject|3|||
131007645|NCT00783692|471655908|FG001|Induction Phase|Withdrawal by Subject|9|||
131007646|NCT00783692|471655909|FG002|Induction Phase|Withdrawal by Subject|16|||
131007647|NCT00783692|471655910|FG003|Induction Phase|Withdrawal by Subject|0|||
131007648|NCT00783692|471655911|FG004|Induction Phase|Withdrawal by Subject|0|||
131007649|NCT00783692|471655912|FG005|Induction Phase|Withdrawal by Subject|0|||
131007650|NCT00783692|471655913|FG006|Induction Phase|Withdrawal by Subject|0|||
131007651|NCT00783692|471655907|FG000|Induction Phase|Lost to Follow-up|0|||
131007652|NCT00783692|471655908|FG001|Induction Phase|Lost to Follow-up|0|||
131007653|NCT00783692|471655909|FG002|Induction Phase|Lost to Follow-up|3|||
131007654|NCT00783692|471655910|FG003|Induction Phase|Lost to Follow-up|0|||
131007655|NCT00783692|471655911|FG004|Induction Phase|Lost to Follow-up|0|||
131007656|NCT00783692|471655912|FG005|Induction Phase|Lost to Follow-up|0|||
131007657|NCT00783692|471655913|FG006|Induction Phase|Lost to Follow-up|0|||
131007658|NCT00783692|471655907|FG000|Induction Phase|Other|0|||
131007659|NCT00783692|471655908|FG001|Induction Phase|Other|0|||
131007660|NCT00783692|471655909|FG002|Induction Phase|Other|2|||
131007661|NCT00783692|471655910|FG003|Induction Phase|Other|0|||
131007662|NCT00783692|471655911|FG004|Induction Phase|Other|0|||
131007663|NCT00783692|471655912|FG005|Induction Phase|Other|0|||
131007664|NCT00783692|471655913|FG006|Induction Phase|Other|0|||
131007665|NCT00783692|471655907|FG000|Maintenance Phase|Adverse Event|7|||
131007666|NCT00783692|471655908|FG001|Maintenance Phase|Adverse Event|0|||
131007667|NCT00783692|471655909|FG002|Maintenance Phase|Adverse Event|0|||
131007668|NCT00783692|471655910|FG003|Maintenance Phase|Adverse Event|15|||
131007669|NCT00783692|471655911|FG004|Maintenance Phase|Adverse Event|12|||
131007670|NCT00783692|471655912|FG005|Maintenance Phase|Adverse Event|9|||
131007671|NCT00783692|471655913|FG006|Maintenance Phase|Adverse Event|38|||
131007672|NCT00783692|471655907|FG000|Maintenance Phase|Protocol Violation|0|||
131007673|NCT00783692|471655908|FG001|Maintenance Phase|Protocol Violation|0|||
131007674|NCT00783692|471655909|FG002|Maintenance Phase|Protocol Violation|0|||
131007675|NCT00783692|471655910|FG003|Maintenance Phase|Protocol Violation|1|||
131007676|NCT00783692|471655911|FG004|Maintenance Phase|Protocol Violation|2|||
131007677|NCT00783692|471655912|FG005|Maintenance Phase|Protocol Violation|3|||
131007678|NCT00783692|471655913|FG006|Maintenance Phase|Protocol Violation|4|||
131007679|NCT00783692|471655907|FG000|Maintenance Phase|Lack of Efficacy|79|||
131007680|NCT00783692|471655908|FG001|Maintenance Phase|Lack of Efficacy|0|||
131007681|NCT00783692|471655909|FG002|Maintenance Phase|Lack of Efficacy|0|||
131007682|NCT00783692|471655910|FG003|Maintenance Phase|Lack of Efficacy|64|||
131007683|NCT00783692|471655911|FG004|Maintenance Phase|Lack of Efficacy|58|||
131007684|NCT00783692|471655912|FG005|Maintenance Phase|Lack of Efficacy|48|||
131007685|NCT00783692|471655913|FG006|Maintenance Phase|Lack of Efficacy|177|||
131007686|NCT00783692|471655907|FG000|Maintenance Phase|Withdrawal by Subject|7|||
131007687|NCT00783692|471655908|FG001|Maintenance Phase|Withdrawal by Subject|0|||
131007688|NCT00783692|471655909|FG002|Maintenance Phase|Withdrawal by Subject|0|||
131007689|NCT00783692|471655910|FG003|Maintenance Phase|Withdrawal by Subject|7|||
131007690|NCT00783692|471655911|FG004|Maintenance Phase|Withdrawal by Subject|6|||
131007691|NCT00783692|471655912|FG005|Maintenance Phase|Withdrawal by Subject|9|||
131007692|NCT00783692|471655913|FG006|Maintenance Phase|Withdrawal by Subject|24|||
131007693|NCT00783692|471655907|FG000|Maintenance Phase|Lost to Follow-up|2|||
131007694|NCT00783692|471655908|FG001|Maintenance Phase|Lost to Follow-up|0|||
131007695|NCT00783692|471655909|FG002|Maintenance Phase|Lost to Follow-up|0|||
131007696|NCT00783692|471655910|FG003|Maintenance Phase|Lost to Follow-up|1|||
131007697|NCT00783692|471655911|FG004|Maintenance Phase|Lost to Follow-up|3|||
131007698|NCT00783692|471655912|FG005|Maintenance Phase|Lost to Follow-up|2|||
131007699|NCT00783692|471655913|FG006|Maintenance Phase|Lost to Follow-up|5|||
131007700|NCT00783692|471655907|FG000|Maintenance Phase|Other|0|||
131007701|NCT00783692|471655908|FG001|Maintenance Phase|Other|0|||
131007702|NCT00783692|471655909|FG002|Maintenance Phase|Other|0|||
131007703|NCT00783692|471655910|FG003|Maintenance Phase|Other|1|||
131007704|NCT00783692|471655911|FG004|Maintenance Phase|Other|0|||
131007705|NCT00783692|471655912|FG005|Maintenance Phase|Other|1|||
131007706|NCT00783692|471655913|FG006|Maintenance Phase|Other|1|||
131007707|NCT00768066|471655916|FG000|Overall Study|Did not receive study product injection.|3|||
131007708|NCT00768066|471655917|FG001|Overall Study|Did not receive study product injection.|3|||
131007709|NCT00768066|471655918|FG002|Overall Study|Did not receive study product injection.|0|||
131007710|NCT04831775|471655919|FG000|Overall Study|Lost to Follow-up|11|||
131007711|NCT04831775|471655920|FG001|Overall Study|Lost to Follow-up|13|||
131007712|NCT03015740|471655921|FG000|Overall Study|Adverse Event|1|||
131007713|NCT03015740|471655922|FG001|Overall Study|Adverse Event|0|||
131007714|NCT03015740|471655923|FG002|Overall Study|Adverse Event|0|||
131007715|NCT03015740|471655921|FG000|Overall Study|Death|3|||
131007716|NCT03015740|471655922|FG001|Overall Study|Death|5|||
131007717|NCT03015740|471655923|FG002|Overall Study|Death|0|||
131007718|NCT03015740|471655921|FG000|Overall Study|Withdrawal by Subject|2|||
131007719|NCT03015740|471655922|FG001|Overall Study|Withdrawal by Subject|0|||
131007720|NCT03015740|471655923|FG002|Overall Study|Withdrawal by Subject|0|||
131007721|NCT02449044|471655924|FG000|Overall Study|Lost to Follow-up|2|||
131007722|NCT02449044|471655924|FG000|Overall Study|Withdrawal by Subject|13|||
131007723|NCT02449044|471655924|FG000|Overall Study|Adverse Event|30|||
131007724|NCT02449044|471655924|FG000|Overall Study|Met Withdrawal Criteria|7|||
131007725|NCT02449044|471655924|FG000|Overall Study|Physician Decision|9|||
131007726|NCT02449044|471655924|FG000|Overall Study|Sponsor Discontinued Trial|3|||
131007727|NCT04672460|471657420|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
131007728|NCT04672460|471657421|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
131007729|NCT04672460|471657420|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
131007730|NCT04672460|471657421|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
131007731|NCT04672460|471657420|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
131007732|NCT04672460|471657421|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
131007733|NCT04672460|471657420|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
131007734|NCT04672460|471657421|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
131007735|NCT04672460|471657420|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
131007736|NCT04672460|471657421|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
131007737|NCT04672460|471657420|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
131007738|NCT04672460|471657421|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
131007739|NCT04672460|471657420|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
131007740|NCT04672460|471657421|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
131007741|NCT04672460|471657420|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
131007742|NCT04672460|471657421|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
131007743|NCT04672460|471657420|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
131007744|NCT04672460|471657421|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
131007745|NCT04672460|471657420|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
131007746|NCT04672460|471657421|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
131007747|NCT04672460|471657420|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
131007748|NCT04672460|471657421|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
131007749|NCT04672460|471657420|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
131007750|NCT04672460|471657421|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
131007751|NCT04672460|471657420|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
131007752|NCT04672460|471657421|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
131007753|NCT04672460|471657420|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
131007754|NCT04672460|471657421|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
131007755|NCT04672460|471657420|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
131007756|NCT04672460|471657421|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
131007757|NCT04672460|471657420|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
131007758|NCT04672460|471657421|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
131007759|NCT04672460|471657420|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
131007760|NCT04672460|471657421|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
131007761|NCT00049517|471657424|FG000|Induction|Disease progression|0|||
131007762|NCT00049517|471657425|FG001|Induction|Disease progression|0|||
131007763|NCT00049517|471657426|FG002|Induction|Disease progression|0|||
131007764|NCT00049517|471657427|FG003|Induction|Disease progression|0|||
131007765|NCT00049517|471657428|FG004|Induction|Disease progression|18|||
131007766|NCT00049517|471657429|FG005|Induction|Disease progression|11|||
131007767|NCT00049517|471657424|FG000|Induction|Adverse Event|0|||
131007768|NCT00049517|471657425|FG001|Induction|Adverse Event|0|||
131007769|NCT00049517|471657426|FG002|Induction|Adverse Event|0|||
131007770|NCT00049517|471657427|FG003|Induction|Adverse Event|0|||
131007771|NCT00049517|471657428|FG004|Induction|Adverse Event|5|||
131007772|NCT00049517|471657429|FG005|Induction|Adverse Event|7|||
131007773|NCT00049517|471657424|FG000|Induction|Death|0|||
131007774|NCT00049517|471657425|FG001|Induction|Death|0|||
131007775|NCT00049517|471657426|FG002|Induction|Death|0|||
131007776|NCT00049517|471657427|FG003|Induction|Death|0|||
131007777|NCT00049517|471657428|FG004|Induction|Death|9|||
131007778|NCT00049517|471657429|FG005|Induction|Death|6|||
131007779|NCT00049517|471657424|FG000|Induction|Withdrawal by Subject|0|||
131007780|NCT00049517|471657425|FG001|Induction|Withdrawal by Subject|0|||
131007781|NCT00049517|471657426|FG002|Induction|Withdrawal by Subject|0|||
131007782|NCT00049517|471657427|FG003|Induction|Withdrawal by Subject|0|||
131007783|NCT00049517|471657428|FG004|Induction|Withdrawal by Subject|1|||
131007784|NCT00049517|471657429|FG005|Induction|Withdrawal by Subject|3|||
131007785|NCT00049517|471657424|FG000|Induction|Alternative therapy|0|||
131007786|NCT00049517|471657425|FG001|Induction|Alternative therapy|0|||
131007787|NCT00049517|471657426|FG002|Induction|Alternative therapy|0|||
131007788|NCT00049517|471657427|FG003|Induction|Alternative therapy|0|||
131007789|NCT00049517|471657428|FG004|Induction|Alternative therapy|2|||
131007790|NCT00049517|471657429|FG005|Induction|Alternative therapy|2|||
131007791|NCT00049517|471657424|FG000|Induction|Other complicating disease|0|||
131007792|NCT00049517|471657425|FG001|Induction|Other complicating disease|0|||
131007793|NCT00049517|471657426|FG002|Induction|Other complicating disease|0|||
131007794|NCT00049517|471657427|FG003|Induction|Other complicating disease|0|||
131007795|NCT00049517|471657428|FG004|Induction|Other complicating disease|3|||
131007796|NCT00049517|471657429|FG005|Induction|Other complicating disease|0|||
131007797|NCT00049517|471657424|FG000|Induction|Reasons not reported|0|||
131007798|NCT00049517|471657425|FG001|Induction|Reasons not reported|0|||
131007799|NCT00049517|471657426|FG002|Induction|Reasons not reported|0|||
131007800|NCT00049517|471657427|FG003|Induction|Reasons not reported|0|||
131007801|NCT00049517|471657428|FG004|Induction|Reasons not reported|22|||
131007802|NCT00049517|471657429|FG005|Induction|Reasons not reported|25|||
131007803|NCT00049517|471657424|FG000|Conditioning/Transplant|Disease progression|14|||
131007804|NCT00049517|471657425|FG001|Conditioning/Transplant|Disease progression|6|||
131007805|NCT00049517|471657426|FG002|Conditioning/Transplant|Disease progression|10|||
131007806|NCT00049517|471657427|FG003|Conditioning/Transplant|Disease progression|6|||
131007807|NCT00049517|471657428|FG004|Conditioning/Transplant|Disease progression|0|||
131007808|NCT00049517|471657429|FG005|Conditioning/Transplant|Disease progression|0|||
131007809|NCT00049517|471657424|FG000|Conditioning/Transplant|Adverse Event|2|||
131007810|NCT00049517|471657425|FG001|Conditioning/Transplant|Adverse Event|1|||
131007811|NCT00049517|471657426|FG002|Conditioning/Transplant|Adverse Event|4|||
131007812|NCT00049517|471657427|FG003|Conditioning/Transplant|Adverse Event|8|||
131007813|NCT00049517|471657428|FG004|Conditioning/Transplant|Adverse Event|0|||
131007814|NCT00049517|471657429|FG005|Conditioning/Transplant|Adverse Event|0|||
131007815|NCT00049517|471657424|FG000|Conditioning/Transplant|Death|1|||
131007816|NCT00049517|471657425|FG001|Conditioning/Transplant|Death|0|||
131007817|NCT00049517|471657426|FG002|Conditioning/Transplant|Death|0|||
131007818|NCT00049517|471657427|FG003|Conditioning/Transplant|Death|2|||
131007819|NCT00049517|471657428|FG004|Conditioning/Transplant|Death|0|||
131007820|NCT00049517|471657429|FG005|Conditioning/Transplant|Death|0|||
131007821|NCT00049517|471657424|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
131007822|NCT00049517|471657425|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
131007823|NCT00049517|471657426|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
131007824|NCT00049517|471657427|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
131007825|NCT00049517|471657428|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
131007826|NCT00049517|471657429|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
131007827|NCT00049517|471657424|FG000|Conditioning/Transplant|Alternative therapy|4|||
131007828|NCT00049517|471657425|FG001|Conditioning/Transplant|Alternative therapy|4|||
131007829|NCT00049517|471657426|FG002|Conditioning/Transplant|Alternative therapy|2|||
131007830|NCT00049517|471657427|FG003|Conditioning/Transplant|Alternative therapy|1|||
131007831|NCT00049517|471657428|FG004|Conditioning/Transplant|Alternative therapy|1|||
131007832|NCT00049517|471657429|FG005|Conditioning/Transplant|Alternative therapy|0|||
131007833|NCT00049517|471657424|FG000|Conditioning/Transplant|Other complicating disease|2|||
131007834|NCT00049517|471657425|FG001|Conditioning/Transplant|Other complicating disease|0|||
131007835|NCT00049517|471657426|FG002|Conditioning/Transplant|Other complicating disease|0|||
131007836|NCT00049517|471657427|FG003|Conditioning/Transplant|Other complicating disease|4|||
131007837|NCT00049517|471657428|FG004|Conditioning/Transplant|Other complicating disease|0|||
131007838|NCT00049517|471657429|FG005|Conditioning/Transplant|Other complicating disease|1|||
131007839|NCT00049517|471657424|FG000|Conditioning/Transplant|Reasons not reported|25|||
131007840|NCT00049517|471657425|FG001|Conditioning/Transplant|Reasons not reported|31|||
131007841|NCT00049517|471657426|FG002|Conditioning/Transplant|Reasons not reported|18|||
131007842|NCT00049517|471657427|FG003|Conditioning/Transplant|Reasons not reported|15|||
131007843|NCT00049517|471657428|FG004|Conditioning/Transplant|Reasons not reported|5|||
131007844|NCT00049517|471657429|FG005|Conditioning/Transplant|Reasons not reported|5|||
131007845|NCT01211665|471657434|FG000|Overall Study|Withdrawal by Subject|1|||
131007846|NCT01211665|471657435|FG001|Overall Study|Withdrawal by Subject|0|||
131007847|NCT01211665|471657434|FG000|Overall Study|Death|1|||
131007848|NCT01211665|471657435|FG001|Overall Study|Death|0|||
131007849|NCT01390857|471657438|FG000|Overall Study|Protocol Violation|2|||
131007850|NCT01390857|471657438|FG000|Overall Study|Lost to Follow-up|1|||
131007851|NCT01390857|471657438|FG000|Overall Study|No Visit after the First Visit|7|||
131007852|NCT01123161|471657439|FG000|Overall Study|Lost to Follow-up|1|||
131007853|NCT01123161|471657440|FG001|Overall Study|Lost to Follow-up|0|||
131007854|NCT01123161|471657439|FG000|Overall Study|Withdrawal by Subject|1|||
131007855|NCT01123161|471657440|FG001|Overall Study|Withdrawal by Subject|0|||
131007856|NCT01244984|471657449|FG000|Overall Study|Adverse Event|2|||
131007857|NCT01244984|471657450|FG001|Overall Study|Adverse Event|11|||
131007858|NCT01244984|471657451|FG002|Overall Study|Adverse Event|2|||
131007859|NCT01244984|471657449|FG000|Overall Study|Protocol Violation|1|||
131007860|NCT01244984|471657450|FG001|Overall Study|Protocol Violation|0|||
131007861|NCT01244984|471657451|FG002|Overall Study|Protocol Violation|0|||
131007862|NCT01244984|471657449|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
131007863|NCT01244984|471657450|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
131007864|NCT01244984|471657451|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
131007865|NCT01244984|471657449|FG000|Overall Study|Withdrawal by Subject|1|||
131007866|NCT01244984|471657450|FG001|Overall Study|Withdrawal by Subject|2|||
131007867|NCT01244984|471657451|FG002|Overall Study|Withdrawal by Subject|2|||
131007868|NCT02072226|471657453|FG000|Overall Study|Lost to Follow-up|11|||
131007869|NCT02072226|471657454|FG001|Overall Study|Lost to Follow-up|7|||
131007870|NCT02072226|471657453|FG000|Overall Study|Patient Non-compliance|2|||
131007871|NCT02072226|471657454|FG001|Overall Study|Patient Non-compliance|3|||
131007872|NCT02072226|471657453|FG000|Overall Study|Death|1|||
131007873|NCT02072226|471657454|FG001|Overall Study|Death|0|||
131007874|NCT02072226|471657453|FG000|Overall Study|Patient Withdrawal of Consent|1|||
131007875|NCT02072226|471657454|FG001|Overall Study|Patient Withdrawal of Consent|0|||
131007876|NCT01124162|471657458|FG000|First Intervention|Adverse Event|2|||
131007877|NCT01124162|471657459|FG001|First Intervention|Adverse Event|0|||
131007878|NCT01124162|471657458|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
131007879|NCT01124162|471657459|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
131007880|NCT02680756|471657462|FG000|Overall Study|Adverse Event|10|||
131007881|NCT02680756|471657463|FG001|Overall Study|Adverse Event|2|||
131007882|NCT02680756|471657462|FG000|Overall Study|Lost to Follow-up|7|||
131007883|NCT02680756|471657463|FG001|Overall Study|Lost to Follow-up|6|||
131007884|NCT02680756|471657462|FG000|Overall Study|Withdrawal by Subject|5|||
131007885|NCT02680756|471657463|FG001|Overall Study|Withdrawal by Subject|5|||
131007886|NCT02680756|471657462|FG000|Overall Study|Physician Decision|4|||
131007887|NCT02680756|471657463|FG001|Overall Study|Physician Decision|1|||
131007888|NCT02680756|471657462|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
131007889|NCT02680756|471657463|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
131007890|NCT02680756|471657462|FG000|Overall Study|Blood transfusion for any reason|0|||
131007891|NCT02680756|471657463|FG001|Overall Study|Blood transfusion for any reason|1|||
131007892|NCT02680756|471657462|FG000|Overall Study|Death|1|||
131007893|NCT02680756|471657463|FG001|Overall Study|Death|0|||
131007894|NCT02680756|471657462|FG000|Overall Study|Protocol Violation|1|||
131007895|NCT02680756|471657463|FG001|Overall Study|Protocol Violation|0|||
131007896|NCT02680756|471657462|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
131007897|NCT02680756|471657463|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
131007898|NCT02680756|471657462|FG000|Overall Study|None of above or not recorded|3|||
131007899|NCT02680756|471657463|FG001|Overall Study|None of above or not recorded|2|||
131007900|NCT01516892|471657464|FG000|Overall Study|Adverse Event|25|||
131007901|NCT01516892|471657464|FG000|Overall Study|Lack of Efficacy|35|||
131007902|NCT01516892|471657464|FG000|Overall Study|Pregnancy|5|||
131007903|NCT01516892|471657464|FG000|Overall Study|Lost to Follow-up|82|||
131007904|NCT01516892|471657464|FG000|Overall Study|Subject Withdrew Consent|92|||
131007905|NCT01516892|471657464|FG000|Overall Study|Protocol Violation|60|||
131007906|NCT01516892|471657464|FG000|Overall Study|Other Miscellaneous Reasons|43|||
131007907|NCT01516892|471657464|FG000|Overall Study|Missing|1|||
131007908|NCT03635112|471657465|FG000|Overall Study|Adverse Event|5|||
131007909|NCT03635112|471657466|FG001|Overall Study|Adverse Event|9|||
131007910|NCT03635112|471657467|FG002|Overall Study|Adverse Event|14|||
131007911|NCT03635112|471657465|FG000|Overall Study|Lost to Follow-up|1|||
131007912|NCT03635112|471657466|FG001|Overall Study|Lost to Follow-up|0|||
131007913|NCT03635112|471657467|FG002|Overall Study|Lost to Follow-up|1|||
131007914|NCT03635112|471657465|FG000|Overall Study|Physician Decision|5|||
131007915|NCT03635112|471657466|FG001|Overall Study|Physician Decision|7|||
131007916|NCT03635112|471657467|FG002|Overall Study|Physician Decision|5|||
131007917|NCT03635112|471657465|FG000|Overall Study|Protocol Violation|0|||
131007918|NCT03635112|471657466|FG001|Overall Study|Protocol Violation|0|||
131007919|NCT03635112|471657467|FG002|Overall Study|Protocol Violation|1|||
131007920|NCT03635112|471657465|FG000|Overall Study|Study Terminated by Sponsor|11|||
131007921|NCT03635112|471657466|FG001|Overall Study|Study Terminated by Sponsor|17|||
131007922|NCT03635112|471657467|FG002|Overall Study|Study Terminated by Sponsor|21|||
131007923|NCT03635112|471657465|FG000|Overall Study|Withdrawal by Subject|4|||
131007924|NCT03635112|471657466|FG001|Overall Study|Withdrawal by Subject|9|||
131007925|NCT03635112|471657467|FG002|Overall Study|Withdrawal by Subject|7|||
131007926|NCT03635112|471657465|FG000|Overall Study|Miscellaneous|0|||
131007927|NCT03635112|471657466|FG001|Overall Study|Miscellaneous|0|||
131007928|NCT03635112|471657467|FG002|Overall Study|Miscellaneous|1|||
131007929|NCT03006341|471657471|FG000|Overall Study|Not linked in the EMR|25069|||
131007930|NCT03006341|471657472|FG001|Overall Study|Not linked in the EMR|67505|||
131007931|NCT03006341|471657473|FG002|Overall Study|Not linked in the EMR|30993|||
131007932|NCT03006341|471657474|FG003|Overall Study|Not linked in the EMR|10685|||
131007933|NCT02950545|471657477|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
131007934|NCT02950545|471657478|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
130884907|NCT00790842|471213226|FG010|Expansion Cohort|Physician Decision|0|||
130884908|NCT00790842|471213216|FG000|Expansion Cohort|Withdrawal by Subject|0|||
130884909|NCT00790842|471213217|FG001|Expansion Cohort|Withdrawal by Subject|0|||
130884910|NCT00790842|471213218|FG002|Expansion Cohort|Withdrawal by Subject|3|||
130884911|NCT00790842|471213219|FG003|Expansion Cohort|Withdrawal by Subject|0|||
130884912|NCT00790842|471213220|FG004|Expansion Cohort|Withdrawal by Subject|0|||
130884913|NCT00790842|471213221|FG005|Expansion Cohort|Withdrawal by Subject|0|||
130884914|NCT00790842|471213222|FG006|Expansion Cohort|Withdrawal by Subject|0|||
130884915|NCT00790842|471213223|FG007|Expansion Cohort|Withdrawal by Subject|0|||
130884916|NCT00790842|471213224|FG008|Expansion Cohort|Withdrawal by Subject|0|||
130884917|NCT00790842|471213225|FG009|Expansion Cohort|Withdrawal by Subject|0|||
130884918|NCT00790842|471213226|FG010|Expansion Cohort|Withdrawal by Subject|0|||
130884919|NCT00790842|471213216|FG000|Expansion Cohort|Study Closure|0|||
130884920|NCT00790842|471213217|FG001|Expansion Cohort|Study Closure|0|||
130884921|NCT00790842|471213218|FG002|Expansion Cohort|Study Closure|1|||
130884922|NCT00790842|471213219|FG003|Expansion Cohort|Study Closure|0|||
130884923|NCT00790842|471213220|FG004|Expansion Cohort|Study Closure|0|||
130884924|NCT00790842|471213221|FG005|Expansion Cohort|Study Closure|0|||
130884925|NCT00790842|471213222|FG006|Expansion Cohort|Study Closure|0|||
130884926|NCT00790842|471213223|FG007|Expansion Cohort|Study Closure|0|||
130884927|NCT00790842|471213224|FG008|Expansion Cohort|Study Closure|0|||
130884928|NCT00790842|471213225|FG009|Expansion Cohort|Study Closure|0|||
130884929|NCT00790842|471213226|FG010|Expansion Cohort|Study Closure|0|||
130884930|NCT00419952|471213227|FG000|Overall Study|Adverse Event|8|||
130884931|NCT00419952|471213228|FG001|Overall Study|Adverse Event|10|||
130884932|NCT00419952|471213227|FG000|Overall Study|Withdrawal by Subject|44|||
130884933|NCT00419952|471213228|FG001|Overall Study|Withdrawal by Subject|43|||
130884934|NCT00419952|471213227|FG000|Overall Study|Lost to Follow-up|43|||
130884935|NCT00419952|471213228|FG001|Overall Study|Lost to Follow-up|34|||
130884936|NCT00419952|471213227|FG000|Overall Study|Protocol Violation|32|||
130884937|NCT00419952|471213228|FG001|Overall Study|Protocol Violation|24|||
130884938|NCT00419952|471213227|FG000|Overall Study|Pregnancy|4|||
130884939|NCT00419952|471213228|FG001|Overall Study|Pregnancy|2|||
130884940|NCT00419952|471213227|FG000|Overall Study|Physician Decision|1|||
130884941|NCT00419952|471213228|FG001|Overall Study|Physician Decision|3|||
130884942|NCT00419952|471213227|FG000|Overall Study|Incorrectly enrolled|10|||
130884943|NCT00419952|471213228|FG001|Overall Study|Incorrectly enrolled|3|||
130884944|NCT00419952|471213227|FG000|Overall Study|Intake of prohibited medication|2|||
130884945|NCT00419952|471213228|FG001|Overall Study|Intake of prohibited medication|2|||
130884946|NCT00419952|471213227|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
130884947|NCT00419952|471213228|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
130884948|NCT00419952|471213227|FG000|Overall Study|Diary or medication non-compliance|2|||
130884949|NCT00419952|471213228|FG001|Overall Study|Diary or medication non-compliance|4|||
130884950|NCT00419952|471213227|FG000|Overall Study|Abnormal ECG|1|||
130884951|NCT00419952|471213228|FG001|Overall Study|Abnormal ECG|0|||
130884952|NCT02351817|471213229|FG000|Period 1|Adverse Event|1|||
130884953|NCT02351817|471213230|FG001|Period 1|Adverse Event|2|||
130884954|NCT02351817|471213229|FG000|Period 1|Lack of Efficacy|0|||
130884955|NCT02351817|471213230|FG001|Period 1|Lack of Efficacy|1|||
130884956|NCT02351817|471213229|FG000|Period 2|Adverse Event|0|||
130884957|NCT02351817|471213230|FG001|Period 2|Adverse Event|2|||
130884958|NCT02351817|471213229|FG000|Period 2|Protocol Violation|1|||
130884959|NCT02351817|471213230|FG001|Period 2|Protocol Violation|0|||
130884960|NCT02976038|471213231|FG000|Overall Study|Physician Decision|22|||
130884961|NCT02976038|471213231|FG000|Overall Study|Withdrawal by Subject|3|||
130884962|NCT02976038|471213231|FG000|Overall Study|Lost to Follow-up|2|||
130884963|NCT02976038|471213231|FG000|Overall Study|Adverse Event|1|||
130884964|NCT01046396|471213232|FG000|Overall Study|Withdrawal by Subject|5|||
130884965|NCT01208207|471213233|FG000|Part I|Adverse Event|19|||
130884966|NCT01208207|471213234|FG001|Part I|Adverse Event|2|||
130884967|NCT01208207|471213235|FG002|Part I|Adverse Event|6|||
130884968|NCT01208207|471213236|FG003|Part I|Adverse Event|0|||
130884969|NCT01208207|471213237|FG004|Part I|Adverse Event|0|||
130884970|NCT01208207|471213238|FG005|Part I|Adverse Event|0|||
130884971|NCT01208207|471213239|FG006|Part I|Adverse Event|0|||
130884972|NCT01208207|471213233|FG000|Part I|Lack of Efficacy|21|||
130884973|NCT01208207|471213234|FG001|Part I|Lack of Efficacy|3|||
130884974|NCT01208207|471213235|FG002|Part I|Lack of Efficacy|2|||
130884975|NCT01208207|471213236|FG003|Part I|Lack of Efficacy|0|||
130884976|NCT01208207|471213237|FG004|Part I|Lack of Efficacy|0|||
131007935|NCT02950545|471657479|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
131007936|NCT02950545|471657480|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
131007937|NCT02950545|471657481|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
131007938|NCT02950545|471657482|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
131007939|NCT02950545|471657477|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
131007940|NCT02950545|471657478|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
131007941|NCT02950545|471657479|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
131007942|NCT02950545|471657480|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
131007943|NCT02950545|471657481|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
131007944|NCT02950545|471657482|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
131007945|NCT02950545|471657477|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
131007946|NCT02950545|471657478|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
131007947|NCT02950545|471657479|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
131007948|NCT02950545|471657480|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
131007949|NCT02950545|471657481|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
131007950|NCT02950545|471657482|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
131007951|NCT02950545|471657477|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
131007952|NCT02950545|471657478|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
131007953|NCT02950545|471657479|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
131007954|NCT02950545|471657480|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
131007955|NCT02950545|471657481|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
131007956|NCT02950545|471657482|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
131007957|NCT02950545|471657477|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
131007958|NCT02950545|471657478|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
131007959|NCT02950545|471657479|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
131007960|NCT02950545|471657480|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
131007961|NCT02950545|471657481|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
131007962|NCT02950545|471657482|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
131007963|NCT03101592|471657483|FG000|Overall Study|participant files could not be located|111|||
131007964|NCT03101592|471657484|FG001|Overall Study|participant files could not be located|170|||
131007965|NCT03101592|471657485|FG002|Overall Study|participant files could not be located|118|||
131007966|NCT01770860|471657486|FG000|Overall Study|Withdrawal by Subject|4|||
131007967|NCT01770860|471657486|FG000|Overall Study|Lost to Follow-up|1|||
131007968|NCT01770860|471657486|FG000|Overall Study|Administrative decision made by the PI|1|||
131007969|NCT03398356|471657489|FG000|Before Treatment|Lost to Follow-up|1|||
131007970|NCT03398356|471657490|FG001|Before Treatment|Lost to Follow-up|2|||
131007971|NCT03398356|471657491|FG002|Before Treatment|Lost to Follow-up|0|||
131007972|NCT03398356|471657489|FG000|Before Treatment|drug intolerance|2|||
131007973|NCT03398356|471657490|FG001|Before Treatment|drug intolerance|1|||
131007974|NCT03398356|471657491|FG002|Before Treatment|drug intolerance|0|||
130884977|NCT01208207|471213238|FG005|Part I|Lack of Efficacy|0|||
131007975|NCT03398356|471657489|FG000|Before Treatment|Withdrawal by Subject|0|||
131007976|NCT03398356|471657490|FG001|Before Treatment|Withdrawal by Subject|5|||
131007977|NCT03398356|471657491|FG002|Before Treatment|Withdrawal by Subject|0|||
131007978|NCT03398356|471657489|FG000|Before Treatment|Physician Decision|0|||
131007979|NCT03398356|471657490|FG001|Before Treatment|Physician Decision|0|||
131007980|NCT03398356|471657491|FG002|Before Treatment|Physician Decision|11|||
131007981|NCT03398356|471657489|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
131007982|NCT03398356|471657490|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
131007983|NCT03398356|471657491|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
131007984|NCT03432533|471657494|FG000|Overall Study|Lost to Follow-up|1|||
131007985|NCT03432533|471657495|FG001|Overall Study|Lost to Follow-up|2|||
131007986|NCT03432533|471657494|FG000|Overall Study|Withdrawal by Subject|14|||
131007987|NCT03432533|471657495|FG001|Overall Study|Withdrawal by Subject|9|||
131007988|NCT01648283|471657496|FG000|Overall Study|Withdrawal by Subject|14|||
131007989|NCT03424239|471657501|FG000|Overall Study|Withdrawal by Subject|2|||
131007990|NCT00318656|471657502|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
131007991|NCT00318656|471657503|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
131007992|NCT00318656|471657502|FG000|Overall Study|Did not receive any treatment|0|||
131007993|NCT00318656|471657503|FG001|Overall Study|Did not receive any treatment|1|||
131007994|NCT01446003|471657504|FG000|Period 1|Protocol Violation|2|||
131007995|NCT01446003|471657505|FG001|Period 1|Protocol Violation|0|||
131007996|NCT01446003|471657504|FG000|Period 2|Adverse Event|1|||
131007997|NCT01446003|471657505|FG001|Period 2|Adverse Event|0|||
131007998|NCT03905135|471657507|FG000|Dose Escalation|Adverse Event|1|||
131007999|NCT03905135|471657508|FG001|Dose Escalation|Adverse Event|1|||
131008000|NCT03905135|471657507|FG000|Dose Escalation|Progressive disease|3|||
131008001|NCT03905135|471657508|FG001|Dose Escalation|Progressive disease|1|||
131008002|NCT03905135|471657507|FG000|Dose Escalation|Intercurrent illness|1|||
131008003|NCT03905135|471657508|FG001|Dose Escalation|Intercurrent illness|0|||
131008004|NCT01740557|471657509|FG000|Overall Study|Ineligible|1|||
131008005|NCT01740557|471657509|FG000|Overall Study|Screen failure|1|||
131008006|NCT00490555|471657510|FG000|Overall Study|noncompliant with drug administration|0|||
131008007|NCT00490555|471657511|FG001|Overall Study|noncompliant with drug administration|0|||
131008008|NCT00490555|471657512|FG002|Overall Study|noncompliant with drug administration|2|||
131008009|NCT00490555|471657513|FG003|Overall Study|noncompliant with drug administration|0|||
131008010|NCT02042443|471657516|FG000|Overall Study|Adverse Event|2|||
131008011|NCT02042443|471657517|FG001|Overall Study|Adverse Event|1|||
131008012|NCT02042443|471657516|FG000|Overall Study|Withdrawal by Subject|0|||
131008013|NCT02042443|471657517|FG001|Overall Study|Withdrawal by Subject|1|||
131008014|NCT02042443|471657516|FG000|Overall Study|Progression|21|||
131008015|NCT02042443|471657517|FG001|Overall Study|Progression|17|||
131008016|NCT02042443|471657516|FG000|Overall Study|not protocol specified|1|||
131008017|NCT02042443|471657517|FG001|Overall Study|not protocol specified|1|||
131008018|NCT02042443|471657516|FG000|Overall Study|Not eligible/not analyzable|3|||
131008019|NCT02042443|471657517|FG001|Overall Study|Not eligible/not analyzable|6|||
131008020|NCT01007149|471657520|FG000|Overall Study|Administrative problems|0|||
131008021|NCT01007149|471657521|FG001|Overall Study|Administrative problems|1|||
131008022|NCT02784704|471657522|FG000|Overall Study|Adverse Event|4|||
131008023|NCT02784704|471657523|FG001|Overall Study|Adverse Event|2|||
131008024|NCT02784704|471657522|FG000|Overall Study|Lost to Follow-up|6|||
131008025|NCT02784704|471657523|FG001|Overall Study|Lost to Follow-up|4|||
131008026|NCT02784704|471657522|FG000|Overall Study|Withdrawal by Subject|1|||
131008027|NCT02784704|471657523|FG001|Overall Study|Withdrawal by Subject|3|||
131008028|NCT02784704|471657522|FG000|Overall Study|Subject Non Compliance|2|||
131008029|NCT02784704|471657523|FG001|Overall Study|Subject Non Compliance|0|||
131008030|NCT01913340|471657524|FG000|Overall Study|Death|2|||
131008031|NCT01913340|471657525|FG001|Overall Study|Death|5|||
131008032|NCT01913340|471657524|FG000|Overall Study|Lost to Follow-up|1|||
131008033|NCT01913340|471657525|FG001|Overall Study|Lost to Follow-up|1|||
131008034|NCT05750745|471657527|FG000|Overall Study|Adverse Event|1|||
131008035|NCT05750745|471657528|FG001|Overall Study|Adverse Event|0|||
131008036|NCT05750745|471657529|FG002|Overall Study|Adverse Event|0|||
131008037|NCT05750745|471657527|FG000|Overall Study|Protocol Violation|1|||
131008038|NCT05750745|471657528|FG001|Overall Study|Protocol Violation|0|||
131008039|NCT05750745|471657529|FG002|Overall Study|Protocol Violation|0|||
131008040|NCT05750745|471657527|FG000|Overall Study|Withdrawal by Subject|0|||
130884978|NCT01208207|471213239|FG006|Part I|Lack of Efficacy|0|||
131008041|NCT05750745|471657528|FG001|Overall Study|Withdrawal by Subject|1|||
131008042|NCT05750745|471657529|FG002|Overall Study|Withdrawal by Subject|0|||
131008043|NCT05550337|471657532|FG000|Overall Study|Lack of Efficacy|0|||
131008044|NCT05550337|471657533|FG001|Overall Study|Lack of Efficacy|0|||
131008045|NCT05550337|471657534|FG002|Overall Study|Lack of Efficacy|1|||
131008046|NCT05550337|471657532|FG000|Overall Study|Adverse Event|1|||
131008047|NCT05550337|471657533|FG001|Overall Study|Adverse Event|5|||
131008048|NCT05550337|471657534|FG002|Overall Study|Adverse Event|0|||
131008049|NCT05550337|471657532|FG000|Overall Study|Withdrawal by Subject|8|||
131008050|NCT05550337|471657533|FG001|Overall Study|Withdrawal by Subject|14|||
131008051|NCT05550337|471657534|FG002|Overall Study|Withdrawal by Subject|10|||
131008052|NCT05550337|471657532|FG000|Overall Study|Pregnancy|0|||
131008053|NCT05550337|471657533|FG001|Overall Study|Pregnancy|0|||
131008054|NCT05550337|471657534|FG002|Overall Study|Pregnancy|1|||
131008055|NCT05550337|471657532|FG000|Overall Study|Protocol Violation|1|||
131008056|NCT05550337|471657533|FG001|Overall Study|Protocol Violation|3|||
131008057|NCT05550337|471657534|FG002|Overall Study|Protocol Violation|4|||
131008058|NCT05550337|471657532|FG000|Overall Study|Physician Decision|2|||
131008059|NCT05550337|471657533|FG001|Overall Study|Physician Decision|1|||
131008060|NCT05550337|471657534|FG002|Overall Study|Physician Decision|1|||
131008061|NCT05550337|471657532|FG000|Overall Study|Lost to Follow-up|16|||
131008062|NCT05550337|471657533|FG001|Overall Study|Lost to Follow-up|11|||
131008063|NCT05550337|471657534|FG002|Overall Study|Lost to Follow-up|11|||
131008064|NCT03115346|471657536|FG000|Overall Study|Did not have AAA surgery|28|||
131008065|NCT03115346|471657537|FG001|Overall Study|Did not have AAA surgery|15|||
131008066|NCT03115346|471657536|FG000|Overall Study|Death|3|||
131008067|NCT03115346|471657537|FG001|Overall Study|Death|1|||
131008068|NCT03115346|471657536|FG000|Overall Study|Withdrawal by Subject|0|||
131008069|NCT03115346|471657537|FG001|Overall Study|Withdrawal by Subject|3|||
131008070|NCT03115346|471657536|FG000|Overall Study|Lost to Follow-up|0|||
131008071|NCT03115346|471657537|FG001|Overall Study|Lost to Follow-up|3|||
131008072|NCT01737268|471657539|FG000|Overall Study|Adverse Event|6|||
131008073|NCT01737268|471657539|FG000|Overall Study|Worsening of Target Disease|2|||
131008074|NCT01737268|471657539|FG000|Overall Study|In consideration of the patient's safety|1|||
131008075|NCT02068885|471657543|FG000|Overall Study|Withdrew|3|||
131008076|NCT02068885|471657544|FG001|Overall Study|Withdrew|5|||
131008077|NCT02068885|471657545|FG002|Overall Study|Withdrew|8|||
131008078|NCT00828919|471657551|FG000|Overall Study|Death|0|||
131008079|NCT00828919|471657552|FG001|Overall Study|Death|1|||
131008080|NCT00828919|471657553|FG002|Overall Study|Death|2|||
131008081|NCT00828919|471657554|FG003|Overall Study|Death|0|||
131008082|NCT00828919|471657555|FG004|Overall Study|Death|0|||
131008083|NCT00828919|471657551|FG000|Overall Study|Adverse Event|2|||
131008084|NCT00828919|471657552|FG001|Overall Study|Adverse Event|2|||
131008085|NCT00828919|471657553|FG002|Overall Study|Adverse Event|2|||
131008086|NCT00828919|471657554|FG003|Overall Study|Adverse Event|1|||
131008087|NCT00828919|471657555|FG004|Overall Study|Adverse Event|3|||
131008088|NCT00828919|471657551|FG000|Overall Study|Objective progression or relapse|4|||
131008089|NCT00828919|471657552|FG001|Overall Study|Objective progression or relapse|4|||
131008090|NCT00828919|471657553|FG002|Overall Study|Objective progression or relapse|11|||
131008091|NCT00828919|471657554|FG003|Overall Study|Objective progression or relapse|0|||
131008092|NCT00828919|471657555|FG004|Overall Study|Objective progression or relapse|5|||
131008093|NCT00828919|471657551|FG000|Overall Study|No longer willing to participate in study|0|||
131008094|NCT00828919|471657552|FG001|Overall Study|No longer willing to participate in study|0|||
131008095|NCT00828919|471657553|FG002|Overall Study|No longer willing to participate in study|2|||
131008096|NCT00828919|471657554|FG003|Overall Study|No longer willing to participate in study|0|||
131008097|NCT00828919|471657555|FG004|Overall Study|No longer willing to participate in study|0|||
131008098|NCT00828919|471657551|FG000|Overall Study|Insufficient Clinical Response|0|||
131008099|NCT00828919|471657552|FG001|Overall Study|Insufficient Clinical Response|1|||
131008100|NCT00828919|471657553|FG002|Overall Study|Insufficient Clinical Response|2|||
131008101|NCT00828919|471657554|FG003|Overall Study|Insufficient Clinical Response|0|||
131008102|NCT00828919|471657555|FG004|Overall Study|Insufficient Clinical Response|0|||
131008103|NCT00828919|471657551|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
131008104|NCT00828919|471657552|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
131008105|NCT00828919|471657553|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
131008106|NCT00828919|471657554|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
131045796|NCT03582033|471802283|FG005|Part B|Study terminated by sponsor|12|||
131008107|NCT00828919|471657555|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
131008108|NCT00828919|471657551|FG000|Overall Study|Other|1|||
131008109|NCT00828919|471657552|FG001|Overall Study|Other|0|||
131008110|NCT00828919|471657553|FG002|Overall Study|Other|1|||
131008111|NCT00828919|471657554|FG003|Overall Study|Other|1|||
131008112|NCT00828919|471657555|FG004|Overall Study|Other|0|||
131008113|NCT00828919|471657551|FG000|Overall Study|Lost to Follow-up|0|||
131008114|NCT00828919|471657552|FG001|Overall Study|Lost to Follow-up|1|||
131008115|NCT00828919|471657553|FG002|Overall Study|Lost to Follow-up|0|||
131008116|NCT00828919|471657554|FG003|Overall Study|Lost to Follow-up|0|||
131008117|NCT00828919|471657555|FG004|Overall Study|Lost to Follow-up|0|||
131008118|NCT05567159|471657558|FG000|Overall Study|Adverse Event|4|||
131008119|NCT05567159|471657558|FG000|Overall Study|Physician Decision|3|||
131008120|NCT05567159|471657558|FG000|Overall Study|Protocol deviation|1|||
131008121|NCT02501811|471657559|FG000|Overall Study|Death|1|||
131008122|NCT02501811|471657560|FG001|Overall Study|Death|3|||
131008123|NCT02501811|471657561|FG002|Overall Study|Death|2|||
131008124|NCT02501811|471657562|FG003|Overall Study|Death|3|||
131008125|NCT02501811|471657559|FG000|Overall Study|Withdrawal by Subject|3|||
131008126|NCT02501811|471657560|FG001|Overall Study|Withdrawal by Subject|3|||
131008127|NCT02501811|471657561|FG002|Overall Study|Withdrawal by Subject|2|||
131008128|NCT02501811|471657562|FG003|Overall Study|Withdrawal by Subject|3|||
131008129|NCT02501811|471657559|FG000|Overall Study|Lost to Follow-up|0|||
131008130|NCT02501811|471657560|FG001|Overall Study|Lost to Follow-up|0|||
131008131|NCT02501811|471657561|FG002|Overall Study|Lost to Follow-up|2|||
131008132|NCT02501811|471657562|FG003|Overall Study|Lost to Follow-up|1|||
131008133|NCT02624778|471659455|FG000|Overall Study|Lost to Follow-up|0|||
131008134|NCT02624778|471659456|FG001|Overall Study|Lost to Follow-up|0|||
131008135|NCT02624778|471659457|FG002|Overall Study|Lost to Follow-up|1|||
131008136|NCT02624778|471659458|FG003|Overall Study|Lost to Follow-up|0|||
131008137|NCT02624778|471659459|FG004|Overall Study|Lost to Follow-up|0|||
131008138|NCT02624778|471659460|FG005|Overall Study|Lost to Follow-up|0|||
131008139|NCT02624778|471659461|FG006|Overall Study|Lost to Follow-up|0|||
131008140|NCT02624778|471659462|FG007|Overall Study|Lost to Follow-up|0|||
130884979|NCT01208207|471213233|FG000|Part I|Lost to Follow-up|6|||
131008141|NCT02624778|471659463|FG008|Overall Study|Lost to Follow-up|0|||
131008142|NCT02624778|471659455|FG000|Overall Study|Withdrawal by Subject|0|||
131008143|NCT02624778|471659456|FG001|Overall Study|Withdrawal by Subject|1|||
131008144|NCT02624778|471659457|FG002|Overall Study|Withdrawal by Subject|0|||
131008145|NCT02624778|471659458|FG003|Overall Study|Withdrawal by Subject|0|||
131008146|NCT02624778|471659459|FG004|Overall Study|Withdrawal by Subject|0|||
131008147|NCT02624778|471659460|FG005|Overall Study|Withdrawal by Subject|1|||
131008148|NCT02624778|471659461|FG006|Overall Study|Withdrawal by Subject|1|||
131008149|NCT02624778|471659462|FG007|Overall Study|Withdrawal by Subject|1|||
131008150|NCT02624778|471659463|FG008|Overall Study|Withdrawal by Subject|1|||
131008151|NCT02624778|471659455|FG000|Overall Study|Adverse Event|0|||
131008152|NCT02624778|471659456|FG001|Overall Study|Adverse Event|0|||
131008153|NCT02624778|471659457|FG002|Overall Study|Adverse Event|0|||
131008154|NCT02624778|471659458|FG003|Overall Study|Adverse Event|0|||
131008155|NCT02624778|471659459|FG004|Overall Study|Adverse Event|0|||
131008156|NCT02624778|471659460|FG005|Overall Study|Adverse Event|0|||
131008157|NCT02624778|471659461|FG006|Overall Study|Adverse Event|0|||
131008158|NCT02624778|471659462|FG007|Overall Study|Adverse Event|0|||
131008159|NCT02624778|471659463|FG008|Overall Study|Adverse Event|2|||
131008160|NCT02624778|471659455|FG000|Overall Study|Death|0|||
131008161|NCT02624778|471659456|FG001|Overall Study|Death|0|||
131008162|NCT02624778|471659457|FG002|Overall Study|Death|0|||
131008163|NCT02624778|471659458|FG003|Overall Study|Death|0|||
131008164|NCT02624778|471659459|FG004|Overall Study|Death|0|||
131008165|NCT02624778|471659460|FG005|Overall Study|Death|0|||
131008166|NCT02624778|471659461|FG006|Overall Study|Death|1|||
131008167|NCT02624778|471659462|FG007|Overall Study|Death|0|||
131008168|NCT02624778|471659463|FG008|Overall Study|Death|0|||
131008169|NCT02624778|471659455|FG000|Overall Study|Physician Decision|0|||
131008170|NCT02624778|471659456|FG001|Overall Study|Physician Decision|0|||
131008171|NCT02624778|471659457|FG002|Overall Study|Physician Decision|0|||
131008172|NCT02624778|471659458|FG003|Overall Study|Physician Decision|0|||
131008173|NCT02624778|471659459|FG004|Overall Study|Physician Decision|0|||
131008174|NCT02624778|471659460|FG005|Overall Study|Physician Decision|0|||
131008175|NCT02624778|471659461|FG006|Overall Study|Physician Decision|0|||
131008176|NCT02624778|471659462|FG007|Overall Study|Physician Decision|3|||
131008177|NCT02624778|471659463|FG008|Overall Study|Physician Decision|3|||
131008178|NCT00359619|471659469|FG000|Overall Study|Adverse Event|0|||
131008179|NCT00359619|471659470|FG001|Overall Study|Adverse Event|0|||
131008180|NCT00359619|471659471|FG002|Overall Study|Adverse Event|1|||
131008181|NCT00359619|471659472|FG003|Overall Study|Adverse Event|0|||
131008182|NCT00359619|471659473|FG004|Overall Study|Adverse Event|0|||
131008183|NCT00359619|471659474|FG005|Overall Study|Adverse Event|0|||
131008184|NCT00359619|471659475|FG006|Overall Study|Adverse Event|1|||
131008185|NCT00359619|471659469|FG000|Overall Study|Withdrawal by Subject|3|||
131008186|NCT00359619|471659470|FG001|Overall Study|Withdrawal by Subject|1|||
131008187|NCT00359619|471659471|FG002|Overall Study|Withdrawal by Subject|4|||
131008188|NCT00359619|471659472|FG003|Overall Study|Withdrawal by Subject|2|||
131008189|NCT00359619|471659473|FG004|Overall Study|Withdrawal by Subject|2|||
131008190|NCT00359619|471659474|FG005|Overall Study|Withdrawal by Subject|0|||
131008191|NCT00359619|471659475|FG006|Overall Study|Withdrawal by Subject|3|||
131008192|NCT00359619|471659469|FG000|Overall Study|Other|1|||
131008193|NCT00359619|471659470|FG001|Overall Study|Other|0|||
131008194|NCT00359619|471659471|FG002|Overall Study|Other|0|||
131008195|NCT00359619|471659472|FG003|Overall Study|Other|0|||
131008196|NCT00359619|471659473|FG004|Overall Study|Other|0|||
131008197|NCT00359619|471659474|FG005|Overall Study|Other|0|||
131008198|NCT00359619|471659475|FG006|Overall Study|Other|0|||
131008199|NCT00359619|471659469|FG000|Overall Study|Lost to Follow-up|4|||
131008200|NCT00359619|471659470|FG001|Overall Study|Lost to Follow-up|4|||
131008201|NCT00359619|471659471|FG002|Overall Study|Lost to Follow-up|2|||
130884980|NCT01208207|471213234|FG001|Part I|Lost to Follow-up|1|||
130884981|NCT01208207|471213235|FG002|Part I|Lost to Follow-up|0|||
130884982|NCT01208207|471213236|FG003|Part I|Lost to Follow-up|0|||
130884983|NCT01208207|471213237|FG004|Part I|Lost to Follow-up|0|||
130884984|NCT01208207|471213238|FG005|Part I|Lost to Follow-up|0|||
130884985|NCT01208207|471213239|FG006|Part I|Lost to Follow-up|0|||
130884986|NCT01208207|471213233|FG000|Part I|Non-Compliance With Study Drug|1|||
130884987|NCT01208207|471213234|FG001|Part I|Non-Compliance With Study Drug|0|||
130884988|NCT01208207|471213235|FG002|Part I|Non-Compliance With Study Drug|1|||
130884989|NCT01208207|471213236|FG003|Part I|Non-Compliance With Study Drug|0|||
130884990|NCT01208207|471213237|FG004|Part I|Non-Compliance With Study Drug|0|||
130884991|NCT01208207|471213238|FG005|Part I|Non-Compliance With Study Drug|0|||
130884992|NCT01208207|471213239|FG006|Part I|Non-Compliance With Study Drug|0|||
130884993|NCT01208207|471213233|FG000|Part I|Physician Decision|0|||
130884994|NCT01208207|471213234|FG001|Part I|Physician Decision|1|||
130884995|NCT01208207|471213235|FG002|Part I|Physician Decision|0|||
130884996|NCT01208207|471213236|FG003|Part I|Physician Decision|0|||
130884997|NCT01208207|471213237|FG004|Part I|Physician Decision|0|||
130884998|NCT01208207|471213238|FG005|Part I|Physician Decision|0|||
130884999|NCT01208207|471213239|FG006|Part I|Physician Decision|0|||
130885000|NCT01208207|471213233|FG000|Part I|Progressive Disease|1|||
130885001|NCT01208207|471213234|FG001|Part I|Progressive Disease|0|||
130885002|NCT01208207|471213235|FG002|Part I|Progressive Disease|0|||
130885003|NCT01208207|471213236|FG003|Part I|Progressive Disease|0|||
130885004|NCT01208207|471213237|FG004|Part I|Progressive Disease|0|||
130885005|NCT01208207|471213238|FG005|Part I|Progressive Disease|0|||
130885006|NCT01208207|471213239|FG006|Part I|Progressive Disease|0|||
130885007|NCT01208207|471213233|FG000|Part I|Protocol Violation|8|||
130885008|NCT01208207|471213234|FG001|Part I|Protocol Violation|0|||
130885009|NCT01208207|471213235|FG002|Part I|Protocol Violation|2|||
130885010|NCT01208207|471213236|FG003|Part I|Protocol Violation|0|||
130885011|NCT01208207|471213237|FG004|Part I|Protocol Violation|0|||
130885012|NCT01208207|471213238|FG005|Part I|Protocol Violation|0|||
130885013|NCT01208207|471213239|FG006|Part I|Protocol Violation|0|||
130885014|NCT01208207|471213233|FG000|Part I|Withdrawal by Subject|14|||
130885015|NCT01208207|471213234|FG001|Part I|Withdrawal by Subject|4|||
130885016|NCT01208207|471213235|FG002|Part I|Withdrawal by Subject|4|||
130885017|NCT01208207|471213236|FG003|Part I|Withdrawal by Subject|0|||
130885018|NCT01208207|471213237|FG004|Part I|Withdrawal by Subject|0|||
130885019|NCT01208207|471213238|FG005|Part I|Withdrawal by Subject|0|||
130885020|NCT01208207|471213239|FG006|Part I|Withdrawal by Subject|0|||
130885021|NCT01208207|471213233|FG000|Part II|Withdrawal by Subject|0|||
130885022|NCT01208207|471213234|FG001|Part II|Withdrawal by Subject|0|||
130885023|NCT01208207|471213235|FG002|Part II|Withdrawal by Subject|0|||
130885024|NCT01208207|471213236|FG003|Part II|Withdrawal by Subject|10|||
130885025|NCT01208207|471213237|FG004|Part II|Withdrawal by Subject|9|||
130885026|NCT01208207|471213238|FG005|Part II|Withdrawal by Subject|3|||
130885027|NCT01208207|471213239|FG006|Part II|Withdrawal by Subject|5|||
130885028|NCT01208207|471213233|FG000|Part II|Adverse Event|0|||
130885029|NCT01208207|471213234|FG001|Part II|Adverse Event|0|||
130885030|NCT01208207|471213235|FG002|Part II|Adverse Event|0|||
130885031|NCT01208207|471213236|FG003|Part II|Adverse Event|5|||
130885032|NCT01208207|471213237|FG004|Part II|Adverse Event|9|||
130885033|NCT01208207|471213238|FG005|Part II|Adverse Event|4|||
130885034|NCT01208207|471213239|FG006|Part II|Adverse Event|2|||
130885035|NCT01208207|471213233|FG000|Part II|Lack of Efficacy|0|||
130885036|NCT01208207|471213234|FG001|Part II|Lack of Efficacy|0|||
130885037|NCT01208207|471213235|FG002|Part II|Lack of Efficacy|0|||
130885038|NCT01208207|471213236|FG003|Part II|Lack of Efficacy|6|||
130885039|NCT01208207|471213237|FG004|Part II|Lack of Efficacy|4|||
130885040|NCT01208207|471213238|FG005|Part II|Lack of Efficacy|3|||
130885041|NCT01208207|471213239|FG006|Part II|Lack of Efficacy|3|||
130885042|NCT01208207|471213233|FG000|Part II|Lost to Follow-up|0|||
130885043|NCT01208207|471213234|FG001|Part II|Lost to Follow-up|0|||
130885044|NCT01208207|471213235|FG002|Part II|Lost to Follow-up|0|||
130885045|NCT01208207|471213236|FG003|Part II|Lost to Follow-up|4|||
130885046|NCT01208207|471213237|FG004|Part II|Lost to Follow-up|0|||
130885047|NCT01208207|471213238|FG005|Part II|Lost to Follow-up|2|||
130885048|NCT01208207|471213239|FG006|Part II|Lost to Follow-up|1|||
130885049|NCT01208207|471213233|FG000|Part II|Non-Compliance With Study Drug|0|||
130885050|NCT01208207|471213234|FG001|Part II|Non-Compliance With Study Drug|0|||
130885051|NCT01208207|471213235|FG002|Part II|Non-Compliance With Study Drug|0|||
130885052|NCT01208207|471213236|FG003|Part II|Non-Compliance With Study Drug|4|||
130885053|NCT01208207|471213237|FG004|Part II|Non-Compliance With Study Drug|1|||
130885054|NCT01208207|471213238|FG005|Part II|Non-Compliance With Study Drug|1|||
130885055|NCT01208207|471213239|FG006|Part II|Non-Compliance With Study Drug|0|||
130885056|NCT01208207|471213233|FG000|Part II|Physician Decision|0|||
130885057|NCT01208207|471213234|FG001|Part II|Physician Decision|0|||
130885058|NCT01208207|471213235|FG002|Part II|Physician Decision|0|||
131008202|NCT00359619|471659472|FG003|Overall Study|Lost to Follow-up|1|||
131008203|NCT00359619|471659473|FG004|Overall Study|Lost to Follow-up|1|||
130885059|NCT01208207|471213236|FG003|Part II|Physician Decision|1|||
131008204|NCT00359619|471659474|FG005|Overall Study|Lost to Follow-up|5|||
131008205|NCT00359619|471659475|FG006|Overall Study|Lost to Follow-up|0|||
131008206|NCT00256308|471659480|FG000|Overall Study|Death|2|||
131008207|NCT01419717|471659481|FG000|Overall Study|Protocol-specified Criteria|62|||
131008208|NCT01419717|471659481|FG000|Overall Study|Adverse Event|19|||
131008209|NCT01419717|471659481|FG000|Overall Study|Death|17|||
131008210|NCT01419717|471659481|FG000|Overall Study|Withdrawal by Subject|10|||
131008211|NCT01419717|471659481|FG000|Overall Study|Disease Progression|9|||
131008212|NCT01419717|471659481|FG000|Overall Study|Other|4|||
131008213|NCT01419717|471659481|FG000|Overall Study|Lost to Follow-up|2|||
131008214|NCT01419717|471659481|FG000|Overall Study|Administrative Decision|1|||
131008215|NCT01419717|471659481|FG000|Overall Study|Noncompliance|1|||
131008216|NCT02857283|471659482|FG000|First Exposure|Withdrawal by Subject|1|||
131008217|NCT02857283|471659483|FG001|First Exposure|Withdrawal by Subject|0|||
131008218|NCT01537133|471659484|FG000|Overall Study|Withdrawal by Subject|2|||
131008219|NCT01537133|471659485|FG001|Overall Study|Withdrawal by Subject|0|||
131008220|NCT01537133|471659486|FG002|Overall Study|Withdrawal by Subject|0|||
131008221|NCT01537133|471659487|FG003|Overall Study|Withdrawal by Subject|0|||
131008222|NCT01537133|471659484|FG000|Overall Study|Lost to Follow-up|1|||
131008223|NCT01537133|471659485|FG001|Overall Study|Lost to Follow-up|0|||
131008224|NCT01537133|471659486|FG002|Overall Study|Lost to Follow-up|0|||
131008225|NCT01537133|471659487|FG003|Overall Study|Lost to Follow-up|0|||
131008226|NCT00587288|471659488|FG000|Overall Study|Adverse Event|0|||
131008227|NCT00587288|471659489|FG001|Overall Study|Adverse Event|1|||
131008228|NCT00587288|471659488|FG000|Overall Study|Lack of Efficacy|2|||
131008229|NCT00587288|471659489|FG001|Overall Study|Lack of Efficacy|8|||
131008230|NCT00587288|471659488|FG000|Overall Study|Protocol Violation|1|||
131008231|NCT00587288|471659489|FG001|Overall Study|Protocol Violation|0|||
131008232|NCT00531479|471659492|FG000|Overall Study|Death|68|||
131008233|NCT00531479|471659493|FG001|Overall Study|Death|71|||
131008234|NCT00531479|471659492|FG000|Overall Study|Lost to Follow-up|0|||
131008235|NCT00531479|471659493|FG001|Overall Study|Lost to Follow-up|2|||
131008236|NCT00531479|471659492|FG000|Overall Study|Other|0|||
131008237|NCT00531479|471659493|FG001|Overall Study|Other|1|||
131008238|NCT00531479|471659492|FG000|Overall Study|Withdrawal by Subject|6|||
131008239|NCT00531479|471659493|FG001|Overall Study|Withdrawal by Subject|6|||
131008240|NCT00531479|471659492|FG000|Overall Study|Did not receive treatment|2|||
131008241|NCT00531479|471659493|FG001|Overall Study|Did not receive treatment|3|||
131008242|NCT05074498|471659496|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
131008243|NCT05074498|471659497|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
131008244|NCT05074498|471659498|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
131008245|NCT05074498|471659499|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
131008246|NCT05074498|471659500|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
131008247|NCT05074498|471659501|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
131008248|NCT05074498|471659496|FG000|Part 1 (Upto Day 104)|Other|1|||
131008249|NCT05074498|471659497|FG001|Part 1 (Upto Day 104)|Other|0|||
131008250|NCT05074498|471659498|FG002|Part 1 (Upto Day 104)|Other|0|||
131008251|NCT05074498|471659499|FG003|Part 1 (Upto Day 104)|Other|0|||
131008252|NCT05074498|471659500|FG004|Part 1 (Upto Day 104)|Other|0|||
131008253|NCT05074498|471659501|FG005|Part 1 (Upto Day 104)|Other|0|||
131008254|NCT05074498|471659496|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
131008255|NCT05074498|471659497|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
131008256|NCT05074498|471659498|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
131008257|NCT05074498|471659499|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
131008258|NCT05074498|471659500|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
131008259|NCT05074498|471659501|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
131008260|NCT05074498|471659496|FG000|Part 2 (Upto Day 104)|Death|0|||
131008261|NCT05074498|471659497|FG001|Part 2 (Upto Day 104)|Death|0|||
131008262|NCT05074498|471659498|FG002|Part 2 (Upto Day 104)|Death|0|||
131008263|NCT05074498|471659499|FG003|Part 2 (Upto Day 104)|Death|0|||
131008264|NCT05074498|471659500|FG004|Part 2 (Upto Day 104)|Death|1|||
131008265|NCT05074498|471659501|FG005|Part 2 (Upto Day 104)|Death|0|||
131008266|NCT05074498|471659496|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
131008267|NCT05074498|471659497|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
131008268|NCT05074498|471659498|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
131008269|NCT05074498|471659499|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
131008270|NCT05074498|471659500|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
131008271|NCT05074498|471659501|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
131008272|NCT05074498|471659496|FG000|Part 2 (Upto Day 104)|Other|0|||
131008273|NCT05074498|471659497|FG001|Part 2 (Upto Day 104)|Other|0|||
131008274|NCT05074498|471659498|FG002|Part 2 (Upto Day 104)|Other|0|||
131008275|NCT05074498|471659499|FG003|Part 2 (Upto Day 104)|Other|0|||
131008276|NCT05074498|471659500|FG004|Part 2 (Upto Day 104)|Other|1|||
131008277|NCT05074498|471659501|FG005|Part 2 (Upto Day 104)|Other|0|||
131008278|NCT01240356|471659502|FG000|Overall Study|Withdrawal by Subject|2|||
131008279|NCT01240356|471659503|FG001|Overall Study|Withdrawal by Subject|0|||
131008280|NCT01240356|471659502|FG000|Overall Study|MRI contraindication|1|||
131008281|NCT01240356|471659503|FG001|Overall Study|MRI contraindication|0|||
131008282|NCT02501629|471659513|FG000|Overall Study|Death|0|||
131008283|NCT02501629|471659514|FG001|Overall Study|Death|1|||
131008284|NCT02501629|471659513|FG000|Overall Study|Withdrawn from study by sponsor|1|||
131008285|NCT02501629|471659514|FG001|Overall Study|Withdrawn from study by sponsor|0|||
131008286|NCT02501629|471659513|FG000|Overall Study|Early termination by sponsor|1|||
131008287|NCT02501629|471659514|FG001|Overall Study|Early termination by sponsor|0|||
131008288|NCT02501629|471659513|FG000|Overall Study|Withdrawal by Subject|3|||
131008289|NCT02501629|471659514|FG001|Overall Study|Withdrawal by Subject|5|||
131008290|NCT02501629|471659513|FG000|Overall Study|Subject did not return to site|0|||
131008291|NCT02501629|471659514|FG001|Overall Study|Subject did not return to site|1|||
131008292|NCT00868231|471659517|FG000|Treatment Period 1|Adverse Event|0|||
131008293|NCT00868231|471659518|FG001|Treatment Period 1|Adverse Event|0|||
131008294|NCT00868231|471659519|FG002|Treatment Period 1|Adverse Event|0|||
131008295|NCT00868231|471659520|FG003|Treatment Period 1|Adverse Event|0|||
131008296|NCT00868231|471659521|FG004|Treatment Period 1|Adverse Event|1|||
131008297|NCT00868231|471659522|FG005|Treatment Period 1|Adverse Event|0|||
131008298|NCT00868231|471659517|FG000|Treatment Period 2|Adverse Event|1|||
131008299|NCT00868231|471659518|FG001|Treatment Period 2|Adverse Event|0|||
131008300|NCT00868231|471659519|FG002|Treatment Period 2|Adverse Event|0|||
131008301|NCT00868231|471659520|FG003|Treatment Period 2|Adverse Event|0|||
131008302|NCT00868231|471659521|FG004|Treatment Period 2|Adverse Event|0|||
131008303|NCT00868231|471659522|FG005|Treatment Period 2|Adverse Event|0|||
131008304|NCT00868231|471659517|FG000|Treatment Period 3|Adverse Event|0|||
131008305|NCT00868231|471659518|FG001|Treatment Period 3|Adverse Event|0|||
131008306|NCT00868231|471659519|FG002|Treatment Period 3|Adverse Event|1|||
131008307|NCT00868231|471659520|FG003|Treatment Period 3|Adverse Event|0|||
131008308|NCT00868231|471659521|FG004|Treatment Period 3|Adverse Event|0|||
131008309|NCT00868231|471659522|FG005|Treatment Period 3|Adverse Event|0|||
131008310|NCT04381494|471659527|FG000|Overall Study|Early termination of trial|19|||
131008311|NCT04381494|471659527|FG000|Overall Study|Investigator's discretion|1|||
131008312|NCT04381494|471659527|FG000|Overall Study|Withdrawal by Subject|9|||
131008313|NCT04381494|471659527|FG000|Overall Study|NSCLC disease progression|4|||
131008314|NCT04381494|471659527|FG000|Overall Study|Device-Related Adverse Event|2|||
131008315|NCT04310579|471659528|FG000|Overall Study|Adverse Event|0|||
131008316|NCT04310579|471659529|FG001|Overall Study|Adverse Event|0|||
131008317|NCT04310579|471659530|FG002|Overall Study|Adverse Event|0|||
131008318|NCT04310579|471659531|FG003|Overall Study|Adverse Event|0|||
131008319|NCT04310579|471659532|FG004|Overall Study|Adverse Event|0|||
131008320|NCT04310579|471659533|FG005|Overall Study|Adverse Event|0|||
131008321|NCT04310579|471659534|FG006|Overall Study|Adverse Event|2|||
131008322|NCT04310579|471659535|FG007|Overall Study|Adverse Event|0|||
131008323|NCT04310579|471659536|FG008|Overall Study|Adverse Event|1|||
131008324|NCT04310579|471659537|FG009|Overall Study|Adverse Event|1|||
131008325|NCT04310579|471659538|FG010|Overall Study|Adverse Event|0|||
131008326|NCT04310579|471659528|FG000|Overall Study|Withdrawal by Subject|0|||
131008327|NCT04310579|471659529|FG001|Overall Study|Withdrawal by Subject|0|||
131008328|NCT04310579|471659530|FG002|Overall Study|Withdrawal by Subject|0|||
131008329|NCT04310579|471659531|FG003|Overall Study|Withdrawal by Subject|0|||
131008330|NCT04310579|471659532|FG004|Overall Study|Withdrawal by Subject|0|||
131008331|NCT04310579|471659533|FG005|Overall Study|Withdrawal by Subject|1|||
131008332|NCT04310579|471659534|FG006|Overall Study|Withdrawal by Subject|0|||
131008333|NCT04310579|471659535|FG007|Overall Study|Withdrawal by Subject|0|||
131008334|NCT04310579|471659536|FG008|Overall Study|Withdrawal by Subject|0|||
131008335|NCT04310579|471659537|FG009|Overall Study|Withdrawal by Subject|0|||
131008336|NCT04310579|471659538|FG010|Overall Study|Withdrawal by Subject|0|||
131008337|NCT04310579|471659528|FG000|Overall Study|Positive COVID-19 test|0|||
131008338|NCT04310579|471659529|FG001|Overall Study|Positive COVID-19 test|0|||
131008339|NCT04310579|471659530|FG002|Overall Study|Positive COVID-19 test|0|||
131008340|NCT04310579|471659531|FG003|Overall Study|Positive COVID-19 test|0|||
131008341|NCT04310579|471659532|FG004|Overall Study|Positive COVID-19 test|0|||
131008342|NCT04310579|471659533|FG005|Overall Study|Positive COVID-19 test|0|||
131008343|NCT04310579|471659534|FG006|Overall Study|Positive COVID-19 test|0|||
131008344|NCT04310579|471659535|FG007|Overall Study|Positive COVID-19 test|0|||
131008345|NCT04310579|471659536|FG008|Overall Study|Positive COVID-19 test|0|||
131008346|NCT04310579|471659537|FG009|Overall Study|Positive COVID-19 test|0|||
131008347|NCT04310579|471659538|FG010|Overall Study|Positive COVID-19 test|1|||
131008348|NCT00601640|471659543|FG000|Overall Study|Withdrawal by Subject|3|||
131008349|NCT00601640|471659544|FG001|Overall Study|Withdrawal by Subject|0|||
131008350|NCT00601640|471659545|FG002|Overall Study|Withdrawal by Subject|7|||
131008351|NCT00601640|471659543|FG000|Overall Study|Death|1|||
131008352|NCT00601640|471659544|FG001|Overall Study|Death|0|||
131008353|NCT00601640|471659545|FG002|Overall Study|Death|0|||
131008354|NCT00601640|471659543|FG000|Overall Study|Adverse Event|0|||
131008355|NCT00601640|471659544|FG001|Overall Study|Adverse Event|4|||
131008356|NCT00601640|471659545|FG002|Overall Study|Adverse Event|2|||
131008357|NCT00601640|471659543|FG000|Overall Study|intercurrent illness|1|||
131008358|NCT00601640|471659544|FG001|Overall Study|intercurrent illness|0|||
131008359|NCT00601640|471659545|FG002|Overall Study|intercurrent illness|0|||
131008360|NCT00601640|471659543|FG000|Overall Study|change in eligibility status|0|||
131008361|NCT00601640|471659544|FG001|Overall Study|change in eligibility status|1|||
131008362|NCT00601640|471659545|FG002|Overall Study|change in eligibility status|1|||
131008363|NCT00530777|471659546|FG000|Overall Study|Lost to Follow-up|0|||
131008364|NCT00530777|471659547|FG001|Overall Study|Lost to Follow-up|1|||
131008365|NCT00530777|471659546|FG000|Overall Study|Death|1|||
131008366|NCT00530777|471659547|FG001|Overall Study|Death|2|||
131008367|NCT00530777|471659546|FG000|Overall Study|Physician Decision|1|||
131008368|NCT00530777|471659547|FG001|Overall Study|Physician Decision|0|||
131008369|NCT00530777|471659546|FG000|Overall Study|Withdrawal by Subject|0|||
131008370|NCT00530777|471659547|FG001|Overall Study|Withdrawal by Subject|1|||
131008371|NCT00530777|471659546|FG000|Overall Study|Unable to adhere to visit schedule|5|||
131008372|NCT00530777|471659547|FG001|Overall Study|Unable to adhere to visit schedule|1|||
131008373|NCT03382821|471659554|FG000|Overall Study|Did not receive allocated intervention.|0|||
131008374|NCT03382821|471659555|FG001|Overall Study|Did not receive allocated intervention.|3|||
131008375|NCT00282438|471659556|FG000|Overall Study|Lack of Efficacy|1|||
131008376|NCT00282438|471659557|FG001|Overall Study|Lack of Efficacy|0|||
131008377|NCT00282438|471659556|FG000|Overall Study|Death|0|||
131008378|NCT00282438|471659557|FG001|Overall Study|Death|1|||
131008379|NCT01008748|471659567|FG000|Overall Study|Lost to Follow-up|80|||
131008380|NCT01008748|471659567|FG000|Overall Study|Other|1|||
131008381|NCT02775435|471659568|FG000|Overall Study|Adverse Event|32|||
131008382|NCT02775435|471659569|FG001|Overall Study|Adverse Event|27|||
131008383|NCT02775435|471659568|FG000|Overall Study|Lost to Follow-up|2|||
131008384|NCT02775435|471659569|FG001|Overall Study|Lost to Follow-up|2|||
131008385|NCT02775435|471659568|FG000|Overall Study|Sponsor decision|44|||
131008386|NCT02775435|471659569|FG001|Overall Study|Sponsor decision|19|||
131008387|NCT02775435|471659568|FG000|Overall Study|Withdrawal by Subject|4|||
131008388|NCT02775435|471659569|FG001|Overall Study|Withdrawal by Subject|9|||
131008389|NCT02775435|471659568|FG000|Overall Study|Death|196|||
131008390|NCT02775435|471659569|FG001|Overall Study|Death|224|||
131008391|NCT03537651|471659572|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
131008392|NCT03537651|471659572|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
131008393|NCT03537651|471659572|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
131008394|NCT03537651|471659572|FG000|Part A (Up to 96 Weeks)|Other|1|||
131008395|NCT03537651|471659572|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
131008396|NCT03537651|471659572|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
131008397|NCT03537651|471659572|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
131008398|NCT03537651|471659572|FG000|Part B (Up to 192 Weeks)|Other|1|||
131008399|NCT05015478|471659573|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
131008400|NCT05015478|471659574|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
131008401|NCT05015478|471659575|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
131008402|NCT05015478|471659576|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
131008403|NCT00654238|471659578|FG000|Overall Study|Screen Failures|4|||
131008404|NCT05096884|471659580|FG000|Overall Study|Excluded based on negative tilt table test|4|||
131008405|NCT01096056|471659581|FG000|Overall Study|Lost to Follow-up|0|||
131008406|NCT01096056|471659582|FG001|Overall Study|Lost to Follow-up|1|||
131008407|NCT03781804|471659586|FG000|Overall Study|Adverse Event|2|||
131008408|NCT03781804|471659587|FG001|Overall Study|Adverse Event|2|||
131008409|NCT03781804|471659588|FG002|Overall Study|Adverse Event|3|||
131008410|NCT03781804|471659586|FG000|Overall Study|Lost to Follow-up|1|||
131008411|NCT03781804|471659587|FG001|Overall Study|Lost to Follow-up|1|||
131008412|NCT03781804|471659588|FG002|Overall Study|Lost to Follow-up|2|||
131008413|NCT03781804|471659586|FG000|Overall Study|Lack of Efficacy|4|||
131008414|NCT03781804|471659587|FG001|Overall Study|Lack of Efficacy|2|||
131008415|NCT03781804|471659588|FG002|Overall Study|Lack of Efficacy|9|||
131008416|NCT03781804|471659586|FG000|Overall Study|Protocol Violation|0|||
131008417|NCT03781804|471659587|FG001|Overall Study|Protocol Violation|0|||
131008418|NCT03781804|471659588|FG002|Overall Study|Protocol Violation|1|||
131008419|NCT03781804|471659586|FG000|Overall Study|Withdrawal by Subject|0|||
131008420|NCT03781804|471659587|FG001|Overall Study|Withdrawal by Subject|1|||
131008421|NCT03781804|471659588|FG002|Overall Study|Withdrawal by Subject|1|||
131008422|NCT03781804|471659586|FG000|Overall Study|Reason not provided|2|||
131008423|NCT03781804|471659587|FG001|Overall Study|Reason not provided|2|||
131008424|NCT03781804|471659588|FG002|Overall Study|Reason not provided|0|||
131008425|NCT00337818|471659589|FG000|Overall Study|Lost to Follow-up|289|||
131008426|NCT00337818|471659590|FG001|Overall Study|Lost to Follow-up|91|||
131008427|NCT00337818|471659591|FG002|Overall Study|Lost to Follow-up|107|||
131008428|NCT04678830|471659592|FG000|Overall Study|Lack of Efficacy|2|||
131008429|NCT04678830|471659593|FG001|Overall Study|Lack of Efficacy|0|||
131008430|NCT04678830|471659592|FG000|Overall Study|Withdrawal by Subject|0|||
131008431|NCT04678830|471659593|FG001|Overall Study|Withdrawal by Subject|1|||
131008432|NCT01190176|471659596|FG000|Overall Study|Withdrawal by Subject|1|||
131008433|NCT01190176|471659596|FG000|Overall Study|Lost to Follow-up|1|||
131008434|NCT02189863|471659597|FG000|First 2 Weeks|Motion Sickness|4|||
131008435|NCT02189863|471659598|FG001|First 2 Weeks|Motion Sickness|2|||
131008436|NCT03697460|471659599|FG000|Overall Study|Withdrawal by Subject|3|||
131008437|NCT03369951|471659601|FG000|Overall Study|Withdrawal by Subject|3|||
131008438|NCT03369951|471659601|FG000|Overall Study|Death|1|||
131008439|NCT03369951|471659601|FG000|Overall Study|Lost to Follow-up|1|||
131008440|NCT03369951|471659601|FG000|Overall Study|Protocol Violation|1|||
131008441|NCT03499600|471659607|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
131008442|NCT03499600|471659608|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
131008443|NCT03425539|471659610|FG000|Overall Study|Randomized but not treated|0|||
131008444|NCT03425539|471659611|FG001|Overall Study|Randomized but not treated|1|||
131008445|NCT03425539|471659610|FG000|Overall Study|Adverse Event|2|||
131008446|NCT03425539|471659611|FG001|Overall Study|Adverse Event|2|||
131008447|NCT03425539|471659610|FG000|Overall Study|Withdrawal by Subject|3|||
131008448|NCT03425539|471659611|FG001|Overall Study|Withdrawal by Subject|0|||
131008449|NCT03425539|471659610|FG000|Overall Study|Lost to Follow-up|0|||
131008450|NCT03425539|471659611|FG001|Overall Study|Lost to Follow-up|1|||
131008451|NCT01137292|471659612|FG000|Overall Study|Death|30|||
130885060|NCT01208207|471213237|FG004|Part II|Physician Decision|0|||
130885061|NCT01208207|471213238|FG005|Part II|Physician Decision|2|||
130885062|NCT01208207|471213239|FG006|Part II|Physician Decision|0|||
130885063|NCT01208207|471213233|FG000|Part II|Protocol Violation|0|||
130885064|NCT01208207|471213234|FG001|Part II|Protocol Violation|0|||
130885065|NCT01208207|471213235|FG002|Part II|Protocol Violation|0|||
130885066|NCT01208207|471213236|FG003|Part II|Protocol Violation|1|||
130885067|NCT01208207|471213237|FG004|Part II|Protocol Violation|0|||
130885068|NCT01208207|471213238|FG005|Part II|Protocol Violation|0|||
130885069|NCT01208207|471213239|FG006|Part II|Protocol Violation|0|||
130885070|NCT01208207|471213233|FG000|Part II|Technical Problems|0|||
130885071|NCT01208207|471213234|FG001|Part II|Technical Problems|0|||
130885072|NCT01208207|471213235|FG002|Part II|Technical Problems|0|||
130885073|NCT01208207|471213236|FG003|Part II|Technical Problems|1|||
130885074|NCT01208207|471213237|FG004|Part II|Technical Problems|0|||
130885075|NCT01208207|471213238|FG005|Part II|Technical Problems|1|||
130885076|NCT01208207|471213239|FG006|Part II|Technical Problems|0|||
130885077|NCT00724698|471213240|FG000|Overall Study|Adverse Event|9|||
130885078|NCT00724698|471213240|FG000|Overall Study|Failure of Therapy|4|||
130885079|NCT00724698|471213240|FG000|Overall Study|Poor Compliance|16|||
130885080|NCT00724698|471213240|FG000|Overall Study|Lost to Follow-up|36|||
130885081|NCT00724698|471213240|FG000|Overall Study|No Info|25|||
130885082|NCT02177032|471213243|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
130885083|NCT02177032|471213244|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
130885084|NCT02177032|471213245|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
130885085|NCT02177032|471213246|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
130885086|NCT02177032|471213243|FG000|Overall Study|Lost to Follow-up|0|||
130885087|NCT02177032|471213244|FG001|Overall Study|Lost to Follow-up|2|||
130885088|NCT02177032|471213245|FG002|Overall Study|Lost to Follow-up|0|||
130885089|NCT02177032|471213246|FG003|Overall Study|Lost to Follow-up|0|||
130885090|NCT02177032|471213243|FG000|Overall Study|OTHER|2|||
130885091|NCT02177032|471213244|FG001|Overall Study|OTHER|0|||
130885092|NCT02177032|471213245|FG002|Overall Study|OTHER|1|||
130885093|NCT02177032|471213246|FG003|Overall Study|OTHER|0|||
130885094|NCT02177032|471213243|FG000|Overall Study|Withdrawal by Subject|1|||
130885095|NCT02177032|471213244|FG001|Overall Study|Withdrawal by Subject|0|||
130885096|NCT02177032|471213245|FG002|Overall Study|Withdrawal by Subject|1|||
130885097|NCT02177032|471213246|FG003|Overall Study|Withdrawal by Subject|0|||
130885098|NCT00665652|471213247|FG000|Overall Study|Adverse Event|4|||
130885099|NCT00665652|471213247|FG000|Overall Study|Death|1|||
130885100|NCT00665652|471213247|FG000|Overall Study|No longer met inclusion criteria.|1|||
130885101|NCT02556177|471213250|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
130885102|NCT02556177|471213251|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
130885103|NCT01055197|471213262|FG000|Overall Study|Protocol Violation|7|||
130885104|NCT01055197|471213263|FG001|Overall Study|Protocol Violation|2|||
130885105|NCT01055197|471213262|FG000|Overall Study|Withdrawal by Subject|2|||
130885106|NCT01055197|471213263|FG001|Overall Study|Withdrawal by Subject|0|||
130885107|NCT00389610|471213264|FG000|Overall Study|Disease Progression|0|||
130885108|NCT00389610|471213265|FG001|Overall Study|Disease Progression|19|||
130885109|NCT00389610|471213264|FG000|Overall Study|Death|0|||
130885110|NCT00389610|471213265|FG001|Overall Study|Death|1|||
130885111|NCT00389610|471213264|FG000|Overall Study|Physician Decision|0|||
130885112|NCT00389610|471213265|FG001|Overall Study|Physician Decision|1|||
130885113|NCT00389610|471213264|FG000|Overall Study|Withdrawal by Subject|0|||
130885114|NCT00389610|471213265|FG001|Overall Study|Withdrawal by Subject|1|||
130885115|NCT00538902|471213266|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
130885116|NCT00538902|471213267|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
130885117|NCT00538902|471213268|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
130885118|NCT00538902|471213266|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
130885119|NCT00538902|471213267|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
130885120|NCT00538902|471213268|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
130885121|NCT00538902|471213266|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
130885122|NCT00538902|471213267|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
130885123|NCT00538902|471213268|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
130885124|NCT00538902|471213266|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
130885125|NCT00538902|471213267|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
131008452|NCT01137292|471659612|FG000|Overall Study|Adverse Event|3|||
130885126|NCT00538902|471213268|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
130885127|NCT00538902|471213266|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
130885128|NCT00538902|471213267|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
130885129|NCT00538902|471213268|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
130885130|NCT00538902|471213266|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
130885131|NCT00538902|471213267|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
131008453|NCT01137292|471659612|FG000|Overall Study|Lack of Efficacy|13|||
131008454|NCT01137292|471659612|FG000|Overall Study|Lost to Follow-up|1|||
131008455|NCT01137292|471659612|FG000|Overall Study|Other|7|||
131008456|NCT02014558|471659615|FG000|Overall Study|Never Received Study Drug|0|||
131008457|NCT02014558|471659616|FG001|Overall Study|Never Received Study Drug|0|||
131008458|NCT02014558|471659617|FG002|Overall Study|Never Received Study Drug|0|||
131008459|NCT02014558|471659618|FG003|Overall Study|Never Received Study Drug|0|||
131008460|NCT02014558|471659619|FG004|Overall Study|Never Received Study Drug|1|||
131008461|NCT02014558|471659620|FG005|Overall Study|Never Received Study Drug|0|||
131008462|NCT02014558|471659621|FG006|Overall Study|Never Received Study Drug|1|||
131008463|NCT02014558|471659622|FG007|Overall Study|Never Received Study Drug|0|||
131008464|NCT02014558|471659623|FG008|Overall Study|Never Received Study Drug|2|||
131008465|NCT02014558|471659624|FG009|Overall Study|Never Received Study Drug|0|||
131008466|NCT02014558|471659625|FG010|Overall Study|Never Received Study Drug|2|||
131008467|NCT02014558|471659626|FG011|Overall Study|Never Received Study Drug|2|||
131008468|NCT02014558|471659627|FG012|Overall Study|Never Received Study Drug|0|||
131008469|NCT02014558|471659615|FG000|Overall Study|Adverse Event|0|||
131008470|NCT02014558|471659616|FG001|Overall Study|Adverse Event|0|||
131008471|NCT02014558|471659617|FG002|Overall Study|Adverse Event|0|||
131008472|NCT02014558|471659618|FG003|Overall Study|Adverse Event|0|||
131008473|NCT02014558|471659619|FG004|Overall Study|Adverse Event|1|||
131008474|NCT02014558|471659620|FG005|Overall Study|Adverse Event|0|||
131008475|NCT02014558|471659621|FG006|Overall Study|Adverse Event|0|||
131008476|NCT02014558|471659622|FG007|Overall Study|Adverse Event|0|||
131008477|NCT02014558|471659623|FG008|Overall Study|Adverse Event|2|||
131008478|NCT02014558|471659624|FG009|Overall Study|Adverse Event|2|||
131008479|NCT02014558|471659625|FG010|Overall Study|Adverse Event|5|||
131008480|NCT02014558|471659626|FG011|Overall Study|Adverse Event|21|||
131008481|NCT02014558|471659627|FG012|Overall Study|Adverse Event|3|||
131008482|NCT02014558|471659615|FG000|Overall Study|Death|1|||
131008483|NCT02014558|471659616|FG001|Overall Study|Death|0|||
131008484|NCT02014558|471659617|FG002|Overall Study|Death|0|||
131008485|NCT02014558|471659618|FG003|Overall Study|Death|0|||
131008486|NCT02014558|471659619|FG004|Overall Study|Death|0|||
131008487|NCT02014558|471659620|FG005|Overall Study|Death|0|||
131008488|NCT02014558|471659621|FG006|Overall Study|Death|1|||
131008489|NCT02014558|471659622|FG007|Overall Study|Death|1|||
131008490|NCT02014558|471659623|FG008|Overall Study|Death|2|||
131008491|NCT02014558|471659624|FG009|Overall Study|Death|5|||
131008492|NCT02014558|471659625|FG010|Overall Study|Death|5|||
131008493|NCT02014558|471659626|FG011|Overall Study|Death|19|||
131008494|NCT02014558|471659627|FG012|Overall Study|Death|2|||
131008495|NCT02014558|471659615|FG000|Overall Study|Lack of Efficacy|1|||
131008496|NCT02014558|471659616|FG001|Overall Study|Lack of Efficacy|2|||
131008497|NCT02014558|471659617|FG002|Overall Study|Lack of Efficacy|1|||
131008498|NCT02014558|471659618|FG003|Overall Study|Lack of Efficacy|1|||
131008499|NCT02014558|471659619|FG004|Overall Study|Lack of Efficacy|0|||
131008500|NCT02014558|471659620|FG005|Overall Study|Lack of Efficacy|0|||
131008501|NCT02014558|471659621|FG006|Overall Study|Lack of Efficacy|1|||
131008502|NCT02014558|471659622|FG007|Overall Study|Lack of Efficacy|3|||
131008503|NCT02014558|471659623|FG008|Overall Study|Lack of Efficacy|3|||
131008504|NCT02014558|471659624|FG009|Overall Study|Lack of Efficacy|3|||
131008505|NCT02014558|471659625|FG010|Overall Study|Lack of Efficacy|16|||
131008506|NCT02014558|471659626|FG011|Overall Study|Lack of Efficacy|8|||
131008507|NCT02014558|471659627|FG012|Overall Study|Lack of Efficacy|5|||
131008508|NCT02014558|471659615|FG000|Overall Study|Lost to Follow-up|0|||
131008509|NCT02014558|471659616|FG001|Overall Study|Lost to Follow-up|0|||
131008510|NCT02014558|471659617|FG002|Overall Study|Lost to Follow-up|0|||
131008511|NCT02014558|471659618|FG003|Overall Study|Lost to Follow-up|0|||
131008512|NCT02014558|471659619|FG004|Overall Study|Lost to Follow-up|0|||
131008513|NCT02014558|471659620|FG005|Overall Study|Lost to Follow-up|0|||
131008514|NCT02014558|471659621|FG006|Overall Study|Lost to Follow-up|0|||
131008515|NCT02014558|471659622|FG007|Overall Study|Lost to Follow-up|0|||
131008516|NCT02014558|471659623|FG008|Overall Study|Lost to Follow-up|0|||
131008517|NCT02014558|471659624|FG009|Overall Study|Lost to Follow-up|0|||
131008518|NCT02014558|471659625|FG010|Overall Study|Lost to Follow-up|1|||
131008519|NCT02014558|471659626|FG011|Overall Study|Lost to Follow-up|0|||
131008520|NCT02014558|471659627|FG012|Overall Study|Lost to Follow-up|0|||
131008521|NCT02014558|471659615|FG000|Overall Study|Progressive Disease|1|||
131008522|NCT02014558|471659616|FG001|Overall Study|Progressive Disease|0|||
131008523|NCT02014558|471659617|FG002|Overall Study|Progressive Disease|1|||
131008524|NCT02014558|471659618|FG003|Overall Study|Progressive Disease|1|||
131008525|NCT02014558|471659619|FG004|Overall Study|Progressive Disease|1|||
131008526|NCT02014558|471659620|FG005|Overall Study|Progressive Disease|2|||
131008527|NCT02014558|471659621|FG006|Overall Study|Progressive Disease|1|||
131008528|NCT02014558|471659622|FG007|Overall Study|Progressive Disease|6|||
131008529|NCT02014558|471659623|FG008|Overall Study|Progressive Disease|5|||
131008530|NCT02014558|471659624|FG009|Overall Study|Progressive Disease|6|||
131008531|NCT02014558|471659625|FG010|Overall Study|Progressive Disease|22|||
131008532|NCT02014558|471659626|FG011|Overall Study|Progressive Disease|31|||
131008533|NCT02014558|471659627|FG012|Overall Study|Progressive Disease|6|||
131008534|NCT02014558|471659615|FG000|Overall Study|Withdrawal by Subject|0|||
131008535|NCT02014558|471659616|FG001|Overall Study|Withdrawal by Subject|0|||
131008536|NCT02014558|471659617|FG002|Overall Study|Withdrawal by Subject|0|||
131008537|NCT02014558|471659618|FG003|Overall Study|Withdrawal by Subject|0|||
131008538|NCT02014558|471659619|FG004|Overall Study|Withdrawal by Subject|1|||
131008539|NCT02014558|471659620|FG005|Overall Study|Withdrawal by Subject|0|||
131008540|NCT02014558|471659621|FG006|Overall Study|Withdrawal by Subject|0|||
131008541|NCT02014558|471659622|FG007|Overall Study|Withdrawal by Subject|0|||
131008542|NCT02014558|471659623|FG008|Overall Study|Withdrawal by Subject|0|||
131008543|NCT02014558|471659624|FG009|Overall Study|Withdrawal by Subject|2|||
131008544|NCT02014558|471659625|FG010|Overall Study|Withdrawal by Subject|6|||
131008545|NCT02014558|471659626|FG011|Overall Study|Withdrawal by Subject|10|||
131008546|NCT02014558|471659627|FG012|Overall Study|Withdrawal by Subject|0|||
131008547|NCT02014558|471659615|FG000|Overall Study|Miscellaneous|2|||
131008548|NCT02014558|471659616|FG001|Overall Study|Miscellaneous|1|||
131008549|NCT02014558|471659617|FG002|Overall Study|Miscellaneous|1|||
131008550|NCT02014558|471659618|FG003|Overall Study|Miscellaneous|1|||
131008551|NCT02014558|471659619|FG004|Overall Study|Miscellaneous|0|||
131008552|NCT02014558|471659620|FG005|Overall Study|Miscellaneous|1|||
131008553|NCT02014558|471659621|FG006|Overall Study|Miscellaneous|0|||
131008554|NCT02014558|471659622|FG007|Overall Study|Miscellaneous|1|||
131008555|NCT02014558|471659623|FG008|Overall Study|Miscellaneous|1|||
131008556|NCT02014558|471659624|FG009|Overall Study|Miscellaneous|3|||
131008557|NCT02014558|471659625|FG010|Overall Study|Miscellaneous|12|||
131008558|NCT02014558|471659626|FG011|Overall Study|Miscellaneous|11|||
131008559|NCT02014558|471659627|FG012|Overall Study|Miscellaneous|1|||
131008560|NCT04580407|471659628|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
131008561|NCT00681811|471659633|FG000|Overall Study|Adverse Event|1|||
131008562|NCT00681811|471659634|FG001|Overall Study|Adverse Event|1|||
131008563|NCT00681811|471659633|FG000|Overall Study|Withdrawal by Subject|2|||
131008564|NCT00681811|471659634|FG001|Overall Study|Withdrawal by Subject|2|||
131008565|NCT00681811|471659633|FG000|Overall Study|Non-compliance|0|||
131008566|NCT00681811|471659634|FG001|Overall Study|Non-compliance|1|||
131008567|NCT00797862|471661130|FG000|Overall Study|Adverse Event|86|||
131008568|NCT00797862|471661131|FG001|Overall Study|Adverse Event|44|||
131008569|NCT00797862|471661132|FG002|Overall Study|Adverse Event|58|||
131008570|NCT00797862|471661130|FG000|Overall Study|Abnormal Test Procedure Result|0|||
131008571|NCT00797862|471661131|FG001|Overall Study|Abnormal Test Procedure Result|1|||
131008572|NCT00797862|471661132|FG002|Overall Study|Abnormal Test Procedure Result|1|||
131008573|NCT00797862|471661130|FG000|Overall Study|Lack of Efficacy|1|||
131008574|NCT00797862|471661131|FG001|Overall Study|Lack of Efficacy|7|||
131008575|NCT00797862|471661132|FG002|Overall Study|Lack of Efficacy|6|||
131008576|NCT00797862|471661130|FG000|Overall Study|No longer required study medication|1|||
131008577|NCT00797862|471661131|FG001|Overall Study|No longer required study medication|0|||
131008578|NCT00797862|471661132|FG002|Overall Study|No longer required study medication|0|||
131008579|NCT00797862|471661130|FG000|Overall Study|Withdrawal by Subject|14|||
131008580|NCT00797862|471661131|FG001|Overall Study|Withdrawal by Subject|7|||
131008581|NCT00797862|471661132|FG002|Overall Study|Withdrawal by Subject|7|||
131008582|NCT00797862|471661130|FG000|Overall Study|Lost to Follow-up|11|||
131008583|NCT00797862|471661131|FG001|Overall Study|Lost to Follow-up|0|||
131008584|NCT00797862|471661132|FG002|Overall Study|Lost to Follow-up|5|||
131008585|NCT00797862|471661130|FG000|Overall Study|Administrative Problem|4|||
131008586|NCT00797862|471661131|FG001|Overall Study|Administrative Problem|0|||
131008587|NCT00797862|471661132|FG002|Overall Study|Administrative Problem|0|||
131008588|NCT00797862|471661130|FG000|Overall Study|Protocol Violation|4|||
131008589|NCT00797862|471661131|FG001|Overall Study|Protocol Violation|6|||
131008590|NCT00797862|471661132|FG002|Overall Study|Protocol Violation|8|||
131008591|NCT00797862|471661130|FG000|Overall Study|Mis-randomized|3|||
131008592|NCT00797862|471661131|FG001|Overall Study|Mis-randomized|3|||
131008593|NCT00797862|471661132|FG002|Overall Study|Mis-randomized|1|||
131008594|NCT00409708|471661136|FG000|Treatment|Abnormal test procedure result(s)|1|||
131008595|NCT00409708|471661137|FG001|Treatment|Abnormal test procedure result(s)|0|||
131008596|NCT00409708|471661136|FG000|Treatment|Lack of Efficacy|0|||
131008597|NCT00409708|471661137|FG001|Treatment|Lack of Efficacy|1|||
131008598|NCT00409708|471661136|FG000|Treatment|Protocol Violation|6|||
131008599|NCT00409708|471661137|FG001|Treatment|Protocol Violation|2|||
131008600|NCT00409708|471661136|FG000|Treatment|Withdrawal by Subject|3|||
131008601|NCT00409708|471661137|FG001|Treatment|Withdrawal by Subject|8|||
131008602|NCT00409708|471661136|FG000|Treatment|Lost to Follow-up|0|||
131008603|NCT00409708|471661137|FG001|Treatment|Lost to Follow-up|6|||
131008604|NCT00409708|471661136|FG000|Treatment|Administrative problems|5|||
131008605|NCT00409708|471661137|FG001|Treatment|Administrative problems|0|||
131008606|NCT00409708|471661136|FG000|Washout|Lack of Efficacy|9|||
131008607|NCT00409708|471661137|FG001|Washout|Lack of Efficacy|1|||
131008608|NCT00409708|471661136|FG000|Washout|Protocol Violation|0|||
131008609|NCT00409708|471661137|FG001|Washout|Protocol Violation|1|||
131008610|NCT00409708|471661136|FG000|Washout|Withdrawal by Subject|11|||
131222548|NCT01625286|472441527|FG003|Overall Study|Any reason not specifically recorded|0|||
131008611|NCT00409708|471661137|FG001|Washout|Withdrawal by Subject|5|||
131008612|NCT00409708|471661136|FG000|Washout|Lost to Follow-up|1|||
131008613|NCT00409708|471661137|FG001|Washout|Lost to Follow-up|3|||
131008614|NCT01474538|471661139|FG000|Treatment Period 1|Death|1|||
131008615|NCT01474538|471661140|FG001|Treatment Period 1|Death|0|||
131008616|NCT01474538|471661139|FG000|Treatment Period 1|Physician Decision|1|||
131008617|NCT01474538|471661140|FG001|Treatment Period 1|Physician Decision|0|||
131008618|NCT01474538|471661139|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131008619|NCT01474538|471661140|FG001|Treatment Period 1|Withdrawal by Subject|3|||
131008620|NCT01474538|471661139|FG000|Treatment Period 1|Protocol Violation|0|||
131008621|NCT01474538|471661140|FG001|Treatment Period 1|Protocol Violation|1|||
131008622|NCT01474538|471661139|FG000|Treatment Period 2|Death|1|||
131008623|NCT01474538|471661140|FG001|Treatment Period 2|Death|0|||
131008624|NCT01474538|471661139|FG000|Treatment Period 2|Adverse Event|1|||
131008625|NCT01474538|471661140|FG001|Treatment Period 2|Adverse Event|1|||
131008626|NCT01474538|471661139|FG000|Treatment Period 2|Withdrawal by Subject|2|||
131008627|NCT01474538|471661140|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131008628|NCT01474538|471661139|FG000|Treatment Period 2|Sponsor decision|1|||
131008629|NCT01474538|471661140|FG001|Treatment Period 2|Sponsor decision|0|||
131008630|NCT01474538|471661139|FG000|Treatment Period 2|Physician Decision|0|||
131008631|NCT01474538|471661140|FG001|Treatment Period 2|Physician Decision|1|||
131008632|NCT01474538|471661139|FG000|Treatment Period 2|Protocol Violation|1|||
131008633|NCT01474538|471661140|FG001|Treatment Period 2|Protocol Violation|0|||
131008634|NCT03120676|471661143|FG000|Overall Study|Not treated|1|||
131008635|NCT00926393|471661144|FG000|Overall Study|Withdrawal by Subject|1|||
131008636|NCT00926393|471661145|FG001|Overall Study|Withdrawal by Subject|2|||
131008637|NCT00926393|471661144|FG000|Overall Study|Adverse Event|1|||
131008638|NCT00926393|471661145|FG001|Overall Study|Adverse Event|1|||
131008639|NCT02333630|471661146|FG000|Overall Study|Lost to Follow-up|5|||
131008640|NCT02333630|471661147|FG001|Overall Study|Lost to Follow-up|2|||
131008641|NCT02359435|471661149|FG000|Overall Study|Lost to Follow-up|4|||
131008642|NCT02359435|471661150|FG001|Overall Study|Lost to Follow-up|4|||
131008643|NCT02321540|471661153|FG000|Overall Study|Death|0|||
131008644|NCT02321540|471661154|FG001|Overall Study|Death|1|||
131008645|NCT02321540|471661153|FG000|Overall Study|Progression|3|||
131008646|NCT02321540|471661154|FG001|Overall Study|Progression|9|||
131008647|NCT00530335|471661155|FG000|Overall Study|Adverse Event|3|||
131008648|NCT00530335|471661155|FG000|Overall Study|Protocol Violation|1|||
131008649|NCT00530335|471661155|FG000|Overall Study|Withdrawal by Subject|1|||
131008650|NCT00530335|471661155|FG000|Overall Study|Physician Decision|1|||
131008651|NCT02534896|471661159|FG000|Overall Study|Adverse Event|2|||
131008652|NCT02534896|471661160|FG001|Overall Study|Adverse Event|1|||
131008653|NCT02534896|471661161|FG002|Overall Study|Adverse Event|1|||
131008654|NCT02534896|471661159|FG000|Overall Study|Insufficient therapeutic response|2|||
131008655|NCT02534896|471661160|FG001|Overall Study|Insufficient therapeutic response|0|||
131008656|NCT02534896|471661161|FG002|Overall Study|Insufficient therapeutic response|0|||
131008657|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
131008658|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
131008659|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
131008660|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
131008661|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Adverse Event|198|||
131008662|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Adverse Event|0|||
131008663|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Adverse Event|0|||
131008664|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Adverse Event|0|||
131008665|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Death|62|||
131008666|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Death|0|||
131008667|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Death|0|||
131008668|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Death|0|||
131008669|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
131008670|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
131008671|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
131008672|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
131008673|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Complicating disease|13|||
131008674|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Complicating disease|0|||
131008675|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Complicating disease|0|||
131008676|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Complicating disease|0|||
131008677|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
131008678|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
131008679|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
131008680|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
131008681|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
131008682|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
131008683|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
131008684|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
131008685|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Non-compliance|4|||
131008686|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Non-compliance|0|||
131008687|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Non-compliance|0|||
131008688|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Non-compliance|0|||
131008689|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Pain|4|||
131008690|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Pain|0|||
131008691|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Pain|0|||
131008692|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Pain|0|||
131008693|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
131008694|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
131008695|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
131008696|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
131008697|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Hospice care|1|||
131008698|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Hospice care|0|||
131008699|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Hospice care|0|||
131008700|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Hospice care|0|||
131008701|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Physician Decision|1|||
131008702|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Physician Decision|0|||
131008703|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Physician Decision|0|||
131008704|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Physician Decision|0|||
131008705|NCT01107626|471661164|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
131008706|NCT01107626|471661165|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
131008707|NCT01107626|471661166|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
131008708|NCT01107626|471661167|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
131008709|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
131008710|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
131008711|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
131008712|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
131008713|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
131008714|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
131008715|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
131008716|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
131008717|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Death|0|||
131008718|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Death|8|||
131008719|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Death|2|||
131008720|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Death|13|||
131008721|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
131008722|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
131008723|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
131008724|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
131008725|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
131008726|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
131008727|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
131008728|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
131008729|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
131008730|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
131008731|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
131008732|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
131008733|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
131008734|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
131008735|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
131008736|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
131008737|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
131008738|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
131008739|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
131008740|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
131008741|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
131008742|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
131008743|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
131008744|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
131008745|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
131008746|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
130765931|NCT01712334|470765905|FG001|Treatment Period 1|Randomized in Error|2|||
131008747|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
131008748|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
131008749|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
131008750|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
131008751|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
131008752|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
131008753|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
131008754|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
131008755|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
131222549|NCT01625286|472441528|FG004|Overall Study|Any reason not specifically recorded|0|||
131008756|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
131008757|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
131008758|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
131008759|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
131008760|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
131008761|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Pain|0|||
131008762|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Pain|0|||
131008763|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Pain|0|||
131008764|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Pain|1|||
131008765|NCT01107626|471661164|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
131008766|NCT01107626|471661165|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
131008767|NCT01107626|471661166|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
131008768|NCT01107626|471661167|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
131008769|NCT04353037|471661168|FG000|Overall Study|Lost to Follow-up|0|||
131008770|NCT04353037|471661169|FG001|Overall Study|Lost to Follow-up|1|||
131008771|NCT04353037|471661170|FG002|Overall Study|Lost to Follow-up|2|||
131008772|NCT04353037|471661171|FG003|Overall Study|Lost to Follow-up|3|||
131008773|NCT04353037|471661168|FG000|Overall Study|Withdrawal by Subject|0|||
131008774|NCT04353037|471661169|FG001|Overall Study|Withdrawal by Subject|2|||
131008775|NCT04353037|471661170|FG002|Overall Study|Withdrawal by Subject|3|||
131008776|NCT04353037|471661171|FG003|Overall Study|Withdrawal by Subject|5|||
131008777|NCT04353037|471661168|FG000|Overall Study|Adverse Event|0|||
131008778|NCT04353037|471661169|FG001|Overall Study|Adverse Event|0|||
131008779|NCT04353037|471661170|FG002|Overall Study|Adverse Event|2|||
131008780|NCT04353037|471661171|FG003|Overall Study|Adverse Event|0|||
131008781|NCT04353037|471661168|FG000|Overall Study|Exposure Change|0|||
131008782|NCT04353037|471661169|FG001|Overall Study|Exposure Change|0|||
131008783|NCT04353037|471661170|FG002|Overall Study|Exposure Change|0|||
131008784|NCT04353037|471661171|FG003|Overall Study|Exposure Change|2|||
131008785|NCT03710564|471661172|FG000|Overall Study|Study Terminated by Sponsor|104|||
131008786|NCT03710564|471661173|FG001|Overall Study|Study Terminated by Sponsor|55|||
131008787|NCT03710564|471661172|FG000|Overall Study|Withdrawal by Subject|57|||
131008788|NCT03710564|471661173|FG001|Overall Study|Withdrawal by Subject|25|||
131008789|NCT03710564|471661172|FG000|Overall Study|Death|10|||
131008790|NCT03710564|471661173|FG001|Overall Study|Death|4|||
131008791|NCT03710564|471661172|FG000|Overall Study|Lost to Follow-up|5|||
131008792|NCT03710564|471661173|FG001|Overall Study|Lost to Follow-up|4|||
131008793|NCT03710564|471661172|FG000|Overall Study|Protocol Violation|3|||
131008794|NCT03710564|471661173|FG001|Overall Study|Protocol Violation|2|||
131008795|NCT03710564|471661172|FG000|Overall Study|Adverse Event|3|||
131008796|NCT03710564|471661173|FG001|Overall Study|Adverse Event|0|||
131008797|NCT03710564|471661172|FG000|Overall Study|Physician Decision|2|||
131008798|NCT03710564|471661173|FG001|Overall Study|Physician Decision|3|||
131008799|NCT00003656|471661174|FG000|Overall Study|Adverse Event|0|||
131008800|NCT00003656|471661175|FG001|Overall Study|Adverse Event|1|||
131008801|NCT01941316|471661176|FG000|Overall Study|Adverse Event|0|||
131008802|NCT01941316|471661177|FG001|Overall Study|Adverse Event|1|||
131008803|NCT01941316|471661178|FG002|Overall Study|Adverse Event|0|||
131008804|NCT01941316|471661179|FG003|Overall Study|Adverse Event|7|||
131008805|NCT01941316|471661176|FG000|Overall Study|Progressive Disease|3|||
131008806|NCT01941316|471661177|FG001|Overall Study|Progressive Disease|6|||
131008807|NCT01941316|471661178|FG002|Overall Study|Progressive Disease|2|||
131008808|NCT01941316|471661179|FG003|Overall Study|Progressive Disease|29|||
131008809|NCT01941316|471661176|FG000|Overall Study|Withdrawal by Subject|0|||
131008810|NCT01941316|471661177|FG001|Overall Study|Withdrawal by Subject|2|||
131008811|NCT01941316|471661178|FG002|Overall Study|Withdrawal by Subject|1|||
131008812|NCT01941316|471661179|FG003|Overall Study|Withdrawal by Subject|8|||
131008813|NCT01941316|471661176|FG000|Overall Study|Death|0|||
131008814|NCT01941316|471661177|FG001|Overall Study|Death|0|||
131008815|NCT01941316|471661178|FG002|Overall Study|Death|0|||
131008816|NCT01941316|471661179|FG003|Overall Study|Death|3|||
131008817|NCT01941316|471661176|FG000|Overall Study|Physician Decision|0|||
131008818|NCT01941316|471661177|FG001|Overall Study|Physician Decision|0|||
131008819|NCT01941316|471661178|FG002|Overall Study|Physician Decision|0|||
131008820|NCT01941316|471661179|FG003|Overall Study|Physician Decision|3|||
131008821|NCT01941316|471661176|FG000|Overall Study|Protocol Violation|0|||
131008822|NCT01941316|471661177|FG001|Overall Study|Protocol Violation|0|||
131008823|NCT01941316|471661178|FG002|Overall Study|Protocol Violation|0|||
131008824|NCT01941316|471661179|FG003|Overall Study|Protocol Violation|3|||
131008825|NCT01941316|471661176|FG000|Overall Study|Intercurrent illness|0|||
131008826|NCT01941316|471661177|FG001|Overall Study|Intercurrent illness|0|||
131008827|NCT01941316|471661178|FG002|Overall Study|Intercurrent illness|0|||
131008828|NCT01941316|471661179|FG003|Overall Study|Intercurrent illness|1|||
131008829|NCT01941316|471661176|FG000|Overall Study|Other, not specified|0|||
131008830|NCT01941316|471661177|FG001|Overall Study|Other, not specified|0|||
131008831|NCT01941316|471661178|FG002|Overall Study|Other, not specified|0|||
131008832|NCT01941316|471661179|FG003|Overall Study|Other, not specified|1|||
131008833|NCT02403323|471661188|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
131222550|NCT01625286|472441529|FG005|Overall Study|Any reason not specifically recorded|1|||
131008834|NCT02403323|471661189|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
131008835|NCT02403323|471661190|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
131008836|NCT02403323|471661188|FG000|Part 1: Open Label Extension Period|Death|3|||
131008837|NCT02403323|471661189|FG001|Part 1: Open Label Extension Period|Death|0|||
131008838|NCT02403323|471661190|FG002|Part 1: Open Label Extension Period|Death|0|||
131008839|NCT02403323|471661188|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
131008840|NCT02403323|471661189|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
131008841|NCT02403323|471661190|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
131008842|NCT02403323|471661188|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
131008843|NCT02403323|471661189|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
131008844|NCT02403323|471661190|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
131008845|NCT02403323|471661188|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
131008846|NCT02403323|471661189|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
131008847|NCT02403323|471661190|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
131008848|NCT02403323|471661188|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
131008849|NCT02403323|471661189|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
131008850|NCT02403323|471661190|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
131008851|NCT02403323|471661188|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
131008852|NCT02403323|471661189|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
131008853|NCT02403323|471661190|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
131008854|NCT02403323|471661188|FG000|Part 1: Open Label Extension Period|Other|1|||
131008855|NCT02403323|471661189|FG001|Part 1: Open Label Extension Period|Other|0|||
131008856|NCT02403323|471661190|FG002|Part 1: Open Label Extension Period|Other|0|||
131008857|NCT02403323|471661188|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
131008858|NCT02403323|471661189|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
131008859|NCT02403323|471661190|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
131008860|NCT02403323|471661188|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
131008861|NCT02403323|471661189|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
131008862|NCT02403323|471661190|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
131008863|NCT02403323|471661188|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
131008864|NCT02403323|471661189|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
131008865|NCT02403323|471661190|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
131008866|NCT02403323|471661188|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
131008867|NCT02403323|471661189|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
131008868|NCT02403323|471661190|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
131008869|NCT02403323|471661188|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
131008870|NCT02403323|471661189|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
131008871|NCT02403323|471661190|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
131008872|NCT02403323|471661188|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
131008873|NCT02403323|471661189|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
131008874|NCT02403323|471661190|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
131008875|NCT02403323|471661188|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
131008876|NCT02403323|471661189|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
131008877|NCT02403323|471661190|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
131008878|NCT02403323|471661188|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
131008879|NCT02403323|471661189|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
131008880|NCT02403323|471661190|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
131008881|NCT02403323|471661188|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
131008882|NCT02403323|471661189|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
131008883|NCT02403323|471661190|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
131008884|NCT02403323|471661188|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
131008885|NCT02403323|471661189|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
131008886|NCT02403323|471661190|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
131008887|NCT00197236|471661194|FG000|Overall Study|Adverse Event|1|||
131008888|NCT00197236|471661195|FG001|Overall Study|Adverse Event|0|||
131008889|NCT00197236|471661196|FG002|Overall Study|Adverse Event|1|||
131008890|NCT00197236|471661194|FG000|Overall Study|Lost to Follow-up|5|||
131008891|NCT00197236|471661195|FG001|Overall Study|Lost to Follow-up|14|||
130885132|NCT00538902|471213268|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
131008892|NCT00197236|471661196|FG002|Overall Study|Lost to Follow-up|6|||
131008893|NCT00197236|471661194|FG000|Overall Study|Protocol Violation|0|||
131008894|NCT00197236|471661195|FG001|Overall Study|Protocol Violation|0|||
131008895|NCT00197236|471661196|FG002|Overall Study|Protocol Violation|1|||
131008896|NCT00197236|471661194|FG000|Overall Study|Withdrawal by Subject|7|||
131008897|NCT00197236|471661195|FG001|Overall Study|Withdrawal by Subject|3|||
131008898|NCT00197236|471661196|FG002|Overall Study|Withdrawal by Subject|11|||
131008899|NCT00197236|471661194|FG000|Overall Study|Study drug/medication expiration|1|||
130765932|NCT01253174|470765906|FG000|Period 1|Randomized but not treated|0|||
130885133|NCT00538902|471213266|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
130885134|NCT00538902|471213267|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
130885135|NCT00538902|471213268|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
130885136|NCT00538902|471213266|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
130885137|NCT00538902|471213267|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
130885138|NCT00538902|471213268|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
130885139|NCT03739203|471213269|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
130885140|NCT03739203|471213270|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
130885141|NCT03739203|471213271|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
130885142|NCT03739203|471213269|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
130885143|NCT03739203|471213270|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130885144|NCT03739203|471213271|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
130885145|NCT03739203|471213269|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
130885146|NCT03739203|471213270|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
130885147|NCT03739203|471213271|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
130885148|NCT03739203|471213269|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
130885149|NCT03739203|471213270|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
130885150|NCT03739203|471213271|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
130885151|NCT03739203|471213269|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
130885152|NCT03739203|471213270|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
130885153|NCT03739203|471213271|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
130885154|NCT03739203|471213269|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
130885155|NCT03739203|471213270|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
130885156|NCT03739203|471213271|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
130885157|NCT03739203|471213269|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
130885158|NCT03739203|471213270|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
130885159|NCT03739203|471213271|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
130885160|NCT03739203|471213269|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
130885161|NCT03739203|471213270|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
130885162|NCT03739203|471213271|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
130885163|NCT03739203|471213269|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
130885164|NCT03739203|471213270|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
130885165|NCT03739203|471213271|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
130885166|NCT03739203|471213269|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
130885167|NCT03739203|471213270|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
130885168|NCT03739203|471213271|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
130885169|NCT03739203|471213269|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
130885170|NCT03739203|471213270|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
130885171|NCT03739203|471213271|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
130885172|NCT03131570|471213272|FG000|Overall Study|Adverse Event|1|||
130885173|NCT03131570|471213273|FG001|Overall Study|Adverse Event|0|||
130885174|NCT00830440|471213274|FG000|Overall Study|Protocol Violation|1|||
130885175|NCT00830440|471213275|FG001|Overall Study|Protocol Violation|0|||
130885176|NCT00830440|471213274|FG000|Overall Study|Withdrawal by Subject|1|||
130885177|NCT00830440|471213275|FG001|Overall Study|Withdrawal by Subject|0|||
130885178|NCT00830440|471213274|FG000|Overall Study|unsuccessful procedure|4|||
130885179|NCT00830440|471213275|FG001|Overall Study|unsuccessful procedure|0|||
130885180|NCT00830440|471213274|FG000|Overall Study|Adverse Event|2|||
130885181|NCT00830440|471213275|FG001|Overall Study|Adverse Event|0|||
130885182|NCT01967940|471213281|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
130885183|NCT01967940|471213282|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
130885184|NCT01967940|471213283|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
130885185|NCT01967940|471213284|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
130885186|NCT01967940|471213281|FG000|Part 2|Adverse Event|0|||
130885187|NCT01967940|471213282|FG001|Part 2|Adverse Event|0|||
130885188|NCT01967940|471213283|FG002|Part 2|Adverse Event|0|||
130885189|NCT01967940|471213284|FG003|Part 2|Adverse Event|1|||
131008900|NCT00197236|471661195|FG001|Overall Study|Study drug/medication expiration|0|||
131008901|NCT00197236|471661196|FG002|Overall Study|Study drug/medication expiration|3|||
131008902|NCT00197236|471661194|FG000|Overall Study|Returned out of specified time window|0|||
131008903|NCT00197236|471661195|FG001|Overall Study|Returned out of specified time window|0|||
131008904|NCT00197236|471661196|FG002|Overall Study|Returned out of specified time window|1|||
131008905|NCT03885596|471661197|FG000|Overall Study|Withdrawal by Subject|2|||
131008906|NCT03885596|471661198|FG001|Overall Study|Withdrawal by Subject|1|||
131008907|NCT03885596|471661199|FG002|Overall Study|Withdrawal by Subject|0|||
131008908|NCT03885596|471661200|FG003|Overall Study|Withdrawal by Subject|0|||
131008909|NCT03852433|471661201|FG000|Overall Study|Withdrawal of consent|5|||
131008910|NCT03852433|471661202|FG001|Overall Study|Withdrawal of consent|8|||
131008911|NCT03852433|471661203|FG002|Overall Study|Withdrawal of consent|1|||
131008912|NCT03852433|471661204|FG003|Overall Study|Withdrawal of consent|1|||
131008913|NCT03852433|471661201|FG000|Overall Study|Adverse Event|1|||
131008914|NCT03852433|471661202|FG001|Overall Study|Adverse Event|1|||
131008915|NCT03852433|471661203|FG002|Overall Study|Adverse Event|1|||
131008916|NCT03852433|471661204|FG003|Overall Study|Adverse Event|1|||
131008917|NCT03852433|471661201|FG000|Overall Study|Lost to Follow-up|0|||
131008918|NCT03852433|471661202|FG001|Overall Study|Lost to Follow-up|1|||
131008919|NCT03852433|471661203|FG002|Overall Study|Lost to Follow-up|0|||
131008920|NCT03852433|471661204|FG003|Overall Study|Lost to Follow-up|1|||
131008921|NCT03852433|471661201|FG000|Overall Study|Pregnancy|0|||
131008922|NCT03852433|471661202|FG001|Overall Study|Pregnancy|1|||
131008923|NCT03852433|471661203|FG002|Overall Study|Pregnancy|1|||
131008924|NCT03852433|471661204|FG003|Overall Study|Pregnancy|0|||
131008925|NCT03852433|471661201|FG000|Overall Study|Protocol Violation|0|||
131008926|NCT03852433|471661202|FG001|Overall Study|Protocol Violation|0|||
131008927|NCT03852433|471661203|FG002|Overall Study|Protocol Violation|1|||
131008928|NCT03852433|471661204|FG003|Overall Study|Protocol Violation|1|||
131008929|NCT03852433|471661201|FG000|Overall Study|Death|0|||
131008930|NCT03852433|471661202|FG001|Overall Study|Death|0|||
131008931|NCT03852433|471661203|FG002|Overall Study|Death|1|||
131008932|NCT03852433|471661204|FG003|Overall Study|Death|0|||
131008933|NCT03852433|471661201|FG000|Overall Study|Lack of Efficacy|0|||
131008934|NCT03852433|471661202|FG001|Overall Study|Lack of Efficacy|1|||
131008935|NCT03852433|471661203|FG002|Overall Study|Lack of Efficacy|0|||
131008936|NCT03852433|471661204|FG003|Overall Study|Lack of Efficacy|0|||
131008937|NCT03852433|471661201|FG000|Overall Study|Non-compliance with study drug|0|||
131008938|NCT03852433|471661202|FG001|Overall Study|Non-compliance with study drug|0|||
131008939|NCT03852433|471661203|FG002|Overall Study|Non-compliance with study drug|0|||
131008940|NCT03852433|471661204|FG003|Overall Study|Non-compliance with study drug|1|||
131008941|NCT03852433|471661201|FG000|Overall Study|Physician Decision|1|||
131008942|NCT03852433|471661202|FG001|Overall Study|Physician Decision|0|||
131008943|NCT03852433|471661203|FG002|Overall Study|Physician Decision|0|||
131008944|NCT03852433|471661204|FG003|Overall Study|Physician Decision|0|||
131008945|NCT03852433|471661201|FG000|Overall Study|Randomized but never treated|1|||
131008946|NCT03852433|471661202|FG001|Overall Study|Randomized but never treated|0|||
131008947|NCT03852433|471661203|FG002|Overall Study|Randomized but never treated|0|||
131008948|NCT03852433|471661204|FG003|Overall Study|Randomized but never treated|0|||
131008949|NCT01076335|471661205|FG000|Overall Study|Withdrawal by Subject|3|||
131008950|NCT01076335|471661205|FG000|Overall Study|Withdrawal without treatment|1|||
131008951|NCT01835899|471661207|FG000|Overall Study|Adverse Event|0|||
131008952|NCT01835899|471661208|FG001|Overall Study|Adverse Event|0|||
131008953|NCT01835899|471661209|FG002|Overall Study|Adverse Event|1|||
131008954|NCT01835899|471661207|FG000|Overall Study|Other than stated above|0|||
131008955|NCT01835899|471661208|FG001|Overall Study|Other than stated above|1|||
131008956|NCT01835899|471661209|FG002|Overall Study|Other than stated above|0|||
131008957|NCT03168438|471661211|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
131008958|NCT03168438|471661212|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
131008959|NCT01268566|471661222|FG000|Overall Study|Lost to Follow-up|1|||
131008960|NCT01268566|471661222|FG000|Overall Study|Withdrawal by Subject|12|||
131008961|NCT01268566|471661222|FG000|Overall Study|Death|30|||
131008962|NCT02138916|471661227|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
131008963|NCT02138916|471661228|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
131008964|NCT02138916|471661229|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
131008965|NCT02138916|471661227|FG000|Overall Study|Death|14|||
131008966|NCT02138916|471661228|FG001|Overall Study|Death|11|||
131008967|NCT02138916|471661229|FG002|Overall Study|Death|12|||
131008968|NCT02138916|471661227|FG000|Overall Study|Withdrawal by Subject|27|||
131008969|NCT02138916|471661228|FG001|Overall Study|Withdrawal by Subject|31|||
131008970|NCT02138916|471661229|FG002|Overall Study|Withdrawal by Subject|32|||
131008971|NCT02138916|471661227|FG000|Overall Study|Study specific withdrawal criteria|0|||
131008972|NCT02138916|471661228|FG001|Overall Study|Study specific withdrawal criteria|0|||
131008973|NCT02138916|471661229|FG002|Overall Study|Study specific withdrawal criteria|1|||
131008974|NCT02138916|471661227|FG000|Overall Study|incorrect enrolment|1|||
131008975|NCT02138916|471661228|FG001|Overall Study|incorrect enrolment|1|||
131008976|NCT02138916|471661229|FG002|Overall Study|incorrect enrolment|0|||
131008977|NCT02138916|471661227|FG000|Overall Study|Severe non-compliance|1|||
131008978|NCT02138916|471661228|FG001|Overall Study|Severe non-compliance|2|||
131008979|NCT02138916|471661229|FG002|Overall Study|Severe non-compliance|1|||
131008980|NCT02138916|471661227|FG000|Overall Study|Lost to Follow-up|4|||
131008981|NCT02138916|471661228|FG001|Overall Study|Lost to Follow-up|2|||
131008982|NCT02138916|471661229|FG002|Overall Study|Lost to Follow-up|3|||
131008983|NCT02138916|471661227|FG000|Overall Study|Adverse Event|4|||
131008984|NCT02138916|471661228|FG001|Overall Study|Adverse Event|4|||
131008985|NCT02138916|471661229|FG002|Overall Study|Adverse Event|3|||
131008986|NCT01348087|471661230|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
131008987|NCT01348087|471661230|FG000|Overall Study|Administrative problems|79|||
131008988|NCT01348087|471661230|FG000|Overall Study|protocol deviation|1|||
131008989|NCT01348087|471661230|FG000|Overall Study|Lost to Follow-up|1|||
131008990|NCT01348087|471661230|FG000|Overall Study|Subject withdrew consent|7|||
131008991|NCT01348087|471661230|FG000|Overall Study|Adverse Event|25|||
131008992|NCT00117988|471661233|FG000|Overall Study|Death|3|||
131008993|NCT00117988|471661233|FG000|Overall Study|Adverse Event|1|||
131008994|NCT04794179|471661234|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
131008995|NCT04794179|471661235|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
131008996|NCT03563053|471661238|FG000|Overall Study|Withdrawal by Subject|17|||
131008997|NCT03563053|471661238|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
131008998|NCT03563053|471661238|FG000|Overall Study|Adverse Event|3|||
131008999|NCT03563053|471661238|FG000|Overall Study|Physician Decision|1|||
131009000|NCT03563053|471661238|FG000|Overall Study|study terminated by sponsor|71|||
131009001|NCT01836458|471661239|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
131009002|NCT01836458|471661240|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131009003|NCT01836458|471661241|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
131009004|NCT01836458|471661242|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
131009005|NCT03677375|471661244|FG000|Overall Study|Incomplete procedure|8|||
131009006|NCT03677375|471661244|FG000|Overall Study|Adverse Event|3|||
131009007|NCT03677375|471661244|FG000|Overall Study|Physician Decision|1|||
131009008|NCT00561574|471661250|FG000|Overall Study|Adverse Event|21|||
131009009|NCT00561574|471661251|FG001|Overall Study|Adverse Event|24|||
130885190|NCT01967940|471213281|FG000|Part 2|Unknown Reason|0|||
131009010|NCT00561574|471661250|FG000|Overall Study|Lack of Efficacy|11|||
131009011|NCT00561574|471661251|FG001|Overall Study|Lack of Efficacy|21|||
131009012|NCT00561574|471661250|FG000|Overall Study|Withdrawal by Subject|4|||
131009013|NCT00561574|471661251|FG001|Overall Study|Withdrawal by Subject|4|||
130885191|NCT01967940|471213282|FG001|Part 2|Unknown Reason|0|||
130885192|NCT01967940|471213283|FG002|Part 2|Unknown Reason|0|||
130885193|NCT01967940|471213284|FG003|Part 2|Unknown Reason|1|||
130885194|NCT00942604|471213285|FG000|Overall Study|Protocol Violation|1|||
130885195|NCT00942604|471213286|FG001|Overall Study|Protocol Violation|1|||
130885196|NCT00942604|471213285|FG000|Overall Study|Adverse Event|0|||
130885197|NCT00942604|471213286|FG001|Overall Study|Adverse Event|1|||
130885198|NCT00942604|471213285|FG000|Overall Study|Withdrawal by Subject|0|||
130885199|NCT00942604|471213286|FG001|Overall Study|Withdrawal by Subject|1|||
130885200|NCT00942604|471213285|FG000|Overall Study|Patient relocation|1|||
130885201|NCT00942604|471213286|FG001|Overall Study|Patient relocation|1|||
130885202|NCT01188343|471213287|FG000|Overall Study|Not vaccinated|0|||
130885203|NCT01188343|471213288|FG001|Overall Study|Not vaccinated|2|||
130885204|NCT01188343|471213289|FG002|Overall Study|Not vaccinated|1|||
130885205|NCT01188343|471213287|FG000|Overall Study|Withdrawal by Subject|1|||
130885206|NCT01188343|471213288|FG001|Overall Study|Withdrawal by Subject|24|||
130885207|NCT01188343|471213289|FG002|Overall Study|Withdrawal by Subject|0|||
130885208|NCT01143246|471213290|FG000|Overall Study|Adverse Event|24|||
130885209|NCT01143246|471213291|FG001|Overall Study|Adverse Event|28|||
130885210|NCT01143246|471213290|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
130885211|NCT01143246|471213291|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
130885212|NCT01143246|471213290|FG000|Overall Study|Lost to Follow-up|0|||
130885213|NCT01143246|471213291|FG001|Overall Study|Lost to Follow-up|1|||
130885214|NCT01143246|471213290|FG000|Overall Study|Death|16|||
130885215|NCT01143246|471213291|FG001|Overall Study|Death|15|||
130885216|NCT01143246|471213290|FG000|Overall Study|Reason not Specified|3|||
130885217|NCT01143246|471213291|FG001|Overall Study|Reason not Specified|5|||
130885218|NCT01663103|471213292|FG000|Overall Study|Withdrawal by Subject|1|||
130885219|NCT01663103|471213293|FG001|Overall Study|Withdrawal by Subject|2|||
130885220|NCT01663103|471213292|FG000|Overall Study|Adverse Event|1|||
130885221|NCT01663103|471213293|FG001|Overall Study|Adverse Event|0|||
130885222|NCT01663103|471213292|FG000|Overall Study|dog bite|1|||
130885223|NCT01663103|471213293|FG001|Overall Study|dog bite|0|||
130885224|NCT05567783|471213296|FG000|Overall Study|Death|2|||
130885225|NCT05567783|471213297|FG001|Overall Study|Death|3|||
130885226|NCT05567783|471213298|FG002|Overall Study|Death|0|||
130885227|NCT05567783|471213296|FG000|Overall Study|Lost to Follow-up|25|||
130885228|NCT05567783|471213297|FG001|Overall Study|Lost to Follow-up|19|||
130885229|NCT05567783|471213298|FG002|Overall Study|Lost to Follow-up|17|||
130885230|NCT05567783|471213296|FG000|Overall Study|Physician Decision|10|||
130885231|NCT05567783|471213297|FG001|Overall Study|Physician Decision|7|||
130885232|NCT05567783|471213298|FG002|Overall Study|Physician Decision|9|||
130885233|NCT05567783|471213296|FG000|Overall Study|Study Terminated by Sponsor|924|||
130885234|NCT05567783|471213297|FG001|Overall Study|Study Terminated by Sponsor|937|||
130885235|NCT05567783|471213298|FG002|Overall Study|Study Terminated by Sponsor|941|||
130885236|NCT05567783|471213296|FG000|Overall Study|Withdrawal by Subject|23|||
130885237|NCT05567783|471213297|FG001|Overall Study|Withdrawal by Subject|27|||
130885238|NCT05567783|471213298|FG002|Overall Study|Withdrawal by Subject|24|||
130885239|NCT05567783|471213296|FG000|Overall Study|Incarcerated|1|||
130885240|NCT05567783|471213297|FG001|Overall Study|Incarcerated|0|||
130885241|NCT05567783|471213298|FG002|Overall Study|Incarcerated|0|||
130885242|NCT05567783|471213296|FG000|Overall Study|Participant randomized in error|4|||
130885243|NCT05567783|471213297|FG001|Overall Study|Participant randomized in error|2|||
130885244|NCT05567783|471213298|FG002|Overall Study|Participant randomized in error|2|||
130885245|NCT03777982|471213299|FG000|Overall Study|Physician Decision|0|||
130885246|NCT03777982|471213300|FG001|Overall Study|Physician Decision|1|||
130885247|NCT03944577|471213306|FG000|Overall Study|Adverse Event|3|||
130885248|NCT00904982|471213308|FG000|Overall Study|Withdrawal by Subject|2|||
130885249|NCT00904982|471213309|FG001|Overall Study|Withdrawal by Subject|0|||
130885250|NCT00904982|471213310|FG002|Overall Study|Withdrawal by Subject|0|||
130885251|NCT00904982|471213311|FG003|Overall Study|Withdrawal by Subject|0|||
130885252|NCT04119414|471213312|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
130885253|NCT01352793|471213316|FG000|Overall Study|Lost to Follow-up|289|||
130885254|NCT01352793|471213317|FG001|Overall Study|Lost to Follow-up|125|||
130885255|NCT01352793|471213316|FG000|Overall Study|Withdrawal by Subject|120|||
130885256|NCT01352793|471213317|FG001|Overall Study|Withdrawal by Subject|55|||
130885257|NCT01352793|471213316|FG000|Overall Study|Protocol Violation|44|||
130885258|NCT01352793|471213317|FG001|Overall Study|Protocol Violation|23|||
130885259|NCT01352793|471213316|FG000|Overall Study|Adverse Event|44|||
130885260|NCT01352793|471213317|FG001|Overall Study|Adverse Event|10|||
130885261|NCT01352793|471213316|FG000|Overall Study|Physician Decision|1|||
130885262|NCT01352793|471213317|FG001|Overall Study|Physician Decision|0|||
130885263|NCT01352793|471213316|FG000|Overall Study|Pregnancy|26|||
130885264|NCT01352793|471213317|FG001|Overall Study|Pregnancy|8|||
130885265|NCT01352793|471213316|FG000|Overall Study|Other|25|||
130885266|NCT01352793|471213317|FG001|Overall Study|Other|7|||
130885267|NCT01352793|471213316|FG000|Overall Study|Medication error|2|||
130885268|NCT01352793|471213317|FG001|Overall Study|Medication error|2|||
130885269|NCT01352793|471213316|FG000|Overall Study|Death|1|||
131009014|NCT00561574|471661250|FG000|Overall Study|Reason Unrelated to Trial|6|||
131009015|NCT00561574|471661251|FG001|Overall Study|Reason Unrelated to Trial|2|||
131009016|NCT00561574|471661250|FG000|Overall Study|Lost to Follow-up|1|||
131009017|NCT00561574|471661251|FG001|Overall Study|Lost to Follow-up|0|||
131009018|NCT00561574|471661250|FG000|Overall Study|Other|5|||
131009019|NCT00561574|471661251|FG001|Overall Study|Other|7|||
131009020|NCT03971357|471661252|FG000|Overall Study|Lack of Efficacy|0|||
131009021|NCT03971357|471661253|FG001|Overall Study|Lack of Efficacy|1|||
131009022|NCT00445692|471661254|FG000|Overall Study|Adverse Event|11|||
131009023|NCT00445692|471661254|FG000|Overall Study|Lack of Efficacy|5|||
131009024|NCT00630864|471661261|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
131009025|NCT00630864|471661261|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
131009026|NCT00124982|471661262|FG000|Short-term Period|Death|1|||
131009027|NCT00124982|471661263|FG001|Short-term Period|Death|1|||
131009028|NCT00124982|471661264|FG002|Short-term Period|Death|0|||
131009029|NCT00124982|471661262|FG000|Short-term Period|Adverse Event|17|||
131009030|NCT00124982|471661263|FG001|Short-term Period|Adverse Event|22|||
131009031|NCT00124982|471661264|FG002|Short-term Period|Adverse Event|0|||
131009032|NCT00124982|471661262|FG000|Short-term Period|Lack of Efficacy|32|||
131009033|NCT00124982|471661263|FG001|Short-term Period|Lack of Efficacy|73|||
131009034|NCT00124982|471661264|FG002|Short-term Period|Lack of Efficacy|0|||
131009035|NCT00124982|471661262|FG000|Short-term Period|Lost to Follow-up|8|||
131009036|NCT00124982|471661263|FG001|Short-term Period|Lost to Follow-up|5|||
131009037|NCT00124982|471661264|FG002|Short-term Period|Lost to Follow-up|0|||
131009038|NCT00124982|471661262|FG000|Short-term Period|Withdrawal of Consent|7|||
131009039|NCT00124982|471661263|FG001|Short-term Period|Withdrawal of Consent|9|||
131009040|NCT00124982|471661264|FG002|Short-term Period|Withdrawal of Consent|0|||
131009041|NCT00124982|471661262|FG000|Short-term Period|Poor/Non-compliance|3|||
131009042|NCT00124982|471661263|FG001|Short-term Period|Poor/Non-compliance|1|||
131009043|NCT00124982|471661264|FG002|Short-term Period|Poor/Non-compliance|0|||
131009044|NCT00124982|471661262|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
131009045|NCT00124982|471661263|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
131009046|NCT00124982|471661264|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
131009047|NCT00124982|471661262|FG000|Short-term Period|Participant Decision|1|||
131009048|NCT00124982|471661263|FG001|Short-term Period|Participant Decision|0|||
131009049|NCT00124982|471661264|FG002|Short-term Period|Participant Decision|0|||
131009050|NCT00124982|471661262|FG000|Short-term Period|Participant Chose Own Doctor|0|||
131009051|NCT00124982|471661263|FG001|Short-term Period|Participant Chose Own Doctor|1|||
131009052|NCT00124982|471661264|FG002|Short-term Period|Participant Chose Own Doctor|0|||
131009053|NCT00124982|471661262|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
131009054|NCT00124982|471661263|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
131009055|NCT00124982|471661264|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
131009056|NCT00124982|471661262|FG000|Short-term Period|Participant Had Lymphopenia|1|||
131009057|NCT00124982|471661263|FG001|Short-term Period|Participant Had Lymphopenia|0|||
131009058|NCT00124982|471661264|FG002|Short-term Period|Participant Had Lymphopenia|0|||
131009059|NCT00124982|471661262|FG000|Long-term Period|Death|0|||
131009060|NCT00124982|471661263|FG001|Long-term Period|Death|0|||
131009061|NCT00124982|471661264|FG002|Long-term Period|Death|1|||
131009062|NCT00124982|471661262|FG000|Long-term Period|Adverse Event|0|||
131009063|NCT00124982|471661263|FG001|Long-term Period|Adverse Event|0|||
131009064|NCT00124982|471661264|FG002|Long-term Period|Adverse Event|17|||
131009065|NCT00124982|471661262|FG000|Long-term Period|Lack of Efficacy|0|||
131009066|NCT00124982|471661263|FG001|Long-term Period|Lack of Efficacy|0|||
131009067|NCT00124982|471661264|FG002|Long-term Period|Lack of Efficacy|46|||
131009068|NCT00124982|471661262|FG000|Long-term Period|Lost to Follow-up|0|||
131009069|NCT00124982|471661263|FG001|Long-term Period|Lost to Follow-up|0|||
131009070|NCT00124982|471661264|FG002|Long-term Period|Lost to Follow-up|4|||
131009071|NCT00124982|471661262|FG000|Long-term Period|Withdrawal by Subject|0|||
131009072|NCT00124982|471661263|FG001|Long-term Period|Withdrawal by Subject|0|||
131009073|NCT00124982|471661264|FG002|Long-term Period|Withdrawal by Subject|16|||
131009074|NCT00124982|471661262|FG000|Long-term Period|Pregnancy|0|||
131009075|NCT00124982|471661263|FG001|Long-term Period|Pregnancy|0|||
131009076|NCT00124982|471661264|FG002|Long-term Period|Pregnancy|1|||
131009077|NCT00124982|471661262|FG000|Long-term Period|Poor/Non-compliance|0|||
131009078|NCT00124982|471661263|FG001|Long-term Period|Poor/Non-compliance|0|||
131009079|NCT00124982|471661264|FG002|Long-term Period|Poor/Non-compliance|2|||
131009080|NCT00124982|471661262|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
131009081|NCT00124982|471661263|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
131009082|NCT00124982|471661264|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
131009083|NCT00124982|471661262|FG000|Long-term Period|Neurologist Recommendation|0|||
131009084|NCT00124982|471661263|FG001|Long-term Period|Neurologist Recommendation|0|||
131009085|NCT00124982|471661264|FG002|Long-term Period|Neurologist Recommendation|1|||
131009086|NCT00430677|471661267|FG000|Short-term Period|Death|1|||
131009087|NCT00430677|471661268|FG001|Short-term Period|Death|1|||
131009088|NCT00430677|471661269|FG002|Short-term Period|Death|5|||
131009089|NCT00430677|471661267|FG000|Short-term Period|Adverse Event|15|||
131009090|NCT00430677|471661268|FG001|Short-term Period|Adverse Event|13|||
131009091|NCT00430677|471661269|FG002|Short-term Period|Adverse Event|9|||
131009092|NCT00430677|471661267|FG000|Short-term Period|Lack of Efficacy|5|||
131009093|NCT00430677|471661268|FG001|Short-term Period|Lack of Efficacy|6|||
131009094|NCT00430677|471661269|FG002|Short-term Period|Lack of Efficacy|4|||
131009095|NCT00430677|471661267|FG000|Short-term Period|Withdrawal by Subject|1|||
131009096|NCT00430677|471661268|FG001|Short-term Period|Withdrawal by Subject|1|||
131009097|NCT00430677|471661269|FG002|Short-term Period|Withdrawal by Subject|2|||
131009098|NCT00430677|471661267|FG000|Short-term Period|Participant no longer met study criteria|1|||
131009099|NCT00430677|471661268|FG001|Short-term Period|Participant no longer met study criteria|1|||
131009100|NCT00430677|471661269|FG002|Short-term Period|Participant no longer met study criteria|2|||
131009101|NCT00430677|471661267|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
131009102|NCT00430677|471661268|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
131009103|NCT00430677|471661269|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
131009104|NCT00430677|471661267|FG000|Short-term Period|Pregnancy|0|||
131009105|NCT00430677|471661268|FG001|Short-term Period|Pregnancy|2|||
131009106|NCT00430677|471661269|FG002|Short-term Period|Pregnancy|0|||
131009107|NCT00430677|471661267|FG000|Long-term Extension Period|Death|1|||
131009108|NCT00430677|471661268|FG001|Long-term Extension Period|Death|0|||
131009109|NCT00430677|471661269|FG002|Long-term Extension Period|Death|0|||
131009110|NCT00430677|471661267|FG000|Long-term Extension Period|Adverse Event|3|||
131009111|NCT00430677|471661268|FG001|Long-term Extension Period|Adverse Event|2|||
131009112|NCT00430677|471661269|FG002|Long-term Extension Period|Adverse Event|5|||
131009113|NCT00430677|471661267|FG000|Long-term Extension Period|Lack of Efficacy|5|||
131009114|NCT00430677|471661268|FG001|Long-term Extension Period|Lack of Efficacy|3|||
131009115|NCT00430677|471661269|FG002|Long-term Extension Period|Lack of Efficacy|8|||
131009116|NCT00430677|471661267|FG000|Long-term Extension Period|Lost to Follow-up|1|||
131009117|NCT00430677|471661268|FG001|Long-term Extension Period|Lost to Follow-up|1|||
131009118|NCT00430677|471661269|FG002|Long-term Extension Period|Lost to Follow-up|1|||
131009119|NCT00430677|471661267|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
131009120|NCT00430677|471661268|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
131009121|NCT00430677|471661269|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
131009122|NCT00430677|471661267|FG000|Long-term Extension Period|Pregnancy|1|||
131009123|NCT00430677|471661268|FG001|Long-term Extension Period|Pregnancy|1|||
131009124|NCT00430677|471661269|FG002|Long-term Extension Period|Pregnancy|0|||
131009125|NCT00430677|471661267|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
131009126|NCT00430677|471661268|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
131009127|NCT00430677|471661269|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
131009128|NCT00430677|471661267|FG000|Long-term Extension Period|Other|2|||
131009129|NCT00430677|471661268|FG001|Long-term Extension Period|Other|1|||
131009130|NCT00430677|471661269|FG002|Long-term Extension Period|Other|1|||
131009131|NCT00430677|471661267|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
131009132|NCT00430677|471661268|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
131009133|NCT00430677|471661269|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
131009134|NCT01555762|471661270|FG000|Overall Study|No information on Bevacizumab intake|11|||
131009135|NCT01555762|471661270|FG000|Overall Study|Missing start date of infusion|8|||
131009136|NCT01555762|471661270|FG000|Overall Study|75 years old or more ticked No|1|||
131009137|NCT01555762|471661270|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
131009138|NCT01555762|471661270|FG000|Overall Study|Death linked to progression of disease|165|||
131009139|NCT01555762|471661270|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
131009140|NCT01555762|471661270|FG000|Overall Study|Investigator's decision|10|||
131009141|NCT01555762|471661270|FG000|Overall Study|Participant not wishing to continue|5|||
131009142|NCT01555762|471661270|FG000|Overall Study|Missing data|1|||
131009143|NCT01555762|471661270|FG000|Overall Study|Death linked to an adverse event|14|||
131009144|NCT01333514|471661271|FG000|Overall Study|Withdrawal by Subject|1|||
131009145|NCT01333514|471661272|FG001|Overall Study|Withdrawal by Subject|0|||
131009146|NCT00836810|471661273|FG000|Overall Study|New diagnosis|1|||
131009147|NCT00836810|471661274|FG001|Overall Study|New diagnosis|0|||
131009148|NCT02040844|471661277|FG000|Overall Study|Adverse Event|0|||
131009149|NCT02040844|471661278|FG001|Overall Study|Adverse Event|0|||
131009150|NCT02040844|471661279|FG002|Overall Study|Adverse Event|1|||
131009151|NCT02040844|471661277|FG000|Overall Study|Withdrawal by Subject|16|||
131009152|NCT02040844|471661278|FG001|Overall Study|Withdrawal by Subject|22|||
131009153|NCT02040844|471661279|FG002|Overall Study|Withdrawal by Subject|25|||
131009154|NCT02040844|471661277|FG000|Overall Study|Lost to Follow-up|12|||
130885270|NCT01352793|471213317|FG001|Overall Study|Death|0|||
130885271|NCT01352793|471213316|FG000|Overall Study|Randomized but not vaccinated|8|||
131009155|NCT02040844|471661278|FG001|Overall Study|Lost to Follow-up|9|||
131009156|NCT02040844|471661279|FG002|Overall Study|Lost to Follow-up|13|||
131009157|NCT02040844|471661277|FG000|Overall Study|Missing|13|||
131009158|NCT02040844|471661278|FG001|Overall Study|Missing|3|||
131009159|NCT02040844|471661279|FG002|Overall Study|Missing|2|||
131009160|NCT02040844|471661277|FG000|Overall Study|Non-specified|8|||
131009161|NCT02040844|471661278|FG001|Overall Study|Non-specified|2|||
131009162|NCT02040844|471661279|FG002|Overall Study|Non-specified|5|||
131009163|NCT02040844|471661277|FG000|Overall Study|Concomitant medication|1|||
131009164|NCT02040844|471661278|FG001|Overall Study|Concomitant medication|3|||
131009165|NCT02040844|471661279|FG002|Overall Study|Concomitant medication|1|||
131009166|NCT01560949|471661286|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
131009167|NCT01560949|471661286|FG000|Surgery Phase|Physician Decision|3|||
131009168|NCT01562743|471661289|FG000|Overall Study|Adverse Event|29|||
131009169|NCT01562743|471661289|FG000|Overall Study|Lack of Efficacy|3|||
131009170|NCT01562743|471661289|FG000|Overall Study|Withdrawal by Subject|13|||
131009171|NCT01562743|471661289|FG000|Overall Study|Protocol Violation|1|||
131009172|NCT01562743|471661289|FG000|Overall Study|Discontinuation criteria|2|||
131009173|NCT01562743|471661289|FG000|Overall Study|Lost to Follow-up|2|||
131009174|NCT01562743|471661289|FG000|Overall Study|Physician Decision|2|||
131009175|NCT01456780|471663343|FG000|Overall Study|Lost to Follow-up|3|||
131009176|NCT01456780|471663344|FG001|Overall Study|Lost to Follow-up|3|||
131009177|NCT01456780|471663345|FG002|Overall Study|Lost to Follow-up|0|||
131009178|NCT05349864|471663346|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
131009179|NCT05349864|471663347|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
131009180|NCT00984282|471663348|FG000|Double Blind Treatment|Adverse Event|40|||
131009181|NCT00984282|471663349|FG001|Double Blind Treatment|Adverse Event|6|||
131009182|NCT00984282|471663348|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
131009183|NCT00984282|471663349|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
131009184|NCT00984282|471663348|FG000|Double Blind Treatment|Physician Decision|1|||
131009185|NCT00984282|471663349|FG001|Double Blind Treatment|Physician Decision|2|||
131009186|NCT00984282|471663348|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
131009187|NCT00984282|471663349|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
131009188|NCT00984282|471663348|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
131009189|NCT00984282|471663349|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
131009190|NCT00984282|471663348|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
131009191|NCT00984282|471663349|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
131009192|NCT00984282|471663348|FG000|Double Blind Treatment|Lost to Follow-up|3|||
131009193|NCT00984282|471663349|FG001|Double Blind Treatment|Lost to Follow-up|0|||
131009194|NCT00984282|471663348|FG000|Double Blind Treatment|Death|8|||
131009195|NCT00984282|471663349|FG001|Double Blind Treatment|Death|4|||
131009196|NCT00984282|471663348|FG000|Double Blind Treatment|Not treated|0|||
131009197|NCT00984282|471663349|FG001|Double Blind Treatment|Not treated|1|||
131009198|NCT00984282|471663348|FG000|Double Blind Treatment|Switched to commercial drug|6|||
131009199|NCT00984282|471663349|FG001|Double Blind Treatment|Switched to commercial drug|1|||
131009200|NCT00984282|471663348|FG000|Double Blind Treatment|protocol driven decision point|1|||
131009201|NCT00984282|471663349|FG001|Double Blind Treatment|protocol driven decision point|1|||
131009202|NCT00984282|471663348|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
131009203|NCT00984282|471663349|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
131009204|NCT00984282|471663348|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
131009205|NCT00984282|471663349|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
131009206|NCT00984282|471663348|FG000|Open-label Treatment|Adverse Event|20|||
131009207|NCT00984282|471663349|FG001|Open-label Treatment|Adverse Event|30|||
131009208|NCT00984282|471663348|FG000|Open-label Treatment|Withdrawal by Subject|6|||
131009209|NCT00984282|471663349|FG001|Open-label Treatment|Withdrawal by Subject|21|||
131009210|NCT00984282|471663348|FG000|Open-label Treatment|Death|7|||
131009211|NCT00984282|471663349|FG001|Open-label Treatment|Death|15|||
131009212|NCT00984282|471663348|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
131009213|NCT00984282|471663349|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
131009214|NCT00984282|471663348|FG000|Open-label Treatment|Lost to Follow-up|1|||
131009215|NCT00984282|471663349|FG001|Open-label Treatment|Lost to Follow-up|1|||
131009216|NCT00984282|471663348|FG000|Open-label Treatment|Patient convenience|1|||
131009217|NCT00984282|471663349|FG001|Open-label Treatment|Patient convenience|0|||
131009218|NCT00984282|471663348|FG000|Open-label Treatment|Non-compliant with study medication|1|||
131009219|NCT00984282|471663349|FG001|Open-label Treatment|Non-compliant with study medication|0|||
131009220|NCT00984282|471663348|FG000|Open-label Treatment|Target lesion removed|0|||
131009221|NCT00984282|471663349|FG001|Open-label Treatment|Target lesion removed|1|||
131009222|NCT00984282|471663348|FG000|Open-label Treatment|Protocol driven decision point|1|||
131009223|NCT00984282|471663349|FG001|Open-label Treatment|Protocol driven decision point|1|||
131009224|NCT00984282|471663348|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
131009225|NCT00984282|471663349|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
131009226|NCT00984282|471663348|FG000|Open-label Treatment|Switched to commercial drug|6|||
131009227|NCT00984282|471663349|FG001|Open-label Treatment|Switched to commercial drug|7|||
131009228|NCT00984282|471663348|FG000|Open-label Treatment|Physician Decision|1|||
131009229|NCT00984282|471663349|FG001|Open-label Treatment|Physician Decision|0|||
131009230|NCT00984282|471663348|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
131009231|NCT00984282|471663349|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
131009232|NCT00984282|471663348|FG000|Long Term Follow-up|Death|27|||
131009233|NCT00984282|471663349|FG001|Long Term Follow-up|Death|68|||
131009234|NCT00984282|471663348|FG000|Long Term Follow-up|Lost to Follow-up|3|||
131009235|NCT00984282|471663349|FG001|Long Term Follow-up|Lost to Follow-up|6|||
131009236|NCT00984282|471663348|FG000|Long Term Follow-up|Protocol driven decision point|25|||
131009237|NCT00984282|471663349|FG001|Long Term Follow-up|Protocol driven decision point|26|||
131009238|NCT00984282|471663348|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
131009239|NCT00984282|471663349|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
131009240|NCT00984282|471663348|FG000|Long Term Follow-up|Switched to commercial drug|4|||
131009241|NCT00984282|471663349|FG001|Long Term Follow-up|Switched to commercial drug|2|||
131009242|NCT00984282|471663348|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
131009243|NCT00984282|471663349|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
131009244|NCT02223793|471663350|FG000|Overall Study|Lost to Follow-up|10|||
131009245|NCT02223793|471663351|FG001|Overall Study|Lost to Follow-up|1|||
131009246|NCT02223793|471663352|FG002|Overall Study|Lost to Follow-up|2|||
131009247|NCT02223793|471663350|FG000|Overall Study|Withdrawal by Subject|3|||
131009248|NCT02223793|471663351|FG001|Overall Study|Withdrawal by Subject|2|||
131009249|NCT02223793|471663352|FG002|Overall Study|Withdrawal by Subject|3|||
131009250|NCT02223793|471663350|FG000|Overall Study|Moved/studycenter unable to participate|4|||
131009251|NCT02223793|471663351|FG001|Overall Study|Moved/studycenter unable to participate|6|||
131009252|NCT02223793|471663352|FG002|Overall Study|Moved/studycenter unable to participate|8|||
131009253|NCT00315055|471663353|FG000|Overall Study|Protocol Violation|2|||
131009254|NCT00315055|471663354|FG001|Overall Study|Protocol Violation|4|||
131009255|NCT00315055|471663353|FG000|Overall Study|Lost to Follow-up|1|||
131009256|NCT00315055|471663354|FG001|Overall Study|Lost to Follow-up|1|||
131009257|NCT01289119|471663355|FG000|Overall Study|Adverse Event|2|||
131009258|NCT01289119|471663356|FG001|Overall Study|Adverse Event|1|||
131009259|NCT01289119|471663357|FG002|Overall Study|Adverse Event|0|||
131009260|NCT01289119|471663358|FG003|Overall Study|Adverse Event|2|||
131009261|NCT01289119|471663359|FG004|Overall Study|Adverse Event|1|||
131009262|NCT01289119|471663360|FG005|Overall Study|Adverse Event|0|||
131009263|NCT01289119|471663355|FG000|Overall Study|Major Protocol Deviation|2|||
131009264|NCT01289119|471663356|FG001|Overall Study|Major Protocol Deviation|1|||
131009265|NCT01289119|471663357|FG002|Overall Study|Major Protocol Deviation|3|||
131009266|NCT01289119|471663358|FG003|Overall Study|Major Protocol Deviation|0|||
131009267|NCT01289119|471663359|FG004|Overall Study|Major Protocol Deviation|2|||
131009268|NCT01289119|471663360|FG005|Overall Study|Major Protocol Deviation|1|||
131009269|NCT01289119|471663355|FG000|Overall Study|Lost to Follow-up|0|||
131009270|NCT01289119|471663356|FG001|Overall Study|Lost to Follow-up|3|||
131009271|NCT01289119|471663357|FG002|Overall Study|Lost to Follow-up|0|||
131009272|NCT01289119|471663358|FG003|Overall Study|Lost to Follow-up|0|||
131009273|NCT01289119|471663359|FG004|Overall Study|Lost to Follow-up|0|||
131009274|NCT01289119|471663360|FG005|Overall Study|Lost to Follow-up|1|||
131009275|NCT01289119|471663355|FG000|Overall Study|Withdrawal by Subject|4|||
131009276|NCT01289119|471663356|FG001|Overall Study|Withdrawal by Subject|2|||
131009277|NCT01289119|471663357|FG002|Overall Study|Withdrawal by Subject|4|||
131009278|NCT01289119|471663358|FG003|Overall Study|Withdrawal by Subject|3|||
131009279|NCT01289119|471663359|FG004|Overall Study|Withdrawal by Subject|1|||
131009280|NCT01289119|471663360|FG005|Overall Study|Withdrawal by Subject|1|||
131009281|NCT01289119|471663355|FG000|Overall Study|Pregnancy|0|||
131009282|NCT01289119|471663356|FG001|Overall Study|Pregnancy|1|||
131009283|NCT01289119|471663357|FG002|Overall Study|Pregnancy|0|||
131009284|NCT01289119|471663358|FG003|Overall Study|Pregnancy|0|||
131009285|NCT01289119|471663359|FG004|Overall Study|Pregnancy|0|||
131009286|NCT01289119|471663360|FG005|Overall Study|Pregnancy|0|||
131009287|NCT01289119|471663355|FG000|Overall Study|Lack of Efficacy|0|||
131009288|NCT01289119|471663356|FG001|Overall Study|Lack of Efficacy|1|||
131009289|NCT01289119|471663357|FG002|Overall Study|Lack of Efficacy|1|||
131009290|NCT01289119|471663358|FG003|Overall Study|Lack of Efficacy|1|||
131009291|NCT01289119|471663359|FG004|Overall Study|Lack of Efficacy|1|||
131009292|NCT01289119|471663360|FG005|Overall Study|Lack of Efficacy|1|||
131009293|NCT01289119|471663355|FG000|Overall Study|Other|1|||
131009294|NCT01289119|471663356|FG001|Overall Study|Other|0|||
131009295|NCT01289119|471663357|FG002|Overall Study|Other|1|||
131009296|NCT01289119|471663358|FG003|Overall Study|Other|0|||
131009297|NCT01289119|471663359|FG004|Overall Study|Other|0|||
131009298|NCT01289119|471663360|FG005|Overall Study|Other|0|||
131009299|NCT01704846|471663361|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131009300|NCT01704846|471663362|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131009301|NCT04577183|471663363|FG000|Overall Study|Death|1|||
131009302|NCT04577183|471663363|FG000|Overall Study|Withdrawal by Subject|3|||
131009303|NCT04577183|471663363|FG000|Overall Study|Early termination|2|||
131009304|NCT01168401|471663364|FG000|Overall Study|Lost to Follow-up|1|||
131009305|NCT01168401|471663365|FG001|Overall Study|Lost to Follow-up|1|||
131009306|NCT01168401|471663366|FG002|Overall Study|Lost to Follow-up|2|||
131009307|NCT01168401|471663367|FG003|Overall Study|Lost to Follow-up|1|||
131009308|NCT01168401|471663368|FG004|Overall Study|Lost to Follow-up|0|||
131009309|NCT01168401|471663369|FG005|Overall Study|Lost to Follow-up|0|||
131009310|NCT01168401|471663370|FG006|Overall Study|Lost to Follow-up|0|||
131009311|NCT01168401|471663371|FG007|Overall Study|Lost to Follow-up|0|||
131009312|NCT01168401|471663372|FG008|Overall Study|Lost to Follow-up|0|||
131009313|NCT01168401|471663373|FG009|Overall Study|Lost to Follow-up|0|||
131009314|NCT01168401|471663374|FG010|Overall Study|Lost to Follow-up|0|||
131009315|NCT01168401|471663364|FG000|Overall Study|Withdrawal by Subject|0|||
131009316|NCT01168401|471663365|FG001|Overall Study|Withdrawal by Subject|0|||
131009317|NCT01168401|471663366|FG002|Overall Study|Withdrawal by Subject|0|||
131009318|NCT01168401|471663367|FG003|Overall Study|Withdrawal by Subject|1|||
131009319|NCT01168401|471663368|FG004|Overall Study|Withdrawal by Subject|0|||
131009320|NCT01168401|471663369|FG005|Overall Study|Withdrawal by Subject|0|||
131009321|NCT01168401|471663370|FG006|Overall Study|Withdrawal by Subject|0|||
131009322|NCT01168401|471663371|FG007|Overall Study|Withdrawal by Subject|0|||
131009323|NCT01168401|471663372|FG008|Overall Study|Withdrawal by Subject|0|||
131009324|NCT01168401|471663373|FG009|Overall Study|Withdrawal by Subject|0|||
131009325|NCT01168401|471663374|FG010|Overall Study|Withdrawal by Subject|0|||
131009326|NCT00672256|471663378|FG000|Overall Study|PI dropped, bad data|44|||
131009327|NCT01720043|471663385|FG000|Overall Study|Withdrawal by Subject|1|||
131009328|NCT01688973|471663386|FG000|Overall Study|Ineligible|2|||
131009329|NCT01688973|471663387|FG001|Overall Study|Ineligible|3|||
131009330|NCT00938340|471663389|FG000|Overall Study|Withdrawal by Subject|3|||
131009331|NCT00938340|471663389|FG000|Overall Study|Protocol Violation|1|||
131009332|NCT00938340|471663389|FG000|Overall Study|Adverse Event|1|||
131009333|NCT00269399|471663390|FG000|Overall Study|Lack of Efficacy|27|||
131009334|NCT00269399|471663391|FG001|Overall Study|Lack of Efficacy|10|||
131009335|NCT00269399|471663390|FG000|Overall Study|Adverse Event|10|||
131009336|NCT00269399|471663391|FG001|Overall Study|Adverse Event|4|||
131009337|NCT00269399|471663390|FG000|Overall Study|Withdrawal by Subject|2|||
131009338|NCT00269399|471663391|FG001|Overall Study|Withdrawal by Subject|5|||
131009339|NCT00269399|471663390|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
131009340|NCT00269399|471663391|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
131009341|NCT00269399|471663390|FG000|Overall Study|Other|0|||
131009342|NCT00269399|471663391|FG001|Overall Study|Other|4|||
131009343|NCT00269399|471663390|FG000|Overall Study|Development of exclusion criteria|0|||
131009344|NCT00269399|471663391|FG001|Overall Study|Development of exclusion criteria|1|||
131009345|NCT03441360|471663392|FG000|Overall Study|Radiological disease progression|5|||
131009346|NCT03441360|471663393|FG001|Overall Study|Radiological disease progression|6|||
131009347|NCT03441360|471663394|FG002|Overall Study|Radiological disease progression|4|||
130885272|NCT01352793|471213317|FG001|Overall Study|Randomized but not vaccinated|0|||
131009348|NCT03441360|471663392|FG000|Overall Study|Clinical disease progression|2|||
131009349|NCT03441360|471663393|FG001|Overall Study|Clinical disease progression|2|||
131009350|NCT03441360|471663394|FG002|Overall Study|Clinical disease progression|0|||
131009351|NCT03441360|471663392|FG000|Overall Study|Adverse Event|1|||
131009352|NCT03441360|471663393|FG001|Overall Study|Adverse Event|0|||
131009353|NCT03441360|471663394|FG002|Overall Study|Adverse Event|1|||
131009354|NCT03396835|471663395|FG000|Overall Study|Withdrawn prior to completion|1|||
131009355|NCT03396835|471663395|FG000|Overall Study|Did not meet criteria for data analysis|1|||
131009356|NCT03467724|471663402|FG000|Overall Study|Lost to Follow-up|5|||
131009357|NCT03467724|471663402|FG000|Overall Study|Withdrawal by Subject|1|||
131009358|NCT03467724|471663402|FG000|Overall Study|Protocol Violation|1|||
131009359|NCT03467724|471663402|FG000|Overall Study|Adverse Event|1|||
131009360|NCT02236559|471663406|FG000|Overall Study|Met Exclusion|3|||
131009361|NCT02236559|471663407|FG001|Overall Study|Met Exclusion|6|||
131009362|NCT02236559|471663406|FG000|Overall Study|Did not Meet Inclusion|3|||
131009363|NCT02236559|471663407|FG001|Overall Study|Did not Meet Inclusion|3|||
131009364|NCT02236559|471663406|FG000|Overall Study|Subject Did Not Consent|4|||
131009365|NCT02236559|471663407|FG001|Overall Study|Subject Did Not Consent|2|||
131009366|NCT02236559|471663406|FG000|Overall Study|Physician Decision|1|||
131009367|NCT02236559|471663407|FG001|Overall Study|Physician Decision|1|||
131009368|NCT02236559|471663406|FG000|Overall Study|Withdrawal by Subject|1|||
131009369|NCT02236559|471663407|FG001|Overall Study|Withdrawal by Subject|0|||
131009370|NCT01149681|471663408|FG000|Overall Study|Withdrawal by Subject|7|||
131009371|NCT01149681|471663408|FG000|Overall Study|Progressive disease|1|||
131009372|NCT01149681|471663408|FG000|Overall Study|Physician Decision|2|||
131009373|NCT01149681|471663408|FG000|Overall Study|adverse events nonrelated study drug|2|||
131009374|NCT00817635|471663409|FG000|Overall Study|Adverse Event|1|||
131009375|NCT00817635|471663410|FG001|Overall Study|Adverse Event|0|||
131009376|NCT00817635|471663411|FG002|Overall Study|Adverse Event|0|||
131009377|NCT00817635|471663412|FG003|Overall Study|Adverse Event|1|||
131009378|NCT00817635|471663413|FG004|Overall Study|Adverse Event|1|||
131009379|NCT00817635|471663409|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
131009380|NCT00817635|471663410|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
131009381|NCT00817635|471663411|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
131009382|NCT00817635|471663412|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
131009383|NCT00817635|471663413|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
131009384|NCT00817635|471663409|FG000|Overall Study|Withdrawal by Subject|2|||
131009385|NCT00817635|471663410|FG001|Overall Study|Withdrawal by Subject|1|||
131009386|NCT00817635|471663411|FG002|Overall Study|Withdrawal by Subject|0|||
131009387|NCT00817635|471663412|FG003|Overall Study|Withdrawal by Subject|1|||
131009388|NCT00817635|471663413|FG004|Overall Study|Withdrawal by Subject|2|||
131009389|NCT00817635|471663409|FG000|Overall Study|Lost to Follow-up|0|||
131009390|NCT00817635|471663410|FG001|Overall Study|Lost to Follow-up|1|||
131009391|NCT00817635|471663411|FG002|Overall Study|Lost to Follow-up|0|||
131009392|NCT00817635|471663412|FG003|Overall Study|Lost to Follow-up|1|||
131009393|NCT00817635|471663413|FG004|Overall Study|Lost to Follow-up|0|||
131009394|NCT00817635|471663409|FG000|Overall Study|Administrative Problems|0|||
131009395|NCT00817635|471663410|FG001|Overall Study|Administrative Problems|0|||
131009396|NCT00817635|471663411|FG002|Overall Study|Administrative Problems|0|||
131009397|NCT00817635|471663412|FG003|Overall Study|Administrative Problems|0|||
131009398|NCT00817635|471663413|FG004|Overall Study|Administrative Problems|1|||
131009399|NCT00817635|471663409|FG000|Overall Study|Protocol Violation|5|||
131009400|NCT00817635|471663410|FG001|Overall Study|Protocol Violation|1|||
131009401|NCT00817635|471663411|FG002|Overall Study|Protocol Violation|3|||
131009402|NCT00817635|471663412|FG003|Overall Study|Protocol Violation|2|||
131009403|NCT00817635|471663413|FG004|Overall Study|Protocol Violation|3|||
131009404|NCT00763282|471663422|FG000|Overall Study|Withdrawal by Subject|6|||
131009405|NCT00763282|471663423|FG001|Overall Study|Withdrawal by Subject|5|||
131009406|NCT00763282|471663422|FG000|Overall Study|Death|4|||
131009407|NCT00763282|471663423|FG001|Overall Study|Death|3|||
131009408|NCT00763282|471663422|FG000|Overall Study|Lost to Follow-up|22|||
131009409|NCT00763282|471663423|FG001|Overall Study|Lost to Follow-up|26|||
131009410|NCT00742274|471663424|FG000|Overall Study|Death|1|||
131009411|NCT00742274|471663425|FG001|Overall Study|Death|0|||
131009412|NCT00742274|471663424|FG000|Overall Study|Withdrawal by Subject|1|||
131009413|NCT00742274|471663425|FG001|Overall Study|Withdrawal by Subject|2|||
131009414|NCT00742274|471663424|FG000|Overall Study|Removed for medical reasons|1|||
131009415|NCT00742274|471663425|FG001|Overall Study|Removed for medical reasons|1|||
131009416|NCT00335556|471663428|FG000|Overall Study|Death|0|||
131009417|NCT00335556|471663429|FG001|Overall Study|Death|5|||
131009418|NCT00335556|471663430|FG002|Overall Study|Death|0|||
131009419|NCT00335556|471663431|FG003|Overall Study|Death|0|||
131009420|NCT00335556|471663432|FG004|Overall Study|Death|1|||
131009421|NCT00335556|471663433|FG005|Overall Study|Death|0|||
131009422|NCT00335556|471663428|FG000|Overall Study|Lack of Efficacy|0|||
131009423|NCT00335556|471663429|FG001|Overall Study|Lack of Efficacy|19|||
131009424|NCT00335556|471663430|FG002|Overall Study|Lack of Efficacy|3|||
131009425|NCT00335556|471663431|FG003|Overall Study|Lack of Efficacy|3|||
131009426|NCT00335556|471663432|FG004|Overall Study|Lack of Efficacy|0|||
131009427|NCT00335556|471663433|FG005|Overall Study|Lack of Efficacy|1|||
131009428|NCT00335556|471663428|FG000|Overall Study|Physician Decision|0|||
131009429|NCT00335556|471663429|FG001|Overall Study|Physician Decision|6|||
131009430|NCT00335556|471663430|FG002|Overall Study|Physician Decision|2|||
131009431|NCT00335556|471663431|FG003|Overall Study|Physician Decision|1|||
131009432|NCT00335556|471663432|FG004|Overall Study|Physician Decision|0|||
131009433|NCT00335556|471663433|FG005|Overall Study|Physician Decision|0|||
131009434|NCT00335556|471663428|FG000|Overall Study|Ineligible|2|||
131009435|NCT00335556|471663429|FG001|Overall Study|Ineligible|0|||
131009436|NCT00335556|471663430|FG002|Overall Study|Ineligible|0|||
131009437|NCT00335556|471663431|FG003|Overall Study|Ineligible|0|||
131009438|NCT00335556|471663432|FG004|Overall Study|Ineligible|0|||
131009439|NCT00335556|471663433|FG005|Overall Study|Ineligible|0|||
131009440|NCT00335556|471663428|FG000|Overall Study|Refusal of further protocol therapy|0|||
131009441|NCT00335556|471663429|FG001|Overall Study|Refusal of further protocol therapy|4|||
131009442|NCT00335556|471663430|FG002|Overall Study|Refusal of further protocol therapy|0|||
131009443|NCT00335556|471663431|FG003|Overall Study|Refusal of further protocol therapy|1|||
131009444|NCT00335556|471663432|FG004|Overall Study|Refusal of further protocol therapy|0|||
131009445|NCT00335556|471663433|FG005|Overall Study|Refusal of further protocol therapy|0|||
131009446|NCT04555044|471663440|FG000|Overall Study|Adverse Event|0|||
131009447|NCT04555044|471663441|FG001|Overall Study|Adverse Event|1|||
131009448|NCT04088188|471663443|FG000|Overall Study|Withdrawal by Subject|2|||
131009449|NCT04088188|471663444|FG001|Overall Study|Withdrawal by Subject|0|||
131009450|NCT04088188|471663443|FG000|Overall Study|Adverse Event|2|||
131009451|NCT04088188|471663444|FG001|Overall Study|Adverse Event|0|||
131009452|NCT03601507|471663447|FG000|Overall Study|Adverse Event|1|||
131009453|NCT02107014|471663450|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
131009454|NCT03761784|471663451|FG000|Overall Study|Adverse Event|4|||
131009455|NCT03761784|471663452|FG001|Overall Study|Adverse Event|0|||
131009456|NCT03761784|471663451|FG000|Overall Study|Lost to Follow-up|10|||
131009457|NCT03761784|471663452|FG001|Overall Study|Lost to Follow-up|7|||
131009458|NCT03761784|471663451|FG000|Overall Study|Pregnancy|1|||
131009459|NCT03761784|471663452|FG001|Overall Study|Pregnancy|0|||
131009460|NCT03761784|471663451|FG000|Overall Study|Protocol Violation|2|||
131009461|NCT03761784|471663452|FG001|Overall Study|Protocol Violation|0|||
131009462|NCT03761784|471663451|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
131009463|NCT03761784|471663452|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
131009464|NCT03761784|471663451|FG000|Overall Study|Withdrawal by Subject|9|||
131009465|NCT03761784|471663452|FG001|Overall Study|Withdrawal by Subject|4|||
131009466|NCT03761784|471663451|FG000|Overall Study|Physician Decision|1|||
131009467|NCT03761784|471663452|FG001|Overall Study|Physician Decision|0|||
131009468|NCT03761784|471663451|FG000|Overall Study|Other Than Specified|1|||
131009469|NCT03761784|471663452|FG001|Overall Study|Other Than Specified|0|||
131009470|NCT00586339|471663453|FG000|Overall Study|Withdrawal by Subject|1|||
131009471|NCT00586339|471663454|FG001|Overall Study|Withdrawal by Subject|3|||
131009472|NCT00586339|471663455|FG002|Overall Study|Withdrawal by Subject|1|||
131009473|NCT00586339|471663453|FG000|Overall Study|Migrated/moved from study area|3|||
131009474|NCT00586339|471663454|FG001|Overall Study|Migrated/moved from study area|2|||
131009475|NCT00586339|471663455|FG002|Overall Study|Migrated/moved from study area|4|||
131009476|NCT00586339|471663453|FG000|Overall Study|Lost to Follow-up|3|||
131009477|NCT00586339|471663454|FG001|Overall Study|Lost to Follow-up|2|||
131009478|NCT00586339|471663455|FG002|Overall Study|Lost to Follow-up|1|||
131009479|NCT01649427|471663457|FG000|Overall Study|Adverse Event|1|||
131009480|NCT01649427|471663458|FG001|Overall Study|Adverse Event|1|||
131009481|NCT01649427|471663457|FG000|Overall Study|Withdrawal by Subject|8|||
131009482|NCT01649427|471663458|FG001|Overall Study|Withdrawal by Subject|7|||
131009483|NCT01649427|471663457|FG000|Overall Study|Lost to Follow-up|0|||
131009484|NCT01649427|471663458|FG001|Overall Study|Lost to Follow-up|1|||
131009485|NCT01649427|471663457|FG000|Overall Study|Graft loss|0|||
131009486|NCT01649427|471663458|FG001|Overall Study|Graft loss|1|||
131009487|NCT01649427|471663457|FG000|Overall Study|Surgical problems during nephrectomy|2|||
131009488|NCT01649427|471663458|FG001|Overall Study|Surgical problems during nephrectomy|2|||
131009489|NCT04927975|471663462|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
131009490|NCT04927975|471663463|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
131009491|NCT04927975|471663464|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
131009492|NCT04927975|471663465|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
131009493|NCT04927975|471663466|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
131009494|NCT04927975|471663467|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
131009495|NCT04927975|471663462|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
131009496|NCT04927975|471663463|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
131009497|NCT04927975|471663464|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
131009498|NCT04927975|471663465|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
131009499|NCT04927975|471663466|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
131009500|NCT04927975|471663467|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
131009501|NCT04927975|471663462|FG000|Period 1 (Baseline-Week 24)|Death|0|||
131009502|NCT04927975|471663463|FG001|Period 1 (Baseline-Week 24)|Death|0|||
131009503|NCT04927975|471663464|FG002|Period 1 (Baseline-Week 24)|Death|0|||
131009504|NCT04927975|471663465|FG003|Period 1 (Baseline-Week 24)|Death|0|||
131009505|NCT04927975|471663466|FG004|Period 1 (Baseline-Week 24)|Death|0|||
131009506|NCT04927975|471663467|FG005|Period 1 (Baseline-Week 24)|Death|1|||
131009507|NCT04927975|471663462|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
131009508|NCT04927975|471663463|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
131009509|NCT04927975|471663464|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
131009510|NCT04927975|471663465|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
131009511|NCT04927975|471663466|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
131009512|NCT04927975|471663467|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
131009513|NCT04927975|471663462|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
131009514|NCT04927975|471663463|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
131009515|NCT04927975|471663464|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
131009516|NCT04927975|471663465|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
131009517|NCT04927975|471663466|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
131009518|NCT04927975|471663467|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
131009519|NCT03568162|471663469|FG000|Overall Study|Adverse Event|0|||
131009520|NCT03568162|471663470|FG001|Overall Study|Adverse Event|1|||
131009521|NCT03568162|471663471|FG002|Overall Study|Adverse Event|2|||
131009522|NCT03568162|471663472|FG003|Overall Study|Adverse Event|0|||
131009523|NCT03568162|471663473|FG004|Overall Study|Adverse Event|0|||
131009524|NCT03568162|471663474|FG005|Overall Study|Adverse Event|1|||
131009525|NCT03568162|471663469|FG000|Overall Study|Death|0|||
131009526|NCT03568162|471663470|FG001|Overall Study|Death|0|||
131009527|NCT03568162|471663471|FG002|Overall Study|Death|0|||
131009528|NCT03568162|471663472|FG003|Overall Study|Death|0|||
131009529|NCT03568162|471663473|FG004|Overall Study|Death|1|||
131009530|NCT03568162|471663474|FG005|Overall Study|Death|0|||
131009531|NCT03568162|471663469|FG000|Overall Study|Lost to Follow-up|3|||
131009532|NCT03568162|471663470|FG001|Overall Study|Lost to Follow-up|2|||
131009533|NCT03568162|471663471|FG002|Overall Study|Lost to Follow-up|4|||
131009534|NCT03568162|471663472|FG003|Overall Study|Lost to Follow-up|2|||
131009535|NCT03568162|471663473|FG004|Overall Study|Lost to Follow-up|3|||
131009536|NCT03568162|471663474|FG005|Overall Study|Lost to Follow-up|2|||
131009537|NCT03568162|471663469|FG000|Overall Study|Physician Decision|0|||
131009538|NCT03568162|471663470|FG001|Overall Study|Physician Decision|1|||
131009539|NCT03568162|471663471|FG002|Overall Study|Physician Decision|1|||
131009540|NCT03568162|471663472|FG003|Overall Study|Physician Decision|0|||
131009541|NCT03568162|471663473|FG004|Overall Study|Physician Decision|1|||
131009542|NCT03568162|471663474|FG005|Overall Study|Physician Decision|0|||
131009543|NCT03568162|471663469|FG000|Overall Study|Pregnancy|0|||
131009544|NCT03568162|471663470|FG001|Overall Study|Pregnancy|0|||
131009545|NCT03568162|471663471|FG002|Overall Study|Pregnancy|0|||
131009546|NCT03568162|471663472|FG003|Overall Study|Pregnancy|1|||
131009547|NCT03568162|471663473|FG004|Overall Study|Pregnancy|0|||
131009548|NCT03568162|471663474|FG005|Overall Study|Pregnancy|0|||
131009549|NCT03568162|471663469|FG000|Overall Study|Protocol Violation|1|||
131009550|NCT03568162|471663470|FG001|Overall Study|Protocol Violation|0|||
131009551|NCT03568162|471663471|FG002|Overall Study|Protocol Violation|1|||
131009552|NCT03568162|471663472|FG003|Overall Study|Protocol Violation|1|||
131009553|NCT03568162|471663473|FG004|Overall Study|Protocol Violation|1|||
131009554|NCT03568162|471663474|FG005|Overall Study|Protocol Violation|1|||
131009555|NCT03568162|471663469|FG000|Overall Study|Withdrawal by Subject|15|||
131009556|NCT03568162|471663470|FG001|Overall Study|Withdrawal by Subject|15|||
131009557|NCT03568162|471663471|FG002|Overall Study|Withdrawal by Subject|26|||
131009558|NCT03568162|471663472|FG003|Overall Study|Withdrawal by Subject|22|||
131009559|NCT03568162|471663473|FG004|Overall Study|Withdrawal by Subject|6|||
131009560|NCT03568162|471663474|FG005|Overall Study|Withdrawal by Subject|9|||
131009561|NCT03568162|471663469|FG000|Overall Study|Others|3|||
131009562|NCT03568162|471663470|FG001|Overall Study|Others|4|||
131009563|NCT03568162|471663471|FG002|Overall Study|Others|1|||
131009564|NCT03568162|471663472|FG003|Overall Study|Others|4|||
131009565|NCT03568162|471663473|FG004|Overall Study|Others|2|||
131009566|NCT03568162|471663474|FG005|Overall Study|Others|1|||
131009567|NCT01458275|471663476|FG000|Overall Study|Adverse Event|3|||
131222551|NCT01625286|472441530|FG006|Overall Study|Any reason not specifically recorded|0|||
131222552|NCT01625286|472441524|FG000|Overall Study|Progressive disease|6|||
131009568|NCT01458275|471663477|FG001|Overall Study|Adverse Event|4|||
131009569|NCT01458275|471663478|FG002|Overall Study|Adverse Event|1|||
131009570|NCT01458275|471663476|FG000|Overall Study|Lost to Follow-up|3|||
131009571|NCT01458275|471663477|FG001|Overall Study|Lost to Follow-up|2|||
131009572|NCT01458275|471663478|FG002|Overall Study|Lost to Follow-up|5|||
131009573|NCT01458275|471663476|FG000|Overall Study|Protocol Violation|5|||
131009574|NCT01458275|471663477|FG001|Overall Study|Protocol Violation|5|||
131009575|NCT01458275|471663478|FG002|Overall Study|Protocol Violation|2|||
131009576|NCT01458275|471663476|FG000|Overall Study|Withdrawal by Subject|3|||
131009577|NCT01458275|471663477|FG001|Overall Study|Withdrawal by Subject|2|||
131009578|NCT01458275|471663478|FG002|Overall Study|Withdrawal by Subject|1|||
131009579|NCT03102242|471663481|FG000|Overall Study|Adverse Event|2|||
131009580|NCT00389519|471663482|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
131009581|NCT00389519|471663483|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
131009582|NCT00389519|471663484|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
131009583|NCT00389519|471663485|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
131009584|NCT00389519|471663482|FG000|Placebo Run-In|Withdrawal by Subject|19|||
131009585|NCT00389519|471663483|FG001|Placebo Run-In|Withdrawal by Subject|0|||
131009586|NCT00389519|471663484|FG002|Placebo Run-In|Withdrawal by Subject|0|||
131009587|NCT00389519|471663485|FG003|Placebo Run-In|Withdrawal by Subject|0|||
131009588|NCT00389519|471663482|FG000|Placebo Run-In|Reason not specified|40|||
131009589|NCT00389519|471663483|FG001|Placebo Run-In|Reason not specified|0|||
131009590|NCT00389519|471663484|FG002|Placebo Run-In|Reason not specified|0|||
131009591|NCT00389519|471663485|FG003|Placebo Run-In|Reason not specified|0|||
131009592|NCT00389519|471663482|FG000|Randomized|Did not receive study drug|2|||
131009593|NCT00389519|471663483|FG001|Randomized|Did not receive study drug|0|||
131009594|NCT00389519|471663484|FG002|Randomized|Did not receive study drug|0|||
131009595|NCT00389519|471663485|FG003|Randomized|Did not receive study drug|0|||
131009596|NCT00389519|471663482|FG000|Treated|Adverse Event|1|||
131009597|NCT00389519|471663483|FG001|Treated|Adverse Event|0|||
131009598|NCT00389519|471663484|FG002|Treated|Adverse Event|0|||
131009599|NCT00389519|471663485|FG003|Treated|Adverse Event|2|||
131009600|NCT00389519|471663482|FG000|Treated|Reason not specified|1|||
131009601|NCT00389519|471663483|FG001|Treated|Reason not specified|1|||
131009602|NCT00389519|471663484|FG002|Treated|Reason not specified|0|||
131009603|NCT00389519|471663485|FG003|Treated|Reason not specified|2|||
131009604|NCT01311713|471663486|FG000|Overall Study|Death|0|||
131009605|NCT01311713|471663487|FG001|Overall Study|Death|0|||
131009606|NCT01311713|471663488|FG002|Overall Study|Death|1|||
131009607|NCT01311713|471663489|FG003|Overall Study|Death|1|||
131009608|NCT01311713|471663490|FG004|Overall Study|Death|0|||
131009609|NCT01311713|471663491|FG005|Overall Study|Death|1|||
131009610|NCT01311713|471663492|FG006|Overall Study|Death|0|||
131009611|NCT01311713|471663486|FG000|Overall Study|Adverse Event|0|||
131009612|NCT01311713|471663487|FG001|Overall Study|Adverse Event|1|||
131009613|NCT01311713|471663488|FG002|Overall Study|Adverse Event|0|||
131009614|NCT01311713|471663489|FG003|Overall Study|Adverse Event|2|||
131009615|NCT01311713|471663490|FG004|Overall Study|Adverse Event|0|||
131009616|NCT01311713|471663491|FG005|Overall Study|Adverse Event|0|||
131009617|NCT01311713|471663492|FG006|Overall Study|Adverse Event|2|||
131009618|NCT01311713|471663486|FG000|Overall Study|Withdrawal by Subject|0|||
131009619|NCT01311713|471663487|FG001|Overall Study|Withdrawal by Subject|1|||
131009620|NCT01311713|471663488|FG002|Overall Study|Withdrawal by Subject|1|||
131009621|NCT01311713|471663489|FG003|Overall Study|Withdrawal by Subject|0|||
131009622|NCT01311713|471663490|FG004|Overall Study|Withdrawal by Subject|0|||
131009623|NCT01311713|471663491|FG005|Overall Study|Withdrawal by Subject|1|||
131009624|NCT01311713|471663492|FG006|Overall Study|Withdrawal by Subject|2|||
131009625|NCT01311713|471663486|FG000|Overall Study|Disease progression|3|||
131009626|NCT01311713|471663487|FG001|Overall Study|Disease progression|4|||
131009627|NCT01311713|471663488|FG002|Overall Study|Disease progression|3|||
131009628|NCT01311713|471663489|FG003|Overall Study|Disease progression|2|||
131009629|NCT01311713|471663490|FG004|Overall Study|Disease progression|4|||
131009630|NCT01311713|471663491|FG005|Overall Study|Disease progression|4|||
131009631|NCT01311713|471663492|FG006|Overall Study|Disease progression|5|||
131009632|NCT01311713|471663486|FG000|Overall Study|Lost to Follow-up|0|||
131009633|NCT01311713|471663487|FG001|Overall Study|Lost to Follow-up|0|||
131009634|NCT01311713|471663488|FG002|Overall Study|Lost to Follow-up|1|||
131009635|NCT01311713|471663489|FG003|Overall Study|Lost to Follow-up|0|||
131009636|NCT01311713|471663490|FG004|Overall Study|Lost to Follow-up|0|||
131009637|NCT01311713|471663491|FG005|Overall Study|Lost to Follow-up|0|||
131009638|NCT01311713|471663492|FG006|Overall Study|Lost to Follow-up|0|||
131009639|NCT01311713|471663486|FG000|Overall Study|Stopped taking study medication|0|||
131009640|NCT01311713|471663487|FG001|Overall Study|Stopped taking study medication|0|||
131009641|NCT01311713|471663488|FG002|Overall Study|Stopped taking study medication|0|||
131009642|NCT01311713|471663489|FG003|Overall Study|Stopped taking study medication|1|||
131009643|NCT01311713|471663490|FG004|Overall Study|Stopped taking study medication|1|||
131009644|NCT01311713|471663491|FG005|Overall Study|Stopped taking study medication|0|||
131009645|NCT01311713|471663492|FG006|Overall Study|Stopped taking study medication|0|||
131009646|NCT01311713|471663486|FG000|Overall Study|Enrolled but not treated|0|||
131009647|NCT01311713|471663487|FG001|Overall Study|Enrolled but not treated|0|||
131009648|NCT01311713|471663488|FG002|Overall Study|Enrolled but not treated|1|||
131009649|NCT01311713|471663489|FG003|Overall Study|Enrolled but not treated|0|||
131009650|NCT01311713|471663490|FG004|Overall Study|Enrolled but not treated|0|||
131009651|NCT01311713|471663491|FG005|Overall Study|Enrolled but not treated|0|||
131009652|NCT01311713|471663492|FG006|Overall Study|Enrolled but not treated|0|||
131009653|NCT01311713|471663486|FG000|Overall Study|Other than specified|0|||
131009654|NCT01311713|471663487|FG001|Overall Study|Other than specified|1|||
131009655|NCT01311713|471663488|FG002|Overall Study|Other than specified|2|||
131009656|NCT01311713|471663489|FG003|Overall Study|Other than specified|0|||
131009657|NCT01311713|471663490|FG004|Overall Study|Other than specified|0|||
131009658|NCT01311713|471663491|FG005|Overall Study|Other than specified|0|||
131009659|NCT01311713|471663492|FG006|Overall Study|Other than specified|0|||
131009660|NCT00946192|471663493|FG000|Overall Study|Lost to Follow-up|6|||
131009661|NCT00946192|471663494|FG001|Overall Study|Lost to Follow-up|11|||
131009662|NCT00946192|471663495|FG002|Overall Study|Lost to Follow-up|9|||
131009663|NCT00946192|471663493|FG000|Overall Study|Withdrawal by Subject|10|||
131009664|NCT00946192|471663494|FG001|Overall Study|Withdrawal by Subject|7|||
131009665|NCT00946192|471663495|FG002|Overall Study|Withdrawal by Subject|3|||
131009666|NCT00946192|471663493|FG000|Overall Study|Did not start medication|2|||
131009667|NCT00946192|471663494|FG001|Overall Study|Did not start medication|0|||
131009668|NCT00946192|471663495|FG002|Overall Study|Did not start medication|0|||
131009669|NCT01080131|471663496|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
131009670|NCT01080131|471663497|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
131009671|NCT01080131|471663496|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
131009672|NCT01080131|471663497|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
131009673|NCT01080131|471663496|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
131009674|NCT01080131|471663497|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
131009675|NCT01080131|471663496|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
131009676|NCT01080131|471663497|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
131009677|NCT01080131|471663496|FG000|Core Study (0- 12 Weeks)|Death|1|||
131009678|NCT01080131|471663497|FG001|Core Study (0- 12 Weeks)|Death|0|||
131009679|NCT01080131|471663496|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
131009680|NCT01080131|471663497|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
131009681|NCT01080131|471663496|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
131009682|NCT01080131|471663497|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
131009683|NCT01080131|471663496|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
131009684|NCT01080131|471663497|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
131009685|NCT01080131|471663496|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
131009686|NCT01080131|471663497|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
131009687|NCT01080131|471663496|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
131009688|NCT01080131|471663497|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
131009689|NCT01080131|471663496|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
131009690|NCT01080131|471663497|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
131009691|NCT01080131|471663496|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
131009692|NCT01080131|471663497|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
131009693|NCT01080131|471663496|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
131009694|NCT01080131|471663497|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
131009695|NCT04155424|471663498|FG000|Overall Study|Other than specified|3|||
131009696|NCT04155424|471663498|FG000|Overall Study|Withdrawal by Subject|1|||
131009697|NCT04155424|471663498|FG000|Overall Study|Adverse Event|1|||
131009698|NCT04159506|471663499|FG000|Overall Study|Lost to Follow-up|2|||
131009699|NCT04159506|471663500|FG001|Overall Study|Lost to Follow-up|5|||
131009700|NCT01268891|471665143|FG000|Overall Study|Adverse Event|3|||
131009701|NCT01268891|471665144|FG001|Overall Study|Adverse Event|7|||
131009702|NCT01268891|471665143|FG000|Overall Study|Lack of Efficacy|1|||
131009703|NCT01268891|471665144|FG001|Overall Study|Lack of Efficacy|0|||
131009704|NCT01268891|471665143|FG000|Overall Study|Withdrawal of Consent|3|||
131009705|NCT01268891|471665144|FG001|Overall Study|Withdrawal of Consent|1|||
131009706|NCT01268891|471665143|FG000|Overall Study|Administrative or other reason(s)|1|||
131009707|NCT01268891|471665144|FG001|Overall Study|Administrative or other reason(s)|0|||
131009708|NCT00991276|471665145|FG000|First Intervention Period|Adverse Event|0|||
131009709|NCT00991276|471665146|FG001|First Intervention Period|Adverse Event|1|||
131009710|NCT00991276|471665147|FG002|First Intervention Period|Adverse Event|0|||
131009711|NCT00991276|471665148|FG003|First Intervention Period|Adverse Event|1|||
131009712|NCT00991276|471665149|FG004|First Intervention Period|Adverse Event|0|||
131009713|NCT00991276|471665150|FG005|First Intervention Period|Adverse Event|0|||
131009714|NCT00991276|471665145|FG000|First Intervention Period|Protocol Violation|0|||
131009715|NCT00991276|471665146|FG001|First Intervention Period|Protocol Violation|0|||
131009716|NCT00991276|471665147|FG002|First Intervention Period|Protocol Violation|0|||
131009717|NCT00991276|471665148|FG003|First Intervention Period|Protocol Violation|0|||
131009718|NCT00991276|471665149|FG004|First Intervention Period|Protocol Violation|2|||
131009719|NCT00991276|471665150|FG005|First Intervention Period|Protocol Violation|0|||
131009720|NCT00991276|471665145|FG000|First Intervention Period|Insufficient clinical response|0|||
131009721|NCT00991276|471665146|FG001|First Intervention Period|Insufficient clinical response|0|||
131009722|NCT00991276|471665147|FG002|First Intervention Period|Insufficient clinical response|0|||
131009723|NCT00991276|471665148|FG003|First Intervention Period|Insufficient clinical response|0|||
131009724|NCT00991276|471665149|FG004|First Intervention Period|Insufficient clinical response|1|||
131009725|NCT00991276|471665150|FG005|First Intervention Period|Insufficient clinical response|0|||
131009726|NCT00991276|471665145|FG000|First Intervention Period|Other|0|||
131009727|NCT00991276|471665146|FG001|First Intervention Period|Other|0|||
131009728|NCT00991276|471665147|FG002|First Intervention Period|Other|0|||
131009729|NCT00991276|471665148|FG003|First Intervention Period|Other|1|||
131009730|NCT00991276|471665149|FG004|First Intervention Period|Other|1|||
131009731|NCT00991276|471665150|FG005|First Intervention Period|Other|0|||
131009732|NCT00991276|471665145|FG000|First Intervention Period|Withdrawal by Subject|0|||
131009733|NCT00991276|471665146|FG001|First Intervention Period|Withdrawal by Subject|1|||
131009734|NCT00991276|471665147|FG002|First Intervention Period|Withdrawal by Subject|0|||
131009735|NCT00991276|471665148|FG003|First Intervention Period|Withdrawal by Subject|1|||
131009736|NCT00991276|471665149|FG004|First Intervention Period|Withdrawal by Subject|0|||
131009737|NCT00991276|471665150|FG005|First Intervention Period|Withdrawal by Subject|1|||
131009738|NCT00991276|471665145|FG000|First Intervention Period|Lost to Follow-up|0|||
131009739|NCT00991276|471665146|FG001|First Intervention Period|Lost to Follow-up|1|||
131009740|NCT00991276|471665147|FG002|First Intervention Period|Lost to Follow-up|0|||
131009741|NCT00991276|471665148|FG003|First Intervention Period|Lost to Follow-up|1|||
131009742|NCT00991276|471665149|FG004|First Intervention Period|Lost to Follow-up|0|||
131009743|NCT00991276|471665150|FG005|First Intervention Period|Lost to Follow-up|0|||
131009744|NCT00991276|471665145|FG000|Second Intervention Period|Adverse Event|0|||
131009745|NCT00991276|471665146|FG001|Second Intervention Period|Adverse Event|2|||
131009746|NCT00991276|471665147|FG002|Second Intervention Period|Adverse Event|0|||
131009747|NCT00991276|471665148|FG003|Second Intervention Period|Adverse Event|1|||
131009748|NCT00991276|471665149|FG004|Second Intervention Period|Adverse Event|1|||
131009749|NCT00991276|471665150|FG005|Second Intervention Period|Adverse Event|0|||
131009750|NCT00991276|471665145|FG000|Second Intervention Period|Protocol Violation|1|||
131009751|NCT00991276|471665146|FG001|Second Intervention Period|Protocol Violation|0|||
131009752|NCT00991276|471665147|FG002|Second Intervention Period|Protocol Violation|0|||
131009753|NCT00991276|471665148|FG003|Second Intervention Period|Protocol Violation|0|||
131009754|NCT00991276|471665149|FG004|Second Intervention Period|Protocol Violation|0|||
131009755|NCT00991276|471665150|FG005|Second Intervention Period|Protocol Violation|0|||
131009756|NCT00991276|471665145|FG000|Second Intervention Period|Other|0|||
131009757|NCT00991276|471665146|FG001|Second Intervention Period|Other|0|||
131009758|NCT00991276|471665147|FG002|Second Intervention Period|Other|0|||
131009759|NCT00991276|471665148|FG003|Second Intervention Period|Other|1|||
131009760|NCT00991276|471665149|FG004|Second Intervention Period|Other|0|||
131009761|NCT00991276|471665150|FG005|Second Intervention Period|Other|1|||
131009762|NCT00991276|471665145|FG000|Third Intervention Period|Protocol Violation|1|||
131009763|NCT00991276|471665146|FG001|Third Intervention Period|Protocol Violation|0|||
131009764|NCT00991276|471665147|FG002|Third Intervention Period|Protocol Violation|0|||
131009765|NCT00991276|471665148|FG003|Third Intervention Period|Protocol Violation|0|||
131009766|NCT00991276|471665149|FG004|Third Intervention Period|Protocol Violation|0|||
131009767|NCT00991276|471665150|FG005|Third Intervention Period|Protocol Violation|0|||
131009768|NCT00991276|471665145|FG000|Third Intervention Period|Other|0|||
131009769|NCT00991276|471665146|FG001|Third Intervention Period|Other|0|||
131009770|NCT00991276|471665147|FG002|Third Intervention Period|Other|0|||
131009771|NCT00991276|471665148|FG003|Third Intervention Period|Other|0|||
131009772|NCT00991276|471665149|FG004|Third Intervention Period|Other|0|||
131009773|NCT00991276|471665150|FG005|Third Intervention Period|Other|1|||
131009774|NCT00991276|471665145|FG000|Third Intervention Period|Adverse Event|0|||
131009775|NCT00991276|471665146|FG001|Third Intervention Period|Adverse Event|0|||
131009776|NCT00991276|471665147|FG002|Third Intervention Period|Adverse Event|1|||
131009777|NCT00991276|471665148|FG003|Third Intervention Period|Adverse Event|0|||
131009778|NCT00991276|471665149|FG004|Third Intervention Period|Adverse Event|0|||
131009779|NCT00991276|471665150|FG005|Third Intervention Period|Adverse Event|0|||
131009780|NCT00991276|471665145|FG000|Third Intervention Period|Withdrawal by Subject|0|||
131009781|NCT00991276|471665146|FG001|Third Intervention Period|Withdrawal by Subject|0|||
131009782|NCT00991276|471665147|FG002|Third Intervention Period|Withdrawal by Subject|0|||
131009783|NCT00991276|471665148|FG003|Third Intervention Period|Withdrawal by Subject|1|||
131009784|NCT00991276|471665149|FG004|Third Intervention Period|Withdrawal by Subject|0|||
131009785|NCT00991276|471665150|FG005|Third Intervention Period|Withdrawal by Subject|0|||
131009786|NCT00711646|471665153|FG000|Overall Study|Adverse Event|6|||
131009787|NCT00711646|471665154|FG001|Overall Study|Adverse Event|1|||
131009788|NCT00711646|471665153|FG000|Overall Study|Withdrawal by Subject|4|||
131009789|NCT00711646|471665154|FG001|Overall Study|Withdrawal by Subject|0|||
131009790|NCT00711646|471665153|FG000|Overall Study|Protocol Violation|0|||
131009791|NCT00711646|471665154|FG001|Overall Study|Protocol Violation|1|||
131009792|NCT00711646|471665153|FG000|Overall Study|Lost to Follow-up|1|||
130765933|NCT01253174|470765907|FG001|Period 1|Randomized but not treated|1|||
131009793|NCT00711646|471665154|FG001|Overall Study|Lost to Follow-up|0|||
131009794|NCT00711646|471665153|FG000|Overall Study|administrative decision|0|||
131009795|NCT00711646|471665154|FG001|Overall Study|administrative decision|1|||
131009796|NCT00711646|471665153|FG000|Overall Study|patient non-compliance|1|||
131009797|NCT00711646|471665154|FG001|Overall Study|patient non-compliance|0|||
131009798|NCT03721016|471665156|FG000|Overall Study|Adverse Event|0|||
131009799|NCT03721016|471665157|FG001|Overall Study|Adverse Event|1|||
131009800|NCT03721016|471665158|FG002|Overall Study|Adverse Event|1|||
131009801|NCT03721016|471665156|FG000|Overall Study|Withdrawal by Subject|8|||
131009802|NCT03721016|471665157|FG001|Overall Study|Withdrawal by Subject|16|||
131009803|NCT03721016|471665158|FG002|Overall Study|Withdrawal by Subject|13|||
131009804|NCT03721016|471665156|FG000|Overall Study|Lost to Follow-up|4|||
131009805|NCT03721016|471665157|FG001|Overall Study|Lost to Follow-up|6|||
131009806|NCT03721016|471665158|FG002|Overall Study|Lost to Follow-up|5|||
131009807|NCT03721016|471665156|FG000|Overall Study|Physician Decision|0|||
131009808|NCT03721016|471665157|FG001|Overall Study|Physician Decision|1|||
131009809|NCT03721016|471665158|FG002|Overall Study|Physician Decision|2|||
131009810|NCT03721016|471665156|FG000|Overall Study|Protocol Violation|0|||
131009811|NCT03721016|471665157|FG001|Overall Study|Protocol Violation|1|||
131009812|NCT03721016|471665158|FG002|Overall Study|Protocol Violation|0|||
131009813|NCT03721016|471665156|FG000|Overall Study|Site terminated by sponsor|3|||
131009814|NCT03721016|471665157|FG001|Overall Study|Site terminated by sponsor|7|||
131009815|NCT03721016|471665158|FG002|Overall Study|Site terminated by sponsor|6|||
131009816|NCT03721016|471665156|FG000|Overall Study|Subject exited early due to COVID-19|1|||
131009817|NCT03721016|471665157|FG001|Overall Study|Subject exited early due to COVID-19|0|||
131009818|NCT03721016|471665158|FG002|Overall Study|Subject exited early due to COVID-19|0|||
131009819|NCT02232178|471665161|FG000|Overall Study|Lost to Follow-up|0|||
131009820|NCT02232178|471665162|FG001|Overall Study|Lost to Follow-up|1|||
131009821|NCT02232178|471665163|FG002|Overall Study|Lost to Follow-up|0|||
131009822|NCT02232178|471665161|FG000|Overall Study|ineligibility|0|||
131009823|NCT02232178|471665162|FG001|Overall Study|ineligibility|0|||
131009824|NCT02232178|471665163|FG002|Overall Study|ineligibility|1|||
131009825|NCT02232178|471665161|FG000|Overall Study|surgical complication|1|||
131009826|NCT02232178|471665162|FG001|Overall Study|surgical complication|0|||
131009827|NCT02232178|471665163|FG002|Overall Study|surgical complication|0|||
131009828|NCT01167426|471665165|FG000|Overall Study|Lost to Follow-up|6|||
131222553|NCT01625286|472441525|FG001|Overall Study|Progressive disease|3|||
131009829|NCT01167426|471665165|FG000|Overall Study|Protocol Violation|1|||
131009830|NCT01167426|471665165|FG000|Overall Study|Withdrawal by Subject|2|||
131009831|NCT01167426|471665165|FG000|Overall Study|Sponsor Decision|1|||
131009832|NCT02993471|471665166|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
131009833|NCT02993471|471665166|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
131009834|NCT04176458|471665168|FG000|Overall Study|Covid 19|4|||
131009835|NCT01570751|471665169|FG000|Period A (16 Weeks)|Protocol Violation|1|||
131009836|NCT01570751|471665170|FG001|Period A (16 Weeks)|Protocol Violation|1|||
131009837|NCT01570751|471665169|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
131009838|NCT01570751|471665170|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
131009839|NCT01570751|471665169|FG000|Period A (16 Weeks)|Unclassified|2|||
131009840|NCT01570751|471665170|FG001|Period A (16 Weeks)|Unclassified|3|||
131009841|NCT01570751|471665169|FG000|Period B (16 Weeks)|Adverse Event|1|||
131009842|NCT01570751|471665170|FG001|Period B (16 Weeks)|Adverse Event|0|||
131009843|NCT01570751|471665169|FG000|Period B (16 Weeks)|Protocol Violation|0|||
131009844|NCT01570751|471665170|FG001|Period B (16 Weeks)|Protocol Violation|1|||
131009845|NCT02317705|471665171|FG000|Overall Study|Withdrawal by Subject|3|||
131009846|NCT02317705|471665171|FG000|Overall Study|Physician Decision|1|||
131009847|NCT02317705|471665171|FG000|Overall Study|Drug not usable|1|||
131009848|NCT02219490|471665172|FG000|Overall Study|Adverse Event|24|||
131009849|NCT02219490|471665172|FG000|Overall Study|Withdrew consent|96|||
131009850|NCT02219490|471665172|FG000|Overall Study|Lost to Follow-up|126|||
131009851|NCT02219490|471665172|FG000|Overall Study|COVID-19 infection|2|||
131009852|NCT02219490|471665172|FG000|Overall Study|COVID-19 logistical restrictions|33|||
131009853|NCT02219490|471665172|FG000|Overall Study|Other, not specified|57|||
131009854|NCT01674569|471665173|FG000|Overall Study|Adverse Event|0|||
131009855|NCT01674569|471665174|FG001|Overall Study|Adverse Event|2|||
131009856|NCT01674569|471665175|FG002|Overall Study|Adverse Event|0|||
131009857|NCT01674569|471665176|FG003|Overall Study|Adverse Event|1|||
131009858|NCT01674569|471665177|FG004|Overall Study|Adverse Event|2|||
131009859|NCT01674569|471665178|FG005|Overall Study|Adverse Event|2|||
131009860|NCT01674569|471665173|FG000|Overall Study|Protocol Violation|0|||
131009861|NCT01674569|471665174|FG001|Overall Study|Protocol Violation|1|||
131009862|NCT01674569|471665175|FG002|Overall Study|Protocol Violation|1|||
131009863|NCT01674569|471665176|FG003|Overall Study|Protocol Violation|0|||
131009864|NCT01674569|471665177|FG004|Overall Study|Protocol Violation|0|||
131009865|NCT01674569|471665178|FG005|Overall Study|Protocol Violation|0|||
131009866|NCT01674569|471665173|FG000|Overall Study|Withdrawal by Subject|0|||
131009867|NCT01674569|471665174|FG001|Overall Study|Withdrawal by Subject|0|||
131009868|NCT01674569|471665175|FG002|Overall Study|Withdrawal by Subject|1|||
131009869|NCT01674569|471665176|FG003|Overall Study|Withdrawal by Subject|0|||
131009870|NCT01674569|471665177|FG004|Overall Study|Withdrawal by Subject|0|||
131009871|NCT01674569|471665178|FG005|Overall Study|Withdrawal by Subject|0|||
131009872|NCT02365298|471665181|FG000|Period 2|incorrect Rx dispensed|1|||
131009873|NCT02365298|471665182|FG001|Period 2|incorrect Rx dispensed|0|||
131009874|NCT02365298|471665181|FG000|Period 2|Discontinued at request of Sponsor|1|||
131009875|NCT02365298|471665182|FG001|Period 2|Discontinued at request of Sponsor|0|||
131009876|NCT02365298|471665181|FG000|Period 2|Test Article longer available|0|||
131009877|NCT02365298|471665182|FG001|Period 2|Test Article longer available|1|||
131009878|NCT02365298|471665181|FG000|Period 2|Protocol Violation|0|||
131009879|NCT02365298|471665182|FG001|Period 2|Protocol Violation|1|||
131009880|NCT01878890|471665183|FG000|Overall Study|Protocol Violation|0|||
131009881|NCT01878890|471665184|FG001|Overall Study|Protocol Violation|1|||
131009882|NCT01878890|471665185|FG002|Overall Study|Protocol Violation|0|||
131009883|NCT01878890|471665186|FG003|Overall Study|Protocol Violation|0|||
131009884|NCT02974010|471665187|FG000|Overall Study|Lost to Follow-up|3|||
131009885|NCT02974010|471665188|FG001|Overall Study|Lost to Follow-up|1|||
131009886|NCT02974010|471665189|FG002|Overall Study|Lost to Follow-up|0|||
131009887|NCT02974010|471665190|FG003|Overall Study|Lost to Follow-up|0|||
131009888|NCT02974010|471665187|FG000|Overall Study|Withdrawal by Subject|2|||
131009889|NCT02974010|471665188|FG001|Overall Study|Withdrawal by Subject|1|||
130765934|NCT01253174|470765908|FG002|Period 1|Randomized but not treated|1|||
131009890|NCT02974010|471665189|FG002|Overall Study|Withdrawal by Subject|0|||
131009891|NCT02974010|471665190|FG003|Overall Study|Withdrawal by Subject|0|||
131009892|NCT02974010|471665187|FG000|Overall Study|Adverse Event|0|||
131009893|NCT02974010|471665188|FG001|Overall Study|Adverse Event|1|||
131009894|NCT02974010|471665189|FG002|Overall Study|Adverse Event|0|||
131009895|NCT02974010|471665190|FG003|Overall Study|Adverse Event|0|||
131009896|NCT02974010|471665187|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
131009897|NCT02974010|471665188|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
131009898|NCT02974010|471665189|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
131009899|NCT02974010|471665190|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
131009900|NCT02974010|471665187|FG000|Overall Study|Lack of Efficacy|0|||
131009901|NCT02974010|471665188|FG001|Overall Study|Lack of Efficacy|0|||
131222554|NCT01625286|472441526|FG002|Overall Study|Progressive disease|4|||
131009902|NCT02974010|471665189|FG002|Overall Study|Lack of Efficacy|1|||
131009903|NCT02974010|471665190|FG003|Overall Study|Lack of Efficacy|0|||
131009904|NCT00320489|471665191|FG000|Overall Study|Adverse Event|26|||
131009905|NCT00320489|471665192|FG001|Overall Study|Adverse Event|25|||
131009906|NCT00320489|471665191|FG000|Overall Study|Clinical Relapse|26|||
131009907|NCT00320489|471665192|FG001|Overall Study|Clinical Relapse|20|||
131009908|NCT00320489|471665191|FG000|Overall Study|Death|0|||
131009909|NCT00320489|471665192|FG001|Overall Study|Death|2|||
131009910|NCT00320489|471665191|FG000|Overall Study|Entry Criteria Exclusion|2|||
131009911|NCT00320489|471665192|FG001|Overall Study|Entry Criteria Exclusion|4|||
131009912|NCT00320489|471665191|FG000|Overall Study|Lack of Efficacy|16|||
131009913|NCT00320489|471665192|FG001|Overall Study|Lack of Efficacy|7|||
131009914|NCT00320489|471665191|FG000|Overall Study|Lost to Follow-up|21|||
131009915|NCT00320489|471665192|FG001|Overall Study|Lost to Follow-up|22|||
131009916|NCT00320489|471665191|FG000|Overall Study|Physician Decision|8|||
131009917|NCT00320489|471665192|FG001|Overall Study|Physician Decision|8|||
131009918|NCT00320489|471665191|FG000|Overall Study|Protocol Violation|4|||
131009919|NCT00320489|471665192|FG001|Overall Study|Protocol Violation|4|||
131009920|NCT00320489|471665191|FG000|Overall Study|Sponsor Decision|3|||
131009921|NCT00320489|471665192|FG001|Overall Study|Sponsor Decision|3|||
131009922|NCT00320489|471665191|FG000|Overall Study|Withdrawal by Subject|39|||
131009923|NCT00320489|471665192|FG001|Overall Study|Withdrawal by Subject|41|||
131009924|NCT03441984|471665194|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009925|NCT03441984|471665195|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009926|NCT03441984|471665196|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
131009927|NCT03441984|471665197|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009928|NCT03441984|471665198|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009929|NCT03441984|471665199|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009930|NCT03441984|471665200|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009931|NCT03441984|471665201|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009932|NCT03441984|471665202|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009933|NCT03441984|471665203|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009934|NCT03441984|471665204|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009935|NCT03441984|471665205|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
131009936|NCT00746330|471665207|FG000|Period 1|Abnormal test procedure result|0|||
131009937|NCT00746330|471665208|FG001|Period 1|Abnormal test procedure result|0|||
131009938|NCT00746330|471665209|FG002|Period 1|Abnormal test procedure result|1|||
131009939|NCT00746330|471665210|FG003|Period 1|Abnormal test procedure result|0|||
131009940|NCT01981850|471665211|FG000|Main Phase Stage 1|Death|2|||
131009941|NCT01981850|471665212|FG001|Main Phase Stage 1|Death|0|||
131009942|NCT01981850|471665213|FG002|Main Phase Stage 1|Death|0|||
131009943|NCT01981850|471665214|FG003|Main Phase Stage 1|Death|0|||
131009944|NCT01981850|471665215|FG004|Main Phase Stage 1|Death|0|||
131009945|NCT01981850|471665216|FG005|Main Phase Stage 1|Death|0|||
131009946|NCT01981850|471665217|FG006|Main Phase Stage 1|Death|0|||
131009947|NCT01981850|471665218|FG007|Main Phase Stage 1|Death|0|||
131009948|NCT01981850|471665219|FG008|Main Phase Stage 1|Death|0|||
131009949|NCT01981850|471665220|FG009|Main Phase Stage 1|Death|0|||
131009950|NCT01981850|471665211|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
131009951|NCT01981850|471665212|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131009952|NCT01981850|471665213|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131009953|NCT01981850|471665214|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131009954|NCT01981850|471665215|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131009955|NCT01981850|471665216|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131009956|NCT01981850|471665217|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131009957|NCT01981850|471665218|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131009958|NCT01981850|471665219|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131009959|NCT01981850|471665220|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
131009960|NCT01981850|471665211|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
131009961|NCT01981850|471665212|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
131009962|NCT01981850|471665213|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
131009963|NCT01981850|471665214|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
131009964|NCT01981850|471665215|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
131009965|NCT01981850|471665216|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
131009966|NCT01981850|471665217|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
131009967|NCT01981850|471665218|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
131009968|NCT01981850|471665219|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
131009969|NCT01981850|471665220|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
131009970|NCT01981850|471665211|FG000|Main Phase Stage 1|Various reasons|0|||
131009971|NCT01981850|471665212|FG001|Main Phase Stage 1|Various reasons|0|||
131009972|NCT01981850|471665213|FG002|Main Phase Stage 1|Various reasons|2|||
131009973|NCT01981850|471665214|FG003|Main Phase Stage 1|Various reasons|0|||
131009974|NCT01981850|471665215|FG004|Main Phase Stage 1|Various reasons|0|||
131009975|NCT01981850|471665216|FG005|Main Phase Stage 1|Various reasons|0|||
131009976|NCT01981850|471665217|FG006|Main Phase Stage 1|Various reasons|0|||
131009977|NCT01981850|471665218|FG007|Main Phase Stage 1|Various reasons|0|||
131009978|NCT01981850|471665219|FG008|Main Phase Stage 1|Various reasons|0|||
131009979|NCT01981850|471665220|FG009|Main Phase Stage 1|Various reasons|0|||
131009980|NCT01981850|471665211|FG000|Main Phase Stage 2|Adverse Event|0|||
131009981|NCT01981850|471665212|FG001|Main Phase Stage 2|Adverse Event|0|||
131009982|NCT01981850|471665213|FG002|Main Phase Stage 2|Adverse Event|0|||
131009983|NCT01981850|471665214|FG003|Main Phase Stage 2|Adverse Event|0|||
131009984|NCT01981850|471665215|FG004|Main Phase Stage 2|Adverse Event|6|||
131009985|NCT01981850|471665216|FG005|Main Phase Stage 2|Adverse Event|5|||
131009986|NCT01981850|471665217|FG006|Main Phase Stage 2|Adverse Event|7|||
131009987|NCT01981850|471665218|FG007|Main Phase Stage 2|Adverse Event|0|||
131009988|NCT01981850|471665219|FG008|Main Phase Stage 2|Adverse Event|0|||
131009989|NCT01981850|471665220|FG009|Main Phase Stage 2|Adverse Event|0|||
131009990|NCT01981850|471665211|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131009991|NCT01981850|471665212|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131009992|NCT01981850|471665213|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131009993|NCT01981850|471665214|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131009994|NCT01981850|471665215|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
131009995|NCT01981850|471665216|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
131009996|NCT01981850|471665217|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
131009997|NCT01981850|471665218|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131009998|NCT01981850|471665219|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131009999|NCT01981850|471665220|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
131010000|NCT01981850|471665211|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
131010001|NCT01981850|471665212|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
131010002|NCT01981850|471665213|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
131010003|NCT01981850|471665214|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
131010004|NCT01981850|471665215|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
131010005|NCT01981850|471665216|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
131010006|NCT01981850|471665217|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
131010007|NCT01981850|471665218|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
131010008|NCT01981850|471665219|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
131010009|NCT01981850|471665220|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
131010010|NCT01981850|471665211|FG000|Main Phase Stage 2|Various reasons|0|||
131010011|NCT01981850|471665212|FG001|Main Phase Stage 2|Various reasons|0|||
131010012|NCT01981850|471665213|FG002|Main Phase Stage 2|Various reasons|0|||
131010013|NCT01981850|471665214|FG003|Main Phase Stage 2|Various reasons|0|||
131010014|NCT01981850|471665215|FG004|Main Phase Stage 2|Various reasons|2|||
131010015|NCT01981850|471665216|FG005|Main Phase Stage 2|Various reasons|0|||
131010016|NCT01981850|471665217|FG006|Main Phase Stage 2|Various reasons|1|||
131010017|NCT01981850|471665218|FG007|Main Phase Stage 2|Various reasons|0|||
131010018|NCT01981850|471665219|FG008|Main Phase Stage 2|Various reasons|0|||
131010019|NCT01981850|471665220|FG009|Main Phase Stage 2|Various reasons|0|||
131010020|NCT01981850|471665211|FG000|Main Phase Stage 2|Progressive Disease|0|||
131010021|NCT01981850|471665212|FG001|Main Phase Stage 2|Progressive Disease|0|||
131010022|NCT01981850|471665213|FG002|Main Phase Stage 2|Progressive Disease|0|||
131010023|NCT01981850|471665214|FG003|Main Phase Stage 2|Progressive Disease|0|||
131010024|NCT01981850|471665215|FG004|Main Phase Stage 2|Progressive Disease|0|||
131010025|NCT01981850|471665216|FG005|Main Phase Stage 2|Progressive Disease|6|||
131010026|NCT01981850|471665217|FG006|Main Phase Stage 2|Progressive Disease|6|||
131010027|NCT01981850|471665218|FG007|Main Phase Stage 2|Progressive Disease|0|||
131010028|NCT01981850|471665219|FG008|Main Phase Stage 2|Progressive Disease|0|||
131010029|NCT01981850|471665220|FG009|Main Phase Stage 2|Progressive Disease|0|||
131010030|NCT01981850|471665211|FG000|Open Label Extension (OLE)|Adverse Event|0|||
131010031|NCT01981850|471665212|FG001|Open Label Extension (OLE)|Adverse Event|0|||
131010032|NCT01981850|471665213|FG002|Open Label Extension (OLE)|Adverse Event|0|||
131010033|NCT01981850|471665214|FG003|Open Label Extension (OLE)|Adverse Event|0|||
131010034|NCT01981850|471665215|FG004|Open Label Extension (OLE)|Adverse Event|0|||
131010035|NCT01981850|471665216|FG005|Open Label Extension (OLE)|Adverse Event|0|||
131010036|NCT01981850|471665217|FG006|Open Label Extension (OLE)|Adverse Event|0|||
131010037|NCT01981850|471665218|FG007|Open Label Extension (OLE)|Adverse Event|2|||
131010038|NCT01981850|471665219|FG008|Open Label Extension (OLE)|Adverse Event|1|||
131010039|NCT01981850|471665220|FG009|Open Label Extension (OLE)|Adverse Event|8|||
131010040|NCT01981850|471665211|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
131010041|NCT01981850|471665212|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
131010042|NCT01981850|471665213|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
131010043|NCT01981850|471665214|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
131010044|NCT01981850|471665215|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
131010045|NCT01981850|471665216|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
131010046|NCT01981850|471665217|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
131010047|NCT01981850|471665218|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
131010048|NCT01981850|471665219|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
131010049|NCT01981850|471665220|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
131010050|NCT01981850|471665211|FG000|Open Label Extension (OLE)|Various reasons|0|||
131010051|NCT01981850|471665212|FG001|Open Label Extension (OLE)|Various reasons|0|||
131010052|NCT01981850|471665213|FG002|Open Label Extension (OLE)|Various reasons|0|||
131010053|NCT01981850|471665214|FG003|Open Label Extension (OLE)|Various reasons|0|||
131010054|NCT01981850|471665215|FG004|Open Label Extension (OLE)|Various reasons|0|||
131010055|NCT01981850|471665216|FG005|Open Label Extension (OLE)|Various reasons|0|||
131010056|NCT01981850|471665217|FG006|Open Label Extension (OLE)|Various reasons|0|||
131010057|NCT01981850|471665218|FG007|Open Label Extension (OLE)|Various reasons|3|||
131010058|NCT01981850|471665219|FG008|Open Label Extension (OLE)|Various reasons|1|||
131010059|NCT01981850|471665220|FG009|Open Label Extension (OLE)|Various reasons|3|||
131010060|NCT01981850|471665211|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
131010061|NCT01981850|471665212|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
131010062|NCT01981850|471665213|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
131010063|NCT01981850|471665214|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
131010064|NCT01981850|471665215|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
131010065|NCT01981850|471665216|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
131010066|NCT01981850|471665217|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
131010067|NCT01981850|471665218|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
131010068|NCT01981850|471665219|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
131010069|NCT01981850|471665220|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
131010070|NCT01981850|471665211|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131010071|NCT01981850|471665212|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131010072|NCT01981850|471665213|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131010073|NCT01981850|471665214|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131010074|NCT01981850|471665215|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131010075|NCT01981850|471665216|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131010076|NCT01981850|471665217|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131010077|NCT01981850|471665218|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131010078|NCT01981850|471665219|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
131010079|NCT01981850|471665220|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
131010080|NCT01981850|471665211|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
131010081|NCT01981850|471665212|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
131010082|NCT01981850|471665213|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
131010083|NCT01981850|471665214|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
131010084|NCT01981850|471665215|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
131010085|NCT01981850|471665216|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
131010086|NCT01981850|471665217|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
131010087|NCT01981850|471665218|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
131010088|NCT01981850|471665219|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
131010089|NCT01981850|471665220|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
131010090|NCT02524288|471665221|FG000|Overall Study|Adverse Event|115|||
131010091|NCT02524288|471665221|FG000|Overall Study|Lost to Follow-up|216|||
131010092|NCT02524288|471665221|FG000|Overall Study|Non-Compliance With Protocol|32|||
131010093|NCT02524288|471665221|FG000|Overall Study|Non-Compliance With Study Drug|14|||
131010094|NCT02524288|471665221|FG000|Overall Study|Pregnancy Wish|6|||
131010095|NCT02524288|471665221|FG000|Overall Study|Protocol Violation|6|||
131010096|NCT02524288|471665221|FG000|Overall Study|Screen Failure|2|||
131010097|NCT02524288|471665221|FG000|Overall Study|Site Discontinued Study Participation|1|||
131010098|NCT02524288|471665221|FG000|Overall Study|Study Terminated By Sponsor|1417|||
131010099|NCT02524288|471665221|FG000|Overall Study|Subject Moved|32|||
131010100|NCT02524288|471665221|FG000|Overall Study|Withdrawal by Subject|76|||
131010101|NCT02524288|471665221|FG000|Overall Study|Pregnancy|22|||
131010102|NCT02524288|471665221|FG000|Overall Study|Physician Decision|2|||
131010103|NCT00517933|471665222|FG000|Period 1|Death|2|||
131010104|NCT00517933|471665223|FG001|Period 1|Death|1|||
131010105|NCT00517933|471665222|FG000|Period 1|Adverse Event|4|||
131010106|NCT00517933|471665223|FG001|Period 1|Adverse Event|4|||
131010107|NCT00517933|471665222|FG000|Period 1|Lost to Follow-up|2|||
131010108|NCT00517933|471665223|FG001|Period 1|Lost to Follow-up|0|||
131010109|NCT00517933|471665222|FG000|Period 1|Underwent lung transplant|0|||
131010110|NCT00517933|471665223|FG001|Period 1|Underwent lung transplant|1|||
131010111|NCT00517933|471665222|FG000|Period 2|Death|2|||
131010112|NCT00517933|471665223|FG001|Period 2|Death|4|||
131010113|NCT00517933|471665222|FG000|Period 2|Adverse Event|2|||
131010114|NCT00517933|471665223|FG001|Period 2|Adverse Event|4|||
131010115|NCT00517933|471665222|FG000|Period 2|Physician Decision|1|||
131010116|NCT00517933|471665223|FG001|Period 2|Physician Decision|0|||
131010117|NCT00517933|471665222|FG000|Period 2|Withdrawal by Subject|1|||
131010118|NCT00517933|471665223|FG001|Period 2|Withdrawal by Subject|3|||
131010119|NCT00517933|471665222|FG000|Period 2|Underwent lung transplant|0|||
131010120|NCT00517933|471665223|FG001|Period 2|Underwent lung transplant|2|||
131010121|NCT00121199|471665225|FG000|Overall Study|Adverse Event|11|||
131010122|NCT00121199|471665225|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
131010123|NCT00121199|471665225|FG000|Overall Study|Progression/Relapse|1|||
131010124|NCT00121199|471665225|FG000|Overall Study|Death|3|||
131010125|NCT00121199|471665225|FG000|Overall Study|Other - Not Protocol Specified|3|||
131010126|NCT00121199|471665225|FG000|Overall Study|Ineligible|9|||
131010127|NCT04109118|471665228|FG000|Overall Study|Lost to Follow-up|3|||
131010128|NCT03235349|471665231|FG000|Overall Study|Adverse Event|1|||
131010129|NCT03235349|471665231|FG000|Overall Study|Other|1|||
131010130|NCT04305912|471665234|FG000|First Intervention|COVID-19 Suspension|2|||
131010131|NCT04305912|471665235|FG001|First Intervention|COVID-19 Suspension|0|||
131010132|NCT04305912|471665234|FG000|First Intervention|Withdrawal by Subject|0|||
131010133|NCT04305912|471665235|FG001|First Intervention|Withdrawal by Subject|1|||
131010134|NCT04305912|471665234|FG000|Second Intervention|Adverse Event|0|||
131010135|NCT04305912|471665235|FG001|Second Intervention|Adverse Event|1|||
131010136|NCT05196737|471665236|FG000|Non-intervention Week|Lost to Follow-up|2|||
131010137|NCT05196737|471665236|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
131010138|NCT04888585|471665237|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
131010139|NCT04888585|471665238|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
131010140|NCT04888585|471665239|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
131010141|NCT04888585|471665240|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
131010142|NCT04888585|471665241|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
131010143|NCT04888585|471665242|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131010144|NCT04888585|471665243|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131010145|NCT04888585|471665244|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131010146|NCT04888585|471665245|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131010147|NCT04888585|471665246|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131010148|NCT04888585|471665247|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
131010149|NCT04888585|471665237|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131010150|NCT04888585|471665238|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
131010151|NCT04888585|471665239|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
131010152|NCT04888585|471665240|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
131010153|NCT04888585|471665241|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
131010154|NCT04888585|471665242|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131010155|NCT04888585|471665243|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131010156|NCT04888585|471665244|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131010157|NCT04888585|471665245|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131010158|NCT04888585|471665246|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131010159|NCT04888585|471665247|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
131010160|NCT04888585|471665237|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131010161|NCT04888585|471665238|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131010162|NCT04888585|471665239|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
131010163|NCT04888585|471665240|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131010164|NCT04888585|471665241|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
131010165|NCT04888585|471665242|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131010166|NCT04888585|471665243|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131010167|NCT04888585|471665244|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131010168|NCT04888585|471665245|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131010169|NCT04888585|471665246|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131010170|NCT04888585|471665247|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
131010171|NCT04888585|471665237|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
131010172|NCT04888585|471665238|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
131010173|NCT04888585|471665239|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
131010174|NCT04888585|471665240|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
131010175|NCT04888585|471665241|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
131010176|NCT04888585|471665242|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
131010177|NCT04888585|471665243|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
131010178|NCT04888585|471665244|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
131010179|NCT04888585|471665245|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
131010180|NCT04888585|471665246|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
131010181|NCT04888585|471665247|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
131010182|NCT04888585|471665237|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
131010183|NCT04888585|471665238|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
131010184|NCT04888585|471665239|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
131010185|NCT04888585|471665240|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
131010186|NCT04888585|471665241|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
131010187|NCT04888585|471665242|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
131010188|NCT04888585|471665243|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
131010189|NCT04888585|471665244|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
131010190|NCT04888585|471665245|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
131010191|NCT04888585|471665246|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
131010192|NCT04888585|471665247|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
131010193|NCT04888585|471665237|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
131010194|NCT04888585|471665238|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
131010195|NCT04888585|471665239|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
131010196|NCT04888585|471665240|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
131010197|NCT04888585|471665241|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
131010198|NCT04888585|471665242|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
131010199|NCT04888585|471665243|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
131010200|NCT04888585|471665244|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
131010201|NCT04888585|471665245|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
131010202|NCT04888585|471665246|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
131010203|NCT04888585|471665247|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
131010204|NCT04888585|471665237|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
131010205|NCT04888585|471665238|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
131010206|NCT04888585|471665239|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
131010207|NCT04888585|471665240|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
131010208|NCT04888585|471665241|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
131010209|NCT04888585|471665242|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
131010210|NCT04888585|471665243|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
131010211|NCT04888585|471665244|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
131010212|NCT04888585|471665245|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
131010213|NCT04888585|471665246|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
131010214|NCT04888585|471665247|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
131222555|NCT01625286|472441527|FG003|Overall Study|Progressive disease|5|||
130885273|NCT01352793|471213316|FG000|Overall Study|No longer meets eligibility criteria|25|||
130885274|NCT01352793|471213317|FG001|Overall Study|No longer meets eligibility criteria|15|||
130885275|NCT01716234|471213322|FG000|Overall Study|Protocol Violation|0|||
130885276|NCT01716234|471213323|FG001|Overall Study|Protocol Violation|0|||
130885277|NCT01716234|471213324|FG002|Overall Study|Protocol Violation|0|||
130885278|NCT01716234|471213325|FG003|Overall Study|Protocol Violation|1|||
130885279|NCT01716234|471213326|FG004|Overall Study|Protocol Violation|1|||
130885280|NCT01716234|471213327|FG005|Overall Study|Protocol Violation|1|||
130885281|NCT01716234|471213328|FG006|Overall Study|Protocol Violation|0|||
130885282|NCT01716234|471213322|FG000|Overall Study|Lack of Efficacy|0|||
130885283|NCT01716234|471213323|FG001|Overall Study|Lack of Efficacy|0|||
130885284|NCT01716234|471213324|FG002|Overall Study|Lack of Efficacy|0|||
130885285|NCT01716234|471213325|FG003|Overall Study|Lack of Efficacy|1|||
130885286|NCT01716234|471213326|FG004|Overall Study|Lack of Efficacy|0|||
130885287|NCT01716234|471213327|FG005|Overall Study|Lack of Efficacy|0|||
130885288|NCT01716234|471213328|FG006|Overall Study|Lack of Efficacy|0|||
130885289|NCT01716234|471213322|FG000|Overall Study|Did not meet protocol eligibility|0|||
130885290|NCT01716234|471213323|FG001|Overall Study|Did not meet protocol eligibility|0|||
130885291|NCT01716234|471213324|FG002|Overall Study|Did not meet protocol eligibility|1|||
130885292|NCT01716234|471213325|FG003|Overall Study|Did not meet protocol eligibility|0|||
130885293|NCT01716234|471213326|FG004|Overall Study|Did not meet protocol eligibility|0|||
130885294|NCT01716234|471213327|FG005|Overall Study|Did not meet protocol eligibility|4|||
130885295|NCT01716234|471213328|FG006|Overall Study|Did not meet protocol eligibility|0|||
130885296|NCT01716234|471213322|FG000|Overall Study|Adverse Event|7|||
131010215|NCT04888585|471665237|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131010216|NCT04888585|471665238|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131010217|NCT04888585|471665239|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131010218|NCT04888585|471665240|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131010219|NCT04888585|471665241|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131010220|NCT04888585|471665242|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131010221|NCT04888585|471665243|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
131010222|NCT04888585|471665244|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
131010223|NCT04888585|471665245|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
131010224|NCT04888585|471665246|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
131010225|NCT04888585|471665247|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
131010226|NCT03717194|471665248|FG000|Overall Study|Withdrawal by Subject|2|||
131010227|NCT03717194|471665249|FG001|Overall Study|Withdrawal by Subject|4|||
131010228|NCT03717194|471665248|FG000|Overall Study|Adverse Event|1|||
131010229|NCT03717194|471665249|FG001|Overall Study|Adverse Event|1|||
131010230|NCT02081391|471665250|FG000|12-hour Treatment|Withdrawal by Subject|3|||
131010231|NCT02081391|471665251|FG001|12-hour Treatment|Withdrawal by Subject|2|||
131010232|NCT02081391|471665252|FG002|12-hour Treatment|Withdrawal by Subject|0|||
131010233|NCT02081391|471665253|FG003|12-hour Treatment|Withdrawal by Subject|0|||
131010234|NCT02081391|471665250|FG000|12-hour Treatment|Physician Decision|4|||
131010235|NCT02081391|471665251|FG001|12-hour Treatment|Physician Decision|1|||
131010236|NCT02081391|471665252|FG002|12-hour Treatment|Physician Decision|0|||
131010237|NCT02081391|471665253|FG003|12-hour Treatment|Physician Decision|0|||
131010238|NCT02081391|471665250|FG000|12-hour Treatment|Lack of Efficacy|3|||
131010239|NCT02081391|471665251|FG001|12-hour Treatment|Lack of Efficacy|0|||
131010240|NCT02081391|471665252|FG002|12-hour Treatment|Lack of Efficacy|0|||
131010241|NCT02081391|471665253|FG003|12-hour Treatment|Lack of Efficacy|0|||
131010242|NCT02081391|471665250|FG000|12-hour Treatment|Adverse Event|4|||
131010243|NCT02081391|471665251|FG001|12-hour Treatment|Adverse Event|2|||
131010244|NCT02081391|471665252|FG002|12-hour Treatment|Adverse Event|0|||
131010245|NCT02081391|471665253|FG003|12-hour Treatment|Adverse Event|0|||
131010246|NCT02081391|471665250|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
131010247|NCT02081391|471665251|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
131010248|NCT02081391|471665252|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
131010249|NCT02081391|471665253|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
131010250|NCT02081391|471665250|FG000|12-hour Treatment|Further reasons|2|||
131010251|NCT02081391|471665251|FG001|12-hour Treatment|Further reasons|1|||
131010252|NCT02081391|471665252|FG002|12-hour Treatment|Further reasons|0|||
131010253|NCT02081391|471665253|FG003|12-hour Treatment|Further reasons|0|||
131010254|NCT02081391|471665250|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
131010255|NCT02081391|471665251|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
131010256|NCT02081391|471665252|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
131010257|NCT02081391|471665253|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
131010258|NCT02081391|471665250|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
131010259|NCT02081391|471665251|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
131010260|NCT02081391|471665252|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
131010261|NCT02081391|471665253|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
131010262|NCT02081391|471665250|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
131010263|NCT02081391|471665251|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
131010264|NCT02081391|471665252|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
131010265|NCT02081391|471665253|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
131010266|NCT02081391|471665250|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
131010267|NCT02081391|471665251|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
131010268|NCT02081391|471665252|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
131010269|NCT02081391|471665253|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
131010270|NCT02081391|471665250|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
131010271|NCT02081391|471665251|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
131010272|NCT02081391|471665252|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
131010273|NCT02081391|471665253|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
131010274|NCT02081391|471665250|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
131010275|NCT02081391|471665251|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
131010276|NCT02081391|471665252|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
131010277|NCT02081391|471665253|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
131010278|NCT02926937|471665254|FG000|Overall Study|Adverse Event|0|||
131010279|NCT02926937|471665255|FG001|Overall Study|Adverse Event|1|||
131010280|NCT02926937|471665256|FG002|Overall Study|Adverse Event|1|||
131010281|NCT02926937|471665254|FG000|Overall Study|Poor Compliance to Protocol|1|||
131010282|NCT02926937|471665255|FG001|Overall Study|Poor Compliance to Protocol|0|||
131010283|NCT02926937|471665256|FG002|Overall Study|Poor Compliance to Protocol|0|||
131010284|NCT02926937|471665254|FG000|Overall Study|Lost to Follow-up|4|||
131010285|NCT02926937|471665255|FG001|Overall Study|Lost to Follow-up|5|||
131010286|NCT02926937|471665256|FG002|Overall Study|Lost to Follow-up|0|||
131010287|NCT02926937|471665254|FG000|Overall Study|At the Participant's own Request|11|||
131010288|NCT02926937|471665255|FG001|Overall Study|At the Participant's own Request|5|||
131010289|NCT02926937|471665256|FG002|Overall Study|At the Participant's own Request|8|||
131010290|NCT02926937|471665254|FG000|Overall Study|Reason not Specified|3|||
131010291|NCT02926937|471665255|FG001|Overall Study|Reason not Specified|4|||
131010292|NCT02926937|471665256|FG002|Overall Study|Reason not Specified|2|||
131010293|NCT01559090|471665257|FG000|Stage I|Withdrawal by Subject|2|||
131010294|NCT01559090|471665258|FG001|Stage I|Withdrawal by Subject|2|||
131010295|NCT01559090|471665259|FG002|Stage I|Withdrawal by Subject|3|||
131010296|NCT01559090|471665257|FG000|Stage II|Withdrawal by Subject|1|||
131010297|NCT01559090|471665258|FG001|Stage II|Withdrawal by Subject|0|||
131010298|NCT01559090|471665259|FG002|Stage II|Withdrawal by Subject|0|||
131010299|NCT03722446|471665260|FG000|Overall Study|Protocol Violation|15|||
131010300|NCT03722446|471665261|FG001|Overall Study|Protocol Violation|2|||
131010301|NCT00819910|471665262|FG000|Overall Study|Adverse Event|0|||
131010302|NCT00819910|471665263|FG001|Overall Study|Adverse Event|0|||
131010303|NCT00819910|471665264|FG002|Overall Study|Adverse Event|2|||
131010304|NCT00819910|471665265|FG003|Overall Study|Adverse Event|1|||
131010305|NCT00819910|471665262|FG000|Overall Study|Withdrawal by Subject|1|||
131010306|NCT00819910|471665263|FG001|Overall Study|Withdrawal by Subject|1|||
131010307|NCT00819910|471665264|FG002|Overall Study|Withdrawal by Subject|1|||
131010308|NCT00819910|471665265|FG003|Overall Study|Withdrawal by Subject|0|||
131010309|NCT00819910|471665262|FG000|Overall Study|Lost to Follow-up|1|||
131010310|NCT00819910|471665263|FG001|Overall Study|Lost to Follow-up|0|||
131010311|NCT00819910|471665264|FG002|Overall Study|Lost to Follow-up|0|||
131010312|NCT00819910|471665265|FG003|Overall Study|Lost to Follow-up|0|||
131010313|NCT00871429|471665267|FG000|Overall Study|Lost to Follow-up|6|||
131010314|NCT00871429|471665267|FG000|Overall Study|Withdrawal by Subject|17|||
131010315|NCT00871429|471665267|FG000|Overall Study|Questionnaire not completed|1|||
131010316|NCT02908464|471665268|FG000|Overall Study|Withdrawal by Subject|2|||
131010317|NCT02908464|471665269|FG001|Overall Study|Withdrawal by Subject|1|||
131010318|NCT02908464|471665268|FG000|Overall Study|Found ineligible after randomization|0|||
131010319|NCT02908464|471665269|FG001|Overall Study|Found ineligible after randomization|2|||
131010320|NCT01772719|471665270|FG000|Overall Study|Withdrawal by Subject|3|||
131010321|NCT01772719|471665270|FG000|Overall Study|Adverse Event|2|||
131010322|NCT01772719|471665270|FG000|Overall Study|Protocol Violation|1|||
131010323|NCT01772719|471665270|FG000|Overall Study|Lost to Follow-up|1|||
131010324|NCT00477412|471665271|FG000|Overall Study|Death|0|||
131010325|NCT00477412|471665272|FG001|Overall Study|Death|0|||
131010326|NCT00477412|471665273|FG002|Overall Study|Death|0|||
131010327|NCT00477412|471665274|FG003|Overall Study|Death|4|||
131010328|NCT00477412|471665271|FG000|Overall Study|Lost to Follow-up|0|||
131010329|NCT00477412|471665272|FG001|Overall Study|Lost to Follow-up|0|||
131010330|NCT00477412|471665273|FG002|Overall Study|Lost to Follow-up|0|||
131010331|NCT00477412|471665274|FG003|Overall Study|Lost to Follow-up|1|||
131010332|NCT00477412|471665271|FG000|Overall Study|Withdrawal by Subject|0|||
131010333|NCT00477412|471665272|FG001|Overall Study|Withdrawal by Subject|0|||
131010334|NCT00477412|471665273|FG002|Overall Study|Withdrawal by Subject|0|||
131010335|NCT00477412|471665274|FG003|Overall Study|Withdrawal by Subject|2|||
131010336|NCT00477412|471665271|FG000|Overall Study|Second Malignancy|0|||
131010337|NCT00477412|471665272|FG001|Overall Study|Second Malignancy|0|||
131010338|NCT00477412|471665273|FG002|Overall Study|Second Malignancy|0|||
131010339|NCT00477412|471665274|FG003|Overall Study|Second Malignancy|1|||
131010340|NCT00477412|471665271|FG000|Overall Study|Adverse Event|1|||
131010341|NCT00477412|471665272|FG001|Overall Study|Adverse Event|0|||
131010342|NCT00477412|471665273|FG002|Overall Study|Adverse Event|1|||
131010343|NCT00477412|471665274|FG003|Overall Study|Adverse Event|0|||
131010344|NCT00299702|471665275|FG000|Overall Study|Death|1|||
131010345|NCT00299702|471665276|FG001|Overall Study|Death|0|||
131010346|NCT00299702|471665275|FG000|Overall Study|Adverse Event|0|||
131010347|NCT00299702|471665276|FG001|Overall Study|Adverse Event|4|||
131010348|NCT00299702|471665275|FG000|Overall Study|Lost to Follow-up|18|||
131010349|NCT00299702|471665276|FG001|Overall Study|Lost to Follow-up|10|||
131010350|NCT00299702|471665275|FG000|Overall Study|Withdrawal by Subject|25|||
131010351|NCT00299702|471665276|FG001|Overall Study|Withdrawal by Subject|23|||
131010352|NCT00299702|471665275|FG000|Overall Study|Pregnancy|0|||
131010353|NCT00299702|471665276|FG001|Overall Study|Pregnancy|1|||
131010354|NCT00299702|471665275|FG000|Overall Study|Insufficient Response|4|||
131010355|NCT00299702|471665276|FG001|Overall Study|Insufficient Response|3|||
131010356|NCT00299702|471665275|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
131010357|NCT00299702|471665276|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
131010358|NCT00751036|471665277|FG000|Overall Study|Disease Progression|28|||
131010359|NCT00751036|471665278|FG001|Overall Study|Disease Progression|29|||
131010360|NCT00751036|471665277|FG000|Overall Study|Adverse Event|6|||
131010361|NCT00751036|471665278|FG001|Overall Study|Adverse Event|4|||
131010362|NCT00751036|471665277|FG000|Overall Study|Administrative Problems|3|||
131010363|NCT00751036|471665278|FG001|Overall Study|Administrative Problems|4|||
131010364|NCT00751036|471665277|FG000|Overall Study|Withdrawal by Subject|5|||
131010365|NCT00751036|471665278|FG001|Overall Study|Withdrawal by Subject|2|||
131010366|NCT00751036|471665277|FG000|Overall Study|Death|3|||
131010367|NCT00751036|471665278|FG001|Overall Study|Death|3|||
131010368|NCT00751036|471665277|FG000|Overall Study|Lost to Follow-up|0|||
131010369|NCT00751036|471665278|FG001|Overall Study|Lost to Follow-up|1|||
131010370|NCT00751036|471665277|FG000|Overall Study|Protocol Violation|1|||
131010371|NCT00751036|471665278|FG001|Overall Study|Protocol Violation|0|||
131010372|NCT00751036|471665277|FG000|Overall Study|Missing end of Treatment Page|2|||
131010373|NCT00751036|471665278|FG001|Overall Study|Missing end of Treatment Page|3|||
131010374|NCT05460663|471665279|FG000|Overall Study|Withdrawal by Subject|2|||
131010375|NCT05460663|471665280|FG001|Overall Study|Withdrawal by Subject|5|||
131010376|NCT05273801|471665281|FG000|Overall Study|Physician Decision|1|||
131010377|NCT05526911|471666730|FG000|Overall Study|Adverse Event|2|||
131010378|NCT05025449|471666731|FG000|Overall Study|Withdrawal by Subject|1|||
131010379|NCT05025449|471666731|FG000|Overall Study|Patient emergently taken to operating room|1|||
131010380|NCT00613301|471666732|FG000|Overall Study|Adverse Event|49|||
131010381|NCT00613301|471666732|FG000|Overall Study|Lost to Follow-up|88|||
131010382|NCT00613301|471666732|FG000|Overall Study|Withdrawal by Subject|5|||
131010383|NCT00613301|471666732|FG000|Overall Study|Death|6|||
131010384|NCT00613301|471666732|FG000|Overall Study|Lack of Efficacy|13|||
131010385|NCT00613301|471666732|FG000|Overall Study|Physician Decision|2|||
131010386|NCT00613301|471666732|FG000|Overall Study|No data was collected|53|||
131010387|NCT00613301|471666732|FG000|Overall Study|Irregularly enrolled patients|12|||
131010388|NCT00569946|471666733|FG000|Overall Study|Adverse Event|16|||
131010389|NCT00569946|471666733|FG000|Overall Study|Objective Progression or Relapse|42|||
131010390|NCT00569946|471666733|FG000|Overall Study|Global Deterioration of Health Status|1|||
131010391|NCT00762463|471666735|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
131010392|NCT00762463|471666736|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
131010393|NCT00762463|471666737|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
131010394|NCT00762463|471666738|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
131010395|NCT00762463|471666735|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
131010396|NCT00762463|471666736|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
131010397|NCT00762463|471666737|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
131010398|NCT00762463|471666738|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
131010399|NCT00762463|471666735|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
131010400|NCT00762463|471666736|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
131010401|NCT00762463|471666737|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
131010402|NCT00762463|471666738|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
131010403|NCT00762463|471666735|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
131010404|NCT00762463|471666736|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
131010405|NCT00762463|471666737|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
131010406|NCT00762463|471666738|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
131010407|NCT00762463|471666735|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
131010408|NCT00762463|471666736|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
131010409|NCT00762463|471666737|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
131010410|NCT00762463|471666738|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
131222556|NCT01625286|472441528|FG004|Overall Study|Progressive disease|5|||
130885297|NCT01716234|471213323|FG001|Overall Study|Adverse Event|10|||
131010411|NCT00762463|471666735|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
131010412|NCT00762463|471666736|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
131010413|NCT00762463|471666737|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
131010414|NCT00762463|471666738|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
131010415|NCT00762463|471666735|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
131010416|NCT00762463|471666736|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
131010417|NCT00762463|471666737|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
131010418|NCT00762463|471666738|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
131010419|NCT00762463|471666735|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
131010420|NCT00762463|471666736|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
131010421|NCT00762463|471666737|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
131010422|NCT00762463|471666738|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
131010423|NCT01306331|471666741|FG000|Overall Study|Adverse Event|28|||
131010424|NCT01306331|471666742|FG001|Overall Study|Adverse Event|25|||
131010425|NCT01306331|471666741|FG000|Overall Study|Lost to Follow-up|321|||
131010426|NCT01306331|471666742|FG001|Overall Study|Lost to Follow-up|323|||
131010427|NCT01306331|471666741|FG000|Overall Study|Physician Decision|26|||
131010428|NCT01306331|471666742|FG001|Overall Study|Physician Decision|22|||
131010429|NCT01306331|471666741|FG000|Overall Study|Pregnancy|136|||
131010430|NCT01306331|471666742|FG001|Overall Study|Pregnancy|151|||
131010431|NCT01306331|471666741|FG000|Overall Study|Protocol Violation|154|||
131010432|NCT01306331|471666742|FG001|Overall Study|Protocol Violation|124|||
131010433|NCT01306331|471666741|FG000|Overall Study|Withdrawal by Subject|163|||
131010434|NCT01306331|471666742|FG001|Overall Study|Withdrawal by Subject|152|||
131010435|NCT01306331|471666741|FG000|Overall Study|Not sexually active|29|||
131010436|NCT01306331|471666742|FG001|Overall Study|Not sexually active|28|||
131010437|NCT01306331|471666741|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
131010438|NCT01306331|471666742|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
131010439|NCT01306331|471666741|FG000|Overall Study|Other|34|||
131010440|NCT01306331|471666742|FG001|Overall Study|Other|32|||
131010441|NCT00172185|471666745|FG000|Overall Study|Adverse Event|0|||
131010442|NCT00172185|471666746|FG001|Overall Study|Adverse Event|1|||
131010443|NCT00172185|471666747|FG002|Overall Study|Adverse Event|3|||
131010444|NCT00172185|471666748|FG003|Overall Study|Adverse Event|4|||
131010445|NCT00172185|471666745|FG000|Overall Study|Physician Decision|0|||
131010446|NCT00172185|471666746|FG001|Overall Study|Physician Decision|0|||
131010447|NCT00172185|471666747|FG002|Overall Study|Physician Decision|1|||
131010448|NCT00172185|471666748|FG003|Overall Study|Physician Decision|0|||
131010449|NCT00172185|471666745|FG000|Overall Study|SPONSOR Decision|0|||
131010450|NCT00172185|471666746|FG001|Overall Study|SPONSOR Decision|1|||
131010451|NCT00172185|471666747|FG002|Overall Study|SPONSOR Decision|0|||
131010452|NCT00172185|471666748|FG003|Overall Study|SPONSOR Decision|0|||
131010453|NCT00172185|471666745|FG000|Overall Study|Withdrawal by Subject|0|||
131010454|NCT00172185|471666746|FG001|Overall Study|Withdrawal by Subject|0|||
131010455|NCT00172185|471666747|FG002|Overall Study|Withdrawal by Subject|1|||
131010456|NCT00172185|471666748|FG003|Overall Study|Withdrawal by Subject|0|||
131010457|NCT04048135|471666749|FG000|Overall Study|Withdrawal by Subject|1|||
131010458|NCT04048135|471666750|FG001|Overall Study|Withdrawal by Subject|1|||
131010459|NCT04048135|471666751|FG002|Overall Study|Withdrawal by Subject|1|||
131010460|NCT04048135|471666752|FG003|Overall Study|Withdrawal by Subject|2|||
131010461|NCT04048135|471666753|FG004|Overall Study|Withdrawal by Subject|0|||
131010462|NCT04048135|471666754|FG005|Overall Study|Withdrawal by Subject|0|||
131010463|NCT04048135|471666755|FG006|Overall Study|Withdrawal by Subject|1|||
131010464|NCT04048135|471666756|FG007|Overall Study|Withdrawal by Subject|1|||
131010465|NCT04048135|471666749|FG000|Overall Study|Adverse Event|0|||
131010466|NCT04048135|471666750|FG001|Overall Study|Adverse Event|0|||
131010467|NCT04048135|471666751|FG002|Overall Study|Adverse Event|0|||
131010468|NCT04048135|471666752|FG003|Overall Study|Adverse Event|1|||
131010469|NCT04048135|471666753|FG004|Overall Study|Adverse Event|1|||
131010470|NCT04048135|471666754|FG005|Overall Study|Adverse Event|0|||
131010471|NCT04048135|471666755|FG006|Overall Study|Adverse Event|0|||
131010472|NCT04048135|471666756|FG007|Overall Study|Adverse Event|0|||
131010473|NCT04048135|471666749|FG000|Overall Study|Protocol Violation|0|||
131010474|NCT04048135|471666750|FG001|Overall Study|Protocol Violation|0|||
131010475|NCT04048135|471666751|FG002|Overall Study|Protocol Violation|0|||
131010476|NCT04048135|471666752|FG003|Overall Study|Protocol Violation|0|||
131010477|NCT04048135|471666753|FG004|Overall Study|Protocol Violation|0|||
131010478|NCT04048135|471666754|FG005|Overall Study|Protocol Violation|1|||
131010479|NCT04048135|471666755|FG006|Overall Study|Protocol Violation|0|||
131010480|NCT04048135|471666756|FG007|Overall Study|Protocol Violation|0|||
131010481|NCT01677936|471666757|FG000|Overall Study|Lost to Follow-up|4|||
130885298|NCT01716234|471213324|FG002|Overall Study|Adverse Event|2|||
131010482|NCT01677936|471666758|FG001|Overall Study|Lost to Follow-up|1|||
131010483|NCT01677936|471666757|FG000|Overall Study|Protocol Violation|3|||
131010484|NCT01677936|471666758|FG001|Overall Study|Protocol Violation|0|||
131010485|NCT01677936|471666757|FG000|Overall Study|Adverse Event|1|||
131010486|NCT01677936|471666758|FG001|Overall Study|Adverse Event|0|||
131010487|NCT01677936|471666757|FG000|Overall Study|Lost to Follow-up|1|||
131010488|NCT01677936|471666758|FG001|Overall Study|Lost to Follow-up|0|||
131010489|NCT01677936|471666757|FG000|Overall Study|Protocol Violation|0|||
131010490|NCT01677936|471666758|FG001|Overall Study|Protocol Violation|4|||
131010491|NCT04565249|471666761|FG000|Overall Study|Death|0|||
131010492|NCT04565249|471666762|FG001|Overall Study|Death|0|||
131010493|NCT04565249|471666763|FG002|Overall Study|Death|0|||
131010494|NCT04565249|471666764|FG003|Overall Study|Death|1|||
131010495|NCT01020838|471666772|FG000|Overall Study|Death|90|||
131010496|NCT01020838|471666772|FG000|Overall Study|Adverse Event|1|||
131010497|NCT01020838|471666772|FG000|Overall Study|Withdrawal by Subject|9|||
131010498|NCT01020838|471666772|FG000|Overall Study|Lost to Follow-up|6|||
131010499|NCT01020838|471666772|FG000|Overall Study|Most common: Study ended by sponsor|77|||
131010500|NCT01908634|471666773|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
131010501|NCT01908634|471666773|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
131010502|NCT00588666|471666776|FG000|Overall Study|Adverse Event|4|||
131010503|NCT03102710|471666777|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
131010504|NCT03102710|471666778|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
131010505|NCT03102710|471666779|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
131010506|NCT03102710|471666777|FG000|Overall Study|Technical issues during final MRI scan|0|||
131010507|NCT03102710|471666778|FG001|Overall Study|Technical issues during final MRI scan|1|||
131010508|NCT03102710|471666779|FG002|Overall Study|Technical issues during final MRI scan|0|||
131010509|NCT03102710|471666777|FG000|Overall Study|Nausea during MRI scan|0|||
131010510|NCT03102710|471666778|FG001|Overall Study|Nausea during MRI scan|1|||
131010511|NCT03102710|471666779|FG002|Overall Study|Nausea during MRI scan|0|||
131010512|NCT03102710|471666777|FG000|Overall Study|Subject unable to attend final session|0|||
131010513|NCT03102710|471666778|FG001|Overall Study|Subject unable to attend final session|1|||
131010514|NCT03102710|471666779|FG002|Overall Study|Subject unable to attend final session|0|||
131010515|NCT04582877|471666780|FG000|Overall Study|Did not use device measurement|5|||
131010516|NCT04582877|471666780|FG000|Overall Study|No fractional flow reserve test results|2|||
131010517|NCT04582877|471666780|FG000|Overall Study|Protocol Violation|1|||
131010518|NCT04012853|471666781|FG000|Overall Study|Withdrawal by Subject|1|||
131010519|NCT04012853|471666782|FG001|Overall Study|Withdrawal by Subject|1|||
131010520|NCT04012853|471666781|FG000|Overall Study|Protocol Violation|1|||
131010521|NCT04012853|471666782|FG001|Overall Study|Protocol Violation|0|||
131010522|NCT04012853|471666781|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
131010523|NCT04012853|471666782|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
131010524|NCT03055767|471666783|FG000|Open-Label Period|Lost to Follow-up|0|||
131010525|NCT03055767|471666784|FG001|Open-Label Period|Lost to Follow-up|0|||
131010526|NCT03055767|471666785|FG002|Open-Label Period|Lost to Follow-up|2|||
131010527|NCT03055767|471666786|FG003|Open-Label Period|Lost to Follow-up|0|||
131010528|NCT03055767|471666783|FG000|Open-Label Period|Withdrawal by Subject|0|||
131010529|NCT03055767|471666784|FG001|Open-Label Period|Withdrawal by Subject|0|||
131010530|NCT03055767|471666785|FG002|Open-Label Period|Withdrawal by Subject|0|||
131010531|NCT03055767|471666786|FG003|Open-Label Period|Withdrawal by Subject|1|||
131010532|NCT02759731|471666787|FG000|Overall Study|Did not complete treatment.|8|||
131010533|NCT01599325|471666788|FG000|Primary Parent Phase|Adverse Event|5|||
131010534|NCT01599325|471666788|FG000|Primary Parent Phase|Disease Progression|7|||
131010535|NCT01599325|471666788|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
131010536|NCT01599325|471666788|FG000|Primary Parent Phase|Death|13|||
131010537|NCT01599325|471666788|FG000|Primary Parent Phase|Protocol Violation|1|||
131010538|NCT01599325|471666788|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
131010539|NCT01599325|471666788|FG000|Primary Parent Phase|Other|2|||
131010540|NCT01599325|471666788|FG000|Extension Phase|Study Closure|1|||
131010541|NCT01599325|471666788|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
131010542|NCT01599325|471666788|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
131010543|NCT01599325|471666788|FG000|Extension Phase|Disease Progression|1|||
131010544|NCT01599325|471666788|FG000|Extension Phase|Withdrawal by Subject|8|||
131010545|NCT03404843|471666790|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
131010546|NCT03404843|471666791|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
131010547|NCT00567164|471666792|FG000|Overall Study|Withdrawal by Subject|171|||
131010548|NCT00567164|471666793|FG001|Overall Study|Withdrawal by Subject|21|||
131010549|NCT00567164|471666794|FG002|Overall Study|Withdrawal by Subject|17|||
131010550|NCT00567164|471666792|FG000|Overall Study|Protocol Violation|23|||
131010551|NCT00567164|471666793|FG001|Overall Study|Protocol Violation|4|||
131010552|NCT00567164|471666794|FG002|Overall Study|Protocol Violation|2|||
131010553|NCT00567164|471666792|FG000|Overall Study|Adverse Event|92|||
131010554|NCT00567164|471666793|FG001|Overall Study|Adverse Event|13|||
131010555|NCT00567164|471666794|FG002|Overall Study|Adverse Event|9|||
131010556|NCT00567164|471666792|FG000|Overall Study|Death|0|||
131010557|NCT00567164|471666793|FG001|Overall Study|Death|0|||
131010558|NCT00567164|471666794|FG002|Overall Study|Death|1|||
131010559|NCT00567164|471666792|FG000|Overall Study|Lost to Follow-up|202|||
131010560|NCT00567164|471666793|FG001|Overall Study|Lost to Follow-up|23|||
131010561|NCT00567164|471666794|FG002|Overall Study|Lost to Follow-up|21|||
131010562|NCT00567164|471666792|FG000|Overall Study|Pregnancy|20|||
131010563|NCT00567164|471666793|FG001|Overall Study|Pregnancy|4|||
131010564|NCT00567164|471666794|FG002|Overall Study|Pregnancy|6|||
131010565|NCT00567164|471666792|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
131222557|NCT01625286|472441529|FG005|Overall Study|Progressive disease|0|||
131010566|NCT00567164|471666793|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
131010567|NCT00567164|471666794|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
131010568|NCT00567164|471666792|FG000|Overall Study|Missing|1|||
131010569|NCT00567164|471666793|FG001|Overall Study|Missing|0|||
131010570|NCT00567164|471666794|FG002|Overall Study|Missing|0|||
131010571|NCT02430532|471666805|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
131010572|NCT02430532|471666806|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
131010573|NCT02430532|471666805|FG000|Overall Study|Consent Withdrawn|0|||
131010574|NCT02430532|471666806|FG001|Overall Study|Consent Withdrawn|2|||
131010575|NCT02430532|471666805|FG000|Overall Study|Adverse Event|0|||
131010576|NCT02430532|471666806|FG001|Overall Study|Adverse Event|1|||
131010577|NCT01190150|471666807|FG000|First Treatment|Withdrawal by Subject|1|||
131010578|NCT01190150|471666808|FG001|First Treatment|Withdrawal by Subject|0|||
131010579|NCT01190150|471666807|FG000|Washout|Withdrawal by Subject|0|||
131010580|NCT01190150|471666808|FG001|Washout|Withdrawal by Subject|1|||
131010581|NCT01190150|471666807|FG000|Washout|Difficulty in adherence|0|||
131010582|NCT01190150|471666808|FG001|Washout|Difficulty in adherence|1|||
131010583|NCT03256344|471666809|FG000|Overall Study|Death|6|||
131010584|NCT03256344|471666810|FG001|Overall Study|Death|22|||
131010585|NCT03256344|471666809|FG000|Overall Study|Withdrawal by Subject|3|||
131010586|NCT03256344|471666810|FG001|Overall Study|Withdrawal by Subject|3|||
131010587|NCT03256344|471666809|FG000|Overall Study|Sponsor Decision|1|||
131010588|NCT03256344|471666810|FG001|Overall Study|Sponsor Decision|0|||
131010589|NCT01670019|471666822|FG000|Overall Study|Adverse Event|3|||
131010590|NCT01670019|471666823|FG001|Overall Study|Adverse Event|0|||
131010591|NCT01670019|471666822|FG000|Overall Study|Withdrawal by Subject|6|||
131010592|NCT01670019|471666823|FG001|Overall Study|Withdrawal by Subject|0|||
131010593|NCT00580801|471666824|FG000|Overall Study|Physician Decision|1|||
131010594|NCT00580801|471666825|FG001|Overall Study|Physician Decision|0|||
131010595|NCT00580801|471666826|FG002|Overall Study|Physician Decision|0|||
131010596|NCT00580801|471666824|FG000|Overall Study|Adverse Event|2|||
131010597|NCT00580801|471666825|FG001|Overall Study|Adverse Event|0|||
131010598|NCT00580801|471666826|FG002|Overall Study|Adverse Event|0|||
131010599|NCT00580801|471666824|FG000|Overall Study|Lost to Follow-up|2|||
131010600|NCT00580801|471666825|FG001|Overall Study|Lost to Follow-up|0|||
131010601|NCT00580801|471666826|FG002|Overall Study|Lost to Follow-up|0|||
131010602|NCT00580801|471666824|FG000|Overall Study|Reached a virologic endpoint|0|||
131010603|NCT00580801|471666825|FG001|Overall Study|Reached a virologic endpoint|1|||
131010604|NCT00580801|471666826|FG002|Overall Study|Reached a virologic endpoint|2|||
131010605|NCT00580801|471666824|FG000|Overall Study|Participant non-compliant|0|||
131010606|NCT00580801|471666825|FG001|Overall Study|Participant non-compliant|0|||
131010607|NCT00580801|471666826|FG002|Overall Study|Participant non-compliant|1|||
131010608|NCT00580801|471666824|FG000|Overall Study|Travel|1|||
131010609|NCT00580801|471666825|FG001|Overall Study|Travel|0|||
131010610|NCT00580801|471666826|FG002|Overall Study|Travel|0|||
131010611|NCT01467700|471666828|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
131010612|NCT01467700|471666829|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
131010613|NCT01467700|471666830|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
131010614|NCT01467700|471666831|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
131222558|NCT01625286|472441530|FG006|Overall Study|Progressive disease|0|||
131010615|NCT01467700|471666828|FG000|Overall Study|Major Protocol Deviation|3|||
131010616|NCT01467700|471666829|FG001|Overall Study|Major Protocol Deviation|3|||
131010617|NCT01467700|471666830|FG002|Overall Study|Major Protocol Deviation|2|||
131010618|NCT01467700|471666831|FG003|Overall Study|Major Protocol Deviation|3|||
131010619|NCT01467700|471666828|FG000|Overall Study|Lost to Follow-up|6|||
131010620|NCT01467700|471666829|FG001|Overall Study|Lost to Follow-up|5|||
131010621|NCT01467700|471666830|FG002|Overall Study|Lost to Follow-up|2|||
131010622|NCT01467700|471666831|FG003|Overall Study|Lost to Follow-up|3|||
131010623|NCT01467700|471666828|FG000|Overall Study|Voluntary Withdrawal|5|||
131010624|NCT01467700|471666829|FG001|Overall Study|Voluntary Withdrawal|7|||
131010625|NCT01467700|471666830|FG002|Overall Study|Voluntary Withdrawal|6|||
131010626|NCT01467700|471666831|FG003|Overall Study|Voluntary Withdrawal|2|||
131010627|NCT01467700|471666828|FG000|Overall Study|Study Termination|6|||
131010628|NCT01467700|471666829|FG001|Overall Study|Study Termination|5|||
131010629|NCT01467700|471666830|FG002|Overall Study|Study Termination|10|||
131010630|NCT01467700|471666831|FG003|Overall Study|Study Termination|7|||
131010631|NCT01467700|471666828|FG000|Overall Study|Pregnancy|0|||
131010632|NCT01467700|471666829|FG001|Overall Study|Pregnancy|1|||
131010633|NCT01467700|471666830|FG002|Overall Study|Pregnancy|1|||
131010634|NCT01467700|471666831|FG003|Overall Study|Pregnancy|0|||
131010635|NCT01467700|471666828|FG000|Overall Study|Lack of Efficacy|2|||
131010636|NCT01467700|471666829|FG001|Overall Study|Lack of Efficacy|0|||
131010637|NCT01467700|471666830|FG002|Overall Study|Lack of Efficacy|2|||
131010638|NCT01467700|471666831|FG003|Overall Study|Lack of Efficacy|1|||
131010639|NCT01467700|471666828|FG000|Overall Study|Reason not Specified|1|||
131010640|NCT01467700|471666829|FG001|Overall Study|Reason not Specified|3|||
131010641|NCT01467700|471666830|FG002|Overall Study|Reason not Specified|2|||
131010642|NCT01467700|471666831|FG003|Overall Study|Reason not Specified|8|||
131010643|NCT03523962|471666832|FG000|Closed Fractures|Death|86|||
131010644|NCT03523962|471666833|FG001|Closed Fractures|Death|71|||
131010645|NCT03523962|471666834|FG002|Closed Fractures|Death|0|||
131010646|NCT03523962|471666835|FG003|Closed Fractures|Death|0|||
131010647|NCT03523962|471666832|FG000|Closed Fractures|Lost to Follow-up|62|||
131010648|NCT03523962|471666833|FG001|Closed Fractures|Lost to Follow-up|36|||
131010649|NCT03523962|471666834|FG002|Closed Fractures|Lost to Follow-up|0|||
131010650|NCT03523962|471666835|FG003|Closed Fractures|Lost to Follow-up|0|||
131010651|NCT03523962|471666832|FG000|Closed Fractures|Withdrawal by Subject|19|||
131010652|NCT03523962|471666833|FG001|Closed Fractures|Withdrawal by Subject|29|||
131010653|NCT03523962|471666834|FG002|Closed Fractures|Withdrawal by Subject|0|||
131010654|NCT03523962|471666835|FG003|Closed Fractures|Withdrawal by Subject|0|||
131010655|NCT03523962|471666832|FG000|Closed Fractures|Incarceration|1|||
131010656|NCT03523962|471666833|FG001|Closed Fractures|Incarceration|4|||
131010657|NCT03523962|471666834|FG002|Closed Fractures|Incarceration|0|||
131010658|NCT03523962|471666835|FG003|Closed Fractures|Incarceration|0|||
131010659|NCT03523962|471666832|FG000|Open Fractures|Death|0|||
131010660|NCT03523962|471666833|FG001|Open Fractures|Death|0|||
131010661|NCT03523962|471666834|FG002|Open Fractures|Death|11|||
131010662|NCT03523962|471666835|FG003|Open Fractures|Death|6|||
131010663|NCT03523962|471666832|FG000|Open Fractures|Lost to Follow-up|0|||
131010664|NCT03523962|471666833|FG001|Open Fractures|Lost to Follow-up|0|||
131010665|NCT03523962|471666834|FG002|Open Fractures|Lost to Follow-up|15|||
131010666|NCT03523962|471666835|FG003|Open Fractures|Lost to Follow-up|8|||
131010667|NCT03523962|471666832|FG000|Open Fractures|Withdrawal by Subject|0|||
131010668|NCT03523962|471666833|FG001|Open Fractures|Withdrawal by Subject|0|||
131010669|NCT03523962|471666834|FG002|Open Fractures|Withdrawal by Subject|6|||
131010670|NCT03523962|471666835|FG003|Open Fractures|Withdrawal by Subject|2|||
130885299|NCT01716234|471213325|FG003|Overall Study|Adverse Event|8|||
131010671|NCT03523962|471666832|FG000|Open Fractures|Incarceration|0|||
131010672|NCT03523962|471666833|FG001|Open Fractures|Incarceration|0|||
131010673|NCT03523962|471666834|FG002|Open Fractures|Incarceration|1|||
131010674|NCT03523962|471666835|FG003|Open Fractures|Incarceration|0|||
131010675|NCT03396913|471666840|FG000|Overall Study|Lost to Follow-up|0|||
131010676|NCT03396913|471666841|FG001|Overall Study|Lost to Follow-up|6|||
131010677|NCT00813488|471666842|FG000|Titration Period 1|Adverse Event|6|||
131010678|NCT00813488|471666843|FG001|Titration Period 1|Adverse Event|1|||
131010679|NCT00813488|471666842|FG000|Titration Period 1|Lack of Efficacy|9|||
131010680|NCT00813488|471666843|FG001|Titration Period 1|Lack of Efficacy|7|||
131010681|NCT00813488|471666842|FG000|Titration Period 1|Withdrawal by Subject|2|||
131010682|NCT00813488|471666843|FG001|Titration Period 1|Withdrawal by Subject|2|||
131010683|NCT00813488|471666842|FG000|Titration Period 1|Protocol Violation|4|||
131010684|NCT00813488|471666843|FG001|Titration Period 1|Protocol Violation|3|||
131010685|NCT00813488|471666842|FG000|Titration Period 1|Non-compliance to study medication|4|||
131010686|NCT00813488|471666843|FG001|Titration Period 1|Non-compliance to study medication|1|||
131010687|NCT00813488|471666842|FG000|Titration Period 1|Non-compliance to study procedures|2|||
131010688|NCT00813488|471666843|FG001|Titration Period 1|Non-compliance to study procedures|2|||
131010689|NCT00813488|471666842|FG000|Titration Period 1|Technical Difficulties|0|||
131010690|NCT00813488|471666843|FG001|Titration Period 1|Technical Difficulties|1|||
131010691|NCT00813488|471666842|FG000|Titration Period 2|Adverse Event|2|||
131010692|NCT00813488|471666843|FG001|Titration Period 2|Adverse Event|3|||
131010693|NCT00813488|471666842|FG000|Titration Period 2|Lack of Efficacy|8|||
131010694|NCT00813488|471666843|FG001|Titration Period 2|Lack of Efficacy|4|||
131010695|NCT00813488|471666842|FG000|Titration Period 2|Protocol Violation|3|||
131010696|NCT00813488|471666843|FG001|Titration Period 2|Protocol Violation|2|||
131010697|NCT00813488|471666842|FG000|Titration Period 2|Lost to Follow-up|1|||
131010698|NCT00813488|471666843|FG001|Titration Period 2|Lost to Follow-up|0|||
131010699|NCT00813488|471666842|FG000|Titration Period 2|Non-compliance with study procedures|2|||
131010700|NCT00813488|471666843|FG001|Titration Period 2|Non-compliance with study procedures|1|||
131010701|NCT00813488|471666842|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
131010702|NCT00813488|471666843|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
131010703|NCT00813488|471666842|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
131010704|NCT00813488|471666843|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
131010705|NCT00813488|471666842|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
131010706|NCT00813488|471666843|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
131010707|NCT00813488|471666842|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
131010708|NCT00813488|471666843|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
131010709|NCT00813488|471666842|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
131010710|NCT00813488|471666843|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
131010711|NCT00813488|471666842|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
131010712|NCT00813488|471666843|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
131010713|NCT00813488|471666842|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
131010714|NCT00813488|471666843|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
131010715|NCT00813488|471666842|FG000|Double-blind Treatment Period 2|Other|1|||
131010716|NCT00813488|471666843|FG001|Double-blind Treatment Period 2|Other|0|||
131010717|NCT00813488|471666842|FG000|Open-label Extension|Adverse Event|1|||
131010718|NCT00813488|471666843|FG001|Open-label Extension|Adverse Event|2|||
131010719|NCT00813488|471666842|FG000|Open-label Extension|Lack of Efficacy|3|||
131010720|NCT00813488|471666843|FG001|Open-label Extension|Lack of Efficacy|0|||
131010721|NCT00813488|471666842|FG000|Open-label Extension|Withdrawal by Subject|0|||
131010722|NCT00813488|471666843|FG001|Open-label Extension|Withdrawal by Subject|2|||
131010723|NCT00813488|471666842|FG000|Open-label Extension|Protocol Violation|1|||
131010724|NCT00813488|471666843|FG001|Open-label Extension|Protocol Violation|2|||
131010725|NCT00813488|471666842|FG000|Open-label Extension|Non-compliance study medication|4|||
131010726|NCT00813488|471666843|FG001|Open-label Extension|Non-compliance study medication|0|||
131010727|NCT00813488|471666842|FG000|Open-label Extension|Non-compliance study procedures|2|||
131010728|NCT00813488|471666843|FG001|Open-label Extension|Non-compliance study procedures|1|||
131010729|NCT00813488|471666842|FG000|Open-label Extension|Other|1|||
131010730|NCT00813488|471666843|FG001|Open-label Extension|Other|0|||
131010731|NCT01729871|471666845|FG000|Overall Study|Adverse Event|7|||
131010732|NCT01729871|471666846|FG001|Overall Study|Adverse Event|7|||
131010733|NCT01729871|471666845|FG000|Overall Study|Death|0|||
131010734|NCT01729871|471666846|FG001|Overall Study|Death|1|||
131010735|NCT01729871|471666845|FG000|Overall Study|Lack of Efficacy|0|||
131010736|NCT01729871|471666846|FG001|Overall Study|Lack of Efficacy|1|||
131010737|NCT01729871|471666845|FG000|Overall Study|Physician Decision|0|||
131010738|NCT01729871|471666846|FG001|Overall Study|Physician Decision|2|||
131010739|NCT01729871|471666845|FG000|Overall Study|Protocol Violation|1|||
131010740|NCT01729871|471666846|FG001|Overall Study|Protocol Violation|0|||
131010741|NCT01729871|471666845|FG000|Overall Study|Withdrawal by Subject|0|||
131010742|NCT01729871|471666846|FG001|Overall Study|Withdrawal by Subject|3|||
131010743|NCT01729871|471666845|FG000|Overall Study|Other|4|||
131010744|NCT01729871|471666846|FG001|Overall Study|Other|9|||
131010745|NCT01143077|471666847|FG000|Overall Study|Lack of Efficacy|0|||
131010746|NCT01143077|471666848|FG001|Overall Study|Lack of Efficacy|2|||
131010747|NCT01143077|471666849|FG002|Overall Study|Lack of Efficacy|1|||
131010748|NCT01143077|471666847|FG000|Overall Study|Adverse Event|5|||
131010749|NCT01143077|471666848|FG001|Overall Study|Adverse Event|6|||
131010750|NCT01143077|471666849|FG002|Overall Study|Adverse Event|5|||
131010751|NCT01143077|471666847|FG000|Overall Study|Lost to Follow-up|2|||
131010752|NCT01143077|471666848|FG001|Overall Study|Lost to Follow-up|3|||
131010753|NCT01143077|471666849|FG002|Overall Study|Lost to Follow-up|4|||
131010754|NCT01143077|471666847|FG000|Overall Study|Protocol Violation|2|||
131010755|NCT01143077|471666848|FG001|Overall Study|Protocol Violation|0|||
131010756|NCT01143077|471666849|FG002|Overall Study|Protocol Violation|0|||
131010757|NCT01143077|471666847|FG000|Overall Study|Withdrawal by Subject|4|||
131010758|NCT01143077|471666848|FG001|Overall Study|Withdrawal by Subject|3|||
131010759|NCT01143077|471666849|FG002|Overall Study|Withdrawal by Subject|3|||
131010760|NCT01143077|471666847|FG000|Overall Study|Non-compliance with study drug|0|||
131010761|NCT01143077|471666848|FG001|Overall Study|Non-compliance with study drug|1|||
131010762|NCT01143077|471666849|FG002|Overall Study|Non-compliance with study drug|1|||
131010763|NCT01143077|471666847|FG000|Overall Study|Administrative|1|||
131010764|NCT01143077|471666848|FG001|Overall Study|Administrative|0|||
131010765|NCT01143077|471666849|FG002|Overall Study|Administrative|0|||
131010766|NCT01143077|471666847|FG000|Overall Study|Principal Investigator Decision|2|||
131010767|NCT01143077|471666848|FG001|Overall Study|Principal Investigator Decision|0|||
131010768|NCT01143077|471666849|FG002|Overall Study|Principal Investigator Decision|1|||
131010777|NCT00708097|471666860|FG000|Period 1|Protocol Violation|0|||
131010778|NCT00708097|471666861|FG001|Period 1|Protocol Violation|1|||
131010779|NCT00708097|471666862|FG002|Period 1|Protocol Violation|0|||
131010780|NCT00708097|471666863|FG003|Period 1|Protocol Violation|2|||
131010781|NCT00708097|471666864|FG004|Period 1|Protocol Violation|0|||
131010782|NCT00708097|471666860|FG000|Period 1|Other Reason|0|||
131010783|NCT00708097|471666861|FG001|Period 1|Other Reason|0|||
131010784|NCT00708097|471666862|FG002|Period 1|Other Reason|0|||
131010785|NCT00708097|471666863|FG003|Period 1|Other Reason|0|||
131010786|NCT00708097|471666864|FG004|Period 1|Other Reason|1|||
131010787|NCT00708097|471666860|FG000|Period 2|Protocol Violation|0|||
131010788|NCT00708097|471666861|FG001|Period 2|Protocol Violation|1|||
131010789|NCT00708097|471666862|FG002|Period 2|Protocol Violation|1|||
131010790|NCT00708097|471666863|FG003|Period 2|Protocol Violation|1|||
131010791|NCT00708097|471666864|FG004|Period 2|Protocol Violation|0|||
131010792|NCT00349908|471669326|FG000|Overall Study|Withdrawal by Subject|0|||
131010793|NCT00349908|471669327|FG001|Overall Study|Withdrawal by Subject|4|||
131010794|NCT00151996|471669328|FG000|Overall Study|Adverse Event|3|||
131010795|NCT00151996|471669329|FG001|Overall Study|Adverse Event|2|||
131010796|NCT00151996|471669328|FG000|Overall Study|Withdrawal by Subject|1|||
131010797|NCT00151996|471669329|FG001|Overall Study|Withdrawal by Subject|1|||
131010798|NCT00151996|471669328|FG000|Overall Study|Protocol Violation|1|||
131010799|NCT00151996|471669329|FG001|Overall Study|Protocol Violation|2|||
131222559|NCT01625286|472441524|FG000|Overall Study|Lost to Follow-up|0|||
131010800|NCT00151996|471669328|FG000|Overall Study|Sponsor's decision|0|||
131010801|NCT00151996|471669329|FG001|Overall Study|Sponsor's decision|2|||
131010802|NCT01649791|471669333|FG000|Overall Study|Disease Progression|2|||
131010803|NCT01649791|471669333|FG000|Overall Study|Adverse Event|1|||
131010804|NCT01801930|471669334|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
131010805|NCT01801930|471669335|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
131010806|NCT01801930|471669336|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
131010807|NCT01801930|471669337|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
131010808|NCT01801930|471669334|FG000|Overall Study|DLT occurs|0|||
131010809|NCT01801930|471669335|FG001|Overall Study|DLT occurs|1|||
131010810|NCT01801930|471669336|FG002|Overall Study|DLT occurs|0|||
131010811|NCT01801930|471669337|FG003|Overall Study|DLT occurs|0|||
131010812|NCT01451814|471669340|FG000|Overall Study|Withdrawal by Subject|1|||
131010813|NCT01451814|471669341|FG001|Overall Study|Withdrawal by Subject|1|||
131010814|NCT01451814|471669340|FG000|Overall Study|Lost to Follow-up|5|||
131010815|NCT01451814|471669341|FG001|Overall Study|Lost to Follow-up|4|||
131010816|NCT02955069|471669343|FG000|Overall Study|Adverse Event|7|||
131010817|NCT02955069|471669344|FG001|Overall Study|Adverse Event|2|||
131010818|NCT02955069|471669343|FG000|Overall Study|Death|7|||
131010819|NCT02955069|471669344|FG001|Overall Study|Death|3|||
131010820|NCT02955069|471669343|FG000|Overall Study|Physician Decision|10|||
131010821|NCT02955069|471669344|FG001|Overall Study|Physician Decision|2|||
131010822|NCT02955069|471669343|FG000|Overall Study|Progressive disease|64|||
131010823|NCT02955069|471669344|FG001|Overall Study|Progressive disease|13|||
131010824|NCT02955069|471669343|FG000|Overall Study|Study terminated by sponsor|4|||
131010825|NCT02955069|471669344|FG001|Overall Study|Study terminated by sponsor|0|||
131010826|NCT02955069|471669343|FG000|Overall Study|Subject/Guardian decision|3|||
131010827|NCT02955069|471669344|FG001|Overall Study|Subject/Guardian decision|1|||
131010828|NCT00943605|471669346|FG000|Overall Study|Study termination|30|||
131010829|NCT00943605|471669347|FG001|Overall Study|Study termination|30|||
131010830|NCT04148937|471669348|FG000|Overall Study|Withdrawal by Subject|0|||
131010831|NCT04148937|471669349|FG001|Overall Study|Withdrawal by Subject|0|||
131010832|NCT04148937|471669350|FG002|Overall Study|Withdrawal by Subject|0|||
131010833|NCT04148937|471669351|FG003|Overall Study|Withdrawal by Subject|1|||
131010834|NCT04148937|471669352|FG004|Overall Study|Withdrawal by Subject|0|||
131010835|NCT04148937|471669353|FG005|Overall Study|Withdrawal by Subject|1|||
131010836|NCT04148937|471669354|FG006|Overall Study|Withdrawal by Subject|1|||
131010837|NCT04148937|471669355|FG007|Overall Study|Withdrawal by Subject|0|||
131010838|NCT04148937|471669348|FG000|Overall Study|Lost to Follow-up|0|||
131010839|NCT04148937|471669349|FG001|Overall Study|Lost to Follow-up|0|||
131010840|NCT04148937|471669350|FG002|Overall Study|Lost to Follow-up|1|||
131010841|NCT04148937|471669351|FG003|Overall Study|Lost to Follow-up|0|||
131010842|NCT04148937|471669352|FG004|Overall Study|Lost to Follow-up|0|||
131010843|NCT04148937|471669353|FG005|Overall Study|Lost to Follow-up|2|||
131010844|NCT04148937|471669354|FG006|Overall Study|Lost to Follow-up|0|||
131010845|NCT04148937|471669355|FG007|Overall Study|Lost to Follow-up|0|||
131010846|NCT03107611|471669356|FG000|Overall Study|Adverse Event|1|||
131010847|NCT03107611|471669357|FG001|Overall Study|Adverse Event|0|||
131010848|NCT03107611|471669358|FG002|Overall Study|Adverse Event|2|||
131010849|NCT03107611|471669356|FG000|Overall Study|Lost to Follow-up|3|||
131010850|NCT03107611|471669357|FG001|Overall Study|Lost to Follow-up|3|||
131010851|NCT03107611|471669358|FG002|Overall Study|Lost to Follow-up|3|||
131010852|NCT03107611|471669356|FG000|Overall Study|Protocol Violation|0|||
131010853|NCT03107611|471669357|FG001|Overall Study|Protocol Violation|0|||
131010854|NCT03107611|471669358|FG002|Overall Study|Protocol Violation|1|||
131010855|NCT03107611|471669356|FG000|Overall Study|Withdrawal by Subject|1|||
131010856|NCT03107611|471669357|FG001|Overall Study|Withdrawal by Subject|0|||
131010857|NCT03107611|471669358|FG002|Overall Study|Withdrawal by Subject|1|||
131010858|NCT03107611|471669356|FG000|Overall Study|Worsening signs/symptoms|2|||
131010859|NCT03107611|471669357|FG001|Overall Study|Worsening signs/symptoms|1|||
131010860|NCT03107611|471669358|FG002|Overall Study|Worsening signs/symptoms|2|||
131010861|NCT01720446|471669359|FG000|Overall Study|Lost to Follow-up|12|||
131010862|NCT01720446|471669360|FG001|Overall Study|Lost to Follow-up|6|||
131010863|NCT01720446|471669361|FG002|Overall Study|Lost to Follow-up|16|||
131010864|NCT01720446|471669362|FG003|Overall Study|Lost to Follow-up|16|||
131010865|NCT01720446|471669359|FG000|Overall Study|Withdrawal by Subject|2|||
131010866|NCT01720446|471669360|FG001|Overall Study|Withdrawal by Subject|5|||
131010867|NCT01720446|471669361|FG002|Overall Study|Withdrawal by Subject|4|||
131010868|NCT01720446|471669362|FG003|Overall Study|Withdrawal by Subject|4|||
131010869|NCT01956669|471669363|FG000|Overall Study|Disease Progression|12|||
131010870|NCT01956669|471669364|FG001|Overall Study|Disease Progression|7|||
131010871|NCT01956669|471669365|FG002|Overall Study|Disease Progression|7|||
131010872|NCT01956669|471669366|FG003|Overall Study|Disease Progression|8|||
131010873|NCT01956669|471669367|FG004|Overall Study|Disease Progression|4|||
131010874|NCT01956669|471669368|FG005|Overall Study|Disease Progression|3|||
131010875|NCT01956669|471669369|FG006|Overall Study|Disease Progression|5|||
131010876|NCT01956669|471669363|FG000|Overall Study|Adverse Event|0|||
131010877|NCT01956669|471669364|FG001|Overall Study|Adverse Event|2|||
131010878|NCT01956669|471669365|FG002|Overall Study|Adverse Event|2|||
131010879|NCT01956669|471669366|FG003|Overall Study|Adverse Event|1|||
131010880|NCT01956669|471669367|FG004|Overall Study|Adverse Event|0|||
131010881|NCT01956669|471669368|FG005|Overall Study|Adverse Event|0|||
131010882|NCT01956669|471669369|FG006|Overall Study|Adverse Event|0|||
131010883|NCT01956669|471669363|FG000|Overall Study|Physician Decision|0|||
131010884|NCT01956669|471669364|FG001|Overall Study|Physician Decision|2|||
131010885|NCT01956669|471669365|FG002|Overall Study|Physician Decision|0|||
131010886|NCT01956669|471669366|FG003|Overall Study|Physician Decision|0|||
131010887|NCT01956669|471669367|FG004|Overall Study|Physician Decision|0|||
131010888|NCT01956669|471669368|FG005|Overall Study|Physician Decision|1|||
131010889|NCT01956669|471669369|FG006|Overall Study|Physician Decision|0|||
131010890|NCT01956669|471669363|FG000|Overall Study|Withdrawal by Subject|0|||
131010891|NCT01956669|471669364|FG001|Overall Study|Withdrawal by Subject|0|||
131010892|NCT01956669|471669365|FG002|Overall Study|Withdrawal by Subject|1|||
131010893|NCT01956669|471669366|FG003|Overall Study|Withdrawal by Subject|1|||
131010894|NCT01956669|471669367|FG004|Overall Study|Withdrawal by Subject|0|||
131010895|NCT01956669|471669368|FG005|Overall Study|Withdrawal by Subject|0|||
131010896|NCT01956669|471669369|FG006|Overall Study|Withdrawal by Subject|1|||
131010897|NCT00930813|471669372|FG000|Overall Study|Death|4|||
131010898|NCT00930813|471669373|FG001|Overall Study|Death|5|||
131010899|NCT00930813|471669372|FG000|Overall Study|Withdrawal by Subject|2|||
131010900|NCT00930813|471669373|FG001|Overall Study|Withdrawal by Subject|5|||
131010901|NCT00930813|471669372|FG000|Overall Study|Lost to Follow-up|2|||
131010902|NCT00930813|471669373|FG001|Overall Study|Lost to Follow-up|4|||
131010903|NCT02131324|471669378|FG000|Overall Study|Withdrawal by Subject|1|||
131010904|NCT02131324|471669379|FG001|Overall Study|Withdrawal by Subject|2|||
131010905|NCT02131324|471669378|FG000|Overall Study|Lost to Follow-up|1|||
131010906|NCT02131324|471669379|FG001|Overall Study|Lost to Follow-up|1|||
131010907|NCT01693614|471669380|FG000|Overall Study|Adverse Event|7|||
131010908|NCT01693614|471669381|FG001|Overall Study|Adverse Event|11|||
131010909|NCT01693614|471669382|FG002|Overall Study|Adverse Event|5|||
131010910|NCT01693614|471669380|FG000|Overall Study|Disease progression|11|||
131010911|NCT01693614|471669381|FG001|Overall Study|Disease progression|8|||
131010912|NCT01693614|471669382|FG002|Overall Study|Disease progression|7|||
131010913|NCT01693614|471669380|FG000|Overall Study|Protocol Violation|5|||
131010914|NCT01693614|471669381|FG001|Overall Study|Protocol Violation|2|||
131010915|NCT01693614|471669382|FG002|Overall Study|Protocol Violation|1|||
131010916|NCT01693614|471669380|FG000|Overall Study|Death|1|||
131010917|NCT01693614|471669381|FG001|Overall Study|Death|0|||
131010918|NCT01693614|471669382|FG002|Overall Study|Death|0|||
131010919|NCT01693614|471669380|FG000|Overall Study|Physician Decision|1|||
131010920|NCT01693614|471669381|FG001|Overall Study|Physician Decision|1|||
131010921|NCT01693614|471669382|FG002|Overall Study|Physician Decision|4|||
131010922|NCT01693614|471669380|FG000|Overall Study|Withdrawal by subject/guardian|0|||
131010923|NCT01693614|471669381|FG001|Overall Study|Withdrawal by subject/guardian|0|||
131010924|NCT01693614|471669382|FG002|Overall Study|Withdrawal by subject/guardian|2|||
131010925|NCT01693614|471669380|FG000|Overall Study|Withdrawal by Subject|1|||
131010926|NCT01693614|471669381|FG001|Overall Study|Withdrawal by Subject|0|||
131010927|NCT01693614|471669382|FG002|Overall Study|Withdrawal by Subject|5|||
131010928|NCT00420316|471669383|FG000|Overall Study|Withdrawal by Subject|0|||
131010929|NCT00420316|471669384|FG001|Overall Study|Withdrawal by Subject|1|||
131010930|NCT00420316|471669383|FG000|Overall Study|Lost to Follow-up|12|||
131010931|NCT00420316|471669384|FG001|Overall Study|Lost to Follow-up|8|||
131010932|NCT02145182|471669385|FG000|Overall Study|Adverse Event|4|||
131010933|NCT02145182|471669386|FG001|Overall Study|Adverse Event|1|||
131010934|NCT02145182|471669385|FG000|Overall Study|Death|7|||
131010935|NCT02145182|471669386|FG001|Overall Study|Death|7|||
131010936|NCT02145182|471669385|FG000|Overall Study|Lost to Follow-up|2|||
131010937|NCT02145182|471669386|FG001|Overall Study|Lost to Follow-up|2|||
131010938|NCT02145182|471669385|FG000|Overall Study|Pre-transplant Withdrawal|0|||
131010939|NCT02145182|471669386|FG001|Overall Study|Pre-transplant Withdrawal|2|||
131010940|NCT02145182|471669385|FG000|Overall Study|Withdrawal by Subject|5|||
131010941|NCT02145182|471669386|FG001|Overall Study|Withdrawal by Subject|4|||
131010942|NCT03999554|471669387|FG000|Overall Study|Lost to Follow-up|4|||
131010943|NCT03999554|471669388|FG001|Overall Study|Lost to Follow-up|5|||
131010944|NCT03999554|471669389|FG002|Overall Study|Lost to Follow-up|4|||
131010945|NCT03999554|471669390|FG003|Overall Study|Lost to Follow-up|5|||
131010946|NCT03999554|471669391|FG004|Overall Study|Lost to Follow-up|8|||
131010947|NCT03999554|471669387|FG000|Overall Study|Protocol Violation|0|||
131010948|NCT03999554|471669388|FG001|Overall Study|Protocol Violation|0|||
131010949|NCT03999554|471669389|FG002|Overall Study|Protocol Violation|5|||
131010950|NCT03999554|471669390|FG003|Overall Study|Protocol Violation|0|||
131010951|NCT03999554|471669391|FG004|Overall Study|Protocol Violation|0|||
131010952|NCT03999554|471669387|FG000|Overall Study|Pregnancy|0|||
131010953|NCT03999554|471669388|FG001|Overall Study|Pregnancy|0|||
131010954|NCT03999554|471669389|FG002|Overall Study|Pregnancy|1|||
131010955|NCT03999554|471669390|FG003|Overall Study|Pregnancy|0|||
131010956|NCT03999554|471669391|FG004|Overall Study|Pregnancy|0|||
131010957|NCT03999554|471669387|FG000|Overall Study|Withdrawal by Subject|2|||
131010958|NCT03999554|471669388|FG001|Overall Study|Withdrawal by Subject|2|||
131010959|NCT03999554|471669389|FG002|Overall Study|Withdrawal by Subject|2|||
131010960|NCT03999554|471669390|FG003|Overall Study|Withdrawal by Subject|1|||
131010961|NCT03999554|471669391|FG004|Overall Study|Withdrawal by Subject|1|||
131010962|NCT03999554|471669387|FG000|Overall Study|failure to comply with protocol requirements|0|||
131010963|NCT03999554|471669388|FG001|Overall Study|failure to comply with protocol requirements|0|||
131010964|NCT03999554|471669389|FG002|Overall Study|failure to comply with protocol requirements|0|||
131010965|NCT03999554|471669390|FG003|Overall Study|failure to comply with protocol requirements|1|||
131010966|NCT03999554|471669391|FG004|Overall Study|failure to comply with protocol requirements|0|||
131010967|NCT02274493|471669392|FG000|Overall Study|Withdrawal by Subject|1|||
131010968|NCT01695317|471669393|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
131010969|NCT01695317|471669394|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
131010970|NCT01695317|471669393|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
131010971|NCT01695317|471669394|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
131010972|NCT00606580|471669395|FG000|Overall Study|Lost to Follow-up|1|||
131010973|NCT00606580|471669396|FG001|Overall Study|Lost to Follow-up|1|||
131010974|NCT00606580|471669397|FG002|Overall Study|Lost to Follow-up|4|||
131010975|NCT00606580|471669395|FG000|Overall Study|Clinical failures|1|||
131010976|NCT00606580|471669396|FG001|Overall Study|Clinical failures|0|||
131010977|NCT00606580|471669397|FG002|Overall Study|Clinical failures|12|||
131010978|NCT00606580|471669395|FG000|Overall Study|Withdrawal by investigator|0|||
131010979|NCT00606580|471669396|FG001|Overall Study|Withdrawal by investigator|1|||
131010980|NCT00606580|471669397|FG002|Overall Study|Withdrawal by investigator|6|||
131010981|NCT00606580|471669395|FG000|Overall Study|Withdrawal by Subject|0|||
131010982|NCT00606580|471669396|FG001|Overall Study|Withdrawal by Subject|1|||
131010983|NCT00606580|471669397|FG002|Overall Study|Withdrawal by Subject|0|||
131010984|NCT01101165|471669398|FG000|Period 1|Adverse Event|1|||
131010985|NCT01101165|471669399|FG001|Period 1|Adverse Event|2|||
131010986|NCT01101165|471669398|FG000|Period 1|Withdrawal by Subject|0|||
131010987|NCT01101165|471669399|FG001|Period 1|Withdrawal by Subject|2|||
131010988|NCT01101165|471669398|FG000|Period 1|Positive Drug Screen|0|||
131010989|NCT01101165|471669399|FG001|Period 1|Positive Drug Screen|1|||
131010990|NCT01101165|471669398|FG000|Period 1|Lost to Follow-up|1|||
131010991|NCT01101165|471669399|FG001|Period 1|Lost to Follow-up|0|||
131010992|NCT01101165|471669398|FG000|Period 2|Withdrawal by Subject|3|||
131010993|NCT01101165|471669399|FG001|Period 2|Withdrawal by Subject|1|||
131010994|NCT01101165|471669398|FG000|Period 2|Adverse Event|1|||
131010995|NCT01101165|471669399|FG001|Period 2|Adverse Event|0|||
131010996|NCT00927823|471669400|FG000|Continuous Dosing Period|Death|0|||
131010997|NCT00927823|471669401|FG001|Continuous Dosing Period|Death|0|||
131010998|NCT00927823|471669402|FG002|Continuous Dosing Period|Death|6|||
131010999|NCT00927823|471669403|FG003|Continuous Dosing Period|Death|0|||
131011000|NCT00927823|471669400|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
131011001|NCT00927823|471669401|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
131011002|NCT00927823|471669402|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
131011003|NCT00927823|471669403|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
131011004|NCT00927823|471669400|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
131011005|NCT00927823|471669401|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
131011006|NCT00927823|471669402|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
131011007|NCT00927823|471669403|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
131011008|NCT00927823|471669400|FG000|Continuous Dosing Period|Other|1|||
131011009|NCT00927823|471669401|FG001|Continuous Dosing Period|Other|2|||
131011010|NCT00927823|471669402|FG002|Continuous Dosing Period|Other|9|||
131011011|NCT00927823|471669403|FG003|Continuous Dosing Period|Other|3|||
131011012|NCT00015457|471669404|FG000|First Intervention|Adverse Event|0|||
131011013|NCT00015457|471669405|FG001|First Intervention|Adverse Event|2|||
131011014|NCT00015457|471669404|FG000|First Intervention|Lack of Efficacy|0|||
131011015|NCT00015457|471669405|FG001|First Intervention|Lack of Efficacy|1|||
131011016|NCT00015457|471669404|FG000|Second Intervention|Withdrawal by Subject|1|||
131011017|NCT00015457|471669405|FG001|Second Intervention|Withdrawal by Subject|0|||
131011018|NCT01744691|471669410|FG000|Overall Study|Progressive Disease|18|||
131011019|NCT01744691|471669410|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
131011020|NCT01744691|471669410|FG000|Overall Study|Withdrawal of consent for treatment|3|||
131011021|NCT01744691|471669410|FG000|Overall Study|Physician Decision|4|||
131011022|NCT00502593|471669414|FG000|Overall Study|Withdrawn unspecified reason|1|||
131011023|NCT00502593|471669415|FG001|Overall Study|Withdrawn unspecified reason|1|||
131011024|NCT00502593|471669416|FG002|Overall Study|Withdrawn unspecified reason|3|||
131011025|NCT00502593|471669417|FG003|Overall Study|Withdrawn unspecified reason|1|||
131011026|NCT00502593|471669418|FG004|Overall Study|Withdrawn unspecified reason|2|||
131011027|NCT00502593|471669419|FG005|Overall Study|Withdrawn unspecified reason|0|||
131011028|NCT00502593|471669420|FG006|Overall Study|Withdrawn unspecified reason|2|||
131011029|NCT00502593|471669421|FG007|Overall Study|Withdrawn unspecified reason|0|||
131011030|NCT00502593|471669422|FG008|Overall Study|Withdrawn unspecified reason|0|||
131011031|NCT00502593|471669423|FG009|Overall Study|Withdrawn unspecified reason|0|||
131011032|NCT00502593|471669424|FG010|Overall Study|Withdrawn unspecified reason|0|||
131011033|NCT00502593|471669425|FG011|Overall Study|Withdrawn unspecified reason|0|||
131011034|NCT00502593|471669414|FG000|Overall Study|Withdrawal by Subject|0|||
131011035|NCT00502593|471669415|FG001|Overall Study|Withdrawal by Subject|0|||
131011036|NCT00502593|471669416|FG002|Overall Study|Withdrawal by Subject|6|||
131011037|NCT00502593|471669417|FG003|Overall Study|Withdrawal by Subject|2|||
131011038|NCT00502593|471669418|FG004|Overall Study|Withdrawal by Subject|2|||
131011039|NCT00502593|471669419|FG005|Overall Study|Withdrawal by Subject|0|||
131011040|NCT00502593|471669420|FG006|Overall Study|Withdrawal by Subject|3|||
131011041|NCT00502593|471669421|FG007|Overall Study|Withdrawal by Subject|0|||
131011042|NCT00502593|471669422|FG008|Overall Study|Withdrawal by Subject|3|||
131011043|NCT00502593|471669423|FG009|Overall Study|Withdrawal by Subject|0|||
131011044|NCT00502593|471669424|FG010|Overall Study|Withdrawal by Subject|1|||
131011045|NCT00502593|471669425|FG011|Overall Study|Withdrawal by Subject|0|||
131011046|NCT00502593|471669414|FG000|Overall Study|Lost to Follow-up|2|||
131011047|NCT00502593|471669415|FG001|Overall Study|Lost to Follow-up|1|||
131011048|NCT00502593|471669416|FG002|Overall Study|Lost to Follow-up|1|||
131011049|NCT00502593|471669417|FG003|Overall Study|Lost to Follow-up|1|||
131011050|NCT00502593|471669418|FG004|Overall Study|Lost to Follow-up|0|||
131011051|NCT00502593|471669419|FG005|Overall Study|Lost to Follow-up|0|||
131011052|NCT00502593|471669420|FG006|Overall Study|Lost to Follow-up|0|||
131011053|NCT00502593|471669421|FG007|Overall Study|Lost to Follow-up|0|||
131011054|NCT00502593|471669422|FG008|Overall Study|Lost to Follow-up|3|||
131011055|NCT00502593|471669423|FG009|Overall Study|Lost to Follow-up|0|||
131011056|NCT00502593|471669424|FG010|Overall Study|Lost to Follow-up|1|||
131011057|NCT00502593|471669425|FG011|Overall Study|Lost to Follow-up|0|||
131011058|NCT04511650|471669426|FG000|Overall Study|Lost to Follow-up|1|||
131011059|NCT04511650|471669427|FG001|Overall Study|Lost to Follow-up|0|||
131011060|NCT04511650|471669428|FG002|Overall Study|Lost to Follow-up|0|||
131011061|NCT04511650|471669426|FG000|Overall Study|Withdrawal by Subject|1|||
131011062|NCT04511650|471669427|FG001|Overall Study|Withdrawal by Subject|0|||
131011063|NCT04511650|471669428|FG002|Overall Study|Withdrawal by Subject|0|||
131011064|NCT04511650|471669426|FG000|Overall Study|reason not provided|0|||
131011065|NCT04511650|471669427|FG001|Overall Study|reason not provided|0|||
131011066|NCT04511650|471669428|FG002|Overall Study|reason not provided|1|||
131011067|NCT04511650|471669426|FG000|Overall Study|Death|1|||
131011068|NCT04511650|471669427|FG001|Overall Study|Death|1|||
131011069|NCT04511650|471669428|FG002|Overall Study|Death|1|||
131011070|NCT01664104|471669430|FG000|Overall Study|Adverse Event|6|||
131011071|NCT01664104|471669430|FG000|Overall Study|Lack of Efficacy|2|||
131011072|NCT01664104|471669430|FG000|Overall Study|Withdrawal by Subject|1|||
131011073|NCT01664104|471669430|FG000|Overall Study|Lost to Follow-up|4|||
131011074|NCT01664104|471669430|FG000|Overall Study|Other|1|||
131011075|NCT01664104|471669430|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
131011076|NCT00591838|471669431|FG000|Overall Study|Withdrawal by Subject|0|||
131011077|NCT00591838|471669432|FG001|Overall Study|Withdrawal by Subject|0|||
131011078|NCT00591838|471669433|FG002|Overall Study|Withdrawal by Subject|0|||
131011079|NCT00591838|471669434|FG003|Overall Study|Withdrawal by Subject|1|||
131011080|NCT00591838|471669435|FG004|Overall Study|Withdrawal by Subject|0|||
131011081|NCT03586167|471669436|FG000|Overall Study|Other|1|||
131011082|NCT03586167|471669437|FG001|Overall Study|Other|0|||
131011083|NCT04163458|471669441|FG000|Overall Study|Protocol Deviation|7|||
131011084|NCT04163458|471669442|FG001|Overall Study|Protocol Deviation|13|||
131011085|NCT04163458|471669441|FG000|Overall Study|Adverse Event|5|||
131011086|NCT04163458|471669442|FG001|Overall Study|Adverse Event|8|||
131011087|NCT04163458|471669441|FG000|Overall Study|Due to COVID-19 pandemic|4|||
131011088|NCT04163458|471669442|FG001|Overall Study|Due to COVID-19 pandemic|2|||
131011089|NCT04163458|471669441|FG000|Overall Study|Participant withdrew consent|2|||
131011090|NCT04163458|471669442|FG001|Overall Study|Participant withdrew consent|3|||
131011091|NCT04163458|471669441|FG000|Overall Study|Randomization failure|2|||
131011092|NCT04163458|471669442|FG001|Overall Study|Randomization failure|2|||
131011093|NCT04163458|471669441|FG000|Overall Study|Other|4|||
131011094|NCT04163458|471669442|FG001|Overall Study|Other|2|||
131011095|NCT03394027|471669446|FG000|Overall Study|Ineligible|3|||
131011096|NCT03394027|471669447|FG001|Overall Study|Ineligible|1|||
131011097|NCT03394027|471669448|FG002|Overall Study|Ineligible|3|||
131011098|NCT03394027|471669446|FG000|Overall Study|Participant declined to participate before treatment started|0|||
131011099|NCT03394027|471669447|FG001|Overall Study|Participant declined to participate before treatment started|0|||
131011100|NCT03394027|471669448|FG002|Overall Study|Participant declined to participate before treatment started|1|||
131011101|NCT01018511|471669450|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
131011102|NCT01018511|471669451|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
131011103|NCT01018511|471669452|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
131011104|NCT01018511|471669453|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
131011105|NCT01018511|471669450|FG000|Overall Study|Adverse Event|5|||
131011106|NCT01018511|471669451|FG001|Overall Study|Adverse Event|9|||
131011107|NCT01018511|471669452|FG002|Overall Study|Adverse Event|13|||
131011108|NCT01018511|471669453|FG003|Overall Study|Adverse Event|10|||
131011109|NCT01018511|471669450|FG000|Overall Study|Lack of Efficacy|4|||
131011110|NCT01018511|471669451|FG001|Overall Study|Lack of Efficacy|1|||
131011111|NCT01018511|471669452|FG002|Overall Study|Lack of Efficacy|1|||
131011112|NCT01018511|471669453|FG003|Overall Study|Lack of Efficacy|2|||
131011113|NCT01018511|471669450|FG000|Overall Study|Withdrawal by Subject|6|||
131011114|NCT01018511|471669451|FG001|Overall Study|Withdrawal by Subject|5|||
131011115|NCT01018511|471669452|FG002|Overall Study|Withdrawal by Subject|11|||
131011116|NCT01018511|471669453|FG003|Overall Study|Withdrawal by Subject|9|||
131011117|NCT01018511|471669450|FG000|Overall Study|Lost to Follow-up|0|||
131011118|NCT01018511|471669451|FG001|Overall Study|Lost to Follow-up|0|||
131011119|NCT01018511|471669452|FG002|Overall Study|Lost to Follow-up|1|||
131011120|NCT01018511|471669453|FG003|Overall Study|Lost to Follow-up|0|||
131011121|NCT01018511|471669450|FG000|Overall Study|Protocol Violation|5|||
131011122|NCT01018511|471669451|FG001|Overall Study|Protocol Violation|8|||
131011123|NCT01018511|471669452|FG002|Overall Study|Protocol Violation|7|||
131011124|NCT01018511|471669453|FG003|Overall Study|Protocol Violation|9|||
131011125|NCT01018511|471669450|FG000|Overall Study|Miscellaneous|0|||
131011126|NCT01018511|471669451|FG001|Overall Study|Miscellaneous|2|||
131011127|NCT01018511|471669452|FG002|Overall Study|Miscellaneous|0|||
131011128|NCT01018511|471669453|FG003|Overall Study|Miscellaneous|0|||
131011129|NCT04523181|471669454|FG000|Overall Study|Withdrawal by Subject|4|||
131011130|NCT04523181|471669455|FG001|Overall Study|Withdrawal by Subject|5|||
131011131|NCT04523181|471669454|FG000|Overall Study|Lost to Follow-up|2|||
131011132|NCT04523181|471669455|FG001|Overall Study|Lost to Follow-up|3|||
131011133|NCT04523181|471669454|FG000|Overall Study|Physician Decision|1|||
131011134|NCT04523181|471669455|FG001|Overall Study|Physician Decision|0|||
131011135|NCT04523181|471669454|FG000|Overall Study|Transferred to external facility.|1|||
131011136|NCT04523181|471669455|FG001|Overall Study|Transferred to external facility.|1|||
131011137|NCT04550039|471669456|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
131011138|NCT04550039|471669457|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
131011139|NCT04550039|471669456|FG000|Overall Study|patient self-withdrew from study|0|||
131011140|NCT04550039|471669457|FG001|Overall Study|patient self-withdrew from study|1|||
131011141|NCT04391309|471669458|FG000|Overall Study|Death|1|||
131011142|NCT04391309|471669459|FG001|Overall Study|Death|1|||
131011143|NCT04391309|471669458|FG000|Overall Study|Lost to Follow-up|3|||
131011144|NCT04391309|471669459|FG001|Overall Study|Lost to Follow-up|2|||
131011145|NCT04391309|471669458|FG000|Overall Study|Withdrawal by Subject|2|||
131011146|NCT04391309|471669459|FG001|Overall Study|Withdrawal by Subject|2|||
131011147|NCT00881335|471669468|FG000|Overall Study|Lost to Follow-up|3|||
131011148|NCT00881335|471669469|FG001|Overall Study|Lost to Follow-up|2|||
131011149|NCT05824351|471669470|FG000|Overall Study|Adverse Event|6|||
131011150|NCT00828945|471669471|FG000|Overall Study|Death|4|||
131011151|NCT00828945|471669471|FG000|Overall Study|Participant was missing|1|||
131011152|NCT00828945|471669471|FG000|Overall Study|Other|36|||
131011153|NCT02482233|471669476|FG000|Overall Study|Lost to Follow-up|1|||
131011154|NCT02482233|471669477|FG001|Overall Study|Lost to Follow-up|1|||
131011155|NCT03822351|471669478|FG000|Overall Study|Death|27|||
131011156|NCT03822351|471669479|FG001|Overall Study|Death|23|||
131011157|NCT03822351|471669480|FG002|Overall Study|Death|24|||
131011158|NCT03822351|471669478|FG000|Overall Study|Lost to Follow-up|6|||
131011159|NCT03822351|471669479|FG001|Overall Study|Lost to Follow-up|2|||
131011160|NCT03822351|471669480|FG002|Overall Study|Lost to Follow-up|1|||
131011161|NCT03822351|471669478|FG000|Overall Study|Withdrawal by Subject|10|||
131011162|NCT03822351|471669479|FG001|Overall Study|Withdrawal by Subject|4|||
131011163|NCT03822351|471669480|FG002|Overall Study|Withdrawal by Subject|6|||
131011164|NCT03822351|471669478|FG000|Overall Study|Progressive Disease|2|||
131011165|NCT03822351|471669479|FG001|Overall Study|Progressive Disease|1|||
131011166|NCT03822351|471669480|FG002|Overall Study|Progressive Disease|0|||
131011167|NCT03822351|471669478|FG000|Overall Study|Not Treated|1|||
131011168|NCT03822351|471669479|FG001|Overall Study|Not Treated|1|||
131011169|NCT03822351|471669480|FG002|Overall Study|Not Treated|1|||
131011170|NCT00462943|471669481|FG000|Overall Study|Failure to achieve a response|5|||
131011171|NCT00462943|471669482|FG001|Overall Study|Failure to achieve a response|5|||
131011172|NCT00462943|471669483|FG002|Overall Study|Failure to achieve a response|1|||
131011173|NCT00462943|471669481|FG000|Overall Study|Adverse Event|6|||
131011174|NCT00462943|471669482|FG001|Overall Study|Adverse Event|4|||
131011175|NCT00462943|471669483|FG002|Overall Study|Adverse Event|1|||
131011176|NCT00462943|471669481|FG000|Overall Study|Protocol Violation|1|||
131011177|NCT00462943|471669482|FG001|Overall Study|Protocol Violation|0|||
131011178|NCT00462943|471669483|FG002|Overall Study|Protocol Violation|0|||
131011179|NCT00462943|471669481|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
131011180|NCT00462943|471669482|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
131011181|NCT00462943|471669483|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
131011182|NCT00462943|471669481|FG000|Overall Study|Disease Progression|15|||
131011183|NCT00462943|471669482|FG001|Overall Study|Disease Progression|15|||
131011184|NCT00462943|471669483|FG002|Overall Study|Disease Progression|9|||
131011185|NCT00462943|471669481|FG000|Overall Study|Death|5|||
131011186|NCT00462943|471669482|FG001|Overall Study|Death|2|||
131011187|NCT00462943|471669483|FG002|Overall Study|Death|7|||
131011188|NCT00462943|471669481|FG000|Overall Study|Stem Cell Transplant|1|||
131011189|NCT00462943|471669482|FG001|Overall Study|Stem Cell Transplant|1|||
131011190|NCT00462943|471669483|FG002|Overall Study|Stem Cell Transplant|0|||
131011191|NCT00462943|471669481|FG000|Overall Study|Bone Marrow Transplant|1|||
131011192|NCT00462943|471669482|FG001|Overall Study|Bone Marrow Transplant|0|||
131011193|NCT00462943|471669483|FG002|Overall Study|Bone Marrow Transplant|0|||
131011194|NCT00462943|471669481|FG000|Overall Study|Required Lymphocyte Infusion|1|||
131011195|NCT00462943|471669482|FG001|Overall Study|Required Lymphocyte Infusion|0|||
131011196|NCT00462943|471669483|FG002|Overall Study|Required Lymphocyte Infusion|0|||
131011197|NCT00462943|471669481|FG000|Overall Study|Transplant - not specified|1|||
131011198|NCT00462943|471669482|FG001|Overall Study|Transplant - not specified|0|||
131011199|NCT00462943|471669483|FG002|Overall Study|Transplant - not specified|1|||
131011200|NCT00462943|471669481|FG000|Overall Study|Physician Decision|1|||
131011201|NCT00462943|471669482|FG001|Overall Study|Physician Decision|0|||
131011202|NCT00462943|471669483|FG002|Overall Study|Physician Decision|0|||
131011203|NCT00462943|471669481|FG000|Overall Study|Withdrawal by Subject|0|||
131011204|NCT00462943|471669482|FG001|Overall Study|Withdrawal by Subject|1|||
131011205|NCT00462943|471669483|FG002|Overall Study|Withdrawal by Subject|0|||
131011206|NCT04358549|471670846|FG000|Overall Study|Adverse Event|0|||
131011207|NCT04358549|471670847|FG001|Overall Study|Adverse Event|1|||
131011208|NCT04358549|471670846|FG000|Overall Study|Death|1|||
131011209|NCT04358549|471670847|FG001|Overall Study|Death|0|||
131011210|NCT04358549|471670846|FG000|Overall Study|Lost to Follow-up|2|||
131011211|NCT04358549|471670847|FG001|Overall Study|Lost to Follow-up|1|||
131011212|NCT04358549|471670846|FG000|Overall Study|Withdrawal by Subject|6|||
131011213|NCT04358549|471670847|FG001|Overall Study|Withdrawal by Subject|6|||
131011214|NCT04358549|471670846|FG000|Overall Study|Start remdesivir|1|||
131011215|NCT04358549|471670847|FG001|Overall Study|Start remdesivir|0|||
131011216|NCT03837028|471670848|FG000|Overall Study|Lost to Follow-up|4|||
131011217|NCT03837028|471670849|FG001|Overall Study|Lost to Follow-up|0|||
131011218|NCT03837028|471670850|FG002|Overall Study|Lost to Follow-up|2|||
131011219|NCT03837028|471670851|FG003|Overall Study|Lost to Follow-up|0|||
131011220|NCT03837028|471670848|FG000|Overall Study|Withdrawal by Subject|12|||
131011221|NCT03837028|471670849|FG001|Overall Study|Withdrawal by Subject|11|||
131011222|NCT03837028|471670850|FG002|Overall Study|Withdrawal by Subject|11|||
131011223|NCT03837028|471670851|FG003|Overall Study|Withdrawal by Subject|7|||
131011224|NCT00157014|471670852|FG000|Overall Study|Death|4|||
131011225|NCT00157014|471670853|FG001|Overall Study|Death|2|||
131011226|NCT00157014|471670854|FG002|Overall Study|Death|1|||
131011227|NCT00157014|471670855|FG003|Overall Study|Death|1|||
131011228|NCT00157014|471670852|FG000|Overall Study|Physician Decision|0|||
131011229|NCT00157014|471670853|FG001|Overall Study|Physician Decision|1|||
131011230|NCT00157014|471670854|FG002|Overall Study|Physician Decision|0|||
131011231|NCT00157014|471670855|FG003|Overall Study|Physician Decision|0|||
131011232|NCT00157014|471670852|FG000|Overall Study|Medications withdrawn on family request|0|||
131011233|NCT00157014|471670853|FG001|Overall Study|Medications withdrawn on family request|1|||
131222560|NCT01625286|472441525|FG001|Overall Study|Lost to Follow-up|0|||
131011234|NCT00157014|471670854|FG002|Overall Study|Medications withdrawn on family request|0|||
131011235|NCT00157014|471670855|FG003|Overall Study|Medications withdrawn on family request|0|||
131011236|NCT00157014|471670852|FG000|Overall Study|Patient withdrawn by investigator|1|||
131011237|NCT00157014|471670853|FG001|Overall Study|Patient withdrawn by investigator|0|||
131011238|NCT00157014|471670854|FG002|Overall Study|Patient withdrawn by investigator|0|||
131011239|NCT00157014|471670855|FG003|Overall Study|Patient withdrawn by investigator|0|||
131011240|NCT00157014|471670852|FG000|Overall Study|Patient unable to return in nursing home|1|||
131011241|NCT00157014|471670853|FG001|Overall Study|Patient unable to return in nursing home|0|||
131011242|NCT00157014|471670854|FG002|Overall Study|Patient unable to return in nursing home|0|||
131011243|NCT00157014|471670855|FG003|Overall Study|Patient unable to return in nursing home|0|||
131011244|NCT00157014|471670852|FG000|Overall Study|Patient would not receive transplant|0|||
131011245|NCT00157014|471670853|FG001|Overall Study|Patient would not receive transplant|1|||
131011246|NCT00157014|471670854|FG002|Overall Study|Patient would not receive transplant|0|||
131011247|NCT00157014|471670855|FG003|Overall Study|Patient would not receive transplant|0|||
131011248|NCT00157014|471670852|FG000|Overall Study|Withdrawal by Subject|1|||
131011249|NCT00157014|471670853|FG001|Overall Study|Withdrawal by Subject|0|||
131011250|NCT00157014|471670854|FG002|Overall Study|Withdrawal by Subject|0|||
131011251|NCT00157014|471670855|FG003|Overall Study|Withdrawal by Subject|0|||
131011252|NCT01362491|471670856|FG000|Overall Study|Ineligible|1|||
131011253|NCT01362491|471670857|FG001|Overall Study|Ineligible|0|||
131011254|NCT01362491|471670858|FG002|Overall Study|Ineligible|0|||
131011255|NCT04867902|471670859|FG000|Overall Study|Lost to Follow-up|1|||
131011256|NCT04867902|471670859|FG000|Overall Study|Withdrawal by Subject|2|||
131011257|NCT04867902|471670859|FG000|Overall Study|Protocol Violation|1|||
131011258|NCT05355116|471670860|FG000|Overall Study|Withdrawal by Subject|2|||
131011259|NCT01090024|471670861|FG000|Period 1|Met exclusion criteria|0|||
131011260|NCT01090024|471670862|FG001|Period 1|Met exclusion criteria|0|||
131011261|NCT01090024|471670863|FG002|Period 1|Met exclusion criteria|0|||
131011262|NCT01090024|471670864|FG003|Period 1|Met exclusion criteria|0|||
131011263|NCT01090024|471670865|FG004|Period 1|Met exclusion criteria|0|||
131011264|NCT01090024|471670866|FG005|Period 1|Met exclusion criteria|0|||
131011265|NCT01090024|471670867|FG006|Period 1|Met exclusion criteria|0|||
131011266|NCT01090024|471670868|FG007|Period 1|Met exclusion criteria|0|||
131011267|NCT01090024|471670869|FG008|Period 1|Met exclusion criteria|0|||
131011268|NCT01090024|471670870|FG009|Period 1|Met exclusion criteria|0|||
131011269|NCT01090024|471670871|FG010|Period 1|Met exclusion criteria|0|||
131011270|NCT01090024|471670872|FG011|Period 1|Met exclusion criteria|0|||
131011271|NCT01090024|471670873|FG012|Period 1|Met exclusion criteria|0|||
131011272|NCT01090024|471670874|FG013|Period 1|Met exclusion criteria|0|||
131011273|NCT01090024|471670875|FG014|Period 1|Met exclusion criteria|1|||
131011274|NCT01090024|471670876|FG015|Period 1|Met exclusion criteria|0|||
131011275|NCT01090024|471670877|FG016|Period 1|Met exclusion criteria|0|||
131011276|NCT01090024|471670878|FG017|Period 1|Met exclusion criteria|0|||
131011277|NCT01090024|471670861|FG000|Period 1|Adverse Event|0|||
131011278|NCT01090024|471670862|FG001|Period 1|Adverse Event|0|||
131011279|NCT01090024|471670863|FG002|Period 1|Adverse Event|0|||
131011280|NCT01090024|471670864|FG003|Period 1|Adverse Event|0|||
131011281|NCT01090024|471670865|FG004|Period 1|Adverse Event|0|||
131011282|NCT01090024|471670866|FG005|Period 1|Adverse Event|0|||
131011283|NCT01090024|471670867|FG006|Period 1|Adverse Event|0|||
131011284|NCT01090024|471670868|FG007|Period 1|Adverse Event|0|||
131011285|NCT01090024|471670869|FG008|Period 1|Adverse Event|0|||
131011286|NCT01090024|471670870|FG009|Period 1|Adverse Event|1|||
131011287|NCT01090024|471670871|FG010|Period 1|Adverse Event|0|||
131011288|NCT01090024|471670872|FG011|Period 1|Adverse Event|1|||
131011289|NCT01090024|471670873|FG012|Period 1|Adverse Event|0|||
131011290|NCT01090024|471670874|FG013|Period 1|Adverse Event|0|||
131011291|NCT01090024|471670875|FG014|Period 1|Adverse Event|0|||
131011292|NCT01090024|471670876|FG015|Period 1|Adverse Event|0|||
131011293|NCT01090024|471670877|FG016|Period 1|Adverse Event|0|||
131011294|NCT01090024|471670878|FG017|Period 1|Adverse Event|1|||
131011295|NCT01090024|471670861|FG000|Period 1|Withdrawal by Subject|0|||
131011296|NCT01090024|471670862|FG001|Period 1|Withdrawal by Subject|0|||
131011297|NCT01090024|471670863|FG002|Period 1|Withdrawal by Subject|0|||
131011298|NCT01090024|471670864|FG003|Period 1|Withdrawal by Subject|1|||
131011299|NCT01090024|471670865|FG004|Period 1|Withdrawal by Subject|0|||
131011300|NCT01090024|471670866|FG005|Period 1|Withdrawal by Subject|0|||
131011301|NCT01090024|471670867|FG006|Period 1|Withdrawal by Subject|0|||
131011302|NCT01090024|471670868|FG007|Period 1|Withdrawal by Subject|0|||
131011303|NCT01090024|471670869|FG008|Period 1|Withdrawal by Subject|0|||
131011304|NCT01090024|471670870|FG009|Period 1|Withdrawal by Subject|0|||
131011305|NCT01090024|471670871|FG010|Period 1|Withdrawal by Subject|0|||
131011306|NCT01090024|471670872|FG011|Period 1|Withdrawal by Subject|0|||
131011307|NCT01090024|471670873|FG012|Period 1|Withdrawal by Subject|0|||
131011308|NCT01090024|471670874|FG013|Period 1|Withdrawal by Subject|0|||
131011309|NCT01090024|471670875|FG014|Period 1|Withdrawal by Subject|0|||
131011310|NCT01090024|471670876|FG015|Period 1|Withdrawal by Subject|0|||
131011311|NCT01090024|471670877|FG016|Period 1|Withdrawal by Subject|0|||
131011312|NCT01090024|471670878|FG017|Period 1|Withdrawal by Subject|0|||
131011313|NCT01090024|471670861|FG000|Period 1|Lost to Follow-up|0|||
131011314|NCT01090024|471670862|FG001|Period 1|Lost to Follow-up|1|||
131011315|NCT01090024|471670863|FG002|Period 1|Lost to Follow-up|0|||
131011316|NCT01090024|471670864|FG003|Period 1|Lost to Follow-up|0|||
131011317|NCT01090024|471670865|FG004|Period 1|Lost to Follow-up|0|||
131011318|NCT01090024|471670866|FG005|Period 1|Lost to Follow-up|0|||
131011319|NCT01090024|471670867|FG006|Period 1|Lost to Follow-up|0|||
131011320|NCT01090024|471670868|FG007|Period 1|Lost to Follow-up|0|||
131011321|NCT01090024|471670869|FG008|Period 1|Lost to Follow-up|0|||
131011322|NCT01090024|471670870|FG009|Period 1|Lost to Follow-up|0|||
131011323|NCT01090024|471670871|FG010|Period 1|Lost to Follow-up|0|||
131011324|NCT01090024|471670872|FG011|Period 1|Lost to Follow-up|0|||
131011325|NCT01090024|471670873|FG012|Period 1|Lost to Follow-up|0|||
131011326|NCT01090024|471670874|FG013|Period 1|Lost to Follow-up|0|||
131011327|NCT01090024|471670875|FG014|Period 1|Lost to Follow-up|0|||
131011328|NCT01090024|471670876|FG015|Period 1|Lost to Follow-up|0|||
131011329|NCT01090024|471670877|FG016|Period 1|Lost to Follow-up|0|||
131011330|NCT01090024|471670878|FG017|Period 1|Lost to Follow-up|0|||
131011331|NCT01090024|471670861|FG000|Period 2|Lost to Follow-up|0|||
131011332|NCT01090024|471670862|FG001|Period 2|Lost to Follow-up|0|||
131011333|NCT01090024|471670863|FG002|Period 2|Lost to Follow-up|0|||
131011334|NCT01090024|471670864|FG003|Period 2|Lost to Follow-up|1|||
131011335|NCT01090024|471670865|FG004|Period 2|Lost to Follow-up|0|||
131011336|NCT01090024|471670866|FG005|Period 2|Lost to Follow-up|0|||
131011337|NCT01090024|471670867|FG006|Period 2|Lost to Follow-up|0|||
131011338|NCT01090024|471670868|FG007|Period 2|Lost to Follow-up|0|||
131011339|NCT01090024|471670869|FG008|Period 2|Lost to Follow-up|0|||
131011340|NCT01090024|471670870|FG009|Period 2|Lost to Follow-up|0|||
131011341|NCT01090024|471670871|FG010|Period 2|Lost to Follow-up|0|||
131011342|NCT01090024|471670872|FG011|Period 2|Lost to Follow-up|0|||
131011343|NCT01090024|471670873|FG012|Period 2|Lost to Follow-up|0|||
131011344|NCT01090024|471670874|FG013|Period 2|Lost to Follow-up|0|||
131011345|NCT01090024|471670875|FG014|Period 2|Lost to Follow-up|0|||
131011346|NCT01090024|471670876|FG015|Period 2|Lost to Follow-up|0|||
131011347|NCT01090024|471670877|FG016|Period 2|Lost to Follow-up|0|||
131011348|NCT01090024|471670878|FG017|Period 2|Lost to Follow-up|0|||
131011349|NCT01090024|471670861|FG000|Period 2|Adverse Event|1|||
131011350|NCT01090024|471670862|FG001|Period 2|Adverse Event|0|||
131011351|NCT01090024|471670863|FG002|Period 2|Adverse Event|0|||
131011352|NCT01090024|471670864|FG003|Period 2|Adverse Event|0|||
131011353|NCT01090024|471670865|FG004|Period 2|Adverse Event|0|||
131011354|NCT01090024|471670866|FG005|Period 2|Adverse Event|0|||
131011355|NCT01090024|471670867|FG006|Period 2|Adverse Event|0|||
131011356|NCT01090024|471670868|FG007|Period 2|Adverse Event|0|||
131011357|NCT01090024|471670869|FG008|Period 2|Adverse Event|0|||
131011358|NCT01090024|471670870|FG009|Period 2|Adverse Event|0|||
131011359|NCT01090024|471670871|FG010|Period 2|Adverse Event|0|||
131011360|NCT01090024|471670872|FG011|Period 2|Adverse Event|0|||
131011361|NCT01090024|471670873|FG012|Period 2|Adverse Event|0|||
131011362|NCT01090024|471670874|FG013|Period 2|Adverse Event|0|||
131011363|NCT01090024|471670875|FG014|Period 2|Adverse Event|0|||
131011364|NCT01090024|471670876|FG015|Period 2|Adverse Event|0|||
131011365|NCT01090024|471670877|FG016|Period 2|Adverse Event|0|||
131011366|NCT01090024|471670878|FG017|Period 2|Adverse Event|0|||
131011367|NCT01090024|471670861|FG000|Period 3|Withdrawal by Subject|0|||
131011368|NCT01090024|471670862|FG001|Period 3|Withdrawal by Subject|0|||
131011369|NCT01090024|471670863|FG002|Period 3|Withdrawal by Subject|0|||
131011370|NCT01090024|471670864|FG003|Period 3|Withdrawal by Subject|0|||
131011371|NCT01090024|471670865|FG004|Period 3|Withdrawal by Subject|0|||
131011372|NCT01090024|471670866|FG005|Period 3|Withdrawal by Subject|0|||
131011373|NCT01090024|471670867|FG006|Period 3|Withdrawal by Subject|0|||
131011374|NCT01090024|471670868|FG007|Period 3|Withdrawal by Subject|0|||
131011375|NCT01090024|471670869|FG008|Period 3|Withdrawal by Subject|0|||
131011376|NCT01090024|471670870|FG009|Period 3|Withdrawal by Subject|0|||
131011377|NCT01090024|471670871|FG010|Period 3|Withdrawal by Subject|0|||
131011378|NCT01090024|471670872|FG011|Period 3|Withdrawal by Subject|0|||
131011379|NCT01090024|471670873|FG012|Period 3|Withdrawal by Subject|0|||
131011380|NCT01090024|471670874|FG013|Period 3|Withdrawal by Subject|0|||
131011381|NCT01090024|471670875|FG014|Period 3|Withdrawal by Subject|0|||
131011382|NCT01090024|471670876|FG015|Period 3|Withdrawal by Subject|1|||
131011383|NCT01090024|471670877|FG016|Period 3|Withdrawal by Subject|0|||
131011384|NCT01090024|471670878|FG017|Period 3|Withdrawal by Subject|0|||
131011385|NCT01090024|471670861|FG000|Period 3|Protocol Violation|0|||
131011386|NCT01090024|471670862|FG001|Period 3|Protocol Violation|0|||
131011387|NCT01090024|471670863|FG002|Period 3|Protocol Violation|0|||
131011388|NCT01090024|471670864|FG003|Period 3|Protocol Violation|0|||
131011389|NCT01090024|471670865|FG004|Period 3|Protocol Violation|0|||
131011390|NCT01090024|471670866|FG005|Period 3|Protocol Violation|0|||
131011391|NCT01090024|471670867|FG006|Period 3|Protocol Violation|0|||
131011392|NCT01090024|471670868|FG007|Period 3|Protocol Violation|0|||
131011393|NCT01090024|471670869|FG008|Period 3|Protocol Violation|1|||
131011394|NCT01090024|471670870|FG009|Period 3|Protocol Violation|0|||
131011395|NCT01090024|471670871|FG010|Period 3|Protocol Violation|0|||
131011396|NCT01090024|471670872|FG011|Period 3|Protocol Violation|0|||
131011397|NCT01090024|471670873|FG012|Period 3|Protocol Violation|0|||
131011398|NCT01090024|471670874|FG013|Period 3|Protocol Violation|0|||
131011399|NCT01090024|471670875|FG014|Period 3|Protocol Violation|0|||
131011400|NCT01090024|471670876|FG015|Period 3|Protocol Violation|0|||
131011401|NCT01090024|471670877|FG016|Period 3|Protocol Violation|0|||
131011402|NCT01090024|471670878|FG017|Period 3|Protocol Violation|0|||
131011403|NCT01090024|471670861|FG000|Period 3|Adverse Event|0|||
131011404|NCT01090024|471670862|FG001|Period 3|Adverse Event|0|||
131011405|NCT01090024|471670863|FG002|Period 3|Adverse Event|0|||
131011406|NCT01090024|471670864|FG003|Period 3|Adverse Event|0|||
131011407|NCT01090024|471670865|FG004|Period 3|Adverse Event|0|||
131011408|NCT01090024|471670866|FG005|Period 3|Adverse Event|1|||
131011409|NCT01090024|471670867|FG006|Period 3|Adverse Event|0|||
131011410|NCT01090024|471670868|FG007|Period 3|Adverse Event|0|||
131011411|NCT01090024|471670869|FG008|Period 3|Adverse Event|0|||
131011412|NCT01090024|471670870|FG009|Period 3|Adverse Event|0|||
131011413|NCT01090024|471670871|FG010|Period 3|Adverse Event|0|||
131011414|NCT01090024|471670872|FG011|Period 3|Adverse Event|0|||
131011415|NCT01090024|471670873|FG012|Period 3|Adverse Event|0|||
131011416|NCT01090024|471670874|FG013|Period 3|Adverse Event|0|||
131011417|NCT01090024|471670875|FG014|Period 3|Adverse Event|0|||
131011418|NCT01090024|471670876|FG015|Period 3|Adverse Event|0|||
131011419|NCT01090024|471670877|FG016|Period 3|Adverse Event|0|||
131011420|NCT01090024|471670878|FG017|Period 3|Adverse Event|0|||
131011421|NCT00567879|471670883|FG000|Overall Study|Adverse Event|2|||
131011422|NCT00567879|471670884|FG001|Overall Study|Adverse Event|0|||
131011423|NCT00567879|471670885|FG002|Overall Study|Adverse Event|1|||
131011424|NCT00567879|471670886|FG003|Overall Study|Adverse Event|0|||
131011425|NCT00567879|471670887|FG004|Overall Study|Adverse Event|1|||
131011426|NCT00567879|471670888|FG005|Overall Study|Adverse Event|0|||
131011427|NCT00567879|471670883|FG000|Overall Study|Abnormal test procedure(s)|0|||
131011428|NCT00567879|471670884|FG001|Overall Study|Abnormal test procedure(s)|0|||
131011429|NCT00567879|471670885|FG002|Overall Study|Abnormal test procedure(s)|1|||
131011430|NCT00567879|471670886|FG003|Overall Study|Abnormal test procedure(s)|0|||
131011431|NCT00567879|471670887|FG004|Overall Study|Abnormal test procedure(s)|0|||
131011432|NCT00567879|471670888|FG005|Overall Study|Abnormal test procedure(s)|0|||
131011433|NCT00567879|471670883|FG000|Overall Study|Withdrawal by Subject|0|||
131011434|NCT00567879|471670884|FG001|Overall Study|Withdrawal by Subject|0|||
131011435|NCT00567879|471670885|FG002|Overall Study|Withdrawal by Subject|3|||
131011436|NCT00567879|471670886|FG003|Overall Study|Withdrawal by Subject|1|||
131011437|NCT00567879|471670887|FG004|Overall Study|Withdrawal by Subject|0|||
131011438|NCT00567879|471670888|FG005|Overall Study|Withdrawal by Subject|0|||
131011439|NCT00567879|471670883|FG000|Overall Study|New cancer therapy|0|||
131011440|NCT00567879|471670884|FG001|Overall Study|New cancer therapy|0|||
131011441|NCT00567879|471670885|FG002|Overall Study|New cancer therapy|1|||
131011442|NCT00567879|471670886|FG003|Overall Study|New cancer therapy|0|||
131011443|NCT00567879|471670887|FG004|Overall Study|New cancer therapy|0|||
131011444|NCT00567879|471670888|FG005|Overall Study|New cancer therapy|0|||
131011445|NCT00567879|471670883|FG000|Overall Study|Disease progression|5|||
131011446|NCT00567879|471670884|FG001|Overall Study|Disease progression|7|||
131011447|NCT00567879|471670885|FG002|Overall Study|Disease progression|15|||
131011448|NCT00567879|471670886|FG003|Overall Study|Disease progression|5|||
131011449|NCT00567879|471670887|FG004|Overall Study|Disease progression|11|||
131011450|NCT00567879|471670888|FG005|Overall Study|Disease progression|3|||
131011451|NCT00777556|471670889|FG000|Overall Study|Inappropriate self-selection|34|||
131011452|NCT00777556|471670889|FG000|Overall Study|Dispensed but did not use product|12|||
131011453|NCT00777556|471670889|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
131011454|NCT03646669|471670890|FG000|Overall Study|Withdrawal by Subject|5|||
131011455|NCT03646669|471670891|FG001|Overall Study|Withdrawal by Subject|0|||
131011456|NCT03439124|471670896|FG000|Overall Study|Adverse Event|2|||
131011457|NCT03439124|471670897|FG001|Overall Study|Adverse Event|0|||
131011458|NCT03439124|471670896|FG000|Overall Study|Lost to Follow-up|1|||
131011459|NCT03439124|471670897|FG001|Overall Study|Lost to Follow-up|0|||
131011460|NCT03439124|471670896|FG000|Overall Study|Other reasons|1|||
131011461|NCT03439124|471670897|FG001|Overall Study|Other reasons|0|||
131011462|NCT02049866|471670898|FG000|Overall Study|Withdrawal by Subject|1|||
131011463|NCT01117480|471670899|FG000|Overall Study|Protocol Violation|8|||
131011464|NCT01117480|471670899|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
131011465|NCT04464421|471670903|FG000|Overall Study|Lost to Follow-up|2|||
131011466|NCT04464421|471670904|FG001|Overall Study|Lost to Follow-up|2|||
131011467|NCT01072357|471670905|FG000|Overall Study|Lost to Follow-up|0|||
131011468|NCT01072357|471670906|FG001|Overall Study|Lost to Follow-up|1|||
131011469|NCT00891618|471670907|FG000|Overall Study|Withdrawal by Subject|1|||
131011470|NCT05790408|471670908|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
131011471|NCT05419557|471670909|FG000|Overall Study|Lost to Follow-up|11|||
131011472|NCT05419557|471670910|FG001|Overall Study|Lost to Follow-up|4|||
131011473|NCT01196988|471670911|FG000|Overall Study|Adverse Event|1|||
131011474|NCT01196988|471670912|FG001|Overall Study|Adverse Event|2|||
131011475|NCT01196988|471670913|FG002|Overall Study|Adverse Event|0|||
131011476|NCT01196988|471670914|FG003|Overall Study|Adverse Event|0|||
131011477|NCT01196988|471670911|FG000|Overall Study|Withdrawal by Subject|5|||
131011478|NCT01196988|471670912|FG001|Overall Study|Withdrawal by Subject|1|||
131011479|NCT01196988|471670913|FG002|Overall Study|Withdrawal by Subject|4|||
131011480|NCT01196988|471670914|FG003|Overall Study|Withdrawal by Subject|0|||
131011481|NCT01196988|471670911|FG000|Overall Study|Lost to Follow-up|16|||
131011482|NCT01196988|471670912|FG001|Overall Study|Lost to Follow-up|29|||
131011483|NCT01196988|471670913|FG002|Overall Study|Lost to Follow-up|21|||
131011484|NCT01196988|471670914|FG003|Overall Study|Lost to Follow-up|1|||
131011485|NCT01196988|471670911|FG000|Overall Study|Other|2|||
131011486|NCT01196988|471670912|FG001|Overall Study|Other|0|||
131011487|NCT01196988|471670913|FG002|Overall Study|Other|0|||
131011488|NCT01196988|471670914|FG003|Overall Study|Other|0|||
131011489|NCT00558363|471670916|FG000|Overall Study|Physician Decision|18|||
131011490|NCT00558363|471670917|FG001|Overall Study|Physician Decision|4|||
131011491|NCT00558363|471670916|FG000|Overall Study|Withdrawal by Subject|11|||
131011492|NCT00558363|471670917|FG001|Overall Study|Withdrawal by Subject|4|||
131011493|NCT00558363|471670916|FG000|Overall Study|Adverse Event|5|||
131011494|NCT00558363|471670917|FG001|Overall Study|Adverse Event|5|||
131011495|NCT00558363|471670916|FG000|Overall Study|Lack of Efficacy|2|||
131011496|NCT00558363|471670917|FG001|Overall Study|Lack of Efficacy|2|||
131011497|NCT00558363|471670916|FG000|Overall Study|Protocol Violation|2|||
131011498|NCT00558363|471670917|FG001|Overall Study|Protocol Violation|1|||
131011499|NCT00558363|471670916|FG000|Overall Study|Lost to Follow-up|0|||
131011500|NCT00558363|471670917|FG001|Overall Study|Lost to Follow-up|1|||
131011501|NCT00558363|471670916|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
131011502|NCT00558363|471670917|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
131011503|NCT00558363|471670916|FG000|Overall Study|Randomized in Error|1|||
131011504|NCT00558363|471670917|FG001|Overall Study|Randomized in Error|2|||
131011505|NCT00558363|471670916|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
131011506|NCT00558363|471670917|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
130765935|NCT01253174|470765909|FG003|Period 1|Randomized but not treated|0|||
130765936|NCT01253174|470765910|FG004|Period 1|Randomized but not treated|1|||
131011507|NCT00920686|471670918|FG000|Overall Study|Lost to Follow-up|2|||
131011508|NCT00920686|471670919|FG001|Overall Study|Lost to Follow-up|3|||
131011509|NCT00920686|471670920|FG002|Overall Study|Lost to Follow-up|1|||
131011510|NCT00920686|471670918|FG000|Overall Study|Study drug dosing criteria not met|17|||
131011511|NCT00920686|471670919|FG001|Overall Study|Study drug dosing criteria not met|19|||
131011512|NCT00920686|471670920|FG002|Overall Study|Study drug dosing criteria not met|12|||
131011513|NCT01313182|471670921|FG000|Overall Study|Protocol Violation|66|||
131011514|NCT01313182|471670922|FG001|Overall Study|Protocol Violation|92|||
131011515|NCT00957229|471670924|FG000|Study Start|Adverse Event|0|||
131011516|NCT00957229|471670925|FG001|Study Start|Adverse Event|3|||
131011517|NCT00957229|471670924|FG000|Study Start|Disease Progression|1|||
131011518|NCT00957229|471670925|FG001|Study Start|Disease Progression|0|||
131011519|NCT00957229|471670924|FG000|Reallocated to or Continued Vismodegib|Death|1|||
131011520|NCT00957229|471670925|FG001|Reallocated to or Continued Vismodegib|Death|1|||
131011521|NCT00957229|471670924|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
131011522|NCT00957229|471670925|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
130885300|NCT01716234|471213326|FG004|Overall Study|Adverse Event|3|||
130885301|NCT01716234|471213327|FG005|Overall Study|Adverse Event|6|||
130885302|NCT01716234|471213328|FG006|Overall Study|Adverse Event|0|||
130885303|NCT01716234|471213322|FG000|Overall Study|Withdrawal by Subject|3|||
130885304|NCT01716234|471213323|FG001|Overall Study|Withdrawal by Subject|0|||
130885305|NCT01716234|471213324|FG002|Overall Study|Withdrawal by Subject|2|||
130885306|NCT01716234|471213325|FG003|Overall Study|Withdrawal by Subject|2|||
130885307|NCT01716234|471213326|FG004|Overall Study|Withdrawal by Subject|1|||
130885308|NCT01716234|471213327|FG005|Overall Study|Withdrawal by Subject|3|||
130885309|NCT01716234|471213328|FG006|Overall Study|Withdrawal by Subject|0|||
130885310|NCT00771758|471213330|FG000|Overall Study|Adverse Event|2|||
130885311|NCT00771758|471213331|FG001|Overall Study|Adverse Event|8|||
130885312|NCT00771758|471213332|FG002|Overall Study|Adverse Event|1|||
130885313|NCT00771758|471213330|FG000|Overall Study|Lack of Efficacy|0|||
130885314|NCT00771758|471213331|FG001|Overall Study|Lack of Efficacy|2|||
130885315|NCT00771758|471213332|FG002|Overall Study|Lack of Efficacy|1|||
130885316|NCT00771758|471213330|FG000|Overall Study|Lost to Follow-up|1|||
130885317|NCT00771758|471213331|FG001|Overall Study|Lost to Follow-up|0|||
130885318|NCT00771758|471213332|FG002|Overall Study|Lost to Follow-up|0|||
131011523|NCT04580303|471670926|FG000|Overall Study|Adverse Event|0|||
131011524|NCT04580303|471670927|FG001|Overall Study|Adverse Event|1|||
130885319|NCT00771758|471213330|FG000|Overall Study|Protocol Violation|1|||
130885320|NCT00771758|471213331|FG001|Overall Study|Protocol Violation|0|||
130885321|NCT00771758|471213332|FG002|Overall Study|Protocol Violation|0|||
131011525|NCT04580303|471670928|FG002|Overall Study|Adverse Event|0|||
131011526|NCT04580303|471670929|FG003|Overall Study|Adverse Event|0|||
131011527|NCT04580303|471670926|FG000|Overall Study|Withdrawal by Subject|0|||
131011528|NCT04580303|471670927|FG001|Overall Study|Withdrawal by Subject|0|||
131011529|NCT04580303|471670928|FG002|Overall Study|Withdrawal by Subject|1|||
131011530|NCT04580303|471670929|FG003|Overall Study|Withdrawal by Subject|0|||
131011531|NCT04044664|471670940|FG000|Stage 1|Adverse Event|3|||
131011532|NCT04044664|471670941|FG001|Stage 1|Adverse Event|3|||
131011533|NCT04044664|471670942|FG002|Stage 1|Adverse Event|1|||
131011534|NCT04044664|471670940|FG000|Stage 1|Lost to Follow-up|3|||
131011535|NCT04044664|471670941|FG001|Stage 1|Lost to Follow-up|2|||
131011536|NCT04044664|471670942|FG002|Stage 1|Lost to Follow-up|2|||
131011537|NCT04044664|471670940|FG000|Stage 1|Withdrawal by Subject|9|||
131011538|NCT04044664|471670941|FG001|Stage 1|Withdrawal by Subject|1|||
131011539|NCT04044664|471670942|FG002|Stage 1|Withdrawal by Subject|0|||
131011540|NCT04044664|471670940|FG000|Stage 1|noncompliance, personal reason|2|||
131011541|NCT04044664|471670941|FG001|Stage 1|noncompliance, personal reason|0|||
131011542|NCT04044664|471670942|FG002|Stage 1|noncompliance, personal reason|0|||
131011543|NCT04044664|471670940|FG000|Stage 1|randomization error|0|||
131011544|NCT04044664|471670941|FG001|Stage 1|randomization error|1|||
131011545|NCT04044664|471670942|FG002|Stage 1|randomization error|0|||
131011546|NCT04044664|471670940|FG000|Stage 2|Adverse Event|2|||
131011547|NCT04044664|471670941|FG001|Stage 2|Adverse Event|0|||
131011548|NCT04044664|471670942|FG002|Stage 2|Adverse Event|0|||
131011549|NCT04044664|471670940|FG000|Stage 2|Lost to Follow-up|3|||
131011550|NCT04044664|471670941|FG001|Stage 2|Lost to Follow-up|2|||
131011551|NCT04044664|471670942|FG002|Stage 2|Lost to Follow-up|1|||
131011552|NCT04044664|471670940|FG000|Stage 2|Withdrawal by Subject|3|||
131011553|NCT04044664|471670941|FG001|Stage 2|Withdrawal by Subject|0|||
131011554|NCT04044664|471670942|FG002|Stage 2|Withdrawal by Subject|0|||
131011555|NCT04044664|471670940|FG000|Stage 2|protocol deviation|1|||
131011556|NCT04044664|471670941|FG001|Stage 2|protocol deviation|0|||
131011557|NCT04044664|471670942|FG002|Stage 2|protocol deviation|0|||
131011558|NCT03736785|471670943|FG000|Overall Study|Adverse Event|1|||
131011559|NCT03736785|471670944|FG001|Overall Study|Adverse Event|1|||
131011560|NCT03736785|471670945|FG002|Overall Study|Adverse Event|1|||
131011561|NCT03736785|471670943|FG000|Overall Study|Death|1|||
131011562|NCT03736785|471670944|FG001|Overall Study|Death|0|||
131011563|NCT03736785|471670945|FG002|Overall Study|Death|1|||
131011564|NCT03736785|471670943|FG000|Overall Study|Lost to Follow-up|0|||
131011565|NCT03736785|471670944|FG001|Overall Study|Lost to Follow-up|2|||
131011566|NCT03736785|471670945|FG002|Overall Study|Lost to Follow-up|3|||
131011567|NCT03736785|471670943|FG000|Overall Study|Non compliance with study drug|1|||
131011568|NCT03736785|471670944|FG001|Overall Study|Non compliance with study drug|1|||
131011569|NCT03736785|471670945|FG002|Overall Study|Non compliance with study drug|0|||
131222561|NCT01625286|472441526|FG002|Overall Study|Lost to Follow-up|0|||
131011570|NCT03736785|471670943|FG000|Overall Study|Physician Decision|0|||
131011571|NCT03736785|471670944|FG001|Overall Study|Physician Decision|1|||
131011572|NCT03736785|471670945|FG002|Overall Study|Physician Decision|1|||
131011573|NCT03736785|471670943|FG000|Overall Study|Protocol Violation|1|||
131011574|NCT03736785|471670944|FG001|Overall Study|Protocol Violation|4|||
131011575|NCT03736785|471670945|FG002|Overall Study|Protocol Violation|3|||
131011576|NCT03736785|471670943|FG000|Overall Study|Sponsor Decision|1|||
131011577|NCT03736785|471670944|FG001|Overall Study|Sponsor Decision|0|||
131011578|NCT03736785|471670945|FG002|Overall Study|Sponsor Decision|0|||
131011579|NCT03736785|471670943|FG000|Overall Study|Unknown/Missing data|3|||
131011580|NCT03736785|471670944|FG001|Overall Study|Unknown/Missing data|2|||
131011581|NCT03736785|471670945|FG002|Overall Study|Unknown/Missing data|1|||
131011582|NCT03736785|471670943|FG000|Overall Study|Withdrawal by Subject|9|||
131011583|NCT03736785|471670944|FG001|Overall Study|Withdrawal by Subject|6|||
131011584|NCT03736785|471670945|FG002|Overall Study|Withdrawal by Subject|4|||
131011585|NCT02701361|471670948|FG000|Overall Study|Lost to Follow-up|5|||
131011586|NCT02701361|471670949|FG001|Overall Study|Lost to Follow-up|2|||
131011587|NCT02701361|471670950|FG002|Overall Study|Lost to Follow-up|1|||
131011588|NCT02701361|471670948|FG000|Overall Study|Withdrawal by Subject|4|||
131011589|NCT02701361|471670949|FG001|Overall Study|Withdrawal by Subject|0|||
131011590|NCT02701361|471670950|FG002|Overall Study|Withdrawal by Subject|0|||
131011591|NCT02701361|471670948|FG000|Overall Study|timed out in rehab center|0|||
131011592|NCT02701361|471670949|FG001|Overall Study|timed out in rehab center|1|||
131011593|NCT02701361|471670950|FG002|Overall Study|timed out in rehab center|0|||
131011594|NCT02701361|471670948|FG000|Overall Study|incarceration|0|||
131011595|NCT02701361|471670949|FG001|Overall Study|incarceration|0|||
131011596|NCT02701361|471670950|FG002|Overall Study|incarceration|1|||
131011597|NCT04588480|471670951|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
131011598|NCT04588480|471670952|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
131011599|NCT04588480|471670953|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
131011600|NCT04588480|471670951|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
131011601|NCT04588480|471670952|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
131011602|NCT04588480|471670953|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
131011603|NCT02750709|471670954|FG000|Treatment Period 1|Adverse Event|0|||
131011604|NCT02750709|471670955|FG001|Treatment Period 1|Adverse Event|0|||
131011605|NCT02750709|471670956|FG002|Treatment Period 1|Adverse Event|0|||
131011606|NCT02750709|471670957|FG003|Treatment Period 1|Adverse Event|0|||
131011607|NCT02750709|471670958|FG004|Treatment Period 1|Adverse Event|0|||
131011608|NCT02750709|471670959|FG005|Treatment Period 1|Adverse Event|1|||
131011609|NCT00290732|471670961|FG000|Overall Study|Inability to instill drug intraductally.|0|||
131011610|NCT00290732|471670962|FG001|Overall Study|Inability to instill drug intraductally.|1|||
131011611|NCT00290732|471670963|FG002|Overall Study|Inability to instill drug intraductally.|1|||
131011612|NCT00290732|471670964|FG003|Overall Study|Inability to instill drug intraductally.|0|||
131011613|NCT00290732|471670965|FG004|Overall Study|Inability to instill drug intraductally.|0|||
131011614|NCT02595398|471670966|FG000|Overall Study|Non-compliance|1|||
131011615|NCT02595398|471670967|FG001|Overall Study|Non-compliance|0|||
131011616|NCT02595398|471670966|FG000|Overall Study|Withdrawal by Subject|2|||
131011617|NCT02595398|471670967|FG001|Overall Study|Withdrawal by Subject|1|||
131011618|NCT02595398|471670966|FG000|Overall Study|Lost to Follow-up|1|||
131011619|NCT02595398|471670967|FG001|Overall Study|Lost to Follow-up|0|||
131011620|NCT00843193|471670968|FG000|Overall Study|Adverse Event|2|||
131011621|NCT00843193|471670969|FG001|Overall Study|Adverse Event|4|||
131011622|NCT00843193|471670968|FG000|Overall Study|Lack of Efficacy|1|||
131011623|NCT00843193|471670969|FG001|Overall Study|Lack of Efficacy|1|||
131011624|NCT00843193|471670968|FG000|Overall Study|Protocol Violation|1|||
131011625|NCT00843193|471670969|FG001|Overall Study|Protocol Violation|2|||
131011626|NCT00843193|471670968|FG000|Overall Study|Lost to Follow-up|1|||
131011627|NCT00843193|471670969|FG001|Overall Study|Lost to Follow-up|0|||
131011628|NCT00843193|471670968|FG000|Overall Study|Physician Decision|0|||
131011629|NCT00843193|471670969|FG001|Overall Study|Physician Decision|1|||
131011630|NCT00843193|471670968|FG000|Overall Study|Withdrawal by Subject|3|||
131011631|NCT00843193|471670969|FG001|Overall Study|Withdrawal by Subject|3|||
131011632|NCT00542386|471670970|FG000|Overall Study|Adverse Event|1|||
131011633|NCT00542386|471670971|FG001|Overall Study|Adverse Event|7|||
131011634|NCT00542386|471670972|FG002|Overall Study|Adverse Event|7|||
131011635|NCT00542386|471670973|FG003|Overall Study|Adverse Event|8|||
131011636|NCT00542386|471670974|FG004|Overall Study|Adverse Event|13|||
131011637|NCT00542386|471670975|FG005|Overall Study|Adverse Event|4|||
131011638|NCT00542386|471670970|FG000|Overall Study|Death|0|||
131011639|NCT00542386|471670971|FG001|Overall Study|Death|0|||
131011640|NCT00542386|471670972|FG002|Overall Study|Death|1|||
131011641|NCT00542386|471670973|FG003|Overall Study|Death|2|||
131011642|NCT00542386|471670974|FG004|Overall Study|Death|1|||
131011643|NCT00542386|471670975|FG005|Overall Study|Death|2|||
131011644|NCT00542386|471670970|FG000|Overall Study|Lack of Efficacy|32|||
131011645|NCT00542386|471670971|FG001|Overall Study|Lack of Efficacy|12|||
131222562|NCT01625286|472441527|FG003|Overall Study|Lost to Follow-up|0|||
131011646|NCT00542386|471670972|FG002|Overall Study|Lack of Efficacy|10|||
131011647|NCT00542386|471670973|FG003|Overall Study|Lack of Efficacy|13|||
131011648|NCT00542386|471670974|FG004|Overall Study|Lack of Efficacy|7|||
131011649|NCT00542386|471670975|FG005|Overall Study|Lack of Efficacy|31|||
131011650|NCT00542386|471670970|FG000|Overall Study|Physician Decision|1|||
131011651|NCT00542386|471670971|FG001|Overall Study|Physician Decision|0|||
131011652|NCT00542386|471670972|FG002|Overall Study|Physician Decision|0|||
131011653|NCT00542386|471670973|FG003|Overall Study|Physician Decision|1|||
131011654|NCT00542386|471670974|FG004|Overall Study|Physician Decision|0|||
131011655|NCT00542386|471670975|FG005|Overall Study|Physician Decision|0|||
131011656|NCT00542386|471670970|FG000|Overall Study|Protocol Violation|0|||
131011657|NCT00542386|471670971|FG001|Overall Study|Protocol Violation|0|||
130885322|NCT00771758|471213330|FG000|Overall Study|Withdrawal by Subject|1|||
130885323|NCT00771758|471213331|FG001|Overall Study|Withdrawal by Subject|0|||
130885324|NCT00771758|471213332|FG002|Overall Study|Withdrawal by Subject|0|||
130885325|NCT00771758|471213330|FG000|Overall Study|Other|3|||
130885326|NCT00771758|471213331|FG001|Overall Study|Other|2|||
130885327|NCT00771758|471213332|FG002|Overall Study|Other|0|||
130885328|NCT00935584|471213335|FG000|Overall Study|Withdrawal by Subject|9|||
130885329|NCT00935584|471213336|FG001|Overall Study|Withdrawal by Subject|0|||
130885330|NCT00935584|471213335|FG000|Overall Study|Death|3|||
130885331|NCT00935584|471213336|FG001|Overall Study|Death|0|||
130885332|NCT00935584|471213335|FG000|Overall Study|Lost to Follow-up|8|||
130885333|NCT00935584|471213336|FG001|Overall Study|Lost to Follow-up|0|||
130885334|NCT00935584|471213335|FG000|Overall Study|No show|9|||
130885335|NCT00935584|471213336|FG001|Overall Study|No show|0|||
130885336|NCT00935584|471213335|FG000|Overall Study|Relocated|3|||
130885337|NCT00935584|471213336|FG001|Overall Study|Relocated|0|||
130885338|NCT00935584|471213335|FG000|Overall Study|Patient changed provider|3|||
130885339|NCT00935584|471213336|FG001|Overall Study|Patient changed provider|0|||
130885340|NCT00935584|471213335|FG000|Overall Study|Provider dropped out of study|14|||
130885341|NCT00935584|471213336|FG001|Overall Study|Provider dropped out of study|4|||
130885342|NCT00687193|471213337|FG000|Overall Study|Adverse Event|0|||
130885343|NCT00687193|471213338|FG001|Overall Study|Adverse Event|1|||
130885344|NCT00687193|471213339|FG002|Overall Study|Adverse Event|2|||
130885345|NCT00687193|471213340|FG003|Overall Study|Adverse Event|3|||
130885346|NCT00687193|471213341|FG004|Overall Study|Adverse Event|0|||
130885347|NCT00687193|471213342|FG005|Overall Study|Adverse Event|2|||
130885348|NCT00687193|471213337|FG000|Overall Study|Lack of Efficacy|1|||
130885349|NCT00687193|471213338|FG001|Overall Study|Lack of Efficacy|1|||
130885350|NCT00687193|471213339|FG002|Overall Study|Lack of Efficacy|0|||
130885351|NCT00687193|471213340|FG003|Overall Study|Lack of Efficacy|0|||
130885352|NCT00687193|471213341|FG004|Overall Study|Lack of Efficacy|0|||
130885353|NCT00687193|471213342|FG005|Overall Study|Lack of Efficacy|2|||
130885354|NCT00687193|471213337|FG000|Overall Study|Protocol Violation|1|||
130885355|NCT00687193|471213338|FG001|Overall Study|Protocol Violation|2|||
130885356|NCT00687193|471213339|FG002|Overall Study|Protocol Violation|0|||
130885357|NCT00687193|471213340|FG003|Overall Study|Protocol Violation|1|||
130885358|NCT00687193|471213341|FG004|Overall Study|Protocol Violation|2|||
130885359|NCT00687193|471213342|FG005|Overall Study|Protocol Violation|0|||
130885360|NCT01285557|471213343|FG000|Overall Study|Death|173|||
130885361|NCT01285557|471213344|FG001|Overall Study|Death|90|||
130885362|NCT01285557|471213343|FG000|Overall Study|Lost to Follow-up|6|||
130885363|NCT01285557|471213344|FG001|Overall Study|Lost to Follow-up|2|||
130885364|NCT01285557|471213343|FG000|Overall Study|Withdrew Consent|6|||
130885365|NCT01285557|471213344|FG001|Overall Study|Withdrew Consent|1|||
130885366|NCT01285557|471213343|FG000|Overall Study|Sponsor Study Termination|23|||
130885367|NCT01285557|471213344|FG001|Overall Study|Sponsor Study Termination|13|||
130885368|NCT01285557|471213343|FG000|Overall Study|Randomized but not treated|1|||
130885369|NCT01285557|471213344|FG001|Overall Study|Randomized but not treated|1|||
130885370|NCT01285557|471213343|FG000|Overall Study|Study follow-up ongoing|28|||
130885371|NCT01285557|471213344|FG001|Overall Study|Study follow-up ongoing|14|||
130885372|NCT01285557|471213343|FG000|Overall Study|Sponsor Decision|2|||
130885373|NCT01285557|471213344|FG001|Overall Study|Sponsor Decision|1|||
130885374|NCT03467750|471213345|FG000|Overall Study|Surgery canceled|1|||
130885375|NCT03467750|471213346|FG001|Overall Study|Surgery canceled|0|||
130885376|NCT03467750|471213345|FG000|Overall Study|Protocol Violation|1|||
131011658|NCT00542386|471670972|FG002|Overall Study|Protocol Violation|1|||
131011659|NCT00542386|471670973|FG003|Overall Study|Protocol Violation|0|||
131011660|NCT00542386|471670974|FG004|Overall Study|Protocol Violation|0|||
131011661|NCT00542386|471670975|FG005|Overall Study|Protocol Violation|4|||
131011662|NCT00542386|471670970|FG000|Overall Study|Withdrawal by Subject|5|||
131011663|NCT00542386|471670971|FG001|Overall Study|Withdrawal by Subject|8|||
131011664|NCT00542386|471670972|FG002|Overall Study|Withdrawal by Subject|10|||
131011665|NCT00542386|471670973|FG003|Overall Study|Withdrawal by Subject|11|||
131011666|NCT00542386|471670974|FG004|Overall Study|Withdrawal by Subject|15|||
131011667|NCT00542386|471670975|FG005|Overall Study|Withdrawal by Subject|7|||
131011668|NCT00542386|471670970|FG000|Overall Study|Other Reasons|4|||
131011669|NCT00542386|471670971|FG001|Overall Study|Other Reasons|1|||
131011670|NCT00542386|471670972|FG002|Overall Study|Other Reasons|4|||
131011671|NCT00542386|471670973|FG003|Overall Study|Other Reasons|3|||
131011672|NCT00542386|471670974|FG004|Overall Study|Other Reasons|4|||
131011673|NCT00542386|471670975|FG005|Overall Study|Other Reasons|2|||
131011674|NCT00197015|471670976|FG000|Overall Study|Adverse Event|3|||
131011675|NCT00197015|471670977|FG001|Overall Study|Adverse Event|0|||
131011676|NCT00197015|471670978|FG002|Overall Study|Adverse Event|1|||
131011677|NCT00197015|471670976|FG000|Overall Study|Protocol Violation|0|||
131011678|NCT00197015|471670977|FG001|Overall Study|Protocol Violation|3|||
131011679|NCT00197015|471670978|FG002|Overall Study|Protocol Violation|3|||
131011680|NCT00197015|471670976|FG000|Overall Study|Withdrawal by Subject|17|||
131011681|NCT00197015|471670977|FG001|Overall Study|Withdrawal by Subject|37|||
131011682|NCT00197015|471670978|FG002|Overall Study|Withdrawal by Subject|34|||
131011683|NCT00197015|471670976|FG000|Overall Study|Lost to Follow-up|28|||
131011684|NCT00197015|471670977|FG001|Overall Study|Lost to Follow-up|46|||
131011685|NCT00197015|471670978|FG002|Overall Study|Lost to Follow-up|37|||
131011686|NCT00197015|471670976|FG000|Overall Study|Other|2|||
131011687|NCT00197015|471670977|FG001|Overall Study|Other|3|||
131011688|NCT00197015|471670978|FG002|Overall Study|Other|2|||
131011689|NCT00544440|471670981|FG000|Overall Study|Other|1|||
131011690|NCT00544440|471670981|FG000|Overall Study|Adverse Event|1|||
131011691|NCT00544440|471670981|FG000|Overall Study|Withdrawal by Subject|2|||
131011692|NCT00544440|471670981|FG000|Overall Study|Subject Non-compliance|1|||
131011693|NCT00544440|471670981|FG000|Overall Study|Progressive Disease|47|||
131011694|NCT00544440|471670981|FG000|Overall Study|Other|5|||
131011695|NCT01549652|471670982|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
131011696|NCT01549652|471670983|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
131011697|NCT01549652|471670984|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
131011698|NCT01549652|471670985|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
131011699|NCT01549652|471670982|FG000|Overall Study|Study Drug Titration Failure|5|||
131011700|NCT01549652|471670983|FG001|Overall Study|Study Drug Titration Failure|6|||
131011701|NCT01549652|471670984|FG002|Overall Study|Study Drug Titration Failure|0|||
131011702|NCT01549652|471670985|FG003|Overall Study|Study Drug Titration Failure|0|||
131011703|NCT01549652|471670982|FG000|Overall Study|Withdrawal Effect|0|||
131011704|NCT01549652|471670983|FG001|Overall Study|Withdrawal Effect|2|||
131011705|NCT01549652|471670984|FG002|Overall Study|Withdrawal Effect|0|||
130885377|NCT03467750|471213346|FG001|Overall Study|Protocol Violation|1|||
130885378|NCT03467750|471213345|FG000|Overall Study|Withdrawal by Subject|0|||
131011706|NCT01549652|471670985|FG003|Overall Study|Withdrawal Effect|0|||
131011707|NCT01549652|471670982|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
131011708|NCT01549652|471670983|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
131011709|NCT01549652|471670984|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
131011710|NCT01549652|471670985|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
131011711|NCT01549652|471670982|FG000|Overall Study|Problem with Infusion|1|||
131011712|NCT01549652|471670983|FG001|Overall Study|Problem with Infusion|0|||
131011713|NCT01549652|471670984|FG002|Overall Study|Problem with Infusion|0|||
131011714|NCT01549652|471670985|FG003|Overall Study|Problem with Infusion|0|||
131011715|NCT01549652|471670982|FG000|Overall Study|Titration Non-Compliance|1|||
131011716|NCT01549652|471670983|FG001|Overall Study|Titration Non-Compliance|3|||
131011717|NCT01549652|471670984|FG002|Overall Study|Titration Non-Compliance|4|||
131011718|NCT01549652|471670985|FG003|Overall Study|Titration Non-Compliance|5|||
131011719|NCT01549652|471670982|FG000|Overall Study|Titration Side Effects|0|||
131011720|NCT01549652|471670983|FG001|Overall Study|Titration Side Effects|0|||
131011721|NCT01549652|471670984|FG002|Overall Study|Titration Side Effects|6|||
131011722|NCT01549652|471670985|FG003|Overall Study|Titration Side Effects|3|||
131011723|NCT01549652|471670982|FG000|Overall Study|Withdrawal by Subject|0|||
131011724|NCT01549652|471670983|FG001|Overall Study|Withdrawal by Subject|0|||
131011725|NCT01549652|471670984|FG002|Overall Study|Withdrawal by Subject|5|||
131011726|NCT01549652|471670985|FG003|Overall Study|Withdrawal by Subject|3|||
131011727|NCT01081145|471670991|FG000|Open-Label Phase|Lack of Efficacy|56|||
131011728|NCT01081145|471670992|FG001|Open-Label Phase|Lack of Efficacy|0|||
131011729|NCT01081145|471670991|FG000|Open-Label Phase|Response criteria not met|46|||
131011730|NCT01081145|471670992|FG001|Open-Label Phase|Response criteria not met|0|||
131011731|NCT01081145|471670991|FG000|Open-Label Phase|Adverse Event|42|||
131011732|NCT01081145|471670992|FG001|Open-Label Phase|Adverse Event|0|||
131011733|NCT01081145|471670991|FG000|Open-Label Phase|Withdrawal by Subject|41|||
131011734|NCT01081145|471670992|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131011735|NCT01081145|471670991|FG000|Open-Label Phase|Other|12|||
131011736|NCT01081145|471670992|FG001|Open-Label Phase|Other|0|||
131011737|NCT01081145|471670991|FG000|Open-Label Phase|Lost to Follow-up|11|||
131011738|NCT01081145|471670992|FG001|Open-Label Phase|Lost to Follow-up|0|||
131011739|NCT01081145|471670991|FG000|Open-Label Phase|Protocol Violation|4|||
131011740|NCT01081145|471670992|FG001|Open-Label Phase|Protocol Violation|0|||
131011741|NCT01081145|471670991|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
131011742|NCT01081145|471670992|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
131011743|NCT01081145|471670991|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
131011744|NCT01081145|471670992|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
131011745|NCT01081145|471670991|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
131011746|NCT01081145|471670992|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
131011747|NCT01081145|471670991|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
131011748|NCT01081145|471670992|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
131011749|NCT01081145|471670991|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
131011750|NCT01081145|471670992|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
131011751|NCT01081145|471670991|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
131011752|NCT01081145|471670992|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
131011753|NCT01081145|471670991|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
131011754|NCT01081145|471670992|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
131011755|NCT01582945|471670994|FG000|Overall Study|Intolerable side-effects|1|||
131011756|NCT01582945|471670994|FG000|Overall Study|Scheduling conflicts|1|||
131011757|NCT02197234|471670995|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
131011758|NCT02197234|471670995|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
131011759|NCT02197234|471670995|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
131011760|NCT02197234|471670995|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
131011761|NCT02197234|471670995|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
131011762|NCT02197234|471670995|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
131011763|NCT01543685|471670996|FG000|Overall Study|Lack of Efficacy|1|||
131011764|NCT01543685|471670997|FG001|Overall Study|Lack of Efficacy|2|||
131011765|NCT01543685|471670998|FG002|Overall Study|Lack of Efficacy|2|||
131011766|NCT01543685|471670999|FG003|Overall Study|Lack of Efficacy|0|||
131011767|NCT01543685|471671000|FG004|Overall Study|Lack of Efficacy|2|||
131011768|NCT01543685|471670996|FG000|Overall Study|Adverse Event|2|||
131011769|NCT01543685|471670997|FG001|Overall Study|Adverse Event|1|||
131011770|NCT01543685|471670998|FG002|Overall Study|Adverse Event|0|||
131011771|NCT01543685|471670999|FG003|Overall Study|Adverse Event|0|||
131011772|NCT01543685|471671000|FG004|Overall Study|Adverse Event|2|||
131011773|NCT02163915|471671001|FG000|Overall Study|Withdrawal by Subject|2|||
131011774|NCT02163915|471671002|FG001|Overall Study|Withdrawal by Subject|0|||
131011775|NCT02163915|471671003|FG002|Overall Study|Withdrawal by Subject|2|||
131011776|NCT02163915|471671004|FG003|Overall Study|Withdrawal by Subject|2|||
131011777|NCT02163915|471671005|FG004|Overall Study|Withdrawal by Subject|2|||
131011778|NCT02163915|471671001|FG000|Overall Study|Study termination|1|||
131011779|NCT02163915|471671002|FG001|Overall Study|Study termination|0|||
131011780|NCT02163915|471671003|FG002|Overall Study|Study termination|0|||
131011781|NCT02163915|471671004|FG003|Overall Study|Study termination|0|||
131011782|NCT02163915|471671005|FG004|Overall Study|Study termination|2|||
131011783|NCT02163915|471671001|FG000|Overall Study|Physician Decision|0|||
131011784|NCT02163915|471671002|FG001|Overall Study|Physician Decision|0|||
131011785|NCT02163915|471671003|FG002|Overall Study|Physician Decision|0|||
131011786|NCT02163915|471671004|FG003|Overall Study|Physician Decision|1|||
131011787|NCT02163915|471671005|FG004|Overall Study|Physician Decision|0|||
131011788|NCT02931396|471671006|FG000|Overall Study|Lost to Follow-up|3|||
131011789|NCT02931396|471671007|FG001|Overall Study|Lost to Follow-up|0|||
131011790|NCT02931396|471671006|FG000|Overall Study|Withdrawal by Subject|2|||
131011791|NCT02931396|471671007|FG001|Overall Study|Withdrawal by Subject|0|||
131011792|NCT01838200|471671012|FG000|Overall Study|Adverse Event|0|||
131011793|NCT01838200|471671013|FG001|Overall Study|Adverse Event|2|||
131011794|NCT01838200|471671012|FG000|Overall Study|Progressive disease|3|||
131011795|NCT01838200|471671013|FG001|Overall Study|Progressive disease|0|||
131011796|NCT03895034|471672529|FG000|Overall Study|Lost to Follow-up|2|||
131011797|NCT01118377|471672530|FG000|Overall Study|Did Not Receive Study Medication|1|||
131011798|NCT01118377|471672530|FG000|Overall Study|Death|38|||
131011799|NCT01118377|471672530|FG000|Overall Study|Failure to Return|3|||
131011800|NCT03784963|471672531|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
130885379|NCT03467750|471213346|FG001|Overall Study|Withdrawal by Subject|1|||
131011801|NCT03784963|471672532|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
131011802|NCT03784963|471672533|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
131011803|NCT03784963|471672534|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
130885380|NCT04721977|471213349|FG000|Overall Study|Death|15|||
131011804|NCT03181958|471672535|FG000|Overall Study|Lost to Follow-up|17|||
131011805|NCT03181958|471672536|FG001|Overall Study|Lost to Follow-up|21|||
131011806|NCT03181958|471672537|FG002|Overall Study|Lost to Follow-up|15|||
131011807|NCT01257503|471672538|FG000|Overall Study|Lost to Follow-up|7|||
131222563|NCT01625286|472441528|FG004|Overall Study|Lost to Follow-up|0|||
130885381|NCT04721977|471213349|FG000|Overall Study|Ongoing|51|||
131011808|NCT01257503|471672539|FG001|Overall Study|Lost to Follow-up|10|||
131011809|NCT01257503|471672538|FG000|Overall Study|Over 5 years old at enrollment|0|||
131011810|NCT01257503|471672539|FG001|Overall Study|Over 5 years old at enrollment|1|||
131011811|NCT01257503|471672538|FG000|Overall Study|strep culture positive at enrollment|1|||
131011812|NCT01257503|471672539|FG001|Overall Study|strep culture positive at enrollment|0|||
131011813|NCT00470626|471672540|FG000|Overall Study|Lost to Follow-up|10|||
131011814|NCT00470626|471672540|FG000|Overall Study|Withdrawal by Subject|7|||
131011815|NCT01729819|471672547|FG000|Overall Study|Adverse Event|2|||
131011816|NCT01729819|471672548|FG001|Overall Study|Adverse Event|4|||
131011817|NCT01729819|471672547|FG000|Overall Study|Lack of Efficacy|1|||
131011818|NCT01729819|471672548|FG001|Overall Study|Lack of Efficacy|0|||
131011819|NCT01729819|471672547|FG000|Overall Study|Lost to Follow-up|2|||
131011820|NCT01729819|471672548|FG001|Overall Study|Lost to Follow-up|0|||
131011821|NCT01729819|471672547|FG000|Overall Study|Other reason|1|||
131011822|NCT01729819|471672548|FG001|Overall Study|Other reason|0|||
131011823|NCT01729819|471672547|FG000|Overall Study|Protocol Violation|0|||
131011824|NCT01729819|471672548|FG001|Overall Study|Protocol Violation|1|||
131011825|NCT01729819|471672547|FG000|Overall Study|Withdrawal by Subject|0|||
131011826|NCT01729819|471672548|FG001|Overall Study|Withdrawal by Subject|2|||
131011827|NCT02987543|471672549|FG000|Overall Study|Ongoing study at data cut off|49|||
131011828|NCT02987543|471672550|FG001|Overall Study|Ongoing study at data cut off|21|||
131011829|NCT02987543|471672551|FG002|Overall Study|Ongoing study at data cut off|19|||
131011830|NCT02987543|471672552|FG003|Overall Study|Ongoing study at data cut off|12|||
131011831|NCT02987543|471672549|FG000|Overall Study|Death|88|||
131011832|NCT02987543|471672550|FG001|Overall Study|Death|54|||
131011833|NCT02987543|471672551|FG002|Overall Study|Death|67|||
131011834|NCT02987543|471672552|FG003|Overall Study|Death|28|||
131011835|NCT02987543|471672549|FG000|Overall Study|Lost to Follow-up|3|||
131011836|NCT02987543|471672550|FG001|Overall Study|Lost to Follow-up|0|||
131011837|NCT02987543|471672551|FG002|Overall Study|Lost to Follow-up|1|||
131011838|NCT02987543|471672552|FG003|Overall Study|Lost to Follow-up|0|||
131011839|NCT02987543|471672549|FG000|Overall Study|Screen failure|0|||
131011840|NCT02987543|471672550|FG001|Overall Study|Screen failure|0|||
131011841|NCT02987543|471672551|FG002|Overall Study|Screen failure|0|||
131011842|NCT02987543|471672552|FG003|Overall Study|Screen failure|1|||
131011843|NCT02987543|471672549|FG000|Overall Study|Withdrawal by Subject|21|||
131011844|NCT02987543|471672550|FG001|Overall Study|Withdrawal by Subject|7|||
131011845|NCT02987543|471672551|FG002|Overall Study|Withdrawal by Subject|7|||
131011846|NCT02987543|471672552|FG003|Overall Study|Withdrawal by Subject|6|||
131011847|NCT02987543|471672549|FG000|Overall Study|Study terminated by sponsor|1|||
131011848|NCT02987543|471672550|FG001|Overall Study|Study terminated by sponsor|0|||
131011849|NCT02987543|471672551|FG002|Overall Study|Study terminated by sponsor|0|||
131011850|NCT02987543|471672552|FG003|Overall Study|Study terminated by sponsor|0|||
131011851|NCT02987543|471672549|FG000|Overall Study|Investigator decision|0|||
131011852|NCT02987543|471672550|FG001|Overall Study|Investigator decision|1|||
131011853|NCT02987543|471672551|FG002|Overall Study|Investigator decision|0|||
131011854|NCT02987543|471672552|FG003|Overall Study|Investigator decision|0|||
131011855|NCT02987543|471672549|FG000|Overall Study|Disease progression|0|||
131011856|NCT02987543|471672550|FG001|Overall Study|Disease progression|0|||
131011857|NCT02987543|471672551|FG002|Overall Study|Disease progression|0|||
131011858|NCT02987543|471672552|FG003|Overall Study|Disease progression|1|||
131011859|NCT01883492|471672555|FG000|Overall Study|Lost to Follow-up|3|||
131011860|NCT01883492|471672556|FG001|Overall Study|Lost to Follow-up|4|||
131011861|NCT01883492|471672555|FG000|Overall Study|Surgery on contra-lateral hip|0|||
131011862|NCT01883492|471672556|FG001|Overall Study|Surgery on contra-lateral hip|1|||
131011863|NCT01883492|471672555|FG000|Overall Study|Poor X-ray quality|7|||
131011864|NCT01883492|471672556|FG001|Overall Study|Poor X-ray quality|4|||
131011865|NCT01883492|471672555|FG000|Overall Study|Withdrawal by Subject|1|||
131011866|NCT01883492|471672556|FG001|Overall Study|Withdrawal by Subject|0|||
131011867|NCT01883492|471672555|FG000|Overall Study|inappropriate implant used|1|||
131011868|NCT01883492|471672556|FG001|Overall Study|inappropriate implant used|1|||
131011869|NCT01883492|471672555|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
131011870|NCT01883492|471672556|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
131011871|NCT01259102|471672557|FG000|Overall Study|Adverse Event|1|||
131011872|NCT01259102|471672558|FG001|Overall Study|Adverse Event|0|||
131011873|NCT01259102|471672559|FG002|Overall Study|Adverse Event|1|||
131011874|NCT01259102|471672560|FG003|Overall Study|Adverse Event|1|||
131011875|NCT01259102|471672561|FG004|Overall Study|Adverse Event|0|||
131011876|NCT01259102|471672557|FG000|Overall Study|Other|0|||
131011877|NCT01259102|471672558|FG001|Overall Study|Other|0|||
131011878|NCT01259102|471672559|FG002|Overall Study|Other|1|||
131011879|NCT01259102|471672560|FG003|Overall Study|Other|1|||
131011880|NCT01259102|471672561|FG004|Overall Study|Other|1|||
131011881|NCT01803646|471672564|FG000|Overall Study|Protocol Violation|1|||
131011882|NCT01803646|471672565|FG001|Overall Study|Protocol Violation|0|||
131011883|NCT01803646|471672564|FG000|Overall Study|Adverse Event|1|||
131011884|NCT01803646|471672565|FG001|Overall Study|Adverse Event|1|||
131011885|NCT01803646|471672564|FG000|Overall Study|Withdrawal by Subject|9|||
131011886|NCT01803646|471672565|FG001|Overall Study|Withdrawal by Subject|6|||
131011887|NCT01803646|471672564|FG000|Overall Study|Randomization error|1|||
131011888|NCT01803646|471672565|FG001|Overall Study|Randomization error|2|||
131011889|NCT01803646|471672564|FG000|Overall Study|Lost to Follow-up|5|||
131011890|NCT01803646|471672565|FG001|Overall Study|Lost to Follow-up|1|||
131011891|NCT01876511|471672567|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
131011892|NCT01876511|471672568|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
131011893|NCT01876511|471672569|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
131011894|NCT01876511|471672567|FG000|Overall Study|Death (unrelated)|3|||
131011895|NCT01876511|471672568|FG001|Overall Study|Death (unrelated)|0|||
131011896|NCT01876511|471672569|FG002|Overall Study|Death (unrelated)|2|||
131011897|NCT01876511|471672567|FG000|Overall Study|Drug-related Toxicity|5|||
131011898|NCT01876511|471672568|FG001|Overall Study|Drug-related Toxicity|1|||
131011899|NCT01876511|471672569|FG002|Overall Study|Drug-related Toxicity|6|||
131011900|NCT01876511|471672567|FG000|Overall Study|Patient Decision|3|||
131011901|NCT01876511|471672568|FG001|Overall Study|Patient Decision|0|||
131011902|NCT01876511|471672569|FG002|Overall Study|Patient Decision|6|||
131011903|NCT01876511|471672567|FG000|Overall Study|Physician Decision|1|||
131011904|NCT01876511|471672568|FG001|Overall Study|Physician Decision|0|||
131011905|NCT01876511|471672569|FG002|Overall Study|Physician Decision|1|||
131011906|NCT01064817|471672571|FG000|Study Completion|Physician Decision|1|||
131011907|NCT01064817|471672572|FG001|Study Completion|Physician Decision|0|||
131011908|NCT01064817|471672571|FG000|Study Completion|Withdrawal by Subject|1|||
131011909|NCT01064817|471672572|FG001|Study Completion|Withdrawal by Subject|0|||
131011910|NCT00464672|471672573|FG000|Overall Study|withdrawal of consent|0|||
131011911|NCT00464672|471672574|FG001|Overall Study|withdrawal of consent|0|||
131011912|NCT00464672|471672575|FG002|Overall Study|withdrawal of consent|0|||
131011913|NCT00464672|471672576|FG003|Overall Study|withdrawal of consent|1|||
131011914|NCT00464672|471672577|FG004|Overall Study|withdrawal of consent|9|||
131011915|NCT00464672|471672578|FG005|Overall Study|withdrawal of consent|4|||
131011916|NCT00464672|471672573|FG000|Overall Study|Lost to Follow-up|25|||
131011917|NCT00464672|471672574|FG001|Overall Study|Lost to Follow-up|10|||
131011918|NCT00464672|471672575|FG002|Overall Study|Lost to Follow-up|0|||
131011919|NCT00464672|471672576|FG003|Overall Study|Lost to Follow-up|0|||
131011920|NCT00464672|471672577|FG004|Overall Study|Lost to Follow-up|1|||
131011921|NCT00464672|471672578|FG005|Overall Study|Lost to Follow-up|0|||
131011922|NCT02299635|471672579|FG000|Overall Study|Adverse Event|2|||
131011923|NCT02299635|471672579|FG000|Overall Study|Death|1|||
131011924|NCT02299635|471672579|FG000|Overall Study|Global deterioration of health status|1|||
131011925|NCT02299635|471672579|FG000|Overall Study|Objective progression or relapse|10|||
131011926|NCT02299635|471672579|FG000|Overall Study|Withdrawal by Subject|2|||
131011927|NCT02299635|471672579|FG000|Overall Study|Other|3|||
131011928|NCT00828672|471672580|FG000|Study Treatment|Lost to Follow-up|1|||
131011929|NCT00828672|471672581|FG001|Study Treatment|Lost to Follow-up|0|||
131011930|NCT00828672|471672580|FG000|Study Treatment|Adverse Event|0|||
131011931|NCT00828672|471672581|FG001|Study Treatment|Adverse Event|1|||
131011932|NCT00828672|471672580|FG000|Study Treatment|Complete response, no surgery|1|||
131011933|NCT00828672|471672581|FG001|Study Treatment|Complete response, no surgery|1|||
131011934|NCT00828672|471672580|FG000|Post-surgery (<30 Days)|No central review materials|0|||
131011935|NCT00828672|471672581|FG001|Post-surgery (<30 Days)|No central review materials|1|||
131011936|NCT01456936|471672592|FG000|Overall Study|Other reason|41|||
131011937|NCT01456936|471672593|FG001|Overall Study|Other reason|30|||
131011938|NCT01456936|471672594|FG002|Overall Study|Other reason|36|||
131011939|NCT01456936|471672595|FG003|Overall Study|Other reason|33|||
131222564|NCT01625286|472441529|FG005|Overall Study|Lost to Follow-up|0|||
131011940|NCT01456936|471672592|FG000|Overall Study|No longer meets eligibility criteria|4|||
131011941|NCT01456936|471672593|FG001|Overall Study|No longer meets eligibility criteria|8|||
131011942|NCT01456936|471672594|FG002|Overall Study|No longer meets eligibility criteria|6|||
131011943|NCT01456936|471672595|FG003|Overall Study|No longer meets eligibility criteria|5|||
131011944|NCT01456936|471672592|FG000|Overall Study|Protocol Violation|4|||
131011945|NCT01456936|471672593|FG001|Overall Study|Protocol Violation|2|||
131011946|NCT01456936|471672594|FG002|Overall Study|Protocol Violation|5|||
131011947|NCT01456936|471672595|FG003|Overall Study|Protocol Violation|5|||
131011948|NCT01456936|471672592|FG000|Overall Study|Pregnancy|1|||
131011949|NCT01456936|471672593|FG001|Overall Study|Pregnancy|0|||
131011950|NCT01456936|471672594|FG002|Overall Study|Pregnancy|0|||
131011951|NCT01456936|471672595|FG003|Overall Study|Pregnancy|1|||
131011952|NCT01456936|471672592|FG000|Overall Study|Insufficient clinical response|4|||
131011953|NCT01456936|471672593|FG001|Overall Study|Insufficient clinical response|4|||
131011954|NCT01456936|471672594|FG002|Overall Study|Insufficient clinical response|14|||
131011955|NCT01456936|471672595|FG003|Overall Study|Insufficient clinical response|13|||
131011956|NCT01456936|471672592|FG000|Overall Study|No longer willing to participate|195|||
131011957|NCT01456936|471672593|FG001|Overall Study|No longer willing to participate|218|||
131011958|NCT01456936|471672594|FG002|Overall Study|No longer willing to participate|224|||
131011959|NCT01456936|471672595|FG003|Overall Study|No longer willing to participate|248|||
131011960|NCT01456936|471672592|FG000|Overall Study|Lost to Follow-up|135|||
131011961|NCT01456936|471672593|FG001|Overall Study|Lost to Follow-up|126|||
131011962|NCT01456936|471672594|FG002|Overall Study|Lost to Follow-up|144|||
131011963|NCT01456936|471672595|FG003|Overall Study|Lost to Follow-up|127|||
131011964|NCT01456936|471672592|FG000|Overall Study|Medication error|0|||
131011965|NCT01456936|471672593|FG001|Overall Study|Medication error|1|||
131011966|NCT01456936|471672594|FG002|Overall Study|Medication error|0|||
131011967|NCT01456936|471672595|FG003|Overall Study|Medication error|1|||
131011968|NCT01456936|471672592|FG000|Overall Study|Adverse event (study drug)|25|||
131011969|NCT01456936|471672593|FG001|Overall Study|Adverse event (study drug)|21|||
131011970|NCT01456936|471672594|FG002|Overall Study|Adverse event (study drug)|26|||
131011971|NCT01456936|471672595|FG003|Overall Study|Adverse event (study drug)|17|||
131011972|NCT01456936|471672592|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
131011973|NCT01456936|471672593|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
131011974|NCT01456936|471672594|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
131011975|NCT01456936|471672595|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
131011976|NCT01456936|471672592|FG000|Overall Study|Death|0|||
131011977|NCT01456936|471672593|FG001|Overall Study|Death|3|||
131011978|NCT01456936|471672594|FG002|Overall Study|Death|1|||
131011979|NCT01456936|471672595|FG003|Overall Study|Death|3|||
131011980|NCT01456936|471672592|FG000|Overall Study|Randomized but not treated|21|||
131011981|NCT01456936|471672593|FG001|Overall Study|Randomized but not treated|28|||
131011982|NCT01456936|471672594|FG002|Overall Study|Randomized but not treated|16|||
131011983|NCT01456936|471672595|FG003|Overall Study|Randomized but not treated|21|||
131011984|NCT01250002|471672596|FG000|Overall Study|Change to open surgical procedure|4|||
131011985|NCT01250002|471672597|FG001|Overall Study|Change to open surgical procedure|3|||
131011986|NCT01710514|471672598|FG000|Overall Study|Adverse Event|6|||
131011987|NCT01710514|471672599|FG001|Overall Study|Adverse Event|7|||
131011988|NCT01710514|471672598|FG000|Overall Study|Withdrawal by Subject|1|||
131011989|NCT01710514|471672599|FG001|Overall Study|Withdrawal by Subject|0|||
131011990|NCT00001575|471672607|FG000|Overall Study|Screening failures-Ph I portion|22|||
131011991|NCT00001575|471672607|FG000|Overall Study|Withdrawn/deaths|23|||
131011992|NCT02982213|471672615|FG000|Overall Study|Did not complete follow up questionnaire|5|||
131011993|NCT02982213|471672616|FG001|Overall Study|Did not complete follow up questionnaire|1|||
131011994|NCT01972152|471672617|FG000|First Treatment Visit|Lost to Follow-up|0|||
131011995|NCT01972152|471672618|FG001|First Treatment Visit|Lost to Follow-up|1|||
131011996|NCT01972152|471672619|FG002|First Treatment Visit|Lost to Follow-up|0|||
131011997|NCT01972152|471672620|FG003|First Treatment Visit|Lost to Follow-up|0|||
131011998|NCT01972152|471672621|FG004|First Treatment Visit|Lost to Follow-up|0|||
131011999|NCT01972152|471672622|FG005|First Treatment Visit|Lost to Follow-up|0|||
131012000|NCT01972152|471672617|FG000|Second Treatment Visit|Protocol Violation|0|||
131012001|NCT01972152|471672618|FG001|Second Treatment Visit|Protocol Violation|1|||
131012002|NCT01972152|471672619|FG002|Second Treatment Visit|Protocol Violation|0|||
131012003|NCT01972152|471672620|FG003|Second Treatment Visit|Protocol Violation|0|||
131012004|NCT01972152|471672621|FG004|Second Treatment Visit|Protocol Violation|0|||
131012005|NCT01972152|471672622|FG005|Second Treatment Visit|Protocol Violation|0|||
131012006|NCT00988637|471672630|FG000|Overall Study|Lost to Follow-up|2|||
131012007|NCT00988637|471672631|FG001|Overall Study|Lost to Follow-up|1|||
131012008|NCT00988637|471672630|FG000|Overall Study|Withdrawal by Subject|1|||
131012009|NCT00988637|471672631|FG001|Overall Study|Withdrawal by Subject|1|||
131012010|NCT00988637|471672630|FG000|Overall Study|non-compliance with study drug|0|||
131012011|NCT00988637|471672631|FG001|Overall Study|non-compliance with study drug|1|||
131012012|NCT03593070|471672632|FG000|Overall Study|administrative withdrawal|1|||
131012013|NCT03593070|471672633|FG001|Overall Study|administrative withdrawal|1|||
131012014|NCT04536077|471672634|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
131012015|NCT04536077|471672635|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
131222565|NCT01625286|472441530|FG006|Overall Study|Lost to Follow-up|1|||
131012016|NCT04536077|471672634|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
131222566|NCT00828516|472441531|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
131012017|NCT04536077|471672635|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
131012018|NCT01656304|471672641|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
131012019|NCT01155869|471672642|FG000|Overall Study|Lost to Follow-up|3|||
131012020|NCT01155869|471672643|FG001|Overall Study|Lost to Follow-up|1|||
131012021|NCT02824432|471672644|FG000|Overall Study|Major Protocol Deviation|1|||
131012022|NCT02824432|471672645|FG001|Overall Study|Major Protocol Deviation|0|||
131012023|NCT05826431|471672647|FG000|Overall Study|Withdrawal by Subject|1|||
131012024|NCT04771273|471672650|FG000|Dose Escalation Period|Not treated with trial medication|0|||
131012025|NCT04771273|471672651|FG001|Dose Escalation Period|Not treated with trial medication|1|||
131012026|NCT04771273|471672652|FG002|Dose Escalation Period|Not treated with trial medication|1|||
131012027|NCT04771273|471672653|FG003|Dose Escalation Period|Not treated with trial medication|0|||
131012028|NCT04771273|471672650|FG000|Dose Escalation Period|Other reasons than listed|2|||
131012029|NCT04771273|471672651|FG001|Dose Escalation Period|Other reasons than listed|0|||
131012030|NCT04771273|471672652|FG002|Dose Escalation Period|Other reasons than listed|2|||
131012031|NCT04771273|471672653|FG003|Dose Escalation Period|Other reasons than listed|1|||
131012032|NCT04771273|471672650|FG000|Dose Escalation Period|Protocol Violation|0|||
131012033|NCT04771273|471672651|FG001|Dose Escalation Period|Protocol Violation|0|||
131012034|NCT04771273|471672652|FG002|Dose Escalation Period|Protocol Violation|3|||
131012035|NCT04771273|471672653|FG003|Dose Escalation Period|Protocol Violation|1|||
131012036|NCT04771273|471672650|FG000|Dose Escalation Period|Burden of study procedures|1|||
131012037|NCT04771273|471672651|FG001|Dose Escalation Period|Burden of study procedures|0|||
131012038|NCT04771273|471672652|FG002|Dose Escalation Period|Burden of study procedures|0|||
131012039|NCT04771273|471672653|FG003|Dose Escalation Period|Burden of study procedures|0|||
131012040|NCT04771273|471672650|FG000|Dose Escalation Period|Change of residence|0|||
131012041|NCT04771273|471672651|FG001|Dose Escalation Period|Change of residence|0|||
130885382|NCT04145349|471215173|FG000|Overall Study|Withdrawal by Subject|3|||
131012042|NCT04771273|471672652|FG002|Dose Escalation Period|Change of residence|0|||
131012043|NCT04771273|471672653|FG003|Dose Escalation Period|Change of residence|1|||
131012044|NCT04771273|471672650|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
131012045|NCT04771273|471672651|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
131012046|NCT04771273|471672652|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
131012047|NCT04771273|471672653|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
131012048|NCT04771273|471672650|FG000|Dose Escalation Period|Adverse Event|8|||
131012049|NCT04771273|471672651|FG001|Dose Escalation Period|Adverse Event|9|||
131012050|NCT04771273|471672652|FG002|Dose Escalation Period|Adverse Event|12|||
131012051|NCT04771273|471672653|FG003|Dose Escalation Period|Adverse Event|2|||
131012052|NCT04771273|471672650|FG000|Maintenance Period|Other than listed|4|||
131012053|NCT04771273|471672651|FG001|Maintenance Period|Other than listed|2|||
131012054|NCT04771273|471672652|FG002|Maintenance Period|Other than listed|0|||
131012055|NCT04771273|471672653|FG003|Maintenance Period|Other than listed|3|||
131012056|NCT04771273|471672650|FG000|Maintenance Period|Burden of study procedures|1|||
131012057|NCT04771273|471672651|FG001|Maintenance Period|Burden of study procedures|0|||
131012058|NCT04771273|471672652|FG002|Maintenance Period|Burden of study procedures|0|||
131012059|NCT04771273|471672653|FG003|Maintenance Period|Burden of study procedures|0|||
131012060|NCT04771273|471672650|FG000|Maintenance Period|Change of residence|0|||
131012061|NCT04771273|471672651|FG001|Maintenance Period|Change of residence|1|||
131012062|NCT04771273|471672652|FG002|Maintenance Period|Change of residence|3|||
131012063|NCT04771273|471672653|FG003|Maintenance Period|Change of residence|0|||
131012064|NCT04771273|471672650|FG000|Maintenance Period|Perceived lack of efficacy|0|||
131012065|NCT04771273|471672651|FG001|Maintenance Period|Perceived lack of efficacy|0|||
131012066|NCT04771273|471672652|FG002|Maintenance Period|Perceived lack of efficacy|0|||
131012067|NCT04771273|471672653|FG003|Maintenance Period|Perceived lack of efficacy|1|||
131012068|NCT04771273|471672650|FG000|Maintenance Period|Adverse Event|4|||
131012069|NCT04771273|471672651|FG001|Maintenance Period|Adverse Event|5|||
131012070|NCT04771273|471672652|FG002|Maintenance Period|Adverse Event|5|||
131012071|NCT04771273|471672653|FG003|Maintenance Period|Adverse Event|0|||
131012072|NCT02698241|471672657|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
131012073|NCT02698241|471672657|FG000|Overall Study|Screening not met|7|||
131012074|NCT02698241|471672657|FG000|Overall Study|Withdrawal by Subject|7|||
131012075|NCT02698241|471672657|FG000|Overall Study|Physician Decision|2|||
131012076|NCT02698241|471672657|FG000|Overall Study|Subject underwent system modification|2|||
131012077|NCT02698241|471672657|FG000|Overall Study|Lost to Follow-up|3|||
131012078|NCT02698241|471672657|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
131012079|NCT02698241|471672657|FG000|Overall Study|geographic and licensing issue|1|||
131012080|NCT02698241|471672657|FG000|Overall Study|Death|2|||
131012081|NCT00906282|471672660|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
131012082|NCT00906282|471672660|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
131012083|NCT00906282|471672660|FG000|Preoperative Chemotherapy|Progressive disease|6|||
131012084|NCT00906282|471672660|FG000|Preoperative Chemotherapy|Toxicity|1|||
131012085|NCT02540213|471672661|FG000|Overall Study|Death/adverse event|18|||
131012086|NCT02540213|471672661|FG000|Overall Study|Administrative reasons|3|||
131012087|NCT02540213|471672661|FG000|Overall Study|Kidney transplant|3|||
131222567|NCT03591107|472443111|FG000|Overall Study|Same patient in both arms|1|||
131012088|NCT02540213|471672661|FG000|Overall Study|Lack of Efficacy|6|||
131012089|NCT02540213|471672661|FG000|Overall Study|Consent withdrawn|7|||
131012090|NCT02540213|471672661|FG000|Overall Study|Enrolled but not treated|2|||
131012091|NCT00290706|471672668|FG000|Overall Study|Withdrawal by Subject|2|||
131012092|NCT00290706|471672669|FG001|Overall Study|Withdrawal by Subject|0|||
131012093|NCT00290706|471672670|FG002|Overall Study|Withdrawal by Subject|0|||
131012094|NCT00290706|471672671|FG003|Overall Study|Withdrawal by Subject|0|||
131012095|NCT00290706|471672668|FG000|Overall Study|Progressive Disease|3|||
131012096|NCT00290706|471672669|FG001|Overall Study|Progressive Disease|5|||
131012097|NCT00290706|471672670|FG002|Overall Study|Progressive Disease|4|||
131012098|NCT00290706|471672671|FG003|Overall Study|Progressive Disease|10|||
131012099|NCT00290706|471672668|FG000|Overall Study|Adverse Event|0|||
131012100|NCT00290706|471672669|FG001|Overall Study|Adverse Event|1|||
131012101|NCT00290706|471672670|FG002|Overall Study|Adverse Event|2|||
131012102|NCT00290706|471672671|FG003|Overall Study|Adverse Event|0|||
131012103|NCT00290706|471672668|FG000|Overall Study|Receive auto transplant or radiation|0|||
131012104|NCT00290706|471672669|FG001|Overall Study|Receive auto transplant or radiation|0|||
131012105|NCT00290706|471672670|FG002|Overall Study|Receive auto transplant or radiation|0|||
131012106|NCT00290706|471672671|FG003|Overall Study|Receive auto transplant or radiation|1|||
131012107|NCT00290706|471672668|FG000|Overall Study|Physician Decision|0|||
131012108|NCT00290706|471672669|FG001|Overall Study|Physician Decision|0|||
131012109|NCT00290706|471672670|FG002|Overall Study|Physician Decision|0|||
131012110|NCT00290706|471672671|FG003|Overall Study|Physician Decision|1|||
131012111|NCT02952261|471672674|FG000|Overall Study|Withdrawal by Subject|4|||
131012112|NCT02952261|471672675|FG001|Overall Study|Withdrawal by Subject|5|||
131012113|NCT02952261|471672674|FG000|Overall Study|Protocol Violation|1|||
131012114|NCT02952261|471672675|FG001|Overall Study|Protocol Violation|0|||
131012115|NCT00603447|471672676|FG000|Overall Study|Adverse Event|0|||
131012116|NCT00603447|471672677|FG001|Overall Study|Adverse Event|1|||
131012117|NCT00603447|471672678|FG002|Overall Study|Adverse Event|1|||
131012118|NCT00603447|471672679|FG003|Overall Study|Adverse Event|2|||
131012119|NCT00603447|471672680|FG004|Overall Study|Adverse Event|1|||
131012120|NCT00603447|471672681|FG005|Overall Study|Adverse Event|2|||
131012121|NCT00603447|471672682|FG006|Overall Study|Adverse Event|10|||
131012122|NCT00603447|471672676|FG000|Overall Study|Other|0|||
131012123|NCT00603447|471672677|FG001|Overall Study|Other|0|||
131012124|NCT00603447|471672678|FG002|Overall Study|Other|1|||
131012125|NCT00603447|471672679|FG003|Overall Study|Other|0|||
131012126|NCT00603447|471672680|FG004|Overall Study|Other|3|||
131012127|NCT00603447|471672681|FG005|Overall Study|Other|0|||
131012128|NCT00603447|471672682|FG006|Overall Study|Other|13|||
131012129|NCT00603447|471672676|FG000|Overall Study|Withdrew Consent|0|||
131012130|NCT00603447|471672677|FG001|Overall Study|Withdrew Consent|2|||
131012131|NCT00603447|471672678|FG002|Overall Study|Withdrew Consent|0|||
131012132|NCT00603447|471672679|FG003|Overall Study|Withdrew Consent|0|||
131012133|NCT00603447|471672680|FG004|Overall Study|Withdrew Consent|1|||
131012134|NCT00603447|471672681|FG005|Overall Study|Withdrew Consent|0|||
131012135|NCT00603447|471672682|FG006|Overall Study|Withdrew Consent|1|||
131012136|NCT05233085|471672683|FG000|Overall Study|Adverse Event|1|||
131012137|NCT05233085|471672684|FG001|Overall Study|Adverse Event|0|||
131012138|NCT05233085|471672685|FG002|Overall Study|Adverse Event|0|||
131012139|NCT05233085|471672686|FG003|Overall Study|Adverse Event|0|||
131012140|NCT00798265|471672687|FG000|Overall Study|Lost to Follow-up|1|||
131012141|NCT00798265|471672688|FG001|Overall Study|Lost to Follow-up|10|||
131012142|NCT00798265|471672687|FG000|Overall Study|Study closing|7|||
131012143|NCT00798265|471672688|FG001|Overall Study|Study closing|6|||
131012144|NCT00798265|471672687|FG000|Overall Study|Withdrawal by Subject|0|||
131012145|NCT00798265|471672688|FG001|Overall Study|Withdrawal by Subject|1|||
131012146|NCT00798265|471672687|FG000|Overall Study|Screen failure|0|||
131012147|NCT00798265|471672688|FG001|Overall Study|Screen failure|1|||
131012148|NCT02738840|471674113|FG000|Overall Study|MRI Scan not Performed|5|||
131012149|NCT02738840|471674113|FG000|Overall Study|Lost to Follow-up|1|||
131012150|NCT02738840|471674113|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
131012151|NCT02738840|471674113|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
131012152|NCT01311648|471674115|FG000|Main Study|Protocol Violation|0|||
131012153|NCT01311648|471674116|FG001|Main Study|Protocol Violation|1|||
131012154|NCT01311648|471674115|FG000|Main Study|Adverse Event|0|||
131012155|NCT01311648|471674116|FG001|Main Study|Adverse Event|1|||
131012156|NCT01311648|471674115|FG000|Main Study|Inhibitor management|0|||
131012157|NCT01311648|471674116|FG001|Main Study|Inhibitor management|17|||
131012158|NCT01311648|471674115|FG000|Main Study|Withdrawal by Subject|0|||
131012159|NCT01311648|471674116|FG001|Main Study|Withdrawal by Subject|2|||
131012160|NCT01311648|471674115|FG000|Extension Study|Physician Decision|0|||
131012161|NCT01311648|471674116|FG001|Extension Study|Physician Decision|1|||
131012162|NCT01311648|471674115|FG000|Extension Study|ITI therapy with marketed product|0|||
131012163|NCT01311648|471674116|FG001|Extension Study|ITI therapy with marketed product|1|||
131012164|NCT01311648|471674115|FG000|Extension Study|Incorrect visit planning|0|||
131012165|NCT01311648|471674116|FG001|Extension Study|Incorrect visit planning|1|||
131012166|NCT01311648|471674115|FG000|Extension Study|Family's decision|0|||
131012167|NCT01311648|471674116|FG001|Extension Study|Family's decision|1|||
131012168|NCT01311648|471674115|FG000|Extension Study|Failure of ITI therapy|0|||
131012169|NCT01311648|471674116|FG001|Extension Study|Failure of ITI therapy|3|||
131012170|NCT01311648|471674115|FG000|Extension Study|Long travel|0|||
131012171|NCT01311648|471674116|FG001|Extension Study|Long travel|1|||
131012172|NCT01311648|471674115|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
131012173|NCT01311648|471674116|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
131012174|NCT01311648|471674115|FG000|Extension Study|Withdrawal by Subject|0|||
131012175|NCT01311648|471674116|FG001|Extension Study|Withdrawal by Subject|1|||
131012176|NCT01311648|471674115|FG000|Extension Study|Inhibitor management|0|||
131012177|NCT01311648|471674116|FG001|Extension Study|Inhibitor management|2|||
131012178|NCT04057196|471674117|FG000|Overall Study|Withdrawal by Subject|3|||
131012179|NCT04057196|471674117|FG000|Overall Study|Death|3|||
130720923|NCT00724048|470601561|FG000|Overall Study|Withdrawal by Subject|1|||
131012180|NCT02466516|471674119|FG000|Overall Study|Adverse Event|1|||
131012181|NCT02466516|471674120|FG001|Overall Study|Adverse Event|1|||
131012182|NCT02466516|471674121|FG002|Overall Study|Adverse Event|0|||
131012183|NCT02466516|471674122|FG003|Overall Study|Adverse Event|0|||
131012184|NCT02466516|471674123|FG004|Overall Study|Adverse Event|0|||
131012185|NCT02466516|471674119|FG000|Overall Study|Withdrew Consent|1|||
130885383|NCT04145349|471215174|FG001|Overall Study|Withdrawal by Subject|0|||
131012186|NCT02466516|471674120|FG001|Overall Study|Withdrew Consent|0|||
131012187|NCT02466516|471674121|FG002|Overall Study|Withdrew Consent|0|||
131012188|NCT02466516|471674122|FG003|Overall Study|Withdrew Consent|0|||
131012189|NCT02466516|471674123|FG004|Overall Study|Withdrew Consent|0|||
131012190|NCT02466516|471674119|FG000|Overall Study|Lost to Follow-up|2|||
131012191|NCT02466516|471674120|FG001|Overall Study|Lost to Follow-up|0|||
131012192|NCT02466516|471674121|FG002|Overall Study|Lost to Follow-up|1|||
131012193|NCT02466516|471674122|FG003|Overall Study|Lost to Follow-up|0|||
131012194|NCT02466516|471674123|FG004|Overall Study|Lost to Follow-up|0|||
131012195|NCT03712930|471674124|FG000|Overall Study|Death|7|||
131012196|NCT03712930|471674124|FG000|Overall Study|Physician Decision|1|||
131012197|NCT03712930|471674124|FG000|Overall Study|Study Terminated by Sponsor|3|||
131012198|NCT03712930|471674124|FG000|Overall Study|Progressive Disease|2|||
131012199|NCT00739102|471674129|FG000|Overall Study|Death|5|||
131012200|NCT00739102|471674129|FG000|Overall Study|Withdrawal by Subject|10|||
131012201|NCT01331824|471674130|FG000|Overall Study|Adverse Event|2|||
131012202|NCT01331824|471674130|FG000|Overall Study|Death|1|||
131012203|NCT01331824|471674130|FG000|Overall Study|Disease Progression|9|||
131012204|NCT01331824|471674130|FG000|Overall Study|Withdrawal by Subject|1|||
131222568|NCT03591107|472443112|FG001|Overall Study|Same patient in both arms|1|||
131012205|NCT01091454|471674133|FG000|Overall Study|Ineligible|1|||
131012206|NCT03179787|471674134|FG000|Overall Study|Lost to Follow-up|15|||
131012207|NCT03179787|471674134|FG000|Overall Study|Case report failures|2|||
131012208|NCT03179787|471674134|FG000|Overall Study|Treatment not administered|1|||
131012209|NCT01510912|471674135|FG000|Overall Study|Adverse Event|99|||
131012210|NCT01510912|471674135|FG000|Overall Study|Lack of Efficacy|12|||
131012211|NCT01510912|471674135|FG000|Overall Study|Non-compliance with trial drug|23|||
131012212|NCT01510912|471674135|FG000|Overall Study|Withdrawal by Subject|49|||
130885384|NCT04145349|471215173|FG000|Overall Study|Lost to Follow-up|0|||
131222569|NCT03591107|472443111|FG000|Overall Study|Sought care at other clinics|0|||
130720924|NCT00724048|470601562|FG001|Overall Study|Withdrawal by Subject|2|||
131222570|NCT03591107|472443112|FG001|Overall Study|Sought care at other clinics|2|||
131012213|NCT01510912|471674135|FG000|Overall Study|Physician Decision|1|||
131012214|NCT01510912|471674135|FG000|Overall Study|Protocol Violation|27|||
131012215|NCT01510912|471674135|FG000|Overall Study|Lost to Follow-up|26|||
131222571|NCT03591107|472443111|FG000|Overall Study|Discharged from clinic|0|||
131222572|NCT03591107|472443112|FG001|Overall Study|Discharged from clinic|1|||
131012216|NCT01510912|471674135|FG000|Overall Study|Other, including joint replacement|5|||
131012217|NCT02030028|471674136|FG000|Overall Study|Withdrawal by Subject|4|||
131012218|NCT02030028|471674136|FG000|Overall Study|lack of transportation|1|||
131012219|NCT02380742|471674138|FG000|Overall Study|Withdrawal by Subject|1|||
131012220|NCT02380742|471674139|FG001|Overall Study|Withdrawal by Subject|0|||
131012221|NCT02930343|471674141|FG000|Overall Study|Lost to Follow-up|9|||
131012222|NCT02930343|471674142|FG001|Overall Study|Lost to Follow-up|7|||
131012223|NCT01977612|471674151|FG000|Overall Study|Lost to Follow-up|1|||
131012224|NCT01977612|471674152|FG001|Overall Study|Lost to Follow-up|1|||
131012225|NCT01280591|471674153|FG000|Overall Study|Withdrawal by Subject|0|||
131012226|NCT01280591|471674154|FG001|Overall Study|Withdrawal by Subject|0|||
131012227|NCT01280591|471674155|FG002|Overall Study|Withdrawal by Subject|0|||
131012228|NCT01280591|471674156|FG003|Overall Study|Withdrawal by Subject|2|||
131012229|NCT01280591|471674153|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
131012230|NCT01280591|471674154|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
131012231|NCT01280591|471674155|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
131012232|NCT01280591|471674156|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
131012233|NCT03357341|471674161|FG000|Overall Study|Withdrawal by Subject|3|||
131012234|NCT03357341|471674162|FG001|Overall Study|Withdrawal by Subject|6|||
131012235|NCT03357341|471674161|FG000|Overall Study|Lost to Follow-up|4|||
131012236|NCT03357341|471674162|FG001|Overall Study|Lost to Follow-up|5|||
130885385|NCT04145349|471215174|FG001|Overall Study|Lost to Follow-up|1|||
131012237|NCT03357341|471674161|FG000|Overall Study|Death|0|||
131012238|NCT03357341|471674162|FG001|Overall Study|Death|1|||
131012239|NCT00918957|471674163|FG000|Overall Study|Adverse Event|2|||
131012240|NCT00918957|471674164|FG001|Overall Study|Adverse Event|0|||
131012241|NCT00918957|471674163|FG000|Overall Study|Withdrawal by Subject|1|||
131012242|NCT00918957|471674164|FG001|Overall Study|Withdrawal by Subject|0|||
131012243|NCT01048788|471674165|FG000|Overall Study|Adverse Event|5|||
131012244|NCT01048788|471674166|FG001|Overall Study|Adverse Event|1|||
131012245|NCT01048788|471674167|FG002|Overall Study|Adverse Event|1|||
131012246|NCT01048788|471674165|FG000|Overall Study|Lack of Efficacy|0|||
131012247|NCT01048788|471674166|FG001|Overall Study|Lack of Efficacy|0|||
131012248|NCT01048788|471674167|FG002|Overall Study|Lack of Efficacy|1|||
131012249|NCT01048788|471674165|FG000|Overall Study|Withdrawal by Subject|0|||
131012250|NCT01048788|471674166|FG001|Overall Study|Withdrawal by Subject|1|||
131012251|NCT01048788|471674167|FG002|Overall Study|Withdrawal by Subject|0|||
131012252|NCT01131494|471674168|FG000|Overall Study|Withdrawal by Subject|2|||
131012253|NCT01233050|471674171|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
131012254|NCT01233050|471674172|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
131012255|NCT00868192|471674174|FG000|Overall Study|Ineligible|4|||
131012256|NCT01368406|471674175|FG000|Overall Study|Lost to Follow-up|8|||
131012257|NCT01368406|471674176|FG001|Overall Study|Lost to Follow-up|4|||
131012258|NCT01368406|471674175|FG000|Overall Study|Withdrawal by Subject|8|||
131012259|NCT01368406|471674176|FG001|Overall Study|Withdrawal by Subject|4|||
131012260|NCT01368406|471674175|FG000|Overall Study|relapse of the disease|3|||
131012261|NCT01368406|471674176|FG001|Overall Study|relapse of the disease|2|||
131012262|NCT01368406|471674175|FG000|Overall Study|started working|2|||
131012263|NCT01368406|471674176|FG001|Overall Study|started working|3|||
131012264|NCT04304534|471674177|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
131012265|NCT04304534|471674178|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
131012266|NCT04304534|471674179|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
131012267|NCT04304534|471674180|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
131012268|NCT04304534|471674177|FG000|Overall Study|Non-Compliance with study drug|0|||
131012269|NCT04304534|471674178|FG001|Overall Study|Non-Compliance with study drug|1|||
131012270|NCT04304534|471674179|FG002|Overall Study|Non-Compliance with study drug|1|||
131012271|NCT04304534|471674180|FG003|Overall Study|Non-Compliance with study drug|1|||
131012272|NCT04304534|471674177|FG000|Overall Study|Lost to Follow-up|0|||
131012273|NCT04304534|471674178|FG001|Overall Study|Lost to Follow-up|1|||
131012274|NCT04304534|471674179|FG002|Overall Study|Lost to Follow-up|2|||
131012275|NCT04304534|471674180|FG003|Overall Study|Lost to Follow-up|3|||
131012276|NCT04304534|471674177|FG000|Overall Study|Unspecific|4|||
131012277|NCT04304534|471674178|FG001|Overall Study|Unspecific|2|||
131012278|NCT04304534|471674179|FG002|Overall Study|Unspecific|2|||
131012279|NCT04304534|471674180|FG003|Overall Study|Unspecific|2|||
131012280|NCT04304534|471674177|FG000|Overall Study|Technical Problems|2|||
131012281|NCT04304534|471674178|FG001|Overall Study|Technical Problems|2|||
131012282|NCT04304534|471674179|FG002|Overall Study|Technical Problems|3|||
131012283|NCT04304534|471674180|FG003|Overall Study|Technical Problems|4|||
131012284|NCT04304534|471674177|FG000|Overall Study|Death|7|||
131012285|NCT04304534|471674178|FG001|Overall Study|Death|2|||
131012286|NCT04304534|471674179|FG002|Overall Study|Death|4|||
131012287|NCT04304534|471674180|FG003|Overall Study|Death|3|||
131012288|NCT04304534|471674177|FG000|Overall Study|Withdrawal by Subject|7|||
131012289|NCT04304534|471674178|FG001|Overall Study|Withdrawal by Subject|2|||
131012290|NCT04304534|471674179|FG002|Overall Study|Withdrawal by Subject|7|||
131012291|NCT04304534|471674180|FG003|Overall Study|Withdrawal by Subject|4|||
131012292|NCT04304534|471674177|FG000|Overall Study|Physician Decision|4|||
131012293|NCT04304534|471674178|FG001|Overall Study|Physician Decision|9|||
131012294|NCT04304534|471674179|FG002|Overall Study|Physician Decision|9|||
131012295|NCT04304534|471674180|FG003|Overall Study|Physician Decision|5|||
131012296|NCT04304534|471674177|FG000|Overall Study|Subject Decision|34|||
131012297|NCT04304534|471674178|FG001|Overall Study|Subject Decision|25|||
131012298|NCT04304534|471674179|FG002|Overall Study|Subject Decision|25|||
131012299|NCT04304534|471674180|FG003|Overall Study|Subject Decision|26|||
131012300|NCT04304534|471674177|FG000|Overall Study|Adverse Event|35|||
131012301|NCT04304534|471674178|FG001|Overall Study|Adverse Event|40|||
131012302|NCT04304534|471674179|FG002|Overall Study|Adverse Event|39|||
131012303|NCT04304534|471674180|FG003|Overall Study|Adverse Event|44|||
131012304|NCT01466881|471674186|FG000|Overall Study|Ineligible|5|||
131012305|NCT01466881|471674186|FG000|Overall Study|Adverse Event|6|||
131012306|NCT01466881|471674186|FG000|Overall Study|Progression/relapse|20|||
131012307|NCT01466881|471674186|FG000|Overall Study|Death|4|||
131012308|NCT01466881|471674186|FG000|Overall Study|Other reason not protocol specified|5|||
131012309|NCT03670602|471674190|FG000|Overall Study|Lost to Follow-up|1|||
131012310|NCT03670602|471674191|FG001|Overall Study|Lost to Follow-up|0|||
131012311|NCT03670602|471674190|FG000|Overall Study|Withdrawal by Subject|0|||
131012312|NCT03670602|471674191|FG001|Overall Study|Withdrawal by Subject|3|||
131012313|NCT00543725|471674192|FG000|Overall Study|Adverse Event|18|||
131012314|NCT00543725|471674193|FG001|Overall Study|Adverse Event|27|||
131012315|NCT00543725|471674192|FG000|Overall Study|Sponsor's Decision|0|||
131012316|NCT00543725|471674193|FG001|Overall Study|Sponsor's Decision|1|||
131012317|NCT00543725|471674192|FG000|Overall Study|Subject Non-Compliant|4|||
131012318|NCT00543725|471674193|FG001|Overall Study|Subject Non-Compliant|4|||
131012319|NCT00543725|471674192|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
131012320|NCT00543725|471674193|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
131012321|NCT00543725|471674192|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
131012322|NCT00543725|471674193|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
131012323|NCT00543725|471674192|FG000|Overall Study|Protocol Violation|0|||
131012324|NCT00543725|471674193|FG001|Overall Study|Protocol Violation|1|||
131012325|NCT00543725|471674192|FG000|Overall Study|Withdrawal by Subject|4|||
131012326|NCT00543725|471674193|FG001|Overall Study|Withdrawal by Subject|13|||
131012327|NCT00543725|471674192|FG000|Overall Study|Lost to Follow-up|15|||
131012328|NCT00543725|471674193|FG001|Overall Study|Lost to Follow-up|11|||
131012329|NCT00543725|471674192|FG000|Overall Study|Other|3|||
131012330|NCT00543725|471674193|FG001|Overall Study|Other|3|||
131012331|NCT00906698|471674194|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
131012332|NCT00906698|471674195|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
131012333|NCT00906698|471674196|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
131012334|NCT00906698|471674197|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
131012335|NCT00906698|471674198|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
131012336|NCT00906698|471674199|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
131012337|NCT00906698|471674194|FG000|Overall Study|Adverse Event|0|||
131012338|NCT00906698|471674195|FG001|Overall Study|Adverse Event|0|||
131012339|NCT00906698|471674196|FG002|Overall Study|Adverse Event|2|||
131012340|NCT00906698|471674197|FG003|Overall Study|Adverse Event|0|||
131012341|NCT00906698|471674198|FG004|Overall Study|Adverse Event|4|||
131012342|NCT00906698|471674199|FG005|Overall Study|Adverse Event|1|||
131012343|NCT00906698|471674194|FG000|Overall Study|Disease progression|3|||
131012344|NCT00906698|471674195|FG001|Overall Study|Disease progression|12|||
131012345|NCT00906698|471674196|FG002|Overall Study|Disease progression|4|||
131012346|NCT00906698|471674197|FG003|Overall Study|Disease progression|4|||
131012347|NCT00906698|471674198|FG004|Overall Study|Disease progression|12|||
131012348|NCT00906698|471674199|FG005|Overall Study|Disease progression|4|||
131012349|NCT00906698|471674194|FG000|Overall Study|Withdrawal by Subject|0|||
131012350|NCT00906698|471674195|FG001|Overall Study|Withdrawal by Subject|0|||
131012351|NCT00906698|471674196|FG002|Overall Study|Withdrawal by Subject|0|||
131012352|NCT00906698|471674197|FG003|Overall Study|Withdrawal by Subject|0|||
131012353|NCT00906698|471674198|FG004|Overall Study|Withdrawal by Subject|1|||
131012354|NCT00906698|471674199|FG005|Overall Study|Withdrawal by Subject|0|||
131012355|NCT00906698|471674194|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
131012356|NCT00906698|471674195|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
131012357|NCT00906698|471674196|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
131012358|NCT00906698|471674197|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
131012359|NCT00906698|471674198|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
131012360|NCT00906698|471674199|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
131012361|NCT03095508|471674200|FG000|Overall Study|Adverse Event|0|||
131012362|NCT03095508|471674201|FG001|Overall Study|Adverse Event|1|||
131012363|NCT01806714|471674202|FG000|Overall Study|No functioning phone number|200|||
131012364|NCT01806714|471674203|FG001|Overall Study|No functioning phone number|170|||
131012365|NCT02469064|471674204|FG000|Overall Study|Request not to receive intervention.|1|||
131012366|NCT02469064|471674205|FG001|Overall Study|Request not to receive intervention.|3|||
131012367|NCT02155829|471674206|FG000|Overall Study|Adverse Event|1|||
131012368|NCT02155829|471674207|FG001|Overall Study|Adverse Event|0|||
131012369|NCT02155829|471674206|FG000|Overall Study|Withdrawal by Subject|3|||
131012370|NCT02155829|471674207|FG001|Overall Study|Withdrawal by Subject|3|||
131012371|NCT02155829|471674206|FG000|Overall Study|Protocol Violation|2|||
131012372|NCT02155829|471674207|FG001|Overall Study|Protocol Violation|0|||
131012373|NCT01585038|471674208|FG000|Overall Study|Adverse Event|2|||
131012374|NCT01585038|471674209|FG001|Overall Study|Adverse Event|2|||
131012375|NCT00678795|471674210|FG000|Overall Study|Adverse Event|7|||
131012376|NCT00678795|471674211|FG001|Overall Study|Adverse Event|3|||
131012377|NCT00678795|471674210|FG000|Overall Study|Withdrawal by Subject|3|||
131012378|NCT00678795|471674211|FG001|Overall Study|Withdrawal by Subject|0|||
131012379|NCT00678795|471674210|FG000|Overall Study|Protocol Violation|0|||
131012380|NCT00678795|471674211|FG001|Overall Study|Protocol Violation|1|||
131012381|NCT00678795|471674210|FG000|Overall Study|Lost to Follow-up|0|||
131012382|NCT00678795|471674211|FG001|Overall Study|Lost to Follow-up|1|||
131012383|NCT00678795|471674210|FG000|Overall Study|Lack of Efficacy|1|||
131012384|NCT00678795|471674211|FG001|Overall Study|Lack of Efficacy|1|||
131012385|NCT04107805|471674212|FG000|Overall Study|Adverse Event|0|||
131012386|NCT04107805|471674213|FG001|Overall Study|Adverse Event|0|||
131012387|NCT04107805|471674214|FG002|Overall Study|Adverse Event|0|||
131012388|NCT04107805|471674215|FG003|Overall Study|Adverse Event|1|||
131012389|NCT04107805|471674216|FG004|Overall Study|Adverse Event|0|||
131012390|NCT04107805|471674217|FG005|Overall Study|Adverse Event|1|||
131012391|NCT04107805|471674218|FG006|Overall Study|Adverse Event|0|||
131012392|NCT04107805|471674219|FG007|Overall Study|Adverse Event|0|||
131012393|NCT04107805|471674220|FG008|Overall Study|Adverse Event|1|||
131012394|NCT02512042|471674221|FG000|Overall Study|Adverse Event|0|||
131012395|NCT02512042|471674222|FG001|Overall Study|Adverse Event|4|||
131012396|NCT02512042|471674221|FG000|Overall Study|Withdrawal by Subject|6|||
131012397|NCT02512042|471674222|FG001|Overall Study|Withdrawal by Subject|6|||
131012398|NCT02512042|471674221|FG000|Overall Study|Non-compliance with study drug|1|||
131012399|NCT02512042|471674222|FG001|Overall Study|Non-compliance with study drug|2|||
131012400|NCT02512042|471674221|FG000|Overall Study|Lost to Follow-up|5|||
131012401|NCT02512042|471674222|FG001|Overall Study|Lost to Follow-up|2|||
131012402|NCT02512042|471674221|FG000|Overall Study|Other|11|||
131012403|NCT02512042|471674222|FG001|Overall Study|Other|11|||
131012404|NCT01194258|471674223|FG000|Titration Period|Withdrawal by Subject|6|||
131012405|NCT01194258|471674224|FG001|Titration Period|Withdrawal by Subject|0|||
131012406|NCT01194258|471674225|FG002|Titration Period|Withdrawal by Subject|0|||
131012407|NCT01194258|471674226|FG003|Titration Period|Withdrawal by Subject|0|||
131012408|NCT01194258|471674227|FG004|Titration Period|Withdrawal by Subject|0|||
131012409|NCT01194258|471674223|FG000|Titration Period|Lost to Follow-up|2|||
131012410|NCT01194258|471674224|FG001|Titration Period|Lost to Follow-up|0|||
131012411|NCT01194258|471674225|FG002|Titration Period|Lost to Follow-up|0|||
131012412|NCT01194258|471674226|FG003|Titration Period|Lost to Follow-up|0|||
131012413|NCT01194258|471674227|FG004|Titration Period|Lost to Follow-up|0|||
131012414|NCT01194258|471674223|FG000|Titration Period|Titration failure|3|||
131012415|NCT01194258|471674224|FG001|Titration Period|Titration failure|0|||
131012416|NCT01194258|471674225|FG002|Titration Period|Titration failure|0|||
131012417|NCT01194258|471674226|FG003|Titration Period|Titration failure|0|||
131012418|NCT01194258|471674227|FG004|Titration Period|Titration failure|0|||
131012419|NCT01194258|471674223|FG000|Period 1 (12 Weeks)|Death|0|||
131012420|NCT01194258|471674224|FG001|Period 1 (12 Weeks)|Death|0|||
131012421|NCT01194258|471674225|FG002|Period 1 (12 Weeks)|Death|0|||
131012422|NCT01194258|471674226|FG003|Period 1 (12 Weeks)|Death|0|||
131012423|NCT01194258|471674227|FG004|Period 1 (12 Weeks)|Death|1|||
131012424|NCT01194258|471674223|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131012425|NCT01194258|471674224|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131012426|NCT01194258|471674225|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131012427|NCT01194258|471674226|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
131012428|NCT01194258|471674227|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
131012429|NCT01194258|471674223|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
131012430|NCT01194258|471674224|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
131012431|NCT01194258|471674225|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
131012432|NCT01194258|471674226|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
131012433|NCT01194258|471674227|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
131012434|NCT01194258|471674223|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131012435|NCT01194258|471674224|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131012436|NCT01194258|471674225|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131012437|NCT01194258|471674226|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131012438|NCT01194258|471674227|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131012439|NCT01253226|471674229|FG000|Overall Study|Adverse Event|0|||
131012440|NCT01253226|471674230|FG001|Overall Study|Adverse Event|0|||
131012441|NCT01253226|471674231|FG002|Overall Study|Adverse Event|1|||
131012442|NCT01253226|471674232|FG003|Overall Study|Adverse Event|0|||
131012443|NCT01253226|471674233|FG004|Overall Study|Adverse Event|0|||
131012444|NCT01253226|471674229|FG000|Overall Study|Death|0|||
131012445|NCT01253226|471674230|FG001|Overall Study|Death|1|||
131012446|NCT01253226|471674231|FG002|Overall Study|Death|0|||
131012447|NCT01253226|471674232|FG003|Overall Study|Death|0|||
131012448|NCT01253226|471674233|FG004|Overall Study|Death|0|||
131012449|NCT01253226|471674229|FG000|Overall Study|Physician Decision|0|||
131012450|NCT01253226|471674230|FG001|Overall Study|Physician Decision|0|||
131012451|NCT01253226|471674231|FG002|Overall Study|Physician Decision|0|||
131012452|NCT01253226|471674232|FG003|Overall Study|Physician Decision|0|||
131012453|NCT01253226|471674233|FG004|Overall Study|Physician Decision|2|||
131012454|NCT01253226|471674229|FG000|Overall Study|Withdrawal by Subject|0|||
131012455|NCT01253226|471674230|FG001|Overall Study|Withdrawal by Subject|0|||
131012456|NCT01253226|471674231|FG002|Overall Study|Withdrawal by Subject|0|||
131012457|NCT01253226|471674232|FG003|Overall Study|Withdrawal by Subject|1|||
131012458|NCT01253226|471674233|FG004|Overall Study|Withdrawal by Subject|0|||
131012459|NCT01726023|471674234|FG000|Overall Study|Death|1|||
131012460|NCT01726023|471674235|FG001|Overall Study|Death|1|||
131012461|NCT01726023|471674234|FG000|Overall Study|Lost to Follow-up|5|||
131012462|NCT01726023|471674235|FG001|Overall Study|Lost to Follow-up|10|||
131012463|NCT01726023|471674234|FG000|Overall Study|Other Eligibility criteria|7|||
131012464|NCT01726023|471674235|FG001|Overall Study|Other Eligibility criteria|7|||
131012465|NCT01726023|471674234|FG000|Overall Study|Withdrawal by Subject|16|||
131012466|NCT01726023|471674235|FG001|Overall Study|Withdrawal by Subject|8|||
131012467|NCT04858425|471674239|FG000|Overall Study|Adverse Event|2|||
131012468|NCT04858425|471674240|FG001|Overall Study|Adverse Event|2|||
131012469|NCT04858425|471674239|FG000|Overall Study|Withdrawal by Subject|3|||
131012470|NCT04858425|471674240|FG001|Overall Study|Withdrawal by Subject|1|||
131012471|NCT04858425|471674239|FG000|Overall Study|Lost to Follow-up|4|||
131012472|NCT04858425|471674240|FG001|Overall Study|Lost to Follow-up|2|||
131012473|NCT04858425|471674239|FG000|Overall Study|Lost to Follow-up|1|||
131012474|NCT04858425|471674240|FG001|Overall Study|Lost to Follow-up|0|||
131012475|NCT03310983|471674241|FG000|Overall Study|Lost to Follow-up|15|||
131012476|NCT03310983|471674242|FG001|Overall Study|Lost to Follow-up|17|||
131012477|NCT02465359|471674244|FG000|Overall Study|Lack of Efficacy|1|||
131012478|NCT02465359|471674244|FG000|Overall Study|Withdrawal by Subject|1|||
131012479|NCT02465359|471674244|FG000|Overall Study|Adverse Event|1|||
131012480|NCT01304147|471674245|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
131012481|NCT01304147|471674246|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
131012482|NCT01244828|471674247|FG000|Overall Study|Adverse Event|37|||
131012483|NCT01244828|471674247|FG000|Overall Study|Withdrawal by Subject|31|||
131012484|NCT01244828|471674247|FG000|Overall Study|Lack of Efficacy|7|||
131012485|NCT01244828|471674247|FG000|Overall Study|Lost to Follow-up|2|||
131012486|NCT01244828|471674247|FG000|Overall Study|Other reason (not specified)|1|||
131012487|NCT01278862|471674248|FG000|Overall Study|Lost to Follow-up|1|||
131012488|NCT01278862|471674249|FG001|Overall Study|Lost to Follow-up|1|||
131012489|NCT03227757|471676127|FG000|Overall Study|Death|25|||
131012490|NCT03227757|471676127|FG000|Overall Study|Withdrawal|10|||
131012491|NCT03227757|471676127|FG000|Overall Study|Missed visits|1|||
131012492|NCT03227757|471676127|FG000|Overall Study|Lost to Follow-up|2|||
131012493|NCT02960659|471676128|FG000|Overall Study|Withdrawal by Subject|1|||
131012494|NCT02960659|471676129|FG001|Overall Study|Withdrawal by Subject|0|||
131012495|NCT02960659|471676128|FG000|Overall Study|Poor compliance|0|||
131012496|NCT02960659|471676129|FG001|Overall Study|Poor compliance|1|||
131012497|NCT01645111|471676131|FG000|Overall Study|Did not require Clevidipine|15|||
131012498|NCT03068468|471676137|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
131012499|NCT03068468|471676138|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
131012500|NCT03068468|471676139|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
130885386|NCT04145349|471215173|FG000|Overall Study|On study treatment (Ongoing)|0|||
131012501|NCT03068468|471676140|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
131012502|NCT03068468|471676137|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
131012503|NCT03068468|471676138|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
131012504|NCT03068468|471676139|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
131012505|NCT03068468|471676140|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
131012506|NCT03068468|471676137|FG000|Placebo-Controlled Period|Adverse Event|16|||
131012507|NCT03068468|471676138|FG001|Placebo-Controlled Period|Adverse Event|21|||
131012508|NCT03068468|471676139|FG002|Placebo-Controlled Period|Adverse Event|0|||
131012509|NCT03068468|471676140|FG003|Placebo-Controlled Period|Adverse Event|0|||
131012510|NCT03068468|471676137|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
131012511|NCT03068468|471676138|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
131012512|NCT03068468|471676139|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
131012513|NCT03068468|471676140|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
131012514|NCT03068468|471676137|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
131012515|NCT03068468|471676138|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
131012516|NCT03068468|471676139|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130885387|NCT04145349|471215174|FG001|Overall Study|On study treatment (Ongoing)|1|||
131012517|NCT03068468|471676140|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131012518|NCT03068468|471676137|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
131012519|NCT03068468|471676138|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
131012520|NCT03068468|471676139|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
131012521|NCT03068468|471676140|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
131012522|NCT03068468|471676137|FG000|Placebo-Controlled Period|Death|0|||
131012523|NCT03068468|471676138|FG001|Placebo-Controlled Period|Death|1|||
131012524|NCT03068468|471676139|FG002|Placebo-Controlled Period|Death|0|||
131012525|NCT03068468|471676140|FG003|Placebo-Controlled Period|Death|0|||
131012526|NCT03068468|471676137|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
131012527|NCT03068468|471676138|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
131012528|NCT03068468|471676139|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
131012529|NCT03068468|471676140|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
131012530|NCT03068468|471676137|FG000|Open-Label Extension Period|Adverse Event|0|||
131012531|NCT03068468|471676138|FG001|Open-Label Extension Period|Adverse Event|0|||
131012532|NCT03068468|471676139|FG002|Open-Label Extension Period|Adverse Event|13|||
131012533|NCT03068468|471676140|FG003|Open-Label Extension Period|Adverse Event|17|||
131012534|NCT03068468|471676137|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
131012535|NCT03068468|471676138|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
131012536|NCT03068468|471676139|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
131222573|NCT03591107|472443111|FG000|Overall Study|Withdrawal by Subject|0|||
131012537|NCT03068468|471676140|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
131012538|NCT03068468|471676137|FG000|Open-Label Extension Period|Death|0|||
131012539|NCT03068468|471676138|FG001|Open-Label Extension Period|Death|0|||
131012540|NCT03068468|471676139|FG002|Open-Label Extension Period|Death|0|||
131012541|NCT03068468|471676140|FG003|Open-Label Extension Period|Death|1|||
131012542|NCT03068468|471676137|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
130885388|NCT01148979|471215184|FG000|Overall Study|Lost to Follow-up|0|||
131012543|NCT03068468|471676138|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
131222574|NCT03591107|472443112|FG001|Overall Study|Withdrawal by Subject|1|||
130885389|NCT01148979|471215185|FG001|Overall Study|Lost to Follow-up|1|||
131012544|NCT03068468|471676139|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
131012545|NCT03068468|471676140|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
131012546|NCT03068468|471676137|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
131012547|NCT03068468|471676138|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
131012548|NCT03068468|471676139|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
131012549|NCT03068468|471676140|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
131012550|NCT03068468|471676137|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
131012551|NCT03068468|471676138|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
131012552|NCT03068468|471676139|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
131012553|NCT03068468|471676140|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
131012554|NCT03068468|471676137|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
131012555|NCT03068468|471676138|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
131012556|NCT03068468|471676139|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
131012557|NCT03068468|471676140|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
131012558|NCT03068468|471676137|FG000|Open-Label Extension Period|Reason not Specified|0|||
131012559|NCT03068468|471676138|FG001|Open-Label Extension Period|Reason not Specified|0|||
131012560|NCT03068468|471676139|FG002|Open-Label Extension Period|Reason not Specified|1|||
131012561|NCT03068468|471676140|FG003|Open-Label Extension Period|Reason not Specified|4|||
131012562|NCT01062126|471676142|FG000|Overall Study|Death|209|||
131012563|NCT01062126|471676142|FG000|Overall Study|All Withdrawals|324|||
131012564|NCT00646451|471676143|FG000|Overall Study|Adverse Event|3|||
131012565|NCT00646451|471676144|FG001|Overall Study|Adverse Event|0|||
131012566|NCT00646451|471676143|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
131012567|NCT00646451|471676144|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
131012568|NCT01249092|471676148|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
131012569|NCT01249092|471676148|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
131012570|NCT01185522|471676149|FG000|Overall Study|Lack of Efficacy|28|||
131012571|NCT01185522|471676149|FG000|Overall Study|Lost to Follow-up|19|||
131012572|NCT01185522|471676149|FG000|Overall Study|Withdrawal by Subject|10|||
131012573|NCT01185522|471676149|FG000|Overall Study|Poor tolerance|39|||
131012574|NCT01185522|471676149|FG000|Overall Study|Other reasons|12|||
131012575|NCT00109967|471676150|FG000|Overall Study|Cancel Prior to Treatment|2|||
131012576|NCT00109967|471676151|FG001|Overall Study|Cancel Prior to Treatment|0|||
131012577|NCT00109967|471676150|FG000|Overall Study|Adverse Event|12|||
131012578|NCT00109967|471676151|FG001|Overall Study|Adverse Event|1|||
131012579|NCT00109967|471676150|FG000|Overall Study|Withdrawal by Subject|5|||
131012580|NCT00109967|471676151|FG001|Overall Study|Withdrawal by Subject|0|||
131012581|NCT00109967|471676150|FG000|Overall Study|Physician Decision|1|||
131012582|NCT00109967|471676151|FG001|Overall Study|Physician Decision|3|||
131012583|NCT00109967|471676150|FG000|Overall Study|Death|0|||
131012584|NCT00109967|471676151|FG001|Overall Study|Death|2|||
131012585|NCT02715258|471676152|FG000|Overall Study|Withdrawal by Subject|6|||
131012586|NCT02715258|471676153|FG001|Overall Study|Withdrawal by Subject|1|||
131012587|NCT02715258|471676152|FG000|Overall Study|Lost to Follow-up|7|||
131012588|NCT02715258|471676153|FG001|Overall Study|Lost to Follow-up|1|||
131012589|NCT02715258|471676152|FG000|Overall Study|Terminated by Sponsor|0|||
131012590|NCT02715258|471676153|FG001|Overall Study|Terminated by Sponsor|1|||
131012591|NCT02715258|471676152|FG000|Overall Study|Death|0|||
131012592|NCT02715258|471676153|FG001|Overall Study|Death|1|||
131012593|NCT02715258|471676152|FG000|Overall Study|Subject non-compliant|1|||
131012594|NCT02715258|471676153|FG001|Overall Study|Subject non-compliant|1|||
131012595|NCT02715258|471676152|FG000|Overall Study|GCP violation|2|||
131012596|NCT02715258|471676153|FG001|Overall Study|GCP violation|1|||
131012597|NCT03265210|471676154|FG000|Overall Study|Withdrawal by Subject|7|||
131012598|NCT03265210|471676155|FG001|Overall Study|Withdrawal by Subject|9|||
131012599|NCT03265210|471676154|FG000|Overall Study|Lost to Follow-up|2|||
131012600|NCT03265210|471676155|FG001|Overall Study|Lost to Follow-up|0|||
131012601|NCT03265210|471676154|FG000|Overall Study|Physician Decision|2|||
131012602|NCT03265210|471676155|FG001|Overall Study|Physician Decision|0|||
131012603|NCT03265210|471676154|FG000|Overall Study|Adverse Event|1|||
131012604|NCT03265210|471676155|FG001|Overall Study|Adverse Event|0|||
131012605|NCT00686517|471676156|FG000|Treatment|Serious Adverse Event|1|||
131012606|NCT00686517|471676157|FG001|Treatment|Serious Adverse Event|2|||
131012607|NCT00686517|471676158|FG002|Treatment|Serious Adverse Event|1|||
131012608|NCT00686517|471676156|FG000|Treatment|Adverse Event|2|||
131012609|NCT00686517|471676157|FG001|Treatment|Adverse Event|0|||
131012610|NCT00686517|471676158|FG002|Treatment|Adverse Event|0|||
131012611|NCT00686517|471676156|FG000|Treatment|Poor Protocol Compliance|1|||
131012612|NCT00686517|471676157|FG001|Treatment|Poor Protocol Compliance|0|||
131012613|NCT00686517|471676158|FG002|Treatment|Poor Protocol Compliance|0|||
131012614|NCT00686517|471676156|FG000|Treatment|Protocol Violation|2|||
131012615|NCT00686517|471676157|FG001|Treatment|Protocol Violation|1|||
131012616|NCT00686517|471676158|FG002|Treatment|Protocol Violation|0|||
131012617|NCT02281318|471676159|FG000|Overall Study|Adverse Event|2|||
131012618|NCT02281318|471676160|FG001|Overall Study|Adverse Event|2|||
131012619|NCT02281318|471676159|FG000|Overall Study|Lack of Efficacy|2|||
131012620|NCT02281318|471676160|FG001|Overall Study|Lack of Efficacy|0|||
131012621|NCT02281318|471676159|FG000|Overall Study|Lost to Follow-up|2|||
131012622|NCT02281318|471676160|FG001|Overall Study|Lost to Follow-up|1|||
131012623|NCT02281318|471676159|FG000|Overall Study|Physician Decision|2|||
131012624|NCT02281318|471676160|FG001|Overall Study|Physician Decision|0|||
131012625|NCT02281318|471676159|FG000|Overall Study|Withdrawal by Subject|6|||
131012626|NCT02281318|471676160|FG001|Overall Study|Withdrawal by Subject|2|||
131012627|NCT02614560|471676163|FG000|Overall Study|Death|6|||
131012628|NCT02614560|471676164|FG001|Overall Study|Death|2|||
131012629|NCT00703911|471676165|FG000|Overall Study|Death|1|||
131012630|NCT00703911|471676165|FG000|Overall Study|Physician Decision|6|||
131012631|NCT00703911|471676165|FG000|Overall Study|Lost to Follow-up|1|||
131012632|NCT00703911|471676165|FG000|Overall Study|Withdrawal by Subject|2|||
131012633|NCT02846415|471676169|FG000|Overall Study|Lost to Follow-up|2|||
131012634|NCT02846415|471676170|FG001|Overall Study|Lost to Follow-up|0|||
131012635|NCT02846415|471676169|FG000|Overall Study|Withdrawal by Subject|1|||
131012636|NCT02846415|471676170|FG001|Overall Study|Withdrawal by Subject|1|||
131012637|NCT03383887|471676171|FG000|Overall Study|Lost to Follow-up|0|||
131012638|NCT03383887|471676172|FG001|Overall Study|Lost to Follow-up|1|||
131012639|NCT00831792|471676173|FG000|Overall Study|Not Eligible|3|||
131012640|NCT00831792|471676173|FG000|Overall Study|Adverse Event|1|||
131012641|NCT00831792|471676173|FG000|Overall Study|Death|1|||
131012642|NCT00831792|471676173|FG000|Overall Study|Lack of Efficacy|1|||
131012643|NCT01242085|471676176|FG000|Overall Study|Withdrawal by Subject|4|||
131012644|NCT01242085|471676177|FG001|Overall Study|Withdrawal by Subject|2|||
131012645|NCT01242085|471676178|FG002|Overall Study|Withdrawal by Subject|0|||
131012646|NCT01242085|471676176|FG000|Overall Study|medically unable to have surgery|4|||
131012647|NCT01242085|471676177|FG001|Overall Study|medically unable to have surgery|5|||
131012648|NCT01242085|471676178|FG002|Overall Study|medically unable to have surgery|0|||
131012649|NCT01178762|471676179|FG000|Overall Study|Lost to Follow-up|15|||
131012650|NCT02377362|471676180|FG000|Part A Second Treatment|Protocol Violation|0|||
131012651|NCT02377362|471676181|FG001|Part A Second Treatment|Protocol Violation|0|||
131012652|NCT02377362|471676182|FG002|Part A Second Treatment|Protocol Violation|0|||
131012653|NCT02377362|471676183|FG003|Part A Second Treatment|Protocol Violation|0|||
131012654|NCT02377362|471676184|FG004|Part A Second Treatment|Protocol Violation|1|||
131012655|NCT02377362|471676185|FG005|Part A Second Treatment|Protocol Violation|0|||
131012656|NCT02377362|471676186|FG006|Part A Second Treatment|Protocol Violation|0|||
131012657|NCT02377362|471676187|FG007|Part A Second Treatment|Protocol Violation|0|||
131012658|NCT02377362|471676188|FG008|Part A Second Treatment|Protocol Violation|0|||
131012659|NCT02377362|471676189|FG009|Part A Second Treatment|Protocol Violation|0|||
131012660|NCT02377362|471676190|FG010|Part A Second Treatment|Protocol Violation|0|||
131012661|NCT02377362|471676191|FG011|Part A Second Treatment|Protocol Violation|0|||
131012662|NCT02377362|471676192|FG012|Part A Second Treatment|Protocol Violation|0|||
131012663|NCT02377362|471676180|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
131012664|NCT02377362|471676181|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
131012665|NCT02377362|471676182|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
131012666|NCT02377362|471676183|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
131012667|NCT02377362|471676184|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
131012668|NCT02377362|471676185|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
131012669|NCT02377362|471676186|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
131012670|NCT02377362|471676187|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
131012671|NCT02377362|471676188|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
131012672|NCT02377362|471676189|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
131012673|NCT02377362|471676190|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
131012674|NCT02377362|471676191|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
131012675|NCT02377362|471676192|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
131012676|NCT02377362|471676180|FG000|Part B Overall|Protocol Violation|0|||
131012677|NCT02377362|471676181|FG001|Part B Overall|Protocol Violation|0|||
131012678|NCT02377362|471676182|FG002|Part B Overall|Protocol Violation|0|||
131012679|NCT02377362|471676183|FG003|Part B Overall|Protocol Violation|0|||
131012680|NCT02377362|471676184|FG004|Part B Overall|Protocol Violation|0|||
131012681|NCT02377362|471676185|FG005|Part B Overall|Protocol Violation|0|||
131012682|NCT02377362|471676186|FG006|Part B Overall|Protocol Violation|0|||
131012683|NCT02377362|471676187|FG007|Part B Overall|Protocol Violation|0|||
131012684|NCT02377362|471676188|FG008|Part B Overall|Protocol Violation|0|||
131012685|NCT02377362|471676189|FG009|Part B Overall|Protocol Violation|1|||
131012686|NCT02377362|471676190|FG010|Part B Overall|Protocol Violation|0|||
131012687|NCT02377362|471676191|FG011|Part B Overall|Protocol Violation|0|||
131012688|NCT02377362|471676192|FG012|Part B Overall|Protocol Violation|0|||
131012689|NCT02377362|471676180|FG000|Part B Overall|Adverse Event|0|||
131012690|NCT02377362|471676181|FG001|Part B Overall|Adverse Event|0|||
131012691|NCT02377362|471676182|FG002|Part B Overall|Adverse Event|0|||
131012692|NCT02377362|471676183|FG003|Part B Overall|Adverse Event|0|||
131012693|NCT02377362|471676184|FG004|Part B Overall|Adverse Event|0|||
131012694|NCT02377362|471676185|FG005|Part B Overall|Adverse Event|0|||
131012695|NCT02377362|471676186|FG006|Part B Overall|Adverse Event|1|||
131012696|NCT02377362|471676187|FG007|Part B Overall|Adverse Event|1|||
131012697|NCT02377362|471676188|FG008|Part B Overall|Adverse Event|0|||
131012698|NCT02377362|471676189|FG009|Part B Overall|Adverse Event|0|||
131012699|NCT02377362|471676190|FG010|Part B Overall|Adverse Event|0|||
131012700|NCT02377362|471676191|FG011|Part B Overall|Adverse Event|0|||
131012701|NCT02377362|471676192|FG012|Part B Overall|Adverse Event|0|||
131012702|NCT02377362|471676180|FG000|Part B Overall|Withdrawal by Subject|0|||
131012703|NCT02377362|471676181|FG001|Part B Overall|Withdrawal by Subject|0|||
131012704|NCT02377362|471676182|FG002|Part B Overall|Withdrawal by Subject|0|||
131012705|NCT02377362|471676183|FG003|Part B Overall|Withdrawal by Subject|0|||
131012706|NCT02377362|471676184|FG004|Part B Overall|Withdrawal by Subject|0|||
131012707|NCT02377362|471676185|FG005|Part B Overall|Withdrawal by Subject|0|||
131012708|NCT02377362|471676186|FG006|Part B Overall|Withdrawal by Subject|1|||
131012709|NCT02377362|471676187|FG007|Part B Overall|Withdrawal by Subject|0|||
131012710|NCT02377362|471676188|FG008|Part B Overall|Withdrawal by Subject|0|||
131012711|NCT02377362|471676189|FG009|Part B Overall|Withdrawal by Subject|0|||
131012712|NCT02377362|471676190|FG010|Part B Overall|Withdrawal by Subject|0|||
131012713|NCT02377362|471676191|FG011|Part B Overall|Withdrawal by Subject|1|||
131012714|NCT02377362|471676192|FG012|Part B Overall|Withdrawal by Subject|0|||
131012715|NCT02322216|471676193|FG000|Overall Study|Adverse Event|1|||
131012716|NCT02322216|471676194|FG001|Overall Study|Adverse Event|0|||
131012717|NCT02322216|471676193|FG000|Overall Study|Withdrawal by Subject|1|||
131012718|NCT02322216|471676194|FG001|Overall Study|Withdrawal by Subject|4|||
131012719|NCT01651949|471676202|FG000|Overall Study|Unknown status|4|||
131012720|NCT01651949|471676203|FG001|Overall Study|Unknown status|4|||
131012721|NCT01651949|471676204|FG002|Overall Study|Unknown status|0|||
131012722|NCT01651949|471676202|FG000|Overall Study|Lost to Follow-up|30|||
131012723|NCT01651949|471676203|FG001|Overall Study|Lost to Follow-up|56|||
131012724|NCT01651949|471676204|FG002|Overall Study|Lost to Follow-up|20|||
131012725|NCT01651949|471676202|FG000|Overall Study|Protocol Violation|0|||
131012726|NCT01651949|471676203|FG001|Overall Study|Protocol Violation|2|||
130885390|NCT01646125|471215186|FG000|Overall Study|Untreated|2|||
131012727|NCT01651949|471676204|FG002|Overall Study|Protocol Violation|1|||
131012728|NCT01651949|471676202|FG000|Overall Study|Physician Decision|0|||
131012729|NCT01651949|471676203|FG001|Overall Study|Physician Decision|2|||
131012730|NCT01651949|471676204|FG002|Overall Study|Physician Decision|0|||
131012731|NCT01651949|471676202|FG000|Overall Study|Adverse Event|0|||
131012732|NCT01651949|471676203|FG001|Overall Study|Adverse Event|2|||
131012733|NCT01651949|471676204|FG002|Overall Study|Adverse Event|1|||
131012734|NCT01651949|471676202|FG000|Overall Study|Screen failure|2|||
131012735|NCT01651949|471676203|FG001|Overall Study|Screen failure|2|||
131012736|NCT01651949|471676204|FG002|Overall Study|Screen failure|0|||
131012737|NCT01651949|471676202|FG000|Overall Study|Withdrawal by Subject|17|||
131012738|NCT01651949|471676203|FG001|Overall Study|Withdrawal by Subject|18|||
131012739|NCT01651949|471676204|FG002|Overall Study|Withdrawal by Subject|9|||
131012740|NCT00404079|471676211|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
131012741|NCT00404079|471676212|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
131012742|NCT01120275|471676213|FG000|Overall Study|Adverse Event|3|||
131012743|NCT01120275|471676213|FG000|Overall Study|Progression|27|||
131012744|NCT01120275|471676213|FG000|Overall Study|Ineligible|3|||
131012745|NCT01120275|471676213|FG000|Overall Study|Withdrawal by Subject|1|||
131012746|NCT01120275|471676213|FG000|Overall Study|Refusal|1|||
131012747|NCT01120275|471676213|FG000|Overall Study|Not specific|1|||
131012748|NCT01191086|471676223|FG000|Overall Study|Adverse Event|20|||
131012749|NCT01191086|471676223|FG000|Overall Study|Lack of Efficacy|10|||
131012750|NCT01191086|471676223|FG000|Overall Study|Lost to Follow-up|4|||
131012751|NCT01191086|471676223|FG000|Overall Study|Physician Decision|2|||
131012752|NCT01191086|471676223|FG000|Overall Study|Withdrawal by Subject|24|||
131012753|NCT01191086|471676223|FG000|Overall Study|Discontinuation criterion met|1|||
131012754|NCT01191086|471676223|FG000|Overall Study|Other|1|||
131012755|NCT00853827|471676224|FG000|Single Blind Period (1 Week)|Other|4|||
131012756|NCT00853827|471676225|FG001|Single Blind Period (1 Week)|Other|0|||
131012757|NCT00853827|471676224|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
131012758|NCT00853827|471676225|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
131012759|NCT00853827|471676224|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
131012760|NCT00853827|471676225|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
131012761|NCT00853827|471676224|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
131012762|NCT00853827|471676225|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
131012763|NCT00853827|471676224|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
131012764|NCT00853827|471676225|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
131012765|NCT00853827|471676224|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
131012766|NCT00853827|471676225|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
131012767|NCT00853827|471676224|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
131012768|NCT00853827|471676225|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
131012769|NCT00853827|471676224|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
131012770|NCT00853827|471676225|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
131012771|NCT00853827|471676224|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
131012772|NCT00853827|471676225|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
131012773|NCT00853827|471676224|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
131012774|NCT00853827|471676225|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
131012775|NCT00853827|471676224|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
131012776|NCT00853827|471676225|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
131012777|NCT00853827|471676224|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
131012778|NCT00853827|471676225|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
131012779|NCT00853827|471676224|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
131012780|NCT00853827|471676225|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
131012781|NCT00853827|471676224|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
131012782|NCT00853827|471676225|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
131012783|NCT00853827|471676224|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
131012784|NCT00853827|471676225|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
131012785|NCT00853827|471676224|FG000|Double Blind Period (103 Weeks)|Death|1|||
131012786|NCT00853827|471676225|FG001|Double Blind Period (103 Weeks)|Death|6|||
131012787|NCT00880906|471676230|FG000|Overall Study|Lost to Follow-up|0|||
131012788|NCT00880906|471676231|FG001|Overall Study|Lost to Follow-up|1|||
131012789|NCT00880906|471676230|FG000|Overall Study|Did not meet criteria following patholog|12|||
131012790|NCT00880906|471676231|FG001|Overall Study|Did not meet criteria following patholog|6|||
131012791|NCT00559949|471676234|FG000|Overall Study|Progressive Disease during cycle 1|1|||
131012792|NCT00559949|471676234|FG000|Overall Study|Adverse Event|1|||
131012793|NCT00559949|471676234|FG000|Overall Study|Withdrawal by Subject|4|||
131012794|NCT00559949|471676234|FG000|Overall Study|No disease evaluation per protocol|1|||
131012795|NCT00414648|471676235|FG000|Overall Study|Adverse Event|5|||
131012796|NCT00414648|471676236|FG001|Overall Study|Adverse Event|5|||
131012797|NCT00414648|471676235|FG000|Overall Study|Death|0|||
131012798|NCT00414648|471676236|FG001|Overall Study|Death|1|||
131012799|NCT00414648|471676235|FG000|Overall Study|Lack of Efficacy|0|||
131012800|NCT00414648|471676236|FG001|Overall Study|Lack of Efficacy|2|||
131012801|NCT00414648|471676235|FG000|Overall Study|Withdrawal by Subject|0|||
131012802|NCT00414648|471676236|FG001|Overall Study|Withdrawal by Subject|1|||
131012803|NCT01235949|471676241|FG000|Primary Phase|Migrated/moved from study area|1|||
131012804|NCT01235949|471676242|FG001|Primary Phase|Migrated/moved from study area|1|||
131012805|NCT01235949|471676243|FG002|Primary Phase|Migrated/moved from study area|0|||
131012806|NCT01235949|471676244|FG003|Primary Phase|Migrated/moved from study area|0|||
131012807|NCT01235949|471676245|FG004|Primary Phase|Migrated/moved from study area|1|||
131012808|NCT01235949|471676246|FG005|Primary Phase|Migrated/moved from study area|2|||
131012809|NCT01235949|471676247|FG006|Primary Phase|Migrated/moved from study area|0|||
131012810|NCT01235949|471676248|FG007|Primary Phase|Migrated/moved from study area|0|||
131012811|NCT01235949|471676249|FG008|Primary Phase|Migrated/moved from study area|0|||
131012812|NCT01235949|471676250|FG009|Primary Phase|Migrated/moved from study area|0|||
131012813|NCT01235949|471676251|FG010|Primary Phase|Migrated/moved from study area|0|||
131012814|NCT01235949|471676252|FG011|Primary Phase|Migrated/moved from study area|0|||
131012815|NCT01235949|471676253|FG012|Primary Phase|Migrated/moved from study area|0|||
131012816|NCT01235949|471676254|FG013|Primary Phase|Migrated/moved from study area|0|||
131012817|NCT01235949|471676255|FG014|Primary Phase|Migrated/moved from study area|0|||
131012818|NCT01235949|471676256|FG015|Primary Phase|Migrated/moved from study area|0|||
131012819|NCT01235949|471676257|FG016|Primary Phase|Migrated/moved from study area|0|||
131012820|NCT01235949|471676258|FG017|Primary Phase|Migrated/moved from study area|0|||
131012821|NCT01235949|471676241|FG000|Primary Phase|Adverse Event|0|||
131012822|NCT01235949|471676242|FG001|Primary Phase|Adverse Event|0|||
131012823|NCT01235949|471676243|FG002|Primary Phase|Adverse Event|0|||
131012824|NCT01235949|471676244|FG003|Primary Phase|Adverse Event|1|||
131012825|NCT01235949|471676245|FG004|Primary Phase|Adverse Event|0|||
131012826|NCT01235949|471676246|FG005|Primary Phase|Adverse Event|0|||
131012827|NCT01235949|471676247|FG006|Primary Phase|Adverse Event|0|||
131012828|NCT01235949|471676248|FG007|Primary Phase|Adverse Event|0|||
131012829|NCT01235949|471676249|FG008|Primary Phase|Adverse Event|0|||
131012830|NCT01235949|471676250|FG009|Primary Phase|Adverse Event|0|||
131012831|NCT01235949|471676251|FG010|Primary Phase|Adverse Event|0|||
131012832|NCT01235949|471676252|FG011|Primary Phase|Adverse Event|0|||
131012833|NCT01235949|471676253|FG012|Primary Phase|Adverse Event|0|||
131012834|NCT01235949|471676254|FG013|Primary Phase|Adverse Event|0|||
131012835|NCT01235949|471676255|FG014|Primary Phase|Adverse Event|0|||
131012836|NCT01235949|471676256|FG015|Primary Phase|Adverse Event|0|||
131012837|NCT01235949|471676257|FG016|Primary Phase|Adverse Event|0|||
131012838|NCT01235949|471676258|FG017|Primary Phase|Adverse Event|0|||
131012839|NCT01235949|471676241|FG000|Primary Phase|Withdrawal by Subject|3|||
131012840|NCT01235949|471676242|FG001|Primary Phase|Withdrawal by Subject|2|||
131012841|NCT01235949|471676243|FG002|Primary Phase|Withdrawal by Subject|2|||
131012842|NCT01235949|471676244|FG003|Primary Phase|Withdrawal by Subject|0|||
131012843|NCT01235949|471676245|FG004|Primary Phase|Withdrawal by Subject|0|||
131012844|NCT01235949|471676246|FG005|Primary Phase|Withdrawal by Subject|3|||
131012845|NCT01235949|471676247|FG006|Primary Phase|Withdrawal by Subject|0|||
131012846|NCT01235949|471676248|FG007|Primary Phase|Withdrawal by Subject|0|||
131012847|NCT01235949|471676249|FG008|Primary Phase|Withdrawal by Subject|0|||
131012848|NCT01235949|471676250|FG009|Primary Phase|Withdrawal by Subject|0|||
131012849|NCT01235949|471676251|FG010|Primary Phase|Withdrawal by Subject|0|||
131012850|NCT01235949|471676252|FG011|Primary Phase|Withdrawal by Subject|0|||
131012851|NCT01235949|471676253|FG012|Primary Phase|Withdrawal by Subject|0|||
131012852|NCT01235949|471676254|FG013|Primary Phase|Withdrawal by Subject|0|||
131012853|NCT01235949|471676255|FG014|Primary Phase|Withdrawal by Subject|0|||
131012854|NCT01235949|471676256|FG015|Primary Phase|Withdrawal by Subject|0|||
131012855|NCT01235949|471676257|FG016|Primary Phase|Withdrawal by Subject|0|||
131012856|NCT01235949|471676258|FG017|Primary Phase|Withdrawal by Subject|0|||
131012857|NCT01235949|471676241|FG000|Primary Phase|Lost to Follow-up|0|||
131012858|NCT01235949|471676242|FG001|Primary Phase|Lost to Follow-up|0|||
131012859|NCT01235949|471676243|FG002|Primary Phase|Lost to Follow-up|1|||
131012860|NCT01235949|471676244|FG003|Primary Phase|Lost to Follow-up|1|||
131012861|NCT01235949|471676245|FG004|Primary Phase|Lost to Follow-up|0|||
131012862|NCT01235949|471676246|FG005|Primary Phase|Lost to Follow-up|2|||
131012863|NCT01235949|471676247|FG006|Primary Phase|Lost to Follow-up|0|||
131012864|NCT01235949|471676248|FG007|Primary Phase|Lost to Follow-up|0|||
131012865|NCT01235949|471676249|FG008|Primary Phase|Lost to Follow-up|0|||
131012866|NCT01235949|471676250|FG009|Primary Phase|Lost to Follow-up|0|||
131012867|NCT01235949|471676251|FG010|Primary Phase|Lost to Follow-up|0|||
131012868|NCT01235949|471676252|FG011|Primary Phase|Lost to Follow-up|0|||
131012869|NCT01235949|471676253|FG012|Primary Phase|Lost to Follow-up|0|||
131012870|NCT01235949|471676254|FG013|Primary Phase|Lost to Follow-up|0|||
131012871|NCT01235949|471676255|FG014|Primary Phase|Lost to Follow-up|0|||
131012872|NCT01235949|471676256|FG015|Primary Phase|Lost to Follow-up|0|||
131012873|NCT01235949|471676257|FG016|Primary Phase|Lost to Follow-up|0|||
130885391|NCT01646125|471215187|FG001|Overall Study|Untreated|5|||
131012874|NCT01235949|471676258|FG017|Primary Phase|Lost to Follow-up|0|||
131012875|NCT01235949|471676241|FG000|Booster Phase|Migrated/moved from study area|0|||
131012876|NCT01235949|471676242|FG001|Booster Phase|Migrated/moved from study area|0|||
131222575|NCT01902134|472443113|FG000|Overall Study|Adverse Event|3|||
131012877|NCT01235949|471676243|FG002|Booster Phase|Migrated/moved from study area|0|||
131012878|NCT01235949|471676244|FG003|Booster Phase|Migrated/moved from study area|0|||
131012879|NCT01235949|471676245|FG004|Booster Phase|Migrated/moved from study area|0|||
131012880|NCT01235949|471676246|FG005|Booster Phase|Migrated/moved from study area|0|||
131012881|NCT01235949|471676247|FG006|Booster Phase|Migrated/moved from study area|0|||
131012882|NCT01235949|471676248|FG007|Booster Phase|Migrated/moved from study area|0|||
131012883|NCT01235949|471676249|FG008|Booster Phase|Migrated/moved from study area|0|||
131012884|NCT01235949|471676250|FG009|Booster Phase|Migrated/moved from study area|0|||
131012885|NCT01235949|471676251|FG010|Booster Phase|Migrated/moved from study area|0|||
131012886|NCT01235949|471676252|FG011|Booster Phase|Migrated/moved from study area|1|||
131012887|NCT01235949|471676253|FG012|Booster Phase|Migrated/moved from study area|1|||
131012888|NCT01235949|471676254|FG013|Booster Phase|Migrated/moved from study area|0|||
131012889|NCT01235949|471676255|FG014|Booster Phase|Migrated/moved from study area|0|||
131012890|NCT01235949|471676256|FG015|Booster Phase|Migrated/moved from study area|0|||
131012891|NCT01235949|471676257|FG016|Booster Phase|Migrated/moved from study area|0|||
131012892|NCT01235949|471676258|FG017|Booster Phase|Migrated/moved from study area|1|||
131012893|NCT01235949|471676241|FG000|Booster Phase|Adverse Event|0|||
131012894|NCT01235949|471676242|FG001|Booster Phase|Adverse Event|0|||
131012895|NCT01235949|471676243|FG002|Booster Phase|Adverse Event|0|||
131012896|NCT01235949|471676244|FG003|Booster Phase|Adverse Event|0|||
131012897|NCT01235949|471676245|FG004|Booster Phase|Adverse Event|0|||
131012898|NCT01235949|471676246|FG005|Booster Phase|Adverse Event|0|||
131012899|NCT01235949|471676247|FG006|Booster Phase|Adverse Event|0|||
131012900|NCT01235949|471676248|FG007|Booster Phase|Adverse Event|0|||
131012901|NCT01235949|471676249|FG008|Booster Phase|Adverse Event|0|||
131012902|NCT01235949|471676250|FG009|Booster Phase|Adverse Event|0|||
131012903|NCT01235949|471676251|FG010|Booster Phase|Adverse Event|0|||
131012904|NCT01235949|471676252|FG011|Booster Phase|Adverse Event|0|||
131012905|NCT01235949|471676253|FG012|Booster Phase|Adverse Event|0|||
131012906|NCT01235949|471676254|FG013|Booster Phase|Adverse Event|0|||
131012907|NCT01235949|471676255|FG014|Booster Phase|Adverse Event|0|||
131012908|NCT01235949|471676256|FG015|Booster Phase|Adverse Event|1|||
131012909|NCT01235949|471676257|FG016|Booster Phase|Adverse Event|0|||
131012910|NCT01235949|471676258|FG017|Booster Phase|Adverse Event|0|||
131012911|NCT01235949|471676241|FG000|Booster Phase|Withdrawal by Subject|0|||
131012912|NCT01235949|471676242|FG001|Booster Phase|Withdrawal by Subject|0|||
131012913|NCT01235949|471676243|FG002|Booster Phase|Withdrawal by Subject|0|||
131012914|NCT01235949|471676244|FG003|Booster Phase|Withdrawal by Subject|0|||
131012915|NCT01235949|471676245|FG004|Booster Phase|Withdrawal by Subject|0|||
131012916|NCT01235949|471676246|FG005|Booster Phase|Withdrawal by Subject|0|||
131012917|NCT01235949|471676247|FG006|Booster Phase|Withdrawal by Subject|0|||
131012918|NCT01235949|471676248|FG007|Booster Phase|Withdrawal by Subject|1|||
131012919|NCT01235949|471676249|FG008|Booster Phase|Withdrawal by Subject|1|||
131012920|NCT01235949|471676250|FG009|Booster Phase|Withdrawal by Subject|0|||
131012921|NCT01235949|471676251|FG010|Booster Phase|Withdrawal by Subject|1|||
131012922|NCT01235949|471676252|FG011|Booster Phase|Withdrawal by Subject|1|||
131012923|NCT01235949|471676253|FG012|Booster Phase|Withdrawal by Subject|2|||
131012924|NCT01235949|471676254|FG013|Booster Phase|Withdrawal by Subject|0|||
131012925|NCT01235949|471676255|FG014|Booster Phase|Withdrawal by Subject|2|||
131012926|NCT01235949|471676256|FG015|Booster Phase|Withdrawal by Subject|0|||
131012927|NCT01235949|471676257|FG016|Booster Phase|Withdrawal by Subject|0|||
131012928|NCT01235949|471676258|FG017|Booster Phase|Withdrawal by Subject|0|||
131012929|NCT01235949|471676241|FG000|Booster Phase|Lost to Follow-up|0|||
131012930|NCT01235949|471676242|FG001|Booster Phase|Lost to Follow-up|0|||
131012931|NCT01235949|471676243|FG002|Booster Phase|Lost to Follow-up|0|||
131012932|NCT01235949|471676244|FG003|Booster Phase|Lost to Follow-up|0|||
131012933|NCT01235949|471676245|FG004|Booster Phase|Lost to Follow-up|0|||
131012934|NCT01235949|471676246|FG005|Booster Phase|Lost to Follow-up|0|||
131012935|NCT01235949|471676247|FG006|Booster Phase|Lost to Follow-up|0|||
131012936|NCT01235949|471676248|FG007|Booster Phase|Lost to Follow-up|0|||
131012937|NCT01235949|471676249|FG008|Booster Phase|Lost to Follow-up|1|||
131012938|NCT01235949|471676250|FG009|Booster Phase|Lost to Follow-up|1|||
131012939|NCT01235949|471676251|FG010|Booster Phase|Lost to Follow-up|1|||
131012940|NCT01235949|471676252|FG011|Booster Phase|Lost to Follow-up|1|||
131012941|NCT01235949|471676253|FG012|Booster Phase|Lost to Follow-up|0|||
131012942|NCT01235949|471676254|FG013|Booster Phase|Lost to Follow-up|0|||
131012943|NCT01235949|471676255|FG014|Booster Phase|Lost to Follow-up|0|||
131012944|NCT01235949|471676256|FG015|Booster Phase|Lost to Follow-up|0|||
131012945|NCT01235949|471676257|FG016|Booster Phase|Lost to Follow-up|0|||
131012946|NCT01235949|471676258|FG017|Booster Phase|Lost to Follow-up|1|||
131012947|NCT04173572|471676259|FG000|Overall Study|Withdrawal by Subject|1|||
131012948|NCT04173572|471676260|FG001|Overall Study|Withdrawal by Subject|5|||
131012949|NCT04173572|471676259|FG000|Overall Study|Lost to Follow-up|3|||
131012950|NCT04173572|471676260|FG001|Overall Study|Lost to Follow-up|1|||
131012951|NCT00383188|471676261|FG000|Overall Study|Adverse Event|4|||
131012952|NCT00383188|471676262|FG001|Overall Study|Adverse Event|7|||
131012953|NCT00383188|471676263|FG002|Overall Study|Adverse Event|9|||
131012954|NCT00383188|471676264|FG003|Overall Study|Adverse Event|8|||
131012955|NCT00383188|471676265|FG004|Overall Study|Adverse Event|8|||
131012956|NCT00383188|471676261|FG000|Overall Study|Lack of Efficacy|9|||
131012957|NCT00383188|471676262|FG001|Overall Study|Lack of Efficacy|3|||
131012958|NCT00383188|471676263|FG002|Overall Study|Lack of Efficacy|3|||
131012959|NCT00383188|471676264|FG003|Overall Study|Lack of Efficacy|2|||
131012960|NCT00383188|471676265|FG004|Overall Study|Lack of Efficacy|6|||
131012961|NCT00383188|471676261|FG000|Overall Study|Other|3|||
131012962|NCT00383188|471676262|FG001|Overall Study|Other|1|||
131012963|NCT00383188|471676263|FG002|Overall Study|Other|0|||
131012964|NCT00383188|471676264|FG003|Overall Study|Other|2|||
131012965|NCT00383188|471676265|FG004|Overall Study|Other|6|||
131012966|NCT00383188|471676261|FG000|Overall Study|No longer willing to participate|1|||
131012967|NCT00383188|471676262|FG001|Overall Study|No longer willing to participate|0|||
131012968|NCT00383188|471676263|FG002|Overall Study|No longer willing to participate|1|||
131012969|NCT00383188|471676264|FG003|Overall Study|No longer willing to participate|0|||
131012970|NCT00383188|471676265|FG004|Overall Study|No longer willing to participate|2|||
131012971|NCT00383188|471676261|FG000|Overall Study|Lost to Follow-up|0|||
131012972|NCT00383188|471676262|FG001|Overall Study|Lost to Follow-up|0|||
131012973|NCT00383188|471676263|FG002|Overall Study|Lost to Follow-up|0|||
131012974|NCT00383188|471676264|FG003|Overall Study|Lost to Follow-up|0|||
131012975|NCT00383188|471676265|FG004|Overall Study|Lost to Follow-up|1|||
131012976|NCT00835380|471676270|FG000|Overall Study|Withdrawal by Subject|2|||
131012977|NCT03247543|471676271|FG000|Overall Study|Adverse Event|3|||
131012978|NCT03247543|471676272|FG001|Overall Study|Adverse Event|6|||
131012979|NCT03247543|471676273|FG002|Overall Study|Adverse Event|4|||
131012980|NCT03247543|471676271|FG000|Overall Study|Lost to Follow-up|10|||
131012981|NCT03247543|471676272|FG001|Overall Study|Lost to Follow-up|7|||
131012982|NCT03247543|471676273|FG002|Overall Study|Lost to Follow-up|8|||
131012983|NCT03247543|471676271|FG000|Overall Study|Consent withdrawn by caregiver|2|||
131012984|NCT03247543|471676272|FG001|Overall Study|Consent withdrawn by caregiver|2|||
131012985|NCT03247543|471676273|FG002|Overall Study|Consent withdrawn by caregiver|9|||
131012986|NCT03247543|471676271|FG000|Overall Study|Withdrawal by Subject|0|||
131012987|NCT03247543|471676272|FG001|Overall Study|Withdrawal by Subject|0|||
131012988|NCT03247543|471676273|FG002|Overall Study|Withdrawal by Subject|1|||
131012989|NCT03247543|471676271|FG000|Overall Study|Failure to Follow study procedures|1|||
131012990|NCT03247543|471676272|FG001|Overall Study|Failure to Follow study procedures|3|||
131012991|NCT03247543|471676273|FG002|Overall Study|Failure to Follow study procedures|1|||
131012992|NCT03247543|471676271|FG000|Overall Study|Lack of Efficacy|1|||
131012993|NCT03247543|471676272|FG001|Overall Study|Lack of Efficacy|0|||
131012994|NCT03247543|471676273|FG002|Overall Study|Lack of Efficacy|0|||
131012995|NCT03247543|471676271|FG000|Overall Study|Non-compliance with study visits|0|||
131012996|NCT03247543|471676272|FG001|Overall Study|Non-compliance with study visits|1|||
131012997|NCT03247543|471676273|FG002|Overall Study|Non-compliance with study visits|0|||
131012998|NCT02059980|471676276|FG000|Overall Study|Lost to Follow-up|2|||
131012999|NCT02059980|471676277|FG001|Overall Study|Lost to Follow-up|1|||
131013000|NCT01104415|471676278|FG000|Core Phase|Consent withdrawn by subjects|1|||
131013001|NCT01104415|471676279|FG001|Core Phase|Consent withdrawn by subjects|0|||
131013002|NCT01104415|471676278|FG000|Extension Period|Progressive disease|0|||
131013003|NCT01104415|471676279|FG001|Extension Period|Progressive disease|4|||
131013004|NCT01104415|471676278|FG000|Extension Period|Death|0|||
131013005|NCT01104415|471676279|FG001|Extension Period|Death|1|||
131013006|NCT01104415|471676278|FG000|Extension Period|Physician Decision|0|||
131013007|NCT01104415|471676279|FG001|Extension Period|Physician Decision|1|||
131013008|NCT01104415|471676278|FG000|Extension Period|Transition to Study LX1606.302|0|||
131013009|NCT01104415|471676279|FG001|Extension Period|Transition to Study LX1606.302|4|||
131013010|NCT01104415|471676278|FG000|Extension Period|Heart surgery/feeling miserable|0|||
131013011|NCT01104415|471676279|FG001|Extension Period|Heart surgery/feeling miserable|1|||
131013012|NCT02341625|471676284|FG000|Overall Study|Disease Progression|2|||
131013013|NCT02341625|471676285|FG001|Overall Study|Disease Progression|2|||
131013014|NCT02341625|471676286|FG002|Overall Study|Disease Progression|3|||
131013015|NCT02341625|471676287|FG003|Overall Study|Disease Progression|6|||
131013016|NCT02341625|471676288|FG004|Overall Study|Disease Progression|7|||
131013017|NCT02341625|471676289|FG005|Overall Study|Disease Progression|7|||
131013018|NCT02341625|471676290|FG006|Overall Study|Disease Progression|28|||
131013019|NCT02341625|471676291|FG007|Overall Study|Disease Progression|5|||
131013020|NCT02341625|471676292|FG008|Overall Study|Disease Progression|4|||
131013021|NCT02341625|471676293|FG009|Overall Study|Disease Progression|19|||
131013022|NCT02341625|471676284|FG000|Overall Study|Study Drug Toxicity|0|||
131013023|NCT02341625|471676285|FG001|Overall Study|Study Drug Toxicity|0|||
131013024|NCT02341625|471676286|FG002|Overall Study|Study Drug Toxicity|0|||
131013025|NCT02341625|471676287|FG003|Overall Study|Study Drug Toxicity|1|||
131013026|NCT02341625|471676288|FG004|Overall Study|Study Drug Toxicity|0|||
131013027|NCT02341625|471676289|FG005|Overall Study|Study Drug Toxicity|3|||
131013028|NCT02341625|471676290|FG006|Overall Study|Study Drug Toxicity|10|||
131013029|NCT02341625|471676291|FG007|Overall Study|Study Drug Toxicity|0|||
131013030|NCT02341625|471676292|FG008|Overall Study|Study Drug Toxicity|0|||
131013031|NCT02341625|471676293|FG009|Overall Study|Study Drug Toxicity|3|||
131013032|NCT02341625|471676284|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131013033|NCT02341625|471676285|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131013034|NCT02341625|471676286|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131013035|NCT02341625|471676287|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131013036|NCT02341625|471676288|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131013037|NCT02341625|471676289|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131013038|NCT02341625|471676290|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
131013039|NCT02341625|471676291|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
131013040|NCT02341625|471676292|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131013041|NCT02341625|471676293|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
131013042|NCT02341625|471676284|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131013043|NCT02341625|471676285|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131013044|NCT02341625|471676286|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131013045|NCT02341625|471676287|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131013046|NCT02341625|471676288|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131013047|NCT02341625|471676289|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131013048|NCT02341625|471676290|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
131013049|NCT02341625|471676291|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
131013050|NCT02341625|471676292|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131013051|NCT02341625|471676293|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
131013052|NCT02341625|471676284|FG000|Overall Study|Participant Withdrew Consent|0|||
131013053|NCT02341625|471676285|FG001|Overall Study|Participant Withdrew Consent|0|||
131013054|NCT02341625|471676286|FG002|Overall Study|Participant Withdrew Consent|0|||
131013055|NCT02341625|471676287|FG003|Overall Study|Participant Withdrew Consent|1|||
131013056|NCT02341625|471676288|FG004|Overall Study|Participant Withdrew Consent|0|||
131013057|NCT02341625|471676289|FG005|Overall Study|Participant Withdrew Consent|0|||
131013058|NCT02341625|471676290|FG006|Overall Study|Participant Withdrew Consent|0|||
131013059|NCT02341625|471676291|FG007|Overall Study|Participant Withdrew Consent|0|||
131013060|NCT02341625|471676292|FG008|Overall Study|Participant Withdrew Consent|0|||
131013061|NCT02341625|471676293|FG009|Overall Study|Participant Withdrew Consent|0|||
131013062|NCT02341625|471676284|FG000|Overall Study|Completed Treatment as per Protocol|0|||
131013063|NCT02341625|471676285|FG001|Overall Study|Completed Treatment as per Protocol|0|||
131013064|NCT02341625|471676286|FG002|Overall Study|Completed Treatment as per Protocol|0|||
131013065|NCT02341625|471676287|FG003|Overall Study|Completed Treatment as per Protocol|0|||
131013066|NCT02341625|471676288|FG004|Overall Study|Completed Treatment as per Protocol|0|||
131013067|NCT02341625|471676289|FG005|Overall Study|Completed Treatment as per Protocol|0|||
131013068|NCT02341625|471676290|FG006|Overall Study|Completed Treatment as per Protocol|0|||
131013069|NCT02341625|471676291|FG007|Overall Study|Completed Treatment as per Protocol|0|||
131013070|NCT02341625|471676292|FG008|Overall Study|Completed Treatment as per Protocol|0|||
131013071|NCT02341625|471676293|FG009|Overall Study|Completed Treatment as per Protocol|1|||
131013072|NCT02341625|471676284|FG000|Overall Study|Other Reasons|0|||
131013073|NCT02341625|471676285|FG001|Overall Study|Other Reasons|0|||
131013074|NCT02341625|471676286|FG002|Overall Study|Other Reasons|0|||
131013075|NCT02341625|471676287|FG003|Overall Study|Other Reasons|0|||
131013076|NCT02341625|471676288|FG004|Overall Study|Other Reasons|1|||
131013077|NCT02341625|471676289|FG005|Overall Study|Other Reasons|0|||
131013078|NCT02341625|471676290|FG006|Overall Study|Other Reasons|5|||
131013079|NCT02341625|471676291|FG007|Overall Study|Other Reasons|0|||
131013080|NCT02341625|471676292|FG008|Overall Study|Other Reasons|0|||
131013081|NCT02341625|471676293|FG009|Overall Study|Other Reasons|2|||
131013082|NCT02341625|471676284|FG000|Overall Study|Not Reported|0|||
131013083|NCT02341625|471676285|FG001|Overall Study|Not Reported|0|||
131013084|NCT02341625|471676286|FG002|Overall Study|Not Reported|0|||
131013085|NCT02341625|471676287|FG003|Overall Study|Not Reported|0|||
131013086|NCT02341625|471676288|FG004|Overall Study|Not Reported|0|||
131013087|NCT02341625|471676289|FG005|Overall Study|Not Reported|0|||
131013088|NCT02341625|471676290|FG006|Overall Study|Not Reported|0|||
131013089|NCT02341625|471676291|FG007|Overall Study|Not Reported|0|||
131013090|NCT02341625|471676292|FG008|Overall Study|Not Reported|0|||
131013091|NCT02341625|471676293|FG009|Overall Study|Not Reported|3|||
131013092|NCT01839877|471676296|FG000|Overall Study|Protocol Violation|1|||
131013093|NCT03098030|471676297|FG000|Overall Study|Death|10|||
131013094|NCT03098030|471676298|FG001|Overall Study|Death|156|||
131013095|NCT03098030|471676299|FG002|Overall Study|Death|156|||
131013096|NCT03098030|471676300|FG003|Overall Study|Death|82|||
131013097|NCT03098030|471676297|FG000|Overall Study|Withdrawal by Subject|0|||
131013098|NCT03098030|471676298|FG001|Overall Study|Withdrawal by Subject|7|||
131013099|NCT03098030|471676299|FG002|Overall Study|Withdrawal by Subject|8|||
131013100|NCT03098030|471676300|FG003|Overall Study|Withdrawal by Subject|2|||
131013101|NCT03098030|471676297|FG000|Overall Study|Lost to Follow-up|0|||
131013102|NCT03098030|471676298|FG001|Overall Study|Lost to Follow-up|0|||
131013103|NCT03098030|471676299|FG002|Overall Study|Lost to Follow-up|2|||
131013104|NCT03098030|471676300|FG003|Overall Study|Lost to Follow-up|1|||
131013105|NCT03643211|471676301|FG000|Overall Study|Contract violation/deficiency|12|||
131013106|NCT03643211|471676301|FG000|Overall Study|Invalid registration|3|||
131013107|NCT03643211|471676301|FG000|Overall Study|No treatment information|2|||
131013108|NCT03643211|471676301|FG000|Overall Study|No adverse event information - No revisit|4|||
131013109|NCT03368001|471676302|FG000|Allocation|Lost to Pretest|16|||
131013110|NCT03368001|471676303|FG001|Allocation|Lost to Pretest|25|||
131013111|NCT03368001|471676302|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
131013112|NCT03368001|471676303|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
131013113|NCT03368001|471676302|FG000|Posttest|Lost to Posttest|7|||
131013114|NCT03368001|471676303|FG001|Posttest|Lost to Posttest|11|||
131013115|NCT03368001|471676302|FG000|Posttest|Discontinued Intervention|6|||
131013116|NCT03368001|471676303|FG001|Posttest|Discontinued Intervention|19|||
131013117|NCT03368001|471676302|FG000|Follow-up|Lost to Follow-up|6|||
131013118|NCT03368001|471676303|FG001|Follow-up|Lost to Follow-up|3|||
131013119|NCT00554801|471676304|FG000|Overall Study|left area before completion|5|||
131013120|NCT00554801|471676305|FG001|Overall Study|left area before completion|0|||
131013121|NCT00554801|471676304|FG000|Overall Study|Withdrawal by Subject|14|||
131013122|NCT00554801|471676305|FG001|Overall Study|Withdrawal by Subject|0|||
131013123|NCT04436120|471676306|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
131013124|NCT04436120|471676307|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
131013125|NCT04436120|471676308|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
131013126|NCT04436120|471676309|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
131013127|NCT04436120|471676310|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
131013128|NCT04436120|471676311|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
131013129|NCT04436120|471676312|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
131013130|NCT01981356|471676313|FG000|Overall Study|Lost to Follow-up|4|||
131013131|NCT01981356|471676314|FG001|Overall Study|Lost to Follow-up|1|||
131013132|NCT01981356|471676313|FG000|Overall Study|Withdrawal by Subject|1|||
131013133|NCT01981356|471676314|FG001|Overall Study|Withdrawal by Subject|1|||
131013134|NCT01981356|471676313|FG000|Overall Study|Protocol Violation|2|||
131013135|NCT01981356|471676314|FG001|Overall Study|Protocol Violation|0|||
131013136|NCT02685033|471676315|FG000|Overall Study|Withdrawal of Consent|0|||
131013137|NCT02685033|471676316|FG001|Overall Study|Withdrawal of Consent|1|||
131013138|NCT02685033|471676315|FG000|Overall Study|Lost to Follow-up|2|||
131013139|NCT02685033|471676316|FG001|Overall Study|Lost to Follow-up|1|||
131013140|NCT02685033|471676315|FG000|Overall Study|Adverse Event|1|||
131013141|NCT02685033|471676316|FG001|Overall Study|Adverse Event|0|||
131013142|NCT01875250|471678029|FG000|Overall Study|Adverse Event|2|||
131013143|NCT01875250|471678030|FG001|Overall Study|Adverse Event|0|||
131013144|NCT03140176|471678031|FG000|Overall Study|Reason missing|23|||
131013145|NCT03140176|471678031|FG000|Overall Study|Death|33|||
131013146|NCT03140176|471678031|FG000|Overall Study|Disease progression|1|||
131013147|NCT03140176|471678031|FG000|Overall Study|Physician Decision|1|||
131013148|NCT03140176|471678031|FG000|Overall Study|Withdrawal by Subject|1|||
131013149|NCT03140176|471678031|FG000|Overall Study|Lost to Follow-up|15|||
131013150|NCT00149630|471678035|FG000|Overall Study|Incarceration|2|||
131013151|NCT00149630|471678036|FG001|Overall Study|Incarceration|0|||
131013152|NCT00149630|471678035|FG000|Overall Study|Treatment Programs|4|||
131013153|NCT00149630|471678036|FG001|Overall Study|Treatment Programs|5|||
131013154|NCT00149630|471678035|FG000|Overall Study|Adverse Event|2|||
131013155|NCT00149630|471678036|FG001|Overall Study|Adverse Event|0|||
131013156|NCT00486759|471678039|FG000|Treatment|Adverse event/intercurrent illness|86|||
131013157|NCT00486759|471678040|FG001|Treatment|Adverse event/intercurrent illness|39|||
131013158|NCT00486759|471678039|FG000|Treatment|Insufficient therapeutic response|37|||
131013159|NCT00486759|471678040|FG001|Treatment|Insufficient therapeutic response|39|||
131013160|NCT00486759|471678039|FG000|Treatment|Death|17|||
131013161|NCT00486759|471678040|FG001|Treatment|Death|10|||
131013162|NCT00486759|471678039|FG000|Treatment|Withdrew consent|15|||
131013163|NCT00486759|471678040|FG001|Treatment|Withdrew consent|12|||
131013164|NCT00486759|471678039|FG000|Treatment|Administrative/reason not specified|17|||
131013165|NCT00486759|471678040|FG001|Treatment|Administrative/reason not specified|21|||
131013166|NCT00486759|471678039|FG000|Treatment|Refused treatment|10|||
131013167|NCT00486759|471678040|FG001|Treatment|Refused treatment|7|||
131013168|NCT00486759|471678039|FG000|Treatment|Violation of selection criteria at entry|3|||
131013169|NCT00486759|471678040|FG001|Treatment|Violation of selection criteria at entry|3|||
131013170|NCT00486759|471678039|FG000|Treatment|Other protocol violation|1|||
131013171|NCT00486759|471678040|FG001|Treatment|Other protocol violation|5|||
131013172|NCT00486759|471678039|FG000|Treatment|Failure to return|1|||
131013173|NCT00486759|471678040|FG001|Treatment|Failure to return|1|||
131013174|NCT00486759|471678039|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
131013175|NCT00486759|471678040|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
131013176|NCT00486759|471678039|FG000|Safety Follow-up|Death|40|||
131013177|NCT00486759|471678040|FG001|Safety Follow-up|Death|29|||
131013178|NCT00486759|471678039|FG000|Safety Follow-up|Withdrew consent|32|||
131013179|NCT00486759|471678040|FG001|Safety Follow-up|Withdrew consent|23|||
131013180|NCT00486759|471678039|FG000|Safety Follow-up|Failure to return|9|||
131013181|NCT00486759|471678040|FG001|Safety Follow-up|Failure to return|6|||
131013182|NCT00486759|471678039|FG000|Safety Follow-up|Administrative/not specified|8|||
131013183|NCT00486759|471678040|FG001|Safety Follow-up|Administrative/not specified|6|||
131013184|NCT00486759|471678039|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
131013185|NCT00486759|471678040|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
131013186|NCT00486759|471678039|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
131013187|NCT00486759|471678040|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
131013188|NCT02001623|471678041|FG000|Overall Study|Disease Progression|2|||
131013189|NCT02001623|471678042|FG001|Overall Study|Disease Progression|2|||
131013190|NCT02001623|471678043|FG002|Overall Study|Disease Progression|3|||
131013191|NCT02001623|471678044|FG003|Overall Study|Disease Progression|2|||
131013192|NCT02001623|471678045|FG004|Overall Study|Disease Progression|3|||
131013193|NCT02001623|471678046|FG005|Overall Study|Disease Progression|2|||
131013194|NCT02001623|471678047|FG006|Overall Study|Disease Progression|3|||
131013195|NCT02001623|471678048|FG007|Overall Study|Disease Progression|3|||
131013196|NCT02001623|471678049|FG008|Overall Study|Disease Progression|7|||
131013197|NCT02001623|471678050|FG009|Overall Study|Disease Progression|40|||
131013198|NCT02001623|471678051|FG010|Overall Study|Disease Progression|5|||
131013199|NCT02001623|471678052|FG011|Overall Study|Disease Progression|9|||
131013200|NCT02001623|471678053|FG012|Overall Study|Disease Progression|9|||
131013201|NCT02001623|471678054|FG013|Overall Study|Disease Progression|20|||
131013202|NCT02001623|471678055|FG014|Overall Study|Disease Progression|9|||
131013203|NCT02001623|471678041|FG000|Overall Study|Physician Decision|0|||
131013204|NCT02001623|471678042|FG001|Overall Study|Physician Decision|0|||
131013205|NCT02001623|471678043|FG002|Overall Study|Physician Decision|0|||
131013206|NCT02001623|471678044|FG003|Overall Study|Physician Decision|0|||
131013207|NCT02001623|471678045|FG004|Overall Study|Physician Decision|0|||
131013208|NCT02001623|471678046|FG005|Overall Study|Physician Decision|0|||
131013209|NCT02001623|471678047|FG006|Overall Study|Physician Decision|0|||
131013210|NCT02001623|471678048|FG007|Overall Study|Physician Decision|0|||
131013211|NCT02001623|471678049|FG008|Overall Study|Physician Decision|3|||
131013212|NCT02001623|471678050|FG009|Overall Study|Physician Decision|2|||
131013213|NCT02001623|471678051|FG010|Overall Study|Physician Decision|3|||
131013214|NCT02001623|471678052|FG011|Overall Study|Physician Decision|3|||
131013215|NCT02001623|471678053|FG012|Overall Study|Physician Decision|1|||
131013216|NCT02001623|471678054|FG013|Overall Study|Physician Decision|2|||
131013217|NCT02001623|471678055|FG014|Overall Study|Physician Decision|1|||
131013218|NCT02001623|471678041|FG000|Overall Study|Death|0|||
131013219|NCT02001623|471678042|FG001|Overall Study|Death|1|||
131013220|NCT02001623|471678043|FG002|Overall Study|Death|0|||
131013221|NCT02001623|471678044|FG003|Overall Study|Death|0|||
131013222|NCT02001623|471678045|FG004|Overall Study|Death|0|||
131013223|NCT02001623|471678046|FG005|Overall Study|Death|0|||
131013224|NCT02001623|471678047|FG006|Overall Study|Death|0|||
131013225|NCT02001623|471678048|FG007|Overall Study|Death|0|||
131013226|NCT02001623|471678049|FG008|Overall Study|Death|0|||
131013227|NCT02001623|471678050|FG009|Overall Study|Death|0|||
131013228|NCT02001623|471678051|FG010|Overall Study|Death|0|||
131013229|NCT02001623|471678052|FG011|Overall Study|Death|0|||
131013230|NCT02001623|471678053|FG012|Overall Study|Death|0|||
131013231|NCT02001623|471678054|FG013|Overall Study|Death|0|||
131013232|NCT02001623|471678055|FG014|Overall Study|Death|0|||
131013233|NCT02001623|471678041|FG000|Overall Study|Adverse Event|0|||
131013234|NCT02001623|471678042|FG001|Overall Study|Adverse Event|0|||
131013235|NCT02001623|471678043|FG002|Overall Study|Adverse Event|0|||
131013236|NCT02001623|471678044|FG003|Overall Study|Adverse Event|0|||
131013237|NCT02001623|471678045|FG004|Overall Study|Adverse Event|0|||
131013238|NCT02001623|471678046|FG005|Overall Study|Adverse Event|1|||
131013239|NCT02001623|471678047|FG006|Overall Study|Adverse Event|0|||
131013240|NCT02001623|471678048|FG007|Overall Study|Adverse Event|3|||
131013241|NCT02001623|471678049|FG008|Overall Study|Adverse Event|4|||
131013242|NCT02001623|471678050|FG009|Overall Study|Adverse Event|6|||
131013243|NCT02001623|471678051|FG010|Overall Study|Adverse Event|4|||
131013244|NCT02001623|471678052|FG011|Overall Study|Adverse Event|0|||
131013245|NCT02001623|471678053|FG012|Overall Study|Adverse Event|3|||
131013246|NCT02001623|471678054|FG013|Overall Study|Adverse Event|5|||
131013247|NCT02001623|471678055|FG014|Overall Study|Adverse Event|6|||
131013248|NCT02001623|471678041|FG000|Overall Study|Other - Miscellaneous|0|||
131013249|NCT02001623|471678042|FG001|Overall Study|Other - Miscellaneous|0|||
131013250|NCT02001623|471678043|FG002|Overall Study|Other - Miscellaneous|0|||
131013251|NCT02001623|471678044|FG003|Overall Study|Other - Miscellaneous|0|||
131013252|NCT02001623|471678045|FG004|Overall Study|Other - Miscellaneous|0|||
131013253|NCT02001623|471678046|FG005|Overall Study|Other - Miscellaneous|0|||
131013254|NCT02001623|471678047|FG006|Overall Study|Other - Miscellaneous|0|||
131013255|NCT02001623|471678048|FG007|Overall Study|Other - Miscellaneous|0|||
131013256|NCT02001623|471678049|FG008|Overall Study|Other - Miscellaneous|0|||
131013257|NCT02001623|471678050|FG009|Overall Study|Other - Miscellaneous|1|||
131013258|NCT02001623|471678051|FG010|Overall Study|Other - Miscellaneous|0|||
131013259|NCT02001623|471678052|FG011|Overall Study|Other - Miscellaneous|0|||
131013260|NCT02001623|471678053|FG012|Overall Study|Other - Miscellaneous|0|||
131013261|NCT02001623|471678054|FG013|Overall Study|Other - Miscellaneous|1|||
131013262|NCT02001623|471678055|FG014|Overall Study|Other - Miscellaneous|0|||
131013263|NCT02001623|471678041|FG000|Overall Study|Withdrawal by Subject|1|||
131013264|NCT02001623|471678042|FG001|Overall Study|Withdrawal by Subject|0|||
131013265|NCT02001623|471678043|FG002|Overall Study|Withdrawal by Subject|0|||
131013266|NCT02001623|471678044|FG003|Overall Study|Withdrawal by Subject|0|||
131013267|NCT02001623|471678045|FG004|Overall Study|Withdrawal by Subject|0|||
131013268|NCT02001623|471678046|FG005|Overall Study|Withdrawal by Subject|0|||
131013269|NCT02001623|471678047|FG006|Overall Study|Withdrawal by Subject|0|||
131013270|NCT02001623|471678048|FG007|Overall Study|Withdrawal by Subject|0|||
131013271|NCT02001623|471678049|FG008|Overall Study|Withdrawal by Subject|1|||
131013272|NCT02001623|471678050|FG009|Overall Study|Withdrawal by Subject|3|||
131013273|NCT02001623|471678051|FG010|Overall Study|Withdrawal by Subject|2|||
131013274|NCT02001623|471678052|FG011|Overall Study|Withdrawal by Subject|2|||
131013275|NCT02001623|471678053|FG012|Overall Study|Withdrawal by Subject|1|||
131013276|NCT02001623|471678054|FG013|Overall Study|Withdrawal by Subject|5|||
131013277|NCT02001623|471678055|FG014|Overall Study|Withdrawal by Subject|2|||
131013278|NCT02001623|471678041|FG000|Overall Study|Lost to Follow-up|0|||
131013279|NCT02001623|471678042|FG001|Overall Study|Lost to Follow-up|0|||
131013280|NCT02001623|471678043|FG002|Overall Study|Lost to Follow-up|0|||
131013281|NCT02001623|471678044|FG003|Overall Study|Lost to Follow-up|0|||
131013282|NCT02001623|471678045|FG004|Overall Study|Lost to Follow-up|0|||
131100948|NCT03541174|471999585|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
131100949|NCT03541174|471999586|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
131100950|NCT03541174|471999587|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
131100951|NCT03541174|471999582|FG000|Part 1 Double-Blind|Other reasons|3|||
131100952|NCT03541174|471999583|FG001|Part 1 Double-Blind|Other reasons|2|||
131100953|NCT03541174|471999584|FG002|Part 1 Double-Blind|Other reasons|3|||
131100954|NCT03541174|471999585|FG003|Part 1 Double-Blind|Other reasons|0|||
131100955|NCT03541174|471999586|FG004|Part 1 Double-Blind|Other reasons|0|||
131100956|NCT03541174|471999587|FG005|Part 1 Double-Blind|Other reasons|0|||
131100957|NCT03541174|471999582|FG000|Part 2 Single-Blind|Adverse Event|0|||
131100958|NCT03541174|471999583|FG001|Part 2 Single-Blind|Adverse Event|0|||
131100959|NCT03541174|471999584|FG002|Part 2 Single-Blind|Adverse Event|0|||
131100960|NCT03541174|471999585|FG003|Part 2 Single-Blind|Adverse Event|25|||
131100961|NCT03541174|471999586|FG004|Part 2 Single-Blind|Adverse Event|0|||
131100962|NCT03541174|471999587|FG005|Part 2 Single-Blind|Adverse Event|0|||
131100963|NCT03541174|471999582|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
131100964|NCT03541174|471999583|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
131100965|NCT03541174|471999584|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
131100966|NCT03541174|471999585|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
131100967|NCT03541174|471999586|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
131100968|NCT03541174|471999587|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
131100969|NCT03541174|471999582|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
131100970|NCT03541174|471999583|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
131100971|NCT03541174|471999584|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
131100972|NCT03541174|471999585|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
131100973|NCT03541174|471999586|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
131013283|NCT02001623|471678046|FG005|Overall Study|Lost to Follow-up|0|||
131013284|NCT02001623|471678047|FG006|Overall Study|Lost to Follow-up|0|||
131013285|NCT02001623|471678048|FG007|Overall Study|Lost to Follow-up|0|||
131013286|NCT02001623|471678049|FG008|Overall Study|Lost to Follow-up|0|||
131013287|NCT02001623|471678050|FG009|Overall Study|Lost to Follow-up|1|||
131013288|NCT02001623|471678051|FG010|Overall Study|Lost to Follow-up|0|||
131013289|NCT02001623|471678052|FG011|Overall Study|Lost to Follow-up|0|||
131013290|NCT02001623|471678053|FG012|Overall Study|Lost to Follow-up|0|||
131013291|NCT02001623|471678054|FG013|Overall Study|Lost to Follow-up|0|||
131013292|NCT02001623|471678055|FG014|Overall Study|Lost to Follow-up|0|||
131013293|NCT02001623|471678041|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
131013294|NCT02001623|471678042|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
131013295|NCT02001623|471678043|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
131013296|NCT02001623|471678044|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
131013297|NCT02001623|471678045|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
131013298|NCT02001623|471678046|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
131013299|NCT02001623|471678047|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
131013300|NCT02001623|471678048|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
131013301|NCT02001623|471678049|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
131013302|NCT02001623|471678050|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
131013303|NCT02001623|471678051|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
131013304|NCT02001623|471678052|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
131013305|NCT02001623|471678053|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
131013306|NCT02001623|471678054|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
131100974|NCT03541174|471999587|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
131100975|NCT03541174|471999582|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
131100976|NCT03541174|471999583|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
131013307|NCT02001623|471678055|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
131013308|NCT02001623|471678041|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
131013309|NCT02001623|471678042|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
131013310|NCT02001623|471678043|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
131013311|NCT02001623|471678044|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
131013312|NCT02001623|471678045|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
131013313|NCT02001623|471678046|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
131013314|NCT02001623|471678047|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
131013315|NCT02001623|471678048|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
131013316|NCT02001623|471678049|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
131013317|NCT02001623|471678050|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
131013318|NCT02001623|471678051|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
131013319|NCT02001623|471678052|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
131013320|NCT02001623|471678053|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
131013321|NCT02001623|471678054|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
131013322|NCT02001623|471678055|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
131013323|NCT00309452|471678056|FG000|Overall Study|Withdrawal by Subject|3|||
131013324|NCT00309452|471678057|FG001|Overall Study|Withdrawal by Subject|0|||
131013325|NCT00771667|471678058|FG000|Induction Phase|Adverse Event|5|||
131013326|NCT00771667|471678059|FG001|Induction Phase|Adverse Event|2|||
131013327|NCT00771667|471678060|FG002|Induction Phase|Adverse Event|4|||
131013328|NCT00771667|471678061|FG003|Induction Phase|Adverse Event|1|||
131013329|NCT00771667|471678062|FG004|Induction Phase|Adverse Event|0|||
131013330|NCT00771667|471678063|FG005|Induction Phase|Adverse Event|0|||
131013331|NCT00771667|471678064|FG006|Induction Phase|Adverse Event|0|||
131013332|NCT00771667|471678065|FG007|Induction Phase|Adverse Event|0|||
131013333|NCT00771667|471678066|FG008|Induction Phase|Adverse Event|0|||
131013334|NCT00771667|471678067|FG009|Induction Phase|Adverse Event|0|||
131013335|NCT00771667|471678058|FG000|Induction Phase|Lack of Efficacy|9|||
131013336|NCT00771667|471678059|FG001|Induction Phase|Lack of Efficacy|2|||
131013337|NCT00771667|471678060|FG002|Induction Phase|Lack of Efficacy|4|||
131013338|NCT00771667|471678061|FG003|Induction Phase|Lack of Efficacy|3|||
131013339|NCT00771667|471678062|FG004|Induction Phase|Lack of Efficacy|0|||
131013340|NCT00771667|471678063|FG005|Induction Phase|Lack of Efficacy|0|||
131013341|NCT00771667|471678064|FG006|Induction Phase|Lack of Efficacy|0|||
131013342|NCT00771667|471678065|FG007|Induction Phase|Lack of Efficacy|0|||
131013343|NCT00771667|471678066|FG008|Induction Phase|Lack of Efficacy|0|||
131013344|NCT00771667|471678067|FG009|Induction Phase|Lack of Efficacy|0|||
131013345|NCT00771667|471678058|FG000|Induction Phase|Lost to Follow-up|1|||
131013346|NCT00771667|471678059|FG001|Induction Phase|Lost to Follow-up|0|||
131013347|NCT00771667|471678060|FG002|Induction Phase|Lost to Follow-up|1|||
131013348|NCT00771667|471678061|FG003|Induction Phase|Lost to Follow-up|0|||
131013349|NCT00771667|471678062|FG004|Induction Phase|Lost to Follow-up|0|||
131013350|NCT00771667|471678063|FG005|Induction Phase|Lost to Follow-up|0|||
131013351|NCT00771667|471678064|FG006|Induction Phase|Lost to Follow-up|0|||
131013352|NCT00771667|471678065|FG007|Induction Phase|Lost to Follow-up|0|||
131013353|NCT00771667|471678066|FG008|Induction Phase|Lost to Follow-up|0|||
131013354|NCT00771667|471678067|FG009|Induction Phase|Lost to Follow-up|0|||
131013355|NCT00771667|471678058|FG000|Induction Phase|Other|4|||
131013356|NCT00771667|471678059|FG001|Induction Phase|Other|6|||
131013357|NCT00771667|471678060|FG002|Induction Phase|Other|3|||
131013358|NCT00771667|471678061|FG003|Induction Phase|Other|4|||
131013359|NCT00771667|471678062|FG004|Induction Phase|Other|0|||
131013360|NCT00771667|471678063|FG005|Induction Phase|Other|0|||
131013361|NCT00771667|471678064|FG006|Induction Phase|Other|0|||
131013362|NCT00771667|471678065|FG007|Induction Phase|Other|0|||
131013363|NCT00771667|471678066|FG008|Induction Phase|Other|0|||
131013364|NCT00771667|471678067|FG009|Induction Phase|Other|0|||
131100977|NCT03541174|471999584|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
131100978|NCT03541174|471999585|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
131100979|NCT03541174|471999586|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
131100980|NCT03541174|471999587|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
131100981|NCT03541174|471999582|FG000|Part 2 Single-Blind|Death|0|||
131100982|NCT03541174|471999583|FG001|Part 2 Single-Blind|Death|0|||
131100983|NCT03541174|471999584|FG002|Part 2 Single-Blind|Death|0|||
131100984|NCT03541174|471999585|FG003|Part 2 Single-Blind|Death|5|||
131100985|NCT03541174|471999586|FG004|Part 2 Single-Blind|Death|0|||
131100986|NCT03541174|471999587|FG005|Part 2 Single-Blind|Death|0|||
131100987|NCT03541174|471999582|FG000|Part 2 Single-Blind|Pregnancy|0|||
131013365|NCT00771667|471678058|FG000|Maintenance Phase|Adverse Event|0|||
131013366|NCT00771667|471678059|FG001|Maintenance Phase|Adverse Event|0|||
131013367|NCT00771667|471678060|FG002|Maintenance Phase|Adverse Event|0|||
131013368|NCT00771667|471678061|FG003|Maintenance Phase|Adverse Event|0|||
131013369|NCT00771667|471678062|FG004|Maintenance Phase|Adverse Event|1|||
131013370|NCT00771667|471678063|FG005|Maintenance Phase|Adverse Event|3|||
131013371|NCT00771667|471678064|FG006|Maintenance Phase|Adverse Event|5|||
131013372|NCT00771667|471678065|FG007|Maintenance Phase|Adverse Event|1|||
131100988|NCT03541174|471999583|FG001|Part 2 Single-Blind|Pregnancy|0|||
131013373|NCT00771667|471678066|FG008|Maintenance Phase|Adverse Event|8|||
131013374|NCT00771667|471678067|FG009|Maintenance Phase|Adverse Event|7|||
131100989|NCT03541174|471999584|FG002|Part 2 Single-Blind|Pregnancy|0|||
131100990|NCT03541174|471999585|FG003|Part 2 Single-Blind|Pregnancy|1|||
131100991|NCT03541174|471999586|FG004|Part 2 Single-Blind|Pregnancy|0|||
131100992|NCT03541174|471999587|FG005|Part 2 Single-Blind|Pregnancy|0|||
131100993|NCT03541174|471999582|FG000|Part 2 Single-Blind|Other reasons|0|||
131100994|NCT03541174|471999583|FG001|Part 2 Single-Blind|Other reasons|0|||
131100995|NCT03541174|471999584|FG002|Part 2 Single-Blind|Other reasons|0|||
131100996|NCT03541174|471999585|FG003|Part 2 Single-Blind|Other reasons|32|||
131100997|NCT03541174|471999586|FG004|Part 2 Single-Blind|Other reasons|0|||
131100998|NCT03541174|471999587|FG005|Part 2 Single-Blind|Other reasons|0|||
131100999|NCT03541174|471999582|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
131101000|NCT03541174|471999583|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
131101001|NCT03541174|471999584|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
131101002|NCT03541174|471999585|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
131101003|NCT03541174|471999586|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
131101004|NCT03541174|471999587|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
131101005|NCT03541174|471999582|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
131101006|NCT03541174|471999583|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
131101007|NCT03541174|471999584|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
131101008|NCT03541174|471999585|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
131101009|NCT03541174|471999586|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
131101010|NCT03541174|471999587|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
131013375|NCT00771667|471678058|FG000|Maintenance Phase|Lack of Efficacy|0|||
131013376|NCT00771667|471678059|FG001|Maintenance Phase|Lack of Efficacy|0|||
131013377|NCT00771667|471678060|FG002|Maintenance Phase|Lack of Efficacy|0|||
131013378|NCT00771667|471678061|FG003|Maintenance Phase|Lack of Efficacy|0|||
131013379|NCT00771667|471678062|FG004|Maintenance Phase|Lack of Efficacy|1|||
131013380|NCT00771667|471678063|FG005|Maintenance Phase|Lack of Efficacy|3|||
131013381|NCT00771667|471678064|FG006|Maintenance Phase|Lack of Efficacy|3|||
131013382|NCT00771667|471678065|FG007|Maintenance Phase|Lack of Efficacy|2|||
131013383|NCT00771667|471678066|FG008|Maintenance Phase|Lack of Efficacy|11|||
131013384|NCT00771667|471678067|FG009|Maintenance Phase|Lack of Efficacy|7|||
131013385|NCT00771667|471678058|FG000|Maintenance Phase|Other|0|||
131013386|NCT00771667|471678059|FG001|Maintenance Phase|Other|0|||
131013387|NCT00771667|471678060|FG002|Maintenance Phase|Other|0|||
131013388|NCT00771667|471678061|FG003|Maintenance Phase|Other|0|||
131013389|NCT00771667|471678062|FG004|Maintenance Phase|Other|0|||
131013390|NCT00771667|471678063|FG005|Maintenance Phase|Other|1|||
131013391|NCT00771667|471678064|FG006|Maintenance Phase|Other|2|||
131013392|NCT00771667|471678065|FG007|Maintenance Phase|Other|2|||
131013393|NCT00771667|471678066|FG008|Maintenance Phase|Other|3|||
131013394|NCT00771667|471678067|FG009|Maintenance Phase|Other|3|||
131013395|NCT00628862|471678068|FG000|Overall Study|Adverse Event|6|||
131013396|NCT00628862|471678069|FG001|Overall Study|Adverse Event|8|||
131013397|NCT00628862|471678070|FG002|Overall Study|Adverse Event|10|||
131013398|NCT00628862|471678068|FG000|Overall Study|Withdrawal by Subject|4|||
131013399|NCT00628862|471678069|FG001|Overall Study|Withdrawal by Subject|6|||
131013400|NCT00628862|471678070|FG002|Overall Study|Withdrawal by Subject|11|||
131013401|NCT00628862|471678068|FG000|Overall Study|Lost to Follow-up|0|||
131013402|NCT00628862|471678069|FG001|Overall Study|Lost to Follow-up|2|||
131013403|NCT00628862|471678070|FG002|Overall Study|Lost to Follow-up|1|||
131013404|NCT00628862|471678068|FG000|Overall Study|Protocol Violation|1|||
131013405|NCT00628862|471678069|FG001|Overall Study|Protocol Violation|0|||
131013406|NCT00628862|471678070|FG002|Overall Study|Protocol Violation|0|||
131013407|NCT00628862|471678068|FG000|Overall Study|COPD Exacerbation|0|||
131013408|NCT00628862|471678069|FG001|Overall Study|COPD Exacerbation|1|||
131013409|NCT00628862|471678070|FG002|Overall Study|COPD Exacerbation|0|||
131013410|NCT01063036|471678071|FG000|Participants Treated With Study Drug|Adverse Event|1|||
131013411|NCT01063036|471678071|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
131013412|NCT01063036|471678071|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
131013413|NCT01063036|471678071|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
131013414|NCT01063036|471678071|FG000|Participants Treated With Study Drug|Pregnancy|1|||
131013415|NCT01063036|471678071|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
131013416|NCT01063036|471678071|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
131013417|NCT01063036|471678071|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
131013418|NCT02814643|471678072|FG000|Overall Study|Lost to Follow-up|0|||
131013419|NCT02814643|471678073|FG001|Overall Study|Lost to Follow-up|1|||
131013420|NCT02814643|471678072|FG000|Overall Study|Withdrawal by Subject|1|||
131013421|NCT02814643|471678073|FG001|Overall Study|Withdrawal by Subject|2|||
131013422|NCT02263508|471678074|FG000|Overall Study|Withdrawal by Subject|1|||
131013423|NCT02263508|471678075|FG001|Overall Study|Withdrawal by Subject|23|||
131013424|NCT02263508|471678076|FG002|Overall Study|Withdrawal by Subject|17|||
131013425|NCT02263508|471678074|FG000|Overall Study|Sponsor Decision|12|||
131013426|NCT02263508|471678075|FG001|Overall Study|Sponsor Decision|165|||
131013427|NCT02263508|471678076|FG002|Overall Study|Sponsor Decision|182|||
131013428|NCT02263508|471678074|FG000|Overall Study|Lost to Follow-up|2|||
131013429|NCT02263508|471678075|FG001|Overall Study|Lost to Follow-up|7|||
131013430|NCT02263508|471678076|FG002|Overall Study|Lost to Follow-up|7|||
131013431|NCT02263508|471678074|FG000|Overall Study|Death|6|||
131013432|NCT02263508|471678075|FG001|Overall Study|Death|151|||
131013433|NCT02263508|471678076|FG002|Overall Study|Death|140|||
131013434|NCT02174562|471678083|FG000|Overall Study|Withdrawal by Subject|7|||
131013435|NCT02174562|471678084|FG001|Overall Study|Withdrawal by Subject|2|||
131013436|NCT02174562|471678083|FG000|Overall Study|Death|2|||
131013437|NCT02174562|471678084|FG001|Overall Study|Death|0|||
131013438|NCT02174562|471678083|FG000|Overall Study|Lost to Follow-up|0|||
131013439|NCT02174562|471678084|FG001|Overall Study|Lost to Follow-up|3|||
131013440|NCT01833065|471678085|FG000|Overall Study|Adverse Event|6|||
131013441|NCT01833065|471678086|FG001|Overall Study|Adverse Event|1|||
131013442|NCT01833065|471678087|FG002|Overall Study|Adverse Event|0|||
131013443|NCT01833065|471678088|FG003|Overall Study|Adverse Event|2|||
131013444|NCT01833065|471678089|FG004|Overall Study|Adverse Event|3|||
131013445|NCT01833065|471678085|FG000|Overall Study|Protocol Violation|1|||
131013446|NCT01833065|471678086|FG001|Overall Study|Protocol Violation|0|||
131013447|NCT01833065|471678087|FG002|Overall Study|Protocol Violation|0|||
131013448|NCT01833065|471678088|FG003|Overall Study|Protocol Violation|0|||
131013449|NCT01833065|471678089|FG004|Overall Study|Protocol Violation|2|||
131013450|NCT01833065|471678085|FG000|Overall Study|Lost to Follow-up|1|||
131013451|NCT01833065|471678086|FG001|Overall Study|Lost to Follow-up|0|||
131013452|NCT01833065|471678087|FG002|Overall Study|Lost to Follow-up|0|||
131013453|NCT01833065|471678088|FG003|Overall Study|Lost to Follow-up|0|||
131013454|NCT01833065|471678089|FG004|Overall Study|Lost to Follow-up|3|||
131013455|NCT01833065|471678085|FG000|Overall Study|Withdrawal by Subject|6|||
131013456|NCT01833065|471678086|FG001|Overall Study|Withdrawal by Subject|2|||
131013457|NCT01833065|471678087|FG002|Overall Study|Withdrawal by Subject|4|||
131013458|NCT01833065|471678088|FG003|Overall Study|Withdrawal by Subject|3|||
131013459|NCT01833065|471678089|FG004|Overall Study|Withdrawal by Subject|11|||
131013460|NCT01833065|471678085|FG000|Overall Study|Subject's substantial non-compliance|0|||
131013461|NCT01833065|471678086|FG001|Overall Study|Subject's substantial non-compliance|1|||
131013462|NCT01833065|471678087|FG002|Overall Study|Subject's substantial non-compliance|0|||
131013463|NCT01833065|471678088|FG003|Overall Study|Subject's substantial non-compliance|0|||
131013464|NCT01833065|471678089|FG004|Overall Study|Subject's substantial non-compliance|0|||
131013465|NCT01833065|471678085|FG000|Overall Study|Trial terminated by sponsor|8|||
131013466|NCT01833065|471678086|FG001|Overall Study|Trial terminated by sponsor|8|||
131013467|NCT01833065|471678087|FG002|Overall Study|Trial terminated by sponsor|7|||
131013468|NCT01833065|471678088|FG003|Overall Study|Trial terminated by sponsor|3|||
131013469|NCT01833065|471678089|FG004|Overall Study|Trial terminated by sponsor|13|||
131013470|NCT01833065|471678085|FG000|Overall Study|Others|2|||
131013471|NCT01833065|471678086|FG001|Overall Study|Others|1|||
131013472|NCT01833065|471678087|FG002|Overall Study|Others|1|||
131013473|NCT01833065|471678088|FG003|Overall Study|Others|1|||
131013474|NCT01833065|471678089|FG004|Overall Study|Others|4|||
131013475|NCT03201809|471678090|FG000|Overall Study|Lost to Follow-up|2|||
131013476|NCT03201809|471678091|FG001|Overall Study|Lost to Follow-up|0|||
131013477|NCT00864682|471678093|FG000|Overall Study|Protocol Violation|2|||
131013478|NCT00864682|471678094|FG001|Overall Study|Protocol Violation|1|||
131013479|NCT00864682|471678095|FG002|Overall Study|Protocol Violation|2|||
131013480|NCT00957658|471678096|FG000|Overall Study|Death|1|||
131013481|NCT00957658|471678096|FG000|Overall Study|Lost to Follow-up|4|||
131013482|NCT00957658|471678096|FG000|Overall Study|Withdrawal by Subject|12|||
131013483|NCT00957658|471678096|FG000|Overall Study|Revision|1|||
131013484|NCT00957658|471678096|FG000|Overall Study|Incomplete 2 yr data|28|||
131013485|NCT00957658|471678096|FG000|Overall Study|Site termination|10|||
131013486|NCT00957658|471678096|FG000|Overall Study|unwilling/unable to return|2|||
131013487|NCT00957658|471678096|FG000|Overall Study|surgery cancelled|2|||
131013488|NCT00957658|471678096|FG000|Overall Study|Protocol Violation|5|||
131013489|NCT00975806|471678097|FG000|Overall Study|Adverse Event|2|||
131013490|NCT00975806|471678098|FG001|Overall Study|Adverse Event|1|||
131013491|NCT00975806|471678099|FG002|Overall Study|Adverse Event|2|||
131013492|NCT00975806|471678097|FG000|Overall Study|Disease Progression|1|||
131013493|NCT00975806|471678098|FG001|Overall Study|Disease Progression|5|||
131013494|NCT00975806|471678099|FG002|Overall Study|Disease Progression|1|||
131013495|NCT00975806|471678097|FG000|Overall Study|Withdrawal by Subject|1|||
131013496|NCT00975806|471678098|FG001|Overall Study|Withdrawal by Subject|0|||
131101011|NCT03541174|471999582|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
131013497|NCT00975806|471678099|FG002|Overall Study|Withdrawal by Subject|0|||
131013498|NCT00975806|471678097|FG000|Overall Study|Death|0|||
131013499|NCT00975806|471678098|FG001|Overall Study|Death|1|||
131013500|NCT00975806|471678099|FG002|Overall Study|Death|0|||
131013501|NCT00975806|471678097|FG000|Overall Study|Physician decision and disease related|1|||
131013502|NCT00975806|471678098|FG001|Overall Study|Physician decision and disease related|0|||
131013503|NCT00975806|471678099|FG002|Overall Study|Physician decision and disease related|1|||
131013504|NCT00246012|471678100|FG000|Overall Study|Adverse Event|0|||
131013505|NCT00246012|471678101|FG001|Overall Study|Adverse Event|0|||
131013506|NCT00246012|471678102|FG002|Overall Study|Adverse Event|0|||
131013507|NCT00246012|471678103|FG003|Overall Study|Adverse Event|0|||
131013508|NCT00246012|471678104|FG004|Overall Study|Adverse Event|0|||
131013509|NCT00246012|471678105|FG005|Overall Study|Adverse Event|1|||
131013510|NCT00246012|471678106|FG006|Overall Study|Adverse Event|0|||
131013511|NCT00246012|471678107|FG007|Overall Study|Adverse Event|0|||
131013512|NCT00246012|471678108|FG008|Overall Study|Adverse Event|2|||
131013513|NCT00246012|471678100|FG000|Overall Study|Withdrawal by Subject|0|||
131013514|NCT00246012|471678101|FG001|Overall Study|Withdrawal by Subject|0|||
131101012|NCT03541174|471999583|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
131101013|NCT03541174|471999584|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
131101014|NCT03541174|471999585|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
131101015|NCT03541174|471999586|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
131013515|NCT00246012|471678102|FG002|Overall Study|Withdrawal by Subject|0|||
131013516|NCT00246012|471678103|FG003|Overall Study|Withdrawal by Subject|0|||
131013517|NCT00246012|471678104|FG004|Overall Study|Withdrawal by Subject|0|||
131013518|NCT00246012|471678105|FG005|Overall Study|Withdrawal by Subject|1|||
131013519|NCT00246012|471678106|FG006|Overall Study|Withdrawal by Subject|0|||
131013520|NCT00246012|471678107|FG007|Overall Study|Withdrawal by Subject|0|||
131013521|NCT00246012|471678108|FG008|Overall Study|Withdrawal by Subject|0|||
131013522|NCT00246012|471678100|FG000|Overall Study|Disease progression|3|||
131013523|NCT00246012|471678101|FG001|Overall Study|Disease progression|1|||
131013524|NCT00246012|471678102|FG002|Overall Study|Disease progression|2|||
131013525|NCT00246012|471678103|FG003|Overall Study|Disease progression|3|||
131013526|NCT00246012|471678104|FG004|Overall Study|Disease progression|3|||
131013527|NCT00246012|471678105|FG005|Overall Study|Disease progression|25|||
131013528|NCT00246012|471678106|FG006|Overall Study|Disease progression|30|||
131013529|NCT00246012|471678107|FG007|Overall Study|Disease progression|27|||
131013530|NCT00246012|471678108|FG008|Overall Study|Disease progression|26|||
131013531|NCT00246012|471678100|FG000|Overall Study|Other|0|||
131013532|NCT00246012|471678101|FG001|Overall Study|Other|0|||
131013533|NCT00246012|471678102|FG002|Overall Study|Other|0|||
131013534|NCT00246012|471678103|FG003|Overall Study|Other|0|||
131013535|NCT00246012|471678104|FG004|Overall Study|Other|0|||
131013536|NCT00246012|471678105|FG005|Overall Study|Other|0|||
131013537|NCT00246012|471678106|FG006|Overall Study|Other|0|||
131013538|NCT00246012|471678107|FG007|Overall Study|Other|1|||
131013539|NCT00246012|471678108|FG008|Overall Study|Other|0|||
131013540|NCT00246012|471678100|FG000|Overall Study|Randomly assigned but not treated|0|||
131013541|NCT00246012|471678101|FG001|Overall Study|Randomly assigned but not treated|0|||
131013542|NCT00246012|471678102|FG002|Overall Study|Randomly assigned but not treated|0|||
131013543|NCT00246012|471678103|FG003|Overall Study|Randomly assigned but not treated|0|||
131013544|NCT00246012|471678104|FG004|Overall Study|Randomly assigned but not treated|0|||
131013545|NCT00246012|471678105|FG005|Overall Study|Randomly assigned but not treated|1|||
131013546|NCT00246012|471678106|FG006|Overall Study|Randomly assigned but not treated|1|||
131013547|NCT00246012|471678107|FG007|Overall Study|Randomly assigned but not treated|0|||
131013548|NCT00246012|471678108|FG008|Overall Study|Randomly assigned but not treated|0|||
131013549|NCT00094809|471678109|FG000|Overall Study|Protocol deviation|2|||
131013550|NCT00094809|471678110|FG001|Overall Study|Protocol deviation|2|||
131013551|NCT00094809|471678109|FG000|Overall Study|Noncompliance|1|||
131013552|NCT00094809|471678110|FG001|Overall Study|Noncompliance|0|||
131013553|NCT00094809|471678109|FG000|Overall Study|Adverse Event|3|||
131013554|NCT00094809|471678110|FG001|Overall Study|Adverse Event|1|||
131013555|NCT00094809|471678109|FG000|Overall Study|Withdrawal by Subject|8|||
131013556|NCT00094809|471678110|FG001|Overall Study|Withdrawal by Subject|9|||
131101016|NCT03541174|471999587|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
131101017|NCT03541174|471999582|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
131101018|NCT03541174|471999583|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
131101019|NCT03541174|471999584|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
131101020|NCT03541174|471999585|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
131101021|NCT03541174|471999586|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
131101022|NCT03541174|471999587|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
131101023|NCT03541174|471999582|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
131101024|NCT03541174|471999583|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
131101025|NCT03541174|471999584|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
131101026|NCT03541174|471999585|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
131013557|NCT00094809|471678109|FG000|Overall Study|Disease progression|3|||
131013558|NCT00094809|471678110|FG001|Overall Study|Disease progression|3|||
131013559|NCT00094809|471678109|FG000|Overall Study|Physician Decision|3|||
131013560|NCT00094809|471678110|FG001|Overall Study|Physician Decision|5|||
131013561|NCT00094809|471678109|FG000|Overall Study|Lost to Follow-up|6|||
131013562|NCT00094809|471678110|FG001|Overall Study|Lost to Follow-up|6|||
131013563|NCT00094809|471678109|FG000|Overall Study|Death|19|||
131013564|NCT00094809|471678110|FG001|Overall Study|Death|25|||
131013565|NCT00094809|471678109|FG000|Overall Study|Protocol-specified criteria|1|||
131013566|NCT00094809|471678110|FG001|Overall Study|Protocol-specified criteria|1|||
131013567|NCT00094809|471678109|FG000|Overall Study|Other|2|||
131013568|NCT00094809|471678110|FG001|Overall Study|Other|4|||
131013569|NCT00094809|471678109|FG000|Overall Study|Informed consent signed after treatment|1|||
131013570|NCT00094809|471678110|FG001|Overall Study|Informed consent signed after treatment|0|||
131013571|NCT00094809|471678109|FG000|Overall Study|Study drug not received|2|||
131013572|NCT00094809|471678110|FG001|Overall Study|Study drug not received|8|||
131013573|NCT00094809|471678109|FG000|Overall Study|Other|1|||
131013574|NCT00094809|471678110|FG001|Overall Study|Other|1|||
131013575|NCT04889664|471678111|FG000|Screen|Lost to Follow-up|1|||
131013576|NCT04889664|471678111|FG000|Screen|Failed to meet screening criteria|1|||
131013577|NCT04889664|471678111|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
131013578|NCT00771849|471678115|FG000|Overall Study|Lost to Follow-up|1|||
131013579|NCT00771849|471678116|FG001|Overall Study|Lost to Follow-up|2|||
131013580|NCT00771849|471678115|FG000|Overall Study|Withdrawal by Subject|1|||
131013581|NCT00771849|471678116|FG001|Overall Study|Withdrawal by Subject|1|||
131013582|NCT00771849|471678115|FG000|Overall Study|Not vaccinated|0|||
131013583|NCT00771849|471678116|FG001|Overall Study|Not vaccinated|1|||
131013584|NCT02046616|471678122|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
131013585|NCT02046616|471678122|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
131013586|NCT02046616|471678122|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
131013587|NCT02046616|471678122|FG000|24-Week Treatment Period|Physician Decision|3|||
131013588|NCT02046616|471678122|FG000|24-Week Treatment Period|Other|1|||
131013589|NCT02046616|471678122|FG000|8-Week FU Period|Lost to Follow-up|1|||
130885392|NCT01646125|471215186|FG000|Overall Study|Adverse Event|2|||
131013590|NCT02736799|471678123|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
131013591|NCT02736799|471678124|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
131013592|NCT02736799|471678125|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
131013593|NCT02736799|471678126|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
131013594|NCT01833832|471678128|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
131013595|NCT01156116|471678130|FG000|Overall Study|Withdrawal by Subject|3|||
131013596|NCT01156116|471678131|FG001|Overall Study|Withdrawal by Subject|1|||
131013597|NCT01156116|471678130|FG000|Overall Study|CPAP intolerance|2|||
131013598|NCT01156116|471678131|FG001|Overall Study|CPAP intolerance|0|||
131013599|NCT00344019|471678132|FG000|Overall Study|did not meet final inclusion criteria|0|||
131013600|NCT00344019|471678133|FG001|Overall Study|did not meet final inclusion criteria|0|||
131013601|NCT00344019|471678134|FG002|Overall Study|did not meet final inclusion criteria|74|||
131013602|NCT02057718|471678135|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
131013603|NCT02057718|471678136|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
131013604|NCT02057718|471678135|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
131013605|NCT02057718|471678136|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
131013606|NCT02057718|471678135|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
131013607|NCT02057718|471678136|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
131013608|NCT02057718|471678135|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
131013609|NCT02057718|471678136|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
131013610|NCT02057718|471678135|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
131013611|NCT02057718|471678136|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
131013612|NCT02057718|471678135|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
131013613|NCT02057718|471678136|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
131013614|NCT02057718|471678135|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
131013615|NCT02057718|471678136|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
131013616|NCT02057718|471678135|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
131013617|NCT02057718|471678136|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
131013618|NCT02057718|471678135|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
131013619|NCT02057718|471678136|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
131013620|NCT02057718|471678135|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
131013621|NCT02057718|471678136|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
131013622|NCT02057718|471678135|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
131013623|NCT02057718|471678136|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
131013624|NCT00608907|471678143|FG000|Overall Study|Adverse Event|6|||
131013625|NCT00608907|471678144|FG001|Overall Study|Adverse Event|0|||
131013626|NCT00608907|471678145|FG002|Overall Study|Adverse Event|1|||
131013627|NCT00608907|471678143|FG000|Overall Study|Death|1|||
131013628|NCT00608907|471678144|FG001|Overall Study|Death|0|||
131013629|NCT00608907|471678145|FG002|Overall Study|Death|0|||
131013630|NCT00608907|471678143|FG000|Overall Study|Withdrawal by Subject|4|||
131013631|NCT00608907|471678144|FG001|Overall Study|Withdrawal by Subject|0|||
131013632|NCT00608907|471678145|FG002|Overall Study|Withdrawal by Subject|0|||
131013633|NCT00608907|471678143|FG000|Overall Study|Progressive Disease|1|||
131013634|NCT00608907|471678144|FG001|Overall Study|Progressive Disease|0|||
131013635|NCT00608907|471678145|FG002|Overall Study|Progressive Disease|0|||
131013636|NCT00906035|471678149|FG000|Overall Study|Withdrawal by Subject|2|||
131013637|NCT00906035|471678150|FG001|Overall Study|Withdrawal by Subject|3|||
131013638|NCT00906035|471678151|FG002|Overall Study|Withdrawal by Subject|0|||
131013639|NCT05046132|471678152|FG000|Overall Study|Adverse Event|4|||
131013640|NCT05046132|471678153|FG001|Overall Study|Adverse Event|0|||
131013641|NCT05046132|471678154|FG002|Overall Study|Adverse Event|0|||
131013642|NCT05046132|471678152|FG000|Overall Study|Withdrawal by Subject|3|||
131013643|NCT05046132|471678153|FG001|Overall Study|Withdrawal by Subject|0|||
131013644|NCT05046132|471678154|FG002|Overall Study|Withdrawal by Subject|0|||
131013645|NCT05046132|471678152|FG000|Overall Study|Positive Covid19 Result.|0|||
131013646|NCT05046132|471678153|FG001|Overall Study|Positive Covid19 Result.|1|||
131013647|NCT05046132|471678154|FG002|Overall Study|Positive Covid19 Result.|0|||
131013648|NCT02596035|471678156|FG000|Overall Study|Disease Progression|64|||
131013649|NCT02596035|471678157|FG001|Overall Study|Disease Progression|32|||
131013650|NCT02596035|471678158|FG002|Overall Study|Disease Progression|1|||
131013651|NCT02596035|471678156|FG000|Overall Study|study drug toxicity|12|||
131013652|NCT02596035|471678157|FG001|Overall Study|study drug toxicity|3|||
131013653|NCT02596035|471678158|FG002|Overall Study|study drug toxicity|0|||
131013654|NCT02596035|471678156|FG000|Overall Study|AE unrelated to study drug|5|||
131013655|NCT02596035|471678157|FG001|Overall Study|AE unrelated to study drug|2|||
131013656|NCT02596035|471678158|FG002|Overall Study|AE unrelated to study drug|0|||
131013657|NCT02596035|471678156|FG000|Overall Study|participant request to discontinue study treatment|2|||
131013658|NCT02596035|471678157|FG001|Overall Study|participant request to discontinue study treatment|0|||
131013659|NCT02596035|471678158|FG002|Overall Study|participant request to discontinue study treatment|0|||
131013660|NCT02596035|471678156|FG000|Overall Study|participant withdrew consent|2|||
131013661|NCT02596035|471678157|FG001|Overall Study|participant withdrew consent|2|||
131013662|NCT02596035|471678158|FG002|Overall Study|participant withdrew consent|0|||
131013663|NCT02596035|471678156|FG000|Overall Study|Poor/Non Comlpiance|0|||
131013664|NCT02596035|471678157|FG001|Overall Study|Poor/Non Comlpiance|1|||
131013665|NCT02596035|471678158|FG002|Overall Study|Poor/Non Comlpiance|0|||
131013666|NCT02596035|471678156|FG000|Overall Study|participant no longer meets study criteria|1|||
131013667|NCT02596035|471678157|FG001|Overall Study|participant no longer meets study criteria|0|||
131013668|NCT02596035|471678158|FG002|Overall Study|participant no longer meets study criteria|0|||
131013669|NCT02596035|471678156|FG000|Overall Study|other reasons|11|||
131013670|NCT02596035|471678157|FG001|Overall Study|other reasons|4|||
131013671|NCT02596035|471678158|FG002|Overall Study|other reasons|0|||
131013672|NCT02357784|471678164|FG000|Overall Study|Withdrawal by Subject|1|||
131013673|NCT00604721|471678166|FG000|Overall Study|Physician Decision|1|||
131013674|NCT00604721|471678166|FG000|Overall Study|Withdrawal by Subject|1|||
131013675|NCT04776213|471678167|FG000|Overall Study|Other|1|||
131013676|NCT04776213|471678167|FG000|Overall Study|Withdrawal by Subject|7|||
131013677|NCT04776213|471678167|FG000|Overall Study|Protocol Violation|1|||
131013678|NCT04776213|471678167|FG000|Overall Study|Lost to Follow-up|2|||
131013679|NCT01838551|471678169|FG000|Overall Study|Adverse Event|16|||
131013680|NCT01838551|471678169|FG000|Overall Study|Death|1|||
131013681|NCT01838551|471678169|FG000|Overall Study|Lack of Efficacy|10|||
131013682|NCT01838551|471678169|FG000|Overall Study|Physician Decision|4|||
131101027|NCT03541174|471999586|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
131101028|NCT03541174|471999587|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
131101029|NCT02217332|471999590|FG000|Overall Study|Adverse Event|3|||
131101030|NCT02217332|471999590|FG000|Overall Study|Dose interruption >1 month|1|||
131101031|NCT02217332|471999590|FG000|Overall Study|Protocol Violation (eligibility)|1|||
131101032|NCT02217332|471999590|FG000|Overall Study|Withdrawal by Subject|1|||
131101033|NCT02217332|471999590|FG000|Overall Study|Lost to Follow-up|1|||
131101034|NCT02407990|471999591|FG000|Overall Study|Death|2|||
131101035|NCT02407990|471999592|FG001|Overall Study|Death|22|||
131101036|NCT02407990|471999593|FG002|Overall Study|Death|23|||
131101037|NCT02407990|471999594|FG003|Overall Study|Death|7|||
131101038|NCT02407990|471999595|FG004|Overall Study|Death|17|||
131101039|NCT02407990|471999596|FG005|Overall Study|Death|16|||
131101040|NCT02407990|471999597|FG006|Overall Study|Death|10|||
131101041|NCT02407990|471999598|FG007|Overall Study|Death|248|||
131101042|NCT02407990|471999591|FG000|Overall Study|Lost to Follow-up|0|||
131101043|NCT02407990|471999592|FG001|Overall Study|Lost to Follow-up|1|||
131101044|NCT02407990|471999593|FG002|Overall Study|Lost to Follow-up|0|||
131101045|NCT02407990|471999594|FG003|Overall Study|Lost to Follow-up|0|||
131222576|NCT01902134|472443114|FG001|Overall Study|Adverse Event|1|||
131013683|NCT01838551|471678169|FG000|Overall Study|Withdrawal by Subject|10|||
131013684|NCT01838551|471678169|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
131013685|NCT02289560|471678172|FG000|Overall Study|Lost to Follow-up|6|||
131013686|NCT02289560|471678172|FG000|Overall Study|Alternative Treatment|4|||
131101046|NCT02407990|471999595|FG004|Overall Study|Lost to Follow-up|0|||
131013687|NCT02289560|471678172|FG000|Overall Study|Inadequate Treatment|2|||
131013688|NCT02289560|471678172|FG000|Overall Study|Withdrawal by Subject|23|||
131013689|NCT01768676|471678178|FG000|Overall Study|Adverse Event|3|||
131013690|NCT01768676|471678179|FG001|Overall Study|Adverse Event|3|||
131013691|NCT01768676|471678178|FG000|Overall Study|Lost to Follow-up|13|||
131101047|NCT02407990|471999596|FG005|Overall Study|Lost to Follow-up|0|||
131101048|NCT02407990|471999597|FG006|Overall Study|Lost to Follow-up|0|||
131101049|NCT02407990|471999598|FG007|Overall Study|Lost to Follow-up|17|||
131101050|NCT02407990|471999591|FG000|Overall Study|Progressive Disease|0|||
131101051|NCT02407990|471999592|FG001|Overall Study|Progressive Disease|0|||
131101052|NCT02407990|471999593|FG002|Overall Study|Progressive Disease|0|||
131101053|NCT02407990|471999594|FG003|Overall Study|Progressive Disease|0|||
131101054|NCT02407990|471999595|FG004|Overall Study|Progressive Disease|0|||
131101055|NCT02407990|471999596|FG005|Overall Study|Progressive Disease|0|||
131101056|NCT02407990|471999597|FG006|Overall Study|Progressive Disease|0|||
131101057|NCT02407990|471999598|FG007|Overall Study|Progressive Disease|1|||
131101058|NCT02407990|471999591|FG000|Overall Study|Withdrawal by Subject|0|||
131101059|NCT02407990|471999592|FG001|Overall Study|Withdrawal by Subject|0|||
131101060|NCT02407990|471999593|FG002|Overall Study|Withdrawal by Subject|0|||
131101061|NCT02407990|471999594|FG003|Overall Study|Withdrawal by Subject|0|||
131101062|NCT02407990|471999595|FG004|Overall Study|Withdrawal by Subject|1|||
131101063|NCT02407990|471999596|FG005|Overall Study|Withdrawal by Subject|0|||
131101064|NCT02407990|471999597|FG006|Overall Study|Withdrawal by Subject|0|||
131101065|NCT02407990|471999598|FG007|Overall Study|Withdrawal by Subject|30|||
131101066|NCT02407990|471999591|FG000|Overall Study|Study Terminated by Sponsor|1|||
131101067|NCT02407990|471999592|FG001|Overall Study|Study Terminated by Sponsor|3|||
131101068|NCT02407990|471999593|FG002|Overall Study|Study Terminated by Sponsor|3|||
131101069|NCT02407990|471999594|FG003|Overall Study|Study Terminated by Sponsor|0|||
131101070|NCT02407990|471999595|FG004|Overall Study|Study Terminated by Sponsor|3|||
131101071|NCT02407990|471999596|FG005|Overall Study|Study Terminated by Sponsor|4|||
131101072|NCT02407990|471999597|FG006|Overall Study|Study Terminated by Sponsor|3|||
131101073|NCT02407990|471999598|FG007|Overall Study|Study Terminated by Sponsor|37|||
131101074|NCT02407990|471999591|FG000|Overall Study|Logistics|0|||
131101075|NCT02407990|471999592|FG001|Overall Study|Logistics|0|||
131101076|NCT02407990|471999593|FG002|Overall Study|Logistics|0|||
131101077|NCT02407990|471999594|FG003|Overall Study|Logistics|0|||
131101078|NCT02407990|471999595|FG004|Overall Study|Logistics|0|||
131101079|NCT02407990|471999596|FG005|Overall Study|Logistics|0|||
131101080|NCT02407990|471999597|FG006|Overall Study|Logistics|0|||
131101081|NCT02407990|471999598|FG007|Overall Study|Logistics|1|||
131101082|NCT02407990|471999591|FG000|Overall Study|Rolled into long-term extension study|0|||
131101083|NCT02407990|471999592|FG001|Overall Study|Rolled into long-term extension study|0|||
131101084|NCT02407990|471999593|FG002|Overall Study|Rolled into long-term extension study|0|||
131101085|NCT02407990|471999594|FG003|Overall Study|Rolled into long-term extension study|0|||
131101086|NCT02407990|471999595|FG004|Overall Study|Rolled into long-term extension study|0|||
131101087|NCT02407990|471999596|FG005|Overall Study|Rolled into long-term extension study|0|||
131101088|NCT02407990|471999597|FG006|Overall Study|Rolled into long-term extension study|0|||
131101089|NCT02407990|471999598|FG007|Overall Study|Rolled into long-term extension study|1|||
131101090|NCT00852540|471999601|FG000|Overall Study|Adverse Event|10|||
131101091|NCT00852540|471999602|FG001|Overall Study|Adverse Event|3|||
131101092|NCT00852540|471999601|FG000|Overall Study|Lack of Efficacy|15|||
131101093|NCT00852540|471999602|FG001|Overall Study|Lack of Efficacy|3|||
131101094|NCT00852540|471999601|FG000|Overall Study|Protocol Violation|1|||
131101095|NCT00852540|471999602|FG001|Overall Study|Protocol Violation|2|||
131101096|NCT00852540|471999601|FG000|Overall Study|Lost to Follow-up|2|||
131101097|NCT00852540|471999602|FG001|Overall Study|Lost to Follow-up|3|||
131101098|NCT00852540|471999601|FG000|Overall Study|Investigator Discretion|2|||
131101099|NCT00852540|471999602|FG001|Overall Study|Investigator Discretion|3|||
131101100|NCT00852540|471999601|FG000|Overall Study|Withdrawal by Subject|3|||
131101101|NCT00852540|471999602|FG001|Overall Study|Withdrawal by Subject|1|||
131101102|NCT00852540|471999601|FG000|Overall Study|Did Not Receive Study Drug|3|||
131101103|NCT00852540|471999602|FG001|Overall Study|Did Not Receive Study Drug|3|||
131101104|NCT01119105|471999603|FG000|Overall Study|Withdrawal by Subject|1|||
131101105|NCT01119105|471999604|FG001|Overall Study|Withdrawal by Subject|1|||
131101106|NCT01119105|471999605|FG002|Overall Study|Withdrawal by Subject|1|||
131101107|NCT01119105|471999603|FG000|Overall Study|Lost to Follow-up|0|||
131101108|NCT01119105|471999604|FG001|Overall Study|Lost to Follow-up|2|||
131101109|NCT01119105|471999605|FG002|Overall Study|Lost to Follow-up|5|||
131101110|NCT01119105|471999603|FG000|Overall Study|Adverse Event|1|||
131101111|NCT01119105|471999604|FG001|Overall Study|Adverse Event|0|||
131101112|NCT01119105|471999605|FG002|Overall Study|Adverse Event|1|||
131101113|NCT01119105|471999603|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
131101114|NCT01119105|471999604|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
131101115|NCT01119105|471999605|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
131101116|NCT01119105|471999603|FG000|Overall Study|Other|1|||
131101117|NCT01119105|471999604|FG001|Overall Study|Other|1|||
131101118|NCT01119105|471999605|FG002|Overall Study|Other|0|||
131101119|NCT00618618|471999606|FG000|Overall Study|Patient Request|0|||
131101120|NCT00618618|471999607|FG001|Overall Study|Patient Request|0|||
131101121|NCT00618618|471999608|FG002|Overall Study|Patient Request|2|||
131101122|NCT00618618|471999609|FG003|Overall Study|Patient Request|0|||
131222577|NCT01902134|472443115|FG002|Overall Study|Adverse Event|2|||
131013692|NCT01768676|471678179|FG001|Overall Study|Lost to Follow-up|16|||
131101123|NCT00618618|471999606|FG000|Overall Study|Inability to Complete Study Procedures|0|||
131101124|NCT00618618|471999607|FG001|Overall Study|Inability to Complete Study Procedures|1|||
131101125|NCT00618618|471999608|FG002|Overall Study|Inability to Complete Study Procedures|0|||
131101126|NCT00618618|471999609|FG003|Overall Study|Inability to Complete Study Procedures|0|||
131101127|NCT00618618|471999606|FG000|Overall Study|Lost to Follow-up|3|||
131101128|NCT00618618|471999607|FG001|Overall Study|Lost to Follow-up|0|||
131101129|NCT00618618|471999608|FG002|Overall Study|Lost to Follow-up|0|||
131101130|NCT00618618|471999609|FG003|Overall Study|Lost to Follow-up|1|||
131101131|NCT00618618|471999606|FG000|Overall Study|Non-compliance|1|||
131101132|NCT00618618|471999607|FG001|Overall Study|Non-compliance|1|||
131101133|NCT00618618|471999608|FG002|Overall Study|Non-compliance|0|||
131101134|NCT00618618|471999609|FG003|Overall Study|Non-compliance|0|||
131101135|NCT00618618|471999606|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
131101136|NCT00618618|471999607|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
131101137|NCT00618618|471999608|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
131101138|NCT00618618|471999609|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
131101139|NCT00618618|471999606|FG000|Overall Study|Death|0|||
131101140|NCT00618618|471999607|FG001|Overall Study|Death|1|||
131101141|NCT00618618|471999608|FG002|Overall Study|Death|0|||
131101142|NCT00618618|471999609|FG003|Overall Study|Death|0|||
131101143|NCT02929329|471999610|FG000|Overall Study|Withdrawal by Subject|24|||
131101144|NCT02929329|471999611|FG001|Overall Study|Withdrawal by Subject|21|||
131101145|NCT02929329|471999610|FG000|Overall Study|Lost to Follow-up|26|||
131101146|NCT02929329|471999611|FG001|Overall Study|Lost to Follow-up|20|||
131101147|NCT02929329|471999610|FG000|Overall Study|Death|1054|||
131101148|NCT02929329|471999611|FG001|Overall Study|Death|1051|||
131101149|NCT01183234|471999612|FG000|First Intervention|Adverse Event|1|||
131101150|NCT01183234|471999613|FG001|First Intervention|Adverse Event|0|||
131101151|NCT02937454|471999618|FG000|Overall Study|Adverse Event|0|||
131101152|NCT02937454|471999619|FG001|Overall Study|Adverse Event|1|||
131101153|NCT02937454|471999618|FG000|Overall Study|Death|98|||
131101154|NCT02937454|471999619|FG001|Overall Study|Death|95|||
131101155|NCT02937454|471999618|FG000|Overall Study|Lost to Follow-up|1|||
131101156|NCT02937454|471999619|FG001|Overall Study|Lost to Follow-up|1|||
131101157|NCT02937454|471999618|FG000|Overall Study|Physician Decision|0|||
131101158|NCT02937454|471999619|FG001|Overall Study|Physician Decision|1|||
131101159|NCT02937454|471999618|FG000|Overall Study|Protocol Violation|6|||
131101160|NCT02937454|471999619|FG001|Overall Study|Protocol Violation|10|||
131101161|NCT02937454|471999618|FG000|Overall Study|Withdrawal by Subject|27|||
131101162|NCT02937454|471999619|FG001|Overall Study|Withdrawal by Subject|15|||
131101163|NCT02937454|471999618|FG000|Overall Study|Other|8|||
131101164|NCT02937454|471999619|FG001|Overall Study|Other|5|||
131101165|NCT00037830|471999622|FG000|Overall Study|Adverse Event|2|||
131101166|NCT00037830|471999623|FG001|Overall Study|Adverse Event|0|||
131101167|NCT00037830|471999624|FG002|Overall Study|Adverse Event|0|||
131101168|NCT00037830|471999622|FG000|Overall Study|Withdrawal by Subject|4|||
131101169|NCT00037830|471999623|FG001|Overall Study|Withdrawal by Subject|5|||
131101170|NCT00037830|471999624|FG002|Overall Study|Withdrawal by Subject|1|||
131101171|NCT00037830|471999622|FG000|Overall Study|Protocol Violation|2|||
131101172|NCT00037830|471999623|FG001|Overall Study|Protocol Violation|2|||
131101173|NCT00037830|471999624|FG002|Overall Study|Protocol Violation|0|||
131101174|NCT00037830|471999622|FG000|Overall Study|Unrelated Medical Problem|2|||
131101175|NCT00037830|471999623|FG001|Overall Study|Unrelated Medical Problem|0|||
131101176|NCT00037830|471999624|FG002|Overall Study|Unrelated Medical Problem|0|||
131101177|NCT03292432|471999625|FG000|Overall Study|Lost to Follow-up|11|||
131101178|NCT03292432|471999626|FG001|Overall Study|Lost to Follow-up|8|||
131101179|NCT03292432|471999625|FG000|Overall Study|Death|2|||
131101180|NCT03292432|471999626|FG001|Overall Study|Death|1|||
131101181|NCT03292432|471999625|FG000|Overall Study|Withdrawal by Subject|1|||
131101182|NCT03292432|471999626|FG001|Overall Study|Withdrawal by Subject|2|||
131101183|NCT03292432|471999625|FG000|Overall Study|Site closed before any data collected|1|||
131013693|NCT01768676|471678178|FG000|Overall Study|Protocol Violation|1|||
131013694|NCT01768676|471678179|FG001|Overall Study|Protocol Violation|1|||
131013695|NCT01768676|471678178|FG000|Overall Study|Physician Decision|4|||
131013696|NCT01768676|471678179|FG001|Overall Study|Physician Decision|1|||
131013697|NCT01768676|471678178|FG000|Overall Study|Withdrawal by Subject|3|||
131013698|NCT01768676|471678179|FG001|Overall Study|Withdrawal by Subject|10|||
131013699|NCT03395353|471678181|FG000|Overall Study|Adverse Event|20|||
131101184|NCT03292432|471999626|FG001|Overall Study|Site closed before any data collected|0|||
131101185|NCT01014143|471999628|FG000|Second Intervention|Lost to Follow-up|2|||
131101186|NCT01014143|471999629|FG001|Second Intervention|Lost to Follow-up|0|||
131101187|NCT01014143|471999630|FG002|Second Intervention|Lost to Follow-up|0|||
131101188|NCT02038543|471999631|FG000|Overall Study|Screen Failure|0|||
131101189|NCT02038543|471999632|FG001|Overall Study|Screen Failure|0|||
131101190|NCT02038543|471999633|FG002|Overall Study|Screen Failure|0|||
131013700|NCT03395353|471678181|FG000|Overall Study|Protocol Violation|1|||
131101191|NCT02038543|471999634|FG003|Overall Study|Screen Failure|1|||
131101192|NCT02038543|471999631|FG000|Overall Study|Withdrawal by Subject|0|||
131013701|NCT03395353|471678181|FG000|Overall Study|Lack of Efficacy|3|||
131013702|NCT03395353|471678181|FG000|Overall Study|Withdrawal by Subject|24|||
131013703|NCT03395353|471678181|FG000|Overall Study|Discontinued visit|1|||
131013704|NCT03395353|471678181|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
131013705|NCT03395353|471678181|FG000|Overall Study|Physician Decision|4|||
131013706|NCT03395353|471678181|FG000|Overall Study|Early termination of overall study|33|||
131013707|NCT01196429|471678182|FG000|Overall Study|Ineligible - inadequate pathology|1|||
131013708|NCT01196429|471678183|FG001|Overall Study|Ineligible - inadequate pathology|0|||
131013709|NCT01196429|471678182|FG000|Overall Study|Ineligible - wrong cell type|1|||
131013710|NCT01196429|471678183|FG001|Overall Study|Ineligible - wrong cell type|0|||
131013711|NCT01196429|471678182|FG000|Overall Study|Refused - Never Treated|1|||
131013712|NCT01196429|471678183|FG001|Overall Study|Refused - Never Treated|0|||
131013713|NCT02486588|471678184|FG000|Overall Study|Randomized in error- ineligible|738|||
131013714|NCT02486588|471678185|FG001|Overall Study|Randomized in error- ineligible|750|||
131013715|NCT02486588|471678186|FG002|Overall Study|Randomized in error- ineligible|755|||
131013716|NCT02486588|471678187|FG003|Overall Study|Randomized in error- ineligible|738|||
131013717|NCT02486588|471678188|FG004|Overall Study|Randomized in error- ineligible|746|||
131013718|NCT02486588|471678189|FG005|Overall Study|Randomized in error- ineligible|746|||
131013719|NCT04248829|471678190|FG000|Overall Study|Disease progression|44|||
131013720|NCT04248829|471678191|FG001|Overall Study|Disease progression|109|||
131013721|NCT04248829|471678190|FG000|Overall Study|Adverse Event|19|||
131013722|NCT04248829|471678191|FG001|Overall Study|Adverse Event|18|||
131013723|NCT04248829|471678190|FG000|Overall Study|Withdrawal by Subject|11|||
131101193|NCT02038543|471999632|FG001|Overall Study|Withdrawal by Subject|0|||
131101194|NCT02038543|471999633|FG002|Overall Study|Withdrawal by Subject|0|||
131101195|NCT02038543|471999634|FG003|Overall Study|Withdrawal by Subject|1|||
131101196|NCT00158860|471999635|FG000|Overall Study|Adverse Event|3|||
130885393|NCT01646125|471215187|FG001|Overall Study|Adverse Event|1|||
131013724|NCT04248829|471678191|FG001|Overall Study|Withdrawal by Subject|2|||
131101197|NCT00158860|471999636|FG001|Overall Study|Adverse Event|6|||
131101198|NCT00158860|471999635|FG000|Overall Study|Lost to Follow-up|11|||
130885394|NCT01646125|471215186|FG000|Overall Study|Death|1|||
131013725|NCT04248829|471678190|FG000|Overall Study|Lost to Follow-up|0|||
131013726|NCT04248829|471678191|FG001|Overall Study|Lost to Follow-up|1|||
131101199|NCT00158860|471999636|FG001|Overall Study|Lost to Follow-up|17|||
130885395|NCT01646125|471215187|FG001|Overall Study|Death|1|||
131013727|NCT04248829|471678190|FG000|Overall Study|Death|12|||
131013728|NCT04248829|471678191|FG001|Overall Study|Death|14|||
131013729|NCT04248829|471678190|FG000|Overall Study|Physician Decision|2|||
131013730|NCT04248829|471678191|FG001|Overall Study|Physician Decision|4|||
131013731|NCT04248829|471678190|FG000|Overall Study|Any reason not specifically recorded|0|||
131013732|NCT04248829|471678191|FG001|Overall Study|Any reason not specifically recorded|2|||
131013733|NCT02132702|471678192|FG000|Overall Study|Protocol Violation|2|||
131013734|NCT02132702|471678192|FG000|Overall Study|Adverse Event|3|||
131013735|NCT02132702|471678192|FG000|Overall Study|Withdrawal by Subject|3|||
131013736|NCT02013037|471678193|FG000|Overall Study|Death|6|||
131222578|NCT01902134|472443116|FG003|Overall Study|Adverse Event|1|||
131013737|NCT02013037|471678193|FG000|Overall Study|Withdrawal by Subject|1|||
131013738|NCT02013037|471678193|FG000|Overall Study|Awaiting Transplantation|7|||
131013739|NCT02013037|471678193|FG000|Overall Study|Transplanted without DSA|2|||
131013740|NCT03354390|471678194|FG000|Level 1|Death|2|||
131013741|NCT03354390|471678195|FG001|Level 1|Death|0|||
131013742|NCT03354390|471678196|FG002|Level 1|Death|0|||
131013743|NCT03354390|471678197|FG003|Level 1|Death|0|||
131013744|NCT03354390|471678194|FG000|Level 1|Physician Decision|1|||
131013745|NCT03354390|471678195|FG001|Level 1|Physician Decision|0|||
131013746|NCT03354390|471678196|FG002|Level 1|Physician Decision|0|||
131013747|NCT03354390|471678197|FG003|Level 1|Physician Decision|0|||
131013748|NCT03354390|471678194|FG000|Level 2|Physician Decision|0|||
131013749|NCT03354390|471678195|FG001|Level 2|Physician Decision|2|||
131013750|NCT03354390|471678196|FG002|Level 2|Physician Decision|0|||
131013751|NCT03354390|471678197|FG003|Level 2|Physician Decision|0|||
131013752|NCT03354390|471678194|FG000|Level 2|Lack of Efficacy|0|||
131013753|NCT03354390|471678195|FG001|Level 2|Lack of Efficacy|1|||
131013754|NCT03354390|471678196|FG002|Level 2|Lack of Efficacy|0|||
131013755|NCT03354390|471678197|FG003|Level 2|Lack of Efficacy|0|||
131013756|NCT03354390|471678194|FG000|Level 2|Lost to Follow-up|0|||
131013757|NCT03354390|471678195|FG001|Level 2|Lost to Follow-up|1|||
131013758|NCT03354390|471678196|FG002|Level 2|Lost to Follow-up|0|||
131101200|NCT00158860|471999635|FG000|Overall Study|Protocol Violation|8|||
131101201|NCT00158860|471999636|FG001|Overall Study|Protocol Violation|23|||
131101202|NCT00158860|471999635|FG000|Overall Study|Withdrawal by Subject|7|||
131101203|NCT00158860|471999636|FG001|Overall Study|Withdrawal by Subject|17|||
131101204|NCT00158860|471999635|FG000|Overall Study|MOVING OUT OF STATE|1|||
131101205|NCT00158860|471999636|FG001|Overall Study|MOVING OUT OF STATE|0|||
131101206|NCT00158860|471999635|FG000|Overall Study|Pregnancy|3|||
131101207|NCT00158860|471999636|FG001|Overall Study|Pregnancy|3|||
131101208|NCT00158860|471999635|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
131101209|NCT00158860|471999636|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
131101210|NCT00158860|471999635|FG000|Overall Study|SPONSOR REQUEST|0|||
131101211|NCT00158860|471999636|FG001|Overall Study|SPONSOR REQUEST|1|||
131101212|NCT00158860|471999635|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
131101213|NCT00158860|471999636|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
131101214|NCT00158860|471999635|FG000|Overall Study|Closed per sponsor|0|||
131101215|NCT00158860|471999636|FG001|Overall Study|Closed per sponsor|1|||
131101216|NCT01029652|471999637|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
131222579|NCT01902134|472443117|FG004|Overall Study|Adverse Event|1|||
131101217|NCT01029652|471999638|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
131101218|NCT01029652|471999637|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
131101219|NCT01029652|471999638|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
131222580|NCT01902134|472443118|FG005|Overall Study|Adverse Event|3|||
131013759|NCT03354390|471678197|FG003|Level 2|Lost to Follow-up|0|||
131013760|NCT03354390|471678194|FG000|Level 3|Death|0|||
131013761|NCT03354390|471678195|FG001|Level 3|Death|0|||
131013762|NCT03354390|471678196|FG002|Level 3|Death|1|||
131013763|NCT03354390|471678197|FG003|Level 3|Death|0|||
131013764|NCT03354390|471678194|FG000|Level 3|Physician Decision|0|||
131013765|NCT03354390|471678195|FG001|Level 3|Physician Decision|0|||
131013766|NCT03354390|471678196|FG002|Level 3|Physician Decision|2|||
131013767|NCT03354390|471678197|FG003|Level 3|Physician Decision|0|||
131013768|NCT03354390|471678194|FG000|Level 4|Death|0|||
131013769|NCT03354390|471678195|FG001|Level 4|Death|0|||
131013770|NCT03354390|471678196|FG002|Level 4|Death|0|||
131013771|NCT03354390|471678197|FG003|Level 4|Death|3|||
131013772|NCT01066923|471678198|FG000|Overall Study|Withdrawal by Subject|3|||
131013773|NCT01066923|471678199|FG001|Overall Study|Withdrawal by Subject|3|||
131013774|NCT01066923|471678200|FG002|Overall Study|Withdrawal by Subject|8|||
131013775|NCT01066923|471678201|FG003|Overall Study|Withdrawal by Subject|8|||
131013776|NCT01144468|471679591|FG000|Overall Study|Lost to Follow-up|4|||
131013777|NCT01144468|471679592|FG001|Overall Study|Lost to Follow-up|7|||
131013778|NCT01144468|471679591|FG000|Overall Study|Adverse Event|3|||
131013779|NCT01144468|471679592|FG001|Overall Study|Adverse Event|2|||
131013780|NCT01144468|471679591|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
131013781|NCT01144468|471679592|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
131013782|NCT05298111|471679596|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
131013783|NCT05298111|471679597|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
131013784|NCT02689349|471679600|FG000|Overall Study|Not implanted|4|||
131013785|NCT02689349|471679601|FG001|Overall Study|Not implanted|0|||
131013786|NCT02689349|471679600|FG000|Overall Study|Withdrawal by Subject|9|||
131013787|NCT02689349|471679601|FG001|Overall Study|Withdrawal by Subject|0|||
131013788|NCT03518112|471679602|FG000|Overall Study|Withdrawal by Subject|1|||
131013789|NCT01546155|471679603|FG000|Overall Study|could not tolerate long scan duration|3|||
131013790|NCT00954707|471679607|FG000|Overall Study|Death|34|||
131013791|NCT00954707|471679607|FG000|Overall Study|Withdrawal by Subject|100|||
131013792|NCT00954707|471679607|FG000|Overall Study|Lost to Follow-up|33|||
131013793|NCT01025843|471679608|FG000|Washout 4|Withdrawal by Subject|0|||
131013794|NCT01025843|471679609|FG001|Washout 4|Withdrawal by Subject|0|||
131013795|NCT01025843|471679610|FG002|Washout 4|Withdrawal by Subject|1|||
131013796|NCT01025843|471679611|FG003|Washout 4|Withdrawal by Subject|1|||
131013797|NCT01025843|471679612|FG004|Washout 4|Withdrawal by Subject|0|||
131013798|NCT01025843|471679613|FG005|Washout 4|Withdrawal by Subject|0|||
131013799|NCT01025843|471679614|FG006|Washout 4|Withdrawal by Subject|0|||
131013800|NCT01025843|471679615|FG007|Washout 4|Withdrawal by Subject|0|||
131013801|NCT01025843|471679616|FG008|Washout 4|Withdrawal by Subject|0|||
131013802|NCT01025843|471679617|FG009|Washout 4|Withdrawal by Subject|0|||
131013803|NCT00377455|471679620|FG000|Overall Study|Withdrawal by Subject|1|||
131013804|NCT01897233|471679623|FG000|Part B (24 Weeks)|Adverse Event|1|||
131013805|NCT01897233|471679623|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
131013806|NCT01897233|471679623|FG000|Part B (24 Weeks)|Physician Decision|1|||
131013807|NCT05193318|471679625|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
131013808|NCT05193318|471679625|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
131013809|NCT00798096|471679626|FG000|Overall Study|Ongoing|2|||
131013810|NCT00545844|471679630|FG000|Overall Study|Lost to Follow-up|9|||
131013811|NCT00545844|471679630|FG000|Overall Study|Protocol Violation|1|||
131013812|NCT00545844|471679630|FG000|Overall Study|Withdrawal by Subject|2|||
131013813|NCT02503202|471679632|FG000|Base Study: Up to Month 6|Death|1|||
131013814|NCT02503202|471679633|FG001|Base Study: Up to Month 6|Death|1|||
131013815|NCT02503202|471679634|FG002|Base Study: Up to Month 6|Death|0|||
131013816|NCT02503202|471679635|FG003|Base Study: Up to Month 6|Death|0|||
131013817|NCT02503202|471679636|FG004|Base Study: Up to Month 6|Death|0|||
131013818|NCT02503202|471679632|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
131013819|NCT02503202|471679633|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
131013820|NCT02503202|471679634|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
131013821|NCT02503202|471679635|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
131013822|NCT02503202|471679636|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
131013823|NCT02503202|471679632|FG000|Base Study: Up to Month 6|Physician Decision|0|||
131013824|NCT02503202|471679633|FG001|Base Study: Up to Month 6|Physician Decision|0|||
131013825|NCT02503202|471679634|FG002|Base Study: Up to Month 6|Physician Decision|0|||
131013826|NCT02503202|471679635|FG003|Base Study: Up to Month 6|Physician Decision|0|||
131101220|NCT01029652|471999637|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
131101221|NCT01029652|471999638|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
131101222|NCT01029652|471999637|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
131101223|NCT01029652|471999638|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
131101224|NCT01029652|471999637|FG000|Core Study (0-12 Weeks)|Death|0|||
131101225|NCT01029652|471999638|FG001|Core Study (0-12 Weeks)|Death|1|||
131222581|NCT01902134|472443113|FG000|Overall Study|Lack of Efficacy|0|||
130885396|NCT01646125|471215186|FG000|Overall Study|Physician Decision|1|||
131101226|NCT01029652|471999637|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
131222582|NCT01902134|472443114|FG001|Overall Study|Lack of Efficacy|0|||
131013827|NCT02503202|471679636|FG004|Base Study: Up to Month 6|Physician Decision|1|||
131013828|NCT02503202|471679632|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
131013829|NCT02503202|471679633|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
131013830|NCT02503202|471679634|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
131013831|NCT02503202|471679635|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
131013832|NCT02503202|471679636|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
131222583|NCT01902134|472443115|FG002|Overall Study|Lack of Efficacy|2|||
131013833|NCT02503202|471679632|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
131013834|NCT02503202|471679633|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
131013835|NCT02503202|471679634|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
131013836|NCT02503202|471679635|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
131013837|NCT02503202|471679636|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
131013838|NCT02503202|471679632|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
131013839|NCT02503202|471679633|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
131013840|NCT02503202|471679634|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
131013841|NCT02503202|471679635|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
131013842|NCT02503202|471679636|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
131013843|NCT02503202|471679632|FG000|Extension: Month 6 to 24|Death|1|||
131013844|NCT02503202|471679633|FG001|Extension: Month 6 to 24|Death|0|||
131013845|NCT02503202|471679634|FG002|Extension: Month 6 to 24|Death|0|||
131013846|NCT02503202|471679635|FG003|Extension: Month 6 to 24|Death|0|||
131013847|NCT02503202|471679636|FG004|Extension: Month 6 to 24|Death|0|||
131013848|NCT02503202|471679632|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
131013849|NCT02503202|471679633|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
131013850|NCT02503202|471679634|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
131013851|NCT02503202|471679635|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
131013852|NCT02503202|471679636|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
131013853|NCT02503202|471679632|FG000|Extension: Month 6 to 24|Physician Decision|1|||
131013854|NCT02503202|471679633|FG001|Extension: Month 6 to 24|Physician Decision|0|||
131013855|NCT02503202|471679634|FG002|Extension: Month 6 to 24|Physician Decision|1|||
131013856|NCT02503202|471679635|FG003|Extension: Month 6 to 24|Physician Decision|3|||
131013857|NCT02503202|471679636|FG004|Extension: Month 6 to 24|Physician Decision|0|||
131013858|NCT02503202|471679632|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
131013859|NCT02503202|471679633|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
131013860|NCT02503202|471679634|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
131013861|NCT02503202|471679635|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
131013862|NCT02503202|471679636|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
131013863|NCT03058991|471679637|FG000|Overall Study|Lost to Follow-up|17|||
131013864|NCT03058991|471679638|FG001|Overall Study|Lost to Follow-up|12|||
131013865|NCT03058991|471679639|FG002|Overall Study|Lost to Follow-up|12|||
131013866|NCT03058991|471679637|FG000|Overall Study|Withdrawal by Subject|1|||
131013867|NCT03058991|471679638|FG001|Overall Study|Withdrawal by Subject|0|||
131013868|NCT03058991|471679639|FG002|Overall Study|Withdrawal by Subject|0|||
131013869|NCT00130637|471679642|FG000|Overall Study|Adverse Event|2|||
131013870|NCT00130637|471679642|FG000|Overall Study|Withdrawal by Subject|1|||
131013871|NCT01460342|471679644|FG000|Overall Study|Adverse Event|5|||
131222584|NCT01902134|472443116|FG003|Overall Study|Lack of Efficacy|0|||
131013872|NCT01460342|471679645|FG001|Overall Study|Adverse Event|4|||
131013873|NCT01460342|471679644|FG000|Overall Study|Lost to Follow-up|1|||
131013874|NCT01460342|471679645|FG001|Overall Study|Lost to Follow-up|2|||
131013875|NCT01460342|471679644|FG000|Overall Study|Protocol Violation|0|||
131013876|NCT01460342|471679645|FG001|Overall Study|Protocol Violation|1|||
131013877|NCT01460342|471679644|FG000|Overall Study|Withdrawal by Subject|3|||
131013878|NCT01460342|471679645|FG001|Overall Study|Withdrawal by Subject|4|||
131013879|NCT01460342|471679644|FG000|Overall Study|Physician Decision|1|||
131013880|NCT01460342|471679645|FG001|Overall Study|Physician Decision|3|||
131013881|NCT01460342|471679644|FG000|Overall Study|Lack of Efficacy|1|||
131013882|NCT01460342|471679645|FG001|Overall Study|Lack of Efficacy|0|||
131013883|NCT01191788|471679646|FG000|Overall Study|Lost to Follow-up|21|||
131013884|NCT01191788|471679647|FG001|Overall Study|Lost to Follow-up|22|||
131013885|NCT01689519|471679648|FG000|Intent to Treat|Death|157|||
131101227|NCT01029652|471999638|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
131101228|NCT01029652|471999637|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
131101229|NCT01029652|471999638|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
131101230|NCT01029652|471999637|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
131101231|NCT01029652|471999638|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
131101232|NCT01029652|471999637|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
131101233|NCT01029652|471999638|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
131101234|NCT01029652|471999637|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
131101235|NCT01029652|471999638|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
131101236|NCT01029652|471999637|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
131101237|NCT01029652|471999638|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
131101238|NCT01029652|471999637|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
131101239|NCT01029652|471999638|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
131101240|NCT02095951|471999639|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
131101241|NCT02095951|471999640|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
131101242|NCT03618823|471999641|FG000|Overall Study|Lost to Follow-up|63|||
131101243|NCT03618823|471999642|FG001|Overall Study|Lost to Follow-up|61|||
131101244|NCT04638920|471999643|FG000|Overall Study|Withdrawal by Subject|5|||
131101245|NCT00523640|471999645|FG000|Overall Study|Death|1|||
130678252|NCT03815942|470449156|FG000|Overall Study|Withdrawal by Subject|0|||
130678253|NCT03815942|470449157|FG001|Overall Study|Withdrawal by Subject|17|||
130678254|NCT02785913|470449158|FG000|Overall Study|Adverse Event|5|||
130678255|NCT02785913|470449158|FG000|Overall Study|Death|2|||
130678256|NCT02785913|470449158|FG000|Overall Study|Progression|18|||
130678257|NCT02785913|470449158|FG000|Overall Study|Not protocol specified|1|||
130678258|NCT03717064|470449159|FG000|Period 2|Adverse Event|1|||
130678259|NCT02841709|470449160|FG000|5th Intervention|Adverse Event|2|||
130678260|NCT02841709|470449161|FG001|5th Intervention|Adverse Event|0|||
130678261|NCT02841709|470449162|FG002|5th Intervention|Adverse Event|0|||
130678262|NCT02841709|470449163|FG003|5th Intervention|Adverse Event|0|||
130678263|NCT02841709|470449164|FG004|5th Intervention|Adverse Event|2|||
130678264|NCT01929109|470449165|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
131013886|NCT01689519|471679649|FG001|Intent to Treat|Death|167|||
130678265|NCT01929109|470449166|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
130678266|NCT01929109|470449167|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
130678267|NCT01929109|470449168|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
130678268|NCT01929109|470449169|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
130678269|NCT00076102|470449170|FG000|Overall Study|Clinical progression|1|||
130678270|NCT00076102|470449170|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
130678271|NCT00076102|470449170|FG000|Overall Study|plexiform neurofibroma surgery|1|||
130678272|NCT00076102|470449170|FG000|Overall Study|refusal of further therapy|2|||
130678273|NCT01402908|470449172|FG000|Overall Study|Withdrawal by Subject|30|||
130678274|NCT01402908|470449173|FG001|Overall Study|Withdrawal by Subject|17|||
130678275|NCT01402908|470449172|FG000|Overall Study|Lost to Follow-up|3|||
130678276|NCT01402908|470449173|FG001|Overall Study|Lost to Follow-up|1|||
130678277|NCT01402908|470449172|FG000|Overall Study|Physician Decision|1|||
130678278|NCT01402908|470449173|FG001|Overall Study|Physician Decision|0|||
130678281|NCT02581345|470449177|FG000|Part 1: up to Week 16|Adverse Event|3|||
130678282|NCT02581345|470449178|FG001|Part 1: up to Week 16|Adverse Event|8|||
130678283|NCT02581345|470449179|FG002|Part 1: up to Week 16|Adverse Event|0|||
130678284|NCT02581345|470449180|FG003|Part 1: up to Week 16|Adverse Event|0|||
130678285|NCT02581345|470449177|FG000|Part 1: up to Week 16|Physician Decision|2|||
130678286|NCT02581345|470449178|FG001|Part 1: up to Week 16|Physician Decision|4|||
130678287|NCT02581345|470449179|FG002|Part 1: up to Week 16|Physician Decision|0|||
130678288|NCT02581345|470449180|FG003|Part 1: up to Week 16|Physician Decision|0|||
130678289|NCT02581345|470449177|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
130678290|NCT02581345|470449178|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
130678291|NCT02581345|470449179|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
130678292|NCT02581345|470449180|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
130678293|NCT02581345|470449177|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
131013887|NCT01689519|471679648|FG000|Intent to Treat|Lost to Follow-up|4|||
131013888|NCT01689519|471679649|FG001|Intent to Treat|Lost to Follow-up|8|||
131013889|NCT01689519|471679648|FG000|Intent to Treat|Other|2|||
130678294|NCT02581345|470449178|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
130678295|NCT02581345|470449179|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
130678296|NCT02581345|470449180|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
130678297|NCT02581345|470449177|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
130678298|NCT02581345|470449178|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
130678299|NCT02581345|470449179|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
130678300|NCT02581345|470449180|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
130678301|NCT02581345|470449177|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
130678302|NCT02581345|470449178|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
131013890|NCT01689519|471679649|FG001|Intent to Treat|Other|4|||
131101246|NCT03775434|471999647|FG000|Overall Study|Adverse Event|2|||
130678303|NCT02581345|470449179|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
130678304|NCT02581345|470449180|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
130678305|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
130678306|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
130678307|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
130678308|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
130678309|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
130678310|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
130678311|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
130678312|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
130678313|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
130678314|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
130678315|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
130678316|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
130678317|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
130678318|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
130678319|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
130678320|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
130678321|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
130678322|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
130678323|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
130678324|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
130678325|NCT02581345|470449177|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
130678326|NCT02581345|470449178|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
130678327|NCT02581345|470449179|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
130678328|NCT02581345|470449180|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
130678329|NCT00376220|470449181|FG000|Overall Study|Lost to Follow-up|7|||
130678330|NCT00376220|470449182|FG001|Overall Study|Lost to Follow-up|10|||
130678331|NCT00376220|470449181|FG000|Overall Study|Withdrawal by Subject|3|||
130678332|NCT00376220|470449182|FG001|Overall Study|Withdrawal by Subject|2|||
130678333|NCT00531206|470449185|FG000|Overall Study|Adverse Event related|5|||
130678334|NCT00531206|470449185|FG000|Overall Study|Lack of Efficacy|2|||
130678335|NCT00531206|470449185|FG000|Overall Study|Lost to Follow-up|5|||
130678336|NCT00531206|470449185|FG000|Overall Study|including non-related adverse events|8|||
130678337|NCT00920140|470449187|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
130678338|NCT00920140|470449188|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
130678339|NCT00920140|470449189|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
130678340|NCT00920140|470449190|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
130678341|NCT00920140|470449191|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
130678342|NCT00920140|470449187|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
130678343|NCT00920140|470449188|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
130678344|NCT00920140|470449189|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
130678345|NCT00920140|470449190|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
130678346|NCT00920140|470449191|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
130678347|NCT00920140|470449187|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130678348|NCT00920140|470449188|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
130678349|NCT00920140|470449189|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130678350|NCT00920140|470449190|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130678351|NCT00920140|470449191|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130678352|NCT00920140|470449187|FG000|Phase 2|Adverse Event|0|||
130678353|NCT00920140|470449188|FG001|Phase 2|Adverse Event|0|||
130678354|NCT00920140|470449189|FG002|Phase 2|Adverse Event|14|||
130678355|NCT00920140|470449190|FG003|Phase 2|Adverse Event|2|||
130678356|NCT00920140|470449191|FG004|Phase 2|Adverse Event|3|||
130678357|NCT00920140|470449187|FG000|Phase 2|Lack of Efficacy|0|||
130678358|NCT00920140|470449188|FG001|Phase 2|Lack of Efficacy|0|||
130678359|NCT00920140|470449189|FG002|Phase 2|Lack of Efficacy|29|||
130678360|NCT00920140|470449190|FG003|Phase 2|Lack of Efficacy|14|||
130678361|NCT00920140|470449191|FG004|Phase 2|Lack of Efficacy|5|||
131013891|NCT01689519|471679648|FG000|Intent to Treat|Physician Decision|4|||
130678362|NCT00920140|470449187|FG000|Phase 2|Lost to Follow-up|0|||
130678363|NCT00920140|470449188|FG001|Phase 2|Lost to Follow-up|0|||
130678364|NCT00920140|470449189|FG002|Phase 2|Lost to Follow-up|0|||
130678365|NCT00920140|470449190|FG003|Phase 2|Lost to Follow-up|1|||
130678366|NCT00920140|470449191|FG004|Phase 2|Lost to Follow-up|0|||
130678367|NCT00920140|470449187|FG000|Phase 2|Physician Decision|0|||
130678368|NCT00920140|470449188|FG001|Phase 2|Physician Decision|0|||
130678369|NCT00920140|470449189|FG002|Phase 2|Physician Decision|3|||
130678370|NCT00920140|470449190|FG003|Phase 2|Physician Decision|3|||
130678371|NCT00920140|470449191|FG004|Phase 2|Physician Decision|2|||
130678372|NCT00920140|470449187|FG000|Phase 2|Withdrawal by Subject|0|||
130678373|NCT00920140|470449188|FG001|Phase 2|Withdrawal by Subject|0|||
130678374|NCT00920140|470449189|FG002|Phase 2|Withdrawal by Subject|4|||
130678375|NCT00920140|470449190|FG003|Phase 2|Withdrawal by Subject|2|||
130678376|NCT00920140|470449191|FG004|Phase 2|Withdrawal by Subject|1|||
131101247|NCT03775434|471999647|FG000|Overall Study|Withdrawal by Subject|1|||
131101248|NCT01859988|471999648|FG000|Overall Study|Withdrawal by Subject|6|||
131101249|NCT01859988|471999649|FG001|Overall Study|Withdrawal by Subject|3|||
131101250|NCT01859988|471999650|FG002|Overall Study|Withdrawal by Subject|4|||
131101251|NCT01859988|471999651|FG003|Overall Study|Withdrawal by Subject|3|||
131101252|NCT01859988|471999652|FG004|Overall Study|Withdrawal by Subject|2|||
131101253|NCT01859988|471999653|FG005|Overall Study|Withdrawal by Subject|2|||
131101254|NCT01859988|471999648|FG000|Overall Study|Lack of Efficacy|1|||
131101255|NCT01859988|471999649|FG001|Overall Study|Lack of Efficacy|1|||
131101256|NCT01859988|471999650|FG002|Overall Study|Lack of Efficacy|5|||
130678377|NCT01124149|470449192|FG000|Acute Phase|Withdrawal by Subject|22|||
130678378|NCT01124149|470449192|FG000|Acute Phase|Adverse Event|21|||
130678379|NCT01124149|470449192|FG000|Acute Phase|Lack of Efficacy|17|||
130678380|NCT01124149|470449192|FG000|Acute Phase|Protocol Violation|14|||
130678381|NCT01124149|470449192|FG000|Acute Phase|Lost to Follow-up|2|||
130678382|NCT01124149|470449192|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
130678383|NCT01124149|470449192|FG000|Acute Phase|Sponsor request|1|||
130678384|NCT01124149|470449192|FG000|Acute Phase|UC symptoms not ameliorated|1|||
130678385|NCT01124149|470449192|FG000|Acute Phase|Non-compliance|1|||
130678386|NCT01124149|470449192|FG000|Acute Phase|Low hemoglobin|1|||
130678387|NCT01124149|470449192|FG000|Acute Phase|Travelling to another country|1|||
130678388|NCT01124149|470449192|FG000|Acute Phase|Sponsor decision|1|||
130678389|NCT01124149|470449192|FG000|Maintenance Phase|Lack of Efficacy|40|||
130678390|NCT01124149|470449192|FG000|Maintenance Phase|Adverse Event|24|||
130678391|NCT01124149|470449192|FG000|Maintenance Phase|Lost to Follow-up|15|||
130678392|NCT01124149|470449192|FG000|Maintenance Phase|Withdrawal by Subject|10|||
130678393|NCT01124149|470449192|FG000|Maintenance Phase|Protocol Violation|5|||
130678394|NCT01124149|470449192|FG000|Maintenance Phase|Coordinator error|1|||
130678395|NCT01124149|470449192|FG000|Maintenance Phase|Non-compliance|1|||
130678396|NCT00977106|470449193|FG000|Overall Study|Adverse Event|5|||
130678397|NCT00977106|470449194|FG001|Overall Study|Adverse Event|6|||
130678398|NCT00977106|470449193|FG000|Overall Study|Withdrawal by Subject|2|||
130678399|NCT00977106|470449194|FG001|Overall Study|Withdrawal by Subject|2|||
130678400|NCT00977106|470449193|FG000|Overall Study|Lack of Efficacy|2|||
130678401|NCT00977106|470449194|FG001|Overall Study|Lack of Efficacy|2|||
130678402|NCT00977106|470449193|FG000|Overall Study|Protocol Violation|0|||
130678403|NCT00977106|470449194|FG001|Overall Study|Protocol Violation|1|||
130678404|NCT00977106|470449193|FG000|Overall Study|Other|1|||
130678405|NCT00977106|470449194|FG001|Overall Study|Other|0|||
131101257|NCT01859988|471999651|FG003|Overall Study|Lack of Efficacy|0|||
131101258|NCT01859988|471999652|FG004|Overall Study|Lack of Efficacy|7|||
131101259|NCT01859988|471999653|FG005|Overall Study|Lack of Efficacy|9|||
130678439|NCT00720096|470449209|FG000|Overall Study|Withdrawal by Subject|0|||
130678440|NCT00720096|470449210|FG001|Overall Study|Withdrawal by Subject|2|||
130678445|NCT03992196|470449215|FG000|Enrollment|lost to follow-up prior dosing|1|||
130678446|NCT03992196|470449216|FG001|Enrollment|lost to follow-up prior dosing|0|||
130678447|NCT03992196|470449217|FG002|Enrollment|lost to follow-up prior dosing|0|||
130678448|NCT03992196|470449215|FG000|Treatment|Protocol Violation|0|||
130678449|NCT03992196|470449216|FG001|Treatment|Protocol Violation|0|||
130678450|NCT03992196|470449217|FG002|Treatment|Protocol Violation|1|||
130678451|NCT03992196|470449215|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
130678452|NCT03992196|470449216|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
130678453|NCT03992196|470449217|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
130678454|NCT03992196|470449215|FG000|Treatment|Withdrawal due to non-compliance|0|||
131013892|NCT01689519|471679649|FG001|Intent to Treat|Physician Decision|1|||
131013893|NCT01689519|471679648|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
131013894|NCT01689519|471679649|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
131013895|NCT01689519|471679648|FG000|Intent to Treat|Withdrawal by Subject|21|||
131013896|NCT01689519|471679649|FG001|Intent to Treat|Withdrawal by Subject|20|||
131013897|NCT01689519|471679648|FG000|Safety Population|Death|158|||
131013898|NCT01689519|471679649|FG001|Safety Population|Death|165|||
131013899|NCT01689519|471679648|FG000|Safety Population|Lost to Follow-up|4|||
131013900|NCT01689519|471679649|FG001|Safety Population|Lost to Follow-up|8|||
131013901|NCT01689519|471679648|FG000|Safety Population|Other|2|||
131013902|NCT01689519|471679649|FG001|Safety Population|Other|4|||
131013903|NCT01689519|471679648|FG000|Safety Population|Physician Decision|4|||
131013904|NCT01689519|471679649|FG001|Safety Population|Physician Decision|1|||
131013905|NCT01689519|471679648|FG000|Safety Population|Study Terminated By Sponsor|60|||
131013906|NCT01689519|471679649|FG001|Safety Population|Study Terminated By Sponsor|47|||
131013907|NCT01689519|471679648|FG000|Safety Population|Withdrawal by Subject|20|||
131013908|NCT01689519|471679649|FG001|Safety Population|Withdrawal by Subject|20|||
131013909|NCT01713530|471679654|FG000|Overall Study|Adverse Event|0|||
131013910|NCT01713530|471679655|FG001|Overall Study|Adverse Event|5|||
131013911|NCT01713530|471679654|FG000|Overall Study|Withdrawal criteria|21|||
131013912|NCT01713530|471679655|FG001|Overall Study|Withdrawal criteria|12|||
131013913|NCT01713530|471679654|FG000|Overall Study|Unclassified|4|||
131013914|NCT01713530|471679655|FG001|Overall Study|Unclassified|2|||
131013915|NCT01959412|471679656|FG000|Overall Study|Protocol deviation|1|||
131013916|NCT01959412|471679657|FG001|Overall Study|Protocol deviation|1|||
131013917|NCT01959412|471679658|FG002|Overall Study|Protocol deviation|0|||
131013918|NCT01959412|471679659|FG003|Overall Study|Protocol deviation|1|||
131013919|NCT01959412|471679660|FG004|Overall Study|Protocol deviation|3|||
131013920|NCT01959412|471679661|FG005|Overall Study|Protocol deviation|0|||
131013921|NCT01959412|471679656|FG000|Overall Study|Adverse Event|0|||
131013922|NCT01959412|471679657|FG001|Overall Study|Adverse Event|0|||
131013923|NCT01959412|471679658|FG002|Overall Study|Adverse Event|0|||
131013924|NCT01959412|471679659|FG003|Overall Study|Adverse Event|1|||
131013925|NCT01959412|471679660|FG004|Overall Study|Adverse Event|0|||
131013926|NCT01959412|471679661|FG005|Overall Study|Adverse Event|0|||
131013927|NCT01186848|471679667|FG000|Overall Study|Lost to Follow-up|4|||
131013928|NCT01186848|471679667|FG000|Overall Study|Withdrawal by Subject|2|||
131013929|NCT01186848|471679667|FG000|Overall Study|Adverse Event|2|||
131013930|NCT02148133|471679672|FG000|Overall Study|Investigator discretion|1|||
131013931|NCT02148133|471679672|FG000|Overall Study|Lack of Efficacy|1|||
131013932|NCT02148133|471679672|FG000|Overall Study|Protocol deviation|1|||
131013933|NCT02148133|471679672|FG000|Overall Study|Protocol-defined stopping criteria|2|||
131013934|NCT00855465|471679674|FG000|Treatment Period|Adverse Event|4|||
131013935|NCT00855465|471679675|FG001|Treatment Period|Adverse Event|2|||
131013936|NCT00855465|471679674|FG000|Treatment Period|Death|2|||
131013937|NCT00855465|471679675|FG001|Treatment Period|Death|2|||
131013938|NCT00855465|471679674|FG000|Treatment Period|Lack of Efficacy|2|||
131013939|NCT00855465|471679675|FG001|Treatment Period|Lack of Efficacy|1|||
131013940|NCT00855465|471679674|FG000|Treatment Period|Non-compliance|1|||
130678455|NCT03992196|470449216|FG001|Treatment|Withdrawal due to non-compliance|0|||
130678456|NCT03992196|470449217|FG002|Treatment|Withdrawal due to non-compliance|1|||
131013941|NCT00855465|471679675|FG001|Treatment Period|Non-compliance|0|||
131013942|NCT00855465|471679674|FG000|Treatment Period|Protocol Violation|2|||
131013943|NCT00855465|471679675|FG001|Treatment Period|Protocol Violation|0|||
131013944|NCT00855465|471679674|FG000|Treatment Period|Withdrawal by Subject|2|||
131013945|NCT00855465|471679675|FG001|Treatment Period|Withdrawal by Subject|0|||
131013946|NCT00855465|471679674|FG000|Treatment Period|Not treated|1|||
131013947|NCT00855465|471679675|FG001|Treatment Period|Not treated|0|||
131013948|NCT00855465|471679674|FG000|Follow-up Period (FUP)|Adverse Event|0|||
131013949|NCT00855465|471679675|FG001|Follow-up Period (FUP)|Adverse Event|1|||
130678457|NCT03992196|470449215|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
131013950|NCT00855465|471679674|FG000|Follow-up Period (FUP)|Death|0|||
131013951|NCT00855465|471679675|FG001|Follow-up Period (FUP)|Death|1|||
131013952|NCT00855465|471679674|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
131013953|NCT00855465|471679675|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
131013954|NCT00855465|471679674|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
130678458|NCT03992196|470449216|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
130678459|NCT03992196|470449217|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
130885397|NCT01646125|471215187|FG001|Overall Study|Physician Decision|3|||
131013955|NCT00855465|471679675|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
131013956|NCT00855465|471679674|FG000|Follow-up Period (FUP)|Missing|1|||
131013957|NCT00855465|471679675|FG001|Follow-up Period (FUP)|Missing|0|||
131013958|NCT00509769|471679679|FG000|Overall Study|Progressive disease|77|||
131013959|NCT00509769|471679679|FG000|Overall Study|Adverse Event|4|||
131013960|NCT00509769|471679679|FG000|Overall Study|Patient's decision|1|||
131013961|NCT00509769|471679679|FG000|Overall Study|Physician Decision|8|||
131013962|NCT00509769|471679679|FG000|Overall Study|Use of prohibited therapies during study|1|||
131013963|NCT00754936|471679681|FG000|Overall Study|Lost to Follow-up|3|||
131013964|NCT00754936|471679681|FG000|Overall Study|Physician Decision|1|||
131013965|NCT00754936|471679681|FG000|Overall Study|Withdrawal by Subject|2|||
131013966|NCT00754936|471679681|FG000|Overall Study|Side Effects|3|||
131013967|NCT00754936|471679681|FG000|Overall Study|Inter-current medical events|3|||
131013968|NCT00619645|471679682|FG000|Overall Study|Adverse Event|1|||
131013969|NCT00436644|471679683|FG000|Overall Study|Adverse Event|2|||
131013970|NCT00436644|471679683|FG000|Overall Study|Death|1|||
131013971|NCT04364269|471679684|FG000|Overall Study|Adverse Event|1|||
131013972|NCT04364269|471679685|FG001|Overall Study|Adverse Event|0|||
131013973|NCT04364269|471679686|FG002|Overall Study|Adverse Event|0|||
131013974|NCT04364269|471679684|FG000|Overall Study|Withdrawal by Subject|0|||
131013975|NCT04364269|471679685|FG001|Overall Study|Withdrawal by Subject|1|||
131013976|NCT04364269|471679686|FG002|Overall Study|Withdrawal by Subject|0|||
131013977|NCT01490580|471679687|FG000|Overall Study|Parents withdrew consent|0|||
131013978|NCT01490580|471679688|FG001|Overall Study|Parents withdrew consent|2|||
131013979|NCT00972504|471679689|FG000|Overall Study|Adverse Event|2|||
131013980|NCT00972504|471679689|FG000|Overall Study|Investigator discretion|1|||
131013981|NCT00597519|471679690|FG000|Overall Study|Death|1|||
131013982|NCT04246762|471679691|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
131013983|NCT00410124|471679692|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
131013984|NCT00410124|471679693|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
131013985|NCT00410124|471679692|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
131013986|NCT00410124|471679693|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
131013987|NCT00410124|471679692|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
131013988|NCT00410124|471679693|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
131013989|NCT00410124|471679692|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
131013990|NCT00410124|471679693|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
131013991|NCT00410124|471679692|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
131013992|NCT00410124|471679693|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
131013993|NCT00410124|471679692|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
131013994|NCT00410124|471679693|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
131013995|NCT00410124|471679692|FG000|Core Phase Double Blind (15 Months)|Death|7|||
131013996|NCT00410124|471679693|FG001|Core Phase Double Blind (15 Months)|Death|4|||
131013997|NCT00410124|471679692|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
131013998|NCT00410124|471679693|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
131013999|NCT00410124|471679692|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
131014000|NCT00410124|471679693|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
131014001|NCT00410124|471679692|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
131014002|NCT00410124|471679693|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
131014003|NCT00410124|471679692|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
131014004|NCT00410124|471679693|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
131014005|NCT00410124|471679692|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
131014006|NCT00410124|471679693|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
131014007|NCT00410124|471679692|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
131014008|NCT00410124|471679693|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
131014009|NCT00410124|471679692|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
131014010|NCT00410124|471679693|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
131014011|NCT00410124|471679692|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
131014012|NCT00410124|471679693|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
131014013|NCT00410124|471679692|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
131014014|NCT00410124|471679693|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
131014015|NCT05484726|471679696|FG000|Overall Study|Protocol Violation|3|||
131014016|NCT05484726|471679697|FG001|Overall Study|Protocol Violation|3|||
131014017|NCT05484726|471679696|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
131014018|NCT05484726|471679697|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
131014019|NCT05484726|471679696|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
131101260|NCT01859988|471999648|FG000|Overall Study|Physician Decision|1|||
130678460|NCT03992196|470449215|FG000|Treatment|Withdrawal by parent/guardian|0|||
130678461|NCT03992196|470449216|FG001|Treatment|Withdrawal by parent/guardian|0|||
131101261|NCT01859988|471999649|FG001|Overall Study|Physician Decision|3|||
131101262|NCT01859988|471999650|FG002|Overall Study|Physician Decision|1|||
131101263|NCT01859988|471999651|FG003|Overall Study|Physician Decision|3|||
131101264|NCT01859988|471999652|FG004|Overall Study|Physician Decision|4|||
131101265|NCT01859988|471999653|FG005|Overall Study|Physician Decision|1|||
131101266|NCT01859988|471999648|FG000|Overall Study|Adverse Event|2|||
131101267|NCT01859988|471999649|FG001|Overall Study|Adverse Event|1|||
131101268|NCT01859988|471999650|FG002|Overall Study|Adverse Event|3|||
131101269|NCT01859988|471999651|FG003|Overall Study|Adverse Event|1|||
131101270|NCT01859988|471999652|FG004|Overall Study|Adverse Event|2|||
131101271|NCT01859988|471999653|FG005|Overall Study|Adverse Event|2|||
131101272|NCT01859988|471999648|FG000|Overall Study|Lost to Follow-up|1|||
131101273|NCT01859988|471999649|FG001|Overall Study|Lost to Follow-up|2|||
131101274|NCT01859988|471999650|FG002|Overall Study|Lost to Follow-up|3|||
131101275|NCT01859988|471999651|FG003|Overall Study|Lost to Follow-up|0|||
131101276|NCT01859988|471999652|FG004|Overall Study|Lost to Follow-up|3|||
131101277|NCT01859988|471999653|FG005|Overall Study|Lost to Follow-up|2|||
131101278|NCT01859988|471999648|FG000|Overall Study|Protocol Violation|0|||
131101279|NCT01859988|471999649|FG001|Overall Study|Protocol Violation|0|||
131101280|NCT01859988|471999650|FG002|Overall Study|Protocol Violation|1|||
131101281|NCT01859988|471999651|FG003|Overall Study|Protocol Violation|0|||
131101282|NCT01859988|471999652|FG004|Overall Study|Protocol Violation|0|||
131101283|NCT01859988|471999653|FG005|Overall Study|Protocol Violation|0|||
131101284|NCT01859988|471999648|FG000|Overall Study|Other than specified above|0|||
131101285|NCT01859988|471999649|FG001|Overall Study|Other than specified above|2|||
131101286|NCT01859988|471999650|FG002|Overall Study|Other than specified above|11|||
131101287|NCT01859988|471999651|FG003|Overall Study|Other than specified above|3|||
131101288|NCT01859988|471999652|FG004|Overall Study|Other than specified above|5|||
131101289|NCT01859988|471999653|FG005|Overall Study|Other than specified above|3|||
131101290|NCT00468559|471999658|FG000|Open-label Treatment Phase|Adverse Event|5|||
131101291|NCT00468559|471999659|FG001|Open-label Treatment Phase|Adverse Event|0|||
131101292|NCT00468559|471999660|FG002|Open-label Treatment Phase|Adverse Event|0|||
131101293|NCT00468559|471999658|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
131101294|NCT00468559|471999659|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
131101295|NCT00468559|471999660|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
131101296|NCT00468559|471999658|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
131101297|NCT00468559|471999659|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
131101298|NCT00468559|471999660|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
131101299|NCT00468559|471999658|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
131101300|NCT00468559|471999659|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
131101301|NCT00468559|471999660|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
131101302|NCT00468559|471999658|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
131101303|NCT00468559|471999659|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
131101304|NCT00468559|471999660|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
131101305|NCT01131182|471999661|FG000|Overall Study|Withdrawal by Subject|1|||
131101306|NCT01131182|471999662|FG001|Overall Study|Withdrawal by Subject|1|||
131101307|NCT01131182|471999661|FG000|Overall Study|Lost to Follow-up|14|||
131101308|NCT01131182|471999662|FG001|Overall Study|Lost to Follow-up|15|||
131101309|NCT01131182|471999661|FG000|Overall Study|Other Reason|1|||
131101310|NCT01131182|471999662|FG001|Overall Study|Other Reason|0|||
130678462|NCT03992196|470449217|FG002|Treatment|Withdrawal by parent/guardian|2|||
130678463|NCT00048048|470449218|FG000|Core Treatment|Withdrawal by Subject|0|||
130678464|NCT00048048|470449219|FG001|Core Treatment|Withdrawal by Subject|0|||
130678465|NCT00048048|470449220|FG002|Core Treatment|Withdrawal by Subject|1|||
130678466|NCT00048048|470449221|FG003|Core Treatment|Withdrawal by Subject|0|||
130678467|NCT00048048|470449222|FG004|Core Treatment|Withdrawal by Subject|0|||
130678468|NCT00048048|470449223|FG005|Core Treatment|Withdrawal by Subject|0|||
130678469|NCT00048048|470449224|FG006|Core Treatment|Withdrawal by Subject|0|||
130678470|NCT00048048|470449225|FG007|Core Treatment|Withdrawal by Subject|0|||
130678471|NCT00048048|470449226|FG008|Core Treatment|Withdrawal by Subject|0|||
130678472|NCT00048048|470449227|FG009|Core Treatment|Withdrawal by Subject|0|||
130678473|NCT00048048|470449228|FG010|Core Treatment|Withdrawal by Subject|0|||
130678474|NCT00048048|470449229|FG011|Core Treatment|Withdrawal by Subject|0|||
130678475|NCT00048048|470449218|FG000|Core Treatment|Adverse Event|0|||
130678476|NCT00048048|470449219|FG001|Core Treatment|Adverse Event|0|||
130678477|NCT00048048|470449220|FG002|Core Treatment|Adverse Event|0|||
131101311|NCT04602221|471999664|FG000|Overall Study|Discontinuation of trial treatment|0|||
131101312|NCT04602221|471999665|FG001|Overall Study|Discontinuation of trial treatment|0|||
131101313|NCT04602221|471999666|FG002|Overall Study|Discontinuation of trial treatment|1|||
131101314|NCT04602221|471999667|FG003|Overall Study|Discontinuation of trial treatment|0|||
131101315|NCT04602221|471999668|FG004|Overall Study|Discontinuation of trial treatment|0|||
131101316|NCT04602221|471999669|FG005|Overall Study|Discontinuation of trial treatment|0|||
130678478|NCT00048048|470449221|FG003|Core Treatment|Adverse Event|0|||
130678479|NCT00048048|470449222|FG004|Core Treatment|Adverse Event|0|||
130678480|NCT00048048|470449223|FG005|Core Treatment|Adverse Event|0|||
130678481|NCT00048048|470449224|FG006|Core Treatment|Adverse Event|0|||
130678482|NCT00048048|470449225|FG007|Core Treatment|Adverse Event|1|||
130678483|NCT00048048|470449226|FG008|Core Treatment|Adverse Event|0|||
130678484|NCT00048048|470449227|FG009|Core Treatment|Adverse Event|0|||
131014020|NCT05484726|471679697|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
131014021|NCT05484726|471679696|FG000|Overall Study|continued need of mechanical ventilation|2|||
131014022|NCT05484726|471679697|FG001|Overall Study|continued need of mechanical ventilation|3|||
131014023|NCT05484726|471679696|FG000|Overall Study|Withdrawal by Subject|2|||
131014024|NCT05484726|471679697|FG001|Overall Study|Withdrawal by Subject|3|||
131014025|NCT05484726|471679696|FG000|Overall Study|IVH (G III & IV)|2|||
131014026|NCT05484726|471679697|FG001|Overall Study|IVH (G III & IV)|1|||
131014027|NCT05484726|471679696|FG000|Overall Study|NEC (stage II & III)|2|||
131014028|NCT05484726|471679697|FG001|Overall Study|NEC (stage II & III)|3|||
131014029|NCT01093534|471679698|FG000|Overall Study|Adverse Event|2|||
131014030|NCT01093534|471679699|FG001|Overall Study|Adverse Event|5|||
131014031|NCT01093534|471679700|FG002|Overall Study|Adverse Event|2|||
131014032|NCT01093534|471679698|FG000|Overall Study|Lack of Efficacy|2|||
131014033|NCT01093534|471679699|FG001|Overall Study|Lack of Efficacy|1|||
131014034|NCT01093534|471679700|FG002|Overall Study|Lack of Efficacy|1|||
131014035|NCT01093534|471679698|FG000|Overall Study|Withdrawal by Subject|5|||
131014036|NCT01093534|471679699|FG001|Overall Study|Withdrawal by Subject|7|||
131014037|NCT01093534|471679700|FG002|Overall Study|Withdrawal by Subject|2|||
131014038|NCT01093534|471679698|FG000|Overall Study|Other|1|||
131014039|NCT01093534|471679699|FG001|Overall Study|Other|3|||
131014040|NCT01093534|471679700|FG002|Overall Study|Other|4|||
131014041|NCT01837641|471679707|FG000|Overall Study|Sponsor decision|1|||
131014042|NCT01837641|471679708|FG001|Overall Study|Sponsor decision|0|||
131014043|NCT01837641|471679709|FG002|Overall Study|Sponsor decision|0|||
131014044|NCT01837641|471679710|FG003|Overall Study|Sponsor decision|0|||
131014045|NCT01837641|471679711|FG004|Overall Study|Sponsor decision|0|||
131014046|NCT01837641|471679712|FG005|Overall Study|Sponsor decision|1|||
131014047|NCT01837641|471679713|FG006|Overall Study|Sponsor decision|0|||
131014048|NCT01837641|471679714|FG007|Overall Study|Sponsor decision|0|||
131014049|NCT01837641|471679707|FG000|Overall Study|Adverse Event|0|||
131014050|NCT01837641|471679708|FG001|Overall Study|Adverse Event|0|||
131014051|NCT01837641|471679709|FG002|Overall Study|Adverse Event|0|||
131014052|NCT01837641|471679710|FG003|Overall Study|Adverse Event|0|||
131014053|NCT01837641|471679711|FG004|Overall Study|Adverse Event|0|||
131014054|NCT01837641|471679712|FG005|Overall Study|Adverse Event|1|||
131014055|NCT01837641|471679713|FG006|Overall Study|Adverse Event|0|||
131014056|NCT01837641|471679714|FG007|Overall Study|Adverse Event|0|||
131014057|NCT01837641|471679707|FG000|Overall Study|Withdrawal by Subject|0|||
131014058|NCT01837641|471679708|FG001|Overall Study|Withdrawal by Subject|0|||
131014059|NCT01837641|471679709|FG002|Overall Study|Withdrawal by Subject|0|||
131014060|NCT01837641|471679710|FG003|Overall Study|Withdrawal by Subject|0|||
131014061|NCT01837641|471679711|FG004|Overall Study|Withdrawal by Subject|1|||
131014062|NCT01837641|471679712|FG005|Overall Study|Withdrawal by Subject|0|||
131014063|NCT01837641|471679713|FG006|Overall Study|Withdrawal by Subject|1|||
131014064|NCT01837641|471679714|FG007|Overall Study|Withdrawal by Subject|0|||
131014065|NCT01769391|471679719|FG000|Overall Study|Death|10|||
131014066|NCT01769391|471679720|FG001|Overall Study|Death|1|||
131014067|NCT01769391|471679719|FG000|Overall Study|Adverse Event|0|||
131014068|NCT01769391|471679720|FG001|Overall Study|Adverse Event|3|||
131014069|NCT01769391|471679719|FG000|Overall Study|Progressive Disease|1|||
131014070|NCT01769391|471679720|FG001|Overall Study|Progressive Disease|2|||
131014071|NCT01769391|471679719|FG000|Overall Study|Withdrawal by Subject|4|||
131014072|NCT01769391|471679720|FG001|Overall Study|Withdrawal by Subject|3|||
131014073|NCT01769391|471679719|FG000|Overall Study|Investigator Decision|2|||
131014074|NCT01769391|471679720|FG001|Overall Study|Investigator Decision|0|||
131014075|NCT01144182|471679721|FG000|Overall Study|Death|5|||
131014076|NCT01144182|471679722|FG001|Overall Study|Death|6|||
131014077|NCT01144182|471679721|FG000|Overall Study|Withdrawal by Subject|3|||
131014078|NCT01144182|471679722|FG001|Overall Study|Withdrawal by Subject|6|||
131014079|NCT01144182|471679721|FG000|Overall Study|Lost to Follow-up|9|||
131014080|NCT01144182|471679722|FG001|Overall Study|Lost to Follow-up|9|||
131014081|NCT02351180|471679725|FG000|Overall Study|Withdrawal by Subject|1|||
130678485|NCT00048048|470449228|FG010|Core Treatment|Adverse Event|0|||
131014082|NCT02351180|471679726|FG001|Overall Study|Withdrawal by Subject|0|||
131014083|NCT02317016|471679727|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
131014084|NCT02317016|471679727|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
131014085|NCT02317016|471679727|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
131014086|NCT02317016|471679727|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
131014087|NCT02317016|471679727|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
131014088|NCT02317016|471679727|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
131014089|NCT02317016|471679727|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
131014090|NCT00536380|471679728|FG000|Overall Study|Adverse Event|0|||
130678486|NCT00048048|470449229|FG011|Core Treatment|Adverse Event|0|||
130678487|NCT00048048|470449218|FG000|Extension Year 1|Early withdrawals|0|||
130678488|NCT00048048|470449219|FG001|Extension Year 1|Early withdrawals|0|||
130678489|NCT00048048|470449220|FG002|Extension Year 1|Early withdrawals|0|||
130678490|NCT00048048|470449221|FG003|Extension Year 1|Early withdrawals|0|||
130678491|NCT00048048|470449222|FG004|Extension Year 1|Early withdrawals|0|||
130678492|NCT00048048|470449223|FG005|Extension Year 1|Early withdrawals|0|||
130678493|NCT00048048|470449224|FG006|Extension Year 1|Early withdrawals|0|||
130678494|NCT00048048|470449225|FG007|Extension Year 1|Early withdrawals|0|||
130678495|NCT00048048|470449226|FG008|Extension Year 1|Early withdrawals|0|||
130678496|NCT00048048|470449227|FG009|Extension Year 1|Early withdrawals|2|||
130678497|NCT00048048|470449228|FG010|Extension Year 1|Early withdrawals|2|||
130678498|NCT00048048|470449229|FG011|Extension Year 1|Early withdrawals|4|||
130678499|NCT00048048|470449218|FG000|Extension Year 2|Early withdrawals|0|||
130678500|NCT00048048|470449219|FG001|Extension Year 2|Early withdrawals|0|||
130678501|NCT00048048|470449220|FG002|Extension Year 2|Early withdrawals|0|||
130678502|NCT00048048|470449221|FG003|Extension Year 2|Early withdrawals|0|||
130678503|NCT00048048|470449222|FG004|Extension Year 2|Early withdrawals|0|||
130678504|NCT00048048|470449223|FG005|Extension Year 2|Early withdrawals|0|||
130678505|NCT00048048|470449224|FG006|Extension Year 2|Early withdrawals|0|||
130678506|NCT00048048|470449225|FG007|Extension Year 2|Early withdrawals|0|||
130678507|NCT00048048|470449226|FG008|Extension Year 2|Early withdrawals|0|||
130678508|NCT00048048|470449227|FG009|Extension Year 2|Early withdrawals|0|||
131014091|NCT00536380|471679729|FG001|Overall Study|Adverse Event|2|||
131014092|NCT00536380|471679730|FG002|Overall Study|Adverse Event|2|||
131014093|NCT00536380|471679728|FG000|Overall Study|Lost to Follow-up|0|||
131014094|NCT00536380|471679729|FG001|Overall Study|Lost to Follow-up|0|||
131014095|NCT00536380|471679730|FG002|Overall Study|Lost to Follow-up|1|||
131014096|NCT00536380|471679728|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
131014097|NCT00536380|471679729|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
131014098|NCT00536380|471679730|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
131014099|NCT00536380|471679728|FG000|Overall Study|Withdrawal related to study drug|7|||
131014100|NCT00536380|471679729|FG001|Overall Study|Withdrawal related to study drug|5|||
131014101|NCT00536380|471679730|FG002|Overall Study|Withdrawal related to study drug|2|||
131014102|NCT00536380|471679728|FG000|Overall Study|Noncompliance with protocol|3|||
131014103|NCT00536380|471679729|FG001|Overall Study|Noncompliance with protocol|2|||
131014104|NCT00536380|471679730|FG002|Overall Study|Noncompliance with protocol|2|||
131014105|NCT00536380|471679728|FG000|Overall Study|Did not meet protocol eligibility|0|||
131014106|NCT00536380|471679729|FG001|Overall Study|Did not meet protocol eligibility|0|||
131014107|NCT00536380|471679730|FG002|Overall Study|Did not meet protocol eligibility|1|||
131014108|NCT00536380|471679728|FG000|Overall Study|Administrative|0|||
131014109|NCT00536380|471679729|FG001|Overall Study|Administrative|0|||
131014110|NCT00536380|471679730|FG002|Overall Study|Administrative|1|||
131014111|NCT01867580|471679733|FG000|Overall Study|Withdrawal by Subject|2|||
131014112|NCT01867580|471679734|FG001|Overall Study|Withdrawal by Subject|3|||
131014113|NCT01867580|471679733|FG000|Overall Study|Physician Decision|17|||
131014114|NCT01867580|471679734|FG001|Overall Study|Physician Decision|12|||
131014115|NCT01867580|471679733|FG000|Overall Study|Lost to Follow-up|3|||
131014116|NCT01867580|471679734|FG001|Overall Study|Lost to Follow-up|5|||
131014117|NCT01867580|471679733|FG000|Overall Study|Sponsor terminated study|1|||
131014118|NCT01867580|471679734|FG001|Overall Study|Sponsor terminated study|0|||
131014119|NCT01867580|471679733|FG000|Overall Study|Missed follow-up assessment|2|||
131014120|NCT01867580|471679734|FG001|Overall Study|Missed follow-up assessment|1|||
131014121|NCT01867580|471679733|FG000|Overall Study|Interruption to therapy|3|||
131014122|NCT01867580|471679734|FG001|Overall Study|Interruption to therapy|0|||
131014123|NCT01867580|471679733|FG000|Overall Study|Osteomyelitis|0|||
131014124|NCT01867580|471679734|FG001|Overall Study|Osteomyelitis|1|||
131014125|NCT01867580|471679733|FG000|Overall Study|Continuation of therapy|0|||
131014126|NCT01867580|471679734|FG001|Overall Study|Continuation of therapy|1|||
131014127|NCT01867580|471679733|FG000|Overall Study|Wound recurrence|0|||
131014128|NCT01867580|471679734|FG001|Overall Study|Wound recurrence|1|||
131014129|NCT03141788|471679735|FG000|Overall Study|Lost to Follow-up|1|||
131014130|NCT03141788|471679735|FG000|Overall Study|Protocol Violation|3|||
131014131|NCT03141788|471679735|FG000|Overall Study|Withdrawal by Subject|4|||
131014132|NCT04257058|471681089|FG000|Overall Study|Lost to Follow-up|31|||
131014133|NCT00661778|471681092|FG000|Overall Study|Disease Progression|23|||
131014134|NCT00661778|471681092|FG000|Overall Study|Adverse Event|18|||
131014135|NCT00661778|471681092|FG000|Overall Study|Reason not Specified|6|||
131014136|NCT00661778|471681092|FG000|Overall Study|Protocol Violation|2|||
130678509|NCT00048048|470449228|FG010|Extension Year 2|Early withdrawals|4|||
130678510|NCT00048048|470449229|FG011|Extension Year 2|Early withdrawals|2|||
130678511|NCT02684578|470449230|FG000|Overall Study|Withdrawal by Subject|10|||
131014137|NCT00661778|471681092|FG000|Overall Study|Withdrawal of Consent|1|||
131014138|NCT03546907|471681101|FG000|Overall Study|Lack of Efficacy|1|||
131014139|NCT03546907|471681102|FG001|Overall Study|Lack of Efficacy|1|||
131014140|NCT03546907|471681101|FG000|Overall Study|Withdrawal by Subject|8|||
130678512|NCT02684578|470449231|FG001|Overall Study|Withdrawal by Subject|7|||
130678513|NCT02684578|470449230|FG000|Overall Study|Lost to Follow-up|0|||
130678514|NCT02684578|470449231|FG001|Overall Study|Lost to Follow-up|3|||
130678515|NCT02684578|470449230|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
130678516|NCT02684578|470449231|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
130678517|NCT02684578|470449230|FG000|Overall Study|Missing follow-up data|0|||
130678518|NCT02684578|470449231|FG001|Overall Study|Missing follow-up data|1|||
130678519|NCT02388763|470449234|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
130678520|NCT02388763|470449235|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
130678521|NCT02388763|470449234|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
130678522|NCT02388763|470449235|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
130678523|NCT01458405|470449246|FG000|Phase 1 (up to 12 Months)|Other|0|||
130678524|NCT01458405|470449247|FG001|Phase 1 (up to 12 Months)|Other|1|||
130678525|NCT01458405|470449248|FG002|Phase 1 (up to 12 Months)|Other|0|||
130678526|NCT01458405|470449249|FG003|Phase 1 (up to 12 Months)|Other|0|||
130678527|NCT01458405|470449246|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
130678528|NCT01458405|470449247|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
130678529|NCT01458405|470449248|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
130678530|NCT01458405|470449249|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
130678531|NCT01458405|470449246|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
130678532|NCT01458405|470449247|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
130678533|NCT01458405|470449248|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
130678534|NCT01458405|470449249|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
130678535|NCT01458405|470449246|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
130678536|NCT01458405|470449247|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
130678537|NCT01458405|470449248|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
130678538|NCT01458405|470449249|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
130678539|NCT02194998|470449250|FG000|On-HCV Treatment|Did not pick up study medication|0|||
130678540|NCT02194998|470449251|FG001|On-HCV Treatment|Did not pick up study medication|1|||
130678541|NCT02194998|470449252|FG002|On-HCV Treatment|Did not pick up study medication|0|||
130678542|NCT02194998|470449253|FG003|On-HCV Treatment|Did not pick up study medication|0|||
130678543|NCT02194998|470449250|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
130678544|NCT02194998|470449251|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
130678545|NCT02194998|470449252|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
130678546|NCT02194998|470449253|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
130678547|NCT02497781|470449254|FG000|Overall Study|Withdrawal by Subject|2|||
130678548|NCT02497781|470449255|FG001|Overall Study|Withdrawal by Subject|0|||
130678549|NCT02497781|470449254|FG000|Overall Study|Lack of Efficacy|0|||
130678550|NCT02497781|470449255|FG001|Overall Study|Lack of Efficacy|1|||
130678551|NCT02497781|470449254|FG000|Overall Study|Randomised but not treated|1|||
130678552|NCT02497781|470449255|FG001|Overall Study|Randomised but not treated|1|||
130678553|NCT02497781|470449254|FG000|Overall Study|Lost to Follow-up|1|||
130678554|NCT02497781|470449255|FG001|Overall Study|Lost to Follow-up|1|||
130678555|NCT02236130|470449256|FG000|Overall Study|Lost to Follow-up|7|||
130678556|NCT02236130|470449257|FG001|Overall Study|Lost to Follow-up|12|||
131014141|NCT03546907|471681102|FG001|Overall Study|Withdrawal by Subject|9|||
131014142|NCT03546907|471681101|FG000|Overall Study|Adverse events (AEs)|7|||
131014143|NCT03546907|471681102|FG001|Overall Study|Adverse events (AEs)|10|||
131014144|NCT03546907|471681101|FG000|Overall Study|Other-unspecified|1|||
131014145|NCT03546907|471681102|FG001|Overall Study|Other-unspecified|1|||
131014146|NCT01281813|471681103|FG000|Overall Study|Adverse Event|0|||
131014147|NCT01281813|471681104|FG001|Overall Study|Adverse Event|0|||
131014148|NCT01281813|471681105|FG002|Overall Study|Adverse Event|10|||
131014149|NCT01281813|471681103|FG000|Overall Study|Lost to Follow-up|0|||
131014150|NCT01281813|471681104|FG001|Overall Study|Lost to Follow-up|0|||
131014151|NCT01281813|471681105|FG002|Overall Study|Lost to Follow-up|31|||
131014152|NCT01281813|471681103|FG000|Overall Study|Withdrawal by Subject|0|||
131014153|NCT01281813|471681104|FG001|Overall Study|Withdrawal by Subject|0|||
131014154|NCT01281813|471681105|FG002|Overall Study|Withdrawal by Subject|13|||
131014155|NCT01281813|471681103|FG000|Overall Study|Subject Non-Compliant|0|||
131014156|NCT01281813|471681104|FG001|Overall Study|Subject Non-Compliant|0|||
131014157|NCT01281813|471681105|FG002|Overall Study|Subject Non-Compliant|6|||
131014158|NCT01281813|471681103|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
131014159|NCT01281813|471681104|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
131014160|NCT01281813|471681105|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
131014161|NCT01281813|471681103|FG000|Overall Study|Sponsor's Decision|4|||
131014162|NCT01281813|471681104|FG001|Overall Study|Sponsor's Decision|3|||
131014163|NCT01281813|471681105|FG002|Overall Study|Sponsor's Decision|7|||
131014164|NCT01281813|471681103|FG000|Overall Study|Switched to Commercially Available Medication|0|||
131014165|NCT01281813|471681104|FG001|Overall Study|Switched to Commercially Available Medication|0|||
131014166|NCT01281813|471681105|FG002|Overall Study|Switched to Commercially Available Medication|26|||
131014167|NCT01281813|471681103|FG000|Overall Study|Other|0|||
131014168|NCT01281813|471681104|FG001|Overall Study|Other|1|||
131014169|NCT01281813|471681105|FG002|Overall Study|Other|39|||
131014170|NCT02810080|471681112|FG000|Overall Study|Adverse Event|3|||
131014171|NCT02810080|471681113|FG001|Overall Study|Adverse Event|0|||
131014172|NCT02810080|471681112|FG000|Overall Study|Death|0|||
131014173|NCT02810080|471681113|FG001|Overall Study|Death|2|||
131014174|NCT02810080|471681112|FG000|Overall Study|Physician Decision|4|||
131014175|NCT02810080|471681113|FG001|Overall Study|Physician Decision|0|||
131014176|NCT02810080|471681112|FG000|Overall Study|Withdrawal by Subject|0|||
131014177|NCT02810080|471681113|FG001|Overall Study|Withdrawal by Subject|2|||
131014178|NCT02034916|471681116|FG000|Overall Study|Death|39|||
131014179|NCT02034916|471681117|FG001|Overall Study|Death|28|||
131014180|NCT02034916|471681116|FG000|Overall Study|Withdrawal by Subject|2|||
130678646|NCT00497796|470449279|FG000|Overall Study|Adverse event (not related)|9|||
130678647|NCT00497796|470449280|FG001|Overall Study|Adverse event (not related)|9|||
130678648|NCT00497796|470449279|FG000|Overall Study|Adverse event (related)|5|||
130678649|NCT00497796|470449280|FG001|Overall Study|Adverse event (related)|4|||
130678650|NCT00497796|470449279|FG000|Overall Study|CMV infection or disease treatment|30|||
130678651|NCT00497796|470449280|FG001|Overall Study|CMV infection or disease treatment|4|||
130678652|NCT00497796|470449279|FG000|Overall Study|Consent withdrawn|10|||
130678653|NCT00497796|470449280|FG001|Overall Study|Consent withdrawn|3|||
130678654|NCT00497796|470449279|FG000|Overall Study|Investigator/sponsor discretion|31|||
130678655|NCT00497796|470449280|FG001|Overall Study|Investigator/sponsor discretion|34|||
130678656|NCT00497796|470449279|FG000|Overall Study|Lost to Follow-up|0|||
130678657|NCT00497796|470449280|FG001|Overall Study|Lost to Follow-up|1|||
130678658|NCT00497796|470449279|FG000|Overall Study|Not applicable (randomized not treated)|0|||
130678659|NCT00497796|470449280|FG001|Overall Study|Not applicable (randomized not treated)|4|||
130678660|NCT00604500|470449281|FG000|Overall Study|Adverse Event|2|||
130678661|NCT00604500|470449281|FG000|Overall Study|Protocol Violation|2|||
130678662|NCT00604500|470449281|FG000|Overall Study|Treatment Failure|1|||
130885398|NCT01646125|471215186|FG000|Overall Study|Progressive disease|22|||
131014181|NCT02034916|471681117|FG001|Overall Study|Withdrawal by Subject|1|||
131014182|NCT02034916|471681116|FG000|Overall Study|Lost to Follow-up|4|||
131014183|NCT02034916|471681117|FG001|Overall Study|Lost to Follow-up|1|||
131014184|NCT02034916|471681116|FG000|Overall Study|Study terminated by sponsor|4|||
131014185|NCT02034916|471681117|FG001|Overall Study|Study terminated by sponsor|5|||
131014186|NCT01616654|471681122|FG000|Overall Study|Lack of Efficacy|1|||
131014187|NCT01616654|471681123|FG001|Overall Study|Lack of Efficacy|0|||
131014188|NCT01616654|471681124|FG002|Overall Study|Lack of Efficacy|0|||
131014189|NCT01616654|471681125|FG003|Overall Study|Lack of Efficacy|0|||
131014190|NCT01616654|471681126|FG004|Overall Study|Lack of Efficacy|1|||
131014191|NCT01616654|471681122|FG000|Overall Study|Adverse Event|0|||
131014192|NCT01616654|471681123|FG001|Overall Study|Adverse Event|1|||
131014193|NCT01616654|471681124|FG002|Overall Study|Adverse Event|2|||
131014194|NCT01616654|471681125|FG003|Overall Study|Adverse Event|1|||
131014195|NCT01616654|471681126|FG004|Overall Study|Adverse Event|0|||
131014196|NCT01616654|471681122|FG000|Overall Study|Withdrawal by Subject|2|||
131014197|NCT01616654|471681123|FG001|Overall Study|Withdrawal by Subject|2|||
131014198|NCT01616654|471681124|FG002|Overall Study|Withdrawal by Subject|3|||
131014199|NCT01616654|471681125|FG003|Overall Study|Withdrawal by Subject|1|||
131014200|NCT01616654|471681126|FG004|Overall Study|Withdrawal by Subject|5|||
131014201|NCT01616654|471681122|FG000|Overall Study|Protocol Violation|0|||
131014202|NCT01616654|471681123|FG001|Overall Study|Protocol Violation|5|||
131014203|NCT01616654|471681124|FG002|Overall Study|Protocol Violation|2|||
131014204|NCT01616654|471681125|FG003|Overall Study|Protocol Violation|4|||
131014205|NCT01616654|471681126|FG004|Overall Study|Protocol Violation|4|||
130678663|NCT00604500|470449281|FG000|Overall Study|Withdrawal by Subject|4|||
130678664|NCT00604500|470449281|FG000|Overall Study|Administrative|1|||
130678665|NCT00604500|470449281|FG000|Overall Study|Did not meet protocol eligibility|1|||
130678666|NCT01492400|470449282|FG000|Overall Study|Miscellaneous Reasons|2|||
130678667|NCT01492400|470449283|FG001|Overall Study|Miscellaneous Reasons|3|||
130885399|NCT01646125|471215187|FG001|Overall Study|Progressive disease|16|||
131014206|NCT01616654|471681122|FG000|Overall Study|Lost to Follow-up|1|||
131014207|NCT01616654|471681123|FG001|Overall Study|Lost to Follow-up|0|||
131014208|NCT01616654|471681124|FG002|Overall Study|Lost to Follow-up|3|||
131101317|NCT04602221|471999670|FG006|Overall Study|Discontinuation of trial treatment|0|||
130678668|NCT01492400|470449282|FG000|Overall Study|Personal Reasons|0|||
131014209|NCT01616654|471681125|FG003|Overall Study|Lost to Follow-up|2|||
131014210|NCT01616654|471681126|FG004|Overall Study|Lost to Follow-up|1|||
131014211|NCT01616654|471681122|FG000|Overall Study|Pregnancy|1|||
131014212|NCT01616654|471681123|FG001|Overall Study|Pregnancy|0|||
130678669|NCT01492400|470449283|FG001|Overall Study|Personal Reasons|5|||
130678670|NCT01492400|470449282|FG000|Overall Study|Lost to Follow-up|3|||
130678671|NCT01492400|470449283|FG001|Overall Study|Lost to Follow-up|1|||
130678672|NCT01492400|470449282|FG000|Overall Study|Pregnancy|0|||
130678673|NCT01492400|470449283|FG001|Overall Study|Pregnancy|1|||
130678674|NCT01492400|470449282|FG000|Overall Study|Lack of Efficacy|1|||
130678675|NCT01492400|470449283|FG001|Overall Study|Lack of Efficacy|1|||
130678676|NCT01492400|470449282|FG000|Overall Study|Adverse Event|10|||
130678677|NCT01492400|470449283|FG001|Overall Study|Adverse Event|5|||
130678678|NCT00320112|470449285|FG000|Overall Study|Lost to Follow-up|3|||
130678679|NCT00320112|470449286|FG001|Overall Study|Lost to Follow-up|4|||
130678680|NCT00320112|470449285|FG000|Overall Study|Withdrawal by Subject|3|||
131014213|NCT01616654|471681124|FG002|Overall Study|Pregnancy|0|||
131101318|NCT04602221|471999671|FG007|Overall Study|Discontinuation of trial treatment|0|||
131101319|NCT04602221|471999672|FG008|Overall Study|Discontinuation of trial treatment|0|||
131101320|NCT04602221|471999673|FG009|Overall Study|Discontinuation of trial treatment|0|||
131101321|NCT04602221|471999674|FG010|Overall Study|Discontinuation of trial treatment|0|||
131101322|NCT04602221|471999675|FG011|Overall Study|Discontinuation of trial treatment|0|||
131101323|NCT04602221|471999676|FG012|Overall Study|Discontinuation of trial treatment|0|||
131101324|NCT04602221|471999677|FG013|Overall Study|Discontinuation of trial treatment|0|||
131101325|NCT04602221|471999678|FG014|Overall Study|Discontinuation of trial treatment|0|||
131101326|NCT04602221|471999679|FG015|Overall Study|Discontinuation of trial treatment|0|||
131101327|NCT04602221|471999680|FG016|Overall Study|Discontinuation of trial treatment|0|||
131101328|NCT04602221|471999681|FG017|Overall Study|Discontinuation of trial treatment|0|||
131101329|NCT04602221|471999664|FG000|Overall Study|Other than listed|0|||
131101330|NCT04602221|471999665|FG001|Overall Study|Other than listed|0|||
131101331|NCT04602221|471999666|FG002|Overall Study|Other than listed|0|||
131101332|NCT04602221|471999667|FG003|Overall Study|Other than listed|0|||
131101333|NCT04602221|471999668|FG004|Overall Study|Other than listed|0|||
131101334|NCT04602221|471999669|FG005|Overall Study|Other than listed|0|||
131101335|NCT04602221|471999670|FG006|Overall Study|Other than listed|0|||
131101336|NCT04602221|471999671|FG007|Overall Study|Other than listed|0|||
131101337|NCT04602221|471999672|FG008|Overall Study|Other than listed|0|||
131101338|NCT04602221|471999673|FG009|Overall Study|Other than listed|0|||
131101339|NCT04602221|471999674|FG010|Overall Study|Other than listed|0|||
131101340|NCT04602221|471999675|FG011|Overall Study|Other than listed|0|||
131101341|NCT04602221|471999676|FG012|Overall Study|Other than listed|0|||
131101342|NCT04602221|471999677|FG013|Overall Study|Other than listed|0|||
131101343|NCT04602221|471999678|FG014|Overall Study|Other than listed|0|||
131101344|NCT04602221|471999679|FG015|Overall Study|Other than listed|1|||
131101345|NCT04602221|471999680|FG016|Overall Study|Other than listed|0|||
131101346|NCT04602221|471999681|FG017|Overall Study|Other than listed|1|||
131101347|NCT04602221|471999664|FG000|Overall Study|Withdrawal by Subject|0|||
131014214|NCT01616654|471681125|FG003|Overall Study|Pregnancy|0|||
131014215|NCT01616654|471681126|FG004|Overall Study|Pregnancy|1|||
131014216|NCT02057692|471681127|FG000|Overall Study|Adverse Event|1|||
131014217|NCT02057692|471681128|FG001|Overall Study|Adverse Event|0|||
131014218|NCT02057692|471681129|FG002|Overall Study|Adverse Event|0|||
131014219|NCT02057692|471681130|FG003|Overall Study|Adverse Event|0|||
131014220|NCT02057692|471681127|FG000|Overall Study|Lost to Follow-up|0|||
131014221|NCT02057692|471681128|FG001|Overall Study|Lost to Follow-up|0|||
131014222|NCT02057692|471681129|FG002|Overall Study|Lost to Follow-up|0|||
131014223|NCT02057692|471681130|FG003|Overall Study|Lost to Follow-up|1|||
131014224|NCT03525119|471681134|FG000|Overall Study|Adverse Event|0|||
131014225|NCT03525119|471681135|FG001|Overall Study|Adverse Event|1|||
131014226|NCT03525119|471681136|FG002|Overall Study|Adverse Event|0|||
131014227|NCT03525119|471681134|FG000|Overall Study|Lost to Follow-up|32|||
131014228|NCT03525119|471681135|FG001|Overall Study|Lost to Follow-up|33|||
131014229|NCT03525119|471681136|FG002|Overall Study|Lost to Follow-up|37|||
131014230|NCT03525119|471681134|FG000|Overall Study|Withdrawal by Subject|5|||
131014231|NCT03525119|471681135|FG001|Overall Study|Withdrawal by Subject|4|||
131101348|NCT04602221|471999665|FG001|Overall Study|Withdrawal by Subject|0|||
131101349|NCT04602221|471999666|FG002|Overall Study|Withdrawal by Subject|0|||
131101350|NCT04602221|471999667|FG003|Overall Study|Withdrawal by Subject|0|||
131101351|NCT04602221|471999668|FG004|Overall Study|Withdrawal by Subject|0|||
131101352|NCT04602221|471999669|FG005|Overall Study|Withdrawal by Subject|0|||
131101353|NCT04602221|471999670|FG006|Overall Study|Withdrawal by Subject|0|||
131014232|NCT03525119|471681136|FG002|Overall Study|Withdrawal by Subject|2|||
131014233|NCT03525119|471681134|FG000|Overall Study|Reason not Specified|2|||
131014234|NCT03525119|471681135|FG001|Overall Study|Reason not Specified|1|||
131014235|NCT03525119|471681136|FG002|Overall Study|Reason not Specified|2|||
131014236|NCT03525119|471681134|FG000|Overall Study|Randomized but not Vaccinated|1|||
131222585|NCT01902134|472443117|FG004|Overall Study|Lack of Efficacy|0|||
131222586|NCT01902134|472443118|FG005|Overall Study|Lack of Efficacy|1|||
130678681|NCT00320112|470449286|FG001|Overall Study|Withdrawal by Subject|0|||
130678682|NCT00320112|470449285|FG000|Overall Study|Death|2|||
130678683|NCT00320112|470449286|FG001|Overall Study|Death|1|||
130678684|NCT02899338|470449287|FG000|Overall Study|Adverse Event|1|||
130678685|NCT02899338|470449288|FG001|Overall Study|Adverse Event|2|||
131014237|NCT03525119|471681135|FG001|Overall Study|Randomized but not Vaccinated|0|||
131014238|NCT03525119|471681136|FG002|Overall Study|Randomized but not Vaccinated|2|||
131014239|NCT03939819|471681137|FG000|Overall Study|Death|2|||
131014240|NCT03939819|471681138|FG001|Overall Study|Death|0|||
131014241|NCT00158054|471681143|FG000|Overall Study|Refused to continue|3|||
131014242|NCT00158054|471681144|FG001|Overall Study|Refused to continue|0|||
131014243|NCT00158054|471681143|FG000|Overall Study|Unavailable for follow up|7|||
131014244|NCT00158054|471681144|FG001|Overall Study|Unavailable for follow up|3|||
131014245|NCT00079183|471681153|FG000|Overall Study|Withdrawal by Subject|4|||
131014246|NCT00079183|471681153|FG000|Overall Study|Study medication non-compliance|2|||
131014247|NCT00079183|471681153|FG000|Overall Study|Specimen collection non-compliance|1|||
131014248|NCT04567888|471681154|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
131014249|NCT04567888|471681155|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
131014250|NCT04567888|471681154|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
131014251|NCT04567888|471681155|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
131014252|NCT04567888|471681154|FG000|Overall Study|Reported Unusual Birth Year|2|||
131014253|NCT04567888|471681155|FG001|Overall Study|Reported Unusual Birth Year|3|||
131014254|NCT04567888|471681154|FG000|Overall Study|Duplicate Responses|0|||
131014255|NCT04567888|471681155|FG001|Overall Study|Duplicate Responses|1|||
131014256|NCT02371746|471681156|FG000|Overall Study|Consent withdrawn|0|||
131014257|NCT02371746|471681157|FG001|Overall Study|Consent withdrawn|0|||
131014258|NCT02371746|471681158|FG002|Overall Study|Consent withdrawn|0|||
131014259|NCT02371746|471681159|FG003|Overall Study|Consent withdrawn|0|||
131014260|NCT02371746|471681160|FG004|Overall Study|Consent withdrawn|0|||
131014261|NCT02371746|471681161|FG005|Overall Study|Consent withdrawn|0|||
131014262|NCT02371746|471681162|FG006|Overall Study|Consent withdrawn|1|||
131014263|NCT02613364|471681163|FG000|Overall Study|Other|19|||
131014264|NCT02613364|471681164|FG001|Overall Study|Other|29|||
131014265|NCT02613364|471681165|FG002|Overall Study|Other|17|||
131014266|NCT02613364|471681163|FG000|Overall Study|Too time consuming|21|||
131014267|NCT02613364|471681164|FG001|Overall Study|Too time consuming|26|||
131014268|NCT02613364|471681165|FG002|Overall Study|Too time consuming|26|||
131014269|NCT02613364|471681163|FG000|Overall Study|Withdrawal by Subject|13|||
131014270|NCT02613364|471681164|FG001|Overall Study|Withdrawal by Subject|18|||
131014271|NCT02613364|471681165|FG002|Overall Study|Withdrawal by Subject|17|||
131014272|NCT02613364|471681163|FG000|Overall Study|Medical|12|||
131014273|NCT02613364|471681164|FG001|Overall Study|Medical|13|||
131014274|NCT02613364|471681165|FG002|Overall Study|Medical|9|||
131014275|NCT02613364|471681163|FG000|Overall Study|Disliked Study Procedure|1|||
131014276|NCT02613364|471681164|FG001|Overall Study|Disliked Study Procedure|1|||
131014277|NCT02613364|471681165|FG002|Overall Study|Disliked Study Procedure|4|||
131014278|NCT02613364|471681163|FG000|Overall Study|Disliked Intervention|0|||
131014279|NCT02613364|471681164|FG001|Overall Study|Disliked Intervention|3|||
131014280|NCT02613364|471681165|FG002|Overall Study|Disliked Intervention|3|||
131014281|NCT00371566|471681172|FG000|Treatment Phase|Withdrawal by Subject|0|||
131014282|NCT00371566|471681173|FG001|Treatment Phase|Withdrawal by Subject|1|||
131014283|NCT00371566|471681172|FG000|Treatment Phase|Adverse Event|0|||
131014284|NCT00371566|471681173|FG001|Treatment Phase|Adverse Event|1|||
131014285|NCT00371566|471681172|FG000|Treatment Phase|Protocol Violation|0|||
131014286|NCT00371566|471681173|FG001|Treatment Phase|Protocol Violation|1|||
131014287|NCT00371566|471681172|FG000|Chemoradiation Phase|Physician Decision|2|||
131014288|NCT00371566|471681173|FG001|Chemoradiation Phase|Physician Decision|0|||
131014289|NCT00371566|471681172|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
131014290|NCT00371566|471681173|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
131014291|NCT00371566|471681172|FG000|Chemoradiation Phase|Non compliant|0|||
131014292|NCT00371566|471681173|FG001|Chemoradiation Phase|Non compliant|1|||
131014293|NCT00371566|471681172|FG000|Chemoradiation Phase|Progressive Disease|1|||
131014294|NCT00371566|471681173|FG001|Chemoradiation Phase|Progressive Disease|1|||
131014295|NCT00371566|471681172|FG000|Chemoradiation Phase|Death|2|||
131014296|NCT00371566|471681173|FG001|Chemoradiation Phase|Death|0|||
131014297|NCT00371566|471681172|FG000|Follow Up Phase|Death|0|||
131101354|NCT04602221|471999671|FG007|Overall Study|Withdrawal by Subject|0|||
131014298|NCT00371566|471681173|FG001|Follow Up Phase|Death|5|||
131014299|NCT00371566|471681172|FG000|Follow Up Phase|Disease progression|1|||
131014300|NCT00371566|471681173|FG001|Follow Up Phase|Disease progression|0|||
131014301|NCT00371566|471681172|FG000|Follow Up Phase|Withdrawal by Subject|0|||
131014302|NCT00371566|471681173|FG001|Follow Up Phase|Withdrawal by Subject|1|||
131014303|NCT00371566|471681172|FG000|Follow Up Phase|Physician Decision|1|||
131014304|NCT00371566|471681173|FG001|Follow Up Phase|Physician Decision|1|||
131014305|NCT00371566|471681172|FG000|Follow Up Phase|Lost to Follow-up|1|||
131014306|NCT00371566|471681173|FG001|Follow Up Phase|Lost to Follow-up|0|||
131014307|NCT00878722|471681174|FG000|Overall Study|Progressive disease|3|||
131014308|NCT00878722|471681175|FG001|Overall Study|Progressive disease|3|||
131014309|NCT00878722|471681176|FG002|Overall Study|Progressive disease|3|||
131014310|NCT00878722|471681177|FG003|Overall Study|Progressive disease|7|||
131014311|NCT00878722|471681178|FG004|Overall Study|Progressive disease|7|||
131014312|NCT00878722|471681179|FG005|Overall Study|Progressive disease|1|||
131014313|NCT00878722|471681180|FG006|Overall Study|Progressive disease|4|||
131014314|NCT00878722|471681181|FG007|Overall Study|Progressive disease|3|||
131014315|NCT00878722|471681174|FG000|Overall Study|Death|0|||
131014316|NCT00878722|471681175|FG001|Overall Study|Death|0|||
131014317|NCT00878722|471681176|FG002|Overall Study|Death|0|||
131014318|NCT00878722|471681177|FG003|Overall Study|Death|1|||
131014319|NCT00878722|471681178|FG004|Overall Study|Death|0|||
131014320|NCT00878722|471681179|FG005|Overall Study|Death|1|||
131014321|NCT00878722|471681180|FG006|Overall Study|Death|0|||
131014322|NCT00878722|471681181|FG007|Overall Study|Death|2|||
131014323|NCT00878722|471681174|FG000|Overall Study|Adverse Event|0|||
131014324|NCT00878722|471681175|FG001|Overall Study|Adverse Event|0|||
131014325|NCT00878722|471681176|FG002|Overall Study|Adverse Event|0|||
131014326|NCT00878722|471681177|FG003|Overall Study|Adverse Event|0|||
131014327|NCT00878722|471681178|FG004|Overall Study|Adverse Event|0|||
131014328|NCT00878722|471681179|FG005|Overall Study|Adverse Event|0|||
131014329|NCT00878722|471681180|FG006|Overall Study|Adverse Event|2|||
131014330|NCT00878722|471681181|FG007|Overall Study|Adverse Event|0|||
131014331|NCT00878722|471681174|FG000|Overall Study|Withdrawal by Subject|0|||
131014332|NCT00878722|471681175|FG001|Overall Study|Withdrawal by Subject|0|||
131014333|NCT00878722|471681176|FG002|Overall Study|Withdrawal by Subject|0|||
131014334|NCT00878722|471681177|FG003|Overall Study|Withdrawal by Subject|0|||
131014335|NCT00878722|471681178|FG004|Overall Study|Withdrawal by Subject|0|||
131014336|NCT00878722|471681179|FG005|Overall Study|Withdrawal by Subject|0|||
131014337|NCT00878722|471681180|FG006|Overall Study|Withdrawal by Subject|0|||
131014338|NCT00878722|471681181|FG007|Overall Study|Withdrawal by Subject|2|||
131014339|NCT00878722|471681174|FG000|Overall Study|Relapse|0|||
131014340|NCT00878722|471681175|FG001|Overall Study|Relapse|0|||
131014341|NCT00878722|471681176|FG002|Overall Study|Relapse|0|||
131014342|NCT00878722|471681177|FG003|Overall Study|Relapse|1|||
131014343|NCT00878722|471681178|FG004|Overall Study|Relapse|0|||
131014344|NCT00878722|471681179|FG005|Overall Study|Relapse|0|||
131014345|NCT00878722|471681180|FG006|Overall Study|Relapse|0|||
131014346|NCT00878722|471681181|FG007|Overall Study|Relapse|0|||
131014347|NCT02873754|471681182|FG000|Overall Study|Lost to Follow-up|5|||
131014348|NCT02873754|471681182|FG000|Overall Study|Couldn't complete study procedures|1|||
131014349|NCT00082810|471681183|FG000|Overall Study|Adverse Event|3|||
131014350|NCT00082810|471681183|FG000|Overall Study|Progressive disease|24|||
131014351|NCT00082810|471681183|FG000|Overall Study|Withdrawal by Subject|4|||
131014352|NCT02807493|471681188|FG000|Overall Study|Adverse Event|5|||
131014353|NCT02807493|471681189|FG001|Overall Study|Adverse Event|2|||
131014354|NCT02807493|471681188|FG000|Overall Study|Lost to Follow-up|6|||
131014355|NCT02807493|471681189|FG001|Overall Study|Lost to Follow-up|0|||
131014356|NCT02807493|471681188|FG000|Overall Study|Physician Decision|4|||
131014357|NCT02807493|471681189|FG001|Overall Study|Physician Decision|1|||
131014358|NCT02807493|471681188|FG000|Overall Study|Protocol Violation|7|||
131014359|NCT02807493|471681189|FG001|Overall Study|Protocol Violation|0|||
131014360|NCT02807493|471681188|FG000|Overall Study|Withdrawal by Subject|17|||
131101355|NCT04602221|471999672|FG008|Overall Study|Withdrawal by Subject|0|||
131101356|NCT04602221|471999673|FG009|Overall Study|Withdrawal by Subject|0|||
131101357|NCT04602221|471999674|FG010|Overall Study|Withdrawal by Subject|0|||
131101358|NCT04602221|471999675|FG011|Overall Study|Withdrawal by Subject|0|||
131101359|NCT04602221|471999676|FG012|Overall Study|Withdrawal by Subject|1|||
131101360|NCT04602221|471999677|FG013|Overall Study|Withdrawal by Subject|0|||
131101361|NCT04602221|471999678|FG014|Overall Study|Withdrawal by Subject|0|||
131101362|NCT04602221|471999679|FG015|Overall Study|Withdrawal by Subject|0|||
131101363|NCT04602221|471999680|FG016|Overall Study|Withdrawal by Subject|0|||
131101364|NCT04602221|471999681|FG017|Overall Study|Withdrawal by Subject|0|||
131101365|NCT04602221|471999664|FG000|Overall Study|Lost to Follow-up|0|||
131101366|NCT04602221|471999665|FG001|Overall Study|Lost to Follow-up|0|||
131101367|NCT04602221|471999666|FG002|Overall Study|Lost to Follow-up|0|||
131101368|NCT04602221|471999667|FG003|Overall Study|Lost to Follow-up|0|||
131101369|NCT04602221|471999668|FG004|Overall Study|Lost to Follow-up|0|||
131101370|NCT04602221|471999669|FG005|Overall Study|Lost to Follow-up|1|||
131101371|NCT04602221|471999670|FG006|Overall Study|Lost to Follow-up|0|||
131014361|NCT02807493|471681189|FG001|Overall Study|Withdrawal by Subject|10|||
131014362|NCT02807493|471681188|FG000|Overall Study|Other withdrawal|17|||
131014363|NCT02807493|471681189|FG001|Overall Study|Other withdrawal|0|||
131014364|NCT02807493|471681188|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
131014365|NCT02807493|471681189|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
131014366|NCT01227707|471681190|FG000|Overall Study|Adverse Event|10|||
131014367|NCT01227707|471681190|FG000|Overall Study|Progression of disease|3|||
131014368|NCT01227707|471681190|FG000|Overall Study|Withdrawal by Subject|1|||
131014369|NCT01227707|471681190|FG000|Overall Study|Patient non-compliance|3|||
131014370|NCT01227707|471681190|FG000|Overall Study|Medical decision|6|||
131014371|NCT01227707|471681190|FG000|Overall Study|Death|1|||
131014372|NCT03612804|471681192|FG000|Overall Study|Death|0|||
131014373|NCT03612804|471681193|FG001|Overall Study|Death|7|||
131014374|NCT03612804|471681194|FG002|Overall Study|Death|0|||
131014375|NCT03612804|471681195|FG003|Overall Study|Death|8|||
131101372|NCT04602221|471999671|FG007|Overall Study|Lost to Follow-up|0|||
131101373|NCT04602221|471999672|FG008|Overall Study|Lost to Follow-up|0|||
131101374|NCT04602221|471999673|FG009|Overall Study|Lost to Follow-up|0|||
131101375|NCT04602221|471999674|FG010|Overall Study|Lost to Follow-up|0|||
131101376|NCT04602221|471999675|FG011|Overall Study|Lost to Follow-up|0|||
131101377|NCT04602221|471999676|FG012|Overall Study|Lost to Follow-up|0|||
131101378|NCT04602221|471999677|FG013|Overall Study|Lost to Follow-up|0|||
131101379|NCT04602221|471999678|FG014|Overall Study|Lost to Follow-up|0|||
131101380|NCT04602221|471999679|FG015|Overall Study|Lost to Follow-up|0|||
131101381|NCT04602221|471999680|FG016|Overall Study|Lost to Follow-up|0|||
131101382|NCT04602221|471999681|FG017|Overall Study|Lost to Follow-up|0|||
131101383|NCT03538301|471999684|FG000|Overall Study|Adverse Event|1|||
131101384|NCT03538301|471999685|FG001|Overall Study|Adverse Event|4|||
131101385|NCT03538301|471999686|FG002|Overall Study|Adverse Event|4|||
131101386|NCT03538301|471999684|FG000|Overall Study|Death|1|||
131101387|NCT03538301|471999685|FG001|Overall Study|Death|1|||
131101388|NCT03538301|471999686|FG002|Overall Study|Death|0|||
131101389|NCT03538301|471999684|FG000|Overall Study|Physician Decision|0|||
131101390|NCT03538301|471999685|FG001|Overall Study|Physician Decision|1|||
131101391|NCT03538301|471999686|FG002|Overall Study|Physician Decision|0|||
131101392|NCT03538301|471999684|FG000|Overall Study|Protocol Violation|0|||
131101393|NCT03538301|471999685|FG001|Overall Study|Protocol Violation|0|||
131101394|NCT03538301|471999686|FG002|Overall Study|Protocol Violation|1|||
131101395|NCT03538301|471999684|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
131101396|NCT03538301|471999685|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
131101397|NCT03538301|471999686|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
131101398|NCT04540887|471999688|FG000|Overall Study|Withdrawal by Subject|2|||
131101399|NCT00515853|471999689|FG000|Overall Study|Lost to Follow-up|9|||
131101400|NCT00515853|471999690|FG001|Overall Study|Lost to Follow-up|13|||
131101401|NCT00515853|471999689|FG000|Overall Study|Withdrawal by Subject|6|||
131101402|NCT00515853|471999690|FG001|Overall Study|Withdrawal by Subject|4|||
131101403|NCT01262027|471999691|FG000|Overall Study|Adverse Event|1|||
131101404|NCT01262027|471999691|FG000|Overall Study|Withdrawal by Subject|3|||
131101405|NCT01262027|471999691|FG000|Overall Study|Protocol Violation|1|||
131101406|NCT00589121|471999692|FG000|Overall Study|Protocol Violation|2|||
131101407|NCT00589121|471999693|FG001|Overall Study|Protocol Violation|6|||
131101408|NCT00589121|471999692|FG000|Overall Study|No protocol treatment received|0|||
131101409|NCT00589121|471999693|FG001|Overall Study|No protocol treatment received|1|||
131101410|NCT01758900|471999697|FG000|Overall Study|difficulty for further intubation|7|||
131101411|NCT01758900|471999698|FG001|Overall Study|difficulty for further intubation|8|||
131101412|NCT01892540|471999700|FG000|Overall Study|Did not complete PET/MRI|0|||
131101413|NCT01892540|471999701|FG001|Overall Study|Did not complete PET/MRI|0|||
131101414|NCT01892540|471999702|FG002|Overall Study|Did not complete PET/MRI|2|||
131101415|NCT01892540|471999700|FG000|Overall Study|Did not fit in scanner|0|||
131101416|NCT01892540|471999701|FG001|Overall Study|Did not fit in scanner|0|||
130678686|NCT02899338|470449287|FG000|Overall Study|Withdrawal by Subject|2|||
130678687|NCT02899338|470449288|FG001|Overall Study|Withdrawal by Subject|0|||
130678688|NCT02353169|470449291|FG000|Overall Study|QTc > 450 msec|1|||
130678689|NCT02353169|470449292|FG001|Overall Study|QTc > 450 msec|1|||
131101417|NCT01892540|471999702|FG002|Overall Study|Did not fit in scanner|1|||
130678690|NCT02353169|470449293|FG002|Overall Study|QTc > 450 msec|1|||
130678691|NCT02353169|470449294|FG003|Overall Study|QTc > 450 msec|1|||
130678692|NCT02353169|470449291|FG000|Overall Study|OR team declined|2|||
130678693|NCT02353169|470449292|FG001|Overall Study|OR team declined|0|||
130678694|NCT02353169|470449293|FG002|Overall Study|OR team declined|0|||
130678695|NCT02353169|470449294|FG003|Overall Study|OR team declined|0|||
130678696|NCT02353169|470449291|FG000|Overall Study|Inhalational induction|0|||
130678697|NCT02353169|470449292|FG001|Overall Study|Inhalational induction|2|||
130678698|NCT02353169|470449293|FG002|Overall Study|Inhalational induction|0|||
130678699|NCT02353169|470449294|FG003|Overall Study|Inhalational induction|0|||
130678700|NCT02353169|470449291|FG000|Overall Study|ECG data error|0|||
130678701|NCT02353169|470449292|FG001|Overall Study|ECG data error|3|||
130678702|NCT02353169|470449293|FG002|Overall Study|ECG data error|2|||
131101418|NCT01370590|471999703|FG000|Period 1|Adverse Event|8|||
131101419|NCT01370590|471999704|FG001|Period 1|Adverse Event|4|||
131101420|NCT01370590|471999703|FG000|Period 1|Lost to Follow-up|2|||
131101421|NCT01370590|471999704|FG001|Period 1|Lost to Follow-up|2|||
131101422|NCT01370590|471999703|FG000|Period 1|Protocol Violation|2|||
131101423|NCT01370590|471999704|FG001|Period 1|Protocol Violation|2|||
131101424|NCT01370590|471999703|FG000|Period 1|Withdrawal by Subject|4|||
131101425|NCT01370590|471999704|FG001|Period 1|Withdrawal by Subject|2|||
131101426|NCT01370590|471999703|FG000|Period 1|Could not access randomization system|0|||
131101427|NCT01370590|471999704|FG001|Period 1|Could not access randomization system|1|||
130678703|NCT02353169|470449294|FG003|Overall Study|ECG data error|2|||
130678704|NCT02353169|470449291|FG000|Overall Study|Pre-op medication|0|||
130678705|NCT02353169|470449292|FG001|Overall Study|Pre-op medication|0|||
130678706|NCT02353169|470449293|FG002|Overall Study|Pre-op medication|1|||
130678707|NCT02353169|470449294|FG003|Overall Study|Pre-op medication|0|||
130678708|NCT00117949|470449295|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
130678709|NCT00117949|470449296|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
130678710|NCT00117949|470449297|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
130678711|NCT00117949|470449298|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
130678712|NCT00117949|470449295|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
130678713|NCT00117949|470449296|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
130678714|NCT00117949|470449297|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
130678715|NCT00117949|470449298|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
130678716|NCT00117949|470449295|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
130678717|NCT00117949|470449296|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
130678718|NCT00117949|470449297|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
130678719|NCT00117949|470449298|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
130678720|NCT00117949|470449295|FG000|Overall Study|PSA increase >=10ng/mL|0|||
130678721|NCT00117949|470449296|FG001|Overall Study|PSA increase >=10ng/mL|1|||
130678722|NCT00117949|470449297|FG002|Overall Study|PSA increase >=10ng/mL|1|||
130678723|NCT00117949|470449298|FG003|Overall Study|PSA increase >=10ng/mL|0|||
130678724|NCT00117949|470449295|FG000|Overall Study|PSA reduction <=50%|0|||
130678725|NCT00117949|470449296|FG001|Overall Study|PSA reduction <=50%|2|||
130678726|NCT00117949|470449297|FG002|Overall Study|PSA reduction <=50%|2|||
131014376|NCT03612804|471681192|FG000|Overall Study|Medication copay coverage issues|0|||
131101428|NCT01370590|471999703|FG000|Crossover Washout Period|Adverse Event|1|||
131014377|NCT03612804|471681193|FG001|Overall Study|Medication copay coverage issues|0|||
131014378|NCT03612804|471681194|FG002|Overall Study|Medication copay coverage issues|0|||
131014379|NCT03612804|471681195|FG003|Overall Study|Medication copay coverage issues|17|||
131014380|NCT03612804|471681192|FG000|Overall Study|Not current smoker at time of screening|0|||
131014381|NCT03612804|471681193|FG001|Overall Study|Not current smoker at time of screening|1|||
131014382|NCT03612804|471681194|FG002|Overall Study|Not current smoker at time of screening|0|||
131014383|NCT03612804|471681195|FG003|Overall Study|Not current smoker at time of screening|3|||
131014384|NCT03612804|471681192|FG000|Overall Study|Non-veteran status|0|||
131014385|NCT03612804|471681193|FG001|Overall Study|Non-veteran status|1|||
131014386|NCT03612804|471681194|FG002|Overall Study|Non-veteran status|0|||
131014387|NCT03612804|471681195|FG003|Overall Study|Non-veteran status|0|||
131014388|NCT03612804|471681192|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
131014389|NCT03612804|471681193|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
131014390|NCT03612804|471681194|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
131014391|NCT03612804|471681195|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
131014392|NCT03612804|471681192|FG000|Overall Study|Provider retired from VA|0|||
131014393|NCT03612804|471681193|FG001|Overall Study|Provider retired from VA|0|||
131014394|NCT03612804|471681194|FG002|Overall Study|Provider retired from VA|2|||
131014395|NCT03612804|471681195|FG003|Overall Study|Provider retired from VA|0|||
131014396|NCT03612804|471681192|FG000|Overall Study|Withdrawal by Subject|0|||
131014397|NCT03612804|471681193|FG001|Overall Study|Withdrawal by Subject|0|||
131014398|NCT03612804|471681194|FG002|Overall Study|Withdrawal by Subject|7|||
131014399|NCT03612804|471681195|FG003|Overall Study|Withdrawal by Subject|0|||
131014400|NCT03612804|471681192|FG000|Overall Study|Provider involved with study activities|1|||
131014401|NCT03612804|471681193|FG001|Overall Study|Provider involved with study activities|0|||
131014402|NCT03612804|471681194|FG002|Overall Study|Provider involved with study activities|0|||
131014403|NCT03612804|471681195|FG003|Overall Study|Provider involved with study activities|0|||
131014404|NCT00741988|471681205|FG000|Overall Study|Adverse Event|2|||
131014405|NCT00741988|471681206|FG001|Overall Study|Adverse Event|4|||
131014406|NCT00741988|471681205|FG000|Overall Study|Lack of Efficacy|2|||
131014407|NCT00741988|471681206|FG001|Overall Study|Lack of Efficacy|0|||
131014408|NCT00712166|471681209|FG000|Overall Study|Noncompliance|0|||
131014409|NCT00712166|471681210|FG001|Overall Study|Noncompliance|1|||
131014410|NCT01773122|471681211|FG000|Overall Study|Due to amended age eligibility criteria|3|||
131014411|NCT01773122|471681212|FG001|Overall Study|Due to amended age eligibility criteria|1|||
131014412|NCT01773122|471681213|FG002|Overall Study|Due to amended age eligibility criteria|0|||
131014413|NCT01773122|471681214|FG003|Overall Study|Due to amended age eligibility criteria|1|||
131014414|NCT01264718|471681215|FG000|Overall Study|Lost to Follow-up|3|||
131014415|NCT01264718|471681216|FG001|Overall Study|Lost to Follow-up|2|||
131014416|NCT01264718|471681215|FG000|Overall Study|Withdrawal by Subject|9|||
131014417|NCT01264718|471681216|FG001|Overall Study|Withdrawal by Subject|15|||
131014418|NCT01264718|471681215|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
131101429|NCT01370590|471999704|FG001|Crossover Washout Period|Adverse Event|4|||
131222587|NCT01902134|472443113|FG000|Overall Study|Physician Decision|0|||
130678727|NCT00117949|470449298|FG003|Overall Study|PSA reduction <=50%|4|||
130678728|NCT00117949|470449295|FG000|Overall Study|Hepatic abnormalities|0|||
130678729|NCT00117949|470449296|FG001|Overall Study|Hepatic abnormalities|1|||
131014419|NCT01264718|471681216|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
131014420|NCT03264456|471681223|FG000|Overall Study|Withdrawal by Subject|3|||
131014421|NCT03264456|471681223|FG000|Overall Study|Lost to Follow-up|1|||
131014422|NCT03254394|471681224|FG000|Overall Study|Withdrawal by Subject|0|||
131014423|NCT03254394|471681225|FG001|Overall Study|Withdrawal by Subject|2|||
130678730|NCT00117949|470449297|FG002|Overall Study|Hepatic abnormalities|0|||
130678731|NCT00117949|470449298|FG003|Overall Study|Hepatic abnormalities|1|||
130678732|NCT03184441|470449304|FG000|Overall Study|Withdrawal by Subject|1|||
130678733|NCT01868009|470449307|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
130678734|NCT01868009|470449308|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
131014424|NCT01123083|471681226|FG000|Overall Study|Investigator recommendation|1|||
131014425|NCT01123083|471681227|FG001|Overall Study|Investigator recommendation|1|||
131014426|NCT01123083|471681226|FG000|Overall Study|Administrative reasons|0|||
131014427|NCT01123083|471681227|FG001|Overall Study|Administrative reasons|4|||
131014428|NCT01123083|471681226|FG000|Overall Study|Lost to Follow-up|2|||
131014429|NCT01123083|471681227|FG001|Overall Study|Lost to Follow-up|6|||
131014430|NCT01123083|471681226|FG000|Overall Study|Adverse Event|1|||
131014431|NCT01123083|471681227|FG001|Overall Study|Adverse Event|0|||
131014432|NCT01123083|471681226|FG000|Overall Study|Withdrew for another reason not covered|0|||
131014433|NCT01123083|471681227|FG001|Overall Study|Withdrew for another reason not covered|1|||
131014434|NCT01123083|471681226|FG000|Overall Study|Participant/legal representative request|7|||
131014435|NCT01123083|471681227|FG001|Overall Study|Participant/legal representative request|3|||
131014436|NCT00387465|471681228|FG000|Overall Study|Withdrawal by Subject|0|||
131014437|NCT00387465|471681229|FG001|Overall Study|Withdrawal by Subject|1|||
131014438|NCT00387465|471681230|FG002|Overall Study|Withdrawal by Subject|0|||
131014439|NCT03418324|471681231|FG000|Overall Study|Death|0|||
131014440|NCT03418324|471681232|FG001|Overall Study|Death|1|||
131014441|NCT03418324|471681231|FG000|Overall Study|Physician Decision|1|||
131014442|NCT03418324|471681232|FG001|Overall Study|Physician Decision|1|||
131014443|NCT01751724|471681233|FG000|Overall Study|extubated bef.start assigned treatment|1|||
131014444|NCT01751724|471681234|FG001|Overall Study|extubated bef.start assigned treatment|0|||
131014445|NCT01751724|471681233|FG000|Overall Study|withdrawn by parent|0|||
131014446|NCT01751724|471681234|FG001|Overall Study|withdrawn by parent|2|||
131014447|NCT00605033|471681235|FG000|Overall Study|Adverse Event|2|||
131014448|NCT00605033|471681236|FG001|Overall Study|Adverse Event|2|||
131014449|NCT00605033|471681235|FG000|Overall Study|Lost to Follow-up|1|||
131014450|NCT00605033|471681236|FG001|Overall Study|Lost to Follow-up|1|||
131014451|NCT00605033|471681235|FG000|Overall Study|Withdrawal by Subject|3|||
131014452|NCT00605033|471681236|FG001|Overall Study|Withdrawal by Subject|4|||
131014453|NCT00605033|471681235|FG000|Overall Study|Protocol Violation|1|||
131014454|NCT00605033|471681236|FG001|Overall Study|Protocol Violation|1|||
131014455|NCT03121950|471681238|FG000|Overall Study|Withdrawal by Subject|11|||
131014456|NCT03121950|471681239|FG001|Overall Study|Withdrawal by Subject|2|||
131014457|NCT05052983|471681245|FG000|Overall Study|Lack of Efficacy|3|||
131014458|NCT05052983|471681246|FG001|Overall Study|Lack of Efficacy|12|||
131014459|NCT05052983|471681245|FG000|Overall Study|Adverse Event|1|||
131014460|NCT05052983|471681246|FG001|Overall Study|Adverse Event|0|||
131014461|NCT03425643|471681247|FG000|Overall Study|Withdrawal by Subject|10|||
131014462|NCT03425643|471681248|FG001|Overall Study|Withdrawal by Subject|12|||
131014463|NCT03425643|471681247|FG000|Overall Study|Lost to Follow-up|2|||
131014464|NCT03425643|471681248|FG001|Overall Study|Lost to Follow-up|0|||
131014465|NCT03425643|471681247|FG000|Overall Study|Death|109|||
131014466|NCT03425643|471681248|FG001|Overall Study|Death|141|||
131014467|NCT03425643|471681247|FG000|Overall Study|Ongoing in study|276|||
131014468|NCT03425643|471681248|FG001|Overall Study|Ongoing in study|247|||
131014469|NCT04133363|471681249|FG000|Overall Study|Lost to Follow-up|2|||
131014470|NCT04133363|471681250|FG001|Overall Study|Lost to Follow-up|1|||
131014471|NCT04133363|471681251|FG002|Overall Study|Lost to Follow-up|4|||
131014472|NCT04199728|471682764|FG000|Overall Study|Adverse Event|1|||
131014473|NCT04199728|471682765|FG001|Overall Study|Adverse Event|0|||
131014474|NCT04199728|471682764|FG000|Overall Study|Withdrawal by Subject|8|||
131014475|NCT04199728|471682765|FG001|Overall Study|Withdrawal by Subject|3|||
131014476|NCT04199728|471682764|FG000|Overall Study|Screen fail after consent|0|||
131014477|NCT04199728|471682765|FG001|Overall Study|Screen fail after consent|1|||
131014478|NCT04199728|471682764|FG000|Overall Study|Early withdraw criteria met|0|||
131014479|NCT04199728|471682765|FG001|Overall Study|Early withdraw criteria met|1|||
131014480|NCT04199728|471682764|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
131014481|NCT04199728|471682765|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
131014482|NCT00482729|471682766|FG000|Overall Study|Adverse Event|29|||
130678735|NCT01868009|470449307|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
131014483|NCT00482729|471682767|FG001|Overall Study|Adverse Event|33|||
131014484|NCT00482729|471682766|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
131014485|NCT00482729|471682767|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
131014486|NCT00482729|471682766|FG000|Overall Study|Hyperglycemia Criteria|7|||
131014487|NCT00482729|471682767|FG001|Overall Study|Hyperglycemia Criteria|5|||
131014488|NCT00482729|471682766|FG000|Overall Study|Lack of Efficacy|4|||
131014489|NCT00482729|471682767|FG001|Overall Study|Lack of Efficacy|16|||
131014490|NCT00482729|471682766|FG000|Overall Study|Lost to Follow-up|86|||
131014491|NCT00482729|471682767|FG001|Overall Study|Lost to Follow-up|66|||
131014492|NCT00482729|471682766|FG000|Overall Study|Physician Decision|10|||
131014493|NCT00482729|471682767|FG001|Overall Study|Physician Decision|7|||
131014494|NCT00482729|471682766|FG000|Overall Study|Pregnancy|4|||
131101430|NCT01370590|471999703|FG000|Crossover Washout Period|Lost to Follow-up|2|||
131101431|NCT01370590|471999704|FG001|Crossover Washout Period|Lost to Follow-up|0|||
131101432|NCT01370590|471999703|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
131101433|NCT01370590|471999704|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
131101434|NCT01370590|471999703|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
131101435|NCT01370590|471999704|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
131101436|NCT01370590|471999703|FG000|Period 2|Adverse Event|0|||
131101437|NCT01370590|471999704|FG001|Period 2|Adverse Event|1|||
131101438|NCT01370590|471999703|FG000|Period 2|Withdrawal by Subject|1|||
131101439|NCT01370590|471999704|FG001|Period 2|Withdrawal by Subject|1|||
131101440|NCT05172050|471999705|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
131101441|NCT05172050|471999706|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
131101442|NCT05172050|471999707|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
131101443|NCT05172050|471999705|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
131101444|NCT05172050|471999706|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
131101445|NCT05172050|471999707|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
131101446|NCT05172050|471999705|FG000|Overall Study|Other|2|||
131101447|NCT05172050|471999706|FG001|Overall Study|Other|2|||
130678736|NCT01868009|470449308|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
130678737|NCT01868009|470449307|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
130678738|NCT01868009|470449308|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
131014495|NCT00482729|471682767|FG001|Overall Study|Pregnancy|2|||
131014496|NCT00482729|471682766|FG000|Overall Study|Protocol Violation|10|||
131014497|NCT00482729|471682767|FG001|Overall Study|Protocol Violation|18|||
131014498|NCT00482729|471682766|FG000|Overall Study|Withdrawal by Subject|67|||
131014499|NCT00482729|471682767|FG001|Overall Study|Withdrawal by Subject|69|||
131014500|NCT02631148|471682773|FG000|Overall Study|8 were ineligible|8|||
131014501|NCT02631148|471682774|FG001|Overall Study|8 were ineligible|0|||
131014502|NCT02631148|471682773|FG000|Overall Study|Withdrawal by Subject|1|||
131014503|NCT02631148|471682774|FG001|Overall Study|Withdrawal by Subject|0|||
131014504|NCT02631148|471682773|FG000|Overall Study|PAH not available to study participant|1|||
131014505|NCT02631148|471682774|FG001|Overall Study|PAH not available to study participant|0|||
131014506|NCT00487578|471682776|FG000|Overall Study|Adverse Event|1|||
131014507|NCT00487578|471682777|FG001|Overall Study|Adverse Event|2|||
131014508|NCT00487578|471682776|FG000|Overall Study|Lack of Efficacy|0|||
131014509|NCT00487578|471682777|FG001|Overall Study|Lack of Efficacy|1|||
131014510|NCT00487578|471682776|FG000|Overall Study|Lost to Follow-up|0|||
131014511|NCT00487578|471682777|FG001|Overall Study|Lost to Follow-up|1|||
131014512|NCT02525796|471682782|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
131014513|NCT02525796|471682783|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
131014514|NCT02525796|471682784|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
131014515|NCT02525796|471682782|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
131014516|NCT02525796|471682783|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
131014517|NCT02525796|471682784|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
131014518|NCT02525796|471682782|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
131014519|NCT02525796|471682783|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
131014520|NCT02525796|471682784|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
131014521|NCT02525796|471682782|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
131014522|NCT02525796|471682783|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
131014523|NCT02525796|471682784|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
131014524|NCT02525796|471682782|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
131014525|NCT02525796|471682783|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
131014526|NCT02525796|471682784|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
131014527|NCT01499134|471682785|FG000|Overall Study|Withdrawal by Subject|0|||
131014528|NCT01499134|471682786|FG001|Overall Study|Withdrawal by Subject|1|||
131014529|NCT01198275|471682787|FG000|Overall Study|Adverse Event|2|||
131014530|NCT01198275|471682788|FG001|Overall Study|Adverse Event|3|||
131014531|NCT01198275|471682787|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
131014532|NCT01198275|471682788|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
131014533|NCT00150176|471682789|FG000|Overall Study|Adverse Event|16|||
131014534|NCT00150176|471682790|FG001|Overall Study|Adverse Event|53|||
131014535|NCT00150176|471682789|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
131014536|NCT00150176|471682790|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
131014537|NCT00150176|471682789|FG000|Overall Study|Withdrawal by Subject|19|||
131101448|NCT05172050|471999707|FG002|Overall Study|Other|1|||
131101449|NCT05180500|471999710|FG000|Overall Study|Adverse Event|1|||
131014538|NCT00150176|471682790|FG001|Overall Study|Withdrawal by Subject|12|||
131014539|NCT00150176|471682789|FG000|Overall Study|Lost to Follow-up|3|||
131014540|NCT00150176|471682790|FG001|Overall Study|Lost to Follow-up|3|||
131014541|NCT00150176|471682789|FG000|Overall Study|OTHER|11|||
131222588|NCT01902134|472443114|FG001|Overall Study|Physician Decision|1|||
131014542|NCT00150176|471682790|FG001|Overall Study|OTHER|13|||
131014543|NCT02385669|471682794|FG000|Overall Study|Adverse Event|2|||
131014544|NCT00970307|471682795|FG000|Overall Study|Serious Adverse Event|1|||
131014545|NCT00970307|471682796|FG001|Overall Study|Serious Adverse Event|0|||
131014546|NCT00970307|471682797|FG002|Overall Study|Serious Adverse Event|0|||
131014547|NCT00970307|471682795|FG000|Overall Study|Withdrawal by Subject|2|||
131014548|NCT00970307|471682796|FG001|Overall Study|Withdrawal by Subject|3|||
131014549|NCT00970307|471682797|FG002|Overall Study|Withdrawal by Subject|2|||
131014550|NCT05257798|471682798|FG000|Follow-up Phase|Lost to Follow-up|1|||
131014551|NCT05257798|471682799|FG001|Follow-up Phase|Lost to Follow-up|0|||
131014552|NCT04033432|471682802|FG000|Overall Study|Progressive Disease|8|||
131014553|NCT04033432|471682802|FG000|Overall Study|Adverse Event|4|||
131014554|NCT04033432|471682802|FG000|Overall Study|Death|1|||
131014555|NCT00393848|471682803|FG000|Overall Study|Surgical schedule|0|||
131014556|NCT00393848|471682804|FG001|Overall Study|Surgical schedule|0|||
131014557|NCT00393848|471682805|FG002|Overall Study|Surgical schedule|0|||
131014558|NCT00393848|471682806|FG003|Overall Study|Surgical schedule|1|||
131014559|NCT00393848|471682803|FG000|Overall Study|Personal reasons|0|||
131014560|NCT00393848|471682804|FG001|Overall Study|Personal reasons|0|||
131014561|NCT00393848|471682805|FG002|Overall Study|Personal reasons|2|||
131014562|NCT00393848|471682806|FG003|Overall Study|Personal reasons|0|||
131014563|NCT02082158|471682809|FG000|Overall Study|Withdrawal by Subject|0|||
131014564|NCT02082158|471682810|FG001|Overall Study|Withdrawal by Subject|0|||
131014565|NCT02082158|471682811|FG002|Overall Study|Withdrawal by Subject|0|||
131014566|NCT02082158|471682812|FG003|Overall Study|Withdrawal by Subject|0|||
131014567|NCT02082158|471682813|FG004|Overall Study|Withdrawal by Subject|1|||
131014568|NCT02082158|471682814|FG005|Overall Study|Withdrawal by Subject|0|||
131014569|NCT02082158|471682809|FG000|Overall Study|Failed Fit-testing|8|||
131014570|NCT02082158|471682810|FG001|Overall Study|Failed Fit-testing|8|||
131014571|NCT02082158|471682811|FG002|Overall Study|Failed Fit-testing|14|||
131014572|NCT02082158|471682812|FG003|Overall Study|Failed Fit-testing|4|||
131014573|NCT02082158|471682813|FG004|Overall Study|Failed Fit-testing|3|||
131014574|NCT02082158|471682814|FG005|Overall Study|Failed Fit-testing|7|||
131014575|NCT02192606|471682818|FG000|Overall Study|surgery type was changed|1|||
131014576|NCT02192606|471682819|FG001|Overall Study|surgery type was changed|1|||
131014577|NCT02192606|471682818|FG000|Overall Study|Physician Decision|1|||
131014578|NCT02192606|471682819|FG001|Overall Study|Physician Decision|2|||
131014579|NCT02192606|471682818|FG000|Overall Study|3D equipment rep unable to join|0|||
131014580|NCT02192606|471682819|FG001|Overall Study|3D equipment rep unable to join|1|||
131014581|NCT01458210|471682822|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
131014582|NCT01458210|471682822|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
131014583|NCT01458210|471682822|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
131014584|NCT01458210|471682822|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
131014585|NCT01027286|471682825|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
131014586|NCT01027286|471682826|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
131014587|NCT01027286|471682825|FG000|Overall Study|Lost to Follow-up|0|||
131014588|NCT01027286|471682826|FG001|Overall Study|Lost to Follow-up|1|||
131014589|NCT01565928|471682829|FG000|Overall Study|Adverse Event|3|||
131014590|NCT01565928|471682829|FG000|Overall Study|Other|3|||
131014591|NCT01565928|471682829|FG000|Overall Study|Progressive Disease|13|||
131014592|NCT01565928|471682829|FG000|Overall Study|Withdrawal by Subject|1|||
131014593|NCT01565928|471682829|FG000|Overall Study|Death|2|||
131014594|NCT01183780|471682832|FG000|Overall Study|Withdrawal by Subject|25|||
131014595|NCT01183780|471682833|FG001|Overall Study|Withdrawal by Subject|14|||
131014596|NCT01183780|471682832|FG000|Overall Study|Lost to Follow-up|6|||
131014597|NCT01183780|471682833|FG001|Overall Study|Lost to Follow-up|11|||
131014598|NCT03808883|471682835|FG000|Overall Study|Withdrawal by Subject|2|||
131014599|NCT03808883|471682836|FG001|Overall Study|Withdrawal by Subject|0|||
131014600|NCT03808883|471682835|FG000|Overall Study|Did not complete pre test or post test survey|4|||
131014601|NCT03808883|471682836|FG001|Overall Study|Did not complete pre test or post test survey|3|||
131014602|NCT00811057|471682841|FG000|Overall Study|Protocol Violation|5|||
131014603|NCT00811057|471682842|FG001|Overall Study|Protocol Violation|10|||
131014604|NCT00811057|471682843|FG002|Overall Study|Protocol Violation|10|||
131014605|NCT00768651|471682848|FG000|Overall Study|Withdrawal by Subject|1|||
131014606|NCT02104765|471682849|FG000|Overall Study|Lost to Follow-up|0|||
131014607|NCT02104765|471682850|FG001|Overall Study|Lost to Follow-up|0|||
131014608|NCT02104765|471682851|FG002|Overall Study|Lost to Follow-up|1|||
131014609|NCT02104765|471682852|FG003|Overall Study|Lost to Follow-up|0|||
131014610|NCT02104765|471682853|FG004|Overall Study|Lost to Follow-up|0|||
131014611|NCT02104765|471682854|FG005|Overall Study|Lost to Follow-up|0|||
131014612|NCT02104765|471682855|FG006|Overall Study|Lost to Follow-up|0|||
131014613|NCT02104765|471682849|FG000|Overall Study|Withdrawal by Subject|0|||
131014614|NCT02104765|471682850|FG001|Overall Study|Withdrawal by Subject|0|||
131014615|NCT02104765|471682851|FG002|Overall Study|Withdrawal by Subject|0|||
131014616|NCT02104765|471682852|FG003|Overall Study|Withdrawal by Subject|1|||
131014617|NCT02104765|471682853|FG004|Overall Study|Withdrawal by Subject|1|||
131014618|NCT02104765|471682854|FG005|Overall Study|Withdrawal by Subject|0|||
131014619|NCT02104765|471682855|FG006|Overall Study|Withdrawal by Subject|1|||
131014620|NCT00995709|471682860|FG000|Overall Study|Adverse Event|4|||
131014621|NCT00995709|471682861|FG001|Overall Study|Adverse Event|2|||
131014622|NCT00995709|471682862|FG002|Overall Study|Adverse Event|0|||
131014623|NCT00995709|471682860|FG000|Overall Study|Lack of Efficacy|0|||
131014624|NCT00995709|471682861|FG001|Overall Study|Lack of Efficacy|1|||
131014625|NCT00995709|471682862|FG002|Overall Study|Lack of Efficacy|4|||
131014626|NCT00995709|471682860|FG000|Overall Study|Withdrawal by Subject|0|||
131014627|NCT00995709|471682861|FG001|Overall Study|Withdrawal by Subject|4|||
131014628|NCT00995709|471682862|FG002|Overall Study|Withdrawal by Subject|1|||
131014629|NCT00995709|471682860|FG000|Overall Study|Lost to Follow-up|1|||
131014630|NCT00995709|471682861|FG001|Overall Study|Lost to Follow-up|0|||
131014631|NCT00995709|471682862|FG002|Overall Study|Lost to Follow-up|0|||
131014632|NCT00995709|471682860|FG000|Overall Study|Death|0|||
131014633|NCT00995709|471682861|FG001|Overall Study|Death|1|||
131014634|NCT00995709|471682862|FG002|Overall Study|Death|0|||
131014635|NCT00995709|471682860|FG000|Overall Study|Protocol Violation|2|||
131014636|NCT00995709|471682861|FG001|Overall Study|Protocol Violation|1|||
131014637|NCT00995709|471682862|FG002|Overall Study|Protocol Violation|0|||
131014638|NCT01697319|471682863|FG000|Primary Phase|Withdrawal by Subject|1|||
131014639|NCT01697319|471682863|FG000|Extension Phase|Terminated by Sponsor|15|||
131014640|NCT04222959|471682864|FG000|Overall Study|Lost to Follow-up|76|||
131014641|NCT04222959|471682865|FG001|Overall Study|Lost to Follow-up|28|||
131014642|NCT03008915|471682866|FG000|Treatment 1|Withdrawal by Subject|0|||
131014643|NCT03008915|471682867|FG001|Treatment 1|Withdrawal by Subject|1|||
131014644|NCT03386929|471682870|FG000|Overall Study|Death|0|||
131014645|NCT03386929|471682871|FG001|Overall Study|Death|0|||
131014646|NCT03386929|471682872|FG002|Overall Study|Death|1|||
131014647|NCT03386929|471682870|FG000|Overall Study|Withdrawal by Subject|0|||
131014648|NCT03386929|471682871|FG001|Overall Study|Withdrawal by Subject|1|||
131014649|NCT03386929|471682872|FG002|Overall Study|Withdrawal by Subject|0|||
131014650|NCT03386929|471682870|FG000|Overall Study|Physician Decision|0|||
131014651|NCT03386929|471682871|FG001|Overall Study|Physician Decision|0|||
131014652|NCT03386929|471682872|FG002|Overall Study|Physician Decision|1|||
131014653|NCT03386929|471682870|FG000|Overall Study|Progression|4|||
131014654|NCT03386929|471682871|FG001|Overall Study|Progression|4|||
131014655|NCT03386929|471682872|FG002|Overall Study|Progression|0|||
131014656|NCT03386929|471682870|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
131014657|NCT03386929|471682871|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
131014658|NCT03386929|471682872|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
131014659|NCT03386929|471682870|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
131014660|NCT03386929|471682871|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
131014661|NCT03386929|471682872|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
131014662|NCT00038103|471682873|FG000|Overall Study|Adverse Event|5|||
131014663|NCT00038103|471682874|FG001|Overall Study|Adverse Event|6|||
131014664|NCT00038103|471682873|FG000|Overall Study|Lack of Efficacy|48|||
131014665|NCT00038103|471682874|FG001|Overall Study|Lack of Efficacy|41|||
131014666|NCT00038103|471682873|FG000|Overall Study|Withdrawal by Subject|0|||
131014667|NCT00038103|471682874|FG001|Overall Study|Withdrawal by Subject|3|||
131014668|NCT00038103|471682873|FG000|Overall Study|Lost to Follow-up|0|||
131014669|NCT00038103|471682874|FG001|Overall Study|Lost to Follow-up|3|||
131014670|NCT00038103|471682873|FG000|Overall Study|Protocol Violation|0|||
131014671|NCT00038103|471682874|FG001|Overall Study|Protocol Violation|2|||
131014672|NCT00038103|471682873|FG000|Overall Study|Sponsor Decision|0|||
131014673|NCT00038103|471682874|FG001|Overall Study|Sponsor Decision|1|||
131014674|NCT00038103|471682873|FG000|Overall Study|Randomized/never treated|2|||
131014675|NCT00038103|471682874|FG001|Overall Study|Randomized/never treated|0|||
131014676|NCT03538054|471682875|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
131014677|NCT03538054|471682875|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
131014678|NCT03538054|471682875|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
131014679|NCT03545984|471682884|FG000|Overall Study|CSF cases not present during rotation|11|||
131014680|NCT03545984|471682885|FG001|Overall Study|CSF cases not present during rotation|9|||
131014681|NCT01212757|471682887|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
130678745|NCT01244126|470450839|FG000|Overall Study|Protocol Violation|3|||
131014682|NCT01212757|471682888|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
131014683|NCT01212757|471682889|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
131014684|NCT01212757|471682890|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131014685|NCT01212757|471682891|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131014686|NCT01212757|471682892|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131014687|NCT01212757|471682893|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131101450|NCT05180500|471999711|FG001|Overall Study|Adverse Event|0|||
131101451|NCT05180500|471999710|FG000|Overall Study|Withdrawal by Subject|2|||
131101452|NCT05180500|471999711|FG001|Overall Study|Withdrawal by Subject|0|||
131101453|NCT04617275|471999712|FG000|Treatment Period|Adverse Event|1|||
131101454|NCT04617275|471999713|FG001|Treatment Period|Adverse Event|6|||
130678746|NCT01244126|470450840|FG001|Overall Study|Protocol Violation|3|||
130678747|NCT01244126|470450841|FG002|Overall Study|Protocol Violation|9|||
130678748|NCT00863746|470450844|FG000|Treatment|Not treated|4|||
130678749|NCT00863746|470450845|FG001|Treatment|Not treated|2|||
130678750|NCT00863746|470450844|FG000|Treatment|Adverse Event|41|||
130678751|NCT00863746|470450845|FG001|Treatment|Adverse Event|16|||
130678752|NCT00863746|470450844|FG000|Treatment|non-compliant with study medication|4|||
130678753|NCT00863746|470450845|FG001|Treatment|non-compliant with study medication|0|||
130678754|NCT00863746|470450844|FG000|Treatment|Consent withdrawn|15|||
130678755|NCT00863746|470450845|FG001|Treatment|Consent withdrawn|14|||
131014688|NCT01212757|471682894|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131014689|NCT01212757|471682895|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131014690|NCT01212757|471682887|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
131014691|NCT01212757|471682888|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
131014692|NCT01212757|471682889|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
131014693|NCT01212757|471682890|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131014694|NCT01212757|471682891|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131014695|NCT01212757|471682892|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131014696|NCT01212757|471682893|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131014697|NCT01212757|471682894|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131014698|NCT01212757|471682895|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131014699|NCT01212757|471682887|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
131014700|NCT01212757|471682888|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
131014701|NCT01212757|471682889|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
131014702|NCT01212757|471682890|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131014703|NCT01212757|471682891|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131014704|NCT01212757|471682892|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131014705|NCT01212757|471682893|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131014706|NCT01212757|471682894|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131014707|NCT01212757|471682895|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131014708|NCT01212757|471682887|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
131014709|NCT01212757|471682888|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131014710|NCT01212757|471682889|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
131014711|NCT01212757|471682890|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131014712|NCT01212757|471682891|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131014713|NCT01212757|471682892|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131014714|NCT01212757|471682893|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131014715|NCT01212757|471682894|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131014716|NCT01212757|471682895|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131014717|NCT01212757|471682887|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
131014718|NCT01212757|471682888|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
131014719|NCT01212757|471682889|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
131014720|NCT01212757|471682890|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131014721|NCT01212757|471682891|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131014722|NCT01212757|471682892|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131014723|NCT01212757|471682893|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131014724|NCT01212757|471682894|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131014725|NCT01212757|471682895|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131014726|NCT01212757|471682887|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131014727|NCT01212757|471682888|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
131014728|NCT01212757|471682889|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
131014729|NCT01212757|471682890|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131014730|NCT01212757|471682891|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131014731|NCT01212757|471682892|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131014732|NCT01212757|471682893|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131014733|NCT01212757|471682894|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131014734|NCT01212757|471682895|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131014735|NCT01212757|471682887|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
131101455|NCT04617275|471999714|FG002|Treatment Period|Adverse Event|4|||
131101456|NCT04617275|471999715|FG003|Treatment Period|Adverse Event|6|||
130678756|NCT00863746|470450844|FG000|Treatment|Lost to Follow-up|1|||
130678757|NCT00863746|470450845|FG001|Treatment|Lost to Follow-up|0|||
130678758|NCT00863746|470450844|FG000|Treatment|Protocol Violation|5|||
130678759|NCT00863746|470450845|FG001|Treatment|Protocol Violation|3|||
130885400|NCT01646125|471215186|FG000|Overall Study|Study terminated by sponsor|2|||
130885401|NCT01646125|471215187|FG001|Overall Study|Study terminated by sponsor|1|||
130885402|NCT01646125|471215186|FG000|Overall Study|Subject/Guardian decision|1|||
131014736|NCT01212757|471682888|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
131014737|NCT01212757|471682889|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131014738|NCT01212757|471682890|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131014739|NCT01212757|471682891|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131014740|NCT01212757|471682892|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131014741|NCT01212757|471682893|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131014742|NCT01212757|471682894|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131014743|NCT01212757|471682895|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131014744|NCT01212757|471682887|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
131014745|NCT01212757|471682888|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
131014746|NCT01212757|471682889|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
131014747|NCT01212757|471682890|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
131014748|NCT01212757|471682891|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
131014749|NCT01212757|471682892|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
131014750|NCT01212757|471682893|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
131014751|NCT01212757|471682894|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
131014752|NCT01212757|471682895|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
131014753|NCT01212757|471682887|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
131014754|NCT01212757|471682888|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
131014755|NCT01212757|471682889|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
131014756|NCT01212757|471682890|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
131014757|NCT01212757|471682891|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
131014758|NCT01212757|471682892|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
131014759|NCT01212757|471682893|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
131014760|NCT01212757|471682894|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
131014761|NCT01212757|471682895|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
131014762|NCT01212757|471682887|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131014763|NCT01212757|471682888|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131014764|NCT01212757|471682889|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
131014765|NCT01212757|471682890|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131014766|NCT01212757|471682891|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131014767|NCT01212757|471682892|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131014768|NCT01212757|471682893|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131014769|NCT01212757|471682894|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131014770|NCT01212757|471682895|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
131014771|NCT01212757|471682887|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131014772|NCT01212757|471682888|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
131014773|NCT01212757|471682889|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
131014774|NCT01212757|471682890|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
131014775|NCT01212757|471682891|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
131014776|NCT01212757|471682892|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
131014777|NCT01212757|471682893|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131014778|NCT01212757|471682894|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131014779|NCT01212757|471682895|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
131014780|NCT01212757|471682887|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131014781|NCT01212757|471682888|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
131014782|NCT01212757|471682889|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131014783|NCT01212757|471682890|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131014784|NCT01212757|471682891|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
131014785|NCT01212757|471682892|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131014786|NCT01212757|471682893|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131014787|NCT01212757|471682894|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131014788|NCT01212757|471682895|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
131014789|NCT01212757|471682887|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131014790|NCT01212757|471682888|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
131014791|NCT01212757|471682889|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
131014792|NCT01212757|471682890|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131014793|NCT01212757|471682891|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131014794|NCT01212757|471682892|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131014795|NCT01212757|471682893|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131014796|NCT01212757|471682894|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131222589|NCT01902134|472443115|FG002|Overall Study|Physician Decision|0|||
130885403|NCT01646125|471215187|FG001|Overall Study|Subject/Guardian decision|1|||
130885404|NCT00775190|471215188|FG000|Overall Study|Lost to Follow-up|2|||
130885405|NCT00775190|471215189|FG001|Overall Study|Lost to Follow-up|3|||
131014797|NCT01212757|471682895|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
131101457|NCT04617275|471999716|FG004|Treatment Period|Adverse Event|7|||
131101458|NCT04617275|471999717|FG005|Treatment Period|Adverse Event|8|||
131101459|NCT04617275|471999718|FG006|Treatment Period|Adverse Event|0|||
131101460|NCT04617275|471999719|FG007|Treatment Period|Adverse Event|12|||
131101461|NCT04617275|471999712|FG000|Treatment Period|Lost to Follow-up|0|||
131101462|NCT04617275|471999713|FG001|Treatment Period|Lost to Follow-up|0|||
131101463|NCT04617275|471999714|FG002|Treatment Period|Lost to Follow-up|2|||
131101464|NCT04617275|471999715|FG003|Treatment Period|Lost to Follow-up|0|||
131101465|NCT04617275|471999716|FG004|Treatment Period|Lost to Follow-up|0|||
131101466|NCT04617275|471999717|FG005|Treatment Period|Lost to Follow-up|3|||
131101467|NCT04617275|471999718|FG006|Treatment Period|Lost to Follow-up|0|||
131101468|NCT04617275|471999719|FG007|Treatment Period|Lost to Follow-up|2|||
131101469|NCT04617275|471999712|FG000|Treatment Period|No longer meets eligibility criteria|0|||
131101470|NCT04617275|471999713|FG001|Treatment Period|No longer meets eligibility criteria|0|||
131101471|NCT04617275|471999714|FG002|Treatment Period|No longer meets eligibility criteria|0|||
131101472|NCT04617275|471999715|FG003|Treatment Period|No longer meets eligibility criteria|1|||
131101473|NCT04617275|471999716|FG004|Treatment Period|No longer meets eligibility criteria|0|||
131101474|NCT04617275|471999717|FG005|Treatment Period|No longer meets eligibility criteria|0|||
131101475|NCT04617275|471999718|FG006|Treatment Period|No longer meets eligibility criteria|0|||
131101476|NCT04617275|471999719|FG007|Treatment Period|No longer meets eligibility criteria|0|||
131101477|NCT04617275|471999712|FG000|Treatment Period|Other|0|||
131101478|NCT04617275|471999713|FG001|Treatment Period|Other|1|||
131101479|NCT04617275|471999714|FG002|Treatment Period|Other|0|||
131101480|NCT04617275|471999715|FG003|Treatment Period|Other|0|||
131101481|NCT04617275|471999716|FG004|Treatment Period|Other|0|||
131101482|NCT04617275|471999717|FG005|Treatment Period|Other|0|||
131101483|NCT04617275|471999718|FG006|Treatment Period|Other|0|||
131101484|NCT04617275|471999719|FG007|Treatment Period|Other|0|||
131101485|NCT04617275|471999712|FG000|Treatment Period|Withdrawal by Subject|2|||
131101486|NCT04617275|471999713|FG001|Treatment Period|Withdrawal by Subject|0|||
131101487|NCT04617275|471999714|FG002|Treatment Period|Withdrawal by Subject|0|||
131101488|NCT04617275|471999715|FG003|Treatment Period|Withdrawal by Subject|2|||
131101489|NCT04617275|471999716|FG004|Treatment Period|Withdrawal by Subject|2|||
131101490|NCT04617275|471999717|FG005|Treatment Period|Withdrawal by Subject|0|||
131101491|NCT04617275|471999718|FG006|Treatment Period|Withdrawal by Subject|1|||
131101492|NCT04617275|471999719|FG007|Treatment Period|Withdrawal by Subject|2|||
131101493|NCT04617275|471999712|FG000|Follow-up Period|Adverse Event|1|||
131101494|NCT04617275|471999713|FG001|Follow-up Period|Adverse Event|1|||
131101495|NCT04617275|471999714|FG002|Follow-up Period|Adverse Event|2|||
131101496|NCT04617275|471999715|FG003|Follow-up Period|Adverse Event|3|||
131101497|NCT04617275|471999716|FG004|Follow-up Period|Adverse Event|4|||
131101498|NCT04617275|471999717|FG005|Follow-up Period|Adverse Event|3|||
131101499|NCT04617275|471999718|FG006|Follow-up Period|Adverse Event|0|||
131101500|NCT04617275|471999719|FG007|Follow-up Period|Adverse Event|3|||
131101501|NCT04617275|471999712|FG000|Follow-up Period|Lost to Follow-up|0|||
131101502|NCT04617275|471999713|FG001|Follow-up Period|Lost to Follow-up|1|||
131101503|NCT04617275|471999714|FG002|Follow-up Period|Lost to Follow-up|2|||
131101504|NCT04617275|471999715|FG003|Follow-up Period|Lost to Follow-up|0|||
131101505|NCT04617275|471999716|FG004|Follow-up Period|Lost to Follow-up|0|||
131101506|NCT04617275|471999717|FG005|Follow-up Period|Lost to Follow-up|4|||
131101507|NCT04617275|471999718|FG006|Follow-up Period|Lost to Follow-up|0|||
131014798|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131014799|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131014800|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131014801|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131014802|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131014803|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131014804|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131014805|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
131014806|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
131101508|NCT04617275|471999719|FG007|Follow-up Period|Lost to Follow-up|3|||
131101509|NCT04617275|471999712|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
131101510|NCT04617275|471999713|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
131101511|NCT04617275|471999714|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
131101512|NCT04617275|471999715|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
131101513|NCT04617275|471999716|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
131101514|NCT04617275|471999717|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
131101515|NCT04617275|471999718|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
131101516|NCT04617275|471999719|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
130885406|NCT00775190|471215188|FG000|Overall Study|Withdrawal by Subject|1|||
131101517|NCT04617275|471999712|FG000|Follow-up Period|Other|0|||
131101518|NCT04617275|471999713|FG001|Follow-up Period|Other|1|||
131101519|NCT04617275|471999714|FG002|Follow-up Period|Other|0|||
131101520|NCT04617275|471999715|FG003|Follow-up Period|Other|0|||
131101521|NCT04617275|471999716|FG004|Follow-up Period|Other|0|||
131101522|NCT04617275|471999717|FG005|Follow-up Period|Other|0|||
131101523|NCT04617275|471999718|FG006|Follow-up Period|Other|0|||
131101524|NCT04617275|471999719|FG007|Follow-up Period|Other|0|||
131101525|NCT04617275|471999712|FG000|Follow-up Period|Withdrawal by Subject|2|||
131101526|NCT04617275|471999713|FG001|Follow-up Period|Withdrawal by Subject|0|||
131101527|NCT04617275|471999714|FG002|Follow-up Period|Withdrawal by Subject|0|||
131101528|NCT04617275|471999715|FG003|Follow-up Period|Withdrawal by Subject|2|||
131101529|NCT04617275|471999716|FG004|Follow-up Period|Withdrawal by Subject|2|||
131101530|NCT04617275|471999717|FG005|Follow-up Period|Withdrawal by Subject|0|||
131101531|NCT04617275|471999718|FG006|Follow-up Period|Withdrawal by Subject|1|||
131101532|NCT04617275|471999719|FG007|Follow-up Period|Withdrawal by Subject|2|||
131101533|NCT04927884|471999723|FG000|Overall Study|Progressive Disease|2|||
131101534|NCT02317432|471999724|FG000|Overall Study|Death|4|||
131101535|NCT02317432|471999725|FG001|Overall Study|Death|1|||
131101536|NCT02317432|471999724|FG000|Overall Study|Lost to Follow-up|0|||
131101537|NCT02317432|471999725|FG001|Overall Study|Lost to Follow-up|5|||
131101538|NCT02317432|471999724|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
131101539|NCT02317432|471999725|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
131101540|NCT05593445|471999726|FG000|12-Week DBVC Period|Adverse Event|1|||
131101541|NCT05593445|471999727|FG001|12-Week DBVC Period|Adverse Event|0|||
131101542|NCT05593445|471999728|FG002|12-Week DBVC Period|Adverse Event|0|||
131101543|NCT05593445|471999729|FG003|12-Week DBVC Period|Adverse Event|0|||
130678760|NCT00863746|470450844|FG000|Treatment|Other|1|||
130678761|NCT00863746|470450845|FG001|Treatment|Other|0|||
131101544|NCT05593445|471999726|FG000|12-Week DBVC Period|Physician Decision|0|||
131101545|NCT05593445|471999727|FG001|12-Week DBVC Period|Physician Decision|1|||
131101546|NCT05593445|471999728|FG002|12-Week DBVC Period|Physician Decision|0|||
131101547|NCT05593445|471999729|FG003|12-Week DBVC Period|Physician Decision|0|||
131101548|NCT05593445|471999726|FG000|12-Week DBVC Period|Protocol Violation|0|||
131101549|NCT05593445|471999727|FG001|12-Week DBVC Period|Protocol Violation|1|||
131101550|NCT05593445|471999728|FG002|12-Week DBVC Period|Protocol Violation|0|||
131101551|NCT05593445|471999729|FG003|12-Week DBVC Period|Protocol Violation|0|||
131101552|NCT05593445|471999726|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
131101553|NCT05593445|471999727|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
131101554|NCT05593445|471999728|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
131101555|NCT05593445|471999729|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
131101556|NCT05593445|471999726|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
131101557|NCT05593445|471999727|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
131101558|NCT05593445|471999728|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
131101559|NCT05593445|471999729|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
131101560|NCT05593445|471999726|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
131101561|NCT05593445|471999727|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
131101562|NCT05593445|471999728|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
131101563|NCT05593445|471999729|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
131101564|NCT05593445|471999726|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
131101565|NCT05593445|471999727|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
131101566|NCT05593445|471999728|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
131101567|NCT05593445|471999729|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
131101568|NCT05593445|471999726|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131101569|NCT05593445|471999727|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131101570|NCT05593445|471999728|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
131101571|NCT05593445|471999729|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
131101572|NCT05559476|471999732|FG000|Overall Study|Adverse Event|2|||
131101573|NCT05559476|471999733|FG001|Overall Study|Adverse Event|0|||
131101574|NCT05559476|471999732|FG000|Overall Study|Lost to Follow-up|13|||
131101575|NCT05559476|471999733|FG001|Overall Study|Lost to Follow-up|12|||
130678762|NCT00863746|470450844|FG000|Survival Follow up|Death|244|||
130678763|NCT00863746|470450845|FG001|Survival Follow up|Death|271|||
130678764|NCT00863746|470450844|FG000|Survival Follow up|Lost to Follow-up|2|||
130678765|NCT00863746|470450845|FG001|Survival Follow up|Lost to Follow-up|1|||
130678766|NCT00863746|470450844|FG000|Survival Follow up|Consent Withdrawn|7|||
131101576|NCT05559476|471999732|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
131101577|NCT05559476|471999733|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
131101578|NCT05559476|471999732|FG000|Overall Study|Other|0|||
131101579|NCT05559476|471999733|FG001|Overall Study|Other|2|||
131101580|NCT00727311|471999734|FG000|Overall Study|Did not receive drug|316|||
131101581|NCT00727311|471999734|FG000|Overall Study|Missing end of therapy data|205|||
130678767|NCT00863746|470450845|FG001|Survival Follow up|Consent Withdrawn|8|||
130678768|NCT01545076|470450847|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
130678769|NCT01545076|470450848|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
131101582|NCT00727311|471999734|FG000|Overall Study|Adverse Event|58|||
131101583|NCT00727311|471999734|FG000|Overall Study|Lack of Efficacy|242|||
131101584|NCT00727311|471999734|FG000|Overall Study|Lost to Follow-up|73|||
131101585|NCT00727311|471999734|FG000|Overall Study|Withdrawal by Subject|77|||
131101586|NCT00727311|471999734|FG000|Overall Study|Other|97|||
131101587|NCT00727311|471999734|FG000|Overall Study|Multiple reasons|39|||
131101588|NCT03992846|471999735|FG000|Overall Study|Adverse Event|8|||
131101589|NCT03992846|471999736|FG001|Overall Study|Adverse Event|6|||
131101590|NCT03992846|471999737|FG002|Overall Study|Adverse Event|3|||
131101591|NCT03992846|471999735|FG000|Overall Study|Lost to Follow-up|0|||
131101592|NCT03992846|471999736|FG001|Overall Study|Lost to Follow-up|1|||
131101593|NCT03992846|471999737|FG002|Overall Study|Lost to Follow-up|1|||
131101594|NCT03992846|471999735|FG000|Overall Study|Pregnancy|2|||
131101595|NCT03992846|471999736|FG001|Overall Study|Pregnancy|0|||
131101596|NCT03992846|471999737|FG002|Overall Study|Pregnancy|1|||
131101597|NCT03992846|471999735|FG000|Overall Study|Protocol Violation|1|||
131101598|NCT03992846|471999736|FG001|Overall Study|Protocol Violation|2|||
131101599|NCT03992846|471999737|FG002|Overall Study|Protocol Violation|0|||
131101600|NCT03992846|471999735|FG000|Overall Study|Withdrawal by Subject|8|||
131101601|NCT03992846|471999736|FG001|Overall Study|Withdrawal by Subject|10|||
131101602|NCT03992846|471999737|FG002|Overall Study|Withdrawal by Subject|20|||
131101603|NCT03992846|471999735|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
131101604|NCT03992846|471999736|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
131101605|NCT03992846|471999737|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
131101606|NCT04058366|472001238|FG000|Overall Study|Adverse Event|14|||
131101607|NCT04058366|472001238|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
131101608|NCT04058366|472001238|FG000|Overall Study|Commercial drug is available for participants|6|||
131101609|NCT04058366|472001238|FG000|Overall Study|Death|1|||
131101610|NCT04058366|472001238|FG000|Overall Study|Other non-compliance|2|||
131101611|NCT04058366|472001238|FG000|Overall Study|Other|6|||
131101612|NCT00734097|472001239|FG000|Screening|Protocol Violation|12|||
131101613|NCT00734097|472001239|FG000|Screening|Withdrawal by Subject|5|||
131101614|NCT00734097|472001239|FG000|Screening|Lost to Follow-up|2|||
131101615|NCT00734097|472001239|FG000|Screening|Unconfirmed pregnancy|1|||
131101616|NCT00734097|472001239|FG000|Open Label|Lost to Follow-up|7|||
131101617|NCT00734097|472001239|FG000|Open Label|Withdrawal by Subject|5|||
131101618|NCT00734097|472001239|FG000|Open Label|Protocol Violation|4|||
131101619|NCT02233543|472001242|FG000|Period 1|Withdrawal by Subject|1|||
131101620|NCT02233543|472001243|FG001|Period 1|Withdrawal by Subject|0|||
131101621|NCT02233543|472001242|FG000|Period 1|Participants required other treatment.|2|||
131101622|NCT02233543|472001243|FG001|Period 1|Participants required other treatment.|3|||
131101623|NCT02233543|472001242|FG000|Period 2|Adverse Event|1|||
131101624|NCT02233543|472001243|FG001|Period 2|Adverse Event|0|||
131101625|NCT02233543|472001242|FG000|Period 2|Participant required other treatment.|0|||
131101626|NCT02233543|472001243|FG001|Period 2|Participant required other treatment.|1|||
131101627|NCT02233543|472001242|FG000|Period 2|COPD exacerbation|1|||
131101628|NCT02233543|472001243|FG001|Period 2|COPD exacerbation|0|||
131101629|NCT00603304|472001244|FG000|Overall Study|Lost to Follow-up|5|||
131101630|NCT00603304|472001245|FG001|Overall Study|Lost to Follow-up|7|||
131101631|NCT00603304|472001244|FG000|Overall Study|Withdrawal by Subject|8|||
131101632|NCT00603304|472001245|FG001|Overall Study|Withdrawal by Subject|5|||
131101633|NCT00603304|472001244|FG000|Overall Study|Protocol Violation|1|||
131101634|NCT00603304|472001245|FG001|Overall Study|Protocol Violation|0|||
131101635|NCT00603304|472001244|FG000|Overall Study|Adverse Event|4|||
131101636|NCT00603304|472001245|FG001|Overall Study|Adverse Event|2|||
131101637|NCT00603304|472001244|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
131101638|NCT00603304|472001245|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
131101639|NCT00603304|472001244|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
130678770|NCT01545076|470450849|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
130678771|NCT01545076|470450850|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
130678772|NCT01545076|470450851|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
130678773|NCT01545076|470450847|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
130678774|NCT01545076|470450848|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
130678775|NCT01545076|470450849|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
130678776|NCT01545076|470450850|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
131101640|NCT00603304|472001245|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
131101641|NCT00603304|472001244|FG000|Overall Study|Exclusionary Medication|2|||
131101642|NCT00603304|472001245|FG001|Overall Study|Exclusionary Medication|3|||
131101643|NCT00603304|472001244|FG000|Overall Study|Non-Compliant|0|||
131101644|NCT00603304|472001245|FG001|Overall Study|Non-Compliant|1|||
131101645|NCT00603304|472001244|FG000|Overall Study|Moved Away|0|||
131101646|NCT00603304|472001245|FG001|Overall Study|Moved Away|2|||
131101647|NCT00603304|472001244|FG000|Overall Study|Other|2|||
131101648|NCT00603304|472001245|FG001|Overall Study|Other|0|||
131101649|NCT00603304|472001244|FG000|Overall Study|Patient Decision|2|||
131101650|NCT00603304|472001245|FG001|Overall Study|Patient Decision|0|||
131101651|NCT00616902|472001246|FG000|Overall Study|Termination of study|6|||
131222590|NCT01902134|472443116|FG003|Overall Study|Physician Decision|0|||
130678777|NCT01545076|470450851|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
131014807|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
131014808|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
131014809|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
131014810|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
131014811|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
131014812|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
131014813|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
131014814|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
131014815|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
131014816|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131014817|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
131014818|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
131014819|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131014820|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131014821|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131014822|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131014823|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
131014824|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
131014825|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131014826|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
131014827|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
131014828|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131014829|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131014830|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131014831|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131014832|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
131014833|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
131014834|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131014835|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131014836|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
131014837|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131014838|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131014839|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131014840|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131014841|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131014842|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
131014843|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131014844|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
131014845|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
131014846|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131014847|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131014848|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131014849|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131014850|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
131014851|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
131014852|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
131014853|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
131014854|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
131014855|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
131014856|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
131014857|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
131014858|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
131014859|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
131014860|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
131014861|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131014862|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131014863|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
131014864|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131014865|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131014866|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131014867|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131014868|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131014869|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
131014870|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131101652|NCT00616902|472001247|FG001|Overall Study|Termination of study|6|||
131101653|NCT03573583|472001248|FG000|Overall Study|Lost to Follow-up|1|||
131101654|NCT03573583|472001249|FG001|Overall Study|Lost to Follow-up|0|||
131014871|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
131014872|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
131014873|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131014874|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131014875|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131014876|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131014877|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
131014878|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
131014879|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131014880|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131014881|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131014882|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131014883|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131014884|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131014885|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131014886|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
131014887|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
131014888|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131014889|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
131014890|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131014891|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131014892|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131014893|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131014894|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131014895|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131014896|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
131014897|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131014898|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131014899|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
131014900|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131014901|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131014902|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131014903|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131014904|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
131014905|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
131014906|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131014907|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
131014908|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131014909|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131014910|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131014911|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131014912|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131014913|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
131014914|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
131014915|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
131014916|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
131014917|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
131014918|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
131014919|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
131014920|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
131014921|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
131014922|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
131014923|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
131014924|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
131014925|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
131014926|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
131014927|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
131014928|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
131014929|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
131014930|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
131014931|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
131014932|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
131014933|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131014934|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
131014935|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
131014936|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131014937|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131014938|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130678778|NCT01545076|470450847|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
130678779|NCT01545076|470450848|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
130678780|NCT01545076|470450849|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
130678781|NCT01545076|470450850|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
130678782|NCT01545076|470450851|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
130678783|NCT01545076|470450847|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
130678784|NCT01545076|470450848|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130678785|NCT01545076|470450849|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130678786|NCT01545076|470450850|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130678787|NCT01545076|470450851|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130678788|NCT01545076|470450847|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
130678789|NCT01545076|470450848|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
131014939|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131014940|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
131014941|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
131014942|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
131014943|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
131014944|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
131014945|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
131014946|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
131014947|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
131014948|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
131014949|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
131014950|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
131014951|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131014952|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131014953|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131014954|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131014955|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131014956|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131014957|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131014958|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
131014959|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
131014960|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131014961|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
131014962|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
131014963|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131014964|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131014965|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131014966|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131014967|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
131014968|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
131014969|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131014970|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
131014971|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
131014972|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131014973|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131014974|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131014975|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131014976|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
131014977|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
131014978|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
131014979|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
131014980|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
131014981|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
131014982|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
131014983|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
131014984|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
131014985|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
131014986|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
131014987|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131014988|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
131014989|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131014990|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131101655|NCT03573583|472001248|FG000|Overall Study|Withdrawal by Subject|1|||
131101656|NCT03573583|472001249|FG001|Overall Study|Withdrawal by Subject|1|||
131014991|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131014992|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131101657|NCT04343872|472001254|FG000|Overall Study|Lost to Follow-up|6|||
131101658|NCT04343872|472001255|FG001|Overall Study|Lost to Follow-up|3|||
131101659|NCT01850446|472001256|FG000|Overall Study|Lack of Efficacy|1|||
131101660|NCT01850446|472001257|FG001|Overall Study|Lack of Efficacy|0|||
131101661|NCT01850446|472001256|FG000|Overall Study|Withdrawal by Subject|4|||
131101662|NCT01850446|472001257|FG001|Overall Study|Withdrawal by Subject|0|||
131101663|NCT01850446|472001256|FG000|Overall Study|Protocol Violation|0|||
131101664|NCT01850446|472001257|FG001|Overall Study|Protocol Violation|2|||
131101665|NCT00759915|472001258|FG000|Overall Study|Withdrawal by Subject|1|||
131101666|NCT00759915|472001259|FG001|Overall Study|Withdrawal by Subject|0|||
131101667|NCT00759915|472001258|FG000|Overall Study|Adverse Event|0|||
131101668|NCT00759915|472001259|FG001|Overall Study|Adverse Event|1|||
131101669|NCT03730480|472001260|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
131101670|NCT01227577|472001261|FG000|Overall Study|Protocol deviation|3|||
131101671|NCT01227577|472001261|FG000|Overall Study|Death|3|||
131101672|NCT01227577|472001261|FG000|Overall Study|Administrative problems|2|||
131101673|NCT01227577|472001261|FG000|Overall Study|Lost to Follow-up|1|||
131101674|NCT01227577|472001261|FG000|Overall Study|Withdrawal by Subject|4|||
131101675|NCT01227577|472001261|FG000|Overall Study|Lack of Efficacy|5|||
131101676|NCT01227577|472001261|FG000|Overall Study|Adverse Event|17|||
131101677|NCT02480153|472001262|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
131101678|NCT02480153|472001263|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
131101679|NCT02480153|472001264|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
131101680|NCT02480153|472001262|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
131101681|NCT02480153|472001263|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
131101682|NCT02480153|472001264|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
131101683|NCT02480153|472001262|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
131101684|NCT02480153|472001263|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
131101685|NCT02480153|472001264|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
131101686|NCT02480153|472001262|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
131101687|NCT02480153|472001263|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
131101688|NCT02480153|472001264|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
131101689|NCT02480153|472001262|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
131101690|NCT02480153|472001263|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
131101691|NCT02480153|472001264|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
131101692|NCT02480153|472001262|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
131101693|NCT02480153|472001263|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
131101694|NCT02480153|472001264|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
131101695|NCT02480153|472001262|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
131101696|NCT02480153|472001263|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
131101697|NCT02480153|472001264|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
131101698|NCT02480153|472001262|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
131101699|NCT02480153|472001263|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
131101700|NCT02480153|472001264|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
131101701|NCT02480153|472001262|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
131101702|NCT02480153|472001263|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
131101703|NCT02480153|472001264|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
131101704|NCT02480153|472001262|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
131101705|NCT02480153|472001263|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
131101706|NCT02480153|472001264|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
131101707|NCT02480153|472001262|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
131101708|NCT02480153|472001263|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
131101709|NCT02480153|472001264|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
131101710|NCT02480153|472001262|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
131101711|NCT02480153|472001263|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
131101712|NCT02480153|472001264|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
131101713|NCT02480153|472001262|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
131101714|NCT02480153|472001263|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
131101715|NCT02480153|472001264|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
131101716|NCT02480153|472001262|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
131101717|NCT02480153|472001263|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
131101718|NCT02480153|472001264|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
131101719|NCT02480153|472001262|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
131101720|NCT02480153|472001263|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
131101721|NCT02480153|472001264|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
130678790|NCT01545076|470450849|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130678791|NCT01545076|470450850|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130678792|NCT01545076|470450851|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130678793|NCT01545076|470450847|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130678794|NCT01545076|470450848|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130678795|NCT01545076|470450849|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130678796|NCT01545076|470450850|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
130678797|NCT01545076|470450851|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130678798|NCT01545076|470450847|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
130678799|NCT01545076|470450848|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
130678800|NCT01545076|470450849|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
130678801|NCT01545076|470450850|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
130678802|NCT01545076|470450851|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
130678803|NCT01545076|470450847|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
130678804|NCT01545076|470450848|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
131014993|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131014994|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131014995|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
131014996|NCT01212757|471682887|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131014997|NCT01212757|471682888|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
131014998|NCT01212757|471682889|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
131014999|NCT01212757|471682890|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131015000|NCT01212757|471682891|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131015001|NCT01212757|471682892|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131015002|NCT01212757|471682893|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131015003|NCT01212757|471682894|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131015004|NCT01212757|471682895|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
131015005|NCT02812966|471682896|FG000|Overall Study|Death|1|||
131015006|NCT02812966|471682897|FG001|Overall Study|Death|0|||
131015007|NCT00849147|471682898|FG000|Overall Study|Withdrawal by Subject|1|||
131015008|NCT00849147|471682898|FG000|Overall Study|Protocol Violation|2|||
131015009|NCT00849147|471682898|FG000|Overall Study|Disease Relapse/Progression|2|||
131015010|NCT01070888|471684935|FG000|First Intervention (14 Days)|Adverse Event|0|||
131015011|NCT01070888|471684936|FG001|First Intervention (14 Days)|Adverse Event|1|||
131015012|NCT01070888|471684935|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
131015013|NCT01070888|471684936|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
131015014|NCT01070888|471684935|FG000|Washout (14 Days)|Physician Decision|1|||
131015015|NCT01070888|471684936|FG001|Washout (14 Days)|Physician Decision|0|||
131015016|NCT02577523|471684940|FG000|Overall Study|Adverse Event|1|||
131015017|NCT02577523|471684941|FG001|Overall Study|Adverse Event|1|||
131015018|NCT02577523|471684940|FG000|Overall Study|Lack of Efficacy|1|||
131015019|NCT02577523|471684941|FG001|Overall Study|Lack of Efficacy|1|||
131015020|NCT02577523|471684940|FG000|Overall Study|Withdrawal by Subject|1|||
131015021|NCT02577523|471684941|FG001|Overall Study|Withdrawal by Subject|0|||
131015022|NCT00726999|471684943|FG000|Overall Study|Physician Decision|0|||
131015023|NCT00726999|471684944|FG001|Overall Study|Physician Decision|1|||
131015024|NCT00726999|471684943|FG000|Overall Study|Withdrawal by Subject|2|||
131015025|NCT00726999|471684944|FG001|Overall Study|Withdrawal by Subject|0|||
131015026|NCT00726999|471684943|FG000|Overall Study|Protocol Violation|1|||
131015027|NCT00726999|471684944|FG001|Overall Study|Protocol Violation|0|||
131015028|NCT00955825|471684945|FG000|Overall Study|Adverse Event|15|||
131015029|NCT00955825|471684946|FG001|Overall Study|Adverse Event|2|||
131015030|NCT00955825|471684945|FG000|Overall Study|Withdrawal by Subject|4|||
131015031|NCT00955825|471684946|FG001|Overall Study|Withdrawal by Subject|6|||
131015032|NCT00955825|471684945|FG000|Overall Study|Any other reason not above-mentioned|7|||
131015033|NCT00955825|471684946|FG001|Overall Study|Any other reason not above-mentioned|9|||
131015034|NCT02488980|471684947|FG000|Overall Study|Protocol Violation|2|||
131015035|NCT02488980|471684948|FG001|Overall Study|Protocol Violation|2|||
131015036|NCT02488980|471684949|FG002|Overall Study|Protocol Violation|2|||
131015037|NCT00738699|471684951|FG000|Overall Study|Withdrawal by Subject|5|||
131015038|NCT00738699|471684952|FG001|Overall Study|Withdrawal by Subject|0|||
131015039|NCT00738699|471684951|FG000|Overall Study|Lost to Follow-up|1|||
131015040|NCT00738699|471684952|FG001|Overall Study|Lost to Follow-up|0|||
130678805|NCT01545076|470450849|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
130678806|NCT01545076|470450850|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
131015041|NCT00738699|471684951|FG000|Overall Study|Death|144|||
131015042|NCT00738699|471684952|FG001|Overall Study|Death|68|||
131015043|NCT00738699|471684951|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
131015044|NCT00738699|471684952|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
131015045|NCT00738699|471684951|FG000|Overall Study|Other|2|||
131015046|NCT00738699|471684952|FG001|Overall Study|Other|0|||
131015047|NCT00549848|471684953|FG000|Overall Study|Death|1|||
130678807|NCT01545076|470450851|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
131015048|NCT00549848|471684954|FG001|Overall Study|Death|4|||
131015049|NCT00549848|471684955|FG002|Overall Study|Death|13|||
130678808|NCT01545076|470450847|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
130678809|NCT01545076|470450848|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
130678810|NCT01545076|470450849|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
130678811|NCT01545076|470450850|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
130678812|NCT01545076|470450851|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
130678813|NCT03444038|470450852|FG000|Overall Study|Adverse Event|12|||
130678814|NCT03444038|470450852|FG000|Overall Study|Withdrawal by Subject|7|||
130678815|NCT03444038|470450852|FG000|Overall Study|Lost to Follow-up|1|||
130678816|NCT03444038|470450852|FG000|Overall Study|Physician Decision|2|||
130678817|NCT03444038|470450852|FG000|Overall Study|Lack of Efficacy|7|||
130678818|NCT00264797|470450856|FG000|Overall Study|Withdrawal by Subject|11|||
130678819|NCT00264797|470450857|FG001|Overall Study|Withdrawal by Subject|11|||
130678820|NCT00264797|470450856|FG000|Overall Study|Lost to Follow-up|9|||
130678821|NCT00264797|470450857|FG001|Overall Study|Lost to Follow-up|17|||
130678822|NCT00264797|470450856|FG000|Overall Study|Moved from area|3|||
130678823|NCT00264797|470450857|FG001|Overall Study|Moved from area|1|||
130678824|NCT00264797|470450856|FG000|Overall Study|Practical Problems|2|||
130678825|NCT00264797|470450857|FG001|Overall Study|Practical Problems|3|||
130678826|NCT00264797|470450856|FG000|Overall Study|Incarceration|4|||
130678827|NCT00264797|470450857|FG001|Overall Study|Incarceration|5|||
130678828|NCT00264797|470450856|FG000|Overall Study|Pressure/advice from Outsiders|1|||
131101722|NCT02480153|472001262|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
131101723|NCT02480153|472001263|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
131101724|NCT02480153|472001264|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
131101725|NCT02480153|472001262|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
131101726|NCT02480153|472001263|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
131101727|NCT02480153|472001264|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
131101728|NCT02480153|472001262|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
131101729|NCT02480153|472001263|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
131101730|NCT02480153|472001264|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
130678829|NCT00264797|470450857|FG001|Overall Study|Pressure/advice from Outsiders|1|||
130678830|NCT00264797|470450856|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
130678831|NCT00264797|470450857|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
130678832|NCT00264797|470450856|FG000|Overall Study|Other|3|||
130678833|NCT00264797|470450857|FG001|Overall Study|Other|4|||
130678834|NCT01153984|470450858|FG000|Overall Study|Withdrawal by Subject|1|||
131101731|NCT00512317|472001265|FG000|Overall Study|Insufficient clinical response|36|||
131101732|NCT00512317|472001265|FG000|Overall Study|Withdrawal by Subject|23|||
131101733|NCT00512317|472001265|FG000|Overall Study|Sponsor closure of study|21|||
131101734|NCT00512317|472001265|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
131101735|NCT00512317|472001265|FG000|Overall Study|Adverse Event|13|||
131101736|NCT00512317|472001265|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
131101737|NCT00512317|472001265|FG000|Overall Study|Lost to Follow-up|2|||
131101738|NCT00512317|472001265|FG000|Overall Study|Other|2|||
131101739|NCT01639495|472001266|FG000|Overall Study|Lost to Follow-up|6|||
131101740|NCT01639495|472001266|FG000|Overall Study|Consented but didn't have study catheter|4|||
131101741|NCT01639495|472001266|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
131101742|NCT01639495|472001266|FG000|Overall Study|No radiofrequency energy applied|2|||
131101743|NCT01775475|472001267|FG000|Overall Study|Death|3|||
131101744|NCT01775475|472001268|FG001|Overall Study|Death|3|||
131101745|NCT01813929|472001269|FG000|Overall Study|Withdrawal by Subject|0|||
131101746|NCT01813929|472001270|FG001|Overall Study|Withdrawal by Subject|1|||
131101747|NCT00007345|472001271|FG000|Overall Study|Refused further treatment|0|||
131101748|NCT00007345|472001272|FG001|Overall Study|Refused further treatment|7|||
131101749|NCT00007345|472001271|FG000|Overall Study|Switched to alternative treatment|0|||
131101750|NCT00007345|472001272|FG001|Overall Study|Switched to alternative treatment|3|||
131101751|NCT00007345|472001271|FG000|Overall Study|Intercurrent illness|1|||
131101752|NCT00007345|472001272|FG001|Overall Study|Intercurrent illness|0|||
131101753|NCT00007345|472001271|FG000|Overall Study|Death on study|1|||
131101754|NCT00007345|472001272|FG001|Overall Study|Death on study|1|||
131101755|NCT04433585|472001273|FG000|Overall Study|Withdrawal by Subject|15|||
131101756|NCT04433585|472001274|FG001|Overall Study|Withdrawal by Subject|3|||
130678835|NCT01153984|470450858|FG000|Overall Study|Adverse Event|1|||
130678836|NCT02460159|470450859|FG000|Overall Study|Adverse Event|4|||
130678837|NCT02460159|470450860|FG001|Overall Study|Adverse Event|1|||
130678838|NCT02460159|470450859|FG000|Overall Study|Withdrawal by Subject|2|||
130678839|NCT02460159|470450860|FG001|Overall Study|Withdrawal by Subject|0|||
131101757|NCT04433585|472001275|FG002|Overall Study|Withdrawal by Subject|15|||
131101758|NCT04433585|472001276|FG003|Overall Study|Withdrawal by Subject|6|||
131101759|NCT04433585|472001273|FG000|Overall Study|Adverse Event|10|||
131101760|NCT04433585|472001274|FG001|Overall Study|Adverse Event|4|||
131101761|NCT04433585|472001275|FG002|Overall Study|Adverse Event|1|||
131101762|NCT04433585|472001276|FG003|Overall Study|Adverse Event|0|||
131101763|NCT04433585|472001273|FG000|Overall Study|Due to the conflict in Ukraine|2|||
130678840|NCT00762086|470450861|FG000|Overall Study|Adverse Event|2|||
130678841|NCT00762086|470450862|FG001|Overall Study|Adverse Event|0|||
130678842|NCT00762086|470450861|FG000|Overall Study|Lost to Follow-up|0|||
130678843|NCT00762086|470450862|FG001|Overall Study|Lost to Follow-up|2|||
130678844|NCT00762086|470450861|FG000|Overall Study|Non compliance|1|||
130678845|NCT00762086|470450862|FG001|Overall Study|Non compliance|0|||
130678846|NCT00762086|470450861|FG000|Overall Study|Withdrawal by Subject|2|||
130678847|NCT00762086|470450862|FG001|Overall Study|Withdrawal by Subject|2|||
130678848|NCT00762086|470450861|FG000|Overall Study|Ineligible to participate in the study|1|||
130678849|NCT00762086|470450862|FG001|Overall Study|Ineligible to participate in the study|0|||
130678850|NCT00860405|470450867|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
130678851|NCT00860405|470450868|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
130678852|NCT01370408|470450871|FG000|Overall Study|treatment failure|9|||
131015050|NCT00549848|471684953|FG000|Overall Study|Physician Decision|0|||
131015051|NCT00549848|471684954|FG001|Overall Study|Physician Decision|0|||
131015052|NCT00549848|471684955|FG002|Overall Study|Physician Decision|4|||
131015053|NCT00549848|471684953|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
131015054|NCT00549848|471684954|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
131015055|NCT00549848|471684955|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
131015056|NCT00549848|471684953|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
131015057|NCT00549848|471684954|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
131015058|NCT00549848|471684955|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
131015059|NCT00549848|471684953|FG000|Overall Study|Participant/Family Withdraw|2|||
131015060|NCT00549848|471684954|FG001|Overall Study|Participant/Family Withdraw|3|||
131015061|NCT00549848|471684955|FG002|Overall Study|Participant/Family Withdraw|5|||
131015062|NCT00549848|471684953|FG000|Overall Study|Second Malignancy|1|||
131015063|NCT00549848|471684954|FG001|Overall Study|Second Malignancy|0|||
131015064|NCT00549848|471684955|FG002|Overall Study|Second Malignancy|0|||
131015065|NCT00549848|471684953|FG000|Overall Study|Transplant|3|||
131015066|NCT00549848|471684954|FG001|Overall Study|Transplant|3|||
131015067|NCT00549848|471684955|FG002|Overall Study|Transplant|18|||
131015068|NCT00549848|471684953|FG000|Overall Study|Unacceptable Toxicity|1|||
131015069|NCT00549848|471684954|FG001|Overall Study|Unacceptable Toxicity|6|||
131015070|NCT00549848|471684955|FG002|Overall Study|Unacceptable Toxicity|6|||
131015071|NCT00419094|471684958|FG000|Overall Study|Adverse Event|3|||
131015072|NCT00419094|471684959|FG001|Overall Study|Adverse Event|7|||
131015073|NCT00419094|471684958|FG000|Overall Study|Lack of Efficacy|1|||
131015074|NCT00419094|471684959|FG001|Overall Study|Lack of Efficacy|0|||
131015075|NCT00419094|471684958|FG000|Overall Study|Lost to Follow-up|0|||
131015076|NCT00419094|471684959|FG001|Overall Study|Lost to Follow-up|2|||
131015077|NCT00419094|471684958|FG000|Overall Study|Protocol Violation|1|||
131015078|NCT00419094|471684959|FG001|Overall Study|Protocol Violation|14|||
131015079|NCT00419094|471684958|FG000|Overall Study|Withdrawal of consent|1|||
131015080|NCT00419094|471684959|FG001|Overall Study|Withdrawal of consent|5|||
131015081|NCT00419094|471684958|FG000|Overall Study|Other: Error determining exit criteria|1|||
131015082|NCT00419094|471684959|FG001|Overall Study|Other: Error determining exit criteria|0|||
131015083|NCT00419094|471684958|FG000|Overall Study|Other: Patient non-compliant|0|||
131015084|NCT00419094|471684959|FG001|Overall Study|Other: Patient non-compliant|1|||
131015085|NCT00419094|471684958|FG000|Overall Study|Other: No contact for extended period|0|||
131015086|NCT00419094|471684959|FG001|Overall Study|Other: No contact for extended period|1|||
131015087|NCT03262935|471684960|FG000|Overall Study|Withdrawal by Subject|6|||
131015088|NCT03262935|471684961|FG001|Overall Study|Withdrawal by Subject|7|||
131015089|NCT03262935|471684960|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
131015090|NCT03262935|471684961|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
131015091|NCT03262935|471684960|FG000|Overall Study|Death|181|||
131015092|NCT03262935|471684961|FG001|Overall Study|Death|94|||
131015093|NCT03262935|471684960|FG000|Overall Study|Lost to Follow-up|9|||
131015094|NCT03262935|471684961|FG001|Overall Study|Lost to Follow-up|4|||
131015095|NCT03262935|471684960|FG000|Overall Study|Other reason|5|||
131015096|NCT03262935|471684961|FG001|Overall Study|Other reason|0|||
131015097|NCT01811706|471684962|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
131015098|NCT01811706|471684963|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
131015099|NCT02224924|471684964|FG000|Overall Study|Withdrawal by Subject|7|||
131015100|NCT02224924|471684965|FG001|Overall Study|Withdrawal by Subject|6|||
131015101|NCT02224924|471684964|FG000|Overall Study|Biopsy cancelled|20|||
131015102|NCT02224924|471684965|FG001|Overall Study|Biopsy cancelled|14|||
131015103|NCT02224924|471684964|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
131015104|NCT02224924|471684965|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
131015105|NCT02224924|471684964|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
131015106|NCT02224924|471684965|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
131015107|NCT03020745|471684966|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
130678853|NCT01062256|470450872|FG000|Overall Study|Adverse Event|1|||
130678854|NCT01062256|470450873|FG001|Overall Study|Adverse Event|0|||
131015108|NCT03020745|471684967|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
131015109|NCT03020745|471684968|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
131015110|NCT03020745|471684969|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
130678855|NCT01062256|470450874|FG002|Overall Study|Adverse Event|0|||
130678856|NCT01062256|470450872|FG000|Overall Study|Withdrawal by Subject|1|||
130678857|NCT01062256|470450873|FG001|Overall Study|Withdrawal by Subject|1|||
130678858|NCT01062256|470450874|FG002|Overall Study|Withdrawal by Subject|1|||
130678859|NCT01062256|470450872|FG000|Overall Study|Ineligible|1|||
130678860|NCT01062256|470450873|FG001|Overall Study|Ineligible|4|||
130678861|NCT01062256|470450874|FG002|Overall Study|Ineligible|3|||
130678862|NCT01062256|470450872|FG000|Overall Study|Administrative|0|||
130678863|NCT01062256|470450873|FG001|Overall Study|Administrative|2|||
130678864|NCT01062256|470450874|FG002|Overall Study|Administrative|0|||
130678865|NCT03049488|470450875|FG000|Overall Study|Lost to Follow-up|1|||
130678866|NCT03049488|470450876|FG001|Overall Study|Lost to Follow-up|1|||
130678867|NCT03049488|470450877|FG002|Overall Study|Lost to Follow-up|0|||
130678868|NCT03049488|470450878|FG003|Overall Study|Lost to Follow-up|0|||
130678869|NCT03049488|470450879|FG004|Overall Study|Lost to Follow-up|0|||
130678870|NCT03049488|470450880|FG005|Overall Study|Lost to Follow-up|0|||
130678871|NCT03049488|470450875|FG000|Overall Study|Moved from Area|1|||
130678872|NCT03049488|470450876|FG001|Overall Study|Moved from Area|0|||
130678873|NCT03049488|470450877|FG002|Overall Study|Moved from Area|0|||
130678874|NCT03049488|470450878|FG003|Overall Study|Moved from Area|1|||
130678875|NCT03049488|470450879|FG004|Overall Study|Moved from Area|1|||
130678876|NCT03049488|470450880|FG005|Overall Study|Moved from Area|0|||
130678877|NCT03049488|470450875|FG000|Overall Study|Physician Decision|0|||
130678878|NCT03049488|470450876|FG001|Overall Study|Physician Decision|1|||
130678879|NCT03049488|470450877|FG002|Overall Study|Physician Decision|0|||
130678880|NCT03049488|470450878|FG003|Overall Study|Physician Decision|0|||
130678881|NCT03049488|470450879|FG004|Overall Study|Physician Decision|0|||
130678882|NCT03049488|470450880|FG005|Overall Study|Physician Decision|0|||
130678883|NCT03049488|470450875|FG000|Overall Study|Withdrawal by Subject|0|||
130678884|NCT03049488|470450876|FG001|Overall Study|Withdrawal by Subject|0|||
131101764|NCT04433585|472001274|FG001|Overall Study|Due to the conflict in Ukraine|1|||
131101765|NCT04433585|472001275|FG002|Overall Study|Due to the conflict in Ukraine|1|||
131101766|NCT04433585|472001276|FG003|Overall Study|Due to the conflict in Ukraine|2|||
131101767|NCT04433585|472001273|FG000|Overall Study|Physician Decision|1|||
131101768|NCT04433585|472001274|FG001|Overall Study|Physician Decision|2|||
131101769|NCT04433585|472001275|FG002|Overall Study|Physician Decision|0|||
131101770|NCT04433585|472001276|FG003|Overall Study|Physician Decision|0|||
131101771|NCT04433585|472001273|FG000|Overall Study|Lost to Follow-up|1|||
131101772|NCT04433585|472001274|FG001|Overall Study|Lost to Follow-up|1|||
131101773|NCT04433585|472001275|FG002|Overall Study|Lost to Follow-up|1|||
131101774|NCT04433585|472001276|FG003|Overall Study|Lost to Follow-up|0|||
131101775|NCT04433585|472001273|FG000|Overall Study|Lack of Efficacy|0|||
131101776|NCT04433585|472001274|FG001|Overall Study|Lack of Efficacy|1|||
131101777|NCT04433585|472001275|FG002|Overall Study|Lack of Efficacy|1|||
131101778|NCT04433585|472001276|FG003|Overall Study|Lack of Efficacy|1|||
131101779|NCT04433585|472001273|FG000|Overall Study|Death|0|||
131101780|NCT04433585|472001274|FG001|Overall Study|Death|1|||
131101781|NCT04433585|472001275|FG002|Overall Study|Death|0|||
131101782|NCT04433585|472001276|FG003|Overall Study|Death|0|||
131101783|NCT02074553|472001277|FG000|Intervention Period 1|Family Emergency|0|||
131101784|NCT02074553|472001278|FG001|Intervention Period 1|Family Emergency|0|||
131101785|NCT02074553|472001279|FG002|Intervention Period 1|Family Emergency|0|||
131101786|NCT02074553|472001280|FG003|Intervention Period 1|Family Emergency|1|||
131101787|NCT02074553|472001281|FG004|Intervention Period 1|Family Emergency|0|||
131101788|NCT02074553|472001282|FG005|Intervention Period 1|Family Emergency|0|||
131101789|NCT02074553|472001283|FG006|Intervention Period 1|Family Emergency|0|||
131101790|NCT02074553|472001284|FG007|Intervention Period 1|Family Emergency|0|||
131101791|NCT02074553|472001277|FG000|Washout Period 1|Adverse Event|1|||
131101792|NCT02074553|472001278|FG001|Washout Period 1|Adverse Event|0|||
131101793|NCT02074553|472001279|FG002|Washout Period 1|Adverse Event|0|||
130885407|NCT00775190|471215189|FG001|Overall Study|Withdrawal by Subject|2|||
131101794|NCT02074553|472001280|FG003|Washout Period 1|Adverse Event|0|||
131101795|NCT02074553|472001281|FG004|Washout Period 1|Adverse Event|0|||
131101796|NCT02074553|472001282|FG005|Washout Period 1|Adverse Event|0|||
131101797|NCT02074553|472001283|FG006|Washout Period 1|Adverse Event|0|||
130678885|NCT03049488|470450877|FG002|Overall Study|Withdrawal by Subject|0|||
130678886|NCT03049488|470450878|FG003|Overall Study|Withdrawal by Subject|1|||
131222591|NCT01902134|472443117|FG004|Overall Study|Physician Decision|0|||
130678887|NCT03049488|470450879|FG004|Overall Study|Withdrawal by Subject|1|||
130678888|NCT03049488|470450880|FG005|Overall Study|Withdrawal by Subject|0|||
130678889|NCT00891293|470450881|FG000|Overall Study|Adverse Event|2|||
130678890|NCT00891293|470450881|FG000|Overall Study|Protocol Violation|2|||
130678891|NCT00891293|470450881|FG000|Overall Study|Laboratory abnormality|4|||
130678892|NCT00891293|470450881|FG000|Overall Study|Lost to Follow-up|7|||
130678893|NCT00891293|470450881|FG000|Overall Study|Subject withdrew consent|7|||
131101798|NCT02074553|472001284|FG007|Washout Period 1|Adverse Event|0|||
131101799|NCT02074553|472001277|FG000|Washout Period 1|Physician Decision|0|||
131101800|NCT02074553|472001278|FG001|Washout Period 1|Physician Decision|0|||
131101801|NCT02074553|472001279|FG002|Washout Period 1|Physician Decision|0|||
130678894|NCT00891293|470450881|FG000|Overall Study|Sponsor termination|62|||
131101802|NCT02074553|472001280|FG003|Washout Period 1|Physician Decision|1|||
131101803|NCT02074553|472001281|FG004|Washout Period 1|Physician Decision|0|||
131101804|NCT02074553|472001282|FG005|Washout Period 1|Physician Decision|0|||
131101805|NCT02074553|472001283|FG006|Washout Period 1|Physician Decision|0|||
131101806|NCT02074553|472001284|FG007|Washout Period 1|Physician Decision|0|||
131101807|NCT02074553|472001277|FG000|Washout Period 1|Other|0|||
131101808|NCT02074553|472001278|FG001|Washout Period 1|Other|0|||
131101809|NCT02074553|472001279|FG002|Washout Period 1|Other|0|||
131101810|NCT02074553|472001280|FG003|Washout Period 1|Other|0|||
131101811|NCT02074553|472001281|FG004|Washout Period 1|Other|0|||
131101812|NCT02074553|472001282|FG005|Washout Period 1|Other|1|||
131101813|NCT02074553|472001283|FG006|Washout Period 1|Other|0|||
131101814|NCT02074553|472001284|FG007|Washout Period 1|Other|0|||
131101815|NCT02074553|472001277|FG000|Washout Period 2|Adverse Event|0|||
131101816|NCT02074553|472001278|FG001|Washout Period 2|Adverse Event|0|||
131101817|NCT02074553|472001279|FG002|Washout Period 2|Adverse Event|0|||
131101818|NCT02074553|472001280|FG003|Washout Period 2|Adverse Event|0|||
131101819|NCT02074553|472001281|FG004|Washout Period 2|Adverse Event|0|||
131101820|NCT02074553|472001282|FG005|Washout Period 2|Adverse Event|0|||
131101821|NCT02074553|472001283|FG006|Washout Period 2|Adverse Event|1|||
131101822|NCT02074553|472001284|FG007|Washout Period 2|Adverse Event|0|||
131101823|NCT02074553|472001277|FG000|Washout Period 2|Physician Decision|0|||
131101824|NCT02074553|472001278|FG001|Washout Period 2|Physician Decision|0|||
131101825|NCT02074553|472001279|FG002|Washout Period 2|Physician Decision|0|||
131101826|NCT02074553|472001280|FG003|Washout Period 2|Physician Decision|0|||
131101827|NCT02074553|472001281|FG004|Washout Period 2|Physician Decision|0|||
131101828|NCT02074553|472001282|FG005|Washout Period 2|Physician Decision|1|||
131101829|NCT02074553|472001283|FG006|Washout Period 2|Physician Decision|0|||
131101830|NCT02074553|472001284|FG007|Washout Period 2|Physician Decision|0|||
131101831|NCT02074553|472001277|FG000|Washout Period 2|Lost to Follow-up|0|||
130678895|NCT01448057|470450882|FG000|Overall Study|Protocol Violation|3|||
130678896|NCT01448057|470450883|FG001|Overall Study|Protocol Violation|2|||
130678897|NCT01448057|470450882|FG000|Overall Study|Lost to Follow-up|3|||
130678898|NCT01448057|470450883|FG001|Overall Study|Lost to Follow-up|0|||
130678899|NCT01448057|470450882|FG000|Overall Study|Adverse Event|0|||
130678900|NCT01448057|470450883|FG001|Overall Study|Adverse Event|2|||
130678901|NCT01448057|470450882|FG000|Overall Study|Withdrawal by Subject|2|||
130678902|NCT01448057|470450883|FG001|Overall Study|Withdrawal by Subject|0|||
130678903|NCT03883906|470450887|FG000|Overall Study|Withdrawal by Subject|2|||
130678904|NCT03883906|470450887|FG000|Overall Study|Physician Decision|5|||
130678905|NCT00486837|470450888|FG000|Overall Study|Withdrawal by Subject|1|||
130678906|NCT00486837|470450889|FG001|Overall Study|Withdrawal by Subject|0|||
131015111|NCT03020745|471684970|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
131015112|NCT03020745|471684971|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
131015113|NCT03020745|471684972|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
131015114|NCT03020745|471684973|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
131015115|NCT03020745|471684974|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
131015116|NCT03020745|471684975|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
131015117|NCT03020745|471684966|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131015118|NCT03020745|471684967|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131015119|NCT03020745|471684968|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131015120|NCT03020745|471684969|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131015121|NCT03020745|471684970|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131015122|NCT03020745|471684971|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131015123|NCT03020745|471684972|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131015124|NCT03020745|471684973|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
131015125|NCT03020745|471684974|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131015126|NCT03020745|471684975|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
131015127|NCT03020745|471684966|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131015128|NCT03020745|471684967|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131015129|NCT03020745|471684968|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131015130|NCT03020745|471684969|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131015131|NCT03020745|471684970|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131015132|NCT03020745|471684971|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
131015133|NCT03020745|471684972|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131015134|NCT03020745|471684973|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131015135|NCT03020745|471684974|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
131015136|NCT03020745|471684975|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
131101832|NCT02074553|472001278|FG001|Washout Period 2|Lost to Follow-up|0|||
131101833|NCT02074553|472001279|FG002|Washout Period 2|Lost to Follow-up|1|||
131101834|NCT02074553|472001280|FG003|Washout Period 2|Lost to Follow-up|0|||
131101835|NCT02074553|472001281|FG004|Washout Period 2|Lost to Follow-up|0|||
131101836|NCT02074553|472001282|FG005|Washout Period 2|Lost to Follow-up|0|||
131101837|NCT02074553|472001283|FG006|Washout Period 2|Lost to Follow-up|0|||
130678907|NCT00486837|470450888|FG000|Overall Study|Adverse Event|1|||
130678908|NCT00486837|470450889|FG001|Overall Study|Adverse Event|1|||
130678909|NCT00486837|470450888|FG000|Overall Study|Protocol Violation|4|||
130678910|NCT00486837|470450889|FG001|Overall Study|Protocol Violation|2|||
130678911|NCT00486837|470450888|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
130678912|NCT00486837|470450889|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
130678913|NCT00796822|470450899|FG000|Overall Study|Lost to Follow-up|2|||
130678914|NCT00796822|470450900|FG001|Overall Study|Lost to Follow-up|0|||
130678915|NCT00796822|470450899|FG000|Overall Study|Adverse Event|1|||
130678916|NCT00796822|470450900|FG001|Overall Study|Adverse Event|0|||
130678917|NCT00906347|470450901|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
130678918|NCT00906347|470450902|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
130678919|NCT00906347|470450901|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
130678920|NCT00906347|470450902|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
130678921|NCT00906347|470450901|FG000|Received Study Drug|Refused study drug|1|||
130678922|NCT00906347|470450902|FG001|Received Study Drug|Refused study drug|0|||
131101838|NCT02074553|472001284|FG007|Washout Period 2|Lost to Follow-up|0|||
131101839|NCT02074553|472001277|FG000|Washout Period 3|Physician Decision|0|||
131101840|NCT02074553|472001278|FG001|Washout Period 3|Physician Decision|0|||
130678923|NCT00906347|470450901|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
130678924|NCT00906347|470450902|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
130678925|NCT00680121|470450904|FG000|Overall Study|Lost to Follow-up|27|||
130678926|NCT00680121|470450905|FG001|Overall Study|Lost to Follow-up|23|||
131015137|NCT03020745|471684966|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131015138|NCT03020745|471684967|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131015139|NCT03020745|471684968|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131015140|NCT03020745|471684969|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131015141|NCT03020745|471684970|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131015142|NCT03020745|471684971|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131015143|NCT03020745|471684972|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131015144|NCT03020745|471684973|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131015145|NCT03020745|471684974|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
131015146|NCT03020745|471684975|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
131015147|NCT03923491|471684978|FG000|Overall Study|Lost to Follow-up|5|||
131015148|NCT03923491|471684979|FG001|Overall Study|Lost to Follow-up|8|||
131015149|NCT03923491|471684978|FG000|Overall Study|Withdrawal by Subject|4|||
131015150|NCT03923491|471684979|FG001|Overall Study|Withdrawal by Subject|6|||
131015151|NCT03823300|471684982|FG000|Overall Study|Withdrawal by Subject|16|||
131015152|NCT03823300|471684983|FG001|Overall Study|Withdrawal by Subject|22|||
131015153|NCT03823300|471684982|FG000|Overall Study|Death|10|||
131015154|NCT03823300|471684983|FG001|Overall Study|Death|14|||
131015155|NCT03823300|471684982|FG000|Overall Study|Adverse Event|3|||
131015156|NCT03823300|471684983|FG001|Overall Study|Adverse Event|5|||
131015157|NCT03823300|471684982|FG000|Overall Study|Physician Decision|1|||
131015158|NCT03823300|471684983|FG001|Overall Study|Physician Decision|7|||
131015159|NCT03823300|471684982|FG000|Overall Study|Lost to Follow-up|1|||
131015160|NCT03823300|471684983|FG001|Overall Study|Lost to Follow-up|3|||
131015161|NCT03823300|471684982|FG000|Overall Study|Protocol Violation|1|||
131015162|NCT03823300|471684983|FG001|Overall Study|Protocol Violation|1|||
131015163|NCT03823300|471684982|FG000|Overall Study|Lack of Efficacy|1|||
131015164|NCT03823300|471684983|FG001|Overall Study|Lack of Efficacy|1|||
131015165|NCT03823300|471684982|FG000|Overall Study|Not Eligible|0|||
131015166|NCT03823300|471684983|FG001|Overall Study|Not Eligible|1|||
131015167|NCT03823300|471684982|FG000|Overall Study|Other|1|||
131015168|NCT03823300|471684983|FG001|Overall Study|Other|0|||
131015169|NCT00753012|471684986|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
131015170|NCT00753012|471684987|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
131015171|NCT00753012|471684986|FG000|Overall Study|Adverse Event|2|||
131015172|NCT00753012|471684987|FG001|Overall Study|Adverse Event|0|||
131015173|NCT00753012|471684986|FG000|Overall Study|Withdrawal by Subject|0|||
131015174|NCT00753012|471684987|FG001|Overall Study|Withdrawal by Subject|1|||
131015175|NCT00753012|471684986|FG000|Overall Study|Lost to Follow-up|4|||
131015176|NCT00753012|471684987|FG001|Overall Study|Lost to Follow-up|0|||
131015177|NCT00753012|471684986|FG000|Overall Study|Confounded endpoint data|1|||
131015178|NCT00753012|471684987|FG001|Overall Study|Confounded endpoint data|0|||
131015179|NCT00241644|471684990|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
131015180|NCT00241644|471684991|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
131015181|NCT00241644|471684992|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
131015182|NCT00241644|471684993|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
131015183|NCT00241644|471684990|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
131015184|NCT00241644|471684991|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
131015185|NCT00241644|471684992|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
131015186|NCT00241644|471684993|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
130678927|NCT02603952|470450908|FG000|Overall Study|Withdrawal by Subject|1|||
130678928|NCT02603952|470450909|FG001|Overall Study|Withdrawal by Subject|0|||
130678929|NCT02603952|470450910|FG002|Overall Study|Withdrawal by Subject|0|||
130678930|NCT02603952|470450911|FG003|Overall Study|Withdrawal by Subject|0|||
130678931|NCT02603952|470450908|FG000|Overall Study|Received oseltamivir by error|0|||
130678932|NCT02603952|470450909|FG001|Overall Study|Received oseltamivir by error|0|||
130678933|NCT02603952|470450910|FG002|Overall Study|Received oseltamivir by error|0|||
130678934|NCT02603952|470450911|FG003|Overall Study|Received oseltamivir by error|1|||
130678935|NCT00577460|470450914|FG000|Overall Study|Adverse Event|11|||
130678936|NCT00577460|470450915|FG001|Overall Study|Adverse Event|7|||
130678937|NCT00577460|470450916|FG002|Overall Study|Adverse Event|14|||
130678938|NCT00577460|470450914|FG000|Overall Study|Protocol Violation|0|||
130678939|NCT00577460|470450915|FG001|Overall Study|Protocol Violation|1|||
130678940|NCT00577460|470450916|FG002|Overall Study|Protocol Violation|1|||
130678941|NCT00577460|470450914|FG000|Overall Study|Lost to Follow-up|0|||
130678942|NCT00577460|470450915|FG001|Overall Study|Lost to Follow-up|3|||
130678943|NCT00577460|470450916|FG002|Overall Study|Lost to Follow-up|4|||
130678944|NCT00577460|470450914|FG000|Overall Study|Withdrawal by Subject|5|||
130678945|NCT00577460|470450915|FG001|Overall Study|Withdrawal by Subject|5|||
130678946|NCT00577460|470450916|FG002|Overall Study|Withdrawal by Subject|6|||
131101841|NCT02074553|472001279|FG002|Washout Period 3|Physician Decision|0|||
131101842|NCT02074553|472001280|FG003|Washout Period 3|Physician Decision|0|||
131101843|NCT02074553|472001281|FG004|Washout Period 3|Physician Decision|0|||
131101844|NCT02074553|472001282|FG005|Washout Period 3|Physician Decision|0|||
131101845|NCT02074553|472001283|FG006|Washout Period 3|Physician Decision|0|||
131101846|NCT02074553|472001284|FG007|Washout Period 3|Physician Decision|1|||
131101847|NCT01658150|472001285|FG000|Overall Study|Withdrawal by Subject|1|||
131101848|NCT02342743|472001286|FG000|Baseline Period|Withdrawal by Subject|3|||
131101849|NCT02342743|472001286|FG000|Baseline Period|Lost to Follow-up|2|||
131101850|NCT02342743|472001286|FG000|Baseline Period|Change in prophylactic medication|3|||
131101851|NCT02342743|472001286|FG000|Baseline Period|Screening failure regarding baseline|7|||
131101852|NCT02342743|472001286|FG000|Treatment Period|Withdrawal by Subject|2|||
131101853|NCT02342743|472001286|FG000|Treatment Period|Lost to Follow-up|8|||
131101854|NCT02342743|472001286|FG000|Treatment Period|Change in prophylactic medication|1|||
131101855|NCT04875676|472001287|FG000|Overall Study|Lost to Follow-up|1|||
131101856|NCT04875676|472001288|FG001|Overall Study|Lost to Follow-up|0|||
131101857|NCT04875676|472001289|FG002|Overall Study|Lost to Follow-up|0|||
131101858|NCT04187989|472001290|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
131101859|NCT04187989|472001291|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
131101860|NCT04187989|472001290|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
131101861|NCT04187989|472001291|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
131101862|NCT03602066|472001292|FG000|Overall Study|Withdrawal by Subject|2|||
131101863|NCT03602066|472001293|FG001|Overall Study|Withdrawal by Subject|0|||
131101864|NCT03602066|472001292|FG000|Overall Study|Physician Decision|1|||
131101865|NCT03602066|472001293|FG001|Overall Study|Physician Decision|0|||
131101866|NCT03646656|472001294|FG000|Overall Study|Lost to Follow-up|1|||
131101867|NCT03646656|472001295|FG001|Overall Study|Lost to Follow-up|0|||
131101868|NCT03646656|472001294|FG000|Overall Study|Withdrawal by Subject|2|||
131101869|NCT03646656|472001295|FG001|Overall Study|Withdrawal by Subject|0|||
131101870|NCT00092495|472001296|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
131101871|NCT00092495|472001297|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
130678947|NCT00577460|470450914|FG000|Overall Study|Other|0|||
130678948|NCT00577460|470450915|FG001|Overall Study|Other|3|||
130678949|NCT00577460|470450916|FG002|Overall Study|Other|2|||
130678950|NCT01318499|470450917|FG000|Overall Study|Adverse Event|16|||
130678951|NCT01318499|470450918|FG001|Overall Study|Adverse Event|11|||
130678952|NCT01318499|470450919|FG002|Overall Study|Adverse Event|6|||
130678953|NCT01318499|470450917|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
130678954|NCT01318499|470450918|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
130678955|NCT01318499|470450919|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
130678956|NCT01318499|470450917|FG000|Overall Study|Noncompliance|2|||
130678957|NCT01318499|470450918|FG001|Overall Study|Noncompliance|3|||
130678958|NCT01318499|470450919|FG002|Overall Study|Noncompliance|0|||
130885408|NCT00775190|471215188|FG000|Overall Study|Protocol Violation|1|||
130885409|NCT00775190|471215189|FG001|Overall Study|Protocol Violation|0|||
130678959|NCT01318499|470450917|FG000|Overall Study|Treatment Failure|19|||
130678960|NCT01318499|470450918|FG001|Overall Study|Treatment Failure|19|||
130678961|NCT01318499|470450919|FG002|Overall Study|Treatment Failure|101|||
130678962|NCT01318499|470450917|FG000|Overall Study|Protocol Violation|2|||
130885410|NCT04610281|471215194|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
131101872|NCT00092495|472001298|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131101873|NCT00092495|472001299|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
131101874|NCT00092495|472001300|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131101875|NCT00092495|472001296|FG000|Base Study Vaccination Period|Extended|0|||
131101876|NCT00092495|472001297|FG001|Base Study Vaccination Period|Extended|0|||
131222592|NCT01902134|472443118|FG005|Overall Study|Physician Decision|0|||
130678963|NCT01318499|470450918|FG001|Overall Study|Protocol Violation|4|||
130678964|NCT01318499|470450919|FG002|Overall Study|Protocol Violation|2|||
130678965|NCT01318499|470450917|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
130678966|NCT01318499|470450918|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
130678967|NCT01318499|470450919|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
130678968|NCT01318499|470450917|FG000|Overall Study|Other|7|||
130678969|NCT01318499|470450918|FG001|Overall Study|Other|10|||
130678970|NCT01318499|470450919|FG002|Overall Study|Other|22|||
130678971|NCT01347710|470450923|FG000|Overall Study|Withdrawal by Subject|2|||
130678972|NCT01347710|470450923|FG000|Overall Study|Adverse Event|4|||
130678973|NCT01347710|470450923|FG000|Overall Study|Angio or SPECT not completed|18|||
130678974|NCT01347710|470450923|FG000|Overall Study|issue with vitals prior to dosing|1|||
130678975|NCT01347710|470450923|FG000|Overall Study|Lost to Follow-up|1|||
130678976|NCT01347710|470450923|FG000|Overall Study|Physician Decision|2|||
130678977|NCT01347710|470450923|FG000|Overall Study|Other|3|||
130678978|NCT04591626|470450924|FG000|Overall Study|Adverse Event|4|||
130678979|NCT04591626|470450925|FG001|Overall Study|Adverse Event|0|||
130678980|NCT04591626|470450924|FG000|Overall Study|Withdrawal by Subject|5|||
130678981|NCT04591626|470450925|FG001|Overall Study|Withdrawal by Subject|3|||
130678982|NCT04591626|470450924|FG000|Overall Study|Physician Decision|0|||
130678983|NCT04591626|470450925|FG001|Overall Study|Physician Decision|1|||
130678984|NCT04591626|470450924|FG000|Overall Study|Death|0|||
130678985|NCT04591626|470450925|FG001|Overall Study|Death|1|||
130678986|NCT04591626|470450924|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130678987|NCT04591626|470450925|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130678988|NCT02672553|470450927|FG000|Overall Study|Death|3|||
130678989|NCT02672553|470450928|FG001|Overall Study|Death|5|||
130678990|NCT02672553|470450927|FG000|Overall Study|Valve Explant|1|||
130678991|NCT02672553|470450928|FG001|Overall Study|Valve Explant|0|||
130678992|NCT02672553|470450927|FG000|Overall Study|Conversion to Commercial Valve|3|||
130678993|NCT02672553|470450928|FG001|Overall Study|Conversion to Commercial Valve|0|||
130678994|NCT02672553|470450927|FG000|Overall Study|Withdrawal by Subject|3|||
130678995|NCT02672553|470450928|FG001|Overall Study|Withdrawal by Subject|3|||
130678996|NCT02672553|470450927|FG000|Overall Study|Intraoperative screen failure|2|||
130678997|NCT02672553|470450928|FG001|Overall Study|Intraoperative screen failure|0|||
130678998|NCT01606306|470450929|FG000|Overall Study|Lack of Efficacy|2|||
130678999|NCT01606306|470450930|FG001|Overall Study|Lack of Efficacy|1|||
130679000|NCT01606306|470450931|FG002|Overall Study|Lack of Efficacy|4|||
130679001|NCT01606306|470450932|FG003|Overall Study|Lack of Efficacy|4|||
130679002|NCT01606306|470450933|FG004|Overall Study|Lack of Efficacy|1|||
130679003|NCT01606306|470450934|FG005|Overall Study|Lack of Efficacy|2|||
130679004|NCT01606306|470450929|FG000|Overall Study|Adverse Event|1|||
130679005|NCT01606306|470450930|FG001|Overall Study|Adverse Event|0|||
130679006|NCT01606306|470450931|FG002|Overall Study|Adverse Event|1|||
130679007|NCT01606306|470450932|FG003|Overall Study|Adverse Event|1|||
130679008|NCT01606306|470450933|FG004|Overall Study|Adverse Event|2|||
130679009|NCT01606306|470450934|FG005|Overall Study|Adverse Event|0|||
130679010|NCT01606306|470450929|FG000|Overall Study|Lost to Follow-up|7|||
130679011|NCT01606306|470450930|FG001|Overall Study|Lost to Follow-up|4|||
130679012|NCT01606306|470450931|FG002|Overall Study|Lost to Follow-up|5|||
130679013|NCT01606306|470450932|FG003|Overall Study|Lost to Follow-up|4|||
130679014|NCT01606306|470450933|FG004|Overall Study|Lost to Follow-up|3|||
130679015|NCT01606306|470450934|FG005|Overall Study|Lost to Follow-up|5|||
130679016|NCT01606306|470450929|FG000|Overall Study|Withdrawal by Subject|4|||
130679017|NCT01606306|470450930|FG001|Overall Study|Withdrawal by Subject|3|||
130679018|NCT01606306|470450931|FG002|Overall Study|Withdrawal by Subject|4|||
130679019|NCT01606306|470450932|FG003|Overall Study|Withdrawal by Subject|4|||
130679020|NCT01606306|470450933|FG004|Overall Study|Withdrawal by Subject|5|||
130679021|NCT01606306|470450934|FG005|Overall Study|Withdrawal by Subject|4|||
130679022|NCT01606306|470450929|FG000|Overall Study|Physician Decision|1|||
130679023|NCT01606306|470450930|FG001|Overall Study|Physician Decision|2|||
130679024|NCT01606306|470450931|FG002|Overall Study|Physician Decision|0|||
130679025|NCT01606306|470450932|FG003|Overall Study|Physician Decision|0|||
130679026|NCT01606306|470450933|FG004|Overall Study|Physician Decision|0|||
131015187|NCT00241644|471684990|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
130679027|NCT01606306|470450934|FG005|Overall Study|Physician Decision|0|||
130679028|NCT00408902|470450937|FG000|Overall Study|Lack of Efficacy|7|||
130679029|NCT00408902|470450937|FG000|Overall Study|Adverse Event|3|||
130679030|NCT00970281|470450938|FG000|Overall Study|Lack of Efficacy|1|||
130679031|NCT00970281|470450939|FG001|Overall Study|Lack of Efficacy|14|||
130679032|NCT00970281|470450938|FG000|Overall Study|Withdrawal by Subject|0|||
130679033|NCT00970281|470450939|FG001|Overall Study|Withdrawal by Subject|1|||
130679034|NCT00970281|470450938|FG000|Overall Study|Physician Decision|1|||
130679035|NCT00970281|470450939|FG001|Overall Study|Physician Decision|1|||
130679036|NCT00878995|470450942|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
130679037|NCT00878995|470450943|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
130679038|NCT00841100|470450944|FG000|Phase 1 (28 Days)|Adverse Event|1|||
130679039|NCT00841100|470450944|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
130679040|NCT03338972|470450945|FG000|Overall Study|Death|1|||
130679041|NCT03338972|470450946|FG001|Overall Study|Death|1|||
131015188|NCT00241644|471684991|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
131015189|NCT00241644|471684992|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
131015190|NCT00241644|471684993|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
131015191|NCT00241644|471684990|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
131015192|NCT00241644|471684991|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
131015193|NCT00241644|471684992|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
131015194|NCT00241644|471684993|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
131015195|NCT00241644|471684990|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
131015196|NCT00241644|471684991|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
131015197|NCT00241644|471684992|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
131015198|NCT00241644|471684993|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
131015199|NCT00241644|471684990|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
131015200|NCT00241644|471684991|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
131015201|NCT00241644|471684992|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
131015202|NCT00241644|471684993|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
131015203|NCT00241644|471684990|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
131015204|NCT00241644|471684991|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
131015205|NCT00241644|471684992|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
131015206|NCT00241644|471684993|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
131015207|NCT00241644|471684990|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
131015208|NCT00241644|471684991|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
131015209|NCT00241644|471684992|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
131015210|NCT00241644|471684993|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
131015211|NCT00241644|471684990|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
131015212|NCT00241644|471684991|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
131015213|NCT00241644|471684992|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
131015214|NCT00241644|471684993|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
131015215|NCT00241644|471684990|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
131015216|NCT00241644|471684991|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
131015217|NCT00241644|471684992|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
131015218|NCT00241644|471684993|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
131015219|NCT00241644|471684990|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
131015220|NCT00241644|471684991|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
131015221|NCT00241644|471684992|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
131015222|NCT00241644|471684993|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
131015223|NCT00241644|471684990|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
131015224|NCT00241644|471684991|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
131015225|NCT00241644|471684992|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
131015226|NCT00241644|471684993|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
131015227|NCT00241644|471684990|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
131015228|NCT00241644|471684991|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
131015229|NCT00241644|471684992|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
131015230|NCT00241644|471684993|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
131015231|NCT00943735|471684994|FG000|Overall Study|Adverse Event|12|||
131015232|NCT00943735|471684994|FG000|Overall Study|Withdrawal by Subject|8|||
131015233|NCT00943735|471684994|FG000|Overall Study|Death|1|||
131015234|NCT00943735|471684994|FG000|Overall Study|Other|8|||
131015235|NCT00943735|471684994|FG000|Overall Study|Other|3|||
131015236|NCT03804918|471684995|FG000|Overall Study|Participant did not use the app|1|||
131015237|NCT01329328|471684996|FG000|Overall Study|Withdrawal by Subject|2|||
131015238|NCT01329328|471684997|FG001|Overall Study|Withdrawal by Subject|4|||
131015239|NCT01329328|471684998|FG002|Overall Study|Withdrawal by Subject|3|||
131015240|NCT00964366|471685000|FG000|Overall Study|Did not qualify at Day 1|1|||
131015241|NCT00964366|471685001|FG001|Overall Study|Did not qualify at Day 1|0|||
131015242|NCT00964366|471685000|FG000|Overall Study|Withdrawal by Subject|0|||
131015243|NCT00964366|471685001|FG001|Overall Study|Withdrawal by Subject|1|||
131015244|NCT01370694|471685002|FG000|Overall Study|Switched to rituximab|4|||
131015245|NCT01370694|471685002|FG000|Overall Study|Progressive disease|2|||
131015246|NCT02393716|471685003|FG000|Overall Study|Death|29|||
131015247|NCT02393716|471685003|FG000|Overall Study|Withdrawal by Subject|8|||
131015248|NCT02393716|471685003|FG000|Overall Study|Device Explanted|8|||
131015249|NCT02393716|471685003|FG000|Overall Study|Missed visit|16|||
131015250|NCT02957539|471685004|FG000|Baseline to Week 16|Lost to Follow-up|8|||
131015251|NCT02957539|471685005|FG001|Baseline to Week 16|Lost to Follow-up|10|||
131015252|NCT02957539|471685006|FG002|Baseline to Week 16|Lost to Follow-up|16|||
131015253|NCT02957539|471685004|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
130679042|NCT03338972|470450947|FG002|Overall Study|Death|0|||
131015254|NCT02957539|471685005|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
131101877|NCT00092495|472001298|FG002|Base Study Vaccination Period|Extended|0|||
131101878|NCT00092495|472001299|FG003|Base Study Vaccination Period|Extended|1|||
131101879|NCT00092495|472001300|FG004|Base Study Vaccination Period|Extended|0|||
131101880|NCT00092495|472001296|FG000|Base Study Vaccination Period|*Clinical AE|1|||
131101881|NCT00092495|472001297|FG001|Base Study Vaccination Period|*Clinical AE|0|||
131101882|NCT00092495|472001298|FG002|Base Study Vaccination Period|*Clinical AE|1|||
131101883|NCT00092495|472001299|FG003|Base Study Vaccination Period|*Clinical AE|2|||
131101884|NCT00092495|472001300|FG004|Base Study Vaccination Period|*Clinical AE|0|||
131101885|NCT00092495|472001296|FG000|Base Study Vaccination Period|*Other reasons|1|||
131101886|NCT00092495|472001297|FG001|Base Study Vaccination Period|*Other reasons|0|||
131101887|NCT00092495|472001298|FG002|Base Study Vaccination Period|*Other reasons|0|||
131101888|NCT00092495|472001299|FG003|Base Study Vaccination Period|*Other reasons|1|||
131101889|NCT00092495|472001300|FG004|Base Study Vaccination Period|*Other reasons|0|||
131101890|NCT00092495|472001296|FG000|Base Study Vaccination Period|*Pregnancy|0|||
131101891|NCT00092495|472001297|FG001|Base Study Vaccination Period|*Pregnancy|2|||
131101892|NCT00092495|472001298|FG002|Base Study Vaccination Period|*Pregnancy|5|||
131101893|NCT00092495|472001299|FG003|Base Study Vaccination Period|*Pregnancy|7|||
131101894|NCT00092495|472001300|FG004|Base Study Vaccination Period|*Pregnancy|0|||
131101895|NCT00092495|472001296|FG000|Base Study Vaccination Period|Adverse Event|1|||
131101896|NCT00092495|472001297|FG001|Base Study Vaccination Period|Adverse Event|0|||
131101897|NCT00092495|472001298|FG002|Base Study Vaccination Period|Adverse Event|0|||
131101898|NCT00092495|472001299|FG003|Base Study Vaccination Period|Adverse Event|3|||
131101899|NCT00092495|472001300|FG004|Base Study Vaccination Period|Adverse Event|0|||
131101900|NCT00092495|472001296|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
131101901|NCT00092495|472001297|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
131101902|NCT00092495|472001298|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
130679043|NCT03338972|470450948|FG003|Overall Study|Death|0|||
130679044|NCT03338972|470450945|FG000|Overall Study|Withdrawal by Subject|1|||
131101903|NCT00092495|472001299|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
131101904|NCT00092495|472001300|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
131101905|NCT00092495|472001296|FG000|Base Study Vaccination Period|Moved|3|||
131101906|NCT00092495|472001297|FG001|Base Study Vaccination Period|Moved|1|||
131101907|NCT00092495|472001298|FG002|Base Study Vaccination Period|Moved|2|||
131101908|NCT00092495|472001299|FG003|Base Study Vaccination Period|Moved|2|||
131101909|NCT00092495|472001300|FG004|Base Study Vaccination Period|Moved|0|||
131101910|NCT00092495|472001296|FG000|Base Study Vaccination Period|Other|1|||
131101911|NCT00092495|472001297|FG001|Base Study Vaccination Period|Other|1|||
131101912|NCT00092495|472001298|FG002|Base Study Vaccination Period|Other|0|||
131101913|NCT00092495|472001299|FG003|Base Study Vaccination Period|Other|2|||
131101914|NCT00092495|472001300|FG004|Base Study Vaccination Period|Other|0|||
131101915|NCT00092495|472001296|FG000|Base Study Vaccination Period|Pregnancy|2|||
131101916|NCT00092495|472001297|FG001|Base Study Vaccination Period|Pregnancy|0|||
131101917|NCT00092495|472001298|FG002|Base Study Vaccination Period|Pregnancy|0|||
131101918|NCT00092495|472001299|FG003|Base Study Vaccination Period|Pregnancy|0|||
131101919|NCT00092495|472001300|FG004|Base Study Vaccination Period|Pregnancy|0|||
131101920|NCT00092495|472001296|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
131101921|NCT00092495|472001297|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
131101922|NCT00092495|472001298|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
131101923|NCT00092495|472001299|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
131101924|NCT00092495|472001300|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
131101925|NCT00092495|472001296|FG000|Base Study Vaccination Period|Protocol Violation|1|||
130679045|NCT03338972|470450946|FG001|Overall Study|Withdrawal by Subject|0|||
130679046|NCT03338972|470450947|FG002|Overall Study|Withdrawal by Subject|0|||
130679047|NCT03338972|470450948|FG003|Overall Study|Withdrawal by Subject|0|||
130679048|NCT01355081|470450949|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
130679049|NCT01355081|470450950|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
130679050|NCT01355081|470450951|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
130679051|NCT01355081|470450949|FG000|Overall Study|Major Protocol Deviation|0|||
131101926|NCT00092495|472001297|FG001|Base Study Vaccination Period|Protocol Violation|0|||
131101927|NCT00092495|472001298|FG002|Base Study Vaccination Period|Protocol Violation|0|||
131101928|NCT00092495|472001299|FG003|Base Study Vaccination Period|Protocol Violation|0|||
131101929|NCT00092495|472001300|FG004|Base Study Vaccination Period|Protocol Violation|0|||
131101930|NCT00092495|472001296|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
131101931|NCT00092495|472001297|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
130679052|NCT01355081|470450950|FG001|Overall Study|Major Protocol Deviation|1|||
130679053|NCT01355081|470450951|FG002|Overall Study|Major Protocol Deviation|0|||
130679054|NCT01355081|470450949|FG000|Overall Study|Lost to Follow-up|0|||
130679055|NCT01355081|470450950|FG001|Overall Study|Lost to Follow-up|0|||
131101932|NCT00092495|472001298|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
131101933|NCT00092495|472001299|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
131101934|NCT00092495|472001300|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
131101935|NCT00092495|472001296|FG000|Base Study Follow-up Period|Extended|0|||
130679056|NCT01355081|470450951|FG002|Overall Study|Lost to Follow-up|1|||
130679057|NCT01355081|470450949|FG000|Overall Study|Withdrawal of Consent|2|||
130679058|NCT01355081|470450950|FG001|Overall Study|Withdrawal of Consent|3|||
130679059|NCT01355081|470450951|FG002|Overall Study|Withdrawal of Consent|3|||
131015255|NCT02957539|471685006|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
131015256|NCT02957539|471685004|FG000|Week 16 to 32|Withdrawal by Subject|3|||
131015257|NCT02957539|471685005|FG001|Week 16 to 32|Withdrawal by Subject|3|||
131015258|NCT02957539|471685006|FG002|Week 16 to 32|Withdrawal by Subject|1|||
131015259|NCT02957539|471685004|FG000|Week 16 to 32|Lost to Follow-up|8|||
131015260|NCT02957539|471685005|FG001|Week 16 to 32|Lost to Follow-up|7|||
131015261|NCT02957539|471685006|FG002|Week 16 to 32|Lost to Follow-up|5|||
131015262|NCT02957539|471685004|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
131015263|NCT02957539|471685005|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
131015264|NCT02957539|471685006|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
131015265|NCT02957539|471685004|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
131015266|NCT02957539|471685005|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
131015267|NCT02957539|471685006|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
131015268|NCT04842604|471685009|FG000|Overall Study|Death|1|||
131015269|NCT04842604|471685010|FG001|Overall Study|Death|0|||
131015270|NCT04842604|471685009|FG000|Overall Study|Other|4|||
131015271|NCT04842604|471685010|FG001|Overall Study|Other|4|||
131015272|NCT04842604|471685009|FG000|Overall Study|Randomized but not treated|1|||
131015273|NCT04842604|471685010|FG001|Overall Study|Randomized but not treated|0|||
131015274|NCT01193153|471685011|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
131015275|NCT01193153|471685012|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
131015276|NCT01193153|471685011|FG000|Open-label Lead in Period|Pregnancy|1|||
131015277|NCT01193153|471685012|FG001|Open-label Lead in Period|Pregnancy|0|||
131015278|NCT01193153|471685011|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
131015279|NCT01193153|471685012|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
131015280|NCT01193153|471685011|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
131015281|NCT01193153|471685012|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
131015282|NCT01193153|471685011|FG000|Open-label Lead in Period|Other|14|||
131015283|NCT01193153|471685012|FG001|Open-label Lead in Period|Other|0|||
131015284|NCT01193153|471685011|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
131015285|NCT01193153|471685012|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
131015286|NCT01193153|471685011|FG000|Open-label Lead in Period|Adverse Event|41|||
131015287|NCT01193153|471685012|FG001|Open-label Lead in Period|Adverse Event|0|||
131015288|NCT01193153|471685011|FG000|Open-label Lead in Period|Death|1|||
131015289|NCT01193153|471685012|FG001|Open-label Lead in Period|Death|0|||
131015290|NCT01193153|471685011|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
131015291|NCT01193153|471685012|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
131015292|NCT01193153|471685011|FG000|Open-label Stabilization Period|Adverse Event|9|||
131015293|NCT01193153|471685012|FG001|Open-label Stabilization Period|Adverse Event|0|||
131015294|NCT01193153|471685011|FG000|Open-label Stabilization Period|Death|2|||
131015295|NCT01193153|471685012|FG001|Open-label Stabilization Period|Death|0|||
131015296|NCT01193153|471685011|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
131015297|NCT01193153|471685012|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
131015298|NCT01193153|471685011|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
131015299|NCT01193153|471685012|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
131015300|NCT01193153|471685011|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
131015301|NCT01193153|471685012|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
131015302|NCT01193153|471685011|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
131015303|NCT01193153|471685012|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
131015304|NCT01193153|471685011|FG000|Open-label Stabilization Period|Other|8|||
131015305|NCT01193153|471685012|FG001|Open-label Stabilization Period|Other|0|||
131015306|NCT01193153|471685011|FG000|Double Blind Relapse Prevention Period|Other|2|||
131015307|NCT01193153|471685012|FG001|Double Blind Relapse Prevention Period|Other|3|||
131015308|NCT01193153|471685011|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
131015309|NCT01193153|471685012|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
131015310|NCT01193153|471685011|FG000|Double Blind Relapse Prevention Period|Death|2|||
131015311|NCT01193153|471685012|FG001|Double Blind Relapse Prevention Period|Death|0|||
131015312|NCT01193153|471685011|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
131015313|NCT01193153|471685012|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
130679060|NCT01355081|470450949|FG000|Overall Study|Lack of Efficacy|2|||
130679061|NCT01355081|470450950|FG001|Overall Study|Lack of Efficacy|1|||
131015314|NCT01193153|471685011|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
131015315|NCT01193153|471685012|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
131015316|NCT01193153|471685011|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
131015317|NCT01193153|471685012|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
131015318|NCT01193153|471685011|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
130679062|NCT01355081|470450951|FG002|Overall Study|Lack of Efficacy|1|||
130679063|NCT01355081|470450949|FG000|Overall Study|Non Compliance with Study Medication|0|||
131101936|NCT00092495|472001297|FG001|Base Study Follow-up Period|Extended|0|||
131101937|NCT00092495|472001298|FG002|Base Study Follow-up Period|Extended|1|||
131101938|NCT00092495|472001299|FG003|Base Study Follow-up Period|Extended|2|||
131101939|NCT00092495|472001300|FG004|Base Study Follow-up Period|Extended|0|||
131101940|NCT00092495|472001296|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
131101941|NCT00092495|472001297|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
131101942|NCT00092495|472001298|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
131101943|NCT00092495|472001299|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
131101944|NCT00092495|472001300|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
131101945|NCT00092495|472001296|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
131101946|NCT00092495|472001297|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
131101947|NCT00092495|472001298|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
131101948|NCT00092495|472001299|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
131101949|NCT00092495|472001300|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
131101950|NCT00938470|472001307|FG000|Overall Study|Disease Progression|3|||
131101951|NCT00938470|472001308|FG001|Overall Study|Disease Progression|0|||
131101952|NCT00938470|472001307|FG000|Overall Study|Alternate Treatment|1|||
131101953|NCT00938470|472001308|FG001|Overall Study|Alternate Treatment|0|||
131101954|NCT00938470|472001307|FG000|Overall Study|Death|3|||
131101955|NCT00938470|472001308|FG001|Overall Study|Death|2|||
131101956|NCT00938470|472001307|FG000|Overall Study|Other Reason|0|||
131101957|NCT00938470|472001308|FG001|Overall Study|Other Reason|1|||
131101958|NCT00309959|472001313|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
131101959|NCT01004848|472001314|FG000|Overall Study|Lost to Follow-up|55|||
131101960|NCT01004848|472001315|FG001|Overall Study|Lost to Follow-up|45|||
131101961|NCT00495586|472001316|FG000|Overall Study|Withdrawal by Subject|4|||
131101962|NCT00495586|472001317|FG001|Overall Study|Withdrawal by Subject|4|||
131101963|NCT00964886|472001318|FG000|Overall Study|Lost to Follow-up|2|||
131101964|NCT00964886|472001319|FG001|Overall Study|Lost to Follow-up|2|||
131101965|NCT00964886|472001320|FG002|Overall Study|Lost to Follow-up|6|||
131101966|NCT00964886|472001321|FG003|Overall Study|Lost to Follow-up|4|||
131101967|NCT00964886|472001318|FG000|Overall Study|Withdrawal by Subject|6|||
131101968|NCT00964886|472001319|FG001|Overall Study|Withdrawal by Subject|2|||
131101969|NCT00964886|472001320|FG002|Overall Study|Withdrawal by Subject|5|||
131101970|NCT00964886|472001321|FG003|Overall Study|Withdrawal by Subject|3|||
131101971|NCT00964886|472001318|FG000|Overall Study|Adverse Event|3|||
131101972|NCT00964886|472001319|FG001|Overall Study|Adverse Event|1|||
131101973|NCT00964886|472001320|FG002|Overall Study|Adverse Event|5|||
131101974|NCT00964886|472001321|FG003|Overall Study|Adverse Event|2|||
131101975|NCT00964886|472001318|FG000|Overall Study|Protocol Violation|0|||
131101976|NCT00964886|472001319|FG001|Overall Study|Protocol Violation|2|||
131101977|NCT00964886|472001320|FG002|Overall Study|Protocol Violation|0|||
131101978|NCT00964886|472001321|FG003|Overall Study|Protocol Violation|0|||
131101979|NCT01621568|472001323|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
131101980|NCT01621568|472001324|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
131101981|NCT01621568|472001323|FG000|Week 5-6 No Treatment|Death|1|||
131101982|NCT01621568|472001324|FG001|Week 5-6 No Treatment|Death|0|||
131101983|NCT02334423|472001325|FG000|Overall Study|Protocol Violation|10|||
131101984|NCT02334423|472001326|FG001|Overall Study|Protocol Violation|3|||
131101985|NCT02930226|472001327|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
131101986|NCT02930226|472001328|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
131101987|NCT02930226|472001329|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
131101988|NCT02930226|472001330|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
131101989|NCT02930226|472001331|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
131101990|NCT02930226|472001332|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
131101991|NCT00652327|472001333|FG000|Overall Study|Adverse Event|0|||
131101992|NCT00652327|472001334|FG001|Overall Study|Adverse Event|2|||
131101993|NCT00652327|472001333|FG000|Overall Study|Lost to Follow-up|0|||
131101994|NCT00652327|472001334|FG001|Overall Study|Lost to Follow-up|3|||
131101995|NCT01076647|472001335|FG000|Overall Study|Adverse Event|4|||
131101996|NCT01076647|472001336|FG001|Overall Study|Adverse Event|1|||
130679064|NCT01355081|470450950|FG001|Overall Study|Non Compliance with Study Medication|1|||
130679065|NCT01355081|470450951|FG002|Overall Study|Non Compliance with Study Medication|0|||
130679066|NCT02480764|470450952|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
131101997|NCT01076647|472001335|FG000|Overall Study|Lack of Efficacy|0|||
131101998|NCT01076647|472001336|FG001|Overall Study|Lack of Efficacy|1|||
131101999|NCT01076647|472001335|FG000|Overall Study|Protocol Violation|7|||
131102000|NCT01076647|472001336|FG001|Overall Study|Protocol Violation|9|||
131102001|NCT01076647|472001335|FG000|Overall Study|Withdrawal criteria|2|||
131102002|NCT01076647|472001336|FG001|Overall Study|Withdrawal criteria|2|||
131102003|NCT01076647|472001335|FG000|Overall Study|Unclassified|12|||
131102004|NCT01076647|472001336|FG001|Overall Study|Unclassified|12|||
131102005|NCT00564889|472001342|FG000|Overall Study|Death|7|||
131102006|NCT00564889|472001342|FG000|Overall Study|Adverse Event|12|||
131102007|NCT00564889|472001342|FG000|Overall Study|Alternative treatment|3|||
130679067|NCT02480764|470450953|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
130679068|NCT02480764|470450954|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
130679069|NCT02480764|470450952|FG000|Overall Study|Major Protocol Deviation|1|||
130679070|NCT02480764|470450953|FG001|Overall Study|Major Protocol Deviation|4|||
131015319|NCT01193153|471685012|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
131015320|NCT01193153|471685011|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
131015321|NCT01193153|471685012|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
131015322|NCT01648140|471685013|FG000|Overall Study|Physician Decision|1|||
131015323|NCT01648140|471685014|FG001|Overall Study|Physician Decision|0|||
131015324|NCT01648140|471685015|FG002|Overall Study|Physician Decision|0|||
131015325|NCT01648140|471685016|FG003|Overall Study|Physician Decision|0|||
131015326|NCT01648140|471685013|FG000|Overall Study|Lack of Efficacy|4|||
131015327|NCT01648140|471685014|FG001|Overall Study|Lack of Efficacy|7|||
131015328|NCT01648140|471685015|FG002|Overall Study|Lack of Efficacy|1|||
131015329|NCT01648140|471685016|FG003|Overall Study|Lack of Efficacy|0|||
131015330|NCT01648140|471685013|FG000|Overall Study|Adverse Event|3|||
131015331|NCT01648140|471685014|FG001|Overall Study|Adverse Event|1|||
131015332|NCT01648140|471685015|FG002|Overall Study|Adverse Event|2|||
131015333|NCT01648140|471685016|FG003|Overall Study|Adverse Event|0|||
131015334|NCT01648140|471685013|FG000|Overall Study|Withdrawal by Subject|2|||
131015335|NCT01648140|471685014|FG001|Overall Study|Withdrawal by Subject|3|||
131015336|NCT01648140|471685015|FG002|Overall Study|Withdrawal by Subject|3|||
131015337|NCT01648140|471685016|FG003|Overall Study|Withdrawal by Subject|2|||
131015338|NCT01648140|471685013|FG000|Overall Study|Lost to Follow-up|2|||
131015339|NCT01648140|471685014|FG001|Overall Study|Lost to Follow-up|1|||
131015340|NCT01648140|471685015|FG002|Overall Study|Lost to Follow-up|2|||
131015341|NCT01648140|471685016|FG003|Overall Study|Lost to Follow-up|0|||
131015342|NCT01563354|471685017|FG000|Core Phase|Adverse Event|5|||
131015343|NCT01563354|471685018|FG001|Core Phase|Adverse Event|15|||
131015344|NCT01563354|471685019|FG002|Core Phase|Adverse Event|13|||
131015345|NCT01563354|471685017|FG000|Core Phase|Withdrawal by Subject|1|||
131015346|NCT01563354|471685018|FG001|Core Phase|Withdrawal by Subject|0|||
131015347|NCT01563354|471685019|FG002|Core Phase|Withdrawal by Subject|3|||
131015348|NCT01563354|471685017|FG000|Core Phase|Lost to Follow-up|1|||
131015349|NCT01563354|471685018|FG001|Core Phase|Lost to Follow-up|0|||
131015350|NCT01563354|471685019|FG002|Core Phase|Lost to Follow-up|0|||
131015351|NCT01563354|471685017|FG000|Core Phase|Death|1|||
131015352|NCT01563354|471685018|FG001|Core Phase|Death|5|||
131015353|NCT01563354|471685019|FG002|Core Phase|Death|2|||
131015354|NCT01563354|471685017|FG000|Core Phase|Diseasse progression|18|||
131015355|NCT01563354|471685018|FG001|Core Phase|Diseasse progression|7|||
131015356|NCT01563354|471685019|FG002|Core Phase|Diseasse progression|8|||
131015357|NCT01563354|471685017|FG000|Core Phase|Protocol deviation|2|||
131015358|NCT01563354|471685018|FG001|Core Phase|Protocol deviation|0|||
131015359|NCT01563354|471685019|FG002|Core Phase|Protocol deviation|0|||
131015360|NCT01563354|471685017|FG000|Core Phase|PI decision - did not enter extension|0|||
131015361|NCT01563354|471685018|FG001|Core Phase|PI decision - did not enter extension|1|||
131015362|NCT01563354|471685019|FG002|Core Phase|PI decision - did not enter extension|0|||
131015363|NCT01563354|471685017|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
131015364|NCT01563354|471685018|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
131015365|NCT01563354|471685019|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
131015366|NCT01563354|471685017|FG000|Extension Phase|Adverse Event|0|||
131015367|NCT01563354|471685018|FG001|Extension Phase|Adverse Event|3|||
131015368|NCT01563354|471685019|FG002|Extension Phase|Adverse Event|2|||
131015369|NCT01563354|471685017|FG000|Extension Phase|Withdrawal by Subject|0|||
131015370|NCT01563354|471685018|FG001|Extension Phase|Withdrawal by Subject|1|||
131015371|NCT01563354|471685019|FG002|Extension Phase|Withdrawal by Subject|0|||
131015372|NCT01563354|471685017|FG000|Extension Phase|Administration problems|3|||
131015373|NCT01563354|471685018|FG001|Extension Phase|Administration problems|2|||
131015374|NCT01563354|471685019|FG002|Extension Phase|Administration problems|3|||
131015375|NCT01563354|471685017|FG000|Extension Phase|Disease progression|9|||
131015376|NCT01563354|471685018|FG001|Extension Phase|Disease progression|8|||
131015377|NCT01563354|471685019|FG002|Extension Phase|Disease progression|10|||
131015378|NCT01119950|471685020|FG000|Overall Study|Adverse Event|25|||
131015379|NCT01119950|471685020|FG000|Overall Study|Withdrawal by Subject|9|||
130679071|NCT02480764|470450954|FG002|Overall Study|Major Protocol Deviation|3|||
131015380|NCT01119950|471685020|FG000|Overall Study|Protocol Violation|5|||
131015381|NCT01119950|471685020|FG000|Overall Study|Lost to Follow-up|4|||
131015382|NCT01119950|471685020|FG000|Overall Study|Administrative|2|||
131015383|NCT01119950|471685020|FG000|Overall Study|Abnormal lab value|1|||
131015384|NCT01119950|471685020|FG000|Overall Study|Death|1|||
131015385|NCT01988233|471685022|FG000|Overall Study|Lost to Follow-up|64|||
131015386|NCT01988233|471685023|FG001|Overall Study|Lost to Follow-up|51|||
131015387|NCT03621761|471685024|FG000|Overall Study|Lost to Follow-up|1|||
131015388|NCT03621761|471685025|FG001|Overall Study|Lost to Follow-up|1|||
131015389|NCT03621761|471685026|FG002|Overall Study|Lost to Follow-up|2|||
131102008|NCT00564889|472001342|FG000|Overall Study|Disease progression|3|||
131222593|NCT01902134|472443113|FG000|Overall Study|Protocol Violation|0|||
131102009|NCT00564889|472001342|FG000|Overall Study|Other, not specified|4|||
131102010|NCT03500159|472001343|FG000|Overall Study|Study Terminated|2|||
131102011|NCT03500159|472001344|FG001|Overall Study|Study Terminated|1|||
131102012|NCT01011387|472001349|FG000|Overall Study|Withdrawal by Subject|3|||
131102013|NCT01011387|472001349|FG000|Overall Study|Adverse Event|2|||
131102014|NCT01011387|472001349|FG000|Overall Study|Protocol Violation|1|||
131102015|NCT01226095|472001350|FG000|Overall Study|Poor compliance|1|||
131102016|NCT02665338|472001352|FG000|Overall Study|Withdrawal by Subject|0|||
131102017|NCT02665338|472001353|FG001|Overall Study|Withdrawal by Subject|1|||
131102018|NCT00847808|472001356|FG000|Overall Study|Adverse Event|7|||
131102019|NCT00847808|472001356|FG000|Overall Study|Protocol Violation|1|||
131102020|NCT00847808|472001356|FG000|Overall Study|Lost to Follow-up|1|||
131102021|NCT00847808|472001356|FG000|Overall Study|Withdrawal by Subject|4|||
131102022|NCT00847808|472001356|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
131102023|NCT00847808|472001356|FG000|Overall Study|Participant Took Excluded Medication|1|||
131102024|NCT05326815|472001358|FG000|Overall Study|Withdrawal by Subject|3|||
131102025|NCT05326815|472001358|FG000|Overall Study|Did not complete required labs|6|||
131102026|NCT05326815|472001358|FG000|Overall Study|Screen fail- abnormal labs|5|||
131102027|NCT03562975|472001359|FG000|Overall Study|Death|1|||
131102028|NCT03562975|472001359|FG000|Overall Study|Lost to Follow-up|1|||
131102029|NCT03562975|472001359|FG000|Overall Study|Withdrawal by Subject|1|||
131102030|NCT02545933|472001360|FG000|Overall Study|Adverse Event|3|||
131102031|NCT02545933|472001361|FG001|Overall Study|Adverse Event|0|||
131102032|NCT02545933|472001362|FG002|Overall Study|Adverse Event|0|||
131102033|NCT02545933|472001360|FG000|Overall Study|Withdrawal by Subject|2|||
130679072|NCT02480764|470450952|FG000|Overall Study|Lost to Follow-up|0|||
130679073|NCT02480764|470450953|FG001|Overall Study|Lost to Follow-up|1|||
130679074|NCT02480764|470450954|FG002|Overall Study|Lost to Follow-up|2|||
130679075|NCT02480764|470450952|FG000|Overall Study|Voluntary Withdrawal|6|||
130679076|NCT02480764|470450953|FG001|Overall Study|Voluntary Withdrawal|5|||
131015390|NCT03621761|471685024|FG000|Overall Study|Withdrawal by Subject|2|||
131015391|NCT03621761|471685025|FG001|Overall Study|Withdrawal by Subject|1|||
131015392|NCT03621761|471685026|FG002|Overall Study|Withdrawal by Subject|1|||
131015393|NCT03621761|471685024|FG000|Overall Study|Became Ineligible|0|||
131015394|NCT03621761|471685025|FG001|Overall Study|Became Ineligible|2|||
131015395|NCT03621761|471685026|FG002|Overall Study|Became Ineligible|0|||
131015396|NCT00217672|471685031|FG000|Allocation|Ineligible|2|||
131015397|NCT00217672|471685032|FG001|Allocation|Ineligible|0|||
131015398|NCT00217672|471685031|FG000|Treatment|disease progression|33|||
131015399|NCT00217672|471685032|FG001|Treatment|disease progression|4|||
131015400|NCT00217672|471685031|FG000|Treatment|Adverse Event|18|||
131015401|NCT00217672|471685032|FG001|Treatment|Adverse Event|2|||
131015402|NCT00217672|471685031|FG000|Treatment|reqd treatment not permitted by protocol|6|||
131015403|NCT00217672|471685032|FG001|Treatment|reqd treatment not permitted by protocol|0|||
131015404|NCT00217672|471685031|FG000|Treatment|Physician Decision|6|||
131015405|NCT00217672|471685032|FG001|Treatment|Physician Decision|0|||
131015406|NCT00217672|471685031|FG000|Treatment|insurance issues|1|||
131015407|NCT00217672|471685032|FG001|Treatment|insurance issues|1|||
131015408|NCT00217672|471685031|FG000|Treatment|Death|2|||
131015409|NCT00217672|471685032|FG001|Treatment|Death|0|||
131015410|NCT00217672|471685031|FG000|Treatment|secondary malignancy|1|||
131015411|NCT00217672|471685032|FG001|Treatment|secondary malignancy|0|||
131015412|NCT00217672|471685031|FG000|Follow-up|Withdrawal by Subject|4|||
131015413|NCT00217672|471685032|FG001|Follow-up|Withdrawal by Subject|0|||
131015414|NCT00217672|471685031|FG000|Follow-up|Lost to Follow-up|1|||
131015415|NCT00217672|471685032|FG001|Follow-up|Lost to Follow-up|0|||
131015416|NCT01050569|471685033|FG000|Overall Study|Lost to Follow-up|20|||
131015417|NCT01050569|471685034|FG001|Overall Study|Lost to Follow-up|14|||
131015418|NCT01050569|471685035|FG002|Overall Study|Lost to Follow-up|16|||
131015419|NCT01050569|471685033|FG000|Overall Study|Withdrawal by Subject|9|||
131015420|NCT01050569|471685034|FG001|Overall Study|Withdrawal by Subject|3|||
131015421|NCT01050569|471685035|FG002|Overall Study|Withdrawal by Subject|11|||
131015422|NCT01050569|471685033|FG000|Overall Study|Lack of Efficacy|5|||
131102034|NCT02545933|472001361|FG001|Overall Study|Withdrawal by Subject|3|||
131102035|NCT02545933|472001362|FG002|Overall Study|Withdrawal by Subject|3|||
131102036|NCT02545933|472001360|FG000|Overall Study|Protocol Violation|1|||
131102037|NCT02545933|472001361|FG001|Overall Study|Protocol Violation|0|||
131102038|NCT02545933|472001362|FG002|Overall Study|Protocol Violation|1|||
131015423|NCT01050569|471685034|FG001|Overall Study|Lack of Efficacy|4|||
131015424|NCT01050569|471685035|FG002|Overall Study|Lack of Efficacy|3|||
131015425|NCT01050569|471685033|FG000|Overall Study|Adverse Event|1|||
131015426|NCT01050569|471685034|FG001|Overall Study|Adverse Event|0|||
131015427|NCT01050569|471685035|FG002|Overall Study|Adverse Event|0|||
131015428|NCT01050569|471685033|FG000|Overall Study|Physician Decision|3|||
131015429|NCT01050569|471685034|FG001|Overall Study|Physician Decision|3|||
131015430|NCT01050569|471685035|FG002|Overall Study|Physician Decision|3|||
131015431|NCT01591616|471685043|FG000|Overall Study|Withdrawal by Subject|1|||
131015432|NCT00758602|471685046|FG000|Overall Study|Adverse Event|11|||
131102039|NCT00935818|472001365|FG000|Overall Study|Withdrawal by Subject|45|||
131102040|NCT00935818|472001366|FG001|Overall Study|Withdrawal by Subject|50|||
131102041|NCT00935818|472001365|FG000|Overall Study|Lost to Follow-up|40|||
131102042|NCT00935818|472001366|FG001|Overall Study|Lost to Follow-up|42|||
131102043|NCT00935818|472001365|FG000|Overall Study|Adverse Event|6|||
131102044|NCT00935818|472001366|FG001|Overall Study|Adverse Event|7|||
131102045|NCT00935818|472001365|FG000|Overall Study|Physician Decision|0|||
131102046|NCT00935818|472001366|FG001|Overall Study|Physician Decision|1|||
131102047|NCT00979134|472001367|FG000|Overall Study|Disease progression|18|||
131102048|NCT00979134|472001368|FG001|Overall Study|Disease progression|2|||
131102049|NCT00979134|472001369|FG002|Overall Study|Disease progression|5|||
131102050|NCT00979134|472001367|FG000|Overall Study|Adverse Event|0|||
131102051|NCT00979134|472001368|FG001|Overall Study|Adverse Event|0|||
131102052|NCT00979134|472001369|FG002|Overall Study|Adverse Event|2|||
131102053|NCT00979134|472001367|FG000|Overall Study|Withdrawal by Subject|1|||
131102054|NCT00979134|472001368|FG001|Overall Study|Withdrawal by Subject|1|||
130679077|NCT02480764|470450954|FG002|Overall Study|Voluntary Withdrawal|10|||
130679078|NCT02480764|470450952|FG000|Overall Study|Lack of Efficacy|0|||
131015433|NCT00758602|471685047|FG001|Overall Study|Adverse Event|10|||
131015434|NCT00758602|471685046|FG000|Overall Study|Lost to Follow-up|4|||
131015435|NCT00758602|471685047|FG001|Overall Study|Lost to Follow-up|3|||
131015436|NCT00758602|471685046|FG000|Overall Study|Withdrawal by Subject|1|||
131015437|NCT00758602|471685047|FG001|Overall Study|Withdrawal by Subject|3|||
131015438|NCT00758602|471685046|FG000|Overall Study|Protocol Violation|0|||
131015439|NCT00758602|471685047|FG001|Overall Study|Protocol Violation|2|||
131015440|NCT00758602|471685046|FG000|Overall Study|Death|0|||
131015441|NCT00758602|471685047|FG001|Overall Study|Death|1|||
131015442|NCT00758602|471685046|FG000|Overall Study|Reason not specified|3|||
131015443|NCT00758602|471685047|FG001|Overall Study|Reason not specified|3|||
131015444|NCT04379713|471685048|FG000|Overall Study|Adverse Event|2|||
131015445|NCT04379713|471685049|FG001|Overall Study|Adverse Event|0|||
131015446|NCT04379713|471685048|FG000|Overall Study|Physician Decision|2|||
131015447|NCT04379713|471685049|FG001|Overall Study|Physician Decision|1|||
131015448|NCT04379713|471685048|FG000|Overall Study|Protocol Violation|11|||
131015449|NCT04379713|471685049|FG001|Overall Study|Protocol Violation|6|||
131015450|NCT04379713|471685048|FG000|Overall Study|No longer met eligibility criteria|14|||
131015451|NCT04379713|471685049|FG001|Overall Study|No longer met eligibility criteria|11|||
131015452|NCT04379713|471685048|FG000|Overall Study|Withdrawal by parent/guardian|36|||
131015453|NCT04379713|471685049|FG001|Overall Study|Withdrawal by parent/guardian|15|||
131015454|NCT04379713|471685048|FG000|Overall Study|Lost to Follow-up|31|||
131015455|NCT04379713|471685049|FG001|Overall Study|Lost to Follow-up|21|||
131015456|NCT01909336|471685052|FG000|Overall Study|Lost to Follow-up|4|||
131015457|NCT01909336|471685053|FG001|Overall Study|Lost to Follow-up|2|||
131015458|NCT01909336|471685054|FG002|Overall Study|Lost to Follow-up|2|||
131015459|NCT01909336|471685052|FG000|Overall Study|Physician Decision|0|||
131015460|NCT01909336|471685053|FG001|Overall Study|Physician Decision|1|||
131015461|NCT01909336|471685054|FG002|Overall Study|Physician Decision|1|||
131015462|NCT01157182|471685055|FG000|Washout of 28 Days|Adverse Event|2|||
131015463|NCT01157182|471685056|FG001|Washout of 28 Days|Adverse Event|0|||
131015464|NCT00716144|471685058|FG000|Overall Study|Withdrawal by Subject|4|||
131015465|NCT00716144|471685059|FG001|Overall Study|Withdrawal by Subject|2|||
131015466|NCT00716144|471685060|FG002|Overall Study|Withdrawal by Subject|6|||
131015467|NCT00716144|471685061|FG003|Overall Study|Withdrawal by Subject|6|||
131015468|NCT00716144|471685058|FG000|Overall Study|Lost to Follow-up|2|||
131015469|NCT00716144|471685059|FG001|Overall Study|Lost to Follow-up|2|||
131015470|NCT00716144|471685060|FG002|Overall Study|Lost to Follow-up|1|||
131015471|NCT00716144|471685061|FG003|Overall Study|Lost to Follow-up|2|||
131015472|NCT00716144|471685058|FG000|Overall Study|Adverse Event|0|||
131015473|NCT00716144|471685059|FG001|Overall Study|Adverse Event|0|||
130679079|NCT02480764|470450953|FG001|Overall Study|Lack of Efficacy|3|||
130679080|NCT02480764|470450954|FG002|Overall Study|Lack of Efficacy|3|||
130679081|NCT02480764|470450952|FG000|Overall Study|Reason not Specified|0|||
130679082|NCT02480764|470450953|FG001|Overall Study|Reason not Specified|1|||
130679083|NCT02480764|470450954|FG002|Overall Study|Reason not Specified|0|||
130679084|NCT01475474|470450955|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
131015474|NCT00716144|471685060|FG002|Overall Study|Adverse Event|0|||
131015475|NCT00716144|471685061|FG003|Overall Study|Adverse Event|2|||
131015476|NCT00716144|471685058|FG000|Overall Study|Non-compliance|1|||
131102055|NCT00979134|472001369|FG002|Overall Study|Withdrawal by Subject|2|||
130679085|NCT01475474|470450955|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
131015477|NCT00716144|471685059|FG001|Overall Study|Non-compliance|0|||
131015478|NCT00716144|471685060|FG002|Overall Study|Non-compliance|0|||
131015479|NCT00716144|471685061|FG003|Overall Study|Non-compliance|0|||
131015480|NCT00716144|471685058|FG000|Overall Study|Protocol Violation|2|||
131015481|NCT00716144|471685059|FG001|Overall Study|Protocol Violation|0|||
131015482|NCT00716144|471685060|FG002|Overall Study|Protocol Violation|1|||
131102056|NCT00979134|472001367|FG000|Overall Study|Lost to Follow-up|2|||
131015483|NCT00716144|471685061|FG003|Overall Study|Protocol Violation|0|||
131015484|NCT00716144|471685058|FG000|Overall Study|Physician Decision|0|||
131102057|NCT00979134|472001368|FG001|Overall Study|Lost to Follow-up|2|||
130679086|NCT01046253|470450956|FG000|Second Intervention|Adverse Event|0|||
130679087|NCT01046253|470450957|FG001|Second Intervention|Adverse Event|1|||
130679088|NCT01046253|470450956|FG000|Second Intervention|Protocol Violation|0|||
130679089|NCT01046253|470450957|FG001|Second Intervention|Protocol Violation|1|||
130679090|NCT02339909|470450960|FG000|Overall Study|Became ineligible after randomisation|89|||
130679091|NCT02339909|470450961|FG001|Overall Study|Became ineligible after randomisation|63|||
130679092|NCT02339909|470450962|FG002|Overall Study|Became ineligible after randomisation|71|||
130679093|NCT00860028|470450970|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
130679094|NCT00860028|470450971|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
130679095|NCT01658943|470450973|FG000|Overall Study|Adverse Event|6|||
130679096|NCT01658943|470450974|FG001|Overall Study|Adverse Event|13|||
130679097|NCT01658943|470450973|FG000|Overall Study|Withdrawal by Subject|9|||
130679098|NCT01658943|470450974|FG001|Overall Study|Withdrawal by Subject|2|||
130679099|NCT01658943|470450973|FG000|Overall Study|Progression/Relapse|39|||
130679100|NCT01658943|470450974|FG001|Overall Study|Progression/Relapse|40|||
130679101|NCT01658943|470450973|FG000|Overall Study|Death|4|||
130679102|NCT01658943|470450974|FG001|Overall Study|Death|2|||
130679103|NCT01658943|470450973|FG000|Overall Study|not protocol specified|4|||
130679104|NCT01658943|470450974|FG001|Overall Study|not protocol specified|1|||
130679105|NCT01658943|470450973|FG000|Overall Study|Not eligible|7|||
130679106|NCT01658943|470450974|FG001|Overall Study|Not eligible|9|||
130679107|NCT01658943|470450973|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
130679108|NCT01658943|470450974|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
130679109|NCT00475020|470450976|FG000|Overall Study|Physician Decision|3|||
130679110|NCT00475020|470450976|FG000|Overall Study|Insurance Denial|1|||
130679111|NCT00475020|470450976|FG000|Overall Study|Donor not able to donate the last minute|1|||
130679112|NCT02514174|470450980|FG000|Overall Study|Patient refused to continue medication|1|||
130679113|NCT02514174|470450980|FG000|Overall Study|Adverse Event|2|||
130679114|NCT02514174|470450980|FG000|Overall Study|Study closed by sponsor|9|||
130679115|NCT02514174|470450980|FG000|Overall Study|Progressive disease|11|||
130679116|NCT02514174|470450980|FG000|Overall Study|Treatment change|1|||
130679117|NCT02514174|470450980|FG000|Overall Study|Treated off study with Afatinib.|1|||
130679118|NCT02130466|470450981|FG000|Overall Study|Death|4|||
130679119|NCT02130466|470450982|FG001|Overall Study|Death|1|||
130679120|NCT02130466|470450983|FG002|Overall Study|Death|1|||
130679121|NCT02130466|470450984|FG003|Overall Study|Death|3|||
130679122|NCT02130466|470450985|FG004|Overall Study|Death|2|||
130679123|NCT02130466|470450986|FG005|Overall Study|Death|30|||
130679124|NCT02130466|470450987|FG006|Overall Study|Death|45|||
130679125|NCT02130466|470450988|FG007|Overall Study|Death|2|||
130679126|NCT02130466|470450989|FG008|Overall Study|Death|3|||
130679127|NCT02130466|470450990|FG009|Overall Study|Death|4|||
130679128|NCT02130466|470450991|FG010|Overall Study|Death|5|||
130679129|NCT02130466|470450992|FG011|Overall Study|Death|3|||
130679130|NCT02130466|470450993|FG012|Overall Study|Death|11|||
130679131|NCT02130466|470450994|FG013|Overall Study|Death|7|||
130679132|NCT02130466|470450981|FG000|Overall Study|Lost to Follow-up|1|||
130679133|NCT02130466|470450982|FG001|Overall Study|Lost to Follow-up|0|||
130679134|NCT02130466|470450983|FG002|Overall Study|Lost to Follow-up|0|||
130679135|NCT02130466|470450984|FG003|Overall Study|Lost to Follow-up|0|||
130679136|NCT02130466|470450985|FG004|Overall Study|Lost to Follow-up|0|||
130679137|NCT02130466|470450986|FG005|Overall Study|Lost to Follow-up|1|||
130679138|NCT02130466|470450987|FG006|Overall Study|Lost to Follow-up|0|||
130679139|NCT02130466|470450988|FG007|Overall Study|Lost to Follow-up|0|||
131015485|NCT00716144|471685059|FG001|Overall Study|Physician Decision|1|||
131015486|NCT00716144|471685060|FG002|Overall Study|Physician Decision|2|||
131015487|NCT00716144|471685061|FG003|Overall Study|Physician Decision|2|||
131015488|NCT00716144|471685058|FG000|Overall Study|Intercurrent illness|0|||
131015489|NCT00716144|471685059|FG001|Overall Study|Intercurrent illness|0|||
131015490|NCT00716144|471685060|FG002|Overall Study|Intercurrent illness|1|||
131015491|NCT00716144|471685061|FG003|Overall Study|Intercurrent illness|0|||
131015492|NCT00716144|471685058|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
131015493|NCT00716144|471685059|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
131015494|NCT00716144|471685060|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
131015495|NCT00716144|471685061|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
131015496|NCT00716144|471685058|FG000|Overall Study|Adverse event: left foot pain|0|||
131015497|NCT00716144|471685059|FG001|Overall Study|Adverse event: left foot pain|1|||
131015498|NCT00716144|471685060|FG002|Overall Study|Adverse event: left foot pain|0|||
131015499|NCT00716144|471685061|FG003|Overall Study|Adverse event: left foot pain|0|||
131015500|NCT00716144|471685058|FG000|Overall Study|Clinical Depression|0|||
131015501|NCT00716144|471685059|FG001|Overall Study|Clinical Depression|1|||
131015502|NCT00716144|471685060|FG002|Overall Study|Clinical Depression|0|||
131015503|NCT00716144|471685061|FG003|Overall Study|Clinical Depression|0|||
131015504|NCT02950558|471685062|FG000|Overall Study|Lost to Follow-up|2|||
131015505|NCT02950558|471685063|FG001|Overall Study|Lost to Follow-up|0|||
131015506|NCT01321606|471685066|FG000|Overall Study|Lost to Follow-up|0|||
131015507|NCT01321606|471685067|FG001|Overall Study|Lost to Follow-up|0|||
131102058|NCT00979134|472001369|FG002|Overall Study|Lost to Follow-up|0|||
131102059|NCT00979134|472001367|FG000|Overall Study|Death|4|||
131102060|NCT00979134|472001368|FG001|Overall Study|Death|0|||
131102061|NCT00979134|472001369|FG002|Overall Study|Death|26|||
130679140|NCT02130466|470450989|FG008|Overall Study|Lost to Follow-up|0|||
130679141|NCT02130466|470450990|FG009|Overall Study|Lost to Follow-up|0|||
130679142|NCT02130466|470450991|FG010|Overall Study|Lost to Follow-up|0|||
130679143|NCT02130466|470450992|FG011|Overall Study|Lost to Follow-up|0|||
130679144|NCT02130466|470450993|FG012|Overall Study|Lost to Follow-up|1|||
130679145|NCT02130466|470450994|FG013|Overall Study|Lost to Follow-up|0|||
130679146|NCT02130466|470450981|FG000|Overall Study|Physician Decision|0|||
130679147|NCT02130466|470450982|FG001|Overall Study|Physician Decision|0|||
130679148|NCT02130466|470450983|FG002|Overall Study|Physician Decision|0|||
130679149|NCT02130466|470450984|FG003|Overall Study|Physician Decision|0|||
130679150|NCT02130466|470450985|FG004|Overall Study|Physician Decision|0|||
130679151|NCT02130466|470450986|FG005|Overall Study|Physician Decision|1|||
130679152|NCT02130466|470450987|FG006|Overall Study|Physician Decision|1|||
130679153|NCT02130466|470450988|FG007|Overall Study|Physician Decision|0|||
130679154|NCT02130466|470450989|FG008|Overall Study|Physician Decision|0|||
130679155|NCT02130466|470450990|FG009|Overall Study|Physician Decision|0|||
130679156|NCT02130466|470450991|FG010|Overall Study|Physician Decision|0|||
130679157|NCT02130466|470450992|FG011|Overall Study|Physician Decision|0|||
130679158|NCT02130466|470450993|FG012|Overall Study|Physician Decision|0|||
130679159|NCT02130466|470450994|FG013|Overall Study|Physician Decision|0|||
131102062|NCT00979134|472001367|FG000|Overall Study|Other|8|||
131102063|NCT00979134|472001368|FG001|Overall Study|Other|1|||
131102064|NCT00979134|472001369|FG002|Overall Study|Other|5|||
131102065|NCT05917470|472001370|FG000|Overall Study|Progressive Disease|1|||
131102066|NCT05917470|472001371|FG001|Overall Study|Progressive Disease|1|||
131102067|NCT05917470|472001372|FG002|Overall Study|Progressive Disease|2|||
131102068|NCT05917470|472001373|FG003|Overall Study|Progressive Disease|3|||
131102069|NCT05917470|472001374|FG004|Overall Study|Progressive Disease|1|||
131102070|NCT05917470|472001375|FG005|Overall Study|Progressive Disease|1|||
131102071|NCT05917470|472001376|FG006|Overall Study|Progressive Disease|0|||
131102072|NCT05917470|472001377|FG007|Overall Study|Progressive Disease|0|||
131102073|NCT05917470|472001370|FG000|Overall Study|Withdrawal by Subject|0|||
131102074|NCT05917470|472001371|FG001|Overall Study|Withdrawal by Subject|0|||
131102075|NCT05917470|472001372|FG002|Overall Study|Withdrawal by Subject|1|||
131102076|NCT05917470|472001373|FG003|Overall Study|Withdrawal by Subject|0|||
131102077|NCT05917470|472001374|FG004|Overall Study|Withdrawal by Subject|0|||
131102078|NCT05917470|472001375|FG005|Overall Study|Withdrawal by Subject|0|||
131102079|NCT05917470|472001376|FG006|Overall Study|Withdrawal by Subject|0|||
131102080|NCT05917470|472001377|FG007|Overall Study|Withdrawal by Subject|0|||
131102081|NCT05917470|472001370|FG000|Overall Study|Sponsor Decision|0|||
131102082|NCT05917470|472001371|FG001|Overall Study|Sponsor Decision|0|||
131102083|NCT05917470|472001372|FG002|Overall Study|Sponsor Decision|1|||
131102084|NCT05917470|472001373|FG003|Overall Study|Sponsor Decision|0|||
131102085|NCT05917470|472001374|FG004|Overall Study|Sponsor Decision|2|||
131102086|NCT05917470|472001375|FG005|Overall Study|Sponsor Decision|1|||
131102087|NCT05917470|472001376|FG006|Overall Study|Sponsor Decision|3|||
131102088|NCT05917470|472001377|FG007|Overall Study|Sponsor Decision|3|||
131102089|NCT05917470|472001370|FG000|Overall Study|Adverse Event|0|||
131102090|NCT05917470|472001371|FG001|Overall Study|Adverse Event|0|||
131102091|NCT05917470|472001372|FG002|Overall Study|Adverse Event|0|||
131102092|NCT05917470|472001373|FG003|Overall Study|Adverse Event|0|||
131102093|NCT05917470|472001374|FG004|Overall Study|Adverse Event|0|||
131102094|NCT05917470|472001375|FG005|Overall Study|Adverse Event|1|||
131102095|NCT05917470|472001376|FG006|Overall Study|Adverse Event|0|||
131102096|NCT05917470|472001377|FG007|Overall Study|Adverse Event|0|||
130679160|NCT02130466|470450981|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130679161|NCT02130466|470450982|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
130679162|NCT02130466|470450983|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130679163|NCT02130466|470450984|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
130679164|NCT02130466|470450985|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130679165|NCT02130466|470450986|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
131102097|NCT01076192|472003835|FG000|Overall Study|Other|197|||
131102098|NCT01034176|472003836|FG000|Overall Study|Physician Decision|2|||
131102099|NCT01034176|472003837|FG001|Overall Study|Physician Decision|0|||
131102100|NCT01034176|472003836|FG000|Overall Study|Withdrawal by Subject|0|||
131102101|NCT01034176|472003837|FG001|Overall Study|Withdrawal by Subject|1|||
131102102|NCT01034176|472003836|FG000|Overall Study|Lost to Follow-up|0|||
131102103|NCT01034176|472003837|FG001|Overall Study|Lost to Follow-up|1|||
131102104|NCT00107120|472003841|FG000|Overall Study|Adverse Event|4|||
131102105|NCT00107120|472003842|FG001|Overall Study|Adverse Event|1|||
131102106|NCT00107120|472003841|FG000|Overall Study|Lack of Efficacy|5|||
131102107|NCT00107120|472003842|FG001|Overall Study|Lack of Efficacy|5|||
130679166|NCT02130466|470450987|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
131102108|NCT00107120|472003841|FG000|Overall Study|Protocol Violation|3|||
131102109|NCT00107120|472003842|FG001|Overall Study|Protocol Violation|0|||
130679167|NCT02130466|470450988|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130679168|NCT02130466|470450989|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130679169|NCT02130466|470450990|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130679170|NCT02130466|470450991|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130679171|NCT02130466|470450992|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130679172|NCT02130466|470450993|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130679173|NCT02130466|470450994|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
130679174|NCT02130466|470450981|FG000|Overall Study|Withdrawal by Subject|1|||
130679175|NCT02130466|470450982|FG001|Overall Study|Withdrawal by Subject|0|||
130679176|NCT02130466|470450983|FG002|Overall Study|Withdrawal by Subject|0|||
130679177|NCT02130466|470450984|FG003|Overall Study|Withdrawal by Subject|0|||
130679178|NCT02130466|470450985|FG004|Overall Study|Withdrawal by Subject|0|||
130679179|NCT02130466|470450986|FG005|Overall Study|Withdrawal by Subject|1|||
131102110|NCT00107120|472003841|FG000|Overall Study|Withdrawal by Subject|8|||
131102111|NCT00107120|472003842|FG001|Overall Study|Withdrawal by Subject|9|||
131102112|NCT00107120|472003841|FG000|Overall Study|Lost to Follow-up|8|||
131102113|NCT00107120|472003842|FG001|Overall Study|Lost to Follow-up|6|||
131102114|NCT00107120|472003841|FG000|Overall Study|Pregnancy|0|||
131102115|NCT00107120|472003842|FG001|Overall Study|Pregnancy|1|||
131102116|NCT00107120|472003841|FG000|Overall Study|moving away from site|1|||
131102117|NCT00107120|472003842|FG001|Overall Study|moving away from site|1|||
131102118|NCT00107120|472003841|FG000|Overall Study|death of parent|0|||
131102119|NCT00107120|472003842|FG001|Overall Study|death of parent|1|||
131102120|NCT01635920|472003843|FG000|Overall Study|Adverse Event|1|||
131102121|NCT01635920|472003844|FG001|Overall Study|Adverse Event|0|||
131102122|NCT01635920|472003843|FG000|Overall Study|Lost to Follow-up|0|||
131102123|NCT01635920|472003844|FG001|Overall Study|Lost to Follow-up|1|||
131102124|NCT01635920|472003843|FG000|Overall Study|Subject decision|2|||
131102125|NCT01635920|472003844|FG001|Overall Study|Subject decision|0|||
131102126|NCT00194987|472003845|FG000|Overall Study|Withdrawal by Subject|0|||
131102127|NCT00194987|472003846|FG001|Overall Study|Withdrawal by Subject|3|||
131102128|NCT01664598|472003847|FG000|Overall Study|Sponsor Decision|1|||
131102129|NCT01664598|472003847|FG000|Overall Study|Withdrawal of Informed Consent|4|||
131102130|NCT01664598|472003847|FG000|Overall Study|Adverse Event|1|||
131102131|NCT00686725|472003848|FG000|Overall Study|Adverse Event|1|||
131102132|NCT00686725|472003849|FG001|Overall Study|Adverse Event|1|||
131102133|NCT00686725|472003848|FG000|Overall Study|Progressive Disease|17|||
131102134|NCT00686725|472003849|FG001|Overall Study|Progressive Disease|23|||
131102135|NCT00686725|472003848|FG000|Overall Study|Lost to Follow-up|7|||
131102136|NCT00686725|472003849|FG001|Overall Study|Lost to Follow-up|5|||
131102137|NCT00686725|472003848|FG000|Overall Study|Death|6|||
131102138|NCT00686725|472003849|FG001|Overall Study|Death|3|||
131102139|NCT00686725|472003848|FG000|Overall Study|Withdrawal by Subject|13|||
131102140|NCT00686725|472003849|FG001|Overall Study|Withdrawal by Subject|4|||
131102141|NCT00686725|472003848|FG000|Overall Study|Protocol Violation|1|||
131102142|NCT00686725|472003849|FG001|Overall Study|Protocol Violation|3|||
131102143|NCT00686725|472003848|FG000|Overall Study|Other|1|||
131102144|NCT00686725|472003849|FG001|Overall Study|Other|3|||
131102145|NCT02630693|472003853|FG000|Overall Study|No receive treatment|0|||
131102146|NCT02630693|472003854|FG001|Overall Study|No receive treatment|1|||
131102147|NCT01639560|472003855|FG000|Overall Study|Withdrawal by Subject|9|||
131102148|NCT01639560|472003856|FG001|Overall Study|Withdrawal by Subject|14|||
131102149|NCT01639560|472003855|FG000|Overall Study|Lack of Efficacy|1|||
131102150|NCT01639560|472003856|FG001|Overall Study|Lack of Efficacy|2|||
131102151|NCT01639560|472003855|FG000|Overall Study|Lost to Follow-up|9|||
131102152|NCT01639560|472003856|FG001|Overall Study|Lost to Follow-up|11|||
131102153|NCT01639560|472003855|FG000|Overall Study|Adverse Event|0|||
131102154|NCT01639560|472003856|FG001|Overall Study|Adverse Event|2|||
131102155|NCT01160289|472003857|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
131102156|NCT01160289|472003858|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
131102157|NCT01160289|472003859|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
130679180|NCT02130466|470450987|FG006|Overall Study|Withdrawal by Subject|0|||
130679181|NCT02130466|470450988|FG007|Overall Study|Withdrawal by Subject|0|||
130679182|NCT02130466|470450989|FG008|Overall Study|Withdrawal by Subject|1|||
130679183|NCT02130466|470450990|FG009|Overall Study|Withdrawal by Subject|0|||
131102158|NCT01160289|472003860|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
131102159|NCT01160289|472003861|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
131102160|NCT01160289|472003862|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
131102161|NCT01160289|472003857|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
131102162|NCT01160289|472003858|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
131102163|NCT01160289|472003859|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
131102164|NCT01160289|472003860|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
131102165|NCT01160289|472003861|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
131102166|NCT01160289|472003862|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
131102167|NCT01160289|472003857|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
131102168|NCT01160289|472003858|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
131102169|NCT01160289|472003859|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
131102170|NCT01160289|472003860|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
131102171|NCT01160289|472003861|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
131102172|NCT01160289|472003862|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
131102173|NCT01160289|472003857|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
131102174|NCT01160289|472003858|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
131102175|NCT01160289|472003859|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
131102176|NCT01160289|472003860|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
131102177|NCT01160289|472003861|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
131102178|NCT01160289|472003862|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
131102179|NCT01160289|472003857|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
131102180|NCT01160289|472003858|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
131102181|NCT01160289|472003859|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
131102182|NCT01160289|472003860|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
131102183|NCT01160289|472003861|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
131102184|NCT01160289|472003862|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
131102185|NCT01160289|472003857|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
131102186|NCT01160289|472003858|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
131102187|NCT01160289|472003859|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
131102188|NCT01160289|472003860|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
131102189|NCT01160289|472003861|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
131102190|NCT01160289|472003862|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
131102191|NCT01160289|472003857|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
131102192|NCT01160289|472003858|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
131102193|NCT01160289|472003859|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
131102194|NCT01160289|472003860|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
131102195|NCT01160289|472003861|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
131102196|NCT01160289|472003862|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
131102197|NCT01160289|472003857|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
131102198|NCT01160289|472003858|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
131102199|NCT01160289|472003859|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
131102200|NCT01160289|472003860|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
131102201|NCT01160289|472003861|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
131102202|NCT01160289|472003862|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
131102203|NCT01160289|472003857|FG000|Post-Randomization Period|Adverse Event|0|||
131102204|NCT01160289|472003858|FG001|Post-Randomization Period|Adverse Event|4|||
131102205|NCT01160289|472003859|FG002|Post-Randomization Period|Adverse Event|4|||
131102206|NCT01160289|472003860|FG003|Post-Randomization Period|Adverse Event|2|||
131102207|NCT01160289|472003861|FG004|Post-Randomization Period|Adverse Event|0|||
131102208|NCT01160289|472003862|FG005|Post-Randomization Period|Adverse Event|0|||
131102209|NCT01160289|472003857|FG000|Post-Randomization Period|Death|0|||
131102210|NCT01160289|472003858|FG001|Post-Randomization Period|Death|0|||
131102211|NCT01160289|472003859|FG002|Post-Randomization Period|Death|0|||
131102212|NCT01160289|472003860|FG003|Post-Randomization Period|Death|1|||
131102213|NCT01160289|472003861|FG004|Post-Randomization Period|Death|0|||
131102214|NCT01160289|472003862|FG005|Post-Randomization Period|Death|0|||
131102215|NCT01160289|472003857|FG000|Post-Randomization Period|Lack of Efficacy|0|||
131102216|NCT01160289|472003858|FG001|Post-Randomization Period|Lack of Efficacy|1|||
131102217|NCT01160289|472003859|FG002|Post-Randomization Period|Lack of Efficacy|0|||
131102218|NCT01160289|472003860|FG003|Post-Randomization Period|Lack of Efficacy|3|||
130679184|NCT02130466|470450991|FG010|Overall Study|Withdrawal by Subject|0|||
130679185|NCT02130466|470450992|FG011|Overall Study|Withdrawal by Subject|0|||
130679186|NCT02130466|470450993|FG012|Overall Study|Withdrawal by Subject|0|||
130679187|NCT02130466|470450994|FG013|Overall Study|Withdrawal by Subject|0|||
130679188|NCT04529109|470450995|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
130679189|NCT04529109|470450996|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130679190|NCT00993616|470450997|FG000|Overall Study|No tumor at entry|1|||
130679191|NCT00993616|470450997|FG000|Overall Study|Never treated|1|||
130679192|NCT00788125|470452198|FG000|Overall Study|Death|6|||
130679193|NCT00453362|470452205|FG000|Overall Study|Adverse Event|5|||
130679194|NCT00453362|470452205|FG000|Overall Study|Death|7|||
130679195|NCT00453362|470452205|FG000|Overall Study|Physician Decision|2|||
130679196|NCT00453362|470452205|FG000|Overall Study|Withdrawal by Subject|3|||
131102219|NCT01160289|472003861|FG004|Post-Randomization Period|Lack of Efficacy|0|||
131102220|NCT01160289|472003862|FG005|Post-Randomization Period|Lack of Efficacy|0|||
130679197|NCT00453362|470452205|FG000|Overall Study|Progression of disease|56|||
130679198|NCT00453362|470452205|FG000|Overall Study|Screening Failure|14|||
130679199|NCT04885296|470452208|FG000|Period 1|Covid-19 Related|1|||
130679200|NCT04885296|470452209|FG001|Period 1|Covid-19 Related|0|||
130679201|NCT04885296|470452208|FG000|Period 1|Adverse Event|0|||
130679202|NCT04885296|470452209|FG001|Period 1|Adverse Event|1|||
130679203|NCT04885296|470452208|FG000|Period 1|Withdrawal by Subject|1|||
130679204|NCT04885296|470452209|FG001|Period 1|Withdrawal by Subject|1|||
130679205|NCT04885296|470452208|FG000|Period 1|Test Article No Longer Available|1|||
130679206|NCT04885296|470452209|FG001|Period 1|Test Article No Longer Available|0|||
130679207|NCT04885296|470452208|FG000|Period 1|Dispensed Study lens in Error|1|||
130679208|NCT04885296|470452209|FG001|Period 1|Dispensed Study lens in Error|0|||
131015508|NCT01321606|471685068|FG002|Overall Study|Lost to Follow-up|0|||
131015509|NCT01321606|471685069|FG003|Overall Study|Lost to Follow-up|1|||
131015510|NCT02781584|471685073|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
131015511|NCT02781584|471685074|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
131015512|NCT02781584|471685075|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
131015513|NCT02781584|471685076|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
131015514|NCT02781584|471685077|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
131015515|NCT02781584|471685078|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
131015516|NCT02781584|471685079|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
131015517|NCT02781584|471685080|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
131015518|NCT02781584|471685081|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
131015519|NCT02781584|471685082|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
131015520|NCT02781584|471685083|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
131015521|NCT02781584|471685084|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
131015522|NCT02781584|471685085|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
131015523|NCT02781584|471685073|FG000|Pre-treatment Phase|Adverse Event|0|||
131015524|NCT02781584|471685074|FG001|Pre-treatment Phase|Adverse Event|0|||
131015525|NCT02781584|471685075|FG002|Pre-treatment Phase|Adverse Event|0|||
131015526|NCT02781584|471685076|FG003|Pre-treatment Phase|Adverse Event|0|||
131015527|NCT02781584|471685077|FG004|Pre-treatment Phase|Adverse Event|0|||
131015528|NCT02781584|471685078|FG005|Pre-treatment Phase|Adverse Event|0|||
131015529|NCT02781584|471685079|FG006|Pre-treatment Phase|Adverse Event|0|||
131015530|NCT02781584|471685080|FG007|Pre-treatment Phase|Adverse Event|0|||
131015531|NCT02781584|471685081|FG008|Pre-treatment Phase|Adverse Event|0|||
131015532|NCT02781584|471685082|FG009|Pre-treatment Phase|Adverse Event|0|||
131015533|NCT02781584|471685083|FG010|Pre-treatment Phase|Adverse Event|0|||
131015534|NCT02781584|471685084|FG011|Pre-treatment Phase|Adverse Event|1|||
131015535|NCT02781584|471685085|FG012|Pre-treatment Phase|Adverse Event|0|||
131015536|NCT02781584|471685073|FG000|Treatment Phase|Withdrew Consent|0|||
131015537|NCT02781584|471685074|FG001|Treatment Phase|Withdrew Consent|0|||
131015538|NCT02781584|471685075|FG002|Treatment Phase|Withdrew Consent|0|||
131015539|NCT02781584|471685076|FG003|Treatment Phase|Withdrew Consent|0|||
131015540|NCT02781584|471685077|FG004|Treatment Phase|Withdrew Consent|0|||
131015541|NCT02781584|471685078|FG005|Treatment Phase|Withdrew Consent|1|||
131015542|NCT02781584|471685079|FG006|Treatment Phase|Withdrew Consent|0|||
131015543|NCT02781584|471685080|FG007|Treatment Phase|Withdrew Consent|0|||
131015544|NCT02781584|471685081|FG008|Treatment Phase|Withdrew Consent|0|||
131015545|NCT02781584|471685082|FG009|Treatment Phase|Withdrew Consent|0|||
131015546|NCT02781584|471685083|FG010|Treatment Phase|Withdrew Consent|1|||
131015547|NCT02781584|471685084|FG011|Treatment Phase|Withdrew Consent|2|||
131015548|NCT02781584|471685085|FG012|Treatment Phase|Withdrew Consent|0|||
131015549|NCT02781584|471685073|FG000|Treatment Phase|Adverse Event|0|||
131015550|NCT02781584|471685074|FG001|Treatment Phase|Adverse Event|0|||
131015551|NCT02781584|471685075|FG002|Treatment Phase|Adverse Event|0|||
131015552|NCT02781584|471685076|FG003|Treatment Phase|Adverse Event|0|||
131015553|NCT02781584|471685077|FG004|Treatment Phase|Adverse Event|0|||
131015554|NCT02781584|471685078|FG005|Treatment Phase|Adverse Event|0|||
131015555|NCT02781584|471685079|FG006|Treatment Phase|Adverse Event|0|||
131015556|NCT02781584|471685080|FG007|Treatment Phase|Adverse Event|1|||
131015557|NCT02781584|471685081|FG008|Treatment Phase|Adverse Event|0|||
131015558|NCT02781584|471685082|FG009|Treatment Phase|Adverse Event|0|||
131015559|NCT02781584|471685083|FG010|Treatment Phase|Adverse Event|0|||
131015560|NCT02781584|471685084|FG011|Treatment Phase|Adverse Event|0|||
131015561|NCT02781584|471685085|FG012|Treatment Phase|Adverse Event|0|||
131015562|NCT00208767|471685090|FG000|Overall Study|Adverse Event|9|||
131015563|NCT00208767|471685091|FG001|Overall Study|Adverse Event|1|||
131015564|NCT00208767|471685090|FG000|Overall Study|Withdrawal by Subject|14|||
131015565|NCT00208767|471685091|FG001|Overall Study|Withdrawal by Subject|3|||
131015566|NCT00208767|471685090|FG000|Overall Study|Death|1|||
131015567|NCT00208767|471685091|FG001|Overall Study|Death|0|||
131015568|NCT00208767|471685090|FG000|Overall Study|Lost to Follow-up|3|||
131015569|NCT00208767|471685091|FG001|Overall Study|Lost to Follow-up|3|||
131045797|NCT03582033|471802284|FG006|Part B|Study terminated by sponsor|0|||
131045798|NCT03582033|471802285|FG007|Part B|Study terminated by sponsor|0|||
131045799|NCT03582033|471802286|FG008|Part B|Study terminated by sponsor|0|||
130679209|NCT04885296|470452208|FG000|Period 1|Lost to Follow-up|1|||
130679210|NCT04885296|470452209|FG001|Period 1|Lost to Follow-up|0|||
131045800|NCT03582033|471802287|FG009|Part B|Study terminated by sponsor|0|||
131045801|NCT03582033|471802278|FG000|Part B|Withdrawal by Subject|0|||
130679211|NCT04885296|470452208|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
130679212|NCT04885296|470452209|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
130679213|NCT00862979|470452210|FG000|Overall Study|Adverse Event|6|||
130679214|NCT00862979|470452211|FG001|Overall Study|Adverse Event|3|||
130679215|NCT00862979|470452210|FG000|Overall Study|Protocol Violation|0|||
130679216|NCT00862979|470452211|FG001|Overall Study|Protocol Violation|1|||
130679217|NCT00862979|470452210|FG000|Overall Study|Patient withdrew consent|2|||
130679218|NCT00862979|470452211|FG001|Overall Study|Patient withdrew consent|1|||
130679219|NCT00862979|470452210|FG000|Overall Study|Administrative problems|0|||
130679220|NCT00862979|470452211|FG001|Overall Study|Administrative problems|1|||
130679221|NCT00862979|470452210|FG000|Overall Study|Death|0|||
130679222|NCT00862979|470452211|FG001|Overall Study|Death|1|||
131102221|NCT01160289|472003857|FG000|Post-Randomization Period|Lost to Follow-up|0|||
131102222|NCT01160289|472003858|FG001|Post-Randomization Period|Lost to Follow-up|3|||
131102223|NCT01160289|472003859|FG002|Post-Randomization Period|Lost to Follow-up|2|||
130679226|NCT00433147|470452215|FG000|Overall Study|Adverse Event|0|||
131015570|NCT05147233|471687024|FG000|Overall Study|Adverse Event|0|||
131015571|NCT05147233|471687025|FG001|Overall Study|Adverse Event|1|||
131015572|NCT05147233|471687024|FG000|Overall Study|Lost to Follow-up|1|||
131015573|NCT05147233|471687025|FG001|Overall Study|Lost to Follow-up|1|||
131015574|NCT05147233|471687024|FG000|Overall Study|Protocol Violation|0|||
131015575|NCT05147233|471687025|FG001|Overall Study|Protocol Violation|1|||
131015576|NCT05147233|471687024|FG000|Overall Study|Withdrawal by Subject|2|||
131015577|NCT05147233|471687025|FG001|Overall Study|Withdrawal by Subject|1|||
131015578|NCT04517864|471687028|FG000|Placebo-Controlled Phase|Adverse Event|1|||
131015579|NCT04517864|471687029|FG001|Placebo-Controlled Phase|Adverse Event|0|||
131015580|NCT04517864|471687030|FG002|Placebo-Controlled Phase|Adverse Event|0|||
131015581|NCT04517864|471687028|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
131015582|NCT04517864|471687029|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
131015583|NCT04517864|471687030|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
131015584|NCT04517864|471687028|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
131015585|NCT04517864|471687029|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
131015586|NCT04517864|471687030|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
131015587|NCT04517864|471687028|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
131015588|NCT04517864|471687029|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
131015589|NCT04517864|471687030|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
131015590|NCT04517864|471687028|FG000|Active Therapy Extension Phase|Adverse Event|1|||
131015591|NCT04517864|471687029|FG001|Active Therapy Extension Phase|Adverse Event|0|||
131015592|NCT04517864|471687030|FG002|Active Therapy Extension Phase|Adverse Event|0|||
131015593|NCT04517864|471687028|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
131015594|NCT04517864|471687029|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
131015595|NCT04517864|471687030|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
131015596|NCT04517864|471687028|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
131015597|NCT04517864|471687029|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
131015598|NCT04517864|471687030|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
131015599|NCT04517864|471687028|FG000|Active Therapy Extension Phase|Physician Decision|1|||
131015600|NCT04517864|471687029|FG001|Active Therapy Extension Phase|Physician Decision|0|||
131015601|NCT04517864|471687030|FG002|Active Therapy Extension Phase|Physician Decision|0|||
131015602|NCT04517864|471687028|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
131015603|NCT04517864|471687029|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
131015604|NCT04517864|471687030|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
131015605|NCT04517864|471687028|FG000|Extension Phase|Adverse Event|0|||
131015606|NCT04517864|471687029|FG001|Extension Phase|Adverse Event|0|||
131015607|NCT04517864|471687030|FG002|Extension Phase|Adverse Event|1|||
131015608|NCT04517864|471687028|FG000|Extension Phase|Lack of Efficacy|0|||
131015609|NCT04517864|471687029|FG001|Extension Phase|Lack of Efficacy|0|||
131015610|NCT04517864|471687030|FG002|Extension Phase|Lack of Efficacy|2|||
131015611|NCT04517864|471687028|FG000|Extension Phase|Study Terminated By Sponsor|0|||
131015612|NCT04517864|471687029|FG001|Extension Phase|Study Terminated By Sponsor|0|||
131015613|NCT04517864|471687030|FG002|Extension Phase|Study Terminated By Sponsor|32|||
131015614|NCT04517864|471687028|FG000|Extension Phase|Withdrawal by Subject|0|||
131015615|NCT04517864|471687029|FG001|Extension Phase|Withdrawal by Subject|0|||
131015616|NCT04517864|471687030|FG002|Extension Phase|Withdrawal by Subject|3|||
131015617|NCT04517864|471687028|FG000|Extension Phase|Approved Drug Available for Indication|0|||
131015618|NCT04517864|471687029|FG001|Extension Phase|Approved Drug Available for Indication|0|||
131015619|NCT04517864|471687030|FG002|Extension Phase|Approved Drug Available for Indication|7|||
131015620|NCT04722003|471687031|FG000|Overall Study|Lost to Follow-up|2|||
131015621|NCT04722003|471687032|FG001|Overall Study|Lost to Follow-up|0|||
131015622|NCT04722003|471687031|FG000|Overall Study|Physician Decision|1|||
131015623|NCT04722003|471687032|FG001|Overall Study|Physician Decision|0|||
131015624|NCT04860258|471687036|FG000|Overall Study|Withdrawal by Subject|0|||
130679227|NCT00433147|470452216|FG001|Overall Study|Adverse Event|1|||
130679228|NCT00433147|470452217|FG002|Overall Study|Adverse Event|0|||
130679229|NCT00433147|470452218|FG003|Overall Study|Adverse Event|0|||
131102224|NCT01160289|472003860|FG003|Post-Randomization Period|Lost to Follow-up|5|||
131102225|NCT01160289|472003861|FG004|Post-Randomization Period|Lost to Follow-up|3|||
131102226|NCT01160289|472003862|FG005|Post-Randomization Period|Lost to Follow-up|4|||
131102227|NCT01160289|472003857|FG000|Post-Randomization Period|Physician Decision|0|||
131102228|NCT01160289|472003858|FG001|Post-Randomization Period|Physician Decision|0|||
131102229|NCT01160289|472003859|FG002|Post-Randomization Period|Physician Decision|1|||
131102230|NCT01160289|472003860|FG003|Post-Randomization Period|Physician Decision|0|||
131102231|NCT01160289|472003861|FG004|Post-Randomization Period|Physician Decision|0|||
131102232|NCT01160289|472003862|FG005|Post-Randomization Period|Physician Decision|0|||
131102233|NCT01160289|472003857|FG000|Post-Randomization Period|Protocol Violation|0|||
131102234|NCT01160289|472003858|FG001|Post-Randomization Period|Protocol Violation|4|||
131102235|NCT01160289|472003859|FG002|Post-Randomization Period|Protocol Violation|2|||
131102236|NCT01160289|472003860|FG003|Post-Randomization Period|Protocol Violation|0|||
131102237|NCT01160289|472003861|FG004|Post-Randomization Period|Protocol Violation|1|||
131102238|NCT01160289|472003862|FG005|Post-Randomization Period|Protocol Violation|3|||
131102239|NCT01160289|472003857|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
131102240|NCT01160289|472003858|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
131102241|NCT01160289|472003859|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
131102242|NCT01160289|472003860|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
131102243|NCT01160289|472003861|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
131102244|NCT01160289|472003862|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
131102245|NCT01160289|472003857|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
131102246|NCT01160289|472003858|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
131102247|NCT01160289|472003859|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
131102248|NCT01160289|472003860|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
131102249|NCT01160289|472003861|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
131102250|NCT01160289|472003862|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
131102251|NCT01160289|472003857|FG000|Post-Randomization Period|Sponsor Decision|0|||
131102252|NCT01160289|472003858|FG001|Post-Randomization Period|Sponsor Decision|1|||
131102253|NCT01160289|472003859|FG002|Post-Randomization Period|Sponsor Decision|0|||
131102254|NCT01160289|472003860|FG003|Post-Randomization Period|Sponsor Decision|0|||
131102255|NCT01160289|472003861|FG004|Post-Randomization Period|Sponsor Decision|0|||
131102256|NCT01160289|472003862|FG005|Post-Randomization Period|Sponsor Decision|0|||
131102257|NCT01156792|472003864|FG000|Overall Study|Adverse Event|1|||
131102258|NCT01156792|472003864|FG000|Overall Study|Lack of Efficacy|36|||
131102259|NCT01156792|472003864|FG000|Overall Study|Protocol Violation|6|||
131102260|NCT01156792|472003864|FG000|Overall Study|Lost to Follow-up|3|||
131102261|NCT01156792|472003864|FG000|Overall Study|Physician Decision|3|||
131102262|NCT01156792|472003864|FG000|Overall Study|Withdrawal by Subject|9|||
130679230|NCT01882647|470452219|FG000|Overall Study|Lost to Follow-up|2|||
130679231|NCT01882647|470452220|FG001|Overall Study|Lost to Follow-up|2|||
130679232|NCT01882647|470452219|FG000|Overall Study|Withdrawal by Subject|0|||
130679233|NCT01882647|470452220|FG001|Overall Study|Withdrawal by Subject|4|||
130679234|NCT01027143|470452223|FG000|Overall Study|Lost to Follow-up|9|||
130679235|NCT01027143|470452224|FG001|Overall Study|Lost to Follow-up|4|||
130679236|NCT03292653|470452226|FG000|Overall Study|Adverse Event|0|||
131015625|NCT04860258|471687037|FG001|Overall Study|Withdrawal by Subject|0|||
131015626|NCT04860258|471687038|FG002|Overall Study|Withdrawal by Subject|4|||
131015627|NCT04860258|471687039|FG003|Overall Study|Withdrawal by Subject|1|||
131015628|NCT04860258|471687040|FG004|Overall Study|Withdrawal by Subject|4|||
131015629|NCT04860258|471687041|FG005|Overall Study|Withdrawal by Subject|1|||
131015630|NCT04860258|471687042|FG006|Overall Study|Withdrawal by Subject|0|||
131015631|NCT00357396|471687043|FG000|Overall Study|Adverse Event|1|||
131015632|NCT00357396|471687044|FG001|Overall Study|Adverse Event|0|||
131015633|NCT02496702|471687045|FG000|Overall Study|Lost to Follow-up|8|||
131015634|NCT02496702|471687046|FG001|Overall Study|Lost to Follow-up|6|||
131015635|NCT02496702|471687045|FG000|Overall Study|Only partially tested|0|||
131015636|NCT02496702|471687046|FG001|Overall Study|Only partially tested|2|||
131015637|NCT03743246|471687061|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
131015638|NCT03743246|471687062|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
131015639|NCT03743246|471687063|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
131015640|NCT03743246|471687064|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
131015641|NCT03743246|471687061|FG000|Pre-Treatment Period|Death|0|||
131015642|NCT03743246|471687062|FG001|Pre-Treatment Period|Death|1|||
131015643|NCT03743246|471687063|FG002|Pre-Treatment Period|Death|0|||
131015644|NCT03743246|471687064|FG003|Pre-Treatment Period|Death|1|||
131015645|NCT03743246|471687061|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
131015646|NCT03743246|471687062|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
131015647|NCT03743246|471687063|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
131102263|NCT01156792|472003864|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
131102264|NCT01474434|472003865|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
130679237|NCT03292653|470452227|FG001|Overall Study|Adverse Event|0|||
130679238|NCT03292653|470452228|FG002|Overall Study|Adverse Event|1|||
131102265|NCT01474434|472003866|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
131102266|NCT01474434|472003867|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
131102267|NCT01474434|472003868|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
131102268|NCT01474434|472003865|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
131102269|NCT01474434|472003866|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
131102270|NCT01474434|472003867|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
131102271|NCT01474434|472003868|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
131102272|NCT01474434|472003865|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
131102273|NCT01474434|472003866|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
131102274|NCT01474434|472003867|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
131102275|NCT01474434|472003868|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
131102276|NCT00993668|472003869|FG000|Single-Blind Period|Adverse Event|1|||
131102277|NCT00993668|472003870|FG001|Single-Blind Period|Adverse Event|1|||
131102278|NCT00993668|472003869|FG000|Single-Blind Period|Lack of Efficacy|0|||
131102279|NCT00993668|472003870|FG001|Single-Blind Period|Lack of Efficacy|1|||
131102280|NCT00993668|472003869|FG000|Single-Blind Period|Lost to Follow-up|3|||
131102281|NCT00993668|472003870|FG001|Single-Blind Period|Lost to Follow-up|1|||
131102282|NCT00993668|472003869|FG000|Open-Label Period|Adverse Event|9|||
131102283|NCT00993668|472003870|FG001|Open-Label Period|Adverse Event|8|||
131102284|NCT00993668|472003869|FG000|Open-Label Period|Lack of Efficacy|4|||
131102285|NCT00993668|472003870|FG001|Open-Label Period|Lack of Efficacy|3|||
131102286|NCT00993668|472003869|FG000|Open-Label Period|Withdrawal by Subject|4|||
131102287|NCT00993668|472003870|FG001|Open-Label Period|Withdrawal by Subject|3|||
131102288|NCT00993668|472003869|FG000|Open-Label Period|Lost to Follow-up|6|||
131102289|NCT00993668|472003870|FG001|Open-Label Period|Lost to Follow-up|1|||
131102290|NCT03606668|472003873|FG000|Overall Study|Screen Failure|1|||
131102291|NCT03606668|472003873|FG000|Overall Study|Lost to Follow-up|1|||
131102292|NCT02057523|472003877|FG000|Overall Study|Withdrawal by Subject|1|||
131102293|NCT02057523|472003877|FG000|Overall Study|Lack of Efficacy|1|||
131102294|NCT02399254|472003881|FG000|Overall Study|Physician Decision|2|||
131102295|NCT02292927|472003882|FG000|Overall Study|Protocol Violation|13|||
131102296|NCT02292927|472003883|FG001|Overall Study|Protocol Violation|7|||
131102297|NCT01656733|472003887|FG000|Overall Study|No permission to collect birth outcomes|0|||
131102298|NCT01656733|472003888|FG001|Overall Study|No permission to collect birth outcomes|1|||
131102299|NCT01656733|472003887|FG000|Overall Study|Delivery at another hospital|0|||
131102300|NCT01656733|472003888|FG001|Overall Study|Delivery at another hospital|2|||
131102301|NCT01656733|472003887|FG000|Overall Study|Spontaneous abortion|0|||
131102302|NCT01656733|472003888|FG001|Overall Study|Spontaneous abortion|1|||
131102303|NCT00141219|472003891|FG000|Overall Study|Protocol violations|5|||
131102304|NCT00141219|472003892|FG001|Overall Study|Protocol violations|4|||
131102305|NCT00141219|472003891|FG000|Overall Study|Adverse Event|8|||
131102306|NCT00141219|472003892|FG001|Overall Study|Adverse Event|6|||
131102307|NCT00141219|472003891|FG000|Overall Study|Lack of Efficacy|5|||
131102308|NCT00141219|472003892|FG001|Overall Study|Lack of Efficacy|4|||
131102309|NCT00141219|472003891|FG000|Overall Study|Withdrawal by Subject|6|||
131102310|NCT00141219|472003892|FG001|Overall Study|Withdrawal by Subject|2|||
131102311|NCT00122460|472003894|FG000|Overall Study|investigational study phase ongoing|7|||
131102312|NCT00122460|472003895|FG001|Overall Study|investigational study phase ongoing|1|||
131102313|NCT02962960|472003896|FG000|Overall Study|Withdrawal by Subject|1|||
131102314|NCT02962960|472003897|FG001|Overall Study|Withdrawal by Subject|1|||
131102315|NCT02962960|472003898|FG002|Overall Study|Withdrawal by Subject|0|||
131102316|NCT02962960|472003896|FG000|Overall Study|Adverse Event|1|||
131102317|NCT02962960|472003897|FG001|Overall Study|Adverse Event|1|||
131102318|NCT02962960|472003898|FG002|Overall Study|Adverse Event|0|||
131102319|NCT02962960|472003896|FG000|Overall Study|Protocol Violation|1|||
131102320|NCT02962960|472003897|FG001|Overall Study|Protocol Violation|0|||
131102321|NCT02962960|472003898|FG002|Overall Study|Protocol Violation|0|||
131102322|NCT02595073|472003899|FG000|Overall Study|Progressive Disease|0|||
131102323|NCT02595073|472003900|FG001|Overall Study|Progressive Disease|1|||
131102324|NCT02595073|472003899|FG000|Overall Study|Protocol Violation|2|||
131102325|NCT02595073|472003900|FG001|Overall Study|Protocol Violation|0|||
131102326|NCT01605019|472003901|FG000|Overall Study|pt did not meet transplant endpoint|3|||
131102327|NCT01605019|472003902|FG001|Overall Study|pt did not meet transplant endpoint|0|||
131102328|NCT01451827|472003903|FG000|Overall Study|Adverse Event|2|||
131102329|NCT01451827|472003904|FG001|Overall Study|Adverse Event|0|||
131102330|NCT01451827|472003905|FG002|Overall Study|Adverse Event|1|||
131102331|NCT01451827|472003906|FG003|Overall Study|Adverse Event|1|||
131102332|NCT01451827|472003903|FG000|Overall Study|Protocol deviation|1|||
131102333|NCT01451827|472003904|FG001|Overall Study|Protocol deviation|0|||
131102334|NCT01451827|472003905|FG002|Overall Study|Protocol deviation|0|||
131102335|NCT01451827|472003906|FG003|Overall Study|Protocol deviation|0|||
131102336|NCT01451827|472003903|FG000|Overall Study|Lost to Follow-up|0|||
131102337|NCT01451827|472003904|FG001|Overall Study|Lost to Follow-up|3|||
131102338|NCT01451827|472003905|FG002|Overall Study|Lost to Follow-up|0|||
131102339|NCT01451827|472003906|FG003|Overall Study|Lost to Follow-up|2|||
130679239|NCT03292653|470452226|FG000|Overall Study|Did not Receive Treatment|1|||
130679240|NCT03292653|470452227|FG001|Overall Study|Did not Receive Treatment|0|||
130679241|NCT03292653|470452228|FG002|Overall Study|Did not Receive Treatment|0|||
130679242|NCT01367275|470452231|FG000|Overall Study|Ineligible|1|||
130679243|NCT01367275|470452231|FG000|Overall Study|Disease Progression|2|||
130679244|NCT05346055|470452232|FG000|Overall Study|Withdrawal by Subject|1|||
130679245|NCT05346055|470452232|FG000|Overall Study|Protocol Violation|1|||
130679246|NCT05346055|470452232|FG000|Overall Study|Therapist decision|1|||
130679247|NCT02564263|470452235|FG000|Overall Study|Adverse Event|31|||
130679248|NCT02564263|470452236|FG001|Overall Study|Adverse Event|29|||
130679249|NCT02564263|470452235|FG000|Overall Study|Death|270|||
130679250|NCT02564263|470452236|FG001|Overall Study|Death|262|||
130985440|NCT02889133|471572912|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
131015648|NCT03743246|471687064|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
131015649|NCT03743246|471687061|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
131015650|NCT03743246|471687062|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
131015651|NCT03743246|471687063|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
131015652|NCT03743246|471687064|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
131015653|NCT03743246|471687061|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
131015654|NCT03743246|471687062|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
131015655|NCT03743246|471687063|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
131015656|NCT03743246|471687064|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
131015657|NCT03743246|471687061|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
131015658|NCT03743246|471687062|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
131015659|NCT03743246|471687063|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
131015660|NCT03743246|471687064|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
131015661|NCT03743246|471687061|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
131015662|NCT03743246|471687062|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
131015663|NCT03743246|471687063|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
131015664|NCT03743246|471687064|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
131015665|NCT03743246|471687061|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
131015666|NCT03743246|471687062|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
131015667|NCT03743246|471687063|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
131015668|NCT03743246|471687064|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
131015669|NCT03743246|471687061|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
131015670|NCT03743246|471687062|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
131015671|NCT03743246|471687063|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
131015672|NCT03743246|471687064|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
131015673|NCT02026258|471687065|FG000|Randomized|Did not start treatment|2|||
131015674|NCT02026258|471687066|FG001|Randomized|Did not start treatment|1|||
131015675|NCT02026258|471687065|FG000|Randomized|Change in treatment plan|1|||
131015676|NCT02026258|471687066|FG001|Randomized|Change in treatment plan|0|||
131015677|NCT02026258|471687065|FG000|Randomized|Presence of periodontal disease|1|||
131015678|NCT02026258|471687066|FG001|Randomized|Presence of periodontal disease|1|||
131015679|NCT02026258|471687065|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
131015680|NCT02026258|471687066|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
131015681|NCT02026258|471687065|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
131015682|NCT02026258|471687066|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
131015683|NCT02534350|471687067|FG000|Overall Study|Randomized But Not Treated|1|||
131015684|NCT02534350|471687068|FG001|Overall Study|Randomized But Not Treated|0|||
130679251|NCT02564263|470452235|FG000|Overall Study|Withdrawal by Subject|4|||
130679252|NCT02564263|470452236|FG001|Overall Study|Withdrawal by Subject|19|||
130985441|NCT02889133|471572913|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
130985442|NCT02889133|471572912|FG000|Completed Primary Outcome|Manufacturing error|3|||
130985443|NCT02889133|471572913|FG001|Completed Primary Outcome|Manufacturing error|8|||
130985444|NCT02889133|471572912|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
130985445|NCT02889133|471572913|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
130985446|NCT02889133|471572912|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
130985447|NCT02889133|471572913|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
130985448|NCT02889133|471572912|FG000|Completed Primary Outcome|Protocol Violation|1|||
130985449|NCT02889133|471572913|FG001|Completed Primary Outcome|Protocol Violation|0|||
130985450|NCT02889133|471572912|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
130985451|NCT02889133|471572913|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
130985452|NCT02889133|471572912|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
130985453|NCT02889133|471572913|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
130985454|NCT02889133|471572912|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
130985455|NCT02889133|471572913|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
130985456|NCT02889133|471572912|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
130985457|NCT02889133|471572913|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
130679253|NCT02564263|470452235|FG000|Overall Study|Sponsor's decision|9|||
130679254|NCT02564263|470452236|FG001|Overall Study|Sponsor's decision|4|||
130679255|NCT03311646|470452237|FG000|Overall Study|Physician Decision|1|||
130679256|NCT03311646|470452237|FG000|Overall Study|Withdrawal by Subject|5|||
130679257|NCT03311646|470452237|FG000|Overall Study|Lost to Follow-up|5|||
130679258|NCT03311646|470452237|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
130679259|NCT00728949|470452243|FG000|Overall Study|Adverse Event|8|||
130679260|NCT00728949|470452244|FG001|Overall Study|Adverse Event|0|||
130679261|NCT00728949|470452243|FG000|Overall Study|Withdrawal by Subject|2|||
131015685|NCT02534350|471687067|FG000|Overall Study|Protocol Violation|1|||
131015686|NCT02534350|471687068|FG001|Overall Study|Protocol Violation|0|||
131015687|NCT02534350|471687067|FG000|Overall Study|Withdrew Consent|2|||
131015688|NCT02534350|471687068|FG001|Overall Study|Withdrew Consent|0|||
131015689|NCT02878330|471687081|FG000|Overall Study|Death|3|||
131015690|NCT02878330|471687082|FG001|Overall Study|Death|2|||
131015691|NCT02878330|471687081|FG000|Overall Study|Lost to Follow-up|11|||
131015692|NCT02878330|471687082|FG001|Overall Study|Lost to Follow-up|26|||
131015693|NCT02878330|471687081|FG000|Overall Study|Withdrawal by Subject|11|||
131015694|NCT02878330|471687082|FG001|Overall Study|Withdrawal by Subject|21|||
131015695|NCT02878330|471687081|FG000|Overall Study|Other|4|||
131015696|NCT02878330|471687082|FG001|Overall Study|Other|7|||
131015697|NCT00319436|471687083|FG000|Overall Study|Withdrawal by Subject|6|||
131015698|NCT00319436|471687084|FG001|Overall Study|Withdrawal by Subject|7|||
131015699|NCT02194933|471687095|FG000|Overall Study|Lost to Follow-up|1|||
131015700|NCT02194933|471687096|FG001|Overall Study|Lost to Follow-up|2|||
131015701|NCT02194933|471687095|FG000|Overall Study|Participant met withdrawal criteria|1|||
131015702|NCT02194933|471687096|FG001|Overall Study|Participant met withdrawal criteria|3|||
131015703|NCT02194933|471687095|FG000|Overall Study|Withdrawal by Subject|0|||
131015704|NCT02194933|471687096|FG001|Overall Study|Withdrawal by Subject|2|||
131015705|NCT02194933|471687095|FG000|Overall Study|Lack of Efficacy|1|||
131015706|NCT02194933|471687096|FG001|Overall Study|Lack of Efficacy|2|||
131015707|NCT02914522|471687097|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
131015708|NCT02914522|471687098|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
131015709|NCT02914522|471687099|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
131015710|NCT02914522|471687100|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
131015711|NCT02914522|471687101|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
131015712|NCT02914522|471687102|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
131015713|NCT02914522|471687103|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
131015714|NCT02914522|471687104|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
131015715|NCT02914522|471687105|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
131015716|NCT02914522|471687106|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
131015717|NCT02914522|471687107|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
131015718|NCT02914522|471687097|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
131015719|NCT02914522|471687098|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
131015720|NCT02914522|471687099|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
131015721|NCT02914522|471687100|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
131015722|NCT02914522|471687101|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
131015723|NCT02914522|471687102|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
131015724|NCT02914522|471687103|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
131015725|NCT02914522|471687104|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
131015726|NCT02914522|471687105|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
131015727|NCT02914522|471687106|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
131015728|NCT02914522|471687107|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
131015729|NCT02914522|471687097|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
131015730|NCT02914522|471687098|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
131015731|NCT02914522|471687099|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
131015732|NCT02914522|471687100|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
131015733|NCT02914522|471687101|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
131015734|NCT02914522|471687102|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
131015735|NCT02914522|471687103|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
131015736|NCT02914522|471687104|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
131015737|NCT02914522|471687105|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
131015738|NCT02914522|471687106|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
131015739|NCT02914522|471687107|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
131015740|NCT02914522|471687097|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131015741|NCT02914522|471687098|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
131015742|NCT02914522|471687099|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
131015743|NCT02914522|471687100|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
131015744|NCT02914522|471687101|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131015745|NCT02914522|471687102|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131015746|NCT02914522|471687103|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131045802|NCT03582033|471802279|FG001|Part B|Withdrawal by Subject|0|||
130679262|NCT00728949|470452244|FG001|Overall Study|Withdrawal by Subject|2|||
130679263|NCT00728949|470452243|FG000|Overall Study|Abnormal Lab Results|0|||
131102340|NCT01451827|472003903|FG000|Overall Study|Participant met withdrawal criteria|0|||
131102341|NCT01451827|472003904|FG001|Overall Study|Participant met withdrawal criteria|2|||
131102342|NCT01451827|472003905|FG002|Overall Study|Participant met withdrawal criteria|0|||
131102343|NCT01451827|472003906|FG003|Overall Study|Participant met withdrawal criteria|0|||
131102344|NCT01451827|472003903|FG000|Overall Study|Withdrawal by Subject|0|||
131102345|NCT01451827|472003904|FG001|Overall Study|Withdrawal by Subject|0|||
131102346|NCT01451827|472003905|FG002|Overall Study|Withdrawal by Subject|1|||
131102347|NCT01451827|472003906|FG003|Overall Study|Withdrawal by Subject|1|||
131102348|NCT02424734|472003907|FG000|Overall Study|Treatment stopped to be discharged home|2|||
131102349|NCT02424734|472003908|FG001|Overall Study|Treatment stopped to be discharged home|2|||
131102350|NCT02424734|472003909|FG002|Overall Study|Treatment stopped to be discharged home|0|||
131102351|NCT01642251|472003910|FG000|Overall Study|Progressive disease|0|||
131102352|NCT01642251|472003911|FG001|Overall Study|Progressive disease|0|||
131102353|NCT01642251|472003912|FG002|Overall Study|Progressive disease|3|||
131102354|NCT01642251|472003913|FG003|Overall Study|Progressive disease|3|||
131102355|NCT01642251|472003910|FG000|Overall Study|Adverse Event|0|||
131102356|NCT01642251|472003911|FG001|Overall Study|Adverse Event|0|||
131102357|NCT01642251|472003912|FG002|Overall Study|Adverse Event|5|||
130679264|NCT00728949|470452244|FG001|Overall Study|Abnormal Lab Results|2|||
130679265|NCT00728949|470452243|FG000|Overall Study|On treatment at cutoff date|1|||
130679266|NCT00728949|470452244|FG001|Overall Study|On treatment at cutoff date|0|||
130679267|NCT03127137|470452246|FG000|Overall Study|Requested sedation after consent|1|||
130679268|NCT03127137|470452247|FG001|Overall Study|Requested sedation after consent|0|||
130679269|NCT03127137|470452246|FG000|Overall Study|Malfunction in electronic data collection|1|||
130679270|NCT03127137|470452247|FG001|Overall Study|Malfunction in electronic data collection|0|||
130679271|NCT03127137|470452246|FG000|Overall Study|Post procedure testing could not be obtained|0|||
130679272|NCT03127137|470452247|FG001|Overall Study|Post procedure testing could not be obtained|1|||
130679273|NCT02319148|470452252|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
130679274|NCT02319148|470452253|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
130679275|NCT02319148|470452254|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
130679276|NCT02319148|470452255|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
130679277|NCT02319148|470452252|FG000|Second Intervention Period|No longer willing to participate|0|||
130679278|NCT02319148|470452253|FG001|Second Intervention Period|No longer willing to participate|1|||
131102358|NCT01642251|472003913|FG003|Overall Study|Adverse Event|4|||
131102359|NCT01642251|472003910|FG000|Overall Study|Death|0|||
131102360|NCT01642251|472003911|FG001|Overall Study|Death|0|||
131102361|NCT01642251|472003912|FG002|Overall Study|Death|1|||
131102362|NCT01642251|472003913|FG003|Overall Study|Death|3|||
131102363|NCT01642251|472003910|FG000|Overall Study|Withdrawal by Subject|0|||
131102364|NCT01642251|472003911|FG001|Overall Study|Withdrawal by Subject|0|||
131102365|NCT01642251|472003912|FG002|Overall Study|Withdrawal by Subject|1|||
131102366|NCT01642251|472003913|FG003|Overall Study|Withdrawal by Subject|3|||
131102367|NCT01642251|472003910|FG000|Overall Study|Alternative therapy|0|||
131102368|NCT01642251|472003911|FG001|Overall Study|Alternative therapy|0|||
131102369|NCT01642251|472003912|FG002|Overall Study|Alternative therapy|0|||
131102370|NCT01642251|472003913|FG003|Overall Study|Alternative therapy|2|||
131102371|NCT01642251|472003910|FG000|Overall Study|Other complicating disease|0|||
131102372|NCT01642251|472003911|FG001|Overall Study|Other complicating disease|0|||
131102373|NCT01642251|472003912|FG002|Overall Study|Other complicating disease|1|||
130679279|NCT02319148|470452254|FG002|Second Intervention Period|No longer willing to participate|0|||
130679280|NCT02319148|470452255|FG003|Second Intervention Period|No longer willing to participate|0|||
130679281|NCT02319148|470452252|FG000|Second Intervention Period|Other|0|||
130679282|NCT02319148|470452253|FG001|Second Intervention Period|Other|0|||
130679283|NCT02319148|470452254|FG002|Second Intervention Period|Other|0|||
130679284|NCT02319148|470452255|FG003|Second Intervention Period|Other|1|||
130679285|NCT01087970|470452257|FG000|Overall Study|Protocol Violation|2|||
130679286|NCT00543309|470452258|FG000|Overall Study|Physician Decision|0|||
131102374|NCT01642251|472003913|FG003|Overall Study|Other complicating disease|0|||
131102375|NCT01642251|472003910|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
130679287|NCT00543309|470452259|FG001|Overall Study|Physician Decision|1|||
130679288|NCT00543309|470452260|FG002|Overall Study|Physician Decision|0|||
130679289|NCT01249664|470452261|FG000|Overall Study|Withdrawal by Subject|5|||
130679290|NCT01249664|470452262|FG001|Overall Study|Withdrawal by Subject|0|||
130679291|NCT01249664|470452261|FG000|Overall Study|Adverse Event|1|||
131102376|NCT01642251|472003911|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
131102377|NCT01642251|472003912|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
130679292|NCT01249664|470452262|FG001|Overall Study|Adverse Event|0|||
131102378|NCT01642251|472003913|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
131102379|NCT00470366|472003914|FG000|Overall Study|Adverse Event|3|||
131102380|NCT00470366|472003914|FG000|Overall Study|Poor compliance|1|||
131102381|NCT02996474|472003915|FG000|Overall Study|Physician Decision|5|||
131102382|NCT04493502|472003916|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
131102383|NCT04493502|472003917|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
130679293|NCT02636907|470452265|FG000|Autoinjector Assessment Period|Adverse Event|2|||
130679294|NCT02636907|470452265|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
130679295|NCT02636907|470452265|FG000|Extension Phase|Adverse Event|2|||
130679296|NCT02636907|470452265|FG000|Extension Phase|Withdrawal by Subject|4|||
130679297|NCT02636907|470452265|FG000|Extension Phase|Physician Decision|1|||
130679298|NCT02636907|470452265|FG000|Extension Phase|Lost to Follow-up|2|||
130679299|NCT02636907|470452265|FG000|Extension Phase|Lack of Efficacy|1|||
130679300|NCT01682083|470452272|FG000|Overall Study|Lost to Follow-up|11|||
130679301|NCT01682083|470452273|FG001|Overall Study|Lost to Follow-up|18|||
130679302|NCT01682083|470452272|FG000|Overall Study|Withdrawal by Subject|31|||
130679303|NCT01682083|470452273|FG001|Overall Study|Withdrawal by Subject|40|||
130679304|NCT01682083|470452272|FG000|Overall Study|Death|60|||
130679305|NCT01682083|470452273|FG001|Overall Study|Death|93|||
130679306|NCT01682083|470452272|FG000|Overall Study|Physician Decision|5|||
130679307|NCT01682083|470452273|FG001|Overall Study|Physician Decision|4|||
130679308|NCT01074554|470452277|FG000|Overall Study|Adverse Event|3|||
130679309|NCT01074554|470452278|FG001|Overall Study|Adverse Event|3|||
130679310|NCT01074554|470452277|FG000|Overall Study|Lost to Follow-up|0|||
130679311|NCT01074554|470452278|FG001|Overall Study|Lost to Follow-up|1|||
130679312|NCT01239121|470452279|FG000|Overall Study|Withdrawal by Subject|2|||
130679313|NCT01239121|470452280|FG001|Overall Study|Withdrawal by Subject|4|||
130679314|NCT01239121|470452281|FG002|Overall Study|Withdrawal by Subject|0|||
130679315|NCT04276883|470452282|FG000|Overall Study|Withdrawal by Subject|2|||
130679316|NCT04276883|470452283|FG001|Overall Study|Withdrawal by Subject|3|||
131102384|NCT04493502|472003916|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
131102385|NCT04493502|472003917|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
131102386|NCT04493502|472003916|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
131102387|NCT04493502|472003917|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
131102388|NCT04493502|472003916|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
130679317|NCT04276883|470452284|FG002|Overall Study|Withdrawal by Subject|6|||
130679318|NCT04276883|470452282|FG000|Overall Study|Lost to Follow-up|1|||
130679319|NCT04276883|470452283|FG001|Overall Study|Lost to Follow-up|3|||
131102389|NCT04493502|472003917|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
131102390|NCT04493502|472003916|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
131102391|NCT04493502|472003917|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
131102392|NCT04493502|472003916|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
131102393|NCT04493502|472003917|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
131102394|NCT04493502|472003916|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
131102395|NCT04493502|472003917|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
131102396|NCT04493502|472003916|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
131102397|NCT04493502|472003917|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
131102398|NCT04493502|472003916|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
131102399|NCT04493502|472003917|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
131102400|NCT04493502|472003916|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
131102401|NCT04493502|472003917|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
131102402|NCT04493502|472003916|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
131102403|NCT04493502|472003917|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
131102404|NCT04493502|472003916|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
131102405|NCT04493502|472003917|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
131102406|NCT04493502|472003916|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
131102407|NCT04493502|472003917|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
131102408|NCT00540046|472003918|FG000|Overall Study|Lost to Follow-up|33|||
131102409|NCT00540046|472003919|FG001|Overall Study|Lost to Follow-up|23|||
131102410|NCT02751320|472003921|FG000|Overall Study|Adverse Event|2|||
131102411|NCT02751320|472003921|FG000|Overall Study|Withdrawal by Subject|1|||
131102412|NCT01021215|472003922|FG000|Overall Study|Lost to Follow-up|3|||
131102413|NCT01021215|472003923|FG001|Overall Study|Lost to Follow-up|0|||
131102414|NCT02549196|472003924|FG000|Overall Study|Protocol Violation|0|||
131102415|NCT02549196|472003925|FG001|Overall Study|Protocol Violation|0|||
130679320|NCT04276883|470452284|FG002|Overall Study|Lost to Follow-up|0|||
130679321|NCT04276883|470452282|FG000|Overall Study|Adverse Event|0|||
130679322|NCT04276883|470452283|FG001|Overall Study|Adverse Event|1|||
130679323|NCT04276883|470452284|FG002|Overall Study|Adverse Event|0|||
130679324|NCT04276883|470452282|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
130679325|NCT04276883|470452283|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
131102416|NCT02549196|472003926|FG002|Overall Study|Protocol Violation|0|||
130679326|NCT04276883|470452284|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
130679327|NCT01876706|470452285|FG000|Overall Study|BPH Intervention|9|||
131102417|NCT02549196|472003927|FG003|Overall Study|Protocol Violation|1|||
131102418|NCT02549196|472003924|FG000|Overall Study|Withdrawal by Subject|1|||
130679328|NCT01876706|470452285|FG000|Overall Study|Lost to Follow-up|7|||
130679329|NCT01876706|470452285|FG000|Overall Study|Withdrawals|6|||
130679330|NCT01876706|470452285|FG000|Overall Study|Death|3|||
130679331|NCT00659607|470452286|FG000|Overall Study|No blood pressure recorded|147|||
130679332|NCT00659607|470452286|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
130679333|NCT00659607|470452286|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
130679334|NCT00659607|470452286|FG000|Overall Study|No recorded efficacy data|15|||
130679335|NCT00659607|470452286|FG000|Overall Study|Inconsistent BP measuring date|2|||
130679336|NCT02073643|470452289|FG000|Overall Study|Lost to Follow-up|24|||
130679337|NCT02468778|470452295|FG000|Overall Study|Death|2|||
130679338|NCT02468778|470452296|FG001|Overall Study|Death|1|||
131102419|NCT02549196|472003925|FG001|Overall Study|Withdrawal by Subject|0|||
131102420|NCT02549196|472003926|FG002|Overall Study|Withdrawal by Subject|1|||
131102421|NCT02549196|472003927|FG003|Overall Study|Withdrawal by Subject|0|||
131102422|NCT01103362|472003928|FG000|Overall Study|study terminated|596|||
131102423|NCT02047903|472003929|FG000|Overall Study|Adverse Event|14|||
131102424|NCT02047903|472003929|FG000|Overall Study|Serious adverse event|10|||
131102425|NCT02047903|472003929|FG000|Overall Study|Withdrawal by Subject|16|||
131102426|NCT02047903|472003929|FG000|Overall Study|Lost to Follow-up|4|||
131102427|NCT02047903|472003929|FG000|Overall Study|Reason not listed|6|||
131102428|NCT02047903|472003929|FG000|Overall Study|Not Treated|9|||
131102429|NCT00296400|472003933|FG000|Overall Study|Adverse Event|7|||
131102430|NCT00296400|472003934|FG001|Overall Study|Adverse Event|7|||
131102431|NCT00296400|472003935|FG002|Overall Study|Adverse Event|7|||
131102432|NCT00296400|472003933|FG000|Overall Study|Withdrawal by Subject|5|||
131102433|NCT00296400|472003934|FG001|Overall Study|Withdrawal by Subject|6|||
131102434|NCT00296400|472003935|FG002|Overall Study|Withdrawal by Subject|2|||
131102435|NCT00296400|472003933|FG000|Overall Study|Incorrect enrollment|2|||
131102436|NCT00296400|472003934|FG001|Overall Study|Incorrect enrollment|0|||
131102437|NCT00296400|472003935|FG002|Overall Study|Incorrect enrollment|0|||
131102438|NCT00296400|472003933|FG000|Overall Study|Protocol Violation|1|||
131102439|NCT00296400|472003934|FG001|Overall Study|Protocol Violation|1|||
131102440|NCT00296400|472003935|FG002|Overall Study|Protocol Violation|1|||
131102441|NCT00296400|472003933|FG000|Overall Study|Lost to Follow-up|1|||
131102442|NCT00296400|472003934|FG001|Overall Study|Lost to Follow-up|1|||
131102443|NCT00296400|472003935|FG002|Overall Study|Lost to Follow-up|2|||
131102444|NCT00296400|472003933|FG000|Overall Study|Study specific discontinuation criteria|0|||
131102445|NCT00296400|472003934|FG001|Overall Study|Study specific discontinuation criteria|0|||
131102446|NCT00296400|472003935|FG002|Overall Study|Study specific discontinuation criteria|1|||
131102447|NCT00296400|472003933|FG000|Overall Study|Visit 10 was performed earlier|0|||
131102448|NCT00296400|472003934|FG001|Overall Study|Visit 10 was performed earlier|1|||
131102449|NCT00296400|472003935|FG002|Overall Study|Visit 10 was performed earlier|0|||
131102450|NCT00296400|472003933|FG000|Overall Study|Pregnancy|1|||
131102451|NCT00296400|472003934|FG001|Overall Study|Pregnancy|2|||
131102452|NCT00296400|472003935|FG002|Overall Study|Pregnancy|0|||
131102453|NCT00412061|472003937|FG000|Double Blind Phase|Disease Progression|101|||
131102454|NCT00412061|472003938|FG001|Double Blind Phase|Disease Progression|154|||
131102455|NCT00412061|472003937|FG000|Double Blind Phase|Adverse Event|61|||
131102456|NCT00412061|472003938|FG001|Double Blind Phase|Adverse Event|16|||
131102457|NCT00412061|472003937|FG000|Double Blind Phase|Final Primary Analysis|26|||
131102458|NCT00412061|472003938|FG001|Double Blind Phase|Final Primary Analysis|14|||
131102459|NCT00412061|472003937|FG000|Double Blind Phase|Withdrawal by Subject|18|||
131102460|NCT00412061|472003938|FG001|Double Blind Phase|Withdrawal by Subject|20|||
131102461|NCT00412061|472003937|FG000|Double Blind Phase|Death|6|||
131102462|NCT00412061|472003938|FG001|Double Blind Phase|Death|3|||
131102463|NCT00412061|472003937|FG000|Double Blind Phase|Protocol Violation|3|||
131102464|NCT00412061|472003938|FG001|Double Blind Phase|Protocol Violation|4|||
131102465|NCT00412061|472003937|FG000|Double Blind Phase|New Cander Therapy|1|||
131102466|NCT00412061|472003938|FG001|Double Blind Phase|New Cander Therapy|1|||
131102467|NCT00412061|472003937|FG000|Double Blind Phase|Lost to Follow-up|0|||
131102468|NCT00412061|472003938|FG001|Double Blind Phase|Lost to Follow-up|1|||
131102469|NCT00412061|472003937|FG000|Open Label Phase|Disease Progression|0|||
131102470|NCT00412061|472003938|FG001|Open Label Phase|Disease Progression|86|||
131102471|NCT00412061|472003937|FG000|Open Label Phase|Adverse Event|0|||
131102472|NCT00412061|472003938|FG001|Open Label Phase|Adverse Event|46|||
131222594|NCT01902134|472443114|FG001|Overall Study|Protocol Violation|0|||
130679339|NCT02468778|470452297|FG002|Overall Study|Death|0|||
130679340|NCT02468778|470452295|FG000|Overall Study|Lost to Follow-up|1|||
130679341|NCT02468778|470452296|FG001|Overall Study|Lost to Follow-up|2|||
130679342|NCT02468778|470452297|FG002|Overall Study|Lost to Follow-up|2|||
130679343|NCT02468778|470452295|FG000|Overall Study|Withdrawal by Subject|0|||
130679344|NCT02468778|470452296|FG001|Overall Study|Withdrawal by Subject|1|||
130679345|NCT02468778|470452297|FG002|Overall Study|Withdrawal by Subject|1|||
131102473|NCT00412061|472003937|FG000|Open Label Phase|Withdrawal by Subject|0|||
131102474|NCT00412061|472003938|FG001|Open Label Phase|Withdrawal by Subject|15|||
131102475|NCT00412061|472003937|FG000|Open Label Phase|Administrative Problems|0|||
131102476|NCT00412061|472003938|FG001|Open Label Phase|Administrative Problems|13|||
131102477|NCT00412061|472003937|FG000|Open Label Phase|Death|0|||
131102478|NCT00412061|472003938|FG001|Open Label Phase|Death|7|||
131102479|NCT00412061|472003937|FG000|Open Label Phase|Lost to Follow-up|0|||
131102480|NCT00412061|472003938|FG001|Open Label Phase|Lost to Follow-up|2|||
131102481|NCT00412061|472003937|FG000|Open Label Phase|New Cancer Therapy|0|||
130679346|NCT00414765|470452300|FG000|Overall Study|Adverse Event|5|||
130679347|NCT00414765|470452301|FG001|Overall Study|Adverse Event|9|||
130679348|NCT00414765|470452300|FG000|Overall Study|Withdrawal by Subject|1|||
130679349|NCT00414765|470452301|FG001|Overall Study|Withdrawal by Subject|1|||
131102482|NCT00412061|472003938|FG001|Open Label Phase|New Cancer Therapy|1|||
131102483|NCT01942590|472003940|FG000|Overall Study|Withdrawal by Subject|0|||
131102484|NCT01942590|472003941|FG001|Overall Study|Withdrawal by Subject|1|||
130679350|NCT00414765|470452300|FG000|Overall Study|Disease Progression|0|||
130679351|NCT00414765|470452301|FG001|Overall Study|Disease Progression|1|||
130679352|NCT03130699|470452302|FG000|Overall Study|Lost to Follow-up|34|||
130679353|NCT03130699|470452303|FG001|Overall Study|Lost to Follow-up|37|||
130679354|NCT03130699|470452304|FG002|Overall Study|Lost to Follow-up|26|||
130679355|NCT03130699|470452302|FG000|Overall Study|Withdrawal by Subject|5|||
130679356|NCT03130699|470452303|FG001|Overall Study|Withdrawal by Subject|1|||
130679357|NCT03130699|470452304|FG002|Overall Study|Withdrawal by Subject|0|||
130679358|NCT03130699|470452302|FG000|Overall Study|Withdrawal by PI|1|||
130679359|NCT03130699|470452303|FG001|Overall Study|Withdrawal by PI|2|||
130679360|NCT03130699|470452304|FG002|Overall Study|Withdrawal by PI|5|||
130679361|NCT03130699|470452302|FG000|Overall Study|Death|0|||
130679362|NCT03130699|470452303|FG001|Overall Study|Death|0|||
131102485|NCT01942590|472003940|FG000|Overall Study|Adverse Event|1|||
131102486|NCT01942590|472003941|FG001|Overall Study|Adverse Event|0|||
131102487|NCT02433340|472003945|FG000|Overall Study|Adverse Event|0|||
131102488|NCT02433340|472003946|FG001|Overall Study|Adverse Event|0|||
131102489|NCT02433340|472003947|FG002|Overall Study|Adverse Event|1|||
131102490|NCT02433340|472003948|FG003|Overall Study|Adverse Event|0|||
131102491|NCT02433340|472003945|FG000|Overall Study|Withdrawal by Subject|1|||
131102492|NCT02433340|472003946|FG001|Overall Study|Withdrawal by Subject|0|||
131102493|NCT02433340|472003947|FG002|Overall Study|Withdrawal by Subject|1|||
131102494|NCT02433340|472003948|FG003|Overall Study|Withdrawal by Subject|2|||
131102495|NCT02433340|472003945|FG000|Overall Study|Lost to Follow-up|0|||
131102496|NCT02433340|472003946|FG001|Overall Study|Lost to Follow-up|1|||
131102497|NCT02433340|472003947|FG002|Overall Study|Lost to Follow-up|0|||
131102498|NCT02433340|472003948|FG003|Overall Study|Lost to Follow-up|0|||
131102499|NCT02433340|472003945|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
131102500|NCT02433340|472003946|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
131102501|NCT02433340|472003947|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
131102502|NCT02433340|472003948|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
131102503|NCT02433340|472003945|FG000|Overall Study|Other|0|||
131102504|NCT02433340|472003946|FG001|Overall Study|Other|1|||
131102505|NCT02433340|472003947|FG002|Overall Study|Other|0|||
131102506|NCT02433340|472003948|FG003|Overall Study|Other|0|||
131102507|NCT01178385|472003949|FG000|Overall Study|Withdrawal by Subject|2|||
131102508|NCT01178385|472003950|FG001|Overall Study|Withdrawal by Subject|0|||
131102509|NCT01688830|472003953|FG000|Overall Study|Lost to Follow-up|0|||
131102510|NCT01688830|472003954|FG001|Overall Study|Lost to Follow-up|0|||
131102511|NCT01688830|472003955|FG002|Overall Study|Lost to Follow-up|0|||
131102512|NCT01688830|472003956|FG003|Overall Study|Lost to Follow-up|0|||
131102513|NCT01688830|472003957|FG004|Overall Study|Lost to Follow-up|0|||
131102514|NCT01688830|472003958|FG005|Overall Study|Lost to Follow-up|0|||
131102515|NCT01688830|472003959|FG006|Overall Study|Lost to Follow-up|0|||
131102516|NCT01688830|472003960|FG007|Overall Study|Lost to Follow-up|0|||
131102517|NCT01688830|472003961|FG008|Overall Study|Lost to Follow-up|0|||
131102518|NCT01688830|472003962|FG009|Overall Study|Lost to Follow-up|0|||
131102519|NCT01688830|472003963|FG010|Overall Study|Lost to Follow-up|1|||
131102520|NCT01688830|472003964|FG011|Overall Study|Lost to Follow-up|0|||
131102521|NCT01688830|472003965|FG012|Overall Study|Lost to Follow-up|0|||
131102522|NCT01688830|472003966|FG013|Overall Study|Lost to Follow-up|0|||
131102523|NCT01688830|472003967|FG014|Overall Study|Lost to Follow-up|0|||
131102524|NCT01688830|472003968|FG015|Overall Study|Lost to Follow-up|0|||
131102525|NCT01688830|472003969|FG016|Overall Study|Lost to Follow-up|0|||
130679363|NCT03130699|470452304|FG002|Overall Study|Death|1|||
130679364|NCT01199861|470452305|FG000|Overall Study|Administrative problems|1|||
130679365|NCT01199861|470452306|FG001|Overall Study|Administrative problems|0|||
130679366|NCT01199861|470452305|FG000|Overall Study|Adverse Event|1|||
130679367|NCT01199861|470452306|FG001|Overall Study|Adverse Event|0|||
130679368|NCT04534283|470452307|FG000|Overall Study|Physician Decision|2|||
131102526|NCT01688830|472003970|FG017|Overall Study|Lost to Follow-up|0|||
131102527|NCT01688830|472003971|FG018|Overall Study|Lost to Follow-up|0|||
131102528|NCT01688830|472003972|FG019|Overall Study|Lost to Follow-up|0|||
131102529|NCT01688830|472003973|FG020|Overall Study|Lost to Follow-up|0|||
131102530|NCT01285609|472003974|FG000|Randomized|Progressive Disease|41|||
131102531|NCT01285609|472003975|FG001|Randomized|Progressive Disease|61|||
131102532|NCT01285609|472003974|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
131102533|NCT01285609|472003975|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
131102534|NCT01285609|472003974|FG000|Randomized|Study Drug Toxicity|13|||
131102535|NCT01285609|472003975|FG001|Randomized|Study Drug Toxicity|14|||
130679369|NCT04534283|470452307|FG000|Overall Study|Withdrawal by Subject|1|||
130679370|NCT04534283|470452307|FG000|Overall Study|Disease Progression|12|||
130679371|NCT04534283|470452307|FG000|Overall Study|Adverse Event|1|||
130679372|NCT00661505|470452308|FG000|Overall Study|Adverse Event|3|||
130679373|NCT00661505|470452308|FG000|Overall Study|Protocol Violation|14|||
130679374|NCT00661505|470452308|FG000|Overall Study|Withdrawal by Subject|8|||
130679375|NCT00661505|470452308|FG000|Overall Study|Lost to Follow-up|3|||
130679376|NCT00661505|470452308|FG000|Overall Study|Other|2|||
130679377|NCT00669864|470452309|FG000|Overall Study|Lost to Follow-up|2|||
130679378|NCT00669864|470452309|FG000|Overall Study|Protocol Violation|2|||
130679379|NCT00669864|470452309|FG000|Overall Study|Withdrawal by Subject|3|||
130679380|NCT00669864|470452309|FG000|Overall Study|Other|2|||
130679381|NCT02545998|470452320|FG000|Overall Study|Lost to Follow-up|12|||
130679382|NCT02545998|470452321|FG001|Overall Study|Lost to Follow-up|3|||
130679383|NCT02545998|470452320|FG000|Overall Study|Withdrawal by Subject|3|||
130679384|NCT02545998|470452321|FG001|Overall Study|Withdrawal by Subject|2|||
130679385|NCT00444145|470454089|FG000|Overall Study|Withdrawal by Subject|2|||
130679386|NCT00444145|470454089|FG000|Overall Study|Lost to Follow-up|1|||
130679387|NCT00444145|470454089|FG000|Overall Study|non-compliant|11|||
130679388|NCT00444145|470454089|FG000|Overall Study|Screen Failures|5|||
130765937|NCT01253174|470765911|FG005|Period 1|Randomized but not treated|0|||
130679390|NCT00630305|470454091|FG000|Overall Study|Withdrawal by Subject|1|||
130679391|NCT00630305|470454091|FG000|Overall Study|Inability to insert contact lens|1|||
130679392|NCT01494506|470454092|FG000|Overall Study|Lack of Efficacy|77|||
130679393|NCT01494506|470454093|FG001|Overall Study|Lack of Efficacy|83|||
130679394|NCT01494506|470454094|FG002|Overall Study|Lack of Efficacy|57|||
130679395|NCT01494506|470454092|FG000|Overall Study|Adverse Event|17|||
130679396|NCT01494506|470454093|FG001|Overall Study|Adverse Event|10|||
130679397|NCT01494506|470454094|FG002|Overall Study|Adverse Event|11|||
130679398|NCT01494506|470454092|FG000|Overall Study|Death|9|||
130679399|NCT01494506|470454093|FG001|Overall Study|Death|5|||
130679400|NCT01494506|470454094|FG002|Overall Study|Death|2|||
130679401|NCT01494506|470454092|FG000|Overall Study|Physician Decision|7|||
130679402|NCT01494506|470454093|FG001|Overall Study|Physician Decision|5|||
130679403|NCT01494506|470454094|FG002|Overall Study|Physician Decision|4|||
130679404|NCT01494506|470454092|FG000|Overall Study|Withdrawal by Subject|17|||
130679405|NCT01494506|470454093|FG001|Overall Study|Withdrawal by Subject|20|||
130679406|NCT01494506|470454094|FG002|Overall Study|Withdrawal by Subject|14|||
130679407|NCT01494506|470454092|FG000|Overall Study|Clinical Deterioration|21|||
130679408|NCT01494506|470454093|FG001|Overall Study|Clinical Deterioration|17|||
130679409|NCT01494506|470454094|FG002|Overall Study|Clinical Deterioration|13|||
130679410|NCT01494506|470454092|FG000|Overall Study|Sponsor Decision|0|||
130679411|NCT01494506|470454093|FG001|Overall Study|Sponsor Decision|0|||
130679412|NCT01494506|470454094|FG002|Overall Study|Sponsor Decision|1|||
130679413|NCT01494506|470454092|FG000|Overall Study|Other|0|||
130679414|NCT01494506|470454093|FG001|Overall Study|Other|3|||
130679415|NCT01494506|470454094|FG002|Overall Study|Other|1|||
130679416|NCT03471078|470454108|FG000|Overall Study|Withdrawal by Subject|9|||
130679417|NCT03471078|470454109|FG001|Overall Study|Withdrawal by Subject|1|||
130679418|NCT03471078|470454108|FG000|Overall Study|Adverse Event|4|||
130679419|NCT03471078|470454109|FG001|Overall Study|Adverse Event|1|||
130679420|NCT03471078|470454108|FG000|Overall Study|Physician Decision|3|||
130679421|NCT03471078|470454109|FG001|Overall Study|Physician Decision|2|||
130679422|NCT03471078|470454108|FG000|Overall Study|Death|2|||
130679423|NCT03471078|470454109|FG001|Overall Study|Death|0|||
130679424|NCT03471078|470454108|FG000|Overall Study|Other|3|||
130679425|NCT03471078|470454109|FG001|Overall Study|Other|2|||
130679426|NCT02473640|470454113|FG000|Treatment Period 1|Adverse Event|1|||
130679427|NCT02395822|470454116|FG000|Overall Study|Withdrawal by Subject|1|||
131015747|NCT02914522|471687104|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131015748|NCT02914522|471687105|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131015749|NCT02914522|471687106|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
131015750|NCT02914522|471687107|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
130679428|NCT02395822|470454116|FG000|Overall Study|Death|1|||
130679429|NCT02777528|470454117|FG000|Overall Study|Still in study|24|||
130679430|NCT02777528|470454118|FG001|Overall Study|Still in study|10|||
130679431|NCT02777528|470454119|FG002|Overall Study|Still in study|1|||
130679432|NCT02777528|470454117|FG000|Overall Study|Study Device Explanted|1|||
130679433|NCT02777528|470454118|FG001|Overall Study|Study Device Explanted|0|||
131015751|NCT02914522|471687097|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
130679434|NCT02777528|470454119|FG002|Overall Study|Study Device Explanted|0|||
130679435|NCT02777528|470454117|FG000|Overall Study|Death|14|||
130679436|NCT02777528|470454118|FG001|Overall Study|Death|7|||
131045803|NCT03582033|471802280|FG002|Part B|Withdrawal by Subject|0|||
130679437|NCT02777528|470454119|FG002|Overall Study|Death|1|||
130679438|NCT02777528|470454117|FG000|Overall Study|Withdrawal by Subject|2|||
130679439|NCT02777528|470454118|FG001|Overall Study|Withdrawal by Subject|2|||
130679440|NCT02777528|470454119|FG002|Overall Study|Withdrawal by Subject|1|||
130679441|NCT02777528|470454117|FG000|Overall Study|Physician Decision|2|||
130679442|NCT02777528|470454118|FG001|Overall Study|Physician Decision|1|||
131102536|NCT01285609|472003974|FG000|Randomized|Death|5|||
131102537|NCT01285609|472003975|FG001|Randomized|Death|7|||
131102538|NCT01285609|472003974|FG000|Randomized|Withdrawal by Subject|8|||
131102539|NCT01285609|472003975|FG001|Randomized|Withdrawal by Subject|11|||
131102540|NCT01285609|472003974|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
131102541|NCT01285609|472003975|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
131102542|NCT01285609|472003974|FG000|Randomized|Undisclosed Reasons|1|||
131102543|NCT01285609|472003975|FG001|Randomized|Undisclosed Reasons|0|||
131102544|NCT01285609|472003974|FG000|Randomized|Randomized but not Treated|4|||
131102545|NCT01285609|472003975|FG001|Randomized|Randomized but not Treated|4|||
131102546|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
131102547|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
131102548|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
131102549|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
131102550|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
131102551|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
131102552|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
131102553|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
131102554|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Death|11|||
131102555|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Death|3|||
131102556|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
131102557|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
131102558|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Not Reported|0|||
131102559|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Not Reported|2|||
131102560|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
131102561|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
131102562|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
131102563|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
131102564|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
131102565|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
131102566|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
131102567|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
131102568|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
131102569|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
131102570|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
131102571|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
131102572|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
131102573|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
131102574|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
131102575|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
131102576|NCT01285609|472003974|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
131102577|NCT01285609|472003975|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
131102578|NCT01285609|472003974|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
131102579|NCT01285609|472003975|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
131102580|NCT04822597|472003976|FG000|Overall Study|Withdrawal by Subject|0|||
131102581|NCT04822597|472003977|FG001|Overall Study|Withdrawal by Subject|1|||
131102582|NCT04822597|472003978|FG002|Overall Study|Withdrawal by Subject|1|||
131102583|NCT04822597|472003979|FG003|Overall Study|Withdrawal by Subject|0|||
131102584|NCT04822597|472003976|FG000|Overall Study|Physician Decision|0|||
131102585|NCT04822597|472003977|FG001|Overall Study|Physician Decision|0|||
131102586|NCT04822597|472003978|FG002|Overall Study|Physician Decision|1|||
131102587|NCT04822597|472003979|FG003|Overall Study|Physician Decision|1|||
131102588|NCT04822597|472003976|FG000|Overall Study|Subject withdrawn after enrollment|0|||
131102589|NCT04822597|472003977|FG001|Overall Study|Subject withdrawn after enrollment|1|||
131102590|NCT04822597|472003978|FG002|Overall Study|Subject withdrawn after enrollment|0|||
131102591|NCT04822597|472003979|FG003|Overall Study|Subject withdrawn after enrollment|1|||
131102592|NCT04822597|472003976|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
131102593|NCT04822597|472003977|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
131102594|NCT04822597|472003978|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
131102595|NCT04822597|472003979|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
131102596|NCT03616977|472003986|FG000|Period 1|Physician Decision|0|||
131102597|NCT03616977|472003987|FG001|Period 1|Physician Decision|1|||
131102598|NCT03616977|472003986|FG000|Period 3|Adverse Event|1|||
131102599|NCT03616977|472003987|FG001|Period 3|Adverse Event|1|||
131102600|NCT00925132|472003988|FG000|Overall Study|Withdrawal by Subject|2|||
131102601|NCT00925132|472003989|FG001|Overall Study|Withdrawal by Subject|0|||
131102602|NCT00925132|472003990|FG002|Overall Study|Withdrawal by Subject|0|||
131102603|NCT00925132|472003991|FG003|Overall Study|Withdrawal by Subject|0|||
131102604|NCT00925132|472003992|FG004|Overall Study|Withdrawal by Subject|1|||
130679443|NCT02777528|470454119|FG002|Overall Study|Physician Decision|0|||
131102605|NCT00925132|472003988|FG000|Overall Study|Removed due to disease progression|0|||
131102606|NCT00925132|472003989|FG001|Overall Study|Removed due to disease progression|0|||
131102607|NCT00925132|472003990|FG002|Overall Study|Removed due to disease progression|0|||
131102608|NCT00925132|472003991|FG003|Overall Study|Removed due to disease progression|0|||
131102609|NCT00925132|472003992|FG004|Overall Study|Removed due to disease progression|4|||
131102610|NCT05087979|472005884|FG000|Overall Study|Converted to general anesthesia|1|||
131102611|NCT05087979|472005885|FG001|Overall Study|Converted to general anesthesia|0|||
131102612|NCT02915302|472005886|FG000|Overall Study|Adverse Event|3|||
131102613|NCT02915302|472005887|FG001|Overall Study|Adverse Event|0|||
131102614|NCT02915302|472005886|FG000|Overall Study|Protocol Violation|20|||
131102615|NCT02915302|472005887|FG001|Overall Study|Protocol Violation|27|||
131102616|NCT02915302|472005886|FG000|Overall Study|Lost to Follow-up|19|||
131102617|NCT02915302|472005887|FG001|Overall Study|Lost to Follow-up|22|||
131102618|NCT02915302|472005886|FG000|Overall Study|Withdrawal by Subject|22|||
131102619|NCT02915302|472005887|FG001|Overall Study|Withdrawal by Subject|29|||
131102620|NCT02915302|472005886|FG000|Overall Study|Other|1|||
131102621|NCT02915302|472005887|FG001|Overall Study|Other|0|||
131015752|NCT02914522|471687098|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131015753|NCT02914522|471687099|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131015754|NCT02914522|471687100|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131015755|NCT02914522|471687101|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
131015756|NCT02914522|471687102|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131015757|NCT02914522|471687103|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131015758|NCT02914522|471687104|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131015759|NCT02914522|471687105|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131015760|NCT02914522|471687106|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131015761|NCT02914522|471687107|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
131015762|NCT02914522|471687097|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
131015763|NCT02914522|471687098|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131015764|NCT02914522|471687099|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131015765|NCT02914522|471687100|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131015766|NCT02914522|471687101|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131015767|NCT02914522|471687102|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131015768|NCT02914522|471687103|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131015769|NCT02914522|471687104|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131015770|NCT02914522|471687105|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131015771|NCT02914522|471687106|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131015772|NCT02914522|471687107|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
131015773|NCT02914522|471687097|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
131015774|NCT02914522|471687098|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
131015775|NCT02914522|471687099|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
131015776|NCT02914522|471687100|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
131015777|NCT02914522|471687101|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
131015778|NCT02914522|471687102|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
131015779|NCT02914522|471687103|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
131015780|NCT02914522|471687104|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
131015781|NCT02914522|471687105|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
131015782|NCT02914522|471687106|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
131015783|NCT02914522|471687107|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
131015784|NCT02914522|471687097|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131015785|NCT02914522|471687098|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
131015786|NCT02914522|471687099|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131015787|NCT02914522|471687100|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131015788|NCT02914522|471687101|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
131015789|NCT02914522|471687102|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
131015790|NCT02914522|471687103|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131015791|NCT02914522|471687104|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131015792|NCT02914522|471687105|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131015793|NCT02914522|471687106|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131015794|NCT02914522|471687107|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
131015795|NCT02914522|471687097|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131015796|NCT02914522|471687098|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131015797|NCT02914522|471687099|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131015798|NCT02914522|471687100|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131015799|NCT02914522|471687101|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131102622|NCT03527173|472005888|FG000|Overall Study|Lost to Follow-up|4|||
131102623|NCT03527173|472005889|FG001|Overall Study|Lost to Follow-up|2|||
131102624|NCT03527173|472005888|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
131015800|NCT02914522|471687102|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
131015801|NCT02914522|471687103|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
131015802|NCT02914522|471687104|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
131015803|NCT02914522|471687105|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
131015804|NCT02914522|471687106|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
131015805|NCT02914522|471687107|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
131015806|NCT02914522|471687097|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131015807|NCT02914522|471687098|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131015808|NCT02914522|471687099|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131015809|NCT02914522|471687100|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131015810|NCT02914522|471687101|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131015811|NCT02914522|471687102|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
131015812|NCT02914522|471687103|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
131015813|NCT02914522|471687104|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
131015814|NCT02914522|471687105|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
131015815|NCT02914522|471687106|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
131015816|NCT02914522|471687107|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
131015817|NCT02914522|471687097|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131015818|NCT02914522|471687098|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131015819|NCT02914522|471687099|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131015820|NCT02914522|471687100|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131015821|NCT02914522|471687101|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131015822|NCT02914522|471687102|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131015823|NCT02914522|471687103|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
131015824|NCT02914522|471687104|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
131015825|NCT02914522|471687105|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
131015826|NCT02914522|471687106|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
131015827|NCT02914522|471687107|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
131015828|NCT02914522|471687097|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131015829|NCT02914522|471687098|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131015830|NCT02914522|471687099|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131015831|NCT02914522|471687100|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131015832|NCT02914522|471687101|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131015833|NCT02914522|471687102|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
131015834|NCT02914522|471687103|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
131015835|NCT02914522|471687104|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
131015836|NCT02914522|471687105|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
131015837|NCT02914522|471687106|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
131015838|NCT02914522|471687107|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
131015839|NCT02914522|471687097|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
131015840|NCT02914522|471687098|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
131015841|NCT02914522|471687099|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
131015842|NCT02914522|471687100|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
131015843|NCT02914522|471687101|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
131015844|NCT02914522|471687102|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
131015845|NCT02914522|471687103|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
131015846|NCT02914522|471687104|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
131015847|NCT02914522|471687105|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
131015848|NCT02914522|471687106|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
131015849|NCT02914522|471687107|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
131015850|NCT02914522|471687097|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131015851|NCT02914522|471687098|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131015852|NCT02914522|471687099|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131015853|NCT02914522|471687100|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131015854|NCT02914522|471687101|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131015855|NCT02914522|471687102|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131015856|NCT02914522|471687103|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131015857|NCT02914522|471687104|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
131015858|NCT02914522|471687105|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
131015859|NCT02914522|471687106|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131015860|NCT02914522|471687107|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
131015861|NCT02914522|471687097|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131015862|NCT02914522|471687098|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131015863|NCT02914522|471687099|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131222595|NCT01902134|472443115|FG002|Overall Study|Protocol Violation|0|||
131102625|NCT03527173|472005889|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
131102626|NCT03527173|472005888|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
131102627|NCT03527173|472005889|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
131102628|NCT03527173|472005888|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
131102629|NCT03527173|472005889|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131102630|NCT02134977|472005890|FG000|Overall Study|Protocol Deviation|102|||
131102631|NCT04097301|472005891|FG000|Overall Study|Death|1|||
131102632|NCT04097301|472005891|FG000|Overall Study|Withdrawal by Subject|1|||
131102633|NCT04097301|472005891|FG000|Overall Study|Screening Failure|5|||
131102634|NCT01773291|472005892|FG000|Overall Study|Protocol Violation|1|||
131102635|NCT01773291|472005893|FG001|Overall Study|Protocol Violation|0|||
131102636|NCT01773291|472005894|FG002|Overall Study|Protocol Violation|0|||
131102637|NCT01773291|472005892|FG000|Overall Study|Withdrawal by Subject|0|||
131102638|NCT01773291|472005893|FG001|Overall Study|Withdrawal by Subject|0|||
131102639|NCT01773291|472005894|FG002|Overall Study|Withdrawal by Subject|1|||
131102640|NCT00203476|472005895|FG000|Overall Study|Lost to Follow-up|1|||
131102641|NCT00203476|472005896|FG001|Overall Study|Lost to Follow-up|0|||
131102642|NCT00203476|472005897|FG002|Overall Study|Lost to Follow-up|0|||
131102643|NCT00203476|472005895|FG000|Overall Study|Withdrawal by Subject|0|||
131102644|NCT00203476|472005896|FG001|Overall Study|Withdrawal by Subject|1|||
131102645|NCT00203476|472005897|FG002|Overall Study|Withdrawal by Subject|0|||
131102646|NCT01190514|472005898|FG000|First Intervention (Period 1)|Adverse Event|1|||
131102647|NCT01190514|472005899|FG001|First Intervention (Period 1)|Adverse Event|0|||
131102648|NCT01190514|472005900|FG002|First Intervention (Period 1)|Adverse Event|0|||
131102649|NCT01190514|472005901|FG003|First Intervention (Period 1)|Adverse Event|0|||
131102650|NCT01190514|472005898|FG000|Third Intervention (Period 3)|Adverse Event|1|||
131102651|NCT01190514|472005899|FG001|Third Intervention (Period 3)|Adverse Event|0|||
131102652|NCT01190514|472005900|FG002|Third Intervention (Period 3)|Adverse Event|0|||
131102653|NCT01190514|472005901|FG003|Third Intervention (Period 3)|Adverse Event|0|||
131102654|NCT03241225|472005904|FG000|Overall Study|Lost to Follow-up|2|||
131102655|NCT03241225|472005905|FG001|Overall Study|Lost to Follow-up|1|||
131102656|NCT03241225|472005904|FG000|Overall Study|Protocol Violation|4|||
131102657|NCT03241225|472005905|FG001|Overall Study|Protocol Violation|1|||
131102658|NCT03241225|472005904|FG000|Overall Study|Withdrawal by Subject|1|||
131102659|NCT03241225|472005905|FG001|Overall Study|Withdrawal by Subject|0|||
131102660|NCT01970345|472005908|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
131102661|NCT01970345|472005909|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
131102662|NCT01970345|472005908|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
131102663|NCT01970345|472005909|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
131102664|NCT03932812|472005916|FG000|Overall Study|Lost to Follow-up|12|||
131102665|NCT03932812|472005917|FG001|Overall Study|Lost to Follow-up|14|||
131102666|NCT03932812|472005916|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
131102667|NCT03932812|472005917|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
131102668|NCT02585232|472005922|FG000|Overall Study|Lost to Follow-up|8|||
131102669|NCT02585232|472005923|FG001|Overall Study|Lost to Follow-up|8|||
131102670|NCT02585232|472005922|FG000|Overall Study|Withdrawal by Subject|4|||
131102671|NCT02585232|472005923|FG001|Overall Study|Withdrawal by Subject|8|||
131102672|NCT03215810|472005924|FG000|Overall Study|Still responding to nivolumab|1|||
131102673|NCT03215810|472005924|FG000|Overall Study|Insufficient TIL growth|1|||
131102674|NCT03215810|472005924|FG000|Overall Study|Decline in performance status|1|||
131102675|NCT03215810|472005924|FG000|Overall Study|Withdrawal by Subject|1|||
131102676|NCT02313233|472005925|FG000|Overall Study|Withdrawal by Subject|1|||
131102677|NCT02313233|472005926|FG001|Overall Study|Withdrawal by Subject|2|||
131102678|NCT02313233|472005925|FG000|Overall Study|Administrative reason|1|||
131102679|NCT02313233|472005926|FG001|Overall Study|Administrative reason|1|||
131102680|NCT02679573|472005932|FG000|Overall Study|Adverse Event|13|||
131102681|NCT02679573|472005933|FG001|Overall Study|Adverse Event|6|||
131102682|NCT02679573|472005932|FG000|Overall Study|Lack of Efficacy|12|||
131102683|NCT02679573|472005933|FG001|Overall Study|Lack of Efficacy|15|||
131102684|NCT02679573|472005932|FG000|Overall Study|Could not complete required study visits|6|||
131102685|NCT02679573|472005933|FG001|Overall Study|Could not complete required study visits|2|||
131102686|NCT02679573|472005932|FG000|Overall Study|Withdrawal by Subject|2|||
131102687|NCT02679573|472005933|FG001|Overall Study|Withdrawal by Subject|9|||
131102688|NCT02679573|472005932|FG000|Overall Study|Death|2|||
131102689|NCT02679573|472005933|FG001|Overall Study|Death|0|||
131102690|NCT02679573|472005932|FG000|Overall Study|Physician Decision|2|||
131102691|NCT02679573|472005933|FG001|Overall Study|Physician Decision|4|||
131102692|NCT02679573|472005932|FG000|Overall Study|Lost to Follow-up|0|||
131102693|NCT02679573|472005933|FG001|Overall Study|Lost to Follow-up|3|||
131102694|NCT03545503|472005934|FG000|Overall Study|Protocol Violation|14|||
131102695|NCT03545503|472005935|FG001|Overall Study|Protocol Violation|16|||
131102696|NCT00682890|472005936|FG000|Overall Study|Lost to Follow-up|1|||
130679444|NCT02777528|470454117|FG000|Overall Study|Lost to Follow-up|2|||
131102697|NCT00682890|472005937|FG001|Overall Study|Lost to Follow-up|1|||
131102698|NCT00682890|472005936|FG000|Overall Study|subject moved away|0|||
131102699|NCT00682890|472005937|FG001|Overall Study|subject moved away|1|||
131102700|NCT00682890|472005936|FG000|Overall Study|heavy menstrual bleeding|1|||
131102701|NCT00682890|472005937|FG001|Overall Study|heavy menstrual bleeding|0|||
131102702|NCT02224690|472005938|FG000|Overall Study|Adverse Event|8|||
131102703|NCT02224690|472005939|FG001|Overall Study|Adverse Event|1|||
131102704|NCT02224690|472005938|FG000|Overall Study|Met Withdrawal Criteria|4|||
131102705|NCT02224690|472005939|FG001|Overall Study|Met Withdrawal Criteria|0|||
131102706|NCT02224690|472005938|FG000|Overall Study|Use of G-tube|1|||
131102707|NCT02224690|472005939|FG001|Overall Study|Use of G-tube|0|||
131102708|NCT02224690|472005938|FG000|Overall Study|Did not meet eligibility criteria|1|||
131102709|NCT02224690|472005939|FG001|Overall Study|Did not meet eligibility criteria|0|||
131102710|NCT01506609|472005940|FG000|Overall Study|Adverse Event Related to Progression|0|||
131102711|NCT01506609|472005941|FG001|Overall Study|Adverse Event Related to Progression|0|||
131102712|NCT01506609|472005942|FG002|Overall Study|Adverse Event Related to Progression|0|||
131102713|NCT01506609|472005943|FG003|Overall Study|Adverse Event Related to Progression|3|||
131102714|NCT01506609|472005944|FG004|Overall Study|Adverse Event Related to Progression|7|||
131102715|NCT01506609|472005945|FG005|Overall Study|Adverse Event Related to Progression|3|||
131102716|NCT01506609|472005940|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
131102717|NCT01506609|472005941|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
131102718|NCT01506609|472005942|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
131102719|NCT01506609|472005943|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
131102720|NCT01506609|472005944|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
131102721|NCT01506609|472005945|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
131102722|NCT01506609|472005940|FG000|Overall Study|Withdrawal by Subject|0|||
131102723|NCT01506609|472005941|FG001|Overall Study|Withdrawal by Subject|0|||
131102724|NCT01506609|472005942|FG002|Overall Study|Withdrawal by Subject|0|||
131102725|NCT01506609|472005943|FG003|Overall Study|Withdrawal by Subject|9|||
131102726|NCT01506609|472005944|FG004|Overall Study|Withdrawal by Subject|7|||
131102727|NCT01506609|472005945|FG005|Overall Study|Withdrawal by Subject|7|||
131102728|NCT01506609|472005940|FG000|Overall Study|Lost to Follow-up|0|||
131102729|NCT01506609|472005941|FG001|Overall Study|Lost to Follow-up|0|||
131102730|NCT01506609|472005942|FG002|Overall Study|Lost to Follow-up|0|||
131102731|NCT01506609|472005943|FG003|Overall Study|Lost to Follow-up|1|||
131102732|NCT01506609|472005944|FG004|Overall Study|Lost to Follow-up|2|||
131102733|NCT01506609|472005945|FG005|Overall Study|Lost to Follow-up|0|||
131102734|NCT01506609|472005940|FG000|Overall Study|Sponsor Discontinued Study|0|||
131102735|NCT01506609|472005941|FG001|Overall Study|Sponsor Discontinued Study|0|||
131102736|NCT01506609|472005942|FG002|Overall Study|Sponsor Discontinued Study|0|||
131102737|NCT01506609|472005943|FG003|Overall Study|Sponsor Discontinued Study|2|||
131102738|NCT01506609|472005944|FG004|Overall Study|Sponsor Discontinued Study|2|||
131102739|NCT01506609|472005945|FG005|Overall Study|Sponsor Discontinued Study|0|||
131102740|NCT01506609|472005940|FG000|Overall Study|Progressive Disease per Protocol|1|||
131102741|NCT01506609|472005941|FG001|Overall Study|Progressive Disease per Protocol|0|||
131102742|NCT01506609|472005942|FG002|Overall Study|Progressive Disease per Protocol|0|||
131102743|NCT01506609|472005943|FG003|Overall Study|Progressive Disease per Protocol|64|||
131102744|NCT01506609|472005944|FG004|Overall Study|Progressive Disease per Protocol|57|||
131102745|NCT01506609|472005945|FG005|Overall Study|Progressive Disease per Protocol|74|||
131102746|NCT01506609|472005940|FG000|Overall Study|Other, Not Specified|0|||
131102747|NCT01506609|472005941|FG001|Overall Study|Other, Not Specified|0|||
131102748|NCT01506609|472005942|FG002|Overall Study|Other, Not Specified|0|||
131102749|NCT01506609|472005943|FG003|Overall Study|Other, Not Specified|10|||
131102750|NCT01506609|472005944|FG004|Overall Study|Other, Not Specified|7|||
131102751|NCT01506609|472005945|FG005|Overall Study|Other, Not Specified|3|||
131102752|NCT01506609|472005940|FG000|Overall Study|Missing / Unknown Reason|1|||
131102753|NCT01506609|472005941|FG001|Overall Study|Missing / Unknown Reason|0|||
131102754|NCT01506609|472005942|FG002|Overall Study|Missing / Unknown Reason|1|||
131102755|NCT01506609|472005943|FG003|Overall Study|Missing / Unknown Reason|4|||
131102756|NCT01506609|472005944|FG004|Overall Study|Missing / Unknown Reason|4|||
131102757|NCT01506609|472005945|FG005|Overall Study|Missing / Unknown Reason|2|||
131102758|NCT01502631|472005946|FG000|Overall Study|Adverse Event|5|||
131102759|NCT01502631|472005947|FG001|Overall Study|Adverse Event|8|||
130679445|NCT02777528|470454118|FG001|Overall Study|Lost to Follow-up|0|||
130679446|NCT02777528|470454119|FG002|Overall Study|Lost to Follow-up|0|||
130679447|NCT02777528|470454117|FG000|Overall Study|Discontinued due to Other|1|||
130679448|NCT02777528|470454118|FG001|Overall Study|Discontinued due to Other|0|||
131102760|NCT01502631|472005946|FG000|Overall Study|Lost to Follow-up|2|||
131102761|NCT01502631|472005947|FG001|Overall Study|Lost to Follow-up|2|||
130679449|NCT02777528|470454119|FG002|Overall Study|Discontinued due to Other|0|||
131102762|NCT01502631|472005946|FG000|Overall Study|Participant withdrew consent|2|||
130679450|NCT02127281|470454120|FG000|Overall Study|Lost to Follow-up|1|||
130679451|NCT02127281|470454121|FG001|Overall Study|Lost to Follow-up|0|||
130679452|NCT02937701|470454122|FG000|Day 1 to Week 22|Adverse Event|11|||
131102763|NCT01502631|472005947|FG001|Overall Study|Participant withdrew consent|4|||
131102764|NCT01502631|472005946|FG000|Overall Study|Participant non-compliant|1|||
131102765|NCT01502631|472005947|FG001|Overall Study|Participant non-compliant|0|||
131102766|NCT01502631|472005946|FG000|Overall Study|Investigator's decision|0|||
131102767|NCT01502631|472005947|FG001|Overall Study|Investigator's decision|1|||
131102768|NCT01502631|472005946|FG000|Overall Study|Other|10|||
131102769|NCT01502631|472005947|FG001|Overall Study|Other|5|||
131102770|NCT01293487|472005948|FG000|Overall Study|Lost to Follow-up|0|||
131102771|NCT01293487|472005949|FG001|Overall Study|Lost to Follow-up|0|||
131102772|NCT01293487|472005950|FG002|Overall Study|Lost to Follow-up|0|||
131102773|NCT01293487|472005951|FG003|Overall Study|Lost to Follow-up|1|||
131102774|NCT01293487|472005952|FG004|Overall Study|Lost to Follow-up|0|||
131102775|NCT01293487|472005953|FG005|Overall Study|Lost to Follow-up|0|||
131102776|NCT01293487|472005954|FG006|Overall Study|Lost to Follow-up|0|||
131102777|NCT01293487|472005955|FG007|Overall Study|Lost to Follow-up|0|||
131102778|NCT01293487|472005948|FG000|Overall Study|Withdrawal by Subject|0|||
131102779|NCT01293487|472005949|FG001|Overall Study|Withdrawal by Subject|0|||
131102780|NCT01293487|472005950|FG002|Overall Study|Withdrawal by Subject|0|||
131102781|NCT01293487|472005951|FG003|Overall Study|Withdrawal by Subject|0|||
131102782|NCT01293487|472005952|FG004|Overall Study|Withdrawal by Subject|0|||
131102783|NCT01293487|472005953|FG005|Overall Study|Withdrawal by Subject|0|||
131102784|NCT01293487|472005954|FG006|Overall Study|Withdrawal by Subject|0|||
131102785|NCT01293487|472005955|FG007|Overall Study|Withdrawal by Subject|2|||
131102786|NCT00395460|472005957|FG000|Overall Study|Withdrawal by Subject|1|||
131102787|NCT00395460|472005958|FG001|Overall Study|Withdrawal by Subject|0|||
131102788|NCT04223830|472005964|FG000|Overall Study|Lost to Follow-up|9|||
131102789|NCT04223830|472005964|FG000|Overall Study|Adverse Event|1|||
131102790|NCT00862719|472005965|FG000|Overall Study|Disease Progression|5|||
131102791|NCT00862719|472005966|FG001|Overall Study|Disease Progression|0|||
131102792|NCT00862719|472005967|FG002|Overall Study|Disease Progression|1|||
131102793|NCT00862719|472005968|FG003|Overall Study|Disease Progression|0|||
131102794|NCT00862719|472005965|FG000|Overall Study|Death|5|||
131102795|NCT00862719|472005966|FG001|Overall Study|Death|6|||
131102796|NCT00862719|472005967|FG002|Overall Study|Death|1|||
131102797|NCT00862719|472005968|FG003|Overall Study|Death|1|||
131102798|NCT00862719|472005965|FG000|Overall Study|Engraftment failure|0|||
131102799|NCT00862719|472005966|FG001|Overall Study|Engraftment failure|0|||
131102800|NCT00862719|472005967|FG002|Overall Study|Engraftment failure|1|||
131102801|NCT00862719|472005968|FG003|Overall Study|Engraftment failure|0|||
131102802|NCT00862719|472005965|FG000|Overall Study|Veno-Occlusive Disease|0|||
131102803|NCT00862719|472005966|FG001|Overall Study|Veno-Occlusive Disease|0|||
131102804|NCT00862719|472005967|FG002|Overall Study|Veno-Occlusive Disease|1|||
131102805|NCT00862719|472005968|FG003|Overall Study|Veno-Occlusive Disease|0|||
131102806|NCT00324116|472005969|FG000|Overall Study|Adverse Event|5|||
131102807|NCT00324116|472005969|FG000|Overall Study|Lack of Efficacy|17|||
131102808|NCT00324116|472005969|FG000|Overall Study|Withdrawal by Subject|5|||
131102809|NCT00324116|472005969|FG000|Overall Study|Other|5|||
131102810|NCT01806623|472005970|FG000|Overall Study|Withdrawal by Subject|1|||
131102811|NCT01806623|472005970|FG000|Overall Study|Adverse Event|1|||
131102812|NCT01806623|472005970|FG000|Overall Study|Did not meet the inclusion criteria|56|||
131102813|NCT01737827|472005971|FG000|Overall Study|Adverse Event|3|||
131102814|NCT01737827|472005972|FG001|Overall Study|Adverse Event|6|||
131102815|NCT01737827|472005973|FG002|Overall Study|Adverse Event|0|||
131102816|NCT01737827|472005971|FG000|Overall Study|Lost to Follow-up|0|||
131102817|NCT01737827|472005972|FG001|Overall Study|Lost to Follow-up|1|||
131102818|NCT01737827|472005973|FG002|Overall Study|Lost to Follow-up|0|||
131102819|NCT01737827|472005971|FG000|Overall Study|Physician Decision|0|||
131102820|NCT01737827|472005972|FG001|Overall Study|Physician Decision|2|||
131102821|NCT01737827|472005973|FG002|Overall Study|Physician Decision|0|||
131102822|NCT01737827|472005971|FG000|Overall Study|Progressive Disease|5|||
131102823|NCT01737827|472005972|FG001|Overall Study|Progressive Disease|16|||
131102824|NCT01737827|472005973|FG002|Overall Study|Progressive Disease|2|||
131102825|NCT01737827|472005971|FG000|Overall Study|Study Terminated by Sponsor|0|||
131102826|NCT01737827|472005972|FG001|Overall Study|Study Terminated by Sponsor|1|||
131102827|NCT01737827|472005973|FG002|Overall Study|Study Terminated by Sponsor|0|||
131102828|NCT01737827|472005971|FG000|Overall Study|Subject/Guardian Decision|0|||
131102829|NCT01737827|472005972|FG001|Overall Study|Subject/Guardian Decision|2|||
131102830|NCT01737827|472005973|FG002|Overall Study|Subject/Guardian Decision|0|||
131102831|NCT01964924|472005974|FG000|Trametinib Monotherapy|Progression|19|||
131102832|NCT01964924|472005975|FG001|Trametinib Monotherapy|Progression|0|||
131102833|NCT01153958|472005976|FG000|Overall Study|Study Terminated|36|||
131102834|NCT01153958|472005977|FG001|Overall Study|Study Terminated|32|||
131102835|NCT02971761|472005978|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
131102836|NCT01034163|472005979|FG000|Overall Study|Treatment completed as per protocol|8|||
131102837|NCT01034163|472005980|FG001|Overall Study|Treatment completed as per protocol|7|||
131102838|NCT01034163|472005979|FG000|Overall Study|Withdrawal by Subject|8|||
131102839|NCT01034163|472005980|FG001|Overall Study|Withdrawal by Subject|2|||
131102840|NCT01034163|472005979|FG000|Overall Study|Protocol deviation|1|||
131102841|NCT01034163|472005980|FG001|Overall Study|Protocol deviation|0|||
131102842|NCT01034163|472005979|FG000|Overall Study|Disease progression|3|||
131102843|NCT01034163|472005980|FG001|Overall Study|Disease progression|4|||
130679453|NCT02937701|470454123|FG001|Day 1 to Week 22|Adverse Event|14|||
130679454|NCT02937701|470454124|FG002|Day 1 to Week 22|Adverse Event|0|||
130679455|NCT02937701|470454125|FG003|Day 1 to Week 22|Adverse Event|0|||
130679456|NCT02937701|470454126|FG004|Day 1 to Week 22|Adverse Event|0|||
130679457|NCT02937701|470454122|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
130679458|NCT02937701|470454123|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
130679459|NCT02937701|470454124|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
130679460|NCT02937701|470454125|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
130679461|NCT02937701|470454126|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
130679462|NCT02937701|470454122|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
130679463|NCT02937701|470454123|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
131015864|NCT02914522|471687100|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131015865|NCT02914522|471687101|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131015866|NCT02914522|471687102|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131015867|NCT02914522|471687103|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131015868|NCT02914522|471687104|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131015869|NCT02914522|471687105|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
131015870|NCT02914522|471687106|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
131015871|NCT02914522|471687107|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
131015872|NCT02914522|471687097|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131015873|NCT02914522|471687098|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131015874|NCT02914522|471687099|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131015875|NCT02914522|471687100|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131015876|NCT02914522|471687101|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131015877|NCT02914522|471687102|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131015878|NCT02914522|471687103|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131015879|NCT02914522|471687104|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131015880|NCT02914522|471687105|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131015881|NCT02914522|471687106|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
131015882|NCT02914522|471687107|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
131015883|NCT00756730|471687109|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
131015884|NCT00756730|471687110|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
131015885|NCT00756730|471687109|FG000|Overall Study|persistent low-level viremmia|0|||
131015886|NCT00756730|471687110|FG001|Overall Study|persistent low-level viremmia|1|||
131015887|NCT03383146|471687112|FG000|Overall Study|Screen Failure|1|||
131015888|NCT03383146|471687113|FG001|Overall Study|Screen Failure|0|||
131015889|NCT03383146|471687112|FG000|Overall Study|Adverse Event|6|||
131015890|NCT03383146|471687113|FG001|Overall Study|Adverse Event|18|||
131015891|NCT03383146|471687112|FG000|Overall Study|Lack of Efficacy|0|||
131015892|NCT03383146|471687113|FG001|Overall Study|Lack of Efficacy|3|||
131015893|NCT03383146|471687112|FG000|Overall Study|Withdrawal by Subject|20|||
131015894|NCT03383146|471687113|FG001|Overall Study|Withdrawal by Subject|36|||
131015895|NCT03383146|471687112|FG000|Overall Study|Lost to Follow-up|5|||
131015896|NCT03383146|471687113|FG001|Overall Study|Lost to Follow-up|15|||
131015897|NCT03383146|471687112|FG000|Overall Study|Death|0|||
131015898|NCT03383146|471687113|FG001|Overall Study|Death|2|||
131015899|NCT03383146|471687112|FG000|Overall Study|Physician Decision|0|||
131015900|NCT03383146|471687113|FG001|Overall Study|Physician Decision|1|||
131015901|NCT03383146|471687112|FG000|Overall Study|Protocol Deviation|1|||
131015902|NCT03383146|471687113|FG001|Overall Study|Protocol Deviation|8|||
131015903|NCT03383146|471687112|FG000|Overall Study|Study Terminated by the Sponsor|48|||
131015904|NCT03383146|471687113|FG001|Overall Study|Study Terminated by the Sponsor|95|||
131015905|NCT03383146|471687112|FG000|Overall Study|Reason not Specified|4|||
131015906|NCT03383146|471687113|FG001|Overall Study|Reason not Specified|6|||
131015907|NCT05382104|471687116|FG000|Period 2 (2 Days)|Adverse Event|0|||
131015908|NCT05382104|471687117|FG001|Period 2 (2 Days)|Adverse Event|1|||
131015909|NCT05382104|471687118|FG002|Period 2 (2 Days)|Adverse Event|0|||
131015910|NCT05382104|471687119|FG003|Period 2 (2 Days)|Adverse Event|0|||
131015911|NCT05382104|471687120|FG004|Period 2 (2 Days)|Adverse Event|0|||
131015912|NCT05382104|471687121|FG005|Period 2 (2 Days)|Adverse Event|0|||
131015913|NCT00639002|471687122|FG000|Overall Study|Death|1|||
131015914|NCT00639002|471687122|FG000|Overall Study|Adverse Event|1|||
131015915|NCT00639002|471687122|FG000|Overall Study|Protocol Violation|1|||
131015916|NCT00639002|471687122|FG000|Overall Study|Disease progression|3|||
131015917|NCT00639002|471687122|FG000|Overall Study|Physician Decision|6|||
131015918|NCT00639002|471687122|FG000|Overall Study|Lack of Efficacy|1|||
130679464|NCT02937701|470454124|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
130765938|NCT01253174|470765906|FG000|Period 2|Adverse Event|0|||
131015919|NCT01161498|471687123|FG000|Overall Study|Disease Progression|0|||
131015920|NCT01161498|471687124|FG001|Overall Study|Disease Progression|1|||
131015921|NCT05686421|471687132|FG000|Overall Study|Screen failure|22|||
131015922|NCT05686421|471687133|FG001|Overall Study|Screen failure|0|||
131015923|NCT05686421|471687134|FG002|Overall Study|Screen failure|0|||
131102844|NCT01034163|472005979|FG000|Overall Study|Adverse Event|6|||
131102845|NCT01034163|472005980|FG001|Overall Study|Adverse Event|0|||
131102846|NCT01034163|472005979|FG000|Overall Study|Administrative problems|0|||
131102847|NCT01034163|472005980|FG001|Overall Study|Administrative problems|1|||
131102848|NCT01034163|472005979|FG000|Overall Study|Abnormal laboratory value|1|||
131102849|NCT01034163|472005980|FG001|Overall Study|Abnormal laboratory value|0|||
131102850|NCT00528645|472005981|FG000|Overall Study|Adverse Event|3|||
131102851|NCT00116753|472005982|FG000|Overall Study|Adverse Event|16|||
131102852|NCT00116753|472005983|FG001|Overall Study|Adverse Event|10|||
131102853|NCT00116753|472005984|FG002|Overall Study|Adverse Event|7|||
131102854|NCT00116753|472005982|FG000|Overall Study|Withdrawal by Subject|11|||
131102855|NCT00116753|472005983|FG001|Overall Study|Withdrawal by Subject|12|||
131102856|NCT00116753|472005984|FG002|Overall Study|Withdrawal by Subject|8|||
131102857|NCT00116753|472005982|FG000|Overall Study|Lost to Follow-up|0|||
131015924|NCT05686421|471687135|FG003|Overall Study|Screen failure|0|||
131015925|NCT00367055|471687139|FG000|Overall Study|Adverse Event|6|||
131015926|NCT00367055|471687140|FG001|Overall Study|Adverse Event|3|||
131015927|NCT00367055|471687139|FG000|Overall Study|Patient's Willing|3|||
131015928|NCT00367055|471687140|FG001|Overall Study|Patient's Willing|2|||
131015929|NCT00367055|471687139|FG000|Overall Study|Lack of Efficacy|1|||
131015930|NCT00367055|471687140|FG001|Overall Study|Lack of Efficacy|2|||
131015931|NCT00367055|471687139|FG000|Overall Study|Lost to Follow-up|1|||
131015932|NCT00367055|471687140|FG001|Overall Study|Lost to Follow-up|1|||
131015933|NCT00367055|471687139|FG000|Overall Study|Protocol Violation|0|||
131015934|NCT00367055|471687140|FG001|Overall Study|Protocol Violation|1|||
131015935|NCT00367055|471687139|FG000|Overall Study|Stopping Criterion Met|0|||
131015936|NCT00367055|471687140|FG001|Overall Study|Stopping Criterion Met|1|||
131015937|NCT00367055|471687139|FG000|Overall Study|Participant Living too Far from Hospital|0|||
131015938|NCT00367055|471687140|FG001|Overall Study|Participant Living too Far from Hospital|1|||
131015939|NCT00940992|471687141|FG000|Overall Study|Adverse Event|2|||
131015940|NCT00940992|471687142|FG001|Overall Study|Adverse Event|0|||
131015941|NCT00940992|471687143|FG002|Overall Study|Adverse Event|1|||
131015942|NCT00940992|471687141|FG000|Overall Study|subject request|2|||
131015943|NCT00940992|471687142|FG001|Overall Study|subject request|1|||
131015944|NCT00940992|471687143|FG002|Overall Study|subject request|0|||
131015945|NCT00940992|471687141|FG000|Overall Study|Lost to Follow-up|0|||
131015946|NCT00940992|471687142|FG001|Overall Study|Lost to Follow-up|1|||
131015947|NCT00940992|471687143|FG002|Overall Study|Lost to Follow-up|1|||
131015948|NCT03210402|471687144|FG000|Overall Study|Withdrawal by Subject|0|||
131015949|NCT03210402|471687145|FG001|Overall Study|Withdrawal by Subject|1|||
131015950|NCT02517307|471687162|FG000|Overall Study|Withdrawal by Subject|1|||
131015951|NCT02517307|471687163|FG001|Overall Study|Withdrawal by Subject|0|||
131015952|NCT02517307|471687164|FG002|Overall Study|Withdrawal by Subject|1|||
131015953|NCT02517307|471687165|FG003|Overall Study|Withdrawal by Subject|0|||
131015954|NCT02517307|471687162|FG000|Overall Study|Protocol Violation|0|||
131015955|NCT02517307|471687163|FG001|Overall Study|Protocol Violation|0|||
131015956|NCT02517307|471687164|FG002|Overall Study|Protocol Violation|1|||
131015957|NCT02517307|471687165|FG003|Overall Study|Protocol Violation|1|||
131015958|NCT00823979|471687166|FG000|Overall Study|Lack of Efficacy|13|||
131015959|NCT00823979|471687167|FG001|Overall Study|Lack of Efficacy|16|||
131015960|NCT00823979|471687168|FG002|Overall Study|Lack of Efficacy|9|||
131015961|NCT00823979|471687166|FG000|Overall Study|Lost to Follow-up|2|||
131015962|NCT00823979|471687167|FG001|Overall Study|Lost to Follow-up|1|||
131015963|NCT00823979|471687168|FG002|Overall Study|Lost to Follow-up|0|||
131015964|NCT00823979|471687166|FG000|Overall Study|Withdrawal by Subject|2|||
131015965|NCT00823979|471687167|FG001|Overall Study|Withdrawal by Subject|3|||
131015966|NCT00823979|471687168|FG002|Overall Study|Withdrawal by Subject|2|||
131015967|NCT00823979|471687166|FG000|Overall Study|Protocol Violation|1|||
131015968|NCT00823979|471687167|FG001|Overall Study|Protocol Violation|1|||
131015969|NCT00823979|471687168|FG002|Overall Study|Protocol Violation|0|||
131015970|NCT00823979|471687166|FG000|Overall Study|Pregnancy|0|||
131015971|NCT00823979|471687167|FG001|Overall Study|Pregnancy|1|||
131015972|NCT00823979|471687168|FG002|Overall Study|Pregnancy|0|||
131015973|NCT00823979|471687166|FG000|Overall Study|Adverse Event|0|||
131015974|NCT00823979|471687167|FG001|Overall Study|Adverse Event|2|||
131015975|NCT00823979|471687168|FG002|Overall Study|Adverse Event|4|||
131015976|NCT00823979|471687166|FG000|Overall Study|Other|2|||
131015977|NCT00823979|471687167|FG001|Overall Study|Other|0|||
131015978|NCT00823979|471687168|FG002|Overall Study|Other|1|||
131015979|NCT00823979|471687166|FG000|Overall Study|Randomized but not Treated|4|||
131015980|NCT00823979|471687167|FG001|Overall Study|Randomized but not Treated|3|||
131102858|NCT00116753|472005983|FG001|Overall Study|Lost to Follow-up|2|||
131102859|NCT00116753|472005984|FG002|Overall Study|Lost to Follow-up|1|||
131102860|NCT00116753|472005982|FG000|Overall Study|Protocol Violation|0|||
131015981|NCT00823979|471687168|FG002|Overall Study|Randomized but not Treated|1|||
131015982|NCT00823979|471687166|FG000|Overall Study|Study Terminated by Sponsor|5|||
130679465|NCT02937701|470454125|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
131015983|NCT00823979|471687167|FG001|Overall Study|Study Terminated by Sponsor|5|||
131102861|NCT00116753|472005983|FG001|Overall Study|Protocol Violation|0|||
131102862|NCT00116753|472005984|FG002|Overall Study|Protocol Violation|1|||
131102863|NCT00116753|472005982|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
131102864|NCT00116753|472005983|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
131102865|NCT00116753|472005984|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
131102866|NCT00116753|472005982|FG000|Overall Study|Disease Progression|3|||
131102867|NCT00116753|472005983|FG001|Overall Study|Disease Progression|4|||
131102868|NCT00116753|472005984|FG002|Overall Study|Disease Progression|3|||
131102869|NCT00116753|472005982|FG000|Overall Study|Abnormal Echocardiogram|0|||
131102870|NCT00116753|472005983|FG001|Overall Study|Abnormal Echocardiogram|0|||
131102871|NCT00116753|472005984|FG002|Overall Study|Abnormal Echocardiogram|1|||
131102872|NCT00116753|472005982|FG000|Overall Study|Progressive Parkinson's Disease|1|||
131102873|NCT00116753|472005983|FG001|Overall Study|Progressive Parkinson's Disease|0|||
131102874|NCT00116753|472005984|FG002|Overall Study|Progressive Parkinson's Disease|0|||
131102875|NCT00116753|472005982|FG000|Overall Study|Dosing Error|0|||
131102876|NCT00116753|472005983|FG001|Overall Study|Dosing Error|1|||
131102877|NCT00116753|472005984|FG002|Overall Study|Dosing Error|0|||
131102878|NCT01445301|472005985|FG000|Overall Study|Adverse Event|15|||
131102879|NCT01445301|472005986|FG001|Overall Study|Adverse Event|25|||
131102880|NCT01445301|472005987|FG002|Overall Study|Adverse Event|4|||
131102881|NCT01445301|472005985|FG000|Overall Study|Lack of Efficacy|0|||
131102882|NCT01445301|472005986|FG001|Overall Study|Lack of Efficacy|1|||
131102883|NCT01445301|472005987|FG002|Overall Study|Lack of Efficacy|0|||
131102884|NCT01445301|472005985|FG000|Overall Study|Protocol Violation|1|||
131102885|NCT01445301|472005986|FG001|Overall Study|Protocol Violation|0|||
131102886|NCT01445301|472005987|FG002|Overall Study|Protocol Violation|0|||
131102887|NCT01445301|472005985|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
131102888|NCT01445301|472005986|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
131102889|NCT01445301|472005987|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
131102890|NCT01445301|472005985|FG000|Overall Study|Physician Decision|0|||
131102891|NCT01445301|472005986|FG001|Overall Study|Physician Decision|2|||
131102892|NCT01445301|472005987|FG002|Overall Study|Physician Decision|0|||
131102893|NCT01445301|472005985|FG000|Overall Study|Withdrawal by Subject|5|||
131102894|NCT01445301|472005986|FG001|Overall Study|Withdrawal by Subject|6|||
131102895|NCT01445301|472005987|FG002|Overall Study|Withdrawal by Subject|4|||
131102896|NCT00752557|472005988|FG000|Overall Study|Withdrawal by Subject|4|||
131102897|NCT00752557|472005989|FG001|Overall Study|Withdrawal by Subject|3|||
131102898|NCT00752557|472005990|FG002|Overall Study|Withdrawal by Subject|3|||
131102899|NCT00752557|472005988|FG000|Overall Study|Unspecified resaons|0|||
131102900|NCT00752557|472005989|FG001|Overall Study|Unspecified resaons|2|||
131102901|NCT00752557|472005990|FG002|Overall Study|Unspecified resaons|2|||
131102902|NCT00752557|472005988|FG000|Overall Study|Lost to Follow-up|1|||
131102903|NCT00752557|472005989|FG001|Overall Study|Lost to Follow-up|0|||
131102904|NCT00752557|472005990|FG002|Overall Study|Lost to Follow-up|1|||
131102905|NCT02150343|472005995|FG000|Overall Study|Adverse Event|2|||
131102906|NCT02150343|472005996|FG001|Overall Study|Adverse Event|0|||
131102907|NCT02150343|472005997|FG002|Overall Study|Adverse Event|1|||
131102908|NCT02150343|472005998|FG003|Overall Study|Adverse Event|1|||
131102909|NCT02150343|472005995|FG000|Overall Study|Withdrawal by Subject|13|||
131102910|NCT02150343|472005996|FG001|Overall Study|Withdrawal by Subject|10|||
131102911|NCT02150343|472005997|FG002|Overall Study|Withdrawal by Subject|9|||
131102912|NCT02150343|472005998|FG003|Overall Study|Withdrawal by Subject|4|||
131102913|NCT02150343|472005995|FG000|Overall Study|Lost to Follow-up|4|||
131102914|NCT02150343|472005996|FG001|Overall Study|Lost to Follow-up|4|||
131102915|NCT02150343|472005997|FG002|Overall Study|Lost to Follow-up|2|||
131102916|NCT02150343|472005998|FG003|Overall Study|Lost to Follow-up|3|||
131102917|NCT02150343|472005995|FG000|Overall Study|Other|2|||
131102918|NCT02150343|472005996|FG001|Overall Study|Other|6|||
131102919|NCT02150343|472005997|FG002|Overall Study|Other|0|||
131102920|NCT02150343|472005998|FG003|Overall Study|Other|2|||
131102921|NCT02729753|472005999|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
131102922|NCT02729753|472006000|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
130679466|NCT02937701|470454126|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
130679467|NCT02937701|470454122|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
131102923|NCT01090427|472006001|FG000|After Controlled Period|Death|0|||
131102924|NCT01090427|472006002|FG001|After Controlled Period|Death|0|||
131102925|NCT01090427|472006003|FG002|After Controlled Period|Death|0|||
131102926|NCT01090427|472006004|FG003|After Controlled Period|Death|0|||
131102927|NCT01090427|472006005|FG004|After Controlled Period|Death|0|||
131102928|NCT01090427|472006006|FG005|After Controlled Period|Death|1|||
131102929|NCT01090427|472006007|FG006|After Controlled Period|Death|0|||
131102930|NCT01090427|472006001|FG000|After Controlled Period|Lack of Efficacy|0|||
130679468|NCT02937701|470454123|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
130679469|NCT02937701|470454124|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
131102931|NCT01090427|472006002|FG001|After Controlled Period|Lack of Efficacy|0|||
131222596|NCT01902134|472443116|FG003|Overall Study|Protocol Violation|0|||
131102932|NCT01090427|472006003|FG002|After Controlled Period|Lack of Efficacy|0|||
131102933|NCT01090427|472006004|FG003|After Controlled Period|Lack of Efficacy|0|||
131102934|NCT01090427|472006005|FG004|After Controlled Period|Lack of Efficacy|0|||
130679470|NCT02937701|470454125|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
130679471|NCT02937701|470454126|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
130679472|NCT02937701|470454122|FG000|Day 1 to Week 22|Death|1|||
130679473|NCT02937701|470454123|FG001|Day 1 to Week 22|Death|1|||
130679474|NCT02937701|470454124|FG002|Day 1 to Week 22|Death|0|||
131015984|NCT00823979|471687168|FG002|Overall Study|Study Terminated by Sponsor|7|||
131015985|NCT03586544|471687169|FG000|First Intervention|Adverse Event|0|||
131015986|NCT03586544|471687170|FG001|First Intervention|Adverse Event|1|||
131015987|NCT03586544|471687169|FG000|Second Intervention|Withdrawal by Subject|0|||
131015988|NCT03586544|471687170|FG001|Second Intervention|Withdrawal by Subject|1|||
131015989|NCT03523091|471687171|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
131015990|NCT03523091|471687172|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
131015991|NCT03523091|471687171|FG000|Overall Study|Withdrawal by Subject|0|||
131015992|NCT03523091|471687172|FG001|Overall Study|Withdrawal by Subject|3|||
131015993|NCT03523091|471687171|FG000|Overall Study|Increase Botox dose|0|||
131015994|NCT03523091|471687172|FG001|Overall Study|Increase Botox dose|1|||
131015995|NCT03863834|471687178|FG000|Overall Study|Lost to Follow-up|3|||
131015996|NCT02685488|471687179|FG000|Overall Study|Withdrawal by Subject|0|||
131015997|NCT02685488|471687180|FG001|Overall Study|Withdrawal by Subject|1|||
131015998|NCT05019729|471687181|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
131015999|NCT05019729|471687182|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
131016000|NCT05019729|471687183|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
131016001|NCT05019729|471687184|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
131016002|NCT05019729|471687185|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
131016003|NCT05019729|471687186|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
131016004|NCT00361283|471687195|FG000|Overall Study|Lost to Follow-up|27|||
131016005|NCT03768206|471687196|FG000|Overall Study|Lost to Follow-up|2|||
131016006|NCT03768206|471687197|FG001|Overall Study|Lost to Follow-up|1|||
131016007|NCT03768206|471687196|FG000|Overall Study|Withdrawal by Subject|0|||
131016008|NCT03768206|471687197|FG001|Overall Study|Withdrawal by Subject|1|||
131016009|NCT02551055|471687200|FG000|Overall Study|Death|2|||
131016010|NCT02551055|471687201|FG001|Overall Study|Death|4|||
131016011|NCT02551055|471687202|FG002|Overall Study|Death|2|||
131016012|NCT02551055|471687203|FG003|Overall Study|Death|2|||
131016013|NCT02551055|471687204|FG004|Overall Study|Death|2|||
131016014|NCT02551055|471687205|FG005|Overall Study|Death|1|||
131016015|NCT02551055|471687206|FG006|Overall Study|Death|2|||
131016016|NCT02551055|471687207|FG007|Overall Study|Death|0|||
131016017|NCT02551055|471687200|FG000|Overall Study|Study Terminated by Sponsor|1|||
131016018|NCT02551055|471687201|FG001|Overall Study|Study Terminated by Sponsor|1|||
131016019|NCT02551055|471687202|FG002|Overall Study|Study Terminated by Sponsor|0|||
131016020|NCT02551055|471687203|FG003|Overall Study|Study Terminated by Sponsor|2|||
131016021|NCT02551055|471687204|FG004|Overall Study|Study Terminated by Sponsor|2|||
131016022|NCT02551055|471687205|FG005|Overall Study|Study Terminated by Sponsor|0|||
131016023|NCT02551055|471687206|FG006|Overall Study|Study Terminated by Sponsor|0|||
131016024|NCT02551055|471687207|FG007|Overall Study|Study Terminated by Sponsor|0|||
131016025|NCT02551055|471687200|FG000|Overall Study|Withdrawal by Subject|1|||
131016026|NCT02551055|471687201|FG001|Overall Study|Withdrawal by Subject|1|||
131016027|NCT02551055|471687202|FG002|Overall Study|Withdrawal by Subject|0|||
131016028|NCT02551055|471687203|FG003|Overall Study|Withdrawal by Subject|1|||
131016029|NCT02551055|471687204|FG004|Overall Study|Withdrawal by Subject|2|||
131016030|NCT02551055|471687205|FG005|Overall Study|Withdrawal by Subject|0|||
131016031|NCT02551055|471687206|FG006|Overall Study|Withdrawal by Subject|0|||
131016032|NCT02551055|471687207|FG007|Overall Study|Withdrawal by Subject|0|||
131016033|NCT02551055|471687200|FG000|Overall Study|Reason not specified|0|||
131016034|NCT02551055|471687201|FG001|Overall Study|Reason not specified|0|||
131016035|NCT02551055|471687202|FG002|Overall Study|Reason not specified|0|||
131016036|NCT02551055|471687203|FG003|Overall Study|Reason not specified|0|||
131016037|NCT02551055|471687204|FG004|Overall Study|Reason not specified|1|||
131016038|NCT02551055|471687205|FG005|Overall Study|Reason not specified|0|||
131016039|NCT02551055|471687206|FG006|Overall Study|Reason not specified|1|||
131016040|NCT02551055|471687207|FG007|Overall Study|Reason not specified|0|||
131016041|NCT00430300|471687208|FG000|Overall Study|Adverse Event|0|||
131016042|NCT00430300|471687209|FG001|Overall Study|Adverse Event|2|||
131016043|NCT00430300|471687210|FG002|Overall Study|Adverse Event|1|||
131016044|NCT00430300|471687211|FG003|Overall Study|Adverse Event|1|||
131016045|NCT00430300|471687208|FG000|Overall Study|Withdrawal by Subject|1|||
131016046|NCT00430300|471687209|FG001|Overall Study|Withdrawal by Subject|0|||
131016047|NCT00430300|471687210|FG002|Overall Study|Withdrawal by Subject|5|||
131016048|NCT00430300|471687211|FG003|Overall Study|Withdrawal by Subject|0|||
131016049|NCT00430300|471687208|FG000|Overall Study|Laboratory abnormality|1|||
131016050|NCT00430300|471687209|FG001|Overall Study|Laboratory abnormality|0|||
131016051|NCT00430300|471687210|FG002|Overall Study|Laboratory abnormality|0|||
130679475|NCT02937701|470454125|FG003|Day 1 to Week 22|Death|0|||
130679476|NCT02937701|470454126|FG004|Day 1 to Week 22|Death|0|||
130679477|NCT02937701|470454122|FG000|Day 1 to Week 22|Protocol Violation|1|||
130679478|NCT02937701|470454123|FG001|Day 1 to Week 22|Protocol Violation|1|||
130679479|NCT02937701|470454124|FG002|Day 1 to Week 22|Protocol Violation|0|||
130679480|NCT02937701|470454125|FG003|Day 1 to Week 22|Protocol Violation|0|||
130679481|NCT02937701|470454126|FG004|Day 1 to Week 22|Protocol Violation|0|||
130679482|NCT02937701|470454122|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
130679483|NCT02937701|470454123|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
130679484|NCT02937701|470454124|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
130679485|NCT02937701|470454125|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
130679486|NCT02937701|470454126|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
130679487|NCT02937701|470454122|FG000|Day 1 to Week 22|Physician Decision|2|||
130679488|NCT02937701|470454123|FG001|Day 1 to Week 22|Physician Decision|0|||
130679489|NCT02937701|470454124|FG002|Day 1 to Week 22|Physician Decision|0|||
130679490|NCT02937701|470454125|FG003|Day 1 to Week 22|Physician Decision|0|||
130679491|NCT02937701|470454126|FG004|Day 1 to Week 22|Physician Decision|0|||
130679492|NCT02937701|470454122|FG000|Day 1 to Week 22|Other|1|||
130679493|NCT02937701|470454123|FG001|Day 1 to Week 22|Other|0|||
130679494|NCT02937701|470454124|FG002|Day 1 to Week 22|Other|0|||
130679495|NCT02937701|470454125|FG003|Day 1 to Week 22|Other|0|||
130679496|NCT02937701|470454126|FG004|Day 1 to Week 22|Other|0|||
130679497|NCT02937701|470454122|FG000|Week 22 to Week 50|Adverse Event|0|||
130679498|NCT02937701|470454123|FG001|Week 22 to Week 50|Adverse Event|0|||
130679499|NCT02937701|470454124|FG002|Week 22 to Week 50|Adverse Event|10|||
130679500|NCT02937701|470454125|FG003|Week 22 to Week 50|Adverse Event|3|||
130679501|NCT02937701|470454126|FG004|Week 22 to Week 50|Adverse Event|3|||
130679502|NCT02937701|470454122|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
130679503|NCT02937701|470454123|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
130679504|NCT02937701|470454124|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
130679505|NCT02937701|470454125|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
130679506|NCT02937701|470454126|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
130679507|NCT02937701|470454122|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
130679508|NCT02937701|470454123|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
131016052|NCT00430300|471687211|FG003|Overall Study|Laboratory abnormality|0|||
131016053|NCT00430300|471687208|FG000|Overall Study|Other|0|||
131016054|NCT00430300|471687209|FG001|Overall Study|Other|0|||
131016055|NCT00430300|471687210|FG002|Overall Study|Other|0|||
131016056|NCT00430300|471687211|FG003|Overall Study|Other|1|||
131016057|NCT02754479|471687215|FG000|Overall Study|Lost to Follow-up|1|||
131016058|NCT01049503|471689283|FG000|Overall Study|Lost to Follow-up|11|||
131016059|NCT01049503|471689284|FG001|Overall Study|Lost to Follow-up|12|||
131016060|NCT01049503|471689285|FG002|Overall Study|Lost to Follow-up|24|||
131016061|NCT01049503|471689286|FG003|Overall Study|Lost to Follow-up|26|||
131016062|NCT01049503|471689287|FG004|Overall Study|Lost to Follow-up|27|||
131016063|NCT01049503|471689288|FG005|Overall Study|Lost to Follow-up|8|||
131016064|NCT00726596|471689289|FG000|Overall Study|Adverse Event|2|||
131016065|NCT00726596|471689290|FG001|Overall Study|Adverse Event|1|||
131016066|NCT00726596|471689289|FG000|Overall Study|Withdrawal by Subject|3|||
131016067|NCT00726596|471689290|FG001|Overall Study|Withdrawal by Subject|3|||
131016068|NCT02974634|471689291|FG000|Overall Study|Advanced disease|12|||
131016069|NCT02974634|471689292|FG001|Overall Study|Advanced disease|3|||
131016070|NCT02974634|471689291|FG000|Overall Study|Noncompliance|3|||
131016071|NCT02974634|471689292|FG001|Overall Study|Noncompliance|7|||
131016072|NCT02974634|471689291|FG000|Overall Study|intervention technology related issues|5|||
131016073|NCT02974634|471689292|FG001|Overall Study|intervention technology related issues|0|||
131016074|NCT02974634|471689291|FG000|Overall Study|Death|8|||
131016075|NCT02974634|471689292|FG001|Overall Study|Death|11|||
131016076|NCT02962674|471689301|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
131016077|NCT00364286|471689302|FG000|Overall Study|Withdrawal by Subject|1|||
131016078|NCT00364286|471689302|FG000|Overall Study|Adverse Event|2|||
131016079|NCT00391846|471689303|FG000|Overall Study|Adverse Event|4|||
131016080|NCT00391846|471689304|FG001|Overall Study|Adverse Event|1|||
131016081|NCT00391846|471689303|FG000|Overall Study|Did not meet the required elig. crit|2|||
131016082|NCT00391846|471689304|FG001|Overall Study|Did not meet the required elig. crit|2|||
131016083|NCT00391846|471689303|FG000|Overall Study|Withdrawal by Subject|2|||
131102935|NCT01090427|472006006|FG005|After Controlled Period|Lack of Efficacy|3|||
130679509|NCT02937701|470454124|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
131016084|NCT00391846|471689304|FG001|Overall Study|Withdrawal by Subject|3|||
131016085|NCT00391846|471689303|FG000|Overall Study|Developed study specific DC criteria|0|||
131016086|NCT00391846|471689304|FG001|Overall Study|Developed study specific DC criteria|1|||
130679510|NCT02937701|470454125|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
130679511|NCT02937701|470454126|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
130679512|NCT02937701|470454122|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
130679513|NCT02937701|470454123|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
130679514|NCT02937701|470454124|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
130679515|NCT02937701|470454125|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
130679516|NCT02937701|470454126|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
130679517|NCT02937701|470454122|FG000|Week 22 to Week 50|Physician Decision|0|||
131102936|NCT01090427|472006007|FG006|After Controlled Period|Lack of Efficacy|2|||
130679518|NCT02937701|470454123|FG001|Week 22 to Week 50|Physician Decision|0|||
130679519|NCT02937701|470454124|FG002|Week 22 to Week 50|Physician Decision|2|||
130679520|NCT02937701|470454125|FG003|Week 22 to Week 50|Physician Decision|0|||
130679521|NCT02937701|470454126|FG004|Week 22 to Week 50|Physician Decision|1|||
130679522|NCT02937701|470454122|FG000|Week 22 to Week 50|Other|0|||
130679523|NCT02937701|470454123|FG001|Week 22 to Week 50|Other|0|||
130679524|NCT02937701|470454124|FG002|Week 22 to Week 50|Other|0|||
130679525|NCT02937701|470454125|FG003|Week 22 to Week 50|Other|0|||
130679526|NCT02937701|470454126|FG004|Week 22 to Week 50|Other|1|||
130679527|NCT04720664|470454127|FG000|Overall Study|Adverse Event|2|||
130679528|NCT04720664|470454127|FG000|Overall Study|Lack of Efficacy|9|||
130679529|NCT01866319|470454131|FG000|Overall Study|Adverse Event|12|||
130679530|NCT01866319|470454132|FG001|Overall Study|Adverse Event|5|||
130679531|NCT01866319|470454133|FG002|Overall Study|Adverse Event|9|||
130679532|NCT01866319|470454131|FG000|Overall Study|Clinical progression|3|||
130679533|NCT01866319|470454132|FG001|Overall Study|Clinical progression|2|||
130679534|NCT01866319|470454133|FG002|Overall Study|Clinical progression|2|||
130679535|NCT01866319|470454131|FG000|Overall Study|Death|153|||
130679536|NCT01866319|470454132|FG001|Overall Study|Death|154|||
130679537|NCT01866319|470454133|FG002|Overall Study|Death|147|||
130679538|NCT01866319|470454131|FG000|Overall Study|Lost to Follow-up|6|||
130679539|NCT01866319|470454132|FG001|Overall Study|Lost to Follow-up|3|||
130679540|NCT01866319|470454133|FG002|Overall Study|Lost to Follow-up|8|||
130679541|NCT01866319|470454131|FG000|Overall Study|Physician Decision|1|||
130679542|NCT01866319|470454132|FG001|Overall Study|Physician Decision|0|||
130679543|NCT01866319|470454133|FG002|Overall Study|Physician Decision|1|||
130679544|NCT01866319|470454131|FG000|Overall Study|Protocol Violation|0|||
130679545|NCT01866319|470454132|FG001|Overall Study|Protocol Violation|0|||
130679546|NCT01866319|470454133|FG002|Overall Study|Protocol Violation|1|||
130679547|NCT01866319|470454131|FG000|Overall Study|Withdrawal by Subject|32|||
130679548|NCT01866319|470454132|FG001|Overall Study|Withdrawal by Subject|14|||
130679549|NCT01866319|470454133|FG002|Overall Study|Withdrawal by Subject|12|||
131102937|NCT01090427|472006001|FG000|After Controlled Period|Adverse Event|0|||
131102938|NCT01090427|472006002|FG001|After Controlled Period|Adverse Event|0|||
131102939|NCT01090427|472006003|FG002|After Controlled Period|Adverse Event|0|||
131102940|NCT01090427|472006004|FG003|After Controlled Period|Adverse Event|2|||
130679550|NCT03980483|470454135|FG000|Overall Study|Adverse Event|13|||
130679551|NCT03980483|470454136|FG001|Overall Study|Adverse Event|29|||
131102941|NCT01090427|472006005|FG004|After Controlled Period|Adverse Event|0|||
131102942|NCT01090427|472006006|FG005|After Controlled Period|Adverse Event|1|||
131102943|NCT01090427|472006007|FG006|After Controlled Period|Adverse Event|0|||
131102944|NCT01200589|472006008|FG000|Overall Study|Withdrawal by Subject|13|||
131102945|NCT01200589|472006009|FG001|Overall Study|Withdrawal by Subject|11|||
131102946|NCT01200589|472006008|FG000|Overall Study|Physician Decision|2|||
131102947|NCT01200589|472006009|FG001|Overall Study|Physician Decision|2|||
131102948|NCT01200589|472006008|FG000|Overall Study|Lost to Follow-up|5|||
131102949|NCT01200589|472006009|FG001|Overall Study|Lost to Follow-up|4|||
131102950|NCT01200589|472006008|FG000|Overall Study|Study terminated|170|||
131102951|NCT01200589|472006009|FG001|Overall Study|Study terminated|172|||
131102952|NCT01605916|472006010|FG000|Overall Study|Adverse Event|1|||
131102953|NCT01605916|472006011|FG001|Overall Study|Adverse Event|0|||
131102954|NCT01605916|472006012|FG002|Overall Study|Adverse Event|0|||
131102955|NCT01605916|472006013|FG003|Overall Study|Adverse Event|1|||
131102956|NCT01605916|472006014|FG004|Overall Study|Adverse Event|0|||
131102957|NCT01605916|472006010|FG000|Overall Study|Lack of Efficacy|2|||
131102958|NCT01605916|472006011|FG001|Overall Study|Lack of Efficacy|3|||
131102959|NCT01605916|472006012|FG002|Overall Study|Lack of Efficacy|3|||
131102960|NCT01605916|472006013|FG003|Overall Study|Lack of Efficacy|5|||
131102961|NCT01605916|472006014|FG004|Overall Study|Lack of Efficacy|4|||
131102962|NCT01605916|472006010|FG000|Overall Study|Withdrawal by Subject|1|||
131102963|NCT01605916|472006011|FG001|Overall Study|Withdrawal by Subject|1|||
130679552|NCT03980483|470454137|FG002|Overall Study|Adverse Event|11|||
130679553|NCT03980483|470454138|FG003|Overall Study|Adverse Event|2|||
130679554|NCT03980483|470454139|FG004|Overall Study|Adverse Event|2|||
130679555|NCT03980483|470454140|FG005|Overall Study|Adverse Event|2|||
130679556|NCT03980483|470454135|FG000|Overall Study|Lack of Efficacy|7|||
130679557|NCT03980483|470454136|FG001|Overall Study|Lack of Efficacy|6|||
130679558|NCT03980483|470454137|FG002|Overall Study|Lack of Efficacy|0|||
131102964|NCT01605916|472006012|FG002|Overall Study|Withdrawal by Subject|0|||
131102965|NCT01605916|472006013|FG003|Overall Study|Withdrawal by Subject|0|||
130679559|NCT03980483|470454138|FG003|Overall Study|Lack of Efficacy|3|||
130679560|NCT03980483|470454139|FG004|Overall Study|Lack of Efficacy|1|||
131102966|NCT01605916|472006014|FG004|Overall Study|Withdrawal by Subject|2|||
131102967|NCT02891837|472006017|FG000|Overall Study|Lost to Follow-up|2|||
131102968|NCT02891837|472006018|FG001|Overall Study|Lost to Follow-up|0|||
131102969|NCT02891837|472006017|FG000|Overall Study|Withdrawal by Subject|1|||
131102970|NCT02891837|472006018|FG001|Overall Study|Withdrawal by Subject|0|||
130679561|NCT03980483|470454140|FG005|Overall Study|Lack of Efficacy|1|||
130679562|NCT03980483|470454135|FG000|Overall Study|Lost to Follow-up|2|||
130679563|NCT03980483|470454136|FG001|Overall Study|Lost to Follow-up|4|||
130679564|NCT03980483|470454137|FG002|Overall Study|Lost to Follow-up|2|||
130679565|NCT03980483|470454138|FG003|Overall Study|Lost to Follow-up|1|||
130679566|NCT03980483|470454139|FG004|Overall Study|Lost to Follow-up|2|||
130679567|NCT03980483|470454140|FG005|Overall Study|Lost to Follow-up|0|||
130679568|NCT03980483|470454135|FG000|Overall Study|Protocol Violation|4|||
130679569|NCT03980483|470454136|FG001|Overall Study|Protocol Violation|2|||
130679570|NCT03980483|470454137|FG002|Overall Study|Protocol Violation|1|||
130679571|NCT03980483|470454138|FG003|Overall Study|Protocol Violation|1|||
130679572|NCT03980483|470454139|FG004|Overall Study|Protocol Violation|0|||
130679573|NCT03980483|470454140|FG005|Overall Study|Protocol Violation|0|||
130679574|NCT03980483|470454135|FG000|Overall Study|Physician Decision|14|||
130679575|NCT03980483|470454136|FG001|Overall Study|Physician Decision|10|||
130679576|NCT03980483|470454137|FG002|Overall Study|Physician Decision|7|||
130679577|NCT03980483|470454138|FG003|Overall Study|Physician Decision|4|||
130679578|NCT03980483|470454139|FG004|Overall Study|Physician Decision|4|||
130679579|NCT03980483|470454140|FG005|Overall Study|Physician Decision|2|||
130679580|NCT03980483|470454135|FG000|Overall Study|Withdrawal by Subject|38|||
130679581|NCT03980483|470454136|FG001|Overall Study|Withdrawal by Subject|21|||
130679582|NCT03980483|470454137|FG002|Overall Study|Withdrawal by Subject|15|||
130679583|NCT03980483|470454138|FG003|Overall Study|Withdrawal by Subject|5|||
130679584|NCT03980483|470454139|FG004|Overall Study|Withdrawal by Subject|3|||
130679585|NCT03980483|470454140|FG005|Overall Study|Withdrawal by Subject|4|||
130679586|NCT03980483|470454135|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
130679587|NCT03980483|470454136|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130679588|NCT03980483|470454137|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130679589|NCT03980483|470454138|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130679590|NCT03980483|470454139|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130679591|NCT03980483|470454140|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130679592|NCT03980483|470454135|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130679593|NCT03980483|470454136|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
130679594|NCT03980483|470454137|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130679595|NCT03980483|470454138|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130679596|NCT03980483|470454139|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130679597|NCT03980483|470454140|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130679598|NCT03980483|470454135|FG000|Overall Study|Other|0|||
130679599|NCT03980483|470454136|FG001|Overall Study|Other|1|||
130679600|NCT03980483|470454137|FG002|Overall Study|Other|0|||
130679601|NCT03980483|470454138|FG003|Overall Study|Other|0|||
130679602|NCT03980483|470454139|FG004|Overall Study|Other|0|||
130679603|NCT03980483|470454140|FG005|Overall Study|Other|0|||
130679604|NCT01225146|470454142|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
130679605|NCT01225146|470454143|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
130679606|NCT00623779|470454147|FG000|Overall Study|Adverse Event|1|||
130679607|NCT00623779|470454148|FG001|Overall Study|Adverse Event|3|||
130679608|NCT00623779|470454149|FG002|Overall Study|Adverse Event|0|||
130679609|NCT00623779|470454147|FG000|Overall Study|Criteria from CSR|2|||
130679610|NCT00623779|470454148|FG001|Overall Study|Criteria from CSR|0|||
130679611|NCT00623779|470454149|FG002|Overall Study|Criteria from CSR|1|||
131102971|NCT00185965|472006027|FG000|Overall Study|Adverse Event|0|||
131102972|NCT00185965|472006028|FG001|Overall Study|Adverse Event|1|||
131102973|NCT02533531|472006029|FG000|Overall Study|Device did not turn on|1|||
131102974|NCT01014533|472006030|FG000|Overall Study|Protocol Violation|3|||
131102975|NCT01014533|472006031|FG001|Overall Study|Protocol Violation|2|||
130679612|NCT00220337|470454152|FG000|Overall Study|Adverse Event|70|||
130679613|NCT00220337|470454152|FG000|Overall Study|Lack of Efficacy|17|||
130679614|NCT00220337|470454152|FG000|Overall Study|Withdrawal by Subject|68|||
130679615|NCT00220337|470454152|FG000|Overall Study|Protocol Violation|2|||
130679616|NCT00220337|470454152|FG000|Overall Study|Lost to Follow-up|5|||
130679617|NCT00220337|470454152|FG000|Overall Study|Other|12|||
130679618|NCT00220337|470454152|FG000|Overall Study|Unsatisfactory compliance|5|||
130679619|NCT00944697|470454153|FG000|Overall Study|Withdrawal by Subject|1|||
130679620|NCT00944697|470454154|FG001|Overall Study|Withdrawal by Subject|1|||
130679621|NCT00944697|470454153|FG000|Overall Study|Adverse Event|0|||
130679622|NCT00944697|470454154|FG001|Overall Study|Adverse Event|3|||
130679623|NCT00944697|470454153|FG000|Overall Study|Administrative|1|||
130679624|NCT00944697|470454154|FG001|Overall Study|Administrative|1|||
130679625|NCT02732210|470454155|FG000|Overall Study|Site Closed|0|||
130679626|NCT02732210|470454156|FG001|Overall Study|Site Closed|11|||
130679627|NCT02732210|470454155|FG000|Overall Study|Study Ended|13|||
130679628|NCT02732210|470454156|FG001|Overall Study|Study Ended|13|||
130679629|NCT02732210|470454155|FG000|Overall Study|Withdrawal by Subject|28|||
130679630|NCT02732210|470454156|FG001|Overall Study|Withdrawal by Subject|87|||
130679631|NCT02732210|470454155|FG000|Overall Study|Lost to Follow-up|5|||
130679632|NCT02732210|470454156|FG001|Overall Study|Lost to Follow-up|57|||
130679633|NCT02732210|470454155|FG000|Overall Study|Death|4|||
131102976|NCT01014533|472006030|FG000|Overall Study|Withdrawal by Subject|2|||
130679634|NCT02732210|470454156|FG001|Overall Study|Death|15|||
130679635|NCT02732210|470454155|FG000|Overall Study|Other|35|||
130679636|NCT02732210|470454156|FG001|Overall Study|Other|103|||
130679637|NCT02732210|470454155|FG000|Overall Study|Missing|0|||
130679638|NCT02732210|470454156|FG001|Overall Study|Missing|8|||
131016087|NCT01227278|471689305|FG000|Overall Study|Withdrawal by Subject|4|||
131016088|NCT01227278|471689306|FG001|Overall Study|Withdrawal by Subject|4|||
131016089|NCT01227278|471689305|FG000|Overall Study|Death|0|||
131016090|NCT01227278|471689306|FG001|Overall Study|Death|2|||
131016091|NCT01227278|471689305|FG000|Overall Study|Other|1|||
131016092|NCT01227278|471689306|FG001|Overall Study|Other|2|||
131016093|NCT04035668|471689307|FG000|Overall Study|Adverse Event|3|||
131222597|NCT01902134|472443117|FG004|Overall Study|Protocol Violation|0|||
131222598|NCT01902134|472443118|FG005|Overall Study|Protocol Violation|1|||
131016094|NCT04035668|471689308|FG001|Overall Study|Adverse Event|4|||
131016095|NCT04035668|471689309|FG002|Overall Study|Adverse Event|2|||
131016096|NCT04035668|471689307|FG000|Overall Study|Lost to Follow-up|0|||
131016097|NCT04035668|471689308|FG001|Overall Study|Lost to Follow-up|1|||
131016098|NCT04035668|471689309|FG002|Overall Study|Lost to Follow-up|0|||
131016099|NCT04035668|471689307|FG000|Overall Study|Physician Decision|2|||
131016100|NCT04035668|471689308|FG001|Overall Study|Physician Decision|1|||
131016101|NCT04035668|471689309|FG002|Overall Study|Physician Decision|1|||
131016102|NCT04035668|471689307|FG000|Overall Study|Subject Decision|2|||
131016103|NCT04035668|471689308|FG001|Overall Study|Subject Decision|2|||
131016104|NCT04035668|471689309|FG002|Overall Study|Subject Decision|0|||
131016105|NCT02320123|471689310|FG000|Overall Study|Lost to Follow-up|4|||
131016106|NCT02320123|471689311|FG001|Overall Study|Lost to Follow-up|6|||
131016107|NCT02320123|471689310|FG000|Overall Study|Death|6|||
131016108|NCT02320123|471689311|FG001|Overall Study|Death|5|||
131016109|NCT00516386|471689314|FG000|Overall Study|not interested in the study|4|||
131016110|NCT00516386|471689314|FG000|Overall Study|Lost to Follow-up|2|||
131016111|NCT01376089|471689317|FG000|Overall Study|Patient received no contrast media|3|||
131016112|NCT01376089|471689318|FG001|Overall Study|Patient received no contrast media|4|||
131016113|NCT05174013|471689321|FG000|Overall Study|Lost to Follow-up|0|||
131016114|NCT05174013|471689322|FG001|Overall Study|Lost to Follow-up|0|||
131016115|NCT05174013|471689323|FG002|Overall Study|Lost to Follow-up|0|||
131016116|NCT05174013|471689324|FG003|Overall Study|Lost to Follow-up|1|||
131016117|NCT05174013|471689325|FG004|Overall Study|Lost to Follow-up|0|||
131016118|NCT05174013|471689326|FG005|Overall Study|Lost to Follow-up|0|||
131016119|NCT05174013|471689321|FG000|Overall Study|Withdrawal by Subject|0|||
131016120|NCT05174013|471689322|FG001|Overall Study|Withdrawal by Subject|0|||
131016121|NCT05174013|471689323|FG002|Overall Study|Withdrawal by Subject|1|||
131016122|NCT05174013|471689324|FG003|Overall Study|Withdrawal by Subject|0|||
131016123|NCT05174013|471689325|FG004|Overall Study|Withdrawal by Subject|0|||
131016124|NCT05174013|471689326|FG005|Overall Study|Withdrawal by Subject|0|||
131016125|NCT03287622|471689327|FG000|Overall Study|Withdrawal by Subject|1|||
131016126|NCT03287622|471689328|FG001|Overall Study|Withdrawal by Subject|0|||
131016127|NCT03287622|471689327|FG000|Overall Study|Lost to Follow-up|27|||
131016128|NCT03287622|471689328|FG001|Overall Study|Lost to Follow-up|15|||
131016129|NCT03287622|471689327|FG000|Overall Study|No prescripion after surgery|28|||
131016130|NCT03287622|471689328|FG001|Overall Study|No prescripion after surgery|31|||
131016131|NCT03287622|471689327|FG000|Overall Study|prolonged Length of stay|2|||
131016132|NCT03287622|471689328|FG001|Overall Study|prolonged Length of stay|0|||
131016133|NCT03287622|471689327|FG000|Overall Study|surgery related|0|||
131016134|NCT03287622|471689328|FG001|Overall Study|surgery related|2|||
131016135|NCT01930045|471689329|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
131016136|NCT01930045|471689330|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
131016137|NCT01930045|471689331|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
131016138|NCT01930045|471689332|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
131016139|NCT01930045|471689333|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
131016140|NCT01930045|471689334|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
131016141|NCT01930045|471689329|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
131016142|NCT01930045|471689330|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
131016143|NCT01930045|471689331|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
131016144|NCT01930045|471689332|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
131016145|NCT01930045|471689333|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
130885411|NCT04610281|471215195|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
131016146|NCT01930045|471689334|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
131016147|NCT02506257|471689335|FG000|Overall Study|Adverse Event|0|||
131016148|NCT02506257|471689336|FG001|Overall Study|Adverse Event|2|||
131016149|NCT02506257|471689337|FG002|Overall Study|Adverse Event|3|||
131016150|NCT02506257|471689338|FG003|Overall Study|Adverse Event|0|||
131016151|NCT02506257|471689335|FG000|Overall Study|Protocol Violation|0|||
131016152|NCT02506257|471689336|FG001|Overall Study|Protocol Violation|0|||
131016153|NCT02506257|471689337|FG002|Overall Study|Protocol Violation|1|||
131016154|NCT02506257|471689338|FG003|Overall Study|Protocol Violation|0|||
131016155|NCT00139737|471689340|FG000|Overall Study|Withdrawal by Subject|190|||
130679639|NCT02191891|470454159|FG000|Overall Study|Withdrawal by Subject|0|||
131102977|NCT01014533|472006031|FG001|Overall Study|Withdrawal by Subject|0|||
131102978|NCT01014533|472006030|FG000|Overall Study|unable to come to appointment|0|||
131102979|NCT01014533|472006031|FG001|Overall Study|unable to come to appointment|3|||
131102980|NCT02689518|472006032|FG000|Overall Study|Withdrawal by Subject|3|||
131102981|NCT03265938|472006035|FG000|Overall Study|Withdrawal by Subject|1|||
131102982|NCT03265938|472006035|FG000|Overall Study|Physician Decision|1|||
131102983|NCT03265938|472006035|FG000|Overall Study|friable mass|6|||
131102984|NCT02679508|472006036|FG000|Healing Phase|Protocol Violation|1|||
131102985|NCT02679508|472006037|FG001|Healing Phase|Protocol Violation|1|||
131102986|NCT02679508|472006036|FG000|Healing Phase|Lost to Follow-up|1|||
131102987|NCT02679508|472006037|FG001|Healing Phase|Lost to Follow-up|0|||
131102988|NCT02679508|472006036|FG000|Maintenance Phase|Adverse Event|12|||
131102989|NCT02679508|472006037|FG001|Maintenance Phase|Adverse Event|2|||
131102990|NCT02679508|472006036|FG000|Maintenance Phase|Lost to Follow-up|0|||
131102991|NCT02679508|472006037|FG001|Maintenance Phase|Lost to Follow-up|1|||
131102992|NCT02679508|472006036|FG000|Maintenance Phase|Withdrawal by Subject|15|||
131102993|NCT02679508|472006037|FG001|Maintenance Phase|Withdrawal by Subject|8|||
131102994|NCT02679508|472006036|FG000|Maintenance Phase|Other|5|||
131102995|NCT02679508|472006037|FG001|Maintenance Phase|Other|4|||
131102996|NCT03143166|472006038|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
131102997|NCT03683823|472006039|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
131102998|NCT03683823|472006040|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
131102999|NCT03683823|472006039|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
131103000|NCT03683823|472006040|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
131103001|NCT03683823|472006039|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
131103002|NCT03683823|472006040|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
131103003|NCT01323972|472006042|FG000|Overall Study|Withdrawal by Subject|1|||
131103004|NCT01323972|472006043|FG001|Overall Study|Withdrawal by Subject|0|||
131103005|NCT01323972|472006044|FG002|Overall Study|Withdrawal by Subject|1|||
131103006|NCT01323972|472006045|FG003|Overall Study|Withdrawal by Subject|0|||
131103007|NCT01323972|472006042|FG000|Overall Study|Migrated/moved from study area|1|||
131103008|NCT01323972|472006043|FG001|Overall Study|Migrated/moved from study area|2|||
131103009|NCT01323972|472006044|FG002|Overall Study|Migrated/moved from study area|0|||
131103010|NCT01323972|472006045|FG003|Overall Study|Migrated/moved from study area|0|||
131103011|NCT01323972|472006042|FG000|Overall Study|Lost to Follow-up|0|||
131103012|NCT01323972|472006043|FG001|Overall Study|Lost to Follow-up|1|||
131103013|NCT01323972|472006044|FG002|Overall Study|Lost to Follow-up|1|||
131103014|NCT01323972|472006045|FG003|Overall Study|Lost to Follow-up|1|||
131103015|NCT05000931|472006054|FG000|Overall Study|Lost to Follow-up|1|||
131103016|NCT03141905|472006055|FG000|Overall Study|Death|3|||
131103017|NCT03141905|472006056|FG001|Overall Study|Death|2|||
131103018|NCT03141905|472006055|FG000|Overall Study|Withdrawal by Subject|1|||
131103019|NCT03141905|472006056|FG001|Overall Study|Withdrawal by Subject|0|||
131103020|NCT03141905|472006055|FG000|Overall Study|Lost to Follow-up|3|||
131103021|NCT03141905|472006056|FG001|Overall Study|Lost to Follow-up|7|||
131103022|NCT03141905|472006055|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
131103023|NCT03141905|472006056|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
131103024|NCT00812331|472007881|FG000|Overall Study|Adverse Event|1|||
131103025|NCT00812331|472007882|FG001|Overall Study|Adverse Event|0|||
131103026|NCT00812331|472007883|FG002|Overall Study|Adverse Event|0|||
131103027|NCT00812331|472007884|FG003|Overall Study|Adverse Event|0|||
131103028|NCT00812331|472007885|FG004|Overall Study|Adverse Event|0|||
131103029|NCT01506453|472007886|FG000|Overall Study|Withdrawal prior to treatment|0|||
131103030|NCT01506453|472007887|FG001|Overall Study|Withdrawal prior to treatment|2|||
131103031|NCT02502799|472007888|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
130679640|NCT02191891|470454160|FG001|Overall Study|Withdrawal by Subject|1|||
131103032|NCT02502799|472007889|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
131103033|NCT02502799|472007890|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
131103034|NCT02502799|472007891|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
131103035|NCT02502799|472007888|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
131103036|NCT02502799|472007889|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
130679641|NCT02191891|470454161|FG002|Overall Study|Withdrawal by Subject|0|||
130679642|NCT02191891|470454162|FG003|Overall Study|Withdrawal by Subject|0|||
131103037|NCT02502799|472007890|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
131103038|NCT02502799|472007891|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
131103039|NCT02502799|472007888|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
131103040|NCT02502799|472007889|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
130679643|NCT02191891|470454163|FG004|Overall Study|Withdrawal by Subject|1|||
130679644|NCT02191891|470454159|FG000|Overall Study|Adverse Event|0|||
130679645|NCT02191891|470454160|FG001|Overall Study|Adverse Event|1|||
130679646|NCT02191891|470454161|FG002|Overall Study|Adverse Event|0|||
131103041|NCT02502799|472007890|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
131103042|NCT02502799|472007891|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
131103043|NCT02502799|472007888|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
130679647|NCT02191891|470454162|FG003|Overall Study|Adverse Event|0|||
131103044|NCT02502799|472007889|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
131103045|NCT02502799|472007890|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
131103046|NCT02502799|472007891|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
131103047|NCT02502799|472007888|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
131103048|NCT02502799|472007889|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
131103049|NCT02502799|472007890|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
131103050|NCT02502799|472007891|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
131103051|NCT00055601|472007894|FG000|Overall Study|Protocol Violation|1|||
131103052|NCT00055601|472007895|FG001|Overall Study|Protocol Violation|1|||
131103053|NCT00055601|472007894|FG000|Overall Study|No protocol treatment received|1|||
131103054|NCT00055601|472007895|FG001|Overall Study|No protocol treatment received|1|||
131103055|NCT00117845|472007896|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
131103056|NCT01022268|472007897|FG000|Overall Study|Withdrawal by Subject|1|||
131103057|NCT01022268|472007898|FG001|Overall Study|Withdrawal by Subject|0|||
131103058|NCT01022268|472007897|FG000|Overall Study|Withdrawal by Subject|1|||
131103059|NCT01022268|472007898|FG001|Overall Study|Withdrawal by Subject|0|||
131103060|NCT00910689|472007899|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
131103061|NCT00910689|472007900|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
131103062|NCT00910689|472007901|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
131103063|NCT00910689|472007902|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
131103064|NCT00910689|472007899|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
131103065|NCT00910689|472007900|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
131103066|NCT00910689|472007901|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
131103067|NCT00910689|472007902|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
131103068|NCT00910689|472007899|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
131103069|NCT00910689|472007900|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
131103070|NCT00910689|472007901|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
131103071|NCT00910689|472007902|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
131103072|NCT00910689|472007899|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
131103073|NCT00910689|472007900|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
131103074|NCT00910689|472007901|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
131103075|NCT00910689|472007902|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
131103076|NCT00910689|472007899|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
131103077|NCT00910689|472007900|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
131103078|NCT00910689|472007901|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
131103079|NCT00910689|472007902|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
131103080|NCT00910689|472007899|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
131103081|NCT00910689|472007900|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
131103082|NCT00910689|472007901|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
131103083|NCT00910689|472007902|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
131103084|NCT00910689|472007899|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
131103085|NCT00910689|472007900|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
131103086|NCT00910689|472007901|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
131103087|NCT00910689|472007902|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
131103088|NCT00910689|472007899|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
131103089|NCT00910689|472007900|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
131103090|NCT00910689|472007901|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
131103091|NCT00910689|472007902|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
131103092|NCT00910689|472007899|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
131103093|NCT00910689|472007900|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
131103094|NCT00910689|472007901|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
131103095|NCT00910689|472007902|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
131103096|NCT00910689|472007899|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
131103097|NCT00910689|472007900|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
131103098|NCT00910689|472007901|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
131103099|NCT00910689|472007902|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
131103100|NCT00910689|472007899|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
131103101|NCT00910689|472007900|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
131103102|NCT00910689|472007901|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
131103103|NCT00910689|472007902|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
131103104|NCT00910689|472007899|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
130679648|NCT02191891|470454163|FG004|Overall Study|Adverse Event|2|||
130679649|NCT02191891|470454159|FG000|Overall Study|Disease Progression|4|||
130679650|NCT02191891|470454160|FG001|Overall Study|Disease Progression|10|||
130679651|NCT02191891|470454161|FG002|Overall Study|Disease Progression|4|||
130679652|NCT02191891|470454162|FG003|Overall Study|Disease Progression|2|||
130679653|NCT02191891|470454163|FG004|Overall Study|Disease Progression|7|||
130679654|NCT01226797|470454174|FG000|Overall Study|Adverse Event|1|||
131016156|NCT00139737|471689340|FG000|Overall Study|Adverse Event|58|||
131016157|NCT00139737|471689340|FG000|Overall Study|Lack of Efficacy|40|||
131016158|NCT00139737|471689340|FG000|Overall Study|Lost to Follow-up|8|||
131016159|NCT00139737|471689340|FG000|Overall Study|Death|3|||
131016160|NCT00139737|471689340|FG000|Overall Study|Laboratory Abnormality|2|||
131016161|NCT00139737|471689340|FG000|Overall Study|Protocol Violation|18|||
131016162|NCT00139737|471689340|FG000|Overall Study|Withdrew During Screening Phase|8|||
131016163|NCT00139737|471689340|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
131016164|NCT00139737|471689340|FG000|Overall Study|Screened, Not Treated|13|||
131016165|NCT03781336|471689341|FG000|Overall Study|Withdrawal by Subject|2|||
131016166|NCT03781336|471689342|FG001|Overall Study|Withdrawal by Subject|2|||
131016167|NCT01596504|471689346|FG000|Overall Study|Participant's Private Reason|0|||
131016168|NCT01596504|471689347|FG001|Overall Study|Participant's Private Reason|1|||
131016169|NCT01596504|471689348|FG002|Overall Study|Participant's Private Reason|0|||
131016170|NCT01596504|471689346|FG000|Overall Study|Adverse Event|1|||
131016171|NCT01596504|471689347|FG001|Overall Study|Adverse Event|2|||
131016172|NCT01596504|471689348|FG002|Overall Study|Adverse Event|1|||
131016173|NCT01596504|471689346|FG000|Overall Study|Withdrawal by Subject|1|||
131016174|NCT01596504|471689347|FG001|Overall Study|Withdrawal by Subject|0|||
131016175|NCT01596504|471689348|FG002|Overall Study|Withdrawal by Subject|0|||
131016176|NCT01901276|471689349|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
131016177|NCT01901276|471689350|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
131016178|NCT00530842|471689351|FG000|Overall Study|Adverse Event|10|||
131016179|NCT00530842|471689352|FG001|Overall Study|Adverse Event|6|||
131016180|NCT00530842|471689351|FG000|Overall Study|Lack of Efficacy|2|||
131016181|NCT00530842|471689352|FG001|Overall Study|Lack of Efficacy|1|||
131016182|NCT00530842|471689351|FG000|Overall Study|Lost to Follow-up|0|||
131016183|NCT00530842|471689352|FG001|Overall Study|Lost to Follow-up|4|||
131016184|NCT00530842|471689351|FG000|Overall Study|Protocol Violation|3|||
131016185|NCT00530842|471689352|FG001|Overall Study|Protocol Violation|2|||
131016186|NCT00530842|471689351|FG000|Overall Study|Withdrawal by Subject|4|||
131016187|NCT00530842|471689352|FG001|Overall Study|Withdrawal by Subject|5|||
131016188|NCT00530842|471689351|FG000|Overall Study|Individual different reasons|4|||
131016189|NCT00530842|471689352|FG001|Overall Study|Individual different reasons|3|||
131016190|NCT00530842|471689351|FG000|Period 1|Adverse Event|7|||
131016191|NCT00530842|471689352|FG001|Period 1|Adverse Event|3|||
131016192|NCT00530842|471689351|FG000|Period 1|Lack of Efficacy|1|||
131016193|NCT00530842|471689352|FG001|Period 1|Lack of Efficacy|1|||
131016194|NCT00530842|471689351|FG000|Period 1|Protocol Violation|2|||
131103105|NCT00910689|472007900|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
131103106|NCT00910689|472007901|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
131103107|NCT00910689|472007902|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
131103108|NCT00910689|472007899|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
131103109|NCT00910689|472007900|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
131103110|NCT00910689|472007901|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
131103111|NCT00910689|472007902|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
131103112|NCT00910689|472007899|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
131103113|NCT00910689|472007900|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
131103114|NCT00910689|472007901|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
130679655|NCT01226797|470454175|FG001|Overall Study|Adverse Event|0|||
130679656|NCT01226797|470454174|FG000|Overall Study|No longer willing to participate|1|||
131016195|NCT00530842|471689352|FG001|Period 1|Protocol Violation|1|||
131016196|NCT00530842|471689351|FG000|Period 1|Withdrawal by Subject|2|||
131016197|NCT00530842|471689352|FG001|Period 1|Withdrawal by Subject|3|||
131016198|NCT00530842|471689351|FG000|Period 1|Individual different reasons|2|||
131016199|NCT00530842|471689352|FG001|Period 1|Individual different reasons|3|||
131016200|NCT00530842|471689351|FG000|Period 2|Adverse Event|3|||
131016201|NCT00530842|471689352|FG001|Period 2|Adverse Event|3|||
131016202|NCT00530842|471689351|FG000|Period 2|Lack of Efficacy|1|||
131016203|NCT00530842|471689352|FG001|Period 2|Lack of Efficacy|0|||
131016204|NCT00530842|471689351|FG000|Period 2|Lost to Follow-up|0|||
131016205|NCT00530842|471689352|FG001|Period 2|Lost to Follow-up|4|||
131016206|NCT00530842|471689351|FG000|Period 2|Protocol Violation|1|||
131016207|NCT00530842|471689352|FG001|Period 2|Protocol Violation|0|||
131016208|NCT00530842|471689351|FG000|Period 2|Withdrawal by Subject|1|||
131016209|NCT00530842|471689352|FG001|Period 2|Withdrawal by Subject|2|||
131103115|NCT00910689|472007902|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
130679657|NCT01226797|470454175|FG001|Overall Study|No longer willing to participate|0|||
131016210|NCT00530842|471689351|FG000|Period 2|Individual different reasons|2|||
131016211|NCT00530842|471689352|FG001|Period 2|Individual different reasons|0|||
131016212|NCT00949975|471689353|FG000|Overall Study|Voluntary discontinuation|6|||
131016213|NCT00949975|471689354|FG001|Overall Study|Voluntary discontinuation|5|||
131016214|NCT00949975|471689355|FG002|Overall Study|Voluntary discontinuation|3|||
131016215|NCT00949975|471689356|FG003|Overall Study|Voluntary discontinuation|6|||
131016216|NCT00949975|471689353|FG000|Overall Study|Adverse Event|11|||
131016217|NCT00949975|471689354|FG001|Overall Study|Adverse Event|11|||
131016218|NCT00949975|471689355|FG002|Overall Study|Adverse Event|10|||
131103116|NCT00910689|472007899|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
131103117|NCT00910689|472007900|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
131103118|NCT00910689|472007901|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
131103119|NCT00910689|472007902|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
131103120|NCT00910689|472007899|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
131103121|NCT00910689|472007900|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
131103122|NCT00910689|472007901|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
131103123|NCT00910689|472007902|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
131103124|NCT00910689|472007899|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
131103125|NCT00910689|472007900|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
131103126|NCT00910689|472007901|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
131103127|NCT00910689|472007902|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
131103128|NCT00910689|472007899|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
131103129|NCT00910689|472007900|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
131103130|NCT00910689|472007901|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
131103131|NCT00910689|472007902|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
131103132|NCT00910689|472007899|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
131103133|NCT00910689|472007900|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
131103134|NCT00910689|472007901|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
131103135|NCT00910689|472007902|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
131103136|NCT00910689|472007899|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
131103137|NCT00910689|472007900|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
131103138|NCT00910689|472007901|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
131103139|NCT00910689|472007902|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
131103140|NCT00910689|472007899|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
131103141|NCT00910689|472007900|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
131103142|NCT00910689|472007901|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
131103143|NCT00910689|472007902|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
131103144|NCT03207009|472007903|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
131103145|NCT02924428|472007904|FG000|Overall Study|Adverse Event|1|||
131103146|NCT02924428|472007905|FG001|Overall Study|Adverse Event|0|||
131103147|NCT02924428|472007904|FG000|Overall Study|Physician Decision|1|||
131103148|NCT02924428|472007905|FG001|Overall Study|Physician Decision|0|||
131103149|NCT02924428|472007904|FG000|Overall Study|Lost to Follow-up|2|||
131103150|NCT02924428|472007905|FG001|Overall Study|Lost to Follow-up|4|||
131103151|NCT02924428|472007904|FG000|Overall Study|Pregnancy|0|||
131103152|NCT02924428|472007905|FG001|Overall Study|Pregnancy|1|||
131103153|NCT02680002|472007906|FG000|Overall Study|Lost to Follow-up|5|||
131103154|NCT02680002|472007907|FG001|Overall Study|Lost to Follow-up|1|||
131103155|NCT02680002|472007908|FG002|Overall Study|Lost to Follow-up|4|||
131103156|NCT02680002|472007909|FG003|Overall Study|Lost to Follow-up|2|||
131103157|NCT02680002|472007910|FG004|Overall Study|Lost to Follow-up|0|||
131103158|NCT02680002|472007911|FG005|Overall Study|Lost to Follow-up|2|||
131103159|NCT02680002|472007906|FG000|Overall Study|Physician Decision|5|||
131103160|NCT02680002|472007907|FG001|Overall Study|Physician Decision|1|||
131103161|NCT02680002|472007908|FG002|Overall Study|Physician Decision|1|||
131103162|NCT02680002|472007909|FG003|Overall Study|Physician Decision|1|||
131103163|NCT02680002|472007910|FG004|Overall Study|Physician Decision|1|||
131103164|NCT02680002|472007911|FG005|Overall Study|Physician Decision|1|||
131103165|NCT02680002|472007906|FG000|Overall Study|Protocol Violation|1|||
131103166|NCT02680002|472007907|FG001|Overall Study|Protocol Violation|0|||
131103167|NCT02680002|472007908|FG002|Overall Study|Protocol Violation|1|||
131103168|NCT02680002|472007909|FG003|Overall Study|Protocol Violation|0|||
131103169|NCT02680002|472007910|FG004|Overall Study|Protocol Violation|1|||
131103170|NCT02680002|472007911|FG005|Overall Study|Protocol Violation|2|||
131103171|NCT02680002|472007906|FG000|Overall Study|Withdrawal by Subject|0|||
131103172|NCT02680002|472007907|FG001|Overall Study|Withdrawal by Subject|0|||
131103173|NCT02680002|472007908|FG002|Overall Study|Withdrawal by Subject|1|||
131103174|NCT02680002|472007909|FG003|Overall Study|Withdrawal by Subject|0|||
131103175|NCT02680002|472007910|FG004|Overall Study|Withdrawal by Subject|2|||
131103176|NCT02680002|472007911|FG005|Overall Study|Withdrawal by Subject|2|||
131103177|NCT02680002|472007906|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
131103178|NCT02680002|472007907|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
131103179|NCT02680002|472007908|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
131103180|NCT02680002|472007909|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
131103181|NCT02680002|472007910|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
131103182|NCT02680002|472007911|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
131103183|NCT02680002|472007906|FG000|Overall Study|Other|0|||
131103184|NCT02680002|472007907|FG001|Overall Study|Other|1|||
131103185|NCT02680002|472007908|FG002|Overall Study|Other|0|||
131103186|NCT02680002|472007909|FG003|Overall Study|Other|0|||
131103187|NCT02680002|472007910|FG004|Overall Study|Other|1|||
131103188|NCT02680002|472007911|FG005|Overall Study|Other|0|||
131103189|NCT02680002|472007906|FG000|Overall Study|Adverse Event|0|||
131103190|NCT02680002|472007907|FG001|Overall Study|Adverse Event|0|||
130679658|NCT01226797|470454174|FG000|Overall Study|Protocol Violation|0|||
130679659|NCT01226797|470454175|FG001|Overall Study|Protocol Violation|1|||
130679660|NCT01974141|470454178|FG000|Overall Study|Other Reasons|28|||
130679661|NCT01974141|470454179|FG001|Overall Study|Other Reasons|18|||
131016219|NCT00949975|471689356|FG003|Overall Study|Adverse Event|10|||
131016220|NCT00949975|471689353|FG000|Overall Study|Safety reason|0|||
131016221|NCT00949975|471689354|FG001|Overall Study|Safety reason|1|||
131016222|NCT00949975|471689355|FG002|Overall Study|Safety reason|0|||
131016223|NCT00949975|471689356|FG003|Overall Study|Safety reason|0|||
131016224|NCT00949975|471689353|FG000|Overall Study|Study-specific criteria|0|||
131016225|NCT00949975|471689354|FG001|Overall Study|Study-specific criteria|1|||
131016226|NCT00949975|471689355|FG002|Overall Study|Study-specific criteria|1|||
131016227|NCT00949975|471689356|FG003|Overall Study|Study-specific criteria|0|||
131016228|NCT00949975|471689353|FG000|Overall Study|Incorrect enrolment|5|||
131016229|NCT00949975|471689354|FG001|Overall Study|Incorrect enrolment|10|||
131016230|NCT00949975|471689355|FG002|Overall Study|Incorrect enrolment|4|||
131016231|NCT00949975|471689356|FG003|Overall Study|Incorrect enrolment|7|||
131016232|NCT00949975|471689353|FG000|Overall Study|Severe non-compliance|3|||
131016233|NCT00949975|471689354|FG001|Overall Study|Severe non-compliance|1|||
131016234|NCT00949975|471689355|FG002|Overall Study|Severe non-compliance|0|||
131016235|NCT00949975|471689356|FG003|Overall Study|Severe non-compliance|2|||
131016236|NCT00949975|471689353|FG000|Overall Study|Lost to Follow-up|1|||
131016237|NCT00949975|471689354|FG001|Overall Study|Lost to Follow-up|0|||
131016238|NCT00949975|471689355|FG002|Overall Study|Lost to Follow-up|1|||
131016239|NCT00949975|471689356|FG003|Overall Study|Lost to Follow-up|3|||
131016240|NCT00949975|471689353|FG000|Overall Study|Other|1|||
131016241|NCT00949975|471689354|FG001|Overall Study|Other|0|||
131016242|NCT00949975|471689355|FG002|Overall Study|Other|0|||
131016243|NCT00949975|471689356|FG003|Overall Study|Other|0|||
131016244|NCT04347954|471689357|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
131016245|NCT04347954|471689358|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
131016246|NCT04347954|471689359|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
131016247|NCT04347954|471689357|FG000|Overall Study|Lost to Follow-up|0|||
131016248|NCT04347954|471689358|FG001|Overall Study|Lost to Follow-up|1|||
131016249|NCT04347954|471689359|FG002|Overall Study|Lost to Follow-up|0|||
131016250|NCT03257813|471689363|FG000|Overall Study|Protocol Violation|6|||
131016251|NCT03257813|471689364|FG001|Overall Study|Protocol Violation|3|||
131016252|NCT05641311|471689369|FG000|Dosing Period 1|Adverse Event|1|||
131016253|NCT05641311|471689370|FG001|Dosing Period 1|Adverse Event|0|||
131016254|NCT00909363|471689371|FG000|Overall Study|Withdrawal by Subject|1|||
131016255|NCT00909363|471689372|FG001|Overall Study|Withdrawal by Subject|0|||
131016256|NCT00909363|471689373|FG002|Overall Study|Withdrawal by Subject|0|||
131016257|NCT00909363|471689371|FG000|Overall Study|Lack of Efficacy|1|||
131016258|NCT00909363|471689372|FG001|Overall Study|Lack of Efficacy|0|||
131016259|NCT00909363|471689373|FG002|Overall Study|Lack of Efficacy|0|||
131016260|NCT00922207|471689376|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
131016261|NCT00922207|471689377|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
131016262|NCT00922207|471689378|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
131016263|NCT00922207|471689376|FG000|Overall Study|Insufficient Therapeutic Response|0|||
131016264|NCT00922207|471689377|FG001|Overall Study|Insufficient Therapeutic Response|0|||
131016265|NCT00922207|471689378|FG002|Overall Study|Insufficient Therapeutic Response|1|||
131016266|NCT00922207|471689376|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
131016267|NCT00922207|471689377|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
131016268|NCT00922207|471689378|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
131016269|NCT00922207|471689376|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
131016270|NCT00922207|471689377|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
131016271|NCT00922207|471689378|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
131016272|NCT00922207|471689376|FG000|Overall Study|Withdrew Consent|2|||
131016273|NCT00922207|471689377|FG001|Overall Study|Withdrew Consent|5|||
131016274|NCT00922207|471689378|FG002|Overall Study|Withdrew Consent|2|||
130679662|NCT01974141|470454178|FG000|Overall Study|Protocol Violation|2|||
131016275|NCT00922207|471689376|FG000|Overall Study|Abnormality of Laboratory Test|0|||
131016276|NCT00922207|471689377|FG001|Overall Study|Abnormality of Laboratory Test|1|||
131016277|NCT00922207|471689378|FG002|Overall Study|Abnormality of Laboratory Test|1|||
131016278|NCT01802632|471689379|FG000|Overall Study|Death|28|||
131016279|NCT01802632|471689380|FG001|Overall Study|Death|1|||
131016280|NCT01802632|471689381|FG002|Overall Study|Death|38|||
131016281|NCT01802632|471689382|FG003|Overall Study|Death|0|||
131016282|NCT01802632|471689383|FG004|Overall Study|Death|2|||
131016283|NCT01802632|471689384|FG005|Overall Study|Death|0|||
131016284|NCT01802632|471689379|FG000|Overall Study|Withdrawal by Subject|4|||
131016285|NCT01802632|471689380|FG001|Overall Study|Withdrawal by Subject|2|||
131016286|NCT01802632|471689381|FG002|Overall Study|Withdrawal by Subject|7|||
131016287|NCT01802632|471689382|FG003|Overall Study|Withdrawal by Subject|3|||
131016288|NCT01802632|471689383|FG004|Overall Study|Withdrawal by Subject|0|||
131016289|NCT01802632|471689384|FG005|Overall Study|Withdrawal by Subject|1|||
130679663|NCT01974141|470454179|FG001|Overall Study|Protocol Violation|6|||
130679664|NCT01974141|470454178|FG000|Overall Study|Personal Reasons|21|||
130679665|NCT01974141|470454179|FG001|Overall Study|Personal Reasons|20|||
130679666|NCT01974141|470454178|FG000|Overall Study|Lost to Follow-up|38|||
130679667|NCT01974141|470454179|FG001|Overall Study|Lost to Follow-up|29|||
130679668|NCT01974141|470454178|FG000|Overall Study|Pregnancy|3|||
130679669|NCT01974141|470454179|FG001|Overall Study|Pregnancy|3|||
130679670|NCT01974141|470454178|FG000|Overall Study|Lack of Efficacy|0|||
130679671|NCT01974141|470454179|FG001|Overall Study|Lack of Efficacy|1|||
131016290|NCT01802632|471689379|FG000|Overall Study|Objective Disease Progression|1|||
131016291|NCT01802632|471689380|FG001|Overall Study|Objective Disease Progression|12|||
131016292|NCT01802632|471689381|FG002|Overall Study|Objective Disease Progression|104|||
131016293|NCT01802632|471689382|FG003|Overall Study|Objective Disease Progression|6|||
131016294|NCT01802632|471689383|FG004|Overall Study|Objective Disease Progression|4|||
131016295|NCT01802632|471689384|FG005|Overall Study|Objective Disease Progression|4|||
131016296|NCT01802632|471689379|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
131016297|NCT01802632|471689380|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
131016298|NCT01802632|471689381|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
131016299|NCT01802632|471689382|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
131016300|NCT01802632|471689383|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
131016301|NCT01802632|471689384|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
131016302|NCT01802632|471689379|FG000|Overall Study|Other (not specified)|0|||
131016303|NCT01802632|471689380|FG001|Overall Study|Other (not specified)|0|||
131016304|NCT01802632|471689381|FG002|Overall Study|Other (not specified)|7|||
131016305|NCT01802632|471689382|FG003|Overall Study|Other (not specified)|1|||
131016306|NCT01802632|471689383|FG004|Overall Study|Other (not specified)|0|||
131016307|NCT01802632|471689384|FG005|Overall Study|Other (not specified)|1|||
131016308|NCT02705586|471689388|FG000|Overall Study|Health Issues|2|||
131016309|NCT02705586|471689388|FG000|Overall Study|Transportation Difficulties|5|||
131016310|NCT02705586|471689388|FG000|Overall Study|Vacation/Planned Absence|1|||
131016311|NCT02045836|471689392|FG000|Overall Study|Adverse Event|4|||
131016312|NCT02045836|471689393|FG001|Overall Study|Adverse Event|4|||
131016313|NCT02045836|471689392|FG000|Overall Study|Withdrawal by Subject|1|||
131016314|NCT02045836|471689393|FG001|Overall Study|Withdrawal by Subject|1|||
131016315|NCT02045836|471689392|FG000|Overall Study|Lost to Follow-up|4|||
131016316|NCT02045836|471689393|FG001|Overall Study|Lost to Follow-up|7|||
131016317|NCT02045836|471689392|FG000|Overall Study|Migrated from study area|0|||
131016318|NCT02045836|471689393|FG001|Overall Study|Migrated from study area|2|||
131016319|NCT03920215|471689396|FG000|Overall Study|Lost to Follow-up|1|||
131016320|NCT03920215|471689397|FG001|Overall Study|Lost to Follow-up|2|||
131016321|NCT03920215|471689398|FG002|Overall Study|Lost to Follow-up|0|||
131016322|NCT03920215|471689399|FG003|Overall Study|Lost to Follow-up|0|||
131016323|NCT03920215|471689396|FG000|Overall Study|Death|0|||
131016324|NCT03920215|471689397|FG001|Overall Study|Death|0|||
131016325|NCT03920215|471689398|FG002|Overall Study|Death|0|||
131016326|NCT03920215|471689399|FG003|Overall Study|Death|1|||
131016327|NCT02000817|471689400|FG000|Overall Study|Withdrawal by Subject|2|||
131016328|NCT02000817|471689401|FG001|Overall Study|Withdrawal by Subject|0|||
131016329|NCT02000817|471689402|FG002|Overall Study|Withdrawal by Subject|0|||
131016330|NCT02000817|471689403|FG003|Overall Study|Withdrawal by Subject|0|||
131016331|NCT02000817|471689400|FG000|Overall Study|Adverse Event|0|||
131016332|NCT02000817|471689401|FG001|Overall Study|Adverse Event|1|||
131016333|NCT02000817|471689402|FG002|Overall Study|Adverse Event|0|||
131016334|NCT02000817|471689403|FG003|Overall Study|Adverse Event|0|||
131016335|NCT02000817|471689400|FG000|Overall Study|Lost to Follow-up|0|||
131016336|NCT02000817|471689401|FG001|Overall Study|Lost to Follow-up|0|||
131016337|NCT02000817|471689402|FG002|Overall Study|Lost to Follow-up|1|||
131016338|NCT02000817|471689403|FG003|Overall Study|Lost to Follow-up|0|||
131016339|NCT02798835|471689406|FG000|Overall Study|Protocol Violation|0|||
131016340|NCT02798835|471689407|FG001|Overall Study|Protocol Violation|0|||
131016341|NCT02798835|471689408|FG002|Overall Study|Protocol Violation|3|||
131016342|NCT00177216|471689409|FG000|Overall Study|Withdrawal by Subject|6|||
131016343|NCT00177216|471689410|FG001|Overall Study|Withdrawal by Subject|3|||
131016344|NCT00177216|471689411|FG002|Overall Study|Withdrawal by Subject|1|||
131016345|NCT02459899|471689416|FG000|Overall Study|Adverse Event|1|||
130679672|NCT01974141|470454178|FG000|Overall Study|Adverse Event|4|||
130679673|NCT01974141|470454179|FG001|Overall Study|Adverse Event|5|||
131016346|NCT02459899|471689417|FG001|Overall Study|Adverse Event|1|||
131016347|NCT02459899|471689418|FG002|Overall Study|Adverse Event|0|||
131016348|NCT02459899|471689419|FG003|Overall Study|Adverse Event|0|||
131016349|NCT02459899|471689416|FG000|Overall Study|Lost to Follow-up|1|||
131016350|NCT02459899|471689417|FG001|Overall Study|Lost to Follow-up|2|||
131016351|NCT02459899|471689418|FG002|Overall Study|Lost to Follow-up|0|||
131016352|NCT02459899|471689419|FG003|Overall Study|Lost to Follow-up|1|||
131016353|NCT02459899|471689416|FG000|Overall Study|Non-compliance with the treatment|0|||
131016354|NCT02459899|471689417|FG001|Overall Study|Non-compliance with the treatment|0|||
131016355|NCT02459899|471689418|FG002|Overall Study|Non-compliance with the treatment|0|||
130679674|NCT04977336|470454180|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
130679675|NCT04977336|470454181|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130679676|NCT04977336|470454182|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130679677|NCT04977336|470454183|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
130679678|NCT04977336|470454184|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
130679679|NCT04977336|470454180|FG000|Overall Study|Lost to Follow-up|0|||
130679680|NCT04977336|470454181|FG001|Overall Study|Lost to Follow-up|0|||
130679681|NCT04977336|470454182|FG002|Overall Study|Lost to Follow-up|1|||
130679682|NCT04977336|470454183|FG003|Overall Study|Lost to Follow-up|0|||
130679683|NCT04977336|470454184|FG004|Overall Study|Lost to Follow-up|0|||
130679684|NCT01004172|470454189|FG000|Overall Study|Progressive Disease in CNS Only|16|||
130679685|NCT01004172|470454189|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
130679686|NCT01004172|470454189|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
130679687|NCT01004172|470454189|FG000|Overall Study|Adverse Event|1|||
130679688|NCT01004172|470454189|FG000|Overall Study|Physician Decision|1|||
130679689|NCT01004172|470454189|FG000|Overall Study|Symptomatic Deterioration|2|||
130679690|NCT00950872|470454190|FG000|Overall Study|Withdrawal by Subject|1|||
130679691|NCT00950872|470454190|FG000|Overall Study|Did not have surgery|2|||
130679692|NCT01139164|470454191|FG000|Overall Study|Withdrawn prior to study start|0|||
130679693|NCT01139164|470454192|FG001|Overall Study|Withdrawn prior to study start|2|||
130679694|NCT01139164|470454193|FG002|Overall Study|Withdrawn prior to study start|0|||
130679695|NCT02003183|470454194|FG000|Overall Study|Lost to Follow-up|0|||
130679696|NCT02003183|470454195|FG001|Overall Study|Lost to Follow-up|2|||
130679697|NCT01759290|470454196|FG000|Overall Study|Subjects withdrawn consent|5|||
130679698|NCT01759290|470454196|FG000|Overall Study|Physician Decision|2|||
130679699|NCT01759290|470454196|FG000|Overall Study|Death|17|||
130679700|NCT01759290|470454196|FG000|Overall Study|Lost to Follow-up|53|||
130679701|NCT01759290|470454196|FG000|Overall Study|Unknown reason|4|||
130679702|NCT00406848|470454197|FG000|Overall Study|Withdrawal by Subject|27|||
130679703|NCT00406848|470454198|FG001|Overall Study|Withdrawal by Subject|22|||
130679704|NCT00406848|470454197|FG000|Overall Study|Adverse Event|38|||
130679705|NCT00406848|470454198|FG001|Overall Study|Adverse Event|7|||
130679706|NCT00406848|470454197|FG000|Overall Study|Lack of Efficacy|9|||
130679707|NCT00406848|470454198|FG001|Overall Study|Lack of Efficacy|14|||
130679708|NCT00406848|470454197|FG000|Overall Study|Protocol Violation|10|||
130679709|NCT00406848|470454198|FG001|Overall Study|Protocol Violation|6|||
130679710|NCT00406848|470454197|FG000|Overall Study|Lost to Follow-up|6|||
130679711|NCT00406848|470454198|FG001|Overall Study|Lost to Follow-up|2|||
130679712|NCT00406848|470454197|FG000|Overall Study|Physician Decision|2|||
130679713|NCT00406848|470454198|FG001|Overall Study|Physician Decision|2|||
130679714|NCT00406848|470454197|FG000|Overall Study|Sponsor Decision|1|||
130679715|NCT00406848|470454198|FG001|Overall Study|Sponsor Decision|1|||
130679716|NCT03629249|470454199|FG000|Overall Study|Study terminated by sponsor|197|||
131016356|NCT02459899|471689419|FG003|Overall Study|Non-compliance with the treatment|1|||
131016357|NCT02459899|471689416|FG000|Overall Study|Withdrawal by Subject|1|||
131016358|NCT02459899|471689417|FG001|Overall Study|Withdrawal by Subject|3|||
131016359|NCT02459899|471689418|FG002|Overall Study|Withdrawal by Subject|0|||
130679717|NCT03629249|470454200|FG001|Overall Study|Study terminated by sponsor|197|||
130679718|NCT03629249|470454201|FG002|Overall Study|Study terminated by sponsor|194|||
130679719|NCT03629249|470454199|FG000|Overall Study|Protocol deviation|0|||
130679720|NCT03629249|470454200|FG001|Overall Study|Protocol deviation|2|||
130679721|NCT03629249|470454201|FG002|Overall Study|Protocol deviation|5|||
130679722|NCT03629249|470454199|FG000|Overall Study|Subject decision|1|||
131016360|NCT02459899|471689419|FG003|Overall Study|Withdrawal by Subject|0|||
131016361|NCT02739035|471689422|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
131016362|NCT02739035|471689423|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
131016363|NCT02739035|471689422|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
131016364|NCT02739035|471689423|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
131016365|NCT02739035|471689422|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
131016366|NCT02739035|471689423|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
131016367|NCT02739035|471689422|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
131016368|NCT02739035|471689423|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
131016369|NCT02770248|471689426|FG000|Overall Study|Adverse Event|0|||
131016370|NCT02770248|471689427|FG001|Overall Study|Adverse Event|1|||
131016371|NCT02770248|471689426|FG000|Overall Study|Randomized in error, prior to treatment|0|||
131016372|NCT02770248|471689427|FG001|Overall Study|Randomized in error, prior to treatment|1|||
131016373|NCT01063517|471689438|FG000|Overall Study|Consent withdrawal|1|||
130679723|NCT03629249|470454200|FG001|Overall Study|Subject decision|1|||
130679724|NCT03629249|470454201|FG002|Overall Study|Subject decision|3|||
130679725|NCT03629249|470454199|FG000|Overall Study|Adverse Event|1|||
130679726|NCT03629249|470454200|FG001|Overall Study|Adverse Event|1|||
130679727|NCT03629249|470454201|FG002|Overall Study|Adverse Event|0|||
130679728|NCT03629249|470454199|FG000|Overall Study|Death|1|||
130679729|NCT03629249|470454200|FG001|Overall Study|Death|0|||
130679730|NCT03629249|470454201|FG002|Overall Study|Death|0|||
130679731|NCT03629249|470454199|FG000|Overall Study|Physician Decision|1|||
130679732|NCT03629249|470454200|FG001|Overall Study|Physician Decision|0|||
130679733|NCT03629249|470454201|FG002|Overall Study|Physician Decision|0|||
130679734|NCT00352690|470454202|FG000|Overall Study|Determined to be ineligible|2|||
130679735|NCT00352690|470454203|FG001|Overall Study|Determined to be ineligible|0|||
130679736|NCT02719522|470454206|FG000|Overall Study|Implant Failure|4|||
130679737|NCT02719522|470454206|FG000|Overall Study|Death|2|||
131016374|NCT01063517|471689439|FG001|Overall Study|Consent withdrawal|0|||
131016375|NCT01063517|471689438|FG000|Overall Study|Study reached data cut-off|19|||
131016376|NCT01063517|471689439|FG001|Overall Study|Study reached data cut-off|7|||
131016377|NCT01063517|471689438|FG000|Overall Study|Lost to Follow-up|4|||
131016378|NCT01063517|471689439|FG001|Overall Study|Lost to Follow-up|3|||
131016379|NCT01063517|471689438|FG000|Overall Study|Withdrawal by Subject|1|||
131016380|NCT01063517|471689439|FG001|Overall Study|Withdrawal by Subject|2|||
131016381|NCT01063517|471689438|FG000|Overall Study|Death|33|||
131016382|NCT01063517|471689439|FG001|Overall Study|Death|48|||
131016383|NCT02041104|471689440|FG000|Overall Study|Lost to Follow-up|1|||
131016384|NCT02041104|471689441|FG001|Overall Study|Lost to Follow-up|4|||
131016385|NCT02041104|471689440|FG000|Overall Study|discomfort during OGTT|0|||
131016386|NCT02041104|471689441|FG001|Overall Study|discomfort during OGTT|3|||
131016387|NCT00617201|471689444|FG000|Overall Study|Lost to Follow-up|9|||
131016388|NCT00617201|471689445|FG001|Overall Study|Lost to Follow-up|13|||
131016389|NCT00546871|471689446|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
131016390|NCT00546871|471689447|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
131016391|NCT00546871|471689446|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
131016392|NCT00546871|471689447|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
131016393|NCT00546871|471689446|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
131016394|NCT00546871|471689447|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
131016395|NCT00546871|471689446|FG000|Study Extension Period|Protocol Violation|1|||
131016396|NCT00546871|471689447|FG001|Study Extension Period|Protocol Violation|0|||
131016397|NCT00546871|471689446|FG000|Study Extension Period|Withdrawal by Subject|0|||
131016398|NCT00546871|471689447|FG001|Study Extension Period|Withdrawal by Subject|1|||
131016399|NCT01713946|471689448|FG000|Overall Study|Death|0|||
131016400|NCT01713946|471689449|FG001|Overall Study|Death|2|||
131016401|NCT01713946|471689450|FG002|Overall Study|Death|2|||
131016402|NCT01713946|471689448|FG000|Overall Study|Adverse Event|19|||
131016403|NCT01713946|471689449|FG001|Overall Study|Adverse Event|14|||
131016404|NCT01713946|471689450|FG002|Overall Study|Adverse Event|13|||
131016405|NCT01713946|471689448|FG000|Overall Study|Withdrawal by Subject|12|||
131016406|NCT01713946|471689449|FG001|Overall Study|Withdrawal by Subject|12|||
131016407|NCT01713946|471689450|FG002|Overall Study|Withdrawal by Subject|8|||
131016408|NCT01713946|471689448|FG000|Overall Study|Lack of Efficacy|8|||
131016409|NCT01713946|471689449|FG001|Overall Study|Lack of Efficacy|8|||
131016410|NCT01713946|471689450|FG002|Overall Study|Lack of Efficacy|14|||
131016411|NCT01713946|471689448|FG000|Overall Study|Protocol Violation|2|||
131016412|NCT01713946|471689449|FG001|Overall Study|Protocol Violation|4|||
131016413|NCT01713946|471689450|FG002|Overall Study|Protocol Violation|1|||
131016414|NCT01713946|471689448|FG000|Overall Study|Lost to Follow-up|0|||
131016415|NCT01713946|471689449|FG001|Overall Study|Lost to Follow-up|0|||
131016416|NCT01713946|471689450|FG002|Overall Study|Lost to Follow-up|1|||
131016417|NCT01713946|471689448|FG000|Overall Study|Administrative problems|1|||
131016418|NCT01713946|471689449|FG001|Overall Study|Administrative problems|0|||
131016419|NCT01713946|471689450|FG002|Overall Study|Administrative problems|0|||
131016420|NCT01713946|471689448|FG000|Overall Study|Did not continue in Ext|0|||
131016421|NCT01713946|471689449|FG001|Overall Study|Did not continue in Ext|3|||
131016422|NCT01713946|471689450|FG002|Overall Study|Did not continue in Ext|0|||
131016423|NCT01713946|471689448|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
131016424|NCT01713946|471689449|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
131016425|NCT01713946|471689450|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
131016426|NCT01713946|471689448|FG000|Overall Study|Patients never switched to everolimus|0|||
131016427|NCT01713946|471689449|FG001|Overall Study|Patients never switched to everolimus|0|||
131016428|NCT01713946|471689450|FG002|Overall Study|Patients never switched to everolimus|5|||
131016429|NCT03183518|471689451|FG000|Overall Study|Other (Not specified)|2|||
131016430|NCT03183518|471689451|FG000|Overall Study|Other (Withdrawal of consent)|1|||
131016431|NCT04493242|471689454|FG000|Overall Study|Death|10|||
131016432|NCT04493242|471689455|FG001|Overall Study|Death|14|||
131016433|NCT04493242|471689456|FG002|Overall Study|Death|16|||
131016434|NCT04493242|471689454|FG000|Overall Study|Lost to Follow-up|1|||
131016435|NCT04493242|471689455|FG001|Overall Study|Lost to Follow-up|1|||
131016436|NCT04493242|471689456|FG002|Overall Study|Lost to Follow-up|0|||
131016437|NCT04493242|471689454|FG000|Overall Study|Withdrawal by Subject|1|||
131016438|NCT04493242|471689455|FG001|Overall Study|Withdrawal by Subject|0|||
131016439|NCT04493242|471689456|FG002|Overall Study|Withdrawal by Subject|0|||
131016440|NCT04493242|471689454|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
131016441|NCT04493242|471689455|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
131016442|NCT04493242|471689456|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
131016443|NCT04493242|471689454|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
130679738|NCT02719522|470454206|FG000|Overall Study|Lost to Follow-up|5|||
130679739|NCT01030965|470454209|FG000|Overall Study|Lack of Efficacy|3|||
130679740|NCT01030965|470454210|FG001|Overall Study|Lack of Efficacy|2|||
130679741|NCT01030965|470454211|FG002|Overall Study|Lack of Efficacy|0|||
130679742|NCT01030965|470454212|FG003|Overall Study|Lack of Efficacy|3|||
130679743|NCT01030965|470454209|FG000|Overall Study|Protocol Violation|1|||
130679744|NCT01030965|470454210|FG001|Overall Study|Protocol Violation|1|||
130679745|NCT01030965|470454211|FG002|Overall Study|Protocol Violation|1|||
130679746|NCT01030965|470454212|FG003|Overall Study|Protocol Violation|1|||
130679747|NCT01030965|470454209|FG000|Overall Study|Adverse Event|0|||
130679748|NCT01030965|470454210|FG001|Overall Study|Adverse Event|1|||
130679749|NCT01030965|470454211|FG002|Overall Study|Adverse Event|2|||
130679750|NCT01030965|470454212|FG003|Overall Study|Adverse Event|1|||
130679751|NCT01030965|470454209|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
131016444|NCT04493242|471689455|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
131016445|NCT04493242|471689456|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
131103191|NCT02680002|472007908|FG002|Overall Study|Adverse Event|0|||
131103192|NCT02680002|472007909|FG003|Overall Study|Adverse Event|0|||
131103193|NCT02680002|472007910|FG004|Overall Study|Adverse Event|1|||
131016446|NCT04513522|471691431|FG000|Overall Study|Other reasons|1|||
131016447|NCT04513522|471691431|FG000|Overall Study|Adverse event unrelated to study drug|9|||
131016448|NCT04513522|471691431|FG000|Overall Study|Study drug toxicity|14|||
131016449|NCT04513522|471691431|FG000|Overall Study|Disease progression|39|||
131016450|NCT04513522|471691431|FG000|Overall Study|Participants withdrew consent|2|||
131016451|NCT00589667|471691432|FG000|Overall Study|Adverse Event|2|||
131016452|NCT00589667|471691432|FG000|Overall Study|Withdrawal by Subject|1|||
131016453|NCT03538041|471691433|FG000|12-Week Treatment Period|Adverse Event|1|||
131016454|NCT03538041|471691434|FG001|12-Week Treatment Period|Adverse Event|1|||
131016455|NCT03538041|471691433|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
131016456|NCT03538041|471691434|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
131016457|NCT03538041|471691433|FG000|Treatment Extension Period|Adverse Event|4|||
131016458|NCT03538041|471691434|FG001|Treatment Extension Period|Adverse Event|1|||
131016459|NCT03538041|471691433|FG000|Treatment Extension Period|Physician Decision|1|||
131016460|NCT03538041|471691434|FG001|Treatment Extension Period|Physician Decision|1|||
131016461|NCT03538041|471691433|FG000|Treatment Extension Period|Lack of Efficacy|1|||
131016462|NCT03538041|471691434|FG001|Treatment Extension Period|Lack of Efficacy|4|||
131016463|NCT03538041|471691433|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
131016464|NCT03538041|471691434|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
131016465|NCT03538041|471691433|FG000|Treatment Extension Period|Death|0|||
131016466|NCT03538041|471691434|FG001|Treatment Extension Period|Death|1|||
131016467|NCT00028769|471691437|FG000|Overall Study|Adverse Event|2|||
131016468|NCT00028769|471691437|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
131016469|NCT00028769|471691437|FG000|Overall Study|Progression or Death|31|||
131016470|NCT00028769|471691437|FG000|Overall Study|Other - Not Protocol Specified|1|||
131016471|NCT00028769|471691437|FG000|Overall Study|Ineligible|5|||
131016472|NCT00028769|471691437|FG000|Overall Study|Not Analyzable|1|||
131016473|NCT01134562|471691438|FG000|Overall Study|Adverse Event|0|||
131016474|NCT01134562|471691439|FG001|Overall Study|Adverse Event|1|||
131016475|NCT01134562|471691440|FG002|Overall Study|Adverse Event|0|||
131016476|NCT01134562|471691441|FG003|Overall Study|Adverse Event|0|||
131016477|NCT01134562|471691442|FG004|Overall Study|Adverse Event|0|||
131016478|NCT00708032|471691445|FG000|Overall Study|Adverse Event|0|||
131016479|NCT00708032|471691446|FG001|Overall Study|Adverse Event|2|||
131016480|NCT00708032|471691445|FG000|Overall Study|Lost to Follow-up|1|||
131016481|NCT00708032|471691446|FG001|Overall Study|Lost to Follow-up|2|||
131016482|NCT00708032|471691445|FG000|Overall Study|Pregnancy|0|||
131016483|NCT00708032|471691446|FG001|Overall Study|Pregnancy|1|||
131016484|NCT00708032|471691445|FG000|Overall Study|Poor vision|0|||
131016485|NCT00708032|471691446|FG001|Overall Study|Poor vision|6|||
131016486|NCT00708032|471691445|FG000|Overall Study|Visit out of range at month 12|4|||
131016487|NCT00708032|471691446|FG001|Overall Study|Visit out of range at month 12|1|||
131016488|NCT00708032|471691445|FG000|Overall Study|Did not meet protocol criteria|1|||
131016489|NCT00708032|471691446|FG001|Overall Study|Did not meet protocol criteria|2|||
131016490|NCT00708032|471691445|FG000|Overall Study|Protocol Violation|4|||
130679752|NCT01030965|470454210|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
130679753|NCT01030965|470454211|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
130679754|NCT01030965|470454212|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
130679755|NCT01030965|470454209|FG000|Overall Study|Withdrawal by Subject|0|||
131016491|NCT00708032|471691446|FG001|Overall Study|Protocol Violation|1|||
130679756|NCT01030965|470454210|FG001|Overall Study|Withdrawal by Subject|1|||
130679757|NCT01030965|470454211|FG002|Overall Study|Withdrawal by Subject|0|||
130679758|NCT01030965|470454212|FG003|Overall Study|Withdrawal by Subject|2|||
130679759|NCT02097290|470454213|FG000|Overall Study|Death|6|||
131016492|NCT00708032|471691445|FG000|Overall Study|Withdrawal by Subject|0|||
131016493|NCT00708032|471691446|FG001|Overall Study|Withdrawal by Subject|1|||
131016494|NCT02983617|471691450|FG000|Overall Study|Adverse Event|0|||
130679760|NCT02097290|470454213|FG000|Overall Study|Total Withdrawals|3|||
130679761|NCT02097290|470454213|FG000|Overall Study|Attempt|8|||
130679762|NCT03144687|470454216|FG000|Overall Study|Death|0|||
130679763|NCT03144687|470454217|FG001|Overall Study|Death|2|||
130679764|NCT03144687|470454216|FG000|Overall Study|Lost to Follow-up|0|||
130679765|NCT03144687|470454217|FG001|Overall Study|Lost to Follow-up|1|||
130679766|NCT03144687|470454216|FG000|Overall Study|Physician Decision|0|||
130679767|NCT03144687|470454217|FG001|Overall Study|Physician Decision|1|||
130679768|NCT03144687|470454216|FG000|Overall Study|Withdrawal by Subject|1|||
130679769|NCT03144687|470454217|FG001|Overall Study|Withdrawal by Subject|3|||
130679770|NCT03144687|470454216|FG000|Overall Study|Not Reported|2|||
130679771|NCT03144687|470454217|FG001|Overall Study|Not Reported|0|||
130679772|NCT01054599|470454218|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
130679773|NCT01054599|470454219|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
131103194|NCT02680002|472007911|FG005|Overall Study|Adverse Event|2|||
131103195|NCT01248780|472007918|FG000|Overall Study|Lack of Efficacy|2|||
131103196|NCT01248780|472007919|FG001|Overall Study|Lack of Efficacy|0|||
131103197|NCT01248780|472007918|FG000|Overall Study|Lost to Follow-up|0|||
131103198|NCT01248780|472007919|FG001|Overall Study|Lost to Follow-up|1|||
131103199|NCT01248780|472007918|FG000|Overall Study|Death|0|||
131103200|NCT01248780|472007919|FG001|Overall Study|Death|1|||
131103201|NCT01248780|472007918|FG000|Overall Study|Adverse Event|2|||
131103202|NCT01248780|472007919|FG001|Overall Study|Adverse Event|7|||
131103203|NCT01248780|472007918|FG000|Overall Study|Protocol Violation|1|||
131103204|NCT01248780|472007919|FG001|Overall Study|Protocol Violation|1|||
131103205|NCT01248780|472007918|FG000|Overall Study|Withdrawal by Subject|4|||
131103206|NCT01248780|472007919|FG001|Overall Study|Withdrawal by Subject|4|||
131103207|NCT01248780|472007918|FG000|Overall Study|Not treated|0|||
131103208|NCT01248780|472007919|FG001|Overall Study|Not treated|1|||
131103209|NCT03064035|472007920|FG000|Overall Study|Did not receive allocated intervention|4|||
131103210|NCT03064035|472007921|FG001|Overall Study|Did not receive allocated intervention|2|||
131103211|NCT03064035|472007920|FG000|Overall Study|Lost to Follow-up|1|||
131103212|NCT03064035|472007921|FG001|Overall Study|Lost to Follow-up|1|||
131103213|NCT03103763|472007922|FG000|Overall Study|Death|15|||
131103214|NCT03103763|472007923|FG001|Overall Study|Death|5|||
131103215|NCT03103763|472007924|FG002|Overall Study|Death|5|||
131103216|NCT03103763|472007922|FG000|Overall Study|Withdrawal by Subject|0|||
131103217|NCT03103763|472007923|FG001|Overall Study|Withdrawal by Subject|3|||
131103218|NCT03103763|472007924|FG002|Overall Study|Withdrawal by Subject|2|||
131103219|NCT04279392|472007925|FG000|Overall Study|Physician Decision|1|||
131103220|NCT04279392|472007926|FG001|Overall Study|Physician Decision|0|||
131103221|NCT04101318|472007933|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
131103222|NCT04101318|472007934|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
131103223|NCT04101318|472007933|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
130679774|NCT01054599|470454218|FG000|Overall Study|Protocol Violation|1|||
130679775|NCT01054599|470454219|FG001|Overall Study|Protocol Violation|0|||
130679776|NCT01054599|470454218|FG000|Overall Study|Spells/seizure-like episodes|1|||
130679777|NCT01054599|470454219|FG001|Overall Study|Spells/seizure-like episodes|1|||
130679778|NCT01054599|470454218|FG000|Overall Study|Timing/scheduling difficulties|1|||
130679779|NCT01054599|470454219|FG001|Overall Study|Timing/scheduling difficulties|1|||
130679780|NCT01054599|470454218|FG000|Overall Study|Visual impairment, WTAR <80|0|||
130679781|NCT01054599|470454219|FG001|Overall Study|Visual impairment, WTAR <80|1|||
130679782|NCT01054599|470454218|FG000|Overall Study|Lost to Follow-up|0|||
130679783|NCT01054599|470454219|FG001|Overall Study|Lost to Follow-up|2|||
130679784|NCT01054599|470454218|FG000|Overall Study|Adverse Event|0|||
130679785|NCT01054599|470454219|FG001|Overall Study|Adverse Event|1|||
130679786|NCT01054599|470454218|FG000|Overall Study|Withdrawal by Subject|0|||
130679787|NCT01054599|470454219|FG001|Overall Study|Withdrawal by Subject|1|||
131016495|NCT02983617|471691451|FG001|Overall Study|Adverse Event|7|||
131016496|NCT02983617|471691450|FG000|Overall Study|Death|0|||
131016497|NCT02983617|471691451|FG001|Overall Study|Death|1|||
131016498|NCT02983617|471691450|FG000|Overall Study|Investigator's Discretion|0|||
131016499|NCT02983617|471691451|FG001|Overall Study|Investigator's Discretion|1|||
131016500|NCT02027558|471691452|FG000|Overall Study|Death|0|||
131016501|NCT02027558|471691453|FG001|Overall Study|Death|1|||
131016502|NCT02027558|471691452|FG000|Overall Study|Withdrawal by Subject|2|||
131016503|NCT02027558|471691453|FG001|Overall Study|Withdrawal by Subject|0|||
131016504|NCT02027558|471691452|FG000|Overall Study|Lost to Follow-up|4|||
130679788|NCT00743197|470454220|FG000|Overall Study|Study terminated due to departure of PI.|1|||
130679789|NCT00743197|470454221|FG001|Overall Study|Study terminated due to departure of PI.|2|||
131103224|NCT04101318|472007934|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
131016505|NCT02027558|471691453|FG001|Overall Study|Lost to Follow-up|1|||
131103225|NCT04101318|472007933|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
131103226|NCT04101318|472007934|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
131103227|NCT00558259|472007935|FG000|Overall Study|Adverse Event|50|||
131103228|NCT00558259|472007936|FG001|Overall Study|Adverse Event|81|||
131103229|NCT00558259|472007935|FG000|Overall Study|Protocol Violation|9|||
131016506|NCT02027558|471691452|FG000|Overall Study|Refused assessment|3|||
131016507|NCT02027558|471691453|FG001|Overall Study|Refused assessment|0|||
131016508|NCT03720210|471691454|FG000|Overall Study|Lost to Follow-up|1|||
131016509|NCT02698891|471691455|FG000|Overall Study|Withdrawal by Subject|2|||
131016510|NCT02698891|471691455|FG000|Overall Study|deemed ineligible|1|||
131016511|NCT02698891|471691455|FG000|Overall Study|Adverse Event|9|||
131016512|NCT00711958|471691456|FG000|Overall Study|Withdrawal by Subject|6|||
131016513|NCT00711958|471691457|FG001|Overall Study|Withdrawal by Subject|8|||
131016514|NCT00711958|471691456|FG000|Overall Study|Lack of Efficacy|3|||
131016515|NCT00711958|471691457|FG001|Overall Study|Lack of Efficacy|1|||
131016516|NCT00711958|471691456|FG000|Overall Study|Clinical deterioration|1|||
131016517|NCT00711958|471691457|FG001|Overall Study|Clinical deterioration|0|||
131016518|NCT00711958|471691456|FG000|Overall Study|Adverse Event|9|||
131016519|NCT00711958|471691457|FG001|Overall Study|Adverse Event|7|||
131016520|NCT00711958|471691456|FG000|Overall Study|Protocol Violation|1|||
131016521|NCT00711958|471691457|FG001|Overall Study|Protocol Violation|0|||
131016522|NCT00711958|471691456|FG000|Overall Study|Lost to Follow-up|2|||
131016523|NCT00711958|471691457|FG001|Overall Study|Lost to Follow-up|2|||
131016524|NCT00711958|471691456|FG000|Overall Study|Death|10|||
131016525|NCT00711958|471691457|FG001|Overall Study|Death|5|||
131016526|NCT00711958|471691456|FG000|Overall Study|Progression of disease|1|||
131016527|NCT00711958|471691457|FG001|Overall Study|Progression of disease|0|||
131016528|NCT01111526|471691458|FG000|Overall Study|GVHD Disease Progression|0|||
131016529|NCT01111526|471691459|FG001|Overall Study|GVHD Disease Progression|1|||
131016530|NCT01111526|471691460|FG002|Overall Study|GVHD Disease Progression|2|||
131016531|NCT04424641|471691461|FG000|Overall Study|Death|1|||
131016532|NCT04424641|471691462|FG001|Overall Study|Death|2|||
131016533|NCT04424641|471691463|FG002|Overall Study|Death|3|||
131016534|NCT04424641|471691464|FG003|Overall Study|Death|0|||
131016535|NCT04424641|471691465|FG004|Overall Study|Death|3|||
131016536|NCT04424641|471691466|FG005|Overall Study|Death|0|||
131016537|NCT04424641|471691467|FG006|Overall Study|Death|1|||
131016538|NCT04424641|471691468|FG007|Overall Study|Death|2|||
131016539|NCT04424641|471691461|FG000|Overall Study|Sponsor decision|0|||
131016540|NCT04424641|471691462|FG001|Overall Study|Sponsor decision|2|||
131016541|NCT04424641|471691463|FG002|Overall Study|Sponsor decision|3|||
131016542|NCT04424641|471691464|FG003|Overall Study|Sponsor decision|7|||
131016543|NCT04424641|471691465|FG004|Overall Study|Sponsor decision|2|||
131016544|NCT04424641|471691466|FG005|Overall Study|Sponsor decision|2|||
131016545|NCT04424641|471691467|FG006|Overall Study|Sponsor decision|3|||
131016546|NCT04424641|471691468|FG007|Overall Study|Sponsor decision|4|||
131016547|NCT04424641|471691461|FG000|Overall Study|Withdrawal by Subject|0|||
131016548|NCT04424641|471691462|FG001|Overall Study|Withdrawal by Subject|0|||
131016549|NCT04424641|471691463|FG002|Overall Study|Withdrawal by Subject|0|||
131016550|NCT04424641|471691464|FG003|Overall Study|Withdrawal by Subject|0|||
131016551|NCT04424641|471691465|FG004|Overall Study|Withdrawal by Subject|1|||
131016552|NCT04424641|471691466|FG005|Overall Study|Withdrawal by Subject|0|||
131016553|NCT04424641|471691467|FG006|Overall Study|Withdrawal by Subject|0|||
131016554|NCT04424641|471691468|FG007|Overall Study|Withdrawal by Subject|0|||
131016555|NCT04424641|471691461|FG000|Overall Study|Other|0|||
131016556|NCT04424641|471691462|FG001|Overall Study|Other|0|||
131016557|NCT04424641|471691463|FG002|Overall Study|Other|1|||
131016558|NCT04424641|471691464|FG003|Overall Study|Other|0|||
131016559|NCT04424641|471691465|FG004|Overall Study|Other|0|||
131016560|NCT04424641|471691466|FG005|Overall Study|Other|0|||
131016561|NCT04424641|471691467|FG006|Overall Study|Other|0|||
131016562|NCT04424641|471691468|FG007|Overall Study|Other|0|||
131016563|NCT02694978|471691473|FG000|Overall Study|Adverse Event|10|||
131016564|NCT02694978|471691474|FG001|Overall Study|Adverse Event|9|||
131016565|NCT02694978|471691473|FG000|Overall Study|Withdrawal by Subject|22|||
131016566|NCT02694978|471691474|FG001|Overall Study|Withdrawal by Subject|19|||
131016567|NCT02694978|471691473|FG000|Overall Study|Lost to Follow-up|14|||
131016568|NCT02694978|471691474|FG001|Overall Study|Lost to Follow-up|17|||
131016569|NCT02694978|471691473|FG000|Overall Study|Death|4|||
131016570|NCT02694978|471691474|FG001|Overall Study|Death|1|||
131016571|NCT02694978|471691473|FG000|Overall Study|Other-Decision of Participant|6|||
131016572|NCT02694978|471691474|FG001|Overall Study|Other-Decision of Participant|1|||
131016573|NCT02694978|471691473|FG000|Overall Study|Other-Investigator's decision|1|||
131016574|NCT02694978|471691474|FG001|Overall Study|Other-Investigator's decision|0|||
131016575|NCT02694978|471691473|FG000|Overall Study|Other-Unable to be reached|0|||
131016576|NCT02694978|471691474|FG001|Overall Study|Other-Unable to be reached|1|||
131016577|NCT02694978|471691473|FG000|Overall Study|Other-Protocol noncompliant|2|||
131016578|NCT02694978|471691474|FG001|Overall Study|Other-Protocol noncompliant|1|||
131016579|NCT02694978|471691473|FG000|Overall Study|Other-Personal reasons|3|||
131016580|NCT02694978|471691474|FG001|Overall Study|Other-Personal reasons|3|||
131016581|NCT02694978|471691473|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
131016582|NCT02694978|471691474|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
131016583|NCT01613716|471691475|FG000|Overall Study|screen failures|3|||
131016584|NCT01613716|471691475|FG000|Overall Study|Lost to Follow-up|4|||
131016585|NCT01171625|471691476|FG000|Overall Study|On-Protocol|67|||
131016586|NCT01171625|471691476|FG000|Overall Study|Death|38|||
131103230|NCT00558259|472007936|FG001|Overall Study|Protocol Violation|5|||
131103231|NCT00558259|472007935|FG000|Overall Study|Withdrawal by Subject|12|||
131103232|NCT00558259|472007936|FG001|Overall Study|Withdrawal by Subject|13|||
131103233|NCT04289051|472007937|FG000|Overall Study|Lost to Follow-up|0|||
131103234|NCT04289051|472007938|FG001|Overall Study|Lost to Follow-up|0|||
131103235|NCT04289051|472007939|FG002|Overall Study|Lost to Follow-up|2|||
131103236|NCT01901341|472007940|FG000|Overall Study|Adverse Event|4|||
131103237|NCT01901341|472007941|FG001|Overall Study|Adverse Event|2|||
131103238|NCT01901341|472007940|FG000|Overall Study|Lack of Efficacy|0|||
131103239|NCT01901341|472007941|FG001|Overall Study|Lack of Efficacy|2|||
131103240|NCT01901341|472007940|FG000|Overall Study|Lost to Follow-up|0|||
131103241|NCT01901341|472007941|FG001|Overall Study|Lost to Follow-up|1|||
131103242|NCT01901341|472007940|FG000|Overall Study|Protocol Violation|2|||
131103243|NCT01901341|472007941|FG001|Overall Study|Protocol Violation|0|||
131103244|NCT01901341|472007940|FG000|Overall Study|Study Terminated by Sponsor|13|||
131103245|NCT01901341|472007941|FG001|Overall Study|Study Terminated by Sponsor|15|||
131103246|NCT01901341|472007940|FG000|Overall Study|Withdrawal by Subject|1|||
131103247|NCT01901341|472007941|FG001|Overall Study|Withdrawal by Subject|1|||
131103248|NCT02966301|472007942|FG000|Overall Study|Death|2|||
131103249|NCT02966301|472007942|FG000|Overall Study|Withdrawal by Subject|1|||
131103250|NCT00370331|472007944|FG000|Overall Study|Adverse Event|4|||
131103251|NCT00370331|472007945|FG001|Overall Study|Adverse Event|13|||
131103252|NCT00370331|472007944|FG000|Overall Study|Withdrawal by Subject|2|||
131103253|NCT00370331|472007945|FG001|Overall Study|Withdrawal by Subject|4|||
131103254|NCT00370331|472007944|FG000|Overall Study|Lost to Follow-up|0|||
131103255|NCT00370331|472007945|FG001|Overall Study|Lost to Follow-up|3|||
131103256|NCT00370331|472007944|FG000|Overall Study|Lack of Efficacy|0|||
131103257|NCT00370331|472007945|FG001|Overall Study|Lack of Efficacy|1|||
131103258|NCT00370331|472007944|FG000|Overall Study|Non-compliance|0|||
131103259|NCT00370331|472007945|FG001|Overall Study|Non-compliance|1|||
131103260|NCT00370331|472007944|FG000|Overall Study|Protocol Violation|1|||
131103261|NCT00370331|472007945|FG001|Overall Study|Protocol Violation|1|||
131103262|NCT01874431|472007946|FG000|Overall Study|Physician Decision|0|||
131103263|NCT01874431|472007947|FG001|Overall Study|Physician Decision|0|||
131103264|NCT01874431|472007948|FG002|Overall Study|Physician Decision|1|||
131103265|NCT01874431|472007949|FG003|Overall Study|Physician Decision|0|||
131103266|NCT01874431|472007950|FG004|Overall Study|Physician Decision|0|||
131103267|NCT01874431|472007951|FG005|Overall Study|Physician Decision|0|||
131103268|NCT01874431|472007952|FG006|Overall Study|Physician Decision|0|||
131103269|NCT01874431|472007953|FG007|Overall Study|Physician Decision|0|||
131103270|NCT01874431|472007946|FG000|Overall Study|Adverse Event|5|||
131103271|NCT01874431|472007947|FG001|Overall Study|Adverse Event|4|||
131103272|NCT01874431|472007948|FG002|Overall Study|Adverse Event|6|||
131103273|NCT01874431|472007949|FG003|Overall Study|Adverse Event|5|||
131103274|NCT01874431|472007950|FG004|Overall Study|Adverse Event|2|||
131103275|NCT01874431|472007951|FG005|Overall Study|Adverse Event|8|||
131103276|NCT01874431|472007952|FG006|Overall Study|Adverse Event|2|||
131103277|NCT01874431|472007953|FG007|Overall Study|Adverse Event|3|||
131103278|NCT01874431|472007946|FG000|Overall Study|Protocol Violation|1|||
131103279|NCT01874431|472007947|FG001|Overall Study|Protocol Violation|1|||
131103280|NCT01874431|472007948|FG002|Overall Study|Protocol Violation|1|||
131103281|NCT01874431|472007949|FG003|Overall Study|Protocol Violation|0|||
131103282|NCT01874431|472007950|FG004|Overall Study|Protocol Violation|3|||
131103283|NCT01874431|472007951|FG005|Overall Study|Protocol Violation|2|||
131103284|NCT01874431|472007952|FG006|Overall Study|Protocol Violation|1|||
131103285|NCT01874431|472007953|FG007|Overall Study|Protocol Violation|1|||
131103286|NCT01874431|472007946|FG000|Overall Study|Non-compliance|0|||
131103287|NCT01874431|472007947|FG001|Overall Study|Non-compliance|0|||
131103288|NCT01874431|472007948|FG002|Overall Study|Non-compliance|0|||
131103289|NCT01874431|472007949|FG003|Overall Study|Non-compliance|0|||
131103290|NCT01874431|472007950|FG004|Overall Study|Non-compliance|1|||
131103291|NCT01874431|472007951|FG005|Overall Study|Non-compliance|0|||
131103292|NCT01874431|472007952|FG006|Overall Study|Non-compliance|1|||
131103293|NCT01874431|472007953|FG007|Overall Study|Non-compliance|0|||
131103294|NCT01874431|472007946|FG000|Overall Study|Logistical difficulties|0|||
131103295|NCT01874431|472007947|FG001|Overall Study|Logistical difficulties|0|||
131103296|NCT01874431|472007948|FG002|Overall Study|Logistical difficulties|0|||
131103297|NCT01874431|472007949|FG003|Overall Study|Logistical difficulties|0|||
131103298|NCT01874431|472007950|FG004|Overall Study|Logistical difficulties|0|||
131103299|NCT01874431|472007951|FG005|Overall Study|Logistical difficulties|0|||
131103300|NCT01874431|472007952|FG006|Overall Study|Logistical difficulties|1|||
131103301|NCT01874431|472007953|FG007|Overall Study|Logistical difficulties|0|||
131103302|NCT01874431|472007946|FG000|Overall Study|Withdrawal by Subject|0|||
131103303|NCT01874431|472007947|FG001|Overall Study|Withdrawal by Subject|0|||
131103304|NCT01874431|472007948|FG002|Overall Study|Withdrawal by Subject|1|||
131103305|NCT01874431|472007949|FG003|Overall Study|Withdrawal by Subject|2|||
131103306|NCT01874431|472007950|FG004|Overall Study|Withdrawal by Subject|1|||
131103307|NCT01874431|472007951|FG005|Overall Study|Withdrawal by Subject|1|||
131103308|NCT01874431|472007952|FG006|Overall Study|Withdrawal by Subject|3|||
131103309|NCT01874431|472007953|FG007|Overall Study|Withdrawal by Subject|0|||
131103310|NCT01874431|472007946|FG000|Overall Study|Sponsor decision|0|||
131103311|NCT01874431|472007947|FG001|Overall Study|Sponsor decision|0|||
131103312|NCT01874431|472007948|FG002|Overall Study|Sponsor decision|0|||
131103313|NCT01874431|472007949|FG003|Overall Study|Sponsor decision|0|||
131103314|NCT01874431|472007950|FG004|Overall Study|Sponsor decision|1|||
131103315|NCT01874431|472007951|FG005|Overall Study|Sponsor decision|0|||
131103316|NCT01874431|472007952|FG006|Overall Study|Sponsor decision|0|||
131103317|NCT01874431|472007953|FG007|Overall Study|Sponsor decision|0|||
131103318|NCT01874431|472007946|FG000|Overall Study|Lost to Follow-up|0|||
131103319|NCT01874431|472007947|FG001|Overall Study|Lost to Follow-up|0|||
131103320|NCT01874431|472007948|FG002|Overall Study|Lost to Follow-up|1|||
131103321|NCT01874431|472007949|FG003|Overall Study|Lost to Follow-up|0|||
131103322|NCT01874431|472007950|FG004|Overall Study|Lost to Follow-up|0|||
131103323|NCT01874431|472007951|FG005|Overall Study|Lost to Follow-up|0|||
131103324|NCT01874431|472007952|FG006|Overall Study|Lost to Follow-up|0|||
131103325|NCT01874431|472007953|FG007|Overall Study|Lost to Follow-up|0|||
131103326|NCT01981473|472007954|FG000|Overall Study|Incorrect diagnosis of RA|0|||
131103327|NCT01981473|472007955|FG001|Overall Study|Incorrect diagnosis of RA|0|||
131103328|NCT01981473|472007956|FG002|Overall Study|Incorrect diagnosis of RA|1|||
131103329|NCT01981473|472007954|FG000|Overall Study|Received treatment for < 6 months|0|||
131103330|NCT01981473|472007955|FG001|Overall Study|Received treatment for < 6 months|0|||
131103331|NCT01981473|472007956|FG002|Overall Study|Received treatment for < 6 months|1|||
131103332|NCT01981473|472007954|FG000|Overall Study|Received treatment for >24 months|2|||
131103333|NCT01981473|472007955|FG001|Overall Study|Received treatment for >24 months|0|||
131103334|NCT01981473|472007956|FG002|Overall Study|Received treatment for >24 months|6|||
131103335|NCT00545051|472007960|FG000|Overall Study|Adverse Event|7|||
131103336|NCT00545051|472007961|FG001|Overall Study|Adverse Event|3|||
131103337|NCT00545051|472007960|FG000|Overall Study|Death|1|||
131103338|NCT00545051|472007961|FG001|Overall Study|Death|0|||
131103339|NCT00545051|472007960|FG000|Overall Study|Violation of inclusion/exclusion|0|||
131103340|NCT00545051|472007961|FG001|Overall Study|Violation of inclusion/exclusion|2|||
131103341|NCT00545051|472007960|FG000|Overall Study|Protocol Violation|1|||
131103342|NCT00545051|472007961|FG001|Overall Study|Protocol Violation|0|||
131103343|NCT00545051|472007960|FG000|Overall Study|Withdrawal by Subject|0|||
131103344|NCT00545051|472007961|FG001|Overall Study|Withdrawal by Subject|1|||
131103345|NCT00545051|472007960|FG000|Overall Study|Administrative reasons|0|||
131103346|NCT00545051|472007961|FG001|Overall Study|Administrative reasons|1|||
131103347|NCT01888900|472007962|FG000|Overall Study|failed treatment|0|||
131103348|NCT01888900|472007963|FG001|Overall Study|failed treatment|2|||
131103349|NCT03271021|472007967|FG000|Overall Study|Adverse Event|3|||
131103350|NCT03271021|472007968|FG001|Overall Study|Adverse Event|2|||
131103351|NCT03271021|472007967|FG000|Overall Study|Withdrawal by Subject|36|||
131103352|NCT03271021|472007968|FG001|Overall Study|Withdrawal by Subject|53|||
131103353|NCT03271021|472007967|FG000|Overall Study|Lost to Follow-up|34|||
131103354|NCT03271021|472007968|FG001|Overall Study|Lost to Follow-up|39|||
131103355|NCT03271021|472007967|FG000|Overall Study|Protocol Violation|6|||
131103356|NCT03271021|472007968|FG001|Overall Study|Protocol Violation|4|||
131103357|NCT03271021|472007967|FG000|Overall Study|Abnormal Lab Results|1|||
131103358|NCT03271021|472007968|FG001|Overall Study|Abnormal Lab Results|0|||
131103359|NCT03271021|472007967|FG000|Overall Study|Miscellaneous|9|||
131103360|NCT03271021|472007968|FG001|Overall Study|Miscellaneous|8|||
131103361|NCT02257567|472007975|FG000|Overall Study|Adverse Event|0|||
131103362|NCT02257567|472007976|FG001|Overall Study|Adverse Event|0|||
131103363|NCT02257567|472007977|FG002|Overall Study|Adverse Event|0|||
131103364|NCT02257567|472007978|FG003|Overall Study|Adverse Event|1|||
131103365|NCT02257567|472007979|FG004|Overall Study|Adverse Event|1|||
131103366|NCT02257567|472007980|FG005|Overall Study|Adverse Event|0|||
131103367|NCT02257567|472007981|FG006|Overall Study|Adverse Event|0|||
131103368|NCT02257567|472007982|FG007|Overall Study|Adverse Event|0|||
131103369|NCT02257567|472007983|FG008|Overall Study|Adverse Event|1|||
131103370|NCT02257567|472007984|FG009|Overall Study|Adverse Event|0|||
131103371|NCT02257567|472007985|FG010|Overall Study|Adverse Event|0|||
131103372|NCT02257567|472007975|FG000|Overall Study|Death|2|||
131103373|NCT02257567|472007976|FG001|Overall Study|Death|2|||
131103374|NCT02257567|472007977|FG002|Overall Study|Death|2|||
131103375|NCT02257567|472007978|FG003|Overall Study|Death|4|||
131103376|NCT02257567|472007979|FG004|Overall Study|Death|15|||
131103377|NCT02257567|472007980|FG005|Overall Study|Death|11|||
131103378|NCT02257567|472007981|FG006|Overall Study|Death|26|||
131103379|NCT02257567|472007982|FG007|Overall Study|Death|30|||
131103380|NCT02257567|472007983|FG008|Overall Study|Death|2|||
131103381|NCT02257567|472007984|FG009|Overall Study|Death|18|||
131103382|NCT02257567|472007985|FG010|Overall Study|Death|65|||
131103383|NCT02257567|472007975|FG000|Overall Study|Lost to Follow-up|0|||
131103384|NCT02257567|472007976|FG001|Overall Study|Lost to Follow-up|0|||
131103385|NCT02257567|472007977|FG002|Overall Study|Lost to Follow-up|0|||
131103386|NCT02257567|472007978|FG003|Overall Study|Lost to Follow-up|0|||
131103387|NCT02257567|472007979|FG004|Overall Study|Lost to Follow-up|2|||
131103388|NCT02257567|472007980|FG005|Overall Study|Lost to Follow-up|2|||
131103389|NCT02257567|472007981|FG006|Overall Study|Lost to Follow-up|0|||
131016587|NCT01171625|471691476|FG000|Overall Study|Withdrawal by Subject|31|||
131016588|NCT01171625|471691476|FG000|Overall Study|Explanted|10|||
131016589|NCT01171625|471691476|FG000|Overall Study|Lost to Follow-up|5|||
131016590|NCT01171625|471691476|FG000|Overall Study|Patient received valve-in-valve|3|||
131016591|NCT01171625|471691476|FG000|Overall Study|Other|1|||
131016592|NCT01171625|471691476|FG000|Overall Study|Consented but did not receive device|25|||
131016593|NCT00743444|471691477|FG000|First Intervention|Catheter placement problems|0|||
131016594|NCT00743444|471691478|FG001|First Intervention|Catheter placement problems|1|||
131016595|NCT00743444|471691477|FG000|Washout Period|Adverse Event|0|||
131016596|NCT00743444|471691478|FG001|Washout Period|Adverse Event|1|||
131016597|NCT01786564|471691485|FG000|Overall Study|Lost to Follow-up|47|||
131016598|NCT01786564|471691485|FG000|Overall Study|Ineligible|17|||
131016599|NCT00486330|471691486|FG000|Overall Study|Adverse Event|2|||
131016600|NCT01924767|471691493|FG000|Overall Study|Adverse Event|1|||
131016601|NCT01924767|471691494|FG001|Overall Study|Adverse Event|0|||
131016602|NCT01924767|471691495|FG002|Overall Study|Adverse Event|1|||
131016603|NCT01924767|471691496|FG003|Overall Study|Adverse Event|0|||
131016604|NCT01924767|471691497|FG004|Overall Study|Adverse Event|0|||
131016605|NCT03460756|471691504|FG000|Overall Study|Adverse Event|0|||
131016606|NCT03460756|471691505|FG001|Overall Study|Adverse Event|0|||
131016607|NCT03460756|471691506|FG002|Overall Study|Adverse Event|0|||
131016608|NCT03460756|471691507|FG003|Overall Study|Adverse Event|1|||
131016609|NCT03460756|471691504|FG000|Overall Study|Lack of Efficacy|0|||
131016610|NCT03460756|471691505|FG001|Overall Study|Lack of Efficacy|0|||
131016611|NCT03460756|471691506|FG002|Overall Study|Lack of Efficacy|0|||
131016612|NCT03460756|471691507|FG003|Overall Study|Lack of Efficacy|2|||
131016613|NCT03460756|471691504|FG000|Overall Study|Lost to Follow-up|0|||
131016614|NCT03460756|471691505|FG001|Overall Study|Lost to Follow-up|1|||
131016615|NCT03460756|471691506|FG002|Overall Study|Lost to Follow-up|2|||
131016616|NCT03460756|471691507|FG003|Overall Study|Lost to Follow-up|1|||
131016617|NCT03460756|471691504|FG000|Overall Study|Pregnancy|0|||
131016618|NCT03460756|471691505|FG001|Overall Study|Pregnancy|0|||
131016619|NCT03460756|471691506|FG002|Overall Study|Pregnancy|0|||
131016620|NCT03460756|471691507|FG003|Overall Study|Pregnancy|1|||
131016621|NCT03460756|471691504|FG000|Overall Study|Protocol Violation|0|||
131016622|NCT03460756|471691505|FG001|Overall Study|Protocol Violation|0|||
131016623|NCT03460756|471691506|FG002|Overall Study|Protocol Violation|0|||
131016624|NCT03460756|471691507|FG003|Overall Study|Protocol Violation|1|||
131016625|NCT03460756|471691504|FG000|Overall Study|Withdrawal by Subject|0|||
131016626|NCT03460756|471691505|FG001|Overall Study|Withdrawal by Subject|4|||
131016627|NCT03460756|471691506|FG002|Overall Study|Withdrawal by Subject|7|||
131016628|NCT03460756|471691507|FG003|Overall Study|Withdrawal by Subject|3|||
131016629|NCT03987451|471691508|FG000|Overall Study|Lost to Follow-up|1|||
131016630|NCT03987451|471691509|FG001|Overall Study|Lost to Follow-up|0|||
131016631|NCT03987451|471691508|FG000|Overall Study|Withdrawal by Subject|1|||
131016632|NCT03987451|471691509|FG001|Overall Study|Withdrawal by Subject|1|||
131016633|NCT02441036|471691510|FG000|Overall Study|No tissue resected|0|||
131016634|NCT02441036|471691511|FG001|Overall Study|No tissue resected|1|||
131016635|NCT02441036|471691512|FG002|Overall Study|No tissue resected|0|||
131016636|NCT02441036|471691513|FG003|Overall Study|No tissue resected|1|||
131016637|NCT02441036|471691514|FG004|Overall Study|No tissue resected|0|||
131016638|NCT00612586|471691515|FG000|Overall Study|Adverse Event|6|||
131016639|NCT00612586|471691516|FG001|Overall Study|Adverse Event|2|||
131016640|NCT00612586|471691515|FG000|Overall Study|Death|1|||
131016641|NCT00612586|471691516|FG001|Overall Study|Death|0|||
131016642|NCT00612586|471691515|FG000|Overall Study|Entry Criteria Not Met|0|||
131016643|NCT00612586|471691516|FG001|Overall Study|Entry Criteria Not Met|2|||
131103390|NCT02257567|472007982|FG007|Overall Study|Lost to Follow-up|0|||
131103391|NCT02257567|472007983|FG008|Overall Study|Lost to Follow-up|0|||
131016644|NCT00612586|471691515|FG000|Overall Study|Withdrawal by Subject|7|||
131016645|NCT00612586|471691516|FG001|Overall Study|Withdrawal by Subject|9|||
131016646|NCT00612586|471691515|FG000|Overall Study|Physician Decision|1|||
131016647|NCT00612586|471691516|FG001|Overall Study|Physician Decision|2|||
131016648|NCT00612586|471691515|FG000|Overall Study|Sponsor Decision|1|||
131016649|NCT00612586|471691516|FG001|Overall Study|Sponsor Decision|1|||
131016650|NCT00612586|471691515|FG000|Overall Study|Progressive Disease|26|||
131016651|NCT00612586|471691516|FG001|Overall Study|Progressive Disease|24|||
131016652|NCT00612586|471691515|FG000|Overall Study|Randomized and Not Treated|1|||
131016653|NCT00612586|471691516|FG001|Overall Study|Randomized and Not Treated|1|||
131016654|NCT01194154|471691517|FG000|Overall Study|Adverse Event|12|||
131016655|NCT01194154|471691518|FG001|Overall Study|Adverse Event|7|||
131016656|NCT01194154|471691517|FG000|Overall Study|Lost to Follow-up|2|||
131016657|NCT01194154|471691518|FG001|Overall Study|Lost to Follow-up|3|||
131103392|NCT02257567|472007984|FG009|Overall Study|Lost to Follow-up|1|||
131016658|NCT01194154|471691517|FG000|Overall Study|Protocol Violation|0|||
131016659|NCT01194154|471691518|FG001|Overall Study|Protocol Violation|1|||
131103393|NCT02257567|472007985|FG010|Overall Study|Lost to Follow-up|1|||
131016660|NCT01194154|471691517|FG000|Overall Study|Withdrawal by Subject|5|||
131016661|NCT01194154|471691518|FG001|Overall Study|Withdrawal by Subject|6|||
131103394|NCT02257567|472007975|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131103395|NCT02257567|472007976|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131103396|NCT02257567|472007977|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131103397|NCT02257567|472007978|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131103398|NCT02257567|472007979|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
131103399|NCT02257567|472007980|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131103400|NCT02257567|472007981|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
131103401|NCT02257567|472007982|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131103402|NCT02257567|472007983|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131103403|NCT02257567|472007984|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131103404|NCT02257567|472007985|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
131103405|NCT02257567|472007975|FG000|Overall Study|Physician Decision|0|||
131103406|NCT02257567|472007976|FG001|Overall Study|Physician Decision|0|||
131103407|NCT02257567|472007977|FG002|Overall Study|Physician Decision|0|||
131103408|NCT02257567|472007978|FG003|Overall Study|Physician Decision|0|||
131103409|NCT02257567|472007979|FG004|Overall Study|Physician Decision|0|||
131103410|NCT02257567|472007980|FG005|Overall Study|Physician Decision|0|||
131103411|NCT02257567|472007981|FG006|Overall Study|Physician Decision|0|||
131103412|NCT02257567|472007982|FG007|Overall Study|Physician Decision|2|||
131103413|NCT02257567|472007983|FG008|Overall Study|Physician Decision|0|||
131103414|NCT02257567|472007984|FG009|Overall Study|Physician Decision|1|||
131103415|NCT02257567|472007985|FG010|Overall Study|Physician Decision|0|||
131103416|NCT02257567|472007975|FG000|Overall Study|Withdrawal by Subject|0|||
131103417|NCT02257567|472007976|FG001|Overall Study|Withdrawal by Subject|0|||
131103418|NCT02257567|472007977|FG002|Overall Study|Withdrawal by Subject|2|||
131103419|NCT02257567|472007978|FG003|Overall Study|Withdrawal by Subject|0|||
131103420|NCT02257567|472007979|FG004|Overall Study|Withdrawal by Subject|0|||
131103421|NCT02257567|472007980|FG005|Overall Study|Withdrawal by Subject|6|||
131103422|NCT02257567|472007981|FG006|Overall Study|Withdrawal by Subject|6|||
131103423|NCT02257567|472007982|FG007|Overall Study|Withdrawal by Subject|6|||
131103424|NCT02257567|472007983|FG008|Overall Study|Withdrawal by Subject|1|||
131103425|NCT02257567|472007984|FG009|Overall Study|Withdrawal by Subject|1|||
131103426|NCT02257567|472007985|FG010|Overall Study|Withdrawal by Subject|10|||
131103427|NCT01065844|472007992|FG000|Overall Study|Adverse Event|5|||
131103428|NCT00190749|472008000|FG000|Overall Study|Lost to Follow-up|8|||
131103429|NCT00190749|472008001|FG001|Overall Study|Lost to Follow-up|11|||
131103430|NCT00190749|472008000|FG000|Overall Study|Withdrawal by Subject|10|||
131103431|NCT00190749|472008001|FG001|Overall Study|Withdrawal by Subject|6|||
131103432|NCT00190749|472008000|FG000|Overall Study|Protocol Violation|5|||
131103433|NCT00190749|472008001|FG001|Overall Study|Protocol Violation|4|||
131103434|NCT00190749|472008000|FG000|Overall Study|Adverse Event|0|||
131103435|NCT00190749|472008001|FG001|Overall Study|Adverse Event|5|||
131103436|NCT00190749|472008000|FG000|Overall Study|Lack of Efficacy|2|||
131103437|NCT00190749|472008001|FG001|Overall Study|Lack of Efficacy|3|||
131103438|NCT00190749|472008000|FG000|Overall Study|Reason Not Specified|0|||
131103439|NCT00190749|472008001|FG001|Overall Study|Reason Not Specified|2|||
131103440|NCT00190749|472008000|FG000|Overall Study|Sponsor Decision|1|||
131103441|NCT00190749|472008001|FG001|Overall Study|Sponsor Decision|0|||
131103442|NCT01154010|472008002|FG000|Overall Study|Lost to Follow-up|0|||
131103443|NCT01154010|472008003|FG001|Overall Study|Lost to Follow-up|1|||
131103444|NCT00439231|472008004|FG000|Overall Study|Lack of Efficacy|28|||
131103445|NCT03814187|472008005|FG000|Overall Study|Sponsor's Administrative Decision|0|||
131103446|NCT03814187|472008006|FG001|Overall Study|Sponsor's Administrative Decision|0|||
131103447|NCT03814187|472008007|FG002|Overall Study|Sponsor's Administrative Decision|272|||
131103448|NCT03814187|472008005|FG000|Overall Study|Death|80|||
131103449|NCT03814187|472008006|FG001|Overall Study|Death|81|||
131103450|NCT03814187|472008007|FG002|Overall Study|Death|4|||
131103451|NCT03814187|472008005|FG000|Overall Study|Withdrew Consent|77|||
131103452|NCT03814187|472008006|FG001|Overall Study|Withdrew Consent|78|||
131103453|NCT03814187|472008007|FG002|Overall Study|Withdrew Consent|2|||
131103454|NCT03814187|472008005|FG000|Overall Study|Lost to Follow-up|47|||
130679818|NCT02888171|470454226|FG000|Overall Study|Lost to Follow-up|2|||
130679819|NCT02888171|470454227|FG001|Overall Study|Lost to Follow-up|1|||
130679820|NCT02888171|470454226|FG000|Overall Study|Withdrawal by Subject|3|||
131103455|NCT03814187|472008006|FG001|Overall Study|Lost to Follow-up|52|||
131103456|NCT03814187|472008007|FG002|Overall Study|Lost to Follow-up|1|||
130679821|NCT02888171|470454227|FG001|Overall Study|Withdrawal by Subject|2|||
131103457|NCT03814187|472008005|FG000|Overall Study|Adverse Event|22|||
130679822|NCT02888171|470454226|FG000|Overall Study|Adverse Event|0|||
130679823|NCT02888171|470454227|FG001|Overall Study|Adverse Event|1|||
131016662|NCT01194154|471691517|FG000|Overall Study|Blood pressure increase|5|||
131016663|NCT01194154|471691518|FG001|Overall Study|Blood pressure increase|3|||
131016664|NCT01194154|471691517|FG000|Overall Study|Hemoglobin decrease|0|||
131016665|NCT01194154|471691518|FG001|Overall Study|Hemoglobin decrease|1|||
131016666|NCT01194154|471691517|FG000|Overall Study|Hemoglobin increase|12|||
131016667|NCT01194154|471691518|FG001|Overall Study|Hemoglobin increase|3|||
131016668|NCT01194154|471691517|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
131016669|NCT01194154|471691518|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
131016670|NCT01194154|471691517|FG000|Overall Study|Treatment with prohibited medication|4|||
131016671|NCT01194154|471691518|FG001|Overall Study|Treatment with prohibited medication|5|||
131016672|NCT01194154|471691517|FG000|Overall Study|Other|4|||
131016673|NCT01194154|471691518|FG001|Overall Study|Other|0|||
131016674|NCT01194154|471691517|FG000|Overall Study|Did not receive study medication|2|||
131016675|NCT01194154|471691518|FG001|Overall Study|Did not receive study medication|4|||
131016676|NCT00395018|471691519|FG000|On-Treatment|Death|4|||
131016677|NCT00395018|471691519|FG000|On-Treatment|Other Reason|2|||
131016678|NCT00395018|471691519|FG000|On-Treatment|Poor/non-compliance|2|||
131016679|NCT00395018|471691519|FG000|On-Treatment|Subject no longer meets study criteria|2|||
131016680|NCT00395018|471691519|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
131016681|NCT00395018|471691519|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
131016682|NCT00395018|471691519|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
131016683|NCT02314117|471691520|FG000|Overall Study|Lost to Follow-up|9|||
131016684|NCT02314117|471691521|FG001|Overall Study|Lost to Follow-up|14|||
131016685|NCT02314117|471691520|FG000|Overall Study|Withdrawal by Subject|3|||
131016686|NCT02314117|471691521|FG001|Overall Study|Withdrawal by Subject|2|||
131016687|NCT03478696|471691522|FG000|Overall Study|Adverse Event|1|||
131016688|NCT03478696|471691523|FG001|Overall Study|Adverse Event|5|||
131016689|NCT03478696|471691522|FG000|Overall Study|Lost to Follow-up|1|||
131016690|NCT03478696|471691523|FG001|Overall Study|Lost to Follow-up|0|||
131016691|NCT03478696|471691522|FG000|Overall Study|Physician Decision|6|||
131016692|NCT03478696|471691523|FG001|Overall Study|Physician Decision|3|||
131016693|NCT03478696|471691522|FG000|Overall Study|Withdrawal by Subject|9|||
131016694|NCT03478696|471691523|FG001|Overall Study|Withdrawal by Subject|4|||
131016695|NCT00880048|471691527|FG000|Overall Study|Adverse Event|2|||
131016696|NCT00880048|471691528|FG001|Overall Study|Adverse Event|3|||
131016697|NCT00880048|471691529|FG002|Overall Study|Adverse Event|5|||
131016698|NCT00880048|471691527|FG000|Overall Study|Lack of Efficacy|1|||
131016699|NCT00880048|471691528|FG001|Overall Study|Lack of Efficacy|2|||
131016700|NCT00880048|471691529|FG002|Overall Study|Lack of Efficacy|2|||
131016701|NCT00880048|471691527|FG000|Overall Study|Protocol Violation|4|||
131016702|NCT00880048|471691528|FG001|Overall Study|Protocol Violation|6|||
131016703|NCT00880048|471691529|FG002|Overall Study|Protocol Violation|5|||
131016704|NCT00880048|471691527|FG000|Overall Study|Lost to Follow-up|6|||
131016705|NCT00880048|471691528|FG001|Overall Study|Lost to Follow-up|6|||
131016706|NCT00880048|471691529|FG002|Overall Study|Lost to Follow-up|5|||
131016707|NCT00880048|471691527|FG000|Overall Study|Physician Decision|1|||
131016708|NCT00880048|471691528|FG001|Overall Study|Physician Decision|1|||
131016709|NCT00880048|471691529|FG002|Overall Study|Physician Decision|7|||
131016710|NCT00880048|471691527|FG000|Overall Study|Withdrawal by Subject|5|||
131016711|NCT00880048|471691528|FG001|Overall Study|Withdrawal by Subject|8|||
131016712|NCT00880048|471691529|FG002|Overall Study|Withdrawal by Subject|5|||
131016713|NCT00880048|471691527|FG000|Overall Study|Study closed/terminated|9|||
131016714|NCT00880048|471691528|FG001|Overall Study|Study closed/terminated|7|||
131016715|NCT00880048|471691529|FG002|Overall Study|Study closed/terminated|6|||
131016716|NCT02954848|471691534|FG000|Overall Study|Randomized but Not Treated|0|||
131016717|NCT02954848|471691535|FG001|Overall Study|Randomized but Not Treated|1|||
131016718|NCT02954848|471691534|FG000|Overall Study|Adverse Event|2|||
131016719|NCT02954848|471691535|FG001|Overall Study|Adverse Event|3|||
131016720|NCT02954848|471691534|FG000|Overall Study|Withdrawal by Participant|0|||
131016721|NCT02954848|471691535|FG001|Overall Study|Withdrawal by Participant|1|||
131016722|NCT01069341|471691536|FG000|Overall Study|Lost to Follow-up|1|||
131016723|NCT01184508|471691538|FG000|Overall Study|Adverse Event|4|||
131016724|NCT01184508|471691539|FG001|Overall Study|Adverse Event|6|||
131016725|NCT01184508|471691538|FG000|Overall Study|Lack of Efficacy|1|||
131016726|NCT01184508|471691539|FG001|Overall Study|Lack of Efficacy|1|||
131016727|NCT01184508|471691538|FG000|Overall Study|Lost to Follow-up|1|||
131016728|NCT01184508|471691539|FG001|Overall Study|Lost to Follow-up|1|||
131016729|NCT01184508|471691538|FG000|Overall Study|Physician Decision|1|||
131016730|NCT01184508|471691539|FG001|Overall Study|Physician Decision|0|||
131016731|NCT01184508|471691538|FG000|Overall Study|Protocol Violation|3|||
131016732|NCT01184508|471691539|FG001|Overall Study|Protocol Violation|1|||
131016733|NCT01184508|471691538|FG000|Overall Study|Sponsor Decision|5|||
131016734|NCT01184508|471691539|FG001|Overall Study|Sponsor Decision|2|||
131016735|NCT01184508|471691538|FG000|Overall Study|Withdrawal by Subject|1|||
131016736|NCT01184508|471691539|FG001|Overall Study|Withdrawal by Subject|3|||
131016737|NCT01184508|471691538|FG000|Overall Study|Randomized, Not Treated|0|||
131016738|NCT01184508|471691539|FG001|Overall Study|Randomized, Not Treated|1|||
131016739|NCT02880241|471691547|FG000|Overall Study|Lack of Efficacy|1|||
130679824|NCT02170688|470454228|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
130679825|NCT02170688|470454229|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
130679826|NCT02170688|470454230|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
130679827|NCT02170688|470454231|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
130679828|NCT02170688|470454232|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
130679829|NCT02170688|470454228|FG000|Overall Study|Full dose not received|0|||
130679830|NCT02170688|470454229|FG001|Overall Study|Full dose not received|1|||
130679831|NCT02170688|470454230|FG002|Overall Study|Full dose not received|0|||
130679832|NCT02170688|470454231|FG003|Overall Study|Full dose not received|0|||
130679833|NCT02170688|470454232|FG004|Overall Study|Full dose not received|0|||
130679834|NCT02170688|470454228|FG000|Overall Study|Physician Decision|0|||
130679835|NCT02170688|470454229|FG001|Overall Study|Physician Decision|0|||
130679836|NCT02170688|470454230|FG002|Overall Study|Physician Decision|1|||
130679837|NCT02170688|470454231|FG003|Overall Study|Physician Decision|0|||
130679838|NCT02170688|470454232|FG004|Overall Study|Physician Decision|0|||
130679839|NCT01471522|470454235|FG000|Overall Study|Withdrawal by Subject|28|||
130679840|NCT01471522|470454236|FG001|Overall Study|Withdrawal by Subject|22|||
130679841|NCT01471522|470454235|FG000|Overall Study|Lost to Follow-up|36|||
130679842|NCT01471522|470454236|FG001|Overall Study|Lost to Follow-up|26|||
130679843|NCT02507375|470454238|FG000|Overall Study|Progressive Disease|4|||
130679844|NCT02507375|470454239|FG001|Overall Study|Progressive Disease|5|||
130679845|NCT02507375|470454238|FG000|Overall Study|Death|0|||
130679846|NCT02507375|470454239|FG001|Overall Study|Death|1|||
130679847|NCT02507375|470454238|FG000|Overall Study|Refused treatment|0|||
130679848|NCT02507375|470454239|FG001|Overall Study|Refused treatment|1|||
130679849|NCT02507375|470454238|FG000|Overall Study|Adverse Event|0|||
130679850|NCT02507375|470454239|FG001|Overall Study|Adverse Event|1|||
130679851|NCT00522457|470454240|FG000|Overall Study|Due to disease progression|16|||
130679852|NCT00522457|470454240|FG000|Overall Study|Adverse Event|2|||
130679853|NCT01691248|470454241|FG000|Overall Study|Protocol Violation|43|||
130679854|NCT01691248|470454242|FG001|Overall Study|Protocol Violation|27|||
130679855|NCT01691248|470454241|FG000|Overall Study|Adverse Event|24|||
130679856|NCT01691248|470454242|FG001|Overall Study|Adverse Event|22|||
130679857|NCT01691248|470454241|FG000|Overall Study|Withdrawal by Subject|20|||
130679858|NCT01691248|470454242|FG001|Overall Study|Withdrawal by Subject|18|||
130679859|NCT01691248|470454241|FG000|Overall Study|Confirmed CDAD|14|||
130679860|NCT01691248|470454242|FG001|Overall Study|Confirmed CDAD|31|||
130679861|NCT01691248|470454241|FG000|Overall Study|Lost to Follow-up|2|||
130679862|NCT01691248|470454242|FG001|Overall Study|Lost to Follow-up|5|||
130679863|NCT01691248|470454241|FG000|Overall Study|Reason not provided|4|||
130679864|NCT01691248|470454242|FG001|Overall Study|Reason not provided|4|||
130679865|NCT01691248|470454241|FG000|Overall Study|Not Treated|4|||
130679866|NCT01691248|470454242|FG001|Overall Study|Not Treated|7|||
130679867|NCT02863575|470454243|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
130679868|NCT02863575|470454244|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
130679869|NCT02863575|470454245|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
130679870|NCT02863575|470454243|FG000|Overall Study|Withdrawal by Subject|0|||
130679871|NCT02863575|470454244|FG001|Overall Study|Withdrawal by Subject|1|||
130679872|NCT02863575|470454245|FG002|Overall Study|Withdrawal by Subject|1|||
130679873|NCT02863575|470454243|FG000|Overall Study|Adverse Event|0|||
130679874|NCT02863575|470454244|FG001|Overall Study|Adverse Event|1|||
130679875|NCT02863575|470454245|FG002|Overall Study|Adverse Event|0|||
130679876|NCT03805438|470455829|FG000|Overall Study|Lack of Efficacy|1|||
130679877|NCT03805438|470455829|FG000|Overall Study|Protocol Violation|1|||
130679878|NCT00366899|470455830|FG000|Infant Series|Withdrawal by Subject|4|||
130679879|NCT00366899|470455831|FG001|Infant Series|Withdrawal by Subject|7|||
130679880|NCT00366899|470455830|FG000|Infant Series|Protocol Violation|2|||
130679881|NCT00366899|470455831|FG001|Infant Series|Protocol Violation|1|||
130679882|NCT00366899|470455830|FG000|Infant Series|Failed to return|1|||
130679883|NCT00366899|470455831|FG001|Infant Series|Failed to return|1|||
130679884|NCT00366899|470455830|FG000|Infant Series|Lost to Follow-up|0|||
131016740|NCT02880241|471691548|FG001|Overall Study|Lack of Efficacy|0|||
131016741|NCT02880241|471691549|FG002|Overall Study|Lack of Efficacy|0|||
130679885|NCT00366899|470455831|FG001|Infant Series|Lost to Follow-up|2|||
130679886|NCT00366899|470455830|FG000|Infant Series|Adverse Event|0|||
130679887|NCT00366899|470455831|FG001|Infant Series|Adverse Event|1|||
130679888|NCT00366899|470455830|FG000|Infant Series|Physician Decision|1|||
130679889|NCT00366899|470455831|FG001|Infant Series|Physician Decision|0|||
130679890|NCT00366899|470455830|FG000|Infant Series|Randomized but not consented|1|||
130679891|NCT00366899|470455831|FG001|Infant Series|Randomized but not consented|0|||
130679892|NCT00366899|470455830|FG000|After Infant Series|Lost to Follow-up|4|||
130679893|NCT00366899|470455831|FG001|After Infant Series|Lost to Follow-up|3|||
130679894|NCT00366899|470455830|FG000|After Infant Series|Withdrawal by Subject|1|||
130679895|NCT00366899|470455831|FG001|After Infant Series|Withdrawal by Subject|4|||
130679896|NCT00366899|470455830|FG000|After Infant Series|Adverse Event|1|||
130679897|NCT00366899|470455831|FG001|After Infant Series|Adverse Event|2|||
130679898|NCT00366899|470455830|FG000|After Infant Series|Protocol Violation|1|||
130679899|NCT00366899|470455831|FG001|After Infant Series|Protocol Violation|0|||
131103458|NCT03814187|472008006|FG001|Overall Study|Adverse Event|23|||
131103459|NCT03814187|472008007|FG002|Overall Study|Adverse Event|0|||
130679900|NCT00366899|470455830|FG000|Toddler Dose|Withdrawal by Subject|1|||
130679901|NCT00366899|470455831|FG001|Toddler Dose|Withdrawal by Subject|1|||
130679902|NCT00366899|470455830|FG000|Toddler Dose|Protocol Violation|1|||
130679903|NCT00366899|470455831|FG001|Toddler Dose|Protocol Violation|0|||
130679904|NCT01619800|470455832|FG000|Overall Study|study terminated|2|||
130679905|NCT01619800|470455833|FG001|Overall Study|study terminated|0|||
130679906|NCT00419770|470455835|FG000|Overall Study|Withdrawal by Subject|5|||
130679907|NCT00419770|470455836|FG001|Overall Study|Withdrawal by Subject|1|||
130679908|NCT02848326|470455837|FG000|Treatment Period|Adverse Event|5|||
130679909|NCT02848326|470455838|FG001|Treatment Period|Adverse Event|4|||
130679910|NCT02848326|470455839|FG002|Treatment Period|Adverse Event|11|||
130679911|NCT02848326|470455840|FG003|Treatment Period|Adverse Event|6|||
130679912|NCT02848326|470455841|FG004|Treatment Period|Adverse Event|5|||
130679913|NCT02848326|470455842|FG005|Treatment Period|Adverse Event|7|||
130679914|NCT02848326|470455837|FG000|Treatment Period|Withdrawal of Consent|20|||
130679915|NCT02848326|470455838|FG001|Treatment Period|Withdrawal of Consent|6|||
130679916|NCT02848326|470455839|FG002|Treatment Period|Withdrawal of Consent|9|||
130679917|NCT02848326|470455840|FG003|Treatment Period|Withdrawal of Consent|6|||
130679918|NCT02848326|470455841|FG004|Treatment Period|Withdrawal of Consent|9|||
130679919|NCT02848326|470455842|FG005|Treatment Period|Withdrawal of Consent|6|||
130679920|NCT02848326|470455837|FG000|Treatment Period|Lost to Follow-up|5|||
130679921|NCT02848326|470455838|FG001|Treatment Period|Lost to Follow-up|1|||
130679922|NCT02848326|470455839|FG002|Treatment Period|Lost to Follow-up|11|||
130679923|NCT02848326|470455840|FG003|Treatment Period|Lost to Follow-up|7|||
130679924|NCT02848326|470455841|FG004|Treatment Period|Lost to Follow-up|2|||
130679925|NCT02848326|470455842|FG005|Treatment Period|Lost to Follow-up|3|||
130679926|NCT02848326|470455837|FG000|Treatment Period|Pregnancy|0|||
131103460|NCT03814187|472008005|FG000|Overall Study|Physician Decision|7|||
131103461|NCT03814187|472008006|FG001|Overall Study|Physician Decision|4|||
131103462|NCT03814187|472008007|FG002|Overall Study|Physician Decision|2|||
131103463|NCT03814187|472008005|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
131103464|NCT03814187|472008006|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
131103465|NCT03814187|472008007|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
131103466|NCT03814187|472008005|FG000|Overall Study|Other reasons|34|||
131103467|NCT03814187|472008006|FG001|Overall Study|Other reasons|40|||
131103468|NCT03814187|472008007|FG002|Overall Study|Other reasons|2|||
131103469|NCT00825825|472008008|FG000|First Medication Period (14 Days)|Adverse Event|1|||
130679927|NCT02848326|470455838|FG001|Treatment Period|Pregnancy|0|||
130679928|NCT02848326|470455839|FG002|Treatment Period|Pregnancy|1|||
130679929|NCT02848326|470455840|FG003|Treatment Period|Pregnancy|1|||
130679930|NCT02848326|470455841|FG004|Treatment Period|Pregnancy|0|||
130679931|NCT02848326|470455842|FG005|Treatment Period|Pregnancy|1|||
130679932|NCT02848326|470455837|FG000|Treatment Period|Protocol Violation|4|||
130679933|NCT02848326|470455838|FG001|Treatment Period|Protocol Violation|3|||
130679934|NCT02848326|470455839|FG002|Treatment Period|Protocol Violation|4|||
130679935|NCT02848326|470455840|FG003|Treatment Period|Protocol Violation|2|||
130679936|NCT02848326|470455841|FG004|Treatment Period|Protocol Violation|3|||
130679937|NCT02848326|470455842|FG005|Treatment Period|Protocol Violation|3|||
130679938|NCT02848326|470455837|FG000|Treatment Period|Non-compliance with Study Drug|4|||
130679939|NCT02848326|470455838|FG001|Treatment Period|Non-compliance with Study Drug|0|||
130679940|NCT02848326|470455839|FG002|Treatment Period|Non-compliance with Study Drug|0|||
130679941|NCT02848326|470455840|FG003|Treatment Period|Non-compliance with Study Drug|1|||
130679942|NCT02848326|470455841|FG004|Treatment Period|Non-compliance with Study Drug|0|||
130679943|NCT02848326|470455842|FG005|Treatment Period|Non-compliance with Study Drug|0|||
130679944|NCT02848326|470455837|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
130679945|NCT02848326|470455838|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
130679946|NCT02848326|470455839|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
130679947|NCT02848326|470455840|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
130679948|NCT02848326|470455841|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
130679949|NCT02848326|470455842|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
130679950|NCT02848326|470455837|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
130679951|NCT02848326|470455838|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
130679952|NCT02848326|470455839|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
130679953|NCT02848326|470455840|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
130679954|NCT02848326|470455841|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
130679955|NCT02848326|470455842|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
131103470|NCT00825825|472008009|FG001|First Medication Period (14 Days)|Adverse Event|0|||
130679956|NCT00414466|470455849|FG000|Overall Study|Adverse Event|0|||
130679957|NCT00414466|470455850|FG001|Overall Study|Adverse Event|0|||
130679958|NCT00414466|470455851|FG002|Overall Study|Adverse Event|1|||
130679959|NCT00414466|470455852|FG003|Overall Study|Adverse Event|1|||
130679960|NCT00414466|470455849|FG000|Overall Study|Lack of Efficacy|1|||
130679961|NCT00414466|470455850|FG001|Overall Study|Lack of Efficacy|0|||
130679962|NCT00414466|470455851|FG002|Overall Study|Lack of Efficacy|0|||
130679963|NCT00414466|470455852|FG003|Overall Study|Lack of Efficacy|0|||
130679964|NCT00414466|470455849|FG000|Overall Study|Withdrawn by Sponsor|1|||
130679965|NCT00414466|470455850|FG001|Overall Study|Withdrawn by Sponsor|0|||
130679966|NCT00414466|470455851|FG002|Overall Study|Withdrawn by Sponsor|0|||
130679967|NCT00414466|470455852|FG003|Overall Study|Withdrawn by Sponsor|0|||
130679968|NCT02999178|470455853|FG000|Overall Study|Adverse Event|85|||
130679969|NCT02999178|470455854|FG001|Overall Study|Adverse Event|62|||
130679970|NCT02999178|470455853|FG000|Overall Study|Protocol Violation|1|||
130679971|NCT02999178|470455854|FG001|Overall Study|Protocol Violation|2|||
130679972|NCT02999178|470455853|FG000|Overall Study|Lost to Follow-up|0|||
130679973|NCT02999178|470455854|FG001|Overall Study|Lost to Follow-up|2|||
130679974|NCT02999178|470455853|FG000|Overall Study|Withdrawal by Subject|21|||
130679975|NCT02999178|470455854|FG001|Overall Study|Withdrawal by Subject|21|||
130679976|NCT02999178|470455853|FG000|Overall Study|Other reason not defined above|7|||
130679977|NCT02999178|470455854|FG001|Overall Study|Other reason not defined above|13|||
130679978|NCT03480425|470455855|FG000|Overall Study|Force transducer technical failure|1|||
130679979|NCT02424188|470455857|FG000|Overall Study|Death|2|||
130679980|NCT02424188|470455858|FG001|Overall Study|Death|2|||
130679981|NCT02424188|470455857|FG000|Overall Study|Lost to Follow-up|1|||
130679982|NCT02424188|470455858|FG001|Overall Study|Lost to Follow-up|3|||
130679983|NCT02424188|470455857|FG000|Overall Study|Incarceration|1|||
130679984|NCT02424188|470455858|FG001|Overall Study|Incarceration|0|||
130679985|NCT01085045|470455859|FG000|Part A|Withdrawal by Subject|4|||
130679986|NCT01085045|470455859|FG000|Part A|Adverse Event|6|||
130679987|NCT01085045|470455859|FG000|Part A|Protocol Violation|1|||
130679988|NCT01085045|470455859|FG000|Part A|Protocol Specified Criteria|7|||
130679989|NCT01085045|470455859|FG000|Part B|Withdrawal by Subject|2|||
130679990|NCT01085045|470455859|FG000|Part B|Protocol Specified Criteria|6|||
130679991|NCT01085045|470455859|FG000|Part B|Lost to Follow-up|1|||
130679992|NCT01085045|470455859|FG000|Part B|Adverse Event|6|||
130679993|NCT00416520|470455864|FG000|Open-label Period|Adverse Event|28|||
130679994|NCT00416520|470455865|FG001|Open-label Period|Adverse Event|10|||
130679995|NCT00416520|470455866|FG002|Open-label Period|Adverse Event|0|||
130679996|NCT00416520|470455867|FG003|Open-label Period|Adverse Event|0|||
130679997|NCT00416520|470455864|FG000|Open-label Period|Death|2|||
130679998|NCT00416520|470455865|FG001|Open-label Period|Death|1|||
130679999|NCT00416520|470455866|FG002|Open-label Period|Death|0|||
130680000|NCT00416520|470455867|FG003|Open-label Period|Death|0|||
130680001|NCT00416520|470455864|FG000|Open-label Period|Lack of Efficacy|8|||
130680002|NCT00416520|470455865|FG001|Open-label Period|Lack of Efficacy|1|||
130680003|NCT00416520|470455866|FG002|Open-label Period|Lack of Efficacy|0|||
130680004|NCT00416520|470455867|FG003|Open-label Period|Lack of Efficacy|0|||
130680005|NCT00416520|470455864|FG000|Open-label Period|Protocol Violation|3|||
130680006|NCT00416520|470455865|FG001|Open-label Period|Protocol Violation|3|||
130680007|NCT00416520|470455866|FG002|Open-label Period|Protocol Violation|0|||
130680008|NCT00416520|470455867|FG003|Open-label Period|Protocol Violation|0|||
130680009|NCT00416520|470455864|FG000|Open-label Period|Withdrawal by Subject|16|||
130680010|NCT00416520|470455865|FG001|Open-label Period|Withdrawal by Subject|5|||
130680011|NCT00416520|470455866|FG002|Open-label Period|Withdrawal by Subject|0|||
130680012|NCT00416520|470455867|FG003|Open-label Period|Withdrawal by Subject|0|||
130680013|NCT00416520|470455864|FG000|Open-label Period|Other Reasons|3|||
130680014|NCT00416520|470455865|FG001|Open-label Period|Other Reasons|12|||
130680015|NCT00416520|470455866|FG002|Open-label Period|Other Reasons|0|||
130680016|NCT00416520|470455867|FG003|Open-label Period|Other Reasons|0|||
130680017|NCT00416520|470455864|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
130680018|NCT00416520|470455865|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
130680019|NCT00416520|470455866|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
130680020|NCT00416520|470455867|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
130680021|NCT00416520|470455864|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
130680022|NCT00416520|470455865|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
130680023|NCT00416520|470455866|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
130680024|NCT00416520|470455867|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
130680025|NCT00416520|470455864|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
130680026|NCT00416520|470455865|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
130680027|NCT00416520|470455866|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
130680028|NCT00416520|470455867|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
130680029|NCT01492361|470455868|FG000|Overall Study|Withdrawal by Subject|281|||
130680030|NCT01492361|470455869|FG001|Overall Study|Withdrawal by Subject|297|||
130680031|NCT01492361|470455868|FG000|Overall Study|Physician Decision|12|||
130680032|NCT01492361|470455869|FG001|Overall Study|Physician Decision|12|||
130680033|NCT01492361|470455868|FG000|Overall Study|Lost to Follow-up|6|||
130680034|NCT01492361|470455869|FG001|Overall Study|Lost to Follow-up|13|||
130680035|NCT01492361|470455868|FG000|Overall Study|Other than specified above|106|||
130680036|NCT01492361|470455869|FG001|Overall Study|Other than specified above|138|||
130680037|NCT01996033|470455875|FG000|Overall Study|Death|1|||
130680038|NCT01996033|470455875|FG000|Overall Study|Physician Decision|1|||
130680039|NCT01996033|470455875|FG000|Overall Study|Withdrawal by Subject|4|||
130680040|NCT01996033|470455875|FG000|Overall Study|Lost to Follow-up|3|||
130680041|NCT03227445|470455880|FG000|Period 1 (28 Days)|Adverse Event|1|||
130680042|NCT03227445|470455881|FG001|Period 1 (28 Days)|Adverse Event|2|||
130680043|NCT03227445|470455882|FG002|Period 1 (28 Days)|Adverse Event|0|||
130680044|NCT03227445|470455883|FG003|Period 1 (28 Days)|Adverse Event|1|||
130680045|NCT03227445|470455880|FG000|Period 1 (28 Days)|Protocol Violation|1|||
130680046|NCT03227445|470455881|FG001|Period 1 (28 Days)|Protocol Violation|0|||
130680047|NCT03227445|470455882|FG002|Period 1 (28 Days)|Protocol Violation|0|||
130680048|NCT03227445|470455883|FG003|Period 1 (28 Days)|Protocol Violation|0|||
130680049|NCT03227445|470455880|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
130680050|NCT03227445|470455881|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
130680051|NCT03227445|470455882|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
130680052|NCT03227445|470455883|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
130680053|NCT03227445|470455880|FG000|Period 2 (28 Days)|Adverse Event|1|||
130680054|NCT03227445|470455881|FG001|Period 2 (28 Days)|Adverse Event|0|||
130680055|NCT03227445|470455882|FG002|Period 2 (28 Days)|Adverse Event|2|||
130680056|NCT03227445|470455883|FG003|Period 2 (28 Days)|Adverse Event|1|||
130680057|NCT03227445|470455880|FG000|Period 2 (28 Days)|Protocol Violation|0|||
130680058|NCT03227445|470455881|FG001|Period 2 (28 Days)|Protocol Violation|0|||
130680059|NCT03227445|470455882|FG002|Period 2 (28 Days)|Protocol Violation|0|||
131016742|NCT02880241|471691550|FG003|Overall Study|Lack of Efficacy|0|||
131016743|NCT02880241|471691551|FG004|Overall Study|Lack of Efficacy|0|||
131016744|NCT02880241|471691552|FG005|Overall Study|Lack of Efficacy|0|||
131016745|NCT01317420|471691563|FG000|Overall Study|Progressive disease according to RECIST|2|||
131016746|NCT01317420|471691564|FG001|Overall Study|Progressive disease according to RECIST|3|||
131016747|NCT01317420|471691565|FG002|Overall Study|Progressive disease according to RECIST|3|||
131016748|NCT01317420|471691566|FG003|Overall Study|Progressive disease according to RECIST|3|||
131016749|NCT01317420|471691567|FG004|Overall Study|Progressive disease according to RECIST|3|||
131016750|NCT01317420|471691568|FG005|Overall Study|Progressive disease according to RECIST|3|||
131016751|NCT01317420|471691569|FG006|Overall Study|Progressive disease according to RECIST|3|||
131016752|NCT01317420|471691570|FG007|Overall Study|Progressive disease according to RECIST|3|||
131016753|NCT01317420|471691571|FG008|Overall Study|Progressive disease according to RECIST|3|||
131016754|NCT01317420|471691572|FG009|Overall Study|Progressive disease according to RECIST|2|||
131016755|NCT01317420|471691573|FG010|Overall Study|Progressive disease according to RECIST|3|||
131016756|NCT01317420|471691574|FG011|Overall Study|Progressive disease according to RECIST|11|||
131016757|NCT01317420|471691575|FG012|Overall Study|Progressive disease according to RECIST|16|||
131016758|NCT01317420|471691563|FG000|Overall Study|Other adverse event|1|||
131016759|NCT01317420|471691564|FG001|Overall Study|Other adverse event|0|||
131016760|NCT01317420|471691565|FG002|Overall Study|Other adverse event|0|||
131016761|NCT01317420|471691566|FG003|Overall Study|Other adverse event|0|||
131016762|NCT01317420|471691567|FG004|Overall Study|Other adverse event|0|||
131016763|NCT01317420|471691568|FG005|Overall Study|Other adverse event|0|||
131016764|NCT01317420|471691569|FG006|Overall Study|Other adverse event|0|||
131016765|NCT01317420|471691570|FG007|Overall Study|Other adverse event|0|||
131016766|NCT01317420|471691571|FG008|Overall Study|Other adverse event|0|||
131016767|NCT01317420|471691572|FG009|Overall Study|Other adverse event|0|||
131016768|NCT01317420|471691573|FG010|Overall Study|Other adverse event|0|||
131016769|NCT01317420|471691574|FG011|Overall Study|Other adverse event|0|||
131016770|NCT01317420|471691575|FG012|Overall Study|Other adverse event|2|||
131016771|NCT01317420|471691563|FG000|Overall Study|Non-compliant with protocol|0|||
131016772|NCT01317420|471691564|FG001|Overall Study|Non-compliant with protocol|0|||
131016773|NCT01317420|471691565|FG002|Overall Study|Non-compliant with protocol|0|||
131016774|NCT01317420|471691566|FG003|Overall Study|Non-compliant with protocol|0|||
131016775|NCT01317420|471691567|FG004|Overall Study|Non-compliant with protocol|0|||
131016776|NCT01317420|471691568|FG005|Overall Study|Non-compliant with protocol|0|||
131016777|NCT01317420|471691569|FG006|Overall Study|Non-compliant with protocol|0|||
131016778|NCT01317420|471691570|FG007|Overall Study|Non-compliant with protocol|0|||
131016779|NCT01317420|471691571|FG008|Overall Study|Non-compliant with protocol|0|||
131016780|NCT01317420|471691572|FG009|Overall Study|Non-compliant with protocol|0|||
131016781|NCT01317420|471691573|FG010|Overall Study|Non-compliant with protocol|0|||
131016782|NCT01317420|471691574|FG011|Overall Study|Non-compliant with protocol|0|||
131016783|NCT01317420|471691575|FG012|Overall Study|Non-compliant with protocol|1|||
131016784|NCT01317420|471691563|FG000|Overall Study|Refused to cont. taking trial medication|0|||
131016785|NCT01317420|471691564|FG001|Overall Study|Refused to cont. taking trial medication|0|||
131016786|NCT01317420|471691565|FG002|Overall Study|Refused to cont. taking trial medication|0|||
131016787|NCT01317420|471691566|FG003|Overall Study|Refused to cont. taking trial medication|0|||
131016788|NCT01317420|471691567|FG004|Overall Study|Refused to cont. taking trial medication|0|||
131016789|NCT01317420|471691568|FG005|Overall Study|Refused to cont. taking trial medication|0|||
131016790|NCT01317420|471691569|FG006|Overall Study|Refused to cont. taking trial medication|0|||
131016791|NCT01317420|471691570|FG007|Overall Study|Refused to cont. taking trial medication|0|||
131016792|NCT01317420|471691571|FG008|Overall Study|Refused to cont. taking trial medication|0|||
131045804|NCT03582033|471802281|FG003|Part B|Withdrawal by Subject|0|||
130680060|NCT03227445|470455883|FG003|Period 2 (28 Days)|Protocol Violation|1|||
131016793|NCT01317420|471691572|FG009|Overall Study|Refused to cont. taking trial medication|0|||
131016794|NCT01317420|471691573|FG010|Overall Study|Refused to cont. taking trial medication|0|||
131016795|NCT01317420|471691574|FG011|Overall Study|Refused to cont. taking trial medication|0|||
131016796|NCT01317420|471691575|FG012|Overall Study|Refused to cont. taking trial medication|1|||
131016797|NCT01317420|471691563|FG000|Overall Study|Reason other than those specified|0|||
131016798|NCT01317420|471691564|FG001|Overall Study|Reason other than those specified|0|||
131016799|NCT01317420|471691565|FG002|Overall Study|Reason other than those specified|0|||
131016800|NCT01317420|471691566|FG003|Overall Study|Reason other than those specified|0|||
131016801|NCT01317420|471691567|FG004|Overall Study|Reason other than those specified|0|||
131016802|NCT01317420|471691568|FG005|Overall Study|Reason other than those specified|0|||
131016803|NCT01317420|471691569|FG006|Overall Study|Reason other than those specified|0|||
131016804|NCT01317420|471691570|FG007|Overall Study|Reason other than those specified|0|||
131016805|NCT01317420|471691571|FG008|Overall Study|Reason other than those specified|0|||
131016806|NCT01317420|471691572|FG009|Overall Study|Reason other than those specified|1|||
131016807|NCT01317420|471691573|FG010|Overall Study|Reason other than those specified|0|||
131016808|NCT01317420|471691574|FG011|Overall Study|Reason other than those specified|0|||
131016809|NCT01317420|471691575|FG012|Overall Study|Reason other than those specified|0|||
131016810|NCT04707313|471691576|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
131016811|NCT04707313|471691577|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
131016812|NCT04707313|471691578|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
131016813|NCT04707313|471691579|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
131016814|NCT04707313|471691580|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
131016815|NCT04707313|471691581|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
131016816|NCT04707313|471691582|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
131016817|NCT04707313|471691583|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
131016818|NCT04707313|471691584|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
131016819|NCT04707313|471691585|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
131016820|NCT04707313|471691586|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
131016821|NCT04707313|471691587|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
131016822|NCT04707313|471691588|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
131016823|NCT04707313|471691576|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
131016824|NCT04707313|471691577|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
131016825|NCT04707313|471691578|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131016826|NCT04707313|471691579|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131016827|NCT04707313|471691580|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
131016828|NCT04707313|471691581|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131016829|NCT04707313|471691582|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131016830|NCT04707313|471691583|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131016831|NCT04707313|471691584|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131016832|NCT04707313|471691585|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131016833|NCT04707313|471691586|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131016834|NCT04707313|471691587|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131016835|NCT04707313|471691588|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
131016836|NCT04707313|471691576|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
131016837|NCT04707313|471691577|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
131016838|NCT04707313|471691578|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
131016839|NCT04707313|471691579|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
131016840|NCT04707313|471691580|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
131016841|NCT04707313|471691581|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
131016842|NCT04707313|471691582|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
131016843|NCT04707313|471691583|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
131016844|NCT04707313|471691584|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
131016845|NCT04707313|471691585|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
131016846|NCT04707313|471691586|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
131016847|NCT04707313|471691587|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
131016848|NCT04707313|471691588|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
131016849|NCT04707313|471691576|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131016850|NCT04707313|471691577|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
131016851|NCT04707313|471691578|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
131016852|NCT04707313|471691579|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131016853|NCT04707313|471691580|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
131016854|NCT04707313|471691581|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131016855|NCT04707313|471691582|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131016856|NCT04707313|471691583|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131016857|NCT04707313|471691584|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131016858|NCT04707313|471691585|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131045805|NCT03582033|471802282|FG004|Part B|Withdrawal by Subject|0|||
130680061|NCT03227445|470455880|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
130680062|NCT03227445|470455881|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
130680063|NCT03227445|470455882|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
130680064|NCT03227445|470455883|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
130680065|NCT00755196|470455884|FG000|Overall Study|Lost to Follow-up|1|||
130680066|NCT00755196|470455884|FG000|Overall Study|Lack of Efficiency|1|||
130680067|NCT01703832|470455885|FG000|Overall Study|Withdrawal by Subject|1|||
130680068|NCT01703832|470455886|FG001|Overall Study|Withdrawal by Subject|0|||
130680069|NCT01991470|470455887|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
130680070|NCT01991470|470455887|FG000|Enlite 1 Period|Adverse Event|1|||
130680071|NCT01991470|470455887|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
130680072|NCT01991470|470455887|FG000|Enlite 3 Period|Lost to Follow-up|1|||
130680073|NCT01991470|470455887|FG000|Enlite 3 Period|Physician Decision|2|||
130680074|NCT01991470|470455887|FG000|Enlite 3 Period|Physician Decision|8|||
130680075|NCT01991470|470455887|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
131016859|NCT04707313|471691586|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131016860|NCT04707313|471691587|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131016861|NCT04707313|471691588|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
131016862|NCT04707313|471691576|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
131016863|NCT04707313|471691577|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
131016864|NCT04707313|471691578|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
131016865|NCT04707313|471691579|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
131016866|NCT04707313|471691580|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
131016867|NCT04707313|471691581|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131016868|NCT04707313|471691582|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131016869|NCT04707313|471691583|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131016870|NCT04707313|471691584|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
131016871|NCT04707313|471691585|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131016872|NCT04707313|471691586|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131016873|NCT04707313|471691587|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131016874|NCT04707313|471691588|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
131016875|NCT04707313|471691576|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
131016876|NCT04707313|471691577|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131016877|NCT04707313|471691578|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131016878|NCT04707313|471691579|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131016879|NCT04707313|471691580|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131016880|NCT04707313|471691581|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
131016881|NCT04707313|471691582|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
131016882|NCT04707313|471691583|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
131016883|NCT04707313|471691584|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131016884|NCT04707313|471691585|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131016885|NCT04707313|471691586|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131016886|NCT04707313|471691587|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131016887|NCT04707313|471691588|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
131016888|NCT04707313|471691576|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
131016889|NCT04707313|471691577|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
131016890|NCT04707313|471691578|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
131016891|NCT04707313|471691579|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
131016892|NCT04707313|471691580|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
131016893|NCT04707313|471691581|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
131016894|NCT04707313|471691582|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
131016895|NCT04707313|471691583|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
131016896|NCT04707313|471691584|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
131016897|NCT04707313|471691585|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
131016898|NCT04707313|471691586|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
131016899|NCT04707313|471691587|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
131016900|NCT04707313|471691588|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
131016901|NCT04707313|471691576|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131016902|NCT04707313|471691577|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131016903|NCT04707313|471691578|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
131016904|NCT04707313|471691579|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131016905|NCT04707313|471691580|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
130680076|NCT00243932|470455888|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
130680077|NCT00243932|470455889|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
130765939|NCT01253174|470765907|FG001|Period 2|Adverse Event|0|||
131016906|NCT04707313|471691581|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131016907|NCT04707313|471691582|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131016908|NCT04707313|471691583|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
131016909|NCT04707313|471691584|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131045806|NCT03582033|471802283|FG005|Part B|Withdrawal by Subject|6|||
130680078|NCT00243932|470455890|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
130680079|NCT02143102|470455891|FG000|Overall Study|Lost to Follow-up|11|||
130680080|NCT02143102|470455892|FG001|Overall Study|Lost to Follow-up|0|||
130680081|NCT03247556|470455893|FG000|Overall Study|Adverse Event|1|||
130680082|NCT03247556|470455894|FG001|Overall Study|Adverse Event|4|||
130680083|NCT03247556|470455895|FG002|Overall Study|Adverse Event|5|||
130680084|NCT03247556|470455893|FG000|Overall Study|Lost to Follow-up|5|||
130680085|NCT03247556|470455894|FG001|Overall Study|Lost to Follow-up|5|||
130680086|NCT03247556|470455895|FG002|Overall Study|Lost to Follow-up|4|||
130680087|NCT03247556|470455893|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
130680088|NCT03247556|470455894|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
130680089|NCT03247556|470455895|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
130680090|NCT03247556|470455893|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
130680091|NCT03247556|470455894|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
130680092|NCT03247556|470455895|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
130680093|NCT03247556|470455893|FG000|Overall Study|Protocol Violation|2|||
130680094|NCT03247556|470455894|FG001|Overall Study|Protocol Violation|0|||
130680095|NCT03247556|470455895|FG002|Overall Study|Protocol Violation|1|||
130680096|NCT03247556|470455893|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
130680097|NCT03247556|470455894|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
130680098|NCT03247556|470455895|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
130680099|NCT03952143|470455896|FG000|Lead-In Period|Adverse Event|2|||
130680100|NCT03952143|470455897|FG001|Lead-In Period|Adverse Event|0|||
130680101|NCT03952143|470455898|FG002|Lead-In Period|Adverse Event|0|||
130680102|NCT03952143|470455896|FG000|Lead-In Period|Lack of Efficacy|2|||
130680103|NCT03952143|470455897|FG001|Lead-In Period|Lack of Efficacy|0|||
130680104|NCT03952143|470455898|FG002|Lead-In Period|Lack of Efficacy|0|||
130680105|NCT03952143|470455896|FG000|Lead-In Period|Physician Decision|5|||
130680106|NCT03952143|470455897|FG001|Lead-In Period|Physician Decision|0|||
130680107|NCT03952143|470455898|FG002|Lead-In Period|Physician Decision|0|||
130680108|NCT03952143|470455896|FG000|Lead-In Period|Protocol Violation|5|||
130680109|NCT03952143|470455897|FG001|Lead-In Period|Protocol Violation|0|||
130680110|NCT03952143|470455898|FG002|Lead-In Period|Protocol Violation|0|||
130680111|NCT03952143|470455896|FG000|Lead-In Period|Withdrawal by Subject|19|||
130680112|NCT03952143|470455897|FG001|Lead-In Period|Withdrawal by Subject|0|||
130680113|NCT03952143|470455898|FG002|Lead-In Period|Withdrawal by Subject|0|||
130680114|NCT03952143|470455896|FG000|Treatment Period|Adverse Event|0|||
130680115|NCT03952143|470455897|FG001|Treatment Period|Adverse Event|0|||
130680116|NCT03952143|470455898|FG002|Treatment Period|Adverse Event|1|||
130680117|NCT03952143|470455896|FG000|Treatment Period|Lost to Follow-up|0|||
130680118|NCT03952143|470455897|FG001|Treatment Period|Lost to Follow-up|2|||
130680119|NCT03952143|470455898|FG002|Treatment Period|Lost to Follow-up|0|||
130680120|NCT03952143|470455896|FG000|Treatment Period|Physician Decision|0|||
130680121|NCT03952143|470455897|FG001|Treatment Period|Physician Decision|0|||
130680122|NCT03952143|470455898|FG002|Treatment Period|Physician Decision|2|||
130680123|NCT03952143|470455896|FG000|Treatment Period|Protocol Violation|0|||
130680124|NCT03952143|470455897|FG001|Treatment Period|Protocol Violation|0|||
130680125|NCT03952143|470455898|FG002|Treatment Period|Protocol Violation|1|||
130680126|NCT03952143|470455896|FG000|Treatment Period|Withdrawal by Subject|0|||
130680127|NCT03952143|470455897|FG001|Treatment Period|Withdrawal by Subject|5|||
130680128|NCT03952143|470455898|FG002|Treatment Period|Withdrawal by Subject|26|||
130680129|NCT03952143|470455896|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
130680130|NCT03952143|470455897|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
130680131|NCT03952143|470455898|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
130680132|NCT03952143|470455896|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
130680133|NCT03952143|470455897|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
130680134|NCT03952143|470455898|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
131016910|NCT04707313|471691585|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131016911|NCT04707313|471691586|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131016912|NCT04707313|471691587|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131016913|NCT04707313|471691588|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
131016914|NCT04707313|471691576|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131045807|NCT03582033|471802284|FG006|Part B|Withdrawal by Subject|0|||
130680135|NCT00760266|470455902|FG000|Overall Study|Adverse Event|13|||
130680136|NCT00760266|470455903|FG001|Overall Study|Adverse Event|7|||
130680137|NCT00760266|470455902|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130680138|NCT00760266|470455903|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130680139|NCT00760266|470455902|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130680140|NCT00760266|470455903|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130680141|NCT00760266|470455902|FG000|Overall Study|Lack of Efficacy|2|||
130680142|NCT00760266|470455903|FG001|Overall Study|Lack of Efficacy|2|||
130680143|NCT00760266|470455902|FG000|Overall Study|Protocol deviation|2|||
130680144|NCT00760266|470455903|FG001|Overall Study|Protocol deviation|4|||
130680145|NCT00760266|470455902|FG000|Overall Study|Patient withdrew consent|3|||
130680146|NCT00760266|470455903|FG001|Overall Study|Patient withdrew consent|3|||
130680147|NCT00760266|470455902|FG000|Overall Study|Lost to Follow-up|2|||
130680148|NCT00760266|470455903|FG001|Overall Study|Lost to Follow-up|1|||
130680149|NCT00760266|470455902|FG000|Overall Study|Administrative Problems|0|||
130680150|NCT00760266|470455903|FG001|Overall Study|Administrative Problems|1|||
130680151|NCT01273181|470455904|FG000|Phase I, Dose 1|Study termination|1|||
130680152|NCT01273181|470455905|FG001|Phase I, Dose 1|Study termination|0|||
130680153|NCT01273181|470455906|FG002|Phase I, Dose 1|Study termination|0|||
130680154|NCT01273181|470455907|FG003|Phase I, Dose 1|Study termination|0|||
130680155|NCT01273181|470455904|FG000|Phase I, Dose 2|Death during treatment|0|||
130680156|NCT01273181|470455905|FG001|Phase I, Dose 2|Death during treatment|1|||
130680157|NCT01273181|470455906|FG002|Phase I, Dose 2|Death during treatment|0|||
130680158|NCT01273181|470455907|FG003|Phase I, Dose 2|Death during treatment|0|||
130680159|NCT01273181|470455904|FG000|Phase 2, Dose 1|Study termination|0|||
130680160|NCT01273181|470455905|FG001|Phase 2, Dose 1|Study termination|0|||
130680161|NCT01273181|470455906|FG002|Phase 2, Dose 1|Study termination|1|||
130680162|NCT01273181|470455907|FG003|Phase 2, Dose 1|Study termination|0|||
130680163|NCT01273181|470455904|FG000|Phase 2, Dose 2|Death during treatment|0|||
130680164|NCT01273181|470455905|FG001|Phase 2, Dose 2|Death during treatment|0|||
130680165|NCT01273181|470455906|FG002|Phase 2, Dose 2|Death during treatment|0|||
130680166|NCT01273181|470455907|FG003|Phase 2, Dose 2|Death during treatment|1|||
130680167|NCT04638153|470455908|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130680168|NCT04638153|470455909|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130680169|NCT04638153|470455910|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130680170|NCT04638153|470455908|FG000|Overall Study|Study terminated by sponsor|4|||
130680171|NCT04638153|470455909|FG001|Overall Study|Study terminated by sponsor|2|||
130680172|NCT04638153|470455910|FG002|Overall Study|Study terminated by sponsor|14|||
130680173|NCT00874237|470455915|FG000|Overall Study|Physician Decision|0|||
130680174|NCT00874237|470455916|FG001|Overall Study|Physician Decision|1|||
130680175|NCT00874237|470455917|FG002|Overall Study|Physician Decision|0|||
130680176|NCT00874237|470455918|FG003|Overall Study|Physician Decision|0|||
130680177|NCT00874237|470455919|FG004|Overall Study|Physician Decision|0|||
130680178|NCT00874237|470455920|FG005|Overall Study|Physician Decision|0|||
130680179|NCT00874237|470455915|FG000|Overall Study|Withdrawal by Subject|0|||
130680180|NCT00874237|470455916|FG001|Overall Study|Withdrawal by Subject|0|||
130680181|NCT00874237|470455917|FG002|Overall Study|Withdrawal by Subject|1|||
130680182|NCT00874237|470455918|FG003|Overall Study|Withdrawal by Subject|0|||
130680183|NCT00874237|470455919|FG004|Overall Study|Withdrawal by Subject|0|||
131016915|NCT04707313|471691577|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131016916|NCT04707313|471691578|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131016917|NCT04707313|471691579|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131016918|NCT04707313|471691580|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131016919|NCT04707313|471691581|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131016920|NCT04707313|471691582|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131016921|NCT04707313|471691583|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131016922|NCT04707313|471691584|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131016923|NCT04707313|471691585|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
131016924|NCT04707313|471691586|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
131016925|NCT04707313|471691587|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
131016926|NCT04707313|471691588|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
131016927|NCT04707313|471691576|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131016928|NCT04707313|471691577|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131016929|NCT04707313|471691578|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131016930|NCT04707313|471691579|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131016931|NCT04707313|471691580|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131016932|NCT04707313|471691581|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131016933|NCT04707313|471691582|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131016934|NCT04707313|471691583|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131016935|NCT04707313|471691584|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131016936|NCT04707313|471691585|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
131016937|NCT04707313|471691586|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
131016938|NCT04707313|471691587|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
131016939|NCT04707313|471691588|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
131016940|NCT04707313|471691576|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131016941|NCT04707313|471691577|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131016942|NCT04707313|471691578|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131016943|NCT04707313|471691579|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131016944|NCT04707313|471691580|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131016945|NCT04707313|471691581|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131016946|NCT04707313|471691582|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131016947|NCT04707313|471691583|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131016948|NCT04707313|471691584|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
131016949|NCT04707313|471691585|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
131016950|NCT04707313|471691586|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
131045808|NCT03582033|471802285|FG007|Part B|Withdrawal by Subject|0|||
130680184|NCT00874237|470455920|FG005|Overall Study|Withdrawal by Subject|0|||
130680185|NCT03912337|470455921|FG000|Overall Study|Withdrawal of Consent From Study|1|||
130680186|NCT03912337|470455922|FG001|Overall Study|Withdrawal of Consent From Study|0|||
130680187|NCT03912337|470455921|FG000|Overall Study|Lost to Follow-up|1|||
130680188|NCT03912337|470455922|FG001|Overall Study|Lost to Follow-up|1|||
130680189|NCT03752528|470455923|FG000|Part A|Lost to Follow-up|1|||
130680190|NCT03752528|470455923|FG000|Part A|Protocol Violation|1|||
131103471|NCT00825825|472008010|FG002|First Medication Period (14 Days)|Adverse Event|0|||
131103472|NCT00825825|472008011|FG003|First Medication Period (14 Days)|Adverse Event|0|||
131103473|NCT00825825|472008012|FG004|First Medication Period (14 Days)|Adverse Event|0|||
131103474|NCT00825825|472008013|FG005|First Medication Period (14 Days)|Adverse Event|1|||
131103475|NCT00825825|472008008|FG000|First Medication Period (14 Days)|Physician Decision|2|||
131103476|NCT00825825|472008009|FG001|First Medication Period (14 Days)|Physician Decision|0|||
131103477|NCT00825825|472008010|FG002|First Medication Period (14 Days)|Physician Decision|1|||
131103478|NCT00825825|472008011|FG003|First Medication Period (14 Days)|Physician Decision|0|||
131103479|NCT00825825|472008012|FG004|First Medication Period (14 Days)|Physician Decision|0|||
131103480|NCT00825825|472008013|FG005|First Medication Period (14 Days)|Physician Decision|1|||
131103481|NCT00825825|472008008|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
131103482|NCT00825825|472008009|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
131103483|NCT00825825|472008010|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
131103484|NCT00825825|472008011|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
131103485|NCT00825825|472008012|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
131103486|NCT00825825|472008013|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
131103487|NCT00825825|472008008|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
131103488|NCT00825825|472008009|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
131103489|NCT00825825|472008010|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
131103490|NCT00825825|472008011|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
131103491|NCT00825825|472008012|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
131103492|NCT00825825|472008013|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
131103493|NCT00825825|472008008|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
131103494|NCT00825825|472008009|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
131103495|NCT00825825|472008010|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
131103496|NCT00825825|472008011|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
131103497|NCT00825825|472008012|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
131103498|NCT00825825|472008013|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
131103499|NCT00825825|472008008|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
131103500|NCT00825825|472008009|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
131103501|NCT00825825|472008010|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
131103502|NCT00825825|472008011|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
131103503|NCT00825825|472008012|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
130680191|NCT03752528|470455923|FG000|Part B|Protocol Violation|1|||
130680192|NCT03752528|470455923|FG000|Part B|Study terminated by sponsor|3|||
130680193|NCT00537030|470455924|FG000|Overall Study|Physician Decision|2|||
130680194|NCT00537030|470455924|FG000|Overall Study|Withdrawal by Subject|2|||
130680195|NCT00537030|470455924|FG000|Overall Study|≥ Grade 2 allergy|7|||
130680196|NCT00537030|470455924|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
130680197|NCT00537030|470455924|FG000|Overall Study|Ineligible|2|||
130680198|NCT00537030|470455924|FG000|Overall Study|Inevaluable|2|||
130680199|NCT02458469|470455925|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130680200|NCT02458469|470455926|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
131103504|NCT00825825|472008013|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
131103505|NCT00825825|472008008|FG000|Third Medication Period (14 Days)|poor data quality|0|||
131103506|NCT00825825|472008009|FG001|Third Medication Period (14 Days)|poor data quality|1|||
131103507|NCT00825825|472008010|FG002|Third Medication Period (14 Days)|poor data quality|0|||
131103508|NCT00825825|472008011|FG003|Third Medication Period (14 Days)|poor data quality|0|||
131103509|NCT00825825|472008012|FG004|Third Medication Period (14 Days)|poor data quality|0|||
131103510|NCT00825825|472008013|FG005|Third Medication Period (14 Days)|poor data quality|0|||
131103511|NCT01920854|472008015|FG000|Overall Study|Withdrawal by Subject|1|||
130680201|NCT02458469|470455927|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
130680202|NCT02458469|470455928|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130680203|NCT02458469|470455929|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130680204|NCT02458469|470455930|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130680205|NCT02458469|470455925|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
130680206|NCT02458469|470455926|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
130680207|NCT02458469|470455927|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
130680208|NCT02458469|470455928|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
131103512|NCT01920854|472008016|FG001|Overall Study|Withdrawal by Subject|0|||
131103513|NCT01920854|472008017|FG002|Overall Study|Withdrawal by Subject|0|||
131103514|NCT01920854|472008018|FG003|Overall Study|Withdrawal by Subject|0|||
130765940|NCT01253174|470765908|FG002|Period 2|Adverse Event|1|||
130680209|NCT02458469|470455929|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
130680210|NCT02458469|470455930|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
130680211|NCT02458469|470455925|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130680212|NCT02458469|470455926|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130680213|NCT02458469|470455927|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130680214|NCT02458469|470455928|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130680215|NCT02458469|470455929|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130680216|NCT02458469|470455930|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
130680217|NCT03561883|470455931|FG000|Overall Study|Adverse Event|10|||
130680218|NCT03561883|470455932|FG001|Overall Study|Adverse Event|13|||
130680219|NCT03561883|470455931|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130680220|NCT03561883|470455932|FG001|Overall Study|Non-Compliance With Study Drug|2|||
130680221|NCT03561883|470455931|FG000|Overall Study|Protocol Violation|2|||
130680222|NCT03561883|470455932|FG001|Overall Study|Protocol Violation|3|||
130680223|NCT03561883|470455931|FG000|Overall Study|Withdrawal by Subject|14|||
130680224|NCT03561883|470455932|FG001|Overall Study|Withdrawal by Subject|6|||
130680225|NCT03561883|470455931|FG000|Overall Study|Lost to Follow-up|2|||
130680226|NCT03561883|470455932|FG001|Overall Study|Lost to Follow-up|6|||
130680227|NCT03561883|470455931|FG000|Overall Study|Study Terminated by Sponsor|12|||
130680228|NCT03561883|470455932|FG001|Overall Study|Study Terminated by Sponsor|11|||
130680229|NCT03561883|470455931|FG000|Overall Study|Physician Decision|1|||
131016951|NCT04707313|471691587|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
131016952|NCT04707313|471691588|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
131016953|NCT04707313|471691576|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016954|NCT04707313|471691577|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016955|NCT04707313|471691578|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016956|NCT04707313|471691579|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016957|NCT04707313|471691580|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016958|NCT04707313|471691581|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016959|NCT04707313|471691582|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016960|NCT04707313|471691583|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016961|NCT04707313|471691584|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016962|NCT04707313|471691585|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016963|NCT04707313|471691586|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
131016964|NCT04707313|471691587|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
131016965|NCT04707313|471691588|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
131016966|NCT04707313|471691576|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016967|NCT04707313|471691577|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016968|NCT04707313|471691578|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016969|NCT04707313|471691579|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016970|NCT04707313|471691580|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016971|NCT04707313|471691581|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016972|NCT04707313|471691582|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016973|NCT04707313|471691583|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016974|NCT04707313|471691584|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016975|NCT04707313|471691585|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
131016976|NCT04707313|471691586|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
131016977|NCT04707313|471691587|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016978|NCT04707313|471691588|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
131016979|NCT04707313|471691576|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131016980|NCT04707313|471691577|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131016981|NCT04707313|471691578|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131016982|NCT04707313|471691579|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131016983|NCT04707313|471691580|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131016984|NCT04707313|471691581|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131016985|NCT04707313|471691582|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131016986|NCT04707313|471691583|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131016987|NCT04707313|471691584|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
131016988|NCT04707313|471691585|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
131016989|NCT04707313|471691586|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
131016990|NCT04707313|471691587|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
131016991|NCT04707313|471691588|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
131016992|NCT00324038|471691592|FG000|Overall Study|Adverse Event|38|||
131016993|NCT00324038|471691593|FG001|Overall Study|Adverse Event|23|||
131016994|NCT00324038|471691592|FG000|Overall Study|Lack of Efficacy|5|||
131016995|NCT00324038|471691593|FG001|Overall Study|Lack of Efficacy|13|||
130680230|NCT03561883|470455932|FG001|Overall Study|Physician Decision|0|||
131016996|NCT00324038|471691592|FG000|Overall Study|Lost to Follow-up|0|||
131016997|NCT00324038|471691593|FG001|Overall Study|Lost to Follow-up|2|||
130680231|NCT03561883|470455931|FG000|Overall Study|Randomized by Mistake|1|||
130680232|NCT03561883|470455932|FG001|Overall Study|Randomized by Mistake|0|||
130680233|NCT03561883|470455931|FG000|Overall Study|Other, Not Specified|3|||
130680234|NCT03561883|470455932|FG001|Overall Study|Other, Not Specified|2|||
130680235|NCT06354270|470455933|FG000|Overall Study|Withdrawal by Subject|1|||
130680236|NCT06354270|470455934|FG001|Overall Study|Withdrawal by Subject|0|||
130680237|NCT01939197|470455935|FG000|Overall Study|Withdrawal by Subject|1|||
130680238|NCT01939197|470455936|FG001|Overall Study|Withdrawal by Subject|0|||
130680239|NCT01939197|470455937|FG002|Overall Study|Withdrawal by Subject|0|||
130680240|NCT01939197|470455938|FG003|Overall Study|Withdrawal by Subject|0|||
130680241|NCT01939197|470455939|FG004|Overall Study|Withdrawal by Subject|1|||
130680242|NCT01939197|470455940|FG005|Overall Study|Withdrawal by Subject|0|||
130680243|NCT01939197|470455941|FG006|Overall Study|Withdrawal by Subject|0|||
130680244|NCT01939197|470455935|FG000|Overall Study|Lost to Follow-up|0|||
130680245|NCT01939197|470455936|FG001|Overall Study|Lost to Follow-up|1|||
130680246|NCT01939197|470455937|FG002|Overall Study|Lost to Follow-up|0|||
130680247|NCT01939197|470455938|FG003|Overall Study|Lost to Follow-up|1|||
130680248|NCT01939197|470455939|FG004|Overall Study|Lost to Follow-up|3|||
130680249|NCT01939197|470455940|FG005|Overall Study|Lost to Follow-up|1|||
130680250|NCT01939197|470455941|FG006|Overall Study|Lost to Follow-up|2|||
130680251|NCT00745095|470455942|FG000|Overall Study|Declined to participate|1|||
130680252|NCT00745095|470455943|FG001|Overall Study|Declined to participate|0|||
130680253|NCT00745095|470455944|FG002|Overall Study|Declined to participate|0|||
130680254|NCT00745095|470455945|FG003|Overall Study|Declined to participate|0|||
130680255|NCT00745095|470455946|FG004|Overall Study|Declined to participate|92|||
130680256|NCT00745095|470455947|FG005|Overall Study|Declined to participate|95|||
130680257|NCT00745095|470455942|FG000|Overall Study|Ineligible due to GFR criteria|0|||
130680258|NCT00745095|470455943|FG001|Overall Study|Ineligible due to GFR criteria|2|||
130680259|NCT00745095|470455944|FG002|Overall Study|Ineligible due to GFR criteria|3|||
130680260|NCT00745095|470455945|FG003|Overall Study|Ineligible due to GFR criteria|3|||
130680261|NCT00745095|470455946|FG004|Overall Study|Ineligible due to GFR criteria|30|||
130680262|NCT00745095|470455947|FG005|Overall Study|Ineligible due to GFR criteria|28|||
130680263|NCT00958243|470455948|FG000|Overall Study|Withdrawal by Subject|0|||
130680264|NCT00958243|470455949|FG001|Overall Study|Withdrawal by Subject|1|||
130680265|NCT00958243|470455950|FG002|Overall Study|Withdrawal by Subject|3|||
130680266|NCT00958243|470455951|FG003|Overall Study|Withdrawal by Subject|1|||
130680267|NCT00958243|470455952|FG004|Overall Study|Withdrawal by Subject|1|||
130680268|NCT00958243|470455953|FG005|Overall Study|Withdrawal by Subject|5|||
130680269|NCT00958243|470455948|FG000|Overall Study|Lost to Follow-up|2|||
130680270|NCT00958243|470455949|FG001|Overall Study|Lost to Follow-up|5|||
130680271|NCT00958243|470455950|FG002|Overall Study|Lost to Follow-up|11|||
130680272|NCT00958243|470455951|FG003|Overall Study|Lost to Follow-up|2|||
130680273|NCT00958243|470455952|FG004|Overall Study|Lost to Follow-up|8|||
130680274|NCT00958243|470455953|FG005|Overall Study|Lost to Follow-up|5|||
130680275|NCT05277389|470455962|FG000|Overall Study|Lost to Follow-up|1|||
130680276|NCT05277389|470455963|FG001|Overall Study|Lost to Follow-up|4|||
130680277|NCT06096168|470455964|FG000|Overall Study|Death|30|||
130680278|NCT06096168|470455964|FG000|Overall Study|Revision|2|||
130680279|NCT03544138|470455967|FG000|Overall Study|Lost to Follow-up|29|||
130680280|NCT01766778|470455968|FG000|Overall Study|Adverse Event|4|||
130680281|NCT01766778|470455969|FG001|Overall Study|Adverse Event|4|||
130680282|NCT01766778|470455968|FG000|Overall Study|Withdrawal by Subject|1|||
130680283|NCT01766778|470455969|FG001|Overall Study|Withdrawal by Subject|0|||
130680284|NCT01478620|470455970|FG000|Overall Study|Lost to Follow-up|6|||
130680285|NCT01411332|470455973|FG000|Enrollment|Protocol Violation|0|||
130680286|NCT01411332|470455974|FG001|Enrollment|Protocol Violation|1|||
130680287|NCT01411332|470455973|FG000|Enrollment|Withdrawal by Subject|0|||
130680288|NCT01411332|470455974|FG001|Enrollment|Withdrawal by Subject|1|||
130680289|NCT01411332|470455973|FG000|Treatment|Lost to Follow-up|1|||
130680290|NCT01411332|470455974|FG001|Treatment|Lost to Follow-up|0|||
130680291|NCT04526210|470457204|FG000|Overall Study|Sponsor decision|7|||
130680292|NCT04526210|470457205|FG001|Overall Study|Sponsor decision|5|||
130680293|NCT04526210|470457204|FG000|Overall Study|Withdrawal by Subject|3|||
130680294|NCT04526210|470457205|FG001|Overall Study|Withdrawal by Subject|2|||
130680295|NCT02637232|470457206|FG000|Overall Study|Lost to Follow-up|42|||
130680296|NCT02637232|470457206|FG000|Overall Study|Adverse Event|11|||
130680297|NCT02637232|470457206|FG000|Overall Study|patient 's decision|2|||
130680298|NCT01781637|470457207|FG000|Overall Study|Adverse Event|1|||
130680299|NCT01781637|470457208|FG001|Overall Study|Adverse Event|0|||
130680300|NCT01781637|470457207|FG000|Overall Study|Lack of Efficacy|2|||
130680301|NCT01781637|470457208|FG001|Overall Study|Lack of Efficacy|6|||
130680302|NCT01781637|470457207|FG000|Overall Study|Withdrawal by Subject|1|||
130680303|NCT01781637|470457208|FG001|Overall Study|Withdrawal by Subject|0|||
130680304|NCT00090857|470457209|FG000|Overall Study|Lost to Follow-up|0|||
130680305|NCT00090857|470457210|FG001|Overall Study|Lost to Follow-up|1|||
130680306|NCT00090857|470457209|FG000|Overall Study|Withdrawal by Subject|2|||
130680307|NCT00090857|470457210|FG001|Overall Study|Withdrawal by Subject|0|||
130680308|NCT00090857|470457209|FG000|Overall Study|Adverse Event|2|||
130680309|NCT00090857|470457210|FG001|Overall Study|Adverse Event|2|||
130680310|NCT05097326|470457212|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
130765941|NCT01253174|470765909|FG003|Period 2|Adverse Event|0|||
130680311|NCT05097326|470457213|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
131016998|NCT00324038|471691592|FG000|Overall Study|Other|6|||
131016999|NCT00324038|471691593|FG001|Overall Study|Other|13|||
131017000|NCT03070483|471691594|FG000|Overall Study|Lost to Follow-up|2|||
131017001|NCT01585558|471691596|FG000|Overall Study|Withdrawal by Subject|4|||
131017002|NCT01585558|471691597|FG001|Overall Study|Withdrawal by Subject|5|||
131017003|NCT01585558|471691598|FG002|Overall Study|Withdrawal by Subject|8|||
131017004|NCT01585558|471691596|FG000|Overall Study|Lost to Follow-up|2|||
131017005|NCT01585558|471691597|FG001|Overall Study|Lost to Follow-up|0|||
131017006|NCT01585558|471691598|FG002|Overall Study|Lost to Follow-up|3|||
131017007|NCT01585558|471691596|FG000|Overall Study|Adverse Event|3|||
131017008|NCT01585558|471691597|FG001|Overall Study|Adverse Event|4|||
131017009|NCT01585558|471691598|FG002|Overall Study|Adverse Event|1|||
131017010|NCT01585558|471691596|FG000|Overall Study|Protocol Violation|4|||
131017011|NCT01585558|471691597|FG001|Overall Study|Protocol Violation|3|||
131017012|NCT01585558|471691598|FG002|Overall Study|Protocol Violation|2|||
131017013|NCT01585558|471691596|FG000|Overall Study|Lack of Efficacy|0|||
131017014|NCT01585558|471691597|FG001|Overall Study|Lack of Efficacy|0|||
131017015|NCT01585558|471691598|FG002|Overall Study|Lack of Efficacy|1|||
131017016|NCT00841035|471691599|FG000|Phase 1 Overall Study|Physician Decision|13|||
131017017|NCT01390402|471691604|FG000|Overall Study|Death|1|||
131017018|NCT01390402|471691604|FG000|Overall Study|Disease Progression|4|||
131017019|NCT01266265|471693670|FG000|Overall Study|Death|95|||
131017020|NCT01266265|471693671|FG001|Overall Study|Death|73|||
131017021|NCT01266265|471693670|FG000|Overall Study|Lost to Follow-up|23|||
131017022|NCT01266265|471693671|FG001|Overall Study|Lost to Follow-up|28|||
131017023|NCT01266265|471693670|FG000|Overall Study|Withdrawal by Subject|13|||
131017024|NCT01266265|471693671|FG001|Overall Study|Withdrawal by Subject|11|||
131017025|NCT01266265|471693670|FG000|Overall Study|Respiratory-related adverse event|2|||
131017026|NCT01266265|471693671|FG001|Overall Study|Respiratory-related adverse event|1|||
131017027|NCT01266265|471693670|FG000|Overall Study|Transferred care to another provider|22|||
131017028|NCT01266265|471693671|FG001|Overall Study|Transferred care to another provider|28|||
131017029|NCT01266265|471693670|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
131017030|NCT01266265|471693671|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
131017031|NCT01266265|471693670|FG000|Overall Study|Enrolled in another clinical study|15|||
131017032|NCT01266265|471693671|FG001|Overall Study|Enrolled in another clinical study|26|||
131017033|NCT01266265|471693670|FG000|Overall Study|Non-compliance|8|||
131017034|NCT01266265|471693671|FG001|Overall Study|Non-compliance|5|||
131017035|NCT01266265|471693670|FG000|Overall Study|Lung transplant|6|||
131017036|NCT01266265|471693671|FG001|Overall Study|Lung transplant|5|||
131017037|NCT01266265|471693670|FG000|Overall Study|Site closed early|4|||
131017038|NCT01266265|471693671|FG001|Overall Study|Site closed early|3|||
131017039|NCT01266265|471693670|FG000|Overall Study|Clinical worsening|1|||
130680312|NCT02684344|470457215|FG000|Overall Study|Withdrawal by Subject|0|||
131017040|NCT01266265|471693671|FG001|Overall Study|Clinical worsening|1|||
131017041|NCT01580293|471693672|FG000|Part A_Main Trial|Adverse Event|0|||
131017042|NCT01580293|471693673|FG001|Part A_Main Trial|Adverse Event|2|||
131017043|NCT01580293|471693674|FG002|Part A_Main Trial|Adverse Event|0|||
130680313|NCT02684344|470457216|FG001|Overall Study|Withdrawal by Subject|1|||
131017044|NCT01580293|471693672|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
131017045|NCT01580293|471693673|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
131017046|NCT01580293|471693674|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
131045809|NCT03582033|471802286|FG008|Part B|Withdrawal by Subject|0|||
131045810|NCT03582033|471802287|FG009|Part B|Withdrawal by Subject|0|||
131045811|NCT03582033|471802278|FG000|Part C|Other|0|||
131045812|NCT03582033|471802279|FG001|Part C|Other|0|||
131045813|NCT03582033|471802280|FG002|Part C|Other|0|||
131045814|NCT03582033|471802281|FG003|Part C|Other|0|||
131045815|NCT03582033|471802282|FG004|Part C|Other|0|||
131045816|NCT03582033|471802283|FG005|Part C|Other|0|||
131045817|NCT03582033|471802284|FG006|Part C|Other|2|||
131045818|NCT03582033|471802285|FG007|Part C|Other|0|||
131045819|NCT03582033|471802286|FG008|Part C|Other|0|||
131045820|NCT03582033|471802287|FG009|Part C|Other|0|||
131045821|NCT03582033|471802278|FG000|Part C|Death|0|||
131045822|NCT03582033|471802279|FG001|Part C|Death|0|||
131045823|NCT03582033|471802280|FG002|Part C|Death|0|||
131045824|NCT03582033|471802281|FG003|Part C|Death|0|||
131045825|NCT03582033|471802282|FG004|Part C|Death|0|||
131045826|NCT03582033|471802283|FG005|Part C|Death|0|||
131045827|NCT03582033|471802284|FG006|Part C|Death|6|||
131045828|NCT03582033|471802285|FG007|Part C|Death|1|||
131045829|NCT03582033|471802286|FG008|Part C|Death|2|||
131045830|NCT03582033|471802287|FG009|Part C|Death|0|||
131045831|NCT03582033|471802278|FG000|Part C|Study terminated by sponsor|0|||
131045832|NCT03582033|471802279|FG001|Part C|Study terminated by sponsor|0|||
131045833|NCT03582033|471802280|FG002|Part C|Study terminated by sponsor|0|||
131045834|NCT03582033|471802281|FG003|Part C|Study terminated by sponsor|0|||
131045835|NCT03582033|471802282|FG004|Part C|Study terminated by sponsor|0|||
131045836|NCT03582033|471802283|FG005|Part C|Study terminated by sponsor|0|||
130680314|NCT00560235|470457221|FG000|Phase 1|Discontinued|8|||
130680315|NCT00560235|470457222|FG001|Phase 1|Discontinued|0|||
130680316|NCT00560235|470457223|FG002|Phase 1|Discontinued|0|||
130680317|NCT00560235|470457221|FG000|Phase 1B|Discontinued|0|||
130680318|NCT00560235|470457222|FG001|Phase 1B|Discontinued|19|||
130680319|NCT00560235|470457223|FG002|Phase 1B|Discontinued|0|||
130680320|NCT00560235|470457221|FG000|Phase 2|Discontinued|0|||
130680321|NCT00560235|470457222|FG001|Phase 2|Discontinued|0|||
130680322|NCT00560235|470457223|FG002|Phase 2|Discontinued|96|||
130680323|NCT00560235|470457221|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
130680324|NCT00560235|470457222|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
130680325|NCT00560235|470457223|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
130680326|NCT01203878|470457227|FG000|Overall Study|Withdrawal by Subject|0|||
130680327|NCT01203878|470457228|FG001|Overall Study|Withdrawal by Subject|0|||
130680328|NCT01203878|470457229|FG002|Overall Study|Withdrawal by Subject|1|||
130680329|NCT01203878|470457227|FG000|Overall Study|Adverse Event|0|||
130680330|NCT01203878|470457228|FG001|Overall Study|Adverse Event|0|||
130680331|NCT01203878|470457229|FG002|Overall Study|Adverse Event|2|||
130680332|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
130680333|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
130680334|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
130680335|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
130680336|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
130680337|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
130680338|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
130680339|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
130680340|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
130680341|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
130680342|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
130680343|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
130680344|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
130680345|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
130680346|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
130680347|NCT00437658|470457230|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
130680348|NCT00437658|470457231|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
130680349|NCT00437658|470457232|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
130680350|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
130680351|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
130680352|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
130680353|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
130680354|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
130680355|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
130680356|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
130680357|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
130680358|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
130680359|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
130680360|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
130680361|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
130680362|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
130680363|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
130680364|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
130680365|NCT00437658|470457230|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
130680366|NCT00437658|470457231|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
130680367|NCT00437658|470457232|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
130680368|NCT04407806|470457233|FG000|Overall Study|Withdrawal by Subject|1|||
130680369|NCT04407806|470457234|FG001|Overall Study|Withdrawal by Subject|2|||
130680370|NCT02731157|470457235|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
130680371|NCT05150964|470457238|FG000|Overall Study|Lost to Follow-up|2|||
130680372|NCT01856309|470457239|FG000|Overall Study|Death|4|||
130680373|NCT01856309|470457240|FG001|Overall Study|Death|6|||
130680374|NCT01856309|470457241|FG002|Overall Study|Death|11|||
130680375|NCT01856309|470457242|FG003|Overall Study|Death|6|||
130680376|NCT01856309|470457239|FG000|Overall Study|Lost to Follow-up|6|||
130680377|NCT01856309|470457240|FG001|Overall Study|Lost to Follow-up|2|||
130680378|NCT01856309|470457241|FG002|Overall Study|Lost to Follow-up|4|||
130680379|NCT01856309|470457242|FG003|Overall Study|Lost to Follow-up|8|||
130680380|NCT01856309|470457239|FG000|Overall Study|Withdrawal by Subject|11|||
130680381|NCT01856309|470457240|FG001|Overall Study|Withdrawal by Subject|13|||
130680382|NCT01856309|470457241|FG002|Overall Study|Withdrawal by Subject|28|||
130680383|NCT01856309|470457242|FG003|Overall Study|Withdrawal by Subject|26|||
130680384|NCT01856309|470457239|FG000|Overall Study|Other|227|||
130680385|NCT01856309|470457240|FG001|Overall Study|Other|225|||
130680386|NCT01856309|470457241|FG002|Overall Study|Other|447|||
130680387|NCT01856309|470457242|FG003|Overall Study|Other|469|||
130680388|NCT01856309|470457239|FG000|Overall Study|Lack of Efficacy|14|||
130680389|NCT01856309|470457240|FG001|Overall Study|Lack of Efficacy|9|||
130680390|NCT01856309|470457241|FG002|Overall Study|Lack of Efficacy|40|||
130680391|NCT01856309|470457242|FG003|Overall Study|Lack of Efficacy|25|||
130680392|NCT01856309|470457239|FG000|Overall Study|Adverse Event|31|||
130680393|NCT01856309|470457240|FG001|Overall Study|Adverse Event|31|||
130680394|NCT01856309|470457241|FG002|Overall Study|Adverse Event|55|||
130680395|NCT01856309|470457242|FG003|Overall Study|Adverse Event|65|||
130680396|NCT01856309|470457239|FG000|Overall Study|Pregnancy|0|||
130680397|NCT01856309|470457240|FG001|Overall Study|Pregnancy|0|||
130680398|NCT01856309|470457241|FG002|Overall Study|Pregnancy|0|||
130680399|NCT01856309|470457242|FG003|Overall Study|Pregnancy|1|||
130680400|NCT01856309|470457239|FG000|Overall Study|Physician Decision|6|||
130680401|NCT01856309|470457240|FG001|Overall Study|Physician Decision|1|||
130680402|NCT01856309|470457241|FG002|Overall Study|Physician Decision|6|||
130680403|NCT01856309|470457242|FG003|Overall Study|Physician Decision|8|||
130680404|NCT01856309|470457239|FG000|Overall Study|Noncompliance With Study Drug|0|||
130680405|NCT01856309|470457240|FG001|Overall Study|Noncompliance With Study Drug|1|||
130680406|NCT01856309|470457241|FG002|Overall Study|Noncompliance With Study Drug|4|||
130680407|NCT01856309|470457242|FG003|Overall Study|Noncompliance With Study Drug|1|||
130680408|NCT03657160|470457243|FG000|Overall Study|Adverse Event|5|||
130680409|NCT03657160|470457244|FG001|Overall Study|Adverse Event|6|||
131103515|NCT01920854|472008019|FG004|Overall Study|Withdrawal by Subject|1|||
131103516|NCT01920854|472008020|FG005|Overall Study|Withdrawal by Subject|0|||
131103517|NCT01920854|472008021|FG006|Overall Study|Withdrawal by Subject|1|||
131103518|NCT00757783|472008022|FG000|Overall Study|Adverse Event|0|||
131103519|NCT00757783|472008023|FG001|Overall Study|Adverse Event|2|||
130680410|NCT03657160|470457243|FG000|Overall Study|Protocol Deviation|3|||
130680411|NCT03657160|470457244|FG001|Overall Study|Protocol Deviation|0|||
131103520|NCT00757783|472008022|FG000|Overall Study|Lost to Follow-up|1|||
131103521|NCT00757783|472008023|FG001|Overall Study|Lost to Follow-up|1|||
131103522|NCT00757783|472008022|FG000|Overall Study|Protocol Violation|1|||
131103523|NCT00757783|472008023|FG001|Overall Study|Protocol Violation|0|||
130680412|NCT03657160|470457243|FG000|Overall Study|Withdrawal by Subject|18|||
131103524|NCT00757783|472008022|FG000|Overall Study|Withdrawal by Subject|2|||
131103525|NCT00757783|472008023|FG001|Overall Study|Withdrawal by Subject|1|||
131103526|NCT00757783|472008022|FG000|Overall Study|Other|1|||
131103527|NCT00757783|472008023|FG001|Overall Study|Other|2|||
131103528|NCT02008877|472008029|FG000|Overall Study|Inevaluable|0|||
131103529|NCT02008877|472008030|FG001|Overall Study|Inevaluable|1|||
131103530|NCT02008877|472008031|FG002|Overall Study|Inevaluable|0|||
131103531|NCT01049217|472008032|FG000|Overall Study|Adverse Event|2|||
131103532|NCT01049217|472008033|FG001|Overall Study|Adverse Event|1|||
131103533|NCT01049217|472008032|FG000|Overall Study|Lack of Efficacy|1|||
131103534|NCT01049217|472008033|FG001|Overall Study|Lack of Efficacy|1|||
131103535|NCT01049217|472008032|FG000|Overall Study|Lost to Follow-up|3|||
131103536|NCT01049217|472008033|FG001|Overall Study|Lost to Follow-up|8|||
130680413|NCT03657160|470457244|FG001|Overall Study|Withdrawal by Subject|16|||
130680414|NCT03657160|470457243|FG000|Overall Study|Site Termination|1|||
130680415|NCT03657160|470457244|FG001|Overall Study|Site Termination|0|||
130680416|NCT03657160|470457243|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
130680417|NCT03657160|470457244|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
131103537|NCT01049217|472008032|FG000|Overall Study|Withdrawal by Subject|4|||
131103538|NCT01049217|472008033|FG001|Overall Study|Withdrawal by Subject|3|||
131103539|NCT01049217|472008032|FG000|Overall Study|Protocol Violation|1|||
131103540|NCT01049217|472008033|FG001|Overall Study|Protocol Violation|3|||
131103541|NCT01049217|472008032|FG000|Overall Study|Pregnancy|1|||
130680418|NCT03657160|470457243|FG000|Overall Study|Death|33|||
130680419|NCT03657160|470457244|FG001|Overall Study|Death|26|||
130680420|NCT03657160|470457243|FG000|Overall Study|Death (COVID-19-Related)|1|||
130680421|NCT03657160|470457244|FG001|Overall Study|Death (COVID-19-Related)|0|||
130680422|NCT03657160|470457243|FG000|Overall Study|Reason Not Specified|5|||
130680423|NCT03657160|470457244|FG001|Overall Study|Reason Not Specified|5|||
130680424|NCT03657160|470457243|FG000|Overall Study|Other (COVID-19-Related)|0|||
131103542|NCT01049217|472008033|FG001|Overall Study|Pregnancy|0|||
131103543|NCT01049217|472008032|FG000|Overall Study|Study Terminated by Sponsor|43|||
131103544|NCT01049217|472008033|FG001|Overall Study|Study Terminated by Sponsor|43|||
131103545|NCT01049217|472008032|FG000|Overall Study|Other|1|||
131103546|NCT01049217|472008033|FG001|Overall Study|Other|2|||
131103547|NCT01049217|472008032|FG000|Overall Study|Randomized but not Treated|0|||
131103548|NCT01049217|472008033|FG001|Overall Study|Randomized but not Treated|2|||
130680425|NCT03657160|470457244|FG001|Overall Study|Other (COVID-19-Related)|1|||
130680426|NCT01434693|470457247|FG000|Overall Study|Adverse Event|1|||
130680427|NCT01434693|470457248|FG001|Overall Study|Adverse Event|0|||
130680428|NCT01434693|470457249|FG002|Overall Study|Adverse Event|0|||
130680429|NCT01434693|470457250|FG003|Overall Study|Adverse Event|0|||
130680430|NCT01434693|470457247|FG000|Overall Study|Withdrawal by Subject|1|||
130680431|NCT01434693|470457248|FG001|Overall Study|Withdrawal by Subject|0|||
131103549|NCT02412371|472008034|FG000|Overall Study|Withdrawal by Subject|0|||
131103550|NCT02412371|472008035|FG001|Overall Study|Withdrawal by Subject|2|||
131103551|NCT02412371|472008036|FG002|Overall Study|Withdrawal by Subject|0|||
130680432|NCT01434693|470457249|FG002|Overall Study|Withdrawal by Subject|1|||
130680433|NCT01434693|470457250|FG003|Overall Study|Withdrawal by Subject|1|||
130680434|NCT01434693|470457247|FG000|Overall Study|Lost to Follow-up|1|||
130680435|NCT01434693|470457248|FG001|Overall Study|Lost to Follow-up|0|||
130680436|NCT01434693|470457249|FG002|Overall Study|Lost to Follow-up|0|||
130680437|NCT01434693|470457250|FG003|Overall Study|Lost to Follow-up|0|||
130680438|NCT04006171|470457251|FG000|Overall Study|Withdrawal by Subject|8|||
130680439|NCT04006171|470457252|FG001|Overall Study|Withdrawal by Subject|7|||
130680440|NCT04006171|470457251|FG000|Overall Study|missing serum samples|2|||
130680441|NCT04006171|470457252|FG001|Overall Study|missing serum samples|2|||
130680442|NCT04006171|470457251|FG000|Overall Study|insufficient sample volume|2|||
130680443|NCT04006171|470457252|FG001|Overall Study|insufficient sample volume|3|||
130680444|NCT01440283|470457253|FG000|Overall Study|Death|3|||
130680445|NCT01440283|470457253|FG000|Overall Study|Withdrawal by Subject|4|||
130680446|NCT01440283|470457253|FG000|Overall Study|Physician Decision|3|||
130680447|NCT00440557|470457255|FG000|Overall Study|Withdrawal by Subject|10|||
130680448|NCT00440557|470457256|FG001|Overall Study|Withdrawal by Subject|5|||
130680449|NCT00440557|470457257|FG002|Overall Study|Withdrawal by Subject|11|||
130680450|NCT00440557|470457255|FG000|Overall Study|Lost to Follow-up|1|||
130680451|NCT00440557|470457256|FG001|Overall Study|Lost to Follow-up|2|||
130680452|NCT00440557|470457257|FG002|Overall Study|Lost to Follow-up|6|||
130680453|NCT00440557|470457255|FG000|Overall Study|Adverse Event|3|||
130680454|NCT00440557|470457256|FG001|Overall Study|Adverse Event|3|||
130680455|NCT00440557|470457257|FG002|Overall Study|Adverse Event|5|||
130680456|NCT00440557|470457255|FG000|Overall Study|Death|2|||
130680457|NCT00440557|470457256|FG001|Overall Study|Death|6|||
130680458|NCT00440557|470457257|FG002|Overall Study|Death|3|||
131103552|NCT02412371|472008037|FG003|Overall Study|Withdrawal by Subject|1|||
131103553|NCT02412371|472008038|FG004|Overall Study|Withdrawal by Subject|1|||
131103554|NCT02412371|472008039|FG005|Overall Study|Withdrawal by Subject|0|||
131103555|NCT02412371|472008034|FG000|Overall Study|Sponsor Discontinued Study|1|||
131103556|NCT02412371|472008035|FG001|Overall Study|Sponsor Discontinued Study|4|||
131103557|NCT02412371|472008036|FG002|Overall Study|Sponsor Discontinued Study|6|||
131103558|NCT02412371|472008037|FG003|Overall Study|Sponsor Discontinued Study|4|||
131103559|NCT02412371|472008038|FG004|Overall Study|Sponsor Discontinued Study|5|||
131103560|NCT02412371|472008039|FG005|Overall Study|Sponsor Discontinued Study|0|||
131103561|NCT02412371|472008034|FG000|Overall Study|Death|4|||
131103562|NCT02412371|472008035|FG001|Overall Study|Death|2|||
131103563|NCT02412371|472008036|FG002|Overall Study|Death|1|||
131103564|NCT02412371|472008037|FG003|Overall Study|Death|3|||
131103565|NCT02412371|472008038|FG004|Overall Study|Death|5|||
131103566|NCT02412371|472008039|FG005|Overall Study|Death|2|||
131103567|NCT02412371|472008034|FG000|Overall Study|Other|2|||
131103568|NCT02412371|472008035|FG001|Overall Study|Other|1|||
131103569|NCT02412371|472008036|FG002|Overall Study|Other|0|||
131103570|NCT02412371|472008037|FG003|Overall Study|Other|0|||
131103571|NCT02412371|472008038|FG004|Overall Study|Other|1|||
131103572|NCT02412371|472008039|FG005|Overall Study|Other|3|||
131103573|NCT02495792|472008040|FG000|Overall Study|Lost to Follow-up|5|||
131103574|NCT02495792|472008041|FG001|Overall Study|Lost to Follow-up|9|||
131103575|NCT02495792|472008040|FG000|Overall Study|Protocol Violation|32|||
131103576|NCT02495792|472008041|FG001|Overall Study|Protocol Violation|31|||
131103577|NCT02053792|472008042|FG000|Overall Study|Physician Decision|0|||
131103578|NCT02053792|472008043|FG001|Overall Study|Physician Decision|1|||
131103579|NCT02053792|472008042|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
131103580|NCT02053792|472008043|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
131103581|NCT02053792|472008042|FG000|Overall Study|Lack of Efficacy|1|||
131103582|NCT02053792|472008043|FG001|Overall Study|Lack of Efficacy|0|||
131103583|NCT02053792|472008042|FG000|Overall Study|Adverse Event|1|||
131103584|NCT02053792|472008043|FG001|Overall Study|Adverse Event|0|||
131103585|NCT02053792|472008042|FG000|Overall Study|Withdrawal by Subject|2|||
131103586|NCT02053792|472008043|FG001|Overall Study|Withdrawal by Subject|2|||
131103587|NCT02053792|472008042|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
131103588|NCT02053792|472008043|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
130680459|NCT00440557|470457255|FG000|Overall Study|Began Dialysis|4|||
130680460|NCT00440557|470457256|FG001|Overall Study|Began Dialysis|1|||
130680461|NCT00440557|470457257|FG002|Overall Study|Began Dialysis|4|||
130680462|NCT00440557|470457255|FG000|Overall Study|Principal Investigator decision|0|||
130680463|NCT00440557|470457256|FG001|Overall Study|Principal Investigator decision|3|||
130680464|NCT00440557|470457257|FG002|Overall Study|Principal Investigator decision|1|||
130680465|NCT00440557|470457255|FG000|Overall Study|Patient moved|1|||
130680466|NCT00440557|470457256|FG001|Overall Study|Patient moved|2|||
130680467|NCT00440557|470457257|FG002|Overall Study|Patient moved|1|||
130680468|NCT00440557|470457255|FG000|Overall Study|Principal Investigator's office closed|3|||
130680469|NCT00440557|470457256|FG001|Overall Study|Principal Investigator's office closed|6|||
131103589|NCT02053792|472008042|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
131103590|NCT02053792|472008043|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
131017047|NCT01580293|471693672|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
131017048|NCT01580293|471693673|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
131017049|NCT01580293|471693674|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
131017050|NCT01580293|471693672|FG000|Part A_Extension|Adverse Event|0|||
131017051|NCT01580293|471693673|FG001|Part A_Extension|Adverse Event|2|||
131017052|NCT01580293|471693674|FG002|Part A_Extension|Adverse Event|0|||
131017053|NCT01580293|471693672|FG000|Part A_Extension|Withdrawal by Subject|0|||
131017054|NCT01580293|471693673|FG001|Part A_Extension|Withdrawal by Subject|3|||
131017055|NCT01580293|471693674|FG002|Part A_Extension|Withdrawal by Subject|0|||
131017056|NCT01580293|471693672|FG000|Part A_Extension|Lost to Follow-up|0|||
131017057|NCT01580293|471693673|FG001|Part A_Extension|Lost to Follow-up|1|||
131017058|NCT01580293|471693674|FG002|Part A_Extension|Lost to Follow-up|0|||
131017059|NCT01580293|471693672|FG000|Part A_Extension|Other Reason|0|||
131017060|NCT01580293|471693673|FG001|Part A_Extension|Other Reason|1|||
131017061|NCT01580293|471693674|FG002|Part A_Extension|Other Reason|0|||
131017062|NCT01580293|471693672|FG000|Part A_Extension|Completed Japan only|0|||
131017063|NCT01580293|471693673|FG001|Part A_Extension|Completed Japan only|5|||
131017064|NCT01580293|471693674|FG002|Part A_Extension|Completed Japan only|0|||
131017065|NCT01580293|471693672|FG000|Part B|Withdrawal by Subject|0|||
131017066|NCT01580293|471693673|FG001|Part B|Withdrawal by Subject|0|||
131017067|NCT01580293|471693674|FG002|Part B|Withdrawal by Subject|1|||
131017068|NCT01580293|471693672|FG000|Part B|Other reason|0|||
131017069|NCT01580293|471693673|FG001|Part B|Other reason|0|||
131017070|NCT01580293|471693674|FG002|Part B|Other reason|1|||
131017071|NCT00768664|471693677|FG000|Overall Study|Death|57|||
131017072|NCT00768664|471693677|FG000|Overall Study|Lost to Follow-up|2|||
131017073|NCT00768664|471693677|FG000|Overall Study|Other|9|||
131017074|NCT00768664|471693677|FG000|Overall Study|Participant refused|1|||
131017075|NCT01400776|471693678|FG000|Overall Study|Adverse Event|7|||
131017076|NCT01400776|471693679|FG001|Overall Study|Adverse Event|2|||
131017077|NCT01400776|471693680|FG002|Overall Study|Adverse Event|9|||
131017078|NCT01400776|471693681|FG003|Overall Study|Adverse Event|2|||
131017079|NCT01400776|471693678|FG000|Overall Study|Lost to Follow-up|1|||
131017080|NCT01400776|471693679|FG001|Overall Study|Lost to Follow-up|0|||
131017081|NCT01400776|471693680|FG002|Overall Study|Lost to Follow-up|4|||
131017082|NCT01400776|471693681|FG003|Overall Study|Lost to Follow-up|1|||
131017083|NCT01400776|471693678|FG000|Overall Study|Withdrew Consent|4|||
131017084|NCT01400776|471693679|FG001|Overall Study|Withdrew Consent|2|||
131017085|NCT01400776|471693680|FG002|Overall Study|Withdrew Consent|6|||
131017086|NCT01400776|471693681|FG003|Overall Study|Withdrew Consent|1|||
131017087|NCT01400776|471693678|FG000|Overall Study|Protocol Deviation|6|||
131017088|NCT01400776|471693679|FG001|Overall Study|Protocol Deviation|1|||
131017089|NCT01400776|471693680|FG002|Overall Study|Protocol Deviation|5|||
131017090|NCT01400776|471693681|FG003|Overall Study|Protocol Deviation|2|||
131017091|NCT01400776|471693678|FG000|Overall Study|Reason not Specified|3|||
131017092|NCT01400776|471693679|FG001|Overall Study|Reason not Specified|0|||
131017093|NCT01400776|471693680|FG002|Overall Study|Reason not Specified|4|||
131017094|NCT01400776|471693681|FG003|Overall Study|Reason not Specified|3|||
131017095|NCT00423098|471693682|FG000|Overall Study|Adverse Event|1|||
131017096|NCT00423098|471693683|FG001|Overall Study|Adverse Event|2|||
130680470|NCT00440557|470457257|FG002|Overall Study|Principal Investigator's office closed|4|||
130680471|NCT00440557|470457255|FG000|Overall Study|Patient transferred to nursing home|0|||
130680472|NCT00440557|470457256|FG001|Overall Study|Patient transferred to nursing home|1|||
130680473|NCT00440557|470457257|FG002|Overall Study|Patient transferred to nursing home|0|||
130680474|NCT00440557|470457255|FG000|Overall Study|Patient had surgery|1|||
130680475|NCT00440557|470457256|FG001|Overall Study|Patient had surgery|0|||
130680476|NCT00440557|470457257|FG002|Overall Study|Patient had surgery|0|||
130680477|NCT00669942|470457259|FG000|Parts 2 and 3|Adverse Event|0|||
130680478|NCT00669942|470457260|FG001|Parts 2 and 3|Adverse Event|0|||
130680479|NCT00669942|470457261|FG002|Parts 2 and 3|Adverse Event|0|||
130680480|NCT00669942|470457262|FG003|Parts 2 and 3|Adverse Event|0|||
130680481|NCT00669942|470457263|FG004|Parts 2 and 3|Adverse Event|0|||
130680482|NCT00669942|470457264|FG005|Parts 2 and 3|Adverse Event|0|||
131017097|NCT00423098|471693682|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131017098|NCT00423098|471693683|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131017099|NCT00423098|471693682|FG000|Overall Study|Administrative problems|0|||
131017100|NCT00423098|471693683|FG001|Overall Study|Administrative problems|1|||
131017101|NCT00423098|471693682|FG000|Overall Study|Death|2|||
131017102|NCT00423098|471693683|FG001|Overall Study|Death|0|||
130680483|NCT00669942|470457265|FG006|Parts 2 and 3|Adverse Event|0|||
130680484|NCT00669942|470457266|FG007|Parts 2 and 3|Adverse Event|2|||
130680485|NCT00669942|470457267|FG008|Parts 2 and 3|Adverse Event|1|||
130680486|NCT00669942|470457268|FG009|Parts 2 and 3|Adverse Event|0|||
131017103|NCT04480827|471693685|FG000|Overall Study|Adverse Event|0|||
131017104|NCT04480827|471693686|FG001|Overall Study|Adverse Event|0|||
131017105|NCT04480827|471693687|FG002|Overall Study|Adverse Event|0|||
131017106|NCT04480827|471693688|FG003|Overall Study|Adverse Event|0|||
131017107|NCT04480827|471693689|FG004|Overall Study|Adverse Event|0|||
131017108|NCT04480827|471693690|FG005|Overall Study|Adverse Event|1|||
130680487|NCT00669942|470457269|FG010|Parts 2 and 3|Adverse Event|0|||
130680488|NCT00669942|470457270|FG011|Parts 2 and 3|Adverse Event|0|||
130680489|NCT00669942|470457259|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
130680490|NCT00669942|470457260|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
130680491|NCT00669942|470457261|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
130680492|NCT00669942|470457262|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
130680493|NCT00669942|470457263|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
130680494|NCT00669942|470457264|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
130680495|NCT00669942|470457265|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
130680496|NCT00669942|470457266|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
130680497|NCT00669942|470457267|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
130680498|NCT00669942|470457268|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
130680499|NCT00669942|470457269|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
130680500|NCT00669942|470457270|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
130680501|NCT00669942|470457259|FG000|Parts 2 and 3|Protocol Violation|0|||
130680502|NCT00669942|470457260|FG001|Parts 2 and 3|Protocol Violation|0|||
130680503|NCT00669942|470457261|FG002|Parts 2 and 3|Protocol Violation|0|||
130680504|NCT00669942|470457262|FG003|Parts 2 and 3|Protocol Violation|0|||
130680505|NCT00669942|470457263|FG004|Parts 2 and 3|Protocol Violation|0|||
130680506|NCT00669942|470457264|FG005|Parts 2 and 3|Protocol Violation|1|||
130680507|NCT00669942|470457265|FG006|Parts 2 and 3|Protocol Violation|0|||
130680508|NCT00669942|470457266|FG007|Parts 2 and 3|Protocol Violation|0|||
130680509|NCT00669942|470457267|FG008|Parts 2 and 3|Protocol Violation|0|||
130680510|NCT00669942|470457268|FG009|Parts 2 and 3|Protocol Violation|0|||
130680511|NCT00669942|470457269|FG010|Parts 2 and 3|Protocol Violation|0|||
130680512|NCT00669942|470457270|FG011|Parts 2 and 3|Protocol Violation|0|||
130680513|NCT00162123|470457283|FG000|Overall Study|Disease progression|27|||
130680514|NCT00162123|470457284|FG001|Overall Study|Disease progression|19|||
130680515|NCT00162123|470457285|FG002|Overall Study|Disease progression|10|||
130680516|NCT00162123|470457286|FG003|Overall Study|Disease progression|4|||
130680517|NCT00162123|470457287|FG004|Overall Study|Disease progression|8|||
130680518|NCT00162123|470457288|FG005|Overall Study|Disease progression|3|||
130680519|NCT00162123|470457289|FG006|Overall Study|Disease progression|1|||
130680520|NCT00162123|470457290|FG007|Overall Study|Disease progression|0|||
130680521|NCT00162123|470457283|FG000|Overall Study|Study drug toxicity|6|||
130680522|NCT00162123|470457284|FG001|Overall Study|Study drug toxicity|1|||
131017109|NCT04480827|471693691|FG006|Overall Study|Adverse Event|0|||
131017110|NCT00941655|471693692|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
131017111|NCT00941655|471693693|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
131017112|NCT00941655|471693692|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
131017113|NCT00941655|471693693|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
131017114|NCT00941655|471693692|FG000|Overall Study|progressed while on chemo|0|||
131017115|NCT00941655|471693693|FG001|Overall Study|progressed while on chemo|2|||
131017116|NCT00941655|471693692|FG000|Overall Study|refused further treatment|0|||
131017117|NCT00941655|471693693|FG001|Overall Study|refused further treatment|1|||
131017118|NCT00941655|471693692|FG000|Overall Study|withdrew consent|0|||
131017119|NCT00941655|471693693|FG001|Overall Study|withdrew consent|1|||
131017120|NCT00941655|471693692|FG000|Overall Study|non-compliant|0|||
131017121|NCT00941655|471693693|FG001|Overall Study|non-compliant|1|||
131017122|NCT02477670|471693696|FG000|Stage 1|Adverse Event|2|||
131017123|NCT02477670|471693697|FG001|Stage 1|Adverse Event|7|||
131017124|NCT02477670|471693698|FG002|Stage 1|Adverse Event|0|||
131017125|NCT02477670|471693699|FG003|Stage 1|Adverse Event|0|||
131017126|NCT02477670|471693700|FG004|Stage 1|Adverse Event|0|||
131017127|NCT02477670|471693701|FG005|Stage 1|Adverse Event|0|||
131017128|NCT02477670|471693702|FG006|Stage 1|Adverse Event|0|||
131017129|NCT02477670|471693696|FG000|Stage 1|Lost to Follow-up|0|||
131017130|NCT02477670|471693697|FG001|Stage 1|Lost to Follow-up|2|||
131017131|NCT02477670|471693698|FG002|Stage 1|Lost to Follow-up|0|||
131017132|NCT02477670|471693699|FG003|Stage 1|Lost to Follow-up|0|||
131017133|NCT02477670|471693700|FG004|Stage 1|Lost to Follow-up|0|||
131017134|NCT02477670|471693701|FG005|Stage 1|Lost to Follow-up|0|||
131017135|NCT02477670|471693702|FG006|Stage 1|Lost to Follow-up|0|||
131017136|NCT02477670|471693696|FG000|Stage 1|Withdrawal by Subject|1|||
131017137|NCT02477670|471693697|FG001|Stage 1|Withdrawal by Subject|2|||
130680523|NCT00162123|470457285|FG002|Overall Study|Study drug toxicity|5|||
130680524|NCT00162123|470457286|FG003|Overall Study|Study drug toxicity|0|||
131017138|NCT02477670|471693698|FG002|Stage 1|Withdrawal by Subject|0|||
131017139|NCT02477670|471693699|FG003|Stage 1|Withdrawal by Subject|0|||
131017140|NCT02477670|471693700|FG004|Stage 1|Withdrawal by Subject|0|||
130680525|NCT00162123|470457287|FG004|Overall Study|Study drug toxicity|4|||
130680526|NCT00162123|470457288|FG005|Overall Study|Study drug toxicity|1|||
130680527|NCT00162123|470457289|FG006|Overall Study|Study drug toxicity|1|||
130680528|NCT00162123|470457290|FG007|Overall Study|Study drug toxicity|0|||
130680529|NCT00162123|470457283|FG000|Overall Study|Death|3|||
130680530|NCT00162123|470457284|FG001|Overall Study|Death|3|||
130680531|NCT00162123|470457285|FG002|Overall Study|Death|1|||
130680532|NCT00162123|470457286|FG003|Overall Study|Death|1|||
130680533|NCT00162123|470457287|FG004|Overall Study|Death|1|||
131017141|NCT02477670|471693701|FG005|Stage 1|Withdrawal by Subject|0|||
131017142|NCT02477670|471693702|FG006|Stage 1|Withdrawal by Subject|0|||
130680534|NCT00162123|470457288|FG005|Overall Study|Death|1|||
130680535|NCT00162123|470457289|FG006|Overall Study|Death|0|||
130680536|NCT00162123|470457290|FG007|Overall Study|Death|0|||
130680537|NCT00162123|470457283|FG000|Overall Study|Withdrawal by Subject|2|||
130680538|NCT00162123|470457284|FG001|Overall Study|Withdrawal by Subject|0|||
130680539|NCT00162123|470457285|FG002|Overall Study|Withdrawal by Subject|2|||
130680540|NCT00162123|470457286|FG003|Overall Study|Withdrawal by Subject|1|||
130680541|NCT00162123|470457287|FG004|Overall Study|Withdrawal by Subject|1|||
130680542|NCT00162123|470457288|FG005|Overall Study|Withdrawal by Subject|2|||
130680543|NCT00162123|470457289|FG006|Overall Study|Withdrawal by Subject|1|||
130680544|NCT00162123|470457290|FG007|Overall Study|Withdrawal by Subject|0|||
130680545|NCT00162123|470457283|FG000|Overall Study|Deterioration without progression|2|||
130680546|NCT00162123|470457284|FG001|Overall Study|Deterioration without progression|2|||
130680547|NCT00162123|470457285|FG002|Overall Study|Deterioration without progression|3|||
130680548|NCT00162123|470457286|FG003|Overall Study|Deterioration without progression|0|||
130680549|NCT00162123|470457287|FG004|Overall Study|Deterioration without progression|1|||
130680550|NCT00162123|470457288|FG005|Overall Study|Deterioration without progression|0|||
130680551|NCT00162123|470457289|FG006|Overall Study|Deterioration without progression|0|||
130680552|NCT00162123|470457290|FG007|Overall Study|Deterioration without progression|0|||
130680553|NCT00162123|470457283|FG000|Overall Study|Adverse Event|1|||
130680554|NCT00162123|470457284|FG001|Overall Study|Adverse Event|2|||
130680555|NCT00162123|470457285|FG002|Overall Study|Adverse Event|0|||
130680556|NCT00162123|470457286|FG003|Overall Study|Adverse Event|2|||
130680557|NCT00162123|470457287|FG004|Overall Study|Adverse Event|1|||
130680558|NCT00162123|470457288|FG005|Overall Study|Adverse Event|0|||
130680559|NCT00162123|470457289|FG006|Overall Study|Adverse Event|0|||
130680560|NCT00162123|470457290|FG007|Overall Study|Adverse Event|0|||
130680561|NCT00162123|470457283|FG000|Overall Study|Not specified (before treatment)|2|||
130680562|NCT00162123|470457284|FG001|Overall Study|Not specified (before treatment)|0|||
130680563|NCT00162123|470457285|FG002|Overall Study|Not specified (before treatment)|0|||
130680564|NCT00162123|470457286|FG003|Overall Study|Not specified (before treatment)|0|||
130680565|NCT00162123|470457287|FG004|Overall Study|Not specified (before treatment)|12|||
130680566|NCT00162123|470457288|FG005|Overall Study|Not specified (before treatment)|1|||
130680567|NCT00162123|470457289|FG006|Overall Study|Not specified (before treatment)|0|||
130680568|NCT00162123|470457290|FG007|Overall Study|Not specified (before treatment)|0|||
130680569|NCT00162123|470457283|FG000|Overall Study|Not specified (after start of treatment)|0|||
130680570|NCT00162123|470457284|FG001|Overall Study|Not specified (after start of treatment)|0|||
130680571|NCT00162123|470457285|FG002|Overall Study|Not specified (after start of treatment)|0|||
130680572|NCT00162123|470457286|FG003|Overall Study|Not specified (after start of treatment)|0|||
130680573|NCT00162123|470457287|FG004|Overall Study|Not specified (after start of treatment)|3|||
130680574|NCT00162123|470457288|FG005|Overall Study|Not specified (after start of treatment)|0|||
130680575|NCT00162123|470457289|FG006|Overall Study|Not specified (after start of treatment)|0|||
130680576|NCT00162123|470457290|FG007|Overall Study|Not specified (after start of treatment)|0|||
130680577|NCT00162123|470457283|FG000|Overall Study|Physician Decision|1|||
130680578|NCT00162123|470457284|FG001|Overall Study|Physician Decision|2|||
130680579|NCT00162123|470457285|FG002|Overall Study|Physician Decision|0|||
130680580|NCT00162123|470457286|FG003|Overall Study|Physician Decision|0|||
130680581|NCT00162123|470457287|FG004|Overall Study|Physician Decision|0|||
130680582|NCT00162123|470457288|FG005|Overall Study|Physician Decision|1|||
130680583|NCT00162123|470457289|FG006|Overall Study|Physician Decision|1|||
130680584|NCT00162123|470457290|FG007|Overall Study|Physician Decision|0|||
130680585|NCT00162123|470457283|FG000|Overall Study|Tumor assessment only (not treated)|0|||
130680586|NCT00162123|470457284|FG001|Overall Study|Tumor assessment only (not treated)|0|||
130680587|NCT00162123|470457285|FG002|Overall Study|Tumor assessment only (not treated)|0|||
130680588|NCT00162123|470457286|FG003|Overall Study|Tumor assessment only (not treated)|0|||
130680589|NCT00162123|470457287|FG004|Overall Study|Tumor assessment only (not treated)|0|||
130680590|NCT00162123|470457288|FG005|Overall Study|Tumor assessment only (not treated)|0|||
130680591|NCT00162123|470457289|FG006|Overall Study|Tumor assessment only (not treated)|0|||
130680592|NCT00162123|470457290|FG007|Overall Study|Tumor assessment only (not treated)|1|||
130680593|NCT00162123|470457283|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
130680594|NCT00162123|470457284|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
130680595|NCT00162123|470457285|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
130680596|NCT00162123|470457286|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
130680597|NCT00162123|470457287|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
130680598|NCT00162123|470457288|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
130680599|NCT00162123|470457289|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
130680600|NCT00162123|470457290|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
130680601|NCT02016170|470457291|FG000|Overall Study|Adverse Event|1|||
130680602|NCT02016170|470457292|FG001|Overall Study|Adverse Event|1|||
130680603|NCT02016170|470457293|FG002|Overall Study|Adverse Event|0|||
130680604|NCT02016170|470457291|FG000|Overall Study|Protocol Violation|1|||
130680605|NCT02016170|470457292|FG001|Overall Study|Protocol Violation|0|||
130680606|NCT02016170|470457293|FG002|Overall Study|Protocol Violation|0|||
130680607|NCT02327130|470457294|FG000|Overall Study|Discharged in less than 5 days|5|||
130680608|NCT02327130|470457294|FG000|Overall Study|Physician Decision|2|||
130680609|NCT02327130|470457294|FG000|Overall Study|Unable to provide breath sample|1|||
130680610|NCT02327130|470457294|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
130680611|NCT02327130|470457294|FG000|Overall Study|Met exclusion criteria|3|||
130680612|NCT02343120|470457299|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
130680613|NCT02343120|470457300|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
130680614|NCT02343120|470457301|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
130680615|NCT02343120|470457302|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
130680616|NCT02343120|470457303|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
130680617|NCT02343120|470457299|FG000|Part 1: Dose Escalation|Death|1|||
130680618|NCT02343120|470457300|FG001|Part 1: Dose Escalation|Death|2|||
130680619|NCT02343120|470457301|FG002|Part 1: Dose Escalation|Death|2|||
130680620|NCT02343120|470457302|FG003|Part 1: Dose Escalation|Death|2|||
130680621|NCT02343120|470457303|FG004|Part 1: Dose Escalation|Death|1|||
130680622|NCT02343120|470457299|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
130680623|NCT02343120|470457300|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
130680624|NCT02343120|470457301|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
130680625|NCT02343120|470457302|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
130680626|NCT02343120|470457303|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
130680627|NCT02343120|470457299|FG000|Part 2: Expansion|Sponsor decision|0|||
130680628|NCT02343120|470457300|FG001|Part 2: Expansion|Sponsor decision|0|||
130680629|NCT02343120|470457301|FG002|Part 2: Expansion|Sponsor decision|0|||
130680630|NCT02343120|470457302|FG003|Part 2: Expansion|Sponsor decision|165|||
130680631|NCT02343120|470457303|FG004|Part 2: Expansion|Sponsor decision|67|||
130680632|NCT02343120|470457299|FG000|Part 2: Expansion|Death|0|||
130680633|NCT02343120|470457300|FG001|Part 2: Expansion|Death|0|||
130680634|NCT02343120|470457301|FG002|Part 2: Expansion|Death|0|||
130680635|NCT02343120|470457302|FG003|Part 2: Expansion|Death|74|||
130680636|NCT02343120|470457303|FG004|Part 2: Expansion|Death|17|||
130680637|NCT02343120|470457299|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
130680638|NCT02343120|470457300|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
130680639|NCT02343120|470457301|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
130680640|NCT02343120|470457302|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
130680641|NCT02343120|470457303|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
130680642|NCT02343120|470457299|FG000|Part 2: Expansion|Lost to Follow-up|0|||
130680643|NCT02343120|470457300|FG001|Part 2: Expansion|Lost to Follow-up|0|||
130680644|NCT02343120|470457301|FG002|Part 2: Expansion|Lost to Follow-up|0|||
130680645|NCT02343120|470457302|FG003|Part 2: Expansion|Lost to Follow-up|5|||
130680646|NCT02343120|470457303|FG004|Part 2: Expansion|Lost to Follow-up|2|||
130680647|NCT02343120|470457299|FG000|Part 2: Expansion|Other|0|||
130680648|NCT02343120|470457300|FG001|Part 2: Expansion|Other|0|||
130680649|NCT02343120|470457301|FG002|Part 2: Expansion|Other|0|||
130680650|NCT02343120|470457302|FG003|Part 2: Expansion|Other|1|||
130680651|NCT02343120|470457303|FG004|Part 2: Expansion|Other|5|||
130680652|NCT02343120|470457299|FG000|Part 2: Expansion|Adverse Event|0|||
130680653|NCT02343120|470457300|FG001|Part 2: Expansion|Adverse Event|0|||
130680654|NCT02343120|470457301|FG002|Part 2: Expansion|Adverse Event|0|||
130680655|NCT02343120|470457302|FG003|Part 2: Expansion|Adverse Event|1|||
130680656|NCT02343120|470457303|FG004|Part 2: Expansion|Adverse Event|1|||
130680657|NCT02534493|470457306|FG000|Overall Study|Lost to Follow-up|1|||
130680658|NCT02534493|470457306|FG000|Overall Study|Withdrawal by Subject|1|||
130680659|NCT01104662|470457309|FG000|Overall Study|Adverse Event|2|||
130680660|NCT01104662|470457310|FG001|Overall Study|Adverse Event|2|||
130680661|NCT01104662|470457311|FG002|Overall Study|Adverse Event|0|||
130680662|NCT01104662|470457312|FG003|Overall Study|Adverse Event|1|||
130680663|NCT01104662|470457313|FG004|Overall Study|Adverse Event|1|||
130680664|NCT01104662|470457314|FG005|Overall Study|Adverse Event|1|||
130680665|NCT01104662|470457315|FG006|Overall Study|Adverse Event|0|||
130680666|NCT01104662|470457316|FG007|Overall Study|Adverse Event|0|||
130680667|NCT01104662|470457309|FG000|Overall Study|Clinical Failure|1|||
130680668|NCT01104662|470457310|FG001|Overall Study|Clinical Failure|0|||
130680669|NCT01104662|470457311|FG002|Overall Study|Clinical Failure|0|||
130680670|NCT01104662|470457312|FG003|Overall Study|Clinical Failure|0|||
130680671|NCT01104662|470457313|FG004|Overall Study|Clinical Failure|0|||
131017143|NCT02477670|471693696|FG000|Stage 1|Non-compliance with Study Drug|1|||
131017144|NCT02477670|471693697|FG001|Stage 1|Non-compliance with Study Drug|2|||
131017145|NCT02477670|471693698|FG002|Stage 1|Non-compliance with Study Drug|0|||
131017146|NCT02477670|471693699|FG003|Stage 1|Non-compliance with Study Drug|0|||
131017147|NCT02477670|471693700|FG004|Stage 1|Non-compliance with Study Drug|0|||
131017148|NCT02477670|471693701|FG005|Stage 1|Non-compliance with Study Drug|0|||
131017149|NCT02477670|471693702|FG006|Stage 1|Non-compliance with Study Drug|0|||
131017150|NCT02477670|471693696|FG000|Stage 2|Adverse Event|0|||
131017151|NCT02477670|471693697|FG001|Stage 2|Adverse Event|0|||
131017152|NCT02477670|471693698|FG002|Stage 2|Adverse Event|1|||
130680672|NCT01104662|470457314|FG005|Overall Study|Clinical Failure|1|||
130680673|NCT01104662|470457315|FG006|Overall Study|Clinical Failure|0|||
130680674|NCT01104662|470457316|FG007|Overall Study|Clinical Failure|0|||
131017153|NCT02477670|471693699|FG003|Stage 2|Adverse Event|0|||
130680675|NCT01104662|470457309|FG000|Overall Study|Participant left investigator's care|1|||
130680676|NCT01104662|470457310|FG001|Overall Study|Participant left investigator's care|1|||
130680677|NCT01104662|470457311|FG002|Overall Study|Participant left investigator's care|0|||
130680678|NCT01104662|470457312|FG003|Overall Study|Participant left investigator's care|0|||
130680679|NCT01104662|470457313|FG004|Overall Study|Participant left investigator's care|0|||
131103591|NCT01028027|472008044|FG000|Overall Study|Lost to Follow-up|4|||
131103592|NCT01028027|472008045|FG001|Overall Study|Lost to Follow-up|1|||
131103593|NCT01028027|472008044|FG000|Overall Study|Withdrawal by Subject|5|||
131103594|NCT01028027|472008045|FG001|Overall Study|Withdrawal by Subject|3|||
131103595|NCT01028027|472008044|FG000|Overall Study|Adverse Event|4|||
131103596|NCT01028027|472008045|FG001|Overall Study|Adverse Event|7|||
131103597|NCT01028027|472008044|FG000|Overall Study|Protocol Violation|3|||
131103598|NCT01028027|472008045|FG001|Overall Study|Protocol Violation|1|||
131103599|NCT01028027|472008044|FG000|Overall Study|Lack of Efficacy|0|||
131103600|NCT01028027|472008045|FG001|Overall Study|Lack of Efficacy|1|||
131103601|NCT03149549|472008046|FG000|Study Discontinuation--Treatment Period|Death|0|||
131103602|NCT03149549|472008047|FG001|Study Discontinuation--Treatment Period|Death|0|||
131103603|NCT03149549|472008048|FG002|Study Discontinuation--Treatment Period|Death|0|||
131103604|NCT03149549|472008049|FG003|Study Discontinuation--Treatment Period|Death|1|||
131103605|NCT03149549|472008050|FG004|Study Discontinuation--Treatment Period|Death|2|||
131103606|NCT03149549|472008051|FG005|Study Discontinuation--Treatment Period|Death|1|||
131103607|NCT03149549|472008052|FG006|Study Discontinuation--Treatment Period|Death|1|||
131103608|NCT03149549|472008053|FG007|Study Discontinuation--Treatment Period|Death|2|||
131103609|NCT03149549|472008054|FG008|Study Discontinuation--Treatment Period|Death|4|||
131103610|NCT03149549|472008055|FG009|Study Discontinuation--Treatment Period|Death|1|||
131103611|NCT03149549|472008056|FG010|Study Discontinuation--Treatment Period|Death|0|||
131103612|NCT03149549|472008057|FG011|Study Discontinuation--Treatment Period|Death|0|||
131103613|NCT03149549|472008058|FG012|Study Discontinuation--Treatment Period|Death|1|||
131103614|NCT03149549|472008046|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131103615|NCT03149549|472008047|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131103616|NCT03149549|472008048|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130680680|NCT01104662|470457314|FG005|Overall Study|Participant left investigator's care|0|||
130680681|NCT01104662|470457315|FG006|Overall Study|Participant left investigator's care|0|||
130680682|NCT01104662|470457316|FG007|Overall Study|Participant left investigator's care|0|||
130680683|NCT01104662|470457309|FG000|Overall Study|Reason not specified|3|||
131017154|NCT02477670|471693700|FG004|Stage 2|Adverse Event|0|||
131017155|NCT02477670|471693701|FG005|Stage 2|Adverse Event|0|||
131017156|NCT02477670|471693702|FG006|Stage 2|Adverse Event|0|||
131017157|NCT02477670|471693696|FG000|Stage 2|Antipsychotic Medication Changed|0|||
131017158|NCT02477670|471693697|FG001|Stage 2|Antipsychotic Medication Changed|0|||
131017159|NCT02477670|471693698|FG002|Stage 2|Antipsychotic Medication Changed|1|||
131017160|NCT02477670|471693699|FG003|Stage 2|Antipsychotic Medication Changed|0|||
131017161|NCT02477670|471693700|FG004|Stage 2|Antipsychotic Medication Changed|0|||
131017162|NCT02477670|471693701|FG005|Stage 2|Antipsychotic Medication Changed|0|||
131017163|NCT02477670|471693702|FG006|Stage 2|Antipsychotic Medication Changed|0|||
131017164|NCT02477670|471693696|FG000|Stage 2|Withdrawal by Subject|0|||
131017165|NCT02477670|471693697|FG001|Stage 2|Withdrawal by Subject|0|||
131017166|NCT02477670|471693698|FG002|Stage 2|Withdrawal by Subject|0|||
131017167|NCT02477670|471693699|FG003|Stage 2|Withdrawal by Subject|1|||
131017168|NCT02477670|471693700|FG004|Stage 2|Withdrawal by Subject|0|||
131017169|NCT02477670|471693701|FG005|Stage 2|Withdrawal by Subject|0|||
131017170|NCT02477670|471693702|FG006|Stage 2|Withdrawal by Subject|0|||
131017171|NCT00446550|471693706|FG000|Overall Study|Adverse Event|1|||
131017172|NCT00446550|471693707|FG001|Overall Study|Adverse Event|0|||
131017173|NCT02937831|471693708|FG000|Overall Study|Protocol Violation|4|||
131017174|NCT00114244|471693711|FG000|Overall Study|Adverse Event|2|||
131017175|NCT00114244|471693712|FG001|Overall Study|Adverse Event|5|||
131017176|NCT00114244|471693711|FG000|Overall Study|Withdrawal by Subject|0|||
131017177|NCT00114244|471693712|FG001|Overall Study|Withdrawal by Subject|2|||
131017178|NCT02383472|471693713|FG000|Overall Study|Withdrawal by Subject|1|||
131017179|NCT02383472|471693714|FG001|Overall Study|Withdrawal by Subject|1|||
131017180|NCT00818454|471693717|FG000|Treatment Period 1|Adverse Event|0|||
131017181|NCT00818454|471693718|FG001|Treatment Period 1|Adverse Event|1|||
131017182|NCT00818454|471693719|FG002|Treatment Period 1|Adverse Event|0|||
131017183|NCT00818454|471693720|FG003|Treatment Period 1|Adverse Event|0|||
131017184|NCT00818454|471693717|FG000|Treatment Period 1|Other|3|||
131017185|NCT00818454|471693718|FG001|Treatment Period 1|Other|0|||
131017186|NCT00818454|471693719|FG002|Treatment Period 1|Other|0|||
131017187|NCT00818454|471693720|FG003|Treatment Period 1|Other|0|||
131103617|NCT03149549|472008049|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131103618|NCT03149549|472008050|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131103619|NCT03149549|472008051|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131103620|NCT03149549|472008052|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131017188|NCT00818454|471693717|FG000|Washout Period of 1 Week|Adverse Event|1|||
130680684|NCT01104662|470457310|FG001|Overall Study|Reason not specified|3|||
130680685|NCT01104662|470457311|FG002|Overall Study|Reason not specified|0|||
130680686|NCT01104662|470457312|FG003|Overall Study|Reason not specified|0|||
130680687|NCT01104662|470457313|FG004|Overall Study|Reason not specified|0|||
130680688|NCT01104662|470457314|FG005|Overall Study|Reason not specified|1|||
130680689|NCT01104662|470457315|FG006|Overall Study|Reason not specified|0|||
130680690|NCT01104662|470457316|FG007|Overall Study|Reason not specified|0|||
130680691|NCT01104662|470457309|FG000|Overall Study|Randomized but not treated|3|||
130680692|NCT01104662|470457310|FG001|Overall Study|Randomized but not treated|4|||
130680693|NCT01104662|470457311|FG002|Overall Study|Randomized but not treated|1|||
130680694|NCT01104662|470457312|FG003|Overall Study|Randomized but not treated|0|||
130680695|NCT01104662|470457313|FG004|Overall Study|Randomized but not treated|0|||
130680696|NCT01104662|470457314|FG005|Overall Study|Randomized but not treated|1|||
130680697|NCT01104662|470457315|FG006|Overall Study|Randomized but not treated|0|||
130680698|NCT01104662|470457316|FG007|Overall Study|Randomized but not treated|0|||
130680699|NCT02079532|470457317|FG000|Overall Study|Adverse Event|7|||
130680700|NCT02079532|470457317|FG000|Overall Study|Additional or changed therapy|2|||
130680701|NCT02079532|470457317|FG000|Overall Study|Lack of Efficacy|9|||
130680702|NCT02079532|470457317|FG000|Overall Study|Protocol Violation|3|||
130680703|NCT02079532|470457317|FG000|Overall Study|Withdrawal by Subject|1|||
130680704|NCT02079532|470457317|FG000|Overall Study|Administrative problems|1|||
130680705|NCT02079532|470457317|FG000|Overall Study|Inclusion into ReFIRST|3|||
130680706|NCT02079532|470457317|FG000|Overall Study|Other|3|||
130680707|NCT02158936|470457320|FG000|Overall Study|Study closed/ terminated|57|||
130680708|NCT02158936|470457321|FG001|Overall Study|Study closed/ terminated|77|||
130680709|NCT02158936|470457320|FG000|Overall Study|Azacitidine tx discontinued|53|||
130680710|NCT02158936|470457321|FG001|Overall Study|Azacitidine tx discontinued|46|||
130680711|NCT02158936|470457320|FG000|Overall Study|Adverse Event|39|||
130680712|NCT02158936|470457321|FG001|Overall Study|Adverse Event|24|||
130680713|NCT02158936|470457320|FG000|Overall Study|Withdrawal by Subject|15|||
130680714|NCT02158936|470457321|FG001|Overall Study|Withdrawal by Subject|16|||
130680715|NCT02158936|470457320|FG000|Overall Study|Physician Decision|15|||
130680716|NCT02158936|470457321|FG001|Overall Study|Physician Decision|13|||
130680717|NCT02158936|470457320|FG000|Overall Study|Lost to Follow-up|0|||
130680718|NCT02158936|470457321|FG001|Overall Study|Lost to Follow-up|1|||
130680719|NCT01432171|470457322|FG000|Overall Study|Death|1|||
130680720|NCT01432171|470457323|FG001|Overall Study|Death|2|||
130680721|NCT01432171|470457322|FG000|Overall Study|Lost to Follow-up|6|||
130680722|NCT01432171|470457323|FG001|Overall Study|Lost to Follow-up|5|||
130680723|NCT01432171|470457322|FG000|Overall Study|Withdrawal by Subject|3|||
130680724|NCT01432171|470457323|FG001|Overall Study|Withdrawal by Subject|1|||
130680725|NCT01432171|470457322|FG000|Overall Study|Noncompliance|2|||
130680726|NCT01432171|470457323|FG001|Overall Study|Noncompliance|3|||
130680727|NCT01432171|470457322|FG000|Overall Study|Insurance denial trial coverage|1|||
130680728|NCT01432171|470457323|FG001|Overall Study|Insurance denial trial coverage|0|||
130680729|NCT01432171|470457322|FG000|Overall Study|Patient moved to palliative care|1|||
130680730|NCT01432171|470457323|FG001|Overall Study|Patient moved to palliative care|0|||
130680731|NCT01706926|470457324|FG000|Overall Study|Lost to Follow-up|0|||
130680732|NCT01706926|470457325|FG001|Overall Study|Lost to Follow-up|0|||
130680733|NCT01706926|470457326|FG002|Overall Study|Lost to Follow-up|1|||
130680734|NCT01706926|470457327|FG003|Overall Study|Lost to Follow-up|0|||
130680735|NCT01706926|470457324|FG000|Overall Study|Withdrawal by Subject|2|||
130680736|NCT01706926|470457325|FG001|Overall Study|Withdrawal by Subject|0|||
130680737|NCT01706926|470457326|FG002|Overall Study|Withdrawal by Subject|1|||
130680738|NCT01706926|470457327|FG003|Overall Study|Withdrawal by Subject|2|||
130680739|NCT01706926|470457324|FG000|Overall Study|Other|4|||
130680740|NCT01706926|470457325|FG001|Overall Study|Other|4|||
130680741|NCT01706926|470457326|FG002|Overall Study|Other|4|||
130680742|NCT01706926|470457327|FG003|Overall Study|Other|3|||
130720827|NCT04524364|470601531|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
130720828|NCT04524364|470601530|FG000|Overall Study|Low International normalized ratio (INR)|1|||
130720829|NCT04524364|470601531|FG001|Overall Study|Low International normalized ratio (INR)|0|||
130720830|NCT04480710|470601538|FG000|Overall Study|Adverse Event|0|||
130720831|NCT04480710|470601539|FG001|Overall Study|Adverse Event|2|||
130720832|NCT04480710|470601540|FG002|Overall Study|Adverse Event|0|||
130720833|NCT04480710|470601541|FG003|Overall Study|Adverse Event|0|||
130720834|NCT04480710|470601538|FG000|Overall Study|Withdrawal by Subject|0|||
130720835|NCT04480710|470601539|FG001|Overall Study|Withdrawal by Subject|1|||
130720836|NCT04480710|470601540|FG002|Overall Study|Withdrawal by Subject|0|||
130720837|NCT04480710|470601541|FG003|Overall Study|Withdrawal by Subject|0|||
130720838|NCT04480710|470601538|FG000|Overall Study|Physician Decision|0|||
130720839|NCT04480710|470601539|FG001|Overall Study|Physician Decision|0|||
130720840|NCT04480710|470601540|FG002|Overall Study|Physician Decision|1|||
130720841|NCT04480710|470601541|FG003|Overall Study|Physician Decision|0|||
130720842|NCT04126213|470601545|FG000|Overall Study|Lost to Follow-up|9|||
131017189|NCT00818454|471693718|FG001|Washout Period of 1 Week|Adverse Event|1|||
131017190|NCT00818454|471693719|FG002|Washout Period of 1 Week|Adverse Event|0|||
131103621|NCT03149549|472008053|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
131103622|NCT03149549|472008054|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131103623|NCT03149549|472008055|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131103624|NCT03149549|472008056|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131103625|NCT03149549|472008057|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
131103626|NCT03149549|472008058|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
131103627|NCT03149549|472008046|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131103628|NCT03149549|472008047|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131103629|NCT03149549|472008048|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131103630|NCT03149549|472008049|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
131103631|NCT03149549|472008050|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
131103632|NCT03149549|472008051|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
131017191|NCT00818454|471693720|FG003|Washout Period of 1 Week|Adverse Event|0|||
131017192|NCT00818454|471693717|FG000|Washout Period of 1 Week|Protocol Violation|2|||
131017193|NCT00818454|471693718|FG001|Washout Period of 1 Week|Protocol Violation|0|||
131017194|NCT00818454|471693719|FG002|Washout Period of 1 Week|Protocol Violation|0|||
131017195|NCT00818454|471693720|FG003|Washout Period of 1 Week|Protocol Violation|0|||
131017196|NCT00818454|471693717|FG000|Washout Period of 1 Week|Other|1|||
131017197|NCT00818454|471693718|FG001|Washout Period of 1 Week|Other|2|||
131017198|NCT00818454|471693719|FG002|Washout Period of 1 Week|Other|0|||
131017199|NCT00818454|471693720|FG003|Washout Period of 1 Week|Other|0|||
131017200|NCT00818454|471693717|FG000|Treatment Period 2|Other|2|||
131103633|NCT03149549|472008052|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
131103634|NCT03149549|472008053|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131103635|NCT03149549|472008054|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
131103636|NCT03149549|472008055|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131103637|NCT03149549|472008056|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131103638|NCT03149549|472008057|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131103639|NCT03149549|472008058|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
131103640|NCT03149549|472008046|FG000|Study Discontinuation--Treatment Period|Other|0|||
131103641|NCT03149549|472008047|FG001|Study Discontinuation--Treatment Period|Other|0|||
131103642|NCT03149549|472008048|FG002|Study Discontinuation--Treatment Period|Other|0|||
131103643|NCT03149549|472008049|FG003|Study Discontinuation--Treatment Period|Other|0|||
131103644|NCT03149549|472008050|FG004|Study Discontinuation--Treatment Period|Other|0|||
131103645|NCT03149549|472008051|FG005|Study Discontinuation--Treatment Period|Other|0|||
131103646|NCT03149549|472008052|FG006|Study Discontinuation--Treatment Period|Other|0|||
131103647|NCT03149549|472008053|FG007|Study Discontinuation--Treatment Period|Other|1|||
131103648|NCT03149549|472008054|FG008|Study Discontinuation--Treatment Period|Other|0|||
131103649|NCT03149549|472008055|FG009|Study Discontinuation--Treatment Period|Other|1|||
131103650|NCT03149549|472008056|FG010|Study Discontinuation--Treatment Period|Other|0|||
130680743|NCT00883090|470458676|FG000|Overall Study|Sponsor's decision|1|||
131017201|NCT00818454|471693718|FG001|Treatment Period 2|Other|1|||
131017202|NCT00818454|471693719|FG002|Treatment Period 2|Other|0|||
131017203|NCT00818454|471693720|FG003|Treatment Period 2|Other|0|||
131017204|NCT00818454|471693717|FG000|Treatment Period 3|Adverse Event|0|||
131017205|NCT00818454|471693718|FG001|Treatment Period 3|Adverse Event|0|||
131017206|NCT00818454|471693719|FG002|Treatment Period 3|Adverse Event|0|||
131017207|NCT00818454|471693720|FG003|Treatment Period 3|Adverse Event|1|||
131017208|NCT02296424|471693722|FG000|Part 1|New therapy for study indication|0|||
131017209|NCT02296424|471693723|FG001|Part 1|New therapy for study indication|1|||
131017210|NCT02296424|471693724|FG002|Part 1|New therapy for study indication|0|||
131017211|NCT02296424|471693725|FG003|Part 1|New therapy for study indication|0|||
131017212|NCT02296424|471693722|FG000|Part 1|Protocol Violation|0|||
131017213|NCT02296424|471693723|FG001|Part 1|Protocol Violation|1|||
131017214|NCT02296424|471693724|FG002|Part 1|Protocol Violation|0|||
131017215|NCT02296424|471693725|FG003|Part 1|Protocol Violation|0|||
131017216|NCT02296424|471693722|FG000|Part 1|Withdrawal by Subject|0|||
131017217|NCT02296424|471693723|FG001|Part 1|Withdrawal by Subject|2|||
131017218|NCT02296424|471693724|FG002|Part 1|Withdrawal by Subject|0|||
131103651|NCT03149549|472008057|FG011|Study Discontinuation--Treatment Period|Other|0|||
130680744|NCT00883090|470458676|FG000|Overall Study|Withdrawal by Subject|1|||
130680745|NCT01475838|470458679|FG000|Randomized Phase|Randomized but Not Treated|0|||
130680746|NCT01475838|470458680|FG001|Randomized Phase|Randomized but Not Treated|5|||
130680747|NCT01475838|470458679|FG000|Randomized Phase|Adverse Event|6|||
130680748|NCT01475838|470458680|FG001|Randomized Phase|Adverse Event|1|||
130680749|NCT01475838|470458679|FG000|Randomized Phase|Pregnancy|0|||
131017219|NCT02296424|471693725|FG003|Part 1|Withdrawal by Subject|0|||
131017220|NCT02296424|471693722|FG000|Part 1|Study terminated by sponsor|0|||
131017221|NCT02296424|471693723|FG001|Part 1|Study terminated by sponsor|1|||
131017222|NCT02296424|471693724|FG002|Part 1|Study terminated by sponsor|0|||
130680750|NCT01475838|470458680|FG001|Randomized Phase|Pregnancy|1|||
131017223|NCT02296424|471693725|FG003|Part 1|Study terminated by sponsor|0|||
131017224|NCT02296424|471693722|FG000|Part 1|Adverse Event|2|||
131017225|NCT02296424|471693723|FG001|Part 1|Adverse Event|11|||
131017226|NCT02296424|471693724|FG002|Part 1|Adverse Event|0|||
131017227|NCT02296424|471693725|FG003|Part 1|Adverse Event|0|||
131017228|NCT02296424|471693722|FG000|Part 1|Lack of Efficacy|5|||
131017229|NCT02296424|471693723|FG001|Part 1|Lack of Efficacy|17|||
131017230|NCT02296424|471693724|FG002|Part 1|Lack of Efficacy|0|||
131017231|NCT02296424|471693725|FG003|Part 1|Lack of Efficacy|0|||
131017232|NCT02296424|471693722|FG000|Part 1|16 directly started part II|16|||
131017233|NCT02296424|471693723|FG001|Part 1|16 directly started part II|0|||
131017234|NCT02296424|471693724|FG002|Part 1|16 directly started part II|0|||
131017235|NCT02296424|471693725|FG003|Part 1|16 directly started part II|0|||
131017236|NCT02296424|471693722|FG000|Part 2|Lack of Efficacy|0|||
131017237|NCT02296424|471693723|FG001|Part 2|Lack of Efficacy|0|||
131017238|NCT02296424|471693724|FG002|Part 2|Lack of Efficacy|1|||
131017239|NCT02296424|471693725|FG003|Part 2|Lack of Efficacy|0|||
131017240|NCT02296424|471693722|FG000|Part 2|Adverse Event|0|||
131017241|NCT02296424|471693723|FG001|Part 2|Adverse Event|0|||
131017242|NCT02296424|471693724|FG002|Part 2|Adverse Event|1|||
131017243|NCT02296424|471693725|FG003|Part 2|Adverse Event|0|||
131017244|NCT02296424|471693722|FG000|Part 2|Lost to Follow-up|0|||
130680751|NCT01475838|470458679|FG000|Randomized Phase|Investigators Discretion|1|||
130680752|NCT01475838|470458680|FG001|Randomized Phase|Investigators Discretion|2|||
130680753|NCT01475838|470458679|FG000|Randomized Phase|Withdrew Consent|10|||
130680754|NCT01475838|470458680|FG001|Randomized Phase|Withdrew Consent|14|||
130680755|NCT01475838|470458679|FG000|Randomized Phase|Lost to Follow-up|3|||
130680756|NCT01475838|470458680|FG001|Randomized Phase|Lost to Follow-up|4|||
130680757|NCT01475838|470458679|FG000|Randomized Phase|Participant Noncompliance|1|||
130680758|NCT01475838|470458680|FG001|Randomized Phase|Participant Noncompliance|5|||
130680759|NCT01475838|470458679|FG000|Randomized Phase|Protocol Violation|9|||
130680760|NCT01475838|470458680|FG001|Randomized Phase|Protocol Violation|4|||
130680761|NCT01475838|470458679|FG000|Extension Phase|Participant Noncompliance|1|||
130680762|NCT01475838|470458680|FG001|Extension Phase|Participant Noncompliance|0|||
130680763|NCT01717976|470458681|FG000|Overall Study|Protocol Violation|0|||
130680764|NCT01717976|470458682|FG001|Overall Study|Protocol Violation|1|||
130680765|NCT00048568|470458683|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
130680766|NCT00048568|470458684|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
130680767|NCT00048568|470458685|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
130680768|NCT00048568|470458683|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
130680769|NCT00048568|470458684|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
130680770|NCT00048568|470458685|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
130680771|NCT00048568|470458683|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
130680772|NCT00048568|470458684|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
130680773|NCT00048568|470458685|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
130680774|NCT00048568|470458683|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
130680775|NCT00048568|470458684|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
130680776|NCT00048568|470458685|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
130680777|NCT00048568|470458683|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
130680778|NCT00048568|470458684|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
130680779|NCT00048568|470458685|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
130680780|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Death|1|||
130680781|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Death|1|||
130680782|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Death|0|||
130680783|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
130680784|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
130680785|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
130680786|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
130680787|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
130680788|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
130680789|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
130680790|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
130680791|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
130680792|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
131017245|NCT02296424|471693723|FG001|Part 2|Lost to Follow-up|0|||
131017246|NCT02296424|471693724|FG002|Part 2|Lost to Follow-up|1|||
130680793|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
130680794|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
131017247|NCT02296424|471693725|FG003|Part 2|Lost to Follow-up|0|||
131017248|NCT00807144|471693726|FG000|Overall Study|Lost to Follow-up|0|||
130680795|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
130680796|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
131017249|NCT00807144|471693727|FG001|Overall Study|Lost to Follow-up|1|||
131017250|NCT00854906|471693728|FG000|Overall Study|One person had no ocular history|1|||
131017251|NCT00814346|471693729|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
131017252|NCT00814346|471693730|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
130680797|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
130680798|NCT00048568|470458683|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
130680799|NCT00048568|470458684|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
130680800|NCT00048568|470458685|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
130680801|NCT00048568|470458683|FG000|Open-Label Period|Death|0|||
130680802|NCT00048568|470458684|FG001|Open-Label Period|Death|0|||
130680803|NCT00048568|470458685|FG002|Open-Label Period|Death|13|||
130680804|NCT00048568|470458683|FG000|Open-Label Period|Adverse Event|0|||
130680805|NCT00048568|470458684|FG001|Open-Label Period|Adverse Event|0|||
130680806|NCT00048568|470458685|FG002|Open-Label Period|Adverse Event|49|||
130680807|NCT00048568|470458683|FG000|Open-Label Period|Lack of Efficacy|0|||
130680808|NCT00048568|470458684|FG001|Open-Label Period|Lack of Efficacy|0|||
130680809|NCT00048568|470458685|FG002|Open-Label Period|Lack of Efficacy|32|||
130680810|NCT00048568|470458683|FG000|Open-Label Period|Withdrawal by Subject|0|||
130680811|NCT00048568|470458684|FG001|Open-Label Period|Withdrawal by Subject|0|||
130680812|NCT00048568|470458685|FG002|Open-Label Period|Withdrawal by Subject|26|||
130680813|NCT00048568|470458683|FG000|Open-Label Period|Pregnancy|0|||
130680814|NCT00048568|470458684|FG001|Open-Label Period|Pregnancy|0|||
130885412|NCT00918255|471215197|FG000|Overall Study|Adverse Event|1|||
131017253|NCT00814346|471693729|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
131017254|NCT00814346|471693730|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
131017255|NCT00814346|471693729|FG000|Open Phase (17 Months)|Adverse Event|5|||
131017256|NCT00814346|471693730|FG001|Open Phase (17 Months)|Adverse Event|0|||
131017257|NCT00814346|471693729|FG000|Open Phase (17 Months)|Consent|2|||
131017258|NCT00814346|471693730|FG001|Open Phase (17 Months)|Consent|0|||
131017259|NCT00814346|471693729|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
131017260|NCT00814346|471693730|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
131017261|NCT00814346|471693729|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
131017262|NCT00814346|471693730|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
131017263|NCT03622580|471693731|FG000|Overall Study|Death|16|||
131017264|NCT03622580|471693732|FG001|Overall Study|Death|21|||
131017265|NCT03622580|471693733|FG002|Overall Study|Death|13|||
131017266|NCT03622580|471693731|FG000|Overall Study|Adverse Event|6|||
131017267|NCT03622580|471693732|FG001|Overall Study|Adverse Event|6|||
131017268|NCT03622580|471693733|FG002|Overall Study|Adverse Event|5|||
131017269|NCT03622580|471693731|FG000|Overall Study|Withdrawal by Subject|12|||
131017270|NCT03622580|471693732|FG001|Overall Study|Withdrawal by Subject|7|||
131017271|NCT03622580|471693733|FG002|Overall Study|Withdrawal by Subject|19|||
131017272|NCT03622580|471693731|FG000|Overall Study|Lost to Follow-up|12|||
131017273|NCT03622580|471693732|FG001|Overall Study|Lost to Follow-up|9|||
131017274|NCT03622580|471693733|FG002|Overall Study|Lost to Follow-up|9|||
131017275|NCT03622580|471693731|FG000|Overall Study|Protocol Violation|1|||
131017276|NCT03622580|471693732|FG001|Overall Study|Protocol Violation|0|||
131017277|NCT03622580|471693733|FG002|Overall Study|Protocol Violation|1|||
131017278|NCT03622580|471693731|FG000|Overall Study|Physician Decision|3|||
131017279|NCT03622580|471693732|FG001|Overall Study|Physician Decision|0|||
131017280|NCT03622580|471693733|FG002|Overall Study|Physician Decision|1|||
131017281|NCT03622580|471693731|FG000|Overall Study|Pregnancy|0|||
131017282|NCT03622580|471693732|FG001|Overall Study|Pregnancy|1|||
131017283|NCT03622580|471693733|FG002|Overall Study|Pregnancy|0|||
131017284|NCT03622580|471693731|FG000|Overall Study|Lack of Efficacy|0|||
131017285|NCT03622580|471693732|FG001|Overall Study|Lack of Efficacy|0|||
131017286|NCT03622580|471693733|FG002|Overall Study|Lack of Efficacy|1|||
131017287|NCT03622580|471693731|FG000|Overall Study|Other|2|||
131017288|NCT03622580|471693732|FG001|Overall Study|Other|0|||
131017289|NCT03622580|471693733|FG002|Overall Study|Other|3|||
131017290|NCT02613871|471693736|FG000|Overall Study|Death|2|||
131017291|NCT02613871|471693736|FG000|Overall Study|Withdrew Consent|1|||
131017292|NCT00507689|471693737|FG000|Pre-Randomization Period|Adverse Event|1|||
131017293|NCT00507689|471693738|FG001|Pre-Randomization Period|Adverse Event|0|||
131017294|NCT00507689|471693737|FG000|Pre-Randomization Period|Physician Decision|1|||
131017295|NCT00507689|471693738|FG001|Pre-Randomization Period|Physician Decision|0|||
131017296|NCT00507689|471693737|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
131017297|NCT00507689|471693738|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
131017298|NCT00507689|471693737|FG000|Randomized Period|Adverse Event|1|||
131017299|NCT00507689|471693738|FG001|Randomized Period|Adverse Event|1|||
131017300|NCT00507689|471693737|FG000|Randomized Period|Withdrawal by Subject|0|||
131017301|NCT00507689|471693738|FG001|Randomized Period|Withdrawal by Subject|1|||
131017302|NCT00494442|471693739|FG000|Overall Study|Death|1|||
131017303|NCT00494442|471693740|FG001|Overall Study|Death|1|||
131017304|NCT00494442|471693739|FG000|Overall Study|Lack of Efficacy|16|||
131017305|NCT00494442|471693740|FG001|Overall Study|Lack of Efficacy|10|||
131017306|NCT00494442|471693739|FG000|Overall Study|Adverse Event|0|||
131017307|NCT00494442|471693740|FG001|Overall Study|Adverse Event|2|||
131017308|NCT00494442|471693739|FG000|Overall Study|Physician Decision|0|||
131017309|NCT00494442|471693740|FG001|Overall Study|Physician Decision|1|||
131017310|NCT00494442|471693739|FG000|Overall Study|Non-compliance|0|||
131017311|NCT00494442|471693740|FG001|Overall Study|Non-compliance|1|||
131017312|NCT00494442|471693739|FG000|Overall Study|Intercurrent illness|0|||
131017313|NCT00494442|471693740|FG001|Overall Study|Intercurrent illness|1|||
131017314|NCT00831415|471693741|FG000|Overall Study|Adverse Event|14|||
131017315|NCT00831415|471693741|FG000|Overall Study|Failed to return|3|||
131017316|NCT00831415|471693741|FG000|Overall Study|Physician Decision|6|||
131017317|NCT00831415|471693741|FG000|Overall Study|Lost to Follow-up|9|||
131017318|NCT00831415|471693741|FG000|Overall Study|Protocol Violation|3|||
131017319|NCT00831415|471693741|FG000|Overall Study|Withdrawal by Subject|35|||
131017320|NCT00831415|471693741|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
131017321|NCT00831415|471693741|FG000|Overall Study|Death|1|||
131017322|NCT01290224|471693742|FG000|Overall Study|Adverse Event|1|||
130680815|NCT00048568|470458685|FG002|Open-Label Period|Pregnancy|5|||
130680816|NCT00048568|470458683|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
130680817|NCT00048568|470458684|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
130680818|NCT00048568|470458685|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
131017323|NCT01290224|471693742|FG000|Overall Study|Refused Further Treatment|4|||
131017324|NCT01241292|471693743|FG000|Overall Study|Administrative Reason by Sponsor|1|||
131017325|NCT01241292|471693744|FG001|Overall Study|Administrative Reason by Sponsor|0|||
131017326|NCT01241292|471693743|FG000|Overall Study|Disease Progression|2|||
131017327|NCT01241292|471693744|FG001|Overall Study|Disease Progression|0|||
131017328|NCT01241292|471693743|FG000|Overall Study|Study Drug Toxicity|0|||
131017329|NCT01241292|471693744|FG001|Overall Study|Study Drug Toxicity|1|||
131017330|NCT01241292|471693743|FG000|Overall Study|Participant Discontinued Treatment|0|||
131017331|NCT01241292|471693744|FG001|Overall Study|Participant Discontinued Treatment|2|||
131017332|NCT03861767|471693745|FG000|Overall Study|Withdrawal by Subject|2|||
131017333|NCT03861767|471693746|FG001|Overall Study|Withdrawal by Subject|1|||
131017334|NCT03861767|471693747|FG002|Overall Study|Withdrawal by Subject|0|||
131017335|NCT03861767|471693748|FG003|Overall Study|Withdrawal by Subject|5|||
131017336|NCT03861767|471693749|FG004|Overall Study|Withdrawal by Subject|2|||
131017337|NCT03861767|471693750|FG005|Overall Study|Withdrawal by Subject|1|||
131017338|NCT03861767|471693751|FG006|Overall Study|Withdrawal by Subject|3|||
131017339|NCT03861767|471693752|FG007|Overall Study|Withdrawal by Subject|1|||
131017340|NCT03861767|471693753|FG008|Overall Study|Withdrawal by Subject|0|||
131017341|NCT03861767|471693754|FG009|Overall Study|Withdrawal by Subject|5|||
131017342|NCT00346333|471693755|FG000|Overall Study|Death|1|||
131017343|NCT00346333|471693756|FG001|Overall Study|Death|0|||
131017344|NCT00346333|471693755|FG000|Overall Study|unwilling or unable to continue|4|||
131017345|NCT00346333|471693756|FG001|Overall Study|unwilling or unable to continue|8|||
131017346|NCT00813904|471693757|FG000|Overall Study|Death|1|||
131017347|NCT01087762|471693758|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
131017348|NCT01087762|471693759|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
131017349|NCT01087762|471693760|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
131017350|NCT01087762|471693761|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
131017351|NCT01087762|471693762|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
131017352|NCT01087762|471693758|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
131017353|NCT01087762|471693759|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
131017354|NCT01087762|471693760|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
131017355|NCT01087762|471693761|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
131017356|NCT01087762|471693762|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
131017357|NCT01087762|471693758|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
130680819|NCT00048568|470458683|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
130680820|NCT00048568|470458684|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
130680821|NCT00048568|470458685|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
130680822|NCT00048568|470458683|FG000|Open-Label Period|Unknown Reasons|0|||
130680823|NCT00048568|470458684|FG001|Open-Label Period|Unknown Reasons|0|||
130680824|NCT00048568|470458685|FG002|Open-Label Period|Unknown Reasons|25|||
130680825|NCT00048568|470458683|FG000|Open-Label Period|Lost to Follow-up|0|||
130680826|NCT00048568|470458684|FG001|Open-Label Period|Lost to Follow-up|0|||
131017358|NCT01087762|471693759|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
131017359|NCT01087762|471693760|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
131017360|NCT01087762|471693761|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
131017361|NCT01087762|471693762|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
131017362|NCT01087762|471693758|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
131017363|NCT01087762|471693759|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
131017364|NCT01087762|471693760|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
131017365|NCT01087762|471693761|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
131017366|NCT01087762|471693762|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
130680827|NCT00048568|470458685|FG002|Open-Label Period|Lost to Follow-up|7|||
131017367|NCT01087762|471693758|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
131017368|NCT01087762|471693759|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
131017369|NCT01087762|471693760|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
131017370|NCT01087762|471693761|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
131017371|NCT01087762|471693762|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
130680828|NCT03831048|470458686|FG000|Overall Study|Protocol Violation|9|||
130680829|NCT03831048|470458687|FG001|Overall Study|Protocol Violation|3|||
130885413|NCT00918255|471215198|FG001|Overall Study|Adverse Event|0|||
130885414|NCT00918255|471215199|FG002|Overall Study|Adverse Event|0|||
131017372|NCT01087762|471693758|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
131017373|NCT01087762|471693759|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
131017374|NCT01087762|471693760|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
131017375|NCT01087762|471693761|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
131017376|NCT01087762|471693762|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
131017377|NCT01087762|471693758|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
131017378|NCT01087762|471693759|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
131017379|NCT01087762|471693760|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
131017380|NCT01087762|471693761|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
131017381|NCT01087762|471693762|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
131017382|NCT01087762|471693758|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
131017383|NCT01087762|471693759|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
131017384|NCT01087762|471693760|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
131017385|NCT01087762|471693761|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
131017386|NCT01087762|471693762|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
131017387|NCT01087762|471693758|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
131017388|NCT01087762|471693759|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
131017389|NCT01087762|471693760|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
131017390|NCT01087762|471693761|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
131017391|NCT01087762|471693762|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
131017392|NCT01087762|471693758|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
131017393|NCT01087762|471693759|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
131017394|NCT01087762|471693760|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
131017395|NCT01087762|471693761|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
131017396|NCT01087762|471693762|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
131017397|NCT01087762|471693758|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
131017398|NCT01087762|471693759|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
131017399|NCT01087762|471693760|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
131017400|NCT01087762|471693761|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
131017401|NCT01087762|471693762|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
131017402|NCT01087762|471693758|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
131017403|NCT01087762|471693759|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
131017404|NCT01087762|471693760|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
131017405|NCT01087762|471693761|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
131017406|NCT01087762|471693762|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
131017407|NCT01087762|471693758|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
131017408|NCT01087762|471693759|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
131017409|NCT01087762|471693760|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
131017410|NCT01087762|471693761|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
131017411|NCT01087762|471693762|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
131017412|NCT01405924|471693763|FG000|Overall Study|Protocol Violation|8|||
131017413|NCT01405924|471693763|FG000|Overall Study|Missing/Incomplete Data|2|||
131017414|NCT03184558|471693764|FG000|Overall Study|Withdrawal by Subject|2|||
131017415|NCT03184558|471693764|FG000|Overall Study|Death|16|||
131017416|NCT03184558|471693764|FG000|Overall Study|Lost to Follow-up|2|||
131017417|NCT03184558|471693764|FG000|Overall Study|Other|9|||
131017418|NCT00723450|471693772|FG000|Open-Label Phase|Adverse Event|26|||
131017419|NCT00723450|471693773|FG001|Open-Label Phase|Adverse Event|0|||
131017420|NCT00723450|471693774|FG002|Open-Label Phase|Adverse Event|0|||
131017421|NCT00723450|471693772|FG000|Open-Label Phase|Lack of Efficacy|18|||
131017422|NCT00723450|471693773|FG001|Open-Label Phase|Lack of Efficacy|0|||
131017423|NCT00723450|471693774|FG002|Open-Label Phase|Lack of Efficacy|0|||
131017424|NCT00723450|471693772|FG000|Open-Label Phase|Protocol Violation|35|||
131017425|NCT00723450|471693773|FG001|Open-Label Phase|Protocol Violation|0|||
131017426|NCT00723450|471693774|FG002|Open-Label Phase|Protocol Violation|0|||
131017427|NCT00723450|471693772|FG000|Open-Label Phase|Lost to Follow-up|7|||
131017428|NCT00723450|471693773|FG001|Open-Label Phase|Lost to Follow-up|0|||
131017429|NCT00723450|471693774|FG002|Open-Label Phase|Lost to Follow-up|0|||
131017430|NCT00723450|471693772|FG000|Open-Label Phase|Physician Decision|2|||
131017431|NCT00723450|471693773|FG001|Open-Label Phase|Physician Decision|0|||
131017432|NCT00723450|471693774|FG002|Open-Label Phase|Physician Decision|0|||
131017433|NCT00723450|471693772|FG000|Open-Label Phase|Withdrawal by Subject|37|||
131017434|NCT00723450|471693773|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131017435|NCT00723450|471693774|FG002|Open-Label Phase|Withdrawal by Subject|0|||
131017436|NCT00723450|471693772|FG000|Randomized Phase|Adverse Event|0|||
131103652|NCT03149549|472008058|FG012|Study Discontinuation--Treatment Period|Other|0|||
130680830|NCT03831048|470458686|FG000|Overall Study|Death|4|||
130885415|NCT00918255|471215197|FG000|Overall Study|Withdrawal by Subject|1|||
130885416|NCT00918255|471215198|FG001|Overall Study|Withdrawal by Subject|0|||
130885417|NCT00918255|471215199|FG002|Overall Study|Withdrawal by Subject|2|||
130885418|NCT00918255|471215197|FG000|Overall Study|Lack of Efficacy|1|||
130885419|NCT00918255|471215198|FG001|Overall Study|Lack of Efficacy|0|||
130885420|NCT00918255|471215199|FG002|Overall Study|Lack of Efficacy|0|||
130885421|NCT00918255|471215197|FG000|Overall Study|Lost to Follow-up|1|||
130885422|NCT00918255|471215198|FG001|Overall Study|Lost to Follow-up|0|||
130885423|NCT00918255|471215199|FG002|Overall Study|Lost to Follow-up|2|||
130885424|NCT00918255|471215197|FG000|Overall Study|Exceeded allowed number of interventions|0|||
130885425|NCT00918255|471215198|FG001|Overall Study|Exceeded allowed number of interventions|0|||
130885426|NCT00918255|471215199|FG002|Overall Study|Exceeded allowed number of interventions|1|||
130885427|NCT00918255|471215197|FG000|Overall Study|Non-compliance|1|||
130885428|NCT00918255|471215198|FG001|Overall Study|Non-compliance|0|||
130885429|NCT00918255|471215199|FG002|Overall Study|Non-compliance|0|||
130885430|NCT00918255|471215197|FG000|Overall Study|Investigator discretion|1|||
130885431|NCT00918255|471215198|FG001|Overall Study|Investigator discretion|0|||
130885432|NCT00918255|471215199|FG002|Overall Study|Investigator discretion|0|||
130885433|NCT03763877|471215201|FG000|Overall Study|Withdrawal by Subject|3|||
130885434|NCT03763877|471215202|FG001|Overall Study|Withdrawal by Subject|1|||
130885435|NCT03763877|471215203|FG002|Overall Study|Withdrawal by Subject|3|||
130885436|NCT03763877|471215204|FG003|Overall Study|Withdrawal by Subject|4|||
130885437|NCT03763877|471215201|FG000|Overall Study|Adverse Event|1|||
130885438|NCT03763877|471215202|FG001|Overall Study|Adverse Event|1|||
130885439|NCT03763877|471215203|FG002|Overall Study|Adverse Event|3|||
130680831|NCT03831048|470458687|FG001|Overall Study|Death|9|||
130680832|NCT03831048|470458686|FG000|Overall Study|Re-transplant|0|||
130680833|NCT03831048|470458687|FG001|Overall Study|Re-transplant|2|||
130680834|NCT03831048|470458686|FG000|Overall Study|Protocol violation and death|1|||
130680835|NCT03831048|470458687|FG001|Overall Study|Protocol violation and death|1|||
130680836|NCT01315249|470458694|FG000|Overall Study|Adverse Event|22|||
130680837|NCT01315249|470458695|FG001|Overall Study|Adverse Event|26|||
130680838|NCT01315249|470458694|FG000|Overall Study|Withdrawal by Subject|11|||
130680839|NCT01315249|470458695|FG001|Overall Study|Withdrawal by Subject|10|||
130680840|NCT01315249|470458694|FG000|Overall Study|Protocol Violation|8|||
130680841|NCT01315249|470458695|FG001|Overall Study|Protocol Violation|5|||
130680842|NCT01315249|470458694|FG000|Overall Study|Abnormal test results|1|||
130680843|NCT01315249|470458695|FG001|Overall Study|Abnormal test results|2|||
130680844|NCT01315249|470458694|FG000|Overall Study|Administrative problems|1|||
130680845|NCT01315249|470458695|FG001|Overall Study|Administrative problems|0|||
130680846|NCT01315249|470458694|FG000|Overall Study|inability to use device|1|||
130680847|NCT01315249|470458695|FG001|Overall Study|inability to use device|0|||
130680848|NCT01315249|470458694|FG000|Overall Study|Lack of Efficacy|0|||
130680849|NCT01315249|470458695|FG001|Overall Study|Lack of Efficacy|1|||
130680850|NCT01315249|470458694|FG000|Overall Study|Lost to Follow-up|0|||
130680851|NCT01315249|470458695|FG001|Overall Study|Lost to Follow-up|2|||
130680852|NCT01315249|470458694|FG000|Overall Study|Death|0|||
130680853|NCT01315249|470458695|FG001|Overall Study|Death|1|||
130680854|NCT04099888|470458716|FG000|Overall Study|Study terminated by sponsor|9|||
130680855|NCT04099888|470458717|FG001|Overall Study|Study terminated by sponsor|11|||
130680856|NCT04099888|470458716|FG000|Overall Study|Lost to Follow-up|1|||
130680857|NCT04099888|470458717|FG001|Overall Study|Lost to Follow-up|1|||
130680858|NCT04099888|470458716|FG000|Overall Study|Withdrawal by Subject|5|||
130680859|NCT04099888|470458717|FG001|Overall Study|Withdrawal by Subject|6|||
130680860|NCT04099888|470458716|FG000|Overall Study|Death|5|||
130680861|NCT04099888|470458717|FG001|Overall Study|Death|2|||
130680862|NCT04099888|470458716|FG000|Overall Study|Other|1|||
130680863|NCT04099888|470458717|FG001|Overall Study|Other|0|||
130680864|NCT04538170|470458718|FG000|Overall Study|Withdrawal by Subject|104|||
130680865|NCT04538170|470458719|FG001|Overall Study|Withdrawal by Subject|210|||
130680866|NCT00274937|470458723|FG000|Overall Study|Physician Decision|10|||
130680867|NCT00274937|470458723|FG000|Overall Study|Withdrawal by Subject|6|||
130885440|NCT03763877|471215204|FG003|Overall Study|Adverse Event|1|||
130885441|NCT03763877|471215201|FG000|Overall Study|Protocol Violation|1|||
130885442|NCT03763877|471215202|FG001|Overall Study|Protocol Violation|1|||
131103653|NCT03149549|472008046|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131103654|NCT03149549|472008047|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131103655|NCT03149549|472008048|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131103656|NCT03149549|472008049|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131103657|NCT03149549|472008050|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
130680868|NCT00274937|470458723|FG000|Overall Study|Progressive Disease|4|||
130680869|NCT00864097|470458726|FG000|Overall Study|Death|0|||
130680870|NCT00864097|470458727|FG001|Overall Study|Death|1|||
130680871|NCT00864097|470458728|FG002|Overall Study|Death|0|||
130680872|NCT00864097|470458729|FG003|Overall Study|Death|0|||
130680873|NCT00864097|470458726|FG000|Overall Study|Adverse Event|6|||
130680874|NCT00864097|470458727|FG001|Overall Study|Adverse Event|8|||
130885443|NCT03763877|471215203|FG002|Overall Study|Protocol Violation|0|||
131103658|NCT03149549|472008051|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
131103659|NCT03149549|472008052|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
131103660|NCT03149549|472008053|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131103661|NCT03149549|472008054|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
131103662|NCT03149549|472008055|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131103663|NCT03149549|472008056|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131103664|NCT03149549|472008057|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131103665|NCT03149549|472008058|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
131103666|NCT03149549|472008046|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131103667|NCT03149549|472008047|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131103668|NCT03149549|472008048|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131103669|NCT03149549|472008049|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131103670|NCT03149549|472008050|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
131103671|NCT03149549|472008051|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131103672|NCT03149549|472008052|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131103673|NCT03149549|472008053|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
131103674|NCT03149549|472008054|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
131103675|NCT03149549|472008055|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131103676|NCT03149549|472008056|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
131103677|NCT03149549|472008057|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
131103678|NCT03149549|472008058|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
131103679|NCT03149549|472008046|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131103680|NCT03149549|472008047|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131103681|NCT03149549|472008048|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131103682|NCT03149549|472008049|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131103683|NCT03149549|472008050|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
131103684|NCT03149549|472008051|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131103685|NCT03149549|472008052|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131103686|NCT03149549|472008053|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
131103687|NCT03149549|472008054|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
131103688|NCT03149549|472008055|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
131103689|NCT03149549|472008056|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
131103690|NCT03149549|472008057|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
131103691|NCT03149549|472008058|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
131103692|NCT03149549|472008046|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
131103693|NCT03149549|472008047|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
131103694|NCT03149549|472008048|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
131103695|NCT03149549|472008049|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
131103696|NCT03149549|472008050|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
131103697|NCT03149549|472008051|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
131103698|NCT03149549|472008052|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
131103699|NCT03149549|472008053|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
131103700|NCT03149549|472008054|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
131103701|NCT03149549|472008055|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
131103702|NCT03149549|472008056|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
131103703|NCT03149549|472008057|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
131103704|NCT03149549|472008058|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
131103705|NCT03149549|472008046|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
131103706|NCT03149549|472008047|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
130680875|NCT00864097|470458728|FG002|Overall Study|Adverse Event|11|||
131103707|NCT03149549|472008048|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
131103708|NCT03149549|472008049|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
131103709|NCT03149549|472008050|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
131103710|NCT03149549|472008051|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
131103711|NCT03149549|472008052|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
131103712|NCT03149549|472008053|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
130680876|NCT00864097|470458729|FG003|Overall Study|Adverse Event|9|||
130680877|NCT00864097|470458726|FG000|Overall Study|Lack of Efficacy|9|||
130680878|NCT00864097|470458727|FG001|Overall Study|Lack of Efficacy|3|||
131103713|NCT03149549|472008054|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
131103714|NCT03149549|472008055|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
131103715|NCT03149549|472008056|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
130885444|NCT03763877|471215204|FG003|Overall Study|Protocol Violation|0|||
130680879|NCT00864097|470458728|FG002|Overall Study|Lack of Efficacy|7|||
130680880|NCT00864097|470458729|FG003|Overall Study|Lack of Efficacy|2|||
130885445|NCT03763877|471215201|FG000|Overall Study|Lost to Follow-up|0|||
130680881|NCT00864097|470458726|FG000|Overall Study|Lost to Follow-up|0|||
130680882|NCT00864097|470458727|FG001|Overall Study|Lost to Follow-up|1|||
130680883|NCT00864097|470458728|FG002|Overall Study|Lost to Follow-up|0|||
130680884|NCT00864097|470458729|FG003|Overall Study|Lost to Follow-up|1|||
130680885|NCT00864097|470458726|FG000|Overall Study|Withdrawal by Subject|15|||
130680886|NCT00864097|470458727|FG001|Overall Study|Withdrawal by Subject|11|||
130680887|NCT00864097|470458728|FG002|Overall Study|Withdrawal by Subject|11|||
130680888|NCT00864097|470458729|FG003|Overall Study|Withdrawal by Subject|12|||
130680889|NCT00864097|470458726|FG000|Overall Study|Protocol Violation|2|||
130680890|NCT00864097|470458727|FG001|Overall Study|Protocol Violation|1|||
130680891|NCT00864097|470458728|FG002|Overall Study|Protocol Violation|0|||
130680892|NCT00864097|470458729|FG003|Overall Study|Protocol Violation|1|||
130680893|NCT00864097|470458726|FG000|Overall Study|Terminated by sponsor|105|||
130680894|NCT00864097|470458727|FG001|Overall Study|Terminated by sponsor|112|||
130680895|NCT00864097|470458728|FG002|Overall Study|Terminated by sponsor|102|||
130680896|NCT00864097|470458729|FG003|Overall Study|Terminated by sponsor|99|||
131017437|NCT00723450|471693773|FG001|Randomized Phase|Adverse Event|26|||
131017438|NCT00723450|471693774|FG002|Randomized Phase|Adverse Event|17|||
131017439|NCT00723450|471693772|FG000|Randomized Phase|Lack of Efficacy|0|||
131017440|NCT00723450|471693773|FG001|Randomized Phase|Lack of Efficacy|11|||
131017441|NCT00723450|471693774|FG002|Randomized Phase|Lack of Efficacy|11|||
131017442|NCT00723450|471693772|FG000|Randomized Phase|Protocol Violation|0|||
131017443|NCT00723450|471693773|FG001|Randomized Phase|Protocol Violation|9|||
131017444|NCT00723450|471693774|FG002|Randomized Phase|Protocol Violation|13|||
131017445|NCT00723450|471693772|FG000|Randomized Phase|Lost to Follow-up|0|||
131017446|NCT00723450|471693773|FG001|Randomized Phase|Lost to Follow-up|2|||
131017447|NCT00723450|471693774|FG002|Randomized Phase|Lost to Follow-up|3|||
131017448|NCT00723450|471693772|FG000|Randomized Phase|Physician Decision|0|||
131017449|NCT00723450|471693773|FG001|Randomized Phase|Physician Decision|3|||
131017450|NCT00723450|471693774|FG002|Randomized Phase|Physician Decision|1|||
131017451|NCT00723450|471693772|FG000|Randomized Phase|Withdrawal by Subject|0|||
131017452|NCT00723450|471693773|FG001|Randomized Phase|Withdrawal by Subject|14|||
131017453|NCT00723450|471693774|FG002|Randomized Phase|Withdrawal by Subject|22|||
131017454|NCT00770965|471693775|FG000|Safety Set|Withdrawal by Subject|0|||
131017455|NCT00770965|471693776|FG001|Safety Set|Withdrawal by Subject|0|||
131017456|NCT00770965|471693777|FG002|Safety Set|Withdrawal by Subject|0|||
131017457|NCT00770965|471693778|FG003|Safety Set|Withdrawal by Subject|1|||
131017458|NCT00770965|471693775|FG000|Safety Set|Protocol deviation|0|||
131017459|NCT00770965|471693776|FG001|Safety Set|Protocol deviation|0|||
131017460|NCT00770965|471693777|FG002|Safety Set|Protocol deviation|1|||
131017461|NCT00770965|471693778|FG003|Safety Set|Protocol deviation|0|||
131017462|NCT00770965|471693775|FG000|Excluded Set|Administrative problems|14|||
131017463|NCT00770965|471693776|FG001|Excluded Set|Administrative problems|12|||
131017464|NCT00770965|471693777|FG002|Excluded Set|Administrative problems|12|||
131017465|NCT00770965|471693778|FG003|Excluded Set|Administrative problems|10|||
131017466|NCT00770965|471693775|FG000|Excluded Set|Withdrawal by Subject|1|||
131017467|NCT00770965|471693776|FG001|Excluded Set|Withdrawal by Subject|1|||
131017468|NCT00770965|471693777|FG002|Excluded Set|Withdrawal by Subject|2|||
131017469|NCT00770965|471693778|FG003|Excluded Set|Withdrawal by Subject|3|||
131017470|NCT03192046|471693780|FG000|Overall Study|Withdrawal by Subject|1|||
131017471|NCT03192046|471693781|FG001|Overall Study|Withdrawal by Subject|1|||
131017472|NCT00762606|471693782|FG000|Overall Study|Lost to Follow-up|18|||
131017473|NCT00762606|471693783|FG001|Overall Study|Lost to Follow-up|13|||
131017474|NCT01505881|471693784|FG000|Overall Study|Adverse Event|0|||
131017475|NCT01505881|471693785|FG001|Overall Study|Adverse Event|1|||
131017476|NCT01505881|471693784|FG000|Overall Study|Lost to Follow-up|2|||
131017477|NCT01505881|471693785|FG001|Overall Study|Lost to Follow-up|0|||
131017478|NCT01505881|471693784|FG000|Overall Study|Withdrawal by Subject|2|||
131017479|NCT01505881|471693785|FG001|Overall Study|Withdrawal by Subject|0|||
131017480|NCT00842257|471693786|FG000|Overall Study|Adverse Event|1|||
131017481|NCT04439799|471693787|FG000|Overall Study|Lost to Follow-up|6|||
131017482|NCT04439799|471693788|FG001|Overall Study|Lost to Follow-up|6|||
131017483|NCT04439799|471693787|FG000|Overall Study|Withdrawal by Subject|2|||
131017484|NCT04439799|471693788|FG001|Overall Study|Withdrawal by Subject|6|||
131017485|NCT04439799|471693787|FG000|Overall Study|Adverse Event|2|||
131017486|NCT04439799|471693788|FG001|Overall Study|Adverse Event|5|||
131017487|NCT01391130|471693796|FG000|Overall Study|Withdrawal by Subject|3|||
130680897|NCT00864097|470458726|FG000|Overall Study|Randomized but not treated|2|||
130680898|NCT00864097|470458727|FG001|Overall Study|Randomized but not treated|0|||
130885446|NCT03763877|471215202|FG001|Overall Study|Lost to Follow-up|1|||
131017488|NCT01391130|471693797|FG001|Overall Study|Withdrawal by Subject|2|||
131017489|NCT01391130|471693796|FG000|Overall Study|Physician Decision|2|||
131017490|NCT01391130|471693797|FG001|Overall Study|Physician Decision|3|||
131017491|NCT01391130|471693796|FG000|Overall Study|Did not Receive Drug|1|||
131017492|NCT01391130|471693797|FG001|Overall Study|Did not Receive Drug|1|||
131017493|NCT03615924|471693798|FG000|Overall Study|Withdrawal by Subject|2|||
131017494|NCT03615924|471693799|FG001|Overall Study|Withdrawal by Subject|5|||
131017495|NCT03615924|471693798|FG000|Overall Study|Death|3|||
131103716|NCT03149549|472008057|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
131103717|NCT03149549|472008058|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
131103718|NCT00153062|472010325|FG000|Overall Study|Death|360|||
131103719|NCT00153062|472010326|FG001|Overall Study|Death|352|||
131103720|NCT00153062|472010327|FG002|Overall Study|Death|369|||
131103721|NCT00153062|472010328|FG003|Overall Study|Death|365|||
131103722|NCT00153062|472010325|FG000|Overall Study|Withdrawal by Subject|14|||
131103723|NCT00153062|472010326|FG001|Overall Study|Withdrawal by Subject|30|||
131103724|NCT00153062|472010327|FG002|Overall Study|Withdrawal by Subject|27|||
130680899|NCT00864097|470458728|FG002|Overall Study|Randomized but not treated|1|||
130680900|NCT00864097|470458729|FG003|Overall Study|Randomized but not treated|0|||
130680901|NCT00864097|470458726|FG000|Overall Study|Other|0|||
130680902|NCT00864097|470458727|FG001|Overall Study|Other|0|||
130680903|NCT00864097|470458728|FG002|Overall Study|Other|0|||
130680904|NCT00864097|470458729|FG003|Overall Study|Other|1|||
130680905|NCT00880568|470458730|FG000|Overall Study|Disease progression|3|||
130680906|NCT00880568|470458731|FG001|Overall Study|Disease progression|3|||
130680907|NCT00880568|470458732|FG002|Overall Study|Disease progression|3|||
131103725|NCT00153062|472010328|FG003|Overall Study|Withdrawal by Subject|28|||
131103726|NCT00153062|472010325|FG000|Overall Study|Lost to Follow-up|12|||
131103727|NCT00153062|472010326|FG001|Overall Study|Lost to Follow-up|20|||
131103728|NCT00153062|472010327|FG002|Overall Study|Lost to Follow-up|15|||
131103729|NCT00153062|472010328|FG003|Overall Study|Lost to Follow-up|16|||
131103730|NCT00153062|472010325|FG000|Overall Study|Adverse Event|0|||
131103731|NCT00153062|472010326|FG001|Overall Study|Adverse Event|1|||
131103732|NCT00153062|472010327|FG002|Overall Study|Adverse Event|1|||
130680908|NCT00880568|470458733|FG003|Overall Study|Disease progression|1|||
130680909|NCT00880568|470458734|FG004|Overall Study|Disease progression|3|||
130680910|NCT00880568|470458735|FG005|Overall Study|Disease progression|3|||
130680911|NCT00880568|470458736|FG006|Overall Study|Disease progression|5|||
130680912|NCT00880568|470458737|FG007|Overall Study|Disease progression|0|||
130680913|NCT00880568|470458738|FG008|Overall Study|Disease progression|3|||
130680914|NCT00880568|470458730|FG000|Overall Study|Adverse Event|0|||
130680915|NCT00880568|470458731|FG001|Overall Study|Adverse Event|0|||
130680916|NCT00880568|470458732|FG002|Overall Study|Adverse Event|0|||
130680917|NCT00880568|470458733|FG003|Overall Study|Adverse Event|0|||
130680918|NCT00880568|470458734|FG004|Overall Study|Adverse Event|0|||
130680919|NCT00880568|470458735|FG005|Overall Study|Adverse Event|0|||
130680920|NCT00880568|470458736|FG006|Overall Study|Adverse Event|1|||
130680921|NCT00880568|470458737|FG007|Overall Study|Adverse Event|1|||
130680922|NCT00880568|470458738|FG008|Overall Study|Adverse Event|0|||
130680923|NCT00880568|470458730|FG000|Overall Study|Withdrawal by Subject|0|||
130680924|NCT00880568|470458731|FG001|Overall Study|Withdrawal by Subject|0|||
130680925|NCT00880568|470458732|FG002|Overall Study|Withdrawal by Subject|0|||
130680926|NCT00880568|470458733|FG003|Overall Study|Withdrawal by Subject|0|||
130680927|NCT00880568|470458734|FG004|Overall Study|Withdrawal by Subject|0|||
130680928|NCT00880568|470458735|FG005|Overall Study|Withdrawal by Subject|0|||
130680929|NCT00880568|470458736|FG006|Overall Study|Withdrawal by Subject|0|||
130680930|NCT00880568|470458737|FG007|Overall Study|Withdrawal by Subject|1|||
130680931|NCT00880568|470458738|FG008|Overall Study|Withdrawal by Subject|0|||
130680932|NCT00849901|470458742|FG000|Acute Treatment Phase|Adverse Event|9|||
130680933|NCT00849901|470458743|FG001|Acute Treatment Phase|Adverse Event|1|||
130680934|NCT00849901|470458744|FG002|Acute Treatment Phase|Adverse Event|3|||
130680935|NCT00849901|470458742|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
130680936|NCT00849901|470458743|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
130680937|NCT00849901|470458744|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
130680938|NCT00849901|470458742|FG000|Acute Treatment Phase|Protocol Violation|0|||
130680939|NCT00849901|470458743|FG001|Acute Treatment Phase|Protocol Violation|2|||
130680940|NCT00849901|470458744|FG002|Acute Treatment Phase|Protocol Violation|1|||
130680941|NCT00849901|470458742|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
130680942|NCT00849901|470458743|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
130680943|NCT00849901|470458744|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
130680944|NCT00849901|470458742|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
130680945|NCT00849901|470458743|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
130680946|NCT00849901|470458744|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
130680947|NCT00849901|470458742|FG000|Acute Treatment Phase|Physician Decision|1|||
131103733|NCT00153062|472010328|FG003|Overall Study|Adverse Event|0|||
131103734|NCT00153062|472010325|FG000|Overall Study|Protocol Violation|0|||
131103735|NCT00153062|472010326|FG001|Overall Study|Protocol Violation|2|||
131103736|NCT00153062|472010327|FG002|Overall Study|Protocol Violation|1|||
131103737|NCT00153062|472010328|FG003|Overall Study|Protocol Violation|1|||
130680948|NCT00849901|470458743|FG001|Acute Treatment Phase|Physician Decision|1|||
130680949|NCT00849901|470458744|FG002|Acute Treatment Phase|Physician Decision|1|||
130680950|NCT00849901|470458742|FG000|Acute Treatment Phase|Sponsor Decision|1|||
130680951|NCT00849901|470458743|FG001|Acute Treatment Phase|Sponsor Decision|0|||
131103738|NCT00153062|472010325|FG000|Overall Study|No disposition data available|1|||
130680952|NCT00849901|470458744|FG002|Acute Treatment Phase|Sponsor Decision|0|||
131103739|NCT00153062|472010326|FG001|Overall Study|No disposition data available|1|||
130680953|NCT00849901|470458742|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
130680954|NCT00849901|470458743|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
130680955|NCT00849901|470458744|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
130680956|NCT00849901|470458742|FG000|Extension Phase|Adverse Event|2|||
130680957|NCT00849901|470458743|FG001|Extension Phase|Adverse Event|8|||
130680958|NCT00849901|470458744|FG002|Extension Phase|Adverse Event|4|||
130680959|NCT00849901|470458742|FG000|Extension Phase|Lost to Follow-up|3|||
130680960|NCT00849901|470458743|FG001|Extension Phase|Lost to Follow-up|0|||
130680961|NCT00849901|470458744|FG002|Extension Phase|Lost to Follow-up|1|||
130680962|NCT00849901|470458742|FG000|Extension Phase|Protocol Violation|2|||
130680963|NCT00849901|470458743|FG001|Extension Phase|Protocol Violation|2|||
130680964|NCT00849901|470458744|FG002|Extension Phase|Protocol Violation|4|||
130680965|NCT00849901|470458742|FG000|Extension Phase|Withdrawal by Subject|7|||
130680966|NCT00849901|470458743|FG001|Extension Phase|Withdrawal by Subject|6|||
130680967|NCT00849901|470458744|FG002|Extension Phase|Withdrawal by Subject|3|||
130680968|NCT00849901|470458742|FG000|Extension Phase|Parent or Caregiver Decision|10|||
130680969|NCT00849901|470458743|FG001|Extension Phase|Parent or Caregiver Decision|4|||
130680970|NCT00849901|470458744|FG002|Extension Phase|Parent or Caregiver Decision|4|||
130680971|NCT00849901|470458742|FG000|Extension Phase|Physician Decision|1|||
130680972|NCT00849901|470458743|FG001|Extension Phase|Physician Decision|2|||
130680973|NCT00849901|470458744|FG002|Extension Phase|Physician Decision|0|||
130680974|NCT00849901|470458742|FG000|Extension Phase|Lack of Efficacy|2|||
130680975|NCT00849901|470458743|FG001|Extension Phase|Lack of Efficacy|4|||
130680976|NCT00849901|470458744|FG002|Extension Phase|Lack of Efficacy|1|||
130680977|NCT00262223|470458745|FG000|Treatment Phase|Withdrawal by Subject|3|||
130680978|NCT00262223|470458746|FG001|Treatment Phase|Withdrawal by Subject|6|||
130680979|NCT00262223|470458745|FG000|Treatment Phase|Adverse Event|1|||
130680980|NCT00262223|470458746|FG001|Treatment Phase|Adverse Event|2|||
130680981|NCT00262223|470458745|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
130680982|NCT00262223|470458746|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
130680983|NCT00262223|470458745|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
130680984|NCT00262223|470458746|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
130680985|NCT00262223|470458745|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
130680986|NCT00262223|470458746|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
130680987|NCT01804270|470458749|FG000|Overall Study|Withdrawal by Subject|1|||
130680988|NCT01804270|470458750|FG001|Overall Study|Withdrawal by Subject|1|||
130680989|NCT02152566|470458752|FG000|Overall Study|Lost to Follow-up|1|||
130680990|NCT02152566|470458752|FG000|Overall Study|Withdrawal by Subject|2|||
130680991|NCT01328093|470458756|FG000|Double-Blind Phase|Adverse Event|78|||
130680992|NCT01328093|470458757|FG001|Double-Blind Phase|Adverse Event|15|||
130680993|NCT01328093|470458756|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
130680994|NCT01328093|470458757|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
130680995|NCT01328093|470458756|FG000|Double-Blind Phase|Lost to Follow-up|39|||
130680996|NCT01328093|470458757|FG001|Double-Blind Phase|Lost to Follow-up|14|||
130680997|NCT01328093|470458756|FG000|Double-Blind Phase|Protocol Violation|30|||
130680998|NCT01328093|470458757|FG001|Double-Blind Phase|Protocol Violation|10|||
130680999|NCT01328093|470458756|FG000|Double-Blind Phase|Lack of Efficacy|55|||
130681000|NCT01328093|470458757|FG001|Double-Blind Phase|Lack of Efficacy|13|||
130681001|NCT01328093|470458756|FG000|Double-Blind Phase|Sponsor Decision|17|||
130681002|NCT01328093|470458757|FG001|Double-Blind Phase|Sponsor Decision|3|||
130681003|NCT01328093|470458756|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
130681004|NCT01328093|470458757|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
130681005|NCT01328093|470458756|FG000|Double-Blind Phase|Scheduling conflict|8|||
130681006|NCT01328093|470458757|FG001|Double-Blind Phase|Scheduling conflict|3|||
130681007|NCT01328093|470458756|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
130681008|NCT01328093|470458757|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
130681009|NCT01328093|470458756|FG000|Double-Blind Phase|Death|1|||
130681010|NCT01328093|470458757|FG001|Double-Blind Phase|Death|0|||
130681011|NCT01328093|470458756|FG000|Open-Label Phase|Sponsor Decision|98|||
130681012|NCT01328093|470458757|FG001|Open-Label Phase|Sponsor Decision|34|||
130681013|NCT01328093|470458756|FG000|Open-Label Phase|Protocol Violation|8|||
130681014|NCT01328093|470458757|FG001|Open-Label Phase|Protocol Violation|3|||
130681015|NCT01328093|470458756|FG000|Open-Label Phase|Lost to Follow-up|10|||
130681016|NCT01328093|470458757|FG001|Open-Label Phase|Lost to Follow-up|1|||
130681017|NCT01328093|470458756|FG000|Open-Label Phase|Adverse Event|10|||
130681018|NCT01328093|470458757|FG001|Open-Label Phase|Adverse Event|4|||
131017496|NCT03615924|471693799|FG001|Overall Study|Death|1|||
131017497|NCT03615924|471693798|FG000|Overall Study|Lost to Follow-up|1|||
131017498|NCT03615924|471693799|FG001|Overall Study|Lost to Follow-up|0|||
130681019|NCT01328093|470458756|FG000|Open-Label Phase|Lack of Efficacy|5|||
130681020|NCT01328093|470458757|FG001|Open-Label Phase|Lack of Efficacy|6|||
130681021|NCT01328093|470458756|FG000|Open-Label Phase|Withdrawal by Subject|4|||
130681022|NCT01328093|470458757|FG001|Open-Label Phase|Withdrawal by Subject|1|||
131017499|NCT03615924|471693798|FG000|Overall Study|Randomized in error|1|||
130681023|NCT01328093|470458756|FG000|Open-Label Phase|Scheduling conflict|2|||
130681024|NCT01328093|470458757|FG001|Open-Label Phase|Scheduling conflict|1|||
130681025|NCT01328093|470458756|FG000|Open-Label Phase|Subject is moving or has moved|2|||
130681026|NCT01328093|470458757|FG001|Open-Label Phase|Subject is moving or has moved|0|||
130681027|NCT01328093|470458756|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
130681028|NCT01328093|470458757|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
130681029|NCT00832377|470458758|FG000|Overall Study|Protocol Violation|1|||
130681030|NCT03661528|470458759|FG000|Overall Study|Death|1|||
130681031|NCT03661528|470458760|FG001|Overall Study|Death|0|||
130681032|NCT03661528|470458759|FG000|Overall Study|Physician Decision|3|||
130681033|NCT03661528|470458760|FG001|Overall Study|Physician Decision|1|||
130681034|NCT03661528|470458759|FG000|Overall Study|Other than Specified|5|||
130681035|NCT03661528|470458760|FG001|Overall Study|Other than Specified|2|||
130681036|NCT03661528|470458759|FG000|Overall Study|Withdrawal by Subject|5|||
130681037|NCT03661528|470458760|FG001|Overall Study|Withdrawal by Subject|3|||
130681038|NCT03661528|470458759|FG000|Overall Study|Disease Progression|8|||
130681039|NCT03661528|470458760|FG001|Overall Study|Disease Progression|13|||
130681040|NCT03661528|470458759|FG000|Overall Study|Adverse Event|61|||
130681041|NCT03661528|470458760|FG001|Overall Study|Adverse Event|55|||
130681042|NCT00925769|470458762|FG000|Overall Study|Major toxicity|1|||
130681043|NCT00925769|470458763|FG001|Overall Study|Major toxicity|0|||
130681044|NCT00925769|470458764|FG002|Overall Study|Major toxicity|1|||
130681045|NCT00925769|470458765|FG003|Overall Study|Major toxicity|1|||
130681046|NCT00925769|470458766|FG004|Overall Study|Major toxicity|0|||
130681047|NCT00925769|470458767|FG005|Overall Study|Major toxicity|0|||
130681048|NCT00925769|470458762|FG000|Overall Study|Disease progression|4|||
130681049|NCT00925769|470458763|FG001|Overall Study|Disease progression|5|||
130681050|NCT00925769|470458764|FG002|Overall Study|Disease progression|3|||
130681051|NCT00925769|470458765|FG003|Overall Study|Disease progression|4|||
130681052|NCT00925769|470458766|FG004|Overall Study|Disease progression|2|||
130681053|NCT00925769|470458767|FG005|Overall Study|Disease progression|3|||
130681054|NCT00925769|470458762|FG000|Overall Study|Death|0|||
130681055|NCT00925769|470458763|FG001|Overall Study|Death|0|||
130681056|NCT00925769|470458764|FG002|Overall Study|Death|1|||
130681057|NCT00925769|470458765|FG003|Overall Study|Death|0|||
130681058|NCT00925769|470458766|FG004|Overall Study|Death|0|||
130681059|NCT00925769|470458767|FG005|Overall Study|Death|0|||
130681060|NCT00925769|470458762|FG000|Overall Study|Physician Decision|1|||
130681061|NCT00925769|470458763|FG001|Overall Study|Physician Decision|0|||
130681062|NCT00925769|470458764|FG002|Overall Study|Physician Decision|0|||
130681063|NCT00925769|470458765|FG003|Overall Study|Physician Decision|0|||
130681064|NCT00925769|470458766|FG004|Overall Study|Physician Decision|0|||
130681065|NCT00925769|470458767|FG005|Overall Study|Physician Decision|0|||
130681066|NCT00925769|470458762|FG000|Overall Study|Missing documentation|0|||
130681067|NCT00925769|470458763|FG001|Overall Study|Missing documentation|1|||
130681068|NCT00925769|470458764|FG002|Overall Study|Missing documentation|0|||
130681069|NCT00925769|470458765|FG003|Overall Study|Missing documentation|0|||
130681070|NCT00925769|470458766|FG004|Overall Study|Missing documentation|0|||
130681071|NCT00925769|470458767|FG005|Overall Study|Missing documentation|0|||
130681072|NCT00925769|470458762|FG000|Overall Study|End of study visit not done|0|||
130681073|NCT00925769|470458763|FG001|Overall Study|End of study visit not done|0|||
130681074|NCT00925769|470458764|FG002|Overall Study|End of study visit not done|1|||
130681075|NCT00925769|470458765|FG003|Overall Study|End of study visit not done|0|||
130681076|NCT00925769|470458766|FG004|Overall Study|End of study visit not done|0|||
130681077|NCT00925769|470458767|FG005|Overall Study|End of study visit not done|0|||
130681078|NCT00925769|470458762|FG000|Overall Study|Participant is unable to swallow drug|0|||
130681079|NCT00925769|470458763|FG001|Overall Study|Participant is unable to swallow drug|0|||
130681080|NCT00925769|470458764|FG002|Overall Study|Participant is unable to swallow drug|0|||
130681081|NCT00925769|470458765|FG003|Overall Study|Participant is unable to swallow drug|1|||
130681082|NCT00925769|470458766|FG004|Overall Study|Participant is unable to swallow drug|0|||
130681083|NCT00925769|470458767|FG005|Overall Study|Participant is unable to swallow drug|0|||
130681084|NCT00925769|470458762|FG000|Overall Study|Adverse Event|0|||
130681085|NCT00925769|470458763|FG001|Overall Study|Adverse Event|0|||
130681086|NCT00925769|470458764|FG002|Overall Study|Adverse Event|0|||
130681087|NCT00925769|470458765|FG003|Overall Study|Adverse Event|0|||
130681088|NCT00925769|470458766|FG004|Overall Study|Adverse Event|1|||
130681089|NCT00925769|470458767|FG005|Overall Study|Adverse Event|0|||
130681090|NCT02017964|470458768|FG000|Overall Study|Patient deemed ineligible|1|||
130681091|NCT01449630|470458770|FG000|Period 1|Physician Decision|1|||
130681092|NCT01449630|470458771|FG001|Period 1|Physician Decision|0|||
130681093|NCT01449630|470458772|FG002|Period 1|Physician Decision|0|||
130681094|NCT01449630|470458773|FG003|Period 1|Physician Decision|1|||
130681095|NCT01449630|470458774|FG004|Period 1|Physician Decision|0|||
130681096|NCT01449630|470458775|FG005|Period 1|Physician Decision|0|||
130681097|NCT01449630|470458776|FG006|Period 1|Physician Decision|0|||
130681098|NCT01449630|470458777|FG007|Period 1|Physician Decision|0|||
130681099|NCT01449630|470458778|FG008|Period 1|Physician Decision|0|||
130681100|NCT01449630|470458770|FG000|Period 1|Sponsor Decision|0|||
130681101|NCT01449630|470458771|FG001|Period 1|Sponsor Decision|0|||
130681102|NCT01449630|470458772|FG002|Period 1|Sponsor Decision|0|||
130681103|NCT01449630|470458773|FG003|Period 1|Sponsor Decision|0|||
131103740|NCT00153062|472010327|FG002|Overall Study|No disposition data available|1|||
131103741|NCT00153062|472010328|FG003|Overall Study|No disposition data available|1|||
131103742|NCT00153062|472010325|FG000|Overall Study|Other|0|||
131103743|NCT00153062|472010326|FG001|Overall Study|Other|0|||
131103744|NCT00153062|472010327|FG002|Overall Study|Other|1|||
131103745|NCT00153062|472010328|FG003|Overall Study|Other|0|||
131103746|NCT00275262|472010335|FG000|Overall Study|Adverse Event|2|||
131103747|NCT00275262|472010336|FG001|Overall Study|Adverse Event|0|||
131103748|NCT00275262|472010335|FG000|Overall Study|Disease progression|2|||
131103749|NCT00275262|472010336|FG001|Overall Study|Disease progression|5|||
131103750|NCT00275262|472010335|FG000|Overall Study|Lost to Follow-up|0|||
131103751|NCT00275262|472010336|FG001|Overall Study|Lost to Follow-up|2|||
131103752|NCT00275262|472010335|FG000|Overall Study|Protocol Violation|0|||
131103753|NCT00275262|472010336|FG001|Overall Study|Protocol Violation|2|||
131103754|NCT00275262|472010335|FG000|Overall Study|Death|1|||
130681104|NCT01449630|470458774|FG004|Period 1|Sponsor Decision|0|||
130681105|NCT01449630|470458775|FG005|Period 1|Sponsor Decision|1|||
130681106|NCT01449630|470458776|FG006|Period 1|Sponsor Decision|0|||
130885447|NCT03763877|471215203|FG002|Overall Study|Lost to Follow-up|1|||
130885448|NCT03763877|471215204|FG003|Overall Study|Lost to Follow-up|0|||
130681107|NCT01449630|470458777|FG007|Period 1|Sponsor Decision|0|||
130681108|NCT01449630|470458778|FG008|Period 1|Sponsor Decision|0|||
130681109|NCT01449630|470458770|FG000|Period 2|Sponsor Decision|0|||
130681110|NCT01449630|470458771|FG001|Period 2|Sponsor Decision|0|||
130681111|NCT01449630|470458772|FG002|Period 2|Sponsor Decision|0|||
130885449|NCT03040336|471215205|FG000|Overall Study|Death|1|||
130885450|NCT03040336|471215206|FG001|Overall Study|Death|0|||
130885451|NCT03040336|471215205|FG000|Overall Study|Withdrawal by Subject|2|||
130885452|NCT03040336|471215206|FG001|Overall Study|Withdrawal by Subject|3|||
130681112|NCT01449630|470458773|FG003|Period 2|Sponsor Decision|0|||
130681113|NCT01449630|470458774|FG004|Period 2|Sponsor Decision|0|||
130681114|NCT01449630|470458775|FG005|Period 2|Sponsor Decision|0|||
130681115|NCT01449630|470458776|FG006|Period 2|Sponsor Decision|1|||
130681116|NCT01449630|470458777|FG007|Period 2|Sponsor Decision|0|||
130681117|NCT01449630|470458778|FG008|Period 2|Sponsor Decision|0|||
130681118|NCT01735630|470458783|FG000|Overall Study|Adverse Event|8|||
130681119|NCT01735630|470458784|FG001|Overall Study|Adverse Event|7|||
130681120|NCT01735630|470458783|FG000|Overall Study|Lost to Follow-up|1|||
130681121|NCT01735630|470458784|FG001|Overall Study|Lost to Follow-up|0|||
130681122|NCT01735630|470458783|FG000|Overall Study|Physician Decision|0|||
130681123|NCT01735630|470458784|FG001|Overall Study|Physician Decision|1|||
130681124|NCT01735630|470458783|FG000|Overall Study|Sponsor Decision|2|||
130681125|NCT01735630|470458784|FG001|Overall Study|Sponsor Decision|1|||
130681126|NCT01735630|470458783|FG000|Overall Study|Withdrawal by Subject|7|||
130681127|NCT01735630|470458784|FG001|Overall Study|Withdrawal by Subject|9|||
130681128|NCT03099538|470458785|FG000|Overall Study|Lack of Efficacy|3|||
130681129|NCT01720264|470458786|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
130681130|NCT01720264|470458786|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
130681131|NCT01720264|470458786|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
130681132|NCT00615069|470458796|FG000|Overall Study|Death|10|||
130681133|NCT00615069|470458796|FG000|Overall Study|Physician Decision|2|||
130681134|NCT00615069|470458796|FG000|Overall Study|Withdrawal by Subject|4|||
130681135|NCT00259012|470458798|FG000|Overall Study|Adverse Event|0|||
130681136|NCT00259012|470458799|FG001|Overall Study|Adverse Event|1|||
130681137|NCT00259012|470458798|FG000|Overall Study|Withdrawal by Subject|1|||
130681138|NCT00259012|470458799|FG001|Overall Study|Withdrawal by Subject|0|||
130681139|NCT00259012|470458798|FG000|Overall Study|Physician Decision|0|||
130681140|NCT00259012|470458799|FG001|Overall Study|Physician Decision|1|||
130681141|NCT00259012|470458798|FG000|Overall Study|Lost to Follow-up|0|||
130681142|NCT00259012|470458799|FG001|Overall Study|Lost to Follow-up|1|||
130681143|NCT00259012|470458798|FG000|Overall Study|Protocol Violation|1|||
130681144|NCT00259012|470458799|FG001|Overall Study|Protocol Violation|1|||
130885453|NCT00068692|471215209|FG000|Step 1: Registration|Disese progression/relapse|5|||
130885454|NCT00068692|471215210|FG001|Step 1: Registration|Disese progression/relapse|0|||
130885455|NCT00068692|471215211|FG002|Step 1: Registration|Disese progression/relapse|0|||
130681145|NCT01941030|470458805|FG000|Overall Study|Death|3|||
130681146|NCT01941030|470458806|FG001|Overall Study|Death|2|||
130681147|NCT01941030|470458805|FG000|Overall Study|Lost to Follow-up|6|||
130681148|NCT01941030|470458806|FG001|Overall Study|Lost to Follow-up|5|||
130681149|NCT01941030|470458805|FG000|Overall Study|Withdrawal by Subject|4|||
130885456|NCT00068692|471215212|FG003|Step 1: Registration|Disese progression/relapse|0|||
130885457|NCT00068692|471215213|FG004|Step 1: Registration|Disese progression/relapse|0|||
131103755|NCT00275262|472010336|FG001|Overall Study|Death|0|||
131103756|NCT00275262|472010335|FG000|Overall Study|Started Chemotherapy|1|||
131103757|NCT00275262|472010336|FG001|Overall Study|Started Chemotherapy|0|||
131103758|NCT01589237|472010349|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
131103759|NCT01589237|472010350|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
130681150|NCT01941030|470458806|FG001|Overall Study|Withdrawal by Subject|6|||
130681151|NCT01479439|470458810|FG000|Overall Study|Adverse Event|1|||
130681152|NCT01479439|470458811|FG001|Overall Study|Adverse Event|0|||
130885458|NCT00068692|471215214|FG005|Step 1: Registration|Disese progression/relapse|0|||
130885459|NCT00068692|471215215|FG006|Step 1: Registration|Disese progression/relapse|0|||
130885460|NCT00068692|471215216|FG007|Step 1: Registration|Disese progression/relapse|0|||
130885461|NCT00068692|471215209|FG000|Step 1: Registration|Adverse Event|7|||
130885462|NCT00068692|471215210|FG001|Step 1: Registration|Adverse Event|0|||
130885463|NCT00068692|471215211|FG002|Step 1: Registration|Adverse Event|0|||
130885464|NCT00068692|471215212|FG003|Step 1: Registration|Adverse Event|0|||
130885465|NCT00068692|471215213|FG004|Step 1: Registration|Adverse Event|0|||
130885466|NCT00068692|471215214|FG005|Step 1: Registration|Adverse Event|0|||
130885467|NCT00068692|471215215|FG006|Step 1: Registration|Adverse Event|0|||
130885468|NCT00068692|471215216|FG007|Step 1: Registration|Adverse Event|0|||
130885469|NCT00068692|471215209|FG000|Step 1: Registration|Death|1|||
130885470|NCT00068692|471215210|FG001|Step 1: Registration|Death|0|||
130885471|NCT00068692|471215211|FG002|Step 1: Registration|Death|0|||
130885472|NCT00068692|471215212|FG003|Step 1: Registration|Death|0|||
130885473|NCT00068692|471215213|FG004|Step 1: Registration|Death|0|||
130885474|NCT00068692|471215214|FG005|Step 1: Registration|Death|0|||
130885475|NCT00068692|471215215|FG006|Step 1: Registration|Death|0|||
130885476|NCT00068692|471215216|FG007|Step 1: Registration|Death|0|||
130885477|NCT00068692|471215209|FG000|Step 1: Registration|Withdrawal by Subject|11|||
130885478|NCT00068692|471215210|FG001|Step 1: Registration|Withdrawal by Subject|0|||
130885479|NCT00068692|471215211|FG002|Step 1: Registration|Withdrawal by Subject|0|||
130885480|NCT00068692|471215212|FG003|Step 1: Registration|Withdrawal by Subject|0|||
130885481|NCT00068692|471215213|FG004|Step 1: Registration|Withdrawal by Subject|0|||
130885482|NCT00068692|471215214|FG005|Step 1: Registration|Withdrawal by Subject|0|||
130885483|NCT00068692|471215215|FG006|Step 1: Registration|Withdrawal by Subject|0|||
130885484|NCT00068692|471215216|FG007|Step 1: Registration|Withdrawal by Subject|0|||
130885485|NCT00068692|471215209|FG000|Step 1: Registration|Alternative therapy|2|||
130885486|NCT00068692|471215210|FG001|Step 1: Registration|Alternative therapy|0|||
130885487|NCT00068692|471215211|FG002|Step 1: Registration|Alternative therapy|0|||
130885488|NCT00068692|471215212|FG003|Step 1: Registration|Alternative therapy|0|||
130885489|NCT00068692|471215213|FG004|Step 1: Registration|Alternative therapy|0|||
130885490|NCT00068692|471215214|FG005|Step 1: Registration|Alternative therapy|0|||
130885491|NCT00068692|471215215|FG006|Step 1: Registration|Alternative therapy|0|||
130885492|NCT00068692|471215216|FG007|Step 1: Registration|Alternative therapy|0|||
130885493|NCT00068692|471215209|FG000|Step 1: Registration|Complicating disease|2|||
130681153|NCT01479439|470458812|FG002|Overall Study|Adverse Event|0|||
130681154|NCT01479439|470458810|FG000|Overall Study|Lost to Follow-up|0|||
130681155|NCT01479439|470458811|FG001|Overall Study|Lost to Follow-up|1|||
130681156|NCT01479439|470458812|FG002|Overall Study|Lost to Follow-up|0|||
130681157|NCT01479439|470458810|FG000|Overall Study|Protocol Violation|0|||
130681158|NCT01479439|470458811|FG001|Overall Study|Protocol Violation|0|||
130681159|NCT01479439|470458812|FG002|Overall Study|Protocol Violation|2|||
130681160|NCT01936948|470458813|FG000|Overall Study|no 30-day follow-up data|0|||
130885494|NCT00068692|471215210|FG001|Step 1: Registration|Complicating disease|0|||
130885495|NCT00068692|471215211|FG002|Step 1: Registration|Complicating disease|0|||
130885496|NCT00068692|471215212|FG003|Step 1: Registration|Complicating disease|0|||
130885497|NCT00068692|471215213|FG004|Step 1: Registration|Complicating disease|0|||
130885498|NCT00068692|471215214|FG005|Step 1: Registration|Complicating disease|0|||
130885499|NCT00068692|471215215|FG006|Step 1: Registration|Complicating disease|0|||
130885500|NCT00068692|471215216|FG007|Step 1: Registration|Complicating disease|0|||
130885501|NCT00068692|471215209|FG000|Step 1: Registration|Protocol Violation|1|||
130885502|NCT00068692|471215210|FG001|Step 1: Registration|Protocol Violation|0|||
130885503|NCT00068692|471215211|FG002|Step 1: Registration|Protocol Violation|0|||
130885504|NCT00068692|471215212|FG003|Step 1: Registration|Protocol Violation|0|||
130681161|NCT01936948|470458814|FG001|Overall Study|no 30-day follow-up data|3|||
130681162|NCT01936948|470458815|FG002|Overall Study|no 30-day follow-up data|3|||
130681163|NCT01936948|470458816|FG003|Overall Study|no 30-day follow-up data|3|||
130681164|NCT02365207|470458817|FG000|Overall Study|Withdrawal by Subject|1|||
130681165|NCT02365207|470458817|FG000|Overall Study|Physician Decision|1|||
130681166|NCT02930005|470458818|FG000|Overall Study|Lost to Follow-up|1|||
130681167|NCT02930005|470458819|FG001|Overall Study|Lost to Follow-up|5|||
130681168|NCT02781727|470458820|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
130885505|NCT00068692|471215213|FG004|Step 1: Registration|Protocol Violation|0|||
130681169|NCT02781727|470458821|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
130681170|NCT02781727|470458820|FG000|Treatment Period|Withdrawal by Subject|1|||
130885506|NCT00068692|471215214|FG005|Step 1: Registration|Protocol Violation|0|||
130885507|NCT00068692|471215215|FG006|Step 1: Registration|Protocol Violation|0|||
130885508|NCT00068692|471215216|FG007|Step 1: Registration|Protocol Violation|0|||
131017500|NCT03615924|471693799|FG001|Overall Study|Randomized in error|0|||
130885509|NCT00068692|471215209|FG000|Step 1: Registration|Not eligible|6|||
130885510|NCT00068692|471215210|FG001|Step 1: Registration|Not eligible|0|||
130885511|NCT00068692|471215211|FG002|Step 1: Registration|Not eligible|0|||
130681171|NCT02781727|470458821|FG001|Treatment Period|Withdrawal by Subject|0|||
130885512|NCT00068692|471215212|FG003|Step 1: Registration|Not eligible|0|||
130681172|NCT02781727|470458820|FG000|Treatment Period|Lost to Follow-up|0|||
130885513|NCT00068692|471215213|FG004|Step 1: Registration|Not eligible|0|||
130885514|NCT00068692|471215214|FG005|Step 1: Registration|Not eligible|0|||
130885515|NCT00068692|471215215|FG006|Step 1: Registration|Not eligible|0|||
130885516|NCT00068692|471215216|FG007|Step 1: Registration|Not eligible|0|||
130885517|NCT00068692|471215209|FG000|Step 1: Registration|Other|2|||
130885518|NCT00068692|471215210|FG001|Step 1: Registration|Other|0|||
130885519|NCT00068692|471215211|FG002|Step 1: Registration|Other|0|||
130885520|NCT00068692|471215212|FG003|Step 1: Registration|Other|0|||
130885521|NCT00068692|471215213|FG004|Step 1: Registration|Other|0|||
130885522|NCT00068692|471215214|FG005|Step 1: Registration|Other|0|||
130885523|NCT00068692|471215215|FG006|Step 1: Registration|Other|0|||
130885524|NCT00068692|471215216|FG007|Step 1: Registration|Other|0|||
130885525|NCT00068692|471215209|FG000|Step 1: Registration|Not start protocol therapy|3|||
130885526|NCT00068692|471215210|FG001|Step 1: Registration|Not start protocol therapy|0|||
130885527|NCT00068692|471215211|FG002|Step 1: Registration|Not start protocol therapy|0|||
130885528|NCT00068692|471215212|FG003|Step 1: Registration|Not start protocol therapy|0|||
130885529|NCT00068692|471215213|FG004|Step 1: Registration|Not start protocol therapy|0|||
130885530|NCT00068692|471215214|FG005|Step 1: Registration|Not start protocol therapy|0|||
130885531|NCT00068692|471215215|FG006|Step 1: Registration|Not start protocol therapy|0|||
130885532|NCT00068692|471215216|FG007|Step 1: Registration|Not start protocol therapy|0|||
130885533|NCT00068692|471215209|FG000|Step 1: Registration|Registered but not randomized|0|||
130885534|NCT00068692|471215210|FG001|Step 1: Registration|Registered but not randomized|1|||
130885535|NCT00068692|471215211|FG002|Step 1: Registration|Registered but not randomized|0|||
130885536|NCT00068692|471215212|FG003|Step 1: Registration|Registered but not randomized|0|||
130885537|NCT00068692|471215213|FG004|Step 1: Registration|Registered but not randomized|0|||
130885538|NCT00068692|471215214|FG005|Step 1: Registration|Registered but not randomized|0|||
130885539|NCT00068692|471215215|FG006|Step 1: Registration|Registered but not randomized|0|||
130885540|NCT00068692|471215216|FG007|Step 1: Registration|Registered but not randomized|0|||
130885541|NCT00068692|471215209|FG000|Step 2: Randomization|Disesae progression/replase|0|||
130885542|NCT00068692|471215210|FG001|Step 2: Randomization|Disesae progression/replase|0|||
130885543|NCT00068692|471215211|FG002|Step 2: Randomization|Disesae progression/replase|1|||
130885544|NCT00068692|471215212|FG003|Step 2: Randomization|Disesae progression/replase|1|||
130885545|NCT00068692|471215213|FG004|Step 2: Randomization|Disesae progression/replase|0|||
130885546|NCT00068692|471215214|FG005|Step 2: Randomization|Disesae progression/replase|0|||
130885547|NCT00068692|471215215|FG006|Step 2: Randomization|Disesae progression/replase|0|||
130885548|NCT00068692|471215216|FG007|Step 2: Randomization|Disesae progression/replase|0|||
130885549|NCT00068692|471215209|FG000|Step 2: Randomization|Adverse Event|0|||
130885550|NCT00068692|471215210|FG001|Step 2: Randomization|Adverse Event|0|||
130885551|NCT00068692|471215211|FG002|Step 2: Randomization|Adverse Event|4|||
130885552|NCT00068692|471215212|FG003|Step 2: Randomization|Adverse Event|2|||
130885553|NCT00068692|471215213|FG004|Step 2: Randomization|Adverse Event|2|||
130885554|NCT00068692|471215214|FG005|Step 2: Randomization|Adverse Event|3|||
130885555|NCT00068692|471215215|FG006|Step 2: Randomization|Adverse Event|4|||
130885556|NCT00068692|471215216|FG007|Step 2: Randomization|Adverse Event|4|||
130885557|NCT00068692|471215209|FG000|Step 2: Randomization|Death|0|||
130885558|NCT00068692|471215210|FG001|Step 2: Randomization|Death|0|||
130885559|NCT00068692|471215211|FG002|Step 2: Randomization|Death|0|||
130885560|NCT00068692|471215212|FG003|Step 2: Randomization|Death|0|||
130885561|NCT00068692|471215213|FG004|Step 2: Randomization|Death|1|||
130885562|NCT00068692|471215214|FG005|Step 2: Randomization|Death|0|||
130885563|NCT00068692|471215215|FG006|Step 2: Randomization|Death|0|||
130885564|NCT00068692|471215216|FG007|Step 2: Randomization|Death|1|||
130885565|NCT00068692|471215209|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
130885566|NCT00068692|471215210|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
130885567|NCT00068692|471215211|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
130885568|NCT00068692|471215212|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
130681173|NCT02781727|470458821|FG001|Treatment Period|Lost to Follow-up|1|||
130681174|NCT01378975|470458825|FG000|Overall Study|Death|77|||
130681175|NCT01378975|470458826|FG001|Overall Study|Death|46|||
130681176|NCT01378975|470458825|FG000|Overall Study|Investigator Request|1|||
130681177|NCT01378975|470458826|FG001|Overall Study|Investigator Request|0|||
130681178|NCT01378975|470458825|FG000|Overall Study|Lost to Follow-up|4|||
130681179|NCT01378975|470458826|FG001|Overall Study|Lost to Follow-up|1|||
130681180|NCT01378975|470458825|FG000|Overall Study|Withdrew Consent|4|||
130681181|NCT01378975|470458826|FG001|Overall Study|Withdrew Consent|3|||
130681182|NCT03991494|470458829|FG000|Overall Study|Progressive Disease|4|||
130681183|NCT02924038|470460234|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
130885569|NCT00068692|471215213|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
130885570|NCT00068692|471215214|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
130885571|NCT00068692|471215215|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
130885572|NCT00068692|471215216|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
130885573|NCT00068692|471215209|FG000|Step 2: Randomization|alternative therapy|0|||
130885574|NCT00068692|471215210|FG001|Step 2: Randomization|alternative therapy|0|||
130885575|NCT00068692|471215211|FG002|Step 2: Randomization|alternative therapy|0|||
130681184|NCT02924038|470460235|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
130681185|NCT01108094|470460236|FG000|Overall Study|Adverse Event|2|||
130681186|NCT01108094|470460237|FG001|Overall Study|Adverse Event|0|||
130681187|NCT01108094|470460238|FG002|Overall Study|Adverse Event|0|||
130681188|NCT01108094|470460239|FG003|Overall Study|Adverse Event|0|||
130681189|NCT01108094|470460236|FG000|Overall Study|Withdrawal by Subject|1|||
130681190|NCT01108094|470460237|FG001|Overall Study|Withdrawal by Subject|0|||
130681191|NCT01108094|470460238|FG002|Overall Study|Withdrawal by Subject|0|||
130681192|NCT01108094|470460239|FG003|Overall Study|Withdrawal by Subject|0|||
130681193|NCT01101022|470460250|FG000|Overall Study|Adverse Event|6|||
130681194|NCT01101022|470460251|FG001|Overall Study|Adverse Event|2|||
130681195|NCT01101022|470460250|FG000|Overall Study|Protocol Violation|4|||
130681196|NCT01101022|470460251|FG001|Overall Study|Protocol Violation|3|||
130681197|NCT01101022|470460250|FG000|Overall Study|Withdrawal by Subject|3|||
130681198|NCT01101022|470460251|FG001|Overall Study|Withdrawal by Subject|8|||
130681199|NCT01101022|470460250|FG000|Overall Study|Lost to Follow-up|1|||
130681200|NCT01101022|470460251|FG001|Overall Study|Lost to Follow-up|4|||
130681201|NCT01101022|470460250|FG000|Overall Study|Lack of Efficacy|0|||
130681202|NCT01101022|470460251|FG001|Overall Study|Lack of Efficacy|7|||
130681203|NCT01101022|470460250|FG000|Overall Study|Sponsor decision|1|||
130681204|NCT01101022|470460251|FG001|Overall Study|Sponsor decision|1|||
130681205|NCT01101022|470460250|FG000|Overall Study|Non-compliance|1|||
130681206|NCT01101022|470460251|FG001|Overall Study|Non-compliance|0|||
130681207|NCT01101022|470460250|FG000|Overall Study|Work schedule|1|||
130681208|NCT01101022|470460251|FG001|Overall Study|Work schedule|1|||
130681209|NCT01101022|470460250|FG000|Overall Study|Vacation|0|||
130681210|NCT01101022|470460251|FG001|Overall Study|Vacation|1|||
130681211|NCT01519661|470460252|FG000|Overall Study|Protocol deviation|6|||
130681212|NCT01519661|470460252|FG000|Overall Study|Lost to Follow-up|3|||
130681213|NCT01519661|470460252|FG000|Overall Study|Withdrawal by Subject|17|||
130681214|NCT01519661|470460252|FG000|Overall Study|Lack of Efficacy|6|||
130681215|NCT01519661|470460252|FG000|Overall Study|Adverse Event|29|||
130681216|NCT01139047|470460253|FG000|Overall Study|Withdrawal by Subject|1|||
130681217|NCT05628675|470460254|FG000|Overall Study|Lost to Follow-up|2|||
130681218|NCT05628675|470460254|FG000|Overall Study|Withdrawal by Subject|1|||
130681219|NCT01941095|470460255|FG000|Overall Study|Insufficient therapeutic response|13|||
130681220|NCT01941095|470460255|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
130681221|NCT01941095|470460255|FG000|Overall Study|Adverse Event|11|||
130681222|NCT01941095|470460255|FG000|Overall Study|Physician Decision|3|||
130681223|NCT01941095|470460255|FG000|Overall Study|Withdrawal by Subject|17|||
130681224|NCT01941095|470460255|FG000|Overall Study|Lost to Follow-up|10|||
130681225|NCT02918877|470460258|FG000|Overall Study|Withdrawal by Subject|2|||
130681226|NCT02918877|470460259|FG001|Overall Study|Withdrawal by Subject|2|||
130681227|NCT02918877|470460258|FG000|Overall Study|Surgery cancelled|1|||
130681228|NCT02918877|470460259|FG001|Overall Study|Surgery cancelled|0|||
130681229|NCT02918877|470460258|FG000|Overall Study|Physician Decision|1|||
130681230|NCT02918877|470460259|FG001|Overall Study|Physician Decision|0|||
130681231|NCT02918877|470460258|FG000|Overall Study|Received intraoperative steroids|1|||
130681232|NCT02918877|470460259|FG001|Overall Study|Received intraoperative steroids|0|||
130681233|NCT02918877|470460258|FG000|Overall Study|Unable to obtain lab samples|1|||
130681234|NCT02918877|470460259|FG001|Overall Study|Unable to obtain lab samples|0|||
130681235|NCT02918877|470460258|FG000|Overall Study|Unsafe to perform BAL|0|||
130681236|NCT02918877|470460259|FG001|Overall Study|Unsafe to perform BAL|1|||
130681237|NCT05818137|470460260|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
130681238|NCT05818137|470460260|FG000|Extension Treatment Period|Ongoing participants|44|||
130681239|NCT01648166|470460263|FG000|Overall Study|inadequate toenail samples|53|||
130681240|NCT01648166|470460264|FG001|Overall Study|inadequate toenail samples|100|||
131017501|NCT03615924|471693798|FG000|Overall Study|Study termination by Sponsor|94|||
131017502|NCT03615924|471693799|FG001|Overall Study|Study termination by Sponsor|86|||
131017503|NCT00790790|471693806|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
131017504|NCT00790790|471693807|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
131017505|NCT00790790|471693808|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
131017506|NCT00790790|471693806|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
131017507|NCT00790790|471693807|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
131017508|NCT00790790|471693808|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
130681241|NCT02532764|470460265|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681242|NCT02532764|470460266|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681243|NCT02532764|470460267|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681244|NCT02532764|470460268|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681245|NCT02532764|470460269|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681246|NCT02532764|470460270|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130720843|NCT04126213|470601546|FG001|Overall Study|Lost to Follow-up|1|||
131017509|NCT00790790|471693806|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
131017510|NCT00790790|471693807|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
130885576|NCT00068692|471215212|FG003|Step 2: Randomization|alternative therapy|1|||
130885577|NCT00068692|471215213|FG004|Step 2: Randomization|alternative therapy|1|||
130885578|NCT00068692|471215214|FG005|Step 2: Randomization|alternative therapy|0|||
130885579|NCT00068692|471215215|FG006|Step 2: Randomization|alternative therapy|0|||
130885580|NCT00068692|471215216|FG007|Step 2: Randomization|alternative therapy|0|||
130885581|NCT00068692|471215209|FG000|Step 2: Randomization|Physician Decision|0|||
130885582|NCT00068692|471215210|FG001|Step 2: Randomization|Physician Decision|0|||
130681247|NCT02532764|470460271|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130681248|NCT02532764|470460272|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
130681249|NCT02532764|470460273|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
130765942|NCT01253174|470765910|FG004|Period 2|Adverse Event|0|||
130885583|NCT00068692|471215211|FG002|Step 2: Randomization|Physician Decision|0|||
130885584|NCT00068692|471215212|FG003|Step 2: Randomization|Physician Decision|1|||
130885585|NCT00068692|471215213|FG004|Step 2: Randomization|Physician Decision|1|||
130885586|NCT00068692|471215214|FG005|Step 2: Randomization|Physician Decision|0|||
131017511|NCT00790790|471693808|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
131017512|NCT00790790|471693806|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
131017513|NCT00790790|471693807|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
131017514|NCT00790790|471693808|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
131017515|NCT00790790|471693806|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
131017516|NCT00790790|471693807|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
131017517|NCT00790790|471693808|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
131017518|NCT02808338|471693809|FG000|Screening|Screen Failure|10|||
131017519|NCT02808338|471693809|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
131017520|NCT02808338|471693809|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
131017521|NCT00057837|471693810|FG000|Overall Study|Progression/relapse|12|||
131017522|NCT00057837|471693811|FG001|Overall Study|Progression/relapse|14|||
131017523|NCT00057837|471693810|FG000|Overall Study|Adverse Event|2|||
131017524|NCT00057837|471693811|FG001|Overall Study|Adverse Event|12|||
131017525|NCT00057837|471693810|FG000|Overall Study|Death|5|||
131017526|NCT00057837|471693811|FG001|Overall Study|Death|4|||
131017527|NCT00057837|471693810|FG000|Overall Study|Withdrawal by Subject|5|||
131017528|NCT00057837|471693811|FG001|Overall Study|Withdrawal by Subject|3|||
130765943|NCT01253174|470765911|FG005|Period 2|Adverse Event|0|||
130765944|NCT01253174|470765906|FG000|Period 3|Withdrawal by Subject|0|||
130765945|NCT01253174|470765907|FG001|Period 3|Withdrawal by Subject|1|||
130765946|NCT01253174|470765908|FG002|Period 3|Withdrawal by Subject|0|||
130765947|NCT01253174|470765909|FG003|Period 3|Withdrawal by Subject|0|||
130765948|NCT01253174|470765910|FG004|Period 3|Withdrawal by Subject|1|||
130765949|NCT01253174|470765911|FG005|Period 3|Withdrawal by Subject|0|||
130765950|NCT01253174|470765906|FG000|Period 3|Pregnancy|0|||
130765951|NCT01253174|470765907|FG001|Period 3|Pregnancy|0|||
130765952|NCT01253174|470765908|FG002|Period 3|Pregnancy|1|||
130765953|NCT01253174|470765909|FG003|Period 3|Pregnancy|0|||
130765954|NCT01253174|470765910|FG004|Period 3|Pregnancy|0|||
130765955|NCT01253174|470765911|FG005|Period 3|Pregnancy|0|||
130765956|NCT02267135|470765912|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
130765957|NCT02267135|470765913|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
130765958|NCT02267135|470765912|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
130765959|NCT02267135|470765913|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
130765960|NCT02267135|470765912|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
130765961|NCT02267135|470765913|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
130765962|NCT02267135|470765912|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
130765963|NCT02267135|470765913|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
130765964|NCT02267135|470765912|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
130765965|NCT02267135|470765913|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
130765966|NCT02892513|470765914|FG000|Overall Study|Withdrawal by Subject|0|||
130765967|NCT02892513|470765915|FG001|Overall Study|Withdrawal by Subject|1|||
130765968|NCT03806231|470765916|FG000|Overall Study|Physician Decision|1|||
130765969|NCT03806231|470765917|FG001|Overall Study|Physician Decision|0|||
130765970|NCT03806231|470765916|FG000|Overall Study|Withdrawal by Subject|1|||
130765971|NCT03806231|470765917|FG001|Overall Study|Withdrawal by Subject|0|||
130765972|NCT00900731|470765918|FG000|Overall Study|Adverse Event|31|||
130765973|NCT00900731|470765919|FG001|Overall Study|Adverse Event|27|||
130765974|NCT00900731|470765918|FG000|Overall Study|Withdrawal by Subject|8|||
130765975|NCT00900731|470765919|FG001|Overall Study|Withdrawal by Subject|7|||
130765976|NCT00900731|470765918|FG000|Overall Study|Protocol Deviation|8|||
130765977|NCT00900731|470765919|FG001|Overall Study|Protocol Deviation|11|||
130765978|NCT00900731|470765918|FG000|Overall Study|Administrative Problems|5|||
130765979|NCT00900731|470765919|FG001|Overall Study|Administrative Problems|4|||
130765980|NCT00900731|470765918|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
130765981|NCT00900731|470765919|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130765982|NCT00900731|470765918|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
130765983|NCT00900731|470765919|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
130765984|NCT00900731|470765918|FG000|Overall Study|Lost to Follow-up|2|||
130765985|NCT00900731|470765919|FG001|Overall Study|Lost to Follow-up|3|||
130681250|NCT02532764|470460274|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
130681251|NCT03527745|470460275|FG000|Overall Study|Lost to Follow-up|3|||
130681252|NCT03527745|470460276|FG001|Overall Study|Lost to Follow-up|6|||
130765986|NCT00900731|470765918|FG000|Overall Study|Lack of Efficacy|1|||
130765987|NCT00900731|470765919|FG001|Overall Study|Lack of Efficacy|3|||
130765988|NCT00900731|470765918|FG000|Overall Study|Death|0|||
130765989|NCT00900731|470765919|FG001|Overall Study|Death|2|||
131017529|NCT00057837|471693810|FG000|Overall Study|Alternative therapy|0|||
131017530|NCT00057837|471693811|FG001|Overall Study|Alternative therapy|1|||
131017531|NCT00057837|471693810|FG000|Overall Study|Other complicating disease|2|||
131017532|NCT00057837|471693811|FG001|Overall Study|Other complicating disease|1|||
131017533|NCT00057837|471693810|FG000|Overall Study|Physician Decision|1|||
131017534|NCT00057837|471693811|FG001|Overall Study|Physician Decision|0|||
131017535|NCT00057837|471693810|FG000|Overall Study|Ineligible|3|||
131017536|NCT00057837|471693811|FG001|Overall Study|Ineligible|3|||
131017537|NCT00057837|471693810|FG000|Overall Study|Never started treatment|1|||
130765990|NCT02919267|470765920|FG000|Overall Study|Protocol Violation|0|||
130765991|NCT02919267|470765921|FG001|Overall Study|Protocol Violation|3|||
130765992|NCT02919267|470765922|FG002|Overall Study|Protocol Violation|3|||
130765993|NCT02919267|470765923|FG003|Overall Study|Protocol Violation|4|||
130765994|NCT00628927|470765924|FG000|Overall Study|Problems performing blood draw|6|||
130765995|NCT00628927|470765925|FG001|Overall Study|Problems performing blood draw|0|||
131017538|NCT00057837|471693811|FG001|Overall Study|Never started treatment|1|||
131017539|NCT02537522|471693812|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
131017540|NCT02537522|471693813|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
131017541|NCT02537522|471693814|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
131017542|NCT02537522|471693815|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
131017543|NCT02537522|471693812|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
131017544|NCT02537522|471693813|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
131017545|NCT02537522|471693814|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
130765996|NCT00628927|470765924|FG000|Overall Study|Lost to Follow-up|1|||
130765997|NCT00628927|470765925|FG001|Overall Study|Lost to Follow-up|0|||
130765998|NCT00628927|470765924|FG000|Overall Study|Equipment failure|1|||
130765999|NCT00628927|470765925|FG001|Overall Study|Equipment failure|0|||
130766000|NCT02437188|470768126|FG000|Overall Study|Randomized but did not receive surgery|4|||
130766001|NCT02437188|470768127|FG001|Overall Study|Randomized but did not receive surgery|8|||
130766002|NCT02437188|470768126|FG000|Overall Study|Adverse Event|0|||
130766003|NCT02437188|470768127|FG001|Overall Study|Adverse Event|1|||
130766004|NCT01172808|470768128|FG000|Overall Study|Adverse Event|8|||
130766005|NCT01172808|470768129|FG001|Overall Study|Adverse Event|4|||
130766006|NCT01172808|470768130|FG002|Overall Study|Adverse Event|8|||
130766007|NCT01172808|470768131|FG003|Overall Study|Adverse Event|3|||
130766008|NCT01172808|470768128|FG000|Overall Study|Lack of Efficacy|1|||
130766009|NCT01172808|470768129|FG001|Overall Study|Lack of Efficacy|0|||
130766010|NCT01172808|470768130|FG002|Overall Study|Lack of Efficacy|0|||
130766011|NCT01172808|470768131|FG003|Overall Study|Lack of Efficacy|0|||
130766012|NCT01172808|470768128|FG000|Overall Study|Protocol Violation|2|||
130766013|NCT01172808|470768129|FG001|Overall Study|Protocol Violation|2|||
130766014|NCT01172808|470768130|FG002|Overall Study|Protocol Violation|2|||
130766015|NCT01172808|470768131|FG003|Overall Study|Protocol Violation|0|||
130766016|NCT01172808|470768128|FG000|Overall Study|Lost to Follow-up|0|||
130766017|NCT01172808|470768129|FG001|Overall Study|Lost to Follow-up|1|||
130766018|NCT01172808|470768130|FG002|Overall Study|Lost to Follow-up|1|||
130766019|NCT01172808|470768131|FG003|Overall Study|Lost to Follow-up|3|||
130766020|NCT01172808|470768128|FG000|Overall Study|Withdrawal by Subject|4|||
130766021|NCT01172808|470768129|FG001|Overall Study|Withdrawal by Subject|1|||
130766022|NCT01172808|470768130|FG002|Overall Study|Withdrawal by Subject|3|||
130766023|NCT01172808|470768131|FG003|Overall Study|Withdrawal by Subject|2|||
130766024|NCT01172808|470768128|FG000|Overall Study|Other|6|||
130766025|NCT01172808|470768129|FG001|Overall Study|Other|5|||
130766026|NCT01172808|470768130|FG002|Overall Study|Other|9|||
130766027|NCT01172808|470768131|FG003|Overall Study|Other|7|||
130766028|NCT03246061|470768132|FG000|Overall Study|Still in follow-up|15|||
130766029|NCT03246061|470768133|FG001|Overall Study|Still in follow-up|21|||
130766030|NCT01937715|470768134|FG000|Overall Study|Death|0|||
130766031|NCT01937715|470768135|FG001|Overall Study|Death|0|||
130766032|NCT01937715|470768136|FG002|Overall Study|Death|0|||
130766033|NCT01937715|470768137|FG003|Overall Study|Death|1|||
130766034|NCT01937715|470768138|FG004|Overall Study|Death|0|||
130766035|NCT01937715|470768134|FG000|Overall Study|Withdrawal by Subject|0|||
131017546|NCT02537522|471693815|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
131017547|NCT02537522|471693812|FG000|Phase I - Contralateral|incorrect randomization|0|||
131017548|NCT02537522|471693813|FG001|Phase I - Contralateral|incorrect randomization|1|||
131017549|NCT02537522|471693814|FG002|Phase I - Contralateral|incorrect randomization|0|||
131017550|NCT02537522|471693815|FG003|Phase I - Contralateral|incorrect randomization|0|||
131017551|NCT02537522|471693812|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
130766036|NCT01937715|470768135|FG001|Overall Study|Withdrawal by Subject|1|||
130766037|NCT01937715|470768136|FG002|Overall Study|Withdrawal by Subject|0|||
130681253|NCT03527745|470460277|FG002|Overall Study|Lost to Follow-up|7|||
130681254|NCT03527745|470460278|FG003|Overall Study|Lost to Follow-up|9|||
130681255|NCT03527745|470460279|FG004|Overall Study|Lost to Follow-up|0|||
130681256|NCT03527745|470460280|FG005|Overall Study|Lost to Follow-up|2|||
130681257|NCT03527745|470460281|FG006|Overall Study|Lost to Follow-up|3|||
130681258|NCT03527745|470460282|FG007|Overall Study|Lost to Follow-up|2|||
130681259|NCT03527745|470460283|FG008|Overall Study|Lost to Follow-up|3|||
130681260|NCT03527745|470460284|FG009|Overall Study|Lost to Follow-up|2|||
130681261|NCT03527745|470460285|FG010|Overall Study|Lost to Follow-up|1|||
130681262|NCT03527745|470460286|FG011|Overall Study|Lost to Follow-up|1|||
130681263|NCT03527745|470460287|FG012|Overall Study|Lost to Follow-up|0|||
130681264|NCT03527745|470460288|FG013|Overall Study|Lost to Follow-up|0|||
130681265|NCT03527745|470460289|FG014|Overall Study|Lost to Follow-up|0|||
130681266|NCT03527745|470460290|FG015|Overall Study|Lost to Follow-up|0|||
130681267|NCT03527745|470460291|FG016|Overall Study|Lost to Follow-up|1|||
130681268|NCT03527745|470460292|FG017|Overall Study|Lost to Follow-up|0|||
130681269|NCT03527745|470460293|FG018|Overall Study|Lost to Follow-up|0|||
130681270|NCT03527745|470460294|FG019|Overall Study|Lost to Follow-up|1|||
130681271|NCT03527745|470460295|FG020|Overall Study|Lost to Follow-up|1|||
130681272|NCT03527745|470460296|FG021|Overall Study|Lost to Follow-up|5|||
130681273|NCT03527745|470460297|FG022|Overall Study|Lost to Follow-up|6|||
130681274|NCT03527745|470460298|FG023|Overall Study|Lost to Follow-up|8|||
130681275|NCT03527745|470460299|FG024|Overall Study|Lost to Follow-up|1|||
130681276|NCT03527745|470460300|FG025|Overall Study|Lost to Follow-up|3|||
130681277|NCT01604850|470460301|FG000|Overall Study|Enrolled but never treated|0|||
130681278|NCT01604850|470460302|FG001|Overall Study|Enrolled but never treated|1|||
130681279|NCT01604850|470460301|FG000|Overall Study|Efficacy Failure|50|||
130681280|NCT01604850|470460302|FG001|Overall Study|Efficacy Failure|29|||
130681281|NCT01604850|470460301|FG000|Overall Study|Lost to Follow-up|1|||
130681282|NCT01604850|470460302|FG001|Overall Study|Lost to Follow-up|0|||
131017552|NCT02537522|471693813|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
131017553|NCT02537522|471693814|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
130766038|NCT01937715|470768137|FG003|Overall Study|Withdrawal by Subject|0|||
130766039|NCT01937715|470768138|FG004|Overall Study|Withdrawal by Subject|2|||
130766040|NCT01937715|470768134|FG000|Overall Study|Other|0|||
130766041|NCT01937715|470768135|FG001|Overall Study|Other|0|||
130766042|NCT01937715|470768136|FG002|Overall Study|Other|0|||
130766043|NCT01937715|470768137|FG003|Overall Study|Other|3|||
130766044|NCT01937715|470768138|FG004|Overall Study|Other|0|||
130766045|NCT02864316|470768139|FG000|Overall Study|Progressive Disease|2|||
131017554|NCT02537522|471693815|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
131017555|NCT02537522|471693812|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
131017556|NCT02537522|471693813|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
131017557|NCT02537522|471693814|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
130766046|NCT02864316|470768140|FG001|Overall Study|Progressive Disease|1|||
130766047|NCT02864316|470768139|FG000|Overall Study|Adverse Event|0|||
130766048|NCT02864316|470768140|FG001|Overall Study|Adverse Event|1|||
130766049|NCT01887288|470768141|FG000|Overall Study|The study was terminated and the PI has|16|||
130766050|NCT03114657|470768145|FG000|Overall Study|Adverse Event|9|||
130766051|NCT03114657|470768146|FG001|Overall Study|Adverse Event|6|||
130766052|NCT03114657|470768145|FG000|Overall Study|Death|4|||
130766053|NCT03114657|470768146|FG001|Overall Study|Death|0|||
130766054|NCT03114657|470768145|FG000|Overall Study|Multiple Reasons|1|||
130766055|NCT03114657|470768146|FG001|Overall Study|Multiple Reasons|2|||
130766056|NCT03114657|470768145|FG000|Overall Study|Physician Decision|2|||
130766057|NCT03114657|470768146|FG001|Overall Study|Physician Decision|2|||
130766058|NCT03114657|470768145|FG000|Overall Study|Study Terminated By Sponsor|355|||
130766059|NCT03114657|470768146|FG001|Overall Study|Study Terminated By Sponsor|374|||
130766060|NCT03114657|470768145|FG000|Overall Study|Symptomatic Deterioration|0|||
131017558|NCT02537522|471693815|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
131017559|NCT02570711|471693817|FG000|Overall Study|Death|1|||
131017560|NCT02570711|471693818|FG001|Overall Study|Death|0|||
131017561|NCT02570711|471693817|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
131017562|NCT02570711|471693818|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
131017563|NCT02547922|471693819|FG000|Overall Study|Withdrawal by Subject|9|||
131017564|NCT02547922|471693820|FG001|Overall Study|Withdrawal by Subject|6|||
130766061|NCT03114657|470768146|FG001|Overall Study|Symptomatic Deterioration|1|||
131222599|NCT01902134|472443113|FG000|Overall Study|Withdrawal by Subject|4|||
130681283|NCT01604850|470460301|FG000|Overall Study|Subject withdrew consent|1|||
130681284|NCT01604850|470460302|FG001|Overall Study|Subject withdrew consent|0|||
130681285|NCT01471093|470460304|FG000|Overall Study|Adverse Event|1|||
130681286|NCT01471093|470460305|FG001|Overall Study|Adverse Event|0|||
130681287|NCT01471093|470460306|FG002|Overall Study|Adverse Event|0|||
130681288|NCT01471093|470460307|FG003|Overall Study|Adverse Event|0|||
130766062|NCT03114657|470768145|FG000|Overall Study|Withdrawal by Subject|28|||
130766063|NCT03114657|470768146|FG001|Overall Study|Withdrawal by Subject|22|||
130766064|NCT01179737|470768148|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
130720844|NCT04126213|470601547|FG002|Overall Study|Lost to Follow-up|5|||
131103760|NCT01589237|472010351|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
131103761|NCT01589237|472010352|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
131103762|NCT01589237|472010349|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
131103763|NCT01589237|472010350|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
130885587|NCT00068692|471215215|FG006|Step 2: Randomization|Physician Decision|0|||
130885588|NCT00068692|471215216|FG007|Step 2: Randomization|Physician Decision|0|||
130885589|NCT00068692|471215209|FG000|Step 2: Randomization|Other|0|||
130885590|NCT00068692|471215210|FG001|Step 2: Randomization|Other|0|||
130885591|NCT00068692|471215211|FG002|Step 2: Randomization|Other|0|||
130885592|NCT00068692|471215212|FG003|Step 2: Randomization|Other|1|||
130885593|NCT00068692|471215213|FG004|Step 2: Randomization|Other|0|||
130885594|NCT00068692|471215214|FG005|Step 2: Randomization|Other|1|||
130885595|NCT00068692|471215215|FG006|Step 2: Randomization|Other|0|||
130885596|NCT00068692|471215216|FG007|Step 2: Randomization|Other|0|||
130885597|NCT00068692|471215209|FG000|Step 2: Randomization|never start protocol therapy|0|||
130885598|NCT00068692|471215210|FG001|Step 2: Randomization|never start protocol therapy|0|||
130885599|NCT00068692|471215211|FG002|Step 2: Randomization|never start protocol therapy|1|||
130885600|NCT00068692|471215212|FG003|Step 2: Randomization|never start protocol therapy|0|||
131103764|NCT01589237|472010351|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
130885601|NCT00068692|471215213|FG004|Step 2: Randomization|never start protocol therapy|1|||
130885602|NCT00068692|471215214|FG005|Step 2: Randomization|never start protocol therapy|0|||
130885603|NCT00068692|471215215|FG006|Step 2: Randomization|never start protocol therapy|0|||
130885604|NCT00068692|471215216|FG007|Step 2: Randomization|never start protocol therapy|0|||
130885605|NCT00248040|471215218|FG000|Overall Study|transplantectomy|2|||
130885606|NCT00248040|471215219|FG001|Overall Study|transplantectomy|1|||
130885607|NCT00248040|471215220|FG002|Overall Study|transplantectomy|3|||
130885608|NCT00248040|471215218|FG000|Overall Study|transplant cancelled post treat start|1|||
130885609|NCT00248040|471215219|FG001|Overall Study|transplant cancelled post treat start|0|||
130885610|NCT00248040|471215220|FG002|Overall Study|transplant cancelled post treat start|0|||
130885611|NCT00248040|471215218|FG000|Overall Study|Death|0|||
130885612|NCT00248040|471215219|FG001|Overall Study|Death|0|||
130885613|NCT00248040|471215220|FG002|Overall Study|Death|1|||
130681289|NCT02475954|470460308|FG000|Overall Study|Withdrawal by Subject|2|||
130681290|NCT02475954|470460309|FG001|Overall Study|Withdrawal by Subject|2|||
130681291|NCT02475954|470460308|FG000|Overall Study|Lost to Follow-up|11|||
130681292|NCT02475954|470460309|FG001|Overall Study|Lost to Follow-up|9|||
130681293|NCT02475954|470460308|FG000|Overall Study|Death|1|||
130681294|NCT02475954|470460309|FG001|Overall Study|Death|1|||
130681295|NCT02932878|470460310|FG000|Overall Study|Due to Lab Results|2|||
130681296|NCT02932878|470460311|FG001|Overall Study|Due to Lab Results|1|||
130681297|NCT01918397|470460312|FG000|Overall Study|Never started treatment|2|||
130681298|NCT01918397|470460313|FG001|Overall Study|Never started treatment|1|||
130681299|NCT01918397|470460314|FG002|Overall Study|Never started treatment|0|||
130681300|NCT01918397|470460315|FG003|Overall Study|Never started treatment|0|||
130681301|NCT01918397|470460312|FG000|Overall Study|Adverse Event|1|||
130681302|NCT01918397|470460313|FG001|Overall Study|Adverse Event|1|||
130681303|NCT01918397|470460314|FG002|Overall Study|Adverse Event|1|||
130681304|NCT01918397|470460315|FG003|Overall Study|Adverse Event|0|||
130681305|NCT01918397|470460312|FG000|Overall Study|Lack of compliance|2|||
130681306|NCT01918397|470460313|FG001|Overall Study|Lack of compliance|2|||
130681307|NCT01918397|470460314|FG002|Overall Study|Lack of compliance|3|||
130681308|NCT01918397|470460315|FG003|Overall Study|Lack of compliance|0|||
130681309|NCT01918397|470460312|FG000|Overall Study|Pregnancy|0|||
130681310|NCT01918397|470460313|FG001|Overall Study|Pregnancy|1|||
130681311|NCT01918397|470460314|FG002|Overall Study|Pregnancy|0|||
130681312|NCT01918397|470460315|FG003|Overall Study|Pregnancy|0|||
130681313|NCT01918397|470460312|FG000|Overall Study|Rifampin susceptible|0|||
130681314|NCT01918397|470460313|FG001|Overall Study|Rifampin susceptible|0|||
130681315|NCT01918397|470460314|FG002|Overall Study|Rifampin susceptible|0|||
130681316|NCT01918397|470460315|FG003|Overall Study|Rifampin susceptible|2|||
130681317|NCT01918397|470460312|FG000|Overall Study|Treatment failure|0|||
130681318|NCT01918397|470460313|FG001|Overall Study|Treatment failure|0|||
130681319|NCT01918397|470460314|FG002|Overall Study|Treatment failure|0|||
130681320|NCT01918397|470460315|FG003|Overall Study|Treatment failure|1|||
130681321|NCT01918397|470460312|FG000|Overall Study|Withdrawal by Subject|3|||
130681322|NCT01918397|470460313|FG001|Overall Study|Withdrawal by Subject|2|||
130681323|NCT01918397|470460314|FG002|Overall Study|Withdrawal by Subject|1|||
130885614|NCT03557034|471215221|FG000|Overall Study|Withdrawal by Subject|1|||
130885615|NCT03557034|471215222|FG001|Overall Study|Withdrawal by Subject|0|||
130885616|NCT00719472|471215225|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
130885617|NCT00719472|471215225|FG000|Enrolled in Study|Subject decision to withdraw|8|||
130885618|NCT00719472|471215225|FG000|Enrolled in Study|Various Reasons|17|||
131103765|NCT01589237|472010352|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
130681324|NCT01918397|470460315|FG003|Overall Study|Withdrawal by Subject|1|||
130681325|NCT01918397|470460312|FG000|Overall Study|XDR at baseline|0|||
130681326|NCT01918397|470460313|FG001|Overall Study|XDR at baseline|0|||
130681327|NCT01918397|470460314|FG002|Overall Study|XDR at baseline|1|||
130681328|NCT01918397|470460315|FG003|Overall Study|XDR at baseline|0|||
130681329|NCT01918397|470460312|FG000|Overall Study|Lost to Follow-up|2|||
130681330|NCT01918397|470460313|FG001|Overall Study|Lost to Follow-up|1|||
130681331|NCT01918397|470460314|FG002|Overall Study|Lost to Follow-up|1|||
130681332|NCT01918397|470460315|FG003|Overall Study|Lost to Follow-up|1|||
130681333|NCT01918397|470460312|FG000|Overall Study|Increased QTc|1|||
130681334|NCT01918397|470460313|FG001|Overall Study|Increased QTc|0|||
130681335|NCT01918397|470460314|FG002|Overall Study|Increased QTc|0|||
130681336|NCT01918397|470460315|FG003|Overall Study|Increased QTc|1|||
130681337|NCT01918397|470460312|FG000|Overall Study|Death|0|||
130681338|NCT01918397|470460313|FG001|Overall Study|Death|0|||
130681339|NCT01918397|470460314|FG002|Overall Study|Death|1|||
130681340|NCT01918397|470460315|FG003|Overall Study|Death|0|||
130885619|NCT00719472|471215225|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
130885620|NCT00719472|471215225|FG000|Received Cycle 1 Treatment|Death|5|||
130885621|NCT00719472|471215225|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
130681341|NCT01918397|470460312|FG000|Overall Study|Involved in another investigative trial|0|||
130681342|NCT01918397|470460313|FG001|Overall Study|Involved in another investigative trial|0|||
130681343|NCT01918397|470460314|FG002|Overall Study|Involved in another investigative trial|0|||
130681344|NCT01918397|470460315|FG003|Overall Study|Involved in another investigative trial|1|||
130681345|NCT00620022|470460316|FG000|Treatment Period 1|Adverse Event|4|||
130681346|NCT00620022|470460317|FG001|Treatment Period 1|Adverse Event|6|||
130681347|NCT00620022|470460316|FG000|Treatment Period 1|Subject withdrew consent|1|||
130681348|NCT00620022|470460317|FG001|Treatment Period 1|Subject withdrew consent|0|||
130681349|NCT00620022|470460316|FG000|Treatment Period 2|Adverse Event|2|||
130681350|NCT00620022|470460317|FG001|Treatment Period 2|Adverse Event|2|||
130681351|NCT03478397|470460318|FG000|Overall Study|Refused to participate|31|||
130681352|NCT03478397|470460319|FG001|Overall Study|Refused to participate|7|||
130681353|NCT02942264|470460320|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681354|NCT02942264|470460321|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
130681355|NCT02942264|470460322|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681356|NCT02942264|470460323|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681357|NCT02942264|470460324|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681358|NCT02942264|470460325|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681359|NCT02942264|470460326|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
130681360|NCT02942264|470460327|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681361|NCT02942264|470460328|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130681362|NCT02942264|470460320|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681363|NCT02942264|470460321|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681364|NCT02942264|470460322|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681365|NCT02942264|470460323|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681366|NCT02942264|470460324|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681367|NCT02942264|470460325|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681368|NCT02942264|470460326|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681369|NCT02942264|470460327|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130681370|NCT02942264|470460328|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
130681371|NCT02334722|470460329|FG000|Overall Study|Lost to Follow-up|4|||
130885622|NCT00719472|471215225|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
130885623|NCT00719472|471215225|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
130885624|NCT00719472|471215225|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
130885625|NCT00719472|471215225|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
130885626|NCT00719472|471215225|FG000|Received Cycle 2 Treatment|Death|6|||
130885627|NCT00719472|471215225|FG000|Received Cycle 2 Treatment|Disease progression|3|||
130885628|NCT00719472|471215225|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
130885629|NCT00719472|471215225|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
130885630|NCT00719472|471215225|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
130885631|NCT00719472|471215225|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
130681372|NCT02334722|470460330|FG001|Overall Study|Lost to Follow-up|0|||
130681373|NCT02334722|470460329|FG000|Overall Study|6 week questionnaire not completed|2|||
130681374|NCT02334722|470460330|FG001|Overall Study|6 week questionnaire not completed|0|||
130885632|NCT01244893|471215226|FG000|Baseline|Protocol Violation|0|||
130885633|NCT01244893|471215227|FG001|Baseline|Protocol Violation|1|||
130681375|NCT02334722|470460329|FG000|Overall Study|Unable to obtain medication|1|||
130681376|NCT02334722|470460330|FG001|Overall Study|Unable to obtain medication|1|||
130681377|NCT02334722|470460329|FG000|Overall Study|Withdrawal by Subject|0|||
130681378|NCT02334722|470460330|FG001|Overall Study|Withdrawal by Subject|3|||
130885634|NCT01244893|471215226|FG000|1-Week Follow Up|Lost to Follow-up|1|||
130681379|NCT02334722|470460329|FG000|Overall Study|Adverse Event|0|||
130681380|NCT02334722|470460330|FG001|Overall Study|Adverse Event|2|||
130681381|NCT02334722|470460329|FG000|Overall Study|Physician Decision|0|||
130885635|NCT01244893|471215227|FG001|1-Week Follow Up|Lost to Follow-up|0|||
130885636|NCT00357552|471215228|FG000|Screening|Did not meet eligibility criteria|84|||
130885637|NCT00357552|471215228|FG000|Weeks 0 to 24|Death|1|||
130885638|NCT00357552|471215228|FG000|Weeks 24 to 104|Death|3|||
130885639|NCT00357552|471215228|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
130885640|NCT00882557|471215231|FG000|Overall Study|Withdrawal by Subject|1|||
130885641|NCT00882557|471215232|FG001|Overall Study|Withdrawal by Subject|0|||
130885642|NCT00882557|471215231|FG000|Overall Study|Trouble with Vein Access|1|||
130885643|NCT00882557|471215232|FG001|Overall Study|Trouble with Vein Access|0|||
130885644|NCT00882557|471215231|FG000|Overall Study|Randomized Not Treated|0|||
130885645|NCT00882557|471215232|FG001|Overall Study|Randomized Not Treated|1|||
130885646|NCT00711191|471215237|FG000|Overall Study|Adverse Event|1|||
130885647|NCT00711191|471215238|FG001|Overall Study|Adverse Event|1|||
130885648|NCT00711191|471215239|FG002|Overall Study|Adverse Event|2|||
130885649|NCT00711191|471215237|FG000|Overall Study|Objective progression or relapse|2|||
130885650|NCT00711191|471215238|FG001|Overall Study|Objective progression or relapse|3|||
130885651|NCT00711191|471215239|FG002|Overall Study|Objective progression or relapse|7|||
130885652|NCT00711191|471215237|FG000|Overall Study|Withdrawal by Subject|0|||
130885653|NCT00711191|471215238|FG001|Overall Study|Withdrawal by Subject|1|||
130885654|NCT00711191|471215239|FG002|Overall Study|Withdrawal by Subject|3|||
130885655|NCT00602472|471215240|FG000|Overall Study|Adverse Event|5|||
130885656|NCT00602472|471215241|FG001|Overall Study|Adverse Event|23|||
130885657|NCT00602472|471215240|FG000|Overall Study|Protocol Violation|4|||
130885658|NCT00602472|471215241|FG001|Overall Study|Protocol Violation|19|||
130885659|NCT00602472|471215240|FG000|Overall Study|Withdrawal by Subject|8|||
130885660|NCT00602472|471215241|FG001|Overall Study|Withdrawal by Subject|14|||
130885661|NCT00602472|471215240|FG000|Overall Study|Other incl. lack of efficacy|4|||
130885662|NCT00602472|471215241|FG001|Overall Study|Other incl. lack of efficacy|2|||
130885663|NCT03038880|471215242|FG000|Overall Study|Death|1|||
130885664|NCT03038880|471215243|FG001|Overall Study|Death|2|||
130885665|NCT03038880|471215244|FG002|Overall Study|Death|0|||
130885666|NCT03038880|471215242|FG000|Overall Study|Physician Decision|2|||
130885667|NCT03038880|471215243|FG001|Overall Study|Physician Decision|1|||
130885668|NCT03038880|471215244|FG002|Overall Study|Physician Decision|0|||
130885669|NCT02803580|471215245|FG000|Overall Study|Death|13|||
130885670|NCT02803580|471215245|FG000|Overall Study|Lost to Follow-up|19|||
130885671|NCT02803580|471215245|FG000|Overall Study|Withdrawal by Subject|3|||
130885672|NCT02803580|471215245|FG000|Overall Study|Inclusion in clinical trial|1|||
130885673|NCT02054104|471215250|FG000|Overall Study|Did not want to continue due to college classes|1|||
130885674|NCT02054104|471215251|FG001|Overall Study|Did not want to continue due to college classes|0|||
130885675|NCT02054104|471215250|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
130885676|NCT02054104|471215251|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
130885677|NCT02054104|471215250|FG000|Overall Study|No evidence of immunologic response|2|||
130885678|NCT02054104|471215251|FG001|Overall Study|No evidence of immunologic response|2|||
130885679|NCT02054104|471215250|FG000|Overall Study|Disease Progression On Study|4|||
130885680|NCT02054104|471215251|FG001|Overall Study|Disease Progression On Study|5|||
130885681|NCT02054104|471215250|FG000|Overall Study|Diagnosis of lymphoma|0|||
130885682|NCT02054104|471215251|FG001|Overall Study|Diagnosis of lymphoma|1|||
130681382|NCT02334722|470460330|FG001|Overall Study|Physician Decision|1|||
130681383|NCT00856388|470460331|FG000|Overall Study|Other|1|||
130681384|NCT01617668|470460334|FG000|Overall Study|Adverse Event|7|||
130681385|NCT01617668|470460335|FG001|Overall Study|Adverse Event|0|||
130681386|NCT01617668|470460336|FG002|Overall Study|Adverse Event|12|||
130885683|NCT02054104|471215250|FG000|Overall Study|Inconclusive response|0|||
130885684|NCT02054104|471215251|FG001|Overall Study|Inconclusive response|1|||
130885685|NCT00084136|471215252|FG000|PI Comparison|Death|10|||
130885686|NCT00084136|471215253|FG001|PI Comparison|Death|9|||
130885687|NCT00084136|471215254|FG002|PI Comparison|Death|0|||
130885688|NCT00084136|471215252|FG000|PI Comparison|Lost to Follow-up|11|||
130885689|NCT00084136|471215253|FG001|PI Comparison|Lost to Follow-up|8|||
130885690|NCT00084136|471215254|FG002|PI Comparison|Lost to Follow-up|0|||
130885691|NCT00084136|471215252|FG000|PI Comparison|Withdrawal by Subject|33|||
130885692|NCT00084136|471215253|FG001|PI Comparison|Withdrawal by Subject|30|||
130885693|NCT00084136|471215254|FG002|PI Comparison|Withdrawal by Subject|0|||
130885694|NCT00084136|471215252|FG000|PI Comparison|Clinic site closed|1|||
130885695|NCT00084136|471215253|FG001|PI Comparison|Clinic site closed|0|||
130885696|NCT00084136|471215254|FG002|PI Comparison|Clinic site closed|0|||
130885697|NCT00084136|471215252|FG000|NRTI Comparison|Death|20|||
130885698|NCT00084136|471215253|FG001|NRTI Comparison|Death|0|||
130885699|NCT00084136|471215254|FG002|NRTI Comparison|Death|18|||
130885700|NCT00084136|471215252|FG000|NRTI Comparison|Lost to Follow-up|14|||
130885701|NCT00084136|471215253|FG001|NRTI Comparison|Lost to Follow-up|0|||
130885702|NCT00084136|471215254|FG002|NRTI Comparison|Lost to Follow-up|12|||
131017565|NCT02547922|471693821|FG002|Overall Study|Withdrawal by Subject|10|||
131017566|NCT02547922|471693819|FG000|Overall Study|Adverse Event|3|||
131017567|NCT02547922|471693820|FG001|Overall Study|Adverse Event|1|||
131017568|NCT02547922|471693821|FG002|Overall Study|Adverse Event|2|||
131017569|NCT02547922|471693819|FG000|Overall Study|Lost to Follow-up|1|||
131017570|NCT02547922|471693820|FG001|Overall Study|Lost to Follow-up|0|||
131017571|NCT02547922|471693821|FG002|Overall Study|Lost to Follow-up|0|||
130885703|NCT00084136|471215252|FG000|NRTI Comparison|Withdrawal by Subject|54|||
130885704|NCT00084136|471215253|FG001|NRTI Comparison|Withdrawal by Subject|0|||
130885705|NCT00084136|471215254|FG002|NRTI Comparison|Withdrawal by Subject|38|||
130885706|NCT00084136|471215252|FG000|NRTI Comparison|Clinic site closed|12|||
130885707|NCT00084136|471215253|FG001|NRTI Comparison|Clinic site closed|0|||
130885708|NCT00084136|471215254|FG002|NRTI Comparison|Clinic site closed|14|||
130885709|NCT00084136|471215252|FG000|NRTI Comparison|Not reason above|1|||
130885710|NCT00084136|471215253|FG001|NRTI Comparison|Not reason above|0|||
130885711|NCT00084136|471215254|FG002|NRTI Comparison|Not reason above|0|||
130885712|NCT00836693|471215257|FG000|Overall Study|Adverse Event|4|||
130885713|NCT00836693|471215258|FG001|Overall Study|Adverse Event|1|||
130885714|NCT00836693|471215257|FG000|Overall Study|Sponsor Decision|0|||
130885715|NCT00836693|471215258|FG001|Overall Study|Sponsor Decision|1|||
130885716|NCT00836693|471215257|FG000|Overall Study|Physician Decision|2|||
130885717|NCT00836693|471215258|FG001|Overall Study|Physician Decision|0|||
130885718|NCT00836693|471215257|FG000|Overall Study|Withdrawal by Subject|9|||
130885719|NCT00836693|471215258|FG001|Overall Study|Withdrawal by Subject|4|||
130885720|NCT00836693|471215257|FG000|Overall Study|Protocol Violation|1|||
130885721|NCT00836693|471215258|FG001|Overall Study|Protocol Violation|0|||
130885722|NCT00836693|471215257|FG000|Overall Study|Lost to Follow-up|1|||
130885723|NCT00836693|471215258|FG001|Overall Study|Lost to Follow-up|0|||
130885724|NCT02612779|471215259|FG000|Overall Study|Administrative reason by sponsor|4|||
130885725|NCT02612779|471215260|FG001|Overall Study|Administrative reason by sponsor|1|||
130885726|NCT02612779|471215259|FG000|Overall Study|No longer meet study criteria|0|||
130885727|NCT02612779|471215260|FG001|Overall Study|No longer meet study criteria|1|||
130885728|NCT02612779|471215259|FG000|Overall Study|Disease progression|29|||
130885729|NCT02612779|471215260|FG001|Overall Study|Disease progression|2|||
130885730|NCT02612779|471215259|FG000|Overall Study|Study drug toxicity|10|||
130885731|NCT02612779|471215260|FG001|Overall Study|Study drug toxicity|1|||
130885732|NCT02612779|471215259|FG000|Overall Study|Death|1|||
130885733|NCT02612779|471215260|FG001|Overall Study|Death|0|||
130885734|NCT02612779|471215259|FG000|Overall Study|Adverse event unrelated to study drug|5|||
130885735|NCT02612779|471215260|FG001|Overall Study|Adverse event unrelated to study drug|0|||
130885736|NCT02612779|471215259|FG000|Overall Study|Participant withdrew consent|4|||
130885737|NCT02612779|471215260|FG001|Overall Study|Participant withdrew consent|0|||
130885738|NCT02612779|471215259|FG000|Overall Study|Lost to Follow-up|1|||
130885739|NCT02612779|471215260|FG001|Overall Study|Lost to Follow-up|0|||
130885740|NCT02612779|471215259|FG000|Overall Study|Maximum clinical benefit|10|||
130885741|NCT02612779|471215260|FG001|Overall Study|Maximum clinical benefit|1|||
130885742|NCT02612779|471215259|FG000|Overall Study|Other reasons|4|||
130885743|NCT02612779|471215260|FG001|Overall Study|Other reasons|0|||
130885744|NCT01002339|471215261|FG000|Overall Study|Withdrawal by Subject|0|||
130885745|NCT01002339|471215262|FG001|Overall Study|Withdrawal by Subject|1|||
130885746|NCT01002339|471215263|FG002|Overall Study|Withdrawal by Subject|0|||
130885747|NCT01002339|471215261|FG000|Overall Study|Incorrect treatment assignment|0|||
130885748|NCT01002339|471215262|FG001|Overall Study|Incorrect treatment assignment|0|||
130885749|NCT01002339|471215263|FG002|Overall Study|Incorrect treatment assignment|1|||
130885750|NCT01002339|471215261|FG000|Overall Study|Protocol Violation|0|||
130885751|NCT01002339|471215262|FG001|Overall Study|Protocol Violation|0|||
130885752|NCT01002339|471215263|FG002|Overall Study|Protocol Violation|2|||
130885753|NCT01002339|471215261|FG000|Overall Study|Lung cancer detected before transplant|0|||
130885754|NCT01002339|471215262|FG001|Overall Study|Lung cancer detected before transplant|0|||
130885755|NCT01002339|471215263|FG002|Overall Study|Lung cancer detected before transplant|1|||
130885756|NCT01002339|471215261|FG000|Overall Study|Randomized. Not transplanted|0|||
130885757|NCT01002339|471215262|FG001|Overall Study|Randomized. Not transplanted|0|||
130885758|NCT01002339|471215263|FG002|Overall Study|Randomized. Not transplanted|1|||
130885759|NCT02118961|471215264|FG000|Overall Study|Withdrawal by Subject|1|||
130885760|NCT02118961|471215265|FG001|Overall Study|Withdrawal by Subject|0|||
130885761|NCT03126591|471215266|FG000|Overall Study|Death|6|||
130885762|NCT03126591|471215267|FG001|Overall Study|Death|3|||
130885763|NCT03126591|471215268|FG002|Overall Study|Death|17|||
130885764|NCT03126591|471215266|FG000|Overall Study|Progressive Disease|0|||
130885765|NCT03126591|471215267|FG001|Overall Study|Progressive Disease|1|||
130885766|NCT03126591|471215268|FG002|Overall Study|Progressive Disease|2|||
130885767|NCT03126591|471215266|FG000|Overall Study|Terminated by Sponsor|0|||
130681387|NCT01617668|470460337|FG003|Overall Study|Adverse Event|5|||
130681388|NCT01617668|470460334|FG000|Overall Study|Physician Decision|1|||
130885768|NCT03126591|471215267|FG001|Overall Study|Terminated by Sponsor|1|||
130885769|NCT03126591|471215268|FG002|Overall Study|Terminated by Sponsor|4|||
130885770|NCT03126591|471215266|FG000|Overall Study|Withdrawal by Subject|1|||
130885771|NCT03126591|471215267|FG001|Overall Study|Withdrawal by Subject|1|||
130885772|NCT03126591|471215268|FG002|Overall Study|Withdrawal by Subject|4|||
130885773|NCT02158546|471215269|FG000|Overall Study|Physician Decision|0|||
130885774|NCT02158546|471215270|FG001|Overall Study|Physician Decision|1|||
130681389|NCT01617668|470460335|FG001|Overall Study|Physician Decision|2|||
130885775|NCT02158546|471215271|FG002|Overall Study|Physician Decision|0|||
130885776|NCT02158546|471215272|FG003|Overall Study|Physician Decision|0|||
131017572|NCT02547922|471693819|FG000|Overall Study|Lack of Efficacy|5|||
131017573|NCT02547922|471693820|FG001|Overall Study|Lack of Efficacy|7|||
131017574|NCT02547922|471693821|FG002|Overall Study|Lack of Efficacy|4|||
131017575|NCT02547922|471693819|FG000|Overall Study|Death|1|||
130766065|NCT01179737|470768149|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
130766066|NCT01179737|470768150|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
130766067|NCT01179737|470768151|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
130766068|NCT01179737|470768148|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
130766069|NCT01179737|470768149|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
130766070|NCT01179737|470768150|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
130766071|NCT01179737|470768151|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
130766072|NCT01179737|470768148|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
130766073|NCT01179737|470768149|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
130766074|NCT01179737|470768150|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
130766075|NCT01179737|470768151|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
130766076|NCT01179737|470768148|FG000|Cohort 1 & Cohort 2|Death|0|||
130766077|NCT01179737|470768149|FG001|Cohort 1 & Cohort 2|Death|0|||
130766078|NCT01179737|470768150|FG002|Cohort 1 & Cohort 2|Death|1|||
130766079|NCT01179737|470768151|FG003|Cohort 1 & Cohort 2|Death|0|||
130766080|NCT01179737|470768148|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
130766081|NCT01179737|470768149|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
130766082|NCT01179737|470768150|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
131017576|NCT02547922|471693820|FG001|Overall Study|Death|0|||
131017577|NCT02547922|471693821|FG002|Overall Study|Death|0|||
131017578|NCT02547922|471693819|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
131017579|NCT02547922|471693820|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
130766083|NCT01179737|470768151|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
130766084|NCT01179737|470768148|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
130766085|NCT01179737|470768149|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
130766086|NCT01179737|470768150|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
130766087|NCT01179737|470768151|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
130766088|NCT01179737|470768148|FG000|Extension|The study was terminated|3|||
130766089|NCT01179737|470768149|FG001|Extension|The study was terminated|0|||
130766090|NCT01179737|470768150|FG002|Extension|The study was terminated|0|||
130766091|NCT01179737|470768151|FG003|Extension|The study was terminated|0|||
130766092|NCT01546038|470768152|FG000|Overall Study|Death|15|||
130766093|NCT01546038|470768153|FG001|Overall Study|Death|6|||
130766094|NCT01546038|470768154|FG002|Overall Study|Death|4|||
130766095|NCT01546038|470768155|FG003|Overall Study|Death|2|||
130766096|NCT01546038|470768156|FG004|Overall Study|Death|9|||
130766097|NCT01546038|470768157|FG005|Overall Study|Death|3|||
130766098|NCT01546038|470768158|FG006|Overall Study|Death|46|||
130766099|NCT01546038|470768159|FG007|Overall Study|Death|76|||
130766100|NCT01546038|470768160|FG008|Overall Study|Death|39|||
130766101|NCT01546038|470768152|FG000|Overall Study|Lost to Follow-up|0|||
130766102|NCT01546038|470768153|FG001|Overall Study|Lost to Follow-up|0|||
130766103|NCT01546038|470768154|FG002|Overall Study|Lost to Follow-up|0|||
130766104|NCT01546038|470768155|FG003|Overall Study|Lost to Follow-up|0|||
130766105|NCT01546038|470768156|FG004|Overall Study|Lost to Follow-up|1|||
130766106|NCT01546038|470768157|FG005|Overall Study|Lost to Follow-up|0|||
130766107|NCT01546038|470768158|FG006|Overall Study|Lost to Follow-up|2|||
130766108|NCT01546038|470768159|FG007|Overall Study|Lost to Follow-up|1|||
130766109|NCT01546038|470768160|FG008|Overall Study|Lost to Follow-up|0|||
130766110|NCT01546038|470768152|FG000|Overall Study|Withdrawal by Subject|1|||
130766111|NCT01546038|470768153|FG001|Overall Study|Withdrawal by Subject|0|||
130766112|NCT01546038|470768154|FG002|Overall Study|Withdrawal by Subject|0|||
130766113|NCT01546038|470768155|FG003|Overall Study|Withdrawal by Subject|1|||
130766114|NCT01546038|470768156|FG004|Overall Study|Withdrawal by Subject|0|||
130766115|NCT01546038|470768157|FG005|Overall Study|Withdrawal by Subject|1|||
130766116|NCT01546038|470768158|FG006|Overall Study|Withdrawal by Subject|3|||
130766117|NCT01546038|470768159|FG007|Overall Study|Withdrawal by Subject|3|||
130766118|NCT01546038|470768160|FG008|Overall Study|Withdrawal by Subject|1|||
130766119|NCT01546038|470768152|FG000|Overall Study|: Randomized, not treated|0|||
130766120|NCT01546038|470768153|FG001|Overall Study|: Randomized, not treated|0|||
130766121|NCT01546038|470768154|FG002|Overall Study|: Randomized, not treated|0|||
130766122|NCT01546038|470768155|FG003|Overall Study|: Randomized, not treated|0|||
130766123|NCT01546038|470768156|FG004|Overall Study|: Randomized, not treated|0|||
130766124|NCT01546038|470768157|FG005|Overall Study|: Randomized, not treated|0|||
130766125|NCT01546038|470768158|FG006|Overall Study|: Randomized, not treated|2|||
130766126|NCT01546038|470768159|FG007|Overall Study|: Randomized, not treated|4|||
130766127|NCT01546038|470768160|FG008|Overall Study|: Randomized, not treated|3|||
130766128|NCT02470403|470768161|FG000|Overall Study|Adverse Event|1|||
130766129|NCT02470403|470768162|FG001|Overall Study|Adverse Event|0|||
130766130|NCT02470403|470768163|FG002|Overall Study|Adverse Event|0|||
130681390|NCT01617668|470460336|FG002|Overall Study|Physician Decision|3|||
130766131|NCT02470403|470768164|FG003|Overall Study|Adverse Event|0|||
130885777|NCT02158546|471215269|FG000|Overall Study|Non-compliance|0|||
130885778|NCT02158546|471215270|FG001|Overall Study|Non-compliance|1|||
130885779|NCT02158546|471215271|FG002|Overall Study|Non-compliance|0|||
130885780|NCT02158546|471215272|FG003|Overall Study|Non-compliance|1|||
130885781|NCT02158546|471215269|FG000|Overall Study|Failure to meet eligibility criteria|0|||
130885782|NCT02158546|471215270|FG001|Overall Study|Failure to meet eligibility criteria|1|||
130885783|NCT02158546|471215271|FG002|Overall Study|Failure to meet eligibility criteria|0|||
130885784|NCT02158546|471215272|FG003|Overall Study|Failure to meet eligibility criteria|0|||
130885785|NCT02158546|471215269|FG000|Overall Study|Lack of Efficacy|1|||
130885786|NCT02158546|471215270|FG001|Overall Study|Lack of Efficacy|1|||
130885787|NCT02158546|471215271|FG002|Overall Study|Lack of Efficacy|0|||
130681391|NCT01617668|470460337|FG003|Overall Study|Physician Decision|0|||
130681392|NCT01617668|470460334|FG000|Overall Study|Progressive Disease|4|||
130681393|NCT01617668|470460335|FG001|Overall Study|Progressive Disease|4|||
130681394|NCT01617668|470460336|FG002|Overall Study|Progressive Disease|6|||
130681395|NCT01617668|470460337|FG003|Overall Study|Progressive Disease|9|||
130681396|NCT01617668|470460334|FG000|Overall Study|Subject/guardian decision|1|||
130681397|NCT01617668|470460335|FG001|Overall Study|Subject/guardian decision|3|||
130681398|NCT01617668|470460336|FG002|Overall Study|Subject/guardian decision|2|||
130681399|NCT01617668|470460337|FG003|Overall Study|Subject/guardian decision|1|||
130681400|NCT00686959|470460338|FG000|Overall Study|Participants censored (no death events)|124|||
130681401|NCT00686959|470460339|FG001|Overall Study|Participants censored (no death events)|117|||
130681402|NCT00150462|470460342|FG000|Overall Study|Disease Progression or Relapse|3|||
130681403|NCT00150462|470460343|FG001|Overall Study|Disease Progression or Relapse|1|||
130681404|NCT00150462|470460344|FG002|Overall Study|Disease Progression or Relapse|2|||
130681405|NCT00150462|470460345|FG003|Overall Study|Disease Progression or Relapse|1|||
130681406|NCT00150462|470460346|FG004|Overall Study|Disease Progression or Relapse|2|||
130681407|NCT00150462|470460347|FG005|Overall Study|Disease Progression or Relapse|2|||
130681408|NCT00150462|470460348|FG006|Overall Study|Disease Progression or Relapse|3|||
130681409|NCT00150462|470460349|FG007|Overall Study|Disease Progression or Relapse|5|||
130681410|NCT00150462|470460350|FG008|Overall Study|Disease Progression or Relapse|5|||
130681411|NCT00150462|470460351|FG009|Overall Study|Disease Progression or Relapse|3|||
130681412|NCT00150462|470460352|FG010|Overall Study|Disease Progression or Relapse|2|||
130681413|NCT00150462|470460342|FG000|Overall Study|Withdrawal by Subject|0|||
130681414|NCT00150462|470460343|FG001|Overall Study|Withdrawal by Subject|1|||
130681415|NCT00150462|470460344|FG002|Overall Study|Withdrawal by Subject|1|||
130681416|NCT00150462|470460345|FG003|Overall Study|Withdrawal by Subject|0|||
130681417|NCT00150462|470460346|FG004|Overall Study|Withdrawal by Subject|1|||
130681418|NCT00150462|470460347|FG005|Overall Study|Withdrawal by Subject|2|||
130681419|NCT00150462|470460348|FG006|Overall Study|Withdrawal by Subject|0|||
130681420|NCT00150462|470460349|FG007|Overall Study|Withdrawal by Subject|1|||
130681421|NCT00150462|470460350|FG008|Overall Study|Withdrawal by Subject|0|||
130681422|NCT00150462|470460351|FG009|Overall Study|Withdrawal by Subject|1|||
130681423|NCT00150462|470460352|FG010|Overall Study|Withdrawal by Subject|0|||
130681424|NCT00150462|470460342|FG000|Overall Study|Death|0|||
130766132|NCT02470403|470768165|FG004|Overall Study|Adverse Event|0|||
130766133|NCT02470403|470768161|FG000|Overall Study|Lost to Follow-up|0|||
130766134|NCT02470403|470768162|FG001|Overall Study|Lost to Follow-up|1|||
130766135|NCT02470403|470768163|FG002|Overall Study|Lost to Follow-up|0|||
130766136|NCT02470403|470768164|FG003|Overall Study|Lost to Follow-up|0|||
130766137|NCT02470403|470768165|FG004|Overall Study|Lost to Follow-up|0|||
130766138|NCT02470403|470768161|FG000|Overall Study|Subject/guardian decision|1|||
130766139|NCT02470403|470768162|FG001|Overall Study|Subject/guardian decision|0|||
130766140|NCT02470403|470768163|FG002|Overall Study|Subject/guardian decision|0|||
130766141|NCT02470403|470768164|FG003|Overall Study|Subject/guardian decision|4|||
130766142|NCT02470403|470768165|FG004|Overall Study|Subject/guardian decision|0|||
130766143|NCT00717275|470768166|FG000|Overall Study|Premature study termination.|3|||
130766144|NCT01362517|470768173|FG000|Overall Study|Protocol Violation|1|||
130766145|NCT01362517|470768173|FG000|Overall Study|Lost to Follow-up|1|||
130766146|NCT03379792|470768175|FG000|Overall Study|Physician Decision|0|||
130681425|NCT00150462|470460343|FG001|Overall Study|Death|1|||
130766147|NCT03379792|470768176|FG001|Overall Study|Physician Decision|0|||
130766148|NCT03379792|470768177|FG002|Overall Study|Physician Decision|0|||
130681426|NCT00150462|470460344|FG002|Overall Study|Death|0|||
130681427|NCT00150462|470460345|FG003|Overall Study|Death|0|||
130681428|NCT00150462|470460346|FG004|Overall Study|Death|0|||
130681429|NCT00150462|470460347|FG005|Overall Study|Death|0|||
130681430|NCT00150462|470460348|FG006|Overall Study|Death|0|||
130681431|NCT00150462|470460349|FG007|Overall Study|Death|0|||
130681432|NCT00150462|470460350|FG008|Overall Study|Death|1|||
130681433|NCT00150462|470460351|FG009|Overall Study|Death|0|||
130681434|NCT00150462|470460352|FG010|Overall Study|Death|0|||
130681435|NCT00150462|470460342|FG000|Overall Study|Adverse Event|0|||
130681436|NCT00150462|470460343|FG001|Overall Study|Adverse Event|0|||
130681437|NCT00150462|470460344|FG002|Overall Study|Adverse Event|0|||
130681438|NCT00150462|470460345|FG003|Overall Study|Adverse Event|1|||
130766149|NCT03379792|470768178|FG003|Overall Study|Physician Decision|1|||
130681439|NCT00150462|470460346|FG004|Overall Study|Adverse Event|0|||
130681440|NCT00150462|470460347|FG005|Overall Study|Adverse Event|0|||
130681441|NCT00150462|470460348|FG006|Overall Study|Adverse Event|0|||
130681442|NCT00150462|470460349|FG007|Overall Study|Adverse Event|2|||
130681443|NCT00150462|470460350|FG008|Overall Study|Adverse Event|0|||
130681444|NCT00150462|470460351|FG009|Overall Study|Adverse Event|1|||
130681445|NCT00150462|470460352|FG010|Overall Study|Adverse Event|0|||
130681446|NCT00150462|470460342|FG000|Overall Study|Physician Decision|0|||
130681447|NCT00150462|470460343|FG001|Overall Study|Physician Decision|0|||
130681448|NCT00150462|470460344|FG002|Overall Study|Physician Decision|1|||
130681449|NCT00150462|470460345|FG003|Overall Study|Physician Decision|1|||
130681450|NCT00150462|470460346|FG004|Overall Study|Physician Decision|0|||
130681451|NCT00150462|470460347|FG005|Overall Study|Physician Decision|0|||
130766150|NCT03379792|470768179|FG004|Overall Study|Physician Decision|0|||
130766151|NCT03379792|470768180|FG005|Overall Study|Physician Decision|0|||
130766152|NCT03379792|470768175|FG000|Overall Study|Withdrawal by Subject|0|||
130766153|NCT03379792|470768176|FG001|Overall Study|Withdrawal by Subject|0|||
130766154|NCT03379792|470768177|FG002|Overall Study|Withdrawal by Subject|0|||
130766155|NCT03379792|470768178|FG003|Overall Study|Withdrawal by Subject|0|||
130766156|NCT03379792|470768179|FG004|Overall Study|Withdrawal by Subject|1|||
130766157|NCT03379792|470768180|FG005|Overall Study|Withdrawal by Subject|1|||
130766158|NCT01121536|470768181|FG000|Overall Study|Adverse Event|63|||
130766159|NCT01121536|470768181|FG000|Overall Study|Lack of Efficacy|35|||
130766160|NCT01121536|470768181|FG000|Overall Study|Withdrawal by Subject|65|||
130766161|NCT01121536|470768181|FG000|Overall Study|Protocol Violation|20|||
130766162|NCT01121536|470768181|FG000|Overall Study|Noncompliance with study medication|12|||
130766163|NCT01121536|470768181|FG000|Overall Study|Noncompliance with study procedures|9|||
130766164|NCT01121536|470768181|FG000|Overall Study|Lost to Follow-up|39|||
130766165|NCT01121536|470768181|FG000|Overall Study|Other|118|||
130766166|NCT00568334|470768182|FG000|Overall Study|Withdrawal by Subject|0|||
130766167|NCT00568334|470768183|FG001|Overall Study|Withdrawal by Subject|1|||
130766168|NCT00568334|470768182|FG000|Overall Study|Lost to Follow-up|1|||
130766169|NCT00568334|470768183|FG001|Overall Study|Lost to Follow-up|0|||
130766170|NCT00306787|470768184|FG000|Overall Study|Discontinued without taking study drug|208|||
130766171|NCT00306787|470768185|FG001|Overall Study|Discontinued without taking study drug|215|||
130766172|NCT00306787|470768184|FG000|Overall Study|Adverse Event|1|||
130766173|NCT00306787|470768185|FG001|Overall Study|Adverse Event|1|||
130766174|NCT00306787|470768184|FG000|Overall Study|Lack of Efficacy|1|||
130766175|NCT00306787|470768185|FG001|Overall Study|Lack of Efficacy|0|||
130766176|NCT00306787|470768184|FG000|Overall Study|Protocol Violation|8|||
130766177|NCT00306787|470768185|FG001|Overall Study|Protocol Violation|10|||
130766178|NCT00306787|470768184|FG000|Overall Study|Withdrawal by Subject|2|||
130766179|NCT00306787|470768185|FG001|Overall Study|Withdrawal by Subject|9|||
130766180|NCT00306787|470768184|FG000|Overall Study|Lost to Follow-up|9|||
130766181|NCT00306787|470768185|FG001|Overall Study|Lost to Follow-up|6|||
130766182|NCT00306787|470768184|FG000|Overall Study|Administrative problems|4|||
130766183|NCT00306787|470768185|FG001|Overall Study|Administrative problems|0|||
130766184|NCT00306787|470768184|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130766185|NCT00306787|470768185|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130766186|NCT02273908|470768186|FG000|Overall Study|Adverse Event|16|||
130766187|NCT02273908|470768187|FG001|Overall Study|Adverse Event|0|||
130766188|NCT02273908|470768186|FG000|Overall Study|Lost to Follow-up|10|||
130766189|NCT02273908|470768187|FG001|Overall Study|Lost to Follow-up|1|||
130766190|NCT02273908|470768186|FG000|Overall Study|Did not meet entrance criteria|3|||
130766191|NCT02273908|470768187|FG001|Overall Study|Did not meet entrance criteria|2|||
130766192|NCT02273908|470768186|FG000|Overall Study|Withdrawal by Subject|4|||
130681452|NCT00150462|470460348|FG006|Overall Study|Physician Decision|0|||
130681453|NCT00150462|470460349|FG007|Overall Study|Physician Decision|0|||
130681454|NCT00150462|470460350|FG008|Overall Study|Physician Decision|0|||
130681455|NCT00150462|470460351|FG009|Overall Study|Physician Decision|0|||
130766193|NCT02273908|470768187|FG001|Overall Study|Withdrawal by Subject|2|||
130766194|NCT04908475|470768188|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
130766195|NCT04908475|470768189|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130766196|NCT04908475|470768190|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130766197|NCT04908475|470768191|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130766198|NCT04908475|470768192|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130766199|NCT04908475|470768193|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130766200|NCT04908475|470768188|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
130681456|NCT00150462|470460352|FG010|Overall Study|Physician Decision|0|||
130681457|NCT00150462|470460342|FG000|Overall Study|Other|0|||
130681458|NCT00150462|470460343|FG001|Overall Study|Other|0|||
130681459|NCT00150462|470460344|FG002|Overall Study|Other|0|||
130681460|NCT00150462|470460345|FG003|Overall Study|Other|0|||
130766201|NCT04908475|470768189|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130766202|NCT04908475|470768190|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130766203|NCT04908475|470768191|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130766204|NCT04908475|470768192|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130681461|NCT00150462|470460346|FG004|Overall Study|Other|0|||
130681462|NCT00150462|470460347|FG005|Overall Study|Other|0|||
130681463|NCT00150462|470460348|FG006|Overall Study|Other|0|||
130681464|NCT00150462|470460349|FG007|Overall Study|Other|0|||
130681465|NCT00150462|470460350|FG008|Overall Study|Other|0|||
130681466|NCT00150462|470460351|FG009|Overall Study|Other|1|||
130681467|NCT00150462|470460352|FG010|Overall Study|Other|1|||
130681468|NCT00569374|470460355|FG000|Overall Study|Withdrawal by Subject|4|||
130681469|NCT00912288|470460356|FG000|Overall Study|Death|0|||
130681470|NCT00912288|470460357|FG001|Overall Study|Death|1|||
130681471|NCT00912288|470460356|FG000|Overall Study|Adverse Event|1|||
130681472|NCT00912288|470460357|FG001|Overall Study|Adverse Event|1|||
130681473|NCT00912288|470460356|FG000|Overall Study|Lost to Follow-up|1|||
130681474|NCT00912288|470460357|FG001|Overall Study|Lost to Follow-up|0|||
130681475|NCT00912288|470460356|FG000|Overall Study|Protocol Violation|1|||
130681476|NCT00912288|470460357|FG001|Overall Study|Protocol Violation|0|||
130681477|NCT00912288|470460356|FG000|Overall Study|Withdrawal by Subject|3|||
130681478|NCT00912288|470460357|FG001|Overall Study|Withdrawal by Subject|3|||
130681479|NCT00912288|470460356|FG000|Overall Study|Study terminated by sponsor|34|||
130681480|NCT00912288|470460357|FG001|Overall Study|Study terminated by sponsor|35|||
130681481|NCT00912288|470460356|FG000|Overall Study|Other|1|||
130681482|NCT00912288|470460357|FG001|Overall Study|Other|0|||
130681483|NCT00877032|470460360|FG000|Overall Study|Did not meet entrance criteria|0|||
130681484|NCT00877032|470460361|FG001|Overall Study|Did not meet entrance criteria|0|||
130681485|NCT00877032|470460362|FG002|Overall Study|Did not meet entrance criteria|0|||
130681486|NCT00877032|470460363|FG003|Overall Study|Did not meet entrance criteria|1|||
130681487|NCT00877032|470460364|FG004|Overall Study|Did not meet entrance criteria|0|||
130681488|NCT00877032|470460365|FG005|Overall Study|Did not meet entrance criteria|0|||
130681489|NCT00877032|470460366|FG006|Overall Study|Did not meet entrance criteria|2|||
130681490|NCT05067647|470460375|FG000|Overall Study|Lost to Follow-up|1|||
130681491|NCT00870870|470460378|FG000|Overall Study|Withdrawal by Subject|0|||
130681492|NCT00870870|470460379|FG001|Overall Study|Withdrawal by Subject|1|||
130681493|NCT00870870|470460380|FG002|Overall Study|Withdrawal by Subject|1|||
130681494|NCT00870870|470460381|FG003|Overall Study|Withdrawal by Subject|3|||
130681495|NCT00870870|470460378|FG000|Overall Study|Adverse Event|0|||
130681496|NCT00870870|470460379|FG001|Overall Study|Adverse Event|0|||
130681497|NCT00870870|470460380|FG002|Overall Study|Adverse Event|2|||
130681498|NCT00870870|470460381|FG003|Overall Study|Adverse Event|2|||
130681499|NCT00822926|470460385|FG000|Second Injection Visit|Lost to Follow-up|1|||
130681500|NCT00822926|470460386|FG001|Second Injection Visit|Lost to Follow-up|0|||
130681501|NCT00822926|470460385|FG000|Second Injection Visit|Withdrawal by Subject|0|||
130681502|NCT00822926|470460386|FG001|Second Injection Visit|Withdrawal by Subject|1|||
130681503|NCT01706536|470460399|FG000|Overall Study|Withdrawal by Subject|1|||
130681504|NCT01706536|470460400|FG001|Overall Study|Withdrawal by Subject|0|||
130681505|NCT01706536|470460401|FG002|Overall Study|Withdrawal by Subject|1|||
130681506|NCT01706536|470460402|FG003|Overall Study|Withdrawal by Subject|0|||
130681507|NCT01706536|470460403|FG004|Overall Study|Withdrawal by Subject|0|||
130681508|NCT01706536|470460399|FG000|Overall Study|Adverse Event|2|||
130681509|NCT01706536|470460400|FG001|Overall Study|Adverse Event|3|||
130681510|NCT01706536|470460401|FG002|Overall Study|Adverse Event|4|||
130681511|NCT01706536|470460402|FG003|Overall Study|Adverse Event|3|||
130681512|NCT01706536|470460403|FG004|Overall Study|Adverse Event|2|||
130681513|NCT01706536|470460399|FG000|Overall Study|Lack of Efficacy|1|||
130681514|NCT01706536|470460400|FG001|Overall Study|Lack of Efficacy|0|||
130681515|NCT01706536|470460401|FG002|Overall Study|Lack of Efficacy|0|||
130681516|NCT01706536|470460402|FG003|Overall Study|Lack of Efficacy|1|||
130681517|NCT01706536|470460403|FG004|Overall Study|Lack of Efficacy|0|||
130681518|NCT01706536|470460399|FG000|Overall Study|non compliance|0|||
130681519|NCT01706536|470460400|FG001|Overall Study|non compliance|1|||
130681520|NCT01706536|470460401|FG002|Overall Study|non compliance|0|||
130681521|NCT01706536|470460402|FG003|Overall Study|non compliance|0|||
130681522|NCT01706536|470460403|FG004|Overall Study|non compliance|0|||
130681523|NCT00683293|470460412|FG000|Overall Study|Withdrawal by Subject|2|||
130885788|NCT02158546|471215272|FG003|Overall Study|Lack of Efficacy|0|||
130681524|NCT00683293|470460413|FG001|Overall Study|Withdrawal by Subject|3|||
130681525|NCT03262012|470460414|FG000|Overall Study|Withdrawal by Subject|15|||
130681526|NCT03262012|470460415|FG001|Overall Study|Withdrawal by Subject|13|||
130681527|NCT03262012|470460416|FG002|Overall Study|Withdrawal by Subject|8|||
130681528|NCT03262012|470460417|FG003|Overall Study|Withdrawal by Subject|7|||
130681529|NCT03262012|470460414|FG000|Overall Study|Adverse Event|10|||
130681530|NCT03262012|470460415|FG001|Overall Study|Adverse Event|12|||
130681531|NCT03262012|470460416|FG002|Overall Study|Adverse Event|4|||
130681532|NCT03262012|470460417|FG003|Overall Study|Adverse Event|6|||
130681533|NCT03262012|470460414|FG000|Overall Study|Physician Decision|2|||
130681534|NCT03262012|470460415|FG001|Overall Study|Physician Decision|5|||
130681535|NCT03262012|470460416|FG002|Overall Study|Physician Decision|1|||
130681536|NCT03262012|470460417|FG003|Overall Study|Physician Decision|0|||
130681537|NCT03262012|470460414|FG000|Overall Study|Lack of Efficacy|0|||
130681538|NCT03262012|470460415|FG001|Overall Study|Lack of Efficacy|5|||
130885789|NCT02158546|471215269|FG000|Overall Study|Adverse Event|2|||
130885790|NCT02158546|471215270|FG001|Overall Study|Adverse Event|2|||
130885791|NCT02158546|471215271|FG002|Overall Study|Adverse Event|0|||
130885792|NCT02158546|471215272|FG003|Overall Study|Adverse Event|0|||
130885793|NCT02158546|471215269|FG000|Overall Study|Withdrawal by Subject|6|||
131103766|NCT01589237|472010349|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
131103767|NCT01589237|472010350|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
131103768|NCT01589237|472010351|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
131103769|NCT01589237|472010352|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
130681539|NCT03262012|470460416|FG002|Overall Study|Lack of Efficacy|1|||
130885794|NCT02158546|471215270|FG001|Overall Study|Withdrawal by Subject|2|||
130885795|NCT02158546|471215271|FG002|Overall Study|Withdrawal by Subject|1|||
130885796|NCT02158546|471215272|FG003|Overall Study|Withdrawal by Subject|0|||
130885797|NCT02158546|471215269|FG000|Overall Study|Lost to Follow-up|5|||
130885798|NCT02158546|471215270|FG001|Overall Study|Lost to Follow-up|4|||
130885799|NCT02158546|471215271|FG002|Overall Study|Lost to Follow-up|0|||
130885800|NCT02158546|471215272|FG003|Overall Study|Lost to Follow-up|1|||
130885801|NCT02158546|471215269|FG000|Overall Study|Site Excluded|5|||
130885802|NCT02158546|471215270|FG001|Overall Study|Site Excluded|5|||
130885803|NCT02158546|471215271|FG002|Overall Study|Site Excluded|3|||
130885804|NCT02158546|471215272|FG003|Overall Study|Site Excluded|4|||
130885805|NCT02488915|471215275|FG000|Overall Study|Death|21|||
130885806|NCT02488915|471215275|FG000|Overall Study|Lost to Follow-up|4|||
130885807|NCT02488915|471215275|FG000|Overall Study|Withdrawal by Subject|1|||
130885808|NCT03326713|471215276|FG000|Overall Study|Death|2|||
130885809|NCT03326713|471215277|FG001|Overall Study|Death|1|||
130885810|NCT03326713|471215278|FG002|Overall Study|Death|0|||
130885811|NCT03326713|471215276|FG000|Overall Study|Lost to Follow-up|20|||
130885812|NCT03326713|471215277|FG001|Overall Study|Lost to Follow-up|21|||
130885813|NCT03326713|471215278|FG002|Overall Study|Lost to Follow-up|33|||
130885814|NCT03326713|471215276|FG000|Overall Study|Withdrawal by Subject|1|||
130885815|NCT03326713|471215277|FG001|Overall Study|Withdrawal by Subject|2|||
130885816|NCT03326713|471215278|FG002|Overall Study|Withdrawal by Subject|11|||
130885817|NCT03326713|471215276|FG000|Overall Study|Found Ineligible|11|||
130885818|NCT03326713|471215277|FG001|Overall Study|Found Ineligible|11|||
130885819|NCT03326713|471215278|FG002|Overall Study|Found Ineligible|8|||
130885820|NCT01394016|471215281|FG000|Overall Study|Progressive Disease|2|||
130885821|NCT01394016|471215282|FG001|Overall Study|Progressive Disease|0|||
130885822|NCT01394016|471215283|FG002|Overall Study|Progressive Disease|0|||
130885823|NCT01394016|471215284|FG003|Overall Study|Progressive Disease|0|||
130885824|NCT01394016|471215285|FG004|Overall Study|Progressive Disease|0|||
130885825|NCT01394016|471215286|FG005|Overall Study|Progressive Disease|0|||
130885826|NCT01394016|471215287|FG006|Overall Study|Progressive Disease|0|||
130885827|NCT01394016|471215288|FG007|Overall Study|Progressive Disease|0|||
130885828|NCT01394016|471215289|FG008|Overall Study|Progressive Disease|0|||
130885829|NCT01394016|471215290|FG009|Overall Study|Progressive Disease|0|||
130885830|NCT01394016|471215291|FG010|Overall Study|Progressive Disease|0|||
130885831|NCT01394016|471215292|FG011|Overall Study|Progressive Disease|0|||
130885832|NCT01394016|471215293|FG012|Overall Study|Progressive Disease|0|||
130885833|NCT01394016|471215294|FG013|Overall Study|Progressive Disease|0|||
130885834|NCT01394016|471215295|FG014|Overall Study|Progressive Disease|0|||
130885835|NCT01394016|471215296|FG015|Overall Study|Progressive Disease|0|||
130885836|NCT01394016|471215297|FG016|Overall Study|Progressive Disease|0|||
130885837|NCT01394016|471215298|FG017|Overall Study|Progressive Disease|0|||
130885838|NCT01394016|471215299|FG018|Overall Study|Progressive Disease|0|||
130885839|NCT01394016|471215281|FG000|Overall Study|Withdrawal by Subject|0|||
130885840|NCT01394016|471215282|FG001|Overall Study|Withdrawal by Subject|0|||
130885841|NCT01394016|471215283|FG002|Overall Study|Withdrawal by Subject|0|||
130885842|NCT01394016|471215284|FG003|Overall Study|Withdrawal by Subject|0|||
130885843|NCT01394016|471215285|FG004|Overall Study|Withdrawal by Subject|0|||
130885844|NCT01394016|471215286|FG005|Overall Study|Withdrawal by Subject|0|||
130885845|NCT01394016|471215287|FG006|Overall Study|Withdrawal by Subject|0|||
130681540|NCT03262012|470460417|FG003|Overall Study|Lack of Efficacy|2|||
130681541|NCT03262012|470460414|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
130681542|NCT03262012|470460415|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
130681543|NCT03262012|470460416|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
130681544|NCT03262012|470460417|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
130681545|NCT01469546|470460418|FG000|Received 5 mg Dose|Adverse Event|13|||
130885846|NCT01394016|471215288|FG007|Overall Study|Withdrawal by Subject|1|||
130885847|NCT01394016|471215289|FG008|Overall Study|Withdrawal by Subject|1|||
130885848|NCT01394016|471215290|FG009|Overall Study|Withdrawal by Subject|1|||
130885849|NCT01394016|471215291|FG010|Overall Study|Withdrawal by Subject|4|||
130885850|NCT01394016|471215292|FG011|Overall Study|Withdrawal by Subject|0|||
130885851|NCT01394016|471215293|FG012|Overall Study|Withdrawal by Subject|0|||
130885852|NCT01394016|471215294|FG013|Overall Study|Withdrawal by Subject|3|||
130885853|NCT01394016|471215295|FG014|Overall Study|Withdrawal by Subject|1|||
130885854|NCT01394016|471215296|FG015|Overall Study|Withdrawal by Subject|3|||
130885855|NCT01394016|471215297|FG016|Overall Study|Withdrawal by Subject|1|||
130885856|NCT01394016|471215298|FG017|Overall Study|Withdrawal by Subject|1|||
130885857|NCT01394016|471215299|FG018|Overall Study|Withdrawal by Subject|2|||
130885858|NCT01394016|471215281|FG000|Overall Study|Adverse Event|0|||
130885859|NCT01394016|471215282|FG001|Overall Study|Adverse Event|0|||
130885860|NCT01394016|471215283|FG002|Overall Study|Adverse Event|0|||
130885861|NCT01394016|471215284|FG003|Overall Study|Adverse Event|0|||
130885862|NCT01394016|471215285|FG004|Overall Study|Adverse Event|0|||
130885863|NCT01394016|471215286|FG005|Overall Study|Adverse Event|0|||
130885864|NCT01394016|471215287|FG006|Overall Study|Adverse Event|0|||
130885865|NCT01394016|471215288|FG007|Overall Study|Adverse Event|0|||
130885866|NCT01394016|471215289|FG008|Overall Study|Adverse Event|0|||
130885867|NCT01394016|471215290|FG009|Overall Study|Adverse Event|1|||
130885868|NCT01394016|471215291|FG010|Overall Study|Adverse Event|0|||
130885869|NCT01394016|471215292|FG011|Overall Study|Adverse Event|0|||
130885870|NCT01394016|471215293|FG012|Overall Study|Adverse Event|0|||
130885871|NCT01394016|471215294|FG013|Overall Study|Adverse Event|0|||
130885872|NCT01394016|471215295|FG014|Overall Study|Adverse Event|0|||
130885873|NCT01394016|471215296|FG015|Overall Study|Adverse Event|0|||
130885874|NCT01394016|471215297|FG016|Overall Study|Adverse Event|1|||
130885875|NCT01394016|471215298|FG017|Overall Study|Adverse Event|1|||
130885876|NCT01394016|471215299|FG018|Overall Study|Adverse Event|0|||
130885877|NCT01394016|471215281|FG000|Overall Study|Sponsor Decision|0|||
131103770|NCT01589237|472010349|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
131103771|NCT01589237|472010350|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
131103772|NCT01589237|472010351|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
131103773|NCT01589237|472010352|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
131103774|NCT02594163|472010353|FG000|Treatment Period|Progressive disease|2|||
130681546|NCT01469546|470460418|FG000|Received 5 mg Dose|Death|2|||
130681547|NCT01469546|470460418|FG000|Received 5 mg Dose|Protocol Violation|2|||
130681548|NCT01469546|470460418|FG000|Received 5 mg Dose|Progressive Disease|3|||
131103775|NCT02594163|472010354|FG001|Treatment Period|Progressive disease|3|||
131103776|NCT02594163|472010353|FG000|Treatment Period|Adverse Event|1|||
131103777|NCT02594163|472010354|FG001|Treatment Period|Adverse Event|5|||
131103778|NCT02594163|472010353|FG000|Treatment Period|Physician Decision|1|||
131103779|NCT02594163|472010354|FG001|Treatment Period|Physician Decision|3|||
131103780|NCT02594163|472010353|FG000|Treatment Period|Study termination by sponsor|2|||
131103781|NCT02594163|472010354|FG001|Treatment Period|Study termination by sponsor|1|||
131103782|NCT02594163|472010353|FG000|Treatment Period|Other, Non-AE|1|||
130681549|NCT01469546|470460418|FG000|Received 5 mg Dose|Physician Decision|3|||
130681550|NCT03601637|470461998|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
130681551|NCT03601637|470461999|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
130681552|NCT03601637|470461998|FG000|Overall Study|Adverse Event|1|||
130681553|NCT03601637|470461999|FG001|Overall Study|Adverse Event|1|||
130885878|NCT01394016|471215282|FG001|Overall Study|Sponsor Decision|0|||
130885879|NCT01394016|471215283|FG002|Overall Study|Sponsor Decision|0|||
130885880|NCT01394016|471215284|FG003|Overall Study|Sponsor Decision|0|||
130885881|NCT01394016|471215285|FG004|Overall Study|Sponsor Decision|0|||
130885882|NCT01394016|471215286|FG005|Overall Study|Sponsor Decision|0|||
130885883|NCT01394016|471215287|FG006|Overall Study|Sponsor Decision|0|||
130885884|NCT01394016|471215288|FG007|Overall Study|Sponsor Decision|0|||
130885885|NCT01394016|471215289|FG008|Overall Study|Sponsor Decision|0|||
130885886|NCT01394016|471215290|FG009|Overall Study|Sponsor Decision|0|||
130885887|NCT01394016|471215291|FG010|Overall Study|Sponsor Decision|0|||
130885888|NCT01394016|471215292|FG011|Overall Study|Sponsor Decision|0|||
130885889|NCT01394016|471215293|FG012|Overall Study|Sponsor Decision|1|||
130885890|NCT01394016|471215294|FG013|Overall Study|Sponsor Decision|0|||
130885891|NCT01394016|471215295|FG014|Overall Study|Sponsor Decision|0|||
130681554|NCT03601637|470461998|FG000|Overall Study|Other|0|||
130681555|NCT03601637|470461999|FG001|Overall Study|Other|1|||
130681556|NCT01507051|470462005|FG000|Overall Study|Withdrawal by Subject|1|||
130885892|NCT01394016|471215296|FG015|Overall Study|Sponsor Decision|0|||
130885893|NCT01394016|471215297|FG016|Overall Study|Sponsor Decision|0|||
130885894|NCT01394016|471215298|FG017|Overall Study|Sponsor Decision|0|||
130885895|NCT01394016|471215299|FG018|Overall Study|Sponsor Decision|0|||
130885896|NCT01394016|471215281|FG000|Overall Study|Lost to Follow-up|0|||
130885897|NCT01394016|471215282|FG001|Overall Study|Lost to Follow-up|0|||
130885898|NCT01394016|471215283|FG002|Overall Study|Lost to Follow-up|0|||
130885899|NCT01394016|471215284|FG003|Overall Study|Lost to Follow-up|0|||
130885900|NCT01394016|471215285|FG004|Overall Study|Lost to Follow-up|0|||
131103783|NCT02594163|472010354|FG001|Treatment Period|Other, Non-AE|0|||
131103784|NCT02594163|472010353|FG000|Follow-up Period|Withdrawal by Subject|0|||
130681557|NCT01507051|470462006|FG001|Overall Study|Withdrawal by Subject|3|||
130885901|NCT01394016|471215286|FG005|Overall Study|Lost to Follow-up|0|||
130885902|NCT01394016|471215287|FG006|Overall Study|Lost to Follow-up|0|||
130885903|NCT01394016|471215288|FG007|Overall Study|Lost to Follow-up|0|||
130885904|NCT01394016|471215289|FG008|Overall Study|Lost to Follow-up|0|||
130885905|NCT01394016|471215290|FG009|Overall Study|Lost to Follow-up|0|||
130681558|NCT01507051|470462007|FG002|Overall Study|Withdrawal by Subject|1|||
130681559|NCT01507051|470462008|FG003|Overall Study|Withdrawal by Subject|6|||
130681560|NCT01507051|470462005|FG000|Overall Study|Physician Decision|0|||
130681561|NCT01507051|470462006|FG001|Overall Study|Physician Decision|0|||
130681562|NCT01507051|470462007|FG002|Overall Study|Physician Decision|0|||
130681563|NCT01507051|470462008|FG003|Overall Study|Physician Decision|1|||
130681564|NCT01507051|470462005|FG000|Overall Study|Adverse Event|1|||
130681565|NCT01507051|470462006|FG001|Overall Study|Adverse Event|0|||
130681566|NCT01507051|470462007|FG002|Overall Study|Adverse Event|0|||
130681567|NCT01507051|470462008|FG003|Overall Study|Adverse Event|0|||
130681568|NCT00420303|470462009|FG000|Overall Study|Serious Adverse Event|1|||
130681569|NCT00420303|470462010|FG001|Overall Study|Serious Adverse Event|0|||
130681570|NCT00420303|470462009|FG000|Overall Study|Lack of Efficacy|0|||
130681571|NCT00420303|470462010|FG001|Overall Study|Lack of Efficacy|3|||
130681572|NCT00420303|470462009|FG000|Overall Study|Physician Decision|0|||
130681573|NCT00420303|470462010|FG001|Overall Study|Physician Decision|1|||
130681574|NCT00745420|470462012|FG000|Overall Study|Ineligible|1|||
130681575|NCT00088829|470462017|FG000|Overall Study|PI left institution and study was close|22|||
130681576|NCT04455633|470462018|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
130681577|NCT04455633|470462019|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
130681578|NCT04455633|470462020|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
130681579|NCT04455633|470462018|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
130681580|NCT04455633|470462019|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
130681581|NCT04455633|470462020|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
130681582|NCT04455633|470462018|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
130681583|NCT04455633|470462019|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
130681584|NCT04455633|470462020|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
130681585|NCT04455633|470462018|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
130681586|NCT04455633|470462019|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
130681587|NCT04455633|470462020|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
130681588|NCT00727571|470462021|FG000|Overall Study|Ineligibility determined|1|||
130681589|NCT00727571|470462022|FG001|Overall Study|Ineligibility determined|1|||
130681590|NCT00727571|470462023|FG002|Overall Study|Ineligibility determined|1|||
130885906|NCT01394016|471215291|FG010|Overall Study|Lost to Follow-up|0|||
130885907|NCT01394016|471215292|FG011|Overall Study|Lost to Follow-up|0|||
130885908|NCT01394016|471215293|FG012|Overall Study|Lost to Follow-up|0|||
130885909|NCT01394016|471215294|FG013|Overall Study|Lost to Follow-up|0|||
130885910|NCT01394016|471215295|FG014|Overall Study|Lost to Follow-up|0|||
130885911|NCT01394016|471215296|FG015|Overall Study|Lost to Follow-up|0|||
130885912|NCT01394016|471215297|FG016|Overall Study|Lost to Follow-up|0|||
130885913|NCT01394016|471215298|FG017|Overall Study|Lost to Follow-up|0|||
130885914|NCT01394016|471215299|FG018|Overall Study|Lost to Follow-up|1|||
130885915|NCT03534804|471215300|FG000|Overall Study|Withdrawal by Subject|1|||
130885916|NCT00174187|471215301|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
130885917|NCT00174187|471215302|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
130885918|NCT00174187|471215303|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
130885919|NCT00174187|471215301|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
130885920|NCT00174187|471215302|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
130885921|NCT00174187|471215303|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
130885922|NCT00174187|471215301|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
130885923|NCT00174187|471215302|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
130885924|NCT00174187|471215303|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
130885925|NCT00174187|471215301|FG000|Period 1 (up to 3 Years)|Other|0|||
130885926|NCT00174187|471215302|FG001|Period 1 (up to 3 Years)|Other|1|||
130885927|NCT00174187|471215303|FG002|Period 1 (up to 3 Years)|Other|0|||
130885928|NCT00174187|471215301|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
130885929|NCT00174187|471215302|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
130885930|NCT00174187|471215303|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
130885931|NCT00174187|471215301|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
130885932|NCT00174187|471215302|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
130885933|NCT00174187|471215303|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
130885934|NCT00174187|471215301|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
130885935|NCT00174187|471215302|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
130885936|NCT00174187|471215303|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
130885937|NCT00174187|471215301|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
130885938|NCT00174187|471215302|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
130681591|NCT00727571|470462024|FG003|Overall Study|Ineligibility determined|0|||
130681592|NCT00727571|470462021|FG000|Overall Study|Death|0|||
130681593|NCT00727571|470462022|FG001|Overall Study|Death|19|||
130681594|NCT00727571|470462023|FG002|Overall Study|Death|5|||
130885939|NCT00174187|471215303|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
130681595|NCT00727571|470462024|FG003|Overall Study|Death|1|||
130885940|NCT00174187|471215301|FG000|Period 2 (After 3 Years)|Other|0|||
130885941|NCT00174187|471215302|FG001|Period 2 (After 3 Years)|Other|0|||
130885942|NCT00174187|471215303|FG002|Period 2 (After 3 Years)|Other|5|||
130885943|NCT00759941|471215304|FG000|Overall Study|Use of medication|1|||
130885944|NCT00759941|471215305|FG001|Overall Study|Use of medication|0|||
130885945|NCT00759941|471215304|FG000|Overall Study|Adverse Event|1|||
130885946|NCT00759941|471215305|FG001|Overall Study|Adverse Event|0|||
130885947|NCT00759941|471215304|FG000|Overall Study|Exited in error by site|1|||
130885948|NCT00759941|471215305|FG001|Overall Study|Exited in error by site|1|||
130885949|NCT06078124|471215306|FG000|Overall Study|Lost to Follow-up|14|||
130885950|NCT06078124|471215307|FG001|Overall Study|Lost to Follow-up|14|||
130885951|NCT01198977|471215308|FG000|Overall Study|Lost to Follow-up|1|||
130885952|NCT01198977|471215309|FG001|Overall Study|Lost to Follow-up|0|||
130885953|NCT05615922|471215310|FG000|Overall Study|Lost to Follow-up|1|||
130885954|NCT03173248|471215314|FG000|Overall Study|Death|28|||
130885955|NCT03173248|471215315|FG001|Overall Study|Death|46|||
130885956|NCT03173248|471215314|FG000|Overall Study|Lost to Follow-up|0|||
130885957|NCT03173248|471215315|FG001|Overall Study|Lost to Follow-up|1|||
130885958|NCT03173248|471215314|FG000|Overall Study|Withdrawal by Subject|6|||
130681596|NCT00727571|470462021|FG000|Overall Study|Physician Decision|0|||
130885959|NCT03173248|471215315|FG001|Overall Study|Withdrawal by Subject|4|||
130885960|NCT03173248|471215314|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
130681597|NCT00727571|470462022|FG001|Overall Study|Physician Decision|5|||
130681598|NCT00727571|470462023|FG002|Overall Study|Physician Decision|0|||
130681599|NCT00727571|470462024|FG003|Overall Study|Physician Decision|0|||
130681600|NCT00727571|470462021|FG000|Overall Study|Withdrawal by Subject|0|||
130681601|NCT00727571|470462022|FG001|Overall Study|Withdrawal by Subject|10|||
130681602|NCT00727571|470462023|FG002|Overall Study|Withdrawal by Subject|11|||
130681603|NCT00727571|470462024|FG003|Overall Study|Withdrawal by Subject|0|||
130681604|NCT00727571|470462021|FG000|Overall Study|Subject Non Compliance|0|||
130681605|NCT00727571|470462022|FG001|Overall Study|Subject Non Compliance|6|||
130681606|NCT00727571|470462023|FG002|Overall Study|Subject Non Compliance|0|||
130681607|NCT00727571|470462024|FG003|Overall Study|Subject Non Compliance|4|||
130681608|NCT00727571|470462021|FG000|Overall Study|Dismissed from nursing home|0|||
130681609|NCT00727571|470462022|FG001|Overall Study|Dismissed from nursing home|9|||
130681610|NCT00727571|470462023|FG002|Overall Study|Dismissed from nursing home|5|||
130681611|NCT00727571|470462024|FG003|Overall Study|Dismissed from nursing home|0|||
130681612|NCT00727571|470462021|FG000|Overall Study|Hospitalization|0|||
130681613|NCT00727571|470462022|FG001|Overall Study|Hospitalization|1|||
130681614|NCT00727571|470462023|FG002|Overall Study|Hospitalization|0|||
130681615|NCT00727571|470462024|FG003|Overall Study|Hospitalization|1|||
130681616|NCT00727571|470462021|FG000|Overall Study|AE not leading to hospitalization|0|||
130681617|NCT00727571|470462022|FG001|Overall Study|AE not leading to hospitalization|0|||
130681618|NCT00727571|470462023|FG002|Overall Study|AE not leading to hospitalization|2|||
130681619|NCT00727571|470462024|FG003|Overall Study|AE not leading to hospitalization|0|||
130681620|NCT00727571|470462021|FG000|Overall Study|Other|0|||
130681621|NCT00727571|470462022|FG001|Overall Study|Other|4|||
130681622|NCT00727571|470462023|FG002|Overall Study|Other|6|||
130681623|NCT00727571|470462024|FG003|Overall Study|Other|0|||
130681624|NCT03164772|470462026|FG000|Overall Study|Death|4|||
130681625|NCT03164772|470462027|FG001|Overall Study|Death|2|||
130681626|NCT03164772|470462026|FG000|Overall Study|Adverse Event|1|||
130681627|NCT03164772|470462027|FG001|Overall Study|Adverse Event|4|||
130681628|NCT03164772|470462026|FG000|Overall Study|Progressive Disease|11|||
130681629|NCT03164772|470462027|FG001|Overall Study|Progressive Disease|21|||
130681630|NCT03164772|470462026|FG000|Overall Study|Physician Decision|2|||
130681631|NCT03164772|470462027|FG001|Overall Study|Physician Decision|0|||
130681632|NCT03164772|470462026|FG000|Overall Study|Withdrawal by Subject|0|||
130681633|NCT03164772|470462027|FG001|Overall Study|Withdrawal by Subject|4|||
130681634|NCT00051025|470462028|FG000|Overall Study|Progressive Disease|1|||
130681635|NCT00051025|470462029|FG001|Overall Study|Progressive Disease|1|||
130885961|NCT03173248|471215315|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
130885962|NCT02991768|471215317|FG000|Overall Study|Physician Decision|4|||
130885963|NCT04500158|471215320|FG000|Overall Study|Physician Decision|17|||
130885964|NCT04500158|471215321|FG001|Overall Study|Physician Decision|11|||
130681636|NCT00051025|470462028|FG000|Overall Study|Adverse Event|1|||
130681637|NCT00051025|470462029|FG001|Overall Study|Adverse Event|1|||
130681638|NCT00051025|470462028|FG000|Overall Study|Withdrawal by Subject|0|||
130681639|NCT00051025|470462029|FG001|Overall Study|Withdrawal by Subject|1|||
130681640|NCT00051025|470462028|FG000|Overall Study|Death|0|||
130681641|NCT00051025|470462029|FG001|Overall Study|Death|1|||
130681642|NCT02189941|470462030|FG000|Overall Study|Non-compliance|0|||
130885965|NCT02807402|471215326|FG000|Overall Study|Failure to Return|1|||
130885966|NCT02807402|471215326|FG000|Overall Study|Death|3|||
130681643|NCT02189941|470462031|FG001|Overall Study|Non-compliance|0|||
130681644|NCT02189941|470462032|FG002|Overall Study|Non-compliance|1|||
130885967|NCT02807402|471215326|FG000|Overall Study|Other|2|||
130681645|NCT00445003|470462033|FG000|Overall Study|Death|1|||
130681646|NCT00445003|470462034|FG001|Overall Study|Death|2|||
130885968|NCT04922216|471215328|FG000|Overall Study|Withdrawal by Subject|0|||
130885969|NCT04922216|471215329|FG001|Overall Study|Withdrawal by Subject|1|||
130885970|NCT04922216|471215330|FG002|Overall Study|Withdrawal by Subject|0|||
130885971|NCT04922216|471215331|FG003|Overall Study|Withdrawal by Subject|0|||
130681647|NCT00445003|470462035|FG002|Overall Study|Death|1|||
130681648|NCT00445003|470462033|FG000|Overall Study|Missed Visit|3|||
130681649|NCT00445003|470462034|FG001|Overall Study|Missed Visit|5|||
130681650|NCT00445003|470462035|FG002|Overall Study|Missed Visit|1|||
130681651|NCT00445003|470462033|FG000|Overall Study|Dropped|1|||
130681652|NCT00445003|470462034|FG001|Overall Study|Dropped|3|||
130681653|NCT00445003|470462035|FG002|Overall Study|Dropped|2|||
130681654|NCT01196052|470462036|FG000|Overall Study|Adverse Event|9|||
130885972|NCT04922216|471215332|FG004|Overall Study|Withdrawal by Subject|0|||
130885973|NCT04922216|471215333|FG005|Overall Study|Withdrawal by Subject|0|||
130885974|NCT04922216|471215334|FG006|Overall Study|Withdrawal by Subject|0|||
130885975|NCT04922216|471215335|FG007|Overall Study|Withdrawal by Subject|2|||
130885976|NCT04922216|471215336|FG008|Overall Study|Withdrawal by Subject|0|||
130885977|NCT04922216|471215337|FG009|Overall Study|Withdrawal by Subject|0|||
130885978|NCT04922216|471215338|FG010|Overall Study|Withdrawal by Subject|0|||
130885979|NCT04922216|471215339|FG011|Overall Study|Withdrawal by Subject|0|||
130885980|NCT04922216|471215340|FG012|Overall Study|Withdrawal by Subject|1|||
130885981|NCT04922216|471215341|FG013|Overall Study|Withdrawal by Subject|1|||
130885982|NCT04922216|471215342|FG014|Overall Study|Withdrawal by Subject|1|||
130681655|NCT01196052|470462036|FG000|Overall Study|Lost to Follow-up|1|||
130681656|NCT01196052|470462036|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
130681657|NCT01196052|470462036|FG000|Overall Study|Reason not Specified|5|||
130681658|NCT01196052|470462036|FG000|Overall Study|Withdrawal by Subject|6|||
130681659|NCT02178722|470462037|FG000|Overall Study|Withdrawal by Subject|0|||
130681660|NCT02178722|470462038|FG001|Overall Study|Withdrawal by Subject|0|||
130681661|NCT02178722|470462039|FG002|Overall Study|Withdrawal by Subject|0|||
130681662|NCT02178722|470462040|FG003|Overall Study|Withdrawal by Subject|2|||
130681663|NCT02178722|470462041|FG004|Overall Study|Withdrawal by Subject|33|||
130681664|NCT02178722|470462037|FG000|Overall Study|Death|2|||
130681665|NCT02178722|470462038|FG001|Overall Study|Death|13|||
130681666|NCT02178722|470462039|FG002|Overall Study|Death|12|||
130681667|NCT02178722|470462040|FG003|Overall Study|Death|12|||
130885983|NCT04922216|471215343|FG015|Overall Study|Withdrawal by Subject|0|||
130885984|NCT04922216|471215344|FG016|Overall Study|Withdrawal by Subject|0|||
130885985|NCT04922216|471215345|FG017|Overall Study|Withdrawal by Subject|1|||
130885986|NCT04922216|471215346|FG018|Overall Study|Withdrawal by Subject|1|||
130885987|NCT04922216|471215347|FG019|Overall Study|Withdrawal by Subject|1|||
130885988|NCT04922216|471215348|FG020|Overall Study|Withdrawal by Subject|1|||
130885989|NCT04922216|471215349|FG021|Overall Study|Withdrawal by Subject|0|||
130885990|NCT04922216|471215350|FG022|Overall Study|Withdrawal by Subject|0|||
130885991|NCT04922216|471215351|FG023|Overall Study|Withdrawal by Subject|2|||
130885992|NCT04922216|471215352|FG024|Overall Study|Withdrawal by Subject|0|||
130885993|NCT04922216|471215353|FG025|Overall Study|Withdrawal by Subject|0|||
130885994|NCT04922216|471215354|FG026|Overall Study|Withdrawal by Subject|1|||
130885995|NCT04922216|471215355|FG027|Overall Study|Withdrawal by Subject|0|||
130885996|NCT04922216|471215356|FG028|Overall Study|Withdrawal by Subject|0|||
130885997|NCT04922216|471215357|FG029|Overall Study|Withdrawal by Subject|0|||
130885998|NCT04922216|471215358|FG030|Overall Study|Withdrawal by Subject|1|||
130885999|NCT04922216|471215359|FG031|Overall Study|Withdrawal by Subject|0|||
130886000|NCT04922216|471215328|FG000|Overall Study|Lost to Follow-up|1|||
130886001|NCT04922216|471215329|FG001|Overall Study|Lost to Follow-up|0|||
130886002|NCT04922216|471215330|FG002|Overall Study|Lost to Follow-up|2|||
130886003|NCT04922216|471215331|FG003|Overall Study|Lost to Follow-up|0|||
130886004|NCT04922216|471215332|FG004|Overall Study|Lost to Follow-up|0|||
130886005|NCT04922216|471215333|FG005|Overall Study|Lost to Follow-up|2|||
130886006|NCT04922216|471215334|FG006|Overall Study|Lost to Follow-up|0|||
130886007|NCT04922216|471215335|FG007|Overall Study|Lost to Follow-up|1|||
130886008|NCT04922216|471215336|FG008|Overall Study|Lost to Follow-up|1|||
130886009|NCT04922216|471215337|FG009|Overall Study|Lost to Follow-up|2|||
130886010|NCT04922216|471215338|FG010|Overall Study|Lost to Follow-up|2|||
130886011|NCT04922216|471215339|FG011|Overall Study|Lost to Follow-up|1|||
130886012|NCT04922216|471215340|FG012|Overall Study|Lost to Follow-up|1|||
130886013|NCT04922216|471215341|FG013|Overall Study|Lost to Follow-up|0|||
130681668|NCT02178722|470462041|FG004|Overall Study|Death|205|||
130886014|NCT04922216|471215342|FG014|Overall Study|Lost to Follow-up|1|||
130886015|NCT04922216|471215343|FG015|Overall Study|Lost to Follow-up|0|||
130681669|NCT02178722|470462037|FG000|Overall Study|Lost to Follow-up|0|||
130681670|NCT02178722|470462038|FG001|Overall Study|Lost to Follow-up|0|||
130886016|NCT04922216|471215344|FG016|Overall Study|Lost to Follow-up|0|||
130886017|NCT04922216|471215345|FG017|Overall Study|Lost to Follow-up|2|||
130886018|NCT04922216|471215346|FG018|Overall Study|Lost to Follow-up|1|||
130886019|NCT04922216|471215347|FG019|Overall Study|Lost to Follow-up|0|||
130681671|NCT02178722|470462039|FG002|Overall Study|Lost to Follow-up|0|||
130681672|NCT02178722|470462040|FG003|Overall Study|Lost to Follow-up|2|||
130886020|NCT04922216|471215348|FG020|Overall Study|Lost to Follow-up|1|||
130886021|NCT04922216|471215349|FG021|Overall Study|Lost to Follow-up|0|||
130886022|NCT04922216|471215350|FG022|Overall Study|Lost to Follow-up|2|||
130886023|NCT04922216|471215351|FG023|Overall Study|Lost to Follow-up|1|||
130886024|NCT04922216|471215352|FG024|Overall Study|Lost to Follow-up|0|||
130886025|NCT04922216|471215353|FG025|Overall Study|Lost to Follow-up|2|||
130886026|NCT04922216|471215354|FG026|Overall Study|Lost to Follow-up|0|||
130886027|NCT04922216|471215355|FG027|Overall Study|Lost to Follow-up|0|||
130886028|NCT04922216|471215356|FG028|Overall Study|Lost to Follow-up|1|||
130886029|NCT04922216|471215357|FG029|Overall Study|Lost to Follow-up|0|||
130886030|NCT04922216|471215358|FG030|Overall Study|Lost to Follow-up|2|||
130886031|NCT04922216|471215359|FG031|Overall Study|Lost to Follow-up|1|||
130886032|NCT04801420|471215360|FG000|Overall Study|Other|1|||
130886033|NCT04801420|471215361|FG001|Overall Study|Other|2|||
130886034|NCT04801420|471215362|FG002|Overall Study|Other|1|||
130886035|NCT04801420|471215360|FG000|Overall Study|Lost to Follow-up|7|||
130886036|NCT04801420|471215361|FG001|Overall Study|Lost to Follow-up|9|||
130886037|NCT04801420|471215362|FG002|Overall Study|Lost to Follow-up|10|||
130886038|NCT04801420|471215360|FG000|Overall Study|Moved from study area|0|||
130886039|NCT04801420|471215361|FG001|Overall Study|Moved from study area|1|||
130886040|NCT04801420|471215362|FG002|Overall Study|Moved from study area|1|||
130886041|NCT04801420|471215360|FG000|Overall Study|Withdrawal by Subject|5|||
130886042|NCT04801420|471215361|FG001|Overall Study|Withdrawal by Subject|1|||
130886043|NCT04801420|471215362|FG002|Overall Study|Withdrawal by Subject|4|||
130886044|NCT04801420|471215360|FG000|Overall Study|Individual stopping criteria reached|0|||
130886045|NCT04801420|471215361|FG001|Overall Study|Individual stopping criteria reached|1|||
130886046|NCT04801420|471215362|FG002|Overall Study|Individual stopping criteria reached|0|||
130886047|NCT04801420|471215360|FG000|Overall Study|Ongoing in the study|195|||
130886048|NCT04801420|471215361|FG001|Overall Study|Ongoing in the study|195|||
130886049|NCT04801420|471215362|FG002|Overall Study|Ongoing in the study|192|||
130886050|NCT04774094|471215363|FG000|Overall Study|Other|2|||
130886051|NCT04774094|471215363|FG000|Overall Study|Withdrawal by Subject|9|||
130886052|NCT04774094|471215363|FG000|Overall Study|Lost to Follow-up|7|||
130886053|NCT04774094|471215363|FG000|Overall Study|Lack of Efficacy|5|||
130886054|NCT04774094|471215363|FG000|Overall Study|Death|17|||
130886055|NCT04774094|471215363|FG000|Overall Study|Adverse Event|4|||
130886056|NCT00753506|471217214|FG000|Overall Study|Withdrawal by Subject|4|||
130886057|NCT00753506|471217215|FG001|Overall Study|Withdrawal by Subject|1|||
130886058|NCT00753506|471217214|FG000|Overall Study|Lost to Follow-up|2|||
130886059|NCT00753506|471217215|FG001|Overall Study|Lost to Follow-up|0|||
130886060|NCT00753506|471217214|FG000|Overall Study|Other reason|1|||
130886061|NCT00753506|471217215|FG001|Overall Study|Other reason|1|||
130886062|NCT01600716|471217216|FG000|Overall Study|Other Reasons|3|||
130886063|NCT01600716|471217217|FG001|Overall Study|Other Reasons|1|||
130886064|NCT01600716|471217216|FG000|Overall Study|Personal Reasons|0|||
130886065|NCT01600716|471217217|FG001|Overall Study|Personal Reasons|2|||
130886066|NCT01600716|471217216|FG000|Overall Study|Lost to Follow-up|0|||
130681673|NCT02178722|470462041|FG004|Overall Study|Lost to Follow-up|11|||
130886067|NCT01600716|471217217|FG001|Overall Study|Lost to Follow-up|2|||
130886068|NCT01600716|471217216|FG000|Overall Study|Pregnancy|1|||
130886069|NCT01600716|471217217|FG001|Overall Study|Pregnancy|0|||
130886070|NCT01600716|471217216|FG000|Overall Study|Lack of Efficacy|2|||
130886071|NCT01600716|471217217|FG001|Overall Study|Lack of Efficacy|1|||
130886072|NCT01600716|471217216|FG000|Overall Study|Adverse Event|1|||
130681674|NCT02178722|470462037|FG000|Overall Study|Study terminated by Sponsor|2|||
130681675|NCT02178722|470462038|FG001|Overall Study|Study terminated by Sponsor|7|||
130681676|NCT02178722|470462039|FG002|Overall Study|Study terminated by Sponsor|6|||
130681677|NCT02178722|470462040|FG003|Overall Study|Study terminated by Sponsor|4|||
130681678|NCT02178722|470462041|FG004|Overall Study|Study terminated by Sponsor|128|||
130681679|NCT02178722|470462037|FG000|Overall Study|Physician Decision|0|||
130681680|NCT02178722|470462038|FG001|Overall Study|Physician Decision|0|||
130681681|NCT02178722|470462039|FG002|Overall Study|Physician Decision|0|||
130681682|NCT02178722|470462040|FG003|Overall Study|Physician Decision|0|||
130886073|NCT01600716|471217217|FG001|Overall Study|Adverse Event|1|||
130886074|NCT03926611|471217221|FG000|Overall Study|Adverse Event|0|||
130886075|NCT03926611|471217222|FG001|Overall Study|Adverse Event|0|||
130886076|NCT03926611|471217223|FG002|Overall Study|Adverse Event|0|||
130886077|NCT03926611|471217224|FG003|Overall Study|Adverse Event|3|||
130886078|NCT03926611|471217225|FG004|Overall Study|Adverse Event|1|||
130886079|NCT03926611|471217226|FG005|Overall Study|Adverse Event|3|||
130886080|NCT03926611|471217227|FG006|Overall Study|Adverse Event|0|||
130681683|NCT02178722|470462041|FG004|Overall Study|Physician Decision|3|||
130681684|NCT02178722|470462037|FG000|Overall Study|Other|0|||
130681685|NCT02178722|470462038|FG001|Overall Study|Other|0|||
130886081|NCT03926611|471217221|FG000|Overall Study|Lack of Efficacy|1|||
130886082|NCT03926611|471217222|FG001|Overall Study|Lack of Efficacy|2|||
130886083|NCT03926611|471217223|FG002|Overall Study|Lack of Efficacy|0|||
130886084|NCT03926611|471217224|FG003|Overall Study|Lack of Efficacy|0|||
130886085|NCT03926611|471217225|FG004|Overall Study|Lack of Efficacy|1|||
130681686|NCT02178722|470462039|FG002|Overall Study|Other|0|||
130681687|NCT02178722|470462040|FG003|Overall Study|Other|0|||
130681688|NCT02178722|470462041|FG004|Overall Study|Other|2|||
130681689|NCT03340727|470462042|FG000|Overall Study|Death|1|||
130681690|NCT03340727|470462043|FG001|Overall Study|Death|0|||
130681691|NCT03340727|470462042|FG000|Overall Study|Lost to Follow-up|31|||
130681692|NCT03340727|470462043|FG001|Overall Study|Lost to Follow-up|35|||
130681693|NCT03340727|470462042|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
130681694|NCT03340727|470462043|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
130681695|NCT03340727|470462042|FG000|Overall Study|Transferred to another facility|10|||
130681696|NCT03340727|470462043|FG001|Overall Study|Transferred to another facility|7|||
130681697|NCT03340727|470462042|FG000|Overall Study|Withdrawal by Subject|28|||
130681698|NCT03340727|470462043|FG001|Overall Study|Withdrawal by Subject|17|||
130681699|NCT03553823|470462044|FG000|Overall Study|Physician Decision|0|||
130681700|NCT03553823|470462045|FG001|Overall Study|Physician Decision|1|||
130681701|NCT01572948|470462046|FG000|Overall Study|Lost to Follow-up|1|||
130681702|NCT01572948|470462047|FG001|Overall Study|Lost to Follow-up|0|||
130681703|NCT01572948|470462046|FG000|Overall Study|unable to contact|0|||
130681704|NCT01572948|470462047|FG001|Overall Study|unable to contact|1|||
130681705|NCT03603314|470462048|FG000|Overall Study|Lost to Follow-up|0|||
130681706|NCT03603314|470462049|FG001|Overall Study|Lost to Follow-up|3|||
130681707|NCT03603314|470462050|FG002|Overall Study|Lost to Follow-up|0|||
130681708|NCT03603314|470462048|FG000|Overall Study|Protocol Violation|0|||
130681709|NCT03603314|470462049|FG001|Overall Study|Protocol Violation|1|||
130681710|NCT03603314|470462050|FG002|Overall Study|Protocol Violation|0|||
130681711|NCT03603314|470462048|FG000|Overall Study|Adverse Event|2|||
130681712|NCT03603314|470462049|FG001|Overall Study|Adverse Event|0|||
130681713|NCT03603314|470462050|FG002|Overall Study|Adverse Event|0|||
130681714|NCT03603314|470462048|FG000|Overall Study|Physician Decision|1|||
130681715|NCT03603314|470462049|FG001|Overall Study|Physician Decision|1|||
130681716|NCT03603314|470462050|FG002|Overall Study|Physician Decision|0|||
130681717|NCT03603314|470462048|FG000|Overall Study|Withdrawal by Subject|4|||
130681718|NCT03603314|470462049|FG001|Overall Study|Withdrawal by Subject|5|||
130681719|NCT03603314|470462050|FG002|Overall Study|Withdrawal by Subject|3|||
130681720|NCT03603314|470462048|FG000|Overall Study|Other|0|||
130681721|NCT03603314|470462049|FG001|Overall Study|Other|1|||
130681722|NCT03603314|470462050|FG002|Overall Study|Other|0|||
130681723|NCT03450070|470462051|FG000|Overall Study|Withdrawal by Subject|8|||
130681724|NCT01496183|470462059|FG000|Overall Study|Physician Decision|3|||
130681725|NCT01496183|470462060|FG001|Overall Study|Physician Decision|1|||
130681726|NCT01496183|470462059|FG000|Overall Study|Withdrawal by Subject|0|||
130681727|NCT01496183|470462060|FG001|Overall Study|Withdrawal by Subject|1|||
130681728|NCT03002077|470462061|FG000|Overall Study|Non-compliance with Study Drug|4|||
130681729|NCT03002077|470462061|FG000|Overall Study|Non-compliance w/Background ADT|1|||
130681730|NCT03002077|470462061|FG000|Overall Study|Study Terminated by Sponsor|257|||
130681731|NCT03002077|470462061|FG000|Overall Study|Site Terminated by Sponsor|5|||
130681732|NCT03002077|470462061|FG000|Overall Study|Miscellaneous Reasons|10|||
130681733|NCT03002077|470462061|FG000|Overall Study|Adverse Event|23|||
130681734|NCT03002077|470462061|FG000|Overall Study|Lack of Efficacy|20|||
130681735|NCT03002077|470462061|FG000|Overall Study|Withdrawal by Subject|72|||
130681736|NCT03002077|470462061|FG000|Overall Study|Lost to Follow-up|21|||
130681737|NCT03002077|470462061|FG000|Overall Study|Pregnancy|4|||
130681738|NCT03002077|470462061|FG000|Overall Study|Protocol Violation|21|||
130681739|NCT04625114|470462062|FG000|Overall Study|Adverse Event|3|||
130681740|NCT04625114|470462063|FG001|Overall Study|Adverse Event|1|||
130681741|NCT04625114|470462062|FG000|Overall Study|Withdrawal by Subject|2|||
130681742|NCT04625114|470462063|FG001|Overall Study|Withdrawal by Subject|0|||
130681743|NCT02849652|470462066|FG000|Overall Study|Lost to Follow-up|104|||
130681744|NCT02849652|470462067|FG001|Overall Study|Lost to Follow-up|35|||
130681745|NCT02849652|470462068|FG002|Overall Study|Lost to Follow-up|116|||
130681746|NCT02849652|470462069|FG003|Overall Study|Lost to Follow-up|22|||
130681747|NCT02849652|470462066|FG000|Overall Study|Withdrawal by Subject|10|||
130681748|NCT02849652|470462067|FG001|Overall Study|Withdrawal by Subject|2|||
130681749|NCT02849652|470462068|FG002|Overall Study|Withdrawal by Subject|8|||
130681750|NCT02849652|470462069|FG003|Overall Study|Withdrawal by Subject|4|||
130681751|NCT01863745|470462070|FG000|Overall Study|Disease Progression|9|||
130681752|NCT01863745|470462070|FG000|Overall Study|Adverse Event|2|||
130681753|NCT01863745|470462070|FG000|Overall Study|Death|1|||
130681754|NCT01863745|470462070|FG000|Overall Study|Withdrawal by Subject|1|||
130681755|NCT00472290|470462071|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
130681756|NCT00472290|470462071|FG000|Overall Study|Protocol Specified Criteria|7|||
130681757|NCT00472290|470462071|FG000|Overall Study|Administrative Decision|37|||
130681758|NCT00472290|470462071|FG000|Overall Study|Death|3|||
130681759|NCT00472290|470462071|FG000|Overall Study|Lost to Follow-up|1|||
130681760|NCT00472290|470462071|FG000|Overall Study|Lack of Efficacy|1|||
130681761|NCT00472290|470462071|FG000|Overall Study|Disease Progression|4|||
130681762|NCT00472290|470462071|FG000|Overall Study|Withdrawal by Subject|5|||
130681763|NCT00472290|470462071|FG000|Overall Study|Adverse Event|6|||
130681764|NCT00472290|470462071|FG000|Overall Study|Requirement for alternative therapy|7|||
130886086|NCT03926611|471217226|FG005|Overall Study|Lack of Efficacy|0|||
130886087|NCT03926611|471217227|FG006|Overall Study|Lack of Efficacy|1|||
130886088|NCT03926611|471217221|FG000|Overall Study|Physician Decision|0|||
130886089|NCT03926611|471217222|FG001|Overall Study|Physician Decision|0|||
130886090|NCT03926611|471217223|FG002|Overall Study|Physician Decision|0|||
130886091|NCT03926611|471217224|FG003|Overall Study|Physician Decision|0|||
130886092|NCT03926611|471217225|FG004|Overall Study|Physician Decision|0|||
130886093|NCT03926611|471217226|FG005|Overall Study|Physician Decision|1|||
130886094|NCT03926611|471217227|FG006|Overall Study|Physician Decision|0|||
130886095|NCT03926611|471217221|FG000|Overall Study|Protocol Violation|1|||
130886096|NCT03926611|471217222|FG001|Overall Study|Protocol Violation|0|||
130886097|NCT03926611|471217223|FG002|Overall Study|Protocol Violation|0|||
130886098|NCT03926611|471217224|FG003|Overall Study|Protocol Violation|1|||
130886099|NCT03926611|471217225|FG004|Overall Study|Protocol Violation|1|||
130886100|NCT03926611|471217226|FG005|Overall Study|Protocol Violation|1|||
130886101|NCT03926611|471217227|FG006|Overall Study|Protocol Violation|1|||
130886102|NCT03926611|471217221|FG000|Overall Study|Technical problems|0|||
130886103|NCT03926611|471217222|FG001|Overall Study|Technical problems|0|||
130886104|NCT03926611|471217223|FG002|Overall Study|Technical problems|0|||
130886105|NCT03926611|471217224|FG003|Overall Study|Technical problems|0|||
130886106|NCT03926611|471217225|FG004|Overall Study|Technical problems|0|||
130886107|NCT03926611|471217226|FG005|Overall Study|Technical problems|1|||
130886108|NCT03926611|471217227|FG006|Overall Study|Technical problems|0|||
130886109|NCT03926611|471217221|FG000|Overall Study|Withdrawal by Subject|1|||
130886110|NCT03926611|471217222|FG001|Overall Study|Withdrawal by Subject|1|||
130886111|NCT03926611|471217223|FG002|Overall Study|Withdrawal by Subject|1|||
131103785|NCT02594163|472010354|FG001|Follow-up Period|Withdrawal by Subject|1|||
131103786|NCT02594163|472010353|FG000|Follow-up Period|Study Termination by Sponsor|6|||
131103787|NCT02594163|472010354|FG001|Follow-up Period|Study Termination by Sponsor|4|||
131103788|NCT02594163|472010353|FG000|Follow-up Period|Lost to Follow-up|1|||
130681765|NCT00777829|470462072|FG000|Overall Study|Withdrawal by Subject|0|||
130681766|NCT00777829|470462073|FG001|Overall Study|Withdrawal by Subject|2|||
130886112|NCT03926611|471217224|FG003|Overall Study|Withdrawal by Subject|0|||
130681767|NCT00336479|470462078|FG000|Overall Study|Adverse Event|8|||
130681768|NCT00336479|470462079|FG001|Overall Study|Adverse Event|11|||
130681769|NCT00336479|470462080|FG002|Overall Study|Adverse Event|18|||
130681770|NCT00336479|470462081|FG003|Overall Study|Adverse Event|4|||
130681771|NCT00336479|470462078|FG000|Overall Study|Noncompliant|1|||
130681772|NCT00336479|470462079|FG001|Overall Study|Noncompliant|7|||
130681773|NCT00336479|470462080|FG002|Overall Study|Noncompliant|3|||
130681774|NCT00336479|470462081|FG003|Overall Study|Noncompliant|0|||
130681775|NCT00336479|470462078|FG000|Overall Study|Physician Decision|2|||
130681776|NCT00336479|470462079|FG001|Overall Study|Physician Decision|3|||
130681777|NCT00336479|470462080|FG002|Overall Study|Physician Decision|1|||
130681778|NCT00336479|470462081|FG003|Overall Study|Physician Decision|0|||
130681779|NCT00336479|470462078|FG000|Overall Study|Lost to Follow-up|3|||
130681780|NCT00336479|470462079|FG001|Overall Study|Lost to Follow-up|2|||
130681781|NCT00336479|470462080|FG002|Overall Study|Lost to Follow-up|0|||
130681782|NCT00336479|470462081|FG003|Overall Study|Lost to Follow-up|0|||
130681783|NCT00336479|470462078|FG000|Overall Study|Withdrawal by Subject|3|||
130681784|NCT00336479|470462079|FG001|Overall Study|Withdrawal by Subject|2|||
130681785|NCT00336479|470462080|FG002|Overall Study|Withdrawal by Subject|3|||
130681786|NCT00336479|470462081|FG003|Overall Study|Withdrawal by Subject|0|||
130681787|NCT00336479|470462078|FG000|Overall Study|Other|0|||
130681788|NCT00336479|470462079|FG001|Overall Study|Other|0|||
130681789|NCT00336479|470462080|FG002|Overall Study|Other|1|||
130681790|NCT00336479|470462081|FG003|Overall Study|Other|0|||
130681791|NCT00336479|470462078|FG000|Overall Study|Virologic Stopping Rule|20|||
130681792|NCT00336479|470462079|FG001|Overall Study|Virologic Stopping Rule|0|||
130681793|NCT00336479|470462080|FG002|Overall Study|Virologic Stopping Rule|0|||
130681794|NCT00336479|470462081|FG003|Overall Study|Virologic Stopping Rule|0|||
130681795|NCT01722877|470462082|FG000|Overall Study|Death|1|||
130681796|NCT01722877|470462082|FG000|Overall Study|Lost to Follow-up|1|||
130681797|NCT01395030|470462085|FG000|Overall Study|Did not complete FCH PET/CT|7|||
130681798|NCT02079766|470462086|FG000|Overall Study|Physician Decision|1|||
130886113|NCT03926611|471217225|FG004|Overall Study|Withdrawal by Subject|0|||
131103789|NCT02594163|472010354|FG001|Follow-up Period|Lost to Follow-up|0|||
130681799|NCT02079766|470462087|FG001|Overall Study|Physician Decision|0|||
130681800|NCT02079766|470462086|FG000|Overall Study|Withdrawal by Subject|1|||
130681801|NCT02079766|470462087|FG001|Overall Study|Withdrawal by Subject|0|||
130681802|NCT02373098|470462088|FG000|Overall Study|Lost to Follow-up|1|||
130681803|NCT02373098|470462089|FG001|Overall Study|Lost to Follow-up|0|||
130681804|NCT02373098|470462088|FG000|Overall Study|Protocol Violation|3|||
130886114|NCT03926611|471217226|FG005|Overall Study|Withdrawal by Subject|1|||
130886115|NCT03926611|471217227|FG006|Overall Study|Withdrawal by Subject|3|||
130886116|NCT03926611|471217221|FG000|Overall Study|Covid-19 pandemic|0|||
130886117|NCT03926611|471217222|FG001|Overall Study|Covid-19 pandemic|0|||
130886118|NCT03926611|471217223|FG002|Overall Study|Covid-19 pandemic|1|||
130886119|NCT03926611|471217224|FG003|Overall Study|Covid-19 pandemic|0|||
130886120|NCT03926611|471217225|FG004|Overall Study|Covid-19 pandemic|1|||
130886121|NCT03926611|471217226|FG005|Overall Study|Covid-19 pandemic|2|||
130886122|NCT03926611|471217227|FG006|Overall Study|Covid-19 pandemic|0|||
130886123|NCT02230670|471217230|FG000|Overall Study|Adverse Event|1|||
130886124|NCT02230670|471217231|FG001|Overall Study|Adverse Event|2|||
130886125|NCT02230670|471217230|FG000|Overall Study|Withdrawal by Subject|2|||
130886126|NCT02230670|471217231|FG001|Overall Study|Withdrawal by Subject|2|||
130886127|NCT02230670|471217230|FG000|Overall Study|Physician Decision|0|||
130886128|NCT02230670|471217231|FG001|Overall Study|Physician Decision|1|||
130886129|NCT02230670|471217230|FG000|Overall Study|Protocol Violation|0|||
130886130|NCT02230670|471217231|FG001|Overall Study|Protocol Violation|1|||
130886131|NCT02230670|471217230|FG000|Overall Study|Progression to Child-Pugh C|1|||
130886132|NCT02230670|471217231|FG001|Overall Study|Progression to Child-Pugh C|2|||
130886133|NCT01657019|471217232|FG000|Overall Study|Withdrawal by Subject|65|||
130886134|NCT01657019|471217232|FG000|Overall Study|Adverse Event|55|||
130886135|NCT01657019|471217232|FG000|Overall Study|Lost to Follow-up|48|||
130886136|NCT01657019|471217232|FG000|Overall Study|Protocol Violation|6|||
130886137|NCT01657019|471217232|FG000|Overall Study|Lack of Efficacy|3|||
130886138|NCT01657019|471217232|FG000|Overall Study|Other|58|||
130886139|NCT01750229|471217235|FG000|Randomized Crossover Phase|Adverse Event|1|||
130886140|NCT01750229|471217235|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
130886141|NCT01750229|471217235|FG000|Long-term Follow-up Phase|Adverse Event|2|||
130886142|NCT01750229|471217235|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
130886143|NCT02346721|471217236|FG000|Overall Study|Withdrew Consent|3|||
130886144|NCT02346721|471217236|FG000|Overall Study|Lack of Efficacy|1|||
130886145|NCT03809104|471217237|FG000|Overall Study|Withdrawal by Subject|3|||
130886146|NCT02968004|471217238|FG000|Main Study Phase|Adverse Event|1|||
130886147|NCT02968004|471217239|FG001|Main Study Phase|Adverse Event|0|||
130886148|NCT02968004|471217238|FG000|Main Study Phase|Withdrawal by Subject|0|||
130886149|NCT02968004|471217239|FG001|Main Study Phase|Withdrawal by Subject|1|||
130886150|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
130886151|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
130886152|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
130886153|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
130886154|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
130886155|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
130886156|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
130886157|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
130886158|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
130886159|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
130886160|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
130886161|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
130886162|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
130886163|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
130886164|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
130886165|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
130886166|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
130886167|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
130886168|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
130886169|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
130886170|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
130886171|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
130886172|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
130886173|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
130886174|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
130886175|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
130886176|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
130886177|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
130886178|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
130886179|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
131103790|NCT02594163|472010353|FG000|Follow-up Period|Death|2|||
130681805|NCT02373098|470462089|FG001|Overall Study|Protocol Violation|0|||
130681806|NCT02373098|470462088|FG000|Overall Study|Withdrawal by Subject|5|||
130681807|NCT02373098|470462089|FG001|Overall Study|Withdrawal by Subject|0|||
130681808|NCT02373098|470462088|FG000|Overall Study|Adverse Event|3|||
130681809|NCT02373098|470462089|FG001|Overall Study|Adverse Event|0|||
130886180|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
130886181|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
130886182|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
130886183|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
130886184|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
130886185|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
130681810|NCT05214560|470462094|FG000|Overall Study|Screening Failure|1|||
130681811|NCT05214560|470462094|FG000|Overall Study|Physician Decision|4|||
130681812|NCT05214560|470462094|FG000|Overall Study|Withdrawal by Subject|1|||
130681813|NCT05214560|470462094|FG000|Overall Study|Lost to Follow-up|2|||
130681814|NCT05214560|470462094|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
130681815|NCT05214560|470462094|FG000|Overall Study|Study physician not available for the anesthesia|3|||
130681816|NCT05214560|470462094|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
130681817|NCT05214560|470462094|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
130681818|NCT05214560|470462094|FG000|Overall Study|Surgery not performed|3|||
130681819|NCT03639311|470462097|FG000|Maintenance Phase|Lost to Follow-up|1|||
130681820|NCT03639311|470462098|FG001|Maintenance Phase|Lost to Follow-up|0|||
130681821|NCT03639311|470462099|FG002|Maintenance Phase|Lost to Follow-up|0|||
130681822|NCT03639311|470462097|FG000|Maintenance Phase|Adverse Event|1|||
130681823|NCT03639311|470462098|FG001|Maintenance Phase|Adverse Event|0|||
130681824|NCT03639311|470462099|FG002|Maintenance Phase|Adverse Event|0|||
130681825|NCT03639311|470462097|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
130681826|NCT03639311|470462098|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
130681827|NCT03639311|470462099|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
130681828|NCT03639311|470462097|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
130681829|NCT03639311|470462098|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
130681830|NCT03639311|470462099|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
130681831|NCT03639311|470462097|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
130681832|NCT03639311|470462098|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
130681833|NCT03639311|470462099|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
130681834|NCT03639311|470462097|FG000|Maintenance Phase|Lack of Efficacy|1|||
130681835|NCT03639311|470462098|FG001|Maintenance Phase|Lack of Efficacy|0|||
130681836|NCT03639311|470462099|FG002|Maintenance Phase|Lack of Efficacy|0|||
130681837|NCT03018249|470462100|FG000|Overall Study|Withdrawal by Subject|2|||
130681838|NCT03018249|470462101|FG001|Overall Study|Withdrawal by Subject|2|||
130681839|NCT03125200|470462111|FG000|Overall Study|Study Termination|0|||
130681840|NCT03125200|470462112|FG001|Overall Study|Study Termination|0|||
130681841|NCT03125200|470462113|FG002|Overall Study|Study Termination|0|||
130681842|NCT03125200|470462114|FG003|Overall Study|Study Termination|1|||
130681843|NCT03125200|470462115|FG004|Overall Study|Study Termination|1|||
130681844|NCT03125200|470462116|FG005|Overall Study|Study Termination|2|||
130681845|NCT03125200|470462117|FG006|Overall Study|Study Termination|1|||
130681846|NCT03125200|470462111|FG000|Overall Study|Clinical Progression|0|||
130681847|NCT03125200|470462112|FG001|Overall Study|Clinical Progression|0|||
130681848|NCT03125200|470462113|FG002|Overall Study|Clinical Progression|0|||
130681849|NCT03125200|470462114|FG003|Overall Study|Clinical Progression|1|||
130681850|NCT03125200|470462115|FG004|Overall Study|Clinical Progression|0|||
130681851|NCT03125200|470462116|FG005|Overall Study|Clinical Progression|1|||
130681852|NCT03125200|470462117|FG006|Overall Study|Clinical Progression|0|||
130681853|NCT03125200|470462111|FG000|Overall Study|Progressive Disease|2|||
130681854|NCT03125200|470462112|FG001|Overall Study|Progressive Disease|1|||
130681855|NCT03125200|470462113|FG002|Overall Study|Progressive Disease|2|||
130681856|NCT03125200|470462114|FG003|Overall Study|Progressive Disease|1|||
130681857|NCT03125200|470462115|FG004|Overall Study|Progressive Disease|2|||
130886186|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
130886187|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
130886188|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
130886189|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
130681858|NCT03125200|470462116|FG005|Overall Study|Progressive Disease|0|||
130681859|NCT03125200|470462117|FG006|Overall Study|Progressive Disease|1|||
130681860|NCT03125200|470462111|FG000|Overall Study|Lack of Efficacy|0|||
130681861|NCT03125200|470462112|FG001|Overall Study|Lack of Efficacy|0|||
130681862|NCT03125200|470462113|FG002|Overall Study|Lack of Efficacy|0|||
130681863|NCT03125200|470462114|FG003|Overall Study|Lack of Efficacy|1|||
130681864|NCT03125200|470462115|FG004|Overall Study|Lack of Efficacy|0|||
130681865|NCT03125200|470462116|FG005|Overall Study|Lack of Efficacy|0|||
130681866|NCT03125200|470462117|FG006|Overall Study|Lack of Efficacy|0|||
130681867|NCT03125200|470462111|FG000|Overall Study|Toxicity|0|||
130681868|NCT03125200|470462112|FG001|Overall Study|Toxicity|0|||
130681869|NCT03125200|470462113|FG002|Overall Study|Toxicity|0|||
130681870|NCT03125200|470462114|FG003|Overall Study|Toxicity|1|||
130681871|NCT03125200|470462115|FG004|Overall Study|Toxicity|0|||
130681872|NCT03125200|470462116|FG005|Overall Study|Toxicity|0|||
130886190|NCT02968004|471217238|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
130681873|NCT03125200|470462117|FG006|Overall Study|Toxicity|0|||
130681874|NCT03125200|470462111|FG000|Overall Study|Consent Withdrawn by Subject|0|||
130681875|NCT03125200|470462112|FG001|Overall Study|Consent Withdrawn by Subject|1|||
130681876|NCT03125200|470462113|FG002|Overall Study|Consent Withdrawn by Subject|0|||
130681877|NCT03125200|470462114|FG003|Overall Study|Consent Withdrawn by Subject|0|||
130681878|NCT03125200|470462115|FG004|Overall Study|Consent Withdrawn by Subject|1|||
130766205|NCT04908475|470768193|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130766206|NCT04908475|470768188|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
130766207|NCT04908475|470768189|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130766208|NCT04908475|470768190|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130766209|NCT04908475|470768191|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130766210|NCT04908475|470768192|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130766211|NCT04908475|470768193|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130766212|NCT04908475|470768188|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130766213|NCT04908475|470768189|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
130766214|NCT04908475|470768190|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
130766215|NCT04908475|470768191|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
130766216|NCT04908475|470768192|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130766217|NCT04908475|470768193|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130766218|NCT04908475|470768188|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
130766219|NCT04908475|470768189|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
130766220|NCT04908475|470768190|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
130766221|NCT04908475|470768191|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
130766222|NCT04908475|470768192|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
130766223|NCT04908475|470768193|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
130766224|NCT04908475|470768188|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
130766225|NCT04908475|470768189|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
130766226|NCT04908475|470768190|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
130766227|NCT04908475|470768191|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
130766228|NCT04908475|470768192|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
130766229|NCT04908475|470768193|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
130766230|NCT03913104|470768196|FG000|Overall Study|Lost to Follow-up|20|||
130766231|NCT03913104|470768196|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
130766232|NCT03913104|470768196|FG000|Overall Study|Withdrawal by Subject|2|||
130766233|NCT01074255|470768197|FG000|Overall Study|Did not receive EMEND|2|||
130766234|NCT01593254|470768198|FG000|Overall Study|Disease progression|2|||
130766235|NCT01593254|470768199|FG001|Overall Study|Disease progression|7|||
130766236|NCT01593254|470768198|FG000|Overall Study|Study drug toxicity|6|||
131017580|NCT02547922|471693821|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
131017581|NCT02547922|471693819|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
131017582|NCT02547922|471693820|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
131017583|NCT02547922|471693821|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
131017584|NCT02547922|471693819|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
131017585|NCT02547922|471693820|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
131017586|NCT02547922|471693821|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
131017587|NCT02547922|471693819|FG000|Overall Study|Physician Decision|2|||
131017588|NCT02547922|471693820|FG001|Overall Study|Physician Decision|1|||
131017589|NCT02547922|471693821|FG002|Overall Study|Physician Decision|2|||
131017590|NCT02547922|471693819|FG000|Overall Study|Patients did not receive IP|1|||
131017591|NCT02547922|471693820|FG001|Overall Study|Patients did not receive IP|1|||
131017592|NCT02547922|471693821|FG002|Overall Study|Patients did not receive IP|0|||
131017593|NCT00102063|471693824|FG000|Overall Study|Lack of Efficacy|5|||
131017594|NCT00102063|471693825|FG001|Overall Study|Lack of Efficacy|1|||
131103791|NCT02594163|472010354|FG001|Follow-up Period|Death|5|||
130766237|NCT01593254|470768199|FG001|Overall Study|Study drug toxicity|20|||
130766238|NCT01593254|470768198|FG000|Overall Study|Death|3|||
130766239|NCT01593254|470768199|FG001|Overall Study|Death|3|||
130766240|NCT01593254|470768198|FG000|Overall Study|AE unrelated to study drug|0|||
130766241|NCT01593254|470768199|FG001|Overall Study|AE unrelated to study drug|1|||
130766242|NCT01593254|470768198|FG000|Overall Study|participant request to discontinue study treatment|1|||
130766243|NCT01593254|470768199|FG001|Overall Study|participant request to discontinue study treatment|3|||
130766244|NCT01593254|470768198|FG000|Overall Study|participant withdrew consent|0|||
130766245|NCT01593254|470768199|FG001|Overall Study|participant withdrew consent|9|||
130766246|NCT01593254|470768198|FG000|Overall Study|lost to follow up|1|||
130766247|NCT01593254|470768199|FG001|Overall Study|lost to follow up|6|||
130766248|NCT01593254|470768198|FG000|Overall Study|maximum clinical benefit|1|||
130766249|NCT01593254|470768199|FG001|Overall Study|maximum clinical benefit|2|||
130766250|NCT01593254|470768198|FG000|Overall Study|Poor/non compliance|1|||
130766251|NCT01593254|470768199|FG001|Overall Study|Poor/non compliance|1|||
130766252|NCT01593254|470768198|FG000|Overall Study|Pregnancy|0|||
130766253|NCT01593254|470768199|FG001|Overall Study|Pregnancy|3|||
130766254|NCT01593254|470768198|FG000|Overall Study|participant no longer meets study criteria|1|||
130766255|NCT01593254|470768199|FG001|Overall Study|participant no longer meets study criteria|1|||
130766256|NCT01593254|470768198|FG000|Overall Study|Admin reason by sponsor|7|||
130766257|NCT01593254|470768199|FG001|Overall Study|Admin reason by sponsor|3|||
130766258|NCT01593254|470768198|FG000|Overall Study|Imatinib treatment failure|2|||
130766259|NCT01593254|470768199|FG001|Overall Study|Imatinib treatment failure|0|||
130766260|NCT01593254|470768198|FG000|Overall Study|Other Reasons|61|||
130886191|NCT02968004|471217239|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
130886192|NCT03722238|471217242|FG000|Overall Study|Protocol Violation|1|||
130886193|NCT03722238|471217243|FG001|Overall Study|Protocol Violation|0|||
130886194|NCT03722238|471217242|FG000|Overall Study|Physician Decision|1|||
130886195|NCT03722238|471217243|FG001|Overall Study|Physician Decision|0|||
130886196|NCT03722238|471217242|FG000|Overall Study|Death|1|||
130886197|NCT03722238|471217243|FG001|Overall Study|Death|0|||
130886198|NCT03722238|471217242|FG000|Overall Study|Lost to Follow-up|6|||
130886199|NCT03722238|471217243|FG001|Overall Study|Lost to Follow-up|0|||
130886200|NCT03722238|471217242|FG000|Overall Study|Partial missing data|44|||
130681879|NCT03125200|470462116|FG005|Overall Study|Consent Withdrawn by Subject|0|||
130681880|NCT03125200|470462117|FG006|Overall Study|Consent Withdrawn by Subject|1|||
130681881|NCT00119379|470462118|FG000|Overall Study|Adverse Event|4|||
130681882|NCT00119379|470462119|FG001|Overall Study|Adverse Event|1|||
130681883|NCT00694551|470462123|FG000|Overall Study|Disease Progression|1|||
130886201|NCT03722238|471217243|FG001|Overall Study|Partial missing data|1|||
130886202|NCT03722238|471217242|FG000|Overall Study|Withdrawal by Subject|2|||
130886203|NCT03722238|471217243|FG001|Overall Study|Withdrawal by Subject|0|||
130886204|NCT03722238|471217242|FG000|Overall Study|Other|4|||
130886205|NCT03722238|471217243|FG001|Overall Study|Other|0|||
130886206|NCT03722238|471217242|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
130886207|NCT03722238|471217243|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
130886208|NCT03722238|471217242|FG000|Overall Study|Did not meet risk classification group criteria|90|||
130886209|NCT03722238|471217243|FG001|Overall Study|Did not meet risk classification group criteria|0|||
130886210|NCT03722238|471217242|FG000|Overall Study|Did not sign consent|17|||
130886211|NCT03722238|471217243|FG001|Overall Study|Did not sign consent|0|||
130886212|NCT03722238|471217242|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
130886213|NCT03722238|471217243|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
130886214|NCT03722238|471217242|FG000|Overall Study|Not willing to purchase study medication|142|||
130886215|NCT03722238|471217243|FG001|Overall Study|Not willing to purchase study medication|0|||
130886216|NCT03722238|471217242|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
130886217|NCT03722238|471217243|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
130886218|NCT00885170|471217252|FG000|Overall Study|Adverse Event|12|||
130886219|NCT00885170|471217253|FG001|Overall Study|Adverse Event|4|||
130886220|NCT00885170|471217252|FG000|Overall Study|Excessive bone loss|6|||
130886221|NCT00885170|471217253|FG001|Overall Study|Excessive bone loss|3|||
130886222|NCT00885170|471217252|FG000|Overall Study|Lost to Follow-up|2|||
130886223|NCT00885170|471217253|FG001|Overall Study|Lost to Follow-up|1|||
130886224|NCT00885170|471217252|FG000|Overall Study|Physician Decision|2|||
130886225|NCT00885170|471217253|FG001|Overall Study|Physician Decision|1|||
130886226|NCT00885170|471217252|FG000|Overall Study|Protocol Violation|3|||
130681884|NCT00694551|470462124|FG001|Overall Study|Disease Progression|0|||
130886227|NCT00885170|471217253|FG001|Overall Study|Protocol Violation|1|||
130886228|NCT00885170|471217252|FG000|Overall Study|Withdrawal by Subject|13|||
130886229|NCT00885170|471217253|FG001|Overall Study|Withdrawal by Subject|13|||
131222600|NCT01902134|472443114|FG001|Overall Study|Withdrawal by Subject|8|||
131222601|NCT01902134|472443115|FG002|Overall Study|Withdrawal by Subject|9|||
131222602|NCT01902134|472443116|FG003|Overall Study|Withdrawal by Subject|1|||
131222603|NCT01902134|472443117|FG004|Overall Study|Withdrawal by Subject|5|||
130681885|NCT00694551|470462125|FG002|Overall Study|Disease Progression|1|||
130681886|NCT01937390|470462128|FG000|Overall Study|Death|2|||
130681887|NCT01937390|470462128|FG000|Overall Study|Lost to Follow-up|7|||
130681888|NCT01937390|470462128|FG000|Overall Study|Withdrawal by Subject|5|||
130766261|NCT01593254|470768199|FG001|Overall Study|Other Reasons|115|||
130766262|NCT01887678|470768200|FG000|Overall Study|Adverse Event|4|||
130766263|NCT01887678|470768201|FG001|Overall Study|Adverse Event|6|||
130766264|NCT01887678|470768200|FG000|Overall Study|Exceeded rescue medication dosage|4|||
130766265|NCT01887678|470768201|FG001|Overall Study|Exceeded rescue medication dosage|5|||
131222604|NCT01902134|472443118|FG005|Overall Study|Withdrawal by Subject|4|||
130681889|NCT01937390|470462128|FG000|Overall Study|Fail to return|21|||
130886230|NCT03771664|471217254|FG000|Overall Study|Adverse Event|1|||
130886231|NCT03771664|471217255|FG001|Overall Study|Adverse Event|0|||
130886232|NCT03771664|471217254|FG000|Overall Study|Lost to Follow-up|1|||
130886233|NCT03771664|471217255|FG001|Overall Study|Lost to Follow-up|0|||
130766266|NCT01887678|470768200|FG000|Overall Study|Withdrawal of consent|3|||
130766267|NCT01887678|470768201|FG001|Overall Study|Withdrawal of consent|4|||
130766268|NCT01887678|470768200|FG000|Overall Study|Lost to Follow-up|4|||
130766269|NCT01887678|470768201|FG001|Overall Study|Lost to Follow-up|2|||
131222605|NCT01902134|472443113|FG000|Overall Study|no compliance|1|||
130886234|NCT03771664|471217254|FG000|Overall Study|Withdrawal by Participant|1|||
130886235|NCT03771664|471217255|FG001|Overall Study|Withdrawal by Participant|4|||
130886236|NCT03771664|471217254|FG000|Overall Study|Randomized but not Treated|0|||
130886237|NCT03771664|471217255|FG001|Overall Study|Randomized but not Treated|1|||
130886238|NCT00561925|471217256|FG000|14 Day Lead-In Period|Adverse Event|38|||
130681890|NCT02920996|470462135|FG000|Overall Study|Adverse Event|8|||
130681891|NCT02920996|470462136|FG001|Overall Study|Adverse Event|0|||
130681892|NCT02920996|470462135|FG000|Overall Study|Physician Decision|1|||
130681893|NCT02920996|470462136|FG001|Overall Study|Physician Decision|0|||
130681894|NCT02920996|470462135|FG000|Overall Study|Death|1|||
130681895|NCT02920996|470462136|FG001|Overall Study|Death|0|||
130681896|NCT02920996|470462135|FG000|Overall Study|Missing|1|||
130681897|NCT02920996|470462136|FG001|Overall Study|Missing|0|||
130681898|NCT02920996|470462135|FG000|Overall Study|Subject Non-Compliance|1|||
130681899|NCT02920996|470462136|FG001|Overall Study|Subject Non-Compliance|0|||
130681900|NCT01402947|470462139|FG000|First Intervention|Adverse Event|0|||
130681901|NCT01402947|470462140|FG001|First Intervention|Adverse Event|1|||
130681902|NCT00385684|470462141|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
130681903|NCT00385684|470462142|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
130681904|NCT00385684|470462141|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
130681905|NCT00385684|470462142|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
130681906|NCT00385684|470462141|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
130681907|NCT00385684|470462142|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
130681908|NCT02801877|470462143|FG000|Overall Study|Lost to Follow-up|1|||
130681909|NCT02801877|470462144|FG001|Overall Study|Lost to Follow-up|1|||
130681910|NCT02801877|470462145|FG002|Overall Study|Lost to Follow-up|2|||
130681911|NCT02801877|470462146|FG003|Overall Study|Lost to Follow-up|0|||
130681912|NCT02801877|470462143|FG000|Overall Study|Never Started Treatment|2|||
130681913|NCT02801877|470462144|FG001|Overall Study|Never Started Treatment|0|||
130681914|NCT02801877|470462145|FG002|Overall Study|Never Started Treatment|4|||
130681915|NCT02801877|470462146|FG003|Overall Study|Never Started Treatment|0|||
130681916|NCT00154102|470462147|FG000|Overall Study|investigational study phase ongoing|7|||
130681917|NCT00154102|470462148|FG001|Overall Study|investigational study phase ongoing|2|||
130681918|NCT01248247|470463808|FG000|Overall Study|Adverse Event|2|||
130681919|NCT01248247|470463809|FG001|Overall Study|Adverse Event|4|||
130681920|NCT01248247|470463810|FG002|Overall Study|Adverse Event|4|||
130681921|NCT01248247|470463811|FG003|Overall Study|Adverse Event|2|||
130681922|NCT01248247|470463808|FG000|Overall Study|Death|0|||
130681923|NCT01248247|470463809|FG001|Overall Study|Death|1|||
130681924|NCT01248247|470463810|FG002|Overall Study|Death|4|||
130681925|NCT01248247|470463811|FG003|Overall Study|Death|7|||
130681926|NCT01248247|470463808|FG000|Overall Study|Lost to Follow-up|0|||
130681927|NCT01248247|470463809|FG001|Overall Study|Lost to Follow-up|1|||
130681928|NCT01248247|470463810|FG002|Overall Study|Lost to Follow-up|1|||
130681929|NCT01248247|470463811|FG003|Overall Study|Lost to Follow-up|0|||
130681930|NCT01248247|470463808|FG000|Overall Study|Alternative treatment|0|||
130681931|NCT01248247|470463809|FG001|Overall Study|Alternative treatment|1|||
130681932|NCT01248247|470463810|FG002|Overall Study|Alternative treatment|0|||
130681933|NCT01248247|470463811|FG003|Overall Study|Alternative treatment|0|||
130681934|NCT01248247|470463808|FG000|Overall Study|Other|2|||
130681935|NCT01248247|470463809|FG001|Overall Study|Other|8|||
130681936|NCT01248247|470463810|FG002|Overall Study|Other|8|||
130681937|NCT01248247|470463811|FG003|Overall Study|Other|5|||
130886239|NCT00561925|471217257|FG001|14 Day Lead-In Period|Adverse Event|0|||
130886240|NCT00561925|471217258|FG002|14 Day Lead-In Period|Adverse Event|0|||
130886241|NCT00561925|471217259|FG003|14 Day Lead-In Period|Adverse Event|0|||
130886242|NCT00561925|471217260|FG004|14 Day Lead-In Period|Adverse Event|0|||
130886243|NCT00561925|471217256|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
130886244|NCT00561925|471217257|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
130886245|NCT00561925|471217258|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
130886246|NCT00561925|471217259|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
130886247|NCT00561925|471217260|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
130886248|NCT00561925|471217256|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
130886249|NCT00561925|471217257|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
130886250|NCT00561925|471217258|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
130886251|NCT00561925|471217259|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
130886252|NCT00561925|471217260|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
130681938|NCT01248247|470463808|FG000|Overall Study|Progression|18|||
130681939|NCT01248247|470463809|FG001|Overall Study|Progression|27|||
130681940|NCT01248247|470463810|FG002|Overall Study|Progression|56|||
130681941|NCT01248247|470463811|FG003|Overall Study|Progression|44|||
130681942|NCT01248247|470463808|FG000|Overall Study|Refuse further treatment|0|||
130681943|NCT01248247|470463809|FG001|Overall Study|Refuse further treatment|0|||
130681944|NCT01248247|470463810|FG002|Overall Study|Refuse further treatment|1|||
130681945|NCT01248247|470463811|FG003|Overall Study|Refuse further treatment|2|||
130681946|NCT01248247|470463808|FG000|Overall Study|Complicating disease|0|||
130681947|NCT01248247|470463809|FG001|Overall Study|Complicating disease|0|||
130681948|NCT01248247|470463810|FG002|Overall Study|Complicating disease|1|||
130886253|NCT00561925|471217256|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
130886254|NCT00561925|471217257|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
130681949|NCT01248247|470463811|FG003|Overall Study|Complicating disease|1|||
130681950|NCT04349917|470463812|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
130681951|NCT04349917|470463813|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
131017595|NCT00102063|471693826|FG002|Overall Study|Lack of Efficacy|1|||
130886255|NCT00561925|471217258|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
130886256|NCT00561925|471217259|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
130886257|NCT00561925|471217260|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
130886258|NCT00561925|471217256|FG000|14 Day Lead-In Period|Other|5|||
130886259|NCT00561925|471217257|FG001|14 Day Lead-In Period|Other|0|||
130886260|NCT00561925|471217258|FG002|14 Day Lead-In Period|Other|0|||
130886261|NCT00561925|471217259|FG003|14 Day Lead-In Period|Other|0|||
130886262|NCT00561925|471217260|FG004|14 Day Lead-In Period|Other|0|||
130886263|NCT00561925|471217256|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
130886264|NCT00561925|471217257|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
130886265|NCT00561925|471217258|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
130886266|NCT00561925|471217259|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
130886267|NCT00561925|471217260|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
130886268|NCT00561925|471217256|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
130886269|NCT00561925|471217257|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
130886270|NCT00561925|471217258|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
130886271|NCT00561925|471217259|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
130886272|NCT00561925|471217260|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
130886273|NCT00561925|471217256|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
130886274|NCT00561925|471217257|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
130886275|NCT00561925|471217258|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
130886276|NCT00561925|471217259|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
130681952|NCT04349917|470463812|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
130681953|NCT04349917|470463813|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
130681954|NCT00441467|470463814|FG000|Overall Study|Adverse Event|6|||
130681955|NCT00441467|470463814|FG000|Overall Study|Withdrawal by Subject|3|||
130681956|NCT00441467|470463814|FG000|Overall Study|Progressive disease|9|||
130681957|NCT01042522|470463815|FG000|Overall Study|Adverse Event|1|||
130681958|NCT01042522|470463816|FG001|Overall Study|Adverse Event|2|||
130681959|NCT01042522|470463815|FG000|Overall Study|Disease Progression|5|||
130681960|NCT01042522|470463816|FG001|Overall Study|Disease Progression|0|||
130681961|NCT01042522|470463815|FG000|Overall Study|Death|1|||
130681962|NCT01042522|470463816|FG001|Overall Study|Death|0|||
130681963|NCT01042522|470463815|FG000|Overall Study|Patient Refused|0|||
130681964|NCT01042522|470463816|FG001|Overall Study|Patient Refused|3|||
130681965|NCT01042522|470463815|FG000|Overall Study|Withdrawal by Subject|1|||
130886277|NCT00561925|471217260|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
130886278|NCT00561925|471217256|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
130886279|NCT00561925|471217257|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
130886280|NCT00561925|471217258|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
130886281|NCT00561925|471217259|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
130886282|NCT00561925|471217260|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
130886283|NCT00561925|471217256|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
130886284|NCT00561925|471217257|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
130886285|NCT00561925|471217258|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
130886286|NCT00561925|471217259|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
130886287|NCT00561925|471217260|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
130886288|NCT00561925|471217256|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
130886289|NCT00561925|471217257|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
130886290|NCT00561925|471217258|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
130886291|NCT00561925|471217259|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
130886292|NCT00561925|471217260|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
130886293|NCT00561925|471217256|FG000|144-week Double-blind, Double-dummy|Death|0|||
130886294|NCT00561925|471217257|FG001|144-week Double-blind, Double-dummy|Death|6|||
130886295|NCT00561925|471217258|FG002|144-week Double-blind, Double-dummy|Death|3|||
130681966|NCT01042522|470463816|FG001|Overall Study|Withdrawal by Subject|1|||
130681967|NCT00485472|470463817|FG000|Overall Study|Adverse Event|8|||
130681968|NCT00485472|470463818|FG001|Overall Study|Adverse Event|5|||
130681969|NCT00485472|470463817|FG000|Overall Study|Lack of Efficacy|5|||
130681970|NCT00485472|470463818|FG001|Overall Study|Lack of Efficacy|4|||
130681971|NCT00485472|470463817|FG000|Overall Study|Withdrawal by Subject|1|||
130886296|NCT00561925|471217259|FG003|144-week Double-blind, Double-dummy|Death|0|||
130886297|NCT00561925|471217260|FG004|144-week Double-blind, Double-dummy|Death|0|||
130886298|NCT00561925|471217256|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130886299|NCT00561925|471217257|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
130886300|NCT00561925|471217258|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130886301|NCT00561925|471217259|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130886302|NCT00561925|471217260|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130681972|NCT00485472|470463818|FG001|Overall Study|Withdrawal by Subject|0|||
130681973|NCT00485472|470463817|FG000|Overall Study|Protocol Violation|0|||
130681974|NCT00485472|470463818|FG001|Overall Study|Protocol Violation|1|||
130886303|NCT00561925|471217256|FG000|144-week Double-blind, Double-dummy|Other|0|||
130886304|NCT00561925|471217257|FG001|144-week Double-blind, Double-dummy|Other|8|||
130886305|NCT00561925|471217258|FG002|144-week Double-blind, Double-dummy|Other|11|||
130681975|NCT00485472|470463817|FG000|Overall Study|Other|2|||
130886306|NCT00561925|471217259|FG003|144-week Double-blind, Double-dummy|Other|0|||
130886307|NCT00561925|471217260|FG004|144-week Double-blind, Double-dummy|Other|0|||
130886308|NCT00561925|471217256|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
130886309|NCT00561925|471217257|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
130886310|NCT00561925|471217258|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
130886311|NCT00561925|471217259|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
130886312|NCT00561925|471217260|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
130886313|NCT00891904|471217261|FG000|Overall Study|Death|1|||
130886314|NCT00891904|471217261|FG000|Overall Study|Adverse Event|1|||
130886315|NCT05021978|471217262|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
130886316|NCT05021978|471217263|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
130886317|NCT05021978|471217264|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
130886318|NCT05021978|471217265|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
130886319|NCT05021978|471217262|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
130886320|NCT05021978|471217263|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
130886321|NCT05021978|471217264|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
130886322|NCT05021978|471217265|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
130886323|NCT03096288|471217267|FG000|Overall Study|Withdrawal by Subject|0|||
130886324|NCT03096288|471217268|FG001|Overall Study|Withdrawal by Subject|1|||
130886325|NCT03096288|471217269|FG002|Overall Study|Withdrawal by Subject|0|||
130886326|NCT03096288|471217270|FG003|Overall Study|Withdrawal by Subject|1|||
130886327|NCT01411891|471217274|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
130886328|NCT01411891|471217275|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
130886329|NCT02004093|471217276|FG000|Overall Study|Death|2|||
130886330|NCT02004093|471217277|FG001|Overall Study|Death|1|||
130886331|NCT02004093|471217276|FG000|Overall Study|Lack of Efficacy|66|||
130886332|NCT02004093|471217277|FG001|Overall Study|Lack of Efficacy|62|||
130886333|NCT02004093|471217276|FG000|Overall Study|Protocol Violation|0|||
130886334|NCT02004093|471217277|FG001|Overall Study|Protocol Violation|1|||
130886335|NCT02004093|471217276|FG000|Overall Study|Lost to Follow-up|0|||
130886336|NCT02004093|471217277|FG001|Overall Study|Lost to Follow-up|1|||
130886337|NCT02004093|471217276|FG000|Overall Study|Withdrawal by Subject|3|||
130886338|NCT02004093|471217277|FG001|Overall Study|Withdrawal by Subject|7|||
130886339|NCT02004093|471217276|FG000|Overall Study|Other|3|||
130886340|NCT02004093|471217277|FG001|Overall Study|Other|1|||
130886341|NCT00414596|471217279|FG000|Overall Study|Protocol Violation|2|||
130886342|NCT04639258|471217280|FG000|Overall Study|Screen failure|5|||
130886343|NCT04639258|471217280|FG000|Overall Study|Physician Decision|2|||
130886344|NCT04639258|471217280|FG000|Overall Study|Early study termination|3|||
130886345|NCT04639258|471217280|FG000|Overall Study|Withdrawal by Subject|1|||
130886346|NCT02558296|471217282|FG000|Completed the Study Through Week 24|Adverse Event|9|||
130886347|NCT02558296|471217283|FG001|Completed the Study Through Week 24|Adverse Event|3|||
130886348|NCT02558296|471217282|FG000|Completed the Study Through Week 24|Death|7|||
130886349|NCT02558296|471217283|FG001|Completed the Study Through Week 24|Death|7|||
130886350|NCT02558296|471217282|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
130886351|NCT02558296|471217283|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
130886352|NCT02558296|471217282|FG000|Completed the Study Through Week 24|Physician Decision|1|||
130886353|NCT02558296|471217283|FG001|Completed the Study Through Week 24|Physician Decision|0|||
130886354|NCT02558296|471217282|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
131017596|NCT00102063|471693824|FG000|Overall Study|Adverse Event|7|||
131017597|NCT00102063|471693825|FG001|Overall Study|Adverse Event|4|||
131017598|NCT00102063|471693826|FG002|Overall Study|Adverse Event|2|||
131017599|NCT00102063|471693824|FG000|Overall Study|Withdrawal by Subject|4|||
130766270|NCT01887678|470768200|FG000|Overall Study|Deterioration of clinical condition|0|||
130766271|NCT01887678|470768201|FG001|Overall Study|Deterioration of clinical condition|4|||
130766272|NCT01887678|470768200|FG000|Overall Study|Lack of Efficacy|1|||
130766273|NCT01887678|470768201|FG001|Overall Study|Lack of Efficacy|2|||
130766274|NCT01887678|470768200|FG000|Overall Study|Non-compliance|0|||
130766275|NCT01887678|470768201|FG001|Overall Study|Non-compliance|3|||
130766276|NCT01887678|470768200|FG000|Overall Study|Specified|1|||
130766277|NCT01887678|470768201|FG001|Overall Study|Specified|2|||
130766278|NCT00791492|470768202|FG000|Overall Study|Withdrawal by Subject|1|||
130766279|NCT00791492|470768203|FG001|Overall Study|Withdrawal by Subject|2|||
130766280|NCT00791492|470768202|FG000|Overall Study|Liver transplantation|5|||
130766281|NCT00791492|470768203|FG001|Overall Study|Liver transplantation|1|||
130766282|NCT00076999|470768204|FG000|Overall Study|Adverse Event|2|||
130766283|NCT00076999|470768205|FG001|Overall Study|Adverse Event|8|||
130766284|NCT00076999|470768206|FG002|Overall Study|Adverse Event|6|||
130766285|NCT00076999|470768207|FG003|Overall Study|Adverse Event|0|||
130766286|NCT00076999|470768208|FG004|Overall Study|Adverse Event|2|||
130766287|NCT00076999|470768204|FG000|Overall Study|Protocol Violation|0|||
130681976|NCT00485472|470463818|FG001|Overall Study|Other|1|||
130681977|NCT00485472|470463817|FG000|Overall Study|Lost to Follow-up|0|||
130681978|NCT00485472|470463818|FG001|Overall Study|Lost to Follow-up|1|||
130681979|NCT04015232|470463820|FG000|Overall Study|Withdrawal by Subject|7|||
130681980|NCT04015232|470463821|FG001|Overall Study|Withdrawal by Subject|4|||
130681981|NCT04015232|470463820|FG000|Overall Study|Protocol Violation|1|||
130681982|NCT04015232|470463821|FG001|Overall Study|Protocol Violation|0|||
130681983|NCT04015232|470463820|FG000|Overall Study|Medical Grounds|3|||
130681984|NCT04015232|470463821|FG001|Overall Study|Medical Grounds|3|||
130681985|NCT01029353|470463823|FG000|Overall Study|Lost to Follow-up|4|||
130681986|NCT01029353|470463824|FG001|Overall Study|Lost to Follow-up|5|||
130681987|NCT01029353|470463825|FG002|Overall Study|Lost to Follow-up|5|||
130681988|NCT01029353|470463826|FG003|Overall Study|Lost to Follow-up|4|||
130681989|NCT01029353|470463823|FG000|Overall Study|Consent Withdrawn|2|||
130681990|NCT01029353|470463824|FG001|Overall Study|Consent Withdrawn|0|||
130681991|NCT01029353|470463825|FG002|Overall Study|Consent Withdrawn|0|||
130681992|NCT01029353|470463826|FG003|Overall Study|Consent Withdrawn|0|||
130681993|NCT01029353|470463823|FG000|Overall Study|Primary Outcome Indeterminate|1|||
130681994|NCT01029353|470463824|FG001|Overall Study|Primary Outcome Indeterminate|3|||
130681995|NCT01029353|470463825|FG002|Overall Study|Primary Outcome Indeterminate|2|||
130681996|NCT01029353|470463826|FG003|Overall Study|Primary Outcome Indeterminate|0|||
130681997|NCT01287013|470463828|FG000|Overall Study|Non-evaluable|3|||
130681998|NCT01287013|470463829|FG001|Overall Study|Non-evaluable|5|||
130681999|NCT01287013|470463830|FG002|Overall Study|Non-evaluable|21|||
130682000|NCT01900730|470463831|FG000|Overall Study|Withdrawal by Subject|1|||
130682001|NCT01900730|470463832|FG001|Overall Study|Withdrawal by Subject|0|||
130682002|NCT01900730|470463831|FG000|Overall Study|Screen Failure|1|||
130682003|NCT01900730|470463832|FG001|Overall Study|Screen Failure|0|||
130682004|NCT02109042|470463833|FG000|Overall Study|Sponsor Decision|15|||
130682005|NCT03203447|470463834|FG000|Overall Study|Withdrawal by Subject|2|||
130682006|NCT03203447|470463835|FG001|Overall Study|Withdrawal by Subject|1|||
130682007|NCT03203447|470463834|FG000|Overall Study|Lost to Follow-up|1|||
130682008|NCT03203447|470463835|FG001|Overall Study|Lost to Follow-up|10|||
130682009|NCT03203447|470463834|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
130682010|NCT03203447|470463835|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
130682011|NCT00528606|470463836|FG000|Overall Study|Withdrew consent|4|||
130682012|NCT00528606|470463837|FG001|Overall Study|Withdrew consent|3|||
130682013|NCT00528606|470463836|FG000|Overall Study|Lost to Follow-up|4|||
130682014|NCT00528606|470463837|FG001|Overall Study|Lost to Follow-up|1|||
130682015|NCT00528606|470463836|FG000|Overall Study|Adverse Event|3|||
130682016|NCT00528606|470463837|FG001|Overall Study|Adverse Event|0|||
130682017|NCT00528606|470463836|FG000|Overall Study|Other|2|||
130682018|NCT00528606|470463837|FG001|Overall Study|Other|0|||
130682019|NCT00050778|470463842|FG000|Overall Study|Adverse Event|13|||
130682020|NCT00050778|470463843|FG001|Overall Study|Adverse Event|3|||
130682021|NCT00050778|470463844|FG002|Overall Study|Adverse Event|2|||
130682022|NCT00050778|470463842|FG000|Overall Study|Death|0|||
130682023|NCT00050778|470463843|FG001|Overall Study|Death|1|||
130682024|NCT00050778|470463844|FG002|Overall Study|Death|1|||
130682025|NCT00050778|470463842|FG000|Overall Study|Lack of Efficacy|16|||
130682026|NCT00050778|470463843|FG001|Overall Study|Lack of Efficacy|2|||
130682027|NCT00050778|470463844|FG002|Overall Study|Lack of Efficacy|2|||
130682028|NCT00050778|470463842|FG000|Overall Study|Lost to Follow-up|0|||
130682029|NCT00050778|470463843|FG001|Overall Study|Lost to Follow-up|2|||
130682030|NCT00050778|470463844|FG002|Overall Study|Lost to Follow-up|4|||
130682031|NCT00050778|470463842|FG000|Overall Study|Physician Decision|3|||
130682032|NCT00050778|470463843|FG001|Overall Study|Physician Decision|0|||
130682033|NCT00050778|470463844|FG002|Overall Study|Physician Decision|2|||
130682034|NCT00050778|470463842|FG000|Overall Study|Protocol Violation|2|||
130682035|NCT00050778|470463843|FG001|Overall Study|Protocol Violation|0|||
130682036|NCT00050778|470463844|FG002|Overall Study|Protocol Violation|1|||
130682037|NCT00050778|470463842|FG000|Overall Study|Withdrawal by Subject|6|||
130682038|NCT00050778|470463843|FG001|Overall Study|Withdrawal by Subject|8|||
130682039|NCT00050778|470463844|FG002|Overall Study|Withdrawal by Subject|4|||
130682040|NCT00050778|470463842|FG000|Overall Study|Randomized but not treated|4|||
130682041|NCT00050778|470463843|FG001|Overall Study|Randomized but not treated|5|||
130682042|NCT00050778|470463844|FG002|Overall Study|Randomized but not treated|2|||
130682043|NCT00050778|470463842|FG000|Overall Study|Familial and personal reasons|1|||
130682044|NCT00050778|470463843|FG001|Overall Study|Familial and personal reasons|0|||
130682045|NCT00050778|470463844|FG002|Overall Study|Familial and personal reasons|0|||
130682046|NCT00064753|470463847|FG000|Overall Study|Death|251|||
130682047|NCT00064753|470463848|FG001|Overall Study|Death|242|||
130682048|NCT00064753|470463847|FG000|Overall Study|Withdrawal by Subject|198|||
130682049|NCT00064753|470463848|FG001|Overall Study|Withdrawal by Subject|171|||
130682050|NCT00064753|470463847|FG000|Overall Study|Lost to Follow-up|225|||
130682051|NCT00064753|470463848|FG001|Overall Study|Lost to Follow-up|235|||
130682052|NCT04869787|470463853|FG000|Screening|Physician Decision|1|||
130682053|NCT04869787|470463853|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
130886355|NCT02558296|471217283|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
130886356|NCT02558296|471217282|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
130886357|NCT02558296|471217283|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
130886358|NCT02558296|471217282|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
130886359|NCT02558296|471217283|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
130886360|NCT02558296|471217282|FG000|Completed the Study|Adverse Event|14|||
130886361|NCT02558296|471217283|FG001|Completed the Study|Adverse Event|5|||
130886362|NCT02558296|471217282|FG000|Completed the Study|Death|39|||
130886363|NCT02558296|471217283|FG001|Completed the Study|Death|25|||
130886364|NCT02558296|471217282|FG000|Completed the Study|Lost to Follow-up|31|||
130886365|NCT02558296|471217283|FG001|Completed the Study|Lost to Follow-up|23|||
130886366|NCT02558296|471217282|FG000|Completed the Study|Physician Decision|6|||
130886367|NCT02558296|471217283|FG001|Completed the Study|Physician Decision|0|||
130886368|NCT02558296|471217282|FG000|Completed the Study|Protocol Violation|2|||
130886369|NCT02558296|471217283|FG001|Completed the Study|Protocol Violation|1|||
130886370|NCT02558296|471217282|FG000|Completed the Study|Withdrawal by Subject|53|||
130886371|NCT02558296|471217283|FG001|Completed the Study|Withdrawal by Subject|31|||
130886372|NCT02558296|471217282|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
130886373|NCT02558296|471217283|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
130886374|NCT00297258|471217284|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
130886375|NCT00297258|471217284|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
130886376|NCT00297258|471217284|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
131017600|NCT00102063|471693825|FG001|Overall Study|Withdrawal by Subject|12|||
131017601|NCT00102063|471693826|FG002|Overall Study|Withdrawal by Subject|5|||
130682054|NCT00813293|470463855|FG000|Overall Study|Intercurrent illness|1|||
130682055|NCT00813293|470463856|FG001|Overall Study|Intercurrent illness|0|||
130682056|NCT00813293|470463855|FG000|Overall Study|Adverse Event|0|||
130682057|NCT00813293|470463856|FG001|Overall Study|Adverse Event|1|||
130682058|NCT02914600|470463857|FG000|Overall Study|Adverse Event|298|||
130682059|NCT02914600|470463858|FG001|Overall Study|Adverse Event|35|||
130682060|NCT02914600|470463859|FG002|Overall Study|Adverse Event|25|||
130682061|NCT02914600|470463857|FG000|Overall Study|Sponsors decision|287|||
130682062|NCT02914600|470463858|FG001|Overall Study|Sponsors decision|41|||
130682063|NCT02914600|470463859|FG002|Overall Study|Sponsors decision|12|||
130682064|NCT02914600|470463857|FG000|Overall Study|Withdrawal by Subject|158|||
130682065|NCT02914600|470463858|FG001|Overall Study|Withdrawal by Subject|20|||
130682066|NCT02914600|470463859|FG002|Overall Study|Withdrawal by Subject|18|||
130682067|NCT02914600|470463857|FG000|Overall Study|Investigators discretion|169|||
130682068|NCT02914600|470463858|FG001|Overall Study|Investigators discretion|14|||
130682069|NCT02914600|470463859|FG002|Overall Study|Investigators discretion|13|||
130682070|NCT02914600|470463857|FG000|Overall Study|Lost to Follow-up|10|||
130682071|NCT02914600|470463858|FG001|Overall Study|Lost to Follow-up|4|||
130682072|NCT02914600|470463859|FG002|Overall Study|Lost to Follow-up|0|||
130682073|NCT02914600|470463857|FG000|Overall Study|Pregnancy|8|||
130682074|NCT02914600|470463858|FG001|Overall Study|Pregnancy|0|||
130682075|NCT02914600|470463859|FG002|Overall Study|Pregnancy|0|||
130682076|NCT02914600|470463857|FG000|Overall Study|Protocol Violation|5|||
130682077|NCT02914600|470463858|FG001|Overall Study|Protocol Violation|3|||
130682078|NCT02914600|470463859|FG002|Overall Study|Protocol Violation|0|||
130766288|NCT00076999|470768205|FG001|Overall Study|Protocol Violation|3|||
130766289|NCT00076999|470768206|FG002|Overall Study|Protocol Violation|4|||
130766290|NCT00076999|470768207|FG003|Overall Study|Protocol Violation|0|||
130766291|NCT00076999|470768208|FG004|Overall Study|Protocol Violation|9|||
130766292|NCT00076999|470768204|FG000|Overall Study|Lost to Follow-up|2|||
130682079|NCT02914600|470463857|FG000|Overall Study|Non-compliance with study drug|6|||
130682080|NCT02914600|470463858|FG001|Overall Study|Non-compliance with study drug|1|||
130682081|NCT02914600|470463859|FG002|Overall Study|Non-compliance with study drug|0|||
130682082|NCT02914600|470463857|FG000|Overall Study|Death|3|||
131017602|NCT00102063|471693824|FG000|Overall Study|Lost to Follow-up|0|||
131017603|NCT00102063|471693825|FG001|Overall Study|Lost to Follow-up|0|||
131017604|NCT00102063|471693826|FG002|Overall Study|Lost to Follow-up|1|||
131017605|NCT00102063|471693824|FG000|Overall Study|Protocol Violation|0|||
131017606|NCT00102063|471693825|FG001|Overall Study|Protocol Violation|1|||
131017607|NCT00102063|471693826|FG002|Overall Study|Protocol Violation|1|||
131017608|NCT01493778|471693827|FG000|Overall Study|Withdrawal by Subject|8|||
131017609|NCT05082025|471693828|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
131017610|NCT04210180|471693829|FG000|Overall Study|Withdrawal by Subject|2|||
131017611|NCT00857649|471693830|FG000|Overall Study|Adverse Event|15|||
131017612|NCT00857649|471693831|FG001|Overall Study|Adverse Event|10|||
131017613|NCT00857649|471693830|FG000|Overall Study|Non-compliance|1|||
131017614|NCT00857649|471693831|FG001|Overall Study|Non-compliance|1|||
131017615|NCT00857649|471693830|FG000|Overall Study|Protocol Violation|2|||
131017616|NCT00857649|471693831|FG001|Overall Study|Protocol Violation|2|||
131017617|NCT00857649|471693830|FG000|Overall Study|Withdrawal of Consent|10|||
130682083|NCT02914600|470463858|FG001|Overall Study|Death|1|||
130682084|NCT02914600|470463859|FG002|Overall Study|Death|1|||
130682085|NCT02914600|470463857|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
130682086|NCT02914600|470463858|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
130682087|NCT02914600|470463859|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
130682088|NCT02914600|470463857|FG000|Overall Study|Enrolled but not treated|1|||
130682089|NCT02914600|470463858|FG001|Overall Study|Enrolled but not treated|0|||
130682090|NCT02914600|470463859|FG002|Overall Study|Enrolled but not treated|0|||
130682091|NCT03522675|470463860|FG000|Overall Study|Screen fail|1|||
130682092|NCT03522675|470463860|FG000|Overall Study|Non-reactive to histamine|1|||
130682093|NCT00707161|470463861|FG000|Overall Study|Physician Decision|6|||
130682094|NCT02661295|470463870|FG000|Overall Study|Death|1|||
130682095|NCT02661295|470463870|FG000|Overall Study|Transferred Out|1|||
130682096|NCT02661295|470463870|FG000|Overall Study|Kidney Transplant|1|||
130682097|NCT02661295|470463870|FG000|Overall Study|Withdrawn due to side effects|8|||
130682098|NCT02661295|470463870|FG000|Overall Study|Withdrawn due to access type|1|||
130682099|NCT02661295|470463870|FG000|Overall Study|Withdrawn due to allergies|1|||
130682100|NCT02661295|470463870|FG000|Overall Study|Withdrawn due to non-compliance|1|||
130682101|NCT02661295|470463870|FG000|Overall Study|Withdrawal by Subject|3|||
130682102|NCT02661295|470463870|FG000|Overall Study|Failed screening|2|||
130682103|NCT04213326|470463871|FG000|Overall Study|Consent withdrawn|51|||
130682104|NCT04213326|470463872|FG001|Overall Study|Consent withdrawn|241|||
130682105|NCT04213326|470463871|FG000|Overall Study|Lost to Follow-up|50|||
130682106|NCT04213326|470463872|FG001|Overall Study|Lost to Follow-up|902|||
130682107|NCT04213326|470463871|FG000|Overall Study|Protocol Violation|3|||
130682108|NCT04213326|470463872|FG001|Overall Study|Protocol Violation|25|||
130682109|NCT04213326|470463871|FG000|Overall Study|Participant eligibility changed|106|||
130682110|NCT04213326|470463872|FG001|Overall Study|Participant eligibility changed|19|||
130682111|NCT04213326|470463871|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
130682112|NCT04213326|470463872|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
130682113|NCT04213326|470463871|FG000|Overall Study|Incomplete study visit|0|||
130682114|NCT04213326|470463872|FG001|Overall Study|Incomplete study visit|367|||
130682115|NCT02549092|470463873|FG000|Treatment Period|Adverse Event|2|||
130682116|NCT02549092|470463874|FG001|Treatment Period|Adverse Event|2|||
130682117|NCT02549092|470463873|FG000|Treatment Period|Withdrawal by Subject|1|||
130682118|NCT02549092|470463874|FG001|Treatment Period|Withdrawal by Subject|3|||
130682119|NCT02549092|470463873|FG000|Treatment Period|Lack of Efficacy|0|||
130682120|NCT02549092|470463874|FG001|Treatment Period|Lack of Efficacy|2|||
130682121|NCT02549092|470463873|FG000|Extension/Transition Period|Adverse Event|1|||
130682122|NCT02549092|470463874|FG001|Extension/Transition Period|Adverse Event|1|||
130682123|NCT02549092|470463873|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
130682124|NCT02549092|470463874|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
130682125|NCT02549092|470463873|FG000|Extension/Transition Period|Other, Not Specified|4|||
130682126|NCT02549092|470463874|FG001|Extension/Transition Period|Other, Not Specified|2|||
130682127|NCT03627091|470463875|FG000|Overall Study|Adverse Event|0|||
130682128|NCT03627091|470463876|FG001|Overall Study|Adverse Event|0|||
130682129|NCT03627091|470463877|FG002|Overall Study|Adverse Event|2|||
130682130|NCT03627091|470463875|FG000|Overall Study|Withdrawal by Subject|2|||
130682131|NCT03627091|470463876|FG001|Overall Study|Withdrawal by Subject|0|||
130682132|NCT03627091|470463877|FG002|Overall Study|Withdrawal by Subject|2|||
130886377|NCT00297258|471217284|FG000|Overall Study|Intercurrent Illness|3|||
130886378|NCT00297258|471217284|FG000|Overall Study|Intercurrent Death|2|||
130886379|NCT00297258|471217284|FG000|Overall Study|Deteriorization of General Condition|1|||
130886380|NCT00297258|471217284|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
130886381|NCT00297258|471217284|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
130886382|NCT00297258|471217284|FG000|Overall Study|Switch to Commercial Treatment|1|||
130886383|NCT00297258|471217284|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
130886384|NCT02819804|471217285|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
130682133|NCT03627091|470463875|FG000|Overall Study|Physician Decision|2|||
130682134|NCT03627091|470463876|FG001|Overall Study|Physician Decision|0|||
130682135|NCT03627091|470463877|FG002|Overall Study|Physician Decision|0|||
130682136|NCT03627091|470463875|FG000|Overall Study|Site terminated by sponsor|0|||
130682137|NCT03627091|470463876|FG001|Overall Study|Site terminated by sponsor|1|||
130682138|NCT03627091|470463877|FG002|Overall Study|Site terminated by sponsor|0|||
130682139|NCT03627091|470463875|FG000|Overall Study|Disease relapse|7|||
130886385|NCT00346697|471217288|FG000|Overall Study|Lost to Follow-up|0|||
130682140|NCT03627091|470463876|FG001|Overall Study|Disease relapse|5|||
130682141|NCT03627091|470463877|FG002|Overall Study|Disease relapse|1|||
130682142|NCT03627091|470463875|FG000|Overall Study|Other|1|||
130682143|NCT03627091|470463876|FG001|Overall Study|Other|0|||
130682144|NCT03627091|470463877|FG002|Overall Study|Other|0|||
130682145|NCT02193165|470463884|FG000|4 Week Product Use|Lost to Follow-up|1|||
130886386|NCT00346697|471217289|FG001|Overall Study|Lost to Follow-up|1|||
130886387|NCT00734539|471217290|FG000|Main Study|Death|33|||
130682146|NCT02193165|470463885|FG001|4 Week Product Use|Lost to Follow-up|1|||
130682147|NCT02193165|470463886|FG002|4 Week Product Use|Lost to Follow-up|1|||
130886388|NCT00734539|471217291|FG001|Main Study|Death|32|||
130886389|NCT00734539|471217290|FG000|Main Study|Physician Decision|2|||
130886390|NCT00734539|471217291|FG001|Main Study|Physician Decision|0|||
130886391|NCT00734539|471217290|FG000|Main Study|Withdrawal by Subject|1|||
130886392|NCT00734539|471217291|FG001|Main Study|Withdrawal by Subject|3|||
130886393|NCT00734539|471217290|FG000|Main Study|Enrolled in error; ineligible|1|||
130886394|NCT00734539|471217291|FG001|Main Study|Enrolled in error; ineligible|0|||
130886395|NCT02504151|471217296|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
130886396|NCT02504151|471217297|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
130886397|NCT02504151|471217296|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
130886398|NCT02504151|471217297|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
130886399|NCT02504151|471217296|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130886400|NCT02504151|471217297|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130886401|NCT02504151|471217296|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
130886402|NCT02504151|471217297|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
130886403|NCT05038982|471217298|FG000|Overall Study|Withdrawal by Subject|0|||
130886404|NCT05038982|471217299|FG001|Overall Study|Withdrawal by Subject|2|||
130886405|NCT02557139|471217305|FG000|Overall Study|Significant liver elevation|1|||
130886406|NCT02557139|471217306|FG001|Overall Study|Significant liver elevation|0|||
130886407|NCT02557139|471217307|FG002|Overall Study|Significant liver elevation|1|||
130886408|NCT02557139|471217305|FG000|Overall Study|Withdrawal by Subject|1|||
130886409|NCT02557139|471217306|FG001|Overall Study|Withdrawal by Subject|0|||
130886410|NCT02557139|471217307|FG002|Overall Study|Withdrawal by Subject|0|||
130886411|NCT02557139|471217305|FG000|Overall Study|Illness of prohibited medication|0|||
130886412|NCT02557139|471217306|FG001|Overall Study|Illness of prohibited medication|0|||
130886413|NCT02557139|471217307|FG002|Overall Study|Illness of prohibited medication|1|||
130886414|NCT01454102|471217308|FG000|Overall Study|Continuing in the treatment period|0|||
130886415|NCT01454102|471217309|FG001|Overall Study|Continuing in the treatment period|0|||
130886416|NCT01454102|471217310|FG002|Overall Study|Continuing in the treatment period|0|||
130886417|NCT01454102|471217311|FG003|Overall Study|Continuing in the treatment period|0|||
131103792|NCT02594163|472010353|FG000|Follow-up Period|Adverse Event|0|||
131103793|NCT02594163|472010354|FG001|Follow-up Period|Adverse Event|1|||
131103794|NCT02594163|472010353|FG000|Follow-up Period|Progressive Disease|2|||
131103795|NCT02594163|472010354|FG001|Follow-up Period|Progressive Disease|0|||
130886418|NCT01454102|471217312|FG004|Overall Study|Continuing in the treatment period|3|||
130886419|NCT01454102|471217313|FG005|Overall Study|Continuing in the treatment period|3|||
130886420|NCT01454102|471217314|FG006|Overall Study|Continuing in the treatment period|2|||
130886421|NCT01454102|471217315|FG007|Overall Study|Continuing in the treatment period|0|||
130886422|NCT01454102|471217316|FG008|Overall Study|Continuing in the treatment period|1|||
130886423|NCT01454102|471217317|FG009|Overall Study|Continuing in the treatment period|0|||
130886424|NCT01454102|471217318|FG010|Overall Study|Continuing in the treatment period|0|||
131103796|NCT02594163|472010353|FG000|Follow-up Period|Physician Decision|0|||
131103797|NCT02594163|472010354|FG001|Follow-up Period|Physician Decision|1|||
131103798|NCT01290029|472010357|FG000|Overall Study|Other|2|||
131103799|NCT00189488|472010358|FG000|Overall Study|Ineligibility determined|1|||
131103800|NCT00189488|472010359|FG001|Overall Study|Ineligibility determined|0|||
130682148|NCT02193165|470463884|FG000|6 Week Product Use|Lost to Follow-up|0|||
130682149|NCT02193165|470463885|FG001|6 Week Product Use|Lost to Follow-up|1|||
130682150|NCT02193165|470463886|FG002|6 Week Product Use|Lost to Follow-up|0|||
130682151|NCT01498120|470463892|FG000|Overall Study|Lost to Follow-up|1|||
130682152|NCT01498120|470463892|FG000|Overall Study|Withdrawal by Subject|5|||
130682153|NCT01498120|470463892|FG000|Overall Study|AE, non-serious non-fatal|3|||
130682154|NCT01498120|470463892|FG000|Overall Study|Other|4|||
130682155|NCT01173692|470463893|FG000|Overall Study|Adverse Event|1|||
130682156|NCT01173692|470463894|FG001|Overall Study|Adverse Event|2|||
130682157|NCT01173692|470463893|FG000|Overall Study|Withdrawal by Subject|1|||
130682158|NCT01173692|470463894|FG001|Overall Study|Withdrawal by Subject|3|||
130682159|NCT00678639|470463895|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
130682160|NCT00678639|470463896|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
130682161|NCT00986245|470463899|FG000|First Intervention|Poor compliance|8|||
130682162|NCT00986245|470463900|FG001|First Intervention|Poor compliance|4|||
130682163|NCT00986245|470463899|FG000|First Intervention|Lack of Efficacy|1|||
130682164|NCT00986245|470463900|FG001|First Intervention|Lack of Efficacy|2|||
130682165|NCT00986245|470463899|FG000|First Intervention|Withdrawal by Subject|0|||
130682166|NCT00986245|470463900|FG001|First Intervention|Withdrawal by Subject|1|||
130682167|NCT00986245|470463899|FG000|First Intervention|Protocol Violation|0|||
130682168|NCT00986245|470463900|FG001|First Intervention|Protocol Violation|1|||
130682169|NCT00986245|470463899|FG000|First Intervention|Out of indication|1|||
130682170|NCT00986245|470463900|FG001|First Intervention|Out of indication|0|||
130682171|NCT00986245|470463899|FG000|Second Intervention|Poor compliance|1|||
130886425|NCT01454102|471217319|FG011|Overall Study|Continuing in the treatment period|4|||
130886426|NCT01454102|471217320|FG012|Overall Study|Continuing in the treatment period|7|||
130886427|NCT01454102|471217321|FG013|Overall Study|Continuing in the treatment period|4|||
130886428|NCT01454102|471217322|FG014|Overall Study|Continuing in the treatment period|3|||
130682172|NCT00986245|470463900|FG001|Second Intervention|Poor compliance|0|||
130682173|NCT00986245|470463899|FG000|Second Intervention|Lost to Follow-up|1|||
130682174|NCT00986245|470463900|FG001|Second Intervention|Lost to Follow-up|0|||
130682175|NCT00986245|470463899|FG000|Second Intervention|Protocol Violation|0|||
130682176|NCT00986245|470463900|FG001|Second Intervention|Protocol Violation|1|||
130682177|NCT01214850|470463903|FG000|Overall Study|Withdrawal by Subject|38|||
130682178|NCT01214850|470463904|FG001|Overall Study|Withdrawal by Subject|31|||
130682179|NCT01214850|470463905|FG002|Overall Study|Withdrawal by Subject|28|||
130682180|NCT01214850|470463903|FG000|Overall Study|Lost to Follow-up|124|||
130682181|NCT01214850|470463904|FG001|Overall Study|Lost to Follow-up|98|||
130682182|NCT01214850|470463905|FG002|Overall Study|Lost to Follow-up|123|||
130682183|NCT01214850|470463903|FG000|Overall Study|Protocol Violation|5|||
130682184|NCT01214850|470463904|FG001|Overall Study|Protocol Violation|5|||
130682185|NCT01214850|470463905|FG002|Overall Study|Protocol Violation|6|||
130682186|NCT01214850|470463903|FG000|Overall Study|Adverse event or death|11|||
130682187|NCT01214850|470463904|FG001|Overall Study|Adverse event or death|8|||
130682188|NCT01214850|470463905|FG002|Overall Study|Adverse event or death|3|||
130682189|NCT01214850|470463903|FG000|Overall Study|Inappropriate enrollment|2|||
130682190|NCT01214850|470463904|FG001|Overall Study|Inappropriate enrollment|1|||
130682191|NCT01214850|470463905|FG002|Overall Study|Inappropriate enrollment|0|||
130682192|NCT01214850|470463903|FG000|Overall Study|Administrative reason|1|||
130682193|NCT01214850|470463904|FG001|Overall Study|Administrative reason|0|||
130682194|NCT01214850|470463905|FG002|Overall Study|Administrative reason|0|||
130682195|NCT01214850|470463903|FG000|Overall Study|Unable to classify|2|||
130682196|NCT01214850|470463904|FG001|Overall Study|Unable to classify|1|||
130682197|NCT01214850|470463905|FG002|Overall Study|Unable to classify|1|||
130682198|NCT00565448|470463909|FG000|Overall Study|Adverse Event|1|||
130682199|NCT00565448|470463910|FG001|Overall Study|Adverse Event|2|||
130682200|NCT00565448|470463909|FG000|Overall Study|Disease progression|1|||
130682201|NCT00565448|470463910|FG001|Overall Study|Disease progression|0|||
130682202|NCT00565448|470463909|FG000|Overall Study|Withdrawal by Subject|1|||
130682203|NCT00565448|470463910|FG001|Overall Study|Withdrawal by Subject|0|||
130682204|NCT00193609|470463911|FG000|Overall Study|Lack of Efficacy|2|||
130682205|NCT00193609|470463911|FG000|Overall Study|Adverse Event|2|||
130682206|NCT00854308|470463913|FG000|Overall Study|Disease progression|42|||
130682207|NCT00854308|470463914|FG001|Overall Study|Disease progression|50|||
130682208|NCT00854308|470463913|FG000|Overall Study|Adverse Event|8|||
130682209|NCT00854308|470463914|FG001|Overall Study|Adverse Event|3|||
130682210|NCT00854308|470463913|FG000|Overall Study|Death|2|||
130682211|NCT00854308|470463914|FG001|Overall Study|Death|5|||
130682212|NCT00854308|470463913|FG000|Overall Study|Physician Decision|6|||
130682213|NCT00854308|470463914|FG001|Overall Study|Physician Decision|6|||
130682214|NCT00854308|470463913|FG000|Overall Study|Withdrawal by Subject|4|||
130682215|NCT00854308|470463914|FG001|Overall Study|Withdrawal by Subject|2|||
130682216|NCT00854308|470463913|FG000|Overall Study|Sponsor's decision to terminate study|0|||
130682217|NCT00854308|470463914|FG001|Overall Study|Sponsor's decision to terminate study|1|||
130682218|NCT00610363|470463915|FG000|Overall Study|Non-compliance with protocol|0|||
130682219|NCT00610363|470463916|FG001|Overall Study|Non-compliance with protocol|1|||
130682220|NCT00610363|470463915|FG000|Overall Study|Adverse Event|3|||
130682221|NCT00610363|470463916|FG001|Overall Study|Adverse Event|1|||
130682222|NCT00610363|470463915|FG000|Overall Study|Lack of Efficacy|2|||
130682223|NCT00610363|470463916|FG001|Overall Study|Lack of Efficacy|0|||
130682224|NCT00610363|470463915|FG000|Overall Study|Lost to Follow-up|4|||
130682225|NCT00610363|470463916|FG001|Overall Study|Lost to Follow-up|0|||
130682226|NCT00610363|470463915|FG000|Overall Study|Withdrawal by Subject|1|||
130682227|NCT00610363|470463916|FG001|Overall Study|Withdrawal by Subject|0|||
130682228|NCT00610363|470463915|FG000|Overall Study|Other than specified above|1|||
130682229|NCT00610363|470463916|FG001|Overall Study|Other than specified above|1|||
130682230|NCT03048500|470463917|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
130682231|NCT03048500|470463917|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
130682232|NCT03048500|470463917|FG000|Reached 1st Response/Continued Treatment|Death|1|||
130682233|NCT03048500|470463917|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
130682234|NCT03048500|470463917|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
130682235|NCT03048500|470463917|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
130682236|NCT03048500|470463917|FG000|Follow up for 3 Years|Death|12|||
130682237|NCT00302952|470463918|FG000|Overall Study|Physician Decision|1|||
130682238|NCT00302952|470463919|FG001|Overall Study|Physician Decision|1|||
130682239|NCT00302952|470463918|FG000|Overall Study|Withdrawal by Subject|2|||
130682240|NCT00302952|470463919|FG001|Overall Study|Withdrawal by Subject|3|||
130682241|NCT00302952|470463918|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
130682242|NCT00302952|470463919|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
130682243|NCT02008565|470463928|FG000|Overall Study|Protocol Violation|1|||
130682244|NCT02008565|470463929|FG001|Overall Study|Protocol Violation|1|||
130682245|NCT02008565|470463930|FG002|Overall Study|Protocol Violation|2|||
130682246|NCT02008565|470463931|FG003|Overall Study|Protocol Violation|0|||
130682247|NCT00857623|470463932|FG000|Overall Study|Adverse Event|5|||
131103801|NCT00189488|472010358|FG000|Overall Study|Protocol deviation|2|||
131103802|NCT00189488|472010359|FG001|Overall Study|Protocol deviation|1|||
131103803|NCT00189488|472010358|FG000|Overall Study|Adverse Event|2|||
131103804|NCT00189488|472010359|FG001|Overall Study|Adverse Event|1|||
131103805|NCT00189488|472010358|FG000|Overall Study|Withdrawal by Subject|2|||
131103806|NCT00189488|472010359|FG001|Overall Study|Withdrawal by Subject|6|||
131103807|NCT00189488|472010358|FG000|Overall Study|Disease progression|2|||
131103808|NCT00189488|472010359|FG001|Overall Study|Disease progression|4|||
131103809|NCT00189488|472010358|FG000|Overall Study|Administrative Decision|0|||
131103810|NCT00189488|472010359|FG001|Overall Study|Administrative Decision|2|||
131103811|NCT00189488|472010358|FG000|Overall Study|Death|5|||
131103812|NCT00189488|472010359|FG001|Overall Study|Death|8|||
131103813|NCT00189488|472010358|FG000|Overall Study|Other|1|||
131103814|NCT00189488|472010359|FG001|Overall Study|Other|0|||
131103815|NCT00484289|472010365|FG000|Long Term Phase|Adverse Event|1|||
131103816|NCT00484289|472010366|FG001|Long Term Phase|Adverse Event|17|||
131103817|NCT00484289|472010367|FG002|Long Term Phase|Adverse Event|5|||
130886429|NCT01454102|471217323|FG015|Overall Study|Continuing in the treatment period|1|||
130886430|NCT01782378|471217329|FG000|First Series|Lost to Follow-up|7|||
130886431|NCT01782378|471217330|FG001|First Series|Lost to Follow-up|8|||
130886432|NCT01782378|471217329|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
130886433|NCT01782378|471217330|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
130886434|NCT01782378|471217329|FG000|Second Series|Lost to Follow-up|8|||
130886435|NCT01782378|471217330|FG001|Second Series|Lost to Follow-up|7|||
130886436|NCT01782378|471217329|FG000|Second Series|Did not choose to complete S2 Optional|18|||
130886437|NCT01782378|471217330|FG001|Second Series|Did not choose to complete S2 Optional|0|||
130886438|NCT02592798|471217331|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
130886439|NCT02592798|471217332|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
130886440|NCT02592798|471217331|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
130886441|NCT02592798|471217332|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
130886442|NCT02592798|471217331|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
130886443|NCT02592798|471217332|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
130886444|NCT02592798|471217331|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
130886445|NCT02592798|471217332|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
130886446|NCT02592798|471217331|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
130886447|NCT02592798|471217332|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
130886448|NCT02592798|471217331|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
130886449|NCT02592798|471217332|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
130886450|NCT02592798|471217331|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
130886451|NCT02592798|471217332|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
130886452|NCT02592798|471217331|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
130886453|NCT02592798|471217332|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
130886454|NCT02592798|471217331|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
130886455|NCT02592798|471217332|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
130886456|NCT02592798|471217331|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
130886457|NCT02592798|471217332|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
130886458|NCT02592798|471217331|FG000|Transition From DB2 to OLE|Other reasons|1|||
130886459|NCT02592798|471217332|FG001|Transition From DB2 to OLE|Other reasons|0|||
130886460|NCT02592798|471217331|FG000|Open Label Period (OLE)|Other reasons|0|||
130886461|NCT02592798|471217332|FG001|Open Label Period (OLE)|Other reasons|2|||
130886462|NCT02592798|471217331|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
130886463|NCT02592798|471217332|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
130886464|NCT02592798|471217331|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
130886465|NCT02592798|471217332|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
130886466|NCT02592798|471217331|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
131103818|NCT00484289|472010365|FG000|Long Term Phase|Withdrawal by Subject|0|||
131103819|NCT00484289|472010366|FG001|Long Term Phase|Withdrawal by Subject|7|||
131103820|NCT00484289|472010367|FG002|Long Term Phase|Withdrawal by Subject|6|||
131103821|NCT00484289|472010365|FG000|Long Term Phase|Inadequate response|2|||
131103822|NCT00484289|472010366|FG001|Long Term Phase|Inadequate response|7|||
131103823|NCT00484289|472010367|FG002|Long Term Phase|Inadequate response|4|||
131103824|NCT00484289|472010365|FG000|Long Term Phase|Other Reason|0|||
131103825|NCT00484289|472010366|FG001|Long Term Phase|Other Reason|5|||
131103826|NCT00484289|472010367|FG002|Long Term Phase|Other Reason|1|||
130886467|NCT02592798|471217332|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
130886468|NCT02592798|471217331|FG000|Open Label Period (OLE)|Adverse Event|0|||
131103827|NCT00484289|472010365|FG000|Post Marketing Phase|Adverse Event|0|||
130886469|NCT02592798|471217332|FG001|Open Label Period (OLE)|Adverse Event|1|||
130886470|NCT00705016|471217333|FG000|Overall Study|Adverse Event|6|||
130886471|NCT00705016|471217334|FG001|Overall Study|Adverse Event|11|||
130886472|NCT00705016|471217335|FG002|Overall Study|Adverse Event|10|||
131103828|NCT00484289|472010366|FG001|Post Marketing Phase|Adverse Event|1|||
131103829|NCT00484289|472010367|FG002|Post Marketing Phase|Adverse Event|0|||
131103830|NCT02349425|472010368|FG000|Period 1|Adverse Event|1|||
130682248|NCT00857623|470463933|FG001|Overall Study|Adverse Event|2|||
130682249|NCT00857623|470463932|FG000|Overall Study|Study-specific discontinuation criteria|5|||
130682250|NCT00857623|470463933|FG001|Overall Study|Study-specific discontinuation criteria|3|||
130682251|NCT00857623|470463932|FG000|Overall Study|Withdrawal by Subject|2|||
130682252|NCT00857623|470463933|FG001|Overall Study|Withdrawal by Subject|1|||
130682253|NCT00857623|470463932|FG000|Overall Study|Lack of Efficacy|1|||
130682254|NCT00857623|470463933|FG001|Overall Study|Lack of Efficacy|1|||
130682255|NCT00857623|470463932|FG000|Overall Study|Severe non-compliance to protocol|1|||
130682256|NCT00857623|470463933|FG001|Overall Study|Severe non-compliance to protocol|1|||
130682257|NCT00857623|470463932|FG000|Overall Study|Intake of prohibited medication|0|||
130682258|NCT00857623|470463933|FG001|Overall Study|Intake of prohibited medication|1|||
130682259|NCT00857623|470463932|FG000|Overall Study|Positive for HEP C|0|||
130682260|NCT00857623|470463933|FG001|Overall Study|Positive for HEP C|1|||
130682261|NCT03435081|470463934|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
130682262|NCT03435081|470463935|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
130682263|NCT03435081|470463936|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
130682264|NCT03435081|470463934|FG000|Week 0 to Week 16|Adverse Event|2|||
130682265|NCT03435081|470463935|FG001|Week 0 to Week 16|Adverse Event|2|||
130682266|NCT03435081|470463936|FG002|Week 0 to Week 16|Adverse Event|2|||
130682267|NCT03435081|470463934|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
130682268|NCT03435081|470463935|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
130682269|NCT03435081|470463936|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
130682270|NCT03435081|470463934|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
130682271|NCT03435081|470463935|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
130682272|NCT03435081|470463936|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
130682273|NCT03435081|470463934|FG000|Week 0 to Week 16|Pregnancy|1|||
130682274|NCT03435081|470463935|FG001|Week 0 to Week 16|Pregnancy|0|||
130682275|NCT03435081|470463936|FG002|Week 0 to Week 16|Pregnancy|0|||
130682276|NCT03435081|470463934|FG000|Week 0 to Week 16|Non-compliance|1|||
130682277|NCT03435081|470463935|FG001|Week 0 to Week 16|Non-compliance|0|||
130682278|NCT03435081|470463936|FG002|Week 0 to Week 16|Non-compliance|2|||
130682279|NCT03435081|470463934|FG000|Week 0 to Week 16|Inadequate Response|0|||
130682280|NCT03435081|470463935|FG001|Week 0 to Week 16|Inadequate Response|1|||
130682281|NCT03435081|470463936|FG002|Week 0 to Week 16|Inadequate Response|0|||
130682282|NCT03435081|470463934|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
130682283|NCT03435081|470463935|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
130682284|NCT03435081|470463936|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
130886473|NCT00705016|471217333|FG000|Overall Study|Death|5|||
131103831|NCT02349425|472010369|FG001|Period 1|Adverse Event|1|||
131103832|NCT02349425|472010370|FG002|Period 1|Adverse Event|0|||
131103833|NCT02349425|472010371|FG003|Period 1|Adverse Event|0|||
131103834|NCT02349425|472010368|FG000|Period 2|Adverse Event|0|||
131103835|NCT02349425|472010369|FG001|Period 2|Adverse Event|1|||
131103836|NCT02349425|472010370|FG002|Period 2|Adverse Event|1|||
131103837|NCT02349425|472010371|FG003|Period 2|Adverse Event|0|||
131103838|NCT01877837|472010372|FG000|Overall Study|Lost to Follow-up|1|||
131103839|NCT01877837|472010372|FG000|Overall Study|Ineligible|4|||
131103840|NCT00645801|472010374|FG000|Overall Study|unclear if patient took all the medication.|1|||
131103841|NCT00645801|472010375|FG001|Overall Study|unclear if patient took all the medication.|0|||
131103842|NCT00645801|472010374|FG000|Overall Study|Lost to Follow-up|19|||
131103843|NCT00645801|472010375|FG001|Overall Study|Lost to Follow-up|15|||
131103844|NCT00705679|472010376|FG000|Overall Study|Adverse Event|1|||
131103845|NCT00705679|472010377|FG001|Overall Study|Adverse Event|1|||
131103846|NCT00705679|472010378|FG002|Overall Study|Adverse Event|0|||
131103847|NCT00705679|472010379|FG003|Overall Study|Adverse Event|0|||
131103848|NCT00705679|472010380|FG004|Overall Study|Adverse Event|0|||
130682285|NCT03435081|470463934|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
130682286|NCT03435081|470463935|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
130682287|NCT03435081|470463936|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
130682288|NCT03435081|470463934|FG000|Week 16 to Week 104|Adverse Event|1|||
130682289|NCT03435081|470463935|FG001|Week 16 to Week 104|Adverse Event|0|||
130682290|NCT03435081|470463936|FG002|Week 16 to Week 104|Adverse Event|2|||
130682291|NCT03435081|470463934|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
130682292|NCT03435081|470463935|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
130682293|NCT03435081|470463936|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
130682294|NCT03435081|470463934|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
130682295|NCT03435081|470463935|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
130682296|NCT03435081|470463936|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
131103849|NCT00705679|472010376|FG000|Overall Study|Death|0|||
131103850|NCT00705679|472010377|FG001|Overall Study|Death|0|||
131103851|NCT00705679|472010378|FG002|Overall Study|Death|3|||
130682297|NCT03435081|470463934|FG000|Week 16 to Week 104|Non--Compliance|0|||
130682298|NCT03435081|470463935|FG001|Week 16 to Week 104|Non--Compliance|0|||
130682299|NCT03435081|470463936|FG002|Week 16 to Week 104|Non--Compliance|1|||
130682300|NCT00420238|470463937|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
130886474|NCT00705016|471217334|FG001|Overall Study|Death|7|||
131103852|NCT00705679|472010379|FG003|Overall Study|Death|2|||
131103853|NCT00705679|472010380|FG004|Overall Study|Death|1|||
130886475|NCT00705016|471217335|FG002|Overall Study|Death|5|||
130886476|NCT00705016|471217333|FG000|Overall Study|Protocol Violation|0|||
130886477|NCT00705016|471217334|FG001|Overall Study|Protocol Violation|1|||
130886478|NCT00705016|471217335|FG002|Overall Study|Protocol Violation|1|||
130886479|NCT00705016|471217333|FG000|Overall Study|Withdrawal by Subject|4|||
130886480|NCT00705016|471217334|FG001|Overall Study|Withdrawal by Subject|3|||
130886481|NCT00705016|471217335|FG002|Overall Study|Withdrawal by Subject|2|||
130886482|NCT00705016|471217333|FG000|Overall Study|Progressive Disease|33|||
130886483|NCT00705016|471217334|FG001|Overall Study|Progressive Disease|29|||
130886484|NCT00705016|471217335|FG002|Overall Study|Progressive Disease|33|||
130886485|NCT00705016|471217333|FG000|Overall Study|Symptomatic Deterioration|3|||
130886486|NCT00705016|471217334|FG001|Overall Study|Symptomatic Deterioration|1|||
130886487|NCT00705016|471217335|FG002|Overall Study|Symptomatic Deterioration|1|||
131103854|NCT00705679|472010376|FG000|Overall Study|Lost to Follow-up|32|||
131103855|NCT00705679|472010377|FG001|Overall Study|Lost to Follow-up|60|||
131103856|NCT00705679|472010378|FG002|Overall Study|Lost to Follow-up|44|||
131103857|NCT00705679|472010379|FG003|Overall Study|Lost to Follow-up|30|||
131103858|NCT00705679|472010380|FG004|Overall Study|Lost to Follow-up|35|||
131103859|NCT00705679|472010376|FG000|Overall Study|Physician Decision|0|||
131103860|NCT00705679|472010377|FG001|Overall Study|Physician Decision|1|||
131103861|NCT00705679|472010378|FG002|Overall Study|Physician Decision|0|||
131103862|NCT00705679|472010379|FG003|Overall Study|Physician Decision|1|||
131103863|NCT00705679|472010380|FG004|Overall Study|Physician Decision|0|||
131103864|NCT00705679|472010376|FG000|Overall Study|Withdrawal by Subject|32|||
131103865|NCT00705679|472010377|FG001|Overall Study|Withdrawal by Subject|77|||
131103866|NCT00705679|472010378|FG002|Overall Study|Withdrawal by Subject|68|||
131103867|NCT00705679|472010379|FG003|Overall Study|Withdrawal by Subject|47|||
131103868|NCT00705679|472010380|FG004|Overall Study|Withdrawal by Subject|33|||
131103869|NCT01143038|472010385|FG000|Overall Study|Withdrawal by Subject|4|||
131103870|NCT01143038|472010385|FG000|Overall Study|Requirement for alternative therapy|5|||
131103871|NCT01143038|472010385|FG000|Overall Study|Adverse Event|3|||
131103872|NCT01143038|472010385|FG000|Overall Study|Lost to Follow-up|2|||
131103873|NCT01143038|472010385|FG000|Overall Study|Protocol Deviation|1|||
131103874|NCT01143038|472010385|FG000|Overall Study|Death|1|||
131103875|NCT01346475|472010389|FG000|First Intervention|Lost to Follow-up|4|||
131103876|NCT01346475|472010390|FG001|First Intervention|Lost to Follow-up|3|||
131103877|NCT01171807|472010391|FG000|Overall Study|Treatment failure|2|||
131103878|NCT01171807|472010392|FG001|Overall Study|Treatment failure|4|||
131103879|NCT01171807|472010391|FG000|Overall Study|Non compliance|1|||
130886488|NCT00705016|471217333|FG000|Overall Study|Other|9|||
130886489|NCT00705016|471217334|FG001|Overall Study|Other|6|||
130886490|NCT00705016|471217335|FG002|Overall Study|Other|6|||
130886491|NCT03853109|471217338|FG000|Overall Study|Withdrawal by Subject|0|||
130886492|NCT03853109|471217339|FG001|Overall Study|Withdrawal by Subject|0|||
130886493|NCT03853109|471217340|FG002|Overall Study|Withdrawal by Subject|1|||
130886494|NCT03853109|471217341|FG003|Overall Study|Withdrawal by Subject|2|||
130886495|NCT03853109|471217342|FG004|Overall Study|Withdrawal by Subject|1|||
130886496|NCT03853109|471217343|FG005|Overall Study|Withdrawal by Subject|4|||
130886497|NCT03853109|471217344|FG006|Overall Study|Withdrawal by Subject|5|||
130886498|NCT03853109|471217345|FG007|Overall Study|Withdrawal by Subject|3|||
130886499|NCT03853109|471217338|FG000|Overall Study|Decision by Sponsor|0|||
130886500|NCT03853109|471217339|FG001|Overall Study|Decision by Sponsor|0|||
130886501|NCT03853109|471217340|FG002|Overall Study|Decision by Sponsor|1|||
130886502|NCT03853109|471217341|FG003|Overall Study|Decision by Sponsor|0|||
130886503|NCT03853109|471217342|FG004|Overall Study|Decision by Sponsor|1|||
130886504|NCT03853109|471217343|FG005|Overall Study|Decision by Sponsor|1|||
130886505|NCT03853109|471217344|FG006|Overall Study|Decision by Sponsor|10|||
130886506|NCT03853109|471217345|FG007|Overall Study|Decision by Sponsor|2|||
130886507|NCT03853109|471217338|FG000|Overall Study|Lost to Follow-up|0|||
130886508|NCT03853109|471217339|FG001|Overall Study|Lost to Follow-up|0|||
130886509|NCT03853109|471217340|FG002|Overall Study|Lost to Follow-up|0|||
130886510|NCT03853109|471217341|FG003|Overall Study|Lost to Follow-up|0|||
130886511|NCT03853109|471217342|FG004|Overall Study|Lost to Follow-up|1|||
130886512|NCT03853109|471217343|FG005|Overall Study|Lost to Follow-up|3|||
130886513|NCT03853109|471217344|FG006|Overall Study|Lost to Follow-up|0|||
130886514|NCT03853109|471217345|FG007|Overall Study|Lost to Follow-up|0|||
130886515|NCT03853109|471217338|FG000|Overall Study|Death|2|||
130886516|NCT03853109|471217339|FG001|Overall Study|Death|5|||
130886517|NCT03853109|471217340|FG002|Overall Study|Death|8|||
130886518|NCT03853109|471217341|FG003|Overall Study|Death|10|||
130886519|NCT03853109|471217342|FG004|Overall Study|Death|3|||
130886520|NCT03853109|471217343|FG005|Overall Study|Death|20|||
130886521|NCT03853109|471217344|FG006|Overall Study|Death|10|||
130886522|NCT03853109|471217345|FG007|Overall Study|Death|5|||
130886523|NCT02952820|471217350|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
130886524|NCT02952820|471217351|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
130886525|NCT02952820|471217352|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
131103880|NCT01171807|472010392|FG001|Overall Study|Non compliance|0|||
130886526|NCT02952820|471217350|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
130682301|NCT00420238|470463938|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
130682302|NCT00420238|470463937|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
130682303|NCT00420238|470463938|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
130682304|NCT00420238|470463937|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
130682305|NCT00420238|470463938|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
130682306|NCT00420238|470463937|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
130682307|NCT00420238|470463938|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
130682308|NCT00420238|470463937|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
130682309|NCT00420238|470463938|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
130682310|NCT00420238|470463937|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
130682311|NCT00420238|470463938|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
130682312|NCT00304083|470463940|FG000|Overall Study|Withdrawal by Subject|4|||
130682313|NCT00304083|470463941|FG001|Overall Study|Withdrawal by Subject|2|||
130682314|NCT00304083|470463940|FG000|Overall Study|Physician Decision|8|||
130682315|NCT00304083|470463941|FG001|Overall Study|Physician Decision|3|||
130682316|NCT00304083|470463940|FG000|Overall Study|Disease Progression|5|||
130682317|NCT00304083|470463941|FG001|Overall Study|Disease Progression|1|||
130682318|NCT00304083|470463940|FG000|Overall Study|Other|5|||
130682319|NCT00304083|470463941|FG001|Overall Study|Other|2|||
130682320|NCT03966365|470463944|FG000|Overall Study|Protocol Violation|1|||
130682321|NCT03966365|470463945|FG001|Overall Study|Protocol Violation|0|||
130682322|NCT01044732|470463946|FG000|Overall Study|Lost to Follow-up|2|||
130682323|NCT01044732|470463947|FG001|Overall Study|Lost to Follow-up|1|||
130682324|NCT01044732|470463946|FG000|Overall Study|Physician Decision|5|||
130682325|NCT01044732|470463947|FG001|Overall Study|Physician Decision|3|||
130682326|NCT01044732|470463946|FG000|Overall Study|Protocol Violation|11|||
130682327|NCT01044732|470463947|FG001|Overall Study|Protocol Violation|12|||
130682328|NCT01044732|470463946|FG000|Overall Study|Withdrawal by Subject|0|||
130682329|NCT01044732|470463947|FG001|Overall Study|Withdrawal by Subject|1|||
130682330|NCT01044732|470463946|FG000|Overall Study|Inadequate bowel preparation|11|||
130682331|NCT01044732|470463947|FG001|Overall Study|Inadequate bowel preparation|17|||
130682332|NCT01044732|470463946|FG000|Overall Study|Inability to reach cecum|5|||
130766293|NCT00076999|470768205|FG001|Overall Study|Lost to Follow-up|1|||
130766294|NCT00076999|470768206|FG002|Overall Study|Lost to Follow-up|0|||
130766295|NCT00076999|470768207|FG003|Overall Study|Lost to Follow-up|0|||
130766296|NCT00076999|470768208|FG004|Overall Study|Lost to Follow-up|0|||
130766297|NCT00076999|470768204|FG000|Overall Study|Withdrawal by Subject|0|||
130766298|NCT00076999|470768205|FG001|Overall Study|Withdrawal by Subject|4|||
130766299|NCT00076999|470768206|FG002|Overall Study|Withdrawal by Subject|3|||
130766300|NCT00076999|470768207|FG003|Overall Study|Withdrawal by Subject|0|||
130766301|NCT00076999|470768208|FG004|Overall Study|Withdrawal by Subject|1|||
130766302|NCT00076999|470768204|FG000|Overall Study|Other reason (not specified)|8|||
130766303|NCT00076999|470768205|FG001|Overall Study|Other reason (not specified)|8|||
130766304|NCT00076999|470768206|FG002|Overall Study|Other reason (not specified)|4|||
130766305|NCT00076999|470768207|FG003|Overall Study|Other reason (not specified)|1|||
130766306|NCT00076999|470768208|FG004|Overall Study|Other reason (not specified)|13|||
130766307|NCT02603562|470768221|FG000|Overall Study|Lost to Follow-up|1|||
130766308|NCT01380691|470768236|FG000|Washout (7 Days)|Protocol Violation|0|||
130766309|NCT01380691|470768237|FG001|Washout (7 Days)|Protocol Violation|0|||
130766310|NCT01380691|470768238|FG002|Washout (7 Days)|Protocol Violation|0|||
131017618|NCT00857649|471693831|FG001|Overall Study|Withdrawal of Consent|7|||
131017619|NCT00857649|471693830|FG000|Overall Study|Nursing Home Placement|2|||
130766311|NCT01380691|470768239|FG003|Washout (7 Days)|Protocol Violation|1|||
130766312|NCT01380691|470768236|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
130766313|NCT01380691|470768237|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
130766314|NCT01380691|470768238|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
130766315|NCT01380691|470768239|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
131017620|NCT00857649|471693831|FG001|Overall Study|Nursing Home Placement|9|||
131017621|NCT00857649|471693830|FG000|Overall Study|Other Reasons|1|||
131017622|NCT00857649|471693831|FG001|Overall Study|Other Reasons|3|||
131017623|NCT05190419|471693832|FG000|Overall Study|Lack of Efficacy|8|||
131017624|NCT05190419|471693833|FG001|Overall Study|Lack of Efficacy|0|||
131017625|NCT05190419|471693834|FG002|Overall Study|Lack of Efficacy|1|||
131017626|NCT05190419|471693835|FG003|Overall Study|Lack of Efficacy|0|||
131017627|NCT05190419|471693832|FG000|Overall Study|Withdrawal by Subject|7|||
131017628|NCT05190419|471693833|FG001|Overall Study|Withdrawal by Subject|1|||
131017629|NCT05190419|471693834|FG002|Overall Study|Withdrawal by Subject|2|||
131017630|NCT05190419|471693835|FG003|Overall Study|Withdrawal by Subject|2|||
131017631|NCT05190419|471693832|FG000|Overall Study|Adverse Event|2|||
131017632|NCT05190419|471693833|FG001|Overall Study|Adverse Event|10|||
130682333|NCT01044732|470463947|FG001|Overall Study|Inability to reach cecum|2|||
131017633|NCT05190419|471693834|FG002|Overall Study|Adverse Event|11|||
130682334|NCT01044732|470463946|FG000|Overall Study|Technical error or malfunction|15|||
130682335|NCT01044732|470463947|FG001|Overall Study|Technical error or malfunction|14|||
131017634|NCT05190419|471693835|FG003|Overall Study|Adverse Event|21|||
130682336|NCT01569152|470463948|FG000|Phase IIa, Period 1|Early Escape|5|||
130682337|NCT01569152|470463949|FG001|Phase IIa, Period 1|Early Escape|22|||
130682338|NCT01569152|470463950|FG002|Phase IIa, Period 1|Early Escape|0|||
130682339|NCT01569152|470463948|FG000|Phase IIa, Period 1|Adverse Event|4|||
130682340|NCT01569152|470463949|FG001|Phase IIa, Period 1|Adverse Event|0|||
130682341|NCT01569152|470463950|FG002|Phase IIa, Period 1|Adverse Event|0|||
130682342|NCT01569152|470463948|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
130682343|NCT01569152|470463949|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
130682344|NCT01569152|470463950|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
130682345|NCT01569152|470463948|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
130682346|NCT01569152|470463949|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
130682347|NCT01569152|470463950|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
130682348|NCT01569152|470463948|FG000|Phase IIa, Period 1|Protocol Violation|0|||
130682349|NCT01569152|470463949|FG001|Phase IIa, Period 1|Protocol Violation|1|||
130682350|NCT01569152|470463950|FG002|Phase IIa, Period 1|Protocol Violation|0|||
130682351|NCT01569152|470463948|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
130682352|NCT01569152|470463949|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
130682353|NCT01569152|470463950|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
130682354|NCT01569152|470463948|FG000|Safety Extension, Period 3|Adverse Event|0|||
130682355|NCT01569152|470463949|FG001|Safety Extension, Period 3|Adverse Event|0|||
130682356|NCT01569152|470463950|FG002|Safety Extension, Period 3|Adverse Event|4|||
130682357|NCT01569152|470463948|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
130682358|NCT01569152|470463949|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
130682359|NCT01569152|470463950|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
130682360|NCT01569152|470463948|FG000|Safety Extension, Period 3|Physician Decision|0|||
130682361|NCT01569152|470463949|FG001|Safety Extension, Period 3|Physician Decision|0|||
130682362|NCT01569152|470463950|FG002|Safety Extension, Period 3|Physician Decision|2|||
130682363|NCT01569152|470463948|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
130682364|NCT01569152|470463949|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
130682365|NCT01569152|470463950|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
130682366|NCT00824265|470463955|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
130682367|NCT00824265|470463956|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
130682368|NCT00824265|470463955|FG000|Treatment Phase|Protocol Violation|1|||
130682369|NCT00824265|470463956|FG001|Treatment Phase|Protocol Violation|0|||
130682370|NCT00824265|470463955|FG000|Treatment Phase|Lost to Follow-up|1|||
130682371|NCT00824265|470463956|FG001|Treatment Phase|Lost to Follow-up|1|||
130682372|NCT00824265|470463955|FG000|Treatment Phase|Physician Decision|6|||
130682373|NCT00824265|470463956|FG001|Treatment Phase|Physician Decision|12|||
130682374|NCT00824265|470463955|FG000|Treatment Phase|Withdrawal by Subject|6|||
130682375|NCT00824265|470463956|FG001|Treatment Phase|Withdrawal by Subject|15|||
130682376|NCT00824265|470463955|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
130682377|NCT00824265|470463956|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
130682378|NCT00824265|470463955|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
130682379|NCT00824265|470463956|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
130682380|NCT00591630|470463957|FG000|Overall Study|Death|0|||
130682381|NCT00591630|470463958|FG001|Overall Study|Death|0|||
130682382|NCT00591630|470463959|FG002|Overall Study|Death|1|||
130682383|NCT00591630|470463960|FG003|Overall Study|Death|0|||
130682384|NCT00463606|470463961|FG000|Overall Study|Adverse Event|21|||
130682385|NCT00463606|470463962|FG001|Overall Study|Adverse Event|18|||
130682386|NCT00463606|470463963|FG002|Overall Study|Adverse Event|11|||
130682387|NCT00463606|470463961|FG000|Overall Study|Withdrawal by Subject|11|||
130682388|NCT00463606|470463962|FG001|Overall Study|Withdrawal by Subject|11|||
130682389|NCT00463606|470463963|FG002|Overall Study|Withdrawal by Subject|5|||
130682390|NCT00463606|470463961|FG000|Overall Study|Lost to Follow-up|2|||
130682391|NCT00463606|470463962|FG001|Overall Study|Lost to Follow-up|2|||
130682392|NCT00463606|470463963|FG002|Overall Study|Lost to Follow-up|3|||
130682393|NCT00463606|470463961|FG000|Overall Study|Subject noncompliance|1|||
130682394|NCT00463606|470463962|FG001|Overall Study|Subject noncompliance|1|||
130682395|NCT00463606|470463963|FG002|Overall Study|Subject noncompliance|0|||
130682396|NCT00463606|470463961|FG000|Overall Study|Subject moved out of town|1|||
130682397|NCT00463606|470463962|FG001|Overall Study|Subject moved out of town|0|||
130682398|NCT00463606|470463963|FG002|Overall Study|Subject moved out of town|0|||
130682399|NCT00463606|470463961|FG000|Overall Study|Physician Decision|0|||
130682400|NCT00463606|470463962|FG001|Overall Study|Physician Decision|1|||
130682401|NCT00463606|470463963|FG002|Overall Study|Physician Decision|0|||
130682402|NCT00463606|470463961|FG000|Overall Study|Sponsor request|0|||
130682403|NCT00463606|470463962|FG001|Overall Study|Sponsor request|1|||
130682404|NCT00463606|470463963|FG002|Overall Study|Sponsor request|0|||
130682405|NCT00463606|470463961|FG000|Overall Study|Exclusion criteria violation|2|||
130682406|NCT00463606|470463962|FG001|Overall Study|Exclusion criteria violation|0|||
130682407|NCT00463606|470463963|FG002|Overall Study|Exclusion criteria violation|0|||
130682408|NCT00463606|470463961|FG000|Overall Study|Coordinator error|1|||
130682409|NCT00463606|470463962|FG001|Overall Study|Coordinator error|0|||
130682410|NCT00463606|470463963|FG002|Overall Study|Coordinator error|0|||
130682411|NCT00463606|470463961|FG000|Overall Study|Patient randomized in error|1|||
130682412|NCT00463606|470463962|FG001|Overall Study|Patient randomized in error|0|||
130682413|NCT00463606|470463963|FG002|Overall Study|Patient randomized in error|0|||
130682414|NCT00463606|470463961|FG000|Overall Study|Participation in another ABT-335 trial|1|||
130682415|NCT00463606|470463962|FG001|Overall Study|Participation in another ABT-335 trial|0|||
130682416|NCT00463606|470463963|FG002|Overall Study|Participation in another ABT-335 trial|0|||
130682417|NCT00463606|470463961|FG000|Overall Study|Protocol Violation|0|||
130682418|NCT00463606|470463962|FG001|Overall Study|Protocol Violation|0|||
130682419|NCT00463606|470463963|FG002|Overall Study|Protocol Violation|1|||
130682420|NCT02682602|470463965|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
130682421|NCT02682602|470463966|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
130682422|NCT02682602|470463965|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
130682423|NCT02682602|470463966|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
130682424|NCT02311361|470465869|FG000|Overall Study|Did not receive treatment|0|||
130682425|NCT02311361|470465870|FG001|Overall Study|Did not receive treatment|1|||
130682426|NCT02311361|470465871|FG002|Overall Study|Did not receive treatment|0|||
130682427|NCT02311361|470465872|FG003|Overall Study|Did not receive treatment|1|||
130682428|NCT00365300|470465873|FG000|Open-label Phase|Adverse Event|4|||
130682429|NCT00365300|470465874|FG001|Open-label Phase|Adverse Event|0|||
130682430|NCT00365300|470465873|FG000|Open-label Phase|Failed to Return|1|||
130682431|NCT00365300|470465874|FG001|Open-label Phase|Failed to Return|0|||
130682432|NCT00365300|470465873|FG000|Open-label Phase|Physician Decision|1|||
130682433|NCT00365300|470465874|FG001|Open-label Phase|Physician Decision|0|||
130682434|NCT00365300|470465873|FG000|Open-label Phase|Noncompliance|9|||
130682435|NCT00365300|470465874|FG001|Open-label Phase|Noncompliance|0|||
130682436|NCT00365300|470465873|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
130682437|NCT00365300|470465874|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
130682438|NCT00365300|470465873|FG000|Open-label Phase|Protocol Violation|1|||
130682439|NCT00365300|470465874|FG001|Open-label Phase|Protocol Violation|0|||
130682440|NCT00365300|470465873|FG000|Open-label Phase|Lack of Efficacy|1|||
130682441|NCT00365300|470465874|FG001|Open-label Phase|Lack of Efficacy|0|||
130682442|NCT00365300|470465873|FG000|Open-label Phase|Patient skipped open label phase|1|||
130682443|NCT00365300|470465874|FG001|Open-label Phase|Patient skipped open label phase|0|||
130682444|NCT00365300|470465873|FG000|Double-blind Phase|Failed to return|1|||
130682445|NCT00365300|470465874|FG001|Double-blind Phase|Failed to return|0|||
130682446|NCT00365300|470465873|FG000|Double-blind Phase|Noncompliance|1|||
130682447|NCT00365300|470465874|FG001|Double-blind Phase|Noncompliance|1|||
130682448|NCT00365300|470465873|FG000|Double-blind Phase|Withdrawal by Subject|0|||
131017635|NCT05190419|471693832|FG000|Overall Study|Lost to Follow-up|1|||
131017636|NCT05190419|471693833|FG001|Overall Study|Lost to Follow-up|2|||
131017637|NCT05190419|471693834|FG002|Overall Study|Lost to Follow-up|3|||
131017638|NCT05190419|471693835|FG003|Overall Study|Lost to Follow-up|1|||
131017639|NCT05190419|471693832|FG000|Overall Study|Other|1|||
131017640|NCT05190419|471693833|FG001|Overall Study|Other|1|||
131017641|NCT05190419|471693834|FG002|Overall Study|Other|0|||
131017642|NCT05190419|471693835|FG003|Overall Study|Other|3|||
131017643|NCT03175172|471695873|FG000|Overall Study|Death|3|||
131017644|NCT03175172|471695873|FG000|Overall Study|Withdrawal by Subject|3|||
131017645|NCT03175172|471695873|FG000|Overall Study|Lost to Follow-up|1|||
131017646|NCT03175172|471695873|FG000|Overall Study|Study Terminated by Sponsor|3|||
131017647|NCT01662336|471695874|FG000|Overall Study|Adverse Event|1|||
131017648|NCT01662336|471695874|FG000|Overall Study|No longer on LPV/r|30|||
131017649|NCT01662336|471695874|FG000|Overall Study|Other|29|||
131017650|NCT01662336|471695874|FG000|Overall Study|Withdrawal by Subject|6|||
131017651|NCT04668339|471695875|FG000|Overall Study|Physician Decision|1|||
131017652|NCT04668339|471695876|FG001|Overall Study|Physician Decision|0|||
131017653|NCT04668339|471695877|FG002|Overall Study|Physician Decision|1|||
131017654|NCT04668339|471695878|FG003|Overall Study|Physician Decision|1|||
131017655|NCT04668339|471695875|FG000|Overall Study|Lost to Follow-up|14|||
131017656|NCT04668339|471695876|FG001|Overall Study|Lost to Follow-up|12|||
131017657|NCT04668339|471695877|FG002|Overall Study|Lost to Follow-up|8|||
131017658|NCT04668339|471695878|FG003|Overall Study|Lost to Follow-up|5|||
131017659|NCT04668339|471695875|FG000|Overall Study|Adverse Event|0|||
131017660|NCT04668339|471695876|FG001|Overall Study|Adverse Event|0|||
131017661|NCT04668339|471695877|FG002|Overall Study|Adverse Event|1|||
131017662|NCT04668339|471695878|FG003|Overall Study|Adverse Event|0|||
131017663|NCT04668339|471695875|FG000|Overall Study|Other than specified|3|||
131017664|NCT04668339|471695876|FG001|Overall Study|Other than specified|0|||
131017665|NCT04668339|471695877|FG002|Overall Study|Other than specified|1|||
130682449|NCT00365300|470465874|FG001|Double-blind Phase|Withdrawal by Subject|1|||
131017666|NCT04668339|471695878|FG003|Overall Study|Other than specified|0|||
131017667|NCT04668339|471695875|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
131017668|NCT04668339|471695876|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
130766316|NCT01987232|470768240|FG000|Overall Study|Ongoing in Study|0|||
130766317|NCT01987232|470768241|FG001|Overall Study|Ongoing in Study|0|||
130766318|NCT01987232|470768242|FG002|Overall Study|Ongoing in Study|0|||
131103881|NCT01171807|472010391|FG000|Overall Study|Lost to Follow-up|3|||
130886527|NCT02952820|471217351|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
130886528|NCT02952820|471217352|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
130886529|NCT02952820|471217350|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
130886530|NCT02952820|471217351|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
130886531|NCT02952820|471217352|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
130886532|NCT02952820|471217350|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
130886533|NCT02952820|471217351|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
130886534|NCT02952820|471217352|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
130886535|NCT02952820|471217350|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
130886536|NCT02952820|471217351|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
130886537|NCT02952820|471217352|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
130886538|NCT02952820|471217350|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
130886539|NCT02952820|471217351|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
130886540|NCT02952820|471217352|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
130886541|NCT02952820|471217350|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
130886542|NCT02952820|471217351|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
130886543|NCT02952820|471217352|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
130886544|NCT02952820|471217350|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
130886545|NCT02952820|471217351|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
130886546|NCT02952820|471217352|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
131103882|NCT01171807|472010392|FG001|Overall Study|Lost to Follow-up|0|||
130766319|NCT01987232|470768243|FG003|Overall Study|Ongoing in Study|1|||
130682450|NCT00365300|470465873|FG000|Double-blind Phase|Protocol Violation|3|||
130682451|NCT00365300|470465874|FG001|Double-blind Phase|Protocol Violation|1|||
130682452|NCT00365300|470465873|FG000|Double-blind Phase|Lack of Efficacy|6|||
130682453|NCT00365300|470465874|FG001|Double-blind Phase|Lack of Efficacy|6|||
130682454|NCT02896361|470465875|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
130682455|NCT02896361|470465876|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
130682456|NCT02896361|470465877|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
130682457|NCT02896361|470465875|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
130682458|NCT02896361|470465876|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
130682459|NCT02896361|470465877|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
130682460|NCT01179048|470465879|FG000|Overall Study|Withdrawn - does not allow contact|4|||
130682461|NCT01179048|470465880|FG001|Overall Study|Withdrawn - does not allow contact|8|||
130682462|NCT01179048|470465879|FG000|Overall Study|Lost to Follow-up|8|||
130682463|NCT01179048|470465880|FG001|Overall Study|Lost to Follow-up|9|||
130682464|NCT01179048|470465879|FG000|Overall Study|Alive|127|||
130682465|NCT01179048|470465880|FG001|Overall Study|Alive|142|||
130682466|NCT01520909|470465892|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
130682467|NCT01520909|470465893|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
130682468|NCT01520909|470465894|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
130682469|NCT01520909|470465892|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
130682470|NCT01520909|470465893|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
130682471|NCT01520909|470465894|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
130682472|NCT01520909|470465892|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
130682473|NCT01520909|470465893|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
130682474|NCT01520909|470465894|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
130682475|NCT01520909|470465892|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
130682476|NCT01520909|470465893|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
130682477|NCT01520909|470465894|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
130682478|NCT02188303|470465895|FG000|Overall Study|Adverse Event|0|||
130682479|NCT02188303|470465896|FG001|Overall Study|Adverse Event|0|||
130682480|NCT02188303|470465897|FG002|Overall Study|Adverse Event|0|||
130682481|NCT02188303|470465898|FG003|Overall Study|Adverse Event|0|||
130682482|NCT02188303|470465899|FG004|Overall Study|Adverse Event|0|||
130682483|NCT02188303|470465900|FG005|Overall Study|Adverse Event|2|||
130682484|NCT02188303|470465901|FG006|Overall Study|Adverse Event|0|||
130682485|NCT02188303|470465902|FG007|Overall Study|Adverse Event|2|||
130682486|NCT02188303|470465895|FG000|Overall Study|Dose Termination Criteria Met|0|||
130682487|NCT02188303|470465896|FG001|Overall Study|Dose Termination Criteria Met|0|||
130682488|NCT02188303|470465897|FG002|Overall Study|Dose Termination Criteria Met|0|||
130682489|NCT02188303|470465898|FG003|Overall Study|Dose Termination Criteria Met|0|||
130682490|NCT02188303|470465899|FG004|Overall Study|Dose Termination Criteria Met|0|||
130682491|NCT02188303|470465900|FG005|Overall Study|Dose Termination Criteria Met|0|||
130682492|NCT02188303|470465901|FG006|Overall Study|Dose Termination Criteria Met|2|||
130682493|NCT02188303|470465902|FG007|Overall Study|Dose Termination Criteria Met|4|||
130682494|NCT04206332|470465904|FG000|Part A|Lost to Follow-up|0|||
130682495|NCT04206332|470465905|FG001|Part A|Lost to Follow-up|1|||
130682496|NCT04206332|470465906|FG002|Part A|Lost to Follow-up|0|||
130682497|NCT04206332|470465907|FG003|Part A|Lost to Follow-up|0|||
130682498|NCT04206332|470465908|FG004|Part A|Lost to Follow-up|0|||
130682499|NCT04206332|470465909|FG005|Part A|Lost to Follow-up|0|||
130682500|NCT04206332|470465910|FG006|Part A|Lost to Follow-up|0|||
130682501|NCT04206332|470465911|FG007|Part A|Lost to Follow-up|0|||
130682502|NCT04206332|470465912|FG008|Part A|Lost to Follow-up|0|||
130682503|NCT04206332|470465913|FG009|Part A|Lost to Follow-up|0|||
130682504|NCT04206332|470465914|FG010|Part A|Lost to Follow-up|0|||
130682505|NCT04206332|470465915|FG011|Part A|Lost to Follow-up|0|||
130682506|NCT04206332|470465916|FG012|Part A|Lost to Follow-up|0|||
130682507|NCT04206332|470465917|FG013|Part A|Lost to Follow-up|0|||
130682508|NCT04206332|470465918|FG014|Part A|Lost to Follow-up|0|||
130682509|NCT04206332|470465919|FG015|Part A|Lost to Follow-up|0|||
130682510|NCT04206332|470465920|FG016|Part A|Lost to Follow-up|0|||
130682511|NCT04206332|470465904|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682512|NCT04206332|470465905|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682513|NCT04206332|470465906|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682514|NCT04206332|470465907|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682515|NCT04206332|470465908|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682516|NCT04206332|470465909|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
130682517|NCT04206332|470465910|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682518|NCT04206332|470465911|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130886547|NCT02952820|471217350|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
130886548|NCT02952820|471217351|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
130886549|NCT02952820|471217352|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
130886550|NCT02952820|471217350|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
130886551|NCT02952820|471217351|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
130886552|NCT02952820|471217352|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
130886553|NCT02952820|471217350|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
130682519|NCT04206332|470465912|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682520|NCT04206332|470465913|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682521|NCT04206332|470465914|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130886554|NCT02952820|471217351|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
130720845|NCT04126213|470601548|FG003|Overall Study|Lost to Follow-up|10|||
130766320|NCT01987232|470768244|FG004|Overall Study|Ongoing in Study|0|||
130886555|NCT02952820|471217352|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
130886556|NCT02952820|471217350|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
130886557|NCT02952820|471217351|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
130886558|NCT02952820|471217352|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
130886559|NCT02952820|471217350|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
130766321|NCT00232596|470768249|FG000|6-Week Titration Phase|Adverse Event|6|||
130766322|NCT00232596|470768250|FG001|6-Week Titration Phase|Adverse Event|19|||
130766323|NCT00232596|470768249|FG000|6-Week Titration Phase|Failed to Return|2|||
130886560|NCT02952820|471217351|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
130886561|NCT02952820|471217352|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
130886562|NCT02952820|471217350|FG000|Active Treatment Period (6 Months)|Not treated|0|||
130886563|NCT02952820|471217351|FG001|Active Treatment Period (6 Months)|Not treated|0|||
130886564|NCT02952820|471217352|FG002|Active Treatment Period (6 Months)|Not treated|1|||
130886565|NCT03486834|471217353|FG000|Overall Study|Withdrawal by Subject|46|||
130886566|NCT03486834|471217354|FG001|Overall Study|Withdrawal by Subject|46|||
130886567|NCT03486834|471217355|FG002|Overall Study|Withdrawal by Subject|52|||
130886568|NCT03486834|471217353|FG000|Overall Study|Adverse Event|8|||
130886569|NCT03486834|471217354|FG001|Overall Study|Adverse Event|7|||
130886570|NCT03486834|471217355|FG002|Overall Study|Adverse Event|0|||
130886571|NCT03486834|471217353|FG000|Overall Study|Lost to Follow-up|41|||
130886572|NCT03486834|471217354|FG001|Overall Study|Lost to Follow-up|24|||
130886573|NCT03486834|471217355|FG002|Overall Study|Lost to Follow-up|39|||
131017669|NCT04668339|471695877|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
131017670|NCT04668339|471695878|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
130766324|NCT00232596|470768250|FG001|6-Week Titration Phase|Failed to Return|1|||
130766325|NCT00232596|470768249|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
131017671|NCT04668339|471695875|FG000|Overall Study|Vaccine not Administered|0|||
131017672|NCT04668339|471695876|FG001|Overall Study|Vaccine not Administered|0|||
131017673|NCT04668339|471695877|FG002|Overall Study|Vaccine not Administered|1|||
131017674|NCT04668339|471695878|FG003|Overall Study|Vaccine not Administered|0|||
131017675|NCT04668339|471695875|FG000|Overall Study|Protocol Violation|18|||
131017676|NCT04668339|471695876|FG001|Overall Study|Protocol Violation|23|||
131017677|NCT04668339|471695877|FG002|Overall Study|Protocol Violation|12|||
130766326|NCT00232596|470768250|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
130766327|NCT00232596|470768249|FG000|6-Week Titration Phase|Protocol Violation|1|||
131103883|NCT02874924|472010393|FG000|Overall Study|Adverse Event|2|||
131103884|NCT02874924|472010394|FG001|Overall Study|Adverse Event|0|||
131103885|NCT02874924|472010395|FG002|Overall Study|Adverse Event|0|||
131103886|NCT02874924|472010393|FG000|Overall Study|Withdrawal by Subject|1|||
131103887|NCT02874924|472010394|FG001|Overall Study|Withdrawal by Subject|0|||
131103888|NCT02874924|472010395|FG002|Overall Study|Withdrawal by Subject|0|||
131103889|NCT02029846|472010398|FG000|Overall Study|n=1 each arm|1|||
131103890|NCT02029846|472010399|FG001|Overall Study|n=1 each arm|1|||
131103891|NCT00642772|472010403|FG000|Overall Study|Lost to Follow-up|3|||
131103892|NCT00642772|472010403|FG000|Overall Study|Withdrawal by Subject|7|||
131103893|NCT00903006|472010404|FG000|Overall Study|Withdrawal by Subject|2|||
131103894|NCT00903006|472010405|FG001|Overall Study|Withdrawal by Subject|0|||
131103895|NCT00903006|472010406|FG002|Overall Study|Withdrawal by Subject|0|||
131103896|NCT00903006|472010407|FG003|Overall Study|Withdrawal by Subject|0|||
131103897|NCT00903006|472010404|FG000|Overall Study|Progressive Disease|0|||
131103898|NCT00903006|472010405|FG001|Overall Study|Progressive Disease|3|||
131103899|NCT00903006|472010406|FG002|Overall Study|Progressive Disease|1|||
131103900|NCT00903006|472010407|FG003|Overall Study|Progressive Disease|0|||
131103901|NCT04275089|472010408|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
131103902|NCT03038438|472010411|FG000|Overall Study|Death|3|||
131103903|NCT03038438|472010411|FG000|Overall Study|Lost to Follow-up|8|||
131103904|NCT03038438|472010411|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
131103905|NCT03038438|472010411|FG000|Overall Study|Withdrawal by Subject|5|||
130682522|NCT04206332|470465915|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682523|NCT04206332|470465916|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682524|NCT04206332|470465917|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
131103906|NCT03038438|472010411|FG000|Overall Study|No 36-Month Follow-Up|18|||
131103907|NCT03625895|472010412|FG000|Overall Study|Protocol Violation|585|||
131103908|NCT00577473|472010415|FG000|Overall Study|Protocol Violation|1|||
131103909|NCT00577473|472010416|FG001|Overall Study|Protocol Violation|4|||
131103910|NCT00577473|472010415|FG000|Overall Study|Adverse Event|8|||
131103911|NCT00577473|472010416|FG001|Overall Study|Adverse Event|5|||
131103912|NCT00577473|472010415|FG000|Overall Study|Withdrawal by Subject|2|||
131103913|NCT00577473|472010416|FG001|Overall Study|Withdrawal by Subject|6|||
131103914|NCT00577473|472010415|FG000|Overall Study|Physician Decision|2|||
131103915|NCT00577473|472010416|FG001|Overall Study|Physician Decision|2|||
131103916|NCT00577473|472010415|FG000|Overall Study|Lack of Efficacy|8|||
131103917|NCT00577473|472010416|FG001|Overall Study|Lack of Efficacy|7|||
131103918|NCT02884908|472010419|FG000|Overall Study|Lost to Follow-up|13|||
131103919|NCT02884908|472010420|FG001|Overall Study|Lost to Follow-up|18|||
131103920|NCT02084056|472010426|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
131103921|NCT02084056|472010427|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131103922|NCT02084056|472010428|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131103923|NCT02084056|472010429|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131103924|NCT02084056|472010426|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
131103925|NCT02084056|472010427|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131103926|NCT02084056|472010428|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131103927|NCT02084056|472010429|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
131103928|NCT00232544|472010431|FG000|Overall Study|Lost to Follow-up|20|||
131103929|NCT00232544|472010432|FG001|Overall Study|Lost to Follow-up|15|||
131103930|NCT00986973|472010436|FG000|Overall Study|Withdrawn by study team|1|||
131103931|NCT02413333|472010437|FG000|Period 1|Adverse Event|1|||
131103932|NCT02413333|472010438|FG001|Period 1|Adverse Event|0|||
131103933|NCT02413333|472010437|FG000|Period 1|Reason Not Specified|0|||
131103934|NCT02413333|472010438|FG001|Period 1|Reason Not Specified|1|||
130682525|NCT04206332|470465918|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682526|NCT04206332|470465919|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682527|NCT04206332|470465920|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130682528|NCT04206332|470465904|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682529|NCT04206332|470465905|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
131103935|NCT02413333|472010437|FG000|Period 2|Protocol Deviation|1|||
131103936|NCT02413333|472010438|FG001|Period 2|Protocol Deviation|0|||
131103937|NCT01465347|472010439|FG000|Overall Study|Withdrawal by Subject|1|||
131103938|NCT01465347|472010440|FG001|Overall Study|Withdrawal by Subject|1|||
131103939|NCT01465347|472010439|FG000|Overall Study|Physician Decision|0|||
131103940|NCT01465347|472010440|FG001|Overall Study|Physician Decision|1|||
130682530|NCT04206332|470465906|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130886574|NCT03486834|471217353|FG000|Overall Study|Non-compliance with Study Drug|2|||
131103941|NCT01465347|472010439|FG000|Overall Study|Admitted to hospice|0|||
131103942|NCT01465347|472010440|FG001|Overall Study|Admitted to hospice|1|||
131103943|NCT01590082|472010441|FG000|Overall Study|Withdrawal by Subject|1|||
131103944|NCT01590082|472010442|FG001|Overall Study|Withdrawal by Subject|0|||
131103945|NCT01590082|472010441|FG000|Overall Study|Ineligible|1|||
130682531|NCT04206332|470465907|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682532|NCT04206332|470465908|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682533|NCT04206332|470465909|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682534|NCT04206332|470465910|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682535|NCT04206332|470465911|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
130682536|NCT04206332|470465912|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682537|NCT04206332|470465913|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682538|NCT04206332|470465914|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
130682539|NCT04206332|470465915|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682540|NCT04206332|470465916|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682541|NCT04206332|470465917|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682542|NCT04206332|470465918|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682543|NCT04206332|470465919|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682544|NCT04206332|470465920|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682545|NCT04206332|470465904|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682546|NCT04206332|470465905|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682547|NCT04206332|470465906|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682548|NCT04206332|470465907|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682549|NCT04206332|470465908|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682550|NCT04206332|470465909|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682551|NCT04206332|470465910|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682552|NCT04206332|470465911|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682553|NCT04206332|470465912|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682554|NCT04206332|470465913|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682555|NCT04206332|470465914|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682556|NCT04206332|470465915|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682557|NCT04206332|470465916|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682558|NCT04206332|470465917|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682559|NCT04206332|470465918|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682560|NCT04206332|470465919|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130682561|NCT04206332|470465920|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
130682562|NCT04206332|470465904|FG000|Part C|Withdrawal by Subject|0|||
130682563|NCT04206332|470465905|FG001|Part C|Withdrawal by Subject|0|||
130682564|NCT04206332|470465906|FG002|Part C|Withdrawal by Subject|0|||
130682565|NCT04206332|470465907|FG003|Part C|Withdrawal by Subject|0|||
130682566|NCT04206332|470465908|FG004|Part C|Withdrawal by Subject|0|||
130682567|NCT04206332|470465909|FG005|Part C|Withdrawal by Subject|0|||
130682568|NCT04206332|470465910|FG006|Part C|Withdrawal by Subject|0|||
130682569|NCT04206332|470465911|FG007|Part C|Withdrawal by Subject|0|||
130682570|NCT04206332|470465912|FG008|Part C|Withdrawal by Subject|0|||
130682571|NCT04206332|470465913|FG009|Part C|Withdrawal by Subject|0|||
130682572|NCT04206332|470465914|FG010|Part C|Withdrawal by Subject|0|||
130682573|NCT04206332|470465915|FG011|Part C|Withdrawal by Subject|0|||
130682574|NCT04206332|470465916|FG012|Part C|Withdrawal by Subject|0|||
130682575|NCT04206332|470465917|FG013|Part C|Withdrawal by Subject|0|||
130682576|NCT04206332|470465918|FG014|Part C|Withdrawal by Subject|2|||
130682577|NCT04206332|470465919|FG015|Part C|Withdrawal by Subject|0|||
130682578|NCT04206332|470465920|FG016|Part C|Withdrawal by Subject|0|||
130682579|NCT01038856|470465928|FG000|Overall Study|Adverse Event|2|||
130682580|NCT02087904|470465929|FG000|Overall Study|Did Not Receive Study Drug|0|||
130682581|NCT02087904|470465930|FG001|Overall Study|Did Not Receive Study Drug|0|||
130682582|NCT02087904|470465931|FG002|Overall Study|Did Not Receive Study Drug|2|||
130682583|NCT02087904|470465932|FG003|Overall Study|Did Not Receive Study Drug|1|||
130682584|NCT02087904|470465929|FG000|Overall Study|Adverse Event|8|||
130682585|NCT02087904|470465930|FG001|Overall Study|Adverse Event|4|||
130682586|NCT02087904|470465931|FG002|Overall Study|Adverse Event|4|||
130682587|NCT02087904|470465932|FG003|Overall Study|Adverse Event|12|||
130682588|NCT02087904|470465929|FG000|Overall Study|Lack of Efficacy|3|||
130682589|NCT02087904|470465930|FG001|Overall Study|Lack of Efficacy|6|||
130682590|NCT02087904|470465931|FG002|Overall Study|Lack of Efficacy|3|||
130682591|NCT02087904|470465932|FG003|Overall Study|Lack of Efficacy|2|||
130682592|NCT02087904|470465929|FG000|Overall Study|Other|6|||
130682593|NCT02087904|470465930|FG001|Overall Study|Other|2|||
130682594|NCT02087904|470465931|FG002|Overall Study|Other|4|||
130682595|NCT02087904|470465932|FG003|Overall Study|Other|4|||
130682596|NCT02087904|470465929|FG000|Overall Study|Withdrawal by Subject|8|||
130682597|NCT02087904|470465930|FG001|Overall Study|Withdrawal by Subject|3|||
130682598|NCT02087904|470465931|FG002|Overall Study|Withdrawal by Subject|7|||
130682599|NCT02087904|470465932|FG003|Overall Study|Withdrawal by Subject|4|||
130682600|NCT02087904|470465929|FG000|Overall Study|Lost to Follow-up|0|||
130682601|NCT02087904|470465930|FG001|Overall Study|Lost to Follow-up|4|||
130682602|NCT02087904|470465931|FG002|Overall Study|Lost to Follow-up|2|||
130682603|NCT02087904|470465932|FG003|Overall Study|Lost to Follow-up|2|||
130682604|NCT02910037|470465933|FG000|Overall Study|Withdrawal by Subject|4|||
130682605|NCT02910037|470465933|FG000|Overall Study|Lost to Follow-up|6|||
130682606|NCT01126736|470465941|FG000|Overall Study|Death|2|||
130682607|NCT01126736|470465942|FG001|Overall Study|Death|2|||
130682608|NCT01126736|470465943|FG002|Overall Study|Death|1|||
130682609|NCT01126736|470465944|FG003|Overall Study|Death|19|||
130682610|NCT01126736|470465945|FG004|Overall Study|Death|19|||
130682611|NCT01126736|470465941|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
130682612|NCT01126736|470465942|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
130682613|NCT01126736|470465943|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
130682614|NCT01126736|470465944|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
130682615|NCT01126736|470465945|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
130682616|NCT01126736|470465941|FG000|Overall Study|Lost to Follow-up|0|||
130682617|NCT01126736|470465942|FG001|Overall Study|Lost to Follow-up|0|||
130682618|NCT01126736|470465943|FG002|Overall Study|Lost to Follow-up|0|||
130682619|NCT01126736|470465944|FG003|Overall Study|Lost to Follow-up|1|||
130682620|NCT01126736|470465945|FG004|Overall Study|Lost to Follow-up|1|||
130682621|NCT01126736|470465941|FG000|Overall Study|Administrative reasons|0|||
130682622|NCT01126736|470465942|FG001|Overall Study|Administrative reasons|0|||
130682623|NCT01126736|470465943|FG002|Overall Study|Administrative reasons|0|||
130682624|NCT01126736|470465944|FG003|Overall Study|Administrative reasons|0|||
130682625|NCT01126736|470465945|FG004|Overall Study|Administrative reasons|1|||
130682626|NCT01126736|470465941|FG000|Overall Study|Progressive disease|0|||
130682627|NCT01126736|470465942|FG001|Overall Study|Progressive disease|0|||
130682628|NCT01126736|470465943|FG002|Overall Study|Progressive disease|0|||
130682629|NCT01126736|470465944|FG003|Overall Study|Progressive disease|2|||
130682630|NCT01126736|470465945|FG004|Overall Study|Progressive disease|1|||
130682631|NCT01126736|470465941|FG000|Overall Study|Withdrawal by Subject|0|||
130682632|NCT01126736|470465942|FG001|Overall Study|Withdrawal by Subject|0|||
130682633|NCT01126736|470465943|FG002|Overall Study|Withdrawal by Subject|0|||
130682634|NCT01126736|470465944|FG003|Overall Study|Withdrawal by Subject|1|||
130682635|NCT01126736|470465945|FG004|Overall Study|Withdrawal by Subject|1|||
130682636|NCT01126736|470465941|FG000|Overall Study|Other|2|||
130766328|NCT00232596|470768250|FG001|6-Week Titration Phase|Protocol Violation|3|||
130766329|NCT00232596|470768249|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
130766330|NCT00232596|470768250|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
130766331|NCT00232596|470768249|FG000|6-Week Titration Phase|Other|3|||
130766332|NCT00232596|470768250|FG001|6-Week Titration Phase|Other|3|||
130766333|NCT00232596|470768249|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
130766334|NCT00232596|470768250|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
130766335|NCT00232596|470768249|FG000|12-Week Maintenance Phase|Adverse Event|7|||
130766336|NCT00232596|470768250|FG001|12-Week Maintenance Phase|Adverse Event|22|||
130766337|NCT00232596|470768249|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
130766338|NCT00232596|470768250|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
130766339|NCT00232596|470768249|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
130766340|NCT00232596|470768250|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
130766341|NCT00232596|470768249|FG000|12-Week Maintenance Phase|Other|1|||
130766342|NCT00232596|470768250|FG001|12-Week Maintenance Phase|Other|3|||
130766343|NCT03426436|470768253|FG000|Overall Study|Incorrect lead placement|12|||
130766344|NCT03426436|470768253|FG000|Overall Study|Withdrawal by Subject|2|||
130766345|NCT03426436|470768253|FG000|Overall Study|Consent issue|1|||
130766346|NCT03426436|470768253|FG000|Overall Study|ECGs not saved|4|||
130766347|NCT00932698|470768254|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
130766348|NCT00932698|470768255|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
130766349|NCT00932698|470768256|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
130766350|NCT00932698|470768257|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
130766351|NCT00932698|470768258|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
130766352|NCT00932698|470768259|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
130766353|NCT00932698|470768260|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
130766354|NCT00932698|470768261|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
130766355|NCT00932698|470768262|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
130682637|NCT01126736|470465942|FG001|Overall Study|Other|4|||
130682638|NCT01126736|470465943|FG002|Overall Study|Other|4|||
130682639|NCT01126736|470465944|FG003|Overall Study|Other|16|||
130682640|NCT01126736|470465945|FG004|Overall Study|Other|15|||
130682641|NCT02015390|470465946|FG000|Overall Study|Lost to Follow-up|1|||
130682642|NCT02015390|470465947|FG001|Overall Study|Lost to Follow-up|0|||
130682643|NCT02015390|470465946|FG000|Overall Study|Adverse Event|0|||
130682644|NCT02015390|470465947|FG001|Overall Study|Adverse Event|3|||
130682645|NCT02015390|470465946|FG000|Overall Study|Physician Decision|0|||
130682646|NCT02015390|470465947|FG001|Overall Study|Physician Decision|1|||
130682647|NCT02193880|470465948|FG000|Overall Study|patients did not collect enough HPC|3|||
130682648|NCT03136380|470465949|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130682649|NCT03136380|470465950|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
130682650|NCT03136380|470465951|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130682651|NCT03136380|470465952|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130682652|NCT03136380|470465953|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130682653|NCT01661686|470465957|FG000|Overall Study|Lost to Follow-up|2|||
130682654|NCT01661686|470465958|FG001|Overall Study|Lost to Follow-up|1|||
130682655|NCT01661686|470465957|FG000|Overall Study|did not receive allocated intervention|0|||
130682656|NCT01661686|470465958|FG001|Overall Study|did not receive allocated intervention|1|||
130682657|NCT02419937|470465962|FG000|Overall Study|Lost to Follow-up|1|||
130682658|NCT02419937|470465963|FG001|Overall Study|Lost to Follow-up|0|||
130682659|NCT00553280|470465964|FG000|Overall Study|Adverse Event|19|||
130682660|NCT00553280|470465964|FG000|Overall Study|Lack of Efficacy|3|||
130682661|NCT00553280|470465964|FG000|Overall Study|Withdrawal by Subject|3|||
131103946|NCT01590082|472010442|FG001|Overall Study|Ineligible|0|||
131103947|NCT02414932|472010443|FG000|Overall Study|Withdrawal by Subject|2|||
131103948|NCT02414932|472010444|FG001|Overall Study|Withdrawal by Subject|3|||
131103949|NCT02414932|472010443|FG000|Overall Study|Adverse Event|1|||
131103950|NCT02414932|472010444|FG001|Overall Study|Adverse Event|0|||
131103951|NCT01210664|472010446|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
130682662|NCT00553280|470465964|FG000|Overall Study|Physician Decision|1|||
130682663|NCT01544127|470465965|FG000|Overall Study|Lost to Follow-up|4|||
130682664|NCT01544127|470465966|FG001|Overall Study|Lost to Follow-up|2|||
130682665|NCT01544127|470465967|FG002|Overall Study|Lost to Follow-up|9|||
130682666|NCT01544127|470465965|FG000|Overall Study|Withdrawal by Subject|2|||
130682667|NCT01544127|470465966|FG001|Overall Study|Withdrawal by Subject|2|||
130682668|NCT01544127|470465967|FG002|Overall Study|Withdrawal by Subject|1|||
130682669|NCT01544127|470465965|FG000|Overall Study|Discharged out of catchment area|1|||
130682670|NCT01544127|470465966|FG001|Overall Study|Discharged out of catchment area|1|||
130682671|NCT01544127|470465967|FG002|Overall Study|Discharged out of catchment area|1|||
130682672|NCT01544127|470465965|FG000|Overall Study|Death|1|||
130682673|NCT01544127|470465966|FG001|Overall Study|Death|0|||
130682674|NCT01544127|470465967|FG002|Overall Study|Death|0|||
130682675|NCT01544127|470465965|FG000|Overall Study|Jail or Prison|1|||
130682676|NCT01544127|470465966|FG001|Overall Study|Jail or Prison|1|||
130682677|NCT01544127|470465967|FG002|Overall Study|Jail or Prison|2|||
130682678|NCT01544127|470465965|FG000|Overall Study|Became Psychotic|1|||
130682679|NCT01544127|470465966|FG001|Overall Study|Became Psychotic|0|||
130682680|NCT01544127|470465967|FG002|Overall Study|Became Psychotic|0|||
130682681|NCT01544127|470465965|FG000|Overall Study|Researcher withdrew|1|||
130682682|NCT01544127|470465966|FG001|Overall Study|Researcher withdrew|0|||
130682683|NCT01544127|470465967|FG002|Overall Study|Researcher withdrew|0|||
130682684|NCT01544127|470465965|FG000|Overall Study|Went active duty|0|||
130682685|NCT01544127|470465966|FG001|Overall Study|Went active duty|0|||
130682686|NCT01544127|470465967|FG002|Overall Study|Went active duty|1|||
130682687|NCT02794974|470465968|FG000|Overall Study|Physician Decision|0|||
130682688|NCT02794974|470465969|FG001|Overall Study|Physician Decision|1|||
130682689|NCT00533273|470465970|FG000|Double-blind|Withdrew consent|0|||
130682690|NCT00533273|470465971|FG001|Double-blind|Withdrew consent|2|||
130682691|NCT00533273|470465970|FG000|Open-label|Withdrawal by Subject|6|||
130682692|NCT00533273|470465971|FG001|Open-label|Withdrawal by Subject|0|||
130682693|NCT02202850|470465975|FG000|Overall Study|Other|2|||
130682694|NCT02202850|470465976|FG001|Overall Study|Other|2|||
130682695|NCT02202850|470465975|FG000|Overall Study|Enbrel treatment discontinued|15|||
130682696|NCT02202850|470465976|FG001|Overall Study|Enbrel treatment discontinued|3|||
130682697|NCT02202850|470465975|FG000|Overall Study|Lost to Follow-up|7|||
130682698|NCT02202850|470465976|FG001|Overall Study|Lost to Follow-up|1|||
130682699|NCT01873586|470465977|FG000|Overall Study|Lost to Follow-up|3|||
130682700|NCT00454909|470465978|FG000|Overall Study|Withdrawal by Subject|1|||
131103952|NCT01210664|472010447|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
130682701|NCT00454909|470465979|FG001|Overall Study|Withdrawal by Subject|0|||
130682702|NCT00454909|470465980|FG002|Overall Study|Withdrawal by Subject|0|||
130682703|NCT00454909|470465978|FG000|Overall Study|Migrated/moved from study area|0|||
130682704|NCT00454909|470465979|FG001|Overall Study|Migrated/moved from study area|0|||
130682705|NCT00454909|470465980|FG002|Overall Study|Migrated/moved from study area|1|||
130886575|NCT03486834|471217354|FG001|Overall Study|Non-compliance with Study Drug|2|||
130682706|NCT00454909|470465978|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
130682707|NCT00454909|470465979|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
131103953|NCT01210664|472010448|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
130682708|NCT00454909|470465980|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
130682709|NCT00454909|470465978|FG000|Overall Study|Others|1|||
130682710|NCT00454909|470465979|FG001|Overall Study|Others|0|||
130682711|NCT00454909|470465980|FG002|Overall Study|Others|0|||
130682712|NCT02996682|470465981|FG000|Overall Study|Death|0|||
130682713|NCT02996682|470465982|FG001|Overall Study|Death|3|||
130682714|NCT02457520|470465983|FG000|Active Treatment Phase|Adverse Event|10|||
130682715|NCT02457520|470465983|FG000|Active Treatment Phase|Lost to Follow-up|8|||
130682716|NCT02457520|470465983|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
130682717|NCT02457520|470465983|FG000|Active Treatment Phase|other|4|||
130682718|NCT02457520|470465983|FG000|Active Treatment Phase|Physician Decision|1|||
130682719|NCT02457520|470465983|FG000|Active Treatment Phase|Protocol Violation|1|||
130682720|NCT02457520|470465983|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
130682721|NCT02457520|470465983|FG000|Post-treatment Period|Other: Retreatment Required|7|||
130682722|NCT02457520|470465983|FG000|Post-treatment Period|Lost to Follow-up|23|||
130682723|NCT02457520|470465983|FG000|Post-treatment Period|Other|3|||
130682724|NCT02457520|470465983|FG000|Post-treatment Period|Physician Decision|1|||
130682725|NCT02457520|470465983|FG000|Post-treatment Period|Withdrawal by Subject|14|||
130682726|NCT02107092|470465984|FG000|Overall Study|Miscellaneous|3|||
130682727|NCT02107092|470465984|FG000|Overall Study|Subject compliance|3|||
130682728|NCT02107092|470465984|FG000|Overall Study|Hypo-or hyperkalemia|2|||
130682729|NCT02107092|470465984|FG000|Overall Study|Met ECG withdrawal criteria|3|||
130682730|NCT02107092|470465984|FG000|Overall Study|Physician Decision|3|||
130682731|NCT02107092|470465984|FG000|Overall Study|Lost to Follow-up|2|||
130682732|NCT02107092|470465984|FG000|Overall Study|Withdrawal by Subject|9|||
130682733|NCT02107092|470465984|FG000|Overall Study|Adverse Event|7|||
130682734|NCT02107092|470465984|FG000|Overall Study|Expected progression of CKD|12|||
130682735|NCT00282048|470465985|FG000|Overall Study|Lack of Efficacy|30|||
130682736|NCT00282048|470465985|FG000|Overall Study|Adverse Event|22|||
130682737|NCT00282048|470465985|FG000|Overall Study|Withdrawal by Subject|1|||
130682738|NCT00282048|470465985|FG000|Overall Study|Other|8|||
130766356|NCT00932698|470768263|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
130766357|NCT00932698|470768264|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
130766358|NCT00932698|470768254|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130766359|NCT00932698|470768255|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130766360|NCT00932698|470768256|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130766361|NCT00932698|470768257|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130766362|NCT00932698|470768258|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130766363|NCT00932698|470768259|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130766364|NCT00932698|470768260|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130766365|NCT00932698|470768261|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130766366|NCT00932698|470768262|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130766367|NCT00932698|470768263|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130766368|NCT00932698|470768264|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130766369|NCT00932698|470768254|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
130766370|NCT00932698|470768255|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
130766371|NCT00932698|470768256|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
130766372|NCT00932698|470768257|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
130766373|NCT00932698|470768258|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
130766374|NCT00932698|470768259|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
130766375|NCT00932698|470768260|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
130766376|NCT00932698|470768261|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
130766377|NCT00932698|470768262|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
130766378|NCT00932698|470768263|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
130766379|NCT00932698|470768264|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
130766380|NCT00932698|470768254|FG000|Part 1 (Dose Escalation)|Other|0|||
130766381|NCT00932698|470768255|FG001|Part 1 (Dose Escalation)|Other|0|||
130766382|NCT00932698|470768256|FG002|Part 1 (Dose Escalation)|Other|1|||
130766383|NCT00932698|470768257|FG003|Part 1 (Dose Escalation)|Other|0|||
130766384|NCT00932698|470768258|FG004|Part 1 (Dose Escalation)|Other|0|||
130766385|NCT00932698|470768259|FG005|Part 1 (Dose Escalation)|Other|0|||
130766386|NCT00932698|470768260|FG006|Part 1 (Dose Escalation)|Other|1|||
130766387|NCT00932698|470768261|FG007|Part 1 (Dose Escalation)|Other|0|||
130766388|NCT00932698|470768262|FG008|Part 1 (Dose Escalation)|Other|0|||
130766389|NCT00932698|470768263|FG009|Part 1 (Dose Escalation)|Other|0|||
130766390|NCT00932698|470768264|FG010|Part 1 (Dose Escalation)|Other|0|||
130766391|NCT00932698|470768254|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
130682739|NCT00282048|470465985|FG000|Overall Study|Ongoing|1|||
130682740|NCT00624065|470465987|FG000|Overall Study|Adverse Event|5|||
130682741|NCT00624065|470465988|FG001|Overall Study|Adverse Event|6|||
130682742|NCT00624065|470465987|FG000|Overall Study|Lost to Follow-up|4|||
130682743|NCT00624065|470465988|FG001|Overall Study|Lost to Follow-up|1|||
130682744|NCT00624065|470465987|FG000|Overall Study|Consent withdrawn|6|||
130766392|NCT00932698|470768255|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
130766393|NCT00932698|470768256|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
131222606|NCT01902134|472443114|FG001|Overall Study|no compliance|0|||
131222607|NCT01902134|472443115|FG002|Overall Study|no compliance|0|||
130682745|NCT00624065|470465988|FG001|Overall Study|Consent withdrawn|5|||
130682746|NCT00624065|470465987|FG000|Overall Study|Lack of Efficacy|0|||
130766394|NCT00932698|470768257|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
130766395|NCT00932698|470768258|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
130766396|NCT00932698|470768259|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
130766397|NCT00932698|470768260|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
130766398|NCT00932698|470768261|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
130766399|NCT00932698|470768262|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
130766400|NCT00932698|470768263|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
130766401|NCT00932698|470768264|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
130682747|NCT00624065|470465988|FG001|Overall Study|Lack of Efficacy|3|||
131017678|NCT04668339|471695878|FG003|Overall Study|Protocol Violation|20|||
131017679|NCT04668339|471695875|FG000|Overall Study|Withdrawal by Subject|45|||
131017680|NCT04668339|471695876|FG001|Overall Study|Withdrawal by Subject|46|||
131017681|NCT04668339|471695877|FG002|Overall Study|Withdrawal by Subject|46|||
131017682|NCT04668339|471695878|FG003|Overall Study|Withdrawal by Subject|27|||
131017683|NCT04668339|471695875|FG000|Overall Study|Study Terminated by Sponsor|59|||
131017684|NCT04668339|471695876|FG001|Overall Study|Study Terminated by Sponsor|59|||
131017685|NCT04668339|471695877|FG002|Overall Study|Study Terminated by Sponsor|71|||
131017686|NCT04668339|471695878|FG003|Overall Study|Study Terminated by Sponsor|1|||
131017687|NCT03622593|471695879|FG000|Overall Study|Withdrawal by Subject|11|||
131017688|NCT03622593|471695880|FG001|Overall Study|Withdrawal by Subject|9|||
131017689|NCT03622593|471695881|FG002|Overall Study|Withdrawal by Subject|13|||
131017690|NCT03622593|471695879|FG000|Overall Study|Death|12|||
131017691|NCT03622593|471695880|FG001|Overall Study|Death|9|||
131017692|NCT03622593|471695881|FG002|Overall Study|Death|10|||
131017693|NCT03622593|471695879|FG000|Overall Study|Lost to Follow-up|11|||
131017694|NCT03622593|471695880|FG001|Overall Study|Lost to Follow-up|5|||
131017695|NCT03622593|471695881|FG002|Overall Study|Lost to Follow-up|8|||
131017696|NCT03622593|471695879|FG000|Overall Study|Adverse Event|4|||
131017697|NCT03622593|471695880|FG001|Overall Study|Adverse Event|5|||
131017698|NCT03622593|471695881|FG002|Overall Study|Adverse Event|6|||
131017699|NCT03622593|471695879|FG000|Overall Study|Physician Decision|2|||
131017700|NCT03622593|471695880|FG001|Overall Study|Physician Decision|1|||
131017701|NCT03622593|471695881|FG002|Overall Study|Physician Decision|6|||
131017702|NCT03622593|471695879|FG000|Overall Study|Other|2|||
131017703|NCT03622593|471695880|FG001|Overall Study|Other|2|||
131017704|NCT03622593|471695881|FG002|Overall Study|Other|3|||
131017705|NCT03622593|471695879|FG000|Overall Study|Protocol Violation|0|||
131017706|NCT03622593|471695880|FG001|Overall Study|Protocol Violation|0|||
131017707|NCT03622593|471695881|FG002|Overall Study|Protocol Violation|1|||
131017708|NCT03622593|471695879|FG000|Overall Study|Pregnancy|0|||
131017709|NCT03622593|471695880|FG001|Overall Study|Pregnancy|0|||
131017710|NCT03622593|471695881|FG002|Overall Study|Pregnancy|1|||
131017711|NCT03762668|471695882|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
131017712|NCT03762668|471695883|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
131017713|NCT01393119|471695884|FG000|Overall Study|Adverse Event|1|||
131017714|NCT01393119|471695885|FG001|Overall Study|Adverse Event|1|||
131017715|NCT01393119|471695886|FG002|Overall Study|Adverse Event|0|||
131017716|NCT01393119|471695887|FG003|Overall Study|Adverse Event|1|||
131017717|NCT01393119|471695884|FG000|Overall Study|Withdrawal by Subject|0|||
131017718|NCT01393119|471695885|FG001|Overall Study|Withdrawal by Subject|1|||
131017719|NCT01393119|471695886|FG002|Overall Study|Withdrawal by Subject|1|||
131017720|NCT01393119|471695887|FG003|Overall Study|Withdrawal by Subject|0|||
131017721|NCT01393119|471695884|FG000|Overall Study|Lack of Efficacy|1|||
131017722|NCT01393119|471695885|FG001|Overall Study|Lack of Efficacy|0|||
131017723|NCT01393119|471695886|FG002|Overall Study|Lack of Efficacy|2|||
131017724|NCT01393119|471695887|FG003|Overall Study|Lack of Efficacy|1|||
131017725|NCT01393119|471695884|FG000|Overall Study|Protocol Violation|0|||
131017726|NCT01393119|471695885|FG001|Overall Study|Protocol Violation|0|||
131017727|NCT01393119|471695886|FG002|Overall Study|Protocol Violation|1|||
131017728|NCT01393119|471695887|FG003|Overall Study|Protocol Violation|0|||
131017729|NCT01393119|471695884|FG000|Overall Study|Death|0|||
131017730|NCT01393119|471695885|FG001|Overall Study|Death|0|||
131017731|NCT01393119|471695886|FG002|Overall Study|Death|0|||
131017732|NCT01393119|471695887|FG003|Overall Study|Death|1|||
131017733|NCT01393119|471695884|FG000|Overall Study|Randomized but Not treated|1|||
131017734|NCT01393119|471695885|FG001|Overall Study|Randomized but Not treated|0|||
131017735|NCT01393119|471695886|FG002|Overall Study|Randomized but Not treated|1|||
131017736|NCT01393119|471695887|FG003|Overall Study|Randomized but Not treated|1|||
131017737|NCT01393119|471695884|FG000|Overall Study|Sponsor Termination of Study|11|||
131017738|NCT01393119|471695885|FG001|Overall Study|Sponsor Termination of Study|12|||
131017739|NCT01393119|471695886|FG002|Overall Study|Sponsor Termination of Study|9|||
131017740|NCT01393119|471695887|FG003|Overall Study|Sponsor Termination of Study|12|||
131103954|NCT01210664|472010449|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
131103955|NCT01210664|472010446|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
131103956|NCT01210664|472010447|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
131103957|NCT01210664|472010448|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
131103958|NCT01210664|472010449|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
131103959|NCT01210664|472010446|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
131103960|NCT01210664|472010447|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
131103961|NCT01210664|472010448|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
131103962|NCT01210664|472010449|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
131103963|NCT01853644|472010450|FG000|Registration and Treatment Start|Did not start treatment|1|||
131103964|NCT01853644|472010450|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
131103965|NCT01853644|472010450|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
131103966|NCT01853644|472010450|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
131103967|NCT01853644|472010450|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
131103968|NCT01853644|472010450|FG000|Continued Treatment After First Response|Adverse Event|2|||
131103969|NCT01853644|472010450|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
131103970|NCT02891408|472010451|FG000|Overall Study|Lost to Follow-up|0|||
131103971|NCT02891408|472010452|FG001|Overall Study|Lost to Follow-up|0|||
131103972|NCT02891408|472010453|FG002|Overall Study|Lost to Follow-up|1|||
131103973|NCT02891408|472010454|FG003|Overall Study|Lost to Follow-up|0|||
131103974|NCT02891408|472010455|FG004|Overall Study|Lost to Follow-up|0|||
131103975|NCT02891408|472010456|FG005|Overall Study|Lost to Follow-up|0|||
131103976|NCT02891408|472010457|FG006|Overall Study|Lost to Follow-up|0|||
131103977|NCT01054170|472010458|FG000|Overall Study|Protocol Violation|1|||
131103978|NCT01054170|472010459|FG001|Overall Study|Protocol Violation|0|||
131103979|NCT01054170|472010458|FG000|Overall Study|Withdrawal by Subject|3|||
131103980|NCT01054170|472010459|FG001|Overall Study|Withdrawal by Subject|2|||
131103981|NCT01054170|472010458|FG000|Overall Study|Adverse Event|0|||
131103982|NCT01054170|472010459|FG001|Overall Study|Adverse Event|4|||
131103983|NCT02951767|472010460|FG000|Overall Study|Study Terminated By Sponsor|9|||
131103984|NCT02951767|472010460|FG000|Overall Study|Withdrawal by Subject|11|||
131103985|NCT02951767|472010460|FG000|Overall Study|Death|96|||
131103986|NCT02951767|472010460|FG000|Overall Study|Lost to Follow-up|2|||
131103987|NCT02951767|472010460|FG000|Overall Study|Physician Decision|1|||
131103988|NCT00709852|472010461|FG000|Period 1|Adverse Event|2|||
131103989|NCT00709852|472010462|FG001|Period 1|Adverse Event|0|||
131103990|NCT00709852|472010461|FG000|Period 1|Withdrawal by Subject|4|||
131103991|NCT00709852|472010462|FG001|Period 1|Withdrawal by Subject|2|||
131103992|NCT00709852|472010461|FG000|Period 1|Protocol Violation|1|||
131103993|NCT00709852|472010462|FG001|Period 1|Protocol Violation|0|||
131103994|NCT00709852|472010461|FG000|Period 1|Defective scanner|0|||
131103995|NCT00709852|472010462|FG001|Period 1|Defective scanner|1|||
131103996|NCT00709852|472010461|FG000|Period 1|Lost to Follow-up|1|||
131103997|NCT00709852|472010462|FG001|Period 1|Lost to Follow-up|0|||
131103998|NCT00709852|472010461|FG000|Period 2|Protocol Violation|4|||
131103999|NCT00709852|472010462|FG001|Period 2|Protocol Violation|1|||
131104000|NCT00709852|472010461|FG000|Period 2|Adverse Event|1|||
131104001|NCT00709852|472010462|FG001|Period 2|Adverse Event|1|||
131104002|NCT00709852|472010461|FG000|Period 2|Lost to Follow-up|1|||
131104003|NCT00709852|472010462|FG001|Period 2|Lost to Follow-up|0|||
131104004|NCT00709852|472010461|FG000|Period 2|No 72-hour follow-up|3|||
131104005|NCT00709852|472010462|FG001|Period 2|No 72-hour follow-up|0|||
131104006|NCT01442779|472010463|FG000|Overall Study|Withdrawal by Subject|3|||
131104007|NCT01442779|472010463|FG000|Overall Study|Death|3|||
131104008|NCT01442779|472010463|FG000|Overall Study|Non-compliance|1|||
131104009|NCT01048671|472010464|FG000|Overall Study|Protocol Violation|0|||
131104010|NCT01048671|472010465|FG001|Overall Study|Protocol Violation|1|||
131104011|NCT01048671|472010466|FG002|Overall Study|Protocol Violation|1|||
131104012|NCT05249829|472010467|FG000|Overall Study|Participant Relocation|0|||
131104013|NCT05249829|472010468|FG001|Overall Study|Participant Relocation|1|||
131104014|NCT05249829|472010469|FG002|Overall Study|Participant Relocation|2|||
131104015|NCT05249829|472010470|FG003|Overall Study|Participant Relocation|2|||
131104016|NCT05249829|472010467|FG000|Overall Study|Withdrawal by Subject|9|||
131104017|NCT05249829|472010468|FG001|Overall Study|Withdrawal by Subject|17|||
131104018|NCT05249829|472010469|FG002|Overall Study|Withdrawal by Subject|40|||
131104019|NCT05249829|472010470|FG003|Overall Study|Withdrawal by Subject|35|||
131104020|NCT05249829|472010467|FG000|Overall Study|Physician Decision|1|||
131104021|NCT05249829|472010468|FG001|Overall Study|Physician Decision|0|||
131104022|NCT05249829|472010469|FG002|Overall Study|Physician Decision|0|||
131104023|NCT05249829|472010470|FG003|Overall Study|Physician Decision|0|||
131104024|NCT05249829|472010467|FG000|Overall Study|Lost to Follow-up|16|||
131104025|NCT05249829|472010468|FG001|Overall Study|Lost to Follow-up|16|||
131104026|NCT05249829|472010469|FG002|Overall Study|Lost to Follow-up|57|||
131104027|NCT05249829|472010470|FG003|Overall Study|Lost to Follow-up|60|||
131104028|NCT05249829|472010467|FG000|Overall Study|Adverse Event|2|||
131104029|NCT05249829|472010468|FG001|Overall Study|Adverse Event|2|||
130682748|NCT00624065|470465987|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
130682749|NCT00624065|470465988|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
130766402|NCT00932698|470768254|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130766403|NCT00932698|470768255|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130766404|NCT00932698|470768256|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130766405|NCT00932698|470768257|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130766406|NCT00932698|470768258|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130766407|NCT00932698|470768259|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130766408|NCT00932698|470768260|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130766409|NCT00932698|470768261|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
130766410|NCT00932698|470768262|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
130766411|NCT00932698|470768263|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
130766412|NCT00932698|470768264|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130766413|NCT00932698|470768254|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
130766414|NCT00932698|470768255|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
130766415|NCT00932698|470768256|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
130766416|NCT00932698|470768257|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
130766417|NCT00932698|470768258|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
130766418|NCT00932698|470768259|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
130766419|NCT00932698|470768260|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
130766420|NCT00932698|470768261|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
130766421|NCT00932698|470768262|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
130766422|NCT00932698|470768263|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
130766423|NCT00932698|470768264|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
130766424|NCT00655681|470768265|FG000|Overall Study|Lost to Follow-up|1|||
130766425|NCT00655681|470768266|FG001|Overall Study|Lost to Follow-up|1|||
130766426|NCT05249127|470768267|FG000|Overall Study|Protocol Violation|13|||
130766427|NCT05249127|470768267|FG000|Overall Study|Physician Decision|4|||
130766428|NCT05249127|470768267|FG000|Overall Study|Withdrawal by Subject|2|||
130766429|NCT05249127|470768267|FG000|Overall Study|Participant Non-compliance|1|||
130766430|NCT02073565|470768269|FG000|Cohort A|Withdrawal by Subject|1|||
130766431|NCT02073565|470768270|FG001|Cohort A|Withdrawal by Subject|0|||
130766432|NCT02073565|470768269|FG000|Cohort B|Withdrawal by Subject|1|||
130766433|NCT02073565|470768270|FG001|Cohort B|Withdrawal by Subject|2|||
130766434|NCT02073565|470768269|FG000|Cohort C|Withdrawal by Subject|0|||
130766435|NCT02073565|470768270|FG001|Cohort C|Withdrawal by Subject|2|||
130766436|NCT02073565|470768269|FG000|Cohort C|Lost to Follow-up|0|||
130766437|NCT02073565|470768270|FG001|Cohort C|Lost to Follow-up|2|||
130766438|NCT02429310|470768271|FG000|Overall Study|Lost to Follow-up|1|||
130766439|NCT02429310|470768272|FG001|Overall Study|Lost to Follow-up|2|||
130766440|NCT02429310|470768271|FG000|Overall Study|Protocol Violation|1|||
130766441|NCT02429310|470768272|FG001|Overall Study|Protocol Violation|1|||
130766442|NCT00394433|470768273|FG000|Overall Study|Adverse Event|2|||
130766443|NCT00394433|470768273|FG000|Overall Study|Alternative Therapy|1|||
130766444|NCT01554176|470768274|FG000|Treatment Phase|Protocol Violation|1|||
130766445|NCT01554176|470768275|FG001|Treatment Phase|Protocol Violation|2|||
130766446|NCT01554176|470768276|FG002|Treatment Phase|Protocol Violation|0|||
130766447|NCT01554176|470768277|FG003|Treatment Phase|Protocol Violation|0|||
130766448|NCT01554176|470768278|FG004|Treatment Phase|Protocol Violation|0|||
130766449|NCT01554176|470768274|FG000|Treatment Phase|Physician Decision|1|||
130766450|NCT01554176|470768275|FG001|Treatment Phase|Physician Decision|1|||
130766451|NCT01554176|470768276|FG002|Treatment Phase|Physician Decision|0|||
130766452|NCT01554176|470768277|FG003|Treatment Phase|Physician Decision|0|||
130766453|NCT01554176|470768278|FG004|Treatment Phase|Physician Decision|0|||
130766454|NCT01554176|470768274|FG000|Treatment Phase|Lack of Efficacy|0|||
130766455|NCT01554176|470768275|FG001|Treatment Phase|Lack of Efficacy|1|||
130766456|NCT01554176|470768276|FG002|Treatment Phase|Lack of Efficacy|0|||
130766457|NCT01554176|470768277|FG003|Treatment Phase|Lack of Efficacy|0|||
130766458|NCT01554176|470768278|FG004|Treatment Phase|Lack of Efficacy|0|||
130766459|NCT01554176|470768274|FG000|Treatment Phase|Adverse event, non-fatal|1|||
130766460|NCT01554176|470768275|FG001|Treatment Phase|Adverse event, non-fatal|1|||
130766461|NCT01554176|470768276|FG002|Treatment Phase|Adverse event, non-fatal|0|||
130766462|NCT01554176|470768277|FG003|Treatment Phase|Adverse event, non-fatal|0|||
130682750|NCT00696020|470465989|FG000|Overall Study|Adverse Event|3|||
130682751|NCT00696020|470465990|FG001|Overall Study|Adverse Event|1|||
130682752|NCT00696020|470465991|FG002|Overall Study|Adverse Event|2|||
130766463|NCT01554176|470768278|FG004|Treatment Phase|Adverse event, non-fatal|0|||
130766464|NCT01554176|470768274|FG000|Treatment Phase|Non-compliance with study drug|1|||
130766465|NCT01554176|470768275|FG001|Treatment Phase|Non-compliance with study drug|0|||
130766466|NCT01554176|470768276|FG002|Treatment Phase|Non-compliance with study drug|0|||
130766467|NCT01554176|470768277|FG003|Treatment Phase|Non-compliance with study drug|0|||
130766468|NCT01554176|470768278|FG004|Treatment Phase|Non-compliance with study drug|0|||
130766469|NCT01554176|470768274|FG000|Treatment Phase|Withdrawal by Subject|1|||
130766470|NCT01554176|470768275|FG001|Treatment Phase|Withdrawal by Subject|0|||
130766471|NCT01554176|470768276|FG002|Treatment Phase|Withdrawal by Subject|0|||
130766472|NCT01554176|470768277|FG003|Treatment Phase|Withdrawal by Subject|0|||
131104030|NCT05249829|472010469|FG002|Overall Study|Adverse Event|2|||
131104031|NCT05249829|472010470|FG003|Overall Study|Adverse Event|2|||
131104032|NCT05249829|472010467|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
131104033|NCT05249829|472010468|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
131104034|NCT05249829|472010469|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
131104035|NCT05249829|472010470|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
131104036|NCT05249829|472010467|FG000|Overall Study|Protocol Violation|2|||
131104037|NCT05249829|472010468|FG001|Overall Study|Protocol Violation|0|||
131104038|NCT05249829|472010469|FG002|Overall Study|Protocol Violation|5|||
131104039|NCT05249829|472010470|FG003|Overall Study|Protocol Violation|3|||
131104040|NCT05249829|472010467|FG000|Overall Study|Death|0|||
131104041|NCT05249829|472010468|FG001|Overall Study|Death|1|||
131104042|NCT05249829|472010469|FG002|Overall Study|Death|2|||
131104043|NCT05249829|472010470|FG003|Overall Study|Death|4|||
131104044|NCT00513604|472010471|FG000|Overall Study|Not treated|2|||
131104045|NCT00513604|472010472|FG001|Overall Study|Not treated|0|||
131104046|NCT00513604|472010473|FG002|Overall Study|Not treated|1|||
131104047|NCT00513604|472010474|FG003|Overall Study|Not treated|0|||
131104048|NCT00513604|472010475|FG004|Overall Study|Not treated|0|||
131104049|NCT00513604|472010471|FG000|Overall Study|Death during treatment|0|||
131104050|NCT00513604|472010472|FG001|Overall Study|Death during treatment|3|||
131104051|NCT00513604|472010473|FG002|Overall Study|Death during treatment|2|||
131104052|NCT00513604|472010474|FG003|Overall Study|Death during treatment|0|||
131104053|NCT00513604|472010475|FG004|Overall Study|Death during treatment|0|||
131104054|NCT00196976|472010476|FG000|Primary Study|Migrated from study area|0|||
131104055|NCT00196976|472010477|FG001|Primary Study|Migrated from study area|0|||
131104056|NCT00196976|472010478|FG002|Primary Study|Migrated from study area|0|||
131104057|NCT00196976|472010479|FG003|Primary Study|Migrated from study area|0|||
131104058|NCT00196976|472010480|FG004|Primary Study|Migrated from study area|0|||
131104059|NCT00196976|472010481|FG005|Primary Study|Migrated from study area|0|||
131104060|NCT00196976|472010482|FG006|Primary Study|Migrated from study area|0|||
131104061|NCT00196976|472010483|FG007|Primary Study|Migrated from study area|1|||
131104062|NCT00196976|472010484|FG008|Primary Study|Migrated from study area|0|||
131104063|NCT00196976|472010485|FG009|Primary Study|Migrated from study area|0|||
131104064|NCT00196976|472010486|FG010|Primary Study|Migrated from study area|0|||
131104065|NCT00196976|472010487|FG011|Primary Study|Migrated from study area|0|||
131104066|NCT00196976|472010488|FG012|Primary Study|Migrated from study area|0|||
131104067|NCT00196976|472010489|FG013|Primary Study|Migrated from study area|0|||
131104068|NCT00196976|472010476|FG000|Primary Study|Protocol Violation|0|||
131104069|NCT00196976|472010477|FG001|Primary Study|Protocol Violation|1|||
131104070|NCT00196976|472010478|FG002|Primary Study|Protocol Violation|1|||
131104071|NCT00196976|472010479|FG003|Primary Study|Protocol Violation|0|||
131104072|NCT00196976|472010480|FG004|Primary Study|Protocol Violation|0|||
131104073|NCT00196976|472010481|FG005|Primary Study|Protocol Violation|0|||
131104074|NCT00196976|472010482|FG006|Primary Study|Protocol Violation|0|||
131104075|NCT00196976|472010483|FG007|Primary Study|Protocol Violation|0|||
131104076|NCT00196976|472010484|FG008|Primary Study|Protocol Violation|0|||
131104077|NCT00196976|472010485|FG009|Primary Study|Protocol Violation|0|||
131104078|NCT00196976|472010486|FG010|Primary Study|Protocol Violation|0|||
131104079|NCT00196976|472010487|FG011|Primary Study|Protocol Violation|0|||
131104080|NCT00196976|472010488|FG012|Primary Study|Protocol Violation|0|||
131104081|NCT00196976|472010489|FG013|Primary Study|Protocol Violation|0|||
131104082|NCT00196976|472010476|FG000|Primary Study|Withdrawal by Subject|1|||
131104083|NCT00196976|472010477|FG001|Primary Study|Withdrawal by Subject|0|||
131104084|NCT00196976|472010478|FG002|Primary Study|Withdrawal by Subject|1|||
131104085|NCT00196976|472010479|FG003|Primary Study|Withdrawal by Subject|1|||
131104086|NCT00196976|472010480|FG004|Primary Study|Withdrawal by Subject|2|||
131104087|NCT00196976|472010481|FG005|Primary Study|Withdrawal by Subject|1|||
131104088|NCT00196976|472010482|FG006|Primary Study|Withdrawal by Subject|0|||
131104089|NCT00196976|472010483|FG007|Primary Study|Withdrawal by Subject|0|||
131104090|NCT00196976|472010484|FG008|Primary Study|Withdrawal by Subject|0|||
131104091|NCT00196976|472010485|FG009|Primary Study|Withdrawal by Subject|1|||
131104092|NCT00196976|472010486|FG010|Primary Study|Withdrawal by Subject|0|||
131104093|NCT00196976|472010487|FG011|Primary Study|Withdrawal by Subject|0|||
131104094|NCT00196976|472010488|FG012|Primary Study|Withdrawal by Subject|0|||
131104095|NCT00196976|472010489|FG013|Primary Study|Withdrawal by Subject|0|||
131104096|NCT00196976|472010476|FG000|Primary Study|Lost to Follow-up|0|||
131104097|NCT00196976|472010477|FG001|Primary Study|Lost to Follow-up|0|||
131104098|NCT00196976|472010478|FG002|Primary Study|Lost to Follow-up|0|||
131104099|NCT00196976|472010479|FG003|Primary Study|Lost to Follow-up|0|||
131104100|NCT00196976|472010480|FG004|Primary Study|Lost to Follow-up|1|||
131104101|NCT00196976|472010481|FG005|Primary Study|Lost to Follow-up|1|||
131104102|NCT00196976|472010482|FG006|Primary Study|Lost to Follow-up|0|||
131104103|NCT00196976|472010483|FG007|Primary Study|Lost to Follow-up|2|||
131104104|NCT00196976|472010484|FG008|Primary Study|Lost to Follow-up|0|||
131104105|NCT00196976|472010485|FG009|Primary Study|Lost to Follow-up|0|||
131104106|NCT00196976|472010486|FG010|Primary Study|Lost to Follow-up|0|||
131104107|NCT00196976|472010487|FG011|Primary Study|Lost to Follow-up|0|||
131104108|NCT00196976|472010488|FG012|Primary Study|Lost to Follow-up|0|||
131104109|NCT00196976|472010489|FG013|Primary Study|Lost to Follow-up|0|||
131104110|NCT00196976|472010476|FG000|Primary Study|Other|0|||
131104111|NCT00196976|472010477|FG001|Primary Study|Other|0|||
131104112|NCT00196976|472010478|FG002|Primary Study|Other|2|||
131104113|NCT00196976|472010479|FG003|Primary Study|Other|0|||
131104114|NCT00196976|472010480|FG004|Primary Study|Other|0|||
131104115|NCT00196976|472010481|FG005|Primary Study|Other|0|||
131104116|NCT00196976|472010482|FG006|Primary Study|Other|0|||
131104117|NCT00196976|472010483|FG007|Primary Study|Other|0|||
131104118|NCT00196976|472010484|FG008|Primary Study|Other|0|||
131104119|NCT00196976|472010485|FG009|Primary Study|Other|0|||
130682753|NCT00696020|470465992|FG003|Overall Study|Adverse Event|1|||
130682754|NCT00696020|470465989|FG000|Overall Study|Lack of Efficacy|1|||
130682755|NCT00696020|470465990|FG001|Overall Study|Lack of Efficacy|0|||
130682756|NCT00696020|470465991|FG002|Overall Study|Lack of Efficacy|0|||
130682757|NCT00696020|470465992|FG003|Overall Study|Lack of Efficacy|0|||
130682758|NCT00696020|470465989|FG000|Overall Study|Protocol Violation|0|||
130682759|NCT00696020|470465990|FG001|Overall Study|Protocol Violation|0|||
130682760|NCT00696020|470465991|FG002|Overall Study|Protocol Violation|0|||
130682761|NCT00696020|470465992|FG003|Overall Study|Protocol Violation|1|||
130682762|NCT00696020|470465989|FG000|Overall Study|Withdrawal by Subject|0|||
130682763|NCT00696020|470465990|FG001|Overall Study|Withdrawal by Subject|1|||
130682764|NCT00696020|470465991|FG002|Overall Study|Withdrawal by Subject|0|||
130682765|NCT00696020|470465992|FG003|Overall Study|Withdrawal by Subject|1|||
130682766|NCT00696020|470465989|FG000|Overall Study|Other not stated above|0|||
130682767|NCT00696020|470465990|FG001|Overall Study|Other not stated above|0|||
130682768|NCT00696020|470465991|FG002|Overall Study|Other not stated above|1|||
130682769|NCT00696020|470465992|FG003|Overall Study|Other not stated above|1|||
130682770|NCT01387022|470465993|FG000|Overall Study|Death|1|||
130682771|NCT01387022|470465994|FG001|Overall Study|Death|1|||
130682772|NCT01387022|470465993|FG000|Overall Study|Lost to Follow-up|0|||
130682773|NCT01387022|470465994|FG001|Overall Study|Lost to Follow-up|3|||
130682774|NCT02076022|470465995|FG000|Overall Study|Withdrawal by Subject|2|||
130682775|NCT02076022|470465996|FG001|Overall Study|Withdrawal by Subject|0|||
130682776|NCT00312663|470465997|FG000|Immunization Phase|Adverse Event|0|||
131104120|NCT00196976|472010486|FG010|Primary Study|Other|0|||
131104121|NCT00196976|472010487|FG011|Primary Study|Other|0|||
131104122|NCT00196976|472010488|FG012|Primary Study|Other|0|||
131104123|NCT00196976|472010489|FG013|Primary Study|Other|0|||
131104124|NCT00196976|472010476|FG000|Booster Study|Withdrawal by Subject|0|||
131104125|NCT00196976|472010477|FG001|Booster Study|Withdrawal by Subject|0|||
131104126|NCT00196976|472010478|FG002|Booster Study|Withdrawal by Subject|0|||
131104127|NCT00196976|472010479|FG003|Booster Study|Withdrawal by Subject|0|||
131104128|NCT00196976|472010480|FG004|Booster Study|Withdrawal by Subject|0|||
131104129|NCT00196976|472010481|FG005|Booster Study|Withdrawal by Subject|0|||
131104130|NCT00196976|472010482|FG006|Booster Study|Withdrawal by Subject|0|||
131104131|NCT00196976|472010483|FG007|Booster Study|Withdrawal by Subject|0|||
131104132|NCT00196976|472010484|FG008|Booster Study|Withdrawal by Subject|0|||
131104133|NCT00196976|472010485|FG009|Booster Study|Withdrawal by Subject|0|||
131104134|NCT00196976|472010486|FG010|Booster Study|Withdrawal by Subject|1|||
131104135|NCT00196976|472010487|FG011|Booster Study|Withdrawal by Subject|0|||
131104136|NCT00196976|472010488|FG012|Booster Study|Withdrawal by Subject|0|||
131104137|NCT00196976|472010489|FG013|Booster Study|Withdrawal by Subject|0|||
131104138|NCT00196976|472010476|FG000|Booster Study|Lost to Follow-up|0|||
131104139|NCT00196976|472010477|FG001|Booster Study|Lost to Follow-up|0|||
131104140|NCT00196976|472010478|FG002|Booster Study|Lost to Follow-up|0|||
131104141|NCT00196976|472010479|FG003|Booster Study|Lost to Follow-up|0|||
131104142|NCT00196976|472010480|FG004|Booster Study|Lost to Follow-up|0|||
131104143|NCT00196976|472010481|FG005|Booster Study|Lost to Follow-up|0|||
131104144|NCT00196976|472010482|FG006|Booster Study|Lost to Follow-up|0|||
131104145|NCT00196976|472010483|FG007|Booster Study|Lost to Follow-up|0|||
131104146|NCT00196976|472010484|FG008|Booster Study|Lost to Follow-up|0|||
131104147|NCT00196976|472010485|FG009|Booster Study|Lost to Follow-up|0|||
131104148|NCT00196976|472010486|FG010|Booster Study|Lost to Follow-up|1|||
131104149|NCT00196976|472010487|FG011|Booster Study|Lost to Follow-up|2|||
130682777|NCT00312663|470465998|FG001|Immunization Phase|Adverse Event|1|||
130682778|NCT00312663|470465999|FG002|Immunization Phase|Adverse Event|0|||
130682779|NCT00301366|470466000|FG000|Overall Study|Adverse Event|1|||
130682780|NCT02511782|470466003|FG000|Overall Study|Withdrawal by Subject|1|||
130682781|NCT02511782|470466004|FG001|Overall Study|Withdrawal by Subject|0|||
130682782|NCT02511782|470466005|FG002|Overall Study|Withdrawal by Subject|0|||
130682783|NCT00450190|470466006|FG000|Overall Study|Withdrawal by Subject|2|||
131104150|NCT00196976|472010488|FG012|Booster Study|Lost to Follow-up|0|||
131104151|NCT00196976|472010489|FG013|Booster Study|Lost to Follow-up|0|||
130682784|NCT01536574|470466007|FG000|Overall Study|Adverse Event|4|||
130682785|NCT01536574|470466008|FG001|Overall Study|Adverse Event|5|||
131104152|NCT01535560|472010491|FG000|Overall Study|Adverse Event|12|||
131104153|NCT01535560|472010492|FG001|Overall Study|Adverse Event|7|||
131104154|NCT01535560|472010491|FG000|Overall Study|Lost to Follow-up|1|||
131104155|NCT01535560|472010492|FG001|Overall Study|Lost to Follow-up|3|||
130766473|NCT01554176|470768278|FG004|Treatment Phase|Withdrawal by Subject|0|||
130766474|NCT01554176|470768274|FG000|Treatment Phase|Lost to Follow-up|3|||
130766475|NCT01554176|470768275|FG001|Treatment Phase|Lost to Follow-up|0|||
130766476|NCT01554176|470768276|FG002|Treatment Phase|Lost to Follow-up|0|||
130766477|NCT01554176|470768277|FG003|Treatment Phase|Lost to Follow-up|0|||
130766478|NCT01554176|470768278|FG004|Treatment Phase|Lost to Follow-up|0|||
130766479|NCT01554176|470768274|FG000|Run-out Phase|Protocol Violation|0|||
130766480|NCT01554176|470768275|FG001|Run-out Phase|Protocol Violation|0|||
130766481|NCT01554176|470768276|FG002|Run-out Phase|Protocol Violation|0|||
130766482|NCT01554176|470768277|FG003|Run-out Phase|Protocol Violation|1|||
130766483|NCT01554176|470768278|FG004|Run-out Phase|Protocol Violation|0|||
130766484|NCT00386425|470768279|FG000|Overall Study|Physician Decision|3|||
130766485|NCT00386425|470768280|FG001|Overall Study|Physician Decision|0|||
130766486|NCT00386425|470768281|FG002|Overall Study|Physician Decision|0|||
130766487|NCT00386425|470768279|FG000|Overall Study|Withdrawal by Subject|0|||
130766488|NCT00386425|470768280|FG001|Overall Study|Withdrawal by Subject|1|||
130766489|NCT00386425|470768281|FG002|Overall Study|Withdrawal by Subject|0|||
130766490|NCT03053427|470768282|FG000|Overall Study|Adverse Event|4|||
130766491|NCT03053427|470768283|FG001|Overall Study|Adverse Event|4|||
130766492|NCT03053427|470768282|FG000|Overall Study|Lack of Efficacy|1|||
130766493|NCT03053427|470768283|FG001|Overall Study|Lack of Efficacy|3|||
130766494|NCT03053427|470768282|FG000|Overall Study|Lost to Follow-up|2|||
130766495|NCT03053427|470768283|FG001|Overall Study|Lost to Follow-up|2|||
130766496|NCT03053427|470768282|FG000|Overall Study|Worsening of the target disease|0|||
130766497|NCT03053427|470768283|FG001|Overall Study|Worsening of the target disease|1|||
130766498|NCT03053427|470768282|FG000|Overall Study|Protocol Deviation|3|||
130766499|NCT03053427|470768283|FG001|Overall Study|Protocol Deviation|3|||
130766500|NCT03053427|470768282|FG000|Overall Study|Withdrawal by Subject|3|||
130766501|NCT03053427|470768283|FG001|Overall Study|Withdrawal by Subject|2|||
130766502|NCT03053427|470768282|FG000|Overall Study|Miscellaneous|0|||
130766503|NCT03053427|470768283|FG001|Overall Study|Miscellaneous|1|||
130766504|NCT02172040|470768287|FG000|Overall Study|Adverse Event|0|||
130766505|NCT02172040|470768288|FG001|Overall Study|Adverse Event|2|||
130766506|NCT02172040|470768289|FG002|Overall Study|Adverse Event|0|||
130766507|NCT02172040|470768290|FG003|Overall Study|Adverse Event|0|||
130766508|NCT02172040|470768287|FG000|Overall Study|Protocol Violation|0|||
130766509|NCT02172040|470768288|FG001|Overall Study|Protocol Violation|1|||
130766510|NCT02172040|470768289|FG002|Overall Study|Protocol Violation|0|||
130766511|NCT02172040|470768290|FG003|Overall Study|Protocol Violation|0|||
130766512|NCT02172040|470768287|FG000|Overall Study|Withdrawal by Subject|0|||
130766513|NCT02172040|470768288|FG001|Overall Study|Withdrawal by Subject|0|||
130766514|NCT02172040|470768289|FG002|Overall Study|Withdrawal by Subject|1|||
130766515|NCT02172040|470768290|FG003|Overall Study|Withdrawal by Subject|0|||
130766516|NCT02172040|470768287|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
130766517|NCT02172040|470768288|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
130766518|NCT02172040|470768289|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
130766519|NCT02172040|470768290|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
130766520|NCT02172040|470768287|FG000|Overall Study|Family emergency abroad|0|||
130766521|NCT02172040|470768288|FG001|Overall Study|Family emergency abroad|0|||
130766522|NCT02172040|470768289|FG002|Overall Study|Family emergency abroad|0|||
130766523|NCT02172040|470768290|FG003|Overall Study|Family emergency abroad|1|||
130766524|NCT02607306|470768295|FG000|Overall Study|Adverse Event|8|||
130766525|NCT02607306|470768296|FG001|Overall Study|Adverse Event|6|||
130766526|NCT02607306|470768297|FG002|Overall Study|Adverse Event|6|||
130766527|NCT02607306|470768295|FG000|Overall Study|Unclassified|1|||
130766528|NCT02607306|470768296|FG001|Overall Study|Unclassified|4|||
130766529|NCT02607306|470768297|FG002|Overall Study|Unclassified|0|||
130766530|NCT02607306|470768295|FG000|Overall Study|Withdrawal by Subject|8|||
130766531|NCT02607306|470768296|FG001|Overall Study|Withdrawal by Subject|10|||
130766532|NCT02607306|470768297|FG002|Overall Study|Withdrawal by Subject|2|||
130766533|NCT02607306|470768295|FG000|Overall Study|Lack of Efficacy|0|||
130766534|NCT02607306|470768296|FG001|Overall Study|Lack of Efficacy|1|||
130766535|NCT02607306|470768297|FG002|Overall Study|Lack of Efficacy|1|||
130766536|NCT02607306|470768295|FG000|Overall Study|Protocol Violation|4|||
130766537|NCT02607306|470768296|FG001|Overall Study|Protocol Violation|2|||
130766538|NCT02607306|470768297|FG002|Overall Study|Protocol Violation|1|||
130766539|NCT01324570|470768298|FG000|Overall Study|Adverse Event|4|||
130766540|NCT01324570|470768299|FG001|Overall Study|Adverse Event|7|||
130766541|NCT01324570|470768298|FG000|Overall Study|Withdrawal by Subject|0|||
130766542|NCT01324570|470768299|FG001|Overall Study|Withdrawal by Subject|3|||
130766543|NCT01324570|470768298|FG000|Overall Study|Lack of Efficacy|0|||
130766544|NCT01324570|470768299|FG001|Overall Study|Lack of Efficacy|1|||
130766545|NCT01324570|470768298|FG000|Overall Study|Confirmed or suspected diversion|0|||
130766546|NCT01324570|470768299|FG001|Overall Study|Confirmed or suspected diversion|1|||
130766547|NCT01324570|470768298|FG000|Overall Study|Administrative|0|||
130766548|NCT01324570|470768299|FG001|Overall Study|Administrative|2|||
130766549|NCT00435019|470768307|FG000|Overall Study|Adverse Event|1|||
130766550|NCT00435019|470768308|FG001|Overall Study|Adverse Event|0|||
131104156|NCT01535560|472010491|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
131104157|NCT01535560|472010492|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
131104158|NCT01535560|472010491|FG000|Overall Study|Treatment Failure|21|||
131104159|NCT01535560|472010492|FG001|Overall Study|Treatment Failure|83|||
131104160|NCT01535560|472010491|FG000|Overall Study|Other|0|||
131104161|NCT01535560|472010492|FG001|Overall Study|Other|1|||
131104162|NCT01535560|472010491|FG000|Overall Study|Randomized in Error|0|||
131104163|NCT01535560|472010492|FG001|Overall Study|Randomized in Error|1|||
131104164|NCT02009761|472010493|FG000|Overall Study|Adverse Event|4|||
131104165|NCT02842827|472010496|FG000|Overall Study|Adverse Event|0|||
131104166|NCT02842827|472010497|FG001|Overall Study|Adverse Event|1|||
131104167|NCT02842827|472010498|FG002|Overall Study|Adverse Event|0|||
131104168|NCT02842827|472010499|FG003|Overall Study|Adverse Event|1|||
131104169|NCT02842827|472010500|FG004|Overall Study|Adverse Event|0|||
131104170|NCT02842827|472010501|FG005|Overall Study|Adverse Event|1|||
131104171|NCT02842827|472010502|FG006|Overall Study|Adverse Event|0|||
131104172|NCT02842827|472010503|FG007|Overall Study|Adverse Event|0|||
131104173|NCT02842827|472010496|FG000|Overall Study|Death|1|||
131104174|NCT02842827|472010497|FG001|Overall Study|Death|0|||
131104175|NCT02842827|472010498|FG002|Overall Study|Death|2|||
131104176|NCT02842827|472010499|FG003|Overall Study|Death|3|||
131104177|NCT02842827|472010500|FG004|Overall Study|Death|2|||
131104178|NCT02842827|472010501|FG005|Overall Study|Death|1|||
131104179|NCT02842827|472010502|FG006|Overall Study|Death|0|||
131104180|NCT02842827|472010503|FG007|Overall Study|Death|4|||
131104181|NCT02842827|472010496|FG000|Overall Study|Physician Decision|1|||
131104182|NCT02842827|472010497|FG001|Overall Study|Physician Decision|3|||
131104183|NCT02842827|472010498|FG002|Overall Study|Physician Decision|0|||
131104184|NCT02842827|472010499|FG003|Overall Study|Physician Decision|0|||
131104185|NCT02842827|472010500|FG004|Overall Study|Physician Decision|1|||
131104186|NCT02842827|472010501|FG005|Overall Study|Physician Decision|4|||
131104187|NCT02842827|472010502|FG006|Overall Study|Physician Decision|2|||
131104188|NCT02842827|472010503|FG007|Overall Study|Physician Decision|1|||
131104189|NCT02842827|472010496|FG000|Overall Study|Protocol Defined Disease Progression|0|||
131104190|NCT02842827|472010497|FG001|Overall Study|Protocol Defined Disease Progression|0|||
131104191|NCT02842827|472010498|FG002|Overall Study|Protocol Defined Disease Progression|0|||
131104192|NCT02842827|472010499|FG003|Overall Study|Protocol Defined Disease Progression|0|||
131104193|NCT02842827|472010500|FG004|Overall Study|Protocol Defined Disease Progression|0|||
131104194|NCT02842827|472010501|FG005|Overall Study|Protocol Defined Disease Progression|1|||
131104195|NCT02842827|472010502|FG006|Overall Study|Protocol Defined Disease Progression|0|||
131104196|NCT02842827|472010503|FG007|Overall Study|Protocol Defined Disease Progression|0|||
131104197|NCT02842827|472010496|FG000|Overall Study|Participant Withdrawal of Consent|1|||
131104198|NCT02842827|472010497|FG001|Overall Study|Participant Withdrawal of Consent|2|||
131104199|NCT02842827|472010498|FG002|Overall Study|Participant Withdrawal of Consent|2|||
131104200|NCT02842827|472010499|FG003|Overall Study|Participant Withdrawal of Consent|2|||
131104201|NCT02842827|472010500|FG004|Overall Study|Participant Withdrawal of Consent|2|||
131104202|NCT02842827|472010501|FG005|Overall Study|Participant Withdrawal of Consent|1|||
131104203|NCT02842827|472010502|FG006|Overall Study|Participant Withdrawal of Consent|2|||
131104204|NCT02842827|472010503|FG007|Overall Study|Participant Withdrawal of Consent|1|||
131104205|NCT02372136|472010508|FG000|Overall Study|Death|3|||
131104206|NCT02372136|472010509|FG001|Overall Study|Death|1|||
131104207|NCT00985946|472010510|FG000|Overall Study|Lost to Follow-up|6|||
131104208|NCT00985946|472010510|FG000|Overall Study|Withdrawal by Subject|1|||
131104209|NCT02471833|472010511|FG000|Overall Study|Lost to Follow-up|1|||
131104210|NCT02471833|472010512|FG001|Overall Study|Lost to Follow-up|0|||
131104211|NCT02471833|472010513|FG002|Overall Study|Lost to Follow-up|0|||
131104212|NCT02471833|472010511|FG000|Overall Study|Withdrawal by Subject|2|||
131104213|NCT02471833|472010512|FG001|Overall Study|Withdrawal by Subject|1|||
131104214|NCT02471833|472010513|FG002|Overall Study|Withdrawal by Subject|5|||
131104215|NCT02673515|472010514|FG000|Overall Study|Lack of motivation|2|||
131104216|NCT02673515|472010515|FG001|Overall Study|Lack of motivation|1|||
130682786|NCT01536574|470466007|FG000|Overall Study|Withdrawal by Subject|1|||
130682787|NCT01536574|470466008|FG001|Overall Study|Withdrawal by Subject|2|||
130682788|NCT01536574|470466007|FG000|Overall Study|Lack of Efficacy|1|||
130682789|NCT01536574|470466008|FG001|Overall Study|Lack of Efficacy|0|||
130682790|NCT01376167|470466009|FG000|Overall Study|Lost to Follow-up|2|||
130682791|NCT01376167|470466010|FG001|Overall Study|Lost to Follow-up|4|||
130682792|NCT01376167|470466011|FG002|Overall Study|Lost to Follow-up|2|||
130682793|NCT01376167|470466009|FG000|Overall Study|Physician Decision|1|||
131104217|NCT00490724|472010517|FG000|Period I|Physician Decision|0|||
131104218|NCT00490724|472010518|FG001|Period I|Physician Decision|0|||
131104219|NCT00490724|472010519|FG002|Period I|Physician Decision|1|||
130682794|NCT01376167|470466010|FG001|Overall Study|Physician Decision|1|||
130682795|NCT01376167|470466011|FG002|Overall Study|Physician Decision|0|||
131104220|NCT00490724|472010517|FG000|Period II|Treatment Discontinuation|3|||
131104221|NCT00490724|472010518|FG001|Period II|Treatment Discontinuation|1|||
131104222|NCT00490724|472010519|FG002|Period II|Treatment Discontinuation|3|||
131104223|NCT00932113|472012771|FG000|Overall Study|Lost to Follow-up|1|||
130682796|NCT01376167|470466009|FG000|Overall Study|Withdrawal by Subject|1|||
130682797|NCT01376167|470466010|FG001|Overall Study|Withdrawal by Subject|5|||
130682798|NCT01376167|470466011|FG002|Overall Study|Withdrawal by Subject|4|||
130682799|NCT03361228|470466014|FG000|Overall Study|Other|1|||
130682800|NCT03361228|470466015|FG001|Overall Study|Other|1|||
130682801|NCT03361228|470466014|FG000|Overall Study|Death|3|||
130682802|NCT03361228|470466015|FG001|Overall Study|Death|0|||
130682803|NCT02193178|470466021|FG000|Overall Study|Lost to Follow-up|1|||
130682804|NCT02193178|470466021|FG000|Overall Study|Dry eyes|1|||
130682805|NCT04320849|470466024|FG000|Overall Study|Withdrawal by Subject|4|||
130682806|NCT04320849|470466024|FG000|Overall Study|Imaging data unavailable|2|||
130766551|NCT00435019|470768307|FG000|Overall Study|Lack of Efficacy|1|||
130766552|NCT00435019|470768308|FG001|Overall Study|Lack of Efficacy|2|||
130766553|NCT00435019|470768307|FG000|Overall Study|Protocol Violation|3|||
130766554|NCT00435019|470768308|FG001|Overall Study|Protocol Violation|1|||
130766555|NCT00435019|470768307|FG000|Overall Study|Personal reasons for withdrawal|8|||
130766556|NCT00435019|470768308|FG001|Overall Study|Personal reasons for withdrawal|7|||
130766557|NCT01764659|470768314|FG000|Overall Study|Death|1|||
130766558|NCT01764659|470768314|FG000|Overall Study|Physician Decision|1|||
130766559|NCT01298141|470768315|FG000|Overall Study|Adverse Event|3|||
130766560|NCT01298141|470768315|FG000|Overall Study|Refusal of Required Study Procedures|1|||
130766561|NCT01298141|470768315|FG000|Overall Study|Withdrawal by Subject|6|||
130766562|NCT01298141|470768315|FG000|Overall Study|Termination of Study by the Investigator|5|||
130766563|NCT01298141|470768315|FG000|Overall Study|Other|5|||
130766564|NCT01298141|470768315|FG000|Overall Study|Lost to Follow-up|1|||
130766565|NCT01298141|470768315|FG000|Overall Study|Death|6|||
130766566|NCT01298141|470768315|FG000|Overall Study|Not treated|4|||
130766567|NCT01854879|470768319|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
130766568|NCT01854879|470768319|FG000|Overall Study|screen fail|3|||
130766569|NCT01854879|470768319|FG000|Overall Study|incomplete data set|1|||
130766570|NCT01066793|470770588|FG000|Overall Study|Death|4|||
130766571|NCT01066793|470770589|FG001|Overall Study|Death|1|||
130766572|NCT01066793|470770590|FG002|Overall Study|Death|1|||
130766573|NCT01066793|470770591|FG003|Overall Study|Death|0|||
130766574|NCT01066793|470770592|FG004|Overall Study|Death|0|||
130766575|NCT01066793|470770593|FG005|Overall Study|Death|0|||
130766576|NCT01066793|470770588|FG000|Overall Study|Lack of Efficacy|2|||
131017741|NCT00465816|471695889|FG000|Overall Study|Lost to Follow-up|0|||
131017742|NCT00465816|471695890|FG001|Overall Study|Lost to Follow-up|0|||
131017743|NCT00465816|471695891|FG002|Overall Study|Lost to Follow-up|2|||
130766577|NCT01066793|470770589|FG001|Overall Study|Lack of Efficacy|1|||
130766578|NCT01066793|470770590|FG002|Overall Study|Lack of Efficacy|0|||
130766579|NCT01066793|470770591|FG003|Overall Study|Lack of Efficacy|0|||
130766580|NCT01066793|470770592|FG004|Overall Study|Lack of Efficacy|0|||
130766581|NCT01066793|470770593|FG005|Overall Study|Lack of Efficacy|0|||
130766582|NCT01066793|470770588|FG000|Overall Study|Lost to Follow-up|180|||
130766583|NCT01066793|470770589|FG001|Overall Study|Lost to Follow-up|39|||
130766584|NCT01066793|470770590|FG002|Overall Study|Lost to Follow-up|82|||
130766585|NCT01066793|470770591|FG003|Overall Study|Lost to Follow-up|16|||
130766586|NCT01066793|470770592|FG004|Overall Study|Lost to Follow-up|0|||
130766587|NCT01066793|470770593|FG005|Overall Study|Lost to Follow-up|1|||
130766588|NCT01066793|470770588|FG000|Overall Study|Physician Decision|3|||
130766589|NCT01066793|470770589|FG001|Overall Study|Physician Decision|0|||
130766590|NCT01066793|470770590|FG002|Overall Study|Physician Decision|0|||
130766591|NCT01066793|470770591|FG003|Overall Study|Physician Decision|0|||
130766592|NCT01066793|470770592|FG004|Overall Study|Physician Decision|0|||
130766593|NCT01066793|470770593|FG005|Overall Study|Physician Decision|0|||
130766594|NCT01066793|470770588|FG000|Overall Study|Protocol Violation|3|||
130766595|NCT01066793|470770589|FG001|Overall Study|Protocol Violation|2|||
130766596|NCT01066793|470770590|FG002|Overall Study|Protocol Violation|2|||
130766597|NCT01066793|470770591|FG003|Overall Study|Protocol Violation|0|||
130766598|NCT01066793|470770592|FG004|Overall Study|Protocol Violation|0|||
130886576|NCT03486834|471217355|FG002|Overall Study|Non-compliance with Study Drug|0|||
130766599|NCT01066793|470770593|FG005|Overall Study|Protocol Violation|0|||
130766600|NCT01066793|470770588|FG000|Overall Study|Withdrawal by Subject|7|||
130766601|NCT01066793|470770589|FG001|Overall Study|Withdrawal by Subject|4|||
130766602|NCT01066793|470770590|FG002|Overall Study|Withdrawal by Subject|1|||
130766603|NCT01066793|470770591|FG003|Overall Study|Withdrawal by Subject|0|||
130766604|NCT01066793|470770592|FG004|Overall Study|Withdrawal by Subject|0|||
130766605|NCT01066793|470770593|FG005|Overall Study|Withdrawal by Subject|0|||
130766606|NCT01066793|470770588|FG000|Overall Study|Early Termination|3|||
130766607|NCT01066793|470770589|FG001|Overall Study|Early Termination|0|||
130766608|NCT01066793|470770590|FG002|Overall Study|Early Termination|0|||
130766609|NCT01066793|470770591|FG003|Overall Study|Early Termination|0|||
130766610|NCT01066793|470770592|FG004|Overall Study|Early Termination|0|||
130682807|NCT04320849|470466024|FG000|Overall Study|Incomplete imaging|2|||
130682808|NCT00214422|470466025|FG000|Overall Study|Physician Decision|2|||
130766611|NCT01066793|470770593|FG005|Overall Study|Early Termination|0|||
130682809|NCT00214422|470466026|FG001|Overall Study|Physician Decision|0|||
130766612|NCT01066793|470770588|FG000|Overall Study|Lab test not done|7|||
131104224|NCT00932113|472012772|FG001|Overall Study|Lost to Follow-up|0|||
131104225|NCT01403610|472012773|FG000|Overall Study|Withdrawal by Subject|2|||
131104226|NCT01403610|472012774|FG001|Overall Study|Withdrawal by Subject|0|||
131104227|NCT01403610|472012775|FG002|Overall Study|Withdrawal by Subject|0|||
131104228|NCT01403610|472012776|FG003|Overall Study|Withdrawal by Subject|0|||
131104229|NCT01403610|472012773|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
131104230|NCT01403610|472012774|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
131104231|NCT01403610|472012775|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
131104232|NCT01403610|472012776|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
131104233|NCT00896051|472012780|FG000|Overall Study|Adverse Event|2|||
131104234|NCT00896051|472012781|FG001|Overall Study|Adverse Event|1|||
131104235|NCT00896051|472012780|FG000|Overall Study|Lost to Follow-up|3|||
131104236|NCT00896051|472012781|FG001|Overall Study|Lost to Follow-up|2|||
131104237|NCT00896051|472012780|FG000|Overall Study|Withdrawal by Subject|3|||
131104238|NCT00896051|472012781|FG001|Overall Study|Withdrawal by Subject|2|||
131104239|NCT00896051|472012780|FG000|Overall Study|Subject noncompliant|1|||
131104240|NCT00896051|472012781|FG001|Overall Study|Subject noncompliant|3|||
131104241|NCT00896051|472012780|FG000|Overall Study|Other|1|||
131104242|NCT00896051|472012781|FG001|Overall Study|Other|1|||
131104243|NCT02935452|472012782|FG000|Overall Study|work and life commintment|3|||
131104244|NCT02935452|472012783|FG001|Overall Study|work and life commintment|1|||
131104245|NCT00876928|472012784|FG000|Overall Study|Lost to Follow-up|2|||
131104246|NCT00876928|472012785|FG001|Overall Study|Lost to Follow-up|5|||
131104247|NCT00876928|472012784|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
131104248|NCT00876928|472012785|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
131104249|NCT02336178|472012786|FG000|Overall Study|Lost to Follow-up|1|||
131104250|NCT02336178|472012786|FG000|Overall Study|Protocol Violation|1|||
131104251|NCT02336178|472012786|FG000|Overall Study|Withdrawal by Subject|1|||
131104252|NCT02336178|472012786|FG000|Overall Study|Other|1|||
131104253|NCT00618982|472012787|FG000|Overall Study|Adverse Event|23|||
131104254|NCT00618982|472012787|FG000|Overall Study|Withdrawal by Subject|1|||
131104255|NCT00618982|472012787|FG000|Overall Study|Protocol Violation|1|||
131104256|NCT00618982|472012787|FG000|Overall Study|ongoing, still treated with study med.|25|||
131104257|NCT01776541|472012790|FG000|Overall Study|Administrative Reason|6|||
131104258|NCT01776541|472012791|FG001|Overall Study|Administrative Reason|2|||
130682810|NCT00214422|470466027|FG002|Overall Study|Physician Decision|0|||
130682811|NCT00214422|470466025|FG000|Overall Study|Developed esophageal ca|1|||
130682812|NCT00214422|470466026|FG001|Overall Study|Developed esophageal ca|0|||
130682813|NCT00214422|470466027|FG002|Overall Study|Developed esophageal ca|0|||
130682814|NCT00214422|470466025|FG000|Overall Study|Pt taken off study|1|||
130682815|NCT00214422|470466026|FG001|Overall Study|Pt taken off study|1|||
130682816|NCT00214422|470466027|FG002|Overall Study|Pt taken off study|0|||
130682817|NCT00214422|470466025|FG000|Overall Study|Disease progression on study|1|||
130682818|NCT00214422|470466026|FG001|Overall Study|Disease progression on study|0|||
130682819|NCT00214422|470466027|FG002|Overall Study|Disease progression on study|0|||
130682820|NCT00214422|470466025|FG000|Overall Study|Unable to make a radiation treatment|0|||
130682821|NCT00214422|470466026|FG001|Overall Study|Unable to make a radiation treatment|0|||
130682822|NCT00214422|470466027|FG002|Overall Study|Unable to make a radiation treatment|1|||
130682823|NCT03929393|470466028|FG000|Overall Study|Death|1|||
130682824|NCT03929393|470466029|FG001|Overall Study|Death|0|||
130682825|NCT03929393|470466028|FG000|Overall Study|Time Commitment|2|||
130682826|NCT03929393|470466029|FG001|Overall Study|Time Commitment|5|||
130682827|NCT03929393|470466028|FG000|Overall Study|Motor Vehicle Accident|0|||
130682828|NCT03929393|470466029|FG001|Overall Study|Motor Vehicle Accident|1|||
130682829|NCT03929393|470466028|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
130682830|NCT03929393|470466029|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
130682831|NCT03929393|470466028|FG000|Overall Study|Other|1|||
130682832|NCT03929393|470466029|FG001|Overall Study|Other|3|||
130682833|NCT00705536|470468060|FG000|Start Period 1|Withdrawal by Subject|0|||
130682834|NCT00705536|470468061|FG001|Start Period 1|Withdrawal by Subject|0|||
130682835|NCT00705536|470468062|FG002|Start Period 1|Withdrawal by Subject|0|||
130682836|NCT00705536|470468063|FG003|Start Period 1|Withdrawal by Subject|1|||
130682837|NCT04188106|470468064|FG000|Overall Study|Lost to Follow-up|5|||
130682838|NCT04188106|470468064|FG000|Overall Study|Non-Compliance|1|||
130682839|NCT02289963|470468065|FG000|Overall Study|Adverse Event|1|||
130682840|NCT02289963|470468066|FG001|Overall Study|Adverse Event|2|||
131104259|NCT01776541|472012790|FG000|Overall Study|Death|4|||
131104260|NCT01776541|472012791|FG001|Overall Study|Death|0|||
131104261|NCT01776541|472012790|FG000|Overall Study|Lost to Follow-up|27|||
130682841|NCT02289963|470468065|FG000|Overall Study|Poor compliance to protocol|1|||
130682842|NCT02289963|470468066|FG001|Overall Study|Poor compliance to protocol|0|||
130682843|NCT02289963|470468065|FG000|Overall Study|Withdrawal by Subject|1|||
130682844|NCT02289963|470468066|FG001|Overall Study|Withdrawal by Subject|0|||
130682845|NCT02289963|470468065|FG000|Overall Study|Last injection missed|2|||
130682846|NCT02289963|470468066|FG001|Overall Study|Last injection missed|2|||
130720846|NCT04126213|470601549|FG004|Overall Study|Lost to Follow-up|4|||
130682847|NCT02289963|470468065|FG000|Overall Study|End treatment visit outside visit window|0|||
130682848|NCT02289963|470468066|FG001|Overall Study|End treatment visit outside visit window|4|||
130682849|NCT02289963|470468065|FG000|Overall Study|Other than specified above|0|||
130682850|NCT02289963|470468066|FG001|Overall Study|Other than specified above|2|||
130682851|NCT00549718|470468069|FG000|Overall Study|Insufficient clinical response|20|||
130766613|NCT01066793|470770589|FG001|Overall Study|Lab test not done|0|||
130766614|NCT01066793|470770590|FG002|Overall Study|Lab test not done|0|||
130766615|NCT01066793|470770591|FG003|Overall Study|Lab test not done|1|||
130766616|NCT01066793|470770592|FG004|Overall Study|Lab test not done|0|||
130766617|NCT01066793|470770593|FG005|Overall Study|Lab test not done|0|||
130766618|NCT01066793|470770588|FG000|Overall Study|Miscellaneous|4|||
130766619|NCT01066793|470770589|FG001|Overall Study|Miscellaneous|5|||
130766620|NCT01066793|470770590|FG002|Overall Study|Miscellaneous|6|||
130766621|NCT01066793|470770591|FG003|Overall Study|Miscellaneous|0|||
130766622|NCT01066793|470770592|FG004|Overall Study|Miscellaneous|0|||
130766623|NCT01066793|470770593|FG005|Overall Study|Miscellaneous|0|||
130766624|NCT01066793|470770588|FG000|Overall Study|Non-responders|104|||
130766625|NCT01066793|470770589|FG001|Overall Study|Non-responders|5|||
130766626|NCT01066793|470770590|FG002|Overall Study|Non-responders|11|||
130766627|NCT01066793|470770591|FG003|Overall Study|Non-responders|25|||
130766628|NCT01066793|470770592|FG004|Overall Study|Non-responders|0|||
130766629|NCT01066793|470770593|FG005|Overall Study|Non-responders|0|||
130766630|NCT01066793|470770588|FG000|Overall Study|Other|15|||
130766631|NCT01066793|470770589|FG001|Overall Study|Other|5|||
130766632|NCT01066793|470770590|FG002|Overall Study|Other|6|||
130766633|NCT01066793|470770591|FG003|Overall Study|Other|2|||
130766634|NCT01066793|470770592|FG004|Overall Study|Other|0|||
130766635|NCT01066793|470770593|FG005|Overall Study|Other|0|||
130766636|NCT01066793|470770588|FG000|Overall Study|Relapse|20|||
130766637|NCT01066793|470770589|FG001|Overall Study|Relapse|8|||
130766638|NCT01066793|470770590|FG002|Overall Study|Relapse|2|||
130766639|NCT01066793|470770591|FG003|Overall Study|Relapse|3|||
130766640|NCT01066793|470770592|FG004|Overall Study|Relapse|0|||
130766641|NCT01066793|470770593|FG005|Overall Study|Relapse|0|||
130766642|NCT01066793|470770588|FG000|Overall Study|Result Not Available|1|||
130766643|NCT01066793|470770589|FG001|Overall Study|Result Not Available|0|||
130766644|NCT01066793|470770590|FG002|Overall Study|Result Not Available|0|||
130766645|NCT01066793|470770591|FG003|Overall Study|Result Not Available|0|||
130766646|NCT01066793|470770592|FG004|Overall Study|Result Not Available|0|||
130766647|NCT01066793|470770593|FG005|Overall Study|Result Not Available|0|||
130766648|NCT01066793|470770588|FG000|Overall Study|Treatment Interrupted|1|||
130766649|NCT01066793|470770589|FG001|Overall Study|Treatment Interrupted|1|||
130766650|NCT01066793|470770590|FG002|Overall Study|Treatment Interrupted|0|||
130766651|NCT01066793|470770591|FG003|Overall Study|Treatment Interrupted|0|||
130766652|NCT01066793|470770592|FG004|Overall Study|Treatment Interrupted|0|||
130766653|NCT01066793|470770593|FG005|Overall Study|Treatment Interrupted|0|||
130766654|NCT01066793|470770588|FG000|Overall Study|Treatment Never Started|18|||
130766655|NCT01066793|470770589|FG001|Overall Study|Treatment Never Started|5|||
130766656|NCT01066793|470770590|FG002|Overall Study|Treatment Never Started|4|||
130766657|NCT01066793|470770591|FG003|Overall Study|Treatment Never Started|1|||
130766658|NCT01066793|470770592|FG004|Overall Study|Treatment Never Started|0|||
130766659|NCT01066793|470770593|FG005|Overall Study|Treatment Never Started|0|||
130766660|NCT01066793|470770588|FG000|Overall Study|Treatment Stopped|2|||
130766661|NCT01066793|470770589|FG001|Overall Study|Treatment Stopped|1|||
130766662|NCT01066793|470770590|FG002|Overall Study|Treatment Stopped|0|||
130766663|NCT01066793|470770591|FG003|Overall Study|Treatment Stopped|1|||
130766664|NCT01066793|470770592|FG004|Overall Study|Treatment Stopped|0|||
130766665|NCT01066793|470770593|FG005|Overall Study|Treatment Stopped|0|||
130766666|NCT03774394|470770595|FG000|Overall Study|Withdrawal by Subject|2|||
130766667|NCT03774394|470770596|FG001|Overall Study|Withdrawal by Subject|0|||
130766668|NCT02697916|470770597|FG000|Overall Study|Death|357|||
130766669|NCT02697916|470770598|FG001|Overall Study|Death|315|||
130766670|NCT02697916|470770597|FG000|Overall Study|Withdrawal by Subject|221|||
130766671|NCT02697916|470770598|FG001|Overall Study|Withdrawal by Subject|393|||
130766672|NCT03334422|470770599|FG000|Overall Study|Adverse Event|1|||
130766673|NCT03334422|470770600|FG001|Overall Study|Adverse Event|3|||
130766674|NCT03334422|470770601|FG002|Overall Study|Adverse Event|2|||
130766675|NCT03334422|470770602|FG003|Overall Study|Adverse Event|2|||
130766676|NCT03334422|470770599|FG000|Overall Study|Lack of Efficacy|10|||
130766677|NCT03334422|470770600|FG001|Overall Study|Lack of Efficacy|2|||
130766678|NCT03334422|470770601|FG002|Overall Study|Lack of Efficacy|7|||
130766679|NCT03334422|470770602|FG003|Overall Study|Lack of Efficacy|3|||
130766680|NCT03334422|470770599|FG000|Overall Study|Withdrawal by Subject|8|||
130766681|NCT03334422|470770600|FG001|Overall Study|Withdrawal by Subject|3|||
130766682|NCT03334422|470770601|FG002|Overall Study|Withdrawal by Subject|1|||
130766683|NCT03334422|470770602|FG003|Overall Study|Withdrawal by Subject|0|||
130766684|NCT03334422|470770599|FG000|Overall Study|Lost to Follow-up|0|||
130766685|NCT03334422|470770600|FG001|Overall Study|Lost to Follow-up|0|||
130766686|NCT03334422|470770601|FG002|Overall Study|Lost to Follow-up|0|||
131104262|NCT01776541|472012791|FG001|Overall Study|Lost to Follow-up|48|||
131104263|NCT01776541|472012790|FG000|Overall Study|Unclassified|5|||
131104264|NCT01776541|472012791|FG001|Overall Study|Unclassified|4|||
131104265|NCT01776541|472012790|FG000|Overall Study|Protocol Violation|2|||
131104266|NCT01776541|472012791|FG001|Overall Study|Protocol Violation|1|||
131104267|NCT01776541|472012790|FG000|Overall Study|Withdrawal by Subject|12|||
131104268|NCT01776541|472012791|FG001|Overall Study|Withdrawal by Subject|20|||
131104269|NCT00156819|472012792|FG000|Overall Study|Lost to Follow-up|1|||
131104270|NCT00156819|472012793|FG001|Overall Study|Lost to Follow-up|1|||
131104271|NCT00156819|472012794|FG002|Overall Study|Lost to Follow-up|3|||
131104272|NCT02090959|472012795|FG000|Overall Study|Withdrawal by Subject|10|||
131104273|NCT02090959|472012795|FG000|Overall Study|Adverse Event|1|||
131104274|NCT02090959|472012795|FG000|Overall Study|Investigator decision|2|||
131104275|NCT02090959|472012795|FG000|Overall Study|Study termination|6|||
131104276|NCT02090959|472012795|FG000|Overall Study|Enrolled but not treated|1|||
131104277|NCT02090959|472012795|FG000|Overall Study|Transfer for compassionate use medicine|4|||
131104278|NCT02090959|472012795|FG000|Overall Study|Move to medical need program|3|||
131104279|NCT02090959|472012795|FG000|Overall Study|Entered in to other study|34|||
131104280|NCT02090959|472012795|FG000|Overall Study|Switched to commercial supply|88|||
131104281|NCT02090959|472012795|FG000|Overall Study|Other than specified|2|||
131104282|NCT00522873|472012798|FG000|Overall Study|Adverse Event|41|||
131104283|NCT00522873|472012799|FG001|Overall Study|Adverse Event|26|||
131104284|NCT00522873|472012798|FG000|Overall Study|Withdrawal by Subject|20|||
131104285|NCT00522873|472012799|FG001|Overall Study|Withdrawal by Subject|9|||
131104286|NCT00522873|472012798|FG000|Overall Study|Protocol Violation|14|||
131104287|NCT00522873|472012799|FG001|Overall Study|Protocol Violation|4|||
131104288|NCT00522873|472012798|FG000|Overall Study|Lost to Follow-up|11|||
131104289|NCT00522873|472012799|FG001|Overall Study|Lost to Follow-up|3|||
131104290|NCT00522873|472012798|FG000|Overall Study|Personal Reasons|8|||
131104291|NCT00522873|472012799|FG001|Overall Study|Personal Reasons|1|||
131104292|NCT00522873|472012798|FG000|Overall Study|Medication Errors|1|||
131104293|NCT00522873|472012799|FG001|Overall Study|Medication Errors|1|||
131104294|NCT00522873|472012798|FG000|Overall Study|Never Received Medication|1|||
131104295|NCT00522873|472012799|FG001|Overall Study|Never Received Medication|0|||
131104296|NCT00822172|472012802|FG000|Overall Study|Adverse Event|10|||
131104297|NCT00822172|472012803|FG001|Overall Study|Adverse Event|12|||
131104298|NCT00822172|472012802|FG000|Overall Study|Death|1|||
131104299|NCT00822172|472012803|FG001|Overall Study|Death|0|||
131104300|NCT00822172|472012802|FG000|Overall Study|Lost to Follow-up|3|||
131104301|NCT00822172|472012803|FG001|Overall Study|Lost to Follow-up|1|||
131104302|NCT00822172|472012802|FG000|Overall Study|Withdrawal by Subject|1|||
131104303|NCT00822172|472012803|FG001|Overall Study|Withdrawal by Subject|4|||
131104304|NCT00822172|472012802|FG000|Overall Study|site closed|0|||
131104305|NCT00822172|472012803|FG001|Overall Study|site closed|1|||
131104306|NCT00822172|472012802|FG000|Overall Study|Other|0|||
131104307|NCT00822172|472012803|FG001|Overall Study|Other|1|||
130682852|NCT00549718|470468070|FG001|Overall Study|Insufficient clinical response|7|||
130682853|NCT00549718|470468071|FG002|Overall Study|Insufficient clinical response|18|||
130682854|NCT00549718|470468072|FG003|Overall Study|Insufficient clinical response|32|||
130682855|NCT00549718|470468069|FG000|Overall Study|Adverse Event|6|||
130682856|NCT00549718|470468070|FG001|Overall Study|Adverse Event|8|||
130682857|NCT00549718|470468071|FG002|Overall Study|Adverse Event|7|||
130682858|NCT00549718|470468072|FG003|Overall Study|Adverse Event|3|||
130682859|NCT00549718|470468069|FG000|Overall Study|Lost to Follow-up|4|||
130682860|NCT00549718|470468070|FG001|Overall Study|Lost to Follow-up|2|||
130682861|NCT00549718|470468071|FG002|Overall Study|Lost to Follow-up|0|||
130682862|NCT00549718|470468072|FG003|Overall Study|Lost to Follow-up|6|||
130682863|NCT00549718|470468069|FG000|Overall Study|Withdrawal by Subject|9|||
130682864|NCT00549718|470468070|FG001|Overall Study|Withdrawal by Subject|18|||
130682865|NCT00549718|470468071|FG002|Overall Study|Withdrawal by Subject|12|||
130682866|NCT00549718|470468072|FG003|Overall Study|Withdrawal by Subject|13|||
130682867|NCT00549718|470468069|FG000|Overall Study|Administrative|2|||
130682868|NCT00549718|470468070|FG001|Overall Study|Administrative|2|||
130682869|NCT00549718|470468071|FG002|Overall Study|Administrative|2|||
131104308|NCT00700258|472012804|FG000|Overall Study|Premature discontinuation of documentation|136|||
131104309|NCT00700258|472012804|FG000|Overall Study|Type of study end not documented|1|||
131104310|NCT00700258|472012804|FG000|Overall Study|Lost to Follow-up|81|||
131104311|NCT00700258|472012804|FG000|Overall Study|Premature discontinuation of therapy|1013|||
131104312|NCT00738582|472012808|FG000|Combination Therapy|Completed Combination Therapy|1|||
131104313|NCT00738582|472012809|FG001|Combination Therapy|Completed Combination Therapy|0|||
131104314|NCT00738582|472012808|FG000|Combination Therapy|Physician Decision|1|||
131104315|NCT00738582|472012809|FG001|Combination Therapy|Physician Decision|0|||
131104316|NCT00738582|472012808|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
130682870|NCT00549718|470468072|FG003|Overall Study|Administrative|1|||
130682871|NCT01675622|470468075|FG000|Overall Study|Withdrawal by Subject|2|||
130682872|NCT01675622|470468076|FG001|Overall Study|Withdrawal by Subject|2|||
130682873|NCT01675622|470468075|FG000|Overall Study|Adverse Event|12|||
130682874|NCT01675622|470468076|FG001|Overall Study|Adverse Event|10|||
130682875|NCT01675622|470468075|FG000|Overall Study|Protocol Violation|4|||
130682876|NCT01675622|470468076|FG001|Overall Study|Protocol Violation|1|||
130682877|NCT01675622|470468075|FG000|Overall Study|Lack of Efficacy|2|||
130682878|NCT01675622|470468076|FG001|Overall Study|Lack of Efficacy|4|||
130682879|NCT01675622|470468075|FG000|Overall Study|Lost to Follow-up|1|||
130682880|NCT01675622|470468076|FG001|Overall Study|Lost to Follow-up|3|||
130682881|NCT01675622|470468075|FG000|Overall Study|Other|5|||
130682882|NCT01675622|470468076|FG001|Overall Study|Other|4|||
130682883|NCT04032977|470468077|FG000|Overall Study|Withdrawal by Subject|6|||
130682884|NCT04032977|470468078|FG001|Overall Study|Withdrawal by Subject|1|||
130682885|NCT04032977|470468077|FG000|Overall Study|Lost to Follow-up|2|||
130682886|NCT04032977|470468078|FG001|Overall Study|Lost to Follow-up|7|||
130682887|NCT04032977|470468077|FG000|Overall Study|Pregnancy|1|||
130682888|NCT04032977|470468078|FG001|Overall Study|Pregnancy|0|||
131104317|NCT00738582|472012809|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
131104318|NCT00738582|472012808|FG000|Combination Therapy|Other|5|||
131104319|NCT00738582|472012809|FG001|Combination Therapy|Other|0|||
130682889|NCT02880761|470468080|FG000|Overall Study|Death|6|||
130766687|NCT03334422|470770602|FG003|Overall Study|Lost to Follow-up|1|||
130766688|NCT03334422|470770599|FG000|Overall Study|Inability to obtain laboratory samples|0|||
130766689|NCT03334422|470770600|FG001|Overall Study|Inability to obtain laboratory samples|1|||
130766690|NCT03334422|470770601|FG002|Overall Study|Inability to obtain laboratory samples|0|||
130766691|NCT03334422|470770602|FG003|Overall Study|Inability to obtain laboratory samples|0|||
130766692|NCT03334422|470770599|FG000|Overall Study|Pregnancy|0|||
130766693|NCT03334422|470770600|FG001|Overall Study|Pregnancy|1|||
130766694|NCT03334422|470770601|FG002|Overall Study|Pregnancy|0|||
130766695|NCT03334422|470770602|FG003|Overall Study|Pregnancy|0|||
130766696|NCT01313221|470770605|FG000|Overall Study|Protocol Violation|0|||
130766697|NCT01313221|470770606|FG001|Overall Study|Protocol Violation|1|||
130766698|NCT01313221|470770607|FG002|Overall Study|Protocol Violation|1|||
130766699|NCT01313221|470770605|FG000|Overall Study|Non-compliance|3|||
130766700|NCT01313221|470770606|FG001|Overall Study|Non-compliance|0|||
130766701|NCT01313221|470770607|FG002|Overall Study|Non-compliance|2|||
130766702|NCT01313221|470770605|FG000|Overall Study|Withdrawal by Subject|2|||
130766703|NCT01313221|470770606|FG001|Overall Study|Withdrawal by Subject|3|||
130766704|NCT01313221|470770607|FG002|Overall Study|Withdrawal by Subject|5|||
130766705|NCT01313221|470770605|FG000|Overall Study|Requirement for alternative therapy|0|||
130766706|NCT01313221|470770606|FG001|Overall Study|Requirement for alternative therapy|1|||
130766707|NCT01313221|470770607|FG002|Overall Study|Requirement for alternative therapy|1|||
130766708|NCT01313221|470770605|FG000|Overall Study|Lost to Follow-up|6|||
130766709|NCT01313221|470770606|FG001|Overall Study|Lost to Follow-up|3|||
130766710|NCT01313221|470770607|FG002|Overall Study|Lost to Follow-up|1|||
130766711|NCT01313221|470770605|FG000|Overall Study|Other|1|||
130766712|NCT01313221|470770606|FG001|Overall Study|Other|0|||
130766713|NCT01313221|470770607|FG002|Overall Study|Other|0|||
130766714|NCT01313221|470770605|FG000|Overall Study|Adverse Event|0|||
130766715|NCT01313221|470770606|FG001|Overall Study|Adverse Event|0|||
130766716|NCT01313221|470770607|FG002|Overall Study|Adverse Event|7|||
130766717|NCT01313221|470770605|FG000|Overall Study|Disease progression|0|||
130766718|NCT01313221|470770606|FG001|Overall Study|Disease progression|0|||
130766719|NCT01313221|470770607|FG002|Overall Study|Disease progression|2|||
130766720|NCT01313221|470770605|FG000|Overall Study|Physician Decision|0|||
130766721|NCT01313221|470770606|FG001|Overall Study|Physician Decision|0|||
131017744|NCT00004124|471695892|FG000|Overall Study|Received no protocol therapy|12|||
131017745|NCT00004124|471695893|FG001|Overall Study|Received no protocol therapy|20|||
131017746|NCT01759264|471695894|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
131017747|NCT01759264|471695894|FG000|Overall Study|Adverse Event|1|||
131017748|NCT01759264|471695894|FG000|Overall Study|Other|2|||
131017749|NCT01759264|471695894|FG000|Overall Study|Lost to Follow-up|2|||
131017750|NCT01759264|471695894|FG000|Overall Study|Withdrawal by Subject|3|||
131017751|NCT01759264|471695894|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
131017752|NCT02013830|471695895|FG000|Overall Study|Adverse Event|3|||
131017753|NCT02013830|471695895|FG000|Overall Study|Death|1|||
131017754|NCT02013830|471695895|FG000|Overall Study|Insufficient therapeutic response|25|||
131017755|NCT02013830|471695895|FG000|Overall Study|Refused treatment|1|||
131017756|NCT00186186|471695899|FG000|Overall Study|Lack of Efficacy|3|||
131104320|NCT00738582|472012808|FG000|Combination Therapy|Adverse Event|16|||
130682890|NCT02880761|470468081|FG001|Overall Study|Death|8|||
130682891|NCT02880761|470468080|FG000|Overall Study|Withdrawal by Subject|3|||
131017757|NCT00186186|471695899|FG000|Overall Study|Withdrawal by Subject|3|||
131017758|NCT00186186|471695899|FG000|Overall Study|Not reported as to reason|2|||
131017759|NCT01337635|471695900|FG000|Overall Study|Lost to Follow-up|0|||
131017760|NCT01337635|471695901|FG001|Overall Study|Lost to Follow-up|1|||
131017761|NCT02567656|471695904|FG000|Overall Study|Premature discontinuation due to PD|1|||
130682892|NCT02880761|470468081|FG001|Overall Study|Withdrawal by Subject|6|||
130682893|NCT02880761|470468080|FG000|Overall Study|Protocol Violation|4|||
130682894|NCT02880761|470468081|FG001|Overall Study|Protocol Violation|3|||
130766722|NCT01313221|470770607|FG002|Overall Study|Physician Decision|2|||
130766723|NCT01313221|470770605|FG000|Overall Study|Pregnancy|0|||
130682895|NCT02880761|470468080|FG000|Overall Study|Lost to Follow-up|3|||
130682896|NCT02880761|470468081|FG001|Overall Study|Lost to Follow-up|4|||
130682897|NCT03075761|470468082|FG000|Overall Study|Lost to Follow-up|1|||
130682898|NCT03075761|470468083|FG001|Overall Study|Lost to Follow-up|6|||
130682899|NCT03597256|470468084|FG000|Overall Study|Lost to Follow-up|3|||
130682900|NCT03597256|470468085|FG001|Overall Study|Lost to Follow-up|1|||
130682901|NCT03597256|470468084|FG000|Overall Study|Withdrawal by Subject|0|||
130682902|NCT03597256|470468085|FG001|Overall Study|Withdrawal by Subject|1|||
130682903|NCT03597256|470468084|FG000|Overall Study|Could not return for treatment|0|||
130682904|NCT03597256|470468085|FG001|Overall Study|Could not return for treatment|1|||
130682905|NCT03597256|470468084|FG000|Overall Study|Moved from location|0|||
130682906|NCT03597256|470468085|FG001|Overall Study|Moved from location|1|||
130682907|NCT03597256|470468084|FG000|Overall Study|Not accepted the treatment|0|||
130682908|NCT03597256|470468085|FG001|Overall Study|Not accepted the treatment|1|||
130682909|NCT02106156|470468086|FG000|Overall Study|Patient Died|19|||
130682910|NCT02106156|470468087|FG001|Overall Study|Patient Died|0|||
130682911|NCT02106156|470468088|FG002|Overall Study|Patient Died|0|||
130682912|NCT02106156|470468086|FG000|Overall Study|Lack of Tolerability|305|||
130682913|NCT02106156|470468087|FG001|Overall Study|Lack of Tolerability|3|||
130682914|NCT02106156|470468088|FG002|Overall Study|Lack of Tolerability|0|||
130682915|NCT02106156|470468086|FG000|Overall Study|Lack of Virological Response|1044|||
130682916|NCT02106156|470468087|FG001|Overall Study|Lack of Virological Response|8|||
130682917|NCT02106156|470468088|FG002|Overall Study|Lack of Virological Response|0|||
130682918|NCT02106156|470468086|FG000|Overall Study|Concomitant Disease|74|||
130682919|NCT02106156|470468087|FG001|Overall Study|Concomitant Disease|2|||
130682920|NCT02106156|470468088|FG002|Overall Study|Concomitant Disease|0|||
130682921|NCT02106156|470468086|FG000|Overall Study|Lack of Compliance|211|||
130682922|NCT02106156|470468087|FG001|Overall Study|Lack of Compliance|7|||
130682923|NCT02106156|470468088|FG002|Overall Study|Lack of Compliance|0|||
130682924|NCT02106156|470468086|FG000|Overall Study|Patients Request|307|||
130682925|NCT02106156|470468087|FG001|Overall Study|Patients Request|9|||
130682926|NCT02106156|470468088|FG002|Overall Study|Patients Request|0|||
130682927|NCT02106156|470468086|FG000|Overall Study|Lost to Follow-up|451|||
130682928|NCT02106156|470468087|FG001|Overall Study|Lost to Follow-up|8|||
130682929|NCT02106156|470468088|FG002|Overall Study|Lost to Follow-up|0|||
130682930|NCT02106156|470468086|FG000|Overall Study|Unplanned Event|82|||
130682931|NCT02106156|470468087|FG001|Overall Study|Unplanned Event|2|||
130682932|NCT02106156|470468088|FG002|Overall Study|Unplanned Event|0|||
131104321|NCT00738582|472012809|FG001|Combination Therapy|Adverse Event|0|||
131104322|NCT00738582|472012808|FG000|Combination Therapy|Progressive Disease|9|||
131104323|NCT00738582|472012809|FG001|Combination Therapy|Progressive Disease|0|||
131104324|NCT00738582|472012808|FG000|Maintenance Therapy|Other|0|||
131104325|NCT00738582|472012809|FG001|Maintenance Therapy|Other|2|||
131104326|NCT00738582|472012808|FG000|Maintenance Therapy|Adverse Event|0|||
131104327|NCT00738582|472012809|FG001|Maintenance Therapy|Adverse Event|6|||
131104328|NCT00738582|472012808|FG000|Maintenance Therapy|Progressive Disease|0|||
131104329|NCT00738582|472012809|FG001|Maintenance Therapy|Progressive Disease|47|||
131104330|NCT00738582|472012808|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
131104331|NCT00738582|472012809|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
131104332|NCT00757588|472012810|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
131104333|NCT00757588|472012811|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
131104334|NCT00757588|472012810|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
131104335|NCT00757588|472012811|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
131104336|NCT00757588|472012810|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
131104337|NCT00757588|472012811|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
131104338|NCT00757588|472012810|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
131104339|NCT00757588|472012811|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
131104340|NCT00757588|472012810|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
131104341|NCT00757588|472012811|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
131104342|NCT00757588|472012810|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
131104343|NCT00757588|472012811|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
131104344|NCT00757588|472012810|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
131104345|NCT00757588|472012811|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
130682933|NCT02106156|470468086|FG000|Overall Study|Change of Laboratory Parameter|10|||
131104346|NCT00757588|472012810|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
131104347|NCT00757588|472012811|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
131222608|NCT01902134|472443116|FG003|Overall Study|no compliance|0|||
130682934|NCT02106156|470468087|FG001|Overall Study|Change of Laboratory Parameter|0|||
130682935|NCT02106156|470468088|FG002|Overall Study|Change of Laboratory Parameter|0|||
130682936|NCT02106156|470468086|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
130682937|NCT02106156|470468087|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
130682938|NCT02106156|470468088|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
130682939|NCT02106156|470468086|FG000|Overall Study|Relocation/Change of Physician|40|||
130720847|NCT04126213|470601550|FG005|Overall Study|Lost to Follow-up|7|||
130682940|NCT02106156|470468087|FG001|Overall Study|Relocation/Change of Physician|1|||
130682941|NCT02106156|470468088|FG002|Overall Study|Relocation/Change of Physician|0|||
130682942|NCT05017480|470468098|FG000|Stage 1 Study|Withdrawal by Subject|8|||
130682943|NCT05017480|470468099|FG001|Stage 1 Study|Withdrawal by Subject|6|||
130682944|NCT05017480|470468100|FG002|Stage 1 Study|Withdrawal by Subject|0|||
130682945|NCT05017480|470468101|FG003|Stage 1 Study|Withdrawal by Subject|0|||
130682946|NCT05017480|470468102|FG004|Stage 1 Study|Withdrawal by Subject|0|||
130682947|NCT05017480|470468098|FG000|Stage 1 Study|Adverse Event|1|||
130682948|NCT05017480|470468099|FG001|Stage 1 Study|Adverse Event|1|||
130682949|NCT05017480|470468100|FG002|Stage 1 Study|Adverse Event|0|||
130682950|NCT05017480|470468101|FG003|Stage 1 Study|Adverse Event|0|||
130682951|NCT05017480|470468102|FG004|Stage 1 Study|Adverse Event|0|||
130682952|NCT05017480|470468098|FG000|Stage 1 Study|Poor Compliance|1|||
130682953|NCT05017480|470468099|FG001|Stage 1 Study|Poor Compliance|1|||
130682954|NCT05017480|470468100|FG002|Stage 1 Study|Poor Compliance|0|||
130682955|NCT05017480|470468101|FG003|Stage 1 Study|Poor Compliance|0|||
130682956|NCT05017480|470468102|FG004|Stage 1 Study|Poor Compliance|0|||
131017762|NCT02567656|471695905|FG001|Overall Study|Premature discontinuation due to PD|1|||
131017763|NCT02567656|471695906|FG002|Overall Study|Premature discontinuation due to PD|2|||
131017764|NCT02567656|471695907|FG003|Overall Study|Premature discontinuation due to PD|0|||
131017765|NCT02567656|471695908|FG004|Overall Study|Premature discontinuation due to PD|0|||
131017766|NCT02567656|471695909|FG005|Overall Study|Premature discontinuation due to PD|0|||
131017767|NCT01307267|471695910|FG000|Overall Study|Death|4|||
131017768|NCT01307267|471695911|FG001|Overall Study|Death|3|||
131017769|NCT01307267|471695912|FG002|Overall Study|Death|5|||
131017770|NCT01307267|471695913|FG003|Overall Study|Death|3|||
131017771|NCT01307267|471695914|FG004|Overall Study|Death|1|||
131017772|NCT01307267|471695915|FG005|Overall Study|Death|26|||
131017773|NCT01307267|471695916|FG006|Overall Study|Death|2|||
131017774|NCT01307267|471695917|FG007|Overall Study|Death|2|||
131017775|NCT01307267|471695918|FG008|Overall Study|Death|21|||
131017776|NCT01307267|471695919|FG009|Overall Study|Death|2|||
131017777|NCT01307267|471695920|FG010|Overall Study|Death|3|||
130766724|NCT01313221|470770606|FG001|Overall Study|Pregnancy|0|||
130766725|NCT01313221|470770607|FG002|Overall Study|Pregnancy|2|||
130766726|NCT00994214|470770608|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
130766727|NCT00994214|470770609|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
130766728|NCT00994214|470770610|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
130766729|NCT00994214|470770611|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
130766730|NCT00994214|470770608|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
130766731|NCT00994214|470770609|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
130766732|NCT00994214|470770610|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
130766733|NCT00994214|470770611|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
130766734|NCT00994214|470770608|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
130766735|NCT00994214|470770609|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
130766736|NCT00994214|470770610|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
130766737|NCT00994214|470770611|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
130766738|NCT00994214|470770608|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
130766739|NCT00994214|470770609|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
130766740|NCT00994214|470770610|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
130766741|NCT00994214|470770611|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
130766742|NCT00994214|470770608|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
130766743|NCT00994214|470770609|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
130766744|NCT00994214|470770610|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
130766745|NCT00994214|470770611|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
130766746|NCT00994214|470770608|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
130766747|NCT00994214|470770609|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
130766748|NCT00994214|470770610|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
130766749|NCT00994214|470770611|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
130766750|NCT01698268|470770615|FG000|Overall Study|Physician Decision|2|||
130766751|NCT01698268|470770616|FG001|Overall Study|Physician Decision|1|||
130766752|NCT00298363|470770617|FG000|Overall Study|Lost to Follow-up|0|||
130766753|NCT00298363|470770618|FG001|Overall Study|Lost to Follow-up|0|||
130766754|NCT00298363|470770619|FG002|Overall Study|Lost to Follow-up|1|||
130766755|NCT00298363|470770617|FG000|Overall Study|Physician Decision|4|||
130766756|NCT00298363|470770618|FG001|Overall Study|Physician Decision|1|||
130766757|NCT00298363|470770619|FG002|Overall Study|Physician Decision|0|||
130766758|NCT00298363|470770617|FG000|Overall Study|Protocol Violation|1|||
131017778|NCT01307267|471695921|FG011|Overall Study|Death|9|||
130682957|NCT05017480|470468098|FG000|Stage 1 Study|Physician Decision|0|||
130682958|NCT05017480|470468099|FG001|Stage 1 Study|Physician Decision|1|||
130682959|NCT05017480|470468100|FG002|Stage 1 Study|Physician Decision|0|||
130682960|NCT05017480|470468101|FG003|Stage 1 Study|Physician Decision|0|||
131104348|NCT00757588|472012810|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
131104349|NCT00757588|472012811|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
131104350|NCT00757588|472012810|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
131104351|NCT00757588|472012811|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
131104352|NCT00757588|472012810|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
131104353|NCT00757588|472012811|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
131104354|NCT00757588|472012810|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
131104355|NCT00757588|472012811|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
131104356|NCT00757588|472012810|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
131104357|NCT00757588|472012811|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
131104358|NCT00757588|472012810|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
131104359|NCT00757588|472012811|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
131104360|NCT00757588|472012810|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
131104361|NCT00757588|472012811|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
131104362|NCT00757588|472012810|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
131104363|NCT00757588|472012811|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
131104364|NCT01052103|472012812|FG000|Overall Study|Adverse Event|10|||
131104365|NCT01052103|472012813|FG001|Overall Study|Adverse Event|6|||
131104366|NCT01052103|472012812|FG000|Overall Study|Entry Criteria Not Met|3|||
131104367|NCT01052103|472012813|FG001|Overall Study|Entry Criteria Not Met|1|||
131104368|NCT01052103|472012812|FG000|Overall Study|Lost to Follow-up|3|||
131104369|NCT01052103|472012813|FG001|Overall Study|Lost to Follow-up|5|||
131104370|NCT01052103|472012812|FG000|Overall Study|Protocol Violation|10|||
131104371|NCT01052103|472012813|FG001|Overall Study|Protocol Violation|4|||
131104372|NCT01052103|472012812|FG000|Overall Study|Scheduling conflict|2|||
131104373|NCT01052103|472012813|FG001|Overall Study|Scheduling conflict|1|||
131104374|NCT01052103|472012812|FG000|Overall Study|Sponsor Decision|2|||
131104375|NCT01052103|472012813|FG001|Overall Study|Sponsor Decision|0|||
131104376|NCT01052103|472012812|FG000|Overall Study|Withdrawal by Subject|3|||
131104377|NCT01052103|472012813|FG001|Overall Study|Withdrawal by Subject|6|||
131104378|NCT01052103|472012812|FG000|Overall Study|Perceived Lack of Efficacy|1|||
131104379|NCT01052103|472012813|FG001|Overall Study|Perceived Lack of Efficacy|0|||
131104380|NCT00799513|472012817|FG000|Overall Study|Physician Decision|1|||
131104381|NCT00799513|472012817|FG000|Overall Study|Adverse Event|1|||
131104382|NCT05398237|472012820|FG000|Overall Study|Withdrawal by Subject|1|||
131104383|NCT05062759|472012826|FG000|Overall Study|Death|0|||
131104384|NCT05062759|472012827|FG001|Overall Study|Death|1|||
131104385|NCT05062759|472012826|FG000|Overall Study|Lost to Follow-up|1|||
131104386|NCT05062759|472012827|FG001|Overall Study|Lost to Follow-up|0|||
131104387|NCT01248065|472012828|FG000|Overall Study|Lost to Follow-up|3|||
131104388|NCT01248065|472012829|FG001|Overall Study|Lost to Follow-up|5|||
131104389|NCT01248065|472012828|FG000|Overall Study|Withdrawal by Subject|14|||
131104390|NCT01248065|472012829|FG001|Overall Study|Withdrawal by Subject|11|||
131104391|NCT01248065|472012828|FG000|Overall Study|Adverse Event|3|||
131104392|NCT01248065|472012829|FG001|Overall Study|Adverse Event|0|||
131104393|NCT01248065|472012828|FG000|Overall Study|Third treatment failure event|3|||
131104394|NCT01248065|472012829|FG001|Overall Study|Third treatment failure event|1|||
131104395|NCT01248065|472012828|FG000|Overall Study|Other|3|||
131104396|NCT01248065|472012829|FG001|Overall Study|Other|5|||
130682961|NCT05017480|470468102|FG004|Stage 1 Study|Physician Decision|0|||
131104397|NCT02781844|472012831|FG000|Treatment Period 1|Adverse Event|0|||
131104398|NCT02781844|472012832|FG001|Treatment Period 1|Adverse Event|0|||
131104399|NCT02781844|472012833|FG002|Treatment Period 1|Adverse Event|0|||
131104400|NCT02781844|472012834|FG003|Treatment Period 1|Adverse Event|0|||
130682962|NCT05017480|470468098|FG000|Stage 2 Study|Withdrawal by Subject|0|||
130682963|NCT05017480|470468099|FG001|Stage 2 Study|Withdrawal by Subject|0|||
130682964|NCT05017480|470468100|FG002|Stage 2 Study|Withdrawal by Subject|6|||
131104401|NCT02781844|472012835|FG004|Treatment Period 1|Adverse Event|0|||
131104402|NCT02781844|472012836|FG005|Treatment Period 1|Adverse Event|1|||
131104403|NCT02781844|472012837|FG006|Treatment Period 1|Adverse Event|0|||
131104404|NCT02781844|472012838|FG007|Treatment Period 1|Adverse Event|0|||
131104405|NCT02518490|472012839|FG000|Overall Study|Withdrawal by Subject|1|||
130682965|NCT05017480|470468101|FG003|Stage 2 Study|Withdrawal by Subject|9|||
130682966|NCT05017480|470468102|FG004|Stage 2 Study|Withdrawal by Subject|11|||
130682967|NCT05017480|470468098|FG000|Stage 2 Study|Lost to Follow-up|0|||
131104406|NCT02518490|472012840|FG001|Overall Study|Withdrawal by Subject|1|||
131104407|NCT03010176|472012841|FG000|Overall Study|Death|21|||
131104408|NCT03010176|472012842|FG001|Overall Study|Death|35|||
130682968|NCT05017480|470468099|FG001|Stage 2 Study|Lost to Follow-up|0|||
130682969|NCT05017480|470468100|FG002|Stage 2 Study|Lost to Follow-up|0|||
131104409|NCT03010176|472012843|FG002|Overall Study|Death|19|||
131104410|NCT03010176|472012844|FG003|Overall Study|Death|19|||
131104411|NCT03010176|472012845|FG004|Overall Study|Death|14|||
131104412|NCT03010176|472012846|FG005|Overall Study|Death|0|||
131104413|NCT03010176|472012841|FG000|Overall Study|Lost to Follow-up|0|||
130682970|NCT05017480|470468101|FG003|Stage 2 Study|Lost to Follow-up|2|||
130682971|NCT05017480|470468102|FG004|Stage 2 Study|Lost to Follow-up|1|||
130766759|NCT00298363|470770618|FG001|Overall Study|Protocol Violation|1|||
130766760|NCT00298363|470770619|FG002|Overall Study|Protocol Violation|0|||
130766761|NCT00298363|470770617|FG000|Overall Study|Withdrawal by Subject|5|||
130766762|NCT00298363|470770618|FG001|Overall Study|Withdrawal by Subject|1|||
130766763|NCT00298363|470770619|FG002|Overall Study|Withdrawal by Subject|3|||
130766764|NCT00298363|470770617|FG000|Overall Study|Adverse Event|5|||
130766765|NCT00298363|470770618|FG001|Overall Study|Adverse Event|2|||
130766766|NCT00298363|470770619|FG002|Overall Study|Adverse Event|2|||
130766767|NCT00298363|470770617|FG000|Overall Study|Lack of Efficacy|2|||
130766768|NCT00298363|470770618|FG001|Overall Study|Lack of Efficacy|3|||
130766769|NCT00298363|470770619|FG002|Overall Study|Lack of Efficacy|0|||
130766770|NCT04710368|470770620|FG000|Overall Study|Withdrawal by Subject|9|||
130766771|NCT04710368|470770620|FG000|Overall Study|Lost to Follow-up|4|||
130766772|NCT04710368|470770620|FG000|Overall Study|Death|2|||
130766773|NCT04710368|470770620|FG000|Overall Study|Patient preference|11|||
130766774|NCT04710368|470770620|FG000|Overall Study|Treatment discontinuation|1|||
130766775|NCT00135356|470770621|FG000|Overall Study|Adverse Event|6|||
130766776|NCT00135356|470770622|FG001|Overall Study|Adverse Event|2|||
130766777|NCT00135356|470770621|FG000|Overall Study|Lack of Efficacy|2|||
130766778|NCT00135356|470770622|FG001|Overall Study|Lack of Efficacy|0|||
130766779|NCT00135356|470770621|FG000|Overall Study|Lost to Follow-up|3|||
130766780|NCT00135356|470770622|FG001|Overall Study|Lost to Follow-up|1|||
130766781|NCT00135356|470770621|FG000|Overall Study|Surgery for abdominal fat|1|||
130766782|NCT00135356|470770622|FG001|Overall Study|Surgery for abdominal fat|0|||
130766783|NCT00135356|470770621|FG000|Overall Study|Change in antiviral regimen|0|||
130766784|NCT00135356|470770622|FG001|Overall Study|Change in antiviral regimen|1|||
130766785|NCT00135356|470770621|FG000|Overall Study|Poor/noncompliance|1|||
130766786|NCT00135356|470770622|FG001|Overall Study|Poor/noncompliance|1|||
130766787|NCT00135356|470770621|FG000|Overall Study|No longer meets study criteria|2|||
130766788|NCT00135356|470770622|FG001|Overall Study|No longer meets study criteria|0|||
130766789|NCT00135356|470770621|FG000|Overall Study|Withdrawal by Subject|2|||
130766790|NCT00135356|470770622|FG001|Overall Study|Withdrawal by Subject|4|||
130766791|NCT00153816|470770623|FG000|Overall Study|Death|6|||
130766792|NCT00153816|470770624|FG001|Overall Study|Death|5|||
130766793|NCT00153816|470770625|FG002|Overall Study|Death|4|||
131017779|NCT01307267|471695922|FG012|Overall Study|Death|0|||
131017780|NCT01307267|471695923|FG013|Overall Study|Death|0|||
131017781|NCT01307267|471695924|FG014|Overall Study|Death|0|||
131017782|NCT01307267|471695925|FG015|Overall Study|Death|0|||
131017783|NCT01307267|471695926|FG016|Overall Study|Death|1|||
131017784|NCT01307267|471695927|FG017|Overall Study|Death|1|||
131017785|NCT01307267|471695928|FG018|Overall Study|Death|2|||
131017786|NCT01307267|471695929|FG019|Overall Study|Death|8|||
131017787|NCT01307267|471695930|FG020|Overall Study|Death|1|||
131017788|NCT01307267|471695931|FG021|Overall Study|Death|2|||
131017789|NCT01307267|471695932|FG022|Overall Study|Death|2|||
131017790|NCT01307267|471695910|FG000|Overall Study|Lost to Follow-up|0|||
131017791|NCT01307267|471695911|FG001|Overall Study|Lost to Follow-up|0|||
131017792|NCT01307267|471695912|FG002|Overall Study|Lost to Follow-up|0|||
131017793|NCT01307267|471695913|FG003|Overall Study|Lost to Follow-up|0|||
131017794|NCT01307267|471695914|FG004|Overall Study|Lost to Follow-up|0|||
131017795|NCT01307267|471695915|FG005|Overall Study|Lost to Follow-up|7|||
131017796|NCT01307267|471695916|FG006|Overall Study|Lost to Follow-up|0|||
130766794|NCT00153816|470770626|FG003|Overall Study|Death|6|||
130766795|NCT00153816|470770627|FG004|Overall Study|Death|0|||
130766796|NCT00153816|470770628|FG005|Overall Study|Death|2|||
130766797|NCT00153816|470770623|FG000|Overall Study|Lost to Follow-up|7|||
130766798|NCT00153816|470770624|FG001|Overall Study|Lost to Follow-up|8|||
130766799|NCT00153816|470770625|FG002|Overall Study|Lost to Follow-up|5|||
130766800|NCT00153816|470770626|FG003|Overall Study|Lost to Follow-up|8|||
130766801|NCT00153816|470770627|FG004|Overall Study|Lost to Follow-up|7|||
130766802|NCT00153816|470770628|FG005|Overall Study|Lost to Follow-up|9|||
130682972|NCT05017480|470468098|FG000|Stage 2 Study|Adverse Event|0|||
130682973|NCT05017480|470468099|FG001|Stage 2 Study|Adverse Event|0|||
130682974|NCT05017480|470468100|FG002|Stage 2 Study|Adverse Event|0|||
130682975|NCT05017480|470468101|FG003|Stage 2 Study|Adverse Event|1|||
130682976|NCT05017480|470468102|FG004|Stage 2 Study|Adverse Event|0|||
130766803|NCT00153816|470770623|FG000|Overall Study|Withdrawal by Subject|9|||
130766804|NCT00153816|470770624|FG001|Overall Study|Withdrawal by Subject|9|||
130766805|NCT00153816|470770625|FG002|Overall Study|Withdrawal by Subject|9|||
130766806|NCT00153816|470770626|FG003|Overall Study|Withdrawal by Subject|4|||
130766807|NCT00153816|470770627|FG004|Overall Study|Withdrawal by Subject|1|||
131017797|NCT01307267|471695917|FG007|Overall Study|Lost to Follow-up|0|||
131017798|NCT01307267|471695918|FG008|Overall Study|Lost to Follow-up|1|||
131017799|NCT01307267|471695919|FG009|Overall Study|Lost to Follow-up|2|||
131017800|NCT01307267|471695920|FG010|Overall Study|Lost to Follow-up|1|||
131104414|NCT03010176|472012842|FG001|Overall Study|Lost to Follow-up|0|||
130766808|NCT00153816|470770628|FG005|Overall Study|Withdrawal by Subject|5|||
130766809|NCT00153816|470770623|FG000|Overall Study|Follow-up exam not done|8|||
131017801|NCT01307267|471695921|FG011|Overall Study|Lost to Follow-up|0|||
131017802|NCT01307267|471695922|FG012|Overall Study|Lost to Follow-up|0|||
131104415|NCT03010176|472012843|FG002|Overall Study|Lost to Follow-up|0|||
131104416|NCT03010176|472012844|FG003|Overall Study|Lost to Follow-up|0|||
131104417|NCT03010176|472012845|FG004|Overall Study|Lost to Follow-up|1|||
131104418|NCT03010176|472012846|FG005|Overall Study|Lost to Follow-up|0|||
131104419|NCT03010176|472012841|FG000|Overall Study|Physician Decision|0|||
131104420|NCT03010176|472012842|FG001|Overall Study|Physician Decision|4|||
131104421|NCT03010176|472012843|FG002|Overall Study|Physician Decision|0|||
131104422|NCT03010176|472012844|FG003|Overall Study|Physician Decision|1|||
131104423|NCT03010176|472012845|FG004|Overall Study|Physician Decision|0|||
131104424|NCT03010176|472012846|FG005|Overall Study|Physician Decision|0|||
131104425|NCT03010176|472012841|FG000|Overall Study|Sponsor Decision|0|||
131104426|NCT03010176|472012842|FG001|Overall Study|Sponsor Decision|4|||
131104427|NCT03010176|472012843|FG002|Overall Study|Sponsor Decision|4|||
131104428|NCT03010176|472012844|FG003|Overall Study|Sponsor Decision|1|||
131104429|NCT03010176|472012845|FG004|Overall Study|Sponsor Decision|6|||
131104430|NCT03010176|472012846|FG005|Overall Study|Sponsor Decision|0|||
131104431|NCT03010176|472012841|FG000|Overall Study|Withdrawal by Subject|11|||
131104432|NCT03010176|472012842|FG001|Overall Study|Withdrawal by Subject|9|||
131104433|NCT03010176|472012843|FG002|Overall Study|Withdrawal by Subject|3|||
131104434|NCT03010176|472012844|FG003|Overall Study|Withdrawal by Subject|0|||
131104435|NCT03010176|472012845|FG004|Overall Study|Withdrawal by Subject|4|||
131104436|NCT03010176|472012846|FG005|Overall Study|Withdrawal by Subject|0|||
131104437|NCT04256629|472012847|FG000|Overall Study|Adverse Event|0|||
131104438|NCT04256629|472012848|FG001|Overall Study|Adverse Event|0|||
131104439|NCT04256629|472012849|FG002|Overall Study|Adverse Event|0|||
131104440|NCT04256629|472012850|FG003|Overall Study|Adverse Event|0|||
131104441|NCT04256629|472012851|FG004|Overall Study|Adverse Event|0|||
131104442|NCT04256629|472012852|FG005|Overall Study|Adverse Event|1|||
131104443|NCT04256629|472012847|FG000|Overall Study|Protocol Violation|0|||
131104444|NCT04256629|472012848|FG001|Overall Study|Protocol Violation|1|||
131104445|NCT04256629|472012849|FG002|Overall Study|Protocol Violation|0|||
131104446|NCT04256629|472012850|FG003|Overall Study|Protocol Violation|0|||
131104447|NCT04256629|472012851|FG004|Overall Study|Protocol Violation|0|||
131104448|NCT04256629|472012852|FG005|Overall Study|Protocol Violation|0|||
131104449|NCT00321373|472012853|FG000|Overall Study|Adverse Event|0|||
131104450|NCT00321373|472012854|FG001|Overall Study|Adverse Event|0|||
131104451|NCT00321373|472012855|FG002|Overall Study|Adverse Event|1|||
131104452|NCT00321373|472012853|FG000|Overall Study|Lost to Follow-up|1|||
131104453|NCT00321373|472012854|FG001|Overall Study|Lost to Follow-up|0|||
131104454|NCT00321373|472012855|FG002|Overall Study|Lost to Follow-up|1|||
131104455|NCT00321373|472012853|FG000|Overall Study|Withdrawal by Subject|1|||
131104456|NCT00321373|472012854|FG001|Overall Study|Withdrawal by Subject|0|||
131104457|NCT00321373|472012855|FG002|Overall Study|Withdrawal by Subject|0|||
131104458|NCT00321373|472012853|FG000|Overall Study|Other|0|||
131104459|NCT00321373|472012854|FG001|Overall Study|Other|0|||
131104460|NCT00321373|472012855|FG002|Overall Study|Other|1|||
131104461|NCT01774487|472012856|FG000|Overall Study|Did not tolerate taste|4|||
131104462|NCT01774487|472012857|FG001|Overall Study|Did not tolerate taste|4|||
131104463|NCT01383499|472012858|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
131104464|NCT01383499|472012859|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131104465|NCT01383499|472012860|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131104466|NCT01383499|472012861|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
131104467|NCT00346632|472012862|FG000|Overall Study|Progressive Disease|2|||
131104468|NCT00346632|472012863|FG001|Overall Study|Progressive Disease|2|||
131104469|NCT00346632|472012864|FG002|Overall Study|Progressive Disease|4|||
131104470|NCT00346632|472012865|FG003|Overall Study|Progressive Disease|3|||
131104471|NCT00346632|472012866|FG004|Overall Study|Progressive Disease|3|||
131104472|NCT00346632|472012867|FG005|Overall Study|Progressive Disease|1|||
131104473|NCT00346632|472012868|FG006|Overall Study|Progressive Disease|2|||
131104474|NCT00346632|472012869|FG007|Overall Study|Progressive Disease|2|||
131104475|NCT00346632|472012870|FG008|Overall Study|Progressive Disease|2|||
131104476|NCT00346632|472012871|FG009|Overall Study|Progressive Disease|2|||
131104477|NCT00346632|472012862|FG000|Overall Study|Adverse Event|0|||
131104478|NCT00346632|472012863|FG001|Overall Study|Adverse Event|0|||
131104479|NCT00346632|472012864|FG002|Overall Study|Adverse Event|0|||
131104480|NCT00346632|472012865|FG003|Overall Study|Adverse Event|0|||
131104481|NCT00346632|472012866|FG004|Overall Study|Adverse Event|1|||
131104482|NCT00346632|472012867|FG005|Overall Study|Adverse Event|1|||
130682977|NCT05017480|470468098|FG000|Stage 2 Study|COVID-19|0|||
131104483|NCT00346632|472012868|FG006|Overall Study|Adverse Event|1|||
131104484|NCT00346632|472012869|FG007|Overall Study|Adverse Event|0|||
131104485|NCT00346632|472012870|FG008|Overall Study|Adverse Event|0|||
131104486|NCT00346632|472012871|FG009|Overall Study|Adverse Event|0|||
131104487|NCT00346632|472012862|FG000|Overall Study|Death|0|||
131104488|NCT00346632|472012863|FG001|Overall Study|Death|0|||
130682978|NCT05017480|470468099|FG001|Stage 2 Study|COVID-19|0|||
131104489|NCT00346632|472012864|FG002|Overall Study|Death|1|||
131104490|NCT00346632|472012865|FG003|Overall Study|Death|0|||
131104491|NCT00346632|472012866|FG004|Overall Study|Death|0|||
131104492|NCT00346632|472012867|FG005|Overall Study|Death|0|||
131104493|NCT00346632|472012868|FG006|Overall Study|Death|0|||
131104494|NCT00346632|472012869|FG007|Overall Study|Death|0|||
131104495|NCT00346632|472012870|FG008|Overall Study|Death|0|||
131104496|NCT00346632|472012871|FG009|Overall Study|Death|0|||
131104497|NCT00346632|472012862|FG000|Overall Study|Protocol Violation|0|||
131104498|NCT00346632|472012863|FG001|Overall Study|Protocol Violation|0|||
131104499|NCT00346632|472012864|FG002|Overall Study|Protocol Violation|0|||
131104500|NCT00346632|472012865|FG003|Overall Study|Protocol Violation|0|||
131104501|NCT00346632|472012866|FG004|Overall Study|Protocol Violation|0|||
131104502|NCT00346632|472012867|FG005|Overall Study|Protocol Violation|0|||
131104503|NCT00346632|472012868|FG006|Overall Study|Protocol Violation|1|||
131104504|NCT00346632|472012869|FG007|Overall Study|Protocol Violation|0|||
131104505|NCT00346632|472012870|FG008|Overall Study|Protocol Violation|0|||
131104506|NCT00346632|472012871|FG009|Overall Study|Protocol Violation|0|||
131104507|NCT00346632|472012862|FG000|Overall Study|Withdrawal by Subject|0|||
131104508|NCT00346632|472012863|FG001|Overall Study|Withdrawal by Subject|0|||
131104509|NCT00346632|472012864|FG002|Overall Study|Withdrawal by Subject|0|||
131104510|NCT00346632|472012865|FG003|Overall Study|Withdrawal by Subject|0|||
130682979|NCT05017480|470468100|FG002|Stage 2 Study|COVID-19|0|||
130682980|NCT05017480|470468101|FG003|Stage 2 Study|COVID-19|1|||
130682981|NCT05017480|470468102|FG004|Stage 2 Study|COVID-19|0|||
131104511|NCT00346632|472012866|FG004|Overall Study|Withdrawal by Subject|0|||
131104512|NCT00346632|472012867|FG005|Overall Study|Withdrawal by Subject|0|||
131104513|NCT00346632|472012868|FG006|Overall Study|Withdrawal by Subject|1|||
131104514|NCT00346632|472012869|FG007|Overall Study|Withdrawal by Subject|0|||
131104515|NCT00346632|472012870|FG008|Overall Study|Withdrawal by Subject|0|||
131104516|NCT00346632|472012871|FG009|Overall Study|Withdrawal by Subject|0|||
131104517|NCT00346632|472012862|FG000|Overall Study|Switched to alternative treatment|0|||
131104518|NCT00346632|472012863|FG001|Overall Study|Switched to alternative treatment|0|||
131104519|NCT00346632|472012864|FG002|Overall Study|Switched to alternative treatment|1|||
131104520|NCT00346632|472012865|FG003|Overall Study|Switched to alternative treatment|0|||
131104521|NCT00346632|472012866|FG004|Overall Study|Switched to alternative treatment|0|||
131104522|NCT00346632|472012867|FG005|Overall Study|Switched to alternative treatment|0|||
131104523|NCT00346632|472012868|FG006|Overall Study|Switched to alternative treatment|0|||
131104524|NCT00346632|472012869|FG007|Overall Study|Switched to alternative treatment|0|||
131104525|NCT00346632|472012870|FG008|Overall Study|Switched to alternative treatment|0|||
131104526|NCT00346632|472012871|FG009|Overall Study|Switched to alternative treatment|0|||
131104527|NCT00346632|472012862|FG000|Overall Study|Not Stated|1|||
131104528|NCT00346632|472012863|FG001|Overall Study|Not Stated|1|||
131104529|NCT00346632|472012864|FG002|Overall Study|Not Stated|0|||
131104530|NCT00346632|472012865|FG003|Overall Study|Not Stated|0|||
131104531|NCT00346632|472012866|FG004|Overall Study|Not Stated|0|||
131104532|NCT00346632|472012867|FG005|Overall Study|Not Stated|0|||
131104533|NCT00346632|472012868|FG006|Overall Study|Not Stated|0|||
131104534|NCT00346632|472012869|FG007|Overall Study|Not Stated|2|||
131104535|NCT00346632|472012870|FG008|Overall Study|Not Stated|2|||
131104536|NCT00346632|472012871|FG009|Overall Study|Not Stated|1|||
131104537|NCT00297232|472012872|FG000|Overall Study|Lack of Efficacy|7|||
131104538|NCT00297232|472012872|FG000|Overall Study|Lost to Follow-up|10|||
131104539|NCT00297232|472012872|FG000|Overall Study|Adverse Event|63|||
131104540|NCT00297232|472012872|FG000|Overall Study|Voluntary Withdrawal|120|||
131104541|NCT00297232|472012872|FG000|Overall Study|Subject was Noncompliant|9|||
131104542|NCT00297232|472012872|FG000|Overall Study|Death|9|||
131104543|NCT00297232|472012872|FG000|Overall Study|Anti-natalizumab Positive|8|||
131104544|NCT00297232|472012872|FG000|Overall Study|Switched to Commercial Tysabri|22|||
131104545|NCT00297232|472012872|FG000|Overall Study|Disease Progression|8|||
131104546|NCT00297232|472012872|FG000|Overall Study|Fear of PML|10|||
131104547|NCT00297232|472012872|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
131104548|NCT00297232|472012872|FG000|Overall Study|Miscellaneous|5|||
131104549|NCT00297232|472012872|FG000|Overall Study|Sponsor Decision|34|||
131104550|NCT00297232|472012872|FG000|Overall Study|Subject Relocated|7|||
130682982|NCT05017480|470468098|FG000|Stage 2 Study|Pregnancy|0|||
130682983|NCT05017480|470468099|FG001|Stage 2 Study|Pregnancy|0|||
130682984|NCT05017480|470468100|FG002|Stage 2 Study|Pregnancy|0|||
131104551|NCT00297232|472012872|FG000|Overall Study|Subject Withdrew Consent|37|||
131104552|NCT00297232|472012872|FG000|Overall Study|Persistently Positive Antibodies|11|||
131104553|NCT00297232|472012872|FG000|Overall Study|Investigator Withdrew From Program|19|||
131104554|NCT00297232|472012872|FG000|Overall Study|Did Not Enroll to Week 264|34|||
131104555|NCT00297232|472012872|FG000|Overall Study|Did Not Enroll to Week 480|17|||
131104556|NCT00297232|472012872|FG000|Overall Study|No data available after Week 264|161|||
131104557|NCT00297232|472012872|FG000|Overall Study|Other|1|||
131104558|NCT00946101|472012873|FG000|Overall Study|Lost to Follow-up|2|||
131104559|NCT00946101|472012874|FG001|Overall Study|Lost to Follow-up|1|||
131104560|NCT00946101|472012873|FG000|Overall Study|Withdrawal of consent|2|||
131104561|NCT00946101|472012874|FG001|Overall Study|Withdrawal of consent|0|||
131104562|NCT00946101|472012873|FG000|Overall Study|Physician Decision|0|||
131104563|NCT00946101|472012874|FG001|Overall Study|Physician Decision|1|||
131104564|NCT00552240|472012880|FG000|Overall Study|Adverse Event|9|||
130682985|NCT05017480|470468101|FG003|Stage 2 Study|Pregnancy|0|||
130682986|NCT05017480|470468102|FG004|Stage 2 Study|Pregnancy|1|||
130682987|NCT01136382|470468103|FG000|Overall Study|Other|8|||
130682988|NCT01136382|470468104|FG001|Overall Study|Other|3|||
130682989|NCT01136382|470468103|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
130682990|NCT01136382|470468104|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
130682991|NCT01136382|470468103|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
130682992|NCT01136382|470468104|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
130682993|NCT01136382|470468103|FG000|Overall Study|Withdrawal by Subject|4|||
130682994|NCT01136382|470468104|FG001|Overall Study|Withdrawal by Subject|1|||
130682995|NCT02653664|470468109|FG000|Post-Treatment|Withdrawal by Subject|6|||
130682996|NCT02653664|470468110|FG001|Post-Treatment|Withdrawal by Subject|5|||
130682997|NCT02653664|470468111|FG002|Post-Treatment|Withdrawal by Subject|7|||
131017803|NCT01307267|471695923|FG013|Overall Study|Lost to Follow-up|0|||
131017804|NCT01307267|471695924|FG014|Overall Study|Lost to Follow-up|0|||
131017805|NCT01307267|471695925|FG015|Overall Study|Lost to Follow-up|0|||
131017806|NCT01307267|471695926|FG016|Overall Study|Lost to Follow-up|0|||
130766810|NCT00153816|470770624|FG001|Overall Study|Follow-up exam not done|7|||
130766811|NCT00153816|470770625|FG002|Overall Study|Follow-up exam not done|11|||
130766812|NCT00153816|470770626|FG003|Overall Study|Follow-up exam not done|10|||
130766813|NCT00153816|470770627|FG004|Overall Study|Follow-up exam not done|8|||
130766814|NCT00153816|470770628|FG005|Overall Study|Follow-up exam not done|9|||
130766815|NCT00153816|470770623|FG000|Overall Study|Follow-up exam done, histology missing|2|||
130766816|NCT00153816|470770624|FG001|Overall Study|Follow-up exam done, histology missing|3|||
130766817|NCT00153816|470770625|FG002|Overall Study|Follow-up exam done, histology missing|3|||
130766818|NCT00153816|470770626|FG003|Overall Study|Follow-up exam done, histology missing|3|||
130766819|NCT00153816|470770627|FG004|Overall Study|Follow-up exam done, histology missing|1|||
130766820|NCT00153816|470770628|FG005|Overall Study|Follow-up exam done, histology missing|2|||
130766821|NCT01533688|470770629|FG000|Overall Study|Withdrawal by Subject|5|||
130766822|NCT01533688|470770630|FG001|Overall Study|Withdrawal by Subject|4|||
130766823|NCT01533688|470770631|FG002|Overall Study|Withdrawal by Subject|3|||
130766824|NCT01533688|470770629|FG000|Overall Study|Medically unstable|1|||
130766825|NCT01533688|470770630|FG001|Overall Study|Medically unstable|3|||
130766826|NCT01533688|470770631|FG002|Overall Study|Medically unstable|3|||
130766827|NCT01533688|470770629|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
130766828|NCT01533688|470770630|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
130766829|NCT01533688|470770631|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
130766830|NCT02509078|470770636|FG000|Overall Study|Protocol Violation|1|||
130766831|NCT02509078|470770637|FG001|Overall Study|Protocol Violation|1|||
130766832|NCT01211483|470770644|FG000|Phase 1b|Death|6|||
130766833|NCT01211483|470770645|FG001|Phase 1b|Death|0|||
130766834|NCT01211483|470770646|FG002|Phase 1b|Death|0|||
130766835|NCT01211483|470770647|FG003|Phase 1b|Death|0|||
130766836|NCT01211483|470770644|FG000|Phase 1b|Withdrawal by Subject|1|||
130766837|NCT01211483|470770645|FG001|Phase 1b|Withdrawal by Subject|0|||
130766838|NCT01211483|470770646|FG002|Phase 1b|Withdrawal by Subject|0|||
130766839|NCT01211483|470770647|FG003|Phase 1b|Withdrawal by Subject|0|||
130766840|NCT01211483|470770644|FG000|Phase 2|Lost to Follow-up|0|||
130766841|NCT01211483|470770645|FG001|Phase 2|Lost to Follow-up|1|||
130766842|NCT01211483|470770646|FG002|Phase 2|Lost to Follow-up|1|||
130766843|NCT01211483|470770647|FG003|Phase 2|Lost to Follow-up|2|||
130766844|NCT01211483|470770644|FG000|Phase 2|Death|0|||
130766845|NCT01211483|470770645|FG001|Phase 2|Death|64|||
130766846|NCT01211483|470770646|FG002|Phase 2|Death|53|||
130766847|NCT01211483|470770647|FG003|Phase 2|Death|53|||
130766848|NCT01211483|470770644|FG000|Phase 2|Withdrawal by Subject|0|||
130766849|NCT01211483|470770645|FG001|Phase 2|Withdrawal by Subject|1|||
130766850|NCT01211483|470770646|FG002|Phase 2|Withdrawal by Subject|10|||
130766851|NCT01211483|470770647|FG003|Phase 2|Withdrawal by Subject|5|||
130766852|NCT01211483|470770644|FG000|Phase 2|Study terminated by Sponsor|0|||
130766853|NCT01211483|470770645|FG001|Phase 2|Study terminated by Sponsor|6|||
130766854|NCT01211483|470770646|FG002|Phase 2|Study terminated by Sponsor|8|||
130766855|NCT01211483|470770647|FG003|Phase 2|Study terminated by Sponsor|11|||
130766856|NCT00460265|470770648|FG000|Overall Study|Lost to Follow-up|14|||
130682998|NCT02653664|470468109|FG000|Post-Treatment|Lost to Follow-up|8|||
130886577|NCT03486834|471217353|FG000|Overall Study|Physician Decision|5|||
130766857|NCT00460265|470770649|FG001|Overall Study|Lost to Follow-up|15|||
130682999|NCT02653664|470468110|FG001|Post-Treatment|Lost to Follow-up|1|||
130766858|NCT00460265|470770648|FG000|Overall Study|Physician Decision|1|||
130766859|NCT00460265|470770649|FG001|Overall Study|Physician Decision|2|||
130766860|NCT00460265|470770648|FG000|Overall Study|Withdrawal by Subject|10|||
130766861|NCT00460265|470770649|FG001|Overall Study|Withdrawal by Subject|25|||
130766862|NCT00460265|470770648|FG000|Overall Study|Ongoing|60|||
130766863|NCT00460265|470770649|FG001|Overall Study|Ongoing|47|||
130766864|NCT02719353|470770650|FG000|First Intervention|Physician Decision|0|||
130766865|NCT02719353|470770651|FG001|First Intervention|Physician Decision|1|||
130766866|NCT01917344|470770653|FG000|Overall Study|Withdrawal by Subject|1|||
130766867|NCT00412217|470770654|FG000|Overall Study|Insufficient Data Available|8|||
130766868|NCT00412217|470770655|FG001|Overall Study|Insufficient Data Available|3|||
131017807|NCT01307267|471695927|FG017|Overall Study|Lost to Follow-up|0|||
131017808|NCT01307267|471695928|FG018|Overall Study|Lost to Follow-up|0|||
131104565|NCT00552240|472012881|FG001|Overall Study|Adverse Event|9|||
131104566|NCT00552240|472012880|FG000|Overall Study|Protocol Violation|1|||
131104567|NCT00552240|472012881|FG001|Overall Study|Protocol Violation|1|||
131104568|NCT00552240|472012880|FG000|Overall Study|Lost to Follow-up|5|||
131104569|NCT00552240|472012881|FG001|Overall Study|Lost to Follow-up|6|||
131104570|NCT00552240|472012880|FG000|Overall Study|Withdrawal by Subject|2|||
131104571|NCT00552240|472012881|FG001|Overall Study|Withdrawal by Subject|2|||
131104572|NCT00552240|472012880|FG000|Overall Study|Lack of Efficacy|6|||
131104573|NCT00552240|472012881|FG001|Overall Study|Lack of Efficacy|0|||
131104574|NCT00552240|472012880|FG000|Overall Study|Other|1|||
131104575|NCT00552240|472012881|FG001|Overall Study|Other|0|||
131104576|NCT02783768|472012883|FG000|Overall Study|Lost to Follow-up|1|||
131104577|NCT02783768|472012884|FG001|Overall Study|Lost to Follow-up|0|||
131104578|NCT02476279|472012885|FG000|Overall Study|Lost to Follow-up|1|||
131104579|NCT02476279|472012886|FG001|Overall Study|Lost to Follow-up|1|||
131104580|NCT01323647|472012887|FG000|Overall Study|Migrated/moved from study area|2|||
131104581|NCT01323647|472012888|FG001|Overall Study|Migrated/moved from study area|0|||
131104582|NCT01323647|472012887|FG000|Overall Study|Withdrawal by Subject|5|||
131104583|NCT01323647|472012888|FG001|Overall Study|Withdrawal by Subject|0|||
131104584|NCT01323647|472012887|FG000|Overall Study|Lost to Follow-up|2|||
131104585|NCT01323647|472012888|FG001|Overall Study|Lost to Follow-up|0|||
131104586|NCT01236339|472012891|FG000|Overall Study|Termination of study by sponsor|11|||
131104587|NCT01236339|472012892|FG001|Overall Study|Termination of study by sponsor|13|||
131104588|NCT02054741|472012893|FG000|Overall Study|Protocol Violation|13|||
131104589|NCT02054741|472012894|FG001|Overall Study|Protocol Violation|2|||
131104590|NCT02054741|472012893|FG000|Overall Study|Withdrawal by Subject|10|||
131104591|NCT02054741|472012894|FG001|Overall Study|Withdrawal by Subject|5|||
131104592|NCT02054741|472012893|FG000|Overall Study|Death|94|||
131104593|NCT02054741|472012894|FG001|Overall Study|Death|90|||
131104594|NCT02054741|472012893|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
131104595|NCT02054741|472012894|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
131104596|NCT01945060|472012895|FG000|Overall Study|Lost to follow up|1|||
131104597|NCT01945060|472012896|FG001|Overall Study|Lost to follow up|0|||
131104598|NCT01945060|472012895|FG000|Overall Study|Distress related to IV access|0|||
131104599|NCT01945060|472012896|FG001|Overall Study|Distress related to IV access|1|||
131104600|NCT00402597|472012897|FG000|Overall Study|Death|15|||
131104601|NCT00402597|472012898|FG001|Overall Study|Death|7|||
131104602|NCT00402597|472012899|FG002|Overall Study|Death|6|||
131104603|NCT00402597|472012900|FG003|Overall Study|Death|4|||
131104604|NCT00402597|472012901|FG004|Overall Study|Death|6|||
131104605|NCT00402597|472012897|FG000|Overall Study|Adverse Event|81|||
131104606|NCT00402597|472012898|FG001|Overall Study|Adverse Event|18|||
131104607|NCT00402597|472012899|FG002|Overall Study|Adverse Event|106|||
131104608|NCT00402597|472012900|FG003|Overall Study|Adverse Event|39|||
131104609|NCT00402597|472012901|FG004|Overall Study|Adverse Event|71|||
131104610|NCT00402597|472012897|FG000|Overall Study|Lost to Follow-up|8|||
131104611|NCT00402597|472012898|FG001|Overall Study|Lost to Follow-up|1|||
131104612|NCT00402597|472012899|FG002|Overall Study|Lost to Follow-up|8|||
131104613|NCT00402597|472012900|FG003|Overall Study|Lost to Follow-up|2|||
131104614|NCT00402597|472012901|FG004|Overall Study|Lost to Follow-up|3|||
131104615|NCT00402597|472012897|FG000|Overall Study|Withdrawal by Subject|57|||
131104616|NCT00402597|472012898|FG001|Overall Study|Withdrawal by Subject|16|||
131104617|NCT00402597|472012899|FG002|Overall Study|Withdrawal by Subject|65|||
131104618|NCT00402597|472012900|FG003|Overall Study|Withdrawal by Subject|15|||
130683000|NCT02653664|470468111|FG002|Post-Treatment|Lost to Follow-up|7|||
130683001|NCT02653664|470468109|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
130683002|NCT02653664|470468110|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
130683003|NCT02653664|470468111|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
130683004|NCT02653664|470468109|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
130683005|NCT02653664|470468110|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
130683006|NCT02653664|470468111|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
130683007|NCT02653664|470468109|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130683008|NCT02653664|470468110|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
130683009|NCT02653664|470468111|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130683010|NCT02653664|470468109|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
130683011|NCT02653664|470468110|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
131104619|NCT00402597|472012901|FG004|Overall Study|Withdrawal by Subject|24|||
131104620|NCT00402597|472012897|FG000|Overall Study|reason not specified|30|||
131104621|NCT00402597|472012898|FG001|Overall Study|reason not specified|4|||
131104622|NCT00402597|472012899|FG002|Overall Study|reason not specified|27|||
131104623|NCT00402597|472012900|FG003|Overall Study|reason not specified|14|||
131104624|NCT00402597|472012901|FG004|Overall Study|reason not specified|20|||
131104625|NCT02319525|472012903|FG000|Overall Study|Withdrawal by Subject|2|||
131104626|NCT02319525|472012904|FG001|Overall Study|Withdrawal by Subject|1|||
131104627|NCT00938860|472012905|FG000|Overall Study|Adverse Event|2|||
131104628|NCT00938860|472012906|FG001|Overall Study|Adverse Event|1|||
130683012|NCT02653664|470468111|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
130683013|NCT02653664|470468109|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
130683014|NCT02653664|470468110|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
130683015|NCT02653664|470468111|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
130683016|NCT02653664|470468109|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
130683017|NCT02653664|470468110|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
130683018|NCT02653664|470468111|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
130683019|NCT02653664|470468109|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130683020|NCT02653664|470468110|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
130683021|NCT02653664|470468111|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130683022|NCT02653664|470468109|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
130683023|NCT02653664|470468110|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
130683024|NCT02653664|470468111|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
130683025|NCT00746798|470468112|FG000|Overall Study|Protocol Violation|0|||
130683026|NCT00746798|470468113|FG001|Overall Study|Protocol Violation|1|||
130683027|NCT00746798|470468114|FG002|Overall Study|Protocol Violation|0|||
130683028|NCT00746798|470468115|FG003|Overall Study|Protocol Violation|0|||
130683029|NCT00746798|470468112|FG000|Overall Study|Withdrawal by Subject|0|||
130683030|NCT00746798|470468113|FG001|Overall Study|Withdrawal by Subject|1|||
130683031|NCT00746798|470468114|FG002|Overall Study|Withdrawal by Subject|1|||
130683032|NCT00746798|470468115|FG003|Overall Study|Withdrawal by Subject|0|||
130683033|NCT00746798|470468112|FG000|Overall Study|Death|0|||
130683034|NCT00746798|470468113|FG001|Overall Study|Death|0|||
130683035|NCT00746798|470468114|FG002|Overall Study|Death|2|||
130683036|NCT00746798|470468115|FG003|Overall Study|Death|0|||
130683037|NCT00746798|470468112|FG000|Overall Study|Participant unable to return for visit|1|||
130683038|NCT00746798|470468113|FG001|Overall Study|Participant unable to return for visit|0|||
130683039|NCT00746798|470468114|FG002|Overall Study|Participant unable to return for visit|0|||
130683040|NCT00746798|470468115|FG003|Overall Study|Participant unable to return for visit|0|||
130683041|NCT00633594|470468116|FG000|Overall Study|Adverse Event|0|||
130683042|NCT00633594|470468117|FG001|Overall Study|Adverse Event|4|||
130683043|NCT00633594|470468118|FG002|Overall Study|Adverse Event|7|||
130683044|NCT00633594|470468116|FG000|Overall Study|Death|0|||
130683045|NCT00633594|470468117|FG001|Overall Study|Death|1|||
130683046|NCT00633594|470468118|FG002|Overall Study|Death|2|||
130683047|NCT00633594|470468116|FG000|Overall Study|Disease Progression|0|||
130683048|NCT00633594|470468117|FG001|Overall Study|Disease Progression|0|||
130683049|NCT00633594|470468118|FG002|Overall Study|Disease Progression|1|||
130683050|NCT01045096|470468122|FG000|Overall Study|Withdrawal by Subject|2|||
130683051|NCT01045096|470468123|FG001|Overall Study|Withdrawal by Subject|0|||
130683052|NCT01045096|470468124|FG002|Overall Study|Withdrawal by Subject|0|||
130766869|NCT00412217|470770654|FG000|Overall Study|Death|5|||
130766870|NCT00412217|470770655|FG001|Overall Study|Death|4|||
130766871|NCT00412217|470770654|FG000|Overall Study|Disease Progression|2|||
130766872|NCT00412217|470770655|FG001|Overall Study|Disease Progression|3|||
130766873|NCT00412217|470770654|FG000|Overall Study|Investigator Decision|1|||
130766874|NCT00412217|470770655|FG001|Overall Study|Investigator Decision|0|||
130766875|NCT00412217|470770654|FG000|Overall Study|Withdrawal by Subject|2|||
130766876|NCT00412217|470770655|FG001|Overall Study|Withdrawal by Subject|0|||
130766877|NCT00412217|470770654|FG000|Overall Study|Lost to Follow-up|1|||
130766878|NCT00412217|470770655|FG001|Overall Study|Lost to Follow-up|4|||
130766879|NCT00412217|470770654|FG000|Overall Study|Study Terminated by Sponsor|26|||
130766880|NCT00412217|470770655|FG001|Overall Study|Study Terminated by Sponsor|33|||
130766881|NCT00412217|470770654|FG000|Overall Study|Other|1|||
130766882|NCT00412217|470770655|FG001|Overall Study|Other|1|||
130766883|NCT01398410|470770657|FG000|Overall Study|Adverse Event|12|||
130766884|NCT01398410|470770658|FG001|Overall Study|Adverse Event|16|||
130766885|NCT01398410|470770657|FG000|Overall Study|Participants Choice|8|||
130766886|NCT01398410|470770658|FG001|Overall Study|Participants Choice|11|||
130766887|NCT01398410|470770657|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
130766888|NCT01398410|470770658|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
130766889|NCT01398410|470770657|FG000|Overall Study|Other|36|||
130766890|NCT01398410|470770658|FG001|Overall Study|Other|29|||
130766891|NCT03209518|470770661|FG000|Overall Study|Case Report Forms Uncollected|1|||
130766892|NCT03209518|470770661|FG000|Overall Study|Protocol Deviation|1|||
130683053|NCT01045096|470468122|FG000|Overall Study|Other|1|||
130766893|NCT00236899|470770662|FG000|Overall Study|Adverse Event (Study Related)|1|||
130683054|NCT01045096|470468123|FG001|Overall Study|Other|0|||
130683055|NCT01045096|470468124|FG002|Overall Study|Other|0|||
130683056|NCT01511939|470468126|FG000|Overall Study|Withdrawal by Subject|2|||
130683057|NCT01511939|470468127|FG001|Overall Study|Withdrawal by Subject|1|||
130683058|NCT01511939|470468128|FG002|Overall Study|Withdrawal by Subject|0|||
130683059|NCT00324168|470468133|FG000|Overall Study|Lost to Follow-up|19|||
130683060|NCT00324168|470468134|FG001|Overall Study|Lost to Follow-up|18|||
130766894|NCT00236899|470770663|FG001|Overall Study|Adverse Event (Study Related)|1|||
130766895|NCT00236899|470770664|FG002|Overall Study|Adverse Event (Study Related)|2|||
130886578|NCT03486834|471217354|FG001|Overall Study|Physician Decision|2|||
131104629|NCT00938860|472012905|FG000|Overall Study|Abnormal laboratory values|2|||
130683061|NCT00324168|470468133|FG000|Overall Study|Death|3|||
130683062|NCT00324168|470468134|FG001|Overall Study|Death|3|||
130683063|NCT00324168|470468133|FG000|Overall Study|Patient did not visit in f/u window|6|||
131104630|NCT00938860|472012906|FG001|Overall Study|Abnormal laboratory values|2|||
131104631|NCT00938860|472012905|FG000|Overall Study|Withdrawal by Subject|11|||
131104632|NCT00938860|472012906|FG001|Overall Study|Withdrawal by Subject|8|||
131104633|NCT00938860|472012905|FG000|Overall Study|Lost to Follow-up|4|||
131104634|NCT00938860|472012906|FG001|Overall Study|Lost to Follow-up|4|||
131104635|NCT00938860|472012905|FG000|Overall Study|Administration problems|2|||
131104636|NCT00938860|472012906|FG001|Overall Study|Administration problems|0|||
131104637|NCT00938860|472012905|FG000|Overall Study|Death|1|||
131104638|NCT00938860|472012906|FG001|Overall Study|Death|1|||
131104639|NCT00938860|472012905|FG000|Overall Study|Protocol Violation|3|||
131104640|NCT00938860|472012906|FG001|Overall Study|Protocol Violation|1|||
131104641|NCT00577577|472012908|FG000|Overall Study|Adverse Event|3|||
131104642|NCT00577577|472012909|FG001|Overall Study|Adverse Event|2|||
131104643|NCT00577577|472012908|FG000|Overall Study|Lost to Follow-up|1|||
131104644|NCT00577577|472012909|FG001|Overall Study|Lost to Follow-up|0|||
131104645|NCT00577577|472012908|FG000|Overall Study|Protocol Violation|0|||
131104646|NCT00577577|472012909|FG001|Overall Study|Protocol Violation|3|||
131104647|NCT00577577|472012908|FG000|Overall Study|Transportation|1|||
131104648|NCT00577577|472012909|FG001|Overall Study|Transportation|0|||
131104649|NCT00906945|472012914|FG000|Overall Study|Found to be not eligible|0|||
131104650|NCT00906945|472012915|FG001|Overall Study|Found to be not eligible|0|||
131104651|NCT00906945|472012916|FG002|Overall Study|Found to be not eligible|0|||
131104652|NCT00906945|472012917|FG003|Overall Study|Found to be not eligible|1|||
131104653|NCT00906945|472012918|FG004|Overall Study|Found to be not eligible|1|||
131104654|NCT00906945|472012919|FG005|Overall Study|Found to be not eligible|1|||
131104655|NCT00906945|472012914|FG000|Overall Study|Physician Decision|0|||
131104656|NCT00906945|472012915|FG001|Overall Study|Physician Decision|0|||
131104657|NCT00906945|472012916|FG002|Overall Study|Physician Decision|0|||
131104658|NCT00906945|472012917|FG003|Overall Study|Physician Decision|0|||
131104659|NCT00906945|472012918|FG004|Overall Study|Physician Decision|0|||
131104660|NCT00906945|472012919|FG005|Overall Study|Physician Decision|1|||
131104661|NCT03965351|472012925|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
131104662|NCT03965351|472012926|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
131104663|NCT03965351|472012925|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
131104664|NCT03965351|472012926|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
131104665|NCT00994682|472012927|FG000|Double Bilnd|Withdrawal by Subject|5|||
131104666|NCT00994682|472012928|FG001|Double Bilnd|Withdrawal by Subject|6|||
131104667|NCT00994682|472012927|FG000|Double Bilnd|Lost to Follow-up|3|||
131104668|NCT00994682|472012928|FG001|Double Bilnd|Lost to Follow-up|3|||
131104669|NCT00994682|472012927|FG000|Double Bilnd|Adverse Event|1|||
131104670|NCT00994682|472012928|FG001|Double Bilnd|Adverse Event|0|||
131104671|NCT00994682|472012927|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
131104672|NCT00994682|472012928|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
131104673|NCT00994682|472012927|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
131104674|NCT00994682|472012928|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
131104675|NCT00994682|472012927|FG000|Pioglitazone Open Label|Physician Decision|6|||
131104676|NCT00994682|472012928|FG001|Pioglitazone Open Label|Physician Decision|1|||
130683064|NCT00324168|470468134|FG001|Overall Study|Patient did not visit in f/u window|9|||
130683065|NCT03497897|470468136|FG000|Overall Study|Adverse Event|1|||
130683066|NCT03497897|470468137|FG001|Overall Study|Adverse Event|1|||
130683067|NCT03497897|470468138|FG002|Overall Study|Adverse Event|1|||
130683068|NCT03497897|470468136|FG000|Overall Study|Lost to Follow-up|2|||
130683069|NCT03497897|470468137|FG001|Overall Study|Lost to Follow-up|0|||
130683070|NCT03497897|470468138|FG002|Overall Study|Lost to Follow-up|2|||
131104677|NCT00943111|472012931|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
130683071|NCT03497897|470468136|FG000|Overall Study|Physician Decision|1|||
130683072|NCT03497897|470468137|FG001|Overall Study|Physician Decision|0|||
130683073|NCT03497897|470468138|FG002|Overall Study|Physician Decision|0|||
131104678|NCT00943111|472012932|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
131104679|NCT00943111|472012933|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
131104680|NCT00943111|472012931|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
131104681|NCT00943111|472012932|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
131104682|NCT00943111|472012933|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
131104683|NCT00943111|472012931|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
130683074|NCT03497897|470468136|FG000|Overall Study|Subject/Guardian Decision|2|||
130683075|NCT03497897|470468137|FG001|Overall Study|Subject/Guardian Decision|1|||
131104684|NCT00943111|472012932|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
131104685|NCT00943111|472012933|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
131104686|NCT00943111|472012931|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
130683076|NCT03497897|470468138|FG002|Overall Study|Subject/Guardian Decision|3|||
130683077|NCT00358449|470468143|FG000|Overall Study|Adverse Event|1|||
130683078|NCT00358449|470468144|FG001|Overall Study|Adverse Event|0|||
130683079|NCT00358449|470468145|FG002|Overall Study|Adverse Event|1|||
130683080|NCT00358449|470468143|FG000|Overall Study|Lost to Follow-up|1|||
130683081|NCT00358449|470468144|FG001|Overall Study|Lost to Follow-up|0|||
130683082|NCT00358449|470468145|FG002|Overall Study|Lost to Follow-up|0|||
130683083|NCT00358449|470468143|FG000|Overall Study|Withdrawal by Subject|2|||
130683084|NCT00358449|470468144|FG001|Overall Study|Withdrawal by Subject|0|||
130683085|NCT00358449|470468145|FG002|Overall Study|Withdrawal by Subject|0|||
130683086|NCT00358449|470468143|FG000|Overall Study|Lack of Efficacy|0|||
130683087|NCT00358449|470468144|FG001|Overall Study|Lack of Efficacy|1|||
130683088|NCT00358449|470468145|FG002|Overall Study|Lack of Efficacy|0|||
130683089|NCT00358449|470468143|FG000|Overall Study|Steriod Inhaler was Increased|0|||
130683090|NCT00358449|470468144|FG001|Overall Study|Steriod Inhaler was Increased|0|||
130683091|NCT00358449|470468145|FG002|Overall Study|Steriod Inhaler was Increased|1|||
130683092|NCT01367457|470468146|FG000|Overall Study|Death|2|||
130683093|NCT01367457|470468147|FG001|Overall Study|Death|0|||
130683094|NCT01367457|470468148|FG002|Overall Study|Death|0|||
130683095|NCT01367457|470468146|FG000|Overall Study|Investigator's decision|2|||
130683096|NCT01367457|470468147|FG001|Overall Study|Investigator's decision|0|||
130766896|NCT00236899|470770665|FG003|Overall Study|Adverse Event (Study Related)|1|||
130766897|NCT00236899|470770662|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
130766898|NCT00236899|470770663|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
130766899|NCT00236899|470770664|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
130766900|NCT00236899|470770665|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
130766901|NCT00236899|470770662|FG000|Overall Study|Death (Study Disease)|1|||
130766902|NCT00236899|470770663|FG001|Overall Study|Death (Study Disease)|4|||
130766903|NCT00236899|470770664|FG002|Overall Study|Death (Study Disease)|0|||
130766904|NCT00236899|470770665|FG003|Overall Study|Death (Study Disease)|0|||
130766905|NCT00236899|470770662|FG000|Overall Study|Death (Not Study Related)|2|||
130766906|NCT00236899|470770663|FG001|Overall Study|Death (Not Study Related)|0|||
130766907|NCT00236899|470770664|FG002|Overall Study|Death (Not Study Related)|0|||
130766908|NCT00236899|470770665|FG003|Overall Study|Death (Not Study Related)|0|||
130766909|NCT00236899|470770662|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
130766910|NCT00236899|470770663|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
130766911|NCT00236899|470770664|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
130766912|NCT00236899|470770665|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
130766913|NCT00236899|470770662|FG000|Overall Study|Lost to Follow-up|0|||
130766914|NCT00236899|470770663|FG001|Overall Study|Lost to Follow-up|1|||
130766915|NCT00236899|470770664|FG002|Overall Study|Lost to Follow-up|0|||
130766916|NCT00236899|470770665|FG003|Overall Study|Lost to Follow-up|0|||
130766917|NCT00236899|470770662|FG000|Overall Study|Entry Criteria Exclusion|0|||
130766918|NCT00236899|470770663|FG001|Overall Study|Entry Criteria Exclusion|1|||
130766919|NCT00236899|470770664|FG002|Overall Study|Entry Criteria Exclusion|1|||
130766920|NCT00236899|470770665|FG003|Overall Study|Entry Criteria Exclusion|0|||
130766921|NCT00236899|470770662|FG000|Overall Study|Protocol Violation|1|||
130766922|NCT00236899|470770663|FG001|Overall Study|Protocol Violation|0|||
130766923|NCT00236899|470770664|FG002|Overall Study|Protocol Violation|0|||
130766924|NCT00236899|470770665|FG003|Overall Study|Protocol Violation|0|||
130766925|NCT00236899|470770662|FG000|Overall Study|Withdrawal by Subject|6|||
130766926|NCT00236899|470770663|FG001|Overall Study|Withdrawal by Subject|4|||
130766927|NCT00236899|470770664|FG002|Overall Study|Withdrawal by Subject|5|||
130766928|NCT00236899|470770665|FG003|Overall Study|Withdrawal by Subject|2|||
130766929|NCT00236899|470770662|FG000|Overall Study|Physician Decision|7|||
130766930|NCT00236899|470770663|FG001|Overall Study|Physician Decision|8|||
130766931|NCT00236899|470770664|FG002|Overall Study|Physician Decision|7|||
130766932|NCT00236899|470770665|FG003|Overall Study|Physician Decision|6|||
130766933|NCT00236899|470770662|FG000|Overall Study|Satisfactory Response|2|||
130766934|NCT00236899|470770663|FG001|Overall Study|Satisfactory Response|0|||
130766935|NCT00236899|470770664|FG002|Overall Study|Satisfactory Response|0|||
130766936|NCT00236899|470770665|FG003|Overall Study|Satisfactory Response|1|||
130683097|NCT01367457|470468148|FG002|Overall Study|Investigator's decision|0|||
130683098|NCT01367457|470468146|FG000|Overall Study|Clinical decline (CD)|2|||
130683099|NCT01367457|470468147|FG001|Overall Study|Clinical decline (CD)|0|||
130683100|NCT01367457|470468148|FG002|Overall Study|Clinical decline (CD)|0|||
130683101|NCT01367457|470468146|FG000|Overall Study|Progression and death|8|||
130683102|NCT01367457|470468147|FG001|Overall Study|Progression and death|0|||
130683103|NCT01367457|470468148|FG002|Overall Study|Progression and death|0|||
130766937|NCT00236899|470770662|FG000|Overall Study|Lack of Efficacy|18|||
130766938|NCT00236899|470770663|FG001|Overall Study|Lack of Efficacy|18|||
130766939|NCT00236899|470770664|FG002|Overall Study|Lack of Efficacy|25|||
130766940|NCT00236899|470770665|FG003|Overall Study|Lack of Efficacy|23|||
130766941|NCT02854605|470770666|FG000|Overall Study|Adverse Event|1|||
130766942|NCT02854605|470770667|FG001|Overall Study|Adverse Event|5|||
130766943|NCT02854605|470770668|FG002|Overall Study|Adverse Event|2|||
130766944|NCT02854605|470770666|FG000|Overall Study|Lost to Follow-up|0|||
130766945|NCT02854605|470770667|FG001|Overall Study|Lost to Follow-up|2|||
130766946|NCT02854605|470770668|FG002|Overall Study|Lost to Follow-up|0|||
130766947|NCT02854605|470770666|FG000|Overall Study|Withdrew Consent|1|||
130766948|NCT02854605|470770667|FG001|Overall Study|Withdrew Consent|0|||
130766949|NCT02854605|470770668|FG002|Overall Study|Withdrew Consent|1|||
130766950|NCT02854605|470770666|FG000|Overall Study|Investigator's Discretion|1|||
130766951|NCT02854605|470770667|FG001|Overall Study|Investigator's Discretion|0|||
130766952|NCT02854605|470770668|FG002|Overall Study|Investigator's Discretion|0|||
130766953|NCT02854605|470770666|FG000|Overall Study|Protocol Violation|0|||
130766954|NCT02854605|470770667|FG001|Overall Study|Protocol Violation|0|||
130766955|NCT02854605|470770668|FG002|Overall Study|Protocol Violation|1|||
130766956|NCT01897571|470770673|FG000|Overall Study|Lost to Follow-up|3|||
130766957|NCT01897571|470770674|FG001|Overall Study|Lost to Follow-up|0|||
130766958|NCT01897571|470770675|FG002|Overall Study|Lost to Follow-up|0|||
130766959|NCT01897571|470770676|FG003|Overall Study|Lost to Follow-up|0|||
130766960|NCT01897571|470770677|FG004|Overall Study|Lost to Follow-up|2|||
130766961|NCT01897571|470770678|FG005|Overall Study|Lost to Follow-up|0|||
130766962|NCT01897571|470770679|FG006|Overall Study|Lost to Follow-up|0|||
130766963|NCT01897571|470770680|FG007|Overall Study|Lost to Follow-up|0|||
130766964|NCT01897571|470770681|FG008|Overall Study|Lost to Follow-up|1|||
130766965|NCT01897571|470770682|FG009|Overall Study|Lost to Follow-up|2|||
130766966|NCT01897571|470770683|FG010|Overall Study|Lost to Follow-up|4|||
130766967|NCT01897571|470770673|FG000|Overall Study|Withdrawal by Subject|0|||
130766968|NCT01897571|470770674|FG001|Overall Study|Withdrawal by Subject|0|||
130766969|NCT01897571|470770675|FG002|Overall Study|Withdrawal by Subject|0|||
130766970|NCT01897571|470770676|FG003|Overall Study|Withdrawal by Subject|0|||
130766971|NCT01897571|470770677|FG004|Overall Study|Withdrawal by Subject|0|||
130683104|NCT01367457|470468146|FG000|Overall Study|Toxicity|16|||
130683105|NCT01367457|470468147|FG001|Overall Study|Toxicity|0|||
130683106|NCT01367457|470468148|FG002|Overall Study|Toxicity|0|||
130683107|NCT01367457|470468146|FG000|Overall Study|Progression|137|||
130683108|NCT01367457|470468147|FG001|Overall Study|Progression|0|||
130683109|NCT01367457|470468148|FG002|Overall Study|Progression|0|||
130683110|NCT01367457|470468146|FG000|Overall Study|Patient asks for rest + slow progression|1|||
130683111|NCT01367457|470468147|FG001|Overall Study|Patient asks for rest + slow progression|0|||
130683112|NCT01367457|470468148|FG002|Overall Study|Patient asks for rest + slow progression|0|||
130683113|NCT01367457|470468146|FG000|Overall Study|Investigator's opinion, stable disease|1|||
130683114|NCT01367457|470468147|FG001|Overall Study|Investigator's opinion, stable disease|0|||
130683115|NCT01367457|470468148|FG002|Overall Study|Investigator's opinion, stable disease|0|||
130683116|NCT01367457|470468146|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
130683117|NCT01367457|470468147|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
130683118|NCT01367457|470468148|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
130683119|NCT01367457|470468146|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
130683120|NCT01367457|470468147|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
130683121|NCT01367457|470468148|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
130683122|NCT01367457|470468146|FG000|Overall Study|low grade toxicities + stable disease|1|||
130683123|NCT01367457|470468147|FG001|Overall Study|low grade toxicities + stable disease|0|||
130683124|NCT01367457|470468148|FG002|Overall Study|low grade toxicities + stable disease|0|||
130683125|NCT01367457|470468146|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
130683126|NCT01367457|470468147|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
130683127|NCT01367457|470468148|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
130683128|NCT01367457|470468146|FG000|Overall Study|Withdrawal by Subject|1|||
130683129|NCT01367457|470468147|FG001|Overall Study|Withdrawal by Subject|0|||
130683130|NCT01367457|470468148|FG002|Overall Study|Withdrawal by Subject|0|||
130683131|NCT01367457|470468146|FG000|Overall Study|CD, associated leukaemia|1|||
130683132|NCT01367457|470468147|FG001|Overall Study|CD, associated leukaemia|0|||
130683133|NCT01367457|470468148|FG002|Overall Study|CD, associated leukaemia|0|||
130683134|NCT01367457|470468146|FG000|Overall Study|Uncontrolled pain|1|||
130683135|NCT01367457|470468147|FG001|Overall Study|Uncontrolled pain|0|||
130683136|NCT01367457|470468148|FG002|Overall Study|Uncontrolled pain|0|||
130683137|NCT01367457|470468146|FG000|Overall Study|Overall status worsens to grade 4|1|||
130683138|NCT01367457|470468147|FG001|Overall Study|Overall status worsens to grade 4|0|||
130683139|NCT01367457|470468148|FG002|Overall Study|Overall status worsens to grade 4|0|||
130683140|NCT01367457|470468146|FG000|Overall Study|Stabilisation + frequent infections|1|||
130683141|NCT01367457|470468147|FG001|Overall Study|Stabilisation + frequent infections|0|||
130683142|NCT01367457|470468148|FG002|Overall Study|Stabilisation + frequent infections|0|||
130683143|NCT01367457|470468146|FG000|Overall Study|No clinical benefit|1|||
130683144|NCT01367457|470468147|FG001|Overall Study|No clinical benefit|0|||
130683145|NCT01367457|470468148|FG002|Overall Study|No clinical benefit|0|||
130683146|NCT01367457|470468146|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
130683147|NCT01367457|470468147|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
130766972|NCT01897571|470770678|FG005|Overall Study|Withdrawal by Subject|0|||
130766973|NCT01897571|470770679|FG006|Overall Study|Withdrawal by Subject|0|||
130766974|NCT01897571|470770680|FG007|Overall Study|Withdrawal by Subject|1|||
130766975|NCT01897571|470770681|FG008|Overall Study|Withdrawal by Subject|4|||
130766976|NCT01897571|470770682|FG009|Overall Study|Withdrawal by Subject|3|||
130766977|NCT01897571|470770683|FG010|Overall Study|Withdrawal by Subject|1|||
130766978|NCT01897571|470770673|FG000|Overall Study|Other|1|||
130683148|NCT01367457|470468148|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
130683149|NCT01367457|470468146|FG000|Overall Study|Overall decline|1|||
130683150|NCT01367457|470468147|FG001|Overall Study|Overall decline|0|||
130683151|NCT01367457|470468148|FG002|Overall Study|Overall decline|0|||
131104687|NCT00943111|472012932|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
131104688|NCT00943111|472012933|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
131104689|NCT00943111|472012931|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
131104690|NCT00943111|472012932|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
131104691|NCT00943111|472012933|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
131104692|NCT00943111|472012931|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
131104693|NCT00943111|472012932|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
131104694|NCT00943111|472012933|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
131104695|NCT00943111|472012931|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
131104696|NCT00943111|472012932|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
131104697|NCT00943111|472012933|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
130683152|NCT01367457|470468146|FG000|Overall Study|Rejection of treatment|1|||
130683153|NCT01367457|470468147|FG001|Overall Study|Rejection of treatment|0|||
130766979|NCT01897571|470770674|FG001|Overall Study|Other|0|||
130766980|NCT01897571|470770675|FG002|Overall Study|Other|0|||
130766981|NCT01897571|470770676|FG003|Overall Study|Other|3|||
130766982|NCT01897571|470770677|FG004|Overall Study|Other|3|||
130766983|NCT01897571|470770678|FG005|Overall Study|Other|4|||
130766984|NCT01897571|470770679|FG006|Overall Study|Other|7|||
130766985|NCT01897571|470770680|FG007|Overall Study|Other|0|||
130766986|NCT01897571|470770681|FG008|Overall Study|Other|0|||
131017809|NCT01307267|471695929|FG019|Overall Study|Lost to Follow-up|2|||
131017810|NCT01307267|471695930|FG020|Overall Study|Lost to Follow-up|0|||
131017811|NCT01307267|471695931|FG021|Overall Study|Lost to Follow-up|0|||
131017812|NCT01307267|471695932|FG022|Overall Study|Lost to Follow-up|0|||
131017813|NCT01307267|471695910|FG000|Overall Study|Withdrawal by Subject|0|||
131017814|NCT01307267|471695911|FG001|Overall Study|Withdrawal by Subject|0|||
131017815|NCT01307267|471695912|FG002|Overall Study|Withdrawal by Subject|0|||
131017816|NCT01307267|471695913|FG003|Overall Study|Withdrawal by Subject|0|||
131017817|NCT01307267|471695914|FG004|Overall Study|Withdrawal by Subject|0|||
131017818|NCT01307267|471695915|FG005|Overall Study|Withdrawal by Subject|1|||
131017819|NCT01307267|471695916|FG006|Overall Study|Withdrawal by Subject|0|||
131017820|NCT01307267|471695917|FG007|Overall Study|Withdrawal by Subject|1|||
131017821|NCT01307267|471695918|FG008|Overall Study|Withdrawal by Subject|5|||
131017822|NCT01307267|471695919|FG009|Overall Study|Withdrawal by Subject|1|||
131017823|NCT01307267|471695920|FG010|Overall Study|Withdrawal by Subject|1|||
131017824|NCT01307267|471695921|FG011|Overall Study|Withdrawal by Subject|1|||
131017825|NCT01307267|471695922|FG012|Overall Study|Withdrawal by Subject|0|||
131017826|NCT01307267|471695923|FG013|Overall Study|Withdrawal by Subject|0|||
131017827|NCT01307267|471695924|FG014|Overall Study|Withdrawal by Subject|0|||
131017828|NCT01307267|471695925|FG015|Overall Study|Withdrawal by Subject|0|||
131017829|NCT01307267|471695926|FG016|Overall Study|Withdrawal by Subject|0|||
131017830|NCT01307267|471695927|FG017|Overall Study|Withdrawal by Subject|0|||
131017831|NCT01307267|471695928|FG018|Overall Study|Withdrawal by Subject|0|||
131017832|NCT01307267|471695929|FG019|Overall Study|Withdrawal by Subject|3|||
131017833|NCT01307267|471695930|FG020|Overall Study|Withdrawal by Subject|0|||
131017834|NCT01307267|471695931|FG021|Overall Study|Withdrawal by Subject|0|||
131017835|NCT01307267|471695932|FG022|Overall Study|Withdrawal by Subject|0|||
131017836|NCT01307267|471695910|FG000|Overall Study|Other|0|||
130766987|NCT01897571|470770682|FG009|Overall Study|Other|0|||
130766988|NCT01897571|470770683|FG010|Overall Study|Other|0|||
130766989|NCT01897571|470770673|FG000|Overall Study|Enrolled in rollover study|0|||
130766990|NCT01897571|470770674|FG001|Overall Study|Enrolled in rollover study|0|||
130766991|NCT01897571|470770675|FG002|Overall Study|Enrolled in rollover study|0|||
131017837|NCT01307267|471695911|FG001|Overall Study|Other|0|||
131017838|NCT01307267|471695912|FG002|Overall Study|Other|0|||
131017839|NCT01307267|471695913|FG003|Overall Study|Other|0|||
131017840|NCT01307267|471695914|FG004|Overall Study|Other|0|||
131017841|NCT01307267|471695915|FG005|Overall Study|Other|7|||
130683154|NCT01367457|470468148|FG002|Overall Study|Rejection of treatment|0|||
130683155|NCT01367457|470468146|FG000|Overall Study|Lost to Follow-up|1|||
131017842|NCT01307267|471695916|FG006|Overall Study|Other|0|||
131017843|NCT01307267|471695917|FG007|Overall Study|Other|1|||
131017844|NCT01307267|471695918|FG008|Overall Study|Other|3|||
131017845|NCT01307267|471695919|FG009|Overall Study|Other|0|||
131017846|NCT01307267|471695920|FG010|Overall Study|Other|1|||
131104698|NCT00943111|472012931|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
131017847|NCT01307267|471695921|FG011|Overall Study|Other|1|||
130683156|NCT01367457|470468147|FG001|Overall Study|Lost to Follow-up|0|||
130683157|NCT01367457|470468148|FG002|Overall Study|Lost to Follow-up|0|||
130683158|NCT01367457|470468146|FG000|Overall Study|Death from septic shock|1|||
131017848|NCT01307267|471695922|FG012|Overall Study|Other|1|||
131017849|NCT01307267|471695923|FG013|Overall Study|Other|0|||
131017850|NCT01307267|471695924|FG014|Overall Study|Other|2|||
130683159|NCT01367457|470468147|FG001|Overall Study|Death from septic shock|0|||
130683160|NCT01367457|470468148|FG002|Overall Study|Death from septic shock|0|||
130683161|NCT01367457|470468146|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
130683162|NCT01367457|470468147|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
130683163|NCT01367457|470468148|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
130683164|NCT01367457|470468146|FG000|Overall Study|Patient's Wish|1|||
131017851|NCT01307267|471695925|FG015|Overall Study|Other|1|||
131017852|NCT01307267|471695926|FG016|Overall Study|Other|0|||
131017853|NCT01307267|471695927|FG017|Overall Study|Other|0|||
131017854|NCT01307267|471695928|FG018|Overall Study|Other|0|||
131017855|NCT01307267|471695929|FG019|Overall Study|Other|19|||
131017856|NCT01307267|471695930|FG020|Overall Study|Other|2|||
131017857|NCT01307267|471695931|FG021|Overall Study|Other|3|||
131017858|NCT01307267|471695932|FG022|Overall Study|Other|2|||
131017859|NCT04956575|471695933|FG000|Overall Study|Death|1|||
131017860|NCT04956575|471695934|FG001|Overall Study|Death|0|||
131017861|NCT04956575|471695935|FG002|Overall Study|Death|0|||
131017862|NCT04956575|471695936|FG003|Overall Study|Death|0|||
131017863|NCT04956575|471695937|FG004|Overall Study|Death|0|||
131017864|NCT04956575|471695938|FG005|Overall Study|Death|0|||
131017865|NCT04956575|471695939|FG006|Overall Study|Death|0|||
131017866|NCT04956575|471695940|FG007|Overall Study|Death|1|||
131017867|NCT04956575|471695941|FG008|Overall Study|Death|0|||
131017868|NCT04956575|471695942|FG009|Overall Study|Death|1|||
131017869|NCT04956575|471695943|FG010|Overall Study|Death|0|||
131017870|NCT04956575|471695944|FG011|Overall Study|Death|0|||
131017871|NCT04956575|471695933|FG000|Overall Study|Lost to Follow-up|3|||
131017872|NCT04956575|471695934|FG001|Overall Study|Lost to Follow-up|4|||
131017873|NCT04956575|471695935|FG002|Overall Study|Lost to Follow-up|2|||
131017874|NCT04956575|471695936|FG003|Overall Study|Lost to Follow-up|3|||
131017875|NCT04956575|471695937|FG004|Overall Study|Lost to Follow-up|1|||
131017876|NCT04956575|471695938|FG005|Overall Study|Lost to Follow-up|10|||
131017877|NCT04956575|471695939|FG006|Overall Study|Lost to Follow-up|11|||
131017878|NCT04956575|471695940|FG007|Overall Study|Lost to Follow-up|7|||
131017879|NCT04956575|471695941|FG008|Overall Study|Lost to Follow-up|4|||
131017880|NCT04956575|471695942|FG009|Overall Study|Lost to Follow-up|2|||
131017881|NCT04956575|471695943|FG010|Overall Study|Lost to Follow-up|3|||
131017882|NCT04956575|471695944|FG011|Overall Study|Lost to Follow-up|8|||
131017883|NCT04956575|471695933|FG000|Overall Study|Withdrawal by Subject|1|||
131017884|NCT04956575|471695934|FG001|Overall Study|Withdrawal by Subject|2|||
131017885|NCT04956575|471695935|FG002|Overall Study|Withdrawal by Subject|1|||
131017886|NCT04956575|471695936|FG003|Overall Study|Withdrawal by Subject|4|||
131017887|NCT04956575|471695937|FG004|Overall Study|Withdrawal by Subject|2|||
131017888|NCT04956575|471695938|FG005|Overall Study|Withdrawal by Subject|8|||
131017889|NCT04956575|471695939|FG006|Overall Study|Withdrawal by Subject|5|||
131017890|NCT04956575|471695940|FG007|Overall Study|Withdrawal by Subject|1|||
131017891|NCT04956575|471695941|FG008|Overall Study|Withdrawal by Subject|1|||
131017892|NCT04956575|471695942|FG009|Overall Study|Withdrawal by Subject|0|||
131017893|NCT04956575|471695943|FG010|Overall Study|Withdrawal by Subject|3|||
131017894|NCT04956575|471695944|FG011|Overall Study|Withdrawal by Subject|1|||
131017895|NCT03593876|471695945|FG000|Overall Study|Withdrawal by Subject|1|||
131017896|NCT03593876|471695945|FG000|Overall Study|Discharged home before intervention completion|2|||
131017897|NCT05136443|471695956|FG000|Overall Study|Lost to Follow-up|2|||
131017898|NCT05136443|471695956|FG000|Overall Study|Adverse Event|2|||
131017899|NCT03034915|471695967|FG000|Overall Study|Adverse Event|29|||
131017900|NCT03034915|471695968|FG001|Overall Study|Adverse Event|32|||
131017901|NCT03034915|471695969|FG002|Overall Study|Adverse Event|22|||
131017902|NCT03034915|471695967|FG000|Overall Study|Lost to Follow-up|5|||
131017903|NCT03034915|471695968|FG001|Overall Study|Lost to Follow-up|13|||
131017904|NCT03034915|471695969|FG002|Overall Study|Lost to Follow-up|3|||
131017905|NCT03034915|471695967|FG000|Overall Study|Withdrawal by Subject|29|||
131017906|NCT03034915|471695968|FG001|Overall Study|Withdrawal by Subject|46|||
131017907|NCT03034915|471695969|FG002|Overall Study|Withdrawal by Subject|41|||
131017908|NCT03034915|471695967|FG000|Overall Study|Protocol Deviation|2|||
131017909|NCT03034915|471695968|FG001|Overall Study|Protocol Deviation|14|||
131017910|NCT03034915|471695969|FG002|Overall Study|Protocol Deviation|7|||
131017911|NCT03034915|471695967|FG000|Overall Study|Lack of Efficacy|8|||
131017912|NCT03034915|471695968|FG001|Overall Study|Lack of Efficacy|16|||
131017913|NCT03034915|471695969|FG002|Overall Study|Lack of Efficacy|18|||
131017914|NCT03034915|471695967|FG000|Overall Study|Site closed|2|||
131017915|NCT03034915|471695968|FG001|Overall Study|Site closed|2|||
131017916|NCT03034915|471695969|FG002|Overall Study|Site closed|4|||
131017917|NCT03034915|471695967|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
131017918|NCT03034915|471695968|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
131017919|NCT03034915|471695969|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
131017920|NCT03034915|471695967|FG000|Overall Study|Physician Decision|1|||
131017921|NCT03034915|471695968|FG001|Overall Study|Physician Decision|5|||
131017922|NCT03034915|471695969|FG002|Overall Study|Physician Decision|2|||
131017923|NCT00424762|471695975|FG000|Overall Study|Withdrawal by Subject|18|||
131017924|NCT00424762|471695976|FG001|Overall Study|Withdrawal by Subject|19|||
131017925|NCT00424762|471695975|FG000|Overall Study|Lost to Follow-up|2|||
131017926|NCT00424762|471695976|FG001|Overall Study|Lost to Follow-up|3|||
131017927|NCT01147341|471695979|FG000|Double Blind Period|Lack of Efficacy|1|||
131017928|NCT01147341|471695980|FG001|Double Blind Period|Lack of Efficacy|1|||
131017929|NCT01147341|471695979|FG000|Double Blind Period|Withdrawal by Subject|0|||
131017930|NCT01147341|471695980|FG001|Double Blind Period|Withdrawal by Subject|1|||
131017931|NCT01147341|471695979|FG000|Open Label Period|Lack of Efficacy|3|||
131017932|NCT01147341|471695980|FG001|Open Label Period|Lack of Efficacy|0|||
131017933|NCT01147341|471695979|FG000|Open Label Period|Subject moved|1|||
131017934|NCT01147341|471695980|FG001|Open Label Period|Subject moved|0|||
131017935|NCT00367991|471695981|FG000|Overall Study|Withdrawal by Subject|1|||
131017936|NCT00367991|471695982|FG001|Overall Study|Withdrawal by Subject|1|||
131017937|NCT00367991|471695981|FG000|Overall Study|Adverse Event|1|||
131017938|NCT00367991|471695982|FG001|Overall Study|Adverse Event|1|||
131017939|NCT03024606|471695987|FG000|Overall Study|Withdrawal by Subject|9|||
131017940|NCT03024606|471695988|FG001|Overall Study|Withdrawal by Subject|10|||
131017941|NCT05323734|471695994|FG000|Overall Study|Adverse Event|5|||
131017942|NCT05323734|471695995|FG001|Overall Study|Adverse Event|2|||
131017943|NCT05323734|471695994|FG000|Overall Study|Physician Decision|1|||
131017944|NCT05323734|471695995|FG001|Overall Study|Physician Decision|0|||
131017945|NCT05323734|471695994|FG000|Overall Study|Lack of Efficacy|1|||
131017946|NCT05323734|471695995|FG001|Overall Study|Lack of Efficacy|2|||
131017947|NCT05323734|471695994|FG000|Overall Study|Withdrawal by Subject|2|||
131017948|NCT05323734|471695995|FG001|Overall Study|Withdrawal by Subject|0|||
131017949|NCT05323734|471695994|FG000|Overall Study|Participant Withdrawn Due|0|||
131017950|NCT05323734|471695995|FG001|Overall Study|Participant Withdrawn Due|1|||
131017951|NCT01595321|471695996|FG000|Overall Study|Adverse Event|1|||
131017952|NCT01595321|471695997|FG001|Overall Study|Adverse Event|1|||
131017953|NCT01595321|471695998|FG002|Overall Study|Adverse Event|1|||
131017954|NCT01595321|471695996|FG000|Overall Study|Lack of Efficacy|0|||
131017955|NCT01595321|471695997|FG001|Overall Study|Lack of Efficacy|0|||
131017956|NCT01595321|471695998|FG002|Overall Study|Lack of Efficacy|4|||
131017957|NCT00834834|471695999|FG000|Overall Study|Withdrawal by Subject|4|||
131017958|NCT00834834|471696000|FG001|Overall Study|Withdrawal by Subject|3|||
131017959|NCT00094575|471696001|FG000|Overall Study|Death|146|||
131017960|NCT00094575|471696002|FG001|Overall Study|Death|146|||
131017961|NCT00961636|471696009|FG000|Overall Study|Adverse Event|35|||
131017962|NCT00961636|471696010|FG001|Overall Study|Adverse Event|54|||
131017963|NCT00961636|471696011|FG002|Overall Study|Adverse Event|13|||
131017964|NCT00961636|471696009|FG000|Overall Study|Flushing Symptoms|29|||
131017965|NCT00961636|471696010|FG001|Overall Study|Flushing Symptoms|46|||
131017966|NCT00961636|471696011|FG002|Overall Study|Flushing Symptoms|3|||
131017967|NCT00961636|471696009|FG000|Overall Study|Lost to Follow-up|2|||
131017968|NCT00961636|471696010|FG001|Overall Study|Lost to Follow-up|3|||
131017969|NCT00961636|471696011|FG002|Overall Study|Lost to Follow-up|1|||
131017970|NCT00961636|471696009|FG000|Overall Study|Physician Decision|3|||
131017971|NCT00961636|471696010|FG001|Overall Study|Physician Decision|1|||
131017972|NCT00961636|471696011|FG002|Overall Study|Physician Decision|1|||
131017973|NCT00961636|471696009|FG000|Overall Study|Protocol Violation|9|||
131017974|NCT00961636|471696010|FG001|Overall Study|Protocol Violation|5|||
131017975|NCT00961636|471696011|FG002|Overall Study|Protocol Violation|1|||
131017976|NCT00961636|471696009|FG000|Overall Study|Withdrawal by Subject|29|||
131017977|NCT00961636|471696010|FG001|Overall Study|Withdrawal by Subject|22|||
131017978|NCT00961636|471696011|FG002|Overall Study|Withdrawal by Subject|13|||
131017979|NCT03603717|471696012|FG000|Overall Study|Lost to Follow-up|20|||
131017980|NCT03603717|471696013|FG001|Overall Study|Lost to Follow-up|20|||
131017981|NCT03603717|471696012|FG000|Overall Study|Withdrawal by Subject|16|||
131017982|NCT03603717|471696013|FG001|Overall Study|Withdrawal by Subject|10|||
131017983|NCT00732381|471696014|FG000|Overall Study|Adverse Event|1|||
131017984|NCT00732381|471696015|FG001|Overall Study|Adverse Event|0|||
131017985|NCT00732381|471696014|FG000|Overall Study|Treatment Failure|1|||
131017986|NCT00732381|471696015|FG001|Overall Study|Treatment Failure|1|||
131017987|NCT01350804|471696018|FG000|Core Study|Withdrawal by Subject|11|||
131017988|NCT01350804|471696019|FG001|Core Study|Withdrawal by Subject|17|||
131017989|NCT01350804|471696020|FG002|Core Study|Withdrawal by Subject|16|||
131017990|NCT01350804|471696021|FG003|Core Study|Withdrawal by Subject|7|||
131017991|NCT01350804|471696018|FG000|Core Study|Study terminated by Sponsor|0|||
131017992|NCT01350804|471696019|FG001|Core Study|Study terminated by Sponsor|0|||
131017993|NCT01350804|471696020|FG002|Core Study|Study terminated by Sponsor|0|||
131017994|NCT01350804|471696021|FG003|Core Study|Study terminated by Sponsor|2|||
131017995|NCT01350804|471696018|FG000|Core Study|Protocol deviation|1|||
131017996|NCT01350804|471696019|FG001|Core Study|Protocol deviation|0|||
131017997|NCT01350804|471696020|FG002|Core Study|Protocol deviation|1|||
131017998|NCT01350804|471696021|FG003|Core Study|Protocol deviation|0|||
131017999|NCT01350804|471696018|FG000|Core Study|Physician Decision|1|||
131018000|NCT01350804|471696019|FG001|Core Study|Physician Decision|0|||
131018001|NCT01350804|471696020|FG002|Core Study|Physician Decision|1|||
131018002|NCT01350804|471696021|FG003|Core Study|Physician Decision|3|||
131018003|NCT01350804|471696018|FG000|Core Study|Lost to Follow-up|3|||
131104699|NCT00943111|472012932|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
131104700|NCT00943111|472012933|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
131104701|NCT00903682|472012934|FG000|Overall Study|Adverse Event|6|||
131104702|NCT00903682|472012935|FG001|Overall Study|Adverse Event|13|||
131104703|NCT00903682|472012934|FG000|Overall Study|Lost to Follow-up|1|||
131104704|NCT00903682|472012935|FG001|Overall Study|Lost to Follow-up|0|||
131104705|NCT00903682|472012934|FG000|Overall Study|Withdrawal by Subject|5|||
131104706|NCT00903682|472012935|FG001|Overall Study|Withdrawal by Subject|0|||
131104707|NCT00903682|472012934|FG000|Overall Study|Pregnancy|0|||
131104708|NCT00903682|472012935|FG001|Overall Study|Pregnancy|1|||
131104709|NCT00903682|472012934|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
131104710|NCT00903682|472012935|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
131104711|NCT00903682|472012934|FG000|Overall Study|Subject Non-Compliant|1|||
131104712|NCT00903682|472012935|FG001|Overall Study|Subject Non-Compliant|0|||
131104713|NCT00903682|472012934|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
131104714|NCT00903682|472012935|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
131104715|NCT00903682|472012934|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
131104716|NCT00903682|472012935|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
131104717|NCT04227704|472012939|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
131104718|NCT04227704|472012940|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
131104719|NCT04227704|472012941|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
131104720|NCT04227704|472012939|FG000|Overall Study|due to C/S being cancelled|1|||
131104721|NCT04227704|472012940|FG001|Overall Study|due to C/S being cancelled|0|||
131104722|NCT04227704|472012941|FG002|Overall Study|due to C/S being cancelled|0|||
131104723|NCT03432260|472012948|FG000|Overall Study|Lost to Follow-up|1|||
131104724|NCT03432260|472012949|FG001|Overall Study|Lost to Follow-up|1|||
131104725|NCT03432260|472012950|FG002|Overall Study|Lost to Follow-up|0|||
131104726|NCT03432260|472012951|FG003|Overall Study|Lost to Follow-up|0|||
131104727|NCT03432260|472012952|FG004|Overall Study|Lost to Follow-up|1|||
131104728|NCT01775124|472012954|FG000|Core Period|Disease Progression|0|||
131104729|NCT01775124|472012955|FG001|Core Period|Disease Progression|1|||
131104730|NCT01775124|472012954|FG000|Core Period|Physician Decision|1|||
131104731|NCT01775124|472012955|FG001|Core Period|Physician Decision|1|||
131104732|NCT01775124|472012954|FG000|Core Period|Death|0|||
131104733|NCT01775124|472012955|FG001|Core Period|Death|1|||
131104734|NCT01775124|472012954|FG000|Core Period|Administrative problems|1|||
131104735|NCT01775124|472012955|FG001|Core Period|Administrative problems|0|||
131104736|NCT01775124|472012954|FG000|Core Period|Withdrawal by Subject|4|||
131104737|NCT01775124|472012955|FG001|Core Period|Withdrawal by Subject|2|||
131104738|NCT01775124|472012954|FG000|Core Period|Adverse Event|5|||
131104739|NCT01775124|472012955|FG001|Core Period|Adverse Event|5|||
131104740|NCT01775124|472012954|FG000|Extension Period|Adverse Event|3|||
131104741|NCT01775124|472012955|FG001|Extension Period|Adverse Event|2|||
131104742|NCT01775124|472012954|FG000|Extension Period|Physician Decision|0|||
131104743|NCT01775124|472012955|FG001|Extension Period|Physician Decision|2|||
131104744|NCT01775124|472012954|FG000|Extension Period|Administrative problems|0|||
131104745|NCT01775124|472012955|FG001|Extension Period|Administrative problems|1|||
131104746|NCT01775124|472012954|FG000|Extension Period|Lost to Follow-up|0|||
131104747|NCT01775124|472012955|FG001|Extension Period|Lost to Follow-up|1|||
131104748|NCT01775124|472012954|FG000|Extension Period|Withdrawal by Subject|9|||
131104749|NCT01775124|472012955|FG001|Extension Period|Withdrawal by Subject|12|||
131104750|NCT02164383|472014945|FG000|Overall Study|Lost to Follow-up|1|||
131104751|NCT02164383|472014946|FG001|Overall Study|Lost to Follow-up|0|||
131104752|NCT02831387|472014947|FG000|Overall Study|Withdrawal by Subject|1|||
131104753|NCT02831387|472014948|FG001|Overall Study|Withdrawal by Subject|1|||
131104754|NCT02831387|472014947|FG000|Overall Study|Discontinued due to stock recovery|0|||
131104755|NCT02831387|472014948|FG001|Overall Study|Discontinued due to stock recovery|1|||
131104756|NCT00192647|472014949|FG000|Overall Study|Death|1|||
131104757|NCT00192647|472014950|FG001|Overall Study|Death|1|||
131104758|NCT00192647|472014949|FG000|Overall Study|Adverse Event|35|||
131104759|NCT00192647|472014950|FG001|Overall Study|Adverse Event|29|||
131104760|NCT00192647|472014949|FG000|Overall Study|Laboratory Test Abnormality|4|||
131104761|NCT00192647|472014950|FG001|Overall Study|Laboratory Test Abnormality|2|||
131104762|NCT00192647|472014949|FG000|Overall Study|Insufficient Therapeutic Response|53|||
131104763|NCT00192647|472014950|FG001|Overall Study|Insufficient Therapeutic Response|83|||
131104764|NCT00192647|472014949|FG000|Overall Study|Entry Criteria Violation|6|||
131104765|NCT00192647|472014950|FG001|Overall Study|Entry Criteria Violation|6|||
131104766|NCT00192647|472014949|FG000|Overall Study|Protocol Violation|3|||
131104767|NCT00192647|472014950|FG001|Overall Study|Protocol Violation|1|||
131104768|NCT00192647|472014949|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
131104769|NCT00192647|472014950|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
131104770|NCT00192647|472014949|FG000|Overall Study|Failure to Return|11|||
131104771|NCT00192647|472014950|FG001|Overall Study|Failure to Return|13|||
131104772|NCT00192647|472014949|FG000|Overall Study|Other/Administrative|5|||
131222609|NCT01902134|472443117|FG004|Overall Study|no compliance|0|||
131222610|NCT01902134|472443118|FG005|Overall Study|no compliance|0|||
130683165|NCT01367457|470468147|FG001|Overall Study|Patient's Wish|0|||
130683166|NCT01367457|470468148|FG002|Overall Study|Patient's Wish|0|||
131104773|NCT00192647|472014950|FG001|Overall Study|Other/Administrative|3|||
131104774|NCT01828073|472014951|FG000|Overall Study|Lost to Follow-up|1|||
131104775|NCT01828073|472014952|FG001|Overall Study|Lost to Follow-up|2|||
131104776|NCT00690443|472014953|FG000|Overall Study|Adverse Event|1|||
131104777|NCT00690443|472014954|FG001|Overall Study|Adverse Event|2|||
131104778|NCT01350336|472014955|FG000|Overall Study|Lost to Follow-up|31|||
131104779|NCT01350336|472014955|FG000|Overall Study|Withdrawal by Subject|14|||
131104780|NCT01350336|472014955|FG000|Overall Study|Physician Decision|8|||
131104781|NCT01350336|472014955|FG000|Overall Study|Death|4|||
131104782|NCT02079610|472014958|FG000|Overall Study|Withdrawal by Subject|1|||
131104783|NCT02079610|472014959|FG001|Overall Study|Withdrawal by Subject|1|||
131104784|NCT01111474|472014963|FG000|Overall Study|Lost to Follow-up|12|||
131104785|NCT01016977|472014964|FG000|Overall Study|Lost to Follow-up|1|||
131104786|NCT01016977|472014965|FG001|Overall Study|Lost to Follow-up|0|||
131104787|NCT01016977|472014964|FG000|Overall Study|Withdrawal by Subject|2|||
131104788|NCT01016977|472014965|FG001|Overall Study|Withdrawal by Subject|2|||
131104789|NCT00666679|472014966|FG000|First Intervention|Lost to Follow-up|1|||
131104790|NCT00666679|472014967|FG001|First Intervention|Lost to Follow-up|0|||
131104791|NCT00666679|472014966|FG000|First Intervention|Protocol Violation|1|||
131104792|NCT00666679|472014967|FG001|First Intervention|Protocol Violation|0|||
131104793|NCT00666679|472014966|FG000|First Intervention|Withdrawal by Subject|1|||
131104794|NCT00666679|472014967|FG001|First Intervention|Withdrawal by Subject|0|||
131104795|NCT00666679|472014966|FG000|First Intervention|Randomized did not start treatment|1|||
131104796|NCT00666679|472014967|FG001|First Intervention|Randomized did not start treatment|1|||
131104797|NCT00666679|472014966|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
131104798|NCT00666679|472014967|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
131104799|NCT00666679|472014966|FG000|Washout Period of 1 Week|Protocol Violation|0|||
130683167|NCT01367457|470468146|FG000|Overall Study|Palliative. Overall decline|1|||
131104800|NCT00666679|472014967|FG001|Washout Period of 1 Week|Protocol Violation|1|||
131104801|NCT00666679|472014966|FG000|Second Intervention|Adverse Event|1|||
131104802|NCT00666679|472014967|FG001|Second Intervention|Adverse Event|0|||
131104803|NCT00666679|472014966|FG000|Second Intervention|Death|0|||
131104804|NCT00666679|472014967|FG001|Second Intervention|Death|1|||
131104805|NCT00918580|472014974|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
131104806|NCT00918580|472014974|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
131104807|NCT00918580|472014974|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
131104808|NCT00918580|472014974|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
131104809|NCT00918580|472014974|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
131104810|NCT00918580|472014974|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
131104811|NCT00918580|472014974|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
131104812|NCT00477334|472014975|FG000|Overall Study|Discontinued prior to taking study drug|106|||
131104813|NCT00477334|472014976|FG001|Overall Study|Discontinued prior to taking study drug|53|||
131104814|NCT00477334|472014975|FG000|Overall Study|Adverse Event|1|||
131104815|NCT00477334|472014976|FG001|Overall Study|Adverse Event|2|||
131104816|NCT00477334|472014975|FG000|Overall Study|Withdrawal by Subject|2|||
131104817|NCT00477334|472014976|FG001|Overall Study|Withdrawal by Subject|1|||
131104818|NCT00477334|472014975|FG000|Overall Study|Lost to Follow-up|15|||
131104819|NCT00477334|472014976|FG001|Overall Study|Lost to Follow-up|4|||
131104820|NCT00477334|472014975|FG000|Overall Study|Administrative Problems|39|||
131104821|NCT00477334|472014976|FG001|Overall Study|Administrative Problems|15|||
131104822|NCT00477334|472014975|FG000|Overall Study|Protocol Violation|7|||
131104823|NCT00477334|472014976|FG001|Overall Study|Protocol Violation|1|||
131104824|NCT01079663|472014977|FG000|Overall Study|Adverse Event|0|||
131104825|NCT01079663|472014978|FG001|Overall Study|Adverse Event|2|||
131104826|NCT01079663|472014977|FG000|Overall Study|Protocol Violation|0|||
131104827|NCT01079663|472014978|FG001|Overall Study|Protocol Violation|2|||
131104828|NCT03587974|472014979|FG000|Overall Study|caregiver demented, care recipient died|3|||
131104829|NCT03587974|472014980|FG001|Overall Study|caregiver demented, care recipient died|3|||
130683168|NCT01367457|470468147|FG001|Overall Study|Palliative. Overall decline|0|||
130683169|NCT01367457|470468148|FG002|Overall Study|Palliative. Overall decline|0|||
130683170|NCT01367457|470468146|FG000|Overall Study|Suspected DP/suspected active infection|1|||
130683171|NCT01367457|470468147|FG001|Overall Study|Suspected DP/suspected active infection|0|||
130683172|NCT01367457|470468148|FG002|Overall Study|Suspected DP/suspected active infection|0|||
131104830|NCT03587974|472014979|FG000|Overall Study|Withdrawal by Subject|2|||
131104831|NCT03587974|472014980|FG001|Overall Study|Withdrawal by Subject|1|||
131104832|NCT02354508|472014982|FG000|Period 1: Core Phase|Adverse Event|1|||
131104833|NCT02354508|472014983|FG001|Period 1: Core Phase|Adverse Event|1|||
131104834|NCT02354508|472014984|FG002|Period 1: Core Phase|Adverse Event|2|||
131104835|NCT02354508|472014982|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
131104836|NCT02354508|472014983|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
131104837|NCT02354508|472014984|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
131222611|NCT01902134|472443113|FG000|Overall Study|Other|0|||
130683173|NCT02300103|470468152|FG000|Overall Study|Lack of Efficacy|3|||
130683174|NCT02300103|470468152|FG000|Overall Study|Protocol Violation|1|||
130683175|NCT02300103|470468152|FG000|Overall Study|Withdrew Consent|2|||
130683176|NCT04091971|470468153|FG000|Overall Study|Withdrawal by Subject|1|||
130683177|NCT04091971|470468153|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
130683178|NCT04091971|470468153|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
130683179|NCT01666730|470468156|FG000|Overall Study|Adverse Event|16|||
130683180|NCT01666730|470468156|FG000|Overall Study|Death|2|||
130683181|NCT01666730|470468156|FG000|Overall Study|Physician Decision|5|||
131018004|NCT01350804|471696019|FG001|Core Study|Lost to Follow-up|0|||
131018005|NCT01350804|471696020|FG002|Core Study|Lost to Follow-up|2|||
131018006|NCT01350804|471696021|FG003|Core Study|Lost to Follow-up|1|||
131018007|NCT01350804|471696018|FG000|Core Study|Lack of Efficacy|16|||
131018008|NCT01350804|471696019|FG001|Core Study|Lack of Efficacy|19|||
131018009|NCT01350804|471696020|FG002|Core Study|Lack of Efficacy|18|||
131018010|NCT01350804|471696021|FG003|Core Study|Lack of Efficacy|5|||
131018011|NCT01350804|471696018|FG000|Core Study|Death|1|||
131018012|NCT01350804|471696019|FG001|Core Study|Death|1|||
131018013|NCT01350804|471696020|FG002|Core Study|Death|1|||
131018014|NCT01350804|471696021|FG003|Core Study|Death|0|||
131018015|NCT01350804|471696018|FG000|Core Study|Adverse Event|8|||
131018016|NCT01350804|471696019|FG001|Core Study|Adverse Event|10|||
131018017|NCT01350804|471696020|FG002|Core Study|Adverse Event|8|||
131018018|NCT01350804|471696021|FG003|Core Study|Adverse Event|8|||
131018019|NCT01350804|471696018|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
131018020|NCT01350804|471696019|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
131018021|NCT01350804|471696020|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
131018022|NCT01350804|471696021|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
131018023|NCT01350804|471696018|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
131018024|NCT01350804|471696019|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
131018025|NCT01350804|471696020|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
131018026|NCT01350804|471696021|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
131018027|NCT01350804|471696018|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
131018028|NCT01350804|471696019|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
131018029|NCT01350804|471696020|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
131018030|NCT01350804|471696021|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
131018031|NCT01350804|471696018|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
131018032|NCT01350804|471696019|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
131018033|NCT01350804|471696020|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
131018034|NCT01350804|471696021|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
131018035|NCT01350804|471696018|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
131018036|NCT01350804|471696019|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
131018037|NCT01350804|471696020|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
131018038|NCT01350804|471696021|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
131018039|NCT01350804|471696018|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
131018040|NCT01350804|471696019|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
131018041|NCT01350804|471696020|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
131018042|NCT01350804|471696021|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
131018043|NCT02299336|471696022|FG000|Overall Study|Withdrawal by Subject|11|||
131018044|NCT02299336|471696022|FG000|Overall Study|Adverse Event|1|||
131018045|NCT02299336|471696022|FG000|Overall Study|Death|1|||
131018046|NCT02299336|471696022|FG000|Overall Study|Lost to Follow-up|1|||
131018047|NCT02106442|471696024|FG000|Overall Study|Case Report Forms Uncollected|7|||
131018048|NCT02106442|471696024|FG000|Overall Study|Protocol Deviation|30|||
131018049|NCT00573833|471696025|FG000|Overall Study|Not Treated|2|||
131018050|NCT05328297|471697282|FG000|Overall Study|Adverse Event|5|||
131018051|NCT05328297|471697283|FG001|Overall Study|Adverse Event|7|||
131018052|NCT05328297|471697282|FG000|Overall Study|Withdrawal by Subject|4|||
131018053|NCT05328297|471697283|FG001|Overall Study|Withdrawal by Subject|3|||
131018054|NCT05328297|471697282|FG000|Overall Study|Lack of Efficacy|1|||
131018055|NCT05328297|471697283|FG001|Overall Study|Lack of Efficacy|0|||
131018056|NCT05328297|471697282|FG000|Overall Study|Lost to Follow-up|1|||
131018057|NCT05328297|471697283|FG001|Overall Study|Lost to Follow-up|0|||
131018058|NCT05328297|471697282|FG000|Overall Study|Protocol Violation|1|||
131018059|NCT05328297|471697283|FG001|Overall Study|Protocol Violation|0|||
131018060|NCT05328297|471697282|FG000|Overall Study|Randomized but not treated|1|||
131018061|NCT05328297|471697283|FG001|Overall Study|Randomized but not treated|1|||
131018062|NCT02015546|471697289|FG000|Overall Study|Withdrawal by Subject|1|||
131018063|NCT02015546|471697290|FG001|Overall Study|Withdrawal by Subject|1|||
131018064|NCT02015546|471697291|FG002|Overall Study|Withdrawal by Subject|1|||
131018065|NCT02015546|471697289|FG000|Overall Study|Screem Failure|2|||
131018066|NCT02015546|471697290|FG001|Overall Study|Screem Failure|1|||
131018067|NCT02015546|471697291|FG002|Overall Study|Screem Failure|3|||
131018068|NCT02202499|471697294|FG000|Overall Study|Cancer diagnosis|0|||
130683182|NCT01666730|470468156|FG000|Overall Study|Withdrawal by Subject|9|||
130683183|NCT01666730|470468156|FG000|Overall Study|Disease progression/relapse|18|||
131104838|NCT02354508|472014982|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
131104839|NCT02354508|472014983|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
131104840|NCT02354508|472014984|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
131104841|NCT02354508|472014982|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
131104842|NCT02354508|472014983|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
131104843|NCT02354508|472014984|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
131104844|NCT02354508|472014982|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
131104845|NCT02354508|472014983|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
131104846|NCT02354508|472014984|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
131104847|NCT02354508|472014982|FG000|Period 2: Extension Phase|Physician Decision|5|||
131104848|NCT02354508|472014983|FG001|Period 2: Extension Phase|Physician Decision|0|||
131104849|NCT02354508|472014984|FG002|Period 2: Extension Phase|Physician Decision|1|||
131104850|NCT02354508|472014982|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
131104851|NCT02354508|472014983|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
131104852|NCT02354508|472014984|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
131104853|NCT02354508|472014982|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
131104854|NCT02354508|472014983|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
131104855|NCT02354508|472014984|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
131104856|NCT02354508|472014982|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
131104857|NCT02354508|472014983|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
131104858|NCT02354508|472014984|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
131104859|NCT04447846|472014985|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
131104860|NCT00461032|472014986|FG000|Overall Study|Adverse Event|5|||
131104861|NCT00461032|472014987|FG001|Overall Study|Adverse Event|6|||
131104862|NCT00461032|472014986|FG000|Overall Study|Lack of Efficacy|5|||
131104863|NCT00461032|472014987|FG001|Overall Study|Lack of Efficacy|1|||
131104864|NCT00461032|472014986|FG000|Overall Study|Lost to Follow-up|7|||
131104865|NCT00461032|472014987|FG001|Overall Study|Lost to Follow-up|12|||
131104866|NCT00461032|472014986|FG000|Overall Study|Protocol Violation|4|||
131104867|NCT00461032|472014987|FG001|Overall Study|Protocol Violation|4|||
131104868|NCT00461032|472014986|FG000|Overall Study|Withdrawal by Subject|7|||
131104869|NCT00461032|472014987|FG001|Overall Study|Withdrawal by Subject|15|||
131104870|NCT00461032|472014986|FG000|Overall Study|Patient Moved or Relocated|2|||
131104871|NCT00461032|472014987|FG001|Overall Study|Patient Moved or Relocated|1|||
131104872|NCT00461032|472014986|FG000|Overall Study|Other|7|||
131104873|NCT00461032|472014987|FG001|Overall Study|Other|5|||
131104874|NCT03486457|472014990|FG000|Up to Month 3|Adverse Event|2|||
131104875|NCT03486457|472014991|FG001|Up to Month 3|Adverse Event|5|||
131104876|NCT03486457|472014990|FG000|Up to Month 3|Lack of Efficacy|1|||
131104877|NCT03486457|472014991|FG001|Up to Month 3|Lack of Efficacy|0|||
131104878|NCT03486457|472014990|FG000|Up to Month 3|Withdrawal by Subject|1|||
131104879|NCT03486457|472014991|FG001|Up to Month 3|Withdrawal by Subject|0|||
131104880|NCT03486457|472014990|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
131104881|NCT03486457|472014991|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
131104882|NCT03486457|472014990|FG000|Up to Month 3|Other|1|||
131104883|NCT03486457|472014991|FG001|Up to Month 3|Other|0|||
131104884|NCT03486457|472014990|FG000|Month 3 to Month 6|Adverse Event|2|||
131104885|NCT03486457|472014991|FG001|Month 3 to Month 6|Adverse Event|0|||
131104886|NCT03486457|472014990|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
131104887|NCT03486457|472014991|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
131104888|NCT03486457|472014990|FG000|Month 3 to Month 6|Pregnancy|0|||
131104889|NCT03486457|472014991|FG001|Month 3 to Month 6|Pregnancy|1|||
131104890|NCT03486457|472014990|FG000|Month 3 to Month 6|Other|1|||
131104891|NCT03486457|472014991|FG001|Month 3 to Month 6|Other|0|||
131104892|NCT00372229|472014992|FG000|Study Phase|Graft loss|0|||
131104893|NCT00372229|472014993|FG001|Study Phase|Graft loss|3|||
131104894|NCT00372229|472014992|FG000|Study Phase|Protocol Violation|3|||
131104895|NCT00372229|472014993|FG001|Study Phase|Protocol Violation|4|||
131104896|NCT00372229|472014992|FG000|Study Phase|Consent withdrawn|16|||
131104897|NCT00372229|472014993|FG001|Study Phase|Consent withdrawn|14|||
131104898|NCT00372229|472014992|FG000|Study Phase|Refused treatment/did not cooperate|3|||
130886579|NCT03486834|471217355|FG002|Overall Study|Physician Decision|3|||
131104899|NCT00372229|472014993|FG001|Study Phase|Refused treatment/did not cooperate|1|||
131104900|NCT00372229|472014992|FG000|Study Phase|Death|3|||
131104901|NCT00372229|472014993|FG001|Study Phase|Death|2|||
131104902|NCT00372229|472014992|FG000|Study Phase|Reason not specified|3|||
131104903|NCT00372229|472014993|FG001|Study Phase|Reason not specified|2|||
131104904|NCT00372229|472014992|FG000|Study Phase|Lost to Follow-up|3|||
131104905|NCT00372229|472014993|FG001|Study Phase|Lost to Follow-up|3|||
131104906|NCT00372229|472014992|FG000|Follow-Up Phase|Graft loss|8|||
131104907|NCT00372229|472014993|FG001|Follow-Up Phase|Graft loss|7|||
131104908|NCT00372229|472014992|FG000|Follow-Up Phase|Consent withdrawn|13|||
131104909|NCT00372229|472014993|FG001|Follow-Up Phase|Consent withdrawn|19|||
131104910|NCT00372229|472014992|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
130683184|NCT04466111|470468157|FG000|Prior to Trial Phase|Physician Decision|1|||
130683185|NCT00893464|470468161|FG000|Overall Study|Did not complete therapy/experience PD|0|||
130683186|NCT00893464|470468162|FG001|Overall Study|Did not complete therapy/experience PD|0|||
130683187|NCT00893464|470468163|FG002|Overall Study|Did not complete therapy/experience PD|0|||
130683188|NCT00893464|470468164|FG003|Overall Study|Did not complete therapy/experience PD|0|||
130683189|NCT00893464|470468165|FG004|Overall Study|Did not complete therapy/experience PD|0|||
130683190|NCT00893464|470468166|FG005|Overall Study|Did not complete therapy/experience PD|0|||
130683191|NCT00893464|470468167|FG006|Overall Study|Did not complete therapy/experience PD|2|||
130683192|NCT00893464|470468168|FG007|Overall Study|Did not complete therapy/experience PD|2|||
130683193|NCT01389102|470468169|FG000|Overall Study|Adverse Event|1|||
130683194|NCT01389102|470468170|FG001|Overall Study|Adverse Event|3|||
130683195|NCT01389102|470468171|FG002|Overall Study|Adverse Event|2|||
130683196|NCT01389102|470468172|FG003|Overall Study|Adverse Event|2|||
130683197|NCT01389102|470468173|FG004|Overall Study|Adverse Event|2|||
130683198|NCT01389102|470468174|FG005|Overall Study|Adverse Event|2|||
130683199|NCT01389102|470468169|FG000|Overall Study|Hurricane Katrina|4|||
130683200|NCT01389102|470468170|FG001|Overall Study|Hurricane Katrina|2|||
130683201|NCT01389102|470468171|FG002|Overall Study|Hurricane Katrina|3|||
130683202|NCT01389102|470468172|FG003|Overall Study|Hurricane Katrina|0|||
130683203|NCT01389102|470468173|FG004|Overall Study|Hurricane Katrina|3|||
130683204|NCT01389102|470468174|FG005|Overall Study|Hurricane Katrina|1|||
130683205|NCT01389102|470468169|FG000|Overall Study|Lost to Follow-up|4|||
130683206|NCT01389102|470468170|FG001|Overall Study|Lost to Follow-up|1|||
130683207|NCT01389102|470468171|FG002|Overall Study|Lost to Follow-up|1|||
130683208|NCT01389102|470468172|FG003|Overall Study|Lost to Follow-up|2|||
130683209|NCT01389102|470468173|FG004|Overall Study|Lost to Follow-up|4|||
130683210|NCT01389102|470468174|FG005|Overall Study|Lost to Follow-up|1|||
130683211|NCT01389102|470468169|FG000|Overall Study|Protocol Violation|0|||
130683212|NCT01389102|470468170|FG001|Overall Study|Protocol Violation|0|||
130683213|NCT01389102|470468171|FG002|Overall Study|Protocol Violation|3|||
130683214|NCT01389102|470468172|FG003|Overall Study|Protocol Violation|0|||
130683215|NCT01389102|470468173|FG004|Overall Study|Protocol Violation|1|||
130683216|NCT01389102|470468174|FG005|Overall Study|Protocol Violation|1|||
130683217|NCT01389102|470468169|FG000|Overall Study|Withdrawal by Subject|7|||
130683218|NCT01389102|470468170|FG001|Overall Study|Withdrawal by Subject|4|||
130683219|NCT01389102|470468171|FG002|Overall Study|Withdrawal by Subject|9|||
130683220|NCT01389102|470468172|FG003|Overall Study|Withdrawal by Subject|2|||
130683221|NCT01389102|470468173|FG004|Overall Study|Withdrawal by Subject|3|||
130683222|NCT01389102|470468174|FG005|Overall Study|Withdrawal by Subject|3|||
130683223|NCT01389102|470468169|FG000|Overall Study|Subject Traveling Out of Country|0|||
130683224|NCT01389102|470468170|FG001|Overall Study|Subject Traveling Out of Country|0|||
130683225|NCT01389102|470468171|FG002|Overall Study|Subject Traveling Out of Country|0|||
130683226|NCT01389102|470468172|FG003|Overall Study|Subject Traveling Out of Country|1|||
130683227|NCT01389102|470468173|FG004|Overall Study|Subject Traveling Out of Country|0|||
130683228|NCT01389102|470468174|FG005|Overall Study|Subject Traveling Out of Country|0|||
130683229|NCT01389102|470468169|FG000|Overall Study|Subject Moved|2|||
130683230|NCT01389102|470468170|FG001|Overall Study|Subject Moved|0|||
131018069|NCT02202499|471697295|FG001|Overall Study|Cancer diagnosis|0|||
131018070|NCT02202499|471697296|FG002|Overall Study|Cancer diagnosis|1|||
131018071|NCT02202499|471697294|FG000|Overall Study|Moved from area|0|||
131018072|NCT02202499|471697295|FG001|Overall Study|Moved from area|0|||
131018073|NCT02202499|471697296|FG002|Overall Study|Moved from area|1|||
131018074|NCT02202499|471697294|FG000|Overall Study|Declined before randomization|1|||
131018075|NCT02202499|471697295|FG001|Overall Study|Declined before randomization|0|||
130683231|NCT01389102|470468171|FG002|Overall Study|Subject Moved|1|||
130683232|NCT01389102|470468172|FG003|Overall Study|Subject Moved|0|||
130683233|NCT01389102|470468173|FG004|Overall Study|Subject Moved|0|||
130683234|NCT01389102|470468174|FG005|Overall Study|Subject Moved|0|||
130683235|NCT01389102|470468169|FG000|Overall Study|Unavailable due to husband's illness|0|||
130683236|NCT01389102|470468170|FG001|Overall Study|Unavailable due to husband's illness|1|||
130683237|NCT01389102|470468171|FG002|Overall Study|Unavailable due to husband's illness|0|||
130683238|NCT01389102|470468172|FG003|Overall Study|Unavailable due to husband's illness|0|||
130683239|NCT01389102|470468173|FG004|Overall Study|Unavailable due to husband's illness|0|||
130683240|NCT01389102|470468174|FG005|Overall Study|Unavailable due to husband's illness|0|||
130683241|NCT01389102|470468169|FG000|Overall Study|Investigator Judgement|0|||
130683242|NCT01389102|470468170|FG001|Overall Study|Investigator Judgement|1|||
130683243|NCT01389102|470468171|FG002|Overall Study|Investigator Judgement|0|||
130683244|NCT01389102|470468172|FG003|Overall Study|Investigator Judgement|0|||
130683245|NCT01389102|470468173|FG004|Overall Study|Investigator Judgement|0|||
130683246|NCT01389102|470468174|FG005|Overall Study|Investigator Judgement|0|||
130683247|NCT00436553|470468175|FG000|Overall Study|Adverse Event|4|||
131018076|NCT02202499|471697296|FG002|Overall Study|Declined before randomization|0|||
130683248|NCT00436553|470468176|FG001|Overall Study|Adverse Event|3|||
130683249|NCT00436553|470468177|FG002|Overall Study|Adverse Event|4|||
130683250|NCT00436553|470468175|FG000|Overall Study|Death|3|||
130683251|NCT00436553|470468176|FG001|Overall Study|Death|1|||
130683252|NCT00436553|470468177|FG002|Overall Study|Death|3|||
130683253|NCT00436553|470468175|FG000|Overall Study|Lost to Follow-up|0|||
130683254|NCT00436553|470468176|FG001|Overall Study|Lost to Follow-up|2|||
131018077|NCT02202499|471697294|FG000|Overall Study|Auto accident|1|||
131018078|NCT02202499|471697295|FG001|Overall Study|Auto accident|0|||
131018079|NCT02202499|471697296|FG002|Overall Study|Auto accident|0|||
131018080|NCT00712335|471697299|FG000|Overall Study|Withdrawal by Subject|0|||
131018081|NCT00712335|471697300|FG001|Overall Study|Withdrawal by Subject|7|||
131018082|NCT00712335|471697301|FG002|Overall Study|Withdrawal by Subject|2|||
131018083|NCT00712335|471697302|FG003|Overall Study|Withdrawal by Subject|3|||
131018084|NCT00712335|471697303|FG004|Overall Study|Withdrawal by Subject|0|||
131018085|NCT00712335|471697299|FG000|Overall Study|Lost to Follow-up|2|||
131018086|NCT00712335|471697300|FG001|Overall Study|Lost to Follow-up|5|||
131018087|NCT00712335|471697301|FG002|Overall Study|Lost to Follow-up|0|||
131018088|NCT00712335|471697302|FG003|Overall Study|Lost to Follow-up|1|||
131018089|NCT00712335|471697303|FG004|Overall Study|Lost to Follow-up|0|||
131018090|NCT00712335|471697299|FG000|Overall Study|Protocol Violation|1|||
131018091|NCT00712335|471697300|FG001|Overall Study|Protocol Violation|2|||
131018092|NCT00712335|471697301|FG002|Overall Study|Protocol Violation|1|||
131018093|NCT00712335|471697302|FG003|Overall Study|Protocol Violation|0|||
131018094|NCT00712335|471697303|FG004|Overall Study|Protocol Violation|0|||
131018095|NCT00712335|471697299|FG000|Overall Study|Lack of Efficacy|0|||
131018096|NCT00712335|471697300|FG001|Overall Study|Lack of Efficacy|0|||
131018097|NCT00712335|471697301|FG002|Overall Study|Lack of Efficacy|1|||
131018098|NCT00712335|471697302|FG003|Overall Study|Lack of Efficacy|1|||
131018099|NCT00712335|471697303|FG004|Overall Study|Lack of Efficacy|0|||
131018100|NCT00712335|471697299|FG000|Overall Study|Other Reason|0|||
131018101|NCT00712335|471697300|FG001|Overall Study|Other Reason|3|||
131018102|NCT00712335|471697301|FG002|Overall Study|Other Reason|1|||
131018103|NCT00712335|471697302|FG003|Overall Study|Other Reason|0|||
131018104|NCT00712335|471697303|FG004|Overall Study|Other Reason|0|||
131018105|NCT03401112|471697304|FG000|Overall Study|Adverse Event|1|||
131018106|NCT03401112|471697305|FG001|Overall Study|Adverse Event|2|||
131018107|NCT03401112|471697306|FG002|Overall Study|Adverse Event|3|||
131018108|NCT03401112|471697307|FG003|Overall Study|Adverse Event|2|||
131018109|NCT03401112|471697308|FG004|Overall Study|Adverse Event|0|||
131018110|NCT03401112|471697304|FG000|Overall Study|Lost to Follow-up|1|||
131018111|NCT03401112|471697305|FG001|Overall Study|Lost to Follow-up|0|||
131018112|NCT03401112|471697306|FG002|Overall Study|Lost to Follow-up|0|||
131018113|NCT03401112|471697307|FG003|Overall Study|Lost to Follow-up|0|||
131018114|NCT03401112|471697308|FG004|Overall Study|Lost to Follow-up|0|||
131018115|NCT03401112|471697304|FG000|Overall Study|Noncompliance|1|||
131018116|NCT03401112|471697305|FG001|Overall Study|Noncompliance|2|||
131018117|NCT03401112|471697306|FG002|Overall Study|Noncompliance|3|||
131018118|NCT03401112|471697307|FG003|Overall Study|Noncompliance|0|||
131018119|NCT03401112|471697308|FG004|Overall Study|Noncompliance|0|||
131018120|NCT03401112|471697304|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
131018121|NCT03401112|471697305|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
131018122|NCT03401112|471697306|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
131018123|NCT03401112|471697307|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
131018124|NCT03401112|471697308|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
131018125|NCT03401112|471697304|FG000|Overall Study|Withdrawal by Subject|0|||
131018126|NCT03401112|471697305|FG001|Overall Study|Withdrawal by Subject|3|||
131018127|NCT03401112|471697306|FG002|Overall Study|Withdrawal by Subject|2|||
131018128|NCT03401112|471697307|FG003|Overall Study|Withdrawal by Subject|1|||
131018129|NCT03401112|471697308|FG004|Overall Study|Withdrawal by Subject|0|||
131018130|NCT03401112|471697304|FG000|Overall Study|Physician Decision|0|||
131018131|NCT03401112|471697305|FG001|Overall Study|Physician Decision|0|||
131018132|NCT03401112|471697306|FG002|Overall Study|Physician Decision|0|||
131018133|NCT03401112|471697307|FG003|Overall Study|Physician Decision|2|||
131018134|NCT03401112|471697308|FG004|Overall Study|Physician Decision|0|||
131018135|NCT03401112|471697304|FG000|Overall Study|Study was Terminated by Sponsor|0|||
131018136|NCT03401112|471697305|FG001|Overall Study|Study was Terminated by Sponsor|0|||
131018137|NCT03401112|471697306|FG002|Overall Study|Study was Terminated by Sponsor|0|||
131018138|NCT03401112|471697307|FG003|Overall Study|Study was Terminated by Sponsor|1|||
131018139|NCT03401112|471697308|FG004|Overall Study|Study was Terminated by Sponsor|0|||
131018140|NCT03401112|471697304|FG000|Overall Study|Day 1 Assessment not Done|1|||
130683255|NCT00436553|470468177|FG002|Overall Study|Lost to Follow-up|0|||
130683256|NCT00436553|470468175|FG000|Overall Study|Protocol Violation|1|||
131018141|NCT03401112|471697305|FG001|Overall Study|Day 1 Assessment not Done|0|||
131018142|NCT03401112|471697306|FG002|Overall Study|Day 1 Assessment not Done|0|||
131018143|NCT03401112|471697307|FG003|Overall Study|Day 1 Assessment not Done|0|||
131018144|NCT03401112|471697308|FG004|Overall Study|Day 1 Assessment not Done|0|||
131018145|NCT03401112|471697304|FG000|Overall Study|Not Dosed|0|||
131018146|NCT03401112|471697305|FG001|Overall Study|Not Dosed|0|||
131018147|NCT03401112|471697306|FG002|Overall Study|Not Dosed|1|||
130683257|NCT00436553|470468176|FG001|Overall Study|Protocol Violation|0|||
131018148|NCT03401112|471697307|FG003|Overall Study|Not Dosed|0|||
131104911|NCT00372229|472014993|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
131104912|NCT00372229|472014992|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
131104913|NCT00372229|472014993|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
131104914|NCT00372229|472014992|FG000|Follow-Up Phase|Death|9|||
131104915|NCT00372229|472014993|FG001|Follow-Up Phase|Death|12|||
131104916|NCT00372229|472014992|FG000|Follow-Up Phase|Administrative|1|||
131104917|NCT00372229|472014993|FG001|Follow-Up Phase|Administrative|0|||
131104918|NCT00372229|472014992|FG000|Follow-Up Phase|Reason not specified|2|||
131104919|NCT00372229|472014993|FG001|Follow-Up Phase|Reason not specified|3|||
131104920|NCT00372229|472014992|FG000|Follow-Up Phase|Lost to Follow-up|12|||
131104921|NCT00372229|472014993|FG001|Follow-Up Phase|Lost to Follow-up|10|||
130683258|NCT00436553|470468177|FG002|Overall Study|Protocol Violation|0|||
130683259|NCT00436553|470468175|FG000|Overall Study|Withdrawal by Subject|5|||
130683260|NCT00436553|470468176|FG001|Overall Study|Withdrawal by Subject|6|||
130683261|NCT00436553|470468177|FG002|Overall Study|Withdrawal by Subject|3|||
130683262|NCT01035060|470468182|FG000|Overall Study|Lost to Follow-up|0|||
130683263|NCT01035060|470468183|FG001|Overall Study|Lost to Follow-up|7|||
131018149|NCT03401112|471697308|FG004|Overall Study|Not Dosed|0|||
131018150|NCT03401112|471697304|FG000|Overall Study|Missed Clinical Visit|0|||
131018151|NCT03401112|471697305|FG001|Overall Study|Missed Clinical Visit|0|||
131018152|NCT03401112|471697306|FG002|Overall Study|Missed Clinical Visit|1|||
131018153|NCT03401112|471697307|FG003|Overall Study|Missed Clinical Visit|0|||
131018154|NCT03401112|471697308|FG004|Overall Study|Missed Clinical Visit|0|||
131018155|NCT03401112|471697304|FG000|Overall Study|Missed Doses|0|||
131018156|NCT03401112|471697305|FG001|Overall Study|Missed Doses|0|||
131018157|NCT03401112|471697306|FG002|Overall Study|Missed Doses|1|||
131018158|NCT03401112|471697307|FG003|Overall Study|Missed Doses|0|||
131018159|NCT03401112|471697308|FG004|Overall Study|Missed Doses|0|||
131018160|NCT03194958|471697309|FG000|Overall Study|Death|0|||
131018161|NCT03194958|471697310|FG001|Overall Study|Death|1|||
131018162|NCT03194958|471697311|FG002|Overall Study|Death|1|||
131018163|NCT03194958|471697312|FG003|Overall Study|Death|1|||
131018164|NCT03194958|471697309|FG000|Overall Study|Withdrawal by Subject|24|||
131018165|NCT03194958|471697310|FG001|Overall Study|Withdrawal by Subject|27|||
131018166|NCT03194958|471697311|FG002|Overall Study|Withdrawal by Subject|7|||
131018167|NCT03194958|471697312|FG003|Overall Study|Withdrawal by Subject|22|||
131018168|NCT03194958|471697309|FG000|Overall Study|Lost to Follow-up|168|||
131018169|NCT03194958|471697310|FG001|Overall Study|Lost to Follow-up|196|||
131018170|NCT03194958|471697311|FG002|Overall Study|Lost to Follow-up|174|||
131018171|NCT03194958|471697312|FG003|Overall Study|Lost to Follow-up|186|||
131018172|NCT01968226|471697314|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
131018173|NCT01202955|471697317|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
131018174|NCT01202955|471697318|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
131018175|NCT04975308|471697323|FG000|Overall Study|Withdrawal by Subject|6|||
131018176|NCT04975308|471697324|FG001|Overall Study|Withdrawal by Subject|16|||
131018177|NCT04975308|471697325|FG002|Overall Study|Withdrawal by Subject|6|||
131018178|NCT04975308|471697323|FG000|Overall Study|Physician Decision|0|||
131018179|NCT04975308|471697324|FG001|Overall Study|Physician Decision|3|||
131018180|NCT04975308|471697325|FG002|Overall Study|Physician Decision|1|||
131018181|NCT04975308|471697323|FG000|Overall Study|Adverse Event|10|||
131018182|NCT04975308|471697324|FG001|Overall Study|Adverse Event|1|||
131018183|NCT04975308|471697325|FG002|Overall Study|Adverse Event|12|||
131018184|NCT04975308|471697323|FG000|Overall Study|On study treatment (Ongoing)|65|||
131018185|NCT04975308|471697324|FG001|Overall Study|On study treatment (Ongoing)|43|||
131018186|NCT04975308|471697325|FG002|Overall Study|On study treatment (Ongoing)|75|||
131018187|NCT04975308|471697323|FG000|Overall Study|Protocol Deviation|4|||
131018188|NCT04975308|471697324|FG001|Overall Study|Protocol Deviation|3|||
131018189|NCT04975308|471697325|FG002|Overall Study|Protocol Deviation|2|||
131018190|NCT02709655|471697326|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
131018191|NCT02709655|471697327|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
131018192|NCT02709655|471697328|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
131018193|NCT02709655|471697329|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
131018194|NCT02709655|471697330|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
131018195|NCT02709655|471697326|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
131104922|NCT01878214|472014994|FG000|Overall Study|Withdrawal by Subject|18|||
131104923|NCT01878214|472014995|FG001|Overall Study|Withdrawal by Subject|7|||
130683264|NCT01035060|470468182|FG000|Overall Study|Did not quality after 2nd screening|14|||
131018196|NCT02709655|471697327|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
131018197|NCT02709655|471697328|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
131018198|NCT02709655|471697329|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
131018199|NCT02709655|471697330|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
131018200|NCT02709655|471697326|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
131018201|NCT02709655|471697327|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
131018202|NCT02709655|471697328|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
131104924|NCT01878214|472014994|FG000|Overall Study|Death|0|||
131104925|NCT01878214|472014995|FG001|Overall Study|Death|1|||
130683265|NCT01035060|470468183|FG001|Overall Study|Did not quality after 2nd screening|1|||
130683266|NCT01035060|470468182|FG000|Overall Study|Withdrawal by Subject|8|||
130683267|NCT01035060|470468183|FG001|Overall Study|Withdrawal by Subject|6|||
130683268|NCT01035060|470468182|FG000|Overall Study|Physician Decision|2|||
130683269|NCT01035060|470468183|FG001|Overall Study|Physician Decision|0|||
130683270|NCT01981720|470468188|FG000|Overall Study|Adverse Event|1|||
130683271|NCT01981720|470468188|FG000|Overall Study|Withdrawal by Subject|3|||
130683272|NCT01981720|470468188|FG000|Overall Study|Pregnancy|1|||
130683273|NCT02674477|470468189|FG000|Overall Study|Protocol Violation|8|||
130683274|NCT02674477|470468190|FG001|Overall Study|Protocol Violation|2|||
130683275|NCT01536405|470468193|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
130683276|NCT01536405|470468194|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
130683277|NCT01536405|470468193|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
130683278|NCT01536405|470468194|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
130683279|NCT01536405|470468193|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
130683280|NCT01536405|470468194|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
130683281|NCT01536405|470468193|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
130683282|NCT01536405|470468194|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
130683283|NCT01536405|470468193|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
130683284|NCT01536405|470468194|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
130683285|NCT01536405|470468193|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
130683286|NCT01536405|470468194|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
130683287|NCT01536405|470468193|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
130683288|NCT01536405|470468194|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
130683289|NCT01536405|470468193|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
130683290|NCT01536405|470468194|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
130683291|NCT01536405|470468193|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
130683292|NCT01536405|470468194|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
130683293|NCT01536405|470468193|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
130683294|NCT01536405|470468194|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
130683295|NCT01536405|470468193|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
130683296|NCT01536405|470468194|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
130683297|NCT01536405|470468193|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
130683298|NCT01536405|470468194|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
130683299|NCT01536405|470468193|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
130683300|NCT01536405|470468194|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
131018203|NCT02709655|471697329|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
131018204|NCT02709655|471697330|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
131018205|NCT02709655|471697326|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
131018206|NCT02709655|471697327|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
131018207|NCT02709655|471697328|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
131018208|NCT02709655|471697329|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
131018209|NCT02709655|471697330|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
131018210|NCT02709655|471697326|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
131018211|NCT02709655|471697327|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
131018212|NCT02709655|471697328|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
131018213|NCT02709655|471697329|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
131018214|NCT02709655|471697330|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
131018215|NCT02709655|471697326|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
131018216|NCT02709655|471697327|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
131018217|NCT02709655|471697328|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
131018218|NCT02709655|471697329|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
131018219|NCT02709655|471697330|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
131018220|NCT02709655|471697326|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
131018221|NCT02709655|471697327|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
131018222|NCT02709655|471697328|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
131018223|NCT02709655|471697329|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
131018224|NCT02709655|471697330|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
131018225|NCT02709655|471697326|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
131018226|NCT02709655|471697327|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
131018227|NCT02709655|471697328|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
130683301|NCT02514122|470468195|FG000|Overall Study|Withdrawal by Subject|2|||
130683302|NCT02514122|470468196|FG001|Overall Study|Withdrawal by Subject|0|||
130683303|NCT01472341|470468197|FG000|Overall Study|Started insulin therapy|55|||
130683304|NCT01472341|470468197|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
130683305|NCT01472341|470468197|FG000|Overall Study|Withdrawal by Subject|39|||
130683306|NCT01472341|470468197|FG000|Overall Study|Lost to Follow-up|52|||
130683307|NCT01472341|470468197|FG000|Overall Study|Laboratory parameters unavailable|25|||
130683308|NCT01472341|470468197|FG000|Overall Study|Death|9|||
130683309|NCT00112463|470468200|FG000|Overall Study|Physician Decision|1|||
130683310|NCT00112463|470468200|FG000|Overall Study|Progression|30|||
130683311|NCT00112463|470468200|FG000|Overall Study|Second Primary|1|||
130683312|NCT00112463|470468200|FG000|Overall Study|Toxicity|3|||
130683313|NCT00112463|470468200|FG000|Overall Study|Withdrawal by Subject|2|||
130683314|NCT00112463|470468200|FG000|Overall Study|Never started treatment|2|||
130683315|NCT01118312|470468207|FG000|Overall Study|Lost to Follow-up|33|||
130683316|NCT01118312|470468208|FG001|Overall Study|Lost to Follow-up|32|||
130683317|NCT01118312|470468207|FG000|Overall Study|Withdrawal by Subject|1|||
130683318|NCT01118312|470468208|FG001|Overall Study|Withdrawal by Subject|3|||
131018228|NCT02709655|471697329|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
131018229|NCT02709655|471697330|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
131018230|NCT02709655|471697326|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
131018231|NCT02709655|471697327|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
131018232|NCT02709655|471697328|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
131018233|NCT02709655|471697329|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
131018234|NCT02709655|471697330|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
131018235|NCT02709655|471697326|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
131018236|NCT02709655|471697327|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
131018237|NCT02709655|471697328|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
131018238|NCT02709655|471697329|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
131018239|NCT02709655|471697330|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
131018240|NCT02709655|471697326|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
131018241|NCT02709655|471697327|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
131018242|NCT02709655|471697328|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
131018243|NCT02709655|471697329|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
131018244|NCT02709655|471697330|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
131018245|NCT02709655|471697326|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
131018246|NCT02709655|471697327|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
131018247|NCT02709655|471697328|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
131018248|NCT02709655|471697329|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
131018249|NCT02709655|471697330|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
131018250|NCT02709655|471697326|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
131018251|NCT02709655|471697327|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
131018252|NCT02709655|471697328|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
131018253|NCT02709655|471697329|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
131018254|NCT02709655|471697330|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
131018255|NCT02709655|471697326|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
131018256|NCT02709655|471697327|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
131018257|NCT02709655|471697328|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
131018258|NCT02709655|471697329|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
131018259|NCT02709655|471697330|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
131018260|NCT02709655|471697326|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
131018261|NCT02709655|471697327|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
131018262|NCT02709655|471697328|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
131018263|NCT02709655|471697329|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
131018264|NCT02709655|471697330|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
131018265|NCT02709655|471697326|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
131018266|NCT02709655|471697327|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
131018267|NCT02709655|471697328|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
131018268|NCT02709655|471697329|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
131018269|NCT02709655|471697330|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
131018270|NCT01179334|471697331|FG000|Treatment Period|Adverse Event|1|||
131018271|NCT01179334|471697332|FG001|Treatment Period|Adverse Event|0|||
131018272|NCT01179334|471697331|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
131018273|NCT01179334|471697332|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
131018274|NCT01179334|471697331|FG000|Long-term Extension (LTE) Period|Death|3|||
131018275|NCT01179334|471697332|FG001|Long-term Extension (LTE) Period|Death|0|||
131018276|NCT01179334|471697331|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
131018277|NCT01179334|471697332|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
131018278|NCT01909778|471697333|FG000|Overall Study|failed screening|1|||
131018279|NCT00919763|471697335|FG000|Overall Study|Adverse Event|7|||
131018280|NCT00919763|471697336|FG001|Overall Study|Adverse Event|1|||
131018281|NCT00919763|471697335|FG000|Overall Study|Lost to Follow-up|1|||
131018282|NCT00919763|471697336|FG001|Overall Study|Lost to Follow-up|0|||
131018283|NCT00919763|471697335|FG000|Overall Study|Protocol Violation|1|||
131018284|NCT00919763|471697336|FG001|Overall Study|Protocol Violation|1|||
131018285|NCT00919763|471697335|FG000|Overall Study|Withdrawal by Subject|3|||
131104926|NCT01878214|472014994|FG000|Overall Study|Lost to Follow-up|35|||
130683319|NCT00296647|470468209|FG000|Overall Study|Death|4|||
130683320|NCT00296647|470468210|FG001|Overall Study|Death|1|||
130683321|NCT00296647|470468211|FG002|Overall Study|Death|2|||
130683322|NCT00296647|470468212|FG003|Overall Study|Death|1|||
130683323|NCT00296647|470468213|FG004|Overall Study|Death|1|||
130683324|NCT00296647|470468209|FG000|Overall Study|Withdrawal by Subject|28|||
130683325|NCT00296647|470468210|FG001|Overall Study|Withdrawal by Subject|27|||
130683326|NCT00296647|470468211|FG002|Overall Study|Withdrawal by Subject|32|||
130683327|NCT00296647|470468212|FG003|Overall Study|Withdrawal by Subject|16|||
130683328|NCT00296647|470468213|FG004|Overall Study|Withdrawal by Subject|19|||
130683329|NCT01629381|470468214|FG000|Overall Study|Withdrawal by Subject|2|||
130683330|NCT01629381|470468215|FG001|Overall Study|Withdrawal by Subject|5|||
130683331|NCT00735904|470468216|FG000|Overall Study|Adverse Event|3|||
130683332|NCT00735904|470468216|FG000|Overall Study|Death|20|||
130683333|NCT00735904|470468216|FG000|Overall Study|Protocol Violation|1|||
130683334|NCT00735904|470468216|FG000|Overall Study|Withdrawal by Subject|1|||
130683335|NCT00735904|470468216|FG000|Overall Study|Study Terminated by Sponsor|5|||
130683336|NCT00735904|470468216|FG000|Overall Study|Other|8|||
130683337|NCT01390844|470468219|FG000|Treatment Phase|Adverse Event|12|||
130683338|NCT01390844|470468220|FG001|Treatment Phase|Adverse Event|2|||
130683339|NCT01390844|470468221|FG002|Treatment Phase|Adverse Event|3|||
130683340|NCT01390844|470468222|FG003|Treatment Phase|Adverse Event|2|||
130683341|NCT01390844|470468219|FG000|Treatment Phase|Treatment Failure|23|||
131018286|NCT00919763|471697336|FG001|Overall Study|Withdrawal by Subject|1|||
131018287|NCT00919763|471697335|FG000|Overall Study|Non-compliance|0|||
131018288|NCT00919763|471697336|FG001|Overall Study|Non-compliance|1|||
131018289|NCT00256243|471697340|FG000|Overall Study|Lost to Follow-up|2|||
131018290|NCT00256243|471697340|FG000|Overall Study|Death|7|||
131018291|NCT00256243|471697340|FG000|Overall Study|Not treated|1|||
131018292|NCT05061693|471697341|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
131018293|NCT05061693|471697342|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
131018294|NCT05061693|471697343|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
131018295|NCT05061693|471697344|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131018296|NCT05061693|471697345|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131018297|NCT05061693|471697346|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131018298|NCT05061693|471697347|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131018299|NCT05061693|471697348|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131018300|NCT05061693|471697349|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131018301|NCT05061693|471697350|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131018302|NCT05061693|471697351|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131018303|NCT05061693|471697352|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
131018304|NCT05061693|471697341|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
131018305|NCT05061693|471697342|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
131018306|NCT05061693|471697343|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
131018307|NCT05061693|471697344|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
131018308|NCT05061693|471697345|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
131018309|NCT05061693|471697346|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
131018310|NCT05061693|471697347|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
131018311|NCT05061693|471697348|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
131018312|NCT05061693|471697349|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
131018313|NCT05061693|471697350|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
131018314|NCT05061693|471697351|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
131018315|NCT05061693|471697352|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
131018316|NCT05061693|471697341|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
131018317|NCT05061693|471697342|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131018318|NCT05061693|471697343|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131018319|NCT05061693|471697344|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131018320|NCT05061693|471697345|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131018321|NCT05061693|471697346|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131018322|NCT05061693|471697347|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131018323|NCT05061693|471697348|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131018324|NCT05061693|471697349|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131018325|NCT05061693|471697350|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131018326|NCT05061693|471697351|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
131018327|NCT05061693|471697352|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
130683342|NCT01390844|470468220|FG001|Treatment Phase|Treatment Failure|25|||
130683343|NCT01390844|470468221|FG002|Treatment Phase|Treatment Failure|10|||
130683344|NCT01390844|470468222|FG003|Treatment Phase|Treatment Failure|13|||
130683345|NCT01390844|470468219|FG000|Treatment Phase|Non-Medical Reasons|5|||
130683346|NCT01390844|470468220|FG001|Treatment Phase|Non-Medical Reasons|1|||
130683347|NCT01390844|470468221|FG002|Treatment Phase|Non-Medical Reasons|8|||
130683348|NCT01390844|470468222|FG003|Treatment Phase|Non-Medical Reasons|1|||
130683349|NCT01390844|470468219|FG000|Treatment Phase|Non-GCP Compliant|0|||
130683350|NCT01390844|470468220|FG001|Treatment Phase|Non-GCP Compliant|0|||
131018328|NCT05061693|471697341|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131104927|NCT01878214|472014995|FG001|Overall Study|Lost to Follow-up|36|||
131104928|NCT00093808|472014998|FG000|Overall Study|Cancel participation before receiving tx|1|||
131104929|NCT00093808|472014998|FG000|Overall Study|Protocol Violation|1|||
131104930|NCT02647866|472014999|FG000|Overall Study|Adverse Event|0|||
131104931|NCT02647866|472015000|FG001|Overall Study|Adverse Event|0|||
131104932|NCT02647866|472015001|FG002|Overall Study|Adverse Event|2|||
131104933|NCT02647866|472015002|FG003|Overall Study|Adverse Event|2|||
131104934|NCT02647866|472015003|FG004|Overall Study|Adverse Event|1|||
131104935|NCT02647866|472014999|FG000|Overall Study|Disease Worsening|3|||
131104936|NCT02647866|472015000|FG001|Overall Study|Disease Worsening|1|||
131104937|NCT02647866|472015001|FG002|Overall Study|Disease Worsening|0|||
131104938|NCT02647866|472015002|FG003|Overall Study|Disease Worsening|0|||
131018329|NCT05061693|471697342|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131018330|NCT05061693|471697343|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
131018331|NCT05061693|471697344|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131018332|NCT05061693|471697345|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131018333|NCT05061693|471697346|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131104939|NCT02647866|472015003|FG004|Overall Study|Disease Worsening|1|||
131104940|NCT02647866|472014999|FG000|Overall Study|Withdrawal by Subject|1|||
131104941|NCT02647866|472015000|FG001|Overall Study|Withdrawal by Subject|1|||
131104942|NCT02647866|472015001|FG002|Overall Study|Withdrawal by Subject|2|||
131104943|NCT02647866|472015002|FG003|Overall Study|Withdrawal by Subject|4|||
131104944|NCT02647866|472015003|FG004|Overall Study|Withdrawal by Subject|4|||
131104945|NCT02647866|472014999|FG000|Overall Study|Physician Decision|0|||
131104946|NCT02647866|472015000|FG001|Overall Study|Physician Decision|1|||
131104947|NCT02647866|472015001|FG002|Overall Study|Physician Decision|1|||
131104948|NCT02647866|472015002|FG003|Overall Study|Physician Decision|0|||
131104949|NCT02647866|472015003|FG004|Overall Study|Physician Decision|2|||
131104950|NCT02647866|472014999|FG000|Overall Study|Death|0|||
131104951|NCT02647866|472015000|FG001|Overall Study|Death|1|||
131104952|NCT02647866|472015001|FG002|Overall Study|Death|0|||
131104953|NCT02647866|472015002|FG003|Overall Study|Death|0|||
131104954|NCT02647866|472015003|FG004|Overall Study|Death|0|||
131104955|NCT02647866|472014999|FG000|Overall Study|Subject moved to different country|1|||
131104956|NCT02647866|472015000|FG001|Overall Study|Subject moved to different country|0|||
131104957|NCT02647866|472015001|FG002|Overall Study|Subject moved to different country|0|||
131104958|NCT02647866|472015002|FG003|Overall Study|Subject moved to different country|0|||
131104959|NCT02647866|472015003|FG004|Overall Study|Subject moved to different country|0|||
131104960|NCT01415531|472015007|FG000|Overall Study|Adverse Event|7|||
131104961|NCT01415531|472015008|FG001|Overall Study|Adverse Event|10|||
131104962|NCT01415531|472015007|FG000|Overall Study|Lack of Efficacy|3|||
131104963|NCT01415531|472015008|FG001|Overall Study|Lack of Efficacy|2|||
131104964|NCT01415531|472015007|FG000|Overall Study|Protocol Violation|0|||
130683351|NCT01390844|470468221|FG002|Treatment Phase|Non-GCP Compliant|10|||
130683352|NCT01390844|470468222|FG003|Treatment Phase|Non-GCP Compliant|3|||
131018334|NCT05061693|471697347|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131018335|NCT05061693|471697348|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131018336|NCT05061693|471697349|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131018337|NCT05061693|471697350|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131018338|NCT05061693|471697351|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131018339|NCT05061693|471697352|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
131018340|NCT05061693|471697341|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
131018341|NCT05061693|471697342|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
131018342|NCT05061693|471697343|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
131018343|NCT05061693|471697344|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
131018344|NCT05061693|471697345|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131018345|NCT05061693|471697346|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131018346|NCT05061693|471697347|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131018347|NCT05061693|471697348|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131018348|NCT05061693|471697349|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131018349|NCT05061693|471697350|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131018350|NCT05061693|471697351|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131018351|NCT05061693|471697352|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
131104965|NCT01415531|472015008|FG001|Overall Study|Protocol Violation|1|||
131104966|NCT01415531|472015007|FG000|Overall Study|Withdrawal by Subject|5|||
131104967|NCT01415531|472015008|FG001|Overall Study|Withdrawal by Subject|4|||
131104968|NCT01415531|472015007|FG000|Overall Study|Lost to Follow-up|6|||
131104969|NCT01415531|472015008|FG001|Overall Study|Lost to Follow-up|14|||
130886580|NCT03486834|471217353|FG000|Overall Study|Pregnancy|10|||
131104970|NCT01415531|472015007|FG000|Overall Study|Lack of Compliance|1|||
131104971|NCT01415531|472015008|FG001|Overall Study|Lack of Compliance|4|||
131104972|NCT01415531|472015007|FG000|Overall Study|Other Reasons|3|||
131104973|NCT01415531|472015008|FG001|Overall Study|Other Reasons|2|||
131104974|NCT02344004|472015010|FG000|Overall Study|Adverse Event|11|||
131104975|NCT02344004|472015011|FG001|Overall Study|Adverse Event|1|||
131104976|NCT02344004|472015010|FG000|Overall Study|Death|9|||
130683353|NCT01390844|470468219|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
130683354|NCT01390844|470468220|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
130683355|NCT01390844|470468221|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
130683356|NCT01390844|470468222|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
130683357|NCT03204539|470468225|FG000|Overall Study|Loss of funding|0|||
130683358|NCT03204539|470468226|FG001|Overall Study|Loss of funding|1|||
130683359|NCT01171963|470468227|FG000|Overall Study|Adverse Event|10|||
130683360|NCT01171963|470468228|FG001|Overall Study|Adverse Event|15|||
130683361|NCT01171963|470468227|FG000|Overall Study|Lost to Follow-up|23|||
130683362|NCT01171963|470468228|FG001|Overall Study|Lost to Follow-up|24|||
130683363|NCT01171963|470468227|FG000|Overall Study|Other - diarrhoea|1|||
130683364|NCT01171963|470468228|FG001|Overall Study|Other - diarrhoea|0|||
130683365|NCT01171963|470468227|FG000|Overall Study|Withdrawal by Subject|114|||
130683366|NCT01171963|470468228|FG001|Overall Study|Withdrawal by Subject|129|||
130683367|NCT05093205|470468229|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
130683368|NCT05093205|470468230|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
130683369|NCT05093205|470468231|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
130683370|NCT05093205|470468232|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
130683371|NCT05093205|470468233|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
130683372|NCT05093205|470468234|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
130683373|NCT05093205|470468235|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
130683374|NCT05093205|470468236|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
130683375|NCT05093205|470468237|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
130683376|NCT05093205|470468238|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
130683377|NCT05093205|470468239|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
130683378|NCT05093205|470468240|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
130683379|NCT05093205|470468241|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
131018352|NCT05061693|471697341|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
131018353|NCT05061693|471697342|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
131018354|NCT05061693|471697343|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
131018355|NCT05061693|471697344|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
131018356|NCT05061693|471697345|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131018357|NCT05061693|471697346|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131018358|NCT05061693|471697347|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131018359|NCT05061693|471697348|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131018360|NCT05061693|471697349|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131018361|NCT05061693|471697350|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131018362|NCT05061693|471697351|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131018363|NCT05061693|471697352|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
131018364|NCT05061693|471697341|FG000|24-week Extension Period|Adverse Event|0|||
131018365|NCT05061693|471697342|FG001|24-week Extension Period|Adverse Event|0|||
131018366|NCT05061693|471697343|FG002|24-week Extension Period|Adverse Event|0|||
131018367|NCT05061693|471697344|FG003|24-week Extension Period|Adverse Event|0|||
131018368|NCT05061693|471697345|FG004|24-week Extension Period|Adverse Event|0|||
131018369|NCT05061693|471697346|FG005|24-week Extension Period|Adverse Event|0|||
131018370|NCT05061693|471697347|FG006|24-week Extension Period|Adverse Event|0|||
131018371|NCT05061693|471697348|FG007|24-week Extension Period|Adverse Event|2|||
131018372|NCT05061693|471697349|FG008|24-week Extension Period|Adverse Event|2|||
131018373|NCT05061693|471697350|FG009|24-week Extension Period|Adverse Event|0|||
131018374|NCT05061693|471697351|FG010|24-week Extension Period|Adverse Event|1|||
131018375|NCT05061693|471697352|FG011|24-week Extension Period|Adverse Event|3|||
131018376|NCT05061693|471697341|FG000|24-week Extension Period|Lack of Efficacy|0|||
131018377|NCT05061693|471697342|FG001|24-week Extension Period|Lack of Efficacy|0|||
131018378|NCT05061693|471697343|FG002|24-week Extension Period|Lack of Efficacy|0|||
131018379|NCT05061693|471697344|FG003|24-week Extension Period|Lack of Efficacy|0|||
131018380|NCT05061693|471697345|FG004|24-week Extension Period|Lack of Efficacy|0|||
131018381|NCT05061693|471697346|FG005|24-week Extension Period|Lack of Efficacy|0|||
131018382|NCT05061693|471697347|FG006|24-week Extension Period|Lack of Efficacy|0|||
131018383|NCT05061693|471697348|FG007|24-week Extension Period|Lack of Efficacy|0|||
131018384|NCT05061693|471697349|FG008|24-week Extension Period|Lack of Efficacy|0|||
131018385|NCT05061693|471697350|FG009|24-week Extension Period|Lack of Efficacy|0|||
131018386|NCT05061693|471697351|FG010|24-week Extension Period|Lack of Efficacy|2|||
131018387|NCT05061693|471697352|FG011|24-week Extension Period|Lack of Efficacy|0|||
131018388|NCT05061693|471697341|FG000|24-week Extension Period|Lost to Follow-up|0|||
131018389|NCT05061693|471697342|FG001|24-week Extension Period|Lost to Follow-up|0|||
131018390|NCT05061693|471697343|FG002|24-week Extension Period|Lost to Follow-up|0|||
130683380|NCT05093205|470468229|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131018391|NCT05061693|471697344|FG003|24-week Extension Period|Lost to Follow-up|0|||
130683381|NCT05093205|470468230|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683382|NCT05093205|470468231|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
130683383|NCT05093205|470468232|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683384|NCT05093205|470468233|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683385|NCT05093205|470468234|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683386|NCT05093205|470468235|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683387|NCT05093205|470468236|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683388|NCT05093205|470468237|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683389|NCT05093205|470468238|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683390|NCT05093205|470468239|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683391|NCT05093205|470468240|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130683392|NCT05093205|470468241|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
131018392|NCT05061693|471697345|FG004|24-week Extension Period|Lost to Follow-up|0|||
131018393|NCT05061693|471697346|FG005|24-week Extension Period|Lost to Follow-up|0|||
131018394|NCT05061693|471697347|FG006|24-week Extension Period|Lost to Follow-up|1|||
131018395|NCT05061693|471697348|FG007|24-week Extension Period|Lost to Follow-up|0|||
131018396|NCT05061693|471697349|FG008|24-week Extension Period|Lost to Follow-up|1|||
131018397|NCT05061693|471697350|FG009|24-week Extension Period|Lost to Follow-up|1|||
131018398|NCT05061693|471697351|FG010|24-week Extension Period|Lost to Follow-up|0|||
131018399|NCT05061693|471697352|FG011|24-week Extension Period|Lost to Follow-up|0|||
131018400|NCT05061693|471697341|FG000|24-week Extension Period|Withdrawal by Subject|0|||
131018401|NCT05061693|471697342|FG001|24-week Extension Period|Withdrawal by Subject|0|||
131018402|NCT05061693|471697343|FG002|24-week Extension Period|Withdrawal by Subject|0|||
131018403|NCT05061693|471697344|FG003|24-week Extension Period|Withdrawal by Subject|0|||
131018404|NCT05061693|471697345|FG004|24-week Extension Period|Withdrawal by Subject|0|||
131018405|NCT05061693|471697346|FG005|24-week Extension Period|Withdrawal by Subject|0|||
131018406|NCT05061693|471697347|FG006|24-week Extension Period|Withdrawal by Subject|0|||
131018407|NCT05061693|471697348|FG007|24-week Extension Period|Withdrawal by Subject|0|||
131018408|NCT05061693|471697349|FG008|24-week Extension Period|Withdrawal by Subject|1|||
131018409|NCT05061693|471697350|FG009|24-week Extension Period|Withdrawal by Subject|2|||
131018410|NCT05061693|471697351|FG010|24-week Extension Period|Withdrawal by Subject|2|||
131018411|NCT05061693|471697352|FG011|24-week Extension Period|Withdrawal by Subject|1|||
131018412|NCT05061693|471697341|FG000|24-week Extension Period|Sponsor Decision|0|||
131018413|NCT05061693|471697342|FG001|24-week Extension Period|Sponsor Decision|0|||
131018414|NCT05061693|471697343|FG002|24-week Extension Period|Sponsor Decision|0|||
131018415|NCT05061693|471697344|FG003|24-week Extension Period|Sponsor Decision|0|||
131018416|NCT05061693|471697345|FG004|24-week Extension Period|Sponsor Decision|0|||
131018417|NCT05061693|471697346|FG005|24-week Extension Period|Sponsor Decision|0|||
131018418|NCT05061693|471697347|FG006|24-week Extension Period|Sponsor Decision|0|||
131018419|NCT05061693|471697348|FG007|24-week Extension Period|Sponsor Decision|1|||
131018420|NCT05061693|471697349|FG008|24-week Extension Period|Sponsor Decision|0|||
131018421|NCT05061693|471697350|FG009|24-week Extension Period|Sponsor Decision|0|||
131018422|NCT05061693|471697351|FG010|24-week Extension Period|Sponsor Decision|0|||
131018423|NCT05061693|471697352|FG011|24-week Extension Period|Sponsor Decision|0|||
131018424|NCT05061693|471697341|FG000|24-week Extension Period|Site Closure|0|||
131018425|NCT05061693|471697342|FG001|24-week Extension Period|Site Closure|0|||
131018426|NCT05061693|471697343|FG002|24-week Extension Period|Site Closure|0|||
131018427|NCT05061693|471697344|FG003|24-week Extension Period|Site Closure|0|||
131018428|NCT05061693|471697345|FG004|24-week Extension Period|Site Closure|0|||
131018429|NCT05061693|471697346|FG005|24-week Extension Period|Site Closure|0|||
131018430|NCT05061693|471697347|FG006|24-week Extension Period|Site Closure|0|||
131018431|NCT05061693|471697348|FG007|24-week Extension Period|Site Closure|0|||
131018432|NCT05061693|471697349|FG008|24-week Extension Period|Site Closure|1|||
131018433|NCT05061693|471697350|FG009|24-week Extension Period|Site Closure|0|||
131018434|NCT05061693|471697351|FG010|24-week Extension Period|Site Closure|0|||
131018435|NCT05061693|471697352|FG011|24-week Extension Period|Site Closure|1|||
131018436|NCT00258895|471697353|FG000|Overall Study|Lost to Follow-up|3|||
131018437|NCT00258895|471697354|FG001|Overall Study|Lost to Follow-up|1|||
131018438|NCT00258895|471697353|FG000|Overall Study|Protocol Violation|6|||
131018439|NCT00258895|471697354|FG001|Overall Study|Protocol Violation|2|||
131018440|NCT00258895|471697353|FG000|Overall Study|Withdrawal by Subject|1|||
131018441|NCT00258895|471697354|FG001|Overall Study|Withdrawal by Subject|0|||
131018442|NCT00547118|471697355|FG000|Overall Study|Did not qualify prior to starting drug|1|||
131018443|NCT00547118|471697356|FG001|Overall Study|Did not qualify prior to starting drug|1|||
131018444|NCT00547118|471697355|FG000|Overall Study|Study suspended|7|||
131018445|NCT00547118|471697356|FG001|Overall Study|Study suspended|8|||
131018446|NCT02248480|471697357|FG000|Overall Study|Lack of Efficacy|4|||
131018447|NCT02248480|471697358|FG001|Overall Study|Lack of Efficacy|6|||
131018448|NCT02248480|471697357|FG000|Overall Study|Adverse Event|11|||
131018449|NCT02248480|471697358|FG001|Overall Study|Adverse Event|2|||
130683393|NCT05093205|470468229|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
130683394|NCT05093205|470468230|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
131018450|NCT02248480|471697357|FG000|Overall Study|Withdrawal by Subject|2|||
131018451|NCT02248480|471697358|FG001|Overall Study|Withdrawal by Subject|4|||
131018452|NCT02248480|471697357|FG000|Overall Study|Entry Criteria Not Met|0|||
131018453|NCT02248480|471697358|FG001|Overall Study|Entry Criteria Not Met|1|||
130683395|NCT05093205|470468231|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
130683396|NCT05093205|470468232|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
130683397|NCT05093205|470468233|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
130683398|NCT05093205|470468234|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
130683399|NCT05093205|470468235|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
130683400|NCT05093205|470468236|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
130683401|NCT05093205|470468237|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
130683402|NCT05093205|470468238|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
130683403|NCT05093205|470468239|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
130683404|NCT05093205|470468240|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
130683405|NCT05093205|470468241|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
130683406|NCT05093205|470468229|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
130683407|NCT05093205|470468230|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
130683408|NCT05093205|470468231|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
131018454|NCT02248480|471697357|FG000|Overall Study|Other:Physician Decision|0|||
131018455|NCT02248480|471697358|FG001|Overall Study|Other:Physician Decision|1|||
131018456|NCT04504916|471697360|FG000|Overall Study|Study terminated|7|||
131018457|NCT04504916|471697361|FG001|Overall Study|Study terminated|8|||
131018458|NCT04504916|471697360|FG000|Overall Study|Death|54|||
131018459|NCT04504916|471697361|FG001|Overall Study|Death|18|||
131018460|NCT04504916|471697360|FG000|Overall Study|Lost to Follow-up|1|||
131018461|NCT04504916|471697361|FG001|Overall Study|Lost to Follow-up|1|||
131018462|NCT04504916|471697360|FG000|Overall Study|Withdrawal by Subject|8|||
131018463|NCT04504916|471697361|FG001|Overall Study|Withdrawal by Subject|4|||
131018464|NCT04504916|471697360|FG000|Overall Study|Did not agree to follow-up|0|||
131018465|NCT04504916|471697361|FG001|Overall Study|Did not agree to follow-up|1|||
131018466|NCT00373529|471697362|FG000|Overall Study|Physician Decision|19|||
131018467|NCT00373529|471697362|FG000|Overall Study|Withdrawal by Subject|7|||
131018468|NCT00373529|471697362|FG000|Overall Study|Adverse Event|7|||
131018469|NCT00373529|471697362|FG000|Overall Study|Treatment failure|36|||
131018470|NCT00373529|471697362|FG000|Overall Study|Disease recurrence|10|||
131018471|NCT00373529|471697362|FG000|Overall Study|Death|16|||
131018472|NCT00373529|471697362|FG000|Overall Study|Need for treatment prohibited by study|1|||
131018473|NCT00373529|471697362|FG000|Overall Study|Other|8|||
131018474|NCT00373529|471697362|FG000|Overall Study|Failed independent confirmation of AML|3|||
131018475|NCT00373529|471697362|FG000|Overall Study|Consent violation|1|||
131018476|NCT00442117|471697363|FG000|Overall Study|Adverse Event|3|||
131018477|NCT00442117|471697364|FG001|Overall Study|Adverse Event|2|||
131018478|NCT00442117|471697363|FG000|Overall Study|Lack of Efficacy|2|||
131018479|NCT00442117|471697364|FG001|Overall Study|Lack of Efficacy|6|||
131018480|NCT00442117|471697363|FG000|Overall Study|Lost to Follow-up|1|||
131018481|NCT00442117|471697364|FG001|Overall Study|Lost to Follow-up|2|||
131018482|NCT00442117|471697363|FG000|Overall Study|Withdrawal by Subject|2|||
131018483|NCT00442117|471697364|FG001|Overall Study|Withdrawal by Subject|2|||
131018484|NCT00442117|471697363|FG000|Overall Study|Major Deviation|25|||
131018485|NCT00442117|471697364|FG001|Overall Study|Major Deviation|20|||
131018486|NCT00442117|471697363|FG000|Overall Study|Non compliance with protocol|3|||
131018487|NCT00442117|471697364|FG001|Overall Study|Non compliance with protocol|5|||
131018488|NCT00442117|471697363|FG000|Overall Study|Met Withdrawal Criteria|2|||
131018489|NCT00442117|471697364|FG001|Overall Study|Met Withdrawal Criteria|1|||
131018490|NCT00539292|471697365|FG000|Overall Study|Physician Decision|1|||
131018491|NCT00539292|471697366|FG001|Overall Study|Physician Decision|0|||
131018492|NCT00630786|471697367|FG000|Overall Study|Physician Decision|0|||
131018493|NCT00630786|471697368|FG001|Overall Study|Physician Decision|0|||
131018494|NCT00630786|471697369|FG002|Overall Study|Physician Decision|1|||
131018495|NCT00630786|471697367|FG000|Overall Study|Withdrawal by Subject|0|||
131018496|NCT00630786|471697368|FG001|Overall Study|Withdrawal by Subject|1|||
131018497|NCT00630786|471697369|FG002|Overall Study|Withdrawal by Subject|1|||
131018498|NCT00630786|471697367|FG000|Overall Study|Lost to Follow-up|0|||
131018499|NCT00630786|471697368|FG001|Overall Study|Lost to Follow-up|1|||
131018500|NCT00630786|471697369|FG002|Overall Study|Lost to Follow-up|0|||
131018501|NCT00630786|471697367|FG000|Overall Study|Other|1|||
131018502|NCT00630786|471697368|FG001|Overall Study|Other|0|||
130683409|NCT05093205|470468232|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
131018503|NCT00630786|471697369|FG002|Overall Study|Other|0|||
130683410|NCT05093205|470468233|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
130683411|NCT05093205|470468234|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
130683412|NCT05093205|470468235|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
130683413|NCT05093205|470468236|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
131018504|NCT04009577|471697370|FG000|Core Study|Adverse Event|1|||
131018505|NCT04009577|471697371|FG001|Core Study|Adverse Event|0|||
131018506|NCT04009577|471697372|FG002|Core Study|Adverse Event|2|||
131018507|NCT04009577|471697373|FG003|Core Study|Adverse Event|4|||
131018508|NCT04009577|471697370|FG000|Core Study|Withdrawal by Subject|0|||
131018509|NCT04009577|471697371|FG001|Core Study|Withdrawal by Subject|0|||
131018510|NCT04009577|471697372|FG002|Core Study|Withdrawal by Subject|2|||
131018511|NCT04009577|471697373|FG003|Core Study|Withdrawal by Subject|0|||
131018512|NCT04009577|471697370|FG000|Core Study|Other|0|||
131104977|NCT02344004|472015011|FG001|Overall Study|Death|7|||
130683414|NCT05093205|470468237|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
130683415|NCT05093205|470468238|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
130683416|NCT05093205|470468239|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
130683417|NCT05093205|470468240|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
130683418|NCT05093205|470468241|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
130683419|NCT05093205|470468229|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
130683420|NCT05093205|470468230|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
130683421|NCT05093205|470468231|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
130683422|NCT05093205|470468232|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
130683423|NCT05093205|470468233|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
130683424|NCT05093205|470468234|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
130683425|NCT05093205|470468235|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
130886581|NCT03486834|471217354|FG001|Overall Study|Pregnancy|12|||
131018513|NCT04009577|471697371|FG001|Core Study|Other|0|||
131018514|NCT04009577|471697372|FG002|Core Study|Other|0|||
131018515|NCT04009577|471697373|FG003|Core Study|Other|1|||
131018516|NCT04009577|471697370|FG000|Extension Phase|Adverse Event|0|||
131018517|NCT04009577|471697371|FG001|Extension Phase|Adverse Event|0|||
131018518|NCT04009577|471697372|FG002|Extension Phase|Adverse Event|0|||
131018519|NCT04009577|471697373|FG003|Extension Phase|Adverse Event|1|||
131104978|NCT02344004|472015010|FG000|Overall Study|Physician Decision|4|||
131104979|NCT02344004|472015011|FG001|Overall Study|Physician Decision|1|||
131104980|NCT02344004|472015010|FG000|Overall Study|Withdrawal by Subject|22|||
131104981|NCT02344004|472015011|FG001|Overall Study|Withdrawal by Subject|5|||
131104982|NCT02344004|472015010|FG000|Overall Study|Rescue Medication|2|||
130683426|NCT05093205|470468236|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
131018520|NCT04009577|471697370|FG000|Extension Phase|Inadequate therapeutic effect|0|||
131018521|NCT04009577|471697371|FG001|Extension Phase|Inadequate therapeutic effect|0|||
131018522|NCT04009577|471697372|FG002|Extension Phase|Inadequate therapeutic effect|1|||
131018523|NCT04009577|471697373|FG003|Extension Phase|Inadequate therapeutic effect|0|||
131018524|NCT04009577|471697370|FG000|Extension Phase|Withdrawal by Subject|0|||
131018525|NCT04009577|471697371|FG001|Extension Phase|Withdrawal by Subject|0|||
131018526|NCT04009577|471697372|FG002|Extension Phase|Withdrawal by Subject|1|||
131018527|NCT04009577|471697373|FG003|Extension Phase|Withdrawal by Subject|0|||
131018528|NCT04009577|471697370|FG000|Extension Phase|Not Treated|0|||
131018529|NCT04009577|471697371|FG001|Extension Phase|Not Treated|0|||
131018530|NCT04009577|471697372|FG002|Extension Phase|Not Treated|2|||
131018531|NCT04009577|471697373|FG003|Extension Phase|Not Treated|0|||
131018532|NCT02020616|471697377|FG000|Overall Study|Adverse Event|0|||
131018533|NCT02020616|471697378|FG001|Overall Study|Adverse Event|0|||
131018534|NCT02020616|471697379|FG002|Overall Study|Adverse Event|0|||
131018535|NCT02020616|471697380|FG003|Overall Study|Adverse Event|0|||
131018536|NCT02020616|471697381|FG004|Overall Study|Adverse Event|0|||
131018537|NCT02020616|471697382|FG005|Overall Study|Adverse Event|1|||
131018538|NCT02020616|471697383|FG006|Overall Study|Adverse Event|1|||
131018539|NCT02020616|471697377|FG000|Overall Study|Physician Decision|0|||
131018540|NCT02020616|471697378|FG001|Overall Study|Physician Decision|0|||
131018541|NCT02020616|471697379|FG002|Overall Study|Physician Decision|0|||
131018542|NCT02020616|471697380|FG003|Overall Study|Physician Decision|0|||
131018543|NCT02020616|471697381|FG004|Overall Study|Physician Decision|0|||
131018544|NCT02020616|471697382|FG005|Overall Study|Physician Decision|1|||
131018545|NCT02020616|471697383|FG006|Overall Study|Physician Decision|2|||
131018546|NCT02020616|471697377|FG000|Overall Study|Withdrawal by Subject|0|||
131018547|NCT02020616|471697378|FG001|Overall Study|Withdrawal by Subject|0|||
131018548|NCT02020616|471697379|FG002|Overall Study|Withdrawal by Subject|1|||
131018549|NCT02020616|471697380|FG003|Overall Study|Withdrawal by Subject|0|||
131018550|NCT02020616|471697381|FG004|Overall Study|Withdrawal by Subject|0|||
131018551|NCT02020616|471697382|FG005|Overall Study|Withdrawal by Subject|1|||
131018552|NCT02020616|471697383|FG006|Overall Study|Withdrawal by Subject|1|||
131018553|NCT02020616|471697377|FG000|Overall Study|Lost to Follow-up|0|||
131018554|NCT02020616|471697378|FG001|Overall Study|Lost to Follow-up|1|||
130683427|NCT05093205|470468237|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
130886582|NCT03486834|471217355|FG002|Overall Study|Pregnancy|12|||
131018555|NCT02020616|471697379|FG002|Overall Study|Lost to Follow-up|0|||
131018556|NCT02020616|471697380|FG003|Overall Study|Lost to Follow-up|1|||
130886583|NCT03486834|471217353|FG000|Overall Study|Protocol Deviation|2|||
131018557|NCT02020616|471697381|FG004|Overall Study|Lost to Follow-up|1|||
131018558|NCT02020616|471697382|FG005|Overall Study|Lost to Follow-up|1|||
131018559|NCT02020616|471697383|FG006|Overall Study|Lost to Follow-up|0|||
131018560|NCT02020616|471697377|FG000|Overall Study|Early Termination Criteria Met|0|||
131018561|NCT02020616|471697378|FG001|Overall Study|Early Termination Criteria Met|0|||
131018562|NCT02020616|471697379|FG002|Overall Study|Early Termination Criteria Met|1|||
131018563|NCT02020616|471697380|FG003|Overall Study|Early Termination Criteria Met|0|||
131018564|NCT02020616|471697381|FG004|Overall Study|Early Termination Criteria Met|0|||
131104983|NCT02344004|472015011|FG001|Overall Study|Rescue Medication|0|||
131104984|NCT02344004|472015010|FG000|Overall Study|Other Not Specified|12|||
131104985|NCT02344004|472015011|FG001|Overall Study|Other Not Specified|0|||
131104986|NCT02344004|472015010|FG000|Overall Study|Protocol Violation|1|||
131104987|NCT02344004|472015011|FG001|Overall Study|Protocol Violation|0|||
131104988|NCT03426605|472015012|FG000|Overall Study|AML relapse or progression|2|||
131104989|NCT03426605|472015013|FG001|Overall Study|AML relapse or progression|1|||
131104990|NCT03426605|472015014|FG002|Overall Study|AML relapse or progression|2|||
131104991|NCT03426605|472015015|FG003|Overall Study|AML relapse or progression|2|||
131104992|NCT03426605|472015012|FG000|Overall Study|Treatment failure|3|||
131104993|NCT03426605|472015013|FG001|Overall Study|Treatment failure|2|||
131104994|NCT03426605|472015014|FG002|Overall Study|Treatment failure|0|||
131104995|NCT03426605|472015015|FG003|Overall Study|Treatment failure|0|||
131104996|NCT03426605|472015012|FG000|Overall Study|Adverse Event|1|||
131104997|NCT03426605|472015013|FG001|Overall Study|Adverse Event|0|||
131104998|NCT03426605|472015014|FG002|Overall Study|Adverse Event|1|||
131104999|NCT03426605|472015015|FG003|Overall Study|Adverse Event|1|||
131105000|NCT03426605|472015012|FG000|Overall Study|Withdrawal by Subject|0|||
131105001|NCT03426605|472015013|FG001|Overall Study|Withdrawal by Subject|0|||
131105002|NCT03426605|472015014|FG002|Overall Study|Withdrawal by Subject|1|||
131105003|NCT03426605|472015015|FG003|Overall Study|Withdrawal by Subject|1|||
131105004|NCT00609765|472015021|FG000|Overall Study|Study ended prior to 12 months|1|||
131105005|NCT02649946|472015028|FG000|Overall Study|Withdrawal by Subject|1|||
131105006|NCT02649946|472015029|FG001|Overall Study|Withdrawal by Subject|1|||
131018565|NCT02020616|471697382|FG005|Overall Study|Early Termination Criteria Met|1|||
131018566|NCT02020616|471697383|FG006|Overall Study|Early Termination Criteria Met|0|||
131018567|NCT02020616|471697377|FG000|Overall Study|Randomized in Error|0|||
131018568|NCT02020616|471697378|FG001|Overall Study|Randomized in Error|0|||
131018569|NCT02020616|471697379|FG002|Overall Study|Randomized in Error|0|||
131018570|NCT02020616|471697380|FG003|Overall Study|Randomized in Error|1|||
131018571|NCT02020616|471697381|FG004|Overall Study|Randomized in Error|0|||
131018572|NCT02020616|471697382|FG005|Overall Study|Randomized in Error|0|||
131018573|NCT02020616|471697383|FG006|Overall Study|Randomized in Error|0|||
131018574|NCT02020616|471697377|FG000|Overall Study|Lack of Efficacy|0|||
131018575|NCT02020616|471697378|FG001|Overall Study|Lack of Efficacy|0|||
131018576|NCT02020616|471697379|FG002|Overall Study|Lack of Efficacy|0|||
131018577|NCT02020616|471697380|FG003|Overall Study|Lack of Efficacy|0|||
131018578|NCT02020616|471697381|FG004|Overall Study|Lack of Efficacy|1|||
131018579|NCT02020616|471697382|FG005|Overall Study|Lack of Efficacy|0|||
131018580|NCT02020616|471697383|FG006|Overall Study|Lack of Efficacy|0|||
131018581|NCT02031471|471697388|FG000|24 Week Treatment Period|Adverse Event|6|||
131018582|NCT02031471|471697388|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
131018583|NCT02031471|471697388|FG000|24 Week Treatment Period|Protocol Violation|1|||
131018584|NCT02031471|471697388|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
131018585|NCT02031471|471697388|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
131018586|NCT02031471|471697388|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
131018587|NCT02031471|471697388|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
131018588|NCT00658996|471697392|FG000|First Intervention|Positive slit lamp finding|1|||
131018589|NCT00658996|471697393|FG001|First Intervention|Positive slit lamp finding|0|||
131018590|NCT00658996|471697392|FG000|First Intervention|Lack of lenses|0|||
131018591|NCT00658996|471697393|FG001|First Intervention|Lack of lenses|1|||
131018592|NCT00658996|471697392|FG000|Crossover Period|Physician Decision|1|||
131018593|NCT00658996|471697393|FG001|Crossover Period|Physician Decision|0|||
131018594|NCT00658996|471697392|FG000|Crossover Period|Ineligible|1|||
131018595|NCT00658996|471697393|FG001|Crossover Period|Ineligible|1|||
131018596|NCT00658996|471697392|FG000|Second Intervention|Developed a stye on upper lid|1|||
131018597|NCT00658996|471697393|FG001|Second Intervention|Developed a stye on upper lid|0|||
131018598|NCT00658996|471697392|FG000|Second Intervention|Positive slit lamp finding|0|||
131018599|NCT00658996|471697393|FG001|Second Intervention|Positive slit lamp finding|1|||
131018600|NCT00997386|471697394|FG000|Overall Study|Death|7|||
131018601|NCT01579916|471697396|FG000|Overall Study|Lost to Follow-up|6|||
131018602|NCT01579916|471697397|FG001|Overall Study|Lost to Follow-up|1|||
131018603|NCT01579916|471697396|FG000|Overall Study|Withdrawal by Subject|1|||
131018604|NCT01579916|471697397|FG001|Overall Study|Withdrawal by Subject|1|||
131018605|NCT01579916|471697396|FG000|Overall Study|Death|1|||
131018606|NCT01579916|471697397|FG001|Overall Study|Death|0|||
131018607|NCT02994654|471697398|FG000|Overall Study|Lost to Follow-up|1|||
131018608|NCT01810263|471697405|FG000|Overall Study|Lost to Follow-up|8|||
131018609|NCT01810263|471697406|FG001|Overall Study|Lost to Follow-up|7|||
131018610|NCT00688519|471697407|FG000|Overall Study|Adverse Event|2|||
131018611|NCT00688519|471697408|FG001|Overall Study|Adverse Event|3|||
131105007|NCT02649946|472015028|FG000|Overall Study|Death|7|||
131105008|NCT02649946|472015029|FG001|Overall Study|Death|9|||
131105009|NCT02649946|472015028|FG000|Overall Study|Physician Decision|1|||
131105010|NCT02649946|472015029|FG001|Overall Study|Physician Decision|0|||
131018612|NCT00688519|471697407|FG000|Overall Study|Lost to Follow-up|3|||
131018613|NCT00688519|471697408|FG001|Overall Study|Lost to Follow-up|3|||
131018614|NCT00688519|471697407|FG000|Overall Study|Lack of Efficacy|3|||
131018615|NCT00688519|471697408|FG001|Overall Study|Lack of Efficacy|1|||
131018616|NCT00688519|471697407|FG000|Overall Study|Withdrawal by Subject|7|||
131105011|NCT02649946|472015028|FG000|Overall Study|Lost to Follow-up|2|||
131105012|NCT02649946|472015029|FG001|Overall Study|Lost to Follow-up|1|||
131105013|NCT02649946|472015028|FG000|Overall Study|Erroneously enrolled|1|||
131105014|NCT02649946|472015029|FG001|Overall Study|Erroneously enrolled|0|||
131105015|NCT02649946|472015028|FG000|Overall Study|Missed 6-month follow-up visit|0|||
131105016|NCT02649946|472015029|FG001|Overall Study|Missed 6-month follow-up visit|4|||
131105017|NCT00950950|472015030|FG000|Overall Study|Adverse Event|1|||
131105018|NCT00950950|472015031|FG001|Overall Study|Adverse Event|0|||
131105019|NCT00950950|472015030|FG000|Overall Study|Withdrawal by Subject|0|||
131105020|NCT00950950|472015031|FG001|Overall Study|Withdrawal by Subject|1|||
131105021|NCT01047293|472015032|FG000|Overall Study|DLT criteria not fulfilled|1|||
131105022|NCT01047293|472015033|FG001|Overall Study|DLT criteria not fulfilled|1|||
131105023|NCT01047293|472015034|FG002|Overall Study|DLT criteria not fulfilled|0|||
131105024|NCT01047293|472015035|FG003|Overall Study|DLT criteria not fulfilled|0|||
131105025|NCT02054520|472015041|FG000|Overall Study|Adverse Event|1|||
131105026|NCT02054520|472015042|FG001|Overall Study|Adverse Event|4|||
131105027|NCT02054520|472015043|FG002|Overall Study|Adverse Event|2|||
131105028|NCT02054520|472015044|FG003|Overall Study|Adverse Event|1|||
131105029|NCT02054520|472015045|FG004|Overall Study|Adverse Event|1|||
131105030|NCT02054520|472015046|FG005|Overall Study|Adverse Event|0|||
131105031|NCT02054520|472015041|FG000|Overall Study|Lack of Efficacy|7|||
131105032|NCT02054520|472015042|FG001|Overall Study|Lack of Efficacy|0|||
131105033|NCT02054520|472015043|FG002|Overall Study|Lack of Efficacy|2|||
131105034|NCT02054520|472015044|FG003|Overall Study|Lack of Efficacy|1|||
131105035|NCT02054520|472015045|FG004|Overall Study|Lack of Efficacy|3|||
131105036|NCT02054520|472015046|FG005|Overall Study|Lack of Efficacy|2|||
131105037|NCT02054520|472015041|FG000|Overall Study|Withdrawal by Subject|1|||
131105038|NCT02054520|472015042|FG001|Overall Study|Withdrawal by Subject|0|||
131105039|NCT02054520|472015043|FG002|Overall Study|Withdrawal by Subject|0|||
131105040|NCT02054520|472015044|FG003|Overall Study|Withdrawal by Subject|2|||
130683428|NCT05093205|470468238|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
130683429|NCT05093205|470468239|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
130683430|NCT05093205|470468240|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
130683431|NCT05093205|470468241|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
130683432|NCT05093205|470468229|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
130683433|NCT05093205|470468230|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
130683434|NCT05093205|470468231|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
130683435|NCT05093205|470468232|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
130683436|NCT05093205|470468233|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
130683437|NCT05093205|470468234|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
130683438|NCT05093205|470468235|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
130683439|NCT05093205|470468236|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
130683440|NCT05093205|470468237|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
130683441|NCT05093205|470468238|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
130683442|NCT05093205|470468239|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
130683443|NCT05093205|470468240|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
130683444|NCT05093205|470468241|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
130683445|NCT05093205|470468229|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
130683446|NCT05093205|470468230|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
130683447|NCT05093205|470468231|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
130683448|NCT05093205|470468232|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
130683449|NCT05093205|470468233|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
130683450|NCT05093205|470468234|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
131018617|NCT00688519|471697408|FG001|Overall Study|Withdrawal by Subject|6|||
131018618|NCT00688519|471697407|FG000|Overall Study|Prohibited medication|1|||
131018619|NCT00688519|471697408|FG001|Overall Study|Prohibited medication|0|||
131018620|NCT00688519|471697407|FG000|Overall Study|Non-compliance|0|||
131018621|NCT00688519|471697408|FG001|Overall Study|Non-compliance|1|||
131018622|NCT00688519|471697407|FG000|Overall Study|Subject moved out of state|1|||
131018623|NCT00688519|471697408|FG001|Overall Study|Subject moved out of state|0|||
131018624|NCT00688519|471697407|FG000|Overall Study|Investigator decision|1|||
131018625|NCT00688519|471697408|FG001|Overall Study|Investigator decision|0|||
131018626|NCT00688519|471697407|FG000|Overall Study|Subject moved out of area|1|||
131018627|NCT00688519|471697408|FG001|Overall Study|Subject moved out of area|0|||
131105041|NCT02054520|472015045|FG004|Overall Study|Withdrawal by Subject|1|||
131018628|NCT00688519|471697407|FG000|Overall Study|Pregnancy|0|||
131105042|NCT02054520|472015046|FG005|Overall Study|Withdrawal by Subject|0|||
131105043|NCT02054520|472015041|FG000|Overall Study|Physician Decision|0|||
131105044|NCT02054520|472015042|FG001|Overall Study|Physician Decision|1|||
131105045|NCT02054520|472015043|FG002|Overall Study|Physician Decision|0|||
130683451|NCT05093205|470468235|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
130683452|NCT05093205|470468236|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
130683453|NCT05093205|470468237|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
130683454|NCT05093205|470468238|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
130683455|NCT05093205|470468239|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
131105046|NCT02054520|472015044|FG003|Overall Study|Physician Decision|1|||
130683456|NCT05093205|470468240|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
130683457|NCT05093205|470468241|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
130683458|NCT05093205|470468229|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
130683459|NCT05093205|470468230|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
130683460|NCT05093205|470468231|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
130683461|NCT05093205|470468232|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
130683462|NCT05093205|470468233|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
130683463|NCT05093205|470468234|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
130683464|NCT05093205|470468235|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
130683465|NCT05093205|470468236|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
130683466|NCT05093205|470468237|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
130683467|NCT05093205|470468238|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
130683468|NCT05093205|470468239|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
130683469|NCT05093205|470468240|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
130683470|NCT05093205|470468241|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
131018629|NCT00688519|471697408|FG001|Overall Study|Pregnancy|1|||
131018630|NCT01353963|471697409|FG000|Overall Study|Adverse Event|2|||
131018631|NCT03544515|471698324|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
131018632|NCT03544515|471698325|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
131018633|NCT03544515|471698324|FG000|Overall Study|Lost to Follow-up|2|||
131018634|NCT03544515|471698325|FG001|Overall Study|Lost to Follow-up|0|||
131018635|NCT03169244|471698326|FG000|Overall Study|Lost to Follow-up|1|||
131018636|NCT03169244|471698327|FG001|Overall Study|Lost to Follow-up|2|||
131018637|NCT03169244|471698326|FG000|Overall Study|Adverse Event|1|||
131018638|NCT03169244|471698327|FG001|Overall Study|Adverse Event|0|||
131018639|NCT03169244|471698326|FG000|Overall Study|Withdrawal by Subject|2|||
131018640|NCT03169244|471698327|FG001|Overall Study|Withdrawal by Subject|2|||
131018641|NCT03169244|471698326|FG000|Overall Study|Physician Decision|1|||
131018642|NCT03169244|471698327|FG001|Overall Study|Physician Decision|0|||
131018643|NCT00178399|471698328|FG000|Overall Study|Physician Decision|4|||
131018644|NCT00178399|471698328|FG000|Overall Study|Withdrawal by Subject|8|||
131018645|NCT00178399|471698328|FG000|Overall Study|Lost to Follow-up|1|||
131018646|NCT02544152|471698329|FG000|Overall Study|Adverse Event|0|||
131018647|NCT02544152|471698330|FG001|Overall Study|Adverse Event|4|||
131018648|NCT02544152|471698329|FG000|Overall Study|Withdrawal by Subject|0|||
131018649|NCT02544152|471698330|FG001|Overall Study|Withdrawal by Subject|3|||
131018650|NCT02544152|471698329|FG000|Overall Study|Other|1|||
131018651|NCT02544152|471698330|FG001|Overall Study|Other|0|||
131018652|NCT00516321|471698331|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
131018653|NCT00516321|471698332|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
131018654|NCT00516321|471698333|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
131018655|NCT00516321|471698331|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
131018656|NCT00516321|471698332|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
131018657|NCT00516321|471698333|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
131018658|NCT00516321|471698331|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
131018659|NCT00516321|471698332|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
131018660|NCT00516321|471698333|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
131018661|NCT00516321|471698331|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
131018662|NCT00516321|471698332|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
131018663|NCT00516321|471698333|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
131018664|NCT00516321|471698331|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
131018665|NCT00516321|471698332|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
131018666|NCT00516321|471698333|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
131018667|NCT00516321|471698331|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
131018668|NCT00516321|471698332|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
131018669|NCT00516321|471698333|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
131018670|NCT00516321|471698331|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
131018671|NCT00516321|471698332|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
131018672|NCT00516321|471698333|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
131018673|NCT00516321|471698331|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
131018674|NCT00516321|471698332|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
131018675|NCT00516321|471698333|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
131018676|NCT00516321|471698331|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
131018677|NCT00516321|471698332|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
131018678|NCT00516321|471698333|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
131018679|NCT00516321|471698331|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
130683471|NCT05093205|470468229|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683472|NCT05093205|470468230|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683473|NCT05093205|470468231|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683474|NCT05093205|470468232|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683475|NCT05093205|470468233|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683476|NCT05093205|470468234|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683477|NCT05093205|470468235|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683478|NCT05093205|470468236|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683479|NCT05093205|470468237|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683480|NCT05093205|470468238|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
130683481|NCT05093205|470468239|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683482|NCT05093205|470468240|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683483|NCT05093205|470468241|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130683484|NCT05093205|470468229|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
130683485|NCT05093205|470468230|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
130683486|NCT05093205|470468231|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
130683487|NCT05093205|470468232|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
130683488|NCT05093205|470468233|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
130683489|NCT05093205|470468234|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
130683490|NCT05093205|470468235|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
130683491|NCT05093205|470468236|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
130683492|NCT05093205|470468237|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
130683493|NCT05093205|470468238|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
130683494|NCT05093205|470468239|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
130683495|NCT05093205|470468240|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
130683496|NCT05093205|470468241|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
130683497|NCT05093205|470468229|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683498|NCT05093205|470468230|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683499|NCT05093205|470468231|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683500|NCT05093205|470468232|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683501|NCT05093205|470468233|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683502|NCT05093205|470468234|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683503|NCT05093205|470468235|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683504|NCT05093205|470468236|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683505|NCT05093205|470468237|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683506|NCT05093205|470468238|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683507|NCT05093205|470468239|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
130683508|NCT05093205|470468240|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683509|NCT05093205|470468241|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130683510|NCT05093205|470468229|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683511|NCT05093205|470468230|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683512|NCT05093205|470468231|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683513|NCT05093205|470468232|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683514|NCT05093205|470468233|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683515|NCT05093205|470468234|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683516|NCT05093205|470468235|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683517|NCT05093205|470468236|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683518|NCT05093205|470468237|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683519|NCT05093205|470468238|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683520|NCT05093205|470468239|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683521|NCT05093205|470468240|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
130683522|NCT05093205|470468241|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130683523|NCT05093205|470468229|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
130683524|NCT05093205|470468230|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
130683525|NCT05093205|470468231|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
130683526|NCT05093205|470468232|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
130683527|NCT05093205|470468233|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
130683528|NCT05093205|470468234|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
131105047|NCT02054520|472015045|FG004|Overall Study|Physician Decision|0|||
131105048|NCT02054520|472015046|FG005|Overall Study|Physician Decision|1|||
131105049|NCT02054520|472015041|FG000|Overall Study|Study terminated by Sponsor|0|||
131105050|NCT02054520|472015042|FG001|Overall Study|Study terminated by Sponsor|0|||
131105051|NCT02054520|472015043|FG002|Overall Study|Study terminated by Sponsor|2|||
131105052|NCT02054520|472015044|FG003|Overall Study|Study terminated by Sponsor|1|||
131105053|NCT02054520|472015045|FG004|Overall Study|Study terminated by Sponsor|0|||
130683529|NCT05093205|470468235|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
130683530|NCT05093205|470468236|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
130683531|NCT05093205|470468237|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
130683532|NCT05093205|470468238|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
130683533|NCT05093205|470468239|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
130683534|NCT05093205|470468240|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
130683535|NCT05093205|470468241|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
130683536|NCT05093205|470468229|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683537|NCT05093205|470468230|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683538|NCT05093205|470468231|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
131105054|NCT02054520|472015046|FG005|Overall Study|Study terminated by Sponsor|0|||
131105055|NCT01272804|472015047|FG000|Overall Study|Adverse Event|1|||
130683539|NCT05093205|470468232|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683540|NCT05093205|470468233|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683541|NCT05093205|470468234|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683542|NCT05093205|470468235|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683543|NCT05093205|470468236|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683544|NCT05093205|470468237|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683545|NCT05093205|470468238|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683546|NCT05093205|470468239|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683547|NCT05093205|470468240|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
130683548|NCT05093205|470468241|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130683549|NCT04185909|470468243|FG000|Overall Study|Lost to Follow-up|1|||
130683550|NCT01417078|470468244|FG000|Overall Study|Withdrawal by Subject|1|||
130683551|NCT00626548|470468245|FG000|Overall Study|Adverse Event|164|||
130683552|NCT00626548|470468246|FG001|Overall Study|Adverse Event|44|||
130683553|NCT00626548|470468245|FG000|Overall Study|Withdrawal by Subject|42|||
130683554|NCT00626548|470468246|FG001|Overall Study|Withdrawal by Subject|46|||
130683555|NCT00626548|470468245|FG000|Overall Study|Protocol Violation|4|||
130683556|NCT00626548|470468246|FG001|Overall Study|Protocol Violation|11|||
130683557|NCT00626548|470468245|FG000|Overall Study|Lost to Follow-up|2|||
130683558|NCT00626548|470468246|FG001|Overall Study|Lost to Follow-up|2|||
130683559|NCT00626548|470468245|FG000|Overall Study|Other termination reason|493|||
130683560|NCT00626548|470468246|FG001|Overall Study|Other termination reason|613|||
130683561|NCT00048581|470468247|FG000|Double-Blind Period|Adverse Event|9|||
130683562|NCT00048581|470468248|FG001|Double-Blind Period|Adverse Event|5|||
130683563|NCT00048581|470468249|FG002|Double-Blind Period|Adverse Event|0|||
130683564|NCT00048581|470468247|FG000|Double-Blind Period|Lack of Efficacy|14|||
130683565|NCT00048581|470468248|FG001|Double-Blind Period|Lack of Efficacy|27|||
130683566|NCT00048581|470468249|FG002|Double-Blind Period|Lack of Efficacy|0|||
130683567|NCT00048581|470468247|FG000|Double-Blind Period|Lost to Follow-up|5|||
130683568|NCT00048581|470468248|FG001|Double-Blind Period|Lost to Follow-up|0|||
130683569|NCT00048581|470468249|FG002|Double-Blind Period|Lost to Follow-up|0|||
130683570|NCT00048581|470468247|FG000|Double-Blind Period|Withdrawal by Subject|5|||
130683571|NCT00048581|470468248|FG001|Double-Blind Period|Withdrawal by Subject|2|||
130683572|NCT00048581|470468249|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130683573|NCT00048581|470468247|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
130683574|NCT00048581|470468248|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
130683575|NCT00048581|470468249|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
130683576|NCT00048581|470468247|FG000|Double-Blind Period|Investigator Decision|1|||
130683577|NCT00048581|470468248|FG001|Double-Blind Period|Investigator Decision|0|||
130683578|NCT00048581|470468249|FG002|Double-Blind Period|Investigator Decision|0|||
130683579|NCT00048581|470468247|FG000|Open-Label Period|Death|0|||
130683580|NCT00048581|470468248|FG001|Open-Label Period|Death|0|||
130683581|NCT00048581|470468249|FG002|Open-Label Period|Death|4|||
130683582|NCT00048581|470468247|FG000|Open-Label Period|Adverse Event|0|||
130683583|NCT00048581|470468248|FG001|Open-Label Period|Adverse Event|0|||
130683584|NCT00048581|470468249|FG002|Open-Label Period|Adverse Event|37|||
130683585|NCT00048581|470468247|FG000|Open-Label Period|Lack of Efficacy|0|||
131018680|NCT00516321|471698332|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
131018681|NCT00516321|471698333|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
131018682|NCT00516321|471698331|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
131018683|NCT00516321|471698332|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
131018684|NCT00516321|471698333|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
131018685|NCT01426269|471698337|FG000|Period 1: 12 Weeks|Adverse Event|5|||
130683586|NCT00048581|470468248|FG001|Open-Label Period|Lack of Efficacy|0|||
131018686|NCT01426269|471698338|FG001|Period 1: 12 Weeks|Adverse Event|0|||
131018687|NCT01426269|471698339|FG002|Period 1: 12 Weeks|Adverse Event|0|||
131018688|NCT01426269|471698337|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
131018689|NCT01426269|471698338|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
131018690|NCT01426269|471698339|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
131018691|NCT01426269|471698337|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
131018692|NCT01426269|471698338|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
130683587|NCT00048581|470468249|FG002|Open-Label Period|Lack of Efficacy|69|||
130683588|NCT00048581|470468247|FG000|Open-Label Period|Lost to Follow-up|0|||
130683589|NCT00048581|470468248|FG001|Open-Label Period|Lost to Follow-up|0|||
130683590|NCT00048581|470468249|FG002|Open-Label Period|Lost to Follow-up|14|||
131018693|NCT01426269|471698339|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
130683591|NCT00048581|470468247|FG000|Open-Label Period|Withdrawal by Subject|0|||
130683592|NCT00048581|470468248|FG001|Open-Label Period|Withdrawal by Subject|0|||
130683593|NCT00048581|470468249|FG002|Open-Label Period|Withdrawal by Subject|20|||
131018694|NCT01426269|471698337|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
130683594|NCT00048581|470468247|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
130683595|NCT00048581|470468248|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
130683596|NCT00048581|470468249|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
131018695|NCT01426269|471698338|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
131105056|NCT01272804|472015048|FG001|Overall Study|Adverse Event|0|||
131105057|NCT01272804|472015049|FG002|Overall Study|Adverse Event|0|||
131105058|NCT01272804|472015050|FG003|Overall Study|Adverse Event|0|||
131105059|NCT01272804|472015051|FG004|Overall Study|Adverse Event|2|||
131105060|NCT01272804|472015052|FG005|Overall Study|Adverse Event|1|||
131105061|NCT02318797|472015053|FG000|Overall Study|Death|3|||
131105062|NCT02318797|472015054|FG001|Overall Study|Death|6|||
131105063|NCT02318797|472015053|FG000|Overall Study|Lost to Follow-up|85|||
131105064|NCT02318797|472015054|FG001|Overall Study|Lost to Follow-up|96|||
131105065|NCT02308020|472015057|FG000|Overall Study|Lost to Follow-up|1|||
131105066|NCT02308020|472015058|FG001|Overall Study|Lost to Follow-up|7|||
131105067|NCT02308020|472015059|FG002|Overall Study|Lost to Follow-up|0|||
131105068|NCT02308020|472015060|FG003|Overall Study|Lost to Follow-up|0|||
131105069|NCT02308020|472015061|FG004|Overall Study|Lost to Follow-up|1|||
131105070|NCT02308020|472015062|FG005|Overall Study|Lost to Follow-up|2|||
131105071|NCT02308020|472015057|FG000|Overall Study|Sponsor Decision|0|||
131105072|NCT02308020|472015058|FG001|Overall Study|Sponsor Decision|8|||
131105073|NCT02308020|472015059|FG002|Overall Study|Sponsor Decision|0|||
131105074|NCT02308020|472015060|FG003|Overall Study|Sponsor Decision|2|||
131105075|NCT02308020|472015061|FG004|Overall Study|Sponsor Decision|2|||
131105076|NCT02308020|472015062|FG005|Overall Study|Sponsor Decision|1|||
131105077|NCT02308020|472015057|FG000|Overall Study|Withdrawal by Subject|3|||
131105078|NCT02308020|472015058|FG001|Overall Study|Withdrawal by Subject|5|||
131105079|NCT02308020|472015059|FG002|Overall Study|Withdrawal by Subject|3|||
131105080|NCT02308020|472015060|FG003|Overall Study|Withdrawal by Subject|2|||
131105081|NCT02308020|472015061|FG004|Overall Study|Withdrawal by Subject|1|||
131105082|NCT02308020|472015062|FG005|Overall Study|Withdrawal by Subject|2|||
131105083|NCT03333837|472015063|FG000|Overall Study|Adverse Event|2|||
131105084|NCT03333837|472015064|FG001|Overall Study|Adverse Event|1|||
131105085|NCT03333837|472015065|FG002|Overall Study|Adverse Event|1|||
131105086|NCT03333837|472015066|FG003|Overall Study|Adverse Event|1|||
131105087|NCT03333837|472015067|FG004|Overall Study|Adverse Event|0|||
131105088|NCT03333837|472015063|FG000|Overall Study|Caregiver withdrew|0|||
131105089|NCT03333837|472015064|FG001|Overall Study|Caregiver withdrew|2|||
131105090|NCT03333837|472015065|FG002|Overall Study|Caregiver withdrew|1|||
130683597|NCT00048581|470468247|FG000|Open-Label Period|Poor/Non-compliance|0|||
130683598|NCT00048581|470468248|FG001|Open-Label Period|Poor/Non-compliance|0|||
130683599|NCT00048581|470468249|FG002|Open-Label Period|Poor/Non-compliance|5|||
130683600|NCT00048581|470468247|FG000|Open-Label Period|Pregnancy|0|||
130683601|NCT00048581|470468248|FG001|Open-Label Period|Pregnancy|0|||
130683602|NCT00048581|470468249|FG002|Open-Label Period|Pregnancy|7|||
130683603|NCT00048581|470468247|FG000|Open-Label Period|Study Site Closure|0|||
130683604|NCT00048581|470468248|FG001|Open-Label Period|Study Site Closure|0|||
130683605|NCT00048581|470468249|FG002|Open-Label Period|Study Site Closure|2|||
130683606|NCT00048581|470468247|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
130683607|NCT00048581|470468248|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
130683608|NCT00048581|470468249|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
130683609|NCT00048581|470468247|FG000|Open-Label Period|Problem With Transportation To Site|0|||
130683610|NCT00048581|470468248|FG001|Open-Label Period|Problem With Transportation To Site|0|||
130683611|NCT00048581|470468249|FG002|Open-Label Period|Problem With Transportation To Site|1|||
130683612|NCT00048581|470468247|FG000|Open-Label Period|Primary Investigator Retired|0|||
130683613|NCT00048581|470468248|FG001|Open-Label Period|Primary Investigator Retired|0|||
130683614|NCT00048581|470468249|FG002|Open-Label Period|Primary Investigator Retired|2|||
130683615|NCT00048581|470468247|FG000|Open-Label Period|Study Ended By Sponsor|0|||
130683616|NCT00048581|470468248|FG001|Open-Label Period|Study Ended By Sponsor|0|||
130683617|NCT00048581|470468249|FG002|Open-Label Period|Study Ended By Sponsor|1|||
130683618|NCT01059903|470468251|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
130683619|NCT01059903|470468252|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
130683620|NCT00385593|470468255|FG000|Overall Study|Adverse Event|3|||
130683621|NCT00385593|470468256|FG001|Overall Study|Adverse Event|2|||
130683622|NCT00385593|470468255|FG000|Overall Study|Withdrawal by Subject|17|||
130683623|NCT00385593|470468256|FG001|Overall Study|Withdrawal by Subject|7|||
131105091|NCT03333837|472015066|FG003|Overall Study|Caregiver withdrew|0|||
131105092|NCT03333837|472015067|FG004|Overall Study|Caregiver withdrew|0|||
131105093|NCT03333837|472015063|FG000|Overall Study|Withdrawal by Subject|0|||
131105094|NCT03333837|472015064|FG001|Overall Study|Withdrawal by Subject|0|||
131105095|NCT03333837|472015065|FG002|Overall Study|Withdrawal by Subject|1|||
131105096|NCT03333837|472015066|FG003|Overall Study|Withdrawal by Subject|1|||
131105097|NCT03333837|472015067|FG004|Overall Study|Withdrawal by Subject|3|||
131105098|NCT03333837|472015063|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
131105099|NCT03333837|472015064|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
131105100|NCT03333837|472015065|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
131105101|NCT03333837|472015066|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
131105102|NCT03333837|472015067|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
131105103|NCT04217590|472015068|FG000|Overall Study|Other|1|||
130683624|NCT00385593|470468255|FG000|Overall Study|Lost to Follow-up|12|||
130683625|NCT00385593|470468256|FG001|Overall Study|Lost to Follow-up|8|||
130683626|NCT00385593|470468255|FG000|Overall Study|Protocol Violation|7|||
130683627|NCT00385593|470468256|FG001|Overall Study|Protocol Violation|4|||
130683628|NCT00385593|470468255|FG000|Overall Study|Several reasons|17|||
130683629|NCT00385593|470468256|FG001|Overall Study|Several reasons|15|||
130683630|NCT00385593|470468255|FG000|Overall Study|Incorrect inclusion|2|||
130683631|NCT00385593|470468256|FG001|Overall Study|Incorrect inclusion|0|||
130683632|NCT00385593|470468255|FG000|Overall Study|Incorrect randomization|0|||
130683633|NCT00385593|470468256|FG001|Overall Study|Incorrect randomization|1|||
130683634|NCT02100228|470468257|FG000|Overall Study|Other|19|||
130683635|NCT02100228|470468258|FG001|Overall Study|Other|19|||
130683636|NCT02100228|470468257|FG000|Overall Study|Administrative reason|0|||
130683637|NCT02100228|470468258|FG001|Overall Study|Administrative reason|1|||
130683638|NCT02100228|470468257|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
130683639|NCT02100228|470468258|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
130683640|NCT02100228|470468257|FG000|Overall Study|Non-compliance|0|||
130683641|NCT02100228|470468258|FG001|Overall Study|Non-compliance|3|||
130683642|NCT02100228|470468257|FG000|Overall Study|Lost to Follow-up|0|||
130683643|NCT02100228|470468258|FG001|Overall Study|Lost to Follow-up|1|||
130683644|NCT02100228|470468257|FG000|Overall Study|Withdrawal by Subject|27|||
130683645|NCT02100228|470468258|FG001|Overall Study|Withdrawal by Subject|37|||
130683646|NCT02100228|470468257|FG000|Overall Study|Adverse Event|16|||
130683647|NCT02100228|470468258|FG001|Overall Study|Adverse Event|12|||
130683648|NCT02100228|470468257|FG000|Overall Study|Death|1|||
130683649|NCT02100228|470468258|FG001|Overall Study|Death|1|||
130683650|NCT04149964|470468259|FG000|Overall Study|Lost to Follow-up|19|||
130683651|NCT04149964|470468260|FG001|Overall Study|Lost to Follow-up|18|||
130683652|NCT01223365|470468261|FG000|Open-label Titration Period|Enrolled but not treated|1|||
130683653|NCT01223365|470468261|FG000|Open-label Titration Period|Adverse Event|23|||
130683654|NCT01223365|470468261|FG000|Open-label Titration Period|Lack of Efficacy|3|||
130683655|NCT01223365|470468261|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
130683656|NCT01223365|470468261|FG000|Open-label Titration Period|Protocol Violation|1|||
130683657|NCT01223365|470468261|FG000|Open-label Titration Period|Lost to Follow-up|2|||
130683658|NCT01223365|470468261|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
130683659|NCT01223365|470468261|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
130683660|NCT01223365|470468261|FG000|Open-label Titration Period|Starting physical therapy|1|||
130683661|NCT01223365|470468261|FG000|Open-label Treatment Period|Adverse Event|39|||
130683662|NCT01223365|470468261|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
130683663|NCT01223365|470468261|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
130683664|NCT01223365|470468261|FG000|Open-label Treatment Period|Protocol Violation|15|||
130683665|NCT01223365|470468261|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
130683666|NCT01223365|470468261|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
130683667|NCT01223365|470468261|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
130683668|NCT01223365|470468261|FG000|Open-label Treatment Period|Moved out of area|2|||
130683669|NCT01223365|470468261|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
130683670|NCT01223365|470468261|FG000|Open-label Treatment Period|"Out of window"|1|||
130683671|NCT01223365|470468261|FG000|Open-label Treatment Period|Starting physical therapy|1|||
130683672|NCT01223365|470468261|FG000|Open-label Treatment Period|Physician Decision|2|||
130683673|NCT03567174|470468262|FG000|Overall Study|Death|24|||
130683674|NCT03567174|470468263|FG001|Overall Study|Death|31|||
130683675|NCT03567174|470468262|FG000|Overall Study|Lost to Follow-up|165|||
130683676|NCT03567174|470468263|FG001|Overall Study|Lost to Follow-up|174|||
130683677|NCT02817841|470469892|FG000|Overall Study|Lost to Follow-up|287|||
130683678|NCT02817841|470469892|FG000|Overall Study|Withdrawal by Subject|183|||
130683679|NCT02817841|470469892|FG000|Overall Study|Adverse event not related to bleeding|131|||
130683680|NCT02817841|470469892|FG000|Overall Study|Adverse event related to bleeding|51|||
130683681|NCT02817841|470469892|FG000|Overall Study|Pregnancy|32|||
130683682|NCT02817841|470469892|FG000|Overall Study|Pregnancy wish|17|||
130683683|NCT02817841|470469892|FG000|Overall Study|Other reasons|53|||
130683684|NCT02817841|470469892|FG000|Overall Study|Protocol Violation|94|||
130683685|NCT01746017|470469895|FG000|Period 1|Withdrawal by Subject|0|||
130683686|NCT01746017|470469896|FG001|Period 1|Withdrawal by Subject|0|||
130683687|NCT01746017|470469897|FG002|Period 1|Withdrawal by Subject|0|||
130683688|NCT01746017|470469898|FG003|Period 1|Withdrawal by Subject|0|||
130683689|NCT01746017|470469899|FG004|Period 1|Withdrawal by Subject|0|||
130683690|NCT01746017|470469900|FG005|Period 1|Withdrawal by Subject|0|||
130683691|NCT01746017|470469901|FG006|Period 1|Withdrawal by Subject|1|||
130683692|NCT01746017|470469902|FG007|Period 1|Withdrawal by Subject|0|||
130683693|NCT01746017|470469903|FG008|Period 1|Withdrawal by Subject|0|||
130683694|NCT01746017|470469904|FG009|Period 1|Withdrawal by Subject|0|||
130683695|NCT01746017|470469905|FG010|Period 1|Withdrawal by Subject|0|||
130683696|NCT01746017|470469895|FG000|Period 3|Withdrawal by Subject|0|||
130683697|NCT01746017|470469896|FG001|Period 3|Withdrawal by Subject|0|||
130683698|NCT01746017|470469897|FG002|Period 3|Withdrawal by Subject|0|||
130683699|NCT01746017|470469898|FG003|Period 3|Withdrawal by Subject|0|||
130683700|NCT01746017|470469899|FG004|Period 3|Withdrawal by Subject|0|||
130683701|NCT01746017|470469900|FG005|Period 3|Withdrawal by Subject|1|||
130683702|NCT01746017|470469901|FG006|Period 3|Withdrawal by Subject|0|||
130683703|NCT01746017|470469902|FG007|Period 3|Withdrawal by Subject|0|||
130683704|NCT01746017|470469903|FG008|Period 3|Withdrawal by Subject|0|||
130683705|NCT01746017|470469904|FG009|Period 3|Withdrawal by Subject|0|||
130683706|NCT01746017|470469905|FG010|Period 3|Withdrawal by Subject|0|||
130683707|NCT00397488|470469906|FG000|Overall Study|Withdrawal by Subject|3|||
130683708|NCT00397488|470469906|FG000|Overall Study|Adverse Event|3|||
130683709|NCT00397488|470469906|FG000|Overall Study|Death|1|||
130683710|NCT02424097|470469907|FG000|Overall Study|Lost to Follow-up|1|||
130683711|NCT02424097|470469908|FG001|Overall Study|Lost to Follow-up|2|||
130683712|NCT02943447|470469909|FG000|Blinded Study Phase|Withdrew Consent|1|||
130683713|NCT02943447|470469910|FG001|Blinded Study Phase|Withdrew Consent|2|||
130683714|NCT02943447|470469911|FG002|Blinded Study Phase|Withdrew Consent|1|||
130683715|NCT02943447|470469909|FG000|Blinded Study Phase|Adverse Event|3|||
130683716|NCT02943447|470469910|FG001|Blinded Study Phase|Adverse Event|0|||
130683717|NCT02943447|470469911|FG002|Blinded Study Phase|Adverse Event|0|||
130683718|NCT02943447|470469909|FG000|Blinded Study Phase|Investigator's discretion|1|||
130683719|NCT02943447|470469910|FG001|Blinded Study Phase|Investigator's discretion|0|||
130683720|NCT02943447|470469911|FG002|Blinded Study Phase|Investigator's discretion|0|||
130683721|NCT02943447|470469909|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
130683722|NCT02943447|470469910|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
130683723|NCT02943447|470469911|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
130683724|NCT02943447|470469909|FG000|Open-Label Extension Phase|Adverse Event|4|||
130683725|NCT02943447|470469910|FG001|Open-Label Extension Phase|Adverse Event|7|||
130683726|NCT02943447|470469911|FG002|Open-Label Extension Phase|Adverse Event|3|||
130683727|NCT02943447|470469909|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
130683728|NCT02943447|470469910|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
130683729|NCT02943447|470469911|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
130683730|NCT02943447|470469909|FG000|Open-Label Extension Phase|Withdrew consent|1|||
130683731|NCT02943447|470469910|FG001|Open-Label Extension Phase|Withdrew consent|1|||
130683732|NCT02943447|470469911|FG002|Open-Label Extension Phase|Withdrew consent|1|||
130683733|NCT02943447|470469909|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130683734|NCT02943447|470469910|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
130683735|NCT02943447|470469911|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130683736|NCT04657770|470469919|FG000|Overall Study|Withdrawal by Subject|3|||
130683737|NCT04657770|470469919|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
130683738|NCT03655106|470469920|FG000|Overall Study|Withdrawal by Subject|3|||
130683739|NCT03655106|470469921|FG001|Overall Study|Withdrawal by Subject|2|||
130683740|NCT03655106|470469920|FG000|Overall Study|Lost to Follow-up|2|||
130683741|NCT03655106|470469921|FG001|Overall Study|Lost to Follow-up|1|||
130683742|NCT03655106|470469920|FG000|Overall Study|Duplicate Enrollment|1|||
130683743|NCT03655106|470469921|FG001|Overall Study|Duplicate Enrollment|1|||
130683744|NCT03655106|470469920|FG000|Overall Study|Protocol Violation|3|||
130683745|NCT03655106|470469921|FG001|Overall Study|Protocol Violation|0|||
130683746|NCT00496964|470469924|FG000|Overall Study|Withdrawal by Subject|0|||
130683747|NCT00496964|470469925|FG001|Overall Study|Withdrawal by Subject|1|||
130683748|NCT02058498|470469926|FG000|Overall Study|Withdrawal by Subject|4|||
130683749|NCT05327491|470469927|FG000|Periods 1 & 2|Miscellaneous|0|||
130683750|NCT05327491|470469928|FG001|Periods 1 & 2|Miscellaneous|1|||
130683751|NCT05327491|470469929|FG002|Periods 1 & 2|Miscellaneous|0|||
130683752|NCT05327491|470469930|FG003|Periods 1 & 2|Miscellaneous|0|||
130683753|NCT05327491|470469927|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
130683754|NCT05327491|470469928|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
130683755|NCT05327491|470469929|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
130683756|NCT05327491|470469930|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
130683757|NCT05038293|470469931|FG000|Overall Study|device was not operating properly for one subject.|1|||
130683758|NCT05038293|470469932|FG001|Overall Study|device was not operating properly for one subject.|0|||
130683759|NCT05038293|470469931|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
130683760|NCT05038293|470469932|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
130683761|NCT01171989|470469933|FG000|Overall Study|Lost to Follow-up|0|||
130683762|NCT01171989|470469934|FG001|Overall Study|Lost to Follow-up|0|||
130683763|NCT01171989|470469935|FG002|Overall Study|Lost to Follow-up|1|||
131018696|NCT01426269|471698339|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
131018697|NCT01426269|471698337|FG000|Period 1: 12 Weeks|Pregnancy|1|||
131018698|NCT01426269|471698338|FG001|Period 1: 12 Weeks|Pregnancy|0|||
131018699|NCT01426269|471698339|FG002|Period 1: 12 Weeks|Pregnancy|0|||
131018700|NCT01426269|471698337|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
131018701|NCT01426269|471698338|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
131018702|NCT01426269|471698339|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
131018703|NCT01426269|471698337|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
131018704|NCT01426269|471698338|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
131105104|NCT04217590|472015069|FG001|Overall Study|Other|1|||
131105105|NCT04217590|472015068|FG000|Overall Study|Withdrawal by Subject|3|||
131105106|NCT04217590|472015069|FG001|Overall Study|Withdrawal by Subject|1|||
130683764|NCT01247701|470469938|FG000|Overall Study|Death|2|||
130683765|NCT01247701|470469938|FG000|Overall Study|Relapsed|8|||
130683766|NCT04166630|470469939|FG000|Overall Study|Withdrawal by Subject|0|||
130683767|NCT04166630|470469940|FG001|Overall Study|Withdrawal by Subject|1|||
130683768|NCT00096447|470469941|FG000|Overall Study|Never treated|1|||
130683769|NCT04088760|470469942|FG000|Overall Study|Physician Decision|1|||
131105107|NCT04217590|472015068|FG000|Overall Study|Death|0|||
131105108|NCT04217590|472015069|FG001|Overall Study|Death|1|||
130683770|NCT01391793|470469943|FG000|Overall Study|Ineligible|3|||
130683771|NCT01391793|470469944|FG001|Overall Study|Ineligible|0|||
130683772|NCT01391793|470469943|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
130683773|NCT01391793|470469944|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
130683774|NCT01391793|470469943|FG000|Overall Study|No DMSA|73|||
131105109|NCT02232243|472015070|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
131105110|NCT02232243|472015071|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
130683775|NCT01391793|470469944|FG001|Overall Study|No DMSA|57|||
130683776|NCT00105196|470469945|FG000|Overall Study|Lack of Efficacy|2|||
130683777|NCT00105196|470469946|FG001|Overall Study|Lack of Efficacy|3|||
130683778|NCT00105196|470469945|FG000|Overall Study|Adverse Event|11|||
130683779|NCT00105196|470469946|FG001|Overall Study|Adverse Event|3|||
130683780|NCT00105196|470469945|FG000|Overall Study|Withdrawal by Subject|6|||
130683781|NCT00105196|470469946|FG001|Overall Study|Withdrawal by Subject|6|||
130683782|NCT00105196|470469945|FG000|Overall Study|Lost to Follow-up|3|||
130683783|NCT00105196|470469946|FG001|Overall Study|Lost to Follow-up|2|||
130683784|NCT00105196|470469945|FG000|Overall Study|Poor/noncompliance|3|||
130683785|NCT00105196|470469946|FG001|Overall Study|Poor/noncompliance|4|||
130683786|NCT00105196|470469945|FG000|Overall Study|Protocol Violation|5|||
130683787|NCT00105196|470469946|FG001|Overall Study|Protocol Violation|2|||
130683788|NCT00105196|470469945|FG000|Overall Study|pending surgery|0|||
130683789|NCT00105196|470469946|FG001|Overall Study|pending surgery|1|||
130683790|NCT00105196|470469945|FG000|Overall Study|marijuana use|0|||
130683791|NCT00105196|470469946|FG001|Overall Study|marijuana use|1|||
130683792|NCT00105196|470469945|FG000|Overall Study|Subject became unblinded|0|||
130683793|NCT00105196|470469946|FG001|Overall Study|Subject became unblinded|1|||
130683794|NCT03025880|470469947|FG000|Overall Study|Adverse Event|1|||
130683795|NCT03025880|470469948|FG001|Overall Study|Adverse Event|0|||
130683796|NCT03025880|470469947|FG000|Overall Study|Death|1|||
130683797|NCT03025880|470469948|FG001|Overall Study|Death|1|||
130683798|NCT03025880|470469947|FG000|Overall Study|Withdrawal by Subject|0|||
130683799|NCT03025880|470469948|FG001|Overall Study|Withdrawal by Subject|1|||
130683800|NCT03025880|470469947|FG000|Overall Study|Physician Decision|0|||
130683801|NCT03025880|470469948|FG001|Overall Study|Physician Decision|1|||
130683802|NCT03025880|470469947|FG000|Overall Study|Progressive Disease|12|||
130683803|NCT03025880|470469948|FG001|Overall Study|Progressive Disease|19|||
130683804|NCT00184600|470469949|FG000|Overall Study|Adverse Event|9|||
130683805|NCT00184600|470469950|FG001|Overall Study|Adverse Event|0|||
130683806|NCT00184600|470469951|FG002|Overall Study|Adverse Event|5|||
130683807|NCT00184600|470469949|FG000|Overall Study|Death|3|||
130683808|NCT00184600|470469950|FG001|Overall Study|Death|9|||
130683809|NCT00184600|470469951|FG002|Overall Study|Death|7|||
130683810|NCT00184600|470469949|FG000|Overall Study|Lack of Efficacy|3|||
130766992|NCT01897571|470770676|FG003|Overall Study|Enrolled in rollover study|0|||
131018705|NCT01426269|471698339|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
131018706|NCT01426269|471698337|FG000|Period 2: 40 Weeks|Adverse Event|0|||
131018707|NCT01426269|471698338|FG001|Period 2: 40 Weeks|Adverse Event|1|||
131018708|NCT01426269|471698339|FG002|Period 2: 40 Weeks|Adverse Event|2|||
131018709|NCT01426269|471698337|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
131018710|NCT01426269|471698338|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
131018711|NCT01426269|471698339|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
131018712|NCT01426269|471698337|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
131018713|NCT01426269|471698338|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
130683811|NCT00184600|470469950|FG001|Overall Study|Lack of Efficacy|1|||
130683812|NCT00184600|470469951|FG002|Overall Study|Lack of Efficacy|3|||
130683813|NCT00184600|470469949|FG000|Overall Study|Lost to Follow-up|4|||
130683814|NCT00184600|470469950|FG001|Overall Study|Lost to Follow-up|6|||
130683815|NCT00184600|470469951|FG002|Overall Study|Lost to Follow-up|1|||
130683816|NCT00184600|470469949|FG000|Overall Study|Protocol Violation|2|||
130683817|NCT00184600|470469950|FG001|Overall Study|Protocol Violation|2|||
130683818|NCT00184600|470469951|FG002|Overall Study|Protocol Violation|3|||
130683819|NCT00184600|470469949|FG000|Overall Study|Withdrawal by Subject|20|||
130683820|NCT00184600|470469950|FG001|Overall Study|Withdrawal by Subject|28|||
131018714|NCT01426269|471698339|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
131018715|NCT01426269|471698337|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
130766993|NCT01897571|470770677|FG004|Overall Study|Enrolled in rollover study|0|||
131018716|NCT01426269|471698338|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
131105111|NCT02232243|472015072|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
131105112|NCT00704405|472015073|FG000|Overall Study (NC Population)|Adverse Event|1|||
131018717|NCT01426269|471698339|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
131018718|NCT01426269|471698337|FG000|Period 2: 40 Weeks|Site closed|0|||
131018719|NCT01426269|471698338|FG001|Period 2: 40 Weeks|Site closed|6|||
131018720|NCT01426269|471698339|FG002|Period 2: 40 Weeks|Site closed|5|||
131018721|NCT01426269|471698337|FG000|Period 2: 40 Weeks|Relapsed|0|||
131018722|NCT01426269|471698338|FG001|Period 2: 40 Weeks|Relapsed|9|||
131018723|NCT01426269|471698339|FG002|Period 2: 40 Weeks|Relapsed|18|||
131018724|NCT03557008|471698340|FG000|Overall Study|Withdrawal by Subject|2|||
131018725|NCT03557008|471698341|FG001|Overall Study|Withdrawal by Subject|2|||
131018726|NCT03557008|471698340|FG000|Overall Study|Early termination from study|3|||
131018727|NCT03557008|471698341|FG001|Overall Study|Early termination from study|1|||
131018728|NCT01113931|471698342|FG000|Overall Study|Adverse Event|2|||
131018729|NCT01113931|471698343|FG001|Overall Study|Adverse Event|2|||
131018730|NCT01113931|471698342|FG000|Overall Study|Physician Decision|0|||
131018731|NCT01113931|471698343|FG001|Overall Study|Physician Decision|2|||
131018732|NCT01113931|471698342|FG000|Overall Study|Lost to Follow-up|12|||
131018733|NCT01113931|471698343|FG001|Overall Study|Lost to Follow-up|9|||
131018734|NCT01113931|471698342|FG000|Overall Study|Various|2|||
131018735|NCT01113931|471698343|FG001|Overall Study|Various|4|||
131018736|NCT01113931|471698342|FG000|Overall Study|Withdrawal by Subject|3|||
131018737|NCT01113931|471698343|FG001|Overall Study|Withdrawal by Subject|0|||
131018738|NCT00071799|471698345|FG000|Overall Study|Adverse Event|19|||
131018739|NCT00071799|471698346|FG001|Overall Study|Adverse Event|10|||
131018740|NCT00071799|471698345|FG000|Overall Study|Protocol Violation|1|||
131018741|NCT00071799|471698346|FG001|Overall Study|Protocol Violation|7|||
131018742|NCT00071799|471698345|FG000|Overall Study|Lost to Follow-up|1|||
131018743|NCT00071799|471698346|FG001|Overall Study|Lost to Follow-up|1|||
131018744|NCT00071799|471698345|FG000|Overall Study|Withdrawal by Subject|15|||
131018745|NCT00071799|471698346|FG001|Overall Study|Withdrawal by Subject|37|||
131018746|NCT00071799|471698345|FG000|Overall Study|Physician Decision|0|||
131018747|NCT00071799|471698346|FG001|Overall Study|Physician Decision|2|||
131018748|NCT00071799|471698345|FG000|Overall Study|Lack of Efficacy|11|||
131018749|NCT00071799|471698346|FG001|Overall Study|Lack of Efficacy|18|||
131018750|NCT00071799|471698345|FG000|Overall Study|Disease Progression|23|||
131018751|NCT00071799|471698346|FG001|Overall Study|Disease Progression|20|||
131018752|NCT00071799|471698345|FG000|Overall Study|Different Central+Local Pathology Review|0|||
131018753|NCT00071799|471698346|FG001|Overall Study|Different Central+Local Pathology Review|1|||
131018754|NCT00071799|471698345|FG000|Overall Study|Not Documented|0|||
131018755|NCT00071799|471698346|FG001|Overall Study|Not Documented|2|||
131018756|NCT03959241|471698347|FG000|Overall Study|Withdrawal by Subject|7|||
131018757|NCT03959241|471698348|FG001|Overall Study|Withdrawal by Subject|8|||
131018758|NCT03959241|471698347|FG000|Overall Study|Lost to Follow-up|1|||
131018759|NCT03959241|471698348|FG001|Overall Study|Lost to Follow-up|0|||
131018760|NCT03959241|471698347|FG000|Overall Study|Move to Hospice Care|1|||
131018761|NCT03959241|471698348|FG001|Overall Study|Move to Hospice Care|0|||
131018762|NCT03959241|471698347|FG000|Overall Study|Screen Failure|1|||
131018763|NCT03959241|471698348|FG001|Overall Study|Screen Failure|0|||
131018764|NCT03959241|471698347|FG000|Overall Study|Disease Relapse|0|||
131018765|NCT03959241|471698348|FG001|Overall Study|Disease Relapse|1|||
131018766|NCT03959241|471698347|FG000|Overall Study|Off Study|1|||
131018767|NCT03959241|471698348|FG001|Overall Study|Off Study|0|||
131018768|NCT01145885|471698349|FG000|Overall Study|Progressive Disease|7|||
131018769|NCT00346151|471698352|FG000|Overall Study|Withdrawal by Subject|3|||
131018770|NCT04054635|471698358|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
131018771|NCT04054635|471698359|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
131018772|NCT04054635|471698360|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
131018773|NCT04054635|471698358|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
131018774|NCT04054635|471698359|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
131018775|NCT04054635|471698360|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
131018776|NCT00545077|471698366|FG000|Overall Study|Treatment not received|5|||
131018777|NCT00545077|471698367|FG001|Overall Study|Treatment not received|1|||
131018778|NCT00545077|471698366|FG000|Overall Study|Disease Progression|131|||
131018779|NCT00545077|471698367|FG001|Overall Study|Disease Progression|98|||
131018780|NCT00545077|471698366|FG000|Overall Study|Withdrawal by Subject|3|||
131018781|NCT00545077|471698367|FG001|Overall Study|Withdrawal by Subject|14|||
131018782|NCT00545077|471698366|FG000|Overall Study|Physician Decision|6|||
131018783|NCT00545077|471698367|FG001|Overall Study|Physician Decision|3|||
131018784|NCT00545077|471698366|FG000|Overall Study|Lost to Follow-up|2|||
131018785|NCT00545077|471698367|FG001|Overall Study|Lost to Follow-up|0|||
131018786|NCT00545077|471698366|FG000|Overall Study|Protocol Violation|1|||
131018787|NCT00545077|471698367|FG001|Overall Study|Protocol Violation|0|||
131018788|NCT00545077|471698366|FG000|Overall Study|Adverse Event|0|||
131018789|NCT00545077|471698367|FG001|Overall Study|Adverse Event|31|||
131018790|NCT00545077|471698366|FG000|Overall Study|Death|0|||
131018791|NCT00545077|471698367|FG001|Overall Study|Death|8|||
131018792|NCT00535145|471698369|FG000|Phase I|Adverse Event|3|||
131018793|NCT00535145|471698369|FG000|Phase I|Lost to Follow-up|7|||
131018794|NCT00535145|471698369|FG000|Phase I|Withdrawal by Subject|6|||
131018795|NCT00535145|471698369|FG000|Phase I|(eligibility)|8|||
131105113|NCT00704405|472015074|FG001|Overall Study (NC Population)|Adverse Event|0|||
131105114|NCT00704405|472015075|FG002|Overall Study (NC Population)|Adverse Event|0|||
131105115|NCT00704405|472015076|FG003|Overall Study (NC Population)|Adverse Event|0|||
131105116|NCT00704405|472015077|FG004|Overall Study (NC Population)|Adverse Event|0|||
131105117|NCT00704405|472015073|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
131105118|NCT00704405|472015074|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
131105119|NCT00704405|472015075|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
131105120|NCT00704405|472015076|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
131105121|NCT00704405|472015077|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
131105122|NCT00704405|472015073|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
131105123|NCT00704405|472015074|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
131105124|NCT00704405|472015075|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
131105125|NCT00704405|472015076|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
131105126|NCT00704405|472015077|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
131105127|NCT00704405|472015073|FG000|Overall Study (NC Population)|Other|0|||
131105128|NCT00704405|472015074|FG001|Overall Study (NC Population)|Other|0|||
131105129|NCT00704405|472015075|FG002|Overall Study (NC Population)|Other|0|||
131105130|NCT00704405|472015076|FG003|Overall Study (NC Population)|Other|0|||
131105131|NCT00704405|472015077|FG004|Overall Study (NC Population)|Other|1|||
131105132|NCT00704405|472015073|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
131105133|NCT00704405|472015074|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
131105134|NCT00704405|472015075|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
131105135|NCT00704405|472015076|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
131105136|NCT00704405|472015077|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
131105137|NCT00704405|472015073|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
131105138|NCT00704405|472015074|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
131105139|NCT00704405|472015075|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
131105140|NCT00704405|472015076|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
131105141|NCT00704405|472015077|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
131105142|NCT01395888|472015078|FG000|2-week Run-in Period|Adverse Event|2|||
131105143|NCT01395888|472015079|FG001|2-week Run-in Period|Adverse Event|0|||
131105144|NCT01395888|472015080|FG002|2-week Run-in Period|Adverse Event|0|||
131105145|NCT01395888|472015078|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
131105146|NCT01395888|472015079|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
131105147|NCT01395888|472015080|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
131105148|NCT01395888|472015078|FG000|2-week Run-in Period|Lost to Follow-up|1|||
131105149|NCT01395888|472015079|FG001|2-week Run-in Period|Lost to Follow-up|0|||
131105150|NCT01395888|472015080|FG002|2-week Run-in Period|Lost to Follow-up|0|||
131105151|NCT01395888|472015078|FG000|2-week Run-in Period|Protocol Violation|2|||
131105152|NCT01395888|472015079|FG001|2-week Run-in Period|Protocol Violation|0|||
131105153|NCT01395888|472015080|FG002|2-week Run-in Period|Protocol Violation|0|||
131105154|NCT01395888|472015078|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
131105155|NCT01395888|472015079|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
131105156|NCT01395888|472015080|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131105157|NCT01395888|472015078|FG000|Treatment Period (TP)|Adverse Event|0|||
131105158|NCT01395888|472015079|FG001|Treatment Period (TP)|Adverse Event|7|||
131105159|NCT01395888|472015080|FG002|Treatment Period (TP)|Adverse Event|6|||
131105160|NCT01395888|472015078|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
131105161|NCT01395888|472015079|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
131105162|NCT01395888|472015080|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
131105163|NCT01395888|472015078|FG000|Treatment Period (TP)|Protocol Violation|0|||
131105164|NCT01395888|472015079|FG001|Treatment Period (TP)|Protocol Violation|1|||
131105165|NCT01395888|472015080|FG002|Treatment Period (TP)|Protocol Violation|5|||
131105166|NCT01395888|472015078|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
131105167|NCT01395888|472015079|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
131105168|NCT01395888|472015080|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
131105169|NCT01395888|472015078|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
131105170|NCT01395888|472015079|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
131105171|NCT01395888|472015080|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
131105172|NCT03218397|472015081|FG000|Overall Study|Prior positive blood culture|8|||
131105173|NCT03218397|472015082|FG001|Overall Study|Prior positive blood culture|13|||
131105174|NCT03218397|472015081|FG000|Overall Study|Comfort care|8|||
130683821|NCT00184600|470469951|FG002|Overall Study|Withdrawal by Subject|12|||
130683822|NCT00184600|470469949|FG000|Overall Study|Unclassified|4|||
131105175|NCT03218397|472015082|FG001|Overall Study|Comfort care|5|||
131105176|NCT03218397|472015081|FG000|Overall Study|Comfort care and positive blood culture|1|||
131105177|NCT03218397|472015082|FG001|Overall Study|Comfort care and positive blood culture|0|||
131105178|NCT03218397|472015081|FG000|Overall Study|Comfort care and mixed culture|0|||
131105179|NCT03218397|472015082|FG001|Overall Study|Comfort care and mixed culture|1|||
131105180|NCT03218397|472015081|FG000|Overall Study|Mixed culture|2|||
131105181|NCT03218397|472015082|FG001|Overall Study|Mixed culture|2|||
130683823|NCT00184600|470469950|FG001|Overall Study|Unclassified|5|||
130683824|NCT00184600|470469951|FG002|Overall Study|Unclassified|3|||
130683825|NCT00286754|470469952|FG000|Overall Study|Adverse Event|2|||
130683826|NCT00286754|470469953|FG001|Overall Study|Adverse Event|2|||
130683827|NCT00286754|470469954|FG002|Overall Study|Adverse Event|3|||
130683828|NCT00286754|470469952|FG000|Overall Study|Withdrawal by Subject|6|||
130683829|NCT00286754|470469953|FG001|Overall Study|Withdrawal by Subject|2|||
130683830|NCT00286754|470469954|FG002|Overall Study|Withdrawal by Subject|0|||
130683831|NCT00286754|470469952|FG000|Overall Study|Lost to Follow-up|12|||
130683832|NCT00286754|470469953|FG001|Overall Study|Lost to Follow-up|14|||
130683833|NCT00286754|470469954|FG002|Overall Study|Lost to Follow-up|6|||
130683834|NCT00286754|470469952|FG000|Overall Study|Moved out of state|0|||
130683835|NCT00286754|470469953|FG001|Overall Study|Moved out of state|0|||
131018796|NCT00535145|471698369|FG000|Phase I|(protocol violation)|1|||
131018797|NCT00535145|471698369|FG000|Phase I|(PI decision)|1|||
131018798|NCT00535145|471698369|FG000|Phase I|(diagnosis)|3|||
131018799|NCT00535145|471698369|FG000|Phase II|Adverse Event|2|||
131018800|NCT00535145|471698369|FG000|Phase II|Lack of Efficacy|1|||
131018801|NCT00535145|471698369|FG000|Phase II|Lost to Follow-up|5|||
131018802|NCT00535145|471698369|FG000|Phase II|Withdrawal by Subject|5|||
131018803|NCT00535145|471698369|FG000|Phase II|Subject non-compliance|2|||
131018804|NCT03260140|471698370|FG000|Overall Study|Death|4|||
131018805|NCT03260140|471698371|FG001|Overall Study|Death|1|||
131018806|NCT03260140|471698370|FG000|Overall Study|Withdrawal by Subject|1|||
131018807|NCT03260140|471698371|FG001|Overall Study|Withdrawal by Subject|4|||
131018808|NCT00463788|471698372|FG000|Overall Study|Progressive Disease|86|||
131018809|NCT00463788|471698373|FG001|Overall Study|Progressive Disease|42|||
131018810|NCT00463788|471698372|FG000|Overall Study|Adverse Event|6|||
131018811|NCT00463788|471698373|FG001|Overall Study|Adverse Event|2|||
131018812|NCT00463788|471698372|FG000|Overall Study|Withdrawal by Subject|6|||
131018813|NCT00463788|471698373|FG001|Overall Study|Withdrawal by Subject|2|||
131018814|NCT00463788|471698372|FG000|Overall Study|Death|4|||
131018815|NCT00463788|471698373|FG001|Overall Study|Death|3|||
131018816|NCT00463788|471698372|FG000|Overall Study|Symptomatic Deterioration|2|||
131018817|NCT00463788|471698373|FG001|Overall Study|Symptomatic Deterioration|3|||
131018818|NCT00463788|471698372|FG000|Overall Study|Lost to Follow-up|1|||
131018819|NCT00463788|471698373|FG001|Overall Study|Lost to Follow-up|0|||
131018820|NCT00463788|471698372|FG000|Overall Study|Protocol Violation|0|||
131018821|NCT00463788|471698373|FG001|Overall Study|Protocol Violation|1|||
131018822|NCT00463788|471698372|FG000|Overall Study|Other|3|||
131018823|NCT00463788|471698373|FG001|Overall Study|Other|0|||
131018824|NCT00463788|471698372|FG000|Overall Study|Randomized but not treated|1|||
131018825|NCT00463788|471698373|FG001|Overall Study|Randomized but not treated|1|||
131018826|NCT00360698|471698374|FG000|Run-In|Physician Decision|0|||
131018827|NCT00360698|471698375|FG001|Run-In|Physician Decision|1|||
131018828|NCT00360698|471698374|FG000|Run-In|Withdrawal by Subject|0|||
131018829|NCT00360698|471698375|FG001|Run-In|Withdrawal by Subject|2|||
131018830|NCT00360698|471698374|FG000|Run-In|Non compliance with treatment procedure|0|||
131018831|NCT00360698|471698375|FG001|Run-In|Non compliance with treatment procedure|1|||
131018832|NCT00360698|471698374|FG000|Run-In|Sponsor request|0|||
131018833|NCT00360698|471698375|FG001|Run-In|Sponsor request|2|||
131018834|NCT00360698|471698374|FG000|Run-In|Patient did not meet inclusion criteria|0|||
131018835|NCT00360698|471698375|FG001|Run-In|Patient did not meet inclusion criteria|1|||
131018836|NCT00360698|471698374|FG000|Run-In|Patient personal reasons|0|||
131018837|NCT00360698|471698375|FG001|Run-In|Patient personal reasons|2|||
131018838|NCT00360698|471698374|FG000|Run-In|Need of insulin with meals|0|||
131018839|NCT00360698|471698375|FG001|Run-In|Need of insulin with meals|1|||
131018840|NCT00360698|471698374|FG000|Treatment Period|Non compliance with treatment procedure|1|||
131018841|NCT00360698|471698375|FG001|Treatment Period|Non compliance with treatment procedure|0|||
131018842|NCT00360698|471698374|FG000|Treatment Period|Early termination by error|0|||
131018843|NCT00360698|471698375|FG001|Treatment Period|Early termination by error|1|||
131018844|NCT01692938|471698379|FG000|Overall Study|Protocol Deviation|1|||
131018845|NCT01692938|471698380|FG001|Overall Study|Protocol Deviation|1|||
131018846|NCT01692938|471698379|FG000|Overall Study|Study completed prior to site completion|3|||
131018847|NCT01692938|471698380|FG001|Overall Study|Study completed prior to site completion|3|||
131018848|NCT02423291|471698382|FG000|Overall Study|Lack of Efficacy|14|||
131018849|NCT02423291|471698382|FG000|Overall Study|Adverse Event|1|||
131018850|NCT05283395|471698384|FG000|Overall Study|Adverse Event|4|||
131018851|NCT05283395|471698385|FG001|Overall Study|Adverse Event|4|||
131018852|NCT05283395|471698386|FG002|Overall Study|Adverse Event|0|||
131018853|NCT05283395|471698384|FG000|Overall Study|Patient Lost to Follow-Up|0|||
131018854|NCT05283395|471698385|FG001|Overall Study|Patient Lost to Follow-Up|0|||
131018855|NCT05283395|471698386|FG002|Overall Study|Patient Lost to Follow-Up|1|||
131018856|NCT05283395|471698384|FG000|Overall Study|Patient Withdrawal|2|||
131018857|NCT05283395|471698385|FG001|Overall Study|Patient Withdrawal|4|||
131018858|NCT05283395|471698386|FG002|Overall Study|Patient Withdrawal|2|||
130683836|NCT00286754|470469954|FG002|Overall Study|Moved out of state|1|||
130683837|NCT02336165|470469955|FG000|Overall Study|Death|3|||
131018859|NCT05283395|471698384|FG000|Overall Study|Investigator Decision|1|||
131105182|NCT03218397|472015081|FG000|Overall Study|Inaccessible hospital records|2|||
131105183|NCT03218397|472015082|FG001|Overall Study|Inaccessible hospital records|5|||
131105184|NCT03218397|472015081|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
131105185|NCT03218397|472015082|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
131105186|NCT03218397|472015081|FG000|Overall Study|Randomized during laboratory off hours|2|||
131105187|NCT03218397|472015082|FG001|Overall Study|Randomized during laboratory off hours|1|||
131105188|NCT01796548|472015083|FG000|Overall Study|Lost to Follow-up|1|||
131105189|NCT01796548|472015083|FG000|Overall Study|Other|2|||
131105190|NCT02859324|472015084|FG000|Overall Study|Death|4|||
131105191|NCT02859324|472015085|FG001|Overall Study|Death|6|||
131105192|NCT02859324|472015086|FG002|Overall Study|Death|5|||
131105193|NCT02859324|472015084|FG000|Overall Study|Other reasons|3|||
131105194|NCT02859324|472015085|FG001|Overall Study|Other reasons|3|||
131105195|NCT02859324|472015086|FG002|Overall Study|Other reasons|0|||
131105196|NCT01946438|472015087|FG000|Overall Study|Adverse Event|0|||
131105197|NCT01946438|472015088|FG001|Overall Study|Adverse Event|0|||
131105198|NCT01946438|472015089|FG002|Overall Study|Adverse Event|0|||
131105199|NCT01946438|472015090|FG003|Overall Study|Adverse Event|1|||
131105200|NCT01946438|472015087|FG000|Overall Study|Serious Adverse event|1|||
131105201|NCT01946438|472015088|FG001|Overall Study|Serious Adverse event|0|||
131105202|NCT01946438|472015089|FG002|Overall Study|Serious Adverse event|0|||
131105203|NCT01946438|472015090|FG003|Overall Study|Serious Adverse event|0|||
131105204|NCT01946438|472015087|FG000|Overall Study|Protocol Violation|0|||
131105205|NCT01946438|472015088|FG001|Overall Study|Protocol Violation|0|||
131105206|NCT01946438|472015089|FG002|Overall Study|Protocol Violation|1|||
131105207|NCT01946438|472015090|FG003|Overall Study|Protocol Violation|0|||
131105208|NCT01946438|472015087|FG000|Overall Study|Withdrawal by Subject|1|||
131105209|NCT01946438|472015088|FG001|Overall Study|Withdrawal by Subject|0|||
131105210|NCT01946438|472015089|FG002|Overall Study|Withdrawal by Subject|0|||
131105211|NCT01946438|472015090|FG003|Overall Study|Withdrawal by Subject|0|||
131105212|NCT03169101|472015093|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
131105213|NCT03169101|472015094|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
131105214|NCT03169101|472015095|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
131105215|NCT03169101|472015096|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
131105216|NCT02641496|472015097|FG000|Overall Study|Lost to Follow-up|13|||
131105217|NCT02641496|472015098|FG001|Overall Study|Lost to Follow-up|12|||
131105218|NCT02641496|472015097|FG000|Overall Study|Withdrawal by Subject|1|||
131105219|NCT02641496|472015098|FG001|Overall Study|Withdrawal by Subject|0|||
131105220|NCT02523599|472015099|FG000|Overall Study|Adverse Event|1|||
131105221|NCT02523599|472015100|FG001|Overall Study|Adverse Event|0|||
131105222|NCT02523599|472015099|FG000|Overall Study|Physician Decision|1|||
131105223|NCT02523599|472015100|FG001|Overall Study|Physician Decision|0|||
131105224|NCT02523599|472015099|FG000|Overall Study|Lost to Follow-up|4|||
131105225|NCT02523599|472015100|FG001|Overall Study|Lost to Follow-up|1|||
131105226|NCT02523599|472015099|FG000|Overall Study|Did not return for Day 30 visit|2|||
131105227|NCT02523599|472015100|FG001|Overall Study|Did not return for Day 30 visit|0|||
131105228|NCT00790751|472015103|FG000|Overall Study|Protocol non-compliance|16|||
131105229|NCT00790751|472015104|FG001|Overall Study|Protocol non-compliance|16|||
131105230|NCT00790751|472015105|FG002|Overall Study|Protocol non-compliance|10|||
131105231|NCT00790751|472015106|FG003|Overall Study|Protocol non-compliance|11|||
131105232|NCT00790751|472015103|FG000|Overall Study|Lost to Follow-up|4|||
131105233|NCT00790751|472015104|FG001|Overall Study|Lost to Follow-up|9|||
131105234|NCT00790751|472015105|FG002|Overall Study|Lost to Follow-up|4|||
131105235|NCT00790751|472015106|FG003|Overall Study|Lost to Follow-up|5|||
131105236|NCT00790751|472015103|FG000|Overall Study|Adverse Event|5|||
131105237|NCT00790751|472015104|FG001|Overall Study|Adverse Event|3|||
131105238|NCT00790751|472015105|FG002|Overall Study|Adverse Event|5|||
131105239|NCT00790751|472015106|FG003|Overall Study|Adverse Event|4|||
131105240|NCT00790751|472015103|FG000|Overall Study|Requirement for restricted medication|0|||
131105241|NCT00790751|472015104|FG001|Overall Study|Requirement for restricted medication|2|||
131105242|NCT00790751|472015105|FG002|Overall Study|Requirement for restricted medication|0|||
131105243|NCT00790751|472015106|FG003|Overall Study|Requirement for restricted medication|0|||
131105244|NCT00790751|472015103|FG000|Overall Study|Death|0|||
131105245|NCT00790751|472015104|FG001|Overall Study|Death|0|||
131105246|NCT00790751|472015105|FG002|Overall Study|Death|1|||
131105247|NCT00790751|472015106|FG003|Overall Study|Death|0|||
131105248|NCT00790751|472015103|FG000|Overall Study|Physician Decision|0|||
131105249|NCT00790751|472015104|FG001|Overall Study|Physician Decision|0|||
131105250|NCT00790751|472015105|FG002|Overall Study|Physician Decision|0|||
131105251|NCT00790751|472015106|FG003|Overall Study|Physician Decision|1|||
131105252|NCT00112047|472015107|FG000|Randomized Phase|Lost to Follow-up|26|||
131105253|NCT00112047|472015108|FG001|Randomized Phase|Lost to Follow-up|33|||
131105254|NCT00112047|472015107|FG000|Randomized Phase|Adverse Event|10|||
131105255|NCT00112047|472015108|FG001|Randomized Phase|Adverse Event|10|||
131105256|NCT00112047|472015107|FG000|Randomized Phase|Withrawal of consent|10|||
131105257|NCT00112047|472015108|FG001|Randomized Phase|Withrawal of consent|18|||
131105258|NCT00112047|472015107|FG000|Randomized Phase|Sub-optimal virological response|3|||
131222612|NCT01902134|472443114|FG001|Overall Study|Other|1|||
130683838|NCT02336165|470469956|FG001|Overall Study|Death|0|||
130683839|NCT02336165|470469957|FG002|Overall Study|Death|0|||
130683840|NCT02336165|470469958|FG003|Overall Study|Death|0|||
130683841|NCT02336165|470469959|FG004|Overall Study|Death|1|||
130683842|NCT02336165|470469955|FG000|Overall Study|Physician Decision|2|||
130683843|NCT02336165|470469956|FG001|Overall Study|Physician Decision|2|||
130683844|NCT02336165|470469957|FG002|Overall Study|Physician Decision|1|||
130683845|NCT02336165|470469958|FG003|Overall Study|Physician Decision|1|||
130683846|NCT02336165|470469959|FG004|Overall Study|Physician Decision|0|||
130683847|NCT02336165|470469955|FG000|Overall Study|Withdrawal by Subject|0|||
130683848|NCT02336165|470469956|FG001|Overall Study|Withdrawal by Subject|0|||
130683849|NCT02336165|470469957|FG002|Overall Study|Withdrawal by Subject|1|||
130683850|NCT02336165|470469958|FG003|Overall Study|Withdrawal by Subject|0|||
130683851|NCT02336165|470469959|FG004|Overall Study|Withdrawal by Subject|1|||
130683852|NCT02336165|470469955|FG000|Overall Study|Adverse Event|4|||
130683853|NCT02336165|470469956|FG001|Overall Study|Adverse Event|1|||
130683854|NCT02336165|470469957|FG002|Overall Study|Adverse Event|2|||
130683855|NCT02336165|470469958|FG003|Overall Study|Adverse Event|4|||
130683856|NCT02336165|470469959|FG004|Overall Study|Adverse Event|1|||
130683857|NCT02336165|470469955|FG000|Overall Study|Progressive disease|23|||
130683858|NCT02336165|470469956|FG001|Overall Study|Progressive disease|22|||
130683859|NCT02336165|470469957|FG002|Overall Study|Progressive disease|27|||
130683860|NCT02336165|470469958|FG003|Overall Study|Progressive disease|24|||
130683861|NCT02336165|470469959|FG004|Overall Study|Progressive disease|19|||
130683862|NCT02336165|470469955|FG000|Overall Study|Non-compliance|1|||
130683863|NCT02336165|470469956|FG001|Overall Study|Non-compliance|0|||
130683864|NCT02336165|470469957|FG002|Overall Study|Non-compliance|0|||
130683865|NCT02336165|470469958|FG003|Overall Study|Non-compliance|1|||
130683866|NCT02336165|470469959|FG004|Overall Study|Non-compliance|0|||
130683867|NCT02336165|470469955|FG000|Overall Study|Other|1|||
130683868|NCT02336165|470469956|FG001|Overall Study|Other|0|||
130683869|NCT02336165|470469957|FG002|Overall Study|Other|0|||
130683870|NCT02336165|470469958|FG003|Overall Study|Other|1|||
130683871|NCT02336165|470469959|FG004|Overall Study|Other|0|||
130683872|NCT02726581|470469962|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130683873|NCT02726581|470469963|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
130683874|NCT02726581|470469964|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130683875|NCT02726581|470469962|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
130683876|NCT02726581|470469963|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
130683877|NCT02726581|470469964|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
130683878|NCT02726581|470469962|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130683879|NCT02726581|470469963|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130683880|NCT02726581|470469964|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130683881|NCT02726581|470469962|FG000|Treatment Period|Disease progression|47|||
130683882|NCT02726581|470469963|FG001|Treatment Period|Disease progression|50|||
130683883|NCT02726581|470469964|FG002|Treatment Period|Disease progression|16|||
130683884|NCT02726581|470469962|FG000|Treatment Period|Other reasons|9|||
130683885|NCT02726581|470469963|FG001|Treatment Period|Other reasons|8|||
130683886|NCT02726581|470469964|FG002|Treatment Period|Other reasons|2|||
130683887|NCT02726581|470469962|FG000|Treatment Period|Study drug toxicity|6|||
131018860|NCT05283395|471698385|FG001|Overall Study|Investigator Decision|0|||
131018861|NCT05283395|471698386|FG002|Overall Study|Investigator Decision|1|||
131018862|NCT05283395|471698384|FG000|Overall Study|Enrolled in error|0|||
131018863|NCT05283395|471698385|FG001|Overall Study|Enrolled in error|0|||
131018864|NCT05283395|471698386|FG002|Overall Study|Enrolled in error|1|||
131018865|NCT00424645|471698390|FG000|Overall Study|Death|1|||
131018866|NCT00424645|471698391|FG001|Overall Study|Death|0|||
131018867|NCT02115139|471698392|FG000|Overall Study|Protocol Violation|1|||
131018868|NCT02115139|471698392|FG000|Overall Study|treatment discontinuation|6|||
131018869|NCT02471755|471698393|FG000|Overall Study|Withdrawal by Subject|1|||
131018870|NCT02471755|471698394|FG001|Overall Study|Withdrawal by Subject|0|||
131018871|NCT02471755|471698393|FG000|Overall Study|Lost to Follow-up|0|||
131018872|NCT02471755|471698394|FG001|Overall Study|Lost to Follow-up|1|||
131018873|NCT03823911|471698395|FG000|Overall Study|Lost to Follow-up|1|||
131018874|NCT03823911|471698396|FG001|Overall Study|Lost to Follow-up|5|||
131018875|NCT03823911|471698397|FG002|Overall Study|Lost to Follow-up|2|||
131018876|NCT03823911|471698395|FG000|Overall Study|Did not meet eligibility criteria|13|||
130683888|NCT02726581|470469963|FG001|Treatment Period|Study drug toxicity|3|||
130683889|NCT02726581|470469964|FG002|Treatment Period|Study drug toxicity|2|||
130683890|NCT02726581|470469962|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
130683891|NCT02726581|470469963|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
130683892|NCT02726581|470469964|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
130683893|NCT02726581|470469962|FG000|Treatment Period|Participant withdrew consent|3|||
131018877|NCT03823911|471698396|FG001|Overall Study|Did not meet eligibility criteria|7|||
131018878|NCT03823911|471698397|FG002|Overall Study|Did not meet eligibility criteria|4|||
130683894|NCT02726581|470469963|FG001|Treatment Period|Participant withdrew consent|1|||
130683895|NCT02726581|470469964|FG002|Treatment Period|Participant withdrew consent|1|||
130683896|NCT02726581|470469962|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
130683897|NCT02726581|470469963|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
130683898|NCT02726581|470469964|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
130683899|NCT02726581|470469962|FG000|Treatment Period|Maximum clinical benefit|0|||
130683900|NCT02726581|470469963|FG001|Treatment Period|Maximum clinical benefit|2|||
131018879|NCT03823911|471698395|FG000|Overall Study|Death|0|||
131105259|NCT00112047|472015108|FG001|Randomized Phase|Sub-optimal virological response|13|||
131105260|NCT00112047|472015107|FG000|Randomized Phase|Noncompliance|8|||
131018880|NCT03823911|471698396|FG001|Overall Study|Death|1|||
131018881|NCT03823911|471698397|FG002|Overall Study|Death|0|||
131018882|NCT01121549|471698402|FG000|Overall Study|Adverse Event|10|||
131018883|NCT01121549|471698402|FG000|Overall Study|Lack of Efficacy|11|||
131018884|NCT01121549|471698402|FG000|Overall Study|Lost to Follow-up|12|||
131018885|NCT01121549|471698402|FG000|Overall Study|Did not meet entrance criteria|9|||
131018886|NCT01121549|471698402|FG000|Overall Study|Study terminated by sponsor|197|||
131018887|NCT01121549|471698402|FG000|Overall Study|Pregnancy|1|||
131018888|NCT01121549|471698402|FG000|Overall Study|Protocol Violation|33|||
131018889|NCT01121549|471698402|FG000|Overall Study|Withdrawal by Subject|16|||
131018890|NCT01121549|471698402|FG000|Overall Study|Other|58|||
131018891|NCT04789408|471698403|FG000|Overall Study|Death|4|||
131018892|NCT04789408|471698404|FG001|Overall Study|Death|3|||
131018893|NCT04789408|471698405|FG002|Overall Study|Death|6|||
131018894|NCT04789408|471698403|FG000|Overall Study|Did not meet eligibility criteria|1|||
131018895|NCT04789408|471698404|FG001|Overall Study|Did not meet eligibility criteria|0|||
131018896|NCT04789408|471698405|FG002|Overall Study|Did not meet eligibility criteria|0|||
131018897|NCT04789408|471698403|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
131018898|NCT04789408|471698404|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
131018899|NCT04789408|471698405|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
131018900|NCT03351075|471699984|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
131018901|NCT03351075|471699985|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
131018902|NCT03351075|471699984|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
131018903|NCT03351075|471699985|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
131018904|NCT03351075|471699984|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
131018905|NCT03351075|471699985|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
131018906|NCT03351075|471699984|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
131018907|NCT03351075|471699985|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
131018908|NCT00493649|471699986|FG000|Overall Study|Adverse Event|44|||
131018909|NCT00493649|471699986|FG000|Overall Study|Patient Request|21|||
131018910|NCT00493649|471699986|FG000|Overall Study|Investigator Request|2|||
131018911|NCT00493649|471699986|FG000|Overall Study|Disease Progression|1|||
131018912|NCT00493649|471699986|FG000|Overall Study|Lost to Follow-up|1|||
131018913|NCT00493649|471699986|FG000|Overall Study|Other|13|||
131018914|NCT05219253|471699987|FG000|Overall Study|Withdrawal by Subject|1|||
131018915|NCT05219253|471699988|FG001|Overall Study|Withdrawal by Subject|2|||
131018916|NCT03086369|471699989|FG000|Overall Study|Lost to Follow-up|1|||
131018917|NCT03086369|471699990|FG001|Overall Study|Lost to Follow-up|0|||
131018918|NCT03086369|471699991|FG002|Overall Study|Lost to Follow-up|0|||
131018919|NCT03086369|471699992|FG003|Overall Study|Lost to Follow-up|2|||
131018920|NCT03086369|471699993|FG004|Overall Study|Lost to Follow-up|1|||
131018921|NCT03086369|471699989|FG000|Overall Study|Physician Decision|0|||
131018922|NCT03086369|471699990|FG001|Overall Study|Physician Decision|0|||
131018923|NCT03086369|471699991|FG002|Overall Study|Physician Decision|0|||
131018924|NCT03086369|471699992|FG003|Overall Study|Physician Decision|1|||
131018925|NCT03086369|471699993|FG004|Overall Study|Physician Decision|2|||
131018926|NCT03086369|471699989|FG000|Overall Study|Withdrawal by Subject|0|||
131018927|NCT03086369|471699990|FG001|Overall Study|Withdrawal by Subject|0|||
131018928|NCT03086369|471699991|FG002|Overall Study|Withdrawal by Subject|0|||
131018929|NCT03086369|471699992|FG003|Overall Study|Withdrawal by Subject|5|||
131018930|NCT03086369|471699993|FG004|Overall Study|Withdrawal by Subject|3|||
131105261|NCT00112047|472015108|FG001|Randomized Phase|Noncompliance|4|||
130683901|NCT02726581|470469964|FG002|Treatment Period|Maximum clinical benefit|0|||
130683902|NCT02726581|470469962|FG000|Treatment Period|Death|1|||
131018931|NCT03086369|471699989|FG000|Overall Study|Progressive Disease|0|||
131018932|NCT03086369|471699990|FG001|Overall Study|Progressive Disease|0|||
131105262|NCT00112047|472015107|FG000|Randomized Phase|Protocol Violation|2|||
131018933|NCT03086369|471699991|FG002|Overall Study|Progressive Disease|0|||
131018934|NCT03086369|471699992|FG003|Overall Study|Progressive Disease|1|||
131018935|NCT03086369|471699993|FG004|Overall Study|Progressive Disease|1|||
131018936|NCT04603924|471699996|FG000|Overall Study|Not Dosed|2|||
131018937|NCT04603924|471699997|FG001|Overall Study|Not Dosed|1|||
131018938|NCT04603924|471699996|FG000|Overall Study|Withdrawal by Subject|6|||
131018939|NCT04603924|471699997|FG001|Overall Study|Withdrawal by Subject|6|||
131018940|NCT04603924|471699996|FG000|Overall Study|Adverse Event|2|||
131018941|NCT04603924|471699997|FG001|Overall Study|Adverse Event|2|||
131018942|NCT02139046|471700005|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
131105263|NCT00112047|472015108|FG001|Randomized Phase|Protocol Violation|0|||
131105264|NCT00112047|472015107|FG000|Randomized Phase|Pregnancy|3|||
131105265|NCT00112047|472015108|FG001|Randomized Phase|Pregnancy|1|||
131105266|NCT00112047|472015107|FG000|Randomized Phase|Death|1|||
131105267|NCT00112047|472015108|FG001|Randomized Phase|Death|3|||
131105268|NCT00112047|472015107|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
131105269|NCT00112047|472015108|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
131105270|NCT00112047|472015107|FG000|Randomized Phase|Inability to swallow pills|0|||
131105271|NCT00112047|472015108|FG001|Randomized Phase|Inability to swallow pills|1|||
131105272|NCT00112047|472015107|FG000|Randomized Phase|Incarceration|3|||
131105273|NCT00112047|472015108|FG001|Randomized Phase|Incarceration|2|||
131105274|NCT00112047|472015107|FG000|Randomized Phase|Moved out of State|0|||
131105275|NCT00112047|472015108|FG001|Randomized Phase|Moved out of State|1|||
131105276|NCT00112047|472015107|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
131105277|NCT00112047|472015108|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
131105278|NCT00112047|472015107|FG000|Randomized Phase|High Hepatitis B DNA|0|||
131105279|NCT00112047|472015108|FG001|Randomized Phase|High Hepatitis B DNA|1|||
130683903|NCT02726581|470469963|FG001|Treatment Period|Death|0|||
130683904|NCT02726581|470469964|FG002|Treatment Period|Death|0|||
130683905|NCT02726581|470469962|FG000|Treatment Period|Poor/non-compliance|1|||
130683906|NCT02726581|470469963|FG001|Treatment Period|Poor/non-compliance|0|||
130683907|NCT02726581|470469964|FG002|Treatment Period|Poor/non-compliance|0|||
130683908|NCT02726581|470469962|FG000|Treatment Period|Participant no longer meets study criteria|0|||
130683909|NCT02726581|470469963|FG001|Treatment Period|Participant no longer meets study criteria|1|||
130683910|NCT02726581|470469964|FG002|Treatment Period|Participant no longer meets study criteria|0|||
130683911|NCT00552669|470469968|FG000|Overall Study|Death|3|||
130683912|NCT00552669|470469969|FG001|Overall Study|Death|7|||
130683913|NCT01844375|470469970|FG000|Overall Study|Protocol Violation|1|||
130683914|NCT01844375|470469971|FG001|Overall Study|Protocol Violation|1|||
130683915|NCT03020615|470469972|FG000|Overall Study|Physician Decision|3|||
130683916|NCT03020615|470469973|FG001|Overall Study|Physician Decision|1|||
130683917|NCT03020615|470469974|FG002|Overall Study|Physician Decision|2|||
130683918|NCT03020615|470469972|FG000|Overall Study|Parent/guardian/patient choice|3|||
130683919|NCT03020615|470469973|FG001|Overall Study|Parent/guardian/patient choice|0|||
130683920|NCT03020615|470469974|FG002|Overall Study|Parent/guardian/patient choice|4|||
130683921|NCT03020615|470469972|FG000|Overall Study|Screen failure|0|||
130683922|NCT03020615|470469973|FG001|Overall Study|Screen failure|0|||
130683923|NCT03020615|470469974|FG002|Overall Study|Screen failure|1|||
130683924|NCT03020615|470469972|FG000|Overall Study|Death|1|||
130683925|NCT03020615|470469973|FG001|Overall Study|Death|0|||
130683926|NCT03020615|470469974|FG002|Overall Study|Death|0|||
130683927|NCT03020615|470469972|FG000|Overall Study|Lost to Follow-up|0|||
130683928|NCT03020615|470469973|FG001|Overall Study|Lost to Follow-up|1|||
130683929|NCT03020615|470469974|FG002|Overall Study|Lost to Follow-up|0|||
130683930|NCT04239872|470469976|FG000|Overall Study|Lost to Follow-up|0|||
130683931|NCT04239872|470469977|FG001|Overall Study|Lost to Follow-up|1|||
131018943|NCT02139046|471700006|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
131018944|NCT02139046|471700007|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
131018945|NCT02139046|471700008|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
131018946|NCT02139046|471700009|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
131018947|NCT02139046|471700005|FG000|Overall Study|Major Protocol Deviation|9|||
131018948|NCT02139046|471700006|FG001|Overall Study|Major Protocol Deviation|10|||
131018949|NCT02139046|471700007|FG002|Overall Study|Major Protocol Deviation|16|||
131018950|NCT02139046|471700008|FG003|Overall Study|Major Protocol Deviation|12|||
131018951|NCT02139046|471700009|FG004|Overall Study|Major Protocol Deviation|6|||
131018952|NCT02139046|471700005|FG000|Overall Study|Lost to Follow-up|13|||
131018953|NCT02139046|471700006|FG001|Overall Study|Lost to Follow-up|16|||
131018954|NCT02139046|471700007|FG002|Overall Study|Lost to Follow-up|16|||
131018955|NCT02139046|471700008|FG003|Overall Study|Lost to Follow-up|18|||
131018956|NCT02139046|471700009|FG004|Overall Study|Lost to Follow-up|13|||
131018957|NCT02139046|471700005|FG000|Overall Study|Voluntary Withdrawal|20|||
131018958|NCT02139046|471700006|FG001|Overall Study|Voluntary Withdrawal|8|||
131018959|NCT02139046|471700007|FG002|Overall Study|Voluntary Withdrawal|10|||
131018960|NCT02139046|471700008|FG003|Overall Study|Voluntary Withdrawal|15|||
131018961|NCT02139046|471700009|FG004|Overall Study|Voluntary Withdrawal|16|||
131018962|NCT02139046|471700005|FG000|Overall Study|Lack of Efficacy|0|||
131018963|NCT02139046|471700006|FG001|Overall Study|Lack of Efficacy|1|||
131105280|NCT00112047|472015107|FG000|Atripla Phase|Adverse Event|2|||
131105281|NCT00112047|472015108|FG001|Atripla Phase|Adverse Event|1|||
131105282|NCT00112047|472015107|FG000|Atripla Phase|Lost to Follow-up|5|||
131105283|NCT00112047|472015108|FG001|Atripla Phase|Lost to Follow-up|7|||
130683932|NCT04060147|470469978|FG000|Overall Study|Withdrew consent|1|||
130683933|NCT02057458|470469982|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
131018964|NCT02139046|471700007|FG002|Overall Study|Lack of Efficacy|2|||
131018965|NCT02139046|471700008|FG003|Overall Study|Lack of Efficacy|1|||
131018966|NCT02139046|471700009|FG004|Overall Study|Lack of Efficacy|2|||
131018967|NCT02139046|471700005|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
130683934|NCT02057458|470469983|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
131105284|NCT00112047|472015107|FG000|Atripla Phase|Pregnancy|0|||
131105285|NCT00112047|472015108|FG001|Atripla Phase|Pregnancy|1|||
131105286|NCT00112047|472015107|FG000|Atripla Phase|Death|0|||
131105287|NCT00112047|472015108|FG001|Atripla Phase|Death|2|||
131105288|NCT00112047|472015107|FG000|Atripla Phase|Withdrew consent|7|||
131105289|NCT00112047|472015108|FG001|Atripla Phase|Withdrew consent|7|||
131105290|NCT00112047|472015107|FG000|Atripla Phase|Sub-optimal virological response|0|||
131105291|NCT00112047|472015108|FG001|Atripla Phase|Sub-optimal virological response|1|||
131105292|NCT00112047|472015107|FG000|Atripla Phase|Non-compliance|1|||
131105293|NCT00112047|472015108|FG001|Atripla Phase|Non-compliance|0|||
131105294|NCT00112047|472015107|FG000|Atripla Phase|Other|3|||
131105295|NCT00112047|472015108|FG001|Atripla Phase|Other|1|||
131105296|NCT01307579|472015109|FG000|Overall Study|Death|3|||
131105297|NCT01307579|472015110|FG001|Overall Study|Death|6|||
131105298|NCT01307579|472015109|FG000|Overall Study|Physician Decision|26|||
131105299|NCT01307579|472015110|FG001|Overall Study|Physician Decision|29|||
131105300|NCT01307579|472015109|FG000|Overall Study|Withdrawal by Subject|7|||
131105301|NCT01307579|472015110|FG001|Overall Study|Withdrawal by Subject|3|||
130683935|NCT02057458|470469984|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
130683936|NCT02057458|470469982|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
131105302|NCT01307579|472015109|FG000|Overall Study|Institutional diagnosis of IFD|21|||
131105303|NCT01307579|472015110|FG001|Overall Study|Institutional diagnosis of IFD|36|||
131105304|NCT01307579|472015109|FG000|Overall Study|Begin conditioning for HSCT|42|||
131105305|NCT01307579|472015110|FG001|Overall Study|Begin conditioning for HSCT|44|||
131105306|NCT01307579|472015109|FG000|Overall Study|Refractory or relapsed AML|38|||
131105307|NCT01307579|472015110|FG001|Overall Study|Refractory or relapsed AML|23|||
131105308|NCT01307579|472015109|FG000|Overall Study|Ineligible|3|||
131105309|NCT01307579|472015110|FG001|Overall Study|Ineligible|4|||
131105310|NCT00031551|472017114|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
131105311|NCT00031551|472017115|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
131105312|NCT00409773|472017116|FG000|Overall Study|Adverse Event|3|||
130683937|NCT02057458|470469983|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
130683938|NCT02057458|470469984|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
130683939|NCT02057458|470469982|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
130683940|NCT02057458|470469983|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
130683941|NCT02057458|470469984|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
130683942|NCT03693430|470469985|FG000|Overall Study|Lost to Follow-up|3|||
130683943|NCT03693430|470469986|FG001|Overall Study|Lost to Follow-up|14|||
130683944|NCT03693430|470469985|FG000|Overall Study|Death|1|||
130683945|NCT03693430|470469986|FG001|Overall Study|Death|0|||
130683946|NCT03693430|470469985|FG000|Overall Study|Withdrawal by Subject|0|||
130683947|NCT03693430|470469986|FG001|Overall Study|Withdrawal by Subject|4|||
130683948|NCT00585689|470469987|FG000|Overall Study|Received different ABI-007 schedule|3|||
130683949|NCT00585689|470469987|FG000|Overall Study|Adverse Event|1|||
130683950|NCT00585689|470469987|FG000|Overall Study|Patient Declined Surgery|1|||
130683951|NCT00585689|470469987|FG000|Overall Study|Patient had unresectable disease|1|||
130683952|NCT00585689|470469987|FG000|Overall Study|Death|1|||
130683953|NCT00319735|470469992|FG000|Overall Study|Death|2|||
130683954|NCT02421952|470469999|FG000|Overall Study|Diary Not Returned|93|||
130683955|NCT02421952|470469999|FG000|Overall Study|Failed seriation task|13|||
130683956|NCT02421952|470469999|FG000|Overall Study|Subject uncooperative for baseline test|2|||
130683957|NCT02421952|470469999|FG000|Overall Study|Surgery cancelled|1|||
130683958|NCT00854100|470470002|FG000|Overall Study|Inability to complete the study visits|0|||
130683959|NCT00854100|470470003|FG001|Overall Study|Inability to complete the study visits|0|||
130683960|NCT00854100|470470004|FG002|Overall Study|Inability to complete the study visits|1|||
130683961|NCT00854100|470470002|FG000|Overall Study|Lost to Follow-up|2|||
130683962|NCT00854100|470470003|FG001|Overall Study|Lost to Follow-up|0|||
130683963|NCT00854100|470470004|FG002|Overall Study|Lost to Follow-up|3|||
130683964|NCT00854100|470470002|FG000|Overall Study|Withdrawal by Subject|3|||
130683965|NCT00854100|470470003|FG001|Overall Study|Withdrawal by Subject|1|||
130683966|NCT00854100|470470004|FG002|Overall Study|Withdrawal by Subject|2|||
130683967|NCT00854100|470470002|FG000|Overall Study|Protocol Violation|2|||
131105313|NCT00409773|472017117|FG001|Overall Study|Adverse Event|4|||
131105314|NCT00409773|472017118|FG002|Overall Study|Adverse Event|4|||
131105315|NCT00409773|472017119|FG003|Overall Study|Adverse Event|2|||
131105316|NCT00409773|472017120|FG004|Overall Study|Adverse Event|6|||
131105317|NCT00409773|472017116|FG000|Overall Study|Lost to Follow-up|6|||
130683968|NCT00854100|470470003|FG001|Overall Study|Protocol Violation|4|||
130683969|NCT00854100|470470004|FG002|Overall Study|Protocol Violation|3|||
130683970|NCT00854100|470470002|FG000|Overall Study|Adverse Event|2|||
130683971|NCT00854100|470470003|FG001|Overall Study|Adverse Event|1|||
130683972|NCT00854100|470470004|FG002|Overall Study|Adverse Event|2|||
130683973|NCT02216071|470470014|FG000|Overall Study|Withdrawal by Subject|7|||
131105318|NCT00409773|472017117|FG001|Overall Study|Lost to Follow-up|1|||
131105319|NCT00409773|472017118|FG002|Overall Study|Lost to Follow-up|2|||
131105320|NCT00409773|472017119|FG003|Overall Study|Lost to Follow-up|3|||
131105321|NCT00409773|472017120|FG004|Overall Study|Lost to Follow-up|1|||
131105322|NCT00409773|472017116|FG000|Overall Study|Physician Decision|0|||
131105323|NCT00409773|472017117|FG001|Overall Study|Physician Decision|0|||
131105324|NCT00409773|472017118|FG002|Overall Study|Physician Decision|0|||
131105325|NCT00409773|472017119|FG003|Overall Study|Physician Decision|2|||
131105326|NCT00409773|472017120|FG004|Overall Study|Physician Decision|0|||
130683974|NCT02216071|470470015|FG001|Overall Study|Withdrawal by Subject|2|||
130683975|NCT02216071|470470014|FG000|Overall Study|Lost to Follow-up|3|||
130683976|NCT02216071|470470015|FG001|Overall Study|Lost to Follow-up|3|||
130683977|NCT02216071|470470014|FG000|Overall Study|Protocol Violation|3|||
130683978|NCT02216071|470470015|FG001|Overall Study|Protocol Violation|5|||
130683979|NCT02216071|470470014|FG000|Overall Study|Other|2|||
131018968|NCT02139046|471700006|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
131105327|NCT00409773|472017116|FG000|Overall Study|Protocol Violation|0|||
131105328|NCT00409773|472017117|FG001|Overall Study|Protocol Violation|2|||
131105329|NCT00409773|472017118|FG002|Overall Study|Protocol Violation|3|||
131105330|NCT00409773|472017119|FG003|Overall Study|Protocol Violation|3|||
131105331|NCT00409773|472017120|FG004|Overall Study|Protocol Violation|1|||
131105332|NCT00409773|472017116|FG000|Overall Study|Withdrawal by Subject|0|||
131105333|NCT00409773|472017117|FG001|Overall Study|Withdrawal by Subject|0|||
131105334|NCT00409773|472017118|FG002|Overall Study|Withdrawal by Subject|0|||
130683980|NCT02216071|470470015|FG001|Overall Study|Other|2|||
131018969|NCT02139046|471700007|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
131018970|NCT02139046|471700008|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
131018971|NCT02139046|471700009|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
131018972|NCT02139046|471700005|FG000|Overall Study|Other Miscellaneous Reasons|10|||
131018973|NCT02139046|471700006|FG001|Overall Study|Other Miscellaneous Reasons|9|||
131018974|NCT02139046|471700007|FG002|Overall Study|Other Miscellaneous Reasons|4|||
131018975|NCT02139046|471700008|FG003|Overall Study|Other Miscellaneous Reasons|9|||
131018976|NCT02139046|471700009|FG004|Overall Study|Other Miscellaneous Reasons|12|||
131018977|NCT01765543|471700011|FG000|Overall Study|Death|1|||
131018978|NCT01765543|471700011|FG000|Overall Study|Withdrawal by Subject|2|||
131018979|NCT01424397|471700012|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018980|NCT01424397|471700013|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018981|NCT01424397|471700014|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
131018982|NCT01424397|471700015|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018983|NCT01424397|471700016|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018984|NCT01424397|471700017|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018985|NCT01424397|471700018|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018986|NCT01424397|471700019|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018987|NCT01424397|471700020|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018988|NCT01424397|471700021|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018989|NCT01424397|471700022|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018990|NCT01424397|471700023|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
131018991|NCT05876949|471700024|FG000|Overall Study|Withdrawal by Subject|1|||
131018992|NCT05876949|471700025|FG001|Overall Study|Withdrawal by Subject|3|||
131018993|NCT05876949|471700024|FG000|Overall Study|Physician Decision|0|||
131018994|NCT05876949|471700025|FG001|Overall Study|Physician Decision|2|||
131018995|NCT05876949|471700024|FG000|Overall Study|Death|0|||
131018996|NCT05876949|471700025|FG001|Overall Study|Death|1|||
131018997|NCT03644849|471700026|FG000|Overall Study|Lost to Follow-up|1|||
131018998|NCT03644849|471700027|FG001|Overall Study|Lost to Follow-up|3|||
131018999|NCT02755805|471700028|FG000|Overall Study|Lost to Follow-up|1|||
131019000|NCT02755805|471700029|FG001|Overall Study|Lost to Follow-up|2|||
131019001|NCT02755805|471700028|FG000|Overall Study|Refused assessments|1|||
131019002|NCT02755805|471700029|FG001|Overall Study|Refused assessments|0|||
131019003|NCT02755805|471700028|FG000|Overall Study|Withdrawal by Subject|0|||
131019004|NCT02755805|471700029|FG001|Overall Study|Withdrawal by Subject|2|||
131019005|NCT02252042|471700032|FG000|Overall Study|Adverse Event|9|||
131019006|NCT02252042|471700033|FG001|Overall Study|Adverse Event|6|||
131019007|NCT02252042|471700032|FG000|Overall Study|Death|209|||
131019008|NCT02252042|471700033|FG001|Overall Study|Death|217|||
131019009|NCT02252042|471700032|FG000|Overall Study|Physician Decision|0|||
130683981|NCT00389064|470470016|FG000|Overall Study|Adverse Event|11|||
130683982|NCT00389064|470470017|FG001|Overall Study|Adverse Event|3|||
131019010|NCT02252042|471700033|FG001|Overall Study|Physician Decision|2|||
131019011|NCT02252042|471700032|FG000|Overall Study|Transferred to Extension Study|7|||
131019012|NCT02252042|471700033|FG001|Overall Study|Transferred to Extension Study|1|||
131019013|NCT02252042|471700032|FG000|Overall Study|Did Not Continue on Extension Study|7|||
131019014|NCT02252042|471700033|FG001|Overall Study|Did Not Continue on Extension Study|2|||
131019015|NCT02252042|471700032|FG000|Overall Study|Withdrawal by Subject|15|||
131019016|NCT02252042|471700033|FG001|Overall Study|Withdrawal by Subject|20|||
131019017|NCT02593149|471700034|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
131105335|NCT00409773|472017119|FG003|Overall Study|Withdrawal by Subject|2|||
130683983|NCT00389064|470470016|FG000|Overall Study|Lack of Efficacy|3|||
131105336|NCT00409773|472017120|FG004|Overall Study|Withdrawal by Subject|1|||
131105337|NCT00409773|472017116|FG000|Overall Study|Lack of Eligibility|0|||
130683984|NCT00389064|470470017|FG001|Overall Study|Lack of Efficacy|14|||
130683985|NCT00389064|470470016|FG000|Overall Study|Withdrawal by Subject|17|||
131019018|NCT02593149|471700035|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
131019019|NCT02593149|471700034|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
131019020|NCT02593149|471700035|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
131019021|NCT01177670|471700037|FG000|Overall Study|Study Terminated|115|||
131019022|NCT01177670|471700037|FG000|Overall Study|Physician Decision|50|||
131019023|NCT01177670|471700037|FG000|Overall Study|Withdrawal by Subject|4|||
131019024|NCT03691428|471700042|FG000|Overall Study|Withdrawal by Subject|6|||
131019025|NCT03691428|471700043|FG001|Overall Study|Withdrawal by Subject|8|||
131019026|NCT02527148|471700044|FG000|Overall Study|Did not receive study intervention|1|||
131019027|NCT02527148|471700045|FG001|Overall Study|Did not receive study intervention|0|||
131019028|NCT01831791|471700050|FG000|Overall Study|Withdrawal by Subject|10|||
131019029|NCT03061474|471700051|FG000|Overall Study|Adverse Event|2|||
131019030|NCT03061474|471700052|FG001|Overall Study|Adverse Event|0|||
131019031|NCT03061474|471700051|FG000|Overall Study|Safety Risk|0|||
131019032|NCT03061474|471700052|FG001|Overall Study|Safety Risk|1|||
131019033|NCT03061474|471700051|FG000|Overall Study|Participant unwilling or unable to participate|0|||
131019034|NCT03061474|471700052|FG001|Overall Study|Participant unwilling or unable to participate|2|||
131019035|NCT03061474|471700051|FG000|Overall Study|Lost to Follow-up|0|||
131019036|NCT03061474|471700052|FG001|Overall Study|Lost to Follow-up|1|||
131019037|NCT00845832|471700053|FG000|Treatment Period|Adverse Event|0|||
131019038|NCT00845832|471700054|FG001|Treatment Period|Adverse Event|2|||
131019039|NCT00845832|471700055|FG002|Treatment Period|Adverse Event|0|||
131019040|NCT00845832|471700053|FG000|Treatment Period|Protocol Violation|1|||
131019041|NCT00845832|471700054|FG001|Treatment Period|Protocol Violation|1|||
131019042|NCT00845832|471700055|FG002|Treatment Period|Protocol Violation|0|||
131019043|NCT00845832|471700053|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
131019044|NCT00845832|471700054|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
131019045|NCT00845832|471700055|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
131019046|NCT00845832|471700053|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
131019047|NCT00845832|471700054|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
131019048|NCT00845832|471700055|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
131019049|NCT00980330|471700056|FG000|Overall Study|Adverse Event|0|||
131019050|NCT00980330|471700057|FG001|Overall Study|Adverse Event|0|||
131019051|NCT00980330|471700058|FG002|Overall Study|Adverse Event|0|||
131019052|NCT00980330|471700059|FG003|Overall Study|Adverse Event|1|||
131019053|NCT00980330|471700060|FG004|Overall Study|Adverse Event|0|||
131019054|NCT00980330|471700061|FG005|Overall Study|Adverse Event|0|||
131019055|NCT00980330|471700062|FG006|Overall Study|Adverse Event|0|||
131019056|NCT00980330|471700056|FG000|Overall Study|Lost to Follow-up|1|||
131019057|NCT00980330|471700057|FG001|Overall Study|Lost to Follow-up|1|||
131019058|NCT00980330|471700058|FG002|Overall Study|Lost to Follow-up|4|||
131019059|NCT00980330|471700059|FG003|Overall Study|Lost to Follow-up|2|||
131019060|NCT00980330|471700060|FG004|Overall Study|Lost to Follow-up|1|||
131019061|NCT00980330|471700061|FG005|Overall Study|Lost to Follow-up|1|||
131019062|NCT00980330|471700062|FG006|Overall Study|Lost to Follow-up|2|||
131019063|NCT00980330|471700056|FG000|Overall Study|Withdrawal by Subject|2|||
131019064|NCT00980330|471700057|FG001|Overall Study|Withdrawal by Subject|4|||
131019065|NCT00980330|471700058|FG002|Overall Study|Withdrawal by Subject|4|||
131019066|NCT00980330|471700059|FG003|Overall Study|Withdrawal by Subject|1|||
131019067|NCT00980330|471700060|FG004|Overall Study|Withdrawal by Subject|3|||
131019068|NCT00980330|471700061|FG005|Overall Study|Withdrawal by Subject|2|||
131019069|NCT00980330|471700062|FG006|Overall Study|Withdrawal by Subject|5|||
131019070|NCT00980330|471700056|FG000|Overall Study|(not specified)|2|||
131019071|NCT00980330|471700057|FG001|Overall Study|(not specified)|0|||
131019072|NCT00980330|471700058|FG002|Overall Study|(not specified)|0|||
131019073|NCT00980330|471700059|FG003|Overall Study|(not specified)|1|||
131019074|NCT00980330|471700060|FG004|Overall Study|(not specified)|1|||
131105338|NCT00409773|472017117|FG001|Overall Study|Lack of Eligibility|0|||
130683986|NCT00389064|470470017|FG001|Overall Study|Withdrawal by Subject|27|||
130683987|NCT00389064|470470016|FG000|Overall Study|Physician Decision|2|||
131019075|NCT00980330|471700061|FG005|Overall Study|(not specified)|1|||
131019076|NCT00980330|471700062|FG006|Overall Study|(not specified)|0|||
131019077|NCT00665444|471700063|FG000|Overall Study|Physician Decision|1|||
131019078|NCT00665444|471700063|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
131019079|NCT00869323|471700066|FG000|Maintenance Therapy|concurrent illness|1|||
131019080|NCT01135511|471700067|FG000|Overall Study|Adverse Event|0|||
131019081|NCT01135511|471700068|FG001|Overall Study|Adverse Event|1|||
131019082|NCT01135511|471700069|FG002|Overall Study|Adverse Event|2|||
131019083|NCT01135511|471700070|FG003|Overall Study|Adverse Event|0|||
131019084|NCT01135511|471700071|FG004|Overall Study|Adverse Event|0|||
131019085|NCT01135511|471700072|FG005|Overall Study|Adverse Event|1|||
131019086|NCT01135511|471700073|FG006|Overall Study|Adverse Event|0|||
131019087|NCT01135511|471700074|FG007|Overall Study|Adverse Event|1|||
131019088|NCT01135511|471700075|FG008|Overall Study|Adverse Event|0|||
131019089|NCT01135511|471700067|FG000|Overall Study|Lack of Efficacy|0|||
131019090|NCT01135511|471700068|FG001|Overall Study|Lack of Efficacy|1|||
131019091|NCT01135511|471700069|FG002|Overall Study|Lack of Efficacy|1|||
131019092|NCT01135511|471700070|FG003|Overall Study|Lack of Efficacy|2|||
131019093|NCT01135511|471700071|FG004|Overall Study|Lack of Efficacy|0|||
131019094|NCT01135511|471700072|FG005|Overall Study|Lack of Efficacy|0|||
131019095|NCT01135511|471700073|FG006|Overall Study|Lack of Efficacy|0|||
131019096|NCT01135511|471700074|FG007|Overall Study|Lack of Efficacy|0|||
131019097|NCT01135511|471700075|FG008|Overall Study|Lack of Efficacy|0|||
131019098|NCT01135511|471700067|FG000|Overall Study|Protocol Violation|0|||
131019099|NCT01135511|471700068|FG001|Overall Study|Protocol Violation|0|||
131019100|NCT01135511|471700069|FG002|Overall Study|Protocol Violation|3|||
131019101|NCT01135511|471700070|FG003|Overall Study|Protocol Violation|0|||
131019102|NCT01135511|471700071|FG004|Overall Study|Protocol Violation|0|||
131019103|NCT01135511|471700072|FG005|Overall Study|Protocol Violation|0|||
131019104|NCT01135511|471700073|FG006|Overall Study|Protocol Violation|0|||
131019105|NCT01135511|471700074|FG007|Overall Study|Protocol Violation|0|||
131019106|NCT01135511|471700075|FG008|Overall Study|Protocol Violation|0|||
131019107|NCT01135511|471700067|FG000|Overall Study|Pregnancy|0|||
131019108|NCT01135511|471700068|FG001|Overall Study|Pregnancy|0|||
131019109|NCT01135511|471700069|FG002|Overall Study|Pregnancy|0|||
131019110|NCT01135511|471700070|FG003|Overall Study|Pregnancy|1|||
131019111|NCT01135511|471700071|FG004|Overall Study|Pregnancy|0|||
131019112|NCT01135511|471700072|FG005|Overall Study|Pregnancy|0|||
131019113|NCT01135511|471700073|FG006|Overall Study|Pregnancy|0|||
131019114|NCT01135511|471700074|FG007|Overall Study|Pregnancy|0|||
131019115|NCT01135511|471700075|FG008|Overall Study|Pregnancy|0|||
131019116|NCT01135511|471700067|FG000|Overall Study|could not visit the clinic|0|||
131019117|NCT01135511|471700068|FG001|Overall Study|could not visit the clinic|1|||
131019118|NCT01135511|471700069|FG002|Overall Study|could not visit the clinic|2|||
131019119|NCT01135511|471700070|FG003|Overall Study|could not visit the clinic|0|||
131019120|NCT01135511|471700071|FG004|Overall Study|could not visit the clinic|0|||
131019121|NCT01135511|471700072|FG005|Overall Study|could not visit the clinic|0|||
131019122|NCT01135511|471700073|FG006|Overall Study|could not visit the clinic|0|||
131019123|NCT01135511|471700074|FG007|Overall Study|could not visit the clinic|0|||
131019124|NCT01135511|471700075|FG008|Overall Study|could not visit the clinic|0|||
131019125|NCT01135511|471700067|FG000|Overall Study|noncompliance with study drug taken|0|||
131019126|NCT01135511|471700068|FG001|Overall Study|noncompliance with study drug taken|0|||
131019127|NCT01135511|471700069|FG002|Overall Study|noncompliance with study drug taken|0|||
131019128|NCT01135511|471700070|FG003|Overall Study|noncompliance with study drug taken|0|||
131019129|NCT01135511|471700071|FG004|Overall Study|noncompliance with study drug taken|1|||
131019130|NCT01135511|471700072|FG005|Overall Study|noncompliance with study drug taken|0|||
131019131|NCT01135511|471700073|FG006|Overall Study|noncompliance with study drug taken|0|||
131019132|NCT01135511|471700074|FG007|Overall Study|noncompliance with study drug taken|0|||
131019133|NCT01135511|471700075|FG008|Overall Study|noncompliance with study drug taken|0|||
131019134|NCT01135511|471700067|FG000|Overall Study|Withdrawal by Subject|0|||
131019135|NCT01135511|471700068|FG001|Overall Study|Withdrawal by Subject|0|||
131019136|NCT01135511|471700069|FG002|Overall Study|Withdrawal by Subject|0|||
131019137|NCT01135511|471700070|FG003|Overall Study|Withdrawal by Subject|0|||
131019138|NCT01135511|471700071|FG004|Overall Study|Withdrawal by Subject|0|||
131019139|NCT01135511|471700072|FG005|Overall Study|Withdrawal by Subject|0|||
131019140|NCT01135511|471700073|FG006|Overall Study|Withdrawal by Subject|1|||
131019141|NCT01135511|471700074|FG007|Overall Study|Withdrawal by Subject|0|||
131019142|NCT01135511|471700075|FG008|Overall Study|Withdrawal by Subject|1|||
131019143|NCT00891930|471700076|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
131019144|NCT00891930|471700076|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
131019145|NCT00891930|471700076|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
131019146|NCT00891930|471700076|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
131019147|NCT00891930|471700076|FG000|Part 2 Panitumumab + AMG479|Death|30|||
131019148|NCT02425111|471700080|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
131019149|NCT02425111|471700080|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
131019150|NCT02425111|471700080|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
131019151|NCT02425111|471700080|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
131019152|NCT02425111|471700080|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
131019153|NCT02425111|471700080|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
131019154|NCT01444417|471700083|FG000|Overall Study|Ineligibility Determined|0|||
131019155|NCT01444417|471700084|FG001|Overall Study|Ineligibility Determined|1|||
131019156|NCT01444417|471700083|FG000|Overall Study|Withdrawal by Subject|2|||
131019157|NCT01444417|471700084|FG001|Overall Study|Withdrawal by Subject|0|||
131019158|NCT02755116|471700085|FG000|Overall Study|surgery converted to open, pt admitted|3|||
131019159|NCT02755116|471700086|FG001|Overall Study|surgery converted to open, pt admitted|1|||
131019160|NCT01124734|471700087|FG000|Overall Study|Disease progression|13|||
131019161|NCT01124734|471700087|FG000|Overall Study|Adverse Event|1|||
131019162|NCT01124734|471700087|FG000|Overall Study|Withdrawal by Subject|1|||
131019163|NCT01124734|471700087|FG000|Overall Study|Elected for alternative treatment|2|||
131019164|NCT01063972|471700088|FG000|Overall Study|Death|12|||
131019165|NCT01063972|471700089|FG001|Overall Study|Death|11|||
131019166|NCT01063972|471700088|FG000|Overall Study|Incarcerated|2|||
131019167|NCT01063972|471700089|FG001|Overall Study|Incarcerated|1|||
130683988|NCT00389064|470470017|FG001|Overall Study|Physician Decision|2|||
130683989|NCT00389064|470470016|FG000|Overall Study|Lost to Follow-up|1|||
130683990|NCT00389064|470470017|FG001|Overall Study|Lost to Follow-up|2|||
130683991|NCT00389064|470470016|FG000|Overall Study|Protocol Violation|2|||
130683992|NCT00389064|470470017|FG001|Overall Study|Protocol Violation|0|||
130683993|NCT00389064|470470016|FG000|Overall Study|Multiple Reasons|9|||
130683994|NCT00389064|470470017|FG001|Overall Study|Multiple Reasons|11|||
131019168|NCT03475316|471700091|FG000|6 Month Intervention|Adverse Event|2|||
131019169|NCT03475316|471700092|FG001|6 Month Intervention|Adverse Event|1|||
131019170|NCT03475316|471700091|FG000|6 Month Intervention|Withdrawal by Subject|2|||
131019171|NCT03475316|471700092|FG001|6 Month Intervention|Withdrawal by Subject|0|||
131019172|NCT03475316|471700091|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
131019173|NCT03475316|471700092|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
131019174|NCT03475316|471700091|FG000|9 Months|Study stopped due to COVID pandemic|3|||
131019175|NCT03475316|471700092|FG001|9 Months|Study stopped due to COVID pandemic|4|||
131019176|NCT00959946|471700097|FG000|Overall Study|Adverse Event|0|||
131019177|NCT00959946|471700098|FG001|Overall Study|Adverse Event|0|||
131019178|NCT00959946|471700099|FG002|Overall Study|Adverse Event|2|||
131019179|NCT00959946|471700100|FG003|Overall Study|Adverse Event|1|||
131019180|NCT00959946|471700101|FG004|Overall Study|Adverse Event|0|||
131019181|NCT00959946|471700102|FG005|Overall Study|Adverse Event|1|||
131019182|NCT00959946|471700103|FG006|Overall Study|Adverse Event|0|||
131019183|NCT00959946|471700104|FG007|Overall Study|Adverse Event|0|||
131019184|NCT00959946|471700097|FG000|Overall Study|Death|0|||
131019185|NCT00959946|471700098|FG001|Overall Study|Death|0|||
131019186|NCT00959946|471700099|FG002|Overall Study|Death|0|||
131019187|NCT00959946|471700100|FG003|Overall Study|Death|0|||
131019188|NCT00959946|471700101|FG004|Overall Study|Death|0|||
131019189|NCT00959946|471700102|FG005|Overall Study|Death|1|||
131019190|NCT00959946|471700103|FG006|Overall Study|Death|0|||
131019191|NCT00959946|471700104|FG007|Overall Study|Death|0|||
131019192|NCT00959946|471700097|FG000|Overall Study|Disease Progression|2|||
131019193|NCT00959946|471700098|FG001|Overall Study|Disease Progression|4|||
131019194|NCT00959946|471700099|FG002|Overall Study|Disease Progression|2|||
131019195|NCT00959946|471700100|FG003|Overall Study|Disease Progression|4|||
131019196|NCT00959946|471700101|FG004|Overall Study|Disease Progression|4|||
131019197|NCT00959946|471700102|FG005|Overall Study|Disease Progression|6|||
131019198|NCT00959946|471700103|FG006|Overall Study|Disease Progression|2|||
131019199|NCT00959946|471700104|FG007|Overall Study|Disease Progression|2|||
131019200|NCT00959946|471700097|FG000|Overall Study|Withdrawal by Subject|0|||
131019201|NCT00959946|471700098|FG001|Overall Study|Withdrawal by Subject|0|||
131019202|NCT00959946|471700099|FG002|Overall Study|Withdrawal by Subject|0|||
131019203|NCT00959946|471700100|FG003|Overall Study|Withdrawal by Subject|0|||
131019204|NCT00959946|471700101|FG004|Overall Study|Withdrawal by Subject|0|||
131019205|NCT00959946|471700102|FG005|Overall Study|Withdrawal by Subject|1|||
131019206|NCT00959946|471700103|FG006|Overall Study|Withdrawal by Subject|0|||
131019207|NCT00959946|471700104|FG007|Overall Study|Withdrawal by Subject|0|||
131019208|NCT00566527|471700105|FG000|Overall Study|Reason not provided|3|||
131019209|NCT00566527|471700106|FG001|Overall Study|Reason not provided|11|||
131019210|NCT00566527|471700107|FG002|Overall Study|Reason not provided|10|||
131019211|NCT00566527|471700105|FG000|Overall Study|Adverse Event|2|||
131019212|NCT00566527|471700106|FG001|Overall Study|Adverse Event|0|||
131019213|NCT00566527|471700107|FG002|Overall Study|Adverse Event|1|||
131019214|NCT00566527|471700105|FG000|Overall Study|Physician Decision|3|||
131019215|NCT00566527|471700106|FG001|Overall Study|Physician Decision|8|||
131019216|NCT00566527|471700107|FG002|Overall Study|Physician Decision|20|||
131019217|NCT00566527|471700105|FG000|Overall Study|Lost to Follow-up|3|||
131019218|NCT00566527|471700106|FG001|Overall Study|Lost to Follow-up|4|||
131019219|NCT00566527|471700107|FG002|Overall Study|Lost to Follow-up|4|||
131019220|NCT00566527|471700105|FG000|Overall Study|Withdrawal by Subject|6|||
131019221|NCT00566527|471700106|FG001|Overall Study|Withdrawal by Subject|43|||
131019222|NCT00566527|471700107|FG002|Overall Study|Withdrawal by Subject|43|||
131019223|NCT00457743|471700108|FG000|Overall Study|Adverse Event|0|||
131019224|NCT00457743|471700109|FG001|Overall Study|Adverse Event|4|||
131019225|NCT00457743|471700110|FG002|Overall Study|Adverse Event|0|||
131019226|NCT00457743|471700108|FG000|Overall Study|Lack of Efficacy|3|||
131019227|NCT00457743|471700109|FG001|Overall Study|Lack of Efficacy|23|||
131019228|NCT00457743|471700110|FG002|Overall Study|Lack of Efficacy|3|||
131019229|NCT04740164|471700116|FG000|Overall Study|Lack of Efficacy|4|||
131019230|NCT04740164|471700117|FG001|Overall Study|Lack of Efficacy|0|||
131019231|NCT04740164|471700116|FG000|Overall Study|Physician Decision|3|||
131019232|NCT04740164|471700117|FG001|Overall Study|Physician Decision|3|||
131019233|NCT04177394|471700118|FG000|Overall Study|Death|16|||
131019234|NCT04177394|471700118|FG000|Overall Study|Withdrawal by Subject|19|||
131019235|NCT04177394|471700118|FG000|Overall Study|Missed visits|61|||
131019236|NCT04177394|471700118|FG000|Overall Study|Expected Visits|15|||
131019237|NCT01152190|471700119|FG000|Overall Study|Adverse Event|2|||
130683995|NCT04753437|470470018|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131019238|NCT01152190|471700120|FG001|Overall Study|Adverse Event|4|||
131019239|NCT01152190|471700119|FG000|Overall Study|Death|1|||
130683996|NCT04753437|470470019|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
130683997|NCT04753437|470470018|FG000|Overall Study|Liver Function Test Abnormalities|2|||
130683998|NCT04753437|470470019|FG001|Overall Study|Liver Function Test Abnormalities|4|||
130683999|NCT03243630|470470020|FG000|Overall Study|Protocol Violation|1|||
130684000|NCT03243630|470470020|FG000|Overall Study|Physician Decision|1|||
130684001|NCT02140060|470470021|FG000|Overall Study|Adverse Event|0|||
130684002|NCT02140060|470470022|FG001|Overall Study|Adverse Event|0|||
130684003|NCT02140060|470470023|FG002|Overall Study|Adverse Event|0|||
130684004|NCT02140060|470470024|FG003|Overall Study|Adverse Event|1|||
130684005|NCT02140060|470470025|FG004|Overall Study|Adverse Event|1|||
130684006|NCT02140060|470470026|FG005|Overall Study|Adverse Event|1|||
130684007|NCT02140060|470470021|FG000|Overall Study|Lack of Efficacy|0|||
130684008|NCT02140060|470470022|FG001|Overall Study|Lack of Efficacy|0|||
130684009|NCT02140060|470470023|FG002|Overall Study|Lack of Efficacy|0|||
130684010|NCT02140060|470470024|FG003|Overall Study|Lack of Efficacy|1|||
130684011|NCT02140060|470470025|FG004|Overall Study|Lack of Efficacy|0|||
130684012|NCT02140060|470470026|FG005|Overall Study|Lack of Efficacy|0|||
130684013|NCT01387737|470471275|FG000|Overall Study|Adverse Event|20|||
130684014|NCT01387737|470471276|FG001|Overall Study|Adverse Event|30|||
130684015|NCT01387737|470471275|FG000|Overall Study|Lack of Efficacy|1|||
130684016|NCT01387737|470471276|FG001|Overall Study|Lack of Efficacy|0|||
130684017|NCT01387737|470471275|FG000|Overall Study|Physician Decision|3|||
130684018|NCT01387737|470471276|FG001|Overall Study|Physician Decision|10|||
130684019|NCT01387737|470471275|FG000|Overall Study|Withdrawal by Subject|27|||
130684020|NCT01387737|470471276|FG001|Overall Study|Withdrawal by Subject|31|||
130684021|NCT01387737|470471275|FG000|Overall Study|Clearly not eligible for the study|1|||
130684022|NCT01387737|470471276|FG001|Overall Study|Clearly not eligible for the study|3|||
130684023|NCT01215981|470471279|FG000|Overall Study|Physician Decision|0|||
130684024|NCT01215981|470471280|FG001|Overall Study|Physician Decision|1|||
130684025|NCT01215981|470471279|FG000|Overall Study|Protocol Violation|1|||
130684026|NCT01215981|470471280|FG001|Overall Study|Protocol Violation|0|||
130684027|NCT01215981|470471279|FG000|Overall Study|Withdrawal by Subject|1|||
130684028|NCT01215981|470471280|FG001|Overall Study|Withdrawal by Subject|0|||
130684029|NCT00840632|470471286|FG000|First Intervention|Withdrawal by Subject|0|||
130684030|NCT00840632|470471287|FG001|First Intervention|Withdrawal by Subject|1|||
130684031|NCT00840632|470471286|FG000|Washout|Withdrawal by Subject|1|||
130684032|NCT00840632|470471287|FG001|Washout|Withdrawal by Subject|1|||
130684033|NCT01294787|470471288|FG000|Period 1|Adverse Event|0|||
130684034|NCT01294787|470471289|FG001|Period 1|Adverse Event|0|||
130684035|NCT01294787|470471290|FG002|Period 1|Adverse Event|0|||
130886584|NCT03486834|471217354|FG001|Overall Study|Protocol Deviation|3|||
131019240|NCT01152190|471700120|FG001|Overall Study|Death|0|||
131019241|NCT01152190|471700119|FG000|Overall Study|Protocol Violation|1|||
131019242|NCT01152190|471700120|FG001|Overall Study|Protocol Violation|1|||
131019243|NCT01152190|471700119|FG000|Overall Study|Withdrawal by Subject|1|||
131019244|NCT01152190|471700120|FG001|Overall Study|Withdrawal by Subject|3|||
131019245|NCT00305695|471700129|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
131019246|NCT00305695|471700130|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
131019247|NCT00305695|471700129|FG000|Overall Study|Did not have baseline scan|1|||
131019248|NCT00305695|471700130|FG001|Overall Study|Did not have baseline scan|1|||
131019249|NCT00206375|471700131|FG000|Overall Study|Lost to Follow-up|1|||
131019250|NCT00206375|471700132|FG001|Overall Study|Lost to Follow-up|0|||
131019251|NCT00206375|471700133|FG002|Overall Study|Lost to Follow-up|0|||
131019252|NCT00206375|471700131|FG000|Overall Study|Withdrawal by Subject|2|||
131019253|NCT00206375|471700132|FG001|Overall Study|Withdrawal by Subject|1|||
131019254|NCT00206375|471700133|FG002|Overall Study|Withdrawal by Subject|3|||
131019255|NCT00206375|471700131|FG000|Overall Study|Study terminated due to lack of funds|0|||
131019256|NCT00206375|471700132|FG001|Overall Study|Study terminated due to lack of funds|1|||
131019257|NCT00206375|471700133|FG002|Overall Study|Study terminated due to lack of funds|1|||
131019258|NCT01420549|471700136|FG000|Overall Study|Adverse Event|1|||
131019259|NCT01420549|471700137|FG001|Overall Study|Adverse Event|1|||
131019260|NCT01420549|471700136|FG000|Overall Study|Lost to Follow-up|2|||
131019261|NCT01420549|471700137|FG001|Overall Study|Lost to Follow-up|2|||
131019262|NCT01420549|471700136|FG000|Overall Study|Protocol Violation|0|||
131019263|NCT01420549|471700137|FG001|Overall Study|Protocol Violation|1|||
131105339|NCT00409773|472017118|FG002|Overall Study|Lack of Eligibility|0|||
131105340|NCT00409773|472017119|FG003|Overall Study|Lack of Eligibility|0|||
130684036|NCT01294787|470471291|FG003|Period 1|Adverse Event|0|||
130684037|NCT01294787|470471292|FG004|Period 1|Adverse Event|1|||
130684038|NCT01294787|470471293|FG005|Period 1|Adverse Event|0|||
130684039|NCT01294787|470471288|FG000|Period 1|Withdrawal by Subject|0|||
130886585|NCT03486834|471217355|FG002|Overall Study|Protocol Deviation|3|||
130684040|NCT01294787|470471289|FG001|Period 1|Withdrawal by Subject|0|||
130684041|NCT01294787|470471290|FG002|Period 1|Withdrawal by Subject|0|||
130684042|NCT01294787|470471291|FG003|Period 1|Withdrawal by Subject|1|||
130684043|NCT01294787|470471292|FG004|Period 1|Withdrawal by Subject|1|||
130684044|NCT01294787|470471293|FG005|Period 1|Withdrawal by Subject|1|||
130684045|NCT01294787|470471288|FG000|Period 1|Administrative problem|0|||
130684046|NCT01294787|470471289|FG001|Period 1|Administrative problem|0|||
131105341|NCT00409773|472017120|FG004|Overall Study|Lack of Eligibility|1|||
131105342|NCT02359877|472017121|FG000|Overall Study|Withdrawal by Subject|1|||
131105343|NCT02359877|472017122|FG001|Overall Study|Withdrawal by Subject|0|||
131105344|NCT02359877|472017123|FG002|Overall Study|Withdrawal by Subject|0|||
131105345|NCT02359877|472017124|FG003|Overall Study|Withdrawal by Subject|2|||
131105346|NCT02359877|472017121|FG000|Overall Study|Adverse Event|0|||
131105347|NCT02359877|472017122|FG001|Overall Study|Adverse Event|0|||
131105348|NCT02359877|472017123|FG002|Overall Study|Adverse Event|0|||
130684047|NCT01294787|470471290|FG002|Period 1|Administrative problem|1|||
130684048|NCT01294787|470471291|FG003|Period 1|Administrative problem|0|||
131105349|NCT02359877|472017124|FG003|Overall Study|Adverse Event|1|||
131105350|NCT01919814|472017125|FG000|Overall Study|Adverse Event|1|||
131105351|NCT01919814|472017126|FG001|Overall Study|Adverse Event|0|||
131105352|NCT01919814|472017125|FG000|Overall Study|Protocol Violation|1|||
131105353|NCT01919814|472017126|FG001|Overall Study|Protocol Violation|0|||
130684049|NCT01294787|470471292|FG004|Period 1|Administrative problem|0|||
130684050|NCT01294787|470471293|FG005|Period 1|Administrative problem|1|||
130684051|NCT01294787|470471288|FG000|Period 2|Adverse Event|0|||
130684052|NCT01294787|470471289|FG001|Period 2|Adverse Event|3|||
130684053|NCT01294787|470471290|FG002|Period 2|Adverse Event|0|||
131105354|NCT01919814|472017125|FG000|Overall Study|Withdrawal by Subject|1|||
131105355|NCT01919814|472017126|FG001|Overall Study|Withdrawal by Subject|0|||
131105356|NCT02502097|472017132|FG000|Period 1|Adverse Event|0|||
131105357|NCT02502097|472017133|FG001|Period 1|Adverse Event|0|||
131105358|NCT02502097|472017134|FG002|Period 1|Adverse Event|1|||
131105359|NCT02502097|472017135|FG003|Period 1|Adverse Event|0|||
131105360|NCT02502097|472017132|FG000|Wash Out Period|Adverse Event|0|||
131105361|NCT02502097|472017133|FG001|Wash Out Period|Adverse Event|1|||
131105362|NCT02502097|472017134|FG002|Wash Out Period|Adverse Event|1|||
131105363|NCT02502097|472017135|FG003|Wash Out Period|Adverse Event|1|||
131105364|NCT02502097|472017132|FG000|Period 2|Adverse Event|0|||
131105365|NCT02502097|472017133|FG001|Period 2|Adverse Event|0|||
131105366|NCT02502097|472017134|FG002|Period 2|Adverse Event|1|||
131105367|NCT02502097|472017135|FG003|Period 2|Adverse Event|0|||
131105368|NCT02186223|472017136|FG000|Overall Study|Not eligible for device placement|6|||
131105369|NCT02186223|472017136|FG000|Overall Study|Unable to obtain femoral access|3|||
131105370|NCT02186223|472017136|FG000|Overall Study|Death|3|||
131105371|NCT02186223|472017136|FG000|Overall Study|Device in place less than 48 hours|9|||
130684054|NCT01294787|470471291|FG003|Period 2|Adverse Event|1|||
130684055|NCT01294787|470471292|FG004|Period 2|Adverse Event|0|||
130684056|NCT01294787|470471293|FG005|Period 2|Adverse Event|0|||
130684057|NCT01294787|470471288|FG000|Period 2|No longer needs study drug|0|||
130684058|NCT01294787|470471289|FG001|Period 2|No longer needs study drug|0|||
130684059|NCT01294787|470471290|FG002|Period 2|No longer needs study drug|0|||
130684060|NCT01294787|470471291|FG003|Period 2|No longer needs study drug|1|||
130684061|NCT01294787|470471292|FG004|Period 2|No longer needs study drug|0|||
130684062|NCT01294787|470471293|FG005|Period 2|No longer needs study drug|0|||
130684063|NCT01294787|470471288|FG000|Period 3|Adverse Event|0|||
130684064|NCT01294787|470471289|FG001|Period 3|Adverse Event|0|||
130684065|NCT01294787|470471290|FG002|Period 3|Adverse Event|0|||
130684066|NCT01294787|470471291|FG003|Period 3|Adverse Event|0|||
130684067|NCT01294787|470471292|FG004|Period 3|Adverse Event|1|||
130684068|NCT01294787|470471293|FG005|Period 3|Adverse Event|0|||
130684069|NCT01725529|470471296|FG000|Overall Study|Adverse Event|1|||
130684070|NCT01725529|470471297|FG001|Overall Study|Adverse Event|0|||
130684071|NCT01725529|470471298|FG002|Overall Study|Adverse Event|0|||
130684072|NCT01725529|470471296|FG000|Overall Study|Lost to Follow-up|2|||
130684073|NCT01725529|470471297|FG001|Overall Study|Lost to Follow-up|1|||
130684074|NCT01725529|470471298|FG002|Overall Study|Lost to Follow-up|1|||
130684075|NCT01725529|470471296|FG000|Overall Study|Protocol Violation|0|||
130684076|NCT01725529|470471297|FG001|Overall Study|Protocol Violation|1|||
130684077|NCT01725529|470471298|FG002|Overall Study|Protocol Violation|1|||
130684078|NCT01725529|470471296|FG000|Overall Study|Withdrawal by Subject|12|||
130684079|NCT01725529|470471297|FG001|Overall Study|Withdrawal by Subject|14|||
130684080|NCT01725529|470471298|FG002|Overall Study|Withdrawal by Subject|8|||
130684081|NCT01948258|470471300|FG000|Overall Study|Pregnancy|41|||
130684082|NCT01948258|470471300|FG000|Overall Study|Did not complete by cut-off date|35|||
130684083|NCT01948258|470471300|FG000|Overall Study|Lost to Follow-up|27|||
130684084|NCT01948258|470471300|FG000|Overall Study|Withdrawal by SPD|8|||
130684085|NCT01948258|470471300|FG000|Overall Study|Withdrawal by Subject|6|||
130684086|NCT01948258|470471300|FG000|Overall Study|Health Care Professional|43|||
131105372|NCT01201317|472017137|FG000|Overall Study|Withdrawal by Subject|5|||
131105373|NCT01201317|472017138|FG001|Overall Study|Withdrawal by Subject|0|||
131105374|NCT01201317|472017139|FG002|Overall Study|Withdrawal by Subject|3|||
130684087|NCT01948258|470471300|FG000|Overall Study|Removed from statistical analysis|2|||
130684088|NCT03785548|470471303|FG000|Overall Study|age > 80|1|||
131105375|NCT01201317|472017137|FG000|Overall Study|Adverse Event|2|||
131105376|NCT01201317|472017138|FG001|Overall Study|Adverse Event|2|||
131105377|NCT01201317|472017139|FG002|Overall Study|Adverse Event|2|||
131105378|NCT01201317|472017137|FG000|Overall Study|Screen failure|1|||
131105379|NCT01201317|472017138|FG001|Overall Study|Screen failure|1|||
130684089|NCT03785548|470471304|FG001|Overall Study|age > 80|0|||
131019264|NCT01420549|471700136|FG000|Overall Study|Non-adherence to medication|4|||
131019265|NCT01420549|471700137|FG001|Overall Study|Non-adherence to medication|1|||
131019266|NCT00979992|471701535|FG000|Overall Study|Ineligible - inadequate pathology|1|||
130684090|NCT03785548|470471303|FG000|Overall Study|no Postop queries|1|||
130684091|NCT03785548|470471304|FG001|Overall Study|no Postop queries|0|||
130684092|NCT01049334|470471307|FG000|Overall Study|Withdrawal by Subject|5|||
130684093|NCT01049334|470471308|FG001|Overall Study|Withdrawal by Subject|3|||
130684094|NCT01049334|470471307|FG000|Overall Study|Adverse Event|2|||
130684095|NCT01049334|470471308|FG001|Overall Study|Adverse Event|3|||
130684096|NCT01049334|470471307|FG000|Overall Study|Physician Decision|2|||
130684097|NCT01049334|470471308|FG001|Overall Study|Physician Decision|0|||
130684098|NCT01049334|470471307|FG000|Overall Study|Protocol Violation|0|||
130684099|NCT01049334|470471308|FG001|Overall Study|Protocol Violation|1|||
130684100|NCT00667095|470471321|FG000|Overall Study|Withdrawal by Subject|0|||
130684101|NCT00667095|470471322|FG001|Overall Study|Withdrawal by Subject|1|||
130684102|NCT03447262|470471323|FG000|Overall Study|Adverse Event|7|||
130684103|NCT03447262|470471323|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
130684104|NCT03447262|470471323|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
130684105|NCT03447262|470471323|FG000|Overall Study|Death|2|||
130684106|NCT03447262|470471323|FG000|Overall Study|Study Termination by Sponsor|455|||
130684107|NCT03447262|470471323|FG000|Overall Study|Other|4|||
131019267|NCT00979992|471701535|FG000|Overall Study|Ineligible - wrong cell type|2|||
131019268|NCT00979992|471701535|FG000|Overall Study|Refused - Never Treated|2|||
131019269|NCT04532528|471701539|FG000|Overall Study|Adverse Event|12|||
131019270|NCT04532528|471701540|FG001|Overall Study|Adverse Event|17|||
131019271|NCT04532528|471701539|FG000|Overall Study|Withdrawal of consent|16|||
131019272|NCT04532528|471701540|FG001|Overall Study|Withdrawal of consent|17|||
131019273|NCT04532528|471701539|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
131019274|NCT04532528|471701540|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
131019275|NCT04532528|471701539|FG000|Overall Study|Lost to Follow-up|69|||
131019276|NCT04532528|471701540|FG001|Overall Study|Lost to Follow-up|68|||
131019277|NCT04532528|471701539|FG000|Overall Study|Administrative problems|12|||
131019278|NCT04532528|471701540|FG001|Overall Study|Administrative problems|14|||
131019279|NCT04532528|471701539|FG000|Overall Study|Death|3|||
131019280|NCT04532528|471701540|FG001|Overall Study|Death|3|||
131019281|NCT04532528|471701539|FG000|Overall Study|Other|38|||
131019282|NCT04532528|471701540|FG001|Overall Study|Other|46|||
131019283|NCT01636687|471701541|FG000|Induction Period|Withdrawal by Subject|1|||
131019284|NCT01636687|471701542|FG001|Induction Period|Withdrawal by Subject|0|||
131019285|NCT01636687|471701543|FG002|Induction Period|Withdrawal by Subject|0|||
131019286|NCT01636687|471701544|FG003|Induction Period|Withdrawal by Subject|0|||
131019287|NCT01636687|471701545|FG004|Induction Period|Withdrawal by Subject|0|||
131019288|NCT01636687|471701541|FG000|Induction Period|Adverse Event|1|||
131019289|NCT01636687|471701542|FG001|Induction Period|Adverse Event|0|||
131019290|NCT01636687|471701543|FG002|Induction Period|Adverse Event|0|||
131019291|NCT01636687|471701544|FG003|Induction Period|Adverse Event|0|||
131019292|NCT01636687|471701545|FG004|Induction Period|Adverse Event|1|||
131019293|NCT01636687|471701541|FG000|Induction Period|Lack of Efficacy|0|||
131019294|NCT01636687|471701542|FG001|Induction Period|Lack of Efficacy|0|||
131019295|NCT01636687|471701543|FG002|Induction Period|Lack of Efficacy|0|||
131019296|NCT01636687|471701544|FG003|Induction Period|Lack of Efficacy|0|||
131019297|NCT01636687|471701545|FG004|Induction Period|Lack of Efficacy|1|||
131019298|NCT01636687|471701541|FG000|Induction Period|Physician Decision|1|||
131019299|NCT01636687|471701542|FG001|Induction Period|Physician Decision|0|||
131019300|NCT01636687|471701543|FG002|Induction Period|Physician Decision|0|||
131019301|NCT01636687|471701544|FG003|Induction Period|Physician Decision|0|||
131019302|NCT01636687|471701545|FG004|Induction Period|Physician Decision|0|||
131019303|NCT01636687|471701541|FG000|Maintenance Period|Withdrawal by Subject|2|||
131019304|NCT01636687|471701542|FG001|Maintenance Period|Withdrawal by Subject|0|||
131019305|NCT01636687|471701543|FG002|Maintenance Period|Withdrawal by Subject|2|||
131019306|NCT01636687|471701544|FG003|Maintenance Period|Withdrawal by Subject|0|||
131019307|NCT01636687|471701545|FG004|Maintenance Period|Withdrawal by Subject|0|||
131019308|NCT01636687|471701541|FG000|Maintenance Period|Adverse Event|1|||
131019309|NCT01636687|471701542|FG001|Maintenance Period|Adverse Event|0|||
131019310|NCT01636687|471701543|FG002|Maintenance Period|Adverse Event|0|||
131019311|NCT01636687|471701544|FG003|Maintenance Period|Adverse Event|0|||
131019312|NCT01636687|471701545|FG004|Maintenance Period|Adverse Event|0|||
131105380|NCT01201317|472017139|FG002|Overall Study|Screen failure|0|||
131019313|NCT01636687|471701541|FG000|Maintenance Period|Lack of Efficacy|4|||
131019314|NCT01636687|471701542|FG001|Maintenance Period|Lack of Efficacy|1|||
131019315|NCT01636687|471701543|FG002|Maintenance Period|Lack of Efficacy|0|||
130684108|NCT01882257|470471325|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
130684109|NCT01882257|470471326|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
130684110|NCT01882257|470471327|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
131019316|NCT01636687|471701544|FG003|Maintenance Period|Lack of Efficacy|0|||
131019317|NCT01636687|471701545|FG004|Maintenance Period|Lack of Efficacy|0|||
131019318|NCT01636687|471701541|FG000|Maintenance Period|Lost to Follow-up|1|||
131019319|NCT01636687|471701542|FG001|Maintenance Period|Lost to Follow-up|1|||
131019320|NCT01636687|471701543|FG002|Maintenance Period|Lost to Follow-up|0|||
131019321|NCT01636687|471701544|FG003|Maintenance Period|Lost to Follow-up|0|||
131019322|NCT01636687|471701545|FG004|Maintenance Period|Lost to Follow-up|1|||
131019323|NCT01636687|471701541|FG000|Maintenance Period|Physician Decision|0|||
131019324|NCT01636687|471701542|FG001|Maintenance Period|Physician Decision|0|||
131019325|NCT01636687|471701543|FG002|Maintenance Period|Physician Decision|0|||
131019326|NCT01636687|471701544|FG003|Maintenance Period|Physician Decision|0|||
131019327|NCT01636687|471701545|FG004|Maintenance Period|Physician Decision|1|||
131019328|NCT01636687|471701541|FG000|Extension Period|technical problems|0|||
131019329|NCT01636687|471701542|FG001|Extension Period|technical problems|1|||
131019330|NCT01636687|471701543|FG002|Extension Period|technical problems|2|||
131019331|NCT01636687|471701544|FG003|Extension Period|technical problems|1|||
131019332|NCT01636687|471701545|FG004|Extension Period|technical problems|0|||
131019333|NCT01636687|471701541|FG000|Extension Period|Adverse Event|4|||
131019334|NCT01636687|471701542|FG001|Extension Period|Adverse Event|3|||
131019335|NCT01636687|471701543|FG002|Extension Period|Adverse Event|2|||
131019336|NCT01636687|471701544|FG003|Extension Period|Adverse Event|1|||
131019337|NCT01636687|471701545|FG004|Extension Period|Adverse Event|0|||
131019338|NCT01636687|471701541|FG000|Extension Period|Lack of Efficacy|7|||
131019339|NCT01636687|471701542|FG001|Extension Period|Lack of Efficacy|0|||
131019340|NCT01636687|471701543|FG002|Extension Period|Lack of Efficacy|2|||
131019341|NCT01636687|471701544|FG003|Extension Period|Lack of Efficacy|1|||
131019342|NCT01636687|471701545|FG004|Extension Period|Lack of Efficacy|0|||
131019343|NCT01636687|471701541|FG000|Extension Period|Lost to Follow-up|1|||
131019344|NCT01636687|471701542|FG001|Extension Period|Lost to Follow-up|0|||
131019345|NCT01636687|471701543|FG002|Extension Period|Lost to Follow-up|1|||
131019346|NCT01636687|471701544|FG003|Extension Period|Lost to Follow-up|0|||
131019347|NCT01636687|471701545|FG004|Extension Period|Lost to Follow-up|0|||
130684111|NCT01882257|470471325|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
130684112|NCT01882257|470471326|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
130684113|NCT01882257|470471327|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
130684114|NCT03351335|470471332|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
130684115|NCT03351335|470471333|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
130684116|NCT03351335|470471334|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
130684117|NCT00469417|470471335|FG000|Overall Study|Treatment failure all lesions|18|||
130684118|NCT00469417|470471336|FG001|Overall Study|Treatment failure all lesions|11|||
130684119|NCT00469417|470471335|FG000|Overall Study|Consent withdrawn|1|||
130684120|NCT00469417|470471336|FG001|Overall Study|Consent withdrawn|1|||
130684121|NCT00469417|470471335|FG000|Overall Study|Adverse Event|8|||
130684122|NCT00469417|470471336|FG001|Overall Study|Adverse Event|2|||
130684123|NCT00469417|470471335|FG000|Overall Study|Lost to Follow-up|1|||
130684124|NCT00469417|470471336|FG001|Overall Study|Lost to Follow-up|2|||
130684125|NCT00469417|470471335|FG000|Overall Study|Intercurrent disease|0|||
130684126|NCT00469417|470471336|FG001|Overall Study|Intercurrent disease|1|||
130684127|NCT00469417|470471335|FG000|Overall Study|Randomized but not treated|2|||
130684128|NCT00469417|470471336|FG001|Overall Study|Randomized but not treated|0|||
130684129|NCT00834743|470471339|FG000|Second Intervention|Withdrawal by Subject|1|||
130684130|NCT00834743|470471340|FG001|Second Intervention|Withdrawal by Subject|0|||
130684131|NCT00086996|470471342|FG000|Overall Study|Adverse Event|29|||
130684132|NCT00086996|470471342|FG000|Overall Study|Death|4|||
130684133|NCT00086996|470471342|FG000|Overall Study|progression/relapse|7|||
130684134|NCT00086996|470471342|FG000|Overall Study|Withdrawal by Subject|13|||
130684135|NCT00086996|470471342|FG000|Overall Study|Other|6|||
130684136|NCT00086996|470471342|FG000|Overall Study|not eligible|5|||
130684137|NCT00004562|470471343|FG000|Overall Study|Lost to Follow-up|102|||
130684138|NCT00004562|470471344|FG001|Overall Study|Lost to Follow-up|91|||
130684139|NCT04274686|470471346|FG000|Overall Study|Physician Decision|1|||
130684140|NCT04274686|470471347|FG001|Overall Study|Physician Decision|0|||
130684141|NCT00376623|470471348|FG000|Overall Study|Progressive disease|35|||
130684142|NCT00376623|470471349|FG001|Overall Study|Progressive disease|22|||
131019348|NCT01636687|471701541|FG000|Extension Period|Physician Decision|1|||
131019349|NCT01636687|471701542|FG001|Extension Period|Physician Decision|0|||
130684143|NCT00376623|470471350|FG002|Overall Study|Progressive disease|17|||
130684144|NCT00376623|470471348|FG000|Overall Study|Lost to Follow-up|0|||
130684145|NCT00376623|470471349|FG001|Overall Study|Lost to Follow-up|1|||
130684146|NCT00376623|470471350|FG002|Overall Study|Lost to Follow-up|0|||
130684147|NCT00376623|470471348|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
131019350|NCT01636687|471701543|FG002|Extension Period|Physician Decision|0|||
131019351|NCT01636687|471701544|FG003|Extension Period|Physician Decision|1|||
131019352|NCT01636687|471701545|FG004|Extension Period|Physician Decision|0|||
131019353|NCT01636687|471701541|FG000|Extension Period|study terminated by sponsor|33|||
131019354|NCT01636687|471701542|FG001|Extension Period|study terminated by sponsor|50|||
131019355|NCT01636687|471701543|FG002|Extension Period|study terminated by sponsor|17|||
130684148|NCT00376623|470471349|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
130684149|NCT00376623|470471350|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
130684150|NCT00376623|470471348|FG000|Overall Study|Not treated with BI 2536|1|||
130684151|NCT00376623|470471349|FG001|Overall Study|Not treated with BI 2536|0|||
130684152|NCT00376623|470471350|FG002|Overall Study|Not treated with BI 2536|0|||
130684153|NCT00376623|470471348|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
130684154|NCT00376623|470471349|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684155|NCT00376623|470471350|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684156|NCT00376623|470471348|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
130684157|NCT00376623|470471349|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
130684158|NCT00376623|470471350|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
130684159|NCT00376623|470471348|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
131019356|NCT01636687|471701544|FG003|Extension Period|study terminated by sponsor|23|||
131019357|NCT01636687|471701545|FG004|Extension Period|study terminated by sponsor|0|||
131019358|NCT01636687|471701541|FG000|Extension Period|Withdrawal by Subject|1|||
130684160|NCT00376623|470471349|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684161|NCT00376623|470471350|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684162|NCT00376623|470471348|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
130684163|NCT00376623|470471349|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
130684164|NCT00376623|470471350|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
130684165|NCT00376623|470471348|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684166|NCT00376623|470471349|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130684167|NCT00376623|470471350|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
130684168|NCT00376623|470471348|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
130684169|NCT00376623|470471349|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
130684170|NCT00376623|470471350|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
130684171|NCT00376623|470471348|FG000|Overall Study|Increase of tumour markers|0|||
130684172|NCT00376623|470471349|FG001|Overall Study|Increase of tumour markers|1|||
131019359|NCT01636687|471701542|FG001|Extension Period|Withdrawal by Subject|0|||
130684173|NCT00376623|470471350|FG002|Overall Study|Increase of tumour markers|0|||
130684174|NCT00376623|470471348|FG000|Overall Study|Bone metastasis|1|||
130684175|NCT00376623|470471349|FG001|Overall Study|Bone metastasis|0|||
130684176|NCT00376623|470471350|FG002|Overall Study|Bone metastasis|0|||
130684177|NCT00910663|470471355|FG000|Period 1|Withdrawal by Subject|0|||
130684178|NCT00910663|470471356|FG001|Period 1|Withdrawal by Subject|1|||
130684179|NCT02865850|470471357|FG000|Overall Study|Death|15|||
130684180|NCT02865850|470471358|FG001|Overall Study|Death|19|||
130684181|NCT02865850|470471357|FG000|Overall Study|Withdrawal by Subject|3|||
130684182|NCT02865850|470471358|FG001|Overall Study|Withdrawal by Subject|2|||
130684183|NCT02865850|470471357|FG000|Overall Study|Lost to Follow-up|3|||
130684184|NCT02865850|470471358|FG001|Overall Study|Lost to Follow-up|2|||
130684185|NCT01772537|470471360|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
131019360|NCT01636687|471701543|FG002|Extension Period|Withdrawal by Subject|1|||
131019361|NCT01636687|471701544|FG003|Extension Period|Withdrawal by Subject|1|||
131019362|NCT01636687|471701545|FG004|Extension Period|Withdrawal by Subject|0|||
131019363|NCT01636687|471701541|FG000|Follow-up Period|Withdrawal by Subject|1|||
131019364|NCT01636687|471701542|FG001|Follow-up Period|Withdrawal by Subject|0|||
131019365|NCT01636687|471701543|FG002|Follow-up Period|Withdrawal by Subject|0|||
131019366|NCT01636687|471701544|FG003|Follow-up Period|Withdrawal by Subject|0|||
131019367|NCT01636687|471701545|FG004|Follow-up Period|Withdrawal by Subject|1|||
131019368|NCT01460290|471701551|FG000|Overall Study|Adverse Event|3|||
131019369|NCT01460290|471701551|FG000|Overall Study|Elevated liver function|1|||
131019370|NCT01140048|471701552|FG000|Overall Study|Physician Decision|1|||
131019371|NCT01140048|471701552|FG000|Overall Study|Withdrawal by Subject|13|||
131019372|NCT01140048|471701552|FG000|Overall Study|Lost to Follow-up|31|||
131019373|NCT00494780|471701553|FG000|Overall Study|Adverse Event|1|||
131019374|NCT00494780|471701554|FG001|Overall Study|Adverse Event|0|||
131019375|NCT00494780|471701553|FG000|Overall Study|Withdrew before Dosed|0|||
130684186|NCT01772537|470471361|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
130684187|NCT01772537|470471362|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
130684188|NCT03195491|470471363|FG000|Overall Study|Study drug toxicity|25|||
131019376|NCT00494780|471701554|FG001|Overall Study|Withdrew before Dosed|1|||
131019377|NCT00494780|471701553|FG000|Overall Study|Progression of Study Disease|7|||
131019378|NCT00494780|471701554|FG001|Overall Study|Progression of Study Disease|8|||
131019379|NCT00494780|471701553|FG000|Overall Study|New Treatment|2|||
131019380|NCT00494780|471701554|FG001|Overall Study|New Treatment|2|||
131019381|NCT00494780|471701553|FG000|Overall Study|Non-compliance|1|||
131019382|NCT00494780|471701554|FG001|Overall Study|Non-compliance|0|||
131019383|NCT00494780|471701553|FG000|Overall Study|Residual Tumour Mass|0|||
131019384|NCT00494780|471701554|FG001|Overall Study|Residual Tumour Mass|1|||
131019385|NCT00494780|471701553|FG000|Overall Study|Insurance Issues|0|||
131019386|NCT00494780|471701554|FG001|Overall Study|Insurance Issues|1|||
131019387|NCT01254019|471701555|FG000|Overall Study|Adverse Event|0|||
131019388|NCT01254019|471701556|FG001|Overall Study|Adverse Event|2|||
131019389|NCT01254019|471701555|FG000|Overall Study|Protocol Violation|1|||
131019390|NCT01254019|471701556|FG001|Overall Study|Protocol Violation|0|||
131019391|NCT01254019|471701555|FG000|Overall Study|Withdrawal by Subject|0|||
131019392|NCT01254019|471701556|FG001|Overall Study|Withdrawal by Subject|2|||
131019393|NCT02888080|471701557|FG000|Overall Study|Subject / Guardian decision|1|||
131019394|NCT02888080|471701558|FG001|Overall Study|Subject / Guardian decision|3|||
131019395|NCT02888080|471701557|FG000|Overall Study|New Therapy for study indication|1|||
131019396|NCT02888080|471701558|FG001|Overall Study|New Therapy for study indication|0|||
131019397|NCT02888080|471701557|FG000|Overall Study|Lack of Efficacy|0|||
131019398|NCT02888080|471701558|FG001|Overall Study|Lack of Efficacy|1|||
131019399|NCT02888080|471701557|FG000|Overall Study|Adverse Event|0|||
131019400|NCT02888080|471701558|FG001|Overall Study|Adverse Event|1|||
131019401|NCT00189202|471701563|FG000|Overall Study|Physician Decision|5|||
131019402|NCT00666276|471701566|FG000|Overall Study|Protocol Violation|34|||
131019403|NCT01039688|471701567|FG000|Overall Study|Adverse Event|38|||
131019404|NCT01039688|471701568|FG001|Overall Study|Adverse Event|39|||
131019405|NCT01039688|471701569|FG002|Overall Study|Adverse Event|24|||
131019406|NCT01039688|471701567|FG000|Overall Study|Lack of Efficacy|20|||
131019407|NCT01039688|471701568|FG001|Overall Study|Lack of Efficacy|11|||
131019408|NCT01039688|471701569|FG002|Overall Study|Lack of Efficacy|26|||
131019409|NCT01039688|471701567|FG000|Overall Study|Lost to Follow-up|11|||
131019410|NCT01039688|471701568|FG001|Overall Study|Lost to Follow-up|9|||
131019411|NCT01039688|471701569|FG002|Overall Study|Lost to Follow-up|5|||
131019412|NCT01039688|471701567|FG000|Overall Study|Other|13|||
131019413|NCT01039688|471701568|FG001|Overall Study|Other|25|||
131019414|NCT01039688|471701569|FG002|Overall Study|Other|12|||
131019415|NCT01039688|471701567|FG000|Overall Study|Withdrawal by Subject|23|||
131019416|NCT01039688|471701568|FG001|Overall Study|Withdrawal by Subject|27|||
131019417|NCT01039688|471701569|FG002|Overall Study|Withdrawal by Subject|13|||
131019418|NCT01039688|471701567|FG000|Overall Study|Death|2|||
131019419|NCT01039688|471701568|FG001|Overall Study|Death|0|||
131019420|NCT01039688|471701569|FG002|Overall Study|Death|0|||
131019421|NCT00668863|471701570|FG000|Overall Study|Objective Progression or Relapse|42|||
131019422|NCT00668863|471701570|FG000|Overall Study|Adverse Event|13|||
131019423|NCT00668863|471701570|FG000|Overall Study|Study Terminated by Sponsor|8|||
131019424|NCT00668863|471701570|FG000|Overall Study|Global Deterioration of Health Status|4|||
131019425|NCT00668863|471701570|FG000|Overall Study|Withdrawal by Subject|1|||
131019426|NCT00668863|471701570|FG000|Overall Study|Surgery|1|||
131019427|NCT00668863|471701570|FG000|Overall Study|Subject's work scheduling problem|1|||
131019428|NCT00668863|471701570|FG000|Overall Study|Physician Decision|1|||
131019429|NCT03299816|471701575|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
131019430|NCT03299816|471701576|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
131019431|NCT03299816|471701575|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
131019432|NCT03299816|471701576|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
131019433|NCT03299816|471701575|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
131019434|NCT03299816|471701576|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
131019435|NCT03520413|471701578|FG000|Overall Study|Lost to Follow-up|1|||
131019436|NCT03520413|471701579|FG001|Overall Study|Lost to Follow-up|1|||
131019437|NCT03520413|471701578|FG000|Overall Study|Withdrawal by Subject|1|||
131019438|NCT03520413|471701579|FG001|Overall Study|Withdrawal by Subject|2|||
131019439|NCT03520413|471701578|FG000|Overall Study|Death|0|||
131019440|NCT03520413|471701579|FG001|Overall Study|Death|1|||
131019441|NCT03520413|471701578|FG000|Overall Study|Physician Decision|3|||
131019442|NCT03520413|471701579|FG001|Overall Study|Physician Decision|3|||
131019443|NCT03520413|471701578|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
131019444|NCT03520413|471701579|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
131019445|NCT02969863|471701580|FG000|Overall Study|Physician Decision|1|||
131019446|NCT02969863|471701581|FG001|Overall Study|Physician Decision|0|||
131019447|NCT02969863|471701582|FG002|Overall Study|Physician Decision|0|||
131019448|NCT02969863|471701583|FG003|Overall Study|Physician Decision|0|||
131019449|NCT02969863|471701584|FG004|Overall Study|Physician Decision|0|||
131019450|NCT02969863|471701585|FG005|Overall Study|Physician Decision|0|||
131019451|NCT03737240|471701588|FG000|Overall Study|Lost to Follow-up|16|||
131019452|NCT03737240|471701589|FG001|Overall Study|Lost to Follow-up|15|||
131019453|NCT00638963|471701590|FG000|Overall Study|Withdrawal by Subject|1|||
131019454|NCT00638963|471701591|FG001|Overall Study|Withdrawal by Subject|0|||
131019455|NCT05001945|471701592|FG000|Overall Study|Adverse Event|0|||
131019456|NCT05001945|471701593|FG001|Overall Study|Adverse Event|0|||
131019457|NCT05001945|471701594|FG002|Overall Study|Adverse Event|0|||
131019458|NCT05001945|471701595|FG003|Overall Study|Adverse Event|1|||
131019459|NCT05001945|471701596|FG004|Overall Study|Adverse Event|0|||
130684189|NCT03195491|470471364|FG001|Overall Study|Study drug toxicity|3|||
130684190|NCT03195491|470471363|FG000|Overall Study|Maximum clinical benefit|5|||
130684191|NCT03195491|470471364|FG001|Overall Study|Maximum clinical benefit|0|||
130684192|NCT03195491|470471363|FG000|Overall Study|Lost to Follow-up|1|||
130684193|NCT03195491|470471364|FG001|Overall Study|Lost to Follow-up|0|||
130684194|NCT03195491|470471363|FG000|Overall Study|Death|3|||
130684195|NCT03195491|470471364|FG001|Overall Study|Death|0|||
130684196|NCT03195491|470471363|FG000|Overall Study|Adverse event unrelated to study drug|19|||
130684197|NCT03195491|470471364|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130684198|NCT03195491|470471363|FG000|Overall Study|Disease progression|266|||
130684199|NCT03195491|470471364|FG001|Overall Study|Disease progression|8|||
130684200|NCT03195491|470471363|FG000|Overall Study|Other reasons|10|||
130684201|NCT03195491|470471364|FG001|Overall Study|Other reasons|0|||
130684202|NCT03195491|470471363|FG000|Overall Study|Participant withdrew consent|8|||
130684203|NCT03195491|470471364|FG001|Overall Study|Participant withdrew consent|1|||
130684204|NCT03195491|470471363|FG000|Overall Study|Participant no longer meets study criteria|0|||
130684205|NCT03195491|470471364|FG001|Overall Study|Participant no longer meets study criteria|1|||
130684206|NCT03195491|470471363|FG000|Overall Study|Participant request to discontinue study treatment|10|||
130684207|NCT03195491|470471364|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130684208|NCT01263704|470471365|FG000|Overall Study|Progressive disease|18|||
130684209|NCT01263704|470471365|FG000|Overall Study|Adverse Event|3|||
130684210|NCT01263704|470471365|FG000|Overall Study|Death|2|||
130684211|NCT01263704|470471365|FG000|Overall Study|Patient withdrew consent|2|||
130684212|NCT01263704|470471365|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
130684213|NCT01263704|470471365|FG000|Overall Study|Lost to Follow-up|1|||
130684214|NCT01263704|470471365|FG000|Overall Study|Colon metastases|1|||
130684215|NCT01263704|470471365|FG000|Overall Study|Principal Investigator (PI) decision|1|||
130684216|NCT00252720|470471367|FG000|Overall Study|Withdrawal by Subject|95|||
130684217|NCT00252720|470471368|FG001|Overall Study|Withdrawal by Subject|97|||
130684218|NCT00252720|470471367|FG000|Overall Study|Death|7|||
130684219|NCT00252720|470471368|FG001|Overall Study|Death|8|||
130684220|NCT00252720|470471367|FG000|Overall Study|Moving|23|||
130684221|NCT00252720|470471368|FG001|Overall Study|Moving|42|||
130684222|NCT00252720|470471367|FG000|Overall Study|Mainly patients lost to follow-up|7|||
130684223|NCT00252720|470471368|FG001|Overall Study|Mainly patients lost to follow-up|18|||
130684224|NCT01185821|470471379|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130684225|NCT01185821|470471380|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130684226|NCT01185821|470471381|FG002|Overall Study|Abnormal laboratory value(s)|1|||
130684227|NCT01185821|470471382|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130684228|NCT01185821|470471383|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130684229|NCT01185821|470471379|FG000|Overall Study|Protocol Violation|0|||
130684230|NCT01185821|470471380|FG001|Overall Study|Protocol Violation|0|||
130684231|NCT01185821|470471381|FG002|Overall Study|Protocol Violation|0|||
130684232|NCT01185821|470471382|FG003|Overall Study|Protocol Violation|1|||
130684233|NCT01185821|470471383|FG004|Overall Study|Protocol Violation|1|||
130684234|NCT01185821|470471379|FG000|Overall Study|Abnormal test procedure result|0|||
130684235|NCT01185821|470471380|FG001|Overall Study|Abnormal test procedure result|0|||
130684236|NCT01185821|470471381|FG002|Overall Study|Abnormal test procedure result|0|||
130684237|NCT01185821|470471382|FG003|Overall Study|Abnormal test procedure result|0|||
130684238|NCT01185821|470471383|FG004|Overall Study|Abnormal test procedure result|1|||
130684239|NCT01185821|470471379|FG000|Overall Study|Death|0|||
130684240|NCT01185821|470471380|FG001|Overall Study|Death|1|||
130684241|NCT01185821|470471381|FG002|Overall Study|Death|0|||
130684242|NCT01185821|470471382|FG003|Overall Study|Death|0|||
130684243|NCT01185821|470471383|FG004|Overall Study|Death|0|||
130684244|NCT01185821|470471379|FG000|Overall Study|Condition no longer required study drug|0|||
130684245|NCT01185821|470471380|FG001|Overall Study|Condition no longer required study drug|0|||
130684246|NCT01185821|470471381|FG002|Overall Study|Condition no longer required study drug|0|||
130684247|NCT01185821|470471382|FG003|Overall Study|Condition no longer required study drug|0|||
130684248|NCT01185821|470471383|FG004|Overall Study|Condition no longer required study drug|1|||
130684249|NCT01185821|470471379|FG000|Overall Study|Adverse Event|2|||
130684250|NCT01185821|470471380|FG001|Overall Study|Adverse Event|3|||
130684251|NCT01185821|470471381|FG002|Overall Study|Adverse Event|1|||
130684252|NCT01185821|470471382|FG003|Overall Study|Adverse Event|2|||
130684253|NCT01185821|470471383|FG004|Overall Study|Adverse Event|5|||
130684254|NCT01185821|470471379|FG000|Overall Study|Lack of Efficacy|0|||
130684255|NCT01185821|470471380|FG001|Overall Study|Lack of Efficacy|0|||
130684256|NCT01185821|470471381|FG002|Overall Study|Lack of Efficacy|3|||
130684257|NCT01185821|470471382|FG003|Overall Study|Lack of Efficacy|0|||
130684258|NCT01185821|470471383|FG004|Overall Study|Lack of Efficacy|9|||
130684259|NCT01185821|470471379|FG000|Overall Study|Withdrawal by Subject|3|||
130684260|NCT01185821|470471380|FG001|Overall Study|Withdrawal by Subject|2|||
130684261|NCT01185821|470471381|FG002|Overall Study|Withdrawal by Subject|2|||
130684262|NCT01185821|470471382|FG003|Overall Study|Withdrawal by Subject|1|||
130684263|NCT01185821|470471383|FG004|Overall Study|Withdrawal by Subject|3|||
130684264|NCT01185821|470471379|FG000|Overall Study|Lost to Follow-up|1|||
130684265|NCT01185821|470471380|FG001|Overall Study|Lost to Follow-up|1|||
130684266|NCT01185821|470471381|FG002|Overall Study|Lost to Follow-up|2|||
130684267|NCT01185821|470471382|FG003|Overall Study|Lost to Follow-up|1|||
130684268|NCT01185821|470471383|FG004|Overall Study|Lost to Follow-up|2|||
130684269|NCT01185821|470471379|FG000|Overall Study|Administrative problems|0|||
130684270|NCT01185821|470471380|FG001|Overall Study|Administrative problems|0|||
130684271|NCT01185821|470471381|FG002|Overall Study|Administrative problems|1|||
130684272|NCT01185821|470471382|FG003|Overall Study|Administrative problems|1|||
130684273|NCT01185821|470471383|FG004|Overall Study|Administrative problems|2|||
130684274|NCT01546545|470471384|FG000|Overall Study|Withdrawal by Subject|1|||
130684275|NCT02979353|470471385|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
130684276|NCT02979353|470471386|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
130684277|NCT02979353|470471385|FG000|Overall Study|Withdrawal by Subject|16|||
130684278|NCT02979353|470471386|FG001|Overall Study|Withdrawal by Subject|12|||
130684279|NCT02979353|470471385|FG000|Overall Study|Death|10|||
130684280|NCT02979353|470471386|FG001|Overall Study|Death|11|||
130684281|NCT02979353|470471385|FG000|Overall Study|Transfer to Hospice Care|19|||
130684282|NCT02979353|470471386|FG001|Overall Study|Transfer to Hospice Care|14|||
130684283|NCT02979353|470471385|FG000|Overall Study|Lost to Follow-up|1|||
130684284|NCT02979353|470471386|FG001|Overall Study|Lost to Follow-up|5|||
130684285|NCT00550537|470471387|FG000|Overall Study|Death|18|||
130684286|NCT00550537|470471387|FG000|Overall Study|Adverse Event|20|||
130684287|NCT00550537|470471387|FG000|Overall Study|Disease progression before|46|||
130684288|NCT00550537|470471387|FG000|Overall Study|Withdrawal by Subject|7|||
130684289|NCT00550537|470471387|FG000|Overall Study|Change in treatment plan|4|||
130684290|NCT00550537|470471387|FG000|Overall Study|Other complicating ilness|3|||
130684291|NCT00550537|470471387|FG000|Overall Study|Declining performance status|2|||
130684292|NCT00550537|470471387|FG000|Overall Study|Treated closer to home|4|||
130684293|NCT00268905|470471388|FG000|Overall Study|Adverse Event|3|||
130684294|NCT00268905|470471389|FG001|Overall Study|Adverse Event|0|||
130684295|NCT00268905|470471390|FG002|Overall Study|Adverse Event|4|||
130684296|NCT00268905|470471388|FG000|Overall Study|Lost to Follow-up|0|||
130684297|NCT00268905|470471389|FG001|Overall Study|Lost to Follow-up|1|||
130684298|NCT00268905|470471390|FG002|Overall Study|Lost to Follow-up|0|||
130684299|NCT00268905|470471388|FG000|Overall Study|Withdrawal by Subject|0|||
130684300|NCT00268905|470471389|FG001|Overall Study|Withdrawal by Subject|0|||
130684301|NCT00268905|470471390|FG002|Overall Study|Withdrawal by Subject|3|||
130684302|NCT00268905|470471388|FG000|Overall Study|Progressive Disease|28|||
130684303|NCT00268905|470471389|FG001|Overall Study|Progressive Disease|4|||
130684304|NCT00268905|470471390|FG002|Overall Study|Progressive Disease|3|||
130684305|NCT00268905|470471388|FG000|Overall Study|Physician Decision|3|||
130684306|NCT00268905|470471389|FG001|Overall Study|Physician Decision|0|||
130684307|NCT00268905|470471390|FG002|Overall Study|Physician Decision|1|||
130684308|NCT00268905|470471388|FG000|Overall Study|Clinical Progression|9|||
130684309|NCT00268905|470471389|FG001|Overall Study|Clinical Progression|4|||
130684310|NCT00268905|470471390|FG002|Overall Study|Clinical Progression|1|||
130684311|NCT00617305|470471391|FG000|Overall Study|Adverse Event|4|||
130684312|NCT00617305|470471392|FG001|Overall Study|Adverse Event|0|||
130684313|NCT00617305|470471393|FG002|Overall Study|Adverse Event|0|||
130684314|NCT00617305|470471391|FG000|Overall Study|Death|1|||
130684315|NCT00617305|470471392|FG001|Overall Study|Death|0|||
130684316|NCT00617305|470471393|FG002|Overall Study|Death|0|||
130684317|NCT00617305|470471391|FG000|Overall Study|Physician Decision|1|||
130684318|NCT00617305|470471392|FG001|Overall Study|Physician Decision|0|||
130684319|NCT00617305|470471393|FG002|Overall Study|Physician Decision|0|||
130684320|NCT00617305|470471391|FG000|Overall Study|Protocol Violation|1|||
130684321|NCT00617305|470471392|FG001|Overall Study|Protocol Violation|0|||
130684322|NCT00617305|470471393|FG002|Overall Study|Protocol Violation|1|||
130684323|NCT00617305|470471391|FG000|Overall Study|Withdrawal by Subject|1|||
130684324|NCT00617305|470471392|FG001|Overall Study|Withdrawal by Subject|0|||
130684325|NCT00617305|470471393|FG002|Overall Study|Withdrawal by Subject|0|||
130684326|NCT04510285|470471394|FG000|Overall Study|Death|1|||
130684327|NCT01406795|470471395|FG000|Overall Study|Withdrawal by Subject|1|||
130684328|NCT03897088|470471396|FG000|Overall Study|Withdrawal by Subject|12|||
130684329|NCT03897088|470471397|FG001|Overall Study|Withdrawal by Subject|12|||
130684330|NCT03897088|470471396|FG000|Overall Study|Lost to Follow-up|7|||
130684331|NCT03897088|470471397|FG001|Overall Study|Lost to Follow-up|15|||
130684332|NCT03897088|470471396|FG000|Overall Study|Sponsor Decision|1|||
130684333|NCT03897088|470471397|FG001|Overall Study|Sponsor Decision|2|||
130684334|NCT03897088|470471396|FG000|Overall Study|COVID-19|2|||
130684335|NCT03897088|470471397|FG001|Overall Study|COVID-19|0|||
130684336|NCT03897088|470471396|FG000|Overall Study|Other|3|||
130684337|NCT03897088|470471397|FG001|Overall Study|Other|0|||
131019460|NCT05001945|471701597|FG005|Overall Study|Adverse Event|0|||
131019461|NCT05001945|471701598|FG006|Overall Study|Adverse Event|0|||
131019462|NCT05001945|471701599|FG007|Overall Study|Adverse Event|0|||
131019463|NCT05001945|471701592|FG000|Overall Study|Lost to Follow-up|0|||
131019464|NCT05001945|471701593|FG001|Overall Study|Lost to Follow-up|1|||
131019465|NCT05001945|471701594|FG002|Overall Study|Lost to Follow-up|1|||
131019466|NCT05001945|471701595|FG003|Overall Study|Lost to Follow-up|2|||
131019467|NCT05001945|471701596|FG004|Overall Study|Lost to Follow-up|0|||
131019468|NCT05001945|471701597|FG005|Overall Study|Lost to Follow-up|1|||
131019469|NCT05001945|471701598|FG006|Overall Study|Lost to Follow-up|0|||
131019470|NCT05001945|471701599|FG007|Overall Study|Lost to Follow-up|0|||
131019471|NCT05001945|471701592|FG000|Overall Study|Protocol Violation|1|||
131019472|NCT05001945|471701593|FG001|Overall Study|Protocol Violation|0|||
131019473|NCT05001945|471701594|FG002|Overall Study|Protocol Violation|1|||
131019474|NCT05001945|471701595|FG003|Overall Study|Protocol Violation|1|||
131019475|NCT05001945|471701596|FG004|Overall Study|Protocol Violation|0|||
131019476|NCT05001945|471701597|FG005|Overall Study|Protocol Violation|1|||
131019477|NCT05001945|471701598|FG006|Overall Study|Protocol Violation|0|||
131019478|NCT05001945|471701599|FG007|Overall Study|Protocol Violation|0|||
131019479|NCT05001945|471701592|FG000|Overall Study|Withdrawal by Subject|0|||
131019480|NCT05001945|471701593|FG001|Overall Study|Withdrawal by Subject|0|||
131019481|NCT05001945|471701594|FG002|Overall Study|Withdrawal by Subject|0|||
131019482|NCT05001945|471701595|FG003|Overall Study|Withdrawal by Subject|1|||
131019483|NCT05001945|471701596|FG004|Overall Study|Withdrawal by Subject|1|||
131019484|NCT05001945|471701597|FG005|Overall Study|Withdrawal by Subject|1|||
131019485|NCT05001945|471701598|FG006|Overall Study|Withdrawal by Subject|0|||
131019486|NCT05001945|471701599|FG007|Overall Study|Withdrawal by Subject|1|||
131019487|NCT05001945|471701592|FG000|Overall Study|Not specified by Investigator|0|||
131019488|NCT05001945|471701593|FG001|Overall Study|Not specified by Investigator|3|||
131019489|NCT05001945|471701594|FG002|Overall Study|Not specified by Investigator|0|||
131019490|NCT05001945|471701595|FG003|Overall Study|Not specified by Investigator|0|||
131019491|NCT05001945|471701596|FG004|Overall Study|Not specified by Investigator|1|||
131019492|NCT05001945|471701597|FG005|Overall Study|Not specified by Investigator|0|||
131019493|NCT05001945|471701598|FG006|Overall Study|Not specified by Investigator|0|||
131019494|NCT05001945|471701599|FG007|Overall Study|Not specified by Investigator|0|||
131019495|NCT02448446|471701600|FG000|Overall Study|Withdrawal by Subject|1|||
131019496|NCT02448446|471701601|FG001|Overall Study|Withdrawal by Subject|0|||
131019497|NCT01254188|471701602|FG000|Overall Study|Disease Progression|6|||
131019498|NCT01254188|471701602|FG000|Overall Study|Protocol Violation|6|||
131105381|NCT01201317|472017137|FG000|Overall Study|Protocol Violation|0|||
131105382|NCT01201317|472017138|FG001|Overall Study|Protocol Violation|1|||
131105383|NCT01201317|472017139|FG002|Overall Study|Protocol Violation|1|||
131105384|NCT01201317|472017137|FG000|Overall Study|Death|0|||
131105385|NCT01201317|472017138|FG001|Overall Study|Death|1|||
130684338|NCT03897088|470471396|FG000|Overall Study|Non-compliance with Study Drug|1|||
130684339|NCT03897088|470471397|FG001|Overall Study|Non-compliance with Study Drug|1|||
130684340|NCT03897088|470471396|FG000|Overall Study|Pregnancy|0|||
130684341|NCT03897088|470471397|FG001|Overall Study|Pregnancy|1|||
130684342|NCT00855738|470471398|FG000|Overall Study|Lost to Follow-up|2|||
130684343|NCT00855738|470471398|FG000|Overall Study|Adverse Event|1|||
130684344|NCT00855738|470471398|FG000|Overall Study|Subject Defaulted|1|||
130684345|NCT00855738|470471398|FG000|Overall Study|Death|1|||
130684346|NCT04384978|470471401|FG000|Overall Study|Withdrawal by Subject|4|||
130684347|NCT04384978|470471402|FG001|Overall Study|Withdrawal by Subject|0|||
130684348|NCT01811953|470472795|FG000|Overall Study|Adverse Event|0|||
130684349|NCT01811953|470472796|FG001|Overall Study|Adverse Event|0|||
130684350|NCT01811953|470472797|FG002|Overall Study|Adverse Event|0|||
131105386|NCT01201317|472017139|FG002|Overall Study|Death|0|||
131105387|NCT01201317|472017137|FG000|Overall Study|Study-specific withdrawal criteria|0|||
131105388|NCT01201317|472017138|FG001|Overall Study|Study-specific withdrawal criteria|0|||
131105389|NCT01201317|472017139|FG002|Overall Study|Study-specific withdrawal criteria|1|||
131105390|NCT01201317|472017137|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
131105391|NCT01201317|472017138|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
131105392|NCT01201317|472017139|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
131105393|NCT01201317|472017137|FG000|Overall Study|Decrease in renal function|0|||
131105394|NCT01201317|472017138|FG001|Overall Study|Decrease in renal function|1|||
131105395|NCT01201317|472017139|FG002|Overall Study|Decrease in renal function|0|||
131105396|NCT01201317|472017137|FG000|Overall Study|Lack of Efficacy|1|||
131105397|NCT01201317|472017138|FG001|Overall Study|Lack of Efficacy|0|||
131105398|NCT01201317|472017139|FG002|Overall Study|Lack of Efficacy|0|||
131105399|NCT01201317|472017137|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
131105400|NCT01201317|472017138|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
131105401|NCT01201317|472017139|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
131105402|NCT00252733|472017140|FG000|Overall Study|Withdrawal by Subject|73|||
131019499|NCT01254188|471701602|FG000|Overall Study|Pregnancy|2|||
131019500|NCT01254188|471701602|FG000|Overall Study|Death|4|||
131019501|NCT01254188|471701602|FG000|Overall Study|Lost to Follow-up|5|||
131019502|NCT01254188|471701602|FG000|Overall Study|Withdrawal by Subject|7|||
131019503|NCT01254188|471701602|FG000|Overall Study|Adverse Event|43|||
131105403|NCT00252733|472017141|FG001|Overall Study|Withdrawal by Subject|67|||
131105404|NCT00252733|472017140|FG000|Overall Study|Death|7|||
131105405|NCT00252733|472017141|FG001|Overall Study|Death|5|||
131105406|NCT00252733|472017140|FG000|Overall Study|Lost to Follow-up|12|||
130684351|NCT01811953|470472798|FG003|Overall Study|Adverse Event|1|||
130684352|NCT01811953|470472799|FG004|Overall Study|Adverse Event|0|||
130684353|NCT01811953|470472800|FG005|Overall Study|Adverse Event|1|||
130684354|NCT01811953|470472795|FG000|Overall Study|Protocol Violation|0|||
130684355|NCT01811953|470472796|FG001|Overall Study|Protocol Violation|0|||
130684356|NCT01811953|470472797|FG002|Overall Study|Protocol Violation|0|||
130684357|NCT01811953|470472798|FG003|Overall Study|Protocol Violation|0|||
130684358|NCT01811953|470472799|FG004|Overall Study|Protocol Violation|1|||
130684359|NCT01811953|470472800|FG005|Overall Study|Protocol Violation|0|||
130684360|NCT02262377|470472802|FG000|Overall Study|Lost to Follow-up|5|||
130684361|NCT02262377|470472803|FG001|Overall Study|Lost to Follow-up|6|||
130684362|NCT02262377|470472802|FG000|Overall Study|Found ineligible after enrollment|3|||
130684363|NCT02262377|470472803|FG001|Overall Study|Found ineligible after enrollment|0|||
130684364|NCT02262377|470472802|FG000|Overall Study|Withdrawal by Subject|4|||
130684365|NCT02262377|470472803|FG001|Overall Study|Withdrawal by Subject|0|||
130684366|NCT00371839|470472805|FG000|Overall Study|Death|4|||
130684367|NCT00371839|470472806|FG001|Overall Study|Death|0|||
130684368|NCT00371839|470472807|FG002|Overall Study|Death|0|||
130684369|NCT00371839|470472805|FG000|Overall Study|Withdrawal by Subject|7|||
130684370|NCT00371839|470472806|FG001|Overall Study|Withdrawal by Subject|4|||
130684371|NCT00371839|470472807|FG002|Overall Study|Withdrawal by Subject|0|||
130684372|NCT00371839|470472805|FG000|Overall Study|Lost to Follow-up|6|||
130684373|NCT00371839|470472806|FG001|Overall Study|Lost to Follow-up|3|||
130684374|NCT00371839|470472807|FG002|Overall Study|Lost to Follow-up|2|||
130684375|NCT00723528|470472808|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
130684376|NCT00723528|470472809|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
130684377|NCT00723528|470472810|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
130684378|NCT00723528|470472811|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
130684379|NCT00723528|470472812|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
130684380|NCT00723528|470472813|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
131105407|NCT00252733|472017141|FG001|Overall Study|Lost to Follow-up|6|||
131105408|NCT00252733|472017140|FG000|Overall Study|Multiple Reasons|14|||
131105409|NCT00252733|472017141|FG001|Overall Study|Multiple Reasons|14|||
131105410|NCT01491672|472017142|FG000|Overall Study|Lost to Follow-up|0|||
131105411|NCT01491672|472017143|FG001|Overall Study|Lost to Follow-up|4|||
131105412|NCT01491672|472017144|FG002|Overall Study|Lost to Follow-up|1|||
131105413|NCT01491672|472017142|FG000|Overall Study|Withdrawal by Subject|6|||
131105414|NCT01491672|472017143|FG001|Overall Study|Withdrawal by Subject|7|||
131105415|NCT01491672|472017144|FG002|Overall Study|Withdrawal by Subject|0|||
131105416|NCT01491672|472017142|FG000|Overall Study|Adverse Event|8|||
131105417|NCT01491672|472017143|FG001|Overall Study|Adverse Event|10|||
131105418|NCT01491672|472017144|FG002|Overall Study|Adverse Event|4|||
131105419|NCT01491672|472017142|FG000|Overall Study|Disease progression|42|||
131105420|NCT01491672|472017143|FG001|Overall Study|Disease progression|34|||
131105421|NCT01491672|472017144|FG002|Overall Study|Disease progression|6|||
131105422|NCT01491672|472017142|FG000|Overall Study|Protocol deviation|0|||
131105423|NCT01491672|472017143|FG001|Overall Study|Protocol deviation|1|||
131105424|NCT01491672|472017144|FG002|Overall Study|Protocol deviation|0|||
131105425|NCT01491672|472017142|FG000|Overall Study|Death|0|||
131105426|NCT01491672|472017143|FG001|Overall Study|Death|4|||
131105427|NCT01491672|472017144|FG002|Overall Study|Death|0|||
131105428|NCT03310268|472017148|FG000|Overall Study|(Not specified)|1|||
131105429|NCT03310268|472017149|FG001|Overall Study|(Not specified)|5|||
131105430|NCT03310268|472017150|FG002|Overall Study|(Not specified)|0|||
131105431|NCT00706433|472017153|FG000|Overall Study|Lost to Follow-up|3|||
131105432|NCT00706433|472017154|FG001|Overall Study|Lost to Follow-up|1|||
131105433|NCT00706433|472017155|FG002|Overall Study|Lost to Follow-up|6|||
131105434|NCT00706433|472017156|FG003|Overall Study|Lost to Follow-up|0|||
131105435|NCT00706433|472017153|FG000|Overall Study|Withdrawal by Subject|1|||
131105436|NCT00706433|472017154|FG001|Overall Study|Withdrawal by Subject|2|||
131105437|NCT00706433|472017155|FG002|Overall Study|Withdrawal by Subject|3|||
131105438|NCT00706433|472017156|FG003|Overall Study|Withdrawal by Subject|1|||
131105439|NCT00706433|472017153|FG000|Overall Study|Adverse Event|0|||
131105440|NCT00706433|472017154|FG001|Overall Study|Adverse Event|0|||
130684381|NCT00723528|470472814|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
130684382|NCT00723528|470472808|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
130684383|NCT00723528|470472809|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130684384|NCT00723528|470472810|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130684385|NCT00723528|470472811|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130684386|NCT00723528|470472812|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
131105441|NCT00706433|472017155|FG002|Overall Study|Adverse Event|1|||
131105442|NCT00706433|472017156|FG003|Overall Study|Adverse Event|0|||
131105443|NCT00706433|472017153|FG000|Overall Study|Protocol Violation|1|||
130684387|NCT00723528|470472813|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130684388|NCT00723528|470472814|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
131105444|NCT00706433|472017154|FG001|Overall Study|Protocol Violation|0|||
131105445|NCT00706433|472017155|FG002|Overall Study|Protocol Violation|0|||
131105446|NCT00706433|472017156|FG003|Overall Study|Protocol Violation|0|||
130684389|NCT00723528|470472808|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684390|NCT00723528|470472809|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684391|NCT00723528|470472810|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
130684392|NCT00723528|470472811|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684393|NCT00723528|470472812|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684394|NCT00723528|470472813|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684395|NCT00723528|470472814|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
130684396|NCT00723528|470472808|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684397|NCT00723528|470472809|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684398|NCT00723528|470472810|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
130684399|NCT00723528|470472811|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684400|NCT00723528|470472812|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684401|NCT00723528|470472813|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684402|NCT00723528|470472814|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130684403|NCT00723528|470472808|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
130684404|NCT00723528|470472809|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
131105447|NCT00706433|472017153|FG000|Overall Study|new job|0|||
131105448|NCT00706433|472017154|FG001|Overall Study|new job|0|||
131105449|NCT00706433|472017155|FG002|Overall Study|new job|0|||
131105450|NCT00706433|472017156|FG003|Overall Study|new job|1|||
131105451|NCT01236365|472017157|FG000|Overall Study|Lost to Follow-up|0|||
131105452|NCT01236365|472017158|FG001|Overall Study|Lost to Follow-up|2|||
131105453|NCT01236365|472017157|FG000|Overall Study|Moved Out of State|1|||
131105454|NCT01236365|472017158|FG001|Overall Study|Moved Out of State|0|||
131105455|NCT01236365|472017157|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
131105456|NCT01236365|472017158|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
131105457|NCT00717067|472017159|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
131105458|NCT00717067|472017160|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
131105459|NCT00717067|472017161|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
131105460|NCT00717067|472017162|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
131105461|NCT00717067|472017163|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
131105462|NCT02808143|472017164|FG000|Maintenance Phase|Disease recurrence|1|||
131105463|NCT02808143|472017165|FG001|Maintenance Phase|Disease recurrence|3|||
131105464|NCT02808143|472017164|FG000|Maintenance Phase|Disease progression|1|||
131105465|NCT02808143|472017165|FG001|Maintenance Phase|Disease progression|2|||
131105466|NCT02808143|472017164|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
131105467|NCT02808143|472017165|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
131105468|NCT02808143|472017164|FG000|Survival Follow-Up|Disease recurrence|0|||
131105469|NCT02808143|472017165|FG001|Survival Follow-Up|Disease recurrence|2|||
131105470|NCT02808143|472017164|FG000|Survival Follow-Up|Adverse Event|0|||
131105471|NCT02808143|472017165|FG001|Survival Follow-Up|Adverse Event|1|||
131105472|NCT02808143|472017164|FG000|Survival Follow-Up|Death|1|||
131105473|NCT02808143|472017165|FG001|Survival Follow-Up|Death|0|||
131105474|NCT04964388|472017166|FG000|Overall Study|Lost to Follow-up|3|||
131105475|NCT04964388|472017167|FG001|Overall Study|Lost to Follow-up|2|||
131105476|NCT01689337|472017168|FG000|Overall Study|Study Discontinuation|1|||
131105477|NCT00871780|472017169|FG000|Overall Study|Enrolled But Not Treated|6|||
131105478|NCT00871780|472017169|FG000|Overall Study|Withdrawal by Subject|9|||
131105479|NCT00871780|472017169|FG000|Overall Study|Adverse Event|6|||
131105480|NCT00871780|472017169|FG000|Overall Study|Voluntary Discontinuation|4|||
131105481|NCT00871780|472017169|FG000|Overall Study|Death|1|||
131105482|NCT00871780|472017169|FG000|Overall Study|Physician Decision|1|||
131105483|NCT03406260|472017170|FG000|Period 1|Adverse Event|0|||
131105484|NCT03406260|472017171|FG001|Period 1|Adverse Event|0|||
131105485|NCT03406260|472017172|FG002|Period 1|Adverse Event|0|||
131105486|NCT03406260|472017173|FG003|Period 1|Adverse Event|0|||
131105487|NCT03406260|472017174|FG004|Period 1|Adverse Event|1|||
131105488|NCT03406260|472017175|FG005|Period 1|Adverse Event|0|||
131105489|NCT00069108|472017180|FG000|Overall Study|Withdrawal by Subject|5|||
131105490|NCT00069108|472017181|FG001|Overall Study|Withdrawal by Subject|9|||
131105491|NCT00069108|472017180|FG000|Overall Study|Adverse Event|64|||
131105492|NCT00069108|472017181|FG001|Overall Study|Adverse Event|42|||
131105493|NCT00069108|472017180|FG000|Overall Study|Death|6|||
131105494|NCT00069108|472017181|FG001|Overall Study|Death|6|||
131105495|NCT00069108|472017180|FG000|Overall Study|Administration|15|||
131105496|NCT00069108|472017181|FG001|Overall Study|Administration|4|||
131105497|NCT00069108|472017180|FG000|Overall Study|Insufficient therapy|117|||
131105498|NCT00069108|472017181|FG001|Overall Study|Insufficient therapy|144|||
131105499|NCT00069108|472017180|FG000|Overall Study|Violation criteria|1|||
131105500|NCT00069108|472017181|FG001|Overall Study|Violation criteria|4|||
131105501|NCT00069108|472017180|FG000|Overall Study|Refused treatment|5|||
131105502|NCT00069108|472017181|FG001|Overall Study|Refused treatment|10|||
131105503|NCT02208999|472017183|FG000|Overall Study|Lost to Follow-up|1|||
131105504|NCT00319839|472017184|FG000|Overall Study|Adverse Event|5|||
131105505|NCT00319839|472017184|FG000|Overall Study|Withdrawal by Subject|1|||
131019504|NCT01254188|471701602|FG000|Overall Study|per investigator discretion|20|||
131019505|NCT02957136|471701615|FG000|Overall Study|Withdrawal by Subject|2|||
131019506|NCT02957136|471701616|FG001|Overall Study|Withdrawal by Subject|1|||
131019507|NCT02200770|471701617|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
131019508|NCT02200770|471701618|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
131019509|NCT02200770|471701617|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
131019510|NCT02200770|471701618|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
131019511|NCT02200770|471701617|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
131019512|NCT02200770|471701618|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
131019513|NCT02200770|471701617|FG000|Randomized-controlled Period (RCP)|Other|1|||
131019514|NCT02200770|471701618|FG001|Randomized-controlled Period (RCP)|Other|2|||
131019515|NCT02200770|471701617|FG000|Open-label Period (OLP)|Adverse Event|1|||
131019516|NCT02200770|471701618|FG001|Open-label Period (OLP)|Adverse Event|2|||
131019517|NCT02200770|471701617|FG000|Open-label Period (OLP)|Death|1|||
131019518|NCT02200770|471701618|FG001|Open-label Period (OLP)|Death|2|||
131019519|NCT02200770|471701617|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
131019520|NCT02200770|471701618|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
131019521|NCT02200770|471701617|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
131019522|NCT02200770|471701618|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
131019523|NCT02200770|471701617|FG000|Open-label Period (OLP)|Other|6|||
131019524|NCT02200770|471701618|FG001|Open-label Period (OLP)|Other|15|||
131019525|NCT02214160|471701623|FG000|Overall Study|Withdrawal by Subject|1|||
131105506|NCT01577745|472017185|FG000|Overall Study|Withdrawal by Subject|0|||
131105507|NCT01577745|472017186|FG001|Overall Study|Withdrawal by Subject|1|||
131105508|NCT01577745|472017187|FG002|Overall Study|Withdrawal by Subject|0|||
131105509|NCT01577745|472017188|FG003|Overall Study|Withdrawal by Subject|3|||
131105510|NCT01577745|472017189|FG004|Overall Study|Withdrawal by Subject|2|||
131105511|NCT01577745|472017190|FG005|Overall Study|Withdrawal by Subject|0|||
131105512|NCT01577745|472017185|FG000|Overall Study|Death|3|||
131105513|NCT01577745|472017186|FG001|Overall Study|Death|2|||
131105514|NCT01577745|472017187|FG002|Overall Study|Death|2|||
131105515|NCT01577745|472017188|FG003|Overall Study|Death|1|||
131105516|NCT01577745|472017189|FG004|Overall Study|Death|1|||
131105517|NCT01577745|472017190|FG005|Overall Study|Death|3|||
131105518|NCT01577745|472017185|FG000|Overall Study|Physician Decision|0|||
131105519|NCT01577745|472017186|FG001|Overall Study|Physician Decision|0|||
131105520|NCT01577745|472017187|FG002|Overall Study|Physician Decision|0|||
131105521|NCT01577745|472017188|FG003|Overall Study|Physician Decision|1|||
131105522|NCT01577745|472017189|FG004|Overall Study|Physician Decision|1|||
131105523|NCT01577745|472017190|FG005|Overall Study|Physician Decision|0|||
131105524|NCT01577745|472017185|FG000|Overall Study|Lost to Follow-up|0|||
131105525|NCT01577745|472017186|FG001|Overall Study|Lost to Follow-up|0|||
131105526|NCT01577745|472017187|FG002|Overall Study|Lost to Follow-up|0|||
131105527|NCT01577745|472017188|FG003|Overall Study|Lost to Follow-up|0|||
131105528|NCT01577745|472017189|FG004|Overall Study|Lost to Follow-up|0|||
130684405|NCT00723528|470472810|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
130684406|NCT00723528|470472811|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
131019526|NCT02214160|471701624|FG001|Overall Study|Withdrawal by Subject|0|||
131105529|NCT01577745|472017190|FG005|Overall Study|Lost to Follow-up|1|||
131105530|NCT01577745|472017185|FG000|Overall Study|Alternative Therapy|0|||
131105531|NCT01577745|472017186|FG001|Overall Study|Alternative Therapy|0|||
131105532|NCT01577745|472017187|FG002|Overall Study|Alternative Therapy|0|||
131105533|NCT01577745|472017188|FG003|Overall Study|Alternative Therapy|1|||
131105534|NCT01577745|472017189|FG004|Overall Study|Alternative Therapy|1|||
131105535|NCT01577745|472017190|FG005|Overall Study|Alternative Therapy|0|||
131105536|NCT00262951|472017191|FG000|Overall Study|Progressive disease/relapse|3|||
131105537|NCT00262951|472017191|FG000|Overall Study|Adverse Event|7|||
131105538|NCT00262951|472017191|FG000|Overall Study|Death|1|||
131105539|NCT00262951|472017191|FG000|Overall Study|Withdrawal by Subject|1|||
131105540|NCT00262951|472017191|FG000|Overall Study|Alternative treatment|3|||
131105541|NCT00262951|472017191|FG000|Overall Study|Off treatment for other disease|1|||
131105542|NCT02483585|472017192|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
131105543|NCT02483585|472017193|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
131105544|NCT02483585|472017192|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
131105545|NCT02483585|472017193|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
131105546|NCT02483585|472017192|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
131105547|NCT02483585|472017193|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
131105548|NCT02483585|472017192|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
131019527|NCT02214160|471701625|FG002|Overall Study|Withdrawal by Subject|6|||
131019528|NCT02214160|471701623|FG000|Overall Study|Death|2|||
131019529|NCT02214160|471701624|FG001|Overall Study|Death|2|||
131019530|NCT02214160|471701625|FG002|Overall Study|Death|1|||
131019531|NCT02214160|471701623|FG000|Overall Study|Subject Non-Compliance|0|||
131105549|NCT02483585|472017193|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
131105550|NCT02483585|472017192|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
131019532|NCT02214160|471701624|FG001|Overall Study|Subject Non-Compliance|3|||
131019533|NCT02214160|471701625|FG002|Overall Study|Subject Non-Compliance|1|||
131019534|NCT02214160|471701623|FG000|Overall Study|Adverse Event|0|||
131019535|NCT02214160|471701624|FG001|Overall Study|Adverse Event|1|||
131019536|NCT02214160|471701625|FG002|Overall Study|Adverse Event|1|||
131019537|NCT02214160|471701623|FG000|Overall Study|Sponsor Decision|0|||
131019538|NCT02214160|471701624|FG001|Overall Study|Sponsor Decision|2|||
131019539|NCT02214160|471701625|FG002|Overall Study|Sponsor Decision|0|||
131019540|NCT02214160|471701623|FG000|Overall Study|Protocol Violation|1|||
131019541|NCT02214160|471701624|FG001|Overall Study|Protocol Violation|0|||
131019542|NCT02214160|471701625|FG002|Overall Study|Protocol Violation|0|||
131019543|NCT02214160|471701623|FG000|Overall Study|Physician Decision|0|||
131105551|NCT02483585|472017193|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
130720848|NCT04126213|470601545|FG000|Overall Study|Withdrawal by Subject|3|||
131019544|NCT02214160|471701624|FG001|Overall Study|Physician Decision|0|||
131019545|NCT02214160|471701625|FG002|Overall Study|Physician Decision|1|||
131019546|NCT02423798|471701626|FG000|Overall Study|Withdrawal by Subject|3|||
131019547|NCT01264679|471701627|FG000|Overall Study|Participation in Another Clinical Trial|1|||
131019548|NCT01264679|471701627|FG000|Overall Study|Physician Decision|1|||
131019549|NCT01264679|471701627|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
131019550|NCT01264679|471701627|FG000|Overall Study|Withdrawal by Subject|1|||
131019551|NCT02555215|471701630|FG000|Overall Study|Other|1|||
131019552|NCT02555215|471701630|FG000|Overall Study|Investigator Decision|2|||
131019553|NCT00468052|471701631|FG000|Overall Study|Protocol Violation|7|||
131019554|NCT00468052|471701632|FG001|Overall Study|Protocol Violation|8|||
131019555|NCT00356265|471701633|FG000|Overall Study|Withdrawal by Subject|0|||
131019556|NCT00356265|471701634|FG001|Overall Study|Withdrawal by Subject|0|||
131019557|NCT00356265|471701635|FG002|Overall Study|Withdrawal by Subject|1|||
131019558|NCT01837966|471701636|FG000|Overall Study|Withdrawal by Subject|2|||
131019559|NCT01837966|471701637|FG001|Overall Study|Withdrawal by Subject|1|||
131019560|NCT00159783|471701638|FG000|Overall Study|Adverse Event|5|||
131019561|NCT00159783|471701639|FG001|Overall Study|Adverse Event|7|||
131019562|NCT00159783|471701640|FG002|Overall Study|Adverse Event|9|||
131019563|NCT00159783|471701638|FG000|Overall Study|Lack of Efficacy|1|||
131019564|NCT00159783|471701639|FG001|Overall Study|Lack of Efficacy|2|||
131019565|NCT00159783|471701640|FG002|Overall Study|Lack of Efficacy|3|||
131019566|NCT00159783|471701638|FG000|Overall Study|Withdrawal by Subject|7|||
131019567|NCT00159783|471701639|FG001|Overall Study|Withdrawal by Subject|11|||
131019568|NCT00159783|471701640|FG002|Overall Study|Withdrawal by Subject|12|||
131019569|NCT00159783|471701638|FG000|Overall Study|Lost to Follow-up|6|||
131019570|NCT00159783|471701639|FG001|Overall Study|Lost to Follow-up|5|||
131019571|NCT00159783|471701640|FG002|Overall Study|Lost to Follow-up|11|||
131019572|NCT00159783|471701638|FG000|Overall Study|Other|0|||
131019573|NCT00159783|471701639|FG001|Overall Study|Other|2|||
131019574|NCT00159783|471701640|FG002|Overall Study|Other|4|||
131019575|NCT02928224|471701641|FG000|Overall Study|Lost to Follow-up|1|||
131019576|NCT02928224|471701642|FG001|Overall Study|Lost to Follow-up|1|||
131019577|NCT02928224|471701643|FG002|Overall Study|Lost to Follow-up|3|||
131019578|NCT02928224|471701644|FG003|Overall Study|Lost to Follow-up|0|||
131019579|NCT02928224|471701641|FG000|Overall Study|Death|30|||
131019580|NCT02928224|471701642|FG001|Overall Study|Death|209|||
131019581|NCT02928224|471701643|FG002|Overall Study|Death|193|||
131105552|NCT02483585|472017192|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
131019582|NCT02928224|471701644|FG003|Overall Study|Death|198|||
131019583|NCT02928224|471701641|FG000|Overall Study|Withdrawal by Subject|0|||
131019584|NCT02928224|471701642|FG001|Overall Study|Withdrawal by Subject|3|||
131019585|NCT02928224|471701643|FG002|Overall Study|Withdrawal by Subject|7|||
131019586|NCT02928224|471701644|FG003|Overall Study|Withdrawal by Subject|20|||
131019587|NCT02928224|471701641|FG000|Overall Study|Study participation terminated by sponsor|3|||
131019588|NCT02928224|471701642|FG001|Overall Study|Study participation terminated by sponsor|8|||
131019589|NCT02928224|471701643|FG002|Overall Study|Study participation terminated by sponsor|12|||
131019590|NCT02928224|471701644|FG003|Overall Study|Study participation terminated by sponsor|3|||
131019591|NCT02928224|471701641|FG000|Overall Study|Other|3|||
131019592|NCT02928224|471701642|FG001|Overall Study|Other|3|||
131019593|NCT02928224|471701643|FG002|Overall Study|Other|5|||
131019594|NCT02928224|471701644|FG003|Overall Study|Other|0|||
131019595|NCT00304031|471702739|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
131019596|NCT00304031|471702740|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
131019597|NCT00304031|471702741|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
131019598|NCT00304031|471702739|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
131019599|NCT00304031|471702740|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
131019600|NCT00304031|471702741|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
131019601|NCT00304031|471702739|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
131019602|NCT00304031|471702740|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
131019603|NCT00304031|471702741|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
131019604|NCT00304031|471702739|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
131105553|NCT02483585|472017193|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
131105554|NCT02483585|472017192|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
131105555|NCT02483585|472017193|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
131105556|NCT00825916|472017195|FG000|Overall Study|Lost to Follow-up|4|||
131105557|NCT00825916|472017196|FG001|Overall Study|Lost to Follow-up|2|||
131105558|NCT00825916|472017197|FG002|Overall Study|Lost to Follow-up|1|||
131105559|NCT01324440|472017201|FG000|Overall Study|Subject moved|0|||
131105560|NCT01324440|472017202|FG001|Overall Study|Subject moved|1|||
131105561|NCT00394082|472017205|FG000|Overall Study|Unacceptable toxicity|15|||
131105562|NCT00394082|472017205|FG000|Overall Study|Adverse Event|4|||
131105563|NCT00394082|472017205|FG000|Overall Study|Physician Decision|4|||
131105564|NCT00394082|472017205|FG000|Overall Study|Withdrawal by Subject|2|||
131105565|NCT00394082|472017205|FG000|Overall Study|Other|1|||
131105566|NCT00903630|472017206|FG000|Phase 2|Adverse Event|0|||
131105567|NCT00903630|472017207|FG001|Phase 2|Adverse Event|0|||
131105568|NCT00903630|472017208|FG002|Phase 2|Adverse Event|1|||
131105569|NCT02325557|472017209|FG000|Overall Study|Progressive disease|1|||
131105570|NCT02325557|472017210|FG001|Overall Study|Progressive disease|0|||
131105571|NCT02325557|472017211|FG002|Overall Study|Progressive disease|0|||
131105572|NCT02325557|472017212|FG003|Overall Study|Progressive disease|0|||
131105573|NCT02325557|472017209|FG000|Overall Study|Withdrawal by Subject|4|||
131105574|NCT02325557|472017210|FG001|Overall Study|Withdrawal by Subject|0|||
131105575|NCT02325557|472017211|FG002|Overall Study|Withdrawal by Subject|0|||
131105576|NCT02325557|472017212|FG003|Overall Study|Withdrawal by Subject|15|||
131105577|NCT02325557|472017209|FG000|Overall Study|Death|5|||
131105578|NCT02325557|472017210|FG001|Overall Study|Death|1|||
131105579|NCT02325557|472017211|FG002|Overall Study|Death|1|||
131105580|NCT02325557|472017212|FG003|Overall Study|Death|16|||
131105581|NCT02325557|472017209|FG000|Overall Study|Lost to Follow-up|0|||
131105582|NCT02325557|472017210|FG001|Overall Study|Lost to Follow-up|0|||
131105583|NCT02325557|472017211|FG002|Overall Study|Lost to Follow-up|1|||
131105584|NCT02325557|472017212|FG003|Overall Study|Lost to Follow-up|1|||
131105585|NCT02325557|472017209|FG000|Overall Study|Other|0|||
131105586|NCT02325557|472017210|FG001|Overall Study|Other|0|||
131105587|NCT02325557|472017211|FG002|Overall Study|Other|0|||
131105588|NCT02325557|472017212|FG003|Overall Study|Other|5|||
131105589|NCT01136772|472017217|FG000|Overall Study|Adverse Event|15|||
131105590|NCT01136772|472017218|FG001|Overall Study|Adverse Event|14|||
131105591|NCT01136772|472017217|FG000|Overall Study|Lack of Efficacy|42|||
131105592|NCT01136772|472017218|FG001|Overall Study|Lack of Efficacy|39|||
131105593|NCT01136772|472017217|FG000|Overall Study|Administrative|14|||
131105594|NCT01136772|472017218|FG001|Overall Study|Administrative|12|||
131105595|NCT01136772|472017217|FG000|Overall Study|Withdrawal by Subject|33|||
131105596|NCT01136772|472017218|FG001|Overall Study|Withdrawal by Subject|36|||
131105597|NCT01136772|472017217|FG000|Overall Study|Did not receive injection|10|||
131105598|NCT01136772|472017218|FG001|Overall Study|Did not receive injection|7|||
131105599|NCT01136772|472017217|FG000|Overall Study|Did not follow up after first injection|2|||
131105600|NCT01136772|472017218|FG001|Overall Study|Did not follow up after first injection|2|||
131105601|NCT01602562|472017224|FG000|Overall Study|Adverse Event|3|||
131105602|NCT01602562|472017225|FG001|Overall Study|Adverse Event|1|||
131105603|NCT01602562|472017224|FG000|Overall Study|Physician Decision|1|||
131105604|NCT01602562|472017225|FG001|Overall Study|Physician Decision|1|||
131105605|NCT01602562|472017224|FG000|Overall Study|Withdrawal by Subject|1|||
131105606|NCT01602562|472017225|FG001|Overall Study|Withdrawal by Subject|1|||
131105607|NCT03881553|472017226|FG000|Overall Study|Discharged prior to participation|1|||
131105608|NCT03881553|472017227|FG001|Overall Study|Discharged prior to participation|1|||
131105609|NCT03881553|472017228|FG002|Overall Study|Discharged prior to participation|0|||
131105610|NCT03881553|472017226|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
131105611|NCT03881553|472017227|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
131105612|NCT03881553|472017228|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
131105613|NCT01477333|472017229|FG000|Overall Study|Adverse Event|1|||
131105614|NCT01477333|472017229|FG000|Overall Study|Withdrawal by Subject|1|||
131105615|NCT01477333|472017229|FG000|Overall Study|Clinical Deterioration|1|||
131105616|NCT00928746|472017232|FG000|Overall Study|Adverse Event|2|||
131105617|NCT00928746|472017232|FG000|Overall Study|Protocol Violation|1|||
131105618|NCT00928746|472017232|FG000|Overall Study|Withdrawal by Subject|1|||
131105619|NCT00928746|472017232|FG000|Overall Study|Other|2|||
130684407|NCT00723528|470472812|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130684408|NCT00723528|470472813|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130684409|NCT00723528|470472814|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
131105620|NCT00336895|472017233|FG000|Overall Study|diarrhea|1|||
131105621|NCT00336895|472017233|FG000|Overall Study|nausea and upset stomach|1|||
131105622|NCT00336895|472017233|FG000|Overall Study|Physician Decision|1|||
131105623|NCT00336895|472017233|FG000|Overall Study|screen failed|1|||
131105624|NCT00598273|472017234|FG000|Overall Study|Adverse Event|4|||
131105625|NCT00598273|472017235|FG001|Overall Study|Adverse Event|5|||
131105626|NCT00598273|472017236|FG002|Overall Study|Adverse Event|2|||
131019605|NCT00304031|471702740|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
131019606|NCT00304031|471702741|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
131019607|NCT00304031|471702739|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
131019608|NCT00304031|471702740|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
131019609|NCT00304031|471702741|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
131019610|NCT00304031|471702739|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
131019611|NCT00304031|471702740|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
131019612|NCT00304031|471702741|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
131019613|NCT00304031|471702739|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
131019614|NCT00304031|471702740|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
131019615|NCT00304031|471702741|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
131019616|NCT00304031|471702739|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
131019617|NCT00304031|471702740|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
131019618|NCT00304031|471702741|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
131019619|NCT00304031|471702739|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
131019620|NCT00304031|471702740|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
131019621|NCT00304031|471702741|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
131019622|NCT00683696|471702742|FG000|Overall Study|Withdrawn due to study closure|337|||
131019623|NCT00683696|471702743|FG001|Overall Study|Withdrawn due to study closure|338|||
131019624|NCT00683696|471702742|FG000|Overall Study|Withdrawn prior to study closure|13|||
131019625|NCT00683696|471702743|FG001|Overall Study|Withdrawn prior to study closure|28|||
131019626|NCT00683696|471702742|FG000|Overall Study|Lost to Follow-up|5|||
131019627|NCT00683696|471702743|FG001|Overall Study|Lost to Follow-up|6|||
131019628|NCT00683696|471702742|FG000|Overall Study|Vital status follow-up only|3|||
131019629|NCT00683696|471702743|FG001|Overall Study|Vital status follow-up only|3|||
131019630|NCT00683696|471702742|FG000|Overall Study|Death|46|||
131019631|NCT00683696|471702743|FG001|Overall Study|Death|30|||
131019632|NCT02396316|471702744|FG000|Overall Study|Physician Decision|1|||
131019633|NCT02396316|471702745|FG001|Overall Study|Physician Decision|0|||
131019634|NCT02396316|471702744|FG000|Overall Study|Progressive disease|6|||
131019635|NCT02396316|471702745|FG001|Overall Study|Progressive disease|3|||
131019636|NCT02396316|471702744|FG000|Overall Study|Protocol Violation|0|||
131019637|NCT02396316|471702745|FG001|Overall Study|Protocol Violation|1|||
131019638|NCT02396316|471702744|FG000|Overall Study|Treatment unblinded|0|||
131019639|NCT02396316|471702745|FG001|Overall Study|Treatment unblinded|1|||
131019640|NCT01823536|471702746|FG000|Overall Study|Lost to Follow-up|1|||
131019641|NCT01823536|471702747|FG001|Overall Study|Lost to Follow-up|0|||
131019642|NCT01823536|471702748|FG002|Overall Study|Lost to Follow-up|0|||
131019643|NCT01823536|471702749|FG003|Overall Study|Lost to Follow-up|1|||
131019644|NCT01823536|471702750|FG004|Overall Study|Lost to Follow-up|1|||
131019645|NCT01823536|471702751|FG005|Overall Study|Lost to Follow-up|0|||
131019646|NCT01823536|471702746|FG000|Overall Study|Protocol Violation|0|||
131019647|NCT01823536|471702747|FG001|Overall Study|Protocol Violation|1|||
131019648|NCT01823536|471702748|FG002|Overall Study|Protocol Violation|0|||
131019649|NCT01823536|471702749|FG003|Overall Study|Protocol Violation|0|||
131019650|NCT01823536|471702750|FG004|Overall Study|Protocol Violation|0|||
131019651|NCT01823536|471702751|FG005|Overall Study|Protocol Violation|0|||
131019652|NCT01823536|471702746|FG000|Overall Study|Withdrawal by Subject|1|||
131019653|NCT01823536|471702747|FG001|Overall Study|Withdrawal by Subject|1|||
131019654|NCT01823536|471702748|FG002|Overall Study|Withdrawal by Subject|0|||
131019655|NCT01823536|471702749|FG003|Overall Study|Withdrawal by Subject|0|||
131019656|NCT01823536|471702750|FG004|Overall Study|Withdrawal by Subject|0|||
131019657|NCT01823536|471702751|FG005|Overall Study|Withdrawal by Subject|0|||
131019658|NCT01823536|471702746|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
131019659|NCT01823536|471702747|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
131019660|NCT01823536|471702748|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
131019661|NCT01823536|471702749|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
131019662|NCT01823536|471702750|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
131019663|NCT01823536|471702751|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
131019664|NCT01823536|471702746|FG000|Overall Study|Met exclusion criterion No 6|0|||
131019665|NCT01823536|471702747|FG001|Overall Study|Met exclusion criterion No 6|0|||
131105627|NCT00598273|472017234|FG000|Overall Study|Death|6|||
130684410|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
131019666|NCT01823536|471702748|FG002|Overall Study|Met exclusion criterion No 6|0|||
131019667|NCT01823536|471702749|FG003|Overall Study|Met exclusion criterion No 6|1|||
131019668|NCT01823536|471702750|FG004|Overall Study|Met exclusion criterion No 6|0|||
131019669|NCT01823536|471702751|FG005|Overall Study|Met exclusion criterion No 6|0|||
131019670|NCT01823536|471702746|FG000|Overall Study|Subject moved out of the state|0|||
131019671|NCT01823536|471702747|FG001|Overall Study|Subject moved out of the state|0|||
131019672|NCT01823536|471702748|FG002|Overall Study|Subject moved out of the state|0|||
131019673|NCT01823536|471702749|FG003|Overall Study|Subject moved out of the state|0|||
131019674|NCT01823536|471702750|FG004|Overall Study|Subject moved out of the state|1|||
131105628|NCT00598273|472017235|FG001|Overall Study|Death|12|||
131105629|NCT00598273|472017236|FG002|Overall Study|Death|8|||
131105630|NCT00598273|472017234|FG000|Overall Study|Lost to Follow-up|8|||
131105631|NCT00598273|472017235|FG001|Overall Study|Lost to Follow-up|3|||
131105632|NCT00598273|472017236|FG002|Overall Study|Lost to Follow-up|5|||
131105633|NCT00598273|472017234|FG000|Overall Study|Physician Decision|0|||
131105634|NCT00598273|472017235|FG001|Overall Study|Physician Decision|0|||
130684411|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
130684412|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
130684413|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
130684414|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
131105635|NCT00598273|472017236|FG002|Overall Study|Physician Decision|1|||
131105636|NCT00598273|472017234|FG000|Overall Study|Withdrawal by Subject|12|||
131105637|NCT00598273|472017235|FG001|Overall Study|Withdrawal by Subject|10|||
131105638|NCT00598273|472017236|FG002|Overall Study|Withdrawal by Subject|10|||
131105639|NCT00598273|472017234|FG000|Overall Study|Noncompliance|3|||
131105640|NCT00598273|472017235|FG001|Overall Study|Noncompliance|2|||
131105641|NCT00598273|472017236|FG002|Overall Study|Noncompliance|3|||
131105642|NCT00598273|472017234|FG000|Overall Study|Relocation|0|||
131105643|NCT00598273|472017235|FG001|Overall Study|Relocation|2|||
131105644|NCT00598273|472017236|FG002|Overall Study|Relocation|4|||
131105645|NCT00598273|472017234|FG000|Overall Study|Renal transplant|1|||
131105646|NCT00598273|472017235|FG001|Overall Study|Renal transplant|0|||
131105647|NCT00598273|472017236|FG002|Overall Study|Renal transplant|1|||
131105648|NCT00598273|472017234|FG000|Overall Study|Site elected to close|1|||
131105649|NCT00598273|472017235|FG001|Overall Study|Site elected to close|0|||
131105650|NCT00598273|472017236|FG002|Overall Study|Site elected to close|0|||
131105651|NCT00598273|472017234|FG000|Overall Study|Started dialysis|6|||
131105652|NCT00598273|472017235|FG001|Overall Study|Started dialysis|4|||
131105653|NCT00598273|472017236|FG002|Overall Study|Started dialysis|5|||
131105654|NCT02481947|472017237|FG000|Overall Study|Withdrawal by Subject|24|||
131105655|NCT02481947|472017238|FG001|Overall Study|Withdrawal by Subject|10|||
131105656|NCT02481947|472017237|FG000|Overall Study|Lost to Follow-up|11|||
131105657|NCT02481947|472017238|FG001|Overall Study|Lost to Follow-up|5|||
131105658|NCT02481947|472017237|FG000|Overall Study|Adverse Event|6|||
131105659|NCT02481947|472017238|FG001|Overall Study|Adverse Event|11|||
131105660|NCT02481947|472017237|FG000|Overall Study|Physician Decision|4|||
131105661|NCT02481947|472017238|FG001|Overall Study|Physician Decision|5|||
131105662|NCT02481947|472017237|FG000|Overall Study|Protocol Violation|1|||
131105663|NCT02481947|472017238|FG001|Overall Study|Protocol Violation|5|||
131105664|NCT03426267|472017239|FG000|Overall Study|Physician Decision|1|||
131105665|NCT03426267|472017240|FG001|Overall Study|Physician Decision|4|||
131105666|NCT03426267|472017239|FG000|Overall Study|Lost to Follow-up|1|||
131105667|NCT03426267|472017240|FG001|Overall Study|Lost to Follow-up|0|||
131105668|NCT03426267|472017239|FG000|Overall Study|Withdrawal by Subject|4|||
131105669|NCT03426267|472017240|FG001|Overall Study|Withdrawal by Subject|10|||
131105670|NCT03426267|472017239|FG000|Overall Study|Protocol Violation|1|||
131105671|NCT03426267|472017240|FG001|Overall Study|Protocol Violation|3|||
131105672|NCT03426267|472017239|FG000|Overall Study|Adverse Event|9|||
131105673|NCT03426267|472017240|FG001|Overall Study|Adverse Event|27|||
131105674|NCT03426267|472017239|FG000|Overall Study|Prohibited Treatment Intake|2|||
131105675|NCT03426267|472017240|FG001|Overall Study|Prohibited Treatment Intake|3|||
131105676|NCT03426267|472017239|FG000|Overall Study|Lack of Efficacy|0|||
131105677|NCT03426267|472017240|FG001|Overall Study|Lack of Efficacy|25|||
131105678|NCT03426267|472017239|FG000|Overall Study|other|3|||
131105679|NCT03426267|472017240|FG001|Overall Study|other|0|||
131105680|NCT03801915|472017241|FG000|Overall Study|Screen failure|0|||
131105681|NCT03801915|472017242|FG001|Overall Study|Screen failure|0|||
131105682|NCT03801915|472017243|FG002|Overall Study|Screen failure|1|||
131105683|NCT03801915|472017241|FG000|Overall Study|Ineligible|1|||
131105684|NCT03801915|472017242|FG001|Overall Study|Ineligible|0|||
131105685|NCT03801915|472017243|FG002|Overall Study|Ineligible|0|||
131105686|NCT03801915|472017241|FG000|Overall Study|Physician Decision|2|||
131105687|NCT03801915|472017242|FG001|Overall Study|Physician Decision|1|||
131105688|NCT03801915|472017243|FG002|Overall Study|Physician Decision|0|||
131105689|NCT02003573|472017256|FG000|Overall Study|Progressive disease|2|||
131105690|NCT02003573|472017257|FG001|Overall Study|Progressive disease|0|||
131105691|NCT02003573|472017258|FG002|Overall Study|Progressive disease|1|||
131105692|NCT02003573|472017256|FG000|Overall Study|Other Adverse event|0|||
131105693|NCT02003573|472017257|FG001|Overall Study|Other Adverse event|1|||
131105694|NCT02003573|472017258|FG002|Overall Study|Other Adverse event|1|||
131105695|NCT02003573|472017256|FG000|Overall Study|Refuse to take trial medication|0|||
131105696|NCT02003573|472017257|FG001|Overall Study|Refuse to take trial medication|1|||
131105697|NCT02003573|472017258|FG002|Overall Study|Refuse to take trial medication|1|||
131105698|NCT02003573|472017256|FG000|Overall Study|Other than specified|1|||
131105699|NCT02003573|472017257|FG001|Overall Study|Other than specified|2|||
131105700|NCT02003573|472017258|FG002|Overall Study|Other than specified|3|||
131105701|NCT00928018|472017265|FG000|Overall Study|Withdrawal by Subject|1|||
131105702|NCT00928018|472017266|FG001|Overall Study|Withdrawal by Subject|0|||
130684415|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
130684416|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
130684417|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684418|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684419|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684420|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684421|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684422|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
130684423|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130684424|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Other|0|||
130684425|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Other|0|||
130684426|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Other|0|||
130684427|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Other|0|||
130684428|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Other|1|||
130684429|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Other|4|||
130684430|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Other|0|||
130684431|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Adverse Event|0|||
130684432|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Adverse Event|0|||
130684433|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Adverse Event|0|||
130684434|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Adverse Event|0|||
130684435|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Adverse Event|1|||
130684436|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Adverse Event|0|||
130684437|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Adverse Event|1|||
130684438|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684439|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684440|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684441|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684442|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684443|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130684444|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
130684445|NCT00723528|470472808|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684446|NCT00723528|470472809|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684447|NCT00723528|470472810|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684448|NCT00723528|470472811|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684449|NCT00723528|470472812|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684450|NCT00723528|470472813|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130684451|NCT00723528|470472814|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
130684452|NCT01993030|470472815|FG000|Overall Study|Adverse Event|0|||
130684453|NCT01993030|470472816|FG001|Overall Study|Adverse Event|4|||
130684454|NCT01710657|470472817|FG000|Overall Study|Lost to Follow-up|2|||
130684455|NCT01710657|470472818|FG001|Overall Study|Lost to Follow-up|0|||
130684456|NCT01710657|470472819|FG002|Overall Study|Lost to Follow-up|1|||
131019675|NCT01823536|471702751|FG005|Overall Study|Subject moved out of the state|0|||
131019676|NCT03648762|471702752|FG000|Overall Study|Lost to Follow-up|1|||
131019677|NCT03648762|471702753|FG001|Overall Study|Lost to Follow-up|2|||
131019678|NCT03648762|471702754|FG002|Overall Study|Lost to Follow-up|0|||
131019679|NCT03648762|471702752|FG000|Overall Study|Withdrawal by Subject|5|||
131019680|NCT03648762|471702753|FG001|Overall Study|Withdrawal by Subject|2|||
131019681|NCT03648762|471702754|FG002|Overall Study|Withdrawal by Subject|1|||
131019682|NCT02731755|471702767|FG000|First Intervention|Withdrawal by Subject|0|||
131019683|NCT02731755|471702768|FG001|First Intervention|Withdrawal by Subject|2|||
131019684|NCT00002842|471702769|FG000|Overall Study|ineligible for surgical resection|27|||
131019685|NCT01599104|471702770|FG000|Overall Study|Withdrawal by Subject|1|||
131019686|NCT01599104|471702771|FG001|Overall Study|Withdrawal by Subject|1|||
131019687|NCT01599104|471702772|FG002|Overall Study|Withdrawal by Subject|2|||
131019688|NCT01599104|471702770|FG000|Overall Study|Technical Problems|1|||
131019689|NCT01599104|471702771|FG001|Overall Study|Technical Problems|0|||
131019690|NCT01599104|471702772|FG002|Overall Study|Technical Problems|0|||
131019691|NCT01599104|471702770|FG000|Overall Study|Physician Decision|3|||
131019692|NCT01599104|471702771|FG001|Overall Study|Physician Decision|2|||
131019693|NCT01599104|471702772|FG002|Overall Study|Physician Decision|2|||
131019694|NCT01599104|471702770|FG000|Overall Study|Non-compliance with study treatment|0|||
131019695|NCT01599104|471702771|FG001|Overall Study|Non-compliance with study treatment|1|||
131019696|NCT01599104|471702772|FG002|Overall Study|Non-compliance with study treatment|0|||
131019697|NCT01599104|471702770|FG000|Overall Study|Lack of Efficacy|4|||
131019698|NCT01599104|471702771|FG001|Overall Study|Lack of Efficacy|4|||
131019699|NCT01599104|471702772|FG002|Overall Study|Lack of Efficacy|10|||
131019700|NCT01599104|471702770|FG000|Overall Study|Adverse Event|7|||
131019701|NCT01599104|471702771|FG001|Overall Study|Adverse Event|6|||
131019702|NCT01599104|471702772|FG002|Overall Study|Adverse Event|12|||
131019703|NCT02271854|471702775|FG000|Overall Study|Withdrawal by Subject|2|||
131019704|NCT02271854|471702775|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
131019705|NCT02271854|471702775|FG000|Overall Study|Lost to Follow-up|1|||
131019706|NCT03454529|471702784|FG000|Overall Study|Did not receive treatment|6|||
131019707|NCT03454529|471702784|FG000|Overall Study|Received < 80% doses|1|||
131019708|NCT01582100|471702788|FG000|Overall Study|Adverse Event|1|||
131019709|NCT01582100|471702788|FG000|Overall Study|Withdrawal by Subject|1|||
131019710|NCT02564744|471702789|FG000|Overall Study|Investigator decision|0|||
131019711|NCT02564744|471702790|FG001|Overall Study|Investigator decision|0|||
131019712|NCT02564744|471702791|FG002|Overall Study|Investigator decision|0|||
131019713|NCT02564744|471702792|FG003|Overall Study|Investigator decision|0|||
131019714|NCT02564744|471702793|FG004|Overall Study|Investigator decision|1|||
131019715|NCT02564744|471702789|FG000|Overall Study|Death|10|||
131019716|NCT02564744|471702790|FG001|Overall Study|Death|5|||
131019717|NCT02564744|471702791|FG002|Overall Study|Death|4|||
131019718|NCT02564744|471702792|FG003|Overall Study|Death|16|||
131019719|NCT02564744|471702793|FG004|Overall Study|Death|16|||
131019720|NCT02564744|471702789|FG000|Overall Study|End of study Page Missing|0|||
131019721|NCT02564744|471702790|FG001|Overall Study|End of study Page Missing|0|||
131019722|NCT02564744|471702791|FG002|Overall Study|End of study Page Missing|3|||
131019723|NCT02564744|471702792|FG003|Overall Study|End of study Page Missing|3|||
131019724|NCT02564744|471702793|FG004|Overall Study|End of study Page Missing|0|||
131019725|NCT02564744|471702789|FG000|Overall Study|Subject Withdrew Consent|1|||
131019726|NCT02564744|471702790|FG001|Overall Study|Subject Withdrew Consent|1|||
131019727|NCT02564744|471702791|FG002|Overall Study|Subject Withdrew Consent|1|||
131019728|NCT02564744|471702792|FG003|Overall Study|Subject Withdrew Consent|0|||
131019729|NCT02564744|471702793|FG004|Overall Study|Subject Withdrew Consent|2|||
131019730|NCT02564744|471702789|FG000|Overall Study|Lost to Follow-up|0|||
131019731|NCT02564744|471702790|FG001|Overall Study|Lost to Follow-up|1|||
131019732|NCT02564744|471702791|FG002|Overall Study|Lost to Follow-up|0|||
131019733|NCT02564744|471702792|FG003|Overall Study|Lost to Follow-up|0|||
131019734|NCT02564744|471702793|FG004|Overall Study|Lost to Follow-up|1|||
131019735|NCT02564744|471702789|FG000|Overall Study|Reason not specified|1|||
131019736|NCT02564744|471702790|FG001|Overall Study|Reason not specified|0|||
131019737|NCT02564744|471702791|FG002|Overall Study|Reason not specified|0|||
131019738|NCT02564744|471702792|FG003|Overall Study|Reason not specified|0|||
131019739|NCT02564744|471702793|FG004|Overall Study|Reason not specified|0|||
131019740|NCT00508924|471702794|FG000|Overall Study|Protocol Violation|0|||
131019741|NCT00508924|471702795|FG001|Overall Study|Protocol Violation|0|||
131019742|NCT00508924|471702796|FG002|Overall Study|Protocol Violation|1|||
131019743|NCT00508924|471702797|FG003|Overall Study|Protocol Violation|1|||
131019744|NCT03593213|471702799|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
131019745|NCT03593213|471702800|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
131019746|NCT03593213|471702801|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
131019747|NCT03593213|471702802|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
131019748|NCT03593213|471702799|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
131019749|NCT03593213|471702800|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
131019750|NCT03593213|471702801|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
131019751|NCT03593213|471702802|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
131019752|NCT03593213|471702799|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
131019753|NCT03593213|471702800|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
131019754|NCT03593213|471702801|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
131019755|NCT03593213|471702802|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
131019756|NCT03593213|471702799|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
131019757|NCT03593213|471702800|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
131019758|NCT03593213|471702801|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
131019759|NCT03593213|471702802|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
131019760|NCT03593213|471702799|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
131019761|NCT03593213|471702800|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
131019762|NCT03593213|471702801|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
131019763|NCT03593213|471702802|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
131019764|NCT03593213|471702799|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
131019765|NCT03593213|471702800|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
131019766|NCT03593213|471702801|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
131019767|NCT03593213|471702802|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
131019768|NCT03593213|471702799|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
131019769|NCT03593213|471702800|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
131019770|NCT03593213|471702801|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
131019771|NCT03593213|471702802|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
131019772|NCT03593213|471702799|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
131105703|NCT00126503|472017267|FG000|Overall Study|disease progression|23|||
131105704|NCT00126503|472017268|FG001|Overall Study|disease progression|14|||
131105705|NCT00126503|472017267|FG000|Overall Study|Withdrawal by Subject|0|||
131105706|NCT00126503|472017268|FG001|Overall Study|Withdrawal by Subject|1|||
131105707|NCT00126503|472017267|FG000|Overall Study|alternative therapy|1|||
131105708|NCT00126503|472017268|FG001|Overall Study|alternative therapy|1|||
131105709|NCT00126503|472017267|FG000|Overall Study|other complicating disease|4|||
131105710|NCT00126503|472017268|FG001|Overall Study|other complicating disease|1|||
131105711|NCT00126503|472017267|FG000|Overall Study|Death|3|||
131105712|NCT00126503|472017268|FG001|Overall Study|Death|0|||
131105713|NCT00126503|472017267|FG000|Overall Study|Adverse Event|13|||
131105714|NCT00126503|472017268|FG001|Overall Study|Adverse Event|3|||
131105715|NCT00126503|472017267|FG000|Overall Study|non-compliant|1|||
131105716|NCT00126503|472017268|FG001|Overall Study|non-compliant|0|||
131105717|NCT00126503|472017267|FG000|Overall Study|Physician Decision|2|||
131105718|NCT00126503|472017268|FG001|Overall Study|Physician Decision|1|||
131105719|NCT02457559|472017269|FG000|Overall Study|Progressive Disease|1|||
131105720|NCT02457559|472017270|FG001|Overall Study|Progressive Disease|2|||
131105721|NCT02457559|472017271|FG002|Overall Study|Progressive Disease|3|||
131105722|NCT02457559|472017272|FG003|Overall Study|Progressive Disease|0|||
131105723|NCT02457559|472017273|FG004|Overall Study|Progressive Disease|0|||
131105724|NCT02457559|472017274|FG005|Overall Study|Progressive Disease|2|||
131105725|NCT02457559|472017275|FG006|Overall Study|Progressive Disease|1|||
131105726|NCT02457559|472017276|FG007|Overall Study|Progressive Disease|0|||
131105727|NCT02457559|472017277|FG008|Overall Study|Progressive Disease|1|||
131105728|NCT02457559|472017278|FG009|Overall Study|Progressive Disease|1|||
131105729|NCT02457559|472017279|FG010|Overall Study|Progressive Disease|1|||
131105730|NCT02457559|472017269|FG000|Overall Study|Investigator's Discretion|0|||
131105731|NCT02457559|472017270|FG001|Overall Study|Investigator's Discretion|0|||
131105732|NCT02457559|472017271|FG002|Overall Study|Investigator's Discretion|2|||
131105733|NCT02457559|472017272|FG003|Overall Study|Investigator's Discretion|0|||
131105734|NCT02457559|472017273|FG004|Overall Study|Investigator's Discretion|1|||
131105735|NCT02457559|472017274|FG005|Overall Study|Investigator's Discretion|0|||
131105736|NCT02457559|472017275|FG006|Overall Study|Investigator's Discretion|1|||
131105737|NCT02457559|472017276|FG007|Overall Study|Investigator's Discretion|0|||
131105738|NCT02457559|472017277|FG008|Overall Study|Investigator's Discretion|1|||
131105739|NCT02457559|472017278|FG009|Overall Study|Investigator's Discretion|0|||
131105740|NCT02457559|472017279|FG010|Overall Study|Investigator's Discretion|1|||
131105741|NCT02457559|472017269|FG000|Overall Study|Adverse Event|0|||
131105742|NCT02457559|472017270|FG001|Overall Study|Adverse Event|1|||
131105743|NCT02457559|472017271|FG002|Overall Study|Adverse Event|2|||
131105744|NCT02457559|472017272|FG003|Overall Study|Adverse Event|0|||
131105745|NCT02457559|472017273|FG004|Overall Study|Adverse Event|0|||
131105746|NCT02457559|472017274|FG005|Overall Study|Adverse Event|0|||
131105747|NCT02457559|472017275|FG006|Overall Study|Adverse Event|0|||
131105748|NCT02457559|472017276|FG007|Overall Study|Adverse Event|0|||
131105749|NCT02457559|472017277|FG008|Overall Study|Adverse Event|0|||
131105750|NCT02457559|472017278|FG009|Overall Study|Adverse Event|0|||
131105751|NCT02457559|472017279|FG010|Overall Study|Adverse Event|0|||
131105752|NCT02457559|472017269|FG000|Overall Study|Reason not Specified|1|||
131105753|NCT02457559|472017270|FG001|Overall Study|Reason not Specified|0|||
131105754|NCT02457559|472017271|FG002|Overall Study|Reason not Specified|0|||
131105755|NCT02457559|472017272|FG003|Overall Study|Reason not Specified|0|||
131105756|NCT02457559|472017273|FG004|Overall Study|Reason not Specified|0|||
131105757|NCT02457559|472017274|FG005|Overall Study|Reason not Specified|0|||
131105758|NCT02457559|472017275|FG006|Overall Study|Reason not Specified|0|||
131105759|NCT02457559|472017276|FG007|Overall Study|Reason not Specified|0|||
131105760|NCT02457559|472017277|FG008|Overall Study|Reason not Specified|0|||
131105761|NCT02457559|472017278|FG009|Overall Study|Reason not Specified|2|||
131105762|NCT02457559|472017279|FG010|Overall Study|Reason not Specified|0|||
131105763|NCT02457559|472017269|FG000|Overall Study|Death|0|||
131105764|NCT02457559|472017270|FG001|Overall Study|Death|0|||
131105765|NCT02457559|472017271|FG002|Overall Study|Death|0|||
131105766|NCT02457559|472017272|FG003|Overall Study|Death|0|||
130684457|NCT01710657|470472817|FG000|Overall Study|Protocol Violation|2|||
130684458|NCT01710657|470472818|FG001|Overall Study|Protocol Violation|2|||
130684459|NCT01710657|470472819|FG002|Overall Study|Protocol Violation|0|||
131105767|NCT02457559|472017273|FG004|Overall Study|Death|0|||
131105768|NCT02457559|472017274|FG005|Overall Study|Death|0|||
131105769|NCT02457559|472017275|FG006|Overall Study|Death|0|||
131105770|NCT02457559|472017276|FG007|Overall Study|Death|0|||
131105771|NCT02457559|472017277|FG008|Overall Study|Death|1|||
131105772|NCT02457559|472017278|FG009|Overall Study|Death|1|||
130684460|NCT01710657|470472817|FG000|Overall Study|Adverse Event|14|||
131105773|NCT02457559|472017279|FG010|Overall Study|Death|0|||
131105774|NCT00998335|472017280|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
131105775|NCT00998335|472017281|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
131105776|NCT02374671|472017282|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
131105777|NCT02374671|472017283|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
131105778|NCT02374671|472017284|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
131105779|NCT02374671|472017282|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
131105780|NCT02374671|472017283|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
131105781|NCT02374671|472017284|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
131105782|NCT02374671|472017282|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
130684461|NCT01710657|470472818|FG001|Overall Study|Adverse Event|8|||
130684462|NCT01710657|470472819|FG002|Overall Study|Adverse Event|28|||
130684463|NCT01710657|470472817|FG000|Overall Study|Withdrawal by Subject|0|||
130684464|NCT01710657|470472818|FG001|Overall Study|Withdrawal by Subject|1|||
130684465|NCT01710657|470472819|FG002|Overall Study|Withdrawal by Subject|2|||
130684466|NCT01710657|470472817|FG000|Overall Study|Lack of Efficacy|0|||
130684467|NCT01710657|470472818|FG001|Overall Study|Lack of Efficacy|1|||
131105783|NCT02374671|472017283|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
131105784|NCT02374671|472017284|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
131105785|NCT02374671|472017282|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
131105786|NCT02374671|472017283|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
131105787|NCT02374671|472017284|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
131105788|NCT02374671|472017282|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
131105789|NCT02374671|472017283|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
131105790|NCT02374671|472017284|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
131105791|NCT05330312|472017289|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
131105792|NCT05330312|472017290|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
131105793|NCT05330312|472017291|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
131105794|NCT05330312|472017289|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
131105795|NCT05330312|472017290|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
131105796|NCT05330312|472017291|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
131105797|NCT05330312|472017289|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
131105798|NCT05330312|472017290|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
131105799|NCT05330312|472017291|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
131105800|NCT05330312|472017289|FG000|Pivotal Investigation - Part 2|Death|1|||
131105801|NCT05330312|472017290|FG001|Pivotal Investigation - Part 2|Death|4|||
131105802|NCT05330312|472017291|FG002|Pivotal Investigation - Part 2|Death|0|||
131105803|NCT01078454|472017294|FG000|Overall Study|Adverse Event|1|||
131105804|NCT01078454|472017295|FG001|Overall Study|Adverse Event|1|||
130684468|NCT01710657|470472819|FG002|Overall Study|Lack of Efficacy|1|||
130684469|NCT01591785|470472822|FG000|Overall Study|worsening condition|1|||
131019773|NCT03593213|471702800|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
131019774|NCT03593213|471702801|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
131019775|NCT03593213|471702802|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
131019776|NCT03593213|471702799|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
131019777|NCT03593213|471702800|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
131019778|NCT03593213|471702801|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
131019779|NCT03593213|471702802|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
131019780|NCT03593213|471702799|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
131019781|NCT03593213|471702800|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
131019782|NCT03593213|471702801|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
131019783|NCT03593213|471702802|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
131019784|NCT03593213|471702799|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
131019785|NCT03593213|471702800|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
131019786|NCT03593213|471702801|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
131019787|NCT03593213|471702802|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
131019788|NCT03593213|471702799|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
131019789|NCT03593213|471702800|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
131019790|NCT03593213|471702801|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
131019791|NCT03593213|471702802|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
131019792|NCT03593213|471702799|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
131019793|NCT03593213|471702800|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
131019794|NCT03593213|471702801|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
131019795|NCT03593213|471702802|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
131105805|NCT01078454|472017294|FG000|Overall Study|Death|0|||
131105806|NCT01078454|472017295|FG001|Overall Study|Death|1|||
130684470|NCT01591785|470472823|FG001|Overall Study|worsening condition|2|||
130684471|NCT01591785|470472822|FG000|Overall Study|Protocol Violation|2|||
130684472|NCT01591785|470472823|FG001|Overall Study|Protocol Violation|0|||
130684473|NCT01591785|470472822|FG000|Overall Study|Lost to Follow-up|1|||
130684474|NCT01591785|470472823|FG001|Overall Study|Lost to Follow-up|0|||
130684475|NCT00667862|470472824|FG000|Overall Study|Adverse Event|9|||
131105807|NCT00346268|472018878|FG000|Overall Study|Adverse Event|1|||
131105808|NCT00346268|472018879|FG001|Overall Study|Adverse Event|0|||
131105809|NCT00346268|472018878|FG000|Overall Study|Protocol Violation|1|||
131105810|NCT00346268|472018879|FG001|Overall Study|Protocol Violation|0|||
131105811|NCT00346268|472018878|FG000|Overall Study|Participant refused|0|||
131105812|NCT00346268|472018879|FG001|Overall Study|Participant refused|3|||
131105813|NCT01036763|472018880|FG000|Overall Study|Adverse Event|25|||
131105814|NCT01036763|472018880|FG000|Overall Study|Lost to Follow-up|28|||
131105815|NCT01036763|472018880|FG000|Overall Study|Other reason (not specified)|40|||
131105816|NCT00743275|472018881|FG000|Overall Study|Protocol Violation|0|||
131105817|NCT00743275|472018882|FG001|Overall Study|Protocol Violation|1|||
131105818|NCT01672723|472018883|FG000|First Intervention|Adverse Event|3|||
131105819|NCT01672723|472018884|FG001|First Intervention|Adverse Event|0|||
131105820|NCT03536143|472018893|FG000|Overall Study|Early termination, Sponsor decision|1|||
130684476|NCT00667862|470472824|FG000|Overall Study|Death|1|||
130684477|NCT00667862|470472824|FG000|Overall Study|Disease Progression|22|||
130684478|NCT00667862|470472824|FG000|Overall Study|Withdrawal by Subject|3|||
130684479|NCT00905346|470472828|FG000|Period 1|Withdrawal by Subject|1|||
130684480|NCT00905346|470472829|FG001|Period 1|Withdrawal by Subject|0|||
130684481|NCT01435265|470472830|FG000|Overall Study|Lost to Follow-up|0|||
130684482|NCT01435265|470472831|FG001|Overall Study|Lost to Follow-up|1|||
130684483|NCT00909610|470472834|FG000|Period: First Intervention|Adverse Event|0|||
130684484|NCT00909610|470472835|FG001|Period: First Intervention|Adverse Event|1|||
130684485|NCT00909610|470472834|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
130684486|NCT00909610|470472835|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
130684487|NCT00909610|470472834|FG000|Period: Second Intervention|Adverse Event|1|||
130684488|NCT00909610|470472835|FG001|Period: Second Intervention|Adverse Event|0|||
130684489|NCT05612724|470472842|FG000|Overall Study|Lost to Follow-up|4|||
131019796|NCT03593213|471702799|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
131019797|NCT03593213|471702800|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
131105821|NCT01174160|472018894|FG000|Overall Study|Adverse Event|1|||
131105822|NCT01174160|472018895|FG001|Overall Study|Adverse Event|0|||
131105823|NCT01174160|472018894|FG000|Overall Study|Lost to Follow-up|1|||
131105824|NCT01174160|472018895|FG001|Overall Study|Lost to Follow-up|0|||
131105825|NCT01174160|472018894|FG000|Overall Study|Physician Decision|1|||
131105826|NCT01174160|472018895|FG001|Overall Study|Physician Decision|0|||
131105827|NCT01174160|472018894|FG000|Overall Study|Protocol Violation|4|||
131105828|NCT01174160|472018895|FG001|Overall Study|Protocol Violation|6|||
131105829|NCT01174160|472018894|FG000|Overall Study|Withdrawal by Subject|1|||
131105830|NCT01174160|472018895|FG001|Overall Study|Withdrawal by Subject|0|||
131105831|NCT02527343|472018896|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
131105832|NCT02527343|472018897|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
131105833|NCT02527343|472018898|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
131105834|NCT02527343|472018899|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
131105835|NCT02527343|472018900|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
131105836|NCT02527343|472018901|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
131105837|NCT02527343|472018896|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
131105838|NCT02527343|472018897|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
131105839|NCT02527343|472018898|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
131105840|NCT02527343|472018899|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
131105841|NCT02527343|472018900|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
131105842|NCT02527343|472018901|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
131105843|NCT02527343|472018896|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131105844|NCT02527343|472018897|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
131105845|NCT02527343|472018898|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131105846|NCT02527343|472018899|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131105847|NCT02527343|472018900|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131105848|NCT02527343|472018901|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131105849|NCT02527343|472018896|FG000|RT Period: Weeks 1 to 52|Other|4|||
131105850|NCT02527343|472018897|FG001|RT Period: Weeks 1 to 52|Other|3|||
131105851|NCT02527343|472018898|FG002|RT Period: Weeks 1 to 52|Other|0|||
131105852|NCT02527343|472018899|FG003|RT Period: Weeks 1 to 52|Other|0|||
131019798|NCT03593213|471702801|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
131019799|NCT03593213|471702802|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
131019800|NCT03593213|471702799|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
131019801|NCT03593213|471702800|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
131019802|NCT03593213|471702801|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
131019803|NCT03593213|471702802|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
131105853|NCT02527343|472018900|FG004|RT Period: Weeks 1 to 52|Other|0|||
131105854|NCT02527343|472018901|FG005|RT Period: Weeks 1 to 52|Other|0|||
131105855|NCT02527343|472018896|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
131105856|NCT02527343|472018897|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
131222613|NCT01902134|472443115|FG002|Overall Study|Other|2|||
130684490|NCT02128997|470472843|FG000|Overall Study|Lost to Follow-up|6|||
130684491|NCT02128997|470472844|FG001|Overall Study|Lost to Follow-up|11|||
130684492|NCT04000815|470472851|FG000|Overall Study|Lost to Follow-up|9|||
131019804|NCT03593213|471702799|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
131019805|NCT03593213|471702800|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
131019806|NCT03593213|471702801|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
130684493|NCT04000815|470472852|FG001|Overall Study|Lost to Follow-up|2|||
130684494|NCT04000815|470472853|FG002|Overall Study|Lost to Follow-up|3|||
130684495|NCT04000815|470472851|FG000|Overall Study|Withdrawal by Subject|4|||
130684496|NCT04000815|470472852|FG001|Overall Study|Withdrawal by Subject|3|||
130684497|NCT04000815|470472853|FG002|Overall Study|Withdrawal by Subject|2|||
130684498|NCT04000815|470472851|FG000|Overall Study|Right ovarian cyst occured|1|||
130684499|NCT04000815|470472852|FG001|Overall Study|Right ovarian cyst occured|0|||
130684500|NCT04000815|470472853|FG002|Overall Study|Right ovarian cyst occured|0|||
130684501|NCT04000815|470472851|FG000|Overall Study|Hypertension occured on follow up|0|||
131019807|NCT03593213|471702802|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
131019808|NCT03593213|471702799|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
131019809|NCT03593213|471702800|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
131019810|NCT03593213|471702801|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
131019811|NCT03593213|471702802|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
131019812|NCT03593213|471702799|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
131019813|NCT03593213|471702800|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
131019814|NCT03593213|471702801|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
131019815|NCT03593213|471702802|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
131019816|NCT03593213|471702799|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
131019817|NCT03593213|471702800|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
131019818|NCT03593213|471702801|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
131019819|NCT03593213|471702802|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
131019820|NCT00585533|471702808|FG000|Overall Study|objective or symptomatic progression|9|||
131019821|NCT05082935|471702809|FG000|Overall Study|Lost to Follow-up|549|||
131019822|NCT05082935|471702810|FG001|Overall Study|Lost to Follow-up|631|||
131019823|NCT05082935|471702809|FG000|Overall Study|Withdrawal by Subject|27|||
131019824|NCT05082935|471702810|FG001|Overall Study|Withdrawal by Subject|58|||
131019825|NCT00439569|471702811|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
131019826|NCT00439569|471702811|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
131019827|NCT00439569|471702811|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
131019828|NCT03482011|471702812|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
131019829|NCT03482011|471702813|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
131019830|NCT03482011|471702814|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
131019831|NCT03482011|471702815|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
131019832|NCT03482011|471702816|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
131019833|NCT03482011|471702817|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
131019834|NCT03482011|471702818|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
131019835|NCT03482011|471702819|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
131019836|NCT03482011|471702812|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
131019837|NCT03482011|471702813|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
131019838|NCT03482011|471702814|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131019839|NCT03482011|471702815|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131019840|NCT03482011|471702816|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131019841|NCT03482011|471702817|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131019842|NCT03482011|471702818|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131019843|NCT03482011|471702819|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
131019844|NCT03482011|471702812|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131019845|NCT03482011|471702813|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
131019846|NCT03482011|471702814|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131019847|NCT03482011|471702815|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131019848|NCT03482011|471702816|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131019849|NCT03482011|471702817|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131019850|NCT03482011|471702818|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131019851|NCT03482011|471702819|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
131019852|NCT03482011|471702812|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
131019853|NCT03482011|471702813|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
131019854|NCT03482011|471702814|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
131019855|NCT03482011|471702815|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
131019856|NCT03482011|471702816|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
131019857|NCT03482011|471702817|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
131019858|NCT03482011|471702818|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
131019859|NCT03482011|471702819|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
131019860|NCT03482011|471702812|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
131105857|NCT02527343|472018898|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
131105858|NCT02527343|472018899|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
131105859|NCT02527343|472018900|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
131019861|NCT03482011|471702813|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
131019862|NCT03482011|471702814|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131019863|NCT03482011|471702815|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131019864|NCT03482011|471702816|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131019865|NCT03482011|471702817|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131019866|NCT03482011|471702818|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131019867|NCT03482011|471702819|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131019868|NCT03482011|471702812|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
131019869|NCT03482011|471702813|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
131019870|NCT03482011|471702814|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
131019871|NCT03482011|471702815|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
131019872|NCT03482011|471702816|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
131019873|NCT03482011|471702817|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
131019874|NCT03482011|471702818|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
131019875|NCT03482011|471702819|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
131019876|NCT03482011|471702812|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
131019877|NCT03482011|471702813|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
131019878|NCT03482011|471702814|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
131019879|NCT03482011|471702815|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
131019880|NCT03482011|471702816|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
131019881|NCT03482011|471702817|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
131019882|NCT03482011|471702818|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
131019883|NCT03482011|471702819|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
131019884|NCT03482011|471702812|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131019885|NCT03482011|471702813|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131019886|NCT03482011|471702814|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131019887|NCT03482011|471702815|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131019888|NCT03482011|471702816|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
131019889|NCT03482011|471702817|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131019890|NCT03482011|471702818|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
131019891|NCT03482011|471702819|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
131019892|NCT03482011|471702812|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
131019893|NCT03482011|471702813|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
131019894|NCT03482011|471702814|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
131019895|NCT03482011|471702815|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
131019896|NCT03482011|471702816|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
131019897|NCT03482011|471702817|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
131019898|NCT03482011|471702818|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
131019899|NCT03482011|471702819|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
131019900|NCT03482011|471702812|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131019901|NCT03482011|471702813|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131019902|NCT03482011|471702814|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
131019903|NCT03482011|471702815|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
131019904|NCT03482011|471702816|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
131019905|NCT03482011|471702817|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
131019906|NCT03482011|471702818|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
131019907|NCT03482011|471702819|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
131019908|NCT03482011|471702812|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131019909|NCT03482011|471702813|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131019910|NCT03482011|471702814|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131019911|NCT03482011|471702815|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
131019912|NCT03482011|471702816|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131019913|NCT03482011|471702817|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
131019914|NCT03482011|471702818|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
131019915|NCT03482011|471702819|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
131019916|NCT03482011|471702812|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
131019917|NCT03482011|471702813|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
131019918|NCT03482011|471702814|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
131019919|NCT03482011|471702815|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
131019920|NCT03482011|471702816|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
131105860|NCT02527343|472018901|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
131105861|NCT02527343|472018896|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
131105862|NCT02527343|472018897|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
131105863|NCT02527343|472018898|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
131019921|NCT03482011|471702817|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
131019922|NCT03482011|471702818|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
131105864|NCT02527343|472018899|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
131105865|NCT02527343|472018900|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
131105866|NCT02527343|472018901|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
131105867|NCT02527343|472018896|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
131105868|NCT02527343|472018897|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
131105869|NCT02527343|472018898|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
131105870|NCT02527343|472018899|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
131105871|NCT02527343|472018900|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
131105872|NCT02527343|472018901|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
131105873|NCT02527343|472018896|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
131105874|NCT02527343|472018897|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
131105875|NCT02527343|472018898|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
131105876|NCT02527343|472018899|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
131105877|NCT02527343|472018900|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
131105878|NCT02527343|472018901|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
131105879|NCT02527343|472018896|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
130684502|NCT04000815|470472852|FG001|Overall Study|Hypertension occured on follow up|0|||
131105880|NCT02527343|472018897|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
131105881|NCT02527343|472018898|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
131105882|NCT02527343|472018899|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
131105883|NCT02527343|472018900|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
131105884|NCT02527343|472018901|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
131105885|NCT02527343|472018896|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
131105886|NCT02527343|472018897|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
131105887|NCT02527343|472018898|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
131105888|NCT02527343|472018899|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
131105889|NCT02527343|472018900|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
131105890|NCT02527343|472018901|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
131105891|NCT02527343|472018896|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
131105892|NCT02527343|472018897|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
131105893|NCT02527343|472018898|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
131105894|NCT02527343|472018899|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
131105895|NCT02527343|472018900|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
131105896|NCT02527343|472018901|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
131105897|NCT02527343|472018896|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
131105898|NCT02527343|472018897|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
131105899|NCT02527343|472018898|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
131105900|NCT02527343|472018899|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
131105901|NCT02527343|472018900|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
131105902|NCT02527343|472018901|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
131105903|NCT02527343|472018896|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
131105904|NCT02527343|472018897|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
131105905|NCT02527343|472018898|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
131105906|NCT02527343|472018899|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
131105907|NCT02527343|472018900|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
131105908|NCT02527343|472018901|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
131105909|NCT00701220|472018902|FG000|Overall Study|Withdrawal by Subject|0|||
131105910|NCT00701220|472018903|FG001|Overall Study|Withdrawal by Subject|2|||
131105911|NCT00701220|472018902|FG000|Overall Study|Protocol Violation|2|||
131105912|NCT00701220|472018903|FG001|Overall Study|Protocol Violation|0|||
131105913|NCT00440999|472018904|FG000|Overall Study|Adverse Event|0|||
131105914|NCT00440999|472018905|FG001|Overall Study|Adverse Event|2|||
131105915|NCT00440999|472018904|FG000|Overall Study|Lack of Efficacy|6|||
131019923|NCT03482011|471702819|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
131019924|NCT03482011|471702812|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
131019925|NCT03482011|471702813|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
131019926|NCT03482011|471702814|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
131019927|NCT03482011|471702815|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
131019928|NCT03482011|471702816|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
131019929|NCT03482011|471702817|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
131019930|NCT03482011|471702818|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
131019931|NCT03482011|471702819|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
131019932|NCT03482011|471702812|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
131019933|NCT03482011|471702813|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
131019934|NCT03482011|471702814|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
131105916|NCT00440999|472018905|FG001|Overall Study|Lack of Efficacy|7|||
130684503|NCT04000815|470472853|FG002|Overall Study|Hypertension occured on follow up|2|||
130684504|NCT00239577|470472854|FG000|Primary Phase|Adverse Event|0|||
131105917|NCT00440999|472018904|FG000|Overall Study|Lost to Follow-up|19|||
131105918|NCT00440999|472018905|FG001|Overall Study|Lost to Follow-up|12|||
131105919|NCT00440999|472018904|FG000|Overall Study|Protocol Violation|1|||
131105920|NCT00440999|472018905|FG001|Overall Study|Protocol Violation|0|||
131105921|NCT00440999|472018904|FG000|Overall Study|Withdrawal by Subject|2|||
131019935|NCT03482011|471702815|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
131019936|NCT03482011|471702816|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
130684505|NCT00239577|470472855|FG001|Primary Phase|Adverse Event|0|||
130684506|NCT00239577|470472856|FG002|Primary Phase|Adverse Event|1|||
130684507|NCT00239577|470472857|FG003|Primary Phase|Adverse Event|0|||
130684508|NCT00239577|470472854|FG000|Primary Phase|Other|5|||
130684509|NCT00239577|470472855|FG001|Primary Phase|Other|3|||
130684510|NCT00239577|470472856|FG002|Primary Phase|Other|2|||
130684511|NCT00239577|470472857|FG003|Primary Phase|Other|0|||
130684512|NCT02736721|470472860|FG000|Overall Study|Adverse Event|8|||
130684513|NCT02736721|470472860|FG000|Overall Study|Lost to Follow-up|3|||
130684514|NCT02736721|470472860|FG000|Overall Study|Other|5|||
130684515|NCT03988803|470472861|FG000|Period 2|Prematurely discontinued from medication|2|||
130684516|NCT03988803|470472861|FG000|Period 2|Adverse Event|1|||
130684517|NCT03021018|470472863|FG000|Overall Study|Adverse Event|1|||
130684518|NCT03021018|470472864|FG001|Overall Study|Adverse Event|0|||
130684519|NCT03021018|470472865|FG002|Overall Study|Adverse Event|0|||
130684520|NCT03021018|470472863|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
130684521|NCT03021018|470472864|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
130684522|NCT03021018|470472865|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
130684523|NCT04123548|470472876|FG000|Overall Study|Withdrawal by Subject|1|||
130684524|NCT04123548|470472876|FG000|Overall Study|Lost to Follow-up|8|||
130684525|NCT04123548|470472876|FG000|Overall Study|Death|4|||
130684526|NCT04123548|470472876|FG000|Overall Study|Reason Not Specified|1|||
130684527|NCT00418184|470472879|FG000|Double-blind Phase|Withdrawal by Subject|22|||
130684528|NCT00418184|470472880|FG001|Double-blind Phase|Withdrawal by Subject|9|||
130684529|NCT00418184|470472879|FG000|Double-blind Phase|Adverse Event|2|||
130684530|NCT00418184|470472880|FG001|Double-blind Phase|Adverse Event|1|||
130684531|NCT00418184|470472879|FG000|Double-blind Phase|Poor compliance|3|||
130684532|NCT00418184|470472880|FG001|Double-blind Phase|Poor compliance|1|||
130684533|NCT00620074|470472881|FG000|Overall Study|Adverse Event|1|||
130684534|NCT01838941|470472882|FG000|Overall Study|Adverse Event|1|||
130684535|NCT01838941|470472882|FG000|Overall Study|Withdrawal by Subject|1|||
131019937|NCT03482011|471702817|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
131019938|NCT03482011|471702818|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
131019939|NCT03482011|471702819|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
131019940|NCT03482011|471702812|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131019941|NCT03482011|471702813|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131019942|NCT03482011|471702814|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131019943|NCT03482011|471702815|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131019944|NCT03482011|471702816|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131019945|NCT03482011|471702817|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131019946|NCT03482011|471702818|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131019947|NCT03482011|471702819|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
131019948|NCT01595061|471702820|FG000|Overall Study|Never Treated|3|||
131019949|NCT01595061|471702820|FG000|Overall Study|Inadequate Pathology|1|||
131019950|NCT02538107|471702821|FG000|Overall Study|Did not receive any Mircera dose|11|||
131019951|NCT02538107|471702821|FG000|Overall Study|Missing|5|||
131019952|NCT02538107|471702821|FG000|Overall Study|Necessity of dialysis|20|||
131019953|NCT02538107|471702821|FG000|Overall Study|Administration of other ESA|11|||
131019954|NCT02538107|471702821|FG000|Overall Study|No further treatment necessary|18|||
131019955|NCT02538107|471702821|FG000|Overall Study|Withdrawal by Subject|17|||
131019956|NCT02538107|471702821|FG000|Overall Study|Death|4|||
131019957|NCT02538107|471702821|FG000|Overall Study|Administrative reason|5|||
131019958|NCT02538107|471702821|FG000|Overall Study|Adverse Event|4|||
131019959|NCT02538107|471702821|FG000|Overall Study|Surgery|1|||
131019960|NCT02538107|471702821|FG000|Overall Study|Other|7|||
131019961|NCT02538107|471702821|FG000|Overall Study|Not recorded|7|||
131019962|NCT01278394|471702824|FG000|Overall Study|Lost to Follow-up|1|||
131019963|NCT01236560|471702825|FG000|Overall Study|Adverse Event|0|||
131019964|NCT01236560|471702826|FG001|Overall Study|Adverse Event|2|||
131019965|NCT01236560|471702827|FG002|Overall Study|Adverse Event|1|||
131019966|NCT01236560|471702828|FG003|Overall Study|Adverse Event|3|||
131019967|NCT01236560|471702829|FG004|Overall Study|Adverse Event|0|||
131019968|NCT01236560|471702830|FG005|Overall Study|Adverse Event|0|||
131019969|NCT01236560|471702825|FG000|Overall Study|Death|0|||
131019970|NCT01236560|471702826|FG001|Overall Study|Death|1|||
131019971|NCT01236560|471702827|FG002|Overall Study|Death|0|||
130684536|NCT02822235|470472883|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
131019972|NCT01236560|471702828|FG003|Overall Study|Death|1|||
131019973|NCT01236560|471702829|FG004|Overall Study|Death|0|||
131019974|NCT01236560|471702830|FG005|Overall Study|Death|0|||
130684537|NCT02822235|470472884|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
130684538|NCT02822235|470472883|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
130684539|NCT02822235|470472884|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
131019975|NCT01236560|471702825|FG000|Overall Study|Lost to Follow-up|0|||
131019976|NCT01236560|471702826|FG001|Overall Study|Lost to Follow-up|1|||
130684540|NCT02822235|470472883|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
130684541|NCT02822235|470472884|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
130684542|NCT02822235|470472883|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
130684543|NCT02822235|470472884|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
130684544|NCT02822235|470472883|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
130684545|NCT02822235|470472884|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
130684546|NCT02822235|470472883|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
130684547|NCT02822235|470472884|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
130684548|NCT03214952|470472885|FG000|Overall Study|Protocol Deviation|45|||
130684549|NCT03214952|470472885|FG000|Overall Study|Case Report Forms Uncollected|13|||
130684550|NCT03769896|470472888|FG000|Open-label Phase|Lack of Efficacy|5|||
130684551|NCT03769896|470472889|FG001|Open-label Phase|Lack of Efficacy|0|||
130684552|NCT03769896|470472888|FG000|Open-label Phase|Adverse Event|3|||
130684553|NCT03769896|470472889|FG001|Open-label Phase|Adverse Event|0|||
130684554|NCT03769896|470472888|FG000|Open-label Phase|Withdrawal by Subject|1|||
130684555|NCT03769896|470472889|FG001|Open-label Phase|Withdrawal by Subject|0|||
130684556|NCT00829530|470472890|FG000|First Intervention|Adverse Event|0|||
130684557|NCT00829530|470472891|FG001|First Intervention|Adverse Event|1|||
130684558|NCT00829530|470472890|FG000|First Intervention|Intolerance to Venopuncture|0|||
130684559|NCT00829530|470472891|FG001|First Intervention|Intolerance to Venopuncture|1|||
130684560|NCT00829530|470472890|FG000|Second Intervention|Intolerance to Venopuncture|1|||
130684561|NCT00829530|470472891|FG001|Second Intervention|Intolerance to Venopuncture|0|||
130684562|NCT01015625|470472894|FG000|Overall Study|Lost to Follow-up|3|||
130684563|NCT01015625|470472895|FG001|Overall Study|Lost to Follow-up|1|||
130684564|NCT01015625|470472894|FG000|Overall Study|Withdrawal by Subject|2|||
130684565|NCT01015625|470472895|FG001|Overall Study|Withdrawal by Subject|3|||
130684566|NCT01015625|470472894|FG000|Overall Study|Physician Decision|2|||
130684567|NCT01015625|470472895|FG001|Overall Study|Physician Decision|0|||
130684568|NCT01015625|470472894|FG000|Overall Study|Death|30|||
130684569|NCT01015625|470472895|FG001|Overall Study|Death|22|||
130684570|NCT04112823|470472896|FG000|Overall Study|Lost to Follow-up|2|||
130684571|NCT04112823|470472897|FG001|Overall Study|Lost to Follow-up|3|||
130684572|NCT00625443|470472898|FG000|Overall Study|Adverse Event|1|||
130684573|NCT00625443|470472899|FG001|Overall Study|Adverse Event|4|||
130684574|NCT00625443|470472900|FG002|Overall Study|Adverse Event|0|||
130684575|NCT00625443|470472898|FG000|Overall Study|Non-compliance with protocol|0|||
130684576|NCT00625443|470472899|FG001|Overall Study|Non-compliance with protocol|1|||
130684577|NCT00625443|470472900|FG002|Overall Study|Non-compliance with protocol|0|||
130684578|NCT00625443|470472898|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
130684579|NCT00625443|470472899|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
130684580|NCT00625443|470472900|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
130684581|NCT00625443|470472898|FG000|Overall Study|Withdrawal by Subject|0|||
130684582|NCT00625443|470472899|FG001|Overall Study|Withdrawal by Subject|1|||
130684583|NCT00625443|470472900|FG002|Overall Study|Withdrawal by Subject|2|||
130684584|NCT00625443|470472898|FG000|Overall Study|Physician Decision|0|||
130684585|NCT00625443|470472899|FG001|Overall Study|Physician Decision|4|||
130684586|NCT00625443|470472900|FG002|Overall Study|Physician Decision|2|||
130684587|NCT00625443|470472898|FG000|Overall Study|Other|0|||
130684588|NCT00625443|470472899|FG001|Overall Study|Other|1|||
130684589|NCT00625443|470472900|FG002|Overall Study|Other|1|||
130684590|NCT02472366|470472901|FG000|Overall Study|Lost to Follow-up|1|||
130684591|NCT02472366|470472902|FG001|Overall Study|Lost to Follow-up|0|||
130684592|NCT02728102|470472903|FG000|Overall Study|Death|3|||
130684593|NCT02728102|470472904|FG001|Overall Study|Death|0|||
130684594|NCT02728102|470472905|FG002|Overall Study|Death|1|||
130684595|NCT02728102|470472903|FG000|Overall Study|Withdrawal by Subject|0|||
130684596|NCT02728102|470472904|FG001|Overall Study|Withdrawal by Subject|2|||
130684597|NCT02728102|470472905|FG002|Overall Study|Withdrawal by Subject|3|||
131105922|NCT00440999|472018905|FG001|Overall Study|Withdrawal by Subject|5|||
131105923|NCT00440999|472018904|FG000|Overall Study|Subjets missed the visit|1|||
131105924|NCT00440999|472018905|FG001|Overall Study|Subjets missed the visit|0|||
131105925|NCT00440999|472018904|FG000|Overall Study|Mixed infection at entry|1|||
131105926|NCT00440999|472018905|FG001|Overall Study|Mixed infection at entry|0|||
130684598|NCT02728102|470472903|FG000|Overall Study|Physician Decision|1|||
130684599|NCT02728102|470472904|FG001|Overall Study|Physician Decision|1|||
130684600|NCT02728102|470472905|FG002|Overall Study|Physician Decision|0|||
130684601|NCT02728102|470472903|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
130684602|NCT02728102|470472904|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
130684603|NCT02728102|470472905|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
130684604|NCT02728102|470472903|FG000|Overall Study|Covid|0|||
130684605|NCT02728102|470472904|FG001|Overall Study|Covid|0|||
130684606|NCT02728102|470472905|FG002|Overall Study|Covid|1|||
131105927|NCT00440999|472018904|FG000|Overall Study|P. falciparum malaria|5|||
130684607|NCT01182415|470472906|FG000|Overall Study|Lost to Follow-up|1|||
130684608|NCT02587962|470472908|FG000|Overall Study|Adverse Event|0|||
130684609|NCT02587962|470472909|FG001|Overall Study|Adverse Event|0|||
130684610|NCT02587962|470472910|FG002|Overall Study|Adverse Event|1|||
130684611|NCT02587962|470472911|FG003|Overall Study|Adverse Event|0|||
130684612|NCT02587962|470472912|FG004|Overall Study|Adverse Event|0|||
130684613|NCT02587962|470472908|FG000|Overall Study|Withdrawal by Subject|0|||
130684614|NCT02587962|470472909|FG001|Overall Study|Withdrawal by Subject|0|||
130684615|NCT02587962|470472910|FG002|Overall Study|Withdrawal by Subject|1|||
130684616|NCT02587962|470472911|FG003|Overall Study|Withdrawal by Subject|1|||
130684617|NCT02587962|470472912|FG004|Overall Study|Withdrawal by Subject|4|||
130684618|NCT02587962|470472908|FG000|Overall Study|Radiological progression|2|||
130684619|NCT02587962|470472909|FG001|Overall Study|Radiological progression|2|||
130684620|NCT02587962|470472910|FG002|Overall Study|Radiological progression|2|||
130684621|NCT02587962|470472911|FG003|Overall Study|Radiological progression|5|||
130684622|NCT02587962|470472912|FG004|Overall Study|Radiological progression|10|||
130684623|NCT02587962|470472908|FG000|Overall Study|Clinical progression|0|||
130684624|NCT02587962|470472909|FG001|Overall Study|Clinical progression|1|||
130684625|NCT02587962|470472910|FG002|Overall Study|Clinical progression|2|||
130684626|NCT02587962|470472911|FG003|Overall Study|Clinical progression|0|||
130684627|NCT02587962|470472912|FG004|Overall Study|Clinical progression|1|||
130766994|NCT01897571|470770678|FG005|Overall Study|Enrolled in rollover study|0|||
130766995|NCT01897571|470770679|FG006|Overall Study|Enrolled in rollover study|0|||
130766996|NCT01897571|470770680|FG007|Overall Study|Enrolled in rollover study|9|||
130766997|NCT01897571|470770681|FG008|Overall Study|Enrolled in rollover study|7|||
130766998|NCT01897571|470770682|FG009|Overall Study|Enrolled in rollover study|9|||
130766999|NCT01897571|470770683|FG010|Overall Study|Enrolled in rollover study|1|||
130767000|NCT01897571|470770673|FG000|Overall Study|Death|2|||
130684628|NCT01422538|470472916|FG000|Overall Study|Lost to Follow-up|0|||
130684629|NCT01422538|470472917|FG001|Overall Study|Lost to Follow-up|1|||
130684630|NCT01422538|470472918|FG002|Overall Study|Lost to Follow-up|1|||
130684631|NCT01422538|470472916|FG000|Overall Study|Missed visit|0|||
130684632|NCT01422538|470472917|FG001|Overall Study|Missed visit|1|||
130684633|NCT01422538|470472918|FG002|Overall Study|Missed visit|1|||
130684634|NCT02770820|470472919|FG000|Overall Study|Death|1|||
130684635|NCT02770820|470472919|FG000|Overall Study|Physician Decision|2|||
130767001|NCT01897571|470770674|FG001|Overall Study|Death|2|||
130767002|NCT01897571|470770675|FG002|Overall Study|Death|3|||
130767003|NCT01897571|470770676|FG003|Overall Study|Death|6|||
130767004|NCT01897571|470770677|FG004|Overall Study|Death|7|||
130767005|NCT01897571|470770678|FG005|Overall Study|Death|9|||
130767006|NCT01897571|470770679|FG006|Overall Study|Death|5|||
130767007|NCT01897571|470770680|FG007|Overall Study|Death|22|||
130767008|NCT01897571|470770681|FG008|Overall Study|Death|23|||
130767009|NCT01897571|470770682|FG009|Overall Study|Death|129|||
130767010|NCT01897571|470770683|FG010|Overall Study|Death|59|||
130767011|NCT00089635|470770685|FG000|Overall Study|Adverse Event|2|||
130767012|NCT00089635|470770685|FG000|Overall Study|Death|17|||
130684636|NCT03555305|470472920|FG000|Period 1|Physician Decision|0|||
130684637|NCT03555305|470472921|FG001|Period 1|Physician Decision|1|||
130767013|NCT00089635|470770685|FG000|Overall Study|Disease Progression|12|||
131019977|NCT01236560|471702827|FG002|Overall Study|Lost to Follow-up|1|||
131019978|NCT01236560|471702828|FG003|Overall Study|Lost to Follow-up|0|||
131019979|NCT01236560|471702829|FG004|Overall Study|Lost to Follow-up|0|||
131019980|NCT01236560|471702830|FG005|Overall Study|Lost to Follow-up|0|||
131019981|NCT01236560|471702825|FG000|Overall Study|Physician Decision|0|||
131019982|NCT01236560|471702826|FG001|Overall Study|Physician Decision|1|||
131019983|NCT01236560|471702827|FG002|Overall Study|Physician Decision|8|||
131019984|NCT01236560|471702828|FG003|Overall Study|Physician Decision|0|||
131019985|NCT01236560|471702829|FG004|Overall Study|Physician Decision|0|||
131019986|NCT01236560|471702830|FG005|Overall Study|Physician Decision|0|||
131019987|NCT01236560|471702825|FG000|Overall Study|Withdrawal by Subject|0|||
131019988|NCT01236560|471702826|FG001|Overall Study|Withdrawal by Subject|0|||
131019989|NCT01236560|471702827|FG002|Overall Study|Withdrawal by Subject|1|||
131019990|NCT01236560|471702828|FG003|Overall Study|Withdrawal by Subject|2|||
131019991|NCT01236560|471702829|FG004|Overall Study|Withdrawal by Subject|0|||
131019992|NCT01236560|471702830|FG005|Overall Study|Withdrawal by Subject|0|||
131019993|NCT01236560|471702825|FG000|Overall Study|Progressive disease|5|||
131019994|NCT01236560|471702826|FG001|Overall Study|Progressive disease|19|||
131019995|NCT01236560|471702827|FG002|Overall Study|Progressive disease|9|||
131019996|NCT01236560|471702828|FG003|Overall Study|Progressive disease|16|||
131019997|NCT01236560|471702829|FG004|Overall Study|Progressive disease|0|||
131019998|NCT01236560|471702830|FG005|Overall Study|Progressive disease|0|||
131019999|NCT00468910|471702831|FG000|Overall Study|Lost to Follow-up|2|||
131020000|NCT00468910|471702832|FG001|Overall Study|Lost to Follow-up|1|||
130684638|NCT03555305|470472920|FG000|Period 1|Adverse Event|0|||
130767014|NCT00089635|470770685|FG000|Overall Study|Lost to Follow-up|3|||
130767015|NCT00089635|470770685|FG000|Overall Study|Withdrawal by Subject|6|||
130767016|NCT00089635|470770685|FG000|Overall Study|Ineligibility determined|1|||
130767017|NCT00089635|470770685|FG000|Overall Study|Other|2|||
131020001|NCT00468910|471702831|FG000|Overall Study|Withdrawal by Subject|2|||
131020002|NCT00468910|471702832|FG001|Overall Study|Withdrawal by Subject|1|||
131020003|NCT00468910|471702831|FG000|Overall Study|Medical Contraindication|0|||
131020004|NCT00468910|471702832|FG001|Overall Study|Medical Contraindication|1|||
131020005|NCT01576484|471702833|FG000|Overall Study|Adverse Event|1|||
131020006|NCT01576484|471702834|FG001|Overall Study|Adverse Event|1|||
131020007|NCT01576484|471702833|FG000|Overall Study|Protocol Violation|0|||
131020008|NCT01576484|471702834|FG001|Overall Study|Protocol Violation|2|||
131020009|NCT01576484|471702833|FG000|Overall Study|Sponsor Decision|2|||
131020010|NCT01576484|471702834|FG001|Overall Study|Sponsor Decision|8|||
130684639|NCT03555305|470472921|FG001|Period 1|Adverse Event|1|||
130684640|NCT03586726|470472929|FG000|Overall Study|Withdrawal by Subject|1|||
130684641|NCT03420300|470472932|FG000|Overall Study|Death|2|||
130684642|NCT03500692|470472947|FG000|Overall Study|Death|163|||
130684643|NCT03500692|470472947|FG000|Overall Study|Lost to Follow-up|75|||
130684644|NCT03500692|470472947|FG000|Overall Study|Termination Reasons|3|||
130684645|NCT06358820|470474310|FG000|Overall Study|Adverse Event|11|||
130684646|NCT06358820|470474310|FG000|Overall Study|kidney transplantation|3|||
130684647|NCT06358820|470474310|FG000|Overall Study|patient voluntary withdrawal|6|||
130684648|NCT06358820|470474310|FG000|Overall Study|Physician Decision|1|||
130684649|NCT01066143|470474311|FG000|Overall Study|ineligible for the study|8|||
130684650|NCT05376319|470474312|FG000|Overall Study|Funding termination|2|||
130684651|NCT05376319|470474313|FG001|Overall Study|Funding termination|4|||
130684652|NCT01124175|470474314|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130684653|NCT01124175|470474315|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
130684654|NCT00942968|470474318|FG000|Overall Study|Adverse Event|60|||
130684655|NCT00942968|470474318|FG000|Overall Study|Death|76|||
130684656|NCT00942968|470474318|FG000|Overall Study|Protocol Violation|9|||
130684657|NCT00942968|470474318|FG000|Overall Study|Lost to Follow-up|4|||
130684658|NCT00942968|470474318|FG000|Overall Study|Withdrawal by Subject|44|||
130684659|NCT00942968|470474318|FG000|Overall Study|Sponsor request|5|||
130684660|NCT00942968|470474318|FG000|Overall Study|Physician Decision|11|||
130684661|NCT00942968|470474318|FG000|Overall Study|Progression of disease|12|||
130684662|NCT00942968|470474318|FG000|Overall Study|Inferior vena cava filter placement|4|||
130684663|NCT00942968|470474318|FG000|Overall Study|Pulmonary embolism (PE)|1|||
130684664|NCT00942968|470474318|FG000|Overall Study|Participant required pancreatic biopsy|1|||
130684665|NCT00942968|470474318|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
130684666|NCT00218257|470474324|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
130684667|NCT00218257|470474325|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
130684668|NCT01466166|470474326|FG000|Overall Study|Death|1|||
130684669|NCT01466166|470474326|FG000|Overall Study|Lost to Follow-up|7|||
130684670|NCT01466166|470474326|FG000|Overall Study|Infusion Reaction (IR)|27|||
130684671|NCT01466166|470474326|FG000|Overall Study|Adverse Event (Other than IR)|11|||
130684672|NCT01466166|470474326|FG000|Overall Study|Elevated Serum Uric Acid|78|||
130684673|NCT01466166|470474326|FG000|Overall Study|Withdrawal by Subject|13|||
130684674|NCT01466166|470474326|FG000|Overall Study|Sponsor Decision|4|||
130684675|NCT01466166|470474326|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
131020011|NCT01576484|471702833|FG000|Overall Study|Withdrawal by Subject|0|||
131020012|NCT01576484|471702834|FG001|Overall Study|Withdrawal by Subject|3|||
130684676|NCT01466166|470474326|FG000|Overall Study|Other|20|||
130684677|NCT01340495|470474333|FG000|Overall Study|Withdrawal by Subject|1|||
130684678|NCT00070291|470474334|FG000|Step 1|Withdrawal by Subject|1|||
131020013|NCT01576484|471702833|FG000|Overall Study|Other|2|||
131020014|NCT01576484|471702834|FG001|Overall Study|Other|5|||
131020015|NCT01943799|471702838|FG000|Overall Study|Lost to Follow-up|0|||
131020016|NCT01943799|471702839|FG001|Overall Study|Lost to Follow-up|1|||
131020017|NCT01943799|471702840|FG002|Overall Study|Lost to Follow-up|1|||
131020018|NCT01943799|471702841|FG003|Overall Study|Lost to Follow-up|0|||
131020019|NCT01943799|471702838|FG000|Overall Study|Protocol Violation|1|||
131020020|NCT01943799|471702839|FG001|Overall Study|Protocol Violation|0|||
131020021|NCT01943799|471702840|FG002|Overall Study|Protocol Violation|0|||
131020022|NCT01943799|471702841|FG003|Overall Study|Protocol Violation|0|||
131020023|NCT01943799|471702838|FG000|Overall Study|Withdrawal by Subject|4|||
131020024|NCT01943799|471702839|FG001|Overall Study|Withdrawal by Subject|2|||
131020025|NCT01943799|471702840|FG002|Overall Study|Withdrawal by Subject|1|||
131020026|NCT01943799|471702841|FG003|Overall Study|Withdrawal by Subject|0|||
131020027|NCT00958633|471702844|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
131020028|NCT00958633|471702845|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
131020029|NCT00958633|471702846|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
131020030|NCT00958633|471702844|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
131020031|NCT00958633|471702845|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
131020032|NCT00958633|471702846|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
130684679|NCT00070291|470474334|FG000|Step 1|Adverse Event|1|||
130684680|NCT00070291|470474334|FG000|Step 2|Adverse Event|1|||
130684681|NCT02028715|470474337|FG000|Overall Study|Adverse Event|2|||
130684682|NCT02028715|470474338|FG001|Overall Study|Adverse Event|2|||
130684683|NCT02028715|470474337|FG000|Overall Study|Physician Decision|1|||
130684684|NCT02028715|470474338|FG001|Overall Study|Physician Decision|0|||
131020033|NCT00958633|471702844|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
131020034|NCT00958633|471702845|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
131020035|NCT00958633|471702846|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
131020036|NCT00958633|471702844|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
130684685|NCT02028715|470474337|FG000|Overall Study|Did not complete satisfaction surveys|2|||
130684686|NCT02028715|470474338|FG001|Overall Study|Did not complete satisfaction surveys|2|||
130684687|NCT00520130|470474341|FG000|Overall Study|Disease progression on study|4|||
130684688|NCT00520130|470474342|FG001|Overall Study|Disease progression on study|0|||
130684689|NCT00520130|470474341|FG000|Overall Study|Physician Decision|1|||
130684690|NCT00520130|470474342|FG001|Overall Study|Physician Decision|1|||
130684691|NCT04915755|470474343|FG000|Overall Study|Physician Decision|3|||
130684692|NCT04915755|470474344|FG001|Overall Study|Physician Decision|2|||
131020037|NCT00958633|471702845|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
131020038|NCT00958633|471702846|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
131020039|NCT00958633|471702844|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
131020040|NCT00958633|471702845|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
131020041|NCT00958633|471702846|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
131020042|NCT00958633|471702844|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
131020043|NCT00958633|471702845|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
131020044|NCT00958633|471702846|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
131020045|NCT00958633|471702844|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
131020046|NCT00958633|471702845|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
131020047|NCT00958633|471702846|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
131020048|NCT00433199|471702848|FG000|Double-Blind Period|Adverse Event|0|||
131020049|NCT00433199|471702849|FG001|Double-Blind Period|Adverse Event|25|||
131020050|NCT00433199|471702848|FG000|Double-Blind Period|Lack of Efficacy|0|||
131020051|NCT00433199|471702849|FG001|Double-Blind Period|Lack of Efficacy|2|||
131020052|NCT00433199|471702848|FG000|Double-Blind Period|Lost to Follow-up|2|||
131020053|NCT00433199|471702849|FG001|Double-Blind Period|Lost to Follow-up|5|||
131020054|NCT00433199|471702848|FG000|Double-Blind Period|Withdrawal by Subject|8|||
131020055|NCT00433199|471702849|FG001|Double-Blind Period|Withdrawal by Subject|19|||
131020056|NCT00433199|471702848|FG000|Double-Blind Period|Protocol Violation|1|||
131020057|NCT00433199|471702849|FG001|Double-Blind Period|Protocol Violation|10|||
131020058|NCT00433199|471702848|FG000|Double-Blind Period|Administrative|1|||
131020059|NCT00433199|471702849|FG001|Double-Blind Period|Administrative|5|||
131020060|NCT00433199|471702848|FG000|Open-Label Period|Adverse Event|0|||
131020061|NCT00433199|471702849|FG001|Open-Label Period|Adverse Event|19|||
131020062|NCT00433199|471702848|FG000|Open-Label Period|Lack of Efficacy|0|||
131020063|NCT00433199|471702849|FG001|Open-Label Period|Lack of Efficacy|2|||
131020064|NCT00433199|471702848|FG000|Open-Label Period|Lost to Follow-up|0|||
131020065|NCT00433199|471702849|FG001|Open-Label Period|Lost to Follow-up|3|||
131020066|NCT00433199|471702848|FG000|Open-Label Period|Withdrawal by Subject|0|||
131020067|NCT00433199|471702849|FG001|Open-Label Period|Withdrawal by Subject|7|||
131020068|NCT00433199|471702848|FG000|Open-Label Period|Protocol Violation|0|||
131020069|NCT00433199|471702849|FG001|Open-Label Period|Protocol Violation|2|||
131020070|NCT00433199|471702848|FG000|Open-Label Period|Administrative|0|||
131020071|NCT00433199|471702849|FG001|Open-Label Period|Administrative|1|||
131020072|NCT04305405|471702852|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131020073|NCT04305405|471702853|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131020074|NCT03368664|471702859|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
131020075|NCT03368664|471702859|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
131020076|NCT03368664|471702859|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
131020077|NCT03368664|471702859|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
131020078|NCT00457691|471702861|FG000|Overall Study|Adverse Event|4|||
131020079|NCT00457691|471702862|FG001|Overall Study|Adverse Event|1|||
131020080|NCT00457691|471702861|FG000|Overall Study|Death|163|||
131020081|NCT00457691|471702862|FG001|Overall Study|Death|148|||
131020082|NCT00457691|471702861|FG000|Overall Study|Protocol Violation|1|||
131020083|NCT00457691|471702862|FG001|Overall Study|Protocol Violation|3|||
131020084|NCT00457691|471702861|FG000|Overall Study|Lost to Follow-up|23|||
131020085|NCT00457691|471702862|FG001|Overall Study|Lost to Follow-up|14|||
131020086|NCT00457691|471702861|FG000|Overall Study|Study terminated by Sponsor|1|||
131020087|NCT00457691|471702862|FG001|Overall Study|Study terminated by Sponsor|1|||
131020088|NCT00457691|471702861|FG000|Overall Study|Subject refused (reason other than AE)|14|||
131020089|NCT00457691|471702862|FG001|Overall Study|Subject refused (reason other than AE)|19|||
131020090|NCT00457691|471702861|FG000|Overall Study|Disease progression, study terminated|180|||
131020091|NCT00457691|471702862|FG001|Overall Study|Disease progression, study terminated|196|||
131020092|NCT01597258|471702863|FG000|Overall Study|No Drug Administration|1|||
131020093|NCT02079844|471702864|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
131020094|NCT02079844|471702865|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
131020095|NCT02079844|471702866|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
131020096|NCT02079844|471702864|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
131020097|NCT02079844|471702865|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
131020098|NCT02079844|471702866|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
131020099|NCT00925899|471705005|FG000|Part 1|Death|1|||
131020100|NCT00925899|471705006|FG001|Part 1|Death|2|||
131105928|NCT00440999|472018905|FG001|Overall Study|P. falciparum malaria|14|||
131105929|NCT00440999|472018904|FG000|Overall Study|Subj left hosp without inform staff|0|||
131105930|NCT00440999|472018905|FG001|Overall Study|Subj left hosp without inform staff|1|||
130684693|NCT04915755|470474343|FG000|Overall Study|Withdrawal by Subject|1|||
130684694|NCT04915755|470474344|FG001|Overall Study|Withdrawal by Subject|1|||
130684695|NCT04915755|470474343|FG000|Overall Study|Ongoing for PACT|3|||
130684696|NCT04915755|470474344|FG001|Overall Study|Ongoing for PACT|2|||
130684697|NCT04915755|470474343|FG000|Overall Study|Other|7|||
131105931|NCT04745026|472018906|FG000|Overall Study|Physician Decision|1|||
131105932|NCT04745026|472018907|FG001|Overall Study|Physician Decision|0|||
131105933|NCT04745026|472018906|FG000|Overall Study|Adverse Event|2|||
131105934|NCT04745026|472018907|FG001|Overall Study|Adverse Event|2|||
131105935|NCT04745026|472018906|FG000|Overall Study|Protocol Violation|1|||
131105936|NCT04745026|472018907|FG001|Overall Study|Protocol Violation|3|||
131105937|NCT04745026|472018906|FG000|Overall Study|Lost to Follow-up|4|||
131105938|NCT04745026|472018907|FG001|Overall Study|Lost to Follow-up|3|||
131105939|NCT04745026|472018906|FG000|Overall Study|Withdrawal by Subject|5|||
131105940|NCT04745026|472018907|FG001|Overall Study|Withdrawal by Subject|5|||
131105941|NCT04426851|472018908|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
131105942|NCT04426851|472018909|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
131105943|NCT04426851|472018908|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
131105944|NCT04426851|472018909|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
131105945|NCT03256851|472018910|FG000|Overall Study|Withdrawal by Subject|1|||
131105946|NCT03256851|472018911|FG001|Overall Study|Withdrawal by Subject|0|||
131105947|NCT01778023|472018912|FG000|Overall Study|Withdrawal by Subject|0|||
131105948|NCT01778023|472018913|FG001|Overall Study|Withdrawal by Subject|3|||
131105949|NCT01990560|472018914|FG000|Overall Study|Withdrawal by Subject|1|||
131105950|NCT01098097|472018915|FG000|Overall Study|Adverse Event|17|||
131105951|NCT01098097|472018915|FG000|Overall Study|Lost to Follow-up|18|||
131105952|NCT01098097|472018915|FG000|Overall Study|Status unknown|16|||
131105953|NCT01098097|472018915|FG000|Overall Study|No reason reported|31|||
131105954|NCT00966277|472018918|FG000|Overall Study|Withdrawal by Subject|3|||
131105955|NCT00966277|472018919|FG001|Overall Study|Withdrawal by Subject|0|||
131105956|NCT00966277|472018918|FG000|Overall Study|Ineligible|1|||
131105957|NCT00966277|472018919|FG001|Overall Study|Ineligible|3|||
130684698|NCT04915755|470474344|FG001|Overall Study|Other|11|||
130684699|NCT02533258|470474345|FG000|Overall Study|Adverse Event|1|||
130684700|NCT02533258|470474345|FG000|Overall Study|Death|2|||
130684701|NCT02533258|470474345|FG000|Overall Study|Other|1|||
130684702|NCT02533258|470474345|FG000|Overall Study|Economic factor|1|||
130684703|NCT02533258|470474345|FG000|Overall Study|Progression of pleural effusion|1|||
130684704|NCT02533258|470474345|FG000|Overall Study|Lack of Efficacy|2|||
130684705|NCT02495857|470474347|FG000|Overall Study|Adverse Event|5|||
130684706|NCT02495857|470474348|FG001|Overall Study|Adverse Event|0|||
130684707|NCT02495857|470474349|FG002|Overall Study|Adverse Event|1|||
130684708|NCT02495857|470474347|FG000|Overall Study|Withdrawal by Subject|9|||
130684709|NCT02495857|470474348|FG001|Overall Study|Withdrawal by Subject|6|||
131105958|NCT00966277|472018918|FG000|Overall Study|Treatment Plan Changed|0|||
131105959|NCT00966277|472018919|FG001|Overall Study|Treatment Plan Changed|1|||
131105960|NCT01488487|472018920|FG000|Overall Study|Adverse Event|6|||
131105961|NCT01488487|472018920|FG000|Overall Study|Death|1|||
131105962|NCT01488487|472018920|FG000|Overall Study|Withdrawal by Subject|2|||
131105963|NCT01959516|472018921|FG000|Epoch 1|Adverse Event|4|||
131105964|NCT01959516|472018922|FG001|Epoch 1|Adverse Event|1|||
131105965|NCT01959516|472018921|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
131105966|NCT01959516|472018922|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
131105967|NCT01959516|472018921|FG000|Epoch 1|Subject withdrew consent|3|||
130684710|NCT02495857|470474349|FG002|Overall Study|Withdrawal by Subject|10|||
130684711|NCT02495857|470474347|FG000|Overall Study|Physician Decision|0|||
130684712|NCT02495857|470474348|FG001|Overall Study|Physician Decision|1|||
130684713|NCT02495857|470474349|FG002|Overall Study|Physician Decision|0|||
130684714|NCT02495857|470474347|FG000|Overall Study|Protocol Violation|1|||
130684715|NCT02495857|470474348|FG001|Overall Study|Protocol Violation|1|||
130767018|NCT02943785|470770686|FG000|Overall Study|Adverse Event|112|||
131105968|NCT01959516|472018922|FG001|Epoch 1|Subject withdrew consent|2|||
131105969|NCT01959516|472018921|FG000|Epoch 1|Administrative problems|1|||
131105970|NCT01959516|472018922|FG001|Epoch 1|Administrative problems|0|||
130684716|NCT02495857|470474349|FG002|Overall Study|Protocol Violation|2|||
130684717|NCT02495857|470474347|FG000|Overall Study|Lost to Follow-up|4|||
130767019|NCT02943785|470770687|FG001|Overall Study|Adverse Event|97|||
131105971|NCT01959516|472018921|FG000|Epoch 1|Use of prohibited treatment|1|||
131105972|NCT01959516|472018922|FG001|Epoch 1|Use of prohibited treatment|0|||
131105973|NCT01959516|472018921|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
131105974|NCT01959516|472018922|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
131105975|NCT01959516|472018921|FG000|Epoch 1|Protocol deviation|0|||
131105976|NCT01959516|472018922|FG001|Epoch 1|Protocol deviation|1|||
131105977|NCT01959516|472018921|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
131105978|NCT01959516|472018922|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
130684718|NCT02495857|470474348|FG001|Overall Study|Lost to Follow-up|5|||
131105979|NCT01959516|472018921|FG000|Epoch 2|Subject withdrew consent|1|||
131105980|NCT01959516|472018922|FG001|Epoch 2|Subject withdrew consent|0|||
131105981|NCT01959516|472018921|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
131105982|NCT01959516|472018922|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
131105983|NCT02004353|472018929|FG000|Overall Study|Voluntary participation|1334|||
131105984|NCT02581631|472018930|FG000|Overall Study|Disease progression|29|||
131105985|NCT02581631|472018931|FG001|Overall Study|Disease progression|19|||
131105986|NCT02581631|472018932|FG002|Overall Study|Disease progression|13|||
131105987|NCT02581631|472018933|FG003|Overall Study|Disease progression|5|||
131105988|NCT02581631|472018934|FG004|Overall Study|Disease progression|8|||
131105989|NCT02581631|472018930|FG000|Overall Study|Study drug toxicity|4|||
131105990|NCT02581631|472018931|FG001|Overall Study|Study drug toxicity|6|||
131105991|NCT02581631|472018932|FG002|Overall Study|Study drug toxicity|7|||
131105992|NCT02581631|472018933|FG003|Overall Study|Study drug toxicity|0|||
131105993|NCT02581631|472018934|FG004|Overall Study|Study drug toxicity|3|||
131105994|NCT02581631|472018930|FG000|Overall Study|AE unrelated to study drug|3|||
131105995|NCT02581631|472018931|FG001|Overall Study|AE unrelated to study drug|1|||
131105996|NCT02581631|472018932|FG002|Overall Study|AE unrelated to study drug|1|||
131105997|NCT02581631|472018933|FG003|Overall Study|AE unrelated to study drug|0|||
131105998|NCT02581631|472018934|FG004|Overall Study|AE unrelated to study drug|2|||
131105999|NCT02581631|472018930|FG000|Overall Study|Request to discontinue|1|||
130684719|NCT02495857|470474349|FG002|Overall Study|Lost to Follow-up|3|||
130684720|NCT02495857|470474347|FG000|Overall Study|Other|3|||
130684721|NCT02495857|470474348|FG001|Overall Study|Other|3|||
131106000|NCT02581631|472018931|FG001|Overall Study|Request to discontinue|0|||
131106001|NCT02581631|472018932|FG002|Overall Study|Request to discontinue|3|||
131106002|NCT02581631|472018933|FG003|Overall Study|Request to discontinue|0|||
131106003|NCT02581631|472018934|FG004|Overall Study|Request to discontinue|1|||
131106004|NCT02581631|472018930|FG000|Overall Study|participant withdrew consent|3|||
131106005|NCT02581631|472018931|FG001|Overall Study|participant withdrew consent|0|||
131106006|NCT02581631|472018932|FG002|Overall Study|participant withdrew consent|1|||
131106007|NCT02581631|472018933|FG003|Overall Study|participant withdrew consent|0|||
131106008|NCT02581631|472018934|FG004|Overall Study|participant withdrew consent|0|||
131106009|NCT02581631|472018930|FG000|Overall Study|Maximum clinical benefit|1|||
131106010|NCT02581631|472018931|FG001|Overall Study|Maximum clinical benefit|7|||
131106011|NCT02581631|472018932|FG002|Overall Study|Maximum clinical benefit|1|||
131106012|NCT02581631|472018933|FG003|Overall Study|Maximum clinical benefit|3|||
131106013|NCT02581631|472018934|FG004|Overall Study|Maximum clinical benefit|13|||
131106014|NCT02581631|472018930|FG000|Overall Study|Other Reasons|1|||
131106015|NCT02581631|472018931|FG001|Overall Study|Other Reasons|0|||
131106016|NCT02581631|472018932|FG002|Overall Study|Other Reasons|2|||
131106017|NCT02581631|472018933|FG003|Overall Study|Other Reasons|2|||
131106018|NCT02581631|472018934|FG004|Overall Study|Other Reasons|3|||
131106019|NCT02581631|472018930|FG000|Overall Study|Poor/Non-Compliance|0|||
131106020|NCT02581631|472018931|FG001|Overall Study|Poor/Non-Compliance|0|||
131106021|NCT02581631|472018932|FG002|Overall Study|Poor/Non-Compliance|1|||
131106022|NCT02581631|472018933|FG003|Overall Study|Poor/Non-Compliance|0|||
131106023|NCT02581631|472018934|FG004|Overall Study|Poor/Non-Compliance|0|||
131106024|NCT00819390|472018935|FG000|Overall Study|Lost to Follow-up|1|||
131106025|NCT00819390|472018936|FG001|Overall Study|Lost to Follow-up|1|||
131106026|NCT00819390|472018937|FG002|Overall Study|Lost to Follow-up|0|||
131106027|NCT00819390|472018938|FG003|Overall Study|Lost to Follow-up|0|||
131106028|NCT00819390|472018935|FG000|Overall Study|Withdrawal by Subject|2|||
131106029|NCT00819390|472018936|FG001|Overall Study|Withdrawal by Subject|0|||
131106030|NCT00819390|472018937|FG002|Overall Study|Withdrawal by Subject|0|||
131106031|NCT00819390|472018938|FG003|Overall Study|Withdrawal by Subject|0|||
131106032|NCT00819390|472018935|FG000|Overall Study|Adverse Event|0|||
131106033|NCT00819390|472018936|FG001|Overall Study|Adverse Event|0|||
131106034|NCT00819390|472018937|FG002|Overall Study|Adverse Event|1|||
131106035|NCT00819390|472018938|FG003|Overall Study|Adverse Event|0|||
131106036|NCT01815138|472018945|FG000|Overall Study|Withdrawal by Subject|0|||
131106037|NCT01815138|472018946|FG001|Overall Study|Withdrawal by Subject|1|||
131106038|NCT01815138|472018945|FG000|Overall Study|Physician Decision|8|||
131106039|NCT01815138|472018946|FG001|Overall Study|Physician Decision|5|||
131106040|NCT01211288|472018948|FG000|Overall Study|Lost to Follow-up|1|||
131106041|NCT01211288|472018949|FG001|Overall Study|Lost to Follow-up|1|||
131106042|NCT01270971|472018950|FG000|Overall Study|Withdrawal by Subject|24|||
131106043|NCT01270971|472018951|FG001|Overall Study|Withdrawal by Subject|11|||
131106044|NCT01270971|472018950|FG000|Overall Study|Lost to Follow-up|18|||
131106045|NCT01270971|472018951|FG001|Overall Study|Lost to Follow-up|5|||
131106046|NCT01270971|472018950|FG000|Overall Study|Adverse Event|1|||
131106047|NCT01270971|472018951|FG001|Overall Study|Adverse Event|2|||
130684722|NCT02495857|470474349|FG002|Overall Study|Other|2|||
130684723|NCT00396279|470474350|FG000|Overall Study|Ongoing in study|26|||
131106048|NCT01270971|472018950|FG000|Overall Study|Non compliance|2|||
131106049|NCT01270971|472018951|FG001|Overall Study|Non compliance|2|||
131106050|NCT01270971|472018950|FG000|Overall Study|Non-specific|7|||
131106051|NCT01270971|472018951|FG001|Overall Study|Non-specific|3|||
131106052|NCT01588496|472018955|FG000|Overall Study|Withdrawal by Subject|0|||
131106053|NCT01588496|472018956|FG001|Overall Study|Withdrawal by Subject|1|||
131106054|NCT01588496|472018957|FG002|Overall Study|Withdrawal by Subject|0|||
131106055|NCT00705523|472018958|FG000|Overall Study|Lost to Follow-up|2|||
131106056|NCT00705523|472018959|FG001|Overall Study|Lost to Follow-up|3|||
131106057|NCT01013285|472018961|FG000|Overall Study|Death|48|||
131106058|NCT01013285|472018962|FG001|Overall Study|Death|89|||
131106059|NCT02112708|472018965|FG000|Baseline|Physician Decision|16|||
131106060|NCT02112708|472018966|FG001|Baseline|Physician Decision|11|||
131106061|NCT02112708|472018965|FG000|Baseline|Lost to Follow-up|12|||
131106062|NCT02112708|472018966|FG001|Baseline|Lost to Follow-up|0|||
130684724|NCT00396279|470474350|FG000|Overall Study|Disease progression|2|||
130684725|NCT00396279|470474350|FG000|Overall Study|Withdrawal by Subject|1|||
130684726|NCT00396279|470474350|FG000|Overall Study|Physician Decision|1|||
130684727|NCT02883452|470474351|FG000|Overall Study|Withdrawal by Subject|1|||
130684728|NCT02883452|470474352|FG001|Overall Study|Withdrawal by Subject|1|||
130684729|NCT02883452|470474353|FG002|Overall Study|Withdrawal by Subject|3|||
131106063|NCT02112708|472018965|FG000|4 Month|Death|0|||
131106064|NCT02112708|472018966|FG001|4 Month|Death|1|||
131106065|NCT02112708|472018965|FG000|4 Month|Withdrawal by Subject|12|||
131106066|NCT02112708|472018966|FG001|4 Month|Withdrawal by Subject|0|||
131106067|NCT01242800|472018967|FG000|Overall Study|Patient refusal|0|||
131106068|NCT01242800|472018968|FG001|Overall Study|Patient refusal|10|||
130684730|NCT02883452|470474354|FG003|Overall Study|Withdrawal by Subject|0|||
130684731|NCT02883452|470474355|FG004|Overall Study|Withdrawal by Subject|2|||
130684732|NCT02883452|470474356|FG005|Overall Study|Withdrawal by Subject|5|||
130684733|NCT02883452|470474351|FG000|Overall Study|Disease progression|1|||
130684734|NCT02883452|470474352|FG001|Overall Study|Disease progression|0|||
130684735|NCT02883452|470474353|FG002|Overall Study|Disease progression|0|||
131020101|NCT00925899|471705005|FG000|Part 1|Withdrawal by Subject|10|||
131020102|NCT00925899|471705006|FG001|Part 1|Withdrawal by Subject|9|||
131020103|NCT01875848|471705007|FG000|Overall Study|Withdrawal by Subject|2|||
131020104|NCT01875848|471705008|FG001|Overall Study|Withdrawal by Subject|0|||
131020105|NCT02189252|471705009|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
131020106|NCT02189252|471705010|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
131020107|NCT02189252|471705011|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
131020108|NCT02189252|471705012|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
131020109|NCT02189252|471705009|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
131020110|NCT02189252|471705010|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
131020111|NCT02189252|471705011|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
131020112|NCT02189252|471705012|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
131020113|NCT00840177|471705013|FG000|Overall Study|Adverse Event|5|||
131020114|NCT00840177|471705014|FG001|Overall Study|Adverse Event|1|||
131020115|NCT00840177|471705015|FG002|Overall Study|Adverse Event|1|||
131020116|NCT00840177|471705013|FG000|Overall Study|Refusal unrelated to adverse events|1|||
131020117|NCT00840177|471705014|FG001|Overall Study|Refusal unrelated to adverse events|0|||
131020118|NCT00840177|471705015|FG002|Overall Study|Refusal unrelated to adverse events|1|||
131020119|NCT00840177|471705013|FG000|Overall Study|Progression/relapse|2|||
131020120|NCT00840177|471705014|FG001|Overall Study|Progression/relapse|0|||
131020121|NCT00840177|471705015|FG002|Overall Study|Progression/relapse|0|||
131020122|NCT00840177|471705013|FG000|Overall Study|Death|4|||
131020123|NCT00840177|471705014|FG001|Overall Study|Death|5|||
131020124|NCT00840177|471705015|FG002|Overall Study|Death|5|||
131020125|NCT00840177|471705013|FG000|Overall Study|not protocol specified|6|||
131020126|NCT00840177|471705014|FG001|Overall Study|not protocol specified|3|||
131020127|NCT00840177|471705015|FG002|Overall Study|not protocol specified|0|||
131020128|NCT00840177|471705013|FG000|Overall Study|Ineligible|0|||
131020129|NCT00840177|471705014|FG001|Overall Study|Ineligible|0|||
131020130|NCT00840177|471705015|FG002|Overall Study|Ineligible|3|||
131020131|NCT00840177|471705013|FG000|Overall Study|Did not start treatment|0|||
131020132|NCT00840177|471705014|FG001|Overall Study|Did not start treatment|0|||
131020133|NCT00840177|471705015|FG002|Overall Study|Did not start treatment|1|||
131020134|NCT01391832|471705016|FG000|Overall Study|Withdrawal by Subject|21|||
131020135|NCT01391832|471705017|FG001|Overall Study|Withdrawal by Subject|22|||
131020136|NCT01391832|471705016|FG000|Overall Study|Lost to Follow-up|0|||
131020137|NCT01391832|471705017|FG001|Overall Study|Lost to Follow-up|1|||
131020138|NCT03345901|471705023|FG000|Overall Study|The study was terminated|18|||
131020139|NCT00566735|471705024|FG000|Overall Study|Withdrawal by Subject|0|||
131106069|NCT01242800|472018967|FG000|Overall Study|Physician Decision|0|||
131106070|NCT01242800|472018968|FG001|Overall Study|Physician Decision|1|||
130684736|NCT02883452|470474354|FG003|Overall Study|Disease progression|1|||
130684737|NCT02883452|470474355|FG004|Overall Study|Disease progression|4|||
131020140|NCT00566735|471705025|FG001|Overall Study|Withdrawal by Subject|1|||
131020141|NCT00566735|471705024|FG000|Overall Study|Refused neuropsychological testing|2|||
131020142|NCT00566735|471705025|FG001|Overall Study|Refused neuropsychological testing|5|||
131020143|NCT00566735|471705024|FG000|Overall Study|Switched into a manic episode|0|||
131106071|NCT01242800|472018967|FG000|Overall Study|Disease progression|0|||
130684738|NCT02883452|470474356|FG005|Overall Study|Disease progression|5|||
130684739|NCT02883452|470474351|FG000|Overall Study|Adverse Event|2|||
130684740|NCT02883452|470474352|FG001|Overall Study|Adverse Event|1|||
130684741|NCT02883452|470474353|FG002|Overall Study|Adverse Event|1|||
130684742|NCT02883452|470474354|FG003|Overall Study|Adverse Event|1|||
130684743|NCT02883452|470474355|FG004|Overall Study|Adverse Event|1|||
130684744|NCT02883452|470474356|FG005|Overall Study|Adverse Event|3|||
130684745|NCT02883452|470474351|FG000|Overall Study|Physician Decision|0|||
131020144|NCT00566735|471705025|FG001|Overall Study|Switched into a manic episode|1|||
131020145|NCT00722046|471705026|FG000|Overall Study|Adverse Event|0|||
131020146|NCT00722046|471705027|FG001|Overall Study|Adverse Event|1|||
131020147|NCT00722046|471705028|FG002|Overall Study|Adverse Event|2|||
131020148|NCT00722046|471705029|FG003|Overall Study|Adverse Event|1|||
131020149|NCT00722046|471705030|FG004|Overall Study|Adverse Event|2|||
131020150|NCT00722046|471705031|FG005|Overall Study|Adverse Event|1|||
131020151|NCT00722046|471705032|FG006|Overall Study|Adverse Event|0|||
131020152|NCT00722046|471705026|FG000|Overall Study|Death|0|||
131020153|NCT00722046|471705027|FG001|Overall Study|Death|1|||
131020154|NCT00722046|471705028|FG002|Overall Study|Death|0|||
131020155|NCT00722046|471705029|FG003|Overall Study|Death|0|||
131020156|NCT00722046|471705030|FG004|Overall Study|Death|0|||
131020157|NCT00722046|471705031|FG005|Overall Study|Death|0|||
131020158|NCT00722046|471705032|FG006|Overall Study|Death|2|||
131020159|NCT00722046|471705026|FG000|Overall Study|Protocol Violation|1|||
131020160|NCT00722046|471705027|FG001|Overall Study|Protocol Violation|0|||
131020161|NCT00722046|471705028|FG002|Overall Study|Protocol Violation|0|||
131020162|NCT00722046|471705029|FG003|Overall Study|Protocol Violation|0|||
131020163|NCT00722046|471705030|FG004|Overall Study|Protocol Violation|0|||
131020164|NCT00722046|471705031|FG005|Overall Study|Protocol Violation|1|||
131020165|NCT00722046|471705032|FG006|Overall Study|Protocol Violation|0|||
131020166|NCT00722046|471705026|FG000|Overall Study|Withdrawal by Subject|3|||
131020167|NCT00722046|471705027|FG001|Overall Study|Withdrawal by Subject|3|||
131020168|NCT00722046|471705028|FG002|Overall Study|Withdrawal by Subject|4|||
130767020|NCT02943785|470770686|FG000|Overall Study|Withdrawal by Subject|63|||
130767021|NCT02943785|470770687|FG001|Overall Study|Withdrawal by Subject|126|||
130767022|NCT02943785|470770686|FG000|Overall Study|Physician Decision|23|||
130767023|NCT02943785|470770687|FG001|Overall Study|Physician Decision|47|||
130767024|NCT02943785|470770686|FG000|Overall Study|Death|46|||
130767025|NCT02943785|470770687|FG001|Overall Study|Death|46|||
130767026|NCT02943785|470770686|FG000|Overall Study|Lost to Follow-up|1|||
130767027|NCT02943785|470770687|FG001|Overall Study|Lost to Follow-up|0|||
130767028|NCT02943785|470770686|FG000|Overall Study|Other|16|||
130767029|NCT02943785|470770687|FG001|Overall Study|Other|19|||
130767030|NCT02943785|470770686|FG000|Overall Study|Did not receive any study medication|21|||
130767031|NCT02943785|470770687|FG001|Overall Study|Did not receive any study medication|28|||
130767032|NCT00821015|470770689|FG000|Overall Study|Lost to Follow-up|12|||
130767033|NCT01281956|470770692|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
130767034|NCT01281956|470770693|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
130767035|NCT03170609|470770694|FG000|Overall Study|Death|0|||
130767036|NCT03170609|470770695|FG001|Overall Study|Death|0|||
130767037|NCT03170609|470770696|FG002|Overall Study|Death|1|||
130767038|NCT03170609|470770697|FG003|Overall Study|Death|0|||
130767039|NCT03170609|470770698|FG004|Overall Study|Death|0|||
130767040|NCT03170609|470770699|FG005|Overall Study|Death|0|||
130767041|NCT03170609|470770700|FG006|Overall Study|Death|0|||
130767042|NCT03170609|470770694|FG000|Overall Study|Withdrawal by Subject|1|||
130767043|NCT03170609|470770695|FG001|Overall Study|Withdrawal by Subject|2|||
130767044|NCT03170609|470770696|FG002|Overall Study|Withdrawal by Subject|0|||
130767045|NCT03170609|470770697|FG003|Overall Study|Withdrawal by Subject|0|||
130767046|NCT03170609|470770698|FG004|Overall Study|Withdrawal by Subject|0|||
130767047|NCT03170609|470770699|FG005|Overall Study|Withdrawal by Subject|0|||
130767048|NCT03170609|470770700|FG006|Overall Study|Withdrawal by Subject|1|||
131020169|NCT00722046|471705029|FG003|Overall Study|Withdrawal by Subject|4|||
131020170|NCT00722046|471705030|FG004|Overall Study|Withdrawal by Subject|4|||
131020171|NCT00722046|471705031|FG005|Overall Study|Withdrawal by Subject|7|||
131020172|NCT00722046|471705032|FG006|Overall Study|Withdrawal by Subject|3|||
130684746|NCT02883452|470474352|FG001|Overall Study|Physician Decision|0|||
130684747|NCT02883452|470474353|FG002|Overall Study|Physician Decision|0|||
131020173|NCT00722046|471705026|FG000|Overall Study|Randomized, but not treated|1|||
131020174|NCT00722046|471705027|FG001|Overall Study|Randomized, but not treated|1|||
131020175|NCT00722046|471705028|FG002|Overall Study|Randomized, but not treated|0|||
130684748|NCT02883452|470474354|FG003|Overall Study|Physician Decision|0|||
130684749|NCT02883452|470474355|FG004|Overall Study|Physician Decision|4|||
131020176|NCT00722046|471705029|FG003|Overall Study|Randomized, but not treated|2|||
131020177|NCT00722046|471705030|FG004|Overall Study|Randomized, but not treated|0|||
131020178|NCT00722046|471705031|FG005|Overall Study|Randomized, but not treated|0|||
131020179|NCT00722046|471705032|FG006|Overall Study|Randomized, but not treated|0|||
131020180|NCT00722046|471705026|FG000|Overall Study|Other|0|||
131020181|NCT00722046|471705027|FG001|Overall Study|Other|0|||
131020182|NCT00722046|471705028|FG002|Overall Study|Other|1|||
131020183|NCT00722046|471705029|FG003|Overall Study|Other|1|||
130684750|NCT02883452|470474356|FG005|Overall Study|Physician Decision|1|||
130684751|NCT02883452|470474351|FG000|Overall Study|Death|1|||
130684752|NCT02883452|470474352|FG001|Overall Study|Death|0|||
130684753|NCT02883452|470474353|FG002|Overall Study|Death|1|||
130684754|NCT02883452|470474354|FG003|Overall Study|Death|0|||
130684755|NCT02883452|470474355|FG004|Overall Study|Death|0|||
130684756|NCT02883452|470474356|FG005|Overall Study|Death|0|||
130684757|NCT02883452|470474351|FG000|Overall Study|Other|0|||
130684758|NCT02883452|470474352|FG001|Overall Study|Other|0|||
130684759|NCT02883452|470474353|FG002|Overall Study|Other|0|||
130684760|NCT02883452|470474354|FG003|Overall Study|Other|0|||
130684761|NCT02883452|470474355|FG004|Overall Study|Other|0|||
130684762|NCT02883452|470474356|FG005|Overall Study|Other|1|||
130684763|NCT00830206|470474357|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
130684764|NCT00830206|470474358|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
130684765|NCT04605094|470474360|FG000|Overall Study|Adverse Event|2|||
130684766|NCT04605094|470474361|FG001|Overall Study|Adverse Event|2|||
130684767|NCT04605094|470474360|FG000|Overall Study|Lost to Follow-up|1|||
130684768|NCT04605094|470474361|FG001|Overall Study|Lost to Follow-up|4|||
130684769|NCT04605094|470474360|FG000|Overall Study|Physician Decision|2|||
130684770|NCT04605094|470474361|FG001|Overall Study|Physician Decision|2|||
130684771|NCT04605094|470474360|FG000|Overall Study|Study terminated by Sponsor|31|||
130684772|NCT04605094|470474361|FG001|Overall Study|Study terminated by Sponsor|33|||
130684773|NCT04605094|470474360|FG000|Overall Study|Withdrawal by Subject|22|||
130684774|NCT04605094|470474361|FG001|Overall Study|Withdrawal by Subject|19|||
130684775|NCT04605094|470474360|FG000|Overall Study|Other|1|||
130684776|NCT04605094|470474361|FG001|Overall Study|Other|1|||
130684777|NCT01900691|470474362|FG000|Overall Study|Death|7|||
130684778|NCT01900691|470474362|FG000|Overall Study|Lost to Follow-up|4|||
130684779|NCT01900691|470474362|FG000|Overall Study|Study Device Not Placed|3|||
130684780|NCT01900691|470474362|FG000|Overall Study|Non study stent placed|2|||
130684781|NCT01900691|470474362|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
130684782|NCT01900691|470474362|FG000|Overall Study|Complete stent migration through digestive tract|1|||
130684783|NCT02724462|470474363|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
130684784|NCT02724462|470474364|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
130684785|NCT02724462|470474363|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
130684786|NCT02724462|470474364|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
130684787|NCT02724462|470474363|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
130684788|NCT02724462|470474364|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
130684789|NCT02724462|470474363|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
130684790|NCT02724462|470474364|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
131020184|NCT00722046|471705030|FG004|Overall Study|Other|3|||
131020185|NCT00722046|471705031|FG005|Overall Study|Other|2|||
131020186|NCT00722046|471705032|FG006|Overall Study|Other|1|||
131020187|NCT00925587|471705034|FG000|Overall Study|Protocol Specified Criteria|6|||
130684791|NCT02724462|470474363|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
130684792|NCT02724462|470474364|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
130684793|NCT02724462|470474363|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
130684794|NCT02724462|470474364|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
130684795|NCT01954394|470474367|FG000|Overall Study|Enrolled but not treated|1|||
130684796|NCT01954394|470474368|FG001|Overall Study|Enrolled but not treated|0|||
130684797|NCT01954394|470474367|FG000|Overall Study|Adverse Event|10|||
130684798|NCT01954394|470474368|FG001|Overall Study|Adverse Event|23|||
130684799|NCT01954394|470474367|FG000|Overall Study|Poor compliance to protocol|7|||
131020188|NCT00925587|471705035|FG001|Overall Study|Protocol Specified Criteria|6|||
131020189|NCT00925587|471705034|FG000|Overall Study|Physician Decision|4|||
131020190|NCT00925587|471705035|FG001|Overall Study|Physician Decision|1|||
131020191|NCT00925587|471705034|FG000|Overall Study|Protocol Violation|6|||
131020192|NCT00925587|471705035|FG001|Overall Study|Protocol Violation|4|||
131020193|NCT00925587|471705034|FG000|Overall Study|Withdrawal by Subject|9|||
131020194|NCT00925587|471705035|FG001|Overall Study|Withdrawal by Subject|6|||
130684800|NCT01954394|470474368|FG001|Overall Study|Poor compliance to protocol|7|||
130684801|NCT01954394|470474367|FG000|Overall Study|Participant Moved|0|||
130684802|NCT01954394|470474368|FG001|Overall Study|Participant Moved|4|||
130684803|NCT01954394|470474367|FG000|Overall Study|Related to Study Drug administration|2|||
130684804|NCT01954394|470474368|FG001|Overall Study|Related to Study Drug administration|2|||
130767049|NCT03170609|470770694|FG000|Overall Study|Lost to Follow-up|1|||
130767050|NCT03170609|470770695|FG001|Overall Study|Lost to Follow-up|0|||
131020195|NCT00925587|471705034|FG000|Overall Study|Death|5|||
131020196|NCT00925587|471705035|FG001|Overall Study|Death|5|||
131020197|NCT00925587|471705034|FG000|Overall Study|Adverse Event|6|||
130684805|NCT01954394|470474367|FG000|Overall Study|Other than specified above|10|||
131106072|NCT01242800|472018968|FG001|Overall Study|Disease progression|3|||
130684806|NCT01954394|470474368|FG001|Overall Study|Other than specified above|21|||
130684807|NCT02422264|470474378|FG000|Overall Study|Serious Adverse Event|1|||
130684808|NCT02422264|470474379|FG001|Overall Study|Serious Adverse Event|0|||
130767051|NCT03170609|470770696|FG002|Overall Study|Lost to Follow-up|5|||
131020198|NCT00925587|471705035|FG001|Overall Study|Adverse Event|2|||
130684809|NCT02422264|470474378|FG000|Overall Study|Withdrawal by Subject|1|||
130684810|NCT02422264|470474379|FG001|Overall Study|Withdrawal by Subject|2|||
130684811|NCT02422264|470474378|FG000|Overall Study|Migrated/moved from study area|3|||
131020199|NCT00925587|471705034|FG000|Overall Study|Lost to Follow-up|0|||
131020200|NCT00925587|471705035|FG001|Overall Study|Lost to Follow-up|1|||
131020201|NCT00686855|471705043|FG000|Overall Study|Lost to Follow-up|1|||
131020202|NCT00686855|471705044|FG001|Overall Study|Lost to Follow-up|0|||
131020203|NCT00686855|471705043|FG000|Overall Study|Progressive GVHD|0|||
131020204|NCT00686855|471705044|FG001|Overall Study|Progressive GVHD|1|||
131020205|NCT01460446|471705050|FG000|Overall Study|Non-compliance|2|||
131020206|NCT01460446|471705051|FG001|Overall Study|Non-compliance|9|||
131020207|NCT01460446|471705050|FG000|Overall Study|Consent Withdrawn|0|||
131020208|NCT01460446|471705051|FG001|Overall Study|Consent Withdrawn|4|||
131020209|NCT01460446|471705050|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
131020210|NCT01460446|471705051|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
131020211|NCT01460446|471705050|FG000|Overall Study|Surgery/Illness|1|||
131020212|NCT01460446|471705051|FG001|Overall Study|Surgery/Illness|1|||
131020213|NCT01460446|471705050|FG000|Overall Study|Pregnancy|1|||
131020214|NCT01460446|471705051|FG001|Overall Study|Pregnancy|0|||
131020215|NCT01460446|471705050|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
131020216|NCT01460446|471705051|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
131020217|NCT04218110|471705052|FG000|Overall Study|Withdrawal by Subject|0|||
131020218|NCT04218110|471705053|FG001|Overall Study|Withdrawal by Subject|0|||
131020219|NCT04218110|471705054|FG002|Overall Study|Withdrawal by Subject|0|||
131020220|NCT04218110|471705055|FG003|Overall Study|Withdrawal by Subject|1|||
131020221|NCT00799396|471705057|FG000|Clopidogrel Treatment|Adverse Event|6|||
131020222|NCT00799396|471705057|FG000|Clopidogrel Treatment|Physician Decision|5|||
131020223|NCT00799396|471705057|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
131020224|NCT00799396|471705057|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
131020225|NCT00799396|471705057|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
131020226|NCT01318382|471705058|FG000|Overall Study|Physician Decision|2|||
131020227|NCT01318382|471705058|FG000|Overall Study|Device Malfunction|10|||
131020228|NCT01318382|471705058|FG000|Overall Study|Protocol Violation|1|||
131020229|NCT01867216|471705059|FG000|Overall Study|Withdrawal by Subject|2|||
131020230|NCT01867216|471705060|FG001|Overall Study|Withdrawal by Subject|0|||
131020231|NCT01867216|471705061|FG002|Overall Study|Withdrawal by Subject|0|||
131020232|NCT01867216|471705062|FG003|Overall Study|Withdrawal by Subject|0|||
131020233|NCT01867216|471705063|FG004|Overall Study|Withdrawal by Subject|1|||
131020234|NCT01867216|471705064|FG005|Overall Study|Withdrawal by Subject|0|||
131020235|NCT01867216|471705065|FG006|Overall Study|Withdrawal by Subject|1|||
131020236|NCT01867216|471705059|FG000|Overall Study|Physician Decision|1|||
131020237|NCT01867216|471705060|FG001|Overall Study|Physician Decision|0|||
131020238|NCT01867216|471705061|FG002|Overall Study|Physician Decision|0|||
131020239|NCT01867216|471705062|FG003|Overall Study|Physician Decision|0|||
131020240|NCT01867216|471705063|FG004|Overall Study|Physician Decision|0|||
131020241|NCT01867216|471705064|FG005|Overall Study|Physician Decision|0|||
131020242|NCT01867216|471705065|FG006|Overall Study|Physician Decision|0|||
131020243|NCT01867216|471705059|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
131020244|NCT01867216|471705060|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131020245|NCT01867216|471705061|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131020246|NCT01867216|471705062|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131020247|NCT01867216|471705063|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131020248|NCT01867216|471705064|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131020249|NCT01867216|471705065|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
131020250|NCT00714714|471705068|FG000|Overall Study|Adverse Event|1|||
131020251|NCT01308567|471705077|FG000|Overall Study|Lost to Follow-up|2|||
131020252|NCT01308567|471705078|FG001|Overall Study|Lost to Follow-up|4|||
131020253|NCT01308567|471705079|FG002|Overall Study|Lost to Follow-up|4|||
131020254|NCT00542789|471705080|FG000|Overall Study|Adverse Event|18|||
131020255|NCT00542789|471705081|FG001|Overall Study|Adverse Event|17|||
131020256|NCT00542789|471705080|FG000|Overall Study|Withdrawal by Subject|7|||
131020257|NCT00542789|471705081|FG001|Overall Study|Withdrawal by Subject|3|||
131020258|NCT00542789|471705080|FG000|Overall Study|Protocol Violation|8|||
131020259|NCT00542789|471705081|FG001|Overall Study|Protocol Violation|1|||
131020260|NCT00542789|471705080|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
130684812|NCT02422264|470474379|FG001|Overall Study|Migrated/moved from study area|1|||
131020261|NCT00542789|471705081|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
131020262|NCT01040689|471705085|FG000|Overall Study|Adverse Event|0|||
131020263|NCT01040689|471705086|FG001|Overall Study|Adverse Event|0|||
131020264|NCT01040689|471705087|FG002|Overall Study|Adverse Event|2|||
131020265|NCT01040689|471705088|FG003|Overall Study|Adverse Event|4|||
131020266|NCT01040689|471705085|FG000|Overall Study|Lack of Efficacy|0|||
131020267|NCT01040689|471705086|FG001|Overall Study|Lack of Efficacy|0|||
131020268|NCT01040689|471705087|FG002|Overall Study|Lack of Efficacy|1|||
130684813|NCT02422264|470474378|FG000|Overall Study|Subject vaccinated outside of the study|0|||
130684814|NCT02422264|470474379|FG001|Overall Study|Subject vaccinated outside of the study|1|||
130684815|NCT00328926|470474380|FG000|Overall Study|Pregnancy|2|||
130684816|NCT00328926|470474381|FG001|Overall Study|Pregnancy|1|||
130684817|NCT00328926|470474382|FG002|Overall Study|Pregnancy|0|||
130684818|NCT00328926|470474380|FG000|Overall Study|Lost to Follow-up|0|||
130684819|NCT00328926|470474381|FG001|Overall Study|Lost to Follow-up|1|||
130684820|NCT00328926|470474382|FG002|Overall Study|Lost to Follow-up|0|||
130684821|NCT00328926|470474380|FG000|Overall Study|Death|0|||
130684822|NCT00328926|470474381|FG001|Overall Study|Death|0|||
130684823|NCT00328926|470474382|FG002|Overall Study|Death|1|||
130684824|NCT00328926|470474380|FG000|Overall Study|In vitro fertilization treatment|0|||
130684825|NCT00328926|470474381|FG001|Overall Study|In vitro fertilization treatment|0|||
130684826|NCT00328926|470474382|FG002|Overall Study|In vitro fertilization treatment|1|||
130684827|NCT00328926|470474380|FG000|Overall Study|Lack of ovarian response|0|||
130684828|NCT00328926|470474381|FG001|Overall Study|Lack of ovarian response|1|||
130684829|NCT00328926|470474382|FG002|Overall Study|Lack of ovarian response|0|||
130684830|NCT02269657|470474383|FG000|Overall Study|Protocol Violation|3|||
130684831|NCT00851877|470474386|FG000|Phase I-1|Death|1|||
130684832|NCT00851877|470474387|FG001|Phase I-1|Death|0|||
130684833|NCT00851877|470474388|FG002|Phase I-1|Death|0|||
130684834|NCT00851877|470474386|FG000|Phase II|Withdrawal by Subject|0|||
130684835|NCT00851877|470474387|FG001|Phase II|Withdrawal by Subject|0|||
131106073|NCT01242800|472018967|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
131106074|NCT01242800|472018968|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
131106075|NCT01242800|472018967|FG000|Overall Study|Reasons not reported|0|||
131106076|NCT01242800|472018968|FG001|Overall Study|Reasons not reported|4|||
131106077|NCT00953745|472018969|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
131106078|NCT00953745|472018970|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
131106079|NCT00953745|472018969|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
131106080|NCT00953745|472018970|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
131106081|NCT00953745|472018969|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
131106082|NCT00953745|472018970|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
131106083|NCT00953745|472018969|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
131106084|NCT00953745|472018970|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
131106085|NCT00953745|472018969|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
131106086|NCT00953745|472018970|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
131106087|NCT00953745|472018969|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
131106088|NCT00953745|472018970|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
131106089|NCT02640157|472018974|FG000|Overall Study|Adverse Event|2|||
131106090|NCT02640157|472018975|FG001|Overall Study|Adverse Event|2|||
131106091|NCT02640157|472018976|FG002|Overall Study|Adverse Event|1|||
131106092|NCT02640157|472018974|FG000|Overall Study|Withdrew consent|2|||
131106093|NCT02640157|472018975|FG001|Overall Study|Withdrew consent|0|||
131106094|NCT02640157|472018976|FG002|Overall Study|Withdrew consent|2|||
131106095|NCT02640157|472018974|FG000|Overall Study|Lost to Follow-up|9|||
131106096|NCT02640157|472018975|FG001|Overall Study|Lost to Follow-up|2|||
131106097|NCT02640157|472018976|FG002|Overall Study|Lost to Follow-up|7|||
131106098|NCT02640157|472018974|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
131106099|NCT02640157|472018975|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
131106100|NCT02640157|472018976|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
131106101|NCT01679405|472018978|FG000|Overall Study|Death|2|||
131106102|NCT01679405|472018979|FG001|Overall Study|Death|5|||
131106103|NCT04677179|472018980|FG000|Induction Treatment Period|Adverse Event|1|||
131106104|NCT04677179|472018981|FG001|Induction Treatment Period|Adverse Event|0|||
131106105|NCT04677179|472018982|FG002|Induction Treatment Period|Adverse Event|0|||
131106106|NCT04677179|472018983|FG003|Induction Treatment Period|Adverse Event|0|||
131106107|NCT04677179|472018984|FG004|Induction Treatment Period|Adverse Event|0|||
130684836|NCT00851877|470474388|FG002|Phase II|Withdrawal by Subject|3|||
130684837|NCT00829673|470474389|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130684838|NCT00829673|470474390|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130684839|NCT03450057|470474391|FG000|Overall Study|Death|17|||
130684840|NCT03450057|470474391|FG000|Overall Study|ICF withdrawal|4|||
131106108|NCT04677179|472018985|FG005|Induction Treatment Period|Adverse Event|0|||
131106109|NCT04677179|472018986|FG006|Induction Treatment Period|Adverse Event|0|||
131106110|NCT04677179|472018987|FG007|Induction Treatment Period|Adverse Event|0|||
131106111|NCT04677179|472018988|FG008|Induction Treatment Period|Adverse Event|0|||
131106112|NCT04677179|472018989|FG009|Induction Treatment Period|Adverse Event|0|||
130684841|NCT03450057|470474391|FG000|Overall Study|Lost to Follow-up|2|||
130684842|NCT00573066|470474392|FG000|Overall Study|Exclusion criteria|18|||
130684843|NCT00573066|470474392|FG000|Overall Study|IV malfunction|1|||
130684844|NCT00573066|470474392|FG000|Overall Study|Postoperative bleeding|1|||
130684845|NCT01034358|470474393|FG000|Overall Study|Withdrawal by Subject|1|||
130684846|NCT01034358|470474393|FG000|Overall Study|Protocol Violation|1|||
130684847|NCT00829790|470474396|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
130684848|NCT00829790|470474397|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
130684849|NCT02246166|470474398|FG000|Overall Study|Protocol Violation|1|||
131020269|NCT01040689|471705088|FG003|Overall Study|Lack of Efficacy|0|||
131020270|NCT01040689|471705085|FG000|Overall Study|Lost to Follow-up|1|||
131020271|NCT01040689|471705086|FG001|Overall Study|Lost to Follow-up|0|||
131020272|NCT01040689|471705087|FG002|Overall Study|Lost to Follow-up|0|||
131020273|NCT01040689|471705088|FG003|Overall Study|Lost to Follow-up|0|||
131020274|NCT01040689|471705085|FG000|Overall Study|Withdrawal by Subject|2|||
131020275|NCT01040689|471705086|FG001|Overall Study|Withdrawal by Subject|1|||
131020276|NCT01040689|471705087|FG002|Overall Study|Withdrawal by Subject|1|||
131020277|NCT01040689|471705088|FG003|Overall Study|Withdrawal by Subject|0|||
131020278|NCT01040689|471705085|FG000|Overall Study|Other reasons not listed above|0|||
131020279|NCT01040689|471705086|FG001|Overall Study|Other reasons not listed above|1|||
131020280|NCT01040689|471705087|FG002|Overall Study|Other reasons not listed above|0|||
131020281|NCT01040689|471705088|FG003|Overall Study|Other reasons not listed above|0|||
131020282|NCT01185561|471705089|FG000|Overall Study|Lost to Follow-up|0|||
131020283|NCT01185561|471705090|FG001|Overall Study|Lost to Follow-up|4|||
131020284|NCT01185561|471705089|FG000|Overall Study|Withdrawal by Subject|2|||
131020285|NCT01185561|471705090|FG001|Overall Study|Withdrawal by Subject|8|||
131020286|NCT02616900|471705091|FG000|Overall Study|Lack of Efficacy|7|||
131020287|NCT02616900|471705091|FG000|Overall Study|Lost to Follow-up|2|||
131020288|NCT02616900|471705091|FG000|Overall Study|Protocol Violation|5|||
131020289|NCT02616900|471705091|FG000|Overall Study|Withdrawal by Subject|3|||
131020290|NCT02616900|471705091|FG000|Overall Study|Incomplete data|6|||
131020291|NCT02499159|471705092|FG000|Randomization|Protocol Violation|1|||
131020292|NCT02499159|471705093|FG001|Randomization|Protocol Violation|1|||
131020293|NCT02499159|471705092|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
131020294|NCT02499159|471705093|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
131020295|NCT02499159|471705092|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
131020296|NCT02499159|471705093|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
131020297|NCT02499159|471705092|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
131020298|NCT02499159|471705093|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
131020299|NCT02499159|471705092|FG000|30-Day Follow-Up Phone Call|Other|1|||
131020300|NCT02499159|471705093|FG001|30-Day Follow-Up Phone Call|Other|0|||
131020301|NCT01190007|471705094|FG000|Overall Study|Withdrawal by Subject|4|||
131020302|NCT01190007|471705094|FG000|Overall Study|Adverse Event|8|||
131020303|NCT01190007|471705094|FG000|Overall Study|Difficulty of visit for complications|1|||
131020304|NCT01190007|471705094|FG000|Overall Study|Participant was arrested|1|||
131106113|NCT04677179|472018980|FG000|Induction Treatment Period|Physician Decision|1|||
131106114|NCT04677179|472018981|FG001|Induction Treatment Period|Physician Decision|0|||
131106115|NCT04677179|472018982|FG002|Induction Treatment Period|Physician Decision|1|||
131106116|NCT04677179|472018983|FG003|Induction Treatment Period|Physician Decision|0|||
130684850|NCT02246166|470474399|FG001|Overall Study|Protocol Violation|0|||
130684851|NCT00627016|470474400|FG000|Overall Study|Adverse Event|1|||
130684852|NCT00627016|470474401|FG001|Overall Study|Adverse Event|1|||
130684853|NCT00627016|470474400|FG000|Overall Study|Protocol Violation|0|||
130684854|NCT00627016|470474401|FG001|Overall Study|Protocol Violation|2|||
130684855|NCT00627016|470474400|FG000|Overall Study|Lost to Follow-up|0|||
130684856|NCT00627016|470474401|FG001|Overall Study|Lost to Follow-up|1|||
130684857|NCT00627016|470474400|FG000|Overall Study|Withdrawal by Subject|2|||
130684858|NCT00627016|470474401|FG001|Overall Study|Withdrawal by Subject|1|||
130684859|NCT00627016|470474400|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130684860|NCT00627016|470474401|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
130684861|NCT00627016|470474400|FG000|Overall Study|Lack of Efficacy|1|||
130684862|NCT00627016|470474401|FG001|Overall Study|Lack of Efficacy|0|||
130684863|NCT00627016|470474400|FG000|Overall Study|Placed on Excluded Drugs|1|||
130684864|NCT00627016|470474401|FG001|Overall Study|Placed on Excluded Drugs|0|||
130684865|NCT00627016|470474400|FG000|Overall Study|Pregnancy|1|||
130684866|NCT00627016|470474401|FG001|Overall Study|Pregnancy|0|||
130684867|NCT01534663|470474402|FG000|Overall Study|Lost to Follow-up|0|||
130684868|NCT01534663|470474403|FG001|Overall Study|Lost to Follow-up|2|||
130684869|NCT01534663|470474402|FG000|Overall Study|Adverse Event|2|||
130684870|NCT01534663|470474403|FG001|Overall Study|Adverse Event|1|||
130684871|NCT00377260|470474404|FG000|Overall Study|Lost to Follow-up|0|||
130684872|NCT00377260|470474405|FG001|Overall Study|Lost to Follow-up|1|||
130684873|NCT00377260|470474404|FG000|Overall Study|Withdrawal by Subject|2|||
130684874|NCT00377260|470474405|FG001|Overall Study|Withdrawal by Subject|4|||
130684875|NCT03107091|470474406|FG000|Overall Study|Physician Decision|1|||
131106117|NCT04677179|472018984|FG004|Induction Treatment Period|Physician Decision|0|||
130684876|NCT04567186|470474411|FG000|Period 1|COVID-19 related|1|||
130684877|NCT04567186|470474412|FG001|Period 1|COVID-19 related|0|||
130684878|NCT04567186|470474411|FG000|Period 1|Protocol Violation|0|||
130684879|NCT04567186|470474412|FG001|Period 1|Protocol Violation|1|||
130684880|NCT04567186|470474411|FG000|Period 1|Adverse Event|0|||
131020305|NCT02594735|471705099|FG000|Overall Study|Adverse Event|1|||
131020306|NCT03844269|471705103|FG000|Overall Study|Withdrawal pre-intervention|1|||
130684881|NCT04567186|470474412|FG001|Period 1|Adverse Event|2|||
130684882|NCT04567186|470474411|FG000|Period 2|COVID-19 Related|0|||
130684883|NCT04567186|470474412|FG001|Period 2|COVID-19 Related|1|||
131020307|NCT03844269|471705103|FG000|Overall Study|Did not complete the intervention|2|||
131020308|NCT00101010|471705104|FG000|Overall Study|Physician Decision|1|||
131020309|NCT00364013|471705105|FG000|Overall Study|Ineligibility determined|4|||
131020310|NCT00364013|471705106|FG001|Overall Study|Ineligibility determined|2|||
131020311|NCT00364013|471705105|FG000|Overall Study|Adverse Event|4|||
131020312|NCT00364013|471705106|FG001|Overall Study|Adverse Event|3|||
131020313|NCT00364013|471705105|FG000|Overall Study|Withdrawal by Subject|13|||
131020314|NCT00364013|471705106|FG001|Overall Study|Withdrawal by Subject|18|||
131020315|NCT00364013|471705105|FG000|Overall Study|Physician Decision|3|||
131020316|NCT00364013|471705106|FG001|Overall Study|Physician Decision|3|||
131020317|NCT00364013|471705105|FG000|Overall Study|Lost to Follow-up|10|||
131020318|NCT00364013|471705106|FG001|Overall Study|Lost to Follow-up|3|||
131020319|NCT00364013|471705105|FG000|Overall Study|Protocol-specified criteria|6|||
131020320|NCT00364013|471705106|FG001|Overall Study|Protocol-specified criteria|6|||
131020321|NCT00364013|471705105|FG000|Overall Study|Other|41|||
131020322|NCT00364013|471705106|FG001|Overall Study|Other|47|||
131020323|NCT00364013|471705105|FG000|Overall Study|Ongoing|20|||
131020324|NCT00364013|471705106|FG001|Overall Study|Ongoing|13|||
131020325|NCT01369498|471705107|FG000|Overall Study|Lack of Efficacy|9|||
131020326|NCT01369498|471705108|FG001|Overall Study|Lack of Efficacy|9|||
131020327|NCT01369498|471705109|FG002|Overall Study|Lack of Efficacy|1|||
131020328|NCT01369498|471705110|FG003|Overall Study|Lack of Efficacy|3|||
131020329|NCT01369498|471705107|FG000|Overall Study|Adverse Event|1|||
131020330|NCT01369498|471705108|FG001|Overall Study|Adverse Event|2|||
131020331|NCT01369498|471705109|FG002|Overall Study|Adverse Event|0|||
131020332|NCT01369498|471705110|FG003|Overall Study|Adverse Event|1|||
131020333|NCT01369498|471705107|FG000|Overall Study|Withdrawal of Consent|0|||
131020334|NCT01369498|471705108|FG001|Overall Study|Withdrawal of Consent|1|||
131020335|NCT01369498|471705109|FG002|Overall Study|Withdrawal of Consent|1|||
131020336|NCT01369498|471705110|FG003|Overall Study|Withdrawal of Consent|1|||
131020337|NCT01369498|471705107|FG000|Overall Study|Death|0|||
131020338|NCT01369498|471705108|FG001|Overall Study|Death|0|||
131020339|NCT01369498|471705109|FG002|Overall Study|Death|1|||
131020340|NCT01369498|471705110|FG003|Overall Study|Death|0|||
131020341|NCT01369498|471705107|FG000|Overall Study|Investigator's Discretion|1|||
131020342|NCT01369498|471705108|FG001|Overall Study|Investigator's Discretion|0|||
131020343|NCT01369498|471705109|FG002|Overall Study|Investigator's Discretion|1|||
131020344|NCT01369498|471705110|FG003|Overall Study|Investigator's Discretion|3|||
131020345|NCT01369498|471705107|FG000|Overall Study|Unknown Reason|1|||
131020346|NCT01369498|471705108|FG001|Overall Study|Unknown Reason|0|||
131020347|NCT01369498|471705109|FG002|Overall Study|Unknown Reason|11|||
131020348|NCT01369498|471705110|FG003|Overall Study|Unknown Reason|6|||
131020349|NCT01369498|471705107|FG000|Overall Study|Disease Progression|0|||
131020350|NCT01369498|471705108|FG001|Overall Study|Disease Progression|0|||
131020351|NCT01369498|471705109|FG002|Overall Study|Disease Progression|0|||
131020352|NCT01369498|471705110|FG003|Overall Study|Disease Progression|1|||
131020353|NCT01510717|471705114|FG000|Overall Study|Adverse Event|1|||
131020354|NCT01510717|471705115|FG001|Overall Study|Adverse Event|2|||
131020355|NCT01510717|471705114|FG000|Overall Study|Death|1|||
131020356|NCT01510717|471705115|FG001|Overall Study|Death|0|||
131020357|NCT01510717|471705114|FG000|Overall Study|Lost to Follow-up|0|||
131020358|NCT01510717|471705115|FG001|Overall Study|Lost to Follow-up|1|||
131020359|NCT01510717|471705114|FG000|Overall Study|Withdrawal by Subject|0|||
131020360|NCT01510717|471705115|FG001|Overall Study|Withdrawal by Subject|2|||
131020361|NCT00529789|471705119|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
131020362|NCT00529789|471705119|FG000|Study Period II/III|Adverse Event|3|||
131020363|NCT00529789|471705119|FG000|Study Period II/III|Lack of Efficacy|2|||
131020364|NCT00529789|471705119|FG000|Study Period II/III|Withdrawal by Subject|1|||
131020365|NCT00529789|471705119|FG000|Study Period II/III|Protocol Violation|3|||
131020366|NCT00529789|471705119|FG000|Study Period II/III|Physician Decision|3|||
130684884|NCT04567186|470474411|FG000|Period 2|Protocol Violation|0|||
131020367|NCT00529789|471705119|FG000|Study Period II/III|Lost to Follow-up|3|||
131020368|NCT00529789|471705119|FG000|Study Period IV|Parent/Caregiver Decision|1|||
131020369|NCT00529789|471705119|FG000|Study Period IV|Adverse Event|1|||
131020370|NCT00529789|471705119|FG000|Study Period IV|Lack of Efficacy|1|||
131020371|NCT00529789|471705119|FG000|Study Period IV|Lost to Follow-up|3|||
131020372|NCT01430611|471705120|FG000|Overall Study|Adverse Event|0|||
131020373|NCT01430611|471705121|FG001|Overall Study|Adverse Event|1|||
131020374|NCT01430611|471705120|FG000|Overall Study|Protocol Violation|1|||
131020375|NCT01430611|471705121|FG001|Overall Study|Protocol Violation|0|||
131020376|NCT01430611|471705120|FG000|Overall Study|Lost to Follow-up|1|||
131020377|NCT01430611|471705121|FG001|Overall Study|Lost to Follow-up|0|||
131020378|NCT01430611|471705120|FG000|Overall Study|Withdrawal by Subject|15|||
131020379|NCT01430611|471705121|FG001|Overall Study|Withdrawal by Subject|14|||
131020380|NCT02204982|471705122|FG000|Overall Study|Patient ineligible-medical monitor|1|||
131020381|NCT02204982|471705123|FG001|Overall Study|Patient ineligible-medical monitor|0|||
131020382|NCT02204982|471705122|FG000|Overall Study|Withdrawal by Subject|1|||
131020383|NCT02204982|471705123|FG001|Overall Study|Withdrawal by Subject|0|||
131020384|NCT02204982|471705122|FG000|Overall Study|Adverse Event|1|||
131106118|NCT04677179|472018985|FG005|Induction Treatment Period|Physician Decision|0|||
131106119|NCT04677179|472018986|FG006|Induction Treatment Period|Physician Decision|0|||
131106120|NCT04677179|472018987|FG007|Induction Treatment Period|Physician Decision|0|||
131106121|NCT04677179|472018988|FG008|Induction Treatment Period|Physician Decision|0|||
130684885|NCT04567186|470474412|FG001|Period 2|Protocol Violation|1|||
130684886|NCT04567186|470474411|FG000|Period 2|Lost to Follow-up|0|||
130684887|NCT04567186|470474412|FG001|Period 2|Lost to Follow-up|1|||
130684888|NCT04567186|470474411|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
130684889|NCT04567186|470474412|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
130684890|NCT02924883|470474413|FG000|Overall Study|Death|39|||
130684891|NCT02924883|470474414|FG001|Overall Study|Death|20|||
130684892|NCT02924883|470474413|FG000|Overall Study|Lost to Follow-up|1|||
130684893|NCT02924883|470474414|FG001|Overall Study|Lost to Follow-up|0|||
130684894|NCT02924883|470474413|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
130684895|NCT02924883|470474414|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
130684896|NCT02924883|470474413|FG000|Overall Study|Protocol Violation|1|||
130684897|NCT02924883|470474414|FG001|Overall Study|Protocol Violation|0|||
130684898|NCT02924883|470474413|FG000|Overall Study|Withdrawal by Subject|22|||
130684899|NCT02924883|470474414|FG001|Overall Study|Withdrawal by Subject|16|||
130684900|NCT02924883|470474413|FG000|Overall Study|Progressive Disease|1|||
130684901|NCT02924883|470474414|FG001|Overall Study|Progressive Disease|0|||
130684902|NCT02924883|470474413|FG000|Overall Study|Study Terminated by Sponsor|69|||
130684903|NCT02924883|470474414|FG001|Overall Study|Study Terminated by Sponsor|32|||
130684904|NCT01256684|470474419|FG000|Overall Study|Adverse Event|1|||
130684905|NCT01256684|470474420|FG001|Overall Study|Adverse Event|4|||
130886586|NCT03486834|471217353|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130886587|NCT03486834|471217354|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130886588|NCT03486834|471217355|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130886589|NCT03486834|471217353|FG000|Overall Study|Randomized but not treated|4|||
130684906|NCT01256684|470474421|FG002|Overall Study|Adverse Event|2|||
130684907|NCT01256684|470474419|FG000|Overall Study|Withdrawal by Subject|4|||
130684908|NCT01256684|470474420|FG001|Overall Study|Withdrawal by Subject|0|||
130684909|NCT01256684|470474421|FG002|Overall Study|Withdrawal by Subject|2|||
130684910|NCT01256684|470474419|FG000|Overall Study|Physician Decision|0|||
130684911|NCT01256684|470474420|FG001|Overall Study|Physician Decision|1|||
130684912|NCT01256684|470474421|FG002|Overall Study|Physician Decision|0|||
130684913|NCT01256684|470474419|FG000|Overall Study|Lack of Efficacy|0|||
130684914|NCT01256684|470474420|FG001|Overall Study|Lack of Efficacy|1|||
130684915|NCT01256684|470474421|FG002|Overall Study|Lack of Efficacy|1|||
130684916|NCT01256684|470474419|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
130684917|NCT01256684|470474420|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
130684918|NCT01256684|470474421|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
130684919|NCT01185548|470474424|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
130684920|NCT02678286|470474425|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
130684921|NCT02678286|470474426|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
130684922|NCT02678286|470474425|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
130684923|NCT02678286|470474426|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
130684924|NCT02678286|470474425|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
130684925|NCT02678286|470474426|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
130684926|NCT02678286|470474425|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
130684927|NCT02678286|470474426|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
130684928|NCT02678286|470474425|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
130684929|NCT02678286|470474426|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
130684930|NCT02098876|470474430|FG000|Overall Study|Withdrawal by Subject|5|||
130684931|NCT02098876|470474431|FG001|Overall Study|Withdrawal by Subject|5|||
130684932|NCT01061866|470474432|FG000|Overall Study|Adverse Event|2|||
130684933|NCT00772941|470474433|FG000|Overall Study|CRFs not available|195|||
130684934|NCT00772941|470474433|FG000|Overall Study|Study not completed|16|||
130684935|NCT00772941|470474433|FG000|Overall Study|Missed Visits|374|||
130684936|NCT00772941|470474433|FG000|Overall Study|Poor Compliance|7|||
130684937|NCT00772941|470474433|FG000|Overall Study|GPSP Violation|90|||
130684938|NCT04786184|470474434|FG000|Overall Study|Adverse Event|4|||
130684939|NCT04786184|470474435|FG001|Overall Study|Adverse Event|0|||
130684940|NCT04786184|470474434|FG000|Overall Study|Withdrawal by Subject|3|||
130684941|NCT04786184|470474435|FG001|Overall Study|Withdrawal by Subject|1|||
130684942|NCT04786184|470474434|FG000|Overall Study|Lost to Follow-up|4|||
130684943|NCT04786184|470474435|FG001|Overall Study|Lost to Follow-up|2|||
130684944|NCT00834756|470474436|FG000|First Intervention|Adverse Event|1|||
130684945|NCT00834756|470474437|FG001|First Intervention|Adverse Event|0|||
130684946|NCT00834756|470474436|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
130684947|NCT00834756|470474437|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
130684948|NCT02017223|470474450|FG000|Overall Study|Algorithm problems|2|||
130684949|NCT04263649|470474452|FG000|Overall Study|Adverse Event|53|||
130684950|NCT04263649|470474452|FG000|Overall Study|Lost to Follow-up|3|||
130684951|NCT04263649|470474452|FG000|Overall Study|Death|29|||
131106122|NCT04677179|472018989|FG009|Induction Treatment Period|Physician Decision|0|||
131106123|NCT04677179|472018980|FG000|Induction Treatment Period|Protocol Violation|0|||
131106124|NCT04677179|472018981|FG001|Induction Treatment Period|Protocol Violation|1|||
131106125|NCT04677179|472018982|FG002|Induction Treatment Period|Protocol Violation|0|||
131106126|NCT04677179|472018983|FG003|Induction Treatment Period|Protocol Violation|0|||
131106127|NCT04677179|472018984|FG004|Induction Treatment Period|Protocol Violation|0|||
131106128|NCT04677179|472018985|FG005|Induction Treatment Period|Protocol Violation|0|||
131106129|NCT04677179|472018986|FG006|Induction Treatment Period|Protocol Violation|0|||
131106130|NCT04677179|472018987|FG007|Induction Treatment Period|Protocol Violation|0|||
131106131|NCT04677179|472018988|FG008|Induction Treatment Period|Protocol Violation|0|||
131106132|NCT04677179|472018989|FG009|Induction Treatment Period|Protocol Violation|0|||
131106133|NCT04677179|472018980|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
131106134|NCT04677179|472018981|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
131106135|NCT04677179|472018982|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
131106136|NCT04677179|472018983|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
131106137|NCT04677179|472018984|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
131106138|NCT04677179|472018985|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
131106139|NCT04677179|472018986|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
131106140|NCT04677179|472018987|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
131106141|NCT04677179|472018988|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
131106142|NCT04677179|472018989|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
131106143|NCT04677179|472018980|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
131106144|NCT04677179|472018981|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
131106145|NCT04677179|472018982|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
131106146|NCT04677179|472018983|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
131106147|NCT04677179|472018984|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
131106148|NCT04677179|472018985|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
131106149|NCT04677179|472018986|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
131106150|NCT04677179|472018987|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
131106151|NCT04677179|472018988|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
131106152|NCT04677179|472018989|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
131106153|NCT04677179|472018980|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
131106154|NCT04677179|472018981|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
131106155|NCT04677179|472018982|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
131106156|NCT04677179|472018983|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
131106157|NCT04677179|472018984|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
131106158|NCT04677179|472018985|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
131106159|NCT04677179|472018986|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
131106160|NCT04677179|472018987|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
131106161|NCT04677179|472018988|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
131106162|NCT04677179|472018989|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
131106163|NCT04677179|472018980|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
131106164|NCT04677179|472018981|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
131106165|NCT04677179|472018982|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
131106166|NCT04677179|472018983|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
131106167|NCT04677179|472018984|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
131106168|NCT04677179|472018985|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
131106169|NCT04677179|472018986|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
131106170|NCT04677179|472018987|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
131106171|NCT04677179|472018988|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
131106172|NCT04677179|472018989|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
131106173|NCT04677179|472018980|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
131106174|NCT04677179|472018981|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
131106175|NCT04677179|472018982|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
131106176|NCT04677179|472018983|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
131106177|NCT04677179|472018984|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
131106178|NCT04677179|472018985|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
131106179|NCT04677179|472018986|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
131106180|NCT04677179|472018987|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
131106181|NCT04677179|472018988|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
131106182|NCT04677179|472018989|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
131106183|NCT04677179|472018980|FG000|Extension Treatment Period|Lack of Efficacy|0|||
131106184|NCT04677179|472018981|FG001|Extension Treatment Period|Lack of Efficacy|0|||
131106185|NCT04677179|472018982|FG002|Extension Treatment Period|Lack of Efficacy|0|||
130684952|NCT04263649|470474452|FG000|Overall Study|Device deficiency|19|||
130684953|NCT04263649|470474452|FG000|Overall Study|other reasons|11|||
130684954|NCT01534520|470474453|FG000|Overall Study|Adverse Event|0|||
130684955|NCT01534520|470474454|FG001|Overall Study|Adverse Event|1|||
130684956|NCT01079988|470474457|FG000|Overall Study|Lost to Follow-up|0|||
130684957|NCT01079988|470474458|FG001|Overall Study|Lost to Follow-up|0|||
130684958|NCT01079988|470474459|FG002|Overall Study|Lost to Follow-up|0|||
130684959|NCT01079988|470474460|FG003|Overall Study|Lost to Follow-up|1|||
130684960|NCT01079988|470474461|FG004|Overall Study|Lost to Follow-up|0|||
130684961|NCT01079988|470474457|FG000|Overall Study|Lack of Efficacy|1|||
130684962|NCT01079988|470474458|FG001|Overall Study|Lack of Efficacy|0|||
130684963|NCT01079988|470474459|FG002|Overall Study|Lack of Efficacy|0|||
130684964|NCT01079988|470474460|FG003|Overall Study|Lack of Efficacy|0|||
130684965|NCT01079988|470474461|FG004|Overall Study|Lack of Efficacy|0|||
130684966|NCT01079988|470474457|FG000|Overall Study|Other|0|||
130684967|NCT01079988|470474458|FG001|Overall Study|Other|0|||
130684968|NCT01079988|470474459|FG002|Overall Study|Other|0|||
130684969|NCT01079988|470474460|FG003|Overall Study|Other|2|||
130684970|NCT01079988|470474461|FG004|Overall Study|Other|1|||
130684971|NCT02392000|470474466|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
130684972|NCT02392000|470474466|FG000|Overall Study|Withdrawal by Subject|1|||
130684973|NCT02392000|470474466|FG000|Overall Study|Lost to Follow-up|8|||
130684974|NCT02331394|470476215|FG000|Overall Study|Disease progression|1|||
130684975|NCT01313273|470476216|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
130684976|NCT01313273|470476217|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
130684977|NCT01313273|470476216|FG000|Overall Study|Withdrawal by Subject|1|||
130684978|NCT01313273|470476217|FG001|Overall Study|Withdrawal by Subject|0|||
130684979|NCT01313273|470476216|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
130684980|NCT01313273|470476217|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
130684981|NCT03687736|470476218|FG000|Overall Study|Lost to Follow-up|7|||
131106186|NCT04677179|472018983|FG003|Extension Treatment Period|Lack of Efficacy|0|||
131106187|NCT04677179|472018984|FG004|Extension Treatment Period|Lack of Efficacy|0|||
131106188|NCT04677179|472018985|FG005|Extension Treatment Period|Lack of Efficacy|0|||
131106189|NCT04677179|472018986|FG006|Extension Treatment Period|Lack of Efficacy|6|||
131106190|NCT04677179|472018987|FG007|Extension Treatment Period|Lack of Efficacy|0|||
131106191|NCT04677179|472018988|FG008|Extension Treatment Period|Lack of Efficacy|0|||
131106192|NCT04677179|472018989|FG009|Extension Treatment Period|Lack of Efficacy|0|||
130684982|NCT03687736|470476218|FG000|Overall Study|Withdrawal by Subject|3|||
131106193|NCT04677179|472018980|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
131106194|NCT04677179|472018981|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
131106195|NCT04677179|472018982|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
131106196|NCT04677179|472018983|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
131106197|NCT04677179|472018984|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
131106198|NCT04677179|472018985|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
131106199|NCT04677179|472018986|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
131106200|NCT04677179|472018987|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
131106201|NCT04677179|472018988|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
131106202|NCT04677179|472018989|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
131106203|NCT04677179|472018980|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
131106204|NCT04677179|472018981|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
131106205|NCT04677179|472018982|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
131106206|NCT04677179|472018983|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
131106207|NCT04677179|472018984|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
131106208|NCT04677179|472018985|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
131106209|NCT04677179|472018986|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
131106210|NCT04677179|472018987|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
131106211|NCT04677179|472018988|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
131106212|NCT04677179|472018989|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
131106213|NCT04677179|472018980|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
131106214|NCT04677179|472018981|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
131106215|NCT04677179|472018982|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
131106216|NCT04677179|472018983|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
131106217|NCT04677179|472018984|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
131106218|NCT04677179|472018985|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
131106219|NCT04677179|472018986|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
131106220|NCT04677179|472018987|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
131106221|NCT04677179|472018988|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
131106222|NCT04677179|472018989|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
131106223|NCT04677179|472018980|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131106224|NCT04677179|472018981|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131106225|NCT04677179|472018982|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
130684983|NCT01270503|470476219|FG000|Overall Study|Lost to Follow-up|1|||
130684984|NCT02459951|470476220|FG000|Overall Study|Unable to meet holding requirement|1|||
130684985|NCT02481830|470476224|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
130684986|NCT02481830|470476225|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
130684987|NCT02481830|470476224|FG000|Pre-treatment|Withdrawal by Subject|0|||
131106226|NCT04677179|472018983|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131106227|NCT04677179|472018984|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131106228|NCT04677179|472018985|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131106229|NCT04677179|472018986|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131106230|NCT04677179|472018987|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
130684988|NCT02481830|470476225|FG001|Pre-treatment|Withdrawal by Subject|10|||
130684989|NCT02481830|470476224|FG000|Pre-treatment|Disease Progression|1|||
130684990|NCT02481830|470476225|FG001|Pre-treatment|Disease Progression|1|||
130684991|NCT02481830|470476224|FG000|Pre-treatment|Other reasons|0|||
130684992|NCT02481830|470476225|FG001|Pre-treatment|Other reasons|1|||
130684993|NCT02481830|470476224|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
130684994|NCT02481830|470476225|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
130684995|NCT02481830|470476224|FG000|Treatment|Disease Progression|233|||
130684996|NCT02481830|470476225|FG001|Treatment|Disease Progression|171|||
130684997|NCT02481830|470476224|FG000|Treatment|Study drug toxicity|18|||
130684998|NCT02481830|470476225|FG001|Treatment|Study drug toxicity|38|||
130684999|NCT02481830|470476224|FG000|Treatment|Death|1|||
130685000|NCT02481830|470476225|FG001|Treatment|Death|1|||
130685001|NCT02481830|470476224|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
130685002|NCT02481830|470476225|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
131020385|NCT02204982|471705123|FG001|Overall Study|Adverse Event|0|||
131020386|NCT02204982|471705122|FG000|Overall Study|Adverse Event and Investigator decision|1|||
131020387|NCT02204982|471705123|FG001|Overall Study|Adverse Event and Investigator decision|0|||
131020388|NCT02204982|471705122|FG000|Overall Study|Physician Decision|0|||
131020389|NCT02204982|471705123|FG001|Overall Study|Physician Decision|2|||
131020390|NCT02204982|471705122|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
131020391|NCT02204982|471705123|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
131020392|NCT02204982|471705122|FG000|Overall Study|Termination of Study bySponsor|0|||
131020393|NCT02204982|471705123|FG001|Overall Study|Termination of Study bySponsor|1|||
131020394|NCT00960141|471705124|FG000|Overall Study|Adverse Event|4|||
131020395|NCT00960141|471705125|FG001|Overall Study|Adverse Event|8|||
131020396|NCT00960141|471705126|FG002|Overall Study|Adverse Event|2|||
131020397|NCT00960141|471705124|FG000|Overall Study|Lack of Efficacy|3|||
131020398|NCT00960141|471705125|FG001|Overall Study|Lack of Efficacy|4|||
131020399|NCT00960141|471705126|FG002|Overall Study|Lack of Efficacy|2|||
131020400|NCT00960141|471705124|FG000|Overall Study|Lost to Follow-up|1|||
131020401|NCT00960141|471705125|FG001|Overall Study|Lost to Follow-up|0|||
131020402|NCT00960141|471705126|FG002|Overall Study|Lost to Follow-up|0|||
131020403|NCT00960141|471705124|FG000|Overall Study|Protocol Violation|1|||
131020404|NCT00960141|471705125|FG001|Overall Study|Protocol Violation|3|||
131020405|NCT00960141|471705126|FG002|Overall Study|Protocol Violation|2|||
131020406|NCT00960141|471705124|FG000|Overall Study|Withdrawal by Subject|1|||
131020407|NCT00960141|471705125|FG001|Overall Study|Withdrawal by Subject|2|||
131020408|NCT00960141|471705126|FG002|Overall Study|Withdrawal by Subject|1|||
131020409|NCT01792830|471705127|FG000|Overall Study|Withdrawal by Subject|22|||
131020410|NCT01792830|471705128|FG001|Overall Study|Withdrawal by Subject|0|||
131020411|NCT01792830|471705129|FG002|Overall Study|Withdrawal by Subject|0|||
131020412|NCT01792830|471705130|FG003|Overall Study|Withdrawal by Subject|2|||
131020413|NCT01792830|471705131|FG004|Overall Study|Withdrawal by Subject|1|||
131020414|NCT01792830|471705132|FG005|Overall Study|Withdrawal by Subject|1|||
131020415|NCT01792830|471705133|FG006|Overall Study|Withdrawal by Subject|1|||
131020416|NCT01792830|471705134|FG007|Overall Study|Withdrawal by Subject|1|||
131020417|NCT01792830|471705135|FG008|Overall Study|Withdrawal by Subject|7|||
131020418|NCT01792830|471705136|FG009|Overall Study|Withdrawal by Subject|0|||
131020419|NCT01792830|471705137|FG010|Overall Study|Withdrawal by Subject|2|||
131020420|NCT01792830|471705127|FG000|Overall Study|Death|3|||
131020421|NCT01792830|471705128|FG001|Overall Study|Death|0|||
131020422|NCT01792830|471705129|FG002|Overall Study|Death|0|||
131020423|NCT01792830|471705130|FG003|Overall Study|Death|1|||
131020424|NCT01792830|471705131|FG004|Overall Study|Death|0|||
131020425|NCT01792830|471705132|FG005|Overall Study|Death|0|||
131020426|NCT01792830|471705133|FG006|Overall Study|Death|1|||
131020427|NCT01792830|471705134|FG007|Overall Study|Death|0|||
131020428|NCT01792830|471705135|FG008|Overall Study|Death|1|||
131020429|NCT01792830|471705136|FG009|Overall Study|Death|0|||
131020430|NCT01792830|471705137|FG010|Overall Study|Death|1|||
131020431|NCT01792830|471705127|FG000|Overall Study|Adverse Event|0|||
131020432|NCT01792830|471705128|FG001|Overall Study|Adverse Event|0|||
131020433|NCT01792830|471705129|FG002|Overall Study|Adverse Event|0|||
131020434|NCT01792830|471705130|FG003|Overall Study|Adverse Event|0|||
131020435|NCT01792830|471705131|FG004|Overall Study|Adverse Event|0|||
130685003|NCT02481830|470476224|FG000|Treatment|Participants request to discontinue Study treatment|6|||
131020436|NCT01792830|471705132|FG005|Overall Study|Adverse Event|0|||
130685004|NCT02481830|470476225|FG001|Treatment|Participants request to discontinue Study treatment|34|||
130685005|NCT02481830|470476224|FG000|Treatment|Withdrawal by Subject|2|||
131020437|NCT01792830|471705133|FG006|Overall Study|Adverse Event|0|||
131020438|NCT01792830|471705134|FG007|Overall Study|Adverse Event|0|||
130685006|NCT02481830|470476225|FG001|Treatment|Withdrawal by Subject|3|||
130685007|NCT02481830|470476224|FG000|Treatment|Lost to Follow-up|1|||
130685008|NCT02481830|470476225|FG001|Treatment|Lost to Follow-up|0|||
130685009|NCT02481830|470476224|FG000|Treatment|Maximum Clinical Benefit|0|||
130685010|NCT02481830|470476225|FG001|Treatment|Maximum Clinical Benefit|5|||
130685011|NCT02481830|470476224|FG000|Treatment|Administrative reason by sponsor|1|||
130685012|NCT02481830|470476225|FG001|Treatment|Administrative reason by sponsor|1|||
130685013|NCT02481830|470476224|FG000|Treatment|Other reasons|6|||
130685014|NCT02481830|470476225|FG001|Treatment|Other reasons|1|||
130685015|NCT00102440|470476226|FG000|Overall Study|Lost to Follow-up|25|||
130685016|NCT00102440|470476227|FG001|Overall Study|Lost to Follow-up|18|||
130685017|NCT00102440|470476228|FG002|Overall Study|Lost to Follow-up|21|||
130685018|NCT00102440|470476226|FG000|Overall Study|Adverse Event|16|||
130685019|NCT00102440|470476227|FG001|Overall Study|Adverse Event|23|||
130685020|NCT00102440|470476228|FG002|Overall Study|Adverse Event|8|||
130685021|NCT00102440|470476226|FG000|Overall Study|Gout Flare|10|||
130685022|NCT00102440|470476227|FG001|Overall Study|Gout Flare|28|||
130685023|NCT00102440|470476228|FG002|Overall Study|Gout Flare|9|||
130685024|NCT00102440|470476226|FG000|Overall Study|Personal Reason(s)|19|||
130685025|NCT00102440|470476227|FG001|Overall Study|Personal Reason(s)|13|||
131020439|NCT01792830|471705135|FG008|Overall Study|Adverse Event|1|||
131020440|NCT01792830|471705136|FG009|Overall Study|Adverse Event|0|||
130685026|NCT00102440|470476228|FG002|Overall Study|Personal Reason(s)|13|||
130685027|NCT00102440|470476226|FG000|Overall Study|Other|11|||
130685028|NCT00102440|470476227|FG001|Overall Study|Other|14|||
131020441|NCT01792830|471705137|FG010|Overall Study|Adverse Event|0|||
131020442|NCT03144674|471705161|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
131020443|NCT03144674|471705162|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
131020444|NCT03144674|471705163|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
131020445|NCT03144674|471705164|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
131020446|NCT03144674|471705161|FG000|Overall Study|Death|3|||
131020447|NCT03144674|471705162|FG001|Overall Study|Death|2|||
131020448|NCT03144674|471705163|FG002|Overall Study|Death|6|||
131020449|NCT03144674|471705164|FG003|Overall Study|Death|24|||
131020450|NCT03144674|471705161|FG000|Overall Study|Lost to Follow-up|0|||
131020451|NCT03144674|471705162|FG001|Overall Study|Lost to Follow-up|1|||
131020452|NCT03144674|471705163|FG002|Overall Study|Lost to Follow-up|0|||
131020453|NCT03144674|471705164|FG003|Overall Study|Lost to Follow-up|4|||
131020454|NCT03144674|471705161|FG000|Overall Study|Withdrawal by Participant|0|||
131020455|NCT03144674|471705162|FG001|Overall Study|Withdrawal by Participant|0|||
131020456|NCT03144674|471705163|FG002|Overall Study|Withdrawal by Participant|2|||
131020457|NCT03144674|471705164|FG003|Overall Study|Withdrawal by Participant|6|||
131020458|NCT03144674|471705161|FG000|Overall Study|Discharged from the Trust|0|||
131020459|NCT03144674|471705162|FG001|Overall Study|Discharged from the Trust|0|||
131020460|NCT03144674|471705163|FG002|Overall Study|Discharged from the Trust|1|||
131020461|NCT03144674|471705164|FG003|Overall Study|Discharged from the Trust|0|||
130685029|NCT00102440|470476228|FG002|Overall Study|Other|14|||
130685030|NCT00102440|470476226|FG000|Overall Study|Protocol Violation|7|||
130685031|NCT00102440|470476227|FG001|Overall Study|Protocol Violation|2|||
130685032|NCT00102440|470476228|FG002|Overall Study|Protocol Violation|1|||
130685033|NCT04627038|470476229|FG000|Overall Study|Adverse Event|36|||
130685034|NCT04627038|470476230|FG001|Overall Study|Adverse Event|8|||
130685035|NCT04627038|470476229|FG000|Overall Study|Lost to Follow-up|1|||
130685036|NCT04627038|470476230|FG001|Overall Study|Lost to Follow-up|0|||
130685037|NCT04627038|470476229|FG000|Overall Study|Physician Decision|0|||
130685038|NCT04627038|470476230|FG001|Overall Study|Physician Decision|1|||
130685039|NCT04627038|470476229|FG000|Overall Study|Protocol Violation|3|||
130685040|NCT04627038|470476230|FG001|Overall Study|Protocol Violation|1|||
130685041|NCT04627038|470476229|FG000|Overall Study|Withdrawal by Subject|13|||
131020462|NCT03144674|471705161|FG000|Overall Study|Exclusion Criteria Met|0|||
131020463|NCT03144674|471705162|FG001|Overall Study|Exclusion Criteria Met|0|||
131020464|NCT03144674|471705163|FG002|Overall Study|Exclusion Criteria Met|1|||
131020465|NCT03144674|471705164|FG003|Overall Study|Exclusion Criteria Met|0|||
131020466|NCT03144674|471705161|FG000|Overall Study|Changed Physicians|0|||
131020467|NCT03144674|471705162|FG001|Overall Study|Changed Physicians|0|||
130685042|NCT04627038|470476230|FG001|Overall Study|Withdrawal by Subject|3|||
131020468|NCT03144674|471705163|FG002|Overall Study|Changed Physicians|0|||
131020469|NCT03144674|471705164|FG003|Overall Study|Changed Physicians|1|||
131020470|NCT03144674|471705161|FG000|Overall Study|Removed for Safety|0|||
131020471|NCT03144674|471705162|FG001|Overall Study|Removed for Safety|0|||
131020472|NCT03144674|471705163|FG002|Overall Study|Removed for Safety|0|||
131020473|NCT03144674|471705164|FG003|Overall Study|Removed for Safety|1|||
130685043|NCT04627038|470476229|FG000|Overall Study|Non-compliance with study drug|0|||
130685044|NCT04627038|470476230|FG001|Overall Study|Non-compliance with study drug|1|||
130685045|NCT04627038|470476229|FG000|Overall Study|Prohibited Concomitant Medication|1|||
130685046|NCT04627038|470476230|FG001|Overall Study|Prohibited Concomitant Medication|0|||
130685047|NCT02255097|470476231|FG000|Overall Study|Death|151|||
130685048|NCT02255097|470476231|FG000|Overall Study|Lost to Follow-up|5|||
130767052|NCT03170609|470770697|FG003|Overall Study|Lost to Follow-up|2|||
130886590|NCT03486834|471217354|FG001|Overall Study|Randomized but not treated|4|||
130886591|NCT03486834|471217355|FG002|Overall Study|Randomized but not treated|1|||
131020474|NCT03144674|471705161|FG000|Overall Study|Site Closed|0|||
131020475|NCT03144674|471705162|FG001|Overall Study|Site Closed|0|||
131020476|NCT03144674|471705163|FG002|Overall Study|Site Closed|0|||
131020477|NCT03144674|471705164|FG003|Overall Study|Site Closed|1|||
131020478|NCT03144674|471705161|FG000|Overall Study|Histological Criteria Not Met|0|||
131020479|NCT03144674|471705162|FG001|Overall Study|Histological Criteria Not Met|0|||
131020480|NCT03144674|471705163|FG002|Overall Study|Histological Criteria Not Met|0|||
131020481|NCT03144674|471705164|FG003|Overall Study|Histological Criteria Not Met|1|||
131020482|NCT03144674|471705161|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
131020483|NCT03144674|471705162|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
131020484|NCT03144674|471705163|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
131020485|NCT03144674|471705164|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
131020486|NCT03144674|471705161|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
131020487|NCT03144674|471705162|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
131020488|NCT03144674|471705163|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
131020489|NCT03144674|471705164|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
131020490|NCT01373346|471705168|FG000|Overall Study|Death|1|||
131020491|NCT01198028|471705169|FG000|Overall Study|Adverse Event|5|||
131020492|NCT01198028|471705169|FG000|Overall Study|Death|3|||
131020493|NCT01198028|471705169|FG000|Overall Study|Physician Decision|2|||
131020494|NCT01395758|471705170|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
131020495|NCT01395758|471705171|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
131020496|NCT01395758|471705172|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
131020497|NCT00357097|471705173|FG000|Overall Study|Did not meet inclusion criteria|5|||
131020498|NCT00357097|471705174|FG001|Overall Study|Did not meet inclusion criteria|3|||
131020499|NCT00357097|471705173|FG000|Overall Study|Adverse Event|34|||
131020500|NCT00357097|471705174|FG001|Overall Study|Adverse Event|6|||
131020501|NCT00357097|471705173|FG000|Overall Study|Withdrawal by Subject|8|||
131020502|NCT00357097|471705174|FG001|Overall Study|Withdrawal by Subject|7|||
131020503|NCT00357097|471705173|FG000|Overall Study|Non-compliance|1|||
131020504|NCT00357097|471705174|FG001|Overall Study|Non-compliance|2|||
131020505|NCT00357097|471705173|FG000|Overall Study|Lack of Efficacy|2|||
131020506|NCT00357097|471705174|FG001|Overall Study|Lack of Efficacy|8|||
131020507|NCT00357097|471705173|FG000|Overall Study|Met Exclusion Criteria|3|||
131020508|NCT00357097|471705174|FG001|Overall Study|Met Exclusion Criteria|1|||
131020509|NCT00357097|471705173|FG000|Overall Study|Other|1|||
131020510|NCT00357097|471705174|FG001|Overall Study|Other|1|||
131020511|NCT00357097|471705173|FG000|Overall Study|Increase of RLS Symptoms|0|||
131020512|NCT00357097|471705174|FG001|Overall Study|Increase of RLS Symptoms|1|||
131020513|NCT00794118|471705175|FG000|Overall Study|Lost to Follow-up|16|||
131020514|NCT00794118|471705175|FG000|Overall Study|Withdrawal by Subject|9|||
131020515|NCT00794118|471705175|FG000|Overall Study|Changed hospital center|2|||
131020516|NCT03887650|471705177|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
131020517|NCT03887650|471705178|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
131020518|NCT03887650|471705177|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
131020519|NCT03887650|471705178|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
131020520|NCT03887650|471705177|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
131020521|NCT03887650|471705178|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
131020522|NCT01170962|471705179|FG000|Treatment Period|Lack of Efficacy|96|||
131020523|NCT01170962|471705180|FG001|Treatment Period|Lack of Efficacy|91|||
131020524|NCT01170962|471705181|FG002|Treatment Period|Lack of Efficacy|7|||
131020525|NCT01170962|471705179|FG000|Treatment Period|Adverse Event|11|||
131020526|NCT01170962|471705180|FG001|Treatment Period|Adverse Event|12|||
131020527|NCT01170962|471705181|FG002|Treatment Period|Adverse Event|3|||
131020528|NCT01170962|471705179|FG000|Treatment Period|Withdrawal by Subject|2|||
131020529|NCT01170962|471705180|FG001|Treatment Period|Withdrawal by Subject|1|||
131020530|NCT01170962|471705181|FG002|Treatment Period|Withdrawal by Subject|0|||
131020531|NCT01170962|471705179|FG000|Treatment Period|Lost to Follow-up|1|||
131020532|NCT01170962|471705180|FG001|Treatment Period|Lost to Follow-up|1|||
131020533|NCT01170962|471705181|FG002|Treatment Period|Lost to Follow-up|1|||
131020534|NCT01170962|471705179|FG000|Treatment Period|Participant no longer meets criteria|0|||
131020535|NCT01170962|471705180|FG001|Treatment Period|Participant no longer meets criteria|1|||
131020536|NCT01170962|471705181|FG002|Treatment Period|Participant no longer meets criteria|0|||
131020537|NCT01170962|471705179|FG000|Treatment Period|Request to discontinue treatment|7|||
131020538|NCT01170962|471705180|FG001|Treatment Period|Request to discontinue treatment|3|||
131020539|NCT01170962|471705181|FG002|Treatment Period|Request to discontinue treatment|1|||
131020540|NCT01170962|471705179|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
131020541|NCT01170962|471705180|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
131020542|NCT01170962|471705181|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
131020543|NCT01170962|471705179|FG000|Follow up Period|Withdrawal by Subject|14|||
131020544|NCT01170962|471705180|FG001|Follow up Period|Withdrawal by Subject|10|||
131020545|NCT01170962|471705181|FG002|Follow up Period|Withdrawal by Subject|2|||
131106231|NCT04677179|472018988|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
131106232|NCT04677179|472018989|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
131106233|NCT04677179|472018980|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131106234|NCT04677179|472018981|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131106235|NCT04677179|472018982|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131106236|NCT04677179|472018983|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131106237|NCT04677179|472018984|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131106238|NCT04677179|472018985|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131106239|NCT04677179|472018986|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131106240|NCT04677179|472018987|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
131106241|NCT04677179|472018988|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131106242|NCT04677179|472018989|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
131106243|NCT04677179|472018980|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131106244|NCT04677179|472018981|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131106245|NCT04677179|472018982|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131106246|NCT04677179|472018983|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131106247|NCT04677179|472018984|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130685049|NCT02255097|470476231|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
130685050|NCT02255097|470476231|FG000|Overall Study|Withdrawal by Subject|7|||
130685051|NCT02255097|470476231|FG000|Overall Study|Allocated but not treated|1|||
130685052|NCT01010542|470476233|FG000|Overall Study|Adverse Event|0|||
130685053|NCT01010542|470476234|FG001|Overall Study|Adverse Event|1|||
130685054|NCT01010542|470476235|FG002|Overall Study|Adverse Event|0|||
130685055|NCT01010542|470476233|FG000|Overall Study|Lost to Follow-up|0|||
130685056|NCT01010542|470476234|FG001|Overall Study|Lost to Follow-up|1|||
130685057|NCT01010542|470476235|FG002|Overall Study|Lost to Follow-up|0|||
130685058|NCT01010542|470476233|FG000|Overall Study|Withdrawal by Subject|0|||
130685059|NCT01010542|470476234|FG001|Overall Study|Withdrawal by Subject|3|||
130685060|NCT01010542|470476235|FG002|Overall Study|Withdrawal by Subject|2|||
130685061|NCT01745120|470476240|FG000|Overall Study|Investigator decision|1|||
130685062|NCT01745120|470476241|FG001|Overall Study|Investigator decision|0|||
130685063|NCT03956862|470476242|FG000|Overall Study|Lost to Follow-up|1|||
130685064|NCT03956862|470476243|FG001|Overall Study|Lost to Follow-up|1|||
130685065|NCT03956862|470476242|FG000|Overall Study|Withdrawal by Subject|1|||
130685066|NCT03956862|470476243|FG001|Overall Study|Withdrawal by Subject|1|||
130685067|NCT00579670|470476247|FG000|Overall Study|Death|1|||
130685068|NCT00579670|470476248|FG001|Overall Study|Death|0|||
130685069|NCT00579670|470476249|FG002|Overall Study|Death|0|||
131106248|NCT04677179|472018985|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131106249|NCT04677179|472018986|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131106250|NCT04677179|472018987|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
131106251|NCT04677179|472018988|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
131106252|NCT04677179|472018989|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131106253|NCT04677179|472018980|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131106254|NCT04677179|472018981|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131106255|NCT04677179|472018982|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131106256|NCT04677179|472018983|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131106257|NCT04677179|472018984|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131106258|NCT04677179|472018985|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131106259|NCT04677179|472018986|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
131106260|NCT04677179|472018987|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
131106261|NCT04677179|472018988|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
130685070|NCT00579670|470476250|FG003|Overall Study|Death|0|||
130685071|NCT00579670|470476251|FG004|Overall Study|Death|0|||
130685072|NCT00579670|470476247|FG000|Overall Study|Adverse Event|1|||
130685073|NCT00579670|470476248|FG001|Overall Study|Adverse Event|0|||
130685074|NCT00579670|470476249|FG002|Overall Study|Adverse Event|1|||
130685075|NCT00579670|470476250|FG003|Overall Study|Adverse Event|2|||
130685076|NCT00579670|470476251|FG004|Overall Study|Adverse Event|0|||
130685077|NCT00579670|470476247|FG000|Overall Study|Lack of Efficacy|0|||
130685078|NCT00579670|470476248|FG001|Overall Study|Lack of Efficacy|0|||
130685079|NCT00579670|470476249|FG002|Overall Study|Lack of Efficacy|1|||
130685080|NCT00579670|470476250|FG003|Overall Study|Lack of Efficacy|14|||
130685081|NCT00579670|470476251|FG004|Overall Study|Lack of Efficacy|0|||
131106262|NCT04677179|472018989|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
131106263|NCT03866473|472018993|FG000|Phase 1|Death|1|||
131106264|NCT03866473|472018994|FG001|Phase 1|Death|0|||
130685082|NCT00579670|470476247|FG000|Overall Study|Lost to Follow-up|0|||
130685083|NCT00579670|470476248|FG001|Overall Study|Lost to Follow-up|1|||
130685084|NCT00579670|470476249|FG002|Overall Study|Lost to Follow-up|0|||
130685085|NCT00579670|470476250|FG003|Overall Study|Lost to Follow-up|4|||
130685086|NCT00579670|470476251|FG004|Overall Study|Lost to Follow-up|0|||
130685087|NCT00579670|470476247|FG000|Overall Study|Other|0|||
131106265|NCT03866473|472018993|FG000|Phase 2|Death|0|||
131106266|NCT03866473|472018994|FG001|Phase 2|Death|2|||
131106267|NCT03866473|472018993|FG000|Phase 2|Dropped|1|||
131106268|NCT03866473|472018994|FG001|Phase 2|Dropped|1|||
131106269|NCT03866473|472018993|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
131106270|NCT03866473|472018994|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
131106271|NCT03110185|472018996|FG000|Overall Study|Death|0|||
131106272|NCT03110185|472018997|FG001|Overall Study|Death|1|||
131106273|NCT03110185|472018996|FG000|Overall Study|Withdrawal by Subject|2|||
131106274|NCT03110185|472018997|FG001|Overall Study|Withdrawal by Subject|7|||
131106275|NCT03110185|472018996|FG000|Overall Study|Time Constraints|0|||
131106276|NCT03110185|472018997|FG001|Overall Study|Time Constraints|6|||
131106277|NCT03110185|472018996|FG000|Overall Study|Conflict with care|5|||
131106278|NCT03110185|472018997|FG001|Overall Study|Conflict with care|12|||
131106279|NCT03110185|472018996|FG000|Overall Study|Protocol Violation|1|||
131106280|NCT03110185|472018997|FG001|Overall Study|Protocol Violation|4|||
131106281|NCT03110185|472018996|FG000|Overall Study|MRI Incompatible|2|||
131106282|NCT03110185|472018997|FG001|Overall Study|MRI Incompatible|0|||
131106283|NCT03110185|472018996|FG000|Overall Study|Patient Refusal|0|||
131106284|NCT03110185|472018997|FG001|Overall Study|Patient Refusal|1|||
131106285|NCT00600886|472018998|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
131106286|NCT00600886|472018999|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
131106287|NCT00600886|472018998|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
131106288|NCT00600886|472018999|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
131106289|NCT00600886|472018998|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
131106290|NCT00600886|472018999|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
131106291|NCT00600886|472018998|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
131106292|NCT00600886|472018999|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
131106293|NCT00600886|472018998|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
131106294|NCT00600886|472018999|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
131106295|NCT00600886|472018998|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
131106296|NCT00600886|472018999|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
131106297|NCT00600886|472018998|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
131106298|NCT00600886|472018999|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
131106299|NCT00600886|472018998|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
131106300|NCT00600886|472018999|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
131106301|NCT00600886|472018998|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
131106302|NCT00600886|472018999|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
131106303|NCT00600886|472018998|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
131106304|NCT00600886|472018999|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
131106305|NCT00600886|472018998|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
131106306|NCT00600886|472018999|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
131106307|NCT00600886|472018998|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
131106308|NCT00600886|472018999|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
131106309|NCT00600886|472018998|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
131106310|NCT00600886|472018999|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
131106311|NCT00600886|472018998|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
131106312|NCT00600886|472018999|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
131106313|NCT00600886|472018998|FG000|Extension - Same Treatment (FAS)|Death|1|||
131106314|NCT00600886|472018999|FG001|Extension - Same Treatment (FAS)|Death|1|||
131106315|NCT00600886|472018998|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
131106316|NCT00600886|472018999|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
131106317|NCT00600886|472018998|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
131106318|NCT00600886|472018999|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
131106319|NCT00600886|472018998|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
131106320|NCT00600886|472018999|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
131106321|NCT00600886|472018998|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
131106322|NCT00600886|472018999|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
131106323|NCT00600886|472018998|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
131106324|NCT00600886|472018999|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
131106325|NCT00600886|472018998|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
131106326|NCT00600886|472018999|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
131106327|NCT00600886|472018998|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
131106328|NCT00600886|472018999|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
131106329|NCT00600886|472018998|FG000|Extension - After Crossover (CAS)|Death|1|||
131106330|NCT00600886|472018999|FG001|Extension - After Crossover (CAS)|Death|0|||
131106331|NCT03075410|472019000|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
130685088|NCT00579670|470476248|FG001|Overall Study|Other|0|||
130685089|NCT00579670|470476249|FG002|Overall Study|Other|1|||
130685090|NCT00579670|470476250|FG003|Overall Study|Other|2|||
130685091|NCT00579670|470476251|FG004|Overall Study|Other|0|||
130685092|NCT00579670|470476247|FG000|Overall Study|Withdrawal by Subject|0|||
130685093|NCT00579670|470476248|FG001|Overall Study|Withdrawal by Subject|0|||
130685094|NCT00579670|470476249|FG002|Overall Study|Withdrawal by Subject|1|||
130685095|NCT00579670|470476250|FG003|Overall Study|Withdrawal by Subject|0|||
130685096|NCT00579670|470476251|FG004|Overall Study|Withdrawal by Subject|0|||
130685097|NCT00850174|470476255|FG000|Washout: One Week|Withdrawal by Subject|0|||
130685098|NCT00850174|470476256|FG001|Washout: One Week|Withdrawal by Subject|2|||
130685099|NCT00850174|470476255|FG000|Second Intervention|Withdrawal by Subject|1|||
130685100|NCT00850174|470476256|FG001|Second Intervention|Withdrawal by Subject|0|||
130685101|NCT01363765|470476259|FG000|Overall Study|non-diagnostic|2621|||
131020546|NCT01170962|471705179|FG000|Follow up Period|Lost to Follow-up|13|||
131020547|NCT01170962|471705180|FG001|Follow up Period|Lost to Follow-up|8|||
131020548|NCT01170962|471705181|FG002|Follow up Period|Lost to Follow-up|1|||
131020549|NCT01170962|471705179|FG000|Follow up Period|Death|2|||
131020550|NCT01170962|471705180|FG001|Follow up Period|Death|2|||
131020551|NCT01170962|471705181|FG002|Follow up Period|Death|0|||
131020552|NCT01170962|471705179|FG000|Follow up Period|Others|10|||
131020553|NCT01170962|471705180|FG001|Follow up Period|Others|7|||
131020554|NCT01170962|471705181|FG002|Follow up Period|Others|3|||
131020555|NCT00837616|471705182|FG000|Overall Study|Withdrawal by Subject|0|||
131020556|NCT00837616|471705183|FG001|Overall Study|Withdrawal by Subject|1|||
131020557|NCT02674750|471705185|FG000|Overall Study|Death|4|||
131020558|NCT02674750|471705186|FG001|Overall Study|Death|5|||
131020559|NCT02674750|471705187|FG002|Overall Study|Death|8|||
131020560|NCT02674750|471705185|FG000|Overall Study|Lost to Follow-up|0|||
131020561|NCT02674750|471705186|FG001|Overall Study|Lost to Follow-up|8|||
131020562|NCT02674750|471705187|FG002|Overall Study|Lost to Follow-up|0|||
131020563|NCT02674750|471705185|FG000|Overall Study|Lack of Efficacy|1|||
131020564|NCT02674750|471705186|FG001|Overall Study|Lack of Efficacy|17|||
131020565|NCT02674750|471705187|FG002|Overall Study|Lack of Efficacy|3|||
131020566|NCT02674750|471705185|FG000|Overall Study|Withdrawal by Subject|0|||
131020567|NCT02674750|471705186|FG001|Overall Study|Withdrawal by Subject|7|||
131020568|NCT02674750|471705187|FG002|Overall Study|Withdrawal by Subject|1|||
131020569|NCT02674750|471705185|FG000|Overall Study|Other|0|||
131020570|NCT02674750|471705186|FG001|Overall Study|Other|8|||
131020571|NCT02674750|471705187|FG002|Overall Study|Other|0|||
131020572|NCT01199705|471705192|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
131020573|NCT01415349|471705193|FG000|Treatment Period 1|Adverse Event|0|||
131020574|NCT01415349|471705194|FG001|Treatment Period 1|Adverse Event|1|||
131020575|NCT01415349|471705193|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131020576|NCT01415349|471705194|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131020577|NCT01616459|471705195|FG000|Overall Study|Adverse Event|1|||
131020578|NCT01616459|471705196|FG001|Overall Study|Adverse Event|1|||
131020579|NCT01616459|471705197|FG002|Overall Study|Adverse Event|2|||
131020580|NCT01616459|471705198|FG003|Overall Study|Adverse Event|0|||
131020581|NCT01616459|471705195|FG000|Overall Study|Lost to Follow-up|1|||
131020582|NCT01616459|471705196|FG001|Overall Study|Lost to Follow-up|11|||
131020583|NCT01616459|471705197|FG002|Overall Study|Lost to Follow-up|3|||
131020584|NCT01616459|471705198|FG003|Overall Study|Lost to Follow-up|2|||
131020585|NCT01616459|471705195|FG000|Overall Study|Protocol Violation|0|||
131020586|NCT01616459|471705196|FG001|Overall Study|Protocol Violation|0|||
131020587|NCT01616459|471705197|FG002|Overall Study|Protocol Violation|0|||
131020588|NCT01616459|471705198|FG003|Overall Study|Protocol Violation|2|||
131020589|NCT01616459|471705195|FG000|Overall Study|Withdrawal by Subject|2|||
131020590|NCT01616459|471705196|FG001|Overall Study|Withdrawal by Subject|4|||
131020591|NCT01616459|471705197|FG002|Overall Study|Withdrawal by Subject|4|||
131020592|NCT01616459|471705198|FG003|Overall Study|Withdrawal by Subject|4|||
131020593|NCT01616459|471705195|FG000|Overall Study|Other reason|0|||
131020594|NCT01616459|471705196|FG001|Overall Study|Other reason|1|||
131020595|NCT01616459|471705197|FG002|Overall Study|Other reason|1|||
131020596|NCT01616459|471705198|FG003|Overall Study|Other reason|0|||
130685102|NCT01363765|470476260|FG001|Overall Study|non-diagnostic|1124|||
130685103|NCT01363765|470476259|FG000|Overall Study|duplicate records|736|||
130685104|NCT01363765|470476260|FG001|Overall Study|duplicate records|3177|||
130685105|NCT01363765|470476259|FG000|Overall Study|non-resident|156|||
130685106|NCT01363765|470476260|FG001|Overall Study|non-resident|76|||
130685107|NCT01363765|470476259|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
130685108|NCT01363765|470476260|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
130685109|NCT01363765|470476259|FG000|Overall Study|smear during intervention|2170|||
131020597|NCT05135000|471705206|FG000|Overall Study|Adverse Event|2|||
131020598|NCT05135000|471705207|FG001|Overall Study|Adverse Event|0|||
131020599|NCT05135000|471705206|FG000|Overall Study|Lost to Follow-up|1|||
131020600|NCT05135000|471705207|FG001|Overall Study|Lost to Follow-up|0|||
131020601|NCT05135000|471705206|FG000|Overall Study|Study Terminated by Sponsor|6|||
130685110|NCT01363765|470476260|FG001|Overall Study|smear during intervention|0|||
130685111|NCT01900626|470476261|FG000|Overall Study|study was closed due to low enrollment|1|||
131020602|NCT05135000|471705207|FG001|Overall Study|Study Terminated by Sponsor|3|||
130685112|NCT01900626|470476262|FG001|Overall Study|study was closed due to low enrollment|1|||
130685113|NCT00635492|470476263|FG000|Overall Study|Death|12|||
130685114|NCT00635492|470476264|FG001|Overall Study|Death|40|||
130685115|NCT00635492|470476263|FG000|Overall Study|Lost to Follow-up|151|||
130685116|NCT00635492|470476264|FG001|Overall Study|Lost to Follow-up|172|||
130685117|NCT00635492|470476263|FG000|Overall Study|Physician Decision|32|||
130685118|NCT00635492|470476264|FG001|Overall Study|Physician Decision|22|||
130685119|NCT00635492|470476263|FG000|Overall Study|Sponsor decision|2|||
130685120|NCT00635492|470476264|FG001|Overall Study|Sponsor decision|3|||
130685121|NCT00635492|470476263|FG000|Overall Study|Withdrawal by Subject|82|||
130685122|NCT00635492|470476264|FG001|Overall Study|Withdrawal by Subject|45|||
130685123|NCT02682784|470476265|FG000|Overall Study|Withdrawal by Subject|0|||
130685124|NCT02682784|470476266|FG001|Overall Study|Withdrawal by Subject|2|||
130685125|NCT02682784|470476267|FG002|Overall Study|Withdrawal by Subject|1|||
130685126|NCT02682784|470476268|FG003|Overall Study|Withdrawal by Subject|2|||
130685127|NCT02682784|470476265|FG000|Overall Study|Physician Decision|1|||
130685128|NCT02682784|470476266|FG001|Overall Study|Physician Decision|0|||
130685129|NCT02682784|470476267|FG002|Overall Study|Physician Decision|1|||
130685130|NCT02682784|470476268|FG003|Overall Study|Physician Decision|1|||
130685131|NCT01702987|470476269|FG000|Overall Study|Withdrawal by Subject|1|||
130685132|NCT01702987|470476270|FG001|Overall Study|Withdrawal by Subject|0|||
130685133|NCT04533594|470476271|FG000|Overall Study|Death|26|||
130685134|NCT03138967|470476278|FG000|Overall Study|Death|0|||
130685135|NCT03138967|470476279|FG001|Overall Study|Death|1|||
130685136|NCT03138967|470476278|FG000|Overall Study|Physician Decision|1|||
130685137|NCT03138967|470476279|FG001|Overall Study|Physician Decision|3|||
130685138|NCT05169710|470476280|FG000|Overall Study|Adverse Event|1|||
130685139|NCT05169710|470476281|FG001|Overall Study|Adverse Event|2|||
130685140|NCT05169710|470476282|FG002|Overall Study|Adverse Event|2|||
130685141|NCT05169710|470476280|FG000|Overall Study|Lost to Follow-up|0|||
130685142|NCT05169710|470476281|FG001|Overall Study|Lost to Follow-up|0|||
130685143|NCT05169710|470476282|FG002|Overall Study|Lost to Follow-up|1|||
130685144|NCT05169710|470476280|FG000|Overall Study|Withdrawal by Subject|2|||
130685145|NCT05169710|470476281|FG001|Overall Study|Withdrawal by Subject|1|||
130685146|NCT05169710|470476282|FG002|Overall Study|Withdrawal by Subject|0|||
130685147|NCT05169710|470476280|FG000|Overall Study|Other Study Discontinuation Reason|0|||
130685148|NCT05169710|470476281|FG001|Overall Study|Other Study Discontinuation Reason|2|||
130685149|NCT05169710|470476282|FG002|Overall Study|Other Study Discontinuation Reason|0|||
130685150|NCT00836056|470476295|FG000|First Intervention|Adverse Event|1|||
130685151|NCT00836056|470476296|FG001|First Intervention|Adverse Event|0|||
130685152|NCT00846495|470476297|FG000|Overall Study|Lost to Follow-up|1|||
130685153|NCT00846495|470476298|FG001|Overall Study|Lost to Follow-up|0|||
130685154|NCT00846495|470476297|FG000|Overall Study|Adverse Event|5|||
130685155|NCT00846495|470476298|FG001|Overall Study|Adverse Event|1|||
130685156|NCT00846495|470476297|FG000|Overall Study|Lack of Efficacy|1|||
130685157|NCT00846495|470476298|FG001|Overall Study|Lack of Efficacy|2|||
130685158|NCT00846495|470476297|FG000|Overall Study|Physician Decision|1|||
130685159|NCT00846495|470476298|FG001|Overall Study|Physician Decision|0|||
130685160|NCT01686438|470476299|FG000|Overall Study|Lost to Follow-up|8|||
130685161|NCT01686438|470476300|FG001|Overall Study|Lost to Follow-up|9|||
131020603|NCT03215927|471706784|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
131020604|NCT03215927|471706785|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
131020605|NCT03215927|471706784|FG000|Open Label Extension|Adverse Event|1|||
131020606|NCT03215927|471706785|FG001|Open Label Extension|Adverse Event|0|||
131020607|NCT03215927|471706784|FG000|Open Label Extension|Lack of Efficacy|1|||
131020608|NCT03215927|471706785|FG001|Open Label Extension|Lack of Efficacy|0|||
131020609|NCT03215927|471706784|FG000|Open Label Extension|Death|0|||
131020610|NCT03215927|471706785|FG001|Open Label Extension|Death|1|||
131020611|NCT03073941|471706786|FG000|Overall Study|Received non-study device intraoperatively|0|||
131020612|NCT03073941|471706787|FG001|Overall Study|Received non-study device intraoperatively|2|||
131020613|NCT03073941|471706786|FG000|Overall Study|Death|1|||
131020614|NCT03073941|471706787|FG001|Overall Study|Death|0|||
130685162|NCT01686438|470476301|FG002|Overall Study|Lost to Follow-up|10|||
130685163|NCT01686438|470476299|FG000|Overall Study|Adverse Event|0|||
131020615|NCT03073941|471706786|FG000|Overall Study|Withdrawal by Subject|1|||
131020616|NCT03073941|471706787|FG001|Overall Study|Withdrawal by Subject|3|||
131020617|NCT03073941|471706786|FG000|Overall Study|Lost to Follow-up|5|||
130685164|NCT01686438|470476300|FG001|Overall Study|Adverse Event|0|||
130685165|NCT01686438|470476301|FG002|Overall Study|Adverse Event|1|||
130685166|NCT01686438|470476299|FG000|Overall Study|Protocol Violation|0|||
130685167|NCT01686438|470476300|FG001|Overall Study|Protocol Violation|0|||
130685168|NCT01686438|470476301|FG002|Overall Study|Protocol Violation|1|||
130685169|NCT01686438|470476299|FG000|Overall Study|Withdrawal by Subject|0|||
130685170|NCT01686438|470476300|FG001|Overall Study|Withdrawal by Subject|0|||
130685171|NCT01686438|470476301|FG002|Overall Study|Withdrawal by Subject|1|||
130685172|NCT01029340|470476304|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
130685173|NCT01029340|470476305|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
130685174|NCT01029340|470476306|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
131106332|NCT03075410|472019001|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
131106333|NCT03075410|472019002|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
131106334|NCT03075410|472019003|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
131106335|NCT03075410|472019004|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
131106336|NCT03075410|472019005|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
131106337|NCT03075410|472019006|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
131106338|NCT03075410|472019007|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
131106339|NCT03075410|472019008|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
131106340|NCT03075410|472019000|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
131106341|NCT03075410|472019001|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131106342|NCT03075410|472019002|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131106343|NCT03075410|472019003|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131106344|NCT03075410|472019004|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131106345|NCT03075410|472019005|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131106346|NCT03075410|472019006|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131106347|NCT03075410|472019007|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
131106348|NCT03075410|472019008|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
130685175|NCT01029340|470476307|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
130685176|NCT01029340|470476308|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
130685177|NCT01029340|470476309|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
130685178|NCT01029340|470476304|FG000|Part B Treatment Period|Protocol Violation|0|||
130685179|NCT01029340|470476305|FG001|Part B Treatment Period|Protocol Violation|0|||
130685180|NCT01029340|470476306|FG002|Part B Treatment Period|Protocol Violation|1|||
130685181|NCT01029340|470476307|FG003|Part B Treatment Period|Protocol Violation|0|||
130685182|NCT01029340|470476308|FG004|Part B Treatment Period|Protocol Violation|0|||
130685183|NCT01029340|470476309|FG005|Part B Treatment Period|Protocol Violation|0|||
130685184|NCT01029340|470476304|FG000|Extension Period|Adverse Event|0|||
130685185|NCT01029340|470476305|FG001|Extension Period|Adverse Event|0|||
130685186|NCT01029340|470476306|FG002|Extension Period|Adverse Event|0|||
130685187|NCT01029340|470476307|FG003|Extension Period|Adverse Event|0|||
130685188|NCT01029340|470476308|FG004|Extension Period|Adverse Event|0|||
130685189|NCT01029340|470476309|FG005|Extension Period|Adverse Event|1|||
130685190|NCT01029340|470476304|FG000|Extension Period|starting another study|0|||
130685191|NCT01029340|470476305|FG001|Extension Period|starting another study|0|||
130685192|NCT01029340|470476306|FG002|Extension Period|starting another study|0|||
130685193|NCT01029340|470476307|FG003|Extension Period|starting another study|0|||
131106349|NCT01427751|472019009|FG000|Overall Study|Adverse Event|18|||
131106350|NCT01427751|472019010|FG001|Overall Study|Adverse Event|2|||
130685194|NCT01029340|470476308|FG004|Extension Period|starting another study|0|||
130685195|NCT01029340|470476309|FG005|Extension Period|starting another study|8|||
130685196|NCT01029340|470476304|FG000|Extension Period|non-compliance|0|||
130685197|NCT01029340|470476305|FG001|Extension Period|non-compliance|0|||
130685198|NCT01029340|470476306|FG002|Extension Period|non-compliance|0|||
130685199|NCT01029340|470476307|FG003|Extension Period|non-compliance|0|||
130685200|NCT01029340|470476308|FG004|Extension Period|non-compliance|0|||
130685201|NCT01029340|470476309|FG005|Extension Period|non-compliance|1|||
130685202|NCT01029340|470476304|FG000|Extension Period|Withdrawal by Subject|0|||
130685203|NCT01029340|470476305|FG001|Extension Period|Withdrawal by Subject|0|||
130685204|NCT01029340|470476306|FG002|Extension Period|Withdrawal by Subject|0|||
131106351|NCT01427751|472019009|FG000|Overall Study|No further treatment benefit expected|5|||
131106352|NCT01427751|472019010|FG001|Overall Study|No further treatment benefit expected|1|||
131106353|NCT01427751|472019009|FG000|Overall Study|Lost to Follow-up|3|||
131106354|NCT01427751|472019010|FG001|Overall Study|Lost to Follow-up|1|||
131106355|NCT01427751|472019009|FG000|Overall Study|Withdrawal of consent|2|||
131106356|NCT01427751|472019010|FG001|Overall Study|Withdrawal of consent|2|||
131106357|NCT01427751|472019009|FG000|Overall Study|Protocol Violation|6|||
131106358|NCT01427751|472019010|FG001|Overall Study|Protocol Violation|4|||
131106359|NCT01427751|472019009|FG000|Overall Study|Death|2|||
131106360|NCT01427751|472019010|FG001|Overall Study|Death|0|||
130685205|NCT01029340|470476307|FG003|Extension Period|Withdrawal by Subject|0|||
130685206|NCT01029340|470476308|FG004|Extension Period|Withdrawal by Subject|0|||
130685207|NCT01029340|470476309|FG005|Extension Period|Withdrawal by Subject|1|||
130685208|NCT01029340|470476304|FG000|Extension Period|Physician Decision|0|||
131106361|NCT01427751|472019009|FG000|Overall Study|Other miscellaneous reasons|6|||
131106362|NCT01427751|472019010|FG001|Overall Study|Other miscellaneous reasons|4|||
131106363|NCT03534284|472019021|FG000|Overall Study|Death|2|||
131106364|NCT03534284|472019022|FG001|Overall Study|Death|3|||
131106365|NCT03534284|472019023|FG002|Overall Study|Death|3|||
131106366|NCT03534284|472019021|FG000|Overall Study|Withdrawal by Subject|5|||
130685209|NCT01029340|470476305|FG001|Extension Period|Physician Decision|0|||
130685210|NCT01029340|470476306|FG002|Extension Period|Physician Decision|0|||
130685211|NCT01029340|470476307|FG003|Extension Period|Physician Decision|0|||
130685212|NCT01029340|470476308|FG004|Extension Period|Physician Decision|0|||
130685213|NCT01029340|470476309|FG005|Extension Period|Physician Decision|1|||
130685214|NCT02648347|470476310|FG000|Overall Study|Death|174|||
130685215|NCT02648347|470476311|FG001|Overall Study|Death|167|||
130685216|NCT02648347|470476310|FG000|Overall Study|Withdrawal by Subject|16|||
130685217|NCT02648347|470476311|FG001|Overall Study|Withdrawal by Subject|9|||
130685218|NCT02648347|470476310|FG000|Overall Study|Lost to Follow-up|18|||
130685219|NCT02648347|470476311|FG001|Overall Study|Lost to Follow-up|21|||
130685220|NCT02648347|470476310|FG000|Overall Study|Missing|1|||
130685221|NCT02648347|470476311|FG001|Overall Study|Missing|0|||
130685222|NCT01265056|470476315|FG000|Initial Study Period|Withdrawal by Subject|1|||
130685223|NCT01265056|470476316|FG001|Initial Study Period|Withdrawal by Subject|1|||
130685224|NCT01265056|470476315|FG000|Initial Study Period|Withdrawal by Subject|1|||
130685225|NCT01265056|470476316|FG001|Initial Study Period|Withdrawal by Subject|1|||
130685226|NCT01265056|470476315|FG000|Follow up|Lost to Follow-up|7|||
130685227|NCT01265056|470476316|FG001|Follow up|Lost to Follow-up|3|||
130685228|NCT02601560|470476321|FG000|Overall Study|Other|0|||
130685229|NCT02601560|470476322|FG001|Overall Study|Other|0|||
130685230|NCT02601560|470476323|FG002|Overall Study|Other|0|||
130685231|NCT02601560|470476324|FG003|Overall Study|Other|0|||
131020618|NCT03073941|471706787|FG001|Overall Study|Lost to Follow-up|4|||
131020619|NCT03073941|471706786|FG000|Overall Study|Adverse Event|4|||
131020620|NCT03073941|471706787|FG001|Overall Study|Adverse Event|2|||
131020621|NCT03073941|471706786|FG000|Overall Study|Met an exclusion criterion|0|||
131020622|NCT03073941|471706787|FG001|Overall Study|Met an exclusion criterion|1|||
131020623|NCT04250883|471706788|FG000|Overall Study|Lost to Follow-up|1|||
131020624|NCT04250883|471706789|FG001|Overall Study|Lost to Follow-up|0|||
131020625|NCT01188655|471706791|FG000|Overall Study|Lack of Efficacy|1|||
131020626|NCT01188655|471706791|FG000|Overall Study|Lost to Follow-up|1|||
131020627|NCT01188655|471706791|FG000|Overall Study|Other|11|||
131020628|NCT00089544|471706792|FG000|Overall Study|Ineligible|1|||
131020629|NCT00089544|471706793|FG001|Overall Study|Ineligible|0|||
131020630|NCT02407249|471706798|FG000|Overall Study|Did not complete 12-month follow-up|13|||
131020631|NCT02407249|471706798|FG000|Overall Study|Not treated|13|||
131020632|NCT04425629|471706799|FG000|Overall Study|Adverse Event|0|||
131020633|NCT04425629|471706800|FG001|Overall Study|Adverse Event|0|||
131020634|NCT04425629|471706801|FG002|Overall Study|Adverse Event|0|||
131020635|NCT04425629|471706802|FG003|Overall Study|Adverse Event|0|||
131020636|NCT04425629|471706803|FG004|Overall Study|Adverse Event|1|||
131020637|NCT04425629|471706804|FG005|Overall Study|Adverse Event|0|||
131020638|NCT04425629|471706805|FG006|Overall Study|Adverse Event|0|||
131020639|NCT04425629|471706806|FG007|Overall Study|Adverse Event|0|||
131020640|NCT04425629|471706807|FG008|Overall Study|Adverse Event|0|||
131020641|NCT04425629|471706808|FG009|Overall Study|Adverse Event|3|||
131020642|NCT04425629|471706809|FG010|Overall Study|Adverse Event|2|||
131020643|NCT04425629|471706810|FG011|Overall Study|Adverse Event|1|||
131020644|NCT04425629|471706811|FG012|Overall Study|Adverse Event|1|||
131020645|NCT04425629|471706812|FG013|Overall Study|Adverse Event|0|||
131020646|NCT04425629|471706813|FG014|Overall Study|Adverse Event|0|||
131020647|NCT04425629|471706814|FG015|Overall Study|Adverse Event|0|||
131020648|NCT04425629|471706815|FG016|Overall Study|Adverse Event|0|||
131020649|NCT04425629|471706816|FG017|Overall Study|Adverse Event|0|||
131020650|NCT04425629|471706817|FG018|Overall Study|Adverse Event|0|||
131020651|NCT04425629|471706799|FG000|Overall Study|Lost to Follow-up|1|||
131020652|NCT04425629|471706800|FG001|Overall Study|Lost to Follow-up|3|||
131020653|NCT04425629|471706801|FG002|Overall Study|Lost to Follow-up|1|||
131020654|NCT04425629|471706802|FG003|Overall Study|Lost to Follow-up|7|||
131020655|NCT04425629|471706803|FG004|Overall Study|Lost to Follow-up|1|||
131020656|NCT04425629|471706804|FG005|Overall Study|Lost to Follow-up|2|||
131020657|NCT04425629|471706805|FG006|Overall Study|Lost to Follow-up|1|||
131020658|NCT04425629|471706806|FG007|Overall Study|Lost to Follow-up|0|||
130685232|NCT02601560|470476325|FG004|Overall Study|Other|0|||
130685233|NCT02601560|470476326|FG005|Overall Study|Other|0|||
130685234|NCT02601560|470476327|FG006|Overall Study|Other|1|||
130685235|NCT02601560|470476328|FG007|Overall Study|Other|0|||
130685236|NCT03459807|470476329|FG000|Overall Study|Withdrawal due to transplant|0|||
130767053|NCT03170609|470770698|FG004|Overall Study|Lost to Follow-up|1|||
130767054|NCT03170609|470770699|FG005|Overall Study|Lost to Follow-up|1|||
131020659|NCT04425629|471706807|FG008|Overall Study|Lost to Follow-up|1|||
131020660|NCT04425629|471706808|FG009|Overall Study|Lost to Follow-up|64|||
131020661|NCT04425629|471706809|FG010|Overall Study|Lost to Follow-up|70|||
131020662|NCT04425629|471706810|FG011|Overall Study|Lost to Follow-up|98|||
131020663|NCT04425629|471706811|FG012|Overall Study|Lost to Follow-up|30|||
131020664|NCT04425629|471706812|FG013|Overall Study|Lost to Follow-up|0|||
131020665|NCT04425629|471706813|FG014|Overall Study|Lost to Follow-up|5|||
131020666|NCT04425629|471706814|FG015|Overall Study|Lost to Follow-up|4|||
131020667|NCT04425629|471706815|FG016|Overall Study|Lost to Follow-up|0|||
131020668|NCT04425629|471706816|FG017|Overall Study|Lost to Follow-up|3|||
130685237|NCT03459807|470476330|FG001|Overall Study|Withdrawal due to transplant|1|||
130767055|NCT03170609|470770700|FG006|Overall Study|Lost to Follow-up|0|||
131020669|NCT04425629|471706817|FG018|Overall Study|Lost to Follow-up|1|||
131020670|NCT04425629|471706799|FG000|Overall Study|Subject Decision|0|||
131020671|NCT04425629|471706800|FG001|Overall Study|Subject Decision|2|||
130685238|NCT00833937|470476336|FG000|Washout|Withdrawal by Subject|1|||
130685239|NCT00833937|470476337|FG001|Washout|Withdrawal by Subject|0|||
130685240|NCT03725605|470476338|FG000|Overall Study|Unsuccessful TIL expansion|2|||
130685241|NCT03135834|470476346|FG000|Stage 1|Adverse Event|1|||
130685242|NCT03135834|470476347|FG001|Stage 1|Adverse Event|2|||
130685243|NCT03135834|470476348|FG002|Stage 1|Adverse Event|2|||
130685244|NCT03135834|470476349|FG003|Stage 1|Adverse Event|1|||
130685245|NCT03135834|470476346|FG000|Stage 1|Death|1|||
130685246|NCT03135834|470476347|FG001|Stage 1|Death|0|||
130685247|NCT03135834|470476348|FG002|Stage 1|Death|0|||
130685248|NCT03135834|470476349|FG003|Stage 1|Death|0|||
130685249|NCT03135834|470476346|FG000|Stage 1|Lost to Follow-up|17|||
130685250|NCT03135834|470476347|FG001|Stage 1|Lost to Follow-up|24|||
130685251|NCT03135834|470476348|FG002|Stage 1|Lost to Follow-up|21|||
130685252|NCT03135834|470476349|FG003|Stage 1|Lost to Follow-up|38|||
130685253|NCT03135834|470476346|FG000|Stage 1|No longer met eligibility criteria|1|||
130685254|NCT03135834|470476347|FG001|Stage 1|No longer met eligibility criteria|6|||
130685255|NCT03135834|470476348|FG002|Stage 1|No longer met eligibility criteria|2|||
130685256|NCT03135834|470476349|FG003|Stage 1|No longer met eligibility criteria|5|||
130685257|NCT03135834|470476346|FG000|Stage 1|Other|0|||
130685258|NCT03135834|470476347|FG001|Stage 1|Other|2|||
130685259|NCT03135834|470476348|FG002|Stage 1|Other|1|||
130685260|NCT03135834|470476349|FG003|Stage 1|Other|0|||
130685261|NCT03135834|470476346|FG000|Stage 1|Physician Decision|0|||
130685262|NCT03135834|470476347|FG001|Stage 1|Physician Decision|1|||
130685263|NCT03135834|470476348|FG002|Stage 1|Physician Decision|0|||
130685264|NCT03135834|470476349|FG003|Stage 1|Physician Decision|0|||
130685265|NCT03135834|470476346|FG000|Stage 1|Pregnancy|0|||
130685266|NCT03135834|470476347|FG001|Stage 1|Pregnancy|4|||
130685267|NCT03135834|470476348|FG002|Stage 1|Pregnancy|2|||
130685268|NCT03135834|470476349|FG003|Stage 1|Pregnancy|4|||
130685269|NCT03135834|470476346|FG000|Stage 1|Protocol Violation|1|||
130685270|NCT03135834|470476347|FG001|Stage 1|Protocol Violation|1|||
130685271|NCT03135834|470476348|FG002|Stage 1|Protocol Violation|2|||
130685272|NCT03135834|470476349|FG003|Stage 1|Protocol Violation|1|||
131020672|NCT04425629|471706801|FG002|Overall Study|Subject Decision|1|||
131020673|NCT04425629|471706802|FG003|Overall Study|Subject Decision|3|||
131020674|NCT04425629|471706803|FG004|Overall Study|Subject Decision|6|||
131020675|NCT04425629|471706804|FG005|Overall Study|Subject Decision|6|||
130685273|NCT03135834|470476346|FG000|Stage 1|Withdrawal by parent/guardian|2|||
130685274|NCT03135834|470476347|FG001|Stage 1|Withdrawal by parent/guardian|10|||
130685275|NCT03135834|470476348|FG002|Stage 1|Withdrawal by parent/guardian|2|||
131020676|NCT04425629|471706805|FG006|Overall Study|Subject Decision|3|||
131020677|NCT04425629|471706806|FG007|Overall Study|Subject Decision|3|||
131020678|NCT04425629|471706807|FG008|Overall Study|Subject Decision|1|||
131020679|NCT04425629|471706808|FG009|Overall Study|Subject Decision|70|||
131020680|NCT04425629|471706809|FG010|Overall Study|Subject Decision|95|||
131020681|NCT04425629|471706810|FG011|Overall Study|Subject Decision|124|||
131020682|NCT04425629|471706811|FG012|Overall Study|Subject Decision|25|||
131020683|NCT04425629|471706812|FG013|Overall Study|Subject Decision|0|||
131020684|NCT04425629|471706813|FG014|Overall Study|Subject Decision|1|||
131020685|NCT04425629|471706814|FG015|Overall Study|Subject Decision|4|||
131020686|NCT04425629|471706815|FG016|Overall Study|Subject Decision|1|||
131020687|NCT04425629|471706816|FG017|Overall Study|Subject Decision|0|||
131020688|NCT04425629|471706817|FG018|Overall Study|Subject Decision|2|||
131020689|NCT04425629|471706799|FG000|Overall Study|Death|0|||
131020690|NCT04425629|471706800|FG001|Overall Study|Death|0|||
131020691|NCT04425629|471706801|FG002|Overall Study|Death|0|||
131020692|NCT04425629|471706802|FG003|Overall Study|Death|0|||
131020693|NCT04425629|471706803|FG004|Overall Study|Death|0|||
131020694|NCT04425629|471706804|FG005|Overall Study|Death|0|||
130685276|NCT03135834|470476349|FG003|Stage 1|Withdrawal by parent/guardian|1|||
130685277|NCT03135834|470476346|FG000|Stage 1|Withdrawal by Subject|16|||
131020695|NCT04425629|471706805|FG006|Overall Study|Death|0|||
130685278|NCT03135834|470476347|FG001|Stage 1|Withdrawal by Subject|22|||
130685279|NCT03135834|470476348|FG002|Stage 1|Withdrawal by Subject|7|||
130685280|NCT03135834|470476349|FG003|Stage 1|Withdrawal by Subject|10|||
130685281|NCT03135834|470476346|FG000|Stage 1|Randomized but not Vaccinated|0|||
130685282|NCT03135834|470476347|FG001|Stage 1|Randomized but not Vaccinated|3|||
130685283|NCT03135834|470476348|FG002|Stage 1|Randomized but not Vaccinated|1|||
130685284|NCT03135834|470476349|FG003|Stage 1|Randomized but not Vaccinated|6|||
130685285|NCT03135834|470476346|FG000|Stage 2|Lost to Follow-up|0|||
130685286|NCT03135834|470476347|FG001|Stage 2|Lost to Follow-up|1|||
130685287|NCT03135834|470476348|FG002|Stage 2|Lost to Follow-up|0|||
130685288|NCT03135834|470476349|FG003|Stage 2|Lost to Follow-up|0|||
130685289|NCT03135834|470476346|FG000|Stage 2|Withdrawal by Subject|0|||
130685290|NCT03135834|470476347|FG001|Stage 2|Withdrawal by Subject|1|||
130685291|NCT03135834|470476348|FG002|Stage 2|Withdrawal by Subject|0|||
130685292|NCT03135834|470476349|FG003|Stage 2|Withdrawal by Subject|0|||
130685293|NCT03135834|470476346|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
131020696|NCT04425629|471706806|FG007|Overall Study|Death|0|||
131020697|NCT04425629|471706807|FG008|Overall Study|Death|0|||
131020698|NCT04425629|471706808|FG009|Overall Study|Death|11|||
130685294|NCT03135834|470476347|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
130685295|NCT03135834|470476348|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
130685296|NCT03135834|470476349|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
130685297|NCT03135834|470476346|FG000|Stage 2|Did not receive Booster Vaccination|1|||
130685298|NCT03135834|470476347|FG001|Stage 2|Did not receive Booster Vaccination|1|||
130685299|NCT03135834|470476348|FG002|Stage 2|Did not receive Booster Vaccination|0|||
130685300|NCT03135834|470476349|FG003|Stage 2|Did not receive Booster Vaccination|0|||
130685301|NCT00965185|470476350|FG000|Overall Study|Lost to Follow-up|2|||
130685302|NCT00965185|470476351|FG001|Overall Study|Lost to Follow-up|0|||
130685303|NCT00965185|470476350|FG000|Overall Study|Withdrawal by Subject|0|||
130685304|NCT00965185|470476351|FG001|Overall Study|Withdrawal by Subject|1|||
130685305|NCT03707912|470476354|FG000|Overall Study|Violation of inclusion criteria|1|||
130685306|NCT03707912|470476355|FG001|Overall Study|Violation of inclusion criteria|0|||
130685307|NCT02039908|470476356|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
130685308|NCT02039908|470476357|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
130685309|NCT02039908|470476358|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
130685310|NCT02039908|470476359|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
130685311|NCT02039908|470476356|FG000|Phase 1-Summer|Protocol Violation|6|||
130685312|NCT02039908|470476357|FG001|Phase 1-Summer|Protocol Violation|0|||
130685313|NCT02039908|470476358|FG002|Phase 1-Summer|Protocol Violation|0|||
130685314|NCT02039908|470476359|FG003|Phase 1-Summer|Protocol Violation|0|||
130685315|NCT02039908|470476356|FG000|Phase 2-School Year|Lost to Follow-up|0|||
130685316|NCT02039908|470476357|FG001|Phase 2-School Year|Lost to Follow-up|0|||
130685317|NCT02039908|470476358|FG002|Phase 2-School Year|Lost to Follow-up|1|||
130685318|NCT02039908|470476359|FG003|Phase 2-School Year|Lost to Follow-up|3|||
130685319|NCT02039908|470476356|FG000|Phase 2-School Year|Protocol Violation|0|||
130685320|NCT02039908|470476357|FG001|Phase 2-School Year|Protocol Violation|0|||
130685321|NCT02039908|470476358|FG002|Phase 2-School Year|Protocol Violation|3|||
130685322|NCT02039908|470476359|FG003|Phase 2-School Year|Protocol Violation|0|||
130685323|NCT02039908|470476356|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
130685324|NCT02039908|470476357|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
130685325|NCT02039908|470476358|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
130685326|NCT02039908|470476359|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
130685327|NCT01802320|470476360|FG000|Overall Study|Death|1|||
130685328|NCT01802320|470476360|FG000|Overall Study|Withdrawal by Subject|1|||
130685329|NCT02956460|470477797|FG000|Lens 1|Lost to Follow-up|1|||
130685330|NCT02956460|470477798|FG001|Lens 1|Lost to Follow-up|0|||
130685331|NCT04129346|470477799|FG000|Overall Study|Death|1|||
130685332|NCT04129346|470477800|FG001|Overall Study|Death|0|||
130685333|NCT02077465|470477801|FG000|Overall Study|Withdrew Consent|0|||
130685334|NCT02077465|470477802|FG001|Overall Study|Withdrew Consent|1|||
130685335|NCT02077465|470477801|FG000|Overall Study|Lost to Follow-up|1|||
130685336|NCT02077465|470477802|FG001|Overall Study|Lost to Follow-up|0|||
130685337|NCT01827163|470477803|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
130685338|NCT01827163|470477803|FG000|Overall Study|Adverse Event|9|||
130685339|NCT03375463|470477804|FG000|Period 1|Lost to Follow-up|0|||
130685340|NCT03375463|470477805|FG001|Period 1|Lost to Follow-up|0|||
130685341|NCT03375463|470477806|FG002|Period 1|Lost to Follow-up|1|||
130685342|NCT03375463|470477807|FG003|Period 1|Lost to Follow-up|0|||
130685343|NCT03375463|470477808|FG004|Period 1|Lost to Follow-up|0|||
130685344|NCT03375463|470477809|FG005|Period 1|Lost to Follow-up|0|||
130685345|NCT03375463|470477804|FG000|Period 1|Adverse Event|0|||
130685346|NCT03375463|470477805|FG001|Period 1|Adverse Event|0|||
130685347|NCT03375463|470477806|FG002|Period 1|Adverse Event|0|||
130685348|NCT03375463|470477807|FG003|Period 1|Adverse Event|0|||
131020699|NCT04425629|471706809|FG010|Overall Study|Death|2|||
131020700|NCT04425629|471706810|FG011|Overall Study|Death|4|||
131020701|NCT04425629|471706811|FG012|Overall Study|Death|0|||
131020702|NCT04425629|471706812|FG013|Overall Study|Death|0|||
131020703|NCT04425629|471706813|FG014|Overall Study|Death|0|||
131020704|NCT04425629|471706814|FG015|Overall Study|Death|0|||
131020705|NCT04425629|471706815|FG016|Overall Study|Death|0|||
130685349|NCT03375463|470477808|FG004|Period 1|Adverse Event|1|||
130685350|NCT03375463|470477809|FG005|Period 1|Adverse Event|0|||
130685351|NCT03375463|470477804|FG000|Period 2|Lost to Follow-up|1|||
130685352|NCT03375463|470477805|FG001|Period 2|Lost to Follow-up|1|||
130685353|NCT03375463|470477806|FG002|Period 2|Lost to Follow-up|0|||
130685354|NCT03375463|470477807|FG003|Period 2|Lost to Follow-up|0|||
130685355|NCT03375463|470477808|FG004|Period 2|Lost to Follow-up|0|||
131020706|NCT04425629|471706816|FG017|Overall Study|Death|0|||
130685356|NCT03375463|470477809|FG005|Period 2|Lost to Follow-up|0|||
130685357|NCT01602419|470477810|FG000|Overall Study|Not treated with Wilate|9|||
130685358|NCT01602419|470477810|FG000|Overall Study|Adverse Drug Reaction|4|||
130685359|NCT01602419|470477810|FG000|Overall Study|Insurance issues|3|||
130685360|NCT01602419|470477810|FG000|Overall Study|Changed treatment centre|1|||
130685361|NCT01602419|470477810|FG000|Overall Study|Treatment centre closed|1|||
130685362|NCT01602419|470477810|FG000|Overall Study|Withdrawal by Subject|5|||
131020707|NCT04425629|471706817|FG018|Overall Study|Death|0|||
131020708|NCT04425629|471706799|FG000|Overall Study|Sponsor Request|0|||
130685363|NCT01602419|470477810|FG000|Overall Study|Lost to Follow-up|6|||
130685364|NCT01792635|470477811|FG000|Part B|Adverse Event|0|||
130685365|NCT01792635|470477812|FG001|Part B|Adverse Event|0|||
130685366|NCT01792635|470477813|FG002|Part B|Adverse Event|1|||
130685367|NCT01792635|470477811|FG000|Part B|Study terminated|0|||
130685368|NCT01792635|470477812|FG001|Part B|Study terminated|4|||
130685369|NCT01792635|470477813|FG002|Part B|Study terminated|3|||
130685370|NCT01513174|470477816|FG000|Overall Study|Inclusion Error|1|||
130685371|NCT01513174|470477817|FG001|Overall Study|Inclusion Error|7|||
130685372|NCT01513174|470477816|FG000|Overall Study|Not receive study treatment|3|||
130685373|NCT01513174|470477817|FG001|Overall Study|Not receive study treatment|1|||
130685374|NCT00467363|470477818|FG000|Overall Study|Lost to Follow-up|80|||
130685375|NCT00467363|470477819|FG001|Overall Study|Lost to Follow-up|70|||
130685376|NCT00365846|470477820|FG000|Overall Study|Lost to Follow-up|1|||
130685377|NCT04400890|470477821|FG000|Overall Study|Withdrawal by Subject|3|||
130685378|NCT04400890|470477822|FG001|Overall Study|Withdrawal by Subject|2|||
130685379|NCT00723710|470477823|FG000|Overall Study|Disease progression|48|||
130685380|NCT00723710|470477823|FG000|Overall Study|Adverse Event|88|||
130685381|NCT00723710|470477823|FG000|Overall Study|Withdrawal by Subject|36|||
130685382|NCT00723710|470477823|FG000|Overall Study|Physician Decision|2|||
130685383|NCT04405570|470477824|FG000|Overall Study|Adverse Event|0|||
130685384|NCT04405570|470477825|FG001|Overall Study|Adverse Event|1|||
130685385|NCT04405570|470477826|FG002|Overall Study|Adverse Event|1|||
130685386|NCT04405570|470477827|FG003|Overall Study|Adverse Event|1|||
130685387|NCT04405570|470477824|FG000|Overall Study|Lost to Follow-up|0|||
130685388|NCT04405570|470477825|FG001|Overall Study|Lost to Follow-up|1|||
130685389|NCT04405570|470477826|FG002|Overall Study|Lost to Follow-up|0|||
130685390|NCT04405570|470477827|FG003|Overall Study|Lost to Follow-up|0|||
130685391|NCT04405570|470477824|FG000|Overall Study|Physician Decision|0|||
130685392|NCT04405570|470477825|FG001|Overall Study|Physician Decision|0|||
130685393|NCT04405570|470477826|FG002|Overall Study|Physician Decision|1|||
130685394|NCT04405570|470477827|FG003|Overall Study|Physician Decision|0|||
130685395|NCT04405570|470477824|FG000|Overall Study|Withdrawal by Subject|0|||
130685396|NCT04405570|470477825|FG001|Overall Study|Withdrawal by Subject|1|||
130685397|NCT04405570|470477826|FG002|Overall Study|Withdrawal by Subject|1|||
130685398|NCT04405570|470477827|FG003|Overall Study|Withdrawal by Subject|0|||
130685399|NCT04405570|470477824|FG000|Overall Study|Randomized not dosed|0|||
130685400|NCT04405570|470477825|FG001|Overall Study|Randomized not dosed|2|||
130685401|NCT04405570|470477826|FG002|Overall Study|Randomized not dosed|0|||
130685402|NCT04405570|470477827|FG003|Overall Study|Randomized not dosed|0|||
130685403|NCT04499963|470477828|FG000|Overall Study|Adverse Event|3|||
130685404|NCT04499963|470477829|FG001|Overall Study|Adverse Event|0|||
130685405|NCT04499963|470477828|FG000|Overall Study|Death|3|||
130685406|NCT04499963|470477829|FG001|Overall Study|Death|0|||
130685407|NCT04499963|470477828|FG000|Overall Study|Lack of Efficacy|7|||
130685408|NCT04499963|470477829|FG001|Overall Study|Lack of Efficacy|0|||
131020709|NCT04425629|471706800|FG001|Overall Study|Sponsor Request|0|||
131020710|NCT04425629|471706801|FG002|Overall Study|Sponsor Request|0|||
131020711|NCT04425629|471706802|FG003|Overall Study|Sponsor Request|2|||
131020712|NCT04425629|471706803|FG004|Overall Study|Sponsor Request|2|||
130685409|NCT04499963|470477828|FG000|Overall Study|Lost to Follow-up|2|||
130685410|NCT04499963|470477829|FG001|Overall Study|Lost to Follow-up|0|||
130685411|NCT02711852|470477836|FG000|Overall Study|Death|5|||
130685412|NCT02711852|470477836|FG000|Overall Study|Lost to Follow-up|1|||
130685413|NCT02711852|470477836|FG000|Overall Study|Completed follow-up|3|||
130685414|NCT02711852|470477836|FG000|Overall Study|Withdrawal by Subject|1|||
130685415|NCT03233724|470477837|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130685416|NCT03233724|470477838|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130685417|NCT03233724|470477839|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130685418|NCT03233724|470477840|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130685419|NCT03233724|470477841|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
130685420|NCT03233724|470477837|FG000|Phase I Dose Escalation|Best interest of participant|1|||
130685421|NCT03233724|470477838|FG001|Phase I Dose Escalation|Best interest of participant|1|||
130685422|NCT03233724|470477839|FG002|Phase I Dose Escalation|Best interest of participant|1|||
130685423|NCT03233724|470477840|FG003|Phase I Dose Escalation|Best interest of participant|0|||
130685424|NCT03233724|470477841|FG004|Phase I Dose Escalation|Best interest of participant|0|||
130685425|NCT03233724|470477837|FG000|Phase I Dose Escalation|Physician Decision|0|||
130685426|NCT03233724|470477838|FG001|Phase I Dose Escalation|Physician Decision|0|||
130685427|NCT03233724|470477839|FG002|Phase I Dose Escalation|Physician Decision|1|||
130685428|NCT03233724|470477840|FG003|Phase I Dose Escalation|Physician Decision|0|||
130685429|NCT03233724|470477841|FG004|Phase I Dose Escalation|Physician Decision|0|||
130685430|NCT03233724|470477837|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130767056|NCT03170609|470770694|FG000|Overall Study|Other|1|||
131020713|NCT04425629|471706804|FG005|Overall Study|Sponsor Request|2|||
130685431|NCT03233724|470477838|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130685432|NCT03233724|470477839|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
130685433|NCT03233724|470477840|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130685434|NCT03233724|470477841|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130685435|NCT02388191|470477843|FG000|Overall Study|Patient did not receive IUD|1|||
130685436|NCT02388191|470477844|FG001|Overall Study|Patient did not receive IUD|0|||
130685437|NCT03686033|470477845|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
130685438|NCT03686033|470477846|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
130685439|NCT03686033|470477847|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
131106367|NCT03534284|472019022|FG001|Overall Study|Withdrawal by Subject|0|||
131106368|NCT03534284|472019023|FG002|Overall Study|Withdrawal by Subject|0|||
131106369|NCT04737187|472019024|FG000|Overall Study|Switched to marketed drug|32|||
130685440|NCT03686033|470477848|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
130685441|NCT03686033|470477849|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
130685442|NCT03686033|470477850|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
130685443|NCT03197883|470477851|FG000|Overall Study|Adverse Event|1|||
130685444|NCT03197883|470477852|FG001|Overall Study|Adverse Event|1|||
130685445|NCT03197883|470477851|FG000|Overall Study|Lost to Follow-up|1|||
130685446|NCT03197883|470477852|FG001|Overall Study|Lost to Follow-up|0|||
130685447|NCT03197883|470477851|FG000|Overall Study|Protocol Violation|1|||
130685448|NCT03197883|470477852|FG001|Overall Study|Protocol Violation|0|||
130685449|NCT03197883|470477851|FG000|Overall Study|Other (Not Specified)|0|||
130685450|NCT03197883|470477852|FG001|Overall Study|Other (Not Specified)|5|||
130685451|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
130685452|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
130685453|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
130685454|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
130685455|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
130685456|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
130685457|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
130685458|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
130685459|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
130685460|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
130685461|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
130685462|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
130685463|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
130685464|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
130685465|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
130685466|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
130685467|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
130685468|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
130685469|NCT01045161|470477853|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
130685470|NCT01045161|470477854|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
130685471|NCT01045161|470477855|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
130685472|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
130685473|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
130685474|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
130685475|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
130685476|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
130685477|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
130685478|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
130685479|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
130685480|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
130685481|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
130685482|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
130685483|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
130685484|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
130685485|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
130685486|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
130685487|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
130685488|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
130685489|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
130685490|NCT01045161|470477853|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
130685491|NCT01045161|470477854|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
130685492|NCT01045161|470477855|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
130685493|NCT03031847|470477856|FG000|Overall Study|Death|1|||
130685494|NCT03031847|470477857|FG001|Overall Study|Death|1|||
130685495|NCT03031847|470477858|FG002|Overall Study|Death|2|||
131020714|NCT04425629|471706805|FG006|Overall Study|Sponsor Request|1|||
131020715|NCT04425629|471706806|FG007|Overall Study|Sponsor Request|0|||
130685496|NCT03031847|470477859|FG003|Overall Study|Death|3|||
130685497|NCT03031847|470477856|FG000|Overall Study|Lost to Follow-up|1|||
130685498|NCT03031847|470477857|FG001|Overall Study|Lost to Follow-up|1|||
130685499|NCT03031847|470477858|FG002|Overall Study|Lost to Follow-up|2|||
130685500|NCT03031847|470477859|FG003|Overall Study|Lost to Follow-up|3|||
130685501|NCT01353664|470477862|FG000|Overall Study|Other|3|||
130685502|NCT01353664|470477862|FG000|Overall Study|Disease Progression|16|||
130685503|NCT02612337|470477867|FG000|Overall Study|Lack of Efficacy|1|||
130685504|NCT02612337|470477868|FG001|Overall Study|Lack of Efficacy|0|||
130685505|NCT02612337|470477867|FG000|Overall Study|Withdrawal by Subject|2|||
130685506|NCT02612337|470477868|FG001|Overall Study|Withdrawal by Subject|2|||
130685507|NCT02612337|470477867|FG000|Overall Study|Did not receive study drug|0|||
130685508|NCT02612337|470477868|FG001|Overall Study|Did not receive study drug|1|||
130685509|NCT02242201|470477869|FG000|Overall Study|preoperative identified neuropathy|2|||
130685510|NCT02242201|470477870|FG001|Overall Study|preoperative identified neuropathy|0|||
130685511|NCT02242201|470477871|FG002|Overall Study|preoperative identified neuropathy|0|||
130685512|NCT02242201|470477869|FG000|Overall Study|planned post-op anticoagulation|1|||
130685513|NCT02242201|470477870|FG001|Overall Study|planned post-op anticoagulation|0|||
130685514|NCT02242201|470477871|FG002|Overall Study|planned post-op anticoagulation|0|||
130685515|NCT02242201|470477869|FG000|Overall Study|changed surgical procedure|1|||
130685516|NCT02242201|470477870|FG001|Overall Study|changed surgical procedure|0|||
130685517|NCT02242201|470477871|FG002|Overall Study|changed surgical procedure|0|||
130685518|NCT02242201|470477869|FG000|Overall Study|postponed surgery|0|||
130685519|NCT02242201|470477870|FG001|Overall Study|postponed surgery|0|||
130685520|NCT02242201|470477871|FG002|Overall Study|postponed surgery|1|||
130685521|NCT02242201|470477869|FG000|Overall Study|preoperative opioid consumption|0|||
130685522|NCT02242201|470477870|FG001|Overall Study|preoperative opioid consumption|1|||
130685523|NCT02242201|470477871|FG002|Overall Study|preoperative opioid consumption|0|||
130685524|NCT01424644|470477874|FG000|Overall Study|Adverse Event|2|||
130685525|NCT01424644|470477875|FG001|Overall Study|Adverse Event|0|||
130685526|NCT01424644|470477874|FG000|Overall Study|Withdrawal by Subject|9|||
130685527|NCT01424644|470477875|FG001|Overall Study|Withdrawal by Subject|12|||
130685528|NCT01424644|470477874|FG000|Overall Study|Lost to Follow-up|16|||
130685529|NCT01424644|470477875|FG001|Overall Study|Lost to Follow-up|12|||
130685530|NCT01424644|470477874|FG000|Overall Study|Protocol Violation|4|||
130685531|NCT01424644|470477875|FG001|Overall Study|Protocol Violation|3|||
130685532|NCT01424644|470477874|FG000|Overall Study|Administrative Reason|1|||
130685533|NCT01424644|470477875|FG001|Overall Study|Administrative Reason|0|||
130685534|NCT01424644|470477874|FG000|Overall Study|Unable to Classify|1|||
130685535|NCT01424644|470477875|FG001|Overall Study|Unable to Classify|0|||
130685536|NCT01880593|470477876|FG000|Overall Study|Adverse Event|1|||
130685537|NCT01880593|470477877|FG001|Overall Study|Adverse Event|0|||
130685538|NCT01880593|470477876|FG000|Overall Study|Lack of Efficacy|1|||
130685539|NCT01880593|470477877|FG001|Overall Study|Lack of Efficacy|5|||
130685540|NCT01880593|470477876|FG000|Overall Study|Withdrawal by Subject|6|||
130685541|NCT01880593|470477877|FG001|Overall Study|Withdrawal by Subject|1|||
130685542|NCT02272777|470477878|FG000|Overall Study|Adverse Event|0|||
130685543|NCT02272777|470477879|FG001|Overall Study|Adverse Event|1|||
130685544|NCT02272777|470477878|FG000|Overall Study|Withdrawal by Subject|0|||
130685545|NCT02272777|470477879|FG001|Overall Study|Withdrawal by Subject|3|||
130685546|NCT02272777|470477878|FG000|Overall Study|Lost to Follow-up|2|||
130685547|NCT02272777|470477879|FG001|Overall Study|Lost to Follow-up|0|||
130685548|NCT02272777|470477878|FG000|Overall Study|Other|2|||
130685549|NCT02272777|470477879|FG001|Overall Study|Other|0|||
130685550|NCT05275205|470477885|FG000|Overall Study|Adverse Event|1|||
130685551|NCT05275205|470477886|FG001|Overall Study|Adverse Event|2|||
130685552|NCT05275205|470477885|FG000|Overall Study|Physician Decision|1|||
130685553|NCT05275205|470477886|FG001|Overall Study|Physician Decision|1|||
130685554|NCT05275205|470477885|FG000|Overall Study|Withdrawal by Subject|2|||
130685555|NCT05275205|470477886|FG001|Overall Study|Withdrawal by Subject|3|||
130685556|NCT05275205|470477885|FG000|Overall Study|Death|1|||
130685557|NCT05275205|470477886|FG001|Overall Study|Death|0|||
130685558|NCT05275205|470477885|FG000|Overall Study|Patient unable to attend visits|1|||
130685559|NCT05275205|470477886|FG001|Overall Study|Patient unable to attend visits|0|||
130685560|NCT02066922|470477887|FG000|Overall Study|Adverse Event|1|||
130685561|NCT00440297|470477888|FG000|Overall Study|Adverse Event|8|||
131020716|NCT04425629|471706807|FG008|Overall Study|Sponsor Request|0|||
131020717|NCT04425629|471706808|FG009|Overall Study|Sponsor Request|9|||
130685562|NCT00440297|470477889|FG001|Overall Study|Adverse Event|5|||
130685563|NCT00440297|470477888|FG000|Overall Study|Lost to Follow-up|1|||
130685564|NCT00440297|470477889|FG001|Overall Study|Lost to Follow-up|0|||
130685565|NCT00440297|470477888|FG000|Overall Study|Physician Decision|1|||
130685566|NCT00440297|470477889|FG001|Overall Study|Physician Decision|0|||
130685567|NCT00440297|470477888|FG000|Overall Study|Protocol Violation|11|||
130685568|NCT00440297|470477889|FG001|Overall Study|Protocol Violation|7|||
130685569|NCT00440297|470477888|FG000|Overall Study|Withdrawal by Subject|1|||
130886592|NCT01094119|471217356|FG000|Overall Study|Lack of Efficacy|2|||
130886593|NCT01094119|471217357|FG001|Overall Study|Lack of Efficacy|4|||
130886594|NCT03815929|471217366|FG000|Overall Study|Lost to Follow-up|2|||
130886595|NCT03815929|471217367|FG001|Overall Study|Lost to Follow-up|1|||
130886596|NCT03815929|471217368|FG002|Overall Study|Lost to Follow-up|0|||
130886597|NCT03815929|471217366|FG000|Overall Study|Physician Decision|2|||
130886598|NCT03815929|471217367|FG001|Overall Study|Physician Decision|2|||
130886599|NCT03815929|471217368|FG002|Overall Study|Physician Decision|0|||
130886600|NCT03815929|471217366|FG000|Overall Study|Withdrawal by Subject|0|||
130886601|NCT03815929|471217367|FG001|Overall Study|Withdrawal by Subject|0|||
130886602|NCT03815929|471217368|FG002|Overall Study|Withdrawal by Subject|1|||
130886603|NCT03313037|471217369|FG000|Overall Study|Protocol Violation|4|||
130886604|NCT03313037|471217370|FG001|Overall Study|Protocol Violation|1|||
130886605|NCT03313037|471217369|FG000|Overall Study|Other|1|||
130886606|NCT03313037|471217370|FG001|Overall Study|Other|1|||
130886607|NCT03313037|471217369|FG000|Overall Study|Withdrawal by Subject|4|||
130886608|NCT03313037|471217370|FG001|Overall Study|Withdrawal by Subject|3|||
130886609|NCT03313037|471217369|FG000|Overall Study|No longer meets eligibility criteria|1|||
130886610|NCT03313037|471217370|FG001|Overall Study|No longer meets eligibility criteria|7|||
131106370|NCT04737187|472019025|FG001|Overall Study|Switched to marketed drug|4|||
131106371|NCT04737187|472019024|FG000|Overall Study|Radiological Progressive Disease|145|||
131106372|NCT04737187|472019025|FG001|Overall Study|Radiological Progressive Disease|146|||
131106373|NCT04737187|472019024|FG000|Overall Study|Clinical Progressive Disease|20|||
131106374|NCT04737187|472019025|FG001|Overall Study|Clinical Progressive Disease|20|||
131106375|NCT04737187|472019024|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
131106376|NCT04737187|472019025|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
131106377|NCT04737187|472019024|FG000|Overall Study|Adverse Event|16|||
131106378|NCT04737187|472019025|FG001|Overall Study|Adverse Event|16|||
131106379|NCT04737187|472019024|FG000|Overall Study|Physician Decision|2|||
131106380|NCT04737187|472019025|FG001|Overall Study|Physician Decision|0|||
131106381|NCT04737187|472019024|FG000|Overall Study|Withdrawal by Subject|5|||
131106382|NCT04737187|472019025|FG001|Overall Study|Withdrawal by Subject|8|||
131106383|NCT03756129|472019026|FG000|Overall Study|Adverse Event|1|||
131106384|NCT03756129|472019027|FG001|Overall Study|Adverse Event|1|||
131106385|NCT03756129|472019028|FG002|Overall Study|Adverse Event|0|||
131106386|NCT03756129|472019029|FG003|Overall Study|Adverse Event|2|||
131106387|NCT03756129|472019030|FG004|Overall Study|Adverse Event|0|||
131106388|NCT03756129|472019031|FG005|Overall Study|Adverse Event|0|||
131106389|NCT03756129|472019026|FG000|Overall Study|Withdrawal by Subject|2|||
131106390|NCT03756129|472019027|FG001|Overall Study|Withdrawal by Subject|1|||
131106391|NCT03756129|472019028|FG002|Overall Study|Withdrawal by Subject|3|||
131106392|NCT03756129|472019029|FG003|Overall Study|Withdrawal by Subject|1|||
131106393|NCT03756129|472019030|FG004|Overall Study|Withdrawal by Subject|1|||
131106394|NCT03756129|472019031|FG005|Overall Study|Withdrawal by Subject|3|||
131106395|NCT03756129|472019026|FG000|Overall Study|Lost to Follow-up|0|||
131106396|NCT03756129|472019027|FG001|Overall Study|Lost to Follow-up|0|||
131106397|NCT03756129|472019028|FG002|Overall Study|Lost to Follow-up|0|||
131106398|NCT03756129|472019029|FG003|Overall Study|Lost to Follow-up|0|||
131106399|NCT03756129|472019030|FG004|Overall Study|Lost to Follow-up|0|||
131106400|NCT03756129|472019031|FG005|Overall Study|Lost to Follow-up|1|||
131106401|NCT03756129|472019026|FG000|Overall Study|Physician Decision|0|||
131106402|NCT03756129|472019027|FG001|Overall Study|Physician Decision|0|||
131106403|NCT03756129|472019028|FG002|Overall Study|Physician Decision|0|||
131106404|NCT03756129|472019029|FG003|Overall Study|Physician Decision|0|||
131106405|NCT03756129|472019030|FG004|Overall Study|Physician Decision|0|||
131106406|NCT03756129|472019031|FG005|Overall Study|Physician Decision|1|||
131106407|NCT05195489|472020842|FG000|Overall Study|Lost to Follow-up|1|||
131106408|NCT05195489|472020843|FG001|Overall Study|Lost to Follow-up|0|||
131106409|NCT05195489|472020842|FG000|Overall Study|Protocol Violation|0|||
131106410|NCT05195489|472020843|FG001|Overall Study|Protocol Violation|2|||
131106411|NCT05195489|472020842|FG000|Overall Study|Withdrawal by Subject|1|||
131106412|NCT05195489|472020843|FG001|Overall Study|Withdrawal by Subject|1|||
131106413|NCT05195489|472020842|FG000|Overall Study|Removed|0|||
131106414|NCT05195489|472020843|FG001|Overall Study|Removed|1|||
131106415|NCT04812548|472020845|FG000|Overall Study|Adverse Event|2|||
130886611|NCT03313037|471217369|FG000|Overall Study|Lost to Follow-up|9|||
131106416|NCT04812548|472020846|FG001|Overall Study|Adverse Event|7|||
131106417|NCT04812548|472020845|FG000|Overall Study|HSCT Planned|2|||
131106418|NCT04812548|472020846|FG001|Overall Study|HSCT Planned|3|||
131106419|NCT04812548|472020845|FG000|Overall Study|Progressive Disease|0|||
131106420|NCT04812548|472020846|FG001|Overall Study|Progressive Disease|2|||
131106421|NCT04812548|472020845|FG000|Overall Study|Death|0|||
131106422|NCT04812548|472020846|FG001|Overall Study|Death|1|||
131106423|NCT04812548|472020845|FG000|Overall Study|Post Study Access to Treatment|0|||
131106424|NCT04812548|472020846|FG001|Overall Study|Post Study Access to Treatment|1|||
130886612|NCT03313037|471217370|FG001|Overall Study|Lost to Follow-up|8|||
130886613|NCT03313037|471217369|FG000|Overall Study|Randomized but not treated|1|||
130886614|NCT03313037|471217370|FG001|Overall Study|Randomized but not treated|0|||
130886615|NCT02379091|471217371|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130886616|NCT02379091|471217372|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
130886617|NCT02379091|471217373|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131020718|NCT04425629|471706809|FG010|Overall Study|Sponsor Request|9|||
131020719|NCT04425629|471706810|FG011|Overall Study|Sponsor Request|10|||
131020720|NCT04425629|471706811|FG012|Overall Study|Sponsor Request|8|||
131020721|NCT04425629|471706812|FG013|Overall Study|Sponsor Request|0|||
131020722|NCT04425629|471706813|FG014|Overall Study|Sponsor Request|0|||
131020723|NCT04425629|471706814|FG015|Overall Study|Sponsor Request|1|||
131020724|NCT04425629|471706815|FG016|Overall Study|Sponsor Request|0|||
131020725|NCT04425629|471706816|FG017|Overall Study|Sponsor Request|0|||
131020726|NCT04425629|471706817|FG018|Overall Study|Sponsor Request|0|||
131020727|NCT04425629|471706799|FG000|Overall Study|Physician Decision|0|||
131020728|NCT04425629|471706800|FG001|Overall Study|Physician Decision|0|||
131020729|NCT04425629|471706801|FG002|Overall Study|Physician Decision|0|||
131020730|NCT04425629|471706802|FG003|Overall Study|Physician Decision|0|||
131020731|NCT04425629|471706803|FG004|Overall Study|Physician Decision|0|||
131020732|NCT04425629|471706804|FG005|Overall Study|Physician Decision|0|||
131020733|NCT04425629|471706805|FG006|Overall Study|Physician Decision|0|||
131020734|NCT04425629|471706806|FG007|Overall Study|Physician Decision|0|||
131020735|NCT04425629|471706807|FG008|Overall Study|Physician Decision|0|||
131020736|NCT04425629|471706808|FG009|Overall Study|Physician Decision|4|||
131020737|NCT04425629|471706809|FG010|Overall Study|Physician Decision|3|||
131020738|NCT04425629|471706810|FG011|Overall Study|Physician Decision|5|||
131020739|NCT04425629|471706811|FG012|Overall Study|Physician Decision|1|||
131020740|NCT04425629|471706812|FG013|Overall Study|Physician Decision|0|||
131020741|NCT04425629|471706813|FG014|Overall Study|Physician Decision|0|||
131020742|NCT04425629|471706814|FG015|Overall Study|Physician Decision|1|||
131020743|NCT04425629|471706815|FG016|Overall Study|Physician Decision|0|||
131020744|NCT04425629|471706816|FG017|Overall Study|Physician Decision|0|||
131020745|NCT04425629|471706817|FG018|Overall Study|Physician Decision|0|||
131020746|NCT04425629|471706799|FG000|Overall Study|Lack of Efficacy|0|||
131020747|NCT04425629|471706800|FG001|Overall Study|Lack of Efficacy|0|||
131020748|NCT04425629|471706801|FG002|Overall Study|Lack of Efficacy|0|||
131020749|NCT04425629|471706802|FG003|Overall Study|Lack of Efficacy|0|||
131020750|NCT04425629|471706803|FG004|Overall Study|Lack of Efficacy|0|||
131020751|NCT04425629|471706804|FG005|Overall Study|Lack of Efficacy|0|||
131020752|NCT04425629|471706805|FG006|Overall Study|Lack of Efficacy|0|||
131020753|NCT04425629|471706806|FG007|Overall Study|Lack of Efficacy|0|||
131020754|NCT04425629|471706807|FG008|Overall Study|Lack of Efficacy|0|||
131020755|NCT04425629|471706808|FG009|Overall Study|Lack of Efficacy|0|||
131020756|NCT04425629|471706809|FG010|Overall Study|Lack of Efficacy|1|||
131020757|NCT04425629|471706810|FG011|Overall Study|Lack of Efficacy|0|||
131020758|NCT04425629|471706811|FG012|Overall Study|Lack of Efficacy|0|||
131020759|NCT04425629|471706812|FG013|Overall Study|Lack of Efficacy|0|||
131020760|NCT04425629|471706813|FG014|Overall Study|Lack of Efficacy|0|||
131020761|NCT04425629|471706814|FG015|Overall Study|Lack of Efficacy|0|||
131020762|NCT04425629|471706815|FG016|Overall Study|Lack of Efficacy|0|||
131020763|NCT04425629|471706816|FG017|Overall Study|Lack of Efficacy|0|||
131020764|NCT04425629|471706817|FG018|Overall Study|Lack of Efficacy|0|||
131020765|NCT00610649|471706819|FG000|Overall Study|Adverse Event|1|||
131020766|NCT00610649|471706820|FG001|Overall Study|Adverse Event|0|||
131020767|NCT00610649|471706821|FG002|Overall Study|Adverse Event|0|||
131020768|NCT00610649|471706822|FG003|Overall Study|Adverse Event|0|||
131020769|NCT00610649|471706823|FG004|Overall Study|Adverse Event|0|||
131020770|NCT00610649|471706824|FG005|Overall Study|Adverse Event|0|||
131020771|NCT00610649|471706825|FG006|Overall Study|Adverse Event|0|||
131020772|NCT00610649|471706826|FG007|Overall Study|Adverse Event|0|||
131020773|NCT00610649|471706827|FG008|Overall Study|Adverse Event|0|||
131020774|NCT00610649|471706828|FG009|Overall Study|Adverse Event|0|||
131020775|NCT00610649|471706829|FG010|Overall Study|Adverse Event|1|||
131020776|NCT00610649|471706819|FG000|Overall Study|Family Emergency|0|||
131020777|NCT00610649|471706820|FG001|Overall Study|Family Emergency|1|||
131020778|NCT00610649|471706821|FG002|Overall Study|Family Emergency|0|||
131020779|NCT00610649|471706822|FG003|Overall Study|Family Emergency|0|||
131020780|NCT00610649|471706823|FG004|Overall Study|Family Emergency|0|||
131020781|NCT00610649|471706824|FG005|Overall Study|Family Emergency|0|||
131020782|NCT00610649|471706825|FG006|Overall Study|Family Emergency|0|||
131020783|NCT00610649|471706826|FG007|Overall Study|Family Emergency|0|||
131020784|NCT00610649|471706827|FG008|Overall Study|Family Emergency|0|||
131020785|NCT00610649|471706828|FG009|Overall Study|Family Emergency|0|||
131020786|NCT00610649|471706829|FG010|Overall Study|Family Emergency|0|||
131020787|NCT00610649|471706819|FG000|Overall Study|Withdrawal by Subject|0|||
131020788|NCT00610649|471706820|FG001|Overall Study|Withdrawal by Subject|0|||
131020789|NCT00610649|471706821|FG002|Overall Study|Withdrawal by Subject|0|||
131020790|NCT00610649|471706822|FG003|Overall Study|Withdrawal by Subject|0|||
131020791|NCT00610649|471706823|FG004|Overall Study|Withdrawal by Subject|0|||
131020792|NCT00610649|471706824|FG005|Overall Study|Withdrawal by Subject|0|||
131020793|NCT00610649|471706825|FG006|Overall Study|Withdrawal by Subject|0|||
131020794|NCT00610649|471706826|FG007|Overall Study|Withdrawal by Subject|0|||
130685570|NCT00440297|470477889|FG001|Overall Study|Withdrawal by Subject|6|||
130685571|NCT00440297|470477888|FG000|Overall Study|Randomized by mistake|1|||
130685572|NCT00440297|470477889|FG001|Overall Study|Randomized by mistake|0|||
130685573|NCT02024932|470477890|FG000|Overall Study|Adverse Event|2|||
130685574|NCT02024932|470477891|FG001|Overall Study|Adverse Event|3|||
130685575|NCT02024932|470477892|FG002|Overall Study|Adverse Event|0|||
130685576|NCT02024932|470477893|FG003|Overall Study|Adverse Event|0|||
130685577|NCT02024932|470477894|FG004|Overall Study|Adverse Event|2|||
130685578|NCT02024932|470477895|FG005|Overall Study|Adverse Event|0|||
130685579|NCT02024932|470477890|FG000|Overall Study|Abnormal laboratory value|0|||
130685580|NCT02024932|470477891|FG001|Overall Study|Abnormal laboratory value|0|||
130685581|NCT02024932|470477892|FG002|Overall Study|Abnormal laboratory value|0|||
130685582|NCT02024932|470477893|FG003|Overall Study|Abnormal laboratory value|2|||
130685583|NCT02024932|470477894|FG004|Overall Study|Abnormal laboratory value|0|||
130685584|NCT02024932|470477895|FG005|Overall Study|Abnormal laboratory value|0|||
130685585|NCT02445339|470477896|FG000|Overall Study|Physician Decision|1|||
130685586|NCT02445339|470477897|FG001|Overall Study|Physician Decision|0|||
130685587|NCT02445339|470477896|FG000|Overall Study|Lost to Follow-up|11|||
130685588|NCT02445339|470477897|FG001|Overall Study|Lost to Follow-up|15|||
130685589|NCT03020641|470477898|FG000|Overall Study|Lost to Follow-up|0|||
130685590|NCT03020641|470477899|FG001|Overall Study|Lost to Follow-up|1|||
130685591|NCT03020641|470477898|FG000|Overall Study|Converted to open surgery|2|||
130685592|NCT03020641|470477899|FG001|Overall Study|Converted to open surgery|1|||
130685593|NCT03020641|470477898|FG000|Overall Study|for surgery not performed|0|||
130685594|NCT03020641|470477899|FG001|Overall Study|for surgery not performed|1|||
130685595|NCT03041025|470477900|FG000|Overall Study|Adverse Event|0|||
130685596|NCT03041025|470477901|FG001|Overall Study|Adverse Event|0|||
130685597|NCT03041025|470477902|FG002|Overall Study|Adverse Event|1|||
130685598|NCT03041025|470477900|FG000|Overall Study|Lost to Follow-up|1|||
130685599|NCT03041025|470477901|FG001|Overall Study|Lost to Follow-up|0|||
130685600|NCT03041025|470477902|FG002|Overall Study|Lost to Follow-up|0|||
130685601|NCT03041025|470477900|FG000|Overall Study|Withdrawal by Subject|0|||
130685602|NCT03041025|470477901|FG001|Overall Study|Withdrawal by Subject|0|||
130685603|NCT03041025|470477902|FG002|Overall Study|Withdrawal by Subject|1|||
130685604|NCT00939003|470477905|FG000|Double-blind Treatment Period|Adverse Event|1|||
130685605|NCT00939003|470477906|FG001|Double-blind Treatment Period|Adverse Event|1|||
130685606|NCT00939003|470477905|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130685607|NCT00939003|470477906|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
130685608|NCT00939003|470477905|FG000|Double-blind Treatment Period|Pregnancy|0|||
131020795|NCT00610649|471706827|FG008|Overall Study|Withdrawal by Subject|0|||
131020796|NCT00610649|471706828|FG009|Overall Study|Withdrawal by Subject|1|||
131020797|NCT00610649|471706829|FG010|Overall Study|Withdrawal by Subject|0|||
131020798|NCT04252586|471706832|FG000|Overall Study|Withdrawal by parent/guardian|3|||
131020799|NCT04252586|471706832|FG000|Overall Study|Adverse Event|1|||
131020800|NCT04252586|471706832|FG000|Overall Study|Death|2|||
131020801|NCT04252586|471706832|FG000|Overall Study|Study terminated by sponsor|4|||
131020802|NCT04252586|471706832|FG000|Overall Study|Sponsor request|10|||
131020803|NCT04252586|471706832|FG000|Overall Study|Did not complete treatment period|1|||
131020804|NCT00414544|471706833|FG000|Overall Study|Lost to Follow-up|14|||
131020805|NCT03452189|471706834|FG000|First Intervention (3 Months)|Adverse Event|1|||
131020806|NCT03452189|471706835|FG001|First Intervention (3 Months)|Adverse Event|0|||
131020807|NCT03452189|471706834|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
131020808|NCT03452189|471706835|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
131020809|NCT02601820|471706836|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
131020810|NCT02601820|471706836|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
131020811|NCT02601820|471706836|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
131020812|NCT02601820|471706836|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
131020813|NCT02242487|471706837|FG000|Overall Study|Adverse Event|13|||
131020814|NCT02242487|471706838|FG001|Overall Study|Adverse Event|15|||
131020815|NCT02242487|471706837|FG000|Overall Study|Lack of Efficacy|4|||
131020816|NCT02242487|471706838|FG001|Overall Study|Lack of Efficacy|6|||
131020817|NCT02242487|471706837|FG000|Overall Study|Protocol Violation|2|||
131020818|NCT02242487|471706838|FG001|Overall Study|Protocol Violation|0|||
131020819|NCT02242487|471706837|FG000|Overall Study|Lost to Follow-up|2|||
131222614|NCT01902134|472443116|FG003|Overall Study|Other|0|||
130685609|NCT00939003|470477906|FG001|Double-blind Treatment Period|Pregnancy|1|||
131020820|NCT02242487|471706838|FG001|Overall Study|Lost to Follow-up|1|||
131020821|NCT02242487|471706837|FG000|Overall Study|Other - Miscellaneous|4|||
131020822|NCT02242487|471706838|FG001|Overall Study|Other - Miscellaneous|6|||
130685610|NCT00939003|470477905|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
130685611|NCT00939003|470477906|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
130685612|NCT00939003|470477905|FG000|Open-label Treatment Period|Adverse Event|4|||
130685613|NCT00939003|470477906|FG001|Open-label Treatment Period|Adverse Event|8|||
130685614|NCT00939003|470477905|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
130685615|NCT00939003|470477906|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
130685616|NCT00939003|470477905|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
131106425|NCT04812548|472020845|FG000|Overall Study|Withdrawal by Subject|0|||
131106426|NCT04812548|472020846|FG001|Overall Study|Withdrawal by Subject|1|||
131106427|NCT04812548|472020845|FG000|Overall Study|Physician Decision|1|||
131106428|NCT04812548|472020846|FG001|Overall Study|Physician Decision|0|||
131106429|NCT03184870|472020847|FG000|Initial Treatment|Death|6|||
131106430|NCT03184870|472020848|FG001|Initial Treatment|Death|6|||
131106431|NCT03184870|472020849|FG002|Initial Treatment|Death|8|||
131106432|NCT03184870|472020850|FG003|Initial Treatment|Death|8|||
131106433|NCT03184870|472020851|FG004|Initial Treatment|Death|6|||
131106434|NCT03184870|472020852|FG005|Initial Treatment|Death|6|||
131106435|NCT03184870|472020853|FG006|Initial Treatment|Death|6|||
131106436|NCT03184870|472020854|FG007|Initial Treatment|Death|7|||
131106437|NCT03184870|472020855|FG008|Initial Treatment|Death|1|||
131106438|NCT03184870|472020856|FG009|Initial Treatment|Death|2|||
131106439|NCT03184870|472020857|FG010|Initial Treatment|Death|26|||
131106440|NCT03184870|472020858|FG011|Initial Treatment|Death|28|||
131106441|NCT03184870|472020859|FG012|Initial Treatment|Death|10|||
131106442|NCT03184870|472020860|FG013|Initial Treatment|Death|33|||
131106443|NCT03184870|472020861|FG014|Initial Treatment|Death|34|||
130685617|NCT00939003|470477906|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
130685618|NCT00939003|470477905|FG000|Open-label Treatment Period|Pregnancy|1|||
130685619|NCT00939003|470477906|FG001|Open-label Treatment Period|Pregnancy|1|||
130685620|NCT00939003|470477905|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
130685621|NCT00939003|470477906|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
130685622|NCT00939003|470477905|FG000|Open-label Treatment Period|Site Closure|3|||
130685623|NCT00939003|470477906|FG001|Open-label Treatment Period|Site Closure|4|||
130685624|NCT02131129|470477907|FG000|Overall Study|Withdrawal by Subject|1|||
130685625|NCT02131129|470477908|FG001|Overall Study|Withdrawal by Subject|0|||
130685626|NCT02865122|470477909|FG000|Overall Study|Adverse Event|1|||
130685627|NCT02865122|470477910|FG001|Overall Study|Adverse Event|0|||
130685628|NCT02865122|470477911|FG002|Overall Study|Adverse Event|0|||
130685629|NCT00837486|470477916|FG000|Blinded-treatment Phase|Physician Decision|1|||
130685630|NCT00837486|470477917|FG001|Blinded-treatment Phase|Physician Decision|0|||
130685631|NCT00837486|470477916|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
130685632|NCT00837486|470477917|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
130685633|NCT00837486|470477916|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
130685634|NCT00837486|470477917|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
130685635|NCT00837486|470477916|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
130685636|NCT00837486|470477917|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
131106444|NCT03184870|472020862|FG015|Initial Treatment|Death|26|||
131106445|NCT03184870|472020863|FG016|Initial Treatment|Death|20|||
131106446|NCT03184870|472020864|FG017|Initial Treatment|Death|18|||
131106447|NCT03184870|472020847|FG000|Initial Treatment|Other Reasons|2|||
131106448|NCT03184870|472020848|FG001|Initial Treatment|Other Reasons|2|||
131106449|NCT03184870|472020849|FG002|Initial Treatment|Other Reasons|0|||
131106450|NCT03184870|472020850|FG003|Initial Treatment|Other Reasons|1|||
131106451|NCT03184870|472020851|FG004|Initial Treatment|Other Reasons|0|||
131106452|NCT03184870|472020852|FG005|Initial Treatment|Other Reasons|0|||
131106453|NCT03184870|472020853|FG006|Initial Treatment|Other Reasons|0|||
131106454|NCT03184870|472020854|FG007|Initial Treatment|Other Reasons|2|||
131106455|NCT03184870|472020855|FG008|Initial Treatment|Other Reasons|0|||
131106456|NCT03184870|472020856|FG009|Initial Treatment|Other Reasons|0|||
131106457|NCT03184870|472020857|FG010|Initial Treatment|Other Reasons|4|||
131106458|NCT03184870|472020858|FG011|Initial Treatment|Other Reasons|2|||
131106459|NCT03184870|472020859|FG012|Initial Treatment|Other Reasons|2|||
131106460|NCT03184870|472020860|FG013|Initial Treatment|Other Reasons|0|||
131106461|NCT03184870|472020861|FG014|Initial Treatment|Other Reasons|0|||
131106462|NCT03184870|472020862|FG015|Initial Treatment|Other Reasons|1|||
131106463|NCT03184870|472020863|FG016|Initial Treatment|Other Reasons|0|||
131106464|NCT03184870|472020864|FG017|Initial Treatment|Other Reasons|2|||
130685637|NCT01577381|470477919|FG000|Overall Study|Discontinued|2|||
131106465|NCT03184870|472020847|FG000|Initial Treatment|Lost to Follow-up|2|||
131106466|NCT03184870|472020848|FG001|Initial Treatment|Lost to Follow-up|0|||
131106467|NCT03184870|472020849|FG002|Initial Treatment|Lost to Follow-up|0|||
131106468|NCT03184870|472020850|FG003|Initial Treatment|Lost to Follow-up|1|||
131106469|NCT03184870|472020851|FG004|Initial Treatment|Lost to Follow-up|1|||
131106470|NCT03184870|472020852|FG005|Initial Treatment|Lost to Follow-up|1|||
131106471|NCT03184870|472020853|FG006|Initial Treatment|Lost to Follow-up|0|||
131106472|NCT03184870|472020854|FG007|Initial Treatment|Lost to Follow-up|2|||
131106473|NCT03184870|472020855|FG008|Initial Treatment|Lost to Follow-up|0|||
130685638|NCT01577381|470477920|FG001|Overall Study|Discontinued|1|||
130685639|NCT01577381|470477921|FG002|Overall Study|Discontinued|2|||
130685640|NCT01577381|470477922|FG003|Overall Study|Discontinued|2|||
130685641|NCT01577381|470477919|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
130767057|NCT03170609|470770695|FG001|Overall Study|Other|0|||
131106474|NCT03184870|472020856|FG009|Initial Treatment|Lost to Follow-up|0|||
131106475|NCT03184870|472020857|FG010|Initial Treatment|Lost to Follow-up|2|||
131106476|NCT03184870|472020858|FG011|Initial Treatment|Lost to Follow-up|0|||
131106477|NCT03184870|472020859|FG012|Initial Treatment|Lost to Follow-up|2|||
130886618|NCT02379091|471217374|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
130886619|NCT02379091|471217371|FG000|Overall Study|Principal Investigator Discretion|0|||
130886620|NCT02379091|471217372|FG001|Overall Study|Principal Investigator Discretion|1|||
130886621|NCT02379091|471217373|FG002|Overall Study|Principal Investigator Discretion|0|||
130886622|NCT02379091|471217374|FG003|Overall Study|Principal Investigator Discretion|0|||
130886623|NCT02379091|471217371|FG000|Overall Study|Lost to Follow-up|0|||
130886624|NCT02379091|471217372|FG001|Overall Study|Lost to Follow-up|0|||
130886625|NCT02379091|471217373|FG002|Overall Study|Lost to Follow-up|0|||
130886626|NCT02379091|471217374|FG003|Overall Study|Lost to Follow-up|1|||
130886627|NCT02379091|471217371|FG000|Overall Study|Voluntary Withdrawal|2|||
130886628|NCT02379091|471217372|FG001|Overall Study|Voluntary Withdrawal|5|||
130886629|NCT02379091|471217373|FG002|Overall Study|Voluntary Withdrawal|2|||
130886630|NCT02379091|471217374|FG003|Overall Study|Voluntary Withdrawal|4|||
130886631|NCT02379091|471217371|FG000|Overall Study|Study Termination|7|||
130886632|NCT02379091|471217372|FG001|Overall Study|Study Termination|2|||
130886633|NCT02379091|471217373|FG002|Overall Study|Study Termination|5|||
130886634|NCT02379091|471217374|FG003|Overall Study|Study Termination|8|||
130886635|NCT02379091|471217371|FG000|Overall Study|Lack of Efficacy|3|||
130886636|NCT02379091|471217372|FG001|Overall Study|Lack of Efficacy|0|||
130886637|NCT02379091|471217373|FG002|Overall Study|Lack of Efficacy|0|||
130886638|NCT02379091|471217374|FG003|Overall Study|Lack of Efficacy|0|||
130886639|NCT02205736|471217375|FG000|Overall Study|Lost to Follow-up|106|||
130886640|NCT04161157|471217379|FG000|Overall Study|Lost to Follow-up|4|||
130886641|NCT04161157|471217379|FG000|Overall Study|Death|3|||
130886642|NCT04161157|471217379|FG000|Overall Study|Ineligible|2|||
130886643|NCT04161157|471217379|FG000|Overall Study|Withdrawal by Subject|4|||
130886644|NCT03278249|471217389|FG000|Overall Study|Withdrawal by Subject|2|||
130886645|NCT03278249|471217389|FG000|Overall Study|Lost to Follow-up|1|||
130886646|NCT04988477|471217390|FG000|Overall Study|Death|1|||
130886647|NCT04988477|471217391|FG001|Overall Study|Death|0|||
130886648|NCT04988477|471217392|FG002|Overall Study|Death|0|||
130886649|NCT04988477|471217390|FG000|Overall Study|Lost to Follow-up|5|||
130886650|NCT04988477|471217391|FG001|Overall Study|Lost to Follow-up|2|||
130886651|NCT04988477|471217392|FG002|Overall Study|Lost to Follow-up|0|||
130886652|NCT04988477|471217390|FG000|Overall Study|Withdrawal by Subject|2|||
130886653|NCT04988477|471217391|FG001|Overall Study|Withdrawal by Subject|0|||
130886654|NCT04988477|471217392|FG002|Overall Study|Withdrawal by Subject|0|||
130886655|NCT01354899|471219039|FG000|Overall Study|discharge from the hospital|2|||
130886656|NCT01354899|471219039|FG000|Overall Study|Protocol Violation|1|||
130886657|NCT01376804|471219040|FG000|Treatment Period|Withdrawal by Subject|1|||
130886658|NCT01376804|471219040|FG000|Treatment Period|Adverse Event|6|||
130886659|NCT01376804|471219040|FG000|Treatment Period|Patient did not receive study drug|1|||
130886660|NCT01071798|471219041|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
130886661|NCT01071798|471219041|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
131020823|NCT02242487|471706837|FG000|Overall Study|Withdrawal by Subject|37|||
131020824|NCT02242487|471706838|FG001|Overall Study|Withdrawal by Subject|19|||
130685642|NCT01577381|470477920|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
130685643|NCT01577381|470477921|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
130685644|NCT01577381|470477922|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
130685645|NCT02186821|470477923|FG000|Overall Study|Adverse Event|9|||
130685646|NCT02186821|470477923|FG000|Overall Study|Death|2|||
130685647|NCT02186821|470477923|FG000|Overall Study|Disease progression|32|||
130685648|NCT02186821|470477923|FG000|Overall Study|Protocol Violation|1|||
130685649|NCT02186821|470477923|FG000|Overall Study|Physician Decision|1|||
130685650|NCT02186821|470477923|FG000|Overall Study|Study terminated by sponsor|2|||
130685651|NCT00819741|470477926|FG000|Overall Study|Adverse Event|5|||
130685652|NCT00819741|470477927|FG001|Overall Study|Adverse Event|2|||
130685653|NCT00819741|470477926|FG000|Overall Study|Lack of Efficacy|0|||
130685654|NCT00819741|470477927|FG001|Overall Study|Lack of Efficacy|2|||
130685655|NCT00819741|470477926|FG000|Overall Study|Lost to Follow-up|3|||
130685656|NCT00819741|470477927|FG001|Overall Study|Lost to Follow-up|1|||
130685657|NCT00819741|470477926|FG000|Overall Study|Protocol Violation|3|||
130685658|NCT00819741|470477927|FG001|Overall Study|Protocol Violation|4|||
130685659|NCT00819741|470477926|FG000|Overall Study|Withdrawal by Subject|2|||
130685660|NCT00819741|470477927|FG001|Overall Study|Withdrawal by Subject|2|||
130685661|NCT00819741|470477926|FG000|Overall Study|Unclassified|6|||
130767058|NCT03170609|470770696|FG002|Overall Study|Other|0|||
130886662|NCT01071798|471219041|FG000|Participants Who Received One Cycle|Patient requirement|20|||
130886663|NCT01071798|471219041|FG000|Participants Who Received One Cycle|Death|5|||
130886664|NCT01071798|471219041|FG000|Participants Who Received One Cycle|Change of therapy|6|||
130685662|NCT00819741|470477927|FG001|Overall Study|Unclassified|0|||
130685663|NCT00819741|470477926|FG000|Overall Study|Reasons unknown|3|||
130886665|NCT01071798|471219041|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
130886666|NCT01071798|471219041|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
130886667|NCT01071798|471219041|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
130886668|NCT01071798|471219041|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
131020825|NCT00391898|471706847|FG000|Overall Study|Adverse Event|3|||
130886669|NCT01071798|471219041|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
130886670|NCT00641667|471219042|FG000|Overall Study|Withdrawal by Subject|1|||
130886671|NCT00641667|471219042|FG000|Overall Study|Adverse Event|1|||
130886672|NCT00641667|471219042|FG000|Overall Study|Physician Decision|1|||
130886673|NCT00641667|471219042|FG000|Overall Study|Worsening of underlying disease|3|||
130886674|NCT01357850|471219043|FG000|Overall Study|Lost to Follow-up|1|||
130886675|NCT01357850|471219044|FG001|Overall Study|Lost to Follow-up|0|||
130886676|NCT01357850|471219045|FG002|Overall Study|Lost to Follow-up|0|||
130886677|NCT01357850|471219046|FG003|Overall Study|Lost to Follow-up|0|||
130886678|NCT03349034|471219049|FG000|Overall Study|catheters dislodged during transport|2|||
130886679|NCT03349034|471219050|FG001|Overall Study|catheters dislodged during transport|0|||
130886680|NCT03349034|471219049|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
130886681|NCT03349034|471219050|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
130886682|NCT03349034|471219049|FG000|Overall Study|soft tissue flap used|1|||
130886683|NCT03349034|471219050|FG001|Overall Study|soft tissue flap used|0|||
130886684|NCT03349034|471219049|FG000|Overall Study|Other|0|||
130886685|NCT03349034|471219050|FG001|Overall Study|Other|1|||
130886686|NCT00865566|471219051|FG000|Overall Study|Death|1|||
130886687|NCT00865566|471219052|FG001|Overall Study|Death|11|||
130886688|NCT00865566|471219051|FG000|Overall Study|Lost to Follow-up|314|||
130886689|NCT00865566|471219052|FG001|Overall Study|Lost to Follow-up|315|||
130886690|NCT00865566|471219051|FG000|Overall Study|Withdrawal by Subject|45|||
130886691|NCT00865566|471219052|FG001|Overall Study|Withdrawal by Subject|65|||
130886692|NCT00865566|471219051|FG000|Overall Study|Physician Decision|0|||
130886693|NCT00865566|471219052|FG001|Overall Study|Physician Decision|1|||
130886694|NCT00865566|471219051|FG000|Overall Study|Participant relocated|78|||
130886695|NCT00865566|471219052|FG001|Overall Study|Participant relocated|107|||
130886696|NCT00865566|471219051|FG000|Overall Study|Participant unable to adhere|27|||
130886697|NCT00865566|471219052|FG001|Overall Study|Participant unable to adhere|42|||
130886698|NCT00865566|471219051|FG000|Overall Study|Other; N=245 due to early study closure|154|||
130886699|NCT00865566|471219052|FG001|Overall Study|Other; N=245 due to early study closure|139|||
130886700|NCT00865566|471219051|FG000|Overall Study|HIV infection|5|||
130886701|NCT00865566|471219052|FG001|Overall Study|HIV infection|7|||
130886702|NCT00815659|471219053|FG000|Overall Study|Adverse Event|9|||
130886703|NCT00815659|471219053|FG000|Overall Study|Withdrawal by Subject|9|||
130886704|NCT00815659|471219053|FG000|Overall Study|Lost to Follow-up|4|||
130886705|NCT00815659|471219053|FG000|Overall Study|Protocol Violation|1|||
130886706|NCT02395471|471219054|FG000|Overall Study|Lost to Follow-up|2|||
130886707|NCT02395471|471219055|FG001|Overall Study|Lost to Follow-up|0|||
130886708|NCT02395471|471219054|FG000|Overall Study|Withdrawal by Subject|2|||
130886709|NCT02395471|471219055|FG001|Overall Study|Withdrawal by Subject|1|||
130886710|NCT02395471|471219054|FG000|Overall Study|Physician Decision|1|||
130685664|NCT00819741|470477927|FG001|Overall Study|Reasons unknown|3|||
130685665|NCT00119015|470477928|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
130685666|NCT00119015|470477929|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
130685667|NCT00119015|470477930|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
130685668|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
130685669|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
130685670|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
130685671|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
130685672|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685673|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685674|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685675|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685676|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685677|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685678|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685679|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685680|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685681|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685682|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685683|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685684|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685685|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685686|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685687|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130767059|NCT03170609|470770697|FG003|Overall Study|Other|0|||
130886711|NCT02395471|471219055|FG001|Overall Study|Physician Decision|0|||
130886712|NCT02395471|471219054|FG000|Overall Study|Protocol Violation|0|||
130886713|NCT02395471|471219055|FG001|Overall Study|Protocol Violation|1|||
130886714|NCT02395471|471219054|FG000|Overall Study|Failure to swollow sponge twice|1|||
130886715|NCT02395471|471219055|FG001|Overall Study|Failure to swollow sponge twice|0|||
130886716|NCT02395471|471219054|FG000|Overall Study|Patient did not return for procedure|0|||
130886717|NCT02395471|471219055|FG001|Overall Study|Patient did not return for procedure|1|||
131020826|NCT00391898|471706848|FG001|Overall Study|Adverse Event|0|||
131020827|NCT00391898|471706847|FG000|Overall Study|Other|8|||
131020828|NCT00391898|471706848|FG001|Overall Study|Other|10|||
131020829|NCT02918279|471706851|FG000|Overall Study|Lost to Follow-up|3|||
131020830|NCT02918279|471706852|FG001|Overall Study|Lost to Follow-up|6|||
131020831|NCT02918279|471706851|FG000|Overall Study|Withdrawal by Subject|5|||
131020832|NCT02918279|471706852|FG001|Overall Study|Withdrawal by Subject|15|||
131020833|NCT02918279|471706851|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131020834|NCT02918279|471706852|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131020835|NCT02918279|471706851|FG000|Overall Study|Other|3|||
131020836|NCT02918279|471706852|FG001|Overall Study|Other|1|||
131020837|NCT00309907|471706853|FG000|Overall Study|Death|4|||
131020838|NCT00309907|471706853|FG000|Overall Study|Physician Decision|1|||
131020839|NCT00309907|471706853|FG000|Overall Study|Ineligible|11|||
131020840|NCT00309907|471706853|FG000|Overall Study|Major infectious event|4|||
131020841|NCT00869258|471706854|FG000|Overall Study|Physician Decision|1|||
131020842|NCT00636207|471706855|FG000|Overall Study|Adverse Event|1|||
131020843|NCT00636207|471706856|FG001|Overall Study|Adverse Event|0|||
131020844|NCT00636207|471706857|FG002|Overall Study|Adverse Event|0|||
131020845|NCT00636207|471706858|FG003|Overall Study|Adverse Event|0|||
131020846|NCT00636207|471706859|FG004|Overall Study|Adverse Event|0|||
131020847|NCT00636207|471706860|FG005|Overall Study|Adverse Event|0|||
131020848|NCT00636207|471706861|FG006|Overall Study|Adverse Event|0|||
131020849|NCT00636207|471706855|FG000|Overall Study|Withdrawal by Subject|0|||
130685688|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130685689|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
130685690|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
130685691|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
130685692|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
130685693|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685694|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685695|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685696|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685697|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685698|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685699|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685700|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685701|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685702|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685703|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685704|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685705|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685706|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685707|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685708|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685709|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130685710|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
130685711|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
130685712|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
130685713|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
130685714|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685715|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685716|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685717|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685718|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685719|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685720|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685721|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685722|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685723|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685724|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685725|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685726|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685727|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130767060|NCT03170609|470770698|FG004|Overall Study|Other|0|||
131020850|NCT00636207|471706856|FG001|Overall Study|Withdrawal by Subject|1|||
131020851|NCT00636207|471706857|FG002|Overall Study|Withdrawal by Subject|0|||
131020852|NCT00636207|471706858|FG003|Overall Study|Withdrawal by Subject|0|||
131020853|NCT00636207|471706859|FG004|Overall Study|Withdrawal by Subject|1|||
131020854|NCT00636207|471706860|FG005|Overall Study|Withdrawal by Subject|0|||
131020855|NCT00636207|471706861|FG006|Overall Study|Withdrawal by Subject|0|||
130685728|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685729|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685730|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130685731|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
130685732|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
130685733|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
130685734|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685735|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130886718|NCT02395471|471219054|FG000|Overall Study|Subject not eligible|1|||
130886719|NCT02395471|471219055|FG001|Overall Study|Subject not eligible|0|||
130886720|NCT03847896|471219056|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130886721|NCT03847896|471219057|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130886722|NCT03847896|471219058|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
130886723|NCT03847896|471219059|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130886724|NCT03847896|471219060|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130886725|NCT03847896|471219056|FG000|Overall Study|Withdrawal by Subject|2|||
131020856|NCT01641198|471706862|FG000|After 12 Months of Function|Lost to Follow-up|3|||
131020857|NCT01641198|471706863|FG001|After 12 Months of Function|Lost to Follow-up|2|||
131020858|NCT01641198|471706864|FG002|After 12 Months of Function|Lost to Follow-up|2|||
131020859|NCT01641198|471706862|FG000|After 12 Months of Function|Protocol Violation|1|||
131020860|NCT01641198|471706863|FG001|After 12 Months of Function|Protocol Violation|0|||
131020861|NCT01641198|471706864|FG002|After 12 Months of Function|Protocol Violation|0|||
131020862|NCT01641198|471706862|FG000|After 12 Months of Function|Adverse Event|0|||
131020863|NCT01641198|471706863|FG001|After 12 Months of Function|Adverse Event|1|||
131020864|NCT01641198|471706864|FG002|After 12 Months of Function|Adverse Event|0|||
131020865|NCT01641198|471706862|FG000|After 24 Months of Function|Lost to Follow-up|4|||
131020866|NCT01641198|471706863|FG001|After 24 Months of Function|Lost to Follow-up|9|||
131020867|NCT01641198|471706864|FG002|After 24 Months of Function|Lost to Follow-up|6|||
131020868|NCT01641198|471706862|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
131020869|NCT01641198|471706863|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
131020870|NCT01641198|471706864|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
131020871|NCT01641198|471706862|FG000|At 15-20 Years of Function|Death|1|||
131020872|NCT01641198|471706863|FG001|At 15-20 Years of Function|Death|0|||
131020873|NCT01641198|471706864|FG002|At 15-20 Years of Function|Death|1|||
131020874|NCT02529995|471706866|FG000|Part A|Ongoing Study at Data Cut-off|14|||
131020875|NCT02529995|471706867|FG001|Part A|Ongoing Study at Data Cut-off|16|||
131020876|NCT02529995|471706866|FG000|Part A|Discontinued Study|1|||
131020877|NCT02529995|471706867|FG001|Part A|Discontinued Study|0|||
131020878|NCT02529995|471706866|FG000|Part B|Ongoing Study at Data Cut-off|0|||
131020879|NCT02529995|471706867|FG001|Part B|Ongoing Study at Data Cut-off|7|||
131020880|NCT02529995|471706866|FG000|Part B|Discontinued Study|6|||
131020881|NCT02529995|471706867|FG001|Part B|Discontinued Study|5|||
131020882|NCT01075217|471706870|FG000|Overall Study|Adverse Event|1|||
131020883|NCT01075217|471706871|FG001|Overall Study|Adverse Event|1|||
131020884|NCT01075217|471706870|FG000|Overall Study|Physician Decision|1|||
131020885|NCT01075217|471706871|FG001|Overall Study|Physician Decision|0|||
131020886|NCT01068743|471706872|FG000|Period 3|Adverse Event|0|||
131020887|NCT01068743|471706873|FG001|Period 3|Adverse Event|1|||
131020888|NCT01068743|471706874|FG002|Period 3|Adverse Event|0|||
131020889|NCT01068743|471706875|FG003|Period 3|Adverse Event|0|||
131020890|NCT01943916|471706876|FG000|Overall Study|Technically invalid images|10|||
131020891|NCT01943916|471706876|FG000|Overall Study|Enrollment Failure|23|||
131020892|NCT01943916|471706876|FG000|Overall Study|Pilot Phase exclusion|100|||
131020893|NCT01943916|471706876|FG000|Overall Study|Quality Assurance Reader Fail|130|||
131020894|NCT01943916|471706876|FG000|Overall Study|Technical Failure|39|||
131020895|NCT01943916|471706876|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
131020896|NCT01943916|471706876|FG000|Overall Study|No Truth Panel Review|38|||
131020897|NCT01943916|471706876|FG000|Overall Study|Protocol Deviation|1|||
131020898|NCT05274217|471706877|FG000|Overall Study|Study terminated.|11|||
131020899|NCT05274217|471706878|FG001|Overall Study|Study terminated.|0|||
131020900|NCT04594759|471706879|FG000|Overall Study|Lost to Follow-up|3|||
131020901|NCT05609032|471706882|FG000|Overall Study|Lost to Follow-up|3|||
131020902|NCT05609032|471706883|FG001|Overall Study|Lost to Follow-up|1|||
131020903|NCT05609032|471706882|FG000|Overall Study|Withdrawal by Subject|1|||
131020904|NCT05609032|471706883|FG001|Overall Study|Withdrawal by Subject|0|||
131020905|NCT02261467|471706884|FG000|Overall Study|Enrolled in Error|1|||
131020906|NCT02261467|471706885|FG001|Overall Study|Enrolled in Error|0|||
131020907|NCT02261467|471706884|FG000|Overall Study|Protocol Violation|0|||
131020908|NCT02261467|471706885|FG001|Overall Study|Protocol Violation|1|||
131020909|NCT02261467|471706884|FG000|Overall Study|Personal Reasons|17|||
131020910|NCT02261467|471706885|FG001|Overall Study|Personal Reasons|22|||
131020911|NCT02261467|471706884|FG000|Overall Study|Lost to Follow-up|2|||
131020912|NCT02261467|471706885|FG001|Overall Study|Lost to Follow-up|13|||
131020913|NCT02261467|471706884|FG000|Overall Study|Adverse Event|1|||
130886726|NCT03847896|471219057|FG001|Overall Study|Withdrawal by Subject|10|||
130886727|NCT03847896|471219058|FG002|Overall Study|Withdrawal by Subject|5|||
130886728|NCT03847896|471219059|FG003|Overall Study|Withdrawal by Subject|9|||
130886729|NCT03847896|471219060|FG004|Overall Study|Withdrawal by Subject|8|||
131020914|NCT02261467|471706885|FG001|Overall Study|Adverse Event|1|||
131020915|NCT00529659|471706886|FG000|Overall Study|Adverse Event|8|||
131020916|NCT00529659|471706887|FG001|Overall Study|Adverse Event|7|||
131020917|NCT00529659|471706886|FG000|Overall Study|Lost to Follow-up|0|||
131020918|NCT00529659|471706887|FG001|Overall Study|Lost to Follow-up|2|||
131020919|NCT00529659|471706886|FG000|Overall Study|Physician Decision|0|||
131020920|NCT00529659|471706887|FG001|Overall Study|Physician Decision|2|||
131020921|NCT00529659|471706886|FG000|Overall Study|Protocol Violation|2|||
131020922|NCT00529659|471706887|FG001|Overall Study|Protocol Violation|6|||
131020923|NCT00529659|471706886|FG000|Overall Study|Withdrawal by Subject|1|||
131020924|NCT00529659|471706887|FG001|Overall Study|Withdrawal by Subject|6|||
131020925|NCT01787760|471706893|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
131020926|NCT01787760|471706894|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
131020927|NCT01787760|471706895|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
131020928|NCT01787760|471706893|FG000|Overall Study|Decompensated on left exotropia|0|||
131020929|NCT01787760|471706894|FG001|Overall Study|Decompensated on left exotropia|0|||
131020930|NCT01787760|471706895|FG002|Overall Study|Decompensated on left exotropia|1|||
131020931|NCT01787760|471706893|FG000|Overall Study|Dryness|0|||
131020932|NCT01787760|471706894|FG001|Overall Study|Dryness|1|||
131020933|NCT01787760|471706895|FG002|Overall Study|Dryness|0|||
131020934|NCT01787760|471706893|FG000|Overall Study|Relocation|1|||
131020935|NCT01787760|471706894|FG001|Overall Study|Relocation|1|||
131020936|NCT01787760|471706895|FG002|Overall Study|Relocation|0|||
131020937|NCT01787760|471706893|FG000|Overall Study|Lens discomfort|3|||
131020938|NCT01787760|471706894|FG001|Overall Study|Lens discomfort|0|||
131020939|NCT01787760|471706895|FG002|Overall Study|Lens discomfort|0|||
131020940|NCT01787760|471706893|FG000|Overall Study|Lens handling difficulty|1|||
131020941|NCT01787760|471706894|FG001|Overall Study|Lens handling difficulty|2|||
131020942|NCT01787760|471706895|FG002|Overall Study|Lens handling difficulty|0|||
131020943|NCT01787760|471706893|FG000|Overall Study|Protocol Violation|6|||
131020944|NCT01787760|471706894|FG001|Overall Study|Protocol Violation|0|||
131020945|NCT01787760|471706895|FG002|Overall Study|Protocol Violation|1|||
131020946|NCT01787760|471706893|FG000|Overall Study|Withdrawal by Subject|5|||
131020947|NCT01787760|471706894|FG001|Overall Study|Withdrawal by Subject|1|||
131020948|NCT01787760|471706895|FG002|Overall Study|Withdrawal by Subject|2|||
131020949|NCT01787760|471706893|FG000|Overall Study|Lost to Follow-up|1|||
131020950|NCT01787760|471706894|FG001|Overall Study|Lost to Follow-up|0|||
131020951|NCT01787760|471706895|FG002|Overall Study|Lost to Follow-up|1|||
131020952|NCT01787760|471706893|FG000|Overall Study|Stroke|1|||
131020953|NCT01787760|471706894|FG001|Overall Study|Stroke|0|||
131020954|NCT01787760|471706895|FG002|Overall Study|Stroke|0|||
131020955|NCT01787760|471706893|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
131020956|NCT01787760|471706894|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
131020957|NCT01787760|471706895|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
131020958|NCT01787760|471706893|FG000|Overall Study|Unsatisfactory physiological response|2|||
131020959|NCT01787760|471706894|FG001|Overall Study|Unsatisfactory physiological response|4|||
131020960|NCT01787760|471706895|FG002|Overall Study|Unsatisfactory physiological response|0|||
131020961|NCT01787760|471706893|FG000|Overall Study|Unsatisfactory visual response|1|||
131020962|NCT01787760|471706894|FG001|Overall Study|Unsatisfactory visual response|1|||
131020963|NCT01787760|471706895|FG002|Overall Study|Unsatisfactory visual response|0|||
131020964|NCT01787760|471706893|FG000|Overall Study|Near vision blur|1|||
131020965|NCT01787760|471706894|FG001|Overall Study|Near vision blur|0|||
131020966|NCT01787760|471706895|FG002|Overall Study|Near vision blur|0|||
131020967|NCT03512756|471706896|FG000|Part 1|Death|23|||
131020968|NCT03512756|471706897|FG001|Part 1|Death|18|||
131020969|NCT03512756|471706898|FG002|Part 1|Death|0|||
131020970|NCT03512756|471706899|FG003|Part 1|Death|0|||
131020971|NCT03512756|471706896|FG000|Part 1|Lost to Follow-up|0|||
131020972|NCT03512756|471706897|FG001|Part 1|Lost to Follow-up|3|||
131020973|NCT03512756|471706898|FG002|Part 1|Lost to Follow-up|0|||
131020974|NCT03512756|471706899|FG003|Part 1|Lost to Follow-up|0|||
131020975|NCT03512756|471706896|FG000|Part 1|Physician Decision|0|||
131020976|NCT03512756|471706897|FG001|Part 1|Physician Decision|1|||
131020977|NCT03512756|471706898|FG002|Part 1|Physician Decision|0|||
131020978|NCT03512756|471706899|FG003|Part 1|Physician Decision|0|||
131020979|NCT03512756|471706896|FG000|Part 1|Withdrawal by Subject|2|||
131020980|NCT03512756|471706897|FG001|Part 1|Withdrawal by Subject|2|||
130767061|NCT03170609|470770699|FG005|Overall Study|Other|1|||
131020981|NCT03512756|471706898|FG002|Part 1|Withdrawal by Subject|0|||
131020982|NCT03512756|471706899|FG003|Part 1|Withdrawal by Subject|0|||
131020983|NCT03512756|471706896|FG000|Part 2|Death|0|||
131020984|NCT03512756|471706897|FG001|Part 2|Death|0|||
131020985|NCT03512756|471706898|FG002|Part 2|Death|32|||
130886730|NCT03847896|471219056|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131020986|NCT03512756|471706899|FG003|Part 2|Death|21|||
131020987|NCT03512756|471706896|FG000|Part 2|Lost to Follow-up|0|||
130886731|NCT03847896|471219057|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130886732|NCT03847896|471219058|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130886733|NCT03847896|471219059|FG003|Overall Study|Withdrawal by parent/guardian|0|||
130886734|NCT03847896|471219060|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130886735|NCT03847896|471219056|FG000|Overall Study|Adverse Event|2|||
130886736|NCT03847896|471219057|FG001|Overall Study|Adverse Event|1|||
130886737|NCT03847896|471219058|FG002|Overall Study|Adverse Event|3|||
130886738|NCT03847896|471219059|FG003|Overall Study|Adverse Event|2|||
130886739|NCT03847896|471219060|FG004|Overall Study|Adverse Event|4|||
130886740|NCT03847896|471219056|FG000|Overall Study|A severe exacerbation event|0|||
130886741|NCT03847896|471219057|FG001|Overall Study|A severe exacerbation event|0|||
130886742|NCT03847896|471219058|FG002|Overall Study|A severe exacerbation event|0|||
130886743|NCT03847896|471219059|FG003|Overall Study|A severe exacerbation event|0|||
130886744|NCT03847896|471219060|FG004|Overall Study|A severe exacerbation event|3|||
130886745|NCT03847896|471219056|FG000|Overall Study|Protocol Violation|0|||
130685736|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685737|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685738|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685739|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685740|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685741|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685742|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685743|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685744|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685745|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685746|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685747|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685748|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685749|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685750|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685751|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130685752|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
130685753|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685754|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685755|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
130685756|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685757|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685758|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130886746|NCT03847896|471219057|FG001|Overall Study|Protocol Violation|2|||
130886747|NCT03847896|471219058|FG002|Overall Study|Protocol Violation|1|||
130886748|NCT03847896|471219059|FG003|Overall Study|Protocol Violation|0|||
130886749|NCT03847896|471219060|FG004|Overall Study|Protocol Violation|2|||
130886750|NCT03847896|471219056|FG000|Overall Study|Lost to Follow-up|0|||
130886751|NCT03847896|471219057|FG001|Overall Study|Lost to Follow-up|0|||
130886752|NCT03847896|471219058|FG002|Overall Study|Lost to Follow-up|0|||
130886753|NCT03847896|471219059|FG003|Overall Study|Lost to Follow-up|1|||
130886754|NCT03847896|471219060|FG004|Overall Study|Lost to Follow-up|0|||
130886755|NCT03847896|471219056|FG000|Overall Study|Condition under investigation worsened|0|||
130886756|NCT03847896|471219057|FG001|Overall Study|Condition under investigation worsened|0|||
130886757|NCT03847896|471219058|FG002|Overall Study|Condition under investigation worsened|0|||
130886758|NCT03847896|471219059|FG003|Overall Study|Condition under investigation worsened|1|||
130886759|NCT03847896|471219060|FG004|Overall Study|Condition under investigation worsened|1|||
130886760|NCT03847896|471219056|FG000|Overall Study|Lack of Efficacy|0|||
130886761|NCT03847896|471219057|FG001|Overall Study|Lack of Efficacy|0|||
130886762|NCT03847896|471219058|FG002|Overall Study|Lack of Efficacy|0|||
130886763|NCT03847896|471219059|FG003|Overall Study|Lack of Efficacy|2|||
130886764|NCT03847896|471219060|FG004|Overall Study|Lack of Efficacy|2|||
130886765|NCT03847896|471219056|FG000|Overall Study|Other reasons|3|||
130886766|NCT03847896|471219057|FG001|Overall Study|Other reasons|3|||
130886767|NCT03847896|471219058|FG002|Overall Study|Other reasons|1|||
131020988|NCT03512756|471706897|FG001|Part 2|Lost to Follow-up|0|||
131020989|NCT03512756|471706898|FG002|Part 2|Lost to Follow-up|1|||
131020990|NCT03512756|471706899|FG003|Part 2|Lost to Follow-up|0|||
131020991|NCT03512756|471706896|FG000|Part 2|Physician Decision|0|||
131020992|NCT03512756|471706897|FG001|Part 2|Physician Decision|0|||
131020993|NCT03512756|471706898|FG002|Part 2|Physician Decision|2|||
131020994|NCT03512756|471706899|FG003|Part 2|Physician Decision|4|||
131020995|NCT03512756|471706896|FG000|Part 2|Study Terminated by Sponsor|0|||
130886768|NCT03847896|471219059|FG003|Overall Study|Other reasons|2|||
131020996|NCT03512756|471706897|FG001|Part 2|Study Terminated by Sponsor|0|||
130886769|NCT03847896|471219060|FG004|Overall Study|Other reasons|1|||
130886770|NCT02978781|471219061|FG000|Part A|Adverse Event|1|||
130886771|NCT02978781|471219062|FG001|Part A|Adverse Event|1|||
130886772|NCT02978781|471219063|FG002|Part A|Adverse Event|0|||
130685759|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685760|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685761|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685762|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685763|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685764|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685765|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685766|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685767|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685768|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685769|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685770|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685771|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685772|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130685773|NCT01597245|470477931|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
130685774|NCT01597245|470477932|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
130685775|NCT01597245|470477933|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
130685776|NCT01597245|470477934|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685777|NCT01597245|470477935|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685778|NCT01597245|470477936|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685779|NCT01597245|470477937|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685780|NCT01597245|470477938|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685781|NCT01597245|470477939|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685782|NCT01597245|470477940|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685783|NCT01597245|470477941|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685784|NCT01597245|470477942|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685785|NCT01597245|470477943|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685786|NCT01597245|470477944|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685787|NCT01597245|470477945|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685788|NCT01597245|470477946|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685789|NCT01597245|470477947|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685790|NCT01597245|470477948|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685791|NCT01597245|470477949|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685792|NCT01597245|470477950|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685793|NCT01597245|470477951|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130685794|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685795|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685796|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685797|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685798|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685799|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
130685800|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
130685801|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685802|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685803|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685804|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685805|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685806|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685807|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685808|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685809|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685810|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685811|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685812|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685813|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685814|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130685815|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685816|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
131106478|NCT03184870|472020860|FG013|Initial Treatment|Lost to Follow-up|2|||
130685817|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685818|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685819|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
131106479|NCT03184870|472020861|FG014|Initial Treatment|Lost to Follow-up|0|||
131106480|NCT03184870|472020862|FG015|Initial Treatment|Lost to Follow-up|0|||
131106481|NCT03184870|472020863|FG016|Initial Treatment|Lost to Follow-up|2|||
131106482|NCT03184870|472020864|FG017|Initial Treatment|Lost to Follow-up|2|||
131106483|NCT03184870|472020847|FG000|Initial Treatment|Withdrawal by Subject|0|||
131106484|NCT03184870|472020848|FG001|Initial Treatment|Withdrawal by Subject|0|||
131106485|NCT03184870|472020849|FG002|Initial Treatment|Withdrawal by Subject|2|||
131106486|NCT03184870|472020850|FG003|Initial Treatment|Withdrawal by Subject|1|||
130685820|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
131106487|NCT03184870|472020851|FG004|Initial Treatment|Withdrawal by Subject|1|||
131106488|NCT03184870|472020852|FG005|Initial Treatment|Withdrawal by Subject|0|||
131106489|NCT03184870|472020853|FG006|Initial Treatment|Withdrawal by Subject|1|||
131106490|NCT03184870|472020854|FG007|Initial Treatment|Withdrawal by Subject|0|||
131106491|NCT03184870|472020855|FG008|Initial Treatment|Withdrawal by Subject|0|||
131106492|NCT03184870|472020856|FG009|Initial Treatment|Withdrawal by Subject|0|||
131106493|NCT03184870|472020857|FG010|Initial Treatment|Withdrawal by Subject|0|||
131106494|NCT03184870|472020858|FG011|Initial Treatment|Withdrawal by Subject|2|||
131106495|NCT03184870|472020859|FG012|Initial Treatment|Withdrawal by Subject|3|||
131106496|NCT03184870|472020860|FG013|Initial Treatment|Withdrawal by Subject|0|||
131106497|NCT03184870|472020861|FG014|Initial Treatment|Withdrawal by Subject|1|||
130685821|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
130685822|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
130685823|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685824|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
130685825|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685826|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685827|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685828|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685829|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685830|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685831|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685832|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685833|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685834|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685835|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130685836|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685837|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685838|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685839|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685840|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685841|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
130685842|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685843|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685844|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
130685845|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685846|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
130685847|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
130685848|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
130685849|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685850|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685851|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685852|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685853|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685854|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685855|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685856|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130685857|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685858|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685859|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685860|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685861|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
130685862|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
130685863|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
130685864|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
130685865|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
130685866|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
130685867|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
131106498|NCT03184870|472020862|FG015|Initial Treatment|Withdrawal by Subject|5|||
131106499|NCT03184870|472020863|FG016|Initial Treatment|Withdrawal by Subject|2|||
131106500|NCT03184870|472020864|FG017|Initial Treatment|Withdrawal by Subject|2|||
131106501|NCT03184870|472020847|FG000|Initial Treatment|Moved to crossover treatment|0|||
131106502|NCT03184870|472020848|FG001|Initial Treatment|Moved to crossover treatment|0|||
130886773|NCT02978781|471219064|FG003|Part A|Adverse Event|0|||
130886774|NCT02978781|471219065|FG004|Part A|Adverse Event|0|||
130886775|NCT02978781|471219061|FG000|Part A|Withdrawal by Subject|0|||
130886776|NCT02978781|471219062|FG001|Part A|Withdrawal by Subject|1|||
130886777|NCT02978781|471219063|FG002|Part A|Withdrawal by Subject|0|||
130886778|NCT02978781|471219064|FG003|Part A|Withdrawal by Subject|0|||
130886779|NCT02978781|471219065|FG004|Part A|Withdrawal by Subject|0|||
130886780|NCT02978781|471219061|FG000|Part B|Withdrawal by Subject|0|||
130886781|NCT02978781|471219062|FG001|Part B|Withdrawal by Subject|0|||
130886782|NCT02978781|471219063|FG002|Part B|Withdrawal by Subject|0|||
130886783|NCT02978781|471219064|FG003|Part B|Withdrawal by Subject|1|||
130886784|NCT02978781|471219065|FG004|Part B|Withdrawal by Subject|0|||
130886785|NCT02978781|471219061|FG000|Part C|Adverse Event|0|||
130886786|NCT02978781|471219062|FG001|Part C|Adverse Event|0|||
130886787|NCT02978781|471219063|FG002|Part C|Adverse Event|0|||
130886788|NCT02978781|471219064|FG003|Part C|Adverse Event|0|||
130886789|NCT02978781|471219065|FG004|Part C|Adverse Event|2|||
130886790|NCT02978781|471219061|FG000|Part C|Withdrawal by Subject|0|||
130886791|NCT02978781|471219062|FG001|Part C|Withdrawal by Subject|0|||
130886792|NCT02978781|471219063|FG002|Part C|Withdrawal by Subject|0|||
130886793|NCT02978781|471219064|FG003|Part C|Withdrawal by Subject|0|||
130886794|NCT02978781|471219065|FG004|Part C|Withdrawal by Subject|1|||
130886795|NCT02978781|471219061|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
130886796|NCT02978781|471219062|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
130886797|NCT02978781|471219063|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
130886798|NCT02978781|471219064|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
130886799|NCT02978781|471219065|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
130886800|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
130886801|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
130886802|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Adverse Event|31|||
130886803|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Adverse Event|21|||
130886804|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
130886805|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
130886806|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
130886807|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
130886808|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
130886809|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
130886810|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
130886811|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
130886812|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Administrative problems|3|||
130886813|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Administrative problems|3|||
130886814|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Death|5|||
130886815|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Death|8|||
130886816|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Disease progression|139|||
130886817|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Disease progression|119|||
130886818|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
130886819|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
130886820|NCT00785785|471219066|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
130886821|NCT00785785|471219067|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
130886822|NCT00785785|471219066|FG000|Optional Extension Phase|Adverse Event|4|||
130886823|NCT00785785|471219067|FG001|Optional Extension Phase|Adverse Event|5|||
130886824|NCT00785785|471219066|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
130886825|NCT00785785|471219067|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
130886826|NCT00785785|471219066|FG000|Optional Extension Phase|Lost to Follow-up|1|||
130886827|NCT00785785|471219067|FG001|Optional Extension Phase|Lost to Follow-up|0|||
130886828|NCT00785785|471219066|FG000|Optional Extension Phase|Administrative problems|2|||
130886829|NCT00785785|471219067|FG001|Optional Extension Phase|Administrative problems|0|||
131106503|NCT03184870|472020849|FG002|Initial Treatment|Moved to crossover treatment|0|||
131106504|NCT03184870|472020850|FG003|Initial Treatment|Moved to crossover treatment|0|||
130886830|NCT00785785|471219066|FG000|Optional Extension Phase|Death|1|||
130886831|NCT00785785|471219067|FG001|Optional Extension Phase|Death|5|||
130886832|NCT00785785|471219066|FG000|Optional Extension Phase|Disease progression|22|||
131106505|NCT03184870|472020851|FG004|Initial Treatment|Moved to crossover treatment|0|||
130886833|NCT00785785|471219067|FG001|Optional Extension Phase|Disease progression|70|||
130886834|NCT00785785|471219066|FG000|Optional Extension Phase|Protocol deviation|0|||
130886835|NCT00785785|471219067|FG001|Optional Extension Phase|Protocol deviation|2|||
130886836|NCT00785785|471219066|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
130886837|NCT00785785|471219067|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
130886838|NCT02453321|471219068|FG000|Overall Study|Weakness|1|||
130886839|NCT02453321|471219069|FG001|Overall Study|Weakness|1|||
130886840|NCT02453321|471219070|FG002|Overall Study|Weakness|2|||
130886841|NCT02453321|471219068|FG000|Overall Study|Deep Venous Thrombosis|0|||
131106506|NCT03184870|472020852|FG005|Initial Treatment|Moved to crossover treatment|0|||
131106507|NCT03184870|472020853|FG006|Initial Treatment|Moved to crossover treatment|0|||
130886842|NCT02453321|471219069|FG001|Overall Study|Deep Venous Thrombosis|1|||
130886843|NCT02453321|471219070|FG002|Overall Study|Deep Venous Thrombosis|0|||
130886844|NCT00521404|471219071|FG000|Overall Study|Adverse Event|13|||
130886845|NCT00521404|471219071|FG000|Overall Study|Disease Progression|33|||
130886846|NCT00521404|471219071|FG000|Overall Study|Investigator decision|5|||
130886847|NCT00521404|471219071|FG000|Overall Study|Withdrawal of consent|3|||
130886848|NCT00521404|471219071|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
130886849|NCT00521404|471219071|FG000|Overall Study|Other|7|||
130886850|NCT02282605|471219076|FG000|Overall Study|negative SA result on Day -1|3|||
130886851|NCT02282605|471219077|FG001|Overall Study|negative SA result on Day -1|0|||
130886852|NCT02282605|471219078|FG002|Overall Study|negative SA result on Day -1|0|||
130886853|NCT03584789|471219079|FG000|Overall Study|refused EHR permission|19|||
130886854|NCT03584789|471219080|FG001|Overall Study|refused EHR permission|28|||
130886855|NCT03584789|471219081|FG002|Overall Study|refused EHR permission|23|||
130886856|NCT03584789|471219079|FG000|Overall Study|patients tied to a provider who retired|0|||
130886857|NCT03584789|471219080|FG001|Overall Study|patients tied to a provider who retired|0|||
130886858|NCT03584789|471219081|FG002|Overall Study|patients tied to a provider who retired|3|||
130886859|NCT02035267|471219082|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
130886860|NCT02035267|471219083|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
130886861|NCT02035267|471219084|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
130886862|NCT02035267|471219085|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
130886863|NCT02035267|471219082|FG000|Overall Study|Adverse Event|0|||
130886864|NCT02035267|471219083|FG001|Overall Study|Adverse Event|0|||
130886865|NCT02035267|471219084|FG002|Overall Study|Adverse Event|1|||
130886866|NCT02035267|471219085|FG003|Overall Study|Adverse Event|0|||
130886867|NCT02035267|471219082|FG000|Overall Study|Lost to Follow-up|0|||
130886868|NCT02035267|471219083|FG001|Overall Study|Lost to Follow-up|0|||
130886869|NCT02035267|471219084|FG002|Overall Study|Lost to Follow-up|0|||
130886870|NCT02035267|471219085|FG003|Overall Study|Lost to Follow-up|1|||
130886871|NCT02035267|471219082|FG000|Overall Study|Other unspecified|0|||
130886872|NCT02035267|471219083|FG001|Overall Study|Other unspecified|1|||
130886873|NCT02035267|471219084|FG002|Overall Study|Other unspecified|0|||
130886874|NCT02035267|471219085|FG003|Overall Study|Other unspecified|0|||
130886875|NCT00823615|471219094|FG000|Period 2|Lost to Follow-up|2|||
130886876|NCT00823615|471219095|FG001|Period 2|Lost to Follow-up|0|||
130886877|NCT00823615|471219094|FG000|Period 2|Time/Job Conflict|1|||
130886878|NCT00823615|471219095|FG001|Period 2|Time/Job Conflict|2|||
130886879|NCT00098813|471219096|FG000|Overall Study|Death|8|||
130886880|NCT00098813|471219096|FG000|Overall Study|Protocol Violation|1|||
130886881|NCT00098813|471219096|FG000|Overall Study|Withdrawal by Subject|7|||
130886882|NCT00098813|471219096|FG000|Overall Study|Progression of Disease|1|||
130886883|NCT00098813|471219096|FG000|Overall Study|Other complicating disease|1|||
130886884|NCT00098813|471219096|FG000|Overall Study|Reversal of RAI resistance|1|||
130886885|NCT00892099|471219098|FG000|Overall Study|Death|1|||
130886886|NCT00892099|471219099|FG001|Overall Study|Death|0|||
130886887|NCT00892099|471219100|FG002|Overall Study|Death|1|||
130886888|NCT00892099|471219098|FG000|Overall Study|Adverse Event|1|||
130886889|NCT00892099|471219099|FG001|Overall Study|Adverse Event|0|||
130886890|NCT00892099|471219100|FG002|Overall Study|Adverse Event|0|||
130886891|NCT00892099|471219098|FG000|Overall Study|replocated|1|||
130886892|NCT00892099|471219099|FG001|Overall Study|replocated|0|||
130886893|NCT00892099|471219100|FG002|Overall Study|replocated|2|||
130886894|NCT00892099|471219098|FG000|Overall Study|Prolonged hospitalization|1|||
130886895|NCT00892099|471219099|FG001|Overall Study|Prolonged hospitalization|0|||
130886896|NCT00892099|471219100|FG002|Overall Study|Prolonged hospitalization|1|||
131106508|NCT03184870|472020854|FG007|Initial Treatment|Moved to crossover treatment|0|||
131106509|NCT03184870|472020855|FG008|Initial Treatment|Moved to crossover treatment|0|||
131106510|NCT03184870|472020856|FG009|Initial Treatment|Moved to crossover treatment|0|||
131106511|NCT03184870|472020857|FG010|Initial Treatment|Moved to crossover treatment|0|||
131106512|NCT03184870|472020858|FG011|Initial Treatment|Moved to crossover treatment|0|||
131106513|NCT03184870|472020859|FG012|Initial Treatment|Moved to crossover treatment|9|||
130886897|NCT00892099|471219098|FG000|Overall Study|no further details|1|||
130886898|NCT00892099|471219099|FG001|Overall Study|no further details|0|||
130886899|NCT00892099|471219100|FG002|Overall Study|no further details|1|||
130886900|NCT00892099|471219098|FG000|Overall Study|kidney function recovered|0|||
130886901|NCT00892099|471219099|FG001|Overall Study|kidney function recovered|1|||
130886902|NCT00892099|471219100|FG002|Overall Study|kidney function recovered|0|||
130886903|NCT00892099|471219098|FG000|Overall Study|investigator decision|0|||
130886904|NCT00892099|471219099|FG001|Overall Study|investigator decision|0|||
130886905|NCT00892099|471219100|FG002|Overall Study|investigator decision|1|||
130886906|NCT00892099|471219098|FG000|Overall Study|Lost to Follow-up|0|||
130886907|NCT00892099|471219099|FG001|Overall Study|Lost to Follow-up|0|||
130886908|NCT00892099|471219100|FG002|Overall Study|Lost to Follow-up|1|||
130886909|NCT04396639|471219101|FG000|Overall Study|Withdrawal by Subject|1|||
130886910|NCT04396639|471219101|FG000|Overall Study|Other|1|||
130886911|NCT01532986|471219102|FG000|Overall Study|Death|9|||
130886912|NCT01532986|471219103|FG001|Overall Study|Death|9|||
130886913|NCT01532986|471219102|FG000|Overall Study|Withdrawal by Subject|7|||
130886914|NCT01532986|471219103|FG001|Overall Study|Withdrawal by Subject|10|||
130886915|NCT01532986|471219102|FG000|Overall Study|Physician Decision|7|||
130886916|NCT01532986|471219103|FG001|Overall Study|Physician Decision|5|||
130886917|NCT00043979|471219104|FG000|Period 1|recipient with progressive disease|7|||
130886918|NCT00043979|471219105|FG001|Period 1|recipient with progressive disease|4|||
130886919|NCT00043979|471219106|FG002|Period 1|recipient with progressive disease|3|||
130886920|NCT00658359|471219109|FG000|Overall Study|Death|3|||
130886921|NCT00658359|471219110|FG001|Overall Study|Death|1|||
130886922|NCT00658359|471219111|FG002|Overall Study|Death|2|||
130886923|NCT00658359|471219109|FG000|Overall Study|Adverse Event|13|||
130886924|NCT00658359|471219110|FG001|Overall Study|Adverse Event|6|||
130886925|NCT00658359|471219111|FG002|Overall Study|Adverse Event|9|||
130886926|NCT00658359|471219109|FG000|Overall Study|Protocol Violation|1|||
130886927|NCT00658359|471219110|FG001|Overall Study|Protocol Violation|0|||
130886928|NCT00658359|471219111|FG002|Overall Study|Protocol Violation|0|||
130886929|NCT00658359|471219109|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
130886930|NCT00658359|471219110|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
130886931|NCT00658359|471219111|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
130886932|NCT00658359|471219109|FG000|Overall Study|Withdrawal by Subject|7|||
130886933|NCT00658359|471219110|FG001|Overall Study|Withdrawal by Subject|4|||
130886934|NCT00658359|471219111|FG002|Overall Study|Withdrawal by Subject|2|||
130886935|NCT00658359|471219109|FG000|Overall Study|Lost to Follow-up|2|||
130886936|NCT00658359|471219110|FG001|Overall Study|Lost to Follow-up|2|||
130886937|NCT00658359|471219111|FG002|Overall Study|Lost to Follow-up|4|||
130886938|NCT00658359|471219109|FG000|Overall Study|Lack of Efficacy|0|||
130886939|NCT00658359|471219110|FG001|Overall Study|Lack of Efficacy|1|||
130886940|NCT00658359|471219111|FG002|Overall Study|Lack of Efficacy|0|||
130886941|NCT02754440|471219112|FG000|Overall Study|Protocol Violation|3|||
130886942|NCT02754440|471219113|FG001|Overall Study|Protocol Violation|2|||
130886943|NCT02754440|471219114|FG002|Overall Study|Protocol Violation|2|||
130886944|NCT02754440|471219115|FG003|Overall Study|Protocol Violation|6|||
130886945|NCT02754440|471219112|FG000|Overall Study|Adverse Event|3|||
130886946|NCT02754440|471219113|FG001|Overall Study|Adverse Event|1|||
130886947|NCT02754440|471219114|FG002|Overall Study|Adverse Event|0|||
130886948|NCT02754440|471219115|FG003|Overall Study|Adverse Event|9|||
130886949|NCT02754440|471219112|FG000|Overall Study|Withdrawal by Subject|0|||
130886950|NCT02754440|471219113|FG001|Overall Study|Withdrawal by Subject|0|||
130886951|NCT02754440|471219114|FG002|Overall Study|Withdrawal by Subject|0|||
130886952|NCT02754440|471219115|FG003|Overall Study|Withdrawal by Subject|1|||
130886953|NCT02754440|471219112|FG000|Overall Study|Equipment failure|0|||
130886954|NCT02754440|471219113|FG001|Overall Study|Equipment failure|5|||
130886955|NCT02754440|471219114|FG002|Overall Study|Equipment failure|5|||
130886956|NCT02754440|471219115|FG003|Overall Study|Equipment failure|7|||
130886957|NCT02754440|471219112|FG000|Overall Study|Subject issues not resulting in AE|0|||
130886958|NCT02754440|471219113|FG001|Overall Study|Subject issues not resulting in AE|0|||
130886959|NCT02754440|471219114|FG002|Overall Study|Subject issues not resulting in AE|0|||
130886960|NCT02754440|471219115|FG003|Overall Study|Subject issues not resulting in AE|12|||
130886961|NCT01189032|471219118|FG000|Overall Study|Adverse Event|1|||
130886962|NCT01189032|471219119|FG001|Overall Study|Adverse Event|3|||
130886963|NCT01189032|471219120|FG002|Overall Study|Adverse Event|4|||
130886964|NCT01189032|471219118|FG000|Overall Study|Lack of Efficacy|2|||
130886965|NCT01189032|471219119|FG001|Overall Study|Lack of Efficacy|3|||
130886966|NCT01189032|471219120|FG002|Overall Study|Lack of Efficacy|0|||
130886967|NCT01189032|471219118|FG000|Overall Study|Withdrawal by Subject|1|||
130886968|NCT01189032|471219119|FG001|Overall Study|Withdrawal by Subject|0|||
130886969|NCT01189032|471219120|FG002|Overall Study|Withdrawal by Subject|1|||
130886970|NCT01189032|471219118|FG000|Overall Study|Protocol Violation|1|||
130886971|NCT01189032|471219119|FG001|Overall Study|Protocol Violation|1|||
130886972|NCT01189032|471219120|FG002|Overall Study|Protocol Violation|1|||
130886973|NCT03388164|471219125|FG000|Overall Study|Withdrawal by Subject|3|||
130886974|NCT03388164|471219126|FG001|Overall Study|Withdrawal by Subject|1|||
130886975|NCT05375760|471219129|FG000|Overall Study|Adverse Event|1|||
130886976|NCT05375760|471219130|FG001|Overall Study|Adverse Event|0|||
130886977|NCT05375760|471219129|FG000|Overall Study|Death|0|||
130886978|NCT05375760|471219130|FG001|Overall Study|Death|1|||
131020997|NCT03512756|471706898|FG002|Part 2|Study Terminated by Sponsor|2|||
131020998|NCT03512756|471706899|FG003|Part 2|Study Terminated by Sponsor|6|||
131020999|NCT03512756|471706896|FG000|Part 2|Protocol Violation|0|||
131021000|NCT03512756|471706897|FG001|Part 2|Protocol Violation|0|||
131021001|NCT03512756|471706898|FG002|Part 2|Protocol Violation|1|||
131021002|NCT03512756|471706899|FG003|Part 2|Protocol Violation|0|||
131021003|NCT03512756|471706896|FG000|Part 2|Withdrawal by Subject|0|||
131021004|NCT03512756|471706897|FG001|Part 2|Withdrawal by Subject|0|||
130685868|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
130685869|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
130767062|NCT03170609|470770700|FG006|Overall Study|Other|0|||
131021005|NCT03512756|471706898|FG002|Part 2|Withdrawal by Subject|3|||
130886979|NCT05375760|471219129|FG000|Overall Study|Lost to Follow-up|6|||
130886980|NCT05375760|471219130|FG001|Overall Study|Lost to Follow-up|6|||
130886981|NCT05375760|471219129|FG000|Overall Study|Withdrawal by Subject|17|||
130886982|NCT05375760|471219130|FG001|Overall Study|Withdrawal by Subject|19|||
130886983|NCT05375760|471219129|FG000|Overall Study|Dosing halted by FDA|96|||
130886984|NCT05375760|471219130|FG001|Overall Study|Dosing halted by FDA|100|||
130886985|NCT05375760|471219129|FG000|Overall Study|Not compliant with study visit|2|||
130886986|NCT05375760|471219130|FG001|Overall Study|Not compliant with study visit|0|||
130886987|NCT05375760|471219129|FG000|Overall Study|Physician Decision|1|||
130886988|NCT05375760|471219130|FG001|Overall Study|Physician Decision|0|||
130886989|NCT05375760|471219129|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
130886990|NCT05375760|471219130|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
130886991|NCT05375760|471219129|FG000|Overall Study|Participant moved|1|||
130886992|NCT05375760|471219130|FG001|Overall Study|Participant moved|0|||
130886993|NCT00363480|471219131|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
130886994|NCT00363480|471219131|FG000|Overall Study|Adverse Event|4|||
130886995|NCT00363480|471219131|FG000|Overall Study|Lost to Follow-up|5|||
130886996|NCT00363480|471219131|FG000|Overall Study|Withdrawal by Subject|5|||
130886997|NCT00363480|471219131|FG000|Overall Study|Non-compliance of subject|1|||
130886998|NCT00363480|471219131|FG000|Overall Study|Participant discontinued on its own|1|||
130886999|NCT01721044|471219132|FG000|Treatment Period|Adverse Event|7|||
130887000|NCT01721044|471219133|FG001|Treatment Period|Adverse Event|7|||
130887001|NCT01721044|471219134|FG002|Treatment Period|Adverse Event|10|||
130887002|NCT01721044|471219132|FG000|Treatment Period|Death|0|||
130887003|NCT01721044|471219133|FG001|Treatment Period|Death|0|||
130887004|NCT01721044|471219134|FG002|Treatment Period|Death|1|||
130887005|NCT01721044|471219132|FG000|Treatment Period|Lack of Efficacy|16|||
130887006|NCT01721044|471219133|FG001|Treatment Period|Lack of Efficacy|4|||
130887007|NCT01721044|471219134|FG002|Treatment Period|Lack of Efficacy|4|||
130887008|NCT01721044|471219132|FG000|Treatment Period|Lost to Follow-up|0|||
130887009|NCT01721044|471219133|FG001|Treatment Period|Lost to Follow-up|0|||
130887010|NCT01721044|471219134|FG002|Treatment Period|Lost to Follow-up|1|||
130887011|NCT01721044|471219132|FG000|Treatment Period|Physician Decision|1|||
130887012|NCT01721044|471219133|FG001|Treatment Period|Physician Decision|0|||
130887013|NCT01721044|471219134|FG002|Treatment Period|Physician Decision|2|||
130887014|NCT01721044|471219132|FG000|Treatment Period|Protocol Violation|1|||
130887015|NCT01721044|471219133|FG001|Treatment Period|Protocol Violation|0|||
130887016|NCT01721044|471219134|FG002|Treatment Period|Protocol Violation|0|||
130887017|NCT01721044|471219132|FG000|Treatment Period|Withdrawal by Subject|7|||
130887018|NCT01721044|471219133|FG001|Treatment Period|Withdrawal by Subject|6|||
130887019|NCT01721044|471219134|FG002|Treatment Period|Withdrawal by Subject|1|||
130887020|NCT04032093|471219137|FG000|Overall Study|Lost to Follow-up|7|||
130887021|NCT04032093|471219138|FG001|Overall Study|Lost to Follow-up|7|||
130887022|NCT04032093|471219139|FG002|Overall Study|Lost to Follow-up|6|||
130887023|NCT04032093|471219140|FG003|Overall Study|Lost to Follow-up|10|||
130887024|NCT04032093|471219141|FG004|Overall Study|Lost to Follow-up|13|||
130887025|NCT04032093|471219142|FG005|Overall Study|Lost to Follow-up|7|||
130887026|NCT04032093|471219143|FG006|Overall Study|Lost to Follow-up|7|||
130887027|NCT04032093|471219144|FG007|Overall Study|Lost to Follow-up|5|||
130887028|NCT04032093|471219145|FG008|Overall Study|Lost to Follow-up|9|||
130887029|NCT04032093|471219146|FG009|Overall Study|Lost to Follow-up|12|||
131021006|NCT03512756|471706899|FG003|Part 2|Withdrawal by Subject|9|||
131021007|NCT00736853|471706900|FG000|Open-Label Period|Physician Decision|2|||
131021008|NCT00736853|471706901|FG001|Open-Label Period|Physician Decision|0|||
131021009|NCT00736853|471706902|FG002|Open-Label Period|Physician Decision|0|||
131021010|NCT00736853|471706900|FG000|Open-Label Period|Adverse Event|31|||
131021011|NCT00736853|471706901|FG001|Open-Label Period|Adverse Event|0|||
130685870|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685871|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130887030|NCT04032093|471219137|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130887031|NCT04032093|471219138|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130887032|NCT04032093|471219139|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130887033|NCT04032093|471219140|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
130887034|NCT04032093|471219141|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
130887035|NCT04032093|471219142|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130887036|NCT04032093|471219143|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
130887037|NCT04032093|471219144|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130887038|NCT04032093|471219145|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
130887039|NCT04032093|471219146|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
130887040|NCT04032093|471219137|FG000|Overall Study|Other|1|||
130887041|NCT04032093|471219138|FG001|Overall Study|Other|0|||
131021012|NCT00736853|471706902|FG002|Open-Label Period|Adverse Event|0|||
131021013|NCT00736853|471706900|FG000|Open-Label Period|Withdrawal by Subject|16|||
131021014|NCT00736853|471706901|FG001|Open-Label Period|Withdrawal by Subject|0|||
130887042|NCT04032093|471219139|FG002|Overall Study|Other|0|||
130887043|NCT04032093|471219140|FG003|Overall Study|Other|1|||
130887044|NCT04032093|471219141|FG004|Overall Study|Other|1|||
130887045|NCT04032093|471219142|FG005|Overall Study|Other|0|||
130887046|NCT04032093|471219143|FG006|Overall Study|Other|0|||
130887047|NCT04032093|471219144|FG007|Overall Study|Other|0|||
130887048|NCT04032093|471219145|FG008|Overall Study|Other|0|||
130887049|NCT04032093|471219146|FG009|Overall Study|Other|1|||
130887050|NCT04032093|471219137|FG000|Overall Study|Withdrawal by Subject|1|||
130887051|NCT04032093|471219138|FG001|Overall Study|Withdrawal by Subject|3|||
130887052|NCT04032093|471219139|FG002|Overall Study|Withdrawal by Subject|2|||
130887053|NCT04032093|471219140|FG003|Overall Study|Withdrawal by Subject|2|||
130887054|NCT04032093|471219141|FG004|Overall Study|Withdrawal by Subject|3|||
130887055|NCT04032093|471219142|FG005|Overall Study|Withdrawal by Subject|0|||
130887056|NCT04032093|471219143|FG006|Overall Study|Withdrawal by Subject|0|||
130887057|NCT04032093|471219144|FG007|Overall Study|Withdrawal by Subject|0|||
130887058|NCT04032093|471219145|FG008|Overall Study|Withdrawal by Subject|0|||
130887059|NCT04032093|471219146|FG009|Overall Study|Withdrawal by Subject|0|||
130887060|NCT04032093|471219137|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130887061|NCT04032093|471219138|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130887062|NCT04032093|471219139|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130887063|NCT04032093|471219140|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130887064|NCT04032093|471219141|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130887065|NCT04032093|471219142|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130887066|NCT04032093|471219143|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
130887067|NCT04032093|471219144|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
130887068|NCT04032093|471219145|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
130887069|NCT04032093|471219146|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
130887070|NCT04032093|471219137|FG000|Overall Study|Adverse Event|0|||
130887071|NCT04032093|471219138|FG001|Overall Study|Adverse Event|0|||
130887072|NCT04032093|471219139|FG002|Overall Study|Adverse Event|0|||
130887073|NCT04032093|471219140|FG003|Overall Study|Adverse Event|0|||
130887074|NCT04032093|471219141|FG004|Overall Study|Adverse Event|0|||
130887075|NCT04032093|471219142|FG005|Overall Study|Adverse Event|0|||
130887076|NCT04032093|471219143|FG006|Overall Study|Adverse Event|0|||
130887077|NCT04032093|471219144|FG007|Overall Study|Adverse Event|0|||
130887078|NCT04032093|471219145|FG008|Overall Study|Adverse Event|0|||
130887079|NCT04032093|471219146|FG009|Overall Study|Adverse Event|1|||
130887080|NCT04032093|471219137|FG000|Overall Study|Physician Decision|0|||
130887081|NCT04032093|471219138|FG001|Overall Study|Physician Decision|0|||
130887082|NCT04032093|471219139|FG002|Overall Study|Physician Decision|0|||
130887083|NCT04032093|471219140|FG003|Overall Study|Physician Decision|0|||
130887084|NCT04032093|471219141|FG004|Overall Study|Physician Decision|0|||
130887085|NCT04032093|471219142|FG005|Overall Study|Physician Decision|1|||
130887086|NCT04032093|471219143|FG006|Overall Study|Physician Decision|0|||
130887087|NCT04032093|471219144|FG007|Overall Study|Physician Decision|0|||
130887088|NCT04032093|471219145|FG008|Overall Study|Physician Decision|0|||
130887089|NCT04032093|471219146|FG009|Overall Study|Physician Decision|0|||
130887090|NCT01457703|471219153|FG000|Overall Study|Screen Failure|5|||
130887091|NCT01457703|471219154|FG001|Overall Study|Screen Failure|7|||
130887092|NCT01457703|471219153|FG000|Overall Study|Withdrawal by Subject|1|||
130887093|NCT01457703|471219154|FG001|Overall Study|Withdrawal by Subject|4|||
130887094|NCT00949702|471219155|FG000|Overall Study|Death|40|||
130887095|NCT00949702|471219155|FG000|Overall Study|Disease progression|7|||
131021015|NCT00736853|471706902|FG002|Open-Label Period|Withdrawal by Subject|0|||
131021016|NCT00736853|471706900|FG000|Open-Label Period|Started but not treated|42|||
131021017|NCT00736853|471706901|FG001|Open-Label Period|Started but not treated|0|||
131021018|NCT00736853|471706902|FG002|Open-Label Period|Started but not treated|0|||
131021019|NCT00736853|471706900|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
131021020|NCT00736853|471706901|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
130887096|NCT00949702|471219155|FG000|Overall Study|Withdrawal of consent|1|||
130887097|NCT01654302|471219156|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
130887098|NCT01654302|471219157|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
130887099|NCT03133793|471219161|FG000|Overall Study|Withdrawal by Subject|0|||
130887100|NCT03133793|471219162|FG001|Overall Study|Withdrawal by Subject|4|||
131021021|NCT00736853|471706902|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
130887101|NCT03133793|471219163|FG002|Overall Study|Withdrawal by Subject|2|||
130887102|NCT03133793|471219164|FG003|Overall Study|Withdrawal by Subject|4|||
130887103|NCT03133793|471219161|FG000|Overall Study|Lost to Follow-up|1|||
130887104|NCT03133793|471219162|FG001|Overall Study|Lost to Follow-up|0|||
130887105|NCT03133793|471219163|FG002|Overall Study|Lost to Follow-up|2|||
130887106|NCT03133793|471219164|FG003|Overall Study|Lost to Follow-up|0|||
130887107|NCT03133793|471219161|FG000|Overall Study|Death|0|||
130887108|NCT03133793|471219162|FG001|Overall Study|Death|0|||
130887109|NCT03133793|471219163|FG002|Overall Study|Death|0|||
130887110|NCT03133793|471219164|FG003|Overall Study|Death|1|||
131021022|NCT00736853|471706900|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
130887111|NCT02839200|471219165|FG000|Overall Study|Withdrawal by Subject|2|||
130887112|NCT02839200|471219166|FG001|Overall Study|Withdrawal by Subject|0|||
130887113|NCT02839200|471219167|FG002|Overall Study|Withdrawal by Subject|1|||
130887114|NCT02839200|471219168|FG003|Overall Study|Withdrawal by Subject|0|||
130887115|NCT02839200|471219169|FG004|Overall Study|Withdrawal by Subject|0|||
130887116|NCT02839200|471219170|FG005|Overall Study|Withdrawal by Subject|1|||
130887117|NCT02839200|471219165|FG000|Overall Study|Lost to Follow-up|2|||
130887118|NCT02839200|471219166|FG001|Overall Study|Lost to Follow-up|0|||
130887119|NCT02839200|471219167|FG002|Overall Study|Lost to Follow-up|0|||
130887120|NCT02839200|471219168|FG003|Overall Study|Lost to Follow-up|0|||
130887121|NCT02839200|471219169|FG004|Overall Study|Lost to Follow-up|1|||
130887122|NCT02839200|471219170|FG005|Overall Study|Lost to Follow-up|0|||
130887123|NCT02839200|471219165|FG000|Overall Study|Adverse Event|0|||
130887124|NCT02839200|471219166|FG001|Overall Study|Adverse Event|0|||
130887125|NCT02839200|471219167|FG002|Overall Study|Adverse Event|0|||
130887126|NCT02839200|471219168|FG003|Overall Study|Adverse Event|0|||
130887127|NCT02839200|471219169|FG004|Overall Study|Adverse Event|1|||
130887128|NCT02839200|471219170|FG005|Overall Study|Adverse Event|0|||
130887129|NCT02839200|471219165|FG000|Overall Study|Randomized in error|0|||
130887130|NCT02839200|471219166|FG001|Overall Study|Randomized in error|1|||
130887131|NCT02839200|471219167|FG002|Overall Study|Randomized in error|0|||
130887132|NCT02839200|471219168|FG003|Overall Study|Randomized in error|0|||
130887133|NCT02839200|471219169|FG004|Overall Study|Randomized in error|0|||
130887134|NCT02839200|471219170|FG005|Overall Study|Randomized in error|0|||
130887135|NCT04139018|471219171|FG000|Overall Study|Screen fail|1|||
130887136|NCT04139018|471219172|FG001|Overall Study|Screen fail|0|||
130887137|NCT04139018|471219171|FG000|Overall Study|Withdrawal by Subject|2|||
130887138|NCT04139018|471219172|FG001|Overall Study|Withdrawal by Subject|0|||
130887139|NCT04139018|471219171|FG000|Overall Study|Lost to Follow-up|0|||
130887140|NCT04139018|471219172|FG001|Overall Study|Lost to Follow-up|1|||
130887141|NCT04476797|471219174|FG000|Overall Study|Withdrawal by Subject|1|||
130887142|NCT04476797|471219175|FG001|Overall Study|Withdrawal by Subject|0|||
130887143|NCT04476797|471219176|FG002|Overall Study|Withdrawal by Subject|0|||
130887144|NCT04476797|471219174|FG000|Overall Study|Death|0|||
130887145|NCT04476797|471219175|FG001|Overall Study|Death|1|||
130887146|NCT04476797|471219176|FG002|Overall Study|Death|2|||
130887147|NCT04476797|471219174|FG000|Overall Study|Sponsor Terminated Study|0|||
130887148|NCT04476797|471219175|FG001|Overall Study|Sponsor Terminated Study|18|||
130887149|NCT04476797|471219176|FG002|Overall Study|Sponsor Terminated Study|17|||
130887150|NCT03614156|471219193|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
130887151|NCT03614156|471219194|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
130887152|NCT03614156|471219195|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
130887153|NCT03614156|471219196|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
130887154|NCT03614156|471219193|FG000|Open-Label Treatment Period|Adverse Event|7|||
130887155|NCT03614156|471219194|FG001|Open-Label Treatment Period|Adverse Event|0|||
130887156|NCT03614156|471219195|FG002|Open-Label Treatment Period|Adverse Event|0|||
130887157|NCT03614156|471219196|FG003|Open-Label Treatment Period|Adverse Event|0|||
130887158|NCT03614156|471219193|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
130887159|NCT03614156|471219194|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
130887160|NCT03614156|471219195|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
130887161|NCT03614156|471219196|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
130887162|NCT03614156|471219193|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
130887163|NCT03614156|471219194|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
130887164|NCT03614156|471219195|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
130887165|NCT03614156|471219196|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
130887166|NCT03614156|471219193|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
130887167|NCT03614156|471219194|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
130887168|NCT03614156|471219195|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
130887169|NCT03614156|471219196|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
130887170|NCT03614156|471219193|FG000|Open-Label Treatment Period|Protocol Violation|2|||
130887171|NCT03614156|471219194|FG001|Open-Label Treatment Period|Protocol Violation|0|||
130887172|NCT03614156|471219195|FG002|Open-Label Treatment Period|Protocol Violation|0|||
130887173|NCT03614156|471219196|FG003|Open-Label Treatment Period|Protocol Violation|0|||
130887174|NCT03614156|471219193|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
130887175|NCT03614156|471219194|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
130887176|NCT03614156|471219195|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
130887177|NCT03614156|471219196|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
130887178|NCT03614156|471219193|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
130887179|NCT03614156|471219194|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
130887180|NCT03614156|471219195|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
130887181|NCT03614156|471219196|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
130887182|NCT03614156|471219193|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
130887183|NCT03614156|471219194|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
131021023|NCT00736853|471706901|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
131021024|NCT00736853|471706902|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
130887184|NCT03614156|471219195|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
130887185|NCT03614156|471219196|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
130887186|NCT03614156|471219193|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130887187|NCT03614156|471219194|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
130887188|NCT03614156|471219195|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130887189|NCT03614156|471219196|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130887190|NCT03614156|471219193|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130887191|NCT03614156|471219194|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130887192|NCT03614156|471219195|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
130887193|NCT03614156|471219196|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
130887194|NCT03614156|471219193|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
130887195|NCT03614156|471219194|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
130887196|NCT03614156|471219195|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
130887197|NCT03614156|471219196|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
130887198|NCT03614156|471219193|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
130887199|NCT03614156|471219194|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
130887200|NCT03614156|471219195|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
130887201|NCT03614156|471219196|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
130887202|NCT03614156|471219193|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
130887203|NCT03614156|471219194|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
130887204|NCT03614156|471219195|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
130887205|NCT03614156|471219196|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
130887206|NCT03614156|471219193|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
130887207|NCT03614156|471219194|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
130887208|NCT03614156|471219195|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
130887209|NCT03614156|471219196|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
130887210|NCT03614156|471219193|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
130887211|NCT03614156|471219194|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
130887212|NCT03614156|471219195|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
130887213|NCT03614156|471219196|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
130887214|NCT03614156|471219193|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
130887215|NCT03614156|471219194|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
130887216|NCT03614156|471219195|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
130887217|NCT03614156|471219196|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
130887218|NCT04287517|471219201|FG000|Overall Study|Withdrawal by Subject|1|||
130887219|NCT04287517|471219202|FG001|Overall Study|Withdrawal by Subject|1|||
130887220|NCT03070964|471219203|FG000|Overall Study|Progressive disease|8|||
130887221|NCT03070964|471219203|FG000|Overall Study|Treatment-unrelated adverse event|2|||
130887222|NCT03070964|471219203|FG000|Overall Study|Never treated|1|||
130887223|NCT03070964|471219203|FG000|Overall Study|Physician Decision|1|||
130887224|NCT03070964|471219203|FG000|Overall Study|Withdrawal by Subject|1|||
130887225|NCT03070964|471219203|FG000|Overall Study|Adverse Event|1|||
130887226|NCT00834093|471219206|FG000|Overall Study|Progressive Disease|3|||
130887227|NCT00834093|471219206|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
130887228|NCT02745119|471219207|FG000|Overall Study|Adverse Event|1|||
130887229|NCT02745119|471219208|FG001|Overall Study|Adverse Event|0|||
130887230|NCT02745119|471219209|FG002|Overall Study|Adverse Event|1|||
130887231|NCT02745119|471219210|FG003|Overall Study|Adverse Event|3|||
130887232|NCT02745119|471219207|FG000|Overall Study|Death|3|||
130887233|NCT02745119|471219208|FG001|Overall Study|Death|3|||
131021025|NCT00736853|471706900|FG000|Double-Blind Period|Lack of Efficacy|0|||
131021026|NCT00736853|471706901|FG001|Double-Blind Period|Lack of Efficacy|19|||
131021027|NCT00736853|471706902|FG002|Double-Blind Period|Lack of Efficacy|42|||
131021028|NCT00736853|471706900|FG000|Double-Blind Period|Adverse Event|0|||
131021029|NCT00736853|471706901|FG001|Double-Blind Period|Adverse Event|3|||
131021030|NCT00736853|471706902|FG002|Double-Blind Period|Adverse Event|2|||
131021031|NCT00736853|471706900|FG000|Double-Blind Period|Withdrawal by Subject|0|||
131021032|NCT00736853|471706901|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131021033|NCT00736853|471706902|FG002|Double-Blind Period|Withdrawal by Subject|4|||
131021034|NCT00736853|471706900|FG000|Double-Blind Period|Ineligible to participate the study|0|||
131222615|NCT01902134|472443117|FG004|Overall Study|Other|1|||
130685872|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685873|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685874|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130887234|NCT02745119|471219209|FG002|Overall Study|Death|0|||
130887235|NCT02745119|471219210|FG003|Overall Study|Death|4|||
130887236|NCT02745119|471219207|FG000|Overall Study|Lost to Follow-up|0|||
130887237|NCT02745119|471219208|FG001|Overall Study|Lost to Follow-up|0|||
130887238|NCT02745119|471219209|FG002|Overall Study|Lost to Follow-up|0|||
130887239|NCT02745119|471219210|FG003|Overall Study|Lost to Follow-up|1|||
130887240|NCT02745119|471219207|FG000|Overall Study|Protocol Deviation|0|||
130887241|NCT02745119|471219208|FG001|Overall Study|Protocol Deviation|0|||
130887242|NCT02745119|471219209|FG002|Overall Study|Protocol Deviation|0|||
130887243|NCT02745119|471219210|FG003|Overall Study|Protocol Deviation|1|||
130887244|NCT02745119|471219207|FG000|Overall Study|Withdrawal by Subject|7|||
130887245|NCT02745119|471219208|FG001|Overall Study|Withdrawal by Subject|15|||
130887246|NCT02745119|471219209|FG002|Overall Study|Withdrawal by Subject|8|||
130887247|NCT02745119|471219210|FG003|Overall Study|Withdrawal by Subject|14|||
130887248|NCT02745119|471219207|FG000|Overall Study|Study Terminated by Sponsor|134|||
130887249|NCT02745119|471219208|FG001|Overall Study|Study Terminated by Sponsor|252|||
130887250|NCT02745119|471219209|FG002|Overall Study|Study Terminated by Sponsor|135|||
130887251|NCT02745119|471219210|FG003|Overall Study|Study Terminated by Sponsor|251|||
130887252|NCT02745119|471219207|FG000|Overall Study|Physician Decision|0|||
130887253|NCT02745119|471219208|FG001|Overall Study|Physician Decision|2|||
130887254|NCT02745119|471219209|FG002|Overall Study|Physician Decision|2|||
130887255|NCT02745119|471219210|FG003|Overall Study|Physician Decision|2|||
130887256|NCT02745119|471219207|FG000|Overall Study|Reason Not Specified|0|||
130887257|NCT02745119|471219208|FG001|Overall Study|Reason Not Specified|2|||
130887258|NCT02745119|471219209|FG002|Overall Study|Reason Not Specified|0|||
130887259|NCT02745119|471219210|FG003|Overall Study|Reason Not Specified|1|||
130887260|NCT01587924|471219211|FG000|Overall Study|Adverse Event|0|||
130887261|NCT01587924|471219212|FG001|Overall Study|Adverse Event|2|||
130887262|NCT01587924|471219213|FG002|Overall Study|Adverse Event|0|||
130887263|NCT01587924|471219214|FG003|Overall Study|Adverse Event|0|||
130887264|NCT01587924|471219211|FG000|Overall Study|Protocol Violation|2|||
130887265|NCT01587924|471219212|FG001|Overall Study|Protocol Violation|1|||
130887266|NCT01587924|471219213|FG002|Overall Study|Protocol Violation|2|||
130887267|NCT01587924|471219214|FG003|Overall Study|Protocol Violation|1|||
130887268|NCT01587924|471219211|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
130887269|NCT01587924|471219212|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
130887270|NCT01587924|471219213|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
130887271|NCT01587924|471219214|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
130887272|NCT01587924|471219211|FG000|Overall Study|Withdrawal by Subject|0|||
130887273|NCT01587924|471219212|FG001|Overall Study|Withdrawal by Subject|1|||
130887274|NCT01587924|471219213|FG002|Overall Study|Withdrawal by Subject|1|||
130887275|NCT01587924|471219214|FG003|Overall Study|Withdrawal by Subject|0|||
130887276|NCT00432172|471219215|FG000|Overall Study|Physician Decision|0|||
130887277|NCT00432172|471219216|FG001|Overall Study|Physician Decision|0|||
130887278|NCT00432172|471219217|FG002|Overall Study|Physician Decision|2|||
130887279|NCT00432172|471219218|FG003|Overall Study|Physician Decision|0|||
130887280|NCT00432172|471219215|FG000|Overall Study|Adverse Event|4|||
130887281|NCT00432172|471219216|FG001|Overall Study|Adverse Event|2|||
130887282|NCT00432172|471219217|FG002|Overall Study|Adverse Event|4|||
130887283|NCT00432172|471219218|FG003|Overall Study|Adverse Event|3|||
130887284|NCT00432172|471219215|FG000|Overall Study|Disease progression|0|||
130887285|NCT00432172|471219216|FG001|Overall Study|Disease progression|2|||
130887286|NCT00432172|471219217|FG002|Overall Study|Disease progression|5|||
130887287|NCT00432172|471219218|FG003|Overall Study|Disease progression|1|||
130887288|NCT00432172|471219215|FG000|Overall Study|Withdrawal by Subject|0|||
130887289|NCT00432172|471219216|FG001|Overall Study|Withdrawal by Subject|1|||
130887290|NCT00432172|471219217|FG002|Overall Study|Withdrawal by Subject|0|||
131021035|NCT00736853|471706901|FG001|Double-Blind Period|Ineligible to participate the study|1|||
131021036|NCT00736853|471706902|FG002|Double-Blind Period|Ineligible to participate the study|0|||
131021037|NCT01041417|471706903|FG000|Overall Study|Adverse Event|5|||
131021038|NCT01041417|471706904|FG001|Overall Study|Adverse Event|2|||
131021039|NCT01041417|471706903|FG000|Overall Study|Lost to Follow-up|1|||
131021040|NCT01041417|471706904|FG001|Overall Study|Lost to Follow-up|1|||
131021041|NCT01041417|471706903|FG000|Overall Study|Death|1|||
131021042|NCT01041417|471706904|FG001|Overall Study|Death|0|||
131021043|NCT00704184|471706907|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
131021044|NCT00704184|471706908|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
131021045|NCT00704184|471706909|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
131021046|NCT00704184|471706910|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
131021047|NCT00704184|471706911|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
131021048|NCT00704184|471706907|FG000|Open-Label Treatment|Adverse Event|0|||
130887291|NCT00432172|471219218|FG003|Overall Study|Withdrawal by Subject|2|||
130887292|NCT00432172|471219215|FG000|Overall Study|No treatment received|2|||
131021049|NCT00704184|471706908|FG001|Open-Label Treatment|Adverse Event|0|||
131021050|NCT00704184|471706909|FG002|Open-Label Treatment|Adverse Event|2|||
130685875|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130887293|NCT00432172|471219216|FG001|Overall Study|No treatment received|2|||
130887294|NCT00432172|471219217|FG002|Overall Study|No treatment received|0|||
130887295|NCT00432172|471219218|FG003|Overall Study|No treatment received|1|||
130887296|NCT02425943|471219219|FG000|Overall Study|Adverse Event|3|||
130887297|NCT02425943|471219220|FG001|Overall Study|Adverse Event|1|||
130887298|NCT02425943|471219219|FG000|Overall Study|Lost to Follow-up|59|||
130887299|NCT02425943|471219220|FG001|Overall Study|Lost to Follow-up|37|||
131021051|NCT00704184|471706910|FG003|Open-Label Treatment|Adverse Event|0|||
131021052|NCT00704184|471706911|FG004|Open-Label Treatment|Adverse Event|1|||
130887300|NCT02425943|471219219|FG000|Overall Study|Protocol Violation|4|||
130887301|NCT02425943|471219220|FG001|Overall Study|Protocol Violation|1|||
130887302|NCT02425943|471219219|FG000|Overall Study|Withdrawal by Subject|64|||
130887303|NCT02425943|471219220|FG001|Overall Study|Withdrawal by Subject|31|||
130887304|NCT02425943|471219219|FG000|Overall Study|Other|6|||
130887305|NCT02425943|471219220|FG001|Overall Study|Other|0|||
130887306|NCT06042855|471219223|FG000|Overall Study|No Receipt of Study Drug|48|||
130887307|NCT06042855|471219224|FG001|Overall Study|No Receipt of Study Drug|57|||
130887308|NCT06042855|471219223|FG000|Overall Study|Administratively Withdrawn|59|||
130887309|NCT06042855|471219224|FG001|Overall Study|Administratively Withdrawn|59|||
130887310|NCT02129699|471219229|FG000|Overall Study|Did not start treatment|3|||
130887311|NCT02129699|471219230|FG001|Overall Study|Did not start treatment|2|||
130887312|NCT05462756|471220433|FG000|Treatment Period|Adverse Event|3|||
130887313|NCT05462756|471220434|FG001|Treatment Period|Adverse Event|0|||
130887314|NCT05462756|471220433|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
130887315|NCT05462756|471220434|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
130887316|NCT05462756|471220433|FG000|Treatment Period|Death|0|||
130887317|NCT05462756|471220434|FG001|Treatment Period|Death|1|||
130887318|NCT05462756|471220433|FG000|Treatment Period|Lost to Follow-up|2|||
130887319|NCT05462756|471220434|FG001|Treatment Period|Lost to Follow-up|1|||
130887320|NCT05462756|471220433|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
130887321|NCT05462756|471220434|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
130887322|NCT05462756|471220433|FG000|Treatment Period|Physician Decision|2|||
130887323|NCT05462756|471220434|FG001|Treatment Period|Physician Decision|0|||
130887324|NCT05462756|471220433|FG000|Treatment Period|Protocol Violation|0|||
130887325|NCT05462756|471220434|FG001|Treatment Period|Protocol Violation|1|||
130887326|NCT05462756|471220433|FG000|Treatment Period|Withdrawal by Subject|5|||
130887327|NCT05462756|471220434|FG001|Treatment Period|Withdrawal by Subject|12|||
130887328|NCT05462756|471220433|FG000|Follow-Up Period|Adverse Event|1|||
130887329|NCT05462756|471220434|FG001|Follow-Up Period|Adverse Event|0|||
130887330|NCT05462756|471220433|FG000|Follow-Up Period|Death|1|||
130887331|NCT05462756|471220434|FG001|Follow-Up Period|Death|0|||
130887332|NCT05462756|471220433|FG000|Follow-Up Period|Lost to Follow-up|3|||
130887333|NCT05462756|471220434|FG001|Follow-Up Period|Lost to Follow-up|1|||
130887334|NCT05462756|471220433|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130887335|NCT05462756|471220434|FG001|Follow-Up Period|Withdrawal by Subject|4|||
130887336|NCT00990704|471220435|FG000|Overall Study|Adverse Event|1|||
130887337|NCT00990704|471220436|FG001|Overall Study|Adverse Event|1|||
130887338|NCT00990704|471220435|FG000|Overall Study|Physician Decision|0|||
130887339|NCT00990704|471220436|FG001|Overall Study|Physician Decision|1|||
130887340|NCT04040933|471220437|FG000|Overall Study|Protocol Violation|1|||
130887341|NCT04040933|471220437|FG000|Overall Study|Withdrawal by Subject|2|||
130887342|NCT01235741|471220441|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
130887343|NCT01235741|471220442|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
130887344|NCT01235741|471220443|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
130887345|NCT01235741|471220441|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
130887346|NCT01235741|471220442|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
130887347|NCT01235741|471220443|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
130887348|NCT01235741|471220441|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
130887349|NCT01235741|471220442|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
130887350|NCT01235741|471220443|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
130887351|NCT01235741|471220441|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
130887352|NCT01235741|471220442|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
130887353|NCT01235741|471220443|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
130887354|NCT01235741|471220441|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
130887355|NCT01235741|471220442|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
130887356|NCT01235741|471220443|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
130887357|NCT01235741|471220441|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
130887358|NCT01235741|471220442|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
130887359|NCT01235741|471220443|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
130887360|NCT01235741|471220441|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
130887361|NCT01235741|471220442|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
130887362|NCT01235741|471220443|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
130887363|NCT01235741|471220441|FG000|Randomized to Treatment|Adverse Event|0|||
130887364|NCT01235741|471220442|FG001|Randomized to Treatment|Adverse Event|1|||
130887365|NCT01235741|471220443|FG002|Randomized to Treatment|Adverse Event|1|||
130887366|NCT01235741|471220441|FG000|Randomized to Treatment|Sponsor terminated study|0|||
130887367|NCT01235741|471220442|FG001|Randomized to Treatment|Sponsor terminated study|35|||
130887368|NCT01235741|471220443|FG002|Randomized to Treatment|Sponsor terminated study|34|||
130887369|NCT01235741|471220441|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
130685876|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130887370|NCT01235741|471220442|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
130887371|NCT01235741|471220443|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
130887372|NCT01235741|471220441|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
130887373|NCT01235741|471220442|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
130887374|NCT01235741|471220443|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
130887375|NCT01235741|471220441|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
130887376|NCT01235741|471220442|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
130887377|NCT01235741|471220443|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
130887378|NCT00904033|471220448|FG000|Overall Study|Withdrawal by Subject|1|||
131021053|NCT00704184|471706907|FG000|Open-Label Treatment|Lack of Efficacy|0|||
131021054|NCT00704184|471706908|FG001|Open-Label Treatment|Lack of Efficacy|2|||
131021055|NCT00704184|471706909|FG002|Open-Label Treatment|Lack of Efficacy|2|||
131021056|NCT00704184|471706910|FG003|Open-Label Treatment|Lack of Efficacy|2|||
131021057|NCT00704184|471706911|FG004|Open-Label Treatment|Lack of Efficacy|1|||
131021058|NCT00704184|471706907|FG000|Open-Label Treatment|Physician Decision|0|||
131021059|NCT00704184|471706908|FG001|Open-Label Treatment|Physician Decision|0|||
131021060|NCT00704184|471706909|FG002|Open-Label Treatment|Physician Decision|0|||
131021061|NCT00704184|471706910|FG003|Open-Label Treatment|Physician Decision|0|||
131021062|NCT00704184|471706911|FG004|Open-Label Treatment|Physician Decision|1|||
131021063|NCT00704184|471706907|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
131021064|NCT00704184|471706908|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
131021065|NCT00704184|471706909|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
131021066|NCT00704184|471706910|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
131021067|NCT00704184|471706911|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
131021068|NCT00716859|471706912|FG000|Overall Study|Adverse Event|4|||
131021069|NCT00716859|471706913|FG001|Overall Study|Adverse Event|1|||
131021070|NCT00716859|471706912|FG000|Overall Study|Lack of Efficacy|3|||
131021071|NCT00716859|471706913|FG001|Overall Study|Lack of Efficacy|0|||
131021072|NCT00716859|471706912|FG000|Overall Study|Withdrawal by Subject|1|||
131021073|NCT00716859|471706913|FG001|Overall Study|Withdrawal by Subject|3|||
131021074|NCT00716859|471706912|FG000|Overall Study|Not treated|1|||
131021075|NCT00716859|471706913|FG001|Overall Study|Not treated|1|||
131021076|NCT01764464|471706914|FG000|First Intervention|Withdrawal by Subject|1|||
131021077|NCT01764464|471706915|FG001|First Intervention|Withdrawal by Subject|0|||
131021078|NCT01764464|471706914|FG000|First Intervention|Lost to Follow-up|1|||
131021079|NCT01764464|471706915|FG001|First Intervention|Lost to Follow-up|0|||
131021080|NCT01764464|471706914|FG000|First Intervention|Adverse Event|0|||
131021081|NCT01764464|471706915|FG001|First Intervention|Adverse Event|2|||
131021082|NCT01764464|471706914|FG000|First Intervention|did not receive study drug|0|||
131021083|NCT01764464|471706915|FG001|First Intervention|did not receive study drug|1|||
131021084|NCT01764464|471706914|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
131021085|NCT01764464|471706915|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
131021086|NCT03473340|471706916|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
131021087|NCT03473340|471706917|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
131021088|NCT03473340|471706916|FG000|Overall Study|Withdrawal by Subject|1|||
131021089|NCT03473340|471706917|FG001|Overall Study|Withdrawal by Subject|0|||
131021090|NCT03473340|471706916|FG000|Overall Study|Lost to Follow-up|1|||
131021091|NCT03473340|471706917|FG001|Overall Study|Lost to Follow-up|2|||
131021092|NCT03394885|471706919|FG000|Overall Study|Adverse Event|4|||
131021093|NCT03394885|471706919|FG000|Overall Study|Lack of Efficacy|1|||
131021094|NCT03394885|471706919|FG000|Overall Study|Physician Decision|1|||
131021095|NCT03394885|471706919|FG000|Overall Study|Withdrawal by Subject|8|||
131021096|NCT03394885|471706919|FG000|Overall Study|Alternative Therapy|1|||
131021097|NCT04980755|471706920|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
131021098|NCT04980755|471706920|FG000|Body Reprogramming Courses|Work commitment|2|||
131021099|NCT04980755|471706920|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
131021100|NCT04980755|471706920|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
131021101|NCT00801983|471706925|FG000|Period 1|Lost to Follow-up|2|||
131021102|NCT00801983|471706926|FG001|Period 1|Lost to Follow-up|0|||
131021103|NCT00801983|471706925|FG000|Period 1|Withdrawal by Subject|2|||
131021104|NCT00801983|471706926|FG001|Period 1|Withdrawal by Subject|8|||
130887379|NCT00904033|471220449|FG001|Overall Study|Withdrawal by Subject|1|||
131021105|NCT00801983|471706925|FG000|Period 2|Withdrawal by Subject|2|||
131021106|NCT00801983|471706926|FG001|Period 2|Withdrawal by Subject|1|||
131021107|NCT01170026|471708386|FG000|Overall Study|Lost to Follow-up|4|||
131021108|NCT01170026|471708387|FG001|Overall Study|Lost to Follow-up|2|||
131021109|NCT04623008|471708388|FG000|Baseline to T2|Withdrawal by Subject|4|||
131021110|NCT04623008|471708389|FG001|Baseline to T2|Withdrawal by Subject|2|||
131021111|NCT04623008|471708388|FG000|Baseline to T3|Withdrawal by Subject|4|||
131021112|NCT04623008|471708389|FG001|Baseline to T3|Withdrawal by Subject|2|||
131021113|NCT03785782|471708398|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
131021114|NCT03785782|471708399|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
131021115|NCT03785782|471708398|FG000|Overall Study|Withdrawal by Subject|1|||
131021116|NCT03785782|471708399|FG001|Overall Study|Withdrawal by Subject|1|||
130685877|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130685878|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685879|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685880|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
131106514|NCT03184870|472020860|FG013|Initial Treatment|Moved to crossover treatment|0|||
131106515|NCT03184870|472020861|FG014|Initial Treatment|Moved to crossover treatment|0|||
131106516|NCT03184870|472020862|FG015|Initial Treatment|Moved to crossover treatment|0|||
131106517|NCT03184870|472020863|FG016|Initial Treatment|Moved to crossover treatment|0|||
131106518|NCT03184870|472020864|FG017|Initial Treatment|Moved to crossover treatment|0|||
131106519|NCT03184870|472020847|FG000|Crossover Treatment|Other reasons|0|||
131106520|NCT03184870|472020848|FG001|Crossover Treatment|Other reasons|0|||
131106521|NCT03184870|472020849|FG002|Crossover Treatment|Other reasons|0|||
131106522|NCT03184870|472020850|FG003|Crossover Treatment|Other reasons|0|||
131106523|NCT03184870|472020851|FG004|Crossover Treatment|Other reasons|0|||
131106524|NCT03184870|472020852|FG005|Crossover Treatment|Other reasons|0|||
131106525|NCT03184870|472020853|FG006|Crossover Treatment|Other reasons|0|||
131106526|NCT03184870|472020854|FG007|Crossover Treatment|Other reasons|0|||
131106527|NCT03184870|472020855|FG008|Crossover Treatment|Other reasons|0|||
131106528|NCT03184870|472020856|FG009|Crossover Treatment|Other reasons|0|||
131106529|NCT03184870|472020857|FG010|Crossover Treatment|Other reasons|0|||
131106530|NCT03184870|472020858|FG011|Crossover Treatment|Other reasons|0|||
131106531|NCT03184870|472020859|FG012|Crossover Treatment|Other reasons|0|||
131106532|NCT03184870|472020860|FG013|Crossover Treatment|Other reasons|0|||
131106533|NCT03184870|472020861|FG014|Crossover Treatment|Other reasons|0|||
131106534|NCT03184870|472020862|FG015|Crossover Treatment|Other reasons|0|||
131106535|NCT03184870|472020863|FG016|Crossover Treatment|Other reasons|0|||
131106536|NCT03184870|472020864|FG017|Crossover Treatment|Other reasons|2|||
131106537|NCT03184870|472020847|FG000|Crossover Treatment|Death|0|||
131106538|NCT03184870|472020848|FG001|Crossover Treatment|Death|0|||
131106539|NCT03184870|472020849|FG002|Crossover Treatment|Death|0|||
131106540|NCT03184870|472020850|FG003|Crossover Treatment|Death|0|||
131106541|NCT03184870|472020851|FG004|Crossover Treatment|Death|0|||
131106542|NCT03184870|472020852|FG005|Crossover Treatment|Death|0|||
131106543|NCT03184870|472020853|FG006|Crossover Treatment|Death|0|||
131106544|NCT03184870|472020854|FG007|Crossover Treatment|Death|0|||
131106545|NCT03184870|472020855|FG008|Crossover Treatment|Death|0|||
131106546|NCT03184870|472020856|FG009|Crossover Treatment|Death|0|||
131106547|NCT03184870|472020857|FG010|Crossover Treatment|Death|0|||
131106548|NCT03184870|472020858|FG011|Crossover Treatment|Death|0|||
131106549|NCT03184870|472020859|FG012|Crossover Treatment|Death|0|||
131106550|NCT03184870|472020860|FG013|Crossover Treatment|Death|0|||
130685881|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685882|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
130685883|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
130685884|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
131021117|NCT03785782|471708398|FG000|Overall Study|insufficient image quality.|3|||
131021118|NCT03785782|471708399|FG001|Overall Study|insufficient image quality.|0|||
131021119|NCT03779048|471708400|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
131021120|NCT03779048|471708401|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
131021121|NCT03779048|471708402|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
131021122|NCT03779048|471708400|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
131021123|NCT03779048|471708401|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
131021124|NCT03779048|471708402|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
131021125|NCT03779048|471708400|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
131021126|NCT03779048|471708401|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
131021127|NCT03779048|471708402|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
131021128|NCT03889925|471708403|FG000|Overall Study|Lost to Follow-up|11|||
131021129|NCT03889925|471708404|FG001|Overall Study|Lost to Follow-up|10|||
131021130|NCT05777785|471708405|FG000|Overall Study|Withdrawal by Subject|5|||
131021131|NCT05777785|471708405|FG000|Overall Study|Lost to Follow-up|1|||
131021132|NCT04588259|471708407|FG000|Run-in Period|Run-in failure|0|||
131021133|NCT04588259|471708408|FG001|Run-in Period|Run-in failure|23|||
131021134|NCT04588259|471708407|FG000|Run-in Period|Withdrawn before randomisation|0|||
131021135|NCT04588259|471708408|FG001|Run-in Period|Withdrawn before randomisation|8|||
131106551|NCT03184870|472020861|FG014|Crossover Treatment|Death|0|||
131106552|NCT03184870|472020862|FG015|Crossover Treatment|Death|0|||
131106553|NCT03184870|472020863|FG016|Crossover Treatment|Death|0|||
131106554|NCT03184870|472020864|FG017|Crossover Treatment|Death|7|||
131106555|NCT03786783|472020866|FG000|Overall Study|Death|1|||
131106556|NCT03786783|472020866|FG000|Overall Study|Physician Decision|6|||
131106557|NCT03786783|472020866|FG000|Overall Study|Withdrawal by Subject|2|||
131106558|NCT03786783|472020866|FG000|Overall Study|Disease Progression|7|||
131106559|NCT03786783|472020866|FG000|Overall Study|Patient/Parent Refusal|4|||
131106560|NCT04363801|472020867|FG000|Overall Study|Death|18|||
131106561|NCT04363801|472020868|FG001|Overall Study|Death|14|||
131106562|NCT04363801|472020869|FG002|Overall Study|Death|16|||
130887380|NCT00904033|471220450|FG002|Overall Study|Withdrawal by Subject|0|||
130887381|NCT00904033|471220451|FG003|Overall Study|Withdrawal by Subject|0|||
130887382|NCT00904033|471220448|FG000|Overall Study|Physician Decision|0|||
130887383|NCT00904033|471220449|FG001|Overall Study|Physician Decision|0|||
130887384|NCT00904033|471220450|FG002|Overall Study|Physician Decision|1|||
130887385|NCT00904033|471220451|FG003|Overall Study|Physician Decision|0|||
130887386|NCT00904033|471220448|FG000|Overall Study|Unable to obtain final blood draw|0|||
130685885|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685886|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
130685887|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
130685888|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
130685889|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
130685890|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
130685891|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685892|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685893|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685894|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685895|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685896|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685897|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685898|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130685899|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685900|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685901|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685902|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685903|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
130685904|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685905|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685906|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685907|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
130685908|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
130685909|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
130685910|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685911|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
130685912|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685913|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685914|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685915|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685916|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130887387|NCT00904033|471220449|FG001|Overall Study|Unable to obtain final blood draw|0|||
130887388|NCT00904033|471220450|FG002|Overall Study|Unable to obtain final blood draw|0|||
130887389|NCT00904033|471220451|FG003|Overall Study|Unable to obtain final blood draw|2|||
130887390|NCT01177397|471220452|FG000|Overall Study|Protocol Violation|0|||
131021136|NCT04588259|471708407|FG000|Treatment Period|Withdrawal by Subject|6|||
131021137|NCT04588259|471708408|FG001|Treatment Period|Withdrawal by Subject|6|||
131021138|NCT02763319|471708412|FG000|Overall Study|Adverse Event|12|||
131021139|NCT02763319|471708413|FG001|Overall Study|Adverse Event|3|||
131021140|NCT02763319|471708412|FG000|Overall Study|Death|123|||
131021141|NCT02763319|471708413|FG001|Overall Study|Death|123|||
131021142|NCT02763319|471708412|FG000|Overall Study|Lost to Follow-up|6|||
131021143|NCT02763319|471708413|FG001|Overall Study|Lost to Follow-up|7|||
131021144|NCT02763319|471708412|FG000|Overall Study|Noncompliance with Study Drug|2|||
131021145|NCT02763319|471708413|FG001|Overall Study|Noncompliance with Study Drug|0|||
131021146|NCT02763319|471708412|FG000|Overall Study|"Captured as Other in Database"|29|||
131021147|NCT02763319|471708413|FG001|Overall Study|"Captured as Other in Database"|34|||
131021148|NCT02763319|471708412|FG000|Overall Study|Physician Decision|1|||
131021149|NCT02763319|471708413|FG001|Overall Study|Physician Decision|7|||
131021150|NCT02763319|471708412|FG000|Overall Study|Progressive Disease|24|||
131021151|NCT02763319|471708413|FG001|Overall Study|Progressive Disease|27|||
131021152|NCT02763319|471708412|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
131021153|NCT02763319|471708413|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
131021154|NCT02763319|471708412|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
131021155|NCT02763319|471708413|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
131021156|NCT02763319|471708412|FG000|Overall Study|Withdrawal by Subject|26|||
131021157|NCT02763319|471708413|FG001|Overall Study|Withdrawal by Subject|25|||
131021158|NCT01149369|471708418|FG000|Overall Study|Adverse Event|6|||
131021159|NCT01149369|471708419|FG001|Overall Study|Adverse Event|3|||
131021160|NCT01078116|471708426|FG000|Overall Study|Lost to Follow-up|17|||
130887391|NCT01177397|471220453|FG001|Overall Study|Protocol Violation|0|||
130887392|NCT01177397|471220454|FG002|Overall Study|Protocol Violation|0|||
130887393|NCT01177397|471220455|FG003|Overall Study|Protocol Violation|0|||
130887394|NCT01177397|471220456|FG004|Overall Study|Protocol Violation|0|||
130887395|NCT01177397|471220457|FG005|Overall Study|Protocol Violation|1|||
130887396|NCT01177397|471220458|FG006|Overall Study|Protocol Violation|0|||
130887397|NCT01177397|471220459|FG007|Overall Study|Protocol Violation|0|||
130887398|NCT01177397|471220460|FG008|Overall Study|Protocol Violation|0|||
130887399|NCT01177397|471220461|FG009|Overall Study|Protocol Violation|0|||
130887400|NCT01177397|471220462|FG010|Overall Study|Protocol Violation|0|||
130887401|NCT01177397|471220463|FG011|Overall Study|Protocol Violation|0|||
130887402|NCT01177397|471220452|FG000|Overall Study|Lost to Follow-up|0|||
131106563|NCT04363801|472020870|FG003|Overall Study|Death|48|||
131106564|NCT04363801|472020871|FG004|Overall Study|Death|38|||
131106565|NCT04363801|472020867|FG000|Overall Study|Withdrawal by Subject|1|||
131106566|NCT04363801|472020868|FG001|Overall Study|Withdrawal by Subject|6|||
131106567|NCT04363801|472020869|FG002|Overall Study|Withdrawal by Subject|1|||
131106568|NCT04363801|472020870|FG003|Overall Study|Withdrawal by Subject|4|||
131106569|NCT04363801|472020871|FG004|Overall Study|Withdrawal by Subject|14|||
131106570|NCT04363801|472020867|FG000|Overall Study|Sponsor Decision|6|||
131106571|NCT04363801|472020868|FG001|Overall Study|Sponsor Decision|4|||
131106572|NCT04363801|472020869|FG002|Overall Study|Sponsor Decision|10|||
131106573|NCT04363801|472020870|FG003|Overall Study|Sponsor Decision|33|||
130685917|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130685918|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130887403|NCT01177397|471220453|FG001|Overall Study|Lost to Follow-up|0|||
131021161|NCT01078116|471708426|FG000|Overall Study|Adverse Event|5|||
131021162|NCT01078116|471708426|FG000|Overall Study|Withdrawal by Subject|8|||
131021163|NCT01078116|471708426|FG000|Overall Study|Lack of effectiveness|15|||
131021164|NCT01078116|471708426|FG000|Overall Study|Case report form not completed|3|||
131021165|NCT01599793|471708427|FG000|Overall Study|Adverse Event|2|||
131021166|NCT02507752|471708433|FG000|Overall Study|Adverse Event|1|||
131021167|NCT02507752|471708433|FG000|Overall Study|Protocol Violation|6|||
131021168|NCT02507752|471708433|FG000|Overall Study|Lost to Follow-up|7|||
131021169|NCT02507752|471708433|FG000|Overall Study|Infusion reaction at first infusion|1|||
131021170|NCT02507752|471708433|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
131021171|NCT02507752|471708433|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
131021172|NCT01236001|471708435|FG000|Overall Study|Adverse Event|5|||
131021173|NCT01236001|471708436|FG001|Overall Study|Adverse Event|14|||
131021174|NCT01236001|471708435|FG000|Overall Study|Lack of Efficacy|6|||
131021175|NCT01236001|471708436|FG001|Overall Study|Lack of Efficacy|6|||
131021176|NCT01236001|471708435|FG000|Overall Study|Lost to Follow-up|6|||
131021177|NCT01236001|471708436|FG001|Overall Study|Lost to Follow-up|1|||
131021178|NCT01236001|471708435|FG000|Overall Study|Incompliance|1|||
131021179|NCT01236001|471708436|FG001|Overall Study|Incompliance|0|||
131021180|NCT01236001|471708435|FG000|Overall Study|Planned Visit After End of Study|0|||
131021181|NCT01236001|471708436|FG001|Overall Study|Planned Visit After End of Study|1|||
131021182|NCT03811574|471708440|FG000|Overall Study|Withdrawal by Subject|2|||
131021183|NCT03811574|471708441|FG001|Overall Study|Withdrawal by Subject|4|||
131021184|NCT03811574|471708442|FG002|Overall Study|Withdrawal by Subject|0|||
131021185|NCT01832480|471708443|FG000|Overall Study|Lost to Follow-up|33|||
131021186|NCT01832480|471708444|FG001|Overall Study|Lost to Follow-up|30|||
131021187|NCT01832480|471708443|FG000|Overall Study|Withdrawal by Subject|0|||
131021188|NCT01832480|471708444|FG001|Overall Study|Withdrawal by Subject|2|||
131021189|NCT01832480|471708443|FG000|Overall Study|post randomization ineligible|8|||
131021190|NCT01832480|471708444|FG001|Overall Study|post randomization ineligible|10|||
131021191|NCT03942042|471708446|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
131021192|NCT03942042|471708447|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
131021193|NCT03942042|471708446|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
131021194|NCT03942042|471708447|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
131021195|NCT01685606|471708450|FG000|Overall Study|Withdrawal by Subject|1|||
131021196|NCT00933400|471708451|FG000|Overall Study|Withdrawal by Subject|21|||
131021197|NCT00933400|471708452|FG001|Overall Study|Withdrawal by Subject|1|||
131021198|NCT02299375|471708455|FG000|Overall Study|Adverse Event, serious fatal|1|||
131021199|NCT02299375|471708456|FG001|Overall Study|Adverse Event, serious fatal|3|||
131021200|NCT02299375|471708455|FG000|Overall Study|Adverse Event, non-fatal|8|||
131021201|NCT02299375|471708456|FG001|Overall Study|Adverse Event, non-fatal|9|||
131021202|NCT02299375|471708455|FG000|Overall Study|Lack of Efficacy|1|||
131021203|NCT02299375|471708456|FG001|Overall Study|Lack of Efficacy|3|||
131021204|NCT02299375|471708455|FG000|Overall Study|Protocol Violation|1|||
131021205|NCT02299375|471708456|FG001|Overall Study|Protocol Violation|3|||
131021206|NCT02299375|471708455|FG000|Overall Study|Other: Met stopping criteria|1|||
130887404|NCT01177397|471220454|FG002|Overall Study|Lost to Follow-up|0|||
131106574|NCT04363801|472020871|FG004|Overall Study|Sponsor Decision|32|||
131106575|NCT04363801|472020867|FG000|Overall Study|Lost to Follow-up|0|||
131106576|NCT04363801|472020868|FG001|Overall Study|Lost to Follow-up|0|||
130887405|NCT01177397|471220455|FG003|Overall Study|Lost to Follow-up|0|||
130887406|NCT01177397|471220456|FG004|Overall Study|Lost to Follow-up|1|||
130887407|NCT01177397|471220457|FG005|Overall Study|Lost to Follow-up|0|||
130887408|NCT01177397|471220458|FG006|Overall Study|Lost to Follow-up|0|||
130887409|NCT01177397|471220459|FG007|Overall Study|Lost to Follow-up|2|||
130887410|NCT01177397|471220460|FG008|Overall Study|Lost to Follow-up|0|||
130887411|NCT01177397|471220461|FG009|Overall Study|Lost to Follow-up|0|||
130887412|NCT01177397|471220462|FG010|Overall Study|Lost to Follow-up|0|||
130887413|NCT01177397|471220463|FG011|Overall Study|Lost to Follow-up|0|||
130887414|NCT01177397|471220452|FG000|Overall Study|Death|0|||
130887415|NCT01177397|471220453|FG001|Overall Study|Death|0|||
130887416|NCT01177397|471220454|FG002|Overall Study|Death|1|||
130887417|NCT01177397|471220455|FG003|Overall Study|Death|1|||
130887418|NCT01177397|471220456|FG004|Overall Study|Death|0|||
130887419|NCT01177397|471220457|FG005|Overall Study|Death|0|||
130887420|NCT01177397|471220458|FG006|Overall Study|Death|0|||
130887421|NCT01177397|471220459|FG007|Overall Study|Death|5|||
130887422|NCT01177397|471220460|FG008|Overall Study|Death|2|||
130887423|NCT01177397|471220461|FG009|Overall Study|Death|1|||
130887424|NCT01177397|471220462|FG010|Overall Study|Death|0|||
130887425|NCT01177397|471220463|FG011|Overall Study|Death|0|||
130887426|NCT01177397|471220452|FG000|Overall Study|Withdrawal by Subject|0|||
130887427|NCT01177397|471220453|FG001|Overall Study|Withdrawal by Subject|0|||
130887428|NCT01177397|471220454|FG002|Overall Study|Withdrawal by Subject|1|||
130887429|NCT01177397|471220455|FG003|Overall Study|Withdrawal by Subject|1|||
130887430|NCT01177397|471220456|FG004|Overall Study|Withdrawal by Subject|1|||
130887431|NCT01177397|471220457|FG005|Overall Study|Withdrawal by Subject|2|||
130887432|NCT01177397|471220458|FG006|Overall Study|Withdrawal by Subject|0|||
130887433|NCT01177397|471220459|FG007|Overall Study|Withdrawal by Subject|5|||
130887434|NCT01177397|471220460|FG008|Overall Study|Withdrawal by Subject|9|||
130887435|NCT01177397|471220461|FG009|Overall Study|Withdrawal by Subject|1|||
130887436|NCT01177397|471220462|FG010|Overall Study|Withdrawal by Subject|1|||
130887437|NCT01177397|471220463|FG011|Overall Study|Withdrawal by Subject|0|||
130887438|NCT01177397|471220452|FG000|Overall Study|Adverse Event|0|||
131021207|NCT02299375|471708456|FG001|Overall Study|Other: Met stopping criteria|0|||
131021208|NCT02299375|471708455|FG000|Overall Study|Other: Study closed/terminated|66|||
131021209|NCT02299375|471708456|FG001|Overall Study|Other: Study closed/terminated|55|||
131021210|NCT02299375|471708455|FG000|Overall Study|Lost to Follow-up|0|||
131021211|NCT02299375|471708456|FG001|Overall Study|Lost to Follow-up|2|||
131021212|NCT02299375|471708455|FG000|Overall Study|Physician Decision|1|||
131021213|NCT02299375|471708456|FG001|Overall Study|Physician Decision|1|||
131021214|NCT02299375|471708455|FG000|Overall Study|Withdrawal by Subject|1|||
131021215|NCT02299375|471708456|FG001|Overall Study|Withdrawal by Subject|4|||
131021216|NCT02918071|471708467|FG000|Overall Study|Withdrawal by Subject|2|||
131021217|NCT02918071|471708467|FG000|Overall Study|Lost to Follow-up|1|||
131021218|NCT00203411|471708469|FG000|Follow-up|Progressive Disease|4|||
131021219|NCT01212991|471708470|FG000|Double-blind|Lost to Follow-up|8|||
131021220|NCT01212991|471708471|FG001|Double-blind|Lost to Follow-up|4|||
131021221|NCT01212991|471708472|FG002|Double-blind|Lost to Follow-up|0|||
131021222|NCT01212991|471708470|FG000|Double-blind|Death|699|||
131021223|NCT01212991|471708471|FG001|Double-blind|Death|550|||
131021224|NCT01212991|471708472|FG002|Double-blind|Death|0|||
131021225|NCT01212991|471708470|FG000|Double-blind|Withdrawal by Subject|16|||
131021226|NCT01212991|471708471|FG001|Double-blind|Withdrawal by Subject|19|||
131021227|NCT01212991|471708472|FG002|Double-blind|Withdrawal by Subject|0|||
131021228|NCT01212991|471708470|FG000|Double-blind|Other|7|||
131021229|NCT01212991|471708471|FG001|Double-blind|Other|0|||
131021230|NCT01212991|471708472|FG002|Double-blind|Other|0|||
131021231|NCT01212991|471708470|FG000|Double-blind|Sponsor decision|142|||
131021232|NCT01212991|471708471|FG001|Double-blind|Sponsor decision|38|||
131021233|NCT01212991|471708472|FG002|Double-blind|Sponsor decision|0|||
131021234|NCT01212991|471708470|FG000|Open-label|Death|0|||
131106577|NCT04363801|472020869|FG002|Overall Study|Lost to Follow-up|1|||
131106578|NCT04363801|472020870|FG003|Overall Study|Lost to Follow-up|0|||
130887439|NCT01177397|471220453|FG001|Overall Study|Adverse Event|0|||
131021235|NCT01212991|471708471|FG001|Open-label|Death|0|||
131021236|NCT01212991|471708472|FG002|Open-label|Death|166|||
130887440|NCT01177397|471220454|FG002|Overall Study|Adverse Event|1|||
131021237|NCT01212991|471708470|FG000|Open-label|Lost to Follow-up|0|||
131021238|NCT01212991|471708471|FG001|Open-label|Lost to Follow-up|0|||
131106579|NCT04363801|472020871|FG004|Overall Study|Lost to Follow-up|1|||
130887441|NCT01177397|471220455|FG003|Overall Study|Adverse Event|2|||
130887442|NCT01177397|471220456|FG004|Overall Study|Adverse Event|0|||
130887443|NCT01177397|471220457|FG005|Overall Study|Adverse Event|12|||
130887444|NCT01177397|471220458|FG006|Overall Study|Adverse Event|1|||
131106580|NCT06336603|472020874|FG000|Overall Study|Withdrawal by Subject|1|||
130887445|NCT01177397|471220459|FG007|Overall Study|Adverse Event|14|||
130887446|NCT01177397|471220460|FG008|Overall Study|Adverse Event|8|||
130887447|NCT01177397|471220461|FG009|Overall Study|Adverse Event|6|||
131021239|NCT01212991|471708472|FG002|Open-label|Lost to Follow-up|5|||
131021240|NCT01212991|471708470|FG000|Open-label|Withdrawal by Subject|0|||
131021241|NCT01212991|471708471|FG001|Open-label|Withdrawal by Subject|0|||
130887448|NCT01177397|471220462|FG010|Overall Study|Adverse Event|3|||
130887449|NCT01177397|471220463|FG011|Overall Study|Adverse Event|7|||
130887450|NCT01177397|471220452|FG000|Overall Study|Disease progression|1|||
130887451|NCT01177397|471220453|FG001|Overall Study|Disease progression|2|||
130887452|NCT01177397|471220454|FG002|Overall Study|Disease progression|5|||
130887453|NCT01177397|471220455|FG003|Overall Study|Disease progression|5|||
130887454|NCT01177397|471220456|FG004|Overall Study|Disease progression|4|||
130887455|NCT01177397|471220457|FG005|Overall Study|Disease progression|10|||
130887456|NCT01177397|471220458|FG006|Overall Study|Disease progression|10|||
130887457|NCT01177397|471220459|FG007|Overall Study|Disease progression|21|||
130887458|NCT01177397|471220460|FG008|Overall Study|Disease progression|18|||
130887459|NCT01177397|471220461|FG009|Overall Study|Disease progression|12|||
130887460|NCT01177397|471220462|FG010|Overall Study|Disease progression|10|||
130887461|NCT01177397|471220463|FG011|Overall Study|Disease progression|8|||
130887462|NCT01177397|471220452|FG000|Overall Study|Other reasons|0|||
130887463|NCT01177397|471220453|FG001|Overall Study|Other reasons|0|||
130887464|NCT01177397|471220454|FG002|Overall Study|Other reasons|1|||
130887465|NCT01177397|471220455|FG003|Overall Study|Other reasons|0|||
130887466|NCT01177397|471220456|FG004|Overall Study|Other reasons|1|||
130887467|NCT01177397|471220457|FG005|Overall Study|Other reasons|1|||
130887468|NCT01177397|471220458|FG006|Overall Study|Other reasons|2|||
130887469|NCT01177397|471220459|FG007|Overall Study|Other reasons|6|||
130887470|NCT01177397|471220460|FG008|Overall Study|Other reasons|10|||
130887471|NCT01177397|471220461|FG009|Overall Study|Other reasons|8|||
130887472|NCT01177397|471220462|FG010|Overall Study|Other reasons|0|||
130887473|NCT01177397|471220463|FG011|Overall Study|Other reasons|2|||
130887474|NCT00118417|471220464|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
130887475|NCT00118417|471220465|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
130887476|NCT00118417|471220464|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
130887477|NCT00118417|471220465|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
130887478|NCT00118417|471220464|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
130887479|NCT00118417|471220465|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
130887480|NCT00118417|471220464|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
130887481|NCT00118417|471220465|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
130887482|NCT00118417|471220464|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
130887483|NCT00118417|471220465|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
130887484|NCT01383356|471220466|FG000|Period 1|Adverse Event|5|||
130887485|NCT01383356|471220467|FG001|Period 1|Adverse Event|3|||
130887486|NCT01383356|471220466|FG000|Period 1|Non-compliance|3|||
130887487|NCT01383356|471220467|FG001|Period 1|Non-compliance|0|||
130887488|NCT01383356|471220466|FG000|Period 1|Out of Range Mid-study-Test|0|||
130887489|NCT01383356|471220467|FG001|Period 1|Out of Range Mid-study-Test|1|||
130887490|NCT01383356|471220466|FG000|Period 1|Personal|0|||
130887491|NCT01383356|471220467|FG001|Period 1|Personal|2|||
130887492|NCT02919995|471220468|FG000|Overall Study|Adverse Event|0|||
130887493|NCT02919995|471220469|FG001|Overall Study|Adverse Event|0|||
130887494|NCT02919995|471220470|FG002|Overall Study|Adverse Event|0|||
130887495|NCT02919995|471220471|FG003|Overall Study|Adverse Event|0|||
130887496|NCT02919995|471220472|FG004|Overall Study|Adverse Event|0|||
130887497|NCT02919995|471220473|FG005|Overall Study|Adverse Event|1|||
130887498|NCT01599637|471220475|FG000|Overall Study|administrative problems|0|||
130887499|NCT01599637|471220476|FG001|Overall Study|administrative problems|2|||
130887500|NCT01599637|471220477|FG002|Overall Study|administrative problems|0|||
130887501|NCT01599637|471220475|FG000|Overall Study|Adverse Event|1|||
130887502|NCT01599637|471220476|FG001|Overall Study|Adverse Event|0|||
130887503|NCT01599637|471220477|FG002|Overall Study|Adverse Event|0|||
130887504|NCT02721966|471220478|FG000|Overall Study|Protocol Violation|1|||
131021242|NCT01212991|471708472|FG002|Open-label|Withdrawal by Subject|7|||
131021243|NCT01212991|471708470|FG000|Open-label|Sponsor decision|0|||
131021244|NCT01212991|471708471|FG001|Open-label|Sponsor decision|0|||
131021245|NCT01212991|471708472|FG002|Open-label|Sponsor decision|53|||
131021246|NCT01212991|471708470|FG000|Open-label|Other|0|||
131021247|NCT01212991|471708471|FG001|Open-label|Other|0|||
131021248|NCT01212991|471708472|FG002|Open-label|Other|3|||
130887505|NCT02721966|471220479|FG001|Overall Study|Protocol Violation|0|||
130887506|NCT02721966|471220480|FG002|Overall Study|Protocol Violation|0|||
131021249|NCT01622868|471710091|FG000|Overall Study|Protocol Violation|7|||
130887507|NCT02721966|471220481|FG003|Overall Study|Protocol Violation|0|||
130887508|NCT02721966|471220482|FG004|Overall Study|Protocol Violation|0|||
130887509|NCT02721966|471220478|FG000|Overall Study|Withdrawal by Subject|9|||
130887510|NCT02721966|471220479|FG001|Overall Study|Withdrawal by Subject|2|||
130887511|NCT02721966|471220480|FG002|Overall Study|Withdrawal by Subject|3|||
130887512|NCT02721966|471220481|FG003|Overall Study|Withdrawal by Subject|7|||
130887513|NCT02721966|471220482|FG004|Overall Study|Withdrawal by Subject|0|||
130887514|NCT02721966|471220478|FG000|Overall Study|Adverse Event|4|||
130887515|NCT02721966|471220479|FG001|Overall Study|Adverse Event|4|||
130887516|NCT02721966|471220480|FG002|Overall Study|Adverse Event|3|||
130887517|NCT02721966|471220481|FG003|Overall Study|Adverse Event|0|||
130887518|NCT02721966|471220482|FG004|Overall Study|Adverse Event|0|||
131021250|NCT01622868|471710092|FG001|Overall Study|Protocol Violation|0|||
130887519|NCT02721966|471220478|FG000|Overall Study|Death|1|||
130887520|NCT02721966|471220479|FG001|Overall Study|Death|0|||
130887521|NCT02721966|471220480|FG002|Overall Study|Death|0|||
130887522|NCT02721966|471220481|FG003|Overall Study|Death|0|||
130887523|NCT02721966|471220482|FG004|Overall Study|Death|0|||
130887524|NCT02721966|471220478|FG000|Overall Study|Lack of Efficacy|7|||
130887525|NCT02721966|471220479|FG001|Overall Study|Lack of Efficacy|4|||
130887526|NCT02721966|471220480|FG002|Overall Study|Lack of Efficacy|0|||
130887527|NCT02721966|471220481|FG003|Overall Study|Lack of Efficacy|0|||
130887528|NCT02721966|471220482|FG004|Overall Study|Lack of Efficacy|0|||
130887529|NCT02721966|471220478|FG000|Overall Study|Lost to Follow-up|0|||
130887530|NCT02721966|471220479|FG001|Overall Study|Lost to Follow-up|0|||
130887531|NCT02721966|471220480|FG002|Overall Study|Lost to Follow-up|3|||
130887532|NCT02721966|471220481|FG003|Overall Study|Lost to Follow-up|0|||
130887533|NCT02721966|471220482|FG004|Overall Study|Lost to Follow-up|0|||
130887534|NCT02721966|471220478|FG000|Overall Study|Physician Decision|1|||
130887535|NCT02721966|471220479|FG001|Overall Study|Physician Decision|1|||
130887536|NCT02721966|471220480|FG002|Overall Study|Physician Decision|0|||
130887537|NCT02721966|471220481|FG003|Overall Study|Physician Decision|0|||
130887538|NCT02721966|471220482|FG004|Overall Study|Physician Decision|0|||
130887539|NCT02721966|471220478|FG000|Overall Study|Pregnancy|1|||
130887540|NCT02721966|471220479|FG001|Overall Study|Pregnancy|0|||
130887541|NCT02721966|471220480|FG002|Overall Study|Pregnancy|0|||
130887542|NCT02721966|471220481|FG003|Overall Study|Pregnancy|0|||
130887543|NCT02721966|471220482|FG004|Overall Study|Pregnancy|0|||
130887544|NCT02721966|471220478|FG000|Overall Study|Did not continue to period 2|5|||
130887545|NCT02721966|471220479|FG001|Overall Study|Did not continue to period 2|12|||
130887546|NCT02721966|471220480|FG002|Overall Study|Did not continue to period 2|0|||
130887547|NCT02721966|471220481|FG003|Overall Study|Did not continue to period 2|0|||
130887548|NCT02721966|471220482|FG004|Overall Study|Did not continue to period 2|5|||
130887549|NCT03857867|471220483|FG000|Overall Study|Physician Decision|1|||
130887550|NCT02157883|471220484|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
130887551|NCT02157883|471220484|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
130887552|NCT02157883|471220484|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
130887553|NCT02157883|471220484|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
130887554|NCT02157883|471220484|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
130887555|NCT01106248|471220486|FG000|Overall Study|Adverse Event|1|||
130887556|NCT01106248|471220486|FG000|Overall Study|Administrative|2|||
130887557|NCT00357903|471220487|FG000|Overall Study|Adverse Event|87|||
130887558|NCT00357903|471220488|FG001|Overall Study|Adverse Event|4|||
130887559|NCT00357903|471220487|FG000|Overall Study|Death|33|||
130887560|NCT00357903|471220488|FG001|Overall Study|Death|0|||
130887561|NCT00357903|471220487|FG000|Overall Study|Lost to Follow-up|23|||
130887562|NCT00357903|471220488|FG001|Overall Study|Lost to Follow-up|4|||
130887563|NCT00357903|471220487|FG000|Overall Study|Physician Decision|39|||
130887564|NCT00357903|471220488|FG001|Overall Study|Physician Decision|5|||
130887565|NCT00357903|471220487|FG000|Overall Study|Withdrawal by Subject|57|||
130887566|NCT00357903|471220488|FG001|Overall Study|Withdrawal by Subject|7|||
130887567|NCT00357903|471220487|FG000|Overall Study|Completed month 12 only|0|||
130887568|NCT00357903|471220488|FG001|Overall Study|Completed month 12 only|1|||
130887569|NCT00357903|471220487|FG000|Overall Study|Protocol issues|14|||
130887570|NCT00357903|471220488|FG001|Overall Study|Protocol issues|3|||
130887571|NCT00357903|471220487|FG000|Overall Study|Response status|61|||
130887572|NCT00357903|471220488|FG001|Overall Study|Response status|9|||
130887573|NCT00357903|471220487|FG000|Overall Study|Other|49|||
130887574|NCT00357903|471220488|FG001|Overall Study|Other|10|||
130887575|NCT00606593|471220489|FG000|Overall Study|Adverse Event|0|||
130887576|NCT00606593|471220490|FG001|Overall Study|Adverse Event|0|||
130887577|NCT00606593|471220491|FG002|Overall Study|Adverse Event|0|||
130887578|NCT00606593|471220492|FG003|Overall Study|Adverse Event|1|||
130887579|NCT00606593|471220493|FG004|Overall Study|Adverse Event|1|||
130887580|NCT00606593|471220494|FG005|Overall Study|Adverse Event|0|||
130887581|NCT00606593|471220495|FG006|Overall Study|Adverse Event|1|||
130887582|NCT00606593|471220496|FG007|Overall Study|Adverse Event|2|||
130887583|NCT00606593|471220497|FG008|Overall Study|Adverse Event|1|||
130887584|NCT00606593|471220498|FG009|Overall Study|Adverse Event|0|||
130887585|NCT00606593|471220489|FG000|Overall Study|Withdrawal of consent|1|||
130685919|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130887586|NCT00606593|471220490|FG001|Overall Study|Withdrawal of consent|0|||
130887587|NCT00606593|471220491|FG002|Overall Study|Withdrawal of consent|1|||
130887588|NCT00606593|471220492|FG003|Overall Study|Withdrawal of consent|0|||
130887589|NCT00606593|471220493|FG004|Overall Study|Withdrawal of consent|0|||
130887590|NCT00606593|471220494|FG005|Overall Study|Withdrawal of consent|0|||
130887591|NCT00606593|471220495|FG006|Overall Study|Withdrawal of consent|0|||
130887592|NCT00606593|471220496|FG007|Overall Study|Withdrawal of consent|0|||
130887593|NCT00606593|471220497|FG008|Overall Study|Withdrawal of consent|0|||
130887594|NCT00606593|471220498|FG009|Overall Study|Withdrawal of consent|0|||
130887595|NCT00606593|471220489|FG000|Overall Study|Administrative/Other|0|||
130887596|NCT00606593|471220490|FG001|Overall Study|Administrative/Other|0|||
130887597|NCT00606593|471220491|FG002|Overall Study|Administrative/Other|1|||
130887598|NCT00606593|471220492|FG003|Overall Study|Administrative/Other|0|||
130887599|NCT00606593|471220493|FG004|Overall Study|Administrative/Other|0|||
130887600|NCT00606593|471220494|FG005|Overall Study|Administrative/Other|0|||
130887601|NCT00606593|471220495|FG006|Overall Study|Administrative/Other|0|||
130887602|NCT00606593|471220496|FG007|Overall Study|Administrative/Other|0|||
130887603|NCT00606593|471220497|FG008|Overall Study|Administrative/Other|0|||
130887604|NCT00606593|471220498|FG009|Overall Study|Administrative/Other|0|||
130887605|NCT03181529|471220499|FG000|Overall Study|Withdrawal by Subject|1|||
130887606|NCT03181529|471220500|FG001|Overall Study|Withdrawal by Subject|1|||
130887607|NCT03181529|471220499|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
130887608|NCT03181529|471220500|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
130887609|NCT00525161|471220503|FG000|Overall Study|Adverse Event|1|||
130887610|NCT01076361|471220507|FG000|Overall Study|22 leads were excluded from analysis|21|||
130887611|NCT02447003|471220508|FG000|Overall Study|Other|0|||
130887612|NCT02447003|471220509|FG001|Overall Study|Other|4|||
130887613|NCT02447003|471220508|FG000|Overall Study|Site discontinued|0|||
130887614|NCT02447003|471220509|FG001|Overall Study|Site discontinued|2|||
130887615|NCT02447003|471220508|FG000|Overall Study|Physician Decision|0|||
130887616|NCT02447003|471220509|FG001|Overall Study|Physician Decision|1|||
130887617|NCT02447003|471220508|FG000|Overall Study|Withdrawal by Subject|4|||
130887618|NCT02447003|471220509|FG001|Overall Study|Withdrawal by Subject|3|||
130887619|NCT02447003|471220508|FG000|Overall Study|Sponsor Decision|6|||
130887620|NCT02447003|471220509|FG001|Overall Study|Sponsor Decision|11|||
130887621|NCT02447003|471220508|FG000|Overall Study|Progressive Disease|1|||
130887622|NCT02447003|471220509|FG001|Overall Study|Progressive Disease|0|||
130887623|NCT02447003|471220508|FG000|Overall Study|Lost to Follow-up|5|||
130887624|NCT02447003|471220509|FG001|Overall Study|Lost to Follow-up|0|||
131021251|NCT00232180|471710095|FG000|Double-blind (DB) Phase|Death|186|||
131021252|NCT00232180|471710096|FG001|Double-blind (DB) Phase|Death|222|||
131021253|NCT00232180|471710097|FG002|Double-blind (DB) Phase|Death|0|||
131021254|NCT00232180|471710095|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
131021255|NCT00232180|471710096|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
131021256|NCT00232180|471710097|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
131021257|NCT00232180|471710095|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
131021258|NCT00232180|471710096|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
131021259|NCT00232180|471710097|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
131021260|NCT00232180|471710095|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
131021261|NCT00232180|471710096|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
131021262|NCT00232180|471710097|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
131021263|NCT00232180|471710095|FG000|Double-blind (DB) Phase|Adverse Event|83|||
131021264|NCT00232180|471710096|FG001|Double-blind (DB) Phase|Adverse Event|100|||
131021265|NCT00232180|471710097|FG002|Double-blind (DB) Phase|Adverse Event|0|||
131021266|NCT00232180|471710095|FG000|Double-blind (DB) Phase|Other|70|||
131021267|NCT00232180|471710096|FG001|Double-blind (DB) Phase|Other|75|||
131021268|NCT00232180|471710097|FG002|Double-blind (DB) Phase|Other|0|||
131021269|NCT00232180|471710095|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
131021270|NCT00232180|471710096|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
131021271|NCT00232180|471710097|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
131021272|NCT00232180|471710095|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
131021273|NCT00232180|471710096|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
131021274|NCT00232180|471710097|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
131021275|NCT00232180|471710095|FG000|Open Label Phase|Death|0|||
131021276|NCT00232180|471710096|FG001|Open Label Phase|Death|0|||
131021277|NCT00232180|471710097|FG002|Open Label Phase|Death|48|||
131021278|NCT00232180|471710095|FG000|Open Label Phase|Lost to Follow-up|0|||
130887625|NCT02447003|471220508|FG000|Overall Study|Death|154|||
130887626|NCT02447003|471220509|FG001|Overall Study|Death|63|||
130887627|NCT03848728|471220510|FG000|Overall Study|Death|16|||
131021279|NCT00232180|471710096|FG001|Open Label Phase|Lost to Follow-up|0|||
131021280|NCT00232180|471710097|FG002|Open Label Phase|Lost to Follow-up|5|||
131021281|NCT00232180|471710095|FG000|Open Label Phase|Protocol Violation|0|||
131021282|NCT00232180|471710096|FG001|Open Label Phase|Protocol Violation|0|||
131021283|NCT00232180|471710097|FG002|Open Label Phase|Protocol Violation|3|||
131021284|NCT00232180|471710095|FG000|Open Label Phase|Study terminated by sponsor|0|||
131021285|NCT00232180|471710096|FG001|Open Label Phase|Study terminated by sponsor|0|||
131021286|NCT00232180|471710097|FG002|Open Label Phase|Study terminated by sponsor|3|||
131021287|NCT00232180|471710095|FG000|Open Label Phase|Withdrawal by Subject|0|||
131106581|NCT06336603|472020874|FG000|Overall Study|Lost to Follow-up|2|||
130887628|NCT03848728|471220511|FG001|Overall Study|Death|13|||
131106582|NCT04776148|472020875|FG000|Overall Study|Death|249|||
130887629|NCT03848728|471220510|FG000|Overall Study|Outmigrated to non-study community|98|||
130887630|NCT03848728|471220511|FG001|Overall Study|Outmigrated to non-study community|106|||
130887631|NCT03848728|471220510|FG000|Overall Study|Transfered to non-study clinic|32|||
130887632|NCT03848728|471220511|FG001|Overall Study|Transfered to non-study clinic|48|||
130887633|NCT03848728|471220510|FG000|Overall Study|Withdrawal by Subject|1|||
130887634|NCT03848728|471220511|FG001|Overall Study|Withdrawal by Subject|0|||
130887635|NCT00630838|471220514|FG000|Overall Study|Death|0|||
130887636|NCT00630838|471220515|FG001|Overall Study|Death|1|||
130887637|NCT00630838|471220514|FG000|Overall Study|Lost to Follow-up|0|||
130887638|NCT00630838|471220515|FG001|Overall Study|Lost to Follow-up|1|||
130887639|NCT01108185|471220516|FG000|Overall Study|Non-compliance|15|||
130887640|NCT01108185|471220516|FG000|Overall Study|Lost to Follow-up|12|||
130887641|NCT02581410|471220517|FG000|Vaccination Phase|Adverse Event|2|||
130887642|NCT02581410|471220518|FG001|Vaccination Phase|Adverse Event|1|||
130887643|NCT02581410|471220517|FG000|Vaccination Phase|Withdrawal by Subject|0|||
130887644|NCT02581410|471220518|FG001|Vaccination Phase|Withdrawal by Subject|1|||
130887645|NCT02581410|471220517|FG000|Vaccination Phase|Migrated/moved from study area|0|||
130887646|NCT02581410|471220518|FG001|Vaccination Phase|Migrated/moved from study area|1|||
130887647|NCT02581410|471220517|FG000|End of Study Phase|Adverse Event|4|||
130887648|NCT02581410|471220518|FG001|End of Study Phase|Adverse Event|3|||
130887649|NCT02581410|471220517|FG000|End of Study Phase|Withdrawal by Subject|1|||
130887650|NCT02581410|471220518|FG001|End of Study Phase|Withdrawal by Subject|2|||
130887651|NCT02581410|471220517|FG000|End of Study Phase|Migrated/moved from study area|0|||
130887652|NCT02581410|471220518|FG001|End of Study Phase|Migrated/moved from study area|3|||
130887653|NCT02581410|471220517|FG000|End of Study Phase|Lost to Follow-up|0|||
130887654|NCT02581410|471220518|FG001|End of Study Phase|Lost to Follow-up|2|||
130887655|NCT02581410|471220517|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
130887656|NCT02581410|471220518|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
130887657|NCT00670748|471220521|FG000|Overall Study|Death during treatment|1|||
130887658|NCT00670748|471220522|FG001|Overall Study|Death during treatment|1|||
130887659|NCT00670748|471220523|FG002|Overall Study|Death during treatment|1|||
130887660|NCT00670748|471220524|FG003|Overall Study|Death during treatment|0|||
130887661|NCT00670748|471220521|FG000|Overall Study|Not off study|2|||
130887662|NCT00670748|471220522|FG001|Overall Study|Not off study|1|||
130887663|NCT00670748|471220523|FG002|Overall Study|Not off study|1|||
130887664|NCT00670748|471220524|FG003|Overall Study|Not off study|1|||
130887665|NCT06083506|471220529|FG000|Overall Study|Physician Decision|2|||
130887666|NCT06083506|471220529|FG000|Overall Study|Lack of Efficacy|1|||
130887667|NCT03529422|471220530|FG000|Overall Study|Withdrawal by Subject|1|||
130887668|NCT03529422|471220530|FG000|Overall Study|Protocol Violation|1|||
130887669|NCT03529422|471220530|FG000|Overall Study|Disease progression|2|||
130887670|NCT02000115|471220531|FG000|Overall Study|Death|56|||
130887671|NCT02000115|471220532|FG001|Overall Study|Death|45|||
130887672|NCT02000115|471220533|FG002|Overall Study|Death|0|||
130887673|NCT02000115|471220534|FG003|Overall Study|Death|0|||
130887674|NCT02000115|471220531|FG000|Overall Study|Missed Visit|6|||
130887675|NCT02000115|471220532|FG001|Overall Study|Missed Visit|8|||
130887676|NCT02000115|471220533|FG002|Overall Study|Missed Visit|1|||
130887677|NCT02000115|471220534|FG003|Overall Study|Missed Visit|0|||
130887678|NCT02000115|471220531|FG000|Overall Study|Protocol Violation|2|||
130887679|NCT02000115|471220532|FG001|Overall Study|Protocol Violation|1|||
130887680|NCT02000115|471220533|FG002|Overall Study|Protocol Violation|0|||
130887681|NCT02000115|471220534|FG003|Overall Study|Protocol Violation|0|||
130887682|NCT02000115|471220531|FG000|Overall Study|Physician Decision|2|||
130887683|NCT02000115|471220532|FG001|Overall Study|Physician Decision|0|||
130887684|NCT02000115|471220533|FG002|Overall Study|Physician Decision|0|||
130887685|NCT02000115|471220534|FG003|Overall Study|Physician Decision|0|||
130887686|NCT02000115|471220531|FG000|Overall Study|Withdrawal by Subject|11|||
131021288|NCT00232180|471710096|FG001|Open Label Phase|Withdrawal by Subject|0|||
131021289|NCT00232180|471710097|FG002|Open Label Phase|Withdrawal by Subject|37|||
131021290|NCT00232180|471710095|FG000|Open Label Phase|Other|0|||
131021291|NCT00232180|471710096|FG001|Open Label Phase|Other|0|||
131021292|NCT00232180|471710097|FG002|Open Label Phase|Other|16|||
131021293|NCT00232180|471710095|FG000|Open Label Phase|Adverse Event|0|||
131021294|NCT00232180|471710096|FG001|Open Label Phase|Adverse Event|0|||
131021295|NCT00232180|471710097|FG002|Open Label Phase|Adverse Event|25|||
131021296|NCT00232180|471710095|FG000|Open Label Phase|Laboratory abnormality|0|||
131021297|NCT00232180|471710096|FG001|Open Label Phase|Laboratory abnormality|0|||
130685920|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130887687|NCT02000115|471220532|FG001|Overall Study|Withdrawal by Subject|11|||
130887688|NCT02000115|471220533|FG002|Overall Study|Withdrawal by Subject|0|||
130887689|NCT02000115|471220534|FG003|Overall Study|Withdrawal by Subject|0|||
130887690|NCT02000115|471220531|FG000|Overall Study|Lost to Follow-up|0|||
130887691|NCT02000115|471220532|FG001|Overall Study|Lost to Follow-up|1|||
130887692|NCT02000115|471220533|FG002|Overall Study|Lost to Follow-up|0|||
130887693|NCT02000115|471220534|FG003|Overall Study|Lost to Follow-up|0|||
130887694|NCT02000115|471220531|FG000|Overall Study|Non-compliance|2|||
130887695|NCT02000115|471220532|FG001|Overall Study|Non-compliance|1|||
130887696|NCT02000115|471220533|FG002|Overall Study|Non-compliance|0|||
130887697|NCT02000115|471220534|FG003|Overall Study|Non-compliance|0|||
130887698|NCT02000115|471220531|FG000|Overall Study|Withdrawn on day of randomization|0|||
131021298|NCT00232180|471710097|FG002|Open Label Phase|Laboratory abnormality|10|||
130887699|NCT02000115|471220532|FG001|Overall Study|Withdrawn on day of randomization|1|||
130887700|NCT02000115|471220533|FG002|Overall Study|Withdrawn on day of randomization|0|||
130887701|NCT02000115|471220534|FG003|Overall Study|Withdrawn on day of randomization|0|||
130887702|NCT02000115|471220531|FG000|Overall Study|Still on Study|0|||
130887703|NCT02000115|471220532|FG001|Overall Study|Still on Study|0|||
130887704|NCT02000115|471220533|FG002|Overall Study|Still on Study|0|||
130887705|NCT02000115|471220534|FG003|Overall Study|Still on Study|53|||
130887706|NCT05006573|471220535|FG000|Double-blind Treatment Period|Physician Decision|2|||
130887707|NCT05006573|471220536|FG001|Double-blind Treatment Period|Physician Decision|0|||
130887708|NCT05006573|471220535|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
130887709|NCT05006573|471220536|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
130887710|NCT05006573|471220535|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
130887711|NCT05006573|471220536|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130887712|NCT05006573|471220535|FG000|Double-blind Treatment Period|Protocol Violation|2|||
130887713|NCT05006573|471220536|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130887714|NCT05006573|471220535|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
130887715|NCT05006573|471220536|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
130887716|NCT05006573|471220535|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
130887717|NCT05006573|471220536|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
130887718|NCT03493464|471220541|FG000|Overall Study|Surgery not performed|1|||
130887719|NCT02374450|471220545|FG000|Overall Study|Protocol Violation|0|||
130887720|NCT02374450|471220546|FG001|Overall Study|Protocol Violation|1|||
130887721|NCT02374450|471220547|FG002|Overall Study|Protocol Violation|0|||
130887722|NCT02374450|471220545|FG000|Overall Study|Withdrawal by Subject|91|||
130887723|NCT02374450|471220546|FG001|Overall Study|Withdrawal by Subject|110|||
130887724|NCT02374450|471220547|FG002|Overall Study|Withdrawal by Subject|4|||
130887725|NCT02374450|471220545|FG000|Overall Study|Lost to Follow-up|168|||
130887726|NCT02374450|471220546|FG001|Overall Study|Lost to Follow-up|194|||
130887727|NCT02374450|471220547|FG002|Overall Study|Lost to Follow-up|138|||
130887728|NCT02374450|471220545|FG000|Overall Study|Death|173|||
130887729|NCT02374450|471220546|FG001|Overall Study|Death|185|||
130887730|NCT02374450|471220547|FG002|Overall Study|Death|81|||
130887731|NCT02374450|471220545|FG000|Overall Study|Migrated from the study area|538|||
130887732|NCT02374450|471220546|FG001|Overall Study|Migrated from the study area|648|||
130887733|NCT02374450|471220547|FG002|Overall Study|Migrated from the study area|181|||
130887734|NCT02374450|471220545|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
130887735|NCT02374450|471220546|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
130887736|NCT02374450|471220547|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
131021299|NCT00232180|471710095|FG000|Open Label Phase|Randomized but not treated|0|||
130887737|NCT02374450|471220545|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
131021300|NCT00232180|471710096|FG001|Open Label Phase|Randomized but not treated|0|||
131021301|NCT00232180|471710097|FG002|Open Label Phase|Randomized but not treated|1|||
131021302|NCT01571596|471710098|FG000|Overall Study|Adverse Event|2|||
131021303|NCT01571596|471710099|FG001|Overall Study|Adverse Event|0|||
131021304|NCT01571596|471710100|FG002|Overall Study|Adverse Event|0|||
131021305|NCT01571596|471710098|FG000|Overall Study|Study Terminated by the Sponsor|0|||
131021306|NCT01571596|471710099|FG001|Overall Study|Study Terminated by the Sponsor|1|||
131021307|NCT01571596|471710100|FG002|Overall Study|Study Terminated by the Sponsor|1|||
131021308|NCT02767765|471710102|FG000|Overall Study|Adverse Event|4|||
131021309|NCT02767765|471710102|FG000|Overall Study|Death|1|||
131021310|NCT02767765|471710102|FG000|Overall Study|Insufficient response|1|||
131021311|NCT02767765|471710102|FG000|Overall Study|Lost to Follow-up|2|||
131021312|NCT02767765|471710102|FG000|Overall Study|Investigator decision|1|||
131021313|NCT02767765|471710102|FG000|Overall Study|Non-Compliance|1|||
131021314|NCT02767765|471710102|FG000|Overall Study|Withdrawal by Subject|1|||
131021315|NCT01951170|471710103|FG000|Overall Study|Investigator decision|1|||
131021316|NCT04512482|471710107|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
131021317|NCT04512482|471710108|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
131021318|NCT00446459|471710113|FG000|8 Months|Protocol Violation|12|||
131021319|NCT00446459|471710113|FG000|12 Months|Protocol Violation|4|||
131021320|NCT00446459|471710113|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
130887738|NCT02374450|471220546|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
130887739|NCT02374450|471220547|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
130887740|NCT02374450|471220545|FG000|Overall Study|Other|0|||
130887741|NCT02374450|471220546|FG001|Overall Study|Other|21|||
131021321|NCT00077675|471710114|FG000|Overall Study|Adverse Event|1|||
131021322|NCT00077675|471710115|FG001|Overall Study|Adverse Event|2|||
131021323|NCT00077675|471710114|FG000|Overall Study|Lost to Follow-up|6|||
130887742|NCT02374450|471220547|FG002|Overall Study|Other|79|||
130685921|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131021324|NCT00077675|471710115|FG001|Overall Study|Lost to Follow-up|3|||
131021325|NCT00077675|471710114|FG000|Overall Study|Withdrawal by Subject|1|||
131021326|NCT00077675|471710115|FG001|Overall Study|Withdrawal by Subject|0|||
131021327|NCT00077675|471710114|FG000|Overall Study|Other|0|||
131106583|NCT04776148|472020876|FG001|Overall Study|Death|260|||
131106584|NCT04776148|472020875|FG000|Overall Study|Lost to Follow-up|0|||
131106585|NCT04776148|472020876|FG001|Overall Study|Lost to Follow-up|1|||
131106586|NCT04776148|472020875|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131106587|NCT04776148|472020876|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131106588|NCT04776148|472020875|FG000|Overall Study|Withdrawal by Subject|3|||
131106589|NCT04776148|472020876|FG001|Overall Study|Withdrawal by Subject|4|||
131106590|NCT04776148|472020875|FG000|Overall Study|Sponsor Decision|30|||
131106591|NCT04776148|472020876|FG001|Overall Study|Sponsor Decision|15|||
131106592|NCT02563522|472020877|FG000|Overall Study|Adverse Event|2|||
130685922|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130685923|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130685924|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
130685925|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
130685926|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
130685927|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
131106593|NCT02563522|472020878|FG001|Overall Study|Adverse Event|3|||
131106594|NCT02563522|472020877|FG000|Overall Study|Lost to Follow-up|1|||
131106595|NCT02563522|472020878|FG001|Overall Study|Lost to Follow-up|0|||
131106596|NCT02563522|472020877|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
131106597|NCT02563522|472020878|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
131106598|NCT00824161|472020879|FG000|Overall Study|Withdrawal by Subject|1|||
131106599|NCT00824161|472020879|FG000|Overall Study|Screen Failure|1|||
131106600|NCT04874415|472020880|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131106601|NCT04874415|472020881|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131106602|NCT04874415|472020882|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131106603|NCT04874415|472020883|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131106604|NCT04874415|472020884|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131106605|NCT04874415|472020885|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131106606|NCT04874415|472020886|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
131106607|NCT04874415|472020887|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131106608|NCT04874415|472020888|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
131106609|NCT04874415|472020889|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
131106610|NCT04874415|472020890|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131106611|NCT04874415|472020891|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
131106612|NCT04874415|472020892|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
131106613|NCT04874415|472020893|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
131106614|NCT04874415|472020894|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
131106615|NCT04874415|472020895|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
131106616|NCT04874415|472020880|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
131106617|NCT04874415|472020881|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
131106618|NCT04874415|472020882|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
131106619|NCT04874415|472020883|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
131106620|NCT04874415|472020884|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
131106621|NCT04874415|472020885|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
131106622|NCT04874415|472020886|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
131106623|NCT04874415|472020887|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
131106624|NCT04874415|472020888|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
130685928|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
130887743|NCT01442103|471222024|FG000|Overall Study|Lost to Follow-up|2|||
131106625|NCT04874415|472020889|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
131106626|NCT04874415|472020890|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
131106627|NCT04874415|472020891|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
131106628|NCT04874415|472020892|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
131106629|NCT04874415|472020893|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
131106630|NCT04874415|472020894|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
131106631|NCT04874415|472020895|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
131106632|NCT04874415|472020880|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106633|NCT04874415|472020881|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106634|NCT04874415|472020882|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106635|NCT04874415|472020883|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106636|NCT04874415|472020884|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
131106637|NCT04874415|472020885|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106638|NCT04874415|472020886|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106639|NCT04874415|472020887|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131222616|NCT01902134|472443118|FG005|Overall Study|Other|0|||
130887744|NCT02202759|471222025|FG000|Overall Study|Study Terminated by Sponsor|3|||
130887745|NCT02202759|471222026|FG001|Overall Study|Study Terminated by Sponsor|3|||
130887746|NCT02202759|471222027|FG002|Overall Study|Study Terminated by Sponsor|3|||
130887747|NCT02202759|471222025|FG000|Overall Study|Withdrawal by Subject|2|||
130887748|NCT02202759|471222026|FG001|Overall Study|Withdrawal by Subject|1|||
130887749|NCT02202759|471222027|FG002|Overall Study|Withdrawal by Subject|1|||
130887750|NCT02202759|471222025|FG000|Overall Study|Reason not Specified|4|||
130887751|NCT02202759|471222026|FG001|Overall Study|Reason not Specified|11|||
130887752|NCT02202759|471222027|FG002|Overall Study|Reason not Specified|10|||
130887753|NCT01987453|471222028|FG000|Overall Study|Death|0|||
130887754|NCT01987453|471222029|FG001|Overall Study|Death|0|||
130887755|NCT01987453|471222030|FG002|Overall Study|Death|1|||
130887756|NCT01987453|471222028|FG000|Overall Study|Lack of Efficacy|1|||
130887757|NCT01987453|471222029|FG001|Overall Study|Lack of Efficacy|12|||
130887758|NCT01987453|471222030|FG002|Overall Study|Lack of Efficacy|0|||
130887759|NCT01590888|471222032|FG000|Overall Study|Adverse Event|3|||
130887760|NCT01590888|471222033|FG001|Overall Study|Adverse Event|0|||
130887761|NCT01590888|471222034|FG002|Overall Study|Adverse Event|1|||
130887762|NCT01590888|471222032|FG000|Overall Study|Lost to Follow-up|1|||
130887763|NCT01590888|471222033|FG001|Overall Study|Lost to Follow-up|0|||
130887764|NCT01590888|471222034|FG002|Overall Study|Lost to Follow-up|0|||
130887765|NCT04953728|471222035|FG000|Overall Study|Withdrawal by Subject|3|||
130887766|NCT04953728|471222035|FG000|Overall Study|Physician Decision|1|||
130887767|NCT02105662|471222036|FG000|Overall Study|Lost to Follow-up|5|||
130887768|NCT02105662|471222036|FG000|Overall Study|Withdrawal by Subject|1|||
130887769|NCT02331277|471222039|FG000|Overall Study|Withdrawal by Subject|1|||
130887770|NCT02331277|471222040|FG001|Overall Study|Withdrawal by Subject|0|||
130887771|NCT03978117|471222041|FG000|Overall Study|Non-Compliance|26|||
130887772|NCT03978117|471222042|FG001|Overall Study|Non-Compliance|26|||
130887773|NCT03978117|471222041|FG000|Overall Study|Lost to Follow-up|4|||
130887774|NCT03978117|471222042|FG001|Overall Study|Lost to Follow-up|4|||
130887775|NCT01528969|471222049|FG000|Overall Study|absent from the school at baseline|2|||
130887776|NCT01528969|471222050|FG001|Overall Study|absent from the school at baseline|0|||
130887777|NCT01106690|471222051|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
130887778|NCT01106690|471222052|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
130887779|NCT01106690|471222053|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
130887780|NCT01106690|471222051|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
130887781|NCT01106690|471222052|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
130887782|NCT01106690|471222053|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
130887783|NCT01106690|471222051|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
130887784|NCT01106690|471222052|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
130887785|NCT01106690|471222053|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
130887786|NCT01106690|471222051|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
130887787|NCT01106690|471222052|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
130887788|NCT01106690|471222053|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
130887789|NCT01106690|471222051|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
130887790|NCT01106690|471222052|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
130887791|NCT01106690|471222053|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
130767063|NCT01857102|470770713|FG000|Period 1|No longer meets Eligibility Criteria|0|||
130887792|NCT01106690|471222051|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130887793|NCT01106690|471222052|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130887794|NCT01106690|471222053|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130887795|NCT01106690|471222051|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
130887796|NCT01106690|471222052|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130887797|NCT01106690|471222053|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130887798|NCT01106690|471222051|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
130887799|NCT01106690|471222052|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130887800|NCT01106690|471222053|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130887801|NCT01106690|471222051|FG000|Core Period: Baseline to Week 26|Other|10|||
130887802|NCT01106690|471222052|FG001|Core Period: Baseline to Week 26|Other|2|||
130887803|NCT01106690|471222053|FG002|Core Period: Baseline to Week 26|Other|6|||
130887804|NCT01106690|471222051|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130887805|NCT01106690|471222052|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130887806|NCT01106690|471222053|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130887807|NCT01106690|471222051|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130887808|NCT01106690|471222052|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130887809|NCT01106690|471222053|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130887810|NCT01106690|471222051|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
131021328|NCT00077675|471710115|FG001|Overall Study|Other|1|||
131021329|NCT00077675|471710114|FG000|Overall Study|Never received study treatment|3|||
131021330|NCT00077675|471710115|FG001|Overall Study|Never received study treatment|3|||
130887811|NCT01106690|471222052|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130887812|NCT01106690|471222053|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130685929|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
130887813|NCT01106690|471222051|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130887814|NCT01106690|471222052|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130887815|NCT01106690|471222053|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
130887816|NCT01106690|471222051|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130887817|NCT01106690|471222052|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130887818|NCT01106690|471222053|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130887819|NCT01106690|471222051|FG000|Extension Period: Week 26 to Week 52|Other|8|||
130887820|NCT01106690|471222052|FG001|Extension Period: Week 26 to Week 52|Other|3|||
130887821|NCT01106690|471222053|FG002|Extension Period: Week 26 to Week 52|Other|4|||
130887822|NCT01106690|471222051|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
130887823|NCT01106690|471222052|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130887824|NCT01106690|471222053|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130887825|NCT00998296|471222054|FG000|Overall Study|Progressive disease|0|||
130887826|NCT00998296|471222055|FG001|Overall Study|Progressive disease|1|||
130887827|NCT00998296|471222056|FG002|Overall Study|Progressive disease|0|||
130887828|NCT00998296|471222057|FG003|Overall Study|Progressive disease|0|||
130887829|NCT00998296|471222058|FG004|Overall Study|Progressive disease|0|||
130887830|NCT00998296|471222059|FG005|Overall Study|Progressive disease|0|||
130887831|NCT00998296|471222060|FG006|Overall Study|Progressive disease|1|||
130887832|NCT00998296|471222061|FG007|Overall Study|Progressive disease|0|||
130887833|NCT00998296|471222062|FG008|Overall Study|Progressive disease|0|||
130887834|NCT00998296|471222063|FG009|Overall Study|Progressive disease|14|||
130887835|NCT00998296|471222064|FG010|Overall Study|Progressive disease|5|||
130887836|NCT00998296|471222054|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
130887837|NCT00998296|471222055|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
130887838|NCT00998296|471222056|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
130887839|NCT00998296|471222057|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
130887840|NCT00998296|471222058|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
130887841|NCT00998296|471222059|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
130887842|NCT00998296|471222060|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
130887843|NCT00998296|471222061|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
130887844|NCT00998296|471222062|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
130887845|NCT00998296|471222063|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
130887846|NCT00998296|471222064|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
130887847|NCT00998296|471222054|FG000|Overall Study|Other adverse event|0|||
130887848|NCT00998296|471222055|FG001|Overall Study|Other adverse event|0|||
130887849|NCT00998296|471222056|FG002|Overall Study|Other adverse event|0|||
130887850|NCT00998296|471222057|FG003|Overall Study|Other adverse event|0|||
130887851|NCT00998296|471222058|FG004|Overall Study|Other adverse event|1|||
130887852|NCT00998296|471222059|FG005|Overall Study|Other adverse event|0|||
130887853|NCT00998296|471222060|FG006|Overall Study|Other adverse event|0|||
130887854|NCT00998296|471222061|FG007|Overall Study|Other adverse event|0|||
130887855|NCT00998296|471222062|FG008|Overall Study|Other adverse event|0|||
130887856|NCT00998296|471222063|FG009|Overall Study|Other adverse event|1|||
130887857|NCT00998296|471222064|FG010|Overall Study|Other adverse event|2|||
131021331|NCT00244855|471710123|FG000|Overall Study|Withdrawal by Subject|0|||
131021332|NCT00244855|471710124|FG001|Overall Study|Withdrawal by Subject|1|||
131021333|NCT02706717|471710125|FG000|Overall Study|Withdrawal by Subject|1|||
131021334|NCT02706717|471710126|FG001|Overall Study|Withdrawal by Subject|8|||
131021335|NCT02706717|471710125|FG000|Overall Study|Lost to Follow-up|0|||
131021336|NCT02706717|471710126|FG001|Overall Study|Lost to Follow-up|1|||
131021337|NCT02706717|471710125|FG000|Overall Study|Physician Decision|0|||
131021338|NCT02706717|471710126|FG001|Overall Study|Physician Decision|1|||
131021339|NCT02706717|471710125|FG000|Overall Study|Death|0|||
131021340|NCT02706717|471710126|FG001|Overall Study|Death|1|||
131021341|NCT00293293|471710129|FG000|Overall Study|Withdrawal by Subject|1|||
131021342|NCT00293293|471710130|FG001|Overall Study|Withdrawal by Subject|1|||
131021343|NCT00293293|471710129|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
131021344|NCT00293293|471710130|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
131021345|NCT00293293|471710129|FG000|Overall Study|Patient discontinued chemotherapy|0|||
131021346|NCT00293293|471710130|FG001|Overall Study|Patient discontinued chemotherapy|1|||
131021347|NCT02512965|471710133|FG000|Overall Study|Withdrawal by Subject|0|||
131021348|NCT02512965|471710134|FG001|Overall Study|Withdrawal by Subject|4|||
131021349|NCT00835770|471710135|FG000|Overall Study|MS Relapse|17|||
131021350|NCT00835770|471710136|FG001|Overall Study|MS Relapse|23|||
131021351|NCT00835770|471710135|FG000|Overall Study|MS Progression|14|||
131021352|NCT00835770|471710136|FG001|Overall Study|MS Progression|9|||
131021353|NCT00835770|471710135|FG000|Overall Study|Adverse Event|113|||
131021354|NCT00835770|471710136|FG001|Overall Study|Adverse Event|124|||
130887858|NCT00998296|471222054|FG000|Overall Study|Refused to continue taking trial med.|0|||
131021355|NCT00835770|471710135|FG000|Overall Study|Lost to Follow-up|22|||
131021356|NCT00835770|471710136|FG001|Overall Study|Lost to Follow-up|19|||
131021357|NCT00835770|471710135|FG000|Overall Study|Consent Withdrawn|144|||
131021358|NCT00835770|471710136|FG001|Overall Study|Consent Withdrawn|156|||
131021359|NCT00835770|471710135|FG000|Overall Study|Investigator Decision|42|||
131021360|NCT00835770|471710136|FG001|Overall Study|Investigator Decision|42|||
131021361|NCT00835770|471710135|FG000|Overall Study|Participant Non-Compliance|11|||
131021362|NCT00835770|471710136|FG001|Overall Study|Participant Non-Compliance|9|||
131021363|NCT00835770|471710135|FG000|Overall Study|Death|4|||
131021364|NCT00835770|471710136|FG001|Overall Study|Death|6|||
131021365|NCT00835770|471710135|FG000|Overall Study|Other|115|||
131021366|NCT00835770|471710136|FG001|Overall Study|Other|104|||
131021367|NCT00835770|471710135|FG000|Overall Study|Other|2|||
131021368|NCT00835770|471710136|FG001|Overall Study|Other|1|||
131021369|NCT01185782|471710137|FG000|Overall Study|Adverse Event|0|||
131021370|NCT01185782|471710138|FG001|Overall Study|Adverse Event|1|||
131021371|NCT01185782|471710137|FG000|Overall Study|Protocol Violation|1|||
131021372|NCT01185782|471710138|FG001|Overall Study|Protocol Violation|0|||
131021373|NCT01185782|471710137|FG000|Overall Study|Poor Response to Treatment|3|||
131021374|NCT01185782|471710138|FG001|Overall Study|Poor Response to Treatment|1|||
131021375|NCT01185782|471710137|FG000|Overall Study|Other|2|||
131021376|NCT01185782|471710138|FG001|Overall Study|Other|5|||
131021377|NCT01185782|471710137|FG000|Overall Study|Randomized but not treated|0|||
131021378|NCT01185782|471710138|FG001|Overall Study|Randomized but not treated|4|||
131021379|NCT02988817|471710143|FG000|Overall Study|Withdrawal by Subject|1|||
131021380|NCT02988817|471710144|FG001|Overall Study|Withdrawal by Subject|0|||
131021381|NCT02988817|471710145|FG002|Overall Study|Withdrawal by Subject|0|||
131021382|NCT02988817|471710146|FG003|Overall Study|Withdrawal by Subject|1|||
131021383|NCT02988817|471710147|FG004|Overall Study|Withdrawal by Subject|3|||
131021384|NCT02988817|471710148|FG005|Overall Study|Withdrawal by Subject|1|||
131021385|NCT02988817|471710149|FG006|Overall Study|Withdrawal by Subject|2|||
131021386|NCT02988817|471710150|FG007|Overall Study|Withdrawal by Subject|1|||
131021387|NCT02988817|471710151|FG008|Overall Study|Withdrawal by Subject|1|||
131021388|NCT02988817|471710152|FG009|Overall Study|Withdrawal by Subject|1|||
131021389|NCT02988817|471710153|FG010|Overall Study|Withdrawal by Subject|1|||
131021390|NCT02988817|471710154|FG011|Overall Study|Withdrawal by Subject|12|||
131021391|NCT02988817|471710155|FG012|Overall Study|Withdrawal by Subject|6|||
131021392|NCT02988817|471710156|FG013|Overall Study|Withdrawal by Subject|6|||
131021393|NCT02988817|471710157|FG014|Overall Study|Withdrawal by Subject|4|||
131021394|NCT02988817|471710158|FG015|Overall Study|Withdrawal by Subject|5|||
131021395|NCT02988817|471710159|FG016|Overall Study|Withdrawal by Subject|4|||
131021396|NCT02988817|471710160|FG017|Overall Study|Withdrawal by Subject|11|||
131021397|NCT02988817|471710161|FG018|Overall Study|Withdrawal by Subject|4|||
131021398|NCT02988817|471710162|FG019|Overall Study|Withdrawal by Subject|2|||
131021399|NCT02988817|471710143|FG000|Overall Study|Death|0|||
131021400|NCT02988817|471710144|FG001|Overall Study|Death|1|||
131021401|NCT02988817|471710145|FG002|Overall Study|Death|3|||
131021402|NCT02988817|471710146|FG003|Overall Study|Death|1|||
131021403|NCT02988817|471710147|FG004|Overall Study|Death|6|||
131021404|NCT02988817|471710148|FG005|Overall Study|Death|10|||
131021405|NCT02988817|471710149|FG006|Overall Study|Death|1|||
131021406|NCT02988817|471710150|FG007|Overall Study|Death|2|||
131021407|NCT02988817|471710151|FG008|Overall Study|Death|1|||
131021408|NCT02988817|471710152|FG009|Overall Study|Death|5|||
131021409|NCT02988817|471710153|FG010|Overall Study|Death|1|||
131021410|NCT02988817|471710154|FG011|Overall Study|Death|8|||
131021411|NCT02988817|471710155|FG012|Overall Study|Death|9|||
131021412|NCT02988817|471710156|FG013|Overall Study|Death|17|||
131021413|NCT02988817|471710157|FG014|Overall Study|Death|18|||
131021414|NCT02988817|471710158|FG015|Overall Study|Death|30|||
131021415|NCT02988817|471710159|FG016|Overall Study|Death|17|||
131021416|NCT02988817|471710160|FG017|Overall Study|Death|38|||
131021417|NCT02988817|471710161|FG018|Overall Study|Death|14|||
131021418|NCT02988817|471710162|FG019|Overall Study|Death|16|||
131021419|NCT02988817|471710143|FG000|Overall Study|Other|0|||
131021420|NCT02988817|471710144|FG001|Overall Study|Other|0|||
131021421|NCT02988817|471710145|FG002|Overall Study|Other|0|||
131021422|NCT02988817|471710146|FG003|Overall Study|Other|1|||
131021423|NCT02988817|471710147|FG004|Overall Study|Other|1|||
131021424|NCT02988817|471710148|FG005|Overall Study|Other|0|||
131021425|NCT02988817|471710149|FG006|Overall Study|Other|0|||
131021426|NCT02988817|471710150|FG007|Overall Study|Other|0|||
131021427|NCT02988817|471710151|FG008|Overall Study|Other|0|||
131021428|NCT02988817|471710152|FG009|Overall Study|Other|0|||
131021429|NCT02988817|471710153|FG010|Overall Study|Other|0|||
131021430|NCT02988817|471710154|FG011|Overall Study|Other|0|||
131021431|NCT02988817|471710155|FG012|Overall Study|Other|0|||
131021432|NCT02988817|471710156|FG013|Overall Study|Other|0|||
131021433|NCT02988817|471710157|FG014|Overall Study|Other|0|||
131021434|NCT02988817|471710158|FG015|Overall Study|Other|1|||
131021435|NCT02988817|471710159|FG016|Overall Study|Other|0|||
131021436|NCT02988817|471710160|FG017|Overall Study|Other|0|||
131021437|NCT02988817|471710161|FG018|Overall Study|Other|0|||
130887859|NCT00998296|471222055|FG001|Overall Study|Refused to continue taking trial med.|0|||
130887860|NCT00998296|471222056|FG002|Overall Study|Refused to continue taking trial med.|0|||
130887861|NCT00998296|471222057|FG003|Overall Study|Refused to continue taking trial med.|0|||
130887862|NCT00998296|471222058|FG004|Overall Study|Refused to continue taking trial med.|0|||
130887863|NCT00998296|471222059|FG005|Overall Study|Refused to continue taking trial med.|0|||
130887864|NCT00998296|471222060|FG006|Overall Study|Refused to continue taking trial med.|0|||
130887865|NCT00998296|471222061|FG007|Overall Study|Refused to continue taking trial med.|0|||
130887866|NCT00998296|471222062|FG008|Overall Study|Refused to continue taking trial med.|0|||
131021438|NCT02988817|471710162|FG019|Overall Study|Other|0|||
131021439|NCT02988817|471710143|FG000|Overall Study|Lost to Follow-up|0|||
131021440|NCT02988817|471710144|FG001|Overall Study|Lost to Follow-up|0|||
131021441|NCT02988817|471710145|FG002|Overall Study|Lost to Follow-up|0|||
131021442|NCT02988817|471710146|FG003|Overall Study|Lost to Follow-up|0|||
131021443|NCT02988817|471710147|FG004|Overall Study|Lost to Follow-up|0|||
131021444|NCT02988817|471710148|FG005|Overall Study|Lost to Follow-up|0|||
131021445|NCT02988817|471710149|FG006|Overall Study|Lost to Follow-up|0|||
131021446|NCT02988817|471710150|FG007|Overall Study|Lost to Follow-up|0|||
131021447|NCT02988817|471710151|FG008|Overall Study|Lost to Follow-up|1|||
131021448|NCT02988817|471710152|FG009|Overall Study|Lost to Follow-up|0|||
131021449|NCT02988817|471710153|FG010|Overall Study|Lost to Follow-up|1|||
131021450|NCT02988817|471710154|FG011|Overall Study|Lost to Follow-up|1|||
131021451|NCT02988817|471710155|FG012|Overall Study|Lost to Follow-up|0|||
131021452|NCT02988817|471710156|FG013|Overall Study|Lost to Follow-up|0|||
131021453|NCT02988817|471710157|FG014|Overall Study|Lost to Follow-up|1|||
131021454|NCT02988817|471710158|FG015|Overall Study|Lost to Follow-up|1|||
131021455|NCT02988817|471710159|FG016|Overall Study|Lost to Follow-up|2|||
131021456|NCT02988817|471710160|FG017|Overall Study|Lost to Follow-up|3|||
131021457|NCT02988817|471710161|FG018|Overall Study|Lost to Follow-up|0|||
131021458|NCT02988817|471710162|FG019|Overall Study|Lost to Follow-up|0|||
131021459|NCT02988817|471710143|FG000|Overall Study|Sponsor decision|0|||
131021460|NCT02988817|471710144|FG001|Overall Study|Sponsor decision|0|||
131021461|NCT02988817|471710145|FG002|Overall Study|Sponsor decision|0|||
131021462|NCT02988817|471710146|FG003|Overall Study|Sponsor decision|0|||
131021463|NCT02988817|471710147|FG004|Overall Study|Sponsor decision|0|||
131021464|NCT02988817|471710148|FG005|Overall Study|Sponsor decision|0|||
131021465|NCT02988817|471710149|FG006|Overall Study|Sponsor decision|0|||
131021466|NCT02988817|471710150|FG007|Overall Study|Sponsor decision|0|||
131021467|NCT02988817|471710151|FG008|Overall Study|Sponsor decision|0|||
131021468|NCT02988817|471710152|FG009|Overall Study|Sponsor decision|0|||
131021469|NCT02988817|471710153|FG010|Overall Study|Sponsor decision|0|||
131021470|NCT02988817|471710154|FG011|Overall Study|Sponsor decision|1|||
131021471|NCT02988817|471710155|FG012|Overall Study|Sponsor decision|1|||
131021472|NCT02988817|471710156|FG013|Overall Study|Sponsor decision|2|||
131021473|NCT02988817|471710157|FG014|Overall Study|Sponsor decision|2|||
131021474|NCT02988817|471710158|FG015|Overall Study|Sponsor decision|6|||
131021475|NCT02988817|471710159|FG016|Overall Study|Sponsor decision|2|||
131021476|NCT02988817|471710160|FG017|Overall Study|Sponsor decision|3|||
131021477|NCT02988817|471710161|FG018|Overall Study|Sponsor decision|2|||
131021478|NCT02988817|471710162|FG019|Overall Study|Sponsor decision|7|||
131021479|NCT02988817|471710143|FG000|Overall Study|Physician Decision|0|||
131021480|NCT02988817|471710144|FG001|Overall Study|Physician Decision|0|||
131021481|NCT02988817|471710145|FG002|Overall Study|Physician Decision|0|||
131021482|NCT02988817|471710146|FG003|Overall Study|Physician Decision|0|||
131021483|NCT02988817|471710147|FG004|Overall Study|Physician Decision|0|||
131021484|NCT02988817|471710148|FG005|Overall Study|Physician Decision|0|||
131021485|NCT02988817|471710149|FG006|Overall Study|Physician Decision|0|||
131021486|NCT02988817|471710150|FG007|Overall Study|Physician Decision|0|||
131021487|NCT02988817|471710151|FG008|Overall Study|Physician Decision|0|||
131021488|NCT02988817|471710152|FG009|Overall Study|Physician Decision|0|||
131021489|NCT02988817|471710153|FG010|Overall Study|Physician Decision|0|||
131021490|NCT02988817|471710154|FG011|Overall Study|Physician Decision|0|||
131021491|NCT02988817|471710155|FG012|Overall Study|Physician Decision|0|||
131021492|NCT02988817|471710156|FG013|Overall Study|Physician Decision|0|||
131021493|NCT02988817|471710157|FG014|Overall Study|Physician Decision|0|||
131021494|NCT02988817|471710158|FG015|Overall Study|Physician Decision|1|||
131021495|NCT02988817|471710159|FG016|Overall Study|Physician Decision|0|||
131021496|NCT02988817|471710160|FG017|Overall Study|Physician Decision|0|||
131021497|NCT02988817|471710161|FG018|Overall Study|Physician Decision|1|||
131021498|NCT02988817|471710162|FG019|Overall Study|Physician Decision|1|||
131021499|NCT04530747|471710171|FG000|Overall Study|Withdrawal by Subject|1|||
131021500|NCT04530747|471710172|FG001|Overall Study|Withdrawal by Subject|0|||
131021501|NCT03292913|471710173|FG000|Overall Study|Death|9|||
131021502|NCT03292913|471710174|FG001|Overall Study|Death|3|||
131021503|NCT03292913|471710173|FG000|Overall Study|Lost to Follow-up|49|||
131021504|NCT03292913|471710174|FG001|Overall Study|Lost to Follow-up|49|||
131021505|NCT03292913|471710173|FG000|Overall Study|Withdrawal by Subject|2|||
131021506|NCT03292913|471710174|FG001|Overall Study|Withdrawal by Subject|0|||
131021507|NCT03292913|471710173|FG000|Overall Study|Clinic closed due to COVID|22|||
131021508|NCT03292913|471710174|FG001|Overall Study|Clinic closed due to COVID|36|||
130887867|NCT00998296|471222063|FG009|Overall Study|Refused to continue taking trial med.|2|||
130887868|NCT00998296|471222064|FG010|Overall Study|Refused to continue taking trial med.|0|||
130887869|NCT00998296|471222054|FG000|Overall Study|Reason other than those specified above|0|||
130887870|NCT00998296|471222055|FG001|Overall Study|Reason other than those specified above|0|||
130887871|NCT00998296|471222056|FG002|Overall Study|Reason other than those specified above|0|||
130887872|NCT00998296|471222057|FG003|Overall Study|Reason other than those specified above|0|||
130887873|NCT00998296|471222058|FG004|Overall Study|Reason other than those specified above|0|||
130887874|NCT00998296|471222059|FG005|Overall Study|Reason other than those specified above|0|||
130887875|NCT00998296|471222060|FG006|Overall Study|Reason other than those specified above|0|||
130887876|NCT00998296|471222061|FG007|Overall Study|Reason other than those specified above|0|||
130887877|NCT00998296|471222062|FG008|Overall Study|Reason other than those specified above|0|||
130887878|NCT00998296|471222063|FG009|Overall Study|Reason other than those specified above|1|||
130887879|NCT00998296|471222064|FG010|Overall Study|Reason other than those specified above|0|||
130887880|NCT01544335|471222067|FG000|Overall Study|Lost to Follow-up|27|||
130887881|NCT01544335|471222067|FG000|Overall Study|Death|4|||
130887882|NCT01544335|471222067|FG000|Overall Study|Disease progression|3|||
130887883|NCT01544335|471222067|FG000|Overall Study|Baseline Measurements not Available|19|||
130887884|NCT03219528|471222073|FG000|Overall Study|Lost to Follow-up|5|||
130887885|NCT03219528|471222074|FG001|Overall Study|Lost to Follow-up|4|||
130887886|NCT03219528|471222073|FG000|Overall Study|Withdrawal by Subject|4|||
130887887|NCT03219528|471222074|FG001|Overall Study|Withdrawal by Subject|4|||
130887888|NCT02120898|471222077|FG000|Overall Study|Withdrawal by Subject|4|||
130887889|NCT02120898|471222078|FG001|Overall Study|Withdrawal by Subject|2|||
130887890|NCT02120898|471222079|FG002|Overall Study|Withdrawal by Subject|2|||
130887891|NCT02120898|471222077|FG000|Overall Study|Non-compliance with study drug|3|||
130887892|NCT02120898|471222078|FG001|Overall Study|Non-compliance with study drug|0|||
130887893|NCT02120898|471222079|FG002|Overall Study|Non-compliance with study drug|0|||
130887894|NCT02120898|471222077|FG000|Overall Study|Adverse Event|1|||
130887895|NCT02120898|471222078|FG001|Overall Study|Adverse Event|2|||
130887896|NCT02120898|471222079|FG002|Overall Study|Adverse Event|1|||
130887897|NCT02120898|471222077|FG000|Overall Study|Protocol Violation|1|||
130887898|NCT02120898|471222078|FG001|Overall Study|Protocol Violation|2|||
130887899|NCT02120898|471222079|FG002|Overall Study|Protocol Violation|0|||
130887900|NCT02120898|471222077|FG000|Overall Study|Lost to Follow-up|0|||
130887901|NCT02120898|471222078|FG001|Overall Study|Lost to Follow-up|0|||
130887902|NCT02120898|471222079|FG002|Overall Study|Lost to Follow-up|1|||
130887903|NCT04085289|471222080|FG000|Overall Study|Withdrawal by Subject|0|||
130887904|NCT04085289|471222081|FG001|Overall Study|Withdrawal by Subject|0|||
130887905|NCT04085289|471222082|FG002|Overall Study|Withdrawal by Subject|1|||
130887906|NCT04614974|471222085|FG000|Overall Study|Lost to Follow-up|14|||
130887907|NCT04614974|471222086|FG001|Overall Study|Lost to Follow-up|11|||
130887908|NCT01635153|471222087|FG000|Overall Study|Lost to Follow-up|40|||
130887909|NCT01635153|471222088|FG001|Overall Study|Lost to Follow-up|43|||
130887910|NCT02560558|471222090|FG000|Overall Study|Adverse Event|1|||
130887911|NCT02560558|471222091|FG001|Overall Study|Adverse Event|0|||
130887912|NCT02560558|471222090|FG000|Overall Study|Death|0|||
130887913|NCT02560558|471222091|FG001|Overall Study|Death|2|||
130887914|NCT02560558|471222090|FG000|Overall Study|Lost to Follow-up|0|||
130887915|NCT02560558|471222091|FG001|Overall Study|Lost to Follow-up|4|||
130887916|NCT02560558|471222090|FG000|Overall Study|Protocol Violation|3|||
130887917|NCT02560558|471222091|FG001|Overall Study|Protocol Violation|0|||
130887918|NCT02560558|471222090|FG000|Overall Study|Withdrawal by Subject|3|||
130887919|NCT02560558|471222091|FG001|Overall Study|Withdrawal by Subject|0|||
130887920|NCT01263197|471222108|FG000|First Intervention (Period 1)|Adverse Event|0|||
130887921|NCT01263197|471222109|FG001|First Intervention (Period 1)|Adverse Event|0|||
130887922|NCT01263197|471222110|FG002|First Intervention (Period 1)|Adverse Event|0|||
130887923|NCT01263197|471222111|FG003|First Intervention (Period 1)|Adverse Event|0|||
130887924|NCT01263197|471222112|FG004|First Intervention (Period 1)|Adverse Event|0|||
131021509|NCT03950622|471710175|FG000|Overall Study|Withdrawal by Subject|1|||
131021510|NCT03950622|471710176|FG001|Overall Study|Withdrawal by Subject|0|||
130887925|NCT01263197|471222113|FG005|First Intervention (Period 1)|Adverse Event|1|||
130887926|NCT01263197|471222108|FG000|Washout Period 1|Protocol Violation|0|||
130887927|NCT01263197|471222109|FG001|Washout Period 1|Protocol Violation|0|||
130887928|NCT01263197|471222110|FG002|Washout Period 1|Protocol Violation|0|||
130887929|NCT01263197|471222111|FG003|Washout Period 1|Protocol Violation|0|||
130887930|NCT01263197|471222112|FG004|Washout Period 1|Protocol Violation|1|||
130887931|NCT01263197|471222113|FG005|Washout Period 1|Protocol Violation|0|||
130887932|NCT01263197|471222108|FG000|Washout Period 2|Physician Decision|0|||
130887933|NCT01263197|471222109|FG001|Washout Period 2|Physician Decision|0|||
130887934|NCT01263197|471222110|FG002|Washout Period 2|Physician Decision|0|||
130887935|NCT01263197|471222111|FG003|Washout Period 2|Physician Decision|0|||
130887936|NCT01263197|471222112|FG004|Washout Period 2|Physician Decision|0|||
130887937|NCT01263197|471222113|FG005|Washout Period 2|Physician Decision|1|||
130887938|NCT01263197|471222108|FG000|Washout Period 2|Protocol Violation|0|||
130887939|NCT01263197|471222109|FG001|Washout Period 2|Protocol Violation|0|||
130887940|NCT01263197|471222110|FG002|Washout Period 2|Protocol Violation|0|||
130887941|NCT01263197|471222111|FG003|Washout Period 2|Protocol Violation|1|||
130887942|NCT01263197|471222112|FG004|Washout Period 2|Protocol Violation|0|||
130887943|NCT01263197|471222113|FG005|Washout Period 2|Protocol Violation|0|||
130887944|NCT01263197|471222108|FG000|Third Intervention (Period 3)|Adverse Event|0|||
130887945|NCT01263197|471222109|FG001|Third Intervention (Period 3)|Adverse Event|1|||
130887946|NCT01263197|471222110|FG002|Third Intervention (Period 3)|Adverse Event|0|||
130887947|NCT01263197|471222111|FG003|Third Intervention (Period 3)|Adverse Event|0|||
130887948|NCT01263197|471222112|FG004|Third Intervention (Period 3)|Adverse Event|0|||
130887949|NCT01263197|471222113|FG005|Third Intervention (Period 3)|Adverse Event|0|||
130887950|NCT02454517|471222114|FG000|Overall Study|Withdrawal by Subject|3|||
130887951|NCT02454517|471222115|FG001|Overall Study|Withdrawal by Subject|0|||
130887952|NCT02454517|471222114|FG000|Overall Study|Lost to Follow-up|4|||
130887953|NCT02454517|471222115|FG001|Overall Study|Lost to Follow-up|7|||
130887954|NCT02454517|471222114|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
130887955|NCT02454517|471222115|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
130887956|NCT00473382|471222116|FG000|Core Study|Adverse Event|3|||
130887957|NCT00473382|471222117|FG001|Core Study|Adverse Event|1|||
130887958|NCT00473382|471222118|FG002|Core Study|Adverse Event|1|||
130887959|NCT00473382|471222116|FG000|Core Study|Death|3|||
130887960|NCT00473382|471222117|FG001|Core Study|Death|5|||
130887961|NCT00473382|471222118|FG002|Core Study|Death|10|||
130887962|NCT00473382|471222116|FG000|Core Study|Lost to Follow-up|3|||
130887963|NCT00473382|471222117|FG001|Core Study|Lost to Follow-up|3|||
131021511|NCT03950622|471710175|FG000|Overall Study|Protocol Deviation|0|||
131021512|NCT03950622|471710176|FG001|Overall Study|Protocol Deviation|1|||
131021513|NCT03950622|471710175|FG000|Overall Study|Physician Decision|1|||
131106640|NCT04874415|472020888|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106641|NCT04874415|472020889|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106642|NCT04874415|472020890|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106643|NCT04874415|472020891|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106644|NCT04874415|472020892|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106645|NCT04874415|472020893|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106646|NCT04874415|472020894|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106647|NCT04874415|472020895|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
131106648|NCT01312857|472020896|FG000|Overall Study|Adverse Event|1|||
131106649|NCT01312857|472020897|FG001|Overall Study|Adverse Event|1|||
131106650|NCT01312857|472020896|FG000|Overall Study|Lost to Follow-up|2|||
131021514|NCT03950622|471710176|FG001|Overall Study|Physician Decision|0|||
131021515|NCT03950622|471710175|FG000|Overall Study|Lost to Follow-up|5|||
131021516|NCT03950622|471710176|FG001|Overall Study|Lost to Follow-up|5|||
131021517|NCT03950622|471710175|FG000|Overall Study|Death|1|||
131021518|NCT03950622|471710176|FG001|Overall Study|Death|1|||
131021519|NCT01546753|471710179|FG000|Overall Study|anxiety|1|||
131021520|NCT01546753|471710180|FG001|Overall Study|anxiety|1|||
131021521|NCT01546753|471710179|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
131021522|NCT01546753|471710180|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
131021523|NCT00939510|471710181|FG000|Overall Study|Withdrawal by Subject|1|||
131021524|NCT00311363|471710195|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
131021525|NCT00311363|471710196|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
131021526|NCT00311363|471710197|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
131021527|NCT00311363|471710195|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
131021528|NCT00311363|471710196|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
131021529|NCT00311363|471710197|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
131021530|NCT00311363|471710195|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
131021531|NCT00311363|471710196|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
131021532|NCT00311363|471710197|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
131021533|NCT00311363|471710195|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
131021534|NCT00311363|471710196|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
131021535|NCT00311363|471710197|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
131021536|NCT00311363|471710195|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
131021537|NCT00311363|471710196|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
131021538|NCT00311363|471710197|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
131106651|NCT01312857|472020897|FG001|Overall Study|Lost to Follow-up|0|||
130887964|NCT00473382|471222118|FG002|Core Study|Lost to Follow-up|3|||
130887965|NCT00473382|471222116|FG000|Core Study|Physician Decision|1|||
130887966|NCT00473382|471222117|FG001|Core Study|Physician Decision|2|||
130887967|NCT00473382|471222118|FG002|Core Study|Physician Decision|2|||
130887968|NCT00473382|471222116|FG000|Core Study|Subject non-compliance|5|||
130887969|NCT00473382|471222117|FG001|Core Study|Subject non-compliance|2|||
130887970|NCT00473382|471222118|FG002|Core Study|Subject non-compliance|1|||
130887971|NCT00473382|471222116|FG000|Core Study|Subject needed other treatment|1|||
130887972|NCT00473382|471222117|FG001|Core Study|Subject needed other treatment|3|||
130887973|NCT00473382|471222118|FG002|Core Study|Subject needed other treatment|2|||
130887974|NCT00473382|471222116|FG000|Core Study|Subject's decision|12|||
130887975|NCT00473382|471222117|FG001|Core Study|Subject's decision|11|||
130887976|NCT00473382|471222118|FG002|Core Study|Subject's decision|10|||
130887977|NCT00473382|471222116|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
130887978|NCT00473382|471222117|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
130887979|NCT00473382|471222118|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
130887980|NCT00473382|471222116|FG000|Open-label Extension Through Month 48|Death|1|||
130887981|NCT00473382|471222117|FG001|Open-label Extension Through Month 48|Death|3|||
130887982|NCT00473382|471222118|FG002|Open-label Extension Through Month 48|Death|3|||
130887983|NCT00473382|471222116|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
130887984|NCT00473382|471222117|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
130887985|NCT00473382|471222118|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
130887986|NCT00473382|471222116|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
130887987|NCT00473382|471222117|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
130887988|NCT00473382|471222118|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
130887989|NCT00473382|471222116|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
130887990|NCT00473382|471222117|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
130887991|NCT00473382|471222118|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
130887992|NCT00473382|471222116|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
130887993|NCT00473382|471222117|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
130887994|NCT00473382|471222118|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
130887995|NCT00473382|471222116|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
130887996|NCT00473382|471222117|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
130887997|NCT00473382|471222118|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
130887998|NCT00473382|471222116|FG000|Open-label Extension Through Month 60|Death|1|||
130887999|NCT00473382|471222117|FG001|Open-label Extension Through Month 60|Death|7|||
130888000|NCT00473382|471222118|FG002|Open-label Extension Through Month 60|Death|4|||
130888001|NCT00473382|471222116|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
130888002|NCT00473382|471222117|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
130888003|NCT00473382|471222118|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
130888004|NCT00473382|471222116|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
130888005|NCT00473382|471222117|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
130888006|NCT00473382|471222118|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
130888007|NCT00473382|471222116|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
130888008|NCT00473382|471222117|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
130888009|NCT00473382|471222118|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
130888010|NCT00473382|471222116|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
130888011|NCT00473382|471222117|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
130888012|NCT00473382|471222118|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
130888013|NCT01134055|471222119|FG000|Overall Study|Adverse Event|5|||
130888014|NCT01134055|471222120|FG001|Overall Study|Adverse Event|2|||
130888015|NCT01134055|471222121|FG002|Overall Study|Adverse Event|2|||
130888016|NCT01134055|471222122|FG003|Overall Study|Adverse Event|2|||
130888017|NCT01134055|471222123|FG004|Overall Study|Adverse Event|5|||
130888018|NCT01134055|471222124|FG005|Overall Study|Adverse Event|7|||
130888019|NCT01134055|471222125|FG006|Overall Study|Adverse Event|2|||
130888020|NCT01134055|471222119|FG000|Overall Study|Lost to Follow-up|0|||
130888021|NCT01134055|471222120|FG001|Overall Study|Lost to Follow-up|1|||
130888022|NCT01134055|471222121|FG002|Overall Study|Lost to Follow-up|0|||
130888023|NCT01134055|471222122|FG003|Overall Study|Lost to Follow-up|1|||
130888024|NCT01134055|471222123|FG004|Overall Study|Lost to Follow-up|0|||
130888025|NCT01134055|471222124|FG005|Overall Study|Lost to Follow-up|0|||
130888026|NCT01134055|471222125|FG006|Overall Study|Lost to Follow-up|0|||
131021539|NCT00311363|471710195|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
131021540|NCT00311363|471710196|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
131021541|NCT00311363|471710197|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
131021542|NCT00311363|471710195|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
130685930|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
130685931|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
130685932|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
130685933|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130888027|NCT01134055|471222119|FG000|Overall Study|Withdrawal by Subject|3|||
130888028|NCT01134055|471222120|FG001|Overall Study|Withdrawal by Subject|3|||
130888029|NCT01134055|471222121|FG002|Overall Study|Withdrawal by Subject|1|||
130888030|NCT01134055|471222122|FG003|Overall Study|Withdrawal by Subject|2|||
130888031|NCT01134055|471222123|FG004|Overall Study|Withdrawal by Subject|0|||
130888032|NCT01134055|471222124|FG005|Overall Study|Withdrawal by Subject|0|||
130888033|NCT01134055|471222125|FG006|Overall Study|Withdrawal by Subject|8|||
130888034|NCT01134055|471222119|FG000|Overall Study|Protocol Violation|0|||
130888035|NCT01134055|471222120|FG001|Overall Study|Protocol Violation|0|||
130888036|NCT01134055|471222121|FG002|Overall Study|Protocol Violation|0|||
130888037|NCT01134055|471222122|FG003|Overall Study|Protocol Violation|1|||
130888038|NCT01134055|471222123|FG004|Overall Study|Protocol Violation|1|||
130888039|NCT01134055|471222124|FG005|Overall Study|Protocol Violation|0|||
130888040|NCT01134055|471222125|FG006|Overall Study|Protocol Violation|0|||
130888041|NCT01134055|471222119|FG000|Overall Study|Physician Decision|0|||
130888042|NCT01134055|471222120|FG001|Overall Study|Physician Decision|0|||
130888043|NCT01134055|471222121|FG002|Overall Study|Physician Decision|0|||
130888044|NCT01134055|471222122|FG003|Overall Study|Physician Decision|0|||
130888045|NCT01134055|471222123|FG004|Overall Study|Physician Decision|0|||
130888046|NCT01134055|471222124|FG005|Overall Study|Physician Decision|0|||
130888047|NCT01134055|471222125|FG006|Overall Study|Physician Decision|1|||
130888048|NCT00275509|471222126|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
130888049|NCT00275509|471222127|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
130888050|NCT02892448|471222128|FG000|Overall Study|Screening failure|2|||
130888051|NCT02892448|471222129|FG001|Overall Study|Screening failure|2|||
130888052|NCT02892448|471222130|FG002|Overall Study|Screening failure|1|||
130888053|NCT00499083|471222131|FG000|Overall Study|Not evaluable|3|||
130888054|NCT00686686|471222132|FG000|Overall Study|Non-compliance|1|||
130888055|NCT00686686|471222132|FG000|Overall Study|Adverse Event|2|||
130888056|NCT00686686|471222132|FG000|Overall Study|Lost to Follow-up|3|||
130888057|NCT01012440|471222133|FG000|Overall Study|Withdrawal by Subject|2|||
130888058|NCT00594815|471222134|FG000|Overall Study|Never Treated|3|||
130888059|NCT00594815|471222134|FG000|Overall Study|Withdrawal by Subject|2|||
130888060|NCT00594815|471222134|FG000|Overall Study|Toxicity|4|||
130888061|NCT00131248|471222138|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
130888062|NCT00131248|471222139|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
130888063|NCT01254422|471222140|FG000|Overall Study|Protocol Violation|1|||
130888064|NCT01254422|471222141|FG001|Overall Study|Protocol Violation|0|||
130888065|NCT01254422|471222140|FG000|Overall Study|Adverse Event|1|||
130888066|NCT01254422|471222141|FG001|Overall Study|Adverse Event|0|||
130888067|NCT01254422|471222140|FG000|Overall Study|Serious adverse event|0|||
130888068|NCT01254422|471222141|FG001|Overall Study|Serious adverse event|1|||
130888069|NCT01254422|471222140|FG000|Overall Study|Lost to Follow-up|1|||
130888070|NCT01254422|471222141|FG001|Overall Study|Lost to Follow-up|0|||
130888071|NCT00643162|471222142|FG000|Overall Study|Withdrawal by Subject|1|||
130888072|NCT00643162|471222143|FG001|Overall Study|Withdrawal by Subject|1|||
130888073|NCT02691507|471222144|FG000|Overall Study|Missed Visit 3|0|||
130888074|NCT02691507|471222145|FG001|Overall Study|Missed Visit 3|1|||
130888075|NCT03023397|471222146|FG000|Run-In|Failed screening allergen challenge|1|||
130888076|NCT03023397|471222147|FG001|Run-In|Failed screening allergen challenge|0|||
130888077|NCT03023397|471222148|FG002|Run-In|Failed screening allergen challenge|0|||
130888078|NCT03023397|471222146|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
130888079|NCT03023397|471222147|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
130888080|NCT03023397|471222148|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
130888081|NCT01146795|471222152|FG000|Overall Study|Withdrawal by Subject|4|||
130888082|NCT01146795|471222152|FG000|Overall Study|Adverse Event|6|||
130888083|NCT01146795|471222152|FG000|Overall Study|Still in treatment at study closure|10|||
130888084|NCT00541385|471222153|FG000|Overall Study|Adverse Event|6|||
130888085|NCT00541385|471222154|FG001|Overall Study|Adverse Event|3|||
130888086|NCT00541385|471222153|FG000|Overall Study|Withdrawal by Subject|2|||
130888087|NCT00541385|471222154|FG001|Overall Study|Withdrawal by Subject|2|||
130888088|NCT00541385|471222153|FG000|Overall Study|Lost to Follow-up|6|||
130888089|NCT00541385|471222154|FG001|Overall Study|Lost to Follow-up|1|||
130888090|NCT00541385|471222153|FG000|Overall Study|Parasite reappearance/malaria|67|||
130888091|NCT00541385|471222154|FG001|Overall Study|Parasite reappearance/malaria|32|||
131021543|NCT00311363|471710196|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
131021544|NCT00311363|471710197|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
131021545|NCT00311363|471710195|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
131106652|NCT01312857|472020896|FG000|Overall Study|Physician Decision|3|||
130888092|NCT04139798|471222156|FG000|Overall Study|Withdrawal by Subject|6|||
130888093|NCT04139798|471222157|FG001|Overall Study|Withdrawal by Subject|5|||
130888094|NCT04139798|471222156|FG000|Overall Study|Lost to Follow-up|2|||
130888095|NCT04139798|471222157|FG001|Overall Study|Lost to Follow-up|5|||
130888096|NCT04139798|471222156|FG000|Overall Study|Discontinued|4|||
130888097|NCT04139798|471222157|FG001|Overall Study|Discontinued|2|||
130888098|NCT04139798|471222156|FG000|Overall Study|Adverse Event|1|||
130888099|NCT04139798|471222157|FG001|Overall Study|Adverse Event|3|||
130888100|NCT04139798|471222156|FG000|Overall Study|Protocol Violation|1|||
130888101|NCT04139798|471222157|FG001|Overall Study|Protocol Violation|0|||
130888102|NCT03155841|471222158|FG000|Overall Study|Protocol Violation|3|||
130888103|NCT03155841|471222159|FG001|Overall Study|Protocol Violation|4|||
130888104|NCT01578486|471222168|FG000|Overall Study|Physician Decision|3|||
130888105|NCT01578486|471222168|FG000|Overall Study|Withdrawal by Subject|2|||
130888106|NCT02536963|471222169|FG000|Overall Study|Withdrawal by Subject|18|||
130888107|NCT02668393|471222171|FG000|Overall Study|Progressive disease|6|||
130888108|NCT02668393|471222172|FG001|Overall Study|Progressive disease|3|||
130888109|NCT02668393|471222171|FG000|Overall Study|Adverse Event|0|||
130888110|NCT02668393|471222172|FG001|Overall Study|Adverse Event|2|||
130888111|NCT02668393|471222171|FG000|Overall Study|Withdrawal from the trial|0|||
130888112|NCT02668393|471222172|FG001|Overall Study|Withdrawal from the trial|1|||
130888113|NCT02668393|471222171|FG000|Overall Study|Lack of benefit and side effects|1|||
130888114|NCT02668393|471222172|FG001|Overall Study|Lack of benefit and side effects|0|||
130888115|NCT02141204|471222173|FG000|Overall Study|Lost to Follow-up|2|||
130888116|NCT02141204|471222174|FG001|Overall Study|Lost to Follow-up|1|||
130888117|NCT02141204|471222173|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
130888118|NCT02141204|471222174|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
130888119|NCT02141204|471222173|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
130888120|NCT02141204|471222174|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
130888121|NCT02141204|471222173|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
130888122|NCT02141204|471222174|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
130888123|NCT00831181|471223653|FG000|Overall Study|Adverse Event|12|||
130888124|NCT00196313|471223654|FG000|Overall Study|Protocol Violation|2|||
130888125|NCT00196313|471223655|FG001|Overall Study|Protocol Violation|3|||
130888126|NCT00196313|471223654|FG000|Overall Study|Withdrawal by Subject|3|||
130888127|NCT00196313|471223655|FG001|Overall Study|Withdrawal by Subject|1|||
130888128|NCT00196313|471223654|FG000|Overall Study|Adverse Event|3|||
130888129|NCT00196313|471223655|FG001|Overall Study|Adverse Event|1|||
130888130|NCT00196313|471223654|FG000|Overall Study|Subject Pregnant|1|||
130888131|NCT00196313|471223655|FG001|Overall Study|Subject Pregnant|1|||
130888132|NCT00196313|471223654|FG000|Overall Study|Lost to Follow-up|2|||
130888133|NCT00196313|471223655|FG001|Overall Study|Lost to Follow-up|2|||
130888134|NCT01967576|471223656|FG000|Overall Study|Withdrawal by Subject|3|||
130888135|NCT01967576|471223656|FG000|Overall Study|Progressed/Removed from treatment|1|||
130888136|NCT01967576|471223656|FG000|Overall Study|Study closing at site|1|||
130888137|NCT01967576|471223656|FG000|Overall Study|Adverse Event|1|||
130888138|NCT01967576|471223656|FG000|Overall Study|Refused further treatment|1|||
130888139|NCT03196349|471223657|FG000|Overall Study|Did not receive study drug|0|||
130888140|NCT03196349|471223658|FG001|Overall Study|Did not receive study drug|1|||
130888141|NCT03196349|471223659|FG002|Overall Study|Did not receive study drug|2|||
130888142|NCT03196349|471223657|FG000|Overall Study|No data entered|2|||
130888143|NCT03196349|471223658|FG001|Overall Study|No data entered|4|||
130888144|NCT03196349|471223659|FG002|Overall Study|No data entered|0|||
130888145|NCT03196349|471223657|FG000|Overall Study|Study Terminated early|15|||
130888146|NCT03196349|471223658|FG001|Overall Study|Study Terminated early|9|||
130888147|NCT03196349|471223659|FG002|Overall Study|Study Terminated early|11|||
130888148|NCT03967444|471223660|FG000|Overall Study|Lost to Follow-up|1|||
130888149|NCT03967444|471223661|FG001|Overall Study|Lost to Follow-up|2|||
130888150|NCT01821118|471223668|FG000|Overall Study|Death|0|||
130888151|NCT01821118|471223669|FG001|Overall Study|Death|1|||
130888152|NCT01605799|471223670|FG000|Overall Study|Withdrawal by Subject|2|||
130888153|NCT01605799|471223671|FG001|Overall Study|Withdrawal by Subject|1|||
130888154|NCT00345358|471223672|FG000|Primary Vaccination Phase|Other|0|||
130888155|NCT00345358|471223673|FG001|Primary Vaccination Phase|Other|1|||
130888156|NCT00345358|471223674|FG002|Primary Vaccination Phase|Other|1|||
130888157|NCT00345358|471223675|FG003|Primary Vaccination Phase|Other|0|||
130888158|NCT00345358|471223672|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
130888159|NCT00345358|471223673|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
130888160|NCT00345358|471223674|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
130888161|NCT00345358|471223675|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
130888162|NCT00345358|471223672|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
131021546|NCT00311363|471710196|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
131021547|NCT00311363|471710197|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
131021548|NCT00311363|471710195|FG000|24-Week Single-Blind Treatment Period|Death|1|||
131021549|NCT00311363|471710196|FG001|24-Week Single-Blind Treatment Period|Death|0|||
131021550|NCT00311363|471710197|FG002|24-Week Single-Blind Treatment Period|Death|0|||
130685934|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130685935|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130888163|NCT00345358|471223673|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
130888164|NCT00345358|471223674|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
130888165|NCT00345358|471223675|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
130888166|NCT00345358|471223672|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
130888167|NCT00345358|471223673|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
130685936|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130888168|NCT00345358|471223674|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
130888169|NCT00345358|471223675|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
130888170|NCT00345358|471223672|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
130888171|NCT00345358|471223673|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
130888172|NCT00345358|471223674|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
130888173|NCT00345358|471223675|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
130888174|NCT00345358|471223672|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
130888175|NCT00345358|471223673|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
130888176|NCT00345358|471223674|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
130888177|NCT00345358|471223675|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
130888178|NCT00477386|471223676|FG000|Overall Study|Adverse Event|4|||
130888179|NCT00477386|471223677|FG001|Overall Study|Adverse Event|8|||
130888180|NCT00477386|471223676|FG000|Overall Study|Disease progression, relapse|3|||
130888181|NCT00477386|471223677|FG001|Overall Study|Disease progression, relapse|4|||
130888182|NCT00477386|471223676|FG000|Overall Study|Disease progression, refractory|1|||
130888183|NCT00477386|471223677|FG001|Overall Study|Disease progression, refractory|3|||
130888184|NCT00477386|471223676|FG000|Overall Study|Other|1|||
130888185|NCT00477386|471223677|FG001|Overall Study|Other|2|||
130888186|NCT00477386|471223676|FG000|Overall Study|Physician Decision|1|||
130888187|NCT00477386|471223677|FG001|Overall Study|Physician Decision|0|||
130888188|NCT00477386|471223676|FG000|Overall Study|Withdrawal by Subject|1|||
130888189|NCT00477386|471223677|FG001|Overall Study|Withdrawal by Subject|0|||
130888190|NCT02207088|471223678|FG000|Overall Study|Adverse Event|2|||
130888191|NCT01812252|471223679|FG000|Overall Study|Persistent Disease|1|||
130888192|NCT01812252|471223680|FG001|Overall Study|Persistent Disease|0|||
130888193|NCT01812252|471223679|FG000|Overall Study|Not transplanted|11|||
130888194|NCT01812252|471223680|FG001|Overall Study|Not transplanted|11|||
130888195|NCT01812252|471223679|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
130888196|NCT01812252|471223680|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
130888197|NCT01812252|471223679|FG000|Overall Study|Withdrawal by Subject|1|||
130888198|NCT01812252|471223680|FG001|Overall Study|Withdrawal by Subject|1|||
130888199|NCT01812252|471223679|FG000|Overall Study|Screen Failure|1|||
130888200|NCT01812252|471223680|FG001|Overall Study|Screen Failure|0|||
130888201|NCT02284243|471223681|FG000|Overall Study|Lack of Efficacy|3|||
130888202|NCT02284243|471223682|FG001|Overall Study|Lack of Efficacy|3|||
130888203|NCT02284243|471223681|FG000|Overall Study|Adverse Event|1|||
130888204|NCT02284243|471223682|FG001|Overall Study|Adverse Event|0|||
130888205|NCT04269889|471223684|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
130888206|NCT04634253|471223685|FG000|Overall Study|Adverse Event|1|||
130888207|NCT04634253|471223686|FG001|Overall Study|Adverse Event|1|||
130888208|NCT04634253|471223687|FG002|Overall Study|Adverse Event|0|||
130888209|NCT04634253|471223685|FG000|Overall Study|Physician Decision|0|||
130888210|NCT04634253|471223686|FG001|Overall Study|Physician Decision|1|||
130888211|NCT04634253|471223687|FG002|Overall Study|Physician Decision|0|||
130888212|NCT04634253|471223685|FG000|Overall Study|Withdrawal by Subject|1|||
130888213|NCT04634253|471223686|FG001|Overall Study|Withdrawal by Subject|0|||
130888214|NCT04634253|471223687|FG002|Overall Study|Withdrawal by Subject|3|||
130888215|NCT01499355|471223688|FG000|Run-In Period|Study Termination|15|||
130888216|NCT01499355|471223689|FG001|Run-In Period|Study Termination|0|||
130888217|NCT01499355|471223690|FG002|Run-In Period|Study Termination|0|||
130888218|NCT01499355|471223691|FG003|Run-In Period|Study Termination|0|||
130888219|NCT01499355|471223688|FG000|Run-In Period|Other|3|||
130888220|NCT01499355|471223689|FG001|Run-In Period|Other|0|||
130888221|NCT01499355|471223690|FG002|Run-In Period|Other|0|||
130888222|NCT01499355|471223691|FG003|Run-In Period|Other|0|||
130888223|NCT01499355|471223688|FG000|Run-In Period|Death|2|||
130888224|NCT01499355|471223689|FG001|Run-In Period|Death|0|||
131021551|NCT00311363|471710195|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
131021552|NCT00311363|471710196|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
131021553|NCT00311363|471710197|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
131021554|NCT00311363|471710195|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
131021555|NCT00311363|471710196|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
131021556|NCT00311363|471710197|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
131021557|NCT00311363|471710195|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
131021558|NCT00311363|471710196|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
131021559|NCT00311363|471710197|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
131021560|NCT00311363|471710195|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
131021561|NCT00311363|471710196|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
131021562|NCT00311363|471710197|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
130888225|NCT01499355|471223690|FG002|Run-In Period|Death|0|||
130888226|NCT01499355|471223691|FG003|Run-In Period|Death|0|||
130888227|NCT01499355|471223688|FG000|Run-In Period|Investigator Decision|2|||
130888228|NCT01499355|471223689|FG001|Run-In Period|Investigator Decision|0|||
130888229|NCT01499355|471223690|FG002|Run-In Period|Investigator Decision|0|||
130888230|NCT01499355|471223691|FG003|Run-In Period|Investigator Decision|0|||
130888231|NCT01499355|471223688|FG000|Run-In Period|Consent Withdrawn|1|||
130888232|NCT01499355|471223689|FG001|Run-In Period|Consent Withdrawn|0|||
130888233|NCT01499355|471223690|FG002|Run-In Period|Consent Withdrawn|0|||
130888234|NCT01499355|471223691|FG003|Run-In Period|Consent Withdrawn|0|||
130888235|NCT01499355|471223688|FG000|Run-In Period|Adverse Event|8|||
130888236|NCT01499355|471223689|FG001|Run-In Period|Adverse Event|0|||
130888237|NCT01499355|471223690|FG002|Run-In Period|Adverse Event|0|||
130888238|NCT01499355|471223691|FG003|Run-In Period|Adverse Event|0|||
130888239|NCT01499355|471223688|FG000|Double-Blind Period|Adverse Event|0|||
130888240|NCT01499355|471223689|FG001|Double-Blind Period|Adverse Event|2|||
130888241|NCT01499355|471223690|FG002|Double-Blind Period|Adverse Event|3|||
130888242|NCT01499355|471223691|FG003|Double-Blind Period|Adverse Event|2|||
130888243|NCT01499355|471223688|FG000|Double-Blind Period|Study Termination|0|||
130888244|NCT01499355|471223689|FG001|Double-Blind Period|Study Termination|18|||
130888245|NCT01499355|471223690|FG002|Double-Blind Period|Study Termination|16|||
130888246|NCT01499355|471223691|FG003|Double-Blind Period|Study Termination|14|||
130888247|NCT01499355|471223688|FG000|Double-Blind Period|Other|0|||
130888248|NCT01499355|471223689|FG001|Double-Blind Period|Other|1|||
130888249|NCT01499355|471223690|FG002|Double-Blind Period|Other|2|||
130888250|NCT01499355|471223691|FG003|Double-Blind Period|Other|2|||
130888251|NCT01499355|471223688|FG000|Double-Blind Period|Death|0|||
130888252|NCT01499355|471223689|FG001|Double-Blind Period|Death|1|||
130888253|NCT01499355|471223690|FG002|Double-Blind Period|Death|0|||
130888254|NCT01499355|471223691|FG003|Double-Blind Period|Death|0|||
130888255|NCT01499355|471223688|FG000|Double-Blind Period|Investigator Decision|0|||
130888256|NCT01499355|471223689|FG001|Double-Blind Period|Investigator Decision|0|||
130888257|NCT01499355|471223690|FG002|Double-Blind Period|Investigator Decision|3|||
130888258|NCT01499355|471223691|FG003|Double-Blind Period|Investigator Decision|3|||
130888259|NCT01499355|471223688|FG000|Double-Blind Period|Consent Withdrawn|0|||
130888260|NCT01499355|471223689|FG001|Double-Blind Period|Consent Withdrawn|0|||
130888261|NCT01499355|471223690|FG002|Double-Blind Period|Consent Withdrawn|1|||
130888262|NCT01499355|471223691|FG003|Double-Blind Period|Consent Withdrawn|2|||
130888263|NCT01499355|471223688|FG000|Double-Blind Period|Lost to Follow-up|0|||
130888264|NCT01499355|471223689|FG001|Double-Blind Period|Lost to Follow-up|1|||
130888265|NCT01499355|471223690|FG002|Double-Blind Period|Lost to Follow-up|0|||
130888266|NCT01499355|471223691|FG003|Double-Blind Period|Lost to Follow-up|0|||
130888267|NCT01526733|471223692|FG000|Phase 1|Protocol Violation|1|||
130888268|NCT01526733|471223693|FG001|Phase 1|Protocol Violation|0|||
130888269|NCT01526733|471223692|FG000|Phase 1|Withdrawal by Subject|1|||
130888270|NCT01526733|471223693|FG001|Phase 1|Withdrawal by Subject|1|||
130888271|NCT02699749|471223696|FG000|Overall Study|Other|0|||
130888272|NCT02699749|471223697|FG001|Overall Study|Other|0|||
130888273|NCT02699749|471223698|FG002|Overall Study|Other|2|||
130888274|NCT02699749|471223699|FG003|Overall Study|Other|0|||
130888275|NCT02699749|471223700|FG004|Overall Study|Other|0|||
130888276|NCT02699749|471223701|FG005|Overall Study|Other|1|||
130888277|NCT02699749|471223702|FG006|Overall Study|Other|1|||
130888278|NCT02699749|471223703|FG007|Overall Study|Other|0|||
130888279|NCT02699749|471223704|FG008|Overall Study|Other|0|||
130888280|NCT02699749|471223705|FG009|Overall Study|Other|0|||
130888281|NCT02699749|471223706|FG010|Overall Study|Other|1|||
130888282|NCT02699749|471223707|FG011|Overall Study|Other|0|||
130888283|NCT02699749|471223708|FG012|Overall Study|Other|0|||
130888284|NCT02699749|471223709|FG013|Overall Study|Other|0|||
130888285|NCT02699749|471223696|FG000|Overall Study|Progressive Disease|3|||
130888286|NCT02699749|471223697|FG001|Overall Study|Progressive Disease|3|||
130888287|NCT02699749|471223698|FG002|Overall Study|Progressive Disease|14|||
130888288|NCT02699749|471223699|FG003|Overall Study|Progressive Disease|3|||
130888289|NCT02699749|471223700|FG004|Overall Study|Progressive Disease|3|||
130888290|NCT02699749|471223701|FG005|Overall Study|Progressive Disease|7|||
130888291|NCT02699749|471223702|FG006|Overall Study|Progressive Disease|5|||
130888292|NCT02699749|471223703|FG007|Overall Study|Progressive Disease|5|||
130888293|NCT02699749|471223704|FG008|Overall Study|Progressive Disease|6|||
130888294|NCT02699749|471223705|FG009|Overall Study|Progressive Disease|6|||
130888295|NCT02699749|471223706|FG010|Overall Study|Progressive Disease|5|||
130888296|NCT02699749|471223707|FG011|Overall Study|Progressive Disease|4|||
130888297|NCT02699749|471223708|FG012|Overall Study|Progressive Disease|3|||
130888298|NCT02699749|471223709|FG013|Overall Study|Progressive Disease|5|||
130888299|NCT02699749|471223696|FG000|Overall Study|Death|0|||
130888300|NCT02699749|471223697|FG001|Overall Study|Death|0|||
130888301|NCT02699749|471223698|FG002|Overall Study|Death|0|||
130685937|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130888302|NCT02699749|471223699|FG003|Overall Study|Death|0|||
130888303|NCT02699749|471223700|FG004|Overall Study|Death|0|||
130888304|NCT02699749|471223701|FG005|Overall Study|Death|0|||
130888305|NCT02699749|471223702|FG006|Overall Study|Death|0|||
130888306|NCT02699749|471223703|FG007|Overall Study|Death|0|||
130888307|NCT02699749|471223704|FG008|Overall Study|Death|0|||
130888308|NCT02699749|471223705|FG009|Overall Study|Death|0|||
130888309|NCT02699749|471223706|FG010|Overall Study|Death|0|||
130888310|NCT02699749|471223707|FG011|Overall Study|Death|0|||
130888311|NCT02699749|471223708|FG012|Overall Study|Death|0|||
130888312|NCT02699749|471223709|FG013|Overall Study|Death|1|||
130888313|NCT02699749|471223696|FG000|Overall Study|Lost to Follow-up|0|||
130888314|NCT02699749|471223697|FG001|Overall Study|Lost to Follow-up|0|||
131106653|NCT01312857|472020897|FG001|Overall Study|Physician Decision|0|||
131021563|NCT00311363|471710195|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
131021564|NCT00311363|471710196|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
131106654|NCT01312857|472020896|FG000|Overall Study|Withdrawal by Subject|2|||
131106655|NCT01312857|472020897|FG001|Overall Study|Withdrawal by Subject|0|||
131106656|NCT04882995|472020898|FG000|Overall Study|Withdrawal by Subject|1|||
131106657|NCT04882995|472020899|FG001|Overall Study|Withdrawal by Subject|2|||
131106658|NCT04882995|472020898|FG000|Overall Study|Protocol Violation|4|||
131106659|NCT04882995|472020899|FG001|Overall Study|Protocol Violation|4|||
131106660|NCT04882995|472020898|FG000|Overall Study|Surgery postponed due to COVID|1|||
131106661|NCT04882995|472020899|FG001|Overall Study|Surgery postponed due to COVID|1|||
131106662|NCT02572882|472020900|FG000|Overall Study|Withdrawal by Subject|1|||
131106663|NCT02572882|472020900|FG000|Overall Study|Participant received kidney transplant|1|||
131106664|NCT04371198|472020901|FG000|Overall Study|inadequate sample|4|||
131106665|NCT04754477|472020902|FG000|Overall Study|Withdrawal by Subject|1|||
131106666|NCT01590017|472020903|FG000|Overall Study|Adverse Event|1|||
131106667|NCT01590017|472020903|FG000|Overall Study|Withdrawal by Subject|1|||
131106668|NCT01590017|472020903|FG000|Overall Study|Lack of Efficacy|1|||
131106669|NCT01590017|472020903|FG000|Overall Study|Physician Decision|1|||
131106670|NCT01347762|472020904|FG000|Overall Study|Lost to Follow-up|0|||
131106671|NCT01347762|472020905|FG001|Overall Study|Lost to Follow-up|1|||
131106672|NCT01347762|472020906|FG002|Overall Study|Lost to Follow-up|6|||
131106673|NCT01347762|472020907|FG003|Overall Study|Lost to Follow-up|5|||
131106674|NCT01347762|472020904|FG000|Overall Study|Withdrawal by Subject|4|||
131106675|NCT01347762|472020905|FG001|Overall Study|Withdrawal by Subject|1|||
131106676|NCT01347762|472020906|FG002|Overall Study|Withdrawal by Subject|3|||
131106677|NCT01347762|472020907|FG003|Overall Study|Withdrawal by Subject|3|||
131106678|NCT03235284|472020908|FG000|Overall Study|Adverse Event|1|||
131106679|NCT03235284|472020909|FG001|Overall Study|Adverse Event|2|||
131106680|NCT03235284|472020910|FG002|Overall Study|Adverse Event|1|||
131106681|NCT01382706|472020913|FG000|Overall Study|Adverse Event|1|||
131106682|NCT01382706|472020913|FG000|Overall Study|Withdrawal by Subject|1|||
131106683|NCT05559099|472020914|FG000|Overall Study|Death|5|||
131106684|NCT05559099|472020915|FG001|Overall Study|Death|4|||
131106685|NCT05559099|472020914|FG000|Overall Study|Lost to Follow-up|0|||
131106686|NCT05559099|472020915|FG001|Overall Study|Lost to Follow-up|2|||
131106687|NCT05559099|472020914|FG000|Overall Study|Adverse Event|1|||
131106688|NCT05559099|472020915|FG001|Overall Study|Adverse Event|1|||
131106689|NCT04018092|472020916|FG000|Overall Study|Withdrawal by Subject|1|||
131106690|NCT04018092|472020917|FG001|Overall Study|Withdrawal by Subject|1|||
131106691|NCT04018092|472020916|FG000|Overall Study|Withdrawal by Subject|1|||
131106692|NCT04018092|472020917|FG001|Overall Study|Withdrawal by Subject|1|||
131021565|NCT00311363|471710197|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
131021566|NCT00311363|471710195|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
131021567|NCT00311363|471710196|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
131021568|NCT00311363|471710197|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
131021569|NCT00988858|471710200|FG000|Overall Study|Adverse Event|7|||
131021570|NCT00988858|471710200|FG000|Overall Study|Death|1|||
131021571|NCT00988858|471710200|FG000|Overall Study|Physician Decision|1|||
131021572|NCT00988858|471710200|FG000|Overall Study|Sponsor Decision|1|||
131021573|NCT05510245|471710204|FG000|Overall Study|Withdrawal by Subject|1|||
131021574|NCT05510245|471710205|FG001|Overall Study|Withdrawal by Subject|0|||
131021575|NCT05510245|471710206|FG002|Overall Study|Withdrawal by Subject|0|||
131021576|NCT01759771|471710214|FG000|Overall Study|Withdrawal by Subject|1|||
131021577|NCT01759771|471710215|FG001|Overall Study|Withdrawal by Subject|1|||
131021578|NCT02528188|471710216|FG000|Overall Study|Adverse Event|23|||
131021579|NCT02528188|471710217|FG001|Overall Study|Adverse Event|22|||
131021580|NCT02528188|471710218|FG002|Overall Study|Adverse Event|8|||
131021581|NCT02528188|471710216|FG000|Overall Study|Protocol Violation|4|||
131021582|NCT02528188|471710217|FG001|Overall Study|Protocol Violation|6|||
131021583|NCT02528188|471710218|FG002|Overall Study|Protocol Violation|4|||
131021584|NCT02528188|471710216|FG000|Overall Study|Lack of Efficacy|19|||
131021585|NCT02528188|471710217|FG001|Overall Study|Lack of Efficacy|21|||
131021586|NCT02528188|471710218|FG002|Overall Study|Lack of Efficacy|22|||
131021587|NCT02528188|471710216|FG000|Overall Study|Withdrawal by Subject|97|||
131021588|NCT02528188|471710217|FG001|Overall Study|Withdrawal by Subject|104|||
131021589|NCT02528188|471710218|FG002|Overall Study|Withdrawal by Subject|100|||
131021590|NCT02528188|471710216|FG000|Overall Study|Lost to Follow-up|25|||
131021591|NCT02528188|471710217|FG001|Overall Study|Lost to Follow-up|21|||
131021592|NCT02528188|471710218|FG002|Overall Study|Lost to Follow-up|31|||
131021593|NCT02528188|471710216|FG000|Overall Study|Death|4|||
131021594|NCT02528188|471710217|FG001|Overall Study|Death|4|||
131021595|NCT02528188|471710218|FG002|Overall Study|Death|0|||
131021596|NCT02528188|471710216|FG000|Overall Study|Other|89|||
131021597|NCT02528188|471710217|FG001|Overall Study|Other|91|||
131021598|NCT02528188|471710218|FG002|Overall Study|Other|74|||
131021599|NCT02528188|471710216|FG000|Overall Study|Randomized but not treated|6|||
131021600|NCT02528188|471710217|FG001|Overall Study|Randomized but not treated|7|||
131021601|NCT02528188|471710218|FG002|Overall Study|Randomized but not treated|12|||
131021602|NCT04411056|471711742|FG000|Overall Study|surgery cancelled|1|||
131021603|NCT04411056|471711743|FG001|Overall Study|surgery cancelled|0|||
131021604|NCT04411056|471711742|FG000|Overall Study|Equipment problem during intubation|0|||
131021605|NCT04411056|471711743|FG001|Overall Study|Equipment problem during intubation|1|||
131021606|NCT03122886|471711747|FG000|Overall Study|Withdrawal by Subject|1|||
131021607|NCT03122886|471711748|FG001|Overall Study|Withdrawal by Subject|2|||
131021608|NCT03422276|471711749|FG000|Overall Study|Withdrawal by Subject|21|||
131021609|NCT03422276|471711750|FG001|Overall Study|Withdrawal by Subject|25|||
131021610|NCT03422276|471711751|FG002|Overall Study|Withdrawal by Subject|14|||
131021611|NCT03422276|471711752|FG003|Overall Study|Withdrawal by Subject|16|||
131021612|NCT03422276|471711749|FG000|Overall Study|Death|14|||
131021613|NCT03422276|471711750|FG001|Overall Study|Death|21|||
131021614|NCT03422276|471711751|FG002|Overall Study|Death|3|||
131021615|NCT03422276|471711752|FG003|Overall Study|Death|1|||
131021616|NCT03422276|471711749|FG000|Overall Study|Discontinued, ineligible|4|||
131021617|NCT03422276|471711750|FG001|Overall Study|Discontinued, ineligible|3|||
131021618|NCT03422276|471711751|FG002|Overall Study|Discontinued, ineligible|0|||
131021619|NCT03422276|471711752|FG003|Overall Study|Discontinued, ineligible|0|||
131021620|NCT03422276|471711749|FG000|Overall Study|Lost to Follow-up|15|||
131021621|NCT03422276|471711750|FG001|Overall Study|Lost to Follow-up|8|||
131021622|NCT03422276|471711751|FG002|Overall Study|Lost to Follow-up|13|||
131021623|NCT03422276|471711752|FG003|Overall Study|Lost to Follow-up|4|||
131021624|NCT03422276|471711749|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
131021625|NCT03422276|471711750|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
131021626|NCT03422276|471711751|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
131021627|NCT03422276|471711752|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
131021628|NCT03422276|471711749|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
131021629|NCT03422276|471711750|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
131021630|NCT03422276|471711751|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
131021631|NCT03422276|471711752|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
131021632|NCT03422276|471711749|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
131021633|NCT03422276|471711750|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
131021634|NCT03422276|471711751|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
131021635|NCT03422276|471711752|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
131021636|NCT03422276|471711749|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
131021637|NCT03422276|471711750|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
131021638|NCT03422276|471711751|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
131021639|NCT03422276|471711752|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
131021640|NCT03422276|471711749|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
131021641|NCT03422276|471711750|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
131021642|NCT03422276|471711751|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
131021643|NCT03422276|471711752|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
131021644|NCT05985044|471711753|FG000|Overall Study|Death|6|||
131021645|NCT05985044|471711753|FG000|Overall Study|Lost to Follow-up|4|||
131021646|NCT05985044|471711753|FG000|Overall Study|Incapacitation|3|||
131021647|NCT05985044|471711753|FG000|Overall Study|Withdrawal by Subject|2|||
131021648|NCT02279095|471711756|FG000|Overall Study|Non-Compliance|1|||
131021649|NCT02279095|471711756|FG000|Overall Study|Withdrawal by Subject|8|||
131021650|NCT02279095|471711756|FG000|Overall Study|Adverse Event|2|||
131021651|NCT02279095|471711756|FG000|Overall Study|Other|7|||
131021652|NCT02279095|471711756|FG000|Overall Study|Lost to Follow-up|1|||
131021653|NCT05938413|471711757|FG000|Overall Study|Lost to Follow-up|1|||
131021654|NCT05938413|471711758|FG001|Overall Study|Lost to Follow-up|7|||
131021655|NCT05938413|471711757|FG000|Overall Study|Withdrawal by Subject|1|||
131021656|NCT05938413|471711758|FG001|Overall Study|Withdrawal by Subject|1|||
130888315|NCT02699749|471223698|FG002|Overall Study|Lost to Follow-up|0|||
130888316|NCT02699749|471223699|FG003|Overall Study|Lost to Follow-up|0|||
130888317|NCT02699749|471223700|FG004|Overall Study|Lost to Follow-up|0|||
130888318|NCT02699749|471223701|FG005|Overall Study|Lost to Follow-up|1|||
130888319|NCT02699749|471223702|FG006|Overall Study|Lost to Follow-up|0|||
130888320|NCT02699749|471223703|FG007|Overall Study|Lost to Follow-up|1|||
130888321|NCT02699749|471223704|FG008|Overall Study|Lost to Follow-up|0|||
130888322|NCT02699749|471223705|FG009|Overall Study|Lost to Follow-up|0|||
130888323|NCT02699749|471223706|FG010|Overall Study|Lost to Follow-up|0|||
130888324|NCT02699749|471223707|FG011|Overall Study|Lost to Follow-up|0|||
130888325|NCT02699749|471223708|FG012|Overall Study|Lost to Follow-up|0|||
130888326|NCT02699749|471223709|FG013|Overall Study|Lost to Follow-up|0|||
130888327|NCT01310075|471223710|FG000|Overall Study|Lost to Follow-up|1|||
130888328|NCT01310075|471223711|FG001|Overall Study|Lost to Follow-up|0|||
130888329|NCT01310075|471223710|FG000|Overall Study|Physician Decision|10|||
130888330|NCT01310075|471223711|FG001|Overall Study|Physician Decision|7|||
130888331|NCT01310075|471223710|FG000|Overall Study|Protocol Violation|2|||
130888332|NCT01310075|471223711|FG001|Overall Study|Protocol Violation|2|||
130888333|NCT01310075|471223710|FG000|Overall Study|Withdrawal by Subject|1|||
130888334|NCT01310075|471223711|FG001|Overall Study|Withdrawal by Subject|1|||
130888335|NCT02395081|471223712|FG000|Overall Study|Withdrawal by Subject|1|||
130888336|NCT02395081|471223713|FG001|Overall Study|Withdrawal by Subject|1|||
130888337|NCT02395081|471223714|FG002|Overall Study|Withdrawal by Subject|0|||
130888338|NCT02395081|471223712|FG000|Overall Study|Moved where blood couldn't be collected|4|||
130888339|NCT02395081|471223713|FG001|Overall Study|Moved where blood couldn't be collected|1|||
130888340|NCT02395081|471223714|FG002|Overall Study|Moved where blood couldn't be collected|3|||
130888341|NCT02395081|471223712|FG000|Overall Study|Fetal Loss|2|||
130888342|NCT02395081|471223713|FG001|Overall Study|Fetal Loss|3|||
130888343|NCT02395081|471223714|FG002|Overall Study|Fetal Loss|1|||
130888344|NCT02991040|471223715|FG000|Overall Study|Withdrawal by Subject|2|||
130888345|NCT02991040|471223715|FG000|Overall Study|Lost to Follow-up|2|||
130888346|NCT01869764|471223716|FG000|Overall Study|Withdrawal by Subject|0|||
130888347|NCT01869764|471223717|FG001|Overall Study|Withdrawal by Subject|2|||
130888348|NCT01286480|471223718|FG000|Overall Study|Withdrawal by Subject|5|||
130888349|NCT01286480|471223719|FG001|Overall Study|Withdrawal by Subject|3|||
130888350|NCT01626872|471223720|FG000|Overall Study|Physician Decision|13|||
130888351|NCT01626872|471223721|FG001|Overall Study|Physician Decision|9|||
130888352|NCT01626872|471223722|FG002|Overall Study|Physician Decision|6|||
130888353|NCT01626872|471223720|FG000|Overall Study|Withdrawal by Subject|19|||
130888354|NCT01626872|471223721|FG001|Overall Study|Withdrawal by Subject|27|||
130888355|NCT01626872|471223722|FG002|Overall Study|Withdrawal by Subject|8|||
130888356|NCT01626872|471223720|FG000|Overall Study|Adverse Event (including Death)|20|||
130888357|NCT01626872|471223721|FG001|Overall Study|Adverse Event (including Death)|28|||
130888358|NCT01626872|471223722|FG002|Overall Study|Adverse Event (including Death)|8|||
130888359|NCT01626872|471223720|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
130888360|NCT01626872|471223721|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
130888361|NCT01626872|471223722|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
130888362|NCT00960999|471223723|FG000|Overall Study|Withdrawal by Subject|1|||
130888363|NCT00960999|471223724|FG001|Overall Study|Withdrawal by Subject|0|||
130888364|NCT00960999|471223723|FG000|Overall Study|Protocol Violation|5|||
130888365|NCT00960999|471223724|FG001|Overall Study|Protocol Violation|2|||
130888366|NCT00960999|471223723|FG000|Overall Study|RT dose constraints not met|2|||
130888367|NCT00960999|471223724|FG001|Overall Study|RT dose constraints not met|0|||
130888368|NCT01696188|471223725|FG000|Overall Study|Protocol Violation|1|||
130888369|NCT01696188|471223726|FG001|Overall Study|Protocol Violation|1|||
130888370|NCT00888940|471223727|FG000|Overall Study|Adverse Event|12|||
130888371|NCT00888940|471223728|FG001|Overall Study|Adverse Event|3|||
130888372|NCT00888940|471223727|FG000|Overall Study|Lost to Follow-up|5|||
130888373|NCT00888940|471223728|FG001|Overall Study|Lost to Follow-up|5|||
130888374|NCT00888940|471223727|FG000|Overall Study|Randomized Not Treated|11|||
130888375|NCT00888940|471223728|FG001|Overall Study|Randomized Not Treated|13|||
131021657|NCT02675244|471711768|FG000|Overall Study|Death|9|||
131021658|NCT02675244|471711769|FG001|Overall Study|Death|6|||
131021659|NCT02675244|471711768|FG000|Overall Study|Withdrawal by Subject|3|||
131021660|NCT02675244|471711769|FG001|Overall Study|Withdrawal by Subject|6|||
130888376|NCT00607373|471223729|FG000|Treatment Period|Adverse Event|0|||
130888377|NCT00607373|471223730|FG001|Treatment Period|Adverse Event|4|||
131021661|NCT02675244|471711768|FG000|Overall Study|Lost to Follow-up|1|||
130888378|NCT00607373|471223729|FG000|Treatment Period|Physician Decision|0|||
130888379|NCT00607373|471223730|FG001|Treatment Period|Physician Decision|1|||
130767064|NCT01857102|470770714|FG001|Period 1|No longer meets Eligibility Criteria|2|||
130888380|NCT00607373|471223729|FG000|Treatment Period|Withdrawal by Subject|0|||
130888381|NCT00607373|471223730|FG001|Treatment Period|Withdrawal by Subject|1|||
130888382|NCT00607373|471223729|FG000|Follow-up Period|Other|0|||
130888383|NCT00607373|471223730|FG001|Follow-up Period|Other|1|||
130888384|NCT00607373|471223729|FG000|Follow-up Period|Protocol Violation|0|||
130888385|NCT00607373|471223730|FG001|Follow-up Period|Protocol Violation|1|||
130888386|NCT00607373|471223729|FG000|Follow-up Period|Withdrawal by Subject|1|||
130888387|NCT00607373|471223730|FG001|Follow-up Period|Withdrawal by Subject|3|||
130888388|NCT01918306|471223731|FG000|Overall Study|progresive disease|4|||
130888389|NCT01918306|471223732|FG001|Overall Study|progresive disease|0|||
130888390|NCT01918306|471223733|FG002|Overall Study|progresive disease|1|||
130888391|NCT01918306|471223734|FG003|Overall Study|progresive disease|1|||
130888392|NCT01918306|471223731|FG000|Overall Study|Withdrawal by Subject|0|||
130888393|NCT01918306|471223732|FG001|Overall Study|Withdrawal by Subject|0|||
130888394|NCT01918306|471223733|FG002|Overall Study|Withdrawal by Subject|0|||
130888395|NCT01918306|471223734|FG003|Overall Study|Withdrawal by Subject|2|||
130888396|NCT01918306|471223731|FG000|Overall Study|neutropenia|1|||
130888397|NCT01918306|471223732|FG001|Overall Study|neutropenia|0|||
130888398|NCT01918306|471223733|FG002|Overall Study|neutropenia|0|||
130888399|NCT01918306|471223734|FG003|Overall Study|neutropenia|0|||
130888400|NCT01918306|471223731|FG000|Overall Study|Lack of Efficacy|1|||
130888401|NCT01918306|471223732|FG001|Overall Study|Lack of Efficacy|0|||
130888402|NCT01918306|471223733|FG002|Overall Study|Lack of Efficacy|0|||
130888403|NCT01918306|471223734|FG003|Overall Study|Lack of Efficacy|0|||
130888404|NCT01918306|471223731|FG000|Overall Study|progress disease, crossover|0|||
130888405|NCT01918306|471223732|FG001|Overall Study|progress disease, crossover|0|||
130888406|NCT01918306|471223733|FG002|Overall Study|progress disease, crossover|1|||
130888407|NCT01918306|471223734|FG003|Overall Study|progress disease, crossover|0|||
130888408|NCT02170077|471223736|FG000|Overall Study|Withdrawal by Subject|3|||
130888409|NCT02170077|471223737|FG001|Overall Study|Withdrawal by Subject|4|||
130888410|NCT02170077|471223738|FG002|Overall Study|Withdrawal by Subject|2|||
130888411|NCT02170077|471223736|FG000|Overall Study|Adverse Event|4|||
130888412|NCT02170077|471223737|FG001|Overall Study|Adverse Event|4|||
130888413|NCT02170077|471223738|FG002|Overall Study|Adverse Event|4|||
130888414|NCT02170077|471223736|FG000|Overall Study|Lost to Follow-up|0|||
130888415|NCT02170077|471223737|FG001|Overall Study|Lost to Follow-up|1|||
130888416|NCT02170077|471223738|FG002|Overall Study|Lost to Follow-up|0|||
130888417|NCT02170077|471223736|FG000|Overall Study|Exclusion criteria|2|||
130888418|NCT02170077|471223737|FG001|Overall Study|Exclusion criteria|2|||
130888419|NCT02170077|471223738|FG002|Overall Study|Exclusion criteria|5|||
130888420|NCT02170077|471223736|FG000|Overall Study|Exacerbation of seizures|0|||
130888421|NCT02170077|471223737|FG001|Overall Study|Exacerbation of seizures|2|||
131021662|NCT02675244|471711769|FG001|Overall Study|Lost to Follow-up|1|||
131021663|NCT02675244|471711768|FG000|Overall Study|Ongoing at 2 Years|190|||
131021664|NCT02675244|471711769|FG001|Overall Study|Ongoing at 2 Years|185|||
131021665|NCT01839331|471711770|FG000|Overall Study|Early Termination|3|||
131021666|NCT01839331|471711771|FG001|Overall Study|Early Termination|0|||
131021667|NCT01839331|471711772|FG002|Overall Study|Early Termination|1|||
131021668|NCT01839331|471711773|FG003|Overall Study|Early Termination|2|||
131021669|NCT01839331|471711770|FG000|Overall Study|Protocol Violation|1|||
131021670|NCT01839331|471711771|FG001|Overall Study|Protocol Violation|6|||
131021671|NCT01839331|471711772|FG002|Overall Study|Protocol Violation|4|||
131021672|NCT01839331|471711773|FG003|Overall Study|Protocol Violation|3|||
131021673|NCT04056624|471711774|FG000|Overall Study|Withdrawal by Subject|0|||
131021674|NCT04056624|471711775|FG001|Overall Study|Withdrawal by Subject|0|||
131021675|NCT04056624|471711776|FG002|Overall Study|Withdrawal by Subject|1|||
131021676|NCT04056624|471711774|FG000|Overall Study|Protocol Violation|1|||
131021677|NCT04056624|471711775|FG001|Overall Study|Protocol Violation|2|||
131021678|NCT04056624|471711776|FG002|Overall Study|Protocol Violation|0|||
131021679|NCT03051165|471711781|FG000|Overall Study|Withdrawal by Subject|1|||
131021680|NCT03051165|471711781|FG000|Overall Study|Early termination of study|12|||
131021681|NCT02092116|471711783|FG000|Overall Study|Withdrawal by Subject|0|||
131021682|NCT02092116|471711784|FG001|Overall Study|Withdrawal by Subject|3|||
131021683|NCT02092116|471711783|FG000|Overall Study|Adverse Event|0|||
131021684|NCT02092116|471711784|FG001|Overall Study|Adverse Event|1|||
131021685|NCT03531840|471711785|FG000|Overall Study|Death on study|3|||
130888422|NCT02170077|471223738|FG002|Overall Study|Exacerbation of seizures|1|||
130888423|NCT01958164|471223739|FG000|Overall Study|Adverse Event|0|||
130888424|NCT01958164|471223740|FG001|Overall Study|Adverse Event|2|||
130888425|NCT01958164|471223739|FG000|Overall Study|Lost to Follow-up|2|||
130888426|NCT01958164|471223740|FG001|Overall Study|Lost to Follow-up|3|||
130888427|NCT02963506|471223743|FG000|Double-Blind Period|Adverse Event|0|||
130888428|NCT02963506|471223744|FG001|Double-Blind Period|Adverse Event|0|||
131021686|NCT03531840|471711786|FG001|Overall Study|Death on study|2|||
131021687|NCT03531840|471711787|FG002|Overall Study|Death on study|1|||
131021688|NCT03531840|471711788|FG003|Overall Study|Death on study|2|||
131021689|NCT03531840|471711785|FG000|Overall Study|Death during follow up|2|||
130888429|NCT02963506|471223745|FG002|Double-Blind Period|Adverse Event|1|||
130888430|NCT02963506|471223746|FG003|Double-Blind Period|Adverse Event|0|||
130888431|NCT02963506|471223747|FG004|Double-Blind Period|Adverse Event|0|||
131021690|NCT03531840|471711786|FG001|Overall Study|Death during follow up|3|||
131021691|NCT03531840|471711787|FG002|Overall Study|Death during follow up|4|||
130888432|NCT02963506|471223748|FG005|Double-Blind Period|Adverse Event|0|||
130888433|NCT02963506|471223749|FG006|Double-Blind Period|Adverse Event|0|||
130888434|NCT02963506|471223750|FG007|Double-Blind Period|Adverse Event|0|||
130888435|NCT02963506|471223751|FG008|Double-Blind Period|Adverse Event|0|||
130888436|NCT02963506|471223752|FG009|Double-Blind Period|Adverse Event|0|||
130888437|NCT02963506|471223753|FG010|Double-Blind Period|Adverse Event|0|||
130888438|NCT02963506|471223754|FG011|Double-Blind Period|Adverse Event|0|||
130888439|NCT02963506|471223755|FG012|Double-Blind Period|Adverse Event|0|||
130888440|NCT02963506|471223743|FG000|Double-Blind Period|Death|0|||
130888441|NCT02963506|471223744|FG001|Double-Blind Period|Death|0|||
130888442|NCT02963506|471223745|FG002|Double-Blind Period|Death|0|||
130888443|NCT02963506|471223746|FG003|Double-Blind Period|Death|1|||
130888444|NCT02963506|471223747|FG004|Double-Blind Period|Death|0|||
130888445|NCT02963506|471223748|FG005|Double-Blind Period|Death|0|||
130888446|NCT02963506|471223749|FG006|Double-Blind Period|Death|0|||
130888447|NCT02963506|471223750|FG007|Double-Blind Period|Death|0|||
130888448|NCT02963506|471223751|FG008|Double-Blind Period|Death|0|||
130888449|NCT02963506|471223752|FG009|Double-Blind Period|Death|0|||
130888450|NCT02963506|471223753|FG010|Double-Blind Period|Death|0|||
130888451|NCT02963506|471223754|FG011|Double-Blind Period|Death|0|||
130888452|NCT02963506|471223755|FG012|Double-Blind Period|Death|0|||
130888453|NCT02963506|471223743|FG000|Double-Blind Period|Lost to Follow-up|0|||
130888454|NCT02963506|471223744|FG001|Double-Blind Period|Lost to Follow-up|1|||
130888455|NCT02963506|471223745|FG002|Double-Blind Period|Lost to Follow-up|0|||
130888456|NCT02963506|471223746|FG003|Double-Blind Period|Lost to Follow-up|0|||
130888457|NCT02963506|471223747|FG004|Double-Blind Period|Lost to Follow-up|0|||
130888458|NCT02963506|471223748|FG005|Double-Blind Period|Lost to Follow-up|0|||
130888459|NCT02963506|471223749|FG006|Double-Blind Period|Lost to Follow-up|0|||
130888460|NCT02963506|471223750|FG007|Double-Blind Period|Lost to Follow-up|0|||
130888461|NCT02963506|471223751|FG008|Double-Blind Period|Lost to Follow-up|0|||
130888462|NCT02963506|471223752|FG009|Double-Blind Period|Lost to Follow-up|0|||
130888463|NCT02963506|471223753|FG010|Double-Blind Period|Lost to Follow-up|0|||
130888464|NCT02963506|471223754|FG011|Double-Blind Period|Lost to Follow-up|0|||
130888465|NCT02963506|471223755|FG012|Double-Blind Period|Lost to Follow-up|0|||
130888466|NCT02963506|471223743|FG000|Double-Blind Period|Withdrawal by Subject|0|||
130888467|NCT02963506|471223744|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130888468|NCT02963506|471223745|FG002|Double-Blind Period|Withdrawal by Subject|1|||
130888469|NCT02963506|471223746|FG003|Double-Blind Period|Withdrawal by Subject|1|||
130888470|NCT02963506|471223747|FG004|Double-Blind Period|Withdrawal by Subject|0|||
130888471|NCT02963506|471223748|FG005|Double-Blind Period|Withdrawal by Subject|0|||
130888472|NCT02963506|471223749|FG006|Double-Blind Period|Withdrawal by Subject|0|||
130888473|NCT02963506|471223750|FG007|Double-Blind Period|Withdrawal by Subject|0|||
130888474|NCT02963506|471223751|FG008|Double-Blind Period|Withdrawal by Subject|0|||
130888475|NCT02963506|471223752|FG009|Double-Blind Period|Withdrawal by Subject|0|||
130888476|NCT02963506|471223753|FG010|Double-Blind Period|Withdrawal by Subject|0|||
130888477|NCT02963506|471223754|FG011|Double-Blind Period|Withdrawal by Subject|0|||
130888478|NCT02963506|471223755|FG012|Double-Blind Period|Withdrawal by Subject|0|||
130888479|NCT02963506|471223743|FG000|Double-Blind Period|No compliance|0|||
130888480|NCT02963506|471223744|FG001|Double-Blind Period|No compliance|1|||
130888481|NCT02963506|471223745|FG002|Double-Blind Period|No compliance|0|||
130888482|NCT02963506|471223746|FG003|Double-Blind Period|No compliance|0|||
130888483|NCT02963506|471223747|FG004|Double-Blind Period|No compliance|0|||
130888484|NCT02963506|471223748|FG005|Double-Blind Period|No compliance|0|||
130888485|NCT02963506|471223749|FG006|Double-Blind Period|No compliance|0|||
130888486|NCT02963506|471223750|FG007|Double-Blind Period|No compliance|0|||
130888487|NCT02963506|471223751|FG008|Double-Blind Period|No compliance|0|||
130888488|NCT02963506|471223752|FG009|Double-Blind Period|No compliance|0|||
130888489|NCT02963506|471223753|FG010|Double-Blind Period|No compliance|0|||
130888490|NCT02963506|471223754|FG011|Double-Blind Period|No compliance|0|||
130888491|NCT02963506|471223755|FG012|Double-Blind Period|No compliance|0|||
130888492|NCT02963506|471223743|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130888493|NCT02963506|471223744|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
130888494|NCT02963506|471223745|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130888495|NCT02963506|471223746|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131021692|NCT03531840|471711788|FG003|Overall Study|Death during follow up|1|||
131021693|NCT02267824|471711789|FG000|Overall Study|Pregnancy|1|||
131021694|NCT02267824|471711790|FG001|Overall Study|Pregnancy|1|||
131021695|NCT02267824|471711789|FG000|Overall Study|Lost to Follow-up|4|||
131021696|NCT02267824|471711790|FG001|Overall Study|Lost to Follow-up|0|||
130888496|NCT02963506|471223747|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130888497|NCT02963506|471223748|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130888498|NCT02963506|471223749|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130888499|NCT02963506|471223750|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130888500|NCT02963506|471223751|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131021697|NCT02267824|471711789|FG000|Overall Study|Protocol Violation|3|||
131021698|NCT02267824|471711790|FG001|Overall Study|Protocol Violation|0|||
130888501|NCT02963506|471223752|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
131021699|NCT02267824|471711789|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
131222617|NCT00305110|472443119|FG000|Overall Study|Missing data|29|||
130888502|NCT02963506|471223753|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130888503|NCT02963506|471223754|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130888504|NCT02963506|471223755|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130888505|NCT02963506|471223743|FG000|Dose-Blind Period|Adverse Event|0|||
130888506|NCT02963506|471223744|FG001|Dose-Blind Period|Adverse Event|0|||
130888507|NCT02963506|471223745|FG002|Dose-Blind Period|Adverse Event|0|||
130888508|NCT02963506|471223746|FG003|Dose-Blind Period|Adverse Event|0|||
130888509|NCT02963506|471223747|FG004|Dose-Blind Period|Adverse Event|0|||
130888510|NCT02963506|471223748|FG005|Dose-Blind Period|Adverse Event|1|||
130888511|NCT02963506|471223749|FG006|Dose-Blind Period|Adverse Event|3|||
130888512|NCT02963506|471223750|FG007|Dose-Blind Period|Adverse Event|2|||
130888513|NCT02963506|471223751|FG008|Dose-Blind Period|Adverse Event|2|||
130888514|NCT02963506|471223752|FG009|Dose-Blind Period|Adverse Event|2|||
130888515|NCT02963506|471223753|FG010|Dose-Blind Period|Adverse Event|1|||
130888516|NCT02963506|471223754|FG011|Dose-Blind Period|Adverse Event|1|||
130888517|NCT02963506|471223755|FG012|Dose-Blind Period|Adverse Event|6|||
130888518|NCT02963506|471223743|FG000|Dose-Blind Period|Lack of Efficacy|0|||
130888519|NCT02963506|471223744|FG001|Dose-Blind Period|Lack of Efficacy|0|||
130888520|NCT02963506|471223745|FG002|Dose-Blind Period|Lack of Efficacy|0|||
130888521|NCT02963506|471223746|FG003|Dose-Blind Period|Lack of Efficacy|0|||
130888522|NCT02963506|471223747|FG004|Dose-Blind Period|Lack of Efficacy|0|||
130888523|NCT02963506|471223748|FG005|Dose-Blind Period|Lack of Efficacy|0|||
130888524|NCT02963506|471223749|FG006|Dose-Blind Period|Lack of Efficacy|0|||
130888525|NCT02963506|471223750|FG007|Dose-Blind Period|Lack of Efficacy|1|||
130888526|NCT02963506|471223751|FG008|Dose-Blind Period|Lack of Efficacy|0|||
130888527|NCT02963506|471223752|FG009|Dose-Blind Period|Lack of Efficacy|1|||
130888528|NCT02963506|471223753|FG010|Dose-Blind Period|Lack of Efficacy|0|||
130888529|NCT02963506|471223754|FG011|Dose-Blind Period|Lack of Efficacy|0|||
130888530|NCT02963506|471223755|FG012|Dose-Blind Period|Lack of Efficacy|0|||
130888531|NCT02963506|471223743|FG000|Dose-Blind Period|Lost to Follow-up|0|||
130888532|NCT02963506|471223744|FG001|Dose-Blind Period|Lost to Follow-up|0|||
130888533|NCT02963506|471223745|FG002|Dose-Blind Period|Lost to Follow-up|0|||
130888534|NCT02963506|471223746|FG003|Dose-Blind Period|Lost to Follow-up|0|||
130888535|NCT02963506|471223747|FG004|Dose-Blind Period|Lost to Follow-up|0|||
130888536|NCT02963506|471223748|FG005|Dose-Blind Period|Lost to Follow-up|1|||
130888537|NCT02963506|471223749|FG006|Dose-Blind Period|Lost to Follow-up|0|||
130888538|NCT02963506|471223750|FG007|Dose-Blind Period|Lost to Follow-up|0|||
130888539|NCT02963506|471223751|FG008|Dose-Blind Period|Lost to Follow-up|1|||
130888540|NCT02963506|471223752|FG009|Dose-Blind Period|Lost to Follow-up|0|||
130888541|NCT02963506|471223753|FG010|Dose-Blind Period|Lost to Follow-up|0|||
130888542|NCT02963506|471223754|FG011|Dose-Blind Period|Lost to Follow-up|1|||
130888543|NCT02963506|471223755|FG012|Dose-Blind Period|Lost to Follow-up|0|||
130888544|NCT02963506|471223743|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
130888545|NCT02963506|471223744|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
130888546|NCT02963506|471223745|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
130888547|NCT02963506|471223746|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
130888548|NCT02963506|471223747|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
130888549|NCT02963506|471223748|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
130888550|NCT02963506|471223749|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
130888551|NCT02963506|471223750|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
130888552|NCT02963506|471223751|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
130888553|NCT02963506|471223752|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
130888554|NCT02963506|471223753|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
130888555|NCT02963506|471223754|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
131021700|NCT02267824|471711790|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
131021701|NCT03074331|471711791|FG000|Overall Study|Enrolled but Not Treated|1|||
131021702|NCT03074331|471711791|FG000|Overall Study|Lost to Follow-up|5|||
131021703|NCT03074331|471711791|FG000|Overall Study|Withdrew Consent|1|||
130888556|NCT02963506|471223755|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
130888557|NCT02963506|471223743|FG000|Dose-Blind Period|Sponsor decision|0|||
130888558|NCT02963506|471223744|FG001|Dose-Blind Period|Sponsor decision|0|||
130888559|NCT02963506|471223745|FG002|Dose-Blind Period|Sponsor decision|0|||
130888560|NCT02963506|471223746|FG003|Dose-Blind Period|Sponsor decision|0|||
130888561|NCT02963506|471223747|FG004|Dose-Blind Period|Sponsor decision|0|||
131021704|NCT03903822|471711798|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
131021705|NCT03903822|471711799|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
131021706|NCT03903822|471711800|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
130888562|NCT02963506|471223748|FG005|Dose-Blind Period|Sponsor decision|1|||
130888563|NCT02963506|471223749|FG006|Dose-Blind Period|Sponsor decision|0|||
130888564|NCT02963506|471223750|FG007|Dose-Blind Period|Sponsor decision|0|||
130888565|NCT02963506|471223751|FG008|Dose-Blind Period|Sponsor decision|0|||
131021707|NCT03903822|471711801|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
131021708|NCT03903822|471711802|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
130888566|NCT02963506|471223752|FG009|Dose-Blind Period|Sponsor decision|0|||
130888567|NCT02963506|471223753|FG010|Dose-Blind Period|Sponsor decision|0|||
131021709|NCT03903822|471711803|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
130888568|NCT02963506|471223754|FG011|Dose-Blind Period|Sponsor decision|0|||
130888569|NCT02963506|471223755|FG012|Dose-Blind Period|Sponsor decision|0|||
130888570|NCT02963506|471223743|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888571|NCT02963506|471223744|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888572|NCT02963506|471223745|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888573|NCT02963506|471223746|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888574|NCT02963506|471223747|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888575|NCT02963506|471223748|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888576|NCT02963506|471223749|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888577|NCT02963506|471223750|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888578|NCT02963506|471223751|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888579|NCT02963506|471223752|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888580|NCT02963506|471223753|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888581|NCT02963506|471223754|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130888582|NCT02963506|471223755|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
130888583|NCT01780974|471223756|FG000|Overall Study|Death|1|||
130888584|NCT01780974|471223757|FG001|Overall Study|Death|0|||
130888585|NCT01780974|471223756|FG000|Overall Study|Adverse Event|1|||
130888586|NCT01780974|471223757|FG001|Overall Study|Adverse Event|3|||
130888587|NCT01724346|471223758|FG000|Overall Study|Death|42|||
130888588|NCT01724346|471223759|FG001|Overall Study|Death|42|||
130888589|NCT01724346|471223758|FG000|Overall Study|Lost to Follow-up|5|||
130888590|NCT01724346|471223759|FG001|Overall Study|Lost to Follow-up|1|||
130888591|NCT01724346|471223758|FG000|Overall Study|Withdrawal by Subject|27|||
130888592|NCT01724346|471223759|FG001|Overall Study|Withdrawal by Subject|19|||
130888593|NCT01724346|471223758|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
130888594|NCT01724346|471223759|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
130888595|NCT00828204|471223762|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
130888596|NCT00828204|471223763|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
130888597|NCT00828204|471223762|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
130888598|NCT00828204|471223763|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
130888599|NCT00828204|471223762|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
130888600|NCT00828204|471223763|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
130888601|NCT00828204|471223762|FG000|Main Study: After Study Restart|Adverse Event|0|||
130888602|NCT00828204|471223763|FG001|Main Study: After Study Restart|Adverse Event|2|||
130888603|NCT00828204|471223762|FG000|Main Study: After Study Restart|Noncompliance|0|||
130888604|NCT00828204|471223763|FG001|Main Study: After Study Restart|Noncompliance|1|||
130888605|NCT00828204|471223762|FG000|Extension Study|Lost to Follow-up|0|||
130888606|NCT00828204|471223763|FG001|Extension Study|Lost to Follow-up|1|||
130888607|NCT00828204|471223762|FG000|Extension Study|Physician Decision|0|||
130888608|NCT00828204|471223763|FG001|Extension Study|Physician Decision|2|||
130888609|NCT00750438|471223766|FG000|Overall Study|Protocol Violation|4|||
130888610|NCT00750438|471223767|FG001|Overall Study|Protocol Violation|1|||
130888611|NCT00750438|471223766|FG000|Overall Study|Physician Decision|2|||
130888612|NCT00750438|471223767|FG001|Overall Study|Physician Decision|2|||
130888613|NCT00750438|471223766|FG000|Overall Study|Withdrawal by Subject|1|||
130888614|NCT00750438|471223767|FG001|Overall Study|Withdrawal by Subject|1|||
130888615|NCT00928408|471223772|FG000|Overall Study|Other|2|||
130888616|NCT00928408|471223772|FG000|Overall Study|Withdrawal by Subject|4|||
130888617|NCT00928408|471223772|FG000|Overall Study|Death|5|||
131021710|NCT03903822|471711804|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
131021711|NCT03903822|471711805|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
131021712|NCT03903822|471711798|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131021713|NCT03903822|471711799|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131021714|NCT03903822|471711800|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131021715|NCT03903822|471711801|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131021716|NCT03903822|471711802|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
131021717|NCT03903822|471711803|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
131021718|NCT03903822|471711804|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131021719|NCT03903822|471711805|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
131021720|NCT03903822|471711798|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
131021721|NCT03903822|471711799|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
130888618|NCT00928408|471223772|FG000|Overall Study|Lost to Follow-up|12|||
130888619|NCT00536744|471223773|FG000|Overall Study|Adverse Event|13|||
130888620|NCT00536744|471223774|FG001|Overall Study|Adverse Event|10|||
131021722|NCT03903822|471711800|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
130888621|NCT00536744|471223773|FG000|Overall Study|Death|2|||
130888622|NCT00536744|471223774|FG001|Overall Study|Death|1|||
130888623|NCT00536744|471223773|FG000|Overall Study|Physician Decision|3|||
130888624|NCT00536744|471223774|FG001|Overall Study|Physician Decision|1|||
130888625|NCT00536744|471223773|FG000|Overall Study|Lost to Follow-up|3|||
130888626|NCT00536744|471223774|FG001|Overall Study|Lost to Follow-up|5|||
130888627|NCT00536744|471223773|FG000|Overall Study|Withdrawal by Subject|7|||
130888628|NCT00536744|471223774|FG001|Overall Study|Withdrawal by Subject|8|||
130888629|NCT00536744|471223773|FG000|Overall Study|PI tried alternative treatment|1|||
130888630|NCT00536744|471223774|FG001|Overall Study|PI tried alternative treatment|3|||
130888631|NCT00787644|471223775|FG000|Overall Study|Lost to Follow-up|1|||
130888632|NCT00787644|471223776|FG001|Overall Study|Lost to Follow-up|1|||
130888633|NCT00787644|471223775|FG000|Overall Study|Withdrawal by Subject|1|||
130888634|NCT00787644|471223776|FG001|Overall Study|Withdrawal by Subject|1|||
130888635|NCT01642589|471223780|FG000|Overall Study|Withdrawal by Subject|1|||
130888636|NCT01642589|471223781|FG001|Overall Study|Withdrawal by Subject|1|||
130888637|NCT02876601|471223786|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
130888638|NCT02876601|471223787|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
130888639|NCT02876601|471223788|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
130888640|NCT02876601|471223789|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
130888641|NCT00256997|471223792|FG000|Overall Study|Protocol Violation|1|||
130888642|NCT00256997|471223793|FG001|Overall Study|Protocol Violation|4|||
130888643|NCT00256997|471223792|FG000|Overall Study|Lack of Efficacy|1|||
130888644|NCT00256997|471223793|FG001|Overall Study|Lack of Efficacy|4|||
130888645|NCT00256997|471223792|FG000|Overall Study|Death|2|||
130888646|NCT00256997|471223793|FG001|Overall Study|Death|0|||
130888647|NCT00256997|471223792|FG000|Overall Study|Adverse Event|4|||
130888648|NCT00256997|471223793|FG001|Overall Study|Adverse Event|0|||
130888649|NCT00256997|471223792|FG000|Overall Study|Lost to Follow-up|3|||
130888650|NCT00256997|471223793|FG001|Overall Study|Lost to Follow-up|5|||
130888651|NCT00256997|471223792|FG000|Overall Study|Withdrawal by Subject|13|||
130888652|NCT00256997|471223793|FG001|Overall Study|Withdrawal by Subject|3|||
130888653|NCT00256997|471223792|FG000|Overall Study|Started but not treated|2|||
130888654|NCT00256997|471223793|FG001|Overall Study|Started but not treated|0|||
130888655|NCT00256997|471223792|FG000|Overall Study|Other|5|||
130888656|NCT00256997|471223793|FG001|Overall Study|Other|8|||
130888657|NCT00256997|471223792|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
130888658|NCT00256997|471223793|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
130888659|NCT00256997|471223792|FG000|Overall Study|Participant Non-compliant|3|||
130888660|NCT00256997|471223793|FG001|Overall Study|Participant Non-compliant|6|||
130888661|NCT00256997|471223792|FG000|Overall Study|Investigator Withdrew Participant|2|||
130888662|NCT00256997|471223793|FG001|Overall Study|Investigator Withdrew Participant|1|||
130888663|NCT00354432|471223794|FG000|Overall Study|Adverse Event|3|||
130888664|NCT00354432|471223795|FG001|Overall Study|Adverse Event|1|||
130888665|NCT00354432|471223796|FG002|Overall Study|Adverse Event|5|||
130888666|NCT00354432|471223797|FG003|Overall Study|Adverse Event|5|||
130888667|NCT00354432|471223794|FG000|Overall Study|Off/Toxicity|3|||
130888668|NCT00354432|471223795|FG001|Overall Study|Off/Toxicity|7|||
130888669|NCT00354432|471223796|FG002|Overall Study|Off/Toxicity|5|||
130888670|NCT00354432|471223797|FG003|Overall Study|Off/Toxicity|5|||
130888671|NCT02736578|471223798|FG000|Overall Study|Adverse Event|1|||
130888672|NCT02736578|471223799|FG001|Overall Study|Adverse Event|0|||
130888673|NCT02827877|471223802|FG000|Overall Study|Withdrawal by Subject|1|||
130888674|NCT04163016|471223803|FG000|Enrollment|Adverse Event|1|||
130888675|NCT04163016|471223804|FG001|Enrollment|Adverse Event|0|||
130888676|NCT04163016|471223805|FG002|Enrollment|Adverse Event|0|||
130888677|NCT04163016|471223806|FG003|Enrollment|Adverse Event|0|||
130888678|NCT04163016|471223803|FG000|Treatment|Adverse Event|0|||
130888679|NCT04163016|471223804|FG001|Treatment|Adverse Event|1|||
130888680|NCT04163016|471223805|FG002|Treatment|Adverse Event|0|||
130888681|NCT04163016|471223806|FG003|Treatment|Adverse Event|0|||
130888682|NCT04163016|471223803|FG000|Treatment|Withdrawal by Subject|0|||
130888683|NCT04163016|471223804|FG001|Treatment|Withdrawal by Subject|2|||
130888684|NCT04163016|471223805|FG002|Treatment|Withdrawal by Subject|0|||
130888685|NCT04163016|471223806|FG003|Treatment|Withdrawal by Subject|0|||
130888686|NCT04163016|471223803|FG000|Treatment|Indeterminate TB-test|0|||
130888687|NCT04163016|471223804|FG001|Treatment|Indeterminate TB-test|0|||
130888688|NCT04163016|471223805|FG002|Treatment|Indeterminate TB-test|0|||
130888689|NCT04163016|471223806|FG003|Treatment|Indeterminate TB-test|1|||
130888690|NCT04163016|471223803|FG000|Treatment|Participant did not want to continue in study|0|||
130888691|NCT04163016|471223804|FG001|Treatment|Participant did not want to continue in study|0|||
130888692|NCT04163016|471223805|FG002|Treatment|Participant did not want to continue in study|0|||
130888693|NCT04163016|471223806|FG003|Treatment|Participant did not want to continue in study|1|||
130888694|NCT01967238|471223807|FG000|Overall Study|Adverse Event|1|||
130888695|NCT01967238|471223808|FG001|Overall Study|Adverse Event|1|||
130888696|NCT01967238|471223809|FG002|Overall Study|Adverse Event|0|||
130888697|NCT01967238|471223807|FG000|Overall Study|Lost to Follow-up|1|||
130685938|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130685939|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130888698|NCT01967238|471223808|FG001|Overall Study|Lost to Follow-up|0|||
130888699|NCT01967238|471223809|FG002|Overall Study|Lost to Follow-up|1|||
130888700|NCT01967238|471223807|FG000|Overall Study|Withdrawal by Subject|0|||
130888701|NCT01967238|471223808|FG001|Overall Study|Withdrawal by Subject|0|||
130888702|NCT01967238|471223809|FG002|Overall Study|Withdrawal by Subject|1|||
130888703|NCT05232682|471223810|FG000|Overall Study|Lost to Follow-up|2|||
130888704|NCT03387085|471223811|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
130888705|NCT00145158|471225086|FG000|Overall Study|premature withdrawal|2|||
130888706|NCT00145158|471225087|FG001|Overall Study|premature withdrawal|3|||
130888707|NCT03252925|471225088|FG000|Overall Study|Withdrawal by Subject|1|||
130888708|NCT03252925|471225089|FG001|Overall Study|Withdrawal by Subject|0|||
130888709|NCT03252925|471225088|FG000|Overall Study|Protocol Violation|6|||
130888710|NCT03252925|471225089|FG001|Overall Study|Protocol Violation|0|||
130888711|NCT03252925|471225088|FG000|Overall Study|Adverse Event|1|||
130888712|NCT03252925|471225089|FG001|Overall Study|Adverse Event|0|||
130888713|NCT03252925|471225088|FG000|Overall Study|Lost to Follow-up|6|||
130888714|NCT03252925|471225089|FG001|Overall Study|Lost to Follow-up|6|||
130888715|NCT00499616|471225090|FG000|Overall Study|Death|1|||
130888716|NCT00499616|471225091|FG001|Overall Study|Death|5|||
130888717|NCT00499616|471225092|FG002|Overall Study|Death|3|||
130888718|NCT00499616|471225093|FG003|Overall Study|Death|1|||
130888719|NCT00499616|471225090|FG000|Overall Study|Lack of Efficacy|5|||
130888720|NCT00499616|471225091|FG001|Overall Study|Lack of Efficacy|0|||
130888721|NCT00499616|471225092|FG002|Overall Study|Lack of Efficacy|19|||
130888722|NCT00499616|471225093|FG003|Overall Study|Lack of Efficacy|0|||
130888723|NCT00499616|471225090|FG000|Overall Study|Lost to Follow-up|0|||
130888724|NCT00499616|471225091|FG001|Overall Study|Lost to Follow-up|0|||
130888725|NCT00499616|471225092|FG002|Overall Study|Lost to Follow-up|1|||
130888726|NCT00499616|471225093|FG003|Overall Study|Lost to Follow-up|0|||
130888727|NCT00499616|471225090|FG000|Overall Study|Physician Decision|6|||
130888728|NCT00499616|471225091|FG001|Overall Study|Physician Decision|16|||
130888729|NCT00499616|471225092|FG002|Overall Study|Physician Decision|9|||
130888730|NCT00499616|471225093|FG003|Overall Study|Physician Decision|0|||
130888731|NCT00499616|471225090|FG000|Overall Study|Withdrawal by Subject|1|||
130888732|NCT00499616|471225091|FG001|Overall Study|Withdrawal by Subject|0|||
130888733|NCT00499616|471225092|FG002|Overall Study|Withdrawal by Subject|1|||
130888734|NCT00499616|471225093|FG003|Overall Study|Withdrawal by Subject|0|||
130888735|NCT00499616|471225090|FG000|Overall Study|Ineligible|1|||
130888736|NCT00499616|471225091|FG001|Overall Study|Ineligible|2|||
130888737|NCT00499616|471225092|FG002|Overall Study|Ineligible|0|||
130888738|NCT00499616|471225093|FG003|Overall Study|Ineligible|15|||
130888739|NCT00499616|471225090|FG000|Overall Study|Not evaluable|0|||
130888740|NCT00499616|471225091|FG001|Overall Study|Not evaluable|0|||
130888741|NCT00499616|471225092|FG002|Overall Study|Not evaluable|0|||
130888742|NCT00499616|471225093|FG003|Overall Study|Not evaluable|41|||
131021723|NCT03903822|471711801|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
131021724|NCT03903822|471711802|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
131021725|NCT03903822|471711803|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
131021726|NCT03903822|471711804|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
131021727|NCT03903822|471711805|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
131021728|NCT03903822|471711798|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
131021729|NCT03903822|471711799|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
131021730|NCT03903822|471711800|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
131021731|NCT03903822|471711801|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
131021732|NCT03903822|471711802|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
131021733|NCT03903822|471711803|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
131021734|NCT03903822|471711804|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
131021735|NCT03903822|471711805|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
131021736|NCT03903822|471711798|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
131021737|NCT03903822|471711799|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
131021738|NCT03903822|471711800|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
131021739|NCT03903822|471711801|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
131021740|NCT03903822|471711802|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
131021741|NCT03903822|471711803|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
131021742|NCT03903822|471711804|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
131021743|NCT03903822|471711805|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
131021744|NCT03903822|471711798|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131021745|NCT03903822|471711799|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131021746|NCT03903822|471711800|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131021747|NCT03903822|471711801|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
131021748|NCT03903822|471711802|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131021749|NCT03903822|471711803|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
130685940|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130888743|NCT00499616|471225090|FG000|Overall Study|Patient/Parent Refusal|1|||
130888744|NCT00499616|471225091|FG001|Overall Study|Patient/Parent Refusal|5|||
130888745|NCT00499616|471225092|FG002|Overall Study|Patient/Parent Refusal|3|||
130888746|NCT00499616|471225093|FG003|Overall Study|Patient/Parent Refusal|0|||
130888747|NCT00123422|471225094|FG000|Overall Study|Physician Decision|2|||
130888748|NCT00123422|471225095|FG001|Overall Study|Physician Decision|2|||
130888749|NCT00123422|471225096|FG002|Overall Study|Physician Decision|6|||
130888750|NCT00123422|471225094|FG000|Overall Study|Withdrawal by Subject|1|||
130888751|NCT00123422|471225095|FG001|Overall Study|Withdrawal by Subject|2|||
130888752|NCT00123422|471225096|FG002|Overall Study|Withdrawal by Subject|2|||
130888753|NCT00123422|471225094|FG000|Overall Study|Lost to Follow-up|1|||
130888754|NCT00123422|471225095|FG001|Overall Study|Lost to Follow-up|2|||
130888755|NCT00123422|471225096|FG002|Overall Study|Lost to Follow-up|2|||
130888756|NCT04555616|471225099|FG000|Overall Study|Death|1|||
130888757|NCT04555616|471225100|FG001|Overall Study|Death|0|||
130888758|NCT04555616|471225101|FG002|Overall Study|Death|1|||
130888759|NCT04555616|471225099|FG000|Overall Study|Withdrawal by Subject|2|||
130888760|NCT04555616|471225100|FG001|Overall Study|Withdrawal by Subject|1|||
130888761|NCT04555616|471225101|FG002|Overall Study|Withdrawal by Subject|0|||
130888762|NCT01938716|471225102|FG000|Overall Study|Physician Decision|2|||
130888763|NCT01938716|471225102|FG000|Overall Study|Withdrawal by Subject|2|||
130888764|NCT01358721|471225103|FG000|Overall Study|Withdrawal by Subject|0|||
130888765|NCT01358721|471225104|FG001|Overall Study|Withdrawal by Subject|0|||
130888766|NCT01358721|471225105|FG002|Overall Study|Withdrawal by Subject|0|||
130888767|NCT01358721|471225106|FG003|Overall Study|Withdrawal by Subject|1|||
130888768|NCT01358721|471225103|FG000|Overall Study|Death|0|||
130888769|NCT01358721|471225104|FG001|Overall Study|Death|2|||
130888770|NCT01358721|471225105|FG002|Overall Study|Death|0|||
130888771|NCT01358721|471225106|FG003|Overall Study|Death|0|||
130888772|NCT01358721|471225103|FG000|Overall Study|Study Drug Toxicity|1|||
130888773|NCT01358721|471225104|FG001|Overall Study|Study Drug Toxicity|3|||
130888774|NCT01358721|471225105|FG002|Overall Study|Study Drug Toxicity|4|||
130888775|NCT01358721|471225106|FG003|Overall Study|Study Drug Toxicity|5|||
130888776|NCT01358721|471225103|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
130888777|NCT01358721|471225104|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
130888778|NCT01358721|471225105|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
130888779|NCT01358721|471225106|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
130888780|NCT01358721|471225103|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
130888781|NCT01358721|471225104|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
130888782|NCT01358721|471225105|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
130888783|NCT01358721|471225106|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
130888784|NCT01358721|471225103|FG000|Overall Study|Adverse Event related to study drug|1|||
130888785|NCT01358721|471225104|FG001|Overall Study|Adverse Event related to study drug|0|||
130888786|NCT01358721|471225105|FG002|Overall Study|Adverse Event related to study drug|0|||
130888787|NCT01358721|471225106|FG003|Overall Study|Adverse Event related to study drug|1|||
130888788|NCT01358721|471225103|FG000|Overall Study|Disease Progression|19|||
130888789|NCT01358721|471225104|FG001|Overall Study|Disease Progression|15|||
130888790|NCT01358721|471225105|FG002|Overall Study|Disease Progression|17|||
130888791|NCT01358721|471225106|FG003|Overall Study|Disease Progression|15|||
130888792|NCT01358721|471225103|FG000|Overall Study|Out of State/Unmet Criteria|0|||
130888793|NCT01358721|471225104|FG001|Overall Study|Out of State/Unmet Criteria|0|||
130888794|NCT01358721|471225105|FG002|Overall Study|Out of State/Unmet Criteria|1|||
130888795|NCT01358721|471225106|FG003|Overall Study|Out of State/Unmet Criteria|0|||
130888796|NCT01908803|471225107|FG000|Overall Study|Adverse Event|1|||
130888797|NCT01908803|471225108|FG001|Overall Study|Adverse Event|0|||
130888798|NCT01908803|471225107|FG000|Overall Study|Physician Decision|0|||
130888799|NCT01908803|471225108|FG001|Overall Study|Physician Decision|1|||
130888800|NCT01908803|471225107|FG000|Overall Study|Withdrawal by Subject|1|||
130888801|NCT01908803|471225108|FG001|Overall Study|Withdrawal by Subject|0|||
130888802|NCT01908803|471225107|FG000|Overall Study|Randomization Error|1|||
130888803|NCT01908803|471225108|FG001|Overall Study|Randomization Error|0|||
130888804|NCT01908803|471225107|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
130888805|NCT01908803|471225108|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
130888806|NCT00867815|471225109|FG000|Overall Study|Lost to Follow-up|1|||
130888807|NCT00001213|471225110|FG000|Overall Study|Death|18|||
130888808|NCT01554241|471225111|FG000|Overall Study|Death|3|||
130888809|NCT01554241|471225112|FG001|Overall Study|Death|1|||
130888810|NCT01554241|471225113|FG002|Overall Study|Death|1|||
130888811|NCT01554241|471225114|FG003|Overall Study|Death|0|||
130888812|NCT01554241|471225111|FG000|Overall Study|protocol specified renal stone|0|||
130888813|NCT01554241|471225112|FG001|Overall Study|protocol specified renal stone|0|||
131021750|NCT03903822|471711804|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131021751|NCT03903822|471711805|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
131021752|NCT03903822|471711798|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
130888814|NCT01554241|471225113|FG002|Overall Study|protocol specified renal stone|0|||
130888815|NCT01554241|471225114|FG003|Overall Study|protocol specified renal stone|1|||
130888816|NCT01554241|471225111|FG000|Overall Study|protocol specified change in eGFR|0|||
130888817|NCT01554241|471225112|FG001|Overall Study|protocol specified change in eGFR|0|||
130888818|NCT01554241|471225113|FG002|Overall Study|protocol specified change in eGFR|1|||
131021753|NCT03903822|471711799|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
130888819|NCT01554241|471225114|FG003|Overall Study|protocol specified change in eGFR|0|||
130888820|NCT01554241|471225111|FG000|Overall Study|Withdrawal by Subject|0|||
130888821|NCT01554241|471225112|FG001|Overall Study|Withdrawal by Subject|0|||
130888822|NCT01554241|471225113|FG002|Overall Study|Withdrawal by Subject|2|||
130888823|NCT01554241|471225114|FG003|Overall Study|Withdrawal by Subject|0|||
130888824|NCT00372593|471225121|FG000|Overall Study|Adverse Event|43|||
130888825|NCT00372593|471225122|FG001|Overall Study|Adverse Event|45|||
130888826|NCT00372593|471225123|FG002|Overall Study|Adverse Event|0|||
130888827|NCT00372593|471225121|FG000|Overall Study|Death|16|||
130888828|NCT00372593|471225122|FG001|Overall Study|Death|20|||
130888829|NCT00372593|471225123|FG002|Overall Study|Death|1|||
130888830|NCT00372593|471225121|FG000|Overall Study|Lack of Efficacy|82|||
130888831|NCT00372593|471225122|FG001|Overall Study|Lack of Efficacy|71|||
130888832|NCT00372593|471225123|FG002|Overall Study|Lack of Efficacy|2|||
130888833|NCT00372593|471225121|FG000|Overall Study|Lost to Follow-up|1|||
130888834|NCT00372593|471225122|FG001|Overall Study|Lost to Follow-up|0|||
130888835|NCT00372593|471225123|FG002|Overall Study|Lost to Follow-up|0|||
130888836|NCT00372593|471225121|FG000|Overall Study|Physician Decision|42|||
130888837|NCT00372593|471225122|FG001|Overall Study|Physician Decision|41|||
130888838|NCT00372593|471225123|FG002|Overall Study|Physician Decision|0|||
130888839|NCT00372593|471225121|FG000|Overall Study|Ineligible|20|||
130888840|NCT00372593|471225122|FG001|Overall Study|Ineligible|21|||
131021754|NCT03903822|471711800|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
131021755|NCT03903822|471711801|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
131021756|NCT03903822|471711802|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
131021757|NCT03903822|471711803|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
131021758|NCT03903822|471711804|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
131021759|NCT03903822|471711805|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
131021760|NCT03903822|471711798|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
131021761|NCT03903822|471711799|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131021762|NCT03903822|471711800|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131021763|NCT03903822|471711801|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131021764|NCT03903822|471711802|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131021765|NCT03903822|471711803|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
131021766|NCT03903822|471711804|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131021767|NCT03903822|471711805|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
131021768|NCT03903822|471711798|FG000|Treatment Phase (6 Weeks)|Other|2|||
131021769|NCT03903822|471711799|FG001|Treatment Phase (6 Weeks)|Other|1|||
131021770|NCT03903822|471711800|FG002|Treatment Phase (6 Weeks)|Other|0|||
131021771|NCT03903822|471711801|FG003|Treatment Phase (6 Weeks)|Other|0|||
131021772|NCT03903822|471711802|FG004|Treatment Phase (6 Weeks)|Other|1|||
131021773|NCT03903822|471711803|FG005|Treatment Phase (6 Weeks)|Other|1|||
131021774|NCT03903822|471711804|FG006|Treatment Phase (6 Weeks)|Other|0|||
131021775|NCT03903822|471711805|FG007|Treatment Phase (6 Weeks)|Other|0|||
131021776|NCT03903822|471711798|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
131021777|NCT03903822|471711799|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
131021778|NCT03903822|471711800|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
131021779|NCT03903822|471711801|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
131021780|NCT03903822|471711802|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
131021781|NCT03903822|471711803|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
131021782|NCT03903822|471711804|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
131021783|NCT03903822|471711805|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
131021784|NCT03903822|471711798|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131021785|NCT03903822|471711799|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131021786|NCT03903822|471711800|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131021787|NCT03903822|471711801|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131021788|NCT03903822|471711802|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
131021789|NCT03903822|471711803|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131021790|NCT03903822|471711804|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131021791|NCT03903822|471711805|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
131021792|NCT03903822|471711798|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
131021793|NCT03903822|471711799|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
131021794|NCT03903822|471711800|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
131021795|NCT03903822|471711801|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
131021796|NCT03903822|471711802|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
131021797|NCT03903822|471711803|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
131021798|NCT03903822|471711804|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
131021799|NCT03903822|471711805|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
131021800|NCT03903822|471711798|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
130888841|NCT00372593|471225123|FG002|Overall Study|Ineligible|1|||
130888842|NCT00433004|471225124|FG000|Overall Study|Lost to Follow-up|5|||
130888843|NCT00433004|471225125|FG001|Overall Study|Lost to Follow-up|7|||
130888844|NCT03534180|471225126|FG000|Overall Study|Withdrawal by Subject|1|||
130888845|NCT02015637|471225131|FG000|Overall Study|Lost to Follow-up|3|||
130888846|NCT02015637|471225132|FG001|Overall Study|Lost to Follow-up|5|||
130888847|NCT02015637|471225131|FG000|Overall Study|Adverse Event|3|||
130888848|NCT02015637|471225132|FG001|Overall Study|Adverse Event|0|||
130888849|NCT02015637|471225131|FG000|Overall Study|Did not take study drug|2|||
130888850|NCT02015637|471225132|FG001|Overall Study|Did not take study drug|0|||
130888851|NCT02223858|471225135|FG000|Overall Study|Death|1|||
130888852|NCT02223858|471225136|FG001|Overall Study|Death|1|||
130888853|NCT02223858|471225135|FG000|Overall Study|Lost to Follow-up|6|||
130888854|NCT02223858|471225136|FG001|Overall Study|Lost to Follow-up|11|||
130888855|NCT02223858|471225135|FG000|Overall Study|Withdrawal by Subject|8|||
130888856|NCT02223858|471225136|FG001|Overall Study|Withdrawal by Subject|5|||
130888857|NCT02223858|471225135|FG000|Overall Study|Refused|9|||
130888858|NCT02223858|471225136|FG001|Overall Study|Refused|9|||
130888859|NCT04455815|471225137|FG000|Randomisation Phase|Adverse Event|1|||
130888860|NCT04455815|471225138|FG001|Randomisation Phase|Adverse Event|0|||
130888861|NCT04455815|471225137|FG000|Treatment Phase|Adverse Event|0|||
130888862|NCT04455815|471225138|FG001|Treatment Phase|Adverse Event|1|||
130888863|NCT04455815|471225137|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
130888864|NCT04455815|471225138|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
130888865|NCT04455815|471225137|FG000|Treatment Phase|Withdrawal by Subject|1|||
130888866|NCT04455815|471225138|FG001|Treatment Phase|Withdrawal by Subject|1|||
130888867|NCT02106390|471225139|FG000|Overall Study|Withdrawal by Subject|15|||
130888868|NCT02106390|471225140|FG001|Overall Study|Withdrawal by Subject|16|||
130888869|NCT02106390|471225141|FG002|Overall Study|Withdrawal by Subject|15|||
130888870|NCT02106390|471225139|FG000|Overall Study|Lost to Follow-up|25|||
130888871|NCT02106390|471225140|FG001|Overall Study|Lost to Follow-up|20|||
130888872|NCT02106390|471225141|FG002|Overall Study|Lost to Follow-up|13|||
130888873|NCT02106390|471225139|FG000|Overall Study|Other: Administrative Reason|8|||
130888874|NCT02106390|471225140|FG001|Overall Study|Other: Administrative Reason|5|||
130888875|NCT02106390|471225141|FG002|Overall Study|Other: Administrative Reason|12|||
130888876|NCT02106390|471225139|FG000|Overall Study|Other: Unspecified|1|||
130888877|NCT02106390|471225140|FG001|Overall Study|Other: Unspecified|4|||
130888878|NCT02106390|471225141|FG002|Overall Study|Other: Unspecified|2|||
130888879|NCT02106390|471225139|FG000|Overall Study|Adverse Event|0|||
130888880|NCT02106390|471225140|FG001|Overall Study|Adverse Event|2|||
130888881|NCT02106390|471225141|FG002|Overall Study|Adverse Event|1|||
130888882|NCT02106390|471225139|FG000|Overall Study|Protocol Violation|0|||
130888883|NCT02106390|471225140|FG001|Overall Study|Protocol Violation|1|||
130888884|NCT02106390|471225141|FG002|Overall Study|Protocol Violation|0|||
130888885|NCT03198507|471225142|FG000|Overall Study|Withdrawal by Subject|1|||
130888886|NCT03198507|471225143|FG001|Overall Study|Withdrawal by Subject|0|||
130888887|NCT00241839|471225146|FG000|Overall Study|Withdrawal by Subject|18|||
130888888|NCT00241839|471225147|FG001|Overall Study|Withdrawal by Subject|17|||
130888889|NCT00241839|471225146|FG000|Overall Study|Adverse Event|1|||
130888890|NCT00241839|471225147|FG001|Overall Study|Adverse Event|1|||
130888891|NCT01662102|471225150|FG000|Overall Study|Sponsor's decision|1|||
131021801|NCT03903822|471711799|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
131021802|NCT03903822|471711800|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
131021803|NCT03903822|471711801|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
131021804|NCT03903822|471711802|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
131021805|NCT03903822|471711803|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
131021806|NCT03903822|471711804|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
131021807|NCT03903822|471711805|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
131021808|NCT03903822|471711798|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
131021809|NCT03903822|471711799|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
131021810|NCT03903822|471711800|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
131021811|NCT03903822|471711801|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
131021812|NCT03903822|471711802|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
131021813|NCT03903822|471711803|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
131021814|NCT03903822|471711804|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
131021815|NCT03903822|471711805|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
131021816|NCT03903822|471711798|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131021817|NCT03903822|471711799|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131021818|NCT03903822|471711800|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131021819|NCT03903822|471711801|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131021820|NCT03903822|471711802|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131222618|NCT01084603|472443120|FG000|Baseline|Withdrawal by Subject|2|||
130888892|NCT01662102|471225151|FG001|Overall Study|Sponsor's decision|0|||
131021821|NCT03903822|471711803|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
131021822|NCT03903822|471711804|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
131021823|NCT03903822|471711805|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
130888893|NCT02863419|471225152|FG000|Overall Study|Lost to Follow-up|0|||
130888894|NCT02863419|471225153|FG001|Overall Study|Lost to Follow-up|1|||
130888895|NCT02863419|471225154|FG002|Overall Study|Lost to Follow-up|4|||
130888896|NCT02863419|471225152|FG000|Overall Study|Withdrawal by Subject|5|||
130888897|NCT02863419|471225153|FG001|Overall Study|Withdrawal by Subject|5|||
130888898|NCT02863419|471225154|FG002|Overall Study|Withdrawal by Subject|3|||
130888899|NCT02863419|471225152|FG000|Overall Study|Died|3|||
130888900|NCT02863419|471225153|FG001|Overall Study|Died|4|||
130888901|NCT02863419|471225154|FG002|Overall Study|Died|1|||
130888902|NCT02577718|471225157|FG000|Overall Study|Death|6|||
130888903|NCT02577718|471225157|FG000|Overall Study|Withdrawal by Subject|2|||
130888904|NCT01995838|471225158|FG000|Overall Study|Lost to Follow-up|0|||
130888905|NCT01995838|471225159|FG001|Overall Study|Lost to Follow-up|1|||
130888906|NCT01995838|471225160|FG002|Overall Study|Lost to Follow-up|0|||
130888907|NCT01995838|471225161|FG003|Overall Study|Lost to Follow-up|0|||
130888908|NCT01995838|471225162|FG004|Overall Study|Lost to Follow-up|0|||
130888909|NCT01995838|471225163|FG005|Overall Study|Lost to Follow-up|0|||
130888910|NCT01995838|471225164|FG006|Overall Study|Lost to Follow-up|1|||
130888911|NCT01995838|471225158|FG000|Overall Study|Participant choice|2|||
130888912|NCT01995838|471225159|FG001|Overall Study|Participant choice|0|||
130888913|NCT01995838|471225160|FG002|Overall Study|Participant choice|0|||
130888914|NCT01995838|471225161|FG003|Overall Study|Participant choice|0|||
130888915|NCT01995838|471225162|FG004|Overall Study|Participant choice|0|||
130888916|NCT01995838|471225163|FG005|Overall Study|Participant choice|1|||
130888917|NCT01995838|471225164|FG006|Overall Study|Participant choice|1|||
130888918|NCT01995838|471225158|FG000|Overall Study|Adverse Event|0|||
130888919|NCT01995838|471225159|FG001|Overall Study|Adverse Event|0|||
130888920|NCT01995838|471225160|FG002|Overall Study|Adverse Event|0|||
130888921|NCT01995838|471225161|FG003|Overall Study|Adverse Event|0|||
130888922|NCT01995838|471225162|FG004|Overall Study|Adverse Event|0|||
130888923|NCT01995838|471225163|FG005|Overall Study|Adverse Event|0|||
130888924|NCT01995838|471225164|FG006|Overall Study|Adverse Event|1|||
130888925|NCT01995838|471225158|FG000|Overall Study|Withdrawal by Subject|0|||
130888926|NCT01995838|471225159|FG001|Overall Study|Withdrawal by Subject|0|||
130888927|NCT01995838|471225160|FG002|Overall Study|Withdrawal by Subject|0|||
130888928|NCT01995838|471225161|FG003|Overall Study|Withdrawal by Subject|0|||
130888929|NCT01995838|471225162|FG004|Overall Study|Withdrawal by Subject|1|||
130888930|NCT01995838|471225163|FG005|Overall Study|Withdrawal by Subject|0|||
130888931|NCT01995838|471225164|FG006|Overall Study|Withdrawal by Subject|0|||
130888932|NCT01995838|471225158|FG000|Overall Study|Other|3|||
130888933|NCT01995838|471225159|FG001|Overall Study|Other|1|||
130888934|NCT01995838|471225160|FG002|Overall Study|Other|0|||
130888935|NCT01995838|471225161|FG003|Overall Study|Other|2|||
130888936|NCT01995838|471225162|FG004|Overall Study|Other|1|||
130888937|NCT01995838|471225163|FG005|Overall Study|Other|1|||
130888938|NCT01995838|471225164|FG006|Overall Study|Other|2|||
130888939|NCT01519921|471225172|FG000|Overall Study|Adverse Event|10|||
130888940|NCT01519921|471225173|FG001|Overall Study|Adverse Event|9|||
130888941|NCT01519921|471225172|FG000|Overall Study|Lack of Efficacy|4|||
130888942|NCT01519921|471225173|FG001|Overall Study|Lack of Efficacy|3|||
130888943|NCT01519921|471225172|FG000|Overall Study|Withdrawal by Subject|3|||
131106723|NCT04055090|472020921|FG000|Overall Study|screen failure|1|||
131106724|NCT04055090|472020922|FG001|Overall Study|screen failure|0|||
131106725|NCT04055090|472020921|FG000|Overall Study|Withdrawal by Subject|1|||
131106726|NCT04055090|472020922|FG001|Overall Study|Withdrawal by Subject|0|||
131106727|NCT04572841|472020923|FG000|Overall Study|Adverse Event|1|||
131106728|NCT04572841|472020924|FG001|Overall Study|Adverse Event|1|||
131106729|NCT04572841|472020923|FG000|Overall Study|Withdrawal by Subject|2|||
131106730|NCT04572841|472020924|FG001|Overall Study|Withdrawal by Subject|1|||
131106731|NCT06469242|472020925|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
130888944|NCT01519921|471225173|FG001|Overall Study|Withdrawal by Subject|0|||
130888945|NCT01519921|471225172|FG000|Overall Study|Lost to Follow-up|2|||
130888946|NCT01519921|471225173|FG001|Overall Study|Lost to Follow-up|1|||
130888947|NCT01519921|471225172|FG000|Overall Study|Treatment refusal|2|||
130888948|NCT01519921|471225173|FG001|Overall Study|Treatment refusal|1|||
130888949|NCT01519921|471225172|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
130888950|NCT01519921|471225173|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
130888951|NCT00125164|471225176|FG000|Overall Study|Adverse Event|0|||
131106732|NCT06469242|472020926|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
131106733|NCT06469242|472020925|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
131106734|NCT06469242|472020926|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
130685941|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130888952|NCT00125164|471225177|FG001|Overall Study|Adverse Event|0|||
130888953|NCT00125164|471225178|FG002|Overall Study|Adverse Event|2|||
130888954|NCT00125164|471225179|FG003|Overall Study|Adverse Event|4|||
130888955|NCT00125164|471225176|FG000|Overall Study|Lost to Follow-up|0|||
130888956|NCT00125164|471225177|FG001|Overall Study|Lost to Follow-up|0|||
131021824|NCT03903822|471711798|FG000|Follow up Phase (4 Weeks)|Other|1|||
131021825|NCT03903822|471711799|FG001|Follow up Phase (4 Weeks)|Other|1|||
131021826|NCT03903822|471711800|FG002|Follow up Phase (4 Weeks)|Other|0|||
131021827|NCT03903822|471711801|FG003|Follow up Phase (4 Weeks)|Other|0|||
131021828|NCT03903822|471711802|FG004|Follow up Phase (4 Weeks)|Other|0|||
131021829|NCT03903822|471711803|FG005|Follow up Phase (4 Weeks)|Other|0|||
131021830|NCT03903822|471711804|FG006|Follow up Phase (4 Weeks)|Other|0|||
131021831|NCT03903822|471711805|FG007|Follow up Phase (4 Weeks)|Other|0|||
131021832|NCT00546754|471711806|FG000|Overall Study|Serious Adverse Event|1|||
131021833|NCT00546754|471711807|FG001|Overall Study|Serious Adverse Event|1|||
131021834|NCT00546754|471711806|FG000|Overall Study|Adverse Event|11|||
131021835|NCT00546754|471711807|FG001|Overall Study|Adverse Event|16|||
131021836|NCT00546754|471711806|FG000|Overall Study|Lack of Efficacy|1|||
131021837|NCT00546754|471711807|FG001|Overall Study|Lack of Efficacy|1|||
131021838|NCT00546754|471711806|FG000|Overall Study|Lost to Follow-up|9|||
131021839|NCT00546754|471711807|FG001|Overall Study|Lost to Follow-up|15|||
131021840|NCT00546754|471711806|FG000|Overall Study|Protocol Violation|3|||
131021841|NCT00546754|471711807|FG001|Overall Study|Protocol Violation|0|||
131021842|NCT00546754|471711806|FG000|Overall Study|Withdrawal by Subject|6|||
131021843|NCT00546754|471711807|FG001|Overall Study|Withdrawal by Subject|7|||
131021844|NCT00546754|471711806|FG000|Overall Study|Dyspnea|1|||
131021845|NCT00546754|471711807|FG001|Overall Study|Dyspnea|0|||
131021846|NCT00546754|471711806|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
131021847|NCT00546754|471711807|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
131021848|NCT00546754|471711806|FG000|Overall Study|Hip Replacement|1|||
131021849|NCT00546754|471711807|FG001|Overall Study|Hip Replacement|0|||
131021850|NCT00546754|471711806|FG000|Overall Study|Suicide|1|||
131021851|NCT00546754|471711807|FG001|Overall Study|Suicide|0|||
131021852|NCT00546754|471711806|FG000|Overall Study|Missing Cooperation|1|||
131021853|NCT00546754|471711807|FG001|Overall Study|Missing Cooperation|0|||
131021854|NCT00546754|471711806|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
131021855|NCT00546754|471711807|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
131021856|NCT00546754|471711806|FG000|Overall Study|Patient's Decision|0|||
131021857|NCT00546754|471711807|FG001|Overall Study|Patient's Decision|1|||
131021858|NCT00546754|471711806|FG000|Overall Study|Missing|14|||
131021859|NCT00546754|471711807|FG001|Overall Study|Missing|7|||
131021860|NCT05782231|471711809|FG000|Overall Study|Withdrawal by Subject|1|||
131021861|NCT03830866|471711810|FG000|Overall Study|Death|90|||
131021862|NCT03830866|471711811|FG001|Overall Study|Death|111|||
131021863|NCT03830866|471711810|FG000|Overall Study|Lost to Follow-up|7|||
131021864|NCT03830866|471711811|FG001|Overall Study|Lost to Follow-up|7|||
131021865|NCT03830866|471711810|FG000|Overall Study|Withdrawal by Subject|19|||
131021866|NCT03830866|471711811|FG001|Overall Study|Withdrawal by Subject|16|||
131021867|NCT03830866|471711810|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
131021868|NCT03830866|471711811|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
131021869|NCT03830866|471711810|FG000|Overall Study|Other|1|||
131021870|NCT03830866|471711811|FG001|Overall Study|Other|1|||
131021871|NCT00510887|471711813|FG000|Overall Study|Lost to Follow-up|1|||
131021872|NCT03485950|471711816|FG000|Overall Study|Adverse Event|1|||
131021873|NCT03485950|471711817|FG001|Overall Study|Adverse Event|0|||
131021874|NCT03485950|471711816|FG000|Overall Study|Death|3|||
131021875|NCT03485950|471711817|FG001|Overall Study|Death|2|||
131021876|NCT03485950|471711816|FG000|Overall Study|Withdrawal by Subject|3|||
131021877|NCT03485950|471711817|FG001|Overall Study|Withdrawal by Subject|0|||
131021878|NCT03764475|471711819|FG000|Overall Study|Adverse Event|11|||
131021879|NCT03764475|471711820|FG001|Overall Study|Adverse Event|2|||
131021880|NCT03764475|471711819|FG000|Overall Study|Lost to Follow-up|24|||
131021881|NCT03764475|471711820|FG001|Overall Study|Lost to Follow-up|10|||
131021882|NCT03764475|471711819|FG000|Overall Study|Withdrawal by Subject|26|||
131021883|NCT03764475|471711820|FG001|Overall Study|Withdrawal by Subject|10|||
131021884|NCT03764475|471711819|FG000|Overall Study|Lack of Efficacy|3|||
131021885|NCT03764475|471711820|FG001|Overall Study|Lack of Efficacy|0|||
131021886|NCT03764475|471711819|FG000|Overall Study|COVID-19 Disruption|2|||
131021887|NCT03764475|471711820|FG001|Overall Study|COVID-19 Disruption|0|||
131021888|NCT00390299|471711824|FG000|Overall Study|Cancellation|1|||
131021889|NCT00390299|471711825|FG001|Overall Study|Cancellation|0|||
131021890|NCT00390299|471711826|FG002|Overall Study|Cancellation|0|||
131021891|NCT00390299|471711827|FG003|Overall Study|Cancellation|0|||
131021892|NCT00390299|471711828|FG004|Overall Study|Cancellation|0|||
131021893|NCT00970359|471711829|FG000|Overall Study|Not Treated|4|||
131021894|NCT01565148|471711830|FG000|Overall Study|Withdrawal by Subject|1|||
131021895|NCT01565148|471711831|FG001|Overall Study|Withdrawal by Subject|1|||
130685942|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685943|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131021896|NCT01565148|471711832|FG002|Overall Study|Withdrawal by Subject|1|||
131021897|NCT01565148|471711833|FG003|Overall Study|Withdrawal by Subject|2|||
131021898|NCT01565148|471711830|FG000|Overall Study|Lost to Follow-up|4|||
131021899|NCT01565148|471711831|FG001|Overall Study|Lost to Follow-up|4|||
131021900|NCT01565148|471711832|FG002|Overall Study|Lost to Follow-up|0|||
131106735|NCT05041101|472020927|FG000|Overall Study|Adverse Event|1|||
131106736|NCT05041101|472020928|FG001|Overall Study|Adverse Event|0|||
131106737|NCT05041101|472020929|FG002|Overall Study|Adverse Event|0|||
131106738|NCT05041101|472020927|FG000|Overall Study|Diease Progression|5|||
131106739|NCT05041101|472020928|FG001|Overall Study|Diease Progression|0|||
131106740|NCT05041101|472020929|FG002|Overall Study|Diease Progression|0|||
131106741|NCT01205152|472020930|FG000|Overall Study|Death|1|||
131106742|NCT00249002|472020931|FG000|Overall Study|Adverse Event|2|||
131106743|NCT00249002|472020931|FG000|Overall Study|Study cancellation|3|||
131106744|NCT00249002|472020931|FG000|Overall Study|Other|2|||
131106745|NCT04494256|472020932|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
131106746|NCT04494256|472020933|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
131106747|NCT04494256|472020934|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
131106748|NCT04494256|472020935|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
131106749|NCT04494256|472020936|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
131106750|NCT04494256|472020937|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
131106751|NCT04494256|472020938|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
131106752|NCT04494256|472020932|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131106753|NCT04494256|472020933|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131106754|NCT04494256|472020934|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131106755|NCT04494256|472020935|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131106756|NCT04494256|472020936|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
131106757|NCT04494256|472020937|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131106758|NCT04494256|472020938|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
131106759|NCT04494256|472020932|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
131106760|NCT04494256|472020933|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
131106761|NCT04494256|472020934|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
131106762|NCT04494256|472020935|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
131106763|NCT04494256|472020936|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
131106764|NCT04494256|472020937|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
131106765|NCT04494256|472020938|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
131106766|NCT04494256|472020932|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131106767|NCT04494256|472020933|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131106768|NCT04494256|472020934|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131106769|NCT04494256|472020935|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
131106770|NCT04494256|472020936|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
131106771|NCT04494256|472020937|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131106772|NCT04494256|472020938|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131106773|NCT04494256|472020932|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
131106774|NCT04494256|472020933|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
131106775|NCT04494256|472020934|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
131106776|NCT04494256|472020935|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
131106777|NCT04494256|472020936|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
131106778|NCT04494256|472020937|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
131106779|NCT04494256|472020938|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
131106780|NCT04494256|472020932|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
131106781|NCT04494256|472020933|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
131106782|NCT04494256|472020934|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
131106783|NCT04494256|472020935|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
131106784|NCT04494256|472020936|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
131106785|NCT04494256|472020937|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
131106786|NCT04494256|472020938|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
131106787|NCT04494256|472020932|FG000|Part 2: Open Label Period|Death|0|||
131106788|NCT04494256|472020933|FG001|Part 2: Open Label Period|Death|0|||
131106789|NCT04494256|472020934|FG002|Part 2: Open Label Period|Death|0|||
131106790|NCT04494256|472020935|FG003|Part 2: Open Label Period|Death|0|||
131106791|NCT04494256|472020936|FG004|Part 2: Open Label Period|Death|0|||
131106792|NCT04494256|472020937|FG005|Part 2: Open Label Period|Death|4|||
131106793|NCT04494256|472020938|FG006|Part 2: Open Label Period|Death|2|||
131106794|NCT04494256|472020932|FG000|Part 2: Open Label Period|Adverse Event|0|||
131106795|NCT04494256|472020933|FG001|Part 2: Open Label Period|Adverse Event|0|||
131106796|NCT04494256|472020934|FG002|Part 2: Open Label Period|Adverse Event|0|||
131106797|NCT04494256|472020935|FG003|Part 2: Open Label Period|Adverse Event|0|||
131106798|NCT04494256|472020936|FG004|Part 2: Open Label Period|Adverse Event|0|||
131106799|NCT04494256|472020937|FG005|Part 2: Open Label Period|Adverse Event|0|||
130685944|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685945|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131021901|NCT01565148|471711833|FG003|Overall Study|Lost to Follow-up|3|||
131021902|NCT01565148|471711830|FG000|Overall Study|Rescue Therapy|8|||
131021903|NCT01565148|471711831|FG001|Overall Study|Rescue Therapy|5|||
131021904|NCT01565148|471711832|FG002|Overall Study|Rescue Therapy|5|||
131021905|NCT01565148|471711833|FG003|Overall Study|Rescue Therapy|8|||
131021906|NCT01565148|471711830|FG000|Overall Study|Death|0|||
131021907|NCT01565148|471711831|FG001|Overall Study|Death|0|||
131021908|NCT01565148|471711832|FG002|Overall Study|Death|1|||
131021909|NCT01565148|471711833|FG003|Overall Study|Death|0|||
131021910|NCT01565148|471711830|FG000|Overall Study|Physician Decision|2|||
131021911|NCT01565148|471711831|FG001|Overall Study|Physician Decision|5|||
131021912|NCT01565148|471711832|FG002|Overall Study|Physician Decision|0|||
131021913|NCT01565148|471711833|FG003|Overall Study|Physician Decision|0|||
131021914|NCT01061671|471711834|FG000|Overall Study|Withdrawal by Subject|16|||
131021915|NCT01061671|471711835|FG001|Overall Study|Withdrawal by Subject|20|||
131021916|NCT01061671|471711834|FG000|Overall Study|Lost to Follow-up|3|||
131021917|NCT01061671|471711835|FG001|Overall Study|Lost to Follow-up|5|||
131021918|NCT01061671|471711834|FG000|Overall Study|Death|28|||
131021919|NCT01061671|471711835|FG001|Overall Study|Death|30|||
131021920|NCT05368831|471711836|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
131021921|NCT01692730|471711844|FG000|Overall Study|Lost to Follow-up|225|||
131021922|NCT01692730|471711845|FG001|Overall Study|Lost to Follow-up|227|||
131021923|NCT01849055|471711846|FG000|Overall Study|Withdrawal by Subject|0|||
131021924|NCT01849055|471711847|FG001|Overall Study|Withdrawal by Subject|0|||
131021925|NCT01849055|471711848|FG002|Overall Study|Withdrawal by Subject|1|||
131021926|NCT01849055|471711849|FG003|Overall Study|Withdrawal by Subject|0|||
131021927|NCT01849055|471711850|FG004|Overall Study|Withdrawal by Subject|0|||
131021928|NCT01849055|471711851|FG005|Overall Study|Withdrawal by Subject|0|||
131021929|NCT01199575|471711852|FG000|Overall Study|Withdrawal by Subject|5|||
131021930|NCT00223795|471711857|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
131021931|NCT00223795|471711858|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
131021932|NCT00223795|471711857|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
131021933|NCT00223795|471711858|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
131021934|NCT01239316|471711859|FG000|Overall Study|Progression/Relapse|11|||
131021935|NCT01239316|471711859|FG000|Overall Study|Adverse Event|1|||
131021936|NCT02139943|471711860|FG000|Overall Study|Adverse Event|0|||
131021937|NCT02139943|471711861|FG001|Overall Study|Adverse Event|1|||
131021938|NCT02139943|471711862|FG002|Overall Study|Adverse Event|2|||
131021939|NCT02139943|471711860|FG000|Overall Study|Lost to Follow-up|3|||
131021940|NCT02139943|471711861|FG001|Overall Study|Lost to Follow-up|2|||
131021941|NCT02139943|471711862|FG002|Overall Study|Lost to Follow-up|2|||
131021942|NCT02139943|471711860|FG000|Overall Study|Withdrawal by Subject|4|||
131021943|NCT02139943|471711861|FG001|Overall Study|Withdrawal by Subject|3|||
131021944|NCT02139943|471711862|FG002|Overall Study|Withdrawal by Subject|0|||
131021945|NCT02139943|471711860|FG000|Overall Study|Other|0|||
131021946|NCT02139943|471711861|FG001|Overall Study|Other|0|||
131021947|NCT02139943|471711862|FG002|Overall Study|Other|1|||
131021948|NCT02139943|471711860|FG000|Overall Study|Participant wishes to discontinue|2|||
131021949|NCT02139943|471711861|FG001|Overall Study|Participant wishes to discontinue|0|||
131021950|NCT02139943|471711862|FG002|Overall Study|Participant wishes to discontinue|0|||
131021951|NCT02139943|471711860|FG000|Overall Study|Participant in Poor Compliance|1|||
131021952|NCT02139943|471711861|FG001|Overall Study|Participant in Poor Compliance|0|||
131021953|NCT02139943|471711862|FG002|Overall Study|Participant in Poor Compliance|1|||
131021954|NCT02139943|471711860|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
131021955|NCT02139943|471711861|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
131021956|NCT02139943|471711862|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
131021957|NCT03750968|471711865|FG000|Overall Study|Adverse Event|2|||
131021958|NCT03750968|471711866|FG001|Overall Study|Adverse Event|0|||
131021959|NCT03750968|471711865|FG000|Overall Study|Lost to Follow-up|1|||
131021960|NCT03750968|471711866|FG001|Overall Study|Lost to Follow-up|3|||
131021961|NCT00088413|471711869|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
131021962|NCT00088413|471711870|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
131021963|NCT00088413|471711871|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
131021964|NCT00088413|471711872|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
131021965|NCT00088413|471711869|FG000|Overall Study|Adverse Events/Side Effects|0|||
131021966|NCT00088413|471711870|FG001|Overall Study|Adverse Events/Side Effects|1|||
131021967|NCT00088413|471711871|FG002|Overall Study|Adverse Events/Side Effects|1|||
131021968|NCT00088413|471711872|FG003|Overall Study|Adverse Events/Side Effects|0|||
131021969|NCT00088413|471711869|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
131021970|NCT00088413|471711870|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
131021971|NCT00088413|471711871|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
131021972|NCT00088413|471711872|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
131021973|NCT00088413|471711869|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
131021974|NCT00088413|471711870|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
131021975|NCT00088413|471711871|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
131106800|NCT04494256|472020938|FG006|Part 2: Open Label Period|Adverse Event|2|||
131106801|NCT04494256|472020932|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
131106802|NCT04494256|472020933|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
131106803|NCT04494256|472020934|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
131106804|NCT04494256|472020935|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
131106805|NCT04494256|472020936|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
131106806|NCT04494256|472020937|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
131106807|NCT04494256|472020938|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
131106808|NCT04494256|472020932|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131106809|NCT04494256|472020933|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131106810|NCT04494256|472020934|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131106811|NCT04494256|472020935|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131106812|NCT04494256|472020936|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131106813|NCT04494256|472020937|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
131106814|NCT04494256|472020938|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
131106815|NCT04494256|472020932|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
131106816|NCT04494256|472020933|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
131106817|NCT04494256|472020934|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
131106818|NCT04494256|472020935|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
131106819|NCT04494256|472020936|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
131106820|NCT04494256|472020937|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
131106821|NCT04494256|472020938|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
131106822|NCT04494256|472020932|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131106823|NCT04494256|472020933|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131106824|NCT04494256|472020934|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131106825|NCT04494256|472020935|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131106826|NCT04494256|472020936|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
131106827|NCT04494256|472020937|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
131106828|NCT04494256|472020938|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
131106829|NCT04494256|472020932|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
131106830|NCT04494256|472020933|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
131106831|NCT04494256|472020934|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
131106832|NCT04494256|472020935|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
131106833|NCT04494256|472020936|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
131106834|NCT04494256|472020937|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
131106835|NCT04494256|472020938|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
131106836|NCT00986674|472020939|FG000|Overall Study|Lack of Efficacy|28|||
131106837|NCT00986674|472020940|FG001|Overall Study|Lack of Efficacy|25|||
131106838|NCT00986674|472020941|FG002|Overall Study|Lack of Efficacy|23|||
131106839|NCT00986674|472020939|FG000|Overall Study|Adverse Event|4|||
131106840|NCT00986674|472020940|FG001|Overall Study|Adverse Event|8|||
131106841|NCT00986674|472020941|FG002|Overall Study|Adverse Event|9|||
131106842|NCT00986674|472020939|FG000|Overall Study|Death|5|||
131106843|NCT00986674|472020940|FG001|Overall Study|Death|0|||
131106844|NCT00986674|472020941|FG002|Overall Study|Death|4|||
131106845|NCT00986674|472020939|FG000|Overall Study|Withdrawal by Subject|6|||
131106846|NCT00986674|472020940|FG001|Overall Study|Withdrawal by Subject|2|||
131106847|NCT00986674|472020941|FG002|Overall Study|Withdrawal by Subject|1|||
131106848|NCT00986674|472020939|FG000|Overall Study|alternative therapy|0|||
131106849|NCT00986674|472020940|FG001|Overall Study|alternative therapy|0|||
131106850|NCT00986674|472020941|FG002|Overall Study|alternative therapy|1|||
131106851|NCT00986674|472020939|FG000|Overall Study|not start protocol therapy|4|||
131106852|NCT00986674|472020940|FG001|Overall Study|not start protocol therapy|3|||
131106853|NCT00986674|472020941|FG002|Overall Study|not start protocol therapy|1|||
131106854|NCT00986674|472020939|FG000|Overall Study|unknown/not specify|0|||
131106855|NCT00986674|472020940|FG001|Overall Study|unknown/not specify|7|||
131106856|NCT00986674|472020941|FG002|Overall Study|unknown/not specify|9|||
131106857|NCT02128542|472020942|FG000|Overall Study|Lost to Follow-up|3|||
131106858|NCT02128542|472020943|FG001|Overall Study|Lost to Follow-up|0|||
131106859|NCT02128542|472020942|FG000|Overall Study|Withdrew Consent|1|||
131106860|NCT02128542|472020943|FG001|Overall Study|Withdrew Consent|0|||
131106861|NCT02513303|472020944|FG000|Overall Study|Withdrawal by Subject|9|||
131106862|NCT02513303|472020945|FG001|Overall Study|Withdrawal by Subject|7|||
131106863|NCT02513303|472020946|FG002|Overall Study|Withdrawal by Subject|2|||
131106864|NCT02513303|472020944|FG000|Overall Study|Lost to Follow-up|2|||
131106865|NCT02513303|472020945|FG001|Overall Study|Lost to Follow-up|4|||
131106866|NCT02513303|472020946|FG002|Overall Study|Lost to Follow-up|0|||
131106867|NCT02513303|472020944|FG000|Overall Study|Adverse Event|0|||
131106868|NCT02513303|472020945|FG001|Overall Study|Adverse Event|1|||
131106869|NCT02513303|472020946|FG002|Overall Study|Adverse Event|0|||
131106870|NCT02513303|472020944|FG000|Overall Study|Physician Decision|1|||
131106871|NCT02513303|472020945|FG001|Overall Study|Physician Decision|1|||
131106872|NCT02513303|472020946|FG002|Overall Study|Physician Decision|0|||
131106873|NCT02513303|472020944|FG000|Overall Study|Death|8|||
131106874|NCT02513303|472020945|FG001|Overall Study|Death|4|||
131106875|NCT02513303|472020946|FG002|Overall Study|Death|2|||
131106876|NCT06338462|472020950|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
131106877|NCT01551212|472020951|FG000|Overall Study|Graft loss/Retransplantation|0|||
131021976|NCT00088413|471711872|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
131021977|NCT00088413|471711869|FG000|Overall Study|Death|0|||
131021978|NCT00088413|471711870|FG001|Overall Study|Death|1|||
131021979|NCT00088413|471711871|FG002|Overall Study|Death|0|||
131021980|NCT00088413|471711872|FG003|Overall Study|Death|0|||
131021981|NCT00088413|471711869|FG000|Overall Study|Progressive disease|9|||
131021982|NCT00088413|471711870|FG001|Overall Study|Progressive disease|11|||
131021983|NCT00088413|471711871|FG002|Overall Study|Progressive disease|8|||
131021984|NCT00088413|471711872|FG003|Overall Study|Progressive disease|14|||
131021985|NCT00088413|471711869|FG000|Overall Study|Other|0|||
131021986|NCT00088413|471711870|FG001|Overall Study|Other|1|||
131021987|NCT00088413|471711871|FG002|Overall Study|Other|0|||
131021988|NCT00088413|471711872|FG003|Overall Study|Other|0|||
131021989|NCT00088413|471711869|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
131021990|NCT00088413|471711870|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
131021991|NCT00088413|471711871|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
131021992|NCT00088413|471711872|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
131021993|NCT00411216|471711873|FG000|Overall Study|Ten participants were entered into the c|0|||
131021994|NCT00411216|471711874|FG001|Overall Study|Ten participants were entered into the c|2|||
131021995|NCT00632424|471711878|FG000|Overall Study|Disease Progression|17|||
131021996|NCT00632424|471711878|FG000|Overall Study|Study Drug Toxicity|1|||
131021997|NCT02531113|471711879|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
131021998|NCT02531113|471711879|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
131021999|NCT02531113|471711879|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
131022000|NCT02531113|471711879|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
131022001|NCT02531113|471711879|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
131022002|NCT02531113|471711879|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
131022003|NCT02531113|471711879|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
131022004|NCT02531113|471711879|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
131022005|NCT01251354|471711880|FG000|Overall Study|Adverse Event|1|||
131022006|NCT01251354|471711880|FG000|Overall Study|Investigator's Decision|1|||
131022007|NCT01251354|471711880|FG000|Overall Study|Disease Progression|4|||
131022008|NCT03807778|471711881|FG000|Overall Study|Adverse Event|0|||
131022009|NCT03807778|471711882|FG001|Overall Study|Adverse Event|0|||
131022010|NCT03807778|471711883|FG002|Overall Study|Adverse Event|3|||
131022011|NCT03807778|471711884|FG003|Overall Study|Adverse Event|5|||
131022012|NCT03807778|471711881|FG000|Overall Study|Progressive Disease|4|||
131022013|NCT03807778|471711882|FG001|Overall Study|Progressive Disease|2|||
131022014|NCT03807778|471711883|FG002|Overall Study|Progressive Disease|8|||
131022015|NCT03807778|471711884|FG003|Overall Study|Progressive Disease|15|||
131022016|NCT03807778|471711881|FG000|Overall Study|Symptomatic Deterioration|0|||
131022017|NCT03807778|471711882|FG001|Overall Study|Symptomatic Deterioration|1|||
131022018|NCT03807778|471711883|FG002|Overall Study|Symptomatic Deterioration|0|||
131022019|NCT03807778|471711884|FG003|Overall Study|Symptomatic Deterioration|1|||
131022020|NCT03807778|471711881|FG000|Overall Study|Withdrawal by Subject|0|||
131022021|NCT03807778|471711882|FG001|Overall Study|Withdrawal by Subject|1|||
131022022|NCT03807778|471711883|FG002|Overall Study|Withdrawal by Subject|0|||
131022023|NCT03807778|471711884|FG003|Overall Study|Withdrawal by Subject|1|||
131022024|NCT03807778|471711881|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
131022025|NCT03807778|471711882|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
131022026|NCT03807778|471711883|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
131022027|NCT03807778|471711884|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
131106878|NCT01551212|472020952|FG001|Overall Study|Graft loss/Retransplantation|1|||
131106879|NCT01551212|472020951|FG000|Overall Study|Administrative problems|1|||
131106880|NCT01551212|472020952|FG001|Overall Study|Administrative problems|2|||
131106881|NCT01551212|472020951|FG000|Overall Study|Lost to Follow-up|0|||
131106882|NCT01551212|472020952|FG001|Overall Study|Lost to Follow-up|1|||
131106883|NCT01551212|472020951|FG000|Overall Study|Protocol Violation|0|||
131106884|NCT01551212|472020952|FG001|Overall Study|Protocol Violation|1|||
131022028|NCT05094141|471711885|FG000|Overall Study|Death|0|||
131022029|NCT05094141|471711886|FG001|Overall Study|Death|0|||
131022030|NCT05094141|471711887|FG002|Overall Study|Death|1|||
131022031|NCT05094141|471711885|FG000|Overall Study|Withdrawal by Subject|0|||
130767065|NCT01857102|470770713|FG000|Period 1|Lost to Follow-up|0|||
131022032|NCT05094141|471711886|FG001|Overall Study|Withdrawal by Subject|0|||
131022033|NCT05094141|471711887|FG002|Overall Study|Withdrawal by Subject|1|||
131022034|NCT05094141|471711885|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
131022035|NCT05094141|471711886|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
131022036|NCT05094141|471711887|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
131022037|NCT05094141|471711885|FG000|Overall Study|Did not participate in randomization|0|||
131022038|NCT05094141|471711886|FG001|Overall Study|Did not participate in randomization|0|||
131022039|NCT05094141|471711887|FG002|Overall Study|Did not participate in randomization|33|||
131022040|NCT05644444|471713480|FG000|Tolerance Phase|Adverse Event|0|||
131022041|NCT05644444|471713481|FG001|Tolerance Phase|Adverse Event|2|||
131022042|NCT05644444|471713480|FG000|Treatment Phase|Adverse Event|0|||
131022043|NCT05644444|471713481|FG001|Treatment Phase|Adverse Event|2|||
131022044|NCT04817670|471713482|FG000|Overall Study|Withdrawal by Subject|1|||
131022045|NCT04817670|471713483|FG001|Overall Study|Withdrawal by Subject|0|||
131022046|NCT04817670|471713484|FG002|Overall Study|Withdrawal by Subject|0|||
131022047|NCT04817670|471713485|FG003|Overall Study|Withdrawal by Subject|0|||
131022048|NCT04817670|471713486|FG004|Overall Study|Withdrawal by Subject|0|||
131022049|NCT04817670|471713482|FG000|Overall Study|Lost to Follow-up|0|||
131022050|NCT04817670|471713483|FG001|Overall Study|Lost to Follow-up|0|||
131022051|NCT04817670|471713484|FG002|Overall Study|Lost to Follow-up|1|||
131022052|NCT04817670|471713485|FG003|Overall Study|Lost to Follow-up|0|||
131022053|NCT04817670|471713486|FG004|Overall Study|Lost to Follow-up|0|||
131022054|NCT03312907|471713487|FG000|Overall Study|Adverse Event|1|||
131022055|NCT03312907|471713488|FG001|Overall Study|Adverse Event|6|||
131022056|NCT03312907|471713489|FG002|Overall Study|Adverse Event|1|||
131022057|NCT03312907|471713487|FG000|Overall Study|Protocol Violation|2|||
131022058|NCT03312907|471713488|FG001|Overall Study|Protocol Violation|3|||
131022059|NCT03312907|471713489|FG002|Overall Study|Protocol Violation|4|||
131022060|NCT03312907|471713487|FG000|Overall Study|Lost to Follow-up|2|||
131022061|NCT03312907|471713488|FG001|Overall Study|Lost to Follow-up|3|||
131022062|NCT03312907|471713489|FG002|Overall Study|Lost to Follow-up|2|||
131022063|NCT03312907|471713487|FG000|Overall Study|Physician Decision|3|||
131022064|NCT03312907|471713488|FG001|Overall Study|Physician Decision|4|||
131022065|NCT03312907|471713489|FG002|Overall Study|Physician Decision|2|||
131022066|NCT03312907|471713487|FG000|Overall Study|Withdrawal by Subject|9|||
131022067|NCT03312907|471713488|FG001|Overall Study|Withdrawal by Subject|14|||
131022068|NCT03312907|471713489|FG002|Overall Study|Withdrawal by Subject|10|||
131022069|NCT03112174|471713493|FG000|Overall Study|Withdrawal by Subject|3|||
131022070|NCT03112174|471713494|FG001|Overall Study|Withdrawal by Subject|0|||
131022071|NCT03112174|471713495|FG002|Overall Study|Withdrawal by Subject|11|||
131022072|NCT03112174|471713496|FG003|Overall Study|Withdrawal by Subject|9|||
131022073|NCT03112174|471713497|FG004|Overall Study|Withdrawal by Subject|7|||
131022074|NCT03112174|471713493|FG000|Overall Study|Lost to Follow-up|1|||
131022075|NCT03112174|471713494|FG001|Overall Study|Lost to Follow-up|1|||
131022076|NCT03112174|471713495|FG002|Overall Study|Lost to Follow-up|2|||
131022077|NCT03112174|471713496|FG003|Overall Study|Lost to Follow-up|3|||
131022078|NCT03112174|471713497|FG004|Overall Study|Lost to Follow-up|2|||
131022079|NCT03112174|471713493|FG000|Overall Study|Death|8|||
131022080|NCT03112174|471713494|FG001|Overall Study|Death|3|||
131022081|NCT03112174|471713495|FG002|Overall Study|Death|67|||
131022082|NCT03112174|471713496|FG003|Overall Study|Death|73|||
131022083|NCT03112174|471713497|FG004|Overall Study|Death|18|||
131022084|NCT03112174|471713493|FG000|Overall Study|Other, Not Specified|1|||
131022085|NCT03112174|471713494|FG001|Overall Study|Other, Not Specified|0|||
131022086|NCT03112174|471713495|FG002|Overall Study|Other, Not Specified|1|||
131022087|NCT03112174|471713496|FG003|Overall Study|Other, Not Specified|2|||
131022088|NCT03112174|471713497|FG004|Overall Study|Other, Not Specified|0|||
131022089|NCT04259450|471713500|FG000|Overall Study|Adverse event/ Toxicity|0|||
131022090|NCT04259450|471713501|FG001|Overall Study|Adverse event/ Toxicity|3|||
131022091|NCT04259450|471713502|FG002|Overall Study|Adverse event/ Toxicity|0|||
131022092|NCT04259450|471713503|FG003|Overall Study|Adverse event/ Toxicity|1|||
131022093|NCT04259450|471713504|FG004|Overall Study|Adverse event/ Toxicity|0|||
131022094|NCT04259450|471713505|FG005|Overall Study|Adverse event/ Toxicity|0|||
131022095|NCT04259450|471713506|FG006|Overall Study|Adverse event/ Toxicity|0|||
131022096|NCT04259450|471713507|FG007|Overall Study|Adverse event/ Toxicity|1|||
131022097|NCT04259450|471713508|FG008|Overall Study|Adverse event/ Toxicity|0|||
131022098|NCT04259450|471713509|FG009|Overall Study|Adverse event/ Toxicity|3|||
131022099|NCT04259450|471713500|FG000|Overall Study|Disease progression|2|||
131022100|NCT04259450|471713501|FG001|Overall Study|Disease progression|3|||
131022101|NCT04259450|471713502|FG002|Overall Study|Disease progression|4|||
131022102|NCT04259450|471713503|FG003|Overall Study|Disease progression|4|||
131022103|NCT04259450|471713504|FG004|Overall Study|Disease progression|6|||
131022104|NCT04259450|471713505|FG005|Overall Study|Disease progression|6|||
131022105|NCT04259450|471713506|FG006|Overall Study|Disease progression|6|||
131022106|NCT04259450|471713507|FG007|Overall Study|Disease progression|15|||
131022107|NCT04259450|471713508|FG008|Overall Study|Disease progression|6|||
131022108|NCT04259450|471713509|FG009|Overall Study|Disease progression|18|||
131022109|NCT04259450|471713500|FG000|Overall Study|Death|0|||
131022110|NCT04259450|471713501|FG001|Overall Study|Death|0|||
131022111|NCT04259450|471713502|FG002|Overall Study|Death|0|||
131022112|NCT04259450|471713503|FG003|Overall Study|Death|0|||
131022113|NCT04259450|471713504|FG004|Overall Study|Death|0|||
131022114|NCT04259450|471713505|FG005|Overall Study|Death|0|||
131022115|NCT04259450|471713506|FG006|Overall Study|Death|0|||
131022116|NCT04259450|471713507|FG007|Overall Study|Death|1|||
131022117|NCT04259450|471713508|FG008|Overall Study|Death|1|||
131022118|NCT04259450|471713509|FG009|Overall Study|Death|0|||
131022119|NCT04259450|471713500|FG000|Overall Study|Withdrawal by Subject|0|||
131022120|NCT04259450|471713501|FG001|Overall Study|Withdrawal by Subject|0|||
131022121|NCT04259450|471713502|FG002|Overall Study|Withdrawal by Subject|0|||
131022122|NCT04259450|471713503|FG003|Overall Study|Withdrawal by Subject|0|||
131022123|NCT04259450|471713504|FG004|Overall Study|Withdrawal by Subject|0|||
131022124|NCT04259450|471713505|FG005|Overall Study|Withdrawal by Subject|0|||
131022125|NCT04259450|471713506|FG006|Overall Study|Withdrawal by Subject|0|||
131022126|NCT04259450|471713507|FG007|Overall Study|Withdrawal by Subject|1|||
131022127|NCT04259450|471713508|FG008|Overall Study|Withdrawal by Subject|0|||
131022128|NCT04259450|471713509|FG009|Overall Study|Withdrawal by Subject|0|||
131022129|NCT04259450|471713500|FG000|Overall Study|Other than listed|0|||
131022130|NCT04259450|471713501|FG001|Overall Study|Other than listed|0|||
131022131|NCT04259450|471713502|FG002|Overall Study|Other than listed|0|||
131022132|NCT04259450|471713503|FG003|Overall Study|Other than listed|0|||
131022133|NCT04259450|471713504|FG004|Overall Study|Other than listed|0|||
131022134|NCT04259450|471713505|FG005|Overall Study|Other than listed|0|||
131022135|NCT04259450|471713506|FG006|Overall Study|Other than listed|0|||
131022136|NCT04259450|471713507|FG007|Overall Study|Other than listed|1|||
131022137|NCT04259450|471713508|FG008|Overall Study|Other than listed|1|||
131022138|NCT04259450|471713509|FG009|Overall Study|Other than listed|2|||
131022139|NCT01534494|471713516|FG000|Overall Study|Withdrawal by Subject|1|||
131022140|NCT02724592|471713517|FG000|Overall Study|Lost to Follow-up|4|||
131022141|NCT02724592|471713518|FG001|Overall Study|Lost to Follow-up|1|||
131022142|NCT02584829|471713519|FG000|Overall Study|Physician Decision|1|||
131022143|NCT02584829|471713520|FG001|Overall Study|Physician Decision|0|||
131022144|NCT02584829|471713519|FG000|Overall Study|Withdrawal by Subject|0|||
131022145|NCT02584829|471713520|FG001|Overall Study|Withdrawal by Subject|1|||
131022146|NCT02584829|471713519|FG000|Overall Study|Progressive Disease|0|||
131022147|NCT02584829|471713520|FG001|Overall Study|Progressive Disease|3|||
131022148|NCT00434304|471713527|FG000|Overall Study|Adverse Event|14|||
131022149|NCT00434304|471713527|FG000|Overall Study|Lack of Efficacy|2|||
131022150|NCT00434304|471713527|FG000|Overall Study|Withdrawal by Subject|4|||
131022151|NCT05262738|471713528|FG000|Overall Study|Withdrawal by Subject|1|||
131022152|NCT05262738|471713529|FG001|Overall Study|Withdrawal by Subject|0|||
131022153|NCT02374463|471713530|FG000|Overall Study|Withdrawal by Subject|3|||
131022154|NCT02374463|471713531|FG001|Overall Study|Withdrawal by Subject|3|||
131022155|NCT01939899|471713538|FG000|Lead-in Dose Finding Phase|Death|0|||
131022156|NCT01939899|471713539|FG001|Lead-in Dose Finding Phase|Death|3|||
131022157|NCT01939899|471713540|FG002|Lead-in Dose Finding Phase|Death|1|||
131022158|NCT01939899|471713541|FG003|Lead-in Dose Finding Phase|Death|0|||
131022159|NCT01939899|471713542|FG004|Lead-in Dose Finding Phase|Death|0|||
131022160|NCT01939899|471713538|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
131022161|NCT01939899|471713539|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
131022162|NCT01939899|471713540|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
131022163|NCT01939899|471713541|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
131022164|NCT01939899|471713542|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
131022165|NCT01939899|471713538|FG000|Lead-in Dose Finding Phase|Other|0|||
131022166|NCT01939899|471713539|FG001|Lead-in Dose Finding Phase|Other|0|||
131022167|NCT01939899|471713540|FG002|Lead-in Dose Finding Phase|Other|1|||
131022168|NCT01939899|471713541|FG003|Lead-in Dose Finding Phase|Other|0|||
131022169|NCT01939899|471713542|FG004|Lead-in Dose Finding Phase|Other|0|||
131022170|NCT01939899|471713538|FG000|Phase 2|Withdrawal by Subject|0|||
131022171|NCT01939899|471713539|FG001|Phase 2|Withdrawal by Subject|0|||
131022172|NCT01939899|471713540|FG002|Phase 2|Withdrawal by Subject|0|||
131022173|NCT01939899|471713541|FG003|Phase 2|Withdrawal by Subject|2|||
131022174|NCT01939899|471713542|FG004|Phase 2|Withdrawal by Subject|0|||
131022175|NCT01939899|471713538|FG000|Phase 2|Disease Progression|0|||
131022176|NCT01939899|471713539|FG001|Phase 2|Disease Progression|0|||
131022177|NCT01939899|471713540|FG002|Phase 2|Disease Progression|0|||
131022178|NCT01939899|471713541|FG003|Phase 2|Disease Progression|9|||
131022179|NCT01939899|471713542|FG004|Phase 2|Disease Progression|1|||
131022180|NCT00585052|471713543|FG000|Overall Study|Withdrawal by Subject|1|||
131022181|NCT04723394|471713544|FG000|Overall Study|Adverse Event|0|||
131022182|NCT04723394|471713545|FG001|Overall Study|Adverse Event|3|||
131022183|NCT04723394|471713544|FG000|Overall Study|Death|8|||
131022184|NCT04723394|471713545|FG001|Overall Study|Death|8|||
131022185|NCT04723394|471713544|FG000|Overall Study|Lost to Follow-up|20|||
131022186|NCT04723394|471713545|FG001|Overall Study|Lost to Follow-up|17|||
131022187|NCT04723394|471713544|FG000|Overall Study|Physician Decision|1|||
131022188|NCT04723394|471713545|FG001|Overall Study|Physician Decision|0|||
130767066|NCT01857102|470770714|FG001|Period 1|Lost to Follow-up|3|||
131022189|NCT04723394|471713544|FG000|Overall Study|Withdrawal by Subject|20|||
131106885|NCT01551212|472020951|FG000|Overall Study|Withdrawal by Subject|0|||
131106886|NCT01551212|472020952|FG001|Overall Study|Withdrawal by Subject|7|||
131106887|NCT01551212|472020951|FG000|Overall Study|Death|2|||
131106888|NCT01551212|472020952|FG001|Overall Study|Death|4|||
131106889|NCT01551212|472020951|FG000|Overall Study|Never Received Study Treatment|2|||
131106890|NCT01551212|472020952|FG001|Overall Study|Never Received Study Treatment|4|||
131106891|NCT03816332|472020953|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
131106892|NCT03816332|472020953|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
131106911|NCT05182125|472020958|FG000|Overall Study|Withdrawal by Subject|0|||
131106912|NCT05182125|472020959|FG001|Overall Study|Withdrawal by Subject|0|||
131106913|NCT05182125|472020960|FG002|Overall Study|Withdrawal by Subject|0|||
131106914|NCT05182125|472020961|FG003|Overall Study|Withdrawal by Subject|0|||
131106915|NCT05182125|472020962|FG004|Overall Study|Withdrawal by Subject|2|||
131106916|NCT05182125|472020963|FG005|Overall Study|Withdrawal by Subject|0|||
131106917|NCT05182125|472020958|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
131106918|NCT05182125|472020959|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
131106919|NCT05182125|472020960|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
131106920|NCT05182125|472020961|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
131106921|NCT05182125|472020962|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
131106922|NCT05182125|472020963|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
131106923|NCT05182125|472020958|FG000|Overall Study|Death|0|||
131106924|NCT05182125|472020959|FG001|Overall Study|Death|0|||
131106925|NCT05182125|472020960|FG002|Overall Study|Death|0|||
131106926|NCT05182125|472020961|FG003|Overall Study|Death|0|||
131106927|NCT05182125|472020962|FG004|Overall Study|Death|1|||
131106928|NCT05182125|472020963|FG005|Overall Study|Death|0|||
131106929|NCT03464097|472020968|FG000|Overall Study|Withdrawal by Subject|15|||
131106930|NCT03464097|472020969|FG001|Overall Study|Withdrawal by Subject|13|||
131106931|NCT03464097|472020970|FG002|Overall Study|Withdrawal by Subject|11|||
131106932|NCT03464097|472020968|FG000|Overall Study|Study terminated by sponsor|47|||
131106933|NCT03464097|472020969|FG001|Overall Study|Study terminated by sponsor|44|||
131106934|NCT03464097|472020970|FG002|Overall Study|Study terminated by sponsor|40|||
131106935|NCT03464097|472020968|FG000|Overall Study|Pregnancy|0|||
131106936|NCT03464097|472020969|FG001|Overall Study|Pregnancy|1|||
131106937|NCT03464097|472020970|FG002|Overall Study|Pregnancy|0|||
131106938|NCT03464097|472020968|FG000|Overall Study|Other reasons|5|||
131106939|NCT03464097|472020969|FG001|Overall Study|Other reasons|12|||
131106940|NCT03464097|472020970|FG002|Overall Study|Other reasons|14|||
131106941|NCT03464097|472020968|FG000|Overall Study|Lost to Follow-up|0|||
131106942|NCT03464097|472020969|FG001|Overall Study|Lost to Follow-up|1|||
131106943|NCT03464097|472020970|FG002|Overall Study|Lost to Follow-up|1|||
131106944|NCT03464097|472020968|FG000|Overall Study|Lack of Efficacy|11|||
131106945|NCT03464097|472020969|FG001|Overall Study|Lack of Efficacy|18|||
131106946|NCT03464097|472020970|FG002|Overall Study|Lack of Efficacy|30|||
131106947|NCT03464097|472020968|FG000|Overall Study|Death|1|||
131106948|NCT03464097|472020969|FG001|Overall Study|Death|0|||
131106949|NCT03464097|472020970|FG002|Overall Study|Death|0|||
131106950|NCT03464097|472020968|FG000|Overall Study|Adverse Event|13|||
131106951|NCT03464097|472020969|FG001|Overall Study|Adverse Event|6|||
130685946|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
131106952|NCT03464097|472020970|FG002|Overall Study|Adverse Event|8|||
131106953|NCT03035201|472020971|FG000|Overall Study|Death|9|||
131106954|NCT03035201|472020972|FG001|Overall Study|Death|12|||
131106955|NCT03035201|472020973|FG002|Overall Study|Death|9|||
131106956|NCT03035201|472020974|FG003|Overall Study|Death|10|||
131106957|NCT03035201|472020971|FG000|Overall Study|Withdrawal by Subject|51|||
131106958|NCT03035201|472020972|FG001|Overall Study|Withdrawal by Subject|49|||
131106959|NCT03035201|472020973|FG002|Overall Study|Withdrawal by Subject|37|||
131106960|NCT03035201|472020974|FG003|Overall Study|Withdrawal by Subject|46|||
131106961|NCT03035201|472020971|FG000|Overall Study|Lost to Follow-up|67|||
131106962|NCT03035201|472020972|FG001|Overall Study|Lost to Follow-up|51|||
131106963|NCT03035201|472020973|FG002|Overall Study|Lost to Follow-up|64|||
131106964|NCT03035201|472020974|FG003|Overall Study|Lost to Follow-up|69|||
131106965|NCT05445843|472020975|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
131106966|NCT05445843|472020976|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
131106967|NCT05445843|472020975|FG000|Overall Study|Progressive disease|17|||
131106968|NCT05445843|472020976|FG001|Overall Study|Progressive disease|9|||
131106969|NCT05445843|472020975|FG000|Overall Study|Physician Decision|16|||
131106970|NCT05445843|472020976|FG001|Overall Study|Physician Decision|4|||
131106971|NCT05445843|472020975|FG000|Overall Study|Death|6|||
131106972|NCT05445843|472020976|FG001|Overall Study|Death|3|||
131106973|NCT05445843|472020975|FG000|Overall Study|Subject decision|6|||
131106974|NCT05445843|472020976|FG001|Overall Study|Subject decision|2|||
131106975|NCT05445843|472020975|FG000|Overall Study|Adverse Event|2|||
131106976|NCT05445843|472020976|FG001|Overall Study|Adverse Event|0|||
131106977|NCT04469270|472020977|FG000|Overall Study|Adverse Event|2|||
131106978|NCT04469270|472020978|FG001|Overall Study|Adverse Event|0|||
131106979|NCT04469270|472020977|FG000|Overall Study|Lost to Follow-up|4|||
131106980|NCT04469270|472020978|FG001|Overall Study|Lost to Follow-up|3|||
131106981|NCT04469270|472020977|FG000|Overall Study|Withdrawal by Subject|7|||
131106982|NCT04469270|472020978|FG001|Overall Study|Withdrawal by Subject|3|||
131106983|NCT04469270|472020977|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
131106984|NCT04469270|472020978|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
131106985|NCT04469270|472020977|FG000|Overall Study|missing|1|||
131106986|NCT04469270|472020978|FG001|Overall Study|missing|0|||
131106987|NCT04576455|472020979|FG000|Overall Study|Ongoing in the Study|48|||
131106988|NCT04576455|472020980|FG001|Overall Study|Ongoing in the Study|58|||
131106989|NCT04576455|472020979|FG000|Overall Study|Death|83|||
131106990|NCT04576455|472020980|FG001|Overall Study|Death|77|||
131106991|NCT04576455|472020979|FG000|Overall Study|Lost to Follow-up|4|||
131106992|NCT04576455|472020980|FG001|Overall Study|Lost to Follow-up|5|||
131106993|NCT04576455|472020979|FG000|Overall Study|Withdrawal by Subject|16|||
131106994|NCT04576455|472020980|FG001|Overall Study|Withdrawal by Subject|12|||
131106995|NCT02186847|472020981|FG000|Overall Study|Protocol Violation|3|||
131106996|NCT02186847|472020982|FG001|Overall Study|Protocol Violation|0|||
131106997|NCT03319849|472020983|FG000|Overall Study|Adverse Event|1|||
131106998|NCT03319849|472020984|FG001|Overall Study|Adverse Event|0|||
131106999|NCT03319849|472020983|FG000|Overall Study|Physician Decision|0|||
131107000|NCT03319849|472020984|FG001|Overall Study|Physician Decision|1|||
131107001|NCT03319849|472020983|FG000|Overall Study|Withdrawal by Subject|0|||
131107002|NCT03319849|472020984|FG001|Overall Study|Withdrawal by Subject|1|||
131107003|NCT03319849|472020983|FG000|Overall Study|COVID-19|0|||
131107004|NCT03319849|472020984|FG001|Overall Study|COVID-19|1|||
131107005|NCT03319849|472020983|FG000|Overall Study|Other|1|||
131107006|NCT03319849|472020984|FG001|Overall Study|Other|2|||
131107007|NCT03319849|472020983|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
131107008|NCT03319849|472020984|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
131107009|NCT03319849|472020983|FG000|Overall Study|Lost to Follow-up|0|||
131107010|NCT03319849|472020984|FG001|Overall Study|Lost to Follow-up|2|||
131107011|NCT02254278|472020985|FG000|Overall Study|Protocol Violation|1|||
131107012|NCT02254278|472020986|FG001|Overall Study|Protocol Violation|1|||
131107013|NCT05774197|472020989|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
131107014|NCT03727438|472020994|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
131107015|NCT03727438|472020995|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
131107016|NCT03727438|472020994|FG000|Intervention Period|Excluded (health)|1|||
131107017|NCT03727438|472020995|FG001|Intervention Period|Excluded (health)|0|||
131107018|NCT03727438|472020994|FG000|Intervention Period|Withdrawal by Subject|3|||
131107019|NCT03727438|472020995|FG001|Intervention Period|Withdrawal by Subject|1|||
131107020|NCT03727438|472020994|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
131107021|NCT03727438|472020995|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
131107022|NCT03727438|472020994|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
131107023|NCT03727438|472020995|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
131107024|NCT03727438|472020994|FG000|8 Week Assessment|Withdrawal by Subject|6|||
131107025|NCT03727438|472020995|FG001|8 Week Assessment|Withdrawal by Subject|1|||
131107026|NCT03727438|472020994|FG000|6 mo Assessment|did not complete assessment|10|||
131107027|NCT03727438|472020995|FG001|6 mo Assessment|did not complete assessment|11|||
131107028|NCT04647253|472020996|FG000|Overall Study|Death ≤ 365 Days|16|||
131107029|NCT04647253|472020997|FG001|Overall Study|Death ≤ 365 Days|7|||
131107030|NCT04647253|472020996|FG000|Overall Study|Physician Decision|0|||
131107031|NCT04647253|472020997|FG001|Overall Study|Physician Decision|1|||
131107032|NCT04647253|472020996|FG000|Overall Study|Withdrawal by Subject|7|||
131107033|NCT04647253|472020997|FG001|Overall Study|Withdrawal by Subject|2|||
131107034|NCT04647253|472020996|FG000|Overall Study|Missed 12-Month Visit|9|||
131107035|NCT04647253|472020997|FG001|Overall Study|Missed 12-Month Visit|7|||
130888957|NCT00125164|471225178|FG002|Overall Study|Lost to Follow-up|1|||
130888958|NCT00125164|471225179|FG003|Overall Study|Lost to Follow-up|1|||
130888959|NCT00125164|471225176|FG000|Overall Study|Withdrawal by Subject|2|||
131022190|NCT04723394|471713545|FG001|Overall Study|Withdrawal by Subject|34|||
131022191|NCT04723394|471713544|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
131022192|NCT04723394|471713545|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
131022193|NCT00774397|471713546|FG000|Overall Study|Adverse Event|1|||
131022194|NCT00774397|471713547|FG001|Overall Study|Adverse Event|3|||
131022195|NCT00774397|471713548|FG002|Overall Study|Adverse Event|16|||
131022196|NCT00774397|471713549|FG003|Overall Study|Adverse Event|8|||
131022197|NCT00774397|471713550|FG004|Overall Study|Adverse Event|8|||
131022198|NCT00774397|471713551|FG005|Overall Study|Adverse Event|3|||
131022199|NCT00774397|471713552|FG006|Overall Study|Adverse Event|16|||
131022200|NCT00774397|471713546|FG000|Overall Study|Lack of Efficacy|11|||
131022201|NCT00774397|471713547|FG001|Overall Study|Lack of Efficacy|4|||
131022202|NCT00774397|471713548|FG002|Overall Study|Lack of Efficacy|5|||
131022203|NCT00774397|471713549|FG003|Overall Study|Lack of Efficacy|3|||
131022204|NCT00774397|471713550|FG004|Overall Study|Lack of Efficacy|27|||
131022205|NCT00774397|471713551|FG005|Overall Study|Lack of Efficacy|15|||
131022206|NCT00774397|471713552|FG006|Overall Study|Lack of Efficacy|9|||
131022207|NCT00774397|471713546|FG000|Overall Study|Protocol Violation|0|||
131022208|NCT00774397|471713547|FG001|Overall Study|Protocol Violation|1|||
131022209|NCT00774397|471713548|FG002|Overall Study|Protocol Violation|3|||
131022210|NCT00774397|471713549|FG003|Overall Study|Protocol Violation|1|||
131022211|NCT00774397|471713550|FG004|Overall Study|Protocol Violation|2|||
131022212|NCT00774397|471713551|FG005|Overall Study|Protocol Violation|1|||
131022213|NCT00774397|471713552|FG006|Overall Study|Protocol Violation|0|||
131022214|NCT00774397|471713546|FG000|Overall Study|Lost to Follow-up|0|||
131022215|NCT00774397|471713547|FG001|Overall Study|Lost to Follow-up|1|||
131022216|NCT00774397|471713548|FG002|Overall Study|Lost to Follow-up|1|||
131022217|NCT00774397|471713549|FG003|Overall Study|Lost to Follow-up|1|||
131022218|NCT00774397|471713550|FG004|Overall Study|Lost to Follow-up|0|||
131022219|NCT00774397|471713551|FG005|Overall Study|Lost to Follow-up|1|||
131022220|NCT00774397|471713552|FG006|Overall Study|Lost to Follow-up|0|||
131022221|NCT00774397|471713546|FG000|Overall Study|Refused to continue trial medication|1|||
131022222|NCT00774397|471713547|FG001|Overall Study|Refused to continue trial medication|3|||
131022223|NCT00774397|471713548|FG002|Overall Study|Refused to continue trial medication|2|||
131022224|NCT00774397|471713549|FG003|Overall Study|Refused to continue trial medication|2|||
131022225|NCT00774397|471713550|FG004|Overall Study|Refused to continue trial medication|6|||
131022226|NCT00774397|471713551|FG005|Overall Study|Refused to continue trial medication|2|||
131022227|NCT00774397|471713552|FG006|Overall Study|Refused to continue trial medication|3|||
131022228|NCT00774397|471713546|FG000|Overall Study|Not treated|0|||
131022229|NCT00774397|471713547|FG001|Overall Study|Not treated|0|||
131022230|NCT00774397|471713548|FG002|Overall Study|Not treated|0|||
131022231|NCT00774397|471713549|FG003|Overall Study|Not treated|0|||
131022232|NCT00774397|471713550|FG004|Overall Study|Not treated|1|||
131022233|NCT00774397|471713551|FG005|Overall Study|Not treated|0|||
131022234|NCT00774397|471713552|FG006|Overall Study|Not treated|1|||
131022235|NCT00774397|471713546|FG000|Overall Study|Other than those stated above|1|||
131022236|NCT00774397|471713547|FG001|Overall Study|Other than those stated above|1|||
131022237|NCT00774397|471713548|FG002|Overall Study|Other than those stated above|3|||
131022238|NCT00774397|471713549|FG003|Overall Study|Other than those stated above|2|||
131022239|NCT00774397|471713550|FG004|Overall Study|Other than those stated above|2|||
131022240|NCT00774397|471713551|FG005|Overall Study|Other than those stated above|0|||
131022241|NCT00774397|471713552|FG006|Overall Study|Other than those stated above|1|||
131022242|NCT00858117|471713554|FG000|Treatment on Study|Adverse Event|2|||
131022243|NCT00858117|471713554|FG000|Follow up for 5 Years|Death|4|||
131022244|NCT00858117|471713554|FG000|Follow up for 5 Years|No further data collected for study|9|||
131022245|NCT02765100|471713557|FG000|Overall Study|subject found ineligible after baseline|1|||
131022246|NCT02765100|471713558|FG001|Overall Study|subject found ineligible after baseline|1|||
131022247|NCT02765100|471713557|FG000|Overall Study|Lost to Follow-up|0|||
131022248|NCT02765100|471713558|FG001|Overall Study|Lost to Follow-up|1|||
131022249|NCT02652442|471713559|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
131022250|NCT00106080|471713565|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
131022251|NCT00106080|471713566|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
131022252|NCT01061151|471713567|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
130888960|NCT00125164|471225177|FG001|Overall Study|Withdrawal by Subject|0|||
131022253|NCT01061151|471713568|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
131022254|NCT01061151|471713569|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
131022255|NCT01061151|471713570|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
131022256|NCT01061151|471713567|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
131022257|NCT01061151|471713568|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
131022258|NCT01061151|471713569|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
131022259|NCT01061151|471713570|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
131107036|NCT04647253|472020996|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
131107037|NCT04647253|472020997|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
131107038|NCT06729606|472021000|FG000|Overall Study|Adverse Event|0|||
131107039|NCT06729606|472021001|FG001|Overall Study|Adverse Event|2|||
131107040|NCT06729606|472021000|FG000|Overall Study|Death|1|||
131107041|NCT06729606|472021001|FG001|Overall Study|Death|0|||
131107042|NCT06729606|472021000|FG000|Overall Study|Physician Decision|0|||
131107043|NCT06729606|472021001|FG001|Overall Study|Physician Decision|1|||
131107044|NCT06729606|472021000|FG000|Overall Study|Withdrawal by Subject|2|||
131107045|NCT06729606|472021001|FG001|Overall Study|Withdrawal by Subject|4|||
131107046|NCT04873232|472021002|FG000|Overall Study|Lost to Follow-up|1|||
130685947|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685948|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685949|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130685950|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130685951|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130685952|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
131107047|NCT04873232|472021003|FG001|Overall Study|Lost to Follow-up|4|||
131107048|NCT04873232|472021002|FG000|Overall Study|Withdrawal by Subject|1|||
131107049|NCT04873232|472021003|FG001|Overall Study|Withdrawal by Subject|0|||
131107050|NCT05437510|472021004|FG000|Overall Study|Adverse Event|2|||
131107051|NCT05437510|472021005|FG001|Overall Study|Adverse Event|1|||
131107052|NCT05437510|472021004|FG000|Overall Study|Protocol Deviation|1|||
131107053|NCT05437510|472021005|FG001|Overall Study|Protocol Deviation|6|||
131107054|NCT05437510|472021004|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
131107055|NCT05437510|472021005|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
131107056|NCT05437510|472021004|FG000|Overall Study|Lost to Follow-up|265|||
131107057|NCT05437510|472021005|FG001|Overall Study|Lost to Follow-up|358|||
131107058|NCT01640054|472022188|FG000|Overall Study|Study-specific disc criteria|1|||
131107059|NCT01640054|472022188|FG000|Overall Study|Lack of Efficacy|3|||
131107060|NCT01640054|472022188|FG000|Overall Study|Adverse Event|2|||
131107061|NCT05220254|472022190|FG000|Overall Study|Withdrawal by Subject|4|||
131107062|NCT05220254|472022190|FG000|Overall Study|Removed due to ineligibility|1|||
131107063|NCT05220254|472022190|FG000|Overall Study|Lost to Follow-up|7|||
131107064|NCT01557283|472022191|FG000|Overall Study|Lost to Follow-up|7|||
131107065|NCT01557283|472022191|FG000|Overall Study|Non-responder|19|||
131107066|NCT01557283|472022191|FG000|Overall Study|Adverse Event|7|||
131107067|NCT01557283|472022191|FG000|Overall Study|Lack of Efficacy|1|||
131107068|NCT01557283|472022191|FG000|Overall Study|Non-compliance|1|||
131107069|NCT01557283|472022191|FG000|Overall Study|Withdrawal by Subject|1|||
131107070|NCT01557283|472022191|FG000|Overall Study|Participant's weight too high for dose|1|||
131107071|NCT01557283|472022191|FG000|Overall Study|Worsening of psoriasis|1|||
131107072|NCT01557283|472022191|FG000|Overall Study|Other|6|||
131107073|NCT00250679|472022192|FG000|Overall Study|Adverse Event|12|||
131107074|NCT00250679|472022193|FG001|Overall Study|Adverse Event|15|||
131107075|NCT00250679|472022194|FG002|Overall Study|Adverse Event|16|||
131107076|NCT00250679|472022192|FG000|Overall Study|Protocol Violation|2|||
131107077|NCT00250679|472022193|FG001|Overall Study|Protocol Violation|4|||
131107078|NCT00250679|472022194|FG002|Overall Study|Protocol Violation|3|||
131107079|NCT00250679|472022192|FG000|Overall Study|Withdrawal by Subject|15|||
131107080|NCT00250679|472022193|FG001|Overall Study|Withdrawal by Subject|18|||
131107081|NCT00250679|472022194|FG002|Overall Study|Withdrawal by Subject|15|||
131107082|NCT00250679|472022192|FG000|Overall Study|Lost to Follow-up|3|||
131107083|NCT00250679|472022193|FG001|Overall Study|Lost to Follow-up|4|||
131107084|NCT00250679|472022194|FG002|Overall Study|Lost to Follow-up|2|||
131107085|NCT00250679|472022192|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
131107086|NCT00250679|472022193|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
131107087|NCT00250679|472022194|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
131107088|NCT00250679|472022192|FG000|Overall Study|Lack of Efficacy|0|||
131107089|NCT00250679|472022193|FG001|Overall Study|Lack of Efficacy|1|||
131107090|NCT00250679|472022194|FG002|Overall Study|Lack of Efficacy|3|||
131107091|NCT00250679|472022192|FG000|Overall Study|Technical Holter issues|1|||
131107092|NCT00250679|472022193|FG001|Overall Study|Technical Holter issues|0|||
131107093|NCT00250679|472022194|FG002|Overall Study|Technical Holter issues|2|||
131107094|NCT00250679|472022192|FG000|Overall Study|Moved|1|||
131107095|NCT00250679|472022193|FG001|Overall Study|Moved|1|||
131107096|NCT00250679|472022194|FG002|Overall Study|Moved|0|||
131107097|NCT00250679|472022192|FG000|Overall Study|Non-compliance|1|||
131107098|NCT00250679|472022193|FG001|Overall Study|Non-compliance|1|||
131107099|NCT00250679|472022194|FG002|Overall Study|Non-compliance|0|||
130685953|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130767067|NCT01857102|470770713|FG000|Period 1|Unsatisfactory Lens Fit|1|||
131107100|NCT00250679|472022192|FG000|Overall Study|various single events: hip surgery,diary|3|||
131107101|NCT00250679|472022193|FG001|Overall Study|various single events: hip surgery,diary|1|||
131107102|NCT00250679|472022194|FG002|Overall Study|various single events: hip surgery,diary|1|||
131107103|NCT00448279|472022196|FG000|Overall Study|Lost to Follow-up|2|||
131107104|NCT00448279|472022197|FG001|Overall Study|Lost to Follow-up|2|||
131107105|NCT00448279|472022196|FG000|Overall Study|Adverse Event|1|||
131107106|NCT00448279|472022197|FG001|Overall Study|Adverse Event|1|||
131107107|NCT00448279|472022196|FG000|Overall Study|Disease progression|16|||
131107108|NCT00448279|472022197|FG001|Overall Study|Disease progression|18|||
131107109|NCT00448279|472022196|FG000|Overall Study|Withdrawal by Subject|4|||
131107110|NCT00448279|472022197|FG001|Overall Study|Withdrawal by Subject|3|||
131107111|NCT00448279|472022196|FG000|Overall Study|Other|6|||
131107112|NCT00448279|472022197|FG001|Overall Study|Other|4|||
131107113|NCT00448279|472022196|FG000|Overall Study|Protocol Violation|0|||
131107114|NCT00448279|472022197|FG001|Overall Study|Protocol Violation|1|||
131107115|NCT03907410|472022198|FG000|Overall Study|Lost to Follow-up|4|||
131107116|NCT03907410|472022199|FG001|Overall Study|Lost to Follow-up|1|||
131107117|NCT03907410|472022200|FG002|Overall Study|Lost to Follow-up|1|||
131107118|NCT03907410|472022198|FG000|Overall Study|Lost to follow-up and research burden|0|||
131107119|NCT03907410|472022199|FG001|Overall Study|Lost to follow-up and research burden|0|||
131107120|NCT03907410|472022200|FG002|Overall Study|Lost to follow-up and research burden|1|||
131107121|NCT03718533|472022201|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
131107122|NCT03718533|472022201|FG000|Overall Study|Protocol deviation|1|||
131107123|NCT03718533|472022201|FG000|Overall Study|Disease progression|1|||
131107124|NCT03718533|472022201|FG000|Overall Study|Relapse|1|||
131107125|NCT03718533|472022201|FG000|Overall Study|Physician Decision|2|||
131107126|NCT03718533|472022201|FG000|Overall Study|Physician Decision and Adverse Event|1|||
131107127|NCT05754333|472022202|FG000|Overall Study|Miscellaneous|3|||
131107128|NCT05754333|472022203|FG001|Overall Study|Miscellaneous|0|||
131107129|NCT05754333|472022204|FG002|Overall Study|Miscellaneous|0|||
131107130|NCT05754333|472022205|FG003|Overall Study|Miscellaneous|0|||
131107131|NCT05754333|472022202|FG000|Overall Study|Lost to Follow-up|2|||
131107132|NCT05754333|472022203|FG001|Overall Study|Lost to Follow-up|1|||
131107133|NCT05754333|472022204|FG002|Overall Study|Lost to Follow-up|0|||
131107134|NCT05754333|472022205|FG003|Overall Study|Lost to Follow-up|1|||
131107135|NCT01853137|472022208|FG000|Overall Study|Lost to Follow-up|4|||
131107136|NCT01853137|472022209|FG001|Overall Study|Lost to Follow-up|1|||
131107137|NCT01037244|472022210|FG000|Overall Study|Adverse Event|3|||
131107138|NCT01037244|472022211|FG001|Overall Study|Adverse Event|2|||
131107139|NCT01037244|472022212|FG002|Overall Study|Adverse Event|6|||
131107140|NCT01037244|472022213|FG003|Overall Study|Adverse Event|3|||
131107141|NCT01037244|472022210|FG000|Overall Study|Lack of Efficacy|1|||
131107142|NCT01037244|472022211|FG001|Overall Study|Lack of Efficacy|1|||
131107143|NCT01037244|472022212|FG002|Overall Study|Lack of Efficacy|0|||
131107144|NCT01037244|472022213|FG003|Overall Study|Lack of Efficacy|1|||
131107145|NCT01037244|472022210|FG000|Overall Study|Lost to Follow-up|3|||
131107146|NCT01037244|472022211|FG001|Overall Study|Lost to Follow-up|3|||
131107147|NCT01037244|472022212|FG002|Overall Study|Lost to Follow-up|4|||
131107148|NCT01037244|472022213|FG003|Overall Study|Lost to Follow-up|4|||
131107149|NCT01037244|472022210|FG000|Overall Study|Withdrawal by Subject|1|||
131107150|NCT01037244|472022211|FG001|Overall Study|Withdrawal by Subject|5|||
131107151|NCT01037244|472022212|FG002|Overall Study|Withdrawal by Subject|3|||
131107152|NCT01037244|472022213|FG003|Overall Study|Withdrawal by Subject|5|||
131107153|NCT01037244|472022210|FG000|Overall Study|Partner Withdrew Consent|2|||
131107154|NCT01037244|472022211|FG001|Overall Study|Partner Withdrew Consent|1|||
131107155|NCT01037244|472022212|FG002|Overall Study|Partner Withdrew Consent|0|||
131107156|NCT01037244|472022213|FG003|Overall Study|Partner Withdrew Consent|0|||
131107157|NCT01037244|472022210|FG000|Overall Study|Various|3|||
131107158|NCT01037244|472022211|FG001|Overall Study|Various|2|||
131107159|NCT01037244|472022212|FG002|Overall Study|Various|1|||
131107160|NCT01037244|472022213|FG003|Overall Study|Various|1|||
131107161|NCT01411215|472022214|FG000|Overall Study|Adverse Event|1|||
131107162|NCT01411215|472022215|FG001|Overall Study|Adverse Event|2|||
131107163|NCT01411215|472022214|FG000|Overall Study|Lack of Efficacy|2|||
131107164|NCT01411215|472022215|FG001|Overall Study|Lack of Efficacy|4|||
131107165|NCT01411215|472022214|FG000|Overall Study|Lost to Follow-up|12|||
131107166|NCT01411215|472022215|FG001|Overall Study|Lost to Follow-up|18|||
131107167|NCT01411215|472022214|FG000|Overall Study|Did not meet entrance criteria|0|||
131107168|NCT01411215|472022215|FG001|Overall Study|Did not meet entrance criteria|1|||
131107169|NCT01411215|472022214|FG000|Overall Study|Study terminated by sponsor|2|||
131107170|NCT01411215|472022215|FG001|Overall Study|Study terminated by sponsor|15|||
131107171|NCT01411215|472022214|FG000|Overall Study|Protocol Violation|3|||
130685954|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
131107172|NCT01411215|472022215|FG001|Overall Study|Protocol Violation|5|||
131107173|NCT01411215|472022214|FG000|Overall Study|Withdrawal by Subject|34|||
131107174|NCT01411215|472022215|FG001|Overall Study|Withdrawal by Subject|21|||
131107175|NCT01411215|472022214|FG000|Overall Study|Other|12|||
131107176|NCT01411215|472022215|FG001|Overall Study|Other|17|||
131107177|NCT01411215|472022214|FG000|Overall Study|Screen failure|0|||
131107178|NCT01411215|472022215|FG001|Overall Study|Screen failure|1|||
130767068|NCT01857102|470770714|FG001|Period 1|Unsatisfactory Lens Fit|0|||
131107179|NCT00848926|472022216|FG000|Treatment Period|Progressive disease|45|||
131107180|NCT00848926|472022216|FG000|Treatment Period|Adverse Event|20|||
131107181|NCT00848926|472022216|FG000|Treatment Period|Physician Decision|12|||
131107182|NCT00848926|472022216|FG000|Treatment Period|Withdrawal by Subject|7|||
131107183|NCT00848926|472022216|FG000|Follow-up Period|Lost to Follow-up|7|||
131107184|NCT00848926|472022216|FG000|Follow-up Period|Withdrawal by Subject|3|||
131107185|NCT00848926|472022216|FG000|Follow-up Period|Other|2|||
131107186|NCT04025580|472022217|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
131107187|NCT04025580|472022218|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
131107188|NCT04025580|472022219|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
131107189|NCT02924064|472022220|FG000|Overall Study|Adverse Event|2|||
131107190|NCT02924064|472022221|FG001|Overall Study|Adverse Event|2|||
131107191|NCT02924064|472022220|FG000|Overall Study|Lost to Follow-up|0|||
131107192|NCT02924064|472022221|FG001|Overall Study|Lost to Follow-up|2|||
131107193|NCT02924064|472022220|FG000|Overall Study|Physician Decision|0|||
131107194|NCT02924064|472022221|FG001|Overall Study|Physician Decision|2|||
131107195|NCT02924064|472022220|FG000|Overall Study|Protocol Violation|1|||
131107196|NCT02924064|472022221|FG001|Overall Study|Protocol Violation|3|||
131107197|NCT02924064|472022220|FG000|Overall Study|Withdrawal by Subject|4|||
131107198|NCT02924064|472022221|FG001|Overall Study|Withdrawal by Subject|5|||
131107199|NCT02924064|472022220|FG000|Overall Study|Other|17|||
131107200|NCT02924064|472022221|FG001|Overall Study|Other|29|||
131107201|NCT04507126|472022222|FG000|Overall Study|Withdrawal by Subject|1|||
131107202|NCT04507126|472022222|FG000|Overall Study|Protocol Violation|2|||
131107203|NCT04507126|472022222|FG000|Overall Study|Physician Decision|1|||
131107204|NCT01249274|472022225|FG000|Overall Study|Lost to Follow-up|3|||
131107205|NCT01249274|472022226|FG001|Overall Study|Lost to Follow-up|4|||
131107206|NCT01249274|472022225|FG000|Overall Study|Received inpatient substance treatment|1|||
131107207|NCT01249274|472022226|FG001|Overall Study|Received inpatient substance treatment|2|||
131107208|NCT00138671|472022227|FG000|Overall Study|Death|0|||
131107209|NCT00138671|472022228|FG001|Overall Study|Death|3|||
131107210|NCT00138671|472022227|FG000|Overall Study|Adverse Event|6|||
131107211|NCT00138671|472022228|FG001|Overall Study|Adverse Event|3|||
131107212|NCT00138671|472022227|FG000|Overall Study|Lost to Follow-up|1|||
131107213|NCT00138671|472022228|FG001|Overall Study|Lost to Follow-up|2|||
131107214|NCT00138671|472022227|FG000|Overall Study|Withdrawal by Subject|3|||
131107215|NCT00138671|472022228|FG001|Overall Study|Withdrawal by Subject|5|||
131107216|NCT00138671|472022227|FG000|Overall Study|Other|3|||
131107217|NCT00138671|472022228|FG001|Overall Study|Other|3|||
131107218|NCT01952054|472022229|FG000|Overall Study|Physician Decision|1|||
131107219|NCT01100034|472022230|FG000|Overall Study|Lost to Follow-up|11|||
131107220|NCT01100034|472022230|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
131107221|NCT01100034|472022230|FG000|Overall Study|Withdrawal by Subject|4|||
131107222|NCT01100034|472022230|FG000|Overall Study|Sponsor decision|21|||
131107223|NCT01100034|472022230|FG000|Overall Study|Participated in another clinical trial|1|||
131107224|NCT01100034|472022230|FG000|Overall Study|Participants moved to another hospital|4|||
131107225|NCT01100034|472022230|FG000|Overall Study|Site closed due to non-responsiveness|1|||
131107226|NCT01831856|472022231|FG000|Overall Study|Adverse Event|5|||
131107227|NCT01831856|472022232|FG001|Overall Study|Adverse Event|8|||
131107228|NCT01831856|472022231|FG000|Overall Study|Lack of Efficacy|13|||
131107229|NCT01831856|472022232|FG001|Overall Study|Lack of Efficacy|11|||
131107230|NCT01831856|472022231|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
131107231|NCT01831856|472022232|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
131107232|NCT01498653|472022233|FG000|Overall Study|Adverse Event|2|||
131107233|NCT01498653|472022234|FG001|Overall Study|Adverse Event|2|||
131107234|NCT01498653|472022233|FG000|Overall Study|Lack of Efficacy|12|||
131107235|NCT01498653|472022234|FG001|Overall Study|Lack of Efficacy|26|||
131107236|NCT01498653|472022233|FG000|Overall Study|Protocol Violation|0|||
131107237|NCT01498653|472022234|FG001|Overall Study|Protocol Violation|4|||
131107238|NCT01498653|472022233|FG000|Overall Study|Lost to Follow-up|1|||
131107239|NCT01498653|472022234|FG001|Overall Study|Lost to Follow-up|0|||
131107240|NCT01498653|472022233|FG000|Overall Study|Physician Decision|2|||
131107241|NCT01498653|472022234|FG001|Overall Study|Physician Decision|0|||
131107242|NCT01498653|472022233|FG000|Overall Study|Withdrawal by Subject|2|||
131107243|NCT01498653|472022234|FG001|Overall Study|Withdrawal by Subject|3|||
131107244|NCT05208866|472022235|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
131107245|NCT02070588|472022236|FG000|Overall Study|Withdrawal by Subject|29|||
131107246|NCT02070588|472022237|FG001|Overall Study|Withdrawal by Subject|1|||
131107247|NCT02070588|472022238|FG002|Overall Study|Withdrawal by Subject|0|||
131107248|NCT02070588|472022236|FG000|Overall Study|Writhdrawal due to early termination|9|||
131107249|NCT02070588|472022237|FG001|Overall Study|Writhdrawal due to early termination|0|||
131107250|NCT02070588|472022238|FG002|Overall Study|Writhdrawal due to early termination|0|||
131107251|NCT02070588|472022236|FG000|Overall Study|Adverse Event|1|||
131107252|NCT02070588|472022237|FG001|Overall Study|Adverse Event|0|||
130888961|NCT00125164|471225178|FG002|Overall Study|Withdrawal by Subject|1|||
131107253|NCT02070588|472022238|FG002|Overall Study|Adverse Event|0|||
131107254|NCT02216357|472022240|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
130685955|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130888962|NCT00125164|471225179|FG003|Overall Study|Withdrawal by Subject|1|||
131107255|NCT02216357|472022241|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
130685956|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685957|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685958|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685959|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685960|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685961|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130685962|NCT01597245|470477931|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685963|NCT01597245|470477932|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685964|NCT01597245|470477933|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685965|NCT01597245|470477934|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685966|NCT01597245|470477935|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685967|NCT01597245|470477936|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685968|NCT01597245|470477937|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685969|NCT01597245|470477938|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685970|NCT01597245|470477939|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685971|NCT01597245|470477940|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685972|NCT01597245|470477941|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
130685973|NCT01597245|470477942|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685974|NCT01597245|470477943|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130888963|NCT01339052|471225180|FG000|Overall Study|Disease progression|13|||
130888964|NCT01339052|471225181|FG001|Overall Study|Disease progression|46|||
130888965|NCT01339052|471225180|FG000|Overall Study|Adverse Event|1|||
130888966|NCT01339052|471225181|FG001|Overall Study|Adverse Event|1|||
130888967|NCT01339052|471225180|FG000|Overall Study|Withdrawal by Subject|0|||
130888968|NCT01339052|471225181|FG001|Overall Study|Withdrawal by Subject|3|||
130888969|NCT01339052|471225180|FG000|Overall Study|Physician Decision|1|||
130888970|NCT01339052|471225181|FG001|Overall Study|Physician Decision|0|||
130888971|NCT02637037|471225182|FG000|Overall Study|Positive drug screen at admission|1|||
130888972|NCT02637037|471225183|FG001|Overall Study|Positive drug screen at admission|0|||
130888973|NCT02637037|471225182|FG000|Overall Study|Withdrawal by Subject|2|||
130888974|NCT02637037|471225183|FG001|Overall Study|Withdrawal by Subject|1|||
130888975|NCT02637037|471225182|FG000|Overall Study|Adverse Event|1|||
130888976|NCT02637037|471225183|FG001|Overall Study|Adverse Event|0|||
130888977|NCT01469377|471225186|FG000|Overall Study|Protocol Deviation|7|||
130888978|NCT01469377|471225187|FG001|Overall Study|Protocol Deviation|10|||
130888979|NCT01469377|471225188|FG002|Overall Study|Protocol Deviation|10|||
130888980|NCT01469377|471225186|FG000|Overall Study|Lost to Follow-up|3|||
130888981|NCT01469377|471225187|FG001|Overall Study|Lost to Follow-up|2|||
130888982|NCT01469377|471225188|FG002|Overall Study|Lost to Follow-up|5|||
130888983|NCT01469377|471225186|FG000|Overall Study|Withdrawal of Consent|12|||
130888984|NCT01469377|471225187|FG001|Overall Study|Withdrawal of Consent|14|||
130888985|NCT01469377|471225188|FG002|Overall Study|Withdrawal of Consent|15|||
130888986|NCT01469377|471225186|FG000|Overall Study|Adverse Event|8|||
130888987|NCT01469377|471225187|FG001|Overall Study|Adverse Event|18|||
130888988|NCT01469377|471225188|FG002|Overall Study|Adverse Event|36|||
130888989|NCT01469377|471225186|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130888990|NCT01469377|471225187|FG001|Overall Study|Insufficient Therapeutic Response|4|||
130888991|NCT01469377|471225188|FG002|Overall Study|Insufficient Therapeutic Response|0|||
130888992|NCT01469377|471225186|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130888993|NCT01469377|471225187|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130888994|NCT01469377|471225188|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130888995|NCT01733680|471225189|FG000|Overall Study|Withdrawal by Subject|0|||
130888996|NCT01733680|471225190|FG001|Overall Study|Withdrawal by Subject|1|||
130888997|NCT02565108|471225197|FG000|Overall Study|Adverse Event|1|||
130888998|NCT02565108|471225198|FG001|Overall Study|Adverse Event|0|||
130888999|NCT02565108|471225197|FG000|Overall Study|Withdrew Consent|1|||
130889000|NCT02565108|471225198|FG001|Overall Study|Withdrew Consent|0|||
130889001|NCT02908672|471225199|FG000|Run-in Period|Death|12|||
130889002|NCT02908672|471225200|FG001|Run-in Period|Death|10|||
130889003|NCT02908672|471225201|FG002|Run-in Period|Death|0|||
130889004|NCT02908672|471225202|FG003|Run-in Period|Death|0|||
130889005|NCT02908672|471225199|FG000|Run-in Period|Lost to Follow-up|1|||
130889006|NCT02908672|471225200|FG001|Run-in Period|Lost to Follow-up|1|||
130889007|NCT02908672|471225201|FG002|Run-in Period|Lost to Follow-up|0|||
130889008|NCT02908672|471225202|FG003|Run-in Period|Lost to Follow-up|0|||
130889009|NCT02908672|471225199|FG000|Run-in Period|Reason Not Specified|2|||
130889010|NCT02908672|471225200|FG001|Run-in Period|Reason Not Specified|0|||
130889011|NCT02908672|471225201|FG002|Run-in Period|Reason Not Specified|0|||
130889012|NCT02908672|471225202|FG003|Run-in Period|Reason Not Specified|0|||
130889013|NCT02908672|471225199|FG000|Run-in Period|Protocol Violation|1|||
130889014|NCT02908672|471225200|FG001|Run-in Period|Protocol Violation|1|||
131107256|NCT00836095|472022243|FG000|Overall Study|Physician Decision|0|||
131107257|NCT00836095|472022244|FG001|Overall Study|Physician Decision|3|||
131107258|NCT04620811|472022247|FG000|Overall Study|Withdrawal by Subject|18|||
131107259|NCT04620811|472022248|FG001|Overall Study|Withdrawal by Subject|15|||
131107260|NCT04620811|472022247|FG000|Overall Study|Adverse Event|6|||
131107261|NCT04620811|472022248|FG001|Overall Study|Adverse Event|11|||
131107262|NCT04620811|472022247|FG000|Overall Study|Lost to Follow-up|4|||
131107263|NCT04620811|472022248|FG001|Overall Study|Lost to Follow-up|8|||
131107264|NCT04620811|472022247|FG000|Overall Study|Physician Decision|1|||
131107265|NCT04620811|472022248|FG001|Overall Study|Physician Decision|4|||
131107266|NCT04620811|472022247|FG000|Overall Study|Sponsor Decision|0|||
131107267|NCT04620811|472022248|FG001|Overall Study|Sponsor Decision|1|||
131107268|NCT04620811|472022247|FG000|Overall Study|Elevation of ALT or AST|1|||
131107269|NCT04620811|472022248|FG001|Overall Study|Elevation of ALT or AST|0|||
131107270|NCT04620811|472022247|FG000|Overall Study|Other|3|||
131107271|NCT04620811|472022248|FG001|Overall Study|Other|5|||
131107272|NCT01078675|472022249|FG000|Overall Study|Withdrawal by Subject|7|||
131107273|NCT01078675|472022250|FG001|Overall Study|Withdrawal by Subject|3|||
131107274|NCT01078675|472022249|FG000|Overall Study|Protocol Violation|56|||
131107275|NCT01078675|472022250|FG001|Overall Study|Protocol Violation|0|||
131107276|NCT01078675|472022249|FG000|Overall Study|Provided in CRF for specific reasons|2|||
131107277|NCT01078675|472022250|FG001|Overall Study|Provided in CRF for specific reasons|3|||
131107278|NCT01078675|472022249|FG000|Overall Study|Adverse Event|3|||
131107279|NCT01078675|472022250|FG001|Overall Study|Adverse Event|0|||
131107280|NCT01759368|472022253|FG000|Overall Study|Lost to Follow-up|1|||
131107281|NCT01759368|472022254|FG001|Overall Study|Lost to Follow-up|0|||
131107282|NCT01191268|472022255|FG000|Overall Study|Withdrawal by Subject|19|||
131107283|NCT01191268|472022256|FG001|Overall Study|Withdrawal by Subject|25|||
131107284|NCT01191268|472022257|FG002|Overall Study|Withdrawal by Subject|21|||
131107285|NCT01191268|472022255|FG000|Overall Study|Adverse Event|21|||
131107286|NCT01191268|472022256|FG001|Overall Study|Adverse Event|13|||
131107287|NCT01191268|472022257|FG002|Overall Study|Adverse Event|8|||
131107288|NCT01191268|472022255|FG000|Overall Study|Physician Decision|6|||
131107289|NCT01191268|472022256|FG001|Overall Study|Physician Decision|8|||
131107290|NCT01191268|472022257|FG002|Overall Study|Physician Decision|9|||
131107291|NCT01191268|472022255|FG000|Overall Study|Lost to Follow-up|8|||
131107292|NCT01191268|472022256|FG001|Overall Study|Lost to Follow-up|5|||
131107293|NCT01191268|472022257|FG002|Overall Study|Lost to Follow-up|9|||
131107294|NCT01191268|472022255|FG000|Overall Study|Entry Criteria Not Met|3|||
131107295|NCT01191268|472022256|FG001|Overall Study|Entry Criteria Not Met|1|||
131107296|NCT01191268|472022257|FG002|Overall Study|Entry Criteria Not Met|1|||
131107297|NCT01191268|472022255|FG000|Overall Study|Death|0|||
131107298|NCT01191268|472022256|FG001|Overall Study|Death|1|||
131107299|NCT01191268|472022257|FG002|Overall Study|Death|3|||
131107300|NCT01191268|472022255|FG000|Overall Study|Protocol Violation|1|||
130889015|NCT02908672|471225201|FG002|Run-in Period|Protocol Violation|0|||
131107301|NCT01191268|472022256|FG001|Overall Study|Protocol Violation|0|||
131107302|NCT01191268|472022257|FG002|Overall Study|Protocol Violation|1|||
131107303|NCT01191268|472022255|FG000|Overall Study|Sponsor Decision|0|||
131107304|NCT01191268|472022256|FG001|Overall Study|Sponsor Decision|2|||
131107305|NCT01191268|472022257|FG002|Overall Study|Sponsor Decision|0|||
131107306|NCT02294227|472022260|FG000|Overall Study|Death|0|||
131107307|NCT02294227|472022261|FG001|Overall Study|Death|0|||
131107308|NCT02294227|472022262|FG002|Overall Study|Death|1|||
131107309|NCT02294227|472022260|FG000|Overall Study|Subject/Guardian Decision|6|||
131107310|NCT02294227|472022261|FG001|Overall Study|Subject/Guardian Decision|3|||
131107311|NCT02294227|472022262|FG002|Overall Study|Subject/Guardian Decision|7|||
131107312|NCT02294227|472022260|FG000|Overall Study|Physician Decision|1|||
131107313|NCT02294227|472022261|FG001|Overall Study|Physician Decision|2|||
131107314|NCT02294227|472022262|FG002|Overall Study|Physician Decision|1|||
130889016|NCT02908672|471225202|FG003|Run-in Period|Protocol Violation|0|||
130889017|NCT02908672|471225199|FG000|Run-in Period|Study Ended by Sponsor|5|||
131107315|NCT02294227|472022260|FG000|Overall Study|Lost to Follow-up|1|||
131107316|NCT02294227|472022261|FG001|Overall Study|Lost to Follow-up|0|||
131107317|NCT02294227|472022262|FG002|Overall Study|Lost to Follow-up|0|||
130889018|NCT02908672|471225200|FG001|Run-in Period|Study Ended by Sponsor|1|||
131107318|NCT02294227|472022260|FG000|Overall Study|Lack of Efficacy|11|||
131107319|NCT02294227|472022261|FG001|Overall Study|Lack of Efficacy|12|||
130889019|NCT02908672|471225201|FG002|Run-in Period|Study Ended by Sponsor|0|||
130889020|NCT02908672|471225202|FG003|Run-in Period|Study Ended by Sponsor|0|||
131107320|NCT02294227|472022262|FG002|Overall Study|Lack of Efficacy|8|||
131107321|NCT02294227|472022260|FG000|Overall Study|Adverse Event|6|||
131107322|NCT02294227|472022261|FG001|Overall Study|Adverse Event|8|||
131107323|NCT02294227|472022262|FG002|Overall Study|Adverse Event|2|||
131107324|NCT01768637|472022265|FG000|Overall Study|Lost to Follow-up|2|||
131107325|NCT01768637|472022266|FG001|Overall Study|Lost to Follow-up|7|||
131107326|NCT01768637|472022265|FG000|Overall Study|Difficult blood draw|1|||
131107327|NCT01768637|472022266|FG001|Overall Study|Difficult blood draw|0|||
131107328|NCT00899548|472022267|FG000|Overall Study|Physician Decision|3|||
131107329|NCT00511472|472022268|FG000|Overall Study|Clinical Adverse Event|1|||
131022260|NCT01061151|471713567|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
131022261|NCT01061151|471713568|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
131022262|NCT01061151|471713569|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
131022263|NCT01061151|471713570|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
131022264|NCT01061151|471713567|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
131022265|NCT01061151|471713568|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
131022266|NCT01061151|471713569|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
131022267|NCT01061151|471713570|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
131022268|NCT01061151|471713567|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
131022269|NCT01061151|471713568|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
131022270|NCT01061151|471713569|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
131022271|NCT01061151|471713570|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
131022272|NCT01061151|471713567|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
131022273|NCT01061151|471713568|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
131022274|NCT01061151|471713569|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
131022275|NCT01061151|471713570|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
131022276|NCT01061151|471713567|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
131022277|NCT01061151|471713568|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
131022278|NCT01061151|471713569|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
131022279|NCT01061151|471713570|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
131022280|NCT01061151|471713567|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
131022281|NCT01061151|471713568|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
131022282|NCT01061151|471713569|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
131022283|NCT01061151|471713570|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
131022284|NCT01061151|471713567|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
131022285|NCT01061151|471713568|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
131022286|NCT01061151|471713569|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
131022287|NCT01061151|471713570|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
131022288|NCT01061151|471713567|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
131022289|NCT01061151|471713568|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
131022290|NCT01061151|471713569|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
131022291|NCT01061151|471713570|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
131022292|NCT01061151|471713567|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
131022293|NCT01061151|471713568|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
131022294|NCT01061151|471713569|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
131022295|NCT01061151|471713570|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
131022296|NCT01061151|471713567|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
131022297|NCT01061151|471713568|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
131022298|NCT01061151|471713569|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
131022299|NCT01061151|471713570|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
131022300|NCT01061151|471713567|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
131022301|NCT01061151|471713568|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
131022302|NCT01061151|471713569|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
131022303|NCT01061151|471713570|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
131022304|NCT01061151|471713567|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
131022305|NCT01061151|471713568|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
131022306|NCT01061151|471713569|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
131022307|NCT01061151|471713570|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
131022308|NCT01061151|471713567|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
131022309|NCT01061151|471713568|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
131022310|NCT01061151|471713569|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
131022311|NCT01061151|471713570|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
131022312|NCT03740009|471713571|FG000|Overall Study|Physician Decision|9|||
131022313|NCT03740009|471713571|FG000|Overall Study|Lost to Follow-up|1|||
131022314|NCT03752151|471713574|FG000|Overall Study|Withdrawal by Subject|1|||
131022315|NCT03752151|471713574|FG000|Overall Study|Protocol Violation|1|||
131022316|NCT00529516|471713575|FG000|Overall Study|Adverse Event|2|||
131022317|NCT00529516|471713576|FG001|Overall Study|Adverse Event|1|||
131022318|NCT00529516|471713577|FG002|Overall Study|Adverse Event|0|||
131022319|NCT00529516|471713575|FG000|Overall Study|Withdrawal by Subject|1|||
131022320|NCT00529516|471713576|FG001|Overall Study|Withdrawal by Subject|1|||
131022321|NCT00529516|471713577|FG002|Overall Study|Withdrawal by Subject|0|||
131022322|NCT00529516|471713575|FG000|Overall Study|Lost to Follow-up|0|||
131022323|NCT00529516|471713576|FG001|Overall Study|Lost to Follow-up|0|||
130685975|NCT01597245|470477944|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685976|NCT01597245|470477945|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
131022324|NCT00529516|471713577|FG002|Overall Study|Lost to Follow-up|1|||
131022325|NCT00761605|471713581|FG000|Overall Study|Adverse Event|26|||
131022326|NCT00761605|471713581|FG000|Overall Study|Death|2|||
131022327|NCT00761605|471713581|FG000|Overall Study|Lack of Efficacy|26|||
131022328|NCT00761605|471713581|FG000|Overall Study|Lost to Follow-up|29|||
131022329|NCT00761605|471713581|FG000|Overall Study|Withdrawal by Subject|37|||
131022330|NCT00761605|471713581|FG000|Overall Study|Other|21|||
131022331|NCT03451721|471713583|FG000|Overall Study|Death|1|||
131022332|NCT01985334|471713584|FG000|Overall Study|Administrative problems|1|||
131022333|NCT01985334|471713585|FG001|Overall Study|Administrative problems|1|||
131022334|NCT01985334|471713586|FG002|Overall Study|Administrative problems|0|||
131022335|NCT01985334|471713587|FG003|Overall Study|Administrative problems|2|||
131022336|NCT01985334|471713588|FG004|Overall Study|Administrative problems|0|||
131022337|NCT01985334|471713589|FG005|Overall Study|Administrative problems|1|||
131022338|NCT01985334|471713590|FG006|Overall Study|Administrative problems|1|||
131022339|NCT01985334|471713591|FG007|Overall Study|Administrative problems|3|||
131022340|NCT01985334|471713584|FG000|Overall Study|Death|1|||
131022341|NCT01985334|471713585|FG001|Overall Study|Death|0|||
131022342|NCT01985334|471713586|FG002|Overall Study|Death|0|||
131022343|NCT01985334|471713587|FG003|Overall Study|Death|3|||
131022344|NCT01985334|471713588|FG004|Overall Study|Death|0|||
131022345|NCT01985334|471713589|FG005|Overall Study|Death|0|||
131022346|NCT01985334|471713590|FG006|Overall Study|Death|1|||
131022347|NCT01985334|471713591|FG007|Overall Study|Death|2|||
131022348|NCT01985334|471713584|FG000|Overall Study|Worsening of disease|0|||
131022349|NCT01985334|471713585|FG001|Overall Study|Worsening of disease|0|||
131022350|NCT01985334|471713586|FG002|Overall Study|Worsening of disease|0|||
131022351|NCT01985334|471713587|FG003|Overall Study|Worsening of disease|1|||
130685977|NCT01597245|470477946|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685978|NCT01597245|470477947|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685979|NCT01597245|470477948|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685980|NCT01597245|470477949|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685981|NCT01597245|470477950|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685982|NCT01597245|470477951|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130685983|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685984|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685985|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685986|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685987|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685988|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685989|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685990|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685991|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685992|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685993|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685994|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685995|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130685996|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
130685997|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
130685998|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
130685999|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130686000|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130686001|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131022352|NCT01985334|471713588|FG004|Overall Study|Worsening of disease|0|||
131022353|NCT01985334|471713589|FG005|Overall Study|Worsening of disease|3|||
131022354|NCT01985334|471713590|FG006|Overall Study|Worsening of disease|0|||
131022355|NCT01985334|471713591|FG007|Overall Study|Worsening of disease|1|||
131022356|NCT01985334|471713584|FG000|Overall Study|Other|2|||
131022357|NCT01985334|471713585|FG001|Overall Study|Other|9|||
131022358|NCT01985334|471713586|FG002|Overall Study|Other|7|||
131022359|NCT01985334|471713587|FG003|Overall Study|Other|17|||
131022360|NCT01985334|471713588|FG004|Overall Study|Other|4|||
131022361|NCT01985334|471713589|FG005|Overall Study|Other|8|||
131022362|NCT01985334|471713590|FG006|Overall Study|Other|4|||
131022363|NCT01985334|471713591|FG007|Overall Study|Other|7|||
131022364|NCT01985334|471713584|FG000|Overall Study|Protocol deviation|6|||
131022365|NCT01985334|471713585|FG001|Overall Study|Protocol deviation|31|||
131022366|NCT01985334|471713586|FG002|Overall Study|Protocol deviation|25|||
131022367|NCT01985334|471713587|FG003|Overall Study|Protocol deviation|84|||
131022368|NCT01985334|471713588|FG004|Overall Study|Protocol deviation|17|||
131022369|NCT01985334|471713589|FG005|Overall Study|Protocol deviation|47|||
131022370|NCT01985334|471713590|FG006|Overall Study|Protocol deviation|15|||
131022371|NCT01985334|471713591|FG007|Overall Study|Protocol deviation|42|||
131022372|NCT01985334|471713584|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
131022373|NCT01985334|471713585|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
131022374|NCT01985334|471713586|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
131022375|NCT01985334|471713587|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
131022376|NCT01985334|471713588|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
131022377|NCT01985334|471713589|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
131022378|NCT01985334|471713590|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
131022379|NCT01985334|471713591|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
131022380|NCT01985334|471713584|FG000|Overall Study|Subject withdrawal of consent|3|||
131022381|NCT01985334|471713585|FG001|Overall Study|Subject withdrawal of consent|6|||
131022382|NCT01985334|471713586|FG002|Overall Study|Subject withdrawal of consent|2|||
131022383|NCT01985334|471713587|FG003|Overall Study|Subject withdrawal of consent|28|||
131022384|NCT01985334|471713588|FG004|Overall Study|Subject withdrawal of consent|4|||
131022385|NCT01985334|471713589|FG005|Overall Study|Subject withdrawal of consent|19|||
131022386|NCT01985334|471713590|FG006|Overall Study|Subject withdrawal of consent|0|||
131022387|NCT01985334|471713591|FG007|Overall Study|Subject withdrawal of consent|20|||
131022388|NCT01985334|471713584|FG000|Overall Study|Adverse Event|0|||
131022389|NCT01985334|471713585|FG001|Overall Study|Adverse Event|8|||
131022390|NCT01985334|471713586|FG002|Overall Study|Adverse Event|2|||
131022391|NCT01985334|471713587|FG003|Overall Study|Adverse Event|26|||
131022392|NCT01985334|471713588|FG004|Overall Study|Adverse Event|3|||
131022393|NCT01985334|471713589|FG005|Overall Study|Adverse Event|18|||
131022394|NCT01985334|471713590|FG006|Overall Study|Adverse Event|3|||
131022395|NCT01985334|471713591|FG007|Overall Study|Adverse Event|15|||
131022396|NCT01985334|471713584|FG000|Overall Study|Other|4|||
131022397|NCT01985334|471713585|FG001|Overall Study|Other|2|||
131022398|NCT01985334|471713586|FG002|Overall Study|Other|3|||
131022399|NCT01985334|471713587|FG003|Overall Study|Other|10|||
131022400|NCT01985334|471713588|FG004|Overall Study|Other|1|||
131022401|NCT01985334|471713589|FG005|Overall Study|Other|6|||
131022402|NCT01985334|471713590|FG006|Overall Study|Other|2|||
131022403|NCT01985334|471713591|FG007|Overall Study|Other|2|||
131022404|NCT01985334|471713584|FG000|Overall Study|Medication non-compliance|0|||
131022405|NCT01985334|471713585|FG001|Overall Study|Medication non-compliance|4|||
131022406|NCT01985334|471713586|FG002|Overall Study|Medication non-compliance|1|||
131022407|NCT01985334|471713587|FG003|Overall Study|Medication non-compliance|6|||
131022408|NCT01985334|471713588|FG004|Overall Study|Medication non-compliance|2|||
131022409|NCT01985334|471713589|FG005|Overall Study|Medication non-compliance|3|||
131022410|NCT01985334|471713590|FG006|Overall Study|Medication non-compliance|1|||
131022411|NCT01985334|471713591|FG007|Overall Study|Medication non-compliance|3|||
131022412|NCT01985334|471713584|FG000|Overall Study|Use of prohibited treatment|1|||
131022413|NCT01985334|471713585|FG001|Overall Study|Use of prohibited treatment|4|||
131022414|NCT01985334|471713586|FG002|Overall Study|Use of prohibited treatment|1|||
131022415|NCT01985334|471713587|FG003|Overall Study|Use of prohibited treatment|2|||
131022416|NCT01985334|471713588|FG004|Overall Study|Use of prohibited treatment|1|||
131022417|NCT01985334|471713589|FG005|Overall Study|Use of prohibited treatment|6|||
131022418|NCT01985334|471713590|FG006|Overall Study|Use of prohibited treatment|2|||
131022419|NCT01985334|471713591|FG007|Overall Study|Use of prohibited treatment|0|||
131022420|NCT01985334|471713584|FG000|Overall Study|Investigator decision|0|||
131022421|NCT01985334|471713585|FG001|Overall Study|Investigator decision|3|||
131022422|NCT01985334|471713586|FG002|Overall Study|Investigator decision|0|||
131022423|NCT01985334|471713587|FG003|Overall Study|Investigator decision|7|||
131022424|NCT01985334|471713588|FG004|Overall Study|Investigator decision|1|||
131022425|NCT01985334|471713589|FG005|Overall Study|Investigator decision|1|||
131022426|NCT01985334|471713590|FG006|Overall Study|Investigator decision|0|||
131022427|NCT01985334|471713591|FG007|Overall Study|Investigator decision|4|||
131022428|NCT01985334|471713584|FG000|Overall Study|Lost to Follow-up|0|||
131022429|NCT01985334|471713585|FG001|Overall Study|Lost to Follow-up|2|||
131022430|NCT01985334|471713586|FG002|Overall Study|Lost to Follow-up|0|||
131022431|NCT01985334|471713587|FG003|Overall Study|Lost to Follow-up|3|||
131022432|NCT01985334|471713588|FG004|Overall Study|Lost to Follow-up|1|||
131022433|NCT01985334|471713589|FG005|Overall Study|Lost to Follow-up|4|||
131022434|NCT01985334|471713590|FG006|Overall Study|Lost to Follow-up|0|||
131022435|NCT01985334|471713591|FG007|Overall Study|Lost to Follow-up|3|||
131022436|NCT01290341|471713592|FG000|Overall Study|Protocol Violation|7|||
131022437|NCT01290341|471713593|FG001|Overall Study|Protocol Violation|3|||
131022438|NCT01290341|471713592|FG000|Overall Study|Adverse Event|1|||
131022439|NCT01290341|471713593|FG001|Overall Study|Adverse Event|0|||
131022440|NCT01290341|471713592|FG000|Overall Study|Lost to Follow-up|21|||
131022441|NCT01290341|471713593|FG001|Overall Study|Lost to Follow-up|10|||
131022442|NCT01290341|471713592|FG000|Overall Study|Withdrawal by Subject|19|||
131022443|NCT01290341|471713593|FG001|Overall Study|Withdrawal by Subject|5|||
131022444|NCT01290341|471713592|FG000|Overall Study|Negative baseline culture and others|44|||
131022445|NCT01290341|471713593|FG001|Overall Study|Negative baseline culture and others|11|||
131107330|NCT00511472|472022269|FG001|Overall Study|Clinical Adverse Event|2|||
131022446|NCT01102231|471713598|FG000|Overall Study|Protocol Violation|3|||
131022447|NCT01102231|471713598|FG000|Overall Study|Lack of Efficacy|2|||
131022448|NCT01102231|471713598|FG000|Overall Study|Death|2|||
131022449|NCT01102231|471713598|FG000|Overall Study|Adverse Event|3|||
131022450|NCT01102231|471713598|FG000|Overall Study|Withdrawal by Subject|1|||
131022451|NCT01102231|471713598|FG000|Overall Study|Did not received the treatment|4|||
131022452|NCT03733119|471713601|FG000|Overall Study|Physician Decision|2|||
131022453|NCT03733119|471713602|FG001|Overall Study|Physician Decision|1|||
131022454|NCT03733119|471713601|FG000|Overall Study|ineligible to treat per protocol|0|||
131022455|NCT03733119|471713602|FG001|Overall Study|ineligible to treat per protocol|1|||
131022456|NCT02409667|471713608|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
131022457|NCT02409667|471713609|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
131022458|NCT02409667|471713610|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
131022459|NCT02409667|471713611|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
131022460|NCT02409667|471713612|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
131022461|NCT02409667|471713608|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
131022462|NCT02409667|471713609|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
131022463|NCT02409667|471713610|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
131022464|NCT02409667|471713611|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
131022465|NCT02409667|471713612|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
131022466|NCT02409667|471713608|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
131022467|NCT02409667|471713609|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
131022468|NCT02409667|471713610|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
131022469|NCT02409667|471713611|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
131022470|NCT02409667|471713612|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
131022471|NCT02409667|471713608|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
131022472|NCT02409667|471713609|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
131022473|NCT02409667|471713610|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
131022474|NCT02409667|471713611|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
131022475|NCT02409667|471713612|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
131022476|NCT02409667|471713608|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
131022477|NCT02409667|471713609|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
131022478|NCT02409667|471713610|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
131022479|NCT02409667|471713611|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
131022480|NCT02409667|471713612|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
131022481|NCT02409667|471713608|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
131022482|NCT02409667|471713609|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
131022483|NCT02409667|471713610|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
131022484|NCT02409667|471713611|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
131022485|NCT02409667|471713612|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
131022486|NCT02409667|471713608|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
131022487|NCT02409667|471713609|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
131022488|NCT02409667|471713610|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
131022489|NCT02409667|471713611|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
131022490|NCT02409667|471713612|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
131022491|NCT02409667|471713608|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
131022492|NCT02409667|471713609|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
131022493|NCT02409667|471713610|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
131022494|NCT02409667|471713611|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
131022495|NCT02409667|471713612|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
131022496|NCT02409667|471713608|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
131022497|NCT02409667|471713609|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
131022498|NCT02409667|471713610|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
131022499|NCT02409667|471713611|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
131022500|NCT02409667|471713612|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
131022501|NCT02409667|471713608|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
131022502|NCT02409667|471713609|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
131022503|NCT02409667|471713610|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
131022504|NCT02409667|471713611|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
131022505|NCT02409667|471713612|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
131022506|NCT02409667|471713608|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
131022507|NCT02409667|471713609|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
131022508|NCT02409667|471713610|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
131022509|NCT02409667|471713611|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
131022510|NCT02409667|471713612|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
131022511|NCT02409667|471713608|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
130686002|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130686003|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
131022512|NCT02409667|471713609|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
131107331|NCT00511472|472022268|FG000|Overall Study|Laboratory Adverse Event|0|||
131107332|NCT00511472|472022269|FG001|Overall Study|Laboratory Adverse Event|2|||
131107333|NCT00511472|472022268|FG000|Overall Study|Not reported|2|||
131107334|NCT00511472|472022269|FG001|Overall Study|Not reported|2|||
131107335|NCT02709096|472022270|FG000|Overall Study|non-compliance|1|||
131107336|NCT02709096|472022271|FG001|Overall Study|non-compliance|1|||
131107337|NCT02427464|472022273|FG000|Overall Study|Adverse Event|6|||
131107338|NCT02427464|472022274|FG001|Overall Study|Adverse Event|1|||
131107339|NCT02427464|472022273|FG000|Overall Study|Lost to Follow-up|16|||
131107340|NCT02427464|472022274|FG001|Overall Study|Lost to Follow-up|5|||
131107341|NCT02427464|472022273|FG000|Overall Study|Physician Decision|2|||
131107342|NCT02427464|472022274|FG001|Overall Study|Physician Decision|0|||
131107343|NCT02427464|472022273|FG000|Overall Study|Withdrawal by Subject|10|||
131107344|NCT02427464|472022274|FG001|Overall Study|Withdrawal by Subject|8|||
131022513|NCT02409667|471713610|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
131022514|NCT02409667|471713611|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
131022515|NCT02409667|471713612|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
131022516|NCT02409667|471713608|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
131022517|NCT02409667|471713609|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
131022518|NCT02409667|471713610|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
131022519|NCT02409667|471713611|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
131022520|NCT02409667|471713612|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
131022521|NCT02409667|471713608|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
131022522|NCT02409667|471713609|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
131022523|NCT02409667|471713610|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
131022524|NCT02409667|471713611|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
131022525|NCT02409667|471713612|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
131022526|NCT02409667|471713608|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
131022527|NCT02409667|471713609|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
131022528|NCT02409667|471713610|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
131022529|NCT02409667|471713611|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
131022530|NCT02409667|471713612|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
131022531|NCT02409667|471713608|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
131022532|NCT02409667|471713609|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
131022533|NCT02409667|471713610|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
131022534|NCT02409667|471713611|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
131022535|NCT02409667|471713612|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
131022536|NCT03997916|471713614|FG000|Overall Study|Protocol Violation|35|||
131107345|NCT02427464|472022273|FG000|Overall Study|Noncompliance|16|||
131107346|NCT02427464|472022274|FG001|Overall Study|Noncompliance|10|||
131107347|NCT03164564|472022277|FG000|Overall Study|Death|3|||
131107348|NCT03164564|472022278|FG001|Overall Study|Death|0|||
131107349|NCT03164564|472022277|FG000|Overall Study|Withdrawal by Subject|20|||
131107350|NCT03164564|472022278|FG001|Overall Study|Withdrawal by Subject|15|||
131022557|NCT03237481|471714672|FG000|Overall Study|Lost to Follow-up|1|||
131022558|NCT03237481|471714673|FG001|Overall Study|Lost to Follow-up|0|||
131022559|NCT03237481|471714674|FG002|Overall Study|Lost to Follow-up|0|||
131022560|NCT03237481|471714672|FG000|Overall Study|Protocol Violation|1|||
131022561|NCT03237481|471714673|FG001|Overall Study|Protocol Violation|0|||
131022562|NCT03237481|471714674|FG002|Overall Study|Protocol Violation|0|||
131022563|NCT03237481|471714672|FG000|Overall Study|Withdrawal by Subject|3|||
131022564|NCT03237481|471714673|FG001|Overall Study|Withdrawal by Subject|2|||
131022565|NCT03237481|471714674|FG002|Overall Study|Withdrawal by Subject|1|||
131022566|NCT01780298|471714675|FG000|Overall Study|Physician Decision|1|||
131022567|NCT01780298|471714676|FG001|Overall Study|Physician Decision|5|||
131022568|NCT01780298|471714677|FG002|Overall Study|Physician Decision|1|||
131022569|NCT01780298|471714678|FG003|Overall Study|Physician Decision|1|||
131022570|NCT01780298|471714675|FG000|Overall Study|Subject not matched|1|||
131022571|NCT01780298|471714676|FG001|Overall Study|Subject not matched|0|||
131022572|NCT01780298|471714677|FG002|Overall Study|Subject not matched|1|||
131022573|NCT01780298|471714678|FG003|Overall Study|Subject not matched|0|||
131022574|NCT01780298|471714675|FG000|Overall Study|Adverse Event|0|||
131022575|NCT01780298|471714676|FG001|Overall Study|Adverse Event|0|||
131022576|NCT01780298|471714677|FG002|Overall Study|Adverse Event|2|||
131022577|NCT01780298|471714678|FG003|Overall Study|Adverse Event|0|||
131022578|NCT04907474|471714679|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
131022579|NCT04907474|471714680|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
131022580|NCT03873779|471714681|FG000|Overall Study|Withdrawal by Subject|1|||
131022581|NCT03936660|471714682|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
131022582|NCT03936660|471714683|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
131107351|NCT03164564|472022277|FG000|Overall Study|Lost to Follow-up|2|||
131107352|NCT03164564|472022278|FG001|Overall Study|Lost to Follow-up|0|||
131107353|NCT03164564|472022277|FG000|Overall Study|Physician Decision|0|||
131107354|NCT03164564|472022278|FG001|Overall Study|Physician Decision|1|||
131107355|NCT03164564|472022277|FG000|Overall Study|Adverse Event|0|||
131107356|NCT03164564|472022278|FG001|Overall Study|Adverse Event|1|||
131107357|NCT03164564|472022277|FG000|Overall Study|Ongoing|1586|||
131107358|NCT03164564|472022278|FG001|Overall Study|Ongoing|1586|||
131107359|NCT05959629|472022281|FG000|Overall Study|partially necrotic/technical issues|2|||
131107360|NCT05959629|472022282|FG001|Overall Study|partially necrotic/technical issues|2|||
131107361|NCT03573401|472022283|FG000|Overall Study|Withdrawal by Subject|2|||
131107362|NCT03573401|472022284|FG001|Overall Study|Withdrawal by Subject|0|||
131107363|NCT03573401|472022283|FG000|Overall Study|Subject non-compliance with study schedule|1|||
131107364|NCT03573401|472022284|FG001|Overall Study|Subject non-compliance with study schedule|0|||
131107365|NCT03573401|472022283|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
131107366|NCT03573401|472022284|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
131107367|NCT03573401|472022283|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
131107368|NCT03573401|472022284|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
131107369|NCT03938545|472023807|FG000|Overall Study|Lost to Follow-up|0|||
131107370|NCT03938545|472023808|FG001|Overall Study|Lost to Follow-up|0|||
131107371|NCT03938545|472023809|FG002|Overall Study|Lost to Follow-up|0|||
131107372|NCT03938545|472023810|FG003|Overall Study|Lost to Follow-up|1|||
131107373|NCT03938545|472023807|FG000|Overall Study|Non-compliance with study drug|0|||
131107374|NCT03938545|472023808|FG001|Overall Study|Non-compliance with study drug|0|||
131107375|NCT03938545|472023809|FG002|Overall Study|Non-compliance with study drug|1|||
131107376|NCT03938545|472023810|FG003|Overall Study|Non-compliance with study drug|0|||
131107377|NCT03938545|472023807|FG000|Overall Study|Pregnancy|1|||
131107378|NCT03938545|472023808|FG001|Overall Study|Pregnancy|0|||
131107379|NCT03938545|472023809|FG002|Overall Study|Pregnancy|0|||
131107380|NCT03938545|472023810|FG003|Overall Study|Pregnancy|0|||
131107381|NCT03938545|472023807|FG000|Overall Study|Study terminated by sponsor|6|||
131107382|NCT03938545|472023808|FG001|Overall Study|Study terminated by sponsor|4|||
131107383|NCT03938545|472023809|FG002|Overall Study|Study terminated by sponsor|2|||
131107384|NCT03938545|472023810|FG003|Overall Study|Study terminated by sponsor|4|||
131107385|NCT03938545|472023807|FG000|Overall Study|Withdrawal by Subject|0|||
131107386|NCT03938545|472023808|FG001|Overall Study|Withdrawal by Subject|1|||
131107387|NCT03938545|472023809|FG002|Overall Study|Withdrawal by Subject|0|||
131107388|NCT03938545|472023810|FG003|Overall Study|Withdrawal by Subject|0|||
131107389|NCT03938545|472023807|FG000|Overall Study|Adverse Event|1|||
131107390|NCT03938545|472023808|FG001|Overall Study|Adverse Event|0|||
131107391|NCT03938545|472023809|FG002|Overall Study|Adverse Event|0|||
131107392|NCT03938545|472023810|FG003|Overall Study|Adverse Event|0|||
131107393|NCT01060540|472023811|FG000|Overall Study|Withdrawal by Subject|10|||
131107394|NCT01060540|472023812|FG001|Overall Study|Withdrawal by Subject|20|||
131107395|NCT01060540|472023811|FG000|Overall Study|Lost to Follow-up|52|||
131107396|NCT01060540|472023812|FG001|Overall Study|Lost to Follow-up|43|||
131107397|NCT01060540|472023811|FG000|Overall Study|Death|2|||
131107398|NCT01060540|472023812|FG001|Overall Study|Death|1|||
131107399|NCT01060540|472023811|FG000|Overall Study|Physician Decision|0|||
131107400|NCT01060540|472023812|FG001|Overall Study|Physician Decision|1|||
131107401|NCT01222507|472023813|FG000|Overall Study|Physician Decision|1|||
131107402|NCT01222507|472023813|FG000|Overall Study|Withdrawal by Subject|1|||
131107403|NCT02647320|472023814|FG000|Overall Study|Adverse Event|0|||
131107404|NCT02647320|472023815|FG001|Overall Study|Adverse Event|1|||
131107405|NCT02647320|472023816|FG002|Overall Study|Adverse Event|3|||
131107406|NCT02647320|472023817|FG003|Overall Study|Adverse Event|2|||
131107407|NCT02647320|472023818|FG004|Overall Study|Adverse Event|1|||
131107408|NCT02647320|472023814|FG000|Overall Study|Protocol Violation|0|||
131107409|NCT02647320|472023815|FG001|Overall Study|Protocol Violation|0|||
131107410|NCT02647320|472023816|FG002|Overall Study|Protocol Violation|3|||
131107411|NCT02647320|472023817|FG003|Overall Study|Protocol Violation|0|||
131107412|NCT02647320|472023818|FG004|Overall Study|Protocol Violation|0|||
130889021|NCT02908672|471225199|FG000|Run-in Period|Withdrawal by Subject|3|||
130889022|NCT02908672|471225200|FG001|Run-in Period|Withdrawal by Subject|9|||
131107413|NCT02647320|472023814|FG000|Overall Study|Withdrawal by Subject|7|||
131107414|NCT02647320|472023815|FG001|Overall Study|Withdrawal by Subject|4|||
131107415|NCT02647320|472023816|FG002|Overall Study|Withdrawal by Subject|2|||
131107416|NCT02647320|472023817|FG003|Overall Study|Withdrawal by Subject|2|||
131107417|NCT02647320|472023818|FG004|Overall Study|Withdrawal by Subject|7|||
131107418|NCT02647320|472023814|FG000|Overall Study|Persistent hyperglycemia|0|||
131107419|NCT02647320|472023815|FG001|Overall Study|Persistent hyperglycemia|1|||
131107420|NCT02647320|472023816|FG002|Overall Study|Persistent hyperglycemia|1|||
131107421|NCT02647320|472023817|FG003|Overall Study|Persistent hyperglycemia|1|||
131107422|NCT02647320|472023818|FG004|Overall Study|Persistent hyperglycemia|1|||
131107423|NCT02647320|472023814|FG000|Overall Study|Study terminated by sponsor|1|||
131107424|NCT02647320|472023815|FG001|Overall Study|Study terminated by sponsor|1|||
131107425|NCT02647320|472023816|FG002|Overall Study|Study terminated by sponsor|1|||
131107426|NCT02647320|472023817|FG003|Overall Study|Study terminated by sponsor|1|||
131107427|NCT02647320|472023818|FG004|Overall Study|Study terminated by sponsor|2|||
131107428|NCT02647320|472023814|FG000|Overall Study|Reason not provided|0|||
131107429|NCT02647320|472023815|FG001|Overall Study|Reason not provided|0|||
131107430|NCT02647320|472023816|FG002|Overall Study|Reason not provided|1|||
131107431|NCT02647320|472023817|FG003|Overall Study|Reason not provided|0|||
131107432|NCT02647320|472023818|FG004|Overall Study|Reason not provided|2|||
131107433|NCT02647320|472023814|FG000|Overall Study|Lost to Follow-up|1|||
131107434|NCT02647320|472023815|FG001|Overall Study|Lost to Follow-up|1|||
131107435|NCT02647320|472023816|FG002|Overall Study|Lost to Follow-up|0|||
131107436|NCT02647320|472023817|FG003|Overall Study|Lost to Follow-up|0|||
131107437|NCT02647320|472023818|FG004|Overall Study|Lost to Follow-up|0|||
131107438|NCT02647320|472023814|FG000|Overall Study|Develop anemia|1|||
131107439|NCT02647320|472023815|FG001|Overall Study|Develop anemia|0|||
131107440|NCT02647320|472023816|FG002|Overall Study|Develop anemia|0|||
131107441|NCT02647320|472023817|FG003|Overall Study|Develop anemia|0|||
131107442|NCT02647320|472023818|FG004|Overall Study|Develop anemia|0|||
131107443|NCT02647320|472023814|FG000|Overall Study|Lack of Efficacy|0|||
131107444|NCT02647320|472023815|FG001|Overall Study|Lack of Efficacy|0|||
131107445|NCT02647320|472023816|FG002|Overall Study|Lack of Efficacy|0|||
131107446|NCT02647320|472023817|FG003|Overall Study|Lack of Efficacy|1|||
131107447|NCT02647320|472023818|FG004|Overall Study|Lack of Efficacy|0|||
131107448|NCT02647320|472023814|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
131107449|NCT02647320|472023815|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
131107450|NCT02647320|472023816|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
131107451|NCT02647320|472023817|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
131107452|NCT02647320|472023818|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
131107453|NCT00596427|472023822|FG000|Overall Study|Withdrawal by Subject|2|||
131107454|NCT00596427|472023823|FG001|Overall Study|Withdrawal by Subject|2|||
131107455|NCT00596427|472023822|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
131107456|NCT00596427|472023823|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
131107457|NCT00596427|472023822|FG000|Overall Study|Protocol Violation|1|||
131107458|NCT00596427|472023823|FG001|Overall Study|Protocol Violation|0|||
131107459|NCT00320541|472023824|FG000|Overall Study|Adverse Event|21|||
131107460|NCT00320541|472023825|FG001|Overall Study|Adverse Event|19|||
131107461|NCT00320541|472023824|FG000|Overall Study|Protocol Violation|0|||
131107462|NCT00320541|472023825|FG001|Overall Study|Protocol Violation|1|||
131107463|NCT00320541|472023824|FG000|Overall Study|Withdrawal by Subject|12|||
131107464|NCT00320541|472023825|FG001|Overall Study|Withdrawal by Subject|16|||
131107465|NCT00320541|472023824|FG000|Overall Study|Physician Decision|9|||
131107466|NCT00320541|472023825|FG001|Overall Study|Physician Decision|13|||
131107467|NCT00320541|472023824|FG000|Overall Study|Other|3|||
131107468|NCT00320541|472023825|FG001|Overall Study|Other|4|||
131107469|NCT00320541|472023824|FG000|Overall Study|Sponsor Decision|2|||
131107470|NCT00320541|472023825|FG001|Overall Study|Sponsor Decision|1|||
131107471|NCT00320541|472023824|FG000|Overall Study|Death due to Study Disease|1|||
131107472|NCT00320541|472023825|FG001|Overall Study|Death due to Study Disease|3|||
131107473|NCT00320541|472023824|FG000|Overall Study|Death due to Adverse Event(s)|1|||
131107474|NCT00320541|472023825|FG001|Overall Study|Death due to Adverse Event(s)|0|||
131107475|NCT00320541|472023824|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
131107476|NCT00320541|472023825|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
131107477|NCT03057977|472023828|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
131107478|NCT03057977|472023829|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
131107479|NCT03057977|472023828|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
131107480|NCT03057977|472023829|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
131107481|NCT03057977|472023828|FG000|Discontinuation From Treatment|Protocol Violation|6|||
131107482|NCT03057977|472023829|FG001|Discontinuation From Treatment|Protocol Violation|5|||
131107483|NCT03057977|472023828|FG000|Discontinuation From Treatment|Not treated|4|||
131107484|NCT03057977|472023829|FG001|Discontinuation From Treatment|Not treated|0|||
131107485|NCT03057977|472023828|FG000|Discontinuation From Treatment|Adverse Event|343|||
131107486|NCT03057977|472023829|FG001|Discontinuation From Treatment|Adverse Event|337|||
131107487|NCT03057977|472023828|FG000|Discontinuation From Treatment|Reason Unknown|0|||
131107488|NCT03057977|472023829|FG001|Discontinuation From Treatment|Reason Unknown|1|||
131107489|NCT03057977|472023828|FG000|Discontinuation From Treatment|Personal Reasons|1|||
131107490|NCT03057977|472023829|FG001|Discontinuation From Treatment|Personal Reasons|1|||
131107491|NCT03057977|472023828|FG000|Discontinuation From Treatment|Unblinded medication|1|||
131107492|NCT03057977|472023829|FG001|Discontinuation From Treatment|Unblinded medication|0|||
131107493|NCT03057977|472023828|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
131107494|NCT03057977|472023829|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
131107495|NCT03057977|472023828|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
131107496|NCT03057977|472023829|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
131107497|NCT03057977|472023828|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
131107498|NCT03057977|472023829|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
131107499|NCT03057977|472023828|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
131107500|NCT03057977|472023829|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
131107501|NCT03057977|472023828|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
131107502|NCT03057977|472023829|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
131107503|NCT03057977|472023828|FG000|Discontinuation From Treatment|Not attending study visit|3|||
131107504|NCT03057977|472023829|FG001|Discontinuation From Treatment|Not attending study visit|10|||
131107505|NCT03057977|472023828|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
131107506|NCT03057977|472023829|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
131107507|NCT03057977|472023828|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
131107508|NCT03057977|472023829|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
131107509|NCT03057977|472023828|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
131107510|NCT03057977|472023829|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
131107511|NCT03057977|472023828|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
131107512|NCT03057977|472023829|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
131107513|NCT03057977|472023828|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
131107514|NCT03057977|472023829|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
131107515|NCT02401867|472023830|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
131107516|NCT02401867|472023830|FG000|Analysis|Cervical assay could not be conducted|9|||
131107517|NCT01650246|472023831|FG000|Overall Study|Adverse Event|23|||
131107518|NCT01650246|472023831|FG000|Overall Study|Protocol Violation|5|||
131107519|NCT01650246|472023831|FG000|Overall Study|Sponsor terminated study|53|||
131107520|NCT01650246|472023831|FG000|Overall Study|Lost to Follow-up|5|||
131107521|NCT01650246|472023831|FG000|Overall Study|Withdrawal by Subject|26|||
131107522|NCT01650246|472023831|FG000|Overall Study|Death|1|||
131107523|NCT01650246|472023831|FG000|Overall Study|Lack of Efficacy|30|||
131107524|NCT00953407|472023832|FG000|Overall Study|Failed inclusion criteria|1|||
131107525|NCT00953407|472023833|FG001|Overall Study|Failed inclusion criteria|1|||
131107526|NCT00953407|472023834|FG002|Overall Study|Failed inclusion criteria|1|||
131107527|NCT00953407|472023835|FG003|Overall Study|Failed inclusion criteria|1|||
131022583|NCT00277355|471714686|FG000|Overall Study|Withdrawal by Subject|3|||
131022584|NCT00277355|471714687|FG001|Overall Study|Withdrawal by Subject|3|||
131022585|NCT00277355|471714686|FG000|Overall Study|Lost to Follow-up|2|||
131022586|NCT00277355|471714687|FG001|Overall Study|Lost to Follow-up|2|||
131022587|NCT00277355|471714686|FG000|Overall Study|Adverse Event|5|||
131022588|NCT00277355|471714687|FG001|Overall Study|Adverse Event|0|||
131022589|NCT00277355|471714686|FG000|Overall Study|Death|3|||
131022590|NCT00277355|471714687|FG001|Overall Study|Death|0|||
131022591|NCT00277355|471714686|FG000|Overall Study|Physician Decision|1|||
131022592|NCT00277355|471714687|FG001|Overall Study|Physician Decision|0|||
131022593|NCT05489484|471714695|FG000|Overall Study|withdrawn|1|||
131022594|NCT00444600|471714698|FG000|Overall Study|Death|7|||
131022595|NCT00444600|471714699|FG001|Overall Study|Death|5|||
131022596|NCT00444600|471714700|FG002|Overall Study|Death|3|||
131022597|NCT00444600|471714701|FG003|Overall Study|Death|2|||
131022598|NCT00444600|471714698|FG000|Overall Study|Dropped|11|||
131022599|NCT00444600|471714699|FG001|Overall Study|Dropped|11|||
131022600|NCT00444600|471714700|FG002|Overall Study|Dropped|7|||
131022601|NCT00444600|471714701|FG003|Overall Study|Dropped|7|||
131022602|NCT00444600|471714698|FG000|Overall Study|Missed visit|1|||
131022603|NCT00444600|471714699|FG001|Overall Study|Missed visit|0|||
131022604|NCT00444600|471714700|FG002|Overall Study|Missed visit|0|||
131022605|NCT00444600|471714701|FG003|Overall Study|Missed visit|1|||
131022606|NCT05132478|471714702|FG000|Overall Study|did not complete survey after consent|1|||
131022607|NCT05132478|471714703|FG001|Overall Study|did not complete survey after consent|1|||
131022608|NCT05132478|471714702|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
131022609|NCT05132478|471714703|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
131022610|NCT02549170|471714704|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
131022611|NCT02549170|471714705|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
131022612|NCT02549170|471714706|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
131022613|NCT02549170|471714707|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
131022614|NCT02549170|471714708|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
131022615|NCT02549170|471714704|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
131022616|NCT02549170|471714705|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
131022617|NCT02549170|471714706|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
131022618|NCT02549170|471714707|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
131022619|NCT02549170|471714708|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
131022620|NCT02549170|471714704|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
131022621|NCT02549170|471714705|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
131107528|NCT00953407|472023836|FG004|Overall Study|Failed inclusion criteria|1|||
131107529|NCT00953407|472023832|FG000|Overall Study|Lost to Follow-up|0|||
131107530|NCT00953407|472023833|FG001|Overall Study|Lost to Follow-up|0|||
131107531|NCT00953407|472023834|FG002|Overall Study|Lost to Follow-up|0|||
131107532|NCT00953407|472023835|FG003|Overall Study|Lost to Follow-up|1|||
131107533|NCT00953407|472023836|FG004|Overall Study|Lost to Follow-up|0|||
131107534|NCT03435497|472023838|FG000|Overall Study|Lost to Follow-up|1|||
131107535|NCT03435497|472023839|FG001|Overall Study|Lost to Follow-up|0|||
131107536|NCT03435497|472023838|FG000|Overall Study|Death|1|||
131107537|NCT03435497|472023839|FG001|Overall Study|Death|0|||
131107538|NCT03435497|472023838|FG000|Overall Study|Withdrawal by Subject|0|||
131107539|NCT03435497|472023839|FG001|Overall Study|Withdrawal by Subject|4|||
131107540|NCT03435497|472023838|FG000|Overall Study|Wrong survey administered|0|||
131107541|NCT03435497|472023839|FG001|Overall Study|Wrong survey administered|2|||
131107542|NCT02795429|472023840|FG000|Overall Study|Adverse Event|1|||
131107543|NCT02795429|472023841|FG001|Overall Study|Adverse Event|2|||
131107544|NCT02795429|472023842|FG002|Overall Study|Adverse Event|1|||
131107545|NCT02795429|472023843|FG003|Overall Study|Adverse Event|2|||
131107546|NCT02795429|472023844|FG004|Overall Study|Adverse Event|1|||
131107547|NCT02795429|472023840|FG000|Overall Study|Death|1|||
131107548|NCT02795429|472023841|FG001|Overall Study|Death|0|||
131107549|NCT02795429|472023842|FG002|Overall Study|Death|1|||
131107550|NCT02795429|472023843|FG003|Overall Study|Death|2|||
131107551|NCT02795429|472023844|FG004|Overall Study|Death|1|||
131107552|NCT02795429|472023840|FG000|Overall Study|Physician Decision|0|||
131107553|NCT02795429|472023841|FG001|Overall Study|Physician Decision|0|||
131107554|NCT02795429|472023842|FG002|Overall Study|Physician Decision|2|||
131107555|NCT02795429|472023843|FG003|Overall Study|Physician Decision|1|||
131107556|NCT02795429|472023844|FG004|Overall Study|Physician Decision|5|||
131107557|NCT02795429|472023840|FG000|Overall Study|Progressive disease|3|||
131107558|NCT02795429|472023841|FG001|Overall Study|Progressive disease|7|||
131107559|NCT02795429|472023842|FG002|Overall Study|Progressive disease|6|||
131107560|NCT02795429|472023843|FG003|Overall Study|Progressive disease|26|||
131107561|NCT02795429|472023844|FG004|Overall Study|Progressive disease|20|||
131107562|NCT02795429|472023840|FG000|Overall Study|Subject/guardian decision|1|||
131107563|NCT02795429|472023841|FG001|Overall Study|Subject/guardian decision|1|||
131107564|NCT02795429|472023842|FG002|Overall Study|Subject/guardian decision|1|||
131107565|NCT02795429|472023843|FG003|Overall Study|Subject/guardian decision|1|||
131107566|NCT02795429|472023844|FG004|Overall Study|Subject/guardian decision|3|||
131107567|NCT00701779|472023845|FG000|Overall Study|Adverse Event|6|||
131107568|NCT00701779|472023845|FG000|Overall Study|Lost to Follow-up|1|||
131107569|NCT00701779|472023845|FG000|Overall Study|Withdrawal by Subject|2|||
131107570|NCT03645057|472023846|FG000|Randomization to Baseline|Lost to Follow-up|1|||
131107571|NCT03645057|472023847|FG001|Randomization to Baseline|Lost to Follow-up|0|||
131107572|NCT03645057|472023848|FG002|Randomization to Baseline|Lost to Follow-up|1|||
131107573|NCT03645057|472023849|FG003|Randomization to Baseline|Lost to Follow-up|0|||
131107574|NCT03645057|472023846|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
131107575|NCT03645057|472023847|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
131107576|NCT03645057|472023848|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
131107577|NCT03645057|472023849|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
131107578|NCT03645057|472023846|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
131107579|NCT03645057|472023847|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
131107580|NCT03645057|472023848|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
131107581|NCT03645057|472023849|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
131107582|NCT03645057|472023846|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
131107583|NCT03645057|472023847|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
131107584|NCT03645057|472023848|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
131107585|NCT03645057|472023849|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
131107586|NCT01873495|472023850|FG000|Overall Study|Withdrawal by Subject|1|||
131107587|NCT01873495|472023850|FG000|Overall Study|Physician Decision|3|||
131107588|NCT01873495|472023850|FG000|Overall Study|Adverse Event|1|||
131107589|NCT01873495|472023850|FG000|Overall Study|Removed for Transplantation|1|||
131107590|NCT01873495|472023850|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
131107591|NCT01206777|472023851|FG000|Overall Study|Death|1|||
131107592|NCT01206777|472023851|FG000|Overall Study|Adverse Event|1|||
131107593|NCT02080221|472023852|FG000|Overall Study|Withdrawal by Subject|1|||
131107594|NCT02080221|472023852|FG000|Overall Study|Clinical Progression of Disease|1|||
131107595|NCT00842985|472023857|FG000|Screening|Did not meet entrance requirements|27|||
131107596|NCT00842985|472023857|FG000|First Intervention|Withdrawal by Subject|3|||
131107597|NCT00842985|472023857|FG000|First Intervention|Protocol Violation|3|||
131107598|NCT00842985|472023857|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
131107599|NCT00842985|472023857|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
131107600|NCT01000636|472023860|FG000|Overall Study|Withdrawal by Subject|1|||
131107601|NCT01000636|472023860|FG000|Overall Study|Adverse Event|1|||
131107602|NCT03451162|472023861|FG000|Overall Study|Lost to Follow-up|1|||
131107603|NCT03451162|472023862|FG001|Overall Study|Lost to Follow-up|0|||
131107604|NCT03451162|472023863|FG002|Overall Study|Lost to Follow-up|0|||
131107605|NCT03451162|472023864|FG003|Overall Study|Lost to Follow-up|0|||
131022622|NCT02549170|471714706|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
131022623|NCT02549170|471714707|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
131022624|NCT02549170|471714708|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
131022625|NCT01414738|471714709|FG000|Overall Study|Death|26|||
131022626|NCT01414738|471714709|FG000|Overall Study|Refused testing|5|||
131022627|NCT01414738|471714709|FG000|Overall Study|Lost to Follow-up|2|||
131022628|NCT01414738|471714709|FG000|Overall Study|Refused, disease progression|8|||
131022629|NCT01414738|471714709|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
131022630|NCT02379819|471714711|FG000|Overall Study|Withdrawal by Subject|10|||
131022631|NCT02379819|471714711|FG000|Overall Study|Death|2|||
131022632|NCT02379819|471714711|FG000|Overall Study|Lack of Efficacy|1|||
131022633|NCT02379819|471714711|FG000|Overall Study|Lost to Follow-up|1|||
131022634|NCT00350792|471714716|FG000|Overall Study|Adverse Event|11|||
131022635|NCT00350792|471714716|FG000|Overall Study|Death from Study Disease|1|||
131022636|NCT00350792|471714716|FG000|Overall Study|Death from Study Drug Toxicity|1|||
131022637|NCT00350792|471714716|FG000|Overall Study|Death Not Study Drug Related|2|||
131022638|NCT00350792|471714716|FG000|Overall Study|Protocol Violation|1|||
131022639|NCT00350792|471714716|FG000|Overall Study|Withdrawal by Subject|4|||
131022640|NCT00350792|471714716|FG000|Overall Study|Physician Decision|2|||
131022641|NCT00350792|471714716|FG000|Overall Study|Lack of Efficacy|11|||
131022642|NCT00914589|471714717|FG000|Overall Study|Adverse Event|1|||
131022643|NCT00914589|471714718|FG001|Overall Study|Adverse Event|0|||
131022644|NCT00914589|471714719|FG002|Overall Study|Adverse Event|1|||
131022645|NCT00914589|471714717|FG000|Overall Study|Protocol Violation|8|||
131022646|NCT00914589|471714718|FG001|Overall Study|Protocol Violation|6|||
131022647|NCT00914589|471714719|FG002|Overall Study|Protocol Violation|3|||
131022648|NCT00914589|471714717|FG000|Overall Study|unclassified|16|||
131022649|NCT00914589|471714718|FG001|Overall Study|unclassified|9|||
131022650|NCT00914589|471714719|FG002|Overall Study|unclassified|7|||
131022651|NCT00914589|471714717|FG000|Overall Study|Death|0|||
131022652|NCT00914589|471714718|FG001|Overall Study|Death|1|||
131022653|NCT00914589|471714719|FG002|Overall Study|Death|1|||
131022654|NCT03988023|471714720|FG000|Overall Study|Non-compliance|3|||
131022655|NCT03988023|471714721|FG001|Overall Study|Non-compliance|0|||
131022656|NCT03988023|471714720|FG000|Overall Study|Withdrawal by Subject|39|||
131022657|NCT03988023|471714721|FG001|Overall Study|Withdrawal by Subject|37|||
131022658|NCT03988023|471714720|FG000|Overall Study|Adverse Event|0|||
131022659|NCT03988023|471714721|FG001|Overall Study|Adverse Event|2|||
131022660|NCT03988023|471714720|FG000|Overall Study|Physician Decision|0|||
131022661|NCT03988023|471714721|FG001|Overall Study|Physician Decision|1|||
131022662|NCT03988023|471714720|FG000|Overall Study|Lost to Follow-up|5|||
131022663|NCT03988023|471714721|FG001|Overall Study|Lost to Follow-up|8|||
131022664|NCT03988023|471714720|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
131022665|NCT03988023|471714721|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
131022666|NCT03988023|471714720|FG000|Overall Study|Lack of Efficacy|3|||
131022667|NCT03988023|471714721|FG001|Overall Study|Lack of Efficacy|1|||
131022668|NCT03988023|471714720|FG000|Overall Study|COVID-19 pandemic|225|||
131022669|NCT03988023|471714721|FG001|Overall Study|COVID-19 pandemic|227|||
131022670|NCT03036813|471714722|FG000|Overall Study|Adverse Event|6|||
131022671|NCT03036813|471714723|FG001|Overall Study|Adverse Event|11|||
131022672|NCT03036813|471714724|FG002|Overall Study|Adverse Event|6|||
131022673|NCT03036813|471714722|FG000|Overall Study|Withdrawal by Subject|12|||
131022674|NCT03036813|471714723|FG001|Overall Study|Withdrawal by Subject|6|||
131022675|NCT03036813|471714724|FG002|Overall Study|Withdrawal by Subject|10|||
131022676|NCT03036813|471714722|FG000|Overall Study|Lost to Follow-up|1|||
131022677|NCT03036813|471714723|FG001|Overall Study|Lost to Follow-up|1|||
131022678|NCT03036813|471714724|FG002|Overall Study|Lost to Follow-up|0|||
131022679|NCT03036813|471714722|FG000|Overall Study|Physician Decision|2|||
131022680|NCT03036813|471714723|FG001|Overall Study|Physician Decision|1|||
131022681|NCT03036813|471714724|FG002|Overall Study|Physician Decision|1|||
131022682|NCT03036813|471714722|FG000|Overall Study|Non-Compliance|1|||
131022683|NCT03036813|471714723|FG001|Overall Study|Non-Compliance|5|||
131022684|NCT03036813|471714724|FG002|Overall Study|Non-Compliance|3|||
131022685|NCT03036813|471714722|FG000|Overall Study|Pregnancy|0|||
131022686|NCT03036813|471714723|FG001|Overall Study|Pregnancy|0|||
131022687|NCT03036813|471714724|FG002|Overall Study|Pregnancy|1|||
131022688|NCT03036813|471714722|FG000|Overall Study|Other|0|||
131022689|NCT03036813|471714723|FG001|Overall Study|Other|3|||
131022690|NCT03036813|471714724|FG002|Overall Study|Other|5|||
130767069|NCT01857102|470770713|FG000|Period 1|Unsatisfactory Visual Response|1|||
130767070|NCT01857102|470770714|FG001|Period 1|Unsatisfactory Visual Response|0|||
131022691|NCT00529100|471714728|FG000|Overall Study|Adverse Event|0|||
131022692|NCT00529100|471714729|FG001|Overall Study|Adverse Event|5|||
131022693|NCT00529100|471714728|FG000|Overall Study|Protocol Violation|0|||
131022694|NCT00529100|471714729|FG001|Overall Study|Protocol Violation|1|||
131022695|NCT00529100|471714728|FG000|Overall Study|Progressive Disease|0|||
131107606|NCT03451162|472023865|FG004|Overall Study|Lost to Follow-up|0|||
131022696|NCT00529100|471714729|FG001|Overall Study|Progressive Disease|1|||
131107607|NCT03451162|472023861|FG000|Overall Study|Physician Decision|0|||
131107608|NCT03451162|472023862|FG001|Overall Study|Physician Decision|1|||
131107609|NCT03451162|472023863|FG002|Overall Study|Physician Decision|0|||
131107610|NCT03451162|472023864|FG003|Overall Study|Physician Decision|0|||
131107611|NCT03451162|472023865|FG004|Overall Study|Physician Decision|0|||
131107612|NCT03451162|472023861|FG000|Overall Study|Withdrawal by Subject|1|||
131107613|NCT03451162|472023862|FG001|Overall Study|Withdrawal by Subject|1|||
131107614|NCT03451162|472023863|FG002|Overall Study|Withdrawal by Subject|0|||
131107615|NCT03451162|472023864|FG003|Overall Study|Withdrawal by Subject|0|||
131107616|NCT03451162|472023865|FG004|Overall Study|Withdrawal by Subject|0|||
131107617|NCT03305731|472023866|FG000|Overall Study|Protocol Violation|1|||
131107618|NCT03658668|472023867|FG000|Overall Study|Time Commitment|1|||
131107619|NCT03658668|472023868|FG001|Overall Study|Time Commitment|1|||
131107620|NCT01127139|472023869|FG000|Overall Study|Adverse Event|40|||
131107621|NCT01127139|472023869|FG000|Overall Study|Incompliance|12|||
131107622|NCT01127139|472023869|FG000|Overall Study|Lack of Efficacy|4|||
131107623|NCT01127139|472023869|FG000|Overall Study|Reason not specified|1|||
131107624|NCT04964414|472023873|FG000|Overall Study|Lost to Follow-up|10|||
131107625|NCT04964414|472023874|FG001|Overall Study|Lost to Follow-up|8|||
131107626|NCT04964414|472023873|FG000|Overall Study|Withdrawal by Subject|1|||
131107627|NCT04964414|472023874|FG001|Overall Study|Withdrawal by Subject|1|||
131107628|NCT01718353|472023875|FG000|Overall Study|Lost to Follow-up|0|||
131107629|NCT01718353|472023876|FG001|Overall Study|Lost to Follow-up|1|||
131107630|NCT01718353|472023875|FG000|Overall Study|Principal Investigator's Decision|10|||
131107631|NCT01718353|472023876|FG001|Overall Study|Principal Investigator's Decision|4|||
131107632|NCT01718353|472023875|FG000|Overall Study|Randomized but not treated|2|||
131107633|NCT01718353|472023876|FG001|Overall Study|Randomized but not treated|0|||
131107634|NCT00455325|472023877|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
131107635|NCT00455325|472023878|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
131107636|NCT00455325|472023879|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
131107637|NCT00455325|472023880|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
131107638|NCT00455325|472023877|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
131107639|NCT00455325|472023878|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
131107640|NCT00455325|472023879|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
131107641|NCT00455325|472023880|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
131107642|NCT00455325|472023877|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
131107643|NCT00455325|472023878|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
131107644|NCT00455325|472023879|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
131107645|NCT00455325|472023880|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
131107646|NCT00455325|472023877|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
131107647|NCT00455325|472023878|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
131107648|NCT00455325|472023879|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
131107649|NCT00455325|472023880|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
131107650|NCT00455325|472023877|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
131107651|NCT00455325|472023878|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
131107652|NCT00455325|472023879|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
131107653|NCT00455325|472023880|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
131107654|NCT00455325|472023877|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
131107655|NCT00455325|472023878|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
131107656|NCT00455325|472023879|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
131107657|NCT00455325|472023880|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
131107658|NCT00455325|472023877|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
131107659|NCT00455325|472023878|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
131107660|NCT00455325|472023879|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
131107661|NCT00455325|472023880|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
131107662|NCT02745392|472023889|FG000|Overall Study|Lost to Follow-up|0|||
131107663|NCT02745392|472023890|FG001|Overall Study|Lost to Follow-up|1|||
131107664|NCT02745392|472023891|FG002|Overall Study|Lost to Follow-up|0|||
131107665|NCT02745392|472023892|FG003|Overall Study|Lost to Follow-up|0|||
131107666|NCT01691768|472023893|FG000|Overall Study|Death|0|||
131107667|NCT01691768|472023894|FG001|Overall Study|Death|2|||
131107668|NCT01691768|472023893|FG000|Overall Study|Lost to Follow-up|4|||
131107669|NCT01691768|472023894|FG001|Overall Study|Lost to Follow-up|3|||
131107670|NCT01691768|472023893|FG000|Overall Study|Withdrawal by Subject|10|||
131107671|NCT01691768|472023894|FG001|Overall Study|Withdrawal by Subject|9|||
130767071|NCT01857102|470770713|FG000|Period 1|Physician Decision|1|||
130889023|NCT02908672|471225201|FG002|Run-in Period|Withdrawal by Subject|0|||
130889024|NCT02908672|471225202|FG003|Run-in Period|Withdrawal by Subject|0|||
131107672|NCT01691768|472023893|FG000|Overall Study|Relocated|0|||
131107673|NCT01691768|472023894|FG001|Overall Study|Relocated|1|||
131107674|NCT01691768|472023893|FG000|Overall Study|Investigator decision|1|||
131107675|NCT01691768|472023894|FG001|Overall Study|Investigator decision|1|||
131107676|NCT01959334|472023895|FG000|Second Dose|Adverse Event|1|||
131107677|NCT01959334|472023896|FG001|Second Dose|Adverse Event|0|||
130889025|NCT02908672|471225199|FG000|Triple Combination Period|Death|0|||
131107678|NCT01959334|472023895|FG000|Third Dose|Adverse Event|0|||
131107679|NCT01959334|472023896|FG001|Third Dose|Adverse Event|1|||
131107680|NCT00887432|472023897|FG000|Overall Study|Start Excluded Therapy|3|||
131107681|NCT00887432|472023898|FG001|Overall Study|Start Excluded Therapy|0|||
131107682|NCT00887432|472023897|FG000|Overall Study|Did not complete treatment|6|||
131107683|NCT00887432|472023898|FG001|Overall Study|Did not complete treatment|8|||
131107684|NCT00887432|472023897|FG000|Overall Study|Protocol Violation|2|||
131107685|NCT00887432|472023898|FG001|Overall Study|Protocol Violation|3|||
131107686|NCT00887432|472023897|FG000|Overall Study|Withdrawal by Subject|3|||
131107687|NCT00887432|472023898|FG001|Overall Study|Withdrawal by Subject|2|||
131107688|NCT00887432|472023897|FG000|Overall Study|Lost to Follow-up|1|||
131107689|NCT00887432|472023898|FG001|Overall Study|Lost to Follow-up|0|||
131107690|NCT00887432|472023897|FG000|Overall Study|No reason provided|0|||
131107691|NCT00887432|472023898|FG001|Overall Study|No reason provided|1|||
131107692|NCT04781387|472023899|FG000|Overall Study|Withdrawal by Subject|1|||
131107693|NCT04781387|472023900|FG001|Overall Study|Withdrawal by Subject|0|||
131107694|NCT04781387|472023901|FG002|Overall Study|Withdrawal by Subject|1|||
131107695|NCT04781387|472023899|FG000|Overall Study|Lost to Follow-up|1|||
131107696|NCT04781387|472023900|FG001|Overall Study|Lost to Follow-up|0|||
131107697|NCT04781387|472023901|FG002|Overall Study|Lost to Follow-up|0|||
131107698|NCT01636960|472023904|FG000|Induction Phase|Adverse Event|2|||
131107699|NCT01636960|472023904|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
131107700|NCT01636960|472023904|FG000|Maintenance Phase|Adverse Event|3|||
131107701|NCT01636960|472023904|FG000|Maintenance Phase|Progressive disease|1|||
131107702|NCT01209780|472023905|FG000|Overall Study|Adverse Event|0|||
131107703|NCT01209780|472023906|FG001|Overall Study|Adverse Event|1|||
131107704|NCT01209780|472023907|FG002|Overall Study|Adverse Event|0|||
131107705|NCT01209780|472023908|FG003|Overall Study|Adverse Event|0|||
131107706|NCT01209780|472023909|FG004|Overall Study|Adverse Event|0|||
131107707|NCT01209780|472023905|FG000|Overall Study|Withdrawal by Subject|9|||
131107708|NCT01209780|472023906|FG001|Overall Study|Withdrawal by Subject|2|||
131107709|NCT01209780|472023907|FG002|Overall Study|Withdrawal by Subject|1|||
131107710|NCT01209780|472023908|FG003|Overall Study|Withdrawal by Subject|1|||
131107711|NCT01209780|472023909|FG004|Overall Study|Withdrawal by Subject|0|||
131107712|NCT01209780|472023905|FG000|Overall Study|Lost to Follow-up|17|||
131107713|NCT01209780|472023906|FG001|Overall Study|Lost to Follow-up|12|||
131107714|NCT01209780|472023907|FG002|Overall Study|Lost to Follow-up|3|||
131107715|NCT01209780|472023908|FG003|Overall Study|Lost to Follow-up|9|||
131107716|NCT01209780|472023909|FG004|Overall Study|Lost to Follow-up|4|||
131107717|NCT01209780|472023905|FG000|Overall Study|Protocol Violation|0|||
131107718|NCT01209780|472023906|FG001|Overall Study|Protocol Violation|1|||
131107719|NCT01209780|472023907|FG002|Overall Study|Protocol Violation|0|||
131107720|NCT01209780|472023908|FG003|Overall Study|Protocol Violation|0|||
131107721|NCT01209780|472023909|FG004|Overall Study|Protocol Violation|0|||
131107722|NCT01209780|472023905|FG000|Overall Study|Inappropriate enrollment|0|||
131107723|NCT01209780|472023906|FG001|Overall Study|Inappropriate enrollment|2|||
131107724|NCT01209780|472023907|FG002|Overall Study|Inappropriate enrollment|0|||
131107725|NCT01209780|472023908|FG003|Overall Study|Inappropriate enrollment|0|||
131107726|NCT01209780|472023909|FG004|Overall Study|Inappropriate enrollment|1|||
131107727|NCT00505284|472023915|FG000|Overall Study|Adverse Event|3|||
131107728|NCT00505284|472023916|FG001|Overall Study|Adverse Event|7|||
131107729|NCT00505284|472023917|FG002|Overall Study|Adverse Event|9|||
131107730|NCT00505284|472023918|FG003|Overall Study|Adverse Event|14|||
131107731|NCT00505284|472023919|FG004|Overall Study|Adverse Event|22|||
131107732|NCT00505284|472023915|FG000|Overall Study|Protocol Violation|0|||
131107733|NCT00505284|472023916|FG001|Overall Study|Protocol Violation|1|||
131107734|NCT00505284|472023917|FG002|Overall Study|Protocol Violation|1|||
131107735|NCT00505284|472023918|FG003|Overall Study|Protocol Violation|0|||
131107736|NCT00505284|472023919|FG004|Overall Study|Protocol Violation|0|||
131107737|NCT00505284|472023915|FG000|Overall Study|Withdrawal by Subject|2|||
131107738|NCT00505284|472023916|FG001|Overall Study|Withdrawal by Subject|6|||
131107739|NCT00505284|472023917|FG002|Overall Study|Withdrawal by Subject|1|||
131107740|NCT00505284|472023918|FG003|Overall Study|Withdrawal by Subject|0|||
131107741|NCT00505284|472023919|FG004|Overall Study|Withdrawal by Subject|6|||
131107742|NCT00505284|472023915|FG000|Overall Study|Lack of Efficacy|0|||
131107743|NCT00505284|472023916|FG001|Overall Study|Lack of Efficacy|1|||
131107744|NCT00505284|472023917|FG002|Overall Study|Lack of Efficacy|1|||
131107745|NCT00505284|472023918|FG003|Overall Study|Lack of Efficacy|1|||
131107746|NCT00505284|472023919|FG004|Overall Study|Lack of Efficacy|1|||
131107747|NCT00505284|472023915|FG000|Overall Study|Physician Decision|0|||
131107748|NCT00505284|472023916|FG001|Overall Study|Physician Decision|1|||
131107749|NCT00505284|472023917|FG002|Overall Study|Physician Decision|0|||
131107750|NCT00505284|472023918|FG003|Overall Study|Physician Decision|0|||
131107751|NCT00505284|472023919|FG004|Overall Study|Physician Decision|0|||
131107752|NCT00505284|472023915|FG000|Overall Study|Other|5|||
131107753|NCT00505284|472023916|FG001|Overall Study|Other|0|||
131107754|NCT00505284|472023917|FG002|Overall Study|Other|0|||
131107755|NCT00505284|472023918|FG003|Overall Study|Other|4|||
131107756|NCT00505284|472023919|FG004|Overall Study|Other|4|||
131107757|NCT01275131|472023920|FG000|Period 1|Withdrawal by Subject|1|||
131107758|NCT01275131|472023921|FG001|Period 1|Withdrawal by Subject|0|||
131107759|NCT01275131|472023922|FG002|Period 1|Withdrawal by Subject|3|||
131107760|NCT01275131|472023923|FG003|Period 1|Withdrawal by Subject|2|||
131107761|NCT01275131|472023920|FG000|Period 1|Physician Decision|1|||
131107762|NCT01275131|472023921|FG001|Period 1|Physician Decision|0|||
131107763|NCT01275131|472023922|FG002|Period 1|Physician Decision|0|||
131107764|NCT01275131|472023923|FG003|Period 1|Physician Decision|0|||
131107765|NCT01275131|472023920|FG000|Period 2 (Crossover)|Adverse Event|0|||
131107766|NCT01275131|472023921|FG001|Period 2 (Crossover)|Adverse Event|1|||
131107767|NCT01275131|472023922|FG002|Period 2 (Crossover)|Adverse Event|0|||
131107768|NCT01275131|472023923|FG003|Period 2 (Crossover)|Adverse Event|0|||
131107769|NCT01275131|472023920|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
131107770|NCT01275131|472023921|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
131107771|NCT01275131|472023922|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
131107772|NCT01275131|472023923|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
131107773|NCT00731120|472023924|FG000|Overall Study|Adverse Event|7|||
131107774|NCT00731120|472023925|FG001|Overall Study|Adverse Event|6|||
131107775|NCT00731120|472023926|FG002|Overall Study|Adverse Event|8|||
131107776|NCT00731120|472023924|FG000|Overall Study|Lack of Efficacy|4|||
131107777|NCT00731120|472023925|FG001|Overall Study|Lack of Efficacy|5|||
131107778|NCT00731120|472023926|FG002|Overall Study|Lack of Efficacy|4|||
131107779|NCT00731120|472023924|FG000|Overall Study|Noncompliance with Study Drug|3|||
131107780|NCT00731120|472023925|FG001|Overall Study|Noncompliance with Study Drug|3|||
131107781|NCT00731120|472023926|FG002|Overall Study|Noncompliance with Study Drug|1|||
131107782|NCT00731120|472023924|FG000|Overall Study|Protocol Deviations|1|||
131107783|NCT00731120|472023925|FG001|Overall Study|Protocol Deviations|6|||
131107784|NCT00731120|472023926|FG002|Overall Study|Protocol Deviations|1|||
131107785|NCT00731120|472023924|FG000|Overall Study|Withdrawal of Consent|13|||
131107786|NCT00731120|472023925|FG001|Overall Study|Withdrawal of Consent|8|||
131107787|NCT00731120|472023926|FG002|Overall Study|Withdrawal of Consent|4|||
131107788|NCT00731120|472023924|FG000|Overall Study|Lost to Follow-up|10|||
131107789|NCT00731120|472023925|FG001|Overall Study|Lost to Follow-up|15|||
131107790|NCT00731120|472023926|FG002|Overall Study|Lost to Follow-up|17|||
131107791|NCT00731120|472023924|FG000|Overall Study|Other|4|||
131107792|NCT00731120|472023925|FG001|Overall Study|Other|0|||
131107793|NCT00731120|472023926|FG002|Overall Study|Other|1|||
131107794|NCT02434939|472023930|FG000|Overall Study|Lack of Efficacy|34|||
131107795|NCT02434939|472023931|FG001|Overall Study|Lack of Efficacy|48|||
131107796|NCT02434939|472023930|FG000|Overall Study|Withdrawal by Subject|3|||
131107797|NCT02434939|472023931|FG001|Overall Study|Withdrawal by Subject|0|||
131107798|NCT02434939|472023930|FG000|Overall Study|Adverse Event|0|||
131107799|NCT02434939|472023931|FG001|Overall Study|Adverse Event|1|||
131107800|NCT00069238|472023934|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
131107801|NCT00069238|472023935|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
131107802|NCT00069238|472023936|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
131107803|NCT00069238|472023934|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
131107804|NCT00069238|472023935|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
131107805|NCT00069238|472023936|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
131107806|NCT00069238|472023934|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
131107807|NCT00069238|472023935|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
131107808|NCT00069238|472023936|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
131107809|NCT01001832|472023937|FG000|Short-term Period|Adverse Event|2|||
131107810|NCT01001832|472023938|FG001|Short-term Period|Adverse Event|3|||
131107811|NCT01001832|472023937|FG000|Long-term Period|Adverse Event|2|||
131107812|NCT01001832|472023938|FG001|Long-term Period|Adverse Event|1|||
131107813|NCT01001832|472023937|FG000|Long-term Period|Withdrawal by Subject|1|||
131107814|NCT01001832|472023938|FG001|Long-term Period|Withdrawal by Subject|0|||
131107815|NCT01001832|472023937|FG000|Long-term Period|Lack of Efficacy|0|||
131107816|NCT01001832|472023938|FG001|Long-term Period|Lack of Efficacy|2|||
131107817|NCT01001832|472023937|FG000|Long-term Period|Other|1|||
131107818|NCT01001832|472023938|FG001|Long-term Period|Other|2|||
131107819|NCT01001832|472023937|FG000|Follow-up Period|Withdrawal by Subject|1|||
131107820|NCT01001832|472023938|FG001|Follow-up Period|Withdrawal by Subject|0|||
131107821|NCT01001832|472023937|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
131107822|NCT01001832|472023938|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
131107823|NCT01001832|472023937|FG000|Follow-up Period|Other|2|||
131107824|NCT01001832|472023938|FG001|Follow-up Period|Other|1|||
131107825|NCT01575028|472023945|FG000|Overall Study|Physician Decision|0|||
131107826|NCT01575028|472023946|FG001|Overall Study|Physician Decision|1|||
131107827|NCT01328717|472025139|FG000|Overall Study|Adverse Event|1|||
131107828|NCT03440320|472025140|FG000|Overall Study|Withdrawal by Subject|0|||
131107829|NCT03440320|472025141|FG001|Overall Study|Withdrawal by Subject|1|||
131107830|NCT01912456|472025142|FG000|Period 1|Physician Decision|0|||
131107831|NCT01912456|472025143|FG001|Period 1|Physician Decision|0|||
131107832|NCT01912456|472025144|FG002|Period 1|Physician Decision|1|||
131107833|NCT01912456|472025145|FG003|Period 1|Physician Decision|0|||
131107834|NCT01912456|472025142|FG000|Period 1|non-compliance|1|||
131107835|NCT01912456|472025143|FG001|Period 1|non-compliance|0|||
131107836|NCT01912456|472025144|FG002|Period 1|non-compliance|0|||
131107837|NCT01912456|472025145|FG003|Period 1|non-compliance|1|||
131107838|NCT01912456|472025142|FG000|Period 1|Adverse Event|1|||
131107839|NCT01912456|472025143|FG001|Period 1|Adverse Event|0|||
131107840|NCT01912456|472025144|FG002|Period 1|Adverse Event|0|||
131107841|NCT01912456|472025145|FG003|Period 1|Adverse Event|1|||
131107842|NCT01912456|472025142|FG000|Period 1|Withdrawal by Subject|0|||
131107843|NCT01912456|472025143|FG001|Period 1|Withdrawal by Subject|1|||
131107844|NCT01912456|472025144|FG002|Period 1|Withdrawal by Subject|1|||
131107845|NCT01912456|472025145|FG003|Period 1|Withdrawal by Subject|1|||
131107846|NCT01912456|472025142|FG000|Period 2|Lack of Efficacy|0|||
131107847|NCT01912456|472025143|FG001|Period 2|Lack of Efficacy|2|||
131107848|NCT01912456|472025144|FG002|Period 2|Lack of Efficacy|0|||
131107849|NCT01912456|472025145|FG003|Period 2|Lack of Efficacy|0|||
131107850|NCT01912456|472025142|FG000|Period 2|Adverse Event|0|||
131107851|NCT01912456|472025143|FG001|Period 2|Adverse Event|0|||
131107852|NCT01912456|472025144|FG002|Period 2|Adverse Event|0|||
131107853|NCT01912456|472025145|FG003|Period 2|Adverse Event|1|||
131107854|NCT01201343|472025146|FG000|Overall Study|Adverse Event|6|||
131107855|NCT01201343|472025146|FG000|Overall Study|Withdrawal by Subject|5|||
131107856|NCT01201343|472025146|FG000|Overall Study|Lost to Follow-up|2|||
131107857|NCT01201343|472025146|FG000|Overall Study|Lack of Efficacy|2|||
131107858|NCT01201343|472025146|FG000|Overall Study|Participant wrongly included in trial|1|||
131107859|NCT01201343|472025146|FG000|Overall Study|Randomized, not treated|3|||
131107860|NCT00001962|472025149|FG000|Overall Study|Lack of Efficacy|18|||
131107861|NCT00001962|472025149|FG000|Overall Study|Lack of Accrual|6|||
131107862|NCT00001962|472025149|FG000|Overall Study|Death|1|||
131107863|NCT00001962|472025149|FG000|Overall Study|Lost to Follow-up|2|||
131107864|NCT00001962|472025149|FG000|Overall Study|Adverse Event|1|||
131107865|NCT01440374|472025150|FG000|Part 1: Open-label Phase|Adverse Event|5|||
131107866|NCT01440374|472025151|FG001|Part 1: Open-label Phase|Adverse Event|0|||
131107867|NCT01440374|472025152|FG002|Part 1: Open-label Phase|Adverse Event|0|||
131107868|NCT01440374|472025153|FG003|Part 1: Open-label Phase|Adverse Event|0|||
131107869|NCT01440374|472025150|FG000|Part 1: Open-label Phase|Physician Decision|1|||
131107870|NCT01440374|472025151|FG001|Part 1: Open-label Phase|Physician Decision|0|||
131107871|NCT01440374|472025152|FG002|Part 1: Open-label Phase|Physician Decision|0|||
131107872|NCT01440374|472025153|FG003|Part 1: Open-label Phase|Physician Decision|0|||
131107873|NCT01440374|472025150|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
131107874|NCT01440374|472025151|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
131107875|NCT01440374|472025152|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
131107876|NCT01440374|472025153|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
131107877|NCT01440374|472025150|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
131107878|NCT01440374|472025151|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
131107879|NCT01440374|472025152|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
131107880|NCT01440374|472025153|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
131107881|NCT01440374|472025150|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
131107882|NCT01440374|472025151|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
131107883|NCT01440374|472025152|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
131107884|NCT01440374|472025153|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
131107885|NCT01440374|472025150|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
131107886|NCT01440374|472025151|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
131107887|NCT01440374|472025152|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
131107888|NCT01440374|472025153|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
131107889|NCT01440374|472025150|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
131107890|NCT01440374|472025151|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
131107891|NCT01440374|472025152|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
131107892|NCT01440374|472025153|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
131107893|NCT01440374|472025150|FG000|Part 2; Double-blind Phase|Not treated|0|||
131107894|NCT01440374|472025151|FG001|Part 2; Double-blind Phase|Not treated|0|||
131107895|NCT01440374|472025152|FG002|Part 2; Double-blind Phase|Not treated|1|||
131107896|NCT01440374|472025153|FG003|Part 2; Double-blind Phase|Not treated|0|||
131107897|NCT01440374|472025150|FG000|Part 3: Extension|Withdrawal by Subject|0|||
131107898|NCT01440374|472025151|FG001|Part 3: Extension|Withdrawal by Subject|0|||
131107899|NCT01440374|472025152|FG002|Part 3: Extension|Withdrawal by Subject|0|||
131107900|NCT01440374|472025153|FG003|Part 3: Extension|Withdrawal by Subject|5|||
131107901|NCT01440374|472025150|FG000|Part 3: Extension|Adverse Event|0|||
130686004|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
131107902|NCT01440374|472025151|FG001|Part 3: Extension|Adverse Event|0|||
131107903|NCT01440374|472025152|FG002|Part 3: Extension|Adverse Event|0|||
131107904|NCT01440374|472025153|FG003|Part 3: Extension|Adverse Event|13|||
131107905|NCT01440374|472025150|FG000|Part 3: Extension|Physician Decision|0|||
131107906|NCT01440374|472025151|FG001|Part 3: Extension|Physician Decision|0|||
131107907|NCT01440374|472025152|FG002|Part 3: Extension|Physician Decision|0|||
131107908|NCT01440374|472025153|FG003|Part 3: Extension|Physician Decision|14|||
131107909|NCT01177722|472025162|FG000|Overall Study|Serious Adverse Event|0|||
131107910|NCT01177722|472025163|FG001|Overall Study|Serious Adverse Event|0|||
131107911|NCT01177722|472025164|FG002|Overall Study|Serious Adverse Event|1|||
131107912|NCT01177722|472025165|FG003|Overall Study|Serious Adverse Event|0|||
131107913|NCT01177722|472025162|FG000|Overall Study|Protocol Violation|0|||
131107914|NCT01177722|472025163|FG001|Overall Study|Protocol Violation|0|||
131107915|NCT01177722|472025164|FG002|Overall Study|Protocol Violation|1|||
131107916|NCT01177722|472025165|FG003|Overall Study|Protocol Violation|0|||
131107917|NCT01177722|472025162|FG000|Overall Study|Lost to Follow-up|3|||
131107918|NCT01177722|472025163|FG001|Overall Study|Lost to Follow-up|4|||
131107919|NCT01177722|472025164|FG002|Overall Study|Lost to Follow-up|3|||
131107920|NCT01177722|472025165|FG003|Overall Study|Lost to Follow-up|1|||
131107921|NCT01177722|472025162|FG000|Overall Study|Withdrawal by Subject|10|||
131107922|NCT01177722|472025163|FG001|Overall Study|Withdrawal by Subject|6|||
131107923|NCT01177722|472025164|FG002|Overall Study|Withdrawal by Subject|4|||
131107924|NCT01177722|472025165|FG003|Overall Study|Withdrawal by Subject|6|||
131107925|NCT03442985|472025170|FG000|Overall Study|Sponsor Request|55|||
131107926|NCT03442985|472025171|FG001|Overall Study|Sponsor Request|60|||
131107927|NCT03442985|472025172|FG002|Overall Study|Sponsor Request|54|||
131107928|NCT03442985|472025170|FG000|Overall Study|Lost to Follow-up|5|||
131107929|NCT03442985|472025171|FG001|Overall Study|Lost to Follow-up|2|||
131107930|NCT03442985|472025172|FG002|Overall Study|Lost to Follow-up|7|||
131107931|NCT03442985|472025170|FG000|Overall Study|Withdrawal by Subject|2|||
131107932|NCT03442985|472025171|FG001|Overall Study|Withdrawal by Subject|3|||
131107933|NCT03442985|472025172|FG002|Overall Study|Withdrawal by Subject|4|||
131107934|NCT03442985|472025170|FG000|Overall Study|Adverse Event|0|||
131107935|NCT03442985|472025171|FG001|Overall Study|Adverse Event|1|||
131107936|NCT03442985|472025172|FG002|Overall Study|Adverse Event|0|||
131107937|NCT01716117|472025173|FG000|Overall Study|Death|5|||
131107938|NCT01716117|472025174|FG001|Overall Study|Death|2|||
131107939|NCT01716117|472025173|FG000|Overall Study|Withdrawal by Subject|2|||
131107940|NCT01716117|472025174|FG001|Overall Study|Withdrawal by Subject|0|||
131107941|NCT01386788|472025180|FG000|Overall Study|Lost to Follow-up|2|||
131107942|NCT02986334|472025183|FG000|Overall Study|Withdrawal by Subject|0|||
131107943|NCT02986334|472025184|FG001|Overall Study|Withdrawal by Subject|1|||
131107944|NCT02986334|472025185|FG002|Overall Study|Withdrawal by Subject|2|||
131107945|NCT02986334|472025183|FG000|Overall Study|Lost to Follow-up|1|||
131107946|NCT02986334|472025184|FG001|Overall Study|Lost to Follow-up|2|||
131107947|NCT02986334|472025185|FG002|Overall Study|Lost to Follow-up|1|||
131107948|NCT02986334|472025183|FG000|Overall Study|Adverse Event|0|||
131107949|NCT02986334|472025184|FG001|Overall Study|Adverse Event|2|||
131107950|NCT02986334|472025185|FG002|Overall Study|Adverse Event|1|||
131107951|NCT02986334|472025183|FG000|Overall Study|non compliance in phone ratings|2|||
131107952|NCT02986334|472025184|FG001|Overall Study|non compliance in phone ratings|1|||
131107953|NCT02986334|472025185|FG002|Overall Study|non compliance in phone ratings|2|||
131107954|NCT02986334|472025183|FG000|Overall Study|undisclosed comorbidities|0|||
131107955|NCT02986334|472025184|FG001|Overall Study|undisclosed comorbidities|1|||
131107956|NCT02986334|472025185|FG002|Overall Study|undisclosed comorbidities|1|||
131107957|NCT00120406|472025186|FG000|Overall Study|Death|9|||
131107958|NCT00120406|472025187|FG001|Overall Study|Death|4|||
131107959|NCT00120406|472025186|FG000|Overall Study|Withdrawal by Subject|5|||
131107960|NCT00120406|472025187|FG001|Overall Study|Withdrawal by Subject|7|||
131107961|NCT00120406|472025186|FG000|Overall Study|Lost to Follow-up|5|||
131107962|NCT00120406|472025187|FG001|Overall Study|Lost to Follow-up|2|||
131107963|NCT00120406|472025186|FG000|Overall Study|received non-study stent|0|||
131107964|NCT00120406|472025187|FG001|Overall Study|received non-study stent|2|||
131107965|NCT00120406|472025186|FG000|Overall Study|patient moved but has not withdrawn|0|||
131107966|NCT00120406|472025187|FG001|Overall Study|patient moved but has not withdrawn|1|||
131107967|NCT01295034|472025188|FG000|Overall Study|Lost to Follow-up|5|||
131107968|NCT01295034|472025189|FG001|Overall Study|Lost to Follow-up|5|||
131107969|NCT01313637|472025195|FG000|Overall Study|Adverse Event|17|||
131107970|NCT01313637|472025196|FG001|Overall Study|Adverse Event|24|||
131107971|NCT01313637|472025197|FG002|Overall Study|Adverse Event|25|||
131107972|NCT01313637|472025198|FG003|Overall Study|Adverse Event|18|||
131107973|NCT01313637|472025195|FG000|Overall Study|Lack of Efficacy|44|||
131107974|NCT01313637|472025196|FG001|Overall Study|Lack of Efficacy|38|||
131107975|NCT01313637|472025197|FG002|Overall Study|Lack of Efficacy|37|||
131107976|NCT01313637|472025198|FG003|Overall Study|Lack of Efficacy|24|||
131107977|NCT01313637|472025195|FG000|Overall Study|Protocol Violation|4|||
131107978|NCT01313637|472025196|FG001|Overall Study|Protocol Violation|3|||
131107979|NCT01313637|472025197|FG002|Overall Study|Protocol Violation|11|||
131107980|NCT01313637|472025198|FG003|Overall Study|Protocol Violation|5|||
131107981|NCT01313637|472025195|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
131107982|NCT01313637|472025196|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
131107983|NCT01313637|472025197|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
131107984|NCT01313637|472025198|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
131107985|NCT01313637|472025195|FG000|Overall Study|Lost to Follow-up|0|||
131107986|NCT01313637|472025196|FG001|Overall Study|Lost to Follow-up|2|||
131107987|NCT01313637|472025197|FG002|Overall Study|Lost to Follow-up|1|||
130767072|NCT01857102|470770714|FG001|Period 1|Physician Decision|0|||
131107988|NCT01313637|472025198|FG003|Overall Study|Lost to Follow-up|3|||
131107989|NCT01313637|472025195|FG000|Overall Study|Withdrawal by Subject|11|||
131107990|NCT01313637|472025196|FG001|Overall Study|Withdrawal by Subject|13|||
131107991|NCT01313637|472025197|FG002|Overall Study|Withdrawal by Subject|18|||
131107992|NCT01313637|472025198|FG003|Overall Study|Withdrawal by Subject|15|||
131107993|NCT04218084|472025200|FG000|Overall Study|Adverse Event|7|||
131107994|NCT04218084|472025201|FG001|Overall Study|Adverse Event|2|||
131107995|NCT04218084|472025200|FG000|Overall Study|Withdrawal of Consent|4|||
131107996|NCT04218084|472025201|FG001|Overall Study|Withdrawal of Consent|5|||
131107997|NCT04218084|472025200|FG000|Overall Study|Physician Decision|1|||
131107998|NCT04218084|472025201|FG001|Overall Study|Physician Decision|1|||
131107999|NCT04218084|472025200|FG000|Overall Study|Lost to Follow-up|1|||
131108000|NCT04218084|472025201|FG001|Overall Study|Lost to Follow-up|1|||
131108001|NCT04218084|472025200|FG000|Overall Study|Non-compliance with study drug|1|||
131108002|NCT04218084|472025201|FG001|Overall Study|Non-compliance with study drug|1|||
131108003|NCT04218084|472025200|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
131108004|NCT04218084|472025201|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
131108005|NCT04218084|472025200|FG000|Overall Study|Other|0|||
131108006|NCT04218084|472025201|FG001|Overall Study|Other|1|||
131108007|NCT04218084|472025200|FG000|Overall Study|Ongoing at data cut-off date|62|||
131108008|NCT04218084|472025201|FG001|Overall Study|Ongoing at data cut-off date|58|||
131108009|NCT05580588|472025202|FG000|Overall Study|Lack of Efficacy|12|||
131108010|NCT00211185|472025205|FG000|Overall Study|Death|2|||
131108011|NCT00211185|472025205|FG000|Overall Study|Disease progression|7|||
131108012|NCT00211185|472025205|FG000|Overall Study|Withdrawal by Subject|6|||
131108013|NCT00211185|472025205|FG000|Overall Study|Physician Decision|5|||
131108014|NCT00712673|472025206|FG000|Overall Study|Adverse Event|3|||
131108015|NCT00712673|472025207|FG001|Overall Study|Adverse Event|3|||
131108016|NCT00712673|472025208|FG002|Overall Study|Adverse Event|21|||
131108017|NCT00712673|472025209|FG003|Overall Study|Adverse Event|26|||
131108018|NCT00712673|472025206|FG000|Overall Study|Lack of Efficacy|2|||
131108019|NCT00712673|472025207|FG001|Overall Study|Lack of Efficacy|8|||
131108020|NCT00712673|472025208|FG002|Overall Study|Lack of Efficacy|8|||
131108021|NCT00712673|472025209|FG003|Overall Study|Lack of Efficacy|6|||
131108022|NCT00712673|472025206|FG000|Overall Study|Poor Compliance to Protocol|3|||
131108023|NCT00712673|472025207|FG001|Overall Study|Poor Compliance to Protocol|3|||
131108024|NCT00712673|472025208|FG002|Overall Study|Poor Compliance to Protocol|4|||
131108025|NCT00712673|472025209|FG003|Overall Study|Poor Compliance to Protocol|16|||
131108026|NCT00712673|472025206|FG000|Overall Study|Lost to Follow-up|1|||
131108027|NCT00712673|472025207|FG001|Overall Study|Lost to Follow-up|0|||
131108028|NCT00712673|472025208|FG002|Overall Study|Lost to Follow-up|2|||
131108029|NCT00712673|472025209|FG003|Overall Study|Lost to Follow-up|0|||
131108030|NCT00712673|472025206|FG000|Overall Study|Withdrawal by Subject|6|||
131108031|NCT00712673|472025207|FG001|Overall Study|Withdrawal by Subject|7|||
131108032|NCT00712673|472025208|FG002|Overall Study|Withdrawal by Subject|15|||
131108033|NCT00712673|472025209|FG003|Overall Study|Withdrawal by Subject|20|||
131108034|NCT00712673|472025206|FG000|Overall Study|Familial and Personal Reasons|5|||
131108035|NCT00712673|472025207|FG001|Overall Study|Familial and Personal Reasons|0|||
131108036|NCT00712673|472025208|FG002|Overall Study|Familial and Personal Reasons|5|||
131108037|NCT00712673|472025209|FG003|Overall Study|Familial and Personal Reasons|2|||
131108038|NCT00712673|472025206|FG000|Overall Study|Investigator's Decision|1|||
131108039|NCT00712673|472025207|FG001|Overall Study|Investigator's Decision|0|||
131108040|NCT00712673|472025208|FG002|Overall Study|Investigator's Decision|0|||
131108041|NCT00712673|472025209|FG003|Overall Study|Investigator's Decision|0|||
131108042|NCT00712673|472025206|FG000|Overall Study|Protocol Violation|0|||
131108043|NCT00712673|472025207|FG001|Overall Study|Protocol Violation|0|||
131108044|NCT00712673|472025208|FG002|Overall Study|Protocol Violation|2|||
131108045|NCT00712673|472025209|FG003|Overall Study|Protocol Violation|0|||
131108046|NCT03603028|472025210|FG000|Overall Study|Withdrawal by Subject|1|||
131108047|NCT01768117|472025215|FG000|Overall Study|Lost to Follow-up|1|||
131108048|NCT01768117|472025215|FG000|Overall Study|Withdrawal by Subject|2|||
131108049|NCT01768117|472025215|FG000|Overall Study|Protocol Violation|3|||
131108050|NCT01580969|472025216|FG000|Overall Study|Physician Decision|3|||
131108051|NCT01580969|472025217|FG001|Overall Study|Physician Decision|0|||
131108052|NCT01580969|472025218|FG002|Overall Study|Physician Decision|0|||
131108053|NCT02076178|472025224|FG000|Oral Phase|Adverse Event|0|||
131108054|NCT02076178|472025225|FG001|Oral Phase|Adverse Event|7|||
131108055|NCT02076178|472025224|FG000|Oral Phase|Withdrawal by Subject|0|||
131108056|NCT02076178|472025225|FG001|Oral Phase|Withdrawal by Subject|4|||
131108057|NCT02076178|472025224|FG000|Oral Phase|Physician Decision|0|||
131108058|NCT02076178|472025225|FG001|Oral Phase|Physician Decision|1|||
131108059|NCT02076178|472025224|FG000|Injection Phase|Protocol defined stopping criteria|1|||
131108060|NCT02076178|472025225|FG001|Injection Phase|Protocol defined stopping criteria|0|||
131108061|NCT02076178|472025224|FG000|Injection Phase|Withdrawal by Subject|0|||
131108062|NCT02076178|472025225|FG001|Injection Phase|Withdrawal by Subject|3|||
131108063|NCT02076178|472025224|FG000|Injection Phase|Physician Decision|0|||
131108064|NCT02076178|472025225|FG001|Injection Phase|Physician Decision|3|||
131108065|NCT02076178|472025224|FG000|Injection Phase|Lost to Follow-up|0|||
131022697|NCT00529100|471714728|FG000|Overall Study|Withdrawal by Subject|0|||
131022698|NCT00529100|471714729|FG001|Overall Study|Withdrawal by Subject|1|||
131022699|NCT00529100|471714728|FG000|Overall Study|Participant Ineligibility|0|||
131022700|NCT00529100|471714729|FG001|Overall Study|Participant Ineligibility|1|||
131022701|NCT00807937|471714730|FG000|Overall Study|Adverse Event|12|||
131022702|NCT00807937|471714731|FG001|Overall Study|Adverse Event|12|||
131022703|NCT00807937|471714732|FG002|Overall Study|Adverse Event|5|||
131022704|NCT00807937|471714733|FG003|Overall Study|Adverse Event|4|||
131022705|NCT00807937|471714730|FG000|Overall Study|Protocol Violation|4|||
131022706|NCT00807937|471714731|FG001|Overall Study|Protocol Violation|5|||
131022707|NCT00807937|471714732|FG002|Overall Study|Protocol Violation|3|||
131022708|NCT00807937|471714733|FG003|Overall Study|Protocol Violation|3|||
131022709|NCT00807937|471714730|FG000|Overall Study|Withdrawal by Subject|5|||
131022710|NCT00807937|471714731|FG001|Overall Study|Withdrawal by Subject|4|||
131022711|NCT00807937|471714732|FG002|Overall Study|Withdrawal by Subject|1|||
131022712|NCT00807937|471714733|FG003|Overall Study|Withdrawal by Subject|4|||
131022713|NCT00807937|471714730|FG000|Overall Study|Lost to Follow-up|4|||
131022714|NCT00807937|471714731|FG001|Overall Study|Lost to Follow-up|0|||
131022715|NCT00807937|471714732|FG002|Overall Study|Lost to Follow-up|2|||
131022716|NCT00807937|471714733|FG003|Overall Study|Lost to Follow-up|1|||
131022717|NCT00807937|471714730|FG000|Overall Study|Lack of Efficacy|0|||
131022718|NCT00807937|471714731|FG001|Overall Study|Lack of Efficacy|0|||
131022719|NCT00807937|471714732|FG002|Overall Study|Lack of Efficacy|1|||
131022720|NCT00807937|471714733|FG003|Overall Study|Lack of Efficacy|2|||
131022721|NCT00807937|471714730|FG000|Overall Study|Intake of prohibited medicine|0|||
131022722|NCT00807937|471714731|FG001|Overall Study|Intake of prohibited medicine|0|||
131022723|NCT00807937|471714732|FG002|Overall Study|Intake of prohibited medicine|2|||
131022724|NCT00807937|471714733|FG003|Overall Study|Intake of prohibited medicine|0|||
131022725|NCT00807937|471714730|FG000|Overall Study|All other reasons (not provided)|2|||
131022726|NCT00807937|471714731|FG001|Overall Study|All other reasons (not provided)|4|||
131022727|NCT00807937|471714732|FG002|Overall Study|All other reasons (not provided)|0|||
131022728|NCT00807937|471714733|FG003|Overall Study|All other reasons (not provided)|1|||
131022729|NCT04629950|471714736|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
131022730|NCT04629950|471714737|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
131022731|NCT04629950|471714738|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
131022732|NCT04629950|471714739|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
131022733|NCT04629950|471714736|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
131022734|NCT04629950|471714737|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
131022735|NCT04629950|471714738|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
131022736|NCT04629950|471714739|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
131022737|NCT04629950|471714736|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
131022738|NCT04629950|471714737|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
131022739|NCT04629950|471714738|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
131022740|NCT04629950|471714739|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
131022741|NCT04629950|471714736|FG000|Extension Study|Withdrawal by Subject|0|||
131022742|NCT04629950|471714737|FG001|Extension Study|Withdrawal by Subject|0|||
131022743|NCT04629950|471714738|FG002|Extension Study|Withdrawal by Subject|1|||
131022744|NCT04629950|471714739|FG003|Extension Study|Withdrawal by Subject|0|||
131022745|NCT04629950|471714736|FG000|Extension Study|Adverse Event|0|||
131022746|NCT04629950|471714737|FG001|Extension Study|Adverse Event|0|||
131022747|NCT04629950|471714738|FG002|Extension Study|Adverse Event|0|||
131022748|NCT04629950|471714739|FG003|Extension Study|Adverse Event|1|||
131022749|NCT00396084|471714740|FG000|Overall Study|Adverse Event|0|||
131022750|NCT00396084|471714741|FG001|Overall Study|Adverse Event|0|||
131022751|NCT00396084|471714742|FG002|Overall Study|Adverse Event|0|||
131022752|NCT00396084|471714743|FG003|Overall Study|Adverse Event|0|||
131022753|NCT00396084|471714744|FG004|Overall Study|Adverse Event|1|||
131022754|NCT00396084|471714745|FG005|Overall Study|Adverse Event|2|||
131022755|NCT00396084|471714740|FG000|Overall Study|Withdrawal by Subject|0|||
131022756|NCT00396084|471714741|FG001|Overall Study|Withdrawal by Subject|0|||
131022757|NCT00396084|471714742|FG002|Overall Study|Withdrawal by Subject|0|||
131022758|NCT00396084|471714743|FG003|Overall Study|Withdrawal by Subject|1|||
131022759|NCT00396084|471714744|FG004|Overall Study|Withdrawal by Subject|0|||
131022760|NCT00396084|471714745|FG005|Overall Study|Withdrawal by Subject|0|||
131022761|NCT02568683|471714746|FG000|Overall Study|Death|0|||
131022762|NCT02568683|471714747|FG001|Overall Study|Death|2|||
131022763|NCT02568683|471714746|FG000|Overall Study|Withdrew Consent|1|||
131022764|NCT02568683|471714747|FG001|Overall Study|Withdrew Consent|0|||
131022765|NCT02568683|471714746|FG000|Overall Study|Study Terminated By Sponsor|5|||
131022766|NCT02568683|471714747|FG001|Overall Study|Study Terminated By Sponsor|2|||
131022767|NCT01248936|471714766|FG000|Overall Study|Sponsor Decision|259|||
131108066|NCT02076178|472025225|FG001|Injection Phase|Lost to Follow-up|1|||
131022768|NCT01248936|471714766|FG000|Overall Study|Progression of Disease|50|||
131022769|NCT01248936|471714766|FG000|Overall Study|Death|26|||
131022770|NCT01248936|471714766|FG000|Overall Study|Withdrawal of Consent|20|||
131108067|NCT00710021|472025226|FG000|Overall Study|Lost to Follow-up|1|||
131108068|NCT00710021|472025227|FG001|Overall Study|Lost to Follow-up|0|||
131108069|NCT00710021|472025228|FG002|Overall Study|Lost to Follow-up|0|||
131108070|NCT00710021|472025226|FG000|Overall Study|Subject's Decision|0|||
131108071|NCT00710021|472025227|FG001|Overall Study|Subject's Decision|1|||
131108072|NCT00710021|472025228|FG002|Overall Study|Subject's Decision|0|||
131108073|NCT00710021|472025226|FG000|Overall Study|Subject misrandomized|0|||
131108074|NCT00710021|472025227|FG001|Overall Study|Subject misrandomized|1|||
131108075|NCT00710021|472025228|FG002|Overall Study|Subject misrandomized|1|||
131108076|NCT00710021|472025226|FG000|Overall Study|Physician Decision|0|||
131108077|NCT00710021|472025227|FG001|Overall Study|Physician Decision|1|||
131108078|NCT00710021|472025228|FG002|Overall Study|Physician Decision|0|||
131108079|NCT03581825|472025229|FG000|Period 1|Lens Discomfort|1|||
131108080|NCT03581825|472025230|FG001|Period 1|Lens Discomfort|0|||
131108081|NCT03581825|472025229|FG000|Period 2|Unsatisfactory Vision to Test|0|||
131108082|NCT03581825|472025230|FG001|Period 2|Unsatisfactory Vision to Test|1|||
131108083|NCT00511901|472025231|FG000|Overall Study|Withdrawal by Subject|1|||
131108084|NCT00511901|472025232|FG001|Overall Study|Withdrawal by Subject|3|||
131108085|NCT02447172|472025233|FG000|Overall Study|Adverse Event|11|||
131108086|NCT02447172|472025234|FG001|Overall Study|Adverse Event|8|||
131108087|NCT02447172|472025235|FG002|Overall Study|Adverse Event|7|||
131108088|NCT02447172|472025233|FG000|Overall Study|Death|3|||
131108089|NCT02447172|472025234|FG001|Overall Study|Death|1|||
131108090|NCT02447172|472025235|FG002|Overall Study|Death|0|||
131108091|NCT02447172|472025233|FG000|Overall Study|Protocol Violation|2|||
131108092|NCT02447172|472025234|FG001|Overall Study|Protocol Violation|1|||
131108093|NCT02447172|472025235|FG002|Overall Study|Protocol Violation|2|||
131108094|NCT02447172|472025233|FG000|Overall Study|Lost to Follow-up|7|||
131108095|NCT02447172|472025234|FG001|Overall Study|Lost to Follow-up|4|||
131108096|NCT02447172|472025235|FG002|Overall Study|Lost to Follow-up|4|||
131108097|NCT02447172|472025233|FG000|Overall Study|Withdrawal by Subject|5|||
131108098|NCT02447172|472025234|FG001|Overall Study|Withdrawal by Subject|1|||
131108099|NCT02447172|472025235|FG002|Overall Study|Withdrawal by Subject|3|||
131108100|NCT02447172|472025233|FG000|Overall Study|protocol specific treatment unrelated|3|||
131108101|NCT02447172|472025234|FG001|Overall Study|protocol specific treatment unrelated|0|||
131108102|NCT02447172|472025235|FG002|Overall Study|protocol specific treatment unrelated|2|||
131108103|NCT00529958|472025238|FG000|2-Year Follow-up|Lost to Follow-up|1|||
131108104|NCT00529958|472025239|FG001|2-Year Follow-up|Lost to Follow-up|2|||
131108105|NCT00529958|472025240|FG002|2-Year Follow-up|Lost to Follow-up|2|||
131108106|NCT00529958|472025238|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
131108107|NCT00529958|472025239|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
131108108|NCT00529958|472025240|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
131108109|NCT00529958|472025238|FG000|5-Year Follow-up|Lost to Follow-up|2|||
131108110|NCT00529958|472025239|FG001|5-Year Follow-up|Lost to Follow-up|3|||
131108111|NCT00529958|472025240|FG002|5-Year Follow-up|Lost to Follow-up|1|||
131108112|NCT00529958|472025238|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
131108113|NCT00529958|472025239|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
131108114|NCT00529958|472025240|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
131108115|NCT03316300|472025241|FG000|Overall Study|Withdrawal by Subject|3|||
131108116|NCT03316300|472025242|FG001|Overall Study|Withdrawal by Subject|2|||
131108117|NCT03316300|472025241|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
131108118|NCT03316300|472025242|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
131108119|NCT03316300|472025241|FG000|Overall Study|Adverse Event|1|||
131108120|NCT03316300|472025242|FG001|Overall Study|Adverse Event|0|||
131108121|NCT03316300|472025241|FG000|Overall Study|COVID-19|0|||
131108122|NCT03316300|472025242|FG001|Overall Study|COVID-19|1|||
131108123|NCT01315353|472025243|FG000|Overall Study|Death|2|||
131108124|NCT01315353|472025244|FG001|Overall Study|Death|1|||
131108125|NCT01315353|472025245|FG002|Overall Study|Death|0|||
131108126|NCT01315353|472025243|FG000|Overall Study|Withdrawal by Subject|2|||
131108127|NCT01315353|472025244|FG001|Overall Study|Withdrawal by Subject|6|||
131108128|NCT01315353|472025245|FG002|Overall Study|Withdrawal by Subject|1|||
131108129|NCT01315353|472025243|FG000|Overall Study|Lost to Follow-up|13|||
131108130|NCT01315353|472025244|FG001|Overall Study|Lost to Follow-up|6|||
131108131|NCT01315353|472025245|FG002|Overall Study|Lost to Follow-up|6|||
131108132|NCT01315353|472025243|FG000|Overall Study|Unwilling to adhere to requirements|5|||
131108133|NCT01315353|472025244|FG001|Overall Study|Unwilling to adhere to requirements|5|||
131108134|NCT01315353|472025245|FG002|Overall Study|Unwilling to adhere to requirements|4|||
131108135|NCT01315353|472025243|FG000|Overall Study|Site closing|7|||
131108136|NCT01315353|472025244|FG001|Overall Study|Site closing|4|||
131108137|NCT01315353|472025245|FG002|Overall Study|Site closing|0|||
131108138|NCT01315353|472025243|FG000|Overall Study|Taken off study by site in error|0|||
131108139|NCT01315353|472025244|FG001|Overall Study|Taken off study by site in error|1|||
131108140|NCT01315353|472025245|FG002|Overall Study|Taken off study by site in error|0|||
131108141|NCT01315353|472025243|FG000|Overall Study|Inadvertent randomization/assignment|0|||
131108142|NCT01315353|472025244|FG001|Overall Study|Inadvertent randomization/assignment|0|||
131108143|NCT01315353|472025245|FG002|Overall Study|Inadvertent randomization/assignment|2|||
131022771|NCT01248936|471714766|FG000|Overall Study|Adverse Event|8|||
131022772|NCT01248936|471714766|FG000|Overall Study|Lost to Follow-up|7|||
131022773|NCT01248936|471714766|FG000|Overall Study|Refused Treatment|1|||
131022774|NCT01248936|471714766|FG000|Overall Study|Other reason|3|||
131022775|NCT01388361|471714767|FG000|Overall Study|Adverse Event|0|||
131022776|NCT01388361|471714768|FG001|Overall Study|Adverse Event|5|||
131022777|NCT01388361|471714769|FG002|Overall Study|Adverse Event|1|||
131022778|NCT01388361|471714767|FG000|Overall Study|Protocol Violation|0|||
131022779|NCT01388361|471714768|FG001|Overall Study|Protocol Violation|0|||
131022780|NCT01388361|471714769|FG002|Overall Study|Protocol Violation|2|||
131022781|NCT01388361|471714767|FG000|Overall Study|Withdrawal criteria|12|||
131022782|NCT01388361|471714768|FG001|Overall Study|Withdrawal criteria|7|||
131022783|NCT01388361|471714769|FG002|Overall Study|Withdrawal criteria|10|||
131022784|NCT01388361|471714767|FG000|Overall Study|Unclassified|0|||
131022785|NCT01388361|471714768|FG001|Overall Study|Unclassified|0|||
131022786|NCT01388361|471714769|FG002|Overall Study|Unclassified|1|||
131022787|NCT00774852|471714772|FG000|Overall Study|Adverse Event|9|||
131022788|NCT00774852|471714773|FG001|Overall Study|Adverse Event|6|||
131022789|NCT00774852|471714772|FG000|Overall Study|Death|2|||
131022790|NCT00774852|471714773|FG001|Overall Study|Death|1|||
131022791|NCT00774852|471714772|FG000|Overall Study|Lack of Efficacy|3|||
131022792|NCT00774852|471714773|FG001|Overall Study|Lack of Efficacy|7|||
131022793|NCT00774852|471714772|FG000|Overall Study|Lost to Follow-up|9|||
131022794|NCT00774852|471714773|FG001|Overall Study|Lost to Follow-up|5|||
131022795|NCT00774852|471714772|FG000|Overall Study|Physician Decision|2|||
131022796|NCT00774852|471714773|FG001|Overall Study|Physician Decision|6|||
131022797|NCT00774852|471714772|FG000|Overall Study|Pregnancy|1|||
131022798|NCT00774852|471714773|FG001|Overall Study|Pregnancy|2|||
131022799|NCT00774852|471714772|FG000|Overall Study|Withdrawal by Subject|2|||
131022800|NCT00774852|471714773|FG001|Overall Study|Withdrawal by Subject|2|||
131022801|NCT00774852|471714772|FG000|Overall Study|Non-responder|15|||
131022802|NCT00774852|471714773|FG001|Overall Study|Non-responder|11|||
131022803|NCT00774852|471714772|FG000|Overall Study|Subject non-compliance|0|||
131022804|NCT00774852|471714773|FG001|Overall Study|Subject non-compliance|1|||
131022805|NCT00774852|471714772|FG000|Overall Study|Protocol Violation|1|||
131022806|NCT00774852|471714773|FG001|Overall Study|Protocol Violation|0|||
131022807|NCT00774852|471714772|FG000|Overall Study|Subject received prohibited medication|1|||
131022808|NCT00774852|471714773|FG001|Overall Study|Subject received prohibited medication|0|||
131022809|NCT04922021|471716021|FG000|Overall Study|Withdrawal by Subject|4|||
131022810|NCT04922021|471716022|FG001|Overall Study|Withdrawal by Subject|10|||
131022811|NCT04922021|471716021|FG000|Overall Study|Adverse Event|2|||
131022812|NCT04922021|471716022|FG001|Overall Study|Adverse Event|2|||
131022813|NCT04922021|471716021|FG000|Overall Study|Lack of Efficacy|0|||
131022814|NCT04922021|471716022|FG001|Overall Study|Lack of Efficacy|1|||
131022815|NCT04922021|471716021|FG000|Overall Study|Multiple reasons|1|||
131022816|NCT04922021|471716022|FG001|Overall Study|Multiple reasons|0|||
131022817|NCT02544074|471716032|FG000|Overall Study|Withdrawal by Subject|0|||
131022818|NCT02544074|471716033|FG001|Overall Study|Withdrawal by Subject|1|||
131022819|NCT02544074|471716034|FG002|Overall Study|Withdrawal by Subject|0|||
131022820|NCT02544074|471716035|FG003|Overall Study|Withdrawal by Subject|0|||
131022821|NCT02544074|471716036|FG004|Overall Study|Withdrawal by Subject|0|||
131022822|NCT02544074|471716037|FG005|Overall Study|Withdrawal by Subject|0|||
131022823|NCT02544074|471716038|FG006|Overall Study|Withdrawal by Subject|0|||
131022824|NCT02544074|471716039|FG007|Overall Study|Withdrawal by Subject|0|||
131022825|NCT02544074|471716040|FG008|Overall Study|Withdrawal by Subject|0|||
131022826|NCT02544074|471716041|FG009|Overall Study|Withdrawal by Subject|0|||
131022827|NCT02544074|471716042|FG010|Overall Study|Withdrawal by Subject|0|||
131022828|NCT02544074|471716043|FG011|Overall Study|Withdrawal by Subject|0|||
131022829|NCT02544074|471716044|FG012|Overall Study|Withdrawal by Subject|0|||
131022830|NCT02544074|471716045|FG013|Overall Study|Withdrawal by Subject|0|||
131022831|NCT02544074|471716046|FG014|Overall Study|Withdrawal by Subject|0|||
131022832|NCT02544074|471716047|FG015|Overall Study|Withdrawal by Subject|0|||
131022833|NCT02544074|471716048|FG016|Overall Study|Withdrawal by Subject|0|||
131022834|NCT02544074|471716049|FG017|Overall Study|Withdrawal by Subject|0|||
131022835|NCT02544074|471716050|FG018|Overall Study|Withdrawal by Subject|0|||
131022836|NCT02544074|471716051|FG019|Overall Study|Withdrawal by Subject|0|||
131022837|NCT02544074|471716052|FG020|Overall Study|Withdrawal by Subject|0|||
131022838|NCT02544074|471716032|FG000|Overall Study|Tablet error|0|||
131022839|NCT02544074|471716033|FG001|Overall Study|Tablet error|0|||
131022840|NCT02544074|471716034|FG002|Overall Study|Tablet error|0|||
131022841|NCT02544074|471716035|FG003|Overall Study|Tablet error|0|||
131022842|NCT02544074|471716036|FG004|Overall Study|Tablet error|0|||
131022843|NCT02544074|471716037|FG005|Overall Study|Tablet error|1|||
131022844|NCT02544074|471716038|FG006|Overall Study|Tablet error|0|||
131022845|NCT02544074|471716039|FG007|Overall Study|Tablet error|0|||
131022846|NCT02544074|471716040|FG008|Overall Study|Tablet error|0|||
131022847|NCT02544074|471716041|FG009|Overall Study|Tablet error|1|||
131022848|NCT02544074|471716042|FG010|Overall Study|Tablet error|0|||
131022849|NCT02544074|471716043|FG011|Overall Study|Tablet error|0|||
130889026|NCT02908672|471225200|FG001|Triple Combination Period|Death|0|||
130889027|NCT02908672|471225201|FG002|Triple Combination Period|Death|150|||
130889028|NCT02908672|471225202|FG003|Triple Combination Period|Death|127|||
130889029|NCT02908672|471225199|FG000|Triple Combination Period|Lost to Follow-up|0|||
130889030|NCT02908672|471225200|FG001|Triple Combination Period|Lost to Follow-up|0|||
130889031|NCT02908672|471225201|FG002|Triple Combination Period|Lost to Follow-up|6|||
130889032|NCT02908672|471225202|FG003|Triple Combination Period|Lost to Follow-up|8|||
130889033|NCT02908672|471225199|FG000|Triple Combination Period|Reason Not Specified|0|||
130889034|NCT02908672|471225200|FG001|Triple Combination Period|Reason Not Specified|0|||
130889035|NCT02908672|471225201|FG002|Triple Combination Period|Reason Not Specified|0|||
131022850|NCT02544074|471716044|FG012|Overall Study|Tablet error|0|||
131022851|NCT02544074|471716045|FG013|Overall Study|Tablet error|0|||
131022852|NCT02544074|471716046|FG014|Overall Study|Tablet error|0|||
131022853|NCT02544074|471716047|FG015|Overall Study|Tablet error|0|||
131022854|NCT02544074|471716048|FG016|Overall Study|Tablet error|0|||
131022855|NCT02544074|471716049|FG017|Overall Study|Tablet error|0|||
131022856|NCT02544074|471716050|FG018|Overall Study|Tablet error|0|||
131022857|NCT02544074|471716051|FG019|Overall Study|Tablet error|0|||
131022858|NCT02544074|471716052|FG020|Overall Study|Tablet error|0|||
131022859|NCT04139668|471716053|FG000|Overall Study|Withdrawal by Subject|1|||
131022860|NCT02581215|471716058|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
131022861|NCT02581215|471716059|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
131022862|NCT02581215|471716058|FG000|Overall Study|Eligibility Criteria Not Met|0|||
131022863|NCT02581215|471716059|FG001|Overall Study|Eligibility Criteria Not Met|1|||
131022864|NCT04279574|471716062|FG000|Overall Study|Death|1|||
131022865|NCT04279574|471716063|FG001|Overall Study|Death|0|||
131022866|NCT04279574|471716062|FG000|Overall Study|lost restoration, tooth fracture|1|||
131022867|NCT04279574|471716063|FG001|Overall Study|lost restoration, tooth fracture|0|||
131022868|NCT04279574|471716062|FG000|Overall Study|Lost to Follow-up|0|||
131022869|NCT04279574|471716063|FG001|Overall Study|Lost to Follow-up|1|||
131022870|NCT04188379|471716064|FG000|Overall Study|Withdrawal by Subject|10|||
131022871|NCT04188379|471716065|FG001|Overall Study|Withdrawal by Subject|3|||
131022872|NCT04188379|471716064|FG000|Overall Study|Physician Decision|0|||
131022873|NCT04188379|471716065|FG001|Overall Study|Physician Decision|1|||
131022874|NCT04188379|471716064|FG000|Overall Study|Adverse Event|3|||
131022875|NCT04188379|471716065|FG001|Overall Study|Adverse Event|1|||
131022876|NCT04188379|471716064|FG000|Overall Study|Pregnancy|1|||
131022877|NCT04188379|471716065|FG001|Overall Study|Pregnancy|0|||
131022878|NCT04188379|471716064|FG000|Overall Study|Lack of Efficacy|8|||
131022879|NCT04188379|471716065|FG001|Overall Study|Lack of Efficacy|5|||
131022880|NCT04188379|471716064|FG000|Overall Study|Other|0|||
131022881|NCT04188379|471716065|FG001|Overall Study|Other|3|||
131022882|NCT02566902|471716071|FG000|Overall Study|Protocol Violation|2|||
131022883|NCT02566902|471716072|FG001|Overall Study|Protocol Violation|1|||
131022884|NCT02411084|471716073|FG000|Overall Study|Lack of Efficacy|6|||
131022885|NCT02411084|471716074|FG001|Overall Study|Lack of Efficacy|3|||
131022886|NCT02411084|471716073|FG000|Overall Study|Death|5|||
131022887|NCT02411084|471716074|FG001|Overall Study|Death|4|||
131022888|NCT02411084|471716073|FG000|Overall Study|Adverse Event|2|||
131022889|NCT02411084|471716074|FG001|Overall Study|Adverse Event|1|||
131022890|NCT02411084|471716073|FG000|Overall Study|Other reasons|0|||
131022891|NCT02411084|471716074|FG001|Overall Study|Other reasons|5|||
131022892|NCT05773313|471716079|FG000|Overall Study|Lost to Follow-up|3|||
131022893|NCT02748317|471716080|FG000|Overall Study|Withdrawal by Subject|14|||
131022894|NCT02748317|471716080|FG000|Overall Study|Lost to Follow-up|8|||
131022895|NCT02748317|471716080|FG000|Overall Study|Death|1|||
131022896|NCT00332241|471716082|FG000|Overall Study|Lack of Efficacy|6|||
131022897|NCT00332241|471716083|FG001|Overall Study|Lack of Efficacy|1|||
131022898|NCT00332241|471716082|FG000|Overall Study|Adverse Event|3|||
131022899|NCT00332241|471716083|FG001|Overall Study|Adverse Event|5|||
131022900|NCT00332241|471716082|FG000|Overall Study|Withdrawal by Subject|2|||
131022901|NCT00332241|471716083|FG001|Overall Study|Withdrawal by Subject|1|||
130889036|NCT02908672|471225202|FG003|Triple Combination Period|Reason Not Specified|1|||
131022902|NCT00332241|471716082|FG000|Overall Study|Lost to Follow-up|4|||
131022903|NCT00332241|471716083|FG001|Overall Study|Lost to Follow-up|1|||
131022904|NCT00802464|471716085|FG000|Month 0 - Month 8|Adverse Event|0|||
131022905|NCT00802464|471716086|FG001|Month 0 - Month 8|Adverse Event|1|||
131022906|NCT00802464|471716087|FG002|Month 0 - Month 8|Adverse Event|1|||
131022907|NCT00802464|471716088|FG003|Month 0 - Month 8|Adverse Event|2|||
130889037|NCT02908672|471225199|FG000|Triple Combination Period|Physician Decision|0|||
131022908|NCT00802464|471716085|FG000|Month 0 - Month 8|Protocol Violation|0|||
131022909|NCT00802464|471716086|FG001|Month 0 - Month 8|Protocol Violation|0|||
131022910|NCT00802464|471716087|FG002|Month 0 - Month 8|Protocol Violation|1|||
131022911|NCT00802464|471716088|FG003|Month 0 - Month 8|Protocol Violation|0|||
131022912|NCT00802464|471716085|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
131022913|NCT00802464|471716086|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
131022914|NCT00802464|471716087|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
131022915|NCT00802464|471716088|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
130889038|NCT02908672|471225200|FG001|Triple Combination Period|Physician Decision|0|||
130889039|NCT02908672|471225201|FG002|Triple Combination Period|Physician Decision|1|||
130889040|NCT02908672|471225202|FG003|Triple Combination Period|Physician Decision|1|||
130889041|NCT02908672|471225199|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
130889042|NCT02908672|471225200|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
130889043|NCT02908672|471225201|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
130889044|NCT02908672|471225202|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
130889045|NCT02908672|471225199|FG000|Triple Combination Period|Withdrawal by Subject|0|||
130889046|NCT02908672|471225200|FG001|Triple Combination Period|Withdrawal by Subject|0|||
130889047|NCT02908672|471225201|FG002|Triple Combination Period|Withdrawal by Subject|13|||
130889048|NCT02908672|471225202|FG003|Triple Combination Period|Withdrawal by Subject|16|||
130889049|NCT01104311|471225203|FG000|Overall Study|Withdrawal by Subject|6|||
130889050|NCT01104311|471225204|FG001|Overall Study|Withdrawal by Subject|6|||
130889051|NCT01104311|471225203|FG000|Overall Study|Protocol Violation|0|||
130889052|NCT01104311|471225204|FG001|Overall Study|Protocol Violation|1|||
130889053|NCT01104311|471225203|FG000|Overall Study|Physician Decision|2|||
131022916|NCT00802464|471716085|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
131022917|NCT00802464|471716086|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
131022918|NCT00802464|471716087|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
131022919|NCT00802464|471716088|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
131022920|NCT00802464|471716085|FG000|Month 0 - Month 8|Other|0|||
131022921|NCT00802464|471716086|FG001|Month 0 - Month 8|Other|0|||
131022922|NCT00802464|471716087|FG002|Month 0 - Month 8|Other|1|||
131022923|NCT00802464|471716088|FG003|Month 0 - Month 8|Other|0|||
131022924|NCT00802464|471716085|FG000|Month 8 - Month 14|Adverse Event|0|||
131022925|NCT00802464|471716086|FG001|Month 8 - Month 14|Adverse Event|1|||
131022926|NCT00802464|471716087|FG002|Month 8 - Month 14|Adverse Event|0|||
131022927|NCT00802464|471716088|FG003|Month 8 - Month 14|Adverse Event|0|||
131022928|NCT00802464|471716085|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
131022929|NCT00802464|471716086|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
131022930|NCT00802464|471716087|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
131022931|NCT00802464|471716088|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
131022932|NCT00802464|471716085|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
131022933|NCT00802464|471716086|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
131022934|NCT00802464|471716087|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
131022935|NCT00802464|471716088|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
131022936|NCT00402246|471716089|FG000|Overall Study|Death|62|||
131022937|NCT00402246|471716090|FG001|Overall Study|Death|58|||
131022938|NCT00402246|471716089|FG000|Overall Study|Lost to Follow-up|20|||
131022939|NCT00402246|471716090|FG001|Overall Study|Lost to Follow-up|28|||
131022940|NCT00402246|471716089|FG000|Overall Study|Withdrawal by Subject|72|||
131022941|NCT00402246|471716090|FG001|Overall Study|Withdrawal by Subject|87|||
131022942|NCT00402246|471716089|FG000|Overall Study|Physician Decision|24|||
131022943|NCT00402246|471716090|FG001|Overall Study|Physician Decision|26|||
131022944|NCT00402246|471716089|FG000|Overall Study|Protocol Violation|25|||
131022945|NCT00402246|471716090|FG001|Overall Study|Protocol Violation|24|||
131022946|NCT00402246|471716089|FG000|Overall Study|Missed Final Visit|1|||
131022947|NCT00402246|471716090|FG001|Overall Study|Missed Final Visit|2|||
131022948|NCT00402246|471716089|FG000|Overall Study|Insurance Issues|2|||
131022949|NCT00402246|471716090|FG001|Overall Study|Insurance Issues|1|||
131022950|NCT00402246|471716089|FG000|Overall Study|Heart Transplant|0|||
131022951|NCT00402246|471716090|FG001|Overall Study|Heart Transplant|1|||
131022952|NCT00402246|471716089|FG000|Overall Study|Patient's device explanted|6|||
131022953|NCT00402246|471716090|FG001|Overall Study|Patient's device explanted|2|||
131022954|NCT00402246|471716089|FG000|Overall Study|Center Closure|5|||
131022955|NCT00402246|471716090|FG001|Overall Study|Center Closure|3|||
131022956|NCT00402246|471716089|FG000|Overall Study|Deterioriating Condition|3|||
131022957|NCT00402246|471716090|FG001|Overall Study|Deterioriating Condition|2|||
130889054|NCT01104311|471225204|FG001|Overall Study|Physician Decision|2|||
130889055|NCT01104311|471225203|FG000|Overall Study|low compliance|1|||
130889056|NCT01104311|471225204|FG001|Overall Study|low compliance|1|||
131022958|NCT01471691|471716094|FG000|Overall Study|Lack of Efficacy|0|||
131022959|NCT01471691|471716095|FG001|Overall Study|Lack of Efficacy|1|||
131022960|NCT01808339|471716096|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131022961|NCT01808339|471716097|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131022962|NCT01808339|471716098|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131022963|NCT01808339|471716099|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
131022964|NCT01808339|471716100|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
131022965|NCT01808339|471716101|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
131022966|NCT01808339|471716096|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131022967|NCT01808339|471716097|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131108144|NCT03567434|472025246|FG000|Overall Study|Lost to Follow-up|1|||
130889057|NCT01104311|471225203|FG000|Overall Study|Adverse Event|1|||
131022968|NCT01808339|471716098|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130889058|NCT01104311|471225204|FG001|Overall Study|Adverse Event|2|||
131022969|NCT01808339|471716099|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
131022970|NCT01808339|471716100|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131022971|NCT01808339|471716101|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
131022972|NCT01808339|471716096|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131022973|NCT01808339|471716097|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131022974|NCT01808339|471716098|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
131022975|NCT01808339|471716099|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131022976|NCT01808339|471716100|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131022977|NCT01808339|471716101|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
131022978|NCT02622568|471716102|FG000|Overall Study|Lost to Follow-up|5|||
131108145|NCT03567434|472025247|FG001|Overall Study|Lost to Follow-up|3|||
131108146|NCT02881957|472025250|FG000|Overall Study|Comfort care|0|||
131108147|NCT02881957|472025251|FG001|Overall Study|Comfort care|1|||
131108148|NCT02881957|472025250|FG000|Overall Study|Concurrent trial enrollment|0|||
131108149|NCT02881957|472025251|FG001|Overall Study|Concurrent trial enrollment|1|||
131108150|NCT02881957|472025250|FG000|Overall Study|Discharged within 48 hours|0|||
131108151|NCT02881957|472025251|FG001|Overall Study|Discharged within 48 hours|1|||
131108152|NCT02881957|472025250|FG000|Overall Study|Withdrawal by Subject|2|||
131108153|NCT02881957|472025251|FG001|Overall Study|Withdrawal by Subject|1|||
131108154|NCT02881957|472025250|FG000|Overall Study|Protocol Violation|1|||
131108155|NCT02881957|472025251|FG001|Overall Study|Protocol Violation|0|||
131108156|NCT01050790|472025253|FG000|Overall Study|Adverse Event|1|||
131108157|NCT03705832|472025254|FG000|Overall Study|Physician Decision|0|||
131108158|NCT03705832|472025255|FG001|Overall Study|Physician Decision|1|||
131108159|NCT03705832|472025254|FG000|Overall Study|Withdrawal by Subject|1|||
131108160|NCT03705832|472025255|FG001|Overall Study|Withdrawal by Subject|0|||
131108161|NCT01880528|472025256|FG000|Overall Study|Other|1|||
131108162|NCT01880528|472025257|FG001|Overall Study|Other|1|||
131108163|NCT01439360|472025258|FG000|Overall Study|Adverse Event|4|||
131108164|NCT01439360|472025259|FG001|Overall Study|Adverse Event|16|||
131108165|NCT01439360|472025258|FG000|Overall Study|Lost to Follow-up|43|||
131108166|NCT01439360|472025259|FG001|Overall Study|Lost to Follow-up|58|||
131108167|NCT01439360|472025258|FG000|Overall Study|Others|10|||
131108168|NCT01439360|472025259|FG001|Overall Study|Others|5|||
131108169|NCT01439360|472025258|FG000|Overall Study|Protocol Violation|1|||
131108170|NCT01439360|472025259|FG001|Overall Study|Protocol Violation|0|||
131108171|NCT01439360|472025258|FG000|Overall Study|Withdrawal by Subject|140|||
131108172|NCT01439360|472025259|FG001|Overall Study|Withdrawal by Subject|129|||
131108173|NCT00345293|472025260|FG000|Overall Study|Unable to access line for sample|1|||
131108174|NCT00345293|472025261|FG001|Overall Study|Unable to access line for sample|0|||
131108175|NCT00345293|472025260|FG000|Overall Study|Withdrawal by Subject|1|||
131108176|NCT00345293|472025261|FG001|Overall Study|Withdrawal by Subject|0|||
131108177|NCT01786174|472026717|FG000|Overall Study|Discontinued Study Drug|2|||
131108178|NCT01786174|472026718|FG001|Overall Study|Discontinued Study Drug|0|||
131108179|NCT04281004|472026727|FG000|Overall Study|Physician Decision|1|||
131108180|NCT04281004|472026728|FG001|Overall Study|Physician Decision|0|||
131108181|NCT03628898|472026729|FG000|Overall Study|Device deficiency|1|||
131108182|NCT01217957|472026730|FG000|Phase 1|Withdrawal by Patient|1|||
131108183|NCT01217957|472026731|FG001|Phase 1|Withdrawal by Patient|0|||
131108184|NCT01217957|472026732|FG002|Phase 1|Withdrawal by Patient|1|||
131108185|NCT01217957|472026733|FG003|Phase 1|Withdrawal by Patient|1|||
131108186|NCT01217957|472026734|FG004|Phase 1|Withdrawal by Patient|0|||
131108187|NCT01217957|472026730|FG000|Phase 2|Withdrawal by Patient|0|||
131108188|NCT01217957|472026731|FG001|Phase 2|Withdrawal by Patient|0|||
130686005|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686006|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130889059|NCT01705509|471226877|FG000|Inclusion CPET|Screen Failure|5|||
131108189|NCT01217957|472026732|FG002|Phase 2|Withdrawal by Patient|0|||
131108190|NCT01217957|472026733|FG003|Phase 2|Withdrawal by Patient|0|||
131108191|NCT01217957|472026734|FG004|Phase 2|Withdrawal by Patient|1|||
131108192|NCT01620255|472026740|FG000|Overall Study|Withdrawal by Subject|4|||
131108193|NCT01620255|472026741|FG001|Overall Study|Withdrawal by Subject|1|||
131108194|NCT01620255|472026742|FG002|Overall Study|Withdrawal by Subject|1|||
131108195|NCT01620255|472026743|FG003|Overall Study|Withdrawal by Subject|2|||
131108196|NCT01620255|472026744|FG004|Overall Study|Withdrawal by Subject|4|||
131108197|NCT01620255|472026740|FG000|Overall Study|Participant underwent fecal transplant|0|||
131108198|NCT01620255|472026741|FG001|Overall Study|Participant underwent fecal transplant|0|||
131108199|NCT01620255|472026742|FG002|Overall Study|Participant underwent fecal transplant|1|||
131108200|NCT01620255|472026743|FG003|Overall Study|Participant underwent fecal transplant|0|||
130889060|NCT01705509|471226877|FG000|Inclusion CPET|Withdrawal by Subject|2|||
131108201|NCT01620255|472026744|FG004|Overall Study|Participant underwent fecal transplant|0|||
131108202|NCT01620255|472026740|FG000|Overall Study|Non-compliance|0|||
131108203|NCT01620255|472026741|FG001|Overall Study|Non-compliance|1|||
131108204|NCT01620255|472026742|FG002|Overall Study|Non-compliance|0|||
131108205|NCT01620255|472026743|FG003|Overall Study|Non-compliance|0|||
130889061|NCT01705509|471226877|FG000|CPET w/ Ranexa|Screen Failure|2|||
130889062|NCT01227018|471226878|FG000|Overall Study|Disease progression|9|||
131022979|NCT02622568|471716103|FG001|Overall Study|Lost to Follow-up|5|||
131022980|NCT00371787|471716106|FG000|Overall Study|Withdrawal by Subject|3|||
131022981|NCT00371787|471716107|FG001|Overall Study|Withdrawal by Subject|1|||
131022982|NCT04425863|471716108|FG000|Overall Study|Death|0|||
131022983|NCT04425863|471716109|FG001|Overall Study|Death|0|||
131022984|NCT04425863|471716110|FG002|Overall Study|Death|1|||
131022985|NCT01854385|471716113|FG000|Pre-Treatment|Withdrawal by Subject|4|||
131022986|NCT01854385|471716113|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
131022987|NCT01854385|471716113|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
131022988|NCT01854385|471716113|FG000|Pre-Treatment|Unable to come for study visits|1|||
131022989|NCT01854385|471716113|FG000|Treatment|Lost to Follow-up|1|||
131022990|NCT02597920|471716115|FG000|Overall Study|Worsening of other pre-existing disease|0|||
131022991|NCT02597920|471716116|FG001|Overall Study|Worsening of other pre-existing disease|1|||
131022992|NCT02597920|471716117|FG002|Overall Study|Worsening of other pre-existing disease|0|||
131022993|NCT02597920|471716115|FG000|Overall Study|Other adverse event|20|||
131022994|NCT02597920|471716116|FG001|Overall Study|Other adverse event|30|||
131022995|NCT02597920|471716117|FG002|Overall Study|Other adverse event|0|||
131022996|NCT02597920|471716115|FG000|Overall Study|Lost to Follow-up|7|||
131022997|NCT02597920|471716116|FG001|Overall Study|Lost to Follow-up|9|||
131022998|NCT02597920|471716117|FG002|Overall Study|Lost to Follow-up|0|||
131022999|NCT02597920|471716115|FG000|Overall Study|Refuse to continue in the study|3|||
131023000|NCT02597920|471716116|FG001|Overall Study|Refuse to continue in the study|13|||
131023001|NCT02597920|471716117|FG002|Overall Study|Refuse to continue in the study|1|||
131023002|NCT02597920|471716115|FG000|Overall Study|Other than specified|10|||
131023003|NCT02597920|471716116|FG001|Overall Study|Other than specified|31|||
131023004|NCT02597920|471716117|FG002|Overall Study|Other than specified|5|||
131023005|NCT02597920|471716115|FG000|Overall Study|Other|1|||
131023006|NCT02597920|471716116|FG001|Overall Study|Other|0|||
131023007|NCT02597920|471716117|FG002|Overall Study|Other|0|||
131023008|NCT00642850|471716118|FG000|Overall Study|Death|7|||
131023009|NCT00642850|471716118|FG000|Overall Study|Adverse Event|2|||
131023010|NCT00642850|471716118|FG000|Overall Study|Lack of Efficacy|1|||
131023011|NCT00642850|471716118|FG000|Overall Study|Protocol Violation|2|||
131023012|NCT00642850|471716118|FG000|Overall Study|Kidney transplantation|8|||
131023013|NCT00642850|471716118|FG000|Overall Study|Blood transfusion|6|||
131023014|NCT00642850|471716118|FG000|Overall Study|Other reasons|7|||
131023015|NCT01266122|471716119|FG000|Overall Study|Lost to Follow-up|6|||
131023016|NCT01266122|471716120|FG001|Overall Study|Lost to Follow-up|6|||
131023017|NCT03756571|471716121|FG000|Overall Study|Lost to Follow-up|1|||
131023018|NCT03756571|471716122|FG001|Overall Study|Lost to Follow-up|1|||
131023019|NCT00421889|471716123|FG000|Overall Study|Adverse Event|1|||
131023020|NCT00421889|471716124|FG001|Overall Study|Adverse Event|0|||
131023021|NCT00421889|471716125|FG002|Overall Study|Adverse Event|1|||
131023022|NCT00421889|471716126|FG003|Overall Study|Adverse Event|1|||
131023023|NCT00421889|471716127|FG004|Overall Study|Adverse Event|1|||
131023024|NCT00421889|471716128|FG005|Overall Study|Adverse Event|4|||
131023025|NCT00421889|471716129|FG006|Overall Study|Adverse Event|1|||
131023026|NCT00421889|471716130|FG007|Overall Study|Adverse Event|0|||
131023027|NCT00421889|471716131|FG008|Overall Study|Adverse Event|2|||
131023028|NCT00421889|471716123|FG000|Overall Study|Withdrawal by Subject|1|||
131023029|NCT00421889|471716124|FG001|Overall Study|Withdrawal by Subject|3|||
131023030|NCT00421889|471716125|FG002|Overall Study|Withdrawal by Subject|0|||
131023031|NCT00421889|471716126|FG003|Overall Study|Withdrawal by Subject|0|||
131023032|NCT00421889|471716127|FG004|Overall Study|Withdrawal by Subject|2|||
131023033|NCT00421889|471716128|FG005|Overall Study|Withdrawal by Subject|0|||
131023034|NCT00421889|471716129|FG006|Overall Study|Withdrawal by Subject|0|||
131023035|NCT00421889|471716130|FG007|Overall Study|Withdrawal by Subject|0|||
131023036|NCT00421889|471716131|FG008|Overall Study|Withdrawal by Subject|0|||
131023037|NCT00421889|471716123|FG000|Overall Study|Death|0|||
131023038|NCT00421889|471716124|FG001|Overall Study|Death|0|||
130889063|NCT01227018|471226878|FG000|Overall Study|Toxicity|2|||
131023039|NCT00421889|471716125|FG002|Overall Study|Death|0|||
131023040|NCT00421889|471716126|FG003|Overall Study|Death|0|||
130889064|NCT01227018|471226878|FG000|Overall Study|Withdrew after beginning treatment|4|||
131023041|NCT00421889|471716127|FG004|Overall Study|Death|1|||
131023042|NCT00421889|471716128|FG005|Overall Study|Death|1|||
131023043|NCT00421889|471716129|FG006|Overall Study|Death|0|||
131023044|NCT00421889|471716130|FG007|Overall Study|Death|0|||
131023045|NCT00421889|471716131|FG008|Overall Study|Death|0|||
131023046|NCT00421889|471716123|FG000|Overall Study|Progressive disease|3|||
131023047|NCT00421889|471716124|FG001|Overall Study|Progressive disease|2|||
131023048|NCT00421889|471716125|FG002|Overall Study|Progressive disease|2|||
131023049|NCT00421889|471716126|FG003|Overall Study|Progressive disease|3|||
131023050|NCT00421889|471716127|FG004|Overall Study|Progressive disease|2|||
131023051|NCT00421889|471716128|FG005|Overall Study|Progressive disease|21|||
131023052|NCT00421889|471716129|FG006|Overall Study|Progressive disease|3|||
131023053|NCT00421889|471716130|FG007|Overall Study|Progressive disease|1|||
131108206|NCT01620255|472026744|FG004|Overall Study|Non-compliance|0|||
131108207|NCT01620255|472026740|FG000|Overall Study|Adverse Event|0|||
131108208|NCT01620255|472026741|FG001|Overall Study|Adverse Event|4|||
131108209|NCT01620255|472026742|FG002|Overall Study|Adverse Event|0|||
131108210|NCT01620255|472026743|FG003|Overall Study|Adverse Event|1|||
131108211|NCT01620255|472026744|FG004|Overall Study|Adverse Event|1|||
131108212|NCT01620255|472026740|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
131108213|NCT01620255|472026741|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
131108214|NCT01620255|472026742|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
131108215|NCT01620255|472026743|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
131108216|NCT01620255|472026744|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
131108217|NCT01155375|472026749|FG000|Overall Study|Adverse Event|1|||
131108218|NCT01155375|472026750|FG001|Overall Study|Adverse Event|0|||
131108219|NCT00762970|472026754|FG000|Overall Study|Withdrawal by Subject|7|||
131108220|NCT00762970|472026755|FG001|Overall Study|Withdrawal by Subject|4|||
131108221|NCT00762970|472026756|FG002|Overall Study|Withdrawal by Subject|0|||
131108222|NCT00762970|472026754|FG000|Overall Study|Protocol Violation|3|||
131108223|NCT00762970|472026755|FG001|Overall Study|Protocol Violation|1|||
131108224|NCT00762970|472026756|FG002|Overall Study|Protocol Violation|1|||
131108225|NCT00762970|472026754|FG000|Overall Study|Lost to Follow-up|1|||
131108226|NCT00762970|472026755|FG001|Overall Study|Lost to Follow-up|2|||
131108227|NCT00762970|472026756|FG002|Overall Study|Lost to Follow-up|0|||
131108228|NCT00762970|472026754|FG000|Overall Study|Difficulty of handling lens|1|||
131108229|NCT00762970|472026755|FG001|Overall Study|Difficulty of handling lens|2|||
131108230|NCT00762970|472026756|FG002|Overall Study|Difficulty of handling lens|0|||
131108231|NCT01480674|472026757|FG000|Overall Study|Death|23|||
131108232|NCT01480674|472026757|FG000|Overall Study|Lost to Follow-up|2|||
131108233|NCT01480674|472026757|FG000|Overall Study|visit not done|10|||
131108234|NCT03818204|472026758|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108235|NCT03818204|472026759|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108236|NCT03818204|472026760|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108237|NCT03818204|472026761|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108238|NCT03818204|472026762|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
131108239|NCT03818204|472026763|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108240|NCT03818204|472026764|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108241|NCT03818204|472026765|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108242|NCT03818204|472026766|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108243|NCT03818204|472026767|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108244|NCT03818204|472026768|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108245|NCT03818204|472026769|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108246|NCT03818204|472026770|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108247|NCT03818204|472026771|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
131108248|NCT03818204|472026772|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108249|NCT03818204|472026773|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108250|NCT03818204|472026774|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108251|NCT03818204|472026775|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108252|NCT03818204|472026776|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
131108253|NCT03818204|472026758|FG000|Overall Study|Physician Decision|0|||
131108254|NCT03818204|472026759|FG001|Overall Study|Physician Decision|0|||
131108255|NCT03818204|472026760|FG002|Overall Study|Physician Decision|0|||
131108256|NCT03818204|472026761|FG003|Overall Study|Physician Decision|0|||
131108257|NCT03818204|472026762|FG004|Overall Study|Physician Decision|0|||
131108258|NCT03818204|472026763|FG005|Overall Study|Physician Decision|0|||
131108259|NCT03818204|472026764|FG006|Overall Study|Physician Decision|0|||
131108260|NCT03818204|472026765|FG007|Overall Study|Physician Decision|0|||
131108261|NCT03818204|472026766|FG008|Overall Study|Physician Decision|0|||
131108262|NCT03818204|472026767|FG009|Overall Study|Physician Decision|0|||
131108263|NCT03818204|472026768|FG010|Overall Study|Physician Decision|0|||
131108264|NCT03818204|472026769|FG011|Overall Study|Physician Decision|0|||
131108265|NCT03818204|472026770|FG012|Overall Study|Physician Decision|0|||
131108266|NCT03818204|472026771|FG013|Overall Study|Physician Decision|0|||
131108267|NCT03818204|472026772|FG014|Overall Study|Physician Decision|1|||
131108268|NCT03818204|472026773|FG015|Overall Study|Physician Decision|0|||
131108269|NCT03818204|472026774|FG016|Overall Study|Physician Decision|0|||
131108270|NCT03818204|472026775|FG017|Overall Study|Physician Decision|0|||
131108271|NCT03818204|472026776|FG018|Overall Study|Physician Decision|0|||
131108272|NCT00887250|472026777|FG000|Overall Study|Adverse Event|3|||
131108273|NCT00887250|472026778|FG001|Overall Study|Adverse Event|0|||
131108274|NCT00887250|472026779|FG002|Overall Study|Adverse Event|7|||
131108275|NCT00887250|472026777|FG000|Overall Study|Lack of Efficacy|9|||
131108276|NCT00887250|472026778|FG001|Overall Study|Lack of Efficacy|6|||
130889065|NCT01864603|471226881|FG000|Stage 2|DSMB design modification|86056|||
131108277|NCT00887250|472026779|FG002|Overall Study|Lack of Efficacy|1|||
131108278|NCT00887250|472026777|FG000|Overall Study|Lost to Follow-up|2|||
131108279|NCT00887250|472026778|FG001|Overall Study|Lost to Follow-up|3|||
131108280|NCT00887250|472026779|FG002|Overall Study|Lost to Follow-up|1|||
131108281|NCT00887250|472026777|FG000|Overall Study|Protocol Violation|2|||
131108282|NCT00887250|472026778|FG001|Overall Study|Protocol Violation|2|||
131108283|NCT00887250|472026779|FG002|Overall Study|Protocol Violation|1|||
131108284|NCT00887250|472026777|FG000|Overall Study|Withdrawal by Subject|2|||
131108285|NCT00887250|472026778|FG001|Overall Study|Withdrawal by Subject|1|||
131108286|NCT00887250|472026779|FG002|Overall Study|Withdrawal by Subject|2|||
131108287|NCT00887250|472026777|FG000|Overall Study|Patient uncooperative|0|||
131108288|NCT00887250|472026778|FG001|Overall Study|Patient uncooperative|0|||
131108289|NCT00887250|472026779|FG002|Overall Study|Patient uncooperative|1|||
131108290|NCT03864146|472026780|FG000|Overall Study|Lost to Follow-up|14|||
131108291|NCT03864146|472026781|FG001|Overall Study|Lost to Follow-up|23|||
131108292|NCT03864146|472026780|FG000|Overall Study|Withdrawal by Subject|3|||
131108293|NCT03864146|472026781|FG001|Overall Study|Withdrawal by Subject|2|||
131108294|NCT01933113|472026782|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
131108295|NCT00879762|472026783|FG000|Overall Study|Lost to Follow-up|3|||
131108296|NCT00879762|472026784|FG001|Overall Study|Lost to Follow-up|1|||
131108297|NCT04981366|472026785|FG000|Overall Study|Withdrawal by Subject|5|||
131108298|NCT04981366|472026786|FG001|Overall Study|Withdrawal by Subject|4|||
131108299|NCT04981366|472026787|FG002|Overall Study|Withdrawal by Subject|8|||
131108300|NCT04981366|472026785|FG000|Overall Study|Health issues unrelated to the trial|1|||
131108301|NCT04981366|472026786|FG001|Overall Study|Health issues unrelated to the trial|2|||
131108302|NCT04981366|472026787|FG002|Overall Study|Health issues unrelated to the trial|0|||
131108303|NCT00881608|472026788|FG000|Overall Study|Study prematurely terminated|11|||
131108304|NCT03214094|472026789|FG000|Overall Study|Case Report Forms Uncollected|14|||
131108305|NCT03214094|472026789|FG000|Overall Study|Protocol Deviation|46|||
131108306|NCT00795951|472026795|FG000|Overall Study|Lost to Follow-up|1|||
131108307|NCT00795951|472026795|FG000|Overall Study|Withdrawal by Subject|1|||
131108308|NCT00690820|472026796|FG000|Period 1|Withdrawal by Subject|0|||
131108309|NCT00690820|472026797|FG001|Period 1|Withdrawal by Subject|1|||
131108310|NCT00846391|472026799|FG000|Overall Study|Physician Decision|0|||
131108311|NCT00846391|472026800|FG001|Overall Study|Physician Decision|0|||
131108312|NCT00846391|472026801|FG002|Overall Study|Physician Decision|1|||
131108313|NCT00846391|472026799|FG000|Overall Study|Study Terminated by Sponsor|1|||
131108314|NCT00846391|472026800|FG001|Overall Study|Study Terminated by Sponsor|2|||
131108315|NCT00846391|472026801|FG002|Overall Study|Study Terminated by Sponsor|2|||
131108316|NCT04634825|472026803|FG000|Overall Study|Death|10|||
131108317|NCT04634825|472026804|FG001|Overall Study|Death|3|||
131108318|NCT04634825|472026803|FG000|Overall Study|Lost to Follow-up|1|||
131108319|NCT04634825|472026804|FG001|Overall Study|Lost to Follow-up|0|||
131108320|NCT04634825|472026803|FG000|Overall Study|Study terminated by sponsor|35|||
131108321|NCT04634825|472026804|FG001|Overall Study|Study terminated by sponsor|11|||
131108322|NCT04634825|472026803|FG000|Overall Study|Withdrawal by Subject|2|||
131108323|NCT04634825|472026804|FG001|Overall Study|Withdrawal by Subject|0|||
131108324|NCT01337115|472026811|FG000|Overall Study|Protocol Violation|2|||
131108325|NCT01337115|472026812|FG001|Overall Study|Protocol Violation|0|||
131108326|NCT00551460|472026818|FG000|Overall Study|Adverse Event|1|||
131108327|NCT00551460|472026818|FG000|Overall Study|Withdrawal by Subject|1|||
131108328|NCT00551460|472026818|FG000|Overall Study|Physician Decision|1|||
131108329|NCT00551460|472026818|FG000|Overall Study|Death|7|||
131108330|NCT00551460|472026818|FG000|Overall Study|Ineligible|4|||
131108331|NCT00551460|472026818|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
131108332|NCT01745848|472026819|FG000|Overall Study|Adverse Event|6|||
131108333|NCT00679627|472026820|FG000|Overall Study|Death|41|||
131108334|NCT00679627|472026821|FG001|Overall Study|Death|29|||
131108335|NCT00679627|472026820|FG000|Overall Study|Adverse Event|43|||
131108336|NCT00679627|472026821|FG001|Overall Study|Adverse Event|53|||
131108337|NCT00679627|472026820|FG000|Overall Study|Withdrawal by Subject|168|||
131108338|NCT00679627|472026821|FG001|Overall Study|Withdrawal by Subject|172|||
131108339|NCT00679627|472026820|FG000|Overall Study|Lost to Follow-up|22|||
131108340|NCT00679627|472026821|FG001|Overall Study|Lost to Follow-up|26|||
131108341|NCT00679627|472026820|FG000|Overall Study|Early Study Closure|425|||
131108342|NCT00679627|472026821|FG001|Overall Study|Early Study Closure|405|||
131108343|NCT00448123|472026822|FG000|Overall Study|Lost to Follow-up|9|||
131108344|NCT00448123|472026823|FG001|Overall Study|Lost to Follow-up|6|||
131108345|NCT00448123|472026822|FG000|Overall Study|Physician Decision|6|||
131108346|NCT00448123|472026823|FG001|Overall Study|Physician Decision|6|||
131108347|NCT02027623|472026825|FG000|Overall Study|Lost to Follow-up|3|||
131108348|NCT02027623|472026826|FG001|Overall Study|Lost to Follow-up|3|||
130889066|NCT01864603|471226882|FG001|Stage 2|DSMB design modification|92558|||
131108349|NCT02027623|472026825|FG000|Overall Study|Withdrawal by Subject|6|||
131108350|NCT02027623|472026826|FG001|Overall Study|Withdrawal by Subject|9|||
131108351|NCT01886378|472026827|FG000|Overall Study|Adverse Event|1|||
131108352|NCT01886378|472026827|FG000|Overall Study|Withdrawal by Subject|4|||
131108353|NCT01079741|472026828|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
131108354|NCT01079741|472026829|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
131108355|NCT01079741|472026830|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
130889067|NCT02446899|471226883|FG000|Overall Study|Adverse Event|4|||
130889068|NCT02446899|471226884|FG001|Overall Study|Adverse Event|7|||
130889069|NCT02446899|471226883|FG000|Overall Study|Condition Under Investigation Worsened|1|||
131023054|NCT00421889|471716131|FG008|Overall Study|Progressive disease|5|||
131023055|NCT00421889|471716123|FG000|Overall Study|Patient/Investigator request|0|||
131023056|NCT00421889|471716124|FG001|Overall Study|Patient/Investigator request|0|||
131023057|NCT00421889|471716125|FG002|Overall Study|Patient/Investigator request|0|||
131023058|NCT00421889|471716126|FG003|Overall Study|Patient/Investigator request|0|||
131023059|NCT00421889|471716127|FG004|Overall Study|Patient/Investigator request|0|||
131023060|NCT00421889|471716128|FG005|Overall Study|Patient/Investigator request|9|||
131023061|NCT00421889|471716129|FG006|Overall Study|Patient/Investigator request|0|||
131023062|NCT00421889|471716130|FG007|Overall Study|Patient/Investigator request|1|||
131023063|NCT00421889|471716131|FG008|Overall Study|Patient/Investigator request|3|||
131023064|NCT00421889|471716123|FG000|Overall Study|Lost to Follow-up|0|||
131023065|NCT00421889|471716124|FG001|Overall Study|Lost to Follow-up|0|||
131023066|NCT00421889|471716125|FG002|Overall Study|Lost to Follow-up|0|||
131023067|NCT00421889|471716126|FG003|Overall Study|Lost to Follow-up|0|||
131023068|NCT00421889|471716127|FG004|Overall Study|Lost to Follow-up|0|||
131023069|NCT00421889|471716128|FG005|Overall Study|Lost to Follow-up|0|||
131023070|NCT00421889|471716129|FG006|Overall Study|Lost to Follow-up|0|||
131023071|NCT00421889|471716130|FG007|Overall Study|Lost to Follow-up|0|||
131023072|NCT00421889|471716131|FG008|Overall Study|Lost to Follow-up|1|||
131023073|NCT00978042|471716132|FG000|Initial Treatment Period|Treated in Error|0|||
131023074|NCT00978042|471716133|FG001|Initial Treatment Period|Treated in Error|3|||
131023075|NCT00978042|471716132|FG000|Initial Treatment Period|Ineligibility|1|||
131023076|NCT00978042|471716133|FG001|Initial Treatment Period|Ineligibility|0|||
131023077|NCT00978042|471716132|FG000|Initial Treatment Period|Lost to Follow-up|21|||
131023078|NCT00978042|471716133|FG001|Initial Treatment Period|Lost to Follow-up|3|||
131023079|NCT00978042|471716132|FG000|Initial Treatment Period|Adverse Event|2|||
131023080|NCT00978042|471716133|FG001|Initial Treatment Period|Adverse Event|0|||
131023081|NCT00978042|471716132|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
131023082|NCT00978042|471716133|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
131023083|NCT00978042|471716132|FG000|Initial Treatment Period|Consent withdrawn|22|||
131023084|NCT00978042|471716133|FG001|Initial Treatment Period|Consent withdrawn|9|||
131023085|NCT00978042|471716132|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
131023086|NCT00978042|471716133|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
131023087|NCT00703820|471716134|FG000|Overall Study|Adverse Event|12|||
131023088|NCT00703820|471716135|FG001|Overall Study|Adverse Event|17|||
131023089|NCT00703820|471716134|FG000|Overall Study|Death|5|||
131023090|NCT00703820|471716135|FG001|Overall Study|Death|0|||
131023091|NCT00703820|471716134|FG000|Overall Study|Lack of Efficacy|11|||
131023092|NCT00703820|471716135|FG001|Overall Study|Lack of Efficacy|11|||
131023093|NCT00703820|471716134|FG000|Overall Study|Received non-protocol therapy|1|||
131023094|NCT00703820|471716135|FG001|Overall Study|Received non-protocol therapy|0|||
131023095|NCT00703820|471716134|FG000|Overall Study|Physician Decision|4|||
131023096|NCT00703820|471716135|FG001|Overall Study|Physician Decision|5|||
131023097|NCT00703820|471716134|FG000|Overall Study|Withdrawal by Subject|2|||
131023098|NCT00703820|471716135|FG001|Overall Study|Withdrawal by Subject|1|||
131023099|NCT00520546|471716136|FG000|Overall Study|Withdrawal by Subject|1|||
131023100|NCT00520546|471716136|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
131023101|NCT00785512|471716137|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
131023102|NCT00785512|471716138|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
131023103|NCT00785512|471716137|FG000|Overall Study|Adverse Event|0|||
131023104|NCT00785512|471716138|FG001|Overall Study|Adverse Event|0|||
131023105|NCT00785512|471716137|FG000|Overall Study|Lack of Efficacy|0|||
131023106|NCT00785512|471716138|FG001|Overall Study|Lack of Efficacy|2|||
131023107|NCT00785512|471716137|FG000|Overall Study|Withdrawal by Subject|0|||
131023108|NCT00785512|471716138|FG001|Overall Study|Withdrawal by Subject|1|||
131023109|NCT00785512|471716137|FG000|Overall Study|Lost to Follow-up|3|||
131023110|NCT00785512|471716138|FG001|Overall Study|Lost to Follow-up|0|||
131023111|NCT00785512|471716137|FG000|Overall Study|Precedure Refused|0|||
131023112|NCT00785512|471716138|FG001|Overall Study|Precedure Refused|0|||
131023113|NCT00785512|471716137|FG000|Overall Study|IVRS Programing Error|0|||
131023114|NCT00785512|471716138|FG001|Overall Study|IVRS Programing Error|0|||
131023115|NCT00785512|471716137|FG000|Overall Study|Physician Decision|0|||
131023116|NCT00785512|471716138|FG001|Overall Study|Physician Decision|0|||
131023117|NCT00785512|471716137|FG000|Overall Study|Lack of compliance|0|||
131023118|NCT00785512|471716138|FG001|Overall Study|Lack of compliance|1|||
131023119|NCT00595413|471716140|FG000|Overall Study|Adverse Event|0|||
131023120|NCT00595413|471716141|FG001|Overall Study|Adverse Event|2|||
131023121|NCT00595413|471716142|FG002|Overall Study|Adverse Event|1|||
131023122|NCT00595413|471716143|FG003|Overall Study|Adverse Event|1|||
131023123|NCT00595413|471716140|FG000|Overall Study|Lost to Follow-up|2|||
131023124|NCT00595413|471716141|FG001|Overall Study|Lost to Follow-up|2|||
131023125|NCT00595413|471716142|FG002|Overall Study|Lost to Follow-up|1|||
131023126|NCT00595413|471716143|FG003|Overall Study|Lost to Follow-up|3|||
131108356|NCT01079741|472026831|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
131108357|NCT01079741|472026832|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
131108358|NCT01079741|472026828|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
131108359|NCT01079741|472026829|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
131108360|NCT01079741|472026830|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
131108361|NCT01079741|472026831|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
131108362|NCT01079741|472026832|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
131108363|NCT00446992|472026833|FG000|Overall Study|Adverse Event|11|||
131108364|NCT00446992|472026833|FG000|Overall Study|Lost to Follow-up|5|||
131108365|NCT03021954|472026838|FG000|Overall Study|Lost to Follow-up|10|||
131108366|NCT03021954|472026839|FG001|Overall Study|Lost to Follow-up|43|||
131108367|NCT03021954|472026838|FG000|Overall Study|Subjects had avulsion trauma|4|||
131108368|NCT03021954|472026839|FG001|Overall Study|Subjects had avulsion trauma|1|||
131108369|NCT01536015|472026844|FG000|Overall Study|Adverse Event|1|||
131108370|NCT01536015|472026845|FG001|Overall Study|Adverse Event|4|||
131108371|NCT01536015|472026844|FG000|Overall Study|Lost to Follow-up|0|||
131108372|NCT01536015|472026845|FG001|Overall Study|Lost to Follow-up|1|||
131108373|NCT01536015|472026844|FG000|Overall Study|Inclusion Criterion not met|2|||
131108374|NCT01536015|472026845|FG001|Overall Study|Inclusion Criterion not met|0|||
131108375|NCT01536015|472026844|FG000|Overall Study|Study closure|5|||
131108376|NCT01536015|472026845|FG001|Overall Study|Study closure|5|||
131108377|NCT01668667|472026847|FG000|Overall Study|Adverse Event|3|||
131108378|NCT01668667|472026848|FG001|Overall Study|Adverse Event|6|||
131108379|NCT01668667|472026849|FG002|Overall Study|Adverse Event|4|||
131108380|NCT01668667|472026850|FG003|Overall Study|Adverse Event|4|||
131108381|NCT01668667|472026847|FG000|Overall Study|Lack of Efficacy|3|||
131108382|NCT01668667|472026848|FG001|Overall Study|Lack of Efficacy|2|||
131108383|NCT01668667|472026849|FG002|Overall Study|Lack of Efficacy|2|||
131108384|NCT01668667|472026850|FG003|Overall Study|Lack of Efficacy|3|||
131108385|NCT01668667|472026847|FG000|Overall Study|Protocol Violation|6|||
131108386|NCT01668667|472026848|FG001|Overall Study|Protocol Violation|10|||
131108387|NCT01668667|472026849|FG002|Overall Study|Protocol Violation|12|||
131108388|NCT01668667|472026850|FG003|Overall Study|Protocol Violation|5|||
131108389|NCT01668667|472026847|FG000|Overall Study|Lost to Follow-up|9|||
131108390|NCT01668667|472026848|FG001|Overall Study|Lost to Follow-up|4|||
131108391|NCT01668667|472026849|FG002|Overall Study|Lost to Follow-up|7|||
131108392|NCT01668667|472026850|FG003|Overall Study|Lost to Follow-up|6|||
131108393|NCT01668667|472026847|FG000|Overall Study|Physician Decision|3|||
131108394|NCT01668667|472026848|FG001|Overall Study|Physician Decision|0|||
131108395|NCT01668667|472026849|FG002|Overall Study|Physician Decision|1|||
131108396|NCT01668667|472026850|FG003|Overall Study|Physician Decision|0|||
131108397|NCT01668667|472026847|FG000|Overall Study|Withdrawal by Subject|7|||
131108398|NCT01668667|472026848|FG001|Overall Study|Withdrawal by Subject|4|||
131108399|NCT01668667|472026849|FG002|Overall Study|Withdrawal by Subject|5|||
131108400|NCT01668667|472026850|FG003|Overall Study|Withdrawal by Subject|5|||
131108401|NCT03343301|472026851|FG000|Overall Study|Withdrawal by Subject|1|||
131108402|NCT03343301|472026852|FG001|Overall Study|Withdrawal by Subject|1|||
131108403|NCT03343301|472026851|FG000|Overall Study|Death|0|||
131108404|NCT03343301|472026852|FG001|Overall Study|Death|2|||
131108405|NCT03343301|472026851|FG000|Overall Study|Other|0|||
131108406|NCT03343301|472026852|FG001|Overall Study|Other|6|||
131222619|NCT01084603|472443120|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
131222620|NCT01084603|472443120|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
131108407|NCT03343301|472026851|FG000|Overall Study|Missing|2|||
131108408|NCT03343301|472026852|FG001|Overall Study|Missing|0|||
131108409|NCT01013597|472026861|FG000|Overall Study|Withdrawal by Subject|1|||
131108410|NCT00427895|472026862|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131108411|NCT00427895|472026863|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131108412|NCT00427895|472026864|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131108413|NCT00427895|472026865|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
131108414|NCT00427895|472026866|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131108415|NCT00427895|472026867|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131108416|NCT00427895|472026868|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131108417|NCT00427895|472026869|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
131108418|NCT00427895|472026862|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131108419|NCT00427895|472026863|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131108420|NCT00427895|472026864|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131108421|NCT00427895|472026865|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131222621|NCT01084603|472443120|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
131108422|NCT00427895|472026866|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131108423|NCT00427895|472026867|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131108424|NCT00427895|472026868|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
131108425|NCT00427895|472026869|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
131108426|NCT00427895|472026862|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
131222622|NCT01084603|472443120|FG000|Washout Period 4|Adverse Event|1|||
131108427|NCT00427895|472026863|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
131108428|NCT00427895|472026864|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
131108429|NCT00427895|472026865|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
131108430|NCT00427895|472026866|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
131108431|NCT00427895|472026867|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
131108432|NCT00427895|472026868|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
131108433|NCT00427895|472026869|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
131108434|NCT00427895|472026862|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
131108435|NCT00427895|472026863|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
131108436|NCT00427895|472026864|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
131108437|NCT00427895|472026865|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
131108438|NCT00427895|472026866|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
131108439|NCT00427895|472026867|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
131108440|NCT00427895|472026868|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
131108441|NCT00427895|472026869|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
131108442|NCT00427895|472026862|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
131108443|NCT00427895|472026863|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
131108444|NCT00427895|472026864|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
131108445|NCT00427895|472026865|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
131108446|NCT00427895|472026866|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
131108447|NCT00427895|472026867|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
131108448|NCT00427895|472026868|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
131108449|NCT00427895|472026869|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
131108450|NCT00427895|472026862|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
131108451|NCT00427895|472026863|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
131108452|NCT00427895|472026864|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
131108453|NCT00427895|472026865|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
131108454|NCT00427895|472026866|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
131108455|NCT00427895|472026867|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
131108456|NCT00427895|472026868|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
131108457|NCT00427895|472026869|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
131108458|NCT00427895|472026862|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
131108459|NCT00427895|472026863|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
131108460|NCT00427895|472026864|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131108461|NCT00427895|472026865|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131108462|NCT00427895|472026866|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131108463|NCT00427895|472026867|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131108464|NCT00427895|472026868|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131108465|NCT00427895|472026869|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
131108466|NCT00427895|472026862|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
131108467|NCT00427895|472026863|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
131108468|NCT00427895|472026864|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
131108469|NCT00427895|472026865|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
131108470|NCT00427895|472026866|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
131108471|NCT00427895|472026867|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
131108472|NCT00427895|472026868|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
131108473|NCT00427895|472026869|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
131108474|NCT00427895|472026862|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131108475|NCT00427895|472026863|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131108476|NCT00427895|472026864|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131108477|NCT00427895|472026865|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
131108478|NCT00427895|472026866|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131108479|NCT00427895|472026867|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131108480|NCT00427895|472026868|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131108481|NCT00427895|472026869|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
131108482|NCT00427895|472026862|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
131108483|NCT00427895|472026863|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
131108484|NCT00427895|472026864|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
131108485|NCT00427895|472026865|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
131108486|NCT00427895|472026866|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
131108487|NCT00427895|472026867|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
131108488|NCT00427895|472026868|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
131108489|NCT00427895|472026869|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
131108490|NCT00427895|472026862|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131108491|NCT00427895|472026863|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131108492|NCT00427895|472026864|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
131108493|NCT00427895|472026865|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
131222623|NCT03836729|472443122|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
131108494|NCT00427895|472026866|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131108495|NCT00427895|472026867|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131108496|NCT00427895|472026868|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131108497|NCT00427895|472026869|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
131108498|NCT00427895|472026862|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
131108499|NCT00427895|472026863|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
131108500|NCT00427895|472026864|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
131108501|NCT00427895|472026865|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
131108502|NCT00427895|472026866|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
131108503|NCT00427895|472026867|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
131108504|NCT00427895|472026868|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
131108505|NCT00427895|472026869|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
131108506|NCT00427895|472026862|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
131108507|NCT00427895|472026863|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
131108508|NCT00427895|472026864|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
131108509|NCT00427895|472026865|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
131108510|NCT00427895|472026866|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
131108511|NCT00427895|472026867|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
131108512|NCT00427895|472026868|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
131108513|NCT00427895|472026869|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
131108514|NCT00427895|472026862|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
131108515|NCT00427895|472026863|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
131108516|NCT00427895|472026864|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
131108517|NCT00427895|472026865|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
131108518|NCT00427895|472026866|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
131108519|NCT00427895|472026867|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
131108520|NCT00427895|472026868|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
131108521|NCT00427895|472026869|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
131108522|NCT00427895|472026862|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131108523|NCT00427895|472026863|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
131108524|NCT00427895|472026864|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131108525|NCT00427895|472026865|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131108526|NCT00427895|472026866|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131108527|NCT00427895|472026867|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131108528|NCT00427895|472026868|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131108529|NCT00427895|472026869|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
131108530|NCT00427895|472026862|FG000|Vax 1/Year 1 Follow-up|Death|1|||
131108531|NCT00427895|472026863|FG001|Vax 1/Year 1 Follow-up|Death|0|||
131108532|NCT00427895|472026864|FG002|Vax 1/Year 1 Follow-up|Death|0|||
131108533|NCT00427895|472026865|FG003|Vax 1/Year 1 Follow-up|Death|0|||
131108534|NCT00427895|472026866|FG004|Vax 1/Year 1 Follow-up|Death|0|||
131108535|NCT00427895|472026867|FG005|Vax 1/Year 1 Follow-up|Death|0|||
131108536|NCT00427895|472026868|FG006|Vax 1/Year 1 Follow-up|Death|0|||
131108537|NCT00427895|472026869|FG007|Vax 1/Year 1 Follow-up|Death|0|||
131108538|NCT00427895|472026862|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131108539|NCT00427895|472026863|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131108540|NCT00427895|472026864|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
131108541|NCT00427895|472026865|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
131108542|NCT00427895|472026866|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131108543|NCT00427895|472026867|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131108544|NCT00427895|472026868|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131108545|NCT00427895|472026869|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
131108546|NCT00427895|472026862|FG000|Vax 1/Year 1 Follow-up|Other|0|||
131108547|NCT00427895|472026863|FG001|Vax 1/Year 1 Follow-up|Other|0|||
131108548|NCT00427895|472026864|FG002|Vax 1/Year 1 Follow-up|Other|0|||
131108549|NCT00427895|472026865|FG003|Vax 1/Year 1 Follow-up|Other|2|||
131108550|NCT00427895|472026866|FG004|Vax 1/Year 1 Follow-up|Other|0|||
131108551|NCT00427895|472026867|FG005|Vax 1/Year 1 Follow-up|Other|0|||
131108552|NCT00427895|472026868|FG006|Vax 1/Year 1 Follow-up|Other|0|||
131108553|NCT00427895|472026869|FG007|Vax 1/Year 1 Follow-up|Other|0|||
131108554|NCT00427895|472026862|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
131108555|NCT00427895|472026863|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
131108556|NCT00427895|472026864|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
131108557|NCT00427895|472026865|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
131108558|NCT00427895|472026866|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
131108559|NCT00427895|472026867|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
131108560|NCT00427895|472026868|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
131108561|NCT00427895|472026869|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
131108562|NCT02796560|472026870|FG000|Overall Study|Adverse Event|2|||
131108563|NCT02796560|472026871|FG001|Overall Study|Adverse Event|0|||
131108564|NCT02796560|472026870|FG000|Overall Study|Withdrawal by Subject|2|||
131222624|NCT00948025|472443124|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
131222625|NCT00948025|472443125|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
131222626|NCT00948025|472443124|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
131023127|NCT00595413|471716140|FG000|Overall Study|Death|0|||
131023128|NCT00595413|471716141|FG001|Overall Study|Death|0|||
131023129|NCT00595413|471716142|FG002|Overall Study|Death|1|||
131023130|NCT00595413|471716143|FG003|Overall Study|Death|0|||
131023131|NCT00595413|471716140|FG000|Overall Study|Other|5|||
131023132|NCT00595413|471716141|FG001|Overall Study|Other|1|||
131023133|NCT00595413|471716142|FG002|Overall Study|Other|5|||
131023134|NCT00595413|471716143|FG003|Overall Study|Other|0|||
131023135|NCT03233633|471716144|FG000|Overall Study|Adverse Event|2|||
131023136|NCT03233633|471716144|FG000|Overall Study|Less Than 3 Days of Data|6|||
131023137|NCT02088853|471716145|FG000|Overall Study|Pregnancy|1|||
131023138|NCT02088853|471716146|FG001|Overall Study|Pregnancy|0|||
131023139|NCT00603954|471716149|FG000|Overall Study|Protocol Violation|1|||
131023140|NCT00603954|471716150|FG001|Overall Study|Protocol Violation|2|||
131023141|NCT02708108|471716151|FG000|Overall Study|Death|1|||
131023142|NCT02708108|471716152|FG001|Overall Study|Death|2|||
131023143|NCT02708108|471716151|FG000|Overall Study|Regimen change|1|||
131023144|NCT02708108|471716152|FG001|Overall Study|Regimen change|0|||
131023145|NCT02708108|471716151|FG000|Overall Study|No MRD and no imaging available|0|||
131023146|NCT02708108|471716152|FG001|Overall Study|No MRD and no imaging available|1|||
131023147|NCT01697969|471716153|FG000|Overall Study|Did not meet inc/exc criteria|3|||
131023148|NCT01561989|471716154|FG000|Overall Study|accural target not met.|5|||
131023149|NCT01561989|471716155|FG001|Overall Study|accural target not met.|6|||
131023150|NCT01736215|471716156|FG000|Overall Study|Early termination of erythropoietin use|1|||
131023151|NCT01736215|471716156|FG000|Overall Study|Adverse Event|4|||
131023152|NCT01736215|471716156|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
131023153|NCT01736215|471716156|FG000|Overall Study|Insufficient data to perform analysis|8|||
131023154|NCT03447249|471716157|FG000|Overall Study|Adverse Event|1|||
131023155|NCT03447249|471716158|FG001|Overall Study|Adverse Event|0|||
131023156|NCT03447249|471716157|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
131023157|NCT03447249|471716158|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
131023158|NCT03447249|471716157|FG000|Overall Study|Other|3|||
131023159|NCT03447249|471716158|FG001|Overall Study|Other|0|||
131023160|NCT04556981|471716159|FG000|Overall Study|Death|0|||
131023161|NCT04556981|471716160|FG001|Overall Study|Death|1|||
131023162|NCT04556981|471716159|FG000|Overall Study|Lost to Follow-up|2|||
131023163|NCT04556981|471716160|FG001|Overall Study|Lost to Follow-up|11|||
131023164|NCT04556981|471716159|FG000|Overall Study|Moved from the study area|1|||
131023165|NCT04556981|471716160|FG001|Overall Study|Moved from the study area|4|||
131023166|NCT04556981|471716159|FG000|Overall Study|Withdrawal by Subject|2|||
131023167|NCT04556981|471716160|FG001|Overall Study|Withdrawal by Subject|2|||
131023168|NCT04556981|471716159|FG000|Overall Study|Other|2|||
131023169|NCT04556981|471716160|FG001|Overall Study|Other|1|||
131023170|NCT00068601|471716162|FG000|Overall Study|Ineligible|11|||
131023171|NCT00068601|471716163|FG001|Overall Study|Ineligible|13|||
131023172|NCT00068601|471716162|FG000|Overall Study|Not evaluable: withdrew consent|5|||
131023173|NCT00068601|471716163|FG001|Overall Study|Not evaluable: withdrew consent|4|||
131023174|NCT00068601|471716162|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
131023175|NCT00068601|471716163|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
131023176|NCT00068601|471716162|FG000|Overall Study|Death|11|||
131023177|NCT00068601|471716163|FG001|Overall Study|Death|3|||
131023178|NCT00068601|471716162|FG000|Overall Study|Lost to Follow-up|3|||
131023179|NCT00068601|471716163|FG001|Overall Study|Lost to Follow-up|2|||
131023180|NCT00068601|471716162|FG000|Overall Study|Missing primary outcome data|30|||
131023181|NCT00068601|471716163|FG001|Overall Study|Missing primary outcome data|34|||
131023182|NCT01070069|471716164|FG000|Overall Study|Death|1|||
131023183|NCT01070069|471716165|FG001|Overall Study|Death|0|||
131023184|NCT01070069|471716166|FG002|Overall Study|Death|2|||
131023185|NCT01070069|471716167|FG003|Overall Study|Death|0|||
131023186|NCT01070069|471716168|FG004|Overall Study|Death|1|||
131023187|NCT01070069|471716164|FG000|Overall Study|Withdrawal by Subject|1|||
131023188|NCT01070069|471716165|FG001|Overall Study|Withdrawal by Subject|1|||
131023189|NCT01070069|471716166|FG002|Overall Study|Withdrawal by Subject|4|||
131023190|NCT01070069|471716167|FG003|Overall Study|Withdrawal by Subject|0|||
131023191|NCT01070069|471716168|FG004|Overall Study|Withdrawal by Subject|0|||
131023192|NCT01070069|471716164|FG000|Overall Study|Lost to Follow-up|4|||
131023193|NCT01070069|471716165|FG001|Overall Study|Lost to Follow-up|1|||
131023194|NCT01070069|471716166|FG002|Overall Study|Lost to Follow-up|0|||
131023195|NCT01070069|471716167|FG003|Overall Study|Lost to Follow-up|0|||
131023196|NCT01070069|471716168|FG004|Overall Study|Lost to Follow-up|3|||
131023197|NCT00440011|471716177|FG000|Overall Study|Adverse Event|2|||
131023198|NCT00440011|471716178|FG001|Overall Study|Adverse Event|0|||
131023199|NCT00440011|471716177|FG000|Overall Study|Lost to Follow-up|0|||
131023200|NCT00440011|471716178|FG001|Overall Study|Lost to Follow-up|2|||
131023201|NCT00440011|471716177|FG000|Overall Study|Protocol Violation|1|||
131023202|NCT00440011|471716178|FG001|Overall Study|Protocol Violation|1|||
131108565|NCT02796560|472026871|FG001|Overall Study|Withdrawal by Subject|2|||
131108566|NCT02533570|472026872|FG000|Overall Study|Adverse Event|0|||
131108567|NCT02533570|472026873|FG001|Overall Study|Adverse Event|1|||
131108568|NCT02533570|472026874|FG002|Overall Study|Adverse Event|1|||
131108569|NCT02390245|472026875|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
131108570|NCT02390245|472026876|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
131108571|NCT02390245|472026877|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
131108572|NCT02390245|472026875|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
131108573|NCT02390245|472026876|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
131108574|NCT02390245|472026877|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
131108575|NCT00655486|472028732|FG000|Overall Study|Adverse Event|10|||
131108576|NCT00655486|472028732|FG000|Overall Study|Lack of Efficacy|8|||
131108577|NCT00655486|472028732|FG000|Overall Study|Withdrawal by Subject|4|||
131108578|NCT00655486|472028732|FG000|Overall Study|Protocol Violation|1|||
130889070|NCT02446899|471226884|FG001|Overall Study|Condition Under Investigation Worsened|4|||
130889071|NCT02446899|471226883|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
130889072|NCT02446899|471226884|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
130889073|NCT02446899|471226883|FG000|Overall Study|Lack of Efficacy|2|||
130889074|NCT02446899|471226884|FG001|Overall Study|Lack of Efficacy|8|||
130889075|NCT02446899|471226883|FG000|Overall Study|Lost to Follow-up|1|||
130889076|NCT02446899|471226884|FG001|Overall Study|Lost to Follow-up|3|||
130889077|NCT02446899|471226883|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
130889078|NCT02446899|471226884|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
130889079|NCT02446899|471226883|FG000|Overall Study|Withdrawal by Subject|11|||
130889080|NCT02446899|471226884|FG001|Overall Study|Withdrawal by Subject|19|||
130889081|NCT02446899|471226883|FG000|Overall Study|Miscellaneous|5|||
130889082|NCT02446899|471226884|FG001|Overall Study|Miscellaneous|4|||
130889083|NCT02446899|471226883|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130889084|NCT02446899|471226884|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
130889085|NCT01499277|471226886|FG000|Overall Study|Adverse Event|3|||
130889086|NCT01499277|471226887|FG001|Overall Study|Adverse Event|6|||
130889087|NCT01499277|471226886|FG000|Overall Study|Death|3|||
130889088|NCT01499277|471226887|FG001|Overall Study|Death|2|||
130889089|NCT01499277|471226886|FG000|Overall Study|Lost to Follow-up|15|||
130889090|NCT01499277|471226887|FG001|Overall Study|Lost to Follow-up|8|||
130889091|NCT01499277|471226886|FG000|Overall Study|Protocol Violation|2|||
130889092|NCT01499277|471226887|FG001|Overall Study|Protocol Violation|3|||
130889093|NCT01499277|471226886|FG000|Overall Study|Withdrawal by Subject|16|||
130889094|NCT01499277|471226887|FG001|Overall Study|Withdrawal by Subject|6|||
130889095|NCT01499277|471226886|FG000|Overall Study|Lack of therapeutic response and other|8|||
130889096|NCT01499277|471226887|FG001|Overall Study|Lack of therapeutic response and other|7|||
130889097|NCT02974543|471226888|FG000|Overall Study|Withdrawal by Subject|1|||
130889098|NCT02974543|471226889|FG001|Overall Study|Withdrawal by Subject|0|||
130889099|NCT00742235|471226890|FG000|Overall Study|Lost to Follow-up|0|||
130889100|NCT00742235|471226891|FG001|Overall Study|Lost to Follow-up|31|||
130889101|NCT00220636|471226892|FG000|Overall Study|Withdrawal by Subject|4|||
130889102|NCT00330967|471226893|FG000|Overall Study|Withdrawal by Subject|0|||
130889103|NCT00330967|471226894|FG001|Overall Study|Withdrawal by Subject|5|||
130889104|NCT00330967|471226893|FG000|Overall Study|Physician Decision|0|||
130889105|NCT00330967|471226894|FG001|Overall Study|Physician Decision|9|||
130889106|NCT01237899|471226897|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
130889107|NCT01237899|471226898|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
130889108|NCT01237899|471226899|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
130889109|NCT01237899|471226900|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
130889110|NCT01237899|471226901|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
130889111|NCT01237899|471226902|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
130889112|NCT01237899|471226903|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
130889113|NCT01237899|471226904|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
130889114|NCT01237899|471226905|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
130889115|NCT01237899|471226906|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
130889116|NCT01237899|471226907|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
130889117|NCT00790088|471226908|FG000|Overall Study|Protocol Violation|11|||
131108579|NCT00655486|472028732|FG000|Overall Study|Unsatisfactory compliance|2|||
131108580|NCT00655486|472028732|FG000|Overall Study|Other: Pregnancy|1|||
131108581|NCT00655486|472028732|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
130889118|NCT00790088|471226908|FG000|Overall Study|Withdrawal by Subject|17|||
131108582|NCT00655486|472028732|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
130889119|NCT00790088|471226908|FG000|Overall Study|Lost to Follow-up|7|||
130889120|NCT00790088|471226908|FG000|Overall Study|Physician Decision|4|||
131108583|NCT02768870|472028743|FG000|Overall Study|Death|1|||
131108584|NCT02768870|472028743|FG000|Overall Study|Reoperation|6|||
131108585|NCT02768870|472028743|FG000|Overall Study|Lost to Follow-up|1|||
131108586|NCT02768870|472028743|FG000|Overall Study|Exit|4|||
131108587|NCT03401229|472028744|FG000|Overall Study|Lost to Follow-up|2|||
131108588|NCT03401229|472028745|FG001|Overall Study|Lost to Follow-up|1|||
131108589|NCT03401229|472028744|FG000|Overall Study|Other|1|||
130889126|NCT05661409|471226911|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
130889127|NCT05661409|471226912|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
130889128|NCT05661409|471226913|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
130889129|NCT05661409|471226914|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
130889130|NCT05661409|471226915|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
130889131|NCT05661409|471226916|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
130889132|NCT05661409|471226911|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
130889133|NCT05661409|471226912|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
130889134|NCT05661409|471226913|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
130889135|NCT05661409|471226914|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
130889136|NCT05661409|471226915|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
130889137|NCT05661409|471226916|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
130889138|NCT05661409|471226911|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
130889139|NCT05661409|471226912|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
130889140|NCT05661409|471226913|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
130889141|NCT05661409|471226914|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
130889142|NCT05661409|471226915|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
130889143|NCT05661409|471226916|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
130889144|NCT05661409|471226911|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
130889145|NCT05661409|471226912|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
130889146|NCT05661409|471226913|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
130889147|NCT05661409|471226914|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
130889148|NCT05661409|471226915|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
130889149|NCT05661409|471226916|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
130889150|NCT05661409|471226911|FG000|Overall Study|Miscommu-nication about administration|0|||
130889151|NCT05661409|471226912|FG001|Overall Study|Miscommu-nication about administration|0|||
130889152|NCT05661409|471226913|FG002|Overall Study|Miscommu-nication about administration|0|||
130889153|NCT05661409|471226914|FG003|Overall Study|Miscommu-nication about administration|0|||
130889154|NCT05661409|471226915|FG004|Overall Study|Miscommu-nication about administration|0|||
130889155|NCT05661409|471226916|FG005|Overall Study|Miscommu-nication about administration|1|||
130889156|NCT04439136|471226917|FG000|Overall Study|Ineligible|1|||
130889157|NCT04439136|471226917|FG000|Overall Study|Never Started Treatment|2|||
130889158|NCT04439136|471226917|FG000|Overall Study|Adverse Event|4|||
130889159|NCT04439136|471226917|FG000|Overall Study|Death|3|||
130889160|NCT04439136|471226917|FG000|Overall Study|Disease Progression|27|||
130889161|NCT04439136|471226917|FG000|Overall Study|Alternative Therapy|1|||
130889162|NCT04439136|471226917|FG000|Overall Study|Increased Tumor Burden|1|||
130889163|NCT04439136|471226917|FG000|Overall Study|Symptomatic Detrioration|1|||
130889164|NCT04329806|471226918|FG000|Overall Study|Physician Decision|3|||
130889165|NCT04329806|471226919|FG001|Overall Study|Physician Decision|4|||
130889166|NCT02636595|471226922|FG000|Overall Study|Lost to Follow-up|1|||
130889167|NCT02636595|471226922|FG000|Overall Study|Other|1|||
130889168|NCT04730271|471226923|FG000|Overall Study|Adverse Event|0|||
130889169|NCT04730271|471226924|FG001|Overall Study|Adverse Event|2|||
130889170|NCT04730271|471226923|FG000|Overall Study|Withdrawal by Subject|1|||
130889171|NCT04730271|471226924|FG001|Overall Study|Withdrawal by Subject|1|||
130889172|NCT04730271|471226923|FG000|Overall Study|Protocol Violation|7|||
130889173|NCT04730271|471226924|FG001|Overall Study|Protocol Violation|13|||
130889174|NCT04730271|471226923|FG000|Overall Study|Lost to Follow-up|3|||
130889175|NCT04730271|471226924|FG001|Overall Study|Lost to Follow-up|3|||
130889176|NCT04730271|471226923|FG000|Overall Study|Death|1|||
130889177|NCT04730271|471226924|FG001|Overall Study|Death|0|||
130889178|NCT02578706|471226927|FG000|Overall Study|Withdrawal by Subject|1|||
130889179|NCT02578706|471226928|FG001|Overall Study|Withdrawal by Subject|0|||
130889180|NCT02578706|471226929|FG002|Overall Study|Withdrawal by Subject|0|||
130889181|NCT02578706|471226927|FG000|Overall Study|Lost to Follow-up|0|||
130889182|NCT02578706|471226928|FG001|Overall Study|Lost to Follow-up|4|||
130889183|NCT02578706|471226929|FG002|Overall Study|Lost to Follow-up|0|||
130889184|NCT02578706|471226927|FG000|Overall Study|Physician Decision|0|||
130889185|NCT02578706|471226928|FG001|Overall Study|Physician Decision|1|||
130889186|NCT02578706|471226929|FG002|Overall Study|Physician Decision|0|||
130889187|NCT02362282|471226932|FG000|Overall Study|Withdrawal by Subject|1|||
130889188|NCT02362282|471226933|FG001|Overall Study|Withdrawal by Subject|0|||
130889189|NCT01470326|471226936|FG000|Overall Study|Protocol Violation|32|||
130889190|NCT01470326|471226936|FG000|Overall Study|No Drug Administration Information|2|||
130889191|NCT01470326|471226936|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
130889192|NCT01166282|471226937|FG000|Open-label Period|Adverse Event|0|||
130889193|NCT01166282|471226938|FG001|Open-label Period|Adverse Event|0|||
130889194|NCT01166282|471226939|FG002|Open-label Period|Adverse Event|6|||
130889195|NCT01166282|471226937|FG000|Open-label Period|Withdrawal by Subject|0|||
130889196|NCT01166282|471226938|FG001|Open-label Period|Withdrawal by Subject|0|||
131108590|NCT03401229|472028745|FG001|Overall Study|Other|3|||
130889197|NCT01166282|471226939|FG002|Open-label Period|Withdrawal by Subject|4|||
130889198|NCT01166282|471226937|FG000|Open-label Period|Lack of Efficacy|0|||
130889199|NCT01166282|471226938|FG001|Open-label Period|Lack of Efficacy|0|||
130889200|NCT01166282|471226939|FG002|Open-label Period|Lack of Efficacy|2|||
130889201|NCT01166282|471226937|FG000|Open-label Period|Remission|0|||
130889202|NCT01166282|471226938|FG001|Open-label Period|Remission|0|||
130889203|NCT01166282|471226939|FG002|Open-label Period|Remission|4|||
130889204|NCT01166282|471226937|FG000|Open-label Period|Irregular Compliance|0|||
130889205|NCT01166282|471226938|FG001|Open-label Period|Irregular Compliance|0|||
130889206|NCT01166282|471226939|FG002|Open-label Period|Irregular Compliance|1|||
130889207|NCT00380367|471226946|FG000|Overall Study|Lost to Follow-up|1|||
130889208|NCT00380367|471226946|FG000|Overall Study|Withdrawal by Subject|1|||
130889209|NCT02194985|471226947|FG000|Overall Study|Adverse Event|1|||
130889210|NCT02194985|471226947|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
130889211|NCT02194985|471226947|FG000|Overall Study|Physician Decision|4|||
130889212|NCT02194985|471226947|FG000|Overall Study|Lost to Follow-up|1|||
130889213|NCT02194985|471226947|FG000|Overall Study|Withdrawal by Subject|2|||
130889214|NCT00392769|471226950|FG000|Overall Study|Clinical Deterioration|9|||
130889215|NCT00392769|471226950|FG000|Overall Study|Adverse Event|1|||
130889216|NCT02561832|471226951|FG000|Overall Study|Withdrawal by Subject|1|||
130889217|NCT02561832|471226952|FG001|Overall Study|Withdrawal by Subject|1|||
130889218|NCT02561832|471226951|FG000|Overall Study|Adverse Event|3|||
130889219|NCT02561832|471226952|FG001|Overall Study|Adverse Event|0|||
130889220|NCT02561832|471226951|FG000|Overall Study|Disease progression|3|||
130889221|NCT02561832|471226952|FG001|Overall Study|Disease progression|3|||
130889222|NCT00439517|471226953|FG000|Overall Study|Subject on treatment|1|||
130889223|NCT00439517|471226954|FG001|Overall Study|Subject on treatment|0|||
130889224|NCT00439517|471226953|FG000|Overall Study|Subject in survival follow-up|1|||
130889225|NCT00439517|471226954|FG001|Overall Study|Subject in survival follow-up|0|||
130889226|NCT02304367|471226957|FG000|Overall Study|Lack of Response to Bruosumab|1|||
130889227|NCT02304367|471226957|FG000|Overall Study|Sponsor Decision|3|||
130889228|NCT02304367|471226957|FG000|Overall Study|Death|2|||
130889229|NCT02304367|471226957|FG000|Overall Study|Physician Decision|1|||
130889230|NCT02304367|471226957|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
130889231|NCT00318643|471226963|FG000|Overall Study|Adverse Event|0|||
130889232|NCT00318643|471226964|FG001|Overall Study|Adverse Event|0|||
130889233|NCT00318643|471226965|FG002|Overall Study|Adverse Event|0|||
130889234|NCT00318643|471226966|FG003|Overall Study|Adverse Event|0|||
130889235|NCT00318643|471226967|FG004|Overall Study|Adverse Event|1|||
130889236|NCT00318643|471226963|FG000|Overall Study|Participant's Decision|0|||
130889237|NCT00318643|471226964|FG001|Overall Study|Participant's Decision|0|||
130889238|NCT00318643|471226965|FG002|Overall Study|Participant's Decision|0|||
130889239|NCT00318643|471226966|FG003|Overall Study|Participant's Decision|0|||
130889240|NCT00318643|471226967|FG004|Overall Study|Participant's Decision|1|||
130889241|NCT00318643|471226963|FG000|Overall Study|Investigator's Decision|0|||
130889242|NCT00318643|471226964|FG001|Overall Study|Investigator's Decision|0|||
130889243|NCT00318643|471226965|FG002|Overall Study|Investigator's Decision|0|||
130889244|NCT00318643|471226966|FG003|Overall Study|Investigator's Decision|0|||
130889245|NCT00318643|471226967|FG004|Overall Study|Investigator's Decision|1|||
130889246|NCT00060840|471226970|FG000|Overall Study|Change in surgical plan|2|||
130889247|NCT00060840|471226971|FG001|Overall Study|Change in surgical plan|6|||
130889248|NCT00060840|471226970|FG000|Overall Study|Death|0|||
130889249|NCT00060840|471226971|FG001|Overall Study|Death|1|||
130889250|NCT00060840|471226970|FG000|Overall Study|Withdrawal by Subject|0|||
130889251|NCT00060840|471226971|FG001|Overall Study|Withdrawal by Subject|1|||
130889252|NCT00060840|471226970|FG000|Overall Study|Subinvestigator unavailable|0|||
130889253|NCT00060840|471226971|FG001|Overall Study|Subinvestigator unavailable|1|||
130889254|NCT00060840|471226970|FG000|Overall Study|Physician Decision|1|||
131108591|NCT03401229|472028744|FG000|Overall Study|Adverse Event|8|||
131108592|NCT03401229|472028745|FG001|Overall Study|Adverse Event|6|||
131108593|NCT03401229|472028744|FG000|Overall Study|Withdrawal by Subject|29|||
130686007|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130889255|NCT00060840|471226971|FG001|Overall Study|Physician Decision|0|||
130889256|NCT00060840|471226970|FG000|Overall Study|Other|1|||
130889257|NCT00060840|471226971|FG001|Overall Study|Other|0|||
130889258|NCT01216189|471226976|FG000|Overall Study|Lost to Follow-up|21|||
130889259|NCT01216189|471226977|FG001|Overall Study|Lost to Follow-up|3|||
130889260|NCT01216189|471226976|FG000|Overall Study|Death|4|||
130889261|NCT01216189|471226977|FG001|Overall Study|Death|2|||
130889262|NCT04308291|471226978|FG000|Run-In Phase|Withdrawal by Subject|4|||
130889263|NCT04308291|471226978|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
131108594|NCT03401229|472028745|FG001|Overall Study|Withdrawal by Subject|26|||
130889264|NCT04308291|471226978|FG000|Study Phase 6-M|Physician Decision|2|||
130889265|NCT04308291|471226978|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
131108595|NCT03401229|472028744|FG000|Overall Study|COVID-19|0|||
130889266|NCT04308291|471226978|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
130889267|NCT04308291|471226978|FG000|Study Phase 12-M|Physician Decision|2|||
130889268|NCT04308291|471226978|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
130889269|NCT04411667|471226981|FG000|Overall Study|Physician Decision|1|||
130889270|NCT04411667|471226982|FG001|Overall Study|Physician Decision|0|||
130889271|NCT00714870|471226984|FG000|Overall Study|Lost to Follow-up|22|||
130889272|NCT00714870|471226985|FG001|Overall Study|Lost to Follow-up|5|||
130889273|NCT00714870|471226984|FG000|Overall Study|patient unable to come b/c back pain|1|||
130889274|NCT00714870|471226985|FG001|Overall Study|patient unable to come b/c back pain|0|||
130889275|NCT00714870|471226984|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
130889276|NCT00714870|471226985|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
130889277|NCT03399552|471226986|FG000|Overall Study|No evidence of disease|1|||
130889278|NCT03399552|471226986|FG000|Overall Study|Unevaluable|1|||
130889279|NCT02357368|471226987|FG000|Overall Study|Lost to Follow-up|0|||
130889280|NCT02357368|471226988|FG001|Overall Study|Lost to Follow-up|0|||
130889281|NCT02357368|471226989|FG002|Overall Study|Lost to Follow-up|0|||
130889282|NCT02357368|471226990|FG003|Overall Study|Lost to Follow-up|1|||
131023203|NCT00440011|471716177|FG000|Overall Study|Withdrawal by Subject|1|||
131023204|NCT00440011|471716178|FG001|Overall Study|Withdrawal by Subject|0|||
131023205|NCT04732338|471716183|FG000|Overall Study|Lost to Follow-up|3|||
131023206|NCT04732338|471716184|FG001|Overall Study|Lost to Follow-up|3|||
131023207|NCT01803555|471716190|FG000|Overall Study|Adverse Event|3|||
131023208|NCT01803555|471716191|FG001|Overall Study|Adverse Event|2|||
131023209|NCT01803555|471716190|FG000|Overall Study|Withdrawal by Subject|3|||
131023210|NCT01803555|471716191|FG001|Overall Study|Withdrawal by Subject|3|||
131023211|NCT01803555|471716190|FG000|Overall Study|Non-compliance|1|||
131023212|NCT01803555|471716191|FG001|Overall Study|Non-compliance|1|||
131023213|NCT01803555|471716190|FG000|Overall Study|Protocol Violation|3|||
131023214|NCT01803555|471716191|FG001|Overall Study|Protocol Violation|5|||
131023215|NCT01803555|471716190|FG000|Overall Study|Lost to Follow-up|0|||
131023216|NCT01803555|471716191|FG001|Overall Study|Lost to Follow-up|2|||
131023217|NCT01803555|471716190|FG000|Overall Study|Other than specified|3|||
131023218|NCT01803555|471716191|FG001|Overall Study|Other than specified|5|||
131023219|NCT02539225|471716192|FG000|Part A|Adverse Event|13|||
131023220|NCT02539225|471716193|FG001|Part A|Adverse Event|4|||
131023221|NCT02539225|471716192|FG000|Part A|Withdrawal by Subject|2|||
131023222|NCT02539225|471716193|FG001|Part A|Withdrawal by Subject|4|||
131023223|NCT02539225|471716192|FG000|Part A|Physician Decision|4|||
131023224|NCT02539225|471716193|FG001|Part A|Physician Decision|7|||
131023225|NCT02539225|471716192|FG000|Part A|Did Not Receive study Drug|1|||
131023226|NCT02539225|471716193|FG001|Part A|Did Not Receive study Drug|1|||
131023227|NCT02539225|471716192|FG000|Pre Treatment for Part B|Progressive disease|1|||
131023228|NCT02539225|471716193|FG001|Pre Treatment for Part B|Progressive disease|1|||
131023229|NCT02539225|471716192|FG000|Pre Treatment for Part B|Adverse Event|1|||
131023230|NCT02539225|471716193|FG001|Pre Treatment for Part B|Adverse Event|1|||
131023231|NCT02539225|471716192|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
131023232|NCT02539225|471716193|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
131023233|NCT02539225|471716192|FG000|Pre Treatment for Part B|Physician Decision|2|||
131023234|NCT02539225|471716193|FG001|Pre Treatment for Part B|Physician Decision|0|||
131023235|NCT02539225|471716192|FG000|Part B|Adverse Event|4|||
131023236|NCT02539225|471716193|FG001|Part B|Adverse Event|4|||
131023237|NCT02539225|471716192|FG000|Part B|Withdrawal by Subject|0|||
131023238|NCT02539225|471716193|FG001|Part B|Withdrawal by Subject|3|||
131023239|NCT02539225|471716192|FG000|Part B|Physician Decision|0|||
131023240|NCT02539225|471716193|FG001|Part B|Physician Decision|9|||
131023241|NCT01551355|471716194|FG000|Overall Study|Lost to Follow-up|51|||
131023242|NCT01551355|471716195|FG001|Overall Study|Lost to Follow-up|49|||
131023243|NCT01551355|471716196|FG002|Overall Study|Lost to Follow-up|34|||
131023244|NCT01551355|471716197|FG003|Overall Study|Lost to Follow-up|24|||
131023245|NCT01551355|471716198|FG004|Overall Study|Lost to Follow-up|9|||
131023246|NCT01551355|471716199|FG005|Overall Study|Lost to Follow-up|6|||
131023247|NCT01925339|471716200|FG000|Overall Study|Adverse Event|2|||
131023248|NCT01925339|471716201|FG001|Overall Study|Adverse Event|0|||
131023249|NCT01538719|471716202|FG000|Overall Study|Lost to Follow-up|2|||
131023250|NCT01538719|471716203|FG001|Overall Study|Lost to Follow-up|0|||
131023251|NCT03664960|471716204|FG000|Overall Study|Adverse Event|0|||
131023252|NCT03664960|471716205|FG001|Overall Study|Adverse Event|3|||
131023253|NCT03664960|471716204|FG000|Overall Study|Lost to Follow-up|3|||
131023254|NCT03664960|471716205|FG001|Overall Study|Lost to Follow-up|2|||
131023255|NCT03664960|471716204|FG000|Overall Study|Physician Decision|1|||
131023256|NCT03664960|471716205|FG001|Overall Study|Physician Decision|0|||
131023257|NCT03664960|471716204|FG000|Overall Study|Withdrawal by Subject|3|||
131023258|NCT03664960|471716205|FG001|Overall Study|Withdrawal by Subject|14|||
131023259|NCT03664960|471716204|FG000|Overall Study|Sponsor Decision|1|||
131023260|NCT03664960|471716205|FG001|Overall Study|Sponsor Decision|1|||
131023261|NCT03664960|471716204|FG000|Overall Study|Other|1|||
131023262|NCT03664960|471716205|FG001|Overall Study|Other|2|||
131023263|NCT04814186|471718505|FG000|Treatment Phase|Adverse Event|1|||
131023264|NCT04814186|471718505|FG000|Treatment Phase|Death|6|||
131023265|NCT04814186|471718505|FG000|Treatment Phase|Withdrawal by Subject|2|||
131023266|NCT04814186|471718505|FG000|Treatment Phase|Other|1|||
131023267|NCT04814186|471718505|FG000|Follow-Up Phase|Adverse Event|1|||
131023268|NCT04814186|471718505|FG000|Follow-Up Phase|Death|6|||
131023269|NCT04814186|471718505|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
131023270|NCT04814186|471718505|FG000|Follow-Up Phase|Other|1|||
131023271|NCT03960463|471718538|FG000|Overall Study|Withdrawal by Subject|2|||
131023272|NCT03960463|471718539|FG001|Overall Study|Withdrawal by Subject|0|||
131023273|NCT04043455|471718540|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
131023274|NCT04043455|471718541|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
131023275|NCT04043455|471718542|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
131023276|NCT04043455|471718543|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
131023277|NCT04043455|471718544|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
131023278|NCT04043455|471718545|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
131023279|NCT04043455|471718540|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
131023280|NCT04043455|471718541|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
131023281|NCT04043455|471718542|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
131023282|NCT04043455|471718543|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
131023283|NCT04043455|471718544|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
131023284|NCT04043455|471718545|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
131023285|NCT04043455|471718540|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
131023286|NCT04043455|471718541|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
131023287|NCT04043455|471718542|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
131023288|NCT04043455|471718543|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
131023289|NCT04043455|471718544|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
131023290|NCT04043455|471718545|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
131023291|NCT04043455|471718540|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
131023292|NCT04043455|471718541|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
131023293|NCT04043455|471718542|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
131023294|NCT04043455|471718543|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
131023295|NCT04043455|471718544|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
131023296|NCT04043455|471718545|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
131023297|NCT04043455|471718540|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
131023298|NCT04043455|471718541|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
131023299|NCT04043455|471718542|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
131023300|NCT04043455|471718543|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
131023301|NCT04043455|471718544|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
131023302|NCT04043455|471718545|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
131023303|NCT04043455|471718540|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
131023304|NCT04043455|471718541|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
131023305|NCT04043455|471718542|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
131023306|NCT04043455|471718543|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
131023307|NCT04043455|471718544|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
131023308|NCT04043455|471718545|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
131023309|NCT04043455|471718540|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
131023310|NCT04043455|471718541|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
131023311|NCT04043455|471718542|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
131023312|NCT04043455|471718543|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
131023313|NCT04043455|471718544|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
131023314|NCT04043455|471718545|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
131023315|NCT04043455|471718540|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
131023316|NCT04043455|471718541|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
131023317|NCT04043455|471718542|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
131023318|NCT04043455|471718543|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
131023319|NCT04043455|471718544|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
131023320|NCT04043455|471718545|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
131023321|NCT04043455|471718540|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
131023322|NCT04043455|471718541|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
131023323|NCT04043455|471718542|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
131023324|NCT04043455|471718543|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
131023325|NCT04043455|471718544|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
131023326|NCT04043455|471718545|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
131023327|NCT04043455|471718540|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
131108596|NCT03401229|472028745|FG001|Overall Study|COVID-19|1|||
130767073|NCT01857102|470770713|FG000|Period 2|Lens Discomfort|1|||
130889283|NCT02357368|471226987|FG000|Overall Study|Pregnancy|3|||
131108597|NCT02963610|472028746|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
131108598|NCT01774110|472028747|FG000|Overall Study|Lost to Follow-up|7|||
131108599|NCT01122862|472028748|FG000|Period 1|Protocol Violation|0|||
131108600|NCT01122862|472028749|FG001|Period 1|Protocol Violation|1|||
131108601|NCT01122862|472028750|FG002|Period 1|Protocol Violation|0|||
131108602|NCT01122862|472028748|FG000|Period 2|Adverse Event|0|||
131108603|NCT01122862|472028749|FG001|Period 2|Adverse Event|0|||
131108604|NCT01122862|472028750|FG002|Period 2|Adverse Event|1|||
131108605|NCT00640016|472028751|FG000|Overall Study|Withdrawal by Subject|0|||
131108606|NCT00640016|472028752|FG001|Overall Study|Withdrawal by Subject|1|||
131108607|NCT00640016|472028753|FG002|Overall Study|Withdrawal by Subject|0|||
131108608|NCT00640016|472028754|FG003|Overall Study|Withdrawal by Subject|0|||
131108609|NCT00640016|472028751|FG000|Overall Study|Study termination|2|||
131108610|NCT00640016|472028752|FG001|Overall Study|Study termination|1|||
131108611|NCT00640016|472028753|FG002|Overall Study|Study termination|3|||
131108612|NCT00640016|472028754|FG003|Overall Study|Study termination|2|||
131108613|NCT00640016|472028751|FG000|Overall Study|Adverse Event|0|||
131108614|NCT00640016|472028752|FG001|Overall Study|Adverse Event|0|||
131108615|NCT00640016|472028753|FG002|Overall Study|Adverse Event|0|||
131108616|NCT00640016|472028754|FG003|Overall Study|Adverse Event|1|||
131108617|NCT02699983|472028757|FG000|Overall Study|Withdrawal by Subject|1|||
131108618|NCT02699983|472028758|FG001|Overall Study|Withdrawal by Subject|0|||
131108619|NCT03575143|472028759|FG000|Overall Study|Lost to Follow-up|0|||
131108620|NCT03575143|472028760|FG001|Overall Study|Lost to Follow-up|0|||
131108621|NCT03575143|472028761|FG002|Overall Study|Lost to Follow-up|4|||
131108622|NCT03575143|472028759|FG000|Overall Study|Withdrawal by Subject|0|||
131108623|NCT03575143|472028760|FG001|Overall Study|Withdrawal by Subject|0|||
131108624|NCT03575143|472028761|FG002|Overall Study|Withdrawal by Subject|5|||
131108625|NCT03575143|472028759|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
131108626|NCT03575143|472028760|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
131108627|NCT03575143|472028761|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
131108628|NCT01287065|472028762|FG000|Treatment Period 1|Adverse Event|0|||
131108629|NCT01287065|472028763|FG001|Treatment Period 1|Adverse Event|0|||
131108630|NCT01287065|472028764|FG002|Treatment Period 1|Adverse Event|0|||
131108631|NCT01287065|472028765|FG003|Treatment Period 1|Adverse Event|0|||
131108632|NCT01287065|472028766|FG004|Treatment Period 1|Adverse Event|1|||
131108633|NCT01287065|472028767|FG005|Treatment Period 1|Adverse Event|0|||
131108634|NCT01287065|472028762|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131108635|NCT01287065|472028763|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131108636|NCT01287065|472028764|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131108637|NCT01287065|472028765|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131108638|NCT01287065|472028766|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131108639|NCT01287065|472028767|FG005|Treatment Period 1|Withdrawal by Subject|1|||
131108640|NCT02875977|472028770|FG000|Overall Study|Lost to Follow-up|42|||
131108641|NCT02875977|472028771|FG001|Overall Study|Lost to Follow-up|29|||
131108642|NCT01259726|472028772|FG000|Overall Study|Death|1|||
131108643|NCT01259726|472028773|FG001|Overall Study|Death|0|||
131108644|NCT01259726|472028774|FG002|Overall Study|Death|0|||
131108645|NCT01259726|472028775|FG003|Overall Study|Death|0|||
131108646|NCT01259726|472028772|FG000|Overall Study|Physician Decision|2|||
131108647|NCT01259726|472028773|FG001|Overall Study|Physician Decision|0|||
131108648|NCT01259726|472028774|FG002|Overall Study|Physician Decision|1|||
131108649|NCT01259726|472028775|FG003|Overall Study|Physician Decision|1|||
131108650|NCT01259726|472028772|FG000|Overall Study|Withdrawal by Subject|1|||
131108651|NCT01259726|472028773|FG001|Overall Study|Withdrawal by Subject|3|||
131108652|NCT01259726|472028774|FG002|Overall Study|Withdrawal by Subject|2|||
131108653|NCT01259726|472028775|FG003|Overall Study|Withdrawal by Subject|1|||
131108654|NCT01259726|472028772|FG000|Overall Study|Lost to Follow-up|1|||
131108655|NCT01259726|472028773|FG001|Overall Study|Lost to Follow-up|1|||
131108656|NCT01259726|472028774|FG002|Overall Study|Lost to Follow-up|1|||
131108657|NCT01259726|472028775|FG003|Overall Study|Lost to Follow-up|3|||
131108658|NCT03421431|472028783|FG000|Overall Study|Adverse Event|2|||
131108659|NCT03421431|472028784|FG001|Overall Study|Adverse Event|1|||
131108660|NCT03421431|472028785|FG002|Overall Study|Adverse Event|12|||
131108661|NCT03421431|472028783|FG000|Overall Study|Lost to Follow-up|1|||
131222627|NCT00948025|472443125|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
131108662|NCT03421431|472028784|FG001|Overall Study|Lost to Follow-up|1|||
131108663|NCT03421431|472028785|FG002|Overall Study|Lost to Follow-up|1|||
131108664|NCT03421431|472028783|FG000|Overall Study|Withdrawal by Subject|3|||
131108665|NCT03421431|472028784|FG001|Overall Study|Withdrawal by Subject|2|||
131108666|NCT03421431|472028785|FG002|Overall Study|Withdrawal by Subject|1|||
131108667|NCT03421431|472028783|FG000|Overall Study|Protocol Violation|0|||
131222628|NCT00948025|472443124|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
131108668|NCT03421431|472028784|FG001|Overall Study|Protocol Violation|1|||
131108669|NCT03421431|472028785|FG002|Overall Study|Protocol Violation|0|||
131108670|NCT03421431|472028783|FG000|Overall Study|Participant met Stopping Rules|0|||
131108671|NCT03421431|472028784|FG001|Overall Study|Participant met Stopping Rules|1|||
130686008|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686009|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686010|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686011|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686012|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686013|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686014|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686015|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686016|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686017|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
131023328|NCT04043455|471718541|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
131023329|NCT04043455|471718542|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
131023330|NCT04043455|471718543|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
131023331|NCT04043455|471718544|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
131023332|NCT04043455|471718545|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
131023333|NCT04043455|471718540|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
131023334|NCT04043455|471718541|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
131023335|NCT04043455|471718542|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
131023336|NCT04043455|471718543|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
131023337|NCT04043455|471718544|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
131023338|NCT04043455|471718545|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
131023339|NCT05568615|471718546|FG000|Overall Study|Death|1|||
131023340|NCT05568615|471718546|FG000|Overall Study|Physician Decision|1|||
131023341|NCT03529110|471718547|FG000|Overall Study|Progressive Disease|66|||
131023342|NCT03529110|471718548|FG001|Overall Study|Progressive Disease|158|||
131023343|NCT03529110|471718547|FG000|Overall Study|Clinical Progression|4|||
131023344|NCT03529110|471718548|FG001|Overall Study|Clinical Progression|12|||
131023345|NCT03529110|471718547|FG000|Overall Study|Adverse Event|35|||
131023346|NCT03529110|471718548|FG001|Overall Study|Adverse Event|17|||
131023347|NCT03529110|471718547|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
131023348|NCT03529110|471718548|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
131023349|NCT03529110|471718547|FG000|Overall Study|Lack of Efficacy|3|||
131023350|NCT03529110|471718548|FG001|Overall Study|Lack of Efficacy|3|||
131023351|NCT03529110|471718547|FG000|Overall Study|Physician Decision|2|||
131023352|NCT03529110|471718548|FG001|Overall Study|Physician Decision|8|||
131023353|NCT03529110|471718547|FG000|Overall Study|Miscellaneous|2|||
131023354|NCT03529110|471718548|FG001|Overall Study|Miscellaneous|5|||
131023355|NCT05194917|471718549|FG000|Overall Study|Lost to Follow-up|7|||
131023356|NCT05194917|471718550|FG001|Overall Study|Lost to Follow-up|5|||
131023357|NCT05194917|471718551|FG002|Overall Study|Lost to Follow-up|6|||
131023358|NCT05194917|471718552|FG003|Overall Study|Lost to Follow-up|5|||
131023359|NCT04688450|471718557|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
131023360|NCT04688450|471718557|FG000|Overall Study|Withdrawal by Subject|1|||
131023361|NCT03189524|471718558|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
131023362|NCT03189524|471718559|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
131023363|NCT03189524|471718560|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
131023364|NCT03189524|471718558|FG000|Overall Study|Death|2|||
131023365|NCT03189524|471718559|FG001|Overall Study|Death|2|||
131023366|NCT03189524|471718560|FG002|Overall Study|Death|1|||
131023367|NCT03189524|471718558|FG000|Overall Study|Lost to Follow-up|1|||
131023368|NCT03189524|471718559|FG001|Overall Study|Lost to Follow-up|0|||
131023369|NCT03189524|471718560|FG002|Overall Study|Lost to Follow-up|8|||
131023370|NCT03189524|471718558|FG000|Overall Study|Withdrawal by Subject|1|||
131023371|NCT03189524|471718559|FG001|Overall Study|Withdrawal by Subject|1|||
131023372|NCT03189524|471718560|FG002|Overall Study|Withdrawal by Subject|3|||
131023373|NCT03189524|471718558|FG000|Overall Study|Progressive Disease|0|||
131023374|NCT03189524|471718559|FG001|Overall Study|Progressive Disease|2|||
131023375|NCT03189524|471718560|FG002|Overall Study|Progressive Disease|0|||
131023376|NCT02723955|471718561|FG000|Escalation Phase|Death|1|||
131023377|NCT02723955|471718562|FG001|Escalation Phase|Death|1|||
131023378|NCT02723955|471718563|FG002|Escalation Phase|Death|2|||
131023379|NCT02723955|471718564|FG003|Escalation Phase|Death|7|||
131023380|NCT02723955|471718565|FG004|Escalation Phase|Death|18|||
131023381|NCT02723955|471718566|FG005|Escalation Phase|Death|17|||
131023382|NCT02723955|471718567|FG006|Escalation Phase|Death|11|||
131108672|NCT03421431|472028785|FG002|Overall Study|Participant met Stopping Rules|0|||
131023383|NCT02723955|471718568|FG007|Escalation Phase|Death|21|||
131023384|NCT02723955|471718569|FG008|Escalation Phase|Death|3|||
131023385|NCT02723955|471718570|FG009|Escalation Phase|Death|0|||
131023386|NCT02723955|471718571|FG010|Escalation Phase|Death|0|||
131023387|NCT02723955|471718572|FG011|Escalation Phase|Death|0|||
131023388|NCT02723955|471718573|FG012|Escalation Phase|Death|2|||
130889284|NCT02357368|471226988|FG001|Overall Study|Pregnancy|2|||
130889285|NCT02357368|471226989|FG002|Overall Study|Pregnancy|0|||
130889286|NCT02357368|471226990|FG003|Overall Study|Pregnancy|0|||
130889287|NCT02357368|471226987|FG000|Overall Study|Withdrawal by Subject|3|||
130889288|NCT02357368|471226988|FG001|Overall Study|Withdrawal by Subject|1|||
130889289|NCT02357368|471226989|FG002|Overall Study|Withdrawal by Subject|1|||
130889290|NCT02357368|471226990|FG003|Overall Study|Withdrawal by Subject|2|||
130889291|NCT02377817|471226991|FG000|Overall Study|Transportation/childcare barriers.|2|||
130889292|NCT02377817|471226992|FG001|Overall Study|Transportation/childcare barriers.|0|||
130889293|NCT02377817|471226991|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
130889294|NCT02377817|471226992|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
130889295|NCT03895840|471226993|FG000|Overall Study|Withdrawal by Subject|21|||
130889296|NCT01931566|471226994|FG000|Overall Study|Randomized But Not Treated|6|||
130889297|NCT01931566|471226995|FG001|Overall Study|Randomized But Not Treated|9|||
130889298|NCT01931566|471226996|FG002|Overall Study|Randomized But Not Treated|14|||
130889299|NCT01931566|471226994|FG000|Overall Study|Adverse Event|37|||
130889300|NCT01931566|471226995|FG001|Overall Study|Adverse Event|167|||
130889301|NCT01931566|471226996|FG002|Overall Study|Adverse Event|132|||
130889302|NCT01931566|471226994|FG000|Overall Study|Major Protocol Deviation|5|||
130889303|NCT01931566|471226995|FG001|Overall Study|Major Protocol Deviation|14|||
130889304|NCT01931566|471226996|FG002|Overall Study|Major Protocol Deviation|21|||
130889305|NCT01931566|471226994|FG000|Overall Study|Lost to Follow-up|3|||
130889306|NCT01931566|471226995|FG001|Overall Study|Lost to Follow-up|26|||
130889307|NCT01931566|471226996|FG002|Overall Study|Lost to Follow-up|23|||
130889308|NCT01931566|471226994|FG000|Overall Study|Voluntary Withdrawal|78|||
130889309|NCT01931566|471226995|FG001|Overall Study|Voluntary Withdrawal|245|||
130889310|NCT01931566|471226996|FG002|Overall Study|Voluntary Withdrawal|225|||
130889311|NCT01931566|471226994|FG000|Overall Study|Study Termination|289|||
130889312|NCT01931566|471226995|FG001|Overall Study|Study Termination|968|||
131023389|NCT02723955|471718574|FG013|Escalation Phase|Death|4|||
131023390|NCT02723955|471718575|FG014|Escalation Phase|Death|5|||
131023391|NCT02723955|471718576|FG015|Escalation Phase|Death|6|||
131023392|NCT02723955|471718577|FG016|Escalation Phase|Death|6|||
131023393|NCT02723955|471718578|FG017|Escalation Phase|Death|7|||
131023394|NCT02723955|471718579|FG018|Escalation Phase|Death|1|||
131023395|NCT02723955|471718580|FG019|Escalation Phase|Death|3|||
131023396|NCT02723955|471718581|FG020|Escalation Phase|Death|13|||
131023397|NCT02723955|471718582|FG021|Escalation Phase|Death|3|||
131023398|NCT02723955|471718583|FG022|Escalation Phase|Death|2|||
131023399|NCT02723955|471718584|FG023|Escalation Phase|Death|4|||
131023400|NCT02723955|471718585|FG024|Escalation Phase|Death|31|||
131023401|NCT02723955|471718586|FG025|Escalation Phase|Death|7|||
130889313|NCT01931566|471226996|FG002|Overall Study|Study Termination|1037|||
130889314|NCT01931566|471226994|FG000|Overall Study|Reason Not Specified|11|||
130889315|NCT01931566|471226995|FG001|Overall Study|Reason Not Specified|47|||
130889316|NCT01931566|471226996|FG002|Overall Study|Reason Not Specified|53|||
130889317|NCT01931566|471226994|FG000|Overall Study|Missing|0|||
130889318|NCT01931566|471226995|FG001|Overall Study|Missing|0|||
130889319|NCT01931566|471226996|FG002|Overall Study|Missing|1|||
130889320|NCT00760617|471227000|FG000|Overall Study|Adverse Event|5|||
130889321|NCT00760617|471227001|FG001|Overall Study|Adverse Event|2|||
130889322|NCT00760617|471227002|FG002|Overall Study|Adverse Event|0|||
130889323|NCT00760617|471227000|FG000|Overall Study|Lost to Follow-up|0|||
130889324|NCT00760617|471227001|FG001|Overall Study|Lost to Follow-up|0|||
130889325|NCT00760617|471227002|FG002|Overall Study|Lost to Follow-up|5|||
130889326|NCT04625101|471227003|FG000|Overall Study|Withdrawal by Subject|0|||
130889327|NCT04625101|471227004|FG001|Overall Study|Withdrawal by Subject|1|||
130889328|NCT04625101|471227003|FG000|Overall Study|Protocol Deviation|1|||
130889329|NCT04625101|471227004|FG001|Overall Study|Protocol Deviation|0|||
130889330|NCT02817464|471227005|FG000|Overall Study|Lost to Follow-up|1|||
130889331|NCT02817464|471227006|FG001|Overall Study|Lost to Follow-up|0|||
130889332|NCT02817464|471227005|FG000|Overall Study|Discontinued early due to personal decision|1|||
130889333|NCT02817464|471227006|FG001|Overall Study|Discontinued early due to personal decision|1|||
130889334|NCT02453711|471227007|FG000|Overall Study|Withdrawal by Subject|5|||
130889335|NCT02453711|471227008|FG001|Overall Study|Withdrawal by Subject|4|||
130889336|NCT02453711|471227009|FG002|Overall Study|Withdrawal by Subject|6|||
130889337|NCT02453711|471227010|FG003|Overall Study|Withdrawal by Subject|4|||
130889338|NCT02453711|471227011|FG004|Overall Study|Withdrawal by Subject|1|||
130889339|NCT02453711|471227012|FG005|Overall Study|Withdrawal by Subject|1|||
130889340|NCT02453711|471227013|FG006|Overall Study|Withdrawal by Subject|0|||
130889341|NCT02453711|471227014|FG007|Overall Study|Withdrawal by Subject|1|||
130889342|NCT02453711|471227015|FG008|Overall Study|Withdrawal by Subject|7|||
130889343|NCT02453711|471227007|FG000|Overall Study|Lost to Follow-up|5|||
131023402|NCT02723955|471718587|FG026|Escalation Phase|Death|13|||
131023403|NCT02723955|471718588|FG027|Escalation Phase|Death|0|||
131023404|NCT02723955|471718589|FG028|Escalation Phase|Death|1|||
131023405|NCT02723955|471718590|FG029|Escalation Phase|Death|0|||
131023406|NCT02723955|471718591|FG030|Escalation Phase|Death|0|||
131023407|NCT02723955|471718592|FG031|Escalation Phase|Death|0|||
130686018|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
130686019|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
130889344|NCT02453711|471227008|FG001|Overall Study|Lost to Follow-up|3|||
130889345|NCT02453711|471227009|FG002|Overall Study|Lost to Follow-up|2|||
130889346|NCT02453711|471227010|FG003|Overall Study|Lost to Follow-up|3|||
130889347|NCT02453711|471227011|FG004|Overall Study|Lost to Follow-up|1|||
130889348|NCT02453711|471227012|FG005|Overall Study|Lost to Follow-up|5|||
130889349|NCT02453711|471227013|FG006|Overall Study|Lost to Follow-up|2|||
130889350|NCT02453711|471227014|FG007|Overall Study|Lost to Follow-up|6|||
130889351|NCT02453711|471227015|FG008|Overall Study|Lost to Follow-up|6|||
130686020|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686021|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686022|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686023|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686024|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130686025|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686026|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686027|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130767074|NCT01857102|470770714|FG001|Period 2|Lens Discomfort|0|||
130889352|NCT02453711|471227007|FG000|Overall Study|Death|0|||
130889353|NCT02453711|471227008|FG001|Overall Study|Death|0|||
130889354|NCT02453711|471227009|FG002|Overall Study|Death|0|||
130889355|NCT02453711|471227010|FG003|Overall Study|Death|0|||
130889356|NCT02453711|471227011|FG004|Overall Study|Death|0|||
130889357|NCT02453711|471227012|FG005|Overall Study|Death|0|||
130889358|NCT02453711|471227013|FG006|Overall Study|Death|1|||
130889359|NCT02453711|471227014|FG007|Overall Study|Death|0|||
130889360|NCT02453711|471227015|FG008|Overall Study|Death|0|||
130889361|NCT02453711|471227007|FG000|Overall Study|Unclassified|1|||
130889362|NCT02453711|471227008|FG001|Overall Study|Unclassified|0|||
130889363|NCT02453711|471227009|FG002|Overall Study|Unclassified|1|||
130889364|NCT02453711|471227010|FG003|Overall Study|Unclassified|0|||
130889365|NCT02453711|471227011|FG004|Overall Study|Unclassified|0|||
131023408|NCT02723955|471718593|FG032|Escalation Phase|Death|0|||
131023409|NCT02723955|471718594|FG033|Escalation Phase|Death|0|||
131023410|NCT02723955|471718595|FG034|Escalation Phase|Death|0|||
131023411|NCT02723955|471718596|FG035|Escalation Phase|Death|0|||
131023412|NCT02723955|471718597|FG036|Escalation Phase|Death|0|||
131023413|NCT02723955|471718598|FG037|Escalation Phase|Death|0|||
131023414|NCT02723955|471718599|FG038|Escalation Phase|Death|0|||
131023415|NCT02723955|471718600|FG039|Escalation Phase|Death|0|||
131023416|NCT02723955|471718601|FG040|Escalation Phase|Death|0|||
131023417|NCT02723955|471718602|FG041|Escalation Phase|Death|0|||
131023418|NCT02723955|471718603|FG042|Escalation Phase|Death|0|||
131023419|NCT02723955|471718561|FG000|Escalation Phase|Lost to Follow-up|0|||
131023420|NCT02723955|471718562|FG001|Escalation Phase|Lost to Follow-up|0|||
131023421|NCT02723955|471718563|FG002|Escalation Phase|Lost to Follow-up|0|||
131023422|NCT02723955|471718564|FG003|Escalation Phase|Lost to Follow-up|0|||
131023423|NCT02723955|471718565|FG004|Escalation Phase|Lost to Follow-up|0|||
131023424|NCT02723955|471718566|FG005|Escalation Phase|Lost to Follow-up|2|||
131023425|NCT02723955|471718567|FG006|Escalation Phase|Lost to Follow-up|1|||
131023426|NCT02723955|471718568|FG007|Escalation Phase|Lost to Follow-up|1|||
131023427|NCT02723955|471718569|FG008|Escalation Phase|Lost to Follow-up|1|||
131023428|NCT02723955|471718570|FG009|Escalation Phase|Lost to Follow-up|0|||
131023429|NCT02723955|471718571|FG010|Escalation Phase|Lost to Follow-up|0|||
131023430|NCT02723955|471718572|FG011|Escalation Phase|Lost to Follow-up|0|||
131023431|NCT02723955|471718573|FG012|Escalation Phase|Lost to Follow-up|1|||
131023432|NCT02723955|471718574|FG013|Escalation Phase|Lost to Follow-up|0|||
131023433|NCT02723955|471718575|FG014|Escalation Phase|Lost to Follow-up|0|||
131023434|NCT02723955|471718576|FG015|Escalation Phase|Lost to Follow-up|0|||
131023435|NCT02723955|471718577|FG016|Escalation Phase|Lost to Follow-up|1|||
131023436|NCT02723955|471718578|FG017|Escalation Phase|Lost to Follow-up|2|||
131023437|NCT02723955|471718579|FG018|Escalation Phase|Lost to Follow-up|0|||
131023438|NCT02723955|471718580|FG019|Escalation Phase|Lost to Follow-up|1|||
131023439|NCT02723955|471718581|FG020|Escalation Phase|Lost to Follow-up|2|||
130889366|NCT02453711|471227012|FG005|Overall Study|Unclassified|0|||
130889367|NCT02453711|471227013|FG006|Overall Study|Unclassified|0|||
130889368|NCT02453711|471227014|FG007|Overall Study|Unclassified|0|||
130889369|NCT02453711|471227015|FG008|Overall Study|Unclassified|0|||
131023440|NCT02723955|471718582|FG021|Escalation Phase|Lost to Follow-up|1|||
131023441|NCT02723955|471718583|FG022|Escalation Phase|Lost to Follow-up|0|||
131023442|NCT02723955|471718584|FG023|Escalation Phase|Lost to Follow-up|0|||
131023443|NCT02723955|471718585|FG024|Escalation Phase|Lost to Follow-up|1|||
130889370|NCT01273519|471227016|FG000|Overall Study|Adverse Event|3|||
130889371|NCT01273519|471227017|FG001|Overall Study|Adverse Event|0|||
131023444|NCT02723955|471718586|FG025|Escalation Phase|Lost to Follow-up|1|||
131023445|NCT02723955|471718587|FG026|Escalation Phase|Lost to Follow-up|3|||
131023446|NCT02723955|471718588|FG027|Escalation Phase|Lost to Follow-up|0|||
131023447|NCT02723955|471718589|FG028|Escalation Phase|Lost to Follow-up|1|||
131023448|NCT02723955|471718590|FG029|Escalation Phase|Lost to Follow-up|0|||
131023449|NCT02723955|471718591|FG030|Escalation Phase|Lost to Follow-up|0|||
131023450|NCT02723955|471718592|FG031|Escalation Phase|Lost to Follow-up|0|||
131023451|NCT02723955|471718593|FG032|Escalation Phase|Lost to Follow-up|0|||
131023452|NCT02723955|471718594|FG033|Escalation Phase|Lost to Follow-up|0|||
131023453|NCT02723955|471718595|FG034|Escalation Phase|Lost to Follow-up|0|||
131023454|NCT02723955|471718596|FG035|Escalation Phase|Lost to Follow-up|0|||
131023455|NCT02723955|471718597|FG036|Escalation Phase|Lost to Follow-up|0|||
131023456|NCT02723955|471718598|FG037|Escalation Phase|Lost to Follow-up|0|||
131023457|NCT02723955|471718599|FG038|Escalation Phase|Lost to Follow-up|0|||
131023458|NCT02723955|471718600|FG039|Escalation Phase|Lost to Follow-up|0|||
131023459|NCT02723955|471718601|FG040|Escalation Phase|Lost to Follow-up|0|||
131023460|NCT02723955|471718602|FG041|Escalation Phase|Lost to Follow-up|0|||
131023461|NCT02723955|471718603|FG042|Escalation Phase|Lost to Follow-up|0|||
131023462|NCT02723955|471718561|FG000|Escalation Phase|Physician Decision|0|||
131023463|NCT02723955|471718562|FG001|Escalation Phase|Physician Decision|0|||
131023464|NCT02723955|471718563|FG002|Escalation Phase|Physician Decision|0|||
131023465|NCT02723955|471718564|FG003|Escalation Phase|Physician Decision|0|||
131023466|NCT02723955|471718565|FG004|Escalation Phase|Physician Decision|0|||
131023467|NCT02723955|471718566|FG005|Escalation Phase|Physician Decision|2|||
131023468|NCT02723955|471718567|FG006|Escalation Phase|Physician Decision|0|||
131023469|NCT02723955|471718568|FG007|Escalation Phase|Physician Decision|0|||
131023470|NCT02723955|471718569|FG008|Escalation Phase|Physician Decision|0|||
131023471|NCT02723955|471718570|FG009|Escalation Phase|Physician Decision|0|||
131023472|NCT02723955|471718571|FG010|Escalation Phase|Physician Decision|0|||
131023473|NCT02723955|471718572|FG011|Escalation Phase|Physician Decision|0|||
131023474|NCT02723955|471718573|FG012|Escalation Phase|Physician Decision|0|||
131023475|NCT02723955|471718574|FG013|Escalation Phase|Physician Decision|0|||
131023476|NCT02723955|471718575|FG014|Escalation Phase|Physician Decision|0|||
131023477|NCT02723955|471718576|FG015|Escalation Phase|Physician Decision|0|||
131023478|NCT02723955|471718577|FG016|Escalation Phase|Physician Decision|0|||
131023479|NCT02723955|471718578|FG017|Escalation Phase|Physician Decision|0|||
131023480|NCT02723955|471718579|FG018|Escalation Phase|Physician Decision|0|||
131023481|NCT02723955|471718580|FG019|Escalation Phase|Physician Decision|0|||
131023482|NCT02723955|471718581|FG020|Escalation Phase|Physician Decision|0|||
131023483|NCT02723955|471718582|FG021|Escalation Phase|Physician Decision|0|||
131023484|NCT02723955|471718583|FG022|Escalation Phase|Physician Decision|0|||
131023485|NCT02723955|471718584|FG023|Escalation Phase|Physician Decision|0|||
131023486|NCT02723955|471718585|FG024|Escalation Phase|Physician Decision|0|||
131023487|NCT02723955|471718586|FG025|Escalation Phase|Physician Decision|0|||
131023488|NCT02723955|471718587|FG026|Escalation Phase|Physician Decision|2|||
131023489|NCT02723955|471718588|FG027|Escalation Phase|Physician Decision|0|||
131023490|NCT02723955|471718589|FG028|Escalation Phase|Physician Decision|0|||
131023491|NCT02723955|471718590|FG029|Escalation Phase|Physician Decision|0|||
131023492|NCT02723955|471718591|FG030|Escalation Phase|Physician Decision|0|||
131023493|NCT02723955|471718592|FG031|Escalation Phase|Physician Decision|0|||
131023494|NCT02723955|471718593|FG032|Escalation Phase|Physician Decision|0|||
131023495|NCT02723955|471718594|FG033|Escalation Phase|Physician Decision|0|||
131023496|NCT02723955|471718595|FG034|Escalation Phase|Physician Decision|0|||
131023497|NCT02723955|471718596|FG035|Escalation Phase|Physician Decision|0|||
131023498|NCT02723955|471718597|FG036|Escalation Phase|Physician Decision|0|||
131023499|NCT02723955|471718598|FG037|Escalation Phase|Physician Decision|0|||
131023500|NCT02723955|471718599|FG038|Escalation Phase|Physician Decision|0|||
131023501|NCT02723955|471718600|FG039|Escalation Phase|Physician Decision|0|||
131023502|NCT02723955|471718601|FG040|Escalation Phase|Physician Decision|0|||
131023503|NCT02723955|471718602|FG041|Escalation Phase|Physician Decision|0|||
131023504|NCT02723955|471718603|FG042|Escalation Phase|Physician Decision|0|||
131023505|NCT02723955|471718561|FG000|Escalation Phase|Withdrawal by Subject|0|||
131023506|NCT02723955|471718562|FG001|Escalation Phase|Withdrawal by Subject|0|||
131023507|NCT02723955|471718563|FG002|Escalation Phase|Withdrawal by Subject|0|||
131023508|NCT02723955|471718564|FG003|Escalation Phase|Withdrawal by Subject|0|||
131023509|NCT02723955|471718565|FG004|Escalation Phase|Withdrawal by Subject|1|||
131023510|NCT02723955|471718566|FG005|Escalation Phase|Withdrawal by Subject|1|||
131023511|NCT02723955|471718567|FG006|Escalation Phase|Withdrawal by Subject|1|||
130686028|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
131023512|NCT02723955|471718568|FG007|Escalation Phase|Withdrawal by Subject|1|||
131023513|NCT02723955|471718569|FG008|Escalation Phase|Withdrawal by Subject|0|||
131023514|NCT02723955|471718570|FG009|Escalation Phase|Withdrawal by Subject|0|||
131023515|NCT02723955|471718571|FG010|Escalation Phase|Withdrawal by Subject|0|||
131023516|NCT02723955|471718572|FG011|Escalation Phase|Withdrawal by Subject|0|||
131023517|NCT02723955|471718573|FG012|Escalation Phase|Withdrawal by Subject|1|||
131023518|NCT02723955|471718574|FG013|Escalation Phase|Withdrawal by Subject|0|||
131023519|NCT02723955|471718575|FG014|Escalation Phase|Withdrawal by Subject|0|||
130889372|NCT01273519|471227018|FG002|Overall Study|Adverse Event|0|||
130889373|NCT01273519|471227016|FG000|Overall Study|Lost to Follow-up|2|||
130889374|NCT01273519|471227017|FG001|Overall Study|Lost to Follow-up|1|||
130889375|NCT01273519|471227018|FG002|Overall Study|Lost to Follow-up|3|||
130889376|NCT01273519|471227016|FG000|Overall Study|Lack of Efficacy|8|||
130889377|NCT01273519|471227017|FG001|Overall Study|Lack of Efficacy|3|||
130889378|NCT01273519|471227018|FG002|Overall Study|Lack of Efficacy|4|||
130889379|NCT01273519|471227016|FG000|Overall Study|Other|6|||
130889380|NCT01273519|471227017|FG001|Overall Study|Other|1|||
130889381|NCT01273519|471227018|FG002|Overall Study|Other|1|||
130889382|NCT02302339|471227019|FG000|Overall Study|Lost to Follow-up|1|||
130889383|NCT02302339|471227020|FG001|Overall Study|Lost to Follow-up|0|||
130889384|NCT02302339|471227021|FG002|Overall Study|Lost to Follow-up|0|||
130889385|NCT02302339|471227022|FG003|Overall Study|Lost to Follow-up|0|||
130889386|NCT02302339|471227019|FG000|Overall Study|Withdrawal by Subject|0|||
130889387|NCT02302339|471227020|FG001|Overall Study|Withdrawal by Subject|2|||
130889388|NCT02302339|471227021|FG002|Overall Study|Withdrawal by Subject|1|||
130889389|NCT02302339|471227022|FG003|Overall Study|Withdrawal by Subject|0|||
130889390|NCT01185080|471227023|FG000|Overall Study|Adverse Event|1|||
130889391|NCT01185080|471227024|FG001|Overall Study|Adverse Event|1|||
130889392|NCT01185080|471227025|FG002|Overall Study|Adverse Event|0|||
130889393|NCT01185080|471227023|FG000|Overall Study|Personal reasons|0|||
130889394|NCT01185080|471227024|FG001|Overall Study|Personal reasons|0|||
130889395|NCT01185080|471227025|FG002|Overall Study|Personal reasons|1|||
130889396|NCT03207763|471228614|FG000|Overall Study|Lost to Follow-up|1|||
130889397|NCT03207763|471228615|FG001|Overall Study|Lost to Follow-up|0|||
130889398|NCT02605122|471228616|FG000|Overall Study|Withdrawal by Subject|4|||
130889399|NCT02605122|471228617|FG001|Overall Study|Withdrawal by Subject|1|||
130889400|NCT02605122|471228616|FG000|Overall Study|Lost to Follow-up|1|||
130889401|NCT02605122|471228617|FG001|Overall Study|Lost to Follow-up|1|||
130889402|NCT00684060|471228618|FG000|Overall Study|Lost to Follow-up|1|||
130889403|NCT00684060|471228619|FG001|Overall Study|Lost to Follow-up|0|||
130889404|NCT00684060|471228618|FG000|Overall Study|New stenosis identified|1|||
130889405|NCT00684060|471228619|FG001|Overall Study|New stenosis identified|0|||
130889406|NCT00684060|471228618|FG000|Overall Study|Unable to collect MRI|1|||
130889407|NCT00684060|471228619|FG001|Overall Study|Unable to collect MRI|2|||
130889408|NCT00684060|471228618|FG000|Overall Study|Death|0|||
130889409|NCT00684060|471228619|FG001|Overall Study|Death|1|||
130889410|NCT00702715|471228624|FG000|Overall Study|Lost to Follow-up|1|||
130889411|NCT00702715|471228625|FG001|Overall Study|Lost to Follow-up|0|||
130889412|NCT03751657|471228626|FG000|Overall Study|Physician Decision|0|||
130889413|NCT03751657|471228627|FG001|Overall Study|Physician Decision|1|||
130889414|NCT03751657|471228626|FG000|Overall Study|Withdrawal by Subject|1|||
130889415|NCT03751657|471228627|FG001|Overall Study|Withdrawal by Subject|1|||
130889416|NCT03751657|471228626|FG000|Overall Study|Lost to Follow-up|2|||
130889417|NCT03751657|471228627|FG001|Overall Study|Lost to Follow-up|1|||
130889418|NCT00807001|471228635|FG000|Overall Study|Non-compliance|0|||
130889419|NCT00807001|471228636|FG001|Overall Study|Non-compliance|1|||
130889420|NCT00807001|471228637|FG002|Overall Study|Non-compliance|0|||
130889421|NCT00807001|471228638|FG003|Overall Study|Non-compliance|0|||
130889422|NCT00807001|471228639|FG004|Overall Study|Non-compliance|0|||
130889423|NCT02736890|471228641|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
130889424|NCT02736890|471228642|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
130889425|NCT02736890|471228641|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
130889426|NCT02736890|471228642|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
130889427|NCT02904954|471228643|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
130889428|NCT02904954|471228644|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
130889429|NCT02904954|471228643|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
130889430|NCT02904954|471228644|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
130889431|NCT02904954|471228643|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
130889432|NCT02904954|471228644|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
130889433|NCT02904954|471228643|FG000|Adjuvant Durvalumab|Recurrence|2|||
130889434|NCT02904954|471228644|FG001|Adjuvant Durvalumab|Recurrence|0|||
130889435|NCT02904954|471228643|FG000|Adjuvant Durvalumab|Adverse Event|2|||
130889436|NCT02904954|471228644|FG001|Adjuvant Durvalumab|Adverse Event|6|||
130889437|NCT02904954|471228643|FG000|Adjuvant Durvalumab|Participant wishes|12|||
130889438|NCT02904954|471228644|FG001|Adjuvant Durvalumab|Participant wishes|7|||
130889439|NCT02904954|471228643|FG000|Adjuvant Durvalumab|Physician Decision|2|||
130889440|NCT02904954|471228644|FG001|Adjuvant Durvalumab|Physician Decision|1|||
130889441|NCT02904954|471228643|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
130889442|NCT02904954|471228644|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
130889443|NCT02904954|471228643|FG000|Adjuvant Durvalumab|Death|0|||
130889444|NCT02904954|471228644|FG001|Adjuvant Durvalumab|Death|1|||
130889445|NCT02904954|471228643|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
130889446|NCT02904954|471228644|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
130889447|NCT05097963|471228645|FG000|Overall Study|Protocol Violation|13|||
130889448|NCT05097963|471228645|FG000|Overall Study|Withdrawal by Subject|21|||
130889449|NCT02873702|471228648|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
131023520|NCT02723955|471718576|FG015|Escalation Phase|Withdrawal by Subject|0|||
131023521|NCT02723955|471718577|FG016|Escalation Phase|Withdrawal by Subject|1|||
131023522|NCT02723955|471718578|FG017|Escalation Phase|Withdrawal by Subject|0|||
131023523|NCT02723955|471718579|FG018|Escalation Phase|Withdrawal by Subject|0|||
131023524|NCT02723955|471718580|FG019|Escalation Phase|Withdrawal by Subject|0|||
131023525|NCT02723955|471718581|FG020|Escalation Phase|Withdrawal by Subject|0|||
131023526|NCT02723955|471718582|FG021|Escalation Phase|Withdrawal by Subject|0|||
131023527|NCT02723955|471718583|FG022|Escalation Phase|Withdrawal by Subject|0|||
131023528|NCT02723955|471718584|FG023|Escalation Phase|Withdrawal by Subject|2|||
131023529|NCT02723955|471718585|FG024|Escalation Phase|Withdrawal by Subject|0|||
131023530|NCT02723955|471718586|FG025|Escalation Phase|Withdrawal by Subject|1|||
131023531|NCT02723955|471718587|FG026|Escalation Phase|Withdrawal by Subject|0|||
131023532|NCT02723955|471718588|FG027|Escalation Phase|Withdrawal by Subject|0|||
131023533|NCT02723955|471718589|FG028|Escalation Phase|Withdrawal by Subject|1|||
131023534|NCT02723955|471718590|FG029|Escalation Phase|Withdrawal by Subject|0|||
131023535|NCT02723955|471718591|FG030|Escalation Phase|Withdrawal by Subject|0|||
131023536|NCT02723955|471718592|FG031|Escalation Phase|Withdrawal by Subject|0|||
131023537|NCT02723955|471718593|FG032|Escalation Phase|Withdrawal by Subject|0|||
131023538|NCT02723955|471718594|FG033|Escalation Phase|Withdrawal by Subject|0|||
131023539|NCT02723955|471718595|FG034|Escalation Phase|Withdrawal by Subject|0|||
131023540|NCT02723955|471718596|FG035|Escalation Phase|Withdrawal by Subject|0|||
131023541|NCT02723955|471718597|FG036|Escalation Phase|Withdrawal by Subject|0|||
131023542|NCT02723955|471718598|FG037|Escalation Phase|Withdrawal by Subject|0|||
131023543|NCT02723955|471718599|FG038|Escalation Phase|Withdrawal by Subject|0|||
131023544|NCT02723955|471718600|FG039|Escalation Phase|Withdrawal by Subject|0|||
131023545|NCT02723955|471718601|FG040|Escalation Phase|Withdrawal by Subject|0|||
131023546|NCT02723955|471718602|FG041|Escalation Phase|Withdrawal by Subject|0|||
131023547|NCT02723955|471718603|FG042|Escalation Phase|Withdrawal by Subject|0|||
131023548|NCT02723955|471718561|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023549|NCT02723955|471718562|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023550|NCT02723955|471718563|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023551|NCT02723955|471718564|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023552|NCT02723955|471718565|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
131023553|NCT02723955|471718566|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
131023554|NCT02723955|471718567|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
131023555|NCT02723955|471718568|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
131023556|NCT02723955|471718569|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
131023557|NCT02723955|471718570|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023558|NCT02723955|471718571|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023559|NCT02723955|471718572|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023560|NCT02723955|471718573|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023561|NCT02723955|471718574|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023562|NCT02723955|471718575|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023563|NCT02723955|471718576|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023564|NCT02723955|471718577|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023565|NCT02723955|471718578|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023566|NCT02723955|471718579|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023567|NCT02723955|471718580|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023568|NCT02723955|471718581|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023569|NCT02723955|471718582|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023570|NCT02723955|471718583|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023571|NCT02723955|471718584|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023572|NCT02723955|471718585|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023573|NCT02723955|471718586|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023574|NCT02723955|471718587|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023575|NCT02723955|471718588|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023576|NCT02723955|471718589|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023577|NCT02723955|471718590|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023578|NCT02723955|471718591|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023579|NCT02723955|471718592|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131045837|NCT03582033|471802284|FG006|Part C|Study terminated by sponsor|3|||
130889450|NCT02873702|471228649|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
130889451|NCT02873702|471228650|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
130889452|NCT02873702|471228651|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
130889453|NCT02873702|471228648|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
130889454|NCT02873702|471228649|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
130889455|NCT02873702|471228650|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
130889456|NCT02873702|471228651|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
130889457|NCT02873702|471228648|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
130889458|NCT02873702|471228649|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
130889459|NCT02873702|471228650|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
130889460|NCT02873702|471228651|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
130889461|NCT02873702|471228648|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
130889462|NCT02873702|471228649|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
130889463|NCT02873702|471228650|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
130889464|NCT02873702|471228651|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
130889465|NCT02873702|471228648|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
130889466|NCT02873702|471228649|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
130889467|NCT02873702|471228650|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
130889468|NCT02873702|471228651|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
130889469|NCT02948634|471228655|FG000|Overall Study|Lack of efficacy and study suspended|10|||
130889470|NCT02948634|471228656|FG001|Overall Study|Lack of efficacy and study suspended|2|||
130889471|NCT01413204|471228661|FG000|Overall Study|Adverse Event|1|||
130889472|NCT01413204|471228662|FG001|Overall Study|Adverse Event|2|||
130889473|NCT01413204|471228663|FG002|Overall Study|Adverse Event|2|||
130889474|NCT01413204|471228661|FG000|Overall Study|Physician Decision|3|||
130889475|NCT01413204|471228662|FG001|Overall Study|Physician Decision|0|||
130889476|NCT01413204|471228663|FG002|Overall Study|Physician Decision|2|||
130889477|NCT01413204|471228661|FG000|Overall Study|Withdrawal by Subject|1|||
130889478|NCT01413204|471228662|FG001|Overall Study|Withdrawal by Subject|4|||
130889479|NCT01413204|471228663|FG002|Overall Study|Withdrawal by Subject|4|||
130889480|NCT01413204|471228661|FG000|Overall Study|Clearly not eligible for the study|0|||
130889481|NCT01413204|471228662|FG001|Overall Study|Clearly not eligible for the study|0|||
130889482|NCT01413204|471228663|FG002|Overall Study|Clearly not eligible for the study|1|||
130889483|NCT01413204|471228661|FG000|Overall Study|Fasting plasma glucose level increased|1|||
130889484|NCT01413204|471228662|FG001|Overall Study|Fasting plasma glucose level increased|0|||
130889485|NCT01413204|471228663|FG002|Overall Study|Fasting plasma glucose level increased|10|||
130889486|NCT01039376|471228664|FG000|Overall Study|Lost to Follow-up|5|||
130889487|NCT01039376|471228665|FG001|Overall Study|Lost to Follow-up|12|||
130889488|NCT01039376|471228664|FG000|Overall Study|Physician Decision|15|||
130889489|NCT01039376|471228665|FG001|Overall Study|Physician Decision|10|||
130889490|NCT01039376|471228664|FG000|Overall Study|Withdrawal by Subject|20|||
130889491|NCT01039376|471228665|FG001|Overall Study|Withdrawal by Subject|32|||
130889492|NCT01039376|471228664|FG000|Overall Study|Study terminated by Sponsor|90|||
130889493|NCT01039376|471228665|FG001|Overall Study|Study terminated by Sponsor|72|||
130889494|NCT00753649|471228666|FG000|Overall Study|Migrated/moved from study area|1|||
130889495|NCT00753649|471228667|FG001|Overall Study|Migrated/moved from study area|0|||
130889496|NCT00753649|471228666|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
130889497|NCT00753649|471228667|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
130889498|NCT00753649|471228666|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
130889499|NCT00753649|471228667|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
130889500|NCT00753649|471228666|FG000|Overall Study|Protocol Violation|2|||
130889501|NCT00753649|471228667|FG001|Overall Study|Protocol Violation|0|||
130889502|NCT01255436|471228670|FG000|Overall Study|Lost to Follow-up|178|||
130889503|NCT01255436|471228671|FG001|Overall Study|Lost to Follow-up|191|||
130889504|NCT01255436|471228670|FG000|Overall Study|Death, stroke, or MI|4|||
130889505|NCT01255436|471228671|FG001|Overall Study|Death, stroke, or MI|3|||
130889506|NCT04816669|471228672|FG000|Part 1|Adverse Event|1|||
130889507|NCT04816669|471228673|FG001|Part 1|Adverse Event|1|||
130889508|NCT04816669|471228674|FG002|Part 1|Adverse Event|0|||
130889509|NCT04816669|471228675|FG003|Part 1|Adverse Event|0|||
130889510|NCT04816669|471228672|FG000|Part 1|Lost to Follow-up|2|||
130889511|NCT04816669|471228673|FG001|Part 1|Lost to Follow-up|2|||
130889512|NCT04816669|471228674|FG002|Part 1|Lost to Follow-up|0|||
130889513|NCT04816669|471228675|FG003|Part 1|Lost to Follow-up|0|||
130889514|NCT04816669|471228672|FG000|Part 1|Protocol Violation|0|||
130889515|NCT04816669|471228673|FG001|Part 1|Protocol Violation|1|||
130889516|NCT04816669|471228674|FG002|Part 1|Protocol Violation|0|||
130889517|NCT04816669|471228675|FG003|Part 1|Protocol Violation|0|||
130889518|NCT04816669|471228672|FG000|Part 1|Withdrawal by Subject|1|||
130889519|NCT04816669|471228673|FG001|Part 1|Withdrawal by Subject|2|||
130889520|NCT04816669|471228674|FG002|Part 1|Withdrawal by Subject|0|||
130889521|NCT04816669|471228675|FG003|Part 1|Withdrawal by Subject|0|||
130889522|NCT04816669|471228672|FG000|Part 2|Other|0|||
130889523|NCT04816669|471228673|FG001|Part 2|Other|0|||
130889524|NCT04816669|471228674|FG002|Part 2|Other|1|||
130889525|NCT04816669|471228675|FG003|Part 2|Other|0|||
130889526|NCT04816669|471228672|FG000|Part 2|Withdrawal by Subject|0|||
130889527|NCT04816669|471228673|FG001|Part 2|Withdrawal by Subject|0|||
130889528|NCT04816669|471228674|FG002|Part 2|Withdrawal by Subject|0|||
130889529|NCT04816669|471228675|FG003|Part 2|Withdrawal by Subject|1|||
130889530|NCT04816669|471228672|FG000|Part 2|Lost to Follow-up|0|||
130889531|NCT04816669|471228673|FG001|Part 2|Lost to Follow-up|0|||
130889532|NCT04816669|471228674|FG002|Part 2|Lost to Follow-up|1|||
130889533|NCT04816669|471228675|FG003|Part 2|Lost to Follow-up|0|||
130889534|NCT01229267|471228676|FG000|Overall Study|Adverse Event|4|||
131108673|NCT00141726|472028789|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
131108674|NCT00235326|472028794|FG000|Overall Study|Lost to Follow-up|746|||
131108675|NCT00235326|472028795|FG001|Overall Study|Lost to Follow-up|1400|||
131108676|NCT01790126|472028796|FG000|Overall Study|PSA Progression|12|||
131108677|NCT01790126|472028797|FG001|Overall Study|PSA Progression|16|||
131108678|NCT01790126|472028798|FG002|Overall Study|PSA Progression|16|||
131108679|NCT01790126|472028796|FG000|Overall Study|Other|5|||
131108680|NCT01790126|472028797|FG001|Overall Study|Other|4|||
131108681|NCT01790126|472028798|FG002|Overall Study|Other|8|||
131108682|NCT01790126|472028796|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
131108683|NCT01790126|472028797|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
131108684|NCT01790126|472028798|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
131108685|NCT01790126|472028796|FG000|Overall Study|Withdrawal by Physician|1|||
131108686|NCT01790126|472028797|FG001|Overall Study|Withdrawal by Physician|1|||
131108687|NCT01790126|472028798|FG002|Overall Study|Withdrawal by Physician|2|||
131108688|NCT01790126|472028796|FG000|Overall Study|Withdrawal by Subject|3|||
131108689|NCT01790126|472028797|FG001|Overall Study|Withdrawal by Subject|1|||
131108690|NCT01790126|472028798|FG002|Overall Study|Withdrawal by Subject|2|||
131108691|NCT01790126|472028796|FG000|Overall Study|Lost to Follow-up|1|||
131108692|NCT01790126|472028797|FG001|Overall Study|Lost to Follow-up|0|||
131108693|NCT01790126|472028798|FG002|Overall Study|Lost to Follow-up|1|||
131108694|NCT01790126|472028796|FG000|Overall Study|Adverse Event|0|||
131108695|NCT01790126|472028797|FG001|Overall Study|Adverse Event|2|||
131108696|NCT01790126|472028798|FG002|Overall Study|Adverse Event|0|||
131108697|NCT01790126|472028796|FG000|Overall Study|Death|2|||
131108698|NCT01790126|472028797|FG001|Overall Study|Death|0|||
131108699|NCT01790126|472028798|FG002|Overall Study|Death|0|||
131108700|NCT01790126|472028796|FG000|Overall Study|Radiographic Progression|3|||
131108701|NCT01790126|472028797|FG001|Overall Study|Radiographic Progression|1|||
131108702|NCT01790126|472028798|FG002|Overall Study|Radiographic Progression|0|||
131108703|NCT01128738|472028799|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
131108704|NCT01128738|472028800|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
131108705|NCT01128738|472028799|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
131108706|NCT01128738|472028800|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
131108707|NCT01128738|472028799|FG000|Second TP|Lost to Follow-up|0|||
131108708|NCT01128738|472028800|FG001|Second TP|Lost to Follow-up|1|||
131108709|NCT01128738|472028799|FG000|Second TP|Withdrawal by Subject|0|||
131108710|NCT01128738|472028800|FG001|Second TP|Withdrawal by Subject|2|||
131108711|NCT01178671|472028801|FG000|Overall Study|Adverse Event|4|||
131108712|NCT01178671|472028802|FG001|Overall Study|Adverse Event|6|||
131108713|NCT01178671|472028801|FG000|Overall Study|Protocol Violation|1|||
131108714|NCT01178671|472028802|FG001|Overall Study|Protocol Violation|1|||
131108715|NCT01178671|472028801|FG000|Overall Study|Lack of Efficacy|0|||
131108716|NCT01178671|472028802|FG001|Overall Study|Lack of Efficacy|1|||
131108717|NCT01178671|472028801|FG000|Overall Study|Lost to Follow-up|3|||
131108718|NCT01178671|472028802|FG001|Overall Study|Lost to Follow-up|1|||
131108719|NCT01178671|472028801|FG000|Overall Study|Physician Decision|4|||
131108720|NCT01178671|472028802|FG001|Overall Study|Physician Decision|6|||
131108721|NCT02435966|472028803|FG000|Overall Study|Withdrawal by Subject|0|||
131108722|NCT02435966|472028804|FG001|Overall Study|Withdrawal by Subject|1|||
131108723|NCT02435966|472028805|FG002|Overall Study|Withdrawal by Subject|0|||
130889535|NCT01229267|471228677|FG001|Overall Study|Adverse Event|6|||
130889536|NCT01229267|471228678|FG002|Overall Study|Adverse Event|3|||
130889537|NCT01229267|471228679|FG003|Overall Study|Adverse Event|2|||
131108724|NCT01211197|472028809|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131108725|NCT01211197|472028810|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131108726|NCT01211197|472028811|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
131108727|NCT01211197|472028812|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131108728|NCT01211197|472028813|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131108729|NCT01211197|472028814|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
131108730|NCT01211197|472028809|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
131108731|NCT01211197|472028810|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
130889538|NCT01229267|471228680|FG004|Overall Study|Adverse Event|10|||
130889539|NCT01229267|471228676|FG000|Overall Study|Death|40|||
130889540|NCT01229267|471228677|FG001|Overall Study|Death|37|||
130889541|NCT01229267|471228678|FG002|Overall Study|Death|35|||
130889542|NCT01229267|471228679|FG003|Overall Study|Death|13|||
131108732|NCT01211197|472028811|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
131108733|NCT01211197|472028812|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
130889543|NCT01229267|471228680|FG004|Overall Study|Death|103|||
130889544|NCT01229267|471228676|FG000|Overall Study|Withdrawal by Subject|23|||
130889545|NCT01229267|471228677|FG001|Overall Study|Withdrawal by Subject|22|||
130889546|NCT01229267|471228678|FG002|Overall Study|Withdrawal by Subject|32|||
130889547|NCT01229267|471228679|FG003|Overall Study|Withdrawal by Subject|14|||
130889548|NCT01229267|471228680|FG004|Overall Study|Withdrawal by Subject|59|||
130889549|NCT01229267|471228676|FG000|Overall Study|Protocol Violation|0|||
130889550|NCT01229267|471228677|FG001|Overall Study|Protocol Violation|1|||
130889551|NCT01229267|471228678|FG002|Overall Study|Protocol Violation|0|||
130889552|NCT01229267|471228679|FG003|Overall Study|Protocol Violation|0|||
130889553|NCT01229267|471228680|FG004|Overall Study|Protocol Violation|0|||
130889554|NCT01229267|471228676|FG000|Overall Study|Progressive disease|0|||
130889555|NCT01229267|471228677|FG001|Overall Study|Progressive disease|0|||
130889556|NCT01229267|471228678|FG002|Overall Study|Progressive disease|0|||
130889557|NCT01229267|471228679|FG003|Overall Study|Progressive disease|0|||
130889558|NCT01229267|471228680|FG004|Overall Study|Progressive disease|1|||
130889559|NCT01229267|471228676|FG000|Overall Study|Physician Decision|8|||
130889560|NCT01229267|471228677|FG001|Overall Study|Physician Decision|11|||
130889561|NCT01229267|471228678|FG002|Overall Study|Physician Decision|8|||
130889562|NCT01229267|471228679|FG003|Overall Study|Physician Decision|3|||
130889563|NCT01229267|471228680|FG004|Overall Study|Physician Decision|25|||
130889564|NCT01229267|471228676|FG000|Overall Study|Lost to Follow-up|6|||
130889565|NCT01229267|471228677|FG001|Overall Study|Lost to Follow-up|5|||
130889566|NCT01229267|471228678|FG002|Overall Study|Lost to Follow-up|8|||
130889567|NCT01229267|471228679|FG003|Overall Study|Lost to Follow-up|3|||
130889568|NCT01229267|471228680|FG004|Overall Study|Lost to Follow-up|22|||
130889569|NCT04050202|471228692|FG000|Overall Study|Lost to Follow-up|2|||
130889570|NCT03830892|471228696|FG000|Overall Study|Physician Decision|2|||
130889571|NCT03830892|471228697|FG001|Overall Study|Physician Decision|3|||
130889572|NCT03830892|471228696|FG000|Overall Study|Study terminated due to COVID|4|||
130889573|NCT03830892|471228697|FG001|Overall Study|Study terminated due to COVID|0|||
130889574|NCT03830892|471228696|FG000|Overall Study|Protocol Violation|0|||
130889575|NCT03830892|471228697|FG001|Overall Study|Protocol Violation|1|||
130889576|NCT03830892|471228696|FG000|Overall Study|Withdrawal by Subject|0|||
130889577|NCT03830892|471228697|FG001|Overall Study|Withdrawal by Subject|2|||
130889578|NCT05782179|471228700|FG000|Overall Study|Adverse Event|0|||
130889579|NCT05782179|471228701|FG001|Overall Study|Adverse Event|0|||
130889580|NCT05782179|471228702|FG002|Overall Study|Adverse Event|2|||
130889581|NCT05782179|471228703|FG003|Overall Study|Adverse Event|0|||
130889582|NCT05782179|471228704|FG004|Overall Study|Adverse Event|0|||
130889583|NCT05782179|471228705|FG005|Overall Study|Adverse Event|0|||
130889584|NCT03682770|471228710|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130889585|NCT03682770|471228711|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
130889586|NCT03682770|471228712|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130889587|NCT03682770|471228713|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130889588|NCT03682770|471228714|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130889589|NCT03682770|471228715|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130889590|NCT03682770|471228716|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130889591|NCT03682770|471228710|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
130889592|NCT03682770|471228711|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
130889593|NCT03682770|471228712|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130889594|NCT03682770|471228713|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130889595|NCT03682770|471228714|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130889596|NCT03682770|471228715|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130889597|NCT03682770|471228716|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130889598|NCT03682770|471228710|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130889599|NCT03682770|471228711|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130889600|NCT03682770|471228712|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
130889601|NCT03682770|471228713|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
130889602|NCT03682770|471228714|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130889603|NCT03682770|471228715|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130889604|NCT03682770|471228716|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130889605|NCT03682770|471228710|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130889606|NCT03682770|471228711|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130889607|NCT03682770|471228712|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130889608|NCT03682770|471228713|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
130889609|NCT03682770|471228714|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130889610|NCT03682770|471228715|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130889611|NCT03682770|471228716|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130889612|NCT03682770|471228710|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130889613|NCT03682770|471228711|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130889614|NCT03682770|471228712|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
130889615|NCT03682770|471228713|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
130889616|NCT03682770|471228714|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130889617|NCT03682770|471228715|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130889618|NCT03682770|471228716|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130889619|NCT03682770|471228710|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130889620|NCT03682770|471228711|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130889621|NCT03682770|471228712|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
130889622|NCT03682770|471228713|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130889623|NCT03682770|471228714|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130889624|NCT03682770|471228715|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130889625|NCT03682770|471228716|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130889626|NCT03682770|471228710|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130889627|NCT03682770|471228711|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130889628|NCT03682770|471228712|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
130889629|NCT03682770|471228713|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130889630|NCT03682770|471228714|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130889631|NCT03682770|471228715|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130889632|NCT03682770|471228716|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130889633|NCT03682770|471228710|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130889634|NCT03682770|471228711|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130889635|NCT03682770|471228712|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130889636|NCT03682770|471228713|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
130889637|NCT03682770|471228714|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130889638|NCT03682770|471228715|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130889639|NCT03682770|471228716|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130889640|NCT03682770|471228710|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130889641|NCT03682770|471228711|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130889642|NCT03682770|471228712|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130889643|NCT03682770|471228713|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130889644|NCT03682770|471228714|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
130889645|NCT03682770|471228715|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
130889646|NCT03682770|471228716|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
130889647|NCT03682770|471228710|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130889648|NCT03682770|471228711|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130889649|NCT03682770|471228712|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130889650|NCT03682770|471228713|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130889651|NCT03682770|471228714|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
130889652|NCT03682770|471228715|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130889653|NCT03682770|471228716|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130889654|NCT03682770|471228710|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130889655|NCT03682770|471228711|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130889656|NCT03682770|471228712|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130889657|NCT03682770|471228713|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130889658|NCT03682770|471228714|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130889659|NCT03682770|471228715|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
130889660|NCT03682770|471228716|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130889661|NCT03682770|471228710|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130889662|NCT03682770|471228711|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130889663|NCT03682770|471228712|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130889664|NCT03682770|471228713|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130889665|NCT03682770|471228714|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130889666|NCT03682770|471228715|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
130889667|NCT03682770|471228716|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
130889668|NCT03599089|471228717|FG000|Overall Study|Lost to Follow-up|1|||
130889669|NCT03599089|471228718|FG001|Overall Study|Lost to Follow-up|0|||
131108734|NCT01211197|472028813|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
131108735|NCT01211197|472028814|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
131108736|NCT00406653|472028819|FG000|Induction Period|Adverse Event|1|||
131108737|NCT00406653|472028820|FG001|Induction Period|Adverse Event|10|||
131108738|NCT00406653|472028821|FG002|Induction Period|Adverse Event|4|||
131108739|NCT00406653|472028822|FG003|Induction Period|Adverse Event|11|||
131108740|NCT00406653|472028823|FG004|Induction Period|Adverse Event|0|||
131108741|NCT00406653|472028824|FG005|Induction Period|Adverse Event|0|||
131108742|NCT00406653|472028825|FG006|Induction Period|Adverse Event|0|||
131108743|NCT00406653|472028819|FG000|Induction Period|Lack of Efficacy|11|||
131108744|NCT00406653|472028820|FG001|Induction Period|Lack of Efficacy|14|||
130889670|NCT03599089|471228719|FG002|Overall Study|Lost to Follow-up|0|||
130889671|NCT03599089|471228720|FG003|Overall Study|Lost to Follow-up|0|||
130889672|NCT03599089|471228717|FG000|Overall Study|Withdrawal by Subject|2|||
130889673|NCT03599089|471228718|FG001|Overall Study|Withdrawal by Subject|1|||
130889674|NCT03599089|471228719|FG002|Overall Study|Withdrawal by Subject|0|||
130889675|NCT03599089|471228720|FG003|Overall Study|Withdrawal by Subject|0|||
130889676|NCT03599089|471228717|FG000|Overall Study|Lack of Efficacy|0|||
130889677|NCT03599089|471228718|FG001|Overall Study|Lack of Efficacy|0|||
130889678|NCT03599089|471228719|FG002|Overall Study|Lack of Efficacy|1|||
130889679|NCT03599089|471228720|FG003|Overall Study|Lack of Efficacy|2|||
130889680|NCT03214666|471228721|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130889681|NCT03214666|471228722|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130889682|NCT03214666|471228723|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
131108745|NCT00406653|472028821|FG002|Induction Period|Lack of Efficacy|8|||
131108746|NCT00406653|472028822|FG003|Induction Period|Lack of Efficacy|10|||
131108747|NCT00406653|472028823|FG004|Induction Period|Lack of Efficacy|0|||
131108748|NCT00406653|472028824|FG005|Induction Period|Lack of Efficacy|0|||
131108749|NCT00406653|472028825|FG006|Induction Period|Lack of Efficacy|0|||
131108750|NCT00406653|472028819|FG000|Induction Period|Lost to Follow-up|0|||
131108751|NCT00406653|472028820|FG001|Induction Period|Lost to Follow-up|2|||
131108752|NCT00406653|472028821|FG002|Induction Period|Lost to Follow-up|0|||
130686029|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686030|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686031|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686032|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686033|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686034|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686035|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686036|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686037|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686038|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686039|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
131108753|NCT00406653|472028822|FG003|Induction Period|Lost to Follow-up|0|||
131108754|NCT00406653|472028823|FG004|Induction Period|Lost to Follow-up|0|||
131108755|NCT00406653|472028824|FG005|Induction Period|Lost to Follow-up|0|||
131108756|NCT00406653|472028825|FG006|Induction Period|Lost to Follow-up|0|||
131108757|NCT00406653|472028819|FG000|Induction Period|Withdrawal of Consent|2|||
131108758|NCT00406653|472028820|FG001|Induction Period|Withdrawal of Consent|5|||
131108759|NCT00406653|472028821|FG002|Induction Period|Withdrawal of Consent|1|||
131108760|NCT00406653|472028822|FG003|Induction Period|Withdrawal of Consent|2|||
131108761|NCT00406653|472028823|FG004|Induction Period|Withdrawal of Consent|0|||
131108762|NCT00406653|472028824|FG005|Induction Period|Withdrawal of Consent|0|||
131108763|NCT00406653|472028825|FG006|Induction Period|Withdrawal of Consent|0|||
131108764|NCT00406653|472028819|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
130686040|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
130686041|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686042|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686043|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686044|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686045|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130686046|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686047|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686048|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686049|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686050|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686051|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686052|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686053|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686054|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686055|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686056|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686057|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130889683|NCT03214666|471228724|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130889684|NCT03214666|471228725|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
130889685|NCT03214666|471228726|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130889686|NCT00526071|471228727|FG000|Overall Study|Adverse Event|1|||
130889687|NCT00526071|471228727|FG000|Overall Study|Withdrawal by Subject|1|||
130889688|NCT00526071|471228727|FG000|Overall Study|Lack of Response to Study Drug|4|||
131108765|NCT00406653|472028820|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
130889689|NCT01415882|471228732|FG000|Overall Study|Ineligible|1|||
130889690|NCT01415882|471228733|FG001|Overall Study|Ineligible|0|||
130889691|NCT01415882|471228734|FG002|Overall Study|Ineligible|0|||
130889692|NCT01415882|471228735|FG003|Overall Study|Ineligible|3|||
130889693|NCT01415882|471228736|FG004|Overall Study|Ineligible|0|||
130889694|NCT01415882|471228732|FG000|Overall Study|Withdrawal by Subject|0|||
130889695|NCT01415882|471228733|FG001|Overall Study|Withdrawal by Subject|1|||
130889696|NCT01415882|471228734|FG002|Overall Study|Withdrawal by Subject|0|||
130889697|NCT01415882|471228735|FG003|Overall Study|Withdrawal by Subject|1|||
130889698|NCT01415882|471228736|FG004|Overall Study|Withdrawal by Subject|0|||
130889699|NCT00357006|471228737|FG000|Overall Study|Lost to Follow-up|1|||
130889700|NCT00357006|471228738|FG001|Overall Study|Lost to Follow-up|2|||
130889701|NCT00357006|471228739|FG002|Overall Study|Lost to Follow-up|1|||
130889702|NCT00357006|471228737|FG000|Overall Study|Withdrawal by Subject|1|||
130889703|NCT00357006|471228738|FG001|Overall Study|Withdrawal by Subject|3|||
130889704|NCT00357006|471228739|FG002|Overall Study|Withdrawal by Subject|2|||
130889705|NCT00976560|471228740|FG000|Overall Study|Adverse Event|5|||
130889706|NCT00976560|471228741|FG001|Overall Study|Adverse Event|5|||
130889707|NCT00976560|471228740|FG000|Overall Study|Lack of Efficacy|3|||
130889708|NCT00976560|471228741|FG001|Overall Study|Lack of Efficacy|5|||
130889709|NCT00976560|471228740|FG000|Overall Study|Protocol Violation|1|||
130889710|NCT00976560|471228741|FG001|Overall Study|Protocol Violation|0|||
130889711|NCT00976560|471228740|FG000|Overall Study|Lost to Follow-up|1|||
130889712|NCT00976560|471228741|FG001|Overall Study|Lost to Follow-up|0|||
130889713|NCT00976560|471228740|FG000|Overall Study|Physician Decision|2|||
130889714|NCT00976560|471228741|FG001|Overall Study|Physician Decision|0|||
130889715|NCT00976560|471228740|FG000|Overall Study|Withdrawal by Subject|2|||
130889716|NCT00976560|471228741|FG001|Overall Study|Withdrawal by Subject|3|||
130889717|NCT03710161|471228742|FG000|Overall Study|Study halted due to COVID pandemic|3|||
130889718|NCT03710161|471228743|FG001|Overall Study|Study halted due to COVID pandemic|2|||
130889719|NCT03339219|471228751|FG000|Overall Study|Death|12|||
130889720|NCT03339219|471228751|FG000|Overall Study|Site Terminated by Sponsor|22|||
130889721|NCT03339219|471228751|FG000|Overall Study|Withdrawal by Subject|1|||
130889722|NCT01932437|471228753|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130889723|NCT01932437|471228754|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130889724|NCT01932437|471228755|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130889725|NCT01932437|471228756|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130889726|NCT01932437|471228757|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130889727|NCT01932437|471228758|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
130889728|NCT00074490|471228759|FG000|Overall Study|Progressive malignancy|0|||
130889729|NCT00074490|471228760|FG001|Overall Study|Progressive malignancy|7|||
130889730|NCT00074490|471228761|FG002|Overall Study|Progressive malignancy|0|||
130889731|NCT00074490|471228762|FG003|Overall Study|Progressive malignancy|0|||
131108766|NCT00406653|472028821|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
131108767|NCT00406653|472028822|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
131108768|NCT00406653|472028823|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
131108769|NCT00406653|472028824|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
131108770|NCT00406653|472028825|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
131108771|NCT00406653|472028819|FG000|Induction Period|Pregnancy|1|||
131108772|NCT00406653|472028820|FG001|Induction Period|Pregnancy|0|||
131108773|NCT00406653|472028821|FG002|Induction Period|Pregnancy|0|||
131108774|NCT00406653|472028822|FG003|Induction Period|Pregnancy|0|||
131108775|NCT00406653|472028823|FG004|Induction Period|Pregnancy|0|||
131108776|NCT00406653|472028824|FG005|Induction Period|Pregnancy|0|||
131108777|NCT00406653|472028825|FG006|Induction Period|Pregnancy|0|||
131108778|NCT00406653|472028819|FG000|Induction Period|Declined participation but followup done|0|||
131108779|NCT00406653|472028820|FG001|Induction Period|Declined participation but followup done|2|||
131108780|NCT00406653|472028821|FG002|Induction Period|Declined participation but followup done|1|||
130889732|NCT00074490|471228763|FG004|Overall Study|Progressive malignancy|3|||
130889733|NCT00074490|471228764|FG005|Overall Study|Progressive malignancy|0|||
130889734|NCT00067002|471228768|FG000|Overall Study|Early Death|1|||
130889735|NCT00067002|471228769|FG001|Overall Study|Early Death|2|||
130889736|NCT00067002|471228768|FG000|Overall Study|Delayed|1|||
130889737|NCT00067002|471228769|FG001|Overall Study|Delayed|1|||
130889738|NCT00067002|471228768|FG000|Overall Study|Graft Failure|5|||
131108781|NCT00406653|472028822|FG003|Induction Period|Declined participation but followup done|1|||
131108782|NCT00406653|472028823|FG004|Induction Period|Declined participation but followup done|0|||
130889739|NCT00067002|471228769|FG001|Overall Study|Graft Failure|6|||
130889740|NCT01354314|471228772|FG000|Overall Study|Lost to Follow-up|1|||
130889741|NCT01354314|471228773|FG001|Overall Study|Lost to Follow-up|0|||
130889742|NCT01354314|471228774|FG002|Overall Study|Lost to Follow-up|1|||
130889743|NCT01354314|471228775|FG003|Overall Study|Lost to Follow-up|1|||
130889744|NCT01354314|471228772|FG000|Overall Study|Withdrawal by Subject|0|||
130889745|NCT01354314|471228773|FG001|Overall Study|Withdrawal by Subject|0|||
130889746|NCT01354314|471228774|FG002|Overall Study|Withdrawal by Subject|1|||
131108783|NCT00406653|472028824|FG005|Induction Period|Declined participation but followup done|0|||
130889747|NCT01354314|471228775|FG003|Overall Study|Withdrawal by Subject|0|||
130889748|NCT01354314|471228772|FG000|Overall Study|Adverse Event|0|||
130889749|NCT01354314|471228773|FG001|Overall Study|Adverse Event|0|||
130889750|NCT01354314|471228774|FG002|Overall Study|Adverse Event|0|||
130889751|NCT01354314|471228775|FG003|Overall Study|Adverse Event|1|||
130889752|NCT01354314|471228772|FG000|Overall Study|Protocol Violation|1|||
130889753|NCT01354314|471228773|FG001|Overall Study|Protocol Violation|1|||
130889754|NCT01354314|471228774|FG002|Overall Study|Protocol Violation|0|||
130889755|NCT01354314|471228775|FG003|Overall Study|Protocol Violation|0|||
130889756|NCT01354314|471228772|FG000|Overall Study|Less than 90% Adherence|4|||
130889757|NCT01354314|471228773|FG001|Overall Study|Less than 90% Adherence|2|||
130889758|NCT01354314|471228774|FG002|Overall Study|Less than 90% Adherence|6|||
130889759|NCT01354314|471228775|FG003|Overall Study|Less than 90% Adherence|4|||
130889760|NCT00467753|471228776|FG000|Overall Study|Lost to Follow-up|1|||
130889761|NCT00467753|471228777|FG001|Overall Study|Lost to Follow-up|2|||
130889762|NCT00467753|471228776|FG000|Overall Study|Adverse Event|2|||
130889763|NCT00467753|471228777|FG001|Overall Study|Adverse Event|0|||
130889764|NCT02175030|471228778|FG000|Overall Study|Failed screen after consent|7|||
130889765|NCT02175030|471228779|FG001|Overall Study|Failed screen after consent|6|||
130889766|NCT02175030|471228778|FG000|Overall Study|Failed IUD Insertion|20|||
130889767|NCT02175030|471228779|FG001|Overall Study|Failed IUD Insertion|21|||
130889768|NCT02175030|471228778|FG000|Overall Study|Physician Decision|1|||
130889769|NCT02175030|471228779|FG001|Overall Study|Physician Decision|1|||
130889770|NCT02175030|471228778|FG000|Overall Study|Lost to Follow-up|6|||
130889771|NCT02175030|471228779|FG001|Overall Study|Lost to Follow-up|6|||
130889772|NCT02175030|471228778|FG000|Overall Study|Withdrawal by Subject|1|||
130889773|NCT02175030|471228779|FG001|Overall Study|Withdrawal by Subject|4|||
130889774|NCT03695367|471228780|FG000|Overall Study|Missed the Day 28 visit.|1|||
130889775|NCT03695367|471228781|FG001|Overall Study|Missed the Day 28 visit.|0|||
130889776|NCT03695367|471228780|FG000|Overall Study|Lost to Follow-up|0|||
130889777|NCT03695367|471228781|FG001|Overall Study|Lost to Follow-up|1|||
130889778|NCT03695367|471228780|FG000|Overall Study|Withdrawal by Subject|0|||
130889779|NCT03695367|471228781|FG001|Overall Study|Withdrawal by Subject|1|||
130889780|NCT03695367|471228780|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
130889781|NCT03695367|471228781|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
130889782|NCT01077050|471230575|FG000|Overall Study|Subjects signed ICF could not be located|1|||
130889783|NCT01077050|471230575|FG000|Overall Study|Screen failure|8|||
130889784|NCT03894813|471230576|FG000|Overall Study|Adverse Event|1|||
130889785|NCT03894813|471230577|FG001|Overall Study|Adverse Event|1|||
130889786|NCT03894813|471230576|FG000|Overall Study|Lack of Efficacy|3|||
130889787|NCT03894813|471230577|FG001|Overall Study|Lack of Efficacy|3|||
130889788|NCT03894813|471230576|FG000|Overall Study|Lost to Follow-up|1|||
130889789|NCT03894813|471230577|FG001|Overall Study|Lost to Follow-up|0|||
130889790|NCT03894813|471230576|FG000|Overall Study|Pregnancy|2|||
130889791|NCT03894813|471230577|FG001|Overall Study|Pregnancy|1|||
130889792|NCT03894813|471230576|FG000|Overall Study|Protocol Violation|3|||
130889793|NCT03894813|471230577|FG001|Overall Study|Protocol Violation|7|||
130889794|NCT03894813|471230576|FG000|Overall Study|Withdrawal by Subject|1|||
130889795|NCT03894813|471230577|FG001|Overall Study|Withdrawal by Subject|3|||
130889796|NCT03894813|471230576|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
130889797|NCT03894813|471230577|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
130889798|NCT03773796|471230578|FG000|Overall Study|Adverse Event|1|||
130889799|NCT03773796|471230578|FG000|Overall Study|Withdrawal by Subject|1|||
130889800|NCT03773796|471230578|FG000|Overall Study|Lack of Efficacy|1|||
130889801|NCT00854113|471230579|FG000|Overall Study|Adverse Event|0|||
130889802|NCT00854113|471230580|FG001|Overall Study|Adverse Event|0|||
130889803|NCT00854113|471230581|FG002|Overall Study|Adverse Event|0|||
130889804|NCT00854113|471230582|FG003|Overall Study|Adverse Event|0|||
130889805|NCT00854113|471230583|FG004|Overall Study|Adverse Event|0|||
130889806|NCT00854113|471230584|FG005|Overall Study|Adverse Event|0|||
130889807|NCT00854113|471230585|FG006|Overall Study|Adverse Event|0|||
130889808|NCT00854113|471230586|FG007|Overall Study|Adverse Event|2|||
130889809|NCT00854113|471230587|FG008|Overall Study|Adverse Event|0|||
130889810|NCT00854113|471230588|FG009|Overall Study|Adverse Event|0|||
130889811|NCT00854113|471230589|FG010|Overall Study|Adverse Event|0|||
130889812|NCT00854113|471230579|FG000|Overall Study|Withdrawal by Subject|0|||
130889813|NCT00854113|471230580|FG001|Overall Study|Withdrawal by Subject|0|||
130889814|NCT00854113|471230581|FG002|Overall Study|Withdrawal by Subject|0|||
130889815|NCT00854113|471230582|FG003|Overall Study|Withdrawal by Subject|0|||
130889816|NCT00854113|471230583|FG004|Overall Study|Withdrawal by Subject|0|||
130889817|NCT00854113|471230584|FG005|Overall Study|Withdrawal by Subject|0|||
130889818|NCT00854113|471230585|FG006|Overall Study|Withdrawal by Subject|0|||
130889819|NCT00854113|471230586|FG007|Overall Study|Withdrawal by Subject|1|||
130889820|NCT00854113|471230587|FG008|Overall Study|Withdrawal by Subject|1|||
130889821|NCT00854113|471230588|FG009|Overall Study|Withdrawal by Subject|0|||
130889822|NCT00854113|471230589|FG010|Overall Study|Withdrawal by Subject|0|||
130889823|NCT03805659|471230590|FG000|Overall Study|Withdrawal by Subject|0|||
130889824|NCT03805659|471230591|FG001|Overall Study|Withdrawal by Subject|1|||
130889825|NCT01250145|471230596|FG000|Overall Study|Adverse Event|2|||
130889826|NCT01250145|471230597|FG001|Overall Study|Adverse Event|1|||
130889827|NCT01250145|471230596|FG000|Overall Study|Withdrawal by Subject|0|||
130889828|NCT01250145|471230597|FG001|Overall Study|Withdrawal by Subject|4|||
130889829|NCT02273596|471230598|FG000|24-Week Treatment Period|Adverse Event|3|||
130889830|NCT02273596|471230598|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
130889831|NCT02273596|471230598|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
130889832|NCT02273596|471230598|FG000|24-Week Treatment Period|Physician Decision|1|||
130889833|NCT02273596|471230598|FG000|24-Week Treatment Period|Protocol Deviation|1|||
130889834|NCT02273596|471230598|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
130889835|NCT02273596|471230598|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
130889836|NCT02273596|471230598|FG000|Extension Period|Lost to Follow-up|1|||
130889837|NCT02273596|471230598|FG000|Extension Period|Protocol Deviation|1|||
130889838|NCT02604160|471230600|FG000|Overall Study|Protocol Violation|0|||
130889839|NCT02604160|471230601|FG001|Overall Study|Protocol Violation|1|||
130889840|NCT02604160|471230600|FG000|Overall Study|Physician Decision|0|||
130889841|NCT02604160|471230601|FG001|Overall Study|Physician Decision|1|||
130889842|NCT01596062|471230602|FG000|Overall Study|Adverse Event|1|||
130889843|NCT01596062|471230603|FG001|Overall Study|Adverse Event|0|||
130889844|NCT01596062|471230604|FG002|Overall Study|Adverse Event|2|||
130889845|NCT01596062|471230602|FG000|Overall Study|Lack of Efficacy|0|||
130889846|NCT01596062|471230603|FG001|Overall Study|Lack of Efficacy|0|||
130889847|NCT01596062|471230604|FG002|Overall Study|Lack of Efficacy|1|||
130889848|NCT02139592|471230605|FG000|Overall Study|Case Report Forms Uncollected|8|||
130889849|NCT01069900|471230607|FG000|Overall Study|Technical problems|0|||
130889850|NCT01069900|471230608|FG001|Overall Study|Technical problems|1|||
130889851|NCT01069900|471230607|FG000|Overall Study|Lost to Follow-up|7|||
130889852|NCT01069900|471230608|FG001|Overall Study|Lost to Follow-up|1|||
130889853|NCT01069900|471230607|FG000|Overall Study|Withdrawal by Subject|6|||
130889854|NCT01069900|471230608|FG001|Overall Study|Withdrawal by Subject|1|||
130889855|NCT01069900|471230607|FG000|Overall Study|Protocol Violation|4|||
130889856|NCT01069900|471230608|FG001|Overall Study|Protocol Violation|1|||
130889857|NCT01069900|471230607|FG000|Overall Study|Insufficient Therapeutic effect|1|||
130889858|NCT01069900|471230608|FG001|Overall Study|Insufficient Therapeutic effect|0|||
130889859|NCT02687191|471230609|FG000|Overall Study|Death|0|||
130889860|NCT02687191|471230610|FG001|Overall Study|Death|1|||
130889861|NCT02687191|471230611|FG002|Overall Study|Death|1|||
130889862|NCT02687191|471230612|FG003|Overall Study|Death|0|||
130889863|NCT02687191|471230613|FG004|Overall Study|Death|1|||
130889864|NCT02687191|471230614|FG005|Overall Study|Death|1|||
130889865|NCT02687191|471230609|FG000|Overall Study|Withdrawal by Subject|0|||
130889866|NCT02687191|471230610|FG001|Overall Study|Withdrawal by Subject|0|||
130889867|NCT02687191|471230611|FG002|Overall Study|Withdrawal by Subject|0|||
130889868|NCT02687191|471230612|FG003|Overall Study|Withdrawal by Subject|1|||
130889869|NCT02687191|471230613|FG004|Overall Study|Withdrawal by Subject|0|||
130889870|NCT02687191|471230614|FG005|Overall Study|Withdrawal by Subject|0|||
130889871|NCT03180840|471230615|FG000|Overall Study|Withdrawal by Subject|1|||
130889872|NCT01675544|471230616|FG000|Overall Study|Withdrawal by Subject|2|||
131108784|NCT00406653|472028825|FG006|Induction Period|Declined participation but followup done|0|||
130889873|NCT01788358|471230618|FG000|Overall Study|Other|11|||
130889874|NCT01788358|471230618|FG000|Overall Study|Logistical difficulties|1|||
130889875|NCT01788358|471230618|FG000|Overall Study|Lost to Follow-up|5|||
130889876|NCT01788358|471230618|FG000|Overall Study|Protocol Violation|3|||
130889877|NCT01788358|471230618|FG000|Overall Study|Withdrawal by Subject|26|||
130889878|NCT01788358|471230618|FG000|Overall Study|Lack of Efficacy|1|||
130889879|NCT01788358|471230618|FG000|Overall Study|Adverse Event|51|||
130889880|NCT03675321|471230621|FG000|Overall Study|Lack of Efficacy|2|||
130889881|NCT03675321|471230622|FG001|Overall Study|Lack of Efficacy|2|||
131023580|NCT02723955|471718593|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023581|NCT02723955|471718594|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023582|NCT02723955|471718595|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023583|NCT02723955|471718596|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023584|NCT02723955|471718597|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023585|NCT02723955|471718598|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023586|NCT02723955|471718599|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130889882|NCT03675321|471230621|FG000|Overall Study|Withdrawal by Subject|1|||
130889883|NCT03675321|471230622|FG001|Overall Study|Withdrawal by Subject|3|||
130889884|NCT01491607|471230626|FG000|Overall Study|Lost to Follow-up|7|||
130889885|NCT01491607|471230626|FG000|Overall Study|Withdrawal by Subject|3|||
130889886|NCT01317277|471230627|FG000|Overall Study|Lost to Follow-up|3|||
130889887|NCT01317277|471230628|FG001|Overall Study|Lost to Follow-up|1|||
131108785|NCT00406653|472028819|FG000|Induction Period|Given prohibited drug|0|||
131108786|NCT00406653|472028820|FG001|Induction Period|Given prohibited drug|1|||
131108787|NCT00406653|472028821|FG002|Induction Period|Given prohibited drug|2|||
131108788|NCT00406653|472028822|FG003|Induction Period|Given prohibited drug|0|||
131108789|NCT00406653|472028823|FG004|Induction Period|Given prohibited drug|0|||
131108790|NCT00406653|472028824|FG005|Induction Period|Given prohibited drug|0|||
131108791|NCT00406653|472028825|FG006|Induction Period|Given prohibited drug|0|||
131108792|NCT00406653|472028819|FG000|Induction Period|Incarcerated|0|||
131108793|NCT00406653|472028820|FG001|Induction Period|Incarcerated|0|||
131108794|NCT00406653|472028821|FG002|Induction Period|Incarcerated|1|||
131108795|NCT00406653|472028822|FG003|Induction Period|Incarcerated|0|||
131108796|NCT00406653|472028823|FG004|Induction Period|Incarcerated|0|||
131108797|NCT00406653|472028824|FG005|Induction Period|Incarcerated|0|||
131108798|NCT00406653|472028825|FG006|Induction Period|Incarcerated|0|||
130686058|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686059|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686060|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
130686061|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
130686062|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686063|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686064|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686065|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686066|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130686067|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686068|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686069|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686070|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686071|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686072|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686073|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686074|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686075|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686076|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686077|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686078|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686079|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686080|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
130686081|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
130686082|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
130686083|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686084|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686085|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686086|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686087|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130686088|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686089|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686090|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686091|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
130889888|NCT01317277|471230627|FG000|Overall Study|Lost MEMS|1|||
130889889|NCT01317277|471230628|FG001|Overall Study|Lost MEMS|1|||
131108799|NCT00406653|472028819|FG000|Induction Period|Patient relocated|0|||
131108800|NCT00406653|472028820|FG001|Induction Period|Patient relocated|0|||
131108801|NCT00406653|472028821|FG002|Induction Period|Patient relocated|1|||
131108802|NCT00406653|472028822|FG003|Induction Period|Patient relocated|0|||
131108803|NCT00406653|472028823|FG004|Induction Period|Patient relocated|0|||
131108804|NCT00406653|472028824|FG005|Induction Period|Patient relocated|0|||
131108805|NCT00406653|472028825|FG006|Induction Period|Patient relocated|0|||
131108806|NCT00406653|472028819|FG000|Maintenance Period|Adverse Event|0|||
131108807|NCT00406653|472028820|FG001|Maintenance Period|Adverse Event|0|||
130686092|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686093|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686094|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686095|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686096|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
130889890|NCT01317277|471230627|FG000|Overall Study|Unable to comply with intervention|1|||
131108808|NCT00406653|472028821|FG002|Maintenance Period|Adverse Event|0|||
131108809|NCT00406653|472028822|FG003|Maintenance Period|Adverse Event|0|||
131108810|NCT00406653|472028823|FG004|Maintenance Period|Adverse Event|1|||
131108811|NCT00406653|472028824|FG005|Maintenance Period|Adverse Event|1|||
130889891|NCT01317277|471230628|FG001|Overall Study|Unable to comply with intervention|0|||
130889892|NCT01317277|471230627|FG000|Overall Study|Withdrawal by Subject|1|||
130889893|NCT01317277|471230628|FG001|Overall Study|Withdrawal by Subject|0|||
130889894|NCT01317277|471230627|FG000|Overall Study|Adverse Event|1|||
130889895|NCT01317277|471230628|FG001|Overall Study|Adverse Event|0|||
130889896|NCT00774566|471230629|FG000|Overall Study|Protocol Violation|18|||
130889897|NCT00774566|471230630|FG001|Overall Study|Protocol Violation|15|||
130889898|NCT01262989|471230637|FG000|Period 1|Lost to Follow-up|1|||
130889899|NCT01262989|471230638|FG001|Period 1|Lost to Follow-up|1|||
130889900|NCT01262989|471230637|FG000|Period 1|Intercurrent disease|0|||
130889901|NCT01262989|471230638|FG001|Period 1|Intercurrent disease|1|||
130889902|NCT01262989|471230637|FG000|Period 1|Positive answer for exclusion criteria|0|||
130889903|NCT01262989|471230638|FG001|Period 1|Positive answer for exclusion criteria|1|||
130889904|NCT01262989|471230637|FG000|Period 2|Intercurrent disease|0|||
130889905|NCT01262989|471230638|FG001|Period 2|Intercurrent disease|1|||
130889906|NCT00470275|471230639|FG000|Overall Study|Death|1|||
130889907|NCT00470275|471230639|FG000|Overall Study|Lack of Efficacy|7|||
130889908|NCT00470275|471230639|FG000|Overall Study|Withdrawal by Subject|2|||
131023587|NCT02723955|471718600|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023588|NCT02723955|471718601|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
130889909|NCT03048578|471230640|FG000|Overall Study|Withdrawal by Subject|5|||
131108812|NCT00406653|472028825|FG006|Maintenance Period|Adverse Event|0|||
131108813|NCT00406653|472028819|FG000|Maintenance Period|Lack of Efficacy|0|||
131108814|NCT00406653|472028820|FG001|Maintenance Period|Lack of Efficacy|0|||
131108815|NCT00406653|472028821|FG002|Maintenance Period|Lack of Efficacy|0|||
131108816|NCT00406653|472028822|FG003|Maintenance Period|Lack of Efficacy|0|||
131108817|NCT00406653|472028823|FG004|Maintenance Period|Lack of Efficacy|20|||
131108818|NCT00406653|472028824|FG005|Maintenance Period|Lack of Efficacy|26|||
131108819|NCT00406653|472028825|FG006|Maintenance Period|Lack of Efficacy|0|||
131108820|NCT00406653|472028819|FG000|Maintenance Period|Lost to Follow-up|0|||
131108821|NCT00406653|472028820|FG001|Maintenance Period|Lost to Follow-up|0|||
131108822|NCT00406653|472028821|FG002|Maintenance Period|Lost to Follow-up|0|||
131108823|NCT00406653|472028822|FG003|Maintenance Period|Lost to Follow-up|0|||
131108824|NCT00406653|472028823|FG004|Maintenance Period|Lost to Follow-up|2|||
131108825|NCT00406653|472028824|FG005|Maintenance Period|Lost to Follow-up|1|||
131108826|NCT00406653|472028825|FG006|Maintenance Period|Lost to Follow-up|0|||
131108827|NCT00406653|472028819|FG000|Maintenance Period|Withdrawal of Consent|0|||
131108828|NCT00406653|472028820|FG001|Maintenance Period|Withdrawal of Consent|0|||
131108829|NCT00406653|472028821|FG002|Maintenance Period|Withdrawal of Consent|0|||
131108830|NCT00406653|472028822|FG003|Maintenance Period|Withdrawal of Consent|0|||
131108831|NCT00406653|472028823|FG004|Maintenance Period|Withdrawal of Consent|2|||
131108832|NCT00406653|472028824|FG005|Maintenance Period|Withdrawal of Consent|0|||
131108833|NCT00406653|472028825|FG006|Maintenance Period|Withdrawal of Consent|0|||
131108834|NCT00406653|472028819|FG000|Maintenance Period|Pregnancy|0|||
131108835|NCT00406653|472028820|FG001|Maintenance Period|Pregnancy|0|||
131108836|NCT00406653|472028821|FG002|Maintenance Period|Pregnancy|0|||
131108837|NCT00406653|472028822|FG003|Maintenance Period|Pregnancy|0|||
131108838|NCT00406653|472028823|FG004|Maintenance Period|Pregnancy|0|||
131108839|NCT00406653|472028824|FG005|Maintenance Period|Pregnancy|1|||
131108840|NCT00406653|472028825|FG006|Maintenance Period|Pregnancy|0|||
131108841|NCT00406653|472028819|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
130889910|NCT03048578|471230641|FG001|Overall Study|Withdrawal by Subject|6|||
131023589|NCT02723955|471718602|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023590|NCT02723955|471718603|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
131023591|NCT02723955|471718561|FG000|Escalation Phase|Site Closed|0|||
131023592|NCT02723955|471718562|FG001|Escalation Phase|Site Closed|0|||
131023593|NCT02723955|471718563|FG002|Escalation Phase|Site Closed|0|||
131023594|NCT02723955|471718564|FG003|Escalation Phase|Site Closed|0|||
131023595|NCT02723955|471718565|FG004|Escalation Phase|Site Closed|0|||
131108842|NCT00406653|472028820|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
131108843|NCT00406653|472028821|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
131108844|NCT00406653|472028822|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
131108845|NCT00406653|472028823|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
131108846|NCT00406653|472028824|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
131108847|NCT00406653|472028825|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
131108848|NCT00406653|472028819|FG000|Maintenance Period|Error in disease score evaluation|0|||
130889911|NCT03048578|471230640|FG000|Overall Study|Lost to Follow-up|22|||
130889912|NCT03048578|471230641|FG001|Overall Study|Lost to Follow-up|10|||
131108849|NCT00406653|472028820|FG001|Maintenance Period|Error in disease score evaluation|0|||
131108850|NCT00406653|472028821|FG002|Maintenance Period|Error in disease score evaluation|0|||
130889913|NCT03048578|471230640|FG000|Overall Study|Adverse Event|1|||
130889914|NCT03048578|471230641|FG001|Overall Study|Adverse Event|2|||
130889915|NCT03048578|471230640|FG000|Overall Study|Terminated|3|||
130889916|NCT03048578|471230641|FG001|Overall Study|Terminated|2|||
130889917|NCT02500797|471230644|FG000|Overall Study|Cancel (rapid disease progression)|0|||
130889918|NCT02500797|471230645|FG001|Overall Study|Cancel (rapid disease progression)|0|||
130889919|NCT02500797|471230646|FG002|Overall Study|Cancel (rapid disease progression)|0|||
130889920|NCT02500797|471230647|FG003|Overall Study|Cancel (rapid disease progression)|0|||
130889921|NCT02500797|471230648|FG004|Overall Study|Cancel (rapid disease progression)|1|||
130889922|NCT02500797|471230649|FG005|Overall Study|Cancel (rapid disease progression)|1|||
130889923|NCT02500797|471230650|FG006|Overall Study|Cancel (rapid disease progression)|0|||
130889924|NCT02500797|471230651|FG007|Overall Study|Cancel (rapid disease progression)|0|||
130889925|NCT02500797|471230644|FG000|Overall Study|Withdrawal by Subject|1|||
130889926|NCT02500797|471230645|FG001|Overall Study|Withdrawal by Subject|0|||
130889927|NCT02500797|471230646|FG002|Overall Study|Withdrawal by Subject|0|||
130889928|NCT02500797|471230647|FG003|Overall Study|Withdrawal by Subject|0|||
130889929|NCT02500797|471230648|FG004|Overall Study|Withdrawal by Subject|0|||
130889930|NCT02500797|471230649|FG005|Overall Study|Withdrawal by Subject|0|||
130889931|NCT02500797|471230650|FG006|Overall Study|Withdrawal by Subject|0|||
130889932|NCT02500797|471230651|FG007|Overall Study|Withdrawal by Subject|0|||
130889933|NCT02722499|471230652|FG000|Overall Study|Lost to Follow-up|2|||
130889934|NCT02722499|471230653|FG001|Overall Study|Lost to Follow-up|0|||
130889935|NCT02722499|471230654|FG002|Overall Study|Lost to Follow-up|1|||
130889936|NCT03566485|471230664|FG000|Overall Study|Disease progression|5|||
130889937|NCT03566485|471230665|FG001|Overall Study|Disease progression|4|||
130889938|NCT03566485|471230664|FG000|Overall Study|Clinical progression|0|||
130889939|NCT03566485|471230665|FG001|Overall Study|Clinical progression|1|||
130889940|NCT03566485|471230664|FG000|Overall Study|Toxicity|0|||
130889941|NCT03566485|471230665|FG001|Overall Study|Toxicity|2|||
130889942|NCT04999852|471230666|FG000|Overall Study|Withdrawal by Subject|11|||
130889943|NCT04999852|471230667|FG001|Overall Study|Withdrawal by Subject|1|||
130889944|NCT04999852|471230666|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
130889945|NCT04999852|471230667|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
130889946|NCT05019521|471230670|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
130889947|NCT05019521|471230671|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
130889948|NCT05019521|471230672|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
130889949|NCT05019521|471230673|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
130889950|NCT05019521|471230674|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
130889951|NCT05019521|471230675|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
130889952|NCT05019521|471230676|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
130889953|NCT05019521|471230670|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130889954|NCT05019521|471230671|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130889955|NCT05019521|471230672|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130889956|NCT05019521|471230673|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
130889957|NCT05019521|471230674|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130889958|NCT05019521|471230675|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130889959|NCT05019521|471230676|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130889960|NCT05019521|471230670|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
130889961|NCT05019521|471230671|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
130889962|NCT05019521|471230672|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
130889963|NCT05019521|471230673|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
130889964|NCT05019521|471230674|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130889965|NCT05019521|471230675|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130889966|NCT05019521|471230676|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130889967|NCT05019521|471230670|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
130889968|NCT05019521|471230671|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130889969|NCT05019521|471230672|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
130889970|NCT05019521|471230673|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130889971|NCT05019521|471230674|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130889972|NCT05019521|471230675|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130889973|NCT05019521|471230676|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130889974|NCT05019521|471230670|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
130889975|NCT05019521|471230671|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
131023596|NCT02723955|471718566|FG005|Escalation Phase|Site Closed|0|||
131023597|NCT02723955|471718567|FG006|Escalation Phase|Site Closed|0|||
131023598|NCT02723955|471718568|FG007|Escalation Phase|Site Closed|0|||
131023599|NCT02723955|471718569|FG008|Escalation Phase|Site Closed|0|||
131023600|NCT02723955|471718570|FG009|Escalation Phase|Site Closed|0|||
131023601|NCT02723955|471718571|FG010|Escalation Phase|Site Closed|0|||
130889976|NCT05019521|471230672|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
130889977|NCT05019521|471230673|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
131023602|NCT02723955|471718572|FG011|Escalation Phase|Site Closed|0|||
131023603|NCT02723955|471718573|FG012|Escalation Phase|Site Closed|0|||
131023604|NCT02723955|471718574|FG013|Escalation Phase|Site Closed|0|||
130889978|NCT05019521|471230674|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
130889979|NCT05019521|471230675|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
130889980|NCT05019521|471230676|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
130889981|NCT05019521|471230670|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
130889982|NCT05019521|471230671|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130889983|NCT05019521|471230672|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130889984|NCT05019521|471230673|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130889985|NCT05019521|471230674|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130889986|NCT05019521|471230675|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130889987|NCT05019521|471230676|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130889988|NCT05019521|471230670|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130889989|NCT05019521|471230671|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130889990|NCT05019521|471230672|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130889991|NCT05019521|471230673|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
130889992|NCT05019521|471230674|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130889993|NCT05019521|471230675|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130889994|NCT05019521|471230676|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130889995|NCT05019521|471230670|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
130889996|NCT05019521|471230671|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
130889997|NCT05019521|471230672|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
130889998|NCT05019521|471230673|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
130889999|NCT05019521|471230674|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
130890000|NCT05019521|471230675|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
130890001|NCT05019521|471230676|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
130890002|NCT05019521|471230670|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130890003|NCT05019521|471230671|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
130890004|NCT05019521|471230672|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130890005|NCT05019521|471230673|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
131023605|NCT02723955|471718575|FG014|Escalation Phase|Site Closed|0|||
131023606|NCT02723955|471718576|FG015|Escalation Phase|Site Closed|1|||
131023607|NCT02723955|471718577|FG016|Escalation Phase|Site Closed|0|||
131023608|NCT02723955|471718578|FG017|Escalation Phase|Site Closed|2|||
131023609|NCT02723955|471718579|FG018|Escalation Phase|Site Closed|0|||
131023610|NCT02723955|471718580|FG019|Escalation Phase|Site Closed|0|||
131023611|NCT02723955|471718581|FG020|Escalation Phase|Site Closed|1|||
131023612|NCT02723955|471718582|FG021|Escalation Phase|Site Closed|0|||
131023613|NCT02723955|471718583|FG022|Escalation Phase|Site Closed|0|||
131023614|NCT02723955|471718584|FG023|Escalation Phase|Site Closed|0|||
131023615|NCT02723955|471718585|FG024|Escalation Phase|Site Closed|3|||
131023616|NCT02723955|471718586|FG025|Escalation Phase|Site Closed|1|||
131023617|NCT02723955|471718587|FG026|Escalation Phase|Site Closed|3|||
131023618|NCT02723955|471718588|FG027|Escalation Phase|Site Closed|1|||
131023619|NCT02723955|471718589|FG028|Escalation Phase|Site Closed|1|||
131023620|NCT02723955|471718590|FG029|Escalation Phase|Site Closed|0|||
131023621|NCT02723955|471718591|FG030|Escalation Phase|Site Closed|0|||
131023622|NCT02723955|471718592|FG031|Escalation Phase|Site Closed|0|||
131023623|NCT02723955|471718593|FG032|Escalation Phase|Site Closed|0|||
131023624|NCT02723955|471718594|FG033|Escalation Phase|Site Closed|0|||
131023625|NCT02723955|471718595|FG034|Escalation Phase|Site Closed|0|||
131023626|NCT02723955|471718596|FG035|Escalation Phase|Site Closed|0|||
131023627|NCT02723955|471718597|FG036|Escalation Phase|Site Closed|0|||
131023628|NCT02723955|471718598|FG037|Escalation Phase|Site Closed|0|||
131023629|NCT02723955|471718599|FG038|Escalation Phase|Site Closed|0|||
131023630|NCT02723955|471718600|FG039|Escalation Phase|Site Closed|0|||
131023631|NCT02723955|471718601|FG040|Escalation Phase|Site Closed|0|||
131023632|NCT02723955|471718602|FG041|Escalation Phase|Site Closed|0|||
131023633|NCT02723955|471718603|FG042|Escalation Phase|Site Closed|0|||
131023634|NCT02723955|471718561|FG000|Expansion Phase|Death|0|||
131023635|NCT02723955|471718562|FG001|Expansion Phase|Death|0|||
131023636|NCT02723955|471718563|FG002|Expansion Phase|Death|0|||
131023637|NCT02723955|471718564|FG003|Expansion Phase|Death|0|||
131023638|NCT02723955|471718565|FG004|Expansion Phase|Death|0|||
131023639|NCT02723955|471718566|FG005|Expansion Phase|Death|0|||
131023640|NCT02723955|471718567|FG006|Expansion Phase|Death|0|||
131023641|NCT02723955|471718568|FG007|Expansion Phase|Death|0|||
131023642|NCT02723955|471718569|FG008|Expansion Phase|Death|0|||
131023643|NCT02723955|471718570|FG009|Expansion Phase|Death|25|||
131023644|NCT02723955|471718571|FG010|Expansion Phase|Death|69|||
131023645|NCT02723955|471718572|FG011|Expansion Phase|Death|48|||
131023646|NCT02723955|471718573|FG012|Expansion Phase|Death|0|||
131023647|NCT02723955|471718574|FG013|Expansion Phase|Death|0|||
131023648|NCT02723955|471718575|FG014|Expansion Phase|Death|0|||
131023649|NCT02723955|471718576|FG015|Expansion Phase|Death|0|||
131023650|NCT02723955|471718577|FG016|Expansion Phase|Death|0|||
130890006|NCT05019521|471230674|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130890007|NCT05019521|471230675|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130890008|NCT05019521|471230676|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130890009|NCT05019521|471230670|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
130890010|NCT05019521|471230671|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130890011|NCT05019521|471230672|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130890012|NCT05019521|471230673|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130890013|NCT05019521|471230674|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
130890014|NCT05019521|471230675|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
130890015|NCT05019521|471230676|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
130890016|NCT05019521|471230670|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130890017|NCT05019521|471230671|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
130890018|NCT05019521|471230672|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
130890019|NCT05019521|471230673|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130890020|NCT05019521|471230674|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130890021|NCT05019521|471230675|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130890022|NCT05019521|471230676|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130890023|NCT05019521|471230670|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
130890024|NCT05019521|471230671|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
130890025|NCT05019521|471230672|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
130890026|NCT05019521|471230673|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
130890027|NCT05019521|471230674|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
130890028|NCT05019521|471230675|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
130890029|NCT05019521|471230676|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
130890030|NCT05019521|471230670|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130890031|NCT05019521|471230671|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130890032|NCT05019521|471230672|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130890033|NCT05019521|471230673|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130890034|NCT05019521|471230674|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130890035|NCT05019521|471230675|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
130890036|NCT05019521|471230676|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130890037|NCT05019521|471230670|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130890038|NCT05019521|471230671|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
130890039|NCT05019521|471230672|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130890040|NCT05019521|471230673|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130890041|NCT05019521|471230674|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130890042|NCT05019521|471230675|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
130890043|NCT05019521|471230676|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130890044|NCT05019521|471230670|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
130890045|NCT05019521|471230671|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
130890046|NCT05019521|471230672|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
130890047|NCT05019521|471230673|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
130890048|NCT05019521|471230674|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
130890049|NCT05019521|471230675|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
130890050|NCT05019521|471230676|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
130890051|NCT00611026|471230677|FG000|Randomized to Double-blind Treatment|Not treated|2|||
130890052|NCT00611026|471230678|FG001|Randomized to Double-blind Treatment|Not treated|1|||
130890053|NCT00611026|471230679|FG002|Randomized to Double-blind Treatment|Not treated|3|||
130890054|NCT00611026|471230677|FG000|Double-blind Treatment Period|Death|1|||
131023651|NCT02723955|471718578|FG017|Expansion Phase|Death|0|||
131023652|NCT02723955|471718579|FG018|Expansion Phase|Death|0|||
131023653|NCT02723955|471718580|FG019|Expansion Phase|Death|0|||
131023654|NCT02723955|471718581|FG020|Expansion Phase|Death|0|||
131023655|NCT02723955|471718582|FG021|Expansion Phase|Death|0|||
131023656|NCT02723955|471718583|FG022|Expansion Phase|Death|0|||
131023657|NCT02723955|471718584|FG023|Expansion Phase|Death|0|||
131023658|NCT02723955|471718585|FG024|Expansion Phase|Death|0|||
131023659|NCT02723955|471718586|FG025|Expansion Phase|Death|0|||
131023660|NCT02723955|471718587|FG026|Expansion Phase|Death|0|||
131023661|NCT02723955|471718588|FG027|Expansion Phase|Death|0|||
131023662|NCT02723955|471718589|FG028|Expansion Phase|Death|0|||
131023663|NCT02723955|471718590|FG029|Expansion Phase|Death|12|||
131023664|NCT02723955|471718591|FG030|Expansion Phase|Death|202|||
131023665|NCT02723955|471718592|FG031|Expansion Phase|Death|31|||
131023666|NCT02723955|471718593|FG032|Expansion Phase|Death|17|||
131108851|NCT00406653|472028822|FG003|Maintenance Period|Error in disease score evaluation|0|||
130890055|NCT00611026|471230678|FG001|Double-blind Treatment Period|Death|0|||
130890056|NCT00611026|471230679|FG002|Double-blind Treatment Period|Death|0|||
130890057|NCT00611026|471230677|FG000|Double-blind Treatment Period|Adverse Event|9|||
130890058|NCT00611026|471230678|FG001|Double-blind Treatment Period|Adverse Event|28|||
130890059|NCT00611026|471230679|FG002|Double-blind Treatment Period|Adverse Event|46|||
130890060|NCT00611026|471230677|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
130890061|NCT00611026|471230678|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
130890062|NCT00611026|471230679|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
130890063|NCT00611026|471230677|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
130890064|NCT00611026|471230678|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
130890065|NCT00611026|471230679|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
130890066|NCT00611026|471230677|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
130890067|NCT00611026|471230678|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
130890068|NCT00611026|471230679|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
130890069|NCT00611026|471230677|FG000|Double-blind Treatment Period|Other|13|||
130890070|NCT00611026|471230678|FG001|Double-blind Treatment Period|Other|20|||
130890071|NCT00611026|471230679|FG002|Double-blind Treatment Period|Other|18|||
130890072|NCT01147874|471230681|FG000|Overall Study|Adverse Event|5|||
130890073|NCT01147874|471230681|FG000|Overall Study|Investigator's Request|1|||
130890074|NCT01147874|471230681|FG000|Overall Study|Lost to Follow-up|25|||
130890075|NCT01147874|471230681|FG000|Overall Study|Other|5|||
130890076|NCT01147874|471230681|FG000|Overall Study|Protocol Violation|5|||
130890077|NCT01147874|471230681|FG000|Overall Study|Sponsor's Decision|2|||
130890078|NCT01147874|471230681|FG000|Overall Study|Withdrawal by Subject|24|||
130890079|NCT02533453|471230689|FG000|Overall Study|Adverse Event|6|||
130890080|NCT02533453|471230689|FG000|Overall Study|Protocol Violation|1|||
130890081|NCT02533453|471230689|FG000|Overall Study|Withdrawal by Subject|2|||
130890082|NCT00885534|471230691|FG000|Overall Study|Patient deemed ineligible|1|||
130890083|NCT04292899|471230694|FG000|Overall Study|Death|21|||
131023667|NCT02723955|471718594|FG033|Expansion Phase|Death|2|||
131023668|NCT02723955|471718595|FG034|Expansion Phase|Death|3|||
131023669|NCT02723955|471718596|FG035|Expansion Phase|Death|3|||
131023670|NCT02723955|471718597|FG036|Expansion Phase|Death|1|||
131108852|NCT00406653|472028823|FG004|Maintenance Period|Error in disease score evaluation|1|||
131108853|NCT00406653|472028824|FG005|Maintenance Period|Error in disease score evaluation|0|||
130890084|NCT04292899|471230695|FG001|Overall Study|Death|28|||
131023671|NCT02723955|471718598|FG037|Expansion Phase|Death|0|||
131023672|NCT02723955|471718599|FG038|Expansion Phase|Death|0|||
131023673|NCT02723955|471718600|FG039|Expansion Phase|Death|0|||
131023674|NCT02723955|471718601|FG040|Expansion Phase|Death|0|||
131023675|NCT02723955|471718602|FG041|Expansion Phase|Death|0|||
131023676|NCT02723955|471718603|FG042|Expansion Phase|Death|0|||
131023677|NCT02723955|471718561|FG000|Expansion Phase|Lost to Follow-up|0|||
131023678|NCT02723955|471718562|FG001|Expansion Phase|Lost to Follow-up|0|||
131023679|NCT02723955|471718563|FG002|Expansion Phase|Lost to Follow-up|0|||
131023680|NCT02723955|471718564|FG003|Expansion Phase|Lost to Follow-up|0|||
131023681|NCT02723955|471718565|FG004|Expansion Phase|Lost to Follow-up|0|||
131023682|NCT02723955|471718566|FG005|Expansion Phase|Lost to Follow-up|0|||
131023683|NCT02723955|471718567|FG006|Expansion Phase|Lost to Follow-up|0|||
131023684|NCT02723955|471718568|FG007|Expansion Phase|Lost to Follow-up|0|||
131023685|NCT02723955|471718569|FG008|Expansion Phase|Lost to Follow-up|0|||
131023686|NCT02723955|471718570|FG009|Expansion Phase|Lost to Follow-up|0|||
131023687|NCT02723955|471718571|FG010|Expansion Phase|Lost to Follow-up|4|||
131023688|NCT02723955|471718572|FG011|Expansion Phase|Lost to Follow-up|1|||
131023689|NCT02723955|471718573|FG012|Expansion Phase|Lost to Follow-up|0|||
131023690|NCT02723955|471718574|FG013|Expansion Phase|Lost to Follow-up|0|||
131023691|NCT02723955|471718575|FG014|Expansion Phase|Lost to Follow-up|0|||
131023692|NCT02723955|471718576|FG015|Expansion Phase|Lost to Follow-up|0|||
131023693|NCT02723955|471718577|FG016|Expansion Phase|Lost to Follow-up|0|||
131023694|NCT02723955|471718578|FG017|Expansion Phase|Lost to Follow-up|0|||
131023695|NCT02723955|471718579|FG018|Expansion Phase|Lost to Follow-up|0|||
131108854|NCT00406653|472028825|FG006|Maintenance Period|Error in disease score evaluation|0|||
130890085|NCT04292899|471230696|FG002|Overall Study|Death|188|||
130890086|NCT04292899|471230697|FG003|Overall Study|Death|371|||
131023696|NCT02723955|471718580|FG019|Expansion Phase|Lost to Follow-up|0|||
131023697|NCT02723955|471718581|FG020|Expansion Phase|Lost to Follow-up|0|||
131023698|NCT02723955|471718582|FG021|Expansion Phase|Lost to Follow-up|0|||
131023699|NCT02723955|471718583|FG022|Expansion Phase|Lost to Follow-up|0|||
131023700|NCT02723955|471718584|FG023|Expansion Phase|Lost to Follow-up|0|||
130890087|NCT04292899|471230694|FG000|Overall Study|Lost to Follow-up|8|||
130890088|NCT04292899|471230695|FG001|Overall Study|Lost to Follow-up|4|||
130890089|NCT04292899|471230696|FG002|Overall Study|Lost to Follow-up|22|||
131023701|NCT02723955|471718585|FG024|Expansion Phase|Lost to Follow-up|0|||
131023702|NCT02723955|471718586|FG025|Expansion Phase|Lost to Follow-up|0|||
131023703|NCT02723955|471718587|FG026|Expansion Phase|Lost to Follow-up|0|||
131023704|NCT02723955|471718588|FG027|Expansion Phase|Lost to Follow-up|0|||
131023705|NCT02723955|471718589|FG028|Expansion Phase|Lost to Follow-up|0|||
131023706|NCT02723955|471718590|FG029|Expansion Phase|Lost to Follow-up|1|||
131023707|NCT02723955|471718591|FG030|Expansion Phase|Lost to Follow-up|19|||
131023708|NCT02723955|471718592|FG031|Expansion Phase|Lost to Follow-up|2|||
131023709|NCT02723955|471718593|FG032|Expansion Phase|Lost to Follow-up|1|||
131023710|NCT02723955|471718594|FG033|Expansion Phase|Lost to Follow-up|0|||
131023711|NCT02723955|471718595|FG034|Expansion Phase|Lost to Follow-up|0|||
131023712|NCT02723955|471718596|FG035|Expansion Phase|Lost to Follow-up|0|||
131023713|NCT02723955|471718597|FG036|Expansion Phase|Lost to Follow-up|0|||
131023714|NCT02723955|471718598|FG037|Expansion Phase|Lost to Follow-up|0|||
131023715|NCT02723955|471718599|FG038|Expansion Phase|Lost to Follow-up|0|||
131023716|NCT02723955|471718600|FG039|Expansion Phase|Lost to Follow-up|0|||
131023717|NCT02723955|471718601|FG040|Expansion Phase|Lost to Follow-up|0|||
131023718|NCT02723955|471718602|FG041|Expansion Phase|Lost to Follow-up|0|||
131023719|NCT02723955|471718603|FG042|Expansion Phase|Lost to Follow-up|0|||
131023720|NCT02723955|471718561|FG000|Expansion Phase|Physician Decision|0|||
131023721|NCT02723955|471718562|FG001|Expansion Phase|Physician Decision|0|||
131023722|NCT02723955|471718563|FG002|Expansion Phase|Physician Decision|0|||
131023723|NCT02723955|471718564|FG003|Expansion Phase|Physician Decision|0|||
131023724|NCT02723955|471718565|FG004|Expansion Phase|Physician Decision|0|||
131023725|NCT02723955|471718566|FG005|Expansion Phase|Physician Decision|0|||
131023726|NCT02723955|471718567|FG006|Expansion Phase|Physician Decision|0|||
131023727|NCT02723955|471718568|FG007|Expansion Phase|Physician Decision|0|||
131023728|NCT02723955|471718569|FG008|Expansion Phase|Physician Decision|0|||
131023729|NCT02723955|471718570|FG009|Expansion Phase|Physician Decision|0|||
131023730|NCT02723955|471718571|FG010|Expansion Phase|Physician Decision|0|||
131023731|NCT02723955|471718572|FG011|Expansion Phase|Physician Decision|0|||
131023732|NCT02723955|471718573|FG012|Expansion Phase|Physician Decision|0|||
131023733|NCT02723955|471718574|FG013|Expansion Phase|Physician Decision|0|||
131023734|NCT02723955|471718575|FG014|Expansion Phase|Physician Decision|0|||
131023735|NCT02723955|471718576|FG015|Expansion Phase|Physician Decision|0|||
131023736|NCT02723955|471718577|FG016|Expansion Phase|Physician Decision|0|||
131023737|NCT02723955|471718578|FG017|Expansion Phase|Physician Decision|0|||
131023738|NCT02723955|471718579|FG018|Expansion Phase|Physician Decision|0|||
131023739|NCT02723955|471718580|FG019|Expansion Phase|Physician Decision|0|||
131023740|NCT02723955|471718581|FG020|Expansion Phase|Physician Decision|0|||
131023741|NCT02723955|471718582|FG021|Expansion Phase|Physician Decision|0|||
131023742|NCT02723955|471718583|FG022|Expansion Phase|Physician Decision|0|||
131023743|NCT02723955|471718584|FG023|Expansion Phase|Physician Decision|0|||
131023744|NCT02723955|471718585|FG024|Expansion Phase|Physician Decision|0|||
131023745|NCT02723955|471718586|FG025|Expansion Phase|Physician Decision|0|||
131023746|NCT02723955|471718587|FG026|Expansion Phase|Physician Decision|0|||
131023747|NCT02723955|471718588|FG027|Expansion Phase|Physician Decision|0|||
131023748|NCT02723955|471718589|FG028|Expansion Phase|Physician Decision|0|||
131023749|NCT02723955|471718590|FG029|Expansion Phase|Physician Decision|0|||
131023750|NCT02723955|471718591|FG030|Expansion Phase|Physician Decision|1|||
131023751|NCT02723955|471718592|FG031|Expansion Phase|Physician Decision|1|||
131023752|NCT02723955|471718593|FG032|Expansion Phase|Physician Decision|0|||
131023753|NCT02723955|471718594|FG033|Expansion Phase|Physician Decision|0|||
131023754|NCT02723955|471718595|FG034|Expansion Phase|Physician Decision|0|||
131023755|NCT02723955|471718596|FG035|Expansion Phase|Physician Decision|0|||
131023756|NCT02723955|471718597|FG036|Expansion Phase|Physician Decision|0|||
131023757|NCT02723955|471718598|FG037|Expansion Phase|Physician Decision|0|||
131023758|NCT02723955|471718599|FG038|Expansion Phase|Physician Decision|0|||
131023759|NCT02723955|471718600|FG039|Expansion Phase|Physician Decision|0|||
131023760|NCT02723955|471718601|FG040|Expansion Phase|Physician Decision|0|||
131023761|NCT02723955|471718602|FG041|Expansion Phase|Physician Decision|0|||
131023762|NCT02723955|471718603|FG042|Expansion Phase|Physician Decision|0|||
131023763|NCT02723955|471718561|FG000|Expansion Phase|Withdrawal by Subject|0|||
131023764|NCT02723955|471718562|FG001|Expansion Phase|Withdrawal by Subject|0|||
131023765|NCT02723955|471718563|FG002|Expansion Phase|Withdrawal by Subject|0|||
131023766|NCT02723955|471718564|FG003|Expansion Phase|Withdrawal by Subject|0|||
131023767|NCT02723955|471718565|FG004|Expansion Phase|Withdrawal by Subject|0|||
131023768|NCT02723955|471718566|FG005|Expansion Phase|Withdrawal by Subject|0|||
131023769|NCT02723955|471718567|FG006|Expansion Phase|Withdrawal by Subject|0|||
131023770|NCT02723955|471718568|FG007|Expansion Phase|Withdrawal by Subject|0|||
131023771|NCT02723955|471718569|FG008|Expansion Phase|Withdrawal by Subject|0|||
131023772|NCT02723955|471718570|FG009|Expansion Phase|Withdrawal by Subject|2|||
131023773|NCT02723955|471718571|FG010|Expansion Phase|Withdrawal by Subject|1|||
131023774|NCT02723955|471718572|FG011|Expansion Phase|Withdrawal by Subject|0|||
131023775|NCT02723955|471718573|FG012|Expansion Phase|Withdrawal by Subject|0|||
131023776|NCT02723955|471718574|FG013|Expansion Phase|Withdrawal by Subject|0|||
131023777|NCT02723955|471718575|FG014|Expansion Phase|Withdrawal by Subject|0|||
131023778|NCT02723955|471718576|FG015|Expansion Phase|Withdrawal by Subject|0|||
131023779|NCT02723955|471718577|FG016|Expansion Phase|Withdrawal by Subject|0|||
131023780|NCT02723955|471718578|FG017|Expansion Phase|Withdrawal by Subject|0|||
131023781|NCT02723955|471718579|FG018|Expansion Phase|Withdrawal by Subject|0|||
131023782|NCT02723955|471718580|FG019|Expansion Phase|Withdrawal by Subject|0|||
131108855|NCT00406653|472028819|FG000|Open-Label Period|Death|0|||
131108856|NCT00406653|472028820|FG001|Open-Label Period|Death|0|||
131108857|NCT00406653|472028821|FG002|Open-Label Period|Death|0|||
131108858|NCT00406653|472028822|FG003|Open-Label Period|Death|0|||
131108859|NCT00406653|472028823|FG004|Open-Label Period|Death|0|||
131108860|NCT00406653|472028824|FG005|Open-Label Period|Death|0|||
131108861|NCT00406653|472028825|FG006|Open-Label Period|Death|1|||
131108862|NCT00406653|472028819|FG000|Open-Label Period|Adverse Event|0|||
131108863|NCT00406653|472028820|FG001|Open-Label Period|Adverse Event|0|||
131108864|NCT00406653|472028821|FG002|Open-Label Period|Adverse Event|0|||
131108865|NCT00406653|472028822|FG003|Open-Label Period|Adverse Event|0|||
130686097|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686098|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686099|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686100|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
131108866|NCT00406653|472028823|FG004|Open-Label Period|Adverse Event|0|||
131108867|NCT00406653|472028824|FG005|Open-Label Period|Adverse Event|0|||
131108868|NCT00406653|472028825|FG006|Open-Label Period|Adverse Event|18|||
131108869|NCT00406653|472028819|FG000|Open-Label Period|Lack of Efficacy|0|||
131108870|NCT00406653|472028820|FG001|Open-Label Period|Lack of Efficacy|0|||
131108871|NCT00406653|472028821|FG002|Open-Label Period|Lack of Efficacy|0|||
131108872|NCT00406653|472028822|FG003|Open-Label Period|Lack of Efficacy|0|||
131108873|NCT00406653|472028823|FG004|Open-Label Period|Lack of Efficacy|0|||
131108874|NCT00406653|472028824|FG005|Open-Label Period|Lack of Efficacy|0|||
131108875|NCT00406653|472028825|FG006|Open-Label Period|Lack of Efficacy|160|||
131108876|NCT00406653|472028819|FG000|Open-Label Period|Lost to Follow-up|0|||
131108877|NCT00406653|472028820|FG001|Open-Label Period|Lost to Follow-up|0|||
131108878|NCT00406653|472028821|FG002|Open-Label Period|Lost to Follow-up|0|||
131108879|NCT00406653|472028822|FG003|Open-Label Period|Lost to Follow-up|0|||
131108880|NCT00406653|472028823|FG004|Open-Label Period|Lost to Follow-up|0|||
131108881|NCT00406653|472028824|FG005|Open-Label Period|Lost to Follow-up|0|||
131108882|NCT00406653|472028825|FG006|Open-Label Period|Lost to Follow-up|6|||
131108883|NCT00406653|472028819|FG000|Open-Label Period|Withdrawal of Consent|0|||
130686101|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686102|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
130686103|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
130686104|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686105|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686106|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686107|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686108|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
130686109|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686110|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686111|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686112|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686113|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686114|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686115|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686116|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686117|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686118|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686119|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686120|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686121|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686122|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686123|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
130686124|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
131108884|NCT00406653|472028820|FG001|Open-Label Period|Withdrawal of Consent|0|||
131108885|NCT00406653|472028821|FG002|Open-Label Period|Withdrawal of Consent|0|||
131108886|NCT00406653|472028822|FG003|Open-Label Period|Withdrawal of Consent|0|||
131108887|NCT00406653|472028823|FG004|Open-Label Period|Withdrawal of Consent|0|||
131108888|NCT00406653|472028824|FG005|Open-Label Period|Withdrawal of Consent|0|||
131108889|NCT00406653|472028825|FG006|Open-Label Period|Withdrawal of Consent|11|||
131108890|NCT00406653|472028819|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131108891|NCT00406653|472028820|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131108892|NCT00406653|472028821|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131108893|NCT00406653|472028822|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131108894|NCT00406653|472028823|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131108895|NCT00406653|472028824|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
131108896|NCT00406653|472028825|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
131108897|NCT00406653|472028819|FG000|Open-Label Period|Pregnancy|0|||
130890090|NCT04292899|471230697|FG003|Overall Study|Lost to Follow-up|235|||
130890091|NCT04292899|471230694|FG000|Overall Study|Withdrew consent|1|||
130890092|NCT04292899|471230695|FG001|Overall Study|Withdrew consent|0|||
130890093|NCT04292899|471230696|FG002|Overall Study|Withdrew consent|11|||
130890094|NCT04292899|471230697|FG003|Overall Study|Withdrew consent|32|||
130890095|NCT04292899|471230694|FG000|Overall Study|Adverse Event|2|||
130890096|NCT04292899|471230695|FG001|Overall Study|Adverse Event|1|||
130890097|NCT04292899|471230696|FG002|Overall Study|Adverse Event|2|||
130890098|NCT04292899|471230697|FG003|Overall Study|Adverse Event|2|||
130890099|NCT04292899|471230694|FG000|Overall Study|Investigator's Discretion|0|||
130890100|NCT04292899|471230695|FG001|Overall Study|Investigator's Discretion|0|||
130890101|NCT04292899|471230696|FG002|Overall Study|Investigator's Discretion|0|||
130890102|NCT04292899|471230697|FG003|Overall Study|Investigator's Discretion|3|||
130890103|NCT04292899|471230694|FG000|Overall Study|Non-compliance With Study Drug|0|||
130890104|NCT04292899|471230695|FG001|Overall Study|Non-compliance With Study Drug|0|||
130890105|NCT04292899|471230696|FG002|Overall Study|Non-compliance With Study Drug|0|||
130890106|NCT04292899|471230697|FG003|Overall Study|Non-compliance With Study Drug|1|||
130890107|NCT04292899|471230694|FG000|Overall Study|Protocol Violation|0|||
130890108|NCT04292899|471230695|FG001|Overall Study|Protocol Violation|0|||
130890109|NCT04292899|471230696|FG002|Overall Study|Protocol Violation|0|||
130890110|NCT04292899|471230697|FG003|Overall Study|Protocol Violation|1|||
130890111|NCT01209325|471230703|FG000|Overall Study|Lost to Follow-up|24|||
130890112|NCT01209325|471230703|FG000|Overall Study|Adverse Event|1|||
131108898|NCT00406653|472028820|FG001|Open-Label Period|Pregnancy|0|||
131108899|NCT00406653|472028821|FG002|Open-Label Period|Pregnancy|0|||
130890113|NCT01209325|471230703|FG000|Overall Study|Relocated|3|||
130890114|NCT01209325|471230703|FG000|Overall Study|Refusal after starting therapy|8|||
130890115|NCT01209325|471230703|FG000|Overall Study|Protocol Violation|4|||
130890116|NCT01209325|471230703|FG000|Overall Study|Refusal prior to therapy|1|||
130890117|NCT01209325|471230703|FG000|Overall Study|Incarceration|2|||
130890118|NCT00396253|471230704|FG000|Overall Study|Protocol Violation|1|||
130890119|NCT00396253|471230704|FG000|Overall Study|Withdrawal by Subject|7|||
130890120|NCT00396253|471230704|FG000|Overall Study|Death|3|||
130890121|NCT00396253|471230704|FG000|Overall Study|Physician Decision|1|||
130890122|NCT00396253|471230704|FG000|Overall Study|Change in eligibility status|1|||
130890123|NCT05340478|471230708|FG000|Overall Study|Scheduling Issues|10|||
130890124|NCT05340478|471230709|FG001|Overall Study|Scheduling Issues|4|||
130890125|NCT05340478|471230708|FG000|Overall Study|Neither member of dyad started treatment|2|||
130890126|NCT05340478|471230709|FG001|Overall Study|Neither member of dyad started treatment|2|||
130890127|NCT05340478|471230708|FG000|Overall Study|Withdrawn from study|2|||
130890128|NCT05340478|471230709|FG001|Overall Study|Withdrawn from study|2|||
130890129|NCT05340478|471230708|FG000|Overall Study|Lost to Follow-up|1|||
130890130|NCT05340478|471230709|FG001|Overall Study|Lost to Follow-up|4|||
130890131|NCT02506244|471230710|FG000|Overall Study|Did not undergo active monitoring|458|||
130890132|NCT02506244|471230711|FG001|Overall Study|Did not undergo active monitoring|459|||
130890133|NCT02506244|471230712|FG002|Overall Study|Did not undergo active monitoring|0|||
130890134|NCT00314795|471230713|FG000|Overall Study|Adverse Event|8|||
130890135|NCT00314795|471230713|FG000|Overall Study|Death|4|||
130890136|NCT00314795|471230713|FG000|Overall Study|Reason not Specified|3|||
130890137|NCT00314795|471230713|FG000|Overall Study|Renal Transplant|3|||
130890138|NCT00314795|471230713|FG000|Overall Study|Participants Withdrew Consent|2|||
130890139|NCT02116205|471230717|FG000|Overall Study|Withdrawal by Subject|2|||
130890140|NCT02116205|471230718|FG001|Overall Study|Withdrawal by Subject|4|||
130890141|NCT02116205|471230719|FG002|Overall Study|Withdrawal by Subject|1|||
130890142|NCT02116205|471230720|FG003|Overall Study|Withdrawal by Subject|3|||
130890143|NCT02116205|471230717|FG000|Overall Study|Lost to Follow-up|0|||
131108900|NCT00406653|472028822|FG003|Open-Label Period|Pregnancy|0|||
131108901|NCT00406653|472028823|FG004|Open-Label Period|Pregnancy|0|||
131108902|NCT00406653|472028824|FG005|Open-Label Period|Pregnancy|0|||
131108903|NCT00406653|472028825|FG006|Open-Label Period|Pregnancy|2|||
131108904|NCT00406653|472028819|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
131108905|NCT00406653|472028820|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
131108906|NCT00406653|472028821|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
131108907|NCT00406653|472028822|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
131108908|NCT00406653|472028823|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
130890144|NCT02116205|471230718|FG001|Overall Study|Lost to Follow-up|2|||
130890145|NCT02116205|471230719|FG002|Overall Study|Lost to Follow-up|1|||
131108909|NCT00406653|472028824|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
130890146|NCT02116205|471230720|FG003|Overall Study|Lost to Follow-up|2|||
130890147|NCT02116205|471230717|FG000|Overall Study|Physician Decision|0|||
130890148|NCT02116205|471230718|FG001|Overall Study|Physician Decision|1|||
130890149|NCT02116205|471230719|FG002|Overall Study|Physician Decision|1|||
130890150|NCT02116205|471230720|FG003|Overall Study|Physician Decision|1|||
130890151|NCT02116205|471230717|FG000|Overall Study|Exclusion criteria|0|||
131108910|NCT00406653|472028825|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
130890152|NCT02116205|471230718|FG001|Overall Study|Exclusion criteria|0|||
130890153|NCT02116205|471230719|FG002|Overall Study|Exclusion criteria|1|||
130890154|NCT02116205|471230720|FG003|Overall Study|Exclusion criteria|0|||
130890155|NCT02541604|471230721|FG000|Overall Study|Death|6|||
130890156|NCT02541604|471230722|FG001|Overall Study|Death|5|||
130890157|NCT02541604|471230723|FG002|Overall Study|Death|7|||
130890158|NCT02541604|471230724|FG003|Overall Study|Death|2|||
130890159|NCT02541604|471230725|FG004|Overall Study|Death|9|||
130890160|NCT02541604|471230726|FG005|Overall Study|Death|8|||
130890161|NCT02541604|471230727|FG006|Overall Study|Death|9|||
130890162|NCT02541604|471230728|FG007|Overall Study|Death|9|||
130890163|NCT02541604|471230729|FG008|Overall Study|Death|3|||
130890164|NCT02541604|471230730|FG009|Overall Study|Death|4|||
130890165|NCT02541604|471230731|FG010|Overall Study|Death|2|||
130890166|NCT02541604|471230732|FG011|Overall Study|Death|3|||
130890167|NCT02541604|471230721|FG000|Overall Study|Lost to Follow-up|2|||
130890168|NCT02541604|471230722|FG001|Overall Study|Lost to Follow-up|0|||
130890169|NCT02541604|471230723|FG002|Overall Study|Lost to Follow-up|1|||
130890170|NCT02541604|471230724|FG003|Overall Study|Lost to Follow-up|0|||
130890171|NCT02541604|471230725|FG004|Overall Study|Lost to Follow-up|0|||
130890172|NCT02541604|471230726|FG005|Overall Study|Lost to Follow-up|1|||
130890173|NCT02541604|471230727|FG006|Overall Study|Lost to Follow-up|1|||
130890174|NCT02541604|471230728|FG007|Overall Study|Lost to Follow-up|0|||
130890175|NCT02541604|471230729|FG008|Overall Study|Lost to Follow-up|0|||
130890176|NCT02541604|471230730|FG009|Overall Study|Lost to Follow-up|0|||
130890177|NCT02541604|471230731|FG010|Overall Study|Lost to Follow-up|0|||
130890178|NCT02541604|471230732|FG011|Overall Study|Lost to Follow-up|0|||
130890179|NCT02541604|471230721|FG000|Overall Study|Withdrawal by Subject|2|||
130890180|NCT02541604|471230722|FG001|Overall Study|Withdrawal by Subject|0|||
130890181|NCT02541604|471230723|FG002|Overall Study|Withdrawal by Subject|1|||
130890182|NCT02541604|471230724|FG003|Overall Study|Withdrawal by Subject|0|||
130890183|NCT02541604|471230725|FG004|Overall Study|Withdrawal by Subject|1|||
130890184|NCT02541604|471230726|FG005|Overall Study|Withdrawal by Subject|1|||
130890185|NCT02541604|471230727|FG006|Overall Study|Withdrawal by Subject|0|||
130890186|NCT02541604|471230728|FG007|Overall Study|Withdrawal by Subject|0|||
130890187|NCT02541604|471230729|FG008|Overall Study|Withdrawal by Subject|1|||
130890188|NCT02541604|471230730|FG009|Overall Study|Withdrawal by Subject|0|||
130890189|NCT02541604|471230731|FG010|Overall Study|Withdrawal by Subject|0|||
130890190|NCT02541604|471230732|FG011|Overall Study|Withdrawal by Subject|0|||
130890191|NCT02541604|471230721|FG000|Overall Study|Study Terminated by Sponsor|1|||
130890192|NCT02541604|471230722|FG001|Overall Study|Study Terminated by Sponsor|4|||
130890193|NCT02541604|471230723|FG002|Overall Study|Study Terminated by Sponsor|2|||
130890194|NCT02541604|471230724|FG003|Overall Study|Study Terminated by Sponsor|1|||
130890195|NCT02541604|471230725|FG004|Overall Study|Study Terminated by Sponsor|0|||
130890196|NCT02541604|471230726|FG005|Overall Study|Study Terminated by Sponsor|0|||
130890197|NCT02541604|471230727|FG006|Overall Study|Study Terminated by Sponsor|0|||
130890198|NCT02541604|471230728|FG007|Overall Study|Study Terminated by Sponsor|0|||
130890199|NCT02541604|471230729|FG008|Overall Study|Study Terminated by Sponsor|0|||
130890200|NCT02541604|471230730|FG009|Overall Study|Study Terminated by Sponsor|0|||
130890201|NCT02541604|471230731|FG010|Overall Study|Study Terminated by Sponsor|0|||
130890202|NCT02541604|471230732|FG011|Overall Study|Study Terminated by Sponsor|0|||
130890203|NCT02541604|471230721|FG000|Overall Study|Medical condition may jeopardize safety|0|||
130890204|NCT02541604|471230722|FG001|Overall Study|Medical condition may jeopardize safety|0|||
130890205|NCT02541604|471230723|FG002|Overall Study|Medical condition may jeopardize safety|0|||
130890206|NCT02541604|471230724|FG003|Overall Study|Medical condition may jeopardize safety|0|||
130890207|NCT02541604|471230725|FG004|Overall Study|Medical condition may jeopardize safety|0|||
130890208|NCT02541604|471230726|FG005|Overall Study|Medical condition may jeopardize safety|0|||
130890209|NCT02541604|471230727|FG006|Overall Study|Medical condition may jeopardize safety|0|||
130890210|NCT02541604|471230728|FG007|Overall Study|Medical condition may jeopardize safety|1|||
130890211|NCT02541604|471230729|FG008|Overall Study|Medical condition may jeopardize safety|0|||
130890212|NCT02541604|471230730|FG009|Overall Study|Medical condition may jeopardize safety|0|||
130890213|NCT02541604|471230731|FG010|Overall Study|Medical condition may jeopardize safety|0|||
130890214|NCT02541604|471230732|FG011|Overall Study|Medical condition may jeopardize safety|0|||
130890215|NCT03565497|471231984|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
130890216|NCT03565497|471231985|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
130890217|NCT03565497|471231986|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
130890218|NCT03565497|471231984|FG000|Overall Study|Lost to Follow-up|1|||
130890219|NCT03565497|471231985|FG001|Overall Study|Lost to Follow-up|1|||
130890220|NCT03565497|471231986|FG002|Overall Study|Lost to Follow-up|2|||
130890221|NCT03565497|471231984|FG000|Overall Study|Withdrawal by Subject|1|||
130890222|NCT03565497|471231985|FG001|Overall Study|Withdrawal by Subject|1|||
130890223|NCT03565497|471231986|FG002|Overall Study|Withdrawal by Subject|1|||
130890224|NCT02999672|471231987|FG000|Overall Study|Death|0|||
130890225|NCT02999672|471231988|FG001|Overall Study|Death|1|||
130890226|NCT02999672|471231987|FG000|Overall Study|Study Terminated by Sponsor|0|||
130890227|NCT02999672|471231988|FG001|Overall Study|Study Terminated by Sponsor|1|||
130890228|NCT02999672|471231987|FG000|Overall Study|Progressive Disease|9|||
130890229|NCT02999672|471231988|FG001|Overall Study|Progressive Disease|5|||
130890230|NCT02999672|471231987|FG000|Overall Study|Adverse Event|4|||
130890231|NCT02999672|471231988|FG001|Overall Study|Adverse Event|0|||
130890232|NCT01075685|471231989|FG000|Overall Study|Protocol Violation|9|||
130890233|NCT01075685|471231990|FG001|Overall Study|Protocol Violation|1|||
130890234|NCT01075685|471231989|FG000|Overall Study|Withdrawal by Subject|20|||
130890235|NCT01075685|471231990|FG001|Overall Study|Withdrawal by Subject|5|||
131023783|NCT02723955|471718581|FG020|Expansion Phase|Withdrawal by Subject|0|||
131023784|NCT02723955|471718582|FG021|Expansion Phase|Withdrawal by Subject|0|||
131023785|NCT02723955|471718583|FG022|Expansion Phase|Withdrawal by Subject|0|||
131023786|NCT02723955|471718584|FG023|Expansion Phase|Withdrawal by Subject|0|||
131023787|NCT02723955|471718585|FG024|Expansion Phase|Withdrawal by Subject|0|||
131023788|NCT02723955|471718586|FG025|Expansion Phase|Withdrawal by Subject|0|||
131023789|NCT02723955|471718587|FG026|Expansion Phase|Withdrawal by Subject|0|||
131023790|NCT02723955|471718588|FG027|Expansion Phase|Withdrawal by Subject|0|||
131023791|NCT02723955|471718589|FG028|Expansion Phase|Withdrawal by Subject|0|||
131023792|NCT02723955|471718590|FG029|Expansion Phase|Withdrawal by Subject|0|||
131023793|NCT02723955|471718591|FG030|Expansion Phase|Withdrawal by Subject|8|||
131023794|NCT02723955|471718592|FG031|Expansion Phase|Withdrawal by Subject|4|||
131023795|NCT02723955|471718593|FG032|Expansion Phase|Withdrawal by Subject|0|||
131023796|NCT02723955|471718594|FG033|Expansion Phase|Withdrawal by Subject|0|||
131023797|NCT02723955|471718595|FG034|Expansion Phase|Withdrawal by Subject|0|||
131023798|NCT02723955|471718596|FG035|Expansion Phase|Withdrawal by Subject|1|||
131023799|NCT02723955|471718597|FG036|Expansion Phase|Withdrawal by Subject|0|||
131023800|NCT02723955|471718598|FG037|Expansion Phase|Withdrawal by Subject|0|||
131023801|NCT02723955|471718599|FG038|Expansion Phase|Withdrawal by Subject|0|||
131023802|NCT02723955|471718600|FG039|Expansion Phase|Withdrawal by Subject|0|||
131023803|NCT02723955|471718601|FG040|Expansion Phase|Withdrawal by Subject|0|||
131023804|NCT02723955|471718602|FG041|Expansion Phase|Withdrawal by Subject|0|||
131023805|NCT02723955|471718603|FG042|Expansion Phase|Withdrawal by Subject|0|||
131023806|NCT02723955|471718561|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023807|NCT02723955|471718562|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023808|NCT02723955|471718563|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023809|NCT02723955|471718564|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023810|NCT02723955|471718565|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023811|NCT02723955|471718566|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023812|NCT02723955|471718567|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023813|NCT02723955|471718568|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023814|NCT02723955|471718569|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023815|NCT02723955|471718570|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
131023816|NCT02723955|471718571|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
131023817|NCT02723955|471718572|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
131023818|NCT02723955|471718573|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023819|NCT02723955|471718574|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023820|NCT02723955|471718575|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023821|NCT02723955|471718576|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023822|NCT02723955|471718577|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023823|NCT02723955|471718578|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023824|NCT02723955|471718579|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023825|NCT02723955|471718580|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023826|NCT02723955|471718581|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023827|NCT02723955|471718582|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023828|NCT02723955|471718583|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023829|NCT02723955|471718584|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023830|NCT02723955|471718585|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023831|NCT02723955|471718586|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023832|NCT02723955|471718587|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023833|NCT02723955|471718588|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023834|NCT02723955|471718589|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023835|NCT02723955|471718590|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130890236|NCT01075685|471231989|FG000|Overall Study|Lost to Follow-up|563|||
130890237|NCT01075685|471231990|FG001|Overall Study|Lost to Follow-up|220|||
131108911|NCT00406653|472028819|FG000|Open-Label Period|Declined participation but followup done|0|||
131108912|NCT00406653|472028820|FG001|Open-Label Period|Declined participation but followup done|0|||
131108913|NCT00406653|472028821|FG002|Open-Label Period|Declined participation but followup done|0|||
131108914|NCT00406653|472028822|FG003|Open-Label Period|Declined participation but followup done|0|||
131108915|NCT00406653|472028823|FG004|Open-Label Period|Declined participation but followup done|0|||
131108916|NCT00406653|472028824|FG005|Open-Label Period|Declined participation but followup done|0|||
131108917|NCT00406653|472028825|FG006|Open-Label Period|Declined participation but followup done|8|||
131108918|NCT00406653|472028819|FG000|Open-Label Period|Discontinued by Sponsor|0|||
131108919|NCT00406653|472028820|FG001|Open-Label Period|Discontinued by Sponsor|0|||
131108920|NCT00406653|472028821|FG002|Open-Label Period|Discontinued by Sponsor|0|||
131108921|NCT00406653|472028822|FG003|Open-Label Period|Discontinued by Sponsor|0|||
131108922|NCT00406653|472028823|FG004|Open-Label Period|Discontinued by Sponsor|0|||
131108923|NCT00406653|472028824|FG005|Open-Label Period|Discontinued by Sponsor|0|||
131108924|NCT00406653|472028825|FG006|Open-Label Period|Discontinued by Sponsor|1|||
131108925|NCT00406653|472028819|FG000|Open-Label Period|Refused followup|0|||
131108926|NCT00406653|472028820|FG001|Open-Label Period|Refused followup|0|||
131108927|NCT00406653|472028821|FG002|Open-Label Period|Refused followup|0|||
131108928|NCT00406653|472028822|FG003|Open-Label Period|Refused followup|0|||
131108929|NCT00406653|472028823|FG004|Open-Label Period|Refused followup|0|||
131108930|NCT00406653|472028824|FG005|Open-Label Period|Refused followup|0|||
131108931|NCT00406653|472028825|FG006|Open-Label Period|Refused followup|1|||
131108932|NCT00818649|472028826|FG000|Overall Study|Declining performance status|2|||
131108933|NCT00818649|472028826|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
131108934|NCT00818649|472028826|FG000|Overall Study|Adverse Event|1|||
131108935|NCT03513588|472028827|FG000|Overall Study|Lost to Follow-up|0|||
131108936|NCT03513588|472028828|FG001|Overall Study|Lost to Follow-up|1|||
131108937|NCT03513588|472028829|FG002|Overall Study|Lost to Follow-up|1|||
131108938|NCT03513588|472028827|FG000|Overall Study|Study dosing paused by sponsor|1|||
131108939|NCT03513588|472028828|FG001|Overall Study|Study dosing paused by sponsor|1|||
131108940|NCT03513588|472028829|FG002|Overall Study|Study dosing paused by sponsor|0|||
131108941|NCT03513588|472028827|FG000|Overall Study|Death|0|||
131108942|NCT03513588|472028828|FG001|Overall Study|Death|0|||
131108943|NCT03513588|472028829|FG002|Overall Study|Death|1|||
131108944|NCT00940108|472028830|FG000|Overall Study|Adverse Event|2|||
131108945|NCT00940108|472028831|FG001|Overall Study|Adverse Event|4|||
131108946|NCT00940108|472028832|FG002|Overall Study|Adverse Event|0|||
131108947|NCT00940108|472028833|FG003|Overall Study|Adverse Event|2|||
131108948|NCT00940108|472028830|FG000|Overall Study|Withdrew Consent|2|||
131108949|NCT00940108|472028831|FG001|Overall Study|Withdrew Consent|1|||
131108950|NCT00940108|472028832|FG002|Overall Study|Withdrew Consent|0|||
131108951|NCT00940108|472028833|FG003|Overall Study|Withdrew Consent|1|||
131108952|NCT00940108|472028830|FG000|Overall Study|Dose 2 contraindicated|1|||
131108953|NCT00940108|472028831|FG001|Overall Study|Dose 2 contraindicated|1|||
131108954|NCT00940108|472028832|FG002|Overall Study|Dose 2 contraindicated|0|||
131108955|NCT00940108|472028833|FG003|Overall Study|Dose 2 contraindicated|1|||
131108956|NCT00940108|472028830|FG000|Overall Study|Declined further vaccination|0|||
131108957|NCT00940108|472028831|FG001|Overall Study|Declined further vaccination|1|||
131108958|NCT00940108|472028832|FG002|Overall Study|Declined further vaccination|3|||
131108959|NCT00940108|472028833|FG003|Overall Study|Declined further vaccination|0|||
131108960|NCT00940108|472028830|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
131108961|NCT00940108|472028831|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
131108962|NCT00940108|472028832|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
131108963|NCT00940108|472028833|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
131108964|NCT00940108|472028830|FG000|Overall Study|Viral illness after Dose 1|0|||
131108965|NCT00940108|472028831|FG001|Overall Study|Viral illness after Dose 1|1|||
131108966|NCT00940108|472028832|FG002|Overall Study|Viral illness after Dose 1|0|||
131108967|NCT00940108|472028833|FG003|Overall Study|Viral illness after Dose 1|0|||
131108968|NCT00940108|472028830|FG000|Overall Study|Diagnosed with H1N1|0|||
131108969|NCT00940108|472028831|FG001|Overall Study|Diagnosed with H1N1|0|||
131108970|NCT00940108|472028832|FG002|Overall Study|Diagnosed with H1N1|0|||
131108971|NCT00940108|472028833|FG003|Overall Study|Diagnosed with H1N1|1|||
131108972|NCT02075541|472028837|FG000|Overall Study|Serious Adverse Event|1|||
131108973|NCT02075541|472028838|FG001|Overall Study|Serious Adverse Event|4|||
131108974|NCT02075541|472028837|FG000|Overall Study|Protocol Violation|1|||
131108975|NCT02075541|472028838|FG001|Overall Study|Protocol Violation|0|||
131108976|NCT02075541|472028837|FG000|Overall Study|Withdrawal by Subject|1|||
131108977|NCT02075541|472028838|FG001|Overall Study|Withdrawal by Subject|3|||
131108978|NCT02075541|472028837|FG000|Overall Study|Sponsor study termination|0|||
131108979|NCT02075541|472028838|FG001|Overall Study|Sponsor study termination|1|||
131108980|NCT02075541|472028837|FG000|Overall Study|Other- unable to perform study procedure|1|||
131108981|NCT02075541|472028838|FG001|Overall Study|Other- unable to perform study procedure|0|||
131108982|NCT01142596|472028840|FG000|Overall Study|Withdrawal by Subject|9|||
131108983|NCT01142596|472028841|FG001|Overall Study|Withdrawal by Subject|35|||
131108984|NCT01142596|472028840|FG000|Overall Study|Adverse Event|8|||
130890238|NCT02858362|471231993|FG000|Overall Study|Protocol Violation|0|||
130890239|NCT02858362|471231994|FG001|Overall Study|Protocol Violation|1|||
130890240|NCT02858362|471231995|FG002|Overall Study|Protocol Violation|0|||
130890241|NCT02858362|471231993|FG000|Overall Study|Withdrawal by Subject|1|||
130890242|NCT02858362|471231994|FG001|Overall Study|Withdrawal by Subject|0|||
130890243|NCT02858362|471231995|FG002|Overall Study|Withdrawal by Subject|0|||
130890244|NCT02858362|471231993|FG000|Overall Study|Early Study Termination|0|||
130890245|NCT02858362|471231994|FG001|Overall Study|Early Study Termination|0|||
130890246|NCT02858362|471231995|FG002|Overall Study|Early Study Termination|3|||
130890247|NCT02858362|471231993|FG000|Overall Study|Lost to Follow-up|1|||
130890248|NCT02858362|471231994|FG001|Overall Study|Lost to Follow-up|0|||
130890249|NCT02858362|471231995|FG002|Overall Study|Lost to Follow-up|0|||
130890250|NCT02813577|471231997|FG000|Overall Study|Study terminated|4|||
130890251|NCT02067676|471231998|FG000|Overall Study|Withdrawal by Subject|1|||
130890252|NCT02067676|471231999|FG001|Overall Study|Withdrawal by Subject|0|||
130890253|NCT02067676|471232000|FG002|Overall Study|Withdrawal by Subject|0|||
130890254|NCT02067676|471232001|FG003|Overall Study|Withdrawal by Subject|0|||
130890255|NCT02067676|471232002|FG004|Overall Study|Withdrawal by Subject|0|||
130890256|NCT02067676|471232003|FG005|Overall Study|Withdrawal by Subject|0|||
130890257|NCT00996333|471232004|FG000|Overall Study|Screen failure|1|||
130890258|NCT00996333|471232004|FG000|Overall Study|Withdrawal by Subject|1|||
130890259|NCT00996333|471232004|FG000|Overall Study|Death|4|||
130890260|NCT00996333|471232004|FG000|Overall Study|Adverse Event|1|||
130890261|NCT00996333|471232004|FG000|Overall Study|Physician Decision|1|||
130890262|NCT00996333|471232004|FG000|Overall Study|Other|5|||
130890263|NCT01301027|471232007|FG000|Overall Study|Physician Decision|2|||
130890264|NCT01301027|471232008|FG001|Overall Study|Physician Decision|0|||
130890265|NCT01301027|471232007|FG000|Overall Study|Withdrawal by Subject|2|||
130890266|NCT01301027|471232008|FG001|Overall Study|Withdrawal by Subject|3|||
130890267|NCT01301027|471232007|FG000|Overall Study|Adverse Event|0|||
130890268|NCT01301027|471232008|FG001|Overall Study|Adverse Event|2|||
130890269|NCT01301027|471232007|FG000|Overall Study|Fracture|1|||
130890270|NCT01301027|471232008|FG001|Overall Study|Fracture|3|||
130890271|NCT01301027|471232007|FG000|Overall Study|Transplant|0|||
130890272|NCT01301027|471232008|FG001|Overall Study|Transplant|2|||
130890273|NCT01301027|471232007|FG000|Overall Study|Volume Overload|3|||
130890274|NCT01301027|471232008|FG001|Overall Study|Volume Overload|0|||
130890275|NCT02023697|471232009|FG000|Treatment Period|Radiological progression|13|||
130890276|NCT02023697|471232010|FG001|Treatment Period|Radiological progression|17|||
130890277|NCT02023697|471232011|FG002|Treatment Period|Radiological progression|26|||
130890278|NCT02023697|471232009|FG000|Treatment Period|Never Treated|5|||
130890279|NCT02023697|471232010|FG001|Treatment Period|Never Treated|6|||
130890280|NCT02023697|471232011|FG002|Treatment Period|Never Treated|10|||
130890281|NCT02023697|471232009|FG000|Treatment Period|Adverse Event|13|||
130890282|NCT02023697|471232010|FG001|Treatment Period|Adverse Event|25|||
130890283|NCT02023697|471232011|FG002|Treatment Period|Adverse Event|23|||
130890284|NCT02023697|471232009|FG000|Treatment Period|Logistical difficulties|1|||
131023836|NCT02723955|471718591|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
131023837|NCT02723955|471718592|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023838|NCT02723955|471718593|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023839|NCT02723955|471718594|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023840|NCT02723955|471718595|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023841|NCT02723955|471718596|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023842|NCT02723955|471718597|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023843|NCT02723955|471718598|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023844|NCT02723955|471718599|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023845|NCT02723955|471718600|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023846|NCT02723955|471718601|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131023847|NCT02723955|471718602|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
130890285|NCT02023697|471232010|FG001|Treatment Period|Logistical difficulties|1|||
130890286|NCT02023697|471232011|FG002|Treatment Period|Logistical difficulties|1|||
130890287|NCT02023697|471232009|FG000|Treatment Period|Clinical progression|10|||
130890288|NCT02023697|471232010|FG001|Treatment Period|Clinical progression|8|||
130890289|NCT02023697|471232011|FG002|Treatment Period|Clinical progression|28|||
130890290|NCT02023697|471232009|FG000|Treatment Period|Withdrawal by Subject|4|||
130890291|NCT02023697|471232010|FG001|Treatment Period|Withdrawal by Subject|5|||
130890292|NCT02023697|471232011|FG002|Treatment Period|Withdrawal by Subject|13|||
130890293|NCT02023697|471232009|FG000|Treatment Period|Safety outcome reached|0|||
130890294|NCT02023697|471232010|FG001|Treatment Period|Safety outcome reached|1|||
130890295|NCT02023697|471232011|FG002|Treatment Period|Safety outcome reached|0|||
130890296|NCT02023697|471232009|FG000|Treatment Period|Physician Decision|0|||
130890297|NCT02023697|471232010|FG001|Treatment Period|Physician Decision|0|||
130890298|NCT02023697|471232011|FG002|Treatment Period|Physician Decision|1|||
130890299|NCT02023697|471232009|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
130890300|NCT02023697|471232010|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
130890301|NCT02023697|471232011|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
130890302|NCT02023697|471232009|FG000|Active Follow-up Period|Lost to Follow-up|1|||
130890303|NCT02023697|471232010|FG001|Active Follow-up Period|Lost to Follow-up|1|||
130890304|NCT02023697|471232011|FG002|Active Follow-up Period|Lost to Follow-up|1|||
130890305|NCT02023697|471232009|FG000|Active Follow-up Period|Deterioration of general condition|1|||
130890306|NCT02023697|471232010|FG001|Active Follow-up Period|Deterioration of general condition|1|||
130890307|NCT02023697|471232011|FG002|Active Follow-up Period|Deterioration of general condition|1|||
130890308|NCT02023697|471232009|FG000|Active Follow-up Period|Other unspecified|2|||
130890309|NCT02023697|471232010|FG001|Active Follow-up Period|Other unspecified|0|||
130890310|NCT02023697|471232011|FG002|Active Follow-up Period|Other unspecified|1|||
130890311|NCT02023697|471232009|FG000|Active Follow-up Period|Clinical progression|0|||
130890312|NCT02023697|471232010|FG001|Active Follow-up Period|Clinical progression|2|||
130890313|NCT02023697|471232011|FG002|Active Follow-up Period|Clinical progression|1|||
130890314|NCT02023697|471232009|FG000|Active Follow-up Period|Radiological progression|0|||
130890315|NCT02023697|471232010|FG001|Active Follow-up Period|Radiological progression|0|||
130890316|NCT02023697|471232011|FG002|Active Follow-up Period|Radiological progression|1|||
130890317|NCT02023697|471232009|FG000|Active Follow-up Period|Death|83|||
130890318|NCT02023697|471232010|FG001|Active Follow-up Period|Death|82|||
130890319|NCT02023697|471232011|FG002|Active Follow-up Period|Death|87|||
130890320|NCT02023697|471232009|FG000|Long-term Follow-up Period|Death|9|||
130890321|NCT02023697|471232010|FG001|Long-term Follow-up Period|Death|6|||
130890322|NCT02023697|471232011|FG002|Long-term Follow-up Period|Death|4|||
130890323|NCT02023697|471232009|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
130890324|NCT02023697|471232010|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
130890325|NCT02023697|471232011|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
130890326|NCT02023697|471232009|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
130890327|NCT02023697|471232010|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
130890328|NCT02023697|471232011|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
130890329|NCT02023697|471232009|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
130890330|NCT02023697|471232010|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
130890331|NCT02023697|471232011|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
130890332|NCT02023697|471232009|FG000|Long-term Follow-up Period|Technical problems|0|||
130890333|NCT02023697|471232010|FG001|Long-term Follow-up Period|Technical problems|0|||
130890334|NCT02023697|471232011|FG002|Long-term Follow-up Period|Technical problems|1|||
130890335|NCT02023697|471232009|FG000|Long-term Follow-up Period|Other unspecified|6|||
130890336|NCT02023697|471232010|FG001|Long-term Follow-up Period|Other unspecified|3|||
130890337|NCT02023697|471232011|FG002|Long-term Follow-up Period|Other unspecified|5|||
130890338|NCT00845897|471232017|FG000|Overall Study|Lost to Follow-up|1|||
130890339|NCT00845897|471232018|FG001|Overall Study|Lost to Follow-up|1|||
131023848|NCT02723955|471718603|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
131108985|NCT01142596|472028841|FG001|Overall Study|Adverse Event|35|||
131108986|NCT01142596|472028840|FG000|Overall Study|Lack of Efficacy|5|||
131108987|NCT01142596|472028841|FG001|Overall Study|Lack of Efficacy|9|||
130686125|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
131023849|NCT02723955|471718561|FG000|Expansion Phase|Site Closed|0|||
131023850|NCT02723955|471718562|FG001|Expansion Phase|Site Closed|0|||
131023851|NCT02723955|471718563|FG002|Expansion Phase|Site Closed|0|||
131023852|NCT02723955|471718564|FG003|Expansion Phase|Site Closed|0|||
131023853|NCT02723955|471718565|FG004|Expansion Phase|Site Closed|0|||
131023854|NCT02723955|471718566|FG005|Expansion Phase|Site Closed|0|||
131023855|NCT02723955|471718567|FG006|Expansion Phase|Site Closed|0|||
131023856|NCT02723955|471718568|FG007|Expansion Phase|Site Closed|0|||
131023857|NCT02723955|471718569|FG008|Expansion Phase|Site Closed|0|||
131023858|NCT02723955|471718570|FG009|Expansion Phase|Site Closed|1|||
131023859|NCT02723955|471718571|FG010|Expansion Phase|Site Closed|2|||
131023860|NCT02723955|471718572|FG011|Expansion Phase|Site Closed|6|||
131023861|NCT02723955|471718573|FG012|Expansion Phase|Site Closed|0|||
131023862|NCT02723955|471718574|FG013|Expansion Phase|Site Closed|0|||
131023863|NCT02723955|471718575|FG014|Expansion Phase|Site Closed|0|||
131023864|NCT02723955|471718576|FG015|Expansion Phase|Site Closed|0|||
131023865|NCT02723955|471718577|FG016|Expansion Phase|Site Closed|0|||
130767075|NCT01857102|470770713|FG000|Period 2|Unsatisfactory Lens Fit|1|||
131023866|NCT02723955|471718578|FG017|Expansion Phase|Site Closed|0|||
131023867|NCT02723955|471718579|FG018|Expansion Phase|Site Closed|0|||
131023868|NCT02723955|471718580|FG019|Expansion Phase|Site Closed|0|||
131023869|NCT02723955|471718581|FG020|Expansion Phase|Site Closed|0|||
131108988|NCT01142596|472028840|FG000|Overall Study|Lost to Follow-up|2|||
130890340|NCT00845897|471232019|FG002|Overall Study|Lost to Follow-up|0|||
130890341|NCT00845897|471232017|FG000|Overall Study|Withdrawal by Subject|0|||
130890342|NCT00845897|471232018|FG001|Overall Study|Withdrawal by Subject|3|||
130890343|NCT00845897|471232019|FG002|Overall Study|Withdrawal by Subject|2|||
130890344|NCT00845897|471232017|FG000|Overall Study|Ulcer did not heal|1|||
130890345|NCT00845897|471232018|FG001|Overall Study|Ulcer did not heal|0|||
130890346|NCT00845897|471232019|FG002|Overall Study|Ulcer did not heal|1|||
130890347|NCT00845897|471232017|FG000|Overall Study|Too ill to participate|0|||
130890348|NCT00845897|471232018|FG001|Overall Study|Too ill to participate|1|||
130890349|NCT00845897|471232019|FG002|Overall Study|Too ill to participate|0|||
130890350|NCT04939415|471232020|FG000|Overall Study|Withdrawal by Subject|1|||
130890351|NCT04939415|471232021|FG001|Overall Study|Withdrawal by Subject|3|||
131023870|NCT02723955|471718582|FG021|Expansion Phase|Site Closed|0|||
130686126|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686127|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686128|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686129|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130686130|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686131|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686132|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686133|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686134|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686135|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686136|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686137|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686138|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686139|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686140|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686141|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686142|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686143|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686144|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
130686145|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
130686146|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686147|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686148|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686149|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686150|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130686151|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686152|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686153|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686154|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686155|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686156|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686157|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
131023871|NCT02723955|471718583|FG022|Expansion Phase|Site Closed|0|||
131023872|NCT02723955|471718584|FG023|Expansion Phase|Site Closed|0|||
131023873|NCT02723955|471718585|FG024|Expansion Phase|Site Closed|0|||
131023874|NCT02723955|471718586|FG025|Expansion Phase|Site Closed|0|||
131023875|NCT02723955|471718587|FG026|Expansion Phase|Site Closed|0|||
131023876|NCT02723955|471718588|FG027|Expansion Phase|Site Closed|0|||
131023877|NCT02723955|471718589|FG028|Expansion Phase|Site Closed|0|||
131023878|NCT02723955|471718590|FG029|Expansion Phase|Site Closed|0|||
131023879|NCT02723955|471718591|FG030|Expansion Phase|Site Closed|8|||
131023880|NCT02723955|471718592|FG031|Expansion Phase|Site Closed|4|||
131023881|NCT02723955|471718593|FG032|Expansion Phase|Site Closed|2|||
131023882|NCT02723955|471718594|FG033|Expansion Phase|Site Closed|2|||
131023883|NCT02723955|471718595|FG034|Expansion Phase|Site Closed|0|||
131023884|NCT02723955|471718596|FG035|Expansion Phase|Site Closed|0|||
131023885|NCT02723955|471718597|FG036|Expansion Phase|Site Closed|0|||
131023886|NCT02723955|471718598|FG037|Expansion Phase|Site Closed|0|||
131023887|NCT02723955|471718599|FG038|Expansion Phase|Site Closed|0|||
131023888|NCT02723955|471718600|FG039|Expansion Phase|Site Closed|0|||
131023889|NCT02723955|471718601|FG040|Expansion Phase|Site Closed|0|||
131023890|NCT02723955|471718602|FG041|Expansion Phase|Site Closed|0|||
131023891|NCT02723955|471718603|FG042|Expansion Phase|Site Closed|0|||
131023892|NCT02723955|471718561|FG000|Crossover/ Re-treatment Phase|Death|0|||
131023893|NCT02723955|471718562|FG001|Crossover/ Re-treatment Phase|Death|0|||
130890352|NCT04939415|471232020|FG000|Overall Study|Lost to Follow-up|0|||
131023894|NCT02723955|471718563|FG002|Crossover/ Re-treatment Phase|Death|0|||
131023895|NCT02723955|471718564|FG003|Crossover/ Re-treatment Phase|Death|0|||
131023896|NCT02723955|471718565|FG004|Crossover/ Re-treatment Phase|Death|0|||
131023897|NCT02723955|471718566|FG005|Crossover/ Re-treatment Phase|Death|0|||
131023898|NCT02723955|471718567|FG006|Crossover/ Re-treatment Phase|Death|0|||
131023899|NCT02723955|471718568|FG007|Crossover/ Re-treatment Phase|Death|0|||
131023900|NCT02723955|471718569|FG008|Crossover/ Re-treatment Phase|Death|0|||
131108989|NCT01142596|472028841|FG001|Overall Study|Lost to Follow-up|3|||
131108990|NCT01142596|472028840|FG000|Overall Study|Other reason (not specified)|5|||
131108991|NCT01142596|472028841|FG001|Overall Study|Other reason (not specified)|4|||
131108992|NCT01971203|472028842|FG000|Overall Study|Protocol Violation|3|||
131108993|NCT01971203|472028843|FG001|Overall Study|Protocol Violation|2|||
131108994|NCT01971203|472028842|FG000|Overall Study|Withdrawal by Subject|5|||
131108995|NCT01971203|472028843|FG001|Overall Study|Withdrawal by Subject|6|||
131108996|NCT01971203|472028842|FG000|Overall Study|Adverse Event|1|||
131108997|NCT01971203|472028843|FG001|Overall Study|Adverse Event|0|||
131108998|NCT01012713|472028844|FG000|Overall Study|Lack of Efficacy|3|||
131108999|NCT00985153|472028845|FG000|Overall Study|Lost to Follow-up|16|||
131109000|NCT00985153|472028846|FG001|Overall Study|Lost to Follow-up|19|||
131109001|NCT00985153|472028847|FG002|Overall Study|Lost to Follow-up|17|||
131109002|NCT00985153|472028848|FG003|Overall Study|Lost to Follow-up|20|||
131109003|NCT00985153|472028845|FG000|Overall Study|Protocol Violation|3|||
131109004|NCT00985153|472028846|FG001|Overall Study|Protocol Violation|2|||
131109005|NCT00985153|472028847|FG002|Overall Study|Protocol Violation|4|||
131109006|NCT00985153|472028848|FG003|Overall Study|Protocol Violation|3|||
131109007|NCT00985153|472028845|FG000|Overall Study|Withdrawal by Subject|6|||
131109008|NCT00985153|472028846|FG001|Overall Study|Withdrawal by Subject|11|||
131222629|NCT00948025|472443125|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
130686158|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686159|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686160|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686161|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686162|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686163|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686164|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686165|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
130686166|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
130686167|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686168|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686169|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686170|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686171|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130686172|NCT01597245|470477931|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686173|NCT01597245|470477932|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686174|NCT01597245|470477933|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686175|NCT01597245|470477934|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686176|NCT01597245|470477935|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686177|NCT01597245|470477936|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686178|NCT01597245|470477937|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686179|NCT01597245|470477938|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686180|NCT01597245|470477939|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686181|NCT01597245|470477940|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686182|NCT01597245|470477941|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686183|NCT01597245|470477942|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686184|NCT01597245|470477943|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686185|NCT01597245|470477944|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
130686186|NCT01597245|470477945|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686187|NCT01597245|470477946|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686188|NCT01597245|470477947|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686189|NCT01597245|470477948|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686190|NCT01597245|470477949|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686191|NCT01597245|470477950|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686192|NCT01597245|470477951|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130686193|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686194|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686195|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130890353|NCT04939415|471232021|FG001|Overall Study|Lost to Follow-up|2|||
130890354|NCT03610269|471232023|FG000|Overall Study|Physician Decision|10|||
131109009|NCT00985153|472028847|FG002|Overall Study|Withdrawal by Subject|11|||
131109010|NCT00985153|472028848|FG003|Overall Study|Withdrawal by Subject|10|||
131109011|NCT00985153|472028845|FG000|Overall Study|Missed One or More Bleeds|7|||
131109012|NCT00985153|472028846|FG001|Overall Study|Missed One or More Bleeds|7|||
131109013|NCT00985153|472028847|FG002|Overall Study|Missed One or More Bleeds|8|||
131222630|NCT01637961|472443126|FG000|Overall Study|Ineligible: wrong primary|1|||
131222631|NCT01637961|472443126|FG000|Overall Study|Ineligible: inadequate pathology|1|||
131109014|NCT00985153|472028848|FG003|Overall Study|Missed One or More Bleeds|10|||
130890355|NCT03610269|471232023|FG000|Overall Study|Protocol Violation|1|||
130890356|NCT03610269|471232023|FG000|Overall Study|Unable to draw blood|1|||
130890357|NCT03610269|471232023|FG000|Overall Study|Screen fail|4|||
130890358|NCT00478023|471232024|FG000|Overall Study|Adverse Event|11|||
130890359|NCT00478023|471232025|FG001|Overall Study|Adverse Event|7|||
130890360|NCT00478023|471232026|FG002|Overall Study|Adverse Event|8|||
130890361|NCT00478023|471232027|FG003|Overall Study|Adverse Event|14|||
130890362|NCT00478023|471232028|FG004|Overall Study|Adverse Event|6|||
130890363|NCT00478023|471232024|FG000|Overall Study|Death|1|||
130890364|NCT00478023|471232025|FG001|Overall Study|Death|0|||
130890365|NCT00478023|471232026|FG002|Overall Study|Death|0|||
130890366|NCT00478023|471232027|FG003|Overall Study|Death|0|||
130890367|NCT00478023|471232028|FG004|Overall Study|Death|0|||
130890368|NCT00478023|471232024|FG000|Overall Study|Lack of Efficacy|11|||
130890369|NCT00478023|471232025|FG001|Overall Study|Lack of Efficacy|10|||
130890370|NCT00478023|471232026|FG002|Overall Study|Lack of Efficacy|4|||
130890371|NCT00478023|471232027|FG003|Overall Study|Lack of Efficacy|5|||
130890372|NCT00478023|471232028|FG004|Overall Study|Lack of Efficacy|41|||
130890373|NCT00478023|471232024|FG000|Overall Study|Lost to Follow-up|3|||
130890374|NCT00478023|471232025|FG001|Overall Study|Lost to Follow-up|1|||
131109015|NCT00985153|472028845|FG000|Overall Study|Incomplete Safety Follow-up|3|||
131109016|NCT00985153|472028846|FG001|Overall Study|Incomplete Safety Follow-up|5|||
131109017|NCT00985153|472028847|FG002|Overall Study|Incomplete Safety Follow-up|4|||
130686196|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686197|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686198|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686199|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686200|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686201|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686202|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686203|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686204|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686205|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686206|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686207|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686208|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130686209|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
130686210|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
130686211|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
130686212|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
130686213|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
130686214|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686215|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686216|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686217|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686218|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
131109018|NCT00985153|472028848|FG003|Overall Study|Incomplete Safety Follow-up|4|||
131109019|NCT00585195|472028851|FG000|Overall Study|Adverse Event|0|||
131109020|NCT00585195|472028852|FG001|Overall Study|Adverse Event|0|||
131109021|NCT00585195|472028853|FG002|Overall Study|Adverse Event|0|||
131109022|NCT00585195|472028854|FG003|Overall Study|Adverse Event|0|||
131109023|NCT00585195|472028855|FG004|Overall Study|Adverse Event|2|||
131109024|NCT00585195|472028856|FG005|Overall Study|Adverse Event|1|||
131109025|NCT00585195|472028857|FG006|Overall Study|Adverse Event|0|||
131109026|NCT00585195|472028858|FG007|Overall Study|Adverse Event|1|||
131109027|NCT00585195|472028859|FG008|Overall Study|Adverse Event|0|||
131109028|NCT00585195|472028860|FG009|Overall Study|Adverse Event|0|||
131109029|NCT00585195|472028861|FG010|Overall Study|Adverse Event|3|||
131109030|NCT00585195|472028862|FG011|Overall Study|Adverse Event|0|||
131109031|NCT00585195|472028863|FG012|Overall Study|Adverse Event|8|||
131109032|NCT00585195|472028864|FG013|Overall Study|Adverse Event|6|||
131109033|NCT00585195|472028865|FG014|Overall Study|Adverse Event|4|||
131109034|NCT00585195|472028866|FG015|Overall Study|Adverse Event|1|||
131109035|NCT00585195|472028867|FG016|Overall Study|Adverse Event|14|||
130767076|NCT01857102|470770714|FG001|Period 2|Unsatisfactory Lens Fit|0|||
130890375|NCT00478023|471232026|FG002|Overall Study|Lost to Follow-up|1|||
130890376|NCT00478023|471232027|FG003|Overall Study|Lost to Follow-up|1|||
130890377|NCT00478023|471232028|FG004|Overall Study|Lost to Follow-up|0|||
131109036|NCT00585195|472028868|FG017|Overall Study|Adverse Event|9|||
131109037|NCT00585195|472028869|FG018|Overall Study|Adverse Event|2|||
130890378|NCT00478023|471232024|FG000|Overall Study|Withdrawal by Subject|2|||
130890379|NCT00478023|471232025|FG001|Overall Study|Withdrawal by Subject|3|||
131109038|NCT00585195|472028870|FG019|Overall Study|Adverse Event|3|||
131109039|NCT00585195|472028871|FG020|Overall Study|Adverse Event|1|||
131109040|NCT00585195|472028851|FG000|Overall Study|Progressive Disease|2|||
131109041|NCT00585195|472028852|FG001|Overall Study|Progressive Disease|2|||
131109042|NCT00585195|472028853|FG002|Overall Study|Progressive Disease|5|||
131109043|NCT00585195|472028854|FG003|Overall Study|Progressive Disease|4|||
131109044|NCT00585195|472028855|FG004|Overall Study|Progressive Disease|6|||
131109045|NCT00585195|472028856|FG005|Overall Study|Progressive Disease|4|||
131109046|NCT00585195|472028857|FG006|Overall Study|Progressive Disease|6|||
131109047|NCT00585195|472028858|FG007|Overall Study|Progressive Disease|3|||
131109048|NCT00585195|472028859|FG008|Overall Study|Progressive Disease|0|||
131109049|NCT00585195|472028860|FG009|Overall Study|Progressive Disease|5|||
131109050|NCT00585195|472028861|FG010|Overall Study|Progressive Disease|2|||
131109051|NCT00585195|472028862|FG011|Overall Study|Progressive Disease|25|||
131109052|NCT00585195|472028863|FG012|Overall Study|Progressive Disease|29|||
131109053|NCT00585195|472028864|FG013|Overall Study|Progressive Disease|26|||
131109054|NCT00585195|472028865|FG014|Overall Study|Progressive Disease|21|||
131109055|NCT00585195|472028866|FG015|Overall Study|Progressive Disease|12|||
130686219|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686220|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686221|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686222|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686223|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686224|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686225|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686226|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686227|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686228|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686229|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686230|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130686231|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
130686232|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
130686233|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
130686234|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
130686235|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686236|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686237|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686238|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686239|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686240|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686241|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686242|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686243|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686244|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686245|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686246|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686247|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686248|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686249|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686250|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686251|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
130686252|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686253|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130686254|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
130686255|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
130686256|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686257|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686258|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686259|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686260|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686261|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686262|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686263|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686264|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
131109056|NCT00585195|472028867|FG016|Overall Study|Progressive Disease|94|||
131109057|NCT00585195|472028868|FG017|Overall Study|Progressive Disease|42|||
131109058|NCT00585195|472028869|FG018|Overall Study|Progressive Disease|4|||
131109059|NCT00585195|472028870|FG019|Overall Study|Progressive Disease|9|||
131109060|NCT00585195|472028871|FG020|Overall Study|Progressive Disease|8|||
131109061|NCT00585195|472028851|FG000|Overall Study|Withdrawal by Subject|1|||
131222632|NCT03101293|472443127|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
130890380|NCT00478023|471232026|FG002|Overall Study|Withdrawal by Subject|2|||
130890381|NCT00478023|471232027|FG003|Overall Study|Withdrawal by Subject|4|||
130890382|NCT00478023|471232028|FG004|Overall Study|Withdrawal by Subject|5|||
130890383|NCT00478023|471232024|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
130890384|NCT00478023|471232025|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
130890385|NCT00478023|471232026|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
130890386|NCT00478023|471232027|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
130890387|NCT00478023|471232028|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
130890388|NCT01160822|471232032|FG000|Overall Study|Adverse Event|0|||
130890389|NCT01160822|471232033|FG001|Overall Study|Adverse Event|0|||
130890390|NCT01160822|471232034|FG002|Overall Study|Adverse Event|0|||
130890391|NCT01160822|471232035|FG003|Overall Study|Adverse Event|0|||
130890392|NCT01160822|471232036|FG004|Overall Study|Adverse Event|1|||
130890393|NCT01160822|471232037|FG005|Overall Study|Adverse Event|2|||
130890394|NCT01160822|471232038|FG006|Overall Study|Adverse Event|5|||
130890395|NCT01160822|471232032|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130890396|NCT01160822|471232033|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130890397|NCT01160822|471232034|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130890398|NCT01160822|471232035|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130890399|NCT01160822|471232036|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
130890400|NCT01160822|471232037|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
130890401|NCT01160822|471232038|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
130890402|NCT01160822|471232032|FG000|Overall Study|Withdrawal by Subject|0|||
130890403|NCT01160822|471232033|FG001|Overall Study|Withdrawal by Subject|0|||
130890404|NCT01160822|471232034|FG002|Overall Study|Withdrawal by Subject|0|||
130890405|NCT01160822|471232035|FG003|Overall Study|Withdrawal by Subject|0|||
130890406|NCT01160822|471232036|FG004|Overall Study|Withdrawal by Subject|0|||
130890407|NCT01160822|471232037|FG005|Overall Study|Withdrawal by Subject|0|||
130890408|NCT01160822|471232038|FG006|Overall Study|Withdrawal by Subject|1|||
130890409|NCT01160822|471232032|FG000|Overall Study|Lost to Follow-up|0|||
130890410|NCT01160822|471232033|FG001|Overall Study|Lost to Follow-up|0|||
130890411|NCT01160822|471232034|FG002|Overall Study|Lost to Follow-up|0|||
130890412|NCT01160822|471232035|FG003|Overall Study|Lost to Follow-up|0|||
130890413|NCT01160822|471232036|FG004|Overall Study|Lost to Follow-up|1|||
130686265|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686266|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686267|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686268|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686269|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686270|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686271|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686272|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686273|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130686274|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
130686275|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
130686276|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
130686277|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686278|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686279|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686280|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686281|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686282|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686283|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686284|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130890414|NCT01160822|471232037|FG005|Overall Study|Lost to Follow-up|0|||
130890415|NCT01160822|471232038|FG006|Overall Study|Lost to Follow-up|0|||
130890416|NCT01160822|471232032|FG000|Overall Study|Administrative problems|0|||
130890417|NCT01160822|471232033|FG001|Overall Study|Administrative problems|0|||
131023901|NCT02723955|471718570|FG009|Crossover/ Re-treatment Phase|Death|0|||
131023902|NCT02723955|471718571|FG010|Crossover/ Re-treatment Phase|Death|0|||
131023903|NCT02723955|471718572|FG011|Crossover/ Re-treatment Phase|Death|0|||
131023904|NCT02723955|471718573|FG012|Crossover/ Re-treatment Phase|Death|0|||
130890418|NCT01160822|471232034|FG002|Overall Study|Administrative problems|0|||
130890419|NCT01160822|471232035|FG003|Overall Study|Administrative problems|0|||
130890420|NCT01160822|471232036|FG004|Overall Study|Administrative problems|1|||
131023905|NCT02723955|471718574|FG013|Crossover/ Re-treatment Phase|Death|0|||
130890421|NCT01160822|471232037|FG005|Overall Study|Administrative problems|0|||
130890422|NCT01160822|471232038|FG006|Overall Study|Administrative problems|0|||
131023906|NCT02723955|471718575|FG014|Crossover/ Re-treatment Phase|Death|0|||
131023907|NCT02723955|471718576|FG015|Crossover/ Re-treatment Phase|Death|0|||
130890423|NCT01160822|471232032|FG000|Overall Study|Protocol deviation|0|||
130890424|NCT01160822|471232033|FG001|Overall Study|Protocol deviation|0|||
130890425|NCT01160822|471232034|FG002|Overall Study|Protocol deviation|0|||
130890426|NCT01160822|471232035|FG003|Overall Study|Protocol deviation|0|||
130890427|NCT01160822|471232036|FG004|Overall Study|Protocol deviation|2|||
130890428|NCT01160822|471232037|FG005|Overall Study|Protocol deviation|0|||
130890429|NCT01160822|471232038|FG006|Overall Study|Protocol deviation|0|||
130890430|NCT02527421|471232040|FG000|Overall Study|Withdrawal by Subject|1|||
130890431|NCT02527421|471232041|FG001|Overall Study|Withdrawal by Subject|0|||
130890432|NCT02752165|471232047|FG000|Overall Study|Withdrawal by Subject|6|||
130890433|NCT02752165|471232048|FG001|Overall Study|Withdrawal by Subject|6|||
130890434|NCT02752165|471232047|FG000|Overall Study|Protocol Violation|6|||
130890435|NCT02752165|471232048|FG001|Overall Study|Protocol Violation|5|||
130890436|NCT02752165|471232047|FG000|Overall Study|Lost to Follow-up|33|||
130890437|NCT02752165|471232048|FG001|Overall Study|Lost to Follow-up|38|||
130890438|NCT01704599|471232050|FG000|Overall Study|Adverse Event|1|||
130890439|NCT02840461|471232051|FG000|Overall Study|Adverse Event|1|||
130890440|NCT02840461|471232052|FG001|Overall Study|Adverse Event|5|||
130890441|NCT02840461|471232053|FG002|Overall Study|Adverse Event|3|||
130890442|NCT02840461|471232051|FG000|Overall Study|Lost to Follow-up|10|||
130890443|NCT02840461|471232052|FG001|Overall Study|Lost to Follow-up|7|||
130890444|NCT02840461|471232053|FG002|Overall Study|Lost to Follow-up|6|||
130890445|NCT02840461|471232051|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
130890446|NCT02840461|471232052|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
130890447|NCT02840461|471232053|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
130890448|NCT02840461|471232051|FG000|Overall Study|Protocol Violation|2|||
130890449|NCT02840461|471232052|FG001|Overall Study|Protocol Violation|3|||
130890450|NCT02840461|471232053|FG002|Overall Study|Protocol Violation|1|||
130890451|NCT02840461|471232051|FG000|Overall Study|Withdrawal by Subject|10|||
130890452|NCT02840461|471232052|FG001|Overall Study|Withdrawal by Subject|6|||
130890453|NCT02840461|471232053|FG002|Overall Study|Withdrawal by Subject|2|||
130890454|NCT02840461|471232051|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
130890455|NCT02840461|471232052|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
130890456|NCT02840461|471232053|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
130890457|NCT01737502|471232056|FG000|Phase I|Disease progression|2|||
130890458|NCT01737502|471232057|FG001|Phase I|Disease progression|3|||
130890459|NCT01737502|471232056|FG000|Phase I|Complicating disease|1|||
130890460|NCT01737502|471232057|FG001|Phase I|Complicating disease|0|||
130890461|NCT01737502|471232056|FG000|Phase II|Adverse Event|0|||
130890462|NCT01737502|471232057|FG001|Phase II|Adverse Event|3|||
130890463|NCT01737502|471232056|FG000|Phase II|Disease progression|0|||
130890464|NCT01737502|471232057|FG001|Phase II|Disease progression|18|||
130890465|NCT01737502|471232056|FG000|Phase II|Death|0|||
130890466|NCT01737502|471232057|FG001|Phase II|Death|1|||
130890467|NCT01737502|471232056|FG000|Phase II|Transition to hospice care|0|||
130890468|NCT01737502|471232057|FG001|Phase II|Transition to hospice care|1|||
130890469|NCT01615029|471232060|FG000|Overall Study|Adverse Event|0|||
130890470|NCT01615029|471232061|FG001|Overall Study|Adverse Event|0|||
130890471|NCT01615029|471232062|FG002|Overall Study|Adverse Event|0|||
130890472|NCT01615029|471232063|FG003|Overall Study|Adverse Event|0|||
130890473|NCT01615029|471232064|FG004|Overall Study|Adverse Event|1|||
131109062|NCT00585195|472028852|FG001|Overall Study|Withdrawal by Subject|1|||
131109063|NCT00585195|472028853|FG002|Overall Study|Withdrawal by Subject|2|||
131109064|NCT00585195|472028854|FG003|Overall Study|Withdrawal by Subject|2|||
131109065|NCT00585195|472028855|FG004|Overall Study|Withdrawal by Subject|0|||
131109066|NCT00585195|472028856|FG005|Overall Study|Withdrawal by Subject|0|||
131109067|NCT00585195|472028857|FG006|Overall Study|Withdrawal by Subject|0|||
131109068|NCT00585195|472028858|FG007|Overall Study|Withdrawal by Subject|1|||
131109069|NCT00585195|472028859|FG008|Overall Study|Withdrawal by Subject|0|||
131109070|NCT00585195|472028860|FG009|Overall Study|Withdrawal by Subject|0|||
131109071|NCT00585195|472028861|FG010|Overall Study|Withdrawal by Subject|3|||
130890474|NCT01615029|471232060|FG000|Overall Study|Death|0|||
130890475|NCT01615029|471232061|FG001|Overall Study|Death|0|||
130890476|NCT01615029|471232062|FG002|Overall Study|Death|0|||
130890477|NCT01615029|471232063|FG003|Overall Study|Death|0|||
130890478|NCT01615029|471232064|FG004|Overall Study|Death|1|||
130890479|NCT01615029|471232060|FG000|Overall Study|Lost to Follow-up|0|||
130890480|NCT01615029|471232061|FG001|Overall Study|Lost to Follow-up|0|||
130890481|NCT01615029|471232062|FG002|Overall Study|Lost to Follow-up|0|||
130890482|NCT01615029|471232063|FG003|Overall Study|Lost to Follow-up|0|||
130890483|NCT01615029|471232064|FG004|Overall Study|Lost to Follow-up|1|||
130890484|NCT01615029|471232060|FG000|Overall Study|Progressive disease|2|||
130890485|NCT01615029|471232061|FG001|Overall Study|Progressive disease|1|||
130890486|NCT01615029|471232062|FG002|Overall Study|Progressive disease|1|||
130890487|NCT01615029|471232063|FG003|Overall Study|Progressive disease|1|||
130890488|NCT01615029|471232064|FG004|Overall Study|Progressive disease|5|||
130890489|NCT01615029|471232060|FG000|Overall Study|Physician Decision|0|||
130890490|NCT01615029|471232061|FG001|Overall Study|Physician Decision|0|||
131109072|NCT00585195|472028862|FG011|Overall Study|Withdrawal by Subject|8|||
130890491|NCT01615029|471232062|FG002|Overall Study|Physician Decision|0|||
130890492|NCT01615029|471232063|FG003|Overall Study|Physician Decision|0|||
130890493|NCT01615029|471232064|FG004|Overall Study|Physician Decision|1|||
130890494|NCT01615029|471232060|FG000|Overall Study|Ongoing|1|||
130890495|NCT01615029|471232061|FG001|Overall Study|Ongoing|2|||
130890496|NCT01615029|471232062|FG002|Overall Study|Ongoing|3|||
130890497|NCT01615029|471232063|FG003|Overall Study|Ongoing|2|||
130890498|NCT01615029|471232064|FG004|Overall Study|Ongoing|23|||
130890499|NCT04672655|471232065|FG000|Overall Study|Lost to Follow-up|12|||
130890500|NCT04672655|471232066|FG001|Overall Study|Lost to Follow-up|17|||
130890501|NCT04672655|471232065|FG000|Overall Study|Withdrawal by Subject|1|||
130890502|NCT04672655|471232066|FG001|Overall Study|Withdrawal by Subject|0|||
130890503|NCT04672655|471232065|FG000|Overall Study|Withdrawal by Study|1|||
130890504|NCT04672655|471232066|FG001|Overall Study|Withdrawal by Study|0|||
130890505|NCT00802945|471232069|FG000|Overall Study|Death|27|||
130890506|NCT00802945|471232070|FG001|Overall Study|Death|23|||
130890507|NCT00802945|471232069|FG000|Overall Study|Terminated by sponsor|8|||
130890508|NCT00802945|471232070|FG001|Overall Study|Terminated by sponsor|12|||
130890509|NCT00494676|471232071|FG000|Allocation|Withdrawal by Subject|2|||
130890510|NCT00494676|471232072|FG001|Allocation|Withdrawal by Subject|4|||
130890511|NCT00494676|471232071|FG000|First Intervention|Withdrawal by Subject|1|||
130890512|NCT00494676|471232072|FG001|First Intervention|Withdrawal by Subject|3|||
130890513|NCT00494676|471232071|FG000|Second Intervention|Withdrawal by Subject|1|||
130890514|NCT00494676|471232072|FG001|Second Intervention|Withdrawal by Subject|1|||
130890515|NCT03843541|471232073|FG000|Overall Study|Adverse Event|4|||
130890516|NCT03843541|471232074|FG001|Overall Study|Adverse Event|2|||
130890517|NCT03843541|471232075|FG002|Overall Study|Adverse Event|3|||
130890518|NCT03843541|471232073|FG000|Overall Study|Death|1|||
130890519|NCT03843541|471232074|FG001|Overall Study|Death|0|||
130890520|NCT03843541|471232075|FG002|Overall Study|Death|0|||
130890521|NCT03843541|471232073|FG000|Overall Study|Lack of adherence to study medication|0|||
130890522|NCT03843541|471232074|FG001|Overall Study|Lack of adherence to study medication|0|||
130890523|NCT03843541|471232075|FG002|Overall Study|Lack of adherence to study medication|1|||
130890524|NCT03843541|471232073|FG000|Overall Study|Physician Decision|1|||
130890525|NCT03843541|471232074|FG001|Overall Study|Physician Decision|2|||
130890526|NCT03843541|471232075|FG002|Overall Study|Physician Decision|2|||
130890527|NCT03843541|471232073|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
130890528|NCT03843541|471232074|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
130890529|NCT03843541|471232075|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
130890530|NCT03843541|471232073|FG000|Overall Study|Withdrawal by Subject|6|||
130890531|NCT03843541|471232074|FG001|Overall Study|Withdrawal by Subject|9|||
130890532|NCT03843541|471232075|FG002|Overall Study|Withdrawal by Subject|7|||
130890533|NCT03843541|471232073|FG000|Overall Study|Administration of rescue mucolytic|0|||
130890534|NCT03843541|471232074|FG001|Overall Study|Administration of rescue mucolytic|0|||
130890535|NCT03843541|471232075|FG002|Overall Study|Administration of rescue mucolytic|1|||
130890536|NCT03843541|471232073|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
130890537|NCT03843541|471232074|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
130890538|NCT03843541|471232075|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
130890539|NCT05307692|471232079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
130890540|NCT05307692|471232080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
130890541|NCT05307692|471232081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
130890542|NCT05307692|471232082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
130890543|NCT05307692|471232079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
131109073|NCT00585195|472028863|FG012|Overall Study|Withdrawal by Subject|15|||
130890544|NCT05307692|471232080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
130890545|NCT05307692|471232081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
130890546|NCT05307692|471232082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
130890547|NCT05307692|471232079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
130890548|NCT05307692|471232080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
130890549|NCT05307692|471232081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
130890550|NCT05307692|471232082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
130890551|NCT05307692|471232079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
130890552|NCT05307692|471232080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
130890553|NCT05307692|471232081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
130890554|NCT05307692|471232082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
131109074|NCT00585195|472028864|FG013|Overall Study|Withdrawal by Subject|0|||
131109075|NCT00585195|472028865|FG014|Overall Study|Withdrawal by Subject|3|||
131109076|NCT00585195|472028866|FG015|Overall Study|Withdrawal by Subject|0|||
131109077|NCT00585195|472028867|FG016|Overall Study|Withdrawal by Subject|7|||
131109078|NCT00585195|472028868|FG017|Overall Study|Withdrawal by Subject|1|||
131222633|NCT03101293|472443128|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
131222634|NCT01270841|472443129|FG000|Overall Study|Adverse Event|0|||
131222635|NCT01270841|472443130|FG001|Overall Study|Adverse Event|1|||
131222636|NCT01270841|472443131|FG002|Overall Study|Adverse Event|0|||
131222637|NCT01270841|472443132|FG003|Overall Study|Adverse Event|3|||
130686285|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686286|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686287|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686288|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686289|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686290|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686291|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686292|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686293|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
130686294|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686295|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130686296|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
130686297|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
130686298|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686299|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686300|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686301|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686302|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686303|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686304|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686305|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686306|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686307|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686308|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686309|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686310|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686311|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686312|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686313|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686314|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
130686315|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686316|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130686317|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
130686318|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
130686319|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686320|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686321|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686322|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686323|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686324|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686325|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686326|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686327|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686328|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686329|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686330|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686331|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686332|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686333|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686334|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686335|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
130686336|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
131222638|NCT01270841|472443129|FG000|Overall Study|Withdrawal by Subject|3|||
131222639|NCT01270841|472443130|FG001|Overall Study|Withdrawal by Subject|2|||
131222640|NCT01270841|472443131|FG002|Overall Study|Withdrawal by Subject|3|||
131222641|NCT01270841|472443132|FG003|Overall Study|Withdrawal by Subject|3|||
131222642|NCT01270841|472443129|FG000|Overall Study|Lost to Follow-up|3|||
131222643|NCT01270841|472443130|FG001|Overall Study|Lost to Follow-up|1|||
131222644|NCT01270841|472443131|FG002|Overall Study|Lost to Follow-up|4|||
130686337|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686338|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
130686339|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130686340|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686341|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686342|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686343|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686344|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686345|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686346|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686347|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686348|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686349|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686350|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130890555|NCT05307692|471232079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
130890556|NCT05307692|471232080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
130890557|NCT05307692|471232081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
130890558|NCT05307692|471232082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
130890559|NCT05307692|471232079|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
130890560|NCT05307692|471232080|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
130890561|NCT05307692|471232081|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
130890562|NCT05307692|471232082|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
130890563|NCT05307692|471232079|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
130890564|NCT05307692|471232080|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
130890565|NCT05307692|471232081|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
130890566|NCT05307692|471232082|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
130890567|NCT05307692|471232079|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
130890568|NCT05307692|471232080|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
130890569|NCT05307692|471232081|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
130890570|NCT05307692|471232082|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
130890571|NCT02003924|471232085|FG000|Double-blind Phase|Lost to Follow-up|2|||
130890572|NCT02003924|471232086|FG001|Double-blind Phase|Lost to Follow-up|1|||
130890573|NCT02003924|471232087|FG002|Double-blind Phase|Lost to Follow-up|0|||
130890574|NCT02003924|471232085|FG000|Double-blind Phase|Protocol Violation|1|||
130890575|NCT02003924|471232086|FG001|Double-blind Phase|Protocol Violation|2|||
130890576|NCT02003924|471232087|FG002|Double-blind Phase|Protocol Violation|0|||
130890577|NCT02003924|471232085|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
130890578|NCT02003924|471232086|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
130890579|NCT02003924|471232087|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
130890580|NCT02003924|471232085|FG000|Double-blind Phase|Disease Progression|229|||
130890581|NCT02003924|471232086|FG001|Double-blind Phase|Disease Progression|247|||
130890582|NCT02003924|471232087|FG002|Double-blind Phase|Disease Progression|0|||
130890583|NCT02003924|471232085|FG000|Double-blind Phase|Adverse Event|120|||
130890584|NCT02003924|471232086|FG001|Double-blind Phase|Adverse Event|31|||
130890585|NCT02003924|471232087|FG002|Double-blind Phase|Adverse Event|0|||
130890586|NCT02003924|471232085|FG000|Double-blind Phase|Randomized But not Treated|3|||
130890587|NCT02003924|471232086|FG001|Double-blind Phase|Randomized But not Treated|3|||
130890588|NCT02003924|471232087|FG002|Double-blind Phase|Randomized But not Treated|0|||
130890589|NCT02003924|471232085|FG000|Double-blind Phase|Other|29|||
130890590|NCT02003924|471232086|FG001|Double-blind Phase|Other|50|||
130890591|NCT02003924|471232087|FG002|Double-blind Phase|Other|0|||
130890592|NCT02003924|471232085|FG000|Open-label Phase|Lost to Follow-up|0|||
130890593|NCT02003924|471232086|FG001|Open-label Phase|Lost to Follow-up|0|||
130890594|NCT02003924|471232087|FG002|Open-label Phase|Lost to Follow-up|1|||
130890595|NCT02003924|471232085|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
130890596|NCT02003924|471232086|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
130890597|NCT02003924|471232087|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
130890598|NCT02003924|471232085|FG000|Open-label Phase|Disease Progression|59|||
130890599|NCT02003924|471232086|FG001|Open-label Phase|Disease Progression|0|||
130686351|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130890600|NCT02003924|471232087|FG002|Open-label Phase|Disease Progression|5|||
130890601|NCT02003924|471232085|FG000|Open-label Phase|Adverse Event|25|||
130890602|NCT02003924|471232086|FG001|Open-label Phase|Adverse Event|0|||
130890603|NCT02003924|471232087|FG002|Open-label Phase|Adverse Event|10|||
130890604|NCT02003924|471232085|FG000|Open-label Phase|Other|7|||
130890605|NCT02003924|471232086|FG001|Open-label Phase|Other|0|||
130890606|NCT02003924|471232087|FG002|Open-label Phase|Other|0|||
130890607|NCT02003924|471232085|FG000|Long-term Follow-up Phase|Death|288|||
131023908|NCT02723955|471718577|FG016|Crossover/ Re-treatment Phase|Death|0|||
131222645|NCT01270841|472443132|FG003|Overall Study|Lost to Follow-up|2|||
130890608|NCT02003924|471232086|FG001|Long-term Follow-up Phase|Death|174|||
131222646|NCT01270841|472443129|FG000|Overall Study|Physician Decision|0|||
131222647|NCT01270841|472443130|FG001|Overall Study|Physician Decision|1|||
131222648|NCT01270841|472443131|FG002|Overall Study|Physician Decision|0|||
131222649|NCT01270841|472443132|FG003|Overall Study|Physician Decision|0|||
131222650|NCT01270841|472443129|FG000|Overall Study|Did not qualify|6|||
131222651|NCT01270841|472443130|FG001|Overall Study|Did not qualify|3|||
131222652|NCT01270841|472443131|FG002|Overall Study|Did not qualify|4|||
131222653|NCT01270841|472443132|FG003|Overall Study|Did not qualify|5|||
131222654|NCT01270841|472443129|FG000|Overall Study|Protocol Violation|1|||
131109079|NCT00585195|472028869|FG018|Overall Study|Withdrawal by Subject|2|||
131109080|NCT00585195|472028870|FG019|Overall Study|Withdrawal by Subject|2|||
131109081|NCT00585195|472028871|FG020|Overall Study|Withdrawal by Subject|0|||
131109082|NCT00585195|472028851|FG000|Overall Study|Other|0|||
131109083|NCT00585195|472028852|FG001|Overall Study|Other|1|||
131109084|NCT00585195|472028853|FG002|Overall Study|Other|1|||
131109085|NCT00585195|472028854|FG003|Overall Study|Other|1|||
131109086|NCT00585195|472028855|FG004|Overall Study|Other|0|||
131109087|NCT00585195|472028856|FG005|Overall Study|Other|1|||
131109088|NCT00585195|472028857|FG006|Overall Study|Other|0|||
131109089|NCT00585195|472028858|FG007|Overall Study|Other|0|||
131222655|NCT01270841|472443130|FG001|Overall Study|Protocol Violation|5|||
130686352|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686353|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686354|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686355|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686356|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
130686357|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686358|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686359|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
130686360|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130686361|NCT01597245|470477931|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686362|NCT01597245|470477932|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686363|NCT01597245|470477933|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686364|NCT01597245|470477934|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686365|NCT01597245|470477935|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686366|NCT01597245|470477936|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686367|NCT01597245|470477937|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686368|NCT01597245|470477938|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686369|NCT01597245|470477939|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686370|NCT01597245|470477940|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686371|NCT01597245|470477941|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686372|NCT01597245|470477942|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686373|NCT01597245|470477943|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
131023909|NCT02723955|471718578|FG017|Crossover/ Re-treatment Phase|Death|0|||
131023910|NCT02723955|471718579|FG018|Crossover/ Re-treatment Phase|Death|0|||
131023911|NCT02723955|471718580|FG019|Crossover/ Re-treatment Phase|Death|0|||
131023912|NCT02723955|471718581|FG020|Crossover/ Re-treatment Phase|Death|0|||
131023913|NCT02723955|471718582|FG021|Crossover/ Re-treatment Phase|Death|0|||
131023914|NCT02723955|471718583|FG022|Crossover/ Re-treatment Phase|Death|0|||
131023915|NCT02723955|471718584|FG023|Crossover/ Re-treatment Phase|Death|0|||
131023916|NCT02723955|471718585|FG024|Crossover/ Re-treatment Phase|Death|0|||
131023917|NCT02723955|471718586|FG025|Crossover/ Re-treatment Phase|Death|0|||
131023918|NCT02723955|471718587|FG026|Crossover/ Re-treatment Phase|Death|0|||
131023919|NCT02723955|471718588|FG027|Crossover/ Re-treatment Phase|Death|0|||
131023920|NCT02723955|471718589|FG028|Crossover/ Re-treatment Phase|Death|0|||
131023921|NCT02723955|471718590|FG029|Crossover/ Re-treatment Phase|Death|0|||
131023922|NCT02723955|471718591|FG030|Crossover/ Re-treatment Phase|Death|0|||
131023923|NCT02723955|471718592|FG031|Crossover/ Re-treatment Phase|Death|0|||
131023924|NCT02723955|471718593|FG032|Crossover/ Re-treatment Phase|Death|0|||
131023925|NCT02723955|471718594|FG033|Crossover/ Re-treatment Phase|Death|0|||
131023926|NCT02723955|471718595|FG034|Crossover/ Re-treatment Phase|Death|0|||
131023927|NCT02723955|471718596|FG035|Crossover/ Re-treatment Phase|Death|0|||
131023928|NCT02723955|471718597|FG036|Crossover/ Re-treatment Phase|Death|0|||
131023929|NCT02723955|471718598|FG037|Crossover/ Re-treatment Phase|Death|1|||
131023930|NCT02723955|471718599|FG038|Crossover/ Re-treatment Phase|Death|14|||
131023931|NCT02723955|471718600|FG039|Crossover/ Re-treatment Phase|Death|32|||
131023932|NCT02723955|471718601|FG040|Crossover/ Re-treatment Phase|Death|2|||
131023933|NCT02723955|471718602|FG041|Crossover/ Re-treatment Phase|Death|1|||
131109090|NCT00585195|472028859|FG008|Overall Study|Other|2|||
131109091|NCT00585195|472028860|FG009|Overall Study|Other|1|||
131109092|NCT00585195|472028861|FG010|Overall Study|Other|0|||
131109093|NCT00585195|472028862|FG011|Overall Study|Other|19|||
131109094|NCT00585195|472028863|FG012|Overall Study|Other|24|||
131222656|NCT01270841|472443131|FG002|Overall Study|Protocol Violation|0|||
131222657|NCT01270841|472443132|FG003|Overall Study|Protocol Violation|0|||
130890609|NCT02003924|471232087|FG002|Long-term Follow-up Phase|Death|4|||
130890610|NCT02003924|471232085|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
130890611|NCT02003924|471232086|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
130890612|NCT02003924|471232087|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
130890613|NCT02003924|471232085|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
130890614|NCT02003924|471232086|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
130890615|NCT02003924|471232087|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
130890616|NCT02003924|471232085|FG000|Long-term Follow-up Phase|Other|5|||
130890617|NCT02003924|471232086|FG001|Long-term Follow-up Phase|Other|2|||
130890618|NCT02003924|471232087|FG002|Long-term Follow-up Phase|Other|1|||
130890619|NCT00560352|471232092|FG000|Overall Study|Adverse event unrelated to study drug|2|||
130890620|NCT00560352|471232093|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130890621|NCT00560352|471232094|FG002|Overall Study|Adverse event unrelated to study drug|1|||
130890622|NCT00560352|471232092|FG000|Overall Study|Study drug toxicity|3|||
130890623|NCT00560352|471232093|FG001|Overall Study|Study drug toxicity|0|||
130890624|NCT00560352|471232094|FG002|Overall Study|Study drug toxicity|1|||
130890625|NCT00560352|471232092|FG000|Overall Study|Disease progression|0|||
130890626|NCT00560352|471232093|FG001|Overall Study|Disease progression|1|||
130890627|NCT00560352|471232094|FG002|Overall Study|Disease progression|1|||
130890628|NCT00560352|471232092|FG000|Overall Study|Withdrawal by Subject|1|||
130890629|NCT00560352|471232093|FG001|Overall Study|Withdrawal by Subject|1|||
130890630|NCT00560352|471232094|FG002|Overall Study|Withdrawal by Subject|1|||
130890631|NCT00560352|471232092|FG000|Overall Study|Maximum clinical benefit|1|||
130890632|NCT00560352|471232093|FG001|Overall Study|Maximum clinical benefit|0|||
130890633|NCT00560352|471232094|FG002|Overall Study|Maximum clinical benefit|0|||
130890634|NCT04434937|471232098|FG000|Overall Study|Death|4|||
130890635|NCT04434937|471232098|FG000|Overall Study|Withdrawal by Subject|1|||
130890636|NCT04434937|471232098|FG000|Overall Study|Transitioned to Rollover Study|19|||
130890637|NCT04434937|471232098|FG000|Overall Study|Progressive Disease|18|||
130890638|NCT05767749|471232099|FG000|Overall Study|Withdrawal by Subject|0|||
130890639|NCT05767749|471232100|FG001|Overall Study|Withdrawal by Subject|0|||
130890640|NCT05767749|471232101|FG002|Overall Study|Withdrawal by Subject|2|||
130890641|NCT05767749|471232102|FG003|Overall Study|Withdrawal by Subject|2|||
130890642|NCT05767749|471232103|FG004|Overall Study|Withdrawal by Subject|2|||
130890643|NCT05767749|471232104|FG005|Overall Study|Withdrawal by Subject|2|||
130890644|NCT04695977|471232109|FG000|Overall Study|Sponsor Decision|9|||
130890645|NCT04695977|471232110|FG001|Overall Study|Sponsor Decision|4|||
130890646|NCT04695977|471232109|FG000|Overall Study|Death|2|||
130890647|NCT04695977|471232110|FG001|Overall Study|Death|5|||
130890648|NCT03083873|471233814|FG000|Overall Study|Death|6|||
130890649|NCT03083873|471233815|FG001|Overall Study|Death|15|||
130890650|NCT03083873|471233816|FG002|Overall Study|Death|13|||
130890651|NCT03083873|471233817|FG003|Overall Study|Death|9|||
130890652|NCT03083873|471233818|FG004|Overall Study|Death|0|||
130890653|NCT03083873|471233814|FG000|Overall Study|Sponsor Terminated Study|0|||
131023934|NCT02723955|471718603|FG042|Crossover/ Re-treatment Phase|Death|0|||
131023935|NCT02723955|471718561|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023936|NCT02723955|471718562|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023937|NCT02723955|471718563|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023938|NCT02723955|471718564|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023939|NCT02723955|471718565|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023940|NCT02723955|471718566|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023941|NCT02723955|471718567|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023942|NCT02723955|471718568|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023943|NCT02723955|471718569|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023944|NCT02723955|471718570|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023945|NCT02723955|471718571|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023946|NCT02723955|471718572|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023947|NCT02723955|471718573|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023948|NCT02723955|471718574|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023949|NCT02723955|471718575|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131109095|NCT00585195|472028864|FG013|Overall Study|Other|7|||
130890654|NCT03083873|471233815|FG001|Overall Study|Sponsor Terminated Study|1|||
130890655|NCT03083873|471233816|FG002|Overall Study|Sponsor Terminated Study|2|||
130890656|NCT03083873|471233817|FG003|Overall Study|Sponsor Terminated Study|3|||
130890657|NCT03083873|471233818|FG004|Overall Study|Sponsor Terminated Study|0|||
130890658|NCT03083873|471233814|FG000|Overall Study|Lost to Follow-up|0|||
130890659|NCT03083873|471233815|FG001|Overall Study|Lost to Follow-up|1|||
130890660|NCT03083873|471233816|FG002|Overall Study|Lost to Follow-up|1|||
130890661|NCT03083873|471233817|FG003|Overall Study|Lost to Follow-up|0|||
130890662|NCT03083873|471233818|FG004|Overall Study|Lost to Follow-up|0|||
130890663|NCT03083873|471233814|FG000|Overall Study|Withdrawal by Subject|2|||
131023950|NCT02723955|471718576|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023951|NCT02723955|471718577|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130890664|NCT03083873|471233815|FG001|Overall Study|Withdrawal by Subject|0|||
130890665|NCT03083873|471233816|FG002|Overall Study|Withdrawal by Subject|0|||
130890666|NCT03083873|471233817|FG003|Overall Study|Withdrawal by Subject|0|||
130890667|NCT03083873|471233818|FG004|Overall Study|Withdrawal by Subject|0|||
130890668|NCT03083873|471233814|FG000|Overall Study|Did Not Receive TIL|2|||
130890669|NCT03083873|471233815|FG001|Overall Study|Did Not Receive TIL|5|||
130890670|NCT03083873|471233816|FG002|Overall Study|Did Not Receive TIL|3|||
130890671|NCT03083873|471233817|FG003|Overall Study|Did Not Receive TIL|1|||
130890672|NCT03083873|471233818|FG004|Overall Study|Did Not Receive TIL|0|||
130890673|NCT01677377|471233819|FG000|Overall Study|Protocol Violation|1|||
130890674|NCT01677377|471233820|FG001|Overall Study|Protocol Violation|0|||
130890675|NCT01677377|471233821|FG002|Overall Study|Protocol Violation|0|||
130890676|NCT01677377|471233819|FG000|Overall Study|Lost to Follow-up|0|||
130890677|NCT01677377|471233820|FG001|Overall Study|Lost to Follow-up|1|||
130890678|NCT01677377|471233821|FG002|Overall Study|Lost to Follow-up|1|||
130890679|NCT01677377|471233819|FG000|Overall Study|Withdrawal by Subject|0|||
130890680|NCT01677377|471233820|FG001|Overall Study|Withdrawal by Subject|0|||
130890681|NCT01677377|471233821|FG002|Overall Study|Withdrawal by Subject|3|||
130890682|NCT01677377|471233819|FG000|Overall Study|Lack of Efficacy|0|||
130890683|NCT01677377|471233820|FG001|Overall Study|Lack of Efficacy|0|||
130890684|NCT01677377|471233821|FG002|Overall Study|Lack of Efficacy|1|||
130890685|NCT01677377|471233819|FG000|Overall Study|Pregnancy|0|||
130890686|NCT01677377|471233820|FG001|Overall Study|Pregnancy|0|||
130890687|NCT01677377|471233821|FG002|Overall Study|Pregnancy|1|||
130890688|NCT02656693|471233835|FG000|Overall Study|Pregnancy|1|||
130890689|NCT02656693|471233836|FG001|Overall Study|Pregnancy|1|||
130890690|NCT02656693|471233837|FG002|Overall Study|Pregnancy|1|||
130890691|NCT02656693|471233835|FG000|Overall Study|Bariatric surgery|0|||
130890692|NCT02656693|471233836|FG001|Overall Study|Bariatric surgery|1|||
130890693|NCT02656693|471233837|FG002|Overall Study|Bariatric surgery|2|||
130890694|NCT02269267|471233839|FG000|Overall Study|Death|5|||
130890695|NCT00796419|471233841|FG000|Overall Study|Death|0|||
130890696|NCT00796419|471233842|FG001|Overall Study|Death|1|||
130890697|NCT01193257|471233846|FG000|Overall Study|Death|202|||
130890698|NCT01193257|471233847|FG001|Overall Study|Death|391|||
130890699|NCT01193257|471233846|FG000|Overall Study|Study termination by sponsor|0|||
130890700|NCT01193257|471233847|FG001|Overall Study|Study termination by sponsor|3|||
130890701|NCT01193257|471233846|FG000|Overall Study|Withdrawal by Subject|26|||
130890702|NCT01193257|471233847|FG001|Overall Study|Withdrawal by Subject|86|||
130890703|NCT01193257|471233846|FG000|Overall Study|Lost to Follow-up|2|||
130890704|NCT01193257|471233847|FG001|Overall Study|Lost to Follow-up|3|||
130890705|NCT01193257|471233846|FG000|Overall Study|Unblinded due to futility|135|||
130890706|NCT01193257|471233847|FG001|Overall Study|Unblinded due to futility|251|||
130890707|NCT00441064|471233850|FG000|Overall Study|Adverse Event|1|||
130890708|NCT00441064|471233851|FG001|Overall Study|Adverse Event|0|||
130890709|NCT00441064|471233850|FG000|Overall Study|Abnormal laboratory values|0|||
130890710|NCT00441064|471233851|FG001|Overall Study|Abnormal laboratory values|2|||
130890711|NCT00441064|471233850|FG000|Overall Study|Abnormal test procedure results|0|||
130890712|NCT00441064|471233851|FG001|Overall Study|Abnormal test procedure results|1|||
130890713|NCT00441064|471233850|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130890714|NCT00441064|471233851|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130890715|NCT00441064|471233850|FG000|Overall Study|Protocol Deviation|3|||
130890716|NCT00441064|471233851|FG001|Overall Study|Protocol Deviation|2|||
130890717|NCT00441064|471233850|FG000|Overall Study|Patient withdrew consent|5|||
130890718|NCT00441064|471233851|FG001|Overall Study|Patient withdrew consent|2|||
130890719|NCT00369265|471233852|FG000|Overall Study|Study terminated|4|||
130890720|NCT00369265|471233853|FG001|Overall Study|Study terminated|7|||
130890721|NCT00068419|471233854|FG000|Overall Study|Adverse Event|3|||
130890722|NCT00068419|471233854|FG000|Overall Study|Lack of Efficacy|24|||
130890723|NCT00068419|471233854|FG000|Overall Study|Lost to Follow-up|1|||
130890724|NCT00068419|471233854|FG000|Overall Study|Physician Decision|7|||
130890725|NCT00068419|471233854|FG000|Overall Study|Withdrawal by Subject|14|||
130890726|NCT00068419|471233854|FG000|Overall Study|Ineligible|11|||
130890727|NCT01032889|471233863|FG000|Overall Study|Adverse Event|2|||
130767077|NCT01490697|470770715|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
130890728|NCT01032889|471233864|FG001|Overall Study|Adverse Event|2|||
130890729|NCT01032889|471233865|FG002|Overall Study|Adverse Event|0|||
130767078|NCT01490697|470770716|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
130890730|NCT01032889|471233863|FG000|Overall Study|Withdrawal of Consent|1|||
130890731|NCT01032889|471233864|FG001|Overall Study|Withdrawal of Consent|2|||
130890732|NCT01032889|471233865|FG002|Overall Study|Withdrawal of Consent|1|||
130890733|NCT01032889|471233863|FG000|Overall Study|Patient Request|0|||
130890734|NCT01032889|471233864|FG001|Overall Study|Patient Request|1|||
131023952|NCT02723955|471718578|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130890735|NCT01032889|471233865|FG002|Overall Study|Patient Request|0|||
130890736|NCT01032889|471233863|FG000|Overall Study|Lost to Follow-up|1|||
130890737|NCT01032889|471233864|FG001|Overall Study|Lost to Follow-up|1|||
130890738|NCT01032889|471233865|FG002|Overall Study|Lost to Follow-up|0|||
130890739|NCT01032889|471233863|FG000|Overall Study|Lack of Submental Fat|2|||
130890740|NCT01032889|471233864|FG001|Overall Study|Lack of Submental Fat|8|||
130890741|NCT01032889|471233865|FG002|Overall Study|Lack of Submental Fat|1|||
130890742|NCT01032889|471233863|FG000|Overall Study|Miscellaneous Reasons|2|||
130890743|NCT01032889|471233864|FG001|Overall Study|Miscellaneous Reasons|1|||
130890744|NCT01032889|471233865|FG002|Overall Study|Miscellaneous Reasons|1|||
130890745|NCT00092443|471233866|FG000|Overall Study|Adverse Event|9|||
130890746|NCT00092443|471233867|FG001|Overall Study|Adverse Event|13|||
130890747|NCT00092443|471233866|FG000|Overall Study|Lost to Follow-up|7|||
130890748|NCT00092443|471233867|FG001|Overall Study|Lost to Follow-up|3|||
130890749|NCT00092443|471233866|FG000|Overall Study|Protocol Violation|11|||
131109096|NCT00585195|472028865|FG014|Overall Study|Other|11|||
131109097|NCT00585195|472028866|FG015|Overall Study|Other|3|||
131109098|NCT00585195|472028867|FG016|Overall Study|Other|28|||
131109099|NCT00585195|472028868|FG017|Overall Study|Other|12|||
131109100|NCT00585195|472028869|FG018|Overall Study|Other|10|||
131109101|NCT00585195|472028870|FG019|Overall Study|Other|4|||
131109102|NCT00585195|472028871|FG020|Overall Study|Other|2|||
131109103|NCT00585195|472028851|FG000|Overall Study|Randomized not treated|0|||
131109104|NCT00585195|472028852|FG001|Overall Study|Randomized not treated|0|||
131109105|NCT00585195|472028853|FG002|Overall Study|Randomized not treated|1|||
131109106|NCT00585195|472028854|FG003|Overall Study|Randomized not treated|0|||
131109107|NCT00585195|472028855|FG004|Overall Study|Randomized not treated|1|||
131109108|NCT00585195|472028856|FG005|Overall Study|Randomized not treated|0|||
130890750|NCT00092443|471233867|FG001|Overall Study|Protocol Violation|9|||
131109109|NCT00585195|472028857|FG006|Overall Study|Randomized not treated|1|||
130686374|NCT01597245|470477944|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686375|NCT01597245|470477945|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686376|NCT01597245|470477946|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686377|NCT01597245|470477947|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686378|NCT01597245|470477948|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686379|NCT01597245|470477949|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686380|NCT01597245|470477950|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
130686381|NCT01597245|470477951|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130686382|NCT01313780|470477952|FG000|Overall Study|Lack of Efficacy|4|||
130686383|NCT01313780|470477953|FG001|Overall Study|Lack of Efficacy|2|||
130686384|NCT01313780|470477952|FG000|Overall Study|Adverse Event|6|||
130686385|NCT01313780|470477953|FG001|Overall Study|Adverse Event|11|||
130686386|NCT01313780|470477952|FG000|Overall Study|Withdrawal by Subject|2|||
130686387|NCT01313780|470477953|FG001|Overall Study|Withdrawal by Subject|8|||
130686388|NCT01313780|470477952|FG000|Overall Study|Protocol Violation|10|||
130686389|NCT01313780|470477953|FG001|Overall Study|Protocol Violation|4|||
131109110|NCT00585195|472028858|FG007|Overall Study|Randomized not treated|0|||
131109111|NCT00585195|472028859|FG008|Overall Study|Randomized not treated|0|||
131109112|NCT00585195|472028860|FG009|Overall Study|Randomized not treated|0|||
131109113|NCT00585195|472028861|FG010|Overall Study|Randomized not treated|2|||
131109114|NCT00585195|472028862|FG011|Overall Study|Randomized not treated|0|||
131109115|NCT00585195|472028863|FG012|Overall Study|Randomized not treated|0|||
131109116|NCT00585195|472028864|FG013|Overall Study|Randomized not treated|0|||
131109117|NCT00585195|472028865|FG014|Overall Study|Randomized not treated|0|||
131109118|NCT00585195|472028866|FG015|Overall Study|Randomized not treated|1|||
131109119|NCT00585195|472028867|FG016|Overall Study|Randomized not treated|0|||
131109120|NCT00585195|472028868|FG017|Overall Study|Randomized not treated|1|||
131109121|NCT00585195|472028869|FG018|Overall Study|Randomized not treated|3|||
131109122|NCT00585195|472028870|FG019|Overall Study|Randomized not treated|0|||
131109123|NCT00585195|472028871|FG020|Overall Study|Randomized not treated|2|||
131109124|NCT00585195|472028851|FG000|Overall Study|Death|0|||
131109125|NCT00585195|472028852|FG001|Overall Study|Death|0|||
131109126|NCT00585195|472028853|FG002|Overall Study|Death|0|||
131109127|NCT00585195|472028854|FG003|Overall Study|Death|0|||
131109128|NCT00585195|472028855|FG004|Overall Study|Death|0|||
131109129|NCT00585195|472028856|FG005|Overall Study|Death|0|||
130686390|NCT01313780|470477952|FG000|Overall Study|missing data|3|||
130686391|NCT01313780|470477953|FG001|Overall Study|missing data|3|||
130686392|NCT00731783|470477954|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
131109130|NCT00585195|472028857|FG006|Overall Study|Death|0|||
131109131|NCT00585195|472028858|FG007|Overall Study|Death|0|||
131109132|NCT00585195|472028859|FG008|Overall Study|Death|1|||
131109133|NCT00585195|472028860|FG009|Overall Study|Death|0|||
131109134|NCT00585195|472028861|FG010|Overall Study|Death|1|||
131109135|NCT00585195|472028862|FG011|Overall Study|Death|1|||
131109136|NCT00585195|472028863|FG012|Overall Study|Death|7|||
131109137|NCT00585195|472028864|FG013|Overall Study|Death|2|||
130686393|NCT00731783|470477955|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
130686394|NCT00731783|470477954|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
130686395|NCT00731783|470477955|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
130890751|NCT00092443|471233866|FG000|Overall Study|Withdrawal by Subject|9|||
130890752|NCT00092443|471233867|FG001|Overall Study|Withdrawal by Subject|11|||
131109138|NCT00585195|472028865|FG014|Overall Study|Death|8|||
131109139|NCT00585195|472028866|FG015|Overall Study|Death|2|||
130686396|NCT00731783|470477954|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
130686397|NCT00731783|470477955|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
130686398|NCT00731783|470477954|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
131109140|NCT00585195|472028867|FG016|Overall Study|Death|11|||
131109141|NCT00585195|472028868|FG017|Overall Study|Death|0|||
131109142|NCT00585195|472028869|FG018|Overall Study|Death|0|||
131109143|NCT00585195|472028870|FG019|Overall Study|Death|0|||
131109144|NCT00585195|472028871|FG020|Overall Study|Death|1|||
131109145|NCT00585195|472028851|FG000|Overall Study|Lost to Follow-up|0|||
131109146|NCT00585195|472028852|FG001|Overall Study|Lost to Follow-up|0|||
131109147|NCT00585195|472028853|FG002|Overall Study|Lost to Follow-up|0|||
131109148|NCT00585195|472028854|FG003|Overall Study|Lost to Follow-up|0|||
131109149|NCT00585195|472028855|FG004|Overall Study|Lost to Follow-up|0|||
131109150|NCT00585195|472028856|FG005|Overall Study|Lost to Follow-up|0|||
131109151|NCT00585195|472028857|FG006|Overall Study|Lost to Follow-up|0|||
131109152|NCT00585195|472028858|FG007|Overall Study|Lost to Follow-up|0|||
131109153|NCT00585195|472028859|FG008|Overall Study|Lost to Follow-up|0|||
131109154|NCT00585195|472028860|FG009|Overall Study|Lost to Follow-up|0|||
131109155|NCT00585195|472028861|FG010|Overall Study|Lost to Follow-up|0|||
131109156|NCT00585195|472028862|FG011|Overall Study|Lost to Follow-up|0|||
131109157|NCT00585195|472028863|FG012|Overall Study|Lost to Follow-up|1|||
131109158|NCT00585195|472028864|FG013|Overall Study|Lost to Follow-up|0|||
130686399|NCT00731783|470477955|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
130686400|NCT05369208|470479530|FG000|Core Phase|Prohibited Medication Required|2|||
130686401|NCT05369208|470479530|FG000|Core Phase|Adverse Event|1|||
130686402|NCT05369208|470479530|FG000|Core Phase|Lack of Efficacy|1|||
130686403|NCT03235739|470479531|FG000|Overall Study|Withdrawal by Subject|2|||
130686404|NCT03235739|470479532|FG001|Overall Study|Withdrawal by Subject|2|||
130686405|NCT03235739|470479531|FG000|Overall Study|Physician Decision|0|||
130686406|NCT03235739|470479532|FG001|Overall Study|Physician Decision|1|||
130686407|NCT00467896|470479533|FG000|Overall Study|Consent Withdrawal|18|||
130686408|NCT00467896|470479533|FG000|Overall Study|Adverse Event|7|||
130686409|NCT00467896|470479533|FG000|Overall Study|Serious Adverse Event|13|||
130686410|NCT00467896|470479533|FG000|Overall Study|Non-compliance|3|||
130686411|NCT00467896|470479533|FG000|Overall Study|Changed therapy|2|||
130686412|NCT00467896|470479533|FG000|Overall Study|Patient received transplant|2|||
130686413|NCT00467896|470479533|FG000|Overall Study|Patient had atrial septostomy|1|||
130686414|NCT00467896|470479533|FG000|Overall Study|Patient weaned off iloprost|1|||
130686415|NCT00467896|470479533|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
130686416|NCT00467896|470479533|FG000|Overall Study|Started intravenous prostacyclin|1|||
130686417|NCT00467896|470479533|FG000|Overall Study|Started inhaled Remodulin|1|||
130686418|NCT00467896|470479533|FG000|Overall Study|Patient had no improvement|1|||
130686419|NCT03772522|470479534|FG000|Pre-intervention|Withdrawal by Subject|3|||
130686420|NCT03772522|470479535|FG001|Pre-intervention|Withdrawal by Subject|4|||
130686421|NCT03772522|470479534|FG000|Intervention|Withdrawal by Subject|1|||
130686422|NCT03772522|470479535|FG001|Intervention|Withdrawal by Subject|0|||
130686423|NCT03772522|470479534|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
130686424|NCT03772522|470479535|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
130686425|NCT03818581|470479536|FG000|Overall Study|Adverse Event|1|||
130686426|NCT03818581|470479537|FG001|Overall Study|Adverse Event|0|||
130686427|NCT03818581|470479538|FG002|Overall Study|Adverse Event|0|||
130686428|NCT03818581|470479539|FG003|Overall Study|Adverse Event|0|||
130686429|NCT03818581|470479540|FG004|Overall Study|Adverse Event|0|||
130686430|NCT03818581|470479536|FG000|Overall Study|Covid-19|2|||
130686431|NCT03818581|470479537|FG001|Overall Study|Covid-19|0|||
130686432|NCT03818581|470479538|FG002|Overall Study|Covid-19|0|||
130686433|NCT03818581|470479539|FG003|Overall Study|Covid-19|0|||
130686434|NCT03818581|470479540|FG004|Overall Study|Covid-19|1|||
130686435|NCT03818581|470479536|FG000|Overall Study|Withdrawal by Subject|0|||
130686436|NCT03818581|470479537|FG001|Overall Study|Withdrawal by Subject|0|||
130686437|NCT03818581|470479538|FG002|Overall Study|Withdrawal by Subject|0|||
130686438|NCT03818581|470479539|FG003|Overall Study|Withdrawal by Subject|0|||
131109159|NCT00585195|472028865|FG014|Overall Study|Lost to Follow-up|0|||
131109160|NCT00585195|472028866|FG015|Overall Study|Lost to Follow-up|0|||
131109161|NCT00585195|472028867|FG016|Overall Study|Lost to Follow-up|0|||
131109162|NCT00585195|472028868|FG017|Overall Study|Lost to Follow-up|2|||
131109163|NCT00585195|472028869|FG018|Overall Study|Lost to Follow-up|0|||
131109164|NCT00585195|472028870|FG019|Overall Study|Lost to Follow-up|0|||
130686439|NCT03818581|470479540|FG004|Overall Study|Withdrawal by Subject|1|||
130686440|NCT03818581|470479536|FG000|Overall Study|No longer met study criteria|0|||
130686441|NCT03818581|470479537|FG001|Overall Study|No longer met study criteria|0|||
130686442|NCT03818581|470479538|FG002|Overall Study|No longer met study criteria|0|||
130686443|NCT03818581|470479539|FG003|Overall Study|No longer met study criteria|0|||
130686444|NCT03818581|470479540|FG004|Overall Study|No longer met study criteria|1|||
130686445|NCT00462345|470479541|FG000|Overall Study|Withdrawal by Subject|2|||
130686446|NCT00462345|470479541|FG000|Overall Study|Did not complete second course|1|||
130686447|NCT01149473|470479542|FG000|First Intervention|Adverse Event|1|||
130686448|NCT01149473|470479543|FG001|First Intervention|Adverse Event|1|||
130686449|NCT01149473|470479542|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130686450|NCT01149473|470479543|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130686451|NCT04089735|470479544|FG000|Overall Study|Adverse Event|1|||
130686452|NCT04089735|470479545|FG001|Overall Study|Adverse Event|0|||
130686453|NCT04089735|470479546|FG002|Overall Study|Adverse Event|1|||
130686454|NCT04089735|470479547|FG003|Overall Study|Adverse Event|1|||
130686455|NCT04089735|470479548|FG004|Overall Study|Adverse Event|0|||
130686456|NCT04089735|470479549|FG005|Overall Study|Adverse Event|0|||
130686457|NCT04089735|470479544|FG000|Overall Study|Physician Decision|0|||
130890753|NCT00092443|471233866|FG000|Overall Study|Moved|5|||
130890754|NCT00092443|471233867|FG001|Overall Study|Moved|5|||
130890755|NCT00092443|471233866|FG000|Overall Study|Other|17|||
130890756|NCT00092443|471233867|FG001|Overall Study|Other|13|||
130890757|NCT04717336|471233871|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
130890758|NCT04717336|471233872|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
130890759|NCT04717336|471233871|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
130890760|NCT04717336|471233872|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
130890761|NCT02039843|471233873|FG000|Randomization and Observation Period|Adverse Event|2|||
130890762|NCT02039843|471233874|FG001|Randomization and Observation Period|Adverse Event|0|||
130890763|NCT02039843|471233873|FG000|Randomization and Observation Period|Death|1|||
130890764|NCT02039843|471233874|FG001|Randomization and Observation Period|Death|0|||
130890765|NCT02039843|471233873|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
130890766|NCT02039843|471233874|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
130890767|NCT02039843|471233873|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
130890768|NCT02039843|471233874|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
130890769|NCT02039843|471233873|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
130890770|NCT02039843|471233874|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
130890771|NCT02039843|471233873|FG000|Pairing With a Study Dog|Death|1|||
130890772|NCT02039843|471233874|FG001|Pairing With a Study Dog|Death|0|||
130890773|NCT02039843|471233873|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
130890774|NCT02039843|471233874|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
130890775|NCT02039843|471233873|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
130890776|NCT02039843|471233874|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
130890777|NCT02039843|471233873|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
130890778|NCT02039843|471233874|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
130890779|NCT01500720|471233884|FG000|Overall Study|Randomized But Not Treated|1|||
130890780|NCT01500720|471233885|FG001|Overall Study|Randomized But Not Treated|1|||
130890781|NCT01500720|471233884|FG000|Overall Study|Other|4|||
130890782|NCT01500720|471233885|FG001|Overall Study|Other|8|||
130890783|NCT02624986|471233886|FG000|Overall Study|Death|0|||
130890784|NCT02624986|471233887|FG001|Overall Study|Death|1|||
130890785|NCT02624986|471233888|FG002|Overall Study|Death|2|||
130890786|NCT02624986|471233889|FG003|Overall Study|Death|2|||
130890787|NCT02624986|471233890|FG004|Overall Study|Death|2|||
130890788|NCT02624986|471233891|FG005|Overall Study|Death|0|||
130890789|NCT02624986|471233892|FG006|Overall Study|Death|0|||
130890790|NCT02624986|471233893|FG007|Overall Study|Death|1|||
130890791|NCT02624986|471233886|FG000|Overall Study|Study Terminated by Sponsor|1|||
130890792|NCT02624986|471233887|FG001|Overall Study|Study Terminated by Sponsor|1|||
130890793|NCT02624986|471233888|FG002|Overall Study|Study Terminated by Sponsor|0|||
130890794|NCT02624986|471233889|FG003|Overall Study|Study Terminated by Sponsor|1|||
130890795|NCT02624986|471233890|FG004|Overall Study|Study Terminated by Sponsor|2|||
130890796|NCT02624986|471233891|FG005|Overall Study|Study Terminated by Sponsor|2|||
130890797|NCT02624986|471233892|FG006|Overall Study|Study Terminated by Sponsor|4|||
130890798|NCT02624986|471233893|FG007|Overall Study|Study Terminated by Sponsor|3|||
130890799|NCT02624986|471233886|FG000|Overall Study|Progressive Disease|0|||
130890800|NCT02624986|471233887|FG001|Overall Study|Progressive Disease|1|||
130890801|NCT02624986|471233888|FG002|Overall Study|Progressive Disease|0|||
130890802|NCT02624986|471233889|FG003|Overall Study|Progressive Disease|0|||
131109165|NCT00585195|472028871|FG020|Overall Study|Lost to Follow-up|0|||
131109166|NCT00585195|472028851|FG000|Overall Study|Site Terminated by Sponsor|0|||
131109167|NCT00585195|472028852|FG001|Overall Study|Site Terminated by Sponsor|0|||
130686458|NCT04089735|470479545|FG001|Overall Study|Physician Decision|3|||
130890803|NCT02624986|471233890|FG004|Overall Study|Progressive Disease|0|||
130890804|NCT02624986|471233891|FG005|Overall Study|Progressive Disease|0|||
130890805|NCT02624986|471233892|FG006|Overall Study|Progressive Disease|0|||
130890806|NCT02624986|471233893|FG007|Overall Study|Progressive Disease|0|||
131109168|NCT00585195|472028853|FG002|Overall Study|Site Terminated by Sponsor|0|||
131109169|NCT00585195|472028854|FG003|Overall Study|Site Terminated by Sponsor|0|||
130890807|NCT02624986|471233886|FG000|Overall Study|Protocol Violation|1|||
130686459|NCT04089735|470479546|FG002|Overall Study|Physician Decision|0|||
130890808|NCT02624986|471233887|FG001|Overall Study|Protocol Violation|0|||
130890809|NCT02624986|471233888|FG002|Overall Study|Protocol Violation|0|||
130686460|NCT04089735|470479547|FG003|Overall Study|Physician Decision|0|||
130890810|NCT02624986|471233889|FG003|Overall Study|Protocol Violation|0|||
130890811|NCT02624986|471233890|FG004|Overall Study|Protocol Violation|0|||
130890812|NCT02624986|471233891|FG005|Overall Study|Protocol Violation|0|||
130890813|NCT02624986|471233892|FG006|Overall Study|Protocol Violation|0|||
130890814|NCT02624986|471233893|FG007|Overall Study|Protocol Violation|0|||
130890815|NCT02624986|471233886|FG000|Overall Study|Withdrawal by Subject|0|||
130890816|NCT02624986|471233887|FG001|Overall Study|Withdrawal by Subject|0|||
130890817|NCT02624986|471233888|FG002|Overall Study|Withdrawal by Subject|0|||
130890818|NCT02624986|471233889|FG003|Overall Study|Withdrawal by Subject|0|||
130890819|NCT02624986|471233890|FG004|Overall Study|Withdrawal by Subject|0|||
130890820|NCT02624986|471233891|FG005|Overall Study|Withdrawal by Subject|0|||
130890821|NCT02624986|471233892|FG006|Overall Study|Withdrawal by Subject|0|||
130890822|NCT02624986|471233893|FG007|Overall Study|Withdrawal by Subject|1|||
130890823|NCT00740857|471233895|FG000|Overall Study|Withdrawal by Subject|1|||
130890824|NCT00740857|471233896|FG001|Overall Study|Withdrawal by Subject|0|||
130890825|NCT00740857|471233897|FG002|Overall Study|Withdrawal by Subject|0|||
130890826|NCT03532451|471233901|FG000|Overall Study|Withdrawal by Subject|0|||
130890827|NCT03532451|471233902|FG001|Overall Study|Withdrawal by Subject|1|||
130890828|NCT03532451|471233901|FG000|Overall Study|Did not undergo surgery|1|||
130890829|NCT03532451|471233902|FG001|Overall Study|Did not undergo surgery|1|||
130890830|NCT00806819|471233903|FG000|Overall Study|progressive disease (modified RECIST )|217|||
130890831|NCT00806819|471233904|FG001|Overall Study|progressive disease (modified RECIST )|216|||
130890832|NCT00806819|471233903|FG000|Overall Study|Worsening or AE of underlying disease|18|||
130890833|NCT00806819|471233904|FG001|Overall Study|Worsening or AE of underlying disease|25|||
130890834|NCT00806819|471233903|FG000|Overall Study|Other AE|38|||
130890835|NCT00806819|471233904|FG001|Overall Study|Other AE|40|||
130890836|NCT00806819|471233903|FG000|Overall Study|Protocol Violation|9|||
130890837|NCT00806819|471233904|FG001|Overall Study|Protocol Violation|4|||
130890838|NCT00806819|471233903|FG000|Overall Study|Lost to Follow-up|1|||
130890839|NCT00806819|471233904|FG001|Overall Study|Lost to Follow-up|0|||
130890840|NCT00806819|471233903|FG000|Overall Study|Withdrawal by Subject|32|||
130890841|NCT00806819|471233904|FG001|Overall Study|Withdrawal by Subject|29|||
130890842|NCT00806819|471233903|FG000|Overall Study|Not treated|6|||
130890843|NCT00806819|471233904|FG001|Overall Study|Not treated|3|||
130890844|NCT00806819|471233903|FG000|Overall Study|Reasons other than stated above|25|||
130890845|NCT00806819|471233904|FG001|Overall Study|Reasons other than stated above|41|||
130890846|NCT00912197|471233907|FG000|Overall Study|Withdrawal by Subject|3|||
130890847|NCT00912197|471233908|FG001|Overall Study|Withdrawal by Subject|3|||
130890848|NCT01326104|471233917|FG000|Overall Study|progressed prior to vaccine|0|||
130890849|NCT01326104|471233918|FG001|Overall Study|progressed prior to vaccine|2|||
130890850|NCT01326104|471233917|FG000|Overall Study|unable to make vaccine|0|||
130890851|NCT01326104|471233918|FG001|Overall Study|unable to make vaccine|2|||
130890852|NCT01287741|471233919|FG000|Overall Study|Withdrawal by Subject|35|||
130890853|NCT01287741|471233920|FG001|Overall Study|Withdrawal by Subject|38|||
130890854|NCT01287741|471233919|FG000|Overall Study|Protocol Violation|2|||
130890855|NCT01287741|471233920|FG001|Overall Study|Protocol Violation|0|||
130890856|NCT01287741|471233919|FG000|Overall Study|Physician Decision|15|||
130890857|NCT01287741|471233920|FG001|Overall Study|Physician Decision|23|||
130890858|NCT01287741|471233919|FG000|Overall Study|Non-compliance|8|||
130890859|NCT01287741|471233920|FG001|Overall Study|Non-compliance|6|||
130890860|NCT01287741|471233919|FG000|Overall Study|Lost to Follow-up|10|||
130890861|NCT01287741|471233920|FG001|Overall Study|Lost to Follow-up|8|||
130890862|NCT01287741|471233919|FG000|Overall Study|Death|32|||
130890863|NCT01287741|471233920|FG001|Overall Study|Death|44|||
130890864|NCT01287741|471233919|FG000|Overall Study|Adverse Event|4|||
130890865|NCT01287741|471233920|FG001|Overall Study|Adverse Event|6|||
130890866|NCT01287741|471233919|FG000|Overall Study|Study terminated by Sponsor|307|||
130890867|NCT01287741|471233920|FG001|Overall Study|Study terminated by Sponsor|315|||
130890868|NCT01287741|471233919|FG000|Overall Study|Progressive disease|190|||
130890869|NCT01287741|471233920|FG001|Overall Study|Progressive disease|166|||
131023953|NCT02723955|471718579|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023954|NCT02723955|471718580|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023955|NCT02723955|471718581|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023956|NCT02723955|471718582|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023957|NCT02723955|471718583|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023958|NCT02723955|471718584|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023959|NCT02723955|471718585|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023960|NCT02723955|471718586|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023961|NCT02723955|471718587|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023962|NCT02723955|471718588|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
130890870|NCT01287741|471233919|FG000|Overall Study|Reason not specified|23|||
130890871|NCT01287741|471233920|FG001|Overall Study|Reason not specified|9|||
130890872|NCT04421027|471233921|FG000|Treatment Period|Adverse Event|5|||
130890873|NCT04421027|471233922|FG001|Treatment Period|Adverse Event|3|||
130890874|NCT04421027|471233923|FG002|Treatment Period|Adverse Event|0|||
130890875|NCT04421027|471233924|FG003|Treatment Period|Adverse Event|0|||
130890876|NCT04421027|471233921|FG000|Treatment Period|Death|98|||
130890877|NCT04421027|471233922|FG001|Treatment Period|Death|61|||
130890878|NCT04421027|471233923|FG002|Treatment Period|Death|0|||
130890879|NCT04421027|471233924|FG003|Treatment Period|Death|0|||
130890880|NCT04421027|471233921|FG000|Treatment Period|Lost to Follow-up|22|||
130890881|NCT04421027|471233922|FG001|Treatment Period|Lost to Follow-up|20|||
130890882|NCT04421027|471233923|FG002|Treatment Period|Lost to Follow-up|0|||
130890883|NCT04421027|471233924|FG003|Treatment Period|Lost to Follow-up|0|||
130890884|NCT04421027|471233921|FG000|Treatment Period|Other-Unknown|15|||
130890885|NCT04421027|471233922|FG001|Treatment Period|Other-Unknown|9|||
130890886|NCT04421027|471233923|FG002|Treatment Period|Other-Unknown|0|||
130890887|NCT04421027|471233924|FG003|Treatment Period|Other-Unknown|0|||
130890888|NCT04421027|471233921|FG000|Treatment Period|Physician Decision|1|||
130890889|NCT04421027|471233922|FG001|Treatment Period|Physician Decision|1|||
130890890|NCT04421027|471233923|FG002|Treatment Period|Physician Decision|0|||
130890891|NCT04421027|471233924|FG003|Treatment Period|Physician Decision|0|||
130890892|NCT04421027|471233921|FG000|Treatment Period|Withdrawal by Subject|7|||
130890893|NCT04421027|471233922|FG001|Treatment Period|Withdrawal by Subject|12|||
130890894|NCT04421027|471233923|FG002|Treatment Period|Withdrawal by Subject|0|||
130890895|NCT04421027|471233924|FG003|Treatment Period|Withdrawal by Subject|0|||
130890896|NCT04421027|471233921|FG000|Treatment Period|Randomized Not Dosed|9|||
130890897|NCT04421027|471233922|FG001|Treatment Period|Randomized Not Dosed|14|||
130890898|NCT04421027|471233923|FG002|Treatment Period|Randomized Not Dosed|0|||
130890899|NCT04421027|471233924|FG003|Treatment Period|Randomized Not Dosed|0|||
130890900|NCT04421027|471233921|FG000|Follow-Up Period|Adverse Event|0|||
130890901|NCT04421027|471233922|FG001|Follow-Up Period|Adverse Event|0|||
130890902|NCT04421027|471233923|FG002|Follow-Up Period|Adverse Event|0|||
130890903|NCT04421027|471233924|FG003|Follow-Up Period|Adverse Event|3|||
130890904|NCT04421027|471233921|FG000|Follow-Up Period|Death|0|||
130890905|NCT04421027|471233922|FG001|Follow-Up Period|Death|0|||
130890906|NCT04421027|471233923|FG002|Follow-Up Period|Death|16|||
130890907|NCT04421027|471233924|FG003|Follow-Up Period|Death|17|||
130890908|NCT04421027|471233921|FG000|Follow-Up Period|Lost to Follow-up|0|||
130890909|NCT04421027|471233922|FG001|Follow-Up Period|Lost to Follow-up|0|||
130890910|NCT04421027|471233923|FG002|Follow-Up Period|Lost to Follow-up|7|||
130890911|NCT04421027|471233924|FG003|Follow-Up Period|Lost to Follow-up|7|||
130890912|NCT04421027|471233921|FG000|Follow-Up Period|Protocol Deviation|0|||
130890913|NCT04421027|471233922|FG001|Follow-Up Period|Protocol Deviation|0|||
130890914|NCT04421027|471233923|FG002|Follow-Up Period|Protocol Deviation|1|||
130890915|NCT04421027|471233924|FG003|Follow-Up Period|Protocol Deviation|0|||
130890916|NCT04421027|471233921|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
130890917|NCT04421027|471233922|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
130890918|NCT04421027|471233923|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
130890919|NCT04421027|471233924|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
130890920|NCT04421027|471233921|FG000|Follow-Up Period|Left message, participant did not call back|0|||
130890921|NCT04421027|471233922|FG001|Follow-Up Period|Left message, participant did not call back|0|||
130890922|NCT04421027|471233923|FG002|Follow-Up Period|Left message, participant did not call back|0|||
130890923|NCT04421027|471233924|FG003|Follow-Up Period|Left message, participant did not call back|1|||
130890924|NCT04421027|471233921|FG000|Follow-Up Period|Participant died|0|||
130890925|NCT04421027|471233922|FG001|Follow-Up Period|Participant died|0|||
130890926|NCT04421027|471233923|FG002|Follow-Up Period|Participant died|0|||
130890927|NCT04421027|471233924|FG003|Follow-Up Period|Participant died|1|||
130890928|NCT04421027|471233921|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
130890929|NCT04421027|471233922|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
130890930|NCT04421027|471233923|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
130890931|NCT04421027|471233924|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
130890932|NCT02930018|471233934|FG000|Overall Study|Lost to Follow-up|1|||
130890933|NCT02930018|471233935|FG001|Overall Study|Lost to Follow-up|1|||
130890934|NCT02930018|471233934|FG000|Overall Study|Withdrawal by Subject|5|||
130890935|NCT02930018|471233935|FG001|Overall Study|Withdrawal by Subject|2|||
130890936|NCT03892967|471233936|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
130890937|NCT03892967|471233937|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
130890938|NCT03892967|471233938|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
130890939|NCT03892967|471233939|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
130890940|NCT03892967|471233940|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
130890941|NCT03892967|471233936|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
131109170|NCT00585195|472028855|FG004|Overall Study|Site Terminated by Sponsor|0|||
131109171|NCT00585195|472028856|FG005|Overall Study|Site Terminated by Sponsor|0|||
131109172|NCT00585195|472028857|FG006|Overall Study|Site Terminated by Sponsor|0|||
130890942|NCT03892967|471233937|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
130890943|NCT03892967|471233938|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
130890944|NCT03892967|471233939|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
130890945|NCT03892967|471233940|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
130890946|NCT03892967|471233936|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
130890947|NCT03892967|471233937|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
130890948|NCT03892967|471233938|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
130890949|NCT03892967|471233939|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
130890950|NCT03892967|471233940|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
130890951|NCT03892967|471233936|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
130890952|NCT03892967|471233937|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
130890953|NCT03892967|471233938|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
130890954|NCT03892967|471233939|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
130890955|NCT03892967|471233940|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
130890956|NCT03892967|471233936|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
130890957|NCT03892967|471233937|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
130890958|NCT03892967|471233938|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
130890959|NCT03892967|471233939|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
130890960|NCT03892967|471233940|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
130890961|NCT03892967|471233936|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
130890962|NCT03892967|471233937|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
130890963|NCT03892967|471233938|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
130890964|NCT03892967|471233939|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
130890965|NCT03892967|471233940|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
131023963|NCT02723955|471718589|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023964|NCT02723955|471718590|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023965|NCT02723955|471718591|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023966|NCT02723955|471718592|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023967|NCT02723955|471718593|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023968|NCT02723955|471718594|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023969|NCT02723955|471718595|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023970|NCT02723955|471718596|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023971|NCT02723955|471718597|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023972|NCT02723955|471718598|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023973|NCT02723955|471718599|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023974|NCT02723955|471718600|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
131023975|NCT02723955|471718601|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023976|NCT02723955|471718602|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023977|NCT02723955|471718603|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
131023978|NCT02723955|471718561|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023979|NCT02723955|471718562|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023980|NCT02723955|471718563|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023981|NCT02723955|471718564|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023982|NCT02723955|471718565|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023983|NCT02723955|471718566|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023984|NCT02723955|471718567|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023985|NCT02723955|471718568|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023986|NCT02723955|471718569|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023987|NCT02723955|471718570|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023988|NCT02723955|471718571|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023989|NCT02723955|471718572|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023990|NCT02723955|471718573|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023991|NCT02723955|471718574|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023992|NCT02723955|471718575|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023993|NCT02723955|471718576|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023994|NCT02723955|471718577|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023995|NCT02723955|471718578|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023996|NCT02723955|471718579|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
130890966|NCT00114517|471233944|FG000|Overall Study|Adverse Event|6|||
130890967|NCT00114517|471233945|FG001|Overall Study|Adverse Event|1|||
130890968|NCT00114517|471233946|FG002|Overall Study|Adverse Event|6|||
130890969|NCT00114517|471233947|FG003|Overall Study|Adverse Event|3|||
130890970|NCT00114517|471233944|FG000|Overall Study|Lost to Follow-up|2|||
130890971|NCT00114517|471233945|FG001|Overall Study|Lost to Follow-up|2|||
130890972|NCT00114517|471233946|FG002|Overall Study|Lost to Follow-up|2|||
130890973|NCT00114517|471233947|FG003|Overall Study|Lost to Follow-up|1|||
130890974|NCT00114517|471233944|FG000|Overall Study|Too busy|3|||
130890975|NCT00114517|471233945|FG001|Overall Study|Too busy|1|||
130890976|NCT00114517|471233946|FG002|Overall Study|Too busy|1|||
130890977|NCT00114517|471233947|FG003|Overall Study|Too busy|2|||
130890978|NCT00114517|471233944|FG000|Overall Study|Moved from area|0|||
130890979|NCT00114517|471233945|FG001|Overall Study|Moved from area|3|||
130890980|NCT00114517|471233946|FG002|Overall Study|Moved from area|2|||
130890981|NCT00114517|471233947|FG003|Overall Study|Moved from area|1|||
130890982|NCT00114517|471233944|FG000|Overall Study|Did not want estradiol|1|||
130890983|NCT00114517|471233945|FG001|Overall Study|Did not want estradiol|1|||
130890984|NCT00114517|471233946|FG002|Overall Study|Did not want estradiol|0|||
130890985|NCT00114517|471233947|FG003|Overall Study|Did not want estradiol|0|||
130890986|NCT00114517|471233944|FG000|Overall Study|Armed-services duty|0|||
130890987|NCT00114517|471233945|FG001|Overall Study|Armed-services duty|1|||
130890988|NCT00114517|471233946|FG002|Overall Study|Armed-services duty|0|||
130890989|NCT00114517|471233947|FG003|Overall Study|Armed-services duty|1|||
130890990|NCT00114517|471233944|FG000|Overall Study|Competing family issue|0|||
130890991|NCT00114517|471233945|FG001|Overall Study|Competing family issue|1|||
130890992|NCT00114517|471233946|FG002|Overall Study|Competing family issue|0|||
130890993|NCT00114517|471233947|FG003|Overall Study|Competing family issue|1|||
130890994|NCT00114517|471233944|FG000|Overall Study|Physician Decision|0|||
130890995|NCT00114517|471233945|FG001|Overall Study|Physician Decision|1|||
130890996|NCT00114517|471233946|FG002|Overall Study|Physician Decision|0|||
130890997|NCT00114517|471233947|FG003|Overall Study|Physician Decision|0|||
130890998|NCT00114517|471233944|FG000|Overall Study|Lost interest|0|||
130890999|NCT00114517|471233945|FG001|Overall Study|Lost interest|0|||
130891000|NCT00114517|471233946|FG002|Overall Study|Lost interest|1|||
130891001|NCT00114517|471233947|FG003|Overall Study|Lost interest|0|||
130891002|NCT00114517|471233944|FG000|Overall Study|Weight increase|0|||
130891003|NCT00114517|471233945|FG001|Overall Study|Weight increase|0|||
130891004|NCT00114517|471233946|FG002|Overall Study|Weight increase|1|||
130891005|NCT00114517|471233947|FG003|Overall Study|Weight increase|0|||
130891006|NCT00114517|471233944|FG000|Overall Study|Concern about blood clots|0|||
130891007|NCT00114517|471233945|FG001|Overall Study|Concern about blood clots|0|||
130891008|NCT00114517|471233946|FG002|Overall Study|Concern about blood clots|1|||
130891009|NCT00114517|471233947|FG003|Overall Study|Concern about blood clots|0|||
130891010|NCT00114517|471233944|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
130891011|NCT00114517|471233945|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
130891012|NCT00114517|471233946|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
130891013|NCT00114517|471233947|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
130891014|NCT01027273|471235318|FG000|Overall Study|Lost to Follow-up|57|||
130891015|NCT01027273|471235319|FG001|Overall Study|Lost to Follow-up|31|||
130891016|NCT01027273|471235318|FG000|Overall Study|Death|2|||
130891017|NCT01027273|471235319|FG001|Overall Study|Death|2|||
130891018|NCT03656562|471235321|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
130686461|NCT04089735|470479548|FG004|Overall Study|Physician Decision|0|||
130686462|NCT04089735|470479549|FG005|Overall Study|Physician Decision|0|||
130686463|NCT04089735|470479544|FG000|Overall Study|Withdrawal by Subject|0|||
130686464|NCT04089735|470479545|FG001|Overall Study|Withdrawal by Subject|0|||
130686465|NCT04089735|470479546|FG002|Overall Study|Withdrawal by Subject|1|||
130686466|NCT04089735|470479547|FG003|Overall Study|Withdrawal by Subject|0|||
130686467|NCT04089735|470479548|FG004|Overall Study|Withdrawal by Subject|0|||
130891019|NCT03656562|471235322|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
130891020|NCT03656562|471235323|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
130891021|NCT03656562|471235324|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
130891022|NCT03656562|471235321|FG000|Overall Study|Physician Decision|1|||
130891023|NCT03656562|471235322|FG001|Overall Study|Physician Decision|2|||
130891024|NCT03656562|471235323|FG002|Overall Study|Physician Decision|0|||
130891025|NCT03656562|471235324|FG003|Overall Study|Physician Decision|0|||
130686468|NCT04089735|470479549|FG005|Overall Study|Withdrawal by Subject|0|||
130686469|NCT04089735|470479544|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
130891026|NCT03656562|471235321|FG000|Overall Study|Subject Decision|3|||
130891027|NCT03656562|471235322|FG001|Overall Study|Subject Decision|5|||
130891028|NCT03656562|471235323|FG002|Overall Study|Subject Decision|0|||
130891029|NCT03656562|471235324|FG003|Overall Study|Subject Decision|2|||
130891030|NCT00337675|471235325|FG000|Overall Study|Adverse Event|10|||
130891031|NCT00337675|471235326|FG001|Overall Study|Adverse Event|9|||
130891032|NCT00337675|471235327|FG002|Overall Study|Adverse Event|19|||
130891033|NCT00337675|471235325|FG000|Overall Study|Lack of Efficacy|10|||
130686470|NCT04089735|470479545|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
130686471|NCT04089735|470479546|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
130686472|NCT04089735|470479547|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
130686473|NCT04089735|470479548|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
130686474|NCT04089735|470479549|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
130686475|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
130686476|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
131109173|NCT00585195|472028858|FG007|Overall Study|Site Terminated by Sponsor|0|||
131109174|NCT00585195|472028859|FG008|Overall Study|Site Terminated by Sponsor|0|||
131109175|NCT00585195|472028860|FG009|Overall Study|Site Terminated by Sponsor|0|||
131109176|NCT00585195|472028861|FG010|Overall Study|Site Terminated by Sponsor|0|||
131109177|NCT00585195|472028862|FG011|Overall Study|Site Terminated by Sponsor|0|||
131109178|NCT00585195|472028863|FG012|Overall Study|Site Terminated by Sponsor|1|||
131109179|NCT00585195|472028864|FG013|Overall Study|Site Terminated by Sponsor|0|||
131109180|NCT00585195|472028865|FG014|Overall Study|Site Terminated by Sponsor|0|||
131109181|NCT00585195|472028866|FG015|Overall Study|Site Terminated by Sponsor|0|||
131109182|NCT00585195|472028867|FG016|Overall Study|Site Terminated by Sponsor|0|||
131109183|NCT00585195|472028868|FG017|Overall Study|Site Terminated by Sponsor|0|||
131109184|NCT00585195|472028869|FG018|Overall Study|Site Terminated by Sponsor|0|||
131109185|NCT00585195|472028870|FG019|Overall Study|Site Terminated by Sponsor|0|||
131109186|NCT00585195|472028871|FG020|Overall Study|Site Terminated by Sponsor|0|||
131109187|NCT00585195|472028851|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
131109188|NCT00585195|472028852|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
131109189|NCT00585195|472028853|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
131109190|NCT00585195|472028854|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
131109191|NCT00585195|472028855|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
131109192|NCT00585195|472028856|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
131109193|NCT00585195|472028857|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
131109194|NCT00585195|472028858|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
131109195|NCT00585195|472028859|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
131109196|NCT00585195|472028860|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
131109197|NCT00585195|472028861|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
131109198|NCT00585195|472028862|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
131109199|NCT00585195|472028863|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
131109200|NCT00585195|472028864|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
131109201|NCT00585195|472028865|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
131109202|NCT00585195|472028866|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
131109203|NCT00585195|472028867|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
131109204|NCT00585195|472028868|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
131109205|NCT00585195|472028869|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
131109206|NCT00585195|472028870|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
131109207|NCT00585195|472028871|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
131109208|NCT00423930|472028873|FG000|Overall Study|Withdrawal by Subject|2|||
131109209|NCT04002401|472028874|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
131109210|NCT04002401|472028874|FG000|Overall Study|Death|10|||
131109211|NCT04002401|472028874|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
131109212|NCT04002401|472028874|FG000|Overall Study|Enrolled but Never Treated|1|||
131109213|NCT04002401|472028874|FG000|Overall Study|Lost to Follow-up|1|||
131109214|NCT02656823|472028875|FG000|Overall Study|Adverse Event|3|||
131109215|NCT02656823|472028875|FG000|Overall Study|Lost to Follow-up|2|||
131109216|NCT01009580|472028880|FG000|Overall Study|Adverse Event|4|||
131109217|NCT01009580|472028881|FG001|Overall Study|Adverse Event|4|||
131109218|NCT01009580|472028880|FG000|Overall Study|Lack of Efficacy|0|||
130686477|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Death|2|||
130686478|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Death|1|||
130686479|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
130686480|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
130686481|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
130686482|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
130686483|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Other|8|||
131109219|NCT01009580|472028881|FG001|Overall Study|Lack of Efficacy|1|||
131109220|NCT01009580|472028880|FG000|Overall Study|Protocol Violation|2|||
131109221|NCT01009580|472028881|FG001|Overall Study|Protocol Violation|3|||
131109222|NCT01009580|472028880|FG000|Overall Study|Withdrawal Criteria|4|||
131109223|NCT01009580|472028881|FG001|Overall Study|Withdrawal Criteria|6|||
131222658|NCT01270841|472443129|FG000|Overall Study|Enrolled in error|0|||
131109224|NCT01009580|472028880|FG000|Overall Study|Unclassified|17|||
131109225|NCT01009580|472028881|FG001|Overall Study|Unclassified|21|||
131109226|NCT05269355|472028885|FG000|Overall Study|Progressive Disease|104|||
131109227|NCT05269355|472028886|FG001|Overall Study|Progressive Disease|68|||
131109228|NCT05269355|472028885|FG000|Overall Study|Study Terminated by Sponsor|87|||
131109229|NCT05269355|472028886|FG001|Overall Study|Study Terminated by Sponsor|29|||
130891034|NCT00337675|471235326|FG001|Overall Study|Lack of Efficacy|7|||
130891035|NCT00337675|471235327|FG002|Overall Study|Lack of Efficacy|9|||
130891036|NCT00337675|471235325|FG000|Overall Study|Lost to Follow-up|22|||
130891037|NCT00337675|471235326|FG001|Overall Study|Lost to Follow-up|19|||
130891038|NCT00337675|471235327|FG002|Overall Study|Lost to Follow-up|17|||
130891039|NCT00337675|471235325|FG000|Overall Study|Physician Decision|9|||
130891040|NCT00337675|471235326|FG001|Overall Study|Physician Decision|17|||
130891041|NCT00337675|471235327|FG002|Overall Study|Physician Decision|14|||
130891042|NCT00337675|471235325|FG000|Overall Study|Protocol Violation|21|||
130891043|NCT00337675|471235326|FG001|Overall Study|Protocol Violation|24|||
130891044|NCT00337675|471235327|FG002|Overall Study|Protocol Violation|19|||
130891045|NCT00337675|471235325|FG000|Overall Study|Withdrawal by Subject|25|||
130891046|NCT00337675|471235326|FG001|Overall Study|Withdrawal by Subject|25|||
130891047|NCT00337675|471235327|FG002|Overall Study|Withdrawal by Subject|19|||
130891048|NCT00337675|471235325|FG000|Overall Study|Progressive Disease|0|||
130891049|NCT00337675|471235326|FG001|Overall Study|Progressive Disease|2|||
130891050|NCT00337675|471235327|FG002|Overall Study|Progressive Disease|0|||
130891051|NCT00337675|471235325|FG000|Overall Study|Trial Terminated|0|||
130891052|NCT00337675|471235326|FG001|Overall Study|Trial Terminated|0|||
130891053|NCT00337675|471235327|FG002|Overall Study|Trial Terminated|2|||
130891054|NCT04269265|471235328|FG000|Overall Study|Physician Decision|1|||
130891055|NCT04269265|471235328|FG000|Overall Study|Withdrawal by Subject|1|||
130891056|NCT04269265|471235328|FG000|Overall Study|Overenrolled (sample size reached)|4|||
130891057|NCT04838626|471235329|FG000|Overall Study|Adverse Event|2|||
130891058|NCT04838626|471235329|FG000|Overall Study|Physician Decision|6|||
130891059|NCT04838626|471235329|FG000|Overall Study|Protocol Violation|3|||
130891060|NCT04838626|471235329|FG000|Overall Study|Withdrawal by Subject|9|||
130891061|NCT04838626|471235329|FG000|Overall Study|Technical Problems|2|||
130891062|NCT02867384|471235330|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
130891063|NCT02867384|471235331|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
130891064|NCT02867384|471235332|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
130891065|NCT02867384|471235330|FG000|Overall Study|Progression/ Relapse|15|||
130891066|NCT02867384|471235331|FG001|Overall Study|Progression/ Relapse|19|||
130891067|NCT02867384|471235332|FG002|Overall Study|Progression/ Relapse|0|||
130891068|NCT02867384|471235330|FG000|Overall Study|Adverse Event|13|||
130891069|NCT02867384|471235331|FG001|Overall Study|Adverse Event|1|||
130891070|NCT02867384|471235332|FG002|Overall Study|Adverse Event|0|||
130891071|NCT02867384|471235330|FG000|Overall Study|Withdrawal by Subject|6|||
130891072|NCT02867384|471235331|FG001|Overall Study|Withdrawal by Subject|5|||
130891073|NCT02867384|471235332|FG002|Overall Study|Withdrawal by Subject|0|||
130891074|NCT02867384|471235330|FG000|Overall Study|Physician Decision|1|||
130891075|NCT02867384|471235331|FG001|Overall Study|Physician Decision|2|||
130891076|NCT02867384|471235332|FG002|Overall Study|Physician Decision|0|||
130891077|NCT02867384|471235330|FG000|Overall Study|Patient compliance|1|||
130891078|NCT02867384|471235331|FG001|Overall Study|Patient compliance|0|||
130891079|NCT02867384|471235332|FG002|Overall Study|Patient compliance|0|||
130891080|NCT02867384|471235330|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
130891081|NCT02867384|471235331|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
130891082|NCT02867384|471235332|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
130891083|NCT02867384|471235330|FG000|Overall Study|Never start treatment|3|||
130891084|NCT02867384|471235331|FG001|Overall Study|Never start treatment|0|||
130891085|NCT02867384|471235332|FG002|Overall Study|Never start treatment|0|||
131109230|NCT05269355|472028885|FG000|Overall Study|Adverse Event|15|||
131109231|NCT05269355|472028886|FG001|Overall Study|Adverse Event|8|||
131109232|NCT05269355|472028885|FG000|Overall Study|Withdrawal by Subject|18|||
130891086|NCT03901469|471235336|FG000|Overall Study|Radiographic Progression|4|||
130891087|NCT03901469|471235337|FG001|Overall Study|Radiographic Progression|6|||
130891088|NCT03901469|471235338|FG002|Overall Study|Radiographic Progression|3|||
130891089|NCT03901469|471235339|FG003|Overall Study|Radiographic Progression|30|||
130891090|NCT03901469|471235340|FG004|Overall Study|Radiographic Progression|7|||
130891091|NCT03901469|471235341|FG005|Overall Study|Radiographic Progression|2|||
130891092|NCT03901469|471235342|FG006|Overall Study|Radiographic Progression|11|||
130891093|NCT03901469|471235336|FG000|Overall Study|Clinical Progression|0|||
130891094|NCT03901469|471235337|FG001|Overall Study|Clinical Progression|2|||
130891095|NCT03901469|471235338|FG002|Overall Study|Clinical Progression|0|||
130891096|NCT03901469|471235339|FG003|Overall Study|Clinical Progression|7|||
130891097|NCT03901469|471235340|FG004|Overall Study|Clinical Progression|6|||
130891098|NCT03901469|471235341|FG005|Overall Study|Clinical Progression|0|||
131109233|NCT05269355|472028886|FG001|Overall Study|Withdrawal by Subject|5|||
131109234|NCT05269355|472028885|FG000|Overall Study|Physician Decision|6|||
131109235|NCT05269355|472028886|FG001|Overall Study|Physician Decision|4|||
130891099|NCT03901469|471235342|FG006|Overall Study|Clinical Progression|2|||
130891100|NCT03901469|471235336|FG000|Overall Study|Adverse Event|1|||
131109236|NCT05269355|472028885|FG000|Overall Study|Death|3|||
130891101|NCT03901469|471235337|FG001|Overall Study|Adverse Event|0|||
130891102|NCT03901469|471235338|FG002|Overall Study|Adverse Event|0|||
131109237|NCT05269355|472028886|FG001|Overall Study|Death|5|||
130891103|NCT03901469|471235339|FG003|Overall Study|Adverse Event|0|||
130891104|NCT03901469|471235340|FG004|Overall Study|Adverse Event|0|||
130891105|NCT03901469|471235341|FG005|Overall Study|Adverse Event|0|||
130891106|NCT03901469|471235342|FG006|Overall Study|Adverse Event|9|||
130891107|NCT03901469|471235336|FG000|Overall Study|Physician Decision|0|||
130891108|NCT03901469|471235337|FG001|Overall Study|Physician Decision|0|||
130891109|NCT03901469|471235338|FG002|Overall Study|Physician Decision|0|||
130891110|NCT03901469|471235339|FG003|Overall Study|Physician Decision|1|||
130891111|NCT03901469|471235340|FG004|Overall Study|Physician Decision|0|||
130891112|NCT03901469|471235341|FG005|Overall Study|Physician Decision|0|||
130891113|NCT03901469|471235342|FG006|Overall Study|Physician Decision|0|||
130891114|NCT03901469|471235336|FG000|Overall Study|Withdrawal by Subject|0|||
130891115|NCT03901469|471235337|FG001|Overall Study|Withdrawal by Subject|0|||
130891116|NCT03901469|471235338|FG002|Overall Study|Withdrawal by Subject|0|||
130891117|NCT03901469|471235339|FG003|Overall Study|Withdrawal by Subject|0|||
130891118|NCT03901469|471235340|FG004|Overall Study|Withdrawal by Subject|2|||
130891119|NCT03901469|471235341|FG005|Overall Study|Withdrawal by Subject|0|||
130891120|NCT03901469|471235342|FG006|Overall Study|Withdrawal by Subject|8|||
130891121|NCT03901469|471235336|FG000|Overall Study|Death|0|||
130891122|NCT03901469|471235337|FG001|Overall Study|Death|0|||
130891123|NCT03901469|471235338|FG002|Overall Study|Death|0|||
130891124|NCT03901469|471235339|FG003|Overall Study|Death|3|||
130891125|NCT03901469|471235340|FG004|Overall Study|Death|5|||
130891126|NCT03901469|471235341|FG005|Overall Study|Death|0|||
130891127|NCT03901469|471235342|FG006|Overall Study|Death|1|||
131109238|NCT05269355|472028885|FG000|Overall Study|Other Than Specified|5|||
131109239|NCT05269355|472028886|FG001|Overall Study|Other Than Specified|1|||
130891128|NCT03901469|471235336|FG000|Overall Study|Termination of study by sponsor|0|||
131109240|NCT05269355|472028885|FG000|Overall Study|Randomized But Not Treated|1|||
131109241|NCT05269355|472028886|FG001|Overall Study|Randomized But Not Treated|0|||
131109242|NCT00081497|472028887|FG000|Overall Study|Adverse Event|2|||
131109243|NCT00081497|472028888|FG001|Overall Study|Adverse Event|0|||
131109244|NCT00081497|472028887|FG000|Overall Study|Death|0|||
131109245|NCT00081497|472028888|FG001|Overall Study|Death|1|||
131109246|NCT00081497|472028887|FG000|Overall Study|Withdrawal by Subject|1|||
131109247|NCT00081497|472028888|FG001|Overall Study|Withdrawal by Subject|0|||
131109248|NCT00081497|472028887|FG000|Overall Study|Non-compliance|0|||
131109249|NCT00081497|472028888|FG001|Overall Study|Non-compliance|1|||
131109250|NCT00959647|472028890|FG000|Overall Study|Adverse Event|2|||
131109251|NCT00959647|472028890|FG000|Overall Study|Progressive disease|6|||
131109252|NCT00959647|472028890|FG000|Overall Study|Study terminated by sponsor|4|||
131109253|NCT00959647|472028890|FG000|Overall Study|Withdrawal by Subject|7|||
131109254|NCT01340196|472030812|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
131109255|NCT00171704|472030815|FG000|Overall Study|Adverse Event|24|||
131109256|NCT00171704|472030816|FG001|Overall Study|Adverse Event|33|||
131109257|NCT00171704|472030815|FG000|Overall Study|Disease Progression|14|||
131109258|NCT00171704|472030816|FG001|Overall Study|Disease Progression|9|||
131109259|NCT00171704|472030815|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
131109260|NCT00171704|472030816|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
131109261|NCT00171704|472030815|FG000|Overall Study|Administrative Problems|2|||
131109262|NCT00171704|472030816|FG001|Overall Study|Administrative Problems|1|||
131109263|NCT00171704|472030815|FG000|Overall Study|Death|2|||
131109264|NCT00171704|472030816|FG001|Overall Study|Death|2|||
131109265|NCT00171704|472030815|FG000|Overall Study|Withdrawal by Subject|1|||
131109266|NCT00171704|472030816|FG001|Overall Study|Withdrawal by Subject|3|||
131109267|NCT00171704|472030815|FG000|Overall Study|Protocol Violation|0|||
131109268|NCT00171704|472030816|FG001|Overall Study|Protocol Violation|1|||
131109269|NCT02141984|472030817|FG000|Overall Study|Lack of Efficacy|2|||
131109270|NCT00816400|472030821|FG000|Overall Study|Death|2|||
131109271|NCT00816400|472030822|FG001|Overall Study|Death|3|||
131109272|NCT00816400|472030823|FG002|Overall Study|Death|3|||
130891129|NCT03901469|471235337|FG001|Overall Study|Termination of study by sponsor|0|||
131109273|NCT00816400|472030824|FG003|Overall Study|Death|3|||
131109274|NCT00816400|472030825|FG004|Overall Study|Death|2|||
131109275|NCT00816400|472030826|FG005|Overall Study|Death|3|||
130891130|NCT03901469|471235338|FG002|Overall Study|Termination of study by sponsor|0|||
130891131|NCT03901469|471235339|FG003|Overall Study|Termination of study by sponsor|0|||
130891132|NCT03901469|471235340|FG004|Overall Study|Termination of study by sponsor|1|||
130891133|NCT03901469|471235341|FG005|Overall Study|Termination of study by sponsor|1|||
130891134|NCT03901469|471235342|FG006|Overall Study|Termination of study by sponsor|0|||
131109276|NCT00816400|472030827|FG006|Overall Study|Death|2|||
131109277|NCT00816400|472030828|FG007|Overall Study|Death|5|||
131109278|NCT00816400|472030829|FG008|Overall Study|Death|6|||
130891135|NCT03901469|471235336|FG000|Overall Study|Not Reported|1|||
131109279|NCT00816400|472030821|FG000|Overall Study|In hospice care at the end of the study|0|||
131109280|NCT00816400|472030822|FG001|Overall Study|In hospice care at the end of the study|0|||
130891136|NCT03901469|471235337|FG001|Overall Study|Not Reported|0|||
130891137|NCT03901469|471235338|FG002|Overall Study|Not Reported|0|||
131109281|NCT00816400|472030823|FG002|Overall Study|In hospice care at the end of the study|2|||
130686484|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Other|13|||
130686485|NCT01439880|470479550|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
130686486|NCT01439880|470479551|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
130686487|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
130686488|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
130686489|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
130686490|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
131023997|NCT02723955|471718580|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023998|NCT02723955|471718581|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
131023999|NCT02723955|471718582|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024000|NCT02723955|471718583|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024001|NCT02723955|471718584|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024002|NCT02723955|471718585|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024003|NCT02723955|471718586|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024004|NCT02723955|471718587|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024005|NCT02723955|471718588|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024006|NCT02723955|471718589|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024007|NCT02723955|471718590|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024008|NCT02723955|471718591|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024009|NCT02723955|471718592|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024010|NCT02723955|471718593|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024011|NCT02723955|471718594|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024012|NCT02723955|471718595|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024013|NCT02723955|471718596|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024014|NCT02723955|471718597|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024015|NCT02723955|471718598|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024016|NCT02723955|471718599|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
131024017|NCT02723955|471718600|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
131024018|NCT02723955|471718601|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024019|NCT02723955|471718602|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
131024020|NCT02723955|471718603|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
131024021|NCT02723955|471718561|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
131024022|NCT02723955|471718562|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
131024023|NCT02723955|471718563|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
131024024|NCT02723955|471718564|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
131024025|NCT02723955|471718565|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
131024026|NCT02723955|471718566|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
131024027|NCT02723955|471718567|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
131024028|NCT02723955|471718568|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
131024029|NCT02723955|471718569|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
131024030|NCT02723955|471718570|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
131024031|NCT02723955|471718571|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
131024032|NCT02723955|471718572|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
131024033|NCT02723955|471718573|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
131024034|NCT02723955|471718574|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
131024035|NCT02723955|471718575|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
131024036|NCT02723955|471718576|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
131024037|NCT02723955|471718577|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
131024038|NCT02723955|471718578|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
131024039|NCT02723955|471718579|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
131024040|NCT02723955|471718580|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
131024041|NCT02723955|471718581|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
131024042|NCT02723955|471718582|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
131024043|NCT02723955|471718583|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
131024044|NCT02723955|471718584|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
131024045|NCT02723955|471718585|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
131024046|NCT02723955|471718586|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
131024047|NCT02723955|471718587|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
131024048|NCT02723955|471718588|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
131024049|NCT02723955|471718589|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
131024050|NCT02723955|471718590|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
131024051|NCT02723955|471718591|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
131024052|NCT02723955|471718592|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
130891138|NCT03901469|471235339|FG003|Overall Study|Not Reported|1|||
131024053|NCT02723955|471718593|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
131024054|NCT02723955|471718594|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
131024055|NCT02723955|471718595|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
131024056|NCT02723955|471718596|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
131024057|NCT02723955|471718597|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
131024058|NCT02723955|471718598|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
131024059|NCT02723955|471718599|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
131109282|NCT00816400|472030824|FG003|Overall Study|In hospice care at the end of the study|0|||
131024060|NCT02723955|471718600|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
131024061|NCT02723955|471718601|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
131024062|NCT02723955|471718602|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
131024063|NCT02723955|471718603|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
131024064|NCT03346538|471718607|FG000|Overall Study|Physician Decision|0|||
131024065|NCT03346538|471718608|FG001|Overall Study|Physician Decision|1|||
131024066|NCT03346538|471718609|FG002|Overall Study|Physician Decision|0|||
131024067|NCT03346538|471718607|FG000|Overall Study|Withdrawal by Subject|3|||
131024068|NCT03346538|471718608|FG001|Overall Study|Withdrawal by Subject|2|||
131024069|NCT03346538|471718609|FG002|Overall Study|Withdrawal by Subject|0|||
131024070|NCT03346538|471718607|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
131024071|NCT03346538|471718608|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
131024072|NCT03346538|471718609|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
131024073|NCT02824029|471718611|FG000|Overall Study|Didn't receive treatment|2|||
131024074|NCT02824029|471718611|FG000|Overall Study|Patient decision to discontinue treatment|3|||
131024075|NCT02824029|471718611|FG000|Overall Study|Non-compliant|5|||
131024076|NCT02824029|471718611|FG000|Overall Study|Progression of disease|15|||
131024077|NCT02824029|471718611|FG000|Overall Study|Inadequate response to therapy|2|||
131024078|NCT02824029|471718611|FG000|Overall Study|Possible progression per treating physician|1|||
131024079|NCT04524390|471718612|FG000|Double Blind|Consent Withdrawal by subject|2|||
131024080|NCT04524390|471718613|FG001|Double Blind|Consent Withdrawal by subject|1|||
131024081|NCT04524390|471718614|FG002|Double Blind|Consent Withdrawal by subject|0|||
131024082|NCT04524390|471718612|FG000|Double Blind|Adverse Event|5|||
131024083|NCT04524390|471718613|FG001|Double Blind|Adverse Event|3|||
131024084|NCT04524390|471718614|FG002|Double Blind|Adverse Event|0|||
131024085|NCT04524390|471718612|FG000|Double Blind|Liver Transplant|5|||
131024086|NCT04524390|471718613|FG001|Double Blind|Liver Transplant|6|||
131024087|NCT04524390|471718614|FG002|Double Blind|Liver Transplant|0|||
131024088|NCT04524390|471718612|FG000|Double Blind|Disease Progression|0|||
131024089|NCT04524390|471718613|FG001|Double Blind|Disease Progression|1|||
131024090|NCT04524390|471718614|FG002|Double Blind|Disease Progression|0|||
131024091|NCT04524390|471718612|FG000|Open-Label|Drug interruption criteria|0|||
131024092|NCT04524390|471718613|FG001|Open-Label|Drug interruption criteria|0|||
131024093|NCT04524390|471718614|FG002|Open-Label|Drug interruption criteria|1|||
131024094|NCT04524390|471718612|FG000|Open-Label|Liver Transplant|0|||
131024095|NCT04524390|471718613|FG001|Open-Label|Liver Transplant|0|||
131024096|NCT04524390|471718614|FG002|Open-Label|Liver Transplant|1|||
131024097|NCT04524390|471718612|FG000|Open-Label|Disease Progression|0|||
131024098|NCT04524390|471718613|FG001|Open-Label|Disease Progression|0|||
131024099|NCT04524390|471718614|FG002|Open-Label|Disease Progression|1|||
131024100|NCT04524390|471718612|FG000|Open-Label|Adverse Event|0|||
131024101|NCT04524390|471718613|FG001|Open-Label|Adverse Event|0|||
131024102|NCT04524390|471718614|FG002|Open-Label|Adverse Event|3|||
131024103|NCT04524390|471718612|FG000|Open-Label|Study Termination by sponsor|0|||
131024104|NCT04524390|471718613|FG001|Open-Label|Study Termination by sponsor|0|||
131024105|NCT04524390|471718614|FG002|Open-Label|Study Termination by sponsor|45|||
131024106|NCT02101281|471718620|FG000|Overall Study|Adverse Event|0|||
131024107|NCT02101281|471718621|FG001|Overall Study|Adverse Event|1|||
131024108|NCT00174382|471718622|FG000|Overall Study|Death|2|||
131024109|NCT00174382|471718622|FG000|Overall Study|Adverse Event|19|||
131024110|NCT00174382|471718622|FG000|Overall Study|Withdrawal by Subject|6|||
131024111|NCT00174382|471718622|FG000|Overall Study|Protocol Violation|3|||
131024112|NCT00174382|471718622|FG000|Overall Study|Arrived early for last visit in error|1|||
131024113|NCT00174382|471718622|FG000|Overall Study|Subject felt pill not effective enough|1|||
131024114|NCT00174382|471718622|FG000|Overall Study|Lost to Follow-up|1|||
131024115|NCT00296036|471718623|FG000|Overall Study|Withdrawal by Subject|1|||
131024116|NCT00296036|471718624|FG001|Overall Study|Withdrawal by Subject|0|||
131024117|NCT00296036|471718625|FG002|Overall Study|Withdrawal by Subject|2|||
131024118|NCT00296036|471718626|FG003|Overall Study|Withdrawal by Subject|1|||
131024119|NCT00296036|471718627|FG004|Overall Study|Withdrawal by Subject|2|||
131024120|NCT00296036|471718628|FG005|Overall Study|Withdrawal by Subject|1|||
131024121|NCT00296036|471718623|FG000|Overall Study|Protocol Violation|0|||
131024122|NCT00296036|471718624|FG001|Overall Study|Protocol Violation|0|||
131024123|NCT00296036|471718625|FG002|Overall Study|Protocol Violation|0|||
131024124|NCT00296036|471718626|FG003|Overall Study|Protocol Violation|0|||
131024125|NCT00296036|471718627|FG004|Overall Study|Protocol Violation|0|||
131024126|NCT00296036|471718628|FG005|Overall Study|Protocol Violation|3|||
131024127|NCT03403413|471718631|FG000|Overall Study|Lack of Efficacy|2|||
131024128|NCT03655262|471718632|FG000|Overall Study|Withdrawal by Subject|0|||
131024129|NCT03655262|471718633|FG001|Overall Study|Withdrawal by Subject|0|||
131024130|NCT03655262|471718634|FG002|Overall Study|Withdrawal by Subject|1|||
131024131|NCT04452318|471718635|FG000|Overall Study|Physician Decision|1|||
131024132|NCT04452318|471718636|FG001|Overall Study|Physician Decision|2|||
131024133|NCT04452318|471718637|FG002|Overall Study|Physician Decision|0|||
131024134|NCT04452318|471718638|FG003|Overall Study|Physician Decision|2|||
131024135|NCT04452318|471718639|FG004|Overall Study|Physician Decision|0|||
131024136|NCT04452318|471718640|FG005|Overall Study|Physician Decision|2|||
130891139|NCT03901469|471235340|FG004|Overall Study|Not Reported|0|||
130891140|NCT03901469|471235341|FG005|Overall Study|Not Reported|0|||
130891141|NCT03901469|471235342|FG006|Overall Study|Not Reported|1|||
130891142|NCT03738228|471235346|FG000|Overall Study|Never received study treatment|2|||
130891143|NCT03738228|471235347|FG001|Overall Study|Never received study treatment|2|||
130891144|NCT06170242|471235348|FG000|Overall Study|Lost to Follow-up|0|||
130891145|NCT06170242|471235349|FG001|Overall Study|Lost to Follow-up|0|||
130891146|NCT06170242|471235350|FG002|Overall Study|Lost to Follow-up|1|||
130891147|NCT06170242|471235351|FG003|Overall Study|Lost to Follow-up|1|||
130891148|NCT02586207|471235359|FG000|Overall Study|Physician Decision|1|||
130891149|NCT02586207|471235359|FG000|Overall Study|Withdrawal by Subject|1|||
130891150|NCT04896073|471235360|FG000|Overall Study|Screen failure|0|||
130891151|NCT04896073|471235361|FG001|Overall Study|Screen failure|2|||
130891152|NCT04896073|471235360|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
130891153|NCT04896073|471235361|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
130891154|NCT01385176|471235362|FG000|Randomization Phase|Death|1|||
130891155|NCT01385176|471235363|FG001|Randomization Phase|Death|2|||
130891156|NCT01385176|471235362|FG000|6-18 Month All VNS Active|Death|1|||
130891157|NCT01385176|471235363|FG001|6-18 Month All VNS Active|Death|2|||
130891158|NCT01385176|471235362|FG000|6-18 Month All VNS Active|Physician Decision|0|||
130891159|NCT01385176|471235363|FG001|6-18 Month All VNS Active|Physician Decision|1|||
130891160|NCT01385176|471235362|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
130891161|NCT01385176|471235363|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
130891162|NCT01385176|471235362|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
130891163|NCT01385176|471235363|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
130891164|NCT02306161|471235364|FG000|Overall Study|Death|1|||
130891165|NCT02306161|471235365|FG001|Overall Study|Death|3|||
130891166|NCT02306161|471235364|FG000|Overall Study|Lack of Efficacy|20|||
130891167|NCT02306161|471235365|FG001|Overall Study|Lack of Efficacy|43|||
130891168|NCT02306161|471235364|FG000|Overall Study|Physician Decision|30|||
130891169|NCT02306161|471235365|FG001|Overall Study|Physician Decision|18|||
130891170|NCT02306161|471235364|FG000|Overall Study|Withdrawal by Subject|4|||
130891171|NCT02306161|471235365|FG001|Overall Study|Withdrawal by Subject|0|||
130891172|NCT02306161|471235364|FG000|Overall Study|Ineligible|9|||
130891173|NCT02306161|471235365|FG001|Overall Study|Ineligible|5|||
130891174|NCT04995419|471235366|FG000|Overall Study|Withdrawal by Subject|3|||
130891175|NCT04995419|471235366|FG000|Overall Study|Progressive Disease|19|||
130891176|NCT04995419|471235366|FG000|Overall Study|Adverse Event|2|||
130891177|NCT04995419|471235366|FG000|Overall Study|Ongoing|16|||
130891178|NCT03306173|471235367|FG000|Overall Study|Lost to Follow-up|16|||
130891179|NCT03306173|471235368|FG001|Overall Study|Lost to Follow-up|23|||
130891180|NCT03306173|471235367|FG000|Overall Study|Withdrawal by Subject|4|||
130891181|NCT03306173|471235368|FG001|Overall Study|Withdrawal by Subject|3|||
130891182|NCT03306173|471235367|FG000|Overall Study|Discontinued|4|||
130891183|NCT03306173|471235368|FG001|Overall Study|Discontinued|4|||
130891184|NCT03962504|471235369|FG000|Overall Study|Other|11|||
130891185|NCT03962504|471235370|FG001|Overall Study|Other|32|||
130891186|NCT03776812|471235371|FG000|Overall Study|Death|53|||
130891187|NCT03776812|471235372|FG001|Overall Study|Death|49|||
130891188|NCT03776812|471235373|FG002|Overall Study|Death|56|||
130891189|NCT03776812|471235371|FG000|Overall Study|Withdrawal by Subject|1|||
130891190|NCT03776812|471235372|FG001|Overall Study|Withdrawal by Subject|7|||
130891191|NCT03776812|471235373|FG002|Overall Study|Withdrawal by Subject|2|||
131109283|NCT00816400|472030825|FG004|Overall Study|In hospice care at the end of the study|0|||
131109284|NCT00816400|472030826|FG005|Overall Study|In hospice care at the end of the study|0|||
131109285|NCT00816400|472030827|FG006|Overall Study|In hospice care at the end of the study|0|||
131109286|NCT00816400|472030828|FG007|Overall Study|In hospice care at the end of the study|0|||
131109287|NCT00816400|472030829|FG008|Overall Study|In hospice care at the end of the study|0|||
130686491|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Death|3|||
130686492|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Death|13|||
130891192|NCT03776812|471235371|FG000|Overall Study|Lost to Follow-up|1|||
130891193|NCT03776812|471235372|FG001|Overall Study|Lost to Follow-up|1|||
130891194|NCT03776812|471235373|FG002|Overall Study|Lost to Follow-up|0|||
130891195|NCT03776812|471235371|FG000|Overall Study|Did not enter long-term follow-up|3|||
130891196|NCT03776812|471235372|FG001|Overall Study|Did not enter long-term follow-up|3|||
130891197|NCT03776812|471235373|FG002|Overall Study|Did not enter long-term follow-up|2|||
130891198|NCT04758637|471235374|FG000|Overall Study|Lost to Follow-up|0|||
130891199|NCT04758637|471235375|FG001|Overall Study|Lost to Follow-up|1|||
130891200|NCT04758637|471235376|FG002|Overall Study|Lost to Follow-up|0|||
131109288|NCT00081770|472030830|FG000|Overall Study|Adverse Event|130|||
131109289|NCT00081770|472030831|FG001|Overall Study|Adverse Event|98|||
131109290|NCT00081770|472030832|FG002|Overall Study|Adverse Event|136|||
130891201|NCT04758637|471235377|FG003|Overall Study|Lost to Follow-up|0|||
130891202|NCT00048074|471235382|FG000|Overall Study|Adverse Event|46|||
130891203|NCT00048074|471235383|FG001|Overall Study|Adverse Event|41|||
130891204|NCT00048074|471235384|FG002|Overall Study|Adverse Event|53|||
130891205|NCT00048074|471235382|FG000|Overall Study|Death|3|||
130891206|NCT00048074|471235383|FG001|Overall Study|Death|3|||
130891207|NCT00048074|471235384|FG002|Overall Study|Death|2|||
130891208|NCT00048074|471235382|FG000|Overall Study|Lost to Follow-up|2|||
130891209|NCT00048074|471235383|FG001|Overall Study|Lost to Follow-up|6|||
130891210|NCT00048074|471235384|FG002|Overall Study|Lost to Follow-up|6|||
130891211|NCT00048074|471235382|FG000|Overall Study|Withdrawal by Subject|28|||
130891212|NCT00048074|471235383|FG001|Overall Study|Withdrawal by Subject|30|||
130891213|NCT00048074|471235384|FG002|Overall Study|Withdrawal by Subject|35|||
130891214|NCT00048074|471235382|FG000|Overall Study|Protocol Violation|1|||
130891215|NCT00048074|471235383|FG001|Overall Study|Protocol Violation|3|||
130891216|NCT00048074|471235384|FG002|Overall Study|Protocol Violation|0|||
130891217|NCT00048074|471235382|FG000|Overall Study|Study participation was terminated|0|||
130891218|NCT00048074|471235383|FG001|Overall Study|Study participation was terminated|1|||
130891219|NCT00048074|471235384|FG002|Overall Study|Study participation was terminated|0|||
130891220|NCT00048074|471235382|FG000|Overall Study|Husband ill|0|||
130891221|NCT00048074|471235383|FG001|Overall Study|Husband ill|1|||
130891222|NCT00048074|471235384|FG002|Overall Study|Husband ill|0|||
130891223|NCT00048074|471235382|FG000|Overall Study|Poor compliance|0|||
130891224|NCT00048074|471235383|FG001|Overall Study|Poor compliance|1|||
130891225|NCT00048074|471235384|FG002|Overall Study|Poor compliance|0|||
130891226|NCT00048074|471235382|FG000|Overall Study|Out of station|0|||
130891227|NCT00048074|471235383|FG001|Overall Study|Out of station|1|||
130891228|NCT00048074|471235384|FG002|Overall Study|Out of station|1|||
130891229|NCT00048074|471235382|FG000|Overall Study|Social reasons|1|||
130891230|NCT00048074|471235383|FG001|Overall Study|Social reasons|0|||
130891231|NCT00048074|471235384|FG002|Overall Study|Social reasons|0|||
130891232|NCT02873377|471235385|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
130891233|NCT02873377|471235386|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
130891234|NCT02873377|471235385|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
130891235|NCT02873377|471235386|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
130891236|NCT05064358|471235388|FG000|Overall Study|Death|23|||
130891237|NCT05064358|471235389|FG001|Overall Study|Death|23|||
130891238|NCT05064358|471235390|FG002|Overall Study|Death|25|||
131024137|NCT04452318|471718641|FG006|Overall Study|Physician Decision|5|||
131024138|NCT04452318|471718635|FG000|Overall Study|Death|2|||
131024139|NCT04452318|471718636|FG001|Overall Study|Death|3|||
131024140|NCT04452318|471718637|FG002|Overall Study|Death|0|||
131024141|NCT04452318|471718638|FG003|Overall Study|Death|0|||
131024142|NCT04452318|471718639|FG004|Overall Study|Death|0|||
131024143|NCT04452318|471718640|FG005|Overall Study|Death|0|||
131024144|NCT04452318|471718641|FG006|Overall Study|Death|0|||
131024145|NCT04452318|471718635|FG000|Overall Study|Lost to Follow-up|38|||
131024146|NCT04452318|471718636|FG001|Overall Study|Lost to Follow-up|28|||
131024147|NCT04452318|471718637|FG002|Overall Study|Lost to Follow-up|0|||
131024148|NCT04452318|471718638|FG003|Overall Study|Lost to Follow-up|3|||
131024149|NCT04452318|471718639|FG004|Overall Study|Lost to Follow-up|3|||
131024150|NCT04452318|471718640|FG005|Overall Study|Lost to Follow-up|2|||
131024151|NCT04452318|471718641|FG006|Overall Study|Lost to Follow-up|1|||
131024152|NCT04452318|471718635|FG000|Overall Study|Withdrawal by Subject|46|||
131024153|NCT04452318|471718636|FG001|Overall Study|Withdrawal by Subject|40|||
131024154|NCT04452318|471718637|FG002|Overall Study|Withdrawal by Subject|0|||
131024155|NCT04452318|471718638|FG003|Overall Study|Withdrawal by Subject|18|||
131024156|NCT04452318|471718639|FG004|Overall Study|Withdrawal by Subject|6|||
131024157|NCT04452318|471718640|FG005|Overall Study|Withdrawal by Subject|8|||
131024158|NCT04452318|471718641|FG006|Overall Study|Withdrawal by Subject|6|||
131024159|NCT04328727|471718644|FG000|Overall Study|Guardian Decision|1|||
131024160|NCT04328727|471718644|FG000|Overall Study|Participant decision|4|||
131024161|NCT04328727|471718644|FG000|Overall Study|Death|3|||
131024162|NCT04149002|471718645|FG000|Overall Study|Lost to Follow-up|1|||
131024163|NCT04149002|471718646|FG001|Overall Study|Lost to Follow-up|0|||
131024164|NCT04149002|471718645|FG000|Overall Study|Withdrawal by Subject|1|||
130891239|NCT05064358|471235391|FG003|Overall Study|Death|21|||
130891240|NCT05064358|471235392|FG004|Overall Study|Death|5|||
130891241|NCT05064358|471235388|FG000|Overall Study|Lost to Follow-up|1|||
130891242|NCT05064358|471235389|FG001|Overall Study|Lost to Follow-up|2|||
131024165|NCT04149002|471718646|FG001|Overall Study|Withdrawal by Subject|0|||
131024166|NCT04583423|471718648|FG000|Overall Study|Lost to Follow-up|0|||
131024167|NCT04583423|471718649|FG001|Overall Study|Lost to Follow-up|1|||
131024168|NCT04583423|471718650|FG002|Overall Study|Lost to Follow-up|0|||
130891243|NCT05064358|471235390|FG002|Overall Study|Lost to Follow-up|0|||
130891244|NCT05064358|471235391|FG003|Overall Study|Lost to Follow-up|2|||
130891245|NCT05064358|471235392|FG004|Overall Study|Lost to Follow-up|0|||
130891246|NCT05064358|471235388|FG000|Overall Study|Physician Decision|1|||
130891247|NCT05064358|471235389|FG001|Overall Study|Physician Decision|1|||
130891248|NCT05064358|471235390|FG002|Overall Study|Physician Decision|2|||
131024169|NCT04583423|471718651|FG003|Overall Study|Lost to Follow-up|2|||
131024170|NCT04583423|471718648|FG000|Overall Study|Study Terminated by Sponsor|32|||
131024171|NCT04583423|471718649|FG001|Overall Study|Study Terminated by Sponsor|35|||
131024172|NCT04583423|471718650|FG002|Overall Study|Study Terminated by Sponsor|36|||
131024173|NCT04583423|471718651|FG003|Overall Study|Study Terminated by Sponsor|33|||
131109291|NCT00081770|472030830|FG000|Overall Study|Lack of Efficacy|262|||
131109292|NCT00081770|472030831|FG001|Overall Study|Lack of Efficacy|357|||
131109293|NCT00081770|472030832|FG002|Overall Study|Lack of Efficacy|211|||
131109294|NCT00081770|472030830|FG000|Overall Study|Lost to Follow-up|45|||
131109295|NCT00081770|472030831|FG001|Overall Study|Lost to Follow-up|34|||
131109296|NCT00081770|472030832|FG002|Overall Study|Lost to Follow-up|45|||
131109297|NCT00081770|472030830|FG000|Overall Study|Protocol Violation|15|||
131109298|NCT00081770|472030831|FG001|Overall Study|Protocol Violation|10|||
131109299|NCT00081770|472030832|FG002|Overall Study|Protocol Violation|10|||
131109300|NCT00081770|472030830|FG000|Overall Study|Withdrawal by Subject|45|||
131109301|NCT00081770|472030831|FG001|Overall Study|Withdrawal by Subject|40|||
131109302|NCT00081770|472030832|FG002|Overall Study|Withdrawal by Subject|42|||
131109303|NCT00081770|472030830|FG000|Overall Study|Did not meet protocol eligibility|2|||
131109304|NCT00081770|472030831|FG001|Overall Study|Did not meet protocol eligibility|0|||
131109305|NCT00081770|472030832|FG002|Overall Study|Did not meet protocol eligibility|3|||
131109306|NCT00081770|472030830|FG000|Overall Study|Administrative|1|||
131109307|NCT00081770|472030831|FG001|Overall Study|Administrative|0|||
131109308|NCT00081770|472030832|FG002|Overall Study|Administrative|1|||
131109309|NCT00081770|472030830|FG000|Overall Study|Other|2|||
130686493|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
130686494|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
130686495|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Other|14|||
130686496|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Other|31|||
130686497|NCT01439880|470479550|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
130686498|NCT01439880|470479551|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
130686499|NCT03874715|470479554|FG000|Overall Study|Adverse Event|2|||
130686500|NCT03874715|470479555|FG001|Overall Study|Adverse Event|0|||
130686501|NCT03874715|470479554|FG000|Overall Study|Poor compliance to protocol|5|||
130686502|NCT03874715|470479555|FG001|Overall Study|Poor compliance to protocol|1|||
130686503|NCT03874715|470479554|FG000|Overall Study|Withdrawal by Subject|1|||
130686504|NCT03874715|470479555|FG001|Overall Study|Withdrawal by Subject|0|||
130686505|NCT03874715|470479554|FG000|Overall Study|Other-unspecified|1|||
130686506|NCT03874715|470479555|FG001|Overall Study|Other-unspecified|0|||
130686507|NCT01083693|470479556|FG000|Overall Study|Adverse Event|1|||
130686508|NCT01083693|470479557|FG001|Overall Study|Adverse Event|1|||
130686509|NCT01083693|470479558|FG002|Overall Study|Adverse Event|0|||
130686510|NCT01083693|470479556|FG000|Overall Study|Lost to Follow-up|2|||
130686511|NCT01083693|470479557|FG001|Overall Study|Lost to Follow-up|0|||
130686512|NCT01083693|470479558|FG002|Overall Study|Lost to Follow-up|2|||
130686513|NCT01083693|470479556|FG000|Overall Study|Lack of effectiveness|13|||
130686514|NCT01083693|470479557|FG001|Overall Study|Lack of effectiveness|2|||
130686515|NCT01083693|470479558|FG002|Overall Study|Lack of effectiveness|2|||
130686516|NCT01083693|470479556|FG000|Overall Study|Patient Moved|0|||
130686517|NCT01083693|470479557|FG001|Overall Study|Patient Moved|1|||
130686518|NCT01083693|470479558|FG002|Overall Study|Patient Moved|0|||
130686519|NCT01083693|470479556|FG000|Overall Study|Complete remission|0|||
130686520|NCT01083693|470479557|FG001|Overall Study|Complete remission|1|||
130686521|NCT01083693|470479558|FG002|Overall Study|Complete remission|0|||
130686522|NCT01083693|470479556|FG000|Overall Study|Other medical condition/surgery|1|||
130686523|NCT01083693|470479557|FG001|Overall Study|Other medical condition/surgery|1|||
130686524|NCT01083693|470479558|FG002|Overall Study|Other medical condition/surgery|0|||
130686525|NCT01083693|470479556|FG000|Overall Study|Withdrawal by Subject|3|||
130686526|NCT01083693|470479557|FG001|Overall Study|Withdrawal by Subject|0|||
130686527|NCT01083693|470479558|FG002|Overall Study|Withdrawal by Subject|2|||
130686528|NCT01083693|470479556|FG000|Overall Study|Reason unknown|0|||
130686529|NCT01083693|470479557|FG001|Overall Study|Reason unknown|0|||
130686530|NCT01083693|470479558|FG002|Overall Study|Reason unknown|1|||
130686531|NCT01401647|470479561|FG000|Overall Study|Withdrawal by Subject|1|||
130686532|NCT01401647|470479562|FG001|Overall Study|Withdrawal by Subject|5|||
130686533|NCT01401647|470479563|FG002|Overall Study|Withdrawal by Subject|2|||
130891249|NCT05064358|471235391|FG003|Overall Study|Physician Decision|0|||
130891250|NCT05064358|471235392|FG004|Overall Study|Physician Decision|0|||
130891251|NCT05064358|471235388|FG000|Overall Study|Withdrawal by Subject|4|||
130891252|NCT05064358|471235389|FG001|Overall Study|Withdrawal by Subject|5|||
130891253|NCT05064358|471235390|FG002|Overall Study|Withdrawal by Subject|3|||
131109310|NCT00081770|472030831|FG001|Overall Study|Other|7|||
131109311|NCT00081770|472030832|FG002|Overall Study|Other|8|||
130686534|NCT01401647|470479561|FG000|Overall Study|Lost to Follow-up|3|||
130686535|NCT01401647|470479562|FG001|Overall Study|Lost to Follow-up|3|||
130686536|NCT01401647|470479563|FG002|Overall Study|Lost to Follow-up|1|||
130686537|NCT00473330|470479566|FG000|Core Study|Adverse Event|4|||
130686538|NCT00473330|470479567|FG001|Core Study|Adverse Event|4|||
130686539|NCT00473330|470479568|FG002|Core Study|Adverse Event|1|||
130891254|NCT05064358|471235391|FG003|Overall Study|Withdrawal by Subject|6|||
130891255|NCT05064358|471235392|FG004|Overall Study|Withdrawal by Subject|3|||
131109312|NCT00601419|472030833|FG000|Overall Study|Lost to Follow-up|3|||
131109313|NCT00601419|472030833|FG000|Overall Study|Missed Visits|1|||
131109314|NCT01614197|472030834|FG000|Overall Study|Withdrawal by Subject|0|||
130891256|NCT05064358|471235388|FG000|Overall Study|Ongoing at the time of analysis|1|||
130891257|NCT05064358|471235389|FG001|Overall Study|Ongoing at the time of analysis|2|||
130891258|NCT05064358|471235390|FG002|Overall Study|Ongoing at the time of analysis|2|||
130891259|NCT05064358|471235391|FG003|Overall Study|Ongoing at the time of analysis|2|||
130891260|NCT05064358|471235392|FG004|Overall Study|Ongoing at the time of analysis|2|||
130891261|NCT04976192|471235393|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130891262|NCT04976192|471235394|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
130891263|NCT04976192|471235395|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130891264|NCT04976192|471235396|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130891265|NCT04976192|471235397|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130891266|NCT04976192|471235398|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130891267|NCT04976192|471235399|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130891268|NCT04976192|471235400|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130891269|NCT04976192|471235401|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130891270|NCT04976192|471235402|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130891271|NCT04976192|471235393|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
130891272|NCT04976192|471235394|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
130891273|NCT04976192|471235395|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
130891274|NCT04976192|471235396|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130891275|NCT04976192|471235397|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130891276|NCT04976192|471235398|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130891277|NCT04976192|471235399|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130891278|NCT04976192|471235400|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130891279|NCT04976192|471235401|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130891280|NCT04976192|471235402|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130891281|NCT04976192|471235393|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
130891282|NCT04976192|471235394|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130891283|NCT04976192|471235395|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
130891284|NCT04976192|471235396|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130891285|NCT04976192|471235397|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130891286|NCT04976192|471235398|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130891287|NCT04976192|471235399|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130891288|NCT04976192|471235400|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
131024174|NCT04583423|471718648|FG000|Overall Study|Withdrawal by Subject|3|||
131024175|NCT04583423|471718649|FG001|Overall Study|Withdrawal by Subject|1|||
131024176|NCT04583423|471718650|FG002|Overall Study|Withdrawal by Subject|2|||
131024177|NCT04583423|471718651|FG003|Overall Study|Withdrawal by Subject|1|||
131024178|NCT01198145|471718652|FG000|Overall Study|Withdrawal by Subject|1|||
131024179|NCT01198145|471718653|FG001|Overall Study|Withdrawal by Subject|1|||
131024180|NCT00580866|471718654|FG000|Overall Study|Lost to Follow-up|2|||
131024181|NCT00580866|471718655|FG001|Overall Study|Lost to Follow-up|2|||
131024182|NCT02477605|471718656|FG000|Overall Study|Discontinued prior to treatment|1|||
131024183|NCT02477605|471718657|FG001|Overall Study|Discontinued prior to treatment|0|||
131024184|NCT02477605|471718656|FG000|Overall Study|Lost to Follow-up|0|||
131024185|NCT02477605|471718657|FG001|Overall Study|Lost to Follow-up|2|||
131024186|NCT02477605|471718656|FG000|Overall Study|Withdrawal by Subject|0|||
131024187|NCT02477605|471718657|FG001|Overall Study|Withdrawal by Subject|1|||
131024188|NCT02477605|471718656|FG000|Overall Study|Administered gas during surgery|0|||
131024189|NCT02477605|471718657|FG001|Overall Study|Administered gas during surgery|1|||
131024190|NCT02574455|471718658|FG000|Overall Study|Death|197|||
131024191|NCT02574455|471718659|FG001|Overall Study|Death|210|||
131024192|NCT02574455|471718658|FG000|Overall Study|Withdrawal of Consent|11|||
131024193|NCT02574455|471718659|FG001|Overall Study|Withdrawal of Consent|28|||
131024194|NCT02574455|471718658|FG000|Overall Study|Lost to Follow-up|4|||
131024195|NCT02574455|471718659|FG001|Overall Study|Lost to Follow-up|4|||
131024196|NCT02574455|471718658|FG000|Overall Study|Sponsor's Decision|55|||
131024197|NCT02574455|471718659|FG001|Overall Study|Sponsor's Decision|20|||
131024198|NCT02677896|471718660|FG000|Double Blind Period (up to 35 Months)|Death|117|||
131024199|NCT02677896|471718661|FG001|Double Blind Period (up to 35 Months)|Death|197|||
131024200|NCT02677896|471718660|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
131024201|NCT02677896|471718661|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
131024202|NCT02677896|471718660|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
131024203|NCT02677896|471718661|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
131222659|NCT01270841|472443130|FG001|Overall Study|Enrolled in error|1|||
131024204|NCT02677896|471718660|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
131024205|NCT02677896|471718661|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
131024206|NCT02677896|471718660|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
131024207|NCT02677896|471718661|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
130891289|NCT04976192|471235401|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130891290|NCT04976192|471235402|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130891291|NCT04976192|471235393|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130891292|NCT04976192|471235394|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130891293|NCT04976192|471235395|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130891294|NCT04976192|471235396|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130891295|NCT04976192|471235397|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
130891296|NCT04976192|471235398|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
130891297|NCT04976192|471235399|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130891298|NCT04976192|471235400|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
130891299|NCT04976192|471235401|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
130891300|NCT04976192|471235402|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
130891301|NCT04976192|471235393|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130891302|NCT04976192|471235394|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130891303|NCT04976192|471235395|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130891304|NCT04976192|471235396|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130891305|NCT04976192|471235397|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
130891306|NCT04976192|471235398|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130891307|NCT04976192|471235399|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130891308|NCT04976192|471235400|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130891309|NCT04976192|471235401|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130891310|NCT04976192|471235402|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130891311|NCT04976192|471235393|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130891312|NCT04976192|471235394|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130891313|NCT04976192|471235395|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131109315|NCT01614197|472030835|FG001|Overall Study|Withdrawal by Subject|1|||
131109316|NCT01614197|472030836|FG002|Overall Study|Withdrawal by Subject|0|||
130686540|NCT00473330|470479566|FG000|Core Study|Death|6|||
130686541|NCT00473330|470479567|FG001|Core Study|Death|4|||
131109317|NCT01614197|472030837|FG003|Overall Study|Withdrawal by Subject|0|||
131109318|NCT02245672|472030838|FG000|Overall Study|Adverse Event|4|||
131109319|NCT02245672|472030839|FG001|Overall Study|Adverse Event|4|||
131109320|NCT02245672|472030840|FG002|Overall Study|Adverse Event|4|||
131109321|NCT02245672|472030838|FG000|Overall Study|Lost to Follow-up|3|||
131109322|NCT02245672|472030839|FG001|Overall Study|Lost to Follow-up|5|||
131109323|NCT02245672|472030840|FG002|Overall Study|Lost to Follow-up|1|||
131109324|NCT02245672|472030838|FG000|Overall Study|Withdrawal by Subject|6|||
131109325|NCT02245672|472030839|FG001|Overall Study|Withdrawal by Subject|3|||
131109326|NCT02245672|472030840|FG002|Overall Study|Withdrawal by Subject|0|||
131109327|NCT02245672|472030838|FG000|Overall Study|Randomized in error (not treated)|0|||
131109328|NCT02245672|472030839|FG001|Overall Study|Randomized in error (not treated)|1|||
131109329|NCT02245672|472030840|FG002|Overall Study|Randomized in error (not treated)|0|||
131109330|NCT00971932|472030841|FG000|Overall Study|Withdrawal by Subject|1|||
131109331|NCT00971932|472030841|FG000|Overall Study|Investigator's decision|2|||
131109332|NCT00971932|472030841|FG000|Overall Study|Ongoing|4|||
131109333|NCT01765192|472030844|FG000|Treatment Period 1|Adverse Event|0|||
131109334|NCT01765192|472030845|FG001|Treatment Period 1|Adverse Event|1|||
131109335|NCT01765192|472030844|FG000|Washout Period|Voluntary Withdrawal|1|||
131109336|NCT01765192|472030845|FG001|Washout Period|Voluntary Withdrawal|1|||
131109337|NCT01765192|472030844|FG000|Washout Period|Reason not specified|1|||
131109338|NCT01765192|472030845|FG001|Washout Period|Reason not specified|0|||
131109339|NCT01765192|472030844|FG000|Treatment Period 2|Reason not specified|0|||
131109340|NCT01765192|472030845|FG001|Treatment Period 2|Reason not specified|2|||
131109341|NCT01765192|472030844|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
131109342|NCT01765192|472030845|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
131109343|NCT00876694|472030850|FG000|Overall Study|Adverse Event|10|||
131109344|NCT00876694|472030851|FG001|Overall Study|Adverse Event|7|||
131109345|NCT00876694|472030850|FG000|Overall Study|Subject withdrew consent|6|||
131109346|NCT00876694|472030851|FG001|Overall Study|Subject withdrew consent|4|||
131109347|NCT00876694|472030850|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131109348|NCT00876694|472030851|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131109349|NCT00876694|472030850|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131109350|NCT00876694|472030851|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131109351|NCT00876694|472030850|FG000|Overall Study|Administrative problems|1|||
131109352|NCT00876694|472030851|FG001|Overall Study|Administrative problems|1|||
131109353|NCT00876694|472030850|FG000|Overall Study|Death|1|||
131109354|NCT00876694|472030851|FG001|Overall Study|Death|0|||
131109355|NCT00288509|472030852|FG000|Treatment Cycle 1|Adverse Event|1|||
130686542|NCT00473330|470479568|FG002|Core Study|Death|4|||
130686543|NCT00473330|470479566|FG000|Core Study|Lost to Follow-up|5|||
131109356|NCT00288509|472030852|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
131109357|NCT00288509|472030852|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
131109358|NCT00288509|472030852|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
131222660|NCT01270841|472443131|FG002|Overall Study|Enrolled in error|0|||
130891314|NCT04976192|471235396|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130891315|NCT04976192|471235397|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130891316|NCT04976192|471235398|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130891317|NCT04976192|471235399|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130891318|NCT04976192|471235400|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130891319|NCT04976192|471235401|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130891320|NCT04976192|471235402|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130891321|NCT02621151|471235403|FG000|Overall Study|Not eligible for trial|6|||
130891322|NCT04073225|471235404|FG000|Overall Study|Lost to Follow-up|4|||
130891323|NCT04073225|471235405|FG001|Overall Study|Lost to Follow-up|3|||
130891324|NCT02253316|471235415|FG000|Consolidation|Progression|4|||
130891325|NCT02253316|471235416|FG001|Consolidation|Progression|0|||
130891326|NCT02253316|471235417|FG002|Consolidation|Progression|0|||
130891327|NCT02253316|471235415|FG000|Consolidation|Non-Compliance|1|||
130891328|NCT02253316|471235416|FG001|Consolidation|Non-Compliance|0|||
130891329|NCT02253316|471235417|FG002|Consolidation|Non-Compliance|0|||
130891330|NCT02253316|471235415|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
130891331|NCT02253316|471235416|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
130891332|NCT02253316|471235417|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
130891333|NCT02253316|471235415|FG000|Consolidation|Secondary Malignancy|2|||
130891334|NCT02253316|471235416|FG001|Consolidation|Secondary Malignancy|0|||
130891335|NCT02253316|471235417|FG002|Consolidation|Secondary Malignancy|0|||
130891336|NCT02253316|471235415|FG000|Consolidation|Adverse Event|7|||
130891337|NCT02253316|471235416|FG001|Consolidation|Adverse Event|0|||
131109359|NCT00288509|472030852|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
131109360|NCT00288509|472030852|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
131109361|NCT00288509|472030852|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
131109362|NCT00288509|472030852|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
130686544|NCT00473330|470479567|FG001|Core Study|Lost to Follow-up|5|||
130686545|NCT00473330|470479568|FG002|Core Study|Lost to Follow-up|10|||
130686546|NCT00473330|470479566|FG000|Core Study|Physician Decision|2|||
130686547|NCT00473330|470479567|FG001|Core Study|Physician Decision|1|||
130686548|NCT00473330|470479568|FG002|Core Study|Physician Decision|3|||
130686549|NCT00473330|470479566|FG000|Core Study|Subject Non-compliance|1|||
130686550|NCT00473330|470479567|FG001|Core Study|Subject Non-compliance|2|||
130686551|NCT00473330|470479568|FG002|Core Study|Subject Non-compliance|1|||
130686552|NCT00473330|470479566|FG000|Core Study|Subject Required Other Therapy|0|||
130686553|NCT00473330|470479567|FG001|Core Study|Subject Required Other Therapy|1|||
130686554|NCT00473330|470479568|FG002|Core Study|Subject Required Other Therapy|3|||
130686555|NCT00473330|470479566|FG000|Core Study|Subject's Decision|9|||
130686556|NCT00473330|470479567|FG001|Core Study|Subject's Decision|8|||
130686557|NCT00473330|470479568|FG002|Core Study|Subject's Decision|19|||
130686558|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
130686559|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
130686560|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
130686561|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Death|2|||
130686562|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Death|0|||
130686563|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Death|0|||
130686564|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
131109363|NCT00288509|472030852|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
131109364|NCT00288509|472030852|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
131109365|NCT00288509|472030852|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
130686565|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
130686566|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
130686567|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
130686568|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
130686569|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
130686570|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
130686571|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
130686572|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
130686573|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
130686574|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
130686575|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
130686576|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
130891338|NCT02253316|471235417|FG002|Consolidation|Adverse Event|0|||
130891339|NCT02253316|471235415|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
130891340|NCT02253316|471235416|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
130891341|NCT02253316|471235417|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
130891342|NCT02253316|471235415|FG000|Maintenance|Physician Decision|0|||
130891343|NCT02253316|471235416|FG001|Maintenance|Physician Decision|7|||
130891344|NCT02253316|471235417|FG002|Maintenance|Physician Decision|16|||
131109366|NCT00288509|472030852|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
130891345|NCT02253316|471235415|FG000|Maintenance|Non-Compliance|0|||
130891346|NCT02253316|471235416|FG001|Maintenance|Non-Compliance|1|||
130891347|NCT02253316|471235417|FG002|Maintenance|Non-Compliance|1|||
130891348|NCT02253316|471235415|FG000|Maintenance|Secondary Malignancy|0|||
130891349|NCT02253316|471235416|FG001|Maintenance|Secondary Malignancy|2|||
130891350|NCT02253316|471235417|FG002|Maintenance|Secondary Malignancy|6|||
130891351|NCT02253316|471235415|FG000|Maintenance|Adverse Event|0|||
130891352|NCT02253316|471235416|FG001|Maintenance|Adverse Event|8|||
130891353|NCT02253316|471235417|FG002|Maintenance|Adverse Event|12|||
130891354|NCT02253316|471235415|FG000|Maintenance|Still receiving active treatment|0|||
130891355|NCT02253316|471235416|FG001|Maintenance|Still receiving active treatment|4|||
130891356|NCT02253316|471235417|FG002|Maintenance|Still receiving active treatment|0|||
130891357|NCT00124306|471235421|FG000|Overall Study|Adverse Event|7|||
130891358|NCT00124306|471235422|FG001|Overall Study|Adverse Event|2|||
130891359|NCT00124306|471235421|FG000|Overall Study|Lost to Follow-up|10|||
130891360|NCT00124306|471235422|FG001|Overall Study|Lost to Follow-up|6|||
130891361|NCT00124306|471235421|FG000|Overall Study|Lack of Efficacy|3|||
130891362|NCT00124306|471235422|FG001|Overall Study|Lack of Efficacy|6|||
130891363|NCT00124306|471235421|FG000|Overall Study|Personal constraints|0|||
130891364|NCT00124306|471235422|FG001|Overall Study|Personal constraints|2|||
130891365|NCT00124306|471235421|FG000|Overall Study|Use of unacceptable medication|1|||
130891366|NCT00124306|471235422|FG001|Overall Study|Use of unacceptable medication|0|||
130891367|NCT00124306|471235421|FG000|Overall Study|Abnormal lab result|0|||
130891368|NCT00124306|471235422|FG001|Overall Study|Abnormal lab result|1|||
130891369|NCT00124306|471235421|FG000|Overall Study|Other|2|||
130891370|NCT00124306|471235422|FG001|Overall Study|Other|0|||
131024208|NCT02677896|471718660|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
131024209|NCT02677896|471718661|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
131024210|NCT02677896|471718660|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
131024211|NCT02677896|471718661|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
131024212|NCT02677896|471718660|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
131024213|NCT02677896|471718661|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
131024214|NCT02677896|471718660|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
131024215|NCT02677896|471718661|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
131024216|NCT02677896|471718660|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
131109367|NCT00288509|472030852|FG000|Treatment Cycle 4|Physician Decision|4|||
130686577|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
130686578|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
130686579|NCT00473330|470479566|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
130686580|NCT00473330|470479567|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
130686581|NCT00473330|470479568|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
130686582|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
130686583|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
130686584|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
130686585|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Death|2|||
130686586|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Death|2|||
130686587|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Death|1|||
130686588|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
130686589|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
130686590|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
130686591|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
130686592|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
130686593|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
130686594|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
130686595|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
130686596|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
130686597|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
130686598|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
130686599|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
130686600|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
130686601|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
130686602|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
130686603|NCT00473330|470479566|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
130686604|NCT00473330|470479567|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
130686605|NCT00473330|470479568|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
130686606|NCT01975948|470479569|FG000|Overall Study|Withdrawal by Subject|17|||
130686607|NCT01975948|470479570|FG001|Overall Study|Withdrawal by Subject|21|||
130686608|NCT01975948|470479571|FG002|Overall Study|Withdrawal by Subject|7|||
130686609|NCT01975948|470479572|FG003|Overall Study|Withdrawal by Subject|6|||
130686610|NCT01675765|470479573|FG000|Overall Study|Progressive disease|4|||
130686611|NCT01675765|470479574|FG001|Overall Study|Progressive disease|4|||
130686612|NCT01675765|470479573|FG000|Overall Study|Adverse Event|1|||
130686613|NCT01675765|470479574|FG001|Overall Study|Adverse Event|2|||
130686614|NCT01675765|470479573|FG000|Overall Study|Withdrawal by Subject|2|||
130686615|NCT01675765|470479574|FG001|Overall Study|Withdrawal by Subject|0|||
130686616|NCT01675765|470479573|FG000|Overall Study|Death|1|||
130686617|NCT01675765|470479574|FG001|Overall Study|Death|0|||
130686618|NCT01675765|470479573|FG000|Overall Study|Clinical progression|3|||
130686619|NCT01675765|470479574|FG001|Overall Study|Clinical progression|2|||
130686620|NCT03965091|470479576|FG000|Overall Study|Adverse Event|0|||
130686621|NCT03965091|470479577|FG001|Overall Study|Adverse Event|2|||
130686622|NCT03965091|470479578|FG002|Overall Study|Adverse Event|3|||
130686623|NCT03965091|470479576|FG000|Overall Study|Withdrawal by Subject|11|||
130686624|NCT03965091|470479577|FG001|Overall Study|Withdrawal by Subject|3|||
130686625|NCT03965091|470479578|FG002|Overall Study|Withdrawal by Subject|5|||
130686626|NCT03965091|470479576|FG000|Overall Study|Non-compliance with study drug|0|||
130686627|NCT03965091|470479577|FG001|Overall Study|Non-compliance with study drug|0|||
130686628|NCT03965091|470479578|FG002|Overall Study|Non-compliance with study drug|1|||
130686629|NCT03965091|470479576|FG000|Overall Study|Lost to Follow-up|1|||
130686630|NCT03965091|470479577|FG001|Overall Study|Lost to Follow-up|1|||
130686631|NCT03965091|470479578|FG002|Overall Study|Lost to Follow-up|1|||
130686632|NCT03965091|470479576|FG000|Overall Study|Lack of Efficacy|2|||
130891427|NCT04238819|471235427|FG000|Overall Study|Ongoing Treatment|0|||
130891428|NCT04238819|471235428|FG001|Overall Study|Ongoing Treatment|0|||
130891429|NCT04238819|471235429|FG002|Overall Study|Ongoing Treatment|0|||
130891430|NCT04238819|471235430|FG003|Overall Study|Ongoing Treatment|0|||
130891431|NCT04238819|471235431|FG004|Overall Study|Ongoing Treatment|1|||
130891432|NCT04238819|471235432|FG005|Overall Study|Ongoing Treatment|4|||
130891433|NCT04238819|471235433|FG006|Overall Study|Ongoing Treatment|0|||
130891434|NCT04238819|471235427|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
130891435|NCT04238819|471235428|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
130891436|NCT04238819|471235429|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
130891437|NCT04238819|471235430|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
130891438|NCT04238819|471235431|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
130891439|NCT04238819|471235432|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
130891440|NCT04238819|471235433|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
130891441|NCT03568461|471235434|FG000|Overall Study|Death|7|||
130891442|NCT03568461|471235434|FG000|Overall Study|Physician Decision|5|||
130891443|NCT03568461|471235434|FG000|Overall Study|Subject decision|5|||
130891444|NCT03568461|471235434|FG000|Overall Study|Lost to Follow-up|1|||
130891445|NCT05109234|471235435|FG000|Overall Study|Adverse Event|2|||
130891446|NCT05109234|471235436|FG001|Overall Study|Adverse Event|2|||
130891447|NCT05109234|471235435|FG000|Overall Study|Lack of Efficacy|5|||
130891448|NCT05109234|471235436|FG001|Overall Study|Lack of Efficacy|0|||
130891449|NCT05109234|471235435|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
130891450|NCT05109234|471235436|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
130891451|NCT05109234|471235435|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
130891452|NCT05109234|471235436|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
130891453|NCT05109234|471235435|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
130891454|NCT05109234|471235436|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
130891455|NCT05109234|471235435|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
130891456|NCT05109234|471235436|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
131109368|NCT00288509|472030852|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
131109369|NCT02349451|472030857|FG000|Overall Study|Withdrawal by Subject|0|||
131109370|NCT02349451|472030858|FG001|Overall Study|Withdrawal by Subject|1|||
131109371|NCT02349451|472030859|FG002|Overall Study|Withdrawal by Subject|2|||
131109372|NCT02349451|472030860|FG003|Overall Study|Withdrawal by Subject|1|||
131109373|NCT05116046|472030863|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131109374|NCT05116046|472030864|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131109375|NCT05116046|472030865|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131109376|NCT05116046|472030863|FG000|Overall Study|Study terminated by sponsor|14|||
131109377|NCT05116046|472030864|FG001|Overall Study|Study terminated by sponsor|16|||
131109378|NCT05116046|472030865|FG002|Overall Study|Study terminated by sponsor|1|||
131109379|NCT02683941|472030866|FG000|Double-blind Phase|Adverse Event|0|||
131109380|NCT02683941|472030867|FG001|Double-blind Phase|Adverse Event|1|||
131109381|NCT02683941|472030866|FG000|Double-blind Phase|Withdrawal by Subject|4|||
131109382|NCT02683941|472030867|FG001|Double-blind Phase|Withdrawal by Subject|2|||
131109383|NCT02683941|472030866|FG000|Double-blind Phase|Lost to Follow-up|1|||
131109384|NCT02683941|472030867|FG001|Double-blind Phase|Lost to Follow-up|0|||
131109385|NCT02683941|472030866|FG000|Double-blind Phase|Disease Progression|5|||
131109386|NCT02683941|472030867|FG001|Double-blind Phase|Disease Progression|2|||
131109387|NCT02683941|472030866|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
131109388|NCT02683941|472030867|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
131109389|NCT02683941|472030866|FG000|Open-label Treatment Phase|Disease Progression|1|||
131109390|NCT02683941|472030867|FG001|Open-label Treatment Phase|Disease Progression|2|||
131109391|NCT02683941|472030866|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
131109392|NCT02683941|472030867|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
130686633|NCT03965091|470479577|FG001|Overall Study|Lack of Efficacy|0|||
130686634|NCT03965091|470479578|FG002|Overall Study|Lack of Efficacy|0|||
130686635|NCT03965091|470479576|FG000|Overall Study|Other than specified|9|||
130891485|NCT00539864|471235997|FG000|Overall Study|Lost to Follow-up|0|||
130891486|NCT00539864|471235998|FG001|Overall Study|Lost to Follow-up|1|||
130891487|NCT00539864|471235997|FG000|Overall Study|Withdrawal by Subject|1|||
130891488|NCT00539864|471235998|FG001|Overall Study|Withdrawal by Subject|1|||
130891489|NCT02255435|471235999|FG000|Overall Study|Patient's Limited Time Availability|0|||
130891490|NCT02255435|471236000|FG001|Overall Study|Patient's Limited Time Availability|0|||
130891491|NCT02255435|471236001|FG002|Overall Study|Patient's Limited Time Availability|0|||
130891492|NCT02255435|471236002|FG003|Overall Study|Patient's Limited Time Availability|0|||
130891493|NCT02255435|471236003|FG004|Overall Study|Patient's Limited Time Availability|0|||
130891494|NCT02255435|471236004|FG005|Overall Study|Patient's Limited Time Availability|0|||
130891495|NCT02255435|471236005|FG006|Overall Study|Patient's Limited Time Availability|0|||
130891496|NCT02255435|471236006|FG007|Overall Study|Patient's Limited Time Availability|1|||
130891497|NCT02255435|471236007|FG008|Overall Study|Patient's Limited Time Availability|0|||
130891498|NCT02255435|471236008|FG009|Overall Study|Patient's Limited Time Availability|0|||
130891499|NCT02255435|471235999|FG000|Overall Study|Withdrawal by Subject|0|||
130891500|NCT02255435|471236000|FG001|Overall Study|Withdrawal by Subject|0|||
130891501|NCT02255435|471236001|FG002|Overall Study|Withdrawal by Subject|0|||
130891502|NCT02255435|471236002|FG003|Overall Study|Withdrawal by Subject|0|||
130891503|NCT02255435|471236003|FG004|Overall Study|Withdrawal by Subject|0|||
130891504|NCT02255435|471236004|FG005|Overall Study|Withdrawal by Subject|0|||
130891505|NCT02255435|471236005|FG006|Overall Study|Withdrawal by Subject|0|||
130891506|NCT02255435|471236006|FG007|Overall Study|Withdrawal by Subject|0|||
130891507|NCT02255435|471236007|FG008|Overall Study|Withdrawal by Subject|1|||
130891508|NCT02255435|471236008|FG009|Overall Study|Withdrawal by Subject|4|||
130891509|NCT02255435|471235999|FG000|Overall Study|Administrative reasons|0|||
130891510|NCT02255435|471236000|FG001|Overall Study|Administrative reasons|0|||
130891511|NCT02255435|471236001|FG002|Overall Study|Administrative reasons|0|||
130891512|NCT02255435|471236002|FG003|Overall Study|Administrative reasons|0|||
130891513|NCT02255435|471236003|FG004|Overall Study|Administrative reasons|0|||
130891514|NCT02255435|471236004|FG005|Overall Study|Administrative reasons|0|||
130891515|NCT02255435|471236005|FG006|Overall Study|Administrative reasons|0|||
130891516|NCT02255435|471236006|FG007|Overall Study|Administrative reasons|0|||
130891517|NCT02255435|471236007|FG008|Overall Study|Administrative reasons|0|||
130891518|NCT02255435|471236008|FG009|Overall Study|Administrative reasons|2|||
130891519|NCT00943072|471236009|FG000|Overall Study|Adverse Event|0|||
130891520|NCT00943072|471236010|FG001|Overall Study|Adverse Event|3|||
130891521|NCT00943072|471236009|FG000|Overall Study|Death|0|||
130891522|NCT00943072|471236010|FG001|Overall Study|Death|2|||
130891523|NCT00943072|471236009|FG000|Overall Study|Withdrawal by Subject|3|||
130891524|NCT00943072|471236010|FG001|Overall Study|Withdrawal by Subject|1|||
130891525|NCT00943072|471236009|FG000|Overall Study|Protocol Violation|0|||
130891526|NCT00943072|471236010|FG001|Overall Study|Protocol Violation|1|||
130891527|NCT00943072|471236009|FG000|Overall Study|Lost to Follow-up|1|||
130891528|NCT00943072|471236010|FG001|Overall Study|Lost to Follow-up|2|||
130891529|NCT00943072|471236009|FG000|Overall Study|Lack of Efficacy|0|||
130891530|NCT00943072|471236010|FG001|Overall Study|Lack of Efficacy|4|||
130891531|NCT00943072|471236009|FG000|Overall Study|Other|1|||
130891532|NCT00943072|471236010|FG001|Overall Study|Other|1|||
130891533|NCT03887702|471236011|FG000|Overall Study|Study terminated|0|||
130891534|NCT03887702|471236012|FG001|Overall Study|Study terminated|0|||
130891535|NCT03887702|471236013|FG002|Overall Study|Study terminated|2|||
130891536|NCT03887702|471236014|FG003|Overall Study|Study terminated|2|||
130891537|NCT01088048|471236017|FG000|Overall Study|Adverse Event|7|||
130891538|NCT01088048|471236018|FG001|Overall Study|Adverse Event|9|||
130891539|NCT01088048|471236019|FG002|Overall Study|Adverse Event|7|||
130891540|NCT01088048|471236020|FG003|Overall Study|Adverse Event|5|||
130891541|NCT01088048|471236021|FG004|Overall Study|Adverse Event|6|||
130891542|NCT01088048|471236022|FG005|Overall Study|Adverse Event|3|||
130891543|NCT01088048|471236023|FG006|Overall Study|Adverse Event|3|||
130891544|NCT01088048|471236024|FG007|Overall Study|Adverse Event|0|||
130891545|NCT01088048|471236025|FG008|Overall Study|Adverse Event|2|||
130891546|NCT01088048|471236026|FG009|Overall Study|Adverse Event|2|||
130891547|NCT01088048|471236017|FG000|Overall Study|Withdrew Consent|1|||
130891548|NCT01088048|471236018|FG001|Overall Study|Withdrew Consent|1|||
130891549|NCT01088048|471236019|FG002|Overall Study|Withdrew Consent|1|||
130891550|NCT01088048|471236020|FG003|Overall Study|Withdrew Consent|1|||
130891551|NCT01088048|471236021|FG004|Overall Study|Withdrew Consent|2|||
130891552|NCT01088048|471236022|FG005|Overall Study|Withdrew Consent|1|||
130891553|NCT01088048|471236023|FG006|Overall Study|Withdrew Consent|0|||
130891554|NCT01088048|471236024|FG007|Overall Study|Withdrew Consent|2|||
130891555|NCT01088048|471236025|FG008|Overall Study|Withdrew Consent|2|||
130891556|NCT01088048|471236026|FG009|Overall Study|Withdrew Consent|1|||
130891557|NCT01088048|471236017|FG000|Overall Study|Concomitant Medication Prohibited|1|||
131024217|NCT02677896|471718661|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
131024218|NCT02677896|471718660|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
131024219|NCT02677896|471718661|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
130891558|NCT01088048|471236018|FG001|Overall Study|Concomitant Medication Prohibited|0|||
130891559|NCT01088048|471236019|FG002|Overall Study|Concomitant Medication Prohibited|0|||
130891560|NCT01088048|471236020|FG003|Overall Study|Concomitant Medication Prohibited|0|||
130891561|NCT01088048|471236021|FG004|Overall Study|Concomitant Medication Prohibited|0|||
130891562|NCT01088048|471236022|FG005|Overall Study|Concomitant Medication Prohibited|0|||
130891563|NCT01088048|471236023|FG006|Overall Study|Concomitant Medication Prohibited|0|||
130891564|NCT01088048|471236024|FG007|Overall Study|Concomitant Medication Prohibited|0|||
130891565|NCT01088048|471236025|FG008|Overall Study|Concomitant Medication Prohibited|0|||
130891566|NCT01088048|471236026|FG009|Overall Study|Concomitant Medication Prohibited|0|||
130891567|NCT01088048|471236017|FG000|Overall Study|Investigator Request|2|||
130891568|NCT01088048|471236018|FG001|Overall Study|Investigator Request|2|||
130891569|NCT01088048|471236019|FG002|Overall Study|Investigator Request|0|||
130891570|NCT01088048|471236020|FG003|Overall Study|Investigator Request|0|||
131109393|NCT02683941|472030866|FG000|Open-label Treatment Phase|Other|1|||
131109394|NCT02683941|472030867|FG001|Open-label Treatment Phase|Other|0|||
131109395|NCT02683941|472030866|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
131109396|NCT02683941|472030867|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
131109397|NCT02683941|472030866|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
131109398|NCT02683941|472030867|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
131109399|NCT02683941|472030866|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
131109400|NCT02683941|472030867|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
131109401|NCT02683941|472030866|FG000|Open-label Follow-up Phase|Other|8|||
131109402|NCT02683941|472030867|FG001|Open-label Follow-up Phase|Other|1|||
131109403|NCT00261846|472030868|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
131109404|NCT00261846|472030869|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
131109405|NCT00261846|472030870|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
131109406|NCT00261846|472030871|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131109407|NCT00261846|472030872|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131109408|NCT00261846|472030873|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131109409|NCT00261846|472030874|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131109410|NCT00261846|472030875|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131109411|NCT00261846|472030876|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131109412|NCT00261846|472030877|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131109413|NCT00261846|472030878|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131109414|NCT00261846|472030879|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
131109415|NCT00261846|472030868|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131109416|NCT00261846|472030869|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131109417|NCT00261846|472030870|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131109418|NCT00261846|472030871|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
131109419|NCT00261846|472030872|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131109420|NCT00261846|472030873|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131109421|NCT00261846|472030874|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131109422|NCT00261846|472030875|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131109423|NCT00261846|472030876|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
131109424|NCT00261846|472030877|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131109425|NCT00261846|472030878|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131109426|NCT00261846|472030879|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
131109427|NCT00261846|472030868|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131109428|NCT00261846|472030869|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131109429|NCT00261846|472030870|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131109430|NCT00261846|472030871|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
131109431|NCT00261846|472030872|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
131109432|NCT00261846|472030873|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
131109433|NCT00261846|472030874|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
131109434|NCT00261846|472030875|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
131109435|NCT00261846|472030876|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131109436|NCT00261846|472030877|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
131109437|NCT00261846|472030878|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131109438|NCT00261846|472030879|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
131109439|NCT00261846|472030868|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131109440|NCT00261846|472030869|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131109441|NCT00261846|472030870|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131109442|NCT00261846|472030871|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
131109443|NCT00261846|472030872|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
131109444|NCT00261846|472030873|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131109445|NCT00261846|472030874|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
131109446|NCT00261846|472030875|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131109447|NCT00261846|472030876|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
131109448|NCT00261846|472030877|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
131109449|NCT00261846|472030878|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
131109450|NCT00261846|472030879|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
131109451|NCT00261846|472030868|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
131109452|NCT00261846|472030869|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
131109453|NCT00261846|472030870|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
131109454|NCT00261846|472030871|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
131109455|NCT00261846|472030872|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
131109456|NCT00261846|472030873|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
131109457|NCT00261846|472030874|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
131109458|NCT00261846|472030875|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
131109459|NCT00261846|472030876|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
131109460|NCT00261846|472030877|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
131109461|NCT00261846|472030878|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
130686636|NCT03965091|470479577|FG001|Overall Study|Other than specified|11|||
130686637|NCT03965091|470479578|FG002|Overall Study|Other than specified|8|||
130686638|NCT02576938|470479579|FG000|Overall Study|Adverse Event|5|||
131109462|NCT00261846|472030879|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
131109463|NCT00261846|472030868|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
131109464|NCT00261846|472030869|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
131109465|NCT00261846|472030870|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
131109466|NCT00261846|472030871|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
131109467|NCT00261846|472030872|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
131109468|NCT00261846|472030873|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
131109469|NCT00261846|472030874|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
131109470|NCT00261846|472030875|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
131109471|NCT00261846|472030876|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
131109472|NCT00261846|472030877|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
131109473|NCT00261846|472030878|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
131109474|NCT00261846|472030879|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
131109475|NCT00261846|472030868|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
131109476|NCT00261846|472030869|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
131109477|NCT00261846|472030870|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
131109478|NCT00261846|472030871|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
131109479|NCT00261846|472030872|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
131109480|NCT00261846|472030873|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
131109481|NCT00261846|472030874|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
131109482|NCT00261846|472030875|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
131109483|NCT00261846|472030876|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
131109484|NCT00261846|472030877|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
131109485|NCT00261846|472030878|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
131109486|NCT00261846|472030879|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
131109487|NCT01007448|472030880|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
131109488|NCT01007448|472030881|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
131109489|NCT01007448|472030880|FG000|Overall Study|Staph Skin Infection Flare|1|||
131109490|NCT01007448|472030881|FG001|Overall Study|Staph Skin Infection Flare|0|||
131109491|NCT01007448|472030880|FG000|Overall Study|Participant Leaving the Country|1|||
131109492|NCT01007448|472030881|FG001|Overall Study|Participant Leaving the Country|0|||
131109493|NCT01007448|472030880|FG000|Overall Study|Participant Given Prohibited Medication|1|||
131109494|NCT01007448|472030881|FG001|Overall Study|Participant Given Prohibited Medication|0|||
131109495|NCT01007448|472030880|FG000|Overall Study|Progressive Disease|1|||
131109496|NCT01007448|472030881|FG001|Overall Study|Progressive Disease|2|||
131109497|NCT01007448|472030880|FG000|Overall Study|Lack of Efficacy|2|||
131109498|NCT01007448|472030881|FG001|Overall Study|Lack of Efficacy|0|||
131109499|NCT01007448|472030880|FG000|Overall Study|Withdrawal by Subject|2|||
131109500|NCT01007448|472030881|FG001|Overall Study|Withdrawal by Subject|3|||
131109501|NCT01007448|472030880|FG000|Overall Study|Adverse Event|1|||
131109502|NCT01007448|472030881|FG001|Overall Study|Adverse Event|4|||
131109503|NCT00343252|472030883|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
131109504|NCT00343252|472030884|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
131109505|NCT00343252|472030883|FG000|6 Months (All Treated Participants)|Death|0|||
131109506|NCT00343252|472030884|FG001|6 Months (All Treated Participants)|Death|2|||
131109507|NCT00343252|472030883|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
131109508|NCT00343252|472030884|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
131109509|NCT00343252|472030883|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
131109510|NCT00343252|472030884|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
131109511|NCT00343252|472030883|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
131109512|NCT00343252|472030884|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
131109513|NCT00343252|472030883|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
131109514|NCT00343252|472030884|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
131109515|NCT00343252|472030883|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
131109516|NCT00343252|472030884|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
131109517|NCT00343252|472030883|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
131109518|NCT00343252|472030884|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
131109519|NCT00343252|472030883|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
131109520|NCT00343252|472030884|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
131222661|NCT01270841|472443132|FG003|Overall Study|Enrolled in error|0|||
131109521|NCT00343252|472030883|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
131109522|NCT00343252|472030884|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
131222662|NCT02082912|472443133|FG000|Overall Study|Physician Decision|0|||
131222663|NCT02082912|472443134|FG001|Overall Study|Physician Decision|1|||
130686639|NCT02576938|470479580|FG001|Overall Study|Adverse Event|3|||
130686640|NCT02576938|470479581|FG002|Overall Study|Adverse Event|6|||
130686641|NCT02576938|470479579|FG000|Overall Study|Protocol Violation|1|||
131109523|NCT00343252|472030883|FG000|12 Months (All Treated Participants)|Death|3|||
131109524|NCT00343252|472030884|FG001|12 Months (All Treated Participants)|Death|3|||
131222664|NCT02513459|472443144|FG000|Overall Study|Adverse Event|7|||
130891571|NCT01088048|471236021|FG004|Overall Study|Investigator Request|3|||
130891572|NCT01088048|471236022|FG005|Overall Study|Investigator Request|1|||
130891573|NCT01088048|471236023|FG006|Overall Study|Investigator Request|1|||
130891574|NCT01088048|471236024|FG007|Overall Study|Investigator Request|0|||
130891575|NCT01088048|471236025|FG008|Overall Study|Investigator Request|0|||
130891576|NCT01088048|471236026|FG009|Overall Study|Investigator Request|0|||
130891577|NCT01088048|471236017|FG000|Overall Study|Patient Non-compliance|0|||
130891578|NCT01088048|471236018|FG001|Overall Study|Patient Non-compliance|1|||
130891579|NCT01088048|471236019|FG002|Overall Study|Patient Non-compliance|0|||
130891580|NCT01088048|471236020|FG003|Overall Study|Patient Non-compliance|0|||
130891581|NCT01088048|471236021|FG004|Overall Study|Patient Non-compliance|0|||
130891582|NCT01088048|471236022|FG005|Overall Study|Patient Non-compliance|0|||
130891583|NCT01088048|471236023|FG006|Overall Study|Patient Non-compliance|0|||
130891584|NCT01088048|471236024|FG007|Overall Study|Patient Non-compliance|0|||
130891585|NCT01088048|471236025|FG008|Overall Study|Patient Non-compliance|0|||
130891586|NCT01088048|471236026|FG009|Overall Study|Patient Non-compliance|0|||
130891587|NCT01088048|471236017|FG000|Overall Study|Disease Progression|7|||
130891588|NCT01088048|471236018|FG001|Overall Study|Disease Progression|4|||
130891589|NCT01088048|471236019|FG002|Overall Study|Disease Progression|3|||
130891590|NCT01088048|471236020|FG003|Overall Study|Disease Progression|5|||
130891591|NCT01088048|471236021|FG004|Overall Study|Disease Progression|3|||
130891592|NCT01088048|471236022|FG005|Overall Study|Disease Progression|3|||
130891593|NCT01088048|471236023|FG006|Overall Study|Disease Progression|2|||
130891594|NCT01088048|471236024|FG007|Overall Study|Disease Progression|1|||
130891595|NCT01088048|471236025|FG008|Overall Study|Disease Progression|0|||
130891596|NCT01088048|471236026|FG009|Overall Study|Disease Progression|0|||
130891597|NCT01088048|471236017|FG000|Overall Study|Death|1|||
130891598|NCT01088048|471236018|FG001|Overall Study|Death|5|||
130891599|NCT01088048|471236019|FG002|Overall Study|Death|3|||
130891600|NCT01088048|471236020|FG003|Overall Study|Death|3|||
130891601|NCT01088048|471236021|FG004|Overall Study|Death|1|||
130891602|NCT01088048|471236022|FG005|Overall Study|Death|3|||
130891603|NCT01088048|471236023|FG006|Overall Study|Death|0|||
130891604|NCT01088048|471236024|FG007|Overall Study|Death|0|||
130891605|NCT01088048|471236025|FG008|Overall Study|Death|3|||
130891606|NCT01088048|471236026|FG009|Overall Study|Death|1|||
130891607|NCT01088048|471236017|FG000|Overall Study|Other|3|||
130891608|NCT01088048|471236018|FG001|Overall Study|Other|5|||
130891609|NCT01088048|471236019|FG002|Overall Study|Other|0|||
130891610|NCT01088048|471236020|FG003|Overall Study|Other|0|||
130891611|NCT01088048|471236021|FG004|Overall Study|Other|2|||
130891612|NCT01088048|471236022|FG005|Overall Study|Other|0|||
130891613|NCT01088048|471236023|FG006|Overall Study|Other|0|||
130891614|NCT01088048|471236024|FG007|Overall Study|Other|2|||
130891615|NCT01088048|471236025|FG008|Overall Study|Other|0|||
130891616|NCT01088048|471236026|FG009|Overall Study|Other|0|||
130891617|NCT01039519|471236035|FG000|Treatment|Progressive disease|20|||
130891618|NCT01039519|471236035|FG000|Treatment|Treatment failure|2|||
130891619|NCT01039519|471236035|FG000|Treatment|Adverse Event|3|||
130891620|NCT01039519|471236035|FG000|Treatment|Physician Decision|2|||
130891621|NCT01039519|471236035|FG000|Survival Follow-up|Death|23|||
131024220|NCT02677896|471718660|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
130686642|NCT02576938|470479580|FG001|Overall Study|Protocol Violation|1|||
131024221|NCT02677896|471718661|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
131024222|NCT02677896|471718660|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
131024223|NCT02677896|471718661|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
131024224|NCT02677896|471718660|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
131024225|NCT02677896|471718661|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
131024226|NCT00567489|471718662|FG000|Overall Study|Adverse Event|6|||
131024227|NCT00567489|471718663|FG001|Overall Study|Adverse Event|14|||
131024228|NCT00567489|471718662|FG000|Overall Study|Physician Decision|0|||
131024229|NCT00567489|471718663|FG001|Overall Study|Physician Decision|4|||
131024230|NCT00567489|471718662|FG000|Overall Study|Withdrawal by Subject|0|||
131024231|NCT00567489|471718663|FG001|Overall Study|Withdrawal by Subject|2|||
130686643|NCT02576938|470479581|FG002|Overall Study|Protocol Violation|1|||
130891622|NCT01039519|471236035|FG000|Survival Follow-up|Sponsor decision|4|||
130891623|NCT01330108|471236038|FG000|Overall Study|Withdrawal by Subject|4|||
130891624|NCT00485134|471236039|FG000|Overall Study|Lost to Follow-up|1|||
130891625|NCT00485134|471236040|FG001|Overall Study|Lost to Follow-up|0|||
130891626|NCT00485134|471236041|FG002|Overall Study|Lost to Follow-up|0|||
130891627|NCT00485134|471236042|FG003|Overall Study|Lost to Follow-up|0|||
130891628|NCT00485134|471236043|FG004|Overall Study|Lost to Follow-up|0|||
130891629|NCT00485134|471236044|FG005|Overall Study|Lost to Follow-up|0|||
130891630|NCT00485134|471236045|FG006|Overall Study|Lost to Follow-up|0|||
130891631|NCT00485134|471236046|FG007|Overall Study|Lost to Follow-up|0|||
130891632|NCT00485134|471236039|FG000|Overall Study|Withdrawal by Subject|0|||
130891633|NCT00485134|471236040|FG001|Overall Study|Withdrawal by Subject|1|||
130891634|NCT00485134|471236041|FG002|Overall Study|Withdrawal by Subject|0|||
130891635|NCT00485134|471236042|FG003|Overall Study|Withdrawal by Subject|0|||
130891636|NCT00485134|471236043|FG004|Overall Study|Withdrawal by Subject|0|||
130891637|NCT00485134|471236044|FG005|Overall Study|Withdrawal by Subject|0|||
130891638|NCT00485134|471236045|FG006|Overall Study|Withdrawal by Subject|0|||
130891639|NCT00485134|471236046|FG007|Overall Study|Withdrawal by Subject|0|||
130891640|NCT00485134|471236039|FG000|Overall Study|Change in health status|0|||
130891641|NCT00485134|471236040|FG001|Overall Study|Change in health status|1|||
130891642|NCT00485134|471236041|FG002|Overall Study|Change in health status|2|||
130891643|NCT00485134|471236042|FG003|Overall Study|Change in health status|1|||
130891644|NCT00485134|471236043|FG004|Overall Study|Change in health status|0|||
130891645|NCT00485134|471236044|FG005|Overall Study|Change in health status|1|||
130891646|NCT00485134|471236045|FG006|Overall Study|Change in health status|0|||
130891647|NCT00485134|471236046|FG007|Overall Study|Change in health status|0|||
130891648|NCT00485134|471236039|FG000|Overall Study|Withdrew for adverse event|0|||
130891649|NCT00485134|471236040|FG001|Overall Study|Withdrew for adverse event|0|||
130891650|NCT00485134|471236041|FG002|Overall Study|Withdrew for adverse event|1|||
130891651|NCT00485134|471236042|FG003|Overall Study|Withdrew for adverse event|0|||
130891652|NCT00485134|471236043|FG004|Overall Study|Withdrew for adverse event|0|||
130891653|NCT00485134|471236044|FG005|Overall Study|Withdrew for adverse event|0|||
130891654|NCT00485134|471236045|FG006|Overall Study|Withdrew for adverse event|0|||
130891655|NCT00485134|471236046|FG007|Overall Study|Withdrew for adverse event|0|||
130891656|NCT00485134|471236039|FG000|Overall Study|Positive drug test|0|||
130891657|NCT00485134|471236040|FG001|Overall Study|Positive drug test|0|||
130891658|NCT00485134|471236041|FG002|Overall Study|Positive drug test|0|||
130891659|NCT00485134|471236042|FG003|Overall Study|Positive drug test|0|||
130891660|NCT00485134|471236043|FG004|Overall Study|Positive drug test|2|||
130891661|NCT00485134|471236044|FG005|Overall Study|Positive drug test|1|||
130891662|NCT00485134|471236045|FG006|Overall Study|Positive drug test|0|||
130891663|NCT00485134|471236046|FG007|Overall Study|Positive drug test|0|||
130891664|NCT00485134|471236039|FG000|Overall Study|Non-compliance|0|||
130891665|NCT00485134|471236040|FG001|Overall Study|Non-compliance|0|||
130891666|NCT00485134|471236041|FG002|Overall Study|Non-compliance|0|||
130891667|NCT00485134|471236042|FG003|Overall Study|Non-compliance|0|||
130891668|NCT00485134|471236043|FG004|Overall Study|Non-compliance|1|||
130891669|NCT00485134|471236044|FG005|Overall Study|Non-compliance|2|||
130891670|NCT00485134|471236045|FG006|Overall Study|Non-compliance|2|||
130891671|NCT00485134|471236046|FG007|Overall Study|Non-compliance|0|||
131024232|NCT00567489|471718662|FG000|Overall Study|Renal Transplantation|0|||
131109525|NCT00343252|472030883|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
131109526|NCT00343252|472030884|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
130891672|NCT00485134|471236039|FG000|Overall Study|Unable to comply with study schedule|0|||
131024233|NCT00567489|471718663|FG001|Overall Study|Renal Transplantation|3|||
131024234|NCT00567489|471718662|FG000|Overall Study|Other|1|||
131024235|NCT00567489|471718663|FG001|Overall Study|Other|0|||
131024236|NCT03565315|471718664|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
131024237|NCT03565315|471718665|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
131024238|NCT03565315|471718666|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
131024239|NCT03565315|471718667|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
131024240|NCT01083316|471718671|FG000|Overall Study|Adverse Event|2|||
131024241|NCT01083316|471718671|FG000|Overall Study|Withdrawal by Subject|1|||
131024242|NCT00419341|471718672|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
131024243|NCT00419341|471718672|FG000|Wash in/Wash Out Period|Adverse Event|2|||
131024244|NCT00419341|471718672|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
131024245|NCT00419341|471718672|FG000|Efficacy Period|Withdrawal by Subject|6|||
131024246|NCT00419341|471718672|FG000|Efficacy Period|Protocol Violation|1|||
131024247|NCT00419341|471718672|FG000|Efficacy Period|Lost to Follow-up|1|||
131024248|NCT00419341|471718672|FG000|Efficacy Period|Non-compliance|1|||
131024249|NCT00419341|471718672|FG000|Efficacy Period|Termination of study site|1|||
131024250|NCT04200365|471718673|FG000|Overall Study|Adverse Event|2|||
131024251|NCT04200365|471718673|FG000|Overall Study|Progressive Disease|4|||
131024252|NCT04200365|471718673|FG000|Overall Study|Lack of Efficacy|1|||
131024253|NCT04200365|471718673|FG000|Overall Study|Study Closure|4|||
131024254|NCT01499199|471718675|FG000|Overall Study|Adverse Event|1|||
131109527|NCT00343252|472030883|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
131222665|NCT02513459|472443144|FG000|Overall Study|Withdrew consent|5|||
131024255|NCT01499199|471718675|FG000|Overall Study|Lack of Efficacy|1|||
131024256|NCT02318134|471718686|FG000|Overall Study|Withdrawal by Subject|2|||
131024257|NCT02318134|471718687|FG001|Overall Study|Withdrawal by Subject|1|||
131024258|NCT04766034|471718688|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
130891673|NCT00485134|471236040|FG001|Overall Study|Unable to comply with study schedule|0|||
130891674|NCT00485134|471236041|FG002|Overall Study|Unable to comply with study schedule|0|||
130891675|NCT00485134|471236042|FG003|Overall Study|Unable to comply with study schedule|0|||
130891676|NCT00485134|471236043|FG004|Overall Study|Unable to comply with study schedule|0|||
130891677|NCT00485134|471236044|FG005|Overall Study|Unable to comply with study schedule|0|||
130891678|NCT00485134|471236045|FG006|Overall Study|Unable to comply with study schedule|0|||
130891679|NCT00485134|471236046|FG007|Overall Study|Unable to comply with study schedule|1|||
130891680|NCT00485134|471236039|FG000|Overall Study|Pregnancy|0|||
130891681|NCT00485134|471236040|FG001|Overall Study|Pregnancy|0|||
130891682|NCT00485134|471236041|FG002|Overall Study|Pregnancy|0|||
130891683|NCT00485134|471236042|FG003|Overall Study|Pregnancy|0|||
130891684|NCT00485134|471236043|FG004|Overall Study|Pregnancy|0|||
130891685|NCT00485134|471236044|FG005|Overall Study|Pregnancy|0|||
130891686|NCT00485134|471236045|FG006|Overall Study|Pregnancy|1|||
130891687|NCT00485134|471236046|FG007|Overall Study|Pregnancy|0|||
130891688|NCT04294680|471236047|FG000|Overall Study|Withdrawal by Subject|2|||
130891689|NCT04294680|471236048|FG001|Overall Study|Withdrawal by Subject|1|||
130891690|NCT04294680|471236047|FG000|Overall Study|Follow-up visits completed outside of window|1|||
130891691|NCT04294680|471236048|FG001|Overall Study|Follow-up visits completed outside of window|0|||
130891692|NCT04027608|471236049|FG000|Overall Study|Withdrawal by Subject|13|||
130891693|NCT04027608|471236050|FG001|Overall Study|Withdrawal by Subject|2|||
130891694|NCT04027608|471236049|FG000|Overall Study|Protocol Violation|2|||
130891695|NCT04027608|471236050|FG001|Overall Study|Protocol Violation|1|||
130891696|NCT04027608|471236049|FG000|Overall Study|Physician Decision|1|||
130891697|NCT04027608|471236050|FG001|Overall Study|Physician Decision|0|||
130891698|NCT04027608|471236049|FG000|Overall Study|Lost to Follow-up|20|||
130891699|NCT04027608|471236050|FG001|Overall Study|Lost to Follow-up|4|||
130891700|NCT00924027|471236058|FG000|Overall Study|Lost to Further Follow-Up|4|||
130891701|NCT00924027|471236059|FG001|Overall Study|Lost to Further Follow-Up|0|||
130891702|NCT00924027|471236060|FG002|Overall Study|Lost to Further Follow-Up|0|||
130891703|NCT00924027|471236061|FG003|Overall Study|Lost to Further Follow-Up|0|||
130891704|NCT00924027|471236058|FG000|Overall Study|Physician Decision|1|||
130891705|NCT00924027|471236059|FG001|Overall Study|Physician Decision|0|||
130891706|NCT00924027|471236060|FG002|Overall Study|Physician Decision|0|||
130891707|NCT00924027|471236061|FG003|Overall Study|Physician Decision|1|||
130891708|NCT00924027|471236058|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
130891709|NCT00924027|471236059|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
130891710|NCT00924027|471236060|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
130891711|NCT00924027|471236061|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
130891712|NCT00924027|471236058|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
130891713|NCT00924027|471236059|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
130891714|NCT00924027|471236060|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
130891715|NCT00924027|471236061|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
130891716|NCT00924027|471236058|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
130891717|NCT00924027|471236059|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
130891718|NCT00924027|471236060|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
130891719|NCT00924027|471236061|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
130891720|NCT02355184|471236062|FG000|Overall Study|Lost to Follow-up|2|||
130891721|NCT02355184|471236062|FG000|Overall Study|Study Terminated|10|||
130891722|NCT04193189|471236063|FG000|Overall Study|Lost to Follow-up|9|||
130891723|NCT04193189|471236064|FG001|Overall Study|Lost to Follow-up|7|||
130891724|NCT04193189|471236065|FG002|Overall Study|Lost to Follow-up|9|||
130891725|NCT04193189|471236066|FG003|Overall Study|Lost to Follow-up|0|||
130891726|NCT04193189|471236063|FG000|Overall Study|Withdrawal by Subject|1|||
130891727|NCT04193189|471236064|FG001|Overall Study|Withdrawal by Subject|2|||
130891728|NCT04193189|471236065|FG002|Overall Study|Withdrawal by Subject|2|||
130891729|NCT04193189|471236066|FG003|Overall Study|Withdrawal by Subject|0|||
130891730|NCT04193189|471236063|FG000|Overall Study|Death|1|||
130891731|NCT04193189|471236064|FG001|Overall Study|Death|1|||
130891732|NCT04193189|471236065|FG002|Overall Study|Death|0|||
130891733|NCT04193189|471236066|FG003|Overall Study|Death|0|||
130891734|NCT04193189|471236063|FG000|Overall Study|Protocol Violation|0|||
130686644|NCT02576938|470479579|FG000|Overall Study|Withdrawal by Subject|3|||
130891735|NCT04193189|471236064|FG001|Overall Study|Protocol Violation|0|||
130891736|NCT04193189|471236065|FG002|Overall Study|Protocol Violation|0|||
131024259|NCT04766034|471718689|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
131024260|NCT04766034|471718690|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
131024261|NCT04766034|471718691|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
131024262|NCT04766034|471718692|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
131024263|NCT04766034|471718688|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
131024264|NCT04766034|471718689|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
131222666|NCT02513459|472443144|FG000|Overall Study|Loss of efficacy|2|||
131222667|NCT02513459|472443144|FG000|Overall Study|Pregnancy|2|||
130891737|NCT04193189|471236066|FG003|Overall Study|Protocol Violation|1|||
130891738|NCT02840799|471237611|FG000|Phase 1|Physician Decision|1|||
130891739|NCT02840799|471237612|FG001|Phase 1|Physician Decision|3|||
130891740|NCT02840799|471237611|FG000|Phase 1|Withdrawal by Subject|4|||
130891741|NCT02840799|471237612|FG001|Phase 1|Withdrawal by Subject|0|||
130891742|NCT02840799|471237611|FG000|Phase 2 (Crossover)|Adverse Event|0|||
130891743|NCT02840799|471237612|FG001|Phase 2 (Crossover)|Adverse Event|1|||
130891744|NCT02840799|471237611|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
130891745|NCT02840799|471237612|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
130891746|NCT02565784|471237613|FG000|First Treatment|Adverse Event|1|||
130891747|NCT02565784|471237613|FG000|First Treatment|Withdrawal by Subject|1|||
130891748|NCT02565784|471237613|FG000|Second Treatment|Withdrawal by Subject|2|||
130891749|NCT00552188|471237623|FG000|Overall Study|Adverse Event|0|||
130891750|NCT00552188|471237624|FG001|Overall Study|Adverse Event|2|||
130891751|NCT00552188|471237623|FG000|Overall Study|Lost to Follow-up|2|||
130891752|NCT00552188|471237624|FG001|Overall Study|Lost to Follow-up|1|||
130891753|NCT00552188|471237623|FG000|Overall Study|Withdrawal of consent|0|||
130891754|NCT00552188|471237624|FG001|Overall Study|Withdrawal of consent|1|||
130891755|NCT00552188|471237623|FG000|Overall Study|Subject returned to home country|0|||
130891756|NCT00552188|471237624|FG001|Overall Study|Subject returned to home country|1|||
130891757|NCT00476008|471237637|FG000|Overall Study|Adverse Event|4|||
130891758|NCT00476008|471237638|FG001|Overall Study|Adverse Event|4|||
130891759|NCT00476008|471237637|FG000|Overall Study|Placebo concerns|2|||
130891760|NCT00476008|471237638|FG001|Overall Study|Placebo concerns|2|||
130891761|NCT00476008|471237637|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
130891762|NCT00476008|471237638|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
130891763|NCT00476008|471237637|FG000|Overall Study|Withdrawal by Subject|0|||
130891764|NCT00476008|471237638|FG001|Overall Study|Withdrawal by Subject|1|||
130891765|NCT00476008|471237637|FG000|Overall Study|Death|1|||
130891766|NCT00476008|471237638|FG001|Overall Study|Death|0|||
130891767|NCT00792571|471237640|FG000|Overall Study|Death|1|||
130891768|NCT00792571|471237640|FG000|Overall Study|Adverse Event|4|||
130891769|NCT00792571|471237640|FG000|Overall Study|Withdrawal by Subject|1|||
130891770|NCT00792571|471237640|FG000|Overall Study|Other|4|||
130891771|NCT02600819|471237641|FG000|GEN Phase|Adverse Event|2|||
130891772|NCT02600819|471237642|FG001|GEN Phase|Adverse Event|0|||
130891773|NCT02600819|471237641|FG000|GEN Phase|Death|2|||
130891774|NCT02600819|471237642|FG001|GEN Phase|Death|0|||
130891775|NCT02600819|471237641|FG000|GEN Phase|Investigator's Discretion|4|||
130891776|NCT02600819|471237642|FG001|GEN Phase|Investigator's Discretion|0|||
130891777|NCT02600819|471237641|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
130891778|NCT02600819|471237642|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
130891779|NCT02600819|471237641|FG000|GEN Phase|Withdrew Consent|5|||
130891780|NCT02600819|471237642|FG001|GEN Phase|Withdrew Consent|0|||
130686645|NCT02576938|470479580|FG001|Overall Study|Withdrawal by Subject|2|||
130686646|NCT02576938|470479581|FG002|Overall Study|Withdrawal by Subject|4|||
130686647|NCT02576938|470479579|FG000|Overall Study|Lack of Efficacy|9|||
130686648|NCT02576938|470479580|FG001|Overall Study|Lack of Efficacy|4|||
130686649|NCT02576938|470479581|FG002|Overall Study|Lack of Efficacy|0|||
130891781|NCT02600819|471237641|FG000|GEN Phase|Lost to Follow-up|2|||
130891782|NCT02600819|471237642|FG001|GEN Phase|Lost to Follow-up|0|||
130891783|NCT03790696|471237643|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
130891784|NCT03790696|471237644|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
130891785|NCT01149148|471237645|FG000|Overall Study|Lost to Follow-up|1|||
130891786|NCT01149148|471237646|FG001|Overall Study|Lost to Follow-up|2|||
130891787|NCT01149148|471237645|FG000|Overall Study|Death|1|||
131024265|NCT04766034|471718690|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
131222668|NCT02513459|472443144|FG000|Overall Study|Subject decision|2|||
130891788|NCT01149148|471237646|FG001|Overall Study|Death|0|||
130891789|NCT03436082|471237647|FG000|Overall Study|Did not undergo procedure|1|||
130891790|NCT03436082|471237648|FG001|Overall Study|Did not undergo procedure|0|||
130891791|NCT00950859|471237651|FG000|Overall Study|Adverse Event|3|||
130891792|NCT00950859|471237652|FG001|Overall Study|Adverse Event|3|||
130891793|NCT00950859|471237651|FG000|Overall Study|Insufficient Viral Load Response|12|||
130891794|NCT00950859|471237652|FG001|Overall Study|Insufficient Viral Load Response|3|||
130891795|NCT00950859|471237651|FG000|Overall Study|Protocol Violation|1|||
130891796|NCT00950859|471237652|FG001|Overall Study|Protocol Violation|1|||
130686650|NCT02576938|470479579|FG000|Overall Study|Lost to Follow-up|2|||
130686651|NCT02576938|470479580|FG001|Overall Study|Lost to Follow-up|0|||
130686652|NCT02576938|470479581|FG002|Overall Study|Lost to Follow-up|1|||
130891797|NCT00950859|471237651|FG000|Overall Study|Lost to Follow-up|0|||
130891798|NCT00950859|471237652|FG001|Overall Study|Lost to Follow-up|3|||
130891799|NCT02563067|471237655|FG000|Overall Study|Subject/guardian decision|14|||
130891800|NCT02563067|471237656|FG001|Overall Study|Subject/guardian decision|20|||
130891801|NCT02563067|471237657|FG002|Overall Study|Subject/guardian decision|16|||
130891802|NCT02563067|471237655|FG000|Overall Study|Physician Decision|0|||
130891803|NCT02563067|471237656|FG001|Overall Study|Physician Decision|1|||
130891804|NCT02563067|471237657|FG002|Overall Study|Physician Decision|3|||
130891805|NCT02563067|471237655|FG000|Overall Study|Lost to Follow-up|1|||
130891806|NCT02563067|471237656|FG001|Overall Study|Lost to Follow-up|2|||
130891807|NCT02563067|471237657|FG002|Overall Study|Lost to Follow-up|0|||
130891808|NCT02563067|471237655|FG000|Overall Study|Technical problems|0|||
130891809|NCT02563067|471237656|FG001|Overall Study|Technical problems|1|||
130891810|NCT02563067|471237657|FG002|Overall Study|Technical problems|0|||
130891811|NCT02563067|471237655|FG000|Overall Study|Lack of Efficacy|1|||
131109528|NCT00343252|472030884|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
130686653|NCT02576938|470479579|FG000|Overall Study|Physician Decision|0|||
130686654|NCT02576938|470479580|FG001|Overall Study|Physician Decision|1|||
130686655|NCT02576938|470479581|FG002|Overall Study|Physician Decision|0|||
130686656|NCT02576938|470479579|FG000|Overall Study|Met Exclusion Criteria|0|||
130686657|NCT02576938|470479580|FG001|Overall Study|Met Exclusion Criteria|1|||
130686658|NCT02576938|470479581|FG002|Overall Study|Met Exclusion Criteria|0|||
130686659|NCT03500341|470479582|FG000|Overall Study|Withdrawn prior to Completion|2|||
130686660|NCT00003659|470479592|FG000|Overall Study|Withdrawal by Subject|3|||
130686661|NCT04022954|470479593|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
130686662|NCT04022954|470479593|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
130686663|NCT04022954|470479593|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
130686664|NCT03017885|470479594|FG000|Overall Study|Adverse Event|2|||
130686665|NCT03017885|470479595|FG001|Overall Study|Adverse Event|0|||
130686666|NCT03017885|470479596|FG002|Overall Study|Adverse Event|0|||
130686667|NCT03017885|470479597|FG003|Overall Study|Adverse Event|0|||
130686668|NCT03017885|470479598|FG004|Overall Study|Adverse Event|0|||
130686669|NCT03017885|470479599|FG005|Overall Study|Adverse Event|0|||
130686670|NCT03017885|470479594|FG000|Overall Study|Progression of disease|4|||
130686671|NCT03017885|470479595|FG001|Overall Study|Progression of disease|3|||
130686672|NCT03017885|470479596|FG002|Overall Study|Progression of disease|4|||
130686673|NCT03017885|470479597|FG003|Overall Study|Progression of disease|0|||
130686674|NCT03017885|470479598|FG004|Overall Study|Progression of disease|0|||
130686675|NCT03017885|470479599|FG005|Overall Study|Progression of disease|0|||
130686676|NCT03017885|470479594|FG000|Overall Study|Other than listed|1|||
130686677|NCT03017885|470479595|FG001|Overall Study|Other than listed|2|||
130686678|NCT03017885|470479596|FG002|Overall Study|Other than listed|1|||
130686679|NCT03017885|470479597|FG003|Overall Study|Other than listed|0|||
130686680|NCT03017885|470479598|FG004|Overall Study|Other than listed|0|||
130686681|NCT03017885|470479599|FG005|Overall Study|Other than listed|0|||
130686682|NCT03017885|470479594|FG000|Overall Study|Lost to Follow-up|2|||
130686683|NCT03017885|470479595|FG001|Overall Study|Lost to Follow-up|0|||
130686684|NCT03017885|470479596|FG002|Overall Study|Lost to Follow-up|3|||
130686685|NCT03017885|470479597|FG003|Overall Study|Lost to Follow-up|0|||
130686686|NCT03017885|470479598|FG004|Overall Study|Lost to Follow-up|0|||
130686687|NCT03017885|470479599|FG005|Overall Study|Lost to Follow-up|0|||
130686688|NCT03017885|470479594|FG000|Overall Study|Change to other anti-cancer therapy|0|||
130686689|NCT03017885|470479595|FG001|Overall Study|Change to other anti-cancer therapy|0|||
130686690|NCT03017885|470479596|FG002|Overall Study|Change to other anti-cancer therapy|1|||
130686691|NCT03017885|470479597|FG003|Overall Study|Change to other anti-cancer therapy|0|||
130686692|NCT03017885|470479598|FG004|Overall Study|Change to other anti-cancer therapy|0|||
130686693|NCT03017885|470479599|FG005|Overall Study|Change to other anti-cancer therapy|0|||
130686694|NCT00984126|470479603|FG000|Overall Study|Protocol Violation|0|||
130686695|NCT00984126|470479604|FG001|Overall Study|Protocol Violation|0|||
130686696|NCT00984126|470479605|FG002|Overall Study|Protocol Violation|1|||
130686697|NCT00984126|470479606|FG003|Overall Study|Protocol Violation|2|||
130686698|NCT00984126|470479603|FG000|Overall Study|Adverse Event|0|||
130686699|NCT00984126|470479604|FG001|Overall Study|Adverse Event|0|||
130686700|NCT00984126|470479605|FG002|Overall Study|Adverse Event|0|||
130686701|NCT00984126|470479606|FG003|Overall Study|Adverse Event|2|||
130686702|NCT00984126|470479603|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
130686703|NCT00984126|470479604|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
130686704|NCT00984126|470479605|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
131109529|NCT00343252|472030883|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
131109530|NCT00343252|472030884|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
131109531|NCT00343252|472030883|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
131109532|NCT00343252|472030884|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
131109533|NCT00343252|472030883|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
131109534|NCT00343252|472030884|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
131109535|NCT00343252|472030883|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
131109536|NCT00343252|472030884|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
131109537|NCT00343252|472030883|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
131109538|NCT00343252|472030884|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
131109539|NCT00343252|472030883|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
131109540|NCT00343252|472030884|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
131109541|NCT00343252|472030883|FG000|18 Months (All Treated Participants)|Death|4|||
130686705|NCT00984126|470479606|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
130686706|NCT00984126|470479603|FG000|Overall Study|Withdrawal criteria|0|||
130686707|NCT00984126|470479604|FG001|Overall Study|Withdrawal criteria|1|||
131109542|NCT00343252|472030884|FG001|18 Months (All Treated Participants)|Death|5|||
130686708|NCT00984126|470479605|FG002|Overall Study|Withdrawal criteria|3|||
130686709|NCT00984126|470479606|FG003|Overall Study|Withdrawal criteria|9|||
130686710|NCT01001208|470479607|FG000|Overall Study|Adverse Event|10|||
130686711|NCT01001208|470479608|FG001|Overall Study|Adverse Event|5|||
130891812|NCT02563067|471237656|FG001|Overall Study|Lack of Efficacy|0|||
130891813|NCT02563067|471237657|FG002|Overall Study|Lack of Efficacy|0|||
130891814|NCT02563067|471237655|FG000|Overall Study|Death|0|||
130891815|NCT02563067|471237656|FG001|Overall Study|Death|1|||
130891816|NCT02563067|471237657|FG002|Overall Study|Death|1|||
130891817|NCT02563067|471237655|FG000|Overall Study|Adverse Event|2|||
130891818|NCT02563067|471237656|FG001|Overall Study|Adverse Event|1|||
130891819|NCT02563067|471237657|FG002|Overall Study|Adverse Event|0|||
130891820|NCT02563067|471237655|FG000|Overall Study|Death post Treatment/safety period|1|||
130891821|NCT02563067|471237656|FG001|Overall Study|Death post Treatment/safety period|0|||
130891822|NCT02563067|471237657|FG002|Overall Study|Death post Treatment/safety period|0|||
130891823|NCT03544333|471237663|FG000|Overall Study|Withdrawal by Subject|1|||
130891824|NCT03544333|471237664|FG001|Overall Study|Withdrawal by Subject|0|||
130891825|NCT00243269|471237665|FG000|Overall Study|Protocol Violation|2|||
130891826|NCT00243269|471237666|FG001|Overall Study|Protocol Violation|1|||
130891827|NCT00243269|471237667|FG002|Overall Study|Protocol Violation|0|||
130891828|NCT00243269|471237668|FG003|Overall Study|Protocol Violation|1|||
130891829|NCT00243269|471237665|FG000|Overall Study|Lost to Follow-up|1|||
130891830|NCT00243269|471237666|FG001|Overall Study|Lost to Follow-up|0|||
130891831|NCT00243269|471237667|FG002|Overall Study|Lost to Follow-up|1|||
130891832|NCT00243269|471237668|FG003|Overall Study|Lost to Follow-up|3|||
130891833|NCT00970684|471237670|FG000|Overall Study|Lack of Efficacy|5|||
130891834|NCT00970684|471237670|FG000|Overall Study|Adverse Event|4|||
130891835|NCT00970684|471237670|FG000|Overall Study|Withdrawal by Subject|1|||
130891836|NCT00481091|471237671|FG000|Overall Study|Withdrawal by Subject|0|||
130891837|NCT00481091|471237672|FG001|Overall Study|Withdrawal by Subject|1|||
130891838|NCT00481091|471237673|FG002|Overall Study|Withdrawal by Subject|1|||
130891839|NCT00481091|471237674|FG003|Overall Study|Withdrawal by Subject|0|||
130891840|NCT00481091|471237675|FG004|Overall Study|Withdrawal by Subject|0|||
130891841|NCT00481091|471237676|FG005|Overall Study|Withdrawal by Subject|0|||
130891842|NCT00481091|471237677|FG006|Overall Study|Withdrawal by Subject|0|||
130891843|NCT00481091|471237678|FG007|Overall Study|Withdrawal by Subject|0|||
130891844|NCT00481091|471237679|FG008|Overall Study|Withdrawal by Subject|1|||
130891845|NCT00481091|471237680|FG009|Overall Study|Withdrawal by Subject|6|||
130891846|NCT00481091|471237671|FG000|Overall Study|Other, Not Specified|0|||
130891847|NCT00481091|471237672|FG001|Overall Study|Other, Not Specified|1|||
130891848|NCT00481091|471237673|FG002|Overall Study|Other, Not Specified|1|||
130891849|NCT00481091|471237674|FG003|Overall Study|Other, Not Specified|0|||
130891850|NCT00481091|471237675|FG004|Overall Study|Other, Not Specified|0|||
130891851|NCT00481091|471237676|FG005|Overall Study|Other, Not Specified|1|||
130891852|NCT00481091|471237677|FG006|Overall Study|Other, Not Specified|0|||
130891853|NCT00481091|471237678|FG007|Overall Study|Other, Not Specified|0|||
130891854|NCT00481091|471237679|FG008|Overall Study|Other, Not Specified|0|||
130891855|NCT00481091|471237680|FG009|Overall Study|Other, Not Specified|4|||
130891856|NCT00481091|471237671|FG000|Overall Study|Adverse Event|1|||
130891857|NCT00481091|471237672|FG001|Overall Study|Adverse Event|2|||
130891858|NCT00481091|471237673|FG002|Overall Study|Adverse Event|0|||
130891859|NCT00481091|471237674|FG003|Overall Study|Adverse Event|1|||
130891860|NCT00481091|471237675|FG004|Overall Study|Adverse Event|1|||
130891861|NCT00481091|471237676|FG005|Overall Study|Adverse Event|1|||
130891862|NCT00481091|471237677|FG006|Overall Study|Adverse Event|2|||
130891863|NCT00481091|471237678|FG007|Overall Study|Adverse Event|1|||
130891864|NCT00481091|471237679|FG008|Overall Study|Adverse Event|1|||
131024266|NCT04766034|471718691|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
131024267|NCT04766034|471718692|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
131024268|NCT04766034|471718688|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
131024269|NCT04766034|471718689|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
131024270|NCT04766034|471718690|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
131024271|NCT04766034|471718691|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
131024272|NCT04766034|471718692|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
131024273|NCT04766034|471718688|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
131024274|NCT04766034|471718689|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
130891865|NCT00481091|471237680|FG009|Overall Study|Adverse Event|6|||
130891866|NCT00481091|471237671|FG000|Overall Study|Progressive disease clinical|0|||
130891867|NCT00481091|471237672|FG001|Overall Study|Progressive disease clinical|0|||
130891868|NCT00481091|471237673|FG002|Overall Study|Progressive disease clinical|0|||
130891869|NCT00481091|471237674|FG003|Overall Study|Progressive disease clinical|0|||
130891870|NCT00481091|471237675|FG004|Overall Study|Progressive disease clinical|0|||
130891871|NCT00481091|471237676|FG005|Overall Study|Progressive disease clinical|0|||
130891872|NCT00481091|471237677|FG006|Overall Study|Progressive disease clinical|0|||
130891873|NCT00481091|471237678|FG007|Overall Study|Progressive disease clinical|0|||
130686712|NCT01001208|470479607|FG000|Overall Study|Lost to Follow-up|5|||
130686713|NCT01001208|470479608|FG001|Overall Study|Lost to Follow-up|9|||
130686714|NCT01001208|470479607|FG000|Overall Study|Physician Decision|1|||
130686715|NCT01001208|470479608|FG001|Overall Study|Physician Decision|0|||
130686716|NCT01001208|470479607|FG000|Overall Study|Withdrawal by Subject|4|||
130686717|NCT01001208|470479608|FG001|Overall Study|Withdrawal by Subject|5|||
130686718|NCT01001208|470479607|FG000|Overall Study|Ineligibility Determined|4|||
130686719|NCT01001208|470479608|FG001|Overall Study|Ineligibility Determined|2|||
130686720|NCT01001208|470479607|FG000|Overall Study|Noncompliance|4|||
130686721|NCT01001208|470479608|FG001|Overall Study|Noncompliance|7|||
130686722|NCT01001208|470479607|FG000|Overall Study|Disease Progression|0|||
130686723|NCT01001208|470479608|FG001|Overall Study|Disease Progression|3|||
130686724|NCT01001208|470479607|FG000|Overall Study|Other|0|||
130686725|NCT01001208|470479608|FG001|Overall Study|Other|2|||
130686726|NCT01864174|470479609|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
130686727|NCT01864174|470479610|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
130686728|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
130686729|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
130686730|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
130686731|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
130686732|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
130686733|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
130686734|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Death|1|||
130686735|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Death|0|||
130686736|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
130686737|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
130686738|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
130767079|NCT00090584|470770717|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
130767080|NCT00090584|470770718|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
130686739|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
130686740|NCT01864174|470479609|FG000|Double Blind - Compliant Randomized|Other|6|||
130686741|NCT01864174|470479610|FG001|Double Blind - Compliant Randomized|Other|10|||
130686742|NCT01864174|470479609|FG000|Off Treatment Follow-Up|Other|2|||
130686743|NCT01864174|470479610|FG001|Off Treatment Follow-Up|Other|0|||
130686744|NCT01864174|470479609|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
130686745|NCT01864174|470479610|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
130686746|NCT03546842|470479614|FG000|Overall Study|Protocol Violation|1|||
130686747|NCT03546842|470479614|FG000|Overall Study|Withdrawal by Subject|2|||
130686748|NCT01723397|470479619|FG000|Study Period 1|Protocol Violation|0|||
130686749|NCT01723397|470479620|FG001|Study Period 1|Protocol Violation|1|||
130686750|NCT01723397|470479619|FG000|Study Period 2|Protocol Violation|0|||
130686751|NCT01723397|470479620|FG001|Study Period 2|Protocol Violation|1|||
130686752|NCT00468286|470479623|FG000|Overall Study|Adverse Event|1|||
130686753|NCT00468286|470479624|FG001|Overall Study|Adverse Event|6|||
130686754|NCT00468286|470479623|FG000|Overall Study|Protocol Violation|2|||
130686755|NCT00468286|470479624|FG001|Overall Study|Protocol Violation|2|||
130686756|NCT00468286|470479623|FG000|Overall Study|Withdrawal by Subject|4|||
130686757|NCT00468286|470479624|FG001|Overall Study|Withdrawal by Subject|3|||
130686758|NCT00468286|470479623|FG000|Overall Study|Physician Decision|0|||
130686759|NCT00468286|470479624|FG001|Overall Study|Physician Decision|1|||
130686760|NCT02158663|470479625|FG000|Overall Study|Withdrawal by Subject|5|||
130686761|NCT02158663|470479626|FG001|Overall Study|Withdrawal by Subject|4|||
130686762|NCT00537979|470479627|FG000|Overall Study|Adverse Event|2|||
130686763|NCT00537979|470479628|FG001|Overall Study|Adverse Event|2|||
130686764|NCT00537979|470479627|FG000|Overall Study|Withdrawal by Subject|1|||
130686765|NCT00537979|470479628|FG001|Overall Study|Withdrawal by Subject|4|||
130686766|NCT00537979|470479627|FG000|Overall Study|Lost to Follow-up|1|||
131024275|NCT04766034|471718690|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
131024276|NCT04766034|471718691|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
131024277|NCT04766034|471718692|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
131024278|NCT01976312|471718693|FG000|Overall Study|Pregnancy|0|||
131024279|NCT01976312|471718694|FG001|Overall Study|Pregnancy|1|||
131024280|NCT01976312|471718693|FG000|Overall Study|Lost to Follow-up|2|||
130686767|NCT00537979|470479628|FG001|Overall Study|Lost to Follow-up|4|||
130686768|NCT00537979|470479627|FG000|Overall Study|Lack of Efficacy|0|||
130686769|NCT00537979|470479628|FG001|Overall Study|Lack of Efficacy|1|||
130686770|NCT00537979|470479627|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
130686771|NCT00537979|470479628|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
130686772|NCT00537979|470479627|FG000|Overall Study|Death|0|||
130686773|NCT00537979|470479628|FG001|Overall Study|Death|3|||
130686774|NCT00537979|470479627|FG000|Overall Study|Kidney transplant|0|||
130686775|NCT00537979|470479628|FG001|Overall Study|Kidney transplant|3|||
130686776|NCT00537979|470479627|FG000|Overall Study|Heart failure|0|||
131024281|NCT01976312|471718694|FG001|Overall Study|Lost to Follow-up|0|||
131024282|NCT01976312|471718693|FG000|Overall Study|Withdrawal by Subject|7|||
130891874|NCT00481091|471237679|FG008|Overall Study|Progressive disease clinical|1|||
130891875|NCT00481091|471237680|FG009|Overall Study|Progressive disease clinical|7|||
130891876|NCT00481091|471237671|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
130891877|NCT00481091|471237672|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
130891878|NCT00481091|471237673|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130891879|NCT00481091|471237674|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130891880|NCT00481091|471237675|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130891881|NCT00481091|471237676|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
130891882|NCT00481091|471237677|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130891883|NCT00481091|471237678|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130891884|NCT00481091|471237679|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130891885|NCT00481091|471237680|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130891886|NCT00481091|471237671|FG000|Overall Study|Progressive disease other|1|||
130891887|NCT00481091|471237672|FG001|Overall Study|Progressive disease other|1|||
130891888|NCT00481091|471237673|FG002|Overall Study|Progressive disease other|0|||
130891889|NCT00481091|471237674|FG003|Overall Study|Progressive disease other|1|||
131109543|NCT00343252|472030883|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
131109544|NCT00343252|472030884|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
131109545|NCT00343252|472030883|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
131109546|NCT00343252|472030884|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
131109547|NCT00343252|472030883|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
131109548|NCT00343252|472030884|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
131109549|NCT00343252|472030883|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
131109550|NCT00343252|472030884|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
131109551|NCT00343252|472030883|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
131109552|NCT00343252|472030884|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
131109553|NCT00343252|472030883|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
131109554|NCT00343252|472030884|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
131109555|NCT00343252|472030883|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
131109556|NCT00343252|472030884|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
131109557|NCT01740323|472030885|FG000|Overall Study|Adverse Event|1|||
131109558|NCT01740323|472030886|FG001|Overall Study|Adverse Event|0|||
131109559|NCT01740323|472030885|FG000|Overall Study|Randomized but did not take study drug|1|||
131109560|NCT01740323|472030886|FG001|Overall Study|Randomized but did not take study drug|0|||
131109561|NCT01054846|472030887|FG000|Overall Study|Lost to Follow-up|76|||
131109562|NCT01054846|472030888|FG001|Overall Study|Lost to Follow-up|17|||
131109563|NCT02446886|472030889|FG000|Overall Study|Adverse Event|1|||
131109564|NCT02446886|472030890|FG001|Overall Study|Adverse Event|3|||
131109565|NCT02446886|472030889|FG000|Overall Study|Withdrawal by Subject|1|||
131109566|NCT02446886|472030890|FG001|Overall Study|Withdrawal by Subject|1|||
131109567|NCT00928447|472030893|FG000|Overall Study|Withdrawal by Subject|1|||
131109568|NCT00928447|472030893|FG000|Overall Study|Investigator's decision|1|||
131109569|NCT01259284|472030896|FG000|Overall Study|Study Termination|2|||
131109570|NCT01259284|472030897|FG001|Overall Study|Study Termination|0|||
131109571|NCT01259284|472030898|FG002|Overall Study|Study Termination|0|||
131109572|NCT03353350|472030900|FG000|30-week Core Treatment Period|Protocol Violation|1|||
131109573|NCT03353350|472030901|FG001|30-week Core Treatment Period|Protocol Violation|1|||
131109574|NCT03353350|472030902|FG002|30-week Core Treatment Period|Protocol Violation|1|||
131109575|NCT03353350|472030903|FG003|30-week Core Treatment Period|Protocol Violation|0|||
131109576|NCT03353350|472030900|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
131109577|NCT03353350|472030901|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
131109578|NCT03353350|472030902|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
131109579|NCT03353350|472030903|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
131109580|NCT03353350|472030900|FG000|30-week Core Treatment Period|Adverse Event|0|||
131109581|NCT03353350|472030901|FG001|30-week Core Treatment Period|Adverse Event|4|||
131109582|NCT03353350|472030902|FG002|30-week Core Treatment Period|Adverse Event|2|||
131109583|NCT03353350|472030903|FG003|30-week Core Treatment Period|Adverse Event|3|||
131109584|NCT03353350|472030900|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
130891890|NCT00481091|471237675|FG004|Overall Study|Progressive disease other|1|||
130891891|NCT00481091|471237676|FG005|Overall Study|Progressive disease other|1|||
130891892|NCT00481091|471237677|FG006|Overall Study|Progressive disease other|0|||
130891893|NCT00481091|471237678|FG007|Overall Study|Progressive disease other|2|||
130891894|NCT00481091|471237679|FG008|Overall Study|Progressive disease other|0|||
130686777|NCT00537979|470479628|FG001|Overall Study|Heart failure|1|||
130891895|NCT00481091|471237680|FG009|Overall Study|Progressive disease other|0|||
131109585|NCT03353350|472030901|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
131109586|NCT03353350|472030902|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
131109587|NCT03353350|472030903|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
130891896|NCT00481091|471237671|FG000|Overall Study|No reason given|0|||
130891897|NCT00481091|471237672|FG001|Overall Study|No reason given|0|||
130891898|NCT00481091|471237673|FG002|Overall Study|No reason given|1|||
130891899|NCT00481091|471237674|FG003|Overall Study|No reason given|1|||
130891900|NCT00481091|471237675|FG004|Overall Study|No reason given|1|||
130891901|NCT00481091|471237676|FG005|Overall Study|No reason given|0|||
130891902|NCT00481091|471237677|FG006|Overall Study|No reason given|1|||
130891903|NCT00481091|471237678|FG007|Overall Study|No reason given|1|||
130891904|NCT00481091|471237679|FG008|Overall Study|No reason given|1|||
130891905|NCT00481091|471237680|FG009|Overall Study|No reason given|4|||
130891906|NCT01296672|471237681|FG000|Overall Study|Lost to Follow-up|73|||
130891907|NCT01296672|471237682|FG001|Overall Study|Lost to Follow-up|18|||
130891908|NCT04661579|471237683|FG000|Overall Study|Lost to Follow-up|19|||
130891909|NCT04661579|471237684|FG001|Overall Study|Lost to Follow-up|10|||
130891910|NCT04661579|471237685|FG002|Overall Study|Lost to Follow-up|2|||
130891911|NCT04661579|471237686|FG003|Overall Study|Lost to Follow-up|7|||
130891912|NCT04661579|471237687|FG004|Overall Study|Lost to Follow-up|11|||
130891913|NCT04661579|471237683|FG000|Overall Study|Physician Decision|2|||
130891914|NCT04661579|471237684|FG001|Overall Study|Physician Decision|0|||
130891915|NCT04661579|471237685|FG002|Overall Study|Physician Decision|0|||
130891916|NCT04661579|471237686|FG003|Overall Study|Physician Decision|1|||
130891917|NCT04661579|471237687|FG004|Overall Study|Physician Decision|0|||
130891918|NCT04661579|471237683|FG000|Overall Study|Withdrawal by Subject|1|||
130891919|NCT04661579|471237684|FG001|Overall Study|Withdrawal by Subject|4|||
130891920|NCT04661579|471237685|FG002|Overall Study|Withdrawal by Subject|0|||
130891921|NCT04661579|471237686|FG003|Overall Study|Withdrawal by Subject|2|||
130891922|NCT04661579|471237687|FG004|Overall Study|Withdrawal by Subject|0|||
130891923|NCT04661579|471237683|FG000|Overall Study|Death|1|||
130891924|NCT04661579|471237684|FG001|Overall Study|Death|0|||
130891925|NCT04661579|471237685|FG002|Overall Study|Death|0|||
130891926|NCT04661579|471237686|FG003|Overall Study|Death|0|||
130891927|NCT04661579|471237687|FG004|Overall Study|Death|0|||
130891928|NCT04661579|471237683|FG000|Overall Study|Other|1|||
130891929|NCT04661579|471237684|FG001|Overall Study|Other|2|||
130891930|NCT04661579|471237685|FG002|Overall Study|Other|1|||
130891931|NCT04661579|471237686|FG003|Overall Study|Other|1|||
130891932|NCT04661579|471237687|FG004|Overall Study|Other|1|||
130891933|NCT04661579|471237683|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
131109588|NCT03353350|472030900|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
130891934|NCT04661579|471237684|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
130891935|NCT04661579|471237685|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
130891936|NCT04661579|471237686|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
130891937|NCT04661579|471237687|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
130891938|NCT00796978|471237689|FG000|Overall Study|Cardiac adverse event|5|||
130891939|NCT00796978|471237689|FG000|Overall Study|Adverse Event|4|||
130891940|NCT00796978|471237689|FG000|Overall Study|Withdrawal by Subject|3|||
130891941|NCT00859456|471237690|FG000|Overall Study|Adverse Event|3|||
131109589|NCT03353350|472030901|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
131109590|NCT03353350|472030902|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
131109591|NCT03353350|472030903|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
131109592|NCT03353350|472030900|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
130891942|NCT00859456|471237690|FG000|Overall Study|Progressive disease|2|||
130891943|NCT00859456|471237690|FG000|Overall Study|Non-compliance|3|||
130891944|NCT00578292|471237691|FG000|Overall Study|Death|1|||
130891945|NCT00578292|471237691|FG000|Overall Study|Graft failure|2|||
130891946|NCT04849559|471237692|FG000|Overall Study|Withdrawal by Subject|2|||
130891947|NCT04849559|471237693|FG001|Overall Study|Withdrawal by Subject|1|||
130891948|NCT02910986|471237694|FG000|Overall Study|non-Latina|14|||
130891949|NCT02910986|471237695|FG001|Overall Study|non-Latina|13|||
130891950|NCT02910986|471237696|FG002|Overall Study|non-Latina|12|||
131109593|NCT03353350|472030901|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
130891951|NCT02910986|471237694|FG000|Overall Study|Failure to return T! survey|72|||
130891952|NCT02910986|471237695|FG001|Overall Study|Failure to return T! survey|84|||
130891953|NCT02910986|471237696|FG002|Overall Study|Failure to return T! survey|72|||
130891954|NCT02910986|471237694|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
130891955|NCT02910986|471237695|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
130891956|NCT02910986|471237696|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
130891957|NCT02910986|471237694|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
130891958|NCT02910986|471237695|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
130891959|NCT02910986|471237696|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
130891960|NCT03527732|471237699|FG000|Overall Study|Lost to Follow-up|21|||
130891961|NCT03527732|471237700|FG001|Overall Study|Lost to Follow-up|23|||
130891962|NCT03527732|471237701|FG002|Overall Study|Lost to Follow-up|80|||
130891963|NCT03527732|471237702|FG003|Overall Study|Lost to Follow-up|62|||
130891964|NCT03527732|471237703|FG004|Overall Study|Lost to Follow-up|12|||
130891965|NCT03527732|471237704|FG005|Overall Study|Lost to Follow-up|20|||
130891966|NCT02280408|471237705|FG000|Overall Study|Lost to Follow-up|0|||
130891967|NCT02280408|471237706|FG001|Overall Study|Lost to Follow-up|2|||
130891968|NCT02280408|471237707|FG002|Overall Study|Lost to Follow-up|0|||
130891969|NCT02280408|471237708|FG003|Overall Study|Lost to Follow-up|0|||
130891970|NCT02474069|471237709|FG000|Selection Phase (SP)|Adverse Event|8|||
130891971|NCT02474069|471237710|FG001|Selection Phase (SP)|Adverse Event|0|||
130891972|NCT02474069|471237711|FG002|Selection Phase (SP)|Adverse Event|0|||
130891973|NCT02474069|471237709|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
130891974|NCT02474069|471237710|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
130891975|NCT02474069|471237711|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
130891976|NCT02474069|471237709|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
130891977|NCT02474069|471237710|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
130891978|NCT02474069|471237711|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
130891979|NCT02474069|471237709|FG000|Selection Phase (SP)|Physician Decision|1|||
130891980|NCT02474069|471237710|FG001|Selection Phase (SP)|Physician Decision|0|||
130891981|NCT02474069|471237711|FG002|Selection Phase (SP)|Physician Decision|0|||
130891982|NCT02474069|471237709|FG000|Selection Phase (SP)|Protocol Violation|1|||
130891983|NCT02474069|471237710|FG001|Selection Phase (SP)|Protocol Violation|0|||
130891984|NCT02474069|471237711|FG002|Selection Phase (SP)|Protocol Violation|0|||
130891985|NCT02474069|471237709|FG000|Selection Phase (SP)|No longer requires treatment|1|||
130891986|NCT02474069|471237710|FG001|Selection Phase (SP)|No longer requires treatment|0|||
130891987|NCT02474069|471237711|FG002|Selection Phase (SP)|No longer requires treatment|0|||
130891988|NCT02474069|471237709|FG000|Selection Phase (SP)|Technical Problem|1|||
130891989|NCT02474069|471237710|FG001|Selection Phase (SP)|Technical Problem|0|||
130891990|NCT02474069|471237711|FG002|Selection Phase (SP)|Technical Problem|0|||
130891991|NCT02474069|471237709|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
130891992|NCT02474069|471237710|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
130891993|NCT02474069|471237711|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
130891994|NCT02474069|471237709|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
130891995|NCT02474069|471237710|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
130891996|NCT02474069|471237711|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
130891997|NCT02474069|471237709|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
130891998|NCT02474069|471237710|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
130891999|NCT02474069|471237711|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
130892000|NCT02474069|471237709|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
130892001|NCT02474069|471237710|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
130892002|NCT02474069|471237711|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
130892003|NCT02474069|471237709|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
130892004|NCT02474069|471237710|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
130892005|NCT02474069|471237711|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
130892006|NCT02474069|471237709|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
130892007|NCT02474069|471237710|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
130892008|NCT02474069|471237711|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
130892009|NCT04173494|471237712|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
130892010|NCT04173494|471237713|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
130892011|NCT04173494|471237712|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
130892012|NCT04173494|471237713|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
130892013|NCT04173494|471237712|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
130892014|NCT04173494|471237713|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
130892015|NCT04173494|471237712|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
130892016|NCT04173494|471237713|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
130892017|NCT04173494|471237712|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
131109594|NCT03353350|472030902|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
131109595|NCT03353350|472030903|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
130686778|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
130686779|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
130686780|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
130892018|NCT04173494|471237713|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
130892019|NCT04173494|471237712|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
131109596|NCT03353350|472030900|FG000|26-week Treatment Extension Period|Adverse Event|1|||
131109597|NCT03353350|472030901|FG001|26-week Treatment Extension Period|Adverse Event|0|||
131109598|NCT03353350|472030902|FG002|26-week Treatment Extension Period|Adverse Event|0|||
131109599|NCT03353350|472030903|FG003|26-week Treatment Extension Period|Adverse Event|1|||
131109600|NCT03353350|472030900|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
131109601|NCT03353350|472030901|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
131109602|NCT03353350|472030902|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
131109603|NCT03353350|472030903|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
130892020|NCT04173494|471237713|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
131109604|NCT00051363|472030904|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
131222669|NCT02513459|472443144|FG000|Overall Study|Lack of response|1|||
130892021|NCT04173494|471237712|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
130892022|NCT04173494|471237713|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
130892023|NCT04173494|471237712|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
130892024|NCT04173494|471237713|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
130892025|NCT04173494|471237712|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
130892026|NCT04173494|471237713|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
130892027|NCT04173494|471237712|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
130892028|NCT04173494|471237713|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
130892029|NCT04173494|471237712|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
130892030|NCT04173494|471237713|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
130892031|NCT04173494|471237712|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
130892032|NCT04173494|471237713|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
130892033|NCT04173494|471237712|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
130892034|NCT04173494|471237713|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
130892035|NCT04173494|471237712|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
130892036|NCT04173494|471237713|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
130892037|NCT04173494|471237712|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
130892038|NCT04173494|471237713|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
130892039|NCT04173494|471237712|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
130892040|NCT04173494|471237713|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
130892041|NCT01623050|471237716|FG000|Overall Study|Lost to Follow-up|9|||
130892042|NCT01191762|471237717|FG000|Overall Study|Adverse Event|1|||
130892043|NCT01191762|471237718|FG001|Overall Study|Adverse Event|0|||
130892044|NCT00459186|471237719|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
130892045|NCT00459186|471237719|FG000|PET Imaging and Assessment|Adverse Event|3|||
130892046|NCT03710083|471237720|FG000|Overall Study|Withdrawal by Subject|2|||
130892047|NCT03710083|471237720|FG000|Overall Study|Unsuccessful Procedure|1|||
130892048|NCT00838513|471237721|FG000|Screening Period|Screen Failure|3|||
130892049|NCT00838513|471237721|FG000|Extension Treatment Period|Death|1|||
130892050|NCT00838513|471237721|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
130892051|NCT01388335|471237726|FG000|Period 1|Progressive Disease|1|||
130892052|NCT01388335|471237726|FG000|Period 2|Progressive Disease|2|||
130892053|NCT01388335|471237726|FG000|Period 2|Sponsor Decision|1|||
130892054|NCT01388335|471237726|FG000|Safety Extension|Progressive Disease|7|||
130892055|NCT00889720|471237727|FG000|Overall Study|Withdrawal by Subject|4|||
130892056|NCT00889720|471237727|FG000|Overall Study|Other|4|||
130892057|NCT00670306|471237728|FG000|Overall Study|Adverse Event|8|||
130892058|NCT00670306|471237728|FG000|Overall Study|Lack of Efficacy|10|||
130892059|NCT00670306|471237728|FG000|Overall Study|Withdrawal by Subject|9|||
130892060|NCT00670306|471237728|FG000|Overall Study|Physician Decision|1|||
130892061|NCT00670306|471237728|FG000|Overall Study|Lost to Follow-up|8|||
131024283|NCT01976312|471718694|FG001|Overall Study|Withdrawal by Subject|2|||
131024284|NCT01976312|471718693|FG000|Overall Study|Adverse Event|6|||
131024285|NCT01976312|471718694|FG001|Overall Study|Adverse Event|6|||
131024286|NCT01976312|471718693|FG000|Overall Study|Protocol Violation|2|||
131024287|NCT01976312|471718694|FG001|Overall Study|Protocol Violation|0|||
131024288|NCT01609218|471718701|FG000|Period 1|Adverse Event|3|||
131024289|NCT01609218|471718702|FG001|Period 1|Adverse Event|5|||
131024290|NCT01609218|471718701|FG000|Period 1|Sponsor Decision|0|||
131024291|NCT01609218|471718702|FG001|Period 1|Sponsor Decision|1|||
131024292|NCT01609218|471718701|FG000|Period 2|Adverse Event|1|||
131024293|NCT01609218|471718702|FG001|Period 2|Adverse Event|0|||
131024294|NCT04428112|471718708|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
131024295|NCT04428112|471718709|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
131024296|NCT04428112|471718708|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
131024297|NCT04428112|471718709|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
131024298|NCT04428112|471718708|FG000|Overall Study|Withdrawal by Subject|9|||
131024299|NCT04428112|471718709|FG001|Overall Study|Withdrawal by Subject|4|||
131024300|NCT04428112|471718708|FG000|Overall Study|Lost to Follow-up|27|||
131024301|NCT04428112|471718709|FG001|Overall Study|Lost to Follow-up|7|||
131024302|NCT01207492|471718710|FG000|Overall Study|Still on study|1|||
131024303|NCT01207492|471718710|FG000|Overall Study|Withdrawal by Subject|9|||
131024304|NCT01207492|471718710|FG000|Overall Study|Physician Decision|1|||
131024305|NCT01207492|471718710|FG000|Overall Study|Progressive disease|3|||
131024306|NCT01207492|471718710|FG000|Overall Study|Toxicity|1|||
130892062|NCT00670306|471237728|FG000|Overall Study|incl/excl criterias did not meet|19|||
130892063|NCT00775593|471237729|FG000|Overall Study|Unmet eligibility criteria|6|||
130892064|NCT00775593|471237729|FG000|Overall Study|Death|1|||
131024307|NCT02769858|471718711|FG000|Overall Study|Withdrawal by Subject|2|||
131024308|NCT02980276|471720103|FG000|Overall Study|Withdrawal by Subject|4|||
131024309|NCT02980276|471720104|FG001|Overall Study|Withdrawal by Subject|4|||
131024310|NCT02980276|471720103|FG000|Overall Study|Physician Decision|0|||
130686781|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
130686782|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
130686783|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
130686784|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
130686785|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
130686786|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
130686787|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
130686788|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
130686789|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
130686790|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
130686791|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
130686792|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
130686793|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
130686794|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
130686795|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
130686796|NCT02009163|470479631|FG000|Open-label Period (Non-randomized)|Other|13|||
130686797|NCT02009163|470479632|FG001|Open-label Period (Non-randomized)|Other|0|||
130686798|NCT02009163|470479633|FG002|Open-label Period (Non-randomized)|Other|0|||
130686799|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
130686800|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
130767081|NCT00090584|470770717|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
130892065|NCT03904693|471237730|FG000|Overall Study|Death|0|||
131024311|NCT02980276|471720104|FG001|Overall Study|Physician Decision|1|||
131024312|NCT02980276|471720103|FG000|Overall Study|Lost to Follow-up|18|||
131024313|NCT02980276|471720104|FG001|Overall Study|Lost to Follow-up|18|||
131024314|NCT02980276|471720103|FG000|Overall Study|Death|1|||
131024315|NCT02980276|471720104|FG001|Overall Study|Death|0|||
131024316|NCT02980276|471720103|FG000|Overall Study|Miscellaneous other|10|||
131024317|NCT02980276|471720104|FG001|Overall Study|Miscellaneous other|4|||
131024318|NCT03025789|471720105|FG000|Overall Study|Lack of Efficacy|6|||
131024319|NCT03025789|471720106|FG001|Overall Study|Lack of Efficacy|1|||
131024320|NCT03025789|471720105|FG000|Overall Study|Death|1|||
131024321|NCT03025789|471720106|FG001|Overall Study|Death|0|||
131024322|NCT03025789|471720105|FG000|Overall Study|Withdrawal by Subject|0|||
131024323|NCT03025789|471720106|FG001|Overall Study|Withdrawal by Subject|2|||
131024324|NCT04300647|471720108|FG000|Pre-Crossover|Death|19|||
131024325|NCT04300647|471720109|FG001|Pre-Crossover|Death|58|||
131024326|NCT04300647|471720110|FG002|Pre-Crossover|Death|0|||
131024327|NCT04300647|471720108|FG000|Pre-Crossover|Lost to Follow-up|0|||
131024328|NCT04300647|471720109|FG001|Pre-Crossover|Lost to Follow-up|3|||
131024329|NCT04300647|471720110|FG002|Pre-Crossover|Lost to Follow-up|0|||
131024330|NCT04300647|471720108|FG000|Pre-Crossover|Withdrawal by Subject|2|||
131024331|NCT04300647|471720109|FG001|Pre-Crossover|Withdrawal by Subject|4|||
131024332|NCT04300647|471720110|FG002|Pre-Crossover|Withdrawal by Subject|0|||
131024333|NCT04300647|471720108|FG000|Pre-Crossover|On-going in Study|24|||
131024334|NCT04300647|471720109|FG001|Pre-Crossover|On-going in Study|61|||
131024335|NCT04300647|471720110|FG002|Pre-Crossover|On-going in Study|0|||
131024336|NCT04300647|471720108|FG000|Post-Crossover|Death|0|||
131024337|NCT04300647|471720109|FG001|Post-Crossover|Death|0|||
131024338|NCT04300647|471720110|FG002|Post-Crossover|Death|3|||
131024339|NCT04300647|471720108|FG000|Post-Crossover|Lost to Follow-up|0|||
131024340|NCT04300647|471720109|FG001|Post-Crossover|Lost to Follow-up|0|||
131024341|NCT04300647|471720110|FG002|Post-Crossover|Lost to Follow-up|1|||
131024342|NCT04300647|471720108|FG000|Post-Crossover|Withdrawal by Subject|0|||
131024343|NCT04300647|471720109|FG001|Post-Crossover|Withdrawal by Subject|0|||
131024344|NCT04300647|471720110|FG002|Post-Crossover|Withdrawal by Subject|1|||
131024345|NCT04300647|471720108|FG000|Post-Crossover|On-going in Study|0|||
131024346|NCT04300647|471720109|FG001|Post-Crossover|On-going in Study|0|||
131024347|NCT04300647|471720110|FG002|Post-Crossover|On-going in Study|8|||
131024348|NCT04999085|471720111|FG000|Overall Study|Death|1|||
131024349|NCT01353313|471720112|FG000|Overall Study|Lost to Follow-up|22|||
131024350|NCT01353313|471720113|FG001|Overall Study|Lost to Follow-up|23|||
131024351|NCT01353313|471720112|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
131024352|NCT01353313|471720113|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
131024353|NCT03088813|471720114|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
131024354|NCT03088813|471720115|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
131024355|NCT03088813|471720116|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
131024356|NCT03088813|471720117|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
131024357|NCT03088813|471720114|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
131024358|NCT03088813|471720115|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
131222670|NCT02513459|472443144|FG000|Overall Study|Reproductive plans|1|||
130767082|NCT00090584|470770718|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
131024359|NCT03088813|471720116|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
131024360|NCT03088813|471720117|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
130892066|NCT03904693|471237731|FG001|Overall Study|Death|0|||
130892067|NCT03904693|471237732|FG002|Overall Study|Death|3|||
130892068|NCT03904693|471237730|FG000|Overall Study|Physician Decision|0|||
130892069|NCT03904693|471237731|FG001|Overall Study|Physician Decision|0|||
130892070|NCT03904693|471237732|FG002|Overall Study|Physician Decision|2|||
130892071|NCT03904693|471237730|FG000|Overall Study|Withdrawal by Subject|0|||
130892072|NCT03904693|471237731|FG001|Overall Study|Withdrawal by Subject|1|||
130892073|NCT03904693|471237732|FG002|Overall Study|Withdrawal by Subject|4|||
130892074|NCT02100696|471237733|FG000|Induction Phase|Adverse Event|0|||
130892075|NCT02100696|471237734|FG001|Induction Phase|Adverse Event|0|||
130892076|NCT02100696|471237735|FG002|Induction Phase|Adverse Event|1|||
130686801|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
130686802|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
130686803|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
130686804|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
130686805|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Adverse Event|0|||
130686806|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Adverse Event|0|||
130686807|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Adverse Event|6|||
130686808|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
130686809|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
131024361|NCT03088813|471720114|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
131024362|NCT03088813|471720115|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
131024363|NCT03088813|471720116|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
131024364|NCT03088813|471720117|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
131024365|NCT03088813|471720114|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
131024366|NCT03088813|471720115|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
131024367|NCT03088813|471720116|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
131024368|NCT03088813|471720117|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
131024369|NCT03088813|471720114|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
131024370|NCT03088813|471720115|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
131024371|NCT03088813|471720116|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
131024372|NCT03088813|471720117|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
131024373|NCT03088813|471720114|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
131024374|NCT03088813|471720115|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
131024375|NCT03088813|471720116|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
131024376|NCT03088813|471720117|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
131024377|NCT03088813|471720114|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
131024378|NCT03088813|471720115|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
131024379|NCT03088813|471720116|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
131024380|NCT03088813|471720117|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
131024381|NCT03613740|471720123|FG000|Overall Study|Lost to Follow-up|1|||
131024382|NCT03613740|471720124|FG001|Overall Study|Lost to Follow-up|1|||
131024383|NCT01693120|471720125|FG000|Enrollment|Lost to Follow-up|1|||
131024384|NCT01693120|471720125|FG000|Enrollment|Withdrawal by Subject|10|||
131024385|NCT01693120|471720125|FG000|Enrollment|Protocol Violation|46|||
131024386|NCT01693120|471720125|FG000|Enrollment|Physician Decision|3|||
131024387|NCT01693120|471720125|FG000|Enrollment|Adverse Event|1|||
131024388|NCT01693120|471720125|FG000|Enrollment|Study closed|8|||
131024389|NCT01693120|471720125|FG000|Enrollment|Other|1|||
131024390|NCT01693120|471720125|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
131024391|NCT01693120|471720125|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
131024392|NCT01693120|471720125|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
131024393|NCT01693120|471720125|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
131024394|NCT01693120|471720125|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
131024395|NCT01443845|471720132|FG000|Overall Study|Protocol Violation|43|||
131024396|NCT01443845|471720133|FG001|Overall Study|Protocol Violation|45|||
131024397|NCT01443845|471720132|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
131024398|NCT01443845|471720133|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
131024399|NCT01443845|471720132|FG000|Overall Study|Deterioration in pulmonary function|1|||
131024400|NCT01443845|471720133|FG001|Overall Study|Deterioration in pulmonary function|4|||
131024401|NCT01443845|471720132|FG000|Overall Study|Lack of Efficacy|10|||
131024402|NCT01443845|471720133|FG001|Overall Study|Lack of Efficacy|5|||
131024403|NCT01443845|471720132|FG000|Overall Study|Adverse Event|64|||
131024404|NCT01443845|471720133|FG001|Overall Study|Adverse Event|138|||
131024405|NCT01443845|471720132|FG000|Overall Study|Withdrawal by Subject|63|||
131024406|NCT01443845|471720133|FG001|Overall Study|Withdrawal by Subject|67|||
130686810|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
130686811|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
130686812|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
130892077|NCT02100696|471237736|FG003|Induction Phase|Adverse Event|0|||
130892078|NCT02100696|471237737|FG004|Induction Phase|Adverse Event|0|||
130892079|NCT02100696|471237738|FG005|Induction Phase|Adverse Event|0|||
130892080|NCT02100696|471237733|FG000|Induction Phase|Lost to Follow-up|1|||
130892081|NCT02100696|471237734|FG001|Induction Phase|Lost to Follow-up|0|||
130892082|NCT02100696|471237735|FG002|Induction Phase|Lost to Follow-up|1|||
130892083|NCT02100696|471237736|FG003|Induction Phase|Lost to Follow-up|0|||
130892084|NCT02100696|471237737|FG004|Induction Phase|Lost to Follow-up|0|||
130892085|NCT02100696|471237738|FG005|Induction Phase|Lost to Follow-up|0|||
130892086|NCT02100696|471237733|FG000|Induction Phase|Protocol Violation|0|||
130892087|NCT02100696|471237734|FG001|Induction Phase|Protocol Violation|1|||
130892088|NCT02100696|471237735|FG002|Induction Phase|Protocol Violation|1|||
130892089|NCT02100696|471237736|FG003|Induction Phase|Protocol Violation|0|||
130892090|NCT02100696|471237737|FG004|Induction Phase|Protocol Violation|0|||
130892091|NCT02100696|471237738|FG005|Induction Phase|Protocol Violation|0|||
130892092|NCT02100696|471237733|FG000|Induction Phase|Withdrawal by Subject|8|||
130892093|NCT02100696|471237734|FG001|Induction Phase|Withdrawal by Subject|2|||
130892094|NCT02100696|471237735|FG002|Induction Phase|Withdrawal by Subject|13|||
130892095|NCT02100696|471237736|FG003|Induction Phase|Withdrawal by Subject|0|||
130892096|NCT02100696|471237737|FG004|Induction Phase|Withdrawal by Subject|0|||
130892097|NCT02100696|471237738|FG005|Induction Phase|Withdrawal by Subject|0|||
130892098|NCT02100696|471237733|FG000|Induction Phase|Physician Decision|1|||
130892099|NCT02100696|471237734|FG001|Induction Phase|Physician Decision|0|||
130892100|NCT02100696|471237735|FG002|Induction Phase|Physician Decision|2|||
130892101|NCT02100696|471237736|FG003|Induction Phase|Physician Decision|0|||
130892102|NCT02100696|471237737|FG004|Induction Phase|Physician Decision|0|||
130892103|NCT02100696|471237738|FG005|Induction Phase|Physician Decision|0|||
130892104|NCT02100696|471237733|FG000|Induction Phase|Multiple Reasons|5|||
130892105|NCT02100696|471237734|FG001|Induction Phase|Multiple Reasons|2|||
130892106|NCT02100696|471237735|FG002|Induction Phase|Multiple Reasons|8|||
130892107|NCT02100696|471237736|FG003|Induction Phase|Multiple Reasons|0|||
130892108|NCT02100696|471237737|FG004|Induction Phase|Multiple Reasons|0|||
130892109|NCT02100696|471237738|FG005|Induction Phase|Multiple Reasons|0|||
130892110|NCT02100696|471237733|FG000|Maintenance Phase|Adverse Event|0|||
130892111|NCT02100696|471237734|FG001|Maintenance Phase|Adverse Event|0|||
130892112|NCT02100696|471237735|FG002|Maintenance Phase|Adverse Event|0|||
130892113|NCT02100696|471237736|FG003|Maintenance Phase|Adverse Event|0|||
130892114|NCT02100696|471237737|FG004|Maintenance Phase|Adverse Event|0|||
130892115|NCT02100696|471237738|FG005|Maintenance Phase|Adverse Event|2|||
130892116|NCT02100696|471237733|FG000|Maintenance Phase|Lost to Follow-up|0|||
130892117|NCT02100696|471237734|FG001|Maintenance Phase|Lost to Follow-up|0|||
130892118|NCT02100696|471237735|FG002|Maintenance Phase|Lost to Follow-up|0|||
130892119|NCT02100696|471237736|FG003|Maintenance Phase|Lost to Follow-up|0|||
130892120|NCT02100696|471237737|FG004|Maintenance Phase|Lost to Follow-up|1|||
130892121|NCT02100696|471237738|FG005|Maintenance Phase|Lost to Follow-up|0|||
130892122|NCT02100696|471237733|FG000|Maintenance Phase|Protocol Violation|0|||
130892123|NCT02100696|471237734|FG001|Maintenance Phase|Protocol Violation|0|||
130892124|NCT02100696|471237735|FG002|Maintenance Phase|Protocol Violation|0|||
130892125|NCT02100696|471237736|FG003|Maintenance Phase|Protocol Violation|0|||
130892126|NCT02100696|471237737|FG004|Maintenance Phase|Protocol Violation|1|||
130892127|NCT02100696|471237738|FG005|Maintenance Phase|Protocol Violation|0|||
130892128|NCT02100696|471237733|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130892129|NCT02100696|471237734|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130892130|NCT02100696|471237735|FG002|Maintenance Phase|Withdrawal by Subject|0|||
130892131|NCT02100696|471237736|FG003|Maintenance Phase|Withdrawal by Subject|1|||
130892132|NCT02100696|471237737|FG004|Maintenance Phase|Withdrawal by Subject|4|||
130892133|NCT02100696|471237738|FG005|Maintenance Phase|Withdrawal by Subject|2|||
130892134|NCT02100696|471237733|FG000|Maintenance Phase|Physician Decision|0|||
130892135|NCT02100696|471237734|FG001|Maintenance Phase|Physician Decision|0|||
130892136|NCT02100696|471237735|FG002|Maintenance Phase|Physician Decision|0|||
130892137|NCT02100696|471237736|FG003|Maintenance Phase|Physician Decision|0|||
130892138|NCT02100696|471237737|FG004|Maintenance Phase|Physician Decision|1|||
130892139|NCT02100696|471237738|FG005|Maintenance Phase|Physician Decision|0|||
130892140|NCT02100696|471237733|FG000|Maintenance Phase|Multiple Reasons|0|||
131024407|NCT01443845|471720132|FG000|Overall Study|Military Conflict - Site Terminated|20|||
131024408|NCT01443845|471720133|FG001|Overall Study|Military Conflict - Site Terminated|21|||
131024409|NCT01443845|471720132|FG000|Overall Study|Lost to Follow-up|9|||
131024410|NCT01443845|471720133|FG001|Overall Study|Lost to Follow-up|13|||
131024411|NCT01610297|471720134|FG000|Overall Study|Lost to Follow-up|1|||
131024412|NCT01007396|471720135|FG000|Overall Study|Lost to Follow-up|47|||
131024413|NCT03076515|471720136|FG000|Overall Study|DMC decision based on interim analysis|25|||
131024414|NCT03076515|471720137|FG001|Overall Study|DMC decision based on interim analysis|29|||
131024415|NCT03951805|471720140|FG000|Overall Study|Adverse Event|1|||
131024416|NCT03951805|471720141|FG001|Overall Study|Adverse Event|0|||
130767083|NCT02117713|470770727|FG000|Week 48|Adverse Event|4|||
130892141|NCT02100696|471237734|FG001|Maintenance Phase|Multiple Reasons|0|||
130892142|NCT02100696|471237735|FG002|Maintenance Phase|Multiple Reasons|0|||
130892143|NCT02100696|471237736|FG003|Maintenance Phase|Multiple Reasons|0|||
130892144|NCT02100696|471237737|FG004|Maintenance Phase|Multiple Reasons|2|||
130892145|NCT02100696|471237738|FG005|Maintenance Phase|Multiple Reasons|1|||
130892146|NCT03865381|471237741|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
130892147|NCT03865381|471237741|FG000|Overall Study|Withdrawal by Subject|2|||
130892148|NCT05626322|471237742|FG000|Overall Study|Death|2|||
130892149|NCT05626322|471237743|FG001|Overall Study|Death|0|||
130892150|NCT05626322|471237744|FG002|Overall Study|Death|0|||
130892151|NCT05626322|471237742|FG000|Overall Study|Physician Decision|1|||
130892152|NCT05626322|471237743|FG001|Overall Study|Physician Decision|0|||
130892153|NCT05626322|471237744|FG002|Overall Study|Physician Decision|0|||
130892154|NCT05626322|471237742|FG000|Overall Study|Progressive Disease|0|||
130892155|NCT05626322|471237743|FG001|Overall Study|Progressive Disease|1|||
130892156|NCT05626322|471237744|FG002|Overall Study|Progressive Disease|1|||
130892157|NCT05626322|471237742|FG000|Overall Study|Study terminated by sponsor|0|||
130892158|NCT05626322|471237743|FG001|Overall Study|Study terminated by sponsor|1|||
130892159|NCT05626322|471237744|FG002|Overall Study|Study terminated by sponsor|0|||
130892160|NCT01668589|471237749|FG000|Overall Study|Lost to Follow-up|29|||
130892161|NCT01668589|471237750|FG001|Overall Study|Lost to Follow-up|37|||
130892162|NCT01668589|471237751|FG002|Overall Study|Lost to Follow-up|15|||
130892163|NCT01668589|471237752|FG003|Overall Study|Lost to Follow-up|5|||
130892164|NCT01668589|471237749|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
130892165|NCT01668589|471237750|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
130892166|NCT01668589|471237751|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
130892167|NCT01668589|471237752|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
130892168|NCT01668589|471237749|FG000|Overall Study|Death|12|||
130892169|NCT01668589|471237750|FG001|Overall Study|Death|3|||
130892170|NCT01668589|471237751|FG002|Overall Study|Death|2|||
130892171|NCT01668589|471237752|FG003|Overall Study|Death|11|||
130892172|NCT01668589|471237749|FG000|Overall Study|Other|44|||
130892173|NCT01668589|471237750|FG001|Overall Study|Other|10|||
130892174|NCT01668589|471237751|FG002|Overall Study|Other|7|||
130892175|NCT01668589|471237752|FG003|Overall Study|Other|15|||
130892176|NCT01519167|471237753|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
130892177|NCT01519167|471237754|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
130892178|NCT01519167|471237753|FG000|Overall Study|Adverse Event|0|||
131109605|NCT00051363|472030905|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
131109606|NCT00051363|472030904|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
131109607|NCT00051363|472030905|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
131109608|NCT00051363|472030904|FG000|Overall Study|Death|2|||
131109609|NCT00051363|472030905|FG001|Overall Study|Death|2|||
131109610|NCT00051363|472030904|FG000|Overall Study|Excluded Pre-Randomization|2|||
130892179|NCT01519167|471237754|FG001|Overall Study|Adverse Event|1|||
130892180|NCT01519167|471237753|FG000|Overall Study|Lack of Efficacy|0|||
130892181|NCT01519167|471237754|FG001|Overall Study|Lack of Efficacy|1|||
130892182|NCT01519167|471237753|FG000|Overall Study|Medical condition changes&deep sedation|0|||
130892183|NCT01519167|471237754|FG001|Overall Study|Medical condition changes&deep sedation|2|||
130892184|NCT01519167|471237753|FG000|Overall Study|Physician Decision|0|||
130892185|NCT01519167|471237754|FG001|Overall Study|Physician Decision|1|||
130892186|NCT04200352|471237762|FG000|Overall Study|Death|1|||
130892187|NCT04200352|471237762|FG000|Overall Study|Adverse Event|6|||
130892188|NCT04200352|471237762|FG000|Overall Study|Withdrawal by parent/guardian|6|||
130892189|NCT04200352|471237762|FG000|Overall Study|Lack of Efficacy|1|||
130892190|NCT04200352|471237762|FG000|Overall Study|Other than specified|6|||
130892191|NCT00993148|471237763|FG000|Overall Study|Lost to Follow-up|2|||
130892192|NCT00993148|471237763|FG000|Overall Study|never initiated treatment|1|||
130892193|NCT00233064|471237764|FG000|Overall Study|Lost to Follow-up|7|||
130892194|NCT00233064|471237765|FG001|Overall Study|Lost to Follow-up|7|||
130892195|NCT00233064|471237764|FG000|Overall Study|Withdrawal by Subject|5|||
130892196|NCT00233064|471237765|FG001|Overall Study|Withdrawal by Subject|3|||
130892197|NCT00233064|471237764|FG000|Overall Study|Death|0|||
130892198|NCT00233064|471237765|FG001|Overall Study|Death|1|||
130892199|NCT00233064|471237764|FG000|Overall Study|Relocation|0|||
130892200|NCT00233064|471237765|FG001|Overall Study|Relocation|1|||
130686813|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
130892201|NCT00233064|471237764|FG000|Overall Study|Protocol Violation|1|||
130892202|NCT00233064|471237765|FG001|Overall Study|Protocol Violation|0|||
130686814|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Pregnancy|0|||
130892203|NCT00233064|471237764|FG000|Overall Study|Moved to Dom. Republic|1|||
130892204|NCT00233064|471237765|FG001|Overall Study|Moved to Dom. Republic|0|||
130892205|NCT01120964|471237768|FG000|Overall Study|Did not receive full treatment|1|||
130892206|NCT01120964|471237769|FG001|Overall Study|Did not receive full treatment|0|||
130892207|NCT00829504|471237772|FG000|First Intervention|Adverse Event|1|||
130892208|NCT00829504|471237773|FG001|First Intervention|Adverse Event|0|||
130892209|NCT00829504|471237772|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130892210|NCT00829504|471237773|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130892211|NCT00829504|471237772|FG000|Second Intervention|Physician Decision|1|||
130892212|NCT00829504|471237773|FG001|Second Intervention|Physician Decision|0|||
130892213|NCT03212144|471237774|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
130892214|NCT03212144|471237775|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
131109611|NCT00051363|472030905|FG001|Overall Study|Excluded Pre-Randomization|5|||
131109612|NCT00807235|472030906|FG000|Overall Study|Adverse Event|1|||
131109613|NCT00807235|472030907|FG001|Overall Study|Adverse Event|0|||
131109614|NCT03370471|472030909|FG000|Overall Study|Withdrawal by Subject|6|||
131109615|NCT03370471|472030910|FG001|Overall Study|Withdrawal by Subject|1|||
131109616|NCT03370471|472030909|FG000|Overall Study|Unable to access veins for blood draw|0|||
131109617|NCT03370471|472030910|FG001|Overall Study|Unable to access veins for blood draw|1|||
131109618|NCT03370471|472030909|FG000|Overall Study|Screen fail|1|||
131109619|NCT03370471|472030910|FG001|Overall Study|Screen fail|0|||
131109620|NCT01765179|472030911|FG000|Overall Study|Adverse Event|3|||
131109621|NCT01765179|472030911|FG000|Overall Study|Lost to Follow-up|5|||
131109622|NCT01765179|472030911|FG000|Overall Study|Non-compliance with study drug|2|||
131109623|NCT01765179|472030911|FG000|Overall Study|Protocol Violation|1|||
131109624|NCT01765179|472030911|FG000|Overall Study|Withdrawal by Subject|8|||
131109625|NCT01765179|472030911|FG000|Overall Study|Hematocrit >54%|3|||
131109626|NCT01765179|472030911|FG000|Overall Study|prohibited med|1|||
131109627|NCT01765179|472030911|FG000|Overall Study|Out of country unable to finish study|1|||
131109628|NCT01765179|472030911|FG000|Overall Study|lack of venous access|1|||
131109629|NCT01765179|472030911|FG000|Overall Study|work conflict|1|||
131109630|NCT01765179|472030911|FG000|Overall Study|Ca elevated 10.6|1|||
131109631|NCT00392327|472030912|FG000|Overall Study|Death|1|||
131109632|NCT00392327|472030913|FG001|Overall Study|Death|0|||
131109633|NCT00392327|472030914|FG002|Overall Study|Death|1|||
131109634|NCT00392327|472030915|FG003|Overall Study|Death|0|||
131109635|NCT00392327|472030916|FG004|Overall Study|Death|0|||
131109636|NCT00392327|472030917|FG005|Overall Study|Death|0|||
131109637|NCT00392327|472030918|FG006|Overall Study|Death|0|||
131109638|NCT00392327|472030919|FG007|Overall Study|Death|0|||
131109639|NCT00392327|472030912|FG000|Overall Study|Lack of Efficacy|8|||
131109640|NCT00392327|472030913|FG001|Overall Study|Lack of Efficacy|8|||
131109641|NCT00392327|472030914|FG002|Overall Study|Lack of Efficacy|9|||
131109642|NCT00392327|472030915|FG003|Overall Study|Lack of Efficacy|6|||
131109643|NCT00392327|472030916|FG004|Overall Study|Lack of Efficacy|3|||
131109644|NCT00392327|472030917|FG005|Overall Study|Lack of Efficacy|3|||
131109645|NCT00392327|472030918|FG006|Overall Study|Lack of Efficacy|3|||
131109646|NCT00392327|472030919|FG007|Overall Study|Lack of Efficacy|3|||
131109647|NCT00392327|472030912|FG000|Overall Study|Physician Decision|3|||
131109648|NCT00392327|472030913|FG001|Overall Study|Physician Decision|5|||
131109649|NCT00392327|472030914|FG002|Overall Study|Physician Decision|2|||
131109650|NCT00392327|472030915|FG003|Overall Study|Physician Decision|2|||
131109651|NCT00392327|472030916|FG004|Overall Study|Physician Decision|0|||
131109652|NCT00392327|472030917|FG005|Overall Study|Physician Decision|1|||
131109653|NCT00392327|472030918|FG006|Overall Study|Physician Decision|5|||
131109654|NCT00392327|472030919|FG007|Overall Study|Physician Decision|3|||
131109655|NCT00392327|472030912|FG000|Overall Study|Protocol Violation|0|||
131109656|NCT00392327|472030913|FG001|Overall Study|Protocol Violation|0|||
131109657|NCT00392327|472030914|FG002|Overall Study|Protocol Violation|1|||
131109658|NCT00392327|472030915|FG003|Overall Study|Protocol Violation|0|||
131109659|NCT00392327|472030916|FG004|Overall Study|Protocol Violation|0|||
131109660|NCT00392327|472030917|FG005|Overall Study|Protocol Violation|0|||
131109661|NCT00392327|472030918|FG006|Overall Study|Protocol Violation|0|||
131109662|NCT00392327|472030919|FG007|Overall Study|Protocol Violation|0|||
131109663|NCT00392327|472030912|FG000|Overall Study|Withdrawal by Subject|3|||
131109664|NCT00392327|472030913|FG001|Overall Study|Withdrawal by Subject|2|||
131109665|NCT00392327|472030914|FG002|Overall Study|Withdrawal by Subject|4|||
131109666|NCT00392327|472030915|FG003|Overall Study|Withdrawal by Subject|6|||
131109667|NCT00392327|472030916|FG004|Overall Study|Withdrawal by Subject|0|||
131109668|NCT00392327|472030917|FG005|Overall Study|Withdrawal by Subject|1|||
131109669|NCT00392327|472030918|FG006|Overall Study|Withdrawal by Subject|1|||
131109670|NCT00392327|472030919|FG007|Overall Study|Withdrawal by Subject|5|||
131109671|NCT00392327|472030912|FG000|Overall Study|Ineligible|0|||
131109672|NCT00392327|472030913|FG001|Overall Study|Ineligible|4|||
131109673|NCT00392327|472030914|FG002|Overall Study|Ineligible|3|||
131109674|NCT00392327|472030915|FG003|Overall Study|Ineligible|2|||
131109675|NCT00392327|472030916|FG004|Overall Study|Ineligible|0|||
131109676|NCT00392327|472030917|FG005|Overall Study|Ineligible|0|||
131109677|NCT00392327|472030918|FG006|Overall Study|Ineligible|0|||
131109678|NCT00392327|472030919|FG007|Overall Study|Ineligible|0|||
131109679|NCT04508023|472030920|FG000|Overall Study|Withdrawal by Subject|1|||
131109680|NCT04508023|472030921|FG001|Overall Study|Withdrawal by Subject|2|||
131109681|NCT02988622|472030922|FG000|Overall Study|Lost to Follow-up|17|||
130767084|NCT02117713|470770727|FG000|Week 48|Withdrawal by caregiver|2|||
131109682|NCT00178126|472030923|FG000|Overall Study|Lost to Follow-up|21|||
131109683|NCT00178126|472030924|FG001|Overall Study|Lost to Follow-up|21|||
131109684|NCT00178126|472030923|FG000|Overall Study|did not receive intervention|4|||
131109685|NCT00178126|472030924|FG001|Overall Study|did not receive intervention|6|||
131109686|NCT01204398|472030928|FG000|Overall Study|Adverse Event|1|||
131109687|NCT03562247|472030929|FG000|Overall Study|Lost to Follow-up|3|||
131109688|NCT03562247|472030930|FG001|Overall Study|Lost to Follow-up|1|||
131109689|NCT03562247|472030931|FG002|Overall Study|Lost to Follow-up|1|||
130892215|NCT03212144|471237774|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
131024417|NCT03951805|471720142|FG002|Overall Study|Adverse Event|0|||
131024418|NCT03951805|471720143|FG003|Overall Study|Adverse Event|0|||
131024419|NCT00604669|471720144|FG000|Overall Study|lack of information in chart|7|||
131024420|NCT01695954|471720145|FG000|Overall Study|Withdrawal by Subject|4|||
131024421|NCT01695954|471720146|FG001|Overall Study|Withdrawal by Subject|0|||
131024422|NCT01695954|471720145|FG000|Overall Study|Adverse Event|0|||
131024423|NCT01695954|471720146|FG001|Overall Study|Adverse Event|2|||
131024424|NCT03684044|471720147|FG000|Overall Study|Adverse Event|3|||
131024425|NCT03684044|471720148|FG001|Overall Study|Adverse Event|0|||
131024426|NCT03684044|471720147|FG000|Overall Study|Death|4|||
131024427|NCT03684044|471720148|FG001|Overall Study|Death|7|||
131024428|NCT03684044|471720147|FG000|Overall Study|Lost to Follow-up|3|||
131024429|NCT03684044|471720148|FG001|Overall Study|Lost to Follow-up|2|||
131024430|NCT03684044|471720147|FG000|Overall Study|Patient Not Available|0|||
131024431|NCT03684044|471720148|FG001|Overall Study|Patient Not Available|2|||
131024432|NCT03684044|471720147|FG000|Overall Study|Physician Decision|1|||
131024433|NCT03684044|471720148|FG001|Overall Study|Physician Decision|0|||
131024434|NCT03684044|471720147|FG000|Overall Study|Withdrawal by Subject|11|||
131024435|NCT03684044|471720148|FG001|Overall Study|Withdrawal by Subject|9|||
131024436|NCT03703336|471720149|FG000|Overall Study|Parent withdrew consent|29|||
131024437|NCT03703336|471720150|FG001|Overall Study|Parent withdrew consent|8|||
131024438|NCT03703336|471720149|FG000|Overall Study|Migration|3|||
131024439|NCT03703336|471720150|FG001|Overall Study|Migration|3|||
131024440|NCT03703336|471720149|FG000|Overall Study|Protocol Violation|3|||
131024441|NCT03703336|471720150|FG001|Overall Study|Protocol Violation|1|||
131024442|NCT03703336|471720149|FG000|Overall Study|Physician Decision|2|||
131024443|NCT03703336|471720150|FG001|Overall Study|Physician Decision|0|||
131024444|NCT03703336|471720149|FG000|Overall Study|Adverse Event|0|||
131024445|NCT03703336|471720150|FG001|Overall Study|Adverse Event|2|||
131024446|NCT03703336|471720149|FG000|Overall Study|Lost to Follow-up|1|||
131024447|NCT03703336|471720150|FG001|Overall Study|Lost to Follow-up|0|||
131024448|NCT03930420|471720152|FG000|Overall Study|Withdrawal by Subject|7|||
131024449|NCT03930420|471720153|FG001|Overall Study|Withdrawal by Subject|9|||
131024450|NCT00609336|471720154|FG000|Overall Study|Protocol Violation|3|||
131024451|NCT00609336|471720154|FG000|Overall Study|Death|1|||
131024452|NCT00609336|471720154|FG000|Overall Study|LA or Met at Surgery|9|||
131024453|NCT02238483|471720155|FG000|Overall Study|Withdrawal by Subject|2|||
131024454|NCT02238483|471720156|FG001|Overall Study|Withdrawal by Subject|7|||
131024455|NCT02238483|471720155|FG000|Overall Study|Lost to Follow-up|1|||
131024456|NCT02238483|471720156|FG001|Overall Study|Lost to Follow-up|1|||
131024457|NCT02238483|471720155|FG000|Overall Study|Protocol Violation|1|||
131024458|NCT02238483|471720156|FG001|Overall Study|Protocol Violation|2|||
131024459|NCT02238483|471720155|FG000|Overall Study|Death|1|||
131024460|NCT02238483|471720156|FG001|Overall Study|Death|0|||
131024461|NCT02238483|471720155|FG000|Overall Study|Adverse Event|7|||
131024462|NCT02238483|471720156|FG001|Overall Study|Adverse Event|3|||
131024463|NCT02238483|471720155|FG000|Overall Study|Withdrawn due to physician decision|1|||
131024464|NCT02238483|471720156|FG001|Overall Study|Withdrawn due to physician decision|0|||
131024465|NCT02238483|471720155|FG000|Overall Study|Completion status not recorded|1|||
131024466|NCT02238483|471720156|FG001|Overall Study|Completion status not recorded|1|||
131024467|NCT02238483|471720155|FG000|Overall Study|Illness in family member|1|||
131024468|NCT02238483|471720156|FG001|Overall Study|Illness in family member|0|||
131024469|NCT02692417|471720162|FG000|Overall Study|Withdrawal by Subject|5|||
131024470|NCT02692417|471720163|FG001|Overall Study|Withdrawal by Subject|1|||
131024471|NCT02692417|471720162|FG000|Overall Study|Adverse Event|1|||
131024472|NCT02692417|471720163|FG001|Overall Study|Adverse Event|0|||
131024473|NCT02372253|471720164|FG000|Overall Study|Non Compliance|2|||
131024474|NCT02372253|471720165|FG001|Overall Study|Non Compliance|0|||
131024475|NCT02178098|471720169|FG000|Overall Study|Withdrawal by Subject|0|||
131024476|NCT02178098|471720170|FG001|Overall Study|Withdrawal by Subject|6|||
131024477|NCT02178098|471720169|FG000|Overall Study|Adverse Event|1|||
131024478|NCT02178098|471720170|FG001|Overall Study|Adverse Event|2|||
131024479|NCT02178098|471720169|FG000|Overall Study|Protocol Violation|1|||
131024480|NCT02178098|471720170|FG001|Overall Study|Protocol Violation|1|||
131024481|NCT02178098|471720169|FG000|Overall Study|Lost to Follow-up|0|||
131024482|NCT02178098|471720170|FG001|Overall Study|Lost to Follow-up|1|||
131024483|NCT02178098|471720169|FG000|Overall Study|Sponsor Request|1|||
131024484|NCT02178098|471720170|FG001|Overall Study|Sponsor Request|0|||
131024485|NCT02178098|471720169|FG000|Overall Study|Other|2|||
131024486|NCT02178098|471720170|FG001|Overall Study|Other|2|||
131024487|NCT01044303|471720175|FG000|Overall Study|Lost to Follow-up|2|||
131024488|NCT01109524|471720176|FG000|Overall Study|Disease Progression|29|||
131024489|NCT01109524|471720176|FG000|Overall Study|Study Drug toxicity|6|||
131024490|NCT01109524|471720176|FG000|Overall Study|Adverse Event|4|||
131024491|NCT01109524|471720176|FG000|Overall Study|Withdrawal by Subject|2|||
131024492|NCT01109524|471720176|FG000|Overall Study|Maximum clinical benefit|3|||
131024493|NCT01109524|471720176|FG000|Overall Study|Death|2|||
131024494|NCT01109524|471720176|FG000|Overall Study|No longer meets criteria|2|||
130892216|NCT03212144|471237775|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
130892217|NCT00599339|471237776|FG000|Overall Study|Adverse Event|79|||
130892218|NCT00599339|471237776|FG000|Overall Study|Withdrawal by Subject|137|||
130892219|NCT00599339|471237776|FG000|Overall Study|Other Reason|179|||
130892220|NCT00599339|471237776|FG000|Overall Study|Lost to Follow-up|221|||
130892221|NCT00599339|471237776|FG000|Overall Study|No valid data consent|36|||
130892222|NCT00599339|471237776|FG000|Overall Study|Study Termination Status Unknown|12|||
130892223|NCT05564052|471237777|FG000|Overall Study|Withdrawal by Subject|0|||
130892224|NCT05564052|471237778|FG001|Overall Study|Withdrawal by Subject|0|||
130892225|NCT05564052|471237779|FG002|Overall Study|Withdrawal by Subject|0|||
130892226|NCT05564052|471237780|FG003|Overall Study|Withdrawal by Subject|1|||
130892227|NCT02102204|471239361|FG000|Overall Study|Withdrawal by Subject|137|||
130892228|NCT02102204|471239361|FG000|Overall Study|Death|92|||
130892229|NCT02102204|471239361|FG000|Overall Study|Lost to Follow-up|65|||
130892230|NCT02102204|471239361|FG000|Overall Study|Sponsor Decision|5|||
130892231|NCT02102204|471239361|FG000|Overall Study|Ongoing|5|||
130892232|NCT02260180|471239362|FG000|Overall Study|Adverse Event|2|||
130892233|NCT02260180|471239363|FG001|Overall Study|Adverse Event|0|||
130892234|NCT02260180|471239364|FG002|Overall Study|Adverse Event|1|||
130892235|NCT01168219|471239369|FG000|Overall Study|off study before starting treatment|2|||
130892236|NCT01168219|471239369|FG000|Overall Study|withdrew before transplant|1|||
130892237|NCT01168219|471239369|FG000|Overall Study|ineligible due to CML|2|||
130892238|NCT03860818|471239370|FG000|Overall Study|Death|144|||
130892239|NCT03860818|471239371|FG001|Overall Study|Death|195|||
130892240|NCT03860818|471239370|FG000|Overall Study|Graft Loss|32|||
130892241|NCT03860818|471239371|FG001|Overall Study|Graft Loss|45|||
130892242|NCT03126344|471239372|FG000|Overall Study|Lost to Follow-up|0|||
130892243|NCT03126344|471239373|FG001|Overall Study|Lost to Follow-up|0|||
130892244|NCT03126344|471239374|FG002|Overall Study|Lost to Follow-up|5|||
130892245|NCT01621802|471239376|FG000|Overall Study|Protocol Violation|0|||
131109690|NCT00983931|472030932|FG000|14 Day Washout Period|Physician Decision|1|||
131109691|NCT01281969|472030935|FG000|Overall Study|not randomized didn't meet criteria|0|||
131109692|NCT01281969|472030936|FG001|Overall Study|not randomized didn't meet criteria|0|||
131109693|NCT01281969|472030937|FG002|Overall Study|not randomized didn't meet criteria|7|||
131109694|NCT01281969|472030935|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
131109695|NCT01281969|472030936|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
131109696|NCT01281969|472030937|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
131109697|NCT01281969|472030935|FG000|Overall Study|not randomized, child consent not given|0|||
130767085|NCT02117713|470770727|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
130892246|NCT01621802|471239377|FG001|Overall Study|Protocol Violation|0|||
130892247|NCT01621802|471239378|FG002|Overall Study|Protocol Violation|0|||
130892248|NCT01621802|471239379|FG003|Overall Study|Protocol Violation|0|||
130892249|NCT01621802|471239380|FG004|Overall Study|Protocol Violation|0|||
130892250|NCT01621802|471239381|FG005|Overall Study|Protocol Violation|1|||
130892251|NCT01621802|471239376|FG000|Overall Study|Withdrawal by Subject|8|||
130892252|NCT01621802|471239377|FG001|Overall Study|Withdrawal by Subject|4|||
130892253|NCT01621802|471239378|FG002|Overall Study|Withdrawal by Subject|4|||
130892254|NCT01621802|471239379|FG003|Overall Study|Withdrawal by Subject|2|||
131024495|NCT01109524|471720176|FG000|Overall Study|Participant requested to end treatment|4|||
131024496|NCT01109524|471720176|FG000|Overall Study|Other|5|||
131024497|NCT00031694|471720192|FG000|Overall Study|Adverse Event|12|||
131024498|NCT00031694|471720192|FG000|Overall Study|Death|2|||
131024499|NCT00031694|471720192|FG000|Overall Study|Withdrawal by Subject|5|||
131024500|NCT04048382|471720193|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
131024501|NCT04048382|471720194|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
131024502|NCT04048382|471720193|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
131024503|NCT04048382|471720194|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
131024504|NCT04048382|471720193|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
131024505|NCT04048382|471720194|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
131024506|NCT01205048|471720196|FG000|Overall Study|Withdrawal by Subject|14|||
131024507|NCT01205048|471720196|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
131024508|NCT01205048|471720196|FG000|Overall Study|Lost to Follow-up|4|||
131024509|NCT01205048|471720196|FG000|Overall Study|Other|2|||
131024510|NCT01255670|471720197|FG000|Overall Study|Adverse Event|10|||
131024511|NCT01255670|471720198|FG001|Overall Study|Adverse Event|10|||
131024512|NCT01255670|471720197|FG000|Overall Study|Lost to Follow-up|16|||
131024513|NCT01255670|471720198|FG001|Overall Study|Lost to Follow-up|10|||
131024514|NCT02269475|471720199|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
131024515|NCT02269475|471720200|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
131024516|NCT02269475|471720199|FG000|Overall Study|Withdrawal by Subject|0|||
131024517|NCT02269475|471720200|FG001|Overall Study|Withdrawal by Subject|1|||
131024518|NCT01037985|471720201|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
131024519|NCT01037985|471720202|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
131109698|NCT01281969|472030936|FG001|Overall Study|not randomized, child consent not given|0|||
131109699|NCT01281969|472030937|FG002|Overall Study|not randomized, child consent not given|2|||
130892255|NCT01621802|471239380|FG004|Overall Study|Withdrawal by Subject|2|||
131222671|NCT02513459|472443144|FG000|Overall Study|Surgery planned-- not done|1|||
131222672|NCT01017029|472443150|FG000|Overall Study|Lost to Follow-up|1|||
131222673|NCT01017029|472443151|FG001|Overall Study|Lost to Follow-up|0|||
131222674|NCT01017029|472443150|FG000|Overall Study|Administrative problem|0|||
131222675|NCT01017029|472443151|FG001|Overall Study|Administrative problem|1|||
131222676|NCT01017029|472443150|FG000|Overall Study|Death|3|||
131222677|NCT01017029|472443151|FG001|Overall Study|Death|1|||
131222678|NCT03876873|472443155|FG000|Overall Study|Physician Decision|0|||
131222679|NCT03876873|472443156|FG001|Overall Study|Physician Decision|1|||
131222680|NCT03547531|472443157|FG000|Overall Study|not coming in data collection : sick|2|||
131222681|NCT03547531|472443158|FG001|Overall Study|not coming in data collection : sick|2|||
131222682|NCT03547531|472443157|FG000|Overall Study|having family occasion|0|||
131222683|NCT03547531|472443158|FG001|Overall Study|having family occasion|2|||
131222684|NCT03402126|472443160|FG000|Overall Study|Lost to Follow-up|6|||
130686815|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Pregnancy|0|||
130686816|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Pregnancy|2|||
130686817|NCT02009163|470479631|FG000|Randomized-withdrawal Period|Other|0|||
130686818|NCT02009163|470479632|FG001|Randomized-withdrawal Period|Other|9|||
130686819|NCT02009163|470479633|FG002|Randomized-withdrawal Period|Other|5|||
130686820|NCT02453386|470479636|FG000|Overall Study|Adverse Event|22|||
130686821|NCT02453386|470479637|FG001|Overall Study|Adverse Event|30|||
130686822|NCT02453386|470479638|FG002|Overall Study|Adverse Event|15|||
130686823|NCT02453386|470479636|FG000|Overall Study|Protocol Violation|1|||
130686824|NCT02453386|470479637|FG001|Overall Study|Protocol Violation|0|||
130686825|NCT02453386|470479638|FG002|Overall Study|Protocol Violation|1|||
130686826|NCT02453386|470479636|FG000|Overall Study|Withdrawal by Subject|10|||
130686827|NCT02453386|470479637|FG001|Overall Study|Withdrawal by Subject|9|||
130686828|NCT02453386|470479638|FG002|Overall Study|Withdrawal by Subject|9|||
130686829|NCT02453386|470479636|FG000|Overall Study|Sponsor Terminated Study|14|||
130686830|NCT02453386|470479637|FG001|Overall Study|Sponsor Terminated Study|8|||
130686831|NCT02453386|470479638|FG002|Overall Study|Sponsor Terminated Study|11|||
130686832|NCT02453386|470479636|FG000|Overall Study|Subject Terminated by Sponsor|1|||
130686833|NCT02453386|470479637|FG001|Overall Study|Subject Terminated by Sponsor|1|||
130686834|NCT02453386|470479638|FG002|Overall Study|Subject Terminated by Sponsor|1|||
130686835|NCT02453386|470479636|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
130686836|NCT02453386|470479637|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
130686837|NCT02453386|470479638|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
130686838|NCT02453386|470479636|FG000|Overall Study|Lost to Follow-up|0|||
130686839|NCT02453386|470479637|FG001|Overall Study|Lost to Follow-up|0|||
130686840|NCT02453386|470479638|FG002|Overall Study|Lost to Follow-up|1|||
130686841|NCT02453386|470479636|FG000|Overall Study|Other|1|||
130686842|NCT02453386|470479637|FG001|Overall Study|Other|0|||
130686843|NCT02453386|470479638|FG002|Overall Study|Other|1|||
130686844|NCT01474551|470479642|FG000|Overall Study|Death|1|||
130686845|NCT00465270|470479646|FG000|Overall Study|Death|7|||
130686846|NCT00465270|470479647|FG001|Overall Study|Death|11|||
130686847|NCT00465270|470479646|FG000|Overall Study|Withdrawal by Subject|34|||
130686848|NCT00465270|470479647|FG001|Overall Study|Withdrawal by Subject|78|||
130686849|NCT00465270|470479646|FG000|Overall Study|Lost to Follow-up|60|||
130686850|NCT00465270|470479647|FG001|Overall Study|Lost to Follow-up|67|||
130686851|NCT00465270|470479646|FG000|Overall Study|Investigator request|3|||
130686852|NCT00465270|470479647|FG001|Overall Study|Investigator request|4|||
130686853|NCT00858845|470479655|FG000|Overall Study|Patient underwent heart transplant.|0|||
130686854|NCT00858845|470479656|FG001|Overall Study|Patient underwent heart transplant.|1|||
130686855|NCT02605928|470479657|FG000|Overall Study|Model tuning phase|28|||
130686856|NCT02605928|470479657|FG000|Overall Study|Lack of Efficacy|5|||
130686857|NCT02089997|470479665|FG000|Overall Study|Case report forms uncollected|99|||
130686858|NCT02089997|470479665|FG000|Overall Study|Protocol Violation|147|||
130686859|NCT02374853|470479670|FG000|Overall Study|Surgery Cancelled|5|||
130686860|NCT02374853|470479671|FG001|Overall Study|Surgery Cancelled|11|||
130686861|NCT02281084|470479672|FG000|Overall Study|Death|21|||
130686862|NCT02281084|470479673|FG001|Overall Study|Death|18|||
130686863|NCT02281084|470479674|FG002|Overall Study|Death|3|||
130686864|NCT02281084|470479675|FG003|Overall Study|Death|5|||
130686865|NCT02281084|470479672|FG000|Overall Study|Adverse Event|1|||
131222685|NCT03402126|472443160|FG000|Overall Study|Protocol Violation|10|||
131222686|NCT03402126|472443160|FG000|Overall Study|Sponsor request/Study termination|29|||
131222687|NCT03402126|472443160|FG000|Overall Study|Study product no longer in use|1|||
130686866|NCT02281084|470479673|FG001|Overall Study|Adverse Event|0|||
130686867|NCT02281084|470479674|FG002|Overall Study|Adverse Event|0|||
130686868|NCT02281084|470479675|FG003|Overall Study|Adverse Event|0|||
130686869|NCT02281084|470479672|FG000|Overall Study|Withdrawal by Subject|2|||
130686870|NCT02281084|470479673|FG001|Overall Study|Withdrawal by Subject|2|||
130686871|NCT02281084|470479674|FG002|Overall Study|Withdrawal by Subject|0|||
130686872|NCT02281084|470479675|FG003|Overall Study|Withdrawal by Subject|0|||
130686873|NCT02281084|470479672|FG000|Overall Study|Site Closure by Sponsor|5|||
130686874|NCT02281084|470479673|FG001|Overall Study|Site Closure by Sponsor|1|||
130686875|NCT02281084|470479674|FG002|Overall Study|Site Closure by Sponsor|2|||
130892256|NCT01621802|471239381|FG005|Overall Study|Withdrawal by Subject|0|||
130892257|NCT01621802|471239376|FG000|Overall Study|Migrated/moved from study area|0|||
130892258|NCT01621802|471239377|FG001|Overall Study|Migrated/moved from study area|0|||
130892259|NCT01621802|471239378|FG002|Overall Study|Migrated/moved from study area|2|||
130892260|NCT01621802|471239379|FG003|Overall Study|Migrated/moved from study area|0|||
130892261|NCT01621802|471239380|FG004|Overall Study|Migrated/moved from study area|1|||
130892262|NCT01621802|471239381|FG005|Overall Study|Migrated/moved from study area|0|||
130892263|NCT01621802|471239376|FG000|Overall Study|Others|3|||
130892264|NCT01621802|471239377|FG001|Overall Study|Others|3|||
130892265|NCT01621802|471239378|FG002|Overall Study|Others|3|||
130892266|NCT01621802|471239379|FG003|Overall Study|Others|2|||
130892267|NCT01621802|471239380|FG004|Overall Study|Others|1|||
130892268|NCT01621802|471239381|FG005|Overall Study|Others|0|||
130892269|NCT01621802|471239376|FG000|Overall Study|Lost to Follow-up|36|||
130892270|NCT01621802|471239377|FG001|Overall Study|Lost to Follow-up|16|||
130892271|NCT01621802|471239378|FG002|Overall Study|Lost to Follow-up|24|||
130892272|NCT01621802|471239379|FG003|Overall Study|Lost to Follow-up|7|||
130892273|NCT01621802|471239380|FG004|Overall Study|Lost to Follow-up|31|||
130892274|NCT01621802|471239381|FG005|Overall Study|Lost to Follow-up|11|||
130892275|NCT04896086|471239382|FG000|Overall Study|Lost to Follow-up|0|||
130892276|NCT04896086|471239383|FG001|Overall Study|Lost to Follow-up|2|||
130892277|NCT04896086|471239384|FG002|Overall Study|Lost to Follow-up|1|||
130892278|NCT04896086|471239385|FG003|Overall Study|Lost to Follow-up|0|||
130892279|NCT04896086|471239386|FG004|Overall Study|Lost to Follow-up|0|||
130892280|NCT04896086|471239382|FG000|Overall Study|Physician Decision|0|||
130892281|NCT04896086|471239383|FG001|Overall Study|Physician Decision|1|||
130892282|NCT04896086|471239384|FG002|Overall Study|Physician Decision|0|||
130892283|NCT04896086|471239385|FG003|Overall Study|Physician Decision|0|||
130892284|NCT04896086|471239386|FG004|Overall Study|Physician Decision|0|||
130892285|NCT04896086|471239382|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130892286|NCT04896086|471239383|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130892287|NCT04896086|471239384|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130892288|NCT04896086|471239385|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
130892289|NCT04896086|471239386|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130892290|NCT04896086|471239382|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
130892291|NCT04896086|471239383|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
130892292|NCT04896086|471239384|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
130892293|NCT04896086|471239385|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
130892294|NCT04896086|471239386|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
130892295|NCT02249832|471239389|FG000|Overall Study|Withdrawal by Subject|3|||
130892296|NCT02249832|471239389|FG000|Overall Study|Lost to Follow-up|10|||
130892297|NCT03052400|471239396|FG000|Overall Study|Lost to Follow-up|1|||
130892298|NCT03052400|471239397|FG001|Overall Study|Lost to Follow-up|0|||
130892299|NCT03052400|471239396|FG000|Overall Study|Withdrawal by Subject|0|||
130892300|NCT03052400|471239397|FG001|Overall Study|Withdrawal by Subject|1|||
130892301|NCT00555061|471239398|FG000|Overall Study|Adverse Event|3|||
130892302|NCT00555061|471239398|FG000|Overall Study|Protocol Violation|1|||
130892303|NCT00555061|471239398|FG000|Overall Study|Lost to Follow-up|2|||
130892304|NCT00555061|471239398|FG000|Overall Study|Withdrawal by Subject|2|||
130892305|NCT00555061|471239398|FG000|Overall Study|Participant enrolled, but never treated|1|||
130892306|NCT01396447|471239399|FG000|Overall Study|Did Not Receive Treatment|3|||
130892307|NCT01396447|471239400|FG001|Overall Study|Did Not Receive Treatment|2|||
130892308|NCT01396447|471239401|FG002|Overall Study|Did Not Receive Treatment|1|||
130892309|NCT01396447|471239402|FG003|Overall Study|Did Not Receive Treatment|0|||
130892310|NCT01396447|471239399|FG000|Overall Study|Adverse Event|15|||
130892311|NCT01396447|471239400|FG001|Overall Study|Adverse Event|12|||
130892312|NCT01396447|471239401|FG002|Overall Study|Adverse Event|12|||
130892313|NCT01396447|471239402|FG003|Overall Study|Adverse Event|17|||
130892314|NCT01396447|471239399|FG000|Overall Study|Insufficient Therapeutic Response|5|||
130892315|NCT01396447|471239400|FG001|Overall Study|Insufficient Therapeutic Response|5|||
130892316|NCT01396447|471239401|FG002|Overall Study|Insufficient Therapeutic Response|2|||
130892317|NCT01396447|471239402|FG003|Overall Study|Insufficient Therapeutic Response|4|||
130892318|NCT01396447|471239399|FG000|Overall Study|Protocol Violation|5|||
131024520|NCT01037985|471720201|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
131024521|NCT01037985|471720202|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
131024522|NCT01037985|471720201|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
131024523|NCT01037985|471720202|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
131024524|NCT01037985|471720201|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
131024525|NCT01037985|471720202|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
131024526|NCT02730871|471720203|FG000|Overall Study|Adverse Event|6|||
131024527|NCT02730871|471720204|FG001|Overall Study|Adverse Event|0|||
130892319|NCT01396447|471239400|FG001|Overall Study|Protocol Violation|2|||
130892320|NCT01396447|471239401|FG002|Overall Study|Protocol Violation|3|||
130686876|NCT02281084|470479675|FG003|Overall Study|Site Closure by Sponsor|0|||
130686877|NCT02335658|470479676|FG000|Overall Study|Adverse Event|18|||
130686878|NCT02335658|470479677|FG001|Overall Study|Adverse Event|12|||
130686879|NCT02335658|470479676|FG000|Overall Study|Lack of Efficacy|4|||
130686880|NCT02335658|470479677|FG001|Overall Study|Lack of Efficacy|5|||
130686881|NCT02335658|470479676|FG000|Overall Study|Pregnancy|1|||
130892321|NCT01396447|471239402|FG003|Overall Study|Protocol Violation|7|||
130892322|NCT01396447|471239399|FG000|Overall Study|Withdrawal of Consent|11|||
130892323|NCT01396447|471239400|FG001|Overall Study|Withdrawal of Consent|9|||
130892324|NCT01396447|471239401|FG002|Overall Study|Withdrawal of Consent|4|||
130892325|NCT01396447|471239402|FG003|Overall Study|Withdrawal of Consent|15|||
130892326|NCT01396447|471239399|FG000|Overall Study|Lost to Follow-up|4|||
130892327|NCT01396447|471239400|FG001|Overall Study|Lost to Follow-up|8|||
130892328|NCT01396447|471239401|FG002|Overall Study|Lost to Follow-up|7|||
130892329|NCT01396447|471239402|FG003|Overall Study|Lost to Follow-up|9|||
130892330|NCT01396447|471239399|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130892331|NCT01396447|471239400|FG001|Overall Study|Other Miscellaneous Reasons|2|||
130892332|NCT01396447|471239401|FG002|Overall Study|Other Miscellaneous Reasons|1|||
130892333|NCT01396447|471239402|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130892334|NCT04881942|471239403|FG000|Overall Study|Adverse Event|0|||
130892335|NCT04881942|471239404|FG001|Overall Study|Adverse Event|0|||
130892336|NCT04881942|471239405|FG002|Overall Study|Adverse Event|0|||
130892337|NCT04881942|471239406|FG003|Overall Study|Adverse Event|0|||
130892338|NCT04881942|471239407|FG004|Overall Study|Adverse Event|1|||
130892339|NCT04881942|471239403|FG000|Overall Study|Alternates|0|||
130892340|NCT04881942|471239404|FG001|Overall Study|Alternates|0|||
130892341|NCT04881942|471239405|FG002|Overall Study|Alternates|0|||
130892342|NCT04881942|471239406|FG003|Overall Study|Alternates|0|||
130892343|NCT04881942|471239407|FG004|Overall Study|Alternates|2|||
131024528|NCT00823472|471720205|FG000|Overall Study|Physician Decision|24|||
131024529|NCT00823472|471720206|FG001|Overall Study|Physician Decision|28|||
131024530|NCT04992390|471720207|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
131024531|NCT04992390|471720208|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
131024532|NCT04992390|471720209|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
131024533|NCT04992390|471720207|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
131024534|NCT04992390|471720208|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
131024535|NCT04992390|471720209|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
131024536|NCT04992390|471720207|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
131024537|NCT04992390|471720208|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
131024538|NCT04992390|471720209|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
131024539|NCT04992390|471720207|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
131024540|NCT04992390|471720208|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
131024541|NCT04992390|471720209|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
131024542|NCT04992390|471720207|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
131024543|NCT04992390|471720208|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
131024544|NCT04992390|471720209|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
131024545|NCT04992390|471720207|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
131024546|NCT04992390|471720208|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
131024547|NCT04992390|471720209|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
131024548|NCT04992390|471720207|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
131024549|NCT04992390|471720208|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
131024550|NCT04992390|471720209|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
131024551|NCT04992390|471720207|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
131024552|NCT04992390|471720208|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
131024553|NCT04992390|471720209|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
131024554|NCT04992390|471720207|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
131024555|NCT04992390|471720208|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
131024556|NCT04992390|471720209|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
131024557|NCT04992390|471720207|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
131024558|NCT04992390|471720208|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
131024559|NCT04992390|471720209|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
131024560|NCT04992390|471720207|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
131024561|NCT04992390|471720208|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
131024562|NCT04992390|471720209|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
131024563|NCT04992390|471720207|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
130892344|NCT01349959|471239408|FG000|Overall Study|Adverse Event|7|||
130892345|NCT02675634|471239409|FG000|Test Period 1|Adverse Event|0|||
130686882|NCT02335658|470479677|FG001|Overall Study|Pregnancy|0|||
130686883|NCT02335658|470479676|FG000|Overall Study|Withdrawal by Subject|13|||
130892346|NCT02675634|471239410|FG001|Test Period 1|Adverse Event|1|||
130892347|NCT02675634|471239411|FG002|Test Period 1|Adverse Event|0|||
130892348|NCT02675634|471239412|FG003|Test Period 1|Adverse Event|1|||
130892349|NCT02675634|471239413|FG004|Test Period 1|Adverse Event|0|||
131109700|NCT01201265|472030942|FG000|Overall Study|Death|14|||
131109701|NCT01201265|472030942|FG000|Overall Study|Insufficient Therapeutic Response|3|||
131109702|NCT01201265|472030942|FG000|Overall Study|Lost to Follow-up|10|||
131109703|NCT01201265|472030942|FG000|Overall Study|Withdrawal by Subject|7|||
131109704|NCT01201265|472030942|FG000|Overall Study|Disease Progression|4|||
131109705|NCT04640077|472030943|FG000|Period 1|Withdrawal by Subject|4|||
131109706|NCT04640077|472030944|FG001|Period 1|Withdrawal by Subject|5|||
131109707|NCT04640077|472030945|FG002|Period 1|Withdrawal by Subject|0|||
131109708|NCT04640077|472030943|FG000|Period 1|Adverse Event|1|||
131109709|NCT04640077|472030944|FG001|Period 1|Adverse Event|1|||
131109710|NCT04640077|472030945|FG002|Period 1|Adverse Event|0|||
131109711|NCT04640077|472030943|FG000|Period 1|Screen Failure|2|||
131109712|NCT04640077|472030944|FG001|Period 1|Screen Failure|0|||
131109713|NCT04640077|472030945|FG002|Period 1|Screen Failure|0|||
131109714|NCT04640077|472030943|FG000|Period 2|Withdrawal by Subject|0|||
131109715|NCT04640077|472030944|FG001|Period 2|Withdrawal by Subject|0|||
131109716|NCT04640077|472030945|FG002|Period 2|Withdrawal by Subject|18|||
131109717|NCT04640077|472030943|FG000|Period 2|Adverse Event|0|||
131109718|NCT04640077|472030944|FG001|Period 2|Adverse Event|0|||
131109719|NCT04640077|472030945|FG002|Period 2|Adverse Event|6|||
131109720|NCT04640077|472030943|FG000|Period 2|Lost to Follow-up|0|||
131109721|NCT04640077|472030944|FG001|Period 2|Lost to Follow-up|0|||
131109722|NCT04640077|472030945|FG002|Period 2|Lost to Follow-up|2|||
131109723|NCT04640077|472030943|FG000|Period 2|Death|0|||
131109724|NCT04640077|472030944|FG001|Period 2|Death|0|||
131109725|NCT04640077|472030945|FG002|Period 2|Death|2|||
131109726|NCT04640077|472030943|FG000|Period 2|Progressive Disease|0|||
131109727|NCT04640077|472030944|FG001|Period 2|Progressive Disease|0|||
131109728|NCT04640077|472030945|FG002|Period 2|Progressive Disease|1|||
131109729|NCT04640077|472030943|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
131109730|NCT04640077|472030944|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
131109731|NCT04640077|472030945|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
131109732|NCT01257425|472030946|FG000|Overall Study|Lack of Efficacy|3|||
131109733|NCT01257425|472030947|FG001|Overall Study|Lack of Efficacy|3|||
131109734|NCT01257425|472030946|FG000|Overall Study|Adverse Event|1|||
131109735|NCT01257425|472030947|FG001|Overall Study|Adverse Event|1|||
131109736|NCT01257425|472030946|FG000|Overall Study|Protocol Violation|1|||
131109737|NCT01257425|472030947|FG001|Overall Study|Protocol Violation|1|||
131109738|NCT01257425|472030946|FG000|Overall Study|Withdrawal by Subject|0|||
131109739|NCT01257425|472030947|FG001|Overall Study|Withdrawal by Subject|1|||
131109740|NCT01257425|472030946|FG000|Overall Study|Death|1|||
131109741|NCT01257425|472030947|FG001|Overall Study|Death|0|||
131109742|NCT01182194|472030949|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
131109743|NCT01182194|472030950|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
131109744|NCT00368992|472030951|FG000|Overall Study|Ineligible|5|||
131109745|NCT00368992|472030951|FG000|Overall Study|Refused treatment|3|||
131109746|NCT00368992|472030951|FG000|Overall Study|Lack of Efficacy|63|||
131109747|NCT00368992|472030951|FG000|Overall Study|Adverse Event|26|||
131109748|NCT00368992|472030951|FG000|Overall Study|Death|4|||
131109749|NCT00368992|472030951|FG000|Overall Study|Other|9|||
131109750|NCT02668185|472030952|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
131109751|NCT02668185|472030953|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
131109752|NCT02668185|472030952|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
131109753|NCT02668185|472030953|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
131109754|NCT02668185|472030952|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
131109755|NCT02668185|472030953|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
131109756|NCT02668185|472030952|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
131109757|NCT02668185|472030953|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
131109758|NCT00723021|472030958|FG000|Intervention Period 4|Adverse Event|0|||
131109759|NCT00723021|472030959|FG001|Intervention Period 4|Adverse Event|0|||
131109760|NCT00723021|472030960|FG002|Intervention Period 4|Adverse Event|0|||
131109761|NCT00723021|472030961|FG003|Intervention Period 4|Adverse Event|0|||
131109762|NCT00723021|472030962|FG004|Intervention Period 4|Adverse Event|1|||
131109763|NCT00770341|472030964|FG000|Overall Study|Did not meet eligibility criteria|1|||
131109764|NCT00770341|472030965|FG001|Overall Study|Did not meet eligibility criteria|0|||
131109765|NCT00770341|472030966|FG002|Overall Study|Did not meet eligibility criteria|0|||
131109766|NCT00770341|472030964|FG000|Overall Study|Withdrawal by Subject|0|||
131109767|NCT00770341|472030965|FG001|Overall Study|Withdrawal by Subject|1|||
131109768|NCT00770341|472030966|FG002|Overall Study|Withdrawal by Subject|0|||
131109769|NCT00770341|472030964|FG000|Overall Study|Clinical Adverse Event|3|||
131109770|NCT00770341|472030965|FG001|Overall Study|Clinical Adverse Event|1|||
131109771|NCT00770341|472030966|FG002|Overall Study|Clinical Adverse Event|2|||
131109772|NCT00770341|472030964|FG000|Overall Study|Laboratory adverse event|3|||
131109773|NCT00770341|472030965|FG001|Overall Study|Laboratory adverse event|3|||
131109774|NCT00770341|472030966|FG002|Overall Study|Laboratory adverse event|0|||
131109775|NCT00770341|472030964|FG000|Overall Study|Lack of Efficacy|3|||
131109776|NCT00770341|472030965|FG001|Overall Study|Lack of Efficacy|0|||
131109777|NCT00770341|472030966|FG002|Overall Study|Lack of Efficacy|1|||
131109778|NCT00770341|472030964|FG000|Overall Study|Other|1|||
131109779|NCT00770341|472030965|FG001|Overall Study|Other|0|||
130892350|NCT02675634|471239414|FG005|Test Period 1|Adverse Event|0|||
130892351|NCT02675634|471239409|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
130892352|NCT02675634|471239410|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
130892353|NCT02675634|471239411|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
131109780|NCT00770341|472030966|FG002|Overall Study|Other|0|||
131109781|NCT00770341|472030964|FG000|Overall Study|Not treated|1|||
131109782|NCT00770341|472030965|FG001|Overall Study|Not treated|0|||
131109783|NCT00770341|472030966|FG002|Overall Study|Not treated|0|||
131109784|NCT00960531|472030972|FG000|Overall Study|Lack of Efficacy|1|||
131109785|NCT00960531|472030973|FG001|Overall Study|Lack of Efficacy|0|||
131109786|NCT00960531|472030974|FG002|Overall Study|Lack of Efficacy|0|||
131109787|NCT00960531|472030975|FG003|Overall Study|Lack of Efficacy|0|||
131109788|NCT00960531|472030976|FG004|Overall Study|Lack of Efficacy|0|||
131109789|NCT00960531|472030977|FG005|Overall Study|Lack of Efficacy|0|||
131109790|NCT00960531|472030978|FG006|Overall Study|Lack of Efficacy|0|||
131109791|NCT00960531|472030979|FG007|Overall Study|Lack of Efficacy|0|||
131109792|NCT00960531|472030980|FG008|Overall Study|Lack of Efficacy|0|||
131109793|NCT00960531|472030981|FG009|Overall Study|Lack of Efficacy|0|||
131109794|NCT00960531|472030972|FG000|Overall Study|Withdrawal by Subject|1|||
131109795|NCT00960531|472030973|FG001|Overall Study|Withdrawal by Subject|0|||
131109796|NCT00960531|472030974|FG002|Overall Study|Withdrawal by Subject|5|||
131109797|NCT00960531|472030975|FG003|Overall Study|Withdrawal by Subject|2|||
131109798|NCT00960531|472030976|FG004|Overall Study|Withdrawal by Subject|0|||
130686884|NCT02335658|470479677|FG001|Overall Study|Withdrawal by Subject|21|||
130686885|NCT02335658|470479676|FG000|Overall Study|non-compliance|2|||
130686886|NCT02335658|470479677|FG001|Overall Study|non-compliance|3|||
130686887|NCT02335658|470479676|FG000|Overall Study|other reason|2|||
130686888|NCT02335658|470479677|FG001|Overall Study|other reason|3|||
131109799|NCT00960531|472030977|FG005|Overall Study|Withdrawal by Subject|0|||
131109800|NCT00960531|472030978|FG006|Overall Study|Withdrawal by Subject|2|||
131109801|NCT00960531|472030979|FG007|Overall Study|Withdrawal by Subject|0|||
131109802|NCT00960531|472030980|FG008|Overall Study|Withdrawal by Subject|1|||
131109803|NCT00960531|472030981|FG009|Overall Study|Withdrawal by Subject|0|||
131109804|NCT00960531|472030972|FG000|Overall Study|Caregiver Request|2|||
131109805|NCT00960531|472030973|FG001|Overall Study|Caregiver Request|0|||
131109806|NCT00960531|472030974|FG002|Overall Study|Caregiver Request|6|||
131109807|NCT00960531|472030975|FG003|Overall Study|Caregiver Request|5|||
131109808|NCT00960531|472030976|FG004|Overall Study|Caregiver Request|0|||
131109809|NCT00960531|472030977|FG005|Overall Study|Caregiver Request|2|||
131109810|NCT00960531|472030978|FG006|Overall Study|Caregiver Request|3|||
131109811|NCT00960531|472030979|FG007|Overall Study|Caregiver Request|1|||
131109812|NCT00960531|472030980|FG008|Overall Study|Caregiver Request|3|||
131109813|NCT00960531|472030981|FG009|Overall Study|Caregiver Request|0|||
131109814|NCT00960531|472030972|FG000|Overall Study|Investigator Request|0|||
131109815|NCT00960531|472030973|FG001|Overall Study|Investigator Request|0|||
131109816|NCT00960531|472030974|FG002|Overall Study|Investigator Request|1|||
131109817|NCT00960531|472030975|FG003|Overall Study|Investigator Request|0|||
131109818|NCT00960531|472030976|FG004|Overall Study|Investigator Request|0|||
131109819|NCT00960531|472030977|FG005|Overall Study|Investigator Request|0|||
131109820|NCT00960531|472030978|FG006|Overall Study|Investigator Request|0|||
131109821|NCT00960531|472030979|FG007|Overall Study|Investigator Request|0|||
131109822|NCT00960531|472030980|FG008|Overall Study|Investigator Request|0|||
131109823|NCT00960531|472030981|FG009|Overall Study|Investigator Request|0|||
131109824|NCT00960531|472030972|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
131109825|NCT00960531|472030973|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
131109826|NCT00960531|472030974|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
131109827|NCT00960531|472030975|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
131109828|NCT00960531|472030976|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
131109829|NCT00960531|472030977|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
131109830|NCT00960531|472030978|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
131109831|NCT00960531|472030979|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
131109832|NCT00960531|472030980|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
131109833|NCT00960531|472030981|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
131109834|NCT00960531|472030972|FG000|Overall Study|Lost to Follow-up|0|||
131109835|NCT00960531|472030973|FG001|Overall Study|Lost to Follow-up|0|||
130686889|NCT02305758|470479678|FG000|Overall Study|Death|27|||
130686890|NCT02305758|470479679|FG001|Overall Study|Death|27|||
130686891|NCT02305758|470479678|FG000|Overall Study|Withdrew consent|9|||
131109836|NCT00960531|472030974|FG002|Overall Study|Lost to Follow-up|1|||
131222688|NCT03402126|472443160|FG000|Overall Study|Technical problems|1|||
130686892|NCT02305758|470479679|FG001|Overall Study|Withdrew consent|2|||
131109837|NCT00960531|472030975|FG003|Overall Study|Lost to Follow-up|0|||
131109838|NCT00960531|472030976|FG004|Overall Study|Lost to Follow-up|0|||
131109839|NCT00960531|472030977|FG005|Overall Study|Lost to Follow-up|0|||
131109840|NCT00960531|472030978|FG006|Overall Study|Lost to Follow-up|1|||
131109841|NCT00960531|472030979|FG007|Overall Study|Lost to Follow-up|0|||
131109842|NCT00960531|472030980|FG008|Overall Study|Lost to Follow-up|0|||
131109843|NCT00960531|472030981|FG009|Overall Study|Lost to Follow-up|0|||
131109844|NCT00960531|472030972|FG000|Overall Study|Failed to Return|2|||
131109845|NCT00960531|472030973|FG001|Overall Study|Failed to Return|0|||
131109846|NCT00960531|472030974|FG002|Overall Study|Failed to Return|0|||
131109847|NCT00960531|472030975|FG003|Overall Study|Failed to Return|0|||
131109848|NCT00960531|472030976|FG004|Overall Study|Failed to Return|0|||
131109849|NCT00960531|472030977|FG005|Overall Study|Failed to Return|0|||
131109850|NCT00960531|472030978|FG006|Overall Study|Failed to Return|0|||
131109851|NCT00960531|472030979|FG007|Overall Study|Failed to Return|2|||
131109852|NCT00960531|472030980|FG008|Overall Study|Failed to Return|0|||
131109853|NCT00960531|472030981|FG009|Overall Study|Failed to Return|0|||
131109854|NCT00960531|472030972|FG000|Overall Study|Adverse Event (AE)|2|||
131109855|NCT00960531|472030973|FG001|Overall Study|Adverse Event (AE)|0|||
131109856|NCT00960531|472030974|FG002|Overall Study|Adverse Event (AE)|0|||
131109857|NCT00960531|472030975|FG003|Overall Study|Adverse Event (AE)|0|||
131109858|NCT00960531|472030976|FG004|Overall Study|Adverse Event (AE)|0|||
131109859|NCT00960531|472030977|FG005|Overall Study|Adverse Event (AE)|1|||
131109860|NCT00960531|472030978|FG006|Overall Study|Adverse Event (AE)|2|||
131109861|NCT00960531|472030979|FG007|Overall Study|Adverse Event (AE)|0|||
131109862|NCT00960531|472030980|FG008|Overall Study|Adverse Event (AE)|2|||
131109863|NCT00960531|472030981|FG009|Overall Study|Adverse Event (AE)|0|||
131109864|NCT00960531|472030972|FG000|Overall Study|Reason not Specified|2|||
131109865|NCT00960531|472030973|FG001|Overall Study|Reason not Specified|1|||
131109866|NCT00960531|472030974|FG002|Overall Study|Reason not Specified|13|||
131109867|NCT00960531|472030975|FG003|Overall Study|Reason not Specified|1|||
131109868|NCT00960531|472030976|FG004|Overall Study|Reason not Specified|2|||
131109869|NCT00960531|472030977|FG005|Overall Study|Reason not Specified|0|||
131109870|NCT00960531|472030978|FG006|Overall Study|Reason not Specified|16|||
131109871|NCT00960531|472030979|FG007|Overall Study|Reason not Specified|0|||
131109872|NCT00960531|472030980|FG008|Overall Study|Reason not Specified|8|||
131109873|NCT00960531|472030981|FG009|Overall Study|Reason not Specified|1|||
131109874|NCT01163916|472030984|FG000|Overall Study|Withdrawal by Subject|2|||
131109875|NCT01163916|472030985|FG001|Overall Study|Withdrawal by Subject|0|||
131109876|NCT01163916|472030986|FG002|Overall Study|Withdrawal by Subject|2|||
131109877|NCT01163916|472030984|FG000|Overall Study|Adverse Event|2|||
131109878|NCT01163916|472030985|FG001|Overall Study|Adverse Event|0|||
131109879|NCT01163916|472030986|FG002|Overall Study|Adverse Event|1|||
131109880|NCT01163916|472030984|FG000|Overall Study|Lack of Efficacy|2|||
131109881|NCT01163916|472030985|FG001|Overall Study|Lack of Efficacy|0|||
131109882|NCT01163916|472030986|FG002|Overall Study|Lack of Efficacy|1|||
131109883|NCT01163916|472030984|FG000|Overall Study|Other|24|||
131109884|NCT01163916|472030985|FG001|Overall Study|Other|4|||
131109885|NCT01163916|472030986|FG002|Overall Study|Other|16|||
131109886|NCT00883051|472030987|FG000|Overall Study|Lost to Follow-up|0|||
131109887|NCT00883051|472030988|FG001|Overall Study|Lost to Follow-up|0|||
131109888|NCT00883051|472030989|FG002|Overall Study|Lost to Follow-up|0|||
131109889|NCT00883051|472030990|FG003|Overall Study|Lost to Follow-up|0|||
131109890|NCT00883051|472030991|FG004|Overall Study|Lost to Follow-up|1|||
131109891|NCT00883051|472030987|FG000|Overall Study|Did not use study medication|24|||
131109892|NCT00883051|472030988|FG001|Overall Study|Did not use study medication|22|||
131109893|NCT00883051|472030989|FG002|Overall Study|Did not use study medication|29|||
131109894|NCT00883051|472030990|FG003|Overall Study|Did not use study medication|29|||
131109895|NCT00883051|472030991|FG004|Overall Study|Did not use study medication|17|||
131109896|NCT02337751|472030992|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
131109897|NCT02337751|472030993|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
131109898|NCT02337751|472030992|FG000|Overall Study|Voluntary Withdrawal|6|||
131109899|NCT02337751|472030993|FG001|Overall Study|Voluntary Withdrawal|8|||
131109900|NCT02337751|472030992|FG000|Overall Study|Lack of Efficacy|2|||
131109901|NCT02337751|472030993|FG001|Overall Study|Lack of Efficacy|5|||
131109902|NCT02337751|472030992|FG000|Overall Study|Investigator's Judgement|1|||
131109903|NCT02337751|472030993|FG001|Overall Study|Investigator's Judgement|0|||
131109904|NCT01910181|472031000|FG000|Overall Study|Death|37|||
131109905|NCT01910181|472031000|FG000|Overall Study|Lost to Follow-up|3|||
131109906|NCT01910181|472031000|FG000|Overall Study|Study Terminated by Sponsor|6|||
131109907|NCT01215422|472033893|FG000|Overall Study|Relocation|1|||
131109908|NCT01215422|472033894|FG001|Overall Study|Relocation|0|||
131109909|NCT01215422|472033895|FG002|Overall Study|Relocation|0|||
131109910|NCT01215422|472033896|FG003|Overall Study|Relocation|0|||
131109911|NCT01215422|472033893|FG000|Overall Study|Failed intubations|0|||
131109912|NCT01215422|472033894|FG001|Overall Study|Failed intubations|0|||
131109913|NCT01215422|472033895|FG002|Overall Study|Failed intubations|3|||
131109914|NCT01215422|472033896|FG003|Overall Study|Failed intubations|8|||
131109915|NCT01215422|472033893|FG000|Overall Study|Did not complete all intubations|7|||
131109916|NCT01215422|472033894|FG001|Overall Study|Did not complete all intubations|0|||
131109917|NCT01215422|472033895|FG002|Overall Study|Did not complete all intubations|0|||
131109918|NCT01215422|472033896|FG003|Overall Study|Did not complete all intubations|0|||
131109919|NCT04142450|472033901|FG000|Overall Study|Screen Failure|1|||
131109920|NCT04142450|472033901|FG000|Overall Study|Lost to Follow-up|1|||
131109921|NCT02544217|472033902|FG000|Overall Study|Withdrawal by Subject|1|||
130892354|NCT02675634|471239412|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
130892355|NCT02675634|471239413|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
130892356|NCT02675634|471239414|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
130892357|NCT02675634|471239409|FG000|Test Period 2|Lack of Efficacy|1|||
130892358|NCT02675634|471239410|FG001|Test Period 2|Lack of Efficacy|0|||
130892359|NCT02675634|471239411|FG002|Test Period 2|Lack of Efficacy|0|||
130892360|NCT02675634|471239412|FG003|Test Period 2|Lack of Efficacy|0|||
130892361|NCT02675634|471239413|FG004|Test Period 2|Lack of Efficacy|0|||
130892362|NCT02675634|471239414|FG005|Test Period 2|Lack of Efficacy|0|||
130892363|NCT02675634|471239409|FG000|Test Period 2|Adverse Event|0|||
130892364|NCT02675634|471239410|FG001|Test Period 2|Adverse Event|0|||
130892365|NCT02675634|471239411|FG002|Test Period 2|Adverse Event|0|||
130892366|NCT02675634|471239412|FG003|Test Period 2|Adverse Event|0|||
130892367|NCT02675634|471239413|FG004|Test Period 2|Adverse Event|0|||
130892368|NCT02675634|471239414|FG005|Test Period 2|Adverse Event|1|||
130892369|NCT01652534|471239415|FG000|Overall Study|Lack of Efficacy|1|||
130892370|NCT01652534|471239416|FG001|Overall Study|Lack of Efficacy|0|||
130892371|NCT02105961|471239417|FG000|Overall Study|Adverse Event|18|||
130892372|NCT02105961|471239418|FG001|Overall Study|Adverse Event|7|||
130892373|NCT02105961|471239419|FG002|Overall Study|Adverse Event|13|||
130892374|NCT02105961|471239417|FG000|Overall Study|Lack of Efficacy|3|||
130892375|NCT02105961|471239418|FG001|Overall Study|Lack of Efficacy|0|||
130892376|NCT02105961|471239419|FG002|Overall Study|Lack of Efficacy|3|||
130892377|NCT02105961|471239417|FG000|Overall Study|Lost to Follow-up|2|||
130892378|NCT02105961|471239418|FG001|Overall Study|Lost to Follow-up|0|||
130892379|NCT02105961|471239419|FG002|Overall Study|Lost to Follow-up|1|||
130892380|NCT02105961|471239417|FG000|Overall Study|Physician Decision|3|||
130892381|NCT02105961|471239418|FG001|Overall Study|Physician Decision|3|||
130892382|NCT02105961|471239419|FG002|Overall Study|Physician Decision|2|||
130892383|NCT02105961|471239417|FG000|Overall Study|Withdrawal by Subject|15|||
130892384|NCT02105961|471239418|FG001|Overall Study|Withdrawal by Subject|7|||
130892385|NCT02105961|471239419|FG002|Overall Study|Withdrawal by Subject|11|||
130892386|NCT03860259|471239420|FG000|Overall Study|Lost to Follow-up|5|||
130892387|NCT03860259|471239421|FG001|Overall Study|Lost to Follow-up|5|||
130892388|NCT03860259|471239420|FG000|Overall Study|Protocol Violation|1|||
130892389|NCT03860259|471239421|FG001|Overall Study|Protocol Violation|0|||
130892390|NCT00811018|471239422|FG000|Overall Study|Additional Chronic Treatment|31|||
130892391|NCT00811018|471239422|FG000|Overall Study|Adverse Event|79|||
130892392|NCT00811018|471239422|FG000|Overall Study|Death|147|||
130892393|NCT00811018|471239422|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
130892394|NCT00811018|471239422|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
130892395|NCT00811018|471239422|FG000|Overall Study|Investigator Decision|57|||
130892396|NCT00811018|471239422|FG000|Overall Study|Lost to Follow-up|19|||
130892397|NCT00811018|471239422|FG000|Overall Study|Pregnancy|6|||
130892398|NCT00811018|471239422|FG000|Overall Study|Sponsor Decision|450|||
130892399|NCT00811018|471239422|FG000|Overall Study|Withdrawal by Subject|70|||
130892400|NCT00811018|471239422|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
130892401|NCT00811018|471239422|FG000|Overall Study|Other|26|||
130892402|NCT04380519|471239426|FG000|Overall Study|Withdrawal by Subject|4|||
130892403|NCT04380519|471239427|FG001|Overall Study|Withdrawal by Subject|0|||
130892404|NCT04380519|471239428|FG002|Overall Study|Withdrawal by Subject|1|||
130892405|NCT04380519|471239426|FG000|Overall Study|Death|14|||
130892406|NCT04380519|471239427|FG001|Overall Study|Death|9|||
130892407|NCT04380519|471239428|FG002|Overall Study|Death|6|||
130892408|NCT04380519|471239426|FG000|Overall Study|Adverse Event|0|||
130892409|NCT04380519|471239427|FG001|Overall Study|Adverse Event|1|||
130892410|NCT04380519|471239428|FG002|Overall Study|Adverse Event|0|||
131024564|NCT04992390|471720208|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
131024565|NCT04992390|471720209|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
131024566|NCT04992390|471720207|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
131024567|NCT04992390|471720208|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
131024568|NCT04992390|471720209|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
131024569|NCT04992390|471720207|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
131024570|NCT04992390|471720208|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
131024571|NCT04992390|471720209|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
131024572|NCT04992390|471720207|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
131024573|NCT04992390|471720208|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
131024574|NCT04992390|471720209|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
131024575|NCT04992390|471720207|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
130892411|NCT04380519|471239426|FG000|Overall Study|relatives' decision|0|||
130892412|NCT04380519|471239427|FG001|Overall Study|relatives' decision|1|||
130892413|NCT04380519|471239428|FG002|Overall Study|relatives' decision|0|||
130892414|NCT02147561|471239429|FG000|Overall Study|Lost to Follow-up|3|||
130892415|NCT02147561|471239429|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
130892416|NCT00393861|471239432|FG000|Overall Study|Adverse Event|2|||
130892417|NCT00393861|471239432|FG000|Overall Study|Disease Progression|24|||
130686893|NCT02305758|470479678|FG000|Overall Study|Lost to Follow-up|6|||
130686894|NCT02305758|470479679|FG001|Overall Study|Lost to Follow-up|1|||
130686895|NCT02305758|470479678|FG000|Overall Study|Study Terminated by Sponsor|21|||
130686896|NCT02305758|470479679|FG001|Overall Study|Study Terminated by Sponsor|34|||
130686897|NCT02305758|470479678|FG000|Overall Study|Other, not specified|2|||
130686898|NCT02305758|470479679|FG001|Overall Study|Other, not specified|1|||
130686899|NCT02032888|470479682|FG000|Treatment Period|Poor compliance/noncompliance|1|||
130686900|NCT02032888|470479683|FG001|Treatment Period|Poor compliance/noncompliance|1|||
130686901|NCT02032888|470479684|FG002|Treatment Period|Poor compliance/noncompliance|0|||
130686902|NCT02032888|470479682|FG000|Treatment Period|Other|1|||
130686903|NCT02032888|470479683|FG001|Treatment Period|Other|1|||
130686904|NCT02032888|470479684|FG002|Treatment Period|Other|0|||
131024576|NCT04992390|471720208|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
131024577|NCT04992390|471720209|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
131024578|NCT02807779|471720210|FG000|Overall Study|Lost to Follow-up|1|||
131024579|NCT02807779|471720211|FG001|Overall Study|Lost to Follow-up|0|||
131024580|NCT02807779|471720212|FG002|Overall Study|Lost to Follow-up|0|||
131024581|NCT02807779|471720210|FG000|Overall Study|Physician Decision|2|||
131024582|NCT02807779|471720211|FG001|Overall Study|Physician Decision|0|||
131024583|NCT02807779|471720212|FG002|Overall Study|Physician Decision|1|||
131024584|NCT02807779|471720210|FG000|Overall Study|Death|1|||
131024585|NCT02807779|471720211|FG001|Overall Study|Death|1|||
131024586|NCT02807779|471720212|FG002|Overall Study|Death|0|||
131024587|NCT04755660|471721340|FG000|Overall Study|Lost to Follow-up|1|||
131024588|NCT04755660|471721341|FG001|Overall Study|Lost to Follow-up|1|||
130686905|NCT02032888|470479682|FG000|Follow-up Period|Lost to Follow-up|1|||
130686906|NCT02032888|470479683|FG001|Follow-up Period|Lost to Follow-up|1|||
131024589|NCT04755660|471721342|FG002|Overall Study|Lost to Follow-up|0|||
131024590|NCT04755660|471721340|FG000|Overall Study|Withdrawal by Subject|0|||
131024591|NCT04755660|471721341|FG001|Overall Study|Withdrawal by Subject|1|||
131024592|NCT04755660|471721342|FG002|Overall Study|Withdrawal by Subject|1|||
131024593|NCT04755660|471721340|FG000|Overall Study|Physician Decision|0|||
131024594|NCT04755660|471721341|FG001|Overall Study|Physician Decision|0|||
131024595|NCT04755660|471721342|FG002|Overall Study|Physician Decision|1|||
131024596|NCT01903811|471721351|FG000|Overall Study|No measurable disease|1|||
131024597|NCT01903811|471721352|FG001|Overall Study|No measurable disease|1|||
131024598|NCT01903811|471721351|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
131024599|NCT01903811|471721352|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
131024600|NCT01903811|471721351|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
131024601|NCT01903811|471721352|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
131024602|NCT01903811|471721351|FG000|Overall Study|Withdrawal by Subject|0|||
131024603|NCT01903811|471721352|FG001|Overall Study|Withdrawal by Subject|1|||
131024604|NCT04540913|471721353|FG000|Overall Study|Withdrawal by Subject|14|||
131024605|NCT04540913|471721354|FG001|Overall Study|Withdrawal by Subject|3|||
131024606|NCT03575052|471721355|FG000|Overall Study|Adverse Event|6|||
131024607|NCT03575052|471721356|FG001|Overall Study|Adverse Event|10|||
131024608|NCT03575052|471721355|FG000|Overall Study|Not further specified|5|||
131024609|NCT03575052|471721356|FG001|Overall Study|Not further specified|7|||
131024610|NCT03575052|471721355|FG000|Overall Study|Withdrawal by Subject|5|||
131024611|NCT03575052|471721356|FG001|Overall Study|Withdrawal by Subject|6|||
131024612|NCT03575052|471721355|FG000|Overall Study|Lost to Follow-up|3|||
131024613|NCT03575052|471721356|FG001|Overall Study|Lost to Follow-up|0|||
131024614|NCT03575052|471721355|FG000|Overall Study|Death|2|||
131024615|NCT03575052|471721356|FG001|Overall Study|Death|1|||
131024616|NCT03575052|471721355|FG000|Overall Study|Lack of Efficacy|2|||
131024617|NCT03575052|471721356|FG001|Overall Study|Lack of Efficacy|1|||
131024618|NCT03575052|471721355|FG000|Overall Study|Study drug noncompliance|1|||
131024619|NCT03575052|471721356|FG001|Overall Study|Study drug noncompliance|2|||
131024620|NCT03575052|471721355|FG000|Overall Study|Protocol Violation|0|||
131024621|NCT03575052|471721356|FG001|Overall Study|Protocol Violation|2|||
131024622|NCT03575052|471721355|FG000|Overall Study|Physician Decision|1|||
131024623|NCT03575052|471721356|FG001|Overall Study|Physician Decision|0|||
131024624|NCT03438188|471721358|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
131024625|NCT03438188|471721359|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
131024626|NCT03438188|471721360|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
131024627|NCT03438188|471721358|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
131024628|NCT03438188|471721359|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
131024629|NCT03438188|471721360|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
131024630|NCT03438188|471721358|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
131024631|NCT03438188|471721359|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
131024632|NCT03438188|471721360|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
131024633|NCT03438188|471721358|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
131024634|NCT03438188|471721359|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
130892418|NCT05300763|471239433|FG000|Overall Study|Adverse Event|0|||
130892419|NCT05300763|471239434|FG001|Overall Study|Adverse Event|1|||
130892420|NCT05300763|471239433|FG000|Overall Study|Major Protocol Deviation|1|||
130892421|NCT05300763|471239434|FG001|Overall Study|Major Protocol Deviation|0|||
130892422|NCT05300763|471239433|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
130892423|NCT05300763|471239434|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130892424|NCT02283762|471239438|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
130892425|NCT02283762|471239439|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
130892426|NCT02283762|471239438|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
130892427|NCT02283762|471239439|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
130892428|NCT02283762|471239438|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
130892429|NCT02283762|471239439|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
130892430|NCT02283762|471239438|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
130892431|NCT02283762|471239439|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
130892432|NCT02283762|471239438|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
130892433|NCT02283762|471239439|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
130892434|NCT02283762|471239438|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
130892435|NCT02283762|471239439|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
130892436|NCT02283762|471239438|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
130892437|NCT02283762|471239439|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
130892438|NCT02283762|471239438|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
130892439|NCT02283762|471239439|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
130892440|NCT02283762|471239438|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
130892441|NCT02283762|471239439|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
130892442|NCT02283762|471239438|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
130892443|NCT02283762|471239439|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
130892444|NCT02283762|471239438|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
130892445|NCT02283762|471239439|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
130892446|NCT02283762|471239438|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
130892447|NCT02283762|471239439|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
130892448|NCT02920242|471239440|FG000|Overall Study|Withdrawal by Subject|1|||
130892449|NCT02920242|471239441|FG001|Overall Study|Withdrawal by Subject|0|||
130892450|NCT02920242|471239442|FG002|Overall Study|Withdrawal by Subject|1|||
130892451|NCT02920242|471239440|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
130892452|NCT02920242|471239441|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
130892453|NCT02920242|471239442|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
130892454|NCT00202878|471239443|FG000|Overall Study|Death|964|||
130892455|NCT00202878|471239444|FG001|Overall Study|Death|968|||
130892456|NCT00202878|471239443|FG000|Overall Study|Only Vital Status Known|357|||
130892457|NCT00202878|471239444|FG001|Overall Study|Only Vital Status Known|356|||
130892458|NCT00202878|471239443|FG000|Overall Study|Lost to Follow-up|44|||
130892459|NCT00202878|471239444|FG001|Overall Study|Lost to Follow-up|49|||
130892460|NCT00202878|471239443|FG000|Overall Study|Site Closure|39|||
130892461|NCT00202878|471239444|FG001|Overall Study|Site Closure|36|||
130892462|NCT00202878|471239443|FG000|Overall Study|Withdrawal by Subject|795|||
130892463|NCT00202878|471239444|FG001|Overall Study|Withdrawal by Subject|808|||
130892464|NCT01587014|471239445|FG000|Overall Study|Death|2|||
130892465|NCT02948088|471239446|FG000|Overall Study|Lost to Follow-up|8|||
130892466|NCT02948088|471239446|FG000|Overall Study|Death|1|||
130892467|NCT02948088|471239446|FG000|Overall Study|Withdrawal by Subject|4|||
130892468|NCT02948088|471239446|FG000|Overall Study|Other|2|||
130892469|NCT00634101|471239447|FG000|Overall Study|Study Terminated|3|||
130892470|NCT00634101|471239448|FG001|Overall Study|Study Terminated|3|||
130892471|NCT00634101|471239447|FG000|Overall Study|Lost to Follow-up|2|||
130892472|NCT00634101|471239448|FG001|Overall Study|Lost to Follow-up|0|||
130892473|NCT00573144|471239453|FG000|Overall Study|Withdrawal by Subject|2|||
130892474|NCT00573144|471239454|FG001|Overall Study|Withdrawal by Subject|3|||
130892475|NCT02367833|471239455|FG000|Overall Study|Withdrawal by Subject|1|||
130892476|NCT02367833|471239456|FG001|Overall Study|Withdrawal by Subject|1|||
130892477|NCT02367833|471239457|FG002|Overall Study|Withdrawal by Subject|0|||
130892478|NCT01077076|471239458|FG000|First Intervention|Withdrawal by Subject|1|||
130892479|NCT01077076|471239459|FG001|First Intervention|Withdrawal by Subject|0|||
130892480|NCT01077076|471239460|FG002|First Intervention|Withdrawal by Subject|0|||
131024635|NCT03438188|471721360|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
131024636|NCT03438188|471721358|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
131024637|NCT03438188|471721359|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
131024638|NCT03438188|471721360|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
131024639|NCT04153565|471721361|FG000|Overall Study|Death|13|||
130892481|NCT01077076|471239461|FG003|First Intervention|Withdrawal by Subject|0|||
130892482|NCT01077076|471239462|FG004|First Intervention|Withdrawal by Subject|0|||
130892483|NCT01077076|471239463|FG005|First Intervention|Withdrawal by Subject|0|||
130892484|NCT01077076|471239458|FG000|Third Intervention|Death in the participant's family|0|||
130892485|NCT01077076|471239459|FG001|Third Intervention|Death in the participant's family|0|||
130686907|NCT02032888|470479684|FG002|Follow-up Period|Lost to Follow-up|0|||
130686908|NCT02032888|470479682|FG000|Follow-up Period|Death|1|||
130686909|NCT02032888|470479683|FG001|Follow-up Period|Death|1|||
130686910|NCT02032888|470479684|FG002|Follow-up Period|Death|0|||
130686911|NCT02032888|470479682|FG000|Follow-up Period|Other|1|||
130686912|NCT02032888|470479683|FG001|Follow-up Period|Other|0|||
130686913|NCT02032888|470479684|FG002|Follow-up Period|Other|0|||
130686914|NCT01697696|470479685|FG000|Overall Study|Study terminated by sponsor|0|||
130686915|NCT01697696|470479686|FG001|Overall Study|Study terminated by sponsor|3|||
130686916|NCT01697696|470479685|FG000|Overall Study|Protocol deviation|1|||
130686917|NCT01697696|470479686|FG001|Overall Study|Protocol deviation|0|||
130686918|NCT01697696|470479685|FG000|Overall Study|Physician Decision|1|||
130686919|NCT01697696|470479686|FG001|Overall Study|Physician Decision|0|||
130686920|NCT01697696|470479685|FG000|Overall Study|Death|4|||
130686921|NCT01697696|470479686|FG001|Overall Study|Death|2|||
130686922|NCT01697696|470479685|FG000|Overall Study|Lost to Follow-up|10|||
130686923|NCT01697696|470479686|FG001|Overall Study|Lost to Follow-up|7|||
130686924|NCT01697696|470479685|FG000|Overall Study|Subject/guardian decision|31|||
130686925|NCT01697696|470479686|FG001|Overall Study|Subject/guardian decision|35|||
130686926|NCT05593965|470479687|FG000|1st Intervention (1 Day)|Technical error|1|||
130686927|NCT05593965|470479688|FG001|1st Intervention (1 Day)|Technical error|0|||
130686928|NCT03616106|470479703|FG000|Overall Study|Removed by PI|6|||
130686929|NCT03616106|470479704|FG001|Overall Study|Removed by PI|0|||
130686930|NCT03616106|470479703|FG000|Overall Study|Withdrawal by Subject|1|||
130686931|NCT03616106|470479704|FG001|Overall Study|Withdrawal by Subject|1|||
130686932|NCT03616106|470479703|FG000|Overall Study|Lost to Follow-up|7|||
130686933|NCT03616106|470479704|FG001|Overall Study|Lost to Follow-up|0|||
130686934|NCT03206177|470479707|FG000|Overall Study|Withdrawal by Subject|1|||
130686935|NCT02963259|470479709|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
130686936|NCT02963259|470479709|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
130686937|NCT02963259|470479709|FG000|Overall Study|Death|1|||
130686938|NCT02963259|470479709|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
130686939|NCT04611789|470479710|FG000|Overall Study|Lost to Follow-up|1|||
130686940|NCT04611789|470479711|FG001|Overall Study|Lost to Follow-up|0|||
130686941|NCT04611789|470479712|FG002|Overall Study|Lost to Follow-up|0|||
130686942|NCT00727961|470479713|FG000|Overall Study|Lost to Follow-up|1|||
130686943|NCT00727961|470479713|FG000|Overall Study|Adverse Event|4|||
130686944|NCT00727961|470479713|FG000|Overall Study|Patient's refusal|2|||
130686945|NCT00727961|470479713|FG000|Overall Study|Progression|30|||
130686946|NCT03880266|470479714|FG000|Overall Study|Withdrawal by Subject|0|||
130686947|NCT03880266|470479715|FG001|Overall Study|Withdrawal by Subject|1|||
130686948|NCT03880266|470479716|FG002|Overall Study|Withdrawal by Subject|1|||
130686949|NCT03880266|470479717|FG003|Overall Study|Withdrawal by Subject|0|||
130686950|NCT03880266|470479718|FG004|Overall Study|Withdrawal by Subject|0|||
130686951|NCT03880266|470479719|FG005|Overall Study|Withdrawal by Subject|0|||
130686952|NCT03880266|470479720|FG006|Overall Study|Withdrawal by Subject|0|||
130686953|NCT03880266|470479721|FG007|Overall Study|Withdrawal by Subject|0|||
130686954|NCT03161405|470479722|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
130686955|NCT02655679|470479723|FG000|Overall Study|Adverse Event|0|||
131024640|NCT04300231|471721362|FG000|Overall Study|Protocol Violation|4|||
131024641|NCT04300231|471721363|FG001|Overall Study|Protocol Violation|3|||
131024642|NCT04300231|471721364|FG002|Overall Study|Protocol Violation|0|||
131024643|NCT04300231|471721365|FG003|Overall Study|Protocol Violation|2|||
131024644|NCT00670046|471721372|FG000|Overall Study|Lost to Follow-up|1|||
131024645|NCT00670046|471721373|FG001|Overall Study|Lost to Follow-up|1|||
131024646|NCT00670046|471721372|FG000|Overall Study|Withdrawal by Subject|0|||
131024647|NCT00670046|471721373|FG001|Overall Study|Withdrawal by Subject|1|||
131024648|NCT02300298|471721376|FG000|Disposition for Nintedanib|Progressive disease|10|||
131024649|NCT02300298|471721377|FG001|Disposition for Nintedanib|Progressive disease|0|||
131024650|NCT02300298|471721376|FG000|Disposition for Docetaxel|Progressive disease|0|||
131024651|NCT02300298|471721377|FG001|Disposition for Docetaxel|Progressive disease|6|||
131024652|NCT02300298|471721376|FG000|Disposition for Docetaxel|other adverse event|0|||
131024653|NCT02300298|471721377|FG001|Disposition for Docetaxel|other adverse event|4|||
131024654|NCT03285763|471721378|FG000|Overall Study|Death|470|||
131024655|NCT03285763|471721378|FG000|Overall Study|Lost to Follow-up|18|||
131024656|NCT03285763|471721378|FG000|Overall Study|Physician Decision|2|||
130686956|NCT02655679|470479724|FG001|Overall Study|Adverse Event|1|||
130686957|NCT02655679|470479725|FG002|Overall Study|Adverse Event|0|||
130686958|NCT02655679|470479726|FG003|Overall Study|Adverse Event|0|||
130686959|NCT02655679|470479727|FG004|Overall Study|Adverse Event|0|||
130686960|NCT02655679|470479723|FG000|Overall Study|Withdrawal by Subject|1|||
131024657|NCT03285763|471721378|FG000|Overall Study|Study Terminated By Sponsor|79|||
131024658|NCT03285763|471721378|FG000|Overall Study|Withdrawal by Subject|33|||
130686961|NCT02655679|470479724|FG001|Overall Study|Withdrawal by Subject|1|||
130686962|NCT02655679|470479725|FG002|Overall Study|Withdrawal by Subject|0|||
130686963|NCT02655679|470479726|FG003|Overall Study|Withdrawal by Subject|3|||
130686964|NCT02655679|470479727|FG004|Overall Study|Withdrawal by Subject|1|||
131024659|NCT03624972|471721379|FG000|Overall Study|Lost to Follow-up|2|||
130892486|NCT01077076|471239460|FG002|Third Intervention|Death in the participant's family|0|||
130892487|NCT01077076|471239461|FG003|Third Intervention|Death in the participant's family|0|||
130892488|NCT01077076|471239462|FG004|Third Intervention|Death in the participant's family|0|||
130892489|NCT01077076|471239463|FG005|Third Intervention|Death in the participant's family|1|||
130892490|NCT00035932|471239464|FG000|Overall Study|Adverse Event|10|||
130892491|NCT00035932|471239465|FG001|Overall Study|Adverse Event|9|||
130892492|NCT00035932|471239466|FG002|Overall Study|Adverse Event|9|||
130892493|NCT00035932|471239464|FG000|Overall Study|Death|0|||
130892494|NCT00035932|471239465|FG001|Overall Study|Death|0|||
130892495|NCT00035932|471239466|FG002|Overall Study|Death|1|||
130892496|NCT00035932|471239464|FG000|Overall Study|Disease Progression / Relapse|1|||
130892497|NCT00035932|471239465|FG001|Overall Study|Disease Progression / Relapse|1|||
130892498|NCT00035932|471239466|FG002|Overall Study|Disease Progression / Relapse|0|||
130892499|NCT00035932|471239464|FG000|Overall Study|Lost to Follow-up|4|||
130892500|NCT00035932|471239465|FG001|Overall Study|Lost to Follow-up|4|||
130892501|NCT00035932|471239466|FG002|Overall Study|Lost to Follow-up|3|||
130892502|NCT00035932|471239464|FG000|Overall Study|Noncompliance|6|||
130892503|NCT00035932|471239465|FG001|Overall Study|Noncompliance|7|||
130892504|NCT00035932|471239466|FG002|Overall Study|Noncompliance|6|||
130892505|NCT00035932|471239464|FG000|Overall Study|Protocol Violation While on Study|0|||
130892506|NCT00035932|471239465|FG001|Overall Study|Protocol Violation While on Study|1|||
130892507|NCT00035932|471239466|FG002|Overall Study|Protocol Violation While on Study|2|||
130892508|NCT00035932|471239464|FG000|Overall Study|Withdrawal by Subject|1|||
130892509|NCT00035932|471239465|FG001|Overall Study|Withdrawal by Subject|5|||
130892510|NCT00035932|471239466|FG002|Overall Study|Withdrawal by Subject|0|||
130892511|NCT00035932|471239464|FG000|Overall Study|Study Termination by Sponsor|1|||
130892512|NCT00035932|471239465|FG001|Overall Study|Study Termination by Sponsor|0|||
130892513|NCT00035932|471239466|FG002|Overall Study|Study Termination by Sponsor|0|||
130892514|NCT00035932|471239464|FG000|Overall Study|Lack of Efficacy|33|||
130892515|NCT00035932|471239465|FG001|Overall Study|Lack of Efficacy|33|||
130892516|NCT00035932|471239466|FG002|Overall Study|Lack of Efficacy|28|||
130892517|NCT04413617|471239469|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130892518|NCT04413617|471239470|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130892519|NCT04413617|471239471|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130892520|NCT04413617|471239472|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
130892521|NCT04413617|471239473|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130892522|NCT04413617|471239469|FG000|Overall Study|Protocol Violation|0|||
130892523|NCT04413617|471239470|FG001|Overall Study|Protocol Violation|1|||
130892524|NCT04413617|471239471|FG002|Overall Study|Protocol Violation|0|||
130892525|NCT04413617|471239472|FG003|Overall Study|Protocol Violation|0|||
130892526|NCT04413617|471239473|FG004|Overall Study|Protocol Violation|1|||
130892527|NCT04413617|471239469|FG000|Overall Study|Lack of Efficacy|2|||
130892528|NCT04413617|471239470|FG001|Overall Study|Lack of Efficacy|0|||
130892529|NCT04413617|471239471|FG002|Overall Study|Lack of Efficacy|2|||
130892530|NCT04413617|471239472|FG003|Overall Study|Lack of Efficacy|1|||
130892531|NCT04413617|471239473|FG004|Overall Study|Lack of Efficacy|0|||
130892532|NCT04413617|471239469|FG000|Overall Study|Withdrawal by Subject|3|||
130892533|NCT04413617|471239470|FG001|Overall Study|Withdrawal by Subject|4|||
130892534|NCT04413617|471239471|FG002|Overall Study|Withdrawal by Subject|2|||
130892535|NCT04413617|471239472|FG003|Overall Study|Withdrawal by Subject|5|||
131024660|NCT03624972|471721380|FG001|Overall Study|Lost to Follow-up|0|||
131024661|NCT03624972|471721381|FG002|Overall Study|Lost to Follow-up|0|||
131024662|NCT03624972|471721379|FG000|Overall Study|Withdrawal by Subject|0|||
131024663|NCT03624972|471721380|FG001|Overall Study|Withdrawal by Subject|2|||
131024664|NCT03624972|471721381|FG002|Overall Study|Withdrawal by Subject|0|||
131024665|NCT03456076|471721386|FG000|Overall Study|Withdrawal by Subject|5|||
131024666|NCT03456076|471721387|FG001|Overall Study|Withdrawal by Subject|9|||
131024667|NCT03456076|471721386|FG000|Overall Study|Protocol deviation|0|||
131024668|NCT03456076|471721387|FG001|Overall Study|Protocol deviation|1|||
131024669|NCT03456076|471721386|FG000|Overall Study|Lost to Follow-up|0|||
131024670|NCT03456076|471721387|FG001|Overall Study|Lost to Follow-up|1|||
131024671|NCT03456076|471721386|FG000|Overall Study|Death|2|||
130892536|NCT04413617|471239473|FG004|Overall Study|Withdrawal by Subject|3|||
130892537|NCT04413617|471239469|FG000|Overall Study|Death|1|||
130892538|NCT04413617|471239470|FG001|Overall Study|Death|0|||
130892539|NCT04413617|471239471|FG002|Overall Study|Death|0|||
130892540|NCT04413617|471239472|FG003|Overall Study|Death|0|||
130892541|NCT04413617|471239473|FG004|Overall Study|Death|0|||
130892542|NCT04413617|471239469|FG000|Overall Study|Adverse Event|1|||
130892543|NCT04413617|471239470|FG001|Overall Study|Adverse Event|0|||
130892544|NCT04413617|471239471|FG002|Overall Study|Adverse Event|0|||
130892545|NCT04413617|471239472|FG003|Overall Study|Adverse Event|1|||
130892546|NCT04413617|471239473|FG004|Overall Study|Adverse Event|1|||
131024672|NCT03456076|471721387|FG001|Overall Study|Death|5|||
131024673|NCT03456076|471721386|FG000|Overall Study|Study ongoing|123|||
131024674|NCT03456076|471721387|FG001|Overall Study|Study ongoing|111|||
130892547|NCT04413617|471239469|FG000|Overall Study|COVID-19|0|||
130892548|NCT04413617|471239470|FG001|Overall Study|COVID-19|1|||
130892549|NCT04413617|471239471|FG002|Overall Study|COVID-19|0|||
130892550|NCT04413617|471239472|FG003|Overall Study|COVID-19|0|||
130892551|NCT04413617|471239473|FG004|Overall Study|COVID-19|0|||
130892552|NCT01327482|471239474|FG000|Overall Study|Adverse Event|1|||
130892553|NCT00476229|471239475|FG000|Overall Study|Progressive shortness of breath|1|||
130892554|NCT02164461|471239476|FG000|Overall Study|Adverse Event|0|||
130892555|NCT02164461|471239477|FG001|Overall Study|Adverse Event|0|||
130892556|NCT02164461|471239478|FG002|Overall Study|Adverse Event|1|||
130892557|NCT02164461|471239476|FG000|Overall Study|Disease Progression|1|||
130892558|NCT02164461|471239477|FG001|Overall Study|Disease Progression|3|||
130892559|NCT02164461|471239478|FG002|Overall Study|Disease Progression|4|||
130892560|NCT02164461|471239476|FG000|Overall Study|Withdrawal by Subject|0|||
130892561|NCT02164461|471239477|FG001|Overall Study|Withdrawal by Subject|3|||
130892562|NCT02164461|471239478|FG002|Overall Study|Withdrawal by Subject|0|||
130892563|NCT01192191|471239480|FG000|Overall Study|Adverse Event|7|||
130892564|NCT01192191|471239481|FG001|Overall Study|Adverse Event|12|||
130892565|NCT01192191|471239480|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
130892566|NCT01192191|471239481|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
130892567|NCT01192191|471239480|FG000|Overall Study|Lost to Follow-up|0|||
130892568|NCT01192191|471239481|FG001|Overall Study|Lost to Follow-up|1|||
130892569|NCT01192191|471239480|FG000|Overall Study|Withdrawal by Subject|1|||
130892570|NCT01192191|471239481|FG001|Overall Study|Withdrawal by Subject|6|||
130892571|NCT01583296|471239484|FG000|Overall Study|Withdrawal by Subject|11|||
130892572|NCT01583296|471239485|FG001|Overall Study|Withdrawal by Subject|10|||
130892573|NCT01047553|471239486|FG000|Overall Study|Adverse Event|10|||
130892574|NCT01047553|471239487|FG001|Overall Study|Adverse Event|5|||
130892575|NCT01047553|471239486|FG000|Overall Study|Withdrawal by Subject|4|||
130892576|NCT01047553|471239487|FG001|Overall Study|Withdrawal by Subject|2|||
130892577|NCT01047553|471239486|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
130892578|NCT01047553|471239487|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
130892579|NCT01047553|471239486|FG000|Overall Study|Lost to Follow-up|1|||
130892580|NCT01047553|471239487|FG001|Overall Study|Lost to Follow-up|0|||
130892581|NCT01047553|471239486|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
130892582|NCT01047553|471239487|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
130892583|NCT01047553|471239486|FG000|Overall Study|PI's decision|0|||
130892584|NCT01047553|471239487|FG001|Overall Study|PI's decision|1|||
130892585|NCT01063283|471239488|FG000|Cycle 1|Adverse Event|2|||
130892586|NCT01063283|471239489|FG001|Cycle 1|Adverse Event|0|||
130892587|NCT01063283|471239490|FG002|Cycle 1|Adverse Event|0|||
130892588|NCT01063283|471239488|FG000|Cycle 1|Technical failure in data collection|1|||
130892589|NCT01063283|471239489|FG001|Cycle 1|Technical failure in data collection|0|||
130892590|NCT01063283|471239490|FG002|Cycle 1|Technical failure in data collection|0|||
130892591|NCT03179319|471239491|FG000|Overall Study|Lost to Follow-up|6|||
130892592|NCT03179319|471239492|FG001|Overall Study|Lost to Follow-up|0|||
130892593|NCT01120717|471239493|FG000|Overall Study|Withdrawal by Subject|11|||
130892594|NCT01120717|471239494|FG001|Overall Study|Withdrawal by Subject|6|||
130892595|NCT01120717|471239493|FG000|Overall Study|Adverse Event|10|||
130892596|NCT01120717|471239494|FG001|Overall Study|Adverse Event|6|||
130892597|NCT01120717|471239493|FG000|Overall Study|Protocol Deviation|2|||
130892598|NCT01120717|471239494|FG001|Overall Study|Protocol Deviation|5|||
130892599|NCT01120717|471239493|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131024675|NCT03990649|471721391|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
131024676|NCT03990649|471721392|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
131024677|NCT03990649|471721393|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
131024678|NCT03990649|471721391|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
131024679|NCT03990649|471721392|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
131024680|NCT03990649|471721393|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
131024681|NCT03990649|471721391|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
131024682|NCT03990649|471721392|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
131024683|NCT03990649|471721393|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
131024684|NCT03990649|471721391|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
131024685|NCT03990649|471721392|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
131024686|NCT03990649|471721393|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
131024687|NCT03990649|471721391|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
130892600|NCT01120717|471239494|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130892601|NCT01120717|471239493|FG000|Overall Study|Lost to Follow-up|2|||
131024688|NCT03990649|471721392|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
130892602|NCT01120717|471239494|FG001|Overall Study|Lost to Follow-up|3|||
130892603|NCT01120717|471239493|FG000|Overall Study|Death|3|||
130892604|NCT01120717|471239494|FG001|Overall Study|Death|1|||
130892605|NCT01120717|471239493|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130892606|NCT01120717|471239494|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130892607|NCT00948441|471239501|FG000|Overall Study|no longer meet inclusion criteria|1|||
131024689|NCT03990649|471721393|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
131024690|NCT03990649|471721391|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
130892608|NCT00948441|471239502|FG001|Overall Study|no longer meet inclusion criteria|4|||
130892609|NCT04237116|471239511|FG000|Overall Study|Adverse Event|0|||
130892610|NCT04237116|471239512|FG001|Overall Study|Adverse Event|1|||
130892611|NCT04237116|471239511|FG000|Overall Study|Study terminated by Sponsor|4|||
130892612|NCT04237116|471239512|FG001|Overall Study|Study terminated by Sponsor|1|||
130892613|NCT00472030|471239513|FG000|Overall Study|Physician Decision|1|||
130892614|NCT00472030|471239514|FG001|Overall Study|Physician Decision|0|||
130892615|NCT04198714|471239515|FG000|Overall Study|Physician Decision|0|||
130892616|NCT04198714|471239516|FG001|Overall Study|Physician Decision|1|||
130892617|NCT02923921|471241540|FG000|Overall Study|Sponsor Decision|39|||
130892618|NCT02923921|471241541|FG001|Overall Study|Sponsor Decision|38|||
130892619|NCT02923921|471241540|FG000|Overall Study|Lost to Follow-up|1|||
130892620|NCT02923921|471241541|FG001|Overall Study|Lost to Follow-up|0|||
130892621|NCT02923921|471241540|FG000|Overall Study|Withdrawal by Subject|6|||
130892622|NCT02923921|471241541|FG001|Overall Study|Withdrawal by Subject|13|||
130892623|NCT02923921|471241540|FG000|Overall Study|Unknown, Not Collected|7|||
130892624|NCT02923921|471241541|FG001|Overall Study|Unknown, Not Collected|6|||
130892625|NCT00479687|471241542|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
130892626|NCT00479687|471241543|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
130892627|NCT00479687|471241544|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
130892628|NCT00479687|471241542|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
130892629|NCT00479687|471241543|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
130892630|NCT00479687|471241544|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
130892631|NCT00479687|471241542|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
130892632|NCT00479687|471241543|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
130892633|NCT00479687|471241544|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
130892634|NCT00479687|471241542|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
130892635|NCT00479687|471241543|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
130892636|NCT00479687|471241544|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
130892637|NCT00479687|471241542|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
130892638|NCT00479687|471241543|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
130892639|NCT00479687|471241544|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
130892640|NCT00479687|471241542|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
130892641|NCT00479687|471241543|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
130892642|NCT00479687|471241544|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
130892643|NCT00479687|471241542|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
130892644|NCT00479687|471241543|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
130892645|NCT00479687|471241544|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
130892646|NCT00479687|471241542|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
130892647|NCT00479687|471241543|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
130892648|NCT00479687|471241544|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
130892649|NCT00479687|471241542|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
130892650|NCT00479687|471241543|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
130892651|NCT00479687|471241544|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
130892652|NCT00295880|471241545|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
131024691|NCT03990649|471721392|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
131024692|NCT03990649|471721393|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
131024693|NCT03990649|471721391|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
130686965|NCT02655679|470479723|FG000|Overall Study|Inability to Comply with the Protocol|1|||
131024694|NCT03990649|471721392|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
131024695|NCT03990649|471721393|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
131024696|NCT00431834|471721398|FG000|Overall Study|Withdrawal by Subject|7|||
131024697|NCT00431834|471721398|FG000|Overall Study|Death|3|||
131024698|NCT00431834|471721398|FG000|Overall Study|Missed Endpoint Visit|2|||
131024699|NCT00431834|471721398|FG000|Overall Study|Lost to Follow-up|1|||
131024700|NCT02461628|471721404|FG000|Overall Study|Refused to complete survey|4|||
131024701|NCT02461628|471721405|FG001|Overall Study|Refused to complete survey|7|||
131024702|NCT02647905|471721410|FG000|Overall Study|Lost to Follow-up|1|||
131109922|NCT02544217|472033903|FG001|Overall Study|Withdrawal by Subject|1|||
131109923|NCT02544217|472033904|FG002|Overall Study|Withdrawal by Subject|0|||
130892653|NCT00295880|471241545|FG000|Overall Study|Unit randomization did not occur|1|||
130892654|NCT01474239|471241546|FG000|Overall Study|Disease Progression|37|||
130892655|NCT01474239|471241547|FG001|Overall Study|Disease Progression|25|||
130892656|NCT01474239|471241546|FG000|Overall Study|Adverse Event|12|||
130892657|NCT01474239|471241547|FG001|Overall Study|Adverse Event|3|||
130892658|NCT01474239|471241546|FG000|Overall Study|Withdrawal by Subject|1|||
131024703|NCT02647905|471721410|FG000|Overall Study|Withdrawal by Subject|2|||
131024704|NCT02015520|471721411|FG000|Overall Study|Lack of Efficacy|1|||
131109924|NCT02544217|472033905|FG003|Overall Study|Withdrawal by Subject|0|||
130892659|NCT01474239|471241547|FG001|Overall Study|Withdrawal by Subject|2|||
130892660|NCT01474239|471241546|FG000|Overall Study|Death|1|||
130892661|NCT01474239|471241547|FG001|Overall Study|Death|1|||
130892662|NCT01474239|471241546|FG000|Overall Study|Clinical Disease Progression|7|||
130892663|NCT01474239|471241547|FG001|Overall Study|Clinical Disease Progression|1|||
130892664|NCT01474239|471241546|FG000|Overall Study|Withdrawal for Economic Reason|1|||
130892665|NCT01474239|471241547|FG001|Overall Study|Withdrawal for Economic Reason|0|||
130892666|NCT01139008|471241548|FG000|Overall Study|Withdrawal by Subject|5|||
130892667|NCT01139008|471241548|FG000|Overall Study|Non-compliant, lost product|1|||
130892668|NCT01715857|471241549|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
130892669|NCT00505778|471241550|FG000|Overall Study|Adverse Event|2|||
130892670|NCT00505778|471241551|FG001|Overall Study|Adverse Event|7|||
130892671|NCT00505778|471241550|FG000|Overall Study|Physician Decision|8|||
130892672|NCT00505778|471241551|FG001|Overall Study|Physician Decision|14|||
130892673|NCT00505778|471241550|FG000|Overall Study|Lost to Follow-up|17|||
130892674|NCT00505778|471241551|FG001|Overall Study|Lost to Follow-up|23|||
130892675|NCT00505778|471241550|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
130892676|NCT00505778|471241551|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
130892677|NCT00505778|471241550|FG000|Overall Study|Protocol Violation|7|||
130892678|NCT00505778|471241551|FG001|Overall Study|Protocol Violation|9|||
130892679|NCT00505778|471241550|FG000|Overall Study|Withdrawal by Subject|29|||
130892680|NCT00505778|471241551|FG001|Overall Study|Withdrawal by Subject|14|||
130892681|NCT00505778|471241550|FG000|Overall Study|Relapse|65|||
130892682|NCT00505778|471241551|FG001|Overall Study|Relapse|65|||
130892683|NCT00505778|471241550|FG000|Overall Study|Took No Study Drug|2|||
130892684|NCT00505778|471241551|FG001|Overall Study|Took No Study Drug|2|||
130892685|NCT05367492|471241553|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
130892686|NCT05367492|471241554|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
130892687|NCT05367492|471241555|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
130892688|NCT05367492|471241553|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
130892689|NCT05367492|471241554|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
130892690|NCT05367492|471241555|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
130892691|NCT05367492|471241553|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
131109925|NCT02544217|472033906|FG004|Overall Study|Withdrawal by Subject|0|||
131109926|NCT02544217|472033907|FG005|Overall Study|Withdrawal by Subject|0|||
131109927|NCT04335812|472033908|FG000|Overall Study|Withdrawal by Subject|1|||
131109928|NCT04335812|472033909|FG001|Overall Study|Withdrawal by Subject|3|||
131109929|NCT04335812|472033908|FG000|Overall Study|Lost to Follow-up|12|||
131109930|NCT04335812|472033909|FG001|Overall Study|Lost to Follow-up|12|||
131109931|NCT04335812|472033908|FG000|Overall Study|Did not engage in the intervention|22|||
131109932|NCT04335812|472033909|FG001|Overall Study|Did not engage in the intervention|18|||
131109933|NCT02901041|472033920|FG000|Overall Study|Withdrawal by PI|4|||
131109934|NCT02901041|472033921|FG001|Overall Study|Withdrawal by PI|8|||
131109935|NCT02901041|472033920|FG000|Overall Study|Withdrawal by Subject|7|||
131109936|NCT02901041|472033921|FG001|Overall Study|Withdrawal by Subject|3|||
131109937|NCT00975507|472033925|FG000|Overall Study|Adverse Event|1|||
131109938|NCT00975507|472033926|FG001|Overall Study|Adverse Event|0|||
131109939|NCT00975507|472033925|FG000|Overall Study|Lost to Follow-up|7|||
131109940|NCT00975507|472033926|FG001|Overall Study|Lost to Follow-up|1|||
131109941|NCT00975507|472033925|FG000|Overall Study|Protocol Violation|2|||
131109942|NCT00975507|472033926|FG001|Overall Study|Protocol Violation|0|||
131109943|NCT00975507|472033925|FG000|Overall Study|Withdrawal by Subject|10|||
131109944|NCT00975507|472033926|FG001|Overall Study|Withdrawal by Subject|3|||
131109945|NCT03249714|472033927|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
131109946|NCT03249714|472033928|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
131109947|NCT03249714|472033927|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
131109948|NCT03249714|472033928|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
130892692|NCT05367492|471241554|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
130892693|NCT05367492|471241555|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
130892694|NCT05367492|471241553|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
130892695|NCT05367492|471241554|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
130892696|NCT05367492|471241555|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
130892697|NCT00808080|471241557|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
130892698|NCT00423917|471241560|FG000|Overall Study|Cancel|2|||
130892699|NCT00423917|471241560|FG000|Overall Study|Ineligible|1|||
130892700|NCT03085797|471241561|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
130892701|NCT03085797|471241562|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
130892702|NCT03085797|471241561|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
130892703|NCT03085797|471241562|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
131109949|NCT03249714|472033927|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
131109950|NCT03249714|472033928|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
131109951|NCT03249714|472033927|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
131109952|NCT03249714|472033928|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
130892704|NCT03085797|471241561|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
130892705|NCT03085797|471241562|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
130892706|NCT01837823|471241563|FG000|Overall Study|Lost to Follow-up|6|||
130892707|NCT00436345|471241568|FG000|Overall Study|ICU resident beyond follow-up period|3|||
130892708|NCT00436345|471241569|FG001|Overall Study|ICU resident beyond follow-up period|0|||
130892709|NCT01175083|471241570|FG000|Primary Epoch|Withdrawal by Subject|0|||
130892710|NCT01175083|471241571|FG001|Primary Epoch|Withdrawal by Subject|0|||
130892711|NCT01175083|471241572|FG002|Primary Epoch|Withdrawal by Subject|0|||
130892712|NCT01175083|471241573|FG003|Primary Epoch|Withdrawal by Subject|0|||
130892713|NCT01175083|471241574|FG004|Primary Epoch|Withdrawal by Subject|0|||
130892714|NCT01175083|471241575|FG005|Primary Epoch|Withdrawal by Subject|2|||
130892715|NCT01175083|471241570|FG000|Primary Epoch|Lost to Follow-up|0|||
130892716|NCT01175083|471241571|FG001|Primary Epoch|Lost to Follow-up|0|||
130892717|NCT01175083|471241572|FG002|Primary Epoch|Lost to Follow-up|0|||
130892718|NCT01175083|471241573|FG003|Primary Epoch|Lost to Follow-up|0|||
130892719|NCT01175083|471241574|FG004|Primary Epoch|Lost to Follow-up|0|||
130892720|NCT01175083|471241575|FG005|Primary Epoch|Lost to Follow-up|1|||
130892721|NCT01175083|471241570|FG000|Booster Epoch|Death|0|||
130892722|NCT01175083|471241571|FG001|Booster Epoch|Death|0|||
130892723|NCT01175083|471241572|FG002|Booster Epoch|Death|1|||
130892724|NCT01175083|471241573|FG003|Booster Epoch|Death|0|||
130892725|NCT01175083|471241574|FG004|Booster Epoch|Death|0|||
130892726|NCT01175083|471241575|FG005|Booster Epoch|Death|0|||
130892727|NCT01175083|471241570|FG000|Booster Epoch|Withdrawal by Subject|0|||
130892728|NCT01175083|471241571|FG001|Booster Epoch|Withdrawal by Subject|0|||
130892729|NCT01175083|471241572|FG002|Booster Epoch|Withdrawal by Subject|0|||
130892730|NCT01175083|471241573|FG003|Booster Epoch|Withdrawal by Subject|1|||
130892731|NCT01175083|471241574|FG004|Booster Epoch|Withdrawal by Subject|0|||
130892732|NCT01175083|471241575|FG005|Booster Epoch|Withdrawal by Subject|0|||
130892733|NCT00475306|471241576|FG000|Overall Study|Protocol Violation|1|||
130892734|NCT00475306|471241577|FG001|Overall Study|Protocol Violation|1|||
130892735|NCT00475306|471241578|FG002|Overall Study|Protocol Violation|0|||
130892736|NCT00475306|471241579|FG003|Overall Study|Protocol Violation|1|||
130892737|NCT01716052|471241580|FG000|Overall Study|Withdrawal of funding|1|||
130892738|NCT01716052|471241581|FG001|Overall Study|Withdrawal of funding|1|||
130892739|NCT02405442|471241582|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
130892740|NCT02405442|471241583|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
130892741|NCT02405442|471241584|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
130892742|NCT02405442|471241585|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
130892743|NCT02405442|471241582|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
130892744|NCT02405442|471241583|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
130892745|NCT02405442|471241584|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
130892746|NCT02405442|471241585|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
130892747|NCT02405442|471241582|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
130892748|NCT02405442|471241583|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
130892749|NCT02405442|471241584|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
130892750|NCT02405442|471241585|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
130892751|NCT02405442|471241582|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
130892752|NCT02405442|471241583|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
130892753|NCT02405442|471241584|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
131024705|NCT02015520|471721412|FG001|Overall Study|Lack of Efficacy|0|||
131024706|NCT02015520|471721413|FG002|Overall Study|Lack of Efficacy|3|||
131024707|NCT02015520|471721414|FG003|Overall Study|Lack of Efficacy|2|||
130686966|NCT02655679|470479724|FG001|Overall Study|Inability to Comply with the Protocol|0|||
131024708|NCT02015520|471721411|FG000|Overall Study|Adverse Event|0|||
131024709|NCT02015520|471721412|FG001|Overall Study|Adverse Event|0|||
131024710|NCT02015520|471721413|FG002|Overall Study|Adverse Event|0|||
130686967|NCT02655679|470479725|FG002|Overall Study|Inability to Comply with the Protocol|0|||
130892754|NCT02405442|471241585|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
130892755|NCT02405442|471241582|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
130686968|NCT02655679|470479726|FG003|Overall Study|Inability to Comply with the Protocol|0|||
130686969|NCT02655679|470479727|FG004|Overall Study|Inability to Comply with the Protocol|0|||
130686970|NCT02655679|470479723|FG000|Overall Study|Lost to Follow-up|0|||
130892756|NCT02405442|471241583|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
130892757|NCT02405442|471241584|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
130892758|NCT02405442|471241585|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
130892759|NCT02405442|471241582|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
130892760|NCT02405442|471241583|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
130892761|NCT02405442|471241584|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
130892762|NCT02405442|471241585|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
131024711|NCT02015520|471721414|FG003|Overall Study|Adverse Event|1|||
131024712|NCT02015520|471721411|FG000|Overall Study|Withdrawal by Subject|2|||
130892763|NCT02405442|471241582|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
130892764|NCT02405442|471241583|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
130892765|NCT02405442|471241584|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
130892766|NCT02405442|471241585|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
130892767|NCT02405442|471241582|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
130892768|NCT02405442|471241583|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
130892769|NCT02405442|471241584|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
130892770|NCT02405442|471241585|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
130892771|NCT02405442|471241582|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
130892772|NCT02405442|471241583|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
130892773|NCT02405442|471241584|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
130892774|NCT02405442|471241585|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
130892775|NCT02405442|471241582|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
130892776|NCT02405442|471241583|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
130892777|NCT02405442|471241584|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
130892778|NCT02405442|471241585|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
130892779|NCT02405442|471241582|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
130892780|NCT02405442|471241583|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
130892781|NCT02405442|471241584|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
130892782|NCT02405442|471241585|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
130892783|NCT02405442|471241582|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
130892784|NCT02405442|471241583|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
130892785|NCT02405442|471241584|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
130892786|NCT02405442|471241585|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
130892787|NCT02405442|471241582|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
130892788|NCT02405442|471241583|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
130892789|NCT02405442|471241584|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
131109953|NCT01112306|472033936|FG000|Overall Study|Death|175|||
131109954|NCT01112306|472033936|FG000|Overall Study|Lost to Follow-up|9|||
131109955|NCT01112306|472033936|FG000|Overall Study|Withdrawal by Subject|31|||
131109956|NCT01112306|472033936|FG000|Overall Study|Other|70|||
131109957|NCT01607554|472033940|FG000|Overall Study|Disease progression|2|||
131109958|NCT03952806|472033941|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
131109959|NCT03952806|472033942|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
131109960|NCT03952806|472033941|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
131109961|NCT03952806|472033942|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
131109962|NCT03952806|472033941|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
131109963|NCT03952806|472033942|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
131109964|NCT03952806|472033941|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
131109965|NCT03952806|472033942|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
131109966|NCT03952806|472033941|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
131109967|NCT03952806|472033942|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
130892790|NCT02405442|471241585|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
130892791|NCT02405442|471241582|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
130892792|NCT02405442|471241583|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
130892793|NCT02405442|471241584|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
130892794|NCT02405442|471241585|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
130892795|NCT02078960|471241586|FG000|Treatment Period|Other|0|||
130892796|NCT02078960|471241587|FG001|Treatment Period|Other|0|||
130892797|NCT02078960|471241588|FG002|Treatment Period|Other|1|||
130892798|NCT02078960|471241586|FG000|Treatment Period|Lack of Efficacy|0|||
130892799|NCT02078960|471241587|FG001|Treatment Period|Lack of Efficacy|1|||
130892800|NCT02078960|471241588|FG002|Treatment Period|Lack of Efficacy|0|||
130892801|NCT02078960|471241586|FG000|Treatment Period|Disease progression - accelerated phase|0|||
130892802|NCT02078960|471241587|FG001|Treatment Period|Disease progression - accelerated phase|1|||
130892803|NCT02078960|471241588|FG002|Treatment Period|Disease progression - accelerated phase|0|||
130892804|NCT02078960|471241586|FG000|Treatment Period|Disease progression - blast phase|1|||
130892805|NCT02078960|471241587|FG001|Treatment Period|Disease progression - blast phase|0|||
130892806|NCT02078960|471241588|FG002|Treatment Period|Disease progression - blast phase|0|||
130892807|NCT02078960|471241586|FG000|Treatment Period|Withdrawal by Subject|0|||
130892808|NCT02078960|471241587|FG001|Treatment Period|Withdrawal by Subject|1|||
130892809|NCT02078960|471241588|FG002|Treatment Period|Withdrawal by Subject|1|||
131109968|NCT03952806|472033941|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
131109969|NCT03952806|472033942|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
131109970|NCT03952806|472033941|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
131109971|NCT03952806|472033942|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
131109972|NCT03952806|472033941|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
130686971|NCT02655679|470479724|FG001|Overall Study|Lost to Follow-up|1|||
130686972|NCT02655679|470479725|FG002|Overall Study|Lost to Follow-up|1|||
130686973|NCT02655679|470479726|FG003|Overall Study|Lost to Follow-up|1|||
130686974|NCT02655679|470479727|FG004|Overall Study|Lost to Follow-up|0|||
130686975|NCT02655679|470479723|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130686976|NCT02655679|470479724|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130686977|NCT02655679|470479725|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130686978|NCT02655679|470479726|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130686979|NCT02655679|470479727|FG004|Overall Study|Other Miscellaneous Reasons|0|||
130686980|NCT01421277|470479728|FG000|Overall Study|Lack of qualifying event|0|||
130686981|NCT01421277|470479729|FG001|Overall Study|Lack of qualifying event|61|||
130686982|NCT01421277|470479728|FG000|Overall Study|Incomplete baseline data|0|||
130686983|NCT01421277|470479729|FG001|Overall Study|Incomplete baseline data|31|||
130686984|NCT05472038|470481323|FG000|Overall Study|Adverse Event|0|||
130686985|NCT05472038|470481324|FG001|Overall Study|Adverse Event|0|||
130686986|NCT05472038|470481325|FG002|Overall Study|Adverse Event|1|||
130686987|NCT05472038|470481326|FG003|Overall Study|Adverse Event|0|||
130686988|NCT05472038|470481327|FG004|Overall Study|Adverse Event|0|||
130686989|NCT05472038|470481328|FG005|Overall Study|Adverse Event|0|||
130686990|NCT05472038|470481329|FG006|Overall Study|Adverse Event|0|||
130686991|NCT05472038|470481330|FG007|Overall Study|Adverse Event|0|||
130686992|NCT05472038|470481331|FG008|Overall Study|Adverse Event|0|||
130686993|NCT05472038|470481332|FG009|Overall Study|Adverse Event|0|||
130686994|NCT05472038|470481333|FG010|Overall Study|Adverse Event|0|||
130686995|NCT05472038|470481334|FG011|Overall Study|Adverse Event|0|||
130686996|NCT05472038|470481323|FG000|Overall Study|Death|0|||
130686997|NCT05472038|470481324|FG001|Overall Study|Death|0|||
130686998|NCT05472038|470481325|FG002|Overall Study|Death|0|||
130892810|NCT02078960|471241586|FG000|Treatment Period|Adverse Event|1|||
130892811|NCT02078960|471241587|FG001|Treatment Period|Adverse Event|0|||
131024713|NCT02015520|471721412|FG001|Overall Study|Withdrawal by Subject|2|||
131024714|NCT02015520|471721413|FG002|Overall Study|Withdrawal by Subject|1|||
131024715|NCT02015520|471721414|FG003|Overall Study|Withdrawal by Subject|0|||
131024716|NCT02015520|471721411|FG000|Overall Study|Death|1|||
131024717|NCT02015520|471721412|FG001|Overall Study|Death|0|||
131024718|NCT02015520|471721413|FG002|Overall Study|Death|0|||
131024719|NCT02015520|471721414|FG003|Overall Study|Death|0|||
131024720|NCT02015520|471721411|FG000|Overall Study|Lost to Follow-up|0|||
131024721|NCT02015520|471721412|FG001|Overall Study|Lost to Follow-up|0|||
131024722|NCT02015520|471721413|FG002|Overall Study|Lost to Follow-up|1|||
131024723|NCT02015520|471721414|FG003|Overall Study|Lost to Follow-up|0|||
131024724|NCT02015520|471721411|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
131024725|NCT02015520|471721412|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
131024726|NCT02015520|471721413|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
131024727|NCT02015520|471721414|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
131024728|NCT02015520|471721411|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
131024729|NCT02015520|471721412|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
131024730|NCT02015520|471721413|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
131024731|NCT02015520|471721414|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
131024732|NCT05119855|471721416|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
131024733|NCT05119855|471721417|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
131024734|NCT05119855|471721416|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
131024735|NCT05119855|471721417|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
131024736|NCT05119855|471721416|FG000|Overall Study|Lost to Follow-up|6|||
131024737|NCT05119855|471721417|FG001|Overall Study|Lost to Follow-up|8|||
131024738|NCT02932579|471721418|FG000|Overall Study|Withdrawal by Subject|4|||
131024739|NCT02932579|471721419|FG001|Overall Study|Withdrawal by Subject|1|||
131024740|NCT01972724|471721420|FG000|Double-Blind|Rescue Criteria Met|1|||
131024741|NCT01972724|471721421|FG001|Double-Blind|Rescue Criteria Met|0|||
131024742|NCT01972724|471721422|FG002|Double-Blind|Rescue Criteria Met|0|||
130892812|NCT02078960|471241588|FG002|Treatment Period|Adverse Event|0|||
130892813|NCT02078960|471241586|FG000|Treatment Period|Death|0|||
131024743|NCT01972724|471721420|FG000|Double-Blind|Adverse Event|1|||
131024744|NCT01972724|471721421|FG001|Double-Blind|Adverse Event|0|||
130686999|NCT05472038|470481326|FG003|Overall Study|Death|0|||
130687000|NCT05472038|470481327|FG004|Overall Study|Death|0|||
130687001|NCT05472038|470481328|FG005|Overall Study|Death|1|||
131024745|NCT01972724|471721422|FG002|Double-Blind|Adverse Event|0|||
131024746|NCT01972724|471721420|FG000|Double-Blind|Withdrawal of Consent|2|||
131109973|NCT03952806|472033942|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
130687002|NCT05472038|470481329|FG006|Overall Study|Death|0|||
130687003|NCT05472038|470481330|FG007|Overall Study|Death|0|||
130687004|NCT05472038|470481331|FG008|Overall Study|Death|0|||
130892814|NCT02078960|471241587|FG001|Treatment Period|Death|0|||
131024747|NCT01972724|471721421|FG001|Double-Blind|Withdrawal of Consent|1|||
131024748|NCT01972724|471721422|FG002|Double-Blind|Withdrawal of Consent|0|||
130687005|NCT05472038|470481332|FG009|Overall Study|Death|0|||
130892815|NCT02078960|471241588|FG002|Treatment Period|Death|1|||
130892816|NCT02078960|471241586|FG000|Follow-up Period|Death|2|||
130892817|NCT02078960|471241587|FG001|Follow-up Period|Death|0|||
130892818|NCT02078960|471241588|FG002|Follow-up Period|Death|0|||
130892819|NCT02078960|471241586|FG000|Follow-up Period|Lost to Follow-up|0|||
130892820|NCT02078960|471241587|FG001|Follow-up Period|Lost to Follow-up|1|||
130892821|NCT02078960|471241588|FG002|Follow-up Period|Lost to Follow-up|0|||
130892822|NCT03275350|471241590|FG000|Overall Study|Lost to Follow-up|4|||
130892823|NCT03275350|471241591|FG001|Overall Study|Lost to Follow-up|6|||
130892824|NCT03275350|471241590|FG000|Overall Study|Death|2|||
130892825|NCT03275350|471241591|FG001|Overall Study|Death|1|||
130892826|NCT03275350|471241590|FG000|Overall Study|Physician Decision|1|||
130892827|NCT03275350|471241591|FG001|Overall Study|Physician Decision|0|||
130892828|NCT03275350|471241590|FG000|Overall Study|Incarcerated|1|||
130892829|NCT03275350|471241591|FG001|Overall Study|Incarcerated|1|||
130892830|NCT02597478|471241594|FG000|Overall Study|Withdrawal by Subject|2|||
130892831|NCT02597478|471241595|FG001|Overall Study|Withdrawal by Subject|0|||
130892832|NCT02597478|471241594|FG000|Overall Study|Change of opioid dose|1|||
130892833|NCT02597478|471241595|FG001|Overall Study|Change of opioid dose|0|||
130892834|NCT02597478|471241594|FG000|Overall Study|Insufficient exertional dyspnea|0|||
130892835|NCT02597478|471241595|FG001|Overall Study|Insufficient exertional dyspnea|1|||
130892836|NCT01402102|471241596|FG000|Overall Study|Protocol Violation|1|||
130892837|NCT01402102|471241597|FG001|Overall Study|Protocol Violation|0|||
130892838|NCT01402102|471241596|FG000|Overall Study|Insufficiency of compliance|1|||
130892839|NCT01402102|471241597|FG001|Overall Study|Insufficiency of compliance|1|||
130892840|NCT01402102|471241596|FG000|Overall Study|Withdrawal by Subject|0|||
130892841|NCT01402102|471241597|FG001|Overall Study|Withdrawal by Subject|2|||
130892842|NCT01386970|471241598|FG000|Overall Study|Withdrawal by Subject|0|||
130892843|NCT01386970|471241599|FG001|Overall Study|Withdrawal by Subject|1|||
130892844|NCT01386970|471241598|FG000|Overall Study|Adverse Event|4|||
130892845|NCT01386970|471241599|FG001|Overall Study|Adverse Event|1|||
130892846|NCT00934362|471241601|FG000|Overall Study|Adverse Event|1|||
130892847|NCT00934362|471241602|FG001|Overall Study|Adverse Event|0|||
130892848|NCT01092117|471241603|FG000|Index Procedure to 1 Month|Death|1|||
130892849|NCT01092117|471241603|FG000|1 Month|Death|1|||
130892850|NCT01092117|471241603|FG000|1 Month|Withdrawal by Subject|1|||
130892851|NCT01092117|471241603|FG000|1 Month|Lost to Follow-up|1|||
130892852|NCT01092117|471241603|FG000|6 Months|Death|2|||
130892853|NCT01092117|471241603|FG000|6 Months|Withdrawal by Subject|3|||
130892854|NCT01092117|471241603|FG000|12 Month|Death|11|||
130892855|NCT01092117|471241603|FG000|12 Month|Withdrawal by Subject|2|||
130892856|NCT01092117|471241603|FG000|12 Month|Lost to Follow-up|1|||
130892857|NCT01092117|471241603|FG000|Year 2|Death|5|||
130892858|NCT01092117|471241603|FG000|Year 2|Withdrawal by Subject|4|||
130892859|NCT01092117|471241603|FG000|Year 2|Lost to Follow-up|1|||
130892860|NCT01092117|471241603|FG000|Year 3|Death|7|||
130892861|NCT01092117|471241603|FG000|Year 3|Withdrawal by Subject|9|||
130892862|NCT01092117|471241603|FG000|Year 3|Lost to Follow-up|3|||
130892863|NCT01092117|471241603|FG000|Year 4|Death|8|||
131109974|NCT03952806|472033941|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
131109975|NCT03952806|472033942|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
131109976|NCT03952806|472033941|FG000|OLE Phase (48 Weeks)|Other|16|||
131109977|NCT03952806|472033942|FG001|OLE Phase (48 Weeks)|Other|13|||
131109978|NCT00655863|472033943|FG000|Overall Study|Lost to Follow-up|0|||
131109979|NCT00655863|472033944|FG001|Overall Study|Lost to Follow-up|0|||
131109980|NCT00655863|472033945|FG002|Overall Study|Lost to Follow-up|1|||
131109981|NCT01138007|472033946|FG000|Overall Study|Adverse Event|4|||
131109982|NCT01138007|472033947|FG001|Overall Study|Adverse Event|12|||
131109983|NCT01138007|472033948|FG002|Overall Study|Adverse Event|9|||
130892864|NCT01092117|471241603|FG000|Year 4|Withdrawal by Subject|4|||
130892865|NCT01092117|471241603|FG000|Year 4|Lost to Follow-up|4|||
130892866|NCT01727024|471241606|FG000|Period 1|Lost to Follow-up|1|||
130892867|NCT01727024|471241607|FG001|Period 1|Lost to Follow-up|1|||
130892868|NCT01727024|471241606|FG000|Period 1|Withdrawal by Subject|2|||
130892869|NCT01727024|471241607|FG001|Period 1|Withdrawal by Subject|3|||
130892870|NCT01485172|471241608|FG000|Overall Study|Adverse Event|2|||
130892871|NCT01485172|471241609|FG001|Overall Study|Adverse Event|1|||
130892872|NCT01485172|471241610|FG002|Overall Study|Adverse Event|2|||
130892873|NCT01485172|471241611|FG003|Overall Study|Adverse Event|2|||
130892874|NCT01485172|471241612|FG004|Overall Study|Adverse Event|1|||
130892875|NCT01485172|471241613|FG005|Overall Study|Adverse Event|2|||
130892876|NCT01485172|471241608|FG000|Overall Study|Lack of Efficacy|2|||
130892877|NCT01485172|471241609|FG001|Overall Study|Lack of Efficacy|0|||
130892878|NCT01485172|471241610|FG002|Overall Study|Lack of Efficacy|0|||
130892879|NCT01485172|471241611|FG003|Overall Study|Lack of Efficacy|0|||
130892880|NCT01485172|471241612|FG004|Overall Study|Lack of Efficacy|0|||
130892881|NCT01485172|471241613|FG005|Overall Study|Lack of Efficacy|0|||
131109984|NCT01138007|472033946|FG000|Overall Study|Lack of Efficacy|2|||
130892882|NCT01485172|471241608|FG000|Overall Study|Protocol Violation|0|||
130892883|NCT01485172|471241609|FG001|Overall Study|Protocol Violation|0|||
130892884|NCT01485172|471241610|FG002|Overall Study|Protocol Violation|4|||
130892885|NCT01485172|471241611|FG003|Overall Study|Protocol Violation|5|||
130892886|NCT01485172|471241612|FG004|Overall Study|Protocol Violation|1|||
130892887|NCT01485172|471241613|FG005|Overall Study|Protocol Violation|0|||
130892888|NCT01485172|471241608|FG000|Overall Study|Protocol defined stopping criteria|1|||
130892889|NCT01485172|471241609|FG001|Overall Study|Protocol defined stopping criteria|0|||
130892890|NCT01485172|471241610|FG002|Overall Study|Protocol defined stopping criteria|0|||
130892891|NCT01485172|471241611|FG003|Overall Study|Protocol defined stopping criteria|0|||
130892892|NCT01485172|471241612|FG004|Overall Study|Protocol defined stopping criteria|1|||
130892893|NCT01485172|471241613|FG005|Overall Study|Protocol defined stopping criteria|0|||
130892894|NCT01485172|471241608|FG000|Overall Study|Lost to Follow-up|0|||
130892895|NCT01485172|471241609|FG001|Overall Study|Lost to Follow-up|0|||
130892896|NCT01485172|471241610|FG002|Overall Study|Lost to Follow-up|1|||
130892897|NCT01485172|471241611|FG003|Overall Study|Lost to Follow-up|0|||
130892898|NCT01485172|471241612|FG004|Overall Study|Lost to Follow-up|0|||
130892899|NCT01485172|471241613|FG005|Overall Study|Lost to Follow-up|1|||
130892900|NCT01485172|471241608|FG000|Overall Study|Physician Decision|0|||
130892901|NCT01485172|471241609|FG001|Overall Study|Physician Decision|0|||
130892902|NCT01485172|471241610|FG002|Overall Study|Physician Decision|0|||
130892903|NCT01485172|471241611|FG003|Overall Study|Physician Decision|0|||
130892904|NCT01485172|471241612|FG004|Overall Study|Physician Decision|1|||
130892905|NCT01485172|471241613|FG005|Overall Study|Physician Decision|0|||
130892906|NCT01485172|471241608|FG000|Overall Study|Withdrawal by Subject|2|||
130892907|NCT01485172|471241609|FG001|Overall Study|Withdrawal by Subject|0|||
130892908|NCT01485172|471241610|FG002|Overall Study|Withdrawal by Subject|0|||
130892909|NCT01485172|471241611|FG003|Overall Study|Withdrawal by Subject|1|||
130892910|NCT01485172|471241612|FG004|Overall Study|Withdrawal by Subject|1|||
130892911|NCT01485172|471241613|FG005|Overall Study|Withdrawal by Subject|1|||
130892912|NCT03801031|471241618|FG000|Overall Study|Lost to Follow-up|1|||
130892913|NCT03801031|471241619|FG001|Overall Study|Lost to Follow-up|0|||
130892914|NCT03801031|471241618|FG000|Overall Study|Unable to comply|1|||
131024749|NCT01972724|471721420|FG000|Double-Blind|Significant Protocol Deviation|5|||
131024750|NCT01972724|471721421|FG001|Double-Blind|Significant Protocol Deviation|8|||
131024751|NCT01972724|471721422|FG002|Double-Blind|Significant Protocol Deviation|0|||
131024752|NCT01972724|471721420|FG000|Open-Label|Withdrew Consent|0|||
131024753|NCT01972724|471721421|FG001|Open-Label|Withdrew Consent|0|||
131024754|NCT01972724|471721422|FG002|Open-Label|Withdrew Consent|3|||
131024755|NCT01972724|471721420|FG000|Open-Label|Significant Protocol Deviation|0|||
131024756|NCT01972724|471721421|FG001|Open-Label|Significant Protocol Deviation|0|||
131024757|NCT01972724|471721422|FG002|Open-Label|Significant Protocol Deviation|2|||
131024758|NCT00111813|471721429|FG000|Overall Study|Adverse Event|1|||
131024759|NCT00111813|471721430|FG001|Overall Study|Adverse Event|2|||
131024760|NCT00111813|471721431|FG002|Overall Study|Adverse Event|4|||
131024761|NCT00111813|471721432|FG003|Overall Study|Adverse Event|2|||
131024762|NCT00111813|471721433|FG004|Overall Study|Adverse Event|2|||
131024763|NCT00111813|471721434|FG005|Overall Study|Adverse Event|2|||
131024764|NCT00111813|471721429|FG000|Overall Study|Progressive disease|2|||
131024765|NCT00111813|471721430|FG001|Overall Study|Progressive disease|1|||
131024766|NCT00111813|471721431|FG002|Overall Study|Progressive disease|5|||
131024767|NCT00111813|471721432|FG003|Overall Study|Progressive disease|3|||
131024768|NCT00111813|471721433|FG004|Overall Study|Progressive disease|4|||
131024769|NCT00111813|471721434|FG005|Overall Study|Progressive disease|3|||
131024770|NCT00111813|471721429|FG000|Overall Study|Lack of Efficacy|0|||
131024771|NCT00111813|471721430|FG001|Overall Study|Lack of Efficacy|0|||
131024772|NCT00111813|471721431|FG002|Overall Study|Lack of Efficacy|0|||
131024773|NCT00111813|471721432|FG003|Overall Study|Lack of Efficacy|0|||
131024774|NCT00111813|471721433|FG004|Overall Study|Lack of Efficacy|0|||
131024775|NCT00111813|471721434|FG005|Overall Study|Lack of Efficacy|1|||
131024776|NCT00111813|471721429|FG000|Overall Study|Other|0|||
131024777|NCT00111813|471721430|FG001|Overall Study|Other|0|||
130687006|NCT05472038|470481333|FG010|Overall Study|Death|0|||
130892915|NCT03801031|471241619|FG001|Overall Study|Unable to comply|0|||
130892916|NCT03801031|471241618|FG000|Overall Study|Withdrawal by Subject|0|||
131024778|NCT00111813|471721431|FG002|Overall Study|Other|1|||
131024779|NCT00111813|471721432|FG003|Overall Study|Other|0|||
131024780|NCT00111813|471721433|FG004|Overall Study|Other|0|||
131024781|NCT00111813|471721434|FG005|Overall Study|Other|0|||
131024782|NCT03283371|471721439|FG000|Placebo-controlled|Adverse Event|1|||
131024783|NCT03283371|471721440|FG001|Placebo-controlled|Adverse Event|1|||
130892917|NCT03801031|471241619|FG001|Overall Study|Withdrawal by Subject|1|||
130892918|NCT01942733|471241620|FG000|Overall Study|Lost to Follow-up|1|||
130892919|NCT01942733|471241620|FG000|Overall Study|Non-compliance with IMP|1|||
130892920|NCT01942733|471241620|FG000|Overall Study|Administrative|1|||
130892921|NCT01409811|471241621|FG000|Overall Study|Insurance denial|1|||
131024784|NCT03283371|471721441|FG002|Placebo-controlled|Adverse Event|0|||
131024785|NCT03283371|471721442|FG003|Placebo-controlled|Adverse Event|0|||
130892922|NCT00139477|471241622|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
131024786|NCT03283371|471721439|FG000|Placebo-controlled|Lack of Efficacy|1|||
131024787|NCT03283371|471721440|FG001|Placebo-controlled|Lack of Efficacy|0|||
131024788|NCT03283371|471721441|FG002|Placebo-controlled|Lack of Efficacy|0|||
130892923|NCT00139477|471241623|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
130892924|NCT00139477|471241622|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
130892925|NCT00139477|471241623|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
130892926|NCT00139477|471241622|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
130892927|NCT00139477|471241623|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
130892928|NCT00139477|471241622|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
130892929|NCT00139477|471241623|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
130892930|NCT00139477|471241622|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
130892931|NCT00139477|471241623|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
130892932|NCT00139477|471241622|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
130892933|NCT00139477|471241623|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
130892934|NCT00139477|471241622|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
130892935|NCT00139477|471241623|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
130892936|NCT02625909|471241627|FG000|Overall Study|Death|2|||
130687007|NCT05472038|470481334|FG011|Overall Study|Death|0|||
130687008|NCT05472038|470481323|FG000|Overall Study|Lost to Follow-up|1|||
130892937|NCT02625909|471241628|FG001|Overall Study|Death|0|||
131024789|NCT03283371|471721442|FG003|Placebo-controlled|Lack of Efficacy|0|||
131024790|NCT03283371|471721439|FG000|Placebo-controlled|Withdrawal by Subject|1|||
131024791|NCT03283371|471721440|FG001|Placebo-controlled|Withdrawal by Subject|1|||
131024792|NCT03283371|471721441|FG002|Placebo-controlled|Withdrawal by Subject|0|||
131024793|NCT03283371|471721442|FG003|Placebo-controlled|Withdrawal by Subject|0|||
131024794|NCT03283371|471721439|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
131024795|NCT03283371|471721440|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
131024796|NCT03283371|471721441|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
131024797|NCT03283371|471721442|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
131024798|NCT03283371|471721439|FG000|Open-label Phase|Adverse Event|0|||
131024799|NCT03283371|471721440|FG001|Open-label Phase|Adverse Event|0|||
131024800|NCT03283371|471721441|FG002|Open-label Phase|Adverse Event|2|||
131024801|NCT03283371|471721442|FG003|Open-label Phase|Adverse Event|0|||
131024802|NCT03283371|471721439|FG000|Open-label Phase|Withdrawal by Subject|0|||
131024803|NCT03283371|471721440|FG001|Open-label Phase|Withdrawal by Subject|0|||
131024804|NCT03283371|471721441|FG002|Open-label Phase|Withdrawal by Subject|1|||
131024805|NCT03283371|471721442|FG003|Open-label Phase|Withdrawal by Subject|0|||
131024806|NCT03283371|471721439|FG000|Open-label Phase|Other|0|||
131024807|NCT03283371|471721440|FG001|Open-label Phase|Other|0|||
131024808|NCT03283371|471721441|FG002|Open-label Phase|Other|1|||
131024809|NCT03283371|471721442|FG003|Open-label Phase|Other|1|||
131024810|NCT02554786|471721444|FG000|Overall Study|Subject/guardian decision|29|||
131024811|NCT02554786|471721445|FG001|Overall Study|Subject/guardian decision|17|||
131024812|NCT02554786|471721446|FG002|Overall Study|Subject/guardian decision|18|||
131024813|NCT02554786|471721447|FG003|Overall Study|Subject/guardian decision|30|||
131024814|NCT02554786|471721448|FG004|Overall Study|Subject/guardian decision|20|||
131024815|NCT02554786|471721444|FG000|Overall Study|Lost to Follow-up|4|||
131024816|NCT02554786|471721445|FG001|Overall Study|Lost to Follow-up|3|||
131024817|NCT02554786|471721446|FG002|Overall Study|Lost to Follow-up|4|||
131024818|NCT02554786|471721447|FG003|Overall Study|Lost to Follow-up|2|||
131024819|NCT02554786|471721448|FG004|Overall Study|Lost to Follow-up|2|||
131024820|NCT02554786|471721444|FG000|Overall Study|Protocol deviation|1|||
131024821|NCT02554786|471721445|FG001|Overall Study|Protocol deviation|3|||
131024822|NCT02554786|471721446|FG002|Overall Study|Protocol deviation|3|||
131024823|NCT02554786|471721447|FG003|Overall Study|Protocol deviation|4|||
131024824|NCT02554786|471721448|FG004|Overall Study|Protocol deviation|2|||
131024825|NCT02554786|471721444|FG000|Overall Study|Technical problems|1|||
131024826|NCT02554786|471721445|FG001|Overall Study|Technical problems|1|||
131024827|NCT02554786|471721446|FG002|Overall Study|Technical problems|0|||
131024828|NCT02554786|471721447|FG003|Overall Study|Technical problems|2|||
131024829|NCT02554786|471721448|FG004|Overall Study|Technical problems|1|||
131024830|NCT02554786|471721444|FG000|Overall Study|Adverse Event|0|||
131024831|NCT02554786|471721445|FG001|Overall Study|Adverse Event|0|||
131024832|NCT02554786|471721446|FG002|Overall Study|Adverse Event|0|||
131024833|NCT02554786|471721447|FG003|Overall Study|Adverse Event|0|||
131109985|NCT01138007|472033947|FG001|Overall Study|Lack of Efficacy|0|||
130687009|NCT05472038|470481324|FG001|Overall Study|Lost to Follow-up|3|||
130892938|NCT02625909|471241627|FG000|Overall Study|Lost to Follow-up|3|||
130892939|NCT02625909|471241628|FG001|Overall Study|Lost to Follow-up|5|||
131024834|NCT02554786|471721448|FG004|Overall Study|Adverse Event|2|||
131024835|NCT02554786|471721444|FG000|Overall Study|Death|0|||
131024836|NCT02554786|471721445|FG001|Overall Study|Death|0|||
131024837|NCT02554786|471721446|FG002|Overall Study|Death|0|||
131024838|NCT02554786|471721447|FG003|Overall Study|Death|1|||
131024839|NCT02554786|471721448|FG004|Overall Study|Death|0|||
131024840|NCT02554786|471721444|FG000|Overall Study|Non-compliance with study treatment|0|||
131024841|NCT02554786|471721445|FG001|Overall Study|Non-compliance with study treatment|1|||
131024842|NCT02554786|471721446|FG002|Overall Study|Non-compliance with study treatment|1|||
131109986|NCT01138007|472033948|FG002|Overall Study|Lack of Efficacy|6|||
131109987|NCT01138007|472033946|FG000|Overall Study|Protocol Violation|2|||
131109988|NCT01138007|472033947|FG001|Overall Study|Protocol Violation|3|||
131109989|NCT01138007|472033948|FG002|Overall Study|Protocol Violation|2|||
131109990|NCT01138007|472033946|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
131109991|NCT01138007|472033947|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
131109992|NCT01138007|472033948|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
131109993|NCT01138007|472033946|FG000|Overall Study|Lost to Follow-up|3|||
131109994|NCT01138007|472033947|FG001|Overall Study|Lost to Follow-up|3|||
131109995|NCT01138007|472033948|FG002|Overall Study|Lost to Follow-up|5|||
131109996|NCT01138007|472033946|FG000|Overall Study|Physician Decision|0|||
131109997|NCT01138007|472033947|FG001|Overall Study|Physician Decision|5|||
131109998|NCT01138007|472033948|FG002|Overall Study|Physician Decision|3|||
131109999|NCT01138007|472033946|FG000|Overall Study|Withdrawal by Subject|5|||
131110000|NCT01138007|472033947|FG001|Overall Study|Withdrawal by Subject|6|||
131110001|NCT01138007|472033948|FG002|Overall Study|Withdrawal by Subject|15|||
131110002|NCT04661878|472033949|FG000|Overall Study|Lost to Follow-up|6|||
131110003|NCT04661878|472033950|FG001|Overall Study|Lost to Follow-up|5|||
131110004|NCT04442737|472033955|FG000|Overall Study|Lost to Follow-up|1|||
131110005|NCT04442737|472033956|FG001|Overall Study|Lost to Follow-up|3|||
131110006|NCT04442737|472033955|FG000|Overall Study|Withdrawal by Subject|3|||
131110007|NCT04442737|472033956|FG001|Overall Study|Withdrawal by Subject|2|||
131110008|NCT04442737|472033955|FG000|Overall Study|Adverse Event|3|||
131110009|NCT04442737|472033956|FG001|Overall Study|Adverse Event|2|||
131110010|NCT04442737|472033955|FG000|Overall Study|Death|0|||
131110011|NCT04442737|472033956|FG001|Overall Study|Death|1|||
131110012|NCT04442737|472033955|FG000|Overall Study|Protocol Violation|0|||
131110013|NCT04442737|472033956|FG001|Overall Study|Protocol Violation|2|||
131110014|NCT04442737|472033955|FG000|Overall Study|Other|1|||
131110015|NCT04442737|472033956|FG001|Overall Study|Other|1|||
131110016|NCT00744523|472033957|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
131110017|NCT00744523|472033958|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
131110018|NCT05333224|472033959|FG000|Overall Study - Infants|Lost to Follow-up|1|||
131110019|NCT05333224|472033960|FG001|Overall Study - Infants|Lost to Follow-up|1|||
131110020|NCT00063154|472033961|FG000|Overall Study|Disease progression|27|||
131110021|NCT00063154|472033961|FG000|Overall Study|Adverse Event|2|||
131110022|NCT00063154|472033961|FG000|Overall Study|Physician Decision|10|||
131110023|NCT00063154|472033961|FG000|Overall Study|Death|3|||
131110024|NCT00063154|472033961|FG000|Overall Study|Reason unspecified|1|||
131110025|NCT00063154|472033961|FG000|Overall Study|Did not receive treatment|8|||
131110026|NCT01978262|472033962|FG000|Overall Study|Withdrawal by Subject|9|||
131110027|NCT01978262|472033962|FG000|Overall Study|Lost to Follow-up|2|||
131110028|NCT00325039|472033964|FG000|Overall Study|Lost to Follow-up|18|||
131110029|NCT00325039|472033965|FG001|Overall Study|Lost to Follow-up|14|||
131110030|NCT01009203|472033966|FG000|Overall Study|Withdrawal by Subject|1|||
131110031|NCT01009203|472033966|FG000|Overall Study|Adverse Event|5|||
131110032|NCT01009203|472033966|FG000|Overall Study|Treatment-unrelated death|1|||
131110033|NCT02974088|472033967|FG000|Overall Study|Lost to Follow-up|0|||
131110034|NCT02974088|472033968|FG001|Overall Study|Lost to Follow-up|2|||
131110035|NCT02974088|472033967|FG000|Overall Study|Adverse Event|0|||
131110036|NCT02974088|472033968|FG001|Overall Study|Adverse Event|1|||
131110037|NCT00892723|472033969|FG000|Overall Study|Lost to Follow-up|1|||
131110038|NCT00892723|472033970|FG001|Overall Study|Lost to Follow-up|3|||
131110039|NCT00892723|472033971|FG002|Overall Study|Lost to Follow-up|1|||
131110040|NCT00892723|472033969|FG000|Overall Study|Withdrawal by Subject|1|||
131110041|NCT00892723|472033970|FG001|Overall Study|Withdrawal by Subject|1|||
131110042|NCT00892723|472033971|FG002|Overall Study|Withdrawal by Subject|1|||
131110043|NCT00150969|472033974|FG000|24 Month Main Study|Adverse Event|3|||
131110044|NCT00150969|472033975|FG001|24 Month Main Study|Adverse Event|4|||
131110045|NCT00150969|472033974|FG000|24 Month Main Study|Death|1|||
131110046|NCT00150969|472033975|FG001|24 Month Main Study|Death|1|||
131110047|NCT00150969|472033974|FG000|24 Month Main Study|Lack of Efficacy|1|||
131110048|NCT00150969|472033975|FG001|24 Month Main Study|Lack of Efficacy|8|||
131110049|NCT00150969|472033974|FG000|24 Month Main Study|Lost to Follow-up|3|||
131110050|NCT00150969|472033975|FG001|24 Month Main Study|Lost to Follow-up|2|||
131110051|NCT00150969|472033974|FG000|24 Month Main Study|Protocol Violation|4|||
131110052|NCT00150969|472033975|FG001|24 Month Main Study|Protocol Violation|2|||
131110053|NCT00150969|472033974|FG000|24 Month Main Study|Withdrawal by Subject|7|||
131110054|NCT00150969|472033975|FG001|24 Month Main Study|Withdrawal by Subject|4|||
131110055|NCT00150969|472033974|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
131110056|NCT00150969|472033975|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
131110057|NCT00150969|472033974|FG000|24-48 Month Extension|Lack of Efficacy|0|||
131110058|NCT00150969|472033975|FG001|24-48 Month Extension|Lack of Efficacy|1|||
131110059|NCT00150969|472033974|FG000|24-48 Month Extension|Adverse Event|1|||
131110060|NCT00150969|472033975|FG001|24-48 Month Extension|Adverse Event|3|||
131110061|NCT00150969|472033974|FG000|24-48 Month Extension|Other Reason|81|||
131110062|NCT00150969|472033975|FG001|24-48 Month Extension|Other Reason|91|||
131110063|NCT00615836|472033976|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
130892940|NCT02625909|471241627|FG000|Overall Study|Lack of Efficacy|9|||
130892941|NCT02625909|471241628|FG001|Overall Study|Lack of Efficacy|2|||
130892942|NCT02625909|471241627|FG000|Overall Study|Reinfection|3|||
130892943|NCT02625909|471241628|FG001|Overall Study|Reinfection|2|||
130892944|NCT00953056|471241629|FG000|Overall Study|Withdrew Consent|0|||
130892945|NCT00953056|471241630|FG001|Overall Study|Withdrew Consent|0|||
130892946|NCT00953056|471241631|FG002|Overall Study|Withdrew Consent|0|||
130892947|NCT00953056|471241632|FG003|Overall Study|Withdrew Consent|0|||
130892948|NCT00953056|471241633|FG004|Overall Study|Withdrew Consent|2|||
130892949|NCT00953056|471241634|FG005|Overall Study|Withdrew Consent|3|||
130892950|NCT00953056|471241629|FG000|Overall Study|Serious Adverse Event|0|||
130892951|NCT00953056|471241630|FG001|Overall Study|Serious Adverse Event|0|||
130892952|NCT00953056|471241631|FG002|Overall Study|Serious Adverse Event|0|||
130892953|NCT00953056|471241632|FG003|Overall Study|Serious Adverse Event|0|||
130892954|NCT00953056|471241633|FG004|Overall Study|Serious Adverse Event|0|||
130892955|NCT00953056|471241634|FG005|Overall Study|Serious Adverse Event|1|||
130892956|NCT01976741|471241635|FG000|Overall Study|Withdrawal by Subject|1|||
130892957|NCT01976741|471241636|FG001|Overall Study|Withdrawal by Subject|0|||
130892958|NCT01976741|471241637|FG002|Overall Study|Withdrawal by Subject|1|||
130892959|NCT01976741|471241638|FG003|Overall Study|Withdrawal by Subject|1|||
130892960|NCT01976741|471241639|FG004|Overall Study|Withdrawal by Subject|0|||
130892961|NCT01976741|471241640|FG005|Overall Study|Withdrawal by Subject|0|||
130892962|NCT01976741|471241641|FG006|Overall Study|Withdrawal by Subject|1|||
130892963|NCT01976741|471241642|FG007|Overall Study|Withdrawal by Subject|4|||
130892964|NCT01976741|471241643|FG008|Overall Study|Withdrawal by Subject|0|||
130892965|NCT01976741|471241644|FG009|Overall Study|Withdrawal by Subject|0|||
130892966|NCT01976741|471241635|FG000|Overall Study|Adverse Event|0|||
130892967|NCT01976741|471241636|FG001|Overall Study|Adverse Event|0|||
130892968|NCT01976741|471241637|FG002|Overall Study|Adverse Event|2|||
130892969|NCT01976741|471241638|FG003|Overall Study|Adverse Event|0|||
130892970|NCT01976741|471241639|FG004|Overall Study|Adverse Event|0|||
130892971|NCT01976741|471241640|FG005|Overall Study|Adverse Event|0|||
130892972|NCT01976741|471241641|FG006|Overall Study|Adverse Event|3|||
130892973|NCT01976741|471241642|FG007|Overall Study|Adverse Event|8|||
130892974|NCT01976741|471241643|FG008|Overall Study|Adverse Event|1|||
130892975|NCT01976741|471241644|FG009|Overall Study|Adverse Event|4|||
130892976|NCT03350672|471241645|FG000|Overall Study|Withdrawal by Subject|7|||
130892977|NCT03350672|471241646|FG001|Overall Study|Withdrawal by Subject|0|||
130892978|NCT03350672|471241647|FG002|Overall Study|Withdrawal by Subject|0|||
130892979|NCT02504216|471241648|FG000|Overall Study|Lost to Follow-up|3|||
130892980|NCT02504216|471241649|FG001|Overall Study|Lost to Follow-up|3|||
130892981|NCT02504216|471241648|FG000|Overall Study|Withdrawal by Subject|8|||
130892982|NCT02504216|471241649|FG001|Overall Study|Withdrawal by Subject|12|||
130892983|NCT00223080|471241650|FG000|Overall Study|Withdrawal by Subject|253|||
130892984|NCT00223080|471241651|FG001|Overall Study|Withdrawal by Subject|232|||
130892985|NCT00223080|471241650|FG000|Overall Study|Required contraindicated med|0|||
130892986|NCT00223080|471241651|FG001|Overall Study|Required contraindicated med|1|||
130892987|NCT00223080|471241650|FG000|Overall Study|Non-compliant|7|||
130892988|NCT00223080|471241651|FG001|Overall Study|Non-compliant|7|||
130892989|NCT00223080|471241650|FG000|Overall Study|Moved from study area|37|||
130892990|NCT00223080|471241651|FG001|Overall Study|Moved from study area|47|||
130892991|NCT00223080|471241650|FG000|Overall Study|Lost to Follow-up|259|||
131024843|NCT02554786|471721447|FG003|Overall Study|Non-compliance with study treatment|0|||
131024844|NCT02554786|471721448|FG004|Overall Study|Non-compliance with study treatment|1|||
131024845|NCT02554786|471721444|FG000|Overall Study|Physician Decision|0|||
131024846|NCT02554786|471721445|FG001|Overall Study|Physician Decision|1|||
131024847|NCT02554786|471721446|FG002|Overall Study|Physician Decision|4|||
131024848|NCT02554786|471721447|FG003|Overall Study|Physician Decision|1|||
131024849|NCT02554786|471721448|FG004|Overall Study|Physician Decision|1|||
131024850|NCT02554786|471721444|FG000|Overall Study|Pregnancy|0|||
131024851|NCT02554786|471721445|FG001|Overall Study|Pregnancy|0|||
131024852|NCT02554786|471721446|FG002|Overall Study|Pregnancy|0|||
131024853|NCT02554786|471721447|FG003|Overall Study|Pregnancy|1|||
131024854|NCT02554786|471721448|FG004|Overall Study|Pregnancy|1|||
131024855|NCT04704284|471721449|FG000|Overall Study|Withdrawal by Subject|1|||
130892992|NCT00223080|471241651|FG001|Overall Study|Lost to Follow-up|284|||
130892993|NCT00223080|471241650|FG000|Overall Study|Death|85|||
130892994|NCT00223080|471241651|FG001|Overall Study|Death|74|||
130892995|NCT00223080|471241650|FG000|Overall Study|Other|14|||
130892996|NCT00223080|471241651|FG001|Overall Study|Other|11|||
130892997|NCT00223080|471241650|FG000|Overall Study|Reason not provided|141|||
130892998|NCT00223080|471241651|FG001|Overall Study|Reason not provided|140|||
130892999|NCT00223080|471241650|FG000|Overall Study|Adverse Event|0|||
130893000|NCT00223080|471241651|FG001|Overall Study|Adverse Event|1|||
130893001|NCT02598583|471241652|FG000|Extension Period|Withdrawal by Subject|1|||
130893002|NCT02598583|471241653|FG001|Extension Period|Withdrawal by Subject|0|||
131024856|NCT00539734|471721455|FG000|Overall Study|Protocol Violation|1|||
131024857|NCT00393484|471721457|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
131024858|NCT00393484|471721458|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
130893003|NCT03237286|471241654|FG000|Overall Study|Withdrawal by Subject|1|||
130893004|NCT03237286|471241655|FG001|Overall Study|Withdrawal by Subject|0|||
130893005|NCT03237286|471241656|FG002|Overall Study|Withdrawal by Subject|2|||
130893006|NCT03237286|471241654|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
130893007|NCT03237286|471241655|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
130893008|NCT03237286|471241656|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
130893009|NCT00947882|471241666|FG000|Overall Study|Adverse Event|0|||
131110064|NCT00615836|472033977|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
131110065|NCT00615836|472033978|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
131110066|NCT00615836|472033979|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
131110067|NCT00615836|472033980|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
130893010|NCT00947882|471241667|FG001|Overall Study|Adverse Event|1|||
130893011|NCT00947882|471241668|FG002|Overall Study|Adverse Event|4|||
130893012|NCT00947882|471241669|FG003|Overall Study|Adverse Event|4|||
130893013|NCT00947882|471241666|FG000|Overall Study|Withdrawal by Subject|2|||
130893014|NCT00947882|471241667|FG001|Overall Study|Withdrawal by Subject|0|||
130893015|NCT00947882|471241668|FG002|Overall Study|Withdrawal by Subject|8|||
130893016|NCT00947882|471241669|FG003|Overall Study|Withdrawal by Subject|2|||
130893017|NCT00947882|471241666|FG000|Overall Study|Protocol Violation|0|||
130893018|NCT00947882|471241667|FG001|Overall Study|Protocol Violation|0|||
130893019|NCT00947882|471241668|FG002|Overall Study|Protocol Violation|1|||
130893020|NCT00947882|471241669|FG003|Overall Study|Protocol Violation|0|||
130893021|NCT00947882|471241666|FG000|Overall Study|Lost to Follow-up|0|||
130893022|NCT00947882|471241667|FG001|Overall Study|Lost to Follow-up|2|||
130893023|NCT00947882|471241668|FG002|Overall Study|Lost to Follow-up|1|||
130893024|NCT00947882|471241669|FG003|Overall Study|Lost to Follow-up|0|||
131110068|NCT00615836|472033976|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
130893025|NCT00947882|471241666|FG000|Overall Study|Other/Unknown|10|||
130893026|NCT00947882|471241667|FG001|Overall Study|Other/Unknown|13|||
130893027|NCT00947882|471241668|FG002|Overall Study|Other/Unknown|3|||
130893028|NCT00947882|471241669|FG003|Overall Study|Other/Unknown|6|||
130893029|NCT00947882|471241666|FG000|Overall Study|Trial Terminated by Sponsor|62|||
130893030|NCT00947882|471241667|FG001|Overall Study|Trial Terminated by Sponsor|61|||
130893031|NCT00947882|471241668|FG002|Overall Study|Trial Terminated by Sponsor|62|||
130893032|NCT00947882|471241669|FG003|Overall Study|Trial Terminated by Sponsor|70|||
130893033|NCT01262820|471241670|FG000|Overall Study|Adverse Event|5|||
130893034|NCT01262820|471241670|FG000|Overall Study|Lack of Efficacy|9|||
130893035|NCT01262820|471241670|FG000|Overall Study|Drug held for 21+ days|1|||
130893036|NCT00104520|471241671|FG000|Overall Study|Unrelated adverse event|34|||
130893037|NCT00104520|471241672|FG001|Overall Study|Unrelated adverse event|47|||
130893038|NCT00104520|471241671|FG000|Overall Study|Study drug intolerance|0|||
130893039|NCT00104520|471241672|FG001|Overall Study|Study drug intolerance|1|||
131110069|NCT00615836|472033977|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
131110070|NCT00615836|472033978|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
131110071|NCT00615836|472033979|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
131110072|NCT00615836|472033980|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
131110073|NCT00615836|472033976|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
131110074|NCT00615836|472033977|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
131110075|NCT00615836|472033978|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
131110076|NCT00615836|472033979|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
131110077|NCT00615836|472033980|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
131110078|NCT00615836|472033976|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
131110079|NCT00615836|472033977|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
131110080|NCT00615836|472033978|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
131110081|NCT00615836|472033979|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
131110082|NCT00615836|472033980|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
131110083|NCT00615836|472033976|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
131110084|NCT00615836|472033977|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
131110085|NCT00615836|472033978|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
131110086|NCT00615836|472033979|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
131110087|NCT00615836|472033980|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
130687010|NCT05472038|470481325|FG002|Overall Study|Lost to Follow-up|3|||
130893040|NCT00104520|471241671|FG000|Overall Study|Related adverse event|13|||
130893041|NCT00104520|471241672|FG001|Overall Study|Related adverse event|15|||
130893042|NCT00104520|471241671|FG000|Overall Study|Lost to Follow-up|1|||
130687011|NCT05472038|470481326|FG003|Overall Study|Lost to Follow-up|9|||
130893043|NCT00104520|471241672|FG001|Overall Study|Lost to Follow-up|0|||
130893044|NCT00104520|471241671|FG000|Overall Study|Noncompliance|0|||
130893045|NCT00104520|471241672|FG001|Overall Study|Noncompliance|2|||
130893046|NCT00104520|471241671|FG000|Overall Study|Personal/administrative|1|||
130893047|NCT00104520|471241672|FG001|Overall Study|Personal/administrative|1|||
130687012|NCT05472038|470481327|FG004|Overall Study|Lost to Follow-up|2|||
130893048|NCT00104520|471241671|FG000|Overall Study|Other|1|||
130893049|NCT00104520|471241672|FG001|Overall Study|Other|5|||
130893050|NCT01026324|471241674|FG000|Follow up/Survival|Withdrawal by Subject|1|||
130893051|NCT01026324|471241675|FG001|Follow up/Survival|Withdrawal by Subject|0|||
130893052|NCT01026324|471241676|FG002|Follow up/Survival|Withdrawal by Subject|0|||
130893053|NCT05188053|471241677|FG000|Overall Study|Lost to Follow-up|23|||
130893054|NCT05188053|471241678|FG001|Overall Study|Lost to Follow-up|30|||
130893055|NCT05188053|471241677|FG000|Overall Study|Protocol Violation|16|||
130893056|NCT05188053|471241678|FG001|Overall Study|Protocol Violation|16|||
130893057|NCT05188053|471241677|FG000|Overall Study|Physician Decision|3|||
130893058|NCT05188053|471241678|FG001|Overall Study|Physician Decision|0|||
130893059|NCT05188053|471241677|FG000|Overall Study|Withdrawal by Subject|0|||
130893060|NCT05188053|471241678|FG001|Overall Study|Withdrawal by Subject|1|||
130893061|NCT05334212|471241679|FG000|Overall Study|Study terminated prematurely|7|||
130893062|NCT01561313|471241680|FG000|Overall Study|Withdrawal by Subject|1|||
130893063|NCT01561313|471241681|FG001|Overall Study|Withdrawal by Subject|0|||
130893064|NCT01561313|471241680|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
130893065|NCT01561313|471241681|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
131110088|NCT00615836|472033976|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
131110089|NCT00615836|472033977|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
131110090|NCT00615836|472033978|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
131110091|NCT00615836|472033979|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
131110092|NCT00615836|472033980|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
131110093|NCT00615836|472033976|FG000|Extension Study (FE992026 CS31)|Other|10|||
131110094|NCT00615836|472033977|FG001|Extension Study (FE992026 CS31)|Other|7|||
131110095|NCT00615836|472033978|FG002|Extension Study (FE992026 CS31)|Other|8|||
131110096|NCT00615836|472033979|FG003|Extension Study (FE992026 CS31)|Other|8|||
131110097|NCT00615836|472033980|FG004|Extension Study (FE992026 CS31)|Other|0|||
131110098|NCT00615836|472033976|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
131110099|NCT00615836|472033977|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
130893066|NCT04393454|471241682|FG000|Overall Study|Death|1|||
130893067|NCT04393454|471241682|FG000|Overall Study|Lost to Follow-up|1|||
130893068|NCT03304249|471241684|FG000|Overall Study|Lost to Follow-up|8|||
130893069|NCT03304249|471241685|FG001|Overall Study|Lost to Follow-up|10|||
130893070|NCT03304249|471241684|FG000|Overall Study|Withdrawal by Subject|12|||
130893071|NCT03304249|471241685|FG001|Overall Study|Withdrawal by Subject|2|||
130893072|NCT03304249|471241684|FG000|Overall Study|Moved Out of District|4|||
131110100|NCT00615836|472033978|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
131110101|NCT00615836|472033979|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
131110102|NCT00615836|472033980|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
131110103|NCT00615836|472033976|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
131110104|NCT00615836|472033977|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
131110105|NCT00615836|472033978|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
130893073|NCT03304249|471241685|FG001|Overall Study|Moved Out of District|2|||
130893074|NCT04189224|471241686|FG000|Period 2|Adverse Event|0|||
130893075|NCT04189224|471241687|FG001|Period 2|Adverse Event|1|||
130893076|NCT02970942|471241688|FG000|Overall Study|Death|0|||
130893077|NCT02970942|471241689|FG001|Overall Study|Death|1|||
130893078|NCT02970942|471241690|FG002|Overall Study|Death|0|||
130893079|NCT02970942|471241691|FG003|Overall Study|Death|0|||
130893080|NCT02970942|471241688|FG000|Overall Study|Lost to Follow-up|1|||
130893081|NCT02970942|471241689|FG001|Overall Study|Lost to Follow-up|0|||
130893082|NCT02970942|471241690|FG002|Overall Study|Lost to Follow-up|2|||
130893083|NCT02970942|471241691|FG003|Overall Study|Lost to Follow-up|1|||
130893084|NCT02970942|471241688|FG000|Overall Study|Withdrawal by Subject|3|||
130893085|NCT02970942|471241689|FG001|Overall Study|Withdrawal by Subject|5|||
130893086|NCT02970942|471241690|FG002|Overall Study|Withdrawal by Subject|3|||
130893087|NCT02970942|471241691|FG003|Overall Study|Withdrawal by Subject|2|||
130893088|NCT02529553|471241692|FG000|Overall Study|Progressive Disease|1|||
130893089|NCT02529553|471241693|FG001|Overall Study|Progressive Disease|0|||
130893090|NCT02529553|471241694|FG002|Overall Study|Progressive Disease|1|||
131110106|NCT00615836|472033979|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
131110107|NCT00615836|472033980|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
131222689|NCT03402126|472443160|FG000|Overall Study|Withdrawal by Subject|6|||
130687013|NCT05472038|470481328|FG005|Overall Study|Lost to Follow-up|2|||
130893091|NCT02529553|471241695|FG003|Overall Study|Progressive Disease|3|||
130893092|NCT02529553|471241696|FG004|Overall Study|Progressive Disease|2|||
130893093|NCT02529553|471241697|FG005|Overall Study|Progressive Disease|3|||
130687014|NCT05472038|470481329|FG006|Overall Study|Lost to Follow-up|1|||
130687015|NCT05472038|470481330|FG007|Overall Study|Lost to Follow-up|0|||
130687016|NCT05472038|470481331|FG008|Overall Study|Lost to Follow-up|1|||
130893094|NCT02529553|471241698|FG006|Overall Study|Progressive Disease|3|||
130893095|NCT02529553|471241699|FG007|Overall Study|Progressive Disease|5|||
130893096|NCT02529553|471241700|FG008|Overall Study|Progressive Disease|3|||
130893097|NCT02529553|471241692|FG000|Overall Study|Physician Decision|0|||
130893098|NCT02529553|471241693|FG001|Overall Study|Physician Decision|1|||
131110108|NCT01313689|472033981|FG000|24-Week Randomization 1|Adverse Event|10|||
131110109|NCT01313689|472033982|FG001|24-Week Randomization 1|Adverse Event|5|||
131110110|NCT01313689|472033983|FG002|24-Week Randomization 1|Adverse Event|0|||
131110111|NCT01313689|472033984|FG003|24-Week Randomization 1|Adverse Event|0|||
131110112|NCT01313689|472033985|FG004|24-Week Randomization 1|Adverse Event|0|||
131110113|NCT01313689|472033981|FG000|24-Week Randomization 1|Physician Decision|4|||
131110114|NCT01313689|472033982|FG001|24-Week Randomization 1|Physician Decision|5|||
131110115|NCT01313689|472033983|FG002|24-Week Randomization 1|Physician Decision|0|||
131110116|NCT01313689|472033984|FG003|24-Week Randomization 1|Physician Decision|0|||
131110117|NCT01313689|472033985|FG004|24-Week Randomization 1|Physician Decision|0|||
131110118|NCT01313689|472033981|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
131110119|NCT01313689|472033982|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
131110120|NCT01313689|472033983|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
131110121|NCT01313689|472033984|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
131110122|NCT01313689|472033985|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
131110123|NCT01313689|472033981|FG000|24-Week Randomization 2|Adverse Event|0|||
131110124|NCT01313689|472033982|FG001|24-Week Randomization 2|Adverse Event|0|||
131110125|NCT01313689|472033983|FG002|24-Week Randomization 2|Adverse Event|2|||
131110126|NCT01313689|472033984|FG003|24-Week Randomization 2|Adverse Event|0|||
131110127|NCT01313689|472033985|FG004|24-Week Randomization 2|Adverse Event|8|||
130893099|NCT02529553|471241694|FG002|Overall Study|Physician Decision|0|||
130893100|NCT02529553|471241695|FG003|Overall Study|Physician Decision|0|||
130893101|NCT02529553|471241696|FG004|Overall Study|Physician Decision|1|||
130893102|NCT02529553|471241697|FG005|Overall Study|Physician Decision|0|||
130893103|NCT02529553|471241698|FG006|Overall Study|Physician Decision|0|||
130893104|NCT02529553|471241699|FG007|Overall Study|Physician Decision|0|||
130893105|NCT02529553|471241700|FG008|Overall Study|Physician Decision|0|||
130893106|NCT02529553|471241692|FG000|Overall Study|Withdrawal by Subject|0|||
130893107|NCT02529553|471241693|FG001|Overall Study|Withdrawal by Subject|0|||
130893108|NCT02529553|471241694|FG002|Overall Study|Withdrawal by Subject|0|||
130893109|NCT02529553|471241695|FG003|Overall Study|Withdrawal by Subject|0|||
131110128|NCT01313689|472033981|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
131110129|NCT01313689|472033982|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
131110130|NCT01313689|472033983|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
131110131|NCT01313689|472033984|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
131110132|NCT01313689|472033985|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
131110133|NCT01313689|472033981|FG000|24-Week Randomization 2|Physician Decision|0|||
131110134|NCT01313689|472033982|FG001|24-Week Randomization 2|Physician Decision|0|||
131110135|NCT01313689|472033983|FG002|24-Week Randomization 2|Physician Decision|0|||
131110136|NCT01313689|472033984|FG003|24-Week Randomization 2|Physician Decision|0|||
131110137|NCT01313689|472033985|FG004|24-Week Randomization 2|Physician Decision|4|||
131110138|NCT00687973|472033986|FG000|Overall Study|Adverse Event|18|||
131110139|NCT00687973|472033987|FG001|Overall Study|Adverse Event|28|||
131110140|NCT00687973|472033986|FG000|Overall Study|Lack of Efficacy|2|||
131110141|NCT00687973|472033987|FG001|Overall Study|Lack of Efficacy|3|||
131110142|NCT00687973|472033986|FG000|Overall Study|Protocol Violation|1|||
131110143|NCT00687973|472033987|FG001|Overall Study|Protocol Violation|2|||
131110144|NCT00687973|472033986|FG000|Overall Study|Administrative Reasons|0|||
131110145|NCT00687973|472033987|FG001|Overall Study|Administrative Reasons|2|||
131110146|NCT00687973|472033986|FG000|Overall Study|Withdrawal by Subject|3|||
131110147|NCT00687973|472033987|FG001|Overall Study|Withdrawal by Subject|3|||
131110148|NCT02121834|472033988|FG000|Overall Study|Protocol Violation|0|||
131110149|NCT02121834|472033989|FG001|Overall Study|Protocol Violation|1|||
131110150|NCT02121834|472033990|FG002|Overall Study|Protocol Violation|0|||
131110151|NCT02121834|472033991|FG003|Overall Study|Protocol Violation|0|||
130687017|NCT05472038|470481332|FG009|Overall Study|Lost to Follow-up|0|||
131110152|NCT02121834|472033992|FG004|Overall Study|Protocol Violation|0|||
131110153|NCT02121834|472033993|FG005|Overall Study|Protocol Violation|0|||
131110154|NCT02121834|472033994|FG006|Overall Study|Protocol Violation|0|||
131110155|NCT02121834|472033988|FG000|Overall Study|Withdrawal by Subject|0|||
131110156|NCT02121834|472033989|FG001|Overall Study|Withdrawal by Subject|1|||
131110157|NCT02121834|472033990|FG002|Overall Study|Withdrawal by Subject|1|||
131110158|NCT02121834|472033991|FG003|Overall Study|Withdrawal by Subject|0|||
131110159|NCT02121834|472033992|FG004|Overall Study|Withdrawal by Subject|0|||
131110160|NCT02121834|472033993|FG005|Overall Study|Withdrawal by Subject|0|||
130687018|NCT05472038|470481333|FG010|Overall Study|Lost to Follow-up|2|||
131110161|NCT02121834|472033994|FG006|Overall Study|Withdrawal by Subject|0|||
131110162|NCT02121834|472033988|FG000|Overall Study|Lost to Follow-up|0|||
131110163|NCT02121834|472033989|FG001|Overall Study|Lost to Follow-up|0|||
130893110|NCT02529553|471241696|FG004|Overall Study|Withdrawal by Subject|0|||
130893111|NCT02529553|471241697|FG005|Overall Study|Withdrawal by Subject|1|||
130893112|NCT02529553|471241698|FG006|Overall Study|Withdrawal by Subject|0|||
131110164|NCT02121834|472033990|FG002|Overall Study|Lost to Follow-up|1|||
130687019|NCT05472038|470481334|FG011|Overall Study|Lost to Follow-up|1|||
130893113|NCT02529553|471241699|FG007|Overall Study|Withdrawal by Subject|1|||
131110165|NCT02121834|472033991|FG003|Overall Study|Lost to Follow-up|0|||
131110166|NCT02121834|472033992|FG004|Overall Study|Lost to Follow-up|0|||
131110167|NCT02121834|472033993|FG005|Overall Study|Lost to Follow-up|0|||
131110168|NCT02121834|472033994|FG006|Overall Study|Lost to Follow-up|0|||
131110169|NCT02019927|472033997|FG000|Overall Study|Lost to Follow-up|2|||
131110170|NCT02019927|472033998|FG001|Overall Study|Lost to Follow-up|4|||
131110171|NCT02019927|472033999|FG002|Overall Study|Lost to Follow-up|1|||
131110172|NCT02019927|472034000|FG003|Overall Study|Lost to Follow-up|2|||
131110173|NCT02019927|472034001|FG004|Overall Study|Lost to Follow-up|3|||
131110174|NCT02019927|472034002|FG005|Overall Study|Lost to Follow-up|1|||
131110175|NCT01423253|472034011|FG000|Overall Study|Adverse Event|2|||
131110176|NCT01423253|472034011|FG000|Overall Study|Lack of Efficacy|2|||
131110177|NCT01423253|472034011|FG000|Overall Study|Lost to Follow-up|1|||
130893114|NCT02529553|471241700|FG008|Overall Study|Withdrawal by Subject|0|||
130893115|NCT00488683|471241701|FG000|Overall Study|Withdrawal by Subject|1|||
130893116|NCT00488683|471241702|FG001|Overall Study|Withdrawal by Subject|2|||
130893117|NCT00488683|471241703|FG002|Overall Study|Withdrawal by Subject|2|||
130893118|NCT00488683|471241701|FG000|Overall Study|Lost to Follow-up|5|||
130893119|NCT00488683|471241702|FG001|Overall Study|Lost to Follow-up|3|||
130893120|NCT00488683|471241703|FG002|Overall Study|Lost to Follow-up|0|||
130893121|NCT00488683|471241701|FG000|Overall Study|Protocol Violation|5|||
130893122|NCT00488683|471241702|FG001|Overall Study|Protocol Violation|1|||
130893123|NCT00488683|471241703|FG002|Overall Study|Protocol Violation|0|||
131110178|NCT01423253|472034011|FG000|Overall Study|Protocol Violation|2|||
131110179|NCT01423253|472034011|FG000|Overall Study|Withdrawal by Subject|2|||
131110180|NCT00307125|472034014|FG000|Screening Phase|Adverse Event|1|||
131110181|NCT00307125|472034015|FG001|Screening Phase|Adverse Event|0|||
131110182|NCT00307125|472034016|FG002|Screening Phase|Adverse Event|0|||
131110183|NCT00307125|472034014|FG000|Screening Phase|Protocol Violation|27|||
131110184|NCT00307125|472034015|FG001|Screening Phase|Protocol Violation|0|||
131110185|NCT00307125|472034016|FG002|Screening Phase|Protocol Violation|0|||
131110186|NCT00307125|472034014|FG000|Screening Phase|Lost to Follow-up|87|||
131110187|NCT00307125|472034015|FG001|Screening Phase|Lost to Follow-up|0|||
131110188|NCT00307125|472034016|FG002|Screening Phase|Lost to Follow-up|0|||
131110189|NCT00307125|472034014|FG000|Screening Phase|Death|10|||
131110190|NCT00307125|472034015|FG001|Screening Phase|Death|0|||
131110191|NCT00307125|472034016|FG002|Screening Phase|Death|0|||
131110192|NCT00307125|472034014|FG000|Screening Phase|Withdrawal by Subject|77|||
131110193|NCT00307125|472034015|FG001|Screening Phase|Withdrawal by Subject|0|||
131110194|NCT00307125|472034016|FG002|Screening Phase|Withdrawal by Subject|0|||
131110195|NCT00307125|472034014|FG000|Screening Phase|Physician Decision|26|||
131110196|NCT00307125|472034015|FG001|Screening Phase|Physician Decision|0|||
131110197|NCT00307125|472034016|FG002|Screening Phase|Physician Decision|0|||
131110198|NCT00307125|472034014|FG000|Screening Phase|Sponsor Decision|4|||
131110199|NCT00307125|472034015|FG001|Screening Phase|Sponsor Decision|0|||
131110200|NCT00307125|472034016|FG002|Screening Phase|Sponsor Decision|0|||
131110201|NCT00307125|472034014|FG000|Screening Phase|Study Terminated|17|||
131110202|NCT00307125|472034015|FG001|Screening Phase|Study Terminated|0|||
131110203|NCT00307125|472034016|FG002|Screening Phase|Study Terminated|0|||
131110204|NCT00307125|472034014|FG000|Screening Phase|Graft Loss|3|||
131110205|NCT00307125|472034015|FG001|Screening Phase|Graft Loss|0|||
131110206|NCT00307125|472034016|FG002|Screening Phase|Graft Loss|0|||
131110207|NCT00307125|472034014|FG000|Screening Phase|Graft Failure|8|||
131110208|NCT00307125|472034015|FG001|Screening Phase|Graft Failure|0|||
131110209|NCT00307125|472034016|FG002|Screening Phase|Graft Failure|0|||
131110210|NCT00307125|472034014|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
131110211|NCT00307125|472034015|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
131110212|NCT00307125|472034016|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
131110213|NCT00307125|472034014|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
131110214|NCT00307125|472034015|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
131110215|NCT00307125|472034016|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
131110216|NCT00307125|472034014|FG000|Screening Phase|Moved or transferred facilities|34|||
131110217|NCT00307125|472034015|FG001|Screening Phase|Moved or transferred facilities|0|||
131110218|NCT00307125|472034016|FG002|Screening Phase|Moved or transferred facilities|0|||
131110219|NCT00307125|472034014|FG000|Screening Phase|Received Pancreas Transplant|8|||
131110220|NCT00307125|472034015|FG001|Screening Phase|Received Pancreas Transplant|0|||
131110221|NCT00307125|472034016|FG002|Screening Phase|Received Pancreas Transplant|0|||
131110222|NCT00307125|472034014|FG000|Screening Phase|Ineligible for pilot|4|||
131110223|NCT00307125|472034015|FG001|Screening Phase|Ineligible for pilot|0|||
131110224|NCT00307125|472034016|FG002|Screening Phase|Ineligible for pilot|0|||
131110225|NCT00307125|472034014|FG000|Screening Phase|Try to get pregnant|1|||
131110226|NCT00307125|472034015|FG001|Screening Phase|Try to get pregnant|0|||
130893124|NCT00488683|471241701|FG000|Overall Study|Unable to Classify|1|||
130893125|NCT00488683|471241702|FG001|Overall Study|Unable to Classify|0|||
131110227|NCT00307125|472034016|FG002|Screening Phase|Try to get pregnant|0|||
131110228|NCT00307125|472034014|FG000|Screening Phase|Developed acute leukemia|1|||
131110229|NCT00307125|472034015|FG001|Screening Phase|Developed acute leukemia|0|||
130893126|NCT00488683|471241703|FG002|Overall Study|Unable to Classify|0|||
131222690|NCT03402126|472443160|FG000|Overall Study|Physician Decision|2|||
131110230|NCT00307125|472034016|FG002|Screening Phase|Developed acute leukemia|0|||
131110231|NCT00307125|472034014|FG000|Screening Phase|Metastatic colon cancer|1|||
131110232|NCT00307125|472034015|FG001|Screening Phase|Metastatic colon cancer|0|||
131110233|NCT00307125|472034016|FG002|Screening Phase|Metastatic colon cancer|0|||
131110234|NCT00307125|472034014|FG000|Screening Phase|Malignancy|1|||
131110235|NCT00307125|472034015|FG001|Screening Phase|Malignancy|0|||
131110236|NCT00307125|472034016|FG002|Screening Phase|Malignancy|0|||
131110237|NCT00307125|472034014|FG000|Screening Phase|PAK|1|||
131110238|NCT00307125|472034015|FG001|Screening Phase|PAK|0|||
131110239|NCT00307125|472034016|FG002|Screening Phase|PAK|0|||
131110240|NCT00307125|472034014|FG000|Screening Phase|Ineligible|1|||
131110241|NCT00307125|472034015|FG001|Screening Phase|Ineligible|0|||
131110242|NCT00307125|472034016|FG002|Screening Phase|Ineligible|0|||
131110243|NCT00307125|472034014|FG000|Screening Phase|Screen Error|1|||
131110244|NCT00307125|472034015|FG001|Screening Phase|Screen Error|0|||
131110245|NCT00307125|472034016|FG002|Screening Phase|Screen Error|0|||
131110246|NCT00307125|472034014|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
131110247|NCT00307125|472034015|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
131110248|NCT00307125|472034016|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
131110249|NCT00307125|472034014|FG000|Screening Phase|AMR and treated with rituximab|1|||
131110250|NCT00307125|472034015|FG001|Screening Phase|AMR and treated with rituximab|0|||
131110251|NCT00307125|472034016|FG002|Screening Phase|AMR and treated with rituximab|0|||
131110252|NCT00307125|472034014|FG000|Screening Phase|Coronary artery bypass|1|||
131110253|NCT00307125|472034015|FG001|Screening Phase|Coronary artery bypass|0|||
131110254|NCT00307125|472034016|FG002|Screening Phase|Coronary artery bypass|0|||
131110255|NCT00307125|472034014|FG000|Pilot Phase|Lost to Follow-up|0|||
131110256|NCT00307125|472034015|FG001|Pilot Phase|Lost to Follow-up|1|||
131110257|NCT00307125|472034016|FG002|Pilot Phase|Lost to Follow-up|0|||
131110258|NCT00307125|472034014|FG000|Pilot Phase|Withdrawal by Subject|0|||
131110259|NCT00307125|472034015|FG001|Pilot Phase|Withdrawal by Subject|1|||
131110260|NCT00307125|472034016|FG002|Pilot Phase|Withdrawal by Subject|1|||
131110261|NCT00147823|472034017|FG000|Overall Study|Lost to Follow-up|6|||
131110262|NCT00147823|472034018|FG001|Overall Study|Lost to Follow-up|12|||
131110263|NCT00147823|472034017|FG000|Overall Study|Physician Decision|1|||
131110264|NCT00147823|472034018|FG001|Overall Study|Physician Decision|0|||
131110265|NCT00147823|472034017|FG000|Overall Study|Withdrawal by Subject|0|||
131110266|NCT00147823|472034018|FG001|Overall Study|Withdrawal by Subject|1|||
131110267|NCT00147823|472034017|FG000|Overall Study|Did not receive vitoss due to infection|6|||
131110268|NCT00147823|472034018|FG001|Overall Study|Did not receive vitoss due to infection|2|||
131110269|NCT01032382|472034021|FG000|Overall Study|Disease dissemination|1|||
131110270|NCT01032382|472034022|FG001|Overall Study|Disease dissemination|1|||
131110271|NCT01032382|472034021|FG000|Overall Study|Treatment failure|3|||
131110272|NCT01032382|472034022|FG001|Overall Study|Treatment failure|1|||
131110273|NCT01032382|472034021|FG000|Overall Study|Index lesion relapse|1|||
131110274|NCT01032382|472034022|FG001|Overall Study|Index lesion relapse|3|||
131110275|NCT00412971|472034023|FG000|Overall Study|Lost to Follow-up|17|||
131110276|NCT00412971|472034024|FG001|Overall Study|Lost to Follow-up|9|||
131110277|NCT00412971|472034023|FG000|Overall Study|Protocol Violation|13|||
130893127|NCT01865552|471243185|FG000|Period 1|Adverse Event|1|||
130893128|NCT01865552|471243186|FG001|Period 1|Adverse Event|0|||
130893129|NCT01865552|471243187|FG002|Period 1|Adverse Event|0|||
131110278|NCT00412971|472034024|FG001|Overall Study|Protocol Violation|1|||
131110279|NCT02571049|472034025|FG000|Screening|Did not meet entry criteria|2|||
131110280|NCT02571049|472034026|FG001|Screening|Did not meet entry criteria|2|||
131110281|NCT02571049|472034025|FG000|Randomization|No migraine attack|0|||
131110282|NCT02571049|472034026|FG001|Randomization|No migraine attack|1|||
131110283|NCT02571049|472034025|FG000|Randomization|Adverse Event|0|||
131110284|NCT02571049|472034026|FG001|Randomization|Adverse Event|1|||
131110285|NCT01055262|472034027|FG000|Overall Study|Adverse Event|5|||
130687020|NCT05472038|470481323|FG000|Overall Study|Physician Decision|0|||
130687021|NCT05472038|470481324|FG001|Overall Study|Physician Decision|0|||
130893130|NCT01865552|471243188|FG003|Period 1|Adverse Event|1|||
130893131|NCT01865552|471243189|FG004|Period 1|Adverse Event|1|||
130893132|NCT01865552|471243190|FG005|Period 1|Adverse Event|1|||
131110286|NCT01055262|472034027|FG000|Overall Study|Protocol Violation|3|||
131110287|NCT01055262|472034027|FG000|Overall Study|Uncooperativeness|1|||
131110288|NCT00561951|472034028|FG000|Overall Study|Adverse Event|11|||
131110289|NCT00561951|472034029|FG001|Overall Study|Adverse Event|14|||
131110290|NCT00561951|472034030|FG002|Overall Study|Adverse Event|14|||
131110291|NCT00561951|472034028|FG000|Overall Study|Lack of Efficacy|5|||
131110292|NCT00561951|472034029|FG001|Overall Study|Lack of Efficacy|3|||
131110293|NCT00561951|472034030|FG002|Overall Study|Lack of Efficacy|2|||
131110294|NCT00561951|472034028|FG000|Overall Study|Lost to Follow-up|1|||
131110295|NCT00561951|472034029|FG001|Overall Study|Lost to Follow-up|1|||
131110296|NCT00561951|472034030|FG002|Overall Study|Lost to Follow-up|0|||
131110297|NCT00561951|472034028|FG000|Overall Study|Withdrawal by Subject|10|||
131110298|NCT00561951|472034029|FG001|Overall Study|Withdrawal by Subject|9|||
131110299|NCT00561951|472034030|FG002|Overall Study|Withdrawal by Subject|10|||
130893133|NCT01865552|471243185|FG000|Period 1|Pathological lab|0|||
130687022|NCT05472038|470481325|FG002|Overall Study|Physician Decision|0|||
130687023|NCT05472038|470481326|FG003|Overall Study|Physician Decision|0|||
130687024|NCT05472038|470481327|FG004|Overall Study|Physician Decision|1|||
130687025|NCT05472038|470481328|FG005|Overall Study|Physician Decision|0|||
130687026|NCT05472038|470481329|FG006|Overall Study|Physician Decision|0|||
130687027|NCT05472038|470481330|FG007|Overall Study|Physician Decision|0|||
130687028|NCT05472038|470481331|FG008|Overall Study|Physician Decision|0|||
130687029|NCT05472038|470481332|FG009|Overall Study|Physician Decision|0|||
130687030|NCT05472038|470481333|FG010|Overall Study|Physician Decision|0|||
130687031|NCT05472038|470481334|FG011|Overall Study|Physician Decision|0|||
130687032|NCT05472038|470481323|FG000|Overall Study|Withdrawal by Subject|1|||
130687033|NCT05472038|470481324|FG001|Overall Study|Withdrawal by Subject|3|||
130687034|NCT05472038|470481325|FG002|Overall Study|Withdrawal by Subject|1|||
130687035|NCT05472038|470481326|FG003|Overall Study|Withdrawal by Subject|6|||
130687036|NCT05472038|470481327|FG004|Overall Study|Withdrawal by Subject|1|||
130687037|NCT05472038|470481328|FG005|Overall Study|Withdrawal by Subject|3|||
130687038|NCT05472038|470481329|FG006|Overall Study|Withdrawal by Subject|0|||
130687039|NCT05472038|470481330|FG007|Overall Study|Withdrawal by Subject|2|||
130687040|NCT05472038|470481331|FG008|Overall Study|Withdrawal by Subject|3|||
130687041|NCT05472038|470481332|FG009|Overall Study|Withdrawal by Subject|1|||
130687042|NCT05472038|470481333|FG010|Overall Study|Withdrawal by Subject|2|||
130687043|NCT05472038|470481334|FG011|Overall Study|Withdrawal by Subject|2|||
130687044|NCT05472038|470481323|FG000|Overall Study|Protocol Violation|0|||
130687045|NCT05472038|470481324|FG001|Overall Study|Protocol Violation|0|||
130687046|NCT05472038|470481325|FG002|Overall Study|Protocol Violation|0|||
130687047|NCT05472038|470481326|FG003|Overall Study|Protocol Violation|0|||
130687048|NCT05472038|470481327|FG004|Overall Study|Protocol Violation|0|||
130687049|NCT05472038|470481328|FG005|Overall Study|Protocol Violation|0|||
130687050|NCT05472038|470481329|FG006|Overall Study|Protocol Violation|0|||
130687051|NCT05472038|470481330|FG007|Overall Study|Protocol Violation|1|||
130687052|NCT05472038|470481331|FG008|Overall Study|Protocol Violation|1|||
130687053|NCT05472038|470481332|FG009|Overall Study|Protocol Violation|1|||
130687054|NCT05472038|470481333|FG010|Overall Study|Protocol Violation|1|||
131024859|NCT00393484|471721457|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
131024860|NCT00393484|471721458|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
131024861|NCT00393484|471721457|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
131024862|NCT00393484|471721458|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
131024863|NCT00393484|471721457|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
131024864|NCT00393484|471721458|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
131024865|NCT00393484|471721457|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
131024866|NCT00393484|471721458|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
131024867|NCT00393484|471721457|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
131024868|NCT00393484|471721458|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
131024869|NCT00393484|471721457|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
131024870|NCT00393484|471721458|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
131024871|NCT00393484|471721457|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
131024872|NCT00393484|471721458|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
131024873|NCT00393484|471721457|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
131024874|NCT00393484|471721458|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
131024875|NCT00393484|471721457|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
131024876|NCT00393484|471721458|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
131024877|NCT03201562|471721459|FG000|Overall Study|Physician Decision|0|||
131024878|NCT03201562|471721460|FG001|Overall Study|Physician Decision|0|||
131024879|NCT03201562|471721461|FG002|Overall Study|Physician Decision|1|||
131024880|NCT03201562|471721459|FG000|Overall Study|Adverse Event|0|||
131024881|NCT03201562|471721460|FG001|Overall Study|Adverse Event|0|||
131024882|NCT03201562|471721461|FG002|Overall Study|Adverse Event|1|||
131024883|NCT03201562|471721459|FG000|Overall Study|Lost to Follow-up|0|||
131024884|NCT03201562|471721460|FG001|Overall Study|Lost to Follow-up|1|||
131024885|NCT03201562|471721461|FG002|Overall Study|Lost to Follow-up|2|||
131024886|NCT02556138|471721467|FG000|Overall Study|Withdrawal by Subject|1|||
130687055|NCT05472038|470481334|FG011|Overall Study|Protocol Violation|1|||
130687056|NCT05472038|470481323|FG000|Overall Study|Not vaccinated|0|||
130687057|NCT05472038|470481324|FG001|Overall Study|Not vaccinated|0|||
130687058|NCT05472038|470481325|FG002|Overall Study|Not vaccinated|0|||
130687059|NCT05472038|470481326|FG003|Overall Study|Not vaccinated|1|||
130687060|NCT05472038|470481327|FG004|Overall Study|Not vaccinated|0|||
130687061|NCT05472038|470481328|FG005|Overall Study|Not vaccinated|0|||
130687062|NCT05472038|470481329|FG006|Overall Study|Not vaccinated|0|||
130687063|NCT05472038|470481330|FG007|Overall Study|Not vaccinated|0|||
130687064|NCT05472038|470481331|FG008|Overall Study|Not vaccinated|0|||
130687065|NCT05472038|470481332|FG009|Overall Study|Not vaccinated|0|||
130687066|NCT05472038|470481333|FG010|Overall Study|Not vaccinated|0|||
130687067|NCT05472038|470481334|FG011|Overall Study|Not vaccinated|0|||
131024887|NCT03783026|471723103|FG000|Treatment Phase|Adverse Event|15|||
130893134|NCT01865552|471243186|FG001|Period 1|Pathological lab|0|||
130893135|NCT01865552|471243187|FG002|Period 1|Pathological lab|0|||
130893136|NCT01865552|471243188|FG003|Period 1|Pathological lab|0|||
130893137|NCT01865552|471243189|FG004|Period 1|Pathological lab|1|||
130893138|NCT01865552|471243190|FG005|Period 1|Pathological lab|0|||
130893139|NCT01865552|471243185|FG000|Period 1|Other|0|||
130893140|NCT01865552|471243186|FG001|Period 1|Other|0|||
130893141|NCT01865552|471243187|FG002|Period 1|Other|0|||
130893142|NCT01865552|471243188|FG003|Period 1|Other|0|||
130893143|NCT01865552|471243189|FG004|Period 1|Other|1|||
130893144|NCT01865552|471243190|FG005|Period 1|Other|0|||
130893145|NCT02175199|471243193|FG000|Overall Study|Withdrawal by Subject|1|||
130893146|NCT02175199|471243194|FG001|Overall Study|Withdrawal by Subject|5|||
130893147|NCT02175199|471243193|FG000|Overall Study|Randomized in Error|1|||
130893148|NCT02175199|471243194|FG001|Overall Study|Randomized in Error|0|||
130893149|NCT02175199|471243193|FG000|Overall Study|Sponsor Decision|1|||
131024888|NCT03783026|471723103|FG000|Treatment Phase|Lack of Efficacy|11|||
131024889|NCT03783026|471723103|FG000|Treatment Phase|Withdrawal by Subject|6|||
131024890|NCT03783026|471723103|FG000|Treatment Phase|Lost to Follow-up|2|||
131024891|NCT03783026|471723103|FG000|Treatment Phase|Protocol Deviation|8|||
131024892|NCT03783026|471723103|FG000|Treatment Phase|Did Not Receive Treatment|1|||
131024893|NCT03783026|471723103|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
131024894|NCT01853748|471723104|FG000|Allocation|Withdrawal by Subject|1|||
131024895|NCT01853748|471723105|FG001|Allocation|Withdrawal by Subject|13|||
131024896|NCT01853748|471723104|FG000|Allocation|not sufficient to receive intervention|0|||
131024897|NCT01853748|471723105|FG001|Allocation|not sufficient to receive intervention|1|||
131024898|NCT01853748|471723104|FG000|Follow-Up|Withdrawal by Subject|7|||
131024899|NCT01853748|471723105|FG001|Follow-Up|Withdrawal by Subject|6|||
131024900|NCT01853748|471723104|FG000|Follow-Up|Adverse Event|67|||
131024901|NCT01853748|471723105|FG001|Follow-Up|Adverse Event|7|||
131024902|NCT01853748|471723104|FG000|Follow-Up|not available for data collection|16|||
131024903|NCT01853748|471723105|FG001|Follow-Up|not available for data collection|4|||
131024904|NCT02576509|471723112|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
131024905|NCT02576509|471723113|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
131024906|NCT02576509|471723112|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
131024907|NCT02576509|471723113|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
131024908|NCT02576509|471723112|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
131024909|NCT02576509|471723113|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
131024910|NCT02576509|471723112|FG000|Treatment Period|Disease progression|263|||
131024911|NCT02576509|471723113|FG001|Treatment Period|Disease progression|244|||
131024912|NCT02576509|471723112|FG000|Treatment Period|Study drug toxicity|37|||
131024913|NCT02576509|471723113|FG001|Treatment Period|Study drug toxicity|41|||
131024914|NCT02576509|471723112|FG000|Treatment Period|Death|1|||
131024915|NCT02576509|471723113|FG001|Treatment Period|Death|1|||
131024916|NCT02576509|471723112|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
131024917|NCT02576509|471723113|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
131024918|NCT02576509|471723112|FG000|Treatment Period|Participant request to stop treatment|8|||
131024919|NCT02576509|471723113|FG001|Treatment Period|Participant request to stop treatment|18|||
131024920|NCT02576509|471723112|FG000|Treatment Period|Participant withdrew consent|3|||
131024921|NCT02576509|471723113|FG001|Treatment Period|Participant withdrew consent|7|||
131024922|NCT02576509|471723112|FG000|Treatment Period|Lost to Follow-up|0|||
131024923|NCT02576509|471723113|FG001|Treatment Period|Lost to Follow-up|1|||
131024924|NCT02576509|471723112|FG000|Treatment Period|Maximum clinical benefit|1|||
131024925|NCT02576509|471723113|FG001|Treatment Period|Maximum clinical benefit|0|||
131024926|NCT02576509|471723112|FG000|Treatment Period|Poor/non-compliance|1|||
131024927|NCT02576509|471723113|FG001|Treatment Period|Poor/non-compliance|1|||
131024928|NCT02576509|471723112|FG000|Treatment Period|Participant no longer meets criteria|1|||
131024929|NCT02576509|471723113|FG001|Treatment Period|Participant no longer meets criteria|0|||
131024930|NCT02576509|471723112|FG000|Treatment Period|Other reason|12|||
131024931|NCT02576509|471723113|FG001|Treatment Period|Other reason|8|||
131024932|NCT02576509|471723112|FG000|Treatment Period|NOT REPORTED|1|||
131024933|NCT02576509|471723113|FG001|Treatment Period|NOT REPORTED|0|||
131024934|NCT02576509|471723112|FG000|Treatment Period|Administrative reason by sponsor|0|||
131024935|NCT02576509|471723113|FG001|Treatment Period|Administrative reason by sponsor|1|||
130893150|NCT02175199|471243194|FG001|Overall Study|Sponsor Decision|0|||
130893151|NCT03983317|471243201|FG000|Overall Study|Physician Decision|5|||
130893152|NCT01761162|471243202|FG000|Overall Study|Withdrawal by Subject|3|||
131024936|NCT03725722|471723119|FG000|Overall Study|Lack of Efficacy|2|||
131024937|NCT03725722|471723120|FG001|Overall Study|Lack of Efficacy|1|||
131024938|NCT03725722|471723121|FG002|Overall Study|Lack of Efficacy|2|||
131024939|NCT03725722|471723122|FG003|Overall Study|Lack of Efficacy|0|||
131024940|NCT03725722|471723123|FG004|Overall Study|Lack of Efficacy|2|||
130893153|NCT02741518|471243203|FG000|Overall Study|Withdrawal by Subject|1|||
130893154|NCT02741518|471243204|FG001|Overall Study|Withdrawal by Subject|1|||
130893155|NCT01349049|471243205|FG000|Overall Study|Disease progression|3|||
130893156|NCT01349049|471243206|FG001|Overall Study|Disease progression|5|||
130893157|NCT01349049|471243207|FG002|Overall Study|Disease progression|3|||
131110300|NCT00561951|472034028|FG000|Overall Study|Protocol Violation|4|||
131110301|NCT00561951|472034029|FG001|Overall Study|Protocol Violation|3|||
131110302|NCT00561951|472034030|FG002|Overall Study|Protocol Violation|4|||
131110303|NCT00561951|472034028|FG000|Overall Study|Physician Decision|1|||
131110304|NCT00561951|472034029|FG001|Overall Study|Physician Decision|0|||
131110305|NCT00561951|472034030|FG002|Overall Study|Physician Decision|0|||
131110306|NCT00561951|472034028|FG000|Overall Study|Pregnancy|0|||
131110307|NCT00561951|472034029|FG001|Overall Study|Pregnancy|1|||
131110308|NCT00561951|472034030|FG002|Overall Study|Pregnancy|0|||
131110309|NCT00561951|472034028|FG000|Overall Study|Meet Withdrawal Criterion|0|||
131110310|NCT00561951|472034029|FG001|Overall Study|Meet Withdrawal Criterion|1|||
131110311|NCT00561951|472034030|FG002|Overall Study|Meet Withdrawal Criterion|1|||
131110312|NCT00561951|472034028|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
131110313|NCT00561951|472034029|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
131110314|NCT00561951|472034030|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
131110315|NCT01596621|472034042|FG000|Overall Study|Death|4|||
131110316|NCT01596621|472034042|FG000|Overall Study|Withdrawal by Subject|9|||
131110317|NCT01596621|472034042|FG000|Overall Study|Disease Progression|49|||
131110318|NCT01596621|472034042|FG000|Overall Study|Lost to Follow-up|3|||
131110319|NCT01596621|472034042|FG000|Overall Study|Other than specified|13|||
131110320|NCT00421707|472034051|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
131110321|NCT00421707|472034052|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
131110322|NCT00421707|472034051|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
131110323|NCT00421707|472034052|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
131110324|NCT00421707|472034051|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
131110325|NCT00421707|472034052|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
131110326|NCT00421707|472034051|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
131110327|NCT00421707|472034052|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
131110328|NCT00421707|472034051|FG000|Period 2: Washout|Adverse Event|1|||
131110329|NCT00421707|472034052|FG001|Period 2: Washout|Adverse Event|1|||
131110330|NCT00421707|472034051|FG000|Period 2: Washout|Withdrawal by Subject|0|||
131110331|NCT00421707|472034052|FG001|Period 2: Washout|Withdrawal by Subject|1|||
131110332|NCT00421707|472034051|FG000|Period 2: Washout|Lost to Follow-up|0|||
131110333|NCT00421707|472034052|FG001|Period 2: Washout|Lost to Follow-up|1|||
131110334|NCT00421707|472034051|FG000|Period 2: Washout|Other: Pregnancy|0|||
131110335|NCT00421707|472034052|FG001|Period 2: Washout|Other: Pregnancy|1|||
131110336|NCT00421707|472034051|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
131110337|NCT00421707|472034052|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
131110338|NCT00421707|472034051|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
131110339|NCT00421707|472034052|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
131110340|NCT00421707|472034051|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
131110341|NCT00421707|472034052|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
131110342|NCT03261700|472034053|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
131110343|NCT03261700|472034054|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
131110344|NCT01723254|472034055|FG000|Overall Study|Conflict with work schedule|0|||
130687068|NCT02847650|470481339|FG000|Overall Study|Adverse Event|2|||
130687069|NCT02847650|470481340|FG001|Overall Study|Adverse Event|4|||
130687070|NCT02847650|470481339|FG000|Overall Study|Lost to Follow-up|1|||
130687071|NCT02847650|470481340|FG001|Overall Study|Lost to Follow-up|0|||
130687072|NCT02847650|470481339|FG000|Overall Study|Protocol Violation|0|||
130687073|NCT02847650|470481340|FG001|Overall Study|Protocol Violation|1|||
130687074|NCT02847650|470481339|FG000|Overall Study|Withdrawal by Subject|1|||
130687075|NCT02847650|470481340|FG001|Overall Study|Withdrawal by Subject|1|||
130687076|NCT00834249|470481345|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130687077|NCT00834249|470481346|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
131110345|NCT01723254|472034056|FG001|Overall Study|Conflict with work schedule|0|||
131110346|NCT01723254|472034057|FG002|Overall Study|Conflict with work schedule|0|||
130687078|NCT00834249|470481345|FG000|Second Intervention|Adverse Event|1|||
130687079|NCT00834249|470481346|FG001|Second Intervention|Adverse Event|0|||
130687080|NCT01111461|470481347|FG000|Overall Study|Adverse Event|32|||
130687081|NCT01111461|470481347|FG000|Overall Study|Participant choice|11|||
130687082|NCT01111461|470481347|FG000|Overall Study|Lost to Follow-up|1|||
130687083|NCT01111461|470481347|FG000|Overall Study|Withdrawal by Subject|1|||
130687084|NCT01111461|470481347|FG000|Overall Study|Other|6|||
130687085|NCT00834067|470481350|FG000|Washout of 21 Days|Protocol Violation|0|||
130687086|NCT00834067|470481351|FG001|Washout of 21 Days|Protocol Violation|1|||
131110347|NCT01723254|472034058|FG003|Overall Study|Conflict with work schedule|0|||
131110348|NCT01723254|472034059|FG004|Overall Study|Conflict with work schedule|0|||
131110349|NCT01723254|472034060|FG005|Overall Study|Conflict with work schedule|0|||
131110350|NCT01723254|472034061|FG006|Overall Study|Conflict with work schedule|0|||
131110351|NCT01723254|472034062|FG007|Overall Study|Conflict with work schedule|1|||
131110352|NCT01723254|472034055|FG000|Overall Study|Personal issues|0|||
131110353|NCT01723254|472034056|FG001|Overall Study|Personal issues|0|||
131110354|NCT01723254|472034057|FG002|Overall Study|Personal issues|0|||
130687087|NCT01015703|470481354|FG000|Overall Study|Withdrawal by Subject|0|||
130893158|NCT01349049|471243208|FG003|Overall Study|Disease progression|2|||
130893159|NCT01349049|471243209|FG004|Overall Study|Disease progression|2|||
131024941|NCT03725722|471723119|FG000|Overall Study|Adverse Event|2|||
131024942|NCT03725722|471723120|FG001|Overall Study|Adverse Event|2|||
131024943|NCT03725722|471723121|FG002|Overall Study|Adverse Event|1|||
131024944|NCT03725722|471723122|FG003|Overall Study|Adverse Event|0|||
131024945|NCT03725722|471723123|FG004|Overall Study|Adverse Event|6|||
131024946|NCT03725722|471723119|FG000|Overall Study|Withdrawal by Subject|4|||
131024947|NCT03725722|471723120|FG001|Overall Study|Withdrawal by Subject|1|||
131024948|NCT03725722|471723121|FG002|Overall Study|Withdrawal by Subject|0|||
131024949|NCT03725722|471723122|FG003|Overall Study|Withdrawal by Subject|4|||
131024950|NCT03725722|471723123|FG004|Overall Study|Withdrawal by Subject|4|||
131024951|NCT03725722|471723119|FG000|Overall Study|Lost to Follow-up|3|||
131024952|NCT03725722|471723120|FG001|Overall Study|Lost to Follow-up|1|||
131024953|NCT03725722|471723121|FG002|Overall Study|Lost to Follow-up|2|||
131024954|NCT03725722|471723122|FG003|Overall Study|Lost to Follow-up|2|||
131024955|NCT03725722|471723123|FG004|Overall Study|Lost to Follow-up|1|||
131024956|NCT03725722|471723119|FG000|Overall Study|Personal reasons|0|||
131024957|NCT03725722|471723120|FG001|Overall Study|Personal reasons|0|||
131024958|NCT03725722|471723121|FG002|Overall Study|Personal reasons|1|||
131024959|NCT03725722|471723122|FG003|Overall Study|Personal reasons|0|||
131024960|NCT03725722|471723123|FG004|Overall Study|Personal reasons|1|||
131024961|NCT03725722|471723119|FG000|Overall Study|COVID-19 situation|0|||
131024962|NCT03725722|471723120|FG001|Overall Study|COVID-19 situation|1|||
131024963|NCT03725722|471723121|FG002|Overall Study|COVID-19 situation|0|||
131024964|NCT03725722|471723122|FG003|Overall Study|COVID-19 situation|0|||
131024965|NCT03725722|471723123|FG004|Overall Study|COVID-19 situation|0|||
131024966|NCT05505045|471723124|FG000|Overall Study|Withdrawal by Subject|2|||
130893160|NCT01349049|471243210|FG005|Overall Study|Disease progression|2|||
130893161|NCT01349049|471243211|FG006|Overall Study|Disease progression|3|||
130893162|NCT01349049|471243212|FG007|Overall Study|Disease progression|2|||
130893163|NCT01349049|471243213|FG008|Overall Study|Disease progression|33|||
130893164|NCT01349049|471243205|FG000|Overall Study|Adverse Event|0|||
130893165|NCT01349049|471243206|FG001|Overall Study|Adverse Event|1|||
130893166|NCT01349049|471243207|FG002|Overall Study|Adverse Event|0|||
130893167|NCT01349049|471243208|FG003|Overall Study|Adverse Event|0|||
130893168|NCT01349049|471243209|FG004|Overall Study|Adverse Event|0|||
131024967|NCT05505045|471723125|FG001|Overall Study|Withdrawal by Subject|1|||
131024968|NCT01643070|471723126|FG000|Overall Study|Withdrawal by Subject|3|||
131024969|NCT01643070|471723127|FG001|Overall Study|Withdrawal by Subject|1|||
131024970|NCT01643070|471723126|FG000|Overall Study|Death|1|||
131024971|NCT01643070|471723127|FG001|Overall Study|Death|0|||
131024972|NCT01643070|471723126|FG000|Overall Study|Pregressive disease|0|||
131024973|NCT01643070|471723127|FG001|Overall Study|Pregressive disease|2|||
131024974|NCT02791230|471723128|FG000|Overall Study|Adverse Event|10|||
131024975|NCT02791230|471723129|FG001|Overall Study|Adverse Event|9|||
131024976|NCT02791230|471723130|FG002|Overall Study|Adverse Event|66|||
131024977|NCT02791230|471723128|FG000|Overall Study|Death|38|||
131024978|NCT02791230|471723129|FG001|Overall Study|Death|25|||
131024979|NCT02791230|471723130|FG002|Overall Study|Death|184|||
131024980|NCT02791230|471723128|FG000|Overall Study|Lack of Efficacy|1|||
131024981|NCT02791230|471723129|FG001|Overall Study|Lack of Efficacy|0|||
131024982|NCT02791230|471723130|FG002|Overall Study|Lack of Efficacy|3|||
131024983|NCT02791230|471723128|FG000|Overall Study|Lost to Follow-up|0|||
131024984|NCT02791230|471723129|FG001|Overall Study|Lost to Follow-up|0|||
131024985|NCT02791230|471723130|FG002|Overall Study|Lost to Follow-up|10|||
131024986|NCT02791230|471723128|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
131024987|NCT02791230|471723129|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
131024988|NCT02791230|471723130|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
131024989|NCT02791230|471723128|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
131024990|NCT02791230|471723129|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
131024991|NCT02791230|471723130|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
131024992|NCT02791230|471723128|FG000|Overall Study|Study sites terminated by sponsor|1|||
131024993|NCT02791230|471723129|FG001|Overall Study|Study sites terminated by sponsor|0|||
131024994|NCT02791230|471723130|FG002|Overall Study|Study sites terminated by sponsor|5|||
131024995|NCT02791230|471723128|FG000|Overall Study|Other|9|||
131024996|NCT02791230|471723129|FG001|Overall Study|Other|1|||
131110355|NCT01723254|472034058|FG003|Overall Study|Personal issues|0|||
131024997|NCT02791230|471723130|FG002|Overall Study|Other|28|||
131024998|NCT02791230|471723128|FG000|Overall Study|Protocol Violation|0|||
131024999|NCT02791230|471723129|FG001|Overall Study|Protocol Violation|0|||
131025000|NCT02791230|471723130|FG002|Overall Study|Protocol Violation|4|||
131025001|NCT02791230|471723128|FG000|Overall Study|Withdrawal by Subject|24|||
131025002|NCT02791230|471723129|FG001|Overall Study|Withdrawal by Subject|13|||
131025003|NCT02791230|471723130|FG002|Overall Study|Withdrawal by Subject|172|||
131110356|NCT01723254|472034059|FG004|Overall Study|Personal issues|0|||
130893169|NCT01349049|471243210|FG005|Overall Study|Adverse Event|3|||
131025004|NCT02791230|471723128|FG000|Overall Study|Enrolled but not treated|0|||
131025005|NCT02791230|471723129|FG001|Overall Study|Enrolled but not treated|0|||
130893170|NCT01349049|471243211|FG006|Overall Study|Adverse Event|1|||
130893171|NCT01349049|471243212|FG007|Overall Study|Adverse Event|0|||
130893172|NCT01349049|471243213|FG008|Overall Study|Adverse Event|4|||
130893173|NCT01349049|471243205|FG000|Overall Study|Physician Decision|0|||
130893174|NCT01349049|471243206|FG001|Overall Study|Physician Decision|1|||
130893175|NCT01349049|471243207|FG002|Overall Study|Physician Decision|0|||
130893176|NCT01349049|471243208|FG003|Overall Study|Physician Decision|0|||
130893177|NCT01349049|471243209|FG004|Overall Study|Physician Decision|0|||
130893178|NCT01349049|471243210|FG005|Overall Study|Physician Decision|0|||
130893179|NCT01349049|471243211|FG006|Overall Study|Physician Decision|0|||
130893180|NCT01349049|471243212|FG007|Overall Study|Physician Decision|0|||
130893181|NCT01349049|471243213|FG008|Overall Study|Physician Decision|2|||
130893182|NCT01349049|471243205|FG000|Overall Study|Protocol Violation|0|||
130893183|NCT01349049|471243206|FG001|Overall Study|Protocol Violation|0|||
130893184|NCT01349049|471243207|FG002|Overall Study|Protocol Violation|0|||
130893185|NCT01349049|471243208|FG003|Overall Study|Protocol Violation|0|||
130893186|NCT01349049|471243209|FG004|Overall Study|Protocol Violation|0|||
130893187|NCT01349049|471243210|FG005|Overall Study|Protocol Violation|0|||
130893188|NCT01349049|471243211|FG006|Overall Study|Protocol Violation|0|||
130893189|NCT01349049|471243212|FG007|Overall Study|Protocol Violation|0|||
130893190|NCT01349049|471243213|FG008|Overall Study|Protocol Violation|1|||
130893191|NCT01349049|471243205|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
130893192|NCT01349049|471243206|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
130893193|NCT01349049|471243207|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
130893194|NCT01349049|471243208|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
130893195|NCT01349049|471243209|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
131110357|NCT01723254|472034060|FG005|Overall Study|Personal issues|1|||
131110358|NCT01723254|472034061|FG006|Overall Study|Personal issues|0|||
131110359|NCT01723254|472034062|FG007|Overall Study|Personal issues|0|||
131110360|NCT01723254|472034055|FG000|Overall Study|No longer have time to participate|0|||
131110361|NCT01723254|472034056|FG001|Overall Study|No longer have time to participate|0|||
131110362|NCT01723254|472034057|FG002|Overall Study|No longer have time to participate|0|||
131110363|NCT01723254|472034058|FG003|Overall Study|No longer have time to participate|1|||
131110364|NCT01723254|472034059|FG004|Overall Study|No longer have time to participate|0|||
131110365|NCT01723254|472034060|FG005|Overall Study|No longer have time to participate|0|||
131110366|NCT01723254|472034061|FG006|Overall Study|No longer have time to participate|0|||
131110367|NCT01723254|472034062|FG007|Overall Study|No longer have time to participate|0|||
131110368|NCT01723254|472034055|FG000|Overall Study|Move/Left to another country/city|0|||
131110369|NCT01723254|472034056|FG001|Overall Study|Move/Left to another country/city|0|||
131110370|NCT01723254|472034057|FG002|Overall Study|Move/Left to another country/city|2|||
131110371|NCT01723254|472034058|FG003|Overall Study|Move/Left to another country/city|1|||
131110372|NCT01723254|472034059|FG004|Overall Study|Move/Left to another country/city|1|||
131110373|NCT01723254|472034060|FG005|Overall Study|Move/Left to another country/city|0|||
131110374|NCT01723254|472034061|FG006|Overall Study|Move/Left to another country/city|0|||
131110375|NCT01723254|472034062|FG007|Overall Study|Move/Left to another country/city|0|||
131110376|NCT01723254|472034055|FG000|Overall Study|Protocol Violation|0|||
131110377|NCT01723254|472034056|FG001|Overall Study|Protocol Violation|1|||
131110378|NCT01723254|472034057|FG002|Overall Study|Protocol Violation|0|||
131110379|NCT01723254|472034058|FG003|Overall Study|Protocol Violation|0|||
131110380|NCT01723254|472034059|FG004|Overall Study|Protocol Violation|0|||
131110381|NCT01723254|472034060|FG005|Overall Study|Protocol Violation|0|||
131110382|NCT01723254|472034061|FG006|Overall Study|Protocol Violation|0|||
131110383|NCT01723254|472034062|FG007|Overall Study|Protocol Violation|0|||
131110384|NCT01723254|472034055|FG000|Overall Study|Withdrawal by Subject|1|||
131110385|NCT01723254|472034056|FG001|Overall Study|Withdrawal by Subject|2|||
131110386|NCT01723254|472034057|FG002|Overall Study|Withdrawal by Subject|1|||
131110387|NCT01723254|472034058|FG003|Overall Study|Withdrawal by Subject|0|||
131110388|NCT01723254|472034059|FG004|Overall Study|Withdrawal by Subject|1|||
131110389|NCT01723254|472034060|FG005|Overall Study|Withdrawal by Subject|1|||
130893196|NCT01349049|471243210|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
130893197|NCT01349049|471243211|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
130893198|NCT01349049|471243212|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
130893199|NCT01349049|471243213|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
130893200|NCT01349049|471243205|FG000|Overall Study|Other|0|||
131110390|NCT01723254|472034061|FG006|Overall Study|Withdrawal by Subject|1|||
131110391|NCT01723254|472034062|FG007|Overall Study|Withdrawal by Subject|2|||
131110392|NCT01074216|472034063|FG000|Overall Study|Physician Decision|1|||
131110393|NCT01074216|472034063|FG000|Overall Study|Not Treated|12|||
131110394|NCT01145755|472034064|FG000|Overall Study|Adverse Event|2|||
131110395|NCT01145755|472034065|FG001|Overall Study|Adverse Event|4|||
131110396|NCT01145755|472034066|FG002|Overall Study|Adverse Event|2|||
131110397|NCT01145755|472034064|FG000|Overall Study|Withdrawal by Subject|2|||
131110398|NCT01145755|472034065|FG001|Overall Study|Withdrawal by Subject|2|||
130893201|NCT01349049|471243206|FG001|Overall Study|Other|0|||
130893202|NCT01349049|471243207|FG002|Overall Study|Other|0|||
130893203|NCT01349049|471243208|FG003|Overall Study|Other|0|||
131110399|NCT01145755|472034066|FG002|Overall Study|Withdrawal by Subject|2|||
130687088|NCT01015703|470481355|FG001|Overall Study|Withdrawal by Subject|1|||
130687089|NCT01015703|470481356|FG002|Overall Study|Withdrawal by Subject|0|||
130687090|NCT01015703|470481357|FG003|Overall Study|Withdrawal by Subject|0|||
130687091|NCT01015703|470481358|FG004|Overall Study|Withdrawal by Subject|0|||
130687092|NCT01015703|470481354|FG000|Overall Study|Adverse Event|1|||
130687093|NCT01015703|470481355|FG001|Overall Study|Adverse Event|0|||
130687094|NCT01015703|470481356|FG002|Overall Study|Adverse Event|0|||
130893204|NCT01349049|471243209|FG004|Overall Study|Other|0|||
130893205|NCT01349049|471243210|FG005|Overall Study|Other|1|||
130893206|NCT01349049|471243211|FG006|Overall Study|Other|0|||
131025006|NCT02791230|471723130|FG002|Overall Study|Enrolled but not treated|5|||
131025007|NCT04201834|471723132|FG000|Overall Study|Screen fail|1|||
131025008|NCT04310735|471723140|FG000|Overall Study|Withdrawal by Subject|1|||
131025009|NCT04310735|471723141|FG001|Overall Study|Withdrawal by Subject|3|||
131025010|NCT04310735|471723142|FG002|Overall Study|Withdrawal by Subject|8|||
131025011|NCT04310735|471723140|FG000|Overall Study|Equipment malfunction|0|||
131025012|NCT04310735|471723141|FG001|Overall Study|Equipment malfunction|1|||
131025013|NCT04310735|471723142|FG002|Overall Study|Equipment malfunction|0|||
131025014|NCT04104321|471723143|FG000|Overall Study|didn't take the study drug|3|||
131025015|NCT03481777|471723144|FG000|Overall Study|Withdrawal by Subject|36|||
131025016|NCT03481777|471723145|FG001|Overall Study|Withdrawal by Subject|31|||
131025017|NCT03481777|471723144|FG000|Overall Study|Non stroke = non target population|277|||
131025018|NCT03481777|471723145|FG001|Overall Study|Non stroke = non target population|254|||
131025019|NCT04038957|471723148|FG000|Overall Study|Withdrawal by Subject|1|||
131025020|NCT04038957|471723148|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
131025021|NCT01998984|471723153|FG000|Overall Study|Adverse Event|0|||
131025022|NCT01998984|471723154|FG001|Overall Study|Adverse Event|0|||
131025023|NCT01998984|471723155|FG002|Overall Study|Adverse Event|0|||
131025024|NCT01998984|471723156|FG003|Overall Study|Adverse Event|1|||
131025025|NCT01998984|471723153|FG000|Overall Study|Lost to Follow-up|0|||
131025026|NCT01998984|471723154|FG001|Overall Study|Lost to Follow-up|1|||
131025027|NCT01998984|471723155|FG002|Overall Study|Lost to Follow-up|0|||
131025028|NCT01998984|471723156|FG003|Overall Study|Lost to Follow-up|1|||
131025029|NCT01998984|471723153|FG000|Overall Study|Withdrawal by Subject|0|||
131025030|NCT01998984|471723154|FG001|Overall Study|Withdrawal by Subject|0|||
131025031|NCT01998984|471723155|FG002|Overall Study|Withdrawal by Subject|1|||
131025032|NCT01998984|471723156|FG003|Overall Study|Withdrawal by Subject|0|||
131025033|NCT01998984|471723153|FG000|Overall Study|Other|0|||
131025034|NCT01998984|471723154|FG001|Overall Study|Other|0|||
131025035|NCT01998984|471723155|FG002|Overall Study|Other|0|||
131025036|NCT01998984|471723156|FG003|Overall Study|Other|1|||
131025037|NCT01843374|471723158|FG000|Overall Study|Death|155|||
131025038|NCT01843374|471723159|FG001|Overall Study|Death|313|||
131025039|NCT01843374|471723158|FG000|Overall Study|Withdrawal by Subject|14|||
131025040|NCT01843374|471723159|FG001|Overall Study|Withdrawal by Subject|20|||
131025041|NCT01843374|471723158|FG000|Overall Study|Withdrawing due to Other reason|20|||
131025042|NCT01843374|471723159|FG001|Overall Study|Withdrawing due to Other reason|46|||
131025043|NCT03397108|471723160|FG000|Overall Study|Lost to Follow-up|15|||
131025044|NCT03397108|471723161|FG001|Overall Study|Lost to Follow-up|0|||
131025045|NCT03397108|471723160|FG000|Overall Study|Insufficient milk production|3|||
131025046|NCT03397108|471723161|FG001|Overall Study|Insufficient milk production|2|||
131025047|NCT03397108|471723160|FG000|Overall Study|Withdrawal by Subject|2|||
131025048|NCT03397108|471723161|FG001|Overall Study|Withdrawal by Subject|0|||
131025049|NCT03554265|471723162|FG000|Overall Study|Withdrawal by Subject|2|||
131025050|NCT03554265|471723163|FG001|Overall Study|Withdrawal by Subject|2|||
131025051|NCT03554265|471723164|FG002|Overall Study|Withdrawal by Subject|3|||
131025052|NCT03554265|471723162|FG000|Overall Study|Physician Decision|0|||
131025053|NCT03554265|471723163|FG001|Overall Study|Physician Decision|0|||
131025054|NCT03554265|471723164|FG002|Overall Study|Physician Decision|1|||
131025055|NCT05386238|471723165|FG000|Overall Study|Lost to Follow-up|3|||
131025056|NCT05386238|471723166|FG001|Overall Study|Lost to Follow-up|2|||
131025057|NCT05386238|471723165|FG000|Overall Study|Withdrawal by Subject|0|||
131025058|NCT05386238|471723166|FG001|Overall Study|Withdrawal by Subject|1|||
131025059|NCT04714320|471723168|FG000|Overall Study|Voluntary Withdrawal|4|||
131025060|NCT04714320|471723169|FG001|Overall Study|Voluntary Withdrawal|1|||
131025061|NCT04714320|471723170|FG002|Overall Study|Voluntary Withdrawal|2|||
131025062|NCT04714320|471723168|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
131025063|NCT04714320|471723169|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
131025064|NCT04714320|471723170|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
131025065|NCT04714320|471723168|FG000|Overall Study|Reason Not Specified|1|||
131025066|NCT04714320|471723169|FG001|Overall Study|Reason Not Specified|3|||
131025067|NCT04714320|471723170|FG002|Overall Study|Reason Not Specified|3|||
131025068|NCT05672667|471723171|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
130687095|NCT01015703|470481357|FG003|Overall Study|Adverse Event|0|||
131025069|NCT00505934|471723172|FG000|Overall Study|Adverse Event|1|||
130893207|NCT01349049|471243212|FG007|Overall Study|Other|0|||
131110400|NCT01145755|472034064|FG000|Overall Study|Lost to Follow-up|2|||
131110401|NCT01145755|472034065|FG001|Overall Study|Lost to Follow-up|3|||
131110402|NCT01145755|472034066|FG002|Overall Study|Lost to Follow-up|1|||
131110403|NCT01145755|472034064|FG000|Overall Study|Protocol Violation|0|||
131110404|NCT01145755|472034065|FG001|Overall Study|Protocol Violation|3|||
131110405|NCT01145755|472034066|FG002|Overall Study|Protocol Violation|1|||
131110406|NCT01145755|472034064|FG000|Overall Study|Study Closure|14|||
131110407|NCT01145755|472034065|FG001|Overall Study|Study Closure|14|||
131110408|NCT01145755|472034066|FG002|Overall Study|Study Closure|17|||
131110409|NCT01145755|472034064|FG000|Overall Study|Lack of Efficacy|0|||
131110410|NCT01145755|472034065|FG001|Overall Study|Lack of Efficacy|1|||
131110411|NCT01145755|472034066|FG002|Overall Study|Lack of Efficacy|0|||
131110412|NCT01145755|472034064|FG000|Overall Study|Patient could not swollow medication|0|||
131110413|NCT01145755|472034065|FG001|Overall Study|Patient could not swollow medication|0|||
131110414|NCT01145755|472034066|FG002|Overall Study|Patient could not swollow medication|1|||
131110415|NCT01145755|472034064|FG000|Overall Study|Withdrawal by Subject|0|||
131110416|NCT01145755|472034065|FG001|Overall Study|Withdrawal by Subject|0|||
131110417|NCT01145755|472034066|FG002|Overall Study|Withdrawal by Subject|1|||
131110418|NCT01145755|472034064|FG000|Overall Study|Positive urine ethanol|0|||
131110419|NCT01145755|472034065|FG001|Overall Study|Positive urine ethanol|1|||
131110420|NCT01145755|472034066|FG002|Overall Study|Positive urine ethanol|0|||
131110421|NCT00753272|472034076|FG000|Overall Study|Adverse Event|878|||
131110422|NCT00753272|472034077|FG001|Overall Study|Adverse Event|869|||
131110423|NCT00753272|472034076|FG000|Overall Study|Protocol Violation|28|||
131110424|NCT00753272|472034077|FG001|Overall Study|Protocol Violation|46|||
131110425|NCT00753272|472034076|FG000|Overall Study|Withdrawal by Subject|2481|||
131110426|NCT00753272|472034077|FG001|Overall Study|Withdrawal by Subject|2407|||
131110427|NCT00753272|472034076|FG000|Overall Study|Lost to Follow-up|491|||
131110428|NCT00753272|472034077|FG001|Overall Study|Lost to Follow-up|497|||
131110429|NCT00753272|472034076|FG000|Overall Study|Other|1104|||
131110430|NCT00753272|472034077|FG001|Overall Study|Other|1088|||
131110431|NCT04223856|472034080|FG000|Overall Study|Progressive disease|153|||
131110432|NCT04223856|472034081|FG001|Overall Study|Progressive disease|73|||
131110433|NCT04223856|472034080|FG000|Overall Study|Adverse Event|97|||
131110434|NCT04223856|472034081|FG001|Overall Study|Adverse Event|62|||
131110435|NCT04223856|472034080|FG000|Overall Study|Physician Decision|9|||
131110436|NCT04223856|472034081|FG001|Overall Study|Physician Decision|28|||
131110437|NCT04223856|472034080|FG000|Overall Study|Withdrawal by Subject|22|||
131110438|NCT04223856|472034081|FG001|Overall Study|Withdrawal by Subject|24|||
131110439|NCT04223856|472034080|FG000|Overall Study|Other|7|||
131110440|NCT04223856|472034081|FG001|Overall Study|Other|2|||
131110441|NCT04223856|472034080|FG000|Overall Study|Randomized but not treated|2|||
131110442|NCT04223856|472034081|FG001|Overall Study|Randomized but not treated|11|||
131110443|NCT04223856|472034080|FG000|Overall Study|On-treatment|144|||
131110444|NCT04223856|472034081|FG001|Overall Study|On-treatment|0|||
130893208|NCT01349049|471243213|FG008|Overall Study|Other|4|||
130893209|NCT01349049|471243205|FG000|Overall Study|Death|0|||
130893210|NCT01349049|471243206|FG001|Overall Study|Death|0|||
130893211|NCT01349049|471243207|FG002|Overall Study|Death|0|||
130893212|NCT01349049|471243208|FG003|Overall Study|Death|0|||
130893213|NCT01349049|471243209|FG004|Overall Study|Death|0|||
130893214|NCT01349049|471243210|FG005|Overall Study|Death|0|||
131110445|NCT03226275|472034082|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
131110446|NCT03226275|472034083|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
131110447|NCT03226275|472034084|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
131110448|NCT03226275|472034085|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
131110449|NCT03226275|472034082|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
131110450|NCT03226275|472034083|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
131110451|NCT03226275|472034084|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
131110452|NCT03226275|472034085|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
131110453|NCT02382016|472035623|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
131110454|NCT02382016|472035624|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
131110455|NCT02382016|472035623|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
130767086|NCT02117713|470770727|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
130893215|NCT01349049|471243211|FG006|Overall Study|Death|0|||
130893216|NCT01349049|471243212|FG007|Overall Study|Death|1|||
130893217|NCT01349049|471243213|FG008|Overall Study|Death|5|||
131110456|NCT02382016|472035624|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
131110457|NCT02382016|472035623|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
131110458|NCT02382016|472035624|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
131110459|NCT02382016|472035623|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
131110460|NCT02382016|472035624|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
131110461|NCT02382016|472035623|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
130893218|NCT01349049|471243205|FG000|Overall Study|Non-compliance|0|||
130893219|NCT01349049|471243206|FG001|Overall Study|Non-compliance|0|||
130893220|NCT01349049|471243207|FG002|Overall Study|Non-compliance|0|||
130893221|NCT01349049|471243208|FG003|Overall Study|Non-compliance|1|||
130893222|NCT01349049|471243209|FG004|Overall Study|Non-compliance|0|||
130893223|NCT01349049|471243210|FG005|Overall Study|Non-compliance|0|||
130893224|NCT01349049|471243211|FG006|Overall Study|Non-compliance|0|||
130893225|NCT01349049|471243212|FG007|Overall Study|Non-compliance|0|||
130893226|NCT01349049|471243213|FG008|Overall Study|Non-compliance|0|||
130893227|NCT01349049|471243205|FG000|Overall Study|Withdrawal by Subject|0|||
130893228|NCT01349049|471243206|FG001|Overall Study|Withdrawal by Subject|0|||
130893229|NCT01349049|471243207|FG002|Overall Study|Withdrawal by Subject|0|||
130893230|NCT01349049|471243208|FG003|Overall Study|Withdrawal by Subject|0|||
130893231|NCT01349049|471243209|FG004|Overall Study|Withdrawal by Subject|0|||
130893232|NCT01349049|471243210|FG005|Overall Study|Withdrawal by Subject|0|||
130893233|NCT01349049|471243211|FG006|Overall Study|Withdrawal by Subject|0|||
130893234|NCT01349049|471243212|FG007|Overall Study|Withdrawal by Subject|0|||
130893235|NCT01349049|471243213|FG008|Overall Study|Withdrawal by Subject|6|||
130893236|NCT04681352|471243220|FG000|Overall Study|Lost to Follow-up|2|||
130893237|NCT04681352|471243220|FG000|Overall Study|Withdrawal by Subject|22|||
131025070|NCT00505934|471723172|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
131025071|NCT00505934|471723172|FG000|Overall Study|Other: IV dose needed to be changed|1|||
131110462|NCT02382016|472035624|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
131110463|NCT02382016|472035623|FG000|Open-label (OL) Treatment Period|Death|4|||
131110464|NCT02382016|472035624|FG001|Open-label (OL) Treatment Period|Death|0|||
131110465|NCT02382016|472035623|FG000|OL Extension Period|Physician Decision|3|||
130893238|NCT01643772|471243221|FG000|Overall Study|Protocol Violation|0|||
131025072|NCT03050814|471723173|FG000|Overall Study|Screen failures|0|||
131025073|NCT03050814|471723174|FG001|Overall Study|Screen failures|0|||
131025074|NCT03050814|471723175|FG002|Overall Study|Screen failures|4|||
131025075|NCT05137236|471723179|FG000|Part A|Other than Specified|1|||
131025076|NCT05137236|471723180|FG001|Part A|Other than Specified|0|||
131025077|NCT05137236|471723181|FG002|Part A|Other than Specified|0|||
131025078|NCT05137236|471723182|FG003|Part A|Other than Specified|0|||
131025079|NCT05137236|471723183|FG004|Part A|Other than Specified|0|||
131025080|NCT05137236|471723184|FG005|Part A|Other than Specified|0|||
131025081|NCT05137236|471723185|FG006|Part A|Other than Specified|0|||
131025082|NCT05137236|471723186|FG007|Part A|Other than Specified|0|||
131025083|NCT05137236|471723179|FG000|Part A|Withdrawal by Subject|0|||
131025084|NCT05137236|471723180|FG001|Part A|Withdrawal by Subject|4|||
131025085|NCT05137236|471723181|FG002|Part A|Withdrawal by Subject|1|||
131025086|NCT05137236|471723182|FG003|Part A|Withdrawal by Subject|1|||
131025087|NCT05137236|471723183|FG004|Part A|Withdrawal by Subject|3|||
131025088|NCT05137236|471723184|FG005|Part A|Withdrawal by Subject|2|||
131025089|NCT05137236|471723185|FG006|Part A|Withdrawal by Subject|0|||
131025090|NCT05137236|471723186|FG007|Part A|Withdrawal by Subject|0|||
131025091|NCT05137236|471723179|FG000|Part A|Lost to Follow-up|5|||
131025092|NCT05137236|471723180|FG001|Part A|Lost to Follow-up|7|||
131025093|NCT05137236|471723181|FG002|Part A|Lost to Follow-up|1|||
131025094|NCT05137236|471723182|FG003|Part A|Lost to Follow-up|3|||
131025095|NCT05137236|471723183|FG004|Part A|Lost to Follow-up|3|||
131025096|NCT05137236|471723184|FG005|Part A|Lost to Follow-up|8|||
131025097|NCT05137236|471723185|FG006|Part A|Lost to Follow-up|0|||
131025098|NCT05137236|471723186|FG007|Part A|Lost to Follow-up|0|||
131025099|NCT05137236|471723179|FG000|Part B|Withdrawal by Subject|0|||
131025100|NCT05137236|471723180|FG001|Part B|Withdrawal by Subject|0|||
131025101|NCT05137236|471723181|FG002|Part B|Withdrawal by Subject|0|||
131025102|NCT05137236|471723182|FG003|Part B|Withdrawal by Subject|0|||
131025103|NCT05137236|471723183|FG004|Part B|Withdrawal by Subject|0|||
131025104|NCT05137236|471723184|FG005|Part B|Withdrawal by Subject|0|||
131025105|NCT05137236|471723185|FG006|Part B|Withdrawal by Subject|0|||
131025106|NCT05137236|471723186|FG007|Part B|Withdrawal by Subject|2|||
131025107|NCT05137236|471723179|FG000|Part B|Lost to Follow-up|0|||
131025108|NCT05137236|471723180|FG001|Part B|Lost to Follow-up|0|||
131025109|NCT05137236|471723181|FG002|Part B|Lost to Follow-up|0|||
131025110|NCT05137236|471723182|FG003|Part B|Lost to Follow-up|0|||
131025111|NCT05137236|471723183|FG004|Part B|Lost to Follow-up|0|||
130893239|NCT01643772|471243222|FG001|Overall Study|Protocol Violation|0|||
130893240|NCT01643772|471243223|FG002|Overall Study|Protocol Violation|0|||
130893241|NCT01643772|471243224|FG003|Overall Study|Protocol Violation|1|||
131025112|NCT05137236|471723184|FG005|Part B|Lost to Follow-up|0|||
131025113|NCT05137236|471723185|FG006|Part B|Lost to Follow-up|5|||
131025114|NCT05137236|471723186|FG007|Part B|Lost to Follow-up|5|||
131229465|NCT04136626|472465929|FG000|Treatment Phase|Withdrawal by Subject|1|||
130893242|NCT01643772|471243221|FG000|Overall Study|Adverse Event|0|||
131025115|NCT05137236|471723179|FG000|Part B|Death|0|||
131025116|NCT05137236|471723180|FG001|Part B|Death|0|||
131025117|NCT05137236|471723181|FG002|Part B|Death|0|||
131025118|NCT05137236|471723182|FG003|Part B|Death|0|||
131025119|NCT05137236|471723183|FG004|Part B|Death|0|||
131025120|NCT05137236|471723184|FG005|Part B|Death|0|||
131025121|NCT05137236|471723185|FG006|Part B|Death|0|||
131025122|NCT05137236|471723186|FG007|Part B|Death|2|||
131025123|NCT02121002|471723195|FG000|Overall Study|Physician Decision|2|||
131110466|NCT02382016|472035624|FG001|OL Extension Period|Physician Decision|0|||
131110467|NCT02382016|472035623|FG000|OL Extension Period|Death|2|||
131110468|NCT02382016|472035624|FG001|OL Extension Period|Death|0|||
131110469|NCT02382016|472035623|FG000|OL Extension Period|Withdrawal by Subject|1|||
131110470|NCT02382016|472035624|FG001|OL Extension Period|Withdrawal by Subject|0|||
131110471|NCT00084266|472035625|FG000|Overall Study|Death|42|||
131110472|NCT00084266|472035626|FG001|Overall Study|Death|39|||
131110473|NCT00084266|472035625|FG000|Overall Study|Adverse Event|8|||
131110474|NCT00084266|472035626|FG001|Overall Study|Adverse Event|5|||
131110475|NCT00084266|472035625|FG000|Overall Study|Lack of Efficacy|2|||
131110476|NCT00084266|472035626|FG001|Overall Study|Lack of Efficacy|4|||
131110477|NCT00084266|472035625|FG000|Overall Study|Lost to Follow-up|5|||
131110478|NCT00084266|472035626|FG001|Overall Study|Lost to Follow-up|3|||
131110479|NCT00084266|472035625|FG000|Overall Study|Participant not willing to participate|3|||
131110480|NCT00084266|472035626|FG001|Overall Study|Participant not willing to participate|8|||
131110481|NCT00084266|472035625|FG000|Overall Study|Other|360|||
131110482|NCT00084266|472035626|FG001|Overall Study|Other|344|||
131110483|NCT00084266|472035625|FG000|Overall Study|Randomized not treated|21|||
131110484|NCT00084266|472035626|FG001|Overall Study|Randomized not treated|20|||
131110485|NCT00730171|472035627|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
131110486|NCT00730171|472035627|FG000|Overall Study|Adverse Event|193|||
131110487|NCT00730171|472035627|FG000|Overall Study|Protocol Violation|48|||
131110488|NCT00730171|472035627|FG000|Overall Study|Withdrawal by Subject|202|||
131110489|NCT00730171|472035627|FG000|Overall Study|Lost to Follow-up|121|||
131110490|NCT00730171|472035627|FG000|Overall Study|Insufficient Therapeutic Response|141|||
131110491|NCT00730171|472035627|FG000|Overall Study|Other|61|||
131110492|NCT01729156|472035628|FG000|Overall Study|Withdrawal by Subject|1|||
131110493|NCT01729156|472035629|FG001|Overall Study|Withdrawal by Subject|0|||
131110494|NCT01729156|472035630|FG002|Overall Study|Withdrawal by Subject|0|||
131110495|NCT00294554|472035633|FG000|Overall Study|Lack of Efficacy|0|||
131110496|NCT00294554|472035634|FG001|Overall Study|Lack of Efficacy|1|||
131110497|NCT00294554|472035633|FG000|Overall Study|Physician Decision|0|||
131110498|NCT00294554|472035634|FG001|Overall Study|Physician Decision|1|||
131110499|NCT00462865|472035635|FG000|Overall Study|Adverse Event|1|||
131110500|NCT02864381|472035636|FG000|Overall Study|Death|58|||
131110501|NCT02864381|472035637|FG001|Overall Study|Death|61|||
131110502|NCT02864381|472035636|FG000|Overall Study|Withdrew Consent|5|||
131110503|NCT02864381|472035637|FG001|Overall Study|Withdrew Consent|6|||
131110504|NCT02864381|472035636|FG000|Overall Study|Reason Unknown|7|||
131110505|NCT02864381|472035637|FG001|Overall Study|Reason Unknown|3|||
131110506|NCT02864381|472035636|FG000|Overall Study|Lost to Follow-up|1|||
131110507|NCT02864381|472035637|FG001|Overall Study|Lost to Follow-up|1|||
131110508|NCT02864381|472035636|FG000|Overall Study|Investigator's Discretion|1|||
131110509|NCT02864381|472035637|FG001|Overall Study|Investigator's Discretion|0|||
131110510|NCT02864381|472035636|FG000|Overall Study|Protocol Violation|0|||
131110511|NCT02864381|472035637|FG001|Overall Study|Protocol Violation|1|||
131110512|NCT01146054|472035640|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
131110513|NCT01146054|472035640|FG000|Overall Study|Rapid tumor progression|2|||
131110514|NCT01146054|472035640|FG000|Overall Study|Other illness precluded treatment|2|||
131110515|NCT01146054|472035640|FG000|Overall Study|Lost to Follow-up|1|||
131110516|NCT03840486|472035641|FG000|Overall Study|Withdrawal by Subject|0|||
131110517|NCT03840486|472035642|FG001|Overall Study|Withdrawal by Subject|1|||
131110518|NCT03840486|472035643|FG002|Overall Study|Withdrawal by Subject|0|||
131110519|NCT03840486|472035644|FG003|Overall Study|Withdrawal by Subject|0|||
131110520|NCT03840486|472035645|FG004|Overall Study|Withdrawal by Subject|0|||
131110521|NCT03840486|472035646|FG005|Overall Study|Withdrawal by Subject|0|||
131110522|NCT03840486|472035647|FG006|Overall Study|Withdrawal by Subject|0|||
131110523|NCT03840486|472035648|FG007|Overall Study|Withdrawal by Subject|0|||
131110524|NCT03840486|472035649|FG008|Overall Study|Withdrawal by Subject|0|||
131110525|NCT03840486|472035650|FG009|Overall Study|Withdrawal by Subject|0|||
131110526|NCT03840486|472035651|FG010|Overall Study|Withdrawal by Subject|0|||
131110527|NCT03840486|472035652|FG011|Overall Study|Withdrawal by Subject|0|||
131110528|NCT01139021|472035657|FG000|Overall Study|Adverse Event|0|||
131110529|NCT01139021|472035658|FG001|Overall Study|Adverse Event|0|||
131110530|NCT01139021|472035659|FG002|Overall Study|Adverse Event|0|||
131110531|NCT01139021|472035660|FG003|Overall Study|Adverse Event|0|||
131110532|NCT01139021|472035661|FG004|Overall Study|Adverse Event|1|||
131110533|NCT01139021|472035662|FG005|Overall Study|Adverse Event|0|||
131110534|NCT01139021|472035657|FG000|Overall Study|Lost to Follow-up|0|||
131110535|NCT01139021|472035658|FG001|Overall Study|Lost to Follow-up|0|||
131110536|NCT01139021|472035659|FG002|Overall Study|Lost to Follow-up|0|||
131110537|NCT01139021|472035660|FG003|Overall Study|Lost to Follow-up|0|||
131110538|NCT01139021|472035661|FG004|Overall Study|Lost to Follow-up|2|||
131110539|NCT01139021|472035662|FG005|Overall Study|Lost to Follow-up|0|||
131110540|NCT01139021|472035657|FG000|Overall Study|Protocol Violation|1|||
131110541|NCT01139021|472035658|FG001|Overall Study|Protocol Violation|0|||
131110542|NCT01139021|472035659|FG002|Overall Study|Protocol Violation|0|||
131110543|NCT01139021|472035660|FG003|Overall Study|Protocol Violation|0|||
131110544|NCT01139021|472035661|FG004|Overall Study|Protocol Violation|2|||
131110545|NCT01139021|472035662|FG005|Overall Study|Protocol Violation|0|||
131110546|NCT01139021|472035657|FG000|Overall Study|Withdrawal by Subject|0|||
131110547|NCT01139021|472035658|FG001|Overall Study|Withdrawal by Subject|0|||
131110548|NCT01139021|472035659|FG002|Overall Study|Withdrawal by Subject|0|||
131110549|NCT01139021|472035660|FG003|Overall Study|Withdrawal by Subject|1|||
131110550|NCT01139021|472035661|FG004|Overall Study|Withdrawal by Subject|4|||
131110551|NCT01139021|472035662|FG005|Overall Study|Withdrawal by Subject|0|||
131110552|NCT03588728|472035663|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
131110553|NCT03588728|472035664|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
131110554|NCT03588728|472035665|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
131110555|NCT03588728|472035666|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
131110556|NCT03588728|472035663|FG000|Overall Study|Lab shut down due to COVID-19|0|||
131110557|NCT03588728|472035664|FG001|Overall Study|Lab shut down due to COVID-19|0|||
131110558|NCT03588728|472035665|FG002|Overall Study|Lab shut down due to COVID-19|0|||
131110559|NCT03588728|472035666|FG003|Overall Study|Lab shut down due to COVID-19|1|||
131110560|NCT03588728|472035663|FG000|Overall Study|multiple technical issues|1|||
131110561|NCT03588728|472035664|FG001|Overall Study|multiple technical issues|0|||
131110562|NCT03588728|472035665|FG002|Overall Study|multiple technical issues|0|||
131110563|NCT03588728|472035666|FG003|Overall Study|multiple technical issues|0|||
131110564|NCT03588728|472035663|FG000|Overall Study|Hospitalized for COVID|1|||
131110565|NCT03588728|472035664|FG001|Overall Study|Hospitalized for COVID|0|||
131110566|NCT03588728|472035665|FG002|Overall Study|Hospitalized for COVID|0|||
131110567|NCT03588728|472035666|FG003|Overall Study|Hospitalized for COVID|0|||
131110568|NCT03588728|472035663|FG000|Overall Study|Schedule change unable to attend sessions|1|||
131110569|NCT03588728|472035664|FG001|Overall Study|Schedule change unable to attend sessions|0|||
131110570|NCT03588728|472035665|FG002|Overall Study|Schedule change unable to attend sessions|0|||
131110571|NCT03588728|472035666|FG003|Overall Study|Schedule change unable to attend sessions|0|||
131110572|NCT02027701|472035667|FG000|Overall Study|Adverse Event|3|||
131110573|NCT02027701|472035667|FG000|Overall Study|Lack of Efficacy|8|||
130893243|NCT01643772|471243222|FG001|Overall Study|Adverse Event|0|||
130893244|NCT01643772|471243223|FG002|Overall Study|Adverse Event|0|||
130893245|NCT01643772|471243224|FG003|Overall Study|Adverse Event|1|||
130893246|NCT02881567|471243229|FG000|Overall Study|Adverse Event|1|||
131110574|NCT02027701|472035667|FG000|Overall Study|Physician Decision|2|||
131110575|NCT02027701|472035667|FG000|Overall Study|Withdrawal by Subject|3|||
131110576|NCT02982187|472035668|FG000|Overall Study|Withdrawal by Subject|0|||
131110577|NCT02982187|472035669|FG001|Overall Study|Withdrawal by Subject|0|||
131110578|NCT02982187|472035670|FG002|Overall Study|Withdrawal by Subject|0|||
130687096|NCT01015703|470481358|FG004|Overall Study|Adverse Event|0|||
130687097|NCT01015703|470481354|FG000|Overall Study|Protocol Violation|1|||
130687098|NCT01015703|470481355|FG001|Overall Study|Protocol Violation|0|||
130687099|NCT01015703|470481356|FG002|Overall Study|Protocol Violation|0|||
130687100|NCT01015703|470481357|FG003|Overall Study|Protocol Violation|0|||
130687101|NCT01015703|470481358|FG004|Overall Study|Protocol Violation|0|||
130687102|NCT03122535|470481359|FG000|Overall Study|Lost to Follow-up|68|||
130687103|NCT03122535|470481360|FG001|Overall Study|Lost to Follow-up|68|||
130687104|NCT03122535|470481359|FG000|Overall Study|Physician Decision|3|||
130687105|NCT03122535|470481360|FG001|Overall Study|Physician Decision|3|||
130687106|NCT03122535|470481359|FG000|Overall Study|Withdrawal by Subject|2|||
130687107|NCT03122535|470481360|FG001|Overall Study|Withdrawal by Subject|2|||
130687108|NCT02718326|470481361|FG000|Overall Study|Adverse Event|4|||
130687109|NCT02718326|470481362|FG001|Overall Study|Adverse Event|9|||
130687110|NCT02718326|470481363|FG002|Overall Study|Adverse Event|0|||
130687111|NCT02718326|470481361|FG000|Overall Study|Death|8|||
130687112|NCT02718326|470481362|FG001|Overall Study|Death|1|||
130687113|NCT02718326|470481363|FG002|Overall Study|Death|2|||
130687114|NCT02718326|470481361|FG000|Overall Study|Withdrawal by Subject|4|||
130687115|NCT02718326|470481362|FG001|Overall Study|Withdrawal by Subject|9|||
130893247|NCT02881567|471243229|FG000|Overall Study|Lost to Follow-up|3|||
130893248|NCT02881567|471243229|FG000|Overall Study|Consent withdrawn|1|||
130893249|NCT02881567|471243229|FG000|Overall Study|Investigator decision|1|||
130893250|NCT02881567|471243229|FG000|Overall Study|Study terminated by sponsor|9|||
130893251|NCT02881567|471243229|FG000|Overall Study|Reason not Specified|3|||
130893252|NCT00373113|471243232|FG000|Overall Study|Death|1|||
130893253|NCT00373113|471243233|FG001|Overall Study|Death|7|||
131110579|NCT02982187|472035671|FG003|Overall Study|Withdrawal by Subject|0|||
131110580|NCT02982187|472035672|FG004|Overall Study|Withdrawal by Subject|0|||
131110581|NCT02982187|472035673|FG005|Overall Study|Withdrawal by Subject|0|||
131110582|NCT02982187|472035674|FG006|Overall Study|Withdrawal by Subject|1|||
131110583|NCT02982187|472035675|FG007|Overall Study|Withdrawal by Subject|0|||
130893254|NCT00373113|471243232|FG000|Overall Study|Adverse Event|38|||
130893255|NCT00373113|471243233|FG001|Overall Study|Adverse Event|24|||
130687116|NCT02718326|470481363|FG002|Overall Study|Withdrawal by Subject|6|||
130687117|NCT02718326|470481361|FG000|Overall Study|Lost to Follow-up|18|||
130687118|NCT02718326|470481362|FG001|Overall Study|Lost to Follow-up|5|||
130893256|NCT00373113|471243232|FG000|Overall Study|Study terminated by sponsor|9|||
131110584|NCT00887679|472035676|FG000|Overall Study|Withdrawal by Subject|1|||
131110585|NCT00887679|472035676|FG000|Overall Study|Lost to Follow-up|4|||
131110586|NCT00887679|472035676|FG000|Overall Study|Physician Decision|5|||
131110587|NCT02168842|472035677|FG000|Overall Study|Withdrawal by Subject|5|||
131110588|NCT02168842|472035678|FG001|Overall Study|Withdrawal by Subject|3|||
131110589|NCT02168842|472035677|FG000|Overall Study|Lost to Follow-up|0|||
131110590|NCT02168842|472035678|FG001|Overall Study|Lost to Follow-up|2|||
131110591|NCT02168842|472035677|FG000|Overall Study|Death|2|||
131110592|NCT02168842|472035678|FG001|Overall Study|Death|1|||
131110593|NCT02168842|472035677|FG000|Overall Study|Physician Decision|1|||
131110594|NCT02168842|472035678|FG001|Overall Study|Physician Decision|2|||
131110595|NCT01026454|472035681|FG000|Second Intervention|Pregnancy|1|||
131110596|NCT01026454|472035682|FG001|Second Intervention|Pregnancy|1|||
131110597|NCT00394953|472035685|FG000|First Treatment Period|Adverse Event|1|||
131110598|NCT00394953|472035686|FG001|First Treatment Period|Adverse Event|2|||
131110599|NCT00394953|472035685|FG000|First Treatment Period|Death|6|||
131110600|NCT00394953|472035686|FG001|First Treatment Period|Death|7|||
131110601|NCT00394953|472035685|FG000|First Treatment Period|Lack of Efficacy|1|||
131110602|NCT00394953|472035686|FG001|First Treatment Period|Lack of Efficacy|1|||
131110603|NCT00394953|472035685|FG000|First Treatment Period|Withdrawal by Subject|6|||
131110604|NCT00394953|472035686|FG001|First Treatment Period|Withdrawal by Subject|3|||
131110605|NCT00394953|472035685|FG000|First Treatment Period|Lost to Follow-up|0|||
131110606|NCT00394953|472035686|FG001|First Treatment Period|Lost to Follow-up|1|||
131110607|NCT00394953|472035685|FG000|First Treatment Period|Renal transplant|11|||
131110608|NCT00394953|472035686|FG001|First Treatment Period|Renal transplant|7|||
131110609|NCT00394953|472035685|FG000|First Treatment Period|Not defined|4|||
131110610|NCT00394953|472035686|FG001|First Treatment Period|Not defined|1|||
131110611|NCT00394953|472035685|FG000|Second Treatment Period|Adverse Event|2|||
131110612|NCT00394953|472035686|FG001|Second Treatment Period|Adverse Event|5|||
131110613|NCT00394953|472035685|FG000|Second Treatment Period|Death|8|||
131110614|NCT00394953|472035686|FG001|Second Treatment Period|Death|4|||
131110615|NCT00394953|472035685|FG000|Second Treatment Period|Lack of Efficacy|9|||
131110616|NCT00394953|472035686|FG001|Second Treatment Period|Lack of Efficacy|47|||
131110617|NCT00394953|472035685|FG000|Second Treatment Period|Withdrawal by Subject|3|||
131110618|NCT00394953|472035686|FG001|Second Treatment Period|Withdrawal by Subject|3|||
131110619|NCT00394953|472035685|FG000|Second Treatment Period|Lost to Follow-up|0|||
131110620|NCT00394953|472035686|FG001|Second Treatment Period|Lost to Follow-up|1|||
131110621|NCT00394953|472035685|FG000|Second Treatment Period|Renal transplant|4|||
131110622|NCT00394953|472035686|FG001|Second Treatment Period|Renal transplant|6|||
131110623|NCT00394953|472035685|FG000|Second Treatment Period|Not defined|3|||
131110624|NCT00394953|472035686|FG001|Second Treatment Period|Not defined|8|||
131110625|NCT03181451|472035690|FG000|Overall Study|Adverse Event|0|||
131110626|NCT03181451|472035691|FG001|Overall Study|Adverse Event|1|||
131110627|NCT03181451|472035692|FG002|Overall Study|Adverse Event|0|||
131110628|NCT03181451|472035690|FG000|Overall Study|Withdrawal by Subject|0|||
131110629|NCT03181451|472035691|FG001|Overall Study|Withdrawal by Subject|1|||
131110630|NCT03181451|472035692|FG002|Overall Study|Withdrawal by Subject|0|||
131110631|NCT02196714|472035696|FG000|Overall Study|Protocol Violation|0|||
131110632|NCT02196714|472035697|FG001|Overall Study|Protocol Violation|0|||
131110633|NCT02196714|472035698|FG002|Overall Study|Protocol Violation|1|||
131110634|NCT02196714|472035699|FG003|Overall Study|Protocol Violation|0|||
131110635|NCT01592864|472035701|FG000|Overall Study|Withdrawal by Subject|0|||
131110636|NCT01592864|472035702|FG001|Overall Study|Withdrawal by Subject|1|||
131110637|NCT01326533|472035710|FG000|Overall Study|Lost to Follow-up|2|||
131110638|NCT01326533|472035711|FG001|Overall Study|Lost to Follow-up|0|||
131110639|NCT01326533|472035710|FG000|Overall Study|Withdrawal by Subject|1|||
131110640|NCT01326533|472035711|FG001|Overall Study|Withdrawal by Subject|0|||
131110641|NCT01326533|472035710|FG000|Overall Study|Adverse Event|1|||
130687119|NCT02718326|470481363|FG002|Overall Study|Lost to Follow-up|14|||
130687120|NCT02718326|470481361|FG000|Overall Study|Protocol Deviation|1|||
130687121|NCT02718326|470481362|FG001|Overall Study|Protocol Deviation|0|||
130687122|NCT02718326|470481363|FG002|Overall Study|Protocol Deviation|0|||
130687123|NCT02718326|470481361|FG000|Overall Study|Pregnancy|1|||
130687124|NCT02718326|470481362|FG001|Overall Study|Pregnancy|0|||
131110642|NCT01326533|472035711|FG001|Overall Study|Adverse Event|0|||
131110643|NCT04079803|472035712|FG000|Overall Study|Withdrawal by Subject|0|||
131110644|NCT04079803|472035713|FG001|Overall Study|Withdrawal by Subject|0|||
131110645|NCT04079803|472035714|FG002|Overall Study|Withdrawal by Subject|1|||
131110646|NCT01294683|472035715|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
131110647|NCT01294683|472035716|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
131110648|NCT01294683|472035715|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
131110649|NCT01294683|472035716|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
131110650|NCT01294683|472035715|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
131110651|NCT01294683|472035716|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
131110652|NCT01294683|472035715|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
131110653|NCT01294683|472035716|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
130687125|NCT02718326|470481363|FG002|Overall Study|Pregnancy|0|||
130687126|NCT00834418|470481369|FG000|Overall Study|Adverse Event|0|||
130687127|NCT00834418|470481370|FG001|Overall Study|Adverse Event|2|||
130687128|NCT01705574|470481371|FG000|Double-Blind Phase|Lost to Follow-up|12|||
130687129|NCT01705574|470481372|FG001|Double-Blind Phase|Lost to Follow-up|16|||
130687130|NCT01705574|470481373|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130687131|NCT01705574|470481374|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130687132|NCT01705574|470481371|FG000|Double-Blind Phase|Adverse Event|3|||
130687133|NCT01705574|470481372|FG001|Double-Blind Phase|Adverse Event|10|||
130687134|NCT01705574|470481373|FG002|Double-Blind Phase|Adverse Event|0|||
130687135|NCT01705574|470481374|FG003|Double-Blind Phase|Adverse Event|0|||
130687136|NCT01705574|470481371|FG000|Double-Blind Phase|Withdrew Consent|8|||
130687137|NCT01705574|470481372|FG001|Double-Blind Phase|Withdrew Consent|5|||
130687138|NCT01705574|470481373|FG002|Double-Blind Phase|Withdrew Consent|0|||
130687139|NCT01705574|470481374|FG003|Double-Blind Phase|Withdrew Consent|0|||
130687140|NCT01705574|470481371|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
130687141|NCT01705574|470481372|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
130687142|NCT01705574|470481373|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
130687143|NCT01705574|470481374|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
130687144|NCT01705574|470481371|FG000|Double-Blind Phase|Pregnancy|1|||
130687145|NCT01705574|470481372|FG001|Double-Blind Phase|Pregnancy|1|||
130687146|NCT01705574|470481373|FG002|Double-Blind Phase|Pregnancy|0|||
130687147|NCT01705574|470481374|FG003|Double-Blind Phase|Pregnancy|0|||
130687148|NCT01705574|470481371|FG000|Double-Blind Phase|Protocol Violation|1|||
130687149|NCT01705574|470481372|FG001|Double-Blind Phase|Protocol Violation|0|||
130687150|NCT01705574|470481373|FG002|Double-Blind Phase|Protocol Violation|0|||
130687151|NCT01705574|470481374|FG003|Double-Blind Phase|Protocol Violation|0|||
130687152|NCT01705574|470481371|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
130687153|NCT01705574|470481372|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
130687154|NCT01705574|470481373|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
130687155|NCT01705574|470481374|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
130687156|NCT01705574|470481371|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
130687157|NCT01705574|470481372|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130687158|NCT01705574|470481373|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
130687159|NCT01705574|470481374|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
130687160|NCT01705574|470481371|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
130687161|NCT01705574|470481372|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
130893257|NCT00373113|471243233|FG001|Overall Study|Study terminated by sponsor|1|||
131025124|NCT02121002|471723196|FG001|Overall Study|Physician Decision|0|||
131025125|NCT02121002|471723197|FG002|Overall Study|Physician Decision|0|||
131025126|NCT02121002|471723195|FG000|Overall Study|Withdrawal by Subject|3|||
131025127|NCT02121002|471723196|FG001|Overall Study|Withdrawal by Subject|1|||
131025128|NCT02121002|471723197|FG002|Overall Study|Withdrawal by Subject|4|||
131025129|NCT02121002|471723195|FG000|Overall Study|Protocol Violation|1|||
131025130|NCT02121002|471723196|FG001|Overall Study|Protocol Violation|2|||
131025131|NCT02121002|471723197|FG002|Overall Study|Protocol Violation|4|||
131025132|NCT02121002|471723195|FG000|Overall Study|Concomitant therapy|0|||
131025133|NCT02121002|471723196|FG001|Overall Study|Concomitant therapy|1|||
131025134|NCT02121002|471723197|FG002|Overall Study|Concomitant therapy|1|||
131025135|NCT02121002|471723195|FG000|Overall Study|Others|1|||
131025136|NCT02121002|471723196|FG001|Overall Study|Others|0|||
131025137|NCT02121002|471723197|FG002|Overall Study|Others|1|||
131025138|NCT02590432|471723198|FG000|Open-label Treatment Period|Adverse Event|97|||
131025139|NCT02590432|471723199|FG001|Open-label Treatment Period|Adverse Event|79|||
131025140|NCT02590432|471723200|FG002|Open-label Treatment Period|Adverse Event|0|||
131025141|NCT02590432|471723201|FG003|Open-label Treatment Period|Adverse Event|0|||
131025142|NCT02590432|471723202|FG004|Open-label Treatment Period|Adverse Event|0|||
131025143|NCT02590432|471723203|FG005|Open-label Treatment Period|Adverse Event|0|||
131025144|NCT02590432|471723204|FG006|Open-label Treatment Period|Adverse Event|0|||
131025145|NCT02590432|471723205|FG007|Open-label Treatment Period|Adverse Event|0|||
131025146|NCT02590432|471723206|FG008|Open-label Treatment Period|Adverse Event|0|||
131025147|NCT02590432|471723198|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
131025148|NCT02590432|471723199|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
131025149|NCT02590432|471723200|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
130687162|NCT01705574|470481373|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
130687163|NCT01705574|470481374|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
130687164|NCT01705574|470481371|FG000|Open-Label Extension Phase|Adverse Event|3|||
130687165|NCT01705574|470481372|FG001|Open-Label Extension Phase|Adverse Event|0|||
130687166|NCT01705574|470481373|FG002|Open-Label Extension Phase|Adverse Event|0|||
130687167|NCT01705574|470481374|FG003|Open-Label Extension Phase|Adverse Event|1|||
130687168|NCT01705574|470481371|FG000|Open-Label Extension Phase|Death|2|||
130687169|NCT01705574|470481372|FG001|Open-Label Extension Phase|Death|0|||
131025150|NCT02590432|471723201|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
131025151|NCT02590432|471723202|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
131025152|NCT02590432|471723203|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
131025153|NCT02590432|471723204|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
130893258|NCT00373113|471243232|FG000|Overall Study|Global deterioration of health status|10|||
130893259|NCT00373113|471243233|FG001|Overall Study|Global deterioration of health status|7|||
130893260|NCT00373113|471243232|FG000|Overall Study|Lost to Follow-up|1|||
130893261|NCT00373113|471243233|FG001|Overall Study|Lost to Follow-up|3|||
130893262|NCT00373113|471243232|FG000|Overall Study|Objective progression or relapse|150|||
130893263|NCT00373113|471243233|FG001|Overall Study|Objective progression or relapse|169|||
130893264|NCT00373113|471243232|FG000|Overall Study|Other|14|||
130893265|NCT00373113|471243233|FG001|Overall Study|Other|17|||
130893266|NCT00373113|471243232|FG000|Overall Study|Protocol Violation|5|||
130893267|NCT00373113|471243233|FG001|Overall Study|Protocol Violation|1|||
130893268|NCT00373113|471243232|FG000|Overall Study|Withdrawal by Subject|10|||
130893269|NCT00373113|471243233|FG001|Overall Study|Withdrawal by Subject|15|||
130893270|NCT04248491|471243234|FG000|Overall Study|Lost to Follow-up|1|||
130893271|NCT04248491|471243235|FG001|Overall Study|Lost to Follow-up|0|||
130893272|NCT00975689|471243239|FG000|Overall Study|Adverse Event|0|||
130893273|NCT00975689|471243240|FG001|Overall Study|Adverse Event|3|||
130893274|NCT00975689|471243239|FG000|Overall Study|Withdrawal by Subject|1|||
130893275|NCT00975689|471243240|FG001|Overall Study|Withdrawal by Subject|0|||
130893276|NCT00975689|471243239|FG000|Overall Study|Physician Decision|1|||
130893277|NCT00975689|471243240|FG001|Overall Study|Physician Decision|0|||
130893278|NCT01652469|471243245|FG000|Overall Study|Withdrawal by Subject|1|||
130893279|NCT01652469|471243246|FG001|Overall Study|Withdrawal by Subject|4|||
130893280|NCT01652469|471243245|FG000|Overall Study|Lost to Follow-up|0|||
130893281|NCT01652469|471243246|FG001|Overall Study|Lost to Follow-up|2|||
130893282|NCT01305577|471243248|FG000|Overall Study|Adverse Event|2|||
131025154|NCT02590432|471723205|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
131025155|NCT02590432|471723206|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
131025156|NCT02590432|471723198|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
131025157|NCT02590432|471723199|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
131025158|NCT02590432|471723200|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
131025159|NCT02590432|471723201|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
131025160|NCT02590432|471723202|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
131025161|NCT02590432|471723203|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
131025162|NCT02590432|471723204|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
131025163|NCT02590432|471723205|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
131025164|NCT02590432|471723206|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
131025165|NCT02590432|471723198|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
131025166|NCT02590432|471723199|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
131025167|NCT02590432|471723200|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
131025168|NCT02590432|471723201|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
131025169|NCT02590432|471723202|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
131025170|NCT02590432|471723203|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
131025171|NCT02590432|471723204|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
131025172|NCT02590432|471723205|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
131025173|NCT02590432|471723206|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
131025174|NCT02590432|471723198|FG000|Open-label Treatment Period|Protocol Violation|10|||
131025175|NCT02590432|471723199|FG001|Open-label Treatment Period|Protocol Violation|4|||
131025176|NCT02590432|471723200|FG002|Open-label Treatment Period|Protocol Violation|0|||
131025177|NCT02590432|471723201|FG003|Open-label Treatment Period|Protocol Violation|0|||
131025178|NCT02590432|471723202|FG004|Open-label Treatment Period|Protocol Violation|0|||
131025179|NCT02590432|471723203|FG005|Open-label Treatment Period|Protocol Violation|0|||
131025180|NCT02590432|471723204|FG006|Open-label Treatment Period|Protocol Violation|0|||
131025181|NCT02590432|471723205|FG007|Open-label Treatment Period|Protocol Violation|0|||
131025182|NCT02590432|471723206|FG008|Open-label Treatment Period|Protocol Violation|0|||
131025183|NCT02590432|471723198|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
131025184|NCT02590432|471723199|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
131025185|NCT02590432|471723200|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131025186|NCT02590432|471723201|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131025187|NCT02590432|471723202|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131025188|NCT02590432|471723203|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131025189|NCT02590432|471723204|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131025190|NCT02590432|471723205|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131025191|NCT02590432|471723206|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
131222691|NCT03402126|472443160|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
130893283|NCT01305577|471243249|FG001|Overall Study|Adverse Event|2|||
130893284|NCT01305577|471243250|FG002|Overall Study|Adverse Event|1|||
130893285|NCT01305577|471243248|FG000|Overall Study|Withdrawal by Subject|7|||
130893286|NCT01305577|471243249|FG001|Overall Study|Withdrawal by Subject|5|||
130893287|NCT01305577|471243250|FG002|Overall Study|Withdrawal by Subject|6|||
131025192|NCT02590432|471723198|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
131025193|NCT02590432|471723199|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
130893288|NCT01305577|471243248|FG000|Overall Study|Lost to Follow-up|4|||
130893289|NCT01305577|471243249|FG001|Overall Study|Lost to Follow-up|3|||
130893290|NCT01305577|471243250|FG002|Overall Study|Lost to Follow-up|2|||
130893291|NCT01305577|471243248|FG000|Overall Study|Protocol Deviation|0|||
130893292|NCT01305577|471243249|FG001|Overall Study|Protocol Deviation|1|||
130893293|NCT01305577|471243250|FG002|Overall Study|Protocol Deviation|1|||
130893294|NCT00905645|471243251|FG000|Overall Study|Death (not device related)|10|||
130893295|NCT00905645|471243252|FG001|Overall Study|Death (not device related)|4|||
130893296|NCT00905645|471243253|FG002|Overall Study|Death (not device related)|15|||
130893297|NCT00905645|471243254|FG003|Overall Study|Death (not device related)|8|||
130893298|NCT00905645|471243251|FG000|Overall Study|Explantation of study device(s)|78|||
130893299|NCT00905645|471243252|FG001|Overall Study|Explantation of study device(s)|47|||
130893300|NCT00905645|471243253|FG002|Overall Study|Explantation of study device(s)|28|||
130893301|NCT00905645|471243254|FG003|Overall Study|Explantation of study device(s)|21|||
130893302|NCT00905645|471243251|FG000|Overall Study|Subject Request|41|||
130893303|NCT00905645|471243252|FG001|Overall Study|Subject Request|17|||
130893304|NCT00905645|471243253|FG002|Overall Study|Subject Request|13|||
130893305|NCT00905645|471243254|FG003|Overall Study|Subject Request|11|||
130893306|NCT00905645|471243251|FG000|Overall Study|Lost to Follow-up|299|||
130687170|NCT01705574|470481373|FG002|Open-Label Extension Phase|Death|1|||
130687171|NCT01705574|470481374|FG003|Open-Label Extension Phase|Death|0|||
130687172|NCT01705574|470481371|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
130687173|NCT01705574|470481372|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
130687174|NCT01705574|470481373|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
130687175|NCT01705574|470481374|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
130687176|NCT01705574|470481371|FG000|Open-Label Extension Phase|Physician Decision|0|||
130687177|NCT01705574|470481372|FG001|Open-Label Extension Phase|Physician Decision|0|||
130687178|NCT01705574|470481373|FG002|Open-Label Extension Phase|Physician Decision|2|||
130687179|NCT01705574|470481374|FG003|Open-Label Extension Phase|Physician Decision|0|||
130687180|NCT01705574|470481371|FG000|Open-Label Extension Phase|Pregnancy|0|||
130687181|NCT01705574|470481372|FG001|Open-Label Extension Phase|Pregnancy|0|||
130893307|NCT00905645|471243252|FG001|Overall Study|Lost to Follow-up|103|||
130893308|NCT00905645|471243253|FG002|Overall Study|Lost to Follow-up|51|||
130893309|NCT00905645|471243254|FG003|Overall Study|Lost to Follow-up|12|||
130893310|NCT02364336|471243255|FG000|Overall Study|Adverse Event|0|||
130893311|NCT02364336|471243256|FG001|Overall Study|Adverse Event|1|||
130893312|NCT01731938|471243257|FG000|Preliminary Part I|Withdrawal by Subject|2|||
130893313|NCT01731938|471243258|FG001|Preliminary Part I|Withdrawal by Subject|2|||
130893314|NCT01731938|471243257|FG000|Preliminary Part I|Physician Decision|1|||
130893315|NCT01731938|471243258|FG001|Preliminary Part I|Physician Decision|0|||
130687182|NCT01705574|470481373|FG002|Open-Label Extension Phase|Pregnancy|1|||
130687183|NCT01705574|470481374|FG003|Open-Label Extension Phase|Pregnancy|1|||
130687184|NCT00777023|470481375|FG000|Overall Study|Adverse Event|15|||
130687185|NCT00777023|470481376|FG001|Overall Study|Adverse Event|21|||
130687186|NCT00777023|470481377|FG002|Overall Study|Adverse Event|8|||
130687187|NCT00777023|470481375|FG000|Overall Study|Lack of Efficacy|1|||
130687188|NCT00777023|470481376|FG001|Overall Study|Lack of Efficacy|0|||
130687189|NCT00777023|470481377|FG002|Overall Study|Lack of Efficacy|14|||
130687190|NCT00777023|470481375|FG000|Overall Study|Protocol Violation|2|||
130687191|NCT00777023|470481376|FG001|Overall Study|Protocol Violation|1|||
130687192|NCT00777023|470481377|FG002|Overall Study|Protocol Violation|1|||
130687193|NCT00777023|470481375|FG000|Overall Study|Lost to Follow-up|2|||
130687194|NCT00777023|470481376|FG001|Overall Study|Lost to Follow-up|3|||
130687195|NCT00777023|470481377|FG002|Overall Study|Lost to Follow-up|3|||
130687196|NCT00777023|470481375|FG000|Overall Study|Death|0|||
130687197|NCT00777023|470481376|FG001|Overall Study|Death|1|||
130687198|NCT00777023|470481377|FG002|Overall Study|Death|0|||
130893316|NCT01731938|471243257|FG000|Preliminary Part I|Lost to Follow-up|0|||
130893317|NCT01731938|471243258|FG001|Preliminary Part I|Lost to Follow-up|3|||
130893318|NCT01731938|471243257|FG000|Preliminary Part I|Missed Week 6 visit|0|||
130893319|NCT01731938|471243258|FG001|Preliminary Part I|Missed Week 6 visit|3|||
131110654|NCT01294683|472035715|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
130767087|NCT02117713|470770727|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
130687199|NCT00777023|470481375|FG000|Overall Study|Withdrawal by Subject|7|||
130687200|NCT00777023|470481376|FG001|Overall Study|Withdrawal by Subject|7|||
130687201|NCT00777023|470481377|FG002|Overall Study|Withdrawal by Subject|8|||
130687202|NCT00777023|470481375|FG000|Overall Study|Missing data|1|||
130687203|NCT00777023|470481376|FG001|Overall Study|Missing data|1|||
130687204|NCT00777023|470481377|FG002|Overall Study|Missing data|0|||
130687205|NCT00777023|470481375|FG000|Overall Study|Reasons not specified|4|||
130893320|NCT01731938|471243257|FG000|Primary Part II|Withdrawal by Subject|5|||
130893321|NCT01731938|471243258|FG001|Primary Part II|Withdrawal by Subject|4|||
130893322|NCT01731938|471243257|FG000|Primary Part II|Lost to Follow-up|4|||
130893323|NCT01731938|471243258|FG001|Primary Part II|Lost to Follow-up|5|||
130687206|NCT00777023|470481376|FG001|Overall Study|Reasons not specified|4|||
130893324|NCT01731938|471243257|FG000|Primary Part II|Death|2|||
130687207|NCT00777023|470481377|FG002|Overall Study|Reasons not specified|2|||
130687208|NCT00777023|470481375|FG000|Overall Study|Last dose date unknown|3|||
130687209|NCT00777023|470481376|FG001|Overall Study|Last dose date unknown|3|||
130687210|NCT00777023|470481377|FG002|Overall Study|Last dose date unknown|1|||
130687211|NCT02659150|470481380|FG000|Subject Enrollment|Physician Decision|3|||
130687212|NCT02659150|470481380|FG000|Subject Enrollment|Withdrawal by Subject|2|||
130687213|NCT02659150|470481380|FG000|Baseline Imaging|Withdrawal by Subject|1|||
130687214|NCT02659150|470481380|FG000|Baseline Imaging|Physician Decision|1|||
130687215|NCT02659150|470481380|FG000|Study Drug Dosing|Adverse Event|1|||
130687216|NCT00448019|470481381|FG000|Overall Study|Withdrawal by Subject|3|||
130687217|NCT00448019|470481381|FG000|Overall Study|Disease progression|1|||
130687218|NCT00448019|470481381|FG000|Overall Study|Death|2|||
130687219|NCT00448019|470481381|FG000|Overall Study|Insurance Issues|1|||
130687220|NCT02543203|470481382|FG000|Overall Study|Unpalatable Fragrance|2|||
130687221|NCT02543203|470481383|FG001|Overall Study|Unpalatable Fragrance|2|||
130687222|NCT02543203|470481382|FG000|Overall Study|Lost to Follow-up|1|||
130687223|NCT02543203|470481383|FG001|Overall Study|Lost to Follow-up|0|||
130687224|NCT02543203|470481382|FG000|Overall Study|Increased Irritability|1|||
130687225|NCT02543203|470481383|FG001|Overall Study|Increased Irritability|0|||
130687226|NCT02543203|470481382|FG000|Overall Study|Family|1|||
130687227|NCT02543203|470481383|FG001|Overall Study|Family|2|||
130687228|NCT02543203|470481382|FG000|Overall Study|Negative Behavior|1|||
130687229|NCT02543203|470481383|FG001|Overall Study|Negative Behavior|0|||
130687230|NCT02543203|470481382|FG000|Overall Study|Withdrawal by Subject|0|||
130687231|NCT02543203|470481383|FG001|Overall Study|Withdrawal by Subject|1|||
131025194|NCT02590432|471723200|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131025195|NCT02590432|471723201|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131025196|NCT02590432|471723202|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131025197|NCT02590432|471723203|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131025198|NCT02590432|471723204|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131025199|NCT02590432|471723205|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131025200|NCT02590432|471723206|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
131025201|NCT02590432|471723198|FG000|Double-blind Treatment Period|Adverse Event|0|||
131025202|NCT02590432|471723199|FG001|Double-blind Treatment Period|Adverse Event|0|||
131025203|NCT02590432|471723200|FG002|Double-blind Treatment Period|Adverse Event|14|||
131025204|NCT02590432|471723201|FG003|Double-blind Treatment Period|Adverse Event|12|||
131025205|NCT02590432|471723202|FG004|Double-blind Treatment Period|Adverse Event|6|||
131025206|NCT02590432|471723203|FG005|Double-blind Treatment Period|Adverse Event|22|||
131025207|NCT02590432|471723204|FG006|Double-blind Treatment Period|Adverse Event|20|||
131025208|NCT02590432|471723205|FG007|Double-blind Treatment Period|Adverse Event|0|||
131025209|NCT02590432|471723206|FG008|Double-blind Treatment Period|Adverse Event|0|||
131025210|NCT02590432|471723198|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
131025211|NCT02590432|471723199|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
131025212|NCT02590432|471723200|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
131025213|NCT02590432|471723201|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
131025214|NCT02590432|471723202|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
131025215|NCT02590432|471723203|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
131025216|NCT02590432|471723204|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
131025217|NCT02590432|471723205|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
131025218|NCT02590432|471723206|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
131025219|NCT02590432|471723198|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
131025220|NCT02590432|471723199|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
131025221|NCT02590432|471723200|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
131025222|NCT02590432|471723201|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
131025223|NCT02590432|471723202|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
131025224|NCT02590432|471723203|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
131025225|NCT02590432|471723204|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
131025226|NCT02590432|471723205|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
131025227|NCT02590432|471723206|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
131025228|NCT02590432|471723198|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
131025229|NCT02590432|471723199|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
131025230|NCT02590432|471723200|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
131025231|NCT02590432|471723201|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
131025232|NCT02590432|471723202|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
131025233|NCT02590432|471723203|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
131025234|NCT02590432|471723204|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
131025235|NCT02590432|471723205|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
131025236|NCT02590432|471723206|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
130687232|NCT00089661|470481384|FG000|Overall Study|Adverse Event|0|||
130687233|NCT00089661|470481385|FG001|Overall Study|Adverse Event|2|||
131025237|NCT02590432|471723198|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130687234|NCT00089661|470481384|FG000|Overall Study|Death|1|||
130687235|NCT00089661|470481385|FG001|Overall Study|Death|0|||
130687236|NCT00089661|470481384|FG000|Overall Study|Lost to Follow-up|0|||
130687237|NCT00089661|470481385|FG001|Overall Study|Lost to Follow-up|3|||
130687238|NCT00089661|470481384|FG000|Overall Study|Withdrawal by Subject|11|||
130687239|NCT00089661|470481385|FG001|Overall Study|Withdrawal by Subject|9|||
130687240|NCT00089661|470481384|FG000|Overall Study|Disease progression|1|||
130687241|NCT00089661|470481385|FG001|Overall Study|Disease progression|3|||
130687242|NCT00089661|470481384|FG000|Overall Study|Ineligibility determined|4|||
130687243|NCT00089661|470481385|FG001|Overall Study|Ineligibility determined|4|||
130687244|NCT00089661|470481384|FG000|Overall Study|Noncompliance|2|||
130893325|NCT01731938|471243258|FG001|Primary Part II|Death|1|||
130893326|NCT01731938|471243257|FG000|Primary Part II|Missed Week 6 visit|2|||
130893327|NCT01731938|471243258|FG001|Primary Part II|Missed Week 6 visit|3|||
130893328|NCT04931888|471243259|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
130893329|NCT04931888|471243260|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
130893330|NCT04931888|471243261|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
130893331|NCT04931888|471243262|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
130893332|NCT00771953|471243263|FG000|Overall Study|Adverse Event|5|||
130893333|NCT00771953|471243264|FG001|Overall Study|Adverse Event|3|||
130893334|NCT00771953|471243263|FG000|Overall Study|Death|2|||
130893335|NCT00771953|471243264|FG001|Overall Study|Death|2|||
130893336|NCT00771953|471243263|FG000|Overall Study|Progression before active Tx|1|||
130893337|NCT00771953|471243264|FG001|Overall Study|Progression before active Tx|2|||
130893338|NCT00771953|471243263|FG000|Overall Study|Sponsor decision|1|||
130893339|NCT00771953|471243264|FG001|Overall Study|Sponsor decision|0|||
130893340|NCT00771953|471243263|FG000|Overall Study|Other complicating disease|1|||
130893341|NCT00771953|471243264|FG001|Overall Study|Other complicating disease|0|||
130893342|NCT00771953|471243263|FG000|Overall Study|Withdrawal by Subject|0|||
130893343|NCT00771953|471243264|FG001|Overall Study|Withdrawal by Subject|3|||
130893344|NCT00856518|471243268|FG000|Overall Study|Lost to Follow-up|4|||
130893345|NCT00856518|471243269|FG001|Overall Study|Lost to Follow-up|2|||
130893346|NCT00947193|471243270|FG000|Overall Study|Lost to Follow-up|1|||
130893347|NCT00947193|471243271|FG001|Overall Study|Lost to Follow-up|0|||
130893348|NCT00947193|471243270|FG000|Overall Study|Withdrawal by Subject|1|||
130893349|NCT00947193|471243271|FG001|Overall Study|Withdrawal by Subject|0|||
130893350|NCT00947193|471243270|FG000|Overall Study|Factor VIII >1%|1|||
130893351|NCT00947193|471243271|FG001|Overall Study|Factor VIII >1%|0|||
130893352|NCT00926029|471243273|FG000|Overall Study|Lost to Follow-up|2|||
130893353|NCT00926029|471243274|FG001|Overall Study|Lost to Follow-up|1|||
130893354|NCT00926029|471243275|FG002|Overall Study|Lost to Follow-up|1|||
130893355|NCT05246514|471243276|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
130893356|NCT05246514|471243276|FG000|Overall Study|Withdrawal by Subject|1|||
130893357|NCT05246514|471243276|FG000|Overall Study|Death|13|||
130893358|NCT04154189|471243277|FG000|Overall Study|Withdrawal by Subject|4|||
130893359|NCT04154189|471243278|FG001|Overall Study|Withdrawal by Subject|6|||
130893360|NCT04154189|471243277|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
130893361|NCT04154189|471243278|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
130893362|NCT04154189|471243277|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
130893363|NCT04154189|471243278|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
130893364|NCT04154189|471243277|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
130893365|NCT04154189|471243278|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
130893366|NCT04154189|471243277|FG000|Overall Study|Death|25|||
130893367|NCT04154189|471243278|FG001|Overall Study|Death|25|||
130893368|NCT00486291|471243279|FG000|Overall Study|Adverse Event|3|||
130893369|NCT00486291|471243280|FG001|Overall Study|Adverse Event|4|||
130893370|NCT00486291|471243279|FG000|Overall Study|Lost to Follow-up|3|||
130893371|NCT00486291|471243280|FG001|Overall Study|Lost to Follow-up|7|||
130893372|NCT00486291|471243279|FG000|Overall Study|protocol non-compliance|10|||
130893373|NCT00486291|471243280|FG001|Overall Study|protocol non-compliance|15|||
130893374|NCT00486291|471243279|FG000|Overall Study|requirement for restricted medication|0|||
130893375|NCT00486291|471243280|FG001|Overall Study|requirement for restricted medication|3|||
130893376|NCT00126490|471243285|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
130893377|NCT00975780|471243286|FG000|Follow Up|Death|88|||
130893378|NCT00975780|471243287|FG001|Follow Up|Death|122|||
130893379|NCT00975780|471243286|FG000|Follow Up|Facility Withdrawal|7|||
130687245|NCT00089661|470481385|FG001|Overall Study|Noncompliance|4|||
130687246|NCT00089661|470481384|FG000|Overall Study|Other|2|||
130687247|NCT00089661|470481385|FG001|Overall Study|Other|1|||
130687248|NCT01273805|470481386|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
130893380|NCT00975780|471243287|FG001|Follow Up|Facility Withdrawal|23|||
130893381|NCT00975780|471243286|FG000|Follow Up|Discharged from Facility|7|||
130893382|NCT00975780|471243287|FG001|Follow Up|Discharged from Facility|12|||
130893383|NCT03051178|471243290|FG000|Overall Study|Withdrawal by Subject|5|||
130893384|NCT01598506|471243291|FG000|Overall Study|Withdrawal by Subject|2|||
130893385|NCT04080167|471243298|FG000|Overall Study|Lost to Follow-up-Patients|7|||
130687249|NCT01273805|470481387|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
130893386|NCT04080167|471243299|FG001|Overall Study|Lost to Follow-up-Patients|14|||
130893387|NCT04080167|471243300|FG002|Overall Study|Lost to Follow-up-Patients|0|||
130893388|NCT04080167|471243298|FG000|Overall Study|Lost to Follow-up-Providers|2|||
130893389|NCT04080167|471243299|FG001|Overall Study|Lost to Follow-up-Providers|2|||
130893390|NCT04080167|471243300|FG002|Overall Study|Lost to Follow-up-Providers|0|||
130893391|NCT04080167|471243298|FG000|Overall Study|Withdrawal by Subject|1|||
130893392|NCT04080167|471243299|FG001|Overall Study|Withdrawal by Subject|2|||
130893393|NCT04080167|471243300|FG002|Overall Study|Withdrawal by Subject|0|||
130893394|NCT04080167|471243298|FG000|Overall Study|Withdrawal by Provider|0|||
130893395|NCT04080167|471243299|FG001|Overall Study|Withdrawal by Provider|0|||
130893396|NCT04080167|471243300|FG002|Overall Study|Withdrawal by Provider|4|||
130893397|NCT04080167|471243298|FG000|Overall Study|Death-Patient|2|||
130893398|NCT04080167|471243299|FG001|Overall Study|Death-Patient|1|||
130893399|NCT04080167|471243300|FG002|Overall Study|Death-Patient|0|||
130893400|NCT04080167|471243298|FG000|Overall Study|Hydroxyurea New Starts|0|||
130893401|NCT04080167|471243299|FG001|Overall Study|Hydroxyurea New Starts|0|||
130893402|NCT04080167|471243300|FG002|Overall Study|Hydroxyurea New Starts|1|||
130893403|NCT04080167|471243298|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
130893404|NCT04080167|471243299|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
130893405|NCT04080167|471243300|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
130893406|NCT02167139|471243301|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
130893407|NCT02167139|471243302|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
130893408|NCT02167139|471243303|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
130893409|NCT02167139|471243304|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
130893410|NCT02167139|471243301|FG000|Randomised, Double-blind|Adverse Event|2|||
130893411|NCT02167139|471243302|FG001|Randomised, Double-blind|Adverse Event|9|||
130893412|NCT02167139|471243303|FG002|Randomised, Double-blind|Adverse Event|0|||
130893413|NCT02167139|471243304|FG003|Randomised, Double-blind|Adverse Event|0|||
130893414|NCT02167139|471243301|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
130893415|NCT02167139|471243302|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
130893416|NCT02167139|471243303|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
130893417|NCT02167139|471243304|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
130893418|NCT02167139|471243301|FG000|Randomised, Double-blind|Other|3|||
130893419|NCT02167139|471243302|FG001|Randomised, Double-blind|Other|0|||
130893420|NCT02167139|471243303|FG002|Randomised, Double-blind|Other|0|||
130893421|NCT02167139|471243304|FG003|Randomised, Double-blind|Other|0|||
130893422|NCT02167139|471243301|FG000|Transition-extension|Adverse Event|2|||
130893423|NCT02167139|471243302|FG001|Transition-extension|Adverse Event|0|||
130893424|NCT02167139|471243303|FG002|Transition-extension|Adverse Event|2|||
130893425|NCT02167139|471243304|FG003|Transition-extension|Adverse Event|3|||
130893426|NCT02167139|471243301|FG000|Transition-extension|Withdrawal by Subject|2|||
130893427|NCT02167139|471243302|FG001|Transition-extension|Withdrawal by Subject|0|||
130893428|NCT02167139|471243303|FG002|Transition-extension|Withdrawal by Subject|4|||
130893429|NCT02167139|471243304|FG003|Transition-extension|Withdrawal by Subject|1|||
130893430|NCT02167139|471243301|FG000|Transition-extension|Lack of Efficacy|0|||
130893431|NCT02167139|471243302|FG001|Transition-extension|Lack of Efficacy|0|||
130893432|NCT02167139|471243303|FG002|Transition-extension|Lack of Efficacy|1|||
130893433|NCT02167139|471243304|FG003|Transition-extension|Lack of Efficacy|1|||
130893434|NCT02167139|471243301|FG000|Transition-extension|Other|1|||
130893435|NCT02167139|471243302|FG001|Transition-extension|Other|0|||
130893436|NCT02167139|471243303|FG002|Transition-extension|Other|1|||
130893437|NCT02167139|471243304|FG003|Transition-extension|Other|0|||
130893438|NCT02167139|471243301|FG000|Transition-extension|Lost to Follow-up|1|||
130893439|NCT02167139|471243302|FG001|Transition-extension|Lost to Follow-up|0|||
130893440|NCT02167139|471243303|FG002|Transition-extension|Lost to Follow-up|0|||
130893441|NCT02167139|471243304|FG003|Transition-extension|Lost to Follow-up|0|||
130893442|NCT00312195|471243305|FG000|Overall Study|Adverse Event|4|||
130687250|NCT02647944|470481388|FG000|Overall Study|Withdrawal by Subject|0|||
130687251|NCT02647944|470481389|FG001|Overall Study|Withdrawal by Subject|3|||
130687252|NCT02647944|470481388|FG000|Overall Study|Adverse Event|2|||
130687253|NCT02647944|470481389|FG001|Overall Study|Adverse Event|0|||
130687254|NCT02760368|470481391|FG000|Overall Study|Withdrawal by Subject|8|||
130687255|NCT02760368|470481392|FG001|Overall Study|Withdrawal by Subject|12|||
130687256|NCT02760368|470481393|FG002|Overall Study|Withdrawal by Subject|9|||
130687257|NCT02760368|470481391|FG000|Overall Study|Screen Failure|0|||
130687258|NCT02760368|470481392|FG001|Overall Study|Screen Failure|0|||
130893443|NCT00312195|471243306|FG001|Overall Study|Adverse Event|6|||
130893444|NCT00312195|471243305|FG000|Overall Study|Lost to Follow-up|1|||
130893445|NCT00312195|471243306|FG001|Overall Study|Lost to Follow-up|0|||
130893446|NCT00312195|471243305|FG000|Overall Study|Protocol Violation|1|||
130893447|NCT00312195|471243306|FG001|Overall Study|Protocol Violation|0|||
130893448|NCT02511106|471243307|FG000|Overall Study|Lost to Follow-up|6|||
130893449|NCT02511106|471243308|FG001|Overall Study|Lost to Follow-up|4|||
130893450|NCT02511106|471243307|FG000|Overall Study|Withdrawal by Subject|24|||
130893451|NCT02511106|471243308|FG001|Overall Study|Withdrawal by Subject|21|||
130893452|NCT02511106|471243307|FG000|Overall Study|Death|42|||
130893453|NCT02511106|471243308|FG001|Overall Study|Death|82|||
130893454|NCT02511106|471243307|FG000|Overall Study|Ongoing study at data cut-off|3|||
130893455|NCT02511106|471243308|FG001|Overall Study|Ongoing study at data cut-off|2|||
130893456|NCT02511106|471243307|FG000|Overall Study|Without specified reason|3|||
130893457|NCT02511106|471243308|FG001|Overall Study|Without specified reason|0|||
130893458|NCT02657408|471243310|FG000|Overall Study|Adverse Event|3|||
130893459|NCT02657408|471243311|FG001|Overall Study|Adverse Event|7|||
130893460|NCT00324961|471243313|FG000|Overall Study|Adverse Event|5|||
130893461|NCT00324961|471243313|FG000|Overall Study|Consent Withdrawn|11|||
130893462|NCT00324961|471243313|FG000|Overall Study|Lost to Follow-up|22|||
130893463|NCT00324961|471243313|FG000|Overall Study|Protocol Violation|3|||
130893464|NCT00324961|471243313|FG000|Overall Study|Other|2|||
130893465|NCT00344487|471243314|FG000|Overall Study|immunologic failure|1|||
130893466|NCT01459497|471243320|FG000|Overall Study|Inability to meet trial constraints.|1|||
130893467|NCT01459497|471243321|FG001|Overall Study|Inability to meet trial constraints.|0|||
130893468|NCT01459497|471243320|FG000|Overall Study|Physician Decision|1|||
130893469|NCT01459497|471243321|FG001|Overall Study|Physician Decision|1|||
130893470|NCT01459497|471243320|FG000|Overall Study|Hospitalization.|0|||
130893471|NCT01459497|471243321|FG001|Overall Study|Hospitalization.|3|||
130893472|NCT01459497|471243320|FG000|Overall Study|Disease progression.|0|||
130893473|NCT01459497|471243321|FG001|Overall Study|Disease progression.|1|||
130893474|NCT03530124|471243324|FG000|Overall Study|Withdrawal by Subject|0|||
130893475|NCT03530124|471243325|FG001|Overall Study|Withdrawal by Subject|1|||
130893476|NCT03530124|471243324|FG000|Overall Study|Protocol Violation|1|||
130893477|NCT03530124|471243325|FG001|Overall Study|Protocol Violation|0|||
130893478|NCT03530124|471243324|FG000|Overall Study|Discharged prior to study completion|1|||
130893479|NCT03530124|471243325|FG001|Overall Study|Discharged prior to study completion|0|||
130893480|NCT04549545|471245315|FG000|Initial Period|Withdrawal by Subject|4|||
130893481|NCT04549545|471245316|FG001|Initial Period|Withdrawal by Subject|0|||
130893482|NCT04549545|471245315|FG000|Initial Period|Additional ENT Procedure|3|||
130893483|NCT04549545|471245316|FG001|Initial Period|Additional ENT Procedure|0|||
130893484|NCT04549545|471245315|FG000|Initial Period|Lost to Follow-up|3|||
130893485|NCT04549545|471245316|FG001|Initial Period|Lost to Follow-up|1|||
130893486|NCT04549545|471245315|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
130893487|NCT04549545|471245316|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
130893488|NCT04549545|471245315|FG000|Crossover Period|Additional ENT Procedure|0|||
130893489|NCT04549545|471245316|FG001|Crossover Period|Additional ENT Procedure|6|||
130893490|NCT04549545|471245315|FG000|Crossover Period|Lost to Follow-up|0|||
130893491|NCT04549545|471245316|FG001|Crossover Period|Lost to Follow-up|1|||
130893492|NCT04549545|471245315|FG000|Crossover Period|Withdrawal by Subject|0|||
130893493|NCT04549545|471245316|FG001|Crossover Period|Withdrawal by Subject|4|||
130893494|NCT01006291|471245317|FG000|Overall Study|Adverse Event|2|||
130893495|NCT01006291|471245318|FG001|Overall Study|Adverse Event|1|||
130893496|NCT01006291|471245319|FG002|Overall Study|Adverse Event|2|||
130893497|NCT01006291|471245317|FG000|Overall Study|Lack of Efficacy|2|||
130893498|NCT01006291|471245318|FG001|Overall Study|Lack of Efficacy|2|||
130893499|NCT01006291|471245319|FG002|Overall Study|Lack of Efficacy|1|||
130893500|NCT01006291|471245317|FG000|Overall Study|Protocol Violation|3|||
130893501|NCT01006291|471245318|FG001|Overall Study|Protocol Violation|3|||
130893502|NCT01006291|471245319|FG002|Overall Study|Protocol Violation|3|||
130893503|NCT01006291|471245317|FG000|Overall Study|Withdrawal criteria|5|||
130893504|NCT01006291|471245318|FG001|Overall Study|Withdrawal criteria|4|||
130893505|NCT01006291|471245319|FG002|Overall Study|Withdrawal criteria|4|||
130893506|NCT01006291|471245317|FG000|Overall Study|Other|14|||
130893507|NCT01006291|471245318|FG001|Overall Study|Other|14|||
130893508|NCT01006291|471245319|FG002|Overall Study|Other|17|||
130893509|NCT03079102|471245320|FG000|Overall Study|Physician Decision|0|||
130893510|NCT03079102|471245321|FG001|Overall Study|Physician Decision|1|||
130893511|NCT02810444|471245322|FG000|Overall Study|Screen Failures|14|||
130893512|NCT02810444|471245322|FG000|Overall Study|Withdrawal by Subject|4|||
130893513|NCT02810444|471245322|FG000|Overall Study|Adverse Event|3|||
131025238|NCT02590432|471723199|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131025239|NCT02590432|471723200|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131025240|NCT02590432|471723201|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130893514|NCT02785770|471245323|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
130893515|NCT02785770|471245324|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
130893516|NCT02785770|471245325|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
130893517|NCT02785770|471245326|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
130893518|NCT02785770|471245323|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
130893519|NCT02785770|471245324|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
130893520|NCT02785770|471245325|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
130893521|NCT02785770|471245326|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
130893522|NCT02785770|471245323|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
130893523|NCT02785770|471245324|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
130893524|NCT02785770|471245325|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
130893525|NCT02785770|471245326|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
130893526|NCT04518995|471245327|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
130893527|NCT04518995|471245328|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
130893528|NCT04518995|471245329|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
130893529|NCT04518995|471245327|FG000|Overall Study|Lack of Efficacy|2|||
130893530|NCT04518995|471245328|FG001|Overall Study|Lack of Efficacy|1|||
130893531|NCT04518995|471245329|FG002|Overall Study|Lack of Efficacy|0|||
130893532|NCT04518995|471245327|FG000|Overall Study|Non-compliance With Study Drug|0|||
130893533|NCT04518995|471245328|FG001|Overall Study|Non-compliance With Study Drug|3|||
130893534|NCT04518995|471245329|FG002|Overall Study|Non-compliance With Study Drug|2|||
130893535|NCT04518995|471245327|FG000|Overall Study|Pregnancy|0|||
130893536|NCT04518995|471245328|FG001|Overall Study|Pregnancy|0|||
130893537|NCT04518995|471245329|FG002|Overall Study|Pregnancy|1|||
130893538|NCT04518995|471245327|FG000|Overall Study|Protocol Violation|2|||
130893539|NCT04518995|471245328|FG001|Overall Study|Protocol Violation|0|||
130893540|NCT04518995|471245329|FG002|Overall Study|Protocol Violation|1|||
130893541|NCT04518995|471245327|FG000|Overall Study|Reason not Specified|4|||
130893542|NCT04518995|471245328|FG001|Overall Study|Reason not Specified|11|||
130893543|NCT04518995|471245329|FG002|Overall Study|Reason not Specified|2|||
130893544|NCT04518995|471245327|FG000|Overall Study|Lost to Follow-up|1|||
130893545|NCT04518995|471245328|FG001|Overall Study|Lost to Follow-up|10|||
130893546|NCT04518995|471245329|FG002|Overall Study|Lost to Follow-up|6|||
130893547|NCT02891070|471245334|FG000|Overall Study|Adverse Event|1|||
130893548|NCT02891070|471245335|FG001|Overall Study|Adverse Event|0|||
130893549|NCT02891070|471245334|FG000|Overall Study|Physician Decision|0|||
130893550|NCT02891070|471245335|FG001|Overall Study|Physician Decision|1|||
130893551|NCT02891070|471245334|FG000|Overall Study|Lost to Follow-up|4|||
130893552|NCT02891070|471245335|FG001|Overall Study|Lost to Follow-up|4|||
130893553|NCT02891070|471245334|FG000|Overall Study|Other|1|||
130893554|NCT02891070|471245335|FG001|Overall Study|Other|0|||
130893555|NCT02891070|471245334|FG000|Overall Study|Protocol Violation|0|||
130893556|NCT02891070|471245335|FG001|Overall Study|Protocol Violation|1|||
130893557|NCT02891070|471245334|FG000|Overall Study|Withdrawal by Subject|1|||
130893558|NCT02891070|471245335|FG001|Overall Study|Withdrawal by Subject|2|||
130893559|NCT02891070|471245334|FG000|Overall Study|Death|3|||
130893560|NCT02891070|471245335|FG001|Overall Study|Death|0|||
130893561|NCT04491604|471245338|FG000|Overall Study|Withdrawal by Subject|3|||
130893562|NCT00545272|471245339|FG000|Overall Study|Protocol deviation|0|||
130893563|NCT00545272|471245340|FG001|Overall Study|Protocol deviation|1|||
130893564|NCT00545272|471245341|FG002|Overall Study|Protocol deviation|0|||
130893565|NCT00545272|471245342|FG003|Overall Study|Protocol deviation|1|||
130893566|NCT00545272|471245343|FG004|Overall Study|Protocol deviation|0|||
130893567|NCT00545272|471245344|FG005|Overall Study|Protocol deviation|1|||
130893568|NCT00545272|471245339|FG000|Overall Study|Adverse Event|0|||
130893569|NCT00545272|471245340|FG001|Overall Study|Adverse Event|0|||
130893570|NCT00545272|471245341|FG002|Overall Study|Adverse Event|1|||
130893571|NCT00545272|471245342|FG003|Overall Study|Adverse Event|0|||
130893572|NCT00545272|471245343|FG004|Overall Study|Adverse Event|0|||
130893573|NCT00545272|471245344|FG005|Overall Study|Adverse Event|1|||
130893574|NCT00545272|471245339|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130893575|NCT00545272|471245340|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130893576|NCT00545272|471245341|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130893577|NCT00545272|471245342|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130893578|NCT00545272|471245343|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130893579|NCT00545272|471245344|FG005|Overall Study|Abnormal laboratory value(s)|1|||
130893580|NCT00545272|471245339|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130893581|NCT00545272|471245340|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130893582|NCT00545272|471245341|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130893583|NCT00545272|471245342|FG003|Overall Study|Abnormal test procedure result(s)|0|||
130893584|NCT00545272|471245343|FG004|Overall Study|Abnormal test procedure result(s)|1|||
130893585|NCT00545272|471245344|FG005|Overall Study|Abnormal test procedure result(s)|0|||
130893586|NCT00545272|471245339|FG000|Overall Study|Lost to Follow-up|0|||
130893587|NCT00545272|471245340|FG001|Overall Study|Lost to Follow-up|0|||
130893588|NCT00545272|471245341|FG002|Overall Study|Lost to Follow-up|0|||
130893589|NCT00545272|471245342|FG003|Overall Study|Lost to Follow-up|0|||
130893590|NCT00545272|471245343|FG004|Overall Study|Lost to Follow-up|1|||
130893591|NCT00545272|471245344|FG005|Overall Study|Lost to Follow-up|0|||
130893592|NCT02934503|471245345|FG000|Overall Study|progression of disease|3|||
130767088|NCT02117713|470770727|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
130893593|NCT02934503|471245345|FG000|Overall Study|Withdrawal by Subject|1|||
130893594|NCT00724867|471245346|FG000|Overall Study|Adverse Event|25|||
130893595|NCT00724867|471245346|FG000|Overall Study|Lack of Efficacy|14|||
130893596|NCT00724867|471245346|FG000|Overall Study|Lost to Follow-up|12|||
130893597|NCT00724867|471245346|FG000|Overall Study|Non-compliance with study drug|6|||
130893598|NCT00724867|471245346|FG000|Overall Study|Physician Decision|17|||
130893599|NCT00724867|471245346|FG000|Overall Study|Protocol Violation|1|||
130893600|NCT00724867|471245346|FG000|Overall Study|Withdrawal by Subject|31|||
130893601|NCT00724867|471245346|FG000|Overall Study|Sponsor decision to end study|14|||
130893602|NCT00724867|471245346|FG000|Overall Study|Subject incarcerated|1|||
130893603|NCT00724867|471245346|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
130893604|NCT00724867|471245346|FG000|Overall Study|Subject moved out of state|1|||
130893605|NCT00724867|471245346|FG000|Overall Study|Elected to exit due to site closure|2|||
130893606|NCT04335136|471245348|FG000|Overall Study|Death|8|||
130893607|NCT04335136|471245349|FG001|Overall Study|Death|4|||
130893608|NCT04335136|471245348|FG000|Overall Study|Lost to Follow-up|2|||
130893609|NCT04335136|471245349|FG001|Overall Study|Lost to Follow-up|0|||
130893610|NCT04335136|471245348|FG000|Overall Study|Protocol Violation|1|||
130893611|NCT04335136|471245349|FG001|Overall Study|Protocol Violation|0|||
130893612|NCT04335136|471245348|FG000|Overall Study|Withdrawal by Subject|1|||
130893613|NCT04335136|471245349|FG001|Overall Study|Withdrawal by Subject|1|||
130893614|NCT04335136|471245348|FG000|Overall Study|Health-threatening condition|0|||
130893615|NCT04335136|471245349|FG001|Overall Study|Health-threatening condition|1|||
130893616|NCT04335136|471245348|FG000|Overall Study|Adverse Event|0|||
130893617|NCT04335136|471245349|FG001|Overall Study|Adverse Event|1|||
130893618|NCT04335136|471245348|FG000|Overall Study|Erroneously randomized|2|||
130893619|NCT04335136|471245349|FG001|Overall Study|Erroneously randomized|0|||
130893620|NCT02834793|471245350|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
130893621|NCT02834793|471245351|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
130893622|NCT02834793|471245352|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
130893623|NCT02834793|471245353|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
130893624|NCT02834793|471245350|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
130893625|NCT02834793|471245351|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
130893626|NCT02834793|471245352|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
130893627|NCT02834793|471245353|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
130893628|NCT02834793|471245350|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
130893629|NCT02834793|471245351|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
130893630|NCT02834793|471245352|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
130893631|NCT02834793|471245353|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
130893632|NCT02834793|471245350|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
130893633|NCT02834793|471245351|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
130893634|NCT02834793|471245352|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
130893635|NCT02834793|471245353|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
130893636|NCT02834793|471245350|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
130893637|NCT02834793|471245351|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
130893638|NCT02834793|471245352|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
130893639|NCT02834793|471245353|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
130893640|NCT02834793|471245350|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
130893641|NCT02834793|471245351|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
130893642|NCT02834793|471245352|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
130893643|NCT02834793|471245353|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
130893644|NCT02834793|471245350|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
130893645|NCT02834793|471245351|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
130893646|NCT02834793|471245352|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
131110655|NCT01294683|472035716|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
131110656|NCT01294683|472035715|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
131110657|NCT01294683|472035716|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
131110658|NCT01294683|472035715|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
130893647|NCT02834793|471245353|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
130893648|NCT02834793|471245350|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
130893649|NCT02834793|471245351|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
130893650|NCT02834793|471245352|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
130893651|NCT02834793|471245353|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
130893652|NCT02834793|471245350|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
130893653|NCT02834793|471245351|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
130893654|NCT02834793|471245352|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
130893655|NCT02834793|471245353|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
130893656|NCT02834793|471245350|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
130893657|NCT02834793|471245351|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
130893658|NCT02834793|471245352|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
130893659|NCT02834793|471245353|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
130893660|NCT02834793|471245350|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
131110659|NCT01294683|472035716|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
131110660|NCT01294683|472035715|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
131110661|NCT01294683|472035716|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
130893661|NCT02834793|471245351|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
130893662|NCT02834793|471245352|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
130893663|NCT02834793|471245353|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
130893664|NCT02834793|471245350|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
130893665|NCT02834793|471245351|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
130893666|NCT02834793|471245352|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
130893667|NCT02834793|471245353|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
130893668|NCT02834793|471245350|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
130893669|NCT02834793|471245351|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
130893670|NCT02834793|471245352|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
130893671|NCT02834793|471245353|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
130893672|NCT02834793|471245350|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
130893673|NCT02834793|471245351|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
130893674|NCT02834793|471245352|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
130893675|NCT02834793|471245353|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
130893676|NCT02834793|471245350|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
130893677|NCT02834793|471245351|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
130893678|NCT02834793|471245352|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
130893679|NCT02834793|471245353|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
130893680|NCT01049009|471245354|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
130893681|NCT01049009|471245355|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
130893682|NCT01049009|471245354|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130893683|NCT01049009|471245355|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130893684|NCT01049009|471245354|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
130893685|NCT01049009|471245355|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
130893686|NCT01049009|471245354|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
130893687|NCT01049009|471245355|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
130893688|NCT02423902|471245356|FG000|Overall Study|Disease progression|1|||
130893689|NCT02423902|471245357|FG001|Overall Study|Disease progression|4|||
130893690|NCT02136069|471245358|FG000|Overall Study|UC flare-up|1|||
130893691|NCT02136069|471245359|FG001|Overall Study|UC flare-up|0|||
130893692|NCT02136069|471245358|FG000|Overall Study|Adverse Event|6|||
130893693|NCT02136069|471245359|FG001|Overall Study|Adverse Event|8|||
130893694|NCT02136069|471245358|FG000|Overall Study|Death|0|||
130893695|NCT02136069|471245359|FG001|Overall Study|Death|1|||
130893696|NCT02136069|471245358|FG000|Overall Study|Lack of Efficacy|10|||
130893697|NCT02136069|471245359|FG001|Overall Study|Lack of Efficacy|4|||
130893698|NCT02136069|471245358|FG000|Overall Study|Lost to Follow-up|1|||
130893699|NCT02136069|471245359|FG001|Overall Study|Lost to Follow-up|0|||
130893700|NCT02136069|471245358|FG000|Overall Study|Non-Compliance|1|||
130893701|NCT02136069|471245359|FG001|Overall Study|Non-Compliance|0|||
130893702|NCT02136069|471245358|FG000|Overall Study|Physician Decision|5|||
130893703|NCT02136069|471245359|FG001|Overall Study|Physician Decision|4|||
130893704|NCT02136069|471245358|FG000|Overall Study|Withdrawal by Subject|10|||
130893705|NCT02136069|471245359|FG001|Overall Study|Withdrawal by Subject|11|||
130893706|NCT04538144|471245360|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
130893707|NCT04538144|471245361|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
130893708|NCT04538144|471245362|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
130893709|NCT04538144|471245363|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
130893710|NCT01092546|471245364|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
130893711|NCT00622440|471245365|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
130893712|NCT00622440|471245366|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
130893713|NCT00622440|471245365|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
130893714|NCT00622440|471245366|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
130893715|NCT00622440|471245365|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
130893716|NCT00622440|471245366|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
130893717|NCT00622440|471245365|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
130893718|NCT00622440|471245366|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
131110662|NCT01294683|472035715|FG000|Post Crossover (Period III)|Adverse Event|6|||
131110663|NCT01294683|472035716|FG001|Post Crossover (Period III)|Adverse Event|6|||
131110664|NCT01294683|472035715|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
131110665|NCT01294683|472035716|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
131110666|NCT01294683|472035715|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
131110667|NCT01294683|472035716|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
131110668|NCT01294683|472035715|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
131110669|NCT01294683|472035716|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
131110670|NCT01881750|472035717|FG000|Overall Study|Changes in concomitant therapies|2|||
130893719|NCT01667419|471245371|FG000|Overall Study|Reason Not Specified|1|||
130893720|NCT01667419|471245372|FG001|Overall Study|Reason Not Specified|0|||
130893721|NCT01667419|471245373|FG002|Overall Study|Reason Not Specified|0|||
130893722|NCT01667419|471245374|FG003|Overall Study|Reason Not Specified|0|||
130893723|NCT01667419|471245371|FG000|Overall Study|Withdrawal by Subject|16|||
130893724|NCT01667419|471245372|FG001|Overall Study|Withdrawal by Subject|8|||
130893725|NCT01667419|471245373|FG002|Overall Study|Withdrawal by Subject|9|||
130893726|NCT01667419|471245374|FG003|Overall Study|Withdrawal by Subject|8|||
130687259|NCT02760368|470481393|FG002|Overall Study|Screen Failure|1|||
130687260|NCT02760368|470481391|FG000|Overall Study|Death|0|||
130687261|NCT02760368|470481392|FG001|Overall Study|Death|1|||
130687262|NCT02760368|470481393|FG002|Overall Study|Death|0|||
130687263|NCT02760368|470481391|FG000|Overall Study|Withdrawal by Sponsor|0|||
130687264|NCT02760368|470481392|FG001|Overall Study|Withdrawal by Sponsor|0|||
130687265|NCT02760368|470481393|FG002|Overall Study|Withdrawal by Sponsor|1|||
130687266|NCT02714062|470481394|FG000|Overall Study|Adverse Event|0|||
130687267|NCT02714062|470481395|FG001|Overall Study|Adverse Event|0|||
130687268|NCT02714062|470481396|FG002|Overall Study|Adverse Event|2|||
130687269|NCT02714062|470481394|FG000|Overall Study|Withdrawal by Subject|1|||
130687270|NCT02714062|470481395|FG001|Overall Study|Withdrawal by Subject|0|||
130687271|NCT02714062|470481396|FG002|Overall Study|Withdrawal by Subject|1|||
130687272|NCT02714062|470481394|FG000|Overall Study|Protocol Violation|0|||
130687273|NCT02714062|470481395|FG001|Overall Study|Protocol Violation|1|||
130687274|NCT02714062|470481396|FG002|Overall Study|Protocol Violation|0|||
130687275|NCT02294604|470481397|FG000|Overall Study|Did not provide samples for culture|0|||
130687276|NCT02294604|470481398|FG001|Overall Study|Did not provide samples for culture|1|||
130687277|NCT02294604|470481399|FG002|Overall Study|Did not provide samples for culture|0|||
130687278|NCT02294604|470481397|FG000|Overall Study|Culture contamination|1|||
130687279|NCT02294604|470481398|FG001|Overall Study|Culture contamination|2|||
130687280|NCT02294604|470481399|FG002|Overall Study|Culture contamination|0|||
130687281|NCT02902211|470481404|FG000|First Three Months|Withdrawal by Subject|7|||
130687282|NCT02902211|470481405|FG001|First Three Months|Withdrawal by Subject|3|||
130687283|NCT01200810|470481415|FG000|Overall Study|Physician Decision|1|||
130687284|NCT01200810|470481416|FG001|Overall Study|Physician Decision|0|||
130687285|NCT01200810|470481415|FG000|Overall Study|Withdrawal by Subject|1|||
130687286|NCT01200810|470481416|FG001|Overall Study|Withdrawal by Subject|2|||
130687287|NCT01200810|470481415|FG000|Overall Study|Sponsor stopped making study drug|3|||
130687288|NCT01200810|470481416|FG001|Overall Study|Sponsor stopped making study drug|3|||
130687289|NCT00904215|470481418|FG000|Overall Study|Adverse Event|25|||
130687290|NCT00904215|470481418|FG000|Overall Study|Protocol Violation|10|||
130687291|NCT00904215|470481418|FG000|Overall Study|Lost to Follow-up|63|||
130687292|NCT00904215|470481418|FG000|Overall Study|Withdrawal by Subject|9|||
130687293|NCT00904215|470481418|FG000|Overall Study|Other|28|||
130687294|NCT00960297|470481419|FG000|Overall Study|Physician Decision|1|||
130687295|NCT00960297|470481419|FG000|Overall Study|Venous port infection|1|||
130687296|NCT00960297|470481419|FG000|Overall Study|Disease progression|1|||
130687297|NCT00838630|470481428|FG000|First Intervention|Adverse Event|1|||
130687298|NCT00838630|470481429|FG001|First Intervention|Adverse Event|0|||
130687299|NCT00838630|470481428|FG000|Washout: 7 Days|Protocol Violation|1|||
130687300|NCT00838630|470481429|FG001|Washout: 7 Days|Protocol Violation|0|||
130687301|NCT02159950|470481437|FG000|Overall Study|Adverse Event|0|||
130687302|NCT02159950|470481438|FG001|Overall Study|Adverse Event|1|||
130687303|NCT02159950|470481437|FG000|Overall Study|Progression|0|||
130687304|NCT02159950|470481438|FG001|Overall Study|Progression|1|||
130687305|NCT03925532|470481439|FG000|Overall Study|Lost to Follow-up|1|||
130687306|NCT01208337|470481440|FG000|Overall Study|Death|3|||
130687307|NCT03663179|470481444|FG000|Overall Study|Withdrawal by Subject|2|||
130687308|NCT03663179|470481445|FG001|Overall Study|Withdrawal by Subject|0|||
130687309|NCT03663179|470481444|FG000|Overall Study|Lost to Follow-up|1|||
130687310|NCT03663179|470481445|FG001|Overall Study|Lost to Follow-up|1|||
130687311|NCT03663179|470481444|FG000|Overall Study|Revealed exclusionary condition|1|||
130687312|NCT03663179|470481445|FG001|Overall Study|Revealed exclusionary condition|0|||
130687313|NCT01615198|470481446|FG000|Overall Study|Withdrawal by Subject|5|||
130687314|NCT01615198|470481447|FG001|Overall Study|Withdrawal by Subject|5|||
130687315|NCT01615198|470481446|FG000|Overall Study|Protocol deviation|1|||
130687316|NCT01615198|470481447|FG001|Overall Study|Protocol deviation|1|||
130687317|NCT01615198|470481446|FG000|Overall Study|Physician Decision|5|||
130687318|NCT01615198|470481447|FG001|Overall Study|Physician Decision|1|||
130687319|NCT01615198|470481446|FG000|Overall Study|Lost to Follow-up|1|||
130687320|NCT01615198|470481447|FG001|Overall Study|Lost to Follow-up|1|||
130687321|NCT01615198|470481446|FG000|Overall Study|Lack of Efficacy|1|||
131025241|NCT02590432|471723202|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131222692|NCT03402126|472443160|FG000|Overall Study|Death|4|||
130687322|NCT01615198|470481447|FG001|Overall Study|Lack of Efficacy|6|||
130687323|NCT01615198|470481446|FG000|Overall Study|Adverse Event|11|||
130687324|NCT01615198|470481447|FG001|Overall Study|Adverse Event|5|||
130687325|NCT02196675|470481448|FG000|Overall Study|Withdrawal by Subject|1|||
130687326|NCT02196675|470481449|FG001|Overall Study|Withdrawal by Subject|0|||
130687327|NCT02196675|470481450|FG002|Overall Study|Withdrawal by Subject|0|||
130687328|NCT02196675|470481448|FG000|Overall Study|Intra-operative surgical exclusion|1|||
130687329|NCT02196675|470481449|FG001|Overall Study|Intra-operative surgical exclusion|1|||
130687330|NCT02196675|470481450|FG002|Overall Study|Intra-operative surgical exclusion|0|||
130687331|NCT02196675|470481448|FG000|Overall Study|Protocol Violation|0|||
130687332|NCT02196675|470481449|FG001|Overall Study|Protocol Violation|1|||
130687333|NCT02196675|470481450|FG002|Overall Study|Protocol Violation|0|||
130687334|NCT02196675|470481448|FG000|Overall Study|Death|0|||
130893727|NCT01667419|471245371|FG000|Overall Study|Non-compliance|0|||
130893728|NCT01667419|471245372|FG001|Overall Study|Non-compliance|0|||
130893729|NCT01667419|471245373|FG002|Overall Study|Non-compliance|0|||
130893730|NCT01667419|471245374|FG003|Overall Study|Non-compliance|1|||
130893731|NCT01667419|471245371|FG000|Overall Study|Protocol Violation|1|||
130893732|NCT01667419|471245372|FG001|Overall Study|Protocol Violation|0|||
130893733|NCT01667419|471245373|FG002|Overall Study|Protocol Violation|0|||
130893734|NCT01667419|471245374|FG003|Overall Study|Protocol Violation|0|||
130893735|NCT01667419|471245371|FG000|Overall Study|Lost to Follow-up|7|||
130893736|NCT01667419|471245372|FG001|Overall Study|Lost to Follow-up|6|||
130893737|NCT01667419|471245373|FG002|Overall Study|Lost to Follow-up|2|||
130893738|NCT01667419|471245374|FG003|Overall Study|Lost to Follow-up|4|||
130893739|NCT01667419|471245371|FG000|Overall Study|Death|18|||
130893740|NCT01667419|471245372|FG001|Overall Study|Death|33|||
130893741|NCT01667419|471245373|FG002|Overall Study|Death|25|||
130893742|NCT01667419|471245374|FG003|Overall Study|Death|26|||
130893743|NCT04364984|471245375|FG000|Overall Study|Death|2|||
130893744|NCT04364984|471245376|FG001|Overall Study|Death|2|||
130893745|NCT04364984|471245377|FG002|Overall Study|Death|0|||
130893746|NCT01941186|471245378|FG000|Follow-up|Lost to Follow-up|1|||
130893747|NCT01941186|471245379|FG001|Follow-up|Lost to Follow-up|0|||
130893748|NCT02722304|471245380|FG000|Overall Study|Study Terminated by Sponsor|1|||
130893749|NCT02722304|471245381|FG001|Overall Study|Study Terminated by Sponsor|0|||
130893750|NCT02722304|471245382|FG002|Overall Study|Study Terminated by Sponsor|2|||
130893751|NCT02722304|471245383|FG003|Overall Study|Study Terminated by Sponsor|1|||
130893752|NCT02722304|471245384|FG004|Overall Study|Study Terminated by Sponsor|1|||
130893753|NCT02722304|471245380|FG000|Overall Study|Other|0|||
130893754|NCT02722304|471245381|FG001|Overall Study|Other|0|||
130893755|NCT02722304|471245382|FG002|Overall Study|Other|0|||
130893756|NCT02722304|471245383|FG003|Overall Study|Other|1|||
130893757|NCT02722304|471245384|FG004|Overall Study|Other|1|||
130893758|NCT01068600|471245385|FG000|Overall Study|Withdrawal by Subject|5|||
130893759|NCT01068600|471245386|FG001|Overall Study|Withdrawal by Subject|6|||
130893760|NCT01068600|471245385|FG000|Overall Study|Adverse Event|3|||
130893761|NCT01068600|471245386|FG001|Overall Study|Adverse Event|3|||
130893762|NCT01068600|471245385|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130893763|NCT01068600|471245386|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130893764|NCT01068600|471245385|FG000|Overall Study|Lost to Follow-up|1|||
130893765|NCT01068600|471245386|FG001|Overall Study|Lost to Follow-up|2|||
130893766|NCT01068600|471245385|FG000|Overall Study|Protocol deviation|1|||
130893767|NCT01068600|471245386|FG001|Overall Study|Protocol deviation|1|||
130893768|NCT01068600|471245385|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130893769|NCT01068600|471245386|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130893770|NCT01068600|471245385|FG000|Overall Study|Administrative problems|0|||
130893771|NCT01068600|471245386|FG001|Overall Study|Administrative problems|1|||
130893772|NCT05343624|471245390|FG000|Overall Study|Chart review not completed|1|||
130893773|NCT00862082|471245391|FG000|Overall Study|Sponsor decision to terminate the study|5|||
130893774|NCT00862082|471245392|FG001|Overall Study|Sponsor decision to terminate the study|0|||
130893775|NCT00862082|471245391|FG000|Overall Study|Withdrawal by Subject|0|||
130893776|NCT00862082|471245392|FG001|Overall Study|Withdrawal by Subject|1|||
130893777|NCT02447302|471245404|FG000|Overall Study|Physician Decision|1|||
130893778|NCT02447302|471245405|FG001|Overall Study|Physician Decision|0|||
130893779|NCT02447302|471245406|FG002|Overall Study|Physician Decision|0|||
130893780|NCT02447302|471245404|FG000|Overall Study|Adverse Event|4|||
130893781|NCT02447302|471245405|FG001|Overall Study|Adverse Event|3|||
130893782|NCT02447302|471245406|FG002|Overall Study|Adverse Event|0|||
130893783|NCT02447302|471245404|FG000|Overall Study|Withdrawal by Subject|0|||
130893784|NCT02447302|471245405|FG001|Overall Study|Withdrawal by Subject|1|||
130893785|NCT02447302|471245406|FG002|Overall Study|Withdrawal by Subject|5|||
130893786|NCT02447302|471245404|FG000|Overall Study|Sponsor Decision|0|||
131025242|NCT02590432|471723203|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
130893787|NCT02447302|471245405|FG001|Overall Study|Sponsor Decision|0|||
131025243|NCT02590432|471723204|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
130893788|NCT02447302|471245406|FG002|Overall Study|Sponsor Decision|1|||
130893789|NCT01456897|471245411|FG000|Overall Study|Adverse Event|19|||
130893790|NCT01456897|471245412|FG001|Overall Study|Adverse Event|22|||
131025244|NCT02590432|471723205|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131025245|NCT02590432|471723206|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
131025246|NCT02590432|471723198|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
130893791|NCT01456897|471245411|FG000|Overall Study|Protocol Violation|3|||
130893792|NCT01456897|471245412|FG001|Overall Study|Protocol Violation|4|||
130893793|NCT01456897|471245411|FG000|Overall Study|Physician Decision|5|||
130893794|NCT01456897|471245412|FG001|Overall Study|Physician Decision|3|||
131025247|NCT02590432|471723199|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
130893795|NCT01456897|471245411|FG000|Overall Study|Withdrawal by Subject|44|||
131025248|NCT02590432|471723200|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
130893796|NCT01456897|471245412|FG001|Overall Study|Withdrawal by Subject|17|||
130893797|NCT01456897|471245411|FG000|Overall Study|Lack of Efficacy|4|||
130893798|NCT01456897|471245412|FG001|Overall Study|Lack of Efficacy|11|||
130893799|NCT01396070|471245418|FG000|Overall Study|Withdrawal by Subject|2|||
130893800|NCT01396070|471245418|FG000|Overall Study|Death|2|||
130893801|NCT01396070|471245418|FG000|Overall Study|Adverse Event|8|||
130893802|NCT01396070|471245418|FG000|Overall Study|Physician Decision|3|||
130893803|NCT01396070|471245418|FG000|Overall Study|Lack of Efficacy|4|||
130893804|NCT04254913|471245420|FG000|Overall Study|Adverse Event|1|||
130893805|NCT01396057|471245421|FG000|Overall Study|Adverse Event|2|||
130893806|NCT01396057|471245422|FG001|Overall Study|Adverse Event|6|||
130893807|NCT01396057|471245421|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130893808|NCT01396057|471245422|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130893809|NCT01396057|471245421|FG000|Overall Study|Protocol deviation|4|||
130893810|NCT01396057|471245422|FG001|Overall Study|Protocol deviation|4|||
130893811|NCT01396057|471245421|FG000|Overall Study|Consent withdrawn|3|||
130893812|NCT01396057|471245422|FG001|Overall Study|Consent withdrawn|2|||
130893813|NCT02695420|471245423|FG000|Overall Study|Death|0|||
130893814|NCT02695420|471245424|FG001|Overall Study|Death|1|||
130893815|NCT02695420|471245425|FG002|Overall Study|Death|0|||
130893816|NCT02695420|471245426|FG003|Overall Study|Death|0|||
130893817|NCT00916929|471245427|FG000|Overall Study|Lost to Follow-up|1|||
130893818|NCT00916929|471245428|FG001|Overall Study|Lost to Follow-up|3|||
130893819|NCT00916929|471245427|FG000|Overall Study|Death|5|||
130893820|NCT00916929|471245428|FG001|Overall Study|Death|10|||
130893821|NCT00916929|471245427|FG000|Overall Study|Withdrawal by Subject|1|||
130893822|NCT00916929|471245428|FG001|Overall Study|Withdrawal by Subject|5|||
130893823|NCT00916929|471245427|FG000|Overall Study|Left ventricular epicardial lead|1|||
130893824|NCT00916929|471245428|FG001|Overall Study|Left ventricular epicardial lead|2|||
130893825|NCT00916929|471245427|FG000|Overall Study|Transferred to hospice care|1|||
130893826|NCT00916929|471245428|FG001|Overall Study|Transferred to hospice care|1|||
130893827|NCT00916929|471245427|FG000|Overall Study|System explant|1|||
130893828|NCT00916929|471245428|FG001|Overall Study|System explant|0|||
130893829|NCT00916929|471245427|FG000|Overall Study|Moved to another state|0|||
130893830|NCT00916929|471245428|FG001|Overall Study|Moved to another state|1|||
130893831|NCT00916929|471245427|FG000|Overall Study|Device unable to process impedance data|0|||
130893832|NCT00916929|471245428|FG001|Overall Study|Device unable to process impedance data|7|||
130893833|NCT01742286|471245430|FG000|Escalation Phase|Administrative problems|1|||
130893834|NCT01742286|471245431|FG001|Escalation Phase|Administrative problems|1|||
130893835|NCT01742286|471245432|FG002|Escalation Phase|Administrative problems|0|||
130893836|NCT01742286|471245433|FG003|Escalation Phase|Administrative problems|0|||
130893837|NCT01742286|471245434|FG004|Escalation Phase|Administrative problems|0|||
130893838|NCT01742286|471245435|FG005|Escalation Phase|Administrative problems|0|||
130893839|NCT01742286|471245436|FG006|Escalation Phase|Administrative problems|2|||
130893840|NCT01742286|471245430|FG000|Escalation Phase|Adverse Event|0|||
130893841|NCT01742286|471245431|FG001|Escalation Phase|Adverse Event|1|||
130893842|NCT01742286|471245432|FG002|Escalation Phase|Adverse Event|2|||
130893843|NCT01742286|471245433|FG003|Escalation Phase|Adverse Event|0|||
130893844|NCT01742286|471245434|FG004|Escalation Phase|Adverse Event|0|||
130893845|NCT01742286|471245435|FG005|Escalation Phase|Adverse Event|1|||
130893846|NCT01742286|471245436|FG006|Escalation Phase|Adverse Event|0|||
130893847|NCT01742286|471245430|FG000|Escalation Phase|Disease progression|3|||
130893848|NCT01742286|471245431|FG001|Escalation Phase|Disease progression|7|||
130893849|NCT01742286|471245432|FG002|Escalation Phase|Disease progression|4|||
130893850|NCT01742286|471245433|FG003|Escalation Phase|Disease progression|1|||
130893851|NCT01742286|471245434|FG004|Escalation Phase|Disease progression|4|||
130893852|NCT01742286|471245435|FG005|Escalation Phase|Disease progression|3|||
130893853|NCT01742286|471245436|FG006|Escalation Phase|Disease progression|2|||
130893854|NCT01742286|471245430|FG000|Escalation Phase|Death|0|||
130893855|NCT01742286|471245431|FG001|Escalation Phase|Death|0|||
130893856|NCT01742286|471245432|FG002|Escalation Phase|Death|0|||
130687335|NCT02196675|470481449|FG001|Overall Study|Death|0|||
130687336|NCT02196675|470481450|FG002|Overall Study|Death|1|||
130687337|NCT02414152|470481451|FG000|Overall Study|Withdrawal by Subject|1|||
130893857|NCT01742286|471245433|FG003|Escalation Phase|Death|0|||
130893858|NCT01742286|471245434|FG004|Escalation Phase|Death|0|||
130893859|NCT01742286|471245435|FG005|Escalation Phase|Death|1|||
130893860|NCT01742286|471245436|FG006|Escalation Phase|Death|0|||
130893861|NCT01742286|471245430|FG000|Escalation Phase|Physician Decision|0|||
130893862|NCT01742286|471245431|FG001|Escalation Phase|Physician Decision|3|||
130893863|NCT01742286|471245432|FG002|Escalation Phase|Physician Decision|0|||
130893864|NCT01742286|471245433|FG003|Escalation Phase|Physician Decision|1|||
130893865|NCT01742286|471245434|FG004|Escalation Phase|Physician Decision|0|||
130893866|NCT01742286|471245435|FG005|Escalation Phase|Physician Decision|0|||
130893867|NCT01742286|471245436|FG006|Escalation Phase|Physician Decision|2|||
130893868|NCT01742286|471245430|FG000|Escalation Phase|Subject/guardian decision|1|||
130893869|NCT01742286|471245431|FG001|Escalation Phase|Subject/guardian decision|0|||
130893870|NCT01742286|471245432|FG002|Escalation Phase|Subject/guardian decision|0|||
130687338|NCT02414152|470481451|FG000|Overall Study|Lack of Efficacy|1|||
130893871|NCT01742286|471245433|FG003|Escalation Phase|Subject/guardian decision|0|||
130893872|NCT01742286|471245434|FG004|Escalation Phase|Subject/guardian decision|0|||
130893873|NCT01742286|471245435|FG005|Escalation Phase|Subject/guardian decision|0|||
130893874|NCT01742286|471245436|FG006|Escalation Phase|Subject/guardian decision|0|||
130893875|NCT01742286|471245430|FG000|Expansion Phase|Administrative problems|0|||
130893876|NCT01742286|471245431|FG001|Expansion Phase|Administrative problems|0|||
130893877|NCT01742286|471245432|FG002|Expansion Phase|Administrative problems|0|||
130893878|NCT01742286|471245433|FG003|Expansion Phase|Administrative problems|0|||
130893879|NCT01742286|471245434|FG004|Expansion Phase|Administrative problems|0|||
130893880|NCT01742286|471245435|FG005|Expansion Phase|Administrative problems|0|||
130893881|NCT01742286|471245436|FG006|Expansion Phase|Administrative problems|5|||
130893882|NCT01742286|471245430|FG000|Expansion Phase|Physician Decision|0|||
130893883|NCT01742286|471245431|FG001|Expansion Phase|Physician Decision|0|||
130893884|NCT01742286|471245432|FG002|Expansion Phase|Physician Decision|4|||
130893885|NCT01742286|471245433|FG003|Expansion Phase|Physician Decision|0|||
130893886|NCT01742286|471245434|FG004|Expansion Phase|Physician Decision|0|||
130893887|NCT01742286|471245435|FG005|Expansion Phase|Physician Decision|0|||
130893888|NCT01742286|471245436|FG006|Expansion Phase|Physician Decision|9|||
130893889|NCT01742286|471245430|FG000|Expansion Phase|Adverse Event|0|||
130893890|NCT01742286|471245431|FG001|Expansion Phase|Adverse Event|0|||
130893891|NCT01742286|471245432|FG002|Expansion Phase|Adverse Event|0|||
130893892|NCT01742286|471245433|FG003|Expansion Phase|Adverse Event|0|||
130893893|NCT01742286|471245434|FG004|Expansion Phase|Adverse Event|0|||
130893894|NCT01742286|471245435|FG005|Expansion Phase|Adverse Event|0|||
130893895|NCT01742286|471245436|FG006|Expansion Phase|Adverse Event|6|||
130893896|NCT01742286|471245430|FG000|Expansion Phase|Disease progression|0|||
130893897|NCT01742286|471245431|FG001|Expansion Phase|Disease progression|0|||
130893898|NCT01742286|471245432|FG002|Expansion Phase|Disease progression|3|||
130893899|NCT01742286|471245433|FG003|Expansion Phase|Disease progression|0|||
130893900|NCT01742286|471245434|FG004|Expansion Phase|Disease progression|0|||
130893901|NCT01742286|471245435|FG005|Expansion Phase|Disease progression|0|||
130893902|NCT01742286|471245436|FG006|Expansion Phase|Disease progression|15|||
130893903|NCT01742286|471245430|FG000|Expansion Phase|Withdrawal by Subject|0|||
130893904|NCT01742286|471245431|FG001|Expansion Phase|Withdrawal by Subject|0|||
130893905|NCT01742286|471245432|FG002|Expansion Phase|Withdrawal by Subject|0|||
130893906|NCT01742286|471245433|FG003|Expansion Phase|Withdrawal by Subject|0|||
130893907|NCT01742286|471245434|FG004|Expansion Phase|Withdrawal by Subject|0|||
130893908|NCT01742286|471245435|FG005|Expansion Phase|Withdrawal by Subject|0|||
130893909|NCT01742286|471245436|FG006|Expansion Phase|Withdrawal by Subject|1|||
130893910|NCT04530136|471245437|FG000|Overall Study|Lost to Follow-up|2|||
130893911|NCT04530136|471245438|FG001|Overall Study|Lost to Follow-up|3|||
130893912|NCT04530136|471245437|FG000|Overall Study|Withdrawal by Subject|1|||
130893913|NCT04530136|471245438|FG001|Overall Study|Withdrawal by Subject|0|||
130893914|NCT04530136|471245437|FG000|Overall Study|Death|0|||
130893915|NCT04530136|471245438|FG001|Overall Study|Death|1|||
130893916|NCT01233232|471245441|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
130893917|NCT01233232|471245442|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
130893918|NCT01233232|471245443|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
130893919|NCT02762370|471245444|FG000|Overall Study|Protocol Violation|1|||
130893920|NCT02762370|471245445|FG001|Overall Study|Protocol Violation|0|||
130893921|NCT03500224|471245446|FG000|Overall Study|Withdrawal by Subject|2|||
130893922|NCT01324401|471245449|FG000|Overall Study|Withdrawn before any treatment|0|||
130893923|NCT01324401|471245450|FG001|Overall Study|Withdrawn before any treatment|3|||
130893924|NCT01324401|471245449|FG000|Overall Study|Adverse Event|1|||
130893925|NCT01324401|471245450|FG001|Overall Study|Adverse Event|3|||
130893926|NCT01708902|471245452|FG000|Overall Study|Adverse Event|3|||
130893927|NCT01708902|471245453|FG001|Overall Study|Adverse Event|4|||
130893928|NCT01708902|471245454|FG002|Overall Study|Adverse Event|9|||
130893929|NCT01708902|471245455|FG003|Overall Study|Adverse Event|2|||
130893930|NCT01708902|471245456|FG004|Overall Study|Adverse Event|7|||
130893931|NCT01708902|471245457|FG005|Overall Study|Adverse Event|3|||
130893932|NCT01708902|471245458|FG006|Overall Study|Adverse Event|5|||
130893933|NCT01708902|471245452|FG000|Overall Study|Lack of Efficacy|3|||
130893934|NCT01708902|471245453|FG001|Overall Study|Lack of Efficacy|1|||
131025249|NCT02590432|471723201|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131025250|NCT02590432|471723202|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131025251|NCT02590432|471723203|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131025252|NCT02590432|471723204|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
131025253|NCT02590432|471723205|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
130893935|NCT01708902|471245454|FG002|Overall Study|Lack of Efficacy|0|||
130893936|NCT01708902|471245455|FG003|Overall Study|Lack of Efficacy|0|||
130893937|NCT01708902|471245456|FG004|Overall Study|Lack of Efficacy|0|||
130893938|NCT01708902|471245457|FG005|Overall Study|Lack of Efficacy|1|||
130893939|NCT01708902|471245458|FG006|Overall Study|Lack of Efficacy|0|||
130893940|NCT01708902|471245452|FG000|Overall Study|Non compliance with protocol|0|||
130893941|NCT01708902|471245453|FG001|Overall Study|Non compliance with protocol|2|||
130893942|NCT01708902|471245454|FG002|Overall Study|Non compliance with protocol|1|||
130687339|NCT01289262|470481452|FG000|Overall Study|Lost to Follow-up|29|||
130687340|NCT01289262|470481453|FG001|Overall Study|Lost to Follow-up|16|||
130687341|NCT01289262|470481452|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
130687342|NCT01289262|470481453|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
130687343|NCT00838279|470481454|FG000|Washout|Protocol Violation|1|||
130687344|NCT00838279|470481455|FG001|Washout|Protocol Violation|0|||
130687345|NCT00838279|470481454|FG000|Washout|Withdrawal by Subject|0|||
130687346|NCT00838279|470481455|FG001|Washout|Withdrawal by Subject|1|||
130687347|NCT01218867|470481458|FG000|Overall Study|Death during treatment|0|||
130687348|NCT01218867|470481459|FG001|Overall Study|Death during treatment|0|||
130687349|NCT01218867|470481460|FG002|Overall Study|Death during treatment|0|||
130687350|NCT01218867|470481461|FG003|Overall Study|Death during treatment|0|||
130687351|NCT01218867|470481462|FG004|Overall Study|Death during treatment|0|||
130687352|NCT01218867|470481463|FG005|Overall Study|Death during treatment|0|||
130687353|NCT01218867|470481464|FG006|Overall Study|Death during treatment|1|||
130893943|NCT01708902|471245455|FG003|Overall Study|Non compliance with protocol|3|||
131025254|NCT02590432|471723206|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
131025255|NCT02590432|471723198|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
130687354|NCT01218867|470481465|FG007|Overall Study|Death during treatment|0|||
130687355|NCT01218867|470481466|FG008|Overall Study|Death during treatment|0|||
130687356|NCT01218867|470481467|FG009|Overall Study|Death during treatment|0|||
130687357|NCT01218867|470481468|FG010|Overall Study|Death during treatment|0|||
130687358|NCT03792477|470481469|FG000|Overall Study|Adverse Event|0|||
130687359|NCT03792477|470481470|FG001|Overall Study|Adverse Event|0|||
130687360|NCT03792477|470481471|FG002|Overall Study|Adverse Event|0|||
130687361|NCT03792477|470481472|FG003|Overall Study|Adverse Event|1|||
130687362|NCT03792477|470481473|FG004|Overall Study|Adverse Event|0|||
130687363|NCT03792477|470481469|FG000|Overall Study|Lost to Follow-up|0|||
130687364|NCT03792477|470481470|FG001|Overall Study|Lost to Follow-up|0|||
130687365|NCT03792477|470481471|FG002|Overall Study|Lost to Follow-up|2|||
130687366|NCT03792477|470481472|FG003|Overall Study|Lost to Follow-up|0|||
130687367|NCT03792477|470481473|FG004|Overall Study|Lost to Follow-up|0|||
130687368|NCT03792477|470481469|FG000|Overall Study|Other|0|||
130687369|NCT03792477|470481470|FG001|Overall Study|Other|0|||
130687370|NCT03792477|470481471|FG002|Overall Study|Other|0|||
130687371|NCT03792477|470481472|FG003|Overall Study|Other|0|||
130687372|NCT03792477|470481473|FG004|Overall Study|Other|1|||
130687373|NCT00840411|470481474|FG000|First Intervention|Adverse Event|1|||
130687374|NCT00840411|470481475|FG001|First Intervention|Adverse Event|0|||
130687375|NCT00840411|470481474|FG000|Washout|Withdrawal by Subject|1|||
130687376|NCT00840411|470481475|FG001|Washout|Withdrawal by Subject|0|||
130687377|NCT04419311|470481476|FG000|Overall Study|Lost to Follow-up|1|||
130687378|NCT04419311|470481477|FG001|Overall Study|Lost to Follow-up|0|||
130687379|NCT01921062|470481484|FG000|Overall Study|Withdrawal by Subject|0|||
130687380|NCT01921062|470481485|FG001|Overall Study|Withdrawal by Subject|7|||
130687381|NCT01921062|470481484|FG000|Overall Study|Adverse Event|5|||
130687382|NCT01921062|470481485|FG001|Overall Study|Adverse Event|6|||
130687383|NCT01921062|470481484|FG000|Overall Study|Protocol Violation|0|||
130687384|NCT01921062|470481485|FG001|Overall Study|Protocol Violation|1|||
130687385|NCT01921062|470481484|FG000|Overall Study|VMIQ score > 72|4|||
130767089|NCT02028169|470770729|FG000|Overall Study|Lost to Follow-up|21|||
130767090|NCT02028169|470770729|FG000|Overall Study|Lack of Efficacy|2|||
130767091|NCT02028169|470770729|FG000|Overall Study|Withdrawal by Subject|2|||
130767092|NCT02028169|470770729|FG000|Overall Study|Adverse Event|1|||
130767093|NCT02028169|470770729|FG000|Overall Study|Cessation of Drug|1|||
130767094|NCT02028169|470770729|FG000|Overall Study|Concomitant Medication Usage|1|||
130767095|NCT04907227|470770730|FG000|Overall Study|Death|12|||
131025256|NCT02590432|471723199|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131025257|NCT02590432|471723200|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131025258|NCT02590432|471723201|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131025259|NCT02590432|471723202|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131025260|NCT02590432|471723203|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131025261|NCT02590432|471723204|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131025262|NCT02590432|471723205|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
130687386|NCT01921062|470481485|FG001|Overall Study|VMIQ score > 72|1|||
130687387|NCT01921062|470481484|FG000|Overall Study|Logistic error|0|||
130687388|NCT01921062|470481485|FG001|Overall Study|Logistic error|1|||
130687389|NCT00576056|470481486|FG000|Overall Study|Adverse Event|1|||
130687390|NCT00576056|470481486|FG000|Overall Study|Death|1|||
130687391|NCT00576056|470481486|FG000|Overall Study|Lack of Efficacy|1|||
130687392|NCT00576056|470481486|FG000|Overall Study|Withdrawal by Subject|2|||
130687393|NCT00576056|470481486|FG000|Overall Study|did not meet eligibility criteria|8|||
130687394|NCT00576056|470481486|FG000|Overall Study|Physician Decision|1|||
130687395|NCT01854047|470481487|FG000|Overall Study|Lack of Efficacy|1|||
130687396|NCT01854047|470481488|FG001|Overall Study|Lack of Efficacy|0|||
130687397|NCT01854047|470481489|FG002|Overall Study|Lack of Efficacy|0|||
130767096|NCT04907227|470770731|FG001|Overall Study|Death|8|||
130687398|NCT01854047|470481490|FG003|Overall Study|Lack of Efficacy|0|||
130687399|NCT01854047|470481491|FG004|Overall Study|Lack of Efficacy|0|||
130687400|NCT01854047|470481487|FG000|Overall Study|Poor compliance to protocol|3|||
130687401|NCT01854047|470481488|FG001|Overall Study|Poor compliance to protocol|0|||
130687402|NCT01854047|470481489|FG002|Overall Study|Poor compliance to protocol|2|||
130687403|NCT01854047|470481490|FG003|Overall Study|Poor compliance to protocol|0|||
130687404|NCT01854047|470481491|FG004|Overall Study|Poor compliance to protocol|0|||
130687405|NCT01854047|470481487|FG000|Overall Study|Adverse Event|5|||
130687406|NCT01854047|470481488|FG001|Overall Study|Adverse Event|4|||
130687407|NCT01854047|470481489|FG002|Overall Study|Adverse Event|6|||
130687408|NCT01854047|470481490|FG003|Overall Study|Adverse Event|10|||
130687409|NCT01854047|470481491|FG004|Overall Study|Adverse Event|7|||
130687410|NCT01854047|470481487|FG000|Overall Study|Randomized but not treated|0|||
130687411|NCT01854047|470481488|FG001|Overall Study|Randomized but not treated|1|||
130687412|NCT01854047|470481489|FG002|Overall Study|Randomized but not treated|2|||
130687413|NCT01854047|470481490|FG003|Overall Study|Randomized but not treated|0|||
130687414|NCT01854047|470481491|FG004|Overall Study|Randomized but not treated|4|||
130687415|NCT01854047|470481487|FG000|Overall Study|Other than specified above|3|||
130687416|NCT01854047|470481488|FG001|Overall Study|Other than specified above|3|||
130687417|NCT01854047|470481489|FG002|Overall Study|Other than specified above|3|||
130687418|NCT01854047|470481490|FG003|Overall Study|Other than specified above|5|||
130687419|NCT01854047|470481491|FG004|Overall Study|Other than specified above|8|||
130687420|NCT02441309|470481494|FG000|Overall Study|Disease progression|2|||
130687421|NCT02441309|470481495|FG001|Overall Study|Disease progression|1|||
130687422|NCT02441309|470481496|FG002|Overall Study|Disease progression|2|||
130687423|NCT02441309|470481494|FG000|Overall Study|Adverse Event|0|||
130687424|NCT02441309|470481495|FG001|Overall Study|Adverse Event|1|||
130687425|NCT02441309|470481496|FG002|Overall Study|Adverse Event|0|||
130687426|NCT02441309|470481494|FG000|Overall Study|Withdrawal by Subject|1|||
130687427|NCT02441309|470481495|FG001|Overall Study|Withdrawal by Subject|0|||
130687428|NCT02441309|470481496|FG002|Overall Study|Withdrawal by Subject|1|||
130687429|NCT02175095|470483069|FG000|Overall Study|Withdrawal by Subject|3|||
130687430|NCT03255733|470483070|FG000|Overall Study|Lost to Follow-up|4|||
130687431|NCT03653507|470483072|FG000|Overall Study|Miscellaneous|28|||
130687432|NCT03653507|470483073|FG001|Overall Study|Miscellaneous|19|||
130687433|NCT03653507|470483072|FG000|Overall Study|Withdrawal by Subject|37|||
130687434|NCT03653507|470483073|FG001|Overall Study|Withdrawal by Subject|22|||
130687435|NCT03653507|470483072|FG000|Overall Study|Protocol Deviation|2|||
130687436|NCT03653507|470483073|FG001|Overall Study|Protocol Deviation|1|||
130687437|NCT03653507|470483072|FG000|Overall Study|Progressive disease|117|||
130687438|NCT03653507|470483073|FG001|Overall Study|Progressive disease|168|||
130687439|NCT03653507|470483072|FG000|Overall Study|Lost to Follow-up|1|||
130687440|NCT03653507|470483073|FG001|Overall Study|Lost to Follow-up|1|||
130687441|NCT03653507|470483072|FG000|Overall Study|Death|25|||
130687442|NCT03653507|470483073|FG001|Overall Study|Death|22|||
130687443|NCT03653507|470483072|FG000|Overall Study|Adverse Event|35|||
130687444|NCT03653507|470483073|FG001|Overall Study|Adverse Event|14|||
130687445|NCT03697109|470483074|FG000|Open-label (OL) Phase|Adverse Event|24|||
130687446|NCT03697109|470483075|FG001|Open-label (OL) Phase|Adverse Event|0|||
130687447|NCT03697109|470483076|FG002|Open-label (OL) Phase|Adverse Event|0|||
130687448|NCT03697109|470483074|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
130687449|NCT03697109|470483075|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
130687450|NCT03697109|470483076|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
130687451|NCT03697109|470483074|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
130687452|NCT03697109|470483075|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
130687453|NCT03697109|470483076|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
130687454|NCT03697109|470483074|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
130687455|NCT03697109|470483075|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
130687456|NCT03697109|470483076|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
130687457|NCT03697109|470483074|FG000|Open-label (OL) Phase|Physician Decision|2|||
130687458|NCT03697109|470483075|FG001|Open-label (OL) Phase|Physician Decision|0|||
130687459|NCT03697109|470483076|FG002|Open-label (OL) Phase|Physician Decision|0|||
130687460|NCT03697109|470483074|FG000|Open-label (OL) Phase|Death|2|||
131110671|NCT01881750|472035718|FG001|Overall Study|Changes in concomitant therapies|3|||
131110672|NCT01881750|472035717|FG000|Overall Study|Lost to Follow-up|0|||
131110673|NCT01881750|472035718|FG001|Overall Study|Lost to Follow-up|1|||
131110674|NCT00926211|472035720|FG000|Overall Study|Lost to Follow-up|1|||
131110675|NCT01323634|472035723|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
130687461|NCT03697109|470483075|FG001|Open-label (OL) Phase|Death|0|||
130687462|NCT03697109|470483076|FG002|Open-label (OL) Phase|Death|0|||
130687463|NCT03697109|470483074|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
130687464|NCT03697109|470483075|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
130687465|NCT03697109|470483076|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
131110676|NCT01323634|472035724|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
130687466|NCT03697109|470483074|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
131110677|NCT01323634|472035725|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
131222693|NCT02117479|472443161|FG000|Overall Study|Death|13|||
130687467|NCT03697109|470483075|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
130687468|NCT03697109|470483076|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
130687469|NCT03697109|470483074|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
130687470|NCT03697109|470483075|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
130687471|NCT03697109|470483076|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
130687472|NCT02096211|470483077|FG000|Overall Study|Death|2|||
130687473|NCT02096211|470483077|FG000|Overall Study|Withdrawal by Subject|8|||
130687474|NCT02096211|470483077|FG000|Overall Study|Revision of implant|7|||
130687475|NCT02096211|470483077|FG000|Overall Study|Lost to Follow-up|43|||
130687476|NCT00834522|470483080|FG000|Washout|Adverse Event|1|||
130687477|NCT00834522|470483081|FG001|Washout|Adverse Event|0|||
130687478|NCT00834522|470483080|FG000|Washout|Withdrawal by Subject|2|||
130687479|NCT00834522|470483081|FG001|Washout|Withdrawal by Subject|1|||
130687480|NCT04516967|470483082|FG000|Core Phase|Adverse Event|2|||
130687481|NCT04516967|470483083|FG001|Core Phase|Adverse Event|1|||
130687482|NCT04516967|470483084|FG002|Core Phase|Adverse Event|0|||
130687483|NCT04516967|470483082|FG000|Core Phase|Physician Decision|1|||
130687484|NCT04516967|470483083|FG001|Core Phase|Physician Decision|1|||
130687485|NCT04516967|470483084|FG002|Core Phase|Physician Decision|0|||
130687486|NCT04516967|470483082|FG000|Core Phase|Lack of Efficacy|7|||
130687487|NCT04516967|470483083|FG001|Core Phase|Lack of Efficacy|18|||
130687488|NCT04516967|470483084|FG002|Core Phase|Lack of Efficacy|0|||
130687489|NCT03165994|470483085|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
130687490|NCT03165994|470483085|FG000|Overall Study|Death|2|||
130687491|NCT03165994|470483085|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
130687492|NCT03165994|470483085|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
130687493|NCT03165994|470483085|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
130687494|NCT03165994|470483085|FG000|Overall Study|Miscellaneous|1|||
130687495|NCT00519194|470483086|FG000|Overall Study|Withdrawal by Subject|9|||
130687496|NCT00519194|470483086|FG000|Overall Study|Death|9|||
130687497|NCT00519194|470483086|FG000|Overall Study|Lost to Follow-up|3|||
130687498|NCT00934050|470483091|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
130687499|NCT00934050|470483092|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130687500|NCT00934050|470483093|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130687501|NCT00934050|470483094|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
130687502|NCT00934050|470483095|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130687503|NCT00934050|470483096|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130687504|NCT00934050|470483091|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
130687505|NCT00934050|470483092|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
130687506|NCT00934050|470483093|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
130687507|NCT00934050|470483094|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
130687508|NCT00934050|470483095|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
130687509|NCT00934050|470483096|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
130687510|NCT00934050|470483091|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130687511|NCT00934050|470483092|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130687512|NCT00934050|470483093|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
130687513|NCT00934050|470483094|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130687514|NCT00934050|470483095|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130687515|NCT00934050|470483096|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130687516|NCT00934050|470483091|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
130687517|NCT00934050|470483092|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
130687518|NCT00934050|470483093|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
130687519|NCT00934050|470483094|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
130687520|NCT00934050|470483095|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
130687521|NCT00934050|470483096|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
130687522|NCT00934050|470483091|FG000|Enrolled After 15 Dec 2009|Death|0|||
130687523|NCT00934050|470483092|FG001|Enrolled After 15 Dec 2009|Death|0|||
130687524|NCT00934050|470483093|FG002|Enrolled After 15 Dec 2009|Death|0|||
130687525|NCT00934050|470483094|FG003|Enrolled After 15 Dec 2009|Death|0|||
130687526|NCT00934050|470483095|FG004|Enrolled After 15 Dec 2009|Death|0|||
130767097|NCT04907227|470770730|FG000|Overall Study|Withdrawal by Subject|2|||
131025263|NCT02590432|471723206|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
131025264|NCT02590432|471723198|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131025265|NCT02590432|471723199|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131025266|NCT02590432|471723200|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131025267|NCT02590432|471723201|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131025268|NCT02590432|471723202|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131025269|NCT02590432|471723203|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131025270|NCT02590432|471723204|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
131025271|NCT02590432|471723205|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
131025272|NCT02590432|471723206|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
131025273|NCT02590432|471723198|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130893944|NCT01708902|471245456|FG004|Overall Study|Non compliance with protocol|0|||
130893945|NCT01708902|471245457|FG005|Overall Study|Non compliance with protocol|0|||
130893946|NCT01708902|471245458|FG006|Overall Study|Non compliance with protocol|0|||
130687527|NCT00934050|470483096|FG005|Enrolled After 15 Dec 2009|Death|1|||
130687528|NCT00934050|470483091|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130687529|NCT00934050|470483092|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130687530|NCT00934050|470483093|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130687531|NCT00934050|470483094|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130687532|NCT00934050|470483095|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130687533|NCT00934050|470483096|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
130687534|NCT00934050|470483091|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130687535|NCT00934050|470483092|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130687536|NCT00934050|470483093|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130687537|NCT00934050|470483094|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130687538|NCT00934050|470483095|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
130687539|NCT00934050|470483096|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
130687540|NCT00461786|470483097|FG000|Overall Study|Entry Criteria Not Met|2|||
130687541|NCT00461786|470483097|FG000|Overall Study|Inevaluable (Never Treated)|1|||
130687542|NCT00835991|470483098|FG000|First Intervention|Adverse Event|0|||
130687543|NCT00835991|470483099|FG001|First Intervention|Adverse Event|1|||
130687544|NCT00835991|470483098|FG000|Washout|Protocol Violation|0|||
130687545|NCT00835991|470483099|FG001|Washout|Protocol Violation|2|||
130687546|NCT00835991|470483098|FG000|Washout|Withdrawal by Subject|3|||
130687547|NCT00835991|470483099|FG001|Washout|Withdrawal by Subject|1|||
130687548|NCT02149420|470483100|FG000|Core Study|Administrative problems|0|||
130687549|NCT02149420|470483101|FG001|Core Study|Administrative problems|1|||
130687550|NCT02149420|470483102|FG002|Core Study|Administrative problems|2|||
130687551|NCT02149420|470483100|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
130687552|NCT02149420|470483101|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
130687553|NCT02149420|470483102|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
130687554|NCT02378935|470483103|FG000|Overall Study|Lack of Efficacy|10|||
130687555|NCT02378935|470483104|FG001|Overall Study|Lack of Efficacy|0|||
130687556|NCT02378935|470483105|FG002|Overall Study|Lack of Efficacy|2|||
130687557|NCT02378935|470483106|FG003|Overall Study|Lack of Efficacy|6|||
130687558|NCT02378935|470483107|FG004|Overall Study|Lack of Efficacy|0|||
130687559|NCT02378935|470483108|FG005|Overall Study|Lack of Efficacy|0|||
130687560|NCT02378935|470483109|FG006|Overall Study|Lack of Efficacy|0|||
130687561|NCT02378935|470483103|FG000|Overall Study|Death|0|||
130687562|NCT02378935|470483104|FG001|Overall Study|Death|0|||
130687563|NCT02378935|470483105|FG002|Overall Study|Death|1|||
130687564|NCT02378935|470483106|FG003|Overall Study|Death|0|||
130687565|NCT02378935|470483107|FG004|Overall Study|Death|0|||
130687566|NCT02378935|470483108|FG005|Overall Study|Death|0|||
130687567|NCT02378935|470483109|FG006|Overall Study|Death|0|||
130687568|NCT03616535|470483110|FG000|Overall Study|Death|2|||
130687569|NCT03616535|470483111|FG001|Overall Study|Death|0|||
130687570|NCT03616535|470483112|FG002|Overall Study|Death|0|||
130687571|NCT03616535|470483113|FG003|Overall Study|Death|1|||
130687572|NCT03616535|470483110|FG000|Overall Study|Lost to Follow-up|2|||
130687573|NCT03616535|470483111|FG001|Overall Study|Lost to Follow-up|1|||
130687574|NCT03616535|470483112|FG002|Overall Study|Lost to Follow-up|0|||
130687575|NCT03616535|470483113|FG003|Overall Study|Lost to Follow-up|2|||
130687576|NCT03616535|470483110|FG000|Overall Study|Withdrawal by Subject|1|||
130687577|NCT03616535|470483111|FG001|Overall Study|Withdrawal by Subject|2|||
130687578|NCT03616535|470483112|FG002|Overall Study|Withdrawal by Subject|5|||
130687579|NCT03616535|470483113|FG003|Overall Study|Withdrawal by Subject|1|||
130687580|NCT03616535|470483110|FG000|Overall Study|Not specified or change in eligibility|2|||
130687581|NCT03616535|470483111|FG001|Overall Study|Not specified or change in eligibility|3|||
130687582|NCT03616535|470483112|FG002|Overall Study|Not specified or change in eligibility|3|||
130687583|NCT03616535|470483113|FG003|Overall Study|Not specified or change in eligibility|1|||
130687584|NCT02146105|470483116|FG000|Overall Study|Adverse Event|1|||
130687585|NCT02146105|470483116|FG000|Overall Study|Withdrawal by Subject|5|||
130687586|NCT05755282|470483117|FG000|Overall Study|Protocol Violation|0|||
130687587|NCT05755282|470483118|FG001|Overall Study|Protocol Violation|1|||
130687588|NCT03935880|470483120|FG000|Overall Study|Lost to Follow-up|0|||
130893947|NCT01708902|471245452|FG000|Overall Study|Lost to Follow-up|2|||
130687589|NCT03935880|470483121|FG001|Overall Study|Lost to Follow-up|1|||
130687590|NCT02476994|470483122|FG000|Overall Study|Based on feedback from FDA|1|||
130687591|NCT02476994|470483123|FG001|Overall Study|Based on feedback from FDA|0|||
130687592|NCT02563561|470483124|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
130687593|NCT02563561|470483125|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
130687594|NCT02563561|470483126|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
130687595|NCT02563561|470483124|FG000|Overall Study|Withdrew of Consent|1|||
130687596|NCT02563561|470483125|FG001|Overall Study|Withdrew of Consent|1|||
130687597|NCT02563561|470483126|FG002|Overall Study|Withdrew of Consent|2|||
130687598|NCT02563561|470483124|FG000|Overall Study|Lost to Follow-up|1|||
130893948|NCT01708902|471245453|FG001|Overall Study|Lost to Follow-up|1|||
130687599|NCT02563561|470483125|FG001|Overall Study|Lost to Follow-up|1|||
130687600|NCT02563561|470483126|FG002|Overall Study|Lost to Follow-up|0|||
130687601|NCT02563561|470483124|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
130687602|NCT02563561|470483125|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
130687603|NCT02563561|470483126|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
130687604|NCT02563561|470483124|FG000|Overall Study|Investigator Decision|3|||
130687605|NCT02563561|470483125|FG001|Overall Study|Investigator Decision|4|||
130687606|NCT02563561|470483126|FG002|Overall Study|Investigator Decision|2|||
130687607|NCT02563561|470483124|FG000|Overall Study|Sponsor Decision|5|||
130687608|NCT02563561|470483125|FG001|Overall Study|Sponsor Decision|2|||
130687609|NCT02563561|470483126|FG002|Overall Study|Sponsor Decision|4|||
130687610|NCT02563561|470483124|FG000|Overall Study|Other|1|||
130687611|NCT02563561|470483125|FG001|Overall Study|Other|5|||
130687612|NCT02563561|470483126|FG002|Overall Study|Other|2|||
130687613|NCT02646124|470483129|FG000|Overall Study|Lost to Follow-up|0|||
130687614|NCT02646124|470483130|FG001|Overall Study|Lost to Follow-up|2|||
130687615|NCT03154047|470483131|FG000|Overall Study|Death|1|||
130687616|NCT03154047|470483131|FG000|Overall Study|Study terminated by sponsor|76|||
130687617|NCT03154047|470483131|FG000|Overall Study|Withdrawal by Subject|3|||
130687618|NCT00857454|470483132|FG000|Overall Study|Withdrawal by Subject|2|||
130687619|NCT00857454|470483132|FG000|Overall Study|Lost to Follow-up|1|||
130687620|NCT00857454|470483132|FG000|Overall Study|Adverse Event|2|||
130687621|NCT00857454|470483132|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
130687622|NCT00857454|470483132|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
130687623|NCT00857454|470483132|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
130687624|NCT00365365|470483133|FG000|Overall Study|Randomized but not treated|0|||
130687625|NCT00365365|470483134|FG001|Overall Study|Randomized but not treated|2|||
130687626|NCT00365365|470483135|FG002|Overall Study|Randomized but not treated|0|||
130687627|NCT00365365|470483133|FG000|Overall Study|Poor compliance to protocol|0|||
130687628|NCT00365365|470483134|FG001|Overall Study|Poor compliance to protocol|1|||
130687629|NCT00365365|470483135|FG002|Overall Study|Poor compliance to protocol|0|||
130687630|NCT00365365|470483133|FG000|Overall Study|Lost to Follow-up|3|||
130687631|NCT00365365|470483134|FG001|Overall Study|Lost to Follow-up|3|||
130687632|NCT00365365|470483135|FG002|Overall Study|Lost to Follow-up|3|||
130687633|NCT00365365|470483133|FG000|Overall Study|Death|1|||
130687634|NCT00365365|470483134|FG001|Overall Study|Death|3|||
130687635|NCT00365365|470483135|FG002|Overall Study|Death|0|||
130687636|NCT00365365|470483133|FG000|Overall Study|Subject's request|11|||
130687637|NCT00365365|470483134|FG001|Overall Study|Subject's request|13|||
130687638|NCT00365365|470483135|FG002|Overall Study|Subject's request|1|||
130687639|NCT00365365|470483133|FG000|Overall Study|Disease progression/relapse|9|||
130687640|NCT00365365|470483134|FG001|Overall Study|Disease progression/relapse|6|||
130687641|NCT00365365|470483135|FG002|Overall Study|Disease progression/relapse|7|||
130687642|NCT00365365|470483133|FG000|Overall Study|Adverse Event|6|||
130687643|NCT00365365|470483134|FG001|Overall Study|Adverse Event|6|||
130687644|NCT00365365|470483135|FG002|Overall Study|Adverse Event|3|||
130687645|NCT00365365|470483133|FG000|Overall Study|Moved|2|||
130687646|NCT00365365|470483134|FG001|Overall Study|Moved|0|||
130687647|NCT00365365|470483135|FG002|Overall Study|Moved|0|||
130687648|NCT00365365|470483133|FG000|Overall Study|New cancer|1|||
130687649|NCT00365365|470483134|FG001|Overall Study|New cancer|0|||
130687650|NCT00365365|470483135|FG002|Overall Study|New cancer|0|||
130687651|NCT00365365|470483133|FG000|Overall Study|Withdrew consent|1|||
130687652|NCT00365365|470483134|FG001|Overall Study|Withdrew consent|1|||
130687653|NCT00365365|470483135|FG002|Overall Study|Withdrew consent|0|||
130687654|NCT00365365|470483133|FG000|Overall Study|Second malignancy|0|||
130687655|NCT00365365|470483134|FG001|Overall Study|Second malignancy|1|||
130687656|NCT00365365|470483135|FG002|Overall Study|Second malignancy|0|||
130687657|NCT00365365|470483133|FG000|Overall Study|Patient/physician decision|0|||
130687658|NCT00365365|470483134|FG001|Overall Study|Patient/physician decision|0|||
130687659|NCT00365365|470483135|FG002|Overall Study|Patient/physician decision|1|||
130687660|NCT00984022|470483136|FG000|Overall Study|Lost to Follow-up|10|||
130687661|NCT00984022|470483137|FG001|Overall Study|Lost to Follow-up|14|||
130893949|NCT01708902|471245454|FG002|Overall Study|Lost to Follow-up|2|||
131222694|NCT02117479|472443162|FG001|Overall Study|Death|8|||
130687662|NCT00573443|470483141|FG000|Double-Blind Phase|Lost to Follow-up|1|||
130687663|NCT00573443|470483142|FG001|Double-Blind Phase|Lost to Follow-up|3|||
130893950|NCT01708902|471245455|FG003|Overall Study|Lost to Follow-up|2|||
130687664|NCT00573443|470483143|FG002|Double-Blind Phase|Lost to Follow-up|2|||
130687665|NCT00573443|470483141|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
130687666|NCT00573443|470483142|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
130687667|NCT00573443|470483143|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
130687668|NCT00573443|470483141|FG000|Double-Blind Phase|Adverse Event|1|||
130687669|NCT00573443|470483142|FG001|Double-Blind Phase|Adverse Event|5|||
130687670|NCT00573443|470483143|FG002|Double-Blind Phase|Adverse Event|0|||
130687671|NCT00573443|470483141|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
130687672|NCT00573443|470483142|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
131110678|NCT01323634|472035723|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
131110679|NCT01323634|472035724|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
131110680|NCT01323634|472035725|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
131110681|NCT01323634|472035723|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
131110682|NCT01323634|472035724|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
131110683|NCT01323634|472035725|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131110684|NCT01323634|472035723|FG000|2-week Run-in Period|Physician Decision|5|||
131110685|NCT01323634|472035724|FG001|2-week Run-in Period|Physician Decision|0|||
131110686|NCT01323634|472035725|FG002|2-week Run-in Period|Physician Decision|0|||
131110687|NCT01323634|472035723|FG000|2-week Run-in Period|Protocol Violation|1|||
131110688|NCT01323634|472035724|FG001|2-week Run-in Period|Protocol Violation|0|||
131110689|NCT01323634|472035725|FG002|2-week Run-in Period|Protocol Violation|0|||
131110690|NCT01323634|472035723|FG000|2-week Run-in Period|Adverse Event|1|||
131110691|NCT01323634|472035724|FG001|2-week Run-in Period|Adverse Event|0|||
131110692|NCT01323634|472035725|FG002|2-week Run-in Period|Adverse Event|0|||
131110693|NCT01323634|472035723|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
131110694|NCT01323634|472035724|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
131110695|NCT01323634|472035725|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
131110696|NCT01323634|472035723|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131110697|NCT01323634|472035724|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
131110698|NCT01323634|472035725|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
131110699|NCT01323634|472035723|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
131110700|NCT01323634|472035724|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
130687673|NCT00573443|470483143|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
130687674|NCT00573443|470483141|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
130687675|NCT00573443|470483142|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
130687676|NCT00573443|470483143|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
130687677|NCT00573443|470483141|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130687678|NCT00573443|470483142|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
130687679|NCT00573443|470483143|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
130687680|NCT00573443|470483141|FG000|Double-Blind Phase|Protocol Violation|0|||
130687681|NCT00573443|470483142|FG001|Double-Blind Phase|Protocol Violation|2|||
130687682|NCT00573443|470483143|FG002|Double-Blind Phase|Protocol Violation|1|||
130687683|NCT00573443|470483141|FG000|Double-Blind Phase|Other|0|||
130687684|NCT00573443|470483142|FG001|Double-Blind Phase|Other|2|||
130687685|NCT00573443|470483143|FG002|Double-Blind Phase|Other|3|||
130687686|NCT00573443|470483141|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
130687687|NCT00573443|470483142|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130687688|NCT00573443|470483143|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130687689|NCT00573443|470483141|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
130687690|NCT00573443|470483142|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
131110701|NCT01323634|472035725|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
131110702|NCT01323634|472035723|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
131110703|NCT01323634|472035724|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
131110704|NCT01323634|472035725|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
131110705|NCT01323634|472035723|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
131110706|NCT01323634|472035724|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
131110707|NCT01323634|472035725|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
131110708|NCT01323634|472035723|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
131110709|NCT01323634|472035724|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
131110710|NCT01323634|472035725|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
131110711|NCT01323634|472035723|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
131110712|NCT01323634|472035724|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
131110713|NCT01323634|472035725|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
130687691|NCT00573443|470483143|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
130687692|NCT00573443|470483141|FG000|Open-Label Extension Phase|Adverse Event|3|||
130687693|NCT00573443|470483142|FG001|Open-Label Extension Phase|Adverse Event|0|||
130687694|NCT00573443|470483143|FG002|Open-Label Extension Phase|Adverse Event|0|||
130687695|NCT00573443|470483141|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
130687696|NCT00573443|470483142|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
130687697|NCT00573443|470483143|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
130687698|NCT00573443|470483141|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
130687699|NCT00573443|470483142|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
131110714|NCT05056987|472035726|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
131110715|NCT05056987|472035727|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
131110716|NCT05056987|472035726|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
130687700|NCT00573443|470483143|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
130687701|NCT00573443|470483141|FG000|Open-Label Extension Phase|Protocol Violation|2|||
130687702|NCT00573443|470483142|FG001|Open-Label Extension Phase|Protocol Violation|0|||
130687703|NCT00573443|470483143|FG002|Open-Label Extension Phase|Protocol Violation|0|||
130687704|NCT00573443|470483141|FG000|Open-Label Extension Phase|Other|2|||
130687705|NCT00573443|470483142|FG001|Open-Label Extension Phase|Other|0|||
130687706|NCT00573443|470483143|FG002|Open-Label Extension Phase|Other|0|||
130687707|NCT00905606|470483144|FG000|Period 1|Adverse Event|0|||
130687708|NCT00905606|470483145|FG001|Period 1|Adverse Event|1|||
130687709|NCT00905606|470483144|FG000|Washout|Withdrawal by Subject|1|||
130687710|NCT00905606|470483145|FG001|Washout|Withdrawal by Subject|0|||
130687711|NCT00804856|470483148|FG000|Overall Study|Progressive Disease|3|||
130687712|NCT00804856|470483149|FG001|Overall Study|Progressive Disease|2|||
130687713|NCT00804856|470483150|FG002|Overall Study|Progressive Disease|4|||
130687714|NCT00804856|470483151|FG003|Overall Study|Progressive Disease|6|||
130687715|NCT00804856|470483152|FG004|Overall Study|Progressive Disease|4|||
130687716|NCT00804856|470483153|FG005|Overall Study|Progressive Disease|1|||
130687717|NCT00804856|470483154|FG006|Overall Study|Progressive Disease|8|||
130687718|NCT00804856|470483155|FG007|Overall Study|Progressive Disease|2|||
130687719|NCT00804856|470483156|FG008|Overall Study|Progressive Disease|4|||
130687720|NCT00804856|470483157|FG009|Overall Study|Progressive Disease|5|||
130687721|NCT00804856|470483158|FG010|Overall Study|Progressive Disease|12|||
130687722|NCT00804856|470483159|FG011|Overall Study|Progressive Disease|2|||
130687723|NCT00804856|470483160|FG012|Overall Study|Progressive Disease|2|||
130687724|NCT00804856|470483161|FG013|Overall Study|Progressive Disease|26|||
130687725|NCT00804856|470483162|FG014|Overall Study|Progressive Disease|20|||
130687726|NCT00804856|470483148|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687727|NCT00804856|470483149|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687728|NCT00804856|470483150|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687729|NCT00804856|470483151|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687730|NCT00804856|470483152|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130687731|NCT00804856|470483153|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687732|NCT00804856|470483154|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687733|NCT00804856|470483155|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687734|NCT00804856|470483156|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687735|NCT00804856|470483157|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687736|NCT00804856|470483158|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687737|NCT00804856|470483159|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687738|NCT00804856|470483160|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687739|NCT00804856|470483161|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130687740|NCT00804856|470483162|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130687741|NCT00804856|470483148|FG000|Overall Study|Other Adverse Event|1|||
130687742|NCT00804856|470483149|FG001|Overall Study|Other Adverse Event|1|||
130687743|NCT00804856|470483150|FG002|Overall Study|Other Adverse Event|1|||
130687744|NCT00804856|470483151|FG003|Overall Study|Other Adverse Event|2|||
130687745|NCT00804856|470483152|FG004|Overall Study|Other Adverse Event|2|||
130687746|NCT00804856|470483153|FG005|Overall Study|Other Adverse Event|1|||
130687747|NCT00804856|470483154|FG006|Overall Study|Other Adverse Event|3|||
130687748|NCT00804856|470483155|FG007|Overall Study|Other Adverse Event|0|||
130687749|NCT00804856|470483156|FG008|Overall Study|Other Adverse Event|0|||
130687750|NCT00804856|470483157|FG009|Overall Study|Other Adverse Event|1|||
130687751|NCT00804856|470483158|FG010|Overall Study|Other Adverse Event|5|||
130687752|NCT00804856|470483159|FG011|Overall Study|Other Adverse Event|2|||
130687753|NCT00804856|470483160|FG012|Overall Study|Other Adverse Event|0|||
130687754|NCT00804856|470483161|FG013|Overall Study|Other Adverse Event|6|||
130687755|NCT00804856|470483162|FG014|Overall Study|Other Adverse Event|13|||
130687756|NCT00804856|470483148|FG000|Overall Study|Non compliance with protocol|0|||
130687757|NCT00804856|470483149|FG001|Overall Study|Non compliance with protocol|0|||
130687758|NCT00804856|470483150|FG002|Overall Study|Non compliance with protocol|0|||
130687759|NCT00804856|470483151|FG003|Overall Study|Non compliance with protocol|0|||
130687760|NCT00804856|470483152|FG004|Overall Study|Non compliance with protocol|0|||
130687761|NCT00804856|470483153|FG005|Overall Study|Non compliance with protocol|0|||
130687762|NCT00804856|470483154|FG006|Overall Study|Non compliance with protocol|0|||
130687763|NCT00804856|470483155|FG007|Overall Study|Non compliance with protocol|0|||
130893951|NCT01708902|471245456|FG004|Overall Study|Lost to Follow-up|0|||
130893952|NCT01708902|471245457|FG005|Overall Study|Lost to Follow-up|0|||
131025274|NCT02590432|471723199|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131025275|NCT02590432|471723200|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130687764|NCT00804856|470483156|FG008|Overall Study|Non compliance with protocol|0|||
130687765|NCT00804856|470483157|FG009|Overall Study|Non compliance with protocol|0|||
130687766|NCT00804856|470483158|FG010|Overall Study|Non compliance with protocol|0|||
130687767|NCT00804856|470483159|FG011|Overall Study|Non compliance with protocol|0|||
130687768|NCT00804856|470483160|FG012|Overall Study|Non compliance with protocol|0|||
130687769|NCT00804856|470483161|FG013|Overall Study|Non compliance with protocol|2|||
130687770|NCT00804856|470483162|FG014|Overall Study|Non compliance with protocol|0|||
130687771|NCT00804856|470483148|FG000|Overall Study|Refused to continue medication|0|||
130687772|NCT00804856|470483149|FG001|Overall Study|Refused to continue medication|0|||
131025276|NCT02590432|471723201|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131025277|NCT02590432|471723202|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130687773|NCT00804856|470483150|FG002|Overall Study|Refused to continue medication|0|||
130687774|NCT00804856|470483151|FG003|Overall Study|Refused to continue medication|1|||
130687775|NCT00804856|470483152|FG004|Overall Study|Refused to continue medication|1|||
130687776|NCT00804856|470483153|FG005|Overall Study|Refused to continue medication|0|||
130687777|NCT00804856|470483154|FG006|Overall Study|Refused to continue medication|0|||
130687778|NCT00804856|470483155|FG007|Overall Study|Refused to continue medication|0|||
130687779|NCT00804856|470483156|FG008|Overall Study|Refused to continue medication|0|||
130687780|NCT00804856|470483157|FG009|Overall Study|Refused to continue medication|0|||
130687781|NCT00804856|470483158|FG010|Overall Study|Refused to continue medication|3|||
130687782|NCT00804856|470483159|FG011|Overall Study|Refused to continue medication|0|||
130687783|NCT00804856|470483160|FG012|Overall Study|Refused to continue medication|1|||
130687784|NCT00804856|470483161|FG013|Overall Study|Refused to continue medication|1|||
130687785|NCT00804856|470483162|FG014|Overall Study|Refused to continue medication|5|||
130687786|NCT00804856|470483148|FG000|Overall Study|Other reason than listed above|0|||
130687787|NCT00804856|470483149|FG001|Overall Study|Other reason than listed above|0|||
130687788|NCT00804856|470483150|FG002|Overall Study|Other reason than listed above|0|||
130687789|NCT00804856|470483151|FG003|Overall Study|Other reason than listed above|0|||
130687790|NCT00804856|470483152|FG004|Overall Study|Other reason than listed above|0|||
130687791|NCT00804856|470483153|FG005|Overall Study|Other reason than listed above|1|||
130687792|NCT00804856|470483154|FG006|Overall Study|Other reason than listed above|0|||
130687793|NCT00804856|470483155|FG007|Overall Study|Other reason than listed above|0|||
130687794|NCT00804856|470483156|FG008|Overall Study|Other reason than listed above|1|||
130687795|NCT00804856|470483157|FG009|Overall Study|Other reason than listed above|0|||
130687796|NCT00804856|470483158|FG010|Overall Study|Other reason than listed above|3|||
130687797|NCT00804856|470483159|FG011|Overall Study|Other reason than listed above|1|||
130687798|NCT00804856|470483160|FG012|Overall Study|Other reason than listed above|1|||
130687799|NCT00804856|470483161|FG013|Overall Study|Other reason than listed above|10|||
130687800|NCT00804856|470483162|FG014|Overall Study|Other reason than listed above|3|||
130687801|NCT01796171|470483163|FG000|Enrolled|Death|0|||
130687802|NCT01796171|470483164|FG001|Enrolled|Death|0|||
130687803|NCT01796171|470483165|FG002|Enrolled|Death|0|||
130767098|NCT04907227|470770731|FG001|Overall Study|Withdrawal by Subject|2|||
130767099|NCT04907227|470770730|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
130767100|NCT04907227|470770731|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
130767101|NCT04907227|470770730|FG000|Overall Study|Sponsor Decision|25|||
130767102|NCT04907227|470770731|FG001|Overall Study|Sponsor Decision|30|||
130767103|NCT04907227|470770730|FG000|Overall Study|Physician Decision|1|||
130767104|NCT04907227|470770731|FG001|Overall Study|Physician Decision|0|||
130767105|NCT02208050|470770732|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
130767106|NCT02208050|470770733|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
130767107|NCT00432276|470770735|FG000|Overall Study|Hyperglycemic Rescue|44|||
130767108|NCT00432276|470770736|FG001|Overall Study|Hyperglycemic Rescue|87|||
130767109|NCT00432276|470770735|FG000|Overall Study|Adverse Event|13|||
130767110|NCT00432276|470770736|FG001|Overall Study|Adverse Event|16|||
130767111|NCT00432276|470770735|FG000|Overall Study|Protocol Violation|25|||
130767112|NCT00432276|470770736|FG001|Overall Study|Protocol Violation|20|||
130767113|NCT00432276|470770735|FG000|Overall Study|Lost to Follow-up|6|||
130767114|NCT00432276|470770736|FG001|Overall Study|Lost to Follow-up|2|||
130767115|NCT00432276|470770735|FG000|Overall Study|Withdrawal by Subject|25|||
130767116|NCT00432276|470770736|FG001|Overall Study|Withdrawal by Subject|20|||
130767117|NCT00432276|470770735|FG000|Overall Study|Physician Decision|6|||
130767118|NCT00432276|470770736|FG001|Overall Study|Physician Decision|8|||
130767119|NCT00432276|470770735|FG000|Overall Study|Other|2|||
130767120|NCT00432276|470770736|FG001|Overall Study|Other|3|||
130767121|NCT00467961|470770737|FG000|Overall Study|Technical Failures|5|||
130767122|NCT00467961|470770737|FG000|Overall Study|Disease Progression|2|||
130767123|NCT03168919|470770740|FG000|Overall Study|Withdrawal by Subject|2|||
130767124|NCT01085136|470770741|FG000|Part A|Other Adverse event|223|||
130767125|NCT01085136|470770742|FG001|Part A|Other Adverse event|0|||
130767126|NCT01085136|470770743|FG002|Part A|Other Adverse event|0|||
130767127|NCT01085136|470770741|FG000|Part A|Protocol Violation|3|||
130767128|NCT01085136|470770742|FG001|Part A|Protocol Violation|0|||
130767129|NCT01085136|470770743|FG002|Part A|Protocol Violation|0|||
130767130|NCT01085136|470770741|FG000|Part A|Lost to Follow-up|3|||
130767131|NCT01085136|470770742|FG001|Part A|Lost to Follow-up|0|||
130893953|NCT01708902|471245458|FG006|Overall Study|Lost to Follow-up|1|||
130687804|NCT01796171|470483166|FG003|Enrolled|Death|0|||
130687805|NCT01796171|470483167|FG004|Enrolled|Death|0|||
130767132|NCT01085136|470770743|FG002|Part A|Lost to Follow-up|0|||
130767133|NCT01085136|470770741|FG000|Part A|Refusal to continue trial medication|64|||
130767134|NCT01085136|470770742|FG001|Part A|Refusal to continue trial medication|0|||
130767135|NCT01085136|470770743|FG002|Part A|Refusal to continue trial medication|0|||
130767136|NCT01085136|470770741|FG000|Part A|Other reason not defined above|30|||
130767137|NCT01085136|470770742|FG001|Part A|Other reason not defined above|0|||
130767138|NCT01085136|470770743|FG002|Part A|Other reason not defined above|0|||
130767139|NCT01085136|470770741|FG000|Part B|Other AE|0|||
130767140|NCT01085136|470770742|FG001|Part B|Other AE|29|||
130687806|NCT01796171|470483168|FG005|Enrolled|Death|0|||
130687807|NCT01796171|470483169|FG006|Enrolled|Death|0|||
130687808|NCT01796171|470483170|FG007|Enrolled|Death|0|||
130687809|NCT01796171|470483171|FG008|Enrolled|Death|0|||
130687810|NCT01796171|470483172|FG009|Enrolled|Death|0|||
130687811|NCT01796171|470483173|FG010|Enrolled|Death|0|||
130687812|NCT01796171|470483174|FG011|Enrolled|Death|0|||
130687813|NCT01796171|470483175|FG012|Enrolled|Death|0|||
130687814|NCT01796171|470483176|FG013|Enrolled|Death|0|||
130687815|NCT01796171|470483177|FG014|Enrolled|Death|1|||
130687816|NCT01796171|470483163|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
130687817|NCT01796171|470483164|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
130687818|NCT01796171|470483165|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
130687819|NCT01796171|470483166|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
130687820|NCT01796171|470483167|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
130687821|NCT01796171|470483168|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
130687822|NCT01796171|470483169|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
130687823|NCT01796171|470483170|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
130687824|NCT01796171|470483171|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
130687825|NCT01796171|470483172|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
130687826|NCT01796171|470483173|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
130687827|NCT01796171|470483174|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
130687828|NCT01796171|470483175|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
130687829|NCT01796171|470483176|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
130687830|NCT01796171|470483177|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
130687831|NCT01796171|470483163|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687832|NCT01796171|470483164|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687833|NCT01796171|470483165|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687834|NCT01796171|470483166|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687835|NCT01796171|470483167|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130767141|NCT01085136|470770743|FG002|Part B|Other AE|8|||
130767142|NCT01085136|470770741|FG000|Part B|Refusal to continue trial medication|0|||
130893954|NCT01708902|471245452|FG000|Overall Study|Refused to continue trial medication|8|||
130893955|NCT01708902|471245453|FG001|Overall Study|Refused to continue trial medication|0|||
130893956|NCT01708902|471245454|FG002|Overall Study|Refused to continue trial medication|4|||
130893957|NCT01708902|471245455|FG003|Overall Study|Refused to continue trial medication|2|||
130893958|NCT01708902|471245456|FG004|Overall Study|Refused to continue trial medication|8|||
130893959|NCT01708902|471245457|FG005|Overall Study|Refused to continue trial medication|1|||
130893960|NCT01708902|471245458|FG006|Overall Study|Refused to continue trial medication|1|||
130893961|NCT01708902|471245452|FG000|Overall Study|Other Reason|1|||
130767143|NCT01085136|470770742|FG001|Part B|Refusal to continue trial medication|12|||
130767144|NCT01085136|470770743|FG002|Part B|Refusal to continue trial medication|7|||
130767145|NCT01085136|470770741|FG000|Part B|Not treated|0|||
130767146|NCT01085136|470770742|FG001|Part B|Not treated|4|||
130767147|NCT01085136|470770743|FG002|Part B|Not treated|8|||
130767148|NCT01085136|470770741|FG000|Part B|Other reason not defined above|0|||
130767149|NCT01085136|470770742|FG001|Part B|Other reason not defined above|6|||
130767150|NCT01085136|470770743|FG002|Part B|Other reason not defined above|3|||
130767151|NCT02678000|470770745|FG000|PART 2|Adverse Event|0|||
130767152|NCT02678000|470770746|FG001|PART 2|Adverse Event|0|||
130767153|NCT02678000|470770747|FG002|PART 2|Adverse Event|2|||
130767154|NCT02678000|470770748|FG003|PART 2|Adverse Event|1|||
130767155|NCT02678000|470770749|FG004|PART 2|Adverse Event|0|||
130767156|NCT02678000|470770745|FG000|PART 2|Withdrawal by Subject|0|||
130767157|NCT02678000|470770746|FG001|PART 2|Withdrawal by Subject|0|||
130767158|NCT02678000|470770747|FG002|PART 2|Withdrawal by Subject|1|||
130767159|NCT02678000|470770748|FG003|PART 2|Withdrawal by Subject|0|||
130767160|NCT02678000|470770749|FG004|PART 2|Withdrawal by Subject|0|||
130767161|NCT02360475|470770751|FG000|Overall Study|Lost to Follow-up|4|||
130767162|NCT02360475|470770752|FG001|Overall Study|Lost to Follow-up|12|||
130767163|NCT02360475|470770753|FG002|Overall Study|Lost to Follow-up|6|||
130767164|NCT02360475|470770754|FG003|Overall Study|Lost to Follow-up|4|||
130767165|NCT02360475|470770751|FG000|Overall Study|Withdrawal by Subject|0|||
130767166|NCT02360475|470770752|FG001|Overall Study|Withdrawal by Subject|1|||
130767167|NCT02360475|470770753|FG002|Overall Study|Withdrawal by Subject|2|||
130767168|NCT02360475|470770754|FG003|Overall Study|Withdrawal by Subject|0|||
130767169|NCT02360475|470770751|FG000|Overall Study|Migrated/moved from study area|0|||
130893962|NCT01708902|471245453|FG001|Overall Study|Other Reason|0|||
131025278|NCT02590432|471723203|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131025279|NCT02590432|471723204|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
130687836|NCT01796171|470483168|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687837|NCT01796171|470483169|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687838|NCT01796171|470483170|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687839|NCT01796171|470483171|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687840|NCT01796171|470483172|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687841|NCT01796171|470483173|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130767170|NCT02360475|470770752|FG001|Overall Study|Migrated/moved from study area|0|||
131110717|NCT05056987|472035727|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
131110718|NCT02409368|472035728|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
131110719|NCT02409368|472035729|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
131110720|NCT02409368|472035730|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
131110721|NCT02409368|472035731|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
131110722|NCT02409368|472035728|FG000|ECOG Reclassification|Death|1|||
131110723|NCT02409368|472035729|FG001|ECOG Reclassification|Death|5|||
131110724|NCT02409368|472035730|FG002|ECOG Reclassification|Death|0|||
131110725|NCT02409368|472035731|FG003|ECOG Reclassification|Death|0|||
131110726|NCT02409368|472035728|FG000|ECOG Reclassification|Disease Progression|113|||
131110727|NCT02409368|472035729|FG001|ECOG Reclassification|Disease Progression|382|||
131110728|NCT02409368|472035730|FG002|ECOG Reclassification|Disease Progression|70|||
131110729|NCT02409368|472035731|FG003|ECOG Reclassification|Disease Progression|1|||
131110730|NCT02409368|472035728|FG000|ECOG Reclassification|Lost to Follow-up|1|||
131110731|NCT02409368|472035729|FG001|ECOG Reclassification|Lost to Follow-up|5|||
131110732|NCT02409368|472035730|FG002|ECOG Reclassification|Lost to Follow-up|0|||
131110733|NCT02409368|472035731|FG003|ECOG Reclassification|Lost to Follow-up|0|||
131110734|NCT02409368|472035728|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
131110735|NCT02409368|472035729|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
131110736|NCT02409368|472035730|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
131110737|NCT02409368|472035731|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
131110738|NCT02409368|472035728|FG000|ECOG Reclassification|Poor/non-compliance|0|||
131110739|NCT02409368|472035729|FG001|ECOG Reclassification|Poor/non-compliance|3|||
131110740|NCT02409368|472035730|FG002|ECOG Reclassification|Poor/non-compliance|2|||
131110741|NCT02409368|472035731|FG003|ECOG Reclassification|Poor/non-compliance|0|||
131110742|NCT02409368|472035728|FG000|ECOG Reclassification|Study drug toxicity|17|||
131110743|NCT02409368|472035729|FG001|ECOG Reclassification|Study drug toxicity|42|||
131110744|NCT02409368|472035730|FG002|ECOG Reclassification|Study drug toxicity|7|||
131110745|NCT02409368|472035731|FG003|ECOG Reclassification|Study drug toxicity|0|||
131110746|NCT02409368|472035728|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
131110747|NCT02409368|472035729|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
131110748|NCT02409368|472035730|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
131110749|NCT02409368|472035731|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
131110750|NCT02409368|472035728|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
131110751|NCT02409368|472035729|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
131110752|NCT02409368|472035730|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
131110753|NCT02409368|472035731|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
131110754|NCT02409368|472035728|FG000|ECOG Reclassification|Participant withdrew consent|2|||
131110755|NCT02409368|472035729|FG001|ECOG Reclassification|Participant withdrew consent|3|||
131110756|NCT02409368|472035730|FG002|ECOG Reclassification|Participant withdrew consent|4|||
131110757|NCT02409368|472035731|FG003|ECOG Reclassification|Participant withdrew consent|0|||
131110758|NCT02409368|472035728|FG000|ECOG Reclassification|Other Reasons|5|||
131222695|NCT02117479|472443161|FG000|Overall Study|Adverse Event|8|||
130767171|NCT02360475|470770753|FG002|Overall Study|Migrated/moved from study area|0|||
130767172|NCT02360475|470770754|FG003|Overall Study|Migrated/moved from study area|1|||
130767173|NCT03759366|470770756|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
130767174|NCT03759366|470770756|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
130767175|NCT03759366|470770756|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
130767176|NCT03759366|470770756|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
130767177|NCT03759366|470770756|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
130767178|NCT03759366|470770756|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
130767179|NCT03759366|470770756|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
130767180|NCT04226495|470770757|FG000|Overall Study|Withdrawal by Subject|3|||
130767181|NCT04226495|470770758|FG001|Overall Study|Withdrawal by Subject|3|||
130767182|NCT04226495|470770757|FG000|Overall Study|PI discretion|3|||
130767183|NCT04226495|470770758|FG001|Overall Study|PI discretion|4|||
130767184|NCT00539032|470770759|FG000|Overall Study|Withdrawal by Subject|2|||
130767185|NCT00539032|470770760|FG001|Overall Study|Withdrawal by Subject|1|||
130767186|NCT01210352|470770761|FG000|Overall Study|Adverse Event|0|||
130767187|NCT01210352|470770762|FG001|Overall Study|Adverse Event|0|||
130767188|NCT01210352|470770763|FG002|Overall Study|Adverse Event|0|||
130767189|NCT01210352|470770764|FG003|Overall Study|Adverse Event|0|||
130767190|NCT01210352|470770765|FG004|Overall Study|Adverse Event|0|||
130767191|NCT01210352|470770766|FG005|Overall Study|Adverse Event|0|||
130767192|NCT01210352|470770767|FG006|Overall Study|Adverse Event|0|||
130767193|NCT01210352|470770768|FG007|Overall Study|Adverse Event|2|||
130767194|NCT01210352|470770769|FG008|Overall Study|Adverse Event|1|||
130893963|NCT01708902|471245454|FG002|Overall Study|Other Reason|1|||
131110759|NCT02409368|472035729|FG001|ECOG Reclassification|Other Reasons|26|||
131110760|NCT02409368|472035730|FG002|ECOG Reclassification|Other Reasons|2|||
131110761|NCT02409368|472035731|FG003|ECOG Reclassification|Other Reasons|0|||
130687842|NCT01796171|470483174|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687843|NCT01796171|470483175|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687844|NCT01796171|470483176|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
130687845|NCT01796171|470483177|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130687846|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Progressive disease|0|||
130687847|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Progressive disease|1|||
130687848|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Progressive disease|0|||
130687849|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Progressive disease|0|||
130687850|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Progressive disease|0|||
130687851|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Progressive disease|0|||
130687852|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Progressive disease|0|||
130687853|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Progressive disease|0|||
130687854|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Progressive disease|0|||
130687855|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Progressive disease|0|||
130687856|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Progressive disease|0|||
130687857|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Progressive disease|0|||
130687858|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Progressive disease|0|||
130687859|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Progressive disease|0|||
130687860|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Progressive disease|0|||
130687861|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687862|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687863|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687864|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687865|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687866|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687867|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687868|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687869|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
130687870|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687871|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
130687872|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
130687873|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687874|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687875|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130687876|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Physician Decision|0|||
130687877|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Physician Decision|0|||
130687878|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Physician Decision|0|||
130687879|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Physician Decision|0|||
130687880|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Physician Decision|0|||
130687881|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Physician Decision|0|||
130687882|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Physician Decision|0|||
130687883|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Physician Decision|0|||
130687884|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Physician Decision|0|||
130687885|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Physician Decision|0|||
130687886|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Physician Decision|5|||
130687887|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Physician Decision|1|||
130687888|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Physician Decision|1|||
130687889|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Physician Decision|0|||
130687890|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Physician Decision|0|||
131110762|NCT02409368|472035728|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
131110763|NCT02409368|472035729|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
131110764|NCT02409368|472035730|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
131110765|NCT02409368|472035731|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
131110766|NCT01585987|472035732|FG000|Randomized|Withdrawal by Subject|0|||
131110767|NCT01585987|472035733|FG001|Randomized|Withdrawal by Subject|4|||
131110768|NCT01585987|472035732|FG000|Randomized|No longer met criteria|0|||
131110769|NCT01585987|472035733|FG001|Randomized|No longer met criteria|2|||
131110770|NCT01585987|472035732|FG000|Treated|Disease Progression|39|||
131110771|NCT01585987|472035733|FG001|Treated|Disease Progression|36|||
131110772|NCT01585987|472035732|FG000|Treated|Study Drug Toxicity|9|||
131110773|NCT01585987|472035733|FG001|Treated|Study Drug Toxicity|5|||
130687891|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Death|0|||
130687892|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Death|0|||
130687893|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Death|0|||
131110774|NCT01585987|472035732|FG000|Treated|Adverse Event|3|||
131110775|NCT01585987|472035733|FG001|Treated|Adverse Event|0|||
130687894|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Death|0|||
130687895|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Death|0|||
130687896|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Death|0|||
130687897|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Death|0|||
130687898|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Death|0|||
130687899|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Death|0|||
130687900|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Death|0|||
130687901|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Death|2|||
130687902|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Death|0|||
130687903|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Death|0|||
130687904|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Death|0|||
130687905|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Death|0|||
130687906|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
130687907|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
130687908|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
130687909|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
130687910|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
130687911|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
130687912|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
130687913|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
130687914|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
130687915|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
130687916|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
130687917|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
130687918|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
130893964|NCT01708902|471245455|FG003|Overall Study|Other Reason|1|||
130893965|NCT01708902|471245456|FG004|Overall Study|Other Reason|1|||
130893966|NCT01708902|471245457|FG005|Overall Study|Other Reason|2|||
130893967|NCT01708902|471245458|FG006|Overall Study|Other Reason|0|||
130893968|NCT02152956|471245460|FG000|Overall Study|Adverse Event|0|||
130893969|NCT02152956|471245461|FG001|Overall Study|Adverse Event|0|||
131025280|NCT02590432|471723205|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
131025281|NCT02590432|471723206|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
131025282|NCT02590432|471723198|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131025283|NCT02590432|471723199|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131025284|NCT02590432|471723200|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131025285|NCT02590432|471723201|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131025286|NCT02590432|471723202|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131025287|NCT02590432|471723203|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131025288|NCT02590432|471723204|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131025289|NCT02590432|471723205|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
131025290|NCT02590432|471723206|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
131025291|NCT02590432|471723198|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131025292|NCT02590432|471723199|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131025293|NCT02590432|471723200|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131025294|NCT02590432|471723201|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131025295|NCT02590432|471723202|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131025296|NCT02590432|471723203|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131025297|NCT02590432|471723204|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131025298|NCT02590432|471723205|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
131025299|NCT02590432|471723206|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
131025300|NCT02590432|471723198|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131025301|NCT02590432|471723199|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131025302|NCT02590432|471723200|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131222696|NCT02117479|472443162|FG001|Overall Study|Adverse Event|16|||
131222697|NCT02117479|472443161|FG000|Overall Study|Subject decision|8|||
131222698|NCT02117479|472443162|FG001|Overall Study|Subject decision|9|||
131222699|NCT02117479|472443161|FG000|Overall Study|Disease progression|104|||
131222700|NCT02117479|472443162|FG001|Overall Study|Disease progression|108|||
131222701|NCT02117479|472443161|FG000|Overall Study|Noncompliance with study treatment|1|||
131222702|NCT02117479|472443162|FG001|Overall Study|Noncompliance with study treatment|0|||
131222703|NCT02117479|472443161|FG000|Overall Study|Study terminated by the sponsor|4|||
131222704|NCT02117479|472443162|FG001|Overall Study|Study terminated by the sponsor|6|||
131222705|NCT02117479|472443161|FG000|Overall Study|Physician Decision|7|||
131222706|NCT02117479|472443162|FG001|Overall Study|Physician Decision|2|||
131222707|NCT02117479|472443161|FG000|Overall Study|Other unspecified|11|||
130687919|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
130687920|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
130893970|NCT02152956|471245462|FG002|Overall Study|Adverse Event|0|||
130687921|NCT01796171|470483163|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687922|NCT01796171|470483164|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687923|NCT01796171|470483165|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687924|NCT01796171|470483166|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687925|NCT01796171|470483167|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687926|NCT01796171|470483168|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687927|NCT01796171|470483169|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687928|NCT01796171|470483170|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687929|NCT01796171|470483171|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687930|NCT01796171|470483172|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687931|NCT01796171|470483173|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
130687932|NCT01796171|470483174|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
130687933|NCT01796171|470483175|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687934|NCT01796171|470483176|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687935|NCT01796171|470483177|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130687936|NCT01796171|470483163|FG000|Follow-up Period|Start of further anticancer therapy|4|||
130687937|NCT01796171|470483164|FG001|Follow-up Period|Start of further anticancer therapy|25|||
130687938|NCT01796171|470483165|FG002|Follow-up Period|Start of further anticancer therapy|2|||
130687939|NCT01796171|470483166|FG003|Follow-up Period|Start of further anticancer therapy|1|||
130687940|NCT01796171|470483167|FG004|Follow-up Period|Start of further anticancer therapy|2|||
130687941|NCT01796171|470483168|FG005|Follow-up Period|Start of further anticancer therapy|2|||
130687942|NCT01796171|470483169|FG006|Follow-up Period|Start of further anticancer therapy|1|||
130687943|NCT01796171|470483170|FG007|Follow-up Period|Start of further anticancer therapy|15|||
130687944|NCT01796171|470483171|FG008|Follow-up Period|Start of further anticancer therapy|2|||
130687945|NCT01796171|470483172|FG009|Follow-up Period|Start of further anticancer therapy|0|||
130687946|NCT01796171|470483173|FG010|Follow-up Period|Start of further anticancer therapy|0|||
130687947|NCT01796171|470483174|FG011|Follow-up Period|Start of further anticancer therapy|0|||
130687948|NCT01796171|470483175|FG012|Follow-up Period|Start of further anticancer therapy|0|||
130687949|NCT01796171|470483176|FG013|Follow-up Period|Start of further anticancer therapy|0|||
130687950|NCT01796171|470483177|FG014|Follow-up Period|Start of further anticancer therapy|0|||
130687951|NCT01796171|470483163|FG000|Follow-up Period|Progressive disease|0|||
130687952|NCT01796171|470483164|FG001|Follow-up Period|Progressive disease|1|||
130687953|NCT01796171|470483165|FG002|Follow-up Period|Progressive disease|0|||
130687954|NCT01796171|470483166|FG003|Follow-up Period|Progressive disease|0|||
130687955|NCT01796171|470483167|FG004|Follow-up Period|Progressive disease|0|||
130687956|NCT01796171|470483168|FG005|Follow-up Period|Progressive disease|0|||
130687957|NCT01796171|470483169|FG006|Follow-up Period|Progressive disease|0|||
130687958|NCT01796171|470483170|FG007|Follow-up Period|Progressive disease|3|||
130687959|NCT01796171|470483171|FG008|Follow-up Period|Progressive disease|0|||
130687960|NCT01796171|470483172|FG009|Follow-up Period|Progressive disease|0|||
131110776|NCT01585987|472035732|FG000|Treated|Withdrawal by Subject|1|||
131110777|NCT01585987|472035733|FG001|Treated|Withdrawal by Subject|2|||
131110778|NCT01585987|472035732|FG000|Treated|Death|1|||
131110779|NCT01585987|472035733|FG001|Treated|Death|0|||
130687961|NCT01796171|470483173|FG010|Follow-up Period|Progressive disease|0|||
130687962|NCT01796171|470483174|FG011|Follow-up Period|Progressive disease|0|||
130687963|NCT01796171|470483175|FG012|Follow-up Period|Progressive disease|0|||
130687964|NCT01796171|470483176|FG013|Follow-up Period|Progressive disease|0|||
131110780|NCT01585987|472035732|FG000|Treated|Lost to Follow-up|0|||
131110781|NCT01585987|472035733|FG001|Treated|Lost to Follow-up|1|||
131110782|NCT01585987|472035732|FG000|Treated|Maximum Clinical Benefit|0|||
131110783|NCT01585987|472035733|FG001|Treated|Maximum Clinical Benefit|1|||
131110784|NCT01585987|472035732|FG000|Treated|Non-Specified|1|||
131110785|NCT01585987|472035733|FG001|Treated|Non-Specified|2|||
131110786|NCT01585987|472035732|FG000|Treated|Subject Request|0|||
131110787|NCT01585987|472035733|FG001|Treated|Subject Request|1|||
131110788|NCT01585987|472035732|FG000|Treated|Poor/Non-Compliance|0|||
131110789|NCT01585987|472035733|FG001|Treated|Poor/Non-Compliance|1|||
131110790|NCT02041520|472035734|FG000|Overall Study|Adverse Event|2|||
131110791|NCT02041520|472035735|FG001|Overall Study|Adverse Event|1|||
131110792|NCT02041520|472035734|FG000|Overall Study|Withdrawal by Subject|3|||
130687965|NCT01796171|470483177|FG014|Follow-up Period|Progressive disease|0|||
130687966|NCT01796171|470483163|FG000|Follow-up Period|Physician Decision|0|||
130687967|NCT01796171|470483164|FG001|Follow-up Period|Physician Decision|2|||
130687968|NCT01796171|470483165|FG002|Follow-up Period|Physician Decision|0|||
130687969|NCT01796171|470483166|FG003|Follow-up Period|Physician Decision|0|||
130687970|NCT01796171|470483167|FG004|Follow-up Period|Physician Decision|0|||
130687971|NCT01796171|470483168|FG005|Follow-up Period|Physician Decision|0|||
130687972|NCT01796171|470483169|FG006|Follow-up Period|Physician Decision|0|||
130687973|NCT01796171|470483170|FG007|Follow-up Period|Physician Decision|0|||
131110793|NCT02041520|472035735|FG001|Overall Study|Withdrawal by Subject|4|||
131110794|NCT02041520|472035734|FG000|Overall Study|Protocol Violation|1|||
131110795|NCT02041520|472035735|FG001|Overall Study|Protocol Violation|0|||
130687974|NCT01796171|470483171|FG008|Follow-up Period|Physician Decision|0|||
130687975|NCT01796171|470483172|FG009|Follow-up Period|Physician Decision|0|||
130687976|NCT01796171|470483173|FG010|Follow-up Period|Physician Decision|5|||
130687977|NCT01796171|470483174|FG011|Follow-up Period|Physician Decision|0|||
130687978|NCT01796171|470483175|FG012|Follow-up Period|Physician Decision|0|||
130687979|NCT01796171|470483176|FG013|Follow-up Period|Physician Decision|0|||
130687980|NCT01796171|470483177|FG014|Follow-up Period|Physician Decision|0|||
130687981|NCT01796171|470483163|FG000|Follow-up Period|Withdrawal by Subject|0|||
130687982|NCT01796171|470483164|FG001|Follow-up Period|Withdrawal by Subject|1|||
130687983|NCT01796171|470483165|FG002|Follow-up Period|Withdrawal by Subject|0|||
130687984|NCT01796171|470483166|FG003|Follow-up Period|Withdrawal by Subject|0|||
130687985|NCT01796171|470483167|FG004|Follow-up Period|Withdrawal by Subject|0|||
130687986|NCT01796171|470483168|FG005|Follow-up Period|Withdrawal by Subject|1|||
130687987|NCT01796171|470483169|FG006|Follow-up Period|Withdrawal by Subject|0|||
130687988|NCT01796171|470483170|FG007|Follow-up Period|Withdrawal by Subject|0|||
130687989|NCT01796171|470483171|FG008|Follow-up Period|Withdrawal by Subject|0|||
130687990|NCT01796171|470483172|FG009|Follow-up Period|Withdrawal by Subject|0|||
130687991|NCT01796171|470483173|FG010|Follow-up Period|Withdrawal by Subject|3|||
130687992|NCT01796171|470483174|FG011|Follow-up Period|Withdrawal by Subject|1|||
130687993|NCT01796171|470483175|FG012|Follow-up Period|Withdrawal by Subject|0|||
130687994|NCT01796171|470483176|FG013|Follow-up Period|Withdrawal by Subject|0|||
130687995|NCT01796171|470483177|FG014|Follow-up Period|Withdrawal by Subject|0|||
130687996|NCT01796171|470483163|FG000|Follow-up Period|Death|0|||
130687997|NCT01796171|470483164|FG001|Follow-up Period|Death|0|||
130687998|NCT01796171|470483165|FG002|Follow-up Period|Death|0|||
130687999|NCT01796171|470483166|FG003|Follow-up Period|Death|0|||
130688000|NCT01796171|470483167|FG004|Follow-up Period|Death|0|||
130688001|NCT01796171|470483168|FG005|Follow-up Period|Death|0|||
130688002|NCT01796171|470483169|FG006|Follow-up Period|Death|1|||
130688003|NCT01796171|470483170|FG007|Follow-up Period|Death|0|||
130688004|NCT01796171|470483171|FG008|Follow-up Period|Death|0|||
130688005|NCT01796171|470483172|FG009|Follow-up Period|Death|0|||
130688006|NCT01796171|470483173|FG010|Follow-up Period|Death|17|||
130688007|NCT01796171|470483174|FG011|Follow-up Period|Death|9|||
130688008|NCT01796171|470483175|FG012|Follow-up Period|Death|1|||
130688009|NCT01796171|470483176|FG013|Follow-up Period|Death|0|||
130688010|NCT01796171|470483177|FG014|Follow-up Period|Death|0|||
130688011|NCT01796171|470483163|FG000|Follow-up Period|Patient transferred to other hospital|0|||
130688012|NCT01796171|470483164|FG001|Follow-up Period|Patient transferred to other hospital|1|||
130688013|NCT01796171|470483165|FG002|Follow-up Period|Patient transferred to other hospital|0|||
130688014|NCT01796171|470483166|FG003|Follow-up Period|Patient transferred to other hospital|0|||
130688015|NCT01796171|470483167|FG004|Follow-up Period|Patient transferred to other hospital|0|||
130688016|NCT01796171|470483168|FG005|Follow-up Period|Patient transferred to other hospital|0|||
130688017|NCT01796171|470483169|FG006|Follow-up Period|Patient transferred to other hospital|0|||
131110796|NCT02041520|472035734|FG000|Overall Study|Lost to Follow-up|0|||
131110797|NCT02041520|472035735|FG001|Overall Study|Lost to Follow-up|1|||
131110798|NCT02041520|472035734|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
131110799|NCT02041520|472035735|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
131110800|NCT00413972|472035741|FG000|Overall Study|Adverse Event|2|||
131110801|NCT00413972|472035742|FG001|Overall Study|Adverse Event|1|||
131110802|NCT00413972|472035743|FG002|Overall Study|Adverse Event|0|||
131110803|NCT00413972|472035744|FG003|Overall Study|Adverse Event|0|||
131110804|NCT00413972|472035741|FG000|Overall Study|Lost to Follow-up|1|||
131110805|NCT00413972|472035742|FG001|Overall Study|Lost to Follow-up|2|||
131110806|NCT00413972|472035743|FG002|Overall Study|Lost to Follow-up|1|||
131110807|NCT00413972|472035744|FG003|Overall Study|Lost to Follow-up|0|||
131110808|NCT00413972|472035741|FG000|Overall Study|Withdrawal by Subject|4|||
131110809|NCT00413972|472035742|FG001|Overall Study|Withdrawal by Subject|5|||
131110810|NCT00413972|472035743|FG002|Overall Study|Withdrawal by Subject|7|||
131110811|NCT00413972|472035744|FG003|Overall Study|Withdrawal by Subject|2|||
131110812|NCT00413972|472035741|FG000|Overall Study|Protocol Violation|0|||
130688018|NCT01796171|470483170|FG007|Follow-up Period|Patient transferred to other hospital|0|||
130688019|NCT01796171|470483171|FG008|Follow-up Period|Patient transferred to other hospital|0|||
130688020|NCT01796171|470483172|FG009|Follow-up Period|Patient transferred to other hospital|0|||
130688021|NCT01796171|470483173|FG010|Follow-up Period|Patient transferred to other hospital|0|||
130688022|NCT01796171|470483174|FG011|Follow-up Period|Patient transferred to other hospital|0|||
130688023|NCT01796171|470483175|FG012|Follow-up Period|Patient transferred to other hospital|0|||
130688024|NCT01796171|470483176|FG013|Follow-up Period|Patient transferred to other hospital|0|||
130688025|NCT01796171|470483177|FG014|Follow-up Period|Patient transferred to other hospital|0|||
130688026|NCT01796171|470483163|FG000|Follow-up Period|Sponsor Decision|0|||
130688027|NCT01796171|470483164|FG001|Follow-up Period|Sponsor Decision|0|||
130688028|NCT01796171|470483165|FG002|Follow-up Period|Sponsor Decision|0|||
130688029|NCT01796171|470483166|FG003|Follow-up Period|Sponsor Decision|0|||
130688030|NCT01796171|470483167|FG004|Follow-up Period|Sponsor Decision|0|||
131110813|NCT00413972|472035742|FG001|Overall Study|Protocol Violation|0|||
131222708|NCT02117479|472443162|FG001|Overall Study|Other unspecified|7|||
131110814|NCT00413972|472035743|FG002|Overall Study|Protocol Violation|2|||
131110815|NCT00413972|472035744|FG003|Overall Study|Protocol Violation|0|||
131110816|NCT00413972|472035741|FG000|Overall Study|Other|0|||
131110817|NCT00413972|472035742|FG001|Overall Study|Other|0|||
131110818|NCT00413972|472035743|FG002|Overall Study|Other|0|||
131110819|NCT00413972|472035744|FG003|Overall Study|Other|1|||
131110820|NCT01759407|472035745|FG000|Overall Study|Protocol Violation|0|||
131110821|NCT01759407|472035746|FG001|Overall Study|Protocol Violation|2|||
131110822|NCT03737474|472035747|FG000|Overall Study|Adverse Event|18|||
131110823|NCT03737474|472035748|FG001|Overall Study|Adverse Event|48|||
131110824|NCT03737474|472035747|FG000|Overall Study|Lack of Efficacy|1|||
131110825|NCT03737474|472035748|FG001|Overall Study|Lack of Efficacy|3|||
131110826|NCT03737474|472035747|FG000|Overall Study|Protocol Violation|0|||
131110827|NCT03737474|472035748|FG001|Overall Study|Protocol Violation|8|||
131110828|NCT03737474|472035747|FG000|Overall Study|Withdrawal by Subject|5|||
131110829|NCT03737474|472035748|FG001|Overall Study|Withdrawal by Subject|20|||
131110830|NCT03737474|472035747|FG000|Overall Study|Non-compliance With Study Drug|0|||
131110831|NCT03737474|472035748|FG001|Overall Study|Non-compliance With Study Drug|1|||
131110832|NCT03737474|472035747|FG000|Overall Study|Physician Decision|1|||
131110833|NCT03737474|472035748|FG001|Overall Study|Physician Decision|4|||
131110834|NCT02513745|472035749|FG000|Overall Study|Criteria at time of surgery not met.|3|||
131110835|NCT02513745|472035750|FG001|Overall Study|Criteria at time of surgery not met.|3|||
131110836|NCT02678247|472035751|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
131110837|NCT02678247|472035752|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
131110838|NCT02678247|472035751|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
131110839|NCT02678247|472035752|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
131110840|NCT02678247|472035751|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
131110841|NCT02678247|472035752|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
130688031|NCT01796171|470483168|FG005|Follow-up Period|Sponsor Decision|0|||
130688032|NCT01796171|470483169|FG006|Follow-up Period|Sponsor Decision|0|||
131110842|NCT02678247|472035751|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
131110843|NCT02678247|472035752|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
131110844|NCT02678247|472035751|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
131110845|NCT02678247|472035752|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
131110846|NCT02678247|472035751|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
131110847|NCT02678247|472035752|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
131110848|NCT01209143|472035753|FG000|Overall Study|Adverse Event|2|||
131110849|NCT01209143|472035754|FG001|Overall Study|Adverse Event|1|||
131110850|NCT01209143|472035753|FG000|Overall Study|Death|0|||
131110851|NCT01209143|472035754|FG001|Overall Study|Death|1|||
131110852|NCT01209143|472035753|FG000|Overall Study|Physician Decision|3|||
131110853|NCT01209143|472035754|FG001|Overall Study|Physician Decision|1|||
131110854|NCT01209143|472035753|FG000|Overall Study|Lost to Follow-up|1|||
131110855|NCT01209143|472035754|FG001|Overall Study|Lost to Follow-up|0|||
130688033|NCT01796171|470483170|FG007|Follow-up Period|Sponsor Decision|0|||
130688034|NCT01796171|470483171|FG008|Follow-up Period|Sponsor Decision|0|||
130688035|NCT01796171|470483172|FG009|Follow-up Period|Sponsor Decision|0|||
130688036|NCT01796171|470483173|FG010|Follow-up Period|Sponsor Decision|40|||
130688037|NCT01796171|470483174|FG011|Follow-up Period|Sponsor Decision|15|||
130688038|NCT01796171|470483175|FG012|Follow-up Period|Sponsor Decision|7|||
130688039|NCT01796171|470483176|FG013|Follow-up Period|Sponsor Decision|0|||
130688040|NCT01796171|470483177|FG014|Follow-up Period|Sponsor Decision|0|||
130688041|NCT00418561|470483178|FG000|Overall Study|Participant's (guardian's) decision|0|||
130688042|NCT00418561|470483179|FG001|Overall Study|Participant's (guardian's) decision|1|||
130688043|NCT00418561|470483180|FG002|Overall Study|Participant's (guardian's) decision|0|||
130688044|NCT00829309|470483183|FG000|Washout: 7 Days|Protocol Violation|1|||
130688045|NCT00829309|470483184|FG001|Washout: 7 Days|Protocol Violation|0|||
130688046|NCT01558635|470483185|FG000|Overall Study|Death|1|||
130688047|NCT01558635|470483185|FG000|Overall Study|Withdrawal by Subject|2|||
130688048|NCT01558635|470483185|FG000|Overall Study|Physician Decision|1|||
131110856|NCT01209143|472035753|FG000|Overall Study|Withdrawal by Subject|2|||
131110857|NCT01209143|472035754|FG001|Overall Study|Withdrawal by Subject|1|||
131110858|NCT01209143|472035753|FG000|Overall Study|Disease progression|11|||
131110859|NCT01209143|472035754|FG001|Overall Study|Disease progression|16|||
131110860|NCT01139658|472035757|FG000|Overall Study|Adverse Event|10|||
131110861|NCT01139658|472035758|FG001|Overall Study|Adverse Event|27|||
131110862|NCT01139658|472035757|FG000|Overall Study|Lack of Efficacy|15|||
131110863|NCT01139658|472035758|FG001|Overall Study|Lack of Efficacy|7|||
130688049|NCT01558635|470483185|FG000|Overall Study|Subject received other treatment|1|||
130688050|NCT01558635|470483185|FG000|Overall Study|Reveal XT was explanted|1|||
130688051|NCT00455312|470483186|FG000|Overall Study|Death|0|||
130767195|NCT01210352|470770761|FG000|Overall Study|Lack of Efficacy|0|||
131110864|NCT01139658|472035757|FG000|Overall Study|Withdrawal by Subject|2|||
131110865|NCT01139658|472035758|FG001|Overall Study|Withdrawal by Subject|4|||
131110866|NCT01139658|472035757|FG000|Overall Study|No documentation of treatment|1|||
131110867|NCT01139658|472035758|FG001|Overall Study|No documentation of treatment|0|||
131110868|NCT01139658|472035757|FG000|Overall Study|Other|28|||
130688052|NCT00455312|470483187|FG001|Overall Study|Death|1|||
130688053|NCT01693523|470483188|FG000|Overall Study|Adverse Event|2|||
130688054|NCT01693523|470483189|FG001|Overall Study|Adverse Event|1|||
130688055|NCT01693523|470483190|FG002|Overall Study|Adverse Event|0|||
130688056|NCT01693523|470483188|FG000|Overall Study|Death|0|||
130688057|NCT01693523|470483189|FG001|Overall Study|Death|1|||
130688058|NCT01693523|470483190|FG002|Overall Study|Death|1|||
130688059|NCT01693523|470483188|FG000|Overall Study|Lost to Follow-up|0|||
130688060|NCT01693523|470483189|FG001|Overall Study|Lost to Follow-up|0|||
130688061|NCT01693523|470483190|FG002|Overall Study|Lost to Follow-up|4|||
130688062|NCT01693523|470483188|FG000|Overall Study|Physician Decision|0|||
130688063|NCT01693523|470483189|FG001|Overall Study|Physician Decision|0|||
130688064|NCT01693523|470483190|FG002|Overall Study|Physician Decision|1|||
130688065|NCT01693523|470483188|FG000|Overall Study|Withdrawal by Subject|1|||
130688066|NCT01693523|470483189|FG001|Overall Study|Withdrawal by Subject|2|||
130688067|NCT01693523|470483190|FG002|Overall Study|Withdrawal by Subject|2|||
130688068|NCT01693523|470483188|FG000|Overall Study|Lack of compliance study medication|1|||
130688069|NCT01693523|470483189|FG001|Overall Study|Lack of compliance study medication|2|||
130688070|NCT01693523|470483190|FG002|Overall Study|Lack of compliance study medication|0|||
130688071|NCT01693523|470483188|FG000|Overall Study|Chemotherapy was held|1|||
130688072|NCT01693523|470483189|FG001|Overall Study|Chemotherapy was held|2|||
130688073|NCT01693523|470483190|FG002|Overall Study|Chemotherapy was held|0|||
130688074|NCT03343535|470483191|FG000|Overall Study|Lost to Follow-up|1|||
130688075|NCT03343535|470483191|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
130688076|NCT03343535|470483191|FG000|Overall Study|Death|12|||
130688077|NCT03699020|470483193|FG000|Overall Study|Withdrawal by Subject|3|||
130688078|NCT03699020|470483194|FG001|Overall Study|Withdrawal by Subject|2|||
130688079|NCT02246920|470483195|FG000|Overall Study|Adverse Event|3|||
130688080|NCT02246920|470483196|FG001|Overall Study|Adverse Event|1|||
130688081|NCT02246920|470483197|FG002|Overall Study|Adverse Event|1|||
130688082|NCT02246920|470483195|FG000|Overall Study|Lost to Follow-up|2|||
130688083|NCT02246920|470483196|FG001|Overall Study|Lost to Follow-up|1|||
130688084|NCT02246920|470483197|FG002|Overall Study|Lost to Follow-up|0|||
130688085|NCT02246920|470483195|FG000|Overall Study|Protocol Violation|2|||
130688086|NCT02246920|470483196|FG001|Overall Study|Protocol Violation|5|||
130688087|NCT02246920|470483197|FG002|Overall Study|Protocol Violation|1|||
130688088|NCT02246920|470483195|FG000|Overall Study|Withdrawal by Subject|0|||
130688089|NCT02246920|470483196|FG001|Overall Study|Withdrawal by Subject|0|||
130688090|NCT02246920|470483197|FG002|Overall Study|Withdrawal by Subject|1|||
130688091|NCT01037114|470483200|FG000|Year 20|Others|1|||
130688092|NCT03620747|470483202|FG000|Overall Study|Participant decision|7|||
130688093|NCT03620747|470483202|FG000|Overall Study|Adverse Event|6|||
130688094|NCT03620747|470483202|FG000|Overall Study|Lack of Efficacy|1|||
130688095|NCT03620747|470483202|FG000|Overall Study|Poor compliance to protocol|2|||
130688096|NCT03620747|470483202|FG000|Overall Study|Other-unspecified|3|||
130688097|NCT00640562|470483205|FG000|Overall Study|Adverse Event|8|||
130688098|NCT00640562|470483206|FG001|Overall Study|Adverse Event|5|||
130767196|NCT01210352|470770762|FG001|Overall Study|Lack of Efficacy|0|||
131110869|NCT01139658|472035758|FG001|Overall Study|Other|75|||
130688099|NCT00640562|470483205|FG000|Overall Study|Lack of Efficacy|1|||
130688100|NCT00640562|470483206|FG001|Overall Study|Lack of Efficacy|4|||
130688101|NCT00640562|470483205|FG000|Overall Study|Protocol Violation|2|||
130767197|NCT01210352|470770763|FG002|Overall Study|Lack of Efficacy|0|||
130767198|NCT01210352|470770764|FG003|Overall Study|Lack of Efficacy|0|||
130767199|NCT01210352|470770765|FG004|Overall Study|Lack of Efficacy|0|||
130767200|NCT01210352|470770766|FG005|Overall Study|Lack of Efficacy|0|||
130767201|NCT01210352|470770767|FG006|Overall Study|Lack of Efficacy|1|||
130767202|NCT01210352|470770768|FG007|Overall Study|Lack of Efficacy|0|||
130767203|NCT01210352|470770769|FG008|Overall Study|Lack of Efficacy|0|||
130767204|NCT01210352|470770761|FG000|Overall Study|Physician Decision|0|||
130767205|NCT01210352|470770762|FG001|Overall Study|Physician Decision|0|||
130767206|NCT01210352|470770763|FG002|Overall Study|Physician Decision|0|||
130767207|NCT01210352|470770764|FG003|Overall Study|Physician Decision|0|||
130767208|NCT01210352|470770765|FG004|Overall Study|Physician Decision|0|||
130767209|NCT01210352|470770766|FG005|Overall Study|Physician Decision|0|||
131110870|NCT00026208|472035760|FG000|Overall Study|Complications of auto accident|1|||
131110871|NCT00026208|472035761|FG001|Overall Study|Complications of auto accident|0|||
130767210|NCT01210352|470770767|FG006|Overall Study|Physician Decision|0|||
130767211|NCT01210352|470770768|FG007|Overall Study|Physician Decision|1|||
130767212|NCT01210352|470770769|FG008|Overall Study|Physician Decision|2|||
130688102|NCT00640562|470483206|FG001|Overall Study|Protocol Violation|4|||
130688103|NCT00640562|470483205|FG000|Overall Study|Withdrawal by Subject|6|||
130688104|NCT00640562|470483206|FG001|Overall Study|Withdrawal by Subject|10|||
130688105|NCT00640562|470483205|FG000|Overall Study|Known risperidone intolerance|0|||
130688106|NCT00640562|470483206|FG001|Overall Study|Known risperidone intolerance|1|||
130688107|NCT00640562|470483205|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
130688108|NCT00640562|470483206|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
130688109|NCT00640562|470483205|FG000|Overall Study|Low study drug dose|0|||
130767213|NCT01210352|470770761|FG000|Overall Study|Withdrawal by Subject|0|||
130688110|NCT00640562|470483206|FG001|Overall Study|Low study drug dose|1|||
130688111|NCT00640562|470483205|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
130688112|NCT00640562|470483206|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
130688113|NCT02937870|470483207|FG000|Overall Study|Adverse Event|1|||
130688114|NCT02937870|470483207|FG000|Overall Study|Protocol Deviation|2|||
130688115|NCT00609674|470483208|FG000|Overall Study|Adverse Event|1|||
130688116|NCT00609674|470483209|FG001|Overall Study|Adverse Event|1|||
130688117|NCT00609674|470483208|FG000|Overall Study|Protocol Violation|3|||
130688118|NCT00609674|470483209|FG001|Overall Study|Protocol Violation|5|||
130688119|NCT00609674|470483208|FG000|Overall Study|Lost to Follow-up|1|||
130688120|NCT00609674|470483209|FG001|Overall Study|Lost to Follow-up|0|||
130688121|NCT00609674|470483208|FG000|Overall Study|Withdrew consent|2|||
130688122|NCT00609674|470483209|FG001|Overall Study|Withdrew consent|1|||
130688123|NCT03098394|470483210|FG000|Overall Study|Pregnancy|0|||
130688124|NCT03098394|470483211|FG001|Overall Study|Pregnancy|1|||
130688125|NCT00571064|470483213|FG000|Overall Study|Adverse Event|13|||
130688126|NCT00571064|470483213|FG000|Overall Study|Protocol Violation|4|||
130688127|NCT00571064|470483213|FG000|Overall Study|Withdrawal by Subject|2|||
130688128|NCT00571064|470483213|FG000|Overall Study|Other|2|||
130688129|NCT00244764|470483214|FG000|Overall Study|Adverse Event|37|||
130688130|NCT00244764|470483214|FG000|Overall Study|Lost to Follow-up|23|||
130688131|NCT00244764|470483214|FG000|Overall Study|Withdrawal by Subject|12|||
130688132|NCT00244764|470483214|FG000|Overall Study|Disease Progression|13|||
130688133|NCT00244764|470483214|FG000|Overall Study|Protocol Violation|2|||
130688134|NCT00244764|470483214|FG000|Overall Study|Death|1|||
130688135|NCT00244764|470483214|FG000|Overall Study|Off Study Medication for >21 Days|1|||
130688136|NCT00244764|470483214|FG000|Overall Study|Declining Performance Status|1|||
130688137|NCT00244764|470483214|FG000|Overall Study|Participant was Hospitalized until Death|1|||
130688138|NCT00244764|470483214|FG000|Overall Study|Primary Investigator Discretion|2|||
130688139|NCT00244764|470483214|FG000|Overall Study|Sponsor Terminated Study|2|||
130688140|NCT00244764|470483214|FG000|Overall Study|Developed Secondary Malignancy|1|||
130688141|NCT03872128|470483217|FG000|Overall Study|Dropped out before treatment|1|||
130688142|NCT03872128|470483218|FG001|Overall Study|Dropped out before treatment|0|||
130688143|NCT03872128|470483219|FG002|Overall Study|Dropped out before treatment|4|||
130688144|NCT03872128|470483217|FG000|Overall Study|Lost to Follow-up|2|||
130688145|NCT03872128|470483218|FG001|Overall Study|Lost to Follow-up|5|||
130688146|NCT03872128|470483219|FG002|Overall Study|Lost to Follow-up|8|||
130688147|NCT03285594|470483221|FG000|Overall Study|At the Participant's Own Request|10|||
130688148|NCT03285594|470483222|FG001|Overall Study|At the Participant's Own Request|5|||
130688149|NCT03285594|470483223|FG002|Overall Study|At the Participant's Own Request|21|||
130688150|NCT03285594|470483221|FG000|Overall Study|Adverse Event|2|||
130688151|NCT03285594|470483222|FG001|Overall Study|Adverse Event|2|||
130688152|NCT03285594|470483223|FG002|Overall Study|Adverse Event|6|||
130688153|NCT03285594|470483221|FG000|Overall Study|Poor Compliance to Protocol|0|||
130688154|NCT03285594|470483222|FG001|Overall Study|Poor Compliance to Protocol|0|||
130688155|NCT03285594|470483223|FG002|Overall Study|Poor Compliance to Protocol|1|||
130688156|NCT03285594|470483221|FG000|Overall Study|Lost to Follow-up|0|||
130688157|NCT03285594|470483222|FG001|Overall Study|Lost to Follow-up|0|||
130688158|NCT03285594|470483223|FG002|Overall Study|Lost to Follow-up|1|||
130688159|NCT03285594|470483221|FG000|Overall Study|Reason Not Specified|3|||
130688160|NCT03285594|470483222|FG001|Overall Study|Reason Not Specified|4|||
130688161|NCT03285594|470483223|FG002|Overall Study|Reason Not Specified|8|||
130688162|NCT03273153|470483227|FG000|Overall Study|Adverse Event|1|||
130688163|NCT03273153|470483228|FG001|Overall Study|Adverse Event|2|||
130688164|NCT03273153|470483227|FG000|Overall Study|Missing|0|||
130688165|NCT03273153|470483228|FG001|Overall Study|Missing|2|||
130688166|NCT03273153|470483227|FG000|Overall Study|Other|3|||
130688167|NCT03273153|470483228|FG001|Overall Study|Other|2|||
130688168|NCT03273153|470483227|FG000|Overall Study|Symptomatic Deterioration|0|||
130688169|NCT03273153|470483228|FG001|Overall Study|Symptomatic Deterioration|1|||
131110872|NCT02225353|472035762|FG000|Overall Study|Lost to Follow-up|0|||
131110873|NCT02225353|472035763|FG001|Overall Study|Lost to Follow-up|1|||
130688170|NCT03273153|470483227|FG000|Overall Study|Progressive Disease|6|||
131110874|NCT02225353|472035764|FG002|Overall Study|Lost to Follow-up|3|||
130688171|NCT03273153|470483228|FG001|Overall Study|Progressive Disease|5|||
130688172|NCT03273153|470483227|FG000|Overall Study|Physician Decision|1|||
130688173|NCT03273153|470483228|FG001|Overall Study|Physician Decision|3|||
130688174|NCT03273153|470483227|FG000|Overall Study|Study Terminated by Sponsor|112|||
130688175|NCT03273153|470483228|FG001|Overall Study|Study Terminated by Sponsor|102|||
130688176|NCT03273153|470483227|FG000|Overall Study|Withdrawal by Subject|26|||
130688177|NCT03273153|470483228|FG001|Overall Study|Withdrawal by Subject|25|||
130688178|NCT03273153|470483227|FG000|Overall Study|Protocol Deviation|3|||
130688179|NCT03273153|470483228|FG001|Overall Study|Protocol Deviation|0|||
130688180|NCT03273153|470483227|FG000|Overall Study|Lost to Follow-up|6|||
130893971|NCT02152956|471245463|FG003|Overall Study|Adverse Event|0|||
130688181|NCT03273153|470483228|FG001|Overall Study|Lost to Follow-up|11|||
130688182|NCT03273153|470483227|FG000|Overall Study|Death|66|||
130688183|NCT03273153|470483228|FG001|Overall Study|Death|69|||
130688184|NCT05323396|470483229|FG000|Overall Study|Lost to Follow-up|1|||
130688185|NCT05323396|470483230|FG001|Overall Study|Lost to Follow-up|35|||
130688186|NCT05323396|470483229|FG000|Overall Study|Pregnancy|1|||
130688187|NCT05323396|470483230|FG001|Overall Study|Pregnancy|0|||
130688188|NCT04646213|470483231|FG000|Overall Study|Physician Decision|3|||
130688189|NCT04646213|470483231|FG000|Overall Study|Withdrawal by Subject|2|||
130688190|NCT00415363|470483236|FG000|Overall Study|Withdrawal by Subject|4|||
131110875|NCT02225353|472035762|FG000|Overall Study|Protocol Violation|4|||
131110876|NCT02225353|472035763|FG001|Overall Study|Protocol Violation|5|||
131110877|NCT02225353|472035764|FG002|Overall Study|Protocol Violation|12|||
131110878|NCT03604523|472035765|FG000|Overall Study|Physician Decision|1|||
131110879|NCT03604523|472035766|FG001|Overall Study|Physician Decision|0|||
131110880|NCT03442114|472035770|FG000|Overall Study|Lost to Follow-up|13|||
131110881|NCT03442114|472035771|FG001|Overall Study|Lost to Follow-up|13|||
131110882|NCT03442114|472035770|FG000|Overall Study|Physician Decision|2|||
131110883|NCT03442114|472035771|FG001|Overall Study|Physician Decision|2|||
131110884|NCT03442114|472035770|FG000|Overall Study|Protocol Violation|0|||
131110885|NCT03442114|472035771|FG001|Overall Study|Protocol Violation|2|||
131110886|NCT03442114|472035770|FG000|Overall Study|Withdrawal by Subject|1|||
131110887|NCT03442114|472035771|FG001|Overall Study|Withdrawal by Subject|3|||
131110888|NCT03442114|472035770|FG000|Overall Study|Guardianship Change|0|||
131110889|NCT03442114|472035771|FG001|Overall Study|Guardianship Change|1|||
131110890|NCT02903368|472035772|FG000|Part 1|Adverse Event|3|||
131110891|NCT02903368|472035773|FG001|Part 1|Adverse Event|0|||
131110892|NCT02903368|472035774|FG002|Part 1|Adverse Event|0|||
131110893|NCT02903368|472035775|FG003|Part 1|Adverse Event|0|||
131110894|NCT02903368|472035772|FG000|Part 1|Withdrawal by Subject|1|||
131110895|NCT02903368|472035773|FG001|Part 1|Withdrawal by Subject|0|||
131110896|NCT02903368|472035774|FG002|Part 1|Withdrawal by Subject|0|||
131110897|NCT02903368|472035775|FG003|Part 1|Withdrawal by Subject|0|||
131110898|NCT02903368|472035772|FG000|Part 2|Adverse Event|0|||
131110899|NCT02903368|472035773|FG001|Part 2|Adverse Event|0|||
131110900|NCT02903368|472035774|FG002|Part 2|Adverse Event|5|||
131110901|NCT02903368|472035775|FG003|Part 2|Adverse Event|0|||
131110902|NCT02903368|472035772|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
131110903|NCT02903368|472035773|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
131110904|NCT02903368|472035774|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
131110905|NCT02903368|472035775|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
131110906|NCT02903368|472035772|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
131110907|NCT02903368|472035773|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
131110908|NCT02903368|472035774|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
131110909|NCT02903368|472035775|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
131110910|NCT02903368|472035772|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
131110911|NCT02903368|472035773|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
131110912|NCT02903368|472035774|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
131110913|NCT02903368|472035775|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
131110914|NCT02952001|472037619|FG000|Overall Study|Adverse Event|3|||
131110915|NCT02952001|472037620|FG001|Overall Study|Adverse Event|0|||
131110916|NCT02952001|472037619|FG000|Overall Study|Prohibited therapy|10|||
131110917|NCT02952001|472037620|FG001|Overall Study|Prohibited therapy|3|||
131110918|NCT02952001|472037619|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
131110919|NCT02952001|472037620|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
131110920|NCT00937833|472037623|FG000|Overall Study|Protocol Violation|1|||
131110921|NCT00937833|472037624|FG001|Overall Study|Protocol Violation|2|||
131110922|NCT00937833|472037623|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
131110923|NCT00937833|472037624|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
131110924|NCT00937833|472037623|FG000|Overall Study|Lost to Follow-up|10|||
131110925|NCT00937833|472037624|FG001|Overall Study|Lost to Follow-up|8|||
131110926|NCT00937833|472037623|FG000|Overall Study|Withdrawal by Subject|4|||
131110927|NCT00937833|472037624|FG001|Overall Study|Withdrawal by Subject|6|||
131110928|NCT03278106|472037626|FG000|Overall Study|No protocol treatment|1|||
131110929|NCT00818389|472037627|FG000|Overall Study|Death|1|||
131110930|NCT00818389|472037628|FG001|Overall Study|Death|3|||
131110931|NCT00818389|472037627|FG000|Overall Study|ALS Disease Progression|1|||
131110932|NCT00818389|472037628|FG001|Overall Study|ALS Disease Progression|0|||
130688191|NCT00415363|470483237|FG001|Overall Study|Withdrawal by Subject|4|||
131110933|NCT00818389|472037627|FG000|Overall Study|Withdrawal by Subject|2|||
131110934|NCT00818389|472037628|FG001|Overall Study|Withdrawal by Subject|2|||
131110935|NCT00818389|472037627|FG000|Overall Study|Adverse Event|0|||
131110936|NCT00818389|472037628|FG001|Overall Study|Adverse Event|1|||
131110937|NCT03548987|472037629|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
131110938|NCT03548987|472037630|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
131110939|NCT03548987|472037629|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
130688192|NCT00415363|470483236|FG000|Overall Study|Adverse Event|4|||
130688193|NCT00415363|470483237|FG001|Overall Study|Adverse Event|4|||
131110940|NCT03548987|472037630|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
131110941|NCT03548987|472037629|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
131110942|NCT03548987|472037630|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
131110943|NCT03548987|472037629|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
131110944|NCT03548987|472037630|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
131110945|NCT03548987|472037629|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
131110946|NCT03548987|472037630|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
131110947|NCT03548987|472037629|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
131110948|NCT03548987|472037630|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
131110949|NCT03548987|472037629|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
131110950|NCT03548987|472037630|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
131110951|NCT03548987|472037629|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
131110952|NCT03548987|472037630|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
131110953|NCT03548987|472037629|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
131110954|NCT03548987|472037630|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
131110955|NCT03548987|472037629|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
131110956|NCT03548987|472037630|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
131110957|NCT03548987|472037629|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
131110958|NCT03548987|472037630|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
131110959|NCT03548987|472037629|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
131110960|NCT03548987|472037630|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
131110961|NCT03548987|472037629|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
131110962|NCT03548987|472037630|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
131110963|NCT03548987|472037629|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
131110964|NCT03548987|472037630|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
131110965|NCT00756470|472037632|FG000|Overall Study|Withdrawal by Subject|1|||
131110966|NCT00756470|472037632|FG000|Overall Study|Adverse Event|4|||
131110967|NCT00820027|472037633|FG000|Overall Study|Adverse Event|15|||
131110968|NCT00820027|472037634|FG001|Overall Study|Adverse Event|8|||
131110969|NCT00820027|472037635|FG002|Overall Study|Adverse Event|10|||
131110970|NCT00820027|472037636|FG003|Overall Study|Adverse Event|5|||
131110971|NCT00820027|472037633|FG000|Overall Study|Lack of Efficacy|2|||
131110972|NCT00820027|472037634|FG001|Overall Study|Lack of Efficacy|1|||
131110973|NCT00820027|472037635|FG002|Overall Study|Lack of Efficacy|2|||
131110974|NCT00820027|472037636|FG003|Overall Study|Lack of Efficacy|2|||
131110975|NCT00820027|472037633|FG000|Overall Study|Physician Decision|0|||
131110976|NCT00820027|472037634|FG001|Overall Study|Physician Decision|1|||
131110977|NCT00820027|472037635|FG002|Overall Study|Physician Decision|1|||
131110978|NCT00820027|472037636|FG003|Overall Study|Physician Decision|0|||
131110979|NCT00820027|472037633|FG000|Overall Study|Protocol Violation|3|||
131110980|NCT00820027|472037634|FG001|Overall Study|Protocol Violation|0|||
131110981|NCT00820027|472037635|FG002|Overall Study|Protocol Violation|4|||
131110982|NCT00820027|472037636|FG003|Overall Study|Protocol Violation|0|||
131110983|NCT00820027|472037633|FG000|Overall Study|Withdrawal by Subject|6|||
131110984|NCT00820027|472037634|FG001|Overall Study|Withdrawal by Subject|4|||
131110985|NCT00820027|472037635|FG002|Overall Study|Withdrawal by Subject|4|||
131110986|NCT00820027|472037636|FG003|Overall Study|Withdrawal by Subject|6|||
131110987|NCT03285178|472037637|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
131110988|NCT03285178|472037638|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131110989|NCT03285178|472037639|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131110990|NCT03285178|472037640|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131110991|NCT03285178|472037641|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131110992|NCT03285178|472037642|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131110993|NCT03285178|472037643|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
131110994|NCT03285178|472037637|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
131110995|NCT03285178|472037638|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131110996|NCT03285178|472037639|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131110997|NCT03285178|472037640|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131110998|NCT03285178|472037641|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131110999|NCT03285178|472037642|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131111000|NCT03285178|472037643|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
131111001|NCT03285178|472037637|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
131111002|NCT03285178|472037638|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
131111003|NCT03285178|472037639|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
131111004|NCT03285178|472037640|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
130688194|NCT00415363|470483236|FG000|Overall Study|Lost to Follow-up|2|||
130688195|NCT00415363|470483237|FG001|Overall Study|Lost to Follow-up|1|||
130688196|NCT00415363|470483236|FG000|Overall Study|Physician Decision|3|||
130688197|NCT00415363|470483237|FG001|Overall Study|Physician Decision|1|||
130688198|NCT00415363|470483236|FG000|Overall Study|Death|16|||
130688199|NCT00415363|470483237|FG001|Overall Study|Death|12|||
130688200|NCT00415363|470483236|FG000|Overall Study|Progressive disease|26|||
130688201|NCT00415363|470483237|FG001|Overall Study|Progressive disease|32|||
130688202|NCT00095212|470483238|FG000|Overall Study|Withdrawal by Subject|1|||
130688203|NCT00095212|470483239|FG001|Overall Study|Withdrawal by Subject|3|||
130688204|NCT05341622|470483240|FG000|Overall Study|Death|0|||
130688205|NCT05341622|470483241|FG001|Overall Study|Death|0|||
130688206|NCT05341622|470483242|FG002|Overall Study|Death|0|||
130688207|NCT05341622|470483243|FG003|Overall Study|Death|0|||
130688208|NCT05341622|470483244|FG004|Overall Study|Death|1|||
130688209|NCT05341622|470483245|FG005|Overall Study|Death|0|||
130688210|NCT05341622|470483246|FG006|Overall Study|Death|0|||
130688211|NCT05341622|470483247|FG007|Overall Study|Death|1|||
130688212|NCT05341622|470483240|FG000|Overall Study|Invalid Address|0|||
130688213|NCT05341622|470483241|FG001|Overall Study|Invalid Address|1|||
130688214|NCT05341622|470483242|FG002|Overall Study|Invalid Address|0|||
130688215|NCT05341622|470483243|FG003|Overall Study|Invalid Address|0|||
130688216|NCT05341622|470483244|FG004|Overall Study|Invalid Address|0|||
130688217|NCT05341622|470483245|FG005|Overall Study|Invalid Address|0|||
130688218|NCT05341622|470483246|FG006|Overall Study|Invalid Address|0|||
130688219|NCT05341622|470483247|FG007|Overall Study|Invalid Address|0|||
130688220|NCT05341622|470483240|FG000|Overall Study|Ineligible|26|||
130688221|NCT05341622|470483241|FG001|Overall Study|Ineligible|21|||
130688222|NCT05341622|470483242|FG002|Overall Study|Ineligible|28|||
130688223|NCT05341622|470483243|FG003|Overall Study|Ineligible|24|||
130688224|NCT05341622|470483244|FG004|Overall Study|Ineligible|29|||
130688225|NCT05341622|470483245|FG005|Overall Study|Ineligible|31|||
130688226|NCT05341622|470483246|FG006|Overall Study|Ineligible|28|||
130688227|NCT05341622|470483247|FG007|Overall Study|Ineligible|26|||
130688228|NCT02658084|470483248|FG000|Overall Study|Withdrawal by Subject|1|||
130688229|NCT02658084|470483249|FG001|Overall Study|Withdrawal by Subject|0|||
130688230|NCT02658084|470483248|FG000|Overall Study|Study Termination|1|||
130688231|NCT02658084|470483249|FG001|Overall Study|Study Termination|0|||
130688232|NCT02674152|470484537|FG000|Overall Study|Personal Reasons|1|||
130688233|NCT02674152|470484538|FG001|Overall Study|Personal Reasons|0|||
130688234|NCT02674152|470484539|FG002|Overall Study|Personal Reasons|0|||
130688235|NCT02674152|470484540|FG003|Overall Study|Personal Reasons|1|||
130688236|NCT02674152|470484541|FG004|Overall Study|Personal Reasons|1|||
131111005|NCT03285178|472037641|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
131111006|NCT03285178|472037642|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
131111007|NCT03285178|472037643|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
131111008|NCT03285178|472037637|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
131111009|NCT03285178|472037638|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131111010|NCT03285178|472037639|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131111011|NCT03285178|472037640|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131111012|NCT03285178|472037641|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131111013|NCT03285178|472037642|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131111014|NCT03285178|472037643|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
131111015|NCT03285178|472037637|FG000|Single-Blind Run-In Period|Physician Decision|2|||
131111016|NCT03285178|472037638|FG001|Single-Blind Run-In Period|Physician Decision|0|||
131111017|NCT03285178|472037639|FG002|Single-Blind Run-In Period|Physician Decision|0|||
131111018|NCT03285178|472037640|FG003|Single-Blind Run-In Period|Physician Decision|0|||
131111019|NCT03285178|472037641|FG004|Single-Blind Run-In Period|Physician Decision|0|||
131111020|NCT03285178|472037642|FG005|Single-Blind Run-In Period|Physician Decision|0|||
131111021|NCT03285178|472037643|FG006|Single-Blind Run-In Period|Physician Decision|0|||
131111022|NCT03285178|472037637|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
131111023|NCT03285178|472037638|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
131111024|NCT03285178|472037639|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
131111025|NCT03285178|472037640|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
131111026|NCT03285178|472037641|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
131111027|NCT03285178|472037642|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
130688237|NCT02674152|470484537|FG000|Overall Study|Other adverse event or clinical progression|0|||
130688238|NCT02674152|470484538|FG001|Overall Study|Other adverse event or clinical progression|1|||
130688239|NCT02674152|470484539|FG002|Overall Study|Other adverse event or clinical progression|0|||
130688240|NCT02674152|470484540|FG003|Overall Study|Other adverse event or clinical progression|3|||
130688241|NCT02674152|470484541|FG004|Overall Study|Other adverse event or clinical progression|0|||
130688242|NCT02674152|470484537|FG000|Overall Study|Dose-limiting toxicity|0|||
130688243|NCT02674152|470484538|FG001|Overall Study|Dose-limiting toxicity|0|||
130688244|NCT02674152|470484539|FG002|Overall Study|Dose-limiting toxicity|0|||
130688245|NCT02674152|470484540|FG003|Overall Study|Dose-limiting toxicity|0|||
130688246|NCT02674152|470484541|FG004|Overall Study|Dose-limiting toxicity|1|||
130688247|NCT02674152|470484537|FG000|Overall Study|Progressive Disease|2|||
130688248|NCT02674152|470484538|FG001|Overall Study|Progressive Disease|1|||
130688249|NCT02674152|470484539|FG002|Overall Study|Progressive Disease|1|||
130688250|NCT02674152|470484540|FG003|Overall Study|Progressive Disease|13|||
130688251|NCT02674152|470484541|FG004|Overall Study|Progressive Disease|2|||
130688252|NCT02674152|470484537|FG000|Overall Study|Adverse Event|0|||
130688253|NCT02674152|470484538|FG001|Overall Study|Adverse Event|0|||
130688254|NCT02674152|470484539|FG002|Overall Study|Adverse Event|1|||
130688255|NCT02674152|470484540|FG003|Overall Study|Adverse Event|0|||
130688256|NCT02674152|470484541|FG004|Overall Study|Adverse Event|1|||
130688257|NCT04934722|470484542|FG000|Overall Study|Death|4|||
130688258|NCT04934722|470484543|FG001|Overall Study|Death|3|||
130688259|NCT04934722|470484542|FG000|Overall Study|Participants Ongoing|88|||
130688260|NCT04934722|470484543|FG001|Overall Study|Participants Ongoing|91|||
130688261|NCT05265624|470484544|FG000|Overall Study|Lost to Follow-up|3|||
130688262|NCT05265624|470484545|FG001|Overall Study|Lost to Follow-up|0|||
130688263|NCT05265624|470484544|FG000|Overall Study|Withdrawal by Subject|1|||
130688264|NCT05265624|470484545|FG001|Overall Study|Withdrawal by Subject|0|||
130688265|NCT03071575|470484546|FG000|Overall Study|Death|0|||
130688266|NCT03071575|470484547|FG001|Overall Study|Death|1|||
130688267|NCT03071575|470484546|FG000|Overall Study|Lost to Follow-up|5|||
130688268|NCT03071575|470484547|FG001|Overall Study|Lost to Follow-up|11|||
130688269|NCT03071575|470484546|FG000|Overall Study|Withdrawal by Subject|4|||
130688270|NCT03071575|470484547|FG001|Overall Study|Withdrawal by Subject|2|||
130688271|NCT00834795|470484548|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
130688272|NCT00834795|470484549|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
130688273|NCT00834795|470484548|FG000|Second Intervention|Adverse Event|1|||
130688274|NCT00834795|470484549|FG001|Second Intervention|Adverse Event|0|||
130688275|NCT00579345|470484550|FG000|Overall Study|Withdrawal by Subject|2|||
130688276|NCT00579345|470484551|FG001|Overall Study|Withdrawal by Subject|0|||
130688277|NCT00579345|470484552|FG002|Overall Study|Withdrawal by Subject|0|||
130688278|NCT00579345|470484553|FG003|Overall Study|Withdrawal by Subject|0|||
130688279|NCT00579345|470484554|FG004|Overall Study|Withdrawal by Subject|0|||
130688280|NCT00579345|470484555|FG005|Overall Study|Withdrawal by Subject|0|||
130688281|NCT00579345|470484556|FG006|Overall Study|Withdrawal by Subject|0|||
130688282|NCT00579345|470484557|FG007|Overall Study|Withdrawal by Subject|1|||
130688283|NCT00579345|470484550|FG000|Overall Study|Lost to Follow-up|1|||
130688284|NCT00579345|470484551|FG001|Overall Study|Lost to Follow-up|0|||
130688285|NCT00579345|470484552|FG002|Overall Study|Lost to Follow-up|0|||
130688286|NCT00579345|470484553|FG003|Overall Study|Lost to Follow-up|0|||
130688287|NCT00579345|470484554|FG004|Overall Study|Lost to Follow-up|0|||
130893972|NCT02152956|471245464|FG004|Overall Study|Adverse Event|0|||
130893973|NCT02152956|471245465|FG005|Overall Study|Adverse Event|0|||
130767214|NCT01210352|470770762|FG001|Overall Study|Withdrawal by Subject|0|||
130767215|NCT01210352|470770763|FG002|Overall Study|Withdrawal by Subject|1|||
130767216|NCT01210352|470770764|FG003|Overall Study|Withdrawal by Subject|0|||
130767217|NCT01210352|470770765|FG004|Overall Study|Withdrawal by Subject|0|||
130767218|NCT01210352|470770766|FG005|Overall Study|Withdrawal by Subject|0|||
130767219|NCT01210352|470770767|FG006|Overall Study|Withdrawal by Subject|1|||
130767220|NCT01210352|470770768|FG007|Overall Study|Withdrawal by Subject|0|||
130767221|NCT01210352|470770769|FG008|Overall Study|Withdrawal by Subject|1|||
130767222|NCT01210352|470770761|FG000|Overall Study|Patient Discharged Early|0|||
130767223|NCT01210352|470770762|FG001|Overall Study|Patient Discharged Early|0|||
130767224|NCT01210352|470770763|FG002|Overall Study|Patient Discharged Early|1|||
130767225|NCT01210352|470770764|FG003|Overall Study|Patient Discharged Early|0|||
130767226|NCT01210352|470770765|FG004|Overall Study|Patient Discharged Early|0|||
130767227|NCT01210352|470770766|FG005|Overall Study|Patient Discharged Early|0|||
130767228|NCT01210352|470770767|FG006|Overall Study|Patient Discharged Early|0|||
130767229|NCT01210352|470770768|FG007|Overall Study|Patient Discharged Early|0|||
130767230|NCT01210352|470770769|FG008|Overall Study|Patient Discharged Early|0|||
130767231|NCT00422292|470770770|FG000|Overall Study|Serious adverse events|1|||
130767232|NCT00422292|470770771|FG001|Overall Study|Serious adverse events|4|||
130688288|NCT00579345|470484555|FG005|Overall Study|Lost to Follow-up|0|||
130688289|NCT00579345|470484556|FG006|Overall Study|Lost to Follow-up|0|||
130767233|NCT00422292|470770772|FG002|Overall Study|Serious adverse events|0|||
130767234|NCT00422292|470770773|FG003|Overall Study|Serious adverse events|0|||
130767235|NCT00422292|470770770|FG000|Overall Study|Adverse Event|1|||
130767236|NCT00422292|470770771|FG001|Overall Study|Adverse Event|0|||
130688290|NCT00579345|470484557|FG007|Overall Study|Lost to Follow-up|0|||
130688291|NCT00579345|470484550|FG000|Overall Study|Adverse Event|0|||
130688292|NCT00579345|470484551|FG001|Overall Study|Adverse Event|0|||
130688293|NCT00579345|470484552|FG002|Overall Study|Adverse Event|1|||
130688294|NCT00579345|470484553|FG003|Overall Study|Adverse Event|0|||
130688295|NCT00579345|470484554|FG004|Overall Study|Adverse Event|0|||
130767237|NCT00422292|470770772|FG002|Overall Study|Adverse Event|1|||
130688296|NCT00579345|470484555|FG005|Overall Study|Adverse Event|0|||
130688297|NCT00579345|470484556|FG006|Overall Study|Adverse Event|0|||
130688298|NCT00579345|470484557|FG007|Overall Study|Adverse Event|0|||
130688299|NCT00579345|470484550|FG000|Overall Study|Protocol Violation|1|||
130688300|NCT00579345|470484551|FG001|Overall Study|Protocol Violation|0|||
130688301|NCT00579345|470484552|FG002|Overall Study|Protocol Violation|0|||
130688302|NCT00579345|470484553|FG003|Overall Study|Protocol Violation|0|||
130688303|NCT00579345|470484554|FG004|Overall Study|Protocol Violation|0|||
130688304|NCT00579345|470484555|FG005|Overall Study|Protocol Violation|0|||
130688305|NCT00579345|470484556|FG006|Overall Study|Protocol Violation|0|||
130688306|NCT00579345|470484557|FG007|Overall Study|Protocol Violation|1|||
130688307|NCT00579345|470484550|FG000|Overall Study|Death|1|||
130688308|NCT00579345|470484551|FG001|Overall Study|Death|1|||
130688309|NCT00579345|470484552|FG002|Overall Study|Death|1|||
130688310|NCT00579345|470484553|FG003|Overall Study|Death|1|||
130688311|NCT00579345|470484554|FG004|Overall Study|Death|0|||
130688312|NCT00579345|470484555|FG005|Overall Study|Death|0|||
130688313|NCT00579345|470484556|FG006|Overall Study|Death|0|||
130688314|NCT00579345|470484557|FG007|Overall Study|Death|0|||
130688315|NCT05604170|470484561|FG000|Overall Study|Lack of Efficacy|5|||
130688316|NCT05604170|470484561|FG000|Overall Study|Adverse Event|6|||
130688317|NCT05604170|470484561|FG000|Overall Study|Physician Decision|6|||
130688318|NCT05604170|470484561|FG000|Overall Study|Lost to Follow-up|6|||
130688319|NCT05604170|470484561|FG000|Overall Study|Withdrawal by Subject|11|||
130688320|NCT05604170|470484561|FG000|Overall Study|Early study termination by sponsor|77|||
130688321|NCT05604170|470484561|FG000|Overall Study|Other|6|||
130688322|NCT00272779|470484564|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
130688323|NCT00272779|470484565|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
130688324|NCT00272779|470484564|FG000|Baseline Through Week 48|Death before Week 48|4|||
130688325|NCT00272779|470484565|FG001|Baseline Through Week 48|Death before Week 48|4|||
130688326|NCT00272779|470484564|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
130688327|NCT00272779|470484565|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
130688328|NCT00272779|470484564|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
130688329|NCT00272779|470484565|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
130688330|NCT00272779|470484564|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
130688331|NCT00272779|470484565|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
130688332|NCT00272779|470484564|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
130688333|NCT00272779|470484565|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
130688334|NCT00272779|470484564|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
130688335|NCT00272779|470484565|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
130688336|NCT00272779|470484564|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
130688337|NCT00272779|470484565|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
130688338|NCT00272779|470484564|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
130688339|NCT00272779|470484565|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
130688340|NCT00272779|470484564|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
130688341|NCT00272779|470484565|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
130688342|NCT00272779|470484564|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
130688343|NCT00272779|470484565|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
130688344|NCT00272779|470484564|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
130688345|NCT00272779|470484565|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
130688346|NCT00272779|470484564|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
130688347|NCT00272779|470484565|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
130688348|NCT00272779|470484564|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
130688349|NCT00272779|470484565|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
130688350|NCT00272779|470484564|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
130688351|NCT00272779|470484565|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
130688352|NCT00272779|470484564|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
130688353|NCT00272779|470484565|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
130688354|NCT00272779|470484564|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
130688355|NCT00272779|470484565|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
130688356|NCT00272779|470484564|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
130688357|NCT00272779|470484565|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
130767238|NCT00422292|470770773|FG003|Overall Study|Adverse Event|0|||
130767239|NCT00422292|470770770|FG000|Overall Study|Protocol Violation|4|||
130767240|NCT00422292|470770771|FG001|Overall Study|Protocol Violation|25|||
130767241|NCT00422292|470770772|FG002|Overall Study|Protocol Violation|8|||
130767242|NCT00422292|470770773|FG003|Overall Study|Protocol Violation|5|||
130767243|NCT00422292|470770770|FG000|Overall Study|Lost to Follow-up|6|||
130767244|NCT00422292|470770771|FG001|Overall Study|Lost to Follow-up|12|||
130767245|NCT00422292|470770772|FG002|Overall Study|Lost to Follow-up|6|||
130767246|NCT00422292|470770773|FG003|Overall Study|Lost to Follow-up|6|||
130767247|NCT00422292|470770770|FG000|Overall Study|Withdrawal by Subject|6|||
130688358|NCT00272779|470484564|FG000|Baseline Through Week 48|Continuing treatment|385|||
130688359|NCT00272779|470484565|FG001|Baseline Through Week 48|Continuing treatment|368|||
130688360|NCT00272779|470484564|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
130688361|NCT00272779|470484565|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
130688362|NCT00272779|470484564|FG000|Baseline Through Week 48|Never treated|2|||
130688363|NCT00272779|470484565|FG001|Baseline Through Week 48|Never treated|3|||
130688364|NCT00272779|470484564|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
130688365|NCT00272779|470484565|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
130688366|NCT00272779|470484564|FG000|Baseline Through Week 96|Death before Week 96|6|||
130688367|NCT00272779|470484565|FG001|Baseline Through Week 96|Death before Week 96|5|||
130688368|NCT00272779|470484564|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
130688369|NCT00272779|470484565|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
130688370|NCT00272779|470484564|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
130688371|NCT00272779|470484565|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
130688372|NCT00272779|470484564|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
130688373|NCT00272779|470484565|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
130688374|NCT00272779|470484564|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
130688375|NCT00272779|470484565|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
130688376|NCT00272779|470484564|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
130688377|NCT00272779|470484565|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
130688378|NCT00272779|470484564|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
130688379|NCT00272779|470484565|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
130688380|NCT00272779|470484564|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
130688381|NCT00272779|470484565|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
130688382|NCT00272779|470484564|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
130688383|NCT00272779|470484565|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
130688384|NCT00272779|470484564|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
130688385|NCT00272779|470484565|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
130688386|NCT00272779|470484564|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
130688387|NCT00272779|470484565|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
130688388|NCT00272779|470484564|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
130688389|NCT00272779|470484565|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
130688390|NCT00272779|470484564|FG000|Baseline Through Week 96|Never treated|2|||
130688391|NCT00272779|470484565|FG001|Baseline Through Week 96|Never treated|3|||
130688392|NCT00272779|470484564|FG000|Baseline Through Week 96|Continuing on treatment|61|||
130688393|NCT00272779|470484565|FG001|Baseline Through Week 96|Continuing on treatment|38|||
130688394|NCT00440518|470484567|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
130688395|NCT00440518|470484568|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
130688396|NCT00440518|470484569|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
130688397|NCT00440518|470484567|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
130688398|NCT00440518|470484568|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
130688399|NCT00440518|470484569|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
130688400|NCT00440518|470484567|FG000|Randomized /Titration Period|Protocol Deviation|1|||
130688401|NCT00440518|470484568|FG001|Randomized /Titration Period|Protocol Deviation|0|||
130688402|NCT00440518|470484569|FG002|Randomized /Titration Period|Protocol Deviation|0|||
130688403|NCT00440518|470484567|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
130688404|NCT00440518|470484568|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
130688405|NCT00440518|470484569|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
130688406|NCT00440518|470484567|FG000|Randomized /Titration Period|Other|1|||
130688407|NCT00440518|470484568|FG001|Randomized /Titration Period|Other|0|||
130688408|NCT00440518|470484569|FG002|Randomized /Titration Period|Other|0|||
130688409|NCT00440518|470484567|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
130688410|NCT00440518|470484568|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
130688411|NCT00440518|470484569|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
130688412|NCT00440518|470484567|FG000|Randomized /Titration Period|Adverse Event|2|||
130688413|NCT00440518|470484568|FG001|Randomized /Titration Period|Adverse Event|3|||
130688414|NCT00440518|470484569|FG002|Randomized /Titration Period|Adverse Event|0|||
130688415|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
130688416|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
130688417|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
130688418|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
130688419|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
130688420|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
130688421|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
130893974|NCT02152956|471245466|FG006|Overall Study|Adverse Event|0|||
130893975|NCT02152956|471245467|FG007|Overall Study|Adverse Event|0|||
130893976|NCT02152956|471245468|FG008|Overall Study|Adverse Event|0|||
130893977|NCT02152956|471245469|FG009|Overall Study|Adverse Event|0|||
130688422|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
130688423|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
130688424|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
130688425|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
130688426|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
130688427|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
131111028|NCT03285178|472037643|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
131111029|NCT03285178|472037637|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131111030|NCT03285178|472037638|FG001|Double-Blind Treatment Period|Adverse Event|0|||
131111031|NCT03285178|472037639|FG002|Double-Blind Treatment Period|Adverse Event|0|||
131111032|NCT03285178|472037640|FG003|Double-Blind Treatment Period|Adverse Event|0|||
131111033|NCT03285178|472037641|FG004|Double-Blind Treatment Period|Adverse Event|0|||
130688428|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
130688429|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
130688430|NCT00440518|470484567|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
130688431|NCT00440518|470484568|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
130688432|NCT00440518|470484569|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
130688433|NCT00561015|470484570|FG000|Overall Study|Adverse Event|0|||
130688434|NCT00561015|470484571|FG001|Overall Study|Adverse Event|0|||
130688435|NCT00561015|470484572|FG002|Overall Study|Adverse Event|0|||
130688436|NCT00561015|470484573|FG003|Overall Study|Adverse Event|0|||
130688437|NCT00561015|470484574|FG004|Overall Study|Adverse Event|1|||
130688438|NCT00561015|470484575|FG005|Overall Study|Adverse Event|0|||
130688439|NCT00561015|470484570|FG000|Overall Study|Lost to Follow-up|2|||
130688440|NCT00561015|470484571|FG001|Overall Study|Lost to Follow-up|0|||
130688441|NCT00561015|470484572|FG002|Overall Study|Lost to Follow-up|0|||
130688442|NCT00561015|470484573|FG003|Overall Study|Lost to Follow-up|1|||
130688443|NCT00561015|470484574|FG004|Overall Study|Lost to Follow-up|0|||
130688444|NCT00561015|470484575|FG005|Overall Study|Lost to Follow-up|3|||
130688445|NCT00561015|470484570|FG000|Overall Study|Participant non-compliance|2|||
130688446|NCT00561015|470484571|FG001|Overall Study|Participant non-compliance|0|||
130688447|NCT00561015|470484572|FG002|Overall Study|Participant non-compliance|0|||
130688448|NCT00561015|470484573|FG003|Overall Study|Participant non-compliance|0|||
130688449|NCT00561015|470484574|FG004|Overall Study|Participant non-compliance|0|||
130688450|NCT00561015|470484575|FG005|Overall Study|Participant non-compliance|0|||
130688451|NCT02440711|470484576|FG000|Second Intervention|Lost to Follow-up|1|||
131111034|NCT03285178|472037642|FG005|Double-Blind Treatment Period|Adverse Event|0|||
131111035|NCT03285178|472037643|FG006|Double-Blind Treatment Period|Adverse Event|2|||
131111036|NCT03285178|472037637|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131111037|NCT03285178|472037638|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
131111038|NCT03285178|472037639|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
131111039|NCT03285178|472037640|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
131111040|NCT03285178|472037641|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
131111041|NCT03285178|472037642|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
131111042|NCT03285178|472037643|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
131111043|NCT03285178|472037637|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131111044|NCT03285178|472037638|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131111045|NCT03285178|472037639|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131111046|NCT03285178|472037640|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131111047|NCT03285178|472037641|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131111048|NCT03285178|472037642|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
131111049|NCT03285178|472037643|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131111050|NCT03285178|472037637|FG000|Double-Blind Treatment Period|COVID-19|0|||
131111051|NCT03285178|472037638|FG001|Double-Blind Treatment Period|COVID-19|0|||
131111052|NCT03285178|472037639|FG002|Double-Blind Treatment Period|COVID-19|1|||
131111053|NCT03285178|472037640|FG003|Double-Blind Treatment Period|COVID-19|0|||
131111054|NCT03285178|472037641|FG004|Double-Blind Treatment Period|COVID-19|0|||
130688452|NCT02440711|470484577|FG001|Second Intervention|Lost to Follow-up|0|||
130688453|NCT04247282|470484583|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
130688454|NCT04247282|470484584|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
130688455|NCT04247282|470484585|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
130688456|NCT04247282|470484586|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
131111055|NCT03285178|472037642|FG005|Double-Blind Treatment Period|COVID-19|0|||
131111056|NCT03285178|472037643|FG006|Double-Blind Treatment Period|COVID-19|0|||
131111057|NCT01388790|472037644|FG000|Overall Study|Ongoing at data cut-off date|8|||
130688457|NCT04247282|470484583|FG000|Overall Study|Refused further treatment|0|||
131111058|NCT01128894|472037645|FG000|Overall Study|Adverse Event|31|||
131111059|NCT01128894|472037646|FG001|Overall Study|Adverse Event|41|||
130688458|NCT04247282|470484584|FG001|Overall Study|Refused further treatment|1|||
131111060|NCT01128894|472037645|FG000|Overall Study|Protocol Violation|2|||
130893978|NCT02152956|471245470|FG010|Overall Study|Adverse Event|0|||
131111061|NCT01128894|472037646|FG001|Overall Study|Protocol Violation|1|||
131111062|NCT01128894|472037645|FG000|Overall Study|Noncompliance|4|||
131111063|NCT01128894|472037646|FG001|Overall Study|Noncompliance|5|||
131111064|NCT01128894|472037645|FG000|Overall Study|Lost to Follow-up|8|||
131111065|NCT01128894|472037646|FG001|Overall Study|Lost to Follow-up|8|||
131111066|NCT01128894|472037645|FG000|Overall Study|Withdrawal by Subject|10|||
131111067|NCT01128894|472037646|FG001|Overall Study|Withdrawal by Subject|12|||
131111068|NCT01128894|472037645|FG000|Overall Study|Physician Decision|2|||
131111069|NCT01128894|472037646|FG001|Overall Study|Physician Decision|1|||
131111070|NCT01128894|472037645|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
131111071|NCT01128894|472037646|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
131111072|NCT00195507|472037647|FG000|Overall Study|Adverse Event|24|||
131111073|NCT00195507|472037648|FG001|Overall Study|Adverse Event|13|||
131111074|NCT00195507|472037647|FG000|Overall Study|Death|0|||
131111075|NCT00195507|472037648|FG001|Overall Study|Death|1|||
131111076|NCT00195507|472037647|FG000|Overall Study|Failed to Return|4|||
131111077|NCT00195507|472037648|FG001|Overall Study|Failed to Return|3|||
131111078|NCT00195507|472037647|FG000|Overall Study|Physician Decision|1|||
131111079|NCT00195507|472037648|FG001|Overall Study|Physician Decision|2|||
131111080|NCT00195507|472037647|FG000|Overall Study|Lost to Follow-up|3|||
131111081|NCT00195507|472037648|FG001|Overall Study|Lost to Follow-up|2|||
131111082|NCT00195507|472037647|FG000|Overall Study|Protocol Violation|5|||
131111083|NCT00195507|472037648|FG001|Overall Study|Protocol Violation|4|||
131111084|NCT00195507|472037647|FG000|Overall Study|Lack of Efficacy|40|||
131111085|NCT00195507|472037648|FG001|Overall Study|Lack of Efficacy|67|||
131111086|NCT00195507|472037647|FG000|Overall Study|Withdrawal by Subject|16|||
131111087|NCT00195507|472037648|FG001|Overall Study|Withdrawal by Subject|23|||
131111088|NCT00195507|472037647|FG000|Overall Study|Protocol Deviation|6|||
131111089|NCT00195507|472037648|FG001|Overall Study|Protocol Deviation|3|||
131111090|NCT00973362|472037649|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
131111091|NCT00973362|472037650|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
131111092|NCT00973362|472037649|FG000|Baseline Evaluation|No colposcopy visit|62|||
131111093|NCT00973362|472037650|FG001|Baseline Evaluation|No colposcopy visit|0|||
131111094|NCT00973362|472037649|FG000|Baseline Evaluation|Inevaluable|686|||
131111095|NCT00973362|472037650|FG001|Baseline Evaluation|Inevaluable|223|||
131111096|NCT00973362|472037649|FG000|3-Year Follow-up|Lost to Follow-up|17|||
131111097|NCT00973362|472037650|FG001|3-Year Follow-up|Lost to Follow-up|0|||
131111098|NCT01630434|472037657|FG000|Overall Study|Donor lungs turned down|1|||
130688459|NCT04247282|470484585|FG002|Overall Study|Refused further treatment|0|||
130688460|NCT04247282|470484586|FG003|Overall Study|Refused further treatment|0|||
130688461|NCT00968812|470484589|FG000|Overall Study|Adverse Event|30|||
130688462|NCT00968812|470484590|FG001|Overall Study|Adverse Event|46|||
130688463|NCT00968812|470484591|FG002|Overall Study|Adverse Event|33|||
130688464|NCT00968812|470484589|FG000|Overall Study|Death|2|||
130893979|NCT02152956|471245471|FG011|Overall Study|Adverse Event|4|||
130893980|NCT02152956|471245472|FG012|Overall Study|Adverse Event|0|||
131111099|NCT01630434|472037658|FG001|Overall Study|Donor lungs turned down|0|||
131111100|NCT01630434|472037657|FG000|Overall Study|Protocol Violation|9|||
131111101|NCT01630434|472037658|FG001|Overall Study|Protocol Violation|4|||
131111102|NCT01630434|472037657|FG000|Overall Study|Death|20|||
131111103|NCT01630434|472037658|FG001|Overall Study|Death|26|||
131111104|NCT02804178|472037661|FG000|Overall Study|Adverse Event|1|||
131111105|NCT01106404|472037662|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
131111106|NCT01106404|472037663|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
131111107|NCT01106404|472037662|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
131111108|NCT01106404|472037663|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
131111109|NCT01106404|472037662|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
130688465|NCT00968812|470484590|FG001|Overall Study|Death|2|||
130688466|NCT00968812|470484591|FG002|Overall Study|Death|1|||
130688467|NCT00968812|470484589|FG000|Overall Study|Lack of Efficacy|9|||
130893981|NCT02152956|471245460|FG000|Overall Study|Death|0|||
131111110|NCT01106404|472037663|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
131111111|NCT01106404|472037662|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
130688468|NCT00968812|470484590|FG001|Overall Study|Lack of Efficacy|7|||
130688469|NCT00968812|470484591|FG002|Overall Study|Lack of Efficacy|16|||
130893982|NCT02152956|471245461|FG001|Overall Study|Death|3|||
130688470|NCT00968812|470484589|FG000|Overall Study|Lost to Follow-up|17|||
130893983|NCT02152956|471245462|FG002|Overall Study|Death|3|||
131111112|NCT01106404|472037663|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
131111113|NCT01290601|472037664|FG000|Overall Study|Adverse Event|0|||
131111114|NCT01290601|472037665|FG001|Overall Study|Adverse Event|2|||
131111115|NCT01290601|472037666|FG002|Overall Study|Adverse Event|0|||
131111116|NCT01290601|472037667|FG003|Overall Study|Adverse Event|0|||
131111117|NCT01290601|472037664|FG000|Overall Study|Lack of Efficacy|2|||
131111118|NCT01290601|472037665|FG001|Overall Study|Lack of Efficacy|1|||
131111119|NCT01290601|472037666|FG002|Overall Study|Lack of Efficacy|0|||
131111120|NCT01290601|472037667|FG003|Overall Study|Lack of Efficacy|0|||
131111121|NCT01290601|472037664|FG000|Overall Study|Lost to Follow-up|7|||
130688471|NCT00968812|470484590|FG001|Overall Study|Lost to Follow-up|12|||
130688472|NCT00968812|470484591|FG002|Overall Study|Lost to Follow-up|11|||
130688473|NCT00968812|470484589|FG000|Overall Study|Physician Decision|8|||
130688474|NCT00968812|470484590|FG001|Overall Study|Physician Decision|5|||
130688475|NCT00968812|470484591|FG002|Overall Study|Physician Decision|9|||
130688476|NCT00968812|470484589|FG000|Overall Study|Protocol Violation|7|||
130688477|NCT00968812|470484590|FG001|Overall Study|Protocol Violation|4|||
130688478|NCT00968812|470484591|FG002|Overall Study|Protocol Violation|3|||
130688479|NCT00968812|470484589|FG000|Overall Study|Withdrawal by Subject|17|||
130688480|NCT00968812|470484590|FG001|Overall Study|Withdrawal by Subject|23|||
130688481|NCT00968812|470484591|FG002|Overall Study|Withdrawal by Subject|25|||
130688482|NCT00968812|470484589|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
130688483|NCT00968812|470484590|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
130688484|NCT00968812|470484591|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
130893984|NCT02152956|471245463|FG003|Overall Study|Death|4|||
130893985|NCT02152956|471245464|FG004|Overall Study|Death|1|||
130893986|NCT02152956|471245465|FG005|Overall Study|Death|2|||
130893987|NCT02152956|471245466|FG006|Overall Study|Death|6|||
130893988|NCT02152956|471245467|FG007|Overall Study|Death|6|||
130688485|NCT00968812|470484589|FG000|Overall Study|Noncompliance with study drug|4|||
130688486|NCT00968812|470484590|FG001|Overall Study|Noncompliance with study drug|1|||
130688487|NCT00968812|470484591|FG002|Overall Study|Noncompliance with study drug|6|||
130688488|NCT00968812|470484589|FG000|Overall Study|Unable to take rescue therapy|12|||
130688489|NCT00968812|470484590|FG001|Overall Study|Unable to take rescue therapy|12|||
130688490|NCT00968812|470484591|FG002|Overall Study|Unable to take rescue therapy|17|||
130688491|NCT00968812|470484589|FG000|Overall Study|Other|25|||
130688492|NCT00968812|470484590|FG001|Overall Study|Other|37|||
130688493|NCT00968812|470484591|FG002|Overall Study|Other|40|||
130688494|NCT00448591|470484592|FG000|Overall Study|Withdrawal by Subject|178|||
130688495|NCT00448591|470484592|FG000|Overall Study|Progressive Disease|1382|||
130688496|NCT00448591|470484592|FG000|Overall Study|Adverse Event|382|||
130688497|NCT00448591|470484592|FG000|Overall Study|Protocol Violation|41|||
130688498|NCT00448591|470484592|FG000|Overall Study|Lost to Follow-up|19|||
130688499|NCT00448591|470484592|FG000|Overall Study|Treatment Regimen Completed|70|||
130688500|NCT00448591|470484592|FG000|Overall Study|Other|154|||
130688501|NCT00448591|470484592|FG000|Overall Study|Termination of Study|70|||
130688502|NCT02648438|470484596|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130688503|NCT02648438|470484597|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
130688504|NCT02648438|470484598|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130688505|NCT02648438|470484596|FG000|Overall Study|Protocol Violation|2|||
130688506|NCT02648438|470484597|FG001|Overall Study|Protocol Violation|0|||
130688507|NCT02648438|470484598|FG002|Overall Study|Protocol Violation|0|||
130688508|NCT02648438|470484596|FG000|Overall Study|Withdrawal by Subject|1|||
130688509|NCT02648438|470484597|FG001|Overall Study|Withdrawal by Subject|1|||
130688510|NCT02648438|470484598|FG002|Overall Study|Withdrawal by Subject|0|||
130688511|NCT04604275|470484599|FG000|Washout-1 Week|Withdrawal by Subject|1|||
130688512|NCT04604275|470484600|FG001|Washout-1 Week|Withdrawal by Subject|0|||
130688513|NCT05615935|470484601|FG000|Overall Study|Lost to Follow-up|1|||
130688514|NCT05615935|470484602|FG001|Overall Study|Lost to Follow-up|1|||
130688515|NCT02258074|470484603|FG000|Overall Study|Withdrawal by Subject|1|||
130688516|NCT02258074|470484604|FG001|Overall Study|Withdrawal by Subject|0|||
130688517|NCT02258074|470484605|FG002|Overall Study|Withdrawal by Subject|0|||
130688518|NCT02258074|470484606|FG003|Overall Study|Withdrawal by Subject|0|||
130688519|NCT05446870|470484607|FG000|Overall Study|Death|6|||
130688520|NCT05446870|470484608|FG001|Overall Study|Death|5|||
130688521|NCT05446870|470484607|FG000|Overall Study|Lost to Follow-up|0|||
130688522|NCT05446870|470484608|FG001|Overall Study|Lost to Follow-up|1|||
130688523|NCT05446870|470484607|FG000|Overall Study|Physician Decision|52|||
130688524|NCT05446870|470484608|FG001|Overall Study|Physician Decision|53|||
130688525|NCT05446870|470484607|FG000|Overall Study|Withdrawal by Subject|3|||
130688526|NCT05446870|470484608|FG001|Overall Study|Withdrawal by Subject|3|||
130688527|NCT02689505|470484610|FG000|Overall Study|Progressive disease|2|||
130688528|NCT02689505|470484611|FG001|Overall Study|Progressive disease|2|||
130688529|NCT02689505|470484612|FG002|Overall Study|Progressive disease|3|||
130688530|NCT02689505|470484613|FG003|Overall Study|Progressive disease|9|||
130688531|NCT02689505|470484614|FG004|Overall Study|Progressive disease|1|||
130688532|NCT02689505|470484610|FG000|Overall Study|Dose Limiting Toxicity|0|||
130688533|NCT02689505|470484611|FG001|Overall Study|Dose Limiting Toxicity|1|||
130688534|NCT02689505|470484612|FG002|Overall Study|Dose Limiting Toxicity|0|||
130688535|NCT02689505|470484613|FG003|Overall Study|Dose Limiting Toxicity|0|||
130688536|NCT02689505|470484614|FG004|Overall Study|Dose Limiting Toxicity|2|||
130688537|NCT02689505|470484610|FG000|Overall Study|Other AE or clinical progression|0|||
130688538|NCT02689505|470484611|FG001|Overall Study|Other AE or clinical progression|2|||
130688539|NCT02689505|470484612|FG002|Overall Study|Other AE or clinical progression|0|||
130688540|NCT02689505|470484613|FG003|Overall Study|Other AE or clinical progression|2|||
130893989|NCT02152956|471245468|FG008|Overall Study|Death|4|||
130893990|NCT02152956|471245469|FG009|Overall Study|Death|5|||
130893991|NCT02152956|471245470|FG010|Overall Study|Death|3|||
130688541|NCT02689505|470484614|FG004|Overall Study|Other AE or clinical progression|0|||
130688542|NCT02446600|470484615|FG000|Overall Study|Never treated|20|||
130688543|NCT02446600|470484616|FG001|Overall Study|Never treated|2|||
130688544|NCT02446600|470484617|FG002|Overall Study|Never treated|6|||
130688545|NCT02446600|470484618|FG003|Overall Study|Never treated|0|||
130688546|NCT02446600|470484615|FG000|Overall Study|Withdrawal by Subject|19|||
130688547|NCT02446600|470484616|FG001|Overall Study|Withdrawal by Subject|5|||
130688548|NCT02446600|470484617|FG002|Overall Study|Withdrawal by Subject|17|||
130688549|NCT02446600|470484618|FG003|Overall Study|Withdrawal by Subject|0|||
130688550|NCT02446600|470484615|FG000|Overall Study|Ineligible|1|||
130688551|NCT02446600|470484616|FG001|Overall Study|Ineligible|4|||
130688552|NCT02446600|470484617|FG002|Overall Study|Ineligible|4|||
130688553|NCT02446600|470484618|FG003|Overall Study|Ineligible|1|||
130688554|NCT02446600|470484615|FG000|Overall Study|Duplicate Enrollment|0|||
130688555|NCT02446600|470484616|FG001|Overall Study|Duplicate Enrollment|1|||
130688556|NCT02446600|470484617|FG002|Overall Study|Duplicate Enrollment|0|||
130688557|NCT02446600|470484618|FG003|Overall Study|Duplicate Enrollment|0|||
130688558|NCT04108858|470484619|FG000|Overall Study|Adverse Event|1|||
130688559|NCT02739997|470484620|FG000|Overall Study|Death|1|||
130688560|NCT02739997|470484620|FG000|Overall Study|Withdrawal by Subject|1|||
130688561|NCT03552393|470484624|FG000|Core Period|Kidney Transplant|1|||
130688562|NCT03552393|470484624|FG000|Core Period|Prohibited Medication|1|||
130688563|NCT03552393|470484624|FG000|Safety Extension Period|Kidney Transplant|4|||
130688564|NCT02601625|470484625|FG000|Overall Study|Lost to Follow-up|0|||
130688565|NCT02601625|470484626|FG001|Overall Study|Lost to Follow-up|0|||
130688566|NCT02601625|470484627|FG002|Overall Study|Lost to Follow-up|1|||
130688567|NCT02601625|470484628|FG003|Overall Study|Lost to Follow-up|1|||
130688568|NCT00359281|470484630|FG000|Overall Study|Adverse Event|1|||
130688569|NCT00359281|470484631|FG001|Overall Study|Adverse Event|0|||
130688570|NCT00359281|470484632|FG002|Overall Study|Adverse Event|0|||
130688571|NCT00359281|470484633|FG003|Overall Study|Adverse Event|0|||
130688572|NCT00359281|470484634|FG004|Overall Study|Adverse Event|0|||
130688573|NCT00359281|470484635|FG005|Overall Study|Adverse Event|0|||
130688574|NCT00359281|470484636|FG006|Overall Study|Adverse Event|1|||
130688575|NCT00359281|470484637|FG007|Overall Study|Adverse Event|0|||
130688576|NCT00359281|470484638|FG008|Overall Study|Adverse Event|0|||
130688577|NCT00359281|470484630|FG000|Overall Study|Withdrawal by Subject|0|||
130688578|NCT00359281|470484631|FG001|Overall Study|Withdrawal by Subject|0|||
130688579|NCT00359281|470484632|FG002|Overall Study|Withdrawal by Subject|0|||
130688580|NCT00359281|470484633|FG003|Overall Study|Withdrawal by Subject|0|||
130688581|NCT00359281|470484634|FG004|Overall Study|Withdrawal by Subject|0|||
130688582|NCT00359281|470484635|FG005|Overall Study|Withdrawal by Subject|0|||
130688583|NCT00359281|470484636|FG006|Overall Study|Withdrawal by Subject|1|||
130688584|NCT00359281|470484637|FG007|Overall Study|Withdrawal by Subject|0|||
130688585|NCT00359281|470484638|FG008|Overall Study|Withdrawal by Subject|0|||
130688586|NCT04887415|470484641|FG000|Overall Study|Lost to Follow-up|2|||
130688587|NCT04608188|470484642|FG000|Overall Study|Withdrawal by Subject|4|||
130688588|NCT04608188|470484643|FG001|Overall Study|Withdrawal by Subject|8|||
130688589|NCT01415986|470484647|FG000|Overall Study|Lost to Follow-up|1|||
130688590|NCT01250912|470484648|FG000|Overall Study|Lost to Follow-up|1|||
130688591|NCT05646251|470484649|FG000|Overall Study|Physician Decision|1|||
130688592|NCT05646251|470484650|FG001|Overall Study|Physician Decision|0|||
130688593|NCT05646251|470484651|FG002|Overall Study|Physician Decision|2|||
130688594|NCT03122457|470484653|FG000|Overall Study|Withdrawal by Subject|6|||
130688595|NCT04659603|470484654|FG000|Overall Study|Study terminated by sponsor|0|||
130688596|NCT04659603|470484655|FG001|Overall Study|Study terminated by sponsor|0|||
130688597|NCT04659603|470484656|FG002|Overall Study|Study terminated by sponsor|2|||
130688598|NCT04659603|470484654|FG000|Overall Study|Withdrawal by Subject|0|||
130688599|NCT04659603|470484655|FG001|Overall Study|Withdrawal by Subject|5|||
130688600|NCT04659603|470484656|FG002|Overall Study|Withdrawal by Subject|0|||
130688601|NCT04659603|470484654|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
130688602|NCT04659603|470484655|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
130688603|NCT04659603|470484656|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
130688604|NCT01231906|470484659|FG000|Overall Study|Lack of Efficacy|75|||
130688605|NCT01231906|470484660|FG001|Overall Study|Lack of Efficacy|68|||
130688606|NCT01231906|470484659|FG000|Overall Study|Lost to Follow-up|1|||
130688607|NCT01231906|470484660|FG001|Overall Study|Lost to Follow-up|0|||
130688608|NCT01231906|470484659|FG000|Overall Study|Physician Decision|34|||
130688609|NCT01231906|470484660|FG001|Overall Study|Physician Decision|24|||
130688610|NCT01231906|470484659|FG000|Overall Study|Withdrawal by Subject|0|||
130688611|NCT01231906|470484660|FG001|Overall Study|Withdrawal by Subject|4|||
130688612|NCT01231906|470484659|FG000|Overall Study|Ineligible|10|||
130688613|NCT01231906|470484660|FG001|Overall Study|Ineligible|3|||
130688614|NCT01231906|470484659|FG000|Overall Study|No treatment|1|||
130688615|NCT01231906|470484660|FG001|Overall Study|No treatment|2|||
130688616|NCT01701674|470485595|FG000|Overall Study|Unable to safely complete treatment|1|||
130688617|NCT03032172|470485596|FG000|Treatment Period|Adverse Event|0|||
130688618|NCT03032172|470485597|FG001|Treatment Period|Adverse Event|1|||
130688619|NCT03032172|470485598|FG002|Treatment Period|Adverse Event|0|||
130688620|NCT03032172|470485599|FG003|Treatment Period|Adverse Event|0|||
130688621|NCT03032172|470485600|FG004|Treatment Period|Adverse Event|0|||
130688622|NCT03032172|470485601|FG005|Treatment Period|Adverse Event|0|||
130688623|NCT03032172|470485602|FG006|Treatment Period|Adverse Event|0|||
130688624|NCT03032172|470485603|FG007|Treatment Period|Adverse Event|0|||
130688625|NCT03032172|470485596|FG000|Treatment Period|Lack of Efficacy|0|||
130688626|NCT03032172|470485597|FG001|Treatment Period|Lack of Efficacy|1|||
130688627|NCT03032172|470485598|FG002|Treatment Period|Lack of Efficacy|0|||
130688628|NCT03032172|470485599|FG003|Treatment Period|Lack of Efficacy|0|||
130688629|NCT03032172|470485600|FG004|Treatment Period|Lack of Efficacy|0|||
130688630|NCT03032172|470485601|FG005|Treatment Period|Lack of Efficacy|0|||
130688631|NCT03032172|470485602|FG006|Treatment Period|Lack of Efficacy|0|||
130688632|NCT03032172|470485603|FG007|Treatment Period|Lack of Efficacy|0|||
130688633|NCT03032172|470485596|FG000|Treatment Period|Non-compliance With Study Drug|0|||
130688634|NCT03032172|470485597|FG001|Treatment Period|Non-compliance With Study Drug|1|||
130688635|NCT03032172|470485598|FG002|Treatment Period|Non-compliance With Study Drug|0|||
130688636|NCT03032172|470485599|FG003|Treatment Period|Non-compliance With Study Drug|0|||
130688637|NCT03032172|470485600|FG004|Treatment Period|Non-compliance With Study Drug|0|||
130688638|NCT03032172|470485601|FG005|Treatment Period|Non-compliance With Study Drug|0|||
130688639|NCT03032172|470485602|FG006|Treatment Period|Non-compliance With Study Drug|0|||
130688640|NCT03032172|470485603|FG007|Treatment Period|Non-compliance With Study Drug|0|||
130688641|NCT03032172|470485596|FG000|Treatment Period|Reason Not Specified|0|||
130688642|NCT03032172|470485597|FG001|Treatment Period|Reason Not Specified|4|||
130688643|NCT03032172|470485598|FG002|Treatment Period|Reason Not Specified|1|||
130688644|NCT03032172|470485599|FG003|Treatment Period|Reason Not Specified|0|||
130688645|NCT03032172|470485600|FG004|Treatment Period|Reason Not Specified|0|||
130688646|NCT03032172|470485601|FG005|Treatment Period|Reason Not Specified|0|||
130688647|NCT03032172|470485602|FG006|Treatment Period|Reason Not Specified|0|||
130688648|NCT03032172|470485603|FG007|Treatment Period|Reason Not Specified|0|||
130688649|NCT03032172|470485596|FG000|Treatment Period|Physician Decision|0|||
130688650|NCT03032172|470485597|FG001|Treatment Period|Physician Decision|2|||
130688651|NCT03032172|470485598|FG002|Treatment Period|Physician Decision|1|||
130688652|NCT03032172|470485599|FG003|Treatment Period|Physician Decision|0|||
131111122|NCT01290601|472037665|FG001|Overall Study|Lost to Follow-up|2|||
131111123|NCT01290601|472037666|FG002|Overall Study|Lost to Follow-up|0|||
131111124|NCT01290601|472037667|FG003|Overall Study|Lost to Follow-up|0|||
131111125|NCT01290601|472037664|FG000|Overall Study|Other|1|||
131111126|NCT01290601|472037665|FG001|Overall Study|Other|0|||
131111127|NCT01290601|472037666|FG002|Overall Study|Other|0|||
131111128|NCT01290601|472037667|FG003|Overall Study|Other|0|||
131111129|NCT01290601|472037664|FG000|Overall Study|Protocol Violation|1|||
131111130|NCT01290601|472037665|FG001|Overall Study|Protocol Violation|0|||
131111131|NCT01290601|472037666|FG002|Overall Study|Protocol Violation|0|||
131111132|NCT01290601|472037667|FG003|Overall Study|Protocol Violation|0|||
131111133|NCT00775450|472037668|FG000|Overall Study|Serious Adverse Event|2|||
131111134|NCT00775450|472037669|FG001|Overall Study|Serious Adverse Event|0|||
131111135|NCT00775450|472037670|FG002|Overall Study|Serious Adverse Event|0|||
131111136|NCT00775450|472037671|FG003|Overall Study|Serious Adverse Event|0|||
131111137|NCT00775450|472037672|FG004|Overall Study|Serious Adverse Event|0|||
131111138|NCT00775450|472037668|FG000|Overall Study|Protocol Violation|0|||
131111139|NCT00775450|472037669|FG001|Overall Study|Protocol Violation|0|||
131111140|NCT00775450|472037670|FG002|Overall Study|Protocol Violation|0|||
131111141|NCT00775450|472037671|FG003|Overall Study|Protocol Violation|0|||
131111142|NCT00775450|472037672|FG004|Overall Study|Protocol Violation|1|||
131111143|NCT00775450|472037668|FG000|Overall Study|Withdrawal by Subject|1|||
131111144|NCT00775450|472037669|FG001|Overall Study|Withdrawal by Subject|0|||
131111145|NCT00775450|472037670|FG002|Overall Study|Withdrawal by Subject|0|||
130688653|NCT03032172|470485600|FG004|Treatment Period|Physician Decision|0|||
130688654|NCT03032172|470485601|FG005|Treatment Period|Physician Decision|0|||
130688655|NCT03032172|470485602|FG006|Treatment Period|Physician Decision|0|||
130893992|NCT02152956|471245471|FG011|Overall Study|Death|143|||
130893993|NCT02152956|471245472|FG012|Overall Study|Death|12|||
130893994|NCT02152956|471245460|FG000|Overall Study|Lost to Follow-up|0|||
131111146|NCT00775450|472037671|FG003|Overall Study|Withdrawal by Subject|0|||
131111147|NCT00775450|472037672|FG004|Overall Study|Withdrawal by Subject|1|||
130688656|NCT03032172|470485603|FG007|Treatment Period|Physician Decision|0|||
130688657|NCT03032172|470485596|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130688658|NCT03032172|470485597|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
130688659|NCT03032172|470485598|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
130893995|NCT02152956|471245461|FG001|Overall Study|Lost to Follow-up|1|||
130893996|NCT02152956|471245462|FG002|Overall Study|Lost to Follow-up|0|||
131111148|NCT01749540|472037678|FG000|Overall Study|Protocol Violation|0|||
131111149|NCT01749540|472037679|FG001|Overall Study|Protocol Violation|0|||
131111150|NCT01749540|472037680|FG002|Overall Study|Protocol Violation|0|||
131111151|NCT01749540|472037681|FG003|Overall Study|Protocol Violation|0|||
130893997|NCT02152956|471245463|FG003|Overall Study|Lost to Follow-up|0|||
130893998|NCT02152956|471245464|FG004|Overall Study|Lost to Follow-up|0|||
130767248|NCT00422292|470770771|FG001|Overall Study|Withdrawal by Subject|25|||
130767249|NCT00422292|470770772|FG002|Overall Study|Withdrawal by Subject|7|||
130767250|NCT00422292|470770773|FG003|Overall Study|Withdrawal by Subject|13|||
130767251|NCT02440854|470770774|FG000|Overall Study|Relocation of patient|1|||
130767252|NCT02440854|470770774|FG000|Overall Study|Death|6|||
130767253|NCT02440854|470770774|FG000|Overall Study|Lost to Follow-up|10|||
130767254|NCT02440854|470770774|FG000|Overall Study|Afatinib discontinuation|46|||
130767255|NCT02440854|470770774|FG000|Overall Study|stopped study at earlier timepoint|14|||
130767256|NCT02440854|470770774|FG000|Overall Study|Study medication not received|1|||
130767257|NCT02440854|470770774|FG000|Overall Study|Violation of inclusion criteria|2|||
130767258|NCT02243046|470770775|FG000|Overall Study|Lost to Follow-up|1|||
130767259|NCT02243046|470770776|FG001|Overall Study|Lost to Follow-up|1|||
130767260|NCT02243046|470770777|FG002|Overall Study|Lost to Follow-up|4|||
130767261|NCT03338569|470770778|FG000|Overall Study|Physician Decision|8|||
130767262|NCT03338569|470770779|FG001|Overall Study|Physician Decision|3|||
130767263|NCT03338569|470770778|FG000|Overall Study|Withdrawal by Subject|0|||
130767264|NCT03338569|470770779|FG001|Overall Study|Withdrawal by Subject|1|||
130767265|NCT03338569|470770778|FG000|Overall Study|Lost to Follow-up|0|||
130767266|NCT03338569|470770779|FG001|Overall Study|Lost to Follow-up|1|||
130767267|NCT02669082|470770780|FG000|Overall Study|Adverse Event|1|||
130767268|NCT04852276|470770781|FG000|Overall Study|Death|2|||
130767269|NCT04852276|470770782|FG001|Overall Study|Death|0|||
130767270|NCT04852276|470770781|FG000|Overall Study|Lost to Follow-up|15|||
130767271|NCT04852276|470770782|FG001|Overall Study|Lost to Follow-up|9|||
130767272|NCT04852276|470770781|FG000|Overall Study|Withdrawal by Subject|26|||
130767273|NCT04852276|470770782|FG001|Overall Study|Withdrawal by Subject|6|||
130767274|NCT02824562|470772345|FG000|Overall Study|Lost to Follow-up|3|||
130767275|NCT02824562|470772346|FG001|Overall Study|Lost to Follow-up|4|||
130767276|NCT02824562|470772345|FG000|Overall Study|Death|0|||
130767277|NCT02824562|470772346|FG001|Overall Study|Death|1|||
130767278|NCT02168777|470772347|FG000|Overall Study|Withdrawal by Subject|1|||
130767279|NCT02168777|470772348|FG001|Overall Study|Withdrawal by Subject|0|||
130767280|NCT02168777|470772349|FG002|Overall Study|Withdrawal by Subject|2|||
130767281|NCT02168777|470772347|FG000|Overall Study|Adverse Event|1|||
130767282|NCT02168777|470772348|FG001|Overall Study|Adverse Event|0|||
130767283|NCT02168777|470772349|FG002|Overall Study|Adverse Event|1|||
130767284|NCT02168777|470772347|FG000|Overall Study|Disease recurrence|0|||
130767285|NCT02168777|470772348|FG001|Overall Study|Disease recurrence|0|||
130767286|NCT02168777|470772349|FG002|Overall Study|Disease recurrence|1|||
130767287|NCT02168777|470772347|FG000|Overall Study|Radiological disease progression|0|||
130767288|NCT02168777|470772348|FG001|Overall Study|Radiological disease progression|5|||
130767289|NCT02168777|470772349|FG002|Overall Study|Radiological disease progression|5|||
130767290|NCT02168777|470772347|FG000|Overall Study|Clinical disease progression|0|||
130767291|NCT02168777|470772348|FG001|Overall Study|Clinical disease progression|1|||
130767292|NCT02168777|470772349|FG002|Overall Study|Clinical disease progression|2|||
130767293|NCT02168777|470772347|FG000|Overall Study|Other reason|0|||
130767294|NCT02168777|470772348|FG001|Overall Study|Other reason|1|||
130767295|NCT02168777|470772349|FG002|Overall Study|Other reason|0|||
130767296|NCT05243563|470772350|FG000|Overall Study|Withdrawal by Subject|1|||
130767297|NCT05243563|470772351|FG001|Overall Study|Withdrawal by Subject|0|||
130767298|NCT05243563|470772350|FG000|Overall Study|Physician Decision|1|||
130767299|NCT05243563|470772351|FG001|Overall Study|Physician Decision|0|||
130767300|NCT02474355|470772355|FG000|Overall Study|Other|43|||
130767301|NCT02474355|470772355|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
130767302|NCT02474355|470772355|FG000|Overall Study|Lost to Follow-up|98|||
130767303|NCT02474355|470772355|FG000|Overall Study|Withdrawal by Subject|124|||
130767304|NCT02474355|470772355|FG000|Overall Study|Death|1361|||
130767305|NCT01911793|470772356|FG000|Overall Study|Physician Decision|1|||
130767306|NCT01911793|470772357|FG001|Overall Study|Physician Decision|5|||
130767307|NCT04767529|470772360|FG000|Overall Study|Adverse Event|0|||
130767308|NCT04767529|470772361|FG001|Overall Study|Adverse Event|4|||
130767309|NCT04767529|470772362|FG002|Overall Study|Adverse Event|3|||
130893999|NCT02152956|471245465|FG005|Overall Study|Lost to Follow-up|0|||
130767310|NCT04767529|470772360|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
130767311|NCT04767529|470772361|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
130767312|NCT04767529|470772362|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
130767313|NCT04767529|470772360|FG000|Overall Study|Required use of a prohibited medication|0|||
130767314|NCT04767529|470772361|FG001|Overall Study|Required use of a prohibited medication|1|||
130767315|NCT04767529|470772362|FG002|Overall Study|Required use of a prohibited medication|0|||
130767316|NCT04767529|470772360|FG000|Overall Study|Withdrawal by Subject|7|||
130767317|NCT04767529|470772361|FG001|Overall Study|Withdrawal by Subject|5|||
130767318|NCT04767529|470772362|FG002|Overall Study|Withdrawal by Subject|4|||
130767319|NCT04767529|470772360|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
130894000|NCT02152956|471245466|FG006|Overall Study|Lost to Follow-up|0|||
130894001|NCT02152956|471245467|FG007|Overall Study|Lost to Follow-up|0|||
131111152|NCT01749540|472037682|FG004|Overall Study|Protocol Violation|0|||
131111153|NCT01749540|472037683|FG005|Overall Study|Protocol Violation|1|||
131111154|NCT01749540|472037684|FG006|Overall Study|Protocol Violation|1|||
131111155|NCT01749540|472037678|FG000|Overall Study|Withdrawal by Subject|0|||
131111156|NCT01749540|472037679|FG001|Overall Study|Withdrawal by Subject|0|||
131111157|NCT01749540|472037680|FG002|Overall Study|Withdrawal by Subject|0|||
131111158|NCT01749540|472037681|FG003|Overall Study|Withdrawal by Subject|1|||
131111159|NCT01749540|472037682|FG004|Overall Study|Withdrawal by Subject|0|||
131111160|NCT01749540|472037683|FG005|Overall Study|Withdrawal by Subject|0|||
131111161|NCT01749540|472037684|FG006|Overall Study|Withdrawal by Subject|0|||
131111162|NCT01749540|472037678|FG000|Overall Study|Initiated into extension study A536-06|0|||
131111163|NCT01749540|472037679|FG001|Overall Study|Initiated into extension study A536-06|0|||
131111164|NCT01749540|472037680|FG002|Overall Study|Initiated into extension study A536-06|0|||
131111165|NCT01749540|472037681|FG003|Overall Study|Initiated into extension study A536-06|0|||
131111166|NCT01749540|472037682|FG004|Overall Study|Initiated into extension study A536-06|0|||
131111167|NCT01749540|472037683|FG005|Overall Study|Initiated into extension study A536-06|2|||
131111168|NCT01749540|472037684|FG006|Overall Study|Initiated into extension study A536-06|24|||
131111169|NCT00576836|472037685|FG000|Overall Study|Death|0|||
131111170|NCT00576836|472037686|FG001|Overall Study|Death|1|||
131111171|NCT00576836|472037685|FG000|Overall Study|Physician Decision|0|||
131111172|NCT00576836|472037686|FG001|Overall Study|Physician Decision|1|||
131111173|NCT01296347|472037687|FG000|Allocation|Withdrawal by Subject|1|||
131111174|NCT01296347|472037688|FG001|Allocation|Withdrawal by Subject|2|||
131111175|NCT01296347|472037687|FG000|Allocation|Lack of Efficacy|1|||
131111176|NCT01296347|472037688|FG001|Allocation|Lack of Efficacy|2|||
131111177|NCT01296347|472037687|FG000|Allocation|not received infusion|1|||
131111178|NCT01296347|472037688|FG001|Allocation|not received infusion|0|||
131111179|NCT01296347|472037687|FG000|6 Week Follow up|Death|0|||
131111180|NCT01296347|472037688|FG001|6 Week Follow up|Death|1|||
131111181|NCT01296347|472037687|FG000|3 Month Follow up|Death|1|||
131111182|NCT01296347|472037688|FG001|3 Month Follow up|Death|0|||
131111183|NCT01296347|472037687|FG000|3 Month Follow up|Lost to Follow-up|0|||
131111184|NCT01296347|472037688|FG001|3 Month Follow up|Lost to Follow-up|1|||
131111185|NCT01296347|472037687|FG000|6 Month Follow up|Death|2|||
131111186|NCT01296347|472037688|FG001|6 Month Follow up|Death|1|||
131111187|NCT01296347|472037687|FG000|6 Month Follow up|Lost to Follow-up|0|||
131111188|NCT01296347|472037688|FG001|6 Month Follow up|Lost to Follow-up|1|||
131111189|NCT01296347|472037687|FG000|12 Month Follow up|Lost to Follow-up|3|||
131111190|NCT01296347|472037688|FG001|12 Month Follow up|Lost to Follow-up|1|||
131111191|NCT01296347|472037687|FG000|12 Month Follow up|Death|1|||
131111192|NCT01296347|472037688|FG001|12 Month Follow up|Death|1|||
131111193|NCT01296347|472037687|FG000|12 Month Follow up|Withdrawal by Subject|0|||
131111194|NCT01296347|472037688|FG001|12 Month Follow up|Withdrawal by Subject|1|||
131111195|NCT02240693|472037689|FG000|Overall Study|Adverse Event|0|||
131111196|NCT02240693|472037690|FG001|Overall Study|Adverse Event|0|||
131111197|NCT02240693|472037691|FG002|Overall Study|Adverse Event|0|||
131111198|NCT02240693|472037692|FG003|Overall Study|Adverse Event|0|||
131111199|NCT02240693|472037693|FG004|Overall Study|Adverse Event|1|||
131111200|NCT02240693|472037689|FG000|Overall Study|Withdrawal by Subject|0|||
131111201|NCT02240693|472037690|FG001|Overall Study|Withdrawal by Subject|0|||
131111202|NCT02240693|472037691|FG002|Overall Study|Withdrawal by Subject|2|||
131111203|NCT02240693|472037692|FG003|Overall Study|Withdrawal by Subject|1|||
131111204|NCT02240693|472037693|FG004|Overall Study|Withdrawal by Subject|0|||
131111205|NCT02240693|472037689|FG000|Overall Study|Other than specified|0|||
131111206|NCT02240693|472037690|FG001|Overall Study|Other than specified|0|||
131111207|NCT02240693|472037691|FG002|Overall Study|Other than specified|2|||
131111208|NCT02240693|472037692|FG003|Overall Study|Other than specified|0|||
131111209|NCT02240693|472037693|FG004|Overall Study|Other than specified|0|||
131111210|NCT01116882|472037694|FG000|30-day|Lost to Follow-up|50|||
131111211|NCT01116882|472037695|FG001|30-day|Lost to Follow-up|21|||
130688660|NCT03032172|470485599|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
131111212|NCT01116882|472037694|FG000|30-day|Withdrawal by Subject|2|||
131111213|NCT01116882|472037695|FG001|30-day|Withdrawal by Subject|4|||
131111214|NCT01116882|472037694|FG000|30-day|Other Reasons|16|||
131111215|NCT01116882|472037695|FG001|30-day|Other Reasons|6|||
131111216|NCT01116882|472037694|FG000|12-month|Lost to Follow-up|111|||
131111217|NCT01116882|472037695|FG001|12-month|Lost to Follow-up|42|||
131111218|NCT01116882|472037694|FG000|12-month|Other Reasons|151|||
131111219|NCT01116882|472037695|FG001|12-month|Other Reasons|49|||
131111220|NCT01116882|472037694|FG000|12-month|Withdrawal by Subject|5|||
131111221|NCT01116882|472037695|FG001|12-month|Withdrawal by Subject|8|||
131111222|NCT00971243|472037698|FG000|Double Blind Period|Adverse Event|2|||
131111223|NCT00971243|472037699|FG001|Double Blind Period|Adverse Event|3|||
131111224|NCT00971243|472037700|FG002|Double Blind Period|Adverse Event|2|||
131111225|NCT00971243|472037701|FG003|Double Blind Period|Adverse Event|2|||
131111226|NCT00971243|472037702|FG004|Double Blind Period|Adverse Event|3|||
131111227|NCT00971243|472037698|FG000|Double Blind Period|Lost to Follow-up|0|||
131111228|NCT00971243|472037699|FG001|Double Blind Period|Lost to Follow-up|1|||
131111229|NCT00971243|472037700|FG002|Double Blind Period|Lost to Follow-up|1|||
131111230|NCT00971243|472037701|FG003|Double Blind Period|Lost to Follow-up|0|||
131111231|NCT00971243|472037702|FG004|Double Blind Period|Lost to Follow-up|1|||
131111232|NCT00971243|472037698|FG000|Double Blind Period|Physician Decision|10|||
131111233|NCT00971243|472037699|FG001|Double Blind Period|Physician Decision|6|||
131111234|NCT00971243|472037700|FG002|Double Blind Period|Physician Decision|7|||
131111235|NCT00971243|472037701|FG003|Double Blind Period|Physician Decision|6|||
131111236|NCT00971243|472037702|FG004|Double Blind Period|Physician Decision|7|||
131111237|NCT00971243|472037698|FG000|Double Blind Period|Protocol Violation|2|||
131111238|NCT00971243|472037699|FG001|Double Blind Period|Protocol Violation|0|||
131111239|NCT00971243|472037700|FG002|Double Blind Period|Protocol Violation|3|||
131111240|NCT00971243|472037701|FG003|Double Blind Period|Protocol Violation|2|||
130688661|NCT03032172|470485600|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130688662|NCT03032172|470485601|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130688663|NCT03032172|470485602|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130688664|NCT03032172|470485603|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130688665|NCT03032172|470485596|FG000|Treatment Period|Withdrawal by Subject|2|||
130688666|NCT03032172|470485597|FG001|Treatment Period|Withdrawal by Subject|0|||
130688667|NCT03032172|470485598|FG002|Treatment Period|Withdrawal by Subject|3|||
130688668|NCT03032172|470485599|FG003|Treatment Period|Withdrawal by Subject|0|||
130688669|NCT03032172|470485600|FG004|Treatment Period|Withdrawal by Subject|0|||
130688670|NCT03032172|470485601|FG005|Treatment Period|Withdrawal by Subject|0|||
130688671|NCT03032172|470485602|FG006|Treatment Period|Withdrawal by Subject|0|||
130688672|NCT03032172|470485603|FG007|Treatment Period|Withdrawal by Subject|0|||
130688673|NCT03032172|470485596|FG000|Open-label Extension Period|Death|0|||
130688674|NCT03032172|470485597|FG001|Open-label Extension Period|Death|0|||
130688675|NCT03032172|470485598|FG002|Open-label Extension Period|Death|0|||
130688676|NCT03032172|470485599|FG003|Open-label Extension Period|Death|0|||
130688677|NCT03032172|470485600|FG004|Open-label Extension Period|Death|0|||
130688678|NCT03032172|470485601|FG005|Open-label Extension Period|Death|0|||
130688679|NCT03032172|470485602|FG006|Open-label Extension Period|Death|0|||
130688680|NCT03032172|470485603|FG007|Open-label Extension Period|Death|2|||
130688681|NCT03032172|470485596|FG000|Open-label Extension Period|Reason Not Specified|0|||
130688682|NCT03032172|470485597|FG001|Open-label Extension Period|Reason Not Specified|0|||
130688683|NCT03032172|470485598|FG002|Open-label Extension Period|Reason Not Specified|0|||
130688684|NCT03032172|470485599|FG003|Open-label Extension Period|Reason Not Specified|0|||
130688685|NCT03032172|470485600|FG004|Open-label Extension Period|Reason Not Specified|0|||
130688686|NCT03032172|470485601|FG005|Open-label Extension Period|Reason Not Specified|5|||
130688687|NCT03032172|470485602|FG006|Open-label Extension Period|Reason Not Specified|3|||
130688688|NCT03032172|470485603|FG007|Open-label Extension Period|Reason Not Specified|0|||
130688689|NCT03032172|470485596|FG000|Open-label Extension Period|Pregnancy|0|||
130688690|NCT03032172|470485597|FG001|Open-label Extension Period|Pregnancy|0|||
130688691|NCT03032172|470485598|FG002|Open-label Extension Period|Pregnancy|0|||
130688692|NCT03032172|470485599|FG003|Open-label Extension Period|Pregnancy|0|||
130688693|NCT03032172|470485600|FG004|Open-label Extension Period|Pregnancy|0|||
130688694|NCT03032172|470485601|FG005|Open-label Extension Period|Pregnancy|0|||
130688695|NCT03032172|470485602|FG006|Open-label Extension Period|Pregnancy|1|||
130688696|NCT03032172|470485603|FG007|Open-label Extension Period|Pregnancy|0|||
130688697|NCT03032172|470485596|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
130688698|NCT03032172|470485597|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
130688699|NCT03032172|470485598|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
130688700|NCT03032172|470485599|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
130688701|NCT03032172|470485600|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
130688702|NCT03032172|470485601|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
130688703|NCT03032172|470485602|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
130688704|NCT03032172|470485603|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
130688705|NCT02869867|470485606|FG000|Overall Study|Protocol Violation|1|||
130894002|NCT02152956|471245468|FG008|Overall Study|Lost to Follow-up|0|||
130894003|NCT02152956|471245469|FG009|Overall Study|Lost to Follow-up|0|||
130894004|NCT02152956|471245470|FG010|Overall Study|Lost to Follow-up|0|||
130894005|NCT02152956|471245471|FG011|Overall Study|Lost to Follow-up|3|||
130894006|NCT02152956|471245472|FG012|Overall Study|Lost to Follow-up|0|||
131111241|NCT00971243|472037702|FG004|Double Blind Period|Protocol Violation|2|||
131111242|NCT00971243|472037698|FG000|Double Blind Period|Withdrawal by Subject|4|||
131111243|NCT00971243|472037699|FG001|Double Blind Period|Withdrawal by Subject|1|||
130688706|NCT02869867|470485607|FG001|Overall Study|Protocol Violation|0|||
130688707|NCT02869867|470485606|FG000|Overall Study|Lost to Follow-up|5|||
130688708|NCT02869867|470485607|FG001|Overall Study|Lost to Follow-up|5|||
130688709|NCT03570749|470485608|FG000|Overall Study|Ongoing|26|||
130688710|NCT03570749|470485609|FG001|Overall Study|Ongoing|25|||
130688711|NCT03570749|470485610|FG002|Overall Study|Ongoing|25|||
130894007|NCT02152956|471245460|FG000|Overall Study|Withdrawal by Subject|1|||
131111244|NCT00971243|472037700|FG002|Double Blind Period|Withdrawal by Subject|4|||
131111245|NCT00971243|472037701|FG003|Double Blind Period|Withdrawal by Subject|4|||
130688712|NCT03570749|470485611|FG003|Overall Study|Ongoing|26|||
130688713|NCT03570749|470485612|FG004|Overall Study|Ongoing|140|||
130688714|NCT03570749|470485613|FG005|Overall Study|Ongoing|142|||
130688715|NCT03570749|470485614|FG006|Overall Study|Ongoing|220|||
130688716|NCT03570749|470485608|FG000|Overall Study|Adverse Event|0|||
130688717|NCT03570749|470485609|FG001|Overall Study|Adverse Event|0|||
130688718|NCT03570749|470485610|FG002|Overall Study|Adverse Event|0|||
130688719|NCT03570749|470485611|FG003|Overall Study|Adverse Event|0|||
130688720|NCT03570749|470485612|FG004|Overall Study|Adverse Event|2|||
130894008|NCT02152956|471245461|FG001|Overall Study|Withdrawal by Subject|0|||
130894009|NCT02152956|471245462|FG002|Overall Study|Withdrawal by Subject|1|||
130894010|NCT02152956|471245463|FG003|Overall Study|Withdrawal by Subject|0|||
130894011|NCT02152956|471245464|FG004|Overall Study|Withdrawal by Subject|2|||
130894012|NCT02152956|471245465|FG005|Overall Study|Withdrawal by Subject|2|||
130894013|NCT02152956|471245466|FG006|Overall Study|Withdrawal by Subject|0|||
130894014|NCT02152956|471245467|FG007|Overall Study|Withdrawal by Subject|0|||
130894015|NCT02152956|471245468|FG008|Overall Study|Withdrawal by Subject|1|||
130767320|NCT04767529|470772361|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
130767321|NCT04767529|470772362|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
130767322|NCT04767529|470772360|FG000|Overall Study|Lost to Follow-up|0|||
130767323|NCT04767529|470772361|FG001|Overall Study|Lost to Follow-up|2|||
130767324|NCT04767529|470772362|FG002|Overall Study|Lost to Follow-up|3|||
130767325|NCT00253370|470772363|FG000|Overall Study|Adverse Event|18|||
130767326|NCT00253370|470772363|FG000|Overall Study|Disease progression|13|||
130767327|NCT00253370|470772363|FG000|Overall Study|Death|2|||
130767328|NCT00253370|470772363|FG000|Overall Study|Withdrawal by Subject|6|||
130767329|NCT00253370|470772363|FG000|Overall Study|Non-protocol therapy|1|||
130767330|NCT00253370|470772363|FG000|Overall Study|Physician Decision|1|||
130767331|NCT00253370|470772363|FG000|Overall Study|Protocol Violation|1|||
130767332|NCT00253370|470772363|FG000|Overall Study|Abdominal pain due to disease|1|||
130767333|NCT05916131|470772364|FG000|Overall Study|Lost to Follow-up|0|||
130767334|NCT05916131|470772365|FG001|Overall Study|Lost to Follow-up|0|||
130767335|NCT05916131|470772366|FG002|Overall Study|Lost to Follow-up|1|||
130767336|NCT05916131|470772367|FG003|Overall Study|Lost to Follow-up|0|||
130767337|NCT00904839|470772370|FG000|Overall Study|Adverse Event|0|||
130767338|NCT00904839|470772371|FG001|Overall Study|Adverse Event|5|||
130767339|NCT00904839|470772372|FG002|Overall Study|Adverse Event|4|||
130767340|NCT00904839|470772370|FG000|Overall Study|Protocol Violation|0|||
130767341|NCT00904839|470772371|FG001|Overall Study|Protocol Violation|1|||
130767342|NCT00904839|470772372|FG002|Overall Study|Protocol Violation|1|||
130767343|NCT00904839|470772370|FG000|Overall Study|Lost to Follow-up|0|||
130767344|NCT00904839|470772371|FG001|Overall Study|Lost to Follow-up|1|||
130767345|NCT00904839|470772372|FG002|Overall Study|Lost to Follow-up|2|||
130767346|NCT00904839|470772370|FG000|Overall Study|Withdrawal by Subject|0|||
130767347|NCT00904839|470772371|FG001|Overall Study|Withdrawal by Subject|2|||
130767348|NCT00904839|470772372|FG002|Overall Study|Withdrawal by Subject|0|||
130767349|NCT00904839|470772370|FG000|Overall Study|Not treated|1|||
130767350|NCT00904839|470772371|FG001|Overall Study|Not treated|0|||
130767351|NCT00904839|470772372|FG002|Overall Study|Not treated|1|||
130767352|NCT00904839|470772370|FG000|Overall Study|Other than above|0|||
130767353|NCT00904839|470772371|FG001|Overall Study|Other than above|9|||
130767354|NCT00904839|470772372|FG002|Overall Study|Other than above|7|||
130767355|NCT00553358|470772375|FG000|Overall Study|Randomized but did not receive treatment|3|||
130767356|NCT00553358|470772376|FG001|Overall Study|Randomized but did not receive treatment|3|||
130767357|NCT00553358|470772377|FG002|Overall Study|Randomized but did not receive treatment|1|||
130767358|NCT00553358|470772375|FG000|Overall Study|Lost to Follow-up|22|||
130767359|NCT00553358|470772376|FG001|Overall Study|Lost to Follow-up|26|||
130767360|NCT00553358|470772377|FG002|Overall Study|Lost to Follow-up|18|||
130767361|NCT00553358|470772375|FG000|Overall Study|Withdrew completely|23|||
130767362|NCT00553358|470772376|FG001|Overall Study|Withdrew completely|33|||
130767363|NCT00553358|470772377|FG002|Overall Study|Withdrew completely|34|||
130894016|NCT02152956|471245469|FG009|Overall Study|Withdrawal by Subject|0|||
130894017|NCT02152956|471245470|FG010|Overall Study|Withdrawal by Subject|0|||
130688721|NCT03570749|470485613|FG005|Overall Study|Adverse Event|3|||
130767364|NCT00553358|470772375|FG000|Overall Study|Died during clinical follow-up|25|||
130767365|NCT00553358|470772376|FG001|Overall Study|Died during clinical follow-up|29|||
130767366|NCT00553358|470772377|FG002|Overall Study|Died during clinical follow-up|32|||
130767367|NCT00553358|470772375|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
130767368|NCT00553358|470772376|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
130767369|NCT00553358|470772377|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
130767370|NCT00553358|470772375|FG000|Overall Study|Died after clinical follow-up ended|1|||
130894018|NCT02152956|471245471|FG011|Overall Study|Withdrawal by Subject|4|||
130894019|NCT02152956|471245472|FG012|Overall Study|Withdrawal by Subject|0|||
130688722|NCT03570749|470485614|FG006|Overall Study|Adverse Event|6|||
130688723|NCT03570749|470485608|FG000|Overall Study|Lack of Efficacy|0|||
130688724|NCT03570749|470485609|FG001|Overall Study|Lack of Efficacy|0|||
131111246|NCT00971243|472037702|FG004|Double Blind Period|Withdrawal by Subject|4|||
131111247|NCT00971243|472037698|FG000|Double Blind Period|Other reasons|1|||
131111248|NCT00971243|472037699|FG001|Double Blind Period|Other reasons|0|||
131111249|NCT00971243|472037700|FG002|Double Blind Period|Other reasons|2|||
131111250|NCT00971243|472037701|FG003|Double Blind Period|Other reasons|0|||
131111251|NCT00971243|472037702|FG004|Double Blind Period|Other reasons|1|||
131111252|NCT00971243|472037698|FG000|Open-label Period|Adverse Event|1|||
131111253|NCT00971243|472037699|FG001|Open-label Period|Adverse Event|0|||
131111254|NCT00971243|472037700|FG002|Open-label Period|Adverse Event|1|||
131111255|NCT00971243|472037701|FG003|Open-label Period|Adverse Event|1|||
131111256|NCT00971243|472037702|FG004|Open-label Period|Adverse Event|0|||
131111257|NCT00971243|472037698|FG000|Open-label Period|Physician Decision|5|||
131111258|NCT00971243|472037699|FG001|Open-label Period|Physician Decision|9|||
130688725|NCT03570749|470485610|FG002|Overall Study|Lack of Efficacy|0|||
130688726|NCT03570749|470485611|FG003|Overall Study|Lack of Efficacy|0|||
130688727|NCT03570749|470485612|FG004|Overall Study|Lack of Efficacy|8|||
130688728|NCT03570749|470485613|FG005|Overall Study|Lack of Efficacy|2|||
130688729|NCT03570749|470485614|FG006|Overall Study|Lack of Efficacy|7|||
130688730|NCT03570749|470485608|FG000|Overall Study|Lost to Follow-up|0|||
130894020|NCT02152956|471245460|FG000|Overall Study|Physician Decision|0|||
131111259|NCT00971243|472037700|FG002|Open-label Period|Physician Decision|3|||
131111260|NCT00971243|472037701|FG003|Open-label Period|Physician Decision|7|||
131111261|NCT00971243|472037702|FG004|Open-label Period|Physician Decision|2|||
131111262|NCT00971243|472037698|FG000|Open-label Period|Protocol Violation|1|||
131111263|NCT00971243|472037699|FG001|Open-label Period|Protocol Violation|1|||
131111264|NCT00971243|472037700|FG002|Open-label Period|Protocol Violation|1|||
131111265|NCT00971243|472037701|FG003|Open-label Period|Protocol Violation|0|||
131111266|NCT00971243|472037702|FG004|Open-label Period|Protocol Violation|1|||
131111267|NCT00971243|472037698|FG000|Open-label Period|Withdrawal by Subject|1|||
131111268|NCT00971243|472037699|FG001|Open-label Period|Withdrawal by Subject|0|||
131111269|NCT00971243|472037700|FG002|Open-label Period|Withdrawal by Subject|0|||
131111270|NCT00971243|472037701|FG003|Open-label Period|Withdrawal by Subject|2|||
131111271|NCT00971243|472037702|FG004|Open-label Period|Withdrawal by Subject|1|||
131111272|NCT00971243|472037698|FG000|Open-label Period|Other reason|0|||
131111273|NCT00971243|472037699|FG001|Open-label Period|Other reason|0|||
131111274|NCT00971243|472037700|FG002|Open-label Period|Other reason|0|||
131111275|NCT00971243|472037701|FG003|Open-label Period|Other reason|0|||
131111276|NCT00971243|472037702|FG004|Open-label Period|Other reason|2|||
131111277|NCT02092220|472037704|FG000|Period 1|Unrelated Illness|0|||
131111278|NCT02092220|472037705|FG001|Period 1|Unrelated Illness|2|||
131111279|NCT02092220|472037704|FG000|Period 2|Severe Hypoglycaemia|1|||
131111280|NCT02092220|472037705|FG001|Period 2|Severe Hypoglycaemia|0|||
131111281|NCT02092220|472037704|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
131111282|NCT02092220|472037705|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
131111283|NCT02739360|472037706|FG000|Overall Study|Adverse Event|1|||
131111284|NCT02739360|472037706|FG000|Overall Study|Study terminated by Sponsor|2|||
131111285|NCT01193920|472037707|FG000|Overall Study|Withdrawal by Subject|1|||
131111286|NCT01193920|472037708|FG001|Overall Study|Withdrawal by Subject|0|||
131111287|NCT01193920|472037709|FG002|Overall Study|Withdrawal by Subject|5|||
131111288|NCT01193920|472037710|FG003|Overall Study|Withdrawal by Subject|1|||
131111289|NCT01193920|472037711|FG004|Overall Study|Withdrawal by Subject|3|||
131111290|NCT01193920|472037712|FG005|Overall Study|Withdrawal by Subject|1|||
131111291|NCT01193920|472037713|FG006|Overall Study|Withdrawal by Subject|3|||
131111292|NCT01193920|472037714|FG007|Overall Study|Withdrawal by Subject|0|||
131111293|NCT01193920|472037715|FG008|Overall Study|Withdrawal by Subject|1|||
131111294|NCT01193920|472037716|FG009|Overall Study|Withdrawal by Subject|0|||
131111295|NCT01193920|472037707|FG000|Overall Study|Lost to Follow-up|1|||
131111296|NCT01193920|472037708|FG001|Overall Study|Lost to Follow-up|0|||
131111297|NCT01193920|472037709|FG002|Overall Study|Lost to Follow-up|1|||
131111298|NCT01193920|472037710|FG003|Overall Study|Lost to Follow-up|1|||
131111299|NCT01193920|472037711|FG004|Overall Study|Lost to Follow-up|3|||
131111300|NCT01193920|472037712|FG005|Overall Study|Lost to Follow-up|3|||
131111301|NCT01193920|472037713|FG006|Overall Study|Lost to Follow-up|1|||
131111302|NCT01193920|472037714|FG007|Overall Study|Lost to Follow-up|0|||
131111303|NCT01193920|472037715|FG008|Overall Study|Lost to Follow-up|2|||
130688731|NCT03570749|470485609|FG001|Overall Study|Lost to Follow-up|0|||
131111304|NCT01193920|472037716|FG009|Overall Study|Lost to Follow-up|3|||
131111305|NCT01193920|472037707|FG000|Overall Study|Protocol Violation|1|||
131111306|NCT01193920|472037708|FG001|Overall Study|Protocol Violation|0|||
131111307|NCT01193920|472037709|FG002|Overall Study|Protocol Violation|0|||
131111308|NCT01193920|472037710|FG003|Overall Study|Protocol Violation|0|||
131111309|NCT01193920|472037711|FG004|Overall Study|Protocol Violation|0|||
131111310|NCT01193920|472037712|FG005|Overall Study|Protocol Violation|0|||
130688732|NCT03570749|470485610|FG002|Overall Study|Lost to Follow-up|0|||
131111311|NCT01193920|472037713|FG006|Overall Study|Protocol Violation|0|||
131111312|NCT01193920|472037714|FG007|Overall Study|Protocol Violation|0|||
131111313|NCT01193920|472037715|FG008|Overall Study|Protocol Violation|0|||
131111314|NCT01193920|472037716|FG009|Overall Study|Protocol Violation|0|||
131111315|NCT01193920|472037707|FG000|Overall Study|Death|0|||
130894021|NCT02152956|471245461|FG001|Overall Study|Physician Decision|0|||
131111316|NCT01193920|472037708|FG001|Overall Study|Death|0|||
131111317|NCT01193920|472037709|FG002|Overall Study|Death|0|||
131111318|NCT01193920|472037710|FG003|Overall Study|Death|1|||
131111319|NCT01193920|472037711|FG004|Overall Study|Death|0|||
130688733|NCT03570749|470485611|FG003|Overall Study|Lost to Follow-up|0|||
130688734|NCT03570749|470485612|FG004|Overall Study|Lost to Follow-up|5|||
130688735|NCT03570749|470485613|FG005|Overall Study|Lost to Follow-up|10|||
130688736|NCT03570749|470485614|FG006|Overall Study|Lost to Follow-up|10|||
130688737|NCT03570749|470485608|FG000|Overall Study|Pregnancy|0|||
130688738|NCT03570749|470485609|FG001|Overall Study|Pregnancy|0|||
130688739|NCT03570749|470485610|FG002|Overall Study|Pregnancy|0|||
130688740|NCT03570749|470485611|FG003|Overall Study|Pregnancy|0|||
130688741|NCT03570749|470485612|FG004|Overall Study|Pregnancy|0|||
130688742|NCT03570749|470485613|FG005|Overall Study|Pregnancy|1|||
130688743|NCT03570749|470485614|FG006|Overall Study|Pregnancy|1|||
130688744|NCT03570749|470485608|FG000|Overall Study|Screen Fail|0|||
130688745|NCT03570749|470485609|FG001|Overall Study|Screen Fail|0|||
130688746|NCT03570749|470485610|FG002|Overall Study|Screen Fail|0|||
130688747|NCT03570749|470485611|FG003|Overall Study|Screen Fail|0|||
130688748|NCT03570749|470485612|FG004|Overall Study|Screen Fail|0|||
130688749|NCT03570749|470485613|FG005|Overall Study|Screen Fail|0|||
130688750|NCT03570749|470485614|FG006|Overall Study|Screen Fail|1|||
130688751|NCT03570749|470485608|FG000|Overall Study|Withdrawal by Subject|2|||
130688752|NCT03570749|470485609|FG001|Overall Study|Withdrawal by Subject|3|||
130688753|NCT03570749|470485610|FG002|Overall Study|Withdrawal by Subject|2|||
130688754|NCT03570749|470485611|FG003|Overall Study|Withdrawal by Subject|1|||
130688755|NCT03570749|470485612|FG004|Overall Study|Withdrawal by Subject|17|||
130688756|NCT03570749|470485613|FG005|Overall Study|Withdrawal by Subject|12|||
130688757|NCT03570749|470485614|FG006|Overall Study|Withdrawal by Subject|15|||
130688758|NCT03570749|470485608|FG000|Overall Study|Other|0|||
130688759|NCT03570749|470485609|FG001|Overall Study|Other|0|||
130688760|NCT03570749|470485610|FG002|Overall Study|Other|0|||
131111320|NCT01193920|472037712|FG005|Overall Study|Death|0|||
131111321|NCT01193920|472037713|FG006|Overall Study|Death|2|||
131111322|NCT01193920|472037714|FG007|Overall Study|Death|3|||
131111323|NCT01193920|472037715|FG008|Overall Study|Death|2|||
131111324|NCT01193920|472037716|FG009|Overall Study|Death|4|||
131111325|NCT01193920|472037707|FG000|Overall Study|Unable to classify|0|||
131111326|NCT01193920|472037708|FG001|Overall Study|Unable to classify|0|||
131111327|NCT01193920|472037709|FG002|Overall Study|Unable to classify|0|||
131111328|NCT01193920|472037710|FG003|Overall Study|Unable to classify|1|||
131111329|NCT01193920|472037711|FG004|Overall Study|Unable to classify|0|||
131111330|NCT01193920|472037712|FG005|Overall Study|Unable to classify|0|||
131111331|NCT01193920|472037713|FG006|Overall Study|Unable to classify|0|||
131111332|NCT01193920|472037714|FG007|Overall Study|Unable to classify|1|||
131111333|NCT01193920|472037715|FG008|Overall Study|Unable to classify|0|||
131111334|NCT01193920|472037716|FG009|Overall Study|Unable to classify|0|||
131111335|NCT01231516|472037719|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
131111336|NCT01231516|472037720|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
131111337|NCT01231516|472037719|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
131111338|NCT01231516|472037720|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
131111339|NCT01231516|472037719|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
131111340|NCT01231516|472037720|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
131111341|NCT01231516|472037719|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
131111342|NCT01231516|472037720|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
130688761|NCT03570749|470485611|FG003|Overall Study|Other|0|||
130688762|NCT03570749|470485612|FG004|Overall Study|Other|17|||
130688763|NCT03570749|470485613|FG005|Overall Study|Other|14|||
130688764|NCT03570749|470485614|FG006|Overall Study|Other|21|||
130688765|NCT00163657|470485615|FG000|Overall Study|Death|12|||
130688766|NCT00163657|470485616|FG001|Overall Study|Death|14|||
130688767|NCT00163657|470485617|FG002|Overall Study|Death|19|||
130688768|NCT00163657|470485615|FG000|Overall Study|graft loss|4|||
130688769|NCT00163657|470485616|FG001|Overall Study|graft loss|1|||
130688770|NCT00163657|470485617|FG002|Overall Study|graft loss|2|||
130688771|NCT00163657|470485615|FG000|Overall Study|Withdrawal by Subject|2|||
130688772|NCT00163657|470485616|FG001|Overall Study|Withdrawal by Subject|3|||
130688773|NCT00163657|470485617|FG002|Overall Study|Withdrawal by Subject|2|||
130688774|NCT00163657|470485615|FG000|Overall Study|Physician Decision|0|||
130894022|NCT02152956|471245462|FG002|Overall Study|Physician Decision|0|||
131111343|NCT01231516|472037719|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
131111344|NCT01231516|472037720|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
130688775|NCT00163657|470485616|FG001|Overall Study|Physician Decision|1|||
130688776|NCT00163657|470485617|FG002|Overall Study|Physician Decision|1|||
130688777|NCT00163657|470485615|FG000|Overall Study|Non Compliance|1|||
131111345|NCT01231516|472037719|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
131111346|NCT01231516|472037720|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
131111347|NCT01231516|472037719|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
130688778|NCT00163657|470485616|FG001|Overall Study|Non Compliance|0|||
130688779|NCT00163657|470485617|FG002|Overall Study|Non Compliance|0|||
130688780|NCT00163657|470485615|FG000|Overall Study|Lost to Follow-up|1|||
130688781|NCT00163657|470485616|FG001|Overall Study|Lost to Follow-up|3|||
130688782|NCT00163657|470485617|FG002|Overall Study|Lost to Follow-up|10|||
130688783|NCT00163657|470485615|FG000|Overall Study|Other reason|0|||
130688784|NCT00163657|470485616|FG001|Overall Study|Other reason|1|||
130688785|NCT00163657|470485617|FG002|Overall Study|Other reason|3|||
130688786|NCT02436005|470485620|FG000|Second Intervention|Adverse Event|0|||
130688787|NCT02436005|470485621|FG001|Second Intervention|Adverse Event|1|||
130688788|NCT00583453|470485622|FG000|Overall Study|discontinued intervention|0|||
130688789|NCT00583453|470485623|FG001|Overall Study|discontinued intervention|2|||
130688790|NCT03868891|470485626|FG000|Overall Study|Adverse Event|1|||
130688791|NCT03868891|470485627|FG001|Overall Study|Adverse Event|0|||
130688792|NCT03868891|470485626|FG000|Overall Study|Lost to Follow-up|2|||
130688793|NCT03868891|470485627|FG001|Overall Study|Lost to Follow-up|1|||
130688794|NCT03868891|470485626|FG000|Overall Study|COVID-19 Restrictions|1|||
130894023|NCT02152956|471245463|FG003|Overall Study|Physician Decision|0|||
130688795|NCT03868891|470485627|FG001|Overall Study|COVID-19 Restrictions|2|||
130688796|NCT03123094|470485629|FG000|Overall Study|Withdrawal by Subject|0|||
130688797|NCT03123094|470485630|FG001|Overall Study|Withdrawal by Subject|2|||
130688798|NCT03123094|470485631|FG002|Overall Study|Withdrawal by Subject|1|||
130688799|NCT03123094|470485632|FG003|Overall Study|Withdrawal by Subject|0|||
130688800|NCT03123094|470485633|FG004|Overall Study|Withdrawal by Subject|1|||
130688801|NCT00794963|470485640|FG000|Overall Study|Withdrawal by Subject|1|||
130688802|NCT00794963|470485641|FG001|Overall Study|Withdrawal by Subject|4|||
130688803|NCT03181594|470485647|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
130688804|NCT03181594|470485647|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
130688805|NCT03181594|470485647|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
130688806|NCT03181594|470485647|FG000|Initial Study Protocol (12-month FU)|Death|1|||
130688807|NCT03181594|470485647|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
130688808|NCT03181594|470485647|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
130688809|NCT03247972|470485649|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
130688810|NCT03247972|470485649|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
130688811|NCT01005745|470485654|FG000|Overall Study|No TIL growth|1|||
130688812|NCT01005745|470485654|FG000|Overall Study|Disease progressed during TIL growth|3|||
130688813|NCT01005745|470485654|FG000|Overall Study|Death prior to treatment|1|||
130688814|NCT01005745|470485654|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
130894024|NCT02152956|471245464|FG004|Overall Study|Physician Decision|0|||
131025303|NCT02590432|471723201|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131025304|NCT02590432|471723202|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131025305|NCT02590432|471723203|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131025306|NCT02590432|471723204|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131025307|NCT02590432|471723205|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
131025308|NCT02590432|471723206|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
131025309|NCT02006758|471723207|FG000|Overall Study|Protocol Violation|1|||
131025310|NCT02006758|471723207|FG000|Overall Study|Death|1|||
131025311|NCT02006758|471723207|FG000|Overall Study|Lost to Follow-up|4|||
131025312|NCT02006758|471723207|FG000|Overall Study|Withdrawal by Subject|4|||
131025313|NCT02006758|471723207|FG000|Overall Study|Procedurally excluded|1|||
131025314|NCT02006758|471723207|FG000|Overall Study|Other|2|||
131025315|NCT01250769|471723212|FG000|Overall Study|Withdrawal by Subject|0|||
131025316|NCT01250769|471723213|FG001|Overall Study|Withdrawal by Subject|1|||
131025317|NCT01250769|471723214|FG002|Overall Study|Withdrawal by Subject|1|||
131025318|NCT01250769|471723215|FG003|Overall Study|Withdrawal by Subject|0|||
131025319|NCT01250769|471723212|FG000|Overall Study|Adverse Event|0|||
131025320|NCT01250769|471723213|FG001|Overall Study|Adverse Event|0|||
131025321|NCT01250769|471723214|FG002|Overall Study|Adverse Event|1|||
131025322|NCT01250769|471723215|FG003|Overall Study|Adverse Event|0|||
131025323|NCT00243503|471723218|FG000|Overall Study|Adverse Event|11|||
131025324|NCT00243503|471723218|FG000|Overall Study|Withdrawal by Subject|1|||
131025325|NCT00243503|471723218|FG000|Overall Study|Lack of Efficacy|44|||
131025326|NCT00243503|471723218|FG000|Overall Study|Death|1|||
131025327|NCT00243503|471723218|FG000|Overall Study|Other|1|||
131025328|NCT02374307|471723224|FG000|3-months Follow-up|Lost to Follow-up|1|||
131025329|NCT02374307|471723225|FG001|3-months Follow-up|Lost to Follow-up|2|||
131025330|NCT02374307|471723224|FG000|3-months Follow-up|Withdrawal by Subject|1|||
131025331|NCT02374307|471723225|FG001|3-months Follow-up|Withdrawal by Subject|4|||
131025332|NCT02374307|471723224|FG000|3-months Follow-up|Death|1|||
131025333|NCT02374307|471723225|FG001|3-months Follow-up|Death|2|||
131025334|NCT02374307|471723224|FG000|3-months Follow-up|Missed first follow-up|5|||
131025335|NCT02374307|471723225|FG001|3-months Follow-up|Missed first follow-up|1|||
131025336|NCT02374307|471723224|FG000|6-months Follow-up|Lost to Follow-up|1|||
131025337|NCT02374307|471723225|FG001|6-months Follow-up|Lost to Follow-up|2|||
131025338|NCT02374307|471723224|FG000|6-months Follow-up|Death|2|||
130894025|NCT02152956|471245465|FG005|Overall Study|Physician Decision|0|||
131111348|NCT01231516|472037720|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
130688815|NCT03769025|470485655|FG000|Overall Study|Withdrawal by Subject|1|||
130688816|NCT03769025|470485656|FG001|Overall Study|Withdrawal by Subject|1|||
130688817|NCT03769025|470485655|FG000|Overall Study|Lost to Follow-up|4|||
130688818|NCT03769025|470485656|FG001|Overall Study|Lost to Follow-up|3|||
130688819|NCT01908205|470485657|FG000|Overall Study|Lost to Follow-up|2|||
130688820|NCT01908205|470485658|FG001|Overall Study|Lost to Follow-up|0|||
130688821|NCT01908205|470485657|FG000|Overall Study|Withdrawal by Subject|3|||
130688822|NCT01908205|470485658|FG001|Overall Study|Withdrawal by Subject|1|||
130688823|NCT03482882|470485659|FG000|Overall Study|Adverse Event|3|||
130688824|NCT03482882|470485659|FG000|Overall Study|Lost to Follow-up|1|||
130688825|NCT03482882|470485659|FG000|Overall Study|Protocol Violation|2|||
130688826|NCT03482882|470485659|FG000|Overall Study|Not further specified|1|||
130688827|NCT02957942|470485667|FG000|Overall Study|Withdrawal by Subject|0|||
130688828|NCT02957942|470485668|FG001|Overall Study|Withdrawal by Subject|1|||
130688829|NCT02957942|470485667|FG000|Overall Study|Practicing experiment protocol|0|||
130688830|NCT02957942|470485668|FG001|Overall Study|Practicing experiment protocol|6|||
130688831|NCT01136174|470485669|FG000|Overall Study|Adverse Event|0|||
130688832|NCT01136174|470485670|FG001|Overall Study|Adverse Event|0|||
130688833|NCT01136174|470485671|FG002|Overall Study|Adverse Event|0|||
130688834|NCT01136174|470485672|FG003|Overall Study|Adverse Event|4|||
130688835|NCT01754597|470485673|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
130688836|NCT01754597|470485674|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
130688837|NCT01588236|470485675|FG000|Overall Study|Adverse Event|5|||
130688838|NCT01588236|470485676|FG001|Overall Study|Adverse Event|4|||
130688839|NCT01588236|470485677|FG002|Overall Study|Adverse Event|1|||
130688840|NCT01588236|470485675|FG000|Overall Study|Lost to Follow-up|8|||
130688841|NCT01588236|470485676|FG001|Overall Study|Lost to Follow-up|13|||
130688842|NCT01588236|470485677|FG002|Overall Study|Lost to Follow-up|6|||
130688843|NCT01588236|470485675|FG000|Overall Study|Physician Decision|1|||
130688844|NCT01588236|470485676|FG001|Overall Study|Physician Decision|2|||
130688845|NCT01588236|470485677|FG002|Overall Study|Physician Decision|0|||
130688846|NCT01588236|470485675|FG000|Overall Study|Protocol Violation|0|||
130688847|NCT01588236|470485676|FG001|Overall Study|Protocol Violation|1|||
130688848|NCT01588236|470485677|FG002|Overall Study|Protocol Violation|1|||
130688849|NCT01588236|470485675|FG000|Overall Study|Withdrawal by Subject|14|||
130688850|NCT01588236|470485676|FG001|Overall Study|Withdrawal by Subject|16|||
130688851|NCT01588236|470485677|FG002|Overall Study|Withdrawal by Subject|18|||
130688852|NCT01588236|470485675|FG000|Overall Study|Exclusion Criteria met during study|2|||
130688853|NCT01588236|470485676|FG001|Overall Study|Exclusion Criteria met during study|1|||
130688854|NCT01588236|470485677|FG002|Overall Study|Exclusion Criteria met during study|0|||
130688855|NCT01588236|470485675|FG000|Overall Study|sponsor decision|1|||
130688856|NCT01588236|470485676|FG001|Overall Study|sponsor decision|6|||
130688857|NCT01588236|470485677|FG002|Overall Study|sponsor decision|2|||
130688858|NCT04544410|470485678|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130688859|NCT04544410|470485679|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130688860|NCT04544410|470485678|FG000|Double-blind Treatment Period|Adverse Event|1|||
130688861|NCT04544410|470485679|FG001|Double-blind Treatment Period|Adverse Event|0|||
130688862|NCT04544410|470485678|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130688863|NCT04544410|470485679|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130688864|NCT04544410|470485678|FG000|Double-blind Treatment Period|Protocol Violation|1|||
130688865|NCT04544410|470485679|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130688866|NCT04544410|470485678|FG000|Open-Label Treatment Period|Study Terminated|15|||
130688867|NCT04544410|470485679|FG001|Open-Label Treatment Period|Study Terminated|19|||
130688868|NCT04544410|470485678|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
130688869|NCT04544410|470485679|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
130688870|NCT04544410|470485678|FG000|Open-Label Treatment Period|Adverse Event|0|||
130688871|NCT04544410|470485679|FG001|Open-Label Treatment Period|Adverse Event|1|||
130688872|NCT04544410|470485678|FG000|Open-Label Treatment Period|Physician Decision|1|||
130688873|NCT04544410|470485679|FG001|Open-Label Treatment Period|Physician Decision|0|||
130688874|NCT04544410|470485678|FG000|Open-Label Treatment Period|Other|0|||
130688875|NCT04544410|470485679|FG001|Open-Label Treatment Period|Other|1|||
130688876|NCT03761173|470485680|FG000|Overall Study|Lost to Follow-up|93|||
130688877|NCT03761173|470485680|FG000|Overall Study|Withdrawal by Subject|74|||
130688878|NCT03761173|470485680|FG000|Overall Study|Death|45|||
130688879|NCT03761173|470485680|FG000|Overall Study|Withdrawal for Other Reasons|29|||
130688880|NCT03761173|470485680|FG000|Overall Study|Protocol Violation|1|||
130688881|NCT06284525|470486954|FG000|Overall Study|Withdrawal by Subject|1|||
130688882|NCT01175018|470486959|FG000|Overall Study|Adverse Event|3|||
130688883|NCT01175018|470486960|FG001|Overall Study|Adverse Event|1|||
130688884|NCT02838420|470486964|FG000|Overall Study|Ongoing in Study|113|||
130688885|NCT02838420|470486965|FG001|Overall Study|Ongoing in Study|45|||
130688886|NCT02838420|470486964|FG000|Overall Study|Lost to Follow-up|1|||
130688887|NCT02838420|470486965|FG001|Overall Study|Lost to Follow-up|0|||
130688888|NCT02838420|470486964|FG000|Overall Study|Withdrawal by Subject|3|||
130688889|NCT02838420|470486965|FG001|Overall Study|Withdrawal by Subject|4|||
130688890|NCT02838420|470486964|FG000|Overall Study|Death|8|||
130688891|NCT02838420|470486965|FG001|Overall Study|Death|13|||
130688892|NCT02964039|470486966|FG000|Overall Study|Medical reason unrelated to study participation|1|||
130688893|NCT02964039|470486967|FG001|Overall Study|Medical reason unrelated to study participation|0|||
130688894|NCT02964039|470486968|FG002|Overall Study|Medical reason unrelated to study participation|3|||
130688895|NCT02964039|470486966|FG000|Overall Study|Research shutdown due to pandemic|2|||
130688896|NCT02964039|470486967|FG001|Overall Study|Research shutdown due to pandemic|0|||
130688897|NCT02964039|470486968|FG002|Overall Study|Research shutdown due to pandemic|1|||
130688898|NCT02964039|470486966|FG000|Overall Study|Withdrawal by Subject|0|||
130688899|NCT02964039|470486967|FG001|Overall Study|Withdrawal by Subject|1|||
130688900|NCT02964039|470486968|FG002|Overall Study|Withdrawal by Subject|0|||
130688901|NCT02964039|470486966|FG000|Overall Study|Lost to Follow-up|1|||
130688902|NCT02964039|470486967|FG001|Overall Study|Lost to Follow-up|0|||
130688903|NCT02964039|470486968|FG002|Overall Study|Lost to Follow-up|1|||
130688904|NCT00185458|470486971|FG000|Contraception Phase|Adverse Event|37|||
130688905|NCT00185458|470486971|FG000|Contraception Phase|Lost to Follow-up|10|||
130688906|NCT00185458|470486971|FG000|Contraception Phase|Protocol Violation|2|||
130688907|NCT00185458|470486971|FG000|Contraception Phase|Physician Decision|2|||
130688908|NCT00185458|470486971|FG000|Contraception Phase|Withdrawal by Subject|7|||
130688909|NCT00185458|470486971|FG000|HRT Phase|Adverse Event|18|||
130688910|NCT00185458|470486971|FG000|HRT Phase|Lost to Follow-up|4|||
130688911|NCT00185458|470486971|FG000|HRT Phase|Protocol Violation|2|||
130688912|NCT00185458|470486971|FG000|HRT Phase|Withdrawal by Subject|3|||
130688913|NCT00251979|470486972|FG000|Overall Study|Protocol Violation|3|||
130688914|NCT00251979|470486973|FG001|Overall Study|Protocol Violation|5|||
130688915|NCT00251979|470486972|FG000|Overall Study|Adverse Event|11|||
130688916|NCT00251979|470486973|FG001|Overall Study|Adverse Event|17|||
130688917|NCT00251979|470486972|FG000|Overall Study|Withdrawal by Subject|13|||
130688918|NCT00251979|470486973|FG001|Overall Study|Withdrawal by Subject|7|||
130688919|NCT00251979|470486972|FG000|Overall Study|Lost to Follow-up|8|||
130688920|NCT00251979|470486973|FG001|Overall Study|Lost to Follow-up|6|||
130688921|NCT00251979|470486972|FG000|Overall Study|Death|3|||
130688922|NCT00251979|470486973|FG001|Overall Study|Death|5|||
130688923|NCT01576042|470486974|FG000|Overall Study|Physician Decision|2|||
130688924|NCT01576042|470486975|FG001|Overall Study|Physician Decision|0|||
130688925|NCT00835536|470486979|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
130688926|NCT00835536|470486980|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
130688927|NCT03173547|470486984|FG000|Overall Study|Adverse Event|2|||
130688928|NCT03173547|470486985|FG001|Overall Study|Adverse Event|0|||
130688929|NCT03173547|470486984|FG000|Overall Study|Withdrawal by Subject|2|||
130688930|NCT03173547|470486985|FG001|Overall Study|Withdrawal by Subject|2|||
130688931|NCT00657553|470486986|FG000|Overall Study|low accrual, no analysis run|5|||
130688932|NCT00657553|470486987|FG001|Overall Study|low accrual, no analysis run|5|||
130688933|NCT00446563|470486988|FG000|Overall Study|Adverse Event|4|||
130688934|NCT00446563|470486989|FG001|Overall Study|Adverse Event|3|||
130688935|NCT00446563|470486988|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130688936|NCT00446563|470486989|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130688937|NCT00446563|470486988|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130688938|NCT00446563|470486989|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130688939|NCT00446563|470486988|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130688940|NCT00446563|470486989|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130688941|NCT00446563|470486988|FG000|Overall Study|Withdrawal by Subject|2|||
130688942|NCT00446563|470486989|FG001|Overall Study|Withdrawal by Subject|1|||
130688943|NCT00446563|470486988|FG000|Overall Study|Administrative problems|0|||
130688944|NCT00446563|470486989|FG001|Overall Study|Administrative problems|1|||
130688945|NCT01169558|470486990|FG000|Overall Study|Disease progression|98|||
130688946|NCT01169558|470486990|FG000|Overall Study|Adverse Event|25|||
130688947|NCT01169558|470486990|FG000|Overall Study|Withdrawal of Consent|8|||
130688948|NCT01169558|470486990|FG000|Overall Study|Medical Decision|7|||
130894026|NCT02152956|471245466|FG006|Overall Study|Physician Decision|0|||
131025339|NCT02374307|471723225|FG001|6-months Follow-up|Death|1|||
131025340|NCT02374307|471723224|FG000|6-months Follow-up|Withdrawal by Subject|0|||
131025341|NCT02374307|471723225|FG001|6-months Follow-up|Withdrawal by Subject|3|||
131025342|NCT01747486|471723240|FG000|Stage 1|Physician Decision|3|||
131025343|NCT01747486|471723241|FG001|Stage 1|Physician Decision|0|||
131025344|NCT01747486|471723240|FG000|Stage 1|Withdrawal by Subject|4|||
131025345|NCT01747486|471723241|FG001|Stage 1|Withdrawal by Subject|3|||
131025346|NCT01747486|471723240|FG000|Stage 1|Disease progression|4|||
131025347|NCT01747486|471723241|FG001|Stage 1|Disease progression|9|||
131025348|NCT01747486|471723240|FG000|Stage 1|Death|1|||
131025349|NCT01747486|471723241|FG001|Stage 1|Death|1|||
131025350|NCT01747486|471723240|FG000|Stage 2|Physician Decision|2|||
131025351|NCT01747486|471723241|FG001|Stage 2|Physician Decision|0|||
131025352|NCT01747486|471723240|FG000|Stage 2|Withdrawal by Subject|1|||
131025353|NCT01747486|471723241|FG001|Stage 2|Withdrawal by Subject|0|||
131025354|NCT01747486|471723240|FG000|Stage 2|New Cancer Therapy|3|||
131025355|NCT01747486|471723241|FG001|Stage 2|New Cancer Therapy|0|||
130688949|NCT01169558|470486990|FG000|Overall Study|Stable Disease|4|||
130688950|NCT01169558|470486990|FG000|Overall Study|Lost to Follow-up|4|||
130688951|NCT01169558|470486990|FG000|Overall Study|Need for Surgery|4|||
130688952|NCT01169558|470486990|FG000|Overall Study|Non-compliance|2|||
130688953|NCT01169558|470486990|FG000|Overall Study|Protocol Violation|2|||
130688954|NCT01169558|470486990|FG000|Overall Study|Partial response|2|||
130688955|NCT02409355|470486996|FG000|Overall Study|Withdrawal by Subject|1|||
130688956|NCT02409355|470486997|FG001|Overall Study|Withdrawal by Subject|0|||
130688957|NCT02409355|470486996|FG000|Overall Study|Death|1|||
130688958|NCT02409355|470486997|FG001|Overall Study|Death|1|||
130688959|NCT02409355|470486996|FG000|Overall Study|Study terminated by Sponsor|2|||
130688960|NCT02409355|470486997|FG001|Overall Study|Study terminated by Sponsor|3|||
130688961|NCT00838539|470486998|FG000|Overall Study|Disease Progression|2|||
130688962|NCT00838539|470486999|FG001|Overall Study|Disease Progression|4|||
130688963|NCT00838539|470487000|FG002|Overall Study|Disease Progression|3|||
130688964|NCT00838539|470487001|FG003|Overall Study|Disease Progression|2|||
130688965|NCT00838539|470487002|FG004|Overall Study|Disease Progression|4|||
130688966|NCT00838539|470487003|FG005|Overall Study|Disease Progression|2|||
130688967|NCT00838539|470487004|FG006|Overall Study|Disease Progression|3|||
130688968|NCT00838539|470487005|FG007|Overall Study|Disease Progression|4|||
130688969|NCT00838539|470487006|FG008|Overall Study|Disease Progression|4|||
130688970|NCT00838539|470487007|FG009|Overall Study|Disease Progression|5|||
130688971|NCT00838539|470487008|FG010|Overall Study|Disease Progression|1|||
130688972|NCT00838539|470487009|FG011|Overall Study|Disease Progression|4|||
130688973|NCT00838539|470486998|FG000|Overall Study|Adverse Event|1|||
130688974|NCT00838539|470486999|FG001|Overall Study|Adverse Event|1|||
130688975|NCT00838539|470487000|FG002|Overall Study|Adverse Event|1|||
130688976|NCT00838539|470487001|FG003|Overall Study|Adverse Event|1|||
130688977|NCT00838539|470487002|FG004|Overall Study|Adverse Event|2|||
130688978|NCT00838539|470487003|FG005|Overall Study|Adverse Event|1|||
130688979|NCT00838539|470487004|FG006|Overall Study|Adverse Event|0|||
130688980|NCT00838539|470487005|FG007|Overall Study|Adverse Event|2|||
130688981|NCT00838539|470487006|FG008|Overall Study|Adverse Event|0|||
130688982|NCT00838539|470487007|FG009|Overall Study|Adverse Event|1|||
130688983|NCT00838539|470487008|FG010|Overall Study|Adverse Event|2|||
130688984|NCT00838539|470487009|FG011|Overall Study|Adverse Event|0|||
130688985|NCT00838539|470486998|FG000|Overall Study|Withdrawal by Subject|0|||
130688986|NCT00838539|470486999|FG001|Overall Study|Withdrawal by Subject|1|||
130688987|NCT00838539|470487000|FG002|Overall Study|Withdrawal by Subject|0|||
130688988|NCT00838539|470487001|FG003|Overall Study|Withdrawal by Subject|0|||
130688989|NCT00838539|470487002|FG004|Overall Study|Withdrawal by Subject|0|||
130688990|NCT00838539|470487003|FG005|Overall Study|Withdrawal by Subject|0|||
130688991|NCT00838539|470487004|FG006|Overall Study|Withdrawal by Subject|0|||
130688992|NCT00838539|470487005|FG007|Overall Study|Withdrawal by Subject|0|||
130688993|NCT00838539|470487006|FG008|Overall Study|Withdrawal by Subject|0|||
130688994|NCT00838539|470487007|FG009|Overall Study|Withdrawal by Subject|1|||
130688995|NCT00838539|470487008|FG010|Overall Study|Withdrawal by Subject|2|||
130688996|NCT00838539|470487009|FG011|Overall Study|Withdrawal by Subject|0|||
130688997|NCT00838539|470486998|FG000|Overall Study|Death|0|||
130688998|NCT00838539|470486999|FG001|Overall Study|Death|0|||
130688999|NCT00838539|470487000|FG002|Overall Study|Death|0|||
130689000|NCT00838539|470487001|FG003|Overall Study|Death|0|||
130689001|NCT00838539|470487002|FG004|Overall Study|Death|0|||
130689002|NCT00838539|470487003|FG005|Overall Study|Death|0|||
130689003|NCT00838539|470487004|FG006|Overall Study|Death|1|||
130689004|NCT00838539|470487005|FG007|Overall Study|Death|0|||
130689005|NCT00838539|470487006|FG008|Overall Study|Death|0|||
130689006|NCT00838539|470487007|FG009|Overall Study|Death|0|||
130689007|NCT00838539|470487008|FG010|Overall Study|Death|0|||
130689008|NCT00838539|470487009|FG011|Overall Study|Death|0|||
130689009|NCT00838539|470486998|FG000|Overall Study|Physician Decision|0|||
130689010|NCT00838539|470486999|FG001|Overall Study|Physician Decision|0|||
130689011|NCT00838539|470487000|FG002|Overall Study|Physician Decision|0|||
130689012|NCT00838539|470487001|FG003|Overall Study|Physician Decision|0|||
130689013|NCT00838539|470487002|FG004|Overall Study|Physician Decision|0|||
130689014|NCT00838539|470487003|FG005|Overall Study|Physician Decision|0|||
130689015|NCT00838539|470487004|FG006|Overall Study|Physician Decision|0|||
130689016|NCT00838539|470487005|FG007|Overall Study|Physician Decision|0|||
130689017|NCT00838539|470487006|FG008|Overall Study|Physician Decision|1|||
130689018|NCT00838539|470487007|FG009|Overall Study|Physician Decision|0|||
130689019|NCT00838539|470487008|FG010|Overall Study|Physician Decision|0|||
130689020|NCT00838539|470487009|FG011|Overall Study|Physician Decision|0|||
130689021|NCT00838539|470486998|FG000|Overall Study|Clinical Progression|0|||
130689022|NCT00838539|470486999|FG001|Overall Study|Clinical Progression|0|||
130689023|NCT00838539|470487000|FG002|Overall Study|Clinical Progression|0|||
130689024|NCT00838539|470487001|FG003|Overall Study|Clinical Progression|0|||
130689025|NCT00838539|470487002|FG004|Overall Study|Clinical Progression|0|||
130689026|NCT00838539|470487003|FG005|Overall Study|Clinical Progression|0|||
130689027|NCT00838539|470487004|FG006|Overall Study|Clinical Progression|1|||
130689028|NCT00838539|470487005|FG007|Overall Study|Clinical Progression|0|||
130689029|NCT00838539|470487006|FG008|Overall Study|Clinical Progression|0|||
130689030|NCT00838539|470487007|FG009|Overall Study|Clinical Progression|0|||
130689031|NCT00838539|470487008|FG010|Overall Study|Clinical Progression|0|||
130689032|NCT00838539|470487009|FG011|Overall Study|Clinical Progression|0|||
130689033|NCT00838539|470486998|FG000|Overall Study|Symptomatic Deterioration|0|||
130689034|NCT00838539|470486999|FG001|Overall Study|Symptomatic Deterioration|0|||
130689035|NCT00838539|470487000|FG002|Overall Study|Symptomatic Deterioration|1|||
130689036|NCT00838539|470487001|FG003|Overall Study|Symptomatic Deterioration|1|||
130689037|NCT00838539|470487002|FG004|Overall Study|Symptomatic Deterioration|0|||
130689038|NCT00838539|470487003|FG005|Overall Study|Symptomatic Deterioration|1|||
130689039|NCT00838539|470487004|FG006|Overall Study|Symptomatic Deterioration|0|||
130689040|NCT00838539|470487005|FG007|Overall Study|Symptomatic Deterioration|0|||
130689041|NCT00838539|470487006|FG008|Overall Study|Symptomatic Deterioration|0|||
130689042|NCT00838539|470487007|FG009|Overall Study|Symptomatic Deterioration|1|||
130689043|NCT00838539|470487008|FG010|Overall Study|Symptomatic Deterioration|0|||
130689044|NCT00838539|470487009|FG011|Overall Study|Symptomatic Deterioration|0|||
130689045|NCT03134222|470487014|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
130689046|NCT03134222|470487015|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
130689047|NCT03134222|470487016|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
130689048|NCT03134222|470487017|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
130689049|NCT03134222|470487018|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
130689050|NCT03134222|470487014|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
130689051|NCT03134222|470487015|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
130689052|NCT03134222|470487016|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
130689053|NCT03134222|470487017|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
130689054|NCT03134222|470487018|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
130689055|NCT03134222|470487014|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130689056|NCT03134222|470487015|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
130689057|NCT03134222|470487016|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130689058|NCT03134222|470487017|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130689059|NCT03134222|470487018|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130689060|NCT03134222|470487014|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
130689061|NCT03134222|470487015|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
130689062|NCT03134222|470487016|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
130689063|NCT03134222|470487017|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
130689064|NCT03134222|470487018|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
130689065|NCT03134222|470487014|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
130689066|NCT03134222|470487015|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
130689067|NCT03134222|470487016|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
130689068|NCT03134222|470487017|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
130689069|NCT03134222|470487018|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
130689070|NCT03134222|470487014|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
130689071|NCT03134222|470487015|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130689072|NCT03134222|470487016|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130689073|NCT03134222|470487017|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130689074|NCT03134222|470487018|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130689075|NCT03134222|470487014|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130689076|NCT03134222|470487015|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130689077|NCT03134222|470487016|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130689078|NCT03134222|470487017|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
130689079|NCT03134222|470487018|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130689080|NCT03134222|470487014|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130689081|NCT03134222|470487015|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
130689082|NCT03134222|470487016|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130689083|NCT03134222|470487017|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130689084|NCT03134222|470487018|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130689085|NCT01110005|470487025|FG000|Overall Study|ineligible|1|||
130689086|NCT01110005|470487026|FG001|Overall Study|ineligible|2|||
130689087|NCT01110005|470487025|FG000|Overall Study|missing consent|3|||
130689088|NCT01110005|470487026|FG001|Overall Study|missing consent|2|||
130689089|NCT01110005|470487025|FG000|Overall Study|Withdrawal by Subject|0|||
130689090|NCT01110005|470487026|FG001|Overall Study|Withdrawal by Subject|1|||
130689091|NCT03123471|470487027|FG000|Placebo-controlled Phase|Adverse Event|3|||
130689092|NCT03123471|470487028|FG001|Placebo-controlled Phase|Adverse Event|8|||
130689093|NCT03123471|470487027|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
130689094|NCT03123471|470487028|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
130689095|NCT03123471|470487027|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
130689096|NCT03123471|470487028|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
130689097|NCT03123471|470487027|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
130689098|NCT03123471|470487028|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
130689099|NCT03123471|470487027|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
130689100|NCT03123471|470487028|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
130689101|NCT03123471|470487027|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
130689102|NCT03123471|470487028|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
130689103|NCT03123471|470487027|FG000|Placebo-controlled Phase|Miscellaneous|0|||
130689104|NCT03123471|470487028|FG001|Placebo-controlled Phase|Miscellaneous|1|||
130689105|NCT03123471|470487027|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
130689106|NCT03123471|470487028|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
130689107|NCT03123471|470487027|FG000|Apremilast Extension Phase|Adverse Event|1|||
130689108|NCT03123471|470487028|FG001|Apremilast Extension Phase|Adverse Event|5|||
130689109|NCT03123471|470487027|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
130689110|NCT03123471|470487028|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
130689111|NCT03123471|470487027|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
130689112|NCT03123471|470487028|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
130689113|NCT03681470|470487031|FG000|Overall Study|Lack of Efficacy|3|||
130689114|NCT03681470|470487031|FG000|Overall Study|Lost to Follow-up|1|||
130689115|NCT03681470|470487031|FG000|Overall Study|Protocol Violation|3|||
130689116|NCT03681470|470487031|FG000|Overall Study|Withdrawal by Subject|1|||
130689117|NCT01686477|470487032|FG000|Feeding Intervention|Death|1|||
130689118|NCT01686477|470487033|FG001|Feeding Intervention|Death|0|||
130689119|NCT01686477|470487034|FG002|Feeding Intervention|Death|1|||
130689120|NCT01686477|470487032|FG000|Feeding Intervention|Withdrawal by Subject|0|||
130689121|NCT01686477|470487033|FG001|Feeding Intervention|Withdrawal by Subject|6|||
130689122|NCT01686477|470487034|FG002|Feeding Intervention|Withdrawal by Subject|0|||
130689123|NCT01686477|470487032|FG000|Feeding Intervention|Physician Decision|1|||
130689124|NCT01686477|470487033|FG001|Feeding Intervention|Physician Decision|2|||
130689125|NCT01686477|470487034|FG002|Feeding Intervention|Physician Decision|0|||
130689126|NCT01686477|470487032|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
130689127|NCT01686477|470487033|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
130689128|NCT01686477|470487034|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
130689129|NCT01686477|470487032|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
130689130|NCT01686477|470487033|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
130689131|NCT01686477|470487034|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
130689132|NCT01686477|470487032|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
130689133|NCT01686477|470487033|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
130689134|NCT01686477|470487034|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
130689135|NCT01686477|470487032|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
130689136|NCT01686477|470487033|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
130689137|NCT01686477|470487034|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
130689138|NCT01686477|470487032|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
130689139|NCT01686477|470487033|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
130689140|NCT01686477|470487034|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
130689141|NCT01686477|470487032|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
130689142|NCT01686477|470487033|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
130689143|NCT01686477|470487034|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
130689144|NCT01686477|470487032|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
130689145|NCT01686477|470487033|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
130689146|NCT01686477|470487034|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
130689147|NCT03290781|470487035|FG000|Overall Study|Adverse Event|5|||
130689148|NCT03290781|470487036|FG001|Overall Study|Adverse Event|7|||
130689149|NCT03290781|470487037|FG002|Overall Study|Adverse Event|4|||
130689150|NCT03290781|470487038|FG003|Overall Study|Adverse Event|1|||
130689151|NCT03290781|470487039|FG004|Overall Study|Adverse Event|0|||
130689152|NCT03290781|470487040|FG005|Overall Study|Adverse Event|0|||
130689153|NCT03290781|470487041|FG006|Overall Study|Adverse Event|0|||
130689154|NCT03290781|470487035|FG000|Overall Study|Death|0|||
130689155|NCT03290781|470487036|FG001|Overall Study|Death|0|||
130689156|NCT03290781|470487037|FG002|Overall Study|Death|1|||
130689157|NCT03290781|470487038|FG003|Overall Study|Death|0|||
130689158|NCT03290781|470487039|FG004|Overall Study|Death|1|||
130689159|NCT03290781|470487040|FG005|Overall Study|Death|0|||
130689160|NCT03290781|470487041|FG006|Overall Study|Death|0|||
130689161|NCT03290781|470487035|FG000|Overall Study|Withdrawal by Subject|6|||
130689162|NCT03290781|470487036|FG001|Overall Study|Withdrawal by Subject|5|||
130689163|NCT03290781|470487037|FG002|Overall Study|Withdrawal by Subject|9|||
130689164|NCT03290781|470487038|FG003|Overall Study|Withdrawal by Subject|10|||
130689165|NCT03290781|470487039|FG004|Overall Study|Withdrawal by Subject|1|||
130689166|NCT03290781|470487040|FG005|Overall Study|Withdrawal by Subject|2|||
130689167|NCT03290781|470487041|FG006|Overall Study|Withdrawal by Subject|0|||
130894027|NCT02152956|471245467|FG007|Overall Study|Physician Decision|0|||
130894028|NCT02152956|471245468|FG008|Overall Study|Physician Decision|0|||
130689168|NCT03290781|470487035|FG000|Overall Study|Physician Decision|0|||
130689169|NCT03290781|470487036|FG001|Overall Study|Physician Decision|1|||
131111349|NCT01231516|472037719|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
131111350|NCT01231516|472037720|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
131111351|NCT01231516|472037719|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
131111352|NCT01231516|472037720|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
131111353|NCT01231516|472037719|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
131111354|NCT01231516|472037720|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
131111355|NCT01231516|472037719|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
131111356|NCT01231516|472037720|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
131111357|NCT01231516|472037719|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
131111358|NCT01231516|472037720|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
131222709|NCT01959230|472443163|FG000|Overall Study|Failure to follow study procedures|0|||
131222710|NCT01959230|472443164|FG001|Overall Study|Failure to follow study procedures|1|||
131222711|NCT01959230|472443163|FG000|Overall Study|Administrative reasons|2|||
130689170|NCT03290781|470487037|FG002|Overall Study|Physician Decision|0|||
130689171|NCT03290781|470487038|FG003|Overall Study|Physician Decision|0|||
130689172|NCT03290781|470487039|FG004|Overall Study|Physician Decision|0|||
130689173|NCT03290781|470487040|FG005|Overall Study|Physician Decision|0|||
130689174|NCT03290781|470487041|FG006|Overall Study|Physician Decision|0|||
130689175|NCT03290781|470487035|FG000|Overall Study|Site Terminated by Sponsor|1|||
130689176|NCT03290781|470487036|FG001|Overall Study|Site Terminated by Sponsor|0|||
130689177|NCT03290781|470487037|FG002|Overall Study|Site Terminated by Sponsor|2|||
130689178|NCT03290781|470487038|FG003|Overall Study|Site Terminated by Sponsor|1|||
130689179|NCT03290781|470487039|FG004|Overall Study|Site Terminated by Sponsor|0|||
130689180|NCT03290781|470487040|FG005|Overall Study|Site Terminated by Sponsor|0|||
130689181|NCT03290781|470487041|FG006|Overall Study|Site Terminated by Sponsor|0|||
130689182|NCT03290781|470487035|FG000|Overall Study|Lost to Follow-up|0|||
130689183|NCT03290781|470487036|FG001|Overall Study|Lost to Follow-up|0|||
130689184|NCT03290781|470487037|FG002|Overall Study|Lost to Follow-up|0|||
130689185|NCT03290781|470487038|FG003|Overall Study|Lost to Follow-up|1|||
130689186|NCT03290781|470487039|FG004|Overall Study|Lost to Follow-up|0|||
130689187|NCT03290781|470487040|FG005|Overall Study|Lost to Follow-up|0|||
130689188|NCT03290781|470487041|FG006|Overall Study|Lost to Follow-up|0|||
130689189|NCT03290781|470487035|FG000|Overall Study|Protocol Deviation|2|||
130689190|NCT03290781|470487036|FG001|Overall Study|Protocol Deviation|0|||
130689191|NCT03290781|470487037|FG002|Overall Study|Protocol Deviation|0|||
130689192|NCT03290781|470487038|FG003|Overall Study|Protocol Deviation|1|||
130689193|NCT03290781|470487039|FG004|Overall Study|Protocol Deviation|0|||
130689194|NCT03290781|470487040|FG005|Overall Study|Protocol Deviation|0|||
130689195|NCT03290781|470487041|FG006|Overall Study|Protocol Deviation|0|||
130689196|NCT03290781|470487035|FG000|Overall Study|Disease Relapse|32|||
130689197|NCT03290781|470487036|FG001|Overall Study|Disease Relapse|5|||
130689198|NCT03290781|470487037|FG002|Overall Study|Disease Relapse|38|||
130689199|NCT03290781|470487038|FG003|Overall Study|Disease Relapse|7|||
130689200|NCT03290781|470487039|FG004|Overall Study|Disease Relapse|3|||
130689201|NCT03290781|470487040|FG005|Overall Study|Disease Relapse|1|||
130689202|NCT03290781|470487041|FG006|Overall Study|Disease Relapse|4|||
130689203|NCT03290781|470487035|FG000|Overall Study|Other|3|||
130689204|NCT03290781|470487036|FG001|Overall Study|Other|0|||
130689205|NCT03290781|470487037|FG002|Overall Study|Other|2|||
130689206|NCT03290781|470487038|FG003|Overall Study|Other|2|||
130689207|NCT03290781|470487039|FG004|Overall Study|Other|0|||
130689208|NCT03290781|470487040|FG005|Overall Study|Other|0|||
130689209|NCT03290781|470487041|FG006|Overall Study|Other|0|||
130689210|NCT03238781|470487042|FG000|Overall Study|Adverse Event|1|||
130689211|NCT03238781|470487043|FG001|Overall Study|Adverse Event|1|||
130689212|NCT03238781|470487044|FG002|Overall Study|Adverse Event|2|||
130689213|NCT03238781|470487042|FG000|Overall Study|Lost to Follow-up|2|||
130689214|NCT03238781|470487043|FG001|Overall Study|Lost to Follow-up|1|||
130689215|NCT03238781|470487044|FG002|Overall Study|Lost to Follow-up|2|||
130689216|NCT03238781|470487042|FG000|Overall Study|Withdrawal by Subject|23|||
130689217|NCT03238781|470487043|FG001|Overall Study|Withdrawal by Subject|14|||
130689218|NCT03238781|470487044|FG002|Overall Study|Withdrawal by Subject|16|||
130689219|NCT03238781|470487042|FG000|Overall Study|Decision by sponsor|0|||
130689220|NCT03238781|470487043|FG001|Overall Study|Decision by sponsor|1|||
130689221|NCT03238781|470487044|FG002|Overall Study|Decision by sponsor|0|||
130689222|NCT00811655|470487057|FG000|Overall Study|Physician Decision|1|||
130689223|NCT00813592|470487058|FG000|Overall Study|Disease assessment was not completed per|2|||
130689224|NCT02820350|470487061|FG000|Overall Study|Withdrawal by Subject|3|||
130689225|NCT02820350|470487061|FG000|Overall Study|Death|4|||
130689271|NCT04299087|470488551|FG000|Overall Study|Lost to Follow-up|2|||
130689272|NCT04299087|470488552|FG001|Overall Study|Lost to Follow-up|1|||
130689273|NCT00594035|470488553|FG000|Overall Study|Lost to Follow-up|1|||
130689274|NCT00594035|470488554|FG001|Overall Study|Lost to Follow-up|1|||
130689275|NCT00594035|470488553|FG000|Overall Study|Withdrawal by Subject|1|||
130689276|NCT00594035|470488554|FG001|Overall Study|Withdrawal by Subject|0|||
130689277|NCT00594035|470488553|FG000|Overall Study|Subject transferred to nursing home|0|||
130689278|NCT00594035|470488554|FG001|Overall Study|Subject transferred to nursing home|1|||
130689279|NCT00594035|470488553|FG000|Overall Study|Subject couldn't return due to job|0|||
130689280|NCT00594035|470488554|FG001|Overall Study|Subject couldn't return due to job|1|||
130689281|NCT00795821|470488555|FG000|Acute Treatment Phase|Adverse Event|23|||
130689282|NCT00795821|470488556|FG001|Acute Treatment Phase|Adverse Event|4|||
130689283|NCT00795821|470488555|FG000|Acute Treatment Phase|Death|1|||
130689284|NCT00795821|470488556|FG001|Acute Treatment Phase|Death|0|||
130689285|NCT00795821|470488555|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
130689286|NCT00795821|470488556|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
130689287|NCT00795821|470488555|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
130689288|NCT00795821|470488556|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
130689289|NCT00795821|470488555|FG000|Acute Treatment Phase|Physician Decision|1|||
130689290|NCT00795821|470488556|FG001|Acute Treatment Phase|Physician Decision|1|||
130689291|NCT00795821|470488555|FG000|Acute Treatment Phase|Protocol Violation|1|||
130689292|NCT00795821|470488556|FG001|Acute Treatment Phase|Protocol Violation|2|||
130689293|NCT00795821|470488555|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
130689294|NCT00795821|470488556|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
130689295|NCT00795821|470488555|FG000|Long-term Extension Phase|Adverse Event|25|||
130689296|NCT00795821|470488556|FG001|Long-term Extension Phase|Adverse Event|32|||
130689297|NCT00795821|470488555|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
130689298|NCT00795821|470488556|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
130689299|NCT00795821|470488555|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
130689300|NCT00795821|470488556|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
130689301|NCT00795821|470488555|FG000|Long-term Extension Phase|Physician Decision|1|||
130689302|NCT00795821|470488556|FG001|Long-term Extension Phase|Physician Decision|2|||
130689303|NCT00795821|470488555|FG000|Long-term Extension Phase|Protocol Violation|3|||
130689304|NCT00795821|470488556|FG001|Long-term Extension Phase|Protocol Violation|5|||
130689305|NCT00795821|470488555|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
130689306|NCT00795821|470488556|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
130689307|NCT00795821|470488555|FG000|Taper Phase|Adverse Event|2|||
130689308|NCT00795821|470488556|FG001|Taper Phase|Adverse Event|0|||
130689309|NCT00795821|470488555|FG000|Taper Phase|Lost to Follow-up|1|||
130689310|NCT00795821|470488556|FG001|Taper Phase|Lost to Follow-up|0|||
130689311|NCT00795821|470488555|FG000|Taper Phase|Physician Decision|2|||
130689312|NCT00795821|470488556|FG001|Taper Phase|Physician Decision|0|||
130689313|NCT00795821|470488555|FG000|Taper Phase|Withdrawal by Subject|4|||
130689314|NCT00795821|470488556|FG001|Taper Phase|Withdrawal by Subject|0|||
130689315|NCT03635320|470488567|FG000|Overall Study|not implanted the device|1|||
130689316|NCT03635320|470488568|FG001|Overall Study|not implanted the device|2|||
130689317|NCT03635320|470488567|FG000|Overall Study|Withdrawal by Subject|11|||
130689318|NCT03635320|470488568|FG001|Overall Study|Withdrawal by Subject|6|||
130689319|NCT03049748|470488575|FG000|Overall Study|Lost to Follow-up|1|||
130689320|NCT03049748|470488576|FG001|Overall Study|Lost to Follow-up|0|||
130689321|NCT03049748|470488575|FG000|Overall Study|Death|3|||
130689322|NCT03049748|470488576|FG001|Overall Study|Death|0|||
130689323|NCT03049748|470488575|FG000|Overall Study|Withdrawal by Subject|0|||
130689324|NCT03049748|470488576|FG001|Overall Study|Withdrawal by Subject|3|||
130689325|NCT03049748|470488575|FG000|Overall Study|Protocol Violation|0|||
130689326|NCT03049748|470488576|FG001|Overall Study|Protocol Violation|2|||
130689327|NCT03049748|470488575|FG000|Overall Study|Moved out of state (relocation)|0|||
130689328|NCT03049748|470488576|FG001|Overall Study|Moved out of state (relocation)|1|||
130689329|NCT03502811|470488579|FG000|Overall Study|Death|157|||
130689330|NCT03502811|470488579|FG000|Overall Study|Withdrawal by Subject|105|||
130689331|NCT03502811|470488579|FG000|Overall Study|Lost to Follow-up|26|||
130689332|NCT03502811|470488579|FG000|Overall Study|No Visits (Missed)|31|||
130689333|NCT01735994|470488580|FG000|Overall Study|Withdrawal by Subject|6|||
130689334|NCT01735994|470488581|FG001|Overall Study|Withdrawal by Subject|4|||
130689335|NCT01735994|470488580|FG000|Overall Study|Injury|2|||
130689336|NCT01735994|470488581|FG001|Overall Study|Injury|0|||
130689337|NCT01735994|470488580|FG000|Overall Study|Kicked off team|5|||
130689338|NCT01735994|470488581|FG001|Overall Study|Kicked off team|0|||
130689339|NCT01735994|470488580|FG000|Overall Study|Lost to Follow-up|50|||
130689340|NCT01735994|470488581|FG001|Overall Study|Lost to Follow-up|62|||
130689341|NCT00905840|470488584|FG000|Overall Study|Lost to Follow-up|11|||
130689342|NCT00905840|470488584|FG000|Overall Study|Death|3|||
130689343|NCT00905840|470488584|FG000|Overall Study|Withdrawal by Subject|1|||
130689344|NCT00905840|470488584|FG000|Overall Study|Adverse Event|1|||
130689345|NCT03496623|470488585|FG000|Run-In Period (2 Weeks)|Death|1|||
130689346|NCT03496623|470488586|FG001|Run-In Period (2 Weeks)|Death|0|||
130689347|NCT03496623|470488587|FG002|Run-In Period (2 Weeks)|Death|0|||
130689348|NCT03496623|470488588|FG003|Run-In Period (2 Weeks)|Death|0|||
130689349|NCT03496623|470488589|FG004|Run-In Period (2 Weeks)|Death|0|||
130689350|NCT03496623|470488585|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
130689351|NCT03496623|470488586|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130689352|NCT03496623|470488587|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130689353|NCT03496623|470488588|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130689354|NCT03496623|470488589|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130689355|NCT03496623|470488585|FG000|Period 1 (12 Weeks)|Death|0|||
130689356|NCT03496623|470488586|FG001|Period 1 (12 Weeks)|Death|3|||
130689357|NCT03496623|470488587|FG002|Period 1 (12 Weeks)|Death|0|||
130689358|NCT03496623|470488588|FG003|Period 1 (12 Weeks)|Death|0|||
130689359|NCT03496623|470488589|FG004|Period 1 (12 Weeks)|Death|0|||
130689360|NCT03496623|470488585|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
130689361|NCT03496623|470488586|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
130689362|NCT03496623|470488587|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
130689363|NCT03496623|470488588|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
130689364|NCT03496623|470488589|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
130689365|NCT03496623|470488585|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130689366|NCT03496623|470488586|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
130689367|NCT03496623|470488587|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
130689368|NCT03496623|470488588|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130689369|NCT03496623|470488589|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130689370|NCT03496623|470488585|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
130689371|NCT03496623|470488586|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
130689372|NCT03496623|470488587|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
130689373|NCT03496623|470488588|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
130689374|NCT03496623|470488589|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
130689375|NCT03496623|470488585|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130689376|NCT03496623|470488586|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130689377|NCT03496623|470488587|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
130689378|NCT03496623|470488588|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130689379|NCT03496623|470488589|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130689380|NCT03496623|470488585|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130689381|NCT03496623|470488586|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130689382|NCT03496623|470488587|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
130689383|NCT03496623|470488588|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130689384|NCT03496623|470488589|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130689385|NCT03496623|470488585|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130689386|NCT03496623|470488586|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
130689387|NCT03496623|470488587|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130689388|NCT03496623|470488588|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130689389|NCT03496623|470488589|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130689390|NCT01527006|470488593|FG000|Core Study|Adverse Event|0|||
130689391|NCT01527006|470488594|FG001|Core Study|Adverse Event|2|||
130689392|NCT01527006|470488593|FG000|Core Study|Lost to Follow-up|0|||
130894029|NCT02152956|471245469|FG009|Overall Study|Physician Decision|0|||
130894030|NCT02152956|471245470|FG010|Overall Study|Physician Decision|0|||
130689393|NCT01527006|470488594|FG001|Core Study|Lost to Follow-up|1|||
130689394|NCT01527006|470488593|FG000|Core Study|Subject Choice|1|||
130689395|NCT01527006|470488594|FG001|Core Study|Subject Choice|0|||
130689396|NCT01527006|470488593|FG000|Core Study|Inadequate Therapeutic Effect|1|||
130689397|NCT01527006|470488594|FG001|Core Study|Inadequate Therapeutic Effect|0|||
130689398|NCT01527006|470488593|FG000|Core Study|Withdrawal by Subject|0|||
130689399|NCT01527006|470488594|FG001|Core Study|Withdrawal by Subject|1|||
130689400|NCT01527006|470488593|FG000|Core Study|Other|0|||
130689401|NCT01527006|470488594|FG001|Core Study|Other|2|||
130689402|NCT01527006|470488593|FG000|Extension Phase|Adverse Event|4|||
130689403|NCT01527006|470488594|FG001|Extension Phase|Adverse Event|2|||
130689404|NCT01527006|470488593|FG000|Extension Phase|Lost to Follow-up|0|||
130689405|NCT01527006|470488594|FG001|Extension Phase|Lost to Follow-up|1|||
130689406|NCT01527006|470488593|FG000|Extension Phase|Subject Choice|1|||
130689407|NCT01527006|470488594|FG001|Extension Phase|Subject Choice|1|||
130689408|NCT01527006|470488593|FG000|Extension Phase|Inadequate therapeutic effect|1|||
130689409|NCT01527006|470488594|FG001|Extension Phase|Inadequate therapeutic effect|1|||
130689410|NCT01527006|470488593|FG000|Extension Phase|Other|0|||
130689411|NCT01527006|470488594|FG001|Extension Phase|Other|3|||
130689412|NCT00123734|470488595|FG000|Overall Study|Death|3|||
130767371|NCT00553358|470772376|FG001|Overall Study|Died after clinical follow-up ended|2|||
130689413|NCT00123734|470488595|FG000|Overall Study|Lost to Follow-up|3|||
130767372|NCT00553358|470772377|FG002|Overall Study|Died after clinical follow-up ended|0|||
130767373|NCT00553358|470772375|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
130767374|NCT00553358|470772376|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
130767375|NCT00553358|470772377|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
130767376|NCT01133288|470772378|FG000|Eligibility Assessment|met exclusion criteria|5|||
130767377|NCT01133288|470772378|FG000|Intervention Allocation|study terminated|2|||
130767378|NCT05268016|470772380|FG000|Overall Study|Unacceptable toxicity or AE|2|||
130767379|NCT05268016|470772381|FG001|Overall Study|Unacceptable toxicity or AE|2|||
130767380|NCT05268016|470772382|FG002|Overall Study|Unacceptable toxicity or AE|4|||
130767381|NCT05268016|470772383|FG003|Overall Study|Unacceptable toxicity or AE|3|||
130767382|NCT05268016|470772384|FG004|Overall Study|Unacceptable toxicity or AE|1|||
130767383|NCT05268016|470772380|FG000|Overall Study|Withdrawal by Subject|1|||
130767384|NCT05268016|470772381|FG001|Overall Study|Withdrawal by Subject|3|||
130767385|NCT05268016|470772382|FG002|Overall Study|Withdrawal by Subject|2|||
130767386|NCT05268016|470772383|FG003|Overall Study|Withdrawal by Subject|2|||
130767387|NCT05268016|470772384|FG004|Overall Study|Withdrawal by Subject|1|||
130767388|NCT05268016|470772380|FG000|Overall Study|Lost to Follow-up|4|||
130767389|NCT05268016|470772381|FG001|Overall Study|Lost to Follow-up|7|||
130767390|NCT05268016|470772382|FG002|Overall Study|Lost to Follow-up|1|||
130767391|NCT05268016|470772383|FG003|Overall Study|Lost to Follow-up|3|||
130767392|NCT05268016|470772384|FG004|Overall Study|Lost to Follow-up|5|||
130767393|NCT05268016|470772380|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
130767394|NCT05268016|470772381|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
130767395|NCT05268016|470772382|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
130767396|NCT05268016|470772383|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
130767397|NCT05268016|470772384|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
130767398|NCT05268016|470772380|FG000|Overall Study|Lack of Efficacy|0|||
130767399|NCT05268016|470772381|FG001|Overall Study|Lack of Efficacy|0|||
130767400|NCT05268016|470772382|FG002|Overall Study|Lack of Efficacy|0|||
130767401|NCT05268016|470772383|FG003|Overall Study|Lack of Efficacy|0|||
130767402|NCT05268016|470772384|FG004|Overall Study|Lack of Efficacy|4|||
130767403|NCT05268016|470772380|FG000|Overall Study|Physician Decision|0|||
130767404|NCT05268016|470772381|FG001|Overall Study|Physician Decision|0|||
130767405|NCT05268016|470772382|FG002|Overall Study|Physician Decision|0|||
130767406|NCT05268016|470772383|FG003|Overall Study|Physician Decision|1|||
130894031|NCT02152956|471245471|FG011|Overall Study|Physician Decision|1|||
130689414|NCT00123734|470488595|FG000|Overall Study|Dropout|1|||
130689415|NCT00123734|470488595|FG000|Overall Study|Withdrawal by Subject|1|||
130689416|NCT00834340|470488596|FG000|Washout|Adverse Event|1|||
130689417|NCT00834340|470488597|FG001|Washout|Adverse Event|0|||
130689418|NCT00834340|470488596|FG000|Washout|Withdrawal by Subject|1|||
130689419|NCT00834340|470488597|FG001|Washout|Withdrawal by Subject|0|||
130689420|NCT04238754|470488603|FG000|Washout - 1 Week|Lost to Follow-up|1|||
130689421|NCT04238754|470488604|FG001|Washout - 1 Week|Lost to Follow-up|0|||
130689422|NCT00840073|470488608|FG000|Second Intervention|Missed 72 hour blood draw|1|||
130689423|NCT00840073|470488609|FG001|Second Intervention|Missed 72 hour blood draw|1|||
130689424|NCT01103713|470488613|FG000|Overall Study|Lost to Follow-up|2|||
130894032|NCT02152956|471245472|FG012|Overall Study|Physician Decision|0|||
131111359|NCT01231516|472037719|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
131111360|NCT01231516|472037720|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
131111361|NCT01231516|472037719|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
131111362|NCT01231516|472037720|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
131111363|NCT01231516|472037719|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
131111364|NCT01231516|472037720|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
131111365|NCT01231516|472037719|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
131111366|NCT01231516|472037720|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
131111367|NCT03170154|472037721|FG000|Overall Study|Lost to Follow-up|4|||
131111368|NCT03170154|472037721|FG000|Overall Study|Death|2|||
131111369|NCT03170154|472037721|FG000|Overall Study|Withdrawal by Subject|2|||
131111370|NCT05266586|472037722|FG000|Overall Study|Adverse Event|2|||
131111371|NCT05266586|472037723|FG001|Overall Study|Adverse Event|2|||
131111372|NCT05266586|472037724|FG002|Overall Study|Adverse Event|1|||
131111373|NCT05266586|472037722|FG000|Overall Study|Withdrawal by Subject|1|||
131111374|NCT05266586|472037723|FG001|Overall Study|Withdrawal by Subject|0|||
131111375|NCT05266586|472037724|FG002|Overall Study|Withdrawal by Subject|1|||
131111376|NCT05266586|472037722|FG000|Overall Study|Non-compliance with study drug|0|||
131111377|NCT05266586|472037723|FG001|Overall Study|Non-compliance with study drug|1|||
131111378|NCT05266586|472037724|FG002|Overall Study|Non-compliance with study drug|0|||
131111379|NCT05266586|472037722|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
131111380|NCT05266586|472037723|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
131111381|NCT05266586|472037724|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
131111382|NCT01117857|472037725|FG000|Overall Study|Lost to Follow-up|4|||
131111383|NCT01117857|472037725|FG000|Overall Study|Withdrawal by Subject|4|||
131111384|NCT01117857|472037725|FG000|Overall Study|Physician Decision|1|||
131111385|NCT00633061|472037726|FG000|Overall Study|Study closed|86|||
131111386|NCT00633061|472037727|FG001|Overall Study|Study closed|0|||
131111387|NCT05245097|472037728|FG000|Overall Study|Adverse Event|13|||
131111388|NCT05245097|472037729|FG001|Overall Study|Adverse Event|2|||
131111389|NCT05245097|472037728|FG000|Overall Study|Protocol Violation|8|||
131111390|NCT05245097|472037729|FG001|Overall Study|Protocol Violation|6|||
131111391|NCT05245097|472037728|FG000|Overall Study|Withdrawal by Subject|18|||
131111392|NCT05245097|472037729|FG001|Overall Study|Withdrawal by Subject|0|||
131111393|NCT05245097|472037728|FG000|Overall Study|Death|6|||
131111394|NCT05245097|472037729|FG001|Overall Study|Death|7|||
131111395|NCT05245097|472037728|FG000|Overall Study|Physician Decision|6|||
131111396|NCT05245097|472037729|FG001|Overall Study|Physician Decision|0|||
131111397|NCT05245097|472037728|FG000|Overall Study|Relocation|4|||
131111398|NCT05245097|472037729|FG001|Overall Study|Relocation|3|||
131111399|NCT00607022|472037737|FG000|Overall Study|Withdrawal by Subject|1|||
131111400|NCT00607022|472037738|FG001|Overall Study|Withdrawal by Subject|0|||
131111401|NCT00607022|472037739|FG002|Overall Study|Withdrawal by Subject|0|||
131111402|NCT02730598|472037742|FG000|Overall Study|Withdrawal by Subject|3|||
131111403|NCT02730598|472037743|FG001|Overall Study|Withdrawal by Subject|3|||
131111404|NCT02730598|472037742|FG000|Overall Study|Protocol Violation|0|||
131111405|NCT02730598|472037743|FG001|Overall Study|Protocol Violation|1|||
131111406|NCT02730598|472037742|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
130689425|NCT01103713|470488613|FG000|Overall Study|Withdrawal by Subject|8|||
130689426|NCT01103713|470488613|FG000|Overall Study|Study terminated by sponsor|2|||
130689427|NCT01103713|470488613|FG000|Overall Study|Other|1|||
130689428|NCT03084471|470488616|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
130689429|NCT03084471|470488616|FG000|Overall Study|Condition under investigation worsened|84|||
130689430|NCT03084471|470488616|FG000|Overall Study|Lack of therapeutic response|2|||
130689431|NCT03084471|470488616|FG000|Overall Study|Protocol Violation|1|||
130689432|NCT03084471|470488616|FG000|Overall Study|Adverse Event|73|||
130689433|NCT03084471|470488616|FG000|Overall Study|Withdrawal by Subject|12|||
130689434|NCT03084471|470488616|FG000|Overall Study|Disease relapse|181|||
130689435|NCT03084471|470488616|FG000|Overall Study|Subjective disease progression|359|||
130689436|NCT03084471|470488616|FG000|Overall Study|Other (as recorded)|33|||
130689437|NCT03084471|470488616|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
130894033|NCT02152956|471245460|FG000|Overall Study|Study terminated by sponsor|0|||
131111407|NCT02730598|472037743|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
131111408|NCT03282240|472037744|FG000|Overall Study|Adverse Event|2|||
131111409|NCT03282240|472037745|FG001|Overall Study|Adverse Event|2|||
130689438|NCT00505622|470488619|FG000|Overall Study|Adverse Event|5|||
130767407|NCT05268016|470772384|FG004|Overall Study|Physician Decision|0|||
130894034|NCT02152956|471245461|FG001|Overall Study|Study terminated by sponsor|0|||
131111410|NCT03282240|472037746|FG002|Overall Study|Adverse Event|0|||
131111411|NCT03282240|472037744|FG000|Overall Study|Lost to Follow-up|3|||
131111412|NCT03282240|472037745|FG001|Overall Study|Lost to Follow-up|0|||
131111413|NCT03282240|472037746|FG002|Overall Study|Lost to Follow-up|0|||
131111414|NCT03282240|472037744|FG000|Overall Study|Protocol Deviation|4|||
130689439|NCT00505622|470488620|FG001|Overall Study|Adverse Event|6|||
130689440|NCT00505622|470488621|FG002|Overall Study|Adverse Event|4|||
130689441|NCT00505622|470488619|FG000|Overall Study|Protocol Violation|1|||
130689442|NCT00505622|470488620|FG001|Overall Study|Protocol Violation|1|||
130689443|NCT00505622|470488621|FG002|Overall Study|Protocol Violation|0|||
130689444|NCT00505622|470488619|FG000|Overall Study|Withdrawal by Subject|0|||
130689445|NCT00505622|470488620|FG001|Overall Study|Withdrawal by Subject|3|||
130689446|NCT00505622|470488621|FG002|Overall Study|Withdrawal by Subject|2|||
130689447|NCT00505622|470488619|FG000|Overall Study|Study termination by sponsor|115|||
130689448|NCT00505622|470488620|FG001|Overall Study|Study termination by sponsor|98|||
130689449|NCT00505622|470488621|FG002|Overall Study|Study termination by sponsor|90|||
130689450|NCT00796653|470488622|FG000|Overall Study|Adverse Event|19|||
130689451|NCT00796653|470488623|FG001|Overall Study|Adverse Event|16|||
130689452|NCT00796653|470488624|FG002|Overall Study|Adverse Event|16|||
130689453|NCT00796653|470488625|FG003|Overall Study|Adverse Event|16|||
130689454|NCT00796653|470488622|FG000|Overall Study|Lost to Follow-up|2|||
130689455|NCT00796653|470488623|FG001|Overall Study|Lost to Follow-up|1|||
130689456|NCT00796653|470488624|FG002|Overall Study|Lost to Follow-up|2|||
130689457|NCT00796653|470488625|FG003|Overall Study|Lost to Follow-up|3|||
130689458|NCT00796653|470488622|FG000|Overall Study|Withdrawal by Subject|16|||
130689459|NCT00796653|470488623|FG001|Overall Study|Withdrawal by Subject|8|||
130689460|NCT00796653|470488624|FG002|Overall Study|Withdrawal by Subject|8|||
130689461|NCT00796653|470488625|FG003|Overall Study|Withdrawal by Subject|13|||
130689462|NCT00796653|470488622|FG000|Overall Study|Lack of Efficacy|8|||
130689463|NCT00796653|470488623|FG001|Overall Study|Lack of Efficacy|1|||
130689464|NCT00796653|470488624|FG002|Overall Study|Lack of Efficacy|3|||
130689465|NCT00796653|470488625|FG003|Overall Study|Lack of Efficacy|2|||
130689466|NCT00796653|470488622|FG000|Overall Study|Non compliance with protocol|2|||
130689467|NCT00796653|470488623|FG001|Overall Study|Non compliance with protocol|2|||
130689468|NCT00796653|470488624|FG002|Overall Study|Non compliance with protocol|0|||
130689469|NCT00796653|470488625|FG003|Overall Study|Non compliance with protocol|2|||
130689470|NCT00796653|470488622|FG000|Overall Study|Other reason not described above|4|||
130689471|NCT00796653|470488623|FG001|Overall Study|Other reason not described above|9|||
130689472|NCT00796653|470488624|FG002|Overall Study|Other reason not described above|7|||
130689473|NCT00796653|470488625|FG003|Overall Study|Other reason not described above|4|||
130689474|NCT01848938|470488636|FG000|Overall Study|Lost to Follow-up|1|||
130689475|NCT01848938|470488637|FG001|Overall Study|Lost to Follow-up|1|||
130689476|NCT01757392|470488638|FG000|Overall Study|Withdrawal by Subject|1|||
130689477|NCT01757392|470488638|FG000|Overall Study|Screen Fail|3|||
130689478|NCT00207090|470488643|FG000|Overall Study|Study drug toxicity|3|||
130689479|NCT00207090|470488643|FG000|Overall Study|Chest wall mass larger|1|||
130689480|NCT00207090|470488643|FG000|Overall Study|Disease progression/relapse|2|||
130689481|NCT00207090|470488643|FG000|Overall Study|Physician Decision|1|||
130689482|NCT00841698|470488646|FG000|First Intervention|Withdrawal by Subject|1|||
130689483|NCT00841698|470488647|FG001|First Intervention|Withdrawal by Subject|0|||
130689484|NCT00651820|470488658|FG000|Overall Study|Lost to Follow-up|2|||
130689485|NCT01878292|470488660|FG000|Randomized|Protocol Violation|1|||
130689486|NCT01878292|470488661|FG001|Randomized|Protocol Violation|0|||
130689487|NCT01878292|470488662|FG002|Randomized|Protocol Violation|0|||
130689488|NCT01878292|470488660|FG000|Randomized|Lost to Follow-up|1|||
130689489|NCT01878292|470488661|FG001|Randomized|Lost to Follow-up|0|||
130689490|NCT01878292|470488662|FG002|Randomized|Lost to Follow-up|0|||
130689491|NCT01878292|470488660|FG000|Randomized|Adverse Event|1|||
130689492|NCT01878292|470488661|FG001|Randomized|Adverse Event|0|||
130689493|NCT01878292|470488662|FG002|Randomized|Adverse Event|0|||
130689494|NCT01878292|470488660|FG000|Double-blind Treatment Period|Other Reasons|2|||
130689495|NCT01878292|470488661|FG001|Double-blind Treatment Period|Other Reasons|0|||
130689496|NCT01878292|470488662|FG002|Double-blind Treatment Period|Other Reasons|0|||
130689497|NCT01878292|470488660|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
130689498|NCT01878292|470488661|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
130689499|NCT01878292|470488662|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
130689500|NCT01878292|470488660|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
130689501|NCT01878292|470488661|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
130689502|NCT01878292|470488662|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
130689503|NCT01878292|470488660|FG000|Double-blind Treatment Period|Protocol Violation|3|||
130767408|NCT05268016|470772380|FG000|Overall Study|Other|1|||
130689504|NCT01878292|470488661|FG001|Double-blind Treatment Period|Protocol Violation|4|||
130689505|NCT01878292|470488662|FG002|Double-blind Treatment Period|Protocol Violation|2|||
130689506|NCT01878292|470488660|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
130689507|NCT01878292|470488661|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
130689508|NCT01878292|470488662|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
130689509|NCT01878292|470488660|FG000|Double-blind Treatment Period|Adverse Event|4|||
130689510|NCT01878292|470488661|FG001|Double-blind Treatment Period|Adverse Event|9|||
130689511|NCT01878292|470488662|FG002|Double-blind Treatment Period|Adverse Event|8|||
130689512|NCT01878292|470488660|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
130767409|NCT05268016|470772381|FG001|Overall Study|Other|0|||
130689513|NCT01878292|470488661|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
130689514|NCT01878292|470488662|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
130689515|NCT00773253|470488663|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
130689516|NCT00773253|470488664|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
130689517|NCT01302548|470488669|FG000|Overall Study|Lost to Follow-up|2|||
130689518|NCT01302548|470488670|FG001|Overall Study|Lost to Follow-up|1|||
130689519|NCT01249651|470488672|FG000|Overall Study|Withdrawal by Subject|4|||
130689520|NCT01249651|470488672|FG000|Overall Study|Adverse Event|1|||
130689521|NCT01249651|470488672|FG000|Overall Study|Protocol Violation|1|||
130689522|NCT01249651|470488672|FG000|Overall Study|Sponsor Decision|1|||
130689523|NCT03801707|470488677|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
130689524|NCT03873272|470488678|FG000|Overall Study|Withdrawal by Subject|2|||
130689525|NCT03873272|470488679|FG001|Overall Study|Withdrawal by Subject|0|||
130689526|NCT03873272|470488680|FG002|Overall Study|Withdrawal by Subject|1|||
130689527|NCT03873272|470488678|FG000|Overall Study|Death|0|||
130689528|NCT03873272|470488679|FG001|Overall Study|Death|2|||
130689529|NCT03873272|470488680|FG002|Overall Study|Death|1|||
130689530|NCT00787254|470488681|FG000|Overall Study|Adverse Event|24|||
130689531|NCT00787254|470488682|FG001|Overall Study|Adverse Event|23|||
130689532|NCT00787254|470488681|FG000|Overall Study|Protocol Violation|26|||
130689533|NCT00787254|470488682|FG001|Overall Study|Protocol Violation|23|||
130689534|NCT00787254|470488681|FG000|Overall Study|Withdrawal by Subject|16|||
130689535|NCT00787254|470488682|FG001|Overall Study|Withdrawal by Subject|11|||
130689536|NCT00787254|470488681|FG000|Overall Study|Lack of Efficacy|4|||
130689537|NCT00787254|470488682|FG001|Overall Study|Lack of Efficacy|15|||
130689538|NCT00787254|470488681|FG000|Overall Study|NSAIDs discontinuation|1|||
130689539|NCT00787254|470488682|FG001|Overall Study|NSAIDs discontinuation|2|||
130689540|NCT00787254|470488681|FG000|Overall Study|Institution closed|1|||
130689541|NCT00787254|470488682|FG001|Overall Study|Institution closed|0|||
130689542|NCT00787254|470488681|FG000|Overall Study|Physician Decision|4|||
130689543|NCT00787254|470488682|FG001|Overall Study|Physician Decision|8|||
130689544|NCT00859430|470488683|FG000|First Intervention|Withdrawal by Subject|0|||
130689545|NCT00859430|470488684|FG001|First Intervention|Withdrawal by Subject|1|||
130689546|NCT04115293|470491186|FG000|Overall Study|Adverse Event|0|||
130689547|NCT04115293|470491187|FG001|Overall Study|Adverse Event|2|||
130689548|NCT04115293|470491186|FG000|Overall Study|Withdrawal by Subject|2|||
130689549|NCT04115293|470491187|FG001|Overall Study|Withdrawal by Subject|1|||
130689550|NCT04115293|470491186|FG000|Overall Study|Physician Decision|1|||
130689551|NCT04115293|470491187|FG001|Overall Study|Physician Decision|0|||
130689552|NCT04115293|470491186|FG000|Overall Study|Death|1|||
130689553|NCT04115293|470491187|FG001|Overall Study|Death|1|||
130689554|NCT00001703|470491188|FG000|Overall Study|progressed disease|2|||
130689555|NCT00001703|470491188|FG000|Overall Study|No evidence of disease|1|||
130689556|NCT00001703|470491188|FG000|Overall Study|recurrent disease|2|||
130689557|NCT02057835|470491189|FG000|Overall Study|Withdrawal by Subject|0|||
130689558|NCT02057835|470491190|FG001|Overall Study|Withdrawal by Subject|2|||
130689559|NCT02057835|470491191|FG002|Overall Study|Withdrawal by Subject|0|||
130689560|NCT02057835|470491192|FG003|Overall Study|Withdrawal by Subject|0|||
130689561|NCT02057835|470491193|FG004|Overall Study|Withdrawal by Subject|0|||
130689562|NCT02057835|470491194|FG005|Overall Study|Withdrawal by Subject|0|||
130689563|NCT02057835|470491195|FG006|Overall Study|Withdrawal by Subject|0|||
130689564|NCT02057835|470491196|FG007|Overall Study|Withdrawal by Subject|0|||
130689565|NCT02057835|470491197|FG008|Overall Study|Withdrawal by Subject|0|||
130689566|NCT02057835|470491198|FG009|Overall Study|Withdrawal by Subject|0|||
130689567|NCT01660243|470491199|FG000|Overall Study|Adverse Event|1|||
130689568|NCT01660243|470491200|FG001|Overall Study|Adverse Event|0|||
130689569|NCT01660243|470491201|FG002|Overall Study|Adverse Event|1|||
130689570|NCT01660243|470491202|FG003|Overall Study|Adverse Event|0|||
130689571|NCT01660243|470491199|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
130689572|NCT01660243|470491200|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
130689573|NCT01660243|470491201|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
130689574|NCT01660243|470491202|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
131025356|NCT01747486|471723240|FG000|Stage 2|Disease Progression|3|||
130689575|NCT01660243|470491199|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
130689576|NCT01660243|470491200|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
130689577|NCT01660243|470491201|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
130689578|NCT01660243|470491202|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
130689579|NCT01660243|470491199|FG000|Overall Study|Randomization error|0|||
130689580|NCT01660243|470491200|FG001|Overall Study|Randomization error|0|||
130689581|NCT01660243|470491201|FG002|Overall Study|Randomization error|0|||
130689582|NCT01660243|470491202|FG003|Overall Study|Randomization error|1|||
131025357|NCT01747486|471723241|FG001|Stage 2|Disease Progression|0|||
130689583|NCT00712959|470491203|FG000|Overall Study|Protocol Violation|3|||
130689584|NCT00712959|470491204|FG001|Overall Study|Protocol Violation|1|||
130689585|NCT00712959|470491203|FG000|Overall Study|Lost to Follow-up|13|||
130689586|NCT00712959|470491204|FG001|Overall Study|Lost to Follow-up|2|||
130689587|NCT00712959|470491203|FG000|Overall Study|Withdrawal by Subject|3|||
130689588|NCT00712959|470491204|FG001|Overall Study|Withdrawal by Subject|0|||
130689589|NCT00508651|470491205|FG000|Overall Study|Lost to Follow-up|3|||
130689590|NCT00508651|470491206|FG001|Overall Study|Lost to Follow-up|1|||
130689591|NCT00508651|470491205|FG000|Overall Study|Withdrawal by Subject|1|||
130689592|NCT00508651|470491206|FG001|Overall Study|Withdrawal by Subject|1|||
130689593|NCT02301975|470491213|FG000|Overall Study|Adverse Event|8|||
130689594|NCT02301975|470491214|FG001|Overall Study|Adverse Event|3|||
130689595|NCT02301975|470491215|FG002|Overall Study|Adverse Event|2|||
130689596|NCT02301975|470491213|FG000|Overall Study|Lack of Efficacy|1|||
130689597|NCT02301975|470491214|FG001|Overall Study|Lack of Efficacy|1|||
130689598|NCT02301975|470491215|FG002|Overall Study|Lack of Efficacy|1|||
130689599|NCT02301975|470491213|FG000|Overall Study|Protocol Violation|3|||
130689600|NCT02301975|470491214|FG001|Overall Study|Protocol Violation|5|||
130689601|NCT02301975|470491215|FG002|Overall Study|Protocol Violation|3|||
130689602|NCT02301975|470491213|FG000|Overall Study|Lost to Follow-up|0|||
130689603|NCT02301975|470491214|FG001|Overall Study|Lost to Follow-up|2|||
130689604|NCT02301975|470491215|FG002|Overall Study|Lost to Follow-up|2|||
130689605|NCT02301975|470491213|FG000|Overall Study|Physician Decision|4|||
130689606|NCT02301975|470491214|FG001|Overall Study|Physician Decision|2|||
130689607|NCT02301975|470491215|FG002|Overall Study|Physician Decision|3|||
130689608|NCT02301975|470491213|FG000|Overall Study|Withdrawal by Subject|15|||
130689609|NCT02301975|470491214|FG001|Overall Study|Withdrawal by Subject|12|||
130689610|NCT02301975|470491215|FG002|Overall Study|Withdrawal by Subject|11|||
130689611|NCT03733730|470491216|FG000|Overall Study|Lost to Follow-up|1|||
130689612|NCT03733730|470491217|FG001|Overall Study|Lost to Follow-up|32|||
130689613|NCT03733730|470491216|FG000|Overall Study|Other|1|||
130689614|NCT03733730|470491217|FG001|Overall Study|Other|0|||
130689615|NCT03733730|470491216|FG000|Overall Study|Adverse Event|0|||
130689616|NCT03733730|470491217|FG001|Overall Study|Adverse Event|4|||
130689617|NCT03733730|470491216|FG000|Overall Study|Death|0|||
130689618|NCT03733730|470491217|FG001|Overall Study|Death|5|||
130689619|NCT03733730|470491216|FG000|Overall Study|Withdrawal by Subject|0|||
130689620|NCT03733730|470491217|FG001|Overall Study|Withdrawal by Subject|8|||
130689621|NCT01531894|470491218|FG000|Overall Study|Physician Decision|8|||
130689622|NCT01531894|470491218|FG000|Overall Study|Death|1|||
130689623|NCT03086460|470491219|FG000|Study Participants|Lost to Follow-up|2|||
130689624|NCT03086460|470491219|FG000|Study Participants|Protocol Violation|1|||
130689625|NCT03086460|470491219|FG000|Study Participants|Withdrawal by Subject|6|||
130689626|NCT03086460|470491219|FG000|Treatment A|Lost to Follow-up|1|||
130689627|NCT03086460|470491219|FG000|Treatment A|Protocol Violation|1|||
130689628|NCT03086460|470491219|FG000|Treatment A|Withdrawal by Subject|2|||
131025358|NCT01771731|471723242|FG000|Overall Study|Physician Decision|1|||
131025359|NCT01771731|471723243|FG001|Overall Study|Physician Decision|0|||
131025360|NCT01771731|471723242|FG000|Overall Study|Protocol Violation|0|||
131025361|NCT01771731|471723243|FG001|Overall Study|Protocol Violation|1|||
131025362|NCT01771731|471723242|FG000|Overall Study|Adverse event: Pain Crisis|1|||
131025363|NCT01771731|471723243|FG001|Overall Study|Adverse event: Pain Crisis|1|||
131025364|NCT00087139|471723244|FG000|Overall Study|Adverse Event|18|||
131025365|NCT00087139|471723245|FG001|Overall Study|Adverse Event|17|||
131025366|NCT00087139|471723246|FG002|Overall Study|Adverse Event|13|||
131025367|NCT00087139|471723244|FG000|Overall Study|Death|2|||
131025368|NCT00087139|471723245|FG001|Overall Study|Death|1|||
131025369|NCT00087139|471723246|FG002|Overall Study|Death|0|||
131025370|NCT00087139|471723244|FG000|Overall Study|Withdrawal by Subject|3|||
131025371|NCT00087139|471723245|FG001|Overall Study|Withdrawal by Subject|2|||
131025372|NCT00087139|471723246|FG002|Overall Study|Withdrawal by Subject|2|||
131025373|NCT00087139|471723244|FG000|Overall Study|Physician Decision|1|||
131025374|NCT00087139|471723245|FG001|Overall Study|Physician Decision|1|||
131025375|NCT00087139|471723246|FG002|Overall Study|Physician Decision|1|||
131025376|NCT00087139|471723244|FG000|Overall Study|Disease progression|9|||
131025377|NCT00087139|471723245|FG001|Overall Study|Disease progression|19|||
131025378|NCT00087139|471723246|FG002|Overall Study|Disease progression|12|||
131025379|NCT00087139|471723244|FG000|Overall Study|Ineligible|4|||
130689629|NCT03086460|470491219|FG000|Treatment C|Withdrawal by Subject|2|||
130689630|NCT03086460|470491219|FG000|Treatment E|Lost to Follow-up|1|||
130689631|NCT03086460|470491219|FG000|Treatment E|Withdrawal by Subject|3|||
130689632|NCT00835575|470491220|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
130689633|NCT00835575|470491221|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
130689634|NCT01440803|470491222|FG000|Overall Study|Met study stopping rule|2|||
130689635|NCT01440803|470491223|FG001|Overall Study|Met study stopping rule|1|||
130689636|NCT01440803|470491222|FG000|Overall Study|Lost to Follow-up|0|||
130689637|NCT01440803|470491223|FG001|Overall Study|Lost to Follow-up|2|||
130689638|NCT01440803|470491222|FG000|Overall Study|Withdrawal by Subject|0|||
131025380|NCT00087139|471723245|FG001|Overall Study|Ineligible|7|||
131025381|NCT00087139|471723246|FG002|Overall Study|Ineligible|4|||
130689639|NCT01440803|470491223|FG001|Overall Study|Withdrawal by Subject|1|||
130689640|NCT03606174|470491224|FG000|Overall Study|Death|37|||
130689641|NCT03606174|470491225|FG001|Overall Study|Death|15|||
130689642|NCT03606174|470491226|FG002|Overall Study|Death|15|||
130689643|NCT03606174|470491227|FG003|Overall Study|Death|7|||
130689644|NCT03606174|470491228|FG004|Overall Study|Death|35|||
130689645|NCT03606174|470491229|FG005|Overall Study|Death|12|||
130689646|NCT03606174|470491230|FG006|Overall Study|Death|35|||
130689647|NCT03606174|470491231|FG007|Overall Study|Death|8|||
130689648|NCT03606174|470491232|FG008|Overall Study|Death|5|||
130689649|NCT03606174|470491233|FG009|Overall Study|Death|3|||
130689650|NCT03606174|470491234|FG010|Overall Study|Death|0|||
130689651|NCT03606174|470491224|FG000|Overall Study|Lost to Follow-up|0|||
130689652|NCT03606174|470491225|FG001|Overall Study|Lost to Follow-up|0|||
130689653|NCT03606174|470491226|FG002|Overall Study|Lost to Follow-up|0|||
130689654|NCT03606174|470491227|FG003|Overall Study|Lost to Follow-up|0|||
130689655|NCT03606174|470491228|FG004|Overall Study|Lost to Follow-up|1|||
130689656|NCT03606174|470491229|FG005|Overall Study|Lost to Follow-up|1|||
130689657|NCT03606174|470491230|FG006|Overall Study|Lost to Follow-up|0|||
130689658|NCT03606174|470491231|FG007|Overall Study|Lost to Follow-up|0|||
130689659|NCT03606174|470491232|FG008|Overall Study|Lost to Follow-up|0|||
130689660|NCT03606174|470491233|FG009|Overall Study|Lost to Follow-up|0|||
131111415|NCT03282240|472037745|FG001|Overall Study|Protocol Deviation|1|||
130689661|NCT03606174|470491234|FG010|Overall Study|Lost to Follow-up|0|||
130689662|NCT03606174|470491224|FG000|Overall Study|Withdrawal by Subject|6|||
130689663|NCT03606174|470491225|FG001|Overall Study|Withdrawal by Subject|0|||
130689664|NCT03606174|470491226|FG002|Overall Study|Withdrawal by Subject|0|||
130689665|NCT03606174|470491227|FG003|Overall Study|Withdrawal by Subject|1|||
130689666|NCT03606174|470491228|FG004|Overall Study|Withdrawal by Subject|2|||
130689667|NCT03606174|470491229|FG005|Overall Study|Withdrawal by Subject|1|||
130689668|NCT03606174|470491230|FG006|Overall Study|Withdrawal by Subject|4|||
130689669|NCT03606174|470491231|FG007|Overall Study|Withdrawal by Subject|0|||
130689670|NCT03606174|470491232|FG008|Overall Study|Withdrawal by Subject|0|||
130689671|NCT03606174|470491233|FG009|Overall Study|Withdrawal by Subject|0|||
130689672|NCT03606174|470491234|FG010|Overall Study|Withdrawal by Subject|1|||
130689673|NCT03606174|470491224|FG000|Overall Study|Study Terminated by Sponsor|5|||
130689674|NCT03606174|470491225|FG001|Overall Study|Study Terminated by Sponsor|7|||
130689675|NCT03606174|470491226|FG002|Overall Study|Study Terminated by Sponsor|3|||
130689676|NCT03606174|470491227|FG003|Overall Study|Study Terminated by Sponsor|0|||
130689677|NCT03606174|470491228|FG004|Overall Study|Study Terminated by Sponsor|11|||
130689678|NCT03606174|470491229|FG005|Overall Study|Study Terminated by Sponsor|6|||
130689679|NCT03606174|470491230|FG006|Overall Study|Study Terminated by Sponsor|12|||
130689680|NCT03606174|470491231|FG007|Overall Study|Study Terminated by Sponsor|1|||
130689681|NCT03606174|470491232|FG008|Overall Study|Study Terminated by Sponsor|3|||
130689682|NCT03606174|470491233|FG009|Overall Study|Study Terminated by Sponsor|1|||
130689683|NCT03606174|470491234|FG010|Overall Study|Study Terminated by Sponsor|2|||
130689684|NCT03606174|470491224|FG000|Overall Study|Miscellaneous|1|||
130689685|NCT03606174|470491225|FG001|Overall Study|Miscellaneous|1|||
130689686|NCT03606174|470491226|FG002|Overall Study|Miscellaneous|0|||
130689687|NCT03606174|470491227|FG003|Overall Study|Miscellaneous|1|||
130689688|NCT03606174|470491228|FG004|Overall Study|Miscellaneous|4|||
130689689|NCT03606174|470491229|FG005|Overall Study|Miscellaneous|7|||
130689690|NCT03606174|470491230|FG006|Overall Study|Miscellaneous|5|||
130689691|NCT03606174|470491231|FG007|Overall Study|Miscellaneous|0|||
130689692|NCT03606174|470491232|FG008|Overall Study|Miscellaneous|0|||
130689693|NCT03606174|470491233|FG009|Overall Study|Miscellaneous|0|||
130689694|NCT03606174|470491234|FG010|Overall Study|Miscellaneous|1|||
130689695|NCT01609257|470491235|FG000|Overall Study|Lost to Follow-up|2|||
130689696|NCT01609257|470491236|FG001|Overall Study|Lost to Follow-up|1|||
130689697|NCT01609257|470491235|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
130689698|NCT01609257|470491236|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
130689699|NCT01609257|470491235|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
130689700|NCT01609257|470491236|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
130689701|NCT02125461|470491237|FG000|Overall Study|Withdrawal by Subject|30|||
130689702|NCT02125461|470491238|FG001|Overall Study|Withdrawal by Subject|16|||
130689703|NCT02125461|470491237|FG000|Overall Study|Lost to Follow-up|8|||
130689704|NCT02125461|470491238|FG001|Overall Study|Lost to Follow-up|3|||
130689705|NCT02125461|470491237|FG000|Overall Study|Death|260|||
130689706|NCT02125461|470491238|FG001|Overall Study|Death|149|||
130689707|NCT02125461|470491237|FG000|Overall Study|Missing Termination Reason|0|||
130689708|NCT02125461|470491238|FG001|Overall Study|Missing Termination Reason|1|||
130689709|NCT01158118|470491240|FG000|Overall Study|Screen failure|1|||
130689710|NCT01158118|470491241|FG001|Overall Study|Screen failure|0|||
130689711|NCT01158118|470491240|FG000|Overall Study|Donor match was a screen failure|0|||
130689712|NCT01158118|470491241|FG001|Overall Study|Donor match was a screen failure|1|||
130689713|NCT01158118|470491240|FG000|Overall Study|Suffered stroke prior to transplant|0|||
130689714|NCT01158118|470491241|FG001|Overall Study|Suffered stroke prior to transplant|1|||
130689715|NCT01158118|470491240|FG000|Overall Study|Death|0|||
130689716|NCT01158118|470491241|FG001|Overall Study|Death|1|||
130689717|NCT04994535|470491242|FG000|Overall Study|Lost to Follow-up|7|||
130689718|NCT04994535|470491243|FG001|Overall Study|Lost to Follow-up|7|||
130689719|NCT04994535|470491242|FG000|Overall Study|Withdrawal by Subject|10|||
130689720|NCT04994535|470491243|FG001|Overall Study|Withdrawal by Subject|7|||
130689721|NCT04994535|470491242|FG000|Overall Study|Other|1|||
130689722|NCT04994535|470491243|FG001|Overall Study|Other|1|||
130689723|NCT00113386|470491246|FG000|Overall Study|Withdrawal by Subject|1|||
130689724|NCT00113386|470491247|FG001|Overall Study|Withdrawal by Subject|0|||
130689725|NCT00113386|470491246|FG000|Overall Study|Physician Decision|0|||
130689726|NCT00113386|470491247|FG001|Overall Study|Physician Decision|1|||
130689727|NCT00113386|470491246|FG000|Overall Study|Toxicity|3|||
130689728|NCT00113386|470491247|FG001|Overall Study|Toxicity|0|||
130689729|NCT00113386|470491246|FG000|Overall Study|Ineligible|1|||
130689730|NCT00113386|470491247|FG001|Overall Study|Ineligible|2|||
130689731|NCT00113386|470491246|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
130689732|NCT00113386|470491247|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
130689733|NCT00392665|470491248|FG000|Overall Study|Death|16|||
130689734|NCT00392665|470491249|FG001|Overall Study|Death|14|||
130689735|NCT00392665|470491248|FG000|Overall Study|Lost to Follow-up|1|||
130689736|NCT00392665|470491249|FG001|Overall Study|Lost to Follow-up|1|||
130689737|NCT04408794|470491252|FG000|Overall Study|Adverse Event|43|||
130689738|NCT04408794|470491252|FG000|Overall Study|Infrequent study drug usage|43|||
130689739|NCT04408794|470491252|FG000|Overall Study|Lack of Efficacy|61|||
130689740|NCT04408794|470491252|FG000|Overall Study|Lost to Follow-up|33|||
130689741|NCT04408794|470491252|FG000|Overall Study|Non-compliance|6|||
130689742|NCT04408794|470491252|FG000|Overall Study|Physician Decision|1|||
130689743|NCT04408794|470491252|FG000|Overall Study|Pregnancy|6|||
130689744|NCT04408794|470491252|FG000|Overall Study|Protocol Deviation|9|||
130689745|NCT04408794|470491252|FG000|Overall Study|Sheehan-STS Result|1|||
130689746|NCT04408794|470491252|FG000|Overall Study|Withdrawal by Subject|57|||
130689747|NCT04408794|470491252|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
130689748|NCT04408794|470491252|FG000|Overall Study|Never Treated Migraine|5|||
130689749|NCT02294786|470491257|FG000|Overall Study|Withdrawal by Subject|0|||
130689750|NCT02294786|470491258|FG001|Overall Study|Withdrawal by Subject|1|||
130689751|NCT02294786|470491257|FG000|Overall Study|Physician Decision|6|||
130689752|NCT02294786|470491258|FG001|Overall Study|Physician Decision|7|||
130689753|NCT02294786|470491257|FG000|Overall Study|Lost to Follow-up|1|||
130689754|NCT02294786|470491258|FG001|Overall Study|Lost to Follow-up|2|||
130689755|NCT02294786|470491257|FG000|Overall Study|Protocol Violation|1|||
130689756|NCT02294786|470491258|FG001|Overall Study|Protocol Violation|0|||
130689757|NCT02294786|470491257|FG000|Overall Study|Adverse Event|1|||
130689758|NCT02294786|470491258|FG001|Overall Study|Adverse Event|1|||
130689759|NCT02294786|470491257|FG000|Overall Study|Death|2|||
130689760|NCT02294786|470491258|FG001|Overall Study|Death|3|||
130689761|NCT01778010|470491259|FG000|Overall Study|Withdrawal by Subject|2|||
130689762|NCT01778010|470491259|FG000|Overall Study|abnormal ECG before meds|1|||
130689763|NCT01778010|470491259|FG000|Overall Study|Arrested|1|||
130689764|NCT01778010|470491259|FG000|Overall Study|rash while on placebo|1|||
130767410|NCT05268016|470772382|FG002|Overall Study|Other|1|||
130767411|NCT05268016|470772383|FG003|Overall Study|Other|2|||
130767412|NCT05268016|470772384|FG004|Overall Study|Other|0|||
130767413|NCT00404924|470772385|FG000|Overall Study|Adverse Event|75|||
130767414|NCT00404924|470772386|FG001|Overall Study|Adverse Event|16|||
130767415|NCT00404924|470772385|FG000|Overall Study|Condition under investigation worsened|475|||
130767416|NCT00404924|470772386|FG001|Overall Study|Condition under investigation worsened|264|||
130767417|NCT00404924|470772385|FG000|Overall Study|Lost to Follow-up|1|||
130767418|NCT00404924|470772386|FG001|Overall Study|Lost to Follow-up|1|||
130767419|NCT00404924|470772385|FG000|Overall Study|Withdrawal by Subject|26|||
130767420|NCT00404924|470772386|FG001|Overall Study|Withdrawal by Subject|13|||
130767421|NCT00404924|470772385|FG000|Overall Study|Other|25|||
130767422|NCT00404924|470772386|FG001|Overall Study|Other|11|||
130767423|NCT00404924|470772385|FG000|Overall Study|Randomised but not received treatment|1|||
130767424|NCT00404924|470772386|FG001|Overall Study|Randomised but not received treatment|1|||
130689765|NCT01518972|470491263|FG000|Overall Study|Lost to Follow-up|2|||
130689766|NCT01518972|470491264|FG001|Overall Study|Lost to Follow-up|1|||
130689767|NCT01518972|470491263|FG000|Overall Study|Withdrawal by Subject|1|||
130767425|NCT02603107|470772391|FG000|Randomized Phase|Withdrew consent|8|||
130767426|NCT02603107|470772392|FG001|Randomized Phase|Withdrew consent|15|||
130689768|NCT01518972|470491264|FG001|Overall Study|Withdrawal by Subject|0|||
130689769|NCT01518972|470491263|FG000|Overall Study|Moved from area|1|||
130689770|NCT01518972|470491264|FG001|Overall Study|Moved from area|0|||
130689771|NCT01518972|470491263|FG000|Overall Study|Transportation problems|1|||
130689772|NCT01518972|470491264|FG001|Overall Study|Transportation problems|0|||
130689773|NCT01518972|470491263|FG000|Overall Study|Exclusionary medical condition|1|||
130689774|NCT01518972|470491264|FG001|Overall Study|Exclusionary medical condition|0|||
130689775|NCT01518972|470491263|FG000|Overall Study|Missed safety visits|0|||
130689776|NCT01518972|470491264|FG001|Overall Study|Missed safety visits|1|||
130689777|NCT01518972|470491263|FG000|Overall Study|Exclusionary medication|0|||
130689778|NCT01518972|470491264|FG001|Overall Study|Exclusionary medication|1|||
130689779|NCT01518972|470491263|FG000|Overall Study|Declined medication starting on day 12|0|||
130689780|NCT01518972|470491264|FG001|Overall Study|Declined medication starting on day 12|1|||
130689781|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
130689782|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
130689783|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
130689784|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
130689785|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
130689786|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
130689787|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
130689788|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
130689789|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
130689790|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
130689791|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
130689792|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
130689793|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
130689794|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
130689795|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
130689796|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
130689797|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
130689798|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
130689799|NCT01667679|470491265|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
130689800|NCT01667679|470491266|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
130689801|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
130689802|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
130689803|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
130689804|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
130689805|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
130689806|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
130689807|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
130689808|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
130689809|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
130689810|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
130689811|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
130689812|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
130689813|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
130689814|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
130689815|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
130689816|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
130689817|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
130689818|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
130689819|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
130689820|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
130689821|NCT01667679|470491265|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
130689822|NCT01667679|470491266|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
130689823|NCT02159183|470491267|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
130689824|NCT02159183|470491268|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
130689825|NCT02159183|470491267|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
130689826|NCT02159183|470491268|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
130689827|NCT02159183|470491267|FG000|Analysis After the 36 Months Follow-up|Death|0|||
130689828|NCT02159183|470491268|FG001|Analysis After the 36 Months Follow-up|Death|1|||
130689829|NCT02159183|470491267|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
130689830|NCT02159183|470491268|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
130689831|NCT02159183|470491267|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
130689832|NCT02159183|470491268|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
130689833|NCT03733444|470491270|FG000|Overall Study|Adverse Event|8|||
130689834|NCT03733444|470491271|FG001|Overall Study|Adverse Event|10|||
130689835|NCT03733444|470491272|FG002|Overall Study|Adverse Event|5|||
130689836|NCT03733444|470491270|FG000|Overall Study|Death|20|||
130689837|NCT03733444|470491271|FG001|Overall Study|Death|19|||
130767427|NCT02603107|470772391|FG000|Randomized Phase|Lost to Follow-up|1|||
130767428|NCT02603107|470772392|FG001|Randomized Phase|Lost to Follow-up|3|||
130767429|NCT02603107|470772391|FG000|Randomized Phase|Adverse Event|2|||
130767430|NCT02603107|470772392|FG001|Randomized Phase|Adverse Event|0|||
130767431|NCT02603107|470772391|FG000|Randomized Phase|Death|1|||
130767432|NCT02603107|470772392|FG001|Randomized Phase|Death|1|||
130767433|NCT02603107|470772391|FG000|Randomized Phase|Non-compliance with study drug|1|||
130767434|NCT02603107|470772392|FG001|Randomized Phase|Non-compliance with study drug|1|||
130767435|NCT02603107|470772391|FG000|Randomized Phase|Investigator's discretion|0|||
131111416|NCT03282240|472037746|FG002|Overall Study|Protocol Deviation|2|||
131111417|NCT03282240|472037744|FG000|Overall Study|Withdrawal by Subject|1|||
131111418|NCT03282240|472037745|FG001|Overall Study|Withdrawal by Subject|0|||
131111419|NCT03282240|472037746|FG002|Overall Study|Withdrawal by Subject|1|||
131111420|NCT01675479|472037747|FG000|Overall Study|Lost to Follow-up|11|||
131111421|NCT03254485|472037748|FG000|Overall Study|Adverse Event|3|||
131111422|NCT03254485|472037749|FG001|Overall Study|Adverse Event|0|||
131111423|NCT03254485|472037750|FG002|Overall Study|Adverse Event|0|||
131111424|NCT03254485|472037751|FG003|Overall Study|Adverse Event|6|||
131111425|NCT03254485|472037748|FG000|Overall Study|Protocol Violation|6|||
131111426|NCT03254485|472037749|FG001|Overall Study|Protocol Violation|0|||
131111427|NCT03254485|472037750|FG002|Overall Study|Protocol Violation|0|||
131111428|NCT03254485|472037751|FG003|Overall Study|Protocol Violation|2|||
131111429|NCT03254485|472037748|FG000|Overall Study|Withdrawal by Subject|1|||
131111430|NCT03254485|472037749|FG001|Overall Study|Withdrawal by Subject|0|||
131111431|NCT03254485|472037750|FG002|Overall Study|Withdrawal by Subject|0|||
131111432|NCT03254485|472037751|FG003|Overall Study|Withdrawal by Subject|4|||
131111433|NCT03254485|472037748|FG000|Overall Study|Death|0|||
131111434|NCT03254485|472037749|FG001|Overall Study|Death|0|||
131111435|NCT03254485|472037750|FG002|Overall Study|Death|0|||
131111436|NCT03254485|472037751|FG003|Overall Study|Death|1|||
130689838|NCT03733444|470491272|FG002|Overall Study|Death|11|||
130689839|NCT03733444|470491270|FG000|Overall Study|Lost to Follow-up|3|||
130689840|NCT03733444|470491271|FG001|Overall Study|Lost to Follow-up|0|||
130689841|NCT03733444|470491272|FG002|Overall Study|Lost to Follow-up|1|||
130689842|NCT03733444|470491270|FG000|Overall Study|Lack of Efficacy|0|||
130689843|NCT03733444|470491271|FG001|Overall Study|Lack of Efficacy|1|||
130689844|NCT03733444|470491272|FG002|Overall Study|Lack of Efficacy|1|||
130689845|NCT03733444|470491270|FG000|Overall Study|Physician Decision|2|||
130689846|NCT03733444|470491271|FG001|Overall Study|Physician Decision|1|||
130689847|NCT03733444|470491272|FG002|Overall Study|Physician Decision|0|||
130689848|NCT03733444|470491270|FG000|Overall Study|Protocol Violation|2|||
130689849|NCT03733444|470491271|FG001|Overall Study|Protocol Violation|1|||
130689850|NCT03733444|470491272|FG002|Overall Study|Protocol Violation|0|||
130689851|NCT03733444|470491270|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
130689852|NCT03733444|470491271|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
130689853|NCT03733444|470491272|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
130689854|NCT03733444|470491270|FG000|Overall Study|Study Terminated by Sponsor|203|||
130689855|NCT03733444|470491271|FG001|Overall Study|Study Terminated by Sponsor|209|||
130689856|NCT03733444|470491272|FG002|Overall Study|Study Terminated by Sponsor|221|||
130689857|NCT03733444|470491270|FG000|Overall Study|Withdrawal by Subject|19|||
130689858|NCT03733444|470491271|FG001|Overall Study|Withdrawal by Subject|18|||
130689859|NCT03733444|470491272|FG002|Overall Study|Withdrawal by Subject|16|||
130689860|NCT03733444|470491270|FG000|Overall Study|Miscellaneous|1|||
130689861|NCT03733444|470491271|FG001|Overall Study|Miscellaneous|0|||
130689862|NCT03733444|470491272|FG002|Overall Study|Miscellaneous|1|||
130689863|NCT03733444|470491270|FG000|Overall Study|Not Treated|1|||
130689864|NCT03733444|470491271|FG001|Overall Study|Not Treated|2|||
130689865|NCT03733444|470491272|FG002|Overall Study|Not Treated|1|||
130689866|NCT00556322|470491273|FG000|Overall Study|Insufficient therapeutic response|158|||
130689867|NCT00556322|470491274|FG001|Overall Study|Insufficient therapeutic response|168|||
130689868|NCT00556322|470491273|FG000|Overall Study|Adverse Event|7|||
130689869|NCT00556322|470491274|FG001|Overall Study|Adverse Event|4|||
130689870|NCT00556322|470491273|FG000|Overall Study|Other|4|||
130689871|NCT00556322|470491274|FG001|Overall Study|Other|1|||
130689872|NCT00556322|470491273|FG000|Overall Study|Lost to Follow-up|5|||
130689873|NCT00556322|470491274|FG001|Overall Study|Lost to Follow-up|3|||
130689874|NCT00556322|470491273|FG000|Overall Study|Withdrawal by Subject|19|||
130689875|NCT00556322|470491274|FG001|Overall Study|Withdrawal by Subject|7|||
130689876|NCT00556322|470491273|FG000|Overall Study|Protocol Violation|5|||
130689877|NCT00556322|470491274|FG001|Overall Study|Protocol Violation|1|||
130689878|NCT00556322|470491273|FG000|Overall Study|Ongoing at data cutoff|3|||
130689879|NCT00556322|470491274|FG001|Overall Study|Ongoing at data cutoff|5|||
130689880|NCT00556322|470491273|FG000|Overall Study|Death|20|||
130689881|NCT00556322|470491274|FG001|Overall Study|Death|14|||
130689882|NCT01788423|470491275|FG000|Overall Study|See Comments in Completed (above)|0|||
131111437|NCT03254485|472037748|FG000|Overall Study|Lost to Follow-up|1|||
131111438|NCT03254485|472037749|FG001|Overall Study|Lost to Follow-up|0|||
131111439|NCT03254485|472037750|FG002|Overall Study|Lost to Follow-up|0|||
131111440|NCT03254485|472037751|FG003|Overall Study|Lost to Follow-up|0|||
130689883|NCT01788423|470491276|FG001|Overall Study|See Comments in Completed (above)|4|||
130689884|NCT01788423|470491277|FG002|Overall Study|See Comments in Completed (above)|5|||
130689885|NCT03637764|470491278|FG000|Overall Study|Adverse Event|2|||
130689886|NCT03637764|470491279|FG001|Overall Study|Adverse Event|0|||
130689887|NCT03637764|470491280|FG002|Overall Study|Adverse Event|0|||
130689888|NCT03637764|470491281|FG003|Overall Study|Adverse Event|1|||
131111441|NCT03254485|472037748|FG000|Overall Study|Other|1|||
131111442|NCT03254485|472037749|FG001|Overall Study|Other|0|||
131111443|NCT03254485|472037750|FG002|Overall Study|Other|0|||
131111444|NCT03254485|472037751|FG003|Overall Study|Other|2|||
130689889|NCT03637764|470491278|FG000|Overall Study|Progressive Disease|23|||
130689890|NCT03637764|470491279|FG001|Overall Study|Progressive Disease|23|||
130689891|NCT03637764|470491280|FG002|Overall Study|Progressive Disease|18|||
130689892|NCT03637764|470491281|FG003|Overall Study|Progressive Disease|31|||
130689893|NCT03637764|470491278|FG000|Overall Study|Withdrawal by Subject|1|||
130689894|NCT03637764|470491279|FG001|Overall Study|Withdrawal by Subject|3|||
130689895|NCT03637764|470491280|FG002|Overall Study|Withdrawal by Subject|0|||
130689896|NCT03637764|470491281|FG003|Overall Study|Withdrawal by Subject|1|||
130689897|NCT02760927|470491286|FG000|Overall Study|Tube Slippage from Device|1|||
130689898|NCT02105272|470491287|FG000|Overall Study|Adverse Event|1|||
130689899|NCT02105272|470491288|FG001|Overall Study|Adverse Event|2|||
130689900|NCT02105272|470491287|FG000|Overall Study|Physician Decision|0|||
130689901|NCT02105272|470491288|FG001|Overall Study|Physician Decision|1|||
130689902|NCT02105272|470491287|FG000|Overall Study|Protocol Violation|2|||
130689903|NCT02105272|470491288|FG001|Overall Study|Protocol Violation|0|||
130689904|NCT02105272|470491287|FG000|Overall Study|Withdrawal by Subject|2|||
130689905|NCT02105272|470491288|FG001|Overall Study|Withdrawal by Subject|0|||
130689906|NCT03190915|470491290|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
130689907|NCT03190915|470491290|FG000|Overall Study|Progressive Disease|3|||
130689908|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
130689909|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
130689910|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
130689911|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
130689912|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
130689913|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
130689914|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130689915|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130689916|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
130689917|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
130689918|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
130689919|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
130689920|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
130689921|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
130689922|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
130689923|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
130689924|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
130689925|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
130689926|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
130689927|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
130689928|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Death|0|||
130689929|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Death|1|||
130689930|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Death|0|||
130689931|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Death|0|||
130689932|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
130689933|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
130689934|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
130689935|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
130689936|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
130689937|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
130689938|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
130689939|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
130689940|NCT01940341|470491291|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130689941|NCT01940341|470491292|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
130689942|NCT01940341|470491293|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130689943|NCT01940341|470491294|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130689944|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
130689945|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
130689946|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
130689947|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
130767436|NCT02603107|470772392|FG001|Randomized Phase|Investigator's discretion|1|||
130767437|NCT02603107|470772391|FG000|Randomized Phase|Lack of Efficacy|1|||
130767438|NCT02603107|470772392|FG001|Randomized Phase|Lack of Efficacy|0|||
130767439|NCT02603107|470772391|FG000|Randomized Phase|Protocol Violation|1|||
130767440|NCT02603107|470772392|FG001|Randomized Phase|Protocol Violation|0|||
130767441|NCT02603107|470772391|FG000|Optional Extension Phase|Lost to Follow-up|3|||
130767442|NCT02603107|470772392|FG001|Optional Extension Phase|Lost to Follow-up|3|||
130689948|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
130689949|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
130689950|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
130689951|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
131111445|NCT02910739|472037752|FG000|Overall Study|Adverse Event|1|||
131111446|NCT02910739|472037753|FG001|Overall Study|Adverse Event|0|||
131111447|NCT02910739|472037754|FG002|Overall Study|Adverse Event|0|||
131111448|NCT02910739|472037755|FG003|Overall Study|Adverse Event|0|||
131111449|NCT02146326|472037756|FG000|Overall Study|Lost to Follow-up|3|||
131111450|NCT02146326|472037757|FG001|Overall Study|Lost to Follow-up|3|||
131111451|NCT02146326|472037758|FG002|Overall Study|Lost to Follow-up|11|||
131111452|NCT02146326|472037759|FG003|Overall Study|Lost to Follow-up|19|||
131111453|NCT02146326|472037756|FG000|Overall Study|Withdrawal by Subject|2|||
131111454|NCT02146326|472037757|FG001|Overall Study|Withdrawal by Subject|1|||
131111455|NCT02146326|472037758|FG002|Overall Study|Withdrawal by Subject|15|||
131111456|NCT02146326|472037759|FG003|Overall Study|Withdrawal by Subject|11|||
131111457|NCT02146326|472037756|FG000|Overall Study|Separated from mental health center|23|||
131111458|NCT02146326|472037757|FG001|Overall Study|Separated from mental health center|33|||
131111459|NCT02146326|472037758|FG002|Overall Study|Separated from mental health center|0|||
131111460|NCT02146326|472037759|FG003|Overall Study|Separated from mental health center|0|||
131111461|NCT02146326|472037756|FG000|Overall Study|Incarcerated|0|||
131111462|NCT02146326|472037757|FG001|Overall Study|Incarcerated|0|||
131111463|NCT02146326|472037758|FG002|Overall Study|Incarcerated|3|||
131111464|NCT02146326|472037759|FG003|Overall Study|Incarcerated|8|||
131111465|NCT02146326|472037756|FG000|Overall Study|Death|0|||
131111466|NCT02146326|472037757|FG001|Overall Study|Death|0|||
131111467|NCT02146326|472037758|FG002|Overall Study|Death|4|||
131111468|NCT02146326|472037759|FG003|Overall Study|Death|4|||
131111469|NCT02146326|472037756|FG000|Overall Study|Unable to complete interview|0|||
131111470|NCT02146326|472037757|FG001|Overall Study|Unable to complete interview|0|||
131111471|NCT02146326|472037758|FG002|Overall Study|Unable to complete interview|10|||
131111472|NCT02146326|472037759|FG003|Overall Study|Unable to complete interview|6|||
131111473|NCT01340651|472037761|FG000|Overall Study|Adverse Event|3|||
131111474|NCT01340651|472037761|FG000|Overall Study|Consent Withdrawn|2|||
131111475|NCT01340651|472037761|FG000|Overall Study|Commercial Supply per Sponsor|12|||
131111476|NCT01696942|472037766|FG000|Overall Study|Withdrawal by Subject|1|||
131111477|NCT01696942|472037767|FG001|Overall Study|Withdrawal by Subject|0|||
131111478|NCT01696942|472037766|FG000|Overall Study|Protocol Violation|1|||
131111479|NCT01696942|472037767|FG001|Overall Study|Protocol Violation|2|||
131111480|NCT01696942|472037766|FG000|Overall Study|screen failure|0|||
131111481|NCT01696942|472037767|FG001|Overall Study|screen failure|1|||
131111482|NCT01598311|472037772|FG000|Overall Study|Physician Decision|4|||
131111483|NCT01598311|472037773|FG001|Overall Study|Physician Decision|5|||
131111484|NCT01598311|472037772|FG000|Overall Study|Adverse Event|9|||
131111485|NCT01598311|472037773|FG001|Overall Study|Adverse Event|13|||
131111486|NCT01598311|472037772|FG000|Overall Study|Lost to Follow-up|7|||
131111487|NCT01598311|472037773|FG001|Overall Study|Lost to Follow-up|12|||
131111488|NCT01598311|472037772|FG000|Overall Study|Withdrawal by Subject|9|||
131111489|NCT01598311|472037773|FG001|Overall Study|Withdrawal by Subject|13|||
131111490|NCT01598311|472037772|FG000|Overall Study|No reason provided.|0|||
131111491|NCT01598311|472037773|FG001|Overall Study|No reason provided.|5|||
131111492|NCT01598311|472037772|FG000|Overall Study|Randomized but never treated|8|||
131111493|NCT01598311|472037773|FG001|Overall Study|Randomized but never treated|5|||
131111494|NCT01598311|472037772|FG000|Overall Study|Treated but no confirmed CDAD|9|||
131111495|NCT01598311|472037773|FG001|Overall Study|Treated but no confirmed CDAD|8|||
130689952|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130689953|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130689954|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
130689955|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130689956|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
130689957|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
130689958|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
131111496|NCT01598311|472037772|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
131111497|NCT01598311|472037773|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
131111498|NCT00688103|472037774|FG000|Overall Study|Adverse Event|4|||
131111499|NCT00688103|472037775|FG001|Overall Study|Adverse Event|1|||
131111500|NCT00688103|472037774|FG000|Overall Study|Lack of Efficacy|11|||
131111501|NCT00688103|472037775|FG001|Overall Study|Lack of Efficacy|1|||
131111502|NCT00688103|472037774|FG000|Overall Study|Withdrawal by Subject|4|||
131111503|NCT00688103|472037775|FG001|Overall Study|Withdrawal by Subject|2|||
131111504|NCT00688103|472037774|FG000|Overall Study|complex reasons|11|||
131111505|NCT00688103|472037775|FG001|Overall Study|complex reasons|9|||
131111506|NCT01313117|472037776|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
131111507|NCT01313117|472037776|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
131111508|NCT03602261|472037779|FG000|Overall Study|Adverse Event|5|||
131111509|NCT03602261|472037780|FG001|Overall Study|Adverse Event|1|||
131111510|NCT03602261|472037779|FG000|Overall Study|Physician Decision|1|||
131111511|NCT03602261|472037780|FG001|Overall Study|Physician Decision|0|||
130689959|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
130689960|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130689961|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130689962|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
130689963|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130689964|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
130689965|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
130689966|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
130689967|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
130689968|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130689969|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130689970|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
130689971|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130689972|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130689973|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130689974|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130689975|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
130689976|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130689977|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130689978|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130689979|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
130689980|NCT01940341|470491291|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
130689981|NCT01940341|470491292|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
130689982|NCT01940341|470491293|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
130689983|NCT01940341|470491294|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
130689984|NCT01911676|470491297|FG000|Period 1 of Study|Withdrawal by Subject|4|||
130689985|NCT01911676|470491298|FG001|Period 1 of Study|Withdrawal by Subject|2|||
130689986|NCT01911676|470491299|FG002|Period 1 of Study|Withdrawal by Subject|1|||
130689987|NCT01911676|470491300|FG003|Period 1 of Study|Withdrawal by Subject|2|||
130689988|NCT01911676|470491297|FG000|Period 1 of Study|Physician Decision|2|||
130689989|NCT01911676|470491298|FG001|Period 1 of Study|Physician Decision|0|||
130689990|NCT01911676|470491299|FG002|Period 1 of Study|Physician Decision|0|||
130689991|NCT01911676|470491300|FG003|Period 1 of Study|Physician Decision|1|||
130689992|NCT01911676|470491297|FG000|Period 2 of Study|Physician Decision|2|||
130689993|NCT01911676|470491298|FG001|Period 2 of Study|Physician Decision|0|||
130689994|NCT01911676|470491299|FG002|Period 2 of Study|Physician Decision|0|||
130689995|NCT01911676|470491300|FG003|Period 2 of Study|Physician Decision|1|||
130689996|NCT01911676|470491297|FG000|Period 2 of Study|Lost to Follow-up|0|||
130689997|NCT01911676|470491298|FG001|Period 2 of Study|Lost to Follow-up|0|||
130689998|NCT01911676|470491299|FG002|Period 2 of Study|Lost to Follow-up|0|||
130689999|NCT01911676|470491300|FG003|Period 2 of Study|Lost to Follow-up|1|||
130690000|NCT01566721|470491301|FG000|Treatment Period|Withdrawal by Subject|35|||
130690001|NCT01566721|470491302|FG001|Treatment Period|Withdrawal by Subject|9|||
130690002|NCT01566721|470491301|FG000|Treatment Period|Disease Progression/Recurrence|37|||
130690003|NCT01566721|470491302|FG001|Treatment Period|Disease Progression/Recurrence|13|||
130690004|NCT01566721|470491301|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
130690005|NCT01566721|470491302|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
130690006|NCT01566721|470491301|FG000|Treatment Period|Other|13|||
130690007|NCT01566721|470491302|FG001|Treatment Period|Other|2|||
130690008|NCT01566721|470491301|FG000|Treatment Period|Lack of Compliance|5|||
130690009|NCT01566721|470491302|FG001|Treatment Period|Lack of Compliance|1|||
130690010|NCT01566721|470491301|FG000|Treatment Period|Adverse Event|100|||
130690011|NCT01566721|470491302|FG001|Treatment Period|Adverse Event|30|||
130690012|NCT01566721|470491301|FG000|Treatment Period|Pregnancy|1|||
130690013|NCT01566721|470491302|FG001|Treatment Period|Pregnancy|0|||
130690014|NCT01566721|470491301|FG000|Safety Follow-up|Physician Decision|6|||
130690015|NCT01566721|470491302|FG001|Safety Follow-up|Physician Decision|4|||
130690016|NCT01566721|470491301|FG000|Safety Follow-up|Lost to Follow-up|101|||
130690017|NCT01566721|470491302|FG001|Safety Follow-up|Lost to Follow-up|48|||
130690018|NCT01566721|470491301|FG000|Safety Follow-up|Withdrawal by Subject|155|||
130690019|NCT01566721|470491302|FG001|Safety Follow-up|Withdrawal by Subject|49|||
130690020|NCT01566721|470491301|FG000|Safety Follow-up|Death|28|||
130690021|NCT01566721|470491302|FG001|Safety Follow-up|Death|4|||
130690022|NCT01566721|470491301|FG000|Safety Follow-up|Non-compliance|7|||
130690023|NCT01566721|470491302|FG001|Safety Follow-up|Non-compliance|3|||
130690024|NCT01566721|470491301|FG000|Safety Follow-up|Protocol Violation|7|||
130690025|NCT01566721|470491302|FG001|Safety Follow-up|Protocol Violation|0|||
130690026|NCT01566721|470491301|FG000|Safety Follow-up|Site closure|2|||
130690027|NCT01566721|470491302|FG001|Safety Follow-up|Site closure|3|||
130690028|NCT01566721|470491301|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
130690029|NCT01566721|470491302|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
130894035|NCT02152956|471245462|FG002|Overall Study|Study terminated by sponsor|0|||
130894036|NCT02152956|471245463|FG003|Overall Study|Study terminated by sponsor|0|||
130767443|NCT02603107|470772391|FG000|Optional Extension Phase|Withdrew consent|3|||
130767444|NCT02603107|470772392|FG001|Optional Extension Phase|Withdrew consent|2|||
130690030|NCT01566721|470491301|FG000|Safety Follow-up|Missing|7|||
130690031|NCT01566721|470491302|FG001|Safety Follow-up|Missing|2|||
130690032|NCT01566721|470491301|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
130690033|NCT01566721|470491302|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
130690034|NCT01566721|470491301|FG000|Safety Follow-up|Sponsor decision|1|||
130690035|NCT01566721|470491302|FG001|Safety Follow-up|Sponsor decision|0|||
130690036|NCT01566721|470491301|FG000|Safety Follow-up|Adverse Event|8|||
130690037|NCT01566721|470491302|FG001|Safety Follow-up|Adverse Event|4|||
130690038|NCT01237054|470491303|FG000|Overall Study|imaging 10C0096|1|||
130690039|NCT02619682|470491304|FG000|Overall Study|Withdrawal by Subject|3|||
130690040|NCT02619682|470491304|FG000|Overall Study|Lack of Efficacy|8|||
130690041|NCT02619682|470491304|FG000|Overall Study|new secondary cancer|1|||
130690042|NCT02619682|470491304|FG000|Overall Study|post surgery complications|2|||
130690043|NCT00268203|470491307|FG000|Overall Study|Lost to Follow-up|92|||
130690044|NCT00268203|470491307|FG000|Overall Study|Withdrawal by Subject|9|||
130690045|NCT00268203|470491307|FG000|Overall Study|Received Other NHL Therapy|7|||
130690046|NCT00268203|470491307|FG000|Overall Study|Progressive Disease|359|||
130690047|NCT00268203|470491307|FG000|Overall Study|Death|84|||
130690048|NCT00268203|470491307|FG000|Overall Study|Reason Not Specified|34|||
130690049|NCT00268203|470491307|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
130690050|NCT00730691|470491314|FG000|Overall Study|Adverse Event|4|||
130690051|NCT00730691|470491315|FG001|Overall Study|Adverse Event|8|||
130690052|NCT00730691|470491316|FG002|Overall Study|Adverse Event|11|||
130690053|NCT00730691|470491317|FG003|Overall Study|Adverse Event|11|||
130767445|NCT02603107|470772391|FG000|Optional Extension Phase|Investigator's discretion|2|||
130767446|NCT02603107|470772392|FG001|Optional Extension Phase|Investigator's discretion|2|||
130767447|NCT02603107|470772391|FG000|Optional Extension Phase|Pregnancy|0|||
130767448|NCT02603107|470772392|FG001|Optional Extension Phase|Pregnancy|3|||
130767449|NCT02603107|470772391|FG000|Optional Extension Phase|Adverse Event|0|||
130767450|NCT02603107|470772392|FG001|Optional Extension Phase|Adverse Event|2|||
130767451|NCT02603107|470772391|FG000|Optional Extension Phase|Not treated in extension phase|0|||
130767452|NCT02603107|470772392|FG001|Optional Extension Phase|Not treated in extension phase|1|||
130690054|NCT00730691|470491318|FG004|Overall Study|Adverse Event|23|||
130690055|NCT00730691|470491314|FG000|Overall Study|Lack of Efficacy|4|||
130690056|NCT00730691|470491315|FG001|Overall Study|Lack of Efficacy|4|||
130690057|NCT00730691|470491316|FG002|Overall Study|Lack of Efficacy|2|||
130690058|NCT00730691|470491317|FG003|Overall Study|Lack of Efficacy|1|||
130690059|NCT00730691|470491318|FG004|Overall Study|Lack of Efficacy|1|||
130690060|NCT00730691|470491314|FG000|Overall Study|Non-compliance with Study Drug|6|||
130690061|NCT00730691|470491315|FG001|Overall Study|Non-compliance with Study Drug|1|||
130690062|NCT00730691|470491316|FG002|Overall Study|Non-compliance with Study Drug|6|||
130690063|NCT00730691|470491317|FG003|Overall Study|Non-compliance with Study Drug|3|||
130690064|NCT00730691|470491318|FG004|Overall Study|Non-compliance with Study Drug|3|||
130690065|NCT00730691|470491314|FG000|Overall Study|Protocol Deviations|3|||
130690066|NCT00730691|470491315|FG001|Overall Study|Protocol Deviations|5|||
130690067|NCT00730691|470491316|FG002|Overall Study|Protocol Deviations|3|||
130690068|NCT00730691|470491317|FG003|Overall Study|Protocol Deviations|7|||
130690069|NCT00730691|470491318|FG004|Overall Study|Protocol Deviations|5|||
130690070|NCT00730691|470491314|FG000|Overall Study|Withdrawal of Consent|7|||
130690071|NCT00730691|470491315|FG001|Overall Study|Withdrawal of Consent|9|||
130690072|NCT00730691|470491316|FG002|Overall Study|Withdrawal of Consent|3|||
130690073|NCT00730691|470491317|FG003|Overall Study|Withdrawal of Consent|6|||
130690074|NCT00730691|470491318|FG004|Overall Study|Withdrawal of Consent|3|||
130690075|NCT00730691|470491314|FG000|Overall Study|Lost to Follow-up|11|||
130690076|NCT00730691|470491315|FG001|Overall Study|Lost to Follow-up|8|||
130690077|NCT00730691|470491316|FG002|Overall Study|Lost to Follow-up|13|||
130690078|NCT00730691|470491317|FG003|Overall Study|Lost to Follow-up|15|||
130690079|NCT00730691|470491318|FG004|Overall Study|Lost to Follow-up|13|||
130767453|NCT02603107|470772391|FG000|Optional Extension Phase|Protocol Violation|1|||
130767454|NCT02603107|470772392|FG001|Optional Extension Phase|Protocol Violation|0|||
130690080|NCT00730691|470491314|FG000|Overall Study|Other|1|||
130690081|NCT00730691|470491315|FG001|Overall Study|Other|1|||
130690082|NCT00730691|470491316|FG002|Overall Study|Other|1|||
130690083|NCT00730691|470491317|FG003|Overall Study|Other|2|||
130894037|NCT02152956|471245464|FG004|Overall Study|Study terminated by sponsor|0|||
130690084|NCT00730691|470491318|FG004|Overall Study|Other|2|||
130690085|NCT02178787|470491319|FG000|Overall Study|Lost to Follow-up|1|||
130690086|NCT02178787|470491320|FG001|Overall Study|Lost to Follow-up|0|||
130690087|NCT02178787|470491319|FG000|Overall Study|Withdrawal by Subject|0|||
130690088|NCT02178787|470491320|FG001|Overall Study|Withdrawal by Subject|2|||
130690089|NCT02178787|470491319|FG000|Overall Study|No TCD window|3|||
130690090|NCT02178787|470491320|FG001|Overall Study|No TCD window|7|||
130690091|NCT02178787|470491319|FG000|Overall Study|Physician Decision|1|||
130894038|NCT02152956|471245465|FG005|Overall Study|Study terminated by sponsor|0|||
130894039|NCT02152956|471245466|FG006|Overall Study|Study terminated by sponsor|0|||
130894040|NCT02152956|471245467|FG007|Overall Study|Study terminated by sponsor|0|||
130894041|NCT02152956|471245468|FG008|Overall Study|Study terminated by sponsor|0|||
130894042|NCT02152956|471245469|FG009|Overall Study|Study terminated by sponsor|0|||
130894043|NCT02152956|471245470|FG010|Overall Study|Study terminated by sponsor|0|||
130894044|NCT02152956|471245471|FG011|Overall Study|Study terminated by sponsor|29|||
130894045|NCT02152956|471245472|FG012|Overall Study|Study terminated by sponsor|0|||
130894046|NCT02152956|471245460|FG000|Overall Study|progressive disease|0|||
130894047|NCT02152956|471245461|FG001|Overall Study|progressive disease|0|||
130894048|NCT02152956|471245462|FG002|Overall Study|progressive disease|0|||
130894049|NCT02152956|471245463|FG003|Overall Study|progressive disease|0|||
130894050|NCT02152956|471245464|FG004|Overall Study|progressive disease|0|||
130894051|NCT02152956|471245465|FG005|Overall Study|progressive disease|0|||
130894052|NCT02152956|471245466|FG006|Overall Study|progressive disease|0|||
130894053|NCT02152956|471245467|FG007|Overall Study|progressive disease|0|||
130894054|NCT02152956|471245468|FG008|Overall Study|progressive disease|1|||
130894055|NCT02152956|471245469|FG009|Overall Study|progressive disease|0|||
130894056|NCT02152956|471245470|FG010|Overall Study|progressive disease|0|||
130894057|NCT02152956|471245471|FG011|Overall Study|progressive disease|1|||
130894058|NCT02152956|471245472|FG012|Overall Study|progressive disease|0|||
130894059|NCT00530816|471245473|FG000|Overall Study|Progressive Disease|16|||
130894060|NCT00530816|471245474|FG001|Overall Study|Progressive Disease|24|||
130894061|NCT00530816|471245475|FG002|Overall Study|Progressive Disease|24|||
130894062|NCT00530816|471245473|FG000|Overall Study|Adverse Event|6|||
130894063|NCT00530816|471245474|FG001|Overall Study|Adverse Event|13|||
130690092|NCT02178787|470491320|FG001|Overall Study|Physician Decision|0|||
130690093|NCT02554890|470491321|FG000|Double-blind|Adverse Event|45|||
130690094|NCT02554890|470491322|FG001|Double-blind|Adverse Event|51|||
130690095|NCT02554890|470491321|FG000|Double-blind|Death|6|||
130690096|NCT02554890|470491322|FG001|Double-blind|Death|4|||
130894064|NCT00530816|471245475|FG002|Overall Study|Adverse Event|7|||
130894065|NCT00530816|471245473|FG000|Overall Study|Other|3|||
130894066|NCT00530816|471245474|FG001|Overall Study|Other|3|||
130894067|NCT00530816|471245475|FG002|Overall Study|Other|4|||
130894068|NCT00530816|471245473|FG000|Overall Study|Withdrawal by Subject|1|||
130894069|NCT00530816|471245474|FG001|Overall Study|Withdrawal by Subject|2|||
130894070|NCT00530816|471245475|FG002|Overall Study|Withdrawal by Subject|6|||
130894071|NCT02445794|471245476|FG000|Overall Study|Adverse Event|0|||
130894072|NCT02445794|471245477|FG001|Overall Study|Adverse Event|0|||
130894073|NCT02445794|471245478|FG002|Overall Study|Adverse Event|2|||
130894074|NCT02445794|471245479|FG003|Overall Study|Adverse Event|0|||
130894075|NCT01136785|471245480|FG000|Overall Study|Protocol Violation|2|||
130690097|NCT02554890|470491321|FG000|Double-blind|Protocol Violation|1|||
130690098|NCT02554890|470491322|FG001|Double-blind|Protocol Violation|1|||
130690099|NCT02554890|470491321|FG000|Double-blind|Physician Decision|4|||
130690100|NCT02554890|470491322|FG001|Double-blind|Physician Decision|3|||
130690101|NCT02554890|470491321|FG000|Double-blind|Subject/Guardian decision|21|||
130690102|NCT02554890|470491322|FG001|Double-blind|Subject/Guardian decision|16|||
130690103|NCT02554890|470491321|FG000|Double-blind|Lost to Follow-up|7|||
130690104|NCT02554890|470491322|FG001|Double-blind|Lost to Follow-up|5|||
130690105|NCT02554890|470491321|FG000|Double-blind|Technical problems|1|||
130690106|NCT02554890|470491322|FG001|Double-blind|Technical problems|0|||
130690107|NCT02554890|470491321|FG000|Double-blind|Withdrawal by Subject|5|||
130690108|NCT02554890|470491322|FG001|Double-blind|Withdrawal by Subject|6|||
130690109|NCT02554890|470491321|FG000|Double-blind|Noncompliance with study treatment|6|||
130690110|NCT02554890|470491322|FG001|Double-blind|Noncompliance with study treatment|5|||
130690111|NCT02554890|470491321|FG000|Open-label|Adverse Event|0|||
130690112|NCT02554890|470491322|FG001|Open-label|Adverse Event|30|||
130690113|NCT02554890|470491321|FG000|Open-label|Death|0|||
130690114|NCT02554890|470491322|FG001|Open-label|Death|1|||
130690115|NCT02554890|470491321|FG000|Open-label|Physician Decision|0|||
130690116|NCT02554890|470491322|FG001|Open-label|Physician Decision|1|||
130690117|NCT02554890|470491321|FG000|Open-label|Subject/Guardian decision|0|||
130690118|NCT02554890|470491322|FG001|Open-label|Subject/Guardian decision|11|||
130690119|NCT02554890|470491321|FG000|Open-label|Lost to Follow-up|0|||
130690120|NCT02554890|470491322|FG001|Open-label|Lost to Follow-up|7|||
130690121|NCT02554890|470491321|FG000|Open-label|Technical problems|0|||
130894076|NCT01136785|471245481|FG001|Overall Study|Protocol Violation|1|||
130894077|NCT01388985|471245482|FG000|Overall Study|Death|0|||
130894078|NCT01388985|471245483|FG001|Overall Study|Death|1|||
130894079|NCT01388985|471245482|FG000|Overall Study|Lost to Follow-up|30|||
130894080|NCT01388985|471245483|FG001|Overall Study|Lost to Follow-up|30|||
130894081|NCT01388985|471245482|FG000|Overall Study|Withdrawal by Subject|13|||
130894082|NCT01388985|471245483|FG001|Overall Study|Withdrawal by Subject|4|||
130894083|NCT01388985|471245482|FG000|Overall Study|Subject unavailable|1|||
130894084|NCT01388985|471245483|FG001|Overall Study|Subject unavailable|1|||
130894085|NCT01388985|471245482|FG000|Overall Study|Other (no reason)|0|||
130894086|NCT01388985|471245483|FG001|Overall Study|Other (no reason)|1|||
130894087|NCT01388985|471245482|FG000|Overall Study|Error of nurse|5|||
130894088|NCT01388985|471245483|FG001|Overall Study|Error of nurse|1|||
130894089|NCT01057589|471245484|FG000|Overall Study|Disease Progression|35|||
130894090|NCT01057589|471245484|FG000|Overall Study|Adverse Event|10|||
130894091|NCT01057589|471245484|FG000|Overall Study|Physician Decision|8|||
130894092|NCT01057589|471245484|FG000|Overall Study|Withdrawal by Subject|3|||
130894093|NCT01057589|471245484|FG000|Overall Study|Sponsor Decision|1|||
130894094|NCT01057589|471245484|FG000|Overall Study|Death|8|||
130894095|NCT01057589|471245484|FG000|Overall Study|Lost to Follow-up|1|||
130894096|NCT02954172|471245487|FG000|Overall Study|Protocol Violation|3|||
130894097|NCT02954172|471245488|FG001|Overall Study|Protocol Violation|0|||
130894098|NCT02954172|471245487|FG000|Overall Study|allergic reaction|2|||
130894099|NCT02954172|471245488|FG001|Overall Study|allergic reaction|1|||
130894100|NCT02954172|471245487|FG000|Overall Study|non-measurable lesions at baseline|1|||
130894101|NCT02954172|471245488|FG001|Overall Study|non-measurable lesions at baseline|2|||
130894102|NCT00853567|471245489|FG000|Overall Study|Study prematurely terminated|71|||
130894103|NCT01497366|471245493|FG000|Overall Study|Virologic failure|2|||
130894104|NCT01497366|471245494|FG001|Overall Study|Virologic failure|50|||
130894105|NCT01497366|471245493|FG000|Overall Study|Lost to Follow-up|11|||
130894106|NCT01497366|471245494|FG001|Overall Study|Lost to Follow-up|10|||
130894107|NCT01497366|471245493|FG000|Overall Study|Withdrawal by Subject|6|||
130894108|NCT01497366|471245494|FG001|Overall Study|Withdrawal by Subject|6|||
130894109|NCT01497366|471245493|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
130894110|NCT01497366|471245494|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
130894111|NCT01497366|471245493|FG000|Overall Study|Other|5|||
130894112|NCT01497366|471245494|FG001|Overall Study|Other|0|||
130894113|NCT01497366|471245493|FG000|Overall Study|Death|1|||
130894114|NCT01497366|471245494|FG001|Overall Study|Death|1|||
130894115|NCT01497366|471245493|FG000|Overall Study|Randomized but not treated|7|||
130894116|NCT01497366|471245494|FG001|Overall Study|Randomized but not treated|21|||
130894117|NCT00531427|471245506|FG000|Overall Study|Withdrawal by Subject|7|||
130894118|NCT00531427|471245507|FG001|Overall Study|Withdrawal by Subject|13|||
130894119|NCT00531427|471245506|FG000|Overall Study|Adverse Event|44|||
130894120|NCT00531427|471245507|FG001|Overall Study|Adverse Event|30|||
130894121|NCT00531427|471245506|FG000|Overall Study|Lost to Follow-up|4|||
130894122|NCT00531427|471245507|FG001|Overall Study|Lost to Follow-up|3|||
131025382|NCT00087139|471723244|FG000|Overall Study|Symptomatic deterioration|1|||
131025383|NCT00087139|471723245|FG001|Overall Study|Symptomatic deterioration|1|||
130690122|NCT02554890|470491322|FG001|Open-label|Technical problems|1|||
130894123|NCT00531427|471245506|FG000|Overall Study|Lack of Efficacy|14|||
130894124|NCT00531427|471245507|FG001|Overall Study|Lack of Efficacy|39|||
130894125|NCT00531427|471245506|FG000|Overall Study|Administrative|4|||
130894126|NCT00531427|471245507|FG001|Overall Study|Administrative|9|||
130894127|NCT01064947|471245509|FG000|Overall Study|negative culture|41|||
130894128|NCT00843284|471247127|FG000|Overall Study|Adverse Event|39|||
130894129|NCT00843284|471247127|FG000|Overall Study|Lack of Efficacy|5|||
130894130|NCT00843284|471247127|FG000|Overall Study|Lost to Follow-up|11|||
130690123|NCT02554890|470491321|FG000|Open-label|Withdrawal by Subject|0|||
130690124|NCT02554890|470491322|FG001|Open-label|Withdrawal by Subject|1|||
130690125|NCT03649477|470491323|FG000|Overall Study|Adverse Event|2|||
130690126|NCT03649477|470491324|FG001|Overall Study|Adverse Event|0|||
130690127|NCT03649477|470491325|FG002|Overall Study|Adverse Event|0|||
130690128|NCT02430480|470491328|FG000|Overall Study|Death|1|||
130690129|NCT02430480|470491328|FG000|Overall Study|Anesthesia concerns|1|||
130690130|NCT02430480|470491328|FG000|Overall Study|Progressed on treatment|1|||
130690131|NCT01097577|470491336|FG000|Overall Study|Adverse Event|0|||
130690132|NCT01097577|470491337|FG001|Overall Study|Adverse Event|1|||
130690133|NCT00316186|470491338|FG000|Overall Study|Adverse Event|6|||
130690134|NCT00316186|470491338|FG000|Overall Study|Disease Progression|4|||
130690135|NCT00316186|470491338|FG000|Overall Study|Lost to Follow-up|1|||
130690136|NCT00316186|470491338|FG000|Overall Study|Other|1|||
130690137|NCT04493684|470491341|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
130690138|NCT04493684|470491342|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690139|NCT04493684|470491343|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
130690140|NCT04493684|470491344|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690141|NCT04493684|470491345|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690142|NCT04493684|470491346|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
130690143|NCT04493684|470491347|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690144|NCT04493684|470491348|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690145|NCT04493684|470491349|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690146|NCT04493684|470491350|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690147|NCT04493684|470491351|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690148|NCT04493684|470491352|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130894131|NCT00843284|471247127|FG000|Overall Study|Other|10|||
130894132|NCT00843284|471247127|FG000|Overall Study|Withdrawal by Subject|4|||
131025384|NCT00087139|471723246|FG002|Overall Study|Symptomatic deterioration|3|||
130894133|NCT00843284|471247127|FG000|Overall Study|Death|3|||
130894134|NCT00798759|471247128|FG000|Overall Study|Adverse Event|3|||
130894135|NCT00798759|471247129|FG001|Overall Study|Adverse Event|3|||
130894136|NCT00798759|471247128|FG000|Overall Study|Lost to Follow-up|1|||
130894137|NCT00798759|471247129|FG001|Overall Study|Lost to Follow-up|1|||
130894138|NCT00798759|471247128|FG000|Overall Study|Protocol Violation|4|||
130894139|NCT00798759|471247129|FG001|Overall Study|Protocol Violation|8|||
130894140|NCT00798759|471247128|FG000|Overall Study|Other|0|||
130894141|NCT00798759|471247129|FG001|Overall Study|Other|1|||
130894142|NCT00724711|471247130|FG000|Overall Study|Adverse Event|7|||
130894143|NCT00724711|471247131|FG001|Overall Study|Adverse Event|3|||
130894144|NCT00724711|471247130|FG000|Overall Study|Pregnancy|0|||
130894145|NCT00724711|471247131|FG001|Overall Study|Pregnancy|1|||
130894146|NCT00724711|471247130|FG000|Overall Study|Lack of Efficacy|0|||
130894147|NCT00724711|471247131|FG001|Overall Study|Lack of Efficacy|1|||
130894148|NCT00724711|471247130|FG000|Overall Study|Physician Decision|0|||
130894149|NCT00724711|471247131|FG001|Overall Study|Physician Decision|3|||
130894150|NCT00724711|471247130|FG000|Overall Study|Withdrawal by Subject|5|||
130894151|NCT00724711|471247131|FG001|Overall Study|Withdrawal by Subject|4|||
130894152|NCT00724711|471247130|FG000|Overall Study|Lost to Follow-up|4|||
130894153|NCT00724711|471247131|FG001|Overall Study|Lost to Follow-up|5|||
130894154|NCT00724711|471247130|FG000|Overall Study|Protocol Violation|1|||
130894155|NCT00724711|471247131|FG001|Overall Study|Protocol Violation|0|||
130894156|NCT04838977|471247132|FG000|Overall Study|Lost to Follow-up|2|||
130894157|NCT04838977|471247133|FG001|Overall Study|Lost to Follow-up|3|||
130894158|NCT04838977|471247132|FG000|Overall Study|Withdrawal by Subject|1|||
130894159|NCT04838977|471247133|FG001|Overall Study|Withdrawal by Subject|1|||
130894160|NCT01256190|471247134|FG000|Overall Study|Lost to Follow-up|2|||
130894161|NCT01256190|471247135|FG001|Overall Study|Lost to Follow-up|0|||
130894162|NCT02644109|471247142|FG000|Overall Study|Adverse Event|0|||
130894163|NCT02644109|471247143|FG001|Overall Study|Adverse Event|4|||
130690149|NCT04493684|470491353|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690150|NCT04493684|470491354|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690151|NCT04493684|470491355|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690152|NCT04493684|470491356|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690153|NCT04493684|470491357|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130690154|NCT04493684|470491341|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
130894164|NCT01519869|471247146|FG000|Overall Study|Lost to Follow-up|1|||
130894165|NCT03023813|471247147|FG000|Overall Study|Lost to Follow-up|1|||
130894166|NCT03023813|471247148|FG001|Overall Study|Lost to Follow-up|2|||
131111512|NCT03602261|472037779|FG000|Overall Study|Withdrawal by Subject|1|||
131111513|NCT03602261|472037780|FG001|Overall Study|Withdrawal by Subject|1|||
131111514|NCT03602261|472037779|FG000|Overall Study|Lack of Efficacy|0|||
131111515|NCT03602261|472037780|FG001|Overall Study|Lack of Efficacy|1|||
131111516|NCT03602261|472037779|FG000|Overall Study|Subject moving out of state|1|||
131111517|NCT03602261|472037780|FG001|Overall Study|Subject moving out of state|0|||
131111518|NCT05677893|472038962|FG000|Overall Study|Withdrawal by Subject|0|||
131111519|NCT05677893|472038963|FG001|Overall Study|Withdrawal by Subject|0|||
131111520|NCT05677893|472038964|FG002|Overall Study|Withdrawal by Subject|0|||
131111521|NCT05677893|472038965|FG003|Overall Study|Withdrawal by Subject|0|||
131111522|NCT05677893|472038966|FG004|Overall Study|Withdrawal by Subject|1|||
131111523|NCT05677893|472038967|FG005|Overall Study|Withdrawal by Subject|1|||
131111524|NCT05677893|472038968|FG006|Overall Study|Withdrawal by Subject|0|||
131111525|NCT05677893|472038962|FG000|Overall Study|Others|1|||
131111526|NCT05677893|472038963|FG001|Overall Study|Others|0|||
131111527|NCT05677893|472038964|FG002|Overall Study|Others|0|||
131111528|NCT05677893|472038965|FG003|Overall Study|Others|0|||
131111529|NCT05677893|472038966|FG004|Overall Study|Others|0|||
131111530|NCT05677893|472038967|FG005|Overall Study|Others|0|||
130690155|NCT04493684|470491342|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690156|NCT04493684|470491343|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690157|NCT04493684|470491344|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690158|NCT04493684|470491345|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690159|NCT04493684|470491346|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130894167|NCT03023813|471247149|FG002|Overall Study|Lost to Follow-up|0|||
130894168|NCT03679754|471247155|FG000|Overall Study|Investigator request|1|||
130894169|NCT00329797|471247156|FG000|Overall Study|Protocol Violation|1|||
130894170|NCT00329797|471247157|FG001|Overall Study|Protocol Violation|0|||
130894171|NCT00329797|471247156|FG000|Overall Study|Withdrawal by Subject|6|||
130894172|NCT00329797|471247157|FG001|Overall Study|Withdrawal by Subject|6|||
130894173|NCT04535453|471247158|FG000|Overall Study|Death|0|||
130894174|NCT04535453|471247159|FG001|Overall Study|Death|1|||
130894175|NCT04535453|471247160|FG002|Overall Study|Death|0|||
130894176|NCT04535453|471247161|FG003|Overall Study|Death|0|||
131111531|NCT05677893|472038968|FG006|Overall Study|Others|0|||
131111532|NCT01485354|472038971|FG000|Overall Study|Withdrawal by Subject|5|||
131111533|NCT02101034|472038972|FG000|Overall Study|Enrolled but did not start treatment|0|||
131111534|NCT02101034|472038973|FG001|Overall Study|Enrolled but did not start treatment|0|||
130894177|NCT04535453|471247162|FG004|Overall Study|Death|0|||
130894178|NCT04535453|471247163|FG005|Overall Study|Death|0|||
130894179|NCT04535453|471247164|FG006|Overall Study|Death|0|||
130894180|NCT04535453|471247165|FG007|Overall Study|Death|0|||
130894181|NCT04535453|471247166|FG008|Overall Study|Death|0|||
130894182|NCT04535453|471247167|FG009|Overall Study|Death|0|||
130894183|NCT04535453|471247168|FG010|Overall Study|Death|0|||
130894184|NCT04535453|471247169|FG011|Overall Study|Death|0|||
130894185|NCT04535453|471247158|FG000|Overall Study|Lost to Follow-up|1|||
130894186|NCT04535453|471247159|FG001|Overall Study|Lost to Follow-up|1|||
130894187|NCT04535453|471247160|FG002|Overall Study|Lost to Follow-up|1|||
130894188|NCT04535453|471247161|FG003|Overall Study|Lost to Follow-up|0|||
130894189|NCT04535453|471247162|FG004|Overall Study|Lost to Follow-up|3|||
130894190|NCT04535453|471247163|FG005|Overall Study|Lost to Follow-up|1|||
130894191|NCT04535453|471247164|FG006|Overall Study|Lost to Follow-up|0|||
130894192|NCT04535453|471247165|FG007|Overall Study|Lost to Follow-up|0|||
130894193|NCT04535453|471247166|FG008|Overall Study|Lost to Follow-up|1|||
130894194|NCT04535453|471247167|FG009|Overall Study|Lost to Follow-up|1|||
130894195|NCT04535453|471247168|FG010|Overall Study|Lost to Follow-up|0|||
130894196|NCT04535453|471247169|FG011|Overall Study|Lost to Follow-up|0|||
130894197|NCT04535453|471247158|FG000|Overall Study|Physician Decision|0|||
130894198|NCT04535453|471247159|FG001|Overall Study|Physician Decision|0|||
130894199|NCT04535453|471247160|FG002|Overall Study|Physician Decision|0|||
130894200|NCT04535453|471247161|FG003|Overall Study|Physician Decision|1|||
130894201|NCT04535453|471247162|FG004|Overall Study|Physician Decision|0|||
130894202|NCT04535453|471247163|FG005|Overall Study|Physician Decision|0|||
130894203|NCT04535453|471247164|FG006|Overall Study|Physician Decision|0|||
130894204|NCT04535453|471247165|FG007|Overall Study|Physician Decision|0|||
130894205|NCT04535453|471247166|FG008|Overall Study|Physician Decision|0|||
130894206|NCT04535453|471247167|FG009|Overall Study|Physician Decision|0|||
130894207|NCT04535453|471247168|FG010|Overall Study|Physician Decision|0|||
130894208|NCT04535453|471247169|FG011|Overall Study|Physician Decision|0|||
130894209|NCT04535453|471247158|FG000|Overall Study|Withdrawal by Subject|3|||
130894210|NCT04535453|471247159|FG001|Overall Study|Withdrawal by Subject|6|||
130894211|NCT04535453|471247160|FG002|Overall Study|Withdrawal by Subject|3|||
130894212|NCT04535453|471247161|FG003|Overall Study|Withdrawal by Subject|3|||
130894213|NCT04535453|471247162|FG004|Overall Study|Withdrawal by Subject|2|||
130894214|NCT04535453|471247163|FG005|Overall Study|Withdrawal by Subject|1|||
130690160|NCT04493684|470491347|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130767455|NCT00187278|470772397|FG000|Overall Study|Protocol Violation|10|||
130767456|NCT00187278|470772398|FG001|Overall Study|Protocol Violation|13|||
130767457|NCT00803205|470772399|FG000|Overall Study|Adverse Event|7|||
130690161|NCT04493684|470491348|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690162|NCT04493684|470491349|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690163|NCT04493684|470491350|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690164|NCT04493684|470491351|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690165|NCT04493684|470491352|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690166|NCT04493684|470491353|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690167|NCT04493684|470491354|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130767458|NCT00803205|470772400|FG001|Overall Study|Adverse Event|2|||
130767459|NCT00803205|470772399|FG000|Overall Study|Lost to Follow-up|1|||
130767460|NCT00803205|470772400|FG001|Overall Study|Lost to Follow-up|0|||
130767461|NCT00803205|470772399|FG000|Overall Study|Withdrawal by Subject|9|||
130767462|NCT00803205|470772400|FG001|Overall Study|Withdrawal by Subject|9|||
130690168|NCT04493684|470491355|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130767463|NCT00803205|470772399|FG000|Overall Study|Physician Decision|1|||
130767464|NCT00803205|470772400|FG001|Overall Study|Physician Decision|0|||
130767465|NCT00803205|470772399|FG000|Overall Study|Protocol Violation|1|||
130767466|NCT00803205|470772400|FG001|Overall Study|Protocol Violation|1|||
130767467|NCT00803205|470772399|FG000|Overall Study|Medical Monitor Decision|1|||
130767468|NCT00803205|470772400|FG001|Overall Study|Medical Monitor Decision|0|||
130767469|NCT00803205|470772399|FG000|Overall Study|Acquired a Lung Infection|0|||
130767470|NCT00803205|470772400|FG001|Overall Study|Acquired a Lung Infection|1|||
130894215|NCT04535453|471247164|FG006|Overall Study|Withdrawal by Subject|1|||
130894216|NCT04535453|471247165|FG007|Overall Study|Withdrawal by Subject|1|||
130894217|NCT04535453|471247166|FG008|Overall Study|Withdrawal by Subject|1|||
130894218|NCT04535453|471247167|FG009|Overall Study|Withdrawal by Subject|1|||
130894219|NCT04535453|471247168|FG010|Overall Study|Withdrawal by Subject|0|||
130894220|NCT04535453|471247169|FG011|Overall Study|Withdrawal by Subject|1|||
130894221|NCT04535453|471247158|FG000|Overall Study|Other|0|||
130894222|NCT04535453|471247159|FG001|Overall Study|Other|0|||
131025385|NCT00087139|471723244|FG000|Overall Study|Use of coumadin|1|||
130767471|NCT00803205|470772399|FG000|Overall Study|Sponsor Decision|0|||
130767472|NCT00803205|470772400|FG001|Overall Study|Sponsor Decision|1|||
130894223|NCT04535453|471247160|FG002|Overall Study|Other|1|||
130894224|NCT04535453|471247161|FG003|Overall Study|Other|0|||
130894225|NCT04535453|471247162|FG004|Overall Study|Other|1|||
130894226|NCT04535453|471247163|FG005|Overall Study|Other|0|||
130690169|NCT04493684|470491356|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690170|NCT04493684|470491357|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130690171|NCT04493684|470491341|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690172|NCT04493684|470491342|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690173|NCT04493684|470491343|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690174|NCT04493684|470491344|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690175|NCT04493684|470491345|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690176|NCT04493684|470491346|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690177|NCT04493684|470491347|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
130690178|NCT04493684|470491348|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690179|NCT04493684|470491349|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690180|NCT04493684|470491350|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690181|NCT04493684|470491351|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690182|NCT04493684|470491352|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690183|NCT04493684|470491353|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690184|NCT04493684|470491354|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690185|NCT04493684|470491355|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690186|NCT04493684|470491356|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690187|NCT04493684|470491357|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130690188|NCT04493684|470491341|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
130690189|NCT04493684|470491342|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690190|NCT04493684|470491343|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690191|NCT04493684|470491344|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690192|NCT04493684|470491345|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690193|NCT04493684|470491346|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690194|NCT04493684|470491347|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690195|NCT04493684|470491348|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690196|NCT04493684|470491349|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690197|NCT04493684|470491350|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690198|NCT04493684|470491351|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690199|NCT04493684|470491352|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690200|NCT04493684|470491353|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690201|NCT04493684|470491354|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690202|NCT04493684|470491355|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690203|NCT04493684|470491356|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690204|NCT04493684|470491357|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130690205|NCT04493684|470491341|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690206|NCT04493684|470491342|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690207|NCT04493684|470491343|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690208|NCT04493684|470491344|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690209|NCT04493684|470491345|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690210|NCT04493684|470491346|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
130690211|NCT04493684|470491347|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690212|NCT04493684|470491348|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690213|NCT04493684|470491349|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690214|NCT04493684|470491350|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690215|NCT04493684|470491351|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690216|NCT04493684|470491352|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690217|NCT04493684|470491353|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690218|NCT04493684|470491354|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690219|NCT04493684|470491355|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690220|NCT04493684|470491356|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690221|NCT04493684|470491357|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130690222|NCT04493684|470491341|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690223|NCT04493684|470491342|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690224|NCT04493684|470491343|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690225|NCT04493684|470491344|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
131025386|NCT00087139|471723245|FG001|Overall Study|Use of coumadin|0|||
131025387|NCT00087139|471723246|FG002|Overall Study|Use of coumadin|0|||
131025388|NCT00087139|471723244|FG000|Overall Study|Response achieved|0|||
131025389|NCT00087139|471723245|FG001|Overall Study|Response achieved|1|||
131025390|NCT00087139|471723246|FG002|Overall Study|Response achieved|0|||
131025391|NCT00087139|471723244|FG000|Overall Study|Extradural disease|0|||
131025392|NCT00087139|471723245|FG001|Overall Study|Extradural disease|0|||
130894227|NCT04535453|471247164|FG006|Overall Study|Other|1|||
130894228|NCT04535453|471247165|FG007|Overall Study|Other|1|||
130894229|NCT04535453|471247166|FG008|Overall Study|Other|1|||
130894230|NCT04535453|471247167|FG009|Overall Study|Other|0|||
130894231|NCT04535453|471247168|FG010|Overall Study|Other|0|||
130894232|NCT04535453|471247169|FG011|Overall Study|Other|0|||
130894233|NCT02442804|471247172|FG000|Overall Study|Withdrawal by Subject|0|||
130894234|NCT02442804|471247173|FG001|Overall Study|Withdrawal by Subject|1|||
130894235|NCT02442804|471247172|FG000|Overall Study|Adverse Event|1|||
130894236|NCT02442804|471247173|FG001|Overall Study|Adverse Event|0|||
130894237|NCT01309282|471247174|FG000|Overall Study|Lost to Follow-up|1|||
130894238|NCT02087423|471247175|FG000|Overall Study|Withdrawal by Subject|20|||
130894239|NCT02087423|471247176|FG001|Overall Study|Withdrawal by Subject|20|||
130894240|NCT02087423|471247177|FG002|Overall Study|Withdrawal by Subject|3|||
130767473|NCT02735096|470772402|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
130767474|NCT00270231|470772403|FG000|First Intervention|Lost to Follow-up|1|||
130767475|NCT00270231|470772404|FG001|First Intervention|Lost to Follow-up|1|||
130767476|NCT00270231|470772403|FG000|Washout Period|Lost to Follow-up|1|||
130767477|NCT00270231|470772404|FG001|Washout Period|Lost to Follow-up|0|||
130767478|NCT00270231|470772403|FG000|Second Intervention|Lost to Follow-up|0|||
130767479|NCT00270231|470772404|FG001|Second Intervention|Lost to Follow-up|1|||
130767480|NCT00379808|470772405|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
130767481|NCT00379808|470772406|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
130767482|NCT04299048|470772411|FG000|Overall Study|Death|1|||
130767483|NCT04299048|470772411|FG000|Overall Study|Global deterioration of health status|2|||
130767484|NCT04299048|470772411|FG000|Overall Study|Enrolled and not treated|1|||
130767485|NCT01706575|470772413|FG000|Overall Study|Participant Withdrew Consent|4|||
130767486|NCT01706575|470772413|FG000|Overall Study|Lost to Follow-up|2|||
130767487|NCT01706575|470772413|FG000|Overall Study|Started but not Treated|6|||
130767488|NCT01094782|470772414|FG000|Overall Study|Withdrawal by Subject|5|||
130767489|NCT01094782|470772415|FG001|Overall Study|Withdrawal by Subject|5|||
130767490|NCT01094782|470772416|FG002|Overall Study|Withdrawal by Subject|1|||
130767491|NCT01094782|470772417|FG003|Overall Study|Withdrawal by Subject|5|||
130767492|NCT01094782|470772418|FG004|Overall Study|Withdrawal by Subject|5|||
130767493|NCT01094782|470772419|FG005|Overall Study|Withdrawal by Subject|0|||
130767494|NCT01094782|470772414|FG000|Overall Study|Lost to Follow-up|1|||
130767495|NCT01094782|470772415|FG001|Overall Study|Lost to Follow-up|0|||
130767496|NCT01094782|470772416|FG002|Overall Study|Lost to Follow-up|0|||
130767497|NCT01094782|470772417|FG003|Overall Study|Lost to Follow-up|2|||
130767498|NCT01094782|470772418|FG004|Overall Study|Lost to Follow-up|1|||
130767499|NCT01094782|470772419|FG005|Overall Study|Lost to Follow-up|4|||
130767500|NCT01094782|470772414|FG000|Overall Study|Positive Drug Screen|2|||
130767501|NCT01094782|470772415|FG001|Overall Study|Positive Drug Screen|2|||
130767502|NCT01094782|470772416|FG002|Overall Study|Positive Drug Screen|1|||
130767503|NCT01094782|470772417|FG003|Overall Study|Positive Drug Screen|1|||
130767504|NCT01094782|470772418|FG004|Overall Study|Positive Drug Screen|3|||
130767505|NCT01094782|470772419|FG005|Overall Study|Positive Drug Screen|2|||
130767506|NCT01094782|470772414|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
130767507|NCT01094782|470772415|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
130767508|NCT01094782|470772416|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
130767509|NCT01094782|470772417|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
130767510|NCT01094782|470772418|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
130767511|NCT01094782|470772419|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
130767512|NCT01094782|470772414|FG000|Overall Study|Unable to Complete Questionnaires|0|||
130767513|NCT01094782|470772415|FG001|Overall Study|Unable to Complete Questionnaires|1|||
130767514|NCT01094782|470772416|FG002|Overall Study|Unable to Complete Questionnaires|0|||
130767515|NCT01094782|470772417|FG003|Overall Study|Unable to Complete Questionnaires|0|||
130767516|NCT01094782|470772418|FG004|Overall Study|Unable to Complete Questionnaires|0|||
130767517|NCT01094782|470772419|FG005|Overall Study|Unable to Complete Questionnaires|0|||
130767518|NCT01094782|470772414|FG000|Overall Study|Healthy Subject Had Pain|0|||
130767519|NCT01094782|470772415|FG001|Overall Study|Healthy Subject Had Pain|1|||
130767520|NCT01094782|470772416|FG002|Overall Study|Healthy Subject Had Pain|0|||
130767521|NCT01094782|470772417|FG003|Overall Study|Healthy Subject Had Pain|0|||
130767522|NCT01094782|470772418|FG004|Overall Study|Healthy Subject Had Pain|0|||
130767523|NCT01094782|470772419|FG005|Overall Study|Healthy Subject Had Pain|0|||
130894241|NCT02087423|471247175|FG000|Overall Study|Death|68|||
130767524|NCT01094782|470772414|FG000|Overall Study|Hypertension|0|||
130767525|NCT01094782|470772415|FG001|Overall Study|Hypertension|0|||
130767526|NCT01094782|470772416|FG002|Overall Study|Hypertension|1|||
130767527|NCT01094782|470772417|FG003|Overall Study|Hypertension|0|||
130894242|NCT02087423|471247176|FG001|Overall Study|Death|207|||
130894243|NCT02087423|471247177|FG002|Overall Study|Death|40|||
130894244|NCT02087423|471247175|FG000|Overall Study|Lost to Follow-up|0|||
130767528|NCT01094782|470772418|FG004|Overall Study|Hypertension|0|||
130894245|NCT02087423|471247176|FG001|Overall Study|Lost to Follow-up|2|||
130894246|NCT02087423|471247177|FG002|Overall Study|Lost to Follow-up|0|||
130894247|NCT02087423|471247175|FG000|Overall Study|Terminated from study at final DCO|23|||
130894248|NCT02087423|471247176|FG001|Overall Study|Terminated from study at final DCO|36|||
130894249|NCT02087423|471247177|FG002|Overall Study|Terminated from study at final DCO|25|||
130894250|NCT01387542|471247178|FG000|Overall Study|Adverse Event|3|||
130894251|NCT01387542|471247178|FG000|Overall Study|Withdrawal by Subject|1|||
130894252|NCT01387542|471247178|FG000|Overall Study|Changed diagnosis|1|||
130894253|NCT01387542|471247178|FG000|Overall Study|Insufficient response|1|||
130894254|NCT01387542|471247178|FG000|Overall Study|Non-compliant|1|||
130894255|NCT01387542|471247178|FG000|Overall Study|Lost to Follow-up|1|||
130894256|NCT01010867|471247179|FG000|Overall Study|< 50% adherence to probiotic|1|||
130894257|NCT00499590|471247182|FG000|Overall Study|Study Terminated|112|||
130894258|NCT00499590|471247183|FG001|Overall Study|Study Terminated|112|||
130894259|NCT00499590|471247184|FG002|Overall Study|Study Terminated|112|||
130894260|NCT00499590|471247182|FG000|Overall Study|Not treated|1|||
130894261|NCT00499590|471247183|FG001|Overall Study|Not treated|0|||
130894262|NCT00499590|471247184|FG002|Overall Study|Not treated|1|||
130894263|NCT02633020|471247186|FG000|Overall Study|Adverse Event|1|||
130894264|NCT02633020|471247187|FG001|Overall Study|Adverse Event|0|||
130894265|NCT05661851|471247188|FG000|Overall Study|Protocol Violation|1|||
130894266|NCT05661851|471247189|FG001|Overall Study|Protocol Violation|1|||
130894267|NCT05661851|471247188|FG000|Overall Study|Covid-19 Related|3|||
130894268|NCT05661851|471247189|FG001|Overall Study|Covid-19 Related|4|||
130894269|NCT05661851|471247188|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
130894270|NCT05661851|471247189|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
130894271|NCT05661851|471247188|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
130894272|NCT05661851|471247189|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
130894273|NCT00612807|471247190|FG000|Overall Study|Withdrawal by Subject|2|||
130894274|NCT00612807|471247191|FG001|Overall Study|Withdrawal by Subject|0|||
130894275|NCT02055118|471247202|FG000|Overall Study|Withdrawal by Subject|0|||
130894276|NCT02055118|471247203|FG001|Overall Study|Withdrawal by Subject|2|||
130894277|NCT02055118|471247204|FG002|Overall Study|Withdrawal by Subject|0|||
130894278|NCT02281383|471247205|FG000|Overall Study|Progressive Disease|1|||
130894279|NCT02281383|471247205|FG000|Overall Study|Withdrawal by Subject|6|||
131111535|NCT02101034|472038974|FG002|Overall Study|Enrolled but did not start treatment|1|||
131111536|NCT02101034|472038975|FG003|Overall Study|Enrolled but did not start treatment|0|||
131111537|NCT02101034|472038976|FG004|Overall Study|Enrolled but did not start treatment|0|||
131111538|NCT01103245|472038981|FG000|Overall Study|Withdrawal by Subject|1|||
131111539|NCT01103245|472038982|FG001|Overall Study|Withdrawal by Subject|0|||
131111540|NCT01103245|472038983|FG002|Overall Study|Withdrawal by Subject|3|||
131111541|NCT01103245|472038984|FG003|Overall Study|Withdrawal by Subject|0|||
131111542|NCT01103245|472038981|FG000|Overall Study|Inadequate IV access|1|||
131111543|NCT01103245|472038982|FG001|Overall Study|Inadequate IV access|0|||
131111544|NCT01103245|472038983|FG002|Overall Study|Inadequate IV access|0|||
131111545|NCT01103245|472038984|FG003|Overall Study|Inadequate IV access|0|||
131111546|NCT01103245|472038981|FG000|Overall Study|Adverse Event|0|||
131111547|NCT01103245|472038982|FG001|Overall Study|Adverse Event|2|||
131111548|NCT01103245|472038983|FG002|Overall Study|Adverse Event|1|||
131111549|NCT01103245|472038984|FG003|Overall Study|Adverse Event|0|||
131111550|NCT01103245|472038981|FG000|Overall Study|Physician Decision|1|||
131111551|NCT01103245|472038982|FG001|Overall Study|Physician Decision|0|||
131111552|NCT01103245|472038983|FG002|Overall Study|Physician Decision|0|||
131111553|NCT01103245|472038984|FG003|Overall Study|Physician Decision|0|||
131111554|NCT01101477|472038986|FG000|Overall Study|Protocol Violation|5|||
131111555|NCT01101477|472038987|FG001|Overall Study|Protocol Violation|3|||
131111556|NCT01101477|472038988|FG002|Overall Study|Protocol Violation|1|||
131111557|NCT00720941|472038989|FG000|Overall Study|Protocol Violation|1|||
131111558|NCT00720941|472038990|FG001|Overall Study|Protocol Violation|2|||
131111559|NCT00720941|472038989|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
131111560|NCT00720941|472038990|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
131111561|NCT00720941|472038989|FG000|Overall Study|Lost to Follow-up|20|||
131111562|NCT00720941|472038990|FG001|Overall Study|Lost to Follow-up|15|||
130894280|NCT02281383|471247205|FG000|Overall Study|Protocol Violation|2|||
131111563|NCT00720941|472038989|FG000|Overall Study|Physician Decision|14|||
131111564|NCT00720941|472038990|FG001|Overall Study|Physician Decision|12|||
131111565|NCT00720941|472038989|FG000|Overall Study|Withdrawal by Subject|29|||
131111566|NCT00720941|472038990|FG001|Overall Study|Withdrawal by Subject|36|||
131111567|NCT00604279|472038991|FG000|Overall Study|Lack of Efficacy|22|||
130894281|NCT02281383|471247205|FG000|Overall Study|Death|1|||
130894282|NCT02281383|471247205|FG000|Overall Study|Adverse Event|2|||
130894283|NCT02259088|471247206|FG000|Overall Study|Adverse Event|6|||
130894284|NCT02259088|471247207|FG001|Overall Study|Adverse Event|4|||
130894285|NCT02259088|471247206|FG000|Overall Study|Lost to Follow-up|2|||
131111568|NCT00604279|472038992|FG001|Overall Study|Lack of Efficacy|9|||
131111569|NCT00604279|472038991|FG000|Overall Study|Lost to Follow-up|9|||
131111570|NCT00604279|472038992|FG001|Overall Study|Lost to Follow-up|14|||
130894286|NCT02259088|471247207|FG001|Overall Study|Lost to Follow-up|0|||
130894287|NCT02259088|471247206|FG000|Overall Study|Death|2|||
130894288|NCT02259088|471247207|FG001|Overall Study|Death|0|||
130894289|NCT02259088|471247206|FG000|Overall Study|Physician Decision|5|||
130690226|NCT04493684|470491345|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130894290|NCT02259088|471247207|FG001|Overall Study|Physician Decision|2|||
130894291|NCT02259088|471247206|FG000|Overall Study|Protocol deviation|5|||
130894292|NCT02259088|471247207|FG001|Overall Study|Protocol deviation|0|||
130894293|NCT02259088|471247206|FG000|Overall Study|Subject/guardian decision|8|||
130894294|NCT02259088|471247207|FG001|Overall Study|Subject/guardian decision|8|||
130894295|NCT02745080|471247212|FG000|Overall Study|Adverse Event|13|||
130894296|NCT02745080|471247213|FG001|Overall Study|Adverse Event|21|||
130894297|NCT02745080|471247212|FG000|Overall Study|Lack of Efficacy|11|||
130894298|NCT02745080|471247213|FG001|Overall Study|Lack of Efficacy|23|||
130894299|NCT02745080|471247212|FG000|Overall Study|Lost to Follow-up|3|||
130894300|NCT02745080|471247213|FG001|Overall Study|Lost to Follow-up|3|||
130894301|NCT02745080|471247212|FG000|Overall Study|Physician Decision|3|||
130894302|NCT02745080|471247213|FG001|Overall Study|Physician Decision|0|||
130894303|NCT02745080|471247212|FG000|Overall Study|Protocol Violation|3|||
130894304|NCT02745080|471247213|FG001|Overall Study|Protocol Violation|1|||
130894305|NCT02745080|471247212|FG000|Overall Study|Withdrawal by Subject|22|||
130894306|NCT02745080|471247213|FG001|Overall Study|Withdrawal by Subject|41|||
130894307|NCT01001325|471247216|FG000|Overall Study|Lost to Follow-up|16|||
130894308|NCT01001325|471247217|FG001|Overall Study|Lost to Follow-up|10|||
130894309|NCT01001325|471247216|FG000|Overall Study|Protocol Violation|2|||
130894310|NCT01001325|471247217|FG001|Overall Study|Protocol Violation|0|||
130894311|NCT01584440|471247218|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
130894312|NCT01584440|471247219|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130894313|NCT01584440|471247220|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130894314|NCT01584440|471247221|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130894315|NCT01584440|471247222|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130894316|NCT01584440|471247218|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
130894317|NCT01584440|471247219|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
131111571|NCT00604279|472038991|FG000|Overall Study|Pregnancy|2|||
130690227|NCT04493684|470491346|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690228|NCT04493684|470491347|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690229|NCT04493684|470491348|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690230|NCT04493684|470491349|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690231|NCT04493684|470491350|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690232|NCT04493684|470491351|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690233|NCT04493684|470491352|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
130690234|NCT04493684|470491353|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690235|NCT04493684|470491354|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690236|NCT04493684|470491355|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690237|NCT04493684|470491356|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690238|NCT04493684|470491357|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130690239|NCT04493684|470491341|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690240|NCT04493684|470491342|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690241|NCT04493684|470491343|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690242|NCT04493684|470491344|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690243|NCT04493684|470491345|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690244|NCT04493684|470491346|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690245|NCT04493684|470491347|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690246|NCT04493684|470491348|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690247|NCT04493684|470491349|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690248|NCT04493684|470491350|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690249|NCT04493684|470491351|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690250|NCT04493684|470491352|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690251|NCT04493684|470491353|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690252|NCT04493684|470491354|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690253|NCT04493684|470491355|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690254|NCT04493684|470491356|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
130767529|NCT01094782|470772419|FG005|Overall Study|Hypertension|0|||
130767530|NCT01094782|470772414|FG000|Overall Study|Wrong Pain Condition|0|||
130894318|NCT01584440|471247220|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
130894319|NCT01584440|471247221|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
130894320|NCT01584440|471247222|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
130894321|NCT01584440|471247218|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
130894322|NCT01584440|471247219|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130894323|NCT01584440|471247220|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
131111572|NCT00604279|472038992|FG001|Overall Study|Pregnancy|0|||
131111573|NCT00604279|472038991|FG000|Overall Study|Protocol Violation|3|||
131111574|NCT00604279|472038992|FG001|Overall Study|Protocol Violation|1|||
131111575|NCT00604279|472038991|FG000|Overall Study|Withdrawal by Subject|16|||
131111576|NCT00604279|472038992|FG001|Overall Study|Withdrawal by Subject|5|||
131111577|NCT00604279|472038991|FG000|Overall Study|Adverse Event|4|||
131111578|NCT00604279|472038992|FG001|Overall Study|Adverse Event|5|||
131111579|NCT00604279|472038991|FG000|Overall Study|Other|8|||
131111580|NCT00604279|472038992|FG001|Overall Study|Other|4|||
131111581|NCT00355056|472038993|FG000|Randomization Period|Early Termination|4|||
131111582|NCT00355056|472038994|FG001|Randomization Period|Early Termination|6|||
131111583|NCT01072877|472039000|FG000|Overall Study|Lost to Follow-up|1|||
131111584|NCT01072877|472039001|FG001|Overall Study|Lost to Follow-up|1|||
131111585|NCT01072877|472039002|FG002|Overall Study|Lost to Follow-up|0|||
131111586|NCT01072877|472039003|FG003|Overall Study|Lost to Follow-up|2|||
131111587|NCT01072877|472039004|FG004|Overall Study|Lost to Follow-up|0|||
130690255|NCT04493684|470491357|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130690256|NCT04493684|470491341|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690257|NCT04493684|470491342|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690258|NCT04493684|470491343|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690259|NCT04493684|470491344|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690260|NCT04493684|470491345|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690261|NCT04493684|470491346|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690262|NCT04493684|470491347|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690263|NCT04493684|470491348|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690264|NCT04493684|470491349|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690265|NCT04493684|470491350|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690266|NCT04493684|470491351|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690267|NCT04493684|470491352|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690268|NCT04493684|470491353|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690269|NCT04493684|470491354|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690270|NCT04493684|470491355|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690271|NCT04493684|470491356|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
130690272|NCT04493684|470491357|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130690273|NCT01963728|470491358|FG000|Overall Study|Study terminated early|0|||
130690274|NCT01963728|470491359|FG001|Overall Study|Study terminated early|1|||
130690275|NCT05152576|470491362|FG000|Overall Study|Lost to Follow-up|3|||
130690276|NCT05152576|470491363|FG001|Overall Study|Lost to Follow-up|0|||
130690277|NCT05152576|470491364|FG002|Overall Study|Lost to Follow-up|0|||
130690278|NCT05152576|470491365|FG003|Overall Study|Lost to Follow-up|1|||
130690279|NCT05152576|470491362|FG000|Overall Study|Withdrawal by Subject|0|||
130690280|NCT05152576|470491363|FG001|Overall Study|Withdrawal by Subject|1|||
130690281|NCT05152576|470491364|FG002|Overall Study|Withdrawal by Subject|0|||
130690282|NCT05152576|470491365|FG003|Overall Study|Withdrawal by Subject|1|||
130690283|NCT05152576|470491362|FG000|Overall Study|Other|2|||
130690284|NCT05152576|470491363|FG001|Overall Study|Other|0|||
130690285|NCT05152576|470491364|FG002|Overall Study|Other|0|||
130690286|NCT05152576|470491365|FG003|Overall Study|Other|0|||
130690287|NCT03447353|470493013|FG000|Overall Study|Failure at Screening Visit|2|||
130690288|NCT03447353|470493013|FG000|Overall Study|Lost to Follow-up|4|||
130690289|NCT03447353|470493013|FG000|Overall Study|Scheduling Conflicts|3|||
130690290|NCT03447353|470493013|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
130690291|NCT02642653|470493016|FG000|Overall Study|Adverse Event|2|||
130690292|NCT02642653|470493017|FG001|Overall Study|Adverse Event|0|||
130690293|NCT02267187|470493018|FG000|Overall Study|Physician Decision|2|||
130690294|NCT02267187|470493018|FG000|Overall Study|Screen fail|3|||
130690295|NCT02222818|470493024|FG000|Period 1|Eligibility criteria not met|0|||
130690296|NCT02222818|470493025|FG001|Period 1|Eligibility criteria not met|3|||
130690297|NCT03025087|470493026|FG000|Overall Study|Physician Decision|3|||
130690298|NCT03025087|470493027|FG001|Overall Study|Physician Decision|3|||
130690299|NCT03025087|470493028|FG002|Overall Study|Physician Decision|0|||
130690300|NCT03025087|470493029|FG003|Overall Study|Physician Decision|0|||
130690301|NCT03025087|470493030|FG004|Overall Study|Physician Decision|0|||
130690302|NCT03025087|470493026|FG000|Overall Study|Withdrawal by Subject|1|||
130690303|NCT03025087|470493027|FG001|Overall Study|Withdrawal by Subject|1|||
131111588|NCT00995020|472039005|FG000|Overall Study|margin analysis not performed|2|||
130690304|NCT03025087|470493028|FG002|Overall Study|Withdrawal by Subject|0|||
130690305|NCT03025087|470493029|FG003|Overall Study|Withdrawal by Subject|0|||
130690306|NCT03025087|470493030|FG004|Overall Study|Withdrawal by Subject|0|||
130690307|NCT03025087|470493026|FG000|Overall Study|Unable to complete MRI|2|||
131111589|NCT00995020|472039006|FG001|Overall Study|margin analysis not performed|5|||
131111590|NCT00995020|472039005|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
131111591|NCT00995020|472039006|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
130894324|NCT01584440|471247221|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130894325|NCT01584440|471247222|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130894326|NCT01584440|471247218|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
130894327|NCT01584440|471247219|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
130894328|NCT01584440|471247220|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
130894329|NCT01584440|471247221|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
130894330|NCT01584440|471247222|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
130894331|NCT01584440|471247218|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
130894332|NCT01584440|471247219|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130894333|NCT01584440|471247220|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130894334|NCT01584440|471247221|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130894335|NCT01584440|471247222|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130894336|NCT01584440|471247218|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130767531|NCT01094782|470772415|FG001|Overall Study|Wrong Pain Condition|0|||
130894337|NCT01584440|471247219|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
130894338|NCT01584440|471247220|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130894339|NCT01584440|471247221|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130894340|NCT01584440|471247222|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130894341|NCT01584440|471247218|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
130767532|NCT01094782|470772416|FG002|Overall Study|Wrong Pain Condition|0|||
130767533|NCT01094782|470772417|FG003|Overall Study|Wrong Pain Condition|2|||
130767534|NCT01094782|470772418|FG004|Overall Study|Wrong Pain Condition|1|||
131111592|NCT02720536|472039007|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
131111593|NCT02720536|472039007|FG000|Overall Study|PR - pregnancy|2|||
131111594|NCT02720536|472039007|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
131111595|NCT02720536|472039007|FG000|Overall Study|PR - death|1|||
131111596|NCT02720536|472039007|FG000|Overall Study|PR - adverse event|1|||
131111597|NCT02720536|472039007|FG000|Overall Study|PR - abnormal lab value(s)|1|||
131111598|NCT02720536|472039007|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
131111599|NCT00719563|472039009|FG000|Overall Study|Adverse Event|16|||
131111600|NCT00719563|472039010|FG001|Overall Study|Adverse Event|13|||
131111601|NCT00719563|472039009|FG000|Overall Study|Medical condition changed|3|||
131111602|NCT00719563|472039010|FG001|Overall Study|Medical condition changed|5|||
131111603|NCT00719563|472039009|FG000|Overall Study|Lack of Efficacy|3|||
131111604|NCT00719563|472039010|FG001|Overall Study|Lack of Efficacy|7|||
131111605|NCT00719563|472039009|FG000|Overall Study|Personal reasons|6|||
131111606|NCT00719563|472039010|FG001|Overall Study|Personal reasons|7|||
131111607|NCT00719563|472039009|FG000|Overall Study|Unknown reasons|4|||
131111608|NCT00719563|472039010|FG001|Overall Study|Unknown reasons|6|||
131111609|NCT00719563|472039009|FG000|Overall Study|Noncompliant|1|||
131111610|NCT00719563|472039010|FG001|Overall Study|Noncompliant|1|||
131111611|NCT00719563|472039009|FG000|Overall Study|Lost to Follow-up|5|||
131111612|NCT00719563|472039010|FG001|Overall Study|Lost to Follow-up|3|||
131111613|NCT00792805|472039013|FG000|Overall Study|Adverse Event|12|||
131111614|NCT00792805|472039014|FG001|Overall Study|Adverse Event|10|||
131111615|NCT00792805|472039015|FG002|Overall Study|Adverse Event|10|||
130894342|NCT01584440|471247219|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
130894343|NCT01584440|471247220|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
130894344|NCT01584440|471247221|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
130894345|NCT01584440|471247222|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
131111616|NCT00792805|472039013|FG000|Overall Study|Subject withdrew consent|5|||
130767535|NCT01094782|470772419|FG005|Overall Study|Wrong Pain Condition|1|||
130767536|NCT01094782|470772414|FG000|Overall Study|Recent Interventional Injection|0|||
130767537|NCT01094782|470772415|FG001|Overall Study|Recent Interventional Injection|0|||
130767538|NCT01094782|470772416|FG002|Overall Study|Recent Interventional Injection|0|||
130767539|NCT01094782|470772417|FG003|Overall Study|Recent Interventional Injection|0|||
130767540|NCT01094782|470772418|FG004|Overall Study|Recent Interventional Injection|0|||
130767541|NCT01094782|470772419|FG005|Overall Study|Recent Interventional Injection|1|||
130767542|NCT01094782|470772414|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130767543|NCT01094782|470772415|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130767544|NCT01094782|470772416|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130767545|NCT01094782|470772417|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130767546|NCT01094782|470772418|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
130767547|NCT01094782|470772419|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130767548|NCT01094782|470772414|FG000|Overall Study|Noncompliance With Study Schedule|0|||
131111617|NCT00792805|472039014|FG001|Overall Study|Subject withdrew consent|6|||
130767549|NCT01094782|470772415|FG001|Overall Study|Noncompliance With Study Schedule|0|||
130767550|NCT01094782|470772416|FG002|Overall Study|Noncompliance With Study Schedule|0|||
130767551|NCT01094782|470772417|FG003|Overall Study|Noncompliance With Study Schedule|1|||
131111618|NCT00792805|472039015|FG002|Overall Study|Subject withdrew consent|5|||
130767552|NCT01094782|470772418|FG004|Overall Study|Noncompliance With Study Schedule|0|||
130894346|NCT01584440|471247218|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
130894347|NCT01584440|471247219|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
130894348|NCT01584440|471247220|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
131111619|NCT00792805|472039013|FG000|Overall Study|Administrative problems|2|||
130894349|NCT01584440|471247221|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
130894350|NCT01584440|471247222|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
130894351|NCT01584440|471247218|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130894352|NCT01584440|471247219|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130894353|NCT01584440|471247220|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
130894354|NCT01584440|471247221|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130894355|NCT01584440|471247222|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130894356|NCT00899431|471247223|FG000|Overall Study|Physician Decision|1|||
130894357|NCT00899431|471247224|FG001|Overall Study|Physician Decision|0|||
130894358|NCT00899431|471247225|FG002|Overall Study|Physician Decision|0|||
130894359|NCT00661427|471247226|FG000|Overall Study|Adverse Event|5|||
130894360|NCT00661427|471247227|FG001|Overall Study|Adverse Event|5|||
130894361|NCT00661427|471247226|FG000|Overall Study|Patient not treated|0|||
130894362|NCT00661427|471247227|FG001|Overall Study|Patient not treated|2|||
130894363|NCT01821560|471247228|FG000|Overall Study|Lost to Follow-up|5|||
130894364|NCT01821560|471247229|FG001|Overall Study|Lost to Follow-up|5|||
130894365|NCT01821560|471247228|FG000|Overall Study|Withdrawal by Subject|1|||
130894366|NCT01821560|471247229|FG001|Overall Study|Withdrawal by Subject|1|||
130894367|NCT01821560|471247228|FG000|Overall Study|Protocol Violation|0|||
130894368|NCT01821560|471247229|FG001|Overall Study|Protocol Violation|1|||
130894369|NCT01338298|471247230|FG000|Overall Study|Withdrawal by Subject|1|||
130894370|NCT01338298|471247231|FG001|Overall Study|Withdrawal by Subject|1|||
130894371|NCT01338298|471247230|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
130894372|NCT01338298|471247231|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
130894373|NCT01338298|471247230|FG000|Overall Study|Administrative error|0|||
130894374|NCT01338298|471247231|FG001|Overall Study|Administrative error|1|||
130894375|NCT01338298|471247230|FG000|Overall Study|Positive symptom worsening|1|||
130894376|NCT01338298|471247231|FG001|Overall Study|Positive symptom worsening|0|||
130894377|NCT01338298|471247230|FG000|Overall Study|Depressive symptoms and nausea|1|||
130894378|NCT01338298|471247231|FG001|Overall Study|Depressive symptoms and nausea|0|||
130894379|NCT01338298|471247230|FG000|Overall Study|Non-adherence|1|||
130894380|NCT01338298|471247231|FG001|Overall Study|Non-adherence|0|||
130894381|NCT02872285|471247232|FG000|Overall Study|Withdrawal by Subject|2|||
130894382|NCT02872285|471247233|FG001|Overall Study|Withdrawal by Subject|0|||
130894383|NCT02872285|471247232|FG000|Overall Study|Lost to Follow-up|2|||
130894384|NCT02872285|471247233|FG001|Overall Study|Lost to Follow-up|2|||
130894385|NCT02872285|471247232|FG000|Overall Study|Discontinued due to back surgery|1|||
130894386|NCT02872285|471247233|FG001|Overall Study|Discontinued due to back surgery|0|||
130894387|NCT01253577|471247236|FG000|Overall Study|Lost to Follow-up|3|||
130894388|NCT00334113|471247237|FG000|Overall Study|Lost to Follow-up|2|||
130894389|NCT00334113|471247238|FG001|Overall Study|Lost to Follow-up|2|||
130894390|NCT00334113|471247237|FG000|Overall Study|Withdrawal by Subject|0|||
130894391|NCT00334113|471247238|FG001|Overall Study|Withdrawal by Subject|1|||
130894392|NCT02509026|471247239|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
130894393|NCT02509026|471247239|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
131111620|NCT00792805|472039014|FG001|Overall Study|Administrative problems|0|||
131111621|NCT00792805|472039015|FG002|Overall Study|Administrative problems|4|||
131111622|NCT00792805|472039013|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131111623|NCT00792805|472039014|FG001|Overall Study|Abnormal test procedure result(s)|2|||
131111624|NCT00792805|472039015|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131111625|NCT00792805|472039013|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131111626|NCT00792805|472039014|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
131111627|NCT00792805|472039015|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
130690308|NCT03025087|470493027|FG001|Overall Study|Unable to complete MRI|2|||
130690309|NCT03025087|470493028|FG002|Overall Study|Unable to complete MRI|0|||
130690310|NCT03025087|470493029|FG003|Overall Study|Unable to complete MRI|0|||
130690311|NCT03025087|470493030|FG004|Overall Study|Unable to complete MRI|0|||
130690312|NCT01376037|470493045|FG000|Overall Study|Lost to Follow-up|0|||
130690313|NCT01376037|470493046|FG001|Overall Study|Lost to Follow-up|2|||
130690314|NCT02328040|470493048|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
130690315|NCT02328040|470493049|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
130690316|NCT03121586|470493052|FG000|Overall Study|Study terminated by sponsor|0|||
130690317|NCT03121586|470493053|FG001|Overall Study|Study terminated by sponsor|0|||
130690318|NCT03121586|470493054|FG002|Overall Study|Study terminated by sponsor|99|||
130690319|NCT03121586|470493052|FG000|Overall Study|Withdrawal by Subject|37|||
130894394|NCT02509026|471247239|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
130894395|NCT02509026|471247239|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
130894396|NCT02509026|471247239|FG000|Induction Period (24 Weeks)|Other|2|||
130894397|NCT02509026|471247239|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
130894398|NCT02509026|471247239|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
130894399|NCT02509026|471247239|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
130894400|NCT02509026|471247239|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
130894401|NCT02509026|471247239|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
130894402|NCT02509026|471247239|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
131111628|NCT00792805|472039013|FG000|Overall Study|Lost to Follow-up|1|||
131111629|NCT00792805|472039014|FG001|Overall Study|Lost to Follow-up|1|||
131111630|NCT00792805|472039015|FG002|Overall Study|Lost to Follow-up|6|||
131111631|NCT00792805|472039013|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131111632|NCT00792805|472039014|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131111633|NCT00792805|472039015|FG002|Overall Study|Abnormal laboratory value(s)|1|||
131111634|NCT00792805|472039013|FG000|Overall Study|Protocol deviation|0|||
131111635|NCT00792805|472039014|FG001|Overall Study|Protocol deviation|1|||
131111636|NCT00792805|472039015|FG002|Overall Study|Protocol deviation|1|||
131111637|NCT03224325|472039016|FG000|Overall Study|Adverse Event|1|||
130690320|NCT03121586|470493053|FG001|Overall Study|Withdrawal by Subject|14|||
130690321|NCT03121586|470493054|FG002|Overall Study|Withdrawal by Subject|9|||
130690322|NCT03121586|470493052|FG000|Overall Study|Not further specified|6|||
130690323|NCT03121586|470493053|FG001|Overall Study|Not further specified|11|||
130690324|NCT03121586|470493054|FG002|Overall Study|Not further specified|10|||
130690325|NCT03121586|470493052|FG000|Overall Study|Adverse Event|16|||
130690326|NCT03121586|470493053|FG001|Overall Study|Adverse Event|5|||
130690327|NCT03121586|470493054|FG002|Overall Study|Adverse Event|6|||
130690328|NCT03121586|470493052|FG000|Overall Study|Protocol Violation|0|||
130690329|NCT03121586|470493053|FG001|Overall Study|Protocol Violation|5|||
130690330|NCT03121586|470493054|FG002|Overall Study|Protocol Violation|0|||
130690331|NCT03121586|470493052|FG000|Overall Study|Lack of Efficacy|3|||
130690332|NCT03121586|470493053|FG001|Overall Study|Lack of Efficacy|3|||
130690333|NCT03121586|470493054|FG002|Overall Study|Lack of Efficacy|1|||
130690334|NCT03121586|470493052|FG000|Overall Study|Physician Decision|2|||
130690335|NCT03121586|470493053|FG001|Overall Study|Physician Decision|2|||
130690336|NCT03121586|470493054|FG002|Overall Study|Physician Decision|0|||
130690337|NCT03121586|470493052|FG000|Overall Study|Noncompliance with study drug|5|||
130690338|NCT03121586|470493053|FG001|Overall Study|Noncompliance with study drug|3|||
130690339|NCT03121586|470493054|FG002|Overall Study|Noncompliance with study drug|5|||
130690340|NCT03121586|470493052|FG000|Overall Study|Lost to Follow-up|4|||
130690341|NCT03121586|470493053|FG001|Overall Study|Lost to Follow-up|2|||
130690342|NCT03121586|470493054|FG002|Overall Study|Lost to Follow-up|0|||
130690343|NCT03121586|470493052|FG000|Overall Study|Death|2|||
130690344|NCT03121586|470493053|FG001|Overall Study|Death|0|||
130690345|NCT03121586|470493054|FG002|Overall Study|Death|0|||
130690346|NCT06381102|470493055|FG000|Washout 5 Days|Withdrawal by Subject|0|||
130690347|NCT06381102|470493056|FG001|Washout 5 Days|Withdrawal by Subject|2|||
130690348|NCT04278560|470493058|FG000|Overall Study|Adverse Event|1|||
130690349|NCT04278560|470493059|FG001|Overall Study|Adverse Event|2|||
130690350|NCT04278560|470493058|FG000|Overall Study|Withdrawal by Subject|0|||
130690351|NCT04278560|470493059|FG001|Overall Study|Withdrawal by Subject|1|||
130690352|NCT02832063|470493060|FG000|Overall Study|Adverse Event|2|||
130690353|NCT02832063|470493061|FG001|Overall Study|Adverse Event|1|||
130690354|NCT02832063|470493060|FG000|Overall Study|Physician Decision|5|||
130690355|NCT02832063|470493061|FG001|Overall Study|Physician Decision|7|||
130690356|NCT02832063|470493060|FG000|Overall Study|Lost to Follow-up|15|||
130690357|NCT02832063|470493061|FG001|Overall Study|Lost to Follow-up|8|||
130690358|NCT02832063|470493060|FG000|Overall Study|Withdrawal by Subject|10|||
130690359|NCT02832063|470493061|FG001|Overall Study|Withdrawal by Subject|21|||
130690360|NCT02832063|470493060|FG000|Overall Study|Other|2|||
130690361|NCT02832063|470493061|FG001|Overall Study|Other|1|||
130690362|NCT00604162|470493062|FG000|Overall Study|Physician Decision|3|||
130690363|NCT00604162|470493062|FG000|Overall Study|Withdrawal by Subject|1|||
130690364|NCT02241551|470493063|FG000|Overall Study|Adverse Event|1|||
130690365|NCT02241551|470493064|FG001|Overall Study|Adverse Event|0|||
130690366|NCT01015287|470493065|FG000|Overall Study|Death|21|||
130690367|NCT01015287|470493066|FG001|Overall Study|Death|16|||
130690368|NCT01015287|470493065|FG000|Overall Study|Adverse Event|1|||
130690369|NCT01015287|470493066|FG001|Overall Study|Adverse Event|0|||
130690370|NCT01015287|470493065|FG000|Overall Study|Sponsor Decision|3|||
130690371|NCT01015287|470493066|FG001|Overall Study|Sponsor Decision|7|||
130690372|NCT01015287|470493065|FG000|Overall Study|Physician Decision|19|||
130690373|NCT01015287|470493066|FG001|Overall Study|Physician Decision|21|||
131111638|NCT03224325|472039017|FG001|Overall Study|Adverse Event|0|||
131111639|NCT03224325|472039018|FG002|Overall Study|Adverse Event|0|||
131111640|NCT03224325|472039019|FG003|Overall Study|Adverse Event|0|||
130690374|NCT01015287|470493065|FG000|Overall Study|Withdrawal by Subject|14|||
130690375|NCT01015287|470493066|FG001|Overall Study|Withdrawal by Subject|19|||
130690376|NCT01015287|470493065|FG000|Overall Study|Entry Criteria not Met|11|||
130690377|NCT01015287|470493066|FG001|Overall Study|Entry Criteria not Met|14|||
130690378|NCT01015287|470493065|FG000|Overall Study|Lost to Follow-up|2|||
130690379|NCT01015287|470493066|FG001|Overall Study|Lost to Follow-up|1|||
130690380|NCT01015287|470493065|FG000|Overall Study|Protocol Violation|1|||
130690381|NCT01015287|470493066|FG001|Overall Study|Protocol Violation|1|||
130690382|NCT00469898|470493067|FG000|Overall Study|Adverse Event|7|||
130690383|NCT00469898|470493067|FG000|Overall Study|Withdrawal by Subject|4|||
130690384|NCT00469898|470493067|FG000|Overall Study|Death|4|||
130690385|NCT00469898|470493067|FG000|Overall Study|Disease progression|9|||
130894403|NCT02509026|471247239|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
130894404|NCT02509026|471247239|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
130894405|NCT00721968|471247240|FG000|Overall Study|Lost to Follow-up|2|||
130894406|NCT00721968|471247241|FG001|Overall Study|Lost to Follow-up|0|||
130894407|NCT05601544|471247242|FG000|Phase 2 Period 1|Adverse Event|0|||
130894408|NCT05601544|471247243|FG001|Phase 2 Period 1|Adverse Event|1|||
130894409|NCT05601544|471247244|FG002|Phase 2 Period 1|Adverse Event|0|||
130894410|NCT05601544|471247245|FG003|Phase 2 Period 1|Adverse Event|0|||
130894411|NCT05601544|471247246|FG004|Phase 2 Period 1|Adverse Event|0|||
130894412|NCT05601544|471247247|FG005|Phase 2 Period 1|Adverse Event|0|||
130894413|NCT02626624|471247260|FG000|Overall Study|Adverse Event|1|||
130894414|NCT02626624|471247260|FG000|Overall Study|Lost to Follow-up|3|||
130894415|NCT02626624|471247260|FG000|Overall Study|Protocol Violation|4|||
130894416|NCT02626624|471247260|FG000|Overall Study|Death|2|||
130894417|NCT03818035|471247263|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
130894418|NCT03818035|471247264|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
130894419|NCT03818035|471247265|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
130894420|NCT03818035|471247266|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
130894421|NCT03818035|471247263|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
130894422|NCT03818035|471247264|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
130894423|NCT03818035|471247265|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
130894424|NCT03818035|471247266|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
130894425|NCT03818035|471247263|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
130894426|NCT03818035|471247264|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
130894427|NCT03818035|471247265|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
130894428|NCT03818035|471247266|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
130894429|NCT03818035|471247263|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
130894430|NCT03818035|471247264|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
130894431|NCT03818035|471247265|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
130894432|NCT03818035|471247266|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
130894433|NCT03818035|471247263|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
130894434|NCT03818035|471247264|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
130894435|NCT03818035|471247265|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
130894436|NCT03818035|471247266|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
130894437|NCT03818035|471247263|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
130894438|NCT03818035|471247264|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
130894439|NCT03818035|471247265|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
130894440|NCT03818035|471247266|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
130894441|NCT03818035|471247263|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
130894442|NCT03818035|471247264|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
130894443|NCT03818035|471247265|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
130894444|NCT03818035|471247266|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
130894445|NCT03818035|471247263|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
130894446|NCT03818035|471247264|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
130894447|NCT03818035|471247265|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
130894448|NCT03818035|471247266|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
130894449|NCT03818035|471247263|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
130894450|NCT03818035|471247264|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
130894451|NCT03818035|471247265|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
130894452|NCT03818035|471247266|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
130894453|NCT03818035|471247263|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
130894454|NCT03818035|471247264|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
130894455|NCT03818035|471247265|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
130894456|NCT03818035|471247266|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
130894457|NCT03818035|471247263|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
130894458|NCT03818035|471247264|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
130894459|NCT03818035|471247265|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
130894460|NCT03818035|471247266|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
130894461|NCT03818035|471247263|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
131111641|NCT03224325|472039020|FG004|Overall Study|Adverse Event|0|||
130894462|NCT03818035|471247264|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
130894463|NCT03818035|471247265|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
130894464|NCT03818035|471247266|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
130894465|NCT03818035|471247263|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
130894466|NCT03818035|471247264|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
130894467|NCT03818035|471247265|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
130894468|NCT03818035|471247266|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
130894469|NCT03818035|471247263|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
130894470|NCT03818035|471247264|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
130894471|NCT03818035|471247265|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
130894472|NCT03818035|471247266|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
130690386|NCT00469898|470493067|FG000|Overall Study|Decreased performance status|1|||
130690387|NCT01370317|470493068|FG000|Overall Study|Participant withdrew consent|1|||
130690388|NCT01370317|470493069|FG001|Overall Study|Participant withdrew consent|0|||
130690389|NCT01370317|470493068|FG000|Overall Study|Protocol deviation|0|||
130690390|NCT01370317|470493069|FG001|Overall Study|Protocol deviation|1|||
130690391|NCT02849457|470493072|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
130690392|NCT02849457|470493073|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
130690393|NCT02849457|470493074|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
130690394|NCT02849457|470493075|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
130690395|NCT03673670|470493076|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
130690396|NCT03673670|470493077|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130690397|NCT03673670|470493078|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130690398|NCT03673670|470493079|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130690399|NCT03673670|470493080|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130690400|NCT03673670|470493081|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130690401|NCT03673670|470493076|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
130690402|NCT03673670|470493077|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
130690403|NCT03673670|470493078|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
130690404|NCT03673670|470493079|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
130690405|NCT03673670|470493080|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
130690406|NCT03673670|470493081|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
130690407|NCT03673670|470493076|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
130690408|NCT03673670|470493077|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
130690409|NCT03673670|470493078|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
130690410|NCT03673670|470493079|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
130690411|NCT03673670|470493080|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
130690412|NCT03673670|470493081|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
130690413|NCT03673670|470493076|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130690414|NCT03673670|470493077|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130690415|NCT03673670|470493078|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130690416|NCT03673670|470493079|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130690417|NCT03673670|470493080|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130690418|NCT03673670|470493081|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
130690419|NCT03673670|470493076|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
130690420|NCT03673670|470493077|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
130690421|NCT03673670|470493078|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
130690422|NCT03673670|470493079|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
130690423|NCT03673670|470493080|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
130690424|NCT03673670|470493081|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
130690425|NCT03673670|470493076|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130690426|NCT03673670|470493077|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130690427|NCT03673670|470493078|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130690428|NCT03673670|470493079|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130690429|NCT03673670|470493080|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
130690430|NCT03673670|470493081|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130690431|NCT03673670|470493076|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
130690432|NCT03673670|470493077|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
130690433|NCT03673670|470493078|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
130690434|NCT03673670|470493079|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
130690435|NCT03673670|470493080|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
130690436|NCT03673670|470493081|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
130690437|NCT01294917|470493085|FG000|Overall Study|Relocation|5|||
130690438|NCT01294917|470493085|FG000|Overall Study|Inconvenience|1|||
130690439|NCT01444378|470493086|FG000|Overall Study|Lost to Follow-up|1|||
130767553|NCT01094782|470772419|FG005|Overall Study|Noncompliance With Study Schedule|0|||
130767554|NCT00957905|470772420|FG000|Part B|Not Treated|0|||
130767555|NCT00957905|470772421|FG001|Part B|Not Treated|1|||
130767556|NCT00957905|470772420|FG000|Part B|Physician Decision|0|||
130767557|NCT00957905|470772421|FG001|Part B|Physician Decision|1|||
130767558|NCT00957905|470772420|FG000|Part B|Death|0|||
130767559|NCT00957905|470772421|FG001|Part B|Death|1|||
131111642|NCT03224325|472039021|FG005|Overall Study|Adverse Event|0|||
130690440|NCT01444378|470493086|FG000|Overall Study|Withdrawal by Subject|1|||
130690441|NCT01444378|470493086|FG000|Overall Study|Death|3|||
130690442|NCT01444378|470493086|FG000|Overall Study|Administrative Closure Of The Study|2|||
130767560|NCT00957905|470772420|FG000|Part B|Protocol Violation|0|||
130767561|NCT00957905|470772421|FG001|Part B|Protocol Violation|1|||
130767562|NCT00508157|470772423|FG000|Overall Study|Adverse Event|0|||
130767563|NCT00508157|470772424|FG001|Overall Study|Adverse Event|1|||
131111643|NCT03224325|472039022|FG006|Overall Study|Adverse Event|1|||
130894473|NCT03818035|471247263|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
130894474|NCT03818035|471247264|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
130894475|NCT03818035|471247265|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
130894476|NCT03818035|471247266|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
130894477|NCT03374202|471247269|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
130894478|NCT03374202|471247270|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
130894479|NCT03374202|471247271|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
130894480|NCT03374202|471247269|FG000|Five Year Long Term Follow Up|Death|0|||
130894481|NCT03374202|471247270|FG001|Five Year Long Term Follow Up|Death|1|||
130894482|NCT03374202|471247271|FG002|Five Year Long Term Follow Up|Death|0|||
130894483|NCT01124864|471249413|FG000|Overall Study|Follow up phase competed as per protocol|18|||
130894484|NCT01124864|471249414|FG001|Overall Study|Follow up phase competed as per protocol|22|||
130894485|NCT01124864|471249415|FG002|Overall Study|Follow up phase competed as per protocol|24|||
130894486|NCT01124864|471249416|FG003|Overall Study|Follow up phase competed as per protocol|18|||
130894487|NCT01124864|471249417|FG004|Overall Study|Follow up phase competed as per protocol|26|||
130894488|NCT01124864|471249418|FG005|Overall Study|Follow up phase competed as per protocol|2|||
130894489|NCT01124864|471249413|FG000|Overall Study|Death|6|||
130894490|NCT01124864|471249414|FG001|Overall Study|Death|9|||
130894491|NCT01124864|471249415|FG002|Overall Study|Death|6|||
130894492|NCT01124864|471249416|FG003|Overall Study|Death|2|||
130894493|NCT01124864|471249417|FG004|Overall Study|Death|1|||
130894494|NCT01124864|471249418|FG005|Overall Study|Death|0|||
130894495|NCT01124864|471249413|FG000|Overall Study|Withdrawal by Subject|2|||
130894496|NCT01124864|471249414|FG001|Overall Study|Withdrawal by Subject|3|||
130894497|NCT01124864|471249415|FG002|Overall Study|Withdrawal by Subject|4|||
130894498|NCT01124864|471249416|FG003|Overall Study|Withdrawal by Subject|0|||
130894499|NCT01124864|471249417|FG004|Overall Study|Withdrawal by Subject|2|||
130894500|NCT01124864|471249418|FG005|Overall Study|Withdrawal by Subject|1|||
130894501|NCT01124864|471249413|FG000|Overall Study|Lost to Follow-up|1|||
130894502|NCT01124864|471249414|FG001|Overall Study|Lost to Follow-up|1|||
130894503|NCT01124864|471249415|FG002|Overall Study|Lost to Follow-up|0|||
130894504|NCT01124864|471249416|FG003|Overall Study|Lost to Follow-up|1|||
130894505|NCT01124864|471249417|FG004|Overall Study|Lost to Follow-up|0|||
130894506|NCT01124864|471249418|FG005|Overall Study|Lost to Follow-up|0|||
130894507|NCT01124864|471249413|FG000|Overall Study|Protocol Violation|1|||
130894508|NCT01124864|471249414|FG001|Overall Study|Protocol Violation|0|||
130894509|NCT01124864|471249415|FG002|Overall Study|Protocol Violation|0|||
130894510|NCT01124864|471249416|FG003|Overall Study|Protocol Violation|0|||
130894511|NCT01124864|471249417|FG004|Overall Study|Protocol Violation|1|||
130894512|NCT01124864|471249418|FG005|Overall Study|Protocol Violation|0|||
130894513|NCT01945710|471249429|FG000|Overall Study|Progressive Disease|5|||
130894514|NCT01945710|471249430|FG001|Overall Study|Progressive Disease|4|||
130894515|NCT01945710|471249431|FG002|Overall Study|Progressive Disease|3|||
130894516|NCT01945710|471249432|FG003|Overall Study|Progressive Disease|2|||
130894517|NCT01945710|471249433|FG004|Overall Study|Progressive Disease|7|||
130894518|NCT01945710|471249434|FG005|Overall Study|Progressive Disease|3|||
130894519|NCT01945710|471249435|FG006|Overall Study|Progressive Disease|19|||
130894520|NCT01945710|471249429|FG000|Overall Study|Adverse Event|0|||
130894521|NCT01945710|471249430|FG001|Overall Study|Adverse Event|1|||
130894522|NCT01945710|471249431|FG002|Overall Study|Adverse Event|0|||
130894523|NCT01945710|471249432|FG003|Overall Study|Adverse Event|0|||
130894524|NCT01945710|471249433|FG004|Overall Study|Adverse Event|0|||
130894525|NCT01945710|471249434|FG005|Overall Study|Adverse Event|0|||
130894526|NCT01945710|471249435|FG006|Overall Study|Adverse Event|0|||
130894527|NCT01945710|471249429|FG000|Overall Study|Other|2|||
130894528|NCT01945710|471249430|FG001|Overall Study|Other|0|||
130894529|NCT01945710|471249431|FG002|Overall Study|Other|3|||
130894530|NCT01945710|471249432|FG003|Overall Study|Other|1|||
130894531|NCT01945710|471249433|FG004|Overall Study|Other|1|||
130894532|NCT01945710|471249434|FG005|Overall Study|Other|0|||
130894533|NCT01945710|471249435|FG006|Overall Study|Other|4|||
130690443|NCT01444378|470493086|FG000|Overall Study|Missed Visits|10|||
130690444|NCT00927069|470493087|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
130690445|NCT00927069|470493088|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
130690446|NCT00927069|470493089|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
130690447|NCT00927069|470493090|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
130894534|NCT01945710|471249429|FG000|Overall Study|Withdrawal by Subject|0|||
130894535|NCT01945710|471249430|FG001|Overall Study|Withdrawal by Subject|1|||
130894536|NCT01945710|471249431|FG002|Overall Study|Withdrawal by Subject|1|||
130894537|NCT01945710|471249432|FG003|Overall Study|Withdrawal by Subject|0|||
130894538|NCT01945710|471249433|FG004|Overall Study|Withdrawal by Subject|1|||
130894539|NCT01945710|471249434|FG005|Overall Study|Withdrawal by Subject|0|||
130894540|NCT01945710|471249435|FG006|Overall Study|Withdrawal by Subject|0|||
130894541|NCT00375609|471249436|FG000|Overall Study|Did not receive treatment|1|||
130894542|NCT00375609|471249437|FG001|Overall Study|Did not receive treatment|0|||
130894543|NCT00375609|471249438|FG002|Overall Study|Did not receive treatment|0|||
130894544|NCT00375609|471249436|FG000|Overall Study|Adverse Event|0|||
130690448|NCT00927069|470493087|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
130894545|NCT00375609|471249437|FG001|Overall Study|Adverse Event|3|||
130894546|NCT00375609|471249438|FG002|Overall Study|Adverse Event|0|||
130894547|NCT00375609|471249436|FG000|Overall Study|Lost to Follow-up|1|||
130894548|NCT00375609|471249437|FG001|Overall Study|Lost to Follow-up|0|||
130894549|NCT00375609|471249438|FG002|Overall Study|Lost to Follow-up|0|||
130894550|NCT00375609|471249436|FG000|Overall Study|Physician Decision|0|||
130894551|NCT00375609|471249437|FG001|Overall Study|Physician Decision|0|||
130894552|NCT00375609|471249438|FG002|Overall Study|Physician Decision|1|||
130894553|NCT00375609|471249436|FG000|Overall Study|Withdrawal by Subject|1|||
130894554|NCT00375609|471249437|FG001|Overall Study|Withdrawal by Subject|4|||
130894555|NCT00375609|471249438|FG002|Overall Study|Withdrawal by Subject|0|||
130894556|NCT00375609|471249436|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
130894557|NCT00375609|471249437|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
130894558|NCT00375609|471249438|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
130894559|NCT01368562|471249439|FG000|Overall Study|Adverse Event|1|||
130894560|NCT01368562|471249439|FG000|Overall Study|Disease progression|1|||
130894561|NCT01368562|471249439|FG000|Overall Study|Lost to Follow-up|1|||
130894562|NCT01368562|471249439|FG000|Overall Study|Death|6|||
130894563|NCT01368562|471249439|FG000|Overall Study|Unresponsive to treatment|5|||
130894564|NCT01368562|471249439|FG000|Overall Study|Other|3|||
130894565|NCT01368562|471249439|FG000|Overall Study|Other than specified|2|||
130894566|NCT01754727|471249442|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
130894567|NCT02338882|471249445|FG000|Overall Study|Death|1|||
130894568|NCT02338882|471249446|FG001|Overall Study|Death|0|||
130894569|NCT02338882|471249445|FG000|Overall Study|Lost to Follow-up|6|||
130894570|NCT02338882|471249446|FG001|Overall Study|Lost to Follow-up|3|||
130894571|NCT00669409|471249451|FG000|Part 2|Withdrawal by Subject|0|||
130690449|NCT00927069|470493088|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
130690450|NCT00927069|470493089|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
130690451|NCT00927069|470493090|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
130690452|NCT00927069|470493087|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
130690453|NCT00927069|470493088|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
130690454|NCT00927069|470493089|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
130690455|NCT00927069|470493090|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
130690456|NCT00927069|470493087|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
130690457|NCT00927069|470493088|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
130690458|NCT00927069|470493089|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
130690459|NCT00927069|470493090|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
130690460|NCT00927069|470493087|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
130690461|NCT00927069|470493088|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
130690462|NCT00927069|470493089|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
130690463|NCT00927069|470493090|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
130690464|NCT02911792|470493091|FG000|Overall Study|Lost to Follow-up|3|||
130690465|NCT02911792|470493092|FG001|Overall Study|Lost to Follow-up|3|||
130690466|NCT02911792|470493093|FG002|Overall Study|Lost to Follow-up|3|||
130690467|NCT02911792|470493094|FG003|Overall Study|Lost to Follow-up|3|||
130690468|NCT01244620|470493097|FG000|Overall Study|Study terminated|4|||
130690469|NCT01244620|470493098|FG001|Overall Study|Study terminated|4|||
130690470|NCT01244620|470493099|FG002|Overall Study|Study terminated|4|||
130690471|NCT01244620|470493100|FG003|Overall Study|Study terminated|4|||
130690472|NCT01663233|470493102|FG000|Overall Study|Withdrawal by Subject|3|||
130690473|NCT01663233|470493103|FG001|Overall Study|Withdrawal by Subject|2|||
130690474|NCT01663233|470493102|FG000|Overall Study|Protocol Deviation|1|||
130690475|NCT01663233|470493103|FG001|Overall Study|Protocol Deviation|4|||
130690476|NCT01663233|470493102|FG000|Overall Study|Lost to Follow-up|0|||
130690477|NCT01663233|470493103|FG001|Overall Study|Lost to Follow-up|1|||
130690478|NCT02321098|470493104|FG000|12 Weeks Treament|Lost to Follow-up|1|||
130690479|NCT02321098|470493105|FG001|12 Weeks Treament|Lost to Follow-up|1|||
130690480|NCT02321098|470493106|FG002|12 Weeks Treament|Lost to Follow-up|0|||
130894572|NCT00669409|471249452|FG001|Part 2|Withdrawal by Subject|0|||
130894573|NCT00669409|471249453|FG002|Part 2|Withdrawal by Subject|0|||
130894574|NCT00669409|471249454|FG003|Part 2|Withdrawal by Subject|0|||
130894575|NCT00669409|471249455|FG004|Part 2|Withdrawal by Subject|0|||
130894576|NCT00669409|471249456|FG005|Part 2|Withdrawal by Subject|0|||
131111644|NCT03224325|472039016|FG000|Overall Study|Withdrawal by Subject|0|||
131111645|NCT03224325|472039017|FG001|Overall Study|Withdrawal by Subject|0|||
131111646|NCT03224325|472039018|FG002|Overall Study|Withdrawal by Subject|0|||
131111647|NCT03224325|472039019|FG003|Overall Study|Withdrawal by Subject|1|||
131111648|NCT03224325|472039020|FG004|Overall Study|Withdrawal by Subject|0|||
130894577|NCT00669409|471249457|FG006|Part 2|Withdrawal by Subject|0|||
131111649|NCT03224325|472039021|FG005|Overall Study|Withdrawal by Subject|0|||
130690481|NCT02321098|470493104|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
130690482|NCT02321098|470493105|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
130690483|NCT02321098|470493106|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
130690484|NCT02321098|470493104|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
130894578|NCT00669409|471249458|FG007|Part 2|Withdrawal by Subject|0|||
130894579|NCT00669409|471249459|FG008|Part 2|Withdrawal by Subject|0|||
130894580|NCT00669409|471249460|FG009|Part 2|Withdrawal by Subject|1|||
130894581|NCT00669409|471249461|FG010|Part 2|Withdrawal by Subject|0|||
130894582|NCT00095940|471249463|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
130894583|NCT00095940|471249464|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
130894584|NCT00095940|471249465|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
130894585|NCT00095940|471249466|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
130894586|NCT00095940|471249467|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
130894587|NCT00095940|471249468|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
130894588|NCT00095940|471249469|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
130894589|NCT00095940|471249470|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
130894590|NCT00095940|471249471|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
130894591|NCT00095940|471249463|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130894592|NCT00095940|471249464|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130894593|NCT00095940|471249465|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130767564|NCT00508157|470772423|FG000|Overall Study|Subject Withdrew Consent|1|||
130767565|NCT00508157|470772424|FG001|Overall Study|Subject Withdrew Consent|0|||
130767566|NCT00508157|470772423|FG000|Overall Study|Lost to Follow-up|1|||
130767567|NCT00508157|470772424|FG001|Overall Study|Lost to Follow-up|0|||
130767568|NCT00508157|470772423|FG000|Overall Study|Subject no longer met study criteria|0|||
130767569|NCT00508157|470772424|FG001|Overall Study|Subject no longer met study criteria|1|||
130767570|NCT00508157|470772423|FG000|Overall Study|Other known cause|0|||
130767571|NCT00508157|470772424|FG001|Overall Study|Other known cause|1|||
130767572|NCT02069093|470772425|FG000|Overall Study|Disease progression|14|||
130767573|NCT02069093|470772425|FG000|Overall Study|New cancer therapy|1|||
130767574|NCT02069093|470772425|FG000|Overall Study|Death|1|||
130767575|NCT02069093|470772425|FG000|Overall Study|Administrative problems|1|||
130767576|NCT02069093|470772425|FG000|Overall Study|Withdrawal by Subject|2|||
130767577|NCT02069093|470772425|FG000|Overall Study|Abnormal laboratory values|1|||
130767578|NCT02069093|470772425|FG000|Overall Study|Adverse Event|10|||
130767579|NCT03564795|470772426|FG000|Overall Study|Withdrawal by Subject|3|||
130767580|NCT03564795|470772426|FG000|Overall Study|Lost to Follow-up|6|||
130767581|NCT03564795|470772426|FG000|Overall Study|Physician Decision|2|||
130767582|NCT02906033|470772427|FG000|Baseline|Protocol Violation|37|||
130767583|NCT02906033|470772428|FG001|Baseline|Protocol Violation|33|||
130767584|NCT02906033|470772427|FG000|Follow-up|Lost to Follow-up|46|||
130767585|NCT02906033|470772428|FG001|Follow-up|Lost to Follow-up|62|||
130767586|NCT01333956|470772439|FG000|Overall Study|Lost to Follow-up|1|||
130767587|NCT01333956|470772440|FG001|Overall Study|Lost to Follow-up|2|||
130767588|NCT01333956|470772441|FG002|Overall Study|Lost to Follow-up|0|||
130767589|NCT01333956|470772442|FG003|Overall Study|Lost to Follow-up|1|||
130767590|NCT01333956|470772439|FG000|Overall Study|Unable to complete study procedure|1|||
130767591|NCT01333956|470772440|FG001|Overall Study|Unable to complete study procedure|0|||
130767592|NCT01333956|470772441|FG002|Overall Study|Unable to complete study procedure|0|||
130767593|NCT01333956|470772442|FG003|Overall Study|Unable to complete study procedure|1|||
130767594|NCT01333956|470772439|FG000|Overall Study|Withdrawal by Subject|0|||
130767595|NCT01333956|470772440|FG001|Overall Study|Withdrawal by Subject|2|||
130767596|NCT01333956|470772441|FG002|Overall Study|Withdrawal by Subject|1|||
130767597|NCT01333956|470772442|FG003|Overall Study|Withdrawal by Subject|0|||
130767598|NCT02240069|470772443|FG000|Overall Study|Withdrawal by Subject|5|||
130767599|NCT02240069|470772444|FG001|Overall Study|Withdrawal by Subject|5|||
130767600|NCT02240069|470772445|FG002|Overall Study|Withdrawal by Subject|2|||
130767601|NCT03723070|470772446|FG000|Overall Study|Lost to Follow-up|2|||
130767602|NCT03723070|470772446|FG000|Overall Study|Physician Decision|1|||
130767603|NCT03723070|470772446|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
130767604|NCT00474786|470772447|FG000|Overall Study|Not Meeting Study Criteria|0|||
130767605|NCT00474786|470772448|FG001|Overall Study|Not Meeting Study Criteria|1|||
130767606|NCT00474786|470772447|FG000|Overall Study|Investigator Request|2|||
130767607|NCT00474786|470772448|FG001|Overall Study|Investigator Request|1|||
130767608|NCT00474786|470772447|FG000|Overall Study|Death|189|||
130767609|NCT00474786|470772448|FG001|Overall Study|Death|170|||
130767610|NCT00474786|470772447|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
130767611|NCT00474786|470772448|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
130767612|NCT00474786|470772447|FG000|Overall Study|Lost to Follow-up|4|||
130767613|NCT00474786|470772448|FG001|Overall Study|Lost to Follow-up|7|||
130767614|NCT00474786|470772447|FG000|Overall Study|Protocol Violation|2|||
130894594|NCT00095940|471249466|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130767615|NCT00474786|470772448|FG001|Overall Study|Protocol Violation|0|||
130767616|NCT00474786|470772447|FG000|Overall Study|Withdrawal by Subject|15|||
130767617|NCT00474786|470772448|FG001|Overall Study|Withdrawal by Subject|15|||
130767618|NCT00474786|470772447|FG000|Overall Study|Other|5|||
130767619|NCT00474786|470772448|FG001|Overall Study|Other|0|||
130767620|NCT03646305|470772451|FG000|Overall Study|Lost to Follow-up|4|||
130767621|NCT03646305|470772452|FG001|Overall Study|Lost to Follow-up|2|||
130767622|NCT03646305|470772453|FG002|Overall Study|Lost to Follow-up|2|||
130767623|NCT03646305|470772454|FG003|Overall Study|Lost to Follow-up|1|||
130894595|NCT00095940|471249467|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130894596|NCT00095940|471249468|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130894597|NCT00095940|471249469|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130894598|NCT00095940|471249470|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130894599|NCT00095940|471249471|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130894600|NCT00095940|471249463|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
130894601|NCT00095940|471249464|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
130894602|NCT00095940|471249465|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
130894603|NCT00095940|471249466|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
130894604|NCT00095940|471249467|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
130894605|NCT00095940|471249468|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
130894606|NCT00095940|471249469|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
130894607|NCT00095940|471249470|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
130894608|NCT00095940|471249471|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
130894609|NCT02314637|471249472|FG000|Overall Study|Adverse Event|4|||
130894610|NCT02314637|471249473|FG001|Overall Study|Adverse Event|8|||
130894611|NCT02314637|471249472|FG000|Overall Study|Lack of Efficacy|1|||
130894612|NCT02314637|471249473|FG001|Overall Study|Lack of Efficacy|0|||
130894613|NCT02314637|471249472|FG000|Overall Study|Physician Decision|5|||
130894614|NCT02314637|471249473|FG001|Overall Study|Physician Decision|2|||
130894615|NCT02314637|471249472|FG000|Overall Study|Withdrawal by Subject|5|||
130894616|NCT02314637|471249473|FG001|Overall Study|Withdrawal by Subject|4|||
130894617|NCT02314637|471249472|FG000|Overall Study|Other Reason|1|||
130894618|NCT02314637|471249473|FG001|Overall Study|Other Reason|0|||
130894619|NCT03539549|471249474|FG000|Overall Study|Adverse Event|12|||
130894620|NCT03539549|471249474|FG000|Overall Study|Lost to Follow-up|1|||
130894621|NCT03539549|471249474|FG000|Overall Study|Death|2|||
130894622|NCT03539549|471249474|FG000|Overall Study|Progressive Disease|1|||
130894623|NCT03539549|471249474|FG000|Overall Study|Reason not Specified|1|||
130894624|NCT02864862|471249475|FG000|Overall Study|Lost to Follow-up|1|||
130894625|NCT02864862|471249476|FG001|Overall Study|Lost to Follow-up|0|||
130894626|NCT02864862|471249477|FG002|Overall Study|Lost to Follow-up|1|||
130894627|NCT02864862|471249475|FG000|Overall Study|Protocol Violation|0|||
130894628|NCT02864862|471249476|FG001|Overall Study|Protocol Violation|0|||
130894629|NCT02864862|471249477|FG002|Overall Study|Protocol Violation|1|||
130894630|NCT01536067|471249484|FG000|Overall Study|Disease Progression|1|||
130894631|NCT03120351|471249485|FG000|Overall Study|Physician Decision|1|||
130894632|NCT03120351|471249486|FG001|Overall Study|Physician Decision|1|||
130894633|NCT04693234|471249487|FG000|Overall Study|Death|79|||
130894634|NCT04693234|471249488|FG001|Overall Study|Death|19|||
130894635|NCT04693234|471249487|FG000|Overall Study|Sponsor Ended Study|47|||
130894636|NCT04693234|471249488|FG001|Overall Study|Sponsor Ended Study|18|||
130894637|NCT04693234|471249487|FG000|Overall Study|Withdrawal by Subject|10|||
130894638|NCT04693234|471249488|FG001|Overall Study|Withdrawal by Subject|2|||
130894639|NCT04693234|471249487|FG000|Overall Study|Lost to Follow-up|2|||
131111650|NCT03224325|472039022|FG006|Overall Study|Withdrawal by Subject|0|||
131111651|NCT02120625|472039024|FG000|Overall Study|Physician Decision|2|||
131111652|NCT01776424|472039030|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
131111653|NCT01776424|472039031|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
131111654|NCT01776424|472039032|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
131111655|NCT01776424|472039030|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
131111656|NCT01776424|472039031|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
131111657|NCT01776424|472039032|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
131111658|NCT01776424|472039030|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
131111659|NCT01776424|472039031|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
131111660|NCT01776424|472039032|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
131111661|NCT01776424|472039030|FG000|LTOLE Part (Open Label)|Refused|5|||
130690485|NCT02321098|470493105|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
130690486|NCT02321098|470493106|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
130690487|NCT02321098|470493104|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
130690488|NCT02321098|470493105|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
130894640|NCT04693234|471249488|FG001|Overall Study|Lost to Follow-up|1|||
130894641|NCT04643158|471249489|FG000|Overall Study|Study terminated by sponsor|0|||
130894642|NCT04643158|471249490|FG001|Overall Study|Study terminated by sponsor|0|||
130894643|NCT04643158|471249491|FG002|Overall Study|Study terminated by sponsor|1|||
131111662|NCT01776424|472039031|FG001|LTOLE Part (Open Label)|Refused|2|||
130690489|NCT02321098|470493106|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
130690490|NCT02558491|470493107|FG000|First Invention|Withdrawal by Subject|3|||
130690491|NCT02558491|470493108|FG001|First Invention|Withdrawal by Subject|1|||
130894644|NCT04643158|471249492|FG003|Overall Study|Study terminated by sponsor|0|||
130894645|NCT04643158|471249493|FG004|Overall Study|Study terminated by sponsor|0|||
130894646|NCT04643158|471249494|FG005|Overall Study|Study terminated by sponsor|1|||
131111663|NCT01776424|472039032|FG002|LTOLE Part (Open Label)|Refused|11|||
130894647|NCT04643158|471249495|FG006|Overall Study|Study terminated by sponsor|0|||
130690492|NCT02558491|470493107|FG000|First Invention|Data collection issues|1|||
130690493|NCT02558491|470493108|FG001|First Invention|Data collection issues|0|||
130690494|NCT02558491|470493107|FG000|First Invention|Stopping criteria|0|||
130690495|NCT02558491|470493108|FG001|First Invention|Stopping criteria|1|||
130690496|NCT02558491|470493107|FG000|First Invention|Changed parameters during trial|1|||
130690497|NCT02558491|470493108|FG001|First Invention|Changed parameters during trial|0|||
130690498|NCT02558491|470493107|FG000|Second Intervention|Withdrawal by Subject|1|||
130690499|NCT02558491|470493108|FG001|Second Intervention|Withdrawal by Subject|0|||
130690500|NCT02558491|470493107|FG000|Second Intervention|Stopping Criteria|1|||
130690501|NCT02558491|470493108|FG001|Second Intervention|Stopping Criteria|0|||
130690502|NCT00834431|470493111|FG000|First Intervention|Adverse Event|0|||
130690503|NCT00834431|470493112|FG001|First Intervention|Adverse Event|1|||
130690504|NCT00834431|470493111|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130690505|NCT00834431|470493112|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130767624|NCT03646305|470772451|FG000|Overall Study|Withdrawal by Subject|1|||
130767625|NCT03646305|470772452|FG001|Overall Study|Withdrawal by Subject|0|||
130767626|NCT03646305|470772453|FG002|Overall Study|Withdrawal by Subject|0|||
130767627|NCT03646305|470772454|FG003|Overall Study|Withdrawal by Subject|1|||
130767628|NCT03417024|470772455|FG000|Overall Study|Study Termination prior to follow-up|11|||
130767629|NCT03417024|470772455|FG000|Overall Study|Physician Decision|2|||
130767630|NCT02195427|470772456|FG000|Overall Study|Did not consent to study extension|13|||
130767631|NCT02195427|470772457|FG001|Overall Study|Did not consent to study extension|9|||
130767632|NCT02195427|470772456|FG000|Overall Study|Withdrawal by Subject|4|||
130767633|NCT02195427|470772457|FG001|Overall Study|Withdrawal by Subject|2|||
130767634|NCT02195427|470772456|FG000|Overall Study|Lost to Follow-up|0|||
130767635|NCT02195427|470772457|FG001|Overall Study|Lost to Follow-up|1|||
130767636|NCT02195427|470772456|FG000|Overall Study|Protocol Violation|7|||
130767637|NCT02195427|470772457|FG001|Overall Study|Protocol Violation|14|||
130767638|NCT02195427|470772456|FG000|Overall Study|Conditional re-treatment at W52|2|||
130767639|NCT02195427|470772457|FG001|Overall Study|Conditional re-treatment at W52|1|||
130767640|NCT02655419|470772458|FG000|Overall Study|Enrolled but not treated|1|||
130767641|NCT02655419|470772459|FG001|Overall Study|Enrolled but not treated|5|||
130767642|NCT02655419|470772458|FG000|Overall Study|Withdrawal by Subject|4|||
130767643|NCT02655419|470772459|FG001|Overall Study|Withdrawal by Subject|1|||
130767644|NCT02655419|470772458|FG000|Overall Study|Other|0|||
130767645|NCT02655419|470772459|FG001|Overall Study|Other|1|||
130767646|NCT00207727|470772460|FG000|Overall Study|Withdrawal by Subject|0|||
130767647|NCT00207727|470772461|FG001|Overall Study|Withdrawal by Subject|0|||
130767648|NCT00207727|470772462|FG002|Overall Study|Withdrawal by Subject|0|||
130767649|NCT00207727|470772463|FG003|Overall Study|Withdrawal by Subject|0|||
130767650|NCT00207727|470772464|FG004|Overall Study|Withdrawal by Subject|1|||
130767651|NCT00207727|470772460|FG000|Overall Study|Lost to Follow-up|0|||
130767652|NCT00207727|470772461|FG001|Overall Study|Lost to Follow-up|1|||
130767653|NCT00207727|470772462|FG002|Overall Study|Lost to Follow-up|0|||
130767654|NCT00207727|470772463|FG003|Overall Study|Lost to Follow-up|0|||
130767655|NCT00207727|470772464|FG004|Overall Study|Lost to Follow-up|0|||
130767656|NCT00207727|470772460|FG000|Overall Study|Other|38|||
130767657|NCT00207727|470772461|FG001|Overall Study|Other|41|||
130767658|NCT00207727|470772462|FG002|Overall Study|Other|41|||
130767659|NCT00207727|470772463|FG003|Overall Study|Other|37|||
130767660|NCT00207727|470772464|FG004|Overall Study|Other|33|||
130767661|NCT00463840|470772469|FG000|Overall Study|Disease progression|7|||
130767662|NCT00463840|470772469|FG000|Overall Study|Withdrawal by Subject|2|||
130767663|NCT00463840|470772469|FG000|Overall Study|Adverse Event|3|||
130767664|NCT01653327|470772470|FG000|Overall Study|Withdrawal by Subject|1|||
130767665|NCT04607980|470772471|FG000|Overall Study|Adverse Event|3|||
130767666|NCT04607980|470772472|FG001|Overall Study|Adverse Event|4|||
130767667|NCT04607980|470772471|FG000|Overall Study|Death|0|||
130767668|NCT04607980|470772472|FG001|Overall Study|Death|1|||
130767669|NCT04607980|470772471|FG000|Overall Study|Withdrawal by Subject|2|||
130767670|NCT04607980|470772472|FG001|Overall Study|Withdrawal by Subject|5|||
130767671|NCT04607980|470772471|FG000|Overall Study|Lost to Follow-up|4|||
130767672|NCT04607980|470772472|FG001|Overall Study|Lost to Follow-up|8|||
130767673|NCT04607980|470772471|FG000|Overall Study|Protocol Violation|0|||
130690506|NCT05630885|470493116|FG000|Study Completion|Took prohibited medications|2|||
130690507|NCT05630885|470493117|FG001|Study Completion|Took prohibited medications|0|||
130767674|NCT04607980|470772472|FG001|Overall Study|Protocol Violation|3|||
130767675|NCT04607980|470772471|FG000|Overall Study|Other|3|||
130767676|NCT04607980|470772472|FG001|Overall Study|Other|0|||
130767677|NCT01716520|470773850|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
130767678|NCT01716520|470773851|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
130767679|NCT01716520|470773852|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
130767680|NCT01716520|470773853|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
130767681|NCT01716520|470773854|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
130690508|NCT05630885|470493116|FG000|Study Completion|Non-compliance with study drug|1|||
130690509|NCT05630885|470493117|FG001|Study Completion|Non-compliance with study drug|0|||
130767682|NCT01716520|470773855|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
130767683|NCT01716520|470773850|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
131111664|NCT01776424|472039030|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
131111665|NCT01776424|472039031|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
131111666|NCT01776424|472039032|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
131111667|NCT00146757|472039033|FG000|Overall Study|Death|1|||
130894648|NCT04643158|471249489|FG000|Overall Study|Global/country situation|0|||
130894649|NCT04643158|471249490|FG001|Overall Study|Global/country situation|0|||
130894650|NCT04643158|471249491|FG002|Overall Study|Global/country situation|1|||
130894651|NCT04643158|471249492|FG003|Overall Study|Global/country situation|0|||
130894652|NCT04643158|471249493|FG004|Overall Study|Global/country situation|0|||
130894653|NCT04643158|471249494|FG005|Overall Study|Global/country situation|0|||
130894654|NCT04643158|471249495|FG006|Overall Study|Global/country situation|0|||
130894655|NCT04643158|471249489|FG000|Overall Study|Withdrawal by Subject|0|||
130894656|NCT04643158|471249490|FG001|Overall Study|Withdrawal by Subject|0|||
130894657|NCT04643158|471249491|FG002|Overall Study|Withdrawal by Subject|0|||
130894658|NCT04643158|471249492|FG003|Overall Study|Withdrawal by Subject|0|||
130894659|NCT04643158|471249493|FG004|Overall Study|Withdrawal by Subject|0|||
130894660|NCT04643158|471249494|FG005|Overall Study|Withdrawal by Subject|1|||
130894661|NCT04643158|471249495|FG006|Overall Study|Withdrawal by Subject|0|||
130894662|NCT04540198|471249496|FG000|Overall Study|Lost to Follow-up|25|||
130894663|NCT04540198|471249497|FG001|Overall Study|Lost to Follow-up|23|||
130894664|NCT04540198|471249496|FG000|Overall Study|Withdrawal by Subject|15|||
130894665|NCT04540198|471249497|FG001|Overall Study|Withdrawal by Subject|9|||
130894666|NCT04540198|471249496|FG000|Overall Study|Discontinued|1|||
130894667|NCT04540198|471249497|FG001|Overall Study|Discontinued|0|||
130894668|NCT02350478|471249498|FG000|Overall Study|Lost to Follow-up|5|||
130894669|NCT02350478|471249499|FG001|Overall Study|Lost to Follow-up|1|||
130894670|NCT02888119|471249512|FG000|Overall Study|Lost to Follow-up|5|||
130894671|NCT02888119|471249513|FG001|Overall Study|Lost to Follow-up|4|||
130894672|NCT02888119|471249514|FG002|Overall Study|Lost to Follow-up|0|||
130894673|NCT03646123|471249515|FG000|Overall Study|Withdrawal by Subject|2|||
130894674|NCT03646123|471249516|FG001|Overall Study|Withdrawal by Subject|2|||
130894675|NCT03646123|471249517|FG002|Overall Study|Withdrawal by Subject|3|||
130894676|NCT03646123|471249515|FG000|Overall Study|Study termination by sponsor|0|||
130894677|NCT03646123|471249516|FG001|Overall Study|Study termination by sponsor|45|||
130894678|NCT03646123|471249517|FG002|Overall Study|Study termination by sponsor|139|||
130894679|NCT03646123|471249515|FG000|Overall Study|Lost to Follow-up|4|||
130894680|NCT03646123|471249516|FG001|Overall Study|Lost to Follow-up|10|||
130894681|NCT03646123|471249517|FG002|Overall Study|Lost to Follow-up|10|||
130894682|NCT03646123|471249515|FG000|Overall Study|Death|2|||
130894683|NCT03646123|471249516|FG001|Overall Study|Death|1|||
130894684|NCT03646123|471249517|FG002|Overall Study|Death|1|||
130894685|NCT03646123|471249515|FG000|Overall Study|Other|2|||
130894686|NCT03646123|471249516|FG001|Overall Study|Other|0|||
130894687|NCT03646123|471249517|FG002|Overall Study|Other|2|||
130894688|NCT04195893|471249518|FG000|Second Intervention|Withdrawal by Subject|1|||
130894689|NCT04195893|471249519|FG001|Second Intervention|Withdrawal by Subject|0|||
130894690|NCT02123472|471249521|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
130894691|NCT02123472|471249522|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
130894692|NCT01474018|471249523|FG000|Overall Study|Lost to Follow-up|0|||
130894693|NCT01474018|471249524|FG001|Overall Study|Lost to Follow-up|1|||
130894694|NCT01474018|471249523|FG000|Overall Study|Withdrawal by Subject|0|||
130894695|NCT01474018|471249524|FG001|Overall Study|Withdrawal by Subject|2|||
130894696|NCT02433080|471249525|FG000|Overall Study|Lost to Follow-up|1|||
130894697|NCT02433080|471249526|FG001|Overall Study|Lost to Follow-up|2|||
130894698|NCT02433080|471249525|FG000|Overall Study|Withdrawal by Subject|0|||
130894699|NCT02433080|471249526|FG001|Overall Study|Withdrawal by Subject|2|||
130894700|NCT01015638|471249529|FG000|Overall Study|Withdrawal by Subject|1|||
130894701|NCT01015638|471249530|FG001|Overall Study|Withdrawal by Subject|0|||
130894702|NCT00964171|471249533|FG000|Overall Study|Death|5|||
131111668|NCT00146757|472039034|FG001|Overall Study|Death|0|||
131111669|NCT00146757|472039033|FG000|Overall Study|Adverse Event|1|||
130690510|NCT05630885|470493116|FG000|Study Completion|Adverse Event|1|||
130690511|NCT05630885|470493117|FG001|Study Completion|Adverse Event|0|||
130894703|NCT00910299|471249537|FG000|Overall Study|Withdrawal by Subject|16|||
130894704|NCT00910299|471249538|FG001|Overall Study|Withdrawal by Subject|13|||
130894705|NCT00910299|471249537|FG000|Overall Study|Sponsor Decision|58|||
130894706|NCT00910299|471249538|FG001|Overall Study|Sponsor Decision|60|||
130894707|NCT00910299|471249537|FG000|Overall Study|Didn't receive any study drug|2|||
130894708|NCT00910299|471249538|FG001|Overall Study|Didn't receive any study drug|1|||
130894709|NCT03037580|471249546|FG000|Overall Study|Withdrawal by Subject|3|||
130894710|NCT03037580|471249547|FG001|Overall Study|Withdrawal by Subject|0|||
131111670|NCT00146757|472039034|FG001|Overall Study|Adverse Event|0|||
131111671|NCT02578862|472039042|FG000|Overall Study|Withdrawal by Subject|0|||
130894711|NCT03037580|471249546|FG000|Overall Study|Adverse Event|1|||
130894712|NCT03037580|471249547|FG001|Overall Study|Adverse Event|0|||
130894713|NCT03037580|471249546|FG000|Overall Study|Study Terminated by Sponsor|12|||
130894714|NCT03037580|471249547|FG001|Overall Study|Study Terminated by Sponsor|15|||
130894715|NCT03037580|471249546|FG000|Overall Study|Death|0|||
130894716|NCT03037580|471249547|FG001|Overall Study|Death|1|||
130894717|NCT02036853|471249548|FG000|Overall Study|Adverse Event|0|||
130894718|NCT02036853|471249549|FG001|Overall Study|Adverse Event|2|||
130894719|NCT02036853|471249548|FG000|Overall Study|Lack of Efficacy|0|||
130894720|NCT02036853|471249549|FG001|Overall Study|Lack of Efficacy|2|||
130894721|NCT02036853|471249548|FG000|Overall Study|Physician Decision|0|||
130894722|NCT02036853|471249549|FG001|Overall Study|Physician Decision|1|||
130894723|NCT02036853|471249548|FG000|Overall Study|Withdrawal by Subject|0|||
130894724|NCT02036853|471249549|FG001|Overall Study|Withdrawal by Subject|1|||
130894725|NCT00884741|471249553|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
130894726|NCT00884741|471249554|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
130894727|NCT00884741|471249555|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
130894728|NCT00884741|471249556|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
130894729|NCT00884741|471249553|FG000|Step 1 Registration: Tissue Screening|Death|3|||
130894730|NCT00884741|471249554|FG001|Step 1 Registration: Tissue Screening|Death|0|||
130894731|NCT00884741|471249555|FG002|Step 1 Registration: Tissue Screening|Death|0|||
130894732|NCT00884741|471249556|FG003|Step 1 Registration: Tissue Screening|Death|0|||
130894733|NCT00884741|471249553|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
130894734|NCT00884741|471249554|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
130894735|NCT00884741|471249555|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
130894736|NCT00884741|471249556|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
130894737|NCT00884741|471249553|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
130894738|NCT00884741|471249554|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
130894739|NCT00884741|471249555|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
130894740|NCT00884741|471249556|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
130894741|NCT00884741|471249553|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
130894742|NCT00884741|471249554|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
130894743|NCT00884741|471249555|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
130894744|NCT00884741|471249556|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
130894745|NCT00884741|471249553|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
130894746|NCT00884741|471249554|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
130894747|NCT00884741|471249555|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
130894748|NCT00884741|471249556|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
130894749|NCT00884741|471249553|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
130894750|NCT00884741|471249554|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
130894751|NCT00884741|471249555|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
130894752|NCT00884741|471249556|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
130894753|NCT00884741|471249553|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
130894754|NCT00884741|471249554|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
130894755|NCT00884741|471249555|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
130894756|NCT00884741|471249556|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
130894757|NCT00884741|471249553|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
130894758|NCT00884741|471249554|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
130894759|NCT00884741|471249555|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
130894760|NCT00884741|471249556|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
130894761|NCT00884741|471249553|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
130894762|NCT00884741|471249554|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
130894763|NCT00884741|471249555|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
130894764|NCT00884741|471249556|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
130894765|NCT00884741|471249553|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
130894766|NCT00884741|471249554|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
130894767|NCT00884741|471249555|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
130894768|NCT00884741|471249556|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
130894769|NCT00884741|471249553|FG000|Randomization|Protocol Violation|0|||
130894770|NCT00884741|471249554|FG001|Randomization|Protocol Violation|0|||
130894771|NCT00884741|471249555|FG002|Randomization|Protocol Violation|8|||
130894772|NCT00884741|471249556|FG003|Randomization|Protocol Violation|8|||
130767684|NCT01716520|470773851|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
130767685|NCT01716520|470773852|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
130767686|NCT01716520|470773853|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
130767687|NCT01716520|470773854|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
130767688|NCT01716520|470773855|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
130767689|NCT01716520|470773850|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130767690|NCT01716520|470773851|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130767691|NCT01716520|470773852|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130767692|NCT01716520|470773853|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130894773|NCT01014910|471249557|FG000|Overall Study|Withdrawal by Subject|0|||
130894774|NCT01014910|471249558|FG001|Overall Study|Withdrawal by Subject|2|||
130894775|NCT01215097|471249559|FG000|Overall Study|Adverse Event|1|||
130894776|NCT01215097|471249560|FG001|Overall Study|Adverse Event|3|||
130894777|NCT01215097|471249559|FG000|Overall Study|Protocol Violation|0|||
130894778|NCT01215097|471249560|FG001|Overall Study|Protocol Violation|2|||
130894779|NCT01215097|471249559|FG000|Overall Study|Lost to Follow-up|2|||
130894780|NCT01215097|471249560|FG001|Overall Study|Lost to Follow-up|0|||
130894781|NCT01215097|471249559|FG000|Overall Study|Withdrawal by Subject|6|||
130894782|NCT01215097|471249560|FG001|Overall Study|Withdrawal by Subject|3|||
130894783|NCT01215097|471249559|FG000|Overall Study|Lack of Efficacy|0|||
130894784|NCT01215097|471249560|FG001|Overall Study|Lack of Efficacy|3|||
130894785|NCT01215097|471249559|FG000|Overall Study|patient's refusal to come|2|||
130894786|NCT01215097|471249560|FG001|Overall Study|patient's refusal to come|2|||
130894787|NCT01215097|471249559|FG000|Overall Study|patient's private reason|1|||
130894788|NCT01215097|471249560|FG001|Overall Study|patient's private reason|1|||
130894789|NCT02252939|471249562|FG000|Overall Study|Lost to Follow-up|3|||
130894790|NCT01033448|471249563|FG000|Overall Study|Withdrawal by Subject|4|||
130894791|NCT01033448|471249563|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
130894792|NCT01033448|471249563|FG000|Overall Study|Lost to Follow-up|3|||
130894793|NCT01033448|471249563|FG000|Overall Study|Withdrew due to other reasons|3|||
130894794|NCT01033448|471249563|FG000|Overall Study|Unknown disposition|1|||
130894795|NCT01818752|471249564|FG000|Overall Study|Adverse Event|64|||
130894796|NCT01818752|471249565|FG001|Overall Study|Adverse Event|74|||
130894797|NCT01818752|471249564|FG000|Overall Study|Death|14|||
130894798|NCT01818752|471249565|FG001|Overall Study|Death|18|||
130894799|NCT01818752|471249564|FG000|Overall Study|Non-compliance|16|||
130894800|NCT01818752|471249565|FG001|Overall Study|Non-compliance|20|||
130894801|NCT01818752|471249564|FG000|Overall Study|Withdrawal by Subject|15|||
130894802|NCT01818752|471249565|FG001|Overall Study|Withdrawal by Subject|14|||
130894803|NCT01818752|471249564|FG000|Overall Study|Physician Decision|9|||
130894804|NCT01818752|471249565|FG001|Overall Study|Physician Decision|8|||
130894805|NCT01818752|471249564|FG000|Overall Study|Disease Progression|54|||
130690512|NCT05630885|470493116|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
130690513|NCT05630885|470493117|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
130690514|NCT05630885|470493116|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
130690515|NCT05630885|470493117|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
130690516|NCT06539676|470493118|FG000|Overall Study|Early study termination|1|||
130690517|NCT06539676|470493119|FG001|Overall Study|Early study termination|0|||
130690518|NCT06539676|470493120|FG002|Overall Study|Early study termination|6|||
130690519|NCT02645409|470493121|FG000|Overall Study|Withdrawal by Subject|3|||
130690520|NCT02645409|470493122|FG001|Overall Study|Withdrawal by Subject|0|||
130690521|NCT02645409|470493121|FG000|Overall Study|Physician Decision|1|||
130690522|NCT02645409|470493122|FG001|Overall Study|Physician Decision|0|||
130690523|NCT03419403|470493123|FG000|Overall Study|Withdrawal by Subject|5|||
130690524|NCT03419403|470493124|FG001|Overall Study|Withdrawal by Subject|2|||
130690525|NCT03419403|470493125|FG002|Overall Study|Withdrawal by Subject|5|||
130690526|NCT03419403|470493126|FG003|Overall Study|Withdrawal by Subject|1|||
130690527|NCT03419403|470493123|FG000|Overall Study|Progressive disease (per protocol)|0|||
130690528|NCT03419403|470493124|FG001|Overall Study|Progressive disease (per protocol)|2|||
130690529|NCT03419403|470493125|FG002|Overall Study|Progressive disease (per protocol)|2|||
130690530|NCT03419403|470493126|FG003|Overall Study|Progressive disease (per protocol)|0|||
130690531|NCT03419403|470493123|FG000|Overall Study|Other, not specified|6|||
130690532|NCT03419403|470493124|FG001|Overall Study|Other, not specified|4|||
130690533|NCT03419403|470493125|FG002|Overall Study|Other, not specified|5|||
130690534|NCT03419403|470493126|FG003|Overall Study|Other, not specified|1|||
130767693|NCT01716520|470773854|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130767694|NCT01716520|470773855|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130767695|NCT01716520|470773850|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130767696|NCT01716520|470773851|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
130767697|NCT01716520|470773852|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130767698|NCT01716520|470773853|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130767699|NCT01716520|470773854|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130767700|NCT01716520|470773855|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130767701|NCT01716520|470773850|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130690535|NCT03419403|470493123|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
130767702|NCT01716520|470773851|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130767703|NCT01716520|470773852|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130767704|NCT01716520|470773853|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130767705|NCT01716520|470773854|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130894806|NCT01818752|471249565|FG001|Overall Study|Disease Progression|48|||
130894807|NCT01818752|471249564|FG000|Overall Study|Other|7|||
130894808|NCT01818752|471249565|FG001|Overall Study|Other|8|||
130894809|NCT01818752|471249564|FG000|Overall Study|Continuing Treatment|1|||
130894810|NCT01818752|471249565|FG001|Overall Study|Continuing Treatment|4|||
130894811|NCT01818752|471249564|FG000|Overall Study|Randomized but not Dosed|7|||
130894812|NCT01818752|471249565|FG001|Overall Study|Randomized but not Dosed|4|||
130894813|NCT04270370|471249566|FG000|Overall Study|Lost to Follow-up|1|||
130894814|NCT04270370|471249567|FG001|Overall Study|Lost to Follow-up|0|||
130894815|NCT04270370|471249568|FG002|Overall Study|Lost to Follow-up|0|||
130894816|NCT04270370|471249569|FG003|Overall Study|Lost to Follow-up|0|||
130894817|NCT04270370|471249570|FG004|Overall Study|Lost to Follow-up|0|||
130894818|NCT04270370|471249571|FG005|Overall Study|Lost to Follow-up|0|||
130894819|NCT04270370|471249572|FG006|Overall Study|Lost to Follow-up|0|||
130894820|NCT04270370|471249573|FG007|Overall Study|Lost to Follow-up|0|||
130894821|NCT04270370|471249574|FG008|Overall Study|Lost to Follow-up|1|||
130894822|NCT04270370|471249575|FG009|Overall Study|Lost to Follow-up|0|||
130894823|NCT04270370|471249576|FG010|Overall Study|Lost to Follow-up|0|||
130894824|NCT04270370|471249577|FG011|Overall Study|Lost to Follow-up|0|||
130894825|NCT01324141|471249578|FG000|Overall Study|Declined to participate before treatment started|1|||
130894826|NCT01324141|471249578|FG000|Overall Study|Disease progression on study|1|||
130894827|NCT00870584|471249581|FG000|Overall Study|Adverse Event|3|||
130894828|NCT00870584|471249582|FG001|Overall Study|Adverse Event|3|||
130894829|NCT00870584|471249581|FG000|Overall Study|Withdrawal by Subject|6|||
130894830|NCT00870584|471249582|FG001|Overall Study|Withdrawal by Subject|7|||
130894831|NCT00870584|471249581|FG000|Overall Study|Lost to Follow-up|5|||
130894832|NCT00870584|471249582|FG001|Overall Study|Lost to Follow-up|1|||
130894833|NCT00870584|471249581|FG000|Overall Study|Protocol Deviation|2|||
130894834|NCT00870584|471249582|FG001|Overall Study|Protocol Deviation|2|||
130894835|NCT02560025|471249583|FG000|Overall Study|Ineligible after consent/ registration|3|||
130894836|NCT02703337|471249584|FG000|Period One (Part A)|Withdrawal by Subject|0|||
130894837|NCT02703337|471249585|FG001|Period One (Part A)|Withdrawal by Subject|0|||
130894838|NCT02703337|471249586|FG002|Period One (Part A)|Withdrawal by Subject|0|||
130894839|NCT02703337|471249587|FG003|Period One (Part A)|Withdrawal by Subject|0|||
130894840|NCT02703337|471249588|FG004|Period One (Part A)|Withdrawal by Subject|1|||
130894841|NCT02703337|471249589|FG005|Period One (Part A)|Withdrawal by Subject|0|||
130894842|NCT02703337|471249590|FG006|Period One (Part A)|Withdrawal by Subject|0|||
130894843|NCT02703337|471249591|FG007|Period One (Part A)|Withdrawal by Subject|0|||
130894844|NCT00282308|471249592|FG000|Treatment Period|Lost to Follow-up|1|||
130894845|NCT00282308|471249593|FG001|Treatment Period|Lost to Follow-up|0|||
130894846|NCT00282308|471249594|FG002|Treatment Period|Lost to Follow-up|0|||
130894847|NCT00282308|471249592|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
130894848|NCT00282308|471249593|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
130894849|NCT00282308|471249594|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
130894850|NCT00282308|471249592|FG000|Treatment Period|Adverse Event|0|||
130894851|NCT00282308|471249593|FG001|Treatment Period|Adverse Event|2|||
130894852|NCT00282308|471249594|FG002|Treatment Period|Adverse Event|0|||
130894853|NCT00282308|471249592|FG000|Treatment Period|Not Treated with Study Drug|1|||
130894854|NCT00282308|471249593|FG001|Treatment Period|Not Treated with Study Drug|0|||
130894855|NCT00282308|471249594|FG002|Treatment Period|Not Treated with Study Drug|0|||
130894856|NCT00282308|471249592|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
130894857|NCT00282308|471249593|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
130894858|NCT00282308|471249594|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
130894859|NCT00282308|471249592|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
130894860|NCT00282308|471249593|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
130894861|NCT00282308|471249594|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
130894862|NCT00282308|471249592|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
130894863|NCT00282308|471249593|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
130894864|NCT00282308|471249594|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
130894865|NCT00282308|471249592|FG000|Safety Follow-up Period|Adverse Event|0|||
130894866|NCT00282308|471249593|FG001|Safety Follow-up Period|Adverse Event|0|||
130894867|NCT00282308|471249594|FG002|Safety Follow-up Period|Adverse Event|1|||
130894868|NCT00282308|471249592|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
130894869|NCT00282308|471249593|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
130894870|NCT00282308|471249594|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
130894871|NCT00282308|471249592|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
131111672|NCT02578862|472039043|FG001|Overall Study|Withdrawal by Subject|1|||
131111673|NCT02578862|472039042|FG000|Overall Study|Unplanned unilateral procedure|0|||
131111674|NCT02578862|472039043|FG001|Overall Study|Unplanned unilateral procedure|1|||
130690536|NCT03419403|470493124|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
130894872|NCT00282308|471249593|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
131111675|NCT02893930|472039046|FG000|Overall Study|Adverse Event|3|||
130894873|NCT00282308|471249594|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
130894874|NCT00282308|471249592|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
130894875|NCT00282308|471249593|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
130894876|NCT00282308|471249594|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
130690537|NCT03419403|470493125|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
131111676|NCT02893930|472039046|FG000|Overall Study|Death|1|||
130894877|NCT04303195|471249595|FG000|Overall Study|Adverse Event|1|||
130894878|NCT04303195|471249596|FG001|Overall Study|Adverse Event|3|||
130894879|NCT04303195|471249597|FG002|Overall Study|Adverse Event|7|||
130894880|NCT04303195|471249598|FG003|Overall Study|Adverse Event|0|||
130894881|NCT04303195|471249595|FG000|Overall Study|Lost to Follow-up|1|||
130894882|NCT04303195|471249596|FG001|Overall Study|Lost to Follow-up|0|||
130894883|NCT04303195|471249597|FG002|Overall Study|Lost to Follow-up|1|||
130894884|NCT04303195|471249598|FG003|Overall Study|Lost to Follow-up|4|||
130894885|NCT04303195|471249595|FG000|Overall Study|Withdrawal by Subject|3|||
130894886|NCT04303195|471249596|FG001|Overall Study|Withdrawal by Subject|1|||
130894887|NCT04303195|471249597|FG002|Overall Study|Withdrawal by Subject|1|||
130894888|NCT04303195|471249598|FG003|Overall Study|Withdrawal by Subject|1|||
130894889|NCT04303195|471249595|FG000|Overall Study|No study drug administered or protocol deviation|0|||
130894890|NCT04303195|471249596|FG001|Overall Study|No study drug administered or protocol deviation|2|||
130894891|NCT04303195|471249597|FG002|Overall Study|No study drug administered or protocol deviation|0|||
130894892|NCT04303195|471249598|FG003|Overall Study|No study drug administered or protocol deviation|2|||
130894893|NCT06457204|471249599|FG000|Washout|Adverse Event|0|||
130894894|NCT06457204|471249600|FG001|Washout|Adverse Event|2|||
130894895|NCT01065454|471249601|FG000|Treatment|Adverse Event|7|||
130894896|NCT01065454|471249602|FG001|Treatment|Adverse Event|4|||
130894897|NCT01065454|471249603|FG002|Treatment|Adverse Event|3|||
130894898|NCT01065454|471249604|FG003|Treatment|Adverse Event|6|||
130894899|NCT01065454|471249601|FG000|Treatment|Death|1|||
130894900|NCT01065454|471249602|FG001|Treatment|Death|0|||
130894901|NCT01065454|471249603|FG002|Treatment|Death|0|||
130894902|NCT01065454|471249604|FG003|Treatment|Death|0|||
130894903|NCT01065454|471249601|FG000|Treatment|Non-compliance|1|||
130894904|NCT01065454|471249602|FG001|Treatment|Non-compliance|0|||
130894905|NCT01065454|471249603|FG002|Treatment|Non-compliance|0|||
130894906|NCT01065454|471249604|FG003|Treatment|Non-compliance|1|||
130894907|NCT01065454|471249601|FG000|Treatment|Protocol Decision|0|||
130894908|NCT01065454|471249602|FG001|Treatment|Protocol Decision|0|||
130894909|NCT01065454|471249603|FG002|Treatment|Protocol Decision|3|||
130894910|NCT01065454|471249604|FG003|Treatment|Protocol Decision|2|||
130894911|NCT01065454|471249601|FG000|Treatment|Protocol Violation|1|||
130894912|NCT01065454|471249602|FG001|Treatment|Protocol Violation|0|||
130894913|NCT01065454|471249603|FG002|Treatment|Protocol Violation|1|||
130894914|NCT01065454|471249604|FG003|Treatment|Protocol Violation|0|||
130894915|NCT01065454|471249601|FG000|Treatment|Withdrawal by Subject|3|||
130894916|NCT01065454|471249602|FG001|Treatment|Withdrawal by Subject|1|||
130894917|NCT01065454|471249603|FG002|Treatment|Withdrawal by Subject|2|||
130894918|NCT01065454|471249604|FG003|Treatment|Withdrawal by Subject|3|||
130894919|NCT01065454|471249601|FG000|Follow up|Adverse Event|1|||
130894920|NCT01065454|471249602|FG001|Follow up|Adverse Event|0|||
130894921|NCT01065454|471249603|FG002|Follow up|Adverse Event|0|||
130894922|NCT01065454|471249604|FG003|Follow up|Adverse Event|1|||
130894923|NCT01065454|471249601|FG000|Follow up|Death|0|||
130894924|NCT01065454|471249602|FG001|Follow up|Death|1|||
130894925|NCT01065454|471249603|FG002|Follow up|Death|1|||
130894926|NCT01065454|471249604|FG003|Follow up|Death|0|||
130894927|NCT01065454|471249601|FG000|Follow up|Lost to Follow-up|0|||
130894928|NCT01065454|471249602|FG001|Follow up|Lost to Follow-up|0|||
130894929|NCT01065454|471249603|FG002|Follow up|Lost to Follow-up|0|||
130894930|NCT01065454|471249604|FG003|Follow up|Lost to Follow-up|1|||
130894931|NCT01065454|471249601|FG000|Follow up|Progressive disease|0|||
130894932|NCT01065454|471249602|FG001|Follow up|Progressive disease|0|||
130894933|NCT01065454|471249603|FG002|Follow up|Progressive disease|0|||
130894934|NCT01065454|471249604|FG003|Follow up|Progressive disease|1|||
130894935|NCT01065454|471249601|FG000|Follow up|Withdrawal by Subject|1|||
130894936|NCT01065454|471249602|FG001|Follow up|Withdrawal by Subject|1|||
130894937|NCT01065454|471249603|FG002|Follow up|Withdrawal by Subject|1|||
130767706|NCT01716520|470773855|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
130767707|NCT01716520|470773850|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130767708|NCT01716520|470773851|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130894938|NCT01065454|471249604|FG003|Follow up|Withdrawal by Subject|0|||
130894939|NCT01065454|471249601|FG000|Follow up|study ongoing|37|||
130894940|NCT01065454|471249602|FG001|Follow up|study ongoing|22|||
130894941|NCT01065454|471249603|FG002|Follow up|study ongoing|15|||
130894942|NCT01065454|471249604|FG003|Follow up|study ongoing|41|||
130894943|NCT01601652|471249605|FG000|Overall Study|Death|1|||
130894944|NCT01097005|471249615|FG000|Overall Study|Case Report Form not collected|18|||
130894945|NCT01097005|471249615|FG000|Overall Study|Subjects cannot visit the hospital|1|||
130894946|NCT01097005|471249615|FG000|Overall Study|Poor medication compliance|1|||
130894947|NCT01097005|471249615|FG000|Overall Study|No examination data available|244|||
130894948|NCT01097005|471249615|FG000|Overall Study|Deviation from exclusion criteria|37|||
130894949|NCT01097005|471249615|FG000|Overall Study|Adverse Event|14|||
130894950|NCT01097005|471249615|FG000|Overall Study|Discontinuance by complication|50|||
130894951|NCT01395524|471250950|FG000|Overall Study|Non-compliance with study schedule|1|||
130894952|NCT01395524|471250951|FG001|Overall Study|Non-compliance with study schedule|0|||
130894953|NCT01395524|471250952|FG002|Overall Study|Non-compliance with study schedule|1|||
130894954|NCT01395524|471250950|FG000|Overall Study|Lost to Follow-up|3|||
130894955|NCT01395524|471250951|FG001|Overall Study|Lost to Follow-up|1|||
130894956|NCT01395524|471250952|FG002|Overall Study|Lost to Follow-up|1|||
130894957|NCT01395524|471250950|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
130894958|NCT01395524|471250951|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
130894959|NCT01395524|471250952|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
130894960|NCT01395524|471250950|FG000|Overall Study|Severe noncompliance with protocol|1|||
130894961|NCT01395524|471250951|FG001|Overall Study|Severe noncompliance with protocol|0|||
130894962|NCT01395524|471250952|FG002|Overall Study|Severe noncompliance with protocol|0|||
130894963|NCT01395524|471250950|FG000|Overall Study|Adverse Event|4|||
130894964|NCT01395524|471250951|FG001|Overall Study|Adverse Event|4|||
130894965|NCT01395524|471250952|FG002|Overall Study|Adverse Event|3|||
130894966|NCT01395524|471250950|FG000|Overall Study|Death|1|||
130894967|NCT01395524|471250951|FG001|Overall Study|Death|0|||
130894968|NCT01395524|471250952|FG002|Overall Study|Death|0|||
130894969|NCT01395524|471250950|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
130894970|NCT01395524|471250951|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130894971|NCT01395524|471250952|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130894972|NCT01395524|471250950|FG000|Overall Study|Withdrawal by Subject|4|||
130894973|NCT01395524|471250951|FG001|Overall Study|Withdrawal by Subject|8|||
130894974|NCT01395524|471250952|FG002|Overall Study|Withdrawal by Subject|8|||
130894975|NCT01395524|471250950|FG000|Overall Study|Did not receive treatment|1|||
130894976|NCT01395524|471250951|FG001|Overall Study|Did not receive treatment|1|||
130894977|NCT01395524|471250952|FG002|Overall Study|Did not receive treatment|3|||
130894978|NCT01395524|471250950|FG000|Overall Study|Subject had spinal surgery|0|||
130894979|NCT01395524|471250951|FG001|Overall Study|Subject had spinal surgery|0|||
130894980|NCT01395524|471250952|FG002|Overall Study|Subject had spinal surgery|1|||
130894981|NCT01657461|471250953|FG000|Overall Study|Death|9|||
130894982|NCT01657461|471250954|FG001|Overall Study|Death|12|||
130894983|NCT01657461|471250953|FG000|Overall Study|Lost to Follow-up|0|||
130894984|NCT01657461|471250954|FG001|Overall Study|Lost to Follow-up|3|||
130894985|NCT01657461|471250953|FG000|Overall Study|Physician Decision|0|||
130894986|NCT01657461|471250954|FG001|Overall Study|Physician Decision|2|||
130894987|NCT01657461|471250953|FG000|Overall Study|Withdrawal by Subject|1|||
130894988|NCT01657461|471250954|FG001|Overall Study|Withdrawal by Subject|3|||
130894989|NCT01868542|471250955|FG000|Overall Study|Protocol Violation|0|||
130894990|NCT01868542|471250956|FG001|Overall Study|Protocol Violation|1|||
130894991|NCT01868542|471250955|FG000|Overall Study|Unclassified|0|||
130894992|NCT01868542|471250956|FG001|Overall Study|Unclassified|1|||
130894993|NCT00122980|471250957|FG000|Overall Study|Death|0|||
130894994|NCT00122980|471250958|FG001|Overall Study|Death|1|||
130894995|NCT00122980|471250957|FG000|Overall Study|Physician Decision|2|||
130894996|NCT00122980|471250958|FG001|Overall Study|Physician Decision|0|||
130894997|NCT00122980|471250957|FG000|Overall Study|Protocol Violation|5|||
130894998|NCT00122980|471250958|FG001|Overall Study|Protocol Violation|1|||
130894999|NCT00122980|471250957|FG000|Overall Study|Withdrawal by Subject|2|||
130895000|NCT00122980|471250958|FG001|Overall Study|Withdrawal by Subject|3|||
130895001|NCT00122980|471250957|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
130895002|NCT00122980|471250958|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
130895003|NCT00122980|471250957|FG000|Overall Study|Study termination|27|||
130895004|NCT00122980|471250958|FG001|Overall Study|Study termination|35|||
130895005|NCT01243242|471250959|FG000|Overall Study|Adverse Event|1|||
130895006|NCT01243242|471250960|FG001|Overall Study|Adverse Event|1|||
130895007|NCT01243242|471250959|FG000|Overall Study|Withdrawal by Subject|1|||
130895008|NCT01243242|471250960|FG001|Overall Study|Withdrawal by Subject|1|||
130895009|NCT01243242|471250959|FG000|Overall Study|Physician Decision|0|||
130895010|NCT01243242|471250960|FG001|Overall Study|Physician Decision|1|||
131111677|NCT02893930|472039046|FG000|Overall Study|Disease progression|5|||
131111678|NCT02893930|472039046|FG000|Overall Study|Withdrawal by Subject|2|||
131111679|NCT02893930|472039046|FG000|Overall Study|Physician Decision|1|||
131111680|NCT02893930|472039046|FG000|Overall Study|Ineligible|1|||
131111681|NCT02349360|472039047|FG000|Overall Study|Withdrawal by Subject|0|||
131111682|NCT02349360|472039048|FG001|Overall Study|Withdrawal by Subject|1|||
131111683|NCT01176773|472039049|FG000|Overall Study|Screen Failure|2|||
131111684|NCT01176773|472039049|FG000|Overall Study|Withdrew consent|1|||
131111685|NCT01794923|472039066|FG000|Overall Study|Adverse Event|0|||
131111686|NCT01794923|472039067|FG001|Overall Study|Adverse Event|0|||
131111687|NCT01794923|472039068|FG002|Overall Study|Adverse Event|1|||
131111688|NCT00752622|472039079|FG000|Induction Phase|Adverse Event|3|||
130895011|NCT01243242|471250959|FG000|Overall Study|sponsor decision|0|||
130895012|NCT01243242|471250960|FG001|Overall Study|sponsor decision|1|||
130895013|NCT01243242|471250959|FG000|Overall Study|non compliance|1|||
130895014|NCT01243242|471250960|FG001|Overall Study|non compliance|0|||
131111689|NCT00752622|472039079|FG000|Induction Phase|Other|3|||
130895015|NCT02160899|471250965|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130895016|NCT02160899|471250966|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130895017|NCT02160899|471250967|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
131111690|NCT00752622|472039079|FG000|Induction Phase|Non-responder|14|||
130895018|NCT02160899|471250968|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
130895019|NCT02160899|471250969|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
130895020|NCT02160899|471250970|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
130895021|NCT01256294|471250971|FG000|Overall Study|Adverse Event|1|||
130895022|NCT01256294|471250972|FG001|Overall Study|Adverse Event|0|||
130895023|NCT01256294|471250971|FG000|Overall Study|Withdrawal by Subject|1|||
130895024|NCT01256294|471250972|FG001|Overall Study|Withdrawal by Subject|1|||
130895025|NCT01256294|471250971|FG000|Overall Study|Protocol deviation|2|||
130895026|NCT01256294|471250972|FG001|Overall Study|Protocol deviation|1|||
130895027|NCT00942994|471250974|FG000|Overall Study|Adverse Event|7|||
130895028|NCT00942994|471250975|FG001|Overall Study|Adverse Event|4|||
130895029|NCT00942994|471250974|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130895030|NCT00942994|471250975|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130895031|NCT00942994|471250974|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130895032|NCT00942994|471250975|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130895033|NCT00942994|471250974|FG000|Overall Study|Patient withdrew consent|5|||
130895034|NCT00942994|471250975|FG001|Overall Study|Patient withdrew consent|8|||
130895035|NCT00942994|471250974|FG000|Overall Study|Lost to Follow-up|1|||
130895036|NCT00942994|471250975|FG001|Overall Study|Lost to Follow-up|4|||
130895037|NCT00942994|471250974|FG000|Overall Study|Protocol deviation|1|||
130895038|NCT00942994|471250975|FG001|Overall Study|Protocol deviation|2|||
130895039|NCT03583385|471250976|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130895040|NCT03583385|471250977|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130895041|NCT03583385|471250976|FG000|Treatment Period 2|Adverse Event|1|||
130895042|NCT03583385|471250977|FG001|Treatment Period 2|Adverse Event|0|||
130895043|NCT01311024|471250989|FG000|Overall Study|Protocol Violation|35|||
130895044|NCT01311024|471250990|FG001|Overall Study|Protocol Violation|22|||
130895045|NCT01523275|471250991|FG000|Overall Study|Lost to Follow-up|1|||
130895046|NCT01523275|471250992|FG001|Overall Study|Lost to Follow-up|2|||
130895047|NCT01523275|471250991|FG000|Overall Study|Withdrawal by Subject|1|||
130895048|NCT01523275|471250992|FG001|Overall Study|Withdrawal by Subject|0|||
130895049|NCT05573386|471250993|FG000|Overall Study|Withdrawal by Subject|3|||
130895050|NCT05573386|471250994|FG001|Overall Study|Withdrawal by Subject|2|||
130895051|NCT01802073|471250995|FG000|Overall Study|Lost to Follow-up|0|||
130895052|NCT01802073|471250996|FG001|Overall Study|Lost to Follow-up|1|||
130895053|NCT01802073|471250995|FG000|Overall Study|Non-compliant|4|||
130895054|NCT01802073|471250996|FG001|Overall Study|Non-compliant|2|||
130895055|NCT01802073|471250995|FG000|Overall Study|Withdrawal by Subject|1|||
130895056|NCT01802073|471250996|FG001|Overall Study|Withdrawal by Subject|1|||
130895057|NCT01802073|471250995|FG000|Overall Study|Physician Decision|0|||
130895058|NCT01802073|471250996|FG001|Overall Study|Physician Decision|7|||
130895059|NCT00918736|471250999|FG000|Overall Study|Withdrawal by Subject|4|||
130895060|NCT01137604|471251000|FG000|Overall Study|Adverse Event|3|||
130895061|NCT01137604|471251001|FG001|Overall Study|Adverse Event|6|||
130895062|NCT01137604|471251002|FG002|Overall Study|Adverse Event|9|||
130895063|NCT01137604|471251003|FG003|Overall Study|Adverse Event|9|||
130895064|NCT01137604|471251000|FG000|Overall Study|Participant Choice|0|||
130895065|NCT01137604|471251001|FG001|Overall Study|Participant Choice|2|||
130895066|NCT01137604|471251002|FG002|Overall Study|Participant Choice|2|||
130895067|NCT01137604|471251003|FG003|Overall Study|Participant Choice|0|||
130895068|NCT01137604|471251000|FG000|Overall Study|Withdrawal of consent|0|||
130895069|NCT01137604|471251001|FG001|Overall Study|Withdrawal of consent|0|||
130895070|NCT01137604|471251002|FG002|Overall Study|Withdrawal of consent|0|||
130895071|NCT01137604|471251003|FG003|Overall Study|Withdrawal of consent|2|||
130895072|NCT01137604|471251000|FG000|Overall Study|Clinical progression/deterioration|1|||
130895073|NCT01137604|471251001|FG001|Overall Study|Clinical progression/deterioration|2|||
130895074|NCT01137604|471251002|FG002|Overall Study|Clinical progression/deterioration|2|||
130895075|NCT01137604|471251003|FG003|Overall Study|Clinical progression/deterioration|0|||
130895076|NCT03462511|471251007|FG000|Overall Study|Withdrawal by Subject|2|||
130895077|NCT03462511|471251008|FG001|Overall Study|Withdrawal by Subject|3|||
130895078|NCT02925416|471251009|FG000|Overall Study|Adverse Event|2|||
130895079|NCT02925416|471251010|FG001|Overall Study|Adverse Event|0|||
130895080|NCT00200356|471251011|FG000|Overall Study|Lack of Efficacy|3|||
130895081|NCT00200356|471251012|FG001|Overall Study|Lack of Efficacy|3|||
130895082|NCT00200356|471251011|FG000|Overall Study|Protocol Violation|4|||
130895083|NCT00200356|471251012|FG001|Overall Study|Protocol Violation|4|||
130895084|NCT00200356|471251011|FG000|Overall Study|Nontreatment|1|||
130895085|NCT00200356|471251012|FG001|Overall Study|Nontreatment|0|||
130895086|NCT01297491|471251013|FG000|Overall Study|Adverse Event|11|||
130895087|NCT01297491|471251014|FG001|Overall Study|Adverse Event|6|||
130895088|NCT01297491|471251013|FG000|Overall Study|Physician Decision|3|||
130895089|NCT01297491|471251014|FG001|Overall Study|Physician Decision|2|||
130895090|NCT01297491|471251013|FG000|Overall Study|Progressive disease|11|||
130895091|NCT01297491|471251014|FG001|Overall Study|Progressive disease|20|||
130895092|NCT01297491|471251013|FG000|Overall Study|Patient/Guardian decision|3|||
130895093|NCT01297491|471251014|FG001|Overall Study|Patient/Guardian decision|4|||
130895094|NCT01297491|471251013|FG000|Overall Study|Death|2|||
130895095|NCT01297491|471251014|FG001|Overall Study|Death|1|||
130895096|NCT02424578|471251018|FG000|Overall Study|Withdrawal by Subject|0|||
130895097|NCT02424578|471251019|FG001|Overall Study|Withdrawal by Subject|1|||
130895098|NCT01703754|471251024|FG000|Overall Study|Clinically significant disease progression|2|||
130895099|NCT01703754|471251025|FG001|Overall Study|Clinically significant disease progression|2|||
130895100|NCT01703754|471251026|FG002|Overall Study|Clinically significant disease progression|1|||
130895101|NCT01703754|471251024|FG000|Overall Study|Adverse Event|1|||
130895102|NCT01703754|471251025|FG001|Overall Study|Adverse Event|1|||
130895103|NCT01703754|471251026|FG002|Overall Study|Adverse Event|0|||
130895104|NCT01703754|471251024|FG000|Overall Study|Withdrawal by Subject|2|||
130895105|NCT01703754|471251025|FG001|Overall Study|Withdrawal by Subject|0|||
130895106|NCT01703754|471251026|FG002|Overall Study|Withdrawal by Subject|0|||
130895107|NCT01989208|471251027|FG000|200 mg (7 Days)|Protocol Violation|0|||
130895108|NCT01989208|471251028|FG001|200 mg (7 Days)|Protocol Violation|1|||
130895109|NCT04973436|471251029|FG000|Overall Study|Lost to Follow-up|3|||
130895110|NCT04973436|471251029|FG000|Overall Study|Withdrawal by Subject|1|||
130895111|NCT04973436|471251029|FG000|Overall Study|Death|2|||
130895112|NCT00566696|471251030|FG000|Overall Study|Met Exclusion Criteria|2|||
130895113|NCT00566696|471251030|FG000|Overall Study|Muromonab not available|1|||
130895114|NCT00566696|471251030|FG000|Overall Study|Health Status Change|1|||
130895115|NCT00566696|471251030|FG000|Overall Study|Physician Decision|1|||
130895116|NCT00566696|471251030|FG000|Overall Study|Non-Patient Donors|37|||
130895117|NCT02872935|471251031|FG000|Overall Study|Other|0|||
130895118|NCT02872935|471251032|FG001|Overall Study|Other|1|||
130895119|NCT01276054|471251036|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
130895120|NCT01276054|471251037|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
130895121|NCT02640508|471251038|FG000|Overall Study|Death|19|||
130895122|NCT02640508|471251038|FG000|Overall Study|Withdrawal by Subject|8|||
130895123|NCT02640508|471251038|FG000|Overall Study|Physician Decision|1|||
130895124|NCT02640508|471251038|FG000|Overall Study|Lost to Follow-up|1|||
130895125|NCT02792829|471251039|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130895126|NCT02792829|471251040|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
130895127|NCT02792829|471251041|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130895128|NCT02792829|471251042|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130895129|NCT02792829|471251043|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130895130|NCT02792829|471251044|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130895131|NCT02792829|471251045|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130895132|NCT02792829|471251046|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130895133|NCT02792829|471251039|FG000|Treatment Period 2|Adverse Event|0|||
130895134|NCT02792829|471251040|FG001|Treatment Period 2|Adverse Event|0|||
130895135|NCT02792829|471251041|FG002|Treatment Period 2|Adverse Event|0|||
130895136|NCT02792829|471251042|FG003|Treatment Period 2|Adverse Event|0|||
130895137|NCT02792829|471251043|FG004|Treatment Period 2|Adverse Event|1|||
130895138|NCT02792829|471251044|FG005|Treatment Period 2|Adverse Event|0|||
130895139|NCT02792829|471251045|FG006|Treatment Period 2|Adverse Event|1|||
130895140|NCT02792829|471251046|FG007|Treatment Period 2|Adverse Event|1|||
130895141|NCT02792829|471251039|FG000|Treatment Period 2|Use of proscribed medications|0|||
130895142|NCT02792829|471251040|FG001|Treatment Period 2|Use of proscribed medications|0|||
130895143|NCT02792829|471251041|FG002|Treatment Period 2|Use of proscribed medications|0|||
130895144|NCT02792829|471251042|FG003|Treatment Period 2|Use of proscribed medications|0|||
130895145|NCT02792829|471251043|FG004|Treatment Period 2|Use of proscribed medications|0|||
130895146|NCT02792829|471251044|FG005|Treatment Period 2|Use of proscribed medications|0|||
130895147|NCT02792829|471251045|FG006|Treatment Period 2|Use of proscribed medications|0|||
130895148|NCT02792829|471251046|FG007|Treatment Period 2|Use of proscribed medications|1|||
130690538|NCT03419403|470493126|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
130690539|NCT02089685|470493131|FG000|Overall Study|Adverse Event|1|||
130690540|NCT02089685|470493132|FG001|Overall Study|Adverse Event|0|||
130690541|NCT02089685|470493133|FG002|Overall Study|Adverse Event|0|||
130690542|NCT02089685|470493134|FG003|Overall Study|Adverse Event|0|||
130690543|NCT02089685|470493135|FG004|Overall Study|Adverse Event|1|||
130690544|NCT02089685|470493136|FG005|Overall Study|Adverse Event|0|||
130895149|NCT05405257|471251047|FG000|Overall Study|Withdrawal by Subject|1|||
130895150|NCT00452361|471251048|FG000|Overall Study|Adverse Event|8|||
130895151|NCT00452361|471251049|FG001|Overall Study|Adverse Event|0|||
130895152|NCT00452361|471251048|FG000|Overall Study|Withdrawal by Subject|0|||
130895153|NCT00452361|471251049|FG001|Overall Study|Withdrawal by Subject|1|||
130895154|NCT00452361|471251048|FG000|Overall Study|Premature termination|13|||
130895155|NCT00452361|471251049|FG001|Overall Study|Premature termination|9|||
130895156|NCT00776919|471251050|FG000|Overall Study|Withdrawal by Subject|16|||
130895157|NCT00776919|471251051|FG001|Overall Study|Withdrawal by Subject|14|||
130895158|NCT00776919|471251052|FG002|Overall Study|Withdrawal by Subject|15|||
130895159|NCT00776919|471251053|FG003|Overall Study|Withdrawal by Subject|26|||
130895160|NCT00776919|471251050|FG000|Overall Study|Lost to Follow-up|8|||
130690545|NCT02089685|470493131|FG000|Overall Study|Clinical Progression|4|||
130690546|NCT02089685|470493132|FG001|Overall Study|Clinical Progression|0|||
130895161|NCT00776919|471251051|FG001|Overall Study|Lost to Follow-up|12|||
130895162|NCT00776919|471251052|FG002|Overall Study|Lost to Follow-up|11|||
130895163|NCT00776919|471251053|FG003|Overall Study|Lost to Follow-up|8|||
130895164|NCT00776919|471251050|FG000|Overall Study|Adverse Event|1|||
130895165|NCT00776919|471251051|FG001|Overall Study|Adverse Event|0|||
130895166|NCT00776919|471251052|FG002|Overall Study|Adverse Event|2|||
130895167|NCT00776919|471251053|FG003|Overall Study|Adverse Event|2|||
130895168|NCT00776919|471251050|FG000|Overall Study|Protocol Violation|1|||
130895169|NCT00776919|471251051|FG001|Overall Study|Protocol Violation|2|||
130895170|NCT00776919|471251052|FG002|Overall Study|Protocol Violation|0|||
130895171|NCT00776919|471251053|FG003|Overall Study|Protocol Violation|1|||
130895172|NCT00776919|471251050|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
130895173|NCT00776919|471251051|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
130895174|NCT00776919|471251052|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
130895175|NCT00776919|471251053|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
130895176|NCT03116152|471251056|FG000|Overall Study|Disease Progression|49|||
130895177|NCT03116152|471251057|FG001|Overall Study|Disease Progression|47|||
130895178|NCT03116152|471251056|FG000|Overall Study|Death|5|||
130895179|NCT03116152|471251057|FG001|Overall Study|Death|2|||
130895180|NCT03116152|471251056|FG000|Overall Study|Adverse Event|21|||
130895181|NCT03116152|471251057|FG001|Overall Study|Adverse Event|7|||
130895182|NCT03116152|471251056|FG000|Overall Study|Protocol Violation|2|||
130895183|NCT03116152|471251057|FG001|Overall Study|Protocol Violation|2|||
130895184|NCT03116152|471251056|FG000|Overall Study|Withdrawal by Subject|0|||
130895185|NCT03116152|471251057|FG001|Overall Study|Withdrawal by Subject|1|||
130895186|NCT03116152|471251056|FG000|Overall Study|Physician Decision|3|||
130895187|NCT03116152|471251057|FG001|Overall Study|Physician Decision|2|||
130895188|NCT03116152|471251056|FG000|Overall Study|other|11|||
130895189|NCT03116152|471251057|FG001|Overall Study|other|34|||
130895190|NCT02379637|471251061|FG000|Overall Study|Protocol Violation|0|||
130895191|NCT02379637|471251062|FG001|Overall Study|Protocol Violation|1|||
130895192|NCT02379637|471251061|FG000|Overall Study|Adverse Event|1|||
130895193|NCT02379637|471251062|FG001|Overall Study|Adverse Event|0|||
130895194|NCT02379637|471251061|FG000|Overall Study|Withdrawal by Subject|1|||
130895195|NCT02379637|471251062|FG001|Overall Study|Withdrawal by Subject|0|||
130895196|NCT02791763|471251063|FG000|Overall Study|Protocol Violation|0|||
130895197|NCT02791763|471251064|FG001|Overall Study|Protocol Violation|0|||
130895198|NCT02791763|471251065|FG002|Overall Study|Protocol Violation|1|||
130895199|NCT02791763|471251063|FG000|Overall Study|Withdrawal by Subject|5|||
130895200|NCT02791763|471251064|FG001|Overall Study|Withdrawal by Subject|1|||
130895201|NCT02791763|471251065|FG002|Overall Study|Withdrawal by Subject|0|||
130895202|NCT02791763|471251063|FG000|Overall Study|Physician Decision|0|||
130895203|NCT02791763|471251064|FG001|Overall Study|Physician Decision|1|||
130895204|NCT02791763|471251065|FG002|Overall Study|Physician Decision|0|||
130895205|NCT02791763|471251063|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
130895206|NCT02791763|471251064|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
130895207|NCT02791763|471251065|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
130895208|NCT02791763|471251063|FG000|Overall Study|Cancer event|1|||
130895209|NCT02791763|471251064|FG001|Overall Study|Cancer event|3|||
130895210|NCT02791763|471251065|FG002|Overall Study|Cancer event|0|||
130895211|NCT02791763|471251063|FG000|Overall Study|Participant had renal transplant|3|||
130895212|NCT02791763|471251064|FG001|Overall Study|Participant had renal transplant|0|||
130895213|NCT02791763|471251065|FG002|Overall Study|Participant had renal transplant|0|||
130895214|NCT02791763|471251063|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
130895215|NCT02791763|471251064|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
130895216|NCT02791763|471251065|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
130895217|NCT02791763|471251063|FG000|Overall Study|Adverse Event|12|||
130895218|NCT02791763|471251064|FG001|Overall Study|Adverse Event|13|||
131111691|NCT00752622|472039079|FG000|Induction Phase|Withdrawal by Subject|1|||
130767709|NCT01716520|470773852|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
130767710|NCT01716520|470773853|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130767711|NCT01716520|470773854|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130767712|NCT01716520|470773855|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
130767713|NCT01716520|470773850|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
130767714|NCT01716520|470773851|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
130895219|NCT02791763|471251065|FG002|Overall Study|Adverse Event|7|||
130895220|NCT03179605|471251066|FG000|Overall Study|Withdrawal by Subject|1|||
130895221|NCT00635999|471251067|FG000|Overall Study|Withdrawal by Subject|4|||
130895222|NCT00635999|471251068|FG001|Overall Study|Withdrawal by Subject|2|||
130895223|NCT00635999|471251069|FG002|Overall Study|Withdrawal by Subject|1|||
130895224|NCT00711477|471251070|FG000|Overall Study|Adverse Event|3|||
130895225|NCT00711477|471251071|FG001|Overall Study|Adverse Event|1|||
130895226|NCT00711477|471251070|FG000|Overall Study|Lost to Follow-up|0|||
130895227|NCT00711477|471251071|FG001|Overall Study|Lost to Follow-up|1|||
130895228|NCT00711477|471251070|FG000|Overall Study|Noncompliance|0|||
130895229|NCT00711477|471251071|FG001|Overall Study|Noncompliance|1|||
130895230|NCT02929407|471251072|FG000|Overall Study|Adverse Event|1|||
130895231|NCT02410343|471251073|FG000|Core Period (24 Weeks)|Adverse Event|1|||
130895232|NCT02410343|471251074|FG001|Core Period (24 Weeks)|Adverse Event|0|||
130895233|NCT02410343|471251073|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
130895234|NCT02410343|471251074|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
130690547|NCT02089685|470493133|FG002|Overall Study|Clinical Progression|0|||
130690548|NCT02089685|470493134|FG003|Overall Study|Clinical Progression|5|||
130690549|NCT02089685|470493135|FG004|Overall Study|Clinical Progression|1|||
130690550|NCT02089685|470493136|FG005|Overall Study|Clinical Progression|2|||
130690551|NCT02089685|470493131|FG000|Overall Study|Excluded Medication|1|||
130690552|NCT02089685|470493132|FG001|Overall Study|Excluded Medication|0|||
130690553|NCT02089685|470493133|FG002|Overall Study|Excluded Medication|0|||
130690554|NCT02089685|470493134|FG003|Overall Study|Excluded Medication|11|||
130690555|NCT02089685|470493135|FG004|Overall Study|Excluded Medication|2|||
130690556|NCT02089685|470493136|FG005|Overall Study|Excluded Medication|1|||
130690557|NCT02089685|470493131|FG000|Overall Study|Progressive disease|13|||
130895235|NCT02410343|471251073|FG000|Extension Period (12 Months)|Adverse Event|1|||
130895236|NCT02410343|471251074|FG001|Extension Period (12 Months)|Adverse Event|0|||
130895237|NCT02410343|471251073|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
130895238|NCT02410343|471251074|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
130895239|NCT00145977|471251075|FG000|Overall Study|Lack of Efficacy|0|||
130895240|NCT00145977|471251076|FG001|Overall Study|Lack of Efficacy|4|||
130895241|NCT00145977|471251075|FG000|Overall Study|Lost to Follow-up|1|||
130895242|NCT00145977|471251076|FG001|Overall Study|Lost to Follow-up|0|||
130895243|NCT00145977|471251075|FG000|Overall Study|Withdrawal by Subject|1|||
130895244|NCT00145977|471251076|FG001|Overall Study|Withdrawal by Subject|0|||
130895245|NCT00782834|471251077|FG000|Treatment Phase|fibrous tumor not GIST|1|||
130895246|NCT01516034|471251079|FG000|Overall Study|Physician Decision|1|||
130895247|NCT01516034|471251079|FG000|Overall Study|Lack of Efficacy|7|||
130895248|NCT01165216|471251086|FG000|Overall Study|Adverse Event|6|||
130895249|NCT01165216|471251087|FG001|Overall Study|Adverse Event|3|||
130895250|NCT01165216|471251086|FG000|Overall Study|Withdrawal by Subject|1|||
130895251|NCT01165216|471251087|FG001|Overall Study|Withdrawal by Subject|1|||
130895252|NCT01165216|471251086|FG000|Overall Study|Disease progression|1|||
130895253|NCT01165216|471251087|FG001|Overall Study|Disease progression|3|||
130895254|NCT05688670|471251088|FG000|Overall Study|Change in surgery plan|1|||
130895255|NCT05688670|471251089|FG001|Overall Study|Change in surgery plan|4|||
130895256|NCT05688670|471251088|FG000|Overall Study|Inability to extubate|1|||
130895257|NCT05688670|471251089|FG001|Overall Study|Inability to extubate|2|||
130895258|NCT05688670|471251088|FG000|Overall Study|Day of surgery cancellation|0|||
130895259|NCT05688670|471251089|FG001|Overall Study|Day of surgery cancellation|1|||
130895260|NCT05688670|471251088|FG000|Overall Study|Reintubated on PCICU arrival|0|||
130895261|NCT05688670|471251089|FG001|Overall Study|Reintubated on PCICU arrival|1|||
130895262|NCT03425253|471251090|FG000|Overall Study|Adverse Event|2|||
130895263|NCT03425253|471251090|FG000|Overall Study|Lost to Follow-up|3|||
130895264|NCT03425253|471251090|FG000|Overall Study|Withdrew Consent|6|||
130895265|NCT03425253|471251090|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
130895266|NCT01217307|471252794|FG000|Overall Study|Withdrawal by Subject|0|||
130895267|NCT01217307|471252795|FG001|Overall Study|Withdrawal by Subject|1|||
130895268|NCT04129151|471252798|FG000|Overall Study|Adverse Event|1|||
130895269|NCT04129151|471252798|FG000|Overall Study|Disease Progression|7|||
130895270|NCT04129151|471252798|FG000|Overall Study|Study closure|1|||
130895271|NCT02730195|471252799|FG000|Overall Study|Withdrawal by Subject|1|||
130895272|NCT01463007|471252800|FG000|Overall Study|Physician Decision|1|||
130895273|NCT01206322|471252801|FG000|Overall Study|Adverse Event|0|||
130895274|NCT01206322|471252802|FG001|Overall Study|Adverse Event|0|||
130895275|NCT01206322|471252803|FG002|Overall Study|Adverse Event|0|||
130895276|NCT01206322|471252804|FG003|Overall Study|Adverse Event|1|||
130895277|NCT00689117|471252805|FG000|Overall Study|Adverse Event|6|||
130895278|NCT00689117|471252806|FG001|Overall Study|Adverse Event|0|||
130895279|NCT00689117|471252807|FG002|Overall Study|Adverse Event|5|||
130895280|NCT00689117|471252808|FG003|Overall Study|Adverse Event|0|||
130895281|NCT00689117|471252805|FG000|Overall Study|Lost to Follow-up|26|||
130895282|NCT00689117|471252806|FG001|Overall Study|Lost to Follow-up|19|||
130895283|NCT00689117|471252807|FG002|Overall Study|Lost to Follow-up|17|||
130895284|NCT00689117|471252808|FG003|Overall Study|Lost to Follow-up|11|||
130690558|NCT02089685|470493132|FG001|Overall Study|Progressive disease|10|||
130690559|NCT02089685|470493133|FG002|Overall Study|Progressive disease|3|||
130895285|NCT00689117|471252805|FG000|Overall Study|Lack of Efficacy|1|||
130895286|NCT00689117|471252806|FG001|Overall Study|Lack of Efficacy|2|||
131025393|NCT00087139|471723246|FG002|Overall Study|Extradural disease|1|||
130895287|NCT00689117|471252807|FG002|Overall Study|Lack of Efficacy|2|||
130895288|NCT00689117|471252808|FG003|Overall Study|Lack of Efficacy|2|||
130895289|NCT00689117|471252805|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
130690560|NCT02089685|470493134|FG003|Overall Study|Progressive disease|51|||
130690561|NCT02089685|470493135|FG004|Overall Study|Progressive disease|17|||
130690562|NCT02089685|470493136|FG005|Overall Study|Progressive disease|12|||
130895290|NCT00689117|471252806|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
130895291|NCT00689117|471252807|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
130895292|NCT00689117|471252808|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
130895293|NCT00689117|471252805|FG000|Overall Study|Withdrawal by Subject|19|||
130895294|NCT00689117|471252806|FG001|Overall Study|Withdrawal by Subject|18|||
130895295|NCT00689117|471252807|FG002|Overall Study|Withdrawal by Subject|26|||
130895296|NCT00689117|471252808|FG003|Overall Study|Withdrawal by Subject|13|||
130895297|NCT00689117|471252805|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
130895298|NCT00689117|471252806|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
130895299|NCT00689117|471252807|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
130895300|NCT00689117|471252808|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
130895301|NCT00689117|471252805|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130895302|NCT00689117|471252806|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
130895303|NCT00689117|471252807|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130895304|NCT00689117|471252808|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130895305|NCT00689117|471252805|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
130895306|NCT00689117|471252806|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
130895307|NCT00689117|471252807|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
130895308|NCT00689117|471252808|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
130895309|NCT00689117|471252805|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
130895310|NCT00689117|471252806|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
130895311|NCT00689117|471252807|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
130895312|NCT00689117|471252808|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
130895313|NCT00689117|471252805|FG000|Overall Study|Use of Prohibitive Medication|2|||
130895314|NCT00689117|471252806|FG001|Overall Study|Use of Prohibitive Medication|1|||
130895315|NCT00689117|471252807|FG002|Overall Study|Use of Prohibitive Medication|3|||
130895316|NCT00689117|471252808|FG003|Overall Study|Use of Prohibitive Medication|0|||
130895317|NCT00689117|471252805|FG000|Overall Study|Pregnancy|0|||
130895318|NCT00689117|471252806|FG001|Overall Study|Pregnancy|2|||
130895319|NCT00689117|471252807|FG002|Overall Study|Pregnancy|0|||
130895320|NCT00689117|471252808|FG003|Overall Study|Pregnancy|2|||
130895321|NCT00689117|471252805|FG000|Overall Study|Incarceration|2|||
130895322|NCT00689117|471252806|FG001|Overall Study|Incarceration|0|||
130895323|NCT00689117|471252807|FG002|Overall Study|Incarceration|0|||
130895324|NCT00689117|471252808|FG003|Overall Study|Incarceration|0|||
130895325|NCT00689117|471252805|FG000|Overall Study|Fear of Birth Defects|0|||
130895326|NCT00689117|471252806|FG001|Overall Study|Fear of Birth Defects|0|||
130895327|NCT00689117|471252807|FG002|Overall Study|Fear of Birth Defects|1|||
130895328|NCT00689117|471252808|FG003|Overall Study|Fear of Birth Defects|0|||
130895329|NCT00689117|471252805|FG000|Overall Study|Transportation|1|||
130895330|NCT00689117|471252806|FG001|Overall Study|Transportation|0|||
130895331|NCT00689117|471252807|FG002|Overall Study|Transportation|0|||
130895332|NCT00689117|471252808|FG003|Overall Study|Transportation|0|||
130895333|NCT00689117|471252805|FG000|Overall Study|Patient Withdrew from Study|0|||
130895334|NCT00689117|471252806|FG001|Overall Study|Patient Withdrew from Study|0|||
130895335|NCT00689117|471252807|FG002|Overall Study|Patient Withdrew from Study|0|||
130895336|NCT00689117|471252808|FG003|Overall Study|Patient Withdrew from Study|1|||
130895337|NCT00689117|471252805|FG000|Overall Study|Personal Reason|0|||
130895338|NCT00689117|471252806|FG001|Overall Study|Personal Reason|1|||
130895339|NCT00689117|471252807|FG002|Overall Study|Personal Reason|0|||
130895340|NCT00689117|471252808|FG003|Overall Study|Personal Reason|0|||
130895341|NCT00689117|471252805|FG000|Overall Study|Dispensing Error|0|||
130895342|NCT00689117|471252806|FG001|Overall Study|Dispensing Error|1|||
130895343|NCT00689117|471252807|FG002|Overall Study|Dispensing Error|0|||
130895344|NCT00689117|471252808|FG003|Overall Study|Dispensing Error|0|||
130895345|NCT00859638|471252811|FG000|Overall Study|Lost to Follow-up|6|||
130895346|NCT00859638|471252812|FG001|Overall Study|Lost to Follow-up|1|||
130895347|NCT00859638|471252811|FG000|Overall Study|Withdrawal by Subject|3|||
130895348|NCT00859638|471252812|FG001|Overall Study|Withdrawal by Subject|2|||
130895349|NCT00859638|471252811|FG000|Overall Study|Ill health|1|||
130690563|NCT02089685|470493131|FG000|Overall Study|Follow up ended by sponsor|2|||
130690564|NCT02089685|470493132|FG001|Overall Study|Follow up ended by sponsor|2|||
130690565|NCT02089685|470493133|FG002|Overall Study|Follow up ended by sponsor|0|||
130690566|NCT02089685|470493134|FG003|Overall Study|Follow up ended by sponsor|70|||
130690567|NCT02089685|470493135|FG004|Overall Study|Follow up ended by sponsor|26|||
130690568|NCT02089685|470493136|FG005|Overall Study|Follow up ended by sponsor|26|||
130690569|NCT02089685|470493131|FG000|Overall Study|Withdrawal by Subject|0|||
130690570|NCT02089685|470493132|FG001|Overall Study|Withdrawal by Subject|2|||
130690571|NCT02089685|470493133|FG002|Overall Study|Withdrawal by Subject|0|||
130767715|NCT01716520|470773852|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
130895350|NCT00859638|471252812|FG001|Overall Study|Ill health|1|||
130895351|NCT02969408|471252813|FG000|Overall Study|Adverse Event|2|||
130895352|NCT02969408|471252813|FG000|Overall Study|Withdrawal by Subject|8|||
130895353|NCT02969408|471252813|FG000|Overall Study|Lost to Follow-up|4|||
130895354|NCT02969408|471252813|FG000|Overall Study|Protocol Violation|1|||
130895355|NCT02969408|471252813|FG000|Overall Study|Other than specified|1|||
130895356|NCT01767142|471252817|FG000|Overall Study|Lost to Follow-up|3|||
130895357|NCT02471612|471252820|FG000|Overall Study|Lost to Follow-up|2|||
130895358|NCT02082340|471252821|FG000|Overall Study|Lost to Follow-up|1|||
130895359|NCT02082340|471252822|FG001|Overall Study|Lost to Follow-up|1|||
130895360|NCT00435045|471252828|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
130895361|NCT00435045|471252829|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
130895362|NCT00435045|471252828|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
130895363|NCT00435045|471252829|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
130895364|NCT00435045|471252828|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
130895365|NCT00435045|471252829|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
130895366|NCT00435045|471252828|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
130895367|NCT00435045|471252829|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
130895368|NCT00435045|471252828|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
130895369|NCT00435045|471252829|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
130895370|NCT00435045|471252828|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
130895371|NCT00435045|471252829|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
130895372|NCT00435045|471252828|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
130895373|NCT00435045|471252829|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
130895374|NCT00435045|471252828|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
130895375|NCT00435045|471252829|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
130895376|NCT00435045|471252828|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
130895377|NCT00435045|471252829|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
130895378|NCT00435045|471252828|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
130895379|NCT00435045|471252829|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
130895380|NCT00435045|471252828|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
130895381|NCT00435045|471252829|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
130895382|NCT00984620|471252830|FG000|Overall Study|Adverse Event|5|||
130895383|NCT00984620|471252831|FG001|Overall Study|Adverse Event|5|||
130895384|NCT00984620|471252830|FG000|Overall Study|Lost to Follow-up|1|||
130895385|NCT00984620|471252831|FG001|Overall Study|Lost to Follow-up|1|||
130895386|NCT00984620|471252830|FG000|Overall Study|Withdrawal by Subject|0|||
130895387|NCT00984620|471252831|FG001|Overall Study|Withdrawal by Subject|2|||
130895388|NCT00984620|471252830|FG000|Overall Study|reason other than listed above|0|||
130895389|NCT00984620|471252831|FG001|Overall Study|reason other than listed above|4|||
130895390|NCT00862641|471252834|FG000|Overall Study|Randomized, but drug not received|1|||
130895391|NCT00862641|471252835|FG001|Overall Study|Randomized, but drug not received|4|||
130895392|NCT00862641|471252836|FG002|Overall Study|Randomized, but drug not received|1|||
130895393|NCT00862641|471252837|FG003|Overall Study|Randomized, but drug not received|4|||
130895394|NCT02365480|471252838|FG000|Overall Study|Withdrawal by Subject|2|||
130895395|NCT02365480|471252839|FG001|Overall Study|Withdrawal by Subject|0|||
130895396|NCT04534686|471252840|FG000|Baseline Measurement|Lost to Follow-up|4|||
130895397|NCT04534686|471252841|FG001|Baseline Measurement|Lost to Follow-up|6|||
130895398|NCT04534686|471252840|FG000|Baseline Measurement|Withdrawal by Subject|3|||
130895399|NCT04534686|471252841|FG001|Baseline Measurement|Withdrawal by Subject|1|||
130895400|NCT04534686|471252840|FG000|Intervention|Withdrawal by Subject|2|||
130895401|NCT04534686|471252841|FG001|Intervention|Withdrawal by Subject|2|||
130895402|NCT01781299|471252845|FG000|Overall Study|Withdrawal by Subject|0|||
130895403|NCT01781299|471252846|FG001|Overall Study|Withdrawal by Subject|1|||
130895404|NCT01798849|471252850|FG000|Overall Study|Physician Decision|0|||
130895405|NCT01798849|471252851|FG001|Overall Study|Physician Decision|0|||
130895406|NCT01798849|471252852|FG002|Overall Study|Physician Decision|1|||
130895407|NCT02636361|471252853|FG000|Period 4|Physician Decision|0|||
130895408|NCT02636361|471252854|FG001|Period 4|Physician Decision|0|||
130895409|NCT02636361|471252855|FG002|Period 4|Physician Decision|0|||
130895410|NCT02636361|471252856|FG003|Period 4|Physician Decision|1|||
130895411|NCT02636361|471252857|FG004|Period 4|Physician Decision|0|||
130895412|NCT02032238|471252858|FG000|Overall Study|Lost to Follow-up|2|||
130895413|NCT02032238|471252859|FG001|Overall Study|Lost to Follow-up|0|||
130895414|NCT00228553|471252862|FG000|Overall Study|Adverse Event|112|||
130895415|NCT00228553|471252862|FG000|Overall Study|Lack of Efficacy|34|||
131111692|NCT00752622|472039079|FG000|Induction Phase|Premature study termination|14|||
131111693|NCT00752622|472039079|FG000|Observational Phase|Premature Study Termination|36|||
130895416|NCT00228553|471252862|FG000|Overall Study|Lost to Follow-up|67|||
130895417|NCT00228553|471252862|FG000|Overall Study|Physician Decision|48|||
130895418|NCT00228553|471252862|FG000|Overall Study|Protocol Violation|6|||
130895419|NCT00228553|471252862|FG000|Overall Study|Withdrawal by Subject|115|||
130895420|NCT00228553|471252862|FG000|Overall Study|Pregnancy|2|||
131111694|NCT00752622|472039079|FG000|Observational Phase|Non-responder|2|||
131111695|NCT00752622|472039079|FG000|Observational Phase|Withdrawal by Subject|2|||
130895421|NCT00228553|471252862|FG000|Overall Study|Miscellaneous|46|||
130895422|NCT02878798|471252865|FG000|Overall Study|Withdrawal by Subject|5|||
130690572|NCT02089685|470493134|FG003|Overall Study|Withdrawal by Subject|8|||
130895423|NCT02878798|471252866|FG001|Overall Study|Withdrawal by Subject|4|||
130895424|NCT02878798|471252865|FG000|Overall Study|Lost to Follow-up|2|||
130895425|NCT02878798|471252866|FG001|Overall Study|Lost to Follow-up|2|||
130895426|NCT02878798|471252865|FG000|Overall Study|Protocol Violation|0|||
130895427|NCT02878798|471252866|FG001|Overall Study|Protocol Violation|1|||
130895428|NCT02720042|471252869|FG000|Overall Study|Death|3|||
130895429|NCT02720042|471252869|FG000|Overall Study|Lost to Follow-up|4|||
130895430|NCT02720042|471252869|FG000|Overall Study|Withdrawal by Subject|1|||
130895431|NCT02720042|471252869|FG000|Overall Study|Physician Decision|3|||
130895432|NCT02720042|471252869|FG000|Overall Study|Phasix Mesh explanted|1|||
130895433|NCT02720042|471252869|FG000|Overall Study|unable due to non-study-related illness|3|||
130895434|NCT00246740|471252872|FG000|Initial Enrollment|Death|1|||
130895435|NCT00246740|471252873|FG001|Initial Enrollment|Death|0|||
130895436|NCT00246740|471252872|FG000|Initial Enrollment|Additional surgery scheduled|0|||
130895437|NCT00246740|471252873|FG001|Initial Enrollment|Additional surgery scheduled|2|||
130895438|NCT00246740|471252872|FG000|Initial Enrollment|Surgery schedule change|4|||
130895439|NCT00246740|471252873|FG001|Initial Enrollment|Surgery schedule change|4|||
130895440|NCT00246740|471252872|FG000|Initial Enrollment|Other|1|||
130895441|NCT00246740|471252873|FG001|Initial Enrollment|Other|2|||
130895442|NCT00101452|471252876|FG000|Overall Study|Adverse Event|2|||
130895443|NCT00101452|471252877|FG001|Overall Study|Adverse Event|0|||
130895444|NCT00101452|471252878|FG002|Overall Study|Adverse Event|1|||
130895445|NCT00101452|471252876|FG000|Overall Study|Lost to Follow-up|13|||
130895446|NCT00101452|471252877|FG001|Overall Study|Lost to Follow-up|8|||
130895447|NCT00101452|471252878|FG002|Overall Study|Lost to Follow-up|14|||
130895448|NCT00101452|471252876|FG000|Overall Study|Withdrawal by Subject|10|||
130895449|NCT00101452|471252877|FG001|Overall Study|Withdrawal by Subject|14|||
130895450|NCT00101452|471252878|FG002|Overall Study|Withdrawal by Subject|9|||
130895451|NCT00101452|471252876|FG000|Overall Study|Baseline Fail|2|||
130895452|NCT00101452|471252877|FG001|Overall Study|Baseline Fail|1|||
130895453|NCT00101452|471252878|FG002|Overall Study|Baseline Fail|2|||
130895454|NCT00101452|471252876|FG000|Overall Study|Physician Decision|0|||
130895455|NCT00101452|471252877|FG001|Overall Study|Physician Decision|3|||
130895456|NCT00101452|471252878|FG002|Overall Study|Physician Decision|2|||
130895457|NCT00101452|471252876|FG000|Overall Study|Protocol Violation|2|||
130895458|NCT00101452|471252877|FG001|Overall Study|Protocol Violation|1|||
130895459|NCT00101452|471252878|FG002|Overall Study|Protocol Violation|3|||
130895460|NCT00101452|471252876|FG000|Overall Study|Other|15|||
130895461|NCT00101452|471252877|FG001|Overall Study|Other|16|||
130895462|NCT00101452|471252878|FG002|Overall Study|Other|12|||
130895463|NCT02969655|471252880|FG000|Overall Study|Withdrawal by Subject|3|||
130895464|NCT02969655|471252881|FG001|Overall Study|Withdrawal by Subject|2|||
130895465|NCT02969655|471252880|FG000|Overall Study|Physician Decision|4|||
130895466|NCT02969655|471252881|FG001|Overall Study|Physician Decision|3|||
130895467|NCT02969655|471252880|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
130895468|NCT02969655|471252881|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
130895469|NCT02969655|471252880|FG000|Overall Study|Adverse Event|10|||
130895470|NCT02969655|471252881|FG001|Overall Study|Adverse Event|8|||
130895471|NCT01510769|471252882|FG000|Overall Study|Adverse Event|7|||
130690573|NCT02089685|470493135|FG004|Overall Study|Withdrawal by Subject|1|||
130690574|NCT02089685|470493136|FG005|Overall Study|Withdrawal by Subject|1|||
130690575|NCT02089685|470493131|FG000|Overall Study|Status not recorded|1|||
130690576|NCT02089685|470493132|FG001|Overall Study|Status not recorded|0|||
130690577|NCT02089685|470493133|FG002|Overall Study|Status not recorded|0|||
130690578|NCT02089685|470493134|FG003|Overall Study|Status not recorded|0|||
130690579|NCT02089685|470493135|FG004|Overall Study|Status not recorded|1|||
130690580|NCT02089685|470493136|FG005|Overall Study|Status not recorded|0|||
130690581|NCT02089685|470493131|FG000|Overall Study|Death|0|||
130690582|NCT02089685|470493132|FG001|Overall Study|Death|0|||
130690583|NCT02089685|470493133|FG002|Overall Study|Death|0|||
130690584|NCT02089685|470493134|FG003|Overall Study|Death|7|||
130690585|NCT02089685|470493135|FG004|Overall Study|Death|2|||
130690586|NCT02089685|470493136|FG005|Overall Study|Death|5|||
130690587|NCT02089685|470493131|FG000|Overall Study|Lost to Follow-up|0|||
130690588|NCT02089685|470493132|FG001|Overall Study|Lost to Follow-up|0|||
130690589|NCT02089685|470493133|FG002|Overall Study|Lost to Follow-up|0|||
130690590|NCT02089685|470493134|FG003|Overall Study|Lost to Follow-up|1|||
130690591|NCT02089685|470493135|FG004|Overall Study|Lost to Follow-up|0|||
130690592|NCT02089685|470493136|FG005|Overall Study|Lost to Follow-up|0|||
130895472|NCT01510769|471252883|FG001|Overall Study|Adverse Event|6|||
130895473|NCT01510769|471252884|FG002|Overall Study|Adverse Event|4|||
130895474|NCT01510769|471252882|FG000|Overall Study|Gout Flare|0|||
130895475|NCT01510769|471252883|FG001|Overall Study|Gout Flare|3|||
130895476|NCT01510769|471252884|FG002|Overall Study|Gout Flare|1|||
130690593|NCT02089685|470493131|FG000|Overall Study|Physician Decision|0|||
130690594|NCT02089685|470493132|FG001|Overall Study|Physician Decision|0|||
130895477|NCT01510769|471252882|FG000|Overall Study|Protocol Violation|11|||
130895478|NCT01510769|471252883|FG001|Overall Study|Protocol Violation|10|||
130895479|NCT01510769|471252884|FG002|Overall Study|Protocol Violation|9|||
130895480|NCT01510769|471252882|FG000|Overall Study|Lost to Follow-up|5|||
130895481|NCT01510769|471252883|FG001|Overall Study|Lost to Follow-up|1|||
130895482|NCT01510769|471252884|FG002|Overall Study|Lost to Follow-up|5|||
130895483|NCT01510769|471252882|FG000|Overall Study|Withdrawal by Subject|3|||
130895484|NCT01510769|471252883|FG001|Overall Study|Withdrawal by Subject|4|||
130895485|NCT01510769|471252884|FG002|Overall Study|Withdrawal by Subject|3|||
130895486|NCT01510769|471252882|FG000|Overall Study|Death|1|||
130895487|NCT01510769|471252883|FG001|Overall Study|Death|1|||
130895488|NCT01510769|471252884|FG002|Overall Study|Death|0|||
130895489|NCT00335764|471252887|FG000|Overall Study|wrong histology|1|||
130895490|NCT00335764|471252888|FG001|Overall Study|wrong histology|0|||
130895491|NCT00335764|471252889|FG002|Overall Study|wrong histology|0|||
130895492|NCT00335764|471252890|FG003|Overall Study|wrong histology|0|||
130895493|NCT00335764|471252891|FG004|Overall Study|wrong histology|1|||
130895494|NCT02466659|471252892|FG000|Overall Study|Lost to Follow-up|5|||
130895495|NCT02466659|471252893|FG001|Overall Study|Lost to Follow-up|2|||
130895496|NCT01536392|471252896|FG000|Overall Study|Adverse Event|2|||
130895497|NCT01536392|471252897|FG001|Overall Study|Adverse Event|2|||
130895498|NCT01536392|471252896|FG000|Overall Study|Physician Decision|2|||
130895499|NCT01536392|471252897|FG001|Overall Study|Physician Decision|3|||
130895500|NCT01536392|471252896|FG000|Overall Study|Withdrawal by Subject|3|||
130895501|NCT01536392|471252897|FG001|Overall Study|Withdrawal by Subject|6|||
130895502|NCT01536392|471252896|FG000|Overall Study|Non Compliance|3|||
130895503|NCT01536392|471252897|FG001|Overall Study|Non Compliance|4|||
130895504|NCT01536392|471252896|FG000|Overall Study|Completed therapy early|3|||
130895505|NCT01536392|471252897|FG001|Overall Study|Completed therapy early|0|||
131111696|NCT00752622|472039079|FG000|Observational Phase|Adverse Event|1|||
131111697|NCT00752622|472039079|FG000|Observational Phase|Other|2|||
131111698|NCT00752622|472039079|FG000|Interventional Phase|Non-responder|2|||
131111699|NCT00752622|472039079|FG000|Interventional Phase|Physician Decision|1|||
131111700|NCT00752622|472039079|FG000|Interventional Phase|Premature Study Termination|5|||
131111701|NCT00894686|472039080|FG000|Overall Study|Withdrawal by Subject|50|||
131111702|NCT00894686|472039080|FG000|Overall Study|Physician Decision|1|||
131111703|NCT00894686|472039080|FG000|Overall Study|Other|5|||
131111704|NCT00564018|472039083|FG000|Overall Study|Withdrawal by Subject|2|||
131111705|NCT00564018|472039084|FG001|Overall Study|Withdrawal by Subject|3|||
131111706|NCT00564018|472039085|FG002|Overall Study|Withdrawal by Subject|1|||
131111707|NCT03291587|472039094|FG000|Overall Study|Lost to Follow-up|62|||
131111708|NCT03291587|472039095|FG001|Overall Study|Lost to Follow-up|43|||
131111709|NCT03291587|472039094|FG000|Overall Study|Refused to Answer|5|||
131111710|NCT03291587|472039095|FG001|Overall Study|Refused to Answer|2|||
131111711|NCT03291587|472039094|FG000|Overall Study|Death|2|||
131111712|NCT03291587|472039095|FG001|Overall Study|Death|4|||
131111713|NCT03291587|472039094|FG000|Overall Study|Not interested in participating|8|||
131111714|NCT03291587|472039095|FG001|Overall Study|Not interested in participating|6|||
131111715|NCT03291587|472039094|FG000|Overall Study|Too busy to participate|4|||
131111716|NCT03291587|472039095|FG001|Overall Study|Too busy to participate|2|||
131111717|NCT00796120|472039097|FG000|Overall Study|Death|3|||
131111718|NCT00796120|472039098|FG001|Overall Study|Death|0|||
131111719|NCT00796120|472039097|FG000|Overall Study|Adverse Event|11|||
131111720|NCT00796120|472039098|FG001|Overall Study|Adverse Event|6|||
131111721|NCT00796120|472039097|FG000|Overall Study|Progressive disease|22|||
131111722|NCT00796120|472039098|FG001|Overall Study|Progressive disease|13|||
131111723|NCT00796120|472039097|FG000|Overall Study|Participant refusal|3|||
131111724|NCT00796120|472039098|FG001|Overall Study|Participant refusal|4|||
131111725|NCT00796120|472039097|FG000|Overall Study|Other|6|||
131111726|NCT00796120|472039098|FG001|Overall Study|Other|17|||
131111727|NCT00796120|472039097|FG000|Overall Study|Physician Decision|16|||
131111728|NCT00796120|472039098|FG001|Overall Study|Physician Decision|17|||
131111729|NCT00796120|472039097|FG000|Overall Study|Randomized but not treated|0|||
131111730|NCT00796120|472039098|FG001|Overall Study|Randomized but not treated|3|||
131111731|NCT02520284|472039099|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
131111732|NCT02520284|472039100|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
131111733|NCT02520284|472039101|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
130690595|NCT02089685|470493133|FG002|Overall Study|Physician Decision|0|||
130895506|NCT00934440|471252898|FG000|Overall Study|Lost to Follow-up|1|||
130895507|NCT03060551|471252901|FG000|Overall Study|Withdrawal by Subject|1|||
131111734|NCT02520284|472039099|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
131111735|NCT02520284|472039100|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
131111736|NCT02520284|472039101|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
131111737|NCT02520284|472039099|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
130895508|NCT03060551|471252901|FG000|Overall Study|Adverse Event|1|||
130895509|NCT05477108|471252904|FG000|Overall Study|Participants randomized, not treated|1|||
130895510|NCT05477108|471252905|FG001|Overall Study|Participants randomized, not treated|1|||
130895511|NCT05477108|471252906|FG002|Overall Study|Participants randomized, not treated|1|||
130895512|NCT05477108|471252904|FG000|Overall Study|Physician Decision|0|||
131111738|NCT02520284|472039100|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
130895513|NCT05477108|471252905|FG001|Overall Study|Physician Decision|0|||
130895514|NCT05477108|471252906|FG002|Overall Study|Physician Decision|1|||
130895515|NCT05477108|471252904|FG000|Overall Study|withdrawn from study|0|||
130895516|NCT05477108|471252905|FG001|Overall Study|withdrawn from study|0|||
130895517|NCT05477108|471252906|FG002|Overall Study|withdrawn from study|1|||
130895518|NCT02660983|471252907|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
130895519|NCT02660983|471252908|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
130895520|NCT02660983|471252907|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
130895521|NCT02660983|471252908|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
130895522|NCT02660983|471252907|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
130895523|NCT02660983|471252908|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
130895524|NCT02660983|471252907|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
130895525|NCT02660983|471252908|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
130895526|NCT02660983|471252907|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
130895527|NCT02660983|471252908|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
130895528|NCT02660983|471252907|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
130895529|NCT02660983|471252908|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
130895530|NCT02660983|471252907|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
130895531|NCT02660983|471252908|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
130895532|NCT04614324|471252917|FG000|Overall Study|Lost to Follow-up|3|||
130895533|NCT04614324|471252917|FG000|Overall Study|Physician Decision|1|||
130895534|NCT04614324|471252917|FG000|Overall Study|Withdrawal by Subject|2|||
130895535|NCT04614324|471252917|FG000|Overall Study|Remaining in Follow up|123|||
130690596|NCT02089685|470493134|FG003|Overall Study|Physician Decision|0|||
130690597|NCT02089685|470493135|FG004|Overall Study|Physician Decision|0|||
130690598|NCT02089685|470493136|FG005|Overall Study|Physician Decision|4|||
130690599|NCT02089685|470493131|FG000|Overall Study|Screen failure|1|||
130690600|NCT02089685|470493132|FG001|Overall Study|Screen failure|0|||
130690601|NCT02089685|470493133|FG002|Overall Study|Screen failure|0|||
130690602|NCT02089685|470493134|FG003|Overall Study|Screen failure|0|||
130690603|NCT02089685|470493135|FG004|Overall Study|Screen failure|0|||
130690604|NCT02089685|470493136|FG005|Overall Study|Screen failure|0|||
130690605|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Adverse Event|11|||
130690606|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Adverse Event|23|||
130690607|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Adverse Event|29|||
130690608|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Adverse Event|2|||
130690609|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Adverse Event|8|||
130690610|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
130690611|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
130690612|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
130690613|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
130690614|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
130690615|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
130690616|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
130690617|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
130690618|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
130690619|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
130690620|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
130690621|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
130690622|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
130690623|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
130690624|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
130690625|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130690626|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
130690627|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130690628|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130690629|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130690630|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
130690631|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
130690632|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
130690633|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
130690634|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
130690635|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
130690636|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
130690637|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
130690638|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
130690639|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
130690640|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Move|0|||
130690641|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Move|1|||
130690642|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Move|0|||
130690643|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Move|0|||
130690644|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Move|0|||
130690645|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130690646|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130690647|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130690648|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130690649|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
130690650|NCT00318461|470493137|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
130690651|NCT00318461|470493138|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
130690652|NCT00318461|470493139|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
130690653|NCT00318461|470493140|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
130767716|NCT01716520|470773853|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
130690654|NCT00318461|470493141|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
130690655|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Work commitment|0|||
130690656|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Work commitment|0|||
130690657|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Work commitment|0|||
130690658|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Work commitment|0|||
130690659|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Work commitment|1|||
130690660|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Investigator decision|0|||
130690661|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Investigator decision|0|||
130690662|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Investigator decision|0|||
130690663|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Investigator decision|0|||
130690664|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Investigator decision|1|||
130767717|NCT01716520|470773854|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
130767718|NCT01716520|470773855|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
130690665|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Lack of time|1|||
130690666|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Lack of time|0|||
130690667|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Lack of time|0|||
130690668|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Lack of time|0|||
130690669|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Lack of time|0|||
130690670|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130690671|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130690672|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130690673|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130690674|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
130690675|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
130690676|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
130690677|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
130690678|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
130690679|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
130690680|NCT00318461|470493137|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130690681|NCT00318461|470493138|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130690682|NCT00318461|470493139|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130690683|NCT00318461|470493140|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130690684|NCT00318461|470493141|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
130690685|NCT00318461|470493137|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130690686|NCT00318461|470493138|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
130690687|NCT00318461|470493139|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130690688|NCT00318461|470493140|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130690689|NCT00318461|470493141|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130690690|NCT00318461|470493137|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
130690691|NCT00318461|470493138|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
130690692|NCT00318461|470493139|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
130690693|NCT00318461|470493140|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
130690694|NCT00318461|470493141|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
130690695|NCT00318461|470493137|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
130690696|NCT00318461|470493138|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
130690697|NCT00318461|470493139|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
130690698|NCT00318461|470493140|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
130690699|NCT00318461|470493141|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
130690700|NCT00318461|470493137|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
130690701|NCT00318461|470493138|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
130690702|NCT00318461|470493139|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
130690703|NCT00318461|470493140|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
130690704|NCT00318461|470493141|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
130690705|NCT00318461|470493137|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
130690706|NCT00318461|470493138|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
130690707|NCT00318461|470493139|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
130690708|NCT00318461|470493140|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
130690709|NCT00318461|470493141|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
130690710|NCT01929863|470493148|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
130690711|NCT01929863|470493149|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
130690712|NCT01929863|470493148|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
130690713|NCT01929863|470493149|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
130690714|NCT01929863|470493148|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
130690715|NCT01929863|470493149|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
130690716|NCT02911701|470493150|FG000|Overall Study|Withdrawal by Subject|2|||
130767719|NCT01716520|470773850|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130767720|NCT01716520|470773851|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131111739|NCT02520284|472039101|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
130690717|NCT02911701|470493151|FG001|Overall Study|Withdrawal by Subject|4|||
130690718|NCT02911701|470493150|FG000|Overall Study|Adverse Event|1|||
130690719|NCT02911701|470493151|FG001|Overall Study|Adverse Event|0|||
130690720|NCT00830024|470493152|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130690721|NCT00830024|470493153|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130690722|NCT00429416|470493154|FG000|Overall Study|Death|1|||
130690723|NCT01983969|470493155|FG000|Overall Study|Disease Progression|0|||
130690724|NCT01983969|470493156|FG001|Overall Study|Disease Progression|1|||
130690725|NCT01983969|470493157|FG002|Overall Study|Disease Progression|0|||
130895638|NCT05141448|471252935|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130895639|NCT05141448|471252936|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
130895640|NCT05141448|471252937|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130895641|NCT05141448|471252938|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130895642|NCT05141448|471252939|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130895643|NCT05141448|471252940|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130895644|NCT05141448|471252935|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130895645|NCT05141448|471252936|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130895646|NCT05141448|471252937|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130895647|NCT05141448|471252938|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130895648|NCT05141448|471252939|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
130895649|NCT05141448|471252940|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130895650|NCT05141448|471252935|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130895651|NCT05141448|471252936|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
130895652|NCT05141448|471252937|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130895653|NCT05141448|471252938|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130895654|NCT05141448|471252939|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130895655|NCT05141448|471252940|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130895656|NCT05141448|471252935|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130895657|NCT05141448|471252936|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130895658|NCT05141448|471252937|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130690726|NCT00436163|470493158|FG000|Overall Study|Lost to Follow-up|2|||
130895659|NCT05141448|471252938|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130895660|NCT05141448|471252939|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130895661|NCT05141448|471252940|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
130895662|NCT05141448|471252935|FG000|Period 2|COVID-19 Related|0|||
130895663|NCT05141448|471252936|FG001|Period 2|COVID-19 Related|0|||
130895664|NCT05141448|471252937|FG002|Period 2|COVID-19 Related|0|||
130895665|NCT05141448|471252938|FG003|Period 2|COVID-19 Related|1|||
130690727|NCT00436163|470493158|FG000|Overall Study|Adverse Event|1|||
130895666|NCT05141448|471252939|FG004|Period 2|COVID-19 Related|0|||
130895667|NCT05141448|471252940|FG005|Period 2|COVID-19 Related|1|||
130895668|NCT05141448|471252935|FG000|3|Covid-19 related|2|||
130895669|NCT05141448|471252936|FG001|3|Covid-19 related|0|||
130895670|NCT05141448|471252937|FG002|3|Covid-19 related|0|||
130895671|NCT05141448|471252938|FG003|3|Covid-19 related|0|||
130895672|NCT05141448|471252939|FG004|3|Covid-19 related|0|||
130895673|NCT05141448|471252940|FG005|3|Covid-19 related|1|||
130895674|NCT05141448|471252935|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
130895675|NCT05141448|471252936|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
130895676|NCT05141448|471252937|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
130895677|NCT05141448|471252938|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
130895678|NCT05141448|471252939|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
130895679|NCT05141448|471252940|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
130895680|NCT04627285|471252941|FG000|Overall Study|Adverse Event|0|||
130895681|NCT04627285|471252942|FG001|Overall Study|Adverse Event|2|||
130895682|NCT04627285|471252941|FG000|Overall Study|Lost to Follow-up|1|||
130895683|NCT04627285|471252942|FG001|Overall Study|Lost to Follow-up|0|||
130895684|NCT04627285|471252941|FG000|Overall Study|Withdrawal by Subject|1|||
130895685|NCT04627285|471252942|FG001|Overall Study|Withdrawal by Subject|1|||
130895686|NCT04627285|471252941|FG000|Overall Study|Sponsor decision|5|||
130895687|NCT04627285|471252942|FG001|Overall Study|Sponsor decision|0|||
130895688|NCT04627285|471252941|FG000|Overall Study|Participant left country; aunt informed the site|0|||
130895689|NCT04627285|471252942|FG001|Overall Study|Participant left country; aunt informed the site|1|||
130895690|NCT02123251|471254528|FG000|Overall Study|Death|1|||
130895691|NCT02123251|471254529|FG001|Overall Study|Death|1|||
130895692|NCT02123251|471254528|FG000|Overall Study|Withdrawal by Subject|0|||
130895693|NCT02123251|471254529|FG001|Overall Study|Withdrawal by Subject|3|||
130895694|NCT02123251|471254528|FG000|Overall Study|Lost Medicaid eligibility|29|||
130895695|NCT02123251|471254529|FG001|Overall Study|Lost Medicaid eligibility|22|||
130895696|NCT02123251|471254528|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
130895697|NCT02123251|471254529|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
130895698|NCT01221285|471254530|FG000|Overall Study|Withdrawal by Subject|1|||
130895699|NCT00220779|471254531|FG000|Overall Study|Adverse Event|1|||
130895700|NCT00220779|471254532|FG001|Overall Study|Adverse Event|0|||
130895701|NCT00220779|471254533|FG002|Overall Study|Adverse Event|0|||
130895702|NCT00220779|471254531|FG000|Overall Study|Withdrawal by Subject|1|||
130895703|NCT00220779|471254532|FG001|Overall Study|Withdrawal by Subject|4|||
130895704|NCT00220779|471254533|FG002|Overall Study|Withdrawal by Subject|1|||
130895705|NCT00220779|471254531|FG000|Overall Study|Non-compliance|1|||
130895706|NCT00220779|471254532|FG001|Overall Study|Non-compliance|0|||
130895707|NCT00220779|471254533|FG002|Overall Study|Non-compliance|0|||
130895708|NCT00220779|471254531|FG000|Overall Study|Too time consuming|1|||
130895709|NCT00220779|471254532|FG001|Overall Study|Too time consuming|0|||
130895710|NCT00220779|471254533|FG002|Overall Study|Too time consuming|0|||
130895711|NCT00220779|471254531|FG000|Overall Study|Pregnancy|0|||
130895712|NCT00220779|471254532|FG001|Overall Study|Pregnancy|0|||
130895713|NCT00220779|471254533|FG002|Overall Study|Pregnancy|2|||
130895714|NCT00220779|471254531|FG000|Overall Study|Lack of Efficacy|3|||
130895715|NCT00220779|471254532|FG001|Overall Study|Lack of Efficacy|0|||
130895716|NCT00220779|471254533|FG002|Overall Study|Lack of Efficacy|1|||
130895717|NCT00281658|471254536|FG000|Randomized Phase|Adverse Event|0|||
130895718|NCT00281658|471254537|FG001|Randomized Phase|Adverse Event|2|||
130895719|NCT00281658|471254538|FG002|Randomized Phase|Adverse Event|0|||
130895720|NCT00281658|471254539|FG003|Randomized Phase|Adverse Event|0|||
130895721|NCT00281658|471254536|FG000|Randomized Phase|Lost to Follow-up|34|||
130895722|NCT00281658|471254537|FG001|Randomized Phase|Lost to Follow-up|27|||
130895723|NCT00281658|471254538|FG002|Randomized Phase|Lost to Follow-up|0|||
130895724|NCT00281658|471254539|FG003|Randomized Phase|Lost to Follow-up|0|||
130895725|NCT00281658|471254536|FG000|Randomized Phase|Withdrawal by Subject|8|||
130895726|NCT00281658|471254537|FG001|Randomized Phase|Withdrawal by Subject|7|||
130895727|NCT00281658|471254538|FG002|Randomized Phase|Withdrawal by Subject|0|||
130895728|NCT00281658|471254539|FG003|Randomized Phase|Withdrawal by Subject|0|||
130895729|NCT00281658|471254536|FG000|Randomized Phase|Study closed/terminated|1|||
130895730|NCT00281658|471254537|FG001|Randomized Phase|Study closed/terminated|1|||
130895731|NCT00281658|471254538|FG002|Randomized Phase|Study closed/terminated|0|||
130895732|NCT00281658|471254539|FG003|Randomized Phase|Study closed/terminated|0|||
130895733|NCT00281658|471254536|FG000|Randomized Phase|Disease progression|36|||
130895734|NCT00281658|471254537|FG001|Randomized Phase|Disease progression|27|||
130895735|NCT00281658|471254538|FG002|Randomized Phase|Disease progression|0|||
130895736|NCT00281658|471254539|FG003|Randomized Phase|Disease progression|0|||
130895737|NCT00281658|471254536|FG000|Randomized Phase|Physician Decision|1|||
130895738|NCT00281658|471254537|FG001|Randomized Phase|Physician Decision|1|||
130895739|NCT00281658|471254538|FG002|Randomized Phase|Physician Decision|0|||
130895740|NCT00281658|471254539|FG003|Randomized Phase|Physician Decision|0|||
130895741|NCT00281658|471254536|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
130895742|NCT00281658|471254537|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
130895743|NCT00281658|471254538|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
130895744|NCT00281658|471254539|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
131111740|NCT02520284|472039099|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
131111741|NCT02520284|472039100|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
131111742|NCT02520284|472039101|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
131111743|NCT02520284|472039099|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
131111744|NCT02520284|472039100|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
131111745|NCT02520284|472039101|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
131111746|NCT02520284|472039099|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
131111747|NCT02520284|472039100|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
131111748|NCT02520284|472039101|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
131111749|NCT02520284|472039099|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
130690728|NCT02530905|470493159|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
130690729|NCT02530905|470493160|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
130895745|NCT00281658|471254536|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
130895746|NCT00281658|471254537|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
130895747|NCT00281658|471254538|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
130895748|NCT00281658|471254539|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
130895749|NCT00281658|471254536|FG000|Randomized Phase|Treatment ongoing|1|||
130895750|NCT00281658|471254537|FG001|Randomized Phase|Treatment ongoing|0|||
130895751|NCT00281658|471254538|FG002|Randomized Phase|Treatment ongoing|0|||
130895752|NCT00281658|471254539|FG003|Randomized Phase|Treatment ongoing|0|||
130895753|NCT00281658|471254536|FG000|Open Label Phase|Adverse Event|0|||
130895754|NCT00281658|471254537|FG001|Open Label Phase|Adverse Event|0|||
130895755|NCT00281658|471254538|FG002|Open Label Phase|Adverse Event|1|||
130895756|NCT00281658|471254539|FG003|Open Label Phase|Adverse Event|0|||
130895757|NCT00281658|471254536|FG000|Open Label Phase|Lost to Follow-up|0|||
130895758|NCT00281658|471254537|FG001|Open Label Phase|Lost to Follow-up|0|||
130895759|NCT00281658|471254538|FG002|Open Label Phase|Lost to Follow-up|16|||
130895760|NCT00281658|471254539|FG003|Open Label Phase|Lost to Follow-up|2|||
130895761|NCT00281658|471254536|FG000|Open Label Phase|Withdrawal by Subject|0|||
130895762|NCT00281658|471254537|FG001|Open Label Phase|Withdrawal by Subject|0|||
130895763|NCT00281658|471254538|FG002|Open Label Phase|Withdrawal by Subject|3|||
130895764|NCT00281658|471254539|FG003|Open Label Phase|Withdrawal by Subject|2|||
130895765|NCT00281658|471254536|FG000|Open Label Phase|Disease progression|0|||
130895766|NCT00281658|471254537|FG001|Open Label Phase|Disease progression|0|||
130895767|NCT00281658|471254538|FG002|Open Label Phase|Disease progression|18|||
130895768|NCT00281658|471254539|FG003|Open Label Phase|Disease progression|0|||
130895769|NCT00281658|471254536|FG000|Open Label Phase|Physician Decision|0|||
130895770|NCT00281658|471254537|FG001|Open Label Phase|Physician Decision|0|||
130895771|NCT00281658|471254538|FG002|Open Label Phase|Physician Decision|1|||
130895772|NCT00281658|471254539|FG003|Open Label Phase|Physician Decision|0|||
130895773|NCT00281658|471254536|FG000|Open Label Phase|Relocation of patient|0|||
130895774|NCT00281658|471254537|FG001|Open Label Phase|Relocation of patient|0|||
130895775|NCT00281658|471254538|FG002|Open Label Phase|Relocation of patient|1|||
130895776|NCT00281658|471254539|FG003|Open Label Phase|Relocation of patient|0|||
130895777|NCT00281658|471254536|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
130895778|NCT00281658|471254537|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
130895779|NCT00281658|471254538|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
130895780|NCT00281658|471254539|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
130895781|NCT00813943|471254542|FG000|Overall Study|Ongoing at cut-off date|5|||
130895782|NCT00813943|471254543|FG001|Overall Study|Ongoing at cut-off date|5|||
130895783|NCT00813943|471254544|FG002|Overall Study|Ongoing at cut-off date|3|||
130895784|NCT02551991|471254545|FG000|Overall Study|Death|5|||
130895785|NCT02551991|471254546|FG001|Overall Study|Death|7|||
130895786|NCT02551991|471254547|FG002|Overall Study|Death|8|||
130895787|NCT02551991|471254548|FG003|Overall Study|Death|7|||
130895788|NCT02551991|471254549|FG004|Overall Study|Death|17|||
130895789|NCT02551991|471254545|FG000|Overall Study|Withdrawal by Subject|1|||
130895790|NCT02551991|471254546|FG001|Overall Study|Withdrawal by Subject|0|||
130690730|NCT02530905|470493161|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
130690731|NCT00950989|470493163|FG000|Overall Study|Death|0|||
130895791|NCT02551991|471254547|FG002|Overall Study|Withdrawal by Subject|0|||
130895792|NCT02551991|471254548|FG003|Overall Study|Withdrawal by Subject|0|||
130895793|NCT02551991|471254549|FG004|Overall Study|Withdrawal by Subject|2|||
130895794|NCT02551991|471254545|FG000|Overall Study|Lost to Follow-up|0|||
130895795|NCT02551991|471254546|FG001|Overall Study|Lost to Follow-up|0|||
130895796|NCT02551991|471254547|FG002|Overall Study|Lost to Follow-up|1|||
131222712|NCT01959230|472443164|FG001|Overall Study|Administrative reasons|0|||
131222713|NCT01959230|472443163|FG000|Overall Study|Withdrawal by Subject|2|||
130895797|NCT02551991|471254548|FG003|Overall Study|Lost to Follow-up|0|||
130895798|NCT02551991|471254549|FG004|Overall Study|Lost to Follow-up|0|||
130690732|NCT00950989|470493164|FG001|Overall Study|Death|0|||
130690733|NCT00950989|470493165|FG002|Overall Study|Death|1|||
130690734|NCT00950989|470493166|FG003|Overall Study|Death|0|||
130690735|NCT00950989|470493163|FG000|Overall Study|Administrative Decision|0|||
130690736|NCT00950989|470493164|FG001|Overall Study|Administrative Decision|1|||
130690737|NCT00950989|470493165|FG002|Overall Study|Administrative Decision|0|||
130690738|NCT00950989|470493166|FG003|Overall Study|Administrative Decision|0|||
130690739|NCT00950989|470493163|FG000|Overall Study|Disease Progression|0|||
130690740|NCT00950989|470493164|FG001|Overall Study|Disease Progression|0|||
130690741|NCT00950989|470493165|FG002|Overall Study|Disease Progression|1|||
130690742|NCT00950989|470493166|FG003|Overall Study|Disease Progression|0|||
130690743|NCT00950989|470493163|FG000|Overall Study|Withdrawal by Subject|2|||
130690744|NCT00950989|470493164|FG001|Overall Study|Withdrawal by Subject|1|||
130690745|NCT00950989|470493165|FG002|Overall Study|Withdrawal by Subject|0|||
130690746|NCT00950989|470493166|FG003|Overall Study|Withdrawal by Subject|0|||
130690747|NCT00950989|470493163|FG000|Overall Study|Adverse Event|2|||
130690748|NCT00950989|470493164|FG001|Overall Study|Adverse Event|1|||
130690749|NCT00950989|470493165|FG002|Overall Study|Adverse Event|1|||
130690750|NCT00950989|470493166|FG003|Overall Study|Adverse Event|0|||
130690751|NCT01841554|470493167|FG000|Overall Study|Death|7|||
130690752|NCT01841554|470493167|FG000|Overall Study|No Implantation|1|||
130690753|NCT01841554|470493167|FG000|Overall Study|Discontinued Follow Up|5|||
130690754|NCT01841554|470493167|FG000|Overall Study|Study exit due to secondary intervention|6|||
130690755|NCT03804983|470493171|FG000|Overall Study|Adverse Event|0|||
130690756|NCT03804983|470493172|FG001|Overall Study|Adverse Event|1|||
130690757|NCT03804983|470493171|FG000|Overall Study|Family Obligation|1|||
130690758|NCT03804983|470493172|FG001|Overall Study|Family Obligation|0|||
130690759|NCT03600376|470493173|FG000|Overall Study|Adverse Event|1|||
130690760|NCT03600376|470493174|FG001|Overall Study|Adverse Event|1|||
130690761|NCT03600376|470493173|FG000|Overall Study|Transferred to other facility|1|||
130690762|NCT03600376|470493174|FG001|Overall Study|Transferred to other facility|0|||
130690763|NCT03600376|470493173|FG000|Overall Study|Investigator Decision|0|||
130690764|NCT03600376|470493174|FG001|Overall Study|Investigator Decision|4|||
130690765|NCT03600376|470493173|FG000|Overall Study|Determined to be ineligible for study|0|||
130690766|NCT03600376|470493174|FG001|Overall Study|Determined to be ineligible for study|1|||
130690767|NCT02152163|470493175|FG000|Overall Study|Physician Decision|12|||
130690768|NCT02152163|470493176|FG001|Overall Study|Physician Decision|13|||
130690769|NCT00796562|470493177|FG000|Overall Study|Death|49|||
130690770|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
130690771|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
130690772|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
130690773|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
130690774|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
130690775|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
130690776|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
130690777|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
130690778|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
130690779|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
130690780|NCT00424047|470493178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
130690781|NCT00424047|470493179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
130690782|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Adverse Event|22|||
130690783|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Adverse Event|12|||
130690784|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Progression of disease|92|||
130690785|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Progression of disease|128|||
130690786|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
130690787|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
130690788|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
130690789|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
130690790|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Death|11|||
130690791|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Death|11|||
130690792|NCT00424047|470493178|FG000|On Study at Time of Unblinding|Other|5|||
130690793|NCT00424047|470493179|FG001|On Study at Time of Unblinding|Other|4|||
130690794|NCT00424047|470493178|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
130690795|NCT00424047|470493179|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
130690796|NCT00424047|470493178|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
130690797|NCT00424047|470493179|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
130690798|NCT00424047|470493178|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
130690799|NCT00424047|470493179|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
130690800|NCT00424047|470493178|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
130690801|NCT00424047|470493179|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
130690802|NCT00424047|470493178|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
130690803|NCT00424047|470493179|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
130895799|NCT02551991|471254545|FG000|Overall Study|Sponsor Decision|1|||
130895800|NCT02551991|471254546|FG001|Overall Study|Sponsor Decision|0|||
130895801|NCT02551991|471254547|FG002|Overall Study|Sponsor Decision|1|||
130895802|NCT02551991|471254548|FG003|Overall Study|Sponsor Decision|0|||
130895803|NCT02551991|471254549|FG004|Overall Study|Sponsor Decision|5|||
130895804|NCT02551991|471254545|FG000|Overall Study|Other|0|||
130895805|NCT02551991|471254546|FG001|Overall Study|Other|0|||
130895806|NCT02551991|471254547|FG002|Overall Study|Other|0|||
130895807|NCT02551991|471254548|FG003|Overall Study|Other|0|||
130895808|NCT02551991|471254549|FG004|Overall Study|Other|1|||
130895809|NCT00265148|471254550|FG000|Overall Study|Adverse Event|2|||
130895810|NCT00265148|471254551|FG001|Overall Study|Adverse Event|2|||
130895811|NCT00265148|471254550|FG000|Overall Study|Lack of Efficacy|0|||
130895812|NCT00265148|471254551|FG001|Overall Study|Lack of Efficacy|2|||
130895813|NCT00265148|471254550|FG000|Overall Study|Protocol Violation|3|||
130895814|NCT00265148|471254551|FG001|Overall Study|Protocol Violation|2|||
130895815|NCT00265148|471254550|FG000|Overall Study|Lost to Follow-up|0|||
130895816|NCT00265148|471254551|FG001|Overall Study|Lost to Follow-up|1|||
130895817|NCT00265148|471254550|FG000|Overall Study|Withdrawal by Subject|2|||
130895818|NCT00265148|471254551|FG001|Overall Study|Withdrawal by Subject|1|||
130895819|NCT00265148|471254550|FG000|Overall Study|Physician Decision|1|||
130895820|NCT00265148|471254551|FG001|Overall Study|Physician Decision|0|||
130895821|NCT00265148|471254550|FG000|Overall Study|Increasing frailty|0|||
130895822|NCT00265148|471254551|FG001|Overall Study|Increasing frailty|1|||
130895823|NCT00265148|471254550|FG000|Overall Study|Subject chose to change of the dose|1|||
130895824|NCT00265148|471254551|FG001|Overall Study|Subject chose to change of the dose|0|||
130895825|NCT01874340|471254556|FG000|Overall Study|Study terminated by Sponsor|6|||
130895826|NCT01874340|471254557|FG001|Overall Study|Study terminated by Sponsor|8|||
130895827|NCT01874340|471254558|FG002|Overall Study|Study terminated by Sponsor|8|||
130895828|NCT01874340|471254559|FG003|Overall Study|Study terminated by Sponsor|4|||
130895829|NCT01874340|471254556|FG000|Overall Study|Withdrawal by Subject|0|||
130895830|NCT01874340|471254557|FG001|Overall Study|Withdrawal by Subject|0|||
130895831|NCT01874340|471254558|FG002|Overall Study|Withdrawal by Subject|0|||
130895832|NCT01874340|471254559|FG003|Overall Study|Withdrawal by Subject|1|||
130895833|NCT00444678|471254568|FG000|Overall Study|Toxicity|11|||
130895834|NCT00444678|471254568|FG000|Overall Study|Disease Progression|12|||
130895835|NCT00444678|471254568|FG000|Overall Study|Death|3|||
130895836|NCT00444678|471254568|FG000|Overall Study|Physician Decision|3|||
130895837|NCT00444678|471254568|FG000|Overall Study|Withdrawal by Subject|2|||
130895838|NCT00606905|471254571|FG000|Overall Study|No Pregnancy|9|||
131111750|NCT02520284|472039100|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
130895839|NCT00606905|471254572|FG001|Overall Study|No Pregnancy|6|||
130895840|NCT00606905|471254571|FG000|Overall Study|Non-Index Pregnancy|1|||
130895841|NCT00606905|471254572|FG001|Overall Study|Non-Index Pregnancy|4|||
130895842|NCT00606905|471254571|FG000|Overall Study|Withdrew|5|||
130895843|NCT00606905|471254572|FG001|Overall Study|Withdrew|5|||
130895844|NCT03179202|471254573|FG000|Overall Study|Screen Failure|67|||
130895845|NCT03179202|471254573|FG000|Overall Study|Subject Lost to Follow Up|12|||
130895846|NCT03179202|471254573|FG000|Overall Study|Withdrawal by Subject|7|||
130895847|NCT03179202|471254573|FG000|Overall Study|Adverse Event|3|||
130895848|NCT03179202|471254573|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
130895849|NCT03179202|471254573|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
130895850|NCT03255629|471254574|FG000|Overall Study|Adverse Event|1|||
130895851|NCT03255629|471254575|FG001|Overall Study|Adverse Event|0|||
131111751|NCT02520284|472039101|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
131111752|NCT02520284|472039099|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
131111753|NCT02520284|472039100|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
131111754|NCT02520284|472039101|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
131111755|NCT02520284|472039099|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
130767721|NCT01716520|470773852|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130767722|NCT01716520|470773853|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130895852|NCT03255629|471254574|FG000|Overall Study|did not experience hypoglycemia|2|||
130895853|NCT03255629|471254575|FG001|Overall Study|did not experience hypoglycemia|1|||
130895854|NCT02779556|471254580|FG000|Baseline|Partial baseline interview completed|1|||
130895855|NCT02779556|471254581|FG001|Baseline|Partial baseline interview completed|0|||
130895856|NCT02779556|471254580|FG000|3 Months|Lost to Follow-up|40|||
130895857|NCT02779556|471254581|FG001|3 Months|Lost to Follow-up|29|||
130895858|NCT02779556|471254580|FG000|3 Months|Missed 3 month clinic visit|27|||
130895859|NCT02779556|471254581|FG001|3 Months|Missed 3 month clinic visit|19|||
130895860|NCT02779556|471254580|FG000|6 Month|Lost to Follow-up|33|||
130895861|NCT02779556|471254581|FG001|6 Month|Lost to Follow-up|39|||
130895862|NCT02779556|471254580|FG000|6 Month HbA1c|No value collected during window|69|||
130895863|NCT02779556|471254581|FG001|6 Month HbA1c|No value collected during window|50|||
130895864|NCT02779556|471254580|FG000|12 Month HbA1c|No value collected during window|138|||
130895865|NCT02779556|471254581|FG001|12 Month HbA1c|No value collected during window|102|||
130895866|NCT03110770|471254584|FG000|Overall Study|Death|1|||
130895867|NCT03110770|471254585|FG001|Overall Study|Death|0|||
130895868|NCT03110770|471254586|FG002|Overall Study|Death|0|||
130895869|NCT03110770|471254587|FG003|Overall Study|Death|1|||
130895870|NCT03110770|471254588|FG004|Overall Study|Death|0|||
130895871|NCT03110770|471254584|FG000|Overall Study|Enrolled but did not receive product|0|||
130895872|NCT03110770|471254585|FG001|Overall Study|Enrolled but did not receive product|0|||
130895873|NCT03110770|471254586|FG002|Overall Study|Enrolled but did not receive product|0|||
130895874|NCT03110770|471254587|FG003|Overall Study|Enrolled but did not receive product|8|||
131111756|NCT02520284|472039100|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
131111757|NCT02520284|472039101|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
131111758|NCT02520284|472039099|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
131111759|NCT02520284|472039100|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
131111760|NCT02520284|472039101|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
131111761|NCT02520284|472039099|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
131111762|NCT02520284|472039100|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
131111763|NCT02520284|472039101|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
131111764|NCT01898923|472039104|FG000|Overall Study|Lack of Efficacy|5|||
131111765|NCT01898923|472039105|FG001|Overall Study|Lack of Efficacy|6|||
131111766|NCT01898923|472039104|FG000|Overall Study|Adverse Event|3|||
131111767|NCT01898923|472039105|FG001|Overall Study|Adverse Event|1|||
131111768|NCT01898923|472039104|FG000|Overall Study|Lost to Follow-up|0|||
131111769|NCT01898923|472039105|FG001|Overall Study|Lost to Follow-up|1|||
131111770|NCT01898923|472039104|FG000|Overall Study|Withdrawal by Subject|4|||
131111771|NCT01898923|472039105|FG001|Overall Study|Withdrawal by Subject|7|||
131111772|NCT01898923|472039104|FG000|Overall Study|Physician Decision|3|||
131111773|NCT01898923|472039105|FG001|Overall Study|Physician Decision|4|||
131111774|NCT01898923|472039104|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
131111775|NCT01898923|472039105|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
131111776|NCT00547365|472039108|FG000|Overall Study|Physician Decision|1|||
131111777|NCT00547365|472039108|FG000|Overall Study|Lost to Follow-up|1|||
131111778|NCT00547365|472039108|FG000|Overall Study|Protocol Violation|2|||
131111779|NCT00547365|472039108|FG000|Overall Study|death (not related to study)|4|||
131111780|NCT00504881|472039109|FG000|Overall Study|Lack of Efficacy|1|||
131111781|NCT00504881|472039110|FG001|Overall Study|Lack of Efficacy|5|||
131111782|NCT00504881|472039109|FG000|Overall Study|Lost to Follow-up|0|||
131111783|NCT00504881|472039110|FG001|Overall Study|Lost to Follow-up|2|||
131111784|NCT00504881|472039109|FG000|Overall Study|Withdrawal by Subject|1|||
131111785|NCT00504881|472039110|FG001|Overall Study|Withdrawal by Subject|4|||
131111786|NCT00504881|472039109|FG000|Overall Study|Non-Compliance|1|||
131111787|NCT00504881|472039110|FG001|Overall Study|Non-Compliance|0|||
131111788|NCT00504881|472039109|FG000|Overall Study|No Birth Control|0|||
131111789|NCT00504881|472039110|FG001|Overall Study|No Birth Control|1|||
131111790|NCT00504881|472039109|FG000|Overall Study|Safety Visit not performed|0|||
131111791|NCT00504881|472039110|FG001|Overall Study|Safety Visit not performed|1|||
131111792|NCT00504881|472039109|FG000|Overall Study|AE, serious fatal|0|||
131111793|NCT00504881|472039110|FG001|Overall Study|AE, serious fatal|1|||
131111794|NCT00504881|472039109|FG000|Overall Study|SAE, non-fatal|2|||
131111795|NCT00504881|472039110|FG001|Overall Study|SAE, non-fatal|6|||
131111796|NCT00504881|472039109|FG000|Overall Study|AE, non-serious non-fatal|4|||
131111797|NCT00504881|472039110|FG001|Overall Study|AE, non-serious non-fatal|14|||
131111798|NCT00504881|472039109|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
131111799|NCT00504881|472039110|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
131111800|NCT00504881|472039109|FG000|Overall Study|AE of unknown type|1|||
131111801|NCT00504881|472039110|FG001|Overall Study|AE of unknown type|0|||
131111802|NCT00810394|472039111|FG000|Overall Study|Withdrawal by Subject|3|||
131111803|NCT03217266|472040936|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
131111804|NCT03217266|472040937|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
131111805|NCT03217266|472040938|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
131111806|NCT03217266|472040939|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
131111807|NCT03217266|472040936|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
131111808|NCT03217266|472040937|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
131111809|NCT03217266|472040938|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
131111810|NCT03217266|472040939|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
130895875|NCT03110770|471254588|FG004|Overall Study|Enrolled but did not receive product|7|||
131111811|NCT03217266|472040936|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
131111812|NCT03217266|472040937|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
131111813|NCT03217266|472040938|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
131111814|NCT03217266|472040939|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
130895876|NCT03110770|471254584|FG000|Overall Study|Lost to Follow-up|0|||
131111815|NCT01390181|472040940|FG000|Overall Study|Lost to Follow-up|1|||
131111816|NCT01390181|472040940|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
130895877|NCT03110770|471254585|FG001|Overall Study|Lost to Follow-up|0|||
130895878|NCT03110770|471254586|FG002|Overall Study|Lost to Follow-up|0|||
130895879|NCT03110770|471254587|FG003|Overall Study|Lost to Follow-up|53|||
130895880|NCT03110770|471254588|FG004|Overall Study|Lost to Follow-up|45|||
130895881|NCT03110770|471254584|FG000|Overall Study|Investigator Decision|0|||
130895882|NCT03110770|471254585|FG001|Overall Study|Investigator Decision|0|||
130895883|NCT03110770|471254586|FG002|Overall Study|Investigator Decision|0|||
130895884|NCT03110770|471254587|FG003|Overall Study|Investigator Decision|5|||
130895885|NCT03110770|471254588|FG004|Overall Study|Investigator Decision|3|||
130895886|NCT03110770|471254584|FG000|Overall Study|Withdrawal by Subject|0|||
130895887|NCT03110770|471254585|FG001|Overall Study|Withdrawal by Subject|0|||
130895888|NCT03110770|471254586|FG002|Overall Study|Withdrawal by Subject|0|||
130895889|NCT03110770|471254587|FG003|Overall Study|Withdrawal by Subject|24|||
130895890|NCT03110770|471254588|FG004|Overall Study|Withdrawal by Subject|24|||
130895891|NCT03110770|471254584|FG000|Overall Study|Moved from area|5|||
130895892|NCT03110770|471254585|FG001|Overall Study|Moved from area|0|||
130895893|NCT03110770|471254586|FG002|Overall Study|Moved from area|2|||
130895894|NCT03110770|471254587|FG003|Overall Study|Moved from area|42|||
130895895|NCT03110770|471254588|FG004|Overall Study|Moved from area|43|||
130895896|NCT03110770|471254584|FG000|Overall Study|Illness/Injury unrelated to product|0|||
130895897|NCT03110770|471254585|FG001|Overall Study|Illness/Injury unrelated to product|0|||
130895898|NCT03110770|471254586|FG002|Overall Study|Illness/Injury unrelated to product|0|||
130895899|NCT03110770|471254587|FG003|Overall Study|Illness/Injury unrelated to product|0|||
130895900|NCT03110770|471254588|FG004|Overall Study|Illness/Injury unrelated to product|1|||
130895901|NCT01086358|471254589|FG000|First Intervention|Lost to Follow-up|9|||
130895902|NCT01086358|471254590|FG001|First Intervention|Lost to Follow-up|4|||
130895903|NCT01086358|471254589|FG000|First Intervention|Withdrawal by Subject|0|||
130895904|NCT01086358|471254590|FG001|First Intervention|Withdrawal by Subject|1|||
130895905|NCT01086358|471254589|FG000|Second Intervention|Lost to Follow-up|4|||
130895906|NCT01086358|471254590|FG001|Second Intervention|Lost to Follow-up|4|||
130895907|NCT03206788|471254594|FG000|Overall Study|Withdrawal by Subject|0|||
130895908|NCT03206788|471254595|FG001|Overall Study|Withdrawal by Subject|1|||
130895909|NCT03206788|471254594|FG000|Overall Study|Adverse Event|0|||
130895910|NCT03206788|471254595|FG001|Overall Study|Adverse Event|1|||
130895911|NCT03206788|471254594|FG000|Overall Study|Physician Decision|0|||
130895912|NCT03206788|471254595|FG001|Overall Study|Physician Decision|1|||
130895913|NCT01625260|471254596|FG000|Overall Study|Adverse Event|3|||
130895914|NCT01625260|471254597|FG001|Overall Study|Adverse Event|0|||
130895915|NCT01625260|471254596|FG000|Overall Study|Study Terminated by Investigator|2|||
130895916|NCT01625260|471254597|FG001|Overall Study|Study Terminated by Investigator|0|||
130895917|NCT01625260|471254596|FG000|Overall Study|Disease Progression|2|||
130895918|NCT01625260|471254597|FG001|Overall Study|Disease Progression|0|||
130895919|NCT01625260|471254596|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
130895920|NCT01625260|471254597|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
130895921|NCT03899805|471254598|FG000|Overall Study|Physician Decision|3|||
130895922|NCT03899805|471254599|FG001|Overall Study|Physician Decision|0|||
130895923|NCT03899805|471254600|FG002|Overall Study|Physician Decision|2|||
130895924|NCT03899805|471254598|FG000|Overall Study|Withdrawal by Subject|1|||
130895925|NCT03899805|471254599|FG001|Overall Study|Withdrawal by Subject|0|||
130895926|NCT03899805|471254600|FG002|Overall Study|Withdrawal by Subject|2|||
130895927|NCT03899805|471254598|FG000|Overall Study|Progressive Disease|10|||
130895928|NCT03899805|471254599|FG001|Overall Study|Progressive Disease|18|||
130895929|NCT03899805|471254600|FG002|Overall Study|Progressive Disease|12|||
130895930|NCT03899805|471254598|FG000|Overall Study|Adverse Event|3|||
130895931|NCT03899805|471254599|FG001|Overall Study|Adverse Event|1|||
130895932|NCT03899805|471254600|FG002|Overall Study|Adverse Event|0|||
130895933|NCT03899805|471254598|FG000|Overall Study|Death|2|||
130895934|NCT03899805|471254599|FG001|Overall Study|Death|0|||
130895935|NCT03899805|471254600|FG002|Overall Study|Death|0|||
130895936|NCT03899805|471254598|FG000|Overall Study|Came off for surgery|0|||
130895937|NCT03899805|471254599|FG001|Overall Study|Came off for surgery|0|||
130895938|NCT03899805|471254600|FG002|Overall Study|Came off for surgery|1|||
130895939|NCT03317405|471254601|FG000|Overall Study|Withdrawal by Subject|1|||
130895940|NCT03317405|471254602|FG001|Overall Study|Withdrawal by Subject|0|||
130895941|NCT03317405|471254603|FG002|Overall Study|Withdrawal by Subject|0|||
130895942|NCT03317405|471254601|FG000|Overall Study|Physician Decision|0|||
130895943|NCT03317405|471254602|FG001|Overall Study|Physician Decision|0|||
130895944|NCT03317405|471254603|FG002|Overall Study|Physician Decision|1|||
130895945|NCT03317405|471254601|FG000|Overall Study|Surgery Rescheduled|0|||
130895946|NCT03317405|471254602|FG001|Overall Study|Surgery Rescheduled|1|||
130895947|NCT03317405|471254603|FG002|Overall Study|Surgery Rescheduled|0|||
130895948|NCT01024309|471254608|FG000|Overall Study|Physician Decision|4|||
130895949|NCT01024309|471254609|FG001|Overall Study|Physician Decision|0|||
130895950|NCT01024309|471254608|FG000|Overall Study|Withdrawal by Subject|4|||
130895951|NCT01024309|471254609|FG001|Overall Study|Withdrawal by Subject|4|||
130895952|NCT05194579|471254612|FG000|Overall Study|Lost to Follow-up|2|||
130895953|NCT05194579|471254613|FG001|Overall Study|Lost to Follow-up|3|||
130895954|NCT05194579|471254612|FG000|Overall Study|Withdrawal by Subject|3|||
130895955|NCT05194579|471254613|FG001|Overall Study|Withdrawal by Subject|4|||
130895956|NCT05194579|471254612|FG000|Overall Study|Refused further study procedures|0|||
130895957|NCT05194579|471254613|FG001|Overall Study|Refused further study procedures|1|||
130895958|NCT05194579|471254612|FG000|Overall Study|Protocol deviation|1|||
130895959|NCT05194579|471254613|FG001|Overall Study|Protocol deviation|0|||
130895960|NCT03595228|471254614|FG000|Overall Study|Death|2|||
130895961|NCT03595228|471254614|FG000|Overall Study|Lack of Efficacy|13|||
130895962|NCT03595228|471254614|FG000|Overall Study|Withdrawal by Subject|3|||
130895963|NCT03595228|471254614|FG000|Overall Study|Withdrawal by Sponsor|1|||
130895964|NCT01639729|471254615|FG000|Overall Study|Withdrawal by Subject|1|||
130895965|NCT01639729|471254616|FG001|Overall Study|Withdrawal by Subject|0|||
130895966|NCT01639729|471254617|FG002|Overall Study|Withdrawal by Subject|1|||
130895967|NCT01639729|471254618|FG003|Overall Study|Withdrawal by Subject|1|||
130895968|NCT01639729|471254619|FG004|Overall Study|Withdrawal by Subject|0|||
130895969|NCT01639729|471254620|FG005|Overall Study|Withdrawal by Subject|0|||
130895970|NCT00567255|471254622|FG000|Overall Study|Adverse Event|241|||
130895971|NCT00567255|471254623|FG001|Overall Study|Adverse Event|68|||
130895972|NCT00567255|471254622|FG000|Overall Study|Lost to Follow-up|77|||
130895973|NCT00567255|471254623|FG001|Overall Study|Lost to Follow-up|48|||
130895974|NCT00567255|471254622|FG000|Overall Study|Withdrawal by Subject|75|||
130895975|NCT00567255|471254623|FG001|Overall Study|Withdrawal by Subject|56|||
130895976|NCT00567255|471254622|FG000|Overall Study|Lack of Efficacy|19|||
130895977|NCT00567255|471254623|FG001|Overall Study|Lack of Efficacy|33|||
130895978|NCT00567255|471254622|FG000|Overall Study|Protocol Violation|20|||
130895979|NCT00567255|471254623|FG001|Overall Study|Protocol Violation|8|||
130895980|NCT00567255|471254622|FG000|Overall Study|Pregnancy|6|||
130895981|NCT00567255|471254623|FG001|Overall Study|Pregnancy|0|||
130895982|NCT00567255|471254622|FG000|Overall Study|Drug noncompliance,moved,other|25|||
130895983|NCT00567255|471254623|FG001|Overall Study|Drug noncompliance,moved,other|15|||
130895984|NCT03083990|471254628|FG000|Overall Study|Adverse Event|1|||
130895985|NCT03083990|471254629|FG001|Overall Study|Adverse Event|0|||
130895986|NCT01018810|471254630|FG000|Overall Study|Withdrawal by Subject|0|||
130895987|NCT01018810|471254631|FG001|Overall Study|Withdrawal by Subject|1|||
130895988|NCT01018810|471254632|FG002|Overall Study|Withdrawal by Subject|0|||
130895989|NCT01018810|471254633|FG003|Overall Study|Withdrawal by Subject|0|||
130895990|NCT01018810|471254634|FG004|Overall Study|Withdrawal by Subject|0|||
130895991|NCT01018810|471254630|FG000|Overall Study|Sponsor Decision|2|||
130895992|NCT01018810|471254631|FG001|Overall Study|Sponsor Decision|0|||
130895993|NCT01018810|471254632|FG002|Overall Study|Sponsor Decision|1|||
130895994|NCT01018810|471254633|FG003|Overall Study|Sponsor Decision|1|||
130895995|NCT01018810|471254634|FG004|Overall Study|Sponsor Decision|1|||
130767723|NCT01716520|470773854|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130895996|NCT03672097|471254635|FG000|Period 1|Withdrawal by Subject|2|||
130895997|NCT03672097|471254635|FG000|Period 1|Adverse Event|1|||
130895998|NCT03672097|471254635|FG000|Period 1|Did not receive treatment|1|||
130895999|NCT03672097|471254635|FG000|Period 2|Withdrawal by Subject|3|||
130896000|NCT03672097|471254635|FG000|Period 2|Other|1|||
130896001|NCT03087617|471254636|FG000|Overall Study|Lost to Follow-up|32|||
130896002|NCT03087617|471254637|FG001|Overall Study|Lost to Follow-up|30|||
130896003|NCT03087617|471254638|FG002|Overall Study|Lost to Follow-up|30|||
130896004|NCT03087617|471254639|FG003|Overall Study|Lost to Follow-up|39|||
130896005|NCT04450381|471254641|FG000|Overall Study|Protocol Violation|4|||
130767724|NCT01716520|470773855|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130767725|NCT01716520|470773850|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130767726|NCT01716520|470773851|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130896006|NCT04450381|471254641|FG000|Overall Study|Wrong device setting|2|||
130896007|NCT00470834|471254642|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
130690812|NCT02571907|470494382|FG000|Overall Study|Death|4|||
130690813|NCT02571907|470494382|FG000|Overall Study|Lost to Follow-up|3|||
130690814|NCT02571907|470494382|FG000|Overall Study|Withdrawal by Subject|3|||
130690815|NCT02286739|470494387|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
130690816|NCT02286739|470494388|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
130690817|NCT02286739|470494387|FG000|Overall Study|No Verasense type documented|0|||
130690818|NCT02286739|470494388|FG001|Overall Study|No Verasense type documented|23|||
130690819|NCT02286739|470494387|FG000|Overall Study|Adverse Event|1|||
130690820|NCT02286739|470494388|FG001|Overall Study|Adverse Event|2|||
130690821|NCT02286739|470494387|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
130690822|NCT02286739|470494388|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
130896008|NCT00470834|471254643|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
130896009|NCT00470834|471254642|FG000|Treatment Period (18 Months)|Adverse Event|7|||
130896010|NCT00470834|471254643|FG001|Treatment Period (18 Months)|Adverse Event|6|||
130896011|NCT00470834|471254642|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
131025394|NCT00065260|471723249|FG000|Overall Study|Death|0|||
131025395|NCT00065260|471723250|FG001|Overall Study|Death|1|||
131025396|NCT00001277|471723251|FG000|Overall Study|Adverse Event|0|||
130896012|NCT00470834|471254643|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
130896013|NCT00470834|471254642|FG000|Treatment Period (18 Months)|Physician Decision|4|||
130896014|NCT00470834|471254643|FG001|Treatment Period (18 Months)|Physician Decision|4|||
130896015|NCT00470834|471254642|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
130896016|NCT00470834|471254643|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
130896017|NCT00470834|471254642|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
130896018|NCT00470834|471254643|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
130896019|NCT00470834|471254642|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
130896020|NCT00470834|471254643|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
130896021|NCT00470834|471254642|FG000|Treatment Period (18 Months)|Non-compliance|1|||
130896022|NCT00470834|471254643|FG001|Treatment Period (18 Months)|Non-compliance|0|||
130896023|NCT00470834|471254642|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
130896024|NCT00470834|471254643|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
130896025|NCT00470834|471254642|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
130896026|NCT00470834|471254643|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
130896027|NCT00470834|471254642|FG000|Extension Period (24 Months)|Adverse Event|3|||
130896028|NCT00470834|471254643|FG001|Extension Period (24 Months)|Adverse Event|4|||
130896029|NCT00470834|471254642|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
130896030|NCT00470834|471254643|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
130896031|NCT00470834|471254642|FG000|Extension Period (24 Months)|Physician Decision|4|||
130896032|NCT00470834|471254643|FG001|Extension Period (24 Months)|Physician Decision|3|||
130896033|NCT00470834|471254642|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
130896034|NCT00470834|471254643|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
130896035|NCT00470834|471254642|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
130896036|NCT00470834|471254643|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
130896037|NCT00470834|471254642|FG000|Extension Period (24 Months)|Non-compliance|0|||
130896038|NCT00470834|471254643|FG001|Extension Period (24 Months)|Non-compliance|1|||
130896039|NCT00470834|471254642|FG000|Extension Period (24 Months)|Disease Progression|0|||
130896040|NCT00470834|471254643|FG001|Extension Period (24 Months)|Disease Progression|1|||
130896041|NCT00929643|471254654|FG000|Overall Study|Protocol Violation|2|||
130896042|NCT02873429|471254655|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
130896043|NCT02873429|471254656|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
130896044|NCT02873429|471254655|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
130767727|NCT01716520|470773852|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130767728|NCT01716520|470773853|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
130767729|NCT01716520|470773854|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130767730|NCT01716520|470773855|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130767731|NCT01716520|470773850|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
130767732|NCT01716520|470773851|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
130767733|NCT01716520|470773852|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
130767734|NCT01716520|470773853|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
130767735|NCT01716520|470773854|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
130767736|NCT01716520|470773855|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
130767737|NCT01716520|470773850|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
130767738|NCT01716520|470773851|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130767739|NCT01716520|470773852|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130767740|NCT01716520|470773853|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130767741|NCT01716520|470773854|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130767742|NCT01716520|470773855|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130767743|NCT01716520|470773850|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130767744|NCT01716520|470773851|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130767745|NCT01716520|470773852|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130767746|NCT01716520|470773853|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130767747|NCT01716520|470773854|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130767748|NCT01716520|470773855|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
130767749|NCT01716520|470773850|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130767750|NCT01716520|470773851|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
130767751|NCT01716520|470773852|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130767752|NCT01716520|470773853|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130767753|NCT01716520|470773854|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130767754|NCT01716520|470773855|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130767755|NCT01716520|470773850|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130767756|NCT01716520|470773851|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130767757|NCT01716520|470773852|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130767758|NCT01716520|470773853|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130896045|NCT02873429|471254656|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
130896046|NCT02873429|471254655|FG000|16 Weeks|Lost to Follow-up|3|||
130896047|NCT02873429|471254656|FG001|16 Weeks|Lost to Follow-up|0|||
130896048|NCT00744042|471254657|FG000|Overall Study|Withdrawal by Subject|1|||
130896049|NCT02228980|471254661|FG000|Overall Study|Adverse Event|14|||
130896050|NCT02228980|471254662|FG001|Overall Study|Adverse Event|0|||
130896051|NCT02228980|471254663|FG002|Overall Study|Adverse Event|0|||
130896052|NCT02228980|471254664|FG003|Overall Study|Adverse Event|0|||
130896053|NCT02228980|471254661|FG000|Overall Study|Protocol Violation|7|||
130896054|NCT02228980|471254662|FG001|Overall Study|Protocol Violation|0|||
130896055|NCT02228980|471254663|FG002|Overall Study|Protocol Violation|0|||
130896056|NCT02228980|471254664|FG003|Overall Study|Protocol Violation|0|||
130896057|NCT02228980|471254661|FG000|Overall Study|Withdrawal by Subject|3|||
130896058|NCT02228980|471254662|FG001|Overall Study|Withdrawal by Subject|3|||
130896059|NCT02228980|471254663|FG002|Overall Study|Withdrawal by Subject|2|||
130896060|NCT02228980|471254664|FG003|Overall Study|Withdrawal by Subject|3|||
130896061|NCT04629066|471254665|FG000|Overall Study|Lost to Follow-up|3|||
130896062|NCT04629066|471254666|FG001|Overall Study|Lost to Follow-up|2|||
130896063|NCT00530504|471254669|FG000|Overall Study|Death|54|||
130896064|NCT00530504|471254669|FG000|Overall Study|Lost to Follow-up|26|||
130896065|NCT00530504|471254669|FG000|Overall Study|Withdrawal by Subject|39|||
130896066|NCT00530504|471254669|FG000|Overall Study|Exited study due to other reasons|33|||
130896067|NCT00557856|471254676|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130896068|NCT00557856|471254677|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
130896069|NCT00557856|471254678|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130896070|NCT00557856|471254679|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
130896071|NCT00557856|471254680|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130690823|NCT00834717|470494389|FG000|First Intervention|Adverse Event|1|||
130690824|NCT00834717|470494390|FG001|First Intervention|Adverse Event|0|||
130896072|NCT00557856|471254681|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
130690825|NCT00834717|470494389|FG000|First Intervention|Withdrawal by Subject|0|||
130896073|NCT00557856|471254682|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
130896074|NCT00557856|471254683|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130896075|NCT00557856|471254684|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
130896076|NCT00557856|471254676|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
130896077|NCT00557856|471254677|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130896078|NCT00557856|471254678|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
130896079|NCT00557856|471254679|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130896080|NCT00557856|471254680|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130690826|NCT00834717|470494390|FG001|First Intervention|Withdrawal by Subject|1|||
130690827|NCT02255149|470494393|FG000|Overall Study|Lost to Follow-up|2|||
130690828|NCT02255149|470494393|FG000|Overall Study|Withdrawal by Subject|1|||
130690829|NCT02255149|470494393|FG000|Overall Study|Withdrawal by PI|1|||
130690830|NCT02255149|470494393|FG000|Overall Study|Implant Failure|1|||
130690831|NCT05710718|470494399|FG000|Overall Study|Withdrawal by Subject|5|||
130690832|NCT05710718|470494400|FG001|Overall Study|Withdrawal by Subject|1|||
130690833|NCT05710718|470494399|FG000|Overall Study|Lost to Follow-up|0|||
130690834|NCT05710718|470494400|FG001|Overall Study|Lost to Follow-up|1|||
130690835|NCT05710718|470494399|FG000|Overall Study|Death|0|||
130896081|NCT00557856|471254681|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130896082|NCT00557856|471254682|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130896083|NCT00557856|471254683|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130896084|NCT00557856|471254684|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130896085|NCT00557856|471254676|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
130896086|NCT00557856|471254677|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
130896087|NCT00557856|471254678|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
130896088|NCT00557856|471254679|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
130896089|NCT00557856|471254680|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
130896090|NCT00557856|471254681|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
130896091|NCT00557856|471254682|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
130896092|NCT00557856|471254683|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
130896093|NCT00557856|471254684|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
130896094|NCT00557856|471254676|FG000|Part 1: Dose Escalation Phase|Other|0|||
130690836|NCT05710718|470494400|FG001|Overall Study|Death|1|||
130690837|NCT01319383|470494401|FG000|Overall Study|No ex vivo or in vivo response|4|||
130690838|NCT01319383|470494402|FG001|Overall Study|No ex vivo or in vivo response|0|||
130896095|NCT00557856|471254677|FG001|Part 1: Dose Escalation Phase|Other|0|||
130896096|NCT00557856|471254678|FG002|Part 1: Dose Escalation Phase|Other|1|||
130896097|NCT00557856|471254679|FG003|Part 1: Dose Escalation Phase|Other|1|||
131111817|NCT02805725|472040941|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
131111818|NCT02805725|472040942|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
130690839|NCT01319383|470494401|FG000|Overall Study|Physician Decision|3|||
130690840|NCT01319383|470494402|FG001|Overall Study|Physician Decision|0|||
130690841|NCT01319383|470494401|FG000|Overall Study|Lack of Efficacy|5|||
130690842|NCT01319383|470494402|FG001|Overall Study|Lack of Efficacy|9|||
130896098|NCT00557856|471254680|FG004|Part 1: Dose Escalation Phase|Other|0|||
130896099|NCT00557856|471254681|FG005|Part 1: Dose Escalation Phase|Other|0|||
130896100|NCT00557856|471254682|FG006|Part 1: Dose Escalation Phase|Other|0|||
130896101|NCT00557856|471254683|FG007|Part 1: Dose Escalation Phase|Other|1|||
130896102|NCT00557856|471254684|FG008|Part 1: Dose Escalation Phase|Other|0|||
130896103|NCT00557856|471254676|FG000|Part 1: Dose Escalation Phase|Death|0|||
130896104|NCT00557856|471254677|FG001|Part 1: Dose Escalation Phase|Death|0|||
130896105|NCT00557856|471254678|FG002|Part 1: Dose Escalation Phase|Death|0|||
130896106|NCT00557856|471254679|FG003|Part 1: Dose Escalation Phase|Death|0|||
130896107|NCT00557856|471254680|FG004|Part 1: Dose Escalation Phase|Death|0|||
130896108|NCT00557856|471254681|FG005|Part 1: Dose Escalation Phase|Death|1|||
130896109|NCT00557856|471254682|FG006|Part 1: Dose Escalation Phase|Death|0|||
130896110|NCT00557856|471254683|FG007|Part 1: Dose Escalation Phase|Death|0|||
130896111|NCT00557856|471254684|FG008|Part 1: Dose Escalation Phase|Death|0|||
130896112|NCT00557856|471254676|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130896113|NCT00557856|471254677|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130896114|NCT00557856|471254678|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130896115|NCT00557856|471254679|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130690843|NCT01319383|470494401|FG000|Overall Study|No in vivo response to interval doses|0|||
130690844|NCT01319383|470494402|FG001|Overall Study|No in vivo response to interval doses|1|||
130896116|NCT00557856|471254680|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130896117|NCT00557856|471254681|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
130896118|NCT00557856|471254682|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
130896119|NCT00557856|471254683|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130896120|NCT00557856|471254684|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130896121|NCT00557856|471254676|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
130896122|NCT00557856|471254677|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130896123|NCT00557856|471254678|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130896124|NCT00557856|471254679|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130896125|NCT00557856|471254680|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130896126|NCT00557856|471254681|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130896127|NCT00557856|471254682|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130896128|NCT00557856|471254683|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130896129|NCT00557856|471254684|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130896130|NCT00557856|471254676|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
130896131|NCT00557856|471254677|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
130896132|NCT00557856|471254678|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
130896133|NCT00557856|471254679|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
130896134|NCT00557856|471254680|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
130896135|NCT00557856|471254681|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
130896136|NCT00557856|471254682|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
130896137|NCT00557856|471254683|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
130896138|NCT00557856|471254684|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
130896139|NCT00557856|471254676|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130896140|NCT00557856|471254677|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
131025397|NCT00001277|471723252|FG001|Overall Study|Adverse Event|0|||
130690845|NCT01987765|470494403|FG000|Overall Study|Protocol Violation|65|||
130690846|NCT01987765|470494403|FG000|Overall Study|Lost to Follow-up|37|||
130690847|NCT01528696|470494412|FG000|Overall Study|See detailed description|18|||
130690848|NCT01528696|470494413|FG001|Overall Study|See detailed description|19|||
130690849|NCT03600805|470494414|FG000|Overall Study|Adverse Event|2|||
130690850|NCT03600805|470494415|FG001|Overall Study|Adverse Event|1|||
130690851|NCT03600805|470494416|FG002|Overall Study|Adverse Event|1|||
130690852|NCT03600805|470494417|FG003|Overall Study|Adverse Event|7|||
130690853|NCT03600805|470494414|FG000|Overall Study|Lack of Efficacy|2|||
130690854|NCT03600805|470494415|FG001|Overall Study|Lack of Efficacy|1|||
130690855|NCT03600805|470494416|FG002|Overall Study|Lack of Efficacy|0|||
130690856|NCT03600805|470494417|FG003|Overall Study|Lack of Efficacy|0|||
130690857|NCT03600805|470494414|FG000|Overall Study|Withdrawal by Subject|1|||
130690858|NCT03600805|470494415|FG001|Overall Study|Withdrawal by Subject|0|||
130690859|NCT03600805|470494416|FG002|Overall Study|Withdrawal by Subject|0|||
130690860|NCT03600805|470494417|FG003|Overall Study|Withdrawal by Subject|1|||
130690861|NCT03600805|470494414|FG000|Overall Study|Other unspecified|14|||
130690862|NCT03600805|470494415|FG001|Overall Study|Other unspecified|6|||
130690863|NCT03600805|470494416|FG002|Overall Study|Other unspecified|7|||
130690864|NCT03600805|470494417|FG003|Overall Study|Other unspecified|11|||
130690865|NCT06195579|470494418|FG000|Overall Study|Withdrawal by Subject|1|||
130690866|NCT02545283|470494419|FG000|Overall Study|Lost to Follow-up|2|||
130690867|NCT02545283|470494420|FG001|Overall Study|Lost to Follow-up|4|||
130690868|NCT02545283|470494419|FG000|Overall Study|Withdrawal by Subject|5|||
130896141|NCT00557856|471254678|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130896142|NCT00557856|471254679|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130896143|NCT00557856|471254680|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130896144|NCT00557856|471254681|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130896145|NCT00557856|471254682|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130896146|NCT00557856|471254683|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130896147|NCT00557856|471254684|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
130896148|NCT00557856|471254676|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
130896149|NCT00557856|471254677|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
130896150|NCT00557856|471254678|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
130896151|NCT00557856|471254679|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
130896152|NCT00557856|471254680|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
130896153|NCT00557856|471254681|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
130896154|NCT00557856|471254682|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
130896155|NCT00557856|471254683|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
130896156|NCT00557856|471254684|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
130896157|NCT00557856|471254676|FG000|Part 2: Exploratory Phase|Other|0|||
130896158|NCT00557856|471254677|FG001|Part 2: Exploratory Phase|Other|0|||
130896159|NCT00557856|471254678|FG002|Part 2: Exploratory Phase|Other|0|||
130896160|NCT00557856|471254679|FG003|Part 2: Exploratory Phase|Other|0|||
130896161|NCT00557856|471254680|FG004|Part 2: Exploratory Phase|Other|0|||
130896162|NCT00557856|471254681|FG005|Part 2: Exploratory Phase|Other|0|||
130896163|NCT00557856|471254682|FG006|Part 2: Exploratory Phase|Other|0|||
130896164|NCT00557856|471254683|FG007|Part 2: Exploratory Phase|Other|0|||
130896165|NCT00557856|471254684|FG008|Part 2: Exploratory Phase|Other|1|||
130896166|NCT00557856|471254676|FG000|Part 2: Exploratory Phase|Death|0|||
130896167|NCT00557856|471254677|FG001|Part 2: Exploratory Phase|Death|0|||
130896168|NCT00557856|471254678|FG002|Part 2: Exploratory Phase|Death|0|||
130896169|NCT00557856|471254679|FG003|Part 2: Exploratory Phase|Death|0|||
130896170|NCT00557856|471254680|FG004|Part 2: Exploratory Phase|Death|0|||
130896171|NCT00557856|471254681|FG005|Part 2: Exploratory Phase|Death|0|||
130896172|NCT00557856|471254682|FG006|Part 2: Exploratory Phase|Death|0|||
130896173|NCT00557856|471254683|FG007|Part 2: Exploratory Phase|Death|0|||
130896174|NCT00557856|471254684|FG008|Part 2: Exploratory Phase|Death|2|||
130896175|NCT00557856|471254676|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
130896176|NCT00557856|471254677|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
130896177|NCT00557856|471254678|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
130896178|NCT00557856|471254679|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
130896179|NCT00557856|471254680|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
130896180|NCT00557856|471254681|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
130896181|NCT00557856|471254682|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
130896182|NCT00557856|471254683|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
130896183|NCT00557856|471254684|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
130896184|NCT02537015|471254685|FG000|Overall Study|Adverse Event|3|||
130896185|NCT02537015|471254685|FG000|Overall Study|Withdrawal by Subject|2|||
130896186|NCT02537015|471254685|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130896187|NCT01808092|471254686|FG000|Overall Study|Death|39|||
130896188|NCT01808092|471254687|FG001|Overall Study|Death|29|||
130896189|NCT01808092|471254686|FG000|Overall Study|Lost to Follow-up|3|||
130896190|NCT01808092|471254687|FG001|Overall Study|Lost to Follow-up|7|||
130896191|NCT01808092|471254686|FG000|Overall Study|Withdrawal by Subject|9|||
130896192|NCT01808092|471254687|FG001|Overall Study|Withdrawal by Subject|4|||
130896193|NCT01808092|471254686|FG000|Overall Study|Other Eligibility criteria|3|||
130896194|NCT01808092|471254687|FG001|Overall Study|Other Eligibility criteria|5|||
130896195|NCT03952039|471254688|FG000|Overall Study|Adverse Event|22|||
130896196|NCT03952039|471254689|FG001|Overall Study|Adverse Event|8|||
130896197|NCT03952039|471254688|FG000|Overall Study|Withdrawal by Participant|17|||
130896198|NCT03952039|471254689|FG001|Overall Study|Withdrawal by Participant|12|||
130896199|NCT03952039|471254688|FG000|Overall Study|Death|13|||
130896200|NCT03952039|471254689|FG001|Overall Study|Death|6|||
130896201|NCT03952039|471254688|FG000|Overall Study|Lack of Efficacy|12|||
130896202|NCT03952039|471254689|FG001|Overall Study|Lack of Efficacy|2|||
130896203|NCT03952039|471254688|FG000|Overall Study|Physician Decision|9|||
130767759|NCT01716520|470773854|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130767760|NCT01716520|470773855|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
130767761|NCT01716520|470773850|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130767762|NCT01716520|470773851|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130896204|NCT03952039|471254689|FG001|Overall Study|Physician Decision|3|||
130896205|NCT03952039|471254688|FG000|Overall Study|Progressive Disease|6|||
130896206|NCT03952039|471254689|FG001|Overall Study|Progressive Disease|4|||
130896207|NCT03952039|471254688|FG000|Overall Study|Other Reasons|12|||
130896208|NCT03952039|471254689|FG001|Overall Study|Other Reasons|4|||
130896209|NCT05009979|471254690|FG000|Overall Study|Withdrawal by Subject|1|||
130896210|NCT01888432|471257064|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
130896211|NCT01888432|471257065|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
130896212|NCT01888432|471257064|FG000|12-month Analysis (FAS)|Physician Decision|1|||
130896213|NCT01888432|471257065|FG001|12-month Analysis (FAS)|Physician Decision|1|||
130896214|NCT01888432|471257064|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
130896215|NCT01888432|471257065|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
130896216|NCT01888432|471257064|FG000|12-month Analysis (FAS)|Death|4|||
130896217|NCT01888432|471257065|FG001|12-month Analysis (FAS)|Death|3|||
130896218|NCT01888432|471257064|FG000|24-month Analysis (FAS)|Graft loss|0|||
130896219|NCT01888432|471257065|FG001|24-month Analysis (FAS)|Graft loss|1|||
130896220|NCT01888432|471257064|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
130896221|NCT01888432|471257065|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
130896222|NCT01888432|471257064|FG000|24-month Analysis (FAS)|Physician Decision|2|||
130896223|NCT01888432|471257065|FG001|24-month Analysis (FAS)|Physician Decision|4|||
130896224|NCT01888432|471257064|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
130896225|NCT01888432|471257065|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
130896226|NCT01888432|471257064|FG000|24-month Analysis (FAS)|Death|8|||
130896227|NCT01888432|471257065|FG001|24-month Analysis (FAS)|Death|4|||
130896228|NCT01888432|471257064|FG000|36-month Analysis (Extension)|Death|1|||
130896229|NCT01888432|471257065|FG001|36-month Analysis (Extension)|Death|0|||
130896230|NCT00130247|471257068|FG000|Overall Study|Pregnancy|1|||
130896231|NCT00130247|471257069|FG001|Overall Study|Pregnancy|0|||
130896232|NCT00130247|471257068|FG000|Overall Study|Post-randomization exclusion|1|||
130896233|NCT00130247|471257069|FG001|Overall Study|Post-randomization exclusion|2|||
130896234|NCT00130247|471257068|FG000|Overall Study|Not compliant with DOT|0|||
130896235|NCT00130247|471257069|FG001|Overall Study|Not compliant with DOT|2|||
130896236|NCT03844945|471257070|FG000|Overall Study|Adverse Event|1|||
130896237|NCT03844945|471257071|FG001|Overall Study|Adverse Event|1|||
130896238|NCT03844945|471257072|FG002|Overall Study|Adverse Event|4|||
130896239|NCT03844945|471257073|FG003|Overall Study|Adverse Event|0|||
130896240|NCT03844945|471257070|FG000|Overall Study|Withdrawal by Subject|0|||
130896241|NCT03844945|471257071|FG001|Overall Study|Withdrawal by Subject|0|||
130896242|NCT03844945|471257072|FG002|Overall Study|Withdrawal by Subject|1|||
130896243|NCT03844945|471257073|FG003|Overall Study|Withdrawal by Subject|0|||
130896244|NCT03844945|471257070|FG000|Overall Study|Lack of Efficacy|0|||
130896245|NCT03844945|471257071|FG001|Overall Study|Lack of Efficacy|0|||
130896246|NCT03844945|471257072|FG002|Overall Study|Lack of Efficacy|0|||
130896247|NCT03844945|471257073|FG003|Overall Study|Lack of Efficacy|1|||
130896248|NCT04473235|471257074|FG000|Overall Study|Lost to Follow-up|6|||
130896249|NCT04473235|471257075|FG001|Overall Study|Lost to Follow-up|5|||
130896250|NCT04473235|471257074|FG000|Overall Study|Declined continuation|2|||
130896251|NCT04473235|471257075|FG001|Overall Study|Declined continuation|0|||
130896252|NCT04473235|471257074|FG000|Overall Study|Physician Decision|1|||
130896253|NCT04473235|471257075|FG001|Overall Study|Physician Decision|1|||
130896254|NCT04473235|471257074|FG000|Overall Study|Protocol Violation|10|||
130896255|NCT04473235|471257075|FG001|Overall Study|Protocol Violation|6|||
130896256|NCT01754402|471257076|FG000|Overall Study|Death|0|||
130896257|NCT01754402|471257077|FG001|Overall Study|Death|0|||
130896258|NCT01754402|471257078|FG002|Overall Study|Death|1|||
130896259|NCT01754402|471257076|FG000|Overall Study|Adverse Event|2|||
130896260|NCT01754402|471257077|FG001|Overall Study|Adverse Event|2|||
130896261|NCT01754402|471257078|FG002|Overall Study|Adverse Event|1|||
130896262|NCT01754402|471257076|FG000|Overall Study|Withdrawal by Subject|0|||
130896263|NCT01754402|471257077|FG001|Overall Study|Withdrawal by Subject|0|||
130896264|NCT01754402|471257078|FG002|Overall Study|Withdrawal by Subject|1|||
130896265|NCT01754402|471257076|FG000|Overall Study|Lack of Efficacy|0|||
130896266|NCT01754402|471257077|FG001|Overall Study|Lack of Efficacy|0|||
130896267|NCT01754402|471257078|FG002|Overall Study|Lack of Efficacy|1|||
130896268|NCT01282463|471257079|FG000|Overall Study|Lost to Follow-up|1|||
130896269|NCT01282463|471257080|FG001|Overall Study|Lost to Follow-up|0|||
130896270|NCT01282463|471257081|FG002|Overall Study|Lost to Follow-up|0|||
130896271|NCT01282463|471257079|FG000|Overall Study|Withdrawal by Subject|6|||
130896272|NCT01282463|471257080|FG001|Overall Study|Withdrawal by Subject|2|||
130896273|NCT01282463|471257081|FG002|Overall Study|Withdrawal by Subject|3|||
130896274|NCT01282463|471257079|FG000|Overall Study|"Never Treated Death"|0|||
130896275|NCT01282463|471257080|FG001|Overall Study|"Never Treated Death"|1|||
130896276|NCT01282463|471257081|FG002|Overall Study|"Never Treated Death"|0|||
130896277|NCT01282463|471257079|FG000|Overall Study|"Never Treated PD"|0|||
130896278|NCT01282463|471257080|FG001|Overall Study|"Never Treated PD"|1|||
130896279|NCT01282463|471257081|FG002|Overall Study|"Never Treated PD"|0|||
130690869|NCT02545283|470494420|FG001|Overall Study|Withdrawal by Subject|9|||
130690870|NCT02545283|470494419|FG000|Overall Study|Death|109|||
130896280|NCT01282463|471257079|FG000|Overall Study|Protocol Violation|0|||
130896281|NCT01282463|471257080|FG001|Overall Study|Protocol Violation|0|||
130896282|NCT01282463|471257081|FG002|Overall Study|Protocol Violation|1|||
130896283|NCT01282463|471257079|FG000|Overall Study|Physician Decision|1|||
130896284|NCT01282463|471257080|FG001|Overall Study|Physician Decision|0|||
130896285|NCT01282463|471257081|FG002|Overall Study|Physician Decision|0|||
130896286|NCT02051933|471257084|FG000|Overall Study|Physician Decision|0|||
130690871|NCT02545283|470494420|FG001|Overall Study|Death|211|||
131111819|NCT02805725|472040943|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
131111820|NCT02805725|472040944|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
131111821|NCT02805725|472040945|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
131111822|NCT02805725|472040941|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
131111823|NCT02805725|472040942|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
131111824|NCT02805725|472040943|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
130690872|NCT02545283|470494419|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
130690873|NCT02545283|470494420|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
130690874|NCT02545283|470494419|FG000|Overall Study|Study Terminated By Sponsor|33|||
130690875|NCT02545283|470494420|FG001|Overall Study|Study Terminated By Sponsor|71|||
130690876|NCT01205035|470494433|FG000|Overall Study|Withdrawal by Subject|1|||
130690877|NCT01205035|470494434|FG001|Overall Study|Withdrawal by Subject|0|||
130690878|NCT01205035|470494433|FG000|Overall Study|Physician Decision|1|||
130690879|NCT01205035|470494434|FG001|Overall Study|Physician Decision|0|||
130690880|NCT02663349|470494435|FG000|Overall Study|Withdrawal by Subject|6|||
130690881|NCT03128723|470494438|FG000|Overall Study|Withdrawal by Subject|2|||
130690882|NCT00075478|470494439|FG000|Overall Study|not eligible|1|||
130690883|NCT00075478|470494440|FG001|Overall Study|not eligible|0|||
130690884|NCT00075478|470494439|FG000|Overall Study|Physician Decision|0|||
130690885|NCT00075478|470494440|FG001|Overall Study|Physician Decision|1|||
130690886|NCT00673660|470494441|FG000|Overall Study|Lost to Follow-up|107|||
130690887|NCT00245063|470494442|FG000|Overall Study|Adverse Event|6|||
130690888|NCT00245063|470494443|FG001|Overall Study|Adverse Event|5|||
130690889|NCT00245063|470494442|FG000|Overall Study|Death|1|||
130690890|NCT00245063|470494443|FG001|Overall Study|Death|0|||
130690891|NCT05099380|470494444|FG000|Overall Study|Subject enrolled in error|1|||
130690892|NCT05099380|470494445|FG001|Overall Study|Subject enrolled in error|0|||
130690893|NCT05099380|470494444|FG000|Overall Study|Study Procedure|1|||
130690894|NCT05099380|470494445|FG001|Overall Study|Study Procedure|0|||
130690895|NCT05099380|470494444|FG000|Overall Study|Protocol Violation|1|||
130690896|NCT05099380|470494445|FG001|Overall Study|Protocol Violation|0|||
130690897|NCT05099380|470494444|FG000|Overall Study|Adverse Event|1|||
130690898|NCT05099380|470494445|FG001|Overall Study|Adverse Event|1|||
130690899|NCT05099380|470494444|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
130690900|NCT05099380|470494445|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
130690901|NCT01020474|470494446|FG000|Overall Study|Adverse Event|4|||
130690902|NCT01020474|470494447|FG001|Overall Study|Adverse Event|4|||
130690903|NCT01020474|470494446|FG000|Overall Study|Protocol Violation|0|||
130690904|NCT01020474|470494447|FG001|Overall Study|Protocol Violation|2|||
130690905|NCT01020474|470494446|FG000|Overall Study|Withdrawal by Subject|5|||
130690906|NCT01020474|470494447|FG001|Overall Study|Withdrawal by Subject|7|||
130690907|NCT01020474|470494446|FG000|Overall Study|Other Reasons|1|||
130690908|NCT01020474|470494447|FG001|Overall Study|Other Reasons|1|||
130690909|NCT01020474|470494446|FG000|Overall Study|Insufficient Clinical Response|0|||
130690910|NCT01020474|470494447|FG001|Overall Study|Insufficient Clinical Response|3|||
130690911|NCT00466167|470494448|FG000|Overall Study|Adverse Event|8|||
130690912|NCT00466167|470494449|FG001|Overall Study|Adverse Event|8|||
130690913|NCT00466167|470494450|FG002|Overall Study|Adverse Event|7|||
130690914|NCT00466167|470494448|FG000|Overall Study|Lack of Efficacy|2|||
130690915|NCT00466167|470494449|FG001|Overall Study|Lack of Efficacy|0|||
130690916|NCT00466167|470494450|FG002|Overall Study|Lack of Efficacy|3|||
130690917|NCT00466167|470494448|FG000|Overall Study|Protocol Violation|1|||
130690918|NCT00466167|470494449|FG001|Overall Study|Protocol Violation|1|||
130690919|NCT00466167|470494450|FG002|Overall Study|Protocol Violation|2|||
130690920|NCT00466167|470494448|FG000|Overall Study|Lost to Follow-up|3|||
130690921|NCT00466167|470494449|FG001|Overall Study|Lost to Follow-up|2|||
130690922|NCT00466167|470494450|FG002|Overall Study|Lost to Follow-up|2|||
130690923|NCT00466167|470494448|FG000|Overall Study|Withdrawal by Subject|4|||
130690924|NCT00466167|470494449|FG001|Overall Study|Withdrawal by Subject|1|||
130690925|NCT00466167|470494450|FG002|Overall Study|Withdrawal by Subject|6|||
130690926|NCT00466167|470494448|FG000|Overall Study|patient did not meet inclusion criteria|1|||
130690927|NCT00466167|470494449|FG001|Overall Study|patient did not meet inclusion criteria|0|||
130690928|NCT00466167|470494450|FG002|Overall Study|patient did not meet inclusion criteria|1|||
130690929|NCT00466167|470494448|FG000|Overall Study|Not treated|1|||
131111825|NCT02805725|472040944|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
130690930|NCT00466167|470494449|FG001|Overall Study|Not treated|0|||
130690931|NCT00466167|470494450|FG002|Overall Study|Not treated|0|||
130690932|NCT03669861|470494451|FG000|Overall Study|Disease Flare|5|||
130690933|NCT03669861|470494451|FG000|Overall Study|Lack of Efficacy|2|||
130690934|NCT05479058|470494459|FG000|Overall Study|Withdrawal by Subject|1|||
130690935|NCT05479058|470494460|FG001|Overall Study|Withdrawal by Subject|1|||
130690936|NCT05479058|470494459|FG000|Overall Study|Study terminated by sponsor|10|||
130690937|NCT05479058|470494460|FG001|Overall Study|Study terminated by sponsor|10|||
130690938|NCT01370733|470494461|FG000|Overall Study|Withdrawal by Subject|8|||
130690939|NCT01370733|470494462|FG001|Overall Study|Withdrawal by Subject|8|||
131111826|NCT02805725|472040945|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
130896287|NCT02051933|471257085|FG001|Overall Study|Physician Decision|1|||
130896288|NCT00588861|471257089|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
130896289|NCT00588861|471257090|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
130896290|NCT00588861|471257089|FG000|6 Months|Patients did not return for follow-up|98|||
130896291|NCT00588861|471257090|FG001|6 Months|Patients did not return for follow-up|73|||
130896292|NCT00588861|471257089|FG000|1 Year|Patients did not return for follow-up|89|||
130896293|NCT00588861|471257090|FG001|1 Year|Patients did not return for follow-up|82|||
130896294|NCT00588861|471257089|FG000|2 Years|Patients did not return for follow-up|92|||
130896295|NCT00588861|471257090|FG001|2 Years|Patients did not return for follow-up|87|||
130896296|NCT00588861|471257089|FG000|4 Years|Patients did not return for follow-up|91|||
130896297|NCT00588861|471257090|FG001|4 Years|Patients did not return for follow-up|103|||
130896298|NCT00588861|471257089|FG000|6 Years|Patients did not return for follow-up|104|||
130896299|NCT00588861|471257090|FG001|6 Years|Patients did not return for follow-up|109|||
130896300|NCT00588861|471257089|FG000|8 Years|Patients did not return for follow-up|105|||
130896301|NCT00588861|471257090|FG001|8 Years|Patients did not return for follow-up|114|||
130896302|NCT00588861|471257089|FG000|10 Years|Incomplete due to study termination|107|||
130896303|NCT00588861|471257090|FG001|10 Years|Incomplete due to study termination|114|||
130896304|NCT01239992|471257091|FG000|Overall Study|Withdrawal by Subject|2|||
130896305|NCT02848729|471257094|FG000|Overall Study|Withdrawal by Subject|1|||
130896306|NCT02848729|471257095|FG001|Overall Study|Withdrawal by Subject|0|||
130896307|NCT02848729|471257094|FG000|Overall Study|Emesis|15|||
130896308|NCT02848729|471257095|FG001|Overall Study|Emesis|11|||
130896309|NCT01904773|471257096|FG000|Screen|Screen failure|3|||
130896310|NCT01904773|471257097|FG001|Screen|Screen failure|0|||
130896311|NCT01904773|471257098|FG002|Screen|Screen failure|0|||
130896312|NCT01904773|471257099|FG003|Screen|Screen failure|0|||
130896313|NCT01904773|471257100|FG004|Screen|Screen failure|0|||
130896314|NCT01904773|471257101|FG005|Screen|Screen failure|0|||
130896315|NCT01904773|471257102|FG006|Screen|Screen failure|0|||
130896316|NCT01904773|471257103|FG007|Screen|Screen failure|0|||
130896317|NCT01904773|471257104|FG008|Screen|Screen failure|0|||
130896318|NCT01904773|471257096|FG000|Screen|Withdrawal by Subject|1|||
130896319|NCT01904773|471257097|FG001|Screen|Withdrawal by Subject|0|||
130896320|NCT01904773|471257098|FG002|Screen|Withdrawal by Subject|0|||
130896321|NCT01904773|471257099|FG003|Screen|Withdrawal by Subject|0|||
130896322|NCT01904773|471257100|FG004|Screen|Withdrawal by Subject|0|||
130896323|NCT01904773|471257101|FG005|Screen|Withdrawal by Subject|0|||
130896324|NCT01904773|471257102|FG006|Screen|Withdrawal by Subject|0|||
130896325|NCT01904773|471257103|FG007|Screen|Withdrawal by Subject|0|||
130896326|NCT01904773|471257104|FG008|Screen|Withdrawal by Subject|0|||
130896327|NCT01904773|471257096|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
130896328|NCT01904773|471257097|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130896329|NCT01904773|471257098|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130896330|NCT01904773|471257099|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130896331|NCT01904773|471257100|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130896332|NCT01904773|471257101|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130896333|NCT01904773|471257102|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130896334|NCT01904773|471257103|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130896335|NCT01904773|471257104|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130896336|NCT01904773|471257096|FG000|First Intervention|Adverse Event|0|||
130896337|NCT01904773|471257097|FG001|First Intervention|Adverse Event|0|||
130896338|NCT01904773|471257098|FG002|First Intervention|Adverse Event|0|||
130896339|NCT01904773|471257099|FG003|First Intervention|Adverse Event|0|||
130896340|NCT01904773|471257100|FG004|First Intervention|Adverse Event|0|||
130896341|NCT01904773|471257101|FG005|First Intervention|Adverse Event|0|||
130896342|NCT01904773|471257102|FG006|First Intervention|Adverse Event|1|||
131111827|NCT02805725|472040941|FG000|Phase II|Protocol Violation|0|||
131111828|NCT02805725|472040942|FG001|Phase II|Protocol Violation|0|||
131111829|NCT02805725|472040943|FG002|Phase II|Protocol Violation|0|||
131111830|NCT02805725|472040944|FG003|Phase II|Protocol Violation|0|||
131111831|NCT02805725|472040945|FG004|Phase II|Protocol Violation|6|||
131111832|NCT01195545|472040946|FG000|Overall Study|Protocol Violation|4|||
131111833|NCT02425644|472040948|FG000|Overall Study|Lost to Follow-up|2|||
130690940|NCT01370733|470494461|FG000|Overall Study|Lost to Follow-up|3|||
130896343|NCT01904773|471257103|FG007|First Intervention|Adverse Event|0|||
130896344|NCT01904773|471257104|FG008|First Intervention|Adverse Event|0|||
130896345|NCT01904773|471257096|FG000|Placebo Washout First Intervention|Condition worsened|0|||
130896346|NCT01904773|471257097|FG001|Placebo Washout First Intervention|Condition worsened|1|||
130896347|NCT01904773|471257098|FG002|Placebo Washout First Intervention|Condition worsened|0|||
130896348|NCT01904773|471257099|FG003|Placebo Washout First Intervention|Condition worsened|0|||
130896349|NCT01904773|471257100|FG004|Placebo Washout First Intervention|Condition worsened|0|||
130896350|NCT01904773|471257101|FG005|Placebo Washout First Intervention|Condition worsened|0|||
130896351|NCT01904773|471257102|FG006|Placebo Washout First Intervention|Condition worsened|0|||
131111834|NCT02425644|472040949|FG001|Overall Study|Lost to Follow-up|3|||
131111835|NCT02425644|472040948|FG000|Overall Study|Withdrawal by Subject|41|||
130896352|NCT01904773|471257103|FG007|Placebo Washout First Intervention|Condition worsened|0|||
130896353|NCT01904773|471257104|FG008|Placebo Washout First Intervention|Condition worsened|0|||
130896354|NCT01904773|471257096|FG000|Fifth Intervention|Adverse Event|0|||
130896355|NCT01904773|471257097|FG001|Fifth Intervention|Adverse Event|0|||
130896356|NCT01904773|471257098|FG002|Fifth Intervention|Adverse Event|0|||
130896357|NCT01904773|471257099|FG003|Fifth Intervention|Adverse Event|0|||
130896358|NCT01904773|471257100|FG004|Fifth Intervention|Adverse Event|0|||
130896359|NCT01904773|471257101|FG005|Fifth Intervention|Adverse Event|0|||
130896360|NCT01904773|471257102|FG006|Fifth Intervention|Adverse Event|0|||
130896361|NCT01904773|471257103|FG007|Fifth Intervention|Adverse Event|1|||
130896362|NCT01904773|471257104|FG008|Fifth Intervention|Adverse Event|0|||
130896363|NCT01904773|471257096|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130896364|NCT01904773|471257097|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
130896365|NCT01904773|471257098|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130896366|NCT01904773|471257099|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130896367|NCT01904773|471257100|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130896368|NCT01904773|471257101|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130896369|NCT01904773|471257102|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130896370|NCT01904773|471257103|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130896371|NCT01904773|471257104|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130896372|NCT00791076|471257108|FG000|Overall Study|Study was terminated,PI left institution|8|||
130896373|NCT02248675|471257109|FG000|Overall Study|Lost to Follow-up|3|||
130896374|NCT02248675|471257110|FG001|Overall Study|Lost to Follow-up|1|||
130896375|NCT03390101|471257111|FG000|Weeks 0-12|Withdrawal by Subject|0|||
130896376|NCT03390101|471257112|FG001|Weeks 0-12|Withdrawal by Subject|1|||
130896377|NCT03390101|471257113|FG002|Weeks 0-12|Withdrawal by Subject|1|||
130896378|NCT03390101|471257111|FG000|Weeks 0-12|Lost to Follow-up|0|||
131111836|NCT02425644|472040949|FG001|Overall Study|Withdrawal by Subject|36|||
131111837|NCT02425644|472040948|FG000|Overall Study|Lack of Efficacy|3|||
131111838|NCT02425644|472040949|FG001|Overall Study|Lack of Efficacy|10|||
131111839|NCT02425644|472040948|FG000|Overall Study|Adverse Event|13|||
131111840|NCT02425644|472040949|FG001|Overall Study|Adverse Event|3|||
131111841|NCT02425644|472040948|FG000|Overall Study|Death|0|||
131111842|NCT02425644|472040949|FG001|Overall Study|Death|2|||
131111843|NCT02425644|472040948|FG000|Overall Study|Other|18|||
131111844|NCT02425644|472040949|FG001|Overall Study|Other|17|||
131111845|NCT01256658|472040950|FG000|Period 1|Lost to Follow-up|837|||
131111846|NCT01256658|472040951|FG001|Period 1|Lost to Follow-up|661|||
131111847|NCT01256658|472040950|FG000|Period 1|Withdrawal by Subject|35|||
131111848|NCT01256658|472040951|FG001|Period 1|Withdrawal by Subject|43|||
131111849|NCT01256658|472040950|FG000|Period 1|Death|48|||
131111850|NCT01256658|472040951|FG001|Period 1|Death|44|||
131111851|NCT00909792|472040952|FG000|Period 1|Did not meet inclusion criteria|0|||
131111852|NCT00909792|472040953|FG001|Period 1|Did not meet inclusion criteria|1|||
131111853|NCT00909792|472040952|FG000|Period 2|Biomicroscopy|1|||
131111854|NCT00909792|472040953|FG001|Period 2|Biomicroscopy|0|||
131111855|NCT00909792|472040952|FG000|Period 2|Lost to Follow-up|0|||
131111856|NCT00909792|472040953|FG001|Period 2|Lost to Follow-up|1|||
131111857|NCT00567268|472040954|FG000|Overall Study|Protocol Violation|7|||
131111858|NCT00567268|472040954|FG000|Overall Study|Lost to Follow-up|36|||
131111859|NCT00567268|472040954|FG000|Overall Study|No Visit After First Day of Treatment|2|||
131111860|NCT00567268|472040954|FG000|Overall Study|No Drug Administration|4|||
131111861|NCT00567268|472040954|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
131111862|NCT01717989|472040955|FG000|Overall Study|Ineligibility determined|6|||
131111863|NCT01717989|472040955|FG000|Overall Study|Protocol deviation|6|||
131111864|NCT01717989|472040955|FG000|Overall Study|Withdrawal by Subject|11|||
131111865|NCT01717989|472040955|FG000|Overall Study|Physician Decision|2|||
131111866|NCT01717989|472040955|FG000|Overall Study|Lost to Follow-up|11|||
131111867|NCT01717989|472040955|FG000|Overall Study|Death|439|||
131111868|NCT01717989|472040955|FG000|Overall Study|Protocol-specified criteria|551|||
131111869|NCT01717989|472040955|FG000|Overall Study|Other|40|||
130896379|NCT03390101|471257112|FG001|Weeks 0-12|Lost to Follow-up|1|||
130896380|NCT03390101|471257113|FG002|Weeks 0-12|Lost to Follow-up|0|||
130896381|NCT03390101|471257111|FG000|Weeks 12-54|Withdrawal by Subject|0|||
130896382|NCT03390101|471257112|FG001|Weeks 12-54|Withdrawal by Subject|3|||
130896383|NCT03390101|471257113|FG002|Weeks 12-54|Withdrawal by Subject|1|||
131111870|NCT02525861|472040961|FG000|Overall Study|Adverse Event|1|||
131111871|NCT02525861|472040962|FG001|Overall Study|Adverse Event|0|||
131111872|NCT02525861|472040961|FG000|Overall Study|Withdrawal by Subject|0|||
131111873|NCT02525861|472040962|FG001|Overall Study|Withdrawal by Subject|1|||
131111874|NCT02525861|472040961|FG000|Overall Study|Physician Decision|0|||
131111875|NCT02525861|472040962|FG001|Overall Study|Physician Decision|1|||
131111876|NCT01794520|472040963|FG000|Overall Study|Adverse events- related to progression|0|||
131111877|NCT01794520|472040964|FG001|Overall Study|Adverse events- related to progression|0|||
131111878|NCT01794520|472040965|FG002|Overall Study|Adverse events- related to progression|1|||
131111879|NCT01794520|472040966|FG003|Overall Study|Adverse events- related to progression|2|||
130896384|NCT03390101|471257111|FG000|Weeks 12-54|Pregnancy|1|||
130896385|NCT03390101|471257112|FG001|Weeks 12-54|Pregnancy|0|||
130896386|NCT03390101|471257113|FG002|Weeks 12-54|Pregnancy|0|||
130896387|NCT03390101|471257111|FG000|Weeks 12-54|Adverse Event|2|||
130896388|NCT03390101|471257112|FG001|Weeks 12-54|Adverse Event|1|||
130896389|NCT03390101|471257113|FG002|Weeks 12-54|Adverse Event|1|||
130896390|NCT02052414|471257120|FG000|Overall Study|Adverse Event|12|||
130896391|NCT02052414|471257120|FG000|Overall Study|Lack of Efficacy|2|||
130896392|NCT02052414|471257120|FG000|Overall Study|Withdrawal by Subject|3|||
130896393|NCT01343693|471257124|FG000|Overall Study|Lost to Follow-up|9|||
130896394|NCT02704143|471257125|FG000|Overall Study|disease progression|10|||
130896395|NCT01235598|471257126|FG000|Overall Study|Adverse Event|0|||
130896396|NCT01235598|471257127|FG001|Overall Study|Adverse Event|3|||
130896397|NCT01235598|471257126|FG000|Overall Study|Lack of Efficacy|0|||
130896398|NCT01235598|471257127|FG001|Overall Study|Lack of Efficacy|1|||
130896399|NCT01235598|471257126|FG000|Overall Study|Withdrawal by Subject|1|||
130896400|NCT01235598|471257127|FG001|Overall Study|Withdrawal by Subject|0|||
130896401|NCT02151773|471257128|FG000|Overall Study|Protocol Deviation|64|||
130896402|NCT00395343|471257129|FG000|Overall Study|Adverse Event|13|||
130896403|NCT00395343|471257130|FG001|Overall Study|Adverse Event|5|||
130896404|NCT00395343|471257129|FG000|Overall Study|Lack of Efficacy|0|||
130896405|NCT00395343|471257130|FG001|Overall Study|Lack of Efficacy|1|||
130896406|NCT00395343|471257129|FG000|Overall Study|Lost to Follow-up|4|||
130896407|NCT00395343|471257130|FG001|Overall Study|Lost to Follow-up|4|||
130896408|NCT00395343|471257129|FG000|Overall Study|Physician Decision|2|||
130896409|NCT00395343|471257130|FG001|Overall Study|Physician Decision|4|||
130896410|NCT00395343|471257129|FG000|Overall Study|Protocol Violation|6|||
130896411|NCT00395343|471257130|FG001|Overall Study|Protocol Violation|8|||
130896412|NCT00395343|471257129|FG000|Overall Study|Withdrawal by Subject|11|||
130896413|NCT00395343|471257130|FG001|Overall Study|Withdrawal by Subject|12|||
130896414|NCT00395343|471257129|FG000|Overall Study|Other|5|||
130896415|NCT00395343|471257130|FG001|Overall Study|Other|2|||
130896416|NCT00387790|471257135|FG000|Overall Study|Adverse Event|5|||
130896417|NCT00387790|471257135|FG000|Overall Study|Lack of Efficacy|2|||
130896418|NCT00387790|471257135|FG000|Overall Study|Physician Decision|2|||
130896419|NCT00387790|471257135|FG000|Overall Study|Withdrawal by Subject|3|||
130896420|NCT00387790|471257135|FG000|Overall Study|Ineligible for study|2|||
130896421|NCT04605991|471257136|FG000|Overall Study|Adverse Event|5|||
130896422|NCT04605991|471257136|FG000|Overall Study|Lack of Efficacy|1|||
130896423|NCT04605991|471257136|FG000|Overall Study|Lost to Follow-up|8|||
130896424|NCT04605991|471257136|FG000|Overall Study|Physician Decision|4|||
130896425|NCT04605991|471257136|FG000|Overall Study|Withdrawal by Subject|14|||
130896426|NCT04605991|471257136|FG000|Overall Study|Non-compliance with study|1|||
130896427|NCT03263702|471257137|FG000|Overall Study|Lost to Follow-up|2|||
130896428|NCT03263702|471257138|FG001|Overall Study|Lost to Follow-up|2|||
130896429|NCT03263702|471257137|FG000|Overall Study|Withdrawal by Subject|1|||
130896430|NCT03263702|471257138|FG001|Overall Study|Withdrawal by Subject|2|||
130896431|NCT00966875|471257140|FG000|Part A|Adverse Event|2|||
130896432|NCT00966875|471257141|FG001|Part A|Adverse Event|1|||
130896433|NCT00966875|471257142|FG002|Part A|Adverse Event|0|||
130896434|NCT00966875|471257143|FG003|Part A|Adverse Event|1|||
130896435|NCT00966875|471257144|FG004|Part A|Adverse Event|0|||
130896436|NCT00966875|471257145|FG005|Part A|Adverse Event|1|||
130896437|NCT00966875|471257146|FG006|Part A|Adverse Event|0|||
130896438|NCT00966875|471257147|FG007|Part A|Adverse Event|3|||
130896439|NCT00966875|471257148|FG008|Part A|Adverse Event|3|||
130896440|NCT00966875|471257140|FG000|Part A|Entry Criteria|0|||
130767763|NCT01716520|470773852|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
130767764|NCT01716520|470773853|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130767765|NCT01716520|470773854|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130767766|NCT01716520|470773855|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130767767|NCT01937884|470773861|FG000|Overall Study|Withdrawal by Subject|1|||
130767768|NCT01937884|470773862|FG001|Overall Study|Withdrawal by Subject|0|||
130767769|NCT00004088|470773863|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
130767770|NCT00004088|470773863|FG000|Overall Study|Withdrawal by Subject|1|||
130767771|NCT00004088|470773863|FG000|Overall Study|Protocol Violation|3|||
130767772|NCT00004088|470773863|FG000|Overall Study|Physician Decision|1|||
130767773|NCT02636699|470773870|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
130767774|NCT02636699|470773871|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
130767775|NCT02636699|470773872|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
130896441|NCT00966875|471257141|FG001|Part A|Entry Criteria|0|||
130896442|NCT00966875|471257142|FG002|Part A|Entry Criteria|0|||
130896443|NCT00966875|471257143|FG003|Part A|Entry Criteria|0|||
130896444|NCT00966875|471257144|FG004|Part A|Entry Criteria|0|||
130896445|NCT00966875|471257145|FG005|Part A|Entry Criteria|2|||
130896446|NCT00966875|471257146|FG006|Part A|Entry Criteria|0|||
130896447|NCT00966875|471257147|FG007|Part A|Entry Criteria|0|||
130896448|NCT00966875|471257148|FG008|Part A|Entry Criteria|0|||
130896449|NCT00966875|471257140|FG000|Part A|Lack of Efficacy|0|||
130896450|NCT00966875|471257141|FG001|Part A|Lack of Efficacy|1|||
130896451|NCT00966875|471257142|FG002|Part A|Lack of Efficacy|0|||
130896452|NCT00966875|471257143|FG003|Part A|Lack of Efficacy|0|||
130896453|NCT00966875|471257144|FG004|Part A|Lack of Efficacy|0|||
130896454|NCT00966875|471257145|FG005|Part A|Lack of Efficacy|0|||
130896455|NCT00966875|471257146|FG006|Part A|Lack of Efficacy|4|||
130896456|NCT00966875|471257147|FG007|Part A|Lack of Efficacy|0|||
130896457|NCT00966875|471257148|FG008|Part A|Lack of Efficacy|0|||
130896458|NCT00966875|471257140|FG000|Part A|Lost to Follow-up|2|||
130896459|NCT00966875|471257141|FG001|Part A|Lost to Follow-up|0|||
130896460|NCT00966875|471257142|FG002|Part A|Lost to Follow-up|0|||
130896461|NCT00966875|471257143|FG003|Part A|Lost to Follow-up|0|||
130896462|NCT00966875|471257144|FG004|Part A|Lost to Follow-up|0|||
130896463|NCT00966875|471257145|FG005|Part A|Lost to Follow-up|1|||
130896464|NCT00966875|471257146|FG006|Part A|Lost to Follow-up|0|||
130896465|NCT00966875|471257147|FG007|Part A|Lost to Follow-up|0|||
130896466|NCT00966875|471257148|FG008|Part A|Lost to Follow-up|0|||
130896467|NCT00966875|471257140|FG000|Part A|Parent/Caregiver Decision|0|||
130896468|NCT00966875|471257141|FG001|Part A|Parent/Caregiver Decision|0|||
130896469|NCT00966875|471257142|FG002|Part A|Parent/Caregiver Decision|0|||
130896470|NCT00966875|471257143|FG003|Part A|Parent/Caregiver Decision|1|||
130896471|NCT00966875|471257144|FG004|Part A|Parent/Caregiver Decision|0|||
130896472|NCT00966875|471257145|FG005|Part A|Parent/Caregiver Decision|0|||
130896473|NCT00966875|471257146|FG006|Part A|Parent/Caregiver Decision|0|||
130896474|NCT00966875|471257147|FG007|Part A|Parent/Caregiver Decision|0|||
130896475|NCT00966875|471257148|FG008|Part A|Parent/Caregiver Decision|0|||
130896476|NCT00966875|471257140|FG000|Part A|Physician Decision|0|||
130896477|NCT00966875|471257141|FG001|Part A|Physician Decision|0|||
130896478|NCT00966875|471257142|FG002|Part A|Physician Decision|0|||
130896479|NCT00966875|471257143|FG003|Part A|Physician Decision|0|||
130896480|NCT00966875|471257144|FG004|Part A|Physician Decision|1|||
130896481|NCT00966875|471257145|FG005|Part A|Physician Decision|0|||
130896482|NCT00966875|471257146|FG006|Part A|Physician Decision|1|||
130896483|NCT00966875|471257147|FG007|Part A|Physician Decision|0|||
130896484|NCT00966875|471257148|FG008|Part A|Physician Decision|2|||
130896485|NCT00966875|471257140|FG000|Part A|Sponsor Decision|0|||
130896486|NCT00966875|471257141|FG001|Part A|Sponsor Decision|0|||
130896487|NCT00966875|471257142|FG002|Part A|Sponsor Decision|1|||
130896488|NCT00966875|471257143|FG003|Part A|Sponsor Decision|0|||
130896489|NCT00966875|471257144|FG004|Part A|Sponsor Decision|1|||
130896490|NCT00966875|471257145|FG005|Part A|Sponsor Decision|0|||
130896491|NCT00966875|471257146|FG006|Part A|Sponsor Decision|0|||
130896492|NCT00966875|471257147|FG007|Part A|Sponsor Decision|2|||
130896493|NCT00966875|471257148|FG008|Part A|Sponsor Decision|1|||
130896494|NCT00966875|471257140|FG000|Part A|Withdrawal by Subject|2|||
130896495|NCT00966875|471257141|FG001|Part A|Withdrawal by Subject|2|||
130896496|NCT00966875|471257142|FG002|Part A|Withdrawal by Subject|1|||
130896497|NCT00966875|471257143|FG003|Part A|Withdrawal by Subject|1|||
130896498|NCT00966875|471257144|FG004|Part A|Withdrawal by Subject|3|||
130896499|NCT00966875|471257145|FG005|Part A|Withdrawal by Subject|0|||
130896500|NCT00966875|471257146|FG006|Part A|Withdrawal by Subject|5|||
130896501|NCT00966875|471257147|FG007|Part A|Withdrawal by Subject|1|||
130896502|NCT00966875|471257148|FG008|Part A|Withdrawal by Subject|1|||
130896503|NCT00966875|471257140|FG000|Part A|Protocol Violation|0|||
130896504|NCT00966875|471257141|FG001|Part A|Protocol Violation|0|||
130896505|NCT00966875|471257142|FG002|Part A|Protocol Violation|0|||
130896506|NCT00966875|471257143|FG003|Part A|Protocol Violation|0|||
130896507|NCT00966875|471257144|FG004|Part A|Protocol Violation|0|||
130896508|NCT00966875|471257145|FG005|Part A|Protocol Violation|0|||
130896509|NCT00966875|471257146|FG006|Part A|Protocol Violation|2|||
130767776|NCT02636699|470773870|FG000|Screening Period|Withdrawal by Subject|0|||
130767777|NCT02636699|470773871|FG001|Screening Period|Withdrawal by Subject|0|||
130767778|NCT02636699|470773872|FG002|Screening Period|Withdrawal by Subject|23|||
130767779|NCT02636699|470773870|FG000|Screening Period|Adverse Event|0|||
130767780|NCT02636699|470773871|FG001|Screening Period|Adverse Event|0|||
130767781|NCT02636699|470773872|FG002|Screening Period|Adverse Event|1|||
130767782|NCT02636699|470773870|FG000|Screening Period|Other not specified|0|||
130896510|NCT00966875|471257147|FG007|Part A|Protocol Violation|1|||
130896511|NCT00966875|471257148|FG008|Part A|Protocol Violation|1|||
130896512|NCT00966875|471257140|FG000|Part B|Adverse Event|0|||
130896513|NCT00966875|471257141|FG001|Part B|Adverse Event|1|||
130896514|NCT00966875|471257142|FG002|Part B|Adverse Event|1|||
130896515|NCT00966875|471257143|FG003|Part B|Adverse Event|0|||
130896516|NCT00966875|471257144|FG004|Part B|Adverse Event|1|||
130896517|NCT00966875|471257145|FG005|Part B|Adverse Event|0|||
130896518|NCT00966875|471257146|FG006|Part B|Adverse Event|5|||
130896519|NCT00966875|471257147|FG007|Part B|Adverse Event|2|||
130896520|NCT00966875|471257148|FG008|Part B|Adverse Event|2|||
130896521|NCT00966875|471257140|FG000|Part B|Death|0|||
130896522|NCT00966875|471257141|FG001|Part B|Death|0|||
130896523|NCT00966875|471257142|FG002|Part B|Death|1|||
130767783|NCT02636699|470773871|FG001|Screening Period|Other not specified|0|||
130896524|NCT00966875|471257143|FG003|Part B|Death|0|||
130896525|NCT00966875|471257144|FG004|Part B|Death|0|||
130896526|NCT00966875|471257145|FG005|Part B|Death|0|||
130896527|NCT00966875|471257146|FG006|Part B|Death|0|||
130896528|NCT00966875|471257147|FG007|Part B|Death|1|||
130896529|NCT00966875|471257148|FG008|Part B|Death|0|||
130896530|NCT00966875|471257140|FG000|Part B|Lack of Efficacy|2|||
130896531|NCT00966875|471257141|FG001|Part B|Lack of Efficacy|1|||
130896532|NCT00966875|471257142|FG002|Part B|Lack of Efficacy|1|||
130896533|NCT00966875|471257143|FG003|Part B|Lack of Efficacy|1|||
130896534|NCT00966875|471257144|FG004|Part B|Lack of Efficacy|2|||
130896535|NCT00966875|471257145|FG005|Part B|Lack of Efficacy|3|||
130896536|NCT00966875|471257146|FG006|Part B|Lack of Efficacy|12|||
130896537|NCT00966875|471257147|FG007|Part B|Lack of Efficacy|9|||
130896538|NCT00966875|471257148|FG008|Part B|Lack of Efficacy|6|||
130896539|NCT00966875|471257140|FG000|Part B|Lost to Follow-up|0|||
130896540|NCT00966875|471257141|FG001|Part B|Lost to Follow-up|0|||
130896541|NCT00966875|471257142|FG002|Part B|Lost to Follow-up|0|||
130896542|NCT00966875|471257143|FG003|Part B|Lost to Follow-up|1|||
130896543|NCT00966875|471257144|FG004|Part B|Lost to Follow-up|0|||
130896544|NCT00966875|471257145|FG005|Part B|Lost to Follow-up|0|||
130896545|NCT00966875|471257146|FG006|Part B|Lost to Follow-up|0|||
130896546|NCT00966875|471257147|FG007|Part B|Lost to Follow-up|0|||
130896547|NCT00966875|471257148|FG008|Part B|Lost to Follow-up|1|||
130896548|NCT00966875|471257140|FG000|Part B|Physician Decision|0|||
130896549|NCT00966875|471257141|FG001|Part B|Physician Decision|0|||
130896550|NCT00966875|471257142|FG002|Part B|Physician Decision|1|||
130896551|NCT00966875|471257143|FG003|Part B|Physician Decision|0|||
130896552|NCT00966875|471257144|FG004|Part B|Physician Decision|2|||
130896553|NCT00966875|471257145|FG005|Part B|Physician Decision|1|||
130896554|NCT00966875|471257146|FG006|Part B|Physician Decision|0|||
130896555|NCT00966875|471257147|FG007|Part B|Physician Decision|0|||
130896556|NCT00966875|471257148|FG008|Part B|Physician Decision|2|||
130896557|NCT00966875|471257140|FG000|Part B|Sponsor Decision|1|||
130896558|NCT00966875|471257141|FG001|Part B|Sponsor Decision|0|||
130896559|NCT00966875|471257142|FG002|Part B|Sponsor Decision|0|||
130896560|NCT00966875|471257143|FG003|Part B|Sponsor Decision|0|||
130896561|NCT00966875|471257144|FG004|Part B|Sponsor Decision|0|||
130896562|NCT00966875|471257145|FG005|Part B|Sponsor Decision|1|||
130896563|NCT00966875|471257146|FG006|Part B|Sponsor Decision|0|||
130896564|NCT00966875|471257147|FG007|Part B|Sponsor Decision|2|||
130896565|NCT00966875|471257148|FG008|Part B|Sponsor Decision|1|||
130896566|NCT00966875|471257140|FG000|Part B|Withdrawal by Subject|2|||
130896567|NCT00966875|471257141|FG001|Part B|Withdrawal by Subject|1|||
130896568|NCT00966875|471257142|FG002|Part B|Withdrawal by Subject|2|||
130896569|NCT00966875|471257143|FG003|Part B|Withdrawal by Subject|1|||
130896570|NCT00966875|471257144|FG004|Part B|Withdrawal by Subject|2|||
130896571|NCT00966875|471257145|FG005|Part B|Withdrawal by Subject|1|||
130896572|NCT00966875|471257146|FG006|Part B|Withdrawal by Subject|4|||
130896573|NCT00966875|471257147|FG007|Part B|Withdrawal by Subject|5|||
130896574|NCT00966875|471257148|FG008|Part B|Withdrawal by Subject|5|||
130896575|NCT00966875|471257140|FG000|Part B|Entry Criteria|0|||
130896576|NCT00966875|471257141|FG001|Part B|Entry Criteria|0|||
130896577|NCT00966875|471257142|FG002|Part B|Entry Criteria|0|||
130896578|NCT00966875|471257143|FG003|Part B|Entry Criteria|0|||
130896579|NCT00966875|471257144|FG004|Part B|Entry Criteria|0|||
130896580|NCT00966875|471257145|FG005|Part B|Entry Criteria|0|||
130896581|NCT00966875|471257146|FG006|Part B|Entry Criteria|1|||
130896582|NCT00966875|471257147|FG007|Part B|Entry Criteria|0|||
130896583|NCT00966875|471257148|FG008|Part B|Entry Criteria|1|||
130896584|NCT01589653|471257149|FG000|Overall Study|Protocol Violation|3|||
130896585|NCT01589653|471257150|FG001|Overall Study|Protocol Violation|1|||
130896586|NCT01589653|471257149|FG000|Overall Study|Withdrawal criteria|4|||
130896587|NCT01589653|471257150|FG001|Overall Study|Withdrawal criteria|7|||
130896588|NCT01589653|471257149|FG000|Overall Study|Unclassified|0|||
130896589|NCT01589653|471257150|FG001|Overall Study|Unclassified|3|||
130896590|NCT02386189|471257151|FG000|Overall Study|Lost to Follow-up|2|||
130896591|NCT02386189|471257152|FG001|Overall Study|Lost to Follow-up|3|||
130896592|NCT02386189|471257151|FG000|Overall Study|Withdrawal by Subject|1|||
130896593|NCT02386189|471257152|FG001|Overall Study|Withdrawal by Subject|0|||
130690941|NCT01370733|470494462|FG001|Overall Study|Lost to Follow-up|0|||
130690942|NCT01370733|470494461|FG000|Overall Study|Adverse Event|2|||
130690943|NCT01370733|470494462|FG001|Overall Study|Adverse Event|4|||
130690944|NCT01370733|470494461|FG000|Overall Study|Lack of Efficacy|3|||
130896594|NCT02386189|471257151|FG000|Overall Study|Death|1|||
130896595|NCT02386189|471257152|FG001|Overall Study|Death|0|||
130896596|NCT04657666|471257153|FG000|Period 1|Withdrawal of participant consent|2|||
130896597|NCT04657666|471257154|FG001|Period 1|Withdrawal of participant consent|1|||
130896598|NCT04657666|471257153|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
130896599|NCT04657666|471257154|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
130896600|NCT04657666|471257153|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
130896601|NCT04657666|471257154|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
130896602|NCT04657666|471257153|FG000|Period 2|Other|2|||
130690945|NCT01370733|470494462|FG001|Overall Study|Lack of Efficacy|5|||
130896603|NCT04657666|471257154|FG001|Period 2|Other|0|||
130896604|NCT04657666|471257153|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
130896605|NCT04657666|471257154|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
130896606|NCT03700684|471257163|FG000|Overall Study|COVID-19|0|||
130896607|NCT03700684|471257164|FG001|Overall Study|COVID-19|0|||
130896608|NCT03700684|471257165|FG002|Overall Study|COVID-19|2|||
130896609|NCT00870103|471257166|FG000|Overall Study|Physician Decision|2|||
130896610|NCT00870103|471257166|FG000|Overall Study|Lost to Follow-up|2|||
130896611|NCT01317550|471257167|FG000|Overall Study|Withdrawal by Subject|1|||
130896612|NCT01317550|471257168|FG001|Overall Study|Withdrawal by Subject|0|||
130896613|NCT01317550|471257169|FG002|Overall Study|Withdrawal by Subject|0|||
130896614|NCT01317550|471257170|FG003|Overall Study|Withdrawal by Subject|0|||
130896615|NCT01317550|471257167|FG000|Overall Study|Lack of compliance study med|1|||
130896616|NCT01317550|471257168|FG001|Overall Study|Lack of compliance study med|0|||
130896617|NCT01317550|471257169|FG002|Overall Study|Lack of compliance study med|0|||
130896618|NCT01317550|471257170|FG003|Overall Study|Lack of compliance study med|0|||
130896619|NCT01640314|471257171|FG000|Overall Study|Protocol Violation|0|||
130896620|NCT01640314|471257172|FG001|Overall Study|Protocol Violation|1|||
130896621|NCT01290796|471257173|FG000|Overall Study|Lost to Follow-up|21|||
130896622|NCT01290796|471257173|FG000|Overall Study|Withdrawal by Subject|4|||
130896623|NCT01290796|471257173|FG000|Overall Study|Physician Decision|2|||
130896624|NCT01290796|471257173|FG000|Overall Study|Secondary Surgical Intervention|2|||
130896625|NCT01290796|471257173|FG000|Overall Study|Withdrawal by Sponsor|1|||
130896626|NCT00787267|471257177|FG000|Overall Study|Screen failure/Ineligible|10|||
130896627|NCT00787267|471257177|FG000|Overall Study|No Reason Provided|1|||
130896628|NCT00787267|471257177|FG000|Overall Study|Withdrawal by Subject|1|||
130896629|NCT00865280|471257178|FG000|Overall Study|Withdrawal by Subject|4|||
130896630|NCT00865280|471257179|FG001|Overall Study|Withdrawal by Subject|1|||
130896631|NCT00865280|471257178|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
130896632|NCT00865280|471257179|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
130896633|NCT00865280|471257178|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
130896634|NCT00865280|471257179|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
130896635|NCT00865280|471257178|FG000|Overall Study|Exclusion Condition|1|||
131111880|NCT01794520|472040967|FG004|Overall Study|Adverse events- related to progression|0|||
131111881|NCT01794520|472040968|FG005|Overall Study|Adverse events- related to progression|1|||
131111882|NCT01794520|472040969|FG006|Overall Study|Adverse events- related to progression|0|||
131111883|NCT01794520|472040963|FG000|Overall Study|Adverse event- not related to progression|1|||
131111884|NCT01794520|472040964|FG001|Overall Study|Adverse event- not related to progression|1|||
131111885|NCT01794520|472040965|FG002|Overall Study|Adverse event- not related to progression|0|||
131111886|NCT01794520|472040966|FG003|Overall Study|Adverse event- not related to progression|0|||
131111887|NCT01794520|472040967|FG004|Overall Study|Adverse event- not related to progression|2|||
131111888|NCT01794520|472040968|FG005|Overall Study|Adverse event- not related to progression|0|||
131111889|NCT01794520|472040969|FG006|Overall Study|Adverse event- not related to progression|0|||
131111890|NCT01794520|472040963|FG000|Overall Study|Progressive disease|5|||
131111891|NCT01794520|472040964|FG001|Overall Study|Progressive disease|6|||
131111892|NCT01794520|472040965|FG002|Overall Study|Progressive disease|2|||
131111893|NCT01794520|472040966|FG003|Overall Study|Progressive disease|5|||
131111894|NCT01794520|472040967|FG004|Overall Study|Progressive disease|27|||
131111895|NCT01794520|472040968|FG005|Overall Study|Progressive disease|18|||
131111896|NCT01794520|472040969|FG006|Overall Study|Progressive disease|0|||
131111897|NCT01794520|472040963|FG000|Overall Study|Withdrew consent|0|||
131111898|NCT01794520|472040964|FG001|Overall Study|Withdrew consent|0|||
131111899|NCT01794520|472040965|FG002|Overall Study|Withdrew consent|1|||
131111900|NCT01794520|472040966|FG003|Overall Study|Withdrew consent|1|||
131111901|NCT01794520|472040967|FG004|Overall Study|Withdrew consent|0|||
131111902|NCT01794520|472040968|FG005|Overall Study|Withdrew consent|0|||
131111903|NCT01794520|472040969|FG006|Overall Study|Withdrew consent|0|||
131111904|NCT01794520|472040963|FG000|Overall Study|Lost to Follow-up|0|||
131111905|NCT01794520|472040964|FG001|Overall Study|Lost to Follow-up|0|||
131111906|NCT01794520|472040965|FG002|Overall Study|Lost to Follow-up|0|||
131111907|NCT01794520|472040966|FG003|Overall Study|Lost to Follow-up|0|||
131111908|NCT01794520|472040967|FG004|Overall Study|Lost to Follow-up|1|||
131111909|NCT01794520|472040968|FG005|Overall Study|Lost to Follow-up|0|||
130690946|NCT01370733|470494461|FG000|Overall Study|Physician Decision|0|||
130896636|NCT00865280|471257179|FG001|Overall Study|Exclusion Condition|0|||
130896637|NCT00865280|471257178|FG000|Overall Study|Adverse Event|0|||
130896638|NCT00865280|471257179|FG001|Overall Study|Adverse Event|1|||
130896639|NCT01419197|471257185|FG000|Overall Study|Death|247|||
130896640|NCT01419197|471257186|FG001|Overall Study|Death|122|||
130896641|NCT01419197|471257185|FG000|Overall Study|Physician Decision|4|||
130896642|NCT01419197|471257186|FG001|Overall Study|Physician Decision|4|||
131111910|NCT01794520|472040969|FG006|Overall Study|Lost to Follow-up|0|||
131111911|NCT01794520|472040963|FG000|Overall Study|Toxicity|0|||
130690947|NCT01370733|470494462|FG001|Overall Study|Physician Decision|2|||
131111912|NCT01794520|472040964|FG001|Overall Study|Toxicity|2|||
130690948|NCT01370733|470494461|FG000|Overall Study|Protocol Violation|1|||
131111913|NCT01794520|472040965|FG002|Overall Study|Toxicity|0|||
131111914|NCT01794520|472040966|FG003|Overall Study|Toxicity|0|||
131111915|NCT01794520|472040967|FG004|Overall Study|Toxicity|0|||
131111916|NCT01794520|472040968|FG005|Overall Study|Toxicity|0|||
131111917|NCT01794520|472040969|FG006|Overall Study|Toxicity|0|||
131111918|NCT01794520|472040963|FG000|Overall Study|Study terminated by sponsor|0|||
131111919|NCT01794520|472040964|FG001|Overall Study|Study terminated by sponsor|0|||
131111920|NCT01794520|472040965|FG002|Overall Study|Study terminated by sponsor|1|||
131111921|NCT01794520|472040966|FG003|Overall Study|Study terminated by sponsor|0|||
131111922|NCT01794520|472040967|FG004|Overall Study|Study terminated by sponsor|1|||
131111923|NCT01794520|472040968|FG005|Overall Study|Study terminated by sponsor|0|||
131111924|NCT01794520|472040969|FG006|Overall Study|Study terminated by sponsor|7|||
131111925|NCT01794520|472040963|FG000|Overall Study|Death|0|||
131111926|NCT01794520|472040964|FG001|Overall Study|Death|0|||
131111927|NCT01794520|472040965|FG002|Overall Study|Death|0|||
131111928|NCT01794520|472040966|FG003|Overall Study|Death|0|||
131111929|NCT01794520|472040967|FG004|Overall Study|Death|1|||
131111930|NCT01794520|472040968|FG005|Overall Study|Death|0|||
131111931|NCT01794520|472040969|FG006|Overall Study|Death|22|||
131111932|NCT01794520|472040963|FG000|Overall Study|Other, not specified|0|||
131111933|NCT01794520|472040964|FG001|Overall Study|Other, not specified|0|||
131111934|NCT01794520|472040965|FG002|Overall Study|Other, not specified|1|||
131111935|NCT01794520|472040966|FG003|Overall Study|Other, not specified|1|||
131111936|NCT01794520|472040967|FG004|Overall Study|Other, not specified|4|||
131111937|NCT01794520|472040968|FG005|Overall Study|Other, not specified|1|||
131111938|NCT01794520|472040969|FG006|Overall Study|Other, not specified|2|||
131111939|NCT04796896|472040971|FG000|Overall Study|Adverse Event|1|||
131111940|NCT04796896|472040972|FG001|Overall Study|Adverse Event|0|||
131111941|NCT04796896|472040973|FG002|Overall Study|Adverse Event|0|||
131111942|NCT04796896|472040974|FG003|Overall Study|Adverse Event|0|||
131111943|NCT04796896|472040975|FG004|Overall Study|Adverse Event|0|||
131111944|NCT04796896|472040976|FG005|Overall Study|Adverse Event|1|||
131111945|NCT04796896|472040977|FG006|Overall Study|Adverse Event|1|||
131111946|NCT04796896|472040978|FG007|Overall Study|Adverse Event|0|||
131111947|NCT04796896|472040979|FG008|Overall Study|Adverse Event|1|||
131111948|NCT04796896|472040980|FG009|Overall Study|Adverse Event|1|||
131111949|NCT04796896|472040981|FG010|Overall Study|Adverse Event|1|||
131111950|NCT04796896|472040982|FG011|Overall Study|Adverse Event|0|||
131111951|NCT04796896|472040971|FG000|Overall Study|Lost to Follow-up|24|||
131111952|NCT04796896|472040972|FG001|Overall Study|Lost to Follow-up|15|||
131111953|NCT04796896|472040973|FG002|Overall Study|Lost to Follow-up|6|||
131111954|NCT04796896|472040974|FG003|Overall Study|Lost to Follow-up|4|||
131111955|NCT04796896|472040975|FG004|Overall Study|Lost to Follow-up|21|||
131111956|NCT04796896|472040976|FG005|Overall Study|Lost to Follow-up|55|||
131111957|NCT04796896|472040977|FG006|Overall Study|Lost to Follow-up|237|||
131111958|NCT04796896|472040978|FG007|Overall Study|Lost to Follow-up|52|||
131111959|NCT04796896|472040979|FG008|Overall Study|Lost to Follow-up|221|||
131111960|NCT04796896|472040980|FG009|Overall Study|Lost to Follow-up|43|||
131111961|NCT04796896|472040981|FG010|Overall Study|Lost to Follow-up|142|||
131111962|NCT04796896|472040982|FG011|Overall Study|Lost to Follow-up|18|||
131111963|NCT04796896|472040971|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
131111964|NCT04796896|472040972|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
131111965|NCT04796896|472040973|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
131111966|NCT04796896|472040974|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
131111967|NCT04796896|472040975|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
131111968|NCT04796896|472040976|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
131111969|NCT04796896|472040977|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
131111970|NCT04796896|472040978|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
131111971|NCT04796896|472040979|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
131111972|NCT04796896|472040980|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
131111973|NCT04796896|472040981|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
131111974|NCT04796896|472040982|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
131111975|NCT04796896|472040971|FG000|Overall Study|Physician Decision|1|||
131111976|NCT04796896|472040972|FG001|Overall Study|Physician Decision|0|||
131111977|NCT04796896|472040973|FG002|Overall Study|Physician Decision|0|||
131111978|NCT04796896|472040974|FG003|Overall Study|Physician Decision|0|||
131111979|NCT04796896|472040975|FG004|Overall Study|Physician Decision|0|||
131111980|NCT04796896|472040976|FG005|Overall Study|Physician Decision|3|||
131111981|NCT04796896|472040977|FG006|Overall Study|Physician Decision|18|||
131111982|NCT04796896|472040978|FG007|Overall Study|Physician Decision|1|||
131111983|NCT04796896|472040979|FG008|Overall Study|Physician Decision|7|||
131111984|NCT04796896|472040980|FG009|Overall Study|Physician Decision|0|||
131111985|NCT04796896|472040981|FG010|Overall Study|Physician Decision|5|||
130896643|NCT01419197|471257185|FG000|Overall Study|Non-compliance|3|||
130896644|NCT01419197|471257186|FG001|Overall Study|Non-compliance|1|||
131111986|NCT04796896|472040982|FG011|Overall Study|Physician Decision|0|||
131111987|NCT04796896|472040971|FG000|Overall Study|Withdrawal by Subject|36|||
131111988|NCT04796896|472040972|FG001|Overall Study|Withdrawal by Subject|31|||
131111989|NCT04796896|472040973|FG002|Overall Study|Withdrawal by Subject|11|||
131111990|NCT04796896|472040974|FG003|Overall Study|Withdrawal by Subject|8|||
131111991|NCT04796896|472040975|FG004|Overall Study|Withdrawal by Subject|16|||
131111992|NCT04796896|472040976|FG005|Overall Study|Withdrawal by Subject|162|||
131111993|NCT04796896|472040977|FG006|Overall Study|Withdrawal by Subject|299|||
130690949|NCT01370733|470494462|FG001|Overall Study|Protocol Violation|3|||
130690950|NCT00463684|470494465|FG000|Overall Study|Withdrawal by Subject|1|||
130690951|NCT00463684|470494465|FG000|Overall Study|Lost to Follow-up|3|||
130690952|NCT00191815|470494466|FG000|Overall Study|Adverse Event|2|||
130690953|NCT00191815|470494466|FG000|Overall Study|Disease progression or relapse|24|||
130690954|NCT00191815|470494466|FG000|Overall Study|Death|2|||
130690955|NCT00191815|470494466|FG000|Overall Study|Protocol Violation|3|||
130690956|NCT00191815|470494466|FG000|Overall Study|Physician Decision|2|||
130690957|NCT00191815|470494466|FG000|Overall Study|Withdrawal by Subject|7|||
130690958|NCT03808376|470494467|FG000|Overall Study|Withdrawal by Subject|10|||
130690959|NCT03644550|470494468|FG000|Overall Study|Withdrawal by Subject|3|||
130690960|NCT03644550|470494468|FG000|Overall Study|Progressive disease|15|||
130690961|NCT00323882|470494469|FG000|Overall Study|Adverse Event|2|||
130690962|NCT00323882|470494470|FG001|Overall Study|Adverse Event|1|||
130690963|NCT00323882|470494471|FG002|Overall Study|Adverse Event|1|||
130690964|NCT00323882|470494472|FG003|Overall Study|Adverse Event|1|||
130690965|NCT00323882|470494473|FG004|Overall Study|Adverse Event|3|||
130690966|NCT00323882|470494469|FG000|Overall Study|Disease Progression|6|||
130690967|NCT00323882|470494470|FG001|Overall Study|Disease Progression|4|||
130690968|NCT00323882|470494471|FG002|Overall Study|Disease Progression|10|||
130690969|NCT00323882|470494472|FG003|Overall Study|Disease Progression|5|||
130690970|NCT00323882|470494473|FG004|Overall Study|Disease Progression|22|||
130690971|NCT00323882|470494469|FG000|Overall Study|Death|0|||
130690972|NCT00323882|470494470|FG001|Overall Study|Death|1|||
130690973|NCT00323882|470494471|FG002|Overall Study|Death|1|||
130690974|NCT00323882|470494472|FG003|Overall Study|Death|0|||
130690975|NCT00323882|470494473|FG004|Overall Study|Death|5|||
130690976|NCT00323882|470494469|FG000|Overall Study|Lost to Follow-up|0|||
130690977|NCT00323882|470494470|FG001|Overall Study|Lost to Follow-up|0|||
130690978|NCT00323882|470494471|FG002|Overall Study|Lost to Follow-up|1|||
130690979|NCT00323882|470494472|FG003|Overall Study|Lost to Follow-up|0|||
130690980|NCT00323882|470494473|FG004|Overall Study|Lost to Follow-up|1|||
130690981|NCT00323882|470494469|FG000|Overall Study|Other|0|||
130690982|NCT00323882|470494470|FG001|Overall Study|Other|0|||
130690983|NCT00323882|470494471|FG002|Overall Study|Other|0|||
130690984|NCT00323882|470494472|FG003|Overall Study|Other|1|||
130690985|NCT00323882|470494473|FG004|Overall Study|Other|1|||
130690986|NCT01794845|470494474|FG000|Overall Study|Withdrawal by Subject|1|||
130690987|NCT01456221|470494475|FG000|Overall Study|Withdrawal by Subject|56|||
130690988|NCT01456221|470494476|FG001|Overall Study|Withdrawal by Subject|49|||
130690989|NCT01456221|470494475|FG000|Overall Study|Lost to Follow-up|1|||
130690990|NCT01456221|470494476|FG001|Overall Study|Lost to Follow-up|4|||
130690991|NCT01456221|470494475|FG000|Overall Study|Received medication|3|||
130690992|NCT01456221|470494476|FG001|Overall Study|Received medication|2|||
130690993|NCT01456221|470494475|FG000|Overall Study|Incomplete data|4|||
130690994|NCT01456221|470494476|FG001|Overall Study|Incomplete data|2|||
130690995|NCT06647173|470494477|FG000|Overall Study|Lost to Follow-up|24|||
130690996|NCT00312897|470494480|FG000|Overall Study|Adverse Event|1|||
130690997|NCT00312897|470494481|FG001|Overall Study|Adverse Event|0|||
130690998|NCT00312897|470494480|FG000|Overall Study|Lost to Follow-up|2|||
130690999|NCT00312897|470494481|FG001|Overall Study|Lost to Follow-up|0|||
130691000|NCT00312897|470494480|FG000|Overall Study|Physician Decision|1|||
130767784|NCT02636699|470773872|FG002|Screening Period|Other not specified|3|||
130767785|NCT02636699|470773870|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
130691001|NCT00312897|470494481|FG001|Overall Study|Physician Decision|0|||
130691002|NCT00312897|470494480|FG000|Overall Study|Withdrawal by Subject|1|||
130691003|NCT00312897|470494481|FG001|Overall Study|Withdrawal by Subject|3|||
130691004|NCT00312897|470494480|FG000|Overall Study|Pregnancy|1|||
130767786|NCT02636699|470773871|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
130767787|NCT02636699|470773872|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
130767788|NCT02636699|470773870|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
130767789|NCT02636699|470773871|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
130767790|NCT02636699|470773872|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
130767791|NCT02636699|470773870|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
130767792|NCT02636699|470773871|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
130896645|NCT01419197|471257185|FG000|Overall Study|Withdrawal by Subject|33|||
130896646|NCT01419197|471257186|FG001|Overall Study|Withdrawal by Subject|32|||
130691005|NCT00312897|470494481|FG001|Overall Study|Pregnancy|0|||
130691006|NCT00312897|470494480|FG000|Overall Study|discontinued prior to getting treatment|0|||
130691007|NCT00312897|470494481|FG001|Overall Study|discontinued prior to getting treatment|3|||
130691008|NCT03100344|470494482|FG000|Overall Study|Adverse Event|0|||
130691009|NCT03100344|470494483|FG001|Overall Study|Adverse Event|3|||
130691010|NCT03100344|470494484|FG002|Overall Study|Adverse Event|2|||
130691011|NCT03100344|470494485|FG003|Overall Study|Adverse Event|3|||
130691012|NCT03100344|470494482|FG000|Overall Study|Lack of Efficacy|2|||
130691013|NCT03100344|470494483|FG001|Overall Study|Lack of Efficacy|0|||
130691014|NCT03100344|470494484|FG002|Overall Study|Lack of Efficacy|0|||
130691015|NCT03100344|470494485|FG003|Overall Study|Lack of Efficacy|0|||
130896647|NCT01419197|471257185|FG000|Overall Study|Study Completed by Sponsor|103|||
130896648|NCT01419197|471257186|FG001|Overall Study|Study Completed by Sponsor|34|||
130896649|NCT01419197|471257185|FG000|Overall Study|Reason Not Specified|0|||
130896650|NCT01419197|471257186|FG001|Overall Study|Reason Not Specified|1|||
130896651|NCT01419197|471257185|FG000|Overall Study|Lost to Follow-up|14|||
130896652|NCT01419197|471257186|FG001|Overall Study|Lost to Follow-up|4|||
130896653|NCT00146848|471257187|FG000|Pre-randomization|Death|19|||
130896654|NCT00146848|471257188|FG001|Pre-randomization|Death|0|||
130896655|NCT00146848|471257189|FG002|Pre-randomization|Death|0|||
130896656|NCT00146848|471257187|FG000|Pre-randomization|Lost to Follow-up|70|||
130896657|NCT00146848|471257188|FG001|Pre-randomization|Lost to Follow-up|0|||
130896658|NCT00146848|471257189|FG002|Pre-randomization|Lost to Follow-up|0|||
130896659|NCT00146848|471257187|FG000|Pre-randomization|Physician Decision|8|||
130896660|NCT00146848|471257188|FG001|Pre-randomization|Physician Decision|0|||
130896661|NCT00146848|471257189|FG002|Pre-randomization|Physician Decision|0|||
130896662|NCT00146848|471257187|FG000|Pre-randomization|Protocol Violation|172|||
130896663|NCT00146848|471257188|FG001|Pre-randomization|Protocol Violation|0|||
130896664|NCT00146848|471257189|FG002|Pre-randomization|Protocol Violation|0|||
130896665|NCT00146848|471257187|FG000|Pre-randomization|Withdrawal by Subject|40|||
130896666|NCT00146848|471257188|FG001|Pre-randomization|Withdrawal by Subject|0|||
130896667|NCT00146848|471257189|FG002|Pre-randomization|Withdrawal by Subject|0|||
130896668|NCT00146848|471257187|FG000|Post-randomization|Lost to Follow-up|12|||
130896669|NCT00146848|471257188|FG001|Post-randomization|Lost to Follow-up|15|||
130896670|NCT00146848|471257189|FG002|Post-randomization|Lost to Follow-up|12|||
130896671|NCT00146848|471257187|FG000|Post-randomization|Withdrawn|26|||
130896672|NCT00146848|471257188|FG001|Post-randomization|Withdrawn|32|||
130896673|NCT00146848|471257189|FG002|Post-randomization|Withdrawn|27|||
130896674|NCT04556383|471257190|FG000|PCP|Lack of Efficacy|28|||
130896675|NCT04556383|471257191|FG001|PCP|Lack of Efficacy|23|||
130896676|NCT04556383|471257192|FG002|PCP|Lack of Efficacy|23|||
130896677|NCT04556383|471257193|FG003|PCP|Lack of Efficacy|0|||
130896678|NCT04556383|471257190|FG000|PCP|Study terminated by sponsor|15|||
130896679|NCT04556383|471257191|FG001|PCP|Study terminated by sponsor|13|||
130896680|NCT04556383|471257192|FG002|PCP|Study terminated by sponsor|16|||
130896681|NCT04556383|471257193|FG003|PCP|Study terminated by sponsor|0|||
130896682|NCT04556383|471257190|FG000|PCP|Withdrawal by Subject|8|||
130896683|NCT04556383|471257191|FG001|PCP|Withdrawal by Subject|6|||
130896684|NCT04556383|471257192|FG002|PCP|Withdrawal by Subject|6|||
130896685|NCT04556383|471257193|FG003|PCP|Withdrawal by Subject|0|||
130896686|NCT04556383|471257190|FG000|PCP|Adverse Event|1|||
130896687|NCT04556383|471257191|FG001|PCP|Adverse Event|7|||
130896688|NCT04556383|471257192|FG002|PCP|Adverse Event|7|||
130896689|NCT04556383|471257193|FG003|PCP|Adverse Event|0|||
130896690|NCT04556383|471257190|FG000|PCP|Other, Not Specified|1|||
130896691|NCT04556383|471257191|FG001|PCP|Other, Not Specified|2|||
130896692|NCT04556383|471257192|FG002|PCP|Other, Not Specified|1|||
130896693|NCT04556383|471257193|FG003|PCP|Other, Not Specified|0|||
130896694|NCT04556383|471257190|FG000|PCP|Protocol Violation|1|||
130896695|NCT04556383|471257191|FG001|PCP|Protocol Violation|0|||
130896696|NCT04556383|471257192|FG002|PCP|Protocol Violation|1|||
130896697|NCT04556383|471257193|FG003|PCP|Protocol Violation|0|||
130896698|NCT04556383|471257190|FG000|PCP|Lost to Follow-up|1|||
130896699|NCT04556383|471257191|FG001|PCP|Lost to Follow-up|0|||
130896700|NCT04556383|471257192|FG002|PCP|Lost to Follow-up|0|||
130896701|NCT04556383|471257193|FG003|PCP|Lost to Follow-up|0|||
130896702|NCT04556383|471257190|FG000|PCP|Physician Decision|0|||
130896703|NCT04556383|471257191|FG001|PCP|Physician Decision|1|||
130896704|NCT04556383|471257192|FG002|PCP|Physician Decision|0|||
131025398|NCT00001277|471723253|FG002|Overall Study|Adverse Event|1|||
131025399|NCT00001277|471723251|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
130767793|NCT02636699|470773872|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
130767794|NCT02636699|470773870|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
130767795|NCT02636699|470773871|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
130767796|NCT02636699|470773872|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
130767797|NCT02636699|470773870|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
130767798|NCT02636699|470773871|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
130767799|NCT02636699|470773872|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
130896705|NCT04556383|471257193|FG003|PCP|Physician Decision|0|||
130896706|NCT04556383|471257190|FG000|PCP|Site terminated by sponsor|0|||
130896707|NCT04556383|471257191|FG001|PCP|Site terminated by sponsor|1|||
130896708|NCT04556383|471257192|FG002|PCP|Site terminated by sponsor|0|||
130896709|NCT04556383|471257193|FG003|PCP|Site terminated by sponsor|0|||
130896710|NCT04556383|471257190|FG000|OLE|Study terminated by sponsor|0|||
130896711|NCT04556383|471257191|FG001|OLE|Study terminated by sponsor|0|||
130896712|NCT04556383|471257192|FG002|OLE|Study terminated by sponsor|0|||
130896713|NCT04556383|471257193|FG003|OLE|Study terminated by sponsor|68|||
130896714|NCT04556383|471257190|FG000|OLE|Withdrawal by Subject|0|||
130896715|NCT04556383|471257191|FG001|OLE|Withdrawal by Subject|0|||
130896716|NCT04556383|471257192|FG002|OLE|Withdrawal by Subject|0|||
130896717|NCT04556383|471257193|FG003|OLE|Withdrawal by Subject|10|||
130896718|NCT04556383|471257190|FG000|OLE|Lack of Efficacy|0|||
130896719|NCT04556383|471257191|FG001|OLE|Lack of Efficacy|0|||
130896720|NCT04556383|471257192|FG002|OLE|Lack of Efficacy|0|||
130896721|NCT04556383|471257193|FG003|OLE|Lack of Efficacy|7|||
130896722|NCT04556383|471257190|FG000|OLE|Adverse Event|0|||
130896723|NCT04556383|471257191|FG001|OLE|Adverse Event|0|||
130896724|NCT04556383|471257192|FG002|OLE|Adverse Event|0|||
130896725|NCT04556383|471257193|FG003|OLE|Adverse Event|2|||
130896726|NCT04556383|471257190|FG000|OLE|Other, Not Specified|0|||
130896727|NCT04556383|471257191|FG001|OLE|Other, Not Specified|0|||
130896728|NCT04556383|471257192|FG002|OLE|Other, Not Specified|0|||
130896729|NCT04556383|471257193|FG003|OLE|Other, Not Specified|2|||
130896730|NCT04556383|471257190|FG000|OLE|Death|0|||
130896731|NCT04556383|471257191|FG001|OLE|Death|0|||
130896732|NCT04556383|471257192|FG002|OLE|Death|0|||
130896733|NCT04556383|471257193|FG003|OLE|Death|1|||
130896734|NCT04556383|471257190|FG000|OLE|Lost to Follow-up|0|||
130896735|NCT04556383|471257191|FG001|OLE|Lost to Follow-up|0|||
130896736|NCT04556383|471257192|FG002|OLE|Lost to Follow-up|0|||
130896737|NCT04556383|471257193|FG003|OLE|Lost to Follow-up|1|||
130896738|NCT00119678|471257194|FG000|Double-blind Treatment Period|Death|1|||
130896739|NCT00119678|471257195|FG001|Double-blind Treatment Period|Death|0|||
130896740|NCT00119678|471257194|FG000|Double-blind Treatment Period|Adverse Event|7|||
130896741|NCT00119678|471257195|FG001|Double-blind Treatment Period|Adverse Event|1|||
130896742|NCT00119678|471257194|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
130896743|NCT00119678|471257195|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
130896744|NCT00119678|471257194|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130896745|NCT00119678|471257195|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
130896746|NCT00119678|471257194|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
130896747|NCT00119678|471257195|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
130896748|NCT00119678|471257194|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
130896749|NCT00119678|471257195|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
130896750|NCT00119678|471257194|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
130896751|NCT00119678|471257195|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
130896752|NCT00119678|471257194|FG000|Double-blind Treatment Period|Pregnancy|0|||
130896753|NCT00119678|471257195|FG001|Double-blind Treatment Period|Pregnancy|2|||
130896754|NCT00119678|471257194|FG000|Double-blind Treatment Period|Not treated|1|||
130896755|NCT00119678|471257195|FG001|Double-blind Treatment Period|Not treated|2|||
130896756|NCT00119678|471257194|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
130896757|NCT00119678|471257195|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
130896758|NCT00119678|471257194|FG000|Open-label Treatment Period|Death|1|||
130896759|NCT00119678|471257195|FG001|Open-label Treatment Period|Death|0|||
130896760|NCT00119678|471257194|FG000|Open-label Treatment Period|Adverse Event|3|||
130896761|NCT00119678|471257195|FG001|Open-label Treatment Period|Adverse Event|0|||
130896762|NCT00119678|471257194|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
130896763|NCT00119678|471257195|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
130896764|NCT00119678|471257194|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
130896765|NCT00119678|471257195|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
130896766|NCT00119678|471257194|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
130896767|NCT00119678|471257195|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
130896768|NCT00119678|471257194|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
130896769|NCT00119678|471257195|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
130896770|NCT00119678|471257194|FG000|Open-label Treatment Period|Pregnancy|1|||
130896771|NCT00119678|471257195|FG001|Open-label Treatment Period|Pregnancy|0|||
130896772|NCT00119678|471257194|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
130896773|NCT00119678|471257195|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
130896774|NCT01761240|471257196|FG000|Overall Study|Progressive disease:radiology assessment|3|||
131111994|NCT04796896|472040978|FG007|Overall Study|Withdrawal by Subject|149|||
131111995|NCT04796896|472040979|FG008|Overall Study|Withdrawal by Subject|303|||
131111996|NCT04796896|472040980|FG009|Overall Study|Withdrawal by Subject|94|||
131111997|NCT04796896|472040981|FG010|Overall Study|Withdrawal by Subject|192|||
131111998|NCT04796896|472040982|FG011|Overall Study|Withdrawal by Subject|16|||
130691016|NCT03100344|470494482|FG000|Overall Study|Protocol Violation|1|||
130691017|NCT03100344|470494483|FG001|Overall Study|Protocol Violation|0|||
130896775|NCT01761240|471257197|FG001|Overall Study|Progressive disease:radiology assessment|3|||
130896776|NCT01761240|471257198|FG002|Overall Study|Progressive disease:radiology assessment|0|||
130896777|NCT01761240|471257199|FG003|Overall Study|Progressive disease:radiology assessment|0|||
130896778|NCT01761240|471257200|FG004|Overall Study|Progressive disease:radiology assessment|0|||
130896779|NCT01761240|471257196|FG000|Overall Study|Progressive disease:clinical assessment|0|||
130896780|NCT01761240|471257197|FG001|Overall Study|Progressive disease:clinical assessment|0|||
130896781|NCT01761240|471257198|FG002|Overall Study|Progressive disease:clinical assessment|3|||
131111999|NCT04796896|472040971|FG000|Overall Study|Other Than Specified|6|||
130896782|NCT01761240|471257199|FG003|Overall Study|Progressive disease:clinical assessment|1|||
130691018|NCT03100344|470494484|FG002|Overall Study|Protocol Violation|0|||
130896783|NCT01761240|471257200|FG004|Overall Study|Progressive disease:clinical assessment|0|||
130896784|NCT01761240|471257196|FG000|Overall Study|Withdrawal by Subject|0|||
130896785|NCT01761240|471257197|FG001|Overall Study|Withdrawal by Subject|0|||
130896786|NCT01761240|471257198|FG002|Overall Study|Withdrawal by Subject|0|||
130896787|NCT01761240|471257199|FG003|Overall Study|Withdrawal by Subject|3|||
130896788|NCT01761240|471257200|FG004|Overall Study|Withdrawal by Subject|1|||
130896789|NCT01761240|471257196|FG000|Overall Study|Adverse Event|0|||
130896790|NCT01761240|471257197|FG001|Overall Study|Adverse Event|0|||
130896791|NCT01761240|471257198|FG002|Overall Study|Adverse Event|0|||
130896792|NCT01761240|471257199|FG003|Overall Study|Adverse Event|1|||
130896793|NCT01761240|471257200|FG004|Overall Study|Adverse Event|6|||
130896794|NCT01761240|471257196|FG000|Overall Study|Death|0|||
130896795|NCT01761240|471257197|FG001|Overall Study|Death|1|||
130896796|NCT01761240|471257198|FG002|Overall Study|Death|1|||
130896797|NCT01761240|471257199|FG003|Overall Study|Death|2|||
130896798|NCT01761240|471257200|FG004|Overall Study|Death|1|||
130896799|NCT01761240|471257196|FG000|Overall Study|Non-compliance|0|||
130896800|NCT01761240|471257197|FG001|Overall Study|Non-compliance|0|||
130896801|NCT01761240|471257198|FG002|Overall Study|Non-compliance|1|||
130896802|NCT01761240|471257199|FG003|Overall Study|Non-compliance|0|||
130896803|NCT01761240|471257200|FG004|Overall Study|Non-compliance|0|||
130896804|NCT00509145|471257201|FG000|Overall Study|Death|0|||
130896805|NCT00509145|471257202|FG001|Overall Study|Death|2|||
130896806|NCT00509145|471257201|FG000|Overall Study|Adverse Event|42|||
130767800|NCT02636699|470773870|FG000|Treatment and Follow-up Periods|Other|3|||
130767801|NCT02636699|470773871|FG001|Treatment and Follow-up Periods|Other|1|||
130767802|NCT02636699|470773872|FG002|Treatment and Follow-up Periods|Other|0|||
130767803|NCT00981058|470773875|FG000|Overall Study|Progressive Disease|38|||
130767804|NCT00981058|470773876|FG001|Overall Study|Progressive Disease|31|||
130767805|NCT00981058|470773875|FG000|Overall Study|Lost to Follow-up|3|||
130896807|NCT00509145|471257202|FG001|Overall Study|Adverse Event|28|||
130896808|NCT00509145|471257201|FG000|Overall Study|Withdrawal by Subject|32|||
130896809|NCT00509145|471257202|FG001|Overall Study|Withdrawal by Subject|38|||
130896810|NCT00509145|471257201|FG000|Overall Study|Physician Decision|11|||
130896811|NCT00509145|471257202|FG001|Overall Study|Physician Decision|14|||
130896812|NCT00509145|471257201|FG000|Overall Study|Protocol Violation|1|||
130896813|NCT00509145|471257202|FG001|Overall Study|Protocol Violation|6|||
130896814|NCT00509145|471257201|FG000|Overall Study|Pregnancy|3|||
130896815|NCT00509145|471257202|FG001|Overall Study|Pregnancy|8|||
130896816|NCT00509145|471257201|FG000|Overall Study|Lost to Follow-up|6|||
130896817|NCT00509145|471257202|FG001|Overall Study|Lost to Follow-up|5|||
130896818|NCT00509145|471257201|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
130896819|NCT00509145|471257202|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
130896820|NCT00509145|471257201|FG000|Overall Study|Other|6|||
130896821|NCT00509145|471257202|FG001|Overall Study|Other|6|||
130896822|NCT01994889|471257203|FG000|Overall Study|Adverse Event|5|||
130896823|NCT01994889|471257204|FG001|Overall Study|Adverse Event|12|||
130896824|NCT01994889|471257205|FG002|Overall Study|Adverse Event|11|||
130896825|NCT01994889|471257203|FG000|Overall Study|Cardiac Device Implantation|0|||
130896826|NCT01994889|471257204|FG001|Overall Study|Cardiac Device Implantation|2|||
130896827|NCT01994889|471257205|FG002|Overall Study|Cardiac Device Implantation|0|||
130896828|NCT01994889|471257203|FG000|Overall Study|Organ Transplantation|1|||
130896829|NCT01994889|471257204|FG001|Overall Study|Organ Transplantation|5|||
130896830|NCT01994889|471257205|FG002|Overall Study|Organ Transplantation|5|||
130767806|NCT00981058|470773876|FG001|Overall Study|Lost to Follow-up|2|||
130767807|NCT00981058|470773875|FG000|Overall Study|Physician Decision|4|||
130767808|NCT00981058|470773876|FG001|Overall Study|Physician Decision|5|||
130896831|NCT01994889|471257203|FG000|Overall Study|No longer willing to participate|8|||
130896832|NCT01994889|471257204|FG001|Overall Study|No longer willing to participate|17|||
130896833|NCT01994889|471257205|FG002|Overall Study|No longer willing to participate|37|||
130896834|NCT01994889|471257203|FG000|Overall Study|Lost to Follow-up|0|||
130896835|NCT01994889|471257204|FG001|Overall Study|Lost to Follow-up|1|||
130767809|NCT00981058|470773875|FG000|Overall Study|Randomization Error|0|||
130767810|NCT00981058|470773876|FG001|Overall Study|Randomization Error|1|||
130767811|NCT00981058|470773875|FG000|Overall Study|Withdrawal by Subject|24|||
130767812|NCT00981058|470773876|FG001|Overall Study|Withdrawal by Subject|22|||
130767813|NCT02667587|470773877|FG000|Pre-Treatment|Not reported|1|||
130896836|NCT01994889|471257205|FG002|Overall Study|Lost to Follow-up|0|||
130896837|NCT01994889|471257203|FG000|Overall Study|Protocol Violation|0|||
130896838|NCT01994889|471257204|FG001|Overall Study|Protocol Violation|1|||
130896839|NCT01994889|471257205|FG002|Overall Study|Protocol Violation|1|||
130896840|NCT01994889|471257203|FG000|Overall Study|Death|14|||
130896841|NCT01994889|471257204|FG001|Overall Study|Death|25|||
131025400|NCT00001277|471723252|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
131025401|NCT00001277|471723253|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
130896842|NCT01994889|471257205|FG002|Overall Study|Death|38|||
130896843|NCT03158285|471257208|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
130896844|NCT03158285|471257209|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
130896845|NCT03158285|471257210|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
130896846|NCT03158285|471257208|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
130896847|NCT03158285|471257209|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
130896848|NCT03158285|471257210|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
130896849|NCT03158285|471257208|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
130896850|NCT03158285|471257209|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
130896851|NCT03158285|471257210|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
130896852|NCT03158285|471257208|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130896853|NCT03158285|471257209|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
130896854|NCT03158285|471257210|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130896855|NCT03158285|471257208|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
130896856|NCT03158285|471257209|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
130896857|NCT03158285|471257210|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
130896858|NCT03158285|471257208|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
130896859|NCT03158285|471257209|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
130896860|NCT03158285|471257210|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
130896861|NCT03158285|471257208|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
130896862|NCT03158285|471257209|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
130896863|NCT03158285|471257210|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
130896864|NCT03158285|471257208|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
130896865|NCT03158285|471257209|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
130896866|NCT03158285|471257210|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
130896867|NCT03158285|471257208|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
130896868|NCT03158285|471257209|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
130896869|NCT03158285|471257210|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
130896870|NCT03158285|471257208|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
130896871|NCT03158285|471257209|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
130896872|NCT03158285|471257210|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
130896873|NCT03158285|471257208|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
130896874|NCT03158285|471257209|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
130896875|NCT03158285|471257210|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
130896876|NCT03158285|471257208|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
130896877|NCT03158285|471257209|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
130896878|NCT03158285|471257210|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
130896879|NCT03158285|471257208|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
130896880|NCT03158285|471257209|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
130896881|NCT03158285|471257210|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
130896882|NCT03158285|471257208|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
130896883|NCT03158285|471257209|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
130896884|NCT03158285|471257210|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
130896885|NCT03158285|471257208|FG000|Active Treatment Period: Week 52-100|Death|1|||
130896886|NCT03158285|471257209|FG001|Active Treatment Period: Week 52-100|Death|0|||
130896887|NCT03158285|471257210|FG002|Active Treatment Period: Week 52-100|Death|0|||
130896888|NCT03158285|471257208|FG000|Active Treatment Period: Week 52-100|Other|4|||
130896889|NCT03158285|471257209|FG001|Active Treatment Period: Week 52-100|Other|1|||
130896890|NCT03158285|471257210|FG002|Active Treatment Period: Week 52-100|Other|0|||
130896891|NCT01642615|471257211|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
130896892|NCT01642615|471257212|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130896893|NCT01642615|471257213|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130896894|NCT01642615|471257211|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
130896895|NCT01642615|471257212|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
130767814|NCT02667587|470773878|FG001|Pre-Treatment|Not reported|0|||
130767815|NCT02667587|470773877|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
130767816|NCT02667587|470773878|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
130767817|NCT02667587|470773877|FG000|Pre-Treatment|Participant withdrew consent|0|||
130767818|NCT02667587|470773878|FG001|Pre-Treatment|Participant withdrew consent|1|||
130767819|NCT02667587|470773877|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
130767820|NCT02667587|470773878|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
130767821|NCT02667587|470773877|FG000|End of Treatment|Disease Progression|193|||
130767822|NCT02667587|470773878|FG001|End of Treatment|Disease Progression|226|||
131222714|NCT01959230|472443164|FG001|Overall Study|Withdrawal by Subject|0|||
130896896|NCT01642615|471257213|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
130896897|NCT01642615|471257211|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
130896898|NCT01642615|471257212|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
131222715|NCT01453374|472443165|FG000|Overall Study|Adverse Event|7|||
131222716|NCT01453374|472443165|FG000|Overall Study|Lack of Efficacy|1|||
130767823|NCT02667587|470773877|FG000|End of Treatment|Study Drug Toxicity|75|||
130896899|NCT01642615|471257213|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
130896900|NCT01642615|471257211|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
130896901|NCT01642615|471257212|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
130896902|NCT01642615|471257213|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
130896903|NCT01642615|471257211|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
130896904|NCT01642615|471257212|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
130896905|NCT01642615|471257213|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
130896906|NCT01642615|471257211|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
130896907|NCT01642615|471257212|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
130896908|NCT01642615|471257213|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
130896909|NCT01642615|471257211|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
130896910|NCT01642615|471257212|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
130896911|NCT01642615|471257213|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
130896912|NCT01642615|471257211|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130896913|NCT01642615|471257212|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
130896914|NCT01642615|471257213|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130896915|NCT01642615|471257211|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
130896916|NCT01642615|471257212|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
130896917|NCT01642615|471257213|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
130896918|NCT00750152|471257214|FG000|Overall Study|Adverse Event|2|||
130896919|NCT00750152|471257215|FG001|Overall Study|Adverse Event|1|||
130896920|NCT00750152|471257214|FG000|Overall Study|Lost to Follow-up|8|||
130896921|NCT00750152|471257215|FG001|Overall Study|Lost to Follow-up|13|||
130896922|NCT00750152|471257214|FG000|Overall Study|Withdrawal by Subject|3|||
130896923|NCT00750152|471257215|FG001|Overall Study|Withdrawal by Subject|3|||
130896924|NCT00750152|471257214|FG000|Overall Study|Physician Decision|1|||
130896925|NCT00750152|471257215|FG001|Overall Study|Physician Decision|1|||
130896926|NCT00750152|471257214|FG000|Overall Study|Non-compliance|0|||
130896927|NCT00750152|471257215|FG001|Overall Study|Non-compliance|1|||
130896928|NCT00750152|471257214|FG000|Overall Study|Termination by sponsor|1|||
130896929|NCT00750152|471257215|FG001|Overall Study|Termination by sponsor|0|||
130896930|NCT00750152|471257214|FG000|Overall Study|Other|7|||
130896931|NCT00750152|471257215|FG001|Overall Study|Other|8|||
130896932|NCT01028300|471257218|FG000|Overall Study|Study Terminated|4|||
130896933|NCT01214395|471257221|FG000|Overall Study|All patients had infection|5|||
130896934|NCT00715910|471257225|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
130896935|NCT00715910|471257226|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
130896936|NCT00715910|471257227|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
130896937|NCT00715910|471257228|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
130896938|NCT00715910|471257229|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
130691019|NCT03100344|470494485|FG003|Overall Study|Protocol Violation|0|||
130691020|NCT03100344|470494482|FG000|Overall Study|Withdrawal by Subject|10|||
130691021|NCT03100344|470494483|FG001|Overall Study|Withdrawal by Subject|7|||
130691022|NCT03100344|470494484|FG002|Overall Study|Withdrawal by Subject|4|||
130691023|NCT03100344|470494485|FG003|Overall Study|Withdrawal by Subject|8|||
130691024|NCT03100344|470494482|FG000|Overall Study|Lost to Follow-up|1|||
130691025|NCT03100344|470494483|FG001|Overall Study|Lost to Follow-up|1|||
130691026|NCT03100344|470494484|FG002|Overall Study|Lost to Follow-up|1|||
130691027|NCT03100344|470494485|FG003|Overall Study|Lost to Follow-up|1|||
130691028|NCT04633564|470494486|FG000|Period 1|Adverse Event|28|||
130896939|NCT00715910|471257230|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
130896940|NCT00715910|471257225|FG000|Booster and ESFU Phase|Other|0|||
130896941|NCT00715910|471257226|FG001|Booster and ESFU Phase|Other|0|||
130767824|NCT02667587|470773878|FG001|End of Treatment|Study Drug Toxicity|19|||
130767825|NCT02667587|470773877|FG000|End of Treatment|Death|2|||
130767826|NCT02667587|470773878|FG001|End of Treatment|Death|1|||
130767827|NCT02667587|470773877|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
130767828|NCT02667587|470773878|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
130767829|NCT02667587|470773877|FG000|End of Treatment|participant request to discontinue treatment|33|||
130767830|NCT02667587|470773878|FG001|End of Treatment|participant request to discontinue treatment|35|||
130767831|NCT02667587|470773877|FG000|End of Treatment|participant withdrew consent|5|||
130767832|NCT02667587|470773878|FG001|End of Treatment|participant withdrew consent|6|||
130767833|NCT02667587|470773877|FG000|End of Treatment|Lost to Follow-up|1|||
130767834|NCT02667587|470773878|FG001|End of Treatment|Lost to Follow-up|2|||
130767835|NCT02667587|470773877|FG000|End of Treatment|maximum clinical benefit|4|||
130767836|NCT02667587|470773878|FG001|End of Treatment|maximum clinical benefit|4|||
130767837|NCT02667587|470773877|FG000|End of Treatment|poor or non compliant|0|||
130896942|NCT00715910|471257227|FG002|Booster and ESFU Phase|Other|0|||
130896943|NCT00715910|471257228|FG003|Booster and ESFU Phase|Other|5|||
130896944|NCT00715910|471257229|FG004|Booster and ESFU Phase|Other|1|||
130896945|NCT00715910|471257230|FG005|Booster and ESFU Phase|Other|0|||
130691029|NCT04633564|470494487|FG001|Period 1|Adverse Event|19|||
130691030|NCT04633564|470494486|FG000|Period 1|Death|8|||
130691031|NCT04633564|470494487|FG001|Period 1|Death|7|||
130896946|NCT02034409|471257231|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
130896947|NCT02034409|471257232|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
130896948|NCT02034409|471257231|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
130896949|NCT02034409|471257232|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
130896950|NCT02034409|471257231|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
130896951|NCT02034409|471257232|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
130896952|NCT02034409|471257231|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
130896953|NCT02034409|471257232|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
130896954|NCT02034409|471257231|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
130896955|NCT02034409|471257232|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
130896956|NCT02034409|471257231|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
130896957|NCT02034409|471257232|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
130896958|NCT01030666|471257233|FG000|Overall Study|Lost to Follow-up|3|||
130896959|NCT01030666|471257234|FG001|Overall Study|Lost to Follow-up|2|||
130896960|NCT01699867|471257235|FG000|Overall Study|Screening Failure|3|||
130896961|NCT00006289|471257236|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
130896962|NCT00006289|471257237|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
130896963|NCT00006289|471257236|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
130896964|NCT00006289|471257237|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
130896965|NCT03703297|471257240|FG000|Overall Study|Death|115|||
130896966|NCT03703297|471257241|FG001|Overall Study|Death|0|||
130896967|NCT03703297|471257242|FG002|Overall Study|Death|144|||
130896968|NCT03703297|471257240|FG000|Overall Study|Withdrawal by Subject|9|||
130896969|NCT03703297|471257241|FG001|Overall Study|Withdrawal by Subject|0|||
130896970|NCT03703297|471257242|FG002|Overall Study|Withdrawal by Subject|11|||
130896971|NCT03703297|471257240|FG000|Overall Study|Ongoing at the time of DCO|140|||
130896972|NCT03703297|471257241|FG001|Overall Study|Ongoing at the time of DCO|200|||
130896973|NCT03703297|471257242|FG002|Overall Study|Ongoing at the time of DCO|111|||
130896974|NCT02156271|471260063|FG000|Overall Study|Physician Decision|4|||
130896975|NCT02156271|471260064|FG001|Overall Study|Physician Decision|3|||
130896976|NCT03320824|471260065|FG000|Overall Study|Withdrawal by Subject|8|||
130896977|NCT03320824|471260066|FG001|Overall Study|Withdrawal by Subject|1|||
130896978|NCT03320824|471260065|FG000|Overall Study|Lost to Follow-up|10|||
130896979|NCT03320824|471260066|FG001|Overall Study|Lost to Follow-up|1|||
130896980|NCT03320824|471260065|FG000|Overall Study|moved out of state|0|||
130896981|NCT03320824|471260066|FG001|Overall Study|moved out of state|1|||
130896982|NCT03320824|471260065|FG000|Overall Study|could not complete final visit|0|||
130896983|NCT03320824|471260066|FG001|Overall Study|could not complete final visit|1|||
130896984|NCT03387111|471260067|FG000|Overall Study|Progressive Disease|3|||
130896985|NCT03387111|471260067|FG000|Overall Study|Other|1|||
130896986|NCT02617485|471260074|FG000|Treatment and Observation Period|Adverse Event|9|||
130896987|NCT02617485|471260075|FG001|Treatment and Observation Period|Adverse Event|1|||
130896988|NCT02617485|471260074|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
130896989|NCT02617485|471260075|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
130896990|NCT02617485|471260074|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
130896991|NCT02617485|471260075|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
130896992|NCT02617485|471260074|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
130896993|NCT02617485|471260075|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
130896994|NCT02617485|471260074|FG000|Treatment and Observation Period|Physician Decision|0|||
130896995|NCT02617485|471260075|FG001|Treatment and Observation Period|Physician Decision|1|||
130896996|NCT02617485|471260074|FG000|Follow-up Period|Adverse Event|1|||
130896997|NCT02617485|471260075|FG001|Follow-up Period|Adverse Event|0|||
130691032|NCT04633564|470494486|FG000|Period 1|Lost to Follow-up|3|||
130691033|NCT04633564|470494487|FG001|Period 1|Lost to Follow-up|5|||
130691034|NCT04633564|470494486|FG000|Period 1|Physician Decision|4|||
130691035|NCT04633564|470494487|FG001|Period 1|Physician Decision|12|||
130691036|NCT04633564|470494486|FG000|Period 1|Protocol Violation|0|||
130896998|NCT02617485|471260074|FG000|Follow-up Period|Withdrawal by Subject|1|||
130896999|NCT02617485|471260075|FG001|Follow-up Period|Withdrawal by Subject|0|||
130897000|NCT02617485|471260074|FG000|Follow-up Period|Disease progression|2|||
130897001|NCT02617485|471260075|FG001|Follow-up Period|Disease progression|1|||
130897002|NCT02617485|471260074|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
130897003|NCT02617485|471260075|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
130897004|NCT02617485|471260074|FG000|Follow-up Period|Patient needed radiotherapy|9|||
130897005|NCT02617485|471260075|FG001|Follow-up Period|Patient needed radiotherapy|5|||
130897006|NCT02617485|471260074|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
131025402|NCT03101371|471723256|FG000|Overall Study|Physician Decision|0|||
131025403|NCT03101371|471723257|FG001|Overall Study|Physician Decision|1|||
131025404|NCT03101371|471723256|FG000|Overall Study|Lost to Follow-up|1|||
131025405|NCT03101371|471723257|FG001|Overall Study|Lost to Follow-up|4|||
131025406|NCT03101371|471723256|FG000|Overall Study|Did not meet eligibility criteria|2|||
131025407|NCT03101371|471723257|FG001|Overall Study|Did not meet eligibility criteria|1|||
131025408|NCT04019444|471723259|FG000|Overall Study|Withdrawal by Subject|0|||
130897007|NCT02617485|471260075|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
130897008|NCT04590248|471260077|FG000|Overall Study|Lost to Follow-up|1|||
130897009|NCT04590248|471260077|FG000|Overall Study|Withdrawal by Subject|16|||
130897010|NCT04590248|471260077|FG000|Overall Study|Other|2|||
130897011|NCT00615901|471260078|FG000|Overall Study|Withdrawal by Subject|2|||
130897012|NCT00615901|471260078|FG000|Overall Study|Adverse Event|7|||
130897013|NCT03598114|471260079|FG000|Overall Study|Staff turnover/left the program|3|||
130897014|NCT03598114|471260080|FG001|Overall Study|Staff turnover/left the program|39|||
130897015|NCT02527200|471260081|FG000|Overall Study|Withdrawal by Subject|3|||
130897016|NCT02527200|471260082|FG001|Overall Study|Withdrawal by Subject|2|||
130897017|NCT02527200|471260083|FG002|Overall Study|Withdrawal by Subject|1|||
130897018|NCT02527200|471260084|FG003|Overall Study|Withdrawal by Subject|0|||
130897019|NCT02527200|471260081|FG000|Overall Study|Unclassified|0|||
130897020|NCT02527200|471260082|FG001|Overall Study|Unclassified|1|||
130897021|NCT02527200|471260083|FG002|Overall Study|Unclassified|0|||
130897022|NCT02527200|471260084|FG003|Overall Study|Unclassified|0|||
130897023|NCT02527200|471260081|FG000|Overall Study|Lost to Follow-up|0|||
130897024|NCT02527200|471260082|FG001|Overall Study|Lost to Follow-up|0|||
130897025|NCT02527200|471260083|FG002|Overall Study|Lost to Follow-up|1|||
130897026|NCT02527200|471260084|FG003|Overall Study|Lost to Follow-up|0|||
130897027|NCT04250077|471260088|FG000|Overall Study|Withdrawal by Subject|0|||
130897028|NCT04250077|471260089|FG001|Overall Study|Withdrawal by Subject|1|||
130897029|NCT04250077|471260090|FG002|Overall Study|Withdrawal by Subject|0|||
130897030|NCT04250077|471260088|FG000|Overall Study|Lost to Follow-up|2|||
130897031|NCT04250077|471260089|FG001|Overall Study|Lost to Follow-up|3|||
130897032|NCT04250077|471260090|FG002|Overall Study|Lost to Follow-up|0|||
130897033|NCT01022398|471260091|FG000|Overall Study|Study terminated|2|||
130897034|NCT01022398|471260092|FG001|Overall Study|Study terminated|2|||
130897035|NCT03319745|471260094|FG000|Overall Study|Death|1|||
130897036|NCT03319745|471260094|FG000|Overall Study|Toxicity Precluding Surgery|1|||
130897037|NCT01120782|471260095|FG000|Overall Study|Test article shipping error|11|||
130897038|NCT00640224|471260096|FG000|Overall Study|Lost to Follow-up|5|||
130897039|NCT00640224|471260097|FG001|Overall Study|Lost to Follow-up|2|||
130897040|NCT00640224|471260098|FG002|Overall Study|Lost to Follow-up|0|||
130897041|NCT00640224|471260099|FG003|Overall Study|Lost to Follow-up|0|||
130691037|NCT04633564|470494487|FG001|Period 1|Protocol Violation|1|||
130691038|NCT04633564|470494486|FG000|Period 1|Withdrawal by Subject|10|||
130691039|NCT04633564|470494487|FG001|Period 1|Withdrawal by Subject|8|||
130691040|NCT04633564|470494486|FG000|Period 1|Progressive disease|47|||
130691041|NCT04633564|470494487|FG001|Period 1|Progressive disease|51|||
130691042|NCT04633564|470494486|FG000|Period 1|Terminated by Sponsor|8|||
130691043|NCT04633564|470494487|FG001|Period 1|Terminated by Sponsor|6|||
130691044|NCT04633564|470494486|FG000|Period 2|Adverse Event|3|||
130691045|NCT04633564|470494487|FG001|Period 2|Adverse Event|4|||
130691046|NCT04633564|470494486|FG000|Period 2|Death|0|||
130691047|NCT04633564|470494487|FG001|Period 2|Death|2|||
130691048|NCT04633564|470494486|FG000|Period 2|Lost to Follow-up|0|||
130691049|NCT04633564|470494487|FG001|Period 2|Lost to Follow-up|1|||
130691050|NCT04633564|470494486|FG000|Period 2|Physician Decision|2|||
130691051|NCT04633564|470494487|FG001|Period 2|Physician Decision|4|||
130691052|NCT04633564|470494486|FG000|Period 2|Withdrawal by Subject|5|||
130691053|NCT04633564|470494487|FG001|Period 2|Withdrawal by Subject|1|||
130691054|NCT04633564|470494486|FG000|Period 2|Progressive Disease|74|||
130767838|NCT02667587|470773878|FG001|End of Treatment|poor or non compliant|1|||
130767839|NCT02667587|470773877|FG000|End of Treatment|participant no longer meets study criteria|1|||
130767840|NCT02667587|470773878|FG001|End of Treatment|participant no longer meets study criteria|1|||
130767841|NCT02667587|470773877|FG000|End of Treatment|administrative reason by sponsor|1|||
130767842|NCT02667587|470773878|FG001|End of Treatment|administrative reason by sponsor|29|||
130767843|NCT02667587|470773877|FG000|End of Treatment|other reasonse|21|||
130767844|NCT02667587|470773878|FG001|End of Treatment|other reasonse|10|||
130767845|NCT02305446|470773885|FG000|Overall Study|Adverse Event|1|||
130767846|NCT01636947|470773886|FG000|Overall Study|Not Treated|2|||
130767847|NCT01636947|470773887|FG001|Overall Study|Not Treated|2|||
130767848|NCT01636947|470773886|FG000|Overall Study|Lost to Follow-up|4|||
130767849|NCT01636947|470773887|FG001|Overall Study|Lost to Follow-up|0|||
130767850|NCT01636947|470773886|FG000|Overall Study|Protocol Violation|1|||
130767851|NCT01636947|470773887|FG001|Overall Study|Protocol Violation|1|||
130897042|NCT00640224|471260096|FG000|Overall Study|Withdrawal by Subject|1|||
130897043|NCT00640224|471260097|FG001|Overall Study|Withdrawal by Subject|0|||
130897044|NCT00640224|471260098|FG002|Overall Study|Withdrawal by Subject|0|||
130897045|NCT00640224|471260099|FG003|Overall Study|Withdrawal by Subject|0|||
130897046|NCT00640224|471260096|FG000|Overall Study|Headaches|0|||
130897047|NCT00640224|471260097|FG001|Overall Study|Headaches|1|||
130897048|NCT00640224|471260098|FG002|Overall Study|Headaches|0|||
130897049|NCT00640224|471260099|FG003|Overall Study|Headaches|0|||
130897050|NCT02937584|471260104|FG000|Period 1|Adverse Event|1|||
130897051|NCT02937584|471260105|FG001|Period 1|Adverse Event|2|||
130897052|NCT02937584|471260104|FG000|Washout|Adverse Event|0|||
130897053|NCT02937584|471260105|FG001|Washout|Adverse Event|1|||
130897054|NCT04075734|471260114|FG000|Overall Study|Lost to Follow-up|1|||
130897055|NCT04075734|471260115|FG001|Overall Study|Lost to Follow-up|1|||
130897056|NCT04075734|471260116|FG002|Overall Study|Lost to Follow-up|0|||
130897057|NCT04075734|471260114|FG000|Overall Study|Withdrawal by Subject|3|||
130897058|NCT04075734|471260115|FG001|Overall Study|Withdrawal by Subject|0|||
130897059|NCT04075734|471260116|FG002|Overall Study|Withdrawal by Subject|0|||
130897060|NCT01776307|471260117|FG000|Overall Study|Not dosed|0|||
130897061|NCT01776307|471260118|FG001|Overall Study|Not dosed|0|||
130897062|NCT01776307|471260119|FG002|Overall Study|Not dosed|1|||
130897063|NCT03615040|471260120|FG000|Overall Study|Withdrawal by Subject|2|||
130897064|NCT03615040|471260121|FG001|Overall Study|Withdrawal by Subject|1|||
130897065|NCT03615040|471260120|FG000|Overall Study|Physician Decision|2|||
130897066|NCT03615040|471260121|FG001|Overall Study|Physician Decision|2|||
130897067|NCT03615040|471260120|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
130897068|NCT03615040|471260121|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
130897069|NCT03615040|471260120|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
130897070|NCT03615040|471260121|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
130897071|NCT03615040|471260120|FG000|Overall Study|Death|0|||
130897072|NCT03615040|471260121|FG001|Overall Study|Death|2|||
130897073|NCT04074161|471260124|FG000|Overall Study|Withdrawal by Subject|2|||
130897074|NCT04074161|471260125|FG001|Overall Study|Withdrawal by Subject|4|||
130897075|NCT04074161|471260126|FG002|Overall Study|Withdrawal by Subject|1|||
130897076|NCT04074161|471260124|FG000|Overall Study|Lost to Follow-up|4|||
130897077|NCT04074161|471260125|FG001|Overall Study|Lost to Follow-up|5|||
130897078|NCT04074161|471260126|FG002|Overall Study|Lost to Follow-up|3|||
130897079|NCT03890666|471260138|FG000|Overall Study|Withdrawal by Subject|0|||
130897080|NCT03890666|471260139|FG001|Overall Study|Withdrawal by Subject|1|||
130897081|NCT03890666|471260138|FG000|Overall Study|Protocol deviation|1|||
130897082|NCT03890666|471260139|FG001|Overall Study|Protocol deviation|4|||
130897083|NCT03890666|471260138|FG000|Overall Study|Lost to Follow-up|2|||
130897084|NCT03890666|471260139|FG001|Overall Study|Lost to Follow-up|5|||
130897085|NCT03890666|471260138|FG000|Overall Study|Other than specified|1|||
130897086|NCT03890666|471260139|FG001|Overall Study|Other than specified|8|||
130897087|NCT03232333|471260140|FG000|Overall Study|Infection or Osteomyelitis|9|||
130897088|NCT03232333|471260140|FG000|Overall Study|Lost to Follow-up|4|||
130897089|NCT03232333|471260140|FG000|Overall Study|Withdrawal by Subject|2|||
130897090|NCT03052426|471260141|FG000|Overall Study|Withdrawal by Subject|0|||
130897091|NCT03052426|471260142|FG001|Overall Study|Withdrawal by Subject|1|||
130897092|NCT03052426|471260143|FG002|Overall Study|Withdrawal by Subject|0|||
130897093|NCT03052426|471260141|FG000|Overall Study|Lost to Follow-up|2|||
130897094|NCT03052426|471260142|FG001|Overall Study|Lost to Follow-up|0|||
130897095|NCT03052426|471260143|FG002|Overall Study|Lost to Follow-up|1|||
130897096|NCT01853839|471260145|FG000|Overall Study|Violated inclusion criteria|2|||
130897097|NCT01853839|471260145|FG000|Overall Study|Not meet ITT population definition|58|||
130897098|NCT01853839|471260145|FG000|Overall Study|End of treatment visit too early|33|||
130897099|NCT01853839|471260145|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
130897100|NCT04145219|471260146|FG000|Overall Study|Adverse Event|18|||
130897101|NCT04145219|471260147|FG001|Overall Study|Adverse Event|6|||
130897102|NCT04145219|471260146|FG000|Overall Study|Lost to Follow-up|2|||
130897103|NCT04145219|471260147|FG001|Overall Study|Lost to Follow-up|3|||
130897104|NCT04145219|471260146|FG000|Overall Study|Physician Decision|0|||
130897105|NCT04145219|471260147|FG001|Overall Study|Physician Decision|2|||
130897106|NCT04145219|471260146|FG000|Overall Study|Withdrawal by Subject|12|||
130897107|NCT04145219|471260147|FG001|Overall Study|Withdrawal by Subject|8|||
130897108|NCT04145219|471260146|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
130767852|NCT01636947|470773886|FG000|Overall Study|Withdrawal by Subject|3|||
130767853|NCT01636947|470773887|FG001|Overall Study|Withdrawal by Subject|3|||
130767854|NCT01636947|470773886|FG000|Overall Study|Adverse Event|1|||
130767855|NCT01636947|470773887|FG001|Overall Study|Adverse Event|1|||
130897109|NCT04145219|471260147|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
130897110|NCT02059291|471260148|FG000|Epoch 2|Lack of Efficacy|0|||
130897111|NCT02059291|471260149|FG001|Epoch 2|Lack of Efficacy|0|||
130897112|NCT02059291|471260150|FG002|Epoch 2|Lack of Efficacy|0|||
130897113|NCT02059291|471260151|FG003|Epoch 2|Lack of Efficacy|1|||
130897114|NCT02059291|471260152|FG004|Epoch 2|Lack of Efficacy|0|||
130897115|NCT02059291|471260153|FG005|Epoch 2|Lack of Efficacy|1|||
130897116|NCT02059291|471260154|FG006|Epoch 2|Lack of Efficacy|0|||
130897117|NCT02059291|471260155|FG007|Epoch 2|Lack of Efficacy|0|||
130897118|NCT02059291|471260156|FG008|Epoch 2|Lack of Efficacy|0|||
130897119|NCT02059291|471260157|FG009|Epoch 2|Lack of Efficacy|0|||
130897120|NCT02059291|471260158|FG010|Epoch 2|Lack of Efficacy|0|||
130897121|NCT02059291|471260159|FG011|Epoch 2|Lack of Efficacy|0|||
130897122|NCT02059291|471260160|FG012|Epoch 2|Lack of Efficacy|0|||
130897123|NCT02059291|471260161|FG013|Epoch 2|Lack of Efficacy|0|||
130897124|NCT02059291|471260162|FG014|Epoch 2|Lack of Efficacy|0|||
130897125|NCT02059291|471260163|FG015|Epoch 2|Lack of Efficacy|0|||
130897126|NCT02059291|471260164|FG016|Epoch 2|Lack of Efficacy|0|||
130897127|NCT02059291|471260165|FG017|Epoch 2|Lack of Efficacy|0|||
130897128|NCT02059291|471260166|FG018|Epoch 2|Lack of Efficacy|0|||
130897129|NCT02059291|471260167|FG019|Epoch 2|Lack of Efficacy|0|||
130897130|NCT02059291|471260168|FG020|Epoch 2|Lack of Efficacy|0|||
130897131|NCT02059291|471260169|FG021|Epoch 2|Lack of Efficacy|0|||
130897132|NCT02059291|471260170|FG022|Epoch 2|Lack of Efficacy|0|||
130897133|NCT02059291|471260171|FG023|Epoch 2|Lack of Efficacy|0|||
130897134|NCT02059291|471260172|FG024|Epoch 2|Lack of Efficacy|0|||
130897135|NCT02059291|471260148|FG000|Epoch 2|Adverse Event|0|||
130897136|NCT02059291|471260149|FG001|Epoch 2|Adverse Event|0|||
130897137|NCT02059291|471260150|FG002|Epoch 2|Adverse Event|1|||
130897138|NCT02059291|471260151|FG003|Epoch 2|Adverse Event|1|||
130897139|NCT02059291|471260152|FG004|Epoch 2|Adverse Event|0|||
130897140|NCT02059291|471260153|FG005|Epoch 2|Adverse Event|0|||
130897141|NCT02059291|471260154|FG006|Epoch 2|Adverse Event|0|||
130897142|NCT02059291|471260155|FG007|Epoch 2|Adverse Event|1|||
130897143|NCT02059291|471260156|FG008|Epoch 2|Adverse Event|1|||
130897144|NCT02059291|471260157|FG009|Epoch 2|Adverse Event|0|||
130897145|NCT02059291|471260158|FG010|Epoch 2|Adverse Event|0|||
130897146|NCT02059291|471260159|FG011|Epoch 2|Adverse Event|0|||
130897147|NCT02059291|471260160|FG012|Epoch 2|Adverse Event|0|||
130897148|NCT02059291|471260161|FG013|Epoch 2|Adverse Event|0|||
130897149|NCT02059291|471260162|FG014|Epoch 2|Adverse Event|0|||
130897150|NCT02059291|471260163|FG015|Epoch 2|Adverse Event|0|||
130897151|NCT02059291|471260164|FG016|Epoch 2|Adverse Event|0|||
130897152|NCT02059291|471260165|FG017|Epoch 2|Adverse Event|0|||
130897153|NCT02059291|471260166|FG018|Epoch 2|Adverse Event|0|||
130897154|NCT02059291|471260167|FG019|Epoch 2|Adverse Event|0|||
130897155|NCT02059291|471260168|FG020|Epoch 2|Adverse Event|0|||
130897156|NCT02059291|471260169|FG021|Epoch 2|Adverse Event|0|||
130897157|NCT02059291|471260170|FG022|Epoch 2|Adverse Event|0|||
130897158|NCT02059291|471260171|FG023|Epoch 2|Adverse Event|0|||
130897159|NCT02059291|471260172|FG024|Epoch 2|Adverse Event|0|||
130897160|NCT02059291|471260148|FG000|Epoch 2|Withdrawal by Subject|0|||
130897161|NCT02059291|471260149|FG001|Epoch 2|Withdrawal by Subject|1|||
130897162|NCT02059291|471260150|FG002|Epoch 2|Withdrawal by Subject|0|||
130897163|NCT02059291|471260151|FG003|Epoch 2|Withdrawal by Subject|0|||
130897164|NCT02059291|471260152|FG004|Epoch 2|Withdrawal by Subject|0|||
130897165|NCT02059291|471260153|FG005|Epoch 2|Withdrawal by Subject|1|||
131112000|NCT04796896|472040972|FG001|Overall Study|Other Than Specified|5|||
131112001|NCT04796896|472040973|FG002|Overall Study|Other Than Specified|3|||
131112002|NCT04796896|472040974|FG003|Overall Study|Other Than Specified|2|||
131112003|NCT04796896|472040975|FG004|Overall Study|Other Than Specified|6|||
131112004|NCT04796896|472040976|FG005|Overall Study|Other Than Specified|31|||
131112005|NCT04796896|472040977|FG006|Overall Study|Other Than Specified|86|||
131112006|NCT04796896|472040978|FG007|Overall Study|Other Than Specified|66|||
131112007|NCT04796896|472040979|FG008|Overall Study|Other Than Specified|388|||
131112008|NCT04796896|472040980|FG009|Overall Study|Other Than Specified|48|||
131112009|NCT04796896|472040981|FG010|Overall Study|Other Than Specified|258|||
131112010|NCT04796896|472040982|FG011|Overall Study|Other Than Specified|4|||
131112011|NCT04796896|472040971|FG000|Overall Study|Protocol Deviation|0|||
131112012|NCT04796896|472040972|FG001|Overall Study|Protocol Deviation|0|||
131112013|NCT04796896|472040973|FG002|Overall Study|Protocol Deviation|0|||
131112014|NCT04796896|472040974|FG003|Overall Study|Protocol Deviation|1|||
131112015|NCT04796896|472040975|FG004|Overall Study|Protocol Deviation|1|||
131112016|NCT04796896|472040976|FG005|Overall Study|Protocol Deviation|2|||
131112017|NCT04796896|472040977|FG006|Overall Study|Protocol Deviation|2|||
131112018|NCT04796896|472040978|FG007|Overall Study|Protocol Deviation|2|||
131112019|NCT04796896|472040979|FG008|Overall Study|Protocol Deviation|2|||
131112020|NCT04796896|472040980|FG009|Overall Study|Protocol Deviation|1|||
131112021|NCT04796896|472040981|FG010|Overall Study|Protocol Deviation|0|||
131112022|NCT04796896|472040982|FG011|Overall Study|Protocol Deviation|0|||
131112023|NCT04796896|472040971|FG000|Overall Study|Missing|0|||
131112024|NCT04796896|472040972|FG001|Overall Study|Missing|0|||
130767856|NCT01636947|470773886|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
130767857|NCT01636947|470773887|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
131112025|NCT04796896|472040973|FG002|Overall Study|Missing|0|||
131112026|NCT04796896|472040974|FG003|Overall Study|Missing|0|||
131112027|NCT04796896|472040975|FG004|Overall Study|Missing|0|||
130767858|NCT00957424|470773888|FG000|Overall Study|Lost to Follow-up|19|||
130897166|NCT02059291|471260154|FG006|Epoch 2|Withdrawal by Subject|0|||
130897167|NCT02059291|471260155|FG007|Epoch 2|Withdrawal by Subject|0|||
130897168|NCT02059291|471260156|FG008|Epoch 2|Withdrawal by Subject|1|||
130897169|NCT02059291|471260157|FG009|Epoch 2|Withdrawal by Subject|0|||
130897170|NCT02059291|471260158|FG010|Epoch 2|Withdrawal by Subject|0|||
130897171|NCT02059291|471260159|FG011|Epoch 2|Withdrawal by Subject|0|||
130897172|NCT02059291|471260160|FG012|Epoch 2|Withdrawal by Subject|0|||
130897173|NCT02059291|471260161|FG013|Epoch 2|Withdrawal by Subject|0|||
130897174|NCT02059291|471260162|FG014|Epoch 2|Withdrawal by Subject|0|||
130897175|NCT02059291|471260163|FG015|Epoch 2|Withdrawal by Subject|0|||
130897176|NCT02059291|471260164|FG016|Epoch 2|Withdrawal by Subject|0|||
130897177|NCT02059291|471260165|FG017|Epoch 2|Withdrawal by Subject|0|||
131112028|NCT04796896|472040976|FG005|Overall Study|Missing|0|||
131112029|NCT04796896|472040977|FG006|Overall Study|Missing|2|||
131112030|NCT04796896|472040978|FG007|Overall Study|Missing|1|||
131112031|NCT04796896|472040979|FG008|Overall Study|Missing|2|||
130897178|NCT02059291|471260166|FG018|Epoch 2|Withdrawal by Subject|0|||
130897179|NCT02059291|471260167|FG019|Epoch 2|Withdrawal by Subject|0|||
130897180|NCT02059291|471260168|FG020|Epoch 2|Withdrawal by Subject|0|||
130897181|NCT02059291|471260169|FG021|Epoch 2|Withdrawal by Subject|0|||
130897182|NCT02059291|471260170|FG022|Epoch 2|Withdrawal by Subject|0|||
130897183|NCT02059291|471260171|FG023|Epoch 2|Withdrawal by Subject|0|||
130897184|NCT02059291|471260172|FG024|Epoch 2|Withdrawal by Subject|0|||
130897185|NCT02059291|471260148|FG000|Epoch 3|Physician Decision|0|||
130897186|NCT02059291|471260149|FG001|Epoch 3|Physician Decision|0|||
130897187|NCT02059291|471260150|FG002|Epoch 3|Physician Decision|0|||
130897188|NCT02059291|471260151|FG003|Epoch 3|Physician Decision|0|||
130897189|NCT02059291|471260152|FG004|Epoch 3|Physician Decision|0|||
130897190|NCT02059291|471260153|FG005|Epoch 3|Physician Decision|0|||
130897191|NCT02059291|471260154|FG006|Epoch 3|Physician Decision|0|||
130897192|NCT02059291|471260155|FG007|Epoch 3|Physician Decision|0|||
130897193|NCT02059291|471260156|FG008|Epoch 3|Physician Decision|0|||
130897194|NCT02059291|471260157|FG009|Epoch 3|Physician Decision|0|||
130897195|NCT02059291|471260158|FG010|Epoch 3|Physician Decision|0|||
130897196|NCT02059291|471260159|FG011|Epoch 3|Physician Decision|0|||
130897197|NCT02059291|471260160|FG012|Epoch 3|Physician Decision|0|||
130897198|NCT02059291|471260161|FG013|Epoch 3|Physician Decision|1|||
130897199|NCT02059291|471260162|FG014|Epoch 3|Physician Decision|0|||
130897200|NCT02059291|471260163|FG015|Epoch 3|Physician Decision|1|||
130897201|NCT02059291|471260164|FG016|Epoch 3|Physician Decision|0|||
130897202|NCT02059291|471260165|FG017|Epoch 3|Physician Decision|0|||
130897203|NCT02059291|471260166|FG018|Epoch 3|Physician Decision|0|||
130897204|NCT02059291|471260167|FG019|Epoch 3|Physician Decision|0|||
130897205|NCT02059291|471260168|FG020|Epoch 3|Physician Decision|0|||
130897206|NCT02059291|471260169|FG021|Epoch 3|Physician Decision|0|||
130897207|NCT02059291|471260170|FG022|Epoch 3|Physician Decision|0|||
130897208|NCT02059291|471260171|FG023|Epoch 3|Physician Decision|0|||
130897209|NCT02059291|471260172|FG024|Epoch 3|Physician Decision|0|||
130897210|NCT02059291|471260148|FG000|Epoch 3|Adverse Event|0|||
130897211|NCT02059291|471260149|FG001|Epoch 3|Adverse Event|0|||
130897212|NCT02059291|471260150|FG002|Epoch 3|Adverse Event|0|||
130897213|NCT02059291|471260151|FG003|Epoch 3|Adverse Event|0|||
130897214|NCT02059291|471260152|FG004|Epoch 3|Adverse Event|0|||
130897215|NCT02059291|471260153|FG005|Epoch 3|Adverse Event|0|||
130897216|NCT02059291|471260154|FG006|Epoch 3|Adverse Event|0|||
130897217|NCT02059291|471260155|FG007|Epoch 3|Adverse Event|0|||
130897218|NCT02059291|471260156|FG008|Epoch 3|Adverse Event|0|||
130897219|NCT02059291|471260157|FG009|Epoch 3|Adverse Event|0|||
130897220|NCT02059291|471260158|FG010|Epoch 3|Adverse Event|0|||
130897221|NCT02059291|471260159|FG011|Epoch 3|Adverse Event|0|||
130897222|NCT02059291|471260160|FG012|Epoch 3|Adverse Event|0|||
130897223|NCT02059291|471260161|FG013|Epoch 3|Adverse Event|0|||
130897224|NCT02059291|471260162|FG014|Epoch 3|Adverse Event|0|||
130897225|NCT02059291|471260163|FG015|Epoch 3|Adverse Event|1|||
130897226|NCT02059291|471260164|FG016|Epoch 3|Adverse Event|0|||
130897227|NCT02059291|471260165|FG017|Epoch 3|Adverse Event|0|||
130897228|NCT02059291|471260166|FG018|Epoch 3|Adverse Event|0|||
130897229|NCT02059291|471260167|FG019|Epoch 3|Adverse Event|0|||
130897230|NCT02059291|471260168|FG020|Epoch 3|Adverse Event|0|||
130897231|NCT02059291|471260169|FG021|Epoch 3|Adverse Event|0|||
130897232|NCT02059291|471260170|FG022|Epoch 3|Adverse Event|0|||
130897233|NCT02059291|471260171|FG023|Epoch 3|Adverse Event|0|||
130897234|NCT02059291|471260172|FG024|Epoch 3|Adverse Event|0|||
130897235|NCT02059291|471260148|FG000|Epoch 3|Lack of Efficacy|0|||
130897236|NCT02059291|471260149|FG001|Epoch 3|Lack of Efficacy|0|||
130691055|NCT04633564|470494487|FG001|Period 2|Progressive Disease|82|||
130691056|NCT04633564|470494486|FG000|Period 2|Terminated by Sponsor|9|||
130691057|NCT04633564|470494487|FG001|Period 2|Terminated by Sponsor|3|||
130691058|NCT01010503|470494488|FG000|Overall Study|Adverse Event|1|||
130691059|NCT01010503|470494488|FG000|Overall Study|Death|1|||
130691060|NCT06999265|470494491|FG000|Overall Study|Lost to Follow-up|1|||
130897237|NCT02059291|471260150|FG002|Epoch 3|Lack of Efficacy|0|||
130897238|NCT02059291|471260151|FG003|Epoch 3|Lack of Efficacy|0|||
130897239|NCT02059291|471260152|FG004|Epoch 3|Lack of Efficacy|0|||
130897240|NCT02059291|471260153|FG005|Epoch 3|Lack of Efficacy|0|||
130897241|NCT02059291|471260154|FG006|Epoch 3|Lack of Efficacy|0|||
130897242|NCT02059291|471260155|FG007|Epoch 3|Lack of Efficacy|0|||
130897243|NCT02059291|471260156|FG008|Epoch 3|Lack of Efficacy|0|||
130897244|NCT02059291|471260157|FG009|Epoch 3|Lack of Efficacy|0|||
130897245|NCT02059291|471260158|FG010|Epoch 3|Lack of Efficacy|0|||
130897246|NCT02059291|471260159|FG011|Epoch 3|Lack of Efficacy|0|||
130897247|NCT02059291|471260160|FG012|Epoch 3|Lack of Efficacy|0|||
130897248|NCT02059291|471260161|FG013|Epoch 3|Lack of Efficacy|0|||
130897249|NCT02059291|471260162|FG014|Epoch 3|Lack of Efficacy|0|||
130897250|NCT02059291|471260163|FG015|Epoch 3|Lack of Efficacy|3|||
130897251|NCT02059291|471260164|FG016|Epoch 3|Lack of Efficacy|0|||
130897252|NCT02059291|471260165|FG017|Epoch 3|Lack of Efficacy|0|||
130897253|NCT02059291|471260166|FG018|Epoch 3|Lack of Efficacy|0|||
130897254|NCT02059291|471260167|FG019|Epoch 3|Lack of Efficacy|0|||
130897255|NCT02059291|471260168|FG020|Epoch 3|Lack of Efficacy|0|||
130897256|NCT02059291|471260169|FG021|Epoch 3|Lack of Efficacy|0|||
130691061|NCT06999265|470494492|FG001|Overall Study|Lost to Follow-up|1|||
130691062|NCT03043872|470494496|FG000|Overall Study|Withdrawal by Subject|6|||
130691063|NCT03043872|470494497|FG001|Overall Study|Withdrawal by Subject|6|||
130691064|NCT03043872|470494498|FG002|Overall Study|Withdrawal by Subject|15|||
130691065|NCT03043872|470494496|FG000|Overall Study|Lost to Follow-up|2|||
130691066|NCT03043872|470494497|FG001|Overall Study|Lost to Follow-up|1|||
130691067|NCT03043872|470494498|FG002|Overall Study|Lost to Follow-up|1|||
130691068|NCT03043872|470494496|FG000|Overall Study|Death|270|||
130691069|NCT03043872|470494497|FG001|Overall Study|Death|269|||
130691070|NCT03043872|470494498|FG002|Overall Study|Death|296|||
130691071|NCT01154231|470494499|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
130691072|NCT01154231|470494499|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
130691073|NCT03114891|470494505|FG000|First Treatment Round|Lost to Follow-up|0|||
130691074|NCT03114891|470494506|FG001|First Treatment Round|Lost to Follow-up|1|||
130691075|NCT03114891|470494507|FG002|First Treatment Round|Lost to Follow-up|1|||
130691076|NCT03114891|470494508|FG003|First Treatment Round|Lost to Follow-up|0|||
130691077|NCT03114891|470494505|FG000|First Treatment Round|Withdrawal by Subject|0|||
130691078|NCT03114891|470494506|FG001|First Treatment Round|Withdrawal by Subject|2|||
130691079|NCT03114891|470494507|FG002|First Treatment Round|Withdrawal by Subject|0|||
130691080|NCT03114891|470494508|FG003|First Treatment Round|Withdrawal by Subject|1|||
130691081|NCT03114891|470494505|FG000|3 Week Break|Lost to Follow-up|1|||
130691082|NCT03114891|470494506|FG001|3 Week Break|Lost to Follow-up|0|||
130691083|NCT03114891|470494507|FG002|3 Week Break|Lost to Follow-up|0|||
130691084|NCT03114891|470494508|FG003|3 Week Break|Lost to Follow-up|1|||
130691085|NCT03114891|470494505|FG000|3 Week Break|Withdrawal by Subject|0|||
131112032|NCT04796896|472040980|FG009|Overall Study|Missing|1|||
130691086|NCT03114891|470494506|FG001|3 Week Break|Withdrawal by Subject|1|||
130691087|NCT03114891|470494507|FG002|3 Week Break|Withdrawal by Subject|0|||
130691088|NCT03114891|470494508|FG003|3 Week Break|Withdrawal by Subject|0|||
130691089|NCT03114891|470494505|FG000|Second Treatment Round|Lost to Follow-up|1|||
130691090|NCT03114891|470494506|FG001|Second Treatment Round|Lost to Follow-up|0|||
130691091|NCT03114891|470494507|FG002|Second Treatment Round|Lost to Follow-up|0|||
130691092|NCT03114891|470494508|FG003|Second Treatment Round|Lost to Follow-up|0|||
130691093|NCT03114891|470494505|FG000|Second Treatment Round|Physician Decision|1|||
130691094|NCT03114891|470494506|FG001|Second Treatment Round|Physician Decision|0|||
130691095|NCT03114891|470494507|FG002|Second Treatment Round|Physician Decision|0|||
130691096|NCT03114891|470494508|FG003|Second Treatment Round|Physician Decision|0|||
131112033|NCT04796896|472040981|FG010|Overall Study|Missing|1|||
131112034|NCT04796896|472040982|FG011|Overall Study|Missing|0|||
131112035|NCT04796896|472040971|FG000|Overall Study|Death|0|||
130691097|NCT00772603|470495816|FG000|Overall Study|Withdrawal by Subject|11|||
130691098|NCT00772603|470495817|FG001|Overall Study|Withdrawal by Subject|10|||
130691099|NCT00772603|470495818|FG002|Overall Study|Withdrawal by Subject|6|||
130691100|NCT00772603|470495816|FG000|Overall Study|Adverse Event|37|||
130691101|NCT00772603|470495817|FG001|Overall Study|Adverse Event|18|||
130691102|NCT00772603|470495818|FG002|Overall Study|Adverse Event|10|||
130691103|NCT00772603|470495816|FG000|Overall Study|Subject Non-compliance|1|||
130691104|NCT00772603|470495817|FG001|Overall Study|Subject Non-compliance|6|||
130691105|NCT00772603|470495818|FG002|Overall Study|Subject Non-compliance|4|||
130691106|NCT00772603|470495816|FG000|Overall Study|Protocol Violation|0|||
130691107|NCT00772603|470495817|FG001|Overall Study|Protocol Violation|1|||
130691108|NCT00772603|470495818|FG002|Overall Study|Protocol Violation|1|||
130691109|NCT00772603|470495816|FG000|Overall Study|Lost to Follow-up|1|||
130691110|NCT00772603|470495817|FG001|Overall Study|Lost to Follow-up|5|||
130691111|NCT00772603|470495818|FG002|Overall Study|Lost to Follow-up|2|||
130691112|NCT00772603|470495816|FG000|Overall Study|Physician Decision|0|||
130691113|NCT00772603|470495817|FG001|Overall Study|Physician Decision|0|||
130691114|NCT00772603|470495818|FG002|Overall Study|Physician Decision|1|||
130691115|NCT00772603|470495816|FG000|Overall Study|Other|2|||
130691116|NCT00772603|470495817|FG001|Overall Study|Other|0|||
130691117|NCT00772603|470495818|FG002|Overall Study|Other|2|||
130691118|NCT01056484|470495821|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
130691119|NCT01056484|470495822|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
130691120|NCT01056484|470495821|FG000|Randomized Controlled Trial|Physician Decision|1|||
130691121|NCT01056484|470495822|FG001|Randomized Controlled Trial|Physician Decision|0|||
130691122|NCT01056484|470495821|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
130691123|NCT01056484|470495822|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
130691124|NCT00446966|470495825|FG000|Overall Study|Lost to Follow-up|10|||
130691125|NCT00446966|470495826|FG001|Overall Study|Lost to Follow-up|7|||
130691126|NCT01564394|470495827|FG000|Overall Study|Withdrawal by Subject|6|||
130691127|NCT01564394|470495828|FG001|Overall Study|Withdrawal by Subject|10|||
130691128|NCT00443651|470495829|FG000|Overall Study|Death|1|||
130691129|NCT00443651|470495830|FG001|Overall Study|Death|5|||
130691130|NCT00443651|470495829|FG000|Overall Study|Adverse Event|5|||
130691131|NCT00443651|470495830|FG001|Overall Study|Adverse Event|6|||
130691132|NCT00443651|470495829|FG000|Overall Study|Lost to Follow-up|18|||
130691133|NCT00443651|470495830|FG001|Overall Study|Lost to Follow-up|12|||
130897257|NCT02059291|471260170|FG022|Epoch 3|Lack of Efficacy|0|||
130897258|NCT02059291|471260171|FG023|Epoch 3|Lack of Efficacy|0|||
130897259|NCT02059291|471260172|FG024|Epoch 3|Lack of Efficacy|0|||
130897260|NCT02059291|471260148|FG000|Epoch 3|Withdrawal by Subject|0|||
130897261|NCT02059291|471260149|FG001|Epoch 3|Withdrawal by Subject|0|||
130897262|NCT02059291|471260150|FG002|Epoch 3|Withdrawal by Subject|0|||
130897263|NCT02059291|471260151|FG003|Epoch 3|Withdrawal by Subject|0|||
130897264|NCT02059291|471260152|FG004|Epoch 3|Withdrawal by Subject|0|||
130897265|NCT02059291|471260153|FG005|Epoch 3|Withdrawal by Subject|0|||
130897266|NCT02059291|471260154|FG006|Epoch 3|Withdrawal by Subject|0|||
130897267|NCT02059291|471260155|FG007|Epoch 3|Withdrawal by Subject|0|||
130897268|NCT02059291|471260156|FG008|Epoch 3|Withdrawal by Subject|0|||
130897269|NCT02059291|471260157|FG009|Epoch 3|Withdrawal by Subject|0|||
130897270|NCT02059291|471260158|FG010|Epoch 3|Withdrawal by Subject|0|||
130897271|NCT02059291|471260159|FG011|Epoch 3|Withdrawal by Subject|0|||
130897272|NCT02059291|471260160|FG012|Epoch 3|Withdrawal by Subject|0|||
130897273|NCT02059291|471260161|FG013|Epoch 3|Withdrawal by Subject|0|||
130897274|NCT02059291|471260162|FG014|Epoch 3|Withdrawal by Subject|0|||
130897275|NCT02059291|471260163|FG015|Epoch 3|Withdrawal by Subject|1|||
130897276|NCT02059291|471260164|FG016|Epoch 3|Withdrawal by Subject|0|||
130897277|NCT02059291|471260165|FG017|Epoch 3|Withdrawal by Subject|0|||
130897278|NCT02059291|471260166|FG018|Epoch 3|Withdrawal by Subject|0|||
130897279|NCT02059291|471260167|FG019|Epoch 3|Withdrawal by Subject|0|||
130897280|NCT02059291|471260168|FG020|Epoch 3|Withdrawal by Subject|0|||
130897281|NCT02059291|471260169|FG021|Epoch 3|Withdrawal by Subject|0|||
130897282|NCT02059291|471260170|FG022|Epoch 3|Withdrawal by Subject|0|||
130897283|NCT02059291|471260171|FG023|Epoch 3|Withdrawal by Subject|0|||
130897284|NCT02059291|471260172|FG024|Epoch 3|Withdrawal by Subject|0|||
130897285|NCT02059291|471260148|FG000|Epoch 4|Adverse Event|0|||
130897286|NCT02059291|471260149|FG001|Epoch 4|Adverse Event|0|||
130897287|NCT02059291|471260150|FG002|Epoch 4|Adverse Event|0|||
130897288|NCT02059291|471260151|FG003|Epoch 4|Adverse Event|0|||
130897289|NCT02059291|471260152|FG004|Epoch 4|Adverse Event|0|||
130897290|NCT02059291|471260153|FG005|Epoch 4|Adverse Event|0|||
130897291|NCT02059291|471260154|FG006|Epoch 4|Adverse Event|0|||
130897292|NCT02059291|471260155|FG007|Epoch 4|Adverse Event|0|||
130897293|NCT02059291|471260156|FG008|Epoch 4|Adverse Event|0|||
130897294|NCT02059291|471260157|FG009|Epoch 4|Adverse Event|0|||
130897295|NCT02059291|471260158|FG010|Epoch 4|Adverse Event|0|||
130897296|NCT02059291|471260159|FG011|Epoch 4|Adverse Event|0|||
130897297|NCT02059291|471260160|FG012|Epoch 4|Adverse Event|0|||
130897298|NCT02059291|471260161|FG013|Epoch 4|Adverse Event|0|||
130897299|NCT02059291|471260162|FG014|Epoch 4|Adverse Event|0|||
130897300|NCT02059291|471260163|FG015|Epoch 4|Adverse Event|0|||
130897301|NCT02059291|471260164|FG016|Epoch 4|Adverse Event|1|||
130897302|NCT02059291|471260165|FG017|Epoch 4|Adverse Event|0|||
130897303|NCT02059291|471260166|FG018|Epoch 4|Adverse Event|0|||
130897304|NCT02059291|471260167|FG019|Epoch 4|Adverse Event|0|||
130897305|NCT02059291|471260168|FG020|Epoch 4|Adverse Event|0|||
130897306|NCT02059291|471260169|FG021|Epoch 4|Adverse Event|0|||
130897307|NCT02059291|471260170|FG022|Epoch 4|Adverse Event|1|||
130897308|NCT02059291|471260171|FG023|Epoch 4|Adverse Event|0|||
130897309|NCT02059291|471260172|FG024|Epoch 4|Adverse Event|0|||
130897310|NCT02059291|471260148|FG000|Epoch 4|Pregnancy|0|||
130897311|NCT02059291|471260149|FG001|Epoch 4|Pregnancy|0|||
130897312|NCT02059291|471260150|FG002|Epoch 4|Pregnancy|0|||
130767859|NCT00957424|470773888|FG000|Overall Study|Protocol Violation|3|||
130897313|NCT02059291|471260151|FG003|Epoch 4|Pregnancy|0|||
130897314|NCT02059291|471260152|FG004|Epoch 4|Pregnancy|0|||
130897315|NCT02059291|471260153|FG005|Epoch 4|Pregnancy|0|||
130897316|NCT02059291|471260154|FG006|Epoch 4|Pregnancy|0|||
130897317|NCT02059291|471260155|FG007|Epoch 4|Pregnancy|0|||
130897318|NCT02059291|471260156|FG008|Epoch 4|Pregnancy|0|||
130897319|NCT02059291|471260157|FG009|Epoch 4|Pregnancy|0|||
130897320|NCT02059291|471260158|FG010|Epoch 4|Pregnancy|0|||
130897321|NCT02059291|471260159|FG011|Epoch 4|Pregnancy|0|||
130897322|NCT02059291|471260160|FG012|Epoch 4|Pregnancy|0|||
130897323|NCT02059291|471260161|FG013|Epoch 4|Pregnancy|0|||
130897324|NCT02059291|471260162|FG014|Epoch 4|Pregnancy|0|||
130897325|NCT02059291|471260163|FG015|Epoch 4|Pregnancy|0|||
130897326|NCT02059291|471260164|FG016|Epoch 4|Pregnancy|1|||
130897327|NCT02059291|471260165|FG017|Epoch 4|Pregnancy|0|||
130897328|NCT02059291|471260166|FG018|Epoch 4|Pregnancy|0|||
130897329|NCT02059291|471260167|FG019|Epoch 4|Pregnancy|0|||
130897330|NCT02059291|471260168|FG020|Epoch 4|Pregnancy|0|||
130897331|NCT02059291|471260169|FG021|Epoch 4|Pregnancy|0|||
130897332|NCT02059291|471260170|FG022|Epoch 4|Pregnancy|0|||
130897333|NCT02059291|471260171|FG023|Epoch 4|Pregnancy|0|||
130897334|NCT02059291|471260172|FG024|Epoch 4|Pregnancy|0|||
130897335|NCT02059291|471260148|FG000|Epoch 4|Withdrawal by Subject|0|||
130897336|NCT02059291|471260149|FG001|Epoch 4|Withdrawal by Subject|0|||
130897337|NCT02059291|471260150|FG002|Epoch 4|Withdrawal by Subject|0|||
130897338|NCT02059291|471260151|FG003|Epoch 4|Withdrawal by Subject|0|||
130897339|NCT02059291|471260152|FG004|Epoch 4|Withdrawal by Subject|0|||
130897340|NCT02059291|471260153|FG005|Epoch 4|Withdrawal by Subject|0|||
130897341|NCT02059291|471260154|FG006|Epoch 4|Withdrawal by Subject|0|||
130897342|NCT02059291|471260155|FG007|Epoch 4|Withdrawal by Subject|0|||
130897343|NCT02059291|471260156|FG008|Epoch 4|Withdrawal by Subject|0|||
130897344|NCT02059291|471260157|FG009|Epoch 4|Withdrawal by Subject|0|||
130897345|NCT02059291|471260158|FG010|Epoch 4|Withdrawal by Subject|0|||
130897346|NCT02059291|471260159|FG011|Epoch 4|Withdrawal by Subject|0|||
130897347|NCT02059291|471260160|FG012|Epoch 4|Withdrawal by Subject|0|||
130897348|NCT02059291|471260161|FG013|Epoch 4|Withdrawal by Subject|0|||
130897349|NCT02059291|471260162|FG014|Epoch 4|Withdrawal by Subject|0|||
130897350|NCT02059291|471260163|FG015|Epoch 4|Withdrawal by Subject|0|||
130897351|NCT02059291|471260164|FG016|Epoch 4|Withdrawal by Subject|0|||
130897352|NCT02059291|471260165|FG017|Epoch 4|Withdrawal by Subject|0|||
130897353|NCT02059291|471260166|FG018|Epoch 4|Withdrawal by Subject|0|||
130897354|NCT02059291|471260167|FG019|Epoch 4|Withdrawal by Subject|0|||
130897355|NCT02059291|471260168|FG020|Epoch 4|Withdrawal by Subject|1|||
130897356|NCT02059291|471260169|FG021|Epoch 4|Withdrawal by Subject|0|||
130897357|NCT02059291|471260170|FG022|Epoch 4|Withdrawal by Subject|0|||
130897358|NCT02059291|471260171|FG023|Epoch 4|Withdrawal by Subject|0|||
130897359|NCT02059291|471260172|FG024|Epoch 4|Withdrawal by Subject|0|||
130897360|NCT02059291|471260148|FG000|Epoch 4|Lack of Efficacy|0|||
130897361|NCT02059291|471260149|FG001|Epoch 4|Lack of Efficacy|0|||
130897362|NCT02059291|471260150|FG002|Epoch 4|Lack of Efficacy|0|||
130897363|NCT02059291|471260151|FG003|Epoch 4|Lack of Efficacy|0|||
130897364|NCT02059291|471260152|FG004|Epoch 4|Lack of Efficacy|0|||
130897365|NCT02059291|471260153|FG005|Epoch 4|Lack of Efficacy|0|||
130897366|NCT02059291|471260154|FG006|Epoch 4|Lack of Efficacy|0|||
130897367|NCT02059291|471260155|FG007|Epoch 4|Lack of Efficacy|0|||
130691134|NCT00443651|470495829|FG000|Overall Study|Patient's/Guardian's Decision|58|||
130691135|NCT00443651|470495830|FG001|Overall Study|Patient's/Guardian's Decision|30|||
130897368|NCT02059291|471260156|FG008|Epoch 4|Lack of Efficacy|0|||
130897369|NCT02059291|471260157|FG009|Epoch 4|Lack of Efficacy|0|||
130897370|NCT02059291|471260158|FG010|Epoch 4|Lack of Efficacy|0|||
130897371|NCT02059291|471260159|FG011|Epoch 4|Lack of Efficacy|0|||
130897372|NCT02059291|471260160|FG012|Epoch 4|Lack of Efficacy|0|||
130897373|NCT02059291|471260161|FG013|Epoch 4|Lack of Efficacy|0|||
130897374|NCT02059291|471260162|FG014|Epoch 4|Lack of Efficacy|0|||
130897375|NCT02059291|471260163|FG015|Epoch 4|Lack of Efficacy|0|||
130897376|NCT02059291|471260164|FG016|Epoch 4|Lack of Efficacy|0|||
130897377|NCT02059291|471260165|FG017|Epoch 4|Lack of Efficacy|0|||
130897378|NCT02059291|471260166|FG018|Epoch 4|Lack of Efficacy|0|||
130897379|NCT02059291|471260167|FG019|Epoch 4|Lack of Efficacy|0|||
130897380|NCT02059291|471260168|FG020|Epoch 4|Lack of Efficacy|0|||
130897381|NCT02059291|471260169|FG021|Epoch 4|Lack of Efficacy|0|||
130897382|NCT02059291|471260170|FG022|Epoch 4|Lack of Efficacy|0|||
130897383|NCT02059291|471260171|FG023|Epoch 4|Lack of Efficacy|1|||
130897384|NCT02059291|471260172|FG024|Epoch 4|Lack of Efficacy|0|||
130897385|NCT04975438|471260173|FG000|Overall Study|Lost to Follow-up|1|||
130897386|NCT04975438|471260174|FG001|Overall Study|Lost to Follow-up|0|||
130897387|NCT04975438|471260175|FG002|Overall Study|Lost to Follow-up|1|||
130897388|NCT04975438|471260176|FG003|Overall Study|Lost to Follow-up|0|||
130897389|NCT04975438|471260173|FG000|Overall Study|Withdrawal by Subject|1|||
130897390|NCT04975438|471260174|FG001|Overall Study|Withdrawal by Subject|0|||
130897391|NCT04975438|471260175|FG002|Overall Study|Withdrawal by Subject|0|||
130897392|NCT04975438|471260176|FG003|Overall Study|Withdrawal by Subject|0|||
130897393|NCT01950013|471260181|FG000|Overall Study|Withdrawal by Subject|0|||
130897394|NCT01950013|471260182|FG001|Overall Study|Withdrawal by Subject|2|||
130897395|NCT01950013|471260183|FG002|Overall Study|Withdrawal by Subject|0|||
130897396|NCT03091348|471260184|FG000|Overall Study|Lost to Follow-up|2|||
130897397|NCT03091348|471260185|FG001|Overall Study|Lost to Follow-up|1|||
130897398|NCT00706342|471260186|FG000|Overall Study|Adverse Event|3|||
130897399|NCT00706342|471260186|FG000|Overall Study|Not responding to treatment|2|||
130897400|NCT00706342|471260186|FG000|Overall Study|Withdrawn due to failure to respond|1|||
130897401|NCT00706342|471260186|FG000|Overall Study|Death|1|||
130897402|NCT00706342|471260186|FG000|Overall Study|Withdrew from the study on his own.|1|||
130691136|NCT00443651|470495829|FG000|Overall Study|Physician Decision|13|||
130897403|NCT00706342|471260186|FG000|Overall Study|Investigator discretion|2|||
130897404|NCT00706342|471260186|FG000|Overall Study|Non-responder Week 12|1|||
130897405|NCT00706342|471260186|FG000|Overall Study|Ongoing|6|||
130897406|NCT00706342|471260186|FG000|Overall Study|WIthdrawal of consent|1|||
130897407|NCT00612105|471260187|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
130897408|NCT00612105|471260188|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
131112036|NCT04796896|472040972|FG001|Overall Study|Death|0|||
130691137|NCT00443651|470495830|FG001|Overall Study|Physician Decision|4|||
130897409|NCT00612105|471260187|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
130897410|NCT00612105|471260188|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
130897411|NCT00612105|471260187|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
130897412|NCT00612105|471260188|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
130897413|NCT00612105|471260187|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
130897414|NCT00612105|471260188|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
130897415|NCT00612105|471260187|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
130897416|NCT00612105|471260188|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
130897417|NCT00612105|471260187|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
130897418|NCT00612105|471260188|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
130897419|NCT00612105|471260187|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
130897420|NCT00612105|471260188|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
130897421|NCT00612105|471260187|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
130897422|NCT00612105|471260188|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
130897423|NCT00612105|471260187|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
130897424|NCT00612105|471260188|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
130897425|NCT00612105|471260187|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
130897426|NCT00612105|471260188|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
130897427|NCT00612105|471260187|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
130897428|NCT00612105|471260188|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
130897429|NCT00612105|471260187|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
130897430|NCT00612105|471260188|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
130897431|NCT01105767|471260189|FG000|Overall Study|Lost to Follow-up|1160|||
130897432|NCT01105767|471260190|FG001|Overall Study|Lost to Follow-up|1614|||
130897433|NCT01105767|471260191|FG002|Overall Study|Lost to Follow-up|1184|||
130897434|NCT00743106|471260192|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
130897435|NCT00743106|471260193|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
130897436|NCT02674204|471260195|FG000|Overall Study|Adverse Event|1|||
130897437|NCT02674204|471260196|FG001|Overall Study|Adverse Event|0|||
130897438|NCT02874144|471260199|FG000|Overall Study|Lost to Follow-up|3|||
130897439|NCT02874144|471260200|FG001|Overall Study|Lost to Follow-up|5|||
130897440|NCT00486811|471260201|FG000|Overall Study|Adverse Event|28|||
130897441|NCT00486811|471260202|FG001|Overall Study|Adverse Event|60|||
130897442|NCT00486811|471260203|FG002|Overall Study|Adverse Event|135|||
130897443|NCT00486811|471260201|FG000|Overall Study|Lack of Efficacy|34|||
130897444|NCT00486811|471260202|FG001|Overall Study|Lack of Efficacy|14|||
130897445|NCT00486811|471260203|FG002|Overall Study|Lack of Efficacy|7|||
130897446|NCT00486811|471260201|FG000|Overall Study|Lost to Follow-up|4|||
130897447|NCT00486811|471260202|FG001|Overall Study|Lost to Follow-up|6|||
130897448|NCT00486811|471260203|FG002|Overall Study|Lost to Follow-up|4|||
130897449|NCT00486811|471260201|FG000|Overall Study|Withdrawal by Subject|33|||
130897450|NCT00486811|471260202|FG001|Overall Study|Withdrawal by Subject|44|||
130897451|NCT00486811|471260203|FG002|Overall Study|Withdrawal by Subject|58|||
130897452|NCT00486811|471260201|FG000|Overall Study|Study drug non-compliant|5|||
130897453|NCT00486811|471260202|FG001|Overall Study|Study drug non-compliant|6|||
130897454|NCT00486811|471260203|FG002|Overall Study|Study drug non-compliant|3|||
130897455|NCT00486811|471260201|FG000|Overall Study|All other|18|||
130897456|NCT00486811|471260202|FG001|Overall Study|All other|11|||
130897457|NCT00486811|471260203|FG002|Overall Study|All other|7|||
130897458|NCT01711216|471260210|FG000|Overall Study|Adverse Event|4|||
130897459|NCT01711216|471260210|FG000|Overall Study|Pregnancy|56|||
130897460|NCT01711216|471260210|FG000|Overall Study|Withdrawal by Subject|6|||
130897461|NCT01711216|471260210|FG000|Overall Study|Lost to Follow-up|46|||
130897462|NCT01711216|471260210|FG000|Overall Study|variety of other minor reasons|83|||
130897463|NCT01711216|471260210|FG000|Overall Study|no reason specified|22|||
130897464|NCT02929498|471260211|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
130897465|NCT02929498|471260212|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
130897466|NCT02929498|471260213|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
130897467|NCT02929498|471260211|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
130897468|NCT02929498|471260212|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
130897469|NCT02929498|471260213|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
130897470|NCT00096356|471260214|FG000|Overall Study|Adverse Event|11|||
130897471|NCT00096356|471260215|FG001|Overall Study|Adverse Event|9|||
131112037|NCT04796896|472040973|FG002|Overall Study|Death|0|||
130691138|NCT00443651|470495829|FG000|Overall Study|Pregnancy|0|||
130691139|NCT00443651|470495830|FG001|Overall Study|Pregnancy|1|||
130691140|NCT00859521|470495833|FG000|Washout|Withdrawal by Subject|0|||
130691141|NCT00859521|470495834|FG001|Washout|Withdrawal by Subject|1|||
130691142|NCT02888756|470495835|FG000|Analytical Treatment Interruption|Physician Decision|10|||
130691143|NCT02888756|470495836|FG001|Analytical Treatment Interruption|Physician Decision|6|||
130897472|NCT00096356|471260214|FG000|Overall Study|Physician Decision|5|||
130897473|NCT00096356|471260215|FG001|Overall Study|Physician Decision|3|||
130897474|NCT00096356|471260214|FG000|Overall Study|Withdrawal by Subject|17|||
130897475|NCT00096356|471260215|FG001|Overall Study|Withdrawal by Subject|23|||
130897476|NCT00096356|471260214|FG000|Overall Study|Lack of Efficacy|1|||
130897477|NCT00096356|471260215|FG001|Overall Study|Lack of Efficacy|0|||
130897478|NCT00096356|471260214|FG000|Overall Study|multiple reasons|10|||
130897479|NCT00096356|471260215|FG001|Overall Study|multiple reasons|18|||
130897480|NCT04359901|471260222|FG000|Overall Study|Withdrawal by Subject|0|||
131112038|NCT04796896|472040974|FG003|Overall Study|Death|0|||
131112039|NCT04796896|472040975|FG004|Overall Study|Death|0|||
130691144|NCT02888756|470495837|FG002|Analytical Treatment Interruption|Physician Decision|5|||
131112040|NCT04796896|472040976|FG005|Overall Study|Death|0|||
131112041|NCT04796896|472040977|FG006|Overall Study|Death|0|||
131112042|NCT04796896|472040978|FG007|Overall Study|Death|0|||
131112043|NCT04796896|472040979|FG008|Overall Study|Death|1|||
131112044|NCT04796896|472040980|FG009|Overall Study|Death|0|||
131112045|NCT04796896|472040981|FG010|Overall Study|Death|0|||
131112046|NCT04796896|472040982|FG011|Overall Study|Death|0|||
131112047|NCT04356183|472040983|FG000|Overall Study|Lost to Follow-up|1|||
131112048|NCT04356183|472040984|FG001|Overall Study|Lost to Follow-up|0|||
131112049|NCT04356183|472040983|FG000|Overall Study|Withdrawal by Subject|1|||
131112050|NCT04356183|472040984|FG001|Overall Study|Withdrawal by Subject|1|||
131112051|NCT01177787|472040985|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
131112052|NCT01177787|472040985|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
131112053|NCT01177787|472040985|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
131112054|NCT00402363|472040988|FG000|Overall Study|Adverse Event|9|||
131112055|NCT00402363|472040989|FG001|Overall Study|Adverse Event|14|||
131112056|NCT00402363|472040990|FG002|Overall Study|Adverse Event|2|||
131112057|NCT00402363|472040991|FG003|Overall Study|Adverse Event|2|||
131112058|NCT00402363|472040988|FG000|Overall Study|Withdrew Consent|10|||
131112059|NCT00402363|472040989|FG001|Overall Study|Withdrew Consent|5|||
131112060|NCT00402363|472040990|FG002|Overall Study|Withdrew Consent|2|||
131112061|NCT00402363|472040991|FG003|Overall Study|Withdrew Consent|1|||
131112062|NCT00402363|472040988|FG000|Overall Study|Protocol Violation|3|||
131112063|NCT00402363|472040989|FG001|Overall Study|Protocol Violation|5|||
131112064|NCT00402363|472040990|FG002|Overall Study|Protocol Violation|0|||
131112065|NCT00402363|472040991|FG003|Overall Study|Protocol Violation|3|||
131112066|NCT00402363|472040988|FG000|Overall Study|Lost to Follow-up|5|||
131112067|NCT00402363|472040989|FG001|Overall Study|Lost to Follow-up|4|||
131112068|NCT00402363|472040990|FG002|Overall Study|Lost to Follow-up|0|||
131112069|NCT00402363|472040991|FG003|Overall Study|Lost to Follow-up|2|||
131112070|NCT00402363|472040988|FG000|Overall Study|"Captured as Other"|6|||
131112071|NCT00402363|472040989|FG001|Overall Study|"Captured as Other"|2|||
131112072|NCT00402363|472040990|FG002|Overall Study|"Captured as Other"|2|||
131112073|NCT00402363|472040991|FG003|Overall Study|"Captured as Other"|2|||
131112074|NCT00293722|472040992|FG000|Overall Study|Other|427|||
131112075|NCT02824263|472040993|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
131112076|NCT02824263|472040994|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
131112077|NCT02824263|472040993|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
131112078|NCT02824263|472040994|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
131112079|NCT00667355|472040995|FG000|Overall Study|Adverse Event|5|||
131112080|NCT00667355|472040995|FG000|Overall Study|Lost to Follow-up|1|||
131112081|NCT00667355|472040995|FG000|Overall Study|Other reason was not specified|5|||
131112082|NCT00068588|472041002|FG000|Overall Study|Adverse Event|0|||
131112083|NCT00068588|472041003|FG001|Overall Study|Adverse Event|0|||
131112084|NCT00068588|472041004|FG002|Overall Study|Adverse Event|2|||
131112085|NCT00068588|472041002|FG000|Overall Study|Withdrawal by Subject|0|||
131112086|NCT00068588|472041003|FG001|Overall Study|Withdrawal by Subject|0|||
131112087|NCT00068588|472041004|FG002|Overall Study|Withdrawal by Subject|1|||
131112088|NCT00068588|472041002|FG000|Overall Study|Poor KPS|0|||
131112089|NCT00068588|472041003|FG001|Overall Study|Poor KPS|0|||
131112090|NCT00068588|472041004|FG002|Overall Study|Poor KPS|1|||
131112091|NCT05193500|472041005|FG000|Overall Study|Withdrawal by Subject|7|||
131112092|NCT05193500|472041006|FG001|Overall Study|Withdrawal by Subject|4|||
131112093|NCT05193500|472041007|FG002|Overall Study|Withdrawal by Subject|3|||
131112094|NCT05193500|472041008|FG003|Overall Study|Withdrawal by Subject|5|||
131112095|NCT02604433|472041011|FG000|Overall Study|Withdrawal by Subject|37|||
131112096|NCT02604433|472041012|FG001|Overall Study|Withdrawal by Subject|16|||
131112097|NCT02604433|472041011|FG000|Overall Study|Adverse Event|4|||
131112098|NCT02604433|472041012|FG001|Overall Study|Adverse Event|0|||
131112099|NCT02604433|472041011|FG000|Overall Study|Other reasons|3|||
131112100|NCT02604433|472041012|FG001|Overall Study|Other reasons|5|||
131112101|NCT02604433|472041011|FG000|Overall Study|Death|4|||
131112102|NCT02604433|472041012|FG001|Overall Study|Death|1|||
131112103|NCT02604433|472041011|FG000|Overall Study|Transition to Rollover Protocol|169|||
131112104|NCT02604433|472041012|FG001|Overall Study|Transition to Rollover Protocol|82|||
131112105|NCT02604433|472041011|FG000|Overall Study|Physician Decision|1|||
131112106|NCT02604433|472041012|FG001|Overall Study|Physician Decision|1|||
131112107|NCT02604433|472041011|FG000|Overall Study|Lack of Efficacy|0|||
131112108|NCT02604433|472041012|FG001|Overall Study|Lack of Efficacy|1|||
131112109|NCT03437278|472041013|FG000|Overall Study|Adverse Event|0|||
131112110|NCT03437278|472041014|FG001|Overall Study|Adverse Event|0|||
131112111|NCT03437278|472041015|FG002|Overall Study|Adverse Event|1|||
131112112|NCT03437278|472041013|FG000|Overall Study|Progressive disease|1|||
131112113|NCT03437278|472041014|FG001|Overall Study|Progressive disease|0|||
131112114|NCT03437278|472041015|FG002|Overall Study|Progressive disease|0|||
131112115|NCT03437278|472041013|FG000|Overall Study|Physician Decision|1|||
131112116|NCT03437278|472041014|FG001|Overall Study|Physician Decision|0|||
131112117|NCT03437278|472041015|FG002|Overall Study|Physician Decision|1|||
131112118|NCT02202551|472041016|FG000|Overall Study|Adverse Event|8|||
131112119|NCT02202551|472041017|FG001|Overall Study|Adverse Event|19|||
130897481|NCT04359901|471260223|FG001|Overall Study|Withdrawal by Subject|1|||
130897482|NCT04359901|471260222|FG000|Overall Study|Death|6|||
130897483|NCT04359901|471260223|FG001|Overall Study|Death|2|||
130897484|NCT05092360|471260224|FG000|Overall Study|Withdrawal by Subject|21|||
130897485|NCT05092360|471260225|FG001|Overall Study|Withdrawal by Subject|4|||
130897486|NCT05092360|471260226|FG002|Overall Study|Withdrawal by Subject|9|||
130897487|NCT05092360|471260227|FG003|Overall Study|Withdrawal by Subject|26|||
130897488|NCT05092360|471260224|FG000|Overall Study|Death|97|||
130897489|NCT05092360|471260225|FG001|Overall Study|Death|14|||
130897490|NCT05092360|471260226|FG002|Overall Study|Death|31|||
130897491|NCT05092360|471260227|FG003|Overall Study|Death|101|||
130897492|NCT05092360|471260224|FG000|Overall Study|Lost to Follow-up|1|||
130897493|NCT05092360|471260225|FG001|Overall Study|Lost to Follow-up|2|||
130897494|NCT05092360|471260226|FG002|Overall Study|Lost to Follow-up|2|||
130897495|NCT05092360|471260227|FG003|Overall Study|Lost to Follow-up|2|||
130897496|NCT05092360|471260224|FG000|Overall Study|Study terminated by sponsor|65|||
130897497|NCT05092360|471260225|FG001|Overall Study|Study terminated by sponsor|7|||
130897498|NCT05092360|471260226|FG002|Overall Study|Study terminated by sponsor|13|||
130897499|NCT05092360|471260227|FG003|Overall Study|Study terminated by sponsor|61|||
130897500|NCT01525225|471260228|FG000|Enrollment|No longer met study criteria|1|||
130897501|NCT01525225|471260228|FG000|Enrollment|Other|1|||
130897502|NCT00243841|471260231|FG000|Overall Study|Physician Decision|0|||
130897503|NCT00243841|471260232|FG001|Overall Study|Physician Decision|0|||
130897504|NCT00243841|471260233|FG002|Overall Study|Physician Decision|1|||
130897505|NCT00243841|471260234|FG003|Overall Study|Physician Decision|0|||
130897506|NCT00243841|471260235|FG004|Overall Study|Physician Decision|0|||
130897507|NCT00243841|471260236|FG005|Overall Study|Physician Decision|2|||
130897508|NCT00363545|471260237|FG000|Overall Study|Serious Adverse Event|0|||
130897509|NCT00363545|471260238|FG001|Overall Study|Serious Adverse Event|1|||
130897510|NCT00363545|471260237|FG000|Overall Study|Withdrawal by Subject|12|||
130897511|NCT00363545|471260238|FG001|Overall Study|Withdrawal by Subject|15|||
130897512|NCT00363545|471260237|FG000|Overall Study|Migrated/moved from study area|3|||
130897513|NCT00363545|471260238|FG001|Overall Study|Migrated/moved from study area|6|||
130897514|NCT00363545|471260237|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
130897515|NCT00363545|471260238|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
130897516|NCT00363545|471260237|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
130897517|NCT00363545|471260238|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
130897518|NCT00363545|471260237|FG000|Overall Study|Others|1|||
130897519|NCT00363545|471260238|FG001|Overall Study|Others|0|||
130897520|NCT01379508|471260239|FG000|Treatment to Week 104|Adverse Event|2|||
130897521|NCT01379508|471260240|FG001|Treatment to Week 104|Adverse Event|0|||
130897522|NCT01379508|471260241|FG002|Treatment to Week 104|Adverse Event|5|||
130897523|NCT01379508|471260242|FG003|Treatment to Week 104|Adverse Event|0|||
130897524|NCT01379508|471260239|FG000|Treatment to Week 104|Abnormal lab value|1|||
130897525|NCT01379508|471260240|FG001|Treatment to Week 104|Abnormal lab value|0|||
130897526|NCT01379508|471260241|FG002|Treatment to Week 104|Abnormal lab value|0|||
130897527|NCT01379508|471260242|FG003|Treatment to Week 104|Abnormal lab value|0|||
130897528|NCT01379508|471260239|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
130897529|NCT01379508|471260240|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
130897530|NCT01379508|471260241|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
130897531|NCT01379508|471260242|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
130897532|NCT01379508|471260239|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
130897533|NCT01379508|471260240|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
130897534|NCT01379508|471260241|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
130897535|NCT01379508|471260242|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
130897536|NCT01379508|471260239|FG000|Treatment to Week 104|Lost to Follow-up|5|||
130897537|NCT01379508|471260240|FG001|Treatment to Week 104|Lost to Follow-up|0|||
130897538|NCT01379508|471260241|FG002|Treatment to Week 104|Lost to Follow-up|3|||
130897539|NCT01379508|471260242|FG003|Treatment to Week 104|Lost to Follow-up|0|||
131112120|NCT02202551|472041018|FG002|Overall Study|Adverse Event|5|||
131112121|NCT02202551|472041019|FG003|Overall Study|Adverse Event|9|||
131112122|NCT02202551|472041016|FG000|Overall Study|Death|3|||
130897540|NCT01379508|471260239|FG000|Treatment to Week 104|Administrative problems|3|||
130897541|NCT01379508|471260240|FG001|Treatment to Week 104|Administrative problems|1|||
131112123|NCT02202551|472041017|FG001|Overall Study|Death|2|||
130897542|NCT01379508|471260241|FG002|Treatment to Week 104|Administrative problems|0|||
130897543|NCT01379508|471260242|FG003|Treatment to Week 104|Administrative problems|0|||
130897544|NCT01379508|471260239|FG000|Treatment to Week 104|Protocol Violation|1|||
130897545|NCT01379508|471260240|FG001|Treatment to Week 104|Protocol Violation|1|||
130897546|NCT01379508|471260241|FG002|Treatment to Week 104|Protocol Violation|1|||
130897547|NCT01379508|471260242|FG003|Treatment to Week 104|Protocol Violation|0|||
131112124|NCT02202551|472041018|FG002|Overall Study|Death|1|||
130897548|NCT01379508|471260239|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
130897549|NCT01379508|471260240|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
130897550|NCT01379508|471260241|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
131112125|NCT02202551|472041019|FG003|Overall Study|Death|1|||
130897551|NCT01379508|471260242|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
130691145|NCT01547286|470495847|FG000|Overall Study|Did not meet all eligibility criteria|1|||
130691146|NCT01547286|470495847|FG000|Overall Study|Physician Decision|1|||
130691147|NCT03415308|470495850|FG000|Overall Study|Lost to Follow-up|0|||
130897552|NCT01379508|471260239|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
130897553|NCT01379508|471260240|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
130897554|NCT01379508|471260241|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
130691148|NCT03415308|470495851|FG001|Overall Study|Lost to Follow-up|0|||
130691149|NCT03415308|470495852|FG002|Overall Study|Lost to Follow-up|1|||
130691150|NCT03415308|470495850|FG000|Overall Study|Scheduling Conflicts|0|||
130691151|NCT03415308|470495851|FG001|Overall Study|Scheduling Conflicts|0|||
130691152|NCT03415308|470495852|FG002|Overall Study|Scheduling Conflicts|7|||
130691153|NCT01471353|470495853|FG000|Overall Study|remain on study|3|||
130691154|NCT00836472|470495854|FG000|Washout|Adverse Event|1|||
130691155|NCT00836472|470495855|FG001|Washout|Adverse Event|2|||
130691156|NCT00836472|470495854|FG000|Washout|Withdrawal by Subject|1|||
130691157|NCT00836472|470495855|FG001|Washout|Withdrawal by Subject|1|||
130691158|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
130691159|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
130691160|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
130691161|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
130691162|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691163|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691164|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691165|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691166|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691167|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691168|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691169|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691170|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691171|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130691172|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
130691173|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
130691174|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
130691175|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
130691176|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691177|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691178|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691179|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691180|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691181|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691182|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691183|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691184|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691185|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130691186|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
130691187|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691188|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
130691189|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691190|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691191|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691192|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691193|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691194|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691195|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691196|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691197|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691198|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691199|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130691200|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
130691201|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
130691202|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
130691203|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691204|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691205|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691206|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691207|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691208|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691209|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130897555|NCT01379508|471260242|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
130897556|NCT01379508|471260239|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
130897557|NCT01379508|471260240|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
130897558|NCT01379508|471260241|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
130897559|NCT01379508|471260242|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
130897560|NCT01379508|471260239|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
130897561|NCT01379508|471260240|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
130897562|NCT01379508|471260241|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
130897563|NCT01379508|471260242|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
130897564|NCT04236141|471261593|FG000|Overall Study|Death|18|||
130897565|NCT04236141|471261594|FG001|Overall Study|Death|10|||
130897566|NCT04236141|471261593|FG000|Overall Study|Withdrawal by Participant|1|||
130897567|NCT04236141|471261594|FG001|Overall Study|Withdrawal by Participant|0|||
130897568|NCT04236141|471261593|FG000|Overall Study|Reason not Specified|1|||
130897569|NCT04236141|471261594|FG001|Overall Study|Reason not Specified|0|||
130897570|NCT04236141|471261593|FG000|Overall Study|Study terminated by Sponsor|8|||
130897571|NCT04236141|471261594|FG001|Overall Study|Study terminated by Sponsor|4|||
130897572|NCT01925131|471261595|FG000|Overall Study|Death|0|||
130897573|NCT01925131|471261596|FG001|Overall Study|Death|0|||
130897574|NCT01925131|471261597|FG002|Overall Study|Death|1|||
130897575|NCT01925131|471261598|FG003|Overall Study|Death|0|||
130897576|NCT01925131|471261599|FG004|Overall Study|Death|0|||
130897577|NCT01925131|471261600|FG005|Overall Study|Death|0|||
130897578|NCT01925131|471261595|FG000|Overall Study|Progression/Relapse|1|||
130897579|NCT01925131|471261596|FG001|Overall Study|Progression/Relapse|1|||
130897580|NCT01925131|471261597|FG002|Overall Study|Progression/Relapse|4|||
130897581|NCT01925131|471261598|FG003|Overall Study|Progression/Relapse|0|||
130897582|NCT01925131|471261599|FG004|Overall Study|Progression/Relapse|0|||
130897583|NCT01925131|471261600|FG005|Overall Study|Progression/Relapse|1|||
130897584|NCT01925131|471261595|FG000|Overall Study|Patient Refusal|1|||
130897585|NCT01925131|471261596|FG001|Overall Study|Patient Refusal|0|||
130897586|NCT01925131|471261597|FG002|Overall Study|Patient Refusal|0|||
130897587|NCT01925131|471261598|FG003|Overall Study|Patient Refusal|0|||
130897588|NCT01925131|471261599|FG004|Overall Study|Patient Refusal|0|||
130897589|NCT01925131|471261600|FG005|Overall Study|Patient Refusal|0|||
130897590|NCT01925131|471261595|FG000|Overall Study|Adverse Event|0|||
130897591|NCT01925131|471261596|FG001|Overall Study|Adverse Event|0|||
130897592|NCT01925131|471261597|FG002|Overall Study|Adverse Event|2|||
130897593|NCT01925131|471261598|FG003|Overall Study|Adverse Event|0|||
130897594|NCT01925131|471261599|FG004|Overall Study|Adverse Event|1|||
130897595|NCT01925131|471261600|FG005|Overall Study|Adverse Event|3|||
130897596|NCT01925131|471261595|FG000|Overall Study|Other - Not Protocol Specified|3|||
130897597|NCT01925131|471261596|FG001|Overall Study|Other - Not Protocol Specified|1|||
130897598|NCT01925131|471261597|FG002|Overall Study|Other - Not Protocol Specified|2|||
130897599|NCT01925131|471261598|FG003|Overall Study|Other - Not Protocol Specified|5|||
130897600|NCT01925131|471261599|FG004|Overall Study|Other - Not Protocol Specified|10|||
130897601|NCT01925131|471261600|FG005|Overall Study|Other - Not Protocol Specified|6|||
130897602|NCT01954927|471261601|FG000|Overall Study|Withdrawal by Subject|3|||
130897603|NCT01954927|471261602|FG001|Overall Study|Withdrawal by Subject|1|||
130897604|NCT03254108|471261606|FG000|Overall Study|Adverse Event|0|||
130897605|NCT03254108|471261607|FG001|Overall Study|Adverse Event|2|||
130897606|NCT03254108|471261608|FG002|Overall Study|Adverse Event|0|||
130897607|NCT03254108|471261609|FG003|Overall Study|Adverse Event|1|||
130897608|NCT03254108|471261610|FG004|Overall Study|Adverse Event|1|||
130897609|NCT03254108|471261606|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130897610|NCT03254108|471261607|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130897611|NCT03254108|471261608|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130897612|NCT03254108|471261609|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130897613|NCT03254108|471261610|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
130897614|NCT00409331|471261614|FG000|Overall Study|Physician Decision|1|||
130897615|NCT01511055|471261619|FG000|Overall Study|Withdrawal by Subject|6|||
130897616|NCT00830869|471261620|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
130897617|NCT00830869|471261621|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
130897618|NCT00830869|471261622|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
130897619|NCT00830869|471261623|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
130897620|NCT00830869|471261624|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
130897621|NCT00830869|471261625|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
130691210|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691211|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691212|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691213|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130691214|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
130691215|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131112126|NCT02202551|472041016|FG000|Overall Study|Lost to Follow-up|0|||
131112127|NCT02202551|472041017|FG001|Overall Study|Lost to Follow-up|1|||
131112128|NCT02202551|472041018|FG002|Overall Study|Lost to Follow-up|0|||
131112129|NCT02202551|472041019|FG003|Overall Study|Lost to Follow-up|1|||
131112130|NCT02202551|472041016|FG000|Overall Study|Needed to take excluded medication|0|||
131112131|NCT02202551|472041017|FG001|Overall Study|Needed to take excluded medication|2|||
131112132|NCT02202551|472041018|FG002|Overall Study|Needed to take excluded medication|0|||
131112133|NCT02202551|472041019|FG003|Overall Study|Needed to take excluded medication|1|||
131112134|NCT02202551|472041016|FG000|Overall Study|Subject moved away|0|||
131112135|NCT02202551|472041017|FG001|Overall Study|Subject moved away|1|||
131112136|NCT02202551|472041018|FG002|Overall Study|Subject moved away|0|||
131112137|NCT02202551|472041019|FG003|Overall Study|Subject moved away|0|||
131112138|NCT02202551|472041016|FG000|Overall Study|DBS surgery|3|||
131112139|NCT02202551|472041017|FG001|Overall Study|DBS surgery|0|||
131112140|NCT02202551|472041018|FG002|Overall Study|DBS surgery|0|||
131112141|NCT02202551|472041019|FG003|Overall Study|DBS surgery|0|||
131112142|NCT02202551|472041016|FG000|Overall Study|Dyskinesia upon taper|1|||
131112143|NCT02202551|472041017|FG001|Overall Study|Dyskinesia upon taper|0|||
131112144|NCT02202551|472041018|FG002|Overall Study|Dyskinesia upon taper|0|||
131112145|NCT02202551|472041019|FG003|Overall Study|Dyskinesia upon taper|0|||
131112146|NCT02202551|472041016|FG000|Overall Study|Lack of Efficacy|0|||
131112147|NCT02202551|472041017|FG001|Overall Study|Lack of Efficacy|1|||
131112148|NCT02202551|472041018|FG002|Overall Study|Lack of Efficacy|0|||
131112149|NCT02202551|472041019|FG003|Overall Study|Lack of Efficacy|0|||
131112150|NCT02202551|472041016|FG000|Overall Study|Physician Decision|1|||
131112151|NCT02202551|472041017|FG001|Overall Study|Physician Decision|0|||
131112152|NCT02202551|472041018|FG002|Overall Study|Physician Decision|0|||
131112153|NCT02202551|472041019|FG003|Overall Study|Physician Decision|0|||
131112154|NCT02202551|472041016|FG000|Overall Study|Site closure|3|||
131112155|NCT02202551|472041017|FG001|Overall Study|Site closure|0|||
131112156|NCT02202551|472041018|FG002|Overall Study|Site closure|0|||
131112157|NCT02202551|472041019|FG003|Overall Study|Site closure|1|||
131112158|NCT02202551|472041016|FG000|Overall Study|Unable to complete visits per protocol|1|||
131112159|NCT02202551|472041017|FG001|Overall Study|Unable to complete visits per protocol|0|||
131112160|NCT02202551|472041018|FG002|Overall Study|Unable to complete visits per protocol|0|||
131112161|NCT02202551|472041019|FG003|Overall Study|Unable to complete visits per protocol|0|||
131112162|NCT02202551|472041016|FG000|Overall Study|Worsening Dyskinesia|0|||
131112163|NCT02202551|472041017|FG001|Overall Study|Worsening Dyskinesia|0|||
131112164|NCT02202551|472041018|FG002|Overall Study|Worsening Dyskinesia|0|||
131112165|NCT02202551|472041019|FG003|Overall Study|Worsening Dyskinesia|1|||
131112166|NCT02202551|472041016|FG000|Overall Study|Protocol Violation|0|||
131112167|NCT02202551|472041017|FG001|Overall Study|Protocol Violation|1|||
131112168|NCT02202551|472041018|FG002|Overall Study|Protocol Violation|0|||
131112169|NCT02202551|472041019|FG003|Overall Study|Protocol Violation|0|||
131112170|NCT02202551|472041016|FG000|Overall Study|Sponsor's decision|2|||
131112171|NCT02202551|472041017|FG001|Overall Study|Sponsor's decision|0|||
131112172|NCT02202551|472041018|FG002|Overall Study|Sponsor's decision|0|||
131112173|NCT02202551|472041019|FG003|Overall Study|Sponsor's decision|0|||
131112174|NCT02202551|472041016|FG000|Overall Study|Subject unwilling to proceed|1|||
131112175|NCT02202551|472041017|FG001|Overall Study|Subject unwilling to proceed|5|||
131112176|NCT02202551|472041018|FG002|Overall Study|Subject unwilling to proceed|3|||
131112177|NCT02202551|472041019|FG003|Overall Study|Subject unwilling to proceed|5|||
131112178|NCT02202551|472041016|FG000|Overall Study|Subject consent withdrawn|0|||
131112179|NCT02202551|472041017|FG001|Overall Study|Subject consent withdrawn|3|||
130691216|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
130691217|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691218|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691219|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691220|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691221|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691222|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691223|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691224|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691225|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691226|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
131112180|NCT02202551|472041018|FG002|Overall Study|Subject consent withdrawn|1|||
131112181|NCT02202551|472041019|FG003|Overall Study|Subject consent withdrawn|2|||
131112182|NCT02202551|472041016|FG000|Overall Study|eGFR<50mL/min/m2|2|||
131112183|NCT02202551|472041017|FG001|Overall Study|eGFR<50mL/min/m2|2|||
131112184|NCT02202551|472041018|FG002|Overall Study|eGFR<50mL/min/m2|0|||
131112185|NCT02202551|472041019|FG003|Overall Study|eGFR<50mL/min/m2|1|||
131112186|NCT02147353|472041020|FG000|Overall Study|Lost to Follow-up|2|||
131112187|NCT02147353|472041021|FG001|Overall Study|Lost to Follow-up|0|||
131112188|NCT02147353|472041020|FG000|Overall Study|unable to make visits|4|||
131112189|NCT02147353|472041021|FG001|Overall Study|unable to make visits|0|||
131222717|NCT01453374|472443165|FG000|Overall Study|Lost to Follow-up|3|||
130691227|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130691228|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
130691229|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691230|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
130691231|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691232|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691233|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691234|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691235|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691236|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691237|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691238|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691239|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691240|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691241|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130691242|NCT01695239|470495856|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
130691243|NCT01695239|470495857|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691244|NCT01695239|470495858|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691245|NCT01695239|470495859|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691246|NCT01695239|470495860|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691247|NCT01695239|470495861|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691248|NCT01695239|470495862|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691249|NCT01695239|470495863|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691250|NCT01695239|470495864|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691251|NCT01695239|470495865|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691252|NCT01695239|470495866|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691253|NCT01695239|470495867|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691254|NCT01695239|470495868|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691255|NCT01695239|470495869|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130691256|NCT01695239|470495856|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691257|NCT01695239|470495857|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691258|NCT01695239|470495858|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691259|NCT01695239|470495859|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691260|NCT01695239|470495860|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691261|NCT01695239|470495861|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691262|NCT01695239|470495862|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691263|NCT01695239|470495863|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
130691264|NCT01695239|470495864|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691265|NCT01695239|470495865|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691266|NCT01695239|470495866|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691267|NCT01695239|470495867|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691268|NCT01695239|470495868|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691269|NCT01695239|470495869|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130691270|NCT01695239|470495856|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691271|NCT01695239|470495857|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691272|NCT01695239|470495858|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691273|NCT01695239|470495859|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130767860|NCT00957424|470773888|FG000|Overall Study|Withdrawal by Subject|1|||
130767862|NCT01167634|470773898|FG000|Overall Study|Lost to Follow-up|1|||
130767863|NCT01167634|470773899|FG001|Overall Study|Lost to Follow-up|3|||
130767864|NCT01167634|470773900|FG002|Overall Study|Lost to Follow-up|3|||
130767865|NCT01167634|470773901|FG003|Overall Study|Lost to Follow-up|4|||
130767866|NCT01167634|470773898|FG000|Overall Study|Withdrawal by Subject|1|||
130767867|NCT01167634|470773899|FG001|Overall Study|Withdrawal by Subject|1|||
130767868|NCT01167634|470773900|FG002|Overall Study|Withdrawal by Subject|0|||
130767869|NCT01167634|470773901|FG003|Overall Study|Withdrawal by Subject|0|||
130767870|NCT00438256|470773902|FG000|Overall Study|Ineligible for Resection|2|||
130767871|NCT00438256|470773903|FG001|Overall Study|Ineligible for Resection|1|||
130767872|NCT00438256|470773904|FG002|Overall Study|Ineligible for Resection|1|||
130767873|NCT00438256|470773905|FG003|Overall Study|Ineligible for Resection|7|||
130767874|NCT00438256|470773902|FG000|Overall Study|Excluded final Diagnosis|0|||
130767875|NCT00438256|470773903|FG001|Overall Study|Excluded final Diagnosis|0|||
130767876|NCT00438256|470773904|FG002|Overall Study|Excluded final Diagnosis|0|||
130767877|NCT00438256|470773905|FG003|Overall Study|Excluded final Diagnosis|2|||
130767878|NCT00369161|470773906|FG000|Overall Study|Adverse Event|15|||
130767879|NCT00369161|470773907|FG001|Overall Study|Adverse Event|13|||
131222718|NCT01453374|472443165|FG000|Overall Study|Withdrawal by Subject|5|||
130897622|NCT00830869|471261626|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
130897623|NCT00830869|471261627|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
130897624|NCT00830869|471261628|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
130897625|NCT00830869|471261629|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
130897626|NCT00830869|471261630|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
130897627|NCT00830869|471261631|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
130897628|NCT00830869|471261620|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
130897629|NCT00830869|471261621|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
130897630|NCT00830869|471261622|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
130897631|NCT00830869|471261623|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
130897632|NCT00830869|471261624|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
130897633|NCT00830869|471261625|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
130897634|NCT00830869|471261626|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
130897635|NCT00830869|471261627|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
130897636|NCT00830869|471261628|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
130897637|NCT00830869|471261629|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
130897638|NCT00830869|471261630|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
130897639|NCT00830869|471261631|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
130897640|NCT00830869|471261620|FG000|Period 1: Part 1|Adverse Event|0|||
130897641|NCT00830869|471261621|FG001|Period 1: Part 1|Adverse Event|0|||
130897642|NCT00830869|471261622|FG002|Period 1: Part 1|Adverse Event|0|||
130897643|NCT00830869|471261623|FG003|Period 1: Part 1|Adverse Event|0|||
130897644|NCT00830869|471261624|FG004|Period 1: Part 1|Adverse Event|0|||
130897645|NCT00830869|471261625|FG005|Period 1: Part 1|Adverse Event|1|||
130897646|NCT00830869|471261626|FG006|Period 1: Part 1|Adverse Event|1|||
130897647|NCT00830869|471261627|FG007|Period 1: Part 1|Adverse Event|0|||
130897648|NCT00830869|471261628|FG008|Period 1: Part 1|Adverse Event|0|||
131112190|NCT02147353|472041020|FG000|Overall Study|medication noncompliance|3|||
130691274|NCT01695239|470495860|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691275|NCT01695239|470495861|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691276|NCT01695239|470495862|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691277|NCT01695239|470495863|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
130691278|NCT01695239|470495864|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691279|NCT01695239|470495865|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691280|NCT01695239|470495866|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691281|NCT01695239|470495867|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691282|NCT01695239|470495868|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691283|NCT01695239|470495869|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130691284|NCT01695239|470495856|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691285|NCT01695239|470495857|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691286|NCT01695239|470495858|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691287|NCT01695239|470495859|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691288|NCT01695239|470495860|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691289|NCT01695239|470495861|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691290|NCT01695239|470495862|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691291|NCT01695239|470495863|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
130691292|NCT01695239|470495864|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691293|NCT01695239|470495865|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691294|NCT01695239|470495866|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691295|NCT01695239|470495867|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691296|NCT01695239|470495868|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691297|NCT01695239|470495869|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130691298|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691299|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691300|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691301|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691302|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691303|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691304|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691305|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691306|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
130897649|NCT00830869|471261629|FG009|Period 1: Part 1|Adverse Event|0|||
130897650|NCT00830869|471261630|FG010|Period 1: Part 1|Adverse Event|0|||
130897651|NCT00830869|471261631|FG011|Period 1: Part 1|Adverse Event|0|||
130897652|NCT00830869|471261620|FG000|Period 1: Part 1|Progressive disease|1|||
130897653|NCT00830869|471261621|FG001|Period 1: Part 1|Progressive disease|0|||
131112191|NCT02147353|472041021|FG001|Overall Study|medication noncompliance|0|||
130897654|NCT00830869|471261622|FG002|Period 1: Part 1|Progressive disease|1|||
130897655|NCT00830869|471261623|FG003|Period 1: Part 1|Progressive disease|6|||
130897656|NCT00830869|471261624|FG004|Period 1: Part 1|Progressive disease|4|||
131112192|NCT03037619|472041023|FG000|Overall Study|Lost to Follow-up|0|||
131112193|NCT03037619|472041024|FG001|Overall Study|Lost to Follow-up|1|||
131112194|NCT01498289|472041025|FG000|Overall Study|Adverse Event|16|||
131112195|NCT01498289|472041026|FG001|Overall Study|Adverse Event|18|||
131112196|NCT01498289|472041025|FG000|Overall Study|Death|6|||
131112197|NCT01498289|472041026|FG001|Overall Study|Death|8|||
131112198|NCT01498289|472041025|FG000|Overall Study|Withdrawal unrelated to AE|16|||
131112199|NCT01498289|472041026|FG001|Overall Study|Withdrawal unrelated to AE|16|||
131112200|NCT01498289|472041025|FG000|Overall Study|Progression/relapse|53|||
131112201|NCT01498289|472041026|FG001|Overall Study|Progression/relapse|59|||
131112202|NCT01498289|472041025|FG000|Overall Study|Not protocol specified|7|||
131112203|NCT01498289|472041026|FG001|Overall Study|Not protocol specified|2|||
131112204|NCT01498289|472041025|FG000|Overall Study|Reason under review|0|||
131112205|NCT01498289|472041026|FG001|Overall Study|Reason under review|1|||
131112206|NCT03267940|472041027|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
131112207|NCT03267940|472041028|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
131112208|NCT03267940|472041029|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
131112209|NCT03267940|472041030|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
131112210|NCT03267940|472041031|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
131112211|NCT03267940|472041032|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
131112212|NCT03267940|472041027|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
131112213|NCT03267940|472041028|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
131112214|NCT03267940|472041029|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
131112215|NCT03267940|472041030|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
131112216|NCT03267940|472041031|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
131112217|NCT03267940|472041032|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
131112218|NCT03267940|472041027|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
131112219|NCT03267940|472041028|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
131112220|NCT03267940|472041029|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
131112221|NCT03267940|472041030|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
131112222|NCT03267940|472041031|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
131112223|NCT03267940|472041032|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
131112224|NCT03267940|472041027|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
131112225|NCT03267940|472041028|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
131112226|NCT03267940|472041029|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
131112227|NCT03267940|472041030|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
131112228|NCT03267940|472041031|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
131112229|NCT03267940|472041032|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
131112230|NCT03267940|472041027|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
131112231|NCT03267940|472041028|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
131112232|NCT03267940|472041029|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
131112233|NCT03267940|472041030|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
131112234|NCT03267940|472041031|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
131112235|NCT03267940|472041032|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
131112236|NCT03267940|472041027|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
131112237|NCT03267940|472041028|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
131112238|NCT03267940|472041029|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
131112239|NCT03267940|472041030|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
131112240|NCT03267940|472041031|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
131112241|NCT03267940|472041032|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
131112242|NCT03267940|472041027|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
131112243|NCT03267940|472041028|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
130691307|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
130691308|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691309|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691310|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691311|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130691312|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
130691313|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
131112244|NCT03267940|472041029|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
131112245|NCT03267940|472041030|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
131112246|NCT03267940|472041031|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
131112247|NCT03267940|472041032|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
131112248|NCT03267940|472041027|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
131112249|NCT03267940|472041028|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
131112250|NCT03267940|472041029|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
131112251|NCT03267940|472041030|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
131112252|NCT03267940|472041031|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
131112253|NCT03267940|472041032|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
131112254|NCT03267940|472041027|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
131112255|NCT03267940|472041028|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
131112256|NCT03267940|472041029|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
131112257|NCT03267940|472041030|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
131112258|NCT03267940|472041031|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
131112259|NCT03267940|472041032|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
131112260|NCT00388154|472041033|FG000|Overall Study|Withdrawal by Subject|1|||
131112261|NCT01948908|472041034|FG000|Overall Study|Protocol Violation|1|||
131112262|NCT01948908|472041035|FG001|Overall Study|Protocol Violation|0|||
131112263|NCT01948908|472041036|FG002|Overall Study|Protocol Violation|2|||
131112264|NCT00381303|472041037|FG000|Overall Study|Lost to Follow-up|25|||
131112265|NCT00381303|472041038|FG001|Overall Study|Lost to Follow-up|9|||
131112266|NCT00381303|472041037|FG000|Overall Study|AE/HIV-related event|22|||
131112267|NCT00381303|472041038|FG001|Overall Study|AE/HIV-related event|6|||
131112268|NCT00381303|472041037|FG000|Overall Study|Non-Adherence|13|||
131112269|NCT00381303|472041038|FG001|Overall Study|Non-Adherence|6|||
131112270|NCT00381303|472041037|FG000|Overall Study|Withdrawal by Subject|13|||
131112271|NCT00381303|472041038|FG001|Overall Study|Withdrawal by Subject|6|||
131112272|NCT00381303|472041037|FG000|Overall Study|Virologic failure|6|||
131112273|NCT00381303|472041038|FG001|Overall Study|Virologic failure|4|||
131112274|NCT00381303|472041037|FG000|Overall Study|Ineligible to continue the trial|2|||
131112275|NCT00381303|472041038|FG001|Overall Study|Ineligible to continue the trial|1|||
131112276|NCT00381303|472041037|FG000|Overall Study|Pregnancy|2|||
131112277|NCT00381303|472041038|FG001|Overall Study|Pregnancy|0|||
131112278|NCT00381303|472041037|FG000|Overall Study|Physician Decision|1|||
130897657|NCT00830869|471261625|FG005|Period 1: Part 1|Progressive disease|4|||
131112279|NCT00381303|472041038|FG001|Overall Study|Physician Decision|0|||
131112280|NCT00381303|472041037|FG000|Overall Study|Physician's decision to close the site|3|||
131112281|NCT00381303|472041038|FG001|Overall Study|Physician's decision to close the site|1|||
131112282|NCT00381303|472041037|FG000|Overall Study|Subject moved out of state|2|||
131112283|NCT00381303|472041038|FG001|Overall Study|Subject moved out of state|0|||
131112284|NCT00381303|472041037|FG000|Overall Study|Subject taking too many different meds|1|||
131112285|NCT00381303|472041038|FG001|Overall Study|Subject taking too many different meds|0|||
131112286|NCT00381303|472041037|FG000|Overall Study|No virologic response by week 12|1|||
131112287|NCT00381303|472041038|FG001|Overall Study|No virologic response by week 12|0|||
131112288|NCT00381303|472041037|FG000|Overall Study|Subject was too busy for appointments|1|||
130691314|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
130691315|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
130897658|NCT00830869|471261626|FG006|Period 1: Part 1|Progressive disease|1|||
130897659|NCT00830869|471261627|FG007|Period 1: Part 1|Progressive disease|0|||
130897660|NCT00830869|471261628|FG008|Period 1: Part 1|Progressive disease|0|||
130897661|NCT00830869|471261629|FG009|Period 1: Part 1|Progressive disease|0|||
130897662|NCT00830869|471261630|FG010|Period 1: Part 1|Progressive disease|0|||
130691316|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
130691317|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
130897663|NCT00830869|471261631|FG011|Period 1: Part 1|Progressive disease|0|||
130897664|NCT00830869|471261620|FG000|Period 2: Part 2|Protocol Violation|0|||
130897665|NCT00830869|471261621|FG001|Period 2: Part 2|Protocol Violation|0|||
130897666|NCT00830869|471261622|FG002|Period 2: Part 2|Protocol Violation|0|||
130897667|NCT00830869|471261623|FG003|Period 2: Part 2|Protocol Violation|0|||
130897668|NCT00830869|471261624|FG004|Period 2: Part 2|Protocol Violation|0|||
131112289|NCT00381303|472041038|FG001|Overall Study|Subject was too busy for appointments|0|||
131112290|NCT00381303|472041037|FG000|Overall Study|Subject did not continue visits|1|||
131112291|NCT00381303|472041038|FG001|Overall Study|Subject did not continue visits|0|||
130691318|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
130691319|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
130691320|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
130691321|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
130897669|NCT00830869|471261625|FG005|Period 2: Part 2|Protocol Violation|0|||
130897670|NCT00830869|471261626|FG006|Period 2: Part 2|Protocol Violation|0|||
131112292|NCT00381303|472041037|FG000|Overall Study|Subject primary physician's decision|1|||
131112293|NCT00381303|472041038|FG001|Overall Study|Subject primary physician's decision|0|||
131112294|NCT01211522|472041039|FG000|Overall Study|Withdrawal by Subject|3|||
131112295|NCT01211522|472041040|FG001|Overall Study|Withdrawal by Subject|7|||
131112296|NCT01211522|472041041|FG002|Overall Study|Withdrawal by Subject|5|||
131112297|NCT01777269|472041043|FG000|Overall Study|Adverse Event|24|||
131112298|NCT01777269|472041044|FG001|Overall Study|Adverse Event|33|||
130897671|NCT00830869|471261627|FG007|Period 2: Part 2|Protocol Violation|1|||
130767880|NCT00369161|470773906|FG000|Overall Study|Abnormal laboratory value|0|||
130767881|NCT00369161|470773907|FG001|Overall Study|Abnormal laboratory value|1|||
130767882|NCT00369161|470773906|FG000|Overall Study|Lack of Efficacy|3|||
130767883|NCT00369161|470773907|FG001|Overall Study|Lack of Efficacy|1|||
130767884|NCT00369161|470773906|FG000|Overall Study|Protocol Violation|0|||
130767885|NCT00369161|470773907|FG001|Overall Study|Protocol Violation|2|||
130691322|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
130767886|NCT00369161|470773906|FG000|Overall Study|Withdrawal by Subject|2|||
130767887|NCT00369161|470773907|FG001|Overall Study|Withdrawal by Subject|3|||
130767888|NCT00369161|470773906|FG000|Overall Study|Death|1|||
130767889|NCT00369161|470773907|FG001|Overall Study|Death|2|||
130767890|NCT00369161|470773906|FG000|Overall Study|Graft loss|4|||
130767891|NCT00369161|470773907|FG001|Overall Study|Graft loss|0|||
130767892|NCT00369161|470773906|FG000|Overall Study|Administrative Problem|2|||
130767893|NCT00369161|470773907|FG001|Overall Study|Administrative Problem|2|||
130767894|NCT02147067|470773910|FG000|Overall Study|Withdrawal by Subject|2|||
130767895|NCT02147067|470773911|FG001|Overall Study|Withdrawal by Subject|2|||
130767896|NCT01404949|470773912|FG000|Overall Study|Not Treated|1|||
130767897|NCT03411902|470773913|FG000|Overall Study|Lost to Follow-up|3|||
130767898|NCT03411902|470773914|FG001|Overall Study|Lost to Follow-up|0|||
130767899|NCT00419159|470773915|FG000|Overall Study|Adverse Event|7|||
130767900|NCT00419159|470773916|FG001|Overall Study|Adverse Event|15|||
130767901|NCT00419159|470773915|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130767902|NCT00419159|470773916|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130767903|NCT00419159|470773915|FG000|Overall Study|Subject's no longer requires study drug|0|||
130767904|NCT00419159|470773916|FG001|Overall Study|Subject's no longer requires study drug|1|||
130691323|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
130691324|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
130691325|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
130691326|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691327|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691328|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691329|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691330|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691331|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691332|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691333|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691334|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
130691335|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
130691336|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691337|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691338|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691339|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130691340|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
130691341|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
130691342|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
130691343|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
130691344|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
130691345|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
130691346|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
130691347|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
130691348|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
130691349|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
130691350|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
130691351|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
130691352|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
130691353|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
130691354|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691355|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691356|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130767905|NCT00419159|470773915|FG000|Overall Study|Protocol Violation|1|||
130767906|NCT00419159|470773916|FG001|Overall Study|Protocol Violation|0|||
130767907|NCT00419159|470773915|FG000|Overall Study|Withdrawal by Subject|10|||
130767908|NCT00419159|470773916|FG001|Overall Study|Withdrawal by Subject|3|||
130767909|NCT00419159|470773915|FG000|Overall Study|Lost to Follow-up|0|||
130767910|NCT00419159|470773916|FG001|Overall Study|Lost to Follow-up|1|||
130767911|NCT00419159|470773915|FG000|Overall Study|Death|2|||
131112299|NCT01777269|472041043|FG000|Overall Study|Lack of Efficacy|8|||
131112300|NCT01777269|472041044|FG001|Overall Study|Lack of Efficacy|10|||
131112301|NCT01777269|472041043|FG000|Overall Study|Protocol Violation|4|||
131112302|NCT01777269|472041044|FG001|Overall Study|Protocol Violation|4|||
130691357|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691358|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691359|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691360|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691361|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691362|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
130691363|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
130691364|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691365|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691366|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691367|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130691368|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691369|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691370|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691371|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691372|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691373|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691374|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691375|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691376|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
130691377|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
130691378|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691379|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691380|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130691381|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130767912|NCT00419159|470773916|FG001|Overall Study|Death|2|||
130691382|NCT01695239|470495856|FG000|Extension Long-Term Extension Periods|Death|0|||
130691383|NCT01695239|470495857|FG001|Extension Long-Term Extension Periods|Death|0|||
130691384|NCT01695239|470495858|FG002|Extension Long-Term Extension Periods|Death|0|||
130691385|NCT01695239|470495859|FG003|Extension Long-Term Extension Periods|Death|0|||
130691386|NCT01695239|470495860|FG004|Extension Long-Term Extension Periods|Death|0|||
130691387|NCT01695239|470495861|FG005|Extension Long-Term Extension Periods|Death|0|||
130691388|NCT01695239|470495862|FG006|Extension Long-Term Extension Periods|Death|0|||
130691389|NCT01695239|470495863|FG007|Extension Long-Term Extension Periods|Death|0|||
130691390|NCT01695239|470495864|FG008|Extension Long-Term Extension Periods|Death|1|||
130691391|NCT01695239|470495865|FG009|Extension Long-Term Extension Periods|Death|0|||
130691392|NCT01695239|470495866|FG010|Extension Long-Term Extension Periods|Death|0|||
130691393|NCT01695239|470495867|FG011|Extension Long-Term Extension Periods|Death|0|||
130691394|NCT01695239|470495868|FG012|Extension Long-Term Extension Periods|Death|0|||
130691395|NCT01695239|470495869|FG013|Extension Long-Term Extension Periods|Death|0|||
130767913|NCT00419159|470773915|FG000|Overall Study|Disease progression|79|||
130767914|NCT00419159|470773916|FG001|Overall Study|Disease progression|76|||
130767915|NCT01017601|470773917|FG000|Overall Study|Disease Progression|12|||
130767916|NCT01017601|470773918|FG001|Overall Study|Disease Progression|12|||
130767917|NCT01017601|470773917|FG000|Overall Study|Withdrawal by Subject|0|||
130767918|NCT01017601|470773918|FG001|Overall Study|Withdrawal by Subject|1|||
130767919|NCT00574795|470773920|FG000|Infant Series|Withdrawal by Subject|2|||
130767920|NCT00574795|470773920|FG000|Infant Series|Protocol Violation|2|||
130767921|NCT00574795|470773920|FG000|Infant Series|Adverse Event|1|||
130767922|NCT00574795|470773920|FG000|After Infant Series|Withdrawal by Subject|1|||
130767923|NCT00574795|470773920|FG000|After Infant Series|Adverse Event|2|||
130767924|NCT00574795|470773920|FG000|Toddler Dose|Withdrawal by Subject|1|||
130767925|NCT02638259|470773921|FG000|Treatment Period 1|Adverse Event|1|||
130767926|NCT02638259|470773922|FG001|Treatment Period 1|Adverse Event|5|||
130767927|NCT02638259|470773921|FG000|Treatment Period 1|Death|0|||
130767928|NCT02638259|470773922|FG001|Treatment Period 1|Death|1|||
130767929|NCT02638259|470773921|FG000|Treatment Period 1|Lack of Efficacy|0|||
130767930|NCT02638259|470773922|FG001|Treatment Period 1|Lack of Efficacy|1|||
130767931|NCT02638259|470773921|FG000|Treatment Period 1|Protocol Violation|0|||
130767932|NCT02638259|470773922|FG001|Treatment Period 1|Protocol Violation|3|||
131025409|NCT04019444|471723260|FG001|Overall Study|Withdrawal by Subject|1|||
131025410|NCT04019444|471723261|FG002|Overall Study|Withdrawal by Subject|0|||
131025411|NCT04019444|471723262|FG003|Overall Study|Withdrawal by Subject|1|||
130767933|NCT02638259|470773921|FG000|Treatment Period 1|Withdrawal by Subject|4|||
130767934|NCT02638259|470773922|FG001|Treatment Period 1|Withdrawal by Subject|6|||
130767935|NCT02638259|470773921|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
130767936|NCT02638259|470773922|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
130767937|NCT02638259|470773921|FG000|Treatment Period 2|Adverse Event|5|||
130767938|NCT02638259|470773922|FG001|Treatment Period 2|Adverse Event|4|||
130767939|NCT02638259|470773921|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131025412|NCT04019444|471723259|FG000|Overall Study|Solicited Event|0|||
131025413|NCT04019444|471723260|FG001|Overall Study|Solicited Event|0|||
130897672|NCT00830869|471261628|FG008|Period 2: Part 2|Protocol Violation|0|||
130897673|NCT00830869|471261629|FG009|Period 2: Part 2|Protocol Violation|1|||
130897674|NCT00830869|471261630|FG010|Period 2: Part 2|Protocol Violation|0|||
130897675|NCT00830869|471261631|FG011|Period 2: Part 2|Protocol Violation|0|||
130897676|NCT00830869|471261620|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
130897677|NCT00830869|471261621|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
130897678|NCT00830869|471261622|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
130897679|NCT00830869|471261623|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
130897680|NCT00830869|471261624|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
130897681|NCT00830869|471261625|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
130897682|NCT00830869|471261626|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
130897683|NCT00830869|471261627|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
130897684|NCT00830869|471261628|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
130897685|NCT00830869|471261629|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
130897686|NCT00830869|471261630|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
130897687|NCT00830869|471261631|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
130897688|NCT00830869|471261620|FG000|Period 2: Part 2|Adverse Event|0|||
130897689|NCT00830869|471261621|FG001|Period 2: Part 2|Adverse Event|0|||
130897690|NCT00830869|471261622|FG002|Period 2: Part 2|Adverse Event|0|||
130897691|NCT00830869|471261623|FG003|Period 2: Part 2|Adverse Event|0|||
130897692|NCT00830869|471261624|FG004|Period 2: Part 2|Adverse Event|0|||
130897693|NCT00830869|471261625|FG005|Period 2: Part 2|Adverse Event|0|||
130897694|NCT00830869|471261626|FG006|Period 2: Part 2|Adverse Event|0|||
130897695|NCT00830869|471261627|FG007|Period 2: Part 2|Adverse Event|4|||
130897696|NCT00830869|471261628|FG008|Period 2: Part 2|Adverse Event|3|||
130897697|NCT00830869|471261629|FG009|Period 2: Part 2|Adverse Event|2|||
130897698|NCT00830869|471261630|FG010|Period 2: Part 2|Adverse Event|2|||
130897699|NCT00830869|471261631|FG011|Period 2: Part 2|Adverse Event|0|||
130897700|NCT00830869|471261620|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
130897701|NCT00830869|471261621|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
130897702|NCT00830869|471261622|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
130897703|NCT00830869|471261623|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
130897704|NCT00830869|471261624|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
130897705|NCT00830869|471261625|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
130897706|NCT00830869|471261626|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
130897707|NCT00830869|471261627|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
130897708|NCT00830869|471261628|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
130897709|NCT00830869|471261629|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
130897710|NCT00830869|471261630|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
130897711|NCT00830869|471261631|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
130897712|NCT00830869|471261620|FG000|Period 2: Part 2|Progressive disease|0|||
130897713|NCT00830869|471261621|FG001|Period 2: Part 2|Progressive disease|0|||
130897714|NCT00830869|471261622|FG002|Period 2: Part 2|Progressive disease|0|||
130897715|NCT00830869|471261623|FG003|Period 2: Part 2|Progressive disease|0|||
130897716|NCT00830869|471261624|FG004|Period 2: Part 2|Progressive disease|0|||
130897717|NCT00830869|471261625|FG005|Period 2: Part 2|Progressive disease|0|||
130897718|NCT00830869|471261626|FG006|Period 2: Part 2|Progressive disease|0|||
130897719|NCT00830869|471261627|FG007|Period 2: Part 2|Progressive disease|14|||
130897720|NCT00830869|471261628|FG008|Period 2: Part 2|Progressive disease|11|||
130897721|NCT00830869|471261629|FG009|Period 2: Part 2|Progressive disease|12|||
130897722|NCT00830869|471261630|FG010|Period 2: Part 2|Progressive disease|8|||
130897723|NCT00830869|471261631|FG011|Period 2: Part 2|Progressive disease|15|||
130897724|NCT00830869|471261620|FG000|Period 2: Part 2|Other|0|||
130897725|NCT00830869|471261621|FG001|Period 2: Part 2|Other|0|||
130897726|NCT00830869|471261622|FG002|Period 2: Part 2|Other|0|||
130897727|NCT00830869|471261623|FG003|Period 2: Part 2|Other|0|||
130897728|NCT00830869|471261624|FG004|Period 2: Part 2|Other|0|||
130897729|NCT00830869|471261625|FG005|Period 2: Part 2|Other|0|||
130897730|NCT00830869|471261626|FG006|Period 2: Part 2|Other|0|||
130897731|NCT00830869|471261627|FG007|Period 2: Part 2|Other|0|||
130897732|NCT00830869|471261628|FG008|Period 2: Part 2|Other|0|||
130897733|NCT00830869|471261629|FG009|Period 2: Part 2|Other|1|||
130897734|NCT00830869|471261630|FG010|Period 2: Part 2|Other|0|||
130897735|NCT00830869|471261631|FG011|Period 2: Part 2|Other|0|||
130897736|NCT03745820|471261632|FG000|Overall Study|Adverse Event|0|||
131025414|NCT04019444|471723261|FG002|Overall Study|Solicited Event|2|||
131025415|NCT04019444|471723262|FG003|Overall Study|Solicited Event|0|||
130897737|NCT03745820|471261633|FG001|Overall Study|Adverse Event|3|||
130897738|NCT03745820|471261634|FG002|Overall Study|Adverse Event|2|||
130897739|NCT03745820|471261632|FG000|Overall Study|Non-Compliance with Study Drug|4|||
130897740|NCT03745820|471261633|FG001|Overall Study|Non-Compliance with Study Drug|3|||
130897741|NCT03745820|471261634|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130897742|NCT03745820|471261632|FG000|Overall Study|Withdrawal by Subject|4|||
130897743|NCT03745820|471261633|FG001|Overall Study|Withdrawal by Subject|4|||
130897744|NCT03745820|471261634|FG002|Overall Study|Withdrawal by Subject|4|||
130897745|NCT03745820|471261632|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
131025416|NCT01303445|471723274|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
130897746|NCT03745820|471261633|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
130897747|NCT03745820|471261634|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
130897748|NCT03745820|471261632|FG000|Overall Study|Lost to Follow-up|2|||
130897749|NCT03745820|471261633|FG001|Overall Study|Lost to Follow-up|0|||
130897750|NCT03745820|471261634|FG002|Overall Study|Lost to Follow-up|3|||
130897751|NCT03745820|471261632|FG000|Overall Study|Reason not Specified|2|||
130897752|NCT03745820|471261633|FG001|Overall Study|Reason not Specified|4|||
130897753|NCT03745820|471261634|FG002|Overall Study|Reason not Specified|1|||
130897754|NCT00507728|471261635|FG000|Randomization to Month 3|Lost to Follow-up|15|||
130897755|NCT00507728|471261636|FG001|Randomization to Month 3|Lost to Follow-up|14|||
130897756|NCT00507728|471261637|FG002|Randomization to Month 3|Lost to Follow-up|20|||
130897757|NCT00507728|471261635|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
130897758|NCT00507728|471261636|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
130897759|NCT00507728|471261637|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
130897760|NCT03680742|471261638|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
130897761|NCT01410357|471261639|FG000|Overall Study|Death|2|||
130897762|NCT01410357|471261640|FG001|Overall Study|Death|1|||
130897763|NCT01410357|471261639|FG000|Overall Study|Withdrawal by Subject|1|||
130897764|NCT01410357|471261640|FG001|Overall Study|Withdrawal by Subject|2|||
130897765|NCT01410357|471261639|FG000|Overall Study|Lost to Follow-up|23|||
130897766|NCT01410357|471261640|FG001|Overall Study|Lost to Follow-up|21|||
130897767|NCT00668733|471261641|FG000|Overall Study|Lost to Follow-up|2|||
130897768|NCT00668733|471261642|FG001|Overall Study|Lost to Follow-up|3|||
130897769|NCT00668733|471261641|FG000|Overall Study|Withdrawal by Subject|0|||
130897770|NCT00668733|471261642|FG001|Overall Study|Withdrawal by Subject|4|||
130897771|NCT01909791|471261643|FG000|Overall Study|Death|9|||
130897772|NCT01909791|471261644|FG001|Overall Study|Death|8|||
130897773|NCT01909791|471261645|FG002|Overall Study|Death|4|||
130897774|NCT01909791|471261643|FG000|Overall Study|Withdrawal by Subject|5|||
130897775|NCT01909791|471261644|FG001|Overall Study|Withdrawal by Subject|9|||
130897776|NCT01909791|471261645|FG002|Overall Study|Withdrawal by Subject|13|||
130897777|NCT01909791|471261643|FG000|Overall Study|Lost to Follow-up|5|||
130897778|NCT01909791|471261644|FG001|Overall Study|Lost to Follow-up|11|||
130897779|NCT01909791|471261645|FG002|Overall Study|Lost to Follow-up|10|||
130897780|NCT01909791|471261643|FG000|Overall Study|Missed Visit|2|||
130897781|NCT01909791|471261644|FG001|Overall Study|Missed Visit|0|||
130897782|NCT01909791|471261645|FG002|Overall Study|Missed Visit|1|||
130897783|NCT01659554|471261646|FG000|Overall Study|Study Termination|4|||
130897784|NCT00945906|471261649|FG000|Overall Study|Withdrawal by Subject|1|||
130897785|NCT00945906|471261649|FG000|Overall Study|Did not want to return for last visit|2|||
130897786|NCT00945906|471261649|FG000|Overall Study|Unable to return for last visit|2|||
130897787|NCT00945906|471261649|FG000|Overall Study|Moved to another country|2|||
130897788|NCT03330002|471261652|FG000|Overall Study|Lost to Follow-up|15|||
130897789|NCT03330002|471261652|FG000|Overall Study|Death|7|||
130897790|NCT00635219|471261653|FG000|Overall Study|Adverse Event|12|||
130897791|NCT00635219|471261654|FG001|Overall Study|Adverse Event|10|||
130897792|NCT00635219|471261655|FG002|Overall Study|Adverse Event|18|||
130897793|NCT00635219|471261656|FG003|Overall Study|Adverse Event|15|||
130897794|NCT00635219|471261657|FG004|Overall Study|Adverse Event|19|||
130897795|NCT00635219|471261653|FG000|Overall Study|Lack of Efficacy|5|||
130897796|NCT00635219|471261654|FG001|Overall Study|Lack of Efficacy|6|||
130897797|NCT00635219|471261655|FG002|Overall Study|Lack of Efficacy|3|||
130897798|NCT00635219|471261656|FG003|Overall Study|Lack of Efficacy|4|||
130897799|NCT00635219|471261657|FG004|Overall Study|Lack of Efficacy|6|||
130897800|NCT00635219|471261653|FG000|Overall Study|Non-compliance With Study Product|0|||
130897801|NCT00635219|471261654|FG001|Overall Study|Non-compliance With Study Product|0|||
130897802|NCT00635219|471261655|FG002|Overall Study|Non-compliance With Study Product|0|||
130897803|NCT00635219|471261656|FG003|Overall Study|Non-compliance With Study Product|2|||
130897804|NCT00635219|471261657|FG004|Overall Study|Non-compliance With Study Product|1|||
130897805|NCT00635219|471261653|FG000|Overall Study|Protocol Violation|0|||
130897806|NCT00635219|471261654|FG001|Overall Study|Protocol Violation|2|||
130897807|NCT00635219|471261655|FG002|Overall Study|Protocol Violation|3|||
130897808|NCT00635219|471261656|FG003|Overall Study|Protocol Violation|2|||
130897809|NCT00635219|471261657|FG004|Overall Study|Protocol Violation|4|||
130897810|NCT00635219|471261653|FG000|Overall Study|Withdrawal of Consent|8|||
130897811|NCT00635219|471261654|FG001|Overall Study|Withdrawal of Consent|6|||
130897812|NCT00635219|471261655|FG002|Overall Study|Withdrawal of Consent|8|||
130897813|NCT00635219|471261656|FG003|Overall Study|Withdrawal of Consent|11|||
130897814|NCT00635219|471261657|FG004|Overall Study|Withdrawal of Consent|8|||
130897815|NCT00635219|471261653|FG000|Overall Study|Lost to Follow-up|0|||
130897816|NCT00635219|471261654|FG001|Overall Study|Lost to Follow-up|0|||
130897817|NCT00635219|471261655|FG002|Overall Study|Lost to Follow-up|2|||
130897818|NCT00635219|471261656|FG003|Overall Study|Lost to Follow-up|0|||
130897819|NCT00635219|471261657|FG004|Overall Study|Lost to Follow-up|3|||
131025417|NCT01303445|471723275|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
131025418|NCT01303445|471723274|FG000|Second Intervention (7 Days)|Adverse Event|0|||
131025419|NCT01303445|471723275|FG001|Second Intervention (7 Days)|Adverse Event|2|||
130897820|NCT00635219|471261653|FG000|Overall Study|Administrative or Other Reasons|0|||
130897821|NCT00635219|471261654|FG001|Overall Study|Administrative or Other Reasons|1|||
130897822|NCT00635219|471261655|FG002|Overall Study|Administrative or Other Reasons|1|||
130897823|NCT00635219|471261656|FG003|Overall Study|Administrative or Other Reasons|0|||
130897824|NCT00635219|471261657|FG004|Overall Study|Administrative or Other Reasons|1|||
130897825|NCT01598129|471261658|FG000|Overall Study|Disease progression|6|||
130897826|NCT01598129|471261658|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
130897827|NCT01598129|471261658|FG000|Overall Study|Withdrawal by Subject|1|||
130897828|NCT00505076|471261659|FG000|Overall Study|Adverse Event|1|||
130897829|NCT00505076|471261660|FG001|Overall Study|Adverse Event|0|||
130897830|NCT00505076|471261661|FG002|Overall Study|Adverse Event|1|||
130897831|NCT00505076|471261659|FG000|Overall Study|Protocol Violation|2|||
130897832|NCT00505076|471261660|FG001|Overall Study|Protocol Violation|1|||
130897833|NCT00505076|471261661|FG002|Overall Study|Protocol Violation|2|||
130897834|NCT00505076|471261659|FG000|Overall Study|Withdrawal by Subject|0|||
130897835|NCT00505076|471261660|FG001|Overall Study|Withdrawal by Subject|1|||
130897836|NCT00505076|471261661|FG002|Overall Study|Withdrawal by Subject|2|||
130897837|NCT00591318|471261664|FG000|Overall Study|Lack of Efficacy|2|||
130897838|NCT00591318|471261665|FG001|Overall Study|Lack of Efficacy|0|||
130897839|NCT00591318|471261664|FG000|Overall Study|Adverse Event|2|||
130897840|NCT00591318|471261665|FG001|Overall Study|Adverse Event|0|||
130897841|NCT00233454|471261668|FG000|Overall Study|Death|6|||
130897842|NCT04224688|471261672|FG000|Overall Study|Withdrawal by Subject|1|||
130897843|NCT04224688|471261673|FG001|Overall Study|Withdrawal by Subject|3|||
130897844|NCT04224688|471261672|FG000|Overall Study|Lack of Efficacy|1|||
130897845|NCT04224688|471261673|FG001|Overall Study|Lack of Efficacy|1|||
130897846|NCT04224688|471261672|FG000|Overall Study|Adverse event, not fatal|0|||
130897847|NCT04224688|471261673|FG001|Overall Study|Adverse event, not fatal|2|||
130897848|NCT04224688|471261672|FG000|Overall Study|COVID-19|0|||
130897849|NCT04224688|471261673|FG001|Overall Study|COVID-19|1|||
130897850|NCT02745145|471261674|FG000|Overall Study|Adverse Event|1|||
130897851|NCT02745145|471261675|FG001|Overall Study|Adverse Event|0|||
130897852|NCT02745145|471261676|FG002|Overall Study|Adverse Event|0|||
130897853|NCT02745145|471261674|FG000|Overall Study|Death|0|||
130897854|NCT02745145|471261675|FG001|Overall Study|Death|1|||
130897855|NCT02745145|471261676|FG002|Overall Study|Death|0|||
130897856|NCT02745145|471261674|FG000|Overall Study|Progressive disease|0|||
130897857|NCT02745145|471261675|FG001|Overall Study|Progressive disease|0|||
130897858|NCT02745145|471261676|FG002|Overall Study|Progressive disease|1|||
130897859|NCT02745145|471261674|FG000|Overall Study|Withdrew consent|1|||
130897860|NCT02745145|471261675|FG001|Overall Study|Withdrew consent|1|||
130897861|NCT02745145|471261676|FG002|Overall Study|Withdrew consent|1|||
130897862|NCT02745145|471261674|FG000|Overall Study|Study Termination|8|||
130897863|NCT02745145|471261675|FG001|Overall Study|Study Termination|3|||
130897864|NCT02745145|471261676|FG002|Overall Study|Study Termination|7|||
130897865|NCT00388583|471261677|FG000|Overall Study|Protocol Violation|1|||
131025420|NCT01303445|471723274|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
131025421|NCT01303445|471723275|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
130691396|NCT01695239|470495856|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691397|NCT01695239|470495857|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691398|NCT01695239|470495858|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691399|NCT01695239|470495859|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691400|NCT01695239|470495860|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691401|NCT01695239|470495861|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691402|NCT01695239|470495862|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130897866|NCT00388583|471261678|FG001|Overall Study|Protocol Violation|0|||
131025422|NCT01303445|471723274|FG000|Washout (14 Days)|Protocol Violation|1|||
131025423|NCT01303445|471723275|FG001|Washout (14 Days)|Protocol Violation|0|||
131025424|NCT01303445|471723274|FG000|Washout (14 Days)|Lost to Follow-up|0|||
131025425|NCT01303445|471723275|FG001|Washout (14 Days)|Lost to Follow-up|2|||
131025426|NCT01303445|471723274|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
131025427|NCT01303445|471723275|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
131025428|NCT01303445|471723274|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
131025429|NCT01303445|471723275|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
131025430|NCT04939246|471723276|FG000|After Treatment|Death|4|||
131025431|NCT04939246|471723276|FG000|After Treatment|Lost to Follow-up|1|||
131025432|NCT04939246|471723276|FG000|After Treatment|Discharged to hospice|2|||
131025433|NCT04994509|471723277|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
130897867|NCT00388583|471261677|FG000|Overall Study|Withdrawal by Subject|3|||
130897868|NCT00388583|471261678|FG001|Overall Study|Withdrawal by Subject|3|||
130897869|NCT00388583|471261677|FG000|Overall Study|Serious Adverse Event|2|||
130691403|NCT01695239|470495863|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130897870|NCT00388583|471261678|FG001|Overall Study|Serious Adverse Event|0|||
130897871|NCT00388583|471261677|FG000|Overall Study|Did not receive vaccine|0|||
130897872|NCT00388583|471261678|FG001|Overall Study|Did not receive vaccine|1|||
130897873|NCT01155011|471261680|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
130897874|NCT01155011|471261681|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
130897875|NCT01155011|471261680|FG000|Baseline to 6 Months|investigator decision, moved|4|||
130897876|NCT01155011|471261681|FG001|Baseline to 6 Months|investigator decision, moved|5|||
130897877|NCT01155011|471261680|FG000|Baseline to 6 Months|Death|0|||
130897878|NCT01155011|471261681|FG001|Baseline to 6 Months|Death|1|||
130897879|NCT01155011|471261680|FG000|6 to 12 Months|Withdrawal by Subject|8|||
130897880|NCT01155011|471261681|FG001|6 to 12 Months|Withdrawal by Subject|5|||
130897881|NCT01155011|471261680|FG000|6 to 12 Months|Death|1|||
130897882|NCT01155011|471261681|FG001|6 to 12 Months|Death|5|||
130897883|NCT01743001|471261682|FG000|Overall Study|Physician Decision|1|||
130897884|NCT01743001|471261683|FG001|Overall Study|Physician Decision|0|||
130897885|NCT01743001|471261682|FG000|Overall Study|Pregnancy|1|||
130897886|NCT01743001|471261683|FG001|Overall Study|Pregnancy|0|||
130897887|NCT01743001|471261682|FG000|Overall Study|Death|1|||
130897888|NCT01743001|471261683|FG001|Overall Study|Death|0|||
130897889|NCT01565343|471261686|FG000|Overall Study|Administrative decision/technical issues|1|||
130897890|NCT01565343|471261687|FG001|Overall Study|Administrative decision/technical issues|0|||
130897891|NCT01565343|471261688|FG002|Overall Study|Administrative decision/technical issues|0|||
130897892|NCT02709538|471261693|FG000|Overall Study|Adverse Event|13|||
130897893|NCT02709538|471261694|FG001|Overall Study|Adverse Event|2|||
130897894|NCT02709538|471261695|FG002|Overall Study|Adverse Event|3|||
130897895|NCT02709538|471261693|FG000|Overall Study|Lack of Efficacy|1|||
130897896|NCT02709538|471261694|FG001|Overall Study|Lack of Efficacy|0|||
130897897|NCT02709538|471261695|FG002|Overall Study|Lack of Efficacy|0|||
130897898|NCT02709538|471261693|FG000|Overall Study|Lost to Follow-up|24|||
130897899|NCT02709538|471261694|FG001|Overall Study|Lost to Follow-up|8|||
130897900|NCT02709538|471261695|FG002|Overall Study|Lost to Follow-up|4|||
130897901|NCT02709538|471261693|FG000|Overall Study|Physician Decision|1|||
130897902|NCT02709538|471261694|FG001|Overall Study|Physician Decision|0|||
130897903|NCT02709538|471261695|FG002|Overall Study|Physician Decision|0|||
130897904|NCT02709538|471261693|FG000|Overall Study|Withdrawal by Subject|40|||
130897905|NCT02709538|471261694|FG001|Overall Study|Withdrawal by Subject|7|||
130897906|NCT02709538|471261695|FG002|Overall Study|Withdrawal by Subject|4|||
130897907|NCT02709538|471261693|FG000|Overall Study|Non-compliance with study procedures|5|||
130897908|NCT02709538|471261694|FG001|Overall Study|Non-compliance with study procedures|0|||
130897909|NCT02709538|471261695|FG002|Overall Study|Non-compliance with study procedures|0|||
130897910|NCT02709538|471261693|FG000|Overall Study|Non-compliance with study drug|2|||
130897911|NCT02709538|471261694|FG001|Overall Study|Non-compliance with study drug|0|||
130897912|NCT02709538|471261695|FG002|Overall Study|Non-compliance with study drug|0|||
130897913|NCT02709538|471261693|FG000|Overall Study|Protocol deviation|10|||
130897914|NCT02709538|471261694|FG001|Overall Study|Protocol deviation|4|||
130897915|NCT02709538|471261695|FG002|Overall Study|Protocol deviation|4|||
130897916|NCT02709538|471261693|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
130897917|NCT02709538|471261694|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
130897918|NCT02709538|471261695|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
130897919|NCT02709538|471261693|FG000|Overall Study|Other|16|||
130767940|NCT02638259|470773922|FG001|Treatment Period 2|Withdrawal by Subject|7|||
130767941|NCT02073656|470773939|FG000|Primary Study|Lost to Follow-up|6|||
130767942|NCT02073656|470773939|FG000|Primary Study|Death|1|||
130767943|NCT02073656|470773939|FG000|Primary Study|Withdrew Consent|1|||
130767944|NCT02536781|470773942|FG000|Overall Study|Lost to Follow-up|2|||
130767945|NCT02536781|470773943|FG001|Overall Study|Lost to Follow-up|0|||
130767946|NCT03423147|470773944|FG000|Overall Study|Lost to Follow-up|5|||
130767947|NCT03423147|470773945|FG001|Overall Study|Lost to Follow-up|8|||
130767948|NCT03423147|470773944|FG000|Overall Study|Withdrawal by Subject|1|||
130767949|NCT03423147|470773945|FG001|Overall Study|Withdrawal by Subject|0|||
130897920|NCT02709538|471261694|FG001|Overall Study|Other|7|||
130897921|NCT02709538|471261695|FG002|Overall Study|Other|5|||
130897922|NCT01433289|471261696|FG000|Overall Study|Pregnancy|0|||
130897923|NCT01433289|471261697|FG001|Overall Study|Pregnancy|1|||
130897924|NCT01433289|471261698|FG002|Overall Study|Pregnancy|0|||
130897925|NCT01433289|471261699|FG003|Overall Study|Pregnancy|0|||
130897926|NCT04343235|471261700|FG000|Overall Study|Lost to Follow-up|3|||
130897927|NCT04343235|471261701|FG001|Overall Study|Lost to Follow-up|2|||
130767950|NCT03423147|470773944|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
130897928|NCT01763996|471261702|FG000|Treatment Period 2|Adverse Event|0|||
130897929|NCT01763996|471261703|FG001|Treatment Period 2|Adverse Event|1|||
130897930|NCT01788215|471261706|FG000|Overall Study|Withdrawal by Subject|0|||
130897931|NCT01788215|471261707|FG001|Overall Study|Withdrawal by Subject|1|||
131025434|NCT04994509|471723278|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
131025435|NCT04994509|471723279|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
130767951|NCT03423147|470773945|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
130897932|NCT01788215|471261706|FG000|Overall Study|Lost to Follow-up|2|||
130897933|NCT01788215|471261707|FG001|Overall Study|Lost to Follow-up|0|||
131025436|NCT04994509|471723277|FG000|Overall Study|Withdrew Consent|73|||
130767952|NCT03423147|470773944|FG000|Overall Study|Age < 18|1|||
130897934|NCT00275340|471261708|FG000|Overall Study|Lost to Follow-up|2|||
130897935|NCT00275340|471261709|FG001|Overall Study|Lost to Follow-up|4|||
130897936|NCT00271505|471261716|FG000|Overall Study|Screen Failure|3|||
130897937|NCT00271505|471261716|FG000|Overall Study|Adverse Event|1|||
130897938|NCT00271505|471261716|FG000|Overall Study|Death|1|||
130897939|NCT03753789|471261720|FG000|Overall Study|Withdrawal by Subject|2|||
130897940|NCT01578850|471261721|FG000|Period 1|Insufficient Clinical Response|1|||
130897941|NCT01578850|471261722|FG001|Period 1|Insufficient Clinical Response|0|||
130897942|NCT01578850|471261723|FG002|Period 1|Insufficient Clinical Response|0|||
130897943|NCT01578850|471261721|FG000|Period 1|Adverse Event|11|||
130897944|NCT01578850|471261722|FG001|Period 1|Adverse Event|0|||
130897945|NCT01578850|471261723|FG002|Period 1|Adverse Event|0|||
130897946|NCT01578850|471261721|FG000|Period 1|Death|1|||
130897947|NCT01578850|471261722|FG001|Period 1|Death|0|||
130897948|NCT01578850|471261723|FG002|Period 1|Death|0|||
130897949|NCT01578850|471261721|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
130897950|NCT01578850|471261722|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
130897951|NCT01578850|471261723|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
130897952|NCT01578850|471261721|FG000|Period 1|Withdrawal by Subject|9|||
130897953|NCT01578850|471261722|FG001|Period 1|Withdrawal by Subject|0|||
130897954|NCT01578850|471261723|FG002|Period 1|Withdrawal by Subject|0|||
130897955|NCT01578850|471261721|FG000|Period 1|Study Terminated by Sponsor|3|||
130897956|NCT01578850|471261722|FG001|Period 1|Study Terminated by Sponsor|0|||
130897957|NCT01578850|471261723|FG002|Period 1|Study Terminated by Sponsor|0|||
130897958|NCT01578850|471261721|FG000|Period 2|Insufficient Clinical Response|0|||
130897959|NCT01578850|471261722|FG001|Period 2|Insufficient Clinical Response|1|||
130897960|NCT01578850|471261723|FG002|Period 2|Insufficient Clinical Response|0|||
130897961|NCT01578850|471261721|FG000|Period 2|Adverse Event|0|||
130897962|NCT01578850|471261722|FG001|Period 2|Adverse Event|3|||
130897963|NCT01578850|471261723|FG002|Period 2|Adverse Event|6|||
130897964|NCT01578850|471261721|FG000|Period 2|Lost to Follow-up|0|||
130897965|NCT01578850|471261722|FG001|Period 2|Lost to Follow-up|1|||
130897966|NCT01578850|471261723|FG002|Period 2|Lost to Follow-up|2|||
130897967|NCT01578850|471261721|FG000|Period 2|Withdrawal by Subject|0|||
130897968|NCT01578850|471261722|FG001|Period 2|Withdrawal by Subject|2|||
130897969|NCT01578850|471261723|FG002|Period 2|Withdrawal by Subject|2|||
130897970|NCT01578850|471261721|FG000|Period 2|Study Terminated by Sponsor|0|||
130897971|NCT01578850|471261722|FG001|Period 2|Study Terminated by Sponsor|5|||
130897972|NCT01578850|471261723|FG002|Period 2|Study Terminated by Sponsor|4|||
130897973|NCT01578850|471261721|FG000|Period 2|Unspecified Reasons|0|||
130897974|NCT01578850|471261722|FG001|Period 2|Unspecified Reasons|1|||
130897975|NCT01578850|471261723|FG002|Period 2|Unspecified Reasons|0|||
130897976|NCT02744040|471261724|FG000|Overall Study|Withdrawal by Subject|3|||
130897977|NCT02744040|471261725|FG001|Overall Study|Withdrawal by Subject|2|||
130897978|NCT02744040|471261726|FG002|Overall Study|Withdrawal by Subject|2|||
130897979|NCT02744040|471261724|FG000|Overall Study|Physician Decision|0|||
130897980|NCT02744040|471261725|FG001|Overall Study|Physician Decision|8|||
130897981|NCT02744040|471261726|FG002|Overall Study|Physician Decision|13|||
130897982|NCT02744040|471261724|FG000|Overall Study|Lost to Follow-up|3|||
130897983|NCT02744040|471261725|FG001|Overall Study|Lost to Follow-up|1|||
130897984|NCT02744040|471261726|FG002|Overall Study|Lost to Follow-up|7|||
130897985|NCT03288142|471261730|FG000|Overall Study|Lost to Follow-up|22|||
130897986|NCT03288142|471261731|FG001|Overall Study|Lost to Follow-up|15|||
130897987|NCT00946153|471261732|FG000|Phase 2|Adverse Event|0|||
130897988|NCT00946153|471261733|FG001|Phase 2|Adverse Event|0|||
130897989|NCT00946153|471261734|FG002|Phase 2|Adverse Event|0|||
130897990|NCT00946153|471261735|FG003|Phase 2|Adverse Event|0|||
130897991|NCT00946153|471261736|FG004|Phase 2|Adverse Event|6|||
130897992|NCT00946153|471261732|FG000|Phase 2|Need more reduction of dose|0|||
130897993|NCT00946153|471261733|FG001|Phase 2|Need more reduction of dose|0|||
130897994|NCT00946153|471261734|FG002|Phase 2|Need more reduction of dose|0|||
130691404|NCT01695239|470495864|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130767953|NCT03423147|470773945|FG001|Overall Study|Age < 18|0|||
130897995|NCT00946153|471261735|FG003|Phase 2|Need more reduction of dose|0|||
130897996|NCT00946153|471261736|FG004|Phase 2|Need more reduction of dose|2|||
130897997|NCT00946153|471261732|FG000|Phase 2|Physician Decision|0|||
130897998|NCT00946153|471261733|FG001|Phase 2|Physician Decision|0|||
130897999|NCT00946153|471261734|FG002|Phase 2|Physician Decision|0|||
130898000|NCT00946153|471261735|FG003|Phase 2|Physician Decision|0|||
130898001|NCT00946153|471261736|FG004|Phase 2|Physician Decision|1|||
130898002|NCT00946153|471261732|FG000|Phase 2|14 days washout for recovery due to AE|0|||
130898003|NCT00946153|471261733|FG001|Phase 2|14 days washout for recovery due to AE|0|||
130898004|NCT00946153|471261734|FG002|Phase 2|14 days washout for recovery due to AE|0|||
130898005|NCT00946153|471261735|FG003|Phase 2|14 days washout for recovery due to AE|0|||
130898006|NCT00946153|471261736|FG004|Phase 2|14 days washout for recovery due to AE|4|||
130898007|NCT04002908|471261739|FG000|Overall Study|Death|41|||
130898008|NCT04002908|471261740|FG001|Overall Study|Death|0|||
130898009|NCT04002908|471261741|FG002|Overall Study|Death|0|||
130898010|NCT04002908|471261742|FG003|Overall Study|Death|0|||
130898011|NCT04002908|471261739|FG000|Overall Study|Withdrawal by Subject|112|||
130898012|NCT04002908|471261740|FG001|Overall Study|Withdrawal by Subject|0|||
130898013|NCT04002908|471261741|FG002|Overall Study|Withdrawal by Subject|0|||
130898014|NCT04002908|471261742|FG003|Overall Study|Withdrawal by Subject|0|||
130898015|NCT04002908|471261739|FG000|Overall Study|Lost to Follow-up|72|||
130898016|NCT04002908|471261740|FG001|Overall Study|Lost to Follow-up|0|||
130898017|NCT04002908|471261741|FG002|Overall Study|Lost to Follow-up|0|||
130898018|NCT04002908|471261742|FG003|Overall Study|Lost to Follow-up|0|||
130898019|NCT04002908|471261739|FG000|Overall Study|Infant died, so mother withdrawn|34|||
130898020|NCT04002908|471261740|FG001|Overall Study|Infant died, so mother withdrawn|0|||
130898021|NCT04002908|471261741|FG002|Overall Study|Infant died, so mother withdrawn|0|||
130898022|NCT04002908|471261742|FG003|Overall Study|Infant died, so mother withdrawn|0|||
130898023|NCT01948193|471263092|FG000|Overall Study|Serious event|2|||
130898024|NCT01948193|471263092|FG000|Overall Study|Lost to Follow-up|7|||
130898025|NCT01696929|471263093|FG000|Overall Study|Physician Decision|1|||
130898026|NCT01794338|471263094|FG000|Overall Study|Death|2|||
130898027|NCT01794338|471263095|FG001|Overall Study|Death|0|||
130898028|NCT01794338|471263094|FG000|Overall Study|Lost to Follow-up|6|||
130898029|NCT01794338|471263095|FG001|Overall Study|Lost to Follow-up|9|||
130898030|NCT02522624|471263096|FG000|Overall Study|Technical failure|1|||
130898031|NCT02522624|471263097|FG001|Overall Study|Technical failure|0|||
130898032|NCT00955305|471263098|FG000|Overall Study|Disease progression|39|||
130898033|NCT00955305|471263099|FG001|Overall Study|Disease progression|41|||
130898034|NCT00955305|471263098|FG000|Overall Study|Adverse Event|22|||
130898035|NCT00955305|471263099|FG001|Overall Study|Adverse Event|22|||
130898036|NCT00955305|471263098|FG000|Overall Study|Death|2|||
130898037|NCT00955305|471263099|FG001|Overall Study|Death|1|||
130898038|NCT00955305|471263098|FG000|Overall Study|Withdrawal by Subject|5|||
130898039|NCT00955305|471263099|FG001|Overall Study|Withdrawal by Subject|4|||
130898040|NCT00955305|471263098|FG000|Overall Study|Alternative therapy|4|||
130898041|NCT00955305|471263099|FG001|Overall Study|Alternative therapy|0|||
130898042|NCT00955305|471263098|FG000|Overall Study|Other complicating disease|2|||
130898043|NCT00955305|471263099|FG001|Overall Study|Other complicating disease|4|||
130898044|NCT00955305|471263098|FG000|Overall Study|Physician Decision|1|||
130898045|NCT00955305|471263099|FG001|Overall Study|Physician Decision|0|||
130898046|NCT00955305|471263098|FG000|Overall Study|Continued presence of residual disease|0|||
130898047|NCT00955305|471263099|FG001|Overall Study|Continued presence of residual disease|1|||
130898048|NCT00955305|471263098|FG000|Overall Study|Functional decline|2|||
130898049|NCT00955305|471263099|FG001|Overall Study|Functional decline|0|||
130898050|NCT00955305|471263098|FG000|Overall Study|Maximum response achieved|0|||
130898051|NCT00955305|471263099|FG001|Overall Study|Maximum response achieved|1|||
130898052|NCT00955305|471263098|FG000|Overall Study|Lost to Follow-up|0|||
130898053|NCT00955305|471263099|FG001|Overall Study|Lost to Follow-up|1|||
130898054|NCT00955305|471263098|FG000|Overall Study|No off-treatment reason submitted|1|||
130898055|NCT00955305|471263099|FG001|Overall Study|No off-treatment reason submitted|0|||
130898056|NCT00955305|471263098|FG000|Overall Study|Never started protocol treatment|5|||
130898057|NCT00955305|471263099|FG001|Overall Study|Never started protocol treatment|5|||
130898058|NCT00955305|471263098|FG000|Overall Study|Ineligible|5|||
130898059|NCT00955305|471263099|FG001|Overall Study|Ineligible|7|||
130898060|NCT00109590|471263100|FG000|Overall Study|Lost to Follow-up|1|||
130898061|NCT00109590|471263101|FG001|Overall Study|Lost to Follow-up|0|||
130898062|NCT00109590|471263102|FG002|Overall Study|Lost to Follow-up|1|||
130898063|NCT00109590|471263100|FG000|Overall Study|Never Started Treatment|1|||
130898064|NCT00109590|471263101|FG001|Overall Study|Never Started Treatment|2|||
130898065|NCT00109590|471263102|FG002|Overall Study|Never Started Treatment|3|||
130898066|NCT00490529|471263103|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
130898067|NCT00490529|471263103|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
130898068|NCT00490529|471263103|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
130898069|NCT00490529|471263103|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
130898070|NCT00490529|471263103|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
130898071|NCT00490529|471263103|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
130898072|NCT00727441|471263104|FG000|Overall Study|Disease Progression|11|||
130898073|NCT00727441|471263105|FG001|Overall Study|Disease Progression|14|||
130898074|NCT00727441|471263106|FG002|Overall Study|Disease Progression|17|||
130898075|NCT00727441|471263104|FG000|Overall Study|Eligibility|7|||
130898076|NCT00727441|471263105|FG001|Overall Study|Eligibility|5|||
130898077|NCT00727441|471263106|FG002|Overall Study|Eligibility|7|||
130898078|NCT00727441|471263104|FG000|Overall Study|Death|0|||
130898079|NCT00727441|471263105|FG001|Overall Study|Death|1|||
130898080|NCT00727441|471263106|FG002|Overall Study|Death|1|||
130898081|NCT00727441|471263104|FG000|Overall Study|Physician Decision|0|||
130898082|NCT00727441|471263105|FG001|Overall Study|Physician Decision|1|||
130898083|NCT00727441|471263106|FG002|Overall Study|Physician Decision|0|||
130898084|NCT00727441|471263104|FG000|Overall Study|Withdrawal by Subject|0|||
130767954|NCT03423147|470773944|FG000|Overall Study|No Trial of Labor|0|||
130898085|NCT00727441|471263105|FG001|Overall Study|Withdrawal by Subject|1|||
130898086|NCT00727441|471263106|FG002|Overall Study|Withdrawal by Subject|0|||
130898087|NCT00745849|471263107|FG000|First Intervention|Withdrawal by Subject|0|||
130898088|NCT00745849|471263108|FG001|First Intervention|Withdrawal by Subject|1|||
130898089|NCT00745849|471263107|FG000|First Intervention|Lost to Follow-up|1|||
130898090|NCT00745849|471263108|FG001|First Intervention|Lost to Follow-up|1|||
130898091|NCT00745849|471263107|FG000|Second Intervention|Lost to Follow-up|2|||
130898092|NCT00745849|471263108|FG001|Second Intervention|Lost to Follow-up|1|||
130898093|NCT01129583|471263114|FG000|Overall Study|Death|1|||
130898094|NCT01129583|471263115|FG001|Overall Study|Death|0|||
130898095|NCT01129583|471263114|FG000|Overall Study|Lost to Follow-up|1|||
130898096|NCT01129583|471263115|FG001|Overall Study|Lost to Follow-up|1|||
130898097|NCT01129583|471263114|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
130898098|NCT01129583|471263115|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
130898099|NCT00617669|471263134|FG000|Overall Study|Withdrawal by Subject|71|||
130898100|NCT00617669|471263135|FG001|Overall Study|Withdrawal by Subject|77|||
131112303|NCT01777269|472041043|FG000|Overall Study|Participants reached stopping criteria|1|||
131112304|NCT01777269|472041044|FG001|Overall Study|Participants reached stopping criteria|1|||
131112305|NCT01777269|472041043|FG000|Overall Study|Lost to Follow-up|4|||
131112306|NCT01777269|472041044|FG001|Overall Study|Lost to Follow-up|0|||
131112307|NCT01777269|472041043|FG000|Overall Study|Physician Decision|5|||
131112308|NCT01777269|472041044|FG001|Overall Study|Physician Decision|2|||
131112309|NCT01777269|472041043|FG000|Overall Study|Withdrawal by Subject|9|||
131112310|NCT01777269|472041044|FG001|Overall Study|Withdrawal by Subject|9|||
131112311|NCT01966471|472041046|FG000|Overall Study|Death|44|||
131112312|NCT01966471|472041047|FG001|Overall Study|Death|56|||
131112313|NCT01966471|472041046|FG000|Overall Study|Lost to Follow-up|46|||
131112314|NCT01966471|472041047|FG001|Overall Study|Lost to Follow-up|39|||
131112315|NCT01966471|472041046|FG000|Overall Study|Various reasons|4|||
131112316|NCT01966471|472041047|FG001|Overall Study|Various reasons|4|||
131112317|NCT01966471|472041046|FG000|Overall Study|Physician Decision|7|||
131112318|NCT01966471|472041047|FG001|Overall Study|Physician Decision|5|||
131112319|NCT01966471|472041046|FG000|Overall Study|Study Terminated By Sponsor|758|||
131112320|NCT01966471|472041047|FG001|Overall Study|Study Terminated By Sponsor|773|||
131112321|NCT01966471|472041046|FG000|Overall Study|Withdrawal by Subject|59|||
131112322|NCT01966471|472041047|FG001|Overall Study|Withdrawal by Subject|51|||
131112323|NCT01030198|472041048|FG000|Overall Study|Could not measure efficacy accurately|0|||
130691405|NCT01695239|470495865|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691406|NCT01695239|470495866|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130691407|NCT01695239|470495867|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
130691408|NCT01695239|470495868|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
130691409|NCT01695239|470495869|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
130691410|NCT01695239|470495856|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691411|NCT01695239|470495857|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691412|NCT01695239|470495858|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691413|NCT01695239|470495859|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691414|NCT01695239|470495860|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691415|NCT01695239|470495861|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691416|NCT01695239|470495862|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691417|NCT01695239|470495863|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691418|NCT01695239|470495864|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691419|NCT01695239|470495865|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691420|NCT01695239|470495866|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691421|NCT01695239|470495867|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130691422|NCT01695239|470495868|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
130691423|NCT01695239|470495869|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
130691424|NCT01695239|470495856|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691425|NCT01695239|470495857|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691426|NCT01695239|470495858|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691427|NCT01695239|470495859|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691428|NCT01695239|470495860|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691429|NCT01695239|470495861|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691430|NCT01695239|470495862|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691431|NCT01695239|470495863|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691432|NCT01695239|470495864|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691433|NCT01695239|470495865|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691434|NCT01695239|470495866|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
130898101|NCT00617669|471263134|FG000|Overall Study|Lost to Follow-up|3|||
131112324|NCT01030198|472041049|FG001|Overall Study|Could not measure efficacy accurately|7|||
130691435|NCT01695239|470495867|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
130691436|NCT01695239|470495868|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
131112325|NCT02370043|472041050|FG000|Overall Study|Withdrawal by Subject|0|||
130691437|NCT01695239|470495869|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
130898102|NCT00617669|471263135|FG001|Overall Study|Lost to Follow-up|2|||
130898103|NCT00617669|471263134|FG000|Overall Study|Adverse Event|87|||
130898104|NCT00617669|471263135|FG001|Overall Study|Adverse Event|76|||
130898105|NCT00617669|471263134|FG000|Overall Study|Protocol Violation|2|||
130898106|NCT00617669|471263135|FG001|Overall Study|Protocol Violation|3|||
130898107|NCT00617669|471263134|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
130898108|NCT00617669|471263135|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
130898109|NCT00617669|471263134|FG000|Overall Study|Patients randomized but not treated|2|||
130898110|NCT00617669|471263135|FG001|Overall Study|Patients randomized but not treated|3|||
130898111|NCT03135119|471263136|FG000|Overall Study|Lost to Follow-up|2|||
130898112|NCT03135119|471263137|FG001|Overall Study|Lost to Follow-up|0|||
130898113|NCT03135119|471263136|FG000|Overall Study|Physician Decision|1|||
130898114|NCT03135119|471263137|FG001|Overall Study|Physician Decision|1|||
130898115|NCT03135119|471263136|FG000|Overall Study|COVID-19 Shutdown|2|||
130898116|NCT03135119|471263137|FG001|Overall Study|COVID-19 Shutdown|2|||
130898117|NCT00361634|471263142|FG000|Overall Study|Lost to Follow-up|1|||
130898118|NCT00361634|471263142|FG000|Overall Study|Withdrawal by Subject|1|||
130898119|NCT00833417|471263143|FG000|Overall Study|Adverse Event|5|||
130898120|NCT00833417|471263144|FG001|Overall Study|Adverse Event|16|||
130898121|NCT00833417|471263143|FG000|Overall Study|Death|1|||
130898122|NCT00833417|471263144|FG001|Overall Study|Death|3|||
130898123|NCT00833417|471263143|FG000|Overall Study|Lost to Follow-up|1|||
130898124|NCT00833417|471263144|FG001|Overall Study|Lost to Follow-up|2|||
130898125|NCT00833417|471263143|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
130898126|NCT00833417|471263144|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
130898127|NCT00833417|471263143|FG000|Overall Study|Patient Decision to Withdraw|4|||
130898128|NCT00833417|471263144|FG001|Overall Study|Patient Decision to Withdraw|23|||
130898129|NCT00833417|471263143|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
130898130|NCT00833417|471263144|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
130898131|NCT00833417|471263143|FG000|Overall Study|Disease Progression|18|||
130898132|NCT00833417|471263144|FG001|Overall Study|Disease Progression|17|||
130898133|NCT00833417|471263143|FG000|Overall Study|Reason Not Specified|0|||
131025437|NCT04994509|471723278|FG001|Overall Study|Withdrew Consent|72|||
131025438|NCT04994509|471723279|FG002|Overall Study|Withdrew Consent|46|||
131025439|NCT04994509|471723277|FG000|Overall Study|Lost to Follow-up|39|||
131025440|NCT04994509|471723278|FG001|Overall Study|Lost to Follow-up|36|||
131025441|NCT04994509|471723279|FG002|Overall Study|Lost to Follow-up|26|||
131025442|NCT04994509|471723277|FG000|Overall Study|HIV-1 Infection|4|||
131025443|NCT04994509|471723278|FG001|Overall Study|HIV-1 Infection|20|||
131025444|NCT04994509|471723279|FG002|Overall Study|HIV-1 Infection|12|||
131025445|NCT04994509|471723277|FG000|Overall Study|Investigator's Discretion|9|||
131025446|NCT04994509|471723278|FG001|Overall Study|Investigator's Discretion|8|||
131025447|NCT04994509|471723279|FG002|Overall Study|Investigator's Discretion|11|||
131025448|NCT04994509|471723277|FG000|Overall Study|Randomized but Never Treated|10|||
131025449|NCT04994509|471723278|FG001|Overall Study|Randomized but Never Treated|10|||
131025450|NCT04994509|471723279|FG002|Overall Study|Randomized but Never Treated|3|||
131025451|NCT04994509|471723277|FG000|Overall Study|Pregnancy|5|||
131025452|NCT04994509|471723278|FG001|Overall Study|Pregnancy|5|||
131025453|NCT04994509|471723279|FG002|Overall Study|Pregnancy|0|||
131025454|NCT04994509|471723277|FG000|Overall Study|Death|0|||
131025455|NCT04994509|471723278|FG001|Overall Study|Death|5|||
131025456|NCT04994509|471723279|FG002|Overall Study|Death|0|||
131025457|NCT04994509|471723277|FG000|Overall Study|Adverse Event|2|||
131025458|NCT04994509|471723278|FG001|Overall Study|Adverse Event|1|||
131025459|NCT04994509|471723279|FG002|Overall Study|Adverse Event|0|||
131025460|NCT04994509|471723277|FG000|Overall Study|Non-compliance With Study Drug|1|||
131025461|NCT04994509|471723278|FG001|Overall Study|Non-compliance With Study Drug|1|||
131025462|NCT04994509|471723279|FG002|Overall Study|Non-compliance With Study Drug|1|||
131025463|NCT04994509|471723277|FG000|Overall Study|Withdrew Assent|3|||
131025464|NCT04994509|471723278|FG001|Overall Study|Withdrew Assent|0|||
131025465|NCT04994509|471723279|FG002|Overall Study|Withdrew Assent|0|||
131025466|NCT04994509|471723277|FG000|Overall Study|Protocol Violation|1|||
131025467|NCT04994509|471723278|FG001|Overall Study|Protocol Violation|0|||
131025468|NCT04994509|471723279|FG002|Overall Study|Protocol Violation|0|||
131112326|NCT02370043|472041051|FG001|Overall Study|Withdrawal by Subject|0|||
131112327|NCT02370043|472041052|FG002|Overall Study|Withdrawal by Subject|0|||
130898134|NCT00833417|471263144|FG001|Overall Study|Reason Not Specified|1|||
130898135|NCT05315908|471263145|FG000|Overall Study|Lost to Follow-up|4477|||
130898136|NCT05315908|471263146|FG001|Overall Study|Lost to Follow-up|4606|||
130898137|NCT01561898|471263147|FG000|Overall Study|Withdrawal by Subject|0|||
131025471|NCT01600014|471725289|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
131025472|NCT01600014|471725290|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
131025473|NCT01600014|471725289|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
131025474|NCT01600014|471725290|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
131025475|NCT01600014|471725289|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
131025476|NCT01600014|471725290|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
131025477|NCT01600014|471725289|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
131025478|NCT01600014|471725290|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
130898138|NCT01561898|471263148|FG001|Overall Study|Withdrawal by Subject|8|||
130898139|NCT01561898|471263149|FG002|Overall Study|Withdrawal by Subject|12|||
130898140|NCT01561898|471263150|FG003|Overall Study|Withdrawal by Subject|5|||
130898141|NCT01561898|471263147|FG000|Overall Study|Lack of Efficacy|0|||
130898142|NCT01561898|471263148|FG001|Overall Study|Lack of Efficacy|8|||
130898143|NCT01561898|471263149|FG002|Overall Study|Lack of Efficacy|10|||
130898144|NCT01561898|471263150|FG003|Overall Study|Lack of Efficacy|5|||
130898145|NCT01561898|471263147|FG000|Overall Study|Worsening of complications|0|||
130898146|NCT01561898|471263148|FG001|Overall Study|Worsening of complications|1|||
130898147|NCT01561898|471263149|FG002|Overall Study|Worsening of complications|0|||
130898148|NCT01561898|471263150|FG003|Overall Study|Worsening of complications|0|||
130898149|NCT01561898|471263147|FG000|Overall Study|Lost to Follow-up|0|||
130898150|NCT01561898|471263148|FG001|Overall Study|Lost to Follow-up|0|||
130898151|NCT01561898|471263149|FG002|Overall Study|Lost to Follow-up|1|||
130898152|NCT01561898|471263150|FG003|Overall Study|Lost to Follow-up|0|||
130898153|NCT01561898|471263147|FG000|Overall Study|Adverse Event|1|||
130898154|NCT01561898|471263148|FG001|Overall Study|Adverse Event|19|||
130898155|NCT01561898|471263149|FG002|Overall Study|Adverse Event|14|||
130898156|NCT01561898|471263150|FG003|Overall Study|Adverse Event|9|||
130898157|NCT01561898|471263147|FG000|Overall Study|Physician Decision|1|||
130898158|NCT01561898|471263148|FG001|Overall Study|Physician Decision|5|||
130898159|NCT01561898|471263149|FG002|Overall Study|Physician Decision|7|||
130898160|NCT01561898|471263150|FG003|Overall Study|Physician Decision|1|||
130898161|NCT00294762|471263151|FG000|Overall Study|Did not receive study treatment|3|||
130898162|NCT00294762|471263152|FG001|Overall Study|Did not receive study treatment|3|||
130898163|NCT02238080|471263153|FG000|Overall Study|Death|13|||
130898164|NCT02238080|471263153|FG000|Overall Study|Treatment interrupted|6|||
130898165|NCT02238080|471263153|FG000|Overall Study|Withdrawal by Subject|2|||
130898166|NCT02238080|471263153|FG000|Overall Study|Other|4|||
130898167|NCT01738646|471263154|FG000|Overall Study|Still Receiving Treatment|2|||
130898168|NCT04093024|471263155|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
130898169|NCT04093024|471263156|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
130898170|NCT04093024|471263155|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
130898171|NCT04093024|471263156|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
130898172|NCT04093024|471263155|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
130898173|NCT04093024|471263156|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
130898174|NCT04093024|471263155|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
130898175|NCT04093024|471263156|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
130898176|NCT00647270|471263163|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
130898177|NCT00647270|471263164|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
130898178|NCT00647270|471263165|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
130898179|NCT00647270|471263163|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
130898180|NCT00647270|471263164|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
130898181|NCT00647270|471263165|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
130898182|NCT00647270|471263163|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
130898183|NCT00647270|471263164|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
130898184|NCT00647270|471263165|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
130898185|NCT00647270|471263163|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
130898186|NCT00647270|471263164|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
130898187|NCT00647270|471263165|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
130898188|NCT00647270|471263163|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
130898189|NCT00647270|471263164|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
130898190|NCT00647270|471263165|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
130898191|NCT00647270|471263163|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
130898192|NCT00647270|471263164|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
130898193|NCT00647270|471263165|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
130898194|NCT00647270|471263163|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
130898195|NCT00647270|471263164|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
130898196|NCT00647270|471263165|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
130898197|NCT04493892|471263166|FG000|Overall Study|Withdrawal by Subject|15|||
130898198|NCT02366091|471263173|FG000|Overall Study|Withdrawal by Subject|3|||
130898199|NCT02366091|471263174|FG001|Overall Study|Withdrawal by Subject|7|||
130898200|NCT02366091|471263175|FG002|Overall Study|Withdrawal by Subject|3|||
130898201|NCT02366091|471263176|FG003|Overall Study|Withdrawal by Subject|1|||
130898202|NCT00322621|471263177|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
130898203|NCT00322621|471263178|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
130898204|NCT00322621|471263179|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
130898205|NCT00322621|471263177|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
130898206|NCT00322621|471263178|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
131222719|NCT01453374|472443165|FG000|Overall Study|Incarcerated|2|||
130898207|NCT00322621|471263179|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
130898208|NCT00322621|471263177|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
130898209|NCT00322621|471263178|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
130898210|NCT00322621|471263179|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
130898211|NCT00322621|471263177|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
130898212|NCT00322621|471263178|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
130898213|NCT00322621|471263179|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
130898214|NCT00322621|471263177|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
130898215|NCT00322621|471263178|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
130898216|NCT00322621|471263179|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
130898217|NCT00322621|471263177|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
130898218|NCT00322621|471263178|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
130898219|NCT00322621|471263179|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
130898220|NCT00322621|471263177|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
130898221|NCT00322621|471263178|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
130898222|NCT00322621|471263179|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
130898223|NCT00322621|471263177|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
130898224|NCT00322621|471263178|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
130898225|NCT00322621|471263179|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
130898226|NCT00322621|471263177|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
130898227|NCT00322621|471263178|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
130898228|NCT00322621|471263179|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
130898229|NCT00322621|471263177|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
130898230|NCT00322621|471263178|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
130898231|NCT00322621|471263179|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
130898232|NCT00322621|471263177|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
130898233|NCT00322621|471263178|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
130898234|NCT00322621|471263179|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
130898235|NCT02160041|471263180|FG000|Overall Study|Adverse Event|11|||
130898236|NCT02160041|471263180|FG000|Overall Study|Death|2|||
130898237|NCT02160041|471263180|FG000|Overall Study|disease progression|57|||
130898238|NCT02160041|471263180|FG000|Overall Study|Protocol Violation|1|||
130898239|NCT02160041|471263180|FG000|Overall Study|non-compliance with study|1|||
130898240|NCT02160041|471263180|FG000|Overall Study|Physician Decision|3|||
130898241|NCT02160041|471263180|FG000|Overall Study|Withdrawal by Subject|8|||
130898242|NCT02160041|471263180|FG000|Overall Study|study terminated by by sponsor|1|||
130898243|NCT01403948|471263181|FG000|Overall Study|Progressive disease|0|||
130898244|NCT01403948|471263182|FG001|Overall Study|Progressive disease|2|||
130898245|NCT01403948|471263183|FG002|Overall Study|Progressive disease|2|||
130898246|NCT01403948|471263184|FG003|Overall Study|Progressive disease|4|||
130898247|NCT01403948|471263185|FG004|Overall Study|Progressive disease|2|||
130898248|NCT01403948|471263186|FG005|Overall Study|Progressive disease|6|||
130898249|NCT01403948|471263187|FG006|Overall Study|Progressive disease|2|||
130898250|NCT01403948|471263188|FG007|Overall Study|Progressive disease|4|||
130898251|NCT01403948|471263189|FG008|Overall Study|Progressive disease|5|||
130898252|NCT01403948|471263190|FG009|Overall Study|Progressive disease|5|||
130898253|NCT01403948|471263181|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
130898254|NCT01403948|471263182|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
130898255|NCT01403948|471263183|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
130898256|NCT01403948|471263184|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
130898257|NCT01403948|471263185|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
130898258|NCT01403948|471263186|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
130898259|NCT01403948|471263187|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
130898260|NCT01403948|471263188|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
131025479|NCT01600014|471725289|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
131025480|NCT01600014|471725290|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
131025481|NCT01600014|471725289|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
131025482|NCT01600014|471725290|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
130691438|NCT01695239|470495856|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691439|NCT01695239|470495857|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691440|NCT01695239|470495858|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691441|NCT01695239|470495859|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130898261|NCT01403948|471263189|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
130898262|NCT01403948|471263190|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
130898263|NCT01403948|471263181|FG000|Overall Study|Lost to Follow-up|0|||
130898264|NCT01403948|471263182|FG001|Overall Study|Lost to Follow-up|0|||
130898265|NCT01403948|471263183|FG002|Overall Study|Lost to Follow-up|0|||
130898266|NCT01403948|471263184|FG003|Overall Study|Lost to Follow-up|0|||
130898267|NCT01403948|471263185|FG004|Overall Study|Lost to Follow-up|0|||
130898268|NCT01403948|471263186|FG005|Overall Study|Lost to Follow-up|0|||
130898269|NCT01403948|471263187|FG006|Overall Study|Lost to Follow-up|0|||
130898270|NCT01403948|471263188|FG007|Overall Study|Lost to Follow-up|0|||
130898271|NCT01403948|471263189|FG008|Overall Study|Lost to Follow-up|0|||
130898272|NCT01403948|471263190|FG009|Overall Study|Lost to Follow-up|1|||
130898273|NCT01403948|471263181|FG000|Overall Study|Refused cont. medication|0|||
130898274|NCT01403948|471263182|FG001|Overall Study|Refused cont. medication|0|||
130898275|NCT01403948|471263183|FG002|Overall Study|Refused cont. medication|0|||
130898276|NCT01403948|471263184|FG003|Overall Study|Refused cont. medication|0|||
130898277|NCT01403948|471263185|FG004|Overall Study|Refused cont. medication|1|||
130898278|NCT01403948|471263186|FG005|Overall Study|Refused cont. medication|0|||
130898279|NCT01403948|471263187|FG006|Overall Study|Refused cont. medication|0|||
130898280|NCT01403948|471263188|FG007|Overall Study|Refused cont. medication|0|||
130898281|NCT01403948|471263189|FG008|Overall Study|Refused cont. medication|0|||
130898282|NCT01403948|471263190|FG009|Overall Study|Refused cont. medication|1|||
130898283|NCT01403948|471263181|FG000|Overall Study|other than above|1|||
130898284|NCT01403948|471263182|FG001|Overall Study|other than above|2|||
130898285|NCT01403948|471263183|FG002|Overall Study|other than above|1|||
130898286|NCT01403948|471263184|FG003|Overall Study|other than above|0|||
130898287|NCT01403948|471263185|FG004|Overall Study|other than above|1|||
130898288|NCT01403948|471263186|FG005|Overall Study|other than above|1|||
130898289|NCT01403948|471263187|FG006|Overall Study|other than above|2|||
130898290|NCT01403948|471263188|FG007|Overall Study|other than above|0|||
130898291|NCT01403948|471263189|FG008|Overall Study|other than above|0|||
130898292|NCT01403948|471263190|FG009|Overall Study|other than above|0|||
130898293|NCT00763698|471263191|FG000|Overall Study|Unsuccessful Implant|5|||
130898294|NCT00763698|471263191|FG000|Overall Study|Death|4|||
130898295|NCT00763698|471263191|FG000|Overall Study|Withdrawal by Subject|1|||
130898296|NCT01960907|471263196|FG000|Overall Study|Death|4|||
130898297|NCT01960907|471263197|FG001|Overall Study|Death|3|||
130898298|NCT01960907|471263196|FG000|Overall Study|Withdrawal by Subject|32|||
130898299|NCT01960907|471263197|FG001|Overall Study|Withdrawal by Subject|42|||
130898300|NCT00717236|471263200|FG000|Double-Blind Period|Adverse Event|33|||
130898301|NCT00717236|471263201|FG001|Double-Blind Period|Adverse Event|6|||
130898302|NCT00717236|471263200|FG000|Double-Blind Period|Lack of Efficacy|6|||
130898303|NCT00717236|471263201|FG001|Double-Blind Period|Lack of Efficacy|6|||
130898304|NCT00717236|471263200|FG000|Double-Blind Period|Lost to Follow-up|3|||
130898305|NCT00717236|471263201|FG001|Double-Blind Period|Lost to Follow-up|5|||
130898306|NCT00717236|471263200|FG000|Double-Blind Period|Withdrawal by Subject|10|||
131025483|NCT01600014|471725289|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
130691442|NCT01695239|470495860|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131025484|NCT01600014|471725290|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
131025485|NCT01600014|471725289|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
131025486|NCT01600014|471725290|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
131025487|NCT01600014|471725289|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
131025488|NCT01600014|471725290|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
131025489|NCT01600014|471725289|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
131025490|NCT01600014|471725290|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
131025491|NCT01600014|471725289|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
131025492|NCT01600014|471725290|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
131025493|NCT01600014|471725289|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
131025494|NCT01600014|471725290|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
131025495|NCT01600014|471725289|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
131025496|NCT01600014|471725290|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
131025497|NCT01600014|471725289|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
131025498|NCT01600014|471725290|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
131025499|NCT01600014|471725289|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
131025500|NCT01600014|471725290|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
131025501|NCT01600014|471725289|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
131025502|NCT01600014|471725290|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
131025503|NCT01600014|471725289|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
130691443|NCT01695239|470495861|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691444|NCT01695239|470495862|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130767955|NCT03423147|470773945|FG001|Overall Study|No Trial of Labor|1|||
130898307|NCT00717236|471263201|FG001|Double-Blind Period|Withdrawal by Subject|2|||
130898308|NCT00717236|471263200|FG000|Double-Blind Period|Loss of efficacy|3|||
130898309|NCT00717236|471263201|FG001|Double-Blind Period|Loss of efficacy|0|||
130898310|NCT00717236|471263200|FG000|Double-Blind Period|Other: Death|1|||
130898311|NCT00717236|471263201|FG001|Double-Blind Period|Other: Death|0|||
130898312|NCT00717236|471263200|FG000|Double-Blind Period|Other: Pregnancy|1|||
130898313|NCT00717236|471263201|FG001|Double-Blind Period|Other: Pregnancy|0|||
130898314|NCT00717236|471263200|FG000|Double-Blind Period|Other: Protocol Violation|2|||
130691445|NCT01695239|470495863|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691446|NCT01695239|470495864|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691447|NCT01695239|470495865|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691448|NCT01695239|470495866|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691449|NCT01695239|470495867|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691450|NCT01695239|470495868|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130691451|NCT01695239|470495869|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
130691452|NCT05239195|470495871|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
130691453|NCT05239195|470495872|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
130691454|NCT03552484|470495873|FG000|Overall Study|Death|6|||
130691455|NCT03552484|470495874|FG001|Overall Study|Death|4|||
130691456|NCT03552484|470495873|FG000|Overall Study|Lost to Follow-up|0|||
130691457|NCT03552484|470495874|FG001|Overall Study|Lost to Follow-up|16|||
130691458|NCT03246503|470495879|FG000|Overall Study|Lost to Follow-up|23|||
130691459|NCT03246503|470495879|FG000|Overall Study|Withdrawal by Subject|20|||
130691460|NCT03246503|470495879|FG000|Overall Study|Physician Decision|5|||
130691461|NCT03246503|470495879|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
130691462|NCT00736190|470495880|FG000|Overall Study|Pregnancy|1|||
130691463|NCT00736190|470495880|FG000|Overall Study|Withdrawal by Subject|1|||
130691464|NCT00736190|470495880|FG000|Overall Study|Adverse Event|1|||
130691465|NCT00716625|470495882|FG000|Overall Study|Safety was not Assessable|1|||
130691466|NCT01492439|470495883|FG000|Overall Study|Withdrew from RTE|4|||
130691467|NCT01492439|470495884|FG001|Overall Study|Withdrew from RTE|9|||
130691468|NCT00488774|470495885|FG000|Overall Study|Withdrawal of consent|2|||
130691469|NCT00488774|470495886|FG001|Overall Study|Withdrawal of consent|2|||
130691470|NCT00488774|470495887|FG002|Overall Study|Withdrawal of consent|2|||
130691471|NCT00488774|470495888|FG003|Overall Study|Withdrawal of consent|0|||
130691472|NCT00488774|470495885|FG000|Overall Study|Other|6|||
130691473|NCT00488774|470495886|FG001|Overall Study|Other|3|||
130691474|NCT00488774|470495887|FG002|Overall Study|Other|2|||
130691475|NCT00488774|470495888|FG003|Overall Study|Other|2|||
130691476|NCT00488774|470495885|FG000|Overall Study|Lost to Follow-up|0|||
130691477|NCT00488774|470495886|FG001|Overall Study|Lost to Follow-up|0|||
130691478|NCT00488774|470495887|FG002|Overall Study|Lost to Follow-up|1|||
130691479|NCT00488774|470495888|FG003|Overall Study|Lost to Follow-up|1|||
130691480|NCT01204294|470495889|FG000|Overall Study|Adverse Event|2|||
130691481|NCT01204294|470495890|FG001|Overall Study|Adverse Event|6|||
130691482|NCT01204294|470495891|FG002|Overall Study|Adverse Event|0|||
130691483|NCT01204294|470495892|FG003|Overall Study|Adverse Event|7|||
130691484|NCT01204294|470495893|FG004|Overall Study|Adverse Event|1|||
130691485|NCT01204294|470495894|FG005|Overall Study|Adverse Event|4|||
130691486|NCT01204294|470495895|FG006|Overall Study|Adverse Event|0|||
130691487|NCT01204294|470495889|FG000|Overall Study|Protocol Violation|1|||
130691488|NCT01204294|470495890|FG001|Overall Study|Protocol Violation|0|||
130691489|NCT01204294|470495891|FG002|Overall Study|Protocol Violation|2|||
130691490|NCT01204294|470495892|FG003|Overall Study|Protocol Violation|1|||
130691491|NCT01204294|470495893|FG004|Overall Study|Protocol Violation|0|||
130691492|NCT01204294|470495894|FG005|Overall Study|Protocol Violation|0|||
130691493|NCT01204294|470495895|FG006|Overall Study|Protocol Violation|0|||
130691494|NCT01204294|470495889|FG000|Overall Study|Withdrawal by Subject|0|||
130691495|NCT01204294|470495890|FG001|Overall Study|Withdrawal by Subject|2|||
130691496|NCT01204294|470495891|FG002|Overall Study|Withdrawal by Subject|2|||
130691497|NCT01204294|470495892|FG003|Overall Study|Withdrawal by Subject|1|||
130691498|NCT01204294|470495893|FG004|Overall Study|Withdrawal by Subject|1|||
130691499|NCT01204294|470495894|FG005|Overall Study|Withdrawal by Subject|1|||
130691500|NCT01204294|470495895|FG006|Overall Study|Withdrawal by Subject|2|||
130691501|NCT01204294|470495889|FG000|Overall Study|Lack of Efficacy|0|||
130691502|NCT01204294|470495890|FG001|Overall Study|Lack of Efficacy|0|||
130691503|NCT01204294|470495891|FG002|Overall Study|Lack of Efficacy|0|||
130691504|NCT01204294|470495892|FG003|Overall Study|Lack of Efficacy|2|||
130767956|NCT01048099|470773946|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
130767957|NCT01048099|470773946|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
130898315|NCT00717236|471263201|FG001|Double-Blind Period|Other: Protocol Violation|0|||
130898316|NCT00717236|471263200|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
130898317|NCT00717236|471263201|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
130691505|NCT01204294|470495893|FG004|Overall Study|Lack of Efficacy|0|||
130767958|NCT02258334|470773949|FG000|Overall Study|Adverse Event|1|||
131112328|NCT02370043|472041053|FG003|Overall Study|Withdrawal by Subject|0|||
130691506|NCT01204294|470495894|FG005|Overall Study|Lack of Efficacy|0|||
130691507|NCT01204294|470495895|FG006|Overall Study|Lack of Efficacy|0|||
130767959|NCT02258334|470773950|FG001|Overall Study|Adverse Event|0|||
131112329|NCT02370043|472041054|FG004|Overall Study|Withdrawal by Subject|1|||
130691508|NCT01204294|470495889|FG000|Overall Study|Other (house moving)|0|||
130691509|NCT01204294|470495890|FG001|Overall Study|Other (house moving)|0|||
130691510|NCT01204294|470495891|FG002|Overall Study|Other (house moving)|1|||
131025504|NCT01600014|471725290|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
131025505|NCT03398148|471725291|FG000|Substudy 1 Period 1|Adverse Event|5|||
130691511|NCT01204294|470495892|FG003|Overall Study|Other (house moving)|0|||
130691512|NCT01204294|470495893|FG004|Overall Study|Other (house moving)|0|||
130691513|NCT01204294|470495894|FG005|Overall Study|Other (house moving)|0|||
130691514|NCT01204294|470495895|FG006|Overall Study|Other (house moving)|0|||
130691515|NCT04590027|470495896|FG000|Overall Study|Lost to Follow-up|17|||
130691516|NCT04590027|470495897|FG001|Overall Study|Lost to Follow-up|14|||
130691517|NCT04590027|470495896|FG000|Overall Study|Protocol Violation|0|||
130691518|NCT04590027|470495897|FG001|Overall Study|Protocol Violation|3|||
130691519|NCT02682238|470495898|FG000|Overall Study|Lost to Follow-up|0|||
130691520|NCT02682238|470495899|FG001|Overall Study|Lost to Follow-up|2|||
130691521|NCT02682238|470495898|FG000|Overall Study|Withdrawal by Subject|1|||
130691522|NCT02682238|470495899|FG001|Overall Study|Withdrawal by Subject|0|||
130691523|NCT02682238|470495898|FG000|Overall Study|Adverse Event|1|||
130691524|NCT02682238|470495899|FG001|Overall Study|Adverse Event|0|||
130691525|NCT02682238|470495898|FG000|Overall Study|Non-compliance with Study Drug|1|||
130691526|NCT02682238|470495899|FG001|Overall Study|Non-compliance with Study Drug|0|||
130691527|NCT02682238|470495898|FG000|Overall Study|Non-compliance with Protocol|0|||
130691528|NCT02682238|470495899|FG001|Overall Study|Non-compliance with Protocol|2|||
130691529|NCT02909907|470495900|FG000|Overall Study|Withdrawal by Subject|0|||
130691530|NCT02909907|470495901|FG001|Overall Study|Withdrawal by Subject|1|||
130691531|NCT02075463|470495903|FG000|Overall Study|Adverse Event|3|||
130691532|NCT02075463|470495903|FG000|Overall Study|Par. reached stopping criteria|4|||
130691533|NCT02075463|470495903|FG000|Overall Study|Withdrawal by Subject|1|||
130691534|NCT00824291|470495905|FG000|Overall Study|Adverse Event|15|||
130691535|NCT00824291|470495906|FG001|Overall Study|Adverse Event|6|||
130691536|NCT00824291|470495905|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130691537|NCT00824291|470495906|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
130691538|NCT00824291|470495905|FG000|Overall Study|Lost to Follow-up|11|||
130691539|NCT00824291|470495906|FG001|Overall Study|Lost to Follow-up|9|||
130691540|NCT00824291|470495905|FG000|Overall Study|Non-compliance|1|||
130691541|NCT00824291|470495906|FG001|Overall Study|Non-compliance|1|||
130691542|NCT00824291|470495905|FG000|Overall Study|Protocol Violation|4|||
130691543|NCT00824291|470495906|FG001|Overall Study|Protocol Violation|1|||
130691544|NCT00824291|470495905|FG000|Overall Study|Withdrawal by Subject|14|||
130691545|NCT00824291|470495906|FG001|Overall Study|Withdrawal by Subject|8|||
130691546|NCT00824291|470495905|FG000|Overall Study|Lack of Efficacy|7|||
130691547|NCT00824291|470495906|FG001|Overall Study|Lack of Efficacy|8|||
130691548|NCT00824291|470495905|FG000|Overall Study|Participant on prohibited medication|1|||
130691549|NCT00824291|470495906|FG001|Overall Study|Participant on prohibited medication|0|||
130691550|NCT00933686|470495907|FG000|Overall Study|Protocol Violation|0|||
130691551|NCT00933686|470495908|FG001|Overall Study|Protocol Violation|1|||
130691552|NCT00933686|470495907|FG000|Overall Study|Lost to Follow-up|2|||
130691553|NCT00933686|470495908|FG001|Overall Study|Lost to Follow-up|2|||
130691554|NCT00933686|470495907|FG000|Overall Study|Withdrawal by Subject|6|||
130691555|NCT00933686|470495908|FG001|Overall Study|Withdrawal by Subject|5|||
130691556|NCT00933686|470495907|FG000|Overall Study|Adverse Event|1|||
130691557|NCT00933686|470495908|FG001|Overall Study|Adverse Event|1|||
130691558|NCT00933686|470495907|FG000|Overall Study|Physician Decision|1|||
130691559|NCT00933686|470495908|FG001|Overall Study|Physician Decision|0|||
130691560|NCT00933686|470495907|FG000|Overall Study|Failure to show up at endpoint visits|0|||
130691561|NCT00933686|470495908|FG001|Overall Study|Failure to show up at endpoint visits|2|||
130691562|NCT01383486|470495909|FG000|Overall Study|Lost to Follow-up|10|||
131025506|NCT03398148|471725292|FG001|Substudy 1 Period 1|Adverse Event|2|||
131025507|NCT03398148|471725293|FG002|Substudy 1 Period 1|Adverse Event|2|||
131025508|NCT03398148|471725294|FG003|Substudy 1 Period 1|Adverse Event|0|||
131025509|NCT03398148|471725295|FG004|Substudy 1 Period 1|Adverse Event|8|||
131025510|NCT03398148|471725296|FG005|Substudy 1 Period 1|Adverse Event|0|||
131025511|NCT03398148|471725297|FG006|Substudy 1 Period 1|Adverse Event|0|||
130691563|NCT01383486|470495909|FG000|Overall Study|Incomplete information for analysis|2|||
130691564|NCT01383486|470495909|FG000|Overall Study|Did not take any product|6|||
130691565|NCT01839279|470495911|FG000|Overall Study|Adverse Event|4|||
130691566|NCT01839279|470495912|FG001|Overall Study|Adverse Event|1|||
130691567|NCT01839279|470495913|FG002|Overall Study|Adverse Event|1|||
130691568|NCT01839279|470495911|FG000|Overall Study|Withdrawal by Subject|4|||
130691569|NCT01839279|470495912|FG001|Overall Study|Withdrawal by Subject|1|||
130691570|NCT01839279|470495913|FG002|Overall Study|Withdrawal by Subject|1|||
130691571|NCT01839279|470495911|FG000|Overall Study|Classified as 'Other'|5|||
130691572|NCT01839279|470495912|FG001|Overall Study|Classified as 'Other'|0|||
130691573|NCT01839279|470495913|FG002|Overall Study|Classified as 'Other'|0|||
130691574|NCT01648582|470495916|FG000|Overall Study|Adverse Event|6|||
130691575|NCT01648582|470495917|FG001|Overall Study|Adverse Event|11|||
130691576|NCT01648582|470495918|FG002|Overall Study|Adverse Event|2|||
130691577|NCT01648582|470495916|FG000|Overall Study|Lost to Follow-up|9|||
130691578|NCT01648582|470495917|FG001|Overall Study|Lost to Follow-up|6|||
131025512|NCT03398148|471725298|FG007|Substudy 1 Period 1|Adverse Event|0|||
130898318|NCT00717236|471263200|FG000|Double-Blind Period|Other: Site withdrew|2|||
130898319|NCT00717236|471263201|FG001|Double-Blind Period|Other: Site withdrew|0|||
130898320|NCT00717236|471263200|FG000|Double-Blind Period|Other: Screening failure|1|||
130898321|NCT00717236|471263201|FG001|Double-Blind Period|Other: Screening failure|0|||
130898322|NCT00717236|471263200|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
130898323|NCT00717236|471263201|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
130898324|NCT00717236|471263200|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
130898325|NCT00717236|471263201|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
130898326|NCT00717236|471263200|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
130898327|NCT00717236|471263201|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
130898328|NCT00717236|471263200|FG000|Double-Blind Period|Other: History of cancer|1|||
130898329|NCT00717236|471263201|FG001|Double-Blind Period|Other: History of cancer|0|||
130898330|NCT00717236|471263200|FG000|Double-Blind Period|Other: Sponsor request|1|||
130898331|NCT00717236|471263201|FG001|Double-Blind Period|Other: Sponsor request|0|||
130898332|NCT00717236|471263200|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
130898333|NCT00717236|471263201|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
130898334|NCT00717236|471263200|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
130898335|NCT00717236|471263201|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
130898336|NCT00717236|471263200|FG000|Double-Blind Period|Other: Subject moved|1|||
130898337|NCT00717236|471263201|FG001|Double-Blind Period|Other: Subject moved|1|||
130898338|NCT00717236|471263200|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
130898339|NCT00717236|471263201|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
130898340|NCT00717236|471263200|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
130898341|NCT00717236|471263201|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
130898342|NCT00717236|471263200|FG000|Double-Blind Period|Other: Transportation problems|0|||
131222720|NCT00720304|472443166|FG000|Overall Study|Withdrawal by Subject|14|||
131222721|NCT00720304|472443167|FG001|Overall Study|Withdrawal by Subject|1|||
130898343|NCT00717236|471263201|FG001|Double-Blind Period|Other: Transportation problems|1|||
130898344|NCT00717236|471263200|FG000|Double-Blind Period|Other: Investigator Decision|0|||
130898345|NCT00717236|471263201|FG001|Double-Blind Period|Other: Investigator Decision|1|||
130898346|NCT00717236|471263200|FG000|Open-Label Period|Adverse Event|29|||
130898347|NCT00717236|471263201|FG001|Open-Label Period|Adverse Event|4|||
130898348|NCT00717236|471263200|FG000|Open-Label Period|Lack of Efficacy|30|||
130898349|NCT00717236|471263201|FG001|Open-Label Period|Lack of Efficacy|8|||
130898350|NCT00717236|471263200|FG000|Open-Label Period|Lost to Follow-up|28|||
130898351|NCT00717236|471263201|FG001|Open-Label Period|Lost to Follow-up|4|||
130898352|NCT00717236|471263200|FG000|Open-Label Period|Withdrawal by Subject|20|||
130898353|NCT00717236|471263201|FG001|Open-Label Period|Withdrawal by Subject|2|||
130898354|NCT00717236|471263200|FG000|Open-Label Period|Loss of Efficacy|6|||
130898355|NCT00717236|471263201|FG001|Open-Label Period|Loss of Efficacy|1|||
130898356|NCT00717236|471263200|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
130898357|NCT00717236|471263201|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
130898358|NCT00717236|471263200|FG000|Open-Label Period|Other: Lack of Compliance|1|||
130898359|NCT00717236|471263201|FG001|Open-Label Period|Other: Lack of Compliance|1|||
130898360|NCT00717236|471263200|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
130898361|NCT00717236|471263201|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
130898362|NCT00717236|471263200|FG000|Open-Label Period|Other: Moved|1|||
130898363|NCT00717236|471263201|FG001|Open-Label Period|Other: Moved|0|||
130898364|NCT00717236|471263200|FG000|Open-Label Period|Other: Investigator Decision|1|||
130898365|NCT00717236|471263201|FG001|Open-Label Period|Other: Investigator Decision|0|||
130898366|NCT00717236|471263200|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
130898367|NCT00717236|471263201|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
130898368|NCT00717236|471263200|FG000|Open-Label Period|Other: Sponsor Request|3|||
130898369|NCT00717236|471263201|FG001|Open-Label Period|Other: Sponsor Request|0|||
130898370|NCT00717236|471263200|FG000|Open-Label Period|Other: Cataract Surgery|1|||
130898371|NCT00717236|471263201|FG001|Open-Label Period|Other: Cataract Surgery|0|||
130898372|NCT00717236|471263200|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
130898373|NCT00717236|471263201|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
130898374|NCT00717236|471263200|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
130898375|NCT00717236|471263201|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
130898376|NCT00717236|471263200|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
130898377|NCT00717236|471263201|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
130898378|NCT03704636|471263207|FG000|Overall Study|Inadequate Venous Flow|3|||
130898379|NCT00539188|471263210|FG000|Overall Study|Withdrawal by Subject|1|||
130898380|NCT00539188|471263211|FG001|Overall Study|Withdrawal by Subject|0|||
130898381|NCT00539188|471263210|FG000|Overall Study|Lost to Follow-up|2|||
130898382|NCT00539188|471263211|FG001|Overall Study|Lost to Follow-up|1|||
130898383|NCT04784442|471263212|FG000|Overall Study|Adverse Event|1|||
130691579|NCT01648582|470495918|FG002|Overall Study|Lost to Follow-up|8|||
130691580|NCT01648582|470495916|FG000|Overall Study|Protocol Violation|1|||
130691581|NCT01648582|470495917|FG001|Overall Study|Protocol Violation|2|||
131025513|NCT03398148|471725299|FG008|Substudy 1 Period 1|Adverse Event|0|||
131025514|NCT03398148|471725300|FG009|Substudy 1 Period 1|Adverse Event|0|||
131025515|NCT03398148|471725301|FG010|Substudy 1 Period 1|Adverse Event|0|||
131025516|NCT03398148|471725302|FG011|Substudy 1 Period 1|Adverse Event|0|||
131025517|NCT03398148|471725303|FG012|Substudy 1 Period 1|Adverse Event|0|||
131025518|NCT03398148|471725304|FG013|Substudy 1 Period 1|Adverse Event|0|||
130691582|NCT01648582|470495918|FG002|Overall Study|Protocol Violation|1|||
130691583|NCT01648582|470495916|FG000|Overall Study|Withdrawal by Subject|15|||
130691584|NCT01648582|470495917|FG001|Overall Study|Withdrawal by Subject|17|||
130691585|NCT01648582|470495918|FG002|Overall Study|Withdrawal by Subject|17|||
130691586|NCT01648582|470495916|FG000|Overall Study|Physician Decision|0|||
130691587|NCT01648582|470495917|FG001|Overall Study|Physician Decision|1|||
130691588|NCT01648582|470495918|FG002|Overall Study|Physician Decision|3|||
130691589|NCT01648582|470495916|FG000|Overall Study|Death|1|||
130691590|NCT01648582|470495917|FG001|Overall Study|Death|0|||
130691591|NCT01648582|470495918|FG002|Overall Study|Death|0|||
130691592|NCT01648582|470495916|FG000|Overall Study|Sponsor Decision|0|||
130691593|NCT01648582|470495917|FG001|Overall Study|Sponsor Decision|1|||
130691594|NCT01648582|470495918|FG002|Overall Study|Sponsor Decision|1|||
130691595|NCT02699866|470495919|FG000|Overall Study|Withdrawal by Subject|3|||
130691596|NCT02699866|470495919|FG000|Overall Study|Physician Decision|2|||
130691597|NCT02699866|470495919|FG000|Overall Study|Adverse Event|3|||
130691598|NCT03276754|470495920|FG000|Overall Study|Withdrawal of informed consent|4|||
130691599|NCT03276754|470495920|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
130691600|NCT03276754|470495920|FG000|Overall Study|Lost to Follow-up|27|||
130691601|NCT03276754|470495920|FG000|Overall Study|No data reported at Month 24|31|||
130691602|NCT03276754|470495920|FG000|Overall Study|Death|39|||
130691603|NCT03437265|470495921|FG000|Overall Study|Protocol Violation|6|||
130691604|NCT00316277|470495923|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
130691605|NCT00316277|470495924|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
130691606|NCT00316277|470495923|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
130691607|NCT00316277|470495924|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
130691608|NCT00316277|470495923|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
130691609|NCT00316277|470495924|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
130691610|NCT00316277|470495923|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
130691611|NCT00316277|470495924|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
130691612|NCT00316277|470495923|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
130691613|NCT00316277|470495924|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
130691614|NCT00835263|470495933|FG000|Second Intervention|Adverse Event|1|||
130691615|NCT00835263|470495934|FG001|Second Intervention|Adverse Event|0|||
130691616|NCT00848536|470495935|FG000|Overall Study|Adverse Event|2|||
130691617|NCT00848536|470495936|FG001|Overall Study|Adverse Event|2|||
130691618|NCT00848536|470495935|FG000|Overall Study|Withdrawal by Subject|0|||
130691619|NCT00848536|470495936|FG001|Overall Study|Withdrawal by Subject|1|||
130691620|NCT00848536|470495935|FG000|Overall Study|Protocol Violation|0|||
130691621|NCT00848536|470495936|FG001|Overall Study|Protocol Violation|1|||
130691622|NCT00848536|470495935|FG000|Overall Study|Noncompliance|1|||
130691623|NCT00848536|470495936|FG001|Overall Study|Noncompliance|0|||
130691624|NCT00848536|470495935|FG000|Overall Study|Inadequate Control of IOP|1|||
130691625|NCT00848536|470495936|FG001|Overall Study|Inadequate Control of IOP|1|||
130691626|NCT00848536|470495935|FG000|Overall Study|Patient Moved|0|||
130691627|NCT00848536|470495936|FG001|Overall Study|Patient Moved|2|||
130691628|NCT03249454|470495937|FG000|Overall Study|Withdrawal by Subject|0|||
130691629|NCT03249454|470495938|FG001|Overall Study|Withdrawal by Subject|0|||
130691630|NCT03249454|470495939|FG002|Overall Study|Withdrawal by Subject|0|||
130691631|NCT03249454|470495940|FG003|Overall Study|Withdrawal by Subject|0|||
130691632|NCT03249454|470495941|FG004|Overall Study|Withdrawal by Subject|0|||
130691633|NCT03249454|470495942|FG005|Overall Study|Withdrawal by Subject|0|||
130691634|NCT03249454|470495943|FG006|Overall Study|Withdrawal by Subject|0|||
130691635|NCT03249454|470495944|FG007|Overall Study|Withdrawal by Subject|0|||
130691636|NCT03249454|470495945|FG008|Overall Study|Withdrawal by Subject|0|||
130691637|NCT03249454|470495946|FG009|Overall Study|Withdrawal by Subject|1|||
130691638|NCT03249454|470495947|FG010|Overall Study|Withdrawal by Subject|1|||
131025519|NCT03398148|471725305|FG014|Substudy 1 Period 1|Adverse Event|0|||
131025520|NCT03398148|471725291|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
131025521|NCT03398148|471725292|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
131025522|NCT03398148|471725293|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130691639|NCT01913405|470495948|FG000|Overall Study|Withdrawal by Subject|1|||
130691640|NCT01913405|470495948|FG000|Overall Study|Adverse Event|1|||
130691641|NCT03987191|470495951|FG000|Overall Study|COVID-19 related research disruption|0|||
130691642|NCT03987191|470495952|FG001|Overall Study|COVID-19 related research disruption|2|||
130691643|NCT03261167|470495953|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
130691644|NCT03261167|470495954|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
131025523|NCT03398148|471725294|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
131025524|NCT03398148|471725295|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
131025525|NCT03398148|471725296|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
130898384|NCT04784442|471263213|FG001|Overall Study|Adverse Event|0|||
130898385|NCT04784442|471263214|FG002|Overall Study|Adverse Event|2|||
130898386|NCT04784442|471263215|FG003|Overall Study|Adverse Event|1|||
130898387|NCT04784442|471263212|FG000|Overall Study|Protocol Violation|1|||
130898388|NCT04784442|471263213|FG001|Overall Study|Protocol Violation|0|||
130898389|NCT04784442|471263214|FG002|Overall Study|Protocol Violation|0|||
130898390|NCT04784442|471263215|FG003|Overall Study|Protocol Violation|0|||
130898391|NCT04784442|471263212|FG000|Overall Study|Non-compliance with study drug|1|||
130898392|NCT04784442|471263213|FG001|Overall Study|Non-compliance with study drug|0|||
130898393|NCT04784442|471263214|FG002|Overall Study|Non-compliance with study drug|0|||
130898394|NCT04784442|471263215|FG003|Overall Study|Non-compliance with study drug|0|||
130898395|NCT00852371|471263216|FG000|Overall Study|Lost to Follow-up|2|||
130898396|NCT00852371|471263217|FG001|Overall Study|Lost to Follow-up|3|||
130898397|NCT00852371|471263218|FG002|Overall Study|Lost to Follow-up|4|||
130898398|NCT00852371|471263219|FG003|Overall Study|Lost to Follow-up|2|||
130898399|NCT01590758|471263220|FG000|Overall Study|Withdrawal by Subject|0|||
130898400|NCT01590758|471263221|FG001|Overall Study|Withdrawal by Subject|3|||
130898401|NCT01590758|471263220|FG000|Overall Study|Physician Decision|1|||
130898402|NCT01590758|471263221|FG001|Overall Study|Physician Decision|2|||
130898403|NCT01590758|471263220|FG000|Overall Study|Lost to Follow-up|4|||
130898404|NCT01590758|471263221|FG001|Overall Study|Lost to Follow-up|2|||
130898405|NCT02756806|471263222|FG000|Overall Study|Study terminated early|5|||
130898406|NCT02717832|471263223|FG000|Overall Study|Inability to place IV|3|||
130898407|NCT03698591|471263226|FG000|Overall Study|Withdrawal by Subject|2|||
130898408|NCT03698591|471263227|FG001|Overall Study|Withdrawal by Subject|2|||
130898409|NCT03698591|471263226|FG000|Overall Study|Failed drug screen|1|||
130898410|NCT03698591|471263227|FG001|Overall Study|Failed drug screen|1|||
130898411|NCT03698591|471263226|FG000|Overall Study|Failed health screen|0|||
130898412|NCT03698591|471263227|FG001|Overall Study|Failed health screen|1|||
130898413|NCT03698591|471263226|FG000|Overall Study|Ineligible for financial compensation|1|||
130898414|NCT03698591|471263227|FG001|Overall Study|Ineligible for financial compensation|0|||
130898415|NCT03698591|471263226|FG000|Overall Study|Equipment Error|1|||
130898416|NCT03698591|471263227|FG001|Overall Study|Equipment Error|0|||
130898417|NCT03698591|471263226|FG000|Overall Study|Could not establish TMS dosage|0|||
130898418|NCT03698591|471263227|FG001|Overall Study|Could not establish TMS dosage|1|||
130898419|NCT01675167|471263229|FG000|Open-label Titration Phase|Adverse Event|81|||
130898420|NCT01675167|471263230|FG001|Open-label Titration Phase|Adverse Event|0|||
130898421|NCT01675167|471263231|FG002|Open-label Titration Phase|Adverse Event|0|||
130898422|NCT01675167|471263229|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
130898423|NCT01675167|471263230|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
130898424|NCT01675167|471263231|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
130898425|NCT01675167|471263229|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
130898426|NCT01675167|471263230|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
130898427|NCT01675167|471263231|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
130898428|NCT01675167|471263229|FG000|Open-label Titration Phase|Protocol Violation|43|||
130898429|NCT01675167|471263230|FG001|Open-label Titration Phase|Protocol Violation|0|||
130898430|NCT01675167|471263231|FG002|Open-label Titration Phase|Protocol Violation|0|||
130898431|NCT01675167|471263229|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
130898432|NCT01675167|471263230|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
130898433|NCT01675167|471263231|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
130898434|NCT01675167|471263229|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
130898435|NCT01675167|471263230|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
131025526|NCT03398148|471725297|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131025527|NCT03398148|471725298|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131025528|NCT03398148|471725299|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131025529|NCT03398148|471725300|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131025530|NCT03398148|471725301|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131025531|NCT03398148|471725302|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131025532|NCT03398148|471725303|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131025533|NCT03398148|471725304|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131025534|NCT03398148|471725305|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
131025535|NCT03398148|471725291|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
131025536|NCT03398148|471725292|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
131025537|NCT03398148|471725293|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
131025538|NCT03398148|471725294|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
131025539|NCT03398148|471725295|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
131025540|NCT03398148|471725296|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
130898436|NCT01675167|471263231|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
131025541|NCT03398148|471725297|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
131025542|NCT03398148|471725298|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
131112330|NCT02370043|472041055|FG005|Overall Study|Withdrawal by Subject|1|||
130898437|NCT01675167|471263229|FG000|Open-label Titration Phase|Other|55|||
130898438|NCT01675167|471263230|FG001|Open-label Titration Phase|Other|0|||
130898439|NCT01675167|471263231|FG002|Open-label Titration Phase|Other|0|||
131112331|NCT00688181|472041056|FG000|Overall Study|Lost to Follow-up|17|||
130898440|NCT01675167|471263229|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
130898441|NCT01675167|471263230|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
130898442|NCT01675167|471263231|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
130898443|NCT01675167|471263229|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130898444|NCT01675167|471263230|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
130898445|NCT01675167|471263231|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
130898446|NCT01675167|471263229|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130898447|NCT01675167|471263230|FG001|Double-blind Treatment Phase|Adverse Event|5|||
130898448|NCT01675167|471263231|FG002|Double-blind Treatment Phase|Adverse Event|13|||
130898449|NCT01675167|471263229|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
130898450|NCT01675167|471263230|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
130898451|NCT01675167|471263231|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
130898452|NCT01675167|471263229|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130898453|NCT01675167|471263230|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
130898454|NCT01675167|471263231|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
130898455|NCT01675167|471263229|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
130898456|NCT01675167|471263230|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
130898457|NCT01675167|471263231|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
130898458|NCT01675167|471263229|FG000|Double-blind Treatment Phase|Other|0|||
130898459|NCT01675167|471263230|FG001|Double-blind Treatment Phase|Other|7|||
130898460|NCT01675167|471263231|FG002|Double-blind Treatment Phase|Other|5|||
130898461|NCT00881868|471263232|FG000|Overall Study|Adverse Event|0|||
130898462|NCT00881868|471263233|FG001|Overall Study|Adverse Event|1|||
130898463|NCT00881868|471263232|FG000|Overall Study|Lost to Follow-up|2|||
130898464|NCT00881868|471263233|FG001|Overall Study|Lost to Follow-up|1|||
130898465|NCT00881868|471263232|FG000|Overall Study|Physician Decision|4|||
130898466|NCT00881868|471263233|FG001|Overall Study|Physician Decision|0|||
130898467|NCT00881868|471263232|FG000|Overall Study|Protocol Violation|2|||
130898468|NCT00881868|471263233|FG001|Overall Study|Protocol Violation|0|||
130898469|NCT03255083|471263234|FG000|Overall Study|Clinical progression|1|||
130898470|NCT03255083|471263235|FG001|Overall Study|Clinical progression|0|||
130898471|NCT03255083|471263236|FG002|Overall Study|Clinical progression|0|||
130898472|NCT03255083|471263237|FG003|Overall Study|Clinical progression|0|||
130898473|NCT03255083|471263234|FG000|Overall Study|Adverse Event|0|||
130898474|NCT03255083|471263235|FG001|Overall Study|Adverse Event|1|||
130898475|NCT03255083|471263236|FG002|Overall Study|Adverse Event|0|||
130898476|NCT03255083|471263237|FG003|Overall Study|Adverse Event|0|||
130898477|NCT03255083|471263234|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
130898478|NCT03255083|471263235|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
130898479|NCT03255083|471263236|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
130898480|NCT03255083|471263237|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
130898481|NCT03255083|471263234|FG000|Overall Study|Withdrawal by Subject|1|||
130898482|NCT03255083|471263235|FG001|Overall Study|Withdrawal by Subject|1|||
130898483|NCT03255083|471263236|FG002|Overall Study|Withdrawal by Subject|1|||
130898484|NCT03255083|471263237|FG003|Overall Study|Withdrawal by Subject|0|||
130898485|NCT01182844|471263238|FG000|Overall Study|Withdrawal by Subject|0|||
130898486|NCT01182844|471263239|FG001|Overall Study|Withdrawal by Subject|2|||
130898487|NCT01457352|471263240|FG000|Period 1|Adverse Event|2|||
130898488|NCT01457352|471263241|FG001|Period 1|Adverse Event|0|||
131025543|NCT03398148|471725299|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
131025544|NCT03398148|471725300|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
131025545|NCT03398148|471725301|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
131025546|NCT03398148|471725302|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
131025547|NCT03398148|471725303|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
131025548|NCT03398148|471725304|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
131025549|NCT03398148|471725305|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
131025550|NCT03398148|471725291|FG000|Substudy 1 Period 1|Other|0|||
131025551|NCT03398148|471725292|FG001|Substudy 1 Period 1|Other|1|||
131025552|NCT03398148|471725293|FG002|Substudy 1 Period 1|Other|0|||
131025553|NCT03398148|471725294|FG003|Substudy 1 Period 1|Other|0|||
131025554|NCT03398148|471725295|FG004|Substudy 1 Period 1|Other|3|||
131025555|NCT03398148|471725296|FG005|Substudy 1 Period 1|Other|0|||
131025556|NCT03398148|471725297|FG006|Substudy 1 Period 1|Other|0|||
131025557|NCT03398148|471725298|FG007|Substudy 1 Period 1|Other|0|||
131025558|NCT03398148|471725299|FG008|Substudy 1 Period 1|Other|0|||
131025559|NCT03398148|471725300|FG009|Substudy 1 Period 1|Other|0|||
131025560|NCT03398148|471725301|FG010|Substudy 1 Period 1|Other|0|||
130898489|NCT01457352|471263240|FG000|Period 1|Withdrawal by Subject|2|||
130898490|NCT01457352|471263241|FG001|Period 1|Withdrawal by Subject|0|||
130898491|NCT01457352|471263240|FG000|Period 1|Physician Decision|2|||
130898492|NCT01457352|471263241|FG001|Period 1|Physician Decision|0|||
130898493|NCT01457352|471263240|FG000|Period 1|MS related disease progression|1|||
130898494|NCT01457352|471263241|FG001|Period 1|MS related disease progression|0|||
131025561|NCT03398148|471725302|FG011|Substudy 1 Period 1|Other|0|||
131025562|NCT03398148|471725303|FG012|Substudy 1 Period 1|Other|0|||
131025563|NCT03398148|471725304|FG013|Substudy 1 Period 1|Other|0|||
130898495|NCT01457352|471263240|FG000|Period 1|Withdrawn|1|||
130898496|NCT01457352|471263241|FG001|Period 1|Withdrawn|0|||
130898497|NCT01457352|471263240|FG000|Period 1|withdrew per sponsor|1|||
130898498|NCT01457352|471263241|FG001|Period 1|withdrew per sponsor|0|||
130898499|NCT01457352|471263240|FG000|Period 1|Protocol Violation|4|||
130898500|NCT01457352|471263241|FG001|Period 1|Protocol Violation|0|||
130898501|NCT01457352|471263240|FG000|Period 1|Did not meet eligibility criteria|3|||
130898502|NCT01457352|471263241|FG001|Period 1|Did not meet eligibility criteria|0|||
130898503|NCT01457352|471263240|FG000|Period 2|Withdrawal by Subject|23|||
130898504|NCT01457352|471263241|FG001|Period 2|Withdrawal by Subject|0|||
130898505|NCT01457352|471263240|FG000|Period 2|Adverse Event|22|||
130898506|NCT01457352|471263241|FG001|Period 2|Adverse Event|0|||
130898507|NCT01457352|471263240|FG000|Period 2|no analysis|10|||
130898508|NCT01457352|471263241|FG001|Period 2|no analysis|0|||
130898509|NCT01457352|471263240|FG000|Period 2|Lack of Efficacy|8|||
130898510|NCT01457352|471263241|FG001|Period 2|Lack of Efficacy|0|||
130898511|NCT01457352|471263240|FG000|Period 2|Protocol Violation|4|||
130898512|NCT01457352|471263241|FG001|Period 2|Protocol Violation|0|||
130898513|NCT01457352|471263240|FG000|Period 2|Sponsor's withdrawal|7|||
130898514|NCT01457352|471263241|FG001|Period 2|Sponsor's withdrawal|0|||
130898515|NCT01457352|471263240|FG000|Period 2|Lost to Follow-up|1|||
130898516|NCT01457352|471263241|FG001|Period 2|Lost to Follow-up|0|||
130898517|NCT01457352|471263240|FG000|Period 2|dose change|1|||
130898518|NCT01457352|471263241|FG001|Period 2|dose change|0|||
130898519|NCT01457352|471263240|FG000|Period 2|Physician Decision|1|||
130898520|NCT01457352|471263241|FG001|Period 2|Physician Decision|0|||
130898521|NCT01457352|471263240|FG000|Period 2|Did not meet eligibility criteria|3|||
130898522|NCT01457352|471263241|FG001|Period 2|Did not meet eligibility criteria|0|||
130898523|NCT01457352|471263240|FG000|Period 3|Adverse Event|1|||
130898524|NCT01457352|471263241|FG001|Period 3|Adverse Event|1|||
130898525|NCT01457352|471263240|FG000|Period 3|Withdrawal by Subject|0|||
130898526|NCT01457352|471263241|FG001|Period 3|Withdrawal by Subject|2|||
130898527|NCT01457352|471263240|FG000|Period 3|incorrect treatment|0|||
130898528|NCT01457352|471263241|FG001|Period 3|incorrect treatment|1|||
130898529|NCT01457352|471263240|FG000|Period 3|Sponsor's withdrawal|0|||
130898530|NCT01457352|471263241|FG001|Period 3|Sponsor's withdrawal|1|||
130898531|NCT04174365|471263242|FG000|Overall Study|Lost to Follow-up|1|||
130898532|NCT04174365|471263243|FG001|Overall Study|Lost to Follow-up|2|||
130898533|NCT04174365|471263242|FG000|Overall Study|Adverse Event|2|||
130898534|NCT04174365|471263243|FG001|Overall Study|Adverse Event|1|||
130898535|NCT04174365|471263242|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
130898536|NCT04174365|471263243|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
130898537|NCT04174365|471263242|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
130898538|NCT04174365|471263243|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
130898539|NCT04174365|471263242|FG000|Overall Study|Protocol Deviation|1|||
130898540|NCT04174365|471263243|FG001|Overall Study|Protocol Deviation|0|||
130898541|NCT04174365|471263242|FG000|Overall Study|Lack of Efficacy|0|||
130898542|NCT04174365|471263243|FG001|Overall Study|Lack of Efficacy|2|||
130898543|NCT04174365|471263242|FG000|Overall Study|Disease Relapse|1|||
130898544|NCT04174365|471263243|FG001|Overall Study|Disease Relapse|0|||
130898545|NCT04174365|471263242|FG000|Overall Study|Reason Not Specified|0|||
130898546|NCT04174365|471263243|FG001|Overall Study|Reason Not Specified|1|||
130898547|NCT03254459|471265042|FG000|Overall Study|Adverse Event|7|||
130898548|NCT03254459|471265043|FG001|Overall Study|Adverse Event|20|||
130898549|NCT03254459|471265042|FG000|Overall Study|Withdrawal by Subject Consent|3|||
130898550|NCT03254459|471265043|FG001|Overall Study|Withdrawal by Subject Consent|1|||
130898551|NCT03254459|471265042|FG000|Overall Study|Lost to Follow-up|0|||
130898552|NCT03254459|471265043|FG001|Overall Study|Lost to Follow-up|1|||
130898553|NCT03254459|471265042|FG000|Overall Study|Miscellaneous|0|||
130898554|NCT03254459|471265043|FG001|Overall Study|Miscellaneous|1|||
130898555|NCT00535288|471265044|FG000|Overall Study|Adverse Event|20|||
130898556|NCT00535288|471265045|FG001|Overall Study|Adverse Event|19|||
130898557|NCT00535288|471265046|FG002|Overall Study|Adverse Event|25|||
130898558|NCT00535288|471265047|FG003|Overall Study|Adverse Event|20|||
130898559|NCT00535288|471265048|FG004|Overall Study|Adverse Event|30|||
130898560|NCT00535288|471265044|FG000|Overall Study|Lost to Follow-up|0|||
130898561|NCT00535288|471265045|FG001|Overall Study|Lost to Follow-up|3|||
130898562|NCT00535288|471265046|FG002|Overall Study|Lost to Follow-up|0|||
130898563|NCT00535288|471265047|FG003|Overall Study|Lost to Follow-up|0|||
130898564|NCT00535288|471265048|FG004|Overall Study|Lost to Follow-up|0|||
130898565|NCT00535288|471265044|FG000|Overall Study|Lack of Efficacy|26|||
130898566|NCT00535288|471265045|FG001|Overall Study|Lack of Efficacy|3|||
130898567|NCT00535288|471265046|FG002|Overall Study|Lack of Efficacy|4|||
130898568|NCT00535288|471265047|FG003|Overall Study|Lack of Efficacy|4|||
130898569|NCT00535288|471265048|FG004|Overall Study|Lack of Efficacy|7|||
130898570|NCT00535288|471265044|FG000|Overall Study|Unwilling to cooperate|6|||
130898571|NCT00535288|471265045|FG001|Overall Study|Unwilling to cooperate|6|||
130898572|NCT00535288|471265046|FG002|Overall Study|Unwilling to cooperate|3|||
130898573|NCT00535288|471265047|FG003|Overall Study|Unwilling to cooperate|3|||
130898574|NCT00535288|471265048|FG004|Overall Study|Unwilling to cooperate|4|||
130898575|NCT00535288|471265044|FG000|Overall Study|Other|2|||
130898576|NCT00535288|471265045|FG001|Overall Study|Other|1|||
130898577|NCT00535288|471265046|FG002|Overall Study|Other|1|||
130898578|NCT00535288|471265047|FG003|Overall Study|Other|2|||
130898579|NCT00535288|471265048|FG004|Overall Study|Other|1|||
130898580|NCT02600871|471265049|FG000|Overall Study|Lost to Follow-up|13|||
130898581|NCT02600871|471265050|FG001|Overall Study|Lost to Follow-up|10|||
130898582|NCT03859973|471265057|FG000|Overall Study|Other reason than listed|3|||
130898583|NCT03859973|471265058|FG001|Overall Study|Other reason than listed|2|||
130898584|NCT03859973|471265057|FG000|Overall Study|COVID-19 related, not due to AE|3|||
130898585|NCT03859973|471265058|FG001|Overall Study|COVID-19 related, not due to AE|4|||
130898586|NCT03859973|471265057|FG000|Overall Study|Withdrawal by Subject|8|||
130898587|NCT03859973|471265058|FG001|Overall Study|Withdrawal by Subject|9|||
130898588|NCT03859973|471265057|FG000|Overall Study|Lost to Follow-up|2|||
130898589|NCT03859973|471265058|FG001|Overall Study|Lost to Follow-up|3|||
130898590|NCT03859973|471265057|FG000|Overall Study|Protocol Violation|1|||
130898591|NCT03859973|471265058|FG001|Overall Study|Protocol Violation|3|||
130898592|NCT03859973|471265057|FG000|Overall Study|Adverse Event|3|||
130898593|NCT03859973|471265058|FG001|Overall Study|Adverse Event|5|||
130898594|NCT02855541|471265059|FG000|Overall Study|Change in health status|2|||
130898595|NCT02855541|471265059|FG000|Overall Study|Withdrawal by Subject|2|||
130898596|NCT00422513|471265060|FG000|Overall Study|Lack of Efficacy|4|||
130898597|NCT00422513|471265061|FG001|Overall Study|Lack of Efficacy|5|||
130898598|NCT00422513|471265060|FG000|Overall Study|Protocol Violation|23|||
130898599|NCT00422513|471265061|FG001|Overall Study|Protocol Violation|7|||
130898600|NCT00422513|471265060|FG000|Overall Study|Refused Treatment|4|||
130898601|NCT00422513|471265061|FG001|Overall Study|Refused Treatment|2|||
130898602|NCT00422513|471265060|FG000|Overall Study|Withdrawal by Subject|2|||
130898603|NCT00422513|471265061|FG001|Overall Study|Withdrawal by Subject|1|||
130898604|NCT00422513|471265060|FG000|Overall Study|early termination of the study|67|||
130898605|NCT00422513|471265061|FG001|Overall Study|early termination of the study|80|||
130898606|NCT00422513|471265060|FG000|Overall Study|Adverse Event|4|||
130898607|NCT00422513|471265061|FG001|Overall Study|Adverse Event|4|||
130898608|NCT00422513|471265060|FG000|Overall Study|Death|3|||
130898609|NCT00422513|471265061|FG001|Overall Study|Death|7|||
130898610|NCT03032380|471265062|FG000|Overall Study|Adverse Event|0|||
130898611|NCT03032380|471265063|FG001|Overall Study|Adverse Event|1|||
130898612|NCT03032380|471265062|FG000|Overall Study|Lack of Efficacy|1|||
130898613|NCT03032380|471265063|FG001|Overall Study|Lack of Efficacy|0|||
130898614|NCT03032380|471265062|FG000|Overall Study|Withdrawal by Subject|2|||
130898615|NCT03032380|471265063|FG001|Overall Study|Withdrawal by Subject|3|||
130898616|NCT03032380|471265062|FG000|Overall Study|Recovery|0|||
130898617|NCT03032380|471265063|FG001|Overall Study|Recovery|1|||
130898618|NCT03032380|471265062|FG000|Overall Study|Death|39|||
130898619|NCT03032380|471265063|FG001|Overall Study|Death|34|||
130898620|NCT03032380|471265062|FG000|Overall Study|Other - Miscellaneous|0|||
130898621|NCT03032380|471265063|FG001|Overall Study|Other - Miscellaneous|1|||
130898622|NCT02267317|471265068|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
130898623|NCT02267317|471265069|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
131025564|NCT03398148|471725305|FG014|Substudy 1 Period 1|Other|0|||
131025565|NCT03398148|471725291|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025566|NCT03398148|471725292|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025567|NCT03398148|471725293|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025568|NCT03398148|471725294|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025569|NCT03398148|471725295|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
131025570|NCT03398148|471725296|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025571|NCT03398148|471725297|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025572|NCT03398148|471725298|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025573|NCT03398148|471725299|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025574|NCT03398148|471725300|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025575|NCT03398148|471725301|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025576|NCT03398148|471725302|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025577|NCT03398148|471725303|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025578|NCT03398148|471725304|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
131025579|NCT03398148|471725305|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
130898624|NCT02267317|471265070|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130898625|NCT02267317|471265071|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130898626|NCT02267317|471265072|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130898627|NCT02267317|471265073|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130898628|NCT02267317|471265068|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
130898629|NCT02267317|471265069|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130898630|NCT02267317|471265070|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130898631|NCT02267317|471265071|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130898632|NCT02267317|471265072|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130898633|NCT02267317|471265073|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130898634|NCT01128621|471265074|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
130898635|NCT01128621|471265075|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
130898636|NCT00796445|471265078|FG000|Overall Study|Protocol Violation|5|||
130898637|NCT00796445|471265079|FG001|Overall Study|Protocol Violation|3|||
130898638|NCT00796445|471265078|FG000|Overall Study|Adverse event, serious fatal|10|||
130898639|NCT00796445|471265079|FG001|Overall Study|Adverse event, serious fatal|5|||
130898640|NCT00796445|471265078|FG000|Overall Study|Adverse event, non-fatal|4|||
130898641|NCT00796445|471265079|FG001|Overall Study|Adverse event, non-fatal|0|||
130898642|NCT00796445|471265078|FG000|Overall Study|Disease progression/recurrence|537|||
130898643|NCT00796445|471265079|FG001|Overall Study|Disease progression/recurrence|268|||
130898644|NCT00796445|471265078|FG000|Overall Study|Other|10|||
130898645|NCT00796445|471265079|FG001|Overall Study|Other|7|||
130898646|NCT00796445|471265078|FG000|Overall Study|Withdrawal by Subject|18|||
130898647|NCT00796445|471265079|FG001|Overall Study|Withdrawal by Subject|9|||
130898648|NCT00796445|471265078|FG000|Overall Study|Invalid Informed Consent Form|1|||
130898649|NCT00796445|471265079|FG001|Overall Study|Invalid Informed Consent Form|0|||
130898650|NCT02208063|471265080|FG000|Overall Study|Death|3|||
130898651|NCT02208063|471265081|FG001|Overall Study|Death|5|||
130898652|NCT02208063|471265080|FG000|Overall Study|Not Specified in report|3|||
130898653|NCT02208063|471265081|FG001|Overall Study|Not Specified in report|4|||
130898654|NCT02208063|471265080|FG000|Overall Study|Withdrawal by Subject|5|||
130898655|NCT02208063|471265081|FG001|Overall Study|Withdrawal by Subject|2|||
130898656|NCT02208063|471265080|FG000|Overall Study|Lost to Follow-up|1|||
130898657|NCT02208063|471265081|FG001|Overall Study|Lost to Follow-up|0|||
130898658|NCT00422084|471265086|FG000|Overall Study|Adverse Event|21|||
130898659|NCT00422084|471265087|FG001|Overall Study|Adverse Event|7|||
130898660|NCT00422084|471265086|FG000|Overall Study|Withdrawal by Subject|12|||
130898661|NCT00422084|471265087|FG001|Overall Study|Withdrawal by Subject|9|||
130898662|NCT00422084|471265086|FG000|Overall Study|Lost to Follow-up|14|||
130898663|NCT00422084|471265087|FG001|Overall Study|Lost to Follow-up|9|||
130898664|NCT00422084|471265086|FG000|Overall Study|Protocol Violation|4|||
130898665|NCT00422084|471265087|FG001|Overall Study|Protocol Violation|1|||
130898666|NCT00422084|471265086|FG000|Overall Study|Lack of Efficacy|40|||
130898667|NCT00422084|471265087|FG001|Overall Study|Lack of Efficacy|42|||
130898668|NCT00422084|471265086|FG000|Overall Study|P. vivax infection|3|||
130898669|NCT00422084|471265087|FG001|Overall Study|P. vivax infection|6|||
130898670|NCT00422084|471265086|FG000|Overall Study|Cyesis|1|||
130898671|NCT00422084|471265087|FG001|Overall Study|Cyesis|0|||
130898672|NCT00422084|471265086|FG000|Overall Study|Withdrawn from study accidentally|1|||
130898673|NCT00422084|471265087|FG001|Overall Study|Withdrawn from study accidentally|0|||
130898674|NCT00422084|471265086|FG000|Overall Study|Non-compliance|1|||
130898675|NCT00422084|471265087|FG001|Overall Study|Non-compliance|0|||
130898676|NCT00422084|471265086|FG000|Overall Study|Re-location|0|||
130898677|NCT00422084|471265087|FG001|Overall Study|Re-location|1|||
130898678|NCT00422084|471265086|FG000|Overall Study|Not defined|1|||
130898679|NCT00422084|471265087|FG001|Overall Study|Not defined|1|||
130898680|NCT03774823|471265088|FG000|Overall Study|Withdrawal by Subject|1|||
130898681|NCT03774823|471265089|FG001|Overall Study|Withdrawal by Subject|1|||
130898682|NCT01253811|471265090|FG000|Overall Study|Withdrawal criteria|1|||
130898683|NCT01087736|471265091|FG000|Overall Study|Lost to Follow-up|1|||
130898684|NCT01087736|471265092|FG001|Overall Study|Lost to Follow-up|0|||
130898685|NCT01087736|471265091|FG000|Overall Study|Death|0|||
131025580|NCT03398148|471725291|FG000|Substudy 1 Period 2|Adverse Event|0|||
131025581|NCT03398148|471725292|FG001|Substudy 1 Period 2|Adverse Event|0|||
131025582|NCT03398148|471725293|FG002|Substudy 1 Period 2|Adverse Event|0|||
131025583|NCT03398148|471725294|FG003|Substudy 1 Period 2|Adverse Event|0|||
131025584|NCT03398148|471725295|FG004|Substudy 1 Period 2|Adverse Event|0|||
131025585|NCT03398148|471725296|FG005|Substudy 1 Period 2|Adverse Event|2|||
131025586|NCT03398148|471725297|FG006|Substudy 1 Period 2|Adverse Event|4|||
131025587|NCT03398148|471725298|FG007|Substudy 1 Period 2|Adverse Event|0|||
131025588|NCT03398148|471725299|FG008|Substudy 1 Period 2|Adverse Event|0|||
131025589|NCT03398148|471725300|FG009|Substudy 1 Period 2|Adverse Event|0|||
130898686|NCT01087736|471265092|FG001|Overall Study|Death|1|||
130898687|NCT01087736|471265091|FG000|Overall Study|Withdrawal by Subject|0|||
130898688|NCT01087736|471265092|FG001|Overall Study|Withdrawal by Subject|1|||
131025590|NCT03398148|471725301|FG010|Substudy 1 Period 2|Adverse Event|0|||
131025591|NCT03398148|471725302|FG011|Substudy 1 Period 2|Adverse Event|0|||
130898689|NCT00958438|471265098|FG000|Overall Study|Protocol Violation|3|||
131025592|NCT03398148|471725303|FG012|Substudy 1 Period 2|Adverse Event|0|||
130898690|NCT00958438|471265099|FG001|Overall Study|Protocol Violation|2|||
130898691|NCT00958438|471265100|FG002|Overall Study|Protocol Violation|2|||
130898692|NCT00958438|471265098|FG000|Overall Study|Withdrawal by Subject|4|||
130898693|NCT00958438|471265099|FG001|Overall Study|Withdrawal by Subject|2|||
130898694|NCT00958438|471265100|FG002|Overall Study|Withdrawal by Subject|1|||
130898695|NCT00958438|471265098|FG000|Overall Study|Adverse Event|0|||
130898696|NCT00958438|471265099|FG001|Overall Study|Adverse Event|3|||
130898697|NCT00958438|471265100|FG002|Overall Study|Adverse Event|0|||
130898698|NCT00958438|471265098|FG000|Overall Study|Physician Decision|1|||
130898699|NCT00958438|471265099|FG001|Overall Study|Physician Decision|0|||
130898700|NCT00958438|471265100|FG002|Overall Study|Physician Decision|1|||
130898701|NCT00958438|471265098|FG000|Overall Study|Other than specified above|2|||
130898702|NCT00958438|471265099|FG001|Overall Study|Other than specified above|3|||
130898703|NCT00958438|471265100|FG002|Overall Study|Other than specified above|2|||
130898704|NCT00759564|471265101|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
130898705|NCT00759564|471265102|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
130898706|NCT00759564|471265103|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
130898707|NCT00759564|471265104|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
130898708|NCT00759564|471265105|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
130898709|NCT02788279|471265106|FG000|Overall Study|Death|62|||
130898710|NCT02788279|471265107|FG001|Overall Study|Death|136|||
130898711|NCT02788279|471265108|FG002|Overall Study|Death|72|||
130898712|NCT02788279|471265106|FG000|Overall Study|Withdrawal by Subject|10|||
130898713|NCT02788279|471265107|FG001|Overall Study|Withdrawal by Subject|15|||
130898714|NCT02788279|471265108|FG002|Overall Study|Withdrawal by Subject|5|||
130898715|NCT02788279|471265106|FG000|Overall Study|Lost to Follow-up|0|||
130898716|NCT02788279|471265107|FG001|Overall Study|Lost to Follow-up|3|||
130898717|NCT02788279|471265108|FG002|Overall Study|Lost to Follow-up|2|||
130898718|NCT02788279|471265106|FG000|Overall Study|Sponsor decision|18|||
130898719|NCT02788279|471265107|FG001|Overall Study|Sponsor decision|29|||
130898720|NCT02788279|471265108|FG002|Overall Study|Sponsor decision|11|||
130898721|NCT00329849|471265109|FG000|Overall Study|Withdrawal by Subject|6|||
130898722|NCT00329849|471265110|FG001|Overall Study|Withdrawal by Subject|4|||
130898723|NCT00653432|471265111|FG000|Overall Study|Adverse Event|4|||
130898724|NCT00653432|471265112|FG001|Overall Study|Adverse Event|1|||
130898725|NCT00653432|471265111|FG000|Overall Study|Withdrawal by Subject|4|||
130898726|NCT00653432|471265112|FG001|Overall Study|Withdrawal by Subject|5|||
130898727|NCT00653432|471265111|FG000|Overall Study|Lost to Follow-up|7|||
130898728|NCT00653432|471265112|FG001|Overall Study|Lost to Follow-up|6|||
130898729|NCT00653432|471265111|FG000|Overall Study|Use/Need of Con Therapy|2|||
130898730|NCT00653432|471265112|FG001|Overall Study|Use/Need of Con Therapy|1|||
130898731|NCT00653432|471265111|FG000|Overall Study|Other - Reason Not Provided|5|||
130898732|NCT00653432|471265112|FG001|Overall Study|Other - Reason Not Provided|3|||
130898733|NCT01782469|471265113|FG000|Overall Study|Lost to Follow-up|1|||
130898734|NCT00835211|471265117|FG000|First Intervention|Withdrawal by Subject|0|||
130898735|NCT00835211|471265118|FG001|First Intervention|Withdrawal by Subject|1|||
130898736|NCT00835211|471265117|FG000|Washout: 7 Days|Adverse Event|2|||
130898737|NCT00835211|471265118|FG001|Washout: 7 Days|Adverse Event|1|||
130898738|NCT00835211|471265117|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
131112332|NCT00688181|472041056|FG000|Overall Study|Unknown Reason|4|||
131112333|NCT00688181|472041056|FG000|Overall Study|Non-clinical Reason|2|||
131112334|NCT01050205|472041057|FG000|Overall Study|Lost to Follow-up|7|||
131112335|NCT01050205|472041058|FG001|Overall Study|Lost to Follow-up|1|||
131112336|NCT01050205|472041057|FG000|Overall Study|Withdrawal by Subject|1|||
131112337|NCT01050205|472041058|FG001|Overall Study|Withdrawal by Subject|1|||
131112338|NCT01050205|472041057|FG000|Overall Study|Relocated from area|1|||
131112339|NCT01050205|472041058|FG001|Overall Study|Relocated from area|2|||
131112340|NCT01050205|472041057|FG000|Overall Study|Discontinued Intervention|2|||
131112341|NCT01050205|472041058|FG001|Overall Study|Discontinued Intervention|0|||
131112342|NCT01119001|472041059|FG000|Overall Study|Withdrawal by Subject|2|||
131112343|NCT00954421|472041060|FG000|Screening|screen failures|3|||
131112344|NCT00954421|472041060|FG000|6 Months of DBS|Withdrawal by Subject|1|||
131112345|NCT00954421|472041060|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
131112346|NCT00777946|472041061|FG000|Overall Study|Adverse Event|11|||
131112347|NCT00777946|472041062|FG001|Overall Study|Adverse Event|1|||
131112348|NCT00777946|472041063|FG002|Overall Study|Adverse Event|3|||
131112349|NCT00777946|472041061|FG000|Overall Study|Lack of Efficacy|0|||
131112350|NCT00777946|472041062|FG001|Overall Study|Lack of Efficacy|0|||
131112351|NCT00777946|472041063|FG002|Overall Study|Lack of Efficacy|9|||
131112352|NCT00777946|472041061|FG000|Overall Study|Condition no longer required study drug|1|||
131112353|NCT00777946|472041062|FG001|Overall Study|Condition no longer required study drug|0|||
131222722|NCT00720304|472443166|FG000|Overall Study|Death|1|||
131112354|NCT00777946|472041063|FG002|Overall Study|Condition no longer required study drug|0|||
131112355|NCT00777946|472041061|FG000|Overall Study|Patient withdrew consent|3|||
130898739|NCT00835211|471265118|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130898740|NCT02343549|471265119|FG000|Overall Study|Death|11|||
130898741|NCT02343549|471265119|FG000|Overall Study|Withdrawal by Subject|2|||
130898742|NCT01090323|471265120|FG000|Overall Study|Adverse Event|12|||
130898743|NCT01090323|471265121|FG001|Overall Study|Adverse Event|2|||
130898744|NCT01090323|471265120|FG000|Overall Study|Abnormal Lab Values|3|||
130898745|NCT01090323|471265121|FG001|Overall Study|Abnormal Lab Values|1|||
130898746|NCT01090323|471265120|FG000|Overall Study|Abnormal Test Procedure Results|2|||
130898747|NCT01090323|471265121|FG001|Overall Study|Abnormal Test Procedure Results|0|||
130898748|NCT01090323|471265120|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130898749|NCT01090323|471265121|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130898750|NCT01090323|471265120|FG000|Overall Study|Condition no longer requires drug|5|||
130898751|NCT01090323|471265121|FG001|Overall Study|Condition no longer requires drug|4|||
130898752|NCT01090323|471265120|FG000|Overall Study|Protocol Violation|2|||
130898753|NCT01090323|471265121|FG001|Overall Study|Protocol Violation|1|||
130898754|NCT01090323|471265120|FG000|Overall Study|Withdrew consent|33|||
130898755|NCT01090323|471265121|FG001|Overall Study|Withdrew consent|11|||
130898756|NCT01090323|471265120|FG000|Overall Study|Lost to Follow-up|11|||
130898757|NCT01090323|471265121|FG001|Overall Study|Lost to Follow-up|6|||
130898758|NCT01090323|471265120|FG000|Overall Study|Administrative problems|6|||
130898759|NCT01090323|471265121|FG001|Overall Study|Administrative problems|4|||
130898760|NCT01090323|471265120|FG000|Overall Study|Death|1|||
130898761|NCT01090323|471265121|FG001|Overall Study|Death|2|||
130898762|NCT01090323|471265120|FG000|Overall Study|Stopped end of core|7|||
130898763|NCT01090323|471265121|FG001|Overall Study|Stopped end of core|0|||
130898764|NCT01090323|471265120|FG000|Overall Study|Stopped end of extension 1#|3|||
130898765|NCT01090323|471265121|FG001|Overall Study|Stopped end of extension 1#|1|||
130898766|NCT05498701|471265122|FG000|Period 3|Adverse Event|1|||
130898767|NCT05498701|471265123|FG001|Period 3|Adverse Event|0|||
130898768|NCT01864005|471265124|FG000|Overall Study|Protocol Violation|0|||
130898769|NCT01864005|471265125|FG001|Overall Study|Protocol Violation|1|||
130898770|NCT01864005|471265124|FG000|Overall Study|Withdrawal by Subject|0|||
130898771|NCT01864005|471265125|FG001|Overall Study|Withdrawal by Subject|1|||
130898772|NCT01864005|471265124|FG000|Overall Study|Incorrect enrolment|1|||
130898773|NCT01864005|471265125|FG001|Overall Study|Incorrect enrolment|0|||
130898774|NCT01864005|471265124|FG000|Overall Study|Disease need|1|||
130898775|NCT01864005|471265125|FG001|Overall Study|Disease need|1|||
130898776|NCT01864005|471265124|FG000|Overall Study|Need GP IIb/IIIa|1|||
130898777|NCT01864005|471265125|FG001|Overall Study|Need GP IIb/IIIa|3|||
130898778|NCT02184572|471265129|FG000|Overall Study|Lost to Follow-up|29|||
130898779|NCT02184572|471265130|FG001|Overall Study|Lost to Follow-up|21|||
130898780|NCT02184572|471265129|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
130898781|NCT02184572|471265130|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
130898782|NCT02184572|471265129|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
130898783|NCT02184572|471265130|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
130898784|NCT02184572|471265129|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
130898785|NCT02184572|471265130|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
130898786|NCT02184572|471265129|FG000|Overall Study|Traveling Outside The Country|1|||
130898787|NCT02184572|471265130|FG001|Overall Study|Traveling Outside The Country|0|||
130898788|NCT02184572|471265129|FG000|Overall Study|Withdrawal by Subject|14|||
130898789|NCT02184572|471265130|FG001|Overall Study|Withdrawal by Subject|9|||
130898790|NCT00638183|471265134|FG000|Overall Study|Adverse Event|23|||
130898791|NCT00638183|471265134|FG000|Overall Study|Lack of Efficacy|14|||
130898792|NCT00638183|471265134|FG000|Overall Study|Physician Decision|9|||
130898793|NCT00638183|471265134|FG000|Overall Study|Lost to Follow-up|46|||
130898794|NCT00638183|471265134|FG000|Overall Study|Other reason not defined above|27|||
130898795|NCT00006409|471265135|FG000|Baseline|Protocol Violation|48|||
130898796|NCT00006409|471265136|FG001|Baseline|Protocol Violation|70|||
130898797|NCT00006409|471265137|FG002|Baseline|Protocol Violation|0|||
130898798|NCT00006409|471265138|FG003|Baseline|Protocol Violation|0|||
130898799|NCT00006409|471265139|FG004|Baseline|Protocol Violation|0|||
130898800|NCT00006409|471265140|FG005|Baseline|Protocol Violation|0|||
130898801|NCT00006409|471265135|FG000|Post-2 Year Intervention|Protocol Violation|0|||
130898802|NCT00006409|471265136|FG001|Post-2 Year Intervention|Protocol Violation|0|||
130898803|NCT00006409|471265137|FG002|Post-2 Year Intervention|Protocol Violation|251|||
130898804|NCT00006409|471265138|FG003|Post-2 Year Intervention|Protocol Violation|168|||
130898805|NCT00006409|471265139|FG004|Post-2 Year Intervention|Protocol Violation|0|||
130898806|NCT00006409|471265140|FG005|Post-2 Year Intervention|Protocol Violation|0|||
130898807|NCT00006409|471265135|FG000|Post-3 Year Intervention|Protocol Violation|0|||
130898808|NCT00006409|471265136|FG001|Post-3 Year Intervention|Protocol Violation|0|||
131025593|NCT03398148|471725304|FG013|Substudy 1 Period 2|Adverse Event|0|||
131025594|NCT03398148|471725305|FG014|Substudy 1 Period 2|Adverse Event|0|||
131025595|NCT03398148|471725291|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131025596|NCT03398148|471725292|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130898809|NCT00006409|471265137|FG002|Post-3 Year Intervention|Protocol Violation|0|||
130898810|NCT00006409|471265138|FG003|Post-3 Year Intervention|Protocol Violation|0|||
130898811|NCT00006409|471265139|FG004|Post-3 Year Intervention|Protocol Violation|62|||
130898812|NCT00006409|471265140|FG005|Post-3 Year Intervention|Protocol Violation|62|||
130898813|NCT02350764|471265141|FG000|Overall Study|Adverse Event|4|||
130898814|NCT02350764|471265141|FG000|Overall Study|Death|3|||
130898815|NCT02350764|471265141|FG000|Overall Study|Physician Decision|2|||
130898816|NCT02350764|471265141|FG000|Overall Study|Withdrawal by Subject|2|||
130898817|NCT01328444|471265142|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
131025597|NCT03398148|471725293|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130898818|NCT01328444|471265143|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130898819|NCT01328444|471265144|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130898820|NCT01328444|471265145|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
130898821|NCT01328444|471265146|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
130898822|NCT01328444|471265147|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
130898823|NCT01328444|471265142|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
130898824|NCT01328444|471265143|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
130898825|NCT01328444|471265144|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
130898826|NCT01328444|471265145|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
130898827|NCT01328444|471265146|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
130898828|NCT01328444|471265147|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
130898829|NCT01328444|471265142|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130898830|NCT01328444|471265143|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130898831|NCT01328444|471265144|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130898832|NCT01328444|471265145|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
130898833|NCT01328444|471265146|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130898834|NCT01328444|471265147|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
130898835|NCT01328444|471265142|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130898836|NCT01328444|471265143|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
130898837|NCT01328444|471265144|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130898838|NCT01328444|471265145|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130898839|NCT01328444|471265146|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
130898840|NCT01328444|471265147|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130898841|NCT01328444|471265142|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
130898842|NCT01328444|471265143|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130898843|NCT01328444|471265144|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130898844|NCT01328444|471265145|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130898845|NCT01328444|471265146|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130898846|NCT01328444|471265147|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130898847|NCT01328444|471265142|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130898848|NCT01328444|471265143|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
130898849|NCT01328444|471265144|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
130898850|NCT01328444|471265145|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
130898851|NCT01328444|471265146|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
130898852|NCT01328444|471265147|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130898853|NCT01328444|471265142|FG000|Washout Period (14 Days)|Adverse Event|1|||
130898854|NCT01328444|471265143|FG001|Washout Period (14 Days)|Adverse Event|1|||
130898855|NCT01328444|471265144|FG002|Washout Period (14 Days)|Adverse Event|0|||
130898856|NCT01328444|471265145|FG003|Washout Period (14 Days)|Adverse Event|1|||
130898857|NCT01328444|471265146|FG004|Washout Period (14 Days)|Adverse Event|1|||
130898858|NCT01328444|471265147|FG005|Washout Period (14 Days)|Adverse Event|2|||
130898859|NCT01328444|471265142|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
130898860|NCT01328444|471265143|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
130898861|NCT01328444|471265144|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
130898862|NCT01328444|471265145|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
130898863|NCT01328444|471265146|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
130898864|NCT01328444|471265147|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
130898865|NCT01328444|471265142|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
130898866|NCT01328444|471265143|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
130898867|NCT01328444|471265144|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
130898868|NCT01328444|471265145|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
130898869|NCT01328444|471265146|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
130898870|NCT01328444|471265147|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
130898871|NCT01328444|471265142|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
130898872|NCT01328444|471265143|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130898873|NCT01328444|471265144|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130898874|NCT01328444|471265145|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130898875|NCT01328444|471265146|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130898876|NCT01328444|471265147|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130898877|NCT01328444|471265142|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
131112356|NCT00777946|472041062|FG001|Overall Study|Patient withdrew consent|2|||
130691645|NCT03261167|470495953|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
130691646|NCT03261167|470495954|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
130691647|NCT03261167|470495953|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
130767960|NCT02258334|470773951|FG002|Overall Study|Adverse Event|0|||
130898878|NCT01328444|471265143|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130898879|NCT01328444|471265144|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130898880|NCT01328444|471265145|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
130898881|NCT01328444|471265146|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
130898882|NCT01328444|471265147|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
130898883|NCT01328444|471265142|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
130898884|NCT01328444|471265143|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130898885|NCT01328444|471265144|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130898886|NCT01328444|471265145|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130898887|NCT01328444|471265146|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
130898888|NCT01328444|471265147|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130898889|NCT01328444|471265142|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130898890|NCT01328444|471265143|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130898891|NCT01328444|471265144|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130898892|NCT01328444|471265145|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
130898893|NCT01328444|471265146|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
130898894|NCT01328444|471265147|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130898895|NCT01328444|471265142|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130898896|NCT01328444|471265143|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130898897|NCT01328444|471265144|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130898898|NCT01328444|471265145|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130898899|NCT01328444|471265146|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130898900|NCT01328444|471265147|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
130898901|NCT01328444|471265142|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130898902|NCT01328444|471265143|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130898903|NCT01328444|471265144|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130898904|NCT01328444|471265145|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130898905|NCT01328444|471265146|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130898906|NCT01328444|471265147|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130898907|NCT03531632|471265148|FG000|Overall Study|Adverse Event|0|||
130898908|NCT03531632|471265149|FG001|Overall Study|Adverse Event|0|||
130898909|NCT03531632|471265150|FG002|Overall Study|Adverse Event|1|||
130898910|NCT03531632|471265148|FG000|Overall Study|Death|4|||
130898911|NCT03531632|471265149|FG001|Overall Study|Death|0|||
130898912|NCT03531632|471265150|FG002|Overall Study|Death|14|||
130898913|NCT03531632|471265148|FG000|Overall Study|Study Terminated|1|||
130898914|NCT03531632|471265149|FG001|Overall Study|Study Terminated|3|||
130898915|NCT03531632|471265150|FG002|Overall Study|Study Terminated|11|||
130898916|NCT00600119|471265151|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
130898917|NCT00600119|471265152|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
130898918|NCT00600119|471265153|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
130898919|NCT00600119|471265154|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
130898920|NCT00600119|471265155|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
130898921|NCT00600119|471265156|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
130898922|NCT00600119|471265151|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130898923|NCT00600119|471265152|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
130898924|NCT00600119|471265153|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
130898925|NCT00600119|471265154|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130898926|NCT00600119|471265155|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130898927|NCT00600119|471265156|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130898928|NCT00600119|471265151|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130898929|NCT00600119|471265152|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130898930|NCT00600119|471265153|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
130898931|NCT00600119|471265154|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130898932|NCT00600119|471265155|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
130898933|NCT00600119|471265156|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130898934|NCT00600119|471265151|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
130898935|NCT00600119|471265152|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130898936|NCT00600119|471265153|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130898937|NCT00600119|471265154|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130898938|NCT00600119|471265155|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130898939|NCT00600119|471265156|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130898940|NCT00600119|471265151|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
130898941|NCT00600119|471265152|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
131025598|NCT03398148|471725294|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131025599|NCT03398148|471725295|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131025600|NCT03398148|471725296|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131025601|NCT03398148|471725297|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
131025602|NCT03398148|471725298|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
131025603|NCT03398148|471725299|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130898942|NCT00600119|471265153|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
131025604|NCT03398148|471725300|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130898943|NCT00600119|471265154|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
130898944|NCT00600119|471265155|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
131025605|NCT03398148|471725301|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
130898945|NCT00600119|471265156|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
130898946|NCT00600119|471265151|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
130898947|NCT00600119|471265152|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
130898948|NCT00600119|471265153|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130898949|NCT00600119|471265154|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130898950|NCT00600119|471265155|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130898951|NCT00600119|471265156|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130898952|NCT00600119|471265151|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
130898953|NCT00600119|471265152|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130898954|NCT00600119|471265153|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130898955|NCT00600119|471265154|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
130898956|NCT00600119|471265155|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
130898957|NCT00600119|471265156|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
130898958|NCT00600119|471265151|FG000|Double-blind Treatment Period|Other|0|||
130898959|NCT00600119|471265152|FG001|Double-blind Treatment Period|Other|0|||
130898960|NCT00600119|471265153|FG002|Double-blind Treatment Period|Other|0|||
130898961|NCT00600119|471265154|FG003|Double-blind Treatment Period|Other|0|||
130898962|NCT00600119|471265155|FG004|Double-blind Treatment Period|Other|2|||
130898963|NCT00600119|471265156|FG005|Double-blind Treatment Period|Other|1|||
130898964|NCT00600119|471265151|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130898965|NCT00600119|471265152|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
130898966|NCT00600119|471265153|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130898967|NCT00600119|471265154|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130898968|NCT00600119|471265155|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
130898969|NCT00600119|471265156|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130898970|NCT00600119|471265151|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130898971|NCT00600119|471265152|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
130898972|NCT00600119|471265153|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130898973|NCT00600119|471265154|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130898974|NCT00600119|471265155|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130898975|NCT00600119|471265156|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130898976|NCT00600119|471265151|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
130898977|NCT00600119|471265152|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
130898978|NCT00600119|471265153|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
130898979|NCT00600119|471265154|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
130898980|NCT00600119|471265155|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
130898981|NCT00600119|471265156|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
130898982|NCT00600119|471265151|FG000|Double-blind Treatment Period|Physician Decision|2|||
130898983|NCT00600119|471265152|FG001|Double-blind Treatment Period|Physician Decision|0|||
130898984|NCT00600119|471265153|FG002|Double-blind Treatment Period|Physician Decision|0|||
130898985|NCT00600119|471265154|FG003|Double-blind Treatment Period|Physician Decision|0|||
130898986|NCT00600119|471265155|FG004|Double-blind Treatment Period|Physician Decision|0|||
130898987|NCT00600119|471265156|FG005|Double-blind Treatment Period|Physician Decision|0|||
130898988|NCT00600119|471265151|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130898989|NCT00600119|471265152|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
130898990|NCT00600119|471265153|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130898991|NCT00600119|471265154|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
130898992|NCT00600119|471265155|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
130898993|NCT00600119|471265156|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
130898994|NCT00600119|471265151|FG000|Double-blind Treatment Period|Adverse Event|1|||
130898995|NCT00600119|471265152|FG001|Double-blind Treatment Period|Adverse Event|1|||
130898996|NCT00600119|471265153|FG002|Double-blind Treatment Period|Adverse Event|0|||
130898997|NCT00600119|471265154|FG003|Double-blind Treatment Period|Adverse Event|1|||
130898998|NCT00600119|471265155|FG004|Double-blind Treatment Period|Adverse Event|2|||
130898999|NCT00600119|471265156|FG005|Double-blind Treatment Period|Adverse Event|10|||
130899000|NCT00600119|471265151|FG000|Follow-up Period|Adverse Event|0|||
130899001|NCT00600119|471265152|FG001|Follow-up Period|Adverse Event|0|||
130899002|NCT00600119|471265153|FG002|Follow-up Period|Adverse Event|0|||
130899003|NCT00600119|471265154|FG003|Follow-up Period|Adverse Event|0|||
130899004|NCT00600119|471265155|FG004|Follow-up Period|Adverse Event|0|||
130899005|NCT00600119|471265156|FG005|Follow-up Period|Adverse Event|1|||
130899006|NCT00600119|471265151|FG000|Follow-up Period|Other|1|||
131222723|NCT00720304|472443167|FG001|Overall Study|Death|0|||
130899007|NCT00600119|471265152|FG001|Follow-up Period|Other|0|||
130899008|NCT00600119|471265153|FG002|Follow-up Period|Other|0|||
130899009|NCT00600119|471265154|FG003|Follow-up Period|Other|0|||
130899010|NCT00600119|471265155|FG004|Follow-up Period|Other|0|||
130899011|NCT00600119|471265156|FG005|Follow-up Period|Other|0|||
130899012|NCT03241368|471265157|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
130899013|NCT03241368|471265157|FG000|Overall Study|Lost to Follow-up|1|||
130899014|NCT03241368|471265157|FG000|Overall Study|Physician Decision|6|||
130899015|NCT03241368|471265157|FG000|Overall Study|Withdrawal by Subject|6|||
130899016|NCT03241368|471265157|FG000|Overall Study|Protocol Violation|1|||
130899017|NCT00729469|471265158|FG000|Overall Study|Adverse Event|14|||
130899018|NCT00729469|471265159|FG001|Overall Study|Adverse Event|25|||
130899019|NCT00729469|471265158|FG000|Overall Study|Lost to Follow-up|9|||
130899020|NCT00729469|471265159|FG001|Overall Study|Lost to Follow-up|9|||
130899021|NCT00729469|471265158|FG000|Overall Study|Protocol Violation|2|||
130899022|NCT00729469|471265159|FG001|Overall Study|Protocol Violation|1|||
130899023|NCT00729469|471265158|FG000|Overall Study|Withdrawal by Subject|19|||
130899024|NCT00729469|471265159|FG001|Overall Study|Withdrawal by Subject|8|||
130899025|NCT00729469|471265158|FG000|Overall Study|Other-Not mentioned|9|||
130899026|NCT00729469|471265159|FG001|Overall Study|Other-Not mentioned|4|||
130899027|NCT01270802|471265162|FG000|Overall Study|Withdrawal by Subject|1|||
130899028|NCT01270802|471265163|FG001|Overall Study|Withdrawal by Subject|0|||
130899029|NCT01270802|471265162|FG000|Overall Study|Adverse Event|1|||
130899030|NCT01270802|471265163|FG001|Overall Study|Adverse Event|0|||
130899031|NCT01270802|471265162|FG000|Overall Study|Lost to Follow-up|0|||
130899032|NCT01270802|471265163|FG001|Overall Study|Lost to Follow-up|1|||
130899033|NCT00561977|471265164|FG000|Overall Study|Withdrawal by Subject|0|||
130899034|NCT00561977|471265165|FG001|Overall Study|Withdrawal by Subject|2|||
130899035|NCT00561977|471265166|FG002|Overall Study|Withdrawal by Subject|1|||
130899036|NCT00561977|471265164|FG000|Overall Study|Pregnancy|0|||
130899037|NCT00561977|471265165|FG001|Overall Study|Pregnancy|1|||
130899038|NCT00561977|471265166|FG002|Overall Study|Pregnancy|1|||
130899039|NCT04620798|471265167|FG000|Overall Study|Lost to Follow-up|126|||
130899040|NCT04620798|471265168|FG001|Overall Study|Lost to Follow-up|138|||
130899041|NCT00080899|471265169|FG000|Overall Study|Adverse Event|1|||
130899042|NCT01616693|471265170|FG000|Evaluated for Safety|Physician Decision|1|||
130899043|NCT01616693|471265171|FG001|Evaluated for Safety|Physician Decision|0|||
130899044|NCT01616693|471265172|FG002|Evaluated for Safety|Physician Decision|1|||
130899045|NCT01616693|471265173|FG003|Evaluated for Safety|Physician Decision|0|||
130899046|NCT01616693|471265170|FG000|Received Both Vaccines|Adverse Event|2|||
130899047|NCT01616693|471265171|FG001|Received Both Vaccines|Adverse Event|0|||
130899048|NCT01616693|471265172|FG002|Received Both Vaccines|Adverse Event|0|||
130899049|NCT01616693|471265173|FG003|Received Both Vaccines|Adverse Event|0|||
130899050|NCT01616693|471265170|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
130899051|NCT01616693|471265171|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
130899052|NCT01616693|471265172|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
130899053|NCT01616693|471265173|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
130899054|NCT01616693|471265170|FG000|Received Both Vaccines|Lost to Follow-up|4|||
130899055|NCT01616693|471265171|FG001|Received Both Vaccines|Lost to Follow-up|3|||
130899056|NCT01616693|471265172|FG002|Received Both Vaccines|Lost to Follow-up|4|||
130899057|NCT01616693|471265173|FG003|Received Both Vaccines|Lost to Follow-up|4|||
130899058|NCT01616693|471265170|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
130899059|NCT01616693|471265171|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
130899060|NCT01616693|471265172|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
130899061|NCT01616693|471265173|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
130899062|NCT00832624|471265174|FG000|Overall Study|Study Terminated|10|||
131025606|NCT03398148|471725302|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131025607|NCT03398148|471725303|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131025608|NCT03398148|471725304|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131025609|NCT03398148|471725305|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
131025610|NCT03398148|471725291|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
131025611|NCT03398148|471725292|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
131025612|NCT03398148|471725293|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
131025613|NCT03398148|471725294|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
131025614|NCT03398148|471725295|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
131025615|NCT03398148|471725296|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
131025616|NCT03398148|471725297|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
130691648|NCT03261167|470495954|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
130899063|NCT00475982|471265175|FG000|Overall Study|surgery rescheduled|7|||
130899064|NCT00475982|471265176|FG001|Overall Study|surgery rescheduled|3|||
130899065|NCT00783198|471265177|FG000|Overall Study|Adverse Event|15|||
130899066|NCT00783198|471265178|FG001|Overall Study|Adverse Event|19|||
130899067|NCT00783198|471265179|FG002|Overall Study|Adverse Event|3|||
130899068|NCT00783198|471265177|FG000|Overall Study|Lost to Follow-up|11|||
130899069|NCT00783198|471265178|FG001|Overall Study|Lost to Follow-up|1|||
130899070|NCT00783198|471265179|FG002|Overall Study|Lost to Follow-up|7|||
130899071|NCT00783198|471265177|FG000|Overall Study|Withdrawal by Subject|22|||
130899072|NCT00783198|471265178|FG001|Overall Study|Withdrawal by Subject|14|||
130899073|NCT00783198|471265179|FG002|Overall Study|Withdrawal by Subject|20|||
130899074|NCT00783198|471265177|FG000|Overall Study|Noncompliance with protocol|7|||
131025617|NCT03398148|471725298|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
131025618|NCT03398148|471725299|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
130899075|NCT00783198|471265178|FG001|Overall Study|Noncompliance with protocol|7|||
130899076|NCT00783198|471265179|FG002|Overall Study|Noncompliance with protocol|10|||
130899077|NCT00783198|471265177|FG000|Overall Study|Did not meet protocol eligibility|0|||
130899078|NCT00783198|471265178|FG001|Overall Study|Did not meet protocol eligibility|1|||
130899079|NCT00783198|471265179|FG002|Overall Study|Did not meet protocol eligibility|0|||
130899080|NCT00783198|471265177|FG000|Overall Study|Administrative|2|||
130691649|NCT03261167|470495953|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
130691650|NCT03261167|470495954|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
130691651|NCT03261167|470495953|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
130691652|NCT03261167|470495954|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
130691653|NCT03199963|470495957|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
130691654|NCT03199963|470495958|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
130691655|NCT03199963|470495957|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
130691656|NCT03199963|470495958|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
130691657|NCT03199963|470495957|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
130691658|NCT03199963|470495958|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
130691659|NCT03199963|470495957|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
130691660|NCT03199963|470495958|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
130691661|NCT03199963|470495957|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
130691662|NCT03199963|470495958|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
130691663|NCT03199963|470495957|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
130691664|NCT03199963|470495958|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
130899081|NCT00783198|471265178|FG001|Overall Study|Administrative|1|||
130899082|NCT00783198|471265179|FG002|Overall Study|Administrative|2|||
130691665|NCT01572662|470495959|FG000|Overall Study|Withdrawal by Subject|1|||
130691666|NCT01572662|470495960|FG001|Overall Study|Withdrawal by Subject|0|||
130691667|NCT01572662|470495959|FG000|Overall Study|Physician Decision|0|||
130691668|NCT01572662|470495960|FG001|Overall Study|Physician Decision|1|||
130691669|NCT03364192|470495963|FG000|Overall Study|Ineligible|10|||
130691670|NCT03364192|470495963|FG000|Overall Study|Withdrawal by Subject|5|||
130691671|NCT03364192|470495963|FG000|Overall Study|Lost to Follow-up|1|||
130691672|NCT00918645|470495964|FG000|Overall Study|Withdrawal by Subject|1|||
130691673|NCT03446768|470495965|FG000|Overall Study|Withdrawal by Subject|0|||
130691674|NCT03446768|470495966|FG001|Overall Study|Withdrawal by Subject|1|||
130899083|NCT01546623|471265180|FG000|Overall Study|Adverse Event|2|||
130899084|NCT01546623|471265181|FG001|Overall Study|Adverse Event|3|||
130899085|NCT01546623|471265180|FG000|Overall Study|Major Protocol Deviation|1|||
130899086|NCT01546623|471265181|FG001|Overall Study|Major Protocol Deviation|1|||
130899087|NCT01546623|471265180|FG000|Overall Study|High Prostate specific antigen|2|||
130899088|NCT01546623|471265181|FG001|Overall Study|High Prostate specific antigen|1|||
130691675|NCT05133180|470495967|FG000|Overall Study|Withdrawal of consent|1|||
130691676|NCT05133180|470495968|FG001|Overall Study|Withdrawal of consent|1|||
130899089|NCT01546623|471265180|FG000|Overall Study|Did Not Receive Study Drug|1|||
130899090|NCT01546623|471265181|FG001|Overall Study|Did Not Receive Study Drug|1|||
130899091|NCT01134705|471265182|FG000|Overall Study|Adverse Event|1|||
130899092|NCT01134705|471265183|FG001|Overall Study|Adverse Event|7|||
130899093|NCT01134705|471265182|FG000|Overall Study|Withdrawal by Subject|6|||
130899094|NCT01134705|471265183|FG001|Overall Study|Withdrawal by Subject|6|||
130691677|NCT05133180|470495967|FG000|Overall Study|Lost to Follow-up|1|||
130899095|NCT01134705|471265182|FG000|Overall Study|Pregnancy|1|||
130899096|NCT01134705|471265183|FG001|Overall Study|Pregnancy|0|||
130691678|NCT05133180|470495968|FG001|Overall Study|Lost to Follow-up|1|||
130691679|NCT05133180|470495967|FG000|Overall Study|Documented disease progression|0|||
130691680|NCT05133180|470495968|FG001|Overall Study|Documented disease progression|1|||
130899097|NCT01134705|471265182|FG000|Overall Study|Lost to Follow-up|5|||
130899098|NCT01134705|471265183|FG001|Overall Study|Lost to Follow-up|2|||
130899099|NCT01134705|471265182|FG000|Overall Study|Protocol Violation|1|||
130899100|NCT01134705|471265183|FG001|Overall Study|Protocol Violation|1|||
130899101|NCT01134705|471265182|FG000|Overall Study|Other|1|||
130899102|NCT01134705|471265183|FG001|Overall Study|Other|6|||
130899103|NCT04525885|471265186|FG000|Overall Study|Screen Failure|1|||
130899104|NCT04525885|471265187|FG001|Overall Study|Screen Failure|0|||
130899105|NCT04525885|471265188|FG002|Overall Study|Screen Failure|0|||
130899106|NCT04525885|471265186|FG000|Overall Study|Withdrawal by Subject|14|||
130691681|NCT01535222|470495969|FG000|Overall Study|Inclusion/exclusion|0|||
130691682|NCT01535222|470495970|FG001|Overall Study|Inclusion/exclusion|0|||
130691683|NCT01535222|470495971|FG002|Overall Study|Inclusion/exclusion|1|||
130691684|NCT01535222|470495972|FG003|Overall Study|Inclusion/exclusion|0|||
130691685|NCT01535222|470495973|FG004|Overall Study|Inclusion/exclusion|0|||
130899107|NCT04525885|471265187|FG001|Overall Study|Withdrawal by Subject|6|||
130899108|NCT04525885|471265188|FG002|Overall Study|Withdrawal by Subject|20|||
130899109|NCT04525885|471265186|FG000|Overall Study|Physician Decision|1|||
130899110|NCT04525885|471265187|FG001|Overall Study|Physician Decision|0|||
130899111|NCT04525885|471265188|FG002|Overall Study|Physician Decision|1|||
130899112|NCT01008423|471265189|FG000|Overall Study|Adverse Event|13|||
130899113|NCT01008423|471265190|FG001|Overall Study|Adverse Event|6|||
130899114|NCT01008423|471265189|FG000|Overall Study|Withdrawal by Subject|4|||
130899115|NCT01008423|471265190|FG001|Overall Study|Withdrawal by Subject|7|||
130899116|NCT01008423|471265189|FG000|Overall Study|Lost to Follow-up|0|||
130899117|NCT01008423|471265190|FG001|Overall Study|Lost to Follow-up|2|||
130899118|NCT01008423|471265189|FG000|Overall Study|Low Cortisol|0|||
130899119|NCT01008423|471265190|FG001|Overall Study|Low Cortisol|1|||
130899120|NCT01008423|471265189|FG000|Overall Study|Lack of Efficacy|0|||
130899121|NCT01008423|471265190|FG001|Overall Study|Lack of Efficacy|5|||
130899122|NCT01008423|471265189|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
130899123|NCT01008423|471265190|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
130899124|NCT01008423|471265189|FG000|Overall Study|Personal Conflict|1|||
130899125|NCT01008423|471265190|FG001|Overall Study|Personal Conflict|0|||
130899126|NCT01008423|471265189|FG000|Overall Study|Other|0|||
130899127|NCT01008423|471265190|FG001|Overall Study|Other|1|||
130899128|NCT00934843|471265192|FG000|Overall Study|Protocol Violation|0|||
130899129|NCT00934843|471265193|FG001|Overall Study|Protocol Violation|1|||
130899130|NCT01144299|471265194|FG000|Overall Study|Lost to Follow-up|1|||
130899131|NCT01144299|471265195|FG001|Overall Study|Lost to Follow-up|0|||
130899132|NCT01144299|471265194|FG000|Overall Study|Withdrawal by Subject|1|||
130899133|NCT01144299|471265195|FG001|Overall Study|Withdrawal by Subject|0|||
130899134|NCT01375075|471265202|FG000|Overall Study|Adverse Event|0|||
130899135|NCT01375075|471265203|FG001|Overall Study|Adverse Event|0|||
130899136|NCT01375075|471265204|FG002|Overall Study|Adverse Event|3|||
130899137|NCT01375075|471265205|FG003|Overall Study|Adverse Event|1|||
130899138|NCT01375075|471265206|FG004|Overall Study|Adverse Event|0|||
130899139|NCT01375075|471265207|FG005|Overall Study|Adverse Event|1|||
130899140|NCT01375075|471265202|FG000|Overall Study|Entry Criterion Not Met|1|||
130899141|NCT01375075|471265203|FG001|Overall Study|Entry Criterion Not Met|0|||
130899142|NCT01375075|471265204|FG002|Overall Study|Entry Criterion Not Met|0|||
130899143|NCT01375075|471265205|FG003|Overall Study|Entry Criterion Not Met|0|||
130899144|NCT01375075|471265206|FG004|Overall Study|Entry Criterion Not Met|0|||
130899145|NCT01375075|471265207|FG005|Overall Study|Entry Criterion Not Met|1|||
130899146|NCT01375075|471265202|FG000|Overall Study|Withdrawal by Subject|0|||
130899147|NCT01375075|471265203|FG001|Overall Study|Withdrawal by Subject|1|||
130899148|NCT01375075|471265204|FG002|Overall Study|Withdrawal by Subject|0|||
130899149|NCT01375075|471265205|FG003|Overall Study|Withdrawal by Subject|0|||
130899150|NCT01375075|471265206|FG004|Overall Study|Withdrawal by Subject|0|||
130899151|NCT01375075|471265207|FG005|Overall Study|Withdrawal by Subject|1|||
130899152|NCT01011309|471265209|FG000|Overall Study|Adverse Event|2|||
130899153|NCT01011309|471265210|FG001|Overall Study|Adverse Event|1|||
130899154|NCT01011309|471265211|FG002|Overall Study|Adverse Event|2|||
130899155|NCT01011309|471265209|FG000|Overall Study|Lack of Efficacy|0|||
130899156|NCT01011309|471265210|FG001|Overall Study|Lack of Efficacy|1|||
130899157|NCT01011309|471265211|FG002|Overall Study|Lack of Efficacy|0|||
130899158|NCT01011309|471265209|FG000|Overall Study|Protocol Violation|0|||
130899159|NCT01011309|471265210|FG001|Overall Study|Protocol Violation|1|||
130899160|NCT01011309|471265211|FG002|Overall Study|Protocol Violation|3|||
130899161|NCT00831493|471265212|FG000|Overall Study|Intractable nausea and vomiting|1|||
130899162|NCT01981551|471265219|FG000|Overall Study|Refused further treatment|8|||
130899163|NCT01981551|471265219|FG000|Overall Study|Adverse Event|1|||
130899164|NCT03472547|471265225|FG000|Overall Study|Withdrawal by Subject|30|||
131025619|NCT03398148|471725300|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
131025620|NCT03398148|471725301|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
131025621|NCT03398148|471725302|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
131025622|NCT03398148|471725303|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
131025623|NCT03398148|471725304|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
131025624|NCT03398148|471725305|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
131025625|NCT03398148|471725291|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025626|NCT03398148|471725292|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025627|NCT03398148|471725293|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025628|NCT03398148|471725294|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025629|NCT03398148|471725295|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130899165|NCT01031836|471266681|FG000|Stage I|Adverse Event|1|||
130899166|NCT01031836|471266682|FG001|Stage I|Adverse Event|1|||
130899167|NCT01031836|471266683|FG002|Stage I|Adverse Event|0|||
130899168|NCT01031836|471266684|FG003|Stage I|Adverse Event|0|||
130899169|NCT01031836|471266685|FG004|Stage I|Adverse Event|0|||
130899170|NCT01031836|471266686|FG005|Stage I|Adverse Event|0|||
131025630|NCT03398148|471725296|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130899171|NCT01031836|471266681|FG000|Stage I|Other|0|||
130899172|NCT01031836|471266682|FG001|Stage I|Other|1|||
130899173|NCT01031836|471266683|FG002|Stage I|Other|0|||
130899174|NCT01031836|471266684|FG003|Stage I|Other|0|||
130899175|NCT01031836|471266685|FG004|Stage I|Other|0|||
130899176|NCT01031836|471266686|FG005|Stage I|Other|1|||
130899177|NCT01031836|471266681|FG000|Stage II|Adverse Event|0|||
130899178|NCT01031836|471266682|FG001|Stage II|Adverse Event|0|||
130899179|NCT01031836|471266683|FG002|Stage II|Adverse Event|2|||
130899180|NCT01031836|471266684|FG003|Stage II|Adverse Event|2|||
130899181|NCT01031836|471266685|FG004|Stage II|Adverse Event|1|||
130899182|NCT01031836|471266686|FG005|Stage II|Adverse Event|1|||
130899183|NCT01031836|471266681|FG000|Stage II|Other|2|||
130899184|NCT01031836|471266682|FG001|Stage II|Other|0|||
130899185|NCT01031836|471266683|FG002|Stage II|Other|0|||
130899186|NCT01031836|471266684|FG003|Stage II|Other|1|||
130899187|NCT01031836|471266685|FG004|Stage II|Other|1|||
130899188|NCT01031836|471266686|FG005|Stage II|Other|0|||
130899189|NCT02043899|471266689|FG000|Overall Study|Adverse Event|3|||
130899190|NCT02043899|471266689|FG000|Overall Study|Physician Decision|1|||
130899191|NCT02043899|471266689|FG000|Overall Study|Withdrawal by Subject|2|||
130899192|NCT02043899|471266689|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
130899193|NCT02043899|471266689|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
130899194|NCT02043899|471266689|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
130899195|NCT02043899|471266689|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
130899196|NCT02043899|471266689|FG000|Overall Study|Treatment delayed|1|||
130899197|NCT01325337|471266690|FG000|Overall Study|Adverse Event|0|||
130899198|NCT01325337|471266691|FG001|Overall Study|Adverse Event|2|||
130899199|NCT01325337|471266692|FG002|Overall Study|Adverse Event|2|||
130899200|NCT01325337|471266693|FG003|Overall Study|Adverse Event|1|||
130899201|NCT01325337|471266694|FG004|Overall Study|Adverse Event|2|||
130899202|NCT01325337|471266690|FG000|Overall Study|Lost to Follow-up|2|||
130899203|NCT01325337|471266691|FG001|Overall Study|Lost to Follow-up|2|||
130899204|NCT01325337|471266692|FG002|Overall Study|Lost to Follow-up|2|||
130899205|NCT01325337|471266693|FG003|Overall Study|Lost to Follow-up|1|||
130899206|NCT01325337|471266694|FG004|Overall Study|Lost to Follow-up|2|||
130899207|NCT01325337|471266690|FG000|Overall Study|Personal Reasons|2|||
130899208|NCT01325337|471266691|FG001|Overall Study|Personal Reasons|5|||
130899209|NCT01325337|471266692|FG002|Overall Study|Personal Reasons|4|||
130899210|NCT01325337|471266693|FG003|Overall Study|Personal Reasons|8|||
130899211|NCT01325337|471266694|FG004|Overall Study|Personal Reasons|3|||
130899212|NCT01325337|471266690|FG000|Overall Study|Withdrawal by Subject|1|||
130899213|NCT01325337|471266691|FG001|Overall Study|Withdrawal by Subject|0|||
130899214|NCT01325337|471266692|FG002|Overall Study|Withdrawal by Subject|1|||
130899215|NCT01325337|471266693|FG003|Overall Study|Withdrawal by Subject|0|||
130899216|NCT01325337|471266694|FG004|Overall Study|Withdrawal by Subject|1|||
130899217|NCT02184455|471266702|FG000|Overall Study|Lost to Follow-up|1|||
130899218|NCT01347580|471266703|FG000|Overall Study|Withdrawal by Subject|13|||
130899219|NCT01347580|471266704|FG001|Overall Study|Withdrawal by Subject|23|||
130899220|NCT01347580|471266703|FG000|Overall Study|Death|30|||
130899221|NCT01347580|471266704|FG001|Overall Study|Death|19|||
130899222|NCT01347580|471266703|FG000|Overall Study|Protocol Violation|10|||
130899223|NCT01347580|471266704|FG001|Overall Study|Protocol Violation|7|||
130899224|NCT01347580|471266703|FG000|Overall Study|Lost to Follow-up|3|||
130899225|NCT01347580|471266704|FG001|Overall Study|Lost to Follow-up|1|||
130899226|NCT01347580|471266703|FG000|Overall Study|Had other reason|9|||
130899227|NCT01347580|471266704|FG001|Overall Study|Had other reason|6|||
130899228|NCT01332799|471266707|FG000|Overall Study|Insufficient funding|10|||
130899229|NCT01332799|471266708|FG001|Overall Study|Insufficient funding|10|||
130899230|NCT02168387|471266709|FG000|Overall Study|Planned exubation|6|||
130899231|NCT02168387|471266710|FG001|Overall Study|Planned exubation|3|||
130899232|NCT02168387|471266709|FG000|Overall Study|Death|1|||
131025631|NCT03398148|471725297|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
131025632|NCT03398148|471725298|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025633|NCT03398148|471725299|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025634|NCT03398148|471725300|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025635|NCT03398148|471725301|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025636|NCT03398148|471725302|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025637|NCT03398148|471725303|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025638|NCT03398148|471725304|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025639|NCT03398148|471725305|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025640|NCT03398148|471725291|FG000|Substudy 1 Period 2|Other|0|||
131025641|NCT03398148|471725292|FG001|Substudy 1 Period 2|Other|0|||
131025642|NCT03398148|471725293|FG002|Substudy 1 Period 2|Other|0|||
131112357|NCT00777946|472041063|FG002|Overall Study|Patient withdrew consent|3|||
130899233|NCT02168387|471266710|FG001|Overall Study|Death|0|||
130899234|NCT03467152|471266711|FG000|Overall Study|Adverse Event|4|||
130899235|NCT03467152|471266712|FG001|Overall Study|Adverse Event|5|||
130899236|NCT03467152|471266713|FG002|Overall Study|Adverse Event|0|||
130899237|NCT03467152|471266711|FG000|Overall Study|Subject Choice|1|||
130899238|NCT03467152|471266712|FG001|Overall Study|Subject Choice|3|||
130899239|NCT03467152|471266713|FG002|Overall Study|Subject Choice|0|||
130899240|NCT03467152|471266711|FG000|Overall Study|Lost to Follow-up|1|||
130899241|NCT03467152|471266712|FG001|Overall Study|Lost to Follow-up|0|||
130899242|NCT03467152|471266713|FG002|Overall Study|Lost to Follow-up|0|||
131112358|NCT00777946|472041061|FG000|Overall Study|Lost to Follow-up|3|||
131112359|NCT00777946|472041062|FG001|Overall Study|Lost to Follow-up|1|||
131112360|NCT00777946|472041063|FG002|Overall Study|Lost to Follow-up|0|||
131112361|NCT00777946|472041061|FG000|Overall Study|Protocol deviation|2|||
131112362|NCT00777946|472041062|FG001|Overall Study|Protocol deviation|1|||
131112363|NCT00777946|472041063|FG002|Overall Study|Protocol deviation|1|||
131112364|NCT00777946|472041061|FG000|Overall Study|Randomized in error|1|||
130899243|NCT03467152|471266711|FG000|Overall Study|Withdrawal by Subject|4|||
130899244|NCT03467152|471266712|FG001|Overall Study|Withdrawal by Subject|2|||
130899245|NCT03467152|471266713|FG002|Overall Study|Withdrawal by Subject|0|||
130899246|NCT03467152|471266711|FG000|Overall Study|Others|3|||
130899247|NCT03467152|471266712|FG001|Overall Study|Others|0|||
130899248|NCT03467152|471266713|FG002|Overall Study|Others|0|||
130899249|NCT03467152|471266711|FG000|Overall Study|Not treated|3|||
130899250|NCT03467152|471266712|FG001|Overall Study|Not treated|1|||
130899251|NCT03467152|471266713|FG002|Overall Study|Not treated|6|||
130899252|NCT01236547|471266714|FG000|Overall Study|Protocol Violation|0|||
130899253|NCT01236547|471266715|FG001|Overall Study|Protocol Violation|1|||
130899254|NCT01236547|471266716|FG002|Overall Study|Protocol Violation|1|||
130899255|NCT01236547|471266717|FG003|Overall Study|Protocol Violation|6|||
130899256|NCT01236547|471266718|FG004|Overall Study|Protocol Violation|12|||
130899257|NCT00910624|471266720|FG000|Treatment Phase|Adverse Event|2|||
130899258|NCT00910624|471266721|FG001|Treatment Phase|Adverse Event|6|||
130899259|NCT00910624|471266722|FG002|Treatment Phase|Adverse Event|6|||
130899260|NCT00910624|471266723|FG003|Treatment Phase|Adverse Event|0|||
130899261|NCT00910624|471266720|FG000|Treatment Phase|Treatment Failure|23|||
130899262|NCT00910624|471266721|FG001|Treatment Phase|Treatment Failure|10|||
130899263|NCT00910624|471266722|FG002|Treatment Phase|Treatment Failure|0|||
130899264|NCT00910624|471266723|FG003|Treatment Phase|Treatment Failure|0|||
130899265|NCT00910624|471266720|FG000|Treatment Phase|Lost to Follow-up|0|||
130899266|NCT00910624|471266721|FG001|Treatment Phase|Lost to Follow-up|0|||
130899267|NCT00910624|471266722|FG002|Treatment Phase|Lost to Follow-up|1|||
130899268|NCT00910624|471266723|FG003|Treatment Phase|Lost to Follow-up|0|||
130899269|NCT00910624|471266720|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
130899270|NCT00910624|471266721|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
130899271|NCT00910624|471266722|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
130899272|NCT00910624|471266723|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
130899273|NCT00910624|471266720|FG000|Treatment Phase|Withdrawal by Subject|2|||
130899274|NCT00910624|471266721|FG001|Treatment Phase|Withdrawal by Subject|1|||
130899275|NCT00910624|471266722|FG002|Treatment Phase|Withdrawal by Subject|0|||
130899276|NCT00910624|471266723|FG003|Treatment Phase|Withdrawal by Subject|0|||
130899277|NCT00910624|471266720|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
130899278|NCT00910624|471266721|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
130899279|NCT00910624|471266722|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
130899280|NCT00910624|471266723|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
130899281|NCT00910624|471266720|FG000|Follow-Up Phase|Adverse Event|0|||
130899282|NCT00910624|471266721|FG001|Follow-Up Phase|Adverse Event|0|||
130899283|NCT00910624|471266722|FG002|Follow-Up Phase|Adverse Event|1|||
130899284|NCT00910624|471266723|FG003|Follow-Up Phase|Adverse Event|0|||
130899285|NCT00910624|471266720|FG000|Follow-Up Phase|Lost to Follow-up|3|||
130899286|NCT00910624|471266721|FG001|Follow-Up Phase|Lost to Follow-up|1|||
131025643|NCT03398148|471725294|FG003|Substudy 1 Period 2|Other|0|||
131025644|NCT03398148|471725295|FG004|Substudy 1 Period 2|Other|0|||
131025645|NCT03398148|471725296|FG005|Substudy 1 Period 2|Other|0|||
131025646|NCT03398148|471725297|FG006|Substudy 1 Period 2|Other|1|||
131025647|NCT03398148|471725298|FG007|Substudy 1 Period 2|Other|0|||
131025648|NCT03398148|471725299|FG008|Substudy 1 Period 2|Other|0|||
131025649|NCT03398148|471725300|FG009|Substudy 1 Period 2|Other|0|||
131025650|NCT03398148|471725301|FG010|Substudy 1 Period 2|Other|0|||
131025651|NCT03398148|471725302|FG011|Substudy 1 Period 2|Other|0|||
131025652|NCT03398148|471725303|FG012|Substudy 1 Period 2|Other|0|||
131025653|NCT03398148|471725304|FG013|Substudy 1 Period 2|Other|0|||
131112365|NCT00777946|472041062|FG001|Overall Study|Randomized in error|1|||
131112366|NCT00777946|472041063|FG002|Overall Study|Randomized in error|0|||
130899287|NCT00910624|471266722|FG002|Follow-Up Phase|Lost to Follow-up|2|||
130899288|NCT00910624|471266723|FG003|Follow-Up Phase|Lost to Follow-up|0|||
131025654|NCT03398148|471725305|FG014|Substudy 1 Period 2|Other|0|||
130899289|NCT00910624|471266720|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
130899290|NCT00910624|471266721|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
130899291|NCT00910624|471266722|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
130899292|NCT00910624|471266723|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
130899293|NCT00910624|471266720|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
131025655|NCT03398148|471725291|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025656|NCT03398148|471725292|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
131112367|NCT01853982|472041064|FG000|Overall Study|Withdrawal by Subject|1|||
131112368|NCT01853982|472041065|FG001|Overall Study|Withdrawal by Subject|0|||
130899294|NCT00910624|471266721|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
130899295|NCT00910624|471266722|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
131025657|NCT03398148|471725293|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
130899296|NCT00910624|471266723|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
130899297|NCT00910624|471266720|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
130899298|NCT00910624|471266721|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
130899299|NCT00910624|471266722|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
130899300|NCT00910624|471266723|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
130899301|NCT00910624|471266720|FG000|Follow-Up Phase|Administrative|0|||
130899302|NCT00910624|471266721|FG001|Follow-Up Phase|Administrative|1|||
130899303|NCT00910624|471266722|FG002|Follow-Up Phase|Administrative|1|||
130899304|NCT00910624|471266723|FG003|Follow-Up Phase|Administrative|0|||
130899305|NCT03005873|471266724|FG000|Overall Study|Prohibited medication use post radnomization|1|||
130899306|NCT03005873|471266725|FG001|Overall Study|Prohibited medication use post radnomization|1|||
130899307|NCT03005873|471266726|FG002|Overall Study|Prohibited medication use post radnomization|1|||
130899308|NCT03005873|471266724|FG000|Overall Study|Withdrew consent|0|||
130899309|NCT03005873|471266725|FG001|Overall Study|Withdrew consent|1|||
130899310|NCT03005873|471266726|FG002|Overall Study|Withdrew consent|2|||
130899311|NCT03005873|471266724|FG000|Overall Study|Lost to Follow-up|0|||
130899312|NCT03005873|471266725|FG001|Overall Study|Lost to Follow-up|1|||
130899313|NCT03005873|471266726|FG002|Overall Study|Lost to Follow-up|0|||
130899314|NCT03005873|471266724|FG000|Overall Study|Ineligible post randomization|0|||
130899315|NCT03005873|471266725|FG001|Overall Study|Ineligible post randomization|0|||
130899316|NCT03005873|471266726|FG002|Overall Study|Ineligible post randomization|1|||
130899317|NCT04140227|471266727|FG000|Overall Study|Withdrawal by Subject|26|||
130899318|NCT04140227|471266727|FG000|Overall Study|Lost to Follow-up|8|||
130899319|NCT04140227|471266727|FG000|Overall Study|Adverse Event|8|||
130899320|NCT04140227|471266727|FG000|Overall Study|Death|1|||
130899321|NCT04140227|471266727|FG000|Overall Study|Other|3|||
130899322|NCT04140227|471266727|FG000|Overall Study|Protocol Violation|2|||
130899323|NCT01713933|471266728|FG000|Overall Study|Lost to Follow-up|2|||
130899324|NCT01713933|471266728|FG000|Overall Study|Withdrawal by Subject|3|||
130899325|NCT01713933|471266728|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
130899326|NCT00412373|471266729|FG000|Overall Study|Adverse Event|8|||
130899327|NCT00412373|471266730|FG001|Overall Study|Adverse Event|13|||
130899328|NCT00412373|471266729|FG000|Overall Study|Lack of Efficacy|16|||
130899329|NCT00412373|471266730|FG001|Overall Study|Lack of Efficacy|22|||
130899330|NCT00412373|471266729|FG000|Overall Study|Lost to Follow-up|7|||
130899331|NCT00412373|471266730|FG001|Overall Study|Lost to Follow-up|13|||
130899332|NCT00412373|471266729|FG000|Overall Study|Withdrawal by Subject|8|||
130899333|NCT00412373|471266730|FG001|Overall Study|Withdrawal by Subject|27|||
130899334|NCT00412373|471266729|FG000|Overall Study|Other|2|||
130899335|NCT00412373|471266730|FG001|Overall Study|Other|2|||
130899336|NCT01009840|471266733|FG000|Overall Study|Lost to Follow-up|1|||
130899337|NCT01009840|471266733|FG000|Overall Study|Adverse Event|4|||
130899338|NCT01009840|471266733|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
130899339|NCT01009840|471266733|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
130899340|NCT01009840|471266733|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
130899341|NCT04022733|471266734|FG000|Overall Study|conversion to open surgery|3|||
130899342|NCT04022733|471266735|FG001|Overall Study|conversion to open surgery|2|||
130899343|NCT04022733|471266734|FG000|Overall Study|bradycardia|0|||
130899344|NCT04022733|471266735|FG001|Overall Study|bradycardia|1|||
130899345|NCT00797966|471266736|FG000|Phase A|Lost to Follow-up|0|||
130899346|NCT00797966|471266737|FG001|Phase A|Lost to Follow-up|0|||
130899347|NCT00797966|471266738|FG002|Phase A|Lost to Follow-up|0|||
130899348|NCT00797966|471266739|FG003|Phase A|Lost to Follow-up|0|||
130899349|NCT00797966|471266740|FG004|Phase A|Lost to Follow-up|33|||
130899350|NCT00797966|471266741|FG005|Phase A|Lost to Follow-up|0|||
130899351|NCT00797966|471266736|FG000|Phase A|Adverse Event|0|||
130899352|NCT00797966|471266737|FG001|Phase A|Adverse Event|0|||
130899353|NCT00797966|471266738|FG002|Phase A|Adverse Event|0|||
130899354|NCT00797966|471266739|FG003|Phase A|Adverse Event|0|||
130899355|NCT00797966|471266740|FG004|Phase A|Adverse Event|46|||
130899356|NCT00797966|471266741|FG005|Phase A|Adverse Event|0|||
130899357|NCT00797966|471266736|FG000|Phase A|Met withdrawal criteria|0|||
130899358|NCT00797966|471266737|FG001|Phase A|Met withdrawal criteria|0|||
130899359|NCT00797966|471266738|FG002|Phase A|Met withdrawal criteria|0|||
130899360|NCT00797966|471266739|FG003|Phase A|Met withdrawal criteria|0|||
130899361|NCT00797966|471266740|FG004|Phase A|Met withdrawal criteria|4|||
130899362|NCT00797966|471266741|FG005|Phase A|Met withdrawal criteria|0|||
130899363|NCT00797966|471266736|FG000|Phase A|Physician Decision|0|||
130899364|NCT00797966|471266737|FG001|Phase A|Physician Decision|0|||
130899365|NCT00797966|471266738|FG002|Phase A|Physician Decision|0|||
130899366|NCT00797966|471266739|FG003|Phase A|Physician Decision|0|||
130899367|NCT00797966|471266740|FG004|Phase A|Physician Decision|13|||
130899368|NCT00797966|471266741|FG005|Phase A|Physician Decision|0|||
130899369|NCT00797966|471266736|FG000|Phase A|Withdrawal by Subject|0|||
130899370|NCT00797966|471266737|FG001|Phase A|Withdrawal by Subject|0|||
130899371|NCT00797966|471266738|FG002|Phase A|Withdrawal by Subject|0|||
130899372|NCT00797966|471266739|FG003|Phase A|Withdrawal by Subject|0|||
130899373|NCT00797966|471266740|FG004|Phase A|Withdrawal by Subject|33|||
130899374|NCT00797966|471266741|FG005|Phase A|Withdrawal by Subject|0|||
130899375|NCT00797966|471266736|FG000|Phase A|Protocol deviation|0|||
130899376|NCT00797966|471266737|FG001|Phase A|Protocol deviation|0|||
130899377|NCT00797966|471266738|FG002|Phase A|Protocol deviation|0|||
130899378|NCT00797966|471266739|FG003|Phase A|Protocol deviation|0|||
130899379|NCT00797966|471266740|FG004|Phase A|Protocol deviation|56|||
130899380|NCT00797966|471266741|FG005|Phase A|Protocol deviation|0|||
130899381|NCT00797966|471266736|FG000|Phase B|Lost to Follow-up|0|||
130899382|NCT00797966|471266737|FG001|Phase B|Lost to Follow-up|1|||
130899383|NCT00797966|471266738|FG002|Phase B|Lost to Follow-up|3|||
130899384|NCT00797966|471266739|FG003|Phase B|Lost to Follow-up|0|||
130899385|NCT00797966|471266740|FG004|Phase B|Lost to Follow-up|0|||
130899386|NCT00797966|471266741|FG005|Phase B|Lost to Follow-up|0|||
130899387|NCT00797966|471266736|FG000|Phase B|Adverse Event|2|||
130899388|NCT00797966|471266737|FG001|Phase B|Adverse Event|1|||
130899389|NCT00797966|471266738|FG002|Phase B|Adverse Event|3|||
130899390|NCT00797966|471266739|FG003|Phase B|Adverse Event|1|||
130899391|NCT00797966|471266740|FG004|Phase B|Adverse Event|0|||
130899392|NCT00797966|471266741|FG005|Phase B|Adverse Event|0|||
130899393|NCT00797966|471266736|FG000|Phase B|Met Withdrawal Criteria|3|||
130899394|NCT00797966|471266737|FG001|Phase B|Met Withdrawal Criteria|3|||
130899395|NCT00797966|471266738|FG002|Phase B|Met Withdrawal Criteria|6|||
130899396|NCT00797966|471266739|FG003|Phase B|Met Withdrawal Criteria|1|||
130899397|NCT00797966|471266740|FG004|Phase B|Met Withdrawal Criteria|0|||
130899398|NCT00797966|471266741|FG005|Phase B|Met Withdrawal Criteria|0|||
130899399|NCT00797966|471266736|FG000|Phase B|Physician Decision|1|||
130899400|NCT00797966|471266737|FG001|Phase B|Physician Decision|0|||
130899401|NCT00797966|471266738|FG002|Phase B|Physician Decision|3|||
130899402|NCT00797966|471266739|FG003|Phase B|Physician Decision|1|||
130899403|NCT00797966|471266740|FG004|Phase B|Physician Decision|0|||
130899404|NCT00797966|471266741|FG005|Phase B|Physician Decision|0|||
130899405|NCT00797966|471266736|FG000|Phase B|Withdrawal by Subject|1|||
130899406|NCT00797966|471266737|FG001|Phase B|Withdrawal by Subject|4|||
130899407|NCT00797966|471266738|FG002|Phase B|Withdrawal by Subject|3|||
130899408|NCT00797966|471266739|FG003|Phase B|Withdrawal by Subject|3|||
130899409|NCT00797966|471266740|FG004|Phase B|Withdrawal by Subject|0|||
130899410|NCT00797966|471266741|FG005|Phase B|Withdrawal by Subject|0|||
130899411|NCT00797966|471266736|FG000|Phase B|Protocol Deviation|4|||
130899412|NCT00797966|471266737|FG001|Phase B|Protocol Deviation|8|||
130899413|NCT00797966|471266738|FG002|Phase B|Protocol Deviation|2|||
130899414|NCT00797966|471266739|FG003|Phase B|Protocol Deviation|6|||
130899415|NCT00797966|471266740|FG004|Phase B|Protocol Deviation|0|||
130899416|NCT00797966|471266741|FG005|Phase B|Protocol Deviation|0|||
130899417|NCT00797966|471266736|FG000|Phase B|Lack of Efficacy|0|||
130899418|NCT00797966|471266737|FG001|Phase B|Lack of Efficacy|1|||
130899419|NCT00797966|471266738|FG002|Phase B|Lack of Efficacy|1|||
130899420|NCT00797966|471266739|FG003|Phase B|Lack of Efficacy|4|||
130899421|NCT00797966|471266740|FG004|Phase B|Lack of Efficacy|0|||
131025658|NCT03398148|471725294|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025659|NCT03398148|471725295|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025660|NCT03398148|471725296|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025661|NCT03398148|471725297|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
131025662|NCT03398148|471725298|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025663|NCT03398148|471725299|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025664|NCT03398148|471725300|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025665|NCT03398148|471725301|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025666|NCT03398148|471725302|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025667|NCT03398148|471725303|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025668|NCT03398148|471725304|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
131025669|NCT03398148|471725305|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
130899422|NCT00797966|471266741|FG005|Phase B|Lack of Efficacy|0|||
130899423|NCT00797966|471266736|FG000|Phase A+|Lost to Follow-up|0|||
130899424|NCT00797966|471266737|FG001|Phase A+|Lost to Follow-up|0|||
130899425|NCT00797966|471266738|FG002|Phase A+|Lost to Follow-up|0|||
130899426|NCT00797966|471266739|FG003|Phase A+|Lost to Follow-up|0|||
130899427|NCT00797966|471266740|FG004|Phase A+|Lost to Follow-up|0|||
130899428|NCT00797966|471266741|FG005|Phase A+|Lost to Follow-up|9|||
130899429|NCT00797966|471266736|FG000|Phase A+|Met withdrawal criteria|0|||
130899430|NCT00797966|471266737|FG001|Phase A+|Met withdrawal criteria|0|||
130899431|NCT00797966|471266738|FG002|Phase A+|Met withdrawal criteria|0|||
130899432|NCT00797966|471266739|FG003|Phase A+|Met withdrawal criteria|0|||
130899433|NCT00797966|471266740|FG004|Phase A+|Met withdrawal criteria|0|||
130899434|NCT00797966|471266741|FG005|Phase A+|Met withdrawal criteria|5|||
130899435|NCT00797966|471266736|FG000|Phase A+|Withdrawal by Subject|0|||
130899436|NCT00797966|471266737|FG001|Phase A+|Withdrawal by Subject|0|||
130899437|NCT00797966|471266738|FG002|Phase A+|Withdrawal by Subject|0|||
131025670|NCT03398148|471725291|FG000|Substudy 2 Period 1|Adverse Event|0|||
131025671|NCT03398148|471725292|FG001|Substudy 2 Period 1|Adverse Event|0|||
130899438|NCT00797966|471266739|FG003|Phase A+|Withdrawal by Subject|0|||
130899439|NCT00797966|471266740|FG004|Phase A+|Withdrawal by Subject|0|||
130899440|NCT00797966|471266741|FG005|Phase A+|Withdrawal by Subject|6|||
130899441|NCT00797966|471266736|FG000|Phase A+|Adverse Event|0|||
130899442|NCT00797966|471266737|FG001|Phase A+|Adverse Event|0|||
130899443|NCT00797966|471266738|FG002|Phase A+|Adverse Event|0|||
130899444|NCT00797966|471266739|FG003|Phase A+|Adverse Event|0|||
130899445|NCT00797966|471266740|FG004|Phase A+|Adverse Event|0|||
130899446|NCT00797966|471266741|FG005|Phase A+|Adverse Event|4|||
130899447|NCT00797966|471266736|FG000|Phase A+|Protocol deviation|0|||
130899448|NCT00797966|471266737|FG001|Phase A+|Protocol deviation|0|||
130899449|NCT00797966|471266738|FG002|Phase A+|Protocol deviation|0|||
130899450|NCT00797966|471266739|FG003|Phase A+|Protocol deviation|0|||
130899451|NCT00797966|471266740|FG004|Phase A+|Protocol deviation|0|||
130899452|NCT00797966|471266741|FG005|Phase A+|Protocol deviation|4|||
130899453|NCT01883453|471266746|FG000|Overall Study|No episode of common cold|25|||
130899454|NCT01883453|471266747|FG001|Overall Study|No episode of common cold|23|||
130899455|NCT00913458|471266750|FG000|Phase 1|Non-Responder|54|||
130899456|NCT00913458|471266751|FG001|Phase 1|Non-Responder|0|||
130899457|NCT00913458|471266752|FG002|Phase 1|Non-Responder|0|||
130899458|NCT00913458|471266753|FG003|Phase 1|Non-Responder|0|||
130899459|NCT00913458|471266754|FG004|Phase 1|Non-Responder|0|||
130899460|NCT00913458|471266755|FG005|Phase 1|Non-Responder|0|||
130899461|NCT00913458|471266756|FG006|Phase 1|Non-Responder|0|||
130899462|NCT00913458|471266750|FG000|Phase 1|Subject Request|17|||
130899463|NCT00913458|471266751|FG001|Phase 1|Subject Request|0|||
130899464|NCT00913458|471266752|FG002|Phase 1|Subject Request|0|||
130899465|NCT00913458|471266753|FG003|Phase 1|Subject Request|0|||
131025672|NCT03398148|471725293|FG002|Substudy 2 Period 1|Adverse Event|0|||
131025673|NCT03398148|471725294|FG003|Substudy 2 Period 1|Adverse Event|0|||
131025674|NCT03398148|471725295|FG004|Substudy 2 Period 1|Adverse Event|0|||
131025675|NCT03398148|471725296|FG005|Substudy 2 Period 1|Adverse Event|0|||
131025676|NCT03398148|471725297|FG006|Substudy 2 Period 1|Adverse Event|0|||
131025677|NCT03398148|471725298|FG007|Substudy 2 Period 1|Adverse Event|0|||
131025678|NCT03398148|471725299|FG008|Substudy 2 Period 1|Adverse Event|0|||
131025679|NCT03398148|471725300|FG009|Substudy 2 Period 1|Adverse Event|12|||
131025680|NCT03398148|471725301|FG010|Substudy 2 Period 1|Adverse Event|2|||
131025681|NCT03398148|471725302|FG011|Substudy 2 Period 1|Adverse Event|0|||
131025682|NCT03398148|471725303|FG012|Substudy 2 Period 1|Adverse Event|0|||
131025683|NCT03398148|471725304|FG013|Substudy 2 Period 1|Adverse Event|0|||
131025684|NCT03398148|471725305|FG014|Substudy 2 Period 1|Adverse Event|0|||
131025685|NCT03398148|471725291|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025686|NCT03398148|471725292|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025687|NCT03398148|471725293|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025688|NCT03398148|471725294|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025689|NCT03398148|471725295|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025690|NCT03398148|471725296|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025691|NCT03398148|471725297|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025692|NCT03398148|471725298|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025693|NCT03398148|471725299|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025694|NCT03398148|471725300|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
131025695|NCT03398148|471725301|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
131025696|NCT03398148|471725302|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025697|NCT03398148|471725303|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025698|NCT03398148|471725304|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025699|NCT03398148|471725305|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
131025700|NCT03398148|471725291|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
131025701|NCT03398148|471725292|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
131025702|NCT03398148|471725293|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
131025703|NCT03398148|471725294|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
131025704|NCT03398148|471725295|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
131025705|NCT03398148|471725296|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
131025706|NCT03398148|471725297|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
131025707|NCT03398148|471725298|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
131025708|NCT03398148|471725299|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
131025709|NCT03398148|471725300|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
131025710|NCT03398148|471725301|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
131025711|NCT03398148|471725302|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
131025712|NCT03398148|471725303|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
130899466|NCT00913458|471266754|FG004|Phase 1|Subject Request|0|||
130899467|NCT00913458|471266755|FG005|Phase 1|Subject Request|0|||
130899468|NCT00913458|471266756|FG006|Phase 1|Subject Request|0|||
131025713|NCT03398148|471725304|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
131025714|NCT03398148|471725305|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
131025715|NCT03398148|471725291|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131025716|NCT03398148|471725292|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131025717|NCT03398148|471725293|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131025718|NCT03398148|471725294|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130899469|NCT00913458|471266750|FG000|Phase 1|Adverse Event|20|||
130899470|NCT00913458|471266751|FG001|Phase 1|Adverse Event|0|||
130899471|NCT00913458|471266752|FG002|Phase 1|Adverse Event|0|||
130899472|NCT00913458|471266753|FG003|Phase 1|Adverse Event|0|||
130899473|NCT00913458|471266754|FG004|Phase 1|Adverse Event|0|||
130899474|NCT00913458|471266755|FG005|Phase 1|Adverse Event|0|||
130899475|NCT00913458|471266756|FG006|Phase 1|Adverse Event|0|||
130899476|NCT00913458|471266750|FG000|Phase 1|Lost to Follow-up|2|||
130899477|NCT00913458|471266751|FG001|Phase 1|Lost to Follow-up|0|||
130899478|NCT00913458|471266752|FG002|Phase 1|Lost to Follow-up|0|||
130899479|NCT00913458|471266753|FG003|Phase 1|Lost to Follow-up|0|||
130899480|NCT00913458|471266754|FG004|Phase 1|Lost to Follow-up|0|||
130899481|NCT00913458|471266755|FG005|Phase 1|Lost to Follow-up|0|||
130899482|NCT00913458|471266756|FG006|Phase 1|Lost to Follow-up|0|||
130899483|NCT00913458|471266750|FG000|Phase 1|Protocol Violation|10|||
130899484|NCT00913458|471266751|FG001|Phase 1|Protocol Violation|0|||
130899485|NCT00913458|471266752|FG002|Phase 1|Protocol Violation|0|||
130899486|NCT00913458|471266753|FG003|Phase 1|Protocol Violation|0|||
130899487|NCT00913458|471266754|FG004|Phase 1|Protocol Violation|0|||
130899488|NCT00913458|471266755|FG005|Phase 1|Protocol Violation|0|||
130899489|NCT00913458|471266756|FG006|Phase 1|Protocol Violation|0|||
130899490|NCT00913458|471266750|FG000|Phase 1|Sponsor|2|||
130899491|NCT00913458|471266751|FG001|Phase 1|Sponsor|0|||
130899492|NCT00913458|471266752|FG002|Phase 1|Sponsor|0|||
130899493|NCT00913458|471266753|FG003|Phase 1|Sponsor|0|||
130899494|NCT00913458|471266754|FG004|Phase 1|Sponsor|0|||
130899495|NCT00913458|471266755|FG005|Phase 1|Sponsor|0|||
130899496|NCT00913458|471266756|FG006|Phase 1|Sponsor|0|||
130899497|NCT00913458|471266750|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
130899498|NCT00913458|471266751|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
130899499|NCT00913458|471266752|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
130899500|NCT00913458|471266753|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
130899501|NCT00913458|471266754|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
130899502|NCT00913458|471266755|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
130899503|NCT00913458|471266756|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
130899504|NCT00913458|471266750|FG000|Phase 2|Non-Responder|0|||
130899505|NCT00913458|471266751|FG001|Phase 2|Non-Responder|5|||
130899506|NCT00913458|471266752|FG002|Phase 2|Non-Responder|7|||
130899507|NCT00913458|471266753|FG003|Phase 2|Non-Responder|12|||
130899508|NCT00913458|471266754|FG004|Phase 2|Non-Responder|0|||
130899509|NCT00913458|471266755|FG005|Phase 2|Non-Responder|0|||
130899510|NCT00913458|471266756|FG006|Phase 2|Non-Responder|0|||
130899511|NCT00913458|471266750|FG000|Phase 2|Subject Request|0|||
130899512|NCT00913458|471266751|FG001|Phase 2|Subject Request|0|||
130899513|NCT00913458|471266752|FG002|Phase 2|Subject Request|1|||
130899514|NCT00913458|471266753|FG003|Phase 2|Subject Request|2|||
130899515|NCT00913458|471266754|FG004|Phase 2|Subject Request|0|||
130899516|NCT00913458|471266755|FG005|Phase 2|Subject Request|0|||
130899517|NCT00913458|471266756|FG006|Phase 2|Subject Request|0|||
130899518|NCT00913458|471266750|FG000|Phase 2|Adverse Event|0|||
130899519|NCT00913458|471266751|FG001|Phase 2|Adverse Event|3|||
130899520|NCT00913458|471266752|FG002|Phase 2|Adverse Event|0|||
130899521|NCT00913458|471266753|FG003|Phase 2|Adverse Event|1|||
130899522|NCT00913458|471266754|FG004|Phase 2|Adverse Event|0|||
130899523|NCT00913458|471266755|FG005|Phase 2|Adverse Event|0|||
130899524|NCT00913458|471266756|FG006|Phase 2|Adverse Event|0|||
130899525|NCT00913458|471266750|FG000|Phase 2|Lost to Follow-up|0|||
130899526|NCT00913458|471266751|FG001|Phase 2|Lost to Follow-up|0|||
130899527|NCT00913458|471266752|FG002|Phase 2|Lost to Follow-up|0|||
130899528|NCT00913458|471266753|FG003|Phase 2|Lost to Follow-up|1|||
130899529|NCT00913458|471266754|FG004|Phase 2|Lost to Follow-up|0|||
130899530|NCT00913458|471266755|FG005|Phase 2|Lost to Follow-up|0|||
130899531|NCT00913458|471266756|FG006|Phase 2|Lost to Follow-up|0|||
130899532|NCT00913458|471266750|FG000|Phase 2|Protocol Violation|0|||
130899533|NCT00913458|471266751|FG001|Phase 2|Protocol Violation|2|||
130899534|NCT00913458|471266752|FG002|Phase 2|Protocol Violation|0|||
130899535|NCT00913458|471266753|FG003|Phase 2|Protocol Violation|0|||
130899536|NCT00913458|471266754|FG004|Phase 2|Protocol Violation|0|||
130899537|NCT00913458|471266755|FG005|Phase 2|Protocol Violation|0|||
130899538|NCT00913458|471266756|FG006|Phase 2|Protocol Violation|0|||
130899539|NCT00913458|471266750|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
131025719|NCT03398148|471725295|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131025720|NCT03398148|471725296|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130899540|NCT00913458|471266751|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
130899541|NCT00913458|471266752|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
130899542|NCT00913458|471266753|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
130899543|NCT00913458|471266754|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
131025721|NCT03398148|471725297|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130899544|NCT00913458|471266755|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
130899545|NCT00913458|471266756|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
130899546|NCT00913458|471266750|FG000|Phase 3|Adverse Event|0|||
130899547|NCT00913458|471266751|FG001|Phase 3|Adverse Event|0|||
130899548|NCT00913458|471266752|FG002|Phase 3|Adverse Event|0|||
130899549|NCT00913458|471266753|FG003|Phase 3|Adverse Event|0|||
130899550|NCT00913458|471266754|FG004|Phase 3|Adverse Event|5|||
130899551|NCT00913458|471266755|FG005|Phase 3|Adverse Event|4|||
130899552|NCT00913458|471266756|FG006|Phase 3|Adverse Event|1|||
130899553|NCT00913458|471266750|FG000|Phase 3|Lost to Follow-up|0|||
130899554|NCT00913458|471266751|FG001|Phase 3|Lost to Follow-up|0|||
130691686|NCT01535222|470495974|FG005|Overall Study|Inclusion/exclusion|0|||
130691687|NCT01117623|470497826|FG000|Overall Study|Adverse Event|0|||
130691688|NCT01117623|470497827|FG001|Overall Study|Adverse Event|2|||
130691689|NCT01117623|470497828|FG002|Overall Study|Adverse Event|4|||
130691690|NCT01117623|470497829|FG003|Overall Study|Adverse Event|0|||
130691691|NCT01117623|470497830|FG004|Overall Study|Adverse Event|2|||
130691692|NCT01117623|470497831|FG005|Overall Study|Adverse Event|0|||
130691693|NCT01117623|470497832|FG006|Overall Study|Adverse Event|0|||
130691694|NCT01117623|470497833|FG007|Overall Study|Adverse Event|2|||
130691695|NCT01117623|470497826|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
130691696|NCT01117623|470497827|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
130691697|NCT01117623|470497828|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
130691698|NCT01117623|470497829|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
130691699|NCT01117623|470497830|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
130691700|NCT01117623|470497831|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
130691701|NCT01117623|470497832|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
130691702|NCT01117623|470497833|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
130691703|NCT01117623|470497826|FG000|Overall Study|Withdrawal by Subject|0|||
130691704|NCT01117623|470497827|FG001|Overall Study|Withdrawal by Subject|0|||
130691705|NCT01117623|470497828|FG002|Overall Study|Withdrawal by Subject|2|||
130691706|NCT01117623|470497829|FG003|Overall Study|Withdrawal by Subject|0|||
130691707|NCT01117623|470497830|FG004|Overall Study|Withdrawal by Subject|0|||
130691708|NCT01117623|470497831|FG005|Overall Study|Withdrawal by Subject|1|||
130691709|NCT01117623|470497832|FG006|Overall Study|Withdrawal by Subject|1|||
130691710|NCT01117623|470497833|FG007|Overall Study|Withdrawal by Subject|1|||
130691711|NCT01117623|470497826|FG000|Overall Study|Non-compliance with study medication|0|||
130691712|NCT01117623|470497827|FG001|Overall Study|Non-compliance with study medication|0|||
130691713|NCT01117623|470497828|FG002|Overall Study|Non-compliance with study medication|0|||
130691714|NCT01117623|470497829|FG003|Overall Study|Non-compliance with study medication|0|||
130691715|NCT01117623|470497830|FG004|Overall Study|Non-compliance with study medication|0|||
130691716|NCT01117623|470497831|FG005|Overall Study|Non-compliance with study medication|0|||
130691717|NCT01117623|470497832|FG006|Overall Study|Non-compliance with study medication|0|||
130691718|NCT01117623|470497833|FG007|Overall Study|Non-compliance with study medication|1|||
130691719|NCT01117623|470497826|FG000|Overall Study|Invest. text: completed all planned txs|0|||
130691720|NCT01117623|470497827|FG001|Overall Study|Invest. text: completed all planned txs|0|||
130691721|NCT01117623|470497828|FG002|Overall Study|Invest. text: completed all planned txs|0|||
130691722|NCT01117623|470497829|FG003|Overall Study|Invest. text: completed all planned txs|0|||
130691723|NCT01117623|470497830|FG004|Overall Study|Invest. text: completed all planned txs|0|||
130691724|NCT01117623|470497831|FG005|Overall Study|Invest. text: completed all planned txs|1|||
130691725|NCT01117623|470497832|FG006|Overall Study|Invest. text: completed all planned txs|0|||
130691726|NCT01117623|470497833|FG007|Overall Study|Invest. text: completed all planned txs|0|||
130691727|NCT00395694|470497839|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
130691728|NCT00395694|470497840|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
130691729|NCT00395694|470497839|FG000|Continuation Phase|Adverse Event|1|||
130691730|NCT00395694|470497840|FG001|Continuation Phase|Adverse Event|0|||
130691731|NCT00395694|470497839|FG000|Continuation Phase|Lack of Efficacy|12|||
130691732|NCT00395694|470497840|FG001|Continuation Phase|Lack of Efficacy|11|||
130691733|NCT00395694|470497839|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
130691734|NCT00395694|470497840|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
130691735|NCT00395694|470497839|FG000|Continuation Phase|Poor Compliance|1|||
130691736|NCT00395694|470497840|FG001|Continuation Phase|Poor Compliance|0|||
130691737|NCT00395694|470497839|FG000|Continuation Phase|Withdrawal by Subject|0|||
130691738|NCT00395694|470497840|FG001|Continuation Phase|Withdrawal by Subject|2|||
130691739|NCT00840216|470497841|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130691740|NCT00840216|470497842|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130691741|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Adverse Event|8|||
130691742|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Adverse Event|15|||
130691743|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Adverse Event|25|||
130691744|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
130691745|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
130691746|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
130691747|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
130691748|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
130691749|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
130691750|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
130691751|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
130691752|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
130691753|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130691754|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
130691755|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
130899555|NCT00913458|471266752|FG002|Phase 3|Lost to Follow-up|0|||
130899556|NCT00913458|471266753|FG003|Phase 3|Lost to Follow-up|0|||
130899557|NCT00913458|471266754|FG004|Phase 3|Lost to Follow-up|2|||
130899558|NCT00913458|471266755|FG005|Phase 3|Lost to Follow-up|0|||
130899559|NCT00913458|471266756|FG006|Phase 3|Lost to Follow-up|0|||
130899560|NCT00913458|471266750|FG000|Phase 3|Non-Responder|0|||
130899561|NCT00913458|471266751|FG001|Phase 3|Non-Responder|0|||
130899562|NCT00913458|471266752|FG002|Phase 3|Non-Responder|0|||
130899563|NCT00913458|471266753|FG003|Phase 3|Non-Responder|0|||
130899564|NCT00913458|471266754|FG004|Phase 3|Non-Responder|0|||
130899565|NCT00913458|471266755|FG005|Phase 3|Non-Responder|1|||
130899566|NCT00913458|471266756|FG006|Phase 3|Non-Responder|3|||
130899567|NCT00913458|471266750|FG000|Phase 3|Withdrawal by Subject|0|||
130899568|NCT00913458|471266751|FG001|Phase 3|Withdrawal by Subject|0|||
130899569|NCT00913458|471266752|FG002|Phase 3|Withdrawal by Subject|0|||
130899570|NCT00913458|471266753|FG003|Phase 3|Withdrawal by Subject|0|||
130899571|NCT00913458|471266754|FG004|Phase 3|Withdrawal by Subject|1|||
130899572|NCT00913458|471266755|FG005|Phase 3|Withdrawal by Subject|2|||
130899573|NCT00913458|471266756|FG006|Phase 3|Withdrawal by Subject|0|||
130899574|NCT00913458|471266750|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
130899575|NCT00913458|471266751|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
130899576|NCT00913458|471266752|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
130899577|NCT00913458|471266753|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
130899578|NCT00913458|471266754|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
130899579|NCT00913458|471266755|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
130899580|NCT00913458|471266756|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
130899581|NCT00917644|471266757|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
130899582|NCT00917644|471266758|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
130899583|NCT00917644|471266757|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
130899584|NCT00917644|471266758|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
130899585|NCT00917644|471266757|FG000|Period 2: Second Intervention|family emergency|1|||
130899586|NCT00917644|471266758|FG001|Period 2: Second Intervention|family emergency|0|||
130899587|NCT00357760|471266762|FG000|Overall Study|Disease progression|44|||
130899588|NCT00357760|471266763|FG001|Overall Study|Disease progression|17|||
130899589|NCT00357760|471266762|FG000|Overall Study|Adverse Event|10|||
130899590|NCT00357760|471266763|FG001|Overall Study|Adverse Event|7|||
130899591|NCT00357760|471266762|FG000|Overall Study|Death|0|||
130899592|NCT00357760|471266763|FG001|Overall Study|Death|3|||
130899593|NCT00357760|471266762|FG000|Overall Study|Alternative therapy|1|||
130899594|NCT00357760|471266763|FG001|Overall Study|Alternative therapy|0|||
130899595|NCT00357760|471266762|FG000|Overall Study|Withdrawal by Subject|0|||
130899596|NCT00357760|471266763|FG001|Overall Study|Withdrawal by Subject|2|||
130899597|NCT00357760|471266762|FG000|Overall Study|Never started treatment|2|||
130899598|NCT00357760|471266763|FG001|Overall Study|Never started treatment|1|||
130899599|NCT00357760|471266762|FG000|Overall Study|Ineligible|0|||
130899600|NCT00357760|471266763|FG001|Overall Study|Ineligible|2|||
130899601|NCT00357760|471266762|FG000|Overall Study|Physician Decision|2|||
130899602|NCT00357760|471266763|FG001|Overall Study|Physician Decision|1|||
130899603|NCT00357760|471266762|FG000|Overall Study|Protocol Violation|0|||
130899604|NCT00357760|471266763|FG001|Overall Study|Protocol Violation|1|||
130899605|NCT00357760|471266762|FG000|Overall Study|To receive hospice care|0|||
130899606|NCT00357760|471266763|FG001|Overall Study|To receive hospice care|1|||
130899607|NCT04136444|471266764|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
130899608|NCT04136444|471266765|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
130899609|NCT02238067|471266766|FG000|Overall Study|Not completed survey at Month 6|45|||
130899610|NCT00869778|471266767|FG000|Overall Study|Adverse Event|2|||
130899611|NCT00869778|471266768|FG001|Overall Study|Adverse Event|0|||
130899612|NCT00869778|471266769|FG002|Overall Study|Adverse Event|0|||
131025722|NCT03398148|471725298|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131025723|NCT03398148|471725299|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130691756|NCT01058668|470497843|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
130691757|NCT01058668|470497844|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
130899613|NCT00869778|471266767|FG000|Overall Study|Withdrawal by Subject|3|||
130899614|NCT00869778|471266768|FG001|Overall Study|Withdrawal by Subject|4|||
130899615|NCT00869778|471266769|FG002|Overall Study|Withdrawal by Subject|5|||
130899616|NCT00869778|471266767|FG000|Overall Study|Pregnancy|1|||
130899617|NCT00869778|471266768|FG001|Overall Study|Pregnancy|0|||
131025724|NCT03398148|471725300|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131025725|NCT03398148|471725301|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
130899618|NCT00869778|471266769|FG002|Overall Study|Pregnancy|0|||
130899619|NCT00869778|471266767|FG000|Overall Study|Protocol Violation|5|||
131025726|NCT03398148|471725302|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131025727|NCT03398148|471725303|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131112369|NCT01853982|472041064|FG000|Overall Study|Death|1|||
130691758|NCT01058668|470497845|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
130899620|NCT00869778|471266768|FG001|Overall Study|Protocol Violation|3|||
130899621|NCT00869778|471266769|FG002|Overall Study|Protocol Violation|5|||
130899622|NCT00869778|471266767|FG000|Overall Study|Unblinding|1|||
130899623|NCT00869778|471266768|FG001|Overall Study|Unblinding|0|||
130899624|NCT00869778|471266769|FG002|Overall Study|Unblinding|0|||
130899625|NCT03726996|471266772|FG000|Overall Study|Parent's decision|2|||
130899626|NCT03726996|471266772|FG000|Overall Study|Study early termination|2|||
130899627|NCT03180619|471266773|FG000|Overall Study|Withdrew Consent|5|||
130899628|NCT03180619|471266774|FG001|Overall Study|Withdrew Consent|0|||
130899629|NCT03180619|471266775|FG002|Overall Study|Withdrew Consent|2|||
130899630|NCT03180619|471266773|FG000|Overall Study|Death|2|||
130899631|NCT03180619|471266774|FG001|Overall Study|Death|1|||
130899632|NCT03180619|471266775|FG002|Overall Study|Death|2|||
130899633|NCT03180619|471266773|FG000|Overall Study|Adverse Event|2|||
130899634|NCT03180619|471266774|FG001|Overall Study|Adverse Event|0|||
130899635|NCT03180619|471266775|FG002|Overall Study|Adverse Event|1|||
130899636|NCT03180619|471266773|FG000|Overall Study|Investigator's discretion|2|||
130899637|NCT03180619|471266774|FG001|Overall Study|Investigator's discretion|0|||
130899638|NCT03180619|471266775|FG002|Overall Study|Investigator's discretion|1|||
130899639|NCT02743611|471266776|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
130899640|NCT02743611|471266777|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
130899641|NCT02743611|471266778|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
130899642|NCT02743611|471266779|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
130899643|NCT01566214|471266782|FG000|Overall Study|Lost to Follow-up|3|||
130899644|NCT01566214|471266783|FG001|Overall Study|Lost to Follow-up|0|||
130899645|NCT02395172|471266792|FG000|Overall Study|Participants randomized but not treated|3|||
130899646|NCT02395172|471266793|FG001|Overall Study|Participants randomized but not treated|31|||
130899647|NCT00653939|471266794|FG000|Overall Study|Adverse Event|1|||
130899648|NCT00653939|471266795|FG001|Overall Study|Adverse Event|3|||
130899649|NCT00653939|471266794|FG000|Overall Study|Withdrawal by Subject|3|||
130899650|NCT00653939|471266795|FG001|Overall Study|Withdrawal by Subject|3|||
130899651|NCT00653939|471266794|FG000|Overall Study|Physician Decision|4|||
130899652|NCT00653939|471266795|FG001|Overall Study|Physician Decision|0|||
130899653|NCT00653939|471266794|FG000|Overall Study|Disease Progression|2|||
130899654|NCT00653939|471266795|FG001|Overall Study|Disease Progression|3|||
130899655|NCT00653939|471266794|FG000|Overall Study|Other|2|||
130899656|NCT00653939|471266795|FG001|Overall Study|Other|6|||
130899657|NCT00402740|471266805|FG000|Overall Study|Withdrawal by Subject|18|||
130899658|NCT00402740|471266805|FG000|Overall Study|Death|50|||
130899659|NCT00402740|471266805|FG000|Overall Study|Lost to Follow-up|6|||
130899660|NCT00402740|471266805|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
130899661|NCT00402740|471266805|FG000|Overall Study|Subject disposition unknown.|1|||
130899662|NCT01159431|471266809|FG000|Overall Study|Adverse Event|1|||
130899663|NCT01159431|471266810|FG001|Overall Study|Adverse Event|2|||
130899664|NCT01159431|471266809|FG000|Overall Study|non-compliance|1|||
130899665|NCT01159431|471266810|FG001|Overall Study|non-compliance|1|||
130899666|NCT01159431|471266809|FG000|Overall Study|Lack of Efficacy|0|||
130899667|NCT01159431|471266810|FG001|Overall Study|Lack of Efficacy|3|||
130899668|NCT00534599|471266816|FG000|Overall Study|Adverse Event|25|||
130899669|NCT00534599|471266817|FG001|Overall Study|Adverse Event|4|||
130899670|NCT00534599|471266816|FG000|Overall Study|Incorrect enrollment|2|||
130899671|NCT00534599|471266817|FG001|Overall Study|Incorrect enrollment|1|||
130899672|NCT00534599|471266816|FG000|Overall Study|Mis-randomization|2|||
130899673|NCT00534599|471266817|FG001|Overall Study|Mis-randomization|2|||
130899674|NCT00534599|471266816|FG000|Overall Study|Developed study-specific d/c criteria|5|||
130899675|NCT00534599|471266817|FG001|Overall Study|Developed study-specific d/c criteria|0|||
130899676|NCT00534599|471266816|FG000|Overall Study|Lack of Efficacy|0|||
130899677|NCT00534599|471266817|FG001|Overall Study|Lack of Efficacy|1|||
130899678|NCT00534599|471266816|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
130899679|NCT00534599|471266817|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
130899680|NCT00534599|471266816|FG000|Overall Study|Protocol Violation|1|||
131025728|NCT03398148|471725304|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
130691759|NCT00935012|470497850|FG000|Overall Study|Death|19|||
131025729|NCT03398148|471725305|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
131025730|NCT03398148|471725291|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025731|NCT03398148|471725292|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025732|NCT03398148|471725293|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130691760|NCT00935012|470497850|FG000|Overall Study|Withdrawal by Subject|3|||
130691761|NCT00935012|470497850|FG000|Overall Study|Other|5|||
130899681|NCT00534599|471266817|FG001|Overall Study|Protocol Violation|3|||
130899682|NCT00534599|471266816|FG000|Overall Study|Lost to Follow-up|11|||
130899683|NCT00534599|471266817|FG001|Overall Study|Lost to Follow-up|14|||
130899684|NCT00534599|471266816|FG000|Overall Study|Withdrawal by Subject|4|||
130899685|NCT00534599|471266817|FG001|Overall Study|Withdrawal by Subject|6|||
130899686|NCT00534599|471266816|FG000|Overall Study|Other|7|||
130899687|NCT00534599|471266817|FG001|Overall Study|Other|0|||
130899688|NCT03976648|471266821|FG000|Overall Study|Adverse Event|0|||
130899689|NCT03976648|471266822|FG001|Overall Study|Adverse Event|2|||
130899690|NCT03976648|471266821|FG000|Overall Study|Study terminated by sponsor|21|||
130899691|NCT03976648|471266822|FG001|Overall Study|Study terminated by sponsor|8|||
131112370|NCT01853982|472041065|FG001|Overall Study|Death|0|||
131112371|NCT01853982|472041064|FG000|Overall Study|Lost to Follow-up|0|||
131112372|NCT01853982|472041065|FG001|Overall Study|Lost to Follow-up|1|||
131112373|NCT05066724|472041070|FG000|Overall Study|Adverse Event|1|||
131112374|NCT05066724|472041070|FG000|Overall Study|Non-Compliance With Study Drug|5|||
131112375|NCT05066724|472041070|FG000|Overall Study|Withdrawal by Subject|6|||
131112376|NCT05066724|472041070|FG000|Overall Study|Physician Decision|2|||
131112377|NCT00475033|472041074|FG000|Infant Series|Failed to return|3|||
131112378|NCT00475033|472041075|FG001|Infant Series|Failed to return|4|||
131112379|NCT00475033|472041074|FG000|Infant Series|Parent or legal guardian request|1|||
131112380|NCT00475033|472041075|FG001|Infant Series|Parent or legal guardian request|5|||
131112381|NCT00475033|472041074|FG000|Infant Series|Protocol Violation|1|||
131112382|NCT00475033|472041075|FG001|Infant Series|Protocol Violation|2|||
131112383|NCT00475033|472041074|FG000|Infant Series|Lost to Follow-up|2|||
131112384|NCT00475033|472041075|FG001|Infant Series|Lost to Follow-up|0|||
131112385|NCT00475033|472041074|FG000|Infant Series|Adverse Event|0|||
131112386|NCT00475033|472041075|FG001|Infant Series|Adverse Event|2|||
130691762|NCT00935012|470497850|FG000|Overall Study|Adverse Event|2|||
130691763|NCT01442155|470497851|FG000|Overall Study|Complete remission|35|||
130691764|NCT01442155|470497851|FG000|Overall Study|Recurrence|26|||
130691765|NCT01442155|470497851|FG000|Overall Study|Adverse Event|2|||
130691766|NCT01442155|470497851|FG000|Overall Study|Lost to Follow-up|2|||
130691767|NCT00705666|470497852|FG000|Overall Study|No post-treatment questionnaire|279|||
130691768|NCT00705666|470497852|FG000|Overall Study|Withdrawal by Subject|21|||
130691769|NCT00705666|470497852|FG000|Overall Study|Physician Decision|7|||
130691770|NCT00705666|470497852|FG000|Overall Study|Lost to Follow-up|5|||
130691771|NCT00705666|470497852|FG000|Overall Study|Death|1|||
130691772|NCT00705666|470497852|FG000|Overall Study|Adverse Event|4|||
130691773|NCT00705666|470497852|FG000|Overall Study|Other|12|||
130691774|NCT00705666|470497852|FG000|Overall Study|Other|2|||
130691775|NCT00705666|470497852|FG000|Overall Study|Lack of data|3|||
130691776|NCT00705666|470497852|FG000|Overall Study|Untreated|5|||
130691777|NCT01590563|470497863|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
130691778|NCT03256695|470497864|FG000|Overall Study|Adverse Event|8|||
130691779|NCT03256695|470497864|FG000|Overall Study|Death|2|||
130691780|NCT03256695|470497864|FG000|Overall Study|Withdrawal by Subject|14|||
130691781|NCT03256695|470497864|FG000|Overall Study|Non-compliance with study drug|1|||
130691782|NCT03256695|470497864|FG000|Overall Study|Lost to Follow-up|3|||
130691783|NCT03256695|470497864|FG000|Overall Study|Lack of Efficacy|3|||
130691784|NCT03256695|470497864|FG000|Overall Study|Protocol Violation|5|||
130691785|NCT03256695|470497864|FG000|Overall Study|Other than specified|3|||
130691786|NCT01604941|470497865|FG000|Overall Study|Adverse Event|1|||
130691787|NCT01604941|470497866|FG001|Overall Study|Adverse Event|2|||
130691788|NCT01604941|470497867|FG002|Overall Study|Adverse Event|0|||
130691789|NCT01604941|470497868|FG003|Overall Study|Adverse Event|0|||
130691790|NCT01604941|470497869|FG004|Overall Study|Adverse Event|1|||
130691791|NCT01604941|470497870|FG005|Overall Study|Adverse Event|5|||
130691792|NCT01604941|470497865|FG000|Overall Study|Non-compliance|1|||
130691793|NCT01604941|470497866|FG001|Overall Study|Non-compliance|0|||
130691794|NCT01604941|470497867|FG002|Overall Study|Non-compliance|0|||
130691795|NCT01604941|470497868|FG003|Overall Study|Non-compliance|0|||
130691796|NCT01604941|470497869|FG004|Overall Study|Non-compliance|0|||
130691797|NCT01604941|470497870|FG005|Overall Study|Non-compliance|0|||
130691798|NCT01604941|470497865|FG000|Overall Study|Participant Decision|0|||
130691799|NCT01604941|470497866|FG001|Overall Study|Participant Decision|0|||
131112387|NCT00475033|472041074|FG000|After the Infant Series|Adverse Event|0|||
131112388|NCT00475033|472041075|FG001|After the Infant Series|Adverse Event|4|||
131112389|NCT00475033|472041074|FG000|After the Infant Series|Parent or legal guardian request|2|||
131222724|NCT00720304|472443166|FG000|Overall Study|Physician Decision|5|||
130691800|NCT01604941|470497867|FG002|Overall Study|Participant Decision|0|||
130691801|NCT01604941|470497868|FG003|Overall Study|Participant Decision|0|||
130691802|NCT01604941|470497869|FG004|Overall Study|Participant Decision|0|||
130691803|NCT01604941|470497870|FG005|Overall Study|Participant Decision|2|||
130691804|NCT01604941|470497865|FG000|Overall Study|Early Study Termination|9|||
130691805|NCT01604941|470497866|FG001|Overall Study|Early Study Termination|2|||
130691806|NCT01604941|470497867|FG002|Overall Study|Early Study Termination|3|||
130691807|NCT01604941|470497868|FG003|Overall Study|Early Study Termination|3|||
130691808|NCT01604941|470497869|FG004|Overall Study|Early Study Termination|0|||
130691809|NCT01604941|470497870|FG005|Overall Study|Early Study Termination|0|||
130691810|NCT03930732|470497871|FG000|Overall Study|Adverse Event|9|||
130691811|NCT03930732|470497872|FG001|Overall Study|Adverse Event|7|||
130691812|NCT03930732|470497871|FG000|Overall Study|Poor compliance to protocol|0|||
130691813|NCT03930732|470497872|FG001|Overall Study|Poor compliance to protocol|1|||
130691814|NCT03930732|470497871|FG000|Overall Study|Withdrawal by Subject|23|||
130691815|NCT03930732|470497872|FG001|Overall Study|Withdrawal by Subject|11|||
130691816|NCT03930732|470497871|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
130691817|NCT03930732|470497872|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
130691818|NCT03930732|470497871|FG000|Overall Study|Other reason not related to COVID-19|5|||
130899692|NCT00960570|471266823|FG000|21 Day Washout Period|Adverse Event|1|||
130899693|NCT00960570|471266823|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
130899694|NCT00960570|471266823|FG000|1 Day Period Between Dosing|Adverse Event|2|||
130899695|NCT00960570|471266823|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
130899696|NCT01451437|471266824|FG000|Overall Study|Adverse Event|0|||
130899697|NCT01451437|471266825|FG001|Overall Study|Adverse Event|0|||
130899698|NCT01451437|471266826|FG002|Overall Study|Adverse Event|0|||
130899699|NCT01451437|471266827|FG003|Overall Study|Adverse Event|0|||
130899700|NCT01451437|471266828|FG004|Overall Study|Adverse Event|0|||
130899701|NCT01451437|471266829|FG005|Overall Study|Adverse Event|1|||
130899702|NCT01451437|471266830|FG006|Overall Study|Adverse Event|1|||
130899703|NCT01451437|471266831|FG007|Overall Study|Adverse Event|2|||
130899704|NCT01451437|471266832|FG008|Overall Study|Adverse Event|1|||
130899705|NCT01451437|471266824|FG000|Overall Study|Physician Decision|1|||
130899706|NCT01451437|471266825|FG001|Overall Study|Physician Decision|1|||
130899707|NCT01451437|471266826|FG002|Overall Study|Physician Decision|2|||
130899708|NCT01451437|471266827|FG003|Overall Study|Physician Decision|0|||
130899709|NCT01451437|471266828|FG004|Overall Study|Physician Decision|0|||
130899710|NCT01451437|471266829|FG005|Overall Study|Physician Decision|0|||
130899711|NCT01451437|471266830|FG006|Overall Study|Physician Decision|0|||
130899712|NCT01451437|471266831|FG007|Overall Study|Physician Decision|0|||
130899713|NCT01451437|471266832|FG008|Overall Study|Physician Decision|0|||
130899714|NCT01451437|471266824|FG000|Overall Study|Disease Progression|0|||
130899715|NCT01451437|471266825|FG001|Overall Study|Disease Progression|0|||
130899716|NCT01451437|471266826|FG002|Overall Study|Disease Progression|1|||
130899717|NCT01451437|471266827|FG003|Overall Study|Disease Progression|1|||
130899718|NCT01451437|471266828|FG004|Overall Study|Disease Progression|3|||
130899719|NCT01451437|471266829|FG005|Overall Study|Disease Progression|2|||
130899720|NCT01451437|471266830|FG006|Overall Study|Disease Progression|3|||
130899721|NCT01451437|471266831|FG007|Overall Study|Disease Progression|1|||
130899722|NCT01451437|471266832|FG008|Overall Study|Disease Progression|3|||
130899723|NCT01451437|471266824|FG000|Overall Study|Protocol Violation|0|||
130899724|NCT01451437|471266825|FG001|Overall Study|Protocol Violation|0|||
130899725|NCT01451437|471266826|FG002|Overall Study|Protocol Violation|0|||
130899726|NCT01451437|471266827|FG003|Overall Study|Protocol Violation|0|||
130899727|NCT01451437|471266828|FG004|Overall Study|Protocol Violation|0|||
130899728|NCT01451437|471266829|FG005|Overall Study|Protocol Violation|0|||
130899729|NCT01451437|471266830|FG006|Overall Study|Protocol Violation|1|||
130899730|NCT01451437|471266831|FG007|Overall Study|Protocol Violation|0|||
130899731|NCT01451437|471266832|FG008|Overall Study|Protocol Violation|0|||
130899732|NCT01451437|471266824|FG000|Overall Study|Withdrawal by Subject|0|||
130899733|NCT01451437|471266825|FG001|Overall Study|Withdrawal by Subject|0|||
130899734|NCT01451437|471266826|FG002|Overall Study|Withdrawal by Subject|0|||
131025733|NCT03398148|471725294|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025734|NCT03398148|471725295|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025735|NCT03398148|471725296|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025736|NCT03398148|471725297|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025737|NCT03398148|471725298|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025738|NCT03398148|471725299|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025739|NCT03398148|471725300|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025740|NCT03398148|471725301|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
131025741|NCT03398148|471725302|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025742|NCT03398148|471725303|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025743|NCT03398148|471725304|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025744|NCT03398148|471725305|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
131025745|NCT03398148|471725291|FG000|Substudy 2 Period 1|Other|0|||
131025746|NCT03398148|471725292|FG001|Substudy 2 Period 1|Other|0|||
131025747|NCT03398148|471725293|FG002|Substudy 2 Period 1|Other|0|||
131025748|NCT03398148|471725294|FG003|Substudy 2 Period 1|Other|0|||
131025749|NCT03398148|471725295|FG004|Substudy 2 Period 1|Other|0|||
131025750|NCT03398148|471725296|FG005|Substudy 2 Period 1|Other|0|||
131025751|NCT03398148|471725297|FG006|Substudy 2 Period 1|Other|0|||
130691819|NCT03930732|470497872|FG001|Overall Study|Other reason not related to COVID-19|8|||
131025752|NCT03398148|471725298|FG007|Substudy 2 Period 1|Other|0|||
131025753|NCT03398148|471725299|FG008|Substudy 2 Period 1|Other|0|||
131025754|NCT03398148|471725300|FG009|Substudy 2 Period 1|Other|4|||
131025755|NCT03398148|471725301|FG010|Substudy 2 Period 1|Other|4|||
131025756|NCT03398148|471725302|FG011|Substudy 2 Period 1|Other|0|||
131222725|NCT00720304|472443167|FG001|Overall Study|Physician Decision|2|||
130899735|NCT01451437|471266827|FG003|Overall Study|Withdrawal by Subject|0|||
130899736|NCT01451437|471266828|FG004|Overall Study|Withdrawal by Subject|1|||
130899737|NCT01451437|471266829|FG005|Overall Study|Withdrawal by Subject|0|||
130899738|NCT01451437|471266830|FG006|Overall Study|Withdrawal by Subject|1|||
130899739|NCT01451437|471266831|FG007|Overall Study|Withdrawal by Subject|0|||
130899740|NCT01451437|471266832|FG008|Overall Study|Withdrawal by Subject|0|||
130899741|NCT03865316|471269096|FG000|Overall Study|Procedure Cancelled|4|||
130899742|NCT03865316|471269096|FG000|Overall Study|Equipment failure|4|||
130899743|NCT03137069|471269101|FG000|Overall Study|Withdrawal by Subject|1|||
130899744|NCT03137069|471269102|FG001|Overall Study|Withdrawal by Subject|2|||
130899745|NCT03137069|471269103|FG002|Overall Study|Withdrawal by Subject|2|||
130899746|NCT03137069|471269104|FG003|Overall Study|Withdrawal by Subject|2|||
130899747|NCT03137069|471269105|FG004|Overall Study|Withdrawal by Subject|0|||
130899748|NCT03137069|471269106|FG005|Overall Study|Withdrawal by Subject|0|||
130899749|NCT03137069|471269101|FG000|Overall Study|Adverse Event|0|||
130899750|NCT03137069|471269102|FG001|Overall Study|Adverse Event|3|||
130899751|NCT03137069|471269103|FG002|Overall Study|Adverse Event|1|||
130899752|NCT03137069|471269104|FG003|Overall Study|Adverse Event|1|||
130899753|NCT03137069|471269105|FG004|Overall Study|Adverse Event|0|||
130899754|NCT03137069|471269106|FG005|Overall Study|Adverse Event|1|||
130899755|NCT03137069|471269101|FG000|Overall Study|Protocol Violation|0|||
130899756|NCT03137069|471269102|FG001|Overall Study|Protocol Violation|1|||
130899757|NCT03137069|471269103|FG002|Overall Study|Protocol Violation|0|||
130899758|NCT03137069|471269104|FG003|Overall Study|Protocol Violation|1|||
130899759|NCT03137069|471269105|FG004|Overall Study|Protocol Violation|1|||
130899760|NCT03137069|471269106|FG005|Overall Study|Protocol Violation|1|||
130899761|NCT03137069|471269101|FG000|Overall Study|Physician Decision|0|||
130899762|NCT03137069|471269102|FG001|Overall Study|Physician Decision|0|||
130899763|NCT03137069|471269103|FG002|Overall Study|Physician Decision|0|||
130899764|NCT03137069|471269104|FG003|Overall Study|Physician Decision|1|||
130899765|NCT03137069|471269105|FG004|Overall Study|Physician Decision|0|||
130899766|NCT03137069|471269106|FG005|Overall Study|Physician Decision|0|||
130899767|NCT03137069|471269101|FG000|Overall Study|Study Terminated by Sponsor|0|||
130899768|NCT03137069|471269102|FG001|Overall Study|Study Terminated by Sponsor|0|||
130899769|NCT03137069|471269103|FG002|Overall Study|Study Terminated by Sponsor|0|||
130899770|NCT03137069|471269104|FG003|Overall Study|Study Terminated by Sponsor|0|||
130899771|NCT03137069|471269105|FG004|Overall Study|Study Terminated by Sponsor|1|||
130899772|NCT03137069|471269106|FG005|Overall Study|Study Terminated by Sponsor|0|||
130899773|NCT03137069|471269101|FG000|Overall Study|Data Entry Error|0|||
130899774|NCT03137069|471269102|FG001|Overall Study|Data Entry Error|0|||
130899775|NCT03137069|471269103|FG002|Overall Study|Data Entry Error|0|||
130899776|NCT03137069|471269104|FG003|Overall Study|Data Entry Error|1|||
130899777|NCT03137069|471269105|FG004|Overall Study|Data Entry Error|0|||
130899778|NCT03137069|471269106|FG005|Overall Study|Data Entry Error|0|||
130899779|NCT00336856|471269107|FG000|Overall Study|Withdrawal by Subject|3|||
130899780|NCT00336856|471269107|FG000|Overall Study|Found ineligible at time of analysis|1|||
130899781|NCT02434471|471269111|FG000|Overall Study|Physician Decision|9|||
130899782|NCT00843778|471269112|FG000|Overall Study|Adverse Event|15|||
130899783|NCT00843778|471269112|FG000|Overall Study|Lack of Efficacy|14|||
130899784|NCT00843778|471269112|FG000|Overall Study|Loss of efficacy|2|||
130899785|NCT00843778|471269112|FG000|Overall Study|Withdrawal by Subject|4|||
130899786|NCT00369629|471269113|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
130899787|NCT00369629|471269114|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
130899788|NCT00369629|471269115|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
130899789|NCT00369629|471269116|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
130899790|NCT00369629|471269113|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
130899791|NCT00369629|471269114|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
130899792|NCT00369629|471269115|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
130899793|NCT00369629|471269116|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
130899794|NCT00369629|471269113|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
130899795|NCT00369629|471269114|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
130899796|NCT00369629|471269115|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
130899797|NCT00369629|471269116|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
130899798|NCT00369629|471269113|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
130899799|NCT00369629|471269114|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
130899800|NCT00369629|471269115|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
130899801|NCT00369629|471269116|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
130899802|NCT00369629|471269113|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
130899803|NCT00369629|471269114|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
130899804|NCT00369629|471269115|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
130899805|NCT00369629|471269116|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
130899806|NCT00369629|471269113|FG000|Completed 4 More Cycles|Progressive disease|2|||
130899807|NCT00369629|471269114|FG001|Completed 4 More Cycles|Progressive disease|1|||
130899808|NCT00369629|471269115|FG002|Completed 4 More Cycles|Progressive disease|2|||
130899809|NCT00369629|471269116|FG003|Completed 4 More Cycles|Progressive disease|0|||
130899810|NCT00369629|471269113|FG000|Follow up for 1 Year|Death|2|||
130899811|NCT00369629|471269114|FG001|Follow up for 1 Year|Death|1|||
130899812|NCT00369629|471269115|FG002|Follow up for 1 Year|Death|1|||
130899813|NCT00369629|471269116|FG003|Follow up for 1 Year|Death|0|||
130899814|NCT00369629|471269113|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
130899815|NCT00369629|471269114|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
130899816|NCT00369629|471269115|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
131025757|NCT03398148|471725303|FG012|Substudy 2 Period 1|Other|0|||
130899817|NCT00369629|471269116|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
130899818|NCT00369629|471269113|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
130899819|NCT00369629|471269114|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
130899820|NCT00369629|471269115|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
130899821|NCT00369629|471269116|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
130899822|NCT01964755|471269117|FG000|Overall Study|Death|2|||
130899823|NCT02894502|471269118|FG000|Baseline|Withdrawal by Subject|24|||
130899824|NCT02894502|471269119|FG001|Baseline|Withdrawal by Subject|31|||
130899825|NCT02894502|471269120|FG002|Baseline|Withdrawal by Subject|36|||
130899826|NCT02894502|471269118|FG000|Baseline|Death|3|||
130899827|NCT02894502|471269119|FG001|Baseline|Death|1|||
130899828|NCT02894502|471269120|FG002|Baseline|Death|9|||
130899829|NCT02894502|471269118|FG000|First Follow up|Withdrawal by Subject|32|||
130899830|NCT02894502|471269119|FG001|First Follow up|Withdrawal by Subject|29|||
130899831|NCT02894502|471269120|FG002|First Follow up|Withdrawal by Subject|37|||
130899832|NCT02894502|471269118|FG000|First Follow up|Death|2|||
130899833|NCT02894502|471269119|FG001|First Follow up|Death|2|||
130899834|NCT02894502|471269120|FG002|First Follow up|Death|3|||
130899835|NCT02894502|471269118|FG000|Second Follow up|Withdrawal by Subject|13|||
130899836|NCT02894502|471269119|FG001|Second Follow up|Withdrawal by Subject|15|||
130899837|NCT02894502|471269120|FG002|Second Follow up|Withdrawal by Subject|13|||
130899838|NCT02894502|471269118|FG000|Second Follow up|Death|2|||
130899839|NCT02894502|471269119|FG001|Second Follow up|Death|3|||
130899840|NCT02894502|471269120|FG002|Second Follow up|Death|1|||
130899841|NCT02894502|471269118|FG000|Third Follow up|Withdrawal by Subject|5|||
130899842|NCT02894502|471269119|FG001|Third Follow up|Withdrawal by Subject|6|||
130899843|NCT02894502|471269120|FG002|Third Follow up|Withdrawal by Subject|3|||
130899844|NCT02894502|471269118|FG000|Third Follow up|Death|1|||
130899845|NCT02894502|471269119|FG001|Third Follow up|Death|1|||
130899846|NCT02894502|471269120|FG002|Third Follow up|Death|0|||
130899847|NCT00538785|471269129|FG000|Overall Study|Death|9|||
130899848|NCT00538785|471269130|FG001|Overall Study|Death|10|||
130899849|NCT00538785|471269129|FG000|Overall Study|Withdrawal of consent|9|||
130899850|NCT00538785|471269130|FG001|Overall Study|Withdrawal of consent|7|||
130899851|NCT00538785|471269129|FG000|Overall Study|Lost to Follow-up|1|||
130899852|NCT00538785|471269130|FG001|Overall Study|Lost to Follow-up|0|||
130899853|NCT01104376|471269131|FG000|Overall Study|Withdrawal by Subject|15|||
130899854|NCT01104376|471269131|FG000|Overall Study|Consented but excluded after labs|13|||
130899855|NCT01478048|471269137|FG000|Overall Study|Disease Progression|52|||
130899856|NCT01478048|471269138|FG001|Overall Study|Disease Progression|35|||
130899857|NCT01478048|471269137|FG000|Overall Study|study drug toxicity|11|||
130691820|NCT03406156|470497873|FG000|Overall Study|Death|9|||
130691821|NCT03406156|470497874|FG001|Overall Study|Death|3|||
130691822|NCT03406156|470497873|FG000|Overall Study|Withdrawal by Subject|1|||
130691823|NCT03406156|470497874|FG001|Overall Study|Withdrawal by Subject|2|||
130691824|NCT03406156|470497873|FG000|Overall Study|COVID-19 infection|1|||
130691825|NCT03406156|470497874|FG001|Overall Study|COVID-19 infection|0|||
130691826|NCT03406156|470497873|FG000|Overall Study|Non-compliance with study procedures|1|||
130691827|NCT03406156|470497874|FG001|Overall Study|Non-compliance with study procedures|1|||
130691828|NCT03406156|470497873|FG000|Overall Study|Lost to Follow-up|0|||
130691829|NCT03406156|470497874|FG001|Overall Study|Lost to Follow-up|2|||
130691830|NCT03406156|470497873|FG000|Overall Study|Other, not specified|72|||
130691831|NCT03406156|470497874|FG001|Overall Study|Other, not specified|28|||
130899858|NCT01478048|471269138|FG001|Overall Study|study drug toxicity|14|||
130899859|NCT01478048|471269137|FG000|Overall Study|Adverse Event|2|||
130899860|NCT01478048|471269138|FG001|Overall Study|Adverse Event|11|||
130899861|NCT01478048|471269137|FG000|Overall Study|subject request to discontinue treatment|3|||
130899862|NCT01478048|471269138|FG001|Overall Study|subject request to discontinue treatment|5|||
130899863|NCT01478048|471269137|FG000|Overall Study|Withdrawal by Subject|2|||
130899864|NCT01478048|471269138|FG001|Overall Study|Withdrawal by Subject|5|||
130899865|NCT01478048|471269137|FG000|Overall Study|non-specified|6|||
130899866|NCT01478048|471269138|FG001|Overall Study|non-specified|4|||
130899867|NCT01478048|471269137|FG000|Overall Study|poor/non-compliance|0|||
130899868|NCT01478048|471269138|FG001|Overall Study|poor/non-compliance|1|||
130899869|NCT01478048|471269137|FG000|Overall Study|no longer meets study criteria|1|||
130899870|NCT01478048|471269138|FG001|Overall Study|no longer meets study criteria|0|||
130899871|NCT01541397|471269144|FG000|Overall Study|Study ended prior to data collection|4|||
130899872|NCT01541397|471269145|FG001|Overall Study|Study ended prior to data collection|2|||
130691832|NCT03366792|470497877|FG000|Overall Study|Withdrawal by Subject|7|||
130691833|NCT03366792|470497877|FG000|Overall Study|Lost to Follow-up|2|||
130691834|NCT03366792|470497877|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
130899873|NCT02577887|471269146|FG000|Overall Study|Death|93|||
130899874|NCT02577887|471269146|FG000|Overall Study|Protocol Violation|125|||
130899875|NCT02577887|471269146|FG000|Overall Study|Withdrawal by Subject|80|||
130899876|NCT03560518|471269147|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
130899877|NCT03560518|471269148|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
130767961|NCT02258334|470773952|FG003|Overall Study|Adverse Event|0|||
130899878|NCT03560518|471269149|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
130899879|NCT03560518|471269147|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
130899880|NCT03560518|471269148|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
130899881|NCT03560518|471269149|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
130899882|NCT03560518|471269147|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130899883|NCT03560518|471269148|FG001|Double Blind Treatment Period|Protocol Violation|2|||
130899884|NCT03560518|471269149|FG002|Double Blind Treatment Period|Protocol Violation|0|||
130899885|NCT03560518|471269147|FG000|Double Blind Treatment Period|Pregnancy|0|||
130899886|NCT03560518|471269148|FG001|Double Blind Treatment Period|Pregnancy|2|||
130899887|NCT03560518|471269149|FG002|Double Blind Treatment Period|Pregnancy|0|||
130899888|NCT03560518|471269147|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
130899889|NCT03560518|471269148|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
130899890|NCT03560518|471269149|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
130899891|NCT03560518|471269147|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
130899892|NCT03560518|471269148|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
130899893|NCT03560518|471269149|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
130899894|NCT03560518|471269147|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
130899895|NCT03560518|471269148|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
130899896|NCT03560518|471269149|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
130899897|NCT03560518|471269147|FG000|Double Blind Treatment Period|Adverse Event|0|||
130899898|NCT03560518|471269148|FG001|Double Blind Treatment Period|Adverse Event|3|||
130899899|NCT03560518|471269149|FG002|Double Blind Treatment Period|Adverse Event|1|||
130899900|NCT01689532|471269150|FG000|Overall Study|Adverse Event|9|||
130899901|NCT01689532|471269151|FG001|Overall Study|Adverse Event|5|||
130899902|NCT01689532|471269150|FG000|Overall Study|Lack of Efficacy|2|||
130899903|NCT01689532|471269151|FG001|Overall Study|Lack of Efficacy|2|||
130899904|NCT01689532|471269150|FG000|Overall Study|Withdrawal by Subject|1|||
130899905|NCT01689532|471269151|FG001|Overall Study|Withdrawal by Subject|2|||
130899906|NCT01689532|471269150|FG000|Overall Study|Physician Decision|2|||
130899907|NCT01689532|471269151|FG001|Overall Study|Physician Decision|0|||
130899908|NCT01363349|471269152|FG000|Overall Study|Adverse Event|6|||
130899909|NCT01363349|471269153|FG001|Overall Study|Adverse Event|7|||
130899910|NCT01363349|471269152|FG000|Overall Study|Lack of Efficacy|3|||
130899911|NCT01363349|471269153|FG001|Overall Study|Lack of Efficacy|10|||
130899912|NCT01363349|471269152|FG000|Overall Study|Non compliance/Protocol deviations|2|||
130899913|NCT01363349|471269153|FG001|Overall Study|Non compliance/Protocol deviations|2|||
130899914|NCT01363349|471269152|FG000|Overall Study|Withdrawal by Subject|14|||
130899915|NCT01363349|471269153|FG001|Overall Study|Withdrawal by Subject|6|||
130899916|NCT01363349|471269152|FG000|Overall Study|Lost to Follow-up|5|||
130899917|NCT01363349|471269153|FG001|Overall Study|Lost to Follow-up|6|||
130899918|NCT01363349|471269152|FG000|Overall Study|Not reported|36|||
130899919|NCT01363349|471269153|FG001|Overall Study|Not reported|37|||
130899920|NCT01363349|471269152|FG000|Overall Study|missing|1|||
130899921|NCT01363349|471269153|FG001|Overall Study|missing|2|||
130899922|NCT01958489|471269154|FG000|Period 2|Adverse Event|0|||
130899923|NCT01958489|471269155|FG001|Period 2|Adverse Event|1|||
130899924|NCT03595618|471269156|FG000|Overall Study|Adverse Event|16|||
130899925|NCT03595618|471269157|FG001|Overall Study|Adverse Event|17|||
130899926|NCT03595618|471269158|FG002|Overall Study|Adverse Event|20|||
130899927|NCT03595618|471269159|FG003|Overall Study|Adverse Event|8|||
130899928|NCT03595618|471269156|FG000|Overall Study|Withdrawal by Subject|12|||
130899929|NCT03595618|471269157|FG001|Overall Study|Withdrawal by Subject|14|||
130899930|NCT03595618|471269158|FG002|Overall Study|Withdrawal by Subject|14|||
130899931|NCT03595618|471269159|FG003|Overall Study|Withdrawal by Subject|10|||
131112390|NCT00475033|472041075|FG001|After the Infant Series|Parent or legal guardian request|2|||
131112391|NCT00475033|472041074|FG000|After the Infant Series|Failed to return|2|||
131112392|NCT00475033|472041075|FG001|After the Infant Series|Failed to return|1|||
131112393|NCT00475033|472041074|FG000|After the Infant Series|Protocol Violation|1|||
131112394|NCT00475033|472041075|FG001|After the Infant Series|Protocol Violation|0|||
131112395|NCT00475033|472041074|FG000|After the Infant Series|Lost to Follow-up|1|||
130767962|NCT01969084|470773953|FG000|Overall Study|Adverse Event|0|||
131112396|NCT00475033|472041075|FG001|After the Infant Series|Lost to Follow-up|0|||
131112397|NCT00475033|472041074|FG000|After the Infant Series|Other|0|||
130899932|NCT03595618|471269156|FG000|Overall Study|Lost to Follow-up|6|||
130899933|NCT03595618|471269157|FG001|Overall Study|Lost to Follow-up|4|||
130899934|NCT03595618|471269158|FG002|Overall Study|Lost to Follow-up|5|||
130899935|NCT03595618|471269159|FG003|Overall Study|Lost to Follow-up|6|||
130899936|NCT03595618|471269156|FG000|Overall Study|Protocol Violation|2|||
130899937|NCT03595618|471269157|FG001|Overall Study|Protocol Violation|0|||
131112398|NCT00475033|472041075|FG001|After the Infant Series|Other|1|||
130899938|NCT03595618|471269158|FG002|Overall Study|Protocol Violation|6|||
130899939|NCT03595618|471269159|FG003|Overall Study|Protocol Violation|2|||
131112399|NCT00475033|472041074|FG000|Toddler Dose|Parent or legal guardian request|2|||
130899940|NCT03595618|471269156|FG000|Overall Study|Physician Decision|0|||
130899941|NCT03595618|471269157|FG001|Overall Study|Physician Decision|0|||
130899942|NCT03595618|471269158|FG002|Overall Study|Physician Decision|1|||
130899943|NCT03595618|471269159|FG003|Overall Study|Physician Decision|2|||
130899944|NCT03595618|471269156|FG000|Overall Study|Miscellaneous|7|||
130899945|NCT03595618|471269157|FG001|Overall Study|Miscellaneous|5|||
130899946|NCT03595618|471269158|FG002|Overall Study|Miscellaneous|10|||
130899947|NCT03595618|471269159|FG003|Overall Study|Miscellaneous|6|||
130899948|NCT02338232|471269160|FG000|Overall Study|Screen Failure|3|||
130899949|NCT02338232|471269160|FG000|Overall Study|Withdrawal by Subject|6|||
130899950|NCT02338232|471269160|FG000|Overall Study|Adverse Event|2|||
130899951|NCT02279407|471269161|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
130899952|NCT02279407|471269162|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
130899953|NCT02279407|471269163|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
130899954|NCT02279407|471269164|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
130899955|NCT02279407|471269161|FG000|Overall Study|Withdrawal by Subject|1|||
130899956|NCT02279407|471269162|FG001|Overall Study|Withdrawal by Subject|0|||
130899957|NCT02279407|471269163|FG002|Overall Study|Withdrawal by Subject|1|||
130899958|NCT02279407|471269164|FG003|Overall Study|Withdrawal by Subject|1|||
130899959|NCT02279407|471269161|FG000|Overall Study|Adverse Event|1|||
130899960|NCT02279407|471269162|FG001|Overall Study|Adverse Event|1|||
130899961|NCT02279407|471269163|FG002|Overall Study|Adverse Event|2|||
130899962|NCT02279407|471269164|FG003|Overall Study|Adverse Event|0|||
130899963|NCT02500056|471269165|FG000|Overall Study|Lost to Follow-up|3|||
130899964|NCT02500056|471269166|FG001|Overall Study|Lost to Follow-up|7|||
130899965|NCT02500056|471269165|FG000|Overall Study|Recurrence|1|||
130899966|NCT02500056|471269166|FG001|Overall Study|Recurrence|0|||
130899967|NCT02500056|471269165|FG000|Overall Study|Death|3|||
130899968|NCT02500056|471269166|FG001|Overall Study|Death|1|||
130899969|NCT00864916|471269167|FG000|Overall Study|Lost to Follow-up|4|||
130899970|NCT00864916|471269168|FG001|Overall Study|Lost to Follow-up|4|||
130899971|NCT00864916|471269167|FG000|Overall Study|Protocol Violation|1|||
130899972|NCT00864916|471269168|FG001|Overall Study|Protocol Violation|0|||
130899973|NCT00864916|471269167|FG000|Overall Study|Withdrawal by Subject|1|||
130899974|NCT00864916|471269168|FG001|Overall Study|Withdrawal by Subject|0|||
130899975|NCT03996369|471269169|FG000|Overall Study|Protocol deviation|1|||
130899976|NCT03996369|471269170|FG001|Overall Study|Protocol deviation|1|||
130899977|NCT03996369|471269169|FG000|Overall Study|Physician Decision|4|||
130899978|NCT03996369|471269170|FG001|Overall Study|Physician Decision|2|||
130899979|NCT03996369|471269169|FG000|Overall Study|Participant decision|0|||
130899980|NCT03996369|471269170|FG001|Overall Study|Participant decision|1|||
130899981|NCT03996369|471269169|FG000|Overall Study|Lack of Efficacy|4|||
130899982|NCT03996369|471269170|FG001|Overall Study|Lack of Efficacy|0|||
130899983|NCT03996369|471269169|FG000|Overall Study|Adverse Event|9|||
130899984|NCT03996369|471269170|FG001|Overall Study|Adverse Event|0|||
130691835|NCT03366792|470497877|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
130691836|NCT02450539|470497878|FG000|Overall Study|Withdrawal by Subject|12|||
130691837|NCT02450539|470497879|FG001|Overall Study|Withdrawal by Subject|6|||
130691838|NCT02450539|470497878|FG000|Overall Study|Lost to Follow-up|4|||
130691839|NCT02450539|470497879|FG001|Overall Study|Lost to Follow-up|1|||
130691840|NCT02699463|470497880|FG000|Overall Study|Lost to Follow-up|11|||
130691841|NCT02699463|470497881|FG001|Overall Study|Lost to Follow-up|8|||
130691842|NCT02699463|470497880|FG000|Overall Study|Withdrawal by Subject|4|||
130691843|NCT02699463|470497881|FG001|Overall Study|Withdrawal by Subject|1|||
130691844|NCT01808651|470497882|FG000|Study Period 1|Lost to Follow-up|1|||
130691845|NCT01808651|470497883|FG001|Study Period 1|Lost to Follow-up|3|||
130899985|NCT03996369|471269169|FG000|Overall Study|Withdrawal by Subject|6|||
130691846|NCT01808651|470497884|FG002|Study Period 1|Lost to Follow-up|0|||
130691847|NCT01808651|470497882|FG000|Study Period 1|Protocol Violation|1|||
130691848|NCT01808651|470497883|FG001|Study Period 1|Protocol Violation|0|||
130691849|NCT01808651|470497884|FG002|Study Period 1|Protocol Violation|1|||
130691850|NCT01808651|470497882|FG000|Study Period 1|Physician Decision|3|||
130899986|NCT03996369|471269170|FG001|Overall Study|Withdrawal by Subject|8|||
130899987|NCT03996369|471269169|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
130899988|NCT03996369|471269170|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
130899989|NCT03996369|471269169|FG000|Overall Study|Lost to Follow-up|0|||
130691851|NCT01808651|470497883|FG001|Study Period 1|Physician Decision|2|||
130899990|NCT03996369|471269170|FG001|Overall Study|Lost to Follow-up|1|||
130899991|NCT01185301|471269172|FG000|Overall Study|Adverse Event|3|||
130899992|NCT01185301|471269173|FG001|Overall Study|Adverse Event|0|||
130899993|NCT01185301|471269174|FG002|Overall Study|Adverse Event|2|||
131025758|NCT03398148|471725304|FG013|Substudy 2 Period 1|Other|0|||
131025759|NCT03398148|471725305|FG014|Substudy 2 Period 1|Other|0|||
131025760|NCT03398148|471725291|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
131025761|NCT03398148|471725292|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
131025762|NCT03398148|471725293|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
131025763|NCT03398148|471725294|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
130899994|NCT01185301|471269175|FG003|Overall Study|Adverse Event|3|||
130899995|NCT01185301|471269172|FG000|Overall Study|Withdrawal by Subject|7|||
130899996|NCT01185301|471269173|FG001|Overall Study|Withdrawal by Subject|5|||
130691852|NCT01808651|470497884|FG002|Study Period 1|Physician Decision|0|||
130691853|NCT01808651|470497882|FG000|Study Period 1|Lack of Efficacy|2|||
130691854|NCT01808651|470497883|FG001|Study Period 1|Lack of Efficacy|1|||
130691855|NCT01808651|470497884|FG002|Study Period 1|Lack of Efficacy|0|||
130691856|NCT01808651|470497882|FG000|Study Period 1|Adverse Event|10|||
130691857|NCT01808651|470497883|FG001|Study Period 1|Adverse Event|4|||
130691858|NCT01808651|470497884|FG002|Study Period 1|Adverse Event|1|||
130691859|NCT01808651|470497882|FG000|Study Period 1|Participant Decision|9|||
130691860|NCT01808651|470497883|FG001|Study Period 1|Participant Decision|7|||
130691861|NCT01808651|470497884|FG002|Study Period 1|Participant Decision|3|||
130691862|NCT00585286|470497888|FG000|Overall Study|Lost to Follow-up|1|||
130691863|NCT03957551|470497889|FG000|Overall Study|Adverse Event|2|||
130691864|NCT03957551|470497890|FG001|Overall Study|Adverse Event|2|||
130691865|NCT03957551|470497891|FG002|Overall Study|Adverse Event|6|||
130691866|NCT03957551|470497889|FG000|Overall Study|Physician Decision|1|||
130899997|NCT01185301|471269174|FG002|Overall Study|Withdrawal by Subject|2|||
130899998|NCT01185301|471269175|FG003|Overall Study|Withdrawal by Subject|3|||
130899999|NCT01185301|471269172|FG000|Overall Study|Lost to Follow-up|2|||
130900000|NCT01185301|471269173|FG001|Overall Study|Lost to Follow-up|0|||
130900001|NCT01185301|471269174|FG002|Overall Study|Lost to Follow-up|0|||
130900002|NCT01185301|471269175|FG003|Overall Study|Lost to Follow-up|1|||
130691867|NCT03957551|470497890|FG001|Overall Study|Physician Decision|0|||
130691868|NCT03957551|470497891|FG002|Overall Study|Physician Decision|2|||
130691869|NCT03957551|470497889|FG000|Overall Study|Withdrawal by Subject|1|||
130691870|NCT03957551|470497890|FG001|Overall Study|Withdrawal by Subject|0|||
130691871|NCT03957551|470497891|FG002|Overall Study|Withdrawal by Subject|2|||
130691872|NCT03957551|470497889|FG000|Overall Study|Disease progression|1|||
130691873|NCT03957551|470497890|FG001|Overall Study|Disease progression|0|||
130691874|NCT03957551|470497891|FG002|Overall Study|Disease progression|8|||
130691875|NCT02294981|470497899|FG000|Overall Study|Lost to Follow-up|1|||
130900003|NCT01185301|471269172|FG000|Overall Study|Other Reason|3|||
130900004|NCT01185301|471269173|FG001|Overall Study|Other Reason|2|||
131025764|NCT03398148|471725295|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
131025765|NCT03398148|471725296|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
130691876|NCT00829712|470497900|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130691877|NCT00829712|470497901|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130691878|NCT00606281|470497902|FG000|Overall Study|Adverse Event|11|||
130691879|NCT00606281|470497903|FG001|Overall Study|Adverse Event|12|||
130691880|NCT00606281|470497902|FG000|Overall Study|Death|1|||
130691881|NCT00606281|470497903|FG001|Overall Study|Death|0|||
130691882|NCT00606281|470497902|FG000|Overall Study|Lack of Efficacy|28|||
130691883|NCT00606281|470497903|FG001|Overall Study|Lack of Efficacy|35|||
130691884|NCT00606281|470497902|FG000|Overall Study|Physician Decision|0|||
130691885|NCT00606281|470497903|FG001|Overall Study|Physician Decision|1|||
130691886|NCT00606281|470497902|FG000|Overall Study|Protocol Violation|3|||
130691887|NCT00606281|470497903|FG001|Overall Study|Protocol Violation|3|||
130691888|NCT00606281|470497902|FG000|Overall Study|Withdrawal by Subject|11|||
130691889|NCT00606281|470497903|FG001|Overall Study|Withdrawal by Subject|13|||
130691890|NCT00606281|470497902|FG000|Overall Study|Progression to depressive phase|1|||
130691891|NCT00606281|470497903|FG001|Overall Study|Progression to depressive phase|1|||
130691892|NCT00606281|470497902|FG000|Overall Study|Change of residence or other commitments|1|||
130691893|NCT00606281|470497903|FG001|Overall Study|Change of residence or other commitments|1|||
130691894|NCT00263588|470497904|FG000|Overall Study|Death|54|||
130691895|NCT00263588|470497905|FG001|Overall Study|Death|90|||
130691896|NCT00263588|470497904|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
130691897|NCT00263588|470497905|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
130691898|NCT00263588|470497904|FG000|Overall Study|Lost to Follow-up|7|||
131025766|NCT03398148|471725297|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
131025767|NCT03398148|471725298|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
131025768|NCT03398148|471725299|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
131025769|NCT03398148|471725300|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
130691899|NCT00263588|470497905|FG001|Overall Study|Lost to Follow-up|10|||
130691900|NCT00263588|470497904|FG000|Overall Study|Withdrawal by Subject|3|||
130691901|NCT00263588|470497905|FG001|Overall Study|Withdrawal by Subject|4|||
130691902|NCT00263588|470497904|FG000|Overall Study|Protocol Violation|0|||
130691903|NCT00263588|470497905|FG001|Overall Study|Protocol Violation|1|||
130900005|NCT01185301|471269174|FG002|Overall Study|Other Reason|2|||
130900006|NCT01185301|471269175|FG003|Overall Study|Other Reason|2|||
131025770|NCT03398148|471725301|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
131025771|NCT03398148|471725302|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
130691904|NCT00263588|470497904|FG000|Overall Study|Investigator decision|7|||
130691905|NCT00263588|470497905|FG001|Overall Study|Investigator decision|15|||
130691906|NCT00263588|470497904|FG000|Overall Study|Sponsor terminated study|0|||
130691907|NCT00263588|470497905|FG001|Overall Study|Sponsor terminated study|1|||
130691908|NCT00918684|470497906|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
130900007|NCT01989468|471269180|FG000|Overall Study|Adverse Event|10|||
130900008|NCT01989468|471269181|FG001|Overall Study|Adverse Event|15|||
130691909|NCT00918684|470497906|FG000|Treatment Phase|Lack of Efficacy|6|||
130691910|NCT00918684|470497906|FG000|Treatment Phase|Lost to Follow-up|2|||
130691911|NCT00918684|470497906|FG000|Treatment Phase|Physician Decision|8|||
130691912|NCT00918684|470497906|FG000|Treatment Phase|Protocol Violation|1|||
130691913|NCT00918684|470497906|FG000|Treatment Phase|Withdrawal by Subject|8|||
130691914|NCT00909038|470497907|FG000|Overall Study|Protocol Violation|187|||
130691915|NCT00909038|470497907|FG000|Overall Study|Non-evaluable Subjects|230|||
130691916|NCT00484679|470497910|FG000|Overall Study|Withdrawal by Subject|3|||
130691917|NCT00402103|470497911|FG000|Overall Study|Adverse Event|60|||
130691918|NCT00402103|470497912|FG001|Overall Study|Adverse Event|7|||
130691919|NCT00402103|470497911|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130691920|NCT00402103|470497912|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130691921|NCT00402103|470497911|FG000|Overall Study|Condition no longer requires study drug|2|||
130691922|NCT00402103|470497912|FG001|Overall Study|Condition no longer requires study drug|0|||
130691923|NCT00402103|470497911|FG000|Overall Study|Protocol Deviation|8|||
130691924|NCT00402103|470497912|FG001|Overall Study|Protocol Deviation|0|||
130691925|NCT00402103|470497911|FG000|Overall Study|Patient withdrew consent|12|||
130691926|NCT00402103|470497912|FG001|Overall Study|Patient withdrew consent|1|||
130691927|NCT00402103|470497911|FG000|Overall Study|Lost to Follow-up|6|||
130691928|NCT00402103|470497912|FG001|Overall Study|Lost to Follow-up|3|||
130691929|NCT00402103|470497911|FG000|Overall Study|Administrative problems|2|||
130691930|NCT00402103|470497912|FG001|Overall Study|Administrative problems|0|||
130691931|NCT00835692|470497913|FG000|First Intervention|Withdrawal by Subject|1|||
130691932|NCT00835692|470497914|FG001|First Intervention|Withdrawal by Subject|0|||
130691933|NCT04345653|470497917|FG000|Overall Study|Withdrawal by Subject|2|||
130900009|NCT01989468|471269182|FG002|Overall Study|Adverse Event|4|||
130900010|NCT01989468|471269183|FG003|Overall Study|Adverse Event|5|||
130900011|NCT01989468|471269184|FG004|Overall Study|Adverse Event|4|||
130900012|NCT01989468|471269180|FG000|Overall Study|Lack of Efficacy|11|||
130900013|NCT01989468|471269181|FG001|Overall Study|Lack of Efficacy|11|||
130900014|NCT01989468|471269182|FG002|Overall Study|Lack of Efficacy|7|||
130900015|NCT01989468|471269183|FG003|Overall Study|Lack of Efficacy|4|||
130900016|NCT01989468|471269184|FG004|Overall Study|Lack of Efficacy|2|||
130900017|NCT01989468|471269180|FG000|Overall Study|Lost to Follow-up|5|||
130900018|NCT01989468|471269181|FG001|Overall Study|Lost to Follow-up|2|||
130900019|NCT01989468|471269182|FG002|Overall Study|Lost to Follow-up|0|||
130900020|NCT01989468|471269183|FG003|Overall Study|Lost to Follow-up|1|||
130900021|NCT01989468|471269184|FG004|Overall Study|Lost to Follow-up|1|||
130900022|NCT01989468|471269180|FG000|Overall Study|Physician Decision|4|||
130900023|NCT01989468|471269181|FG001|Overall Study|Physician Decision|1|||
130900024|NCT01989468|471269182|FG002|Overall Study|Physician Decision|0|||
130900025|NCT01989468|471269183|FG003|Overall Study|Physician Decision|1|||
131025772|NCT03398148|471725303|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
131025773|NCT03398148|471725304|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
131025774|NCT03398148|471725305|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
131025775|NCT03398148|471725291|FG000|Substudy 2 Period 2|Adverse Event|0|||
131025776|NCT03398148|471725292|FG001|Substudy 2 Period 2|Adverse Event|0|||
131025777|NCT03398148|471725293|FG002|Substudy 2 Period 2|Adverse Event|0|||
131025778|NCT03398148|471725294|FG003|Substudy 2 Period 2|Adverse Event|0|||
131025779|NCT03398148|471725295|FG004|Substudy 2 Period 2|Adverse Event|0|||
131025780|NCT03398148|471725296|FG005|Substudy 2 Period 2|Adverse Event|0|||
131025781|NCT03398148|471725297|FG006|Substudy 2 Period 2|Adverse Event|0|||
131025782|NCT03398148|471725298|FG007|Substudy 2 Period 2|Adverse Event|0|||
131025783|NCT03398148|471725299|FG008|Substudy 2 Period 2|Adverse Event|0|||
131025784|NCT03398148|471725300|FG009|Substudy 2 Period 2|Adverse Event|0|||
131025785|NCT03398148|471725301|FG010|Substudy 2 Period 2|Adverse Event|0|||
131025786|NCT03398148|471725302|FG011|Substudy 2 Period 2|Adverse Event|0|||
131025787|NCT03398148|471725303|FG012|Substudy 2 Period 2|Adverse Event|0|||
131025788|NCT03398148|471725304|FG013|Substudy 2 Period 2|Adverse Event|1|||
131025789|NCT03398148|471725305|FG014|Substudy 2 Period 2|Adverse Event|3|||
130691934|NCT04078022|470497918|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
130691935|NCT04078022|470497919|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
130691936|NCT01895335|470497924|FG000|Overall Study|Adverse Event|106|||
130900026|NCT01989468|471269184|FG004|Overall Study|Physician Decision|0|||
131025790|NCT03398148|471725291|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
131025791|NCT03398148|471725292|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
131025792|NCT03398148|471725293|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
131025793|NCT03398148|471725294|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
131025794|NCT03398148|471725295|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
130691937|NCT01895335|470497924|FG000|Overall Study|Lack of Efficacy|53|||
130900027|NCT01989468|471269180|FG000|Overall Study|Pregnancy|0|||
130900028|NCT01989468|471269181|FG001|Overall Study|Pregnancy|1|||
130900029|NCT01989468|471269182|FG002|Overall Study|Pregnancy|0|||
130900030|NCT01989468|471269183|FG003|Overall Study|Pregnancy|0|||
131025795|NCT03398148|471725296|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
130691938|NCT01895335|470497924|FG000|Overall Study|Poor Compliance to Protocol|11|||
130900031|NCT01989468|471269184|FG004|Overall Study|Pregnancy|0|||
130900032|NCT01989468|471269180|FG000|Overall Study|Technical Problems|3|||
130900033|NCT01989468|471269181|FG001|Overall Study|Technical Problems|1|||
130900034|NCT01989468|471269182|FG002|Overall Study|Technical Problems|3|||
130900035|NCT01989468|471269183|FG003|Overall Study|Technical Problems|1|||
130900036|NCT01989468|471269184|FG004|Overall Study|Technical Problems|0|||
130900037|NCT01989468|471269180|FG000|Overall Study|Subject Guardian Decision|11|||
130900038|NCT01989468|471269181|FG001|Overall Study|Subject Guardian Decision|6|||
130900039|NCT01989468|471269182|FG002|Overall Study|Subject Guardian Decision|4|||
130900040|NCT01989468|471269183|FG003|Overall Study|Subject Guardian Decision|4|||
130900041|NCT01989468|471269184|FG004|Overall Study|Subject Guardian Decision|1|||
130900042|NCT01989468|471269180|FG000|Overall Study|Death|3|||
130900043|NCT01989468|471269181|FG001|Overall Study|Death|0|||
130900044|NCT01989468|471269182|FG002|Overall Study|Death|1|||
130900045|NCT01989468|471269183|FG003|Overall Study|Death|0|||
130900046|NCT01989468|471269184|FG004|Overall Study|Death|0|||
130900047|NCT02112045|471269190|FG000|Overall Study|Withdrawal by Subject|1|||
130900048|NCT02112045|471269191|FG001|Overall Study|Withdrawal by Subject|0|||
130900049|NCT00977080|471269192|FG000|Overall Study|Adverse Event|2|||
130900050|NCT00977080|471269193|FG001|Overall Study|Adverse Event|7|||
130900051|NCT00977080|471269194|FG002|Overall Study|Adverse Event|7|||
130900052|NCT00977080|471269195|FG003|Overall Study|Adverse Event|7|||
130900053|NCT00977080|471269192|FG000|Overall Study|Withdrawal by Subject|1|||
130900054|NCT00977080|471269193|FG001|Overall Study|Withdrawal by Subject|5|||
130900055|NCT00977080|471269194|FG002|Overall Study|Withdrawal by Subject|1|||
130900056|NCT00977080|471269195|FG003|Overall Study|Withdrawal by Subject|5|||
130900057|NCT00977080|471269192|FG000|Overall Study|Protocol Violation|7|||
131025796|NCT03398148|471725297|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
131025797|NCT03398148|471725298|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
131025798|NCT03398148|471725299|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
131025799|NCT03398148|471725300|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
131025800|NCT03398148|471725301|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
131025801|NCT03398148|471725302|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
131025802|NCT03398148|471725303|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
131025803|NCT03398148|471725304|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
131025804|NCT03398148|471725305|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
131025805|NCT03398148|471725291|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025806|NCT03398148|471725292|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025807|NCT03398148|471725293|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025808|NCT03398148|471725294|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025809|NCT03398148|471725295|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025810|NCT03398148|471725296|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025811|NCT03398148|471725297|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025812|NCT03398148|471725298|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025813|NCT03398148|471725299|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025814|NCT03398148|471725300|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025815|NCT03398148|471725301|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025816|NCT03398148|471725302|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
131025817|NCT03398148|471725303|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
131025818|NCT03398148|471725304|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
131025819|NCT03398148|471725305|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
131025820|NCT03398148|471725291|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
131025821|NCT03398148|471725292|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
131025822|NCT03398148|471725293|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
131025823|NCT03398148|471725294|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
131025824|NCT03398148|471725295|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
131025825|NCT03398148|471725296|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
131025826|NCT03398148|471725297|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
131025827|NCT03398148|471725298|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
131025828|NCT03398148|471725299|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
131025829|NCT03398148|471725300|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
131025830|NCT03398148|471725301|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
131025831|NCT03398148|471725302|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
131025832|NCT03398148|471725303|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
131025833|NCT03398148|471725304|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
131025834|NCT03398148|471725305|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
131025835|NCT03398148|471725291|FG000|Substudy 2 Period 2|Other|0|||
131025836|NCT03398148|471725292|FG001|Substudy 2 Period 2|Other|0|||
131025837|NCT03398148|471725293|FG002|Substudy 2 Period 2|Other|0|||
130767963|NCT01969084|470773954|FG001|Overall Study|Adverse Event|1|||
131025838|NCT03398148|471725294|FG003|Substudy 2 Period 2|Other|0|||
131025839|NCT03398148|471725295|FG004|Substudy 2 Period 2|Other|0|||
131025840|NCT03398148|471725296|FG005|Substudy 2 Period 2|Other|0|||
131025841|NCT03398148|471725297|FG006|Substudy 2 Period 2|Other|0|||
130900058|NCT00977080|471269193|FG001|Overall Study|Protocol Violation|3|||
130900059|NCT00977080|471269194|FG002|Overall Study|Protocol Violation|4|||
130900060|NCT00977080|471269195|FG003|Overall Study|Protocol Violation|3|||
130900061|NCT00977080|471269192|FG000|Overall Study|Noncompliance|0|||
130900062|NCT00977080|471269193|FG001|Overall Study|Noncompliance|2|||
130900063|NCT00977080|471269194|FG002|Overall Study|Noncompliance|1|||
130691939|NCT01895335|470497924|FG000|Overall Study|Included But Not treated|1|||
130691940|NCT01895335|470497924|FG000|Overall Study|Other than Specified Above|44|||
130691941|NCT00418938|470497925|FG000|Overall Study|Reimbursement|1|||
130691942|NCT00418938|470497926|FG001|Overall Study|Reimbursement|0|||
130691943|NCT00418938|470497925|FG000|Overall Study|Administrative decision|3|||
130691944|NCT00418938|470497926|FG001|Overall Study|Administrative decision|3|||
130691945|NCT00418938|470497925|FG000|Overall Study|Withdrawal by Subject|16|||
130691946|NCT00418938|470497926|FG001|Overall Study|Withdrawal by Subject|15|||
131112400|NCT00475033|472041075|FG001|Toddler Dose|Parent or legal guardian request|0|||
131112401|NCT00475033|472041074|FG000|Toddler Dose|Failed to return|1|||
130691947|NCT00418938|470497925|FG000|Overall Study|Lost to Follow-up|1|||
130691948|NCT00418938|470497926|FG001|Overall Study|Lost to Follow-up|3|||
130691949|NCT00418938|470497925|FG000|Overall Study|Adverse Event|1|||
130691950|NCT00418938|470497926|FG001|Overall Study|Adverse Event|1|||
130691951|NCT00418938|470497925|FG000|Overall Study|On-going|1|||
130691952|NCT00418938|470497926|FG001|Overall Study|On-going|1|||
130691953|NCT00418938|470497925|FG000|Overall Study|Ineligibility Determined|1|||
130691954|NCT00418938|470497926|FG001|Overall Study|Ineligibility Determined|0|||
130691955|NCT00115063|470497927|FG000|Overall Study|Lost to Follow-up|98|||
130691956|NCT00115063|470497928|FG001|Overall Study|Lost to Follow-up|104|||
130900064|NCT00977080|471269195|FG003|Overall Study|Noncompliance|0|||
130900065|NCT00977080|471269192|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
130900066|NCT00977080|471269193|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
130900067|NCT00977080|471269194|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
130900068|NCT00977080|471269195|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
130900069|NCT00977080|471269192|FG000|Overall Study|Required kidney transplantation|1|||
130900070|NCT00977080|471269193|FG001|Overall Study|Required kidney transplantation|3|||
130900071|NCT00977080|471269194|FG002|Overall Study|Required kidney transplantation|3|||
130900072|NCT00977080|471269195|FG003|Overall Study|Required kidney transplantation|1|||
130900073|NCT00977080|471269192|FG000|Overall Study|Travel for family reasons|1|||
131112402|NCT00475033|472041075|FG001|Toddler Dose|Failed to return|0|||
131112403|NCT00475033|472041074|FG000|Toddler Dose|Lost to Follow-up|1|||
131112404|NCT00475033|472041075|FG001|Toddler Dose|Lost to Follow-up|0|||
131112405|NCT03444324|472041076|FG000|Overall Study|Withdrawal by Subject|0|||
131112406|NCT03444324|472041077|FG001|Overall Study|Withdrawal by Subject|1|||
131112407|NCT03444324|472041076|FG000|Overall Study|Lost to Follow-up|4|||
130691957|NCT00115063|470497927|FG000|Overall Study|Death|1|||
130691958|NCT00115063|470497928|FG001|Overall Study|Death|0|||
130691959|NCT01075282|470497929|FG000|Overall Study|Withdrawal by Subject|11|||
130691960|NCT01075282|470497930|FG001|Overall Study|Withdrawal by Subject|7|||
130691961|NCT01075282|470497931|FG002|Overall Study|Withdrawal by Subject|11|||
130691962|NCT01075282|470497929|FG000|Overall Study|Adverse Event|9|||
130691963|NCT01075282|470497930|FG001|Overall Study|Adverse Event|8|||
130691964|NCT01075282|470497931|FG002|Overall Study|Adverse Event|5|||
130691965|NCT01075282|470497929|FG000|Overall Study|Entry Criteria Not Met|3|||
130691966|NCT01075282|470497930|FG001|Overall Study|Entry Criteria Not Met|2|||
130691967|NCT01075282|470497931|FG002|Overall Study|Entry Criteria Not Met|0|||
130691968|NCT01075282|470497929|FG000|Overall Study|Lost to Follow-up|3|||
130691969|NCT01075282|470497930|FG001|Overall Study|Lost to Follow-up|3|||
130691970|NCT01075282|470497931|FG002|Overall Study|Lost to Follow-up|3|||
130691971|NCT01075282|470497929|FG000|Overall Study|Physician Decision|3|||
130691972|NCT01075282|470497930|FG001|Overall Study|Physician Decision|3|||
130691973|NCT01075282|470497931|FG002|Overall Study|Physician Decision|3|||
130691974|NCT01075282|470497929|FG000|Overall Study|Lack of Efficacy|1|||
130691975|NCT01075282|470497930|FG001|Overall Study|Lack of Efficacy|1|||
131112408|NCT03444324|472041077|FG001|Overall Study|Lost to Follow-up|2|||
131112409|NCT03444324|472041076|FG000|Overall Study|Protocol Violation|0|||
131112410|NCT03444324|472041077|FG001|Overall Study|Protocol Violation|1|||
131112411|NCT03444324|472041076|FG000|Overall Study|Lack of Trial Compliance|1|||
131112412|NCT03444324|472041077|FG001|Overall Study|Lack of Trial Compliance|1|||
131112413|NCT03444324|472041076|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
131112414|NCT03444324|472041077|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
130691976|NCT01075282|470497931|FG002|Overall Study|Lack of Efficacy|0|||
130691977|NCT01075282|470497929|FG000|Overall Study|Treatment Non-compliance|1|||
130691978|NCT01075282|470497930|FG001|Overall Study|Treatment Non-compliance|2|||
130691979|NCT01075282|470497931|FG002|Overall Study|Treatment Non-compliance|2|||
130691980|NCT01075282|470497929|FG000|Overall Study|Protocol Violation|0|||
130767964|NCT00862459|470773957|FG000|Overall Study|Lost to Follow-up|1|||
130767965|NCT00862459|470773958|FG001|Overall Study|Lost to Follow-up|2|||
130900074|NCT00977080|471269193|FG001|Overall Study|Travel for family reasons|0|||
130900075|NCT00977080|471269194|FG002|Overall Study|Travel for family reasons|0|||
130900076|NCT00977080|471269195|FG003|Overall Study|Travel for family reasons|0|||
130691981|NCT01075282|470497930|FG001|Overall Study|Protocol Violation|2|||
130691982|NCT01075282|470497931|FG002|Overall Study|Protocol Violation|1|||
130691983|NCT01075282|470497929|FG000|Overall Study|Death|0|||
130691984|NCT01075282|470497930|FG001|Overall Study|Death|1|||
130691985|NCT01075282|470497931|FG002|Overall Study|Death|2|||
130900077|NCT02509117|471269201|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130900078|NCT02509117|471269202|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
130900079|NCT02509117|471269203|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130900080|NCT02509117|471269204|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130900081|NCT02509117|471269205|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130900082|NCT02509117|471269206|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130900083|NCT02509117|471269207|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130900084|NCT02509117|471269208|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130900085|NCT02509117|471269209|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130900086|NCT02509117|471269210|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130900087|NCT02509117|471269201|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130900088|NCT02509117|471269202|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130900089|NCT02509117|471269203|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130900090|NCT02509117|471269204|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130900091|NCT02509117|471269205|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130900092|NCT02509117|471269206|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130900093|NCT02509117|471269207|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130900094|NCT02509117|471269208|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130900095|NCT02509117|471269209|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
131222726|NCT00720304|472443166|FG000|Overall Study|Adverse Event|3|||
130691986|NCT00700739|470497932|FG000|Overall Study|Lost to Follow-up|4|||
130691987|NCT00700739|470497933|FG001|Overall Study|Lost to Follow-up|4|||
130691988|NCT01316055|470497941|FG000|Overall Study|Lost to Follow-up|1|||
130691989|NCT01316055|470497942|FG001|Overall Study|Lost to Follow-up|0|||
130691990|NCT01316055|470497943|FG002|Overall Study|Lost to Follow-up|0|||
130900096|NCT02509117|471269210|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
130900097|NCT02509117|471269201|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130900098|NCT02509117|471269202|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130900099|NCT02509117|471269203|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
131025842|NCT03398148|471725298|FG007|Substudy 2 Period 2|Other|0|||
131025843|NCT03398148|471725299|FG008|Substudy 2 Period 2|Other|0|||
131025844|NCT03398148|471725300|FG009|Substudy 2 Period 2|Other|0|||
130691991|NCT00003470|470497944|FG000|Overall Study|Not evaluable|6|||
130691992|NCT02679729|470497945|FG000|Overall Study|Lost to Follow-up|0|||
131025845|NCT03398148|471725301|FG010|Substudy 2 Period 2|Other|0|||
131025846|NCT03398148|471725302|FG011|Substudy 2 Period 2|Other|0|||
131025847|NCT03398148|471725303|FG012|Substudy 2 Period 2|Other|0|||
131025848|NCT03398148|471725304|FG013|Substudy 2 Period 2|Other|1|||
131025849|NCT03398148|471725305|FG014|Substudy 2 Period 2|Other|1|||
131025850|NCT03398148|471725291|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025851|NCT03398148|471725292|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025852|NCT03398148|471725293|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025853|NCT03398148|471725294|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025854|NCT03398148|471725295|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025855|NCT03398148|471725296|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025856|NCT03398148|471725297|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025857|NCT03398148|471725298|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025858|NCT03398148|471725299|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025859|NCT03398148|471725300|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025860|NCT03398148|471725301|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025861|NCT03398148|471725302|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025862|NCT03398148|471725303|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
131025863|NCT03398148|471725304|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
131025864|NCT03398148|471725305|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
131025865|NCT04278586|471725306|FG000|Overall Study|Withdrawal by Subject|13|||
131025866|NCT04278586|471725307|FG001|Overall Study|Withdrawal by Subject|6|||
131025867|NCT04278586|471725306|FG000|Overall Study|Lost to Follow-up|37|||
131025868|NCT04278586|471725307|FG001|Overall Study|Lost to Follow-up|24|||
131025869|NCT05696080|471725314|FG000|Overall Study|Lost to Follow-up|2|||
131025870|NCT05696080|471725315|FG001|Overall Study|Lost to Follow-up|1|||
131025871|NCT05696080|471725314|FG000|Overall Study|Physician Decision|1|||
131025872|NCT05696080|471725315|FG001|Overall Study|Physician Decision|0|||
131025873|NCT05696080|471725314|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131025874|NCT05696080|471725315|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131025875|NCT05696080|471725314|FG000|Overall Study|Withdrawal by Subject|12|||
131025876|NCT05696080|471725315|FG001|Overall Study|Withdrawal by Subject|0|||
131025877|NCT05478525|471725316|FG000|Overall Study|Withdrawal by Subject|0|||
131025878|NCT05478525|471725317|FG001|Overall Study|Withdrawal by Subject|1|||
131025879|NCT05478525|471725318|FG002|Overall Study|Withdrawal by Subject|2|||
130900100|NCT02509117|471269204|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130900101|NCT02509117|471269205|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130900102|NCT02509117|471269206|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130900103|NCT02509117|471269207|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130900104|NCT02509117|471269208|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130900105|NCT02509117|471269209|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130691993|NCT02679729|470497946|FG001|Overall Study|Lost to Follow-up|1|||
130691994|NCT02679729|470497947|FG002|Overall Study|Lost to Follow-up|0|||
130691995|NCT02679729|470497948|FG003|Overall Study|Lost to Follow-up|0|||
130691996|NCT02679729|470497949|FG004|Overall Study|Lost to Follow-up|1|||
130691997|NCT02679729|470497950|FG005|Overall Study|Lost to Follow-up|0|||
130691998|NCT02679729|470497951|FG006|Overall Study|Lost to Follow-up|0|||
130691999|NCT02679729|470497952|FG007|Overall Study|Lost to Follow-up|0|||
130692000|NCT02679729|470497953|FG008|Overall Study|Lost to Follow-up|0|||
130692001|NCT02679729|470497945|FG000|Overall Study|Participant decision|0|||
130900106|NCT02509117|471269210|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
130900107|NCT00548184|471269211|FG000|Overall Study|Adverse Event|3|||
130900108|NCT00548184|471269211|FG000|Overall Study|took other drug|1|||
130900109|NCT00548184|471269211|FG000|Overall Study|Found Her2 negative|1|||
131112415|NCT06515483|472041078|FG000|Overall Study|Subject withdraw due to family issues|1|||
131112416|NCT06515483|472041079|FG001|Overall Study|Subject withdraw due to family issues|0|||
131112417|NCT00568321|472042368|FG000|Overall Study|Adverse Event|1|||
131112418|NCT00568321|472042369|FG001|Overall Study|Adverse Event|0|||
131112419|NCT00568321|472042370|FG002|Overall Study|Adverse Event|0|||
131112420|NCT00568321|472042368|FG000|Overall Study|Lack of Efficacy|8|||
131112421|NCT00568321|472042369|FG001|Overall Study|Lack of Efficacy|5|||
131112422|NCT00568321|472042370|FG002|Overall Study|Lack of Efficacy|6|||
131112423|NCT00568321|472042368|FG000|Overall Study|Lost to Follow-up|0|||
131112424|NCT00568321|472042369|FG001|Overall Study|Lost to Follow-up|0|||
131112425|NCT00568321|472042370|FG002|Overall Study|Lost to Follow-up|1|||
131112426|NCT00568321|472042368|FG000|Overall Study|Withdrawal by Subject|2|||
131112427|NCT00568321|472042369|FG001|Overall Study|Withdrawal by Subject|0|||
131112428|NCT00568321|472042370|FG002|Overall Study|Withdrawal by Subject|0|||
131112429|NCT00568321|472042368|FG000|Overall Study|Protocol Violation|0|||
131112430|NCT00568321|472042369|FG001|Overall Study|Protocol Violation|0|||
131112431|NCT00568321|472042370|FG002|Overall Study|Protocol Violation|1|||
131112432|NCT00568321|472042368|FG000|Overall Study|Randomized, not treated|2|||
131112433|NCT00568321|472042369|FG001|Overall Study|Randomized, not treated|0|||
131112434|NCT00568321|472042370|FG002|Overall Study|Randomized, not treated|1|||
131112435|NCT01676909|472042371|FG000|Overall Study|Withdrawal by Subject|3|||
131112436|NCT01676909|472042372|FG001|Overall Study|Withdrawal by Subject|5|||
131112437|NCT01676909|472042371|FG000|Overall Study|Lost to Follow-up|15|||
131112438|NCT01676909|472042372|FG001|Overall Study|Lost to Follow-up|9|||
131112439|NCT00162032|472042373|FG000|Overall Study|Lost to Follow-up|4|||
131112440|NCT00162032|472042374|FG001|Overall Study|Lost to Follow-up|2|||
131112441|NCT00162032|472042373|FG000|Overall Study|Reason not specified|1|||
131112442|NCT00162032|472042374|FG001|Overall Study|Reason not specified|0|||
131112443|NCT01176968|472042375|FG000|Overall Study|Adverse Event|10|||
131112444|NCT01176968|472042376|FG001|Overall Study|Adverse Event|11|||
131112445|NCT01176968|472042375|FG000|Overall Study|Death|2|||
131112446|NCT01176968|472042376|FG001|Overall Study|Death|3|||
131112447|NCT01176968|472042375|FG000|Overall Study|Lack of Efficacy|0|||
131112448|NCT01176968|472042376|FG001|Overall Study|Lack of Efficacy|1|||
131112449|NCT01176968|472042375|FG000|Overall Study|Lost to Follow-up|16|||
131112450|NCT01176968|472042376|FG001|Overall Study|Lost to Follow-up|14|||
131112451|NCT01176968|472042375|FG000|Overall Study|Withdrawal by Subject|48|||
131112452|NCT01176968|472042376|FG001|Overall Study|Withdrawal by Subject|48|||
131112453|NCT01176968|472042375|FG000|Overall Study|Protocol Violation|2|||
131112454|NCT01176968|472042376|FG001|Overall Study|Protocol Violation|1|||
131112455|NCT01176968|472042375|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
131112456|NCT01176968|472042376|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
130692002|NCT02679729|470497946|FG001|Overall Study|Participant decision|1|||
130692003|NCT02679729|470497947|FG002|Overall Study|Participant decision|0|||
130692004|NCT02679729|470497948|FG003|Overall Study|Participant decision|0|||
130900110|NCT00946985|471269212|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
130900111|NCT00946985|471269212|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
130900112|NCT00946985|471269212|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
131112457|NCT01176968|472042375|FG000|Overall Study|Study terminated by sponsor|0|||
130692005|NCT02679729|470497949|FG004|Overall Study|Participant decision|0|||
131112458|NCT01176968|472042376|FG001|Overall Study|Study terminated by sponsor|1|||
131112459|NCT01176968|472042375|FG000|Overall Study|Reason not defined|5|||
131112460|NCT01176968|472042376|FG001|Overall Study|Reason not defined|3|||
131112461|NCT00833911|472042377|FG000|Titration|Adverse Event|18|||
131112462|NCT00833911|472042377|FG000|Titration|Withdrawal by Subject|3|||
131112463|NCT00833911|472042377|FG000|Maintenance Phase I|Adverse Event|73|||
131112464|NCT00833911|472042377|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
130767966|NCT00862459|470773959|FG002|Overall Study|Lost to Follow-up|2|||
130767967|NCT00862459|470773957|FG000|Overall Study|Protocol Violation|1|||
130767968|NCT00862459|470773958|FG001|Overall Study|Protocol Violation|0|||
130767969|NCT00862459|470773959|FG002|Overall Study|Protocol Violation|0|||
130767970|NCT00862459|470773957|FG000|Overall Study|Withdrawal by Subject|1|||
130767971|NCT00862459|470773958|FG001|Overall Study|Withdrawal by Subject|1|||
130767972|NCT00862459|470773959|FG002|Overall Study|Withdrawal by Subject|3|||
130767973|NCT00862459|470773957|FG000|Overall Study|Adverse Event|0|||
130767974|NCT00862459|470773958|FG001|Overall Study|Adverse Event|1|||
130767975|NCT00862459|470773959|FG002|Overall Study|Adverse Event|0|||
130767976|NCT00862459|470773957|FG000|Overall Study|Personal reasons|1|||
130767977|NCT00862459|470773958|FG001|Overall Study|Personal reasons|0|||
130767978|NCT00862459|470773959|FG002|Overall Study|Personal reasons|0|||
130767979|NCT00862459|470773957|FG000|Overall Study|Operation|1|||
130767980|NCT00862459|470773958|FG001|Overall Study|Operation|1|||
130767981|NCT00862459|470773959|FG002|Overall Study|Operation|0|||
130767982|NCT00862459|470773957|FG000|Overall Study|Intravenous (IV) site problems|1|||
130767983|NCT00862459|470773958|FG001|Overall Study|Intravenous (IV) site problems|0|||
130767984|NCT00862459|470773959|FG002|Overall Study|Intravenous (IV) site problems|1|||
130767985|NCT00862459|470773957|FG000|Overall Study|Unable to hold still for imaging|0|||
130767986|NCT00862459|470773958|FG001|Overall Study|Unable to hold still for imaging|1|||
130767987|NCT00862459|470773959|FG002|Overall Study|Unable to hold still for imaging|0|||
130767988|NCT00862459|470773957|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
130767989|NCT00862459|470773958|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
130767990|NCT00862459|470773959|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
130767991|NCT00862459|470773957|FG000|Overall Study|Administrative problems|0|||
130767992|NCT00862459|470773958|FG001|Overall Study|Administrative problems|1|||
130767993|NCT00862459|470773959|FG002|Overall Study|Administrative problems|0|||
130767994|NCT02908074|470773964|FG000|Overall Study|sponsor/ICON decision|0|||
130767995|NCT02908074|470773965|FG001|Overall Study|sponsor/ICON decision|0|||
130767996|NCT02908074|470773966|FG002|Overall Study|sponsor/ICON decision|1|||
130767997|NCT02908074|470773967|FG003|Overall Study|sponsor/ICON decision|0|||
130767998|NCT02908074|470773968|FG004|Overall Study|sponsor/ICON decision|0|||
130767999|NCT02908074|470773969|FG005|Overall Study|sponsor/ICON decision|0|||
130768000|NCT02908074|470773964|FG000|Overall Study|Protocol Violation|0|||
130768001|NCT02908074|470773965|FG001|Overall Study|Protocol Violation|1|||
130768002|NCT02908074|470773966|FG002|Overall Study|Protocol Violation|0|||
130768003|NCT02908074|470773967|FG003|Overall Study|Protocol Violation|0|||
130768004|NCT02908074|470773968|FG004|Overall Study|Protocol Violation|0|||
130768005|NCT02908074|470773969|FG005|Overall Study|Protocol Violation|0|||
130768006|NCT02908074|470773964|FG000|Overall Study|Adverse Event|5|||
130768007|NCT02908074|470773965|FG001|Overall Study|Adverse Event|2|||
130768008|NCT02908074|470773966|FG002|Overall Study|Adverse Event|0|||
130768009|NCT02908074|470773967|FG003|Overall Study|Adverse Event|0|||
130768010|NCT02908074|470773968|FG004|Overall Study|Adverse Event|1|||
130768011|NCT02908074|470773969|FG005|Overall Study|Adverse Event|0|||
130768012|NCT02908074|470773964|FG000|Overall Study|AESI|1|||
130900113|NCT00946985|471269212|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
130900114|NCT00946985|471269212|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
130900115|NCT00946985|471269212|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
130900116|NCT00946985|471269212|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
130900117|NCT00946985|471269212|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
130900118|NCT00946985|471269212|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
130900119|NCT03148691|471269213|FG000|Overall Study|Protocol Violation|1|||
130900120|NCT03148691|471269214|FG001|Overall Study|Protocol Violation|2|||
130900121|NCT03148691|471269215|FG002|Overall Study|Protocol Violation|7|||
130900122|NCT03148691|471269213|FG000|Overall Study|Lost to Follow-up|0|||
130900123|NCT03148691|471269214|FG001|Overall Study|Lost to Follow-up|0|||
130900124|NCT03148691|471269215|FG002|Overall Study|Lost to Follow-up|1|||
130900125|NCT03148691|471269213|FG000|Overall Study|Other|1|||
130900126|NCT03148691|471269214|FG001|Overall Study|Other|0|||
131025880|NCT05478525|471725319|FG003|Overall Study|Withdrawal by Subject|0|||
131025881|NCT05478525|471725316|FG000|Overall Study|COVID-19 Infection|2|||
131025882|NCT05478525|471725317|FG001|Overall Study|COVID-19 Infection|0|||
130900127|NCT03148691|471269215|FG002|Overall Study|Other|0|||
130900128|NCT03148691|471269213|FG000|Overall Study|Withdrawal by Subject|1|||
131025883|NCT05478525|471725318|FG002|Overall Study|COVID-19 Infection|1|||
130768013|NCT02908074|470773965|FG001|Overall Study|AESI|0|||
130768014|NCT02908074|470773966|FG002|Overall Study|AESI|1|||
130768015|NCT02908074|470773967|FG003|Overall Study|AESI|0|||
130768016|NCT02908074|470773968|FG004|Overall Study|AESI|1|||
130768017|NCT02908074|470773969|FG005|Overall Study|AESI|0|||
130768018|NCT02908074|470773964|FG000|Overall Study|Discontinuation criteria per protocol|0|||
130768019|NCT02908074|470773965|FG001|Overall Study|Discontinuation criteria per protocol|0|||
130768020|NCT02908074|470773966|FG002|Overall Study|Discontinuation criteria per protocol|1|||
130900129|NCT03148691|471269214|FG001|Overall Study|Withdrawal by Subject|0|||
130900130|NCT03148691|471269215|FG002|Overall Study|Withdrawal by Subject|0|||
130900131|NCT00171834|471269216|FG000|Overall Study|Adverse Event|2|||
130692006|NCT02679729|470497950|FG005|Overall Study|Participant decision|0|||
130692007|NCT02679729|470497951|FG006|Overall Study|Participant decision|1|||
130692008|NCT02679729|470497952|FG007|Overall Study|Participant decision|0|||
130692009|NCT02679729|470497953|FG008|Overall Study|Participant decision|0|||
130692010|NCT03488108|470497960|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
130692011|NCT03488108|470497961|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130692012|NCT03488108|470497960|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
130692013|NCT03488108|470497961|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
130692014|NCT01348789|470497963|FG000|Overall Study|Protocol Violation|2|||
130692015|NCT01348789|470497963|FG000|Overall Study|Withdrawal by Subject|2|||
130692016|NCT03503318|470497966|FG000|Overall Study|Death|1|||
130692017|NCT03503318|470497967|FG001|Overall Study|Death|0|||
130692018|NCT03503318|470497968|FG002|Overall Study|Death|4|||
130692019|NCT03503318|470497966|FG000|Overall Study|Adverse Event|3|||
130692020|NCT03503318|470497967|FG001|Overall Study|Adverse Event|4|||
130692021|NCT03503318|470497968|FG002|Overall Study|Adverse Event|2|||
130692022|NCT03503318|470497966|FG000|Overall Study|Withdrawal by Subject|12|||
130692023|NCT03503318|470497967|FG001|Overall Study|Withdrawal by Subject|17|||
130692024|NCT03503318|470497968|FG002|Overall Study|Withdrawal by Subject|16|||
130692025|NCT03503318|470497966|FG000|Overall Study|Protocol Violation|5|||
130692026|NCT03503318|470497967|FG001|Overall Study|Protocol Violation|0|||
130692027|NCT03503318|470497968|FG002|Overall Study|Protocol Violation|3|||
130692028|NCT03503318|470497966|FG000|Overall Study|Lost to Follow-up|17|||
130692029|NCT03503318|470497967|FG001|Overall Study|Lost to Follow-up|15|||
130900132|NCT00171834|471269217|FG001|Overall Study|Adverse Event|1|||
130900133|NCT00171834|471269218|FG002|Overall Study|Adverse Event|3|||
130900134|NCT00171834|471269219|FG003|Overall Study|Adverse Event|2|||
130900135|NCT00171834|471269220|FG004|Overall Study|Adverse Event|2|||
130900136|NCT00171834|471269221|FG005|Overall Study|Adverse Event|15|||
130900137|NCT00171834|471269222|FG006|Overall Study|Adverse Event|1|||
130900138|NCT00171834|471269216|FG000|Overall Study|Withdrawal by Subject|0|||
130900139|NCT00171834|471269217|FG001|Overall Study|Withdrawal by Subject|2|||
130900140|NCT00171834|471269218|FG002|Overall Study|Withdrawal by Subject|0|||
130900141|NCT00171834|471269219|FG003|Overall Study|Withdrawal by Subject|1|||
130692030|NCT03503318|470497968|FG002|Overall Study|Lost to Follow-up|12|||
130692031|NCT03503318|470497966|FG000|Overall Study|Other than specified|1|||
130692032|NCT03503318|470497967|FG001|Overall Study|Other than specified|3|||
130692033|NCT03503318|470497968|FG002|Overall Study|Other than specified|3|||
130692034|NCT02139826|470497975|FG000|Overall Study|Adverse Event|1|||
130768021|NCT02908074|470773967|FG003|Overall Study|Discontinuation criteria per protocol|0|||
130768022|NCT02908074|470773968|FG004|Overall Study|Discontinuation criteria per protocol|0|||
130900142|NCT00171834|471269220|FG004|Overall Study|Withdrawal by Subject|1|||
130900143|NCT00171834|471269221|FG005|Overall Study|Withdrawal by Subject|1|||
130900144|NCT00171834|471269222|FG006|Overall Study|Withdrawal by Subject|0|||
130900145|NCT00171834|471269216|FG000|Overall Study|Death from study indication|0|||
130900146|NCT00171834|471269217|FG001|Overall Study|Death from study indication|1|||
130900147|NCT00171834|471269218|FG002|Overall Study|Death from study indication|0|||
130900148|NCT00171834|471269219|FG003|Overall Study|Death from study indication|0|||
130900149|NCT00171834|471269220|FG004|Overall Study|Death from study indication|1|||
130900150|NCT00171834|471269221|FG005|Overall Study|Death from study indication|0|||
130900151|NCT00171834|471269222|FG006|Overall Study|Death from study indication|0|||
130900152|NCT00171834|471269216|FG000|Overall Study|Disease Progression|4|||
131112465|NCT00833911|472042377|FG000|Maintenance Phase I|Physician Decision|10|||
131112466|NCT00833911|472042377|FG000|Maintenance Phase I|Lack of Efficacy|4|||
131112467|NCT00833911|472042377|FG000|Maintenance Phase II|Adverse Event|6|||
131112468|NCT00833911|472042377|FG000|Maintenance Phase II|Physician Decision|2|||
130692035|NCT01825798|470497976|FG000|Overall Study|Adverse Event|1|||
130768023|NCT02908074|470773969|FG005|Overall Study|Discontinuation criteria per protocol|1|||
130768024|NCT02908074|470773964|FG000|Overall Study|Withdrawal by Subject|3|||
130768025|NCT02908074|470773965|FG001|Overall Study|Withdrawal by Subject|2|||
130768026|NCT02908074|470773966|FG002|Overall Study|Withdrawal by Subject|2|||
130768027|NCT02908074|470773967|FG003|Overall Study|Withdrawal by Subject|2|||
130692036|NCT01825798|470497977|FG001|Overall Study|Adverse Event|5|||
130692037|NCT01825798|470497976|FG000|Overall Study|Lost to Follow-up|1|||
130692038|NCT01825798|470497977|FG001|Overall Study|Lost to Follow-up|0|||
130692039|NCT00834873|470497980|FG000|First Intervention|Adverse Event|0|||
130692040|NCT00834873|470497981|FG001|First Intervention|Adverse Event|1|||
130692041|NCT05098743|470497982|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
130768028|NCT02908074|470773968|FG004|Overall Study|Withdrawal by Subject|2|||
130768029|NCT02908074|470773969|FG005|Overall Study|Withdrawal by Subject|2|||
130768030|NCT02908074|470773964|FG000|Overall Study|Lost to Follow-up|0|||
130900153|NCT00171834|471269217|FG001|Overall Study|Disease Progression|8|||
130900154|NCT00171834|471269218|FG002|Overall Study|Disease Progression|8|||
130900155|NCT00171834|471269219|FG003|Overall Study|Disease Progression|9|||
130900156|NCT00171834|471269220|FG004|Overall Study|Disease Progression|2|||
130692042|NCT05098743|470497983|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
130692043|NCT05098743|470497982|FG000|Overall Study|Lost to Follow-up|1|||
130692044|NCT05098743|470497983|FG001|Overall Study|Lost to Follow-up|2|||
130692045|NCT02911025|470497988|FG000|Overall Study|Lost to Follow-up|3|||
130692046|NCT04063878|470497991|FG000|Overall Study|Withdrawal by Subject|2|||
130692047|NCT04063878|470497991|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
130692048|NCT01473953|470497994|FG000|Overall Study|Other|1|||
130692049|NCT01473953|470497995|FG001|Overall Study|Other|0|||
130692050|NCT01473953|470497996|FG002|Overall Study|Other|0|||
130692051|NCT01473953|470497997|FG003|Overall Study|Other|0|||
130692052|NCT01473953|470497998|FG004|Overall Study|Other|0|||
130692053|NCT02358538|470497999|FG000|Through Week 26|Adverse Event|0|||
130692054|NCT02358538|470498000|FG001|Through Week 26|Adverse Event|1|||
130692055|NCT02358538|470498001|FG002|Through Week 26|Adverse Event|1|||
130692056|NCT02358538|470498002|FG003|Through Week 26|Adverse Event|2|||
130692057|NCT02358538|470497999|FG000|Through Week 26|Lack of Efficacy|1|||
130692058|NCT02358538|470498000|FG001|Through Week 26|Lack of Efficacy|1|||
130692059|NCT02358538|470498001|FG002|Through Week 26|Lack of Efficacy|3|||
130692060|NCT02358538|470498002|FG003|Through Week 26|Lack of Efficacy|3|||
130692061|NCT02358538|470497999|FG000|Through Week 26|Withdrawal by Subject|1|||
130692062|NCT02358538|470498000|FG001|Through Week 26|Withdrawal by Subject|0|||
130692063|NCT02358538|470498001|FG002|Through Week 26|Withdrawal by Subject|0|||
130692064|NCT02358538|470498002|FG003|Through Week 26|Withdrawal by Subject|0|||
130692065|NCT02358538|470497999|FG000|Through Week 26|Non-Compliance|0|||
130692066|NCT02358538|470498000|FG001|Through Week 26|Non-Compliance|0|||
130692067|NCT02358538|470498001|FG002|Through Week 26|Non-Compliance|1|||
130692068|NCT02358538|470498002|FG003|Through Week 26|Non-Compliance|0|||
130692069|NCT02358538|470497999|FG000|Through Week 26|Family did not see benefit from IP|1|||
130692070|NCT02358538|470498000|FG001|Through Week 26|Family did not see benefit from IP|0|||
130692071|NCT02358538|470498001|FG002|Through Week 26|Family did not see benefit from IP|0|||
130692072|NCT02358538|470498002|FG003|Through Week 26|Family did not see benefit from IP|0|||
130692073|NCT02358538|470497999|FG000|52 Week Extension Period|Lack of Efficacy|0|||
130692074|NCT02358538|470498000|FG001|52 Week Extension Period|Lack of Efficacy|0|||
130692075|NCT02358538|470498001|FG002|52 Week Extension Period|Lack of Efficacy|2|||
130692076|NCT02358538|470498002|FG003|52 Week Extension Period|Lack of Efficacy|4|||
130692077|NCT01494532|470498003|FG000|Overall Study|Adverse Event|4|||
130692078|NCT01494532|470498004|FG001|Overall Study|Adverse Event|1|||
130692079|NCT01494532|470498005|FG002|Overall Study|Adverse Event|8|||
130692080|NCT01494532|470498006|FG003|Overall Study|Adverse Event|6|||
130692081|NCT01494532|470498007|FG004|Overall Study|Adverse Event|5|||
130692082|NCT01494532|470498008|FG005|Overall Study|Adverse Event|0|||
130692083|NCT01494532|470498003|FG000|Overall Study|Lack of Efficacy|0|||
130692084|NCT01494532|470498004|FG001|Overall Study|Lack of Efficacy|0|||
130692085|NCT01494532|470498005|FG002|Overall Study|Lack of Efficacy|0|||
130692086|NCT01494532|470498006|FG003|Overall Study|Lack of Efficacy|0|||
130692087|NCT01494532|470498007|FG004|Overall Study|Lack of Efficacy|2|||
130692088|NCT01494532|470498008|FG005|Overall Study|Lack of Efficacy|0|||
130692089|NCT01494532|470498003|FG000|Overall Study|Protocol deviation|2|||
130692090|NCT01494532|470498004|FG001|Overall Study|Protocol deviation|1|||
130692091|NCT01494532|470498005|FG002|Overall Study|Protocol deviation|3|||
130692092|NCT01494532|470498006|FG003|Overall Study|Protocol deviation|2|||
130692093|NCT01494532|470498007|FG004|Overall Study|Protocol deviation|3|||
130692094|NCT01494532|470498008|FG005|Overall Study|Protocol deviation|0|||
130692095|NCT01494532|470498003|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130692096|NCT01494532|470498004|FG001|Overall Study|Protocol-defined stopping criteria|0|||
130692097|NCT01494532|470498005|FG002|Overall Study|Protocol-defined stopping criteria|1|||
130692098|NCT01494532|470498006|FG003|Overall Study|Protocol-defined stopping criteria|0|||
130692099|NCT01494532|470498007|FG004|Overall Study|Protocol-defined stopping criteria|0|||
130692100|NCT01494532|470498008|FG005|Overall Study|Protocol-defined stopping criteria|0|||
130692101|NCT01494532|470498003|FG000|Overall Study|Lost to Follow-up|1|||
130692102|NCT01494532|470498004|FG001|Overall Study|Lost to Follow-up|0|||
130692103|NCT01494532|470498005|FG002|Overall Study|Lost to Follow-up|0|||
130692104|NCT01494532|470498006|FG003|Overall Study|Lost to Follow-up|2|||
130692105|NCT01494532|470498007|FG004|Overall Study|Lost to Follow-up|0|||
130692106|NCT01494532|470498008|FG005|Overall Study|Lost to Follow-up|0|||
130692107|NCT01494532|470498003|FG000|Overall Study|Physician Decision|0|||
130692108|NCT01494532|470498004|FG001|Overall Study|Physician Decision|1|||
130692109|NCT01494532|470498005|FG002|Overall Study|Physician Decision|1|||
130692110|NCT01494532|470498006|FG003|Overall Study|Physician Decision|2|||
130692111|NCT01494532|470498007|FG004|Overall Study|Physician Decision|0|||
130692112|NCT01494532|470498008|FG005|Overall Study|Physician Decision|0|||
130692113|NCT01494532|470498003|FG000|Overall Study|Withdrawal by Subject|3|||
130692114|NCT01494532|470498004|FG001|Overall Study|Withdrawal by Subject|1|||
130692115|NCT01494532|470498005|FG002|Overall Study|Withdrawal by Subject|4|||
130692116|NCT01494532|470498006|FG003|Overall Study|Withdrawal by Subject|3|||
130692117|NCT01494532|470498007|FG004|Overall Study|Withdrawal by Subject|2|||
130692118|NCT01494532|470498008|FG005|Overall Study|Withdrawal by Subject|0|||
130692119|NCT02068794|470500056|FG000|Overall Study|Withdrawal by Subject|0|||
130692120|NCT02068794|470500057|FG001|Overall Study|Withdrawal by Subject|1|||
130692121|NCT02068794|470500058|FG002|Overall Study|Withdrawal by Subject|2|||
130692122|NCT02068794|470500056|FG000|Overall Study|Early Progression|1|||
130692123|NCT02068794|470500057|FG001|Overall Study|Early Progression|0|||
130692124|NCT02068794|470500058|FG002|Overall Study|Early Progression|1|||
130692125|NCT02068794|470500056|FG000|Overall Study|Ineligible|0|||
130692126|NCT02068794|470500057|FG001|Overall Study|Ineligible|0|||
130692127|NCT02068794|470500058|FG002|Overall Study|Ineligible|1|||
130692128|NCT02316548|470500060|FG000|Overall Study|Protocol Violation|0|||
130692129|NCT02316548|470500061|FG001|Overall Study|Protocol Violation|1|||
130692130|NCT01958294|470500062|FG000|Overall Study|Clinical Circumstances|2|||
130692131|NCT02566850|470500064|FG000|Overall Study|Protocol Violation|1|||
130692132|NCT02635750|470500065|FG000|Part 1, Period 2|Adverse Event|1|||
130692133|NCT02635750|470500066|FG001|Part 1, Period 2|Adverse Event|0|||
130692134|NCT02635750|470500067|FG002|Part 1, Period 2|Adverse Event|0|||
130692135|NCT00830258|470500070|FG000|First Intervention|Adverse Event|1|||
130692136|NCT00830258|470500071|FG001|First Intervention|Adverse Event|0|||
130692137|NCT00830258|470500070|FG000|Washout: 7 Days|Protocol Violation|1|||
130692138|NCT00830258|470500071|FG001|Washout: 7 Days|Protocol Violation|0|||
130692139|NCT00682461|470500076|FG000|Overall Study|Adverse Event|5|||
130692140|NCT00682461|470500077|FG001|Overall Study|Adverse Event|7|||
130692141|NCT00682461|470500076|FG000|Overall Study|Lost to Follow-up|8|||
130692142|NCT00682461|470500077|FG001|Overall Study|Lost to Follow-up|5|||
130692143|NCT00682461|470500076|FG000|Overall Study|Withdrawal by Subject|12|||
130692144|NCT00682461|470500077|FG001|Overall Study|Withdrawal by Subject|19|||
130692145|NCT00665925|470500078|FG000|Overall Study|Lack of Efficacy|10|||
130692146|NCT00665925|470500079|FG001|Overall Study|Lack of Efficacy|8|||
130692147|NCT00665925|470500080|FG002|Overall Study|Lack of Efficacy|9|||
130692148|NCT00665925|470500081|FG003|Overall Study|Lack of Efficacy|8|||
130692149|NCT00665925|470500078|FG000|Overall Study|Lost to Follow-up|1|||
130692150|NCT00665925|470500079|FG001|Overall Study|Lost to Follow-up|2|||
130692151|NCT00665925|470500080|FG002|Overall Study|Lost to Follow-up|2|||
130692152|NCT00665925|470500081|FG003|Overall Study|Lost to Follow-up|2|||
130692153|NCT00665925|470500078|FG000|Overall Study|Withdrawal by Subject|2|||
130692154|NCT00665925|470500079|FG001|Overall Study|Withdrawal by Subject|2|||
130692155|NCT00665925|470500080|FG002|Overall Study|Withdrawal by Subject|3|||
130692156|NCT00665925|470500081|FG003|Overall Study|Withdrawal by Subject|2|||
130692157|NCT00665925|470500078|FG000|Overall Study|Physician Decision|0|||
130692158|NCT00665925|470500079|FG001|Overall Study|Physician Decision|0|||
130692159|NCT00665925|470500080|FG002|Overall Study|Physician Decision|1|||
130692160|NCT00665925|470500081|FG003|Overall Study|Physician Decision|2|||
130692161|NCT00665925|470500078|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
130692162|NCT00665925|470500079|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
130692163|NCT00665925|470500080|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
130692164|NCT00665925|470500081|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
130692165|NCT00665925|470500078|FG000|Overall Study|Adverse Event|1|||
130692166|NCT00665925|470500079|FG001|Overall Study|Adverse Event|5|||
130692167|NCT00665925|470500080|FG002|Overall Study|Adverse Event|10|||
130692168|NCT00665925|470500081|FG003|Overall Study|Adverse Event|5|||
130692169|NCT00665925|470500078|FG000|Overall Study|Enrolled by mistake|0|||
130692170|NCT00665925|470500079|FG001|Overall Study|Enrolled by mistake|0|||
130692171|NCT00665925|470500080|FG002|Overall Study|Enrolled by mistake|0|||
130692172|NCT00665925|470500081|FG003|Overall Study|Enrolled by mistake|1|||
130692173|NCT00665925|470500078|FG000|Overall Study|Due to exclusion criteria|1|||
130692174|NCT00665925|470500079|FG001|Overall Study|Due to exclusion criteria|0|||
130692175|NCT00665925|470500080|FG002|Overall Study|Due to exclusion criteria|0|||
130692176|NCT00665925|470500081|FG003|Overall Study|Due to exclusion criteria|0|||
130692177|NCT04035187|470500084|FG000|Overall Study|Withdrawal by Subject|2|||
130692178|NCT04035187|470500085|FG001|Overall Study|Withdrawal by Subject|1|||
130692179|NCT04035187|470500086|FG002|Overall Study|Withdrawal by Subject|0|||
130692180|NCT04035187|470500087|FG003|Overall Study|Withdrawal by Subject|0|||
130692181|NCT04035187|470500084|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
130692182|NCT04035187|470500085|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
131222727|NCT00720304|472443167|FG001|Overall Study|Adverse Event|1|||
130692183|NCT04035187|470500086|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
130692184|NCT04035187|470500087|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
130692185|NCT01116739|470500088|FG000|Overall Study|Child had 2 years of HS|110|||
130692186|NCT01116739|470500089|FG001|Overall Study|Child had 2 years of HS|128|||
130692187|NCT01116739|470500088|FG000|Overall Study|Withdrawal by Subject|6|||
130692188|NCT01116739|470500089|FG001|Overall Study|Withdrawal by Subject|0|||
130692189|NCT01116739|470500088|FG000|Overall Study|child too young|2|||
130692190|NCT01116739|470500089|FG001|Overall Study|child too young|6|||
130692191|NCT01116739|470500088|FG000|Overall Study|child not enrolled in head start|10|||
130692192|NCT01116739|470500089|FG001|Overall Study|child not enrolled in head start|2|||
130768031|NCT02908074|470773965|FG001|Overall Study|Lost to Follow-up|1|||
130768032|NCT02908074|470773966|FG002|Overall Study|Lost to Follow-up|1|||
130768033|NCT02908074|470773967|FG003|Overall Study|Lost to Follow-up|1|||
130768034|NCT02908074|470773968|FG004|Overall Study|Lost to Follow-up|0|||
130768035|NCT02908074|470773969|FG005|Overall Study|Lost to Follow-up|1|||
131112469|NCT00833911|472042377|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
131112470|NCT00833911|472042377|FG000|Maintenance Phase II|Lack of Efficacy|1|||
131112471|NCT00718640|472042378|FG000|Overall Study|Adverse Event|4|||
131112472|NCT00718640|472042378|FG000|Overall Study|Death|1|||
130692193|NCT01116739|470500088|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
131112473|NCT00718640|472042378|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
131112474|NCT01137955|472042381|FG000|Overall Study|Withdrawal by Subject|5|||
131112475|NCT01137955|472042382|FG001|Overall Study|Withdrawal by Subject|4|||
131112476|NCT01207596|472042383|FG000|Overall Study|Physician Decision|4|||
131112477|NCT01207596|472042383|FG000|Overall Study|Lack of Efficacy|1|||
131112478|NCT01207596|472042383|FG000|Overall Study|Adverse Event|3|||
131112479|NCT01207596|472042383|FG000|Overall Study|Withdrawal by Subject|1|||
131112480|NCT00216203|472042384|FG000|Overall Study|Withdrawal by Subject|2|||
131112481|NCT04098068|472042385|FG000|Overall Study|Disease Progression|7|||
131112482|NCT04098068|472042385|FG000|Overall Study|Withdrawal by Subject|2|||
131112483|NCT04098068|472042385|FG000|Overall Study|New Cancer Diagnosis|1|||
131112484|NCT02030405|472042393|FG000|Overall Study|Withdrawal by Subject|1|||
131112485|NCT02030405|472042393|FG000|Overall Study|Lost to Follow-up|1|||
131112486|NCT00986440|472042394|FG000|Overall Study|Progressive disease|27|||
131112487|NCT00986440|472042395|FG001|Overall Study|Progressive disease|37|||
131112488|NCT00986440|472042394|FG000|Overall Study|Serious adverse event or adverse event|9|||
131112489|NCT00986440|472042395|FG001|Overall Study|Serious adverse event or adverse event|2|||
131112490|NCT00986440|472042394|FG000|Overall Study|Withdrawal by Subject|1|||
131112491|NCT00986440|472042395|FG001|Overall Study|Withdrawal by Subject|2|||
131112492|NCT00986440|472042394|FG000|Overall Study|Screen failure (not dosed)|4|||
131112493|NCT00986440|472042395|FG001|Overall Study|Screen failure (not dosed)|2|||
131112494|NCT00803270|472042396|FG000|Overall Study|Lost to Follow-up|1|||
131112495|NCT00803270|472042397|FG001|Overall Study|Lost to Follow-up|2|||
131112496|NCT00593957|472042401|FG000|Overall Study|Physician Decision|0|||
131112497|NCT00593957|472042402|FG001|Overall Study|Physician Decision|1|||
131112498|NCT00593957|472042403|FG002|Overall Study|Physician Decision|2|||
131112499|NCT00494481|472042406|FG000|Overall Study|Condition under investigation worsened|11|||
131112500|NCT00494481|472042407|FG001|Overall Study|Condition under investigation worsened|13|||
131112501|NCT00494481|472042406|FG000|Overall Study|Adverse Event|15|||
131112502|NCT00494481|472042407|FG001|Overall Study|Adverse Event|11|||
130900157|NCT00171834|471269221|FG005|Overall Study|Disease Progression|18|||
130900158|NCT00171834|471269222|FG006|Overall Study|Disease Progression|3|||
130900159|NCT00171834|471269216|FG000|Overall Study|Treatment Duration Completed|0|||
130692194|NCT01116739|470500089|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
130692195|NCT05511935|470500090|FG000|Overall Study|Lost to Follow-up|9|||
130692196|NCT05511935|470500091|FG001|Overall Study|Lost to Follow-up|27|||
130692197|NCT05090839|470500094|FG000|Overall Study|Lost to Follow-up|2|||
130692198|NCT05090839|470500095|FG001|Overall Study|Lost to Follow-up|3|||
130692199|NCT05090839|470500096|FG002|Overall Study|Lost to Follow-up|1|||
130692200|NCT05090839|470500097|FG003|Overall Study|Lost to Follow-up|1|||
130692201|NCT00334815|470500098|FG000|Overall Study|Adverse Event|3|||
130692202|NCT00334815|470500099|FG001|Overall Study|Adverse Event|2|||
130692203|NCT00334815|470500098|FG000|Overall Study|Death|0|||
130692204|NCT00334815|470500099|FG001|Overall Study|Death|2|||
130692205|NCT00334815|470500098|FG000|Overall Study|Progression|1|||
130692206|NCT00334815|470500099|FG001|Overall Study|Progression|0|||
130692207|NCT00334815|470500098|FG000|Overall Study|ineligible|1|||
130692208|NCT00334815|470500099|FG001|Overall Study|ineligible|1|||
130692209|NCT00334815|470500098|FG000|Overall Study|patient refused treatment|0|||
130692210|NCT00334815|470500099|FG001|Overall Study|patient refused treatment|1|||
131112503|NCT00494481|472042406|FG000|Overall Study|Other|1|||
131112504|NCT00494481|472042407|FG001|Overall Study|Other|0|||
130900160|NCT00171834|471269217|FG001|Overall Study|Treatment Duration Completed|0|||
130900161|NCT00171834|471269218|FG002|Overall Study|Treatment Duration Completed|1|||
130900162|NCT00171834|471269219|FG003|Overall Study|Treatment Duration Completed|0|||
131025884|NCT05478525|471725319|FG003|Overall Study|COVID-19 Infection|1|||
131025885|NCT02605837|471725323|FG000|Overall Study|Adverse Event|3|||
131025886|NCT02605837|471725324|FG001|Overall Study|Adverse Event|1|||
131112505|NCT00494481|472042406|FG000|Overall Study|Never received IP|2|||
131025887|NCT02605837|471725323|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131025888|NCT02605837|471725324|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130692211|NCT00334815|470500098|FG000|Overall Study|Physician Decision|2|||
130692212|NCT00334815|470500099|FG001|Overall Study|Physician Decision|4|||
130692213|NCT03913377|470500100|FG000|Period 1|Test Article no longer available|0|||
130692214|NCT03913377|470500101|FG001|Period 1|Test Article no longer available|1|||
130900163|NCT00171834|471269220|FG004|Overall Study|Treatment Duration Completed|2|||
131112506|NCT00494481|472042407|FG001|Overall Study|Never received IP|0|||
131112507|NCT02973048|472042408|FG000|Overall Study|Epidural catheter insertion failure|1|||
131222728|NCT00720304|472443166|FG000|Overall Study|Disease progression|6|||
130692215|NCT03913377|470500102|FG002|Period 1|Test Article no longer available|0|||
130692216|NCT03913377|470500100|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
130692217|NCT03913377|470500101|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
130692218|NCT03913377|470500102|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
130692219|NCT03499353|470500103|FG000|Treatment|Adverse Event|3|||
130692220|NCT03499353|470500103|FG000|Treatment|Progressive Disease|10|||
130692221|NCT03499353|470500103|FG000|Treatment|Other|1|||
130692222|NCT03499353|470500103|FG000|Treatment|Withdrawal by Subject|2|||
130692223|NCT03499353|470500103|FG000|Long-Term Follow-up|Death|2|||
130692224|NCT03499353|470500103|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
130692225|NCT03499353|470500103|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
130692226|NCT01592240|470500104|FG000|Overall Study|Adverse Event|1|||
130692227|NCT01592240|470500105|FG001|Overall Study|Adverse Event|0|||
130692228|NCT01592240|470500106|FG002|Overall Study|Adverse Event|0|||
130692229|NCT01592240|470500107|FG003|Overall Study|Adverse Event|1|||
130692230|NCT01592240|470500108|FG004|Overall Study|Adverse Event|1|||
130692231|NCT01592240|470500109|FG005|Overall Study|Adverse Event|0|||
130692232|NCT01592240|470500110|FG006|Overall Study|Adverse Event|0|||
130692233|NCT01592240|470500104|FG000|Overall Study|Death|0|||
130692234|NCT01592240|470500105|FG001|Overall Study|Death|1|||
130692235|NCT01592240|470500106|FG002|Overall Study|Death|0|||
130692236|NCT01592240|470500107|FG003|Overall Study|Death|0|||
130692237|NCT01592240|470500108|FG004|Overall Study|Death|0|||
130692238|NCT01592240|470500109|FG005|Overall Study|Death|0|||
130692239|NCT01592240|470500110|FG006|Overall Study|Death|0|||
130692240|NCT01592240|470500104|FG000|Overall Study|Lost to Follow-up|1|||
130692241|NCT01592240|470500105|FG001|Overall Study|Lost to Follow-up|3|||
130692242|NCT01592240|470500106|FG002|Overall Study|Lost to Follow-up|1|||
130692243|NCT01592240|470500107|FG003|Overall Study|Lost to Follow-up|0|||
130692244|NCT01592240|470500108|FG004|Overall Study|Lost to Follow-up|3|||
130692245|NCT01592240|470500109|FG005|Overall Study|Lost to Follow-up|2|||
130692246|NCT01592240|470500110|FG006|Overall Study|Lost to Follow-up|0|||
130692247|NCT01592240|470500104|FG000|Overall Study|Protocol Violation|0|||
130692248|NCT01592240|470500105|FG001|Overall Study|Protocol Violation|0|||
130692249|NCT01592240|470500106|FG002|Overall Study|Protocol Violation|0|||
130692250|NCT01592240|470500107|FG003|Overall Study|Protocol Violation|0|||
130692251|NCT01592240|470500108|FG004|Overall Study|Protocol Violation|0|||
130692252|NCT01592240|470500109|FG005|Overall Study|Protocol Violation|1|||
130692253|NCT01592240|470500110|FG006|Overall Study|Protocol Violation|0|||
130692254|NCT01592240|470500104|FG000|Overall Study|Withdrawal by Subject|0|||
130692255|NCT01592240|470500105|FG001|Overall Study|Withdrawal by Subject|4|||
130692256|NCT01592240|470500106|FG002|Overall Study|Withdrawal by Subject|4|||
130692257|NCT01592240|470500107|FG003|Overall Study|Withdrawal by Subject|1|||
130692258|NCT01592240|470500108|FG004|Overall Study|Withdrawal by Subject|3|||
130692259|NCT01592240|470500109|FG005|Overall Study|Withdrawal by Subject|0|||
130692260|NCT01592240|470500110|FG006|Overall Study|Withdrawal by Subject|2|||
130692261|NCT01592240|470500104|FG000|Overall Study|Other|0|||
130692262|NCT01592240|470500105|FG001|Overall Study|Other|3|||
130692263|NCT01592240|470500106|FG002|Overall Study|Other|1|||
130692264|NCT01592240|470500107|FG003|Overall Study|Other|1|||
130692265|NCT01592240|470500108|FG004|Overall Study|Other|0|||
130692266|NCT01592240|470500109|FG005|Overall Study|Other|0|||
130692267|NCT01592240|470500110|FG006|Overall Study|Other|1|||
130692268|NCT01592240|470500104|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
130692269|NCT01592240|470500105|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
130692270|NCT01592240|470500106|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
130692271|NCT01592240|470500107|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
130692272|NCT01592240|470500108|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
131112508|NCT02973048|472042409|FG001|Overall Study|Epidural catheter insertion failure|0|||
131112509|NCT02973048|472042408|FG000|Overall Study|Withdrawal by Subject|0|||
130900164|NCT00171834|471269221|FG005|Overall Study|Treatment Duration Completed|1|||
130900165|NCT00171834|471269222|FG006|Overall Study|Treatment Duration Completed|0|||
131025889|NCT02605837|471725323|FG000|Overall Study|Withdrawal by Subject|8|||
131025890|NCT02605837|471725324|FG001|Overall Study|Withdrawal by Subject|8|||
131025891|NCT02605837|471725323|FG000|Overall Study|Physician Decision|0|||
131112510|NCT02973048|472042409|FG001|Overall Study|Withdrawal by Subject|3|||
131112511|NCT00332189|472042410|FG000|Overall Study|Adverse Event|3|||
131112512|NCT00332189|472042410|FG000|Overall Study|Uncooperative/Noncompliant|3|||
130900166|NCT04345367|471269223|FG000|Overall Study|Other|3|||
131025892|NCT02605837|471725324|FG001|Overall Study|Physician Decision|1|||
131025893|NCT02652260|471725325|FG000|Base Study|Pregnancy|0|||
130692273|NCT01592240|470500109|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
130692274|NCT01592240|470500110|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
130692275|NCT02751424|470500111|FG000|Part 2|Adverse Event|0|||
130692276|NCT02751424|470500112|FG001|Part 2|Adverse Event|0|||
130692277|NCT02751424|470500113|FG002|Part 2|Adverse Event|0|||
130692278|NCT02751424|470500114|FG003|Part 2|Adverse Event|0|||
130692279|NCT02751424|470500115|FG004|Part 2|Adverse Event|0|||
130692280|NCT02751424|470500116|FG005|Part 2|Adverse Event|0|||
130692281|NCT02751424|470500117|FG006|Part 2|Adverse Event|0|||
130900167|NCT04345367|471269224|FG001|Overall Study|Other|4|||
130900168|NCT04345367|471269223|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
130692282|NCT02751424|470500118|FG007|Part 2|Adverse Event|5|||
130692283|NCT02751424|470500119|FG008|Part 2|Adverse Event|0|||
130692284|NCT01896934|470500120|FG000|Overall Study|Adverse Event|1|||
130692285|NCT01896934|470500120|FG000|Overall Study|Withdrawal by Subject|1|||
130692286|NCT02197416|470500121|FG000|Overall Study|Other reasons|0|||
130692287|NCT02197416|470500122|FG001|Overall Study|Other reasons|2|||
130692288|NCT02197416|470500123|FG002|Overall Study|Other reasons|5|||
130692289|NCT02197416|470500121|FG000|Overall Study|Withdrawal by Subject|0|||
130692290|NCT02197416|470500122|FG001|Overall Study|Withdrawal by Subject|2|||
130692291|NCT02197416|470500123|FG002|Overall Study|Withdrawal by Subject|1|||
130692292|NCT02197416|470500121|FG000|Overall Study|Protocol Violation|1|||
130692293|NCT02197416|470500122|FG001|Overall Study|Protocol Violation|0|||
130692294|NCT02197416|470500123|FG002|Overall Study|Protocol Violation|1|||
130692295|NCT02197416|470500121|FG000|Overall Study|Adverse Event|0|||
130692296|NCT02197416|470500122|FG001|Overall Study|Adverse Event|0|||
130692297|NCT02197416|470500123|FG002|Overall Study|Adverse Event|1|||
130692298|NCT02451696|470500124|FG000|Overall Study|Surgery postponed|1|||
130692299|NCT02451696|470500125|FG001|Overall Study|Surgery postponed|0|||
130692300|NCT05014828|470500126|FG000|Overall Study|Study Completed by Sponsor|16|||
130692301|NCT05014828|470500127|FG001|Overall Study|Study Completed by Sponsor|16|||
130692302|NCT05014828|470500128|FG002|Overall Study|Study Completed by Sponsor|3|||
130692303|NCT05014828|470500129|FG003|Overall Study|Study Completed by Sponsor|3|||
130692304|NCT05014828|470500126|FG000|Overall Study|Death|11|||
130692305|NCT05014828|470500127|FG001|Overall Study|Death|6|||
130692306|NCT05014828|470500128|FG002|Overall Study|Death|0|||
130692307|NCT05014828|470500129|FG003|Overall Study|Death|0|||
130692308|NCT05014828|470500126|FG000|Overall Study|Lost to Follow-up|0|||
130692309|NCT05014828|470500127|FG001|Overall Study|Lost to Follow-up|0|||
130692310|NCT05014828|470500128|FG002|Overall Study|Lost to Follow-up|2|||
130692311|NCT05014828|470500129|FG003|Overall Study|Lost to Follow-up|0|||
130692312|NCT05014828|470500126|FG000|Overall Study|Miscellaneous.|0|||
130692313|NCT05014828|470500127|FG001|Overall Study|Miscellaneous.|1|||
130692314|NCT05014828|470500128|FG002|Overall Study|Miscellaneous.|0|||
130692315|NCT05014828|470500129|FG003|Overall Study|Miscellaneous.|0|||
130692316|NCT05523895|470500130|FG000|Overall Study|Adverse Event|2|||
130692317|NCT05523895|470500131|FG001|Overall Study|Adverse Event|1|||
130692318|NCT05523895|470500132|FG002|Overall Study|Adverse Event|1|||
130692319|NCT05523895|470500130|FG000|Overall Study|Lost to Follow-up|0|||
130692320|NCT05523895|470500131|FG001|Overall Study|Lost to Follow-up|1|||
130692321|NCT05523895|470500132|FG002|Overall Study|Lost to Follow-up|2|||
130692322|NCT05523895|470500130|FG000|Overall Study|Noncompliance with study drug|1|||
130692323|NCT05523895|470500131|FG001|Overall Study|Noncompliance with study drug|1|||
130692324|NCT05523895|470500132|FG002|Overall Study|Noncompliance with study drug|1|||
130692325|NCT05523895|470500130|FG000|Overall Study|Protocol Violation|0|||
130692326|NCT05523895|470500131|FG001|Overall Study|Protocol Violation|2|||
130692327|NCT05523895|470500132|FG002|Overall Study|Protocol Violation|0|||
130692328|NCT05523895|470500130|FG000|Overall Study|Withdrawal by Subject|1|||
130692329|NCT05523895|470500131|FG001|Overall Study|Withdrawal by Subject|3|||
130692330|NCT05523895|470500132|FG002|Overall Study|Withdrawal by Subject|1|||
130692331|NCT05523895|470500130|FG000|Overall Study|Not further specified|0|||
130692332|NCT05523895|470500131|FG001|Overall Study|Not further specified|3|||
130692333|NCT05523895|470500132|FG002|Overall Study|Not further specified|1|||
130692334|NCT03674892|470500133|FG000|Overall Study|Lack of Efficacy|5|||
130692335|NCT03674892|470500133|FG000|Overall Study|Lost to Follow-up|3|||
130692336|NCT03674892|470500133|FG000|Overall Study|Migraine|2|||
130692337|NCT03674892|470500133|FG000|Overall Study|Excessive Tearing|1|||
130692338|NCT03674892|470500133|FG000|Overall Study|Increased Eye Pain|1|||
130692339|NCT03674892|470500133|FG000|Overall Study|Increased Facial Pain|1|||
130692340|NCT03674892|470500133|FG000|Overall Study|Sinus Irritation|1|||
130692341|NCT03674892|470500133|FG000|Overall Study|Sinus Infection|1|||
130692342|NCT01959672|470500138|FG000|Overall Study|Death|1|||
130692343|NCT05041361|470500141|FG000|Overall Study|Lost to Follow-up|1|||
130692344|NCT05041361|470500142|FG001|Overall Study|Lost to Follow-up|3|||
130692345|NCT01642277|470500143|FG000|Overall Study|Adverse Event|10|||
130692346|NCT01642277|470500144|FG001|Overall Study|Adverse Event|0|||
130692347|NCT01642277|470500143|FG000|Overall Study|Physician Decision|2|||
130692348|NCT01642277|470500144|FG001|Overall Study|Physician Decision|0|||
130692349|NCT01642277|470500143|FG000|Overall Study|Protocol Violation|1|||
130692350|NCT01642277|470500144|FG001|Overall Study|Protocol Violation|0|||
130692351|NCT01642277|470500143|FG000|Overall Study|Withdrawal by Subject|11|||
130692352|NCT01642277|470500144|FG001|Overall Study|Withdrawal by Subject|0|||
130692353|NCT03605342|470500145|FG000|Overall Study|Withdrawal by Subject|9|||
130692354|NCT03605342|470500146|FG001|Overall Study|Withdrawal by Subject|7|||
130692355|NCT03605342|470500145|FG000|Overall Study|Lost to Follow-up|1|||
130692356|NCT03605342|470500146|FG001|Overall Study|Lost to Follow-up|1|||
130692357|NCT00796328|470500149|FG000|Overall Study|experienced hypotension requiring tx|6|||
130692358|NCT02842853|470500150|FG000|Overall Study|Non-compliance with the protocol|3|||
130692359|NCT02842853|470500151|FG001|Overall Study|Non-compliance with the protocol|7|||
130692360|NCT02842853|470500152|FG002|Overall Study|Non-compliance with the protocol|2|||
130692361|NCT02842853|470500153|FG003|Overall Study|Non-compliance with the protocol|5|||
130692362|NCT02842853|470500150|FG000|Overall Study|Subject met exclusion criteria|0|||
130692363|NCT02842853|470500151|FG001|Overall Study|Subject met exclusion criteria|1|||
130692364|NCT02842853|470500152|FG002|Overall Study|Subject met exclusion criteria|0|||
130692365|NCT02842853|470500153|FG003|Overall Study|Subject met exclusion criteria|0|||
130692366|NCT02842853|470500150|FG000|Overall Study|Withdrawal by Subject|11|||
130692367|NCT02842853|470500151|FG001|Overall Study|Withdrawal by Subject|13|||
130692368|NCT02842853|470500152|FG002|Overall Study|Withdrawal by Subject|9|||
130692369|NCT02842853|470500153|FG003|Overall Study|Withdrawal by Subject|8|||
130692370|NCT02842853|470500150|FG000|Overall Study|Lost to Follow-up|9|||
130692371|NCT02842853|470500151|FG001|Overall Study|Lost to Follow-up|13|||
130692372|NCT02842853|470500152|FG002|Overall Study|Lost to Follow-up|10|||
130692373|NCT02842853|470500153|FG003|Overall Study|Lost to Follow-up|11|||
130692374|NCT04089553|470500154|FG000|Overall Study|Death|1|||
130692375|NCT04089553|470500155|FG001|Overall Study|Death|1|||
130692376|NCT04089553|470500154|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
130692377|NCT04089553|470500155|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
130692378|NCT04089553|470500154|FG000|Overall Study|Withdrawal by Subject|3|||
130692379|NCT04089553|470500155|FG001|Overall Study|Withdrawal by Subject|3|||
130692380|NCT04089553|470500154|FG000|Overall Study|Physician Decision|1|||
130692381|NCT04089553|470500155|FG001|Overall Study|Physician Decision|0|||
130692382|NCT04089553|470500154|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
130692383|NCT04089553|470500155|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
130692384|NCT04089553|470500154|FG000|Overall Study|Other|1|||
130692385|NCT04089553|470500155|FG001|Overall Study|Other|0|||
130692386|NCT04089553|470500154|FG000|Overall Study|Adverse Event|1|||
130692387|NCT04089553|470500155|FG001|Overall Study|Adverse Event|1|||
130692388|NCT01403194|470500163|FG000|Overall Study|Screen Failure|2|||
130692389|NCT01403194|470500163|FG000|Overall Study|Lost to Follow-up|8|||
130692390|NCT00107991|470500168|FG000|Eligibility Assessment|Disease not severe enough|7|||
130692391|NCT00107991|470500168|FG000|Eligibility Assessment|Unwilling to participate|7|||
130692392|NCT00107991|470500168|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
130692393|NCT00107991|470500168|FG000|Eligibility Assessment|Abnormal labs|2|||
130692394|NCT00107991|470500168|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
130692395|NCT00107991|470500168|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
130692396|NCT00107991|470500168|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
130692397|NCT00107991|470500168|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
130692398|NCT00107991|470500168|FG000|12 Week Treatment Period|Adverse Event|1|||
130692399|NCT00107991|470500168|FG000|12 Week Treatment Period|Protocol Violation|1|||
130692400|NCT00107991|470500168|FG000|12 Week Treatment Period|Incarcerated|1|||
130692401|NCT00107991|470500168|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
130692402|NCT00506831|470500175|FG000|Overall Study|Death|1|||
130692403|NCT00506831|470500175|FG000|Overall Study|Withdrawal by Subject|1|||
130692404|NCT02488239|470500179|FG000|Overall Study|Death|3|||
130692405|NCT02488239|470500179|FG000|Overall Study|Withdrawal by Subject|3|||
130692406|NCT02488239|470500179|FG000|Overall Study|Physician Decision|2|||
130692407|NCT02488239|470500179|FG000|Overall Study|Consent ineligible|1|||
130692408|NCT02488239|470500179|FG000|Overall Study|Did not undergo implant procedure|1|||
130692409|NCT00608322|470500182|FG000|Overall Study|Death|2|||
130692410|NCT00608322|470500183|FG001|Overall Study|Death|1|||
130692411|NCT00834444|470500184|FG000|First Intervention|Adverse Event|1|||
130692412|NCT00834444|470500185|FG001|First Intervention|Adverse Event|0|||
130692413|NCT00834444|470500184|FG000|First Intervention|Intolerance to Venopuncture|0|||
130692414|NCT00834444|470500185|FG001|First Intervention|Intolerance to Venopuncture|1|||
130692415|NCT00834444|470500184|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130692416|NCT00834444|470500185|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
131025894|NCT02652260|471725326|FG001|Base Study|Pregnancy|1|||
131025895|NCT02652260|471725325|FG000|Base Study|Withdrawal by Subject|0|||
131025896|NCT02652260|471725326|FG001|Base Study|Withdrawal by Subject|1|||
131025897|NCT02652260|471725325|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
131025898|NCT02652260|471725326|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
131222729|NCT00720304|472443167|FG001|Overall Study|Disease progression|1|||
130692417|NCT00834444|470500184|FG000|Second Intervention|Adverse Event|1|||
130692418|NCT00834444|470500185|FG001|Second Intervention|Adverse Event|0|||
130692419|NCT02213263|470500189|FG000|Overall Study|Insufficient clinical response|4|||
130692420|NCT02213263|470500190|FG001|Overall Study|Insufficient clinical response|3|||
130692421|NCT02213263|470500189|FG000|Overall Study|Lost to Follow-up|0|||
130692422|NCT02213263|470500190|FG001|Overall Study|Lost to Follow-up|1|||
130692423|NCT02213263|470500189|FG000|Overall Study|No longer willing to participate|3|||
130692424|NCT02213263|470500190|FG001|Overall Study|No longer willing to participate|4|||
130692425|NCT02213263|470500189|FG000|Overall Study|Progressive disease|20|||
130692426|NCT02213263|470500190|FG001|Overall Study|Progressive disease|14|||
130692427|NCT02213263|470500189|FG000|Overall Study|Protocol Violation|0|||
131112513|NCT00332189|472042410|FG000|Overall Study|Withdrawal by Subject|9|||
131112514|NCT00332189|472042410|FG000|Overall Study|Lack of Efficacy|4|||
131112515|NCT00332189|472042410|FG000|Overall Study|Moved out of country|2|||
131112516|NCT02279862|472042412|FG000|Overall Study|Study drug toxicity|3|||
131112517|NCT02279862|472042413|FG001|Overall Study|Study drug toxicity|6|||
131112518|NCT02279862|472042412|FG000|Overall Study|No longer meets criteria|0|||
131112519|NCT02279862|472042413|FG001|Overall Study|No longer meets criteria|1|||
131112520|NCT02279862|472042412|FG000|Overall Study|Administrative reason by sponsor|0|||
131112521|NCT02279862|472042413|FG001|Overall Study|Administrative reason by sponsor|1|||
131112522|NCT02279862|472042412|FG000|Overall Study|Disease progression|5|||
131112523|NCT02279862|472042413|FG001|Overall Study|Disease progression|2|||
131112524|NCT02279862|472042412|FG000|Overall Study|Study closed by sponsor|16|||
131112525|NCT02279862|472042413|FG001|Overall Study|Study closed by sponsor|13|||
131112526|NCT02279862|472042412|FG000|Overall Study|Other|1|||
131112527|NCT02279862|472042413|FG001|Overall Study|Other|2|||
131112528|NCT02279862|472042412|FG000|Overall Study|Withdrawal by Subject|1|||
131112529|NCT02279862|472042413|FG001|Overall Study|Withdrawal by Subject|0|||
131112530|NCT03707925|472042415|FG000|Overall Study|Inevaluable|1|||
131112531|NCT03431857|472042417|FG000|Overall Study|Death|6|||
131112532|NCT03431857|472042417|FG000|Overall Study|Lost to Follow-up|41|||
131112533|NCT03431857|472042417|FG000|Overall Study|Adverse Event|6|||
131112534|NCT03431857|472042417|FG000|Overall Study|Withdrawal by Subject|1|||
131112535|NCT00651157|472042419|FG000|Overall Study|Death|1|||
130768101|NCT00505661|470773977|FG000|Overall Study|Not Eligible|4|||
130768102|NCT03611582|470773980|FG000|Overall Study|Adverse Event|26|||
130768103|NCT03611582|470773981|FG001|Overall Study|Adverse Event|6|||
130768104|NCT03611582|470773980|FG000|Overall Study|Protocol Violation|0|||
130768105|NCT03611582|470773981|FG001|Overall Study|Protocol Violation|1|||
130768106|NCT03611582|470773980|FG000|Overall Study|Pregnancy|1|||
130768107|NCT03611582|470773981|FG001|Overall Study|Pregnancy|2|||
130768108|NCT03611582|470773980|FG000|Overall Study|Lack of Efficacy|0|||
130768109|NCT03611582|470773981|FG001|Overall Study|Lack of Efficacy|1|||
130768110|NCT03611582|470773980|FG000|Overall Study|At the discretion of the investigator|1|||
130768111|NCT03611582|470773981|FG001|Overall Study|At the discretion of the investigator|0|||
130768112|NCT03611582|470773980|FG000|Overall Study|Safety concern as judged by the investigator|1|||
130768113|NCT03611582|470773981|FG001|Overall Study|Safety concern as judged by the investigator|2|||
130768114|NCT03611582|470773980|FG000|Overall Study|Withdrawal by Subject|4|||
130768115|NCT03611582|470773981|FG001|Overall Study|Withdrawal by Subject|3|||
130768116|NCT03611582|470773980|FG000|Overall Study|Lost to Follow-up|18|||
130768117|NCT03611582|470773981|FG001|Overall Study|Lost to Follow-up|7|||
130768118|NCT03611582|470773980|FG000|Overall Study|other|17|||
130768119|NCT03611582|470773981|FG001|Overall Study|other|16|||
130768120|NCT01783821|470773982|FG000|Overall Study|Screen Failure|1|||
130768121|NCT01783821|470773983|FG001|Overall Study|Screen Failure|1|||
130768122|NCT01738191|470773984|FG000|Overall Study|Withdrawal by Subject|4|||
130768123|NCT01738191|470773985|FG001|Overall Study|Withdrawal by Subject|1|||
130768124|NCT02109445|470773988|FG000|Overall Study|Symptomatic deterioration|2|||
130768125|NCT02109445|470773988|FG000|Overall Study|Adverse Event|1|||
130768126|NCT03089853|470775448|FG000|Overall Study|Lost to Follow-up|2|||
130768127|NCT03089853|470775449|FG001|Overall Study|Lost to Follow-up|1|||
130768128|NCT00642954|470775450|FG000|Overall Study|Progressive Disease|3|||
130768129|NCT00642954|470775451|FG001|Overall Study|Progressive Disease|3|||
130768130|NCT00642954|470775452|FG002|Overall Study|Progressive Disease|3|||
130768131|NCT00642954|470775453|FG003|Overall Study|Progressive Disease|3|||
130768132|NCT00642954|470775454|FG004|Overall Study|Progressive Disease|9|||
130768133|NCT00642954|470775450|FG000|Overall Study|Withdrawal by Subject|0|||
130768134|NCT00642954|470775451|FG001|Overall Study|Withdrawal by Subject|0|||
131025899|NCT02652260|471725325|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
131025900|NCT02652260|471725326|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
131025901|NCT02652260|471725325|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
131025902|NCT02652260|471725326|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
131025903|NCT02652260|471725325|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
131025904|NCT02652260|471725326|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
131025905|NCT02652260|471725325|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
130768135|NCT00642954|470775452|FG002|Overall Study|Withdrawal by Subject|0|||
130768136|NCT00642954|470775453|FG003|Overall Study|Withdrawal by Subject|0|||
130768137|NCT00642954|470775454|FG004|Overall Study|Withdrawal by Subject|1|||
130768138|NCT00642954|470775450|FG000|Overall Study|Adverse Event|1|||
130768139|NCT00642954|470775451|FG001|Overall Study|Adverse Event|1|||
130768140|NCT00642954|470775452|FG002|Overall Study|Adverse Event|0|||
131025906|NCT02652260|471725326|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
130768141|NCT00642954|470775453|FG003|Overall Study|Adverse Event|0|||
130768142|NCT00642954|470775454|FG004|Overall Study|Adverse Event|6|||
130768143|NCT00441363|470775455|FG000|Overall Study|Adverse Event|4|||
131025907|NCT02652260|471725325|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
130768144|NCT00441363|470775456|FG001|Overall Study|Adverse Event|2|||
130768145|NCT00441363|470775455|FG000|Overall Study|Withdrawal by Subject|3|||
130692428|NCT02213263|470500190|FG001|Overall Study|Protocol Violation|1|||
130692429|NCT02213263|470500189|FG000|Overall Study|Adverse Event|1|||
130692430|NCT02213263|470500190|FG001|Overall Study|Adverse Event|3|||
130692431|NCT05752721|470500191|FG000|Overall Study|Lost to Follow-up|22|||
130692432|NCT05752721|470500192|FG001|Overall Study|Lost to Follow-up|20|||
130692433|NCT05752721|470500191|FG000|Overall Study|Withdrawal by Subject|15|||
130692434|NCT05752721|470500192|FG001|Overall Study|Withdrawal by Subject|12|||
130692435|NCT01188681|470500193|FG000|Overall Study|bladder cancer|0|||
130692436|NCT01188681|470500194|FG001|Overall Study|bladder cancer|0|||
130692437|NCT01188681|470500195|FG002|Overall Study|bladder cancer|1|||
130692438|NCT01188681|470500196|FG003|Overall Study|bladder cancer|0|||
130692439|NCT01188681|470500193|FG000|Overall Study|Withdrawal by Subject|0|||
130692440|NCT01188681|470500194|FG001|Overall Study|Withdrawal by Subject|0|||
130692441|NCT01188681|470500195|FG002|Overall Study|Withdrawal by Subject|0|||
130692442|NCT01188681|470500196|FG003|Overall Study|Withdrawal by Subject|1|||
130692443|NCT04827394|470500200|FG000|Overall Study|Physician Decision|0|||
130692444|NCT04827394|470500201|FG001|Overall Study|Physician Decision|2|||
130692445|NCT03500094|470500202|FG000|Overall Study|Withdrawal by Subject|1|||
130900169|NCT04345367|471269224|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
130900170|NCT04345367|471269223|FG000|Overall Study|Withdrawal by Subject|11|||
130900171|NCT04345367|471269224|FG001|Overall Study|Withdrawal by Subject|11|||
130900172|NCT04345367|471269223|FG000|Overall Study|Protocol Violation|4|||
130900173|NCT04345367|471269224|FG001|Overall Study|Protocol Violation|3|||
130900174|NCT04345367|471269223|FG000|Overall Study|Lost to Follow-up|2|||
130900175|NCT04345367|471269224|FG001|Overall Study|Lost to Follow-up|4|||
130900176|NCT04345367|471269223|FG000|Overall Study|Lack of Efficacy|2|||
130900177|NCT04345367|471269224|FG001|Overall Study|Lack of Efficacy|0|||
130900178|NCT04345367|471269223|FG000|Overall Study|Death|2|||
130900179|NCT04345367|471269224|FG001|Overall Study|Death|0|||
130900180|NCT04345367|471269223|FG000|Overall Study|Adverse Event|10|||
130900181|NCT04345367|471269224|FG001|Overall Study|Adverse Event|9|||
130900182|NCT02431260|471269225|FG000|Overall Study|Subject Decision|0|||
130900183|NCT02431260|471269226|FG001|Overall Study|Subject Decision|1|||
130900184|NCT02431260|471269227|FG002|Overall Study|Subject Decision|1|||
130900185|NCT02431260|471269228|FG003|Overall Study|Subject Decision|0|||
130692446|NCT03500094|470500202|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
130692447|NCT03500094|470500202|FG000|Overall Study|Lost to Follow-up|1|||
130692448|NCT01030133|470500205|FG000|Overall Study|failed to experience pain at level 7/10|2|||
130692449|NCT01030133|470500206|FG001|Overall Study|failed to experience pain at level 7/10|2|||
130692450|NCT00477594|470500207|FG000|Year 1 and Year 2|Adverse Event|4|||
130692451|NCT00477594|470500208|FG001|Year 1 and Year 2|Adverse Event|2|||
130692452|NCT00477594|470500207|FG000|Year 1 and Year 2|Physician Decision|2|||
130692453|NCT00477594|470500208|FG001|Year 1 and Year 2|Physician Decision|1|||
130692454|NCT00477594|470500207|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
130692455|NCT00477594|470500208|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
130692456|NCT00477594|470500207|FG000|Year 1 and Year 2|Other|1|||
130692457|NCT00477594|470500208|FG001|Year 1 and Year 2|Other|0|||
130692458|NCT00477594|470500207|FG000|Year 3|Adverse Event|1|||
130692459|NCT00477594|470500208|FG001|Year 3|Adverse Event|0|||
130692460|NCT00477594|470500207|FG000|Year 3|Withdrawal by Subject|1|||
130692461|NCT00477594|470500208|FG001|Year 3|Withdrawal by Subject|0|||
130692462|NCT00477594|470500207|FG000|Follow-up Period|Withdrawal by Subject|2|||
130692463|NCT00477594|470500208|FG001|Follow-up Period|Withdrawal by Subject|1|||
130692464|NCT00477594|470500207|FG000|Follow-up Period|Other|1|||
130692465|NCT00477594|470500208|FG001|Follow-up Period|Other|0|||
130692466|NCT02875392|470501893|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
130692467|NCT02875392|470501894|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
130692468|NCT03599193|470501895|FG000|Overall Study|Adverse Event|0|||
130692469|NCT03599193|470501896|FG001|Overall Study|Adverse Event|2|||
130692470|NCT03599193|470501895|FG000|Overall Study|Withdrawal by Subject|1|||
130692471|NCT03599193|470501896|FG001|Overall Study|Withdrawal by Subject|0|||
130692472|NCT03599193|470501895|FG000|Overall Study|Protocol Violation|1|||
130692473|NCT03599193|470501896|FG001|Overall Study|Protocol Violation|0|||
130692474|NCT03599193|470501895|FG000|Overall Study|Lost to Follow-up|0|||
130692475|NCT03599193|470501896|FG001|Overall Study|Lost to Follow-up|1|||
130692476|NCT00835705|470501897|FG000|First Intervention|Difficulty with vein|1|||
130900186|NCT02431260|471269229|FG004|Overall Study|Subject Decision|0|||
130692477|NCT00835705|470501898|FG001|First Intervention|Difficulty with vein|0|||
130692478|NCT00835705|470501897|FG000|Second Intervention|Difficulty with vein|1|||
130692479|NCT00835705|470501898|FG001|Second Intervention|Difficulty with vein|0|||
130692480|NCT01750294|470501899|FG000|Overall Study|Withdrawal by Subject|1|||
130900187|NCT02431260|471269230|FG005|Overall Study|Subject Decision|0|||
130900188|NCT02431260|471269231|FG006|Overall Study|Subject Decision|0|||
130900189|NCT02431260|471269232|FG007|Overall Study|Subject Decision|0|||
130900190|NCT02431260|471269233|FG008|Overall Study|Subject Decision|1|||
130900191|NCT02431260|471269234|FG009|Overall Study|Subject Decision|1|||
130900192|NCT02431260|471269235|FG010|Overall Study|Subject Decision|0|||
130692481|NCT01750294|470501899|FG000|Overall Study|Safety Endpoint|1|||
130692482|NCT04372238|470501902|FG000|Overall Study|Duplicate|3|||
130692483|NCT04372238|470501903|FG001|Overall Study|Duplicate|3|||
130692484|NCT04372238|470501902|FG000|Overall Study|Did not consent for data linkage|6|||
130692485|NCT04372238|470501903|FG001|Overall Study|Did not consent for data linkage|10|||
130692486|NCT03206749|470501913|FG000|Overall Study|Withdrawal of consent|5|||
130692487|NCT03206749|470501914|FG001|Overall Study|Withdrawal of consent|3|||
130692488|NCT03206749|470501915|FG002|Overall Study|Withdrawal of consent|6|||
130692489|NCT03206749|470501913|FG000|Overall Study|Lost to Follow-up|0|||
130692490|NCT03206749|470501914|FG001|Overall Study|Lost to Follow-up|0|||
130692491|NCT03206749|470501915|FG002|Overall Study|Lost to Follow-up|1|||
130692492|NCT03779334|470501919|FG000|Overall Study|Withdrawal by Subject|3|||
130692493|NCT03779334|470501920|FG001|Overall Study|Withdrawal by Subject|0|||
130692494|NCT03779334|470501921|FG002|Overall Study|Withdrawal by Subject|0|||
130692495|NCT03779334|470501919|FG000|Overall Study|Ongoing in Study|5|||
130692496|NCT03779334|470501920|FG001|Overall Study|Ongoing in Study|13|||
130692497|NCT03779334|470501921|FG002|Overall Study|Ongoing in Study|5|||
130692498|NCT01175135|470501922|FG000|Overall Study|Adverse Event|2|||
130692499|NCT01175135|470501923|FG001|Overall Study|Adverse Event|5|||
130692500|NCT01175135|470501924|FG002|Overall Study|Adverse Event|3|||
130692501|NCT01175135|470501925|FG003|Overall Study|Adverse Event|4|||
130692502|NCT01175135|470501922|FG000|Overall Study|Death|1|||
130692503|NCT01175135|470501923|FG001|Overall Study|Death|0|||
130692504|NCT01175135|470501924|FG002|Overall Study|Death|0|||
130692505|NCT01175135|470501925|FG003|Overall Study|Death|0|||
130692506|NCT01175135|470501922|FG000|Overall Study|Lack of Efficacy|4|||
130692507|NCT01175135|470501923|FG001|Overall Study|Lack of Efficacy|5|||
130692508|NCT01175135|470501924|FG002|Overall Study|Lack of Efficacy|0|||
130692509|NCT01175135|470501925|FG003|Overall Study|Lack of Efficacy|5|||
130692510|NCT01175135|470501922|FG000|Overall Study|Lost to Follow-up|1|||
130692511|NCT01175135|470501923|FG001|Overall Study|Lost to Follow-up|2|||
130692512|NCT01175135|470501924|FG002|Overall Study|Lost to Follow-up|0|||
130692513|NCT01175135|470501925|FG003|Overall Study|Lost to Follow-up|0|||
130692514|NCT01175135|470501922|FG000|Overall Study|Protocol Violation|1|||
130692515|NCT01175135|470501923|FG001|Overall Study|Protocol Violation|1|||
130692516|NCT01175135|470501924|FG002|Overall Study|Protocol Violation|0|||
130692517|NCT01175135|470501925|FG003|Overall Study|Protocol Violation|0|||
130692518|NCT01175135|470501922|FG000|Overall Study|Withdrawal by Subject|4|||
130692519|NCT01175135|470501923|FG001|Overall Study|Withdrawal by Subject|8|||
130692520|NCT01175135|470501924|FG002|Overall Study|Withdrawal by Subject|5|||
130692521|NCT01175135|470501925|FG003|Overall Study|Withdrawal by Subject|5|||
130692522|NCT01175135|470501922|FG000|Overall Study|Other|3|||
130692523|NCT01175135|470501923|FG001|Overall Study|Other|1|||
130692524|NCT01175135|470501924|FG002|Overall Study|Other|3|||
130692525|NCT01175135|470501925|FG003|Overall Study|Other|0|||
130692526|NCT01175135|470501922|FG000|Overall Study|Randomized But Not Treated|0|||
130692527|NCT01175135|470501923|FG001|Overall Study|Randomized But Not Treated|0|||
130692528|NCT01175135|470501924|FG002|Overall Study|Randomized But Not Treated|1|||
130692529|NCT01175135|470501925|FG003|Overall Study|Randomized But Not Treated|0|||
130692530|NCT04692155|470501929|FG000|Overall Study|Death|1|||
130692531|NCT03325881|470501933|FG000|Overall Study|Protocol Violation|0|||
130692532|NCT03325881|470501934|FG001|Overall Study|Protocol Violation|1|||
130692533|NCT03325881|470501933|FG000|Overall Study|Withdrawal by Subject|0|||
130692534|NCT03325881|470501934|FG001|Overall Study|Withdrawal by Subject|2|||
130692535|NCT03325881|470501933|FG000|Overall Study|Lack of Efficacy|2|||
130692536|NCT03325881|470501934|FG001|Overall Study|Lack of Efficacy|0|||
130692537|NCT03325881|470501933|FG000|Overall Study|Not treated|1|||
130692538|NCT03325881|470501934|FG001|Overall Study|Not treated|0|||
130692539|NCT03676634|470501939|FG000|Overall Study|Red blood cell loss|1|||
130692540|NCT03676634|470501939|FG000|Overall Study|Out-of-limit pulse|2|||
130692541|NCT03131895|470501943|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
130692542|NCT03131895|470501944|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
130692543|NCT03131895|470501945|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
130692544|NCT03131895|470501946|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
130692545|NCT03131895|470501943|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
130692546|NCT03131895|470501944|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
130692547|NCT03131895|470501945|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
130692548|NCT03131895|470501946|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
130692549|NCT03131895|470501943|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130692550|NCT03131895|470501944|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
130692551|NCT03131895|470501945|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130692552|NCT03131895|470501946|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
130692553|NCT03131895|470501943|FG000|Washout Period (at Least 5 Days)|Other|0|||
130692554|NCT03131895|470501944|FG001|Washout Period (at Least 5 Days)|Other|0|||
130692555|NCT03131895|470501945|FG002|Washout Period (at Least 5 Days)|Other|2|||
130692556|NCT03131895|470501946|FG003|Washout Period (at Least 5 Days)|Other|0|||
130692557|NCT03131895|470501943|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
130900193|NCT02431260|471269236|FG011|Overall Study|Subject Decision|1|||
130692558|NCT03131895|470501944|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
130692559|NCT03131895|470501945|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
130692560|NCT03131895|470501946|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
130692561|NCT03131895|470501943|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
130692562|NCT03131895|470501944|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
130692563|NCT03131895|470501945|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
130692564|NCT03131895|470501946|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
130692565|NCT00540423|470501947|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130692566|NCT00540423|470501948|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130692567|NCT00540423|470501949|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130692568|NCT00540423|470501947|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
130692569|NCT00540423|470501948|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
130692570|NCT00540423|470501949|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
130692571|NCT02280863|470501953|FG000|Integrated Platform|Met stopping criteria|0|||
130692572|NCT02280863|470501954|FG001|Integrated Platform|Met stopping criteria|1|||
130692573|NCT00216736|470501960|FG000|Overall Study|Lost to Follow-up|1|||
130692574|NCT00216736|470501961|FG001|Overall Study|Lost to Follow-up|1|||
130692575|NCT02622386|470501962|FG000|First Assignment|Withdrawal by Subject|3|||
130692576|NCT02622386|470501963|FG001|First Assignment|Withdrawal by Subject|2|||
130768146|NCT00441363|470775456|FG001|Overall Study|Withdrawal by Subject|4|||
130768147|NCT00441363|470775455|FG000|Overall Study|Physician Decision|6|||
130768148|NCT00441363|470775456|FG001|Overall Study|Physician Decision|7|||
130768149|NCT00441363|470775455|FG000|Overall Study|Lost to Follow-up|2|||
130768150|NCT00441363|470775456|FG001|Overall Study|Lost to Follow-up|2|||
130900194|NCT02431260|471269237|FG012|Overall Study|Subject Decision|0|||
130900195|NCT02431260|471269238|FG013|Overall Study|Subject Decision|0|||
130900196|NCT02431260|471269225|FG000|Overall Study|Death|4|||
130900197|NCT02431260|471269226|FG001|Overall Study|Death|4|||
130900198|NCT02431260|471269227|FG002|Overall Study|Death|3|||
130900199|NCT02431260|471269228|FG003|Overall Study|Death|4|||
130900200|NCT02431260|471269229|FG004|Overall Study|Death|2|||
130900201|NCT02431260|471269230|FG005|Overall Study|Death|2|||
130900202|NCT02431260|471269231|FG006|Overall Study|Death|3|||
130900203|NCT02431260|471269232|FG007|Overall Study|Death|1|||
130900204|NCT02431260|471269233|FG008|Overall Study|Death|6|||
130900205|NCT02431260|471269234|FG009|Overall Study|Death|6|||
130900206|NCT02431260|471269235|FG010|Overall Study|Death|3|||
130900207|NCT02431260|471269236|FG011|Overall Study|Death|2|||
130900208|NCT02431260|471269237|FG012|Overall Study|Death|5|||
130900209|NCT02431260|471269238|FG013|Overall Study|Death|1|||
130900210|NCT02431260|471269225|FG000|Overall Study|Lost to Follow-up|0|||
130900211|NCT02431260|471269226|FG001|Overall Study|Lost to Follow-up|0|||
130900212|NCT02431260|471269227|FG002|Overall Study|Lost to Follow-up|0|||
130900213|NCT02431260|471269228|FG003|Overall Study|Lost to Follow-up|0|||
130900214|NCT02431260|471269229|FG004|Overall Study|Lost to Follow-up|0|||
130900215|NCT02431260|471269230|FG005|Overall Study|Lost to Follow-up|1|||
130900216|NCT02431260|471269231|FG006|Overall Study|Lost to Follow-up|0|||
130900217|NCT02431260|471269232|FG007|Overall Study|Lost to Follow-up|0|||
130900218|NCT02431260|471269233|FG008|Overall Study|Lost to Follow-up|0|||
130900219|NCT02431260|471269234|FG009|Overall Study|Lost to Follow-up|0|||
130900220|NCT02431260|471269235|FG010|Overall Study|Lost to Follow-up|0|||
130900221|NCT02431260|471269236|FG011|Overall Study|Lost to Follow-up|0|||
130900222|NCT02431260|471269237|FG012|Overall Study|Lost to Follow-up|0|||
130900223|NCT02431260|471269238|FG013|Overall Study|Lost to Follow-up|0|||
130900224|NCT02431260|471269225|FG000|Overall Study|Study Terminated by the Sponsor|0|||
131025908|NCT02652260|471725326|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
130692577|NCT02622386|470501962|FG000|Washout|Withdrawal by Subject|4|||
130692578|NCT02622386|470501963|FG001|Washout|Withdrawal by Subject|4|||
130692579|NCT02622386|470501962|FG000|Second Assignment|Withdrawal by Subject|0|||
130692580|NCT02622386|470501963|FG001|Second Assignment|Withdrawal by Subject|2|||
130692581|NCT02890992|470501964|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692582|NCT02890992|470501965|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
130692583|NCT02890992|470501966|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130768151|NCT00441363|470775455|FG000|Overall Study|Other|2|||
130768152|NCT00441363|470775456|FG001|Overall Study|Other|0|||
130768153|NCT01663857|470775459|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
130768154|NCT01663857|470775460|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
130900225|NCT02431260|471269226|FG001|Overall Study|Study Terminated by the Sponsor|0|||
130900226|NCT02431260|471269227|FG002|Overall Study|Study Terminated by the Sponsor|2|||
130900227|NCT02431260|471269228|FG003|Overall Study|Study Terminated by the Sponsor|1|||
130900228|NCT02431260|471269229|FG004|Overall Study|Study Terminated by the Sponsor|1|||
130900229|NCT02431260|471269230|FG005|Overall Study|Study Terminated by the Sponsor|0|||
130900230|NCT02431260|471269231|FG006|Overall Study|Study Terminated by the Sponsor|1|||
130900231|NCT02431260|471269232|FG007|Overall Study|Study Terminated by the Sponsor|2|||
130900232|NCT02431260|471269233|FG008|Overall Study|Study Terminated by the Sponsor|1|||
130900233|NCT02431260|471269234|FG009|Overall Study|Study Terminated by the Sponsor|1|||
131112536|NCT00651157|472042419|FG000|Overall Study|Protocol Violation|1|||
130692584|NCT02890992|470501967|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692585|NCT02890992|470501968|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692586|NCT02890992|470501969|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692587|NCT02890992|470501970|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692588|NCT02890992|470501971|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130692589|NCT02890992|470501964|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692590|NCT02890992|470501965|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692591|NCT02890992|470501966|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692592|NCT02890992|470501967|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692593|NCT02890992|470501968|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692594|NCT02890992|470501969|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130692595|NCT02890992|470501970|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
130692596|NCT02890992|470501971|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
130692597|NCT02890992|470501964|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692598|NCT02890992|470501965|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
130692599|NCT02890992|470501966|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692600|NCT02890992|470501967|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692601|NCT02890992|470501968|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692602|NCT02890992|470501969|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692603|NCT02890992|470501970|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692604|NCT02890992|470501971|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
130692605|NCT03236311|470501972|FG000|Overall Study|Study terminated by sponsor|0|||
130692606|NCT03236311|470501973|FG001|Overall Study|Study terminated by sponsor|2|||
130692607|NCT03236311|470501972|FG000|Overall Study|Adverse Event|0|||
130692608|NCT03236311|470501973|FG001|Overall Study|Adverse Event|1|||
130692609|NCT00807495|470501975|FG000|Overall Study|Adverse Event|6|||
130692610|NCT00807495|470501976|FG001|Overall Study|Adverse Event|3|||
130692611|NCT00807495|470501977|FG002|Overall Study|Adverse Event|1|||
130692612|NCT00807495|470501978|FG003|Overall Study|Adverse Event|1|||
130692613|NCT00807495|470501979|FG004|Overall Study|Adverse Event|2|||
130692614|NCT00807495|470501975|FG000|Overall Study|Withdrawal by Patient|2|||
130692615|NCT00807495|470501976|FG001|Overall Study|Withdrawal by Patient|0|||
130692616|NCT00807495|470501977|FG002|Overall Study|Withdrawal by Patient|1|||
130692617|NCT00807495|470501978|FG003|Overall Study|Withdrawal by Patient|0|||
130692618|NCT00807495|470501979|FG004|Overall Study|Withdrawal by Patient|0|||
130692619|NCT00807495|470501975|FG000|Overall Study|Reason Not Specified|0|||
130692620|NCT00807495|470501976|FG001|Overall Study|Reason Not Specified|3|||
130692621|NCT00807495|470501977|FG002|Overall Study|Reason Not Specified|2|||
130692622|NCT00807495|470501978|FG003|Overall Study|Reason Not Specified|0|||
130692623|NCT00807495|470501979|FG004|Overall Study|Reason Not Specified|3|||
130692624|NCT01174186|470501982|FG000|Overall Study|Lost to Follow-up|0|||
130692625|NCT01174186|470501983|FG001|Overall Study|Lost to Follow-up|1|||
130692626|NCT01174186|470501982|FG000|Overall Study|Withdrawal by Subject|0|||
130692627|NCT01174186|470501983|FG001|Overall Study|Withdrawal by Subject|2|||
130692628|NCT05274763|470501984|FG000|Overall Study|Lost to Follow-up|1|||
130692629|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
130692630|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
130692631|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
130692632|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
130692633|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
130692634|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
130692635|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Death|9|||
130692636|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Death|7|||
130692637|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Death|14|||
130692638|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Death|7|||
130692639|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Death|0|||
130692640|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Death|0|||
130692641|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
130692642|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
130692643|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
130692644|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
130692645|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
130692646|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
130692647|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Other Event|49|||
130692648|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Other Event|52|||
130692649|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Other Event|41|||
130692650|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Other Event|58|||
130692651|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Other Event|0|||
130900234|NCT02431260|471269235|FG010|Overall Study|Study Terminated by the Sponsor|1|||
130692652|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Other Event|0|||
130692653|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
131112537|NCT01163721|472042421|FG000|Overall Study|Adverse Event|5|||
130900235|NCT02431260|471269236|FG011|Overall Study|Study Terminated by the Sponsor|0|||
130900236|NCT02431260|471269237|FG012|Overall Study|Study Terminated by the Sponsor|4|||
130692654|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
130692655|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
130900237|NCT02431260|471269238|FG013|Overall Study|Study Terminated by the Sponsor|0|||
130900238|NCT02431260|471269225|FG000|Overall Study|Physician Decision|0|||
130900239|NCT02431260|471269226|FG001|Overall Study|Physician Decision|0|||
130692656|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
130692657|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
130692658|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
130692659|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
130692660|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
130692661|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
130692662|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
130692663|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
130692664|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
130692665|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
130692666|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
130692667|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
130692668|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
130692669|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
130692670|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
130692671|NCT00205777|470501990|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
130692672|NCT00205777|470501991|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
130692673|NCT00205777|470501992|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
130692674|NCT00205777|470501993|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
130692675|NCT00205777|470501994|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
130692676|NCT00205777|470501995|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
130692677|NCT00205777|470501990|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
130692678|NCT00205777|470501991|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
130692679|NCT00205777|470501992|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
130692680|NCT00205777|470501993|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
130692681|NCT00205777|470501994|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
130692682|NCT00205777|470501995|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
130692683|NCT00205777|470501990|FG000|Completed Core Study, Entered SE I|Other Event|52|||
130692684|NCT00205777|470501991|FG001|Completed Core Study, Entered SE I|Other Event|46|||
130692685|NCT00205777|470501992|FG002|Completed Core Study, Entered SE I|Other Event|47|||
130692686|NCT00205777|470501993|FG003|Completed Core Study, Entered SE I|Other Event|50|||
130692687|NCT00205777|470501994|FG004|Completed Core Study, Entered SE I|Other Event|0|||
130692688|NCT00205777|470501995|FG005|Completed Core Study, Entered SE I|Other Event|0|||
130692689|NCT00205777|470501990|FG000|Study Extension I|Adverse Event|57|||
130692690|NCT00205777|470501991|FG001|Study Extension I|Adverse Event|0|||
130692691|NCT00205777|470501992|FG002|Study Extension I|Adverse Event|0|||
130692692|NCT00205777|470501993|FG003|Study Extension I|Adverse Event|61|||
130692693|NCT00205777|470501994|FG004|Study Extension I|Adverse Event|58|||
130900240|NCT02431260|471269227|FG002|Overall Study|Physician Decision|0|||
130900241|NCT02431260|471269228|FG003|Overall Study|Physician Decision|0|||
130900242|NCT02431260|471269229|FG004|Overall Study|Physician Decision|0|||
130900243|NCT02431260|471269230|FG005|Overall Study|Physician Decision|1|||
130900244|NCT02431260|471269231|FG006|Overall Study|Physician Decision|0|||
130900245|NCT02431260|471269232|FG007|Overall Study|Physician Decision|0|||
130900246|NCT02431260|471269233|FG008|Overall Study|Physician Decision|0|||
130900247|NCT02431260|471269234|FG009|Overall Study|Physician Decision|0|||
130900248|NCT02431260|471269235|FG010|Overall Study|Physician Decision|0|||
130900249|NCT02431260|471269236|FG011|Overall Study|Physician Decision|0|||
130900250|NCT02431260|471269237|FG012|Overall Study|Physician Decision|0|||
130900251|NCT02431260|471269238|FG013|Overall Study|Physician Decision|0|||
130900252|NCT02431260|471269225|FG000|Overall Study|Other Unspecified|0|||
130900253|NCT02431260|471269226|FG001|Overall Study|Other Unspecified|0|||
130900254|NCT02431260|471269227|FG002|Overall Study|Other Unspecified|0|||
130692694|NCT00205777|470501995|FG005|Study Extension I|Adverse Event|0|||
130692695|NCT00205777|470501990|FG000|Study Extension I|Death|5|||
131025909|NCT02652260|471725325|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
130692696|NCT00205777|470501991|FG001|Study Extension I|Death|0|||
130692697|NCT00205777|470501992|FG002|Study Extension I|Death|0|||
130692698|NCT00205777|470501993|FG003|Study Extension I|Death|1|||
130692699|NCT00205777|470501994|FG004|Study Extension I|Death|2|||
130900255|NCT02431260|471269228|FG003|Overall Study|Other Unspecified|0|||
130900256|NCT02431260|471269229|FG004|Overall Study|Other Unspecified|0|||
130900257|NCT02431260|471269230|FG005|Overall Study|Other Unspecified|0|||
130900258|NCT02431260|471269231|FG006|Overall Study|Other Unspecified|0|||
130900259|NCT02431260|471269232|FG007|Overall Study|Other Unspecified|0|||
130900260|NCT02431260|471269233|FG008|Overall Study|Other Unspecified|0|||
130900261|NCT02431260|471269234|FG009|Overall Study|Other Unspecified|0|||
130692700|NCT00205777|470501995|FG005|Study Extension I|Death|0|||
130692701|NCT00205777|470501990|FG000|Study Extension I|Withdrawal by Subject|99|||
130692702|NCT00205777|470501991|FG001|Study Extension I|Withdrawal by Subject|0|||
130692703|NCT00205777|470501992|FG002|Study Extension I|Withdrawal by Subject|0|||
130692704|NCT00205777|470501993|FG003|Study Extension I|Withdrawal by Subject|106|||
130692705|NCT00205777|470501994|FG004|Study Extension I|Withdrawal by Subject|89|||
130692706|NCT00205777|470501995|FG005|Study Extension I|Withdrawal by Subject|0|||
130692707|NCT00205777|470501990|FG000|Study Extension I|Protocol Violation|4|||
130692708|NCT00205777|470501991|FG001|Study Extension I|Protocol Violation|0|||
130692709|NCT00205777|470501992|FG002|Study Extension I|Protocol Violation|0|||
130692710|NCT00205777|470501993|FG003|Study Extension I|Protocol Violation|8|||
130692711|NCT00205777|470501994|FG004|Study Extension I|Protocol Violation|8|||
130692712|NCT00205777|470501995|FG005|Study Extension I|Protocol Violation|0|||
130692713|NCT00205777|470501990|FG000|Study Extension I|Lack of Efficacy|0|||
130692714|NCT00205777|470501991|FG001|Study Extension I|Lack of Efficacy|0|||
130692715|NCT00205777|470501992|FG002|Study Extension I|Lack of Efficacy|0|||
130692716|NCT00205777|470501993|FG003|Study Extension I|Lack of Efficacy|1|||
130692717|NCT00205777|470501994|FG004|Study Extension I|Lack of Efficacy|2|||
130692718|NCT00205777|470501995|FG005|Study Extension I|Lack of Efficacy|0|||
130692719|NCT00205777|470501990|FG000|Study Extension I|Failed to return|15|||
130692720|NCT00205777|470501991|FG001|Study Extension I|Failed to return|0|||
130692721|NCT00205777|470501992|FG002|Study Extension I|Failed to return|0|||
130692722|NCT00205777|470501993|FG003|Study Extension I|Failed to return|17|||
130692723|NCT00205777|470501994|FG004|Study Extension I|Failed to return|13|||
130692724|NCT00205777|470501995|FG005|Study Extension I|Failed to return|0|||
130692725|NCT00205777|470501990|FG000|Study Extension I|Other Event|34|||
130692726|NCT00205777|470501991|FG001|Study Extension I|Other Event|0|||
130692727|NCT00205777|470501992|FG002|Study Extension I|Other Event|0|||
130692728|NCT00205777|470501993|FG003|Study Extension I|Other Event|34|||
130692729|NCT00205777|470501994|FG004|Study Extension I|Other Event|29|||
130692730|NCT00205777|470501995|FG005|Study Extension I|Other Event|0|||
130900262|NCT02431260|471269235|FG010|Overall Study|Other Unspecified|0|||
130900263|NCT02431260|471269236|FG011|Overall Study|Other Unspecified|1|||
130900264|NCT02431260|471269237|FG012|Overall Study|Other Unspecified|1|||
130900265|NCT02431260|471269238|FG013|Overall Study|Other Unspecified|0|||
130900266|NCT00439738|471269242|FG000|Overall Study|Withdrawal by Subject|16|||
130900267|NCT00439738|471269243|FG001|Overall Study|Withdrawal by Subject|13|||
130900268|NCT00439738|471269242|FG000|Overall Study|Adverse Event|6|||
130900269|NCT00439738|471269243|FG001|Overall Study|Adverse Event|4|||
130900270|NCT00439738|471269242|FG000|Overall Study|Lost to Follow-up|5|||
130900271|NCT00439738|471269243|FG001|Overall Study|Lost to Follow-up|6|||
130900272|NCT00439738|471269242|FG000|Overall Study|Protocol Violation|6|||
130900273|NCT00439738|471269243|FG001|Overall Study|Protocol Violation|3|||
130900274|NCT00439738|471269242|FG000|Overall Study|Lack of Efficacy|2|||
130900275|NCT00439738|471269243|FG001|Overall Study|Lack of Efficacy|2|||
130900276|NCT00439738|471269242|FG000|Overall Study|Abnormal Lab Values|1|||
130900277|NCT00439738|471269243|FG001|Overall Study|Abnormal Lab Values|0|||
130900278|NCT00978757|471269244|FG000|Overall Study|Physician Decision|1|||
130900279|NCT00978757|471269245|FG001|Overall Study|Physician Decision|3|||
130900280|NCT01700387|471269246|FG000|Overall Study|Withdrawal by Subject|1|||
130900281|NCT01700387|471269247|FG001|Overall Study|Withdrawal by Subject|2|||
130900282|NCT01700387|471269246|FG000|Overall Study|Adverse Event|1|||
130900283|NCT01700387|471269247|FG001|Overall Study|Adverse Event|1|||
130900284|NCT01700387|471269246|FG000|Overall Study|Lost to Follow-up|2|||
130900285|NCT01700387|471269247|FG001|Overall Study|Lost to Follow-up|1|||
130900286|NCT01185353|471269249|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130900287|NCT01185353|471269250|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130900288|NCT01185353|471269251|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130900289|NCT01185353|471269252|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
131112538|NCT01163721|472042422|FG001|Overall Study|Adverse Event|6|||
130692731|NCT00205777|470501990|FG000|Study Extension I|Withdrawn as per protocol|0|||
130692732|NCT00205777|470501991|FG001|Study Extension I|Withdrawn as per protocol|0|||
130692733|NCT00205777|470501992|FG002|Study Extension I|Withdrawn as per protocol|1070|||
130692734|NCT00205777|470501993|FG003|Study Extension I|Withdrawn as per protocol|0|||
130692735|NCT00205777|470501994|FG004|Study Extension I|Withdrawn as per protocol|0|||
130692736|NCT00205777|470501995|FG005|Study Extension I|Withdrawn as per protocol|0|||
130692737|NCT00205777|470501990|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
130692738|NCT00205777|470501991|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
130692739|NCT00205777|470501992|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
130900290|NCT01185353|471269253|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
130900291|NCT01185353|471269254|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130900292|NCT01185353|471269255|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130900293|NCT01185353|471269256|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130900294|NCT01185353|471269257|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130900295|NCT01185353|471269258|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130900296|NCT01185353|471269249|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130900297|NCT01185353|471269250|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130900298|NCT01185353|471269251|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130900299|NCT01185353|471269252|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130900300|NCT01185353|471269253|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
130900301|NCT01185353|471269254|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130900302|NCT01185353|471269255|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130900303|NCT01185353|471269256|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130900304|NCT01185353|471269257|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130900305|NCT01185353|471269258|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130900306|NCT01185353|471269249|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
130900307|NCT01185353|471269250|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131112539|NCT01163721|472042421|FG000|Overall Study|Withdrawal by Subject|3|||
131112540|NCT01163721|472042422|FG001|Overall Study|Withdrawal by Subject|4|||
131112541|NCT01163721|472042421|FG000|Overall Study|Lost to Follow-up|0|||
131112542|NCT01163721|472042422|FG001|Overall Study|Lost to Follow-up|1|||
130692740|NCT00205777|470501993|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
130692741|NCT00205777|470501994|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
130692742|NCT00205777|470501995|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
130692743|NCT00205777|470501990|FG000|Study Extension II|Adverse Event|0|||
130692744|NCT00205777|470501991|FG001|Study Extension II|Adverse Event|0|||
130692745|NCT00205777|470501992|FG002|Study Extension II|Adverse Event|0|||
130692746|NCT00205777|470501993|FG003|Study Extension II|Adverse Event|14|||
130692747|NCT00205777|470501994|FG004|Study Extension II|Adverse Event|0|||
130692748|NCT00205777|470501995|FG005|Study Extension II|Adverse Event|30|||
130692749|NCT00205777|470501990|FG000|Study Extension II|Death|0|||
130692750|NCT00205777|470501991|FG001|Study Extension II|Death|0|||
130692751|NCT00205777|470501992|FG002|Study Extension II|Death|0|||
130692752|NCT00205777|470501993|FG003|Study Extension II|Death|2|||
131112543|NCT01163721|472042421|FG000|Overall Study|Physician Decision|0|||
131112544|NCT01163721|472042422|FG001|Overall Study|Physician Decision|1|||
131112545|NCT01472380|472042425|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
131112546|NCT01472380|472042425|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
131112547|NCT02511678|472042426|FG000|Overall Study|Withdrawal by Subject|2|||
131112548|NCT02511678|472042426|FG000|Overall Study|Lost to Follow-up|4|||
131112549|NCT02511678|472042426|FG000|Overall Study|Death|19|||
130692753|NCT00205777|470501994|FG004|Study Extension II|Death|0|||
130692754|NCT00205777|470501995|FG005|Study Extension II|Death|5|||
130692755|NCT00205777|470501990|FG000|Study Extension II|Withdrawal by Subject|0|||
130692756|NCT00205777|470501991|FG001|Study Extension II|Withdrawal by Subject|0|||
130692757|NCT00205777|470501992|FG002|Study Extension II|Withdrawal by Subject|0|||
130692758|NCT00205777|470501993|FG003|Study Extension II|Withdrawal by Subject|35|||
130692759|NCT00205777|470501994|FG004|Study Extension II|Withdrawal by Subject|0|||
130692760|NCT00205777|470501995|FG005|Study Extension II|Withdrawal by Subject|59|||
130692761|NCT00205777|470501990|FG000|Study Extension II|Protocol Violation|0|||
130692762|NCT00205777|470501991|FG001|Study Extension II|Protocol Violation|0|||
130692763|NCT00205777|470501992|FG002|Study Extension II|Protocol Violation|0|||
131112550|NCT02511678|472042426|FG000|Overall Study|Adverse Event|1|||
131112551|NCT02511678|472042426|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
131112552|NCT02511678|472042426|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
131112553|NCT02511678|472042426|FG000|Overall Study|Required Radiofrequency Ablation|1|||
131112554|NCT02511678|472042426|FG000|Overall Study|Biopsy was Negative|1|||
130692764|NCT00205777|470501993|FG003|Study Extension II|Protocol Violation|1|||
130692765|NCT00205777|470501994|FG004|Study Extension II|Protocol Violation|0|||
130692766|NCT00205777|470501995|FG005|Study Extension II|Protocol Violation|10|||
130692767|NCT00205777|470501990|FG000|Study Extension II|Lack of Efficacy|0|||
130692768|NCT00205777|470501991|FG001|Study Extension II|Lack of Efficacy|0|||
130692769|NCT00205777|470501992|FG002|Study Extension II|Lack of Efficacy|0|||
130692770|NCT00205777|470501993|FG003|Study Extension II|Lack of Efficacy|0|||
130900308|NCT01185353|471269251|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130900309|NCT01185353|471269252|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131112555|NCT02511678|472042426|FG000|Overall Study|Protocol Violation|1|||
131112556|NCT02511678|472042426|FG000|Overall Study|Received Radiation Treatment|1|||
131112557|NCT01295281|472042427|FG000|First Intervention (7 Days)|Death|0|||
131112558|NCT01295281|472042428|FG001|First Intervention (7 Days)|Death|1|||
131112559|NCT00292461|472042429|FG000|Overall Study|Adverse Event|4|||
130692771|NCT00205777|470501994|FG004|Study Extension II|Lack of Efficacy|0|||
131112560|NCT00292461|472042430|FG001|Overall Study|Adverse Event|2|||
131112561|NCT00292461|472042429|FG000|Overall Study|Lack of Efficacy|1|||
131112562|NCT00292461|472042430|FG001|Overall Study|Lack of Efficacy|0|||
130692772|NCT00205777|470501995|FG005|Study Extension II|Lack of Efficacy|1|||
130692773|NCT00205777|470501990|FG000|Study Extension II|Failed to return|0|||
130692774|NCT00205777|470501991|FG001|Study Extension II|Failed to return|0|||
131112563|NCT00292461|472042429|FG000|Overall Study|Withdrawal by Subject|0|||
131112564|NCT00292461|472042430|FG001|Overall Study|Withdrawal by Subject|1|||
130692775|NCT00205777|470501992|FG002|Study Extension II|Failed to return|0|||
130692776|NCT00205777|470501993|FG003|Study Extension II|Failed to return|14|||
130692777|NCT00205777|470501994|FG004|Study Extension II|Failed to return|0|||
130692778|NCT00205777|470501995|FG005|Study Extension II|Failed to return|26|||
130692779|NCT00205777|470501990|FG000|Study Extension II|Other Event|0|||
130692780|NCT00205777|470501991|FG001|Study Extension II|Other Event|0|||
130692781|NCT00205777|470501992|FG002|Study Extension II|Other Event|0|||
130692782|NCT00205777|470501993|FG003|Study Extension II|Other Event|12|||
130692783|NCT00205777|470501994|FG004|Study Extension II|Other Event|0|||
130692784|NCT00205777|470501995|FG005|Study Extension II|Other Event|20|||
130692785|NCT00205777|470501990|FG000|Study Extension II|Enrolled but not treated|0|||
130692786|NCT00205777|470501991|FG001|Study Extension II|Enrolled but not treated|0|||
130692787|NCT00205777|470501992|FG002|Study Extension II|Enrolled but not treated|0|||
130692788|NCT00205777|470501993|FG003|Study Extension II|Enrolled but not treated|71|||
130692789|NCT00205777|470501994|FG004|Study Extension II|Enrolled but not treated|0|||
130692790|NCT00205777|470501995|FG005|Study Extension II|Enrolled but not treated|131|||
130692791|NCT00367133|470501998|FG000|2 Years|Death|20|||
130692792|NCT00367133|470501999|FG001|2 Years|Death|12|||
130692793|NCT00367133|470502000|FG002|2 Years|Death|12|||
130692794|NCT00367133|470501998|FG000|2 Years|Dropped|34|||
130692795|NCT00367133|470501999|FG001|2 Years|Dropped|19|||
130692796|NCT00367133|470502000|FG002|2 Years|Dropped|33|||
130692797|NCT00367133|470501998|FG000|2 Years|Missed visit|4|||
130692798|NCT00367133|470501999|FG001|2 Years|Missed visit|5|||
130692799|NCT00367133|470502000|FG002|2 Years|Missed visit|4|||
130692800|NCT02336074|470502001|FG000|Overall Study|Adverse Event|0|||
130692801|NCT02336074|470502002|FG001|Overall Study|Adverse Event|2|||
130692802|NCT00906399|470502003|FG000|Year 1|Randomized But Not Treated|0|||
130692803|NCT00906399|470502004|FG001|Year 1|Randomized But Not Treated|1|||
130692804|NCT00906399|470502005|FG002|Year 1|Randomized But Not Treated|3|||
130692805|NCT00906399|470502006|FG003|Year 1|Randomized But Not Treated|0|||
130692806|NCT00906399|470502007|FG004|Year 1|Randomized But Not Treated|0|||
130692807|NCT00906399|470502008|FG005|Year 1|Randomized But Not Treated|0|||
130692808|NCT00906399|470502009|FG006|Year 1|Randomized But Not Treated|0|||
130692809|NCT00906399|470502003|FG000|Year 1|Adverse Event|4|||
130692810|NCT00906399|470502004|FG001|Year 1|Adverse Event|22|||
130692811|NCT00906399|470502005|FG002|Year 1|Adverse Event|24|||
130692812|NCT00906399|470502006|FG003|Year 1|Adverse Event|0|||
130692813|NCT00906399|470502007|FG004|Year 1|Adverse Event|0|||
130692814|NCT00906399|470502008|FG005|Year 1|Adverse Event|0|||
130692815|NCT00906399|470502009|FG006|Year 1|Adverse Event|0|||
130692816|NCT00906399|470502003|FG000|Year 1|Lost to Follow-up|4|||
130692817|NCT00906399|470502004|FG001|Year 1|Lost to Follow-up|4|||
130692818|NCT00906399|470502005|FG002|Year 1|Lost to Follow-up|2|||
130692819|NCT00906399|470502006|FG003|Year 1|Lost to Follow-up|0|||
130692820|NCT00906399|470502007|FG004|Year 1|Lost to Follow-up|0|||
130692821|NCT00906399|470502008|FG005|Year 1|Lost to Follow-up|0|||
130692822|NCT00906399|470502009|FG006|Year 1|Lost to Follow-up|0|||
130692823|NCT00906399|470502003|FG000|Year 1|Withdrawal by Subject|30|||
130692824|NCT00906399|470502004|FG001|Year 1|Withdrawal by Subject|32|||
130692825|NCT00906399|470502005|FG002|Year 1|Withdrawal by Subject|36|||
130692826|NCT00906399|470502006|FG003|Year 1|Withdrawal by Subject|0|||
130692827|NCT00906399|470502007|FG004|Year 1|Withdrawal by Subject|0|||
130692828|NCT00906399|470502008|FG005|Year 1|Withdrawal by Subject|0|||
130692829|NCT00906399|470502009|FG006|Year 1|Withdrawal by Subject|0|||
130692830|NCT00906399|470502003|FG000|Year 1|Physician Decision|0|||
130692831|NCT00906399|470502004|FG001|Year 1|Physician Decision|1|||
130692832|NCT00906399|470502005|FG002|Year 1|Physician Decision|3|||
130692833|NCT00906399|470502006|FG003|Year 1|Physician Decision|0|||
130692834|NCT00906399|470502007|FG004|Year 1|Physician Decision|0|||
130692835|NCT00906399|470502008|FG005|Year 1|Physician Decision|0|||
130692836|NCT00906399|470502009|FG006|Year 1|Physician Decision|0|||
130692837|NCT00906399|470502003|FG000|Year 1|Death|2|||
130692838|NCT00906399|470502004|FG001|Year 1|Death|1|||
130692839|NCT00906399|470502005|FG002|Year 1|Death|1|||
130692840|NCT00906399|470502006|FG003|Year 1|Death|0|||
130692841|NCT00906399|470502007|FG004|Year 1|Death|0|||
130692842|NCT00906399|470502008|FG005|Year 1|Death|0|||
130692843|NCT00906399|470502009|FG006|Year 1|Death|0|||
130692844|NCT00906399|470502003|FG000|Year 1|Other|4|||
130692845|NCT00906399|470502004|FG001|Year 1|Other|2|||
130692846|NCT00906399|470502005|FG002|Year 1|Other|7|||
130692847|NCT00906399|470502006|FG003|Year 1|Other|0|||
130692848|NCT00906399|470502007|FG004|Year 1|Other|0|||
130692849|NCT00906399|470502008|FG005|Year 1|Other|0|||
130692850|NCT00906399|470502009|FG006|Year 1|Other|0|||
130692851|NCT00906399|470502003|FG000|Year 2|Adverse Event|0|||
130692852|NCT00906399|470502004|FG001|Year 2|Adverse Event|0|||
130692853|NCT00906399|470502005|FG002|Year 2|Adverse Event|0|||
130692854|NCT00906399|470502006|FG003|Year 2|Adverse Event|9|||
130692855|NCT00906399|470502007|FG004|Year 2|Adverse Event|8|||
130692856|NCT00906399|470502008|FG005|Year 2|Adverse Event|11|||
130692857|NCT00906399|470502009|FG006|Year 2|Adverse Event|6|||
130692858|NCT00906399|470502003|FG000|Year 2|Lost to Follow-up|0|||
130692859|NCT00906399|470502004|FG001|Year 2|Lost to Follow-up|0|||
130692860|NCT00906399|470502005|FG002|Year 2|Lost to Follow-up|0|||
130692861|NCT00906399|470502006|FG003|Year 2|Lost to Follow-up|1|||
130692862|NCT00906399|470502007|FG004|Year 2|Lost to Follow-up|4|||
130692863|NCT00906399|470502008|FG005|Year 2|Lost to Follow-up|2|||
130692864|NCT00906399|470502009|FG006|Year 2|Lost to Follow-up|4|||
130692865|NCT00906399|470502003|FG000|Year 2|Withdrawal by Subject|0|||
130692866|NCT00906399|470502004|FG001|Year 2|Withdrawal by Subject|0|||
130692867|NCT00906399|470502005|FG002|Year 2|Withdrawal by Subject|0|||
130692868|NCT00906399|470502006|FG003|Year 2|Withdrawal by Subject|17|||
130692869|NCT00906399|470502007|FG004|Year 2|Withdrawal by Subject|18|||
130692870|NCT00906399|470502008|FG005|Year 2|Withdrawal by Subject|27|||
130692871|NCT00906399|470502009|FG006|Year 2|Withdrawal by Subject|13|||
130692872|NCT00906399|470502003|FG000|Year 2|Physician Decision|0|||
130692873|NCT00906399|470502004|FG001|Year 2|Physician Decision|0|||
130692874|NCT00906399|470502005|FG002|Year 2|Physician Decision|0|||
130692875|NCT00906399|470502006|FG003|Year 2|Physician Decision|0|||
130692876|NCT00906399|470502007|FG004|Year 2|Physician Decision|2|||
130692877|NCT00906399|470502008|FG005|Year 2|Physician Decision|6|||
130692878|NCT00906399|470502009|FG006|Year 2|Physician Decision|3|||
130692879|NCT00906399|470502003|FG000|Year 2|Death|0|||
130692880|NCT00906399|470502004|FG001|Year 2|Death|0|||
130692881|NCT00906399|470502005|FG002|Year 2|Death|0|||
130692882|NCT00906399|470502006|FG003|Year 2|Death|1|||
130692883|NCT00906399|470502007|FG004|Year 2|Death|0|||
130692884|NCT00906399|470502008|FG005|Year 2|Death|0|||
130692885|NCT00906399|470502009|FG006|Year 2|Death|3|||
130692886|NCT00906399|470502003|FG000|Year 2|Other|0|||
130692887|NCT00906399|470502004|FG001|Year 2|Other|0|||
130692888|NCT00906399|470502005|FG002|Year 2|Other|0|||
130692889|NCT00906399|470502006|FG003|Year 2|Other|2|||
130692890|NCT00906399|470502007|FG004|Year 2|Other|3|||
130692891|NCT00906399|470502008|FG005|Year 2|Other|1|||
130692892|NCT00906399|470502009|FG006|Year 2|Other|0|||
130692893|NCT00858780|470502024|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
130692894|NCT00858780|470502025|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130692895|NCT00858780|470502026|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130692896|NCT00858780|470502027|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130692897|NCT00858780|470502028|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130692898|NCT00858780|470502024|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130692899|NCT00858780|470502025|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130692900|NCT00858780|470502026|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
130692901|NCT00858780|470502027|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130692902|NCT00858780|470502028|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130692903|NCT00858780|470502024|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
130692904|NCT00858780|470502025|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
130692905|NCT00858780|470502026|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
130692906|NCT00858780|470502027|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
130692907|NCT00858780|470502028|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
130692908|NCT00858780|470502024|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130692909|NCT00858780|470502025|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
130692910|NCT00858780|470502026|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130692911|NCT00858780|470502027|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130692912|NCT00858780|470502028|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130692913|NCT00858780|470502024|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130692914|NCT00858780|470502025|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130692915|NCT00858780|470502026|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130692916|NCT00858780|470502027|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130692917|NCT00858780|470502028|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
130692918|NCT00858780|470502024|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
130692919|NCT00858780|470502025|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
130692920|NCT00858780|470502026|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
130692921|NCT00858780|470502027|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
131025910|NCT02652260|471725326|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
130692922|NCT00858780|470502028|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
130692923|NCT00863330|470502029|FG000|Overall Study|study terminated early due to administra|6|||
130692924|NCT03602339|470502030|FG000|Overall Study|Withdrawal by Subject|9|||
130692925|NCT03602339|470502030|FG000|Overall Study|Physician Decision|2|||
130692926|NCT03602339|470502030|FG000|Overall Study|Other reason|4|||
130692927|NCT01297504|470502031|FG000|Overall Study|Invalid Consent|1|||
130692928|NCT01297504|470502031|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
130692929|NCT01297504|470502031|FG000|Overall Study|No Study Visits|4|||
130692930|NCT01297504|470502031|FG000|Overall Study|Death|3|||
130692931|NCT01297504|470502031|FG000|Overall Study|Lost to Follow-up|43|||
130692932|NCT01297504|470502031|FG000|Overall Study|Withdrawal by Subject|9|||
130692933|NCT01297504|470502031|FG000|Overall Study|Site Closure|3|||
130692934|NCT01297504|470502031|FG000|Overall Study|Protocol Violation|3|||
130692935|NCT02615249|470502032|FG000|Overall Study|Withdrawal by Subject|1|||
130692936|NCT00574847|470502033|FG000|Overall Study|Adverse Event|2|||
130692937|NCT00574847|470502034|FG001|Overall Study|Adverse Event|0|||
130692938|NCT00574847|470502033|FG000|Overall Study|Death|1|||
130692939|NCT00574847|470502034|FG001|Overall Study|Death|0|||
130692940|NCT00574847|470502033|FG000|Overall Study|Withdrawal by Subject|2|||
130692941|NCT00574847|470502034|FG001|Overall Study|Withdrawal by Subject|2|||
130692942|NCT00574847|470502033|FG000|Overall Study|Physician Decision|1|||
130692943|NCT00574847|470502034|FG001|Overall Study|Physician Decision|0|||
130692944|NCT00574847|470502033|FG000|Overall Study|Did not receive medication (declined)|2|||
130692945|NCT00574847|470502034|FG001|Overall Study|Did not receive medication (declined)|5|||
130692946|NCT03719040|470502041|FG000|Overall Study|Withdrawal by Subject|177|||
130692947|NCT03719040|470502041|FG000|Overall Study|Lost to Follow-up|26|||
130692948|NCT02923349|470502042|FG000|Overall Study|Other|1|||
130692949|NCT02923349|470502043|FG001|Overall Study|Other|2|||
130692950|NCT02923349|470502044|FG002|Overall Study|Other|4|||
130692951|NCT02923349|470502045|FG003|Overall Study|Other|1|||
130692952|NCT02923349|470502046|FG004|Overall Study|Other|3|||
130692953|NCT02923349|470502047|FG005|Overall Study|Other|0|||
130692954|NCT02923349|470502048|FG006|Overall Study|Other|1|||
130692955|NCT02923349|470502042|FG000|Overall Study|Withdrawal by Subject|2|||
130692956|NCT02923349|470502043|FG001|Overall Study|Withdrawal by Subject|2|||
130692957|NCT02923349|470502044|FG002|Overall Study|Withdrawal by Subject|8|||
130692958|NCT02923349|470502045|FG003|Overall Study|Withdrawal by Subject|10|||
130692959|NCT02923349|470502046|FG004|Overall Study|Withdrawal by Subject|12|||
130692960|NCT02923349|470502047|FG005|Overall Study|Withdrawal by Subject|3|||
130692961|NCT02923349|470502048|FG006|Overall Study|Withdrawal by Subject|0|||
130692962|NCT02923349|470502042|FG000|Overall Study|Physician Decision|0|||
130692963|NCT02923349|470502043|FG001|Overall Study|Physician Decision|0|||
130692964|NCT02923349|470502044|FG002|Overall Study|Physician Decision|0|||
130692965|NCT02923349|470502045|FG003|Overall Study|Physician Decision|1|||
130692966|NCT02923349|470502046|FG004|Overall Study|Physician Decision|1|||
130692967|NCT02923349|470502047|FG005|Overall Study|Physician Decision|0|||
130692968|NCT02923349|470502048|FG006|Overall Study|Physician Decision|2|||
130692969|NCT02923349|470502042|FG000|Overall Study|Lost to Follow-up|0|||
130692970|NCT02923349|470502043|FG001|Overall Study|Lost to Follow-up|0|||
130692971|NCT02923349|470502044|FG002|Overall Study|Lost to Follow-up|3|||
130692972|NCT02923349|470502045|FG003|Overall Study|Lost to Follow-up|0|||
130692973|NCT02923349|470502046|FG004|Overall Study|Lost to Follow-up|1|||
130692974|NCT02923349|470502047|FG005|Overall Study|Lost to Follow-up|1|||
130692975|NCT02923349|470502048|FG006|Overall Study|Lost to Follow-up|0|||
130692976|NCT02923349|470502042|FG000|Overall Study|Death|1|||
130692977|NCT02923349|470502043|FG001|Overall Study|Death|0|||
130692978|NCT02923349|470502044|FG002|Overall Study|Death|2|||
130692979|NCT02923349|470502045|FG003|Overall Study|Death|4|||
130692980|NCT02923349|470502046|FG004|Overall Study|Death|2|||
130692981|NCT02923349|470502047|FG005|Overall Study|Death|3|||
130692982|NCT02923349|470502048|FG006|Overall Study|Death|0|||
130692983|NCT02751827|470502049|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
130692984|NCT02751827|470502050|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
130692985|NCT02751827|470502051|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
130692986|NCT03428750|470503529|FG000|Overall Study|Withdrawal by Subject|11|||
130692987|NCT03428750|470503530|FG001|Overall Study|Withdrawal by Subject|10|||
130692988|NCT03428750|470503529|FG000|Overall Study|Lost to Follow-up|3|||
130692989|NCT03428750|470503530|FG001|Overall Study|Lost to Follow-up|9|||
130768155|NCT01663857|470775461|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
130900310|NCT01185353|471269253|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
131025911|NCT02652260|471725325|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
131025912|NCT02652260|471725326|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
131025913|NCT02652260|471725325|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
130692990|NCT03428750|470503529|FG000|Overall Study|Adverse Event|9|||
130692991|NCT03428750|470503530|FG001|Overall Study|Adverse Event|1|||
130692992|NCT03428750|470503529|FG000|Overall Study|Protocol Violation|1|||
130692993|NCT03428750|470503530|FG001|Overall Study|Protocol Violation|0|||
130692994|NCT03428750|470503529|FG000|Overall Study|Administrative|0|||
130692995|NCT03428750|470503530|FG001|Overall Study|Administrative|1|||
130692996|NCT04547192|470503531|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
130692997|NCT04547192|470503532|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
130692998|NCT04547192|470503533|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
130692999|NCT04547192|470503534|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
130900311|NCT01185353|471269254|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
131025914|NCT02652260|471725326|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
130768156|NCT01663857|470775462|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
130768157|NCT01663857|470775459|FG000|Overall Study|Lost to Follow-up|0|||
130693000|NCT04547192|470503531|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
130693001|NCT04547192|470503532|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
130693002|NCT04547192|470503533|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
130693003|NCT04547192|470503534|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
130693004|NCT04547192|470503531|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
130693005|NCT04547192|470503532|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
130693006|NCT04547192|470503533|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
130693007|NCT04547192|470503534|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
130693008|NCT04547192|470503531|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
130693009|NCT04547192|470503532|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
130693010|NCT04547192|470503533|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
130693011|NCT04547192|470503534|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
130693012|NCT04547192|470503531|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
130693013|NCT04547192|470503532|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
130693014|NCT04547192|470503533|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
130693015|NCT04547192|470503534|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
130693016|NCT04723693|470503535|FG000|Overall Study|Withdrawal by Subject|2|||
130693017|NCT03497130|470503536|FG000|Overall Study|Lost to Follow-up|1|||
130693018|NCT03497130|470503537|FG001|Overall Study|Lost to Follow-up|1|||
130693019|NCT04002648|470503538|FG000|Overall Study|Lost to Follow-up|2|||
130693020|NCT04002648|470503539|FG001|Overall Study|Lost to Follow-up|0|||
130693021|NCT00669162|470503543|FG000|Overall Study|Withdrawal by Subject|1|||
130693022|NCT02412852|470503544|FG000|Overall Study|Withdrawal by Subject|0|||
130693023|NCT02412852|470503545|FG001|Overall Study|Withdrawal by Subject|1|||
130693024|NCT02412852|470503546|FG002|Overall Study|Withdrawal by Subject|0|||
130693025|NCT02412852|470503547|FG003|Overall Study|Withdrawal by Subject|0|||
130693026|NCT02412852|470503544|FG000|Overall Study|Physician Decision|0|||
130693027|NCT02412852|470503545|FG001|Overall Study|Physician Decision|0|||
130693028|NCT02412852|470503546|FG002|Overall Study|Physician Decision|0|||
130693029|NCT02412852|470503547|FG003|Overall Study|Physician Decision|1|||
130693030|NCT01051349|470503548|FG000|Overall Study|Adverse Event|88|||
130693031|NCT01051349|470503548|FG000|Overall Study|Consent Withdrawn|54|||
130693032|NCT01051349|470503548|FG000|Overall Study|Investigator Decision|6|||
130693033|NCT01051349|470503548|FG000|Overall Study|Lost to Follow-up|6|||
130693034|NCT01051349|470503548|FG000|Overall Study|Subject non-compliance|7|||
130693035|NCT01051349|470503548|FG000|Overall Study|Reason not Specified|12|||
130693036|NCT00909753|470503549|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
130693037|NCT00909753|470503550|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
130693038|NCT00909753|470503549|FG000|Period: Second Intervention|Protocol Violation|1|||
130693039|NCT00909753|470503550|FG001|Period: Second Intervention|Protocol Violation|0|||
130693040|NCT00841542|470503553|FG000|Period 1|Adverse Event|1|||
130693041|NCT00841542|470503554|FG001|Period 1|Adverse Event|0|||
130693042|NCT00418145|470503555|FG000|Overall Study|study terminated|6|||
130693043|NCT03214588|470503556|FG000|Overall Study|Adverse Event|1|||
130693044|NCT03214588|470503557|FG001|Overall Study|Adverse Event|0|||
130693045|NCT03214588|470503558|FG002|Overall Study|Adverse Event|2|||
130693046|NCT03214588|470503556|FG000|Overall Study|Reason Not Specified|0|||
130693047|NCT03214588|470503557|FG001|Overall Study|Reason Not Specified|1|||
130693048|NCT03214588|470503558|FG002|Overall Study|Reason Not Specified|0|||
130693049|NCT00472212|470503559|FG000|Overall Study|Lost to Follow-up|6|||
130693050|NCT00472212|470503560|FG001|Overall Study|Lost to Follow-up|4|||
130693051|NCT03480763|470503561|FG000|Overall Study|Withdrawal by Subject|18|||
130693052|NCT03480763|470503562|FG001|Overall Study|Withdrawal by Subject|10|||
130693053|NCT03480763|470503561|FG000|Overall Study|Lost to Follow-up|4|||
130693054|NCT03480763|470503562|FG001|Overall Study|Lost to Follow-up|7|||
130693055|NCT03480763|470503561|FG000|Overall Study|non-study pneumococcal vaccine|1|||
130693056|NCT03480763|470503562|FG001|Overall Study|non-study pneumococcal vaccine|0|||
130693057|NCT03480763|470503561|FG000|Overall Study|oncological treatment|0|||
130693058|NCT03480763|470503562|FG001|Overall Study|oncological treatment|2|||
131025915|NCT02652260|471725325|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
131025916|NCT02652260|471725326|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
131025917|NCT02652260|471725325|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
131025918|NCT02652260|471725326|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
131025919|NCT02652260|471725325|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
131025920|NCT02652260|471725326|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
131025921|NCT05056246|471725327|FG000|Overall Study|Adverse Event|0|||
131025922|NCT05056246|471725328|FG001|Overall Study|Adverse Event|0|||
130693059|NCT03480763|470503561|FG000|Overall Study|pain with vaccination|1|||
131025923|NCT05056246|471725329|FG002|Overall Study|Adverse Event|0|||
131025924|NCT05056246|471725330|FG003|Overall Study|Adverse Event|0|||
131025925|NCT05056246|471725331|FG004|Overall Study|Adverse Event|1|||
130693060|NCT03480763|470503562|FG001|Overall Study|pain with vaccination|0|||
130693061|NCT01647828|470503567|FG000|Overall Study|Death|3|||
130693062|NCT01647828|470503568|FG001|Overall Study|Death|4|||
130693063|NCT01647828|470503569|FG002|Overall Study|Death|4|||
130693064|NCT01647828|470503570|FG003|Overall Study|Death|5|||
130693065|NCT01647828|470503571|FG004|Overall Study|Death|6|||
130693066|NCT01647828|470503572|FG005|Overall Study|Death|3|||
131025926|NCT05056246|471725327|FG000|Overall Study|Lost to Follow-up|0|||
131025927|NCT05056246|471725328|FG001|Overall Study|Lost to Follow-up|0|||
130693067|NCT01647828|470503573|FG006|Overall Study|Death|10|||
130693068|NCT01647828|470503574|FG007|Overall Study|Death|60|||
130693069|NCT01647828|470503575|FG008|Overall Study|Death|71|||
130693070|NCT01647828|470503567|FG000|Overall Study|Withdrawal by Subject|2|||
130693071|NCT01647828|470503568|FG001|Overall Study|Withdrawal by Subject|0|||
130693072|NCT01647828|470503569|FG002|Overall Study|Withdrawal by Subject|0|||
130693073|NCT01647828|470503570|FG003|Overall Study|Withdrawal by Subject|1|||
130693074|NCT01647828|470503571|FG004|Overall Study|Withdrawal by Subject|0|||
130693075|NCT01647828|470503572|FG005|Overall Study|Withdrawal by Subject|0|||
130693076|NCT01647828|470503573|FG006|Overall Study|Withdrawal by Subject|1|||
130693077|NCT01647828|470503574|FG007|Overall Study|Withdrawal by Subject|0|||
130693078|NCT01647828|470503575|FG008|Overall Study|Withdrawal by Subject|2|||
130693079|NCT01647828|470503567|FG000|Overall Study|Study terminated by Sponsor|0|||
130693080|NCT01647828|470503568|FG001|Overall Study|Study terminated by Sponsor|0|||
130693081|NCT01647828|470503569|FG002|Overall Study|Study terminated by Sponsor|0|||
130693082|NCT01647828|470503570|FG003|Overall Study|Study terminated by Sponsor|0|||
130693083|NCT01647828|470503571|FG004|Overall Study|Study terminated by Sponsor|0|||
130693084|NCT01647828|470503572|FG005|Overall Study|Study terminated by Sponsor|0|||
130693085|NCT01647828|470503573|FG006|Overall Study|Study terminated by Sponsor|1|||
130693086|NCT01647828|470503574|FG007|Overall Study|Study terminated by Sponsor|26|||
130693087|NCT01647828|470503575|FG008|Overall Study|Study terminated by Sponsor|16|||
130693088|NCT01647828|470503567|FG000|Overall Study|Lost to Follow-up|0|||
130693089|NCT01647828|470503568|FG001|Overall Study|Lost to Follow-up|0|||
130693090|NCT01647828|470503569|FG002|Overall Study|Lost to Follow-up|0|||
130693091|NCT01647828|470503570|FG003|Overall Study|Lost to Follow-up|0|||
130693092|NCT01647828|470503571|FG004|Overall Study|Lost to Follow-up|0|||
130693093|NCT01647828|470503572|FG005|Overall Study|Lost to Follow-up|0|||
130693094|NCT01647828|470503573|FG006|Overall Study|Lost to Follow-up|0|||
130693095|NCT01647828|470503574|FG007|Overall Study|Lost to Follow-up|2|||
130693096|NCT01647828|470503575|FG008|Overall Study|Lost to Follow-up|0|||
130693097|NCT01906372|470503576|FG000|Overall Study|Withdrawal by Subject|2|||
130693098|NCT03629054|470503577|FG000|Period 2 (4 Days)|Not treated|0|||
130693099|NCT03629054|470503578|FG001|Period 2 (4 Days)|Not treated|1|||
130693100|NCT00624286|470503585|FG000|Overall Study|Protocol Deviation|7|||
130693101|NCT00624286|470503586|FG001|Overall Study|Protocol Deviation|9|||
130693102|NCT00624286|470503585|FG000|Overall Study|Adverse Event|6|||
130693103|NCT00624286|470503586|FG001|Overall Study|Adverse Event|3|||
130693104|NCT00624286|470503585|FG000|Overall Study|Withdrawal by Subject|5|||
130693105|NCT00624286|470503586|FG001|Overall Study|Withdrawal by Subject|4|||
130693106|NCT00624286|470503585|FG000|Overall Study|Lost to Follow-up|3|||
130693107|NCT00624286|470503586|FG001|Overall Study|Lost to Follow-up|2|||
130693108|NCT00624286|470503585|FG000|Overall Study|Administrative problems|3|||
130693109|NCT00624286|470503586|FG001|Overall Study|Administrative problems|0|||
130693110|NCT00624286|470503585|FG000|Overall Study|Lack of Efficacy|1|||
130693111|NCT00624286|470503586|FG001|Overall Study|Lack of Efficacy|6|||
130693112|NCT00624286|470503585|FG000|Overall Study|Not stated|0|||
130693113|NCT00624286|470503586|FG001|Overall Study|Not stated|1|||
130693114|NCT00624286|470503585|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130693115|NCT00624286|470503586|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130693116|NCT00624286|470503585|FG000|Overall Study|Death|0|||
130693117|NCT00624286|470503586|FG001|Overall Study|Death|1|||
130693118|NCT04404725|470503587|FG000|First Intervention|Withdrawal by Subject|0|||
130693119|NCT04404725|470503588|FG001|First Intervention|Withdrawal by Subject|2|||
130693120|NCT04404725|470503587|FG000|Second Intervention|Adverse Event|1|||
130693121|NCT04404725|470503588|FG001|Second Intervention|Adverse Event|1|||
130693122|NCT04404725|470503587|FG000|Second Intervention|Withdrawal by Subject|0|||
130693123|NCT04404725|470503588|FG001|Second Intervention|Withdrawal by Subject|1|||
130693124|NCT01075516|470503589|FG000|Overall Study|Death|5|||
130693125|NCT01075516|470503590|FG001|Overall Study|Death|9|||
130693126|NCT01075516|470503589|FG000|Overall Study|Lost to Follow-up|10|||
130693127|NCT01075516|470503590|FG001|Overall Study|Lost to Follow-up|2|||
130693128|NCT01075516|470503589|FG000|Overall Study|Withdrawal by Subject|3|||
130693129|NCT01075516|470503590|FG001|Overall Study|Withdrawal by Subject|5|||
130693130|NCT02252016|470503591|FG000|Overall Study|Lost to Follow-up|2|||
130693131|NCT02252016|470503592|FG001|Overall Study|Lost to Follow-up|1|||
130693132|NCT02252016|470503591|FG000|Overall Study|Physician Decision|1|||
130693133|NCT02252016|470503592|FG001|Overall Study|Physician Decision|0|||
130693134|NCT02252016|470503591|FG000|Overall Study|Withdrawal by Subject|0|||
130693135|NCT02252016|470503592|FG001|Overall Study|Withdrawal by Subject|2|||
130693136|NCT01190865|470503593|FG000|Overall Study|Withdrawal by Subject|1|||
130693137|NCT01190865|470503593|FG000|Overall Study|Non-compliance|2|||
130693138|NCT02055547|470503604|FG000|Overall Study|Protocol Violation|0|||
130693139|NCT02055547|470503605|FG001|Overall Study|Protocol Violation|0|||
130693140|NCT02055547|470503606|FG002|Overall Study|Protocol Violation|1|||
130693141|NCT02055547|470503607|FG003|Overall Study|Protocol Violation|0|||
130693142|NCT02055547|470503608|FG004|Overall Study|Protocol Violation|0|||
130693143|NCT02055547|470503609|FG005|Overall Study|Protocol Violation|0|||
130693144|NCT02055547|470503610|FG006|Overall Study|Protocol Violation|1|||
130693145|NCT02055547|470503611|FG007|Overall Study|Protocol Violation|0|||
130693146|NCT02055547|470503612|FG008|Overall Study|Protocol Violation|0|||
130693147|NCT02055547|470503613|FG009|Overall Study|Protocol Violation|0|||
130693148|NCT02055547|470503614|FG010|Overall Study|Protocol Violation|0|||
130693149|NCT02055547|470503615|FG011|Overall Study|Protocol Violation|0|||
130693150|NCT02055547|470503616|FG012|Overall Study|Protocol Violation|0|||
130693151|NCT02055547|470503617|FG013|Overall Study|Protocol Violation|0|||
130693152|NCT02055547|470503618|FG014|Overall Study|Protocol Violation|0|||
130693153|NCT02055547|470503619|FG015|Overall Study|Protocol Violation|0|||
130693154|NCT02055547|470503620|FG016|Overall Study|Protocol Violation|0|||
130693155|NCT02055547|470503621|FG017|Overall Study|Protocol Violation|0|||
130693156|NCT02055547|470503622|FG018|Overall Study|Protocol Violation|0|||
130693157|NCT02055547|470503604|FG000|Overall Study|Physician Decision|0|||
130693158|NCT02055547|470503605|FG001|Overall Study|Physician Decision|1|||
130693159|NCT02055547|470503606|FG002|Overall Study|Physician Decision|1|||
130693160|NCT02055547|470503607|FG003|Overall Study|Physician Decision|0|||
130693161|NCT02055547|470503608|FG004|Overall Study|Physician Decision|1|||
130693162|NCT02055547|470503609|FG005|Overall Study|Physician Decision|0|||
130693163|NCT02055547|470503610|FG006|Overall Study|Physician Decision|0|||
130693164|NCT02055547|470503611|FG007|Overall Study|Physician Decision|0|||
130693165|NCT02055547|470503612|FG008|Overall Study|Physician Decision|0|||
130693166|NCT02055547|470503613|FG009|Overall Study|Physician Decision|1|||
130693167|NCT02055547|470503614|FG010|Overall Study|Physician Decision|1|||
130693168|NCT02055547|470503615|FG011|Overall Study|Physician Decision|0|||
130693169|NCT02055547|470503616|FG012|Overall Study|Physician Decision|0|||
130693170|NCT02055547|470503617|FG013|Overall Study|Physician Decision|0|||
130693171|NCT02055547|470503618|FG014|Overall Study|Physician Decision|0|||
130693172|NCT02055547|470503619|FG015|Overall Study|Physician Decision|0|||
130693173|NCT02055547|470503620|FG016|Overall Study|Physician Decision|0|||
130693174|NCT02055547|470503621|FG017|Overall Study|Physician Decision|0|||
130693175|NCT02055547|470503622|FG018|Overall Study|Physician Decision|0|||
130693176|NCT02055547|470503604|FG000|Overall Study|Adverse Event|0|||
130693177|NCT02055547|470503605|FG001|Overall Study|Adverse Event|0|||
130693178|NCT02055547|470503606|FG002|Overall Study|Adverse Event|0|||
130693179|NCT02055547|470503607|FG003|Overall Study|Adverse Event|0|||
130693180|NCT02055547|470503608|FG004|Overall Study|Adverse Event|0|||
130693181|NCT02055547|470503609|FG005|Overall Study|Adverse Event|0|||
130693182|NCT02055547|470503610|FG006|Overall Study|Adverse Event|1|||
130693183|NCT02055547|470503611|FG007|Overall Study|Adverse Event|0|||
130693184|NCT02055547|470503612|FG008|Overall Study|Adverse Event|1|||
130900312|NCT01185353|471269255|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130693185|NCT02055547|470503613|FG009|Overall Study|Adverse Event|0|||
130693186|NCT02055547|470503614|FG010|Overall Study|Adverse Event|0|||
130693187|NCT02055547|470503615|FG011|Overall Study|Adverse Event|0|||
130693188|NCT02055547|470503616|FG012|Overall Study|Adverse Event|0|||
130693189|NCT02055547|470503617|FG013|Overall Study|Adverse Event|0|||
130693190|NCT02055547|470503618|FG014|Overall Study|Adverse Event|0|||
130693191|NCT02055547|470503619|FG015|Overall Study|Adverse Event|0|||
130693192|NCT02055547|470503620|FG016|Overall Study|Adverse Event|0|||
130693193|NCT02055547|470503621|FG017|Overall Study|Adverse Event|0|||
130693194|NCT02055547|470503622|FG018|Overall Study|Adverse Event|0|||
130693195|NCT02055547|470503604|FG000|Overall Study|Withdrawal by Subject|0|||
130693196|NCT02055547|470503605|FG001|Overall Study|Withdrawal by Subject|0|||
130693197|NCT02055547|470503606|FG002|Overall Study|Withdrawal by Subject|0|||
130900313|NCT01185353|471269256|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130900314|NCT01185353|471269257|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130900315|NCT01185353|471269258|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130900316|NCT01185353|471269249|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130900317|NCT01185353|471269250|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
131025928|NCT05056246|471725329|FG002|Overall Study|Lost to Follow-up|0|||
131025929|NCT05056246|471725330|FG003|Overall Study|Lost to Follow-up|2|||
130693198|NCT02055547|470503607|FG003|Overall Study|Withdrawal by Subject|0|||
130693199|NCT02055547|470503608|FG004|Overall Study|Withdrawal by Subject|0|||
130693200|NCT02055547|470503609|FG005|Overall Study|Withdrawal by Subject|1|||
131025930|NCT05056246|471725331|FG004|Overall Study|Lost to Follow-up|0|||
131025931|NCT05056246|471725327|FG000|Overall Study|Withdrawal by Subject|0|||
131025932|NCT05056246|471725328|FG001|Overall Study|Withdrawal by Subject|1|||
130693201|NCT02055547|470503610|FG006|Overall Study|Withdrawal by Subject|0|||
130693202|NCT02055547|470503611|FG007|Overall Study|Withdrawal by Subject|0|||
130693203|NCT02055547|470503612|FG008|Overall Study|Withdrawal by Subject|1|||
130693204|NCT02055547|470503613|FG009|Overall Study|Withdrawal by Subject|0|||
130693205|NCT02055547|470503614|FG010|Overall Study|Withdrawal by Subject|0|||
130693206|NCT02055547|470503615|FG011|Overall Study|Withdrawal by Subject|0|||
130693207|NCT02055547|470503616|FG012|Overall Study|Withdrawal by Subject|0|||
130693208|NCT02055547|470503617|FG013|Overall Study|Withdrawal by Subject|1|||
130693209|NCT02055547|470503618|FG014|Overall Study|Withdrawal by Subject|0|||
130693210|NCT02055547|470503619|FG015|Overall Study|Withdrawal by Subject|1|||
130693211|NCT02055547|470503620|FG016|Overall Study|Withdrawal by Subject|0|||
130693212|NCT02055547|470503621|FG017|Overall Study|Withdrawal by Subject|0|||
131025933|NCT05056246|471725329|FG002|Overall Study|Withdrawal by Subject|0|||
130693213|NCT02055547|470503622|FG018|Overall Study|Withdrawal by Subject|0|||
130693214|NCT02055547|470503604|FG000|Overall Study|Lost to Follow-up|0|||
130693215|NCT02055547|470503605|FG001|Overall Study|Lost to Follow-up|0|||
130693216|NCT02055547|470503606|FG002|Overall Study|Lost to Follow-up|1|||
130693217|NCT02055547|470503607|FG003|Overall Study|Lost to Follow-up|0|||
130693218|NCT02055547|470503608|FG004|Overall Study|Lost to Follow-up|0|||
130693219|NCT02055547|470503609|FG005|Overall Study|Lost to Follow-up|0|||
130693220|NCT02055547|470503610|FG006|Overall Study|Lost to Follow-up|0|||
130693221|NCT02055547|470503611|FG007|Overall Study|Lost to Follow-up|0|||
130693222|NCT02055547|470503612|FG008|Overall Study|Lost to Follow-up|0|||
130693223|NCT02055547|470503613|FG009|Overall Study|Lost to Follow-up|0|||
130693224|NCT02055547|470503614|FG010|Overall Study|Lost to Follow-up|0|||
130693225|NCT02055547|470503615|FG011|Overall Study|Lost to Follow-up|0|||
130693226|NCT02055547|470503616|FG012|Overall Study|Lost to Follow-up|0|||
130693227|NCT02055547|470503617|FG013|Overall Study|Lost to Follow-up|0|||
130693228|NCT02055547|470503618|FG014|Overall Study|Lost to Follow-up|0|||
130693229|NCT02055547|470503619|FG015|Overall Study|Lost to Follow-up|0|||
130693230|NCT02055547|470503620|FG016|Overall Study|Lost to Follow-up|0|||
130693231|NCT02055547|470503621|FG017|Overall Study|Lost to Follow-up|0|||
130693232|NCT02055547|470503622|FG018|Overall Study|Lost to Follow-up|0|||
130693233|NCT00868998|470503630|FG000|Overall Study|Screen Failure|1|||
130693234|NCT00868998|470503630|FG000|Overall Study|Withdrawal by Subject|1|||
130693235|NCT00868998|470503630|FG000|Overall Study|Progression of disease|2|||
130693236|NCT00868998|470503630|FG000|Overall Study|Death|1|||
130693237|NCT01483820|470503632|FG000|Overall Study|Lack of Efficacy|6|||
130693238|NCT01483820|470503632|FG000|Overall Study|Adverse Event|1|||
130693239|NCT01483820|470503632|FG000|Overall Study|Death|1|||
130693240|NCT00867360|470503633|FG000|Overall Study|Withdrawal by Subject|1|||
130693241|NCT00867360|470503634|FG001|Overall Study|Withdrawal by Subject|0|||
130693242|NCT00867360|470503633|FG000|Overall Study|Physician Decision|0|||
130693243|NCT00867360|470503634|FG001|Overall Study|Physician Decision|1|||
130693244|NCT00842309|470503636|FG000|Overall Study|Withdrawal by Subject|3|||
130693245|NCT00842309|470503637|FG001|Overall Study|Withdrawal by Subject|1|||
130693246|NCT03218787|470503638|FG000|Overall Study|Lost to Follow-up|12|||
130693247|NCT03218787|470503638|FG000|Overall Study|Withdrawal by Subject|72|||
130693248|NCT03218787|470503638|FG000|Overall Study|Physician Decision|11|||
130693249|NCT03218787|470503638|FG000|Overall Study|Death|111|||
130693250|NCT02264977|470503639|FG000|Overall Study|Death|3|||
130693251|NCT02264977|470503639|FG000|Overall Study|Physician Decision|1|||
130693252|NCT02264977|470503639|FG000|Overall Study|Refuse to return|1|||
130693253|NCT03573544|470503640|FG000|Overall Study|Adverse Event|0|||
130693254|NCT03573544|470503641|FG001|Overall Study|Adverse Event|0|||
130693255|NCT03573544|470503642|FG002|Overall Study|Adverse Event|0|||
130693256|NCT03573544|470503643|FG003|Overall Study|Adverse Event|3|||
130693257|NCT03573544|470503644|FG004|Overall Study|Adverse Event|1|||
130693258|NCT03573544|470503645|FG005|Overall Study|Adverse Event|0|||
130693259|NCT03573544|470503646|FG006|Overall Study|Adverse Event|2|||
131025934|NCT05056246|471725330|FG003|Overall Study|Withdrawal by Subject|0|||
131025935|NCT05056246|471725331|FG004|Overall Study|Withdrawal by Subject|0|||
131025936|NCT05057897|471725332|FG000|Overall Study|Site closure|2|||
131025937|NCT05057897|471725333|FG001|Overall Study|Site closure|2|||
131025938|NCT05057897|471725332|FG000|Overall Study|Death|1|||
131025939|NCT05057897|471725333|FG001|Overall Study|Death|0|||
130693260|NCT03573544|470503647|FG007|Overall Study|Adverse Event|0|||
130693261|NCT03573544|470503640|FG000|Overall Study|Physician Decision|0|||
130693262|NCT03573544|470503641|FG001|Overall Study|Physician Decision|0|||
130693263|NCT03573544|470503642|FG002|Overall Study|Physician Decision|0|||
130693264|NCT03573544|470503643|FG003|Overall Study|Physician Decision|0|||
130693265|NCT03573544|470503644|FG004|Overall Study|Physician Decision|0|||
130693266|NCT03573544|470503645|FG005|Overall Study|Physician Decision|0|||
130693267|NCT03573544|470503646|FG006|Overall Study|Physician Decision|1|||
130693268|NCT03573544|470503647|FG007|Overall Study|Physician Decision|0|||
130693269|NCT03573544|470503640|FG000|Overall Study|Withdrawal by Subject|2|||
130693270|NCT03573544|470503641|FG001|Overall Study|Withdrawal by Subject|0|||
130693271|NCT03573544|470503642|FG002|Overall Study|Withdrawal by Subject|0|||
130693272|NCT03573544|470503643|FG003|Overall Study|Withdrawal by Subject|1|||
130693273|NCT03573544|470503644|FG004|Overall Study|Withdrawal by Subject|1|||
130693274|NCT03573544|470503645|FG005|Overall Study|Withdrawal by Subject|1|||
130768158|NCT01663857|470775460|FG001|Overall Study|Lost to Follow-up|0|||
131025940|NCT05307978|471725338|FG000|Overall Study|Lost to Follow-up|0|||
131025941|NCT05307978|471725339|FG001|Overall Study|Lost to Follow-up|1|||
130693275|NCT03573544|470503646|FG006|Overall Study|Withdrawal by Subject|0|||
130693276|NCT03573544|470503647|FG007|Overall Study|Withdrawal by Subject|1|||
130693277|NCT03573544|470503640|FG000|Overall Study|Disease progression|3|||
130693278|NCT03573544|470503641|FG001|Overall Study|Disease progression|3|||
130693279|NCT03573544|470503642|FG002|Overall Study|Disease progression|6|||
130693280|NCT03573544|470503643|FG003|Overall Study|Disease progression|4|||
130768159|NCT01663857|470775461|FG002|Overall Study|Lost to Follow-up|3|||
130693281|NCT03573544|470503644|FG004|Overall Study|Disease progression|5|||
130693282|NCT03573544|470503645|FG005|Overall Study|Disease progression|7|||
130693283|NCT03573544|470503646|FG006|Overall Study|Disease progression|6|||
130693284|NCT03573544|470503647|FG007|Overall Study|Disease progression|7|||
130693285|NCT01248728|470503651|FG000|Overall Study|Adverse Event|1|||
130693286|NCT01248728|470503652|FG001|Overall Study|Adverse Event|1|||
130693287|NCT01248728|470503651|FG000|Overall Study|Withdrawal by Subject|2|||
130693288|NCT01248728|470503652|FG001|Overall Study|Withdrawal by Subject|1|||
130693289|NCT01248728|470503651|FG000|Overall Study|Lack of Efficacy|1|||
130693290|NCT01248728|470503652|FG001|Overall Study|Lack of Efficacy|0|||
130693291|NCT00147498|470503653|FG000|Overall Study|Adverse Event|1|||
130693292|NCT00147498|470503654|FG001|Overall Study|Adverse Event|6|||
130693293|NCT00147498|470503655|FG002|Overall Study|Adverse Event|7|||
130900318|NCT01185353|471269251|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
130900319|NCT01185353|471269252|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130900320|NCT01185353|471269253|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
130900321|NCT01185353|471269254|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130900322|NCT01185353|471269255|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130900323|NCT01185353|471269256|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130900324|NCT01185353|471269257|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130900325|NCT01185353|471269258|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130900326|NCT01185353|471269249|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130900327|NCT01185353|471269250|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130900328|NCT01185353|471269251|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130900329|NCT01185353|471269252|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130900330|NCT01185353|471269253|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
130900331|NCT01185353|471269254|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130900332|NCT01185353|471269255|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130900333|NCT01185353|471269256|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130900334|NCT01185353|471269257|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130900335|NCT01185353|471269258|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130900336|NCT01185353|471269249|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
130900337|NCT01185353|471269250|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130900338|NCT01185353|471269251|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130900339|NCT01185353|471269252|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130900340|NCT01185353|471269253|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
130900341|NCT01185353|471269254|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130693294|NCT00147498|470503656|FG003|Overall Study|Adverse Event|3|||
130693295|NCT00147498|470503653|FG000|Overall Study|Lack of Efficacy|1|||
130693296|NCT00147498|470503654|FG001|Overall Study|Lack of Efficacy|1|||
130693297|NCT00147498|470503655|FG002|Overall Study|Lack of Efficacy|1|||
130693298|NCT00147498|470503656|FG003|Overall Study|Lack of Efficacy|8|||
130693299|NCT00147498|470503653|FG000|Overall Study|Laboratory abnormality|0|||
130693300|NCT00147498|470503654|FG001|Overall Study|Laboratory abnormality|0|||
130693301|NCT00147498|470503655|FG002|Overall Study|Laboratory abnormality|2|||
130693302|NCT00147498|470503656|FG003|Overall Study|Laboratory abnormality|0|||
130693303|NCT00147498|470503653|FG000|Overall Study|Participant defaulted|0|||
130693304|NCT00147498|470503654|FG001|Overall Study|Participant defaulted|1|||
130693305|NCT00147498|470503655|FG002|Overall Study|Participant defaulted|4|||
130693306|NCT00147498|470503656|FG003|Overall Study|Participant defaulted|3|||
130693307|NCT00147498|470503653|FG000|Overall Study|Other|1|||
130693308|NCT00147498|470503654|FG001|Overall Study|Other|1|||
130693309|NCT00147498|470503655|FG002|Overall Study|Other|3|||
130693310|NCT00147498|470503656|FG003|Overall Study|Other|3|||
130693311|NCT01838681|470503657|FG000|Period A|Adverse Event|39|||
130693312|NCT01838681|470503658|FG001|Period A|Adverse Event|0|||
130693313|NCT01838681|470503659|FG002|Period A|Adverse Event|0|||
130693314|NCT01838681|470503660|FG003|Period A|Adverse Event|0|||
130693315|NCT01838681|470503657|FG000|Period A|Lack of Efficacy|21|||
130693316|NCT01838681|470503658|FG001|Period A|Lack of Efficacy|0|||
130693317|NCT01838681|470503659|FG002|Period A|Lack of Efficacy|0|||
130693318|NCT01838681|470503660|FG003|Period A|Lack of Efficacy|0|||
130693319|NCT01838681|470503657|FG000|Period A|Early response|148|||
130693320|NCT01838681|470503658|FG001|Period A|Early response|0|||
130900342|NCT01185353|471269255|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130900343|NCT01185353|471269256|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130900344|NCT01185353|471269257|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130900345|NCT01185353|471269258|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130693321|NCT01838681|470503659|FG002|Period A|Early response|0|||
130693322|NCT01838681|470503660|FG003|Period A|Early response|0|||
130693323|NCT01838681|470503657|FG000|Period A|Withdrawal by Subject|70|||
130693324|NCT01838681|470503658|FG001|Period A|Withdrawal by Subject|0|||
130693325|NCT01838681|470503659|FG002|Period A|Withdrawal by Subject|0|||
130693326|NCT01838681|470503660|FG003|Period A|Withdrawal by Subject|0|||
130693327|NCT01838681|470503657|FG000|Period A|Protocol Violation|16|||
130693328|NCT01838681|470503658|FG001|Period A|Protocol Violation|0|||
130900346|NCT01185353|471269249|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130900347|NCT01185353|471269250|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130900348|NCT01185353|471269251|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
130900349|NCT01185353|471269252|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130900350|NCT01185353|471269253|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130900351|NCT01185353|471269254|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
130900352|NCT01185353|471269255|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130900353|NCT01185353|471269256|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130900354|NCT01185353|471269257|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130900355|NCT01185353|471269258|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130900356|NCT01185353|471269249|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130900357|NCT01185353|471269250|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
130900358|NCT01185353|471269251|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130900359|NCT01185353|471269252|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
130900360|NCT01185353|471269253|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130900361|NCT01185353|471269254|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130900362|NCT01185353|471269255|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130900363|NCT01185353|471269256|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130900364|NCT01185353|471269257|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130900365|NCT01185353|471269258|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130900366|NCT01185353|471269249|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130900367|NCT01185353|471269250|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130900368|NCT01185353|471269251|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130900369|NCT01185353|471269252|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
130900370|NCT01185353|471269253|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130900371|NCT01185353|471269254|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130900372|NCT01185353|471269255|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
130900373|NCT01185353|471269256|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130900374|NCT01185353|471269257|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130900375|NCT01185353|471269258|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130900376|NCT01185353|471269249|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130900377|NCT01185353|471269250|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130900378|NCT01185353|471269251|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
130900379|NCT01185353|471269252|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
130900380|NCT01185353|471269253|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130900381|NCT01185353|471269254|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
130900382|NCT01185353|471269255|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
130900383|NCT01185353|471269256|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130900384|NCT01185353|471269257|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130900385|NCT01185353|471269258|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130900386|NCT01185353|471269249|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130900387|NCT01185353|471269250|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130900388|NCT01185353|471269251|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130900389|NCT01185353|471269252|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130900390|NCT01185353|471269253|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130900391|NCT01185353|471269254|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130900392|NCT01185353|471269255|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
130900393|NCT01185353|471269256|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131112565|NCT00292461|472042429|FG000|Overall Study|Protocol Violation|4|||
131112566|NCT00292461|472042430|FG001|Overall Study|Protocol Violation|3|||
131112567|NCT00292461|472042429|FG000|Overall Study|Lost to Follow-up|1|||
131112568|NCT00292461|472042430|FG001|Overall Study|Lost to Follow-up|0|||
131112569|NCT05125679|472042434|FG000|Overall Study|Study Terminated by Sponsor|2|||
131112570|NCT05125679|472042435|FG001|Overall Study|Study Terminated by Sponsor|5|||
131112571|NCT04484259|472042452|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
131112572|NCT04484259|472042453|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
130693329|NCT01838681|470503659|FG002|Period A|Protocol Violation|0|||
130693330|NCT01838681|470503660|FG003|Period A|Protocol Violation|0|||
130693331|NCT01838681|470503657|FG000|Period A|Non-compliance with IMP|6|||
130900394|NCT01185353|471269257|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
131025942|NCT05307978|471725340|FG002|Overall Study|Lost to Follow-up|0|||
131025943|NCT05307978|471725341|FG003|Overall Study|Lost to Follow-up|4|||
131025944|NCT05307978|471725342|FG004|Overall Study|Lost to Follow-up|0|||
131025945|NCT05307978|471725343|FG005|Overall Study|Lost to Follow-up|0|||
130693332|NCT01838681|470503658|FG001|Period A|Non-compliance with IMP|0|||
131025946|NCT05307978|471725344|FG006|Overall Study|Lost to Follow-up|1|||
131025947|NCT03324984|471725345|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
131025948|NCT03324984|471725346|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
131025949|NCT05656911|471725347|FG000|Treatment Phase|Physician Decision|2|||
131025950|NCT05656911|471725348|FG001|Treatment Phase|Physician Decision|0|||
131025951|NCT05656911|471725347|FG000|Treatment Phase|Lack of Efficacy|6|||
131025952|NCT05656911|471725348|FG001|Treatment Phase|Lack of Efficacy|3|||
131025953|NCT05656911|471725347|FG000|Treatment Phase|Subject Decision|4|||
130900395|NCT01185353|471269258|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130900396|NCT01185353|471269249|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130900397|NCT01185353|471269250|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130900398|NCT01185353|471269251|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130900399|NCT01185353|471269252|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130900400|NCT01185353|471269253|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130900401|NCT01185353|471269254|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130900402|NCT01185353|471269255|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130900403|NCT01185353|471269256|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
130900404|NCT01185353|471269257|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
130900405|NCT01185353|471269258|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
130900406|NCT01185353|471269249|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130900407|NCT01185353|471269250|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130900408|NCT01185353|471269251|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130900409|NCT01185353|471269252|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130900410|NCT01185353|471269253|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130900411|NCT01185353|471269254|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130900412|NCT01185353|471269255|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130900413|NCT01185353|471269256|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
130900414|NCT01185353|471269257|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
130900415|NCT01185353|471269258|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
130900416|NCT01185353|471269249|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130900417|NCT01185353|471269250|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130900418|NCT01185353|471269251|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130900419|NCT01185353|471269252|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130900420|NCT01185353|471269253|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130900421|NCT01185353|471269254|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130900422|NCT01185353|471269255|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130900423|NCT01185353|471269256|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
130900424|NCT01185353|471269257|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
130900425|NCT01185353|471269258|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
130693333|NCT01838681|470503659|FG002|Period A|Non-compliance with IMP|0|||
130693334|NCT01838681|470503660|FG003|Period A|Non-compliance with IMP|0|||
130693335|NCT01838681|470503657|FG000|Period A|Lost to Follow-up|4|||
130693336|NCT01838681|470503658|FG001|Period A|Lost to Follow-up|0|||
130693337|NCT01838681|470503659|FG002|Period A|Lost to Follow-up|0|||
130693338|NCT01838681|470503660|FG003|Period A|Lost to Follow-up|0|||
130693339|NCT01838681|470503657|FG000|Period A|Withdrawal before treatment|4|||
130693340|NCT01838681|470503658|FG001|Period A|Withdrawal before treatment|0|||
130693341|NCT01838681|470503659|FG002|Period A|Withdrawal before treatment|0|||
130693342|NCT01838681|470503660|FG003|Period A|Withdrawal before treatment|0|||
130693343|NCT01838681|470503657|FG000|Period A|Administrative or other reasons|17|||
130693344|NCT01838681|470503658|FG001|Period A|Administrative or other reasons|0|||
130693345|NCT01838681|470503659|FG002|Period A|Administrative or other reasons|0|||
130693346|NCT01838681|470503660|FG003|Period A|Administrative or other reasons|0|||
130693347|NCT01838681|470503657|FG000|Period B/A+|Adverse Event|0|||
130693348|NCT01838681|470503658|FG001|Period B/A+|Adverse Event|13|||
130693349|NCT01838681|470503659|FG002|Period B/A+|Adverse Event|27|||
130693350|NCT01838681|470503660|FG003|Period B/A+|Adverse Event|16|||
130693351|NCT01838681|470503657|FG000|Period B/A+|Lack of Efficacy|0|||
130693352|NCT01838681|470503658|FG001|Period B/A+|Lack of Efficacy|9|||
130693353|NCT01838681|470503659|FG002|Period B/A+|Lack of Efficacy|11|||
130693354|NCT01838681|470503660|FG003|Period B/A+|Lack of Efficacy|6|||
130693355|NCT01838681|470503657|FG000|Period B/A+|Withdrawal by Subject|0|||
130693356|NCT01838681|470503658|FG001|Period B/A+|Withdrawal by Subject|28|||
130693357|NCT01838681|470503659|FG002|Period B/A+|Withdrawal by Subject|35|||
130693358|NCT01838681|470503660|FG003|Period B/A+|Withdrawal by Subject|47|||
130693359|NCT01838681|470503657|FG000|Period B/A+|Protocol Violation|0|||
130693360|NCT01838681|470503658|FG001|Period B/A+|Protocol Violation|1|||
130693361|NCT01838681|470503659|FG002|Period B/A+|Protocol Violation|4|||
130900426|NCT01185353|471269249|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131025954|NCT05656911|471725348|FG001|Treatment Phase|Subject Decision|2|||
131025955|NCT05656911|471725347|FG000|Treatment Phase|Other Reasons|1|||
131025956|NCT05656911|471725348|FG001|Treatment Phase|Other Reasons|0|||
131025957|NCT05656911|471725347|FG000|Treatment Phase|Adverse Event|3|||
131025958|NCT05656911|471725348|FG001|Treatment Phase|Adverse Event|1|||
131025959|NCT05656911|471725347|FG000|Follow-up Phase|Subject Decision|0|||
130900427|NCT01185353|471269250|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
131025960|NCT05656911|471725348|FG001|Follow-up Phase|Subject Decision|1|||
130693362|NCT01838681|470503660|FG003|Period B/A+|Protocol Violation|6|||
130693363|NCT01838681|470503657|FG000|Period B/A+|Non-compliance with IMP|0|||
130693364|NCT01838681|470503658|FG001|Period B/A+|Non-compliance with IMP|2|||
130693365|NCT01838681|470503659|FG002|Period B/A+|Non-compliance with IMP|3|||
130693366|NCT01838681|470503660|FG003|Period B/A+|Non-compliance with IMP|3|||
130900428|NCT01185353|471269251|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130900429|NCT01185353|471269252|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130900430|NCT01185353|471269253|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130900431|NCT01185353|471269254|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130900432|NCT01185353|471269255|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130900433|NCT01185353|471269256|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130900434|NCT01185353|471269257|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
130900435|NCT01185353|471269258|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130900436|NCT01185353|471269249|FG000|Part C (Weeks 24 Through 76)|Death|0|||
130900437|NCT01185353|471269250|FG001|Part C (Weeks 24 Through 76)|Death|0|||
130900438|NCT01185353|471269251|FG002|Part C (Weeks 24 Through 76)|Death|0|||
130900439|NCT01185353|471269252|FG003|Part C (Weeks 24 Through 76)|Death|0|||
130900440|NCT01185353|471269253|FG004|Part C (Weeks 24 Through 76)|Death|0|||
130900441|NCT01185353|471269254|FG005|Part C (Weeks 24 Through 76)|Death|0|||
130900442|NCT01185353|471269255|FG006|Part C (Weeks 24 Through 76)|Death|0|||
130900443|NCT01185353|471269256|FG007|Part C (Weeks 24 Through 76)|Death|0|||
130900444|NCT01185353|471269257|FG008|Part C (Weeks 24 Through 76)|Death|0|||
130900445|NCT01185353|471269258|FG009|Part C (Weeks 24 Through 76)|Death|1|||
130900446|NCT01185353|471269249|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130900447|NCT01185353|471269250|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130900448|NCT01185353|471269251|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130900449|NCT01185353|471269252|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130900450|NCT01185353|471269253|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130900451|NCT01185353|471269254|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130900452|NCT01185353|471269255|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130900453|NCT01185353|471269256|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130900454|NCT01185353|471269257|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130900455|NCT01185353|471269258|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
130900456|NCT01185353|471269249|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130900457|NCT01185353|471269250|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130900458|NCT01185353|471269251|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130900459|NCT01185353|471269252|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130900460|NCT01185353|471269253|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130900461|NCT01185353|471269254|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130900462|NCT01185353|471269255|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130900463|NCT01185353|471269256|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130900464|NCT01185353|471269257|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130900465|NCT01185353|471269258|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
130900466|NCT01185353|471269249|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
130900467|NCT01185353|471269250|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
130900468|NCT01185353|471269251|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
130900469|NCT01185353|471269252|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
130900470|NCT01185353|471269253|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
130900471|NCT01185353|471269254|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
130900472|NCT01185353|471269255|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
130900473|NCT01185353|471269256|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
130900474|NCT01185353|471269257|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
130900475|NCT01185353|471269258|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
130900476|NCT01185353|471269249|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130900477|NCT01185353|471269250|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130900478|NCT01185353|471269251|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130900479|NCT01185353|471269252|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130900480|NCT01185353|471269253|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130900481|NCT01185353|471269254|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130900482|NCT01185353|471269255|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130900483|NCT01185353|471269256|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
130900484|NCT01185353|471269257|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
130900485|NCT01185353|471269258|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130900486|NCT01185353|471269249|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130900487|NCT01185353|471269250|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130900488|NCT01185353|471269251|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130900489|NCT01185353|471269252|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130900490|NCT01185353|471269253|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130900491|NCT01185353|471269254|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130900492|NCT01185353|471269255|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130900493|NCT01185353|471269256|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
130900494|NCT01185353|471269257|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
130900495|NCT01185353|471269258|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
130900496|NCT01185353|471269249|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130900497|NCT01185353|471269250|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130900498|NCT01185353|471269251|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130900499|NCT01185353|471269252|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130900500|NCT01185353|471269253|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130900501|NCT01185353|471269254|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130900502|NCT01185353|471269255|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130900503|NCT01185353|471269256|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
130900504|NCT01185353|471269257|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
130900505|NCT01185353|471269258|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130900506|NCT02270944|471269259|FG000|Overall Study|Lost to Follow-up|9|||
130900507|NCT02270944|471269260|FG001|Overall Study|Lost to Follow-up|4|||
130900508|NCT02270944|471269259|FG000|Overall Study|Withdrawal by Subject|2|||
130900509|NCT02270944|471269260|FG001|Overall Study|Withdrawal by Subject|1|||
130900510|NCT01978938|471269261|FG000|Overall Study|Lost to Follow-up|12|||
130900511|NCT01978938|471269262|FG001|Overall Study|Lost to Follow-up|6|||
130900512|NCT01978938|471269261|FG000|Overall Study|Withdrawal by Subject|8|||
130900513|NCT01978938|471269262|FG001|Overall Study|Withdrawal by Subject|4|||
130900514|NCT01978938|471269261|FG000|Overall Study|Adverse Event, non-fatal|2|||
130900515|NCT01978938|471269262|FG001|Overall Study|Adverse Event, non-fatal|1|||
130900516|NCT01978938|471269261|FG000|Overall Study|Participant noncompliance|1|||
130900517|NCT01978938|471269262|FG001|Overall Study|Participant noncompliance|1|||
130900518|NCT01978938|471269261|FG000|Overall Study|Did not meet inclusion criteria|0|||
130900519|NCT01978938|471269262|FG001|Overall Study|Did not meet inclusion criteria|1|||
130900520|NCT01978938|471269261|FG000|Overall Study|Previously scheduled procedure|0|||
130900521|NCT01978938|471269262|FG001|Overall Study|Previously scheduled procedure|1|||
130900522|NCT00095147|471269263|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
130900523|NCT00095147|471269264|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
130900524|NCT00095147|471269265|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
130900525|NCT00095147|471269266|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
130900526|NCT00095147|471269267|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
130900527|NCT00095147|471269263|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
130900528|NCT00095147|471269264|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
130900529|NCT00095147|471269265|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
130900530|NCT00095147|471269266|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
130900531|NCT00095147|471269267|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
130900532|NCT00095147|471269263|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
130900533|NCT00095147|471269264|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
130900534|NCT00095147|471269265|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
130900535|NCT00095147|471269266|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
130900536|NCT00095147|471269267|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
130900537|NCT00095147|471269263|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
130900538|NCT00095147|471269264|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
130900539|NCT00095147|471269265|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
130900540|NCT00095147|471269266|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
130900541|NCT00095147|471269267|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
130900542|NCT00095147|471269263|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
130900543|NCT00095147|471269264|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
130900544|NCT00095147|471269265|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
130900545|NCT00095147|471269266|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
130900546|NCT00095147|471269267|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
130900547|NCT00095147|471269263|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
130900548|NCT00095147|471269264|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
130900549|NCT00095147|471269265|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
130900550|NCT00095147|471269266|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
130900551|NCT00095147|471269267|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
130900552|NCT00095147|471269263|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
130900553|NCT00095147|471269264|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
130900554|NCT00095147|471269265|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
130900555|NCT00095147|471269266|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
130900556|NCT00095147|471269267|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
130693367|NCT01838681|470503657|FG000|Period B/A+|Lost to Follow-up|0|||
130693368|NCT01838681|470503658|FG001|Period B/A+|Lost to Follow-up|2|||
130900557|NCT00095147|471269263|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
131025961|NCT05656911|471725347|FG000|Follow-up Phase|Missing|1|||
131025962|NCT05656911|471725348|FG001|Follow-up Phase|Missing|0|||
131025963|NCT05075408|471725349|FG000|Overall Study|Withdrawal by Subject|5|||
131025964|NCT05075408|471725350|FG001|Overall Study|Withdrawal by Subject|3|||
131025965|NCT05075408|471725351|FG002|Overall Study|Withdrawal by Subject|4|||
130693369|NCT01838681|470503659|FG002|Period B/A+|Lost to Follow-up|5|||
130693370|NCT01838681|470503660|FG003|Period B/A+|Lost to Follow-up|11|||
130693371|NCT01838681|470503657|FG000|Period B/A+|Withdrawal before treatment|0|||
130693372|NCT01838681|470503658|FG001|Period B/A+|Withdrawal before treatment|1|||
130900558|NCT00095147|471269264|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
130900559|NCT00095147|471269265|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
130900560|NCT00095147|471269266|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
130900561|NCT00095147|471269267|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
130900562|NCT00095147|471269263|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
130900563|NCT00095147|471269264|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
130900564|NCT00095147|471269265|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
130900565|NCT00095147|471269266|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
130900566|NCT00095147|471269267|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
130900567|NCT00095147|471269263|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
130900568|NCT00095147|471269264|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
130900569|NCT00095147|471269265|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
130900570|NCT00095147|471269266|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
130900571|NCT00095147|471269267|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
130900572|NCT00095147|471269263|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
130900573|NCT00095147|471269264|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
130900574|NCT00095147|471269265|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
130900575|NCT00095147|471269266|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
130900576|NCT00095147|471269267|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
130900577|NCT00095147|471269263|FG000|Long-term Extension Period|Death|0|||
130900578|NCT00095147|471269264|FG001|Long-term Extension Period|Death|0|||
130900579|NCT00095147|471269265|FG002|Long-term Extension Period|Death|0|||
130900580|NCT00095147|471269266|FG003|Long-term Extension Period|Death|0|||
130900581|NCT00095147|471269267|FG004|Long-term Extension Period|Death|3|||
130900582|NCT00095147|471269263|FG000|Long-term Extension Period|Adverse Event|0|||
130900583|NCT00095147|471269264|FG001|Long-term Extension Period|Adverse Event|0|||
130900584|NCT00095147|471269265|FG002|Long-term Extension Period|Adverse Event|0|||
130900585|NCT00095147|471269266|FG003|Long-term Extension Period|Adverse Event|0|||
130900586|NCT00095147|471269267|FG004|Long-term Extension Period|Adverse Event|11|||
130900587|NCT00095147|471269263|FG000|Long-term Extension Period|Lack of Efficacy|0|||
130900588|NCT00095147|471269264|FG001|Long-term Extension Period|Lack of Efficacy|0|||
130900589|NCT00095147|471269265|FG002|Long-term Extension Period|Lack of Efficacy|0|||
130900590|NCT00095147|471269266|FG003|Long-term Extension Period|Lack of Efficacy|0|||
130900591|NCT00095147|471269267|FG004|Long-term Extension Period|Lack of Efficacy|9|||
130900592|NCT00095147|471269263|FG000|Long-term Extension Period|Lost to Follow-up|0|||
130900593|NCT00095147|471269264|FG001|Long-term Extension Period|Lost to Follow-up|0|||
130900594|NCT00095147|471269265|FG002|Long-term Extension Period|Lost to Follow-up|0|||
130900595|NCT00095147|471269266|FG003|Long-term Extension Period|Lost to Follow-up|0|||
130900596|NCT00095147|471269267|FG004|Long-term Extension Period|Lost to Follow-up|6|||
130900597|NCT00095147|471269263|FG000|Long-term Extension Period|Withdrawal of consent|0|||
130900598|NCT00095147|471269264|FG001|Long-term Extension Period|Withdrawal of consent|0|||
130900599|NCT00095147|471269265|FG002|Long-term Extension Period|Withdrawal of consent|0|||
130900600|NCT00095147|471269266|FG003|Long-term Extension Period|Withdrawal of consent|0|||
130900601|NCT00095147|471269267|FG004|Long-term Extension Period|Withdrawal of consent|12|||
130900602|NCT00095147|471269263|FG000|Long-term Extension Period|Pregnancy|0|||
130900603|NCT00095147|471269264|FG001|Long-term Extension Period|Pregnancy|0|||
130900604|NCT00095147|471269265|FG002|Long-term Extension Period|Pregnancy|0|||
130900605|NCT00095147|471269266|FG003|Long-term Extension Period|Pregnancy|0|||
131112573|NCT04484259|472042454|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
131112574|NCT04484259|472042455|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
131112575|NCT04484259|472042456|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
131112576|NCT04484259|472042452|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
130900606|NCT00095147|471269267|FG004|Long-term Extension Period|Pregnancy|1|||
131112577|NCT04484259|472042453|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
131112578|NCT04484259|472042454|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
131112579|NCT04484259|472042455|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
131112580|NCT04484259|472042456|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
131112581|NCT04484259|472042452|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
131112582|NCT04484259|472042453|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
131112583|NCT04484259|472042454|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
131112584|NCT04484259|472042455|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
131112585|NCT04484259|472042456|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
131112586|NCT04484259|472042452|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
130900607|NCT00095147|471269263|FG000|Long-term Extension Period|No longer meets study criteria|0|||
131112587|NCT04484259|472042453|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
130900608|NCT00095147|471269264|FG001|Long-term Extension Period|No longer meets study criteria|0|||
130900609|NCT00095147|471269265|FG002|Long-term Extension Period|No longer meets study criteria|0|||
130900610|NCT00095147|471269266|FG003|Long-term Extension Period|No longer meets study criteria|0|||
130900611|NCT00095147|471269267|FG004|Long-term Extension Period|No longer meets study criteria|1|||
130900612|NCT00095147|471269263|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
130900613|NCT00095147|471269264|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
130900614|NCT00095147|471269265|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
130900615|NCT00095147|471269266|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
130900616|NCT00095147|471269267|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
130900617|NCT00095147|471269263|FG000|Long-term Extension Period|Leaving country|0|||
130900618|NCT00095147|471269264|FG001|Long-term Extension Period|Leaving country|0|||
130900619|NCT00095147|471269265|FG002|Long-term Extension Period|Leaving country|0|||
130900620|NCT00095147|471269266|FG003|Long-term Extension Period|Leaving country|0|||
130900621|NCT00095147|471269267|FG004|Long-term Extension Period|Leaving country|1|||
130900622|NCT02342418|471269268|FG000|Overall Study|Adverse Event|0|||
130900623|NCT02342418|471269269|FG001|Overall Study|Adverse Event|1|||
130900624|NCT04255394|471269270|FG000|Overall Study|Death|35|||
130900625|NCT04255394|471269271|FG001|Overall Study|Death|25|||
130900626|NCT04255394|471269270|FG000|Overall Study|Device removed|2|||
130900627|NCT04255394|471269271|FG001|Overall Study|Device removed|10|||
130900628|NCT04255394|471269270|FG000|Overall Study|Withdrawal by Subject|9|||
130900629|NCT04255394|471269271|FG001|Overall Study|Withdrawal by Subject|8|||
130900630|NCT04255394|471269270|FG000|Overall Study|Screen Failure/Not treated|12|||
130900631|NCT04255394|471269271|FG001|Overall Study|Screen Failure/Not treated|8|||
130900632|NCT04255394|471269270|FG000|Overall Study|Lost to Follow-up|123|||
130900633|NCT04255394|471269271|FG001|Overall Study|Lost to Follow-up|265|||
130900634|NCT04255394|471269270|FG000|Overall Study|Adverse Event|1|||
130900635|NCT04255394|471269271|FG001|Overall Study|Adverse Event|3|||
130900636|NCT03678870|471269274|FG000|Overall Study|prescribed non- protocol medications|10|||
130900637|NCT03678870|471269275|FG001|Overall Study|prescribed non- protocol medications|6|||
130900638|NCT03678870|471269274|FG000|Overall Study|Lost to Follow-up|3|||
130900639|NCT03678870|471269275|FG001|Overall Study|Lost to Follow-up|2|||
130900640|NCT03104816|471269277|FG000|Overall Study|Lack of Efficacy|0|||
130900641|NCT03104816|471269278|FG001|Overall Study|Lack of Efficacy|2|||
130900642|NCT03104816|471269279|FG002|Overall Study|Lack of Efficacy|0|||
130900643|NCT03104816|471269277|FG000|Overall Study|Protocol Violation|2|||
130900644|NCT03104816|471269278|FG001|Overall Study|Protocol Violation|0|||
130900645|NCT03104816|471269279|FG002|Overall Study|Protocol Violation|2|||
130900646|NCT01227629|471269281|FG000|Overall Study|Adverse Event|2|||
130900647|NCT01227629|471269282|FG001|Overall Study|Adverse Event|2|||
130900648|NCT01227629|471269283|FG002|Overall Study|Adverse Event|1|||
130900649|NCT01227629|471269284|FG003|Overall Study|Adverse Event|6|||
130900650|NCT01227629|471269285|FG004|Overall Study|Adverse Event|1|||
130900651|NCT01227629|471269286|FG005|Overall Study|Adverse Event|1|||
130900652|NCT01227629|471269287|FG006|Overall Study|Adverse Event|6|||
130900653|NCT01227629|471269288|FG007|Overall Study|Adverse Event|6|||
130900654|NCT01227629|471269289|FG008|Overall Study|Adverse Event|4|||
130900655|NCT01227629|471269290|FG009|Overall Study|Adverse Event|0|||
130900656|NCT01227629|471269281|FG000|Overall Study|Protocol Violation|0|||
130900657|NCT01227629|471269282|FG001|Overall Study|Protocol Violation|0|||
130900658|NCT01227629|471269283|FG002|Overall Study|Protocol Violation|0|||
130900659|NCT01227629|471269284|FG003|Overall Study|Protocol Violation|1|||
130900660|NCT01227629|471269285|FG004|Overall Study|Protocol Violation|0|||
130900661|NCT01227629|471269286|FG005|Overall Study|Protocol Violation|0|||
130900662|NCT01227629|471269287|FG006|Overall Study|Protocol Violation|0|||
130900663|NCT01227629|471269288|FG007|Overall Study|Protocol Violation|0|||
130900664|NCT01227629|471269289|FG008|Overall Study|Protocol Violation|0|||
130900665|NCT01227629|471269290|FG009|Overall Study|Protocol Violation|0|||
131112588|NCT04484259|472042454|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
131112589|NCT04484259|472042455|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
131112590|NCT04484259|472042456|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
131112591|NCT04484259|472042452|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
131112592|NCT04484259|472042453|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
131112593|NCT04484259|472042454|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
130900666|NCT01227629|471269281|FG000|Overall Study|Lost to Follow-up|0|||
131112594|NCT04484259|472042455|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
130768160|NCT01663857|470775462|FG003|Overall Study|Lost to Follow-up|1|||
130900667|NCT01227629|471269282|FG001|Overall Study|Lost to Follow-up|0|||
130900668|NCT01227629|471269283|FG002|Overall Study|Lost to Follow-up|0|||
130900669|NCT01227629|471269284|FG003|Overall Study|Lost to Follow-up|0|||
130900670|NCT01227629|471269285|FG004|Overall Study|Lost to Follow-up|1|||
130900671|NCT01227629|471269286|FG005|Overall Study|Lost to Follow-up|0|||
130900672|NCT01227629|471269287|FG006|Overall Study|Lost to Follow-up|0|||
130900673|NCT01227629|471269288|FG007|Overall Study|Lost to Follow-up|0|||
130900674|NCT01227629|471269289|FG008|Overall Study|Lost to Follow-up|0|||
130900675|NCT01227629|471269290|FG009|Overall Study|Lost to Follow-up|0|||
130900676|NCT01227629|471269281|FG000|Overall Study|Withdrawal by Subject|0|||
130900677|NCT01227629|471269282|FG001|Overall Study|Withdrawal by Subject|0|||
131112595|NCT04484259|472042456|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
131112596|NCT04484259|472042452|FG000|Randomized Treatment|Withdrawal by Subject|1|||
131112597|NCT04484259|472042453|FG001|Randomized Treatment|Withdrawal by Subject|0|||
131112598|NCT04484259|472042454|FG002|Randomized Treatment|Withdrawal by Subject|0|||
131112599|NCT04484259|472042455|FG003|Randomized Treatment|Withdrawal by Subject|0|||
131112600|NCT04484259|472042456|FG004|Randomized Treatment|Withdrawal by Subject|0|||
131112601|NCT04908189|472042457|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
131112602|NCT04908189|472042458|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
131112603|NCT04908189|472042459|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
131112604|NCT04908189|472042457|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
131112605|NCT04908189|472042458|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
131112606|NCT04908189|472042459|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
131112607|NCT04908189|472042457|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
131112608|NCT04908189|472042458|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
131112609|NCT04908189|472042459|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
131112610|NCT04908189|472042457|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
130900678|NCT01227629|471269283|FG002|Overall Study|Withdrawal by Subject|0|||
131112611|NCT04908189|472042458|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
131112612|NCT04908189|472042459|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
131112613|NCT04908189|472042457|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
131112614|NCT04908189|472042458|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
131112615|NCT04908189|472042459|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
131112616|NCT04908189|472042457|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
131112617|NCT04908189|472042458|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
131112618|NCT04908189|472042459|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
131112619|NCT04908189|472042457|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
131112620|NCT04908189|472042458|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
131112621|NCT04908189|472042459|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
131112622|NCT04908189|472042457|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
131112623|NCT04908189|472042458|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
131112624|NCT04908189|472042459|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
131112625|NCT04908189|472042457|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
131112626|NCT04908189|472042458|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
131112627|NCT04908189|472042459|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
131112628|NCT04908189|472042457|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
131112629|NCT04908189|472042458|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
131112630|NCT04908189|472042459|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
130693373|NCT01838681|470503659|FG002|Period B/A+|Withdrawal before treatment|0|||
130900679|NCT01227629|471269284|FG003|Overall Study|Withdrawal by Subject|0|||
130900680|NCT01227629|471269285|FG004|Overall Study|Withdrawal by Subject|0|||
130900681|NCT01227629|471269286|FG005|Overall Study|Withdrawal by Subject|0|||
130900682|NCT01227629|471269287|FG006|Overall Study|Withdrawal by Subject|2|||
130900683|NCT01227629|471269288|FG007|Overall Study|Withdrawal by Subject|0|||
130900684|NCT01227629|471269289|FG008|Overall Study|Withdrawal by Subject|0|||
130900685|NCT01227629|471269290|FG009|Overall Study|Withdrawal by Subject|1|||
130900686|NCT01227629|471269281|FG000|Overall Study|Other|0|||
130900687|NCT01227629|471269282|FG001|Overall Study|Other|0|||
130900688|NCT01227629|471269283|FG002|Overall Study|Other|0|||
130900689|NCT01227629|471269284|FG003|Overall Study|Other|1|||
130900690|NCT01227629|471269285|FG004|Overall Study|Other|0|||
130900691|NCT01227629|471269286|FG005|Overall Study|Other|0|||
130900692|NCT01227629|471269287|FG006|Overall Study|Other|0|||
130900693|NCT01227629|471269288|FG007|Overall Study|Other|0|||
130900694|NCT01227629|471269289|FG008|Overall Study|Other|2|||
130900695|NCT01227629|471269290|FG009|Overall Study|Other|1|||
130900696|NCT03645434|471269291|FG000|Period 1|Adverse Event|0|||
130900697|NCT03645434|471269292|FG001|Period 1|Adverse Event|0|||
130900698|NCT03645434|471269293|FG002|Period 1|Adverse Event|0|||
130900699|NCT03645434|471269294|FG003|Period 1|Adverse Event|1|||
130693374|NCT01838681|470503660|FG003|Period B/A+|Withdrawal before treatment|0|||
130900700|NCT03645434|471269295|FG004|Period 1|Adverse Event|0|||
130900701|NCT03645434|471269296|FG005|Period 1|Adverse Event|0|||
130900702|NCT03645434|471269291|FG000|Period 1|COPD exacerbation|0|||
130900703|NCT03645434|471269292|FG001|Period 1|COPD exacerbation|0|||
130900704|NCT03645434|471269293|FG002|Period 1|COPD exacerbation|0|||
130900705|NCT03645434|471269294|FG003|Period 1|COPD exacerbation|0|||
130900706|NCT03645434|471269295|FG004|Period 1|COPD exacerbation|1|||
130900707|NCT03645434|471269296|FG005|Period 1|COPD exacerbation|0|||
130900708|NCT00362180|471271238|FG000|Treated Period|Withdrawal by Subject|1|||
130900709|NCT00362180|471271239|FG001|Treated Period|Withdrawal by Subject|0|||
130900710|NCT00362180|471271240|FG002|Treated Period|Withdrawal by Subject|0|||
130900711|NCT00362180|471271241|FG003|Treated Period|Withdrawal by Subject|0|||
130900712|NCT00362180|471271242|FG004|Treated Period|Withdrawal by Subject|0|||
130900713|NCT00362180|471271243|FG005|Treated Period|Withdrawal by Subject|0|||
130900714|NCT00362180|471271244|FG006|Treated Period|Withdrawal by Subject|0|||
130900715|NCT00362180|471271245|FG007|Treated Period|Withdrawal by Subject|0|||
130900716|NCT00362180|471271246|FG008|Treated Period|Withdrawal by Subject|0|||
130900717|NCT00362180|471271238|FG000|Treated Period|Adverse Event|0|||
130900718|NCT00362180|471271239|FG001|Treated Period|Adverse Event|0|||
130900719|NCT00362180|471271240|FG002|Treated Period|Adverse Event|0|||
130900720|NCT00362180|471271241|FG003|Treated Period|Adverse Event|0|||
130900721|NCT00362180|471271242|FG004|Treated Period|Adverse Event|0|||
130900722|NCT00362180|471271243|FG005|Treated Period|Adverse Event|1|||
130900723|NCT00362180|471271244|FG006|Treated Period|Adverse Event|0|||
130900724|NCT00362180|471271245|FG007|Treated Period|Adverse Event|1|||
130900725|NCT00362180|471271246|FG008|Treated Period|Adverse Event|0|||
130900726|NCT03338959|471271247|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
130900727|NCT03338959|471271247|FG000|Overall Study|Physician Decision|1|||
130900728|NCT01604278|471271248|FG000|Overall Study|Lack of Efficacy|0|||
130900729|NCT01604278|471271249|FG001|Overall Study|Lack of Efficacy|1|||
130900730|NCT01604278|471271248|FG000|Overall Study|Lost to Follow-up|1|||
130900731|NCT01604278|471271249|FG001|Overall Study|Lost to Follow-up|0|||
130900732|NCT01604278|471271248|FG000|Overall Study|Administrative problems|2|||
130900733|NCT01604278|471271249|FG001|Overall Study|Administrative problems|1|||
130900734|NCT01604278|471271248|FG000|Overall Study|Withdrawal by Subject|3|||
130900735|NCT01604278|471271249|FG001|Overall Study|Withdrawal by Subject|3|||
130900736|NCT01604278|471271248|FG000|Overall Study|Adverse Event|3|||
130900737|NCT01604278|471271249|FG001|Overall Study|Adverse Event|5|||
130900738|NCT01604278|471271248|FG000|Overall Study|Protocol Deviation|5|||
130900739|NCT01604278|471271249|FG001|Overall Study|Protocol Deviation|3|||
130900740|NCT00874939|471271254|FG000|Overall Study|Study terminated|4|||
130900741|NCT02870933|471271255|FG000|Overall Study|Death|2|||
130900742|NCT02870933|471271256|FG001|Overall Study|Death|1|||
130900743|NCT02870933|471271255|FG000|Overall Study|Withdrawal by Subject|0|||
130900744|NCT02870933|471271256|FG001|Overall Study|Withdrawal by Subject|1|||
130900745|NCT01250496|471271257|FG000|Overall Study|Study terminated|124|||
131025966|NCT05075408|471725349|FG000|Overall Study|Adverse Event|5|||
131025967|NCT05075408|471725350|FG001|Overall Study|Adverse Event|7|||
131025968|NCT05075408|471725351|FG002|Overall Study|Adverse Event|8|||
130768161|NCT04114656|470775463|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
130900746|NCT01250496|471271258|FG001|Overall Study|Study terminated|124|||
130900747|NCT01425463|471271264|FG000|Overall Study|Adverse Event|5|||
130900748|NCT01425463|471271265|FG001|Overall Study|Adverse Event|7|||
130900749|NCT01425463|471271264|FG000|Overall Study|Lack of Efficacy|1|||
131025969|NCT05075408|471725349|FG000|Overall Study|Protocol Violation|0|||
131025970|NCT05075408|471725350|FG001|Overall Study|Protocol Violation|1|||
131025971|NCT05075408|471725351|FG002|Overall Study|Protocol Violation|0|||
131025972|NCT05075408|471725349|FG000|Overall Study|Lost to Follow-up|2|||
131025973|NCT05075408|471725350|FG001|Overall Study|Lost to Follow-up|1|||
131025974|NCT05075408|471725351|FG002|Overall Study|Lost to Follow-up|1|||
131025975|NCT05075408|471725349|FG000|Overall Study|Physician Decision|1|||
131025976|NCT05075408|471725350|FG001|Overall Study|Physician Decision|0|||
131025977|NCT05075408|471725351|FG002|Overall Study|Physician Decision|0|||
131025978|NCT05075408|471725349|FG000|Overall Study|Other-unspecified|3|||
131025979|NCT05075408|471725350|FG001|Overall Study|Other-unspecified|2|||
131025980|NCT05075408|471725351|FG002|Overall Study|Other-unspecified|0|||
131025981|NCT02837510|471725352|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
131025982|NCT02837510|471725353|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
131025983|NCT02837510|471725352|FG000|Washout (2 Weeks)|Adverse Event|0|||
131025984|NCT02837510|471725353|FG001|Washout (2 Weeks)|Adverse Event|1|||
131025985|NCT02837510|471725352|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
131025986|NCT02837510|471725353|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
131025987|NCT02837510|471725352|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
131025988|NCT02837510|471725353|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
131112631|NCT04908189|472042457|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
131112632|NCT04908189|472042458|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
131112633|NCT04908189|472042459|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
130900750|NCT01425463|471271265|FG001|Overall Study|Lack of Efficacy|1|||
130900751|NCT01425463|471271264|FG000|Overall Study|Protocol Violation|2|||
130900752|NCT01425463|471271265|FG001|Overall Study|Protocol Violation|2|||
130900753|NCT01425463|471271264|FG000|Overall Study|Lost to Follow-up|5|||
130900754|NCT01425463|471271265|FG001|Overall Study|Lost to Follow-up|2|||
130900755|NCT01425463|471271264|FG000|Overall Study|Withdrawal by Subject|7|||
130900756|NCT01425463|471271265|FG001|Overall Study|Withdrawal by Subject|5|||
131025989|NCT02837510|471725352|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
131025990|NCT02837510|471725353|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
131025991|NCT02837510|471725352|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
130900757|NCT01425463|471271264|FG000|Overall Study|Unknown Reason|4|||
130693375|NCT01838681|470503657|FG000|Period B/A+|Administrative or other reasons|0|||
130693376|NCT01838681|470503658|FG001|Period B/A+|Administrative or other reasons|6|||
130693377|NCT01838681|470503659|FG002|Period B/A+|Administrative or other reasons|10|||
130693378|NCT01838681|470503660|FG003|Period B/A+|Administrative or other reasons|28|||
130693379|NCT01229150|470503661|FG000|Overall Study|Toxicity|2|||
130693380|NCT01229150|470503662|FG001|Overall Study|Toxicity|2|||
130693381|NCT01229150|470503663|FG002|Overall Study|Toxicity|0|||
130693382|NCT01229150|470503664|FG003|Overall Study|Toxicity|0|||
130693383|NCT02011945|470503665|FG000|Overall Study|Participant requested to Discontinue|0|||
130693384|NCT02011945|470503666|FG001|Overall Study|Participant requested to Discontinue|1|||
130693385|NCT02011945|470503667|FG002|Overall Study|Participant requested to Discontinue|1|||
130693386|NCT02011945|470503665|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
130693387|NCT02011945|470503666|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
130693388|NCT02011945|470503667|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
130693389|NCT02011945|470503665|FG000|Overall Study|Study Drug Toxicity|0|||
130693390|NCT02011945|470503666|FG001|Overall Study|Study Drug Toxicity|0|||
130693391|NCT02011945|470503667|FG002|Overall Study|Study Drug Toxicity|1|||
130693392|NCT02011945|470503665|FG000|Overall Study|Treatment Failure|0|||
130693393|NCT02011945|470503666|FG001|Overall Study|Treatment Failure|7|||
130693394|NCT02011945|470503667|FG002|Overall Study|Treatment Failure|6|||
130693395|NCT02011945|470503665|FG000|Overall Study|No Longer Meets Study Criteria|1|||
130693396|NCT02011945|470503666|FG001|Overall Study|No Longer Meets Study Criteria|0|||
130693397|NCT02011945|470503667|FG002|Overall Study|No Longer Meets Study Criteria|0|||
130693398|NCT02011945|470503665|FG000|Overall Study|Proceeded to stem cell transplant|0|||
130693399|NCT02011945|470503666|FG001|Overall Study|Proceeded to stem cell transplant|0|||
130693400|NCT02011945|470503667|FG002|Overall Study|Proceeded to stem cell transplant|1|||
130693401|NCT02011945|470503665|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
130693402|NCT02011945|470503666|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
130693403|NCT02011945|470503667|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
130693404|NCT00902538|470503668|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
130693405|NCT00902538|470503669|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130693406|NCT00902538|470503670|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130693407|NCT00902538|470503671|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130693408|NCT00902538|470503672|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130693409|NCT00902538|470503673|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130693410|NCT00902538|470503668|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
130693411|NCT00902538|470503669|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130693412|NCT00902538|470503670|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130693413|NCT00902538|470503671|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130693414|NCT00902538|470503672|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130693415|NCT00902538|470503673|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130693416|NCT00902538|470503668|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
130693417|NCT00902538|470503669|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130693418|NCT00902538|470503670|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130693419|NCT00902538|470503671|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130693420|NCT00902538|470503672|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130693421|NCT00902538|470503673|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130693422|NCT00902538|470503668|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
130693423|NCT00902538|470503669|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130693424|NCT00902538|470503670|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130693425|NCT00902538|470503671|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130693426|NCT00902538|470503672|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130693427|NCT00902538|470503673|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130693428|NCT00902538|470503668|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
130693429|NCT00902538|470503669|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130693430|NCT00902538|470503670|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130693431|NCT00902538|470503671|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130693432|NCT00902538|470503672|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130693433|NCT00902538|470503673|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130693434|NCT00902538|470503668|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
130693435|NCT00902538|470503669|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
130900758|NCT01425463|471271265|FG001|Overall Study|Unknown Reason|7|||
131025992|NCT02837510|471725353|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
131025993|NCT05419505|471725354|FG000|Overall Study|Adverse Event|0|||
131025994|NCT05419505|471725355|FG001|Overall Study|Adverse Event|0|||
131025995|NCT05419505|471725356|FG002|Overall Study|Adverse Event|0|||
131025996|NCT05419505|471725357|FG003|Overall Study|Adverse Event|1|||
131025997|NCT05419505|471725358|FG004|Overall Study|Adverse Event|0|||
131025998|NCT05419505|471725359|FG005|Overall Study|Adverse Event|0|||
130900759|NCT01328366|471271270|FG000|Overall Study|Death|1|||
130900760|NCT01328366|471271270|FG000|Overall Study|Withdrawal by Subject|2|||
130900761|NCT01328366|471271270|FG000|Overall Study|Lost to Follow-up|7|||
130900762|NCT01122264|471271271|FG000|Overall Study|Adverse Event|6|||
130900763|NCT01122264|471271272|FG001|Overall Study|Adverse Event|5|||
130900764|NCT01122264|471271273|FG002|Overall Study|Adverse Event|7|||
130900765|NCT01122264|471271271|FG000|Overall Study|Death|1|||
130900766|NCT01122264|471271272|FG001|Overall Study|Death|0|||
130900767|NCT01122264|471271273|FG002|Overall Study|Death|0|||
130900768|NCT01122264|471271271|FG000|Overall Study|Lost to Follow-up|5|||
130900769|NCT01122264|471271272|FG001|Overall Study|Lost to Follow-up|9|||
130900770|NCT01122264|471271273|FG002|Overall Study|Lost to Follow-up|13|||
130900771|NCT01122264|471271271|FG000|Overall Study|Entry Criteria Not Met|1|||
130900772|NCT01122264|471271272|FG001|Overall Study|Entry Criteria Not Met|0|||
130900773|NCT01122264|471271273|FG002|Overall Study|Entry Criteria Not Met|0|||
130900774|NCT01122264|471271271|FG000|Overall Study|Protocol Violation|7|||
130900775|NCT01122264|471271272|FG001|Overall Study|Protocol Violation|7|||
130900776|NCT01122264|471271273|FG002|Overall Study|Protocol Violation|9|||
130900777|NCT01122264|471271271|FG000|Overall Study|Withdrawal by Subject|6|||
130900778|NCT01122264|471271272|FG001|Overall Study|Withdrawal by Subject|6|||
130900779|NCT01122264|471271273|FG002|Overall Study|Withdrawal by Subject|16|||
130900780|NCT01122264|471271271|FG000|Overall Study|Physician Decision|3|||
130900781|NCT01122264|471271272|FG001|Overall Study|Physician Decision|1|||
130900782|NCT01122264|471271273|FG002|Overall Study|Physician Decision|1|||
130900783|NCT01122264|471271271|FG000|Overall Study|Lack of Efficacy|3|||
130900784|NCT01122264|471271272|FG001|Overall Study|Lack of Efficacy|1|||
130900785|NCT01122264|471271273|FG002|Overall Study|Lack of Efficacy|1|||
130900786|NCT04585009|471271274|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
130900787|NCT04585009|471271275|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900788|NCT04585009|471271276|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900789|NCT04585009|471271277|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900790|NCT04585009|471271278|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900791|NCT04585009|471271279|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900792|NCT04585009|471271280|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900793|NCT04585009|471271281|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900794|NCT04585009|471271282|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900795|NCT04585009|471271283|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900796|NCT04585009|471271284|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900797|NCT04585009|471271285|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130900798|NCT04585009|471271274|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
130900799|NCT04585009|471271275|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900800|NCT04585009|471271276|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900801|NCT04585009|471271277|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900802|NCT04585009|471271278|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900803|NCT04585009|471271279|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900804|NCT04585009|471271280|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900805|NCT04585009|471271281|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900806|NCT04585009|471271282|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900807|NCT04585009|471271283|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900808|NCT04585009|471271284|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900809|NCT04585009|471271285|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130900810|NCT04585009|471271274|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900811|NCT04585009|471271275|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900812|NCT04585009|471271276|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900813|NCT04585009|471271277|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900814|NCT04585009|471271278|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900815|NCT04585009|471271279|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900816|NCT04585009|471271280|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900817|NCT04585009|471271281|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
130900818|NCT04585009|471271282|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900819|NCT04585009|471271283|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900820|NCT04585009|471271284|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900821|NCT04585009|471271285|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130900822|NCT04585009|471271274|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131025999|NCT05419505|471725360|FG006|Overall Study|Adverse Event|0|||
131026000|NCT05419505|471725361|FG007|Overall Study|Adverse Event|0|||
131026001|NCT05419505|471725354|FG000|Overall Study|Withdrawal by Subject|1|||
131026002|NCT05419505|471725355|FG001|Overall Study|Withdrawal by Subject|2|||
131026003|NCT05419505|471725356|FG002|Overall Study|Withdrawal by Subject|0|||
131026004|NCT05419505|471725357|FG003|Overall Study|Withdrawal by Subject|0|||
130900823|NCT04585009|471271275|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130900824|NCT04585009|471271276|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130900825|NCT04585009|471271277|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131112634|NCT04908189|472042457|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
130693436|NCT00902538|470503670|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
130693437|NCT00902538|470503671|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
130693438|NCT00902538|470503672|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
130693439|NCT00902538|470503673|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
130693440|NCT00902538|470503668|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
130693441|NCT00902538|470503669|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
130693442|NCT00902538|470503670|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
130693443|NCT00902538|470503671|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
130693444|NCT00902538|470503672|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
130693445|NCT00902538|470503673|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
130693446|NCT00902538|470503668|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
130693447|NCT00902538|470503669|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130693448|NCT00902538|470503670|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
130693449|NCT00902538|470503671|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130693450|NCT00902538|470503672|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130693451|NCT00902538|470503673|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130693452|NCT00902538|470503668|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
130693453|NCT00902538|470503669|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
130693454|NCT00902538|470503670|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
130693455|NCT00902538|470503671|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
130693456|NCT00902538|470503672|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
130693457|NCT00902538|470503673|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
130693458|NCT00902538|470503668|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
130693459|NCT00902538|470503669|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
130693460|NCT00902538|470503670|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
130693461|NCT00902538|470503671|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
130693462|NCT00902538|470503672|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
130693463|NCT00902538|470503673|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
130693464|NCT00902538|470503668|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
130693465|NCT00902538|470503669|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
130693466|NCT00902538|470503670|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
130693467|NCT00902538|470503671|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
130693468|NCT00902538|470503672|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
130693469|NCT00902538|470503673|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
130693470|NCT00902538|470503668|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
130693471|NCT00902538|470503669|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
130693472|NCT00902538|470503670|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
130693473|NCT00902538|470503671|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
130693474|NCT00902538|470503672|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
130693475|NCT00902538|470503673|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
130693476|NCT00902538|470503668|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130693477|NCT00902538|470503669|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
130693478|NCT00902538|470503670|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130693479|NCT00902538|470503671|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130693480|NCT00902538|470503672|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130693481|NCT00902538|470503673|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130693482|NCT00902538|470503668|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130693483|NCT00902538|470503669|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
130693484|NCT00902538|470503670|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130693485|NCT00902538|470503671|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130693486|NCT00902538|470503672|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130693487|NCT00902538|470503673|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130693488|NCT00902538|470503668|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
130693489|NCT00902538|470503669|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
130693490|NCT00902538|470503670|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
130693491|NCT00902538|470503671|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
130900826|NCT04585009|471271278|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
130900827|NCT04585009|471271279|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
131112635|NCT04908189|472042458|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
130693492|NCT00902538|470503672|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
130693493|NCT00902538|470503673|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
130900828|NCT04585009|471271280|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130900829|NCT04585009|471271281|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130900830|NCT04585009|471271282|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130900831|NCT04585009|471271283|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130900832|NCT04585009|471271284|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130900833|NCT04585009|471271285|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130900834|NCT04585009|471271274|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900835|NCT04585009|471271275|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900836|NCT04585009|471271276|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900837|NCT04585009|471271277|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900838|NCT04585009|471271278|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900839|NCT04585009|471271279|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900840|NCT04585009|471271280|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900841|NCT04585009|471271281|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900842|NCT04585009|471271282|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900843|NCT04585009|471271283|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
130900844|NCT04585009|471271284|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900845|NCT04585009|471271285|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130900846|NCT04585009|471271274|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900847|NCT04585009|471271275|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900848|NCT04585009|471271276|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900849|NCT04585009|471271277|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900850|NCT04585009|471271278|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900851|NCT04585009|471271279|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900852|NCT04585009|471271280|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900853|NCT04585009|471271281|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900854|NCT04585009|471271282|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900855|NCT04585009|471271283|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900856|NCT04585009|471271284|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130900857|NCT04585009|471271285|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
130900858|NCT01002820|471271296|FG000|Overall Study|Adverse Event|1|||
130900859|NCT01002820|471271296|FG000|Overall Study|Withdrawal by Subject|2|||
130900860|NCT01002820|471271296|FG000|Overall Study|Lack of Efficacy|1|||
130900861|NCT01673347|471271298|FG000|Overall Study|failure of allograft|7|||
130900862|NCT00895011|471271302|FG000|Overall Study|Withdrawal by Subject|14|||
130900863|NCT00895011|471271303|FG001|Overall Study|Withdrawal by Subject|7|||
130900864|NCT00895011|471271304|FG002|Overall Study|Withdrawal by Subject|2|||
130900865|NCT00895011|471271302|FG000|Overall Study|Lost to Follow-up|5|||
130900866|NCT00895011|471271303|FG001|Overall Study|Lost to Follow-up|4|||
130900867|NCT00895011|471271304|FG002|Overall Study|Lost to Follow-up|1|||
130900868|NCT00895011|471271302|FG000|Overall Study|Protocol Violation|3|||
130900869|NCT00895011|471271303|FG001|Overall Study|Protocol Violation|1|||
130900870|NCT00895011|471271304|FG002|Overall Study|Protocol Violation|3|||
130900871|NCT00895011|471271302|FG000|Overall Study|Adverse Event|1|||
130900872|NCT00895011|471271303|FG001|Overall Study|Adverse Event|2|||
130900873|NCT00895011|471271304|FG002|Overall Study|Adverse Event|2|||
130900874|NCT00895011|471271302|FG000|Overall Study|schedule conflict|1|||
130900875|NCT00895011|471271303|FG001|Overall Study|schedule conflict|0|||
130900876|NCT00895011|471271304|FG002|Overall Study|schedule conflict|0|||
130900877|NCT02661178|471271305|FG000|Part 1|Protocol Violation|1|||
130900878|NCT02661178|471271306|FG001|Part 1|Protocol Violation|0|||
130900879|NCT02661178|471271307|FG002|Part 1|Protocol Violation|0|||
130900880|NCT02661178|471271308|FG003|Part 1|Protocol Violation|0|||
130900881|NCT02661178|471271309|FG004|Part 1|Protocol Violation|0|||
130900882|NCT02661178|471271310|FG005|Part 1|Protocol Violation|0|||
130900883|NCT02661178|471271311|FG006|Part 1|Protocol Violation|0|||
130900884|NCT02661178|471271312|FG007|Part 1|Protocol Violation|0|||
130900885|NCT02661178|471271313|FG008|Part 1|Protocol Violation|0|||
130900886|NCT02661178|471271314|FG009|Part 1|Protocol Violation|0|||
130900887|NCT02661178|471271315|FG010|Part 1|Protocol Violation|0|||
130900888|NCT02661178|471271316|FG011|Part 1|Protocol Violation|0|||
130900889|NCT02661178|471271317|FG012|Part 1|Protocol Violation|0|||
130900890|NCT02661178|471271318|FG013|Part 1|Protocol Violation|0|||
130900891|NCT02661178|471271319|FG014|Part 1|Protocol Violation|0|||
130900892|NCT03642132|471271321|FG000|Chemotherapy Period|Adverse Event|1|||
130900893|NCT03642132|471271322|FG001|Chemotherapy Period|Adverse Event|1|||
130900894|NCT03642132|471271323|FG002|Chemotherapy Period|Adverse Event|0|||
130900895|NCT03642132|471271321|FG000|Chemotherapy Period|Physician's decision|4|||
130900896|NCT03642132|471271322|FG001|Chemotherapy Period|Physician's decision|1|||
130900897|NCT03642132|471271323|FG002|Chemotherapy Period|Physician's decision|0|||
130900898|NCT03642132|471271321|FG000|Chemotherapy Period|Progressive disease|0|||
130900899|NCT03642132|471271322|FG001|Chemotherapy Period|Progressive disease|0|||
130900900|NCT03642132|471271323|FG002|Chemotherapy Period|Progressive disease|1|||
130900901|NCT03642132|471271321|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
130693494|NCT00902538|470503668|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130900902|NCT03642132|471271322|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
130900903|NCT03642132|471271323|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
130900904|NCT03642132|471271321|FG000|Chemotherapy Period|Other|1|||
130900905|NCT03642132|471271322|FG001|Chemotherapy Period|Other|0|||
130900906|NCT03642132|471271323|FG002|Chemotherapy Period|Other|2|||
130900907|NCT03642132|471271321|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
130900908|NCT03642132|471271322|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
130900909|NCT03642132|471271323|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
130900910|NCT03642132|471271321|FG000|Maintenance Period|Adverse Event|1|||
130900911|NCT03642132|471271322|FG001|Maintenance Period|Adverse Event|2|||
130900912|NCT03642132|471271323|FG002|Maintenance Period|Adverse Event|0|||
130900913|NCT03642132|471271321|FG000|Maintenance Period|Non-compliance with study drug|0|||
130900914|NCT03642132|471271322|FG001|Maintenance Period|Non-compliance with study drug|0|||
130900915|NCT03642132|471271323|FG002|Maintenance Period|Non-compliance with study drug|1|||
130900916|NCT03642132|471271321|FG000|Maintenance Period|Physician's decision|2|||
130900917|NCT03642132|471271322|FG001|Maintenance Period|Physician's decision|2|||
130900918|NCT03642132|471271323|FG002|Maintenance Period|Physician's decision|2|||
130900919|NCT03642132|471271321|FG000|Maintenance Period|Progressive disease|9|||
130900920|NCT03642132|471271322|FG001|Maintenance Period|Progressive disease|3|||
130900921|NCT03642132|471271323|FG002|Maintenance Period|Progressive disease|6|||
130900922|NCT03642132|471271321|FG000|Maintenance Period|Other|0|||
130900923|NCT03642132|471271322|FG001|Maintenance Period|Other|0|||
130900924|NCT03642132|471271323|FG002|Maintenance Period|Other|3|||
130900925|NCT03642132|471271321|FG000|Maintenance Period|Withdrawal by Subject|1|||
130900926|NCT03642132|471271322|FG001|Maintenance Period|Withdrawal by Subject|1|||
130900927|NCT03642132|471271323|FG002|Maintenance Period|Withdrawal by Subject|2|||
130900928|NCT03642132|471271321|FG000|Follow-up Period|Other|0|||
130900929|NCT03642132|471271322|FG001|Follow-up Period|Other|0|||
130900930|NCT03642132|471271323|FG002|Follow-up Period|Other|1|||
130900931|NCT03642132|471271321|FG000|Follow-up Period|Withdrawal by Subject|1|||
130900932|NCT03642132|471271322|FG001|Follow-up Period|Withdrawal by Subject|2|||
130900933|NCT03642132|471271323|FG002|Follow-up Period|Withdrawal by Subject|0|||
130900934|NCT03642132|471271321|FG000|Follow-up Period|Study terminated by sponsor|1|||
130900935|NCT03642132|471271322|FG001|Follow-up Period|Study terminated by sponsor|0|||
130900936|NCT03642132|471271323|FG002|Follow-up Period|Study terminated by sponsor|1|||
131026005|NCT05419505|471725358|FG004|Overall Study|Withdrawal by Subject|0|||
131026006|NCT05419505|471725359|FG005|Overall Study|Withdrawal by Subject|0|||
131026007|NCT05419505|471725360|FG006|Overall Study|Withdrawal by Subject|1|||
131026008|NCT05419505|471725361|FG007|Overall Study|Withdrawal by Subject|0|||
130693495|NCT00902538|470503669|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130693496|NCT00902538|470503670|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130693497|NCT00902538|470503671|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
130693498|NCT00902538|470503672|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
130693499|NCT00902538|470503673|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130693500|NCT00902538|470503668|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130693501|NCT00902538|470503669|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130693502|NCT00902538|470503670|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130693503|NCT00902538|470503671|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
130693504|NCT00902538|470503672|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130693505|NCT00902538|470503673|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130693506|NCT03531827|470503674|FG000|Overall Study|Adverse Event|2|||
130900937|NCT03642132|471271321|FG000|Follow-up Period|Lack of Efficacy|1|||
130900938|NCT03642132|471271322|FG001|Follow-up Period|Lack of Efficacy|0|||
130900939|NCT03642132|471271323|FG002|Follow-up Period|Lack of Efficacy|0|||
131026009|NCT05419505|471725354|FG000|Overall Study|Lost to Follow-up|2|||
131026010|NCT05419505|471725355|FG001|Overall Study|Lost to Follow-up|1|||
131026011|NCT05419505|471725356|FG002|Overall Study|Lost to Follow-up|0|||
131026012|NCT05419505|471725357|FG003|Overall Study|Lost to Follow-up|0|||
131112636|NCT04908189|472042459|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
131112637|NCT04683731|472042460|FG000|Overall Study|Withdrawal by Subject|1|||
130693507|NCT03531827|470503675|FG001|Overall Study|Adverse Event|0|||
130693508|NCT03531827|470503674|FG000|Overall Study|Progressive disease|1|||
130900940|NCT03642132|471271321|FG000|Follow-up Period|Death|1|||
130768162|NCT04114656|470775464|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
131026013|NCT05419505|471725358|FG004|Overall Study|Lost to Follow-up|1|||
131026014|NCT05419505|471725359|FG005|Overall Study|Lost to Follow-up|2|||
131026015|NCT05419505|471725360|FG006|Overall Study|Lost to Follow-up|0|||
131026016|NCT05419505|471725361|FG007|Overall Study|Lost to Follow-up|1|||
130900941|NCT03642132|471271322|FG001|Follow-up Period|Death|0|||
130900942|NCT03642132|471271323|FG002|Follow-up Period|Death|2|||
130900943|NCT03642132|471271321|FG000|Follow-up Period|Adverse Event|1|||
130900944|NCT03642132|471271322|FG001|Follow-up Period|Adverse Event|0|||
130900945|NCT03642132|471271323|FG002|Follow-up Period|Adverse Event|0|||
130900946|NCT03337490|471271324|FG000|Overall Study|Withdrawal by Subject|1|||
130900947|NCT03337490|471271325|FG001|Overall Study|Withdrawal by Subject|0|||
130900948|NCT03337490|471271326|FG002|Overall Study|Withdrawal by Subject|0|||
130900949|NCT03337490|471271324|FG000|Overall Study|Lack of Efficacy|10|||
130900950|NCT03337490|471271325|FG001|Overall Study|Lack of Efficacy|12|||
130900951|NCT03337490|471271326|FG002|Overall Study|Lack of Efficacy|35|||
130900952|NCT03337490|471271324|FG000|Overall Study|Physician Decision|0|||
130900953|NCT03337490|471271325|FG001|Overall Study|Physician Decision|1|||
130900954|NCT03337490|471271326|FG002|Overall Study|Physician Decision|0|||
130900955|NCT03337490|471271324|FG000|Overall Study|Lost to Follow-up|0|||
130900956|NCT03337490|471271325|FG001|Overall Study|Lost to Follow-up|1|||
130900957|NCT03337490|471271326|FG002|Overall Study|Lost to Follow-up|0|||
130900958|NCT01579812|471271329|FG000|Overall Study|Ineligible after treatment start|40|||
130900959|NCT01579812|471271329|FG000|Overall Study|Patient choice|3|||
130900960|NCT01579812|471271329|FG000|Overall Study|Noncompliance|3|||
130900961|NCT01579812|471271329|FG000|Overall Study|Withdrawal by Subject|6|||
130900962|NCT01133990|471271332|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
130900963|NCT01133990|471271333|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130900964|NCT01133990|471271334|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130900965|NCT01133990|471271335|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130900966|NCT01133990|471271336|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130900967|NCT01133990|471271337|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130900968|NCT01133990|471271332|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
130900969|NCT01133990|471271333|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130900970|NCT01133990|471271334|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130900971|NCT01133990|471271335|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130900972|NCT01133990|471271336|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130900973|NCT01133990|471271337|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130900974|NCT01133990|471271332|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
130900975|NCT01133990|471271333|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130900976|NCT01133990|471271334|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130900977|NCT01133990|471271335|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130900978|NCT01133990|471271336|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130693509|NCT03531827|470503675|FG001|Overall Study|Progressive disease|0|||
130693510|NCT00849797|470503676|FG000|First Intervention|bad veins|1|||
130900979|NCT01133990|471271337|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130900980|NCT01133990|471271332|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
130900981|NCT01133990|471271333|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
131026017|NCT02780388|471725364|FG000|Overall Study|Lost to Follow-up|0|||
131026018|NCT02780388|471725365|FG001|Overall Study|Lost to Follow-up|1|||
131026019|NCT02780388|471725366|FG002|Overall Study|Lost to Follow-up|0|||
131026020|NCT02780388|471725367|FG003|Overall Study|Lost to Follow-up|0|||
131026021|NCT02780388|471725368|FG004|Overall Study|Lost to Follow-up|0|||
131026022|NCT02780388|471725364|FG000|Overall Study|Withdrawal by Subject|1|||
131026023|NCT02780388|471725365|FG001|Overall Study|Withdrawal by Subject|1|||
131026024|NCT02780388|471725366|FG002|Overall Study|Withdrawal by Subject|0|||
131026025|NCT02780388|471725367|FG003|Overall Study|Withdrawal by Subject|0|||
131026026|NCT02780388|471725368|FG004|Overall Study|Withdrawal by Subject|0|||
131026027|NCT02724956|471725377|FG000|Overall Study|Physician Decision|1|||
131026028|NCT02724956|471725378|FG001|Overall Study|Physician Decision|0|||
131026029|NCT02724956|471725377|FG000|Overall Study|Lack of Efficacy|0|||
131026030|NCT02724956|471725378|FG001|Overall Study|Lack of Efficacy|1|||
131026031|NCT02724956|471725377|FG000|Overall Study|Withdrawal by Subject|0|||
131026032|NCT02724956|471725378|FG001|Overall Study|Withdrawal by Subject|1|||
131026033|NCT02058108|471725379|FG000|Overall Study|Abnormal Laboratory Values|0|||
131026034|NCT02058108|471725380|FG001|Overall Study|Abnormal Laboratory Values|1|||
131026035|NCT02058108|471725379|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
131026036|NCT02058108|471725380|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
131026037|NCT02058108|471725379|FG000|Overall Study|No longer requires study drug|0|||
131026038|NCT02058108|471725380|FG001|Overall Study|No longer requires study drug|1|||
131026039|NCT02058108|471725379|FG000|Overall Study|Withdrawal by Subject|1|||
131026040|NCT02058108|471725380|FG001|Overall Study|Withdrawal by Subject|0|||
131026041|NCT02058108|471725379|FG000|Overall Study|Administrative problems|3|||
131026042|NCT02058108|471725380|FG001|Overall Study|Administrative problems|3|||
131026043|NCT02058108|471725379|FG000|Overall Study|Protocol Violation|0|||
131026044|NCT02058108|471725380|FG001|Overall Study|Protocol Violation|1|||
131026045|NCT04759833|471725384|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
131026046|NCT04759833|471725385|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
131026047|NCT04759833|471725386|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
131026048|NCT04759833|471725387|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
131026049|NCT04759833|471725388|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
131026050|NCT04759833|471725384|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
131026051|NCT04759833|471725385|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
130693511|NCT00849797|470503677|FG001|First Intervention|bad veins|0|||
130900982|NCT01133990|471271334|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130900983|NCT01133990|471271335|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130900984|NCT01133990|471271336|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130900985|NCT01133990|471271337|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130900986|NCT05277337|471271338|FG000|Overall Study|Lost to Follow-up|2|||
130900987|NCT05277337|471271339|FG001|Overall Study|Lost to Follow-up|0|||
130900988|NCT05277337|471271338|FG000|Overall Study|Withdrawal by Subject|1|||
130900989|NCT05277337|471271339|FG001|Overall Study|Withdrawal by Subject|0|||
130900990|NCT02683746|471271340|FG000|Overall Study|Adverse Event|3|||
130900991|NCT02683746|471271341|FG001|Overall Study|Adverse Event|2|||
130900992|NCT02683746|471271340|FG000|Overall Study|Lost to Follow-up|5|||
130900993|NCT02683746|471271341|FG001|Overall Study|Lost to Follow-up|6|||
130900994|NCT02683746|471271340|FG000|Overall Study|Withdrawal by Subject|6|||
130900995|NCT02683746|471271341|FG001|Overall Study|Withdrawal by Subject|5|||
130900996|NCT02683746|471271340|FG000|Overall Study|Physician Decision|2|||
130900997|NCT02683746|471271341|FG001|Overall Study|Physician Decision|1|||
130900998|NCT04987944|471271342|FG000|Overall Study|Adverse Event|0|||
130900999|NCT04987944|471271343|FG001|Overall Study|Adverse Event|1|||
130901000|NCT04987944|471271342|FG000|Overall Study|Withdrawal by Subject|0|||
130901001|NCT04987944|471271343|FG001|Overall Study|Withdrawal by Subject|1|||
130901002|NCT01038869|471271346|FG000|Overall Study|Withdrawal by Subject|1|||
130901003|NCT01038869|471271346|FG000|Overall Study|Lost to Follow-up|6|||
130901004|NCT04905498|471271347|FG000|Overall Study|Lost to Follow-up|0|||
130901005|NCT04905498|471271348|FG001|Overall Study|Lost to Follow-up|2|||
130901006|NCT04905498|471271347|FG000|Overall Study|COVID lockdown|1|||
130901007|NCT04905498|471271348|FG001|Overall Study|COVID lockdown|0|||
130901008|NCT03077087|471271351|FG000|Overall Study|Physician Decision|2|||
130901009|NCT03222492|471271352|FG000|Overall Study|Withdrawal by Subject|0|||
130901010|NCT03222492|471271353|FG001|Overall Study|Withdrawal by Subject|0|||
130901011|NCT03222492|471271354|FG002|Overall Study|Withdrawal by Subject|1|||
130901012|NCT03222492|471271355|FG003|Overall Study|Withdrawal by Subject|0|||
130901013|NCT03222492|471271352|FG000|Overall Study|COVID-19 related|0|||
130901014|NCT03222492|471271353|FG001|Overall Study|COVID-19 related|0|||
130901015|NCT03222492|471271354|FG002|Overall Study|COVID-19 related|1|||
130901016|NCT03222492|471271355|FG003|Overall Study|COVID-19 related|0|||
130901017|NCT01224782|471271360|FG000|Overall Study|Lost to Follow-up|177|||
130901018|NCT01224782|471271360|FG000|Overall Study|Withdrawal by Subject|16|||
130901019|NCT01224782|471271360|FG000|Overall Study|Death|14|||
130901020|NCT01224782|471271360|FG000|Overall Study|Improvement|13|||
130901021|NCT01224782|471271360|FG000|Overall Study|Adverse Event|12|||
130901022|NCT01224782|471271360|FG000|Overall Study|Adverse Reaction|11|||
130901023|NCT01224782|471271360|FG000|Overall Study|Noncompliance|10|||
130901024|NCT01224782|471271360|FG000|Overall Study|Other|4|||
130901025|NCT01224782|471271360|FG000|Overall Study|Start of Dialysis|3|||
130901026|NCT01224782|471271360|FG000|Overall Study|Change of Treatment|1|||
130901027|NCT01224782|471271360|FG000|Overall Study|Financial Reasons|1|||
130901028|NCT01224782|471271360|FG000|Overall Study|Deterioration|1|||
130901029|NCT01224782|471271360|FG000|Overall Study|Transplantation|1|||
130901030|NCT00065429|471271363|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130901031|NCT00065429|471271364|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130901032|NCT00065429|471271365|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130901033|NCT00065429|471271366|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130901034|NCT00065429|471271367|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130901035|NCT00065429|471271368|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
130901036|NCT00065429|471271369|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130901037|NCT00065429|471271363|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130901038|NCT00065429|471271364|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130901039|NCT00065429|471271365|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
130901040|NCT00065429|471271366|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130901041|NCT00065429|471271367|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
131026052|NCT04759833|471725386|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
131026053|NCT04759833|471725387|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
131026054|NCT04759833|471725388|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
131026055|NCT04759833|471725384|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
131026056|NCT04759833|471725385|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
131026057|NCT04759833|471725386|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
130901042|NCT00065429|471271368|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130901043|NCT00065429|471271369|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130901044|NCT00065429|471271363|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
130901045|NCT00065429|471271364|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130901046|NCT00065429|471271365|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130901047|NCT00065429|471271366|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130901048|NCT00065429|471271367|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130901049|NCT00065429|471271368|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130901050|NCT00065429|471271369|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130901051|NCT00065429|471271363|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
130901052|NCT00065429|471271364|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
130901053|NCT00065429|471271365|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
130901054|NCT00065429|471271366|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
130901055|NCT00065429|471271367|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
130901056|NCT00065429|471271368|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
130901057|NCT00065429|471271369|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
130901058|NCT00065429|471271363|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130901059|NCT00065429|471271364|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130901060|NCT00065429|471271365|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130901061|NCT00065429|471271366|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
130901062|NCT00065429|471271367|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130901063|NCT00065429|471271368|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
130901064|NCT00065429|471271369|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
130901065|NCT00065429|471271363|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130901066|NCT00065429|471271364|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130901067|NCT00065429|471271365|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130901068|NCT00065429|471271366|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130901069|NCT00065429|471271367|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
130901070|NCT00065429|471271368|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130901071|NCT00065429|471271369|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130901072|NCT00065429|471271363|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130901073|NCT00065429|471271364|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130901074|NCT00065429|471271365|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130901075|NCT00065429|471271366|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130901076|NCT00065429|471271367|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
130901077|NCT00065429|471271368|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130901078|NCT00065429|471271369|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130901079|NCT00441116|471271371|FG000|Overall Study|Adverse Event|1|||
130901080|NCT00441116|471271372|FG001|Overall Study|Adverse Event|1|||
130901081|NCT00441116|471271371|FG000|Overall Study|Withdrawal by Subject|1|||
130901082|NCT00441116|471271372|FG001|Overall Study|Withdrawal by Subject|0|||
130901083|NCT00441116|471271371|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
130901084|NCT00441116|471271372|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
130901085|NCT01765218|471271383|FG000|Overall Study|Protocol Violation|1|||
130901086|NCT01765218|471271384|FG001|Overall Study|Protocol Violation|2|||
130901087|NCT00796523|471271385|FG000|Overall Study|Lost to Follow-up|9|||
130901088|NCT00796523|471271386|FG001|Overall Study|Lost to Follow-up|7|||
130901089|NCT00781885|471271388|FG000|Overall Study|Physician Decision|1|||
130901090|NCT01755026|471271389|FG000|Overall Study|Adverse Event|1|||
130901091|NCT01755026|471271390|FG001|Overall Study|Adverse Event|0|||
130901092|NCT01755026|471271389|FG000|Overall Study|Withdrawal by Subject|1|||
130901093|NCT01755026|471271390|FG001|Overall Study|Withdrawal by Subject|1|||
130901094|NCT01806662|471271400|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
130901095|NCT01806662|471271401|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
130901096|NCT01806662|471271400|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
130901097|NCT01806662|471271401|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
130901098|NCT01806662|471271400|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
130901099|NCT01806662|471271401|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
130901100|NCT01806662|471271400|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
130901101|NCT01806662|471271401|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
130901102|NCT01917656|471271407|FG000|Overall Study|Adverse Event|11|||
130901103|NCT01917656|471271408|FG001|Overall Study|Adverse Event|0|||
131026058|NCT04759833|471725387|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
130768163|NCT04114656|470775463|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
130768164|NCT04114656|470775464|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
130768165|NCT04114656|470775463|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
130768166|NCT04114656|470775464|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
130768167|NCT04114656|470775463|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
130901104|NCT01917656|471271407|FG000|Overall Study|Withdrawal criteria|8|||
130901105|NCT01917656|471271408|FG001|Overall Study|Withdrawal criteria|14|||
130901106|NCT01917656|471271407|FG000|Overall Study|Unclassified|0|||
130901107|NCT01917656|471271408|FG001|Overall Study|Unclassified|3|||
130901108|NCT01917656|471271407|FG000|Overall Study|Withdrawal by Subject|4|||
130901109|NCT01917656|471271408|FG001|Overall Study|Withdrawal by Subject|3|||
130901110|NCT01917656|471271407|FG000|Overall Study|Lost to Follow-up|3|||
130901111|NCT01917656|471271408|FG001|Overall Study|Lost to Follow-up|4|||
130901112|NCT02081859|471271409|FG000|Overall Study|No fertilization|2|||
130901113|NCT02081859|471271410|FG001|Overall Study|No fertilization|2|||
130901114|NCT02081859|471271409|FG000|Overall Study|No sperm|1|||
131026059|NCT04759833|471725388|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
130768168|NCT04114656|470775464|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
130768169|NCT04114656|470775463|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
130768170|NCT04114656|470775464|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
130768171|NCT03052920|470775465|FG000|Overall Study|Withdrawal by Subject|1|||
130768172|NCT02578940|470775466|FG000|Overall Study|Screening failure|5|||
130768173|NCT02578940|470775466|FG000|Overall Study|Lost to Follow-up|1|||
130768174|NCT04591015|470775469|FG000|Overall Study|Death|6|||
130768175|NCT04591015|470775470|FG001|Overall Study|Death|4|||
130768176|NCT04591015|470775469|FG000|Overall Study|Withdrawal by Subject|6|||
130768177|NCT04591015|470775470|FG001|Overall Study|Withdrawal by Subject|3|||
130768178|NCT04591015|470775469|FG000|Overall Study|Lost to Follow-up|16|||
130768179|NCT04591015|470775470|FG001|Overall Study|Lost to Follow-up|11|||
130768180|NCT02686814|470775471|FG000|Overall Study|Physician Decision|14|||
130768181|NCT02686814|470775471|FG000|Overall Study|Withdrawal by Subject|4|||
130768182|NCT02686814|470775471|FG000|Overall Study|Death|1|||
130768183|NCT00290693|470775472|FG000|Overall Study|Withdrawal by Subject|2|||
130768184|NCT02907619|470775473|FG000|Overall Study|Study terminated by sponsor|18|||
130768185|NCT02907619|470775474|FG001|Overall Study|Study terminated by sponsor|18|||
130768186|NCT02907619|470775475|FG002|Overall Study|Study terminated by sponsor|19|||
130768187|NCT02907619|470775473|FG000|Overall Study|Death|0|||
130768188|NCT02907619|470775474|FG001|Overall Study|Death|0|||
130768189|NCT02907619|470775475|FG002|Overall Study|Death|1|||
130768190|NCT02907619|470775473|FG000|Overall Study|Withdrawal by Subject|1|||
130768191|NCT02907619|470775474|FG001|Overall Study|Withdrawal by Subject|1|||
130768192|NCT02907619|470775475|FG002|Overall Study|Withdrawal by Subject|0|||
130768193|NCT02907619|470775473|FG000|Overall Study|Other|0|||
130768194|NCT02907619|470775474|FG001|Overall Study|Other|1|||
130768195|NCT02907619|470775475|FG002|Overall Study|Other|0|||
130901115|NCT02081859|471271410|FG001|Overall Study|No sperm|0|||
130901116|NCT02081859|471271409|FG000|Overall Study|Unanticipated freeze all cycle|2|||
130901117|NCT02081859|471271410|FG001|Overall Study|Unanticipated freeze all cycle|6|||
130901118|NCT02081859|471271409|FG000|Overall Study|< 4 embryos|27|||
130901119|NCT02081859|471271410|FG001|Overall Study|< 4 embryos|23|||
130768196|NCT01908582|470775476|FG000|Period 2|Physician Decision|1|||
130768197|NCT01908582|470775476|FG000|Period 2|Withdrawal by Subject|1|||
130768198|NCT03484403|470775478|FG000|Overall Study|Withdrawal by Subject|6|||
130768199|NCT03484403|470775479|FG001|Overall Study|Withdrawal by Subject|4|||
130768200|NCT02722746|470775491|FG000|Overall Study|Withdrawal by Subject|0|||
130768201|NCT02722746|470775492|FG001|Overall Study|Withdrawal by Subject|1|||
130768202|NCT02722746|470775493|FG002|Overall Study|Withdrawal by Subject|0|||
130768203|NCT02722746|470775491|FG000|Overall Study|Protocol Violation|8|||
130768204|NCT02722746|470775492|FG001|Overall Study|Protocol Violation|4|||
130768205|NCT02722746|470775493|FG002|Overall Study|Protocol Violation|6|||
130768206|NCT01134263|470775494|FG000|Overall Study|Serious adverse event|2|||
130768207|NCT01134263|470775495|FG001|Overall Study|Serious adverse event|1|||
130768208|NCT01134263|470775496|FG002|Overall Study|Serious adverse event|1|||
130768209|NCT01134263|470775497|FG003|Overall Study|Serious adverse event|1|||
130768210|NCT01134263|470775498|FG004|Overall Study|Serious adverse event|1|||
130768211|NCT01134263|470775494|FG000|Overall Study|Other adverse event|1|||
130768212|NCT01134263|470775495|FG001|Overall Study|Other adverse event|2|||
130768213|NCT01134263|470775496|FG002|Overall Study|Other adverse event|5|||
130768214|NCT01134263|470775497|FG003|Overall Study|Other adverse event|3|||
130768215|NCT01134263|470775498|FG004|Overall Study|Other adverse event|0|||
130768216|NCT01134263|470775494|FG000|Overall Study|Protocol Violation|8|||
130768217|NCT01134263|470775495|FG001|Overall Study|Protocol Violation|7|||
130768218|NCT01134263|470775496|FG002|Overall Study|Protocol Violation|2|||
130768219|NCT01134263|470775497|FG003|Overall Study|Protocol Violation|4|||
130768220|NCT01134263|470775498|FG004|Overall Study|Protocol Violation|2|||
130768221|NCT01134263|470775494|FG000|Overall Study|Lost to Follow-up|4|||
130768222|NCT01134263|470775495|FG001|Overall Study|Lost to Follow-up|3|||
130768223|NCT01134263|470775496|FG002|Overall Study|Lost to Follow-up|5|||
130901120|NCT02081859|471271409|FG000|Overall Study|Other reasons|2|||
130901121|NCT02081859|471271410|FG001|Overall Study|Other reasons|0|||
130901122|NCT02285062|471271411|FG000|Pre-Treatment Period|Protocol Violation|0|||
130768224|NCT01134263|470775497|FG003|Overall Study|Lost to Follow-up|3|||
130768225|NCT01134263|470775498|FG004|Overall Study|Lost to Follow-up|1|||
130768226|NCT01134263|470775494|FG000|Overall Study|Withdrawal by Subject|8|||
130768227|NCT01134263|470775495|FG001|Overall Study|Withdrawal by Subject|6|||
130901123|NCT02285062|471271412|FG001|Pre-Treatment Period|Protocol Violation|2|||
130901124|NCT02285062|471271411|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
130901125|NCT02285062|471271412|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
131026060|NCT04759833|471725384|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
130768228|NCT01134263|470775496|FG002|Overall Study|Withdrawal by Subject|16|||
130768229|NCT01134263|470775497|FG003|Overall Study|Withdrawal by Subject|7|||
130768230|NCT01134263|470775498|FG004|Overall Study|Withdrawal by Subject|5|||
130768231|NCT01134263|470775494|FG000|Overall Study|Enrolled, but not treated|1|||
130768232|NCT01134263|470775495|FG001|Overall Study|Enrolled, but not treated|1|||
130693512|NCT00849797|470503676|FG000|First Intervention|Adverse Event|0|||
130693513|NCT00849797|470503677|FG001|First Intervention|Adverse Event|1|||
130693514|NCT00849797|470503676|FG000|Washout: One Week|Withdrawal by Subject|0|||
130693515|NCT00849797|470503677|FG001|Washout: One Week|Withdrawal by Subject|2|||
130693516|NCT00679081|470503678|FG000|Overall Study|Lost to Follow-up|1|||
130693517|NCT00725322|470503679|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
130693518|NCT00725322|470503680|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
130693519|NCT00725322|470503679|FG000|Washout (28 Days)|Protocol Violation|0|||
130693520|NCT00725322|470503680|FG001|Washout (28 Days)|Protocol Violation|1|||
130693521|NCT01279486|470503681|FG000|Overall Study|Lost to Follow-up|1|||
130693522|NCT04198363|470503685|FG000|Overall Study|Adverse Event|1|||
130693523|NCT04198363|470503686|FG001|Overall Study|Adverse Event|1|||
130693524|NCT04198363|470503685|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
130693525|NCT04198363|470503686|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
130693526|NCT04198363|470503685|FG000|Overall Study|Reason not Specified|1|||
130693527|NCT04198363|470503686|FG001|Overall Study|Reason not Specified|0|||
130693528|NCT03067987|470503688|FG000|Overall Study|Lost to Follow-up|7|||
130693529|NCT03067987|470503689|FG001|Overall Study|Lost to Follow-up|10|||
130693530|NCT03067987|470503688|FG000|Overall Study|Protocol Violation|1|||
130693531|NCT03067987|470503689|FG001|Overall Study|Protocol Violation|2|||
130693532|NCT03067987|470503688|FG000|Overall Study|Withdrawal by Subject|2|||
130693533|NCT03067987|470503689|FG001|Overall Study|Withdrawal by Subject|1|||
130693534|NCT01404988|470503692|FG000|Overall Study|Death|2|||
130693535|NCT01404988|470503693|FG001|Overall Study|Death|0|||
130693536|NCT01404988|470503694|FG002|Overall Study|Death|2|||
130693537|NCT01404988|470503692|FG000|Overall Study|Adverse Event|1|||
130693538|NCT01404988|470503693|FG001|Overall Study|Adverse Event|0|||
130693539|NCT01404988|470503694|FG002|Overall Study|Adverse Event|0|||
130693540|NCT01404988|470503692|FG000|Overall Study|Withdrawal by Subject|2|||
130693541|NCT01404988|470503693|FG001|Overall Study|Withdrawal by Subject|2|||
130693542|NCT01404988|470503694|FG002|Overall Study|Withdrawal by Subject|0|||
130693543|NCT01404988|470503692|FG000|Overall Study|Lost to Follow-up|1|||
130693544|NCT01404988|470503693|FG001|Overall Study|Lost to Follow-up|2|||
130693545|NCT01404988|470503694|FG002|Overall Study|Lost to Follow-up|1|||
130693546|NCT00829764|470503695|FG000|First Intervention|Adverse Event|1|||
130693547|NCT00829764|470503696|FG001|First Intervention|Adverse Event|0|||
130693548|NCT00829764|470503695|FG000|First Intervention|Withdrawal by Subject|1|||
130693549|NCT00829764|470503696|FG001|First Intervention|Withdrawal by Subject|1|||
130693550|NCT04594252|470503697|FG000|Overall Study|Adverse Event|0|||
130693551|NCT04594252|470503698|FG001|Overall Study|Adverse Event|2|||
130693552|NCT03578809|470505750|FG000|Overall Study|Death|0|||
130693553|NCT03578809|470505751|FG001|Overall Study|Death|2|||
130693554|NCT03578809|470505752|FG002|Overall Study|Death|0|||
130693555|NCT03578809|470505753|FG003|Overall Study|Death|1|||
130693556|NCT03578809|470505750|FG000|Overall Study|Lost to Follow-up|0|||
130693557|NCT03578809|470505751|FG001|Overall Study|Lost to Follow-up|1|||
130693558|NCT03578809|470505752|FG002|Overall Study|Lost to Follow-up|0|||
130693559|NCT03578809|470505753|FG003|Overall Study|Lost to Follow-up|0|||
130693560|NCT03578809|470505750|FG000|Overall Study|Withdrawal by Subject|3|||
130693561|NCT03578809|470505751|FG001|Overall Study|Withdrawal by Subject|5|||
130693562|NCT03578809|470505752|FG002|Overall Study|Withdrawal by Subject|2|||
130693563|NCT03578809|470505753|FG003|Overall Study|Withdrawal by Subject|0|||
130693564|NCT03578809|470505750|FG000|Overall Study|Other|3|||
130693565|NCT03578809|470505751|FG001|Overall Study|Other|6|||
130693566|NCT03578809|470505752|FG002|Overall Study|Other|2|||
130693567|NCT03578809|470505753|FG003|Overall Study|Other|8|||
130693568|NCT01952691|470505754|FG000|Overall Study|Lost to Follow-up|2|||
130693569|NCT00199901|470505755|FG000|Overall Study|Protocol Violation|2|||
130693570|NCT00199901|470505756|FG001|Overall Study|Protocol Violation|0|||
130693571|NCT00199901|470505755|FG000|Overall Study|Withdrawal by Subject|1|||
130693572|NCT00199901|470505756|FG001|Overall Study|Withdrawal by Subject|0|||
130693573|NCT00199901|470505755|FG000|Overall Study|Progressive Disease|24|||
130693574|NCT00199901|470505756|FG001|Overall Study|Progressive Disease|24|||
130693575|NCT05776901|470505759|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
130693576|NCT02997176|470505764|FG000|Overall Study|Adverse Event|0|||
130693577|NCT02997176|470505765|FG001|Overall Study|Adverse Event|0|||
130693578|NCT02997176|470505766|FG002|Overall Study|Adverse Event|0|||
130693579|NCT02997176|470505767|FG003|Overall Study|Adverse Event|8|||
130693580|NCT02997176|470505764|FG000|Overall Study|Progressive Disease|1|||
130693581|NCT02997176|470505765|FG001|Overall Study|Progressive Disease|0|||
130693582|NCT02997176|470505766|FG002|Overall Study|Progressive Disease|1|||
130693583|NCT02997176|470505767|FG003|Overall Study|Progressive Disease|1|||
130693584|NCT02997176|470505764|FG000|Overall Study|Death|0|||
130693585|NCT02997176|470505765|FG001|Overall Study|Death|0|||
130693586|NCT02997176|470505766|FG002|Overall Study|Death|1|||
130693587|NCT02997176|470505767|FG003|Overall Study|Death|1|||
130693588|NCT02997176|470505764|FG000|Overall Study|Withdrawal by Subject|0|||
130693589|NCT02997176|470505765|FG001|Overall Study|Withdrawal by Subject|2|||
130693590|NCT02997176|470505766|FG002|Overall Study|Withdrawal by Subject|0|||
130901126|NCT02015221|471271413|FG000|Overall Study|Withdrawal by Subject|8|||
130901127|NCT02015221|471271414|FG001|Overall Study|Withdrawal by Subject|6|||
130901128|NCT02015221|471271413|FG000|Overall Study|Lost to Follow-up|1|||
130901129|NCT02015221|471271414|FG001|Overall Study|Lost to Follow-up|0|||
130901130|NCT00492063|471271415|FG000|Overall Study|Death|0|||
130901131|NCT00492063|471271416|FG001|Overall Study|Death|0|||
130901132|NCT00492063|471271417|FG002|Overall Study|Death|1|||
130901133|NCT00492063|471271418|FG003|Overall Study|Death|2|||
130901134|NCT00492063|471271415|FG000|Overall Study|Withdrawal by Subject|4|||
130901135|NCT00492063|471271416|FG001|Overall Study|Withdrawal by Subject|3|||
130901136|NCT00492063|471271417|FG002|Overall Study|Withdrawal by Subject|5|||
130901137|NCT00492063|471271418|FG003|Overall Study|Withdrawal by Subject|4|||
130901138|NCT00492063|471271415|FG000|Overall Study|Lost to Follow-up|6|||
130901139|NCT00492063|471271416|FG001|Overall Study|Lost to Follow-up|11|||
130901140|NCT00492063|471271417|FG002|Overall Study|Lost to Follow-up|5|||
130901141|NCT00492063|471271418|FG003|Overall Study|Lost to Follow-up|3|||
130901142|NCT00492063|471271415|FG000|Overall Study|Protocol Violation|0|||
130901143|NCT00492063|471271416|FG001|Overall Study|Protocol Violation|0|||
130901144|NCT00492063|471271417|FG002|Overall Study|Protocol Violation|0|||
130901145|NCT00492063|471271418|FG003|Overall Study|Protocol Violation|1|||
130901146|NCT01870076|471271419|FG000|Overall Study|Withdrawal by Subject|1|||
130901147|NCT01870076|471271420|FG001|Overall Study|Withdrawal by Subject|0|||
130901148|NCT01870076|471271421|FG002|Overall Study|Withdrawal by Subject|1|||
130901149|NCT01870076|471271422|FG003|Overall Study|Withdrawal by Subject|0|||
130901150|NCT03041129|471271431|FG000|Overall Study|Withdrawal by Subject|2|||
130901151|NCT03041129|471271432|FG001|Overall Study|Withdrawal by Subject|0|||
130901152|NCT03041129|471271433|FG002|Overall Study|Withdrawal by Subject|0|||
130901153|NCT03041129|471271434|FG003|Overall Study|Withdrawal by Subject|0|||
130901154|NCT00510653|471271435|FG000|Overall Study|Withdrawal by Subject|8|||
130901155|NCT00510653|471271435|FG000|Overall Study|Monetary|3|||
130901156|NCT01947855|471271436|FG000|Overall Study|Withdrawal by Subject|1|||
130901157|NCT01947855|471271437|FG001|Overall Study|Withdrawal by Subject|0|||
130901158|NCT01947855|471271438|FG002|Overall Study|Withdrawal by Subject|0|||
130901159|NCT00821509|471271439|FG000|Overall Study|Withdrawal by Subject|12|||
130901160|NCT00821509|471271440|FG001|Overall Study|Withdrawal by Subject|11|||
130901161|NCT00821509|471271441|FG002|Overall Study|Withdrawal by Subject|34|||
130901162|NCT01246466|471272787|FG000|Overall Study|Death|1|||
130901163|NCT01246466|471272787|FG000|Overall Study|Withdrawal by Subject|1|||
130901164|NCT00877773|471272788|FG000|Overall Study|Disease Progression|44|||
130901165|NCT03328182|471272791|FG000|Overall Study|Withdrawal by Subject|1|||
130901166|NCT03328182|471272791|FG000|Overall Study|Protocol Violation|2|||
130901167|NCT03328182|471272791|FG000|Overall Study|No Product Evaluated|1|||
130901168|NCT01012219|471272793|FG000|Period 1|Withdrawal by Subject|1|||
130901169|NCT01012219|471272793|FG000|Period 2|Withdrawal by Subject|1|||
130901170|NCT00003590|471272796|FG000|Overall Study|Ineligible Patient|1|||
130901171|NCT00003590|471272796|FG000|Overall Study|Adverse Event|7|||
130901172|NCT00003590|471272796|FG000|Overall Study|Withdrawal by Subject|1|||
130901173|NCT00003590|471272796|FG000|Overall Study|Lack of Efficacy|11|||
130901174|NCT00003590|471272796|FG000|Overall Study|Death|1|||
130901175|NCT00003590|471272796|FG000|Overall Study|Physician Decision|1|||
130901176|NCT00883688|471272797|FG000|Overall Study|Ineligible|2|||
130901177|NCT01350544|471272801|FG000|Overall Study|Administrative Withdrawal|0|||
130901178|NCT01350544|471272802|FG001|Overall Study|Administrative Withdrawal|1|||
130901179|NCT01350544|471272801|FG000|Overall Study|Death|1|||
130901180|NCT01350544|471272802|FG001|Overall Study|Death|2|||
131026061|NCT04759833|471725385|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
131026062|NCT04759833|471725386|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
131026063|NCT04759833|471725387|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
130693591|NCT02997176|470505767|FG003|Overall Study|Withdrawal by Subject|1|||
130693592|NCT01624233|470505768|FG000|Period 2 - Induction|Adverse Event|1|||
130901181|NCT01350544|471272801|FG000|Overall Study|Moved out of LA County|2|||
130901182|NCT01350544|471272802|FG001|Overall Study|Moved out of LA County|2|||
130901183|NCT01350544|471272801|FG000|Overall Study|Medical Issues|1|||
130901184|NCT01350544|471272802|FG001|Overall Study|Medical Issues|1|||
130901185|NCT01350544|471272801|FG000|Overall Study|Withdrawal by Subject|0|||
130693593|NCT01624233|470505768|FG000|Period 3 - Maintenance|Adverse Event|2|||
130901186|NCT01350544|471272802|FG001|Overall Study|Withdrawal by Subject|1|||
130901187|NCT01350544|471272801|FG000|Overall Study|Incarceration|1|||
130901188|NCT01350544|471272802|FG001|Overall Study|Incarceration|0|||
130901189|NCT01350544|471272801|FG000|Overall Study|Lost to Follow-up|18|||
130901190|NCT01350544|471272802|FG001|Overall Study|Lost to Follow-up|15|||
130693594|NCT01624233|470505768|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
130901191|NCT01444092|471272803|FG000|Overall Study|Adverse Event|8|||
130901192|NCT01444092|471272803|FG000|Overall Study|Protocol Violation|1|||
130901193|NCT01444092|471272803|FG000|Overall Study|Withdrawal by Subject|1|||
130901194|NCT01444092|471272803|FG000|Overall Study|Other Eligibility criteria|7|||
130901195|NCT00097981|471272807|FG000|Overall Study|Adverse Event|31|||
130901196|NCT00097981|471272808|FG001|Overall Study|Adverse Event|44|||
130901197|NCT00097981|471272807|FG000|Overall Study|Withdrawal by Subject|10|||
130901198|NCT00097981|471272808|FG001|Overall Study|Withdrawal by Subject|8|||
130901199|NCT00097981|471272807|FG000|Overall Study|Protocol Violation|1|||
130901200|NCT00097981|471272808|FG001|Overall Study|Protocol Violation|1|||
130901201|NCT00097981|471272807|FG000|Overall Study|Death|2|||
130901202|NCT00097981|471272808|FG001|Overall Study|Death|4|||
130901203|NCT00097981|471272807|FG000|Overall Study|Physician Decision|7|||
130901204|NCT00097981|471272808|FG001|Overall Study|Physician Decision|1|||
130901205|NCT00097981|471272807|FG000|Overall Study|Disease Progression|8|||
130901206|NCT00097981|471272808|FG001|Overall Study|Disease Progression|2|||
130901207|NCT00097981|471272807|FG000|Overall Study|Transplant planned|28|||
130901208|NCT00097981|471272808|FG001|Overall Study|Transplant planned|27|||
130901209|NCT00097981|471272807|FG000|Overall Study|Other|19|||
130901210|NCT00097981|471272808|FG001|Overall Study|Other|13|||
130901211|NCT03085914|471272810|FG000|Overall Study|Death|6|||
130901212|NCT03085914|471272811|FG001|Overall Study|Death|6|||
130901213|NCT03085914|471272812|FG002|Overall Study|Death|4|||
130901214|NCT03085914|471272813|FG003|Overall Study|Death|1|||
130901215|NCT03085914|471272814|FG004|Overall Study|Death|5|||
130901216|NCT03085914|471272815|FG005|Overall Study|Death|2|||
130901217|NCT03085914|471272816|FG006|Overall Study|Death|2|||
130901218|NCT03085914|471272810|FG000|Overall Study|Withdrawal by Subject|1|||
130901219|NCT03085914|471272811|FG001|Overall Study|Withdrawal by Subject|1|||
130901220|NCT03085914|471272812|FG002|Overall Study|Withdrawal by Subject|2|||
130901221|NCT03085914|471272813|FG003|Overall Study|Withdrawal by Subject|2|||
130901222|NCT03085914|471272814|FG004|Overall Study|Withdrawal by Subject|2|||
130901223|NCT03085914|471272815|FG005|Overall Study|Withdrawal by Subject|0|||
130901224|NCT03085914|471272816|FG006|Overall Study|Withdrawal by Subject|1|||
130901225|NCT03085914|471272810|FG000|Overall Study|Lost to Follow-up|0|||
130901226|NCT03085914|471272811|FG001|Overall Study|Lost to Follow-up|0|||
130901227|NCT03085914|471272812|FG002|Overall Study|Lost to Follow-up|1|||
130901228|NCT03085914|471272813|FG003|Overall Study|Lost to Follow-up|0|||
130901229|NCT03085914|471272814|FG004|Overall Study|Lost to Follow-up|0|||
130901230|NCT03085914|471272815|FG005|Overall Study|Lost to Follow-up|1|||
130901231|NCT03085914|471272816|FG006|Overall Study|Lost to Follow-up|1|||
130901232|NCT03085914|471272810|FG000|Overall Study|Reason was not specified,|2|||
130901233|NCT03085914|471272811|FG001|Overall Study|Reason was not specified,|2|||
130901234|NCT03085914|471272812|FG002|Overall Study|Reason was not specified,|2|||
130901235|NCT03085914|471272813|FG003|Overall Study|Reason was not specified,|3|||
130901236|NCT03085914|471272814|FG004|Overall Study|Reason was not specified,|3|||
130901237|NCT03085914|471272815|FG005|Overall Study|Reason was not specified,|3|||
130901238|NCT03085914|471272816|FG006|Overall Study|Reason was not specified,|6|||
130901239|NCT03085914|471272810|FG000|Overall Study|Progressive Disease|0|||
130901240|NCT03085914|471272811|FG001|Overall Study|Progressive Disease|0|||
130901241|NCT03085914|471272812|FG002|Overall Study|Progressive Disease|2|||
130901242|NCT03085914|471272813|FG003|Overall Study|Progressive Disease|2|||
130901243|NCT03085914|471272814|FG004|Overall Study|Progressive Disease|1|||
130901244|NCT03085914|471272815|FG005|Overall Study|Progressive Disease|1|||
130901245|NCT03085914|471272816|FG006|Overall Study|Progressive Disease|1|||
130901246|NCT03085914|471272810|FG000|Overall Study|Study Terminated by the Sponsor|0|||
130901247|NCT03085914|471272811|FG001|Overall Study|Study Terminated by the Sponsor|0|||
130901248|NCT03085914|471272812|FG002|Overall Study|Study Terminated by the Sponsor|0|||
130901249|NCT03085914|471272813|FG003|Overall Study|Study Terminated by the Sponsor|1|||
130901250|NCT03085914|471272814|FG004|Overall Study|Study Terminated by the Sponsor|2|||
130901251|NCT03085914|471272815|FG005|Overall Study|Study Terminated by the Sponsor|1|||
130901252|NCT03085914|471272816|FG006|Overall Study|Study Terminated by the Sponsor|0|||
130901253|NCT01242813|471272817|FG000|Overall Study|Lost to Follow-up|2|||
130901254|NCT01369329|471272819|FG000|Overall Study|Withdrawal by Subject|8|||
130901255|NCT01369329|471272820|FG001|Overall Study|Withdrawal by Subject|6|||
130901256|NCT01369329|471272821|FG002|Overall Study|Withdrawal by Subject|10|||
130901257|NCT01369329|471272819|FG000|Overall Study|Lost to Follow-up|2|||
130901258|NCT01369329|471272820|FG001|Overall Study|Lost to Follow-up|2|||
130901259|NCT01369329|471272821|FG002|Overall Study|Lost to Follow-up|2|||
130901260|NCT01369329|471272819|FG000|Overall Study|Other|2|||
130901261|NCT01369329|471272820|FG001|Overall Study|Other|3|||
130901262|NCT01369329|471272821|FG002|Overall Study|Other|2|||
130901263|NCT01252667|471272822|FG000|Overall Study|Transplant aborted post-conditioning|0|||
130901264|NCT01252667|471272823|FG001|Overall Study|Transplant aborted post-conditioning|0|||
130901265|NCT01252667|471272824|FG002|Overall Study|Transplant aborted post-conditioning|0|||
130901266|NCT01252667|471272825|FG003|Overall Study|Transplant aborted post-conditioning|0|||
130901267|NCT01252667|471272826|FG004|Overall Study|Transplant aborted post-conditioning|0|||
131045838|NCT03582033|471802285|FG007|Part C|Study terminated by sponsor|3|||
130901268|NCT01252667|471272827|FG005|Overall Study|Transplant aborted post-conditioning|1|||
130901269|NCT04644315|471272828|FG000|Overall Study|Subject withdrawal of consent|1|||
130901270|NCT01836276|471272829|FG000|Overall Study|Lost to Follow-up|28|||
130901271|NCT01836276|471272830|FG001|Overall Study|Lost to Follow-up|51|||
130901272|NCT00331552|471272833|FG000|Period 3: Phase II|Neurological Symptoms|1|||
130901273|NCT00331552|471272834|FG001|Period 3: Phase II|Neurological Symptoms|0|||
130901274|NCT00331552|471272833|FG000|Period 3: Phase II|Severe Nausea|1|||
130901275|NCT00331552|471272834|FG001|Period 3: Phase II|Severe Nausea|0|||
130901276|NCT01445548|471272835|FG000|Overall Study|Adverse Event|1|||
130901277|NCT01101308|471272838|FG000|Period 1|Adverse Event|2|||
130901278|NCT01101308|471272839|FG001|Period 1|Adverse Event|1|||
130901279|NCT01101308|471272838|FG000|Period 1|Positive for cotinine|1|||
130901280|NCT01101308|471272839|FG001|Period 1|Positive for cotinine|0|||
130901281|NCT02282345|471272841|FG000|Overall Study|Progression|0|||
130901282|NCT02282345|471272842|FG001|Overall Study|Progression|1|||
130901283|NCT02946931|471272857|FG000|Overall Study|Did not require collection of CRFs|588|||
130901284|NCT02946931|471272857|FG000|Overall Study|Other than listed|37|||
130901285|NCT02946931|471272857|FG000|Overall Study|Discharge from hospital|118|||
130901286|NCT02946931|471272857|FG000|Overall Study|Adverse Event|81|||
130901287|NCT02946931|471272857|FG000|Overall Study|CRFs not valid|1|||
130901288|NCT02946931|471272857|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
130901289|NCT03339297|471272858|FG000|Overall Study|Relapse of Hematologic Disease|1|||
130901290|NCT03339297|471272859|FG001|Overall Study|Relapse of Hematologic Disease|0|||
130901291|NCT03339297|471272858|FG000|Overall Study|Death|10|||
130901292|NCT03339297|471272859|FG001|Overall Study|Death|7|||
130901293|NCT03339297|471272858|FG000|Overall Study|Hepatic Candidosis|1|||
130901294|NCT03339297|471272859|FG001|Overall Study|Hepatic Candidosis|0|||
130901295|NCT03339297|471272858|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
130901296|NCT03339297|471272859|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
130901297|NCT03339297|471272858|FG000|Overall Study|Consent Withdrawn by Participant|3|||
130901298|NCT03339297|471272859|FG001|Overall Study|Consent Withdrawn by Participant|3|||
130901299|NCT03339297|471272858|FG000|Overall Study|Disease Relapse|2|||
130901300|NCT03339297|471272859|FG001|Overall Study|Disease Relapse|0|||
130901301|NCT03339297|471272858|FG000|Overall Study|Physician Decision|1|||
130901302|NCT03339297|471272859|FG001|Overall Study|Physician Decision|1|||
130901303|NCT03339297|471272858|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
130901304|NCT03339297|471272859|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
130901305|NCT03339297|471272858|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
130901306|NCT03339297|471272859|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
130901307|NCT03339297|471272858|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
130901308|NCT03339297|471272859|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
130901309|NCT03339297|471272858|FG000|Overall Study|Adverse Event, Non-fatal|1|||
130901310|NCT03339297|471272859|FG001|Overall Study|Adverse Event, Non-fatal|0|||
130901311|NCT03339297|471272858|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
130901312|NCT03339297|471272859|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
130901313|NCT03339297|471272858|FG000|Overall Study|Patient Was Not Eligible|1|||
130901314|NCT03339297|471272859|FG001|Overall Study|Patient Was Not Eligible|0|||
130901315|NCT02213133|471272860|FG000|Overall Study|Participant discontinued study therapy|2|||
130901316|NCT02213133|471272861|FG001|Overall Study|Participant discontinued study therapy|0|||
130901317|NCT02213133|471272862|FG002|Overall Study|Participant discontinued study therapy|0|||
130901318|NCT02213133|471272860|FG000|Overall Study|Participant withdrew informed consent|2|||
130901319|NCT02213133|471272861|FG001|Overall Study|Participant withdrew informed consent|1|||
130901320|NCT02213133|471272862|FG002|Overall Study|Participant withdrew informed consent|2|||
130901321|NCT02213133|471272860|FG000|Overall Study|Disease progression|11|||
130901322|NCT02213133|471272861|FG001|Overall Study|Disease progression|2|||
130901323|NCT02213133|471272862|FG002|Overall Study|Disease progression|0|||
130901324|NCT02213133|471272860|FG000|Overall Study|Adverse Event (AE)|1|||
130901325|NCT02213133|471272861|FG001|Overall Study|Adverse Event (AE)|0|||
130901326|NCT02213133|471272862|FG002|Overall Study|Adverse Event (AE)|0|||
130901327|NCT02213133|471272860|FG000|Overall Study|Death|16|||
130901328|NCT02213133|471272861|FG001|Overall Study|Death|2|||
130901329|NCT02213133|471272862|FG002|Overall Study|Death|1|||
130901330|NCT02213133|471272860|FG000|Overall Study|Other|5|||
130901331|NCT02213133|471272861|FG001|Overall Study|Other|0|||
130901332|NCT02213133|471272862|FG002|Overall Study|Other|0|||
130901333|NCT03051620|471272865|FG000|Overall Study|Lost to Follow-up|6|||
130901334|NCT03051620|471272865|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
131112638|NCT04683731|472042461|FG001|Overall Study|Withdrawal by Subject|0|||
130693595|NCT01624233|470505768|FG000|Period 3 - Maintenance|Physician Decision|2|||
130693596|NCT01624233|470505768|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
130693597|NCT01624233|470505768|FG000|Period 4 - Drug Free Period|Relapsed|61|||
130901335|NCT00393510|471272867|FG000|Overall Study|Physician Decision|3|||
130901336|NCT00393510|471272868|FG001|Overall Study|Physician Decision|9|||
130901337|NCT02412488|471272871|FG000|Overall Study|Lost to Follow-up|10|||
130901338|NCT02412488|471272871|FG000|Overall Study|Withdrawal by Subject|5|||
130901339|NCT02412488|471272871|FG000|Overall Study|Physician Decision|1|||
130901340|NCT02412488|471272871|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
130901341|NCT02412488|471272871|FG000|Overall Study|Reveal LINQ explant|1|||
130901342|NCT00796991|471272872|FG000|Overall Study|Adverse Event|0|||
130901343|NCT00796991|471272873|FG001|Overall Study|Adverse Event|0|||
130693598|NCT01624233|470505768|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
130901344|NCT00796991|471272874|FG002|Overall Study|Adverse Event|1|||
130901345|NCT00796991|471272872|FG000|Overall Study|Death|2|||
130901346|NCT00796991|471272873|FG001|Overall Study|Death|0|||
130901347|NCT00796991|471272874|FG002|Overall Study|Death|0|||
130901348|NCT00796991|471272872|FG000|Overall Study|Disease Progression|10|||
130901349|NCT00796991|471272873|FG001|Overall Study|Disease Progression|9|||
130901350|NCT00796991|471272874|FG002|Overall Study|Disease Progression|7|||
130901351|NCT00796991|471272872|FG000|Overall Study|Study Drug Toxicity|3|||
130901352|NCT00796991|471272873|FG001|Overall Study|Study Drug Toxicity|3|||
130901353|NCT00796991|471272874|FG002|Overall Study|Study Drug Toxicity|5|||
130901354|NCT00796991|471272872|FG000|Overall Study|Withdrawal by Subject|0|||
130901355|NCT00796991|471272873|FG001|Overall Study|Withdrawal by Subject|0|||
130901356|NCT00796991|471272874|FG002|Overall Study|Withdrawal by Subject|1|||
130901357|NCT00029146|471272875|FG000|Overall Study|Lost to Follow-up|2|||
130901358|NCT00029146|471272876|FG001|Overall Study|Lost to Follow-up|1|||
130901359|NCT00313781|471272877|FG000|Before Crossover|Death|22|||
130901360|NCT00313781|471272878|FG001|Before Crossover|Death|8|||
130901361|NCT00313781|471272879|FG002|Before Crossover|Death|0|||
130901362|NCT00313781|471272877|FG000|Before Crossover|Lost to Follow-up|0|||
130901363|NCT00313781|471272878|FG001|Before Crossover|Lost to Follow-up|3|||
130901364|NCT00313781|471272879|FG002|Before Crossover|Lost to Follow-up|0|||
130901365|NCT00313781|471272877|FG000|Before Crossover|Withdrawal by Subject|3|||
130901366|NCT00313781|471272878|FG001|Before Crossover|Withdrawal by Subject|1|||
130901367|NCT00313781|471272879|FG002|Before Crossover|Withdrawal by Subject|0|||
130901368|NCT00313781|471272877|FG000|Before Crossover|Other|45|||
130901369|NCT00313781|471272878|FG001|Before Crossover|Other|30|||
130901370|NCT00313781|471272879|FG002|Before Crossover|Other|0|||
130901371|NCT00313781|471272877|FG000|Before Crossover|Crossover|0|||
130901372|NCT00313781|471272878|FG001|Before Crossover|Crossover|37|||
130901373|NCT00313781|471272879|FG002|Before Crossover|Crossover|0|||
130901374|NCT00313781|471272877|FG000|Before Crossover|Randomized, not treated|5|||
130901375|NCT00313781|471272878|FG001|Before Crossover|Randomized, not treated|0|||
130901376|NCT00313781|471272879|FG002|Before Crossover|Randomized, not treated|0|||
130901377|NCT00313781|471272877|FG000|After Crossover|Death|0|||
130901378|NCT00313781|471272878|FG001|After Crossover|Death|0|||
130901379|NCT00313781|471272879|FG002|After Crossover|Death|6|||
130901380|NCT00313781|471272877|FG000|After Crossover|Withdrawal by Subject|0|||
130901381|NCT00313781|471272878|FG001|After Crossover|Withdrawal by Subject|0|||
130901382|NCT00313781|471272879|FG002|After Crossover|Withdrawal by Subject|3|||
130901383|NCT00313781|471272877|FG000|After Crossover|Other|0|||
130901384|NCT00313781|471272878|FG001|After Crossover|Other|0|||
130901385|NCT00313781|471272879|FG002|After Crossover|Other|18|||
130901386|NCT03567343|471272880|FG000|Overall Study|Lost to Follow-up|2|||
130901387|NCT03567343|471272881|FG001|Overall Study|Lost to Follow-up|1|||
130901388|NCT03567343|471272880|FG000|Overall Study|No longer eligible|2|||
130901389|NCT03567343|471272881|FG001|Overall Study|No longer eligible|1|||
130901390|NCT03567343|471272880|FG000|Overall Study|Adverse Event|1|||
130901391|NCT03567343|471272881|FG001|Overall Study|Adverse Event|0|||
130901392|NCT03567343|471272880|FG000|Overall Study|Protocol Violation|1|||
130901393|NCT03567343|471272881|FG001|Overall Study|Protocol Violation|1|||
130901394|NCT00834080|471272882|FG000|Overall Study|Adverse Event|7|||
130901395|NCT00834080|471272882|FG000|Overall Study|Lost to Follow-up|7|||
130901396|NCT00834080|471272882|FG000|Overall Study|Withdrawal by Subject|5|||
130901397|NCT00834080|471272882|FG000|Overall Study|Other - Pregnancy|1|||
130901398|NCT00834080|471272882|FG000|Overall Study|Other - False positive tests of the UDS|1|||
130901399|NCT00834080|471272882|FG000|Overall Study|Physician Decision|1|||
130901400|NCT00834080|471272882|FG000|Overall Study|Subject Relocated|1|||
130901401|NCT02282293|471272890|FG000|Overall Study|Lost to Follow-up|2|||
130901402|NCT02282293|471272891|FG001|Overall Study|Lost to Follow-up|2|||
130901403|NCT02282293|471272890|FG000|Overall Study|Unable to comply with study procedures|1|||
130901404|NCT02282293|471272891|FG001|Overall Study|Unable to comply with study procedures|0|||
130901405|NCT02282293|471272890|FG000|Overall Study|Moved out of study area|0|||
130901406|NCT02282293|471272891|FG001|Overall Study|Moved out of study area|1|||
130901407|NCT00608569|471272892|FG000|Overall Study|Death|4|||
130901408|NCT00608569|471272893|FG001|Overall Study|Death|3|||
131112639|NCT04683731|472042462|FG002|Overall Study|Withdrawal by Subject|3|||
131112640|NCT04683731|472042463|FG003|Overall Study|Withdrawal by Subject|2|||
131112641|NCT04683731|472042460|FG000|Overall Study|Determined patient was not eligible|3|||
130693599|NCT01624233|470505768|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
130901409|NCT00608569|471272892|FG000|Overall Study|Lost to Follow-up|4|||
130901410|NCT00608569|471272893|FG001|Overall Study|Lost to Follow-up|5|||
130901411|NCT00608569|471272892|FG000|Overall Study|Withdrawal by Subject|1|||
130901412|NCT00608569|471272893|FG001|Overall Study|Withdrawal by Subject|0|||
130901413|NCT00608569|471272892|FG000|Overall Study|Adverse Event|1|||
130901414|NCT00608569|471272893|FG001|Overall Study|Adverse Event|0|||
130901415|NCT00608569|471272892|FG000|Overall Study|Unable to adhere with study requirements|0|||
130901416|NCT00608569|471272893|FG001|Overall Study|Unable to adhere with study requirements|1|||
130901417|NCT03011892|471272894|FG000|Double Blind (DB) Period|Adverse Event|0|||
130901418|NCT03011892|471272895|FG001|Double Blind (DB) Period|Adverse Event|1|||
130901419|NCT03011892|471272896|FG002|Double Blind (DB) Period|Adverse Event|1|||
130901420|NCT03011892|471272897|FG003|Double Blind (DB) Period|Adverse Event|0|||
130901421|NCT03011892|471272898|FG004|Double Blind (DB) Period|Adverse Event|0|||
130693600|NCT01624233|470505768|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
130693601|NCT01624233|470505768|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
130901422|NCT03011892|471272899|FG005|Double Blind (DB) Period|Adverse Event|0|||
130901423|NCT03011892|471272900|FG006|Double Blind (DB) Period|Adverse Event|0|||
130693602|NCT01624233|470505768|FG000|Period 6: Follow-up|Adverse Event|3|||
130693603|NCT01624233|470505768|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
130693604|NCT01624233|470505768|FG000|Period 6: Follow-up|Physician Decision|1|||
130693605|NCT01624233|470505768|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
130693606|NCT00373256|470505769|FG000|Overall Study|Adverse Event (AE)|1|||
130693607|NCT00373256|470505770|FG001|Overall Study|Adverse Event (AE)|5|||
130693608|NCT00373256|470505769|FG000|Overall Study|Lost to Follow-up|2|||
130693609|NCT00373256|470505770|FG001|Overall Study|Lost to Follow-up|1|||
130693610|NCT00373256|470505769|FG000|Overall Study|Death|9|||
130693611|NCT00373256|470505770|FG001|Overall Study|Death|8|||
130693612|NCT00373256|470505769|FG000|Overall Study|Objective Progression or Relapse|111|||
130693613|NCT00373256|470505770|FG001|Overall Study|Objective Progression or Relapse|104|||
130693614|NCT00373256|470505769|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
130693615|NCT00373256|470505770|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
130693616|NCT00373256|470505769|FG000|Overall Study|Other|73|||
130693617|NCT00373256|470505770|FG001|Overall Study|Other|107|||
130693618|NCT00373256|470505769|FG000|Overall Study|Protocol Violation|0|||
130693619|NCT00373256|470505770|FG001|Overall Study|Protocol Violation|2|||
130693620|NCT00373256|470505769|FG000|Overall Study|Study Terminated by Sponsor|41|||
130693621|NCT00373256|470505770|FG001|Overall Study|Study Terminated by Sponsor|13|||
130693622|NCT04241458|470505771|FG000|Overall Study|Withdrawal by Subject|0|||
130693623|NCT04241458|470505772|FG001|Overall Study|Withdrawal by Subject|0|||
130901424|NCT03011892|471272901|FG007|Double Blind (DB) Period|Adverse Event|0|||
130901425|NCT03011892|471272902|FG008|Double Blind (DB) Period|Adverse Event|0|||
130901426|NCT03011892|471272903|FG009|Double Blind (DB) Period|Adverse Event|0|||
130901427|NCT03011892|471272904|FG010|Double Blind (DB) Period|Adverse Event|0|||
130901428|NCT03011892|471272905|FG011|Double Blind (DB) Period|Adverse Event|0|||
130693624|NCT04241458|470505773|FG002|Overall Study|Withdrawal by Subject|0|||
130693625|NCT04241458|470505774|FG003|Overall Study|Withdrawal by Subject|0|||
130901429|NCT03011892|471272894|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
130901430|NCT03011892|471272895|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
130693626|NCT04241458|470505775|FG004|Overall Study|Withdrawal by Subject|1|||
130693627|NCT06144424|470505776|FG000|Overall Study|Withdrawal by Subject|2|||
130693628|NCT06144424|470505777|FG001|Overall Study|Withdrawal by Subject|0|||
130693629|NCT06144424|470505776|FG000|Overall Study|Incarceration|1|||
130693630|NCT06144424|470505777|FG001|Overall Study|Incarceration|0|||
130693631|NCT02727192|470505785|FG000|Overall Study|Lost to Follow-up|1|||
130768233|NCT01134263|470775496|FG002|Overall Study|Enrolled, but not treated|0|||
130901431|NCT03011892|471272896|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
130901432|NCT03011892|471272897|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
130901433|NCT03011892|471272898|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
130901434|NCT03011892|471272899|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
130901435|NCT03011892|471272900|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
130901436|NCT03011892|471272901|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
130901437|NCT03011892|471272902|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
130901438|NCT03011892|471272903|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
130901439|NCT03011892|471272904|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
130901440|NCT03011892|471272905|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
130901441|NCT03011892|471272894|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
130901442|NCT03011892|471272895|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
130901443|NCT03011892|471272896|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
130901444|NCT03011892|471272897|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
130901445|NCT03011892|471272898|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
130768234|NCT01134263|470775497|FG003|Overall Study|Enrolled, but not treated|1|||
130768235|NCT01134263|470775498|FG004|Overall Study|Enrolled, but not treated|0|||
130693632|NCT02727192|470505786|FG001|Overall Study|Lost to Follow-up|0|||
130693633|NCT02727192|470505787|FG002|Overall Study|Lost to Follow-up|0|||
130693634|NCT00928057|470505788|FG000|Overall Study|Adverse Event|1|||
130693635|NCT00928057|470505789|FG001|Overall Study|Adverse Event|2|||
130693636|NCT00928057|470505788|FG000|Overall Study|Withdrawal by Subject|1|||
130693637|NCT00928057|470505789|FG001|Overall Study|Withdrawal by Subject|0|||
130693638|NCT00928057|470505788|FG000|Overall Study|Lost to Follow-up|0|||
130693639|NCT00928057|470505789|FG001|Overall Study|Lost to Follow-up|1|||
130768236|NCT01955109|470775504|FG000|Overall Study|Adverse Event|2|||
130901446|NCT03011892|471272899|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
130901447|NCT03011892|471272900|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
130901448|NCT03011892|471272901|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
130901449|NCT03011892|471272902|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
130901450|NCT03011892|471272903|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
130901451|NCT03011892|471272904|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
130901452|NCT03011892|471272905|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
130901453|NCT03011892|471272894|FG000|Double Blind (DB) Period|Other|1|||
130901454|NCT03011892|471272895|FG001|Double Blind (DB) Period|Other|1|||
130901455|NCT03011892|471272896|FG002|Double Blind (DB) Period|Other|1|||
130901456|NCT03011892|471272897|FG003|Double Blind (DB) Period|Other|0|||
130901457|NCT03011892|471272898|FG004|Double Blind (DB) Period|Other|1|||
130901458|NCT03011892|471272899|FG005|Double Blind (DB) Period|Other|0|||
130693640|NCT00928057|470505788|FG000|Overall Study|Protocol Violation|0|||
130693641|NCT00928057|470505789|FG001|Overall Study|Protocol Violation|1|||
130693642|NCT05497557|470505790|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
130693643|NCT05497557|470505791|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
130693644|NCT05497557|470505792|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
130693645|NCT02752074|470505795|FG000|Overall Study|Lost to Follow-up|1|||
130693646|NCT02752074|470505796|FG001|Overall Study|Lost to Follow-up|4|||
130901459|NCT03011892|471272900|FG006|Double Blind (DB) Period|Other|0|||
130901460|NCT03011892|471272901|FG007|Double Blind (DB) Period|Other|0|||
130901461|NCT03011892|471272902|FG008|Double Blind (DB) Period|Other|0|||
130901462|NCT03011892|471272903|FG009|Double Blind (DB) Period|Other|0|||
130901463|NCT03011892|471272904|FG010|Double Blind (DB) Period|Other|0|||
130901464|NCT03011892|471272905|FG011|Double Blind (DB) Period|Other|0|||
130901465|NCT03011892|471272894|FG000|Double Blind (DB) Period|Physician Decision|1|||
130901466|NCT03011892|471272895|FG001|Double Blind (DB) Period|Physician Decision|0|||
130901467|NCT03011892|471272896|FG002|Double Blind (DB) Period|Physician Decision|1|||
130901468|NCT03011892|471272897|FG003|Double Blind (DB) Period|Physician Decision|0|||
130901469|NCT03011892|471272898|FG004|Double Blind (DB) Period|Physician Decision|0|||
130901470|NCT03011892|471272899|FG005|Double Blind (DB) Period|Physician Decision|0|||
130901471|NCT03011892|471272900|FG006|Double Blind (DB) Period|Physician Decision|0|||
130901472|NCT03011892|471272901|FG007|Double Blind (DB) Period|Physician Decision|0|||
130901473|NCT03011892|471272902|FG008|Double Blind (DB) Period|Physician Decision|0|||
130901474|NCT03011892|471272903|FG009|Double Blind (DB) Period|Physician Decision|0|||
130901475|NCT03011892|471272904|FG010|Double Blind (DB) Period|Physician Decision|0|||
130693647|NCT02752074|470505795|FG000|Overall Study|Death|146|||
130693648|NCT02752074|470505796|FG001|Overall Study|Death|129|||
130693649|NCT02752074|470505795|FG000|Overall Study|Withdrawal by Subject|9|||
130693650|NCT02752074|470505796|FG001|Overall Study|Withdrawal by Subject|10|||
130693651|NCT02392195|470505799|FG000|Overall Study|Lost to Follow-up|4|||
130693652|NCT02392195|470505799|FG000|Overall Study|Withdrawal by Subject|4|||
130901476|NCT03011892|471272905|FG011|Double Blind (DB) Period|Physician Decision|0|||
130901477|NCT03011892|471272894|FG000|Double Blind (DB) Period|Pregnancy|0|||
130901478|NCT03011892|471272895|FG001|Double Blind (DB) Period|Pregnancy|0|||
130901479|NCT03011892|471272896|FG002|Double Blind (DB) Period|Pregnancy|0|||
130901480|NCT03011892|471272897|FG003|Double Blind (DB) Period|Pregnancy|0|||
130901481|NCT03011892|471272898|FG004|Double Blind (DB) Period|Pregnancy|1|||
130901482|NCT03011892|471272899|FG005|Double Blind (DB) Period|Pregnancy|0|||
131026064|NCT04759833|471725388|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
131026065|NCT04759833|471725384|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
131026066|NCT04759833|471725385|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
131026067|NCT04759833|471725386|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
131026068|NCT04759833|471725387|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
131026069|NCT04759833|471725388|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
131026070|NCT04759833|471725384|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
131026071|NCT04759833|471725385|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
131026072|NCT04759833|471725386|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
130768237|NCT01955109|470775505|FG001|Overall Study|Adverse Event|0|||
131026073|NCT04759833|471725387|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
131026074|NCT04759833|471725388|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
131026075|NCT04759833|471725384|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
130901483|NCT03011892|471272900|FG006|Double Blind (DB) Period|Pregnancy|0|||
130901484|NCT03011892|471272901|FG007|Double Blind (DB) Period|Pregnancy|0|||
130901485|NCT03011892|471272902|FG008|Double Blind (DB) Period|Pregnancy|0|||
130693653|NCT00545792|470505802|FG000|Overall Study|Withdrawal by Subject|1|||
130901486|NCT03011892|471272903|FG009|Double Blind (DB) Period|Pregnancy|0|||
130693654|NCT01380782|470505807|FG000|Overall Study|Adverse Event|0|||
130693655|NCT01380782|470505808|FG001|Overall Study|Adverse Event|1|||
130693656|NCT01380782|470505809|FG002|Overall Study|Adverse Event|0|||
130693657|NCT01380782|470505810|FG003|Overall Study|Adverse Event|0|||
130693658|NCT01380782|470505807|FG000|Overall Study|Death|1|||
130693659|NCT01380782|470505808|FG001|Overall Study|Death|0|||
130693660|NCT01380782|470505809|FG002|Overall Study|Death|0|||
130693661|NCT01380782|470505810|FG003|Overall Study|Death|0|||
130901487|NCT03011892|471272904|FG010|Double Blind (DB) Period|Pregnancy|0|||
130901488|NCT03011892|471272905|FG011|Double Blind (DB) Period|Pregnancy|0|||
130901489|NCT03011892|471272894|FG000|Double Blind (DB) Period|Protocol Violation|1|||
130901490|NCT03011892|471272895|FG001|Double Blind (DB) Period|Protocol Violation|0|||
130901491|NCT03011892|471272896|FG002|Double Blind (DB) Period|Protocol Violation|0|||
130901492|NCT03011892|471272897|FG003|Double Blind (DB) Period|Protocol Violation|0|||
130901493|NCT03011892|471272898|FG004|Double Blind (DB) Period|Protocol Violation|0|||
130901494|NCT03011892|471272899|FG005|Double Blind (DB) Period|Protocol Violation|0|||
130901495|NCT03011892|471272900|FG006|Double Blind (DB) Period|Protocol Violation|0|||
130901496|NCT03011892|471272901|FG007|Double Blind (DB) Period|Protocol Violation|0|||
130901497|NCT03011892|471272902|FG008|Double Blind (DB) Period|Protocol Violation|0|||
130901498|NCT03011892|471272903|FG009|Double Blind (DB) Period|Protocol Violation|0|||
130901499|NCT03011892|471272904|FG010|Double Blind (DB) Period|Protocol Violation|0|||
130901500|NCT03011892|471272905|FG011|Double Blind (DB) Period|Protocol Violation|0|||
130901501|NCT03011892|471272894|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
130901502|NCT03011892|471272895|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
130901503|NCT03011892|471272896|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
130901504|NCT03011892|471272897|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
130901505|NCT03011892|471272898|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
130901506|NCT03011892|471272899|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
130901507|NCT03011892|471272900|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
130901508|NCT03011892|471272901|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
130901509|NCT03011892|471272902|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
130901510|NCT03011892|471272903|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
130901511|NCT03011892|471272904|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
130901512|NCT03011892|471272905|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
130901513|NCT03011892|471272894|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
130901514|NCT03011892|471272895|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
130901515|NCT03011892|471272896|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
130901516|NCT03011892|471272897|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
130901517|NCT03011892|471272898|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
130901518|NCT03011892|471272899|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
130901519|NCT03011892|471272900|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
130901520|NCT03011892|471272901|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
130901521|NCT03011892|471272902|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
130901522|NCT03011892|471272903|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
130901523|NCT03011892|471272904|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
130901524|NCT03011892|471272905|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
130901525|NCT03011892|471272894|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
130901526|NCT03011892|471272895|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
130901527|NCT03011892|471272896|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
130901528|NCT03011892|471272897|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
131026076|NCT04759833|471725385|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
131026077|NCT04759833|471725386|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
131026078|NCT04759833|471725387|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
131026079|NCT04759833|471725388|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
131026080|NCT04759833|471725384|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
131026081|NCT04759833|471725385|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
131026082|NCT04759833|471725386|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
131026083|NCT04759833|471725387|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
130693662|NCT01380782|470505807|FG000|Overall Study|Lack of Efficacy|10|||
130693663|NCT01380782|470505808|FG001|Overall Study|Lack of Efficacy|9|||
130693664|NCT01380782|470505809|FG002|Overall Study|Lack of Efficacy|10|||
130693665|NCT01380782|470505810|FG003|Overall Study|Lack of Efficacy|3|||
130693666|NCT01380782|470505807|FG000|Overall Study|Physician Decision|1|||
130693667|NCT01380782|470505808|FG001|Overall Study|Physician Decision|0|||
130693668|NCT01380782|470505809|FG002|Overall Study|Physician Decision|0|||
130901529|NCT03011892|471272898|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
130901530|NCT03011892|471272899|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
130901531|NCT03011892|471272900|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
130901532|NCT03011892|471272901|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
130901533|NCT03011892|471272902|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
130901534|NCT03011892|471272903|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
130901535|NCT03011892|471272904|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
130693669|NCT01380782|470505810|FG003|Overall Study|Physician Decision|0|||
130693670|NCT01380782|470505807|FG000|Overall Study|Withdrawal by Subject|0|||
130693671|NCT01380782|470505808|FG001|Overall Study|Withdrawal by Subject|0|||
130693672|NCT01380782|470505809|FG002|Overall Study|Withdrawal by Subject|1|||
130693673|NCT01380782|470505810|FG003|Overall Study|Withdrawal by Subject|1|||
130768238|NCT01955109|470775504|FG000|Overall Study|Participant unwilling to continue|35|||
130901536|NCT03011892|471272905|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
130901537|NCT03011892|471272894|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
130901538|NCT03011892|471272895|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
130901539|NCT03011892|471272896|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
130901540|NCT03011892|471272897|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
130901541|NCT03011892|471272898|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
130901542|NCT03011892|471272899|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
130901543|NCT03011892|471272900|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
130901544|NCT03011892|471272901|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
130901545|NCT03011892|471272902|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
130901546|NCT03011892|471272903|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
130901547|NCT03011892|471272904|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
130901548|NCT03011892|471272905|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
130901549|NCT03011892|471272894|FG000|Open Label (OL) Period|Reason not specified|0|||
130901550|NCT03011892|471272895|FG001|Open Label (OL) Period|Reason not specified|0|||
130901551|NCT03011892|471272896|FG002|Open Label (OL) Period|Reason not specified|0|||
130901552|NCT03011892|471272897|FG003|Open Label (OL) Period|Reason not specified|0|||
130901553|NCT03011892|471272898|FG004|Open Label (OL) Period|Reason not specified|0|||
130901554|NCT03011892|471272899|FG005|Open Label (OL) Period|Reason not specified|0|||
130901555|NCT03011892|471272900|FG006|Open Label (OL) Period|Reason not specified|0|||
130901556|NCT03011892|471272901|FG007|Open Label (OL) Period|Reason not specified|1|||
130901557|NCT03011892|471272902|FG008|Open Label (OL) Period|Reason not specified|0|||
130901558|NCT03011892|471272903|FG009|Open Label (OL) Period|Reason not specified|0|||
130901559|NCT03011892|471272904|FG010|Open Label (OL) Period|Reason not specified|0|||
130901560|NCT03011892|471272905|FG011|Open Label (OL) Period|Reason not specified|0|||
130901561|NCT02312687|471272907|FG000|Overall Study|Other, Not Specified|1|||
130901562|NCT00384111|471272908|FG000|Overall Study|Disease Progression|3|||
130901563|NCT00384111|471272908|FG000|Overall Study|Adverse Event|1|||
130901564|NCT00384111|471272908|FG000|Overall Study|Investigator Decision|3|||
130901565|NCT00384111|471272908|FG000|Overall Study|Study Terminated by the Sponsor|19|||
130901566|NCT03720652|471272909|FG000|Overall Study|Withdrawal by Subject|2|||
130901567|NCT03720652|471272910|FG001|Overall Study|Withdrawal by Subject|7|||
130901568|NCT03720652|471272909|FG000|Overall Study|Lost to Follow-up|0|||
130901569|NCT03720652|471272910|FG001|Overall Study|Lost to Follow-up|4|||
130901570|NCT01454778|471272915|FG000|Overall Study|Lost to Follow-up|2|||
130901571|NCT01454778|471272915|FG000|Overall Study|Death|1|||
130901572|NCT00348881|471272916|FG000|Overall Study|Lost to Follow-up|12|||
130901573|NCT00348881|471272917|FG001|Overall Study|Lost to Follow-up|6|||
130901574|NCT00348881|471272916|FG000|Overall Study|Withdrawal by Subject|3|||
130901575|NCT00348881|471272917|FG001|Overall Study|Withdrawal by Subject|4|||
130901576|NCT00348881|471272916|FG000|Overall Study|Adverse Event|2|||
130901577|NCT00348881|471272917|FG001|Overall Study|Adverse Event|0|||
130901578|NCT00348881|471272916|FG000|Overall Study|Serious Adverse Event|0|||
130901579|NCT00348881|471272917|FG001|Overall Study|Serious Adverse Event|2|||
130901580|NCT03658876|471275176|FG000|Overall Study|Protocol Violation|3|||
130901581|NCT03658876|471275177|FG001|Overall Study|Protocol Violation|2|||
130901582|NCT03658876|471275176|FG000|Overall Study|Withdrawal by Subject|2|||
130901583|NCT03658876|471275177|FG001|Overall Study|Withdrawal by Subject|0|||
130901584|NCT03658876|471275176|FG000|Overall Study|Death|0|||
130901585|NCT03658876|471275177|FG001|Overall Study|Death|1|||
131026084|NCT04759833|471725388|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
131026085|NCT04759833|471725384|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
131026086|NCT04759833|471725385|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
131026087|NCT04759833|471725386|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
130901586|NCT03658876|471275176|FG000|Overall Study|Intercurrent illness|6|||
130901587|NCT03658876|471275177|FG001|Overall Study|Intercurrent illness|4|||
130901588|NCT03658876|471275176|FG000|Overall Study|Transplantation/other operation|1|||
130901589|NCT03658876|471275177|FG001|Overall Study|Transplantation/other operation|5|||
130901590|NCT01330017|471275178|FG000|Overall Study|Adverse Event|0|||
130901591|NCT01330017|471275179|FG001|Overall Study|Adverse Event|1|||
130901592|NCT01330017|471275180|FG002|Overall Study|Adverse Event|1|||
131026088|NCT04759833|471725387|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
130901593|NCT01330017|471275181|FG003|Overall Study|Adverse Event|4|||
130901594|NCT01330017|471275182|FG004|Overall Study|Adverse Event|0|||
131026089|NCT04759833|471725388|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
131222730|NCT01333475|472443168|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
130693674|NCT02554877|470505813|FG000|Overall Study|Adverse Event|2|||
130693675|NCT02554877|470505814|FG001|Overall Study|Adverse Event|0|||
130693676|NCT02554877|470505815|FG002|Overall Study|Adverse Event|0|||
130693677|NCT02554877|470505816|FG003|Overall Study|Adverse Event|1|||
130693678|NCT02554877|470505813|FG000|Overall Study|Lost to Follow-up|1|||
130693679|NCT02554877|470505814|FG001|Overall Study|Lost to Follow-up|1|||
130693680|NCT02554877|470505815|FG002|Overall Study|Lost to Follow-up|1|||
130693681|NCT02554877|470505816|FG003|Overall Study|Lost to Follow-up|2|||
130901595|NCT01330017|471275178|FG000|Overall Study|Withdrawal by Subject|0|||
130901596|NCT01330017|471275179|FG001|Overall Study|Withdrawal by Subject|0|||
130901597|NCT01330017|471275180|FG002|Overall Study|Withdrawal by Subject|1|||
130901598|NCT01330017|471275181|FG003|Overall Study|Withdrawal by Subject|0|||
130901599|NCT01330017|471275182|FG004|Overall Study|Withdrawal by Subject|1|||
130901600|NCT01330017|471275178|FG000|Overall Study|Lost to Follow-up|0|||
130901601|NCT01330017|471275179|FG001|Overall Study|Lost to Follow-up|0|||
130901602|NCT01330017|471275180|FG002|Overall Study|Lost to Follow-up|1|||
130901603|NCT01330017|471275181|FG003|Overall Study|Lost to Follow-up|0|||
130901604|NCT01330017|471275182|FG004|Overall Study|Lost to Follow-up|0|||
130901605|NCT01330017|471275178|FG000|Overall Study|Protocol Violation|0|||
130901606|NCT01330017|471275179|FG001|Overall Study|Protocol Violation|0|||
130901607|NCT01330017|471275180|FG002|Overall Study|Protocol Violation|0|||
130901608|NCT01330017|471275181|FG003|Overall Study|Protocol Violation|1|||
130901609|NCT01330017|471275182|FG004|Overall Study|Protocol Violation|0|||
130901610|NCT01330017|471275178|FG000|Overall Study|Unknown Reason|5|||
130901611|NCT01330017|471275179|FG001|Overall Study|Unknown Reason|3|||
130901612|NCT01330017|471275180|FG002|Overall Study|Unknown Reason|5|||
130901613|NCT01330017|471275181|FG003|Overall Study|Unknown Reason|7|||
130901614|NCT01330017|471275182|FG004|Overall Study|Unknown Reason|2|||
130901615|NCT02616146|471275184|FG000|Overall Study|Adverse Event|64|||
130901616|NCT02616146|471275185|FG001|Overall Study|Adverse Event|24|||
130901617|NCT02616146|471275184|FG000|Overall Study|Lost to Follow-up|23|||
130901618|NCT02616146|471275185|FG001|Overall Study|Lost to Follow-up|13|||
130901619|NCT02616146|471275184|FG000|Overall Study|Non-compliance with study protocol|2|||
130901620|NCT02616146|471275185|FG001|Overall Study|Non-compliance with study protocol|0|||
130901621|NCT02616146|471275184|FG000|Overall Study|Non-compliance with study drug|4|||
130901622|NCT02616146|471275185|FG001|Overall Study|Non-compliance with study drug|2|||
130901623|NCT02616146|471275184|FG000|Overall Study|Pregnancy|2|||
130901624|NCT02616146|471275185|FG001|Overall Study|Pregnancy|2|||
130901625|NCT02616146|471275184|FG000|Overall Study|Pregnancy wish|3|||
130901626|NCT02616146|471275185|FG001|Overall Study|Pregnancy wish|0|||
130901627|NCT02616146|471275184|FG000|Overall Study|Protocol Violation|6|||
130901628|NCT02616146|471275185|FG001|Overall Study|Protocol Violation|3|||
130901629|NCT02616146|471275184|FG000|Overall Study|Study terminated by sponsor|1372|||
130901630|NCT02616146|471275185|FG001|Overall Study|Study terminated by sponsor|432|||
130901631|NCT02616146|471275184|FG000|Overall Study|Participant moved|4|||
130901632|NCT02616146|471275185|FG001|Overall Study|Participant moved|3|||
130901633|NCT02616146|471275184|FG000|Overall Study|Withdrawal by Subject|30|||
130901634|NCT02616146|471275185|FG001|Overall Study|Withdrawal by Subject|24|||
130901635|NCT02616146|471275184|FG000|Overall Study|Physician Decision|2|||
130901636|NCT02616146|471275185|FG001|Overall Study|Physician Decision|1|||
130901637|NCT01221272|471275186|FG000|Period 1|Adverse Event|2|||
130901638|NCT01221272|471275187|FG001|Period 1|Adverse Event|0|||
130901639|NCT01221272|471275186|FG000|Period 1|Consent Withdrawal|0|||
130901640|NCT01221272|471275187|FG001|Period 1|Consent Withdrawal|1|||
130901641|NCT01221272|471275186|FG000|Period 1|Significant Dosing Noncompliance|0|||
130901642|NCT01221272|471275187|FG001|Period 1|Significant Dosing Noncompliance|1|||
130901643|NCT01221272|471275186|FG000|Period 2|Adverse Event|0|||
130901644|NCT01221272|471275187|FG001|Period 2|Adverse Event|2|||
130901645|NCT01106092|471275190|FG000|Overall Study|Withdrawal by Subject|0|||
130901646|NCT01106092|471275191|FG001|Overall Study|Withdrawal by Subject|0|||
130901647|NCT01106092|471275192|FG002|Overall Study|Withdrawal by Subject|0|||
130901648|NCT01106092|471275193|FG003|Overall Study|Withdrawal by Subject|1|||
130901649|NCT04839562|471275200|FG000|Overall Study|Withdrawal by Subject|0|||
130901650|NCT04839562|471275201|FG001|Overall Study|Withdrawal by Subject|1|||
130901651|NCT04839562|471275200|FG000|Overall Study|Physician Decision|0|||
130901652|NCT04839562|471275201|FG001|Overall Study|Physician Decision|1|||
130901653|NCT00730028|471275202|FG000|Overall Study|Adverse Event|23|||
130901654|NCT00730028|471275203|FG001|Overall Study|Adverse Event|26|||
130901655|NCT00730028|471275204|FG002|Overall Study|Adverse Event|16|||
130901656|NCT00730028|471275205|FG003|Overall Study|Adverse Event|20|||
130901657|NCT00730028|471275206|FG004|Overall Study|Adverse Event|43|||
130901658|NCT00730028|471275202|FG000|Overall Study|Lost to Follow-up|13|||
130901659|NCT00730028|471275203|FG001|Overall Study|Lost to Follow-up|26|||
130901660|NCT00730028|471275204|FG002|Overall Study|Lost to Follow-up|22|||
130901661|NCT00730028|471275205|FG003|Overall Study|Lost to Follow-up|26|||
130901662|NCT00730028|471275206|FG004|Overall Study|Lost to Follow-up|25|||
130901663|NCT00730028|471275202|FG000|Overall Study|Protocol Violation|6|||
130901664|NCT00730028|471275203|FG001|Overall Study|Protocol Violation|1|||
130901665|NCT00730028|471275204|FG002|Overall Study|Protocol Violation|1|||
130901666|NCT00730028|471275205|FG003|Overall Study|Protocol Violation|2|||
130901667|NCT00730028|471275206|FG004|Overall Study|Protocol Violation|0|||
130901668|NCT00730028|471275202|FG000|Overall Study|Withdrawal by Subject|9|||
130901669|NCT00730028|471275203|FG001|Overall Study|Withdrawal by Subject|5|||
130901670|NCT00730028|471275204|FG002|Overall Study|Withdrawal by Subject|4|||
130901671|NCT00730028|471275205|FG003|Overall Study|Withdrawal by Subject|5|||
130901672|NCT00730028|471275206|FG004|Overall Study|Withdrawal by Subject|9|||
130901673|NCT00730028|471275202|FG000|Overall Study|Physician Decision|3|||
130901674|NCT00730028|471275203|FG001|Overall Study|Physician Decision|3|||
130901675|NCT00730028|471275204|FG002|Overall Study|Physician Decision|2|||
130901676|NCT00730028|471275205|FG003|Overall Study|Physician Decision|3|||
130901677|NCT00730028|471275206|FG004|Overall Study|Physician Decision|2|||
130901678|NCT00730028|471275202|FG000|Overall Study|Treatment Failure|5|||
130901679|NCT00730028|471275203|FG001|Overall Study|Treatment Failure|5|||
130901680|NCT00730028|471275204|FG002|Overall Study|Treatment Failure|0|||
130901681|NCT00730028|471275205|FG003|Overall Study|Treatment Failure|0|||
130901682|NCT00730028|471275206|FG004|Overall Study|Treatment Failure|1|||
130901683|NCT00730028|471275202|FG000|Overall Study|Randomization Error|1|||
130901684|NCT00730028|471275203|FG001|Overall Study|Randomization Error|0|||
130901685|NCT00730028|471275204|FG002|Overall Study|Randomization Error|0|||
130901686|NCT00730028|471275205|FG003|Overall Study|Randomization Error|0|||
130901687|NCT00730028|471275206|FG004|Overall Study|Randomization Error|2|||
130901688|NCT00003472|471275207|FG000|Overall Study|Not evaluable|3|||
130901689|NCT00528970|471275208|FG000|Overall Study|Adverse Event|6|||
130901690|NCT00528970|471275209|FG001|Overall Study|Adverse Event|8|||
130901691|NCT00528970|471275210|FG002|Overall Study|Adverse Event|5|||
130901692|NCT00528970|471275208|FG000|Overall Study|Lost to Follow-up|0|||
130901693|NCT00528970|471275209|FG001|Overall Study|Lost to Follow-up|0|||
130901694|NCT00528970|471275210|FG002|Overall Study|Lost to Follow-up|1|||
130901695|NCT00528970|471275208|FG000|Overall Study|Other than specified|2|||
130901696|NCT00528970|471275209|FG001|Overall Study|Other than specified|3|||
130901697|NCT00528970|471275210|FG002|Overall Study|Other than specified|3|||
130901698|NCT00528970|471275208|FG000|Overall Study|Protocol Violation|2|||
130901699|NCT00528970|471275209|FG001|Overall Study|Protocol Violation|1|||
130901700|NCT00528970|471275210|FG002|Overall Study|Protocol Violation|4|||
130901701|NCT00528970|471275208|FG000|Overall Study|Lack of Efficacy|0|||
130901702|NCT00528970|471275209|FG001|Overall Study|Lack of Efficacy|0|||
130901703|NCT00528970|471275210|FG002|Overall Study|Lack of Efficacy|1|||
130901704|NCT00528970|471275208|FG000|Overall Study|Withdrawal by Subject|4|||
130901705|NCT00528970|471275209|FG001|Overall Study|Withdrawal by Subject|3|||
130901706|NCT00528970|471275210|FG002|Overall Study|Withdrawal by Subject|5|||
130901707|NCT00528970|471275208|FG000|Overall Study|Randomized but not treated|0|||
130901708|NCT00528970|471275209|FG001|Overall Study|Randomized but not treated|0|||
130901709|NCT00528970|471275210|FG002|Overall Study|Randomized but not treated|1|||
130901710|NCT02122783|471275216|FG000|Overall Study|Adverse Event|0|||
130901711|NCT02122783|471275217|FG001|Overall Study|Adverse Event|1|||
130901712|NCT02353143|471275218|FG000|Overall Study|Withdrawal by Subject|1|||
130901713|NCT02353143|471275219|FG001|Overall Study|Withdrawal by Subject|0|||
130901714|NCT02353143|471275220|FG002|Overall Study|Withdrawal by Subject|0|||
130901715|NCT02353143|471275221|FG003|Overall Study|Withdrawal by Subject|0|||
130901716|NCT02353143|471275222|FG004|Overall Study|Withdrawal by Subject|1|||
130901717|NCT02353143|471275223|FG005|Overall Study|Withdrawal by Subject|0|||
130901718|NCT02353143|471275224|FG006|Overall Study|Withdrawal by Subject|0|||
130901719|NCT02353143|471275225|FG007|Overall Study|Withdrawal by Subject|1|||
130901720|NCT02353143|471275226|FG008|Overall Study|Withdrawal by Subject|1|||
130901721|NCT02353143|471275218|FG000|Overall Study|Lack of Efficacy|2|||
130901722|NCT02353143|471275219|FG001|Overall Study|Lack of Efficacy|1|||
130901723|NCT02353143|471275220|FG002|Overall Study|Lack of Efficacy|2|||
130901724|NCT02353143|471275221|FG003|Overall Study|Lack of Efficacy|4|||
130901725|NCT02353143|471275222|FG004|Overall Study|Lack of Efficacy|13|||
130901726|NCT02353143|471275223|FG005|Overall Study|Lack of Efficacy|2|||
130901727|NCT02353143|471275224|FG006|Overall Study|Lack of Efficacy|2|||
130901728|NCT02353143|471275225|FG007|Overall Study|Lack of Efficacy|2|||
130901729|NCT02353143|471275226|FG008|Overall Study|Lack of Efficacy|1|||
130901730|NCT02353143|471275218|FG000|Overall Study|reason not specified|1|||
130901731|NCT02353143|471275219|FG001|Overall Study|reason not specified|2|||
131026090|NCT04759833|471725384|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
131026091|NCT04759833|471725385|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
131026092|NCT04759833|471725386|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
131026093|NCT04759833|471725387|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
131026094|NCT04759833|471725388|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
131026095|NCT04759833|471725384|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
131026096|NCT04759833|471725385|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
130901732|NCT02353143|471275220|FG002|Overall Study|reason not specified|0|||
130901733|NCT02353143|471275221|FG003|Overall Study|reason not specified|0|||
130901734|NCT02353143|471275222|FG004|Overall Study|reason not specified|6|||
130901735|NCT02353143|471275223|FG005|Overall Study|reason not specified|1|||
130901736|NCT02353143|471275224|FG006|Overall Study|reason not specified|0|||
130901737|NCT02353143|471275225|FG007|Overall Study|reason not specified|3|||
130901738|NCT02353143|471275226|FG008|Overall Study|reason not specified|1|||
130901739|NCT02353143|471275218|FG000|Overall Study|Physician Decision|0|||
130901740|NCT02353143|471275219|FG001|Overall Study|Physician Decision|4|||
130901741|NCT02353143|471275220|FG002|Overall Study|Physician Decision|2|||
130901742|NCT02353143|471275221|FG003|Overall Study|Physician Decision|3|||
130693682|NCT02554877|470505813|FG000|Overall Study|Did not meet entrance criteria|0|||
130693683|NCT02554877|470505814|FG001|Overall Study|Did not meet entrance criteria|0|||
130693684|NCT02554877|470505815|FG002|Overall Study|Did not meet entrance criteria|1|||
130901743|NCT02353143|471275222|FG004|Overall Study|Physician Decision|4|||
130901744|NCT02353143|471275223|FG005|Overall Study|Physician Decision|0|||
130901745|NCT02353143|471275224|FG006|Overall Study|Physician Decision|1|||
130901746|NCT02353143|471275225|FG007|Overall Study|Physician Decision|2|||
130901747|NCT02353143|471275226|FG008|Overall Study|Physician Decision|0|||
130901748|NCT02353143|471275218|FG000|Overall Study|Adverse Event|0|||
130901749|NCT02353143|471275219|FG001|Overall Study|Adverse Event|0|||
130901750|NCT02353143|471275220|FG002|Overall Study|Adverse Event|1|||
130901751|NCT02353143|471275221|FG003|Overall Study|Adverse Event|0|||
130901752|NCT02353143|471275222|FG004|Overall Study|Adverse Event|1|||
130901753|NCT02353143|471275223|FG005|Overall Study|Adverse Event|1|||
130901754|NCT02353143|471275224|FG006|Overall Study|Adverse Event|0|||
130901755|NCT02353143|471275225|FG007|Overall Study|Adverse Event|0|||
130901756|NCT02353143|471275226|FG008|Overall Study|Adverse Event|0|||
130901757|NCT02353143|471275218|FG000|Overall Study|patient receiving other treatment for AML|0|||
130901758|NCT02353143|471275219|FG001|Overall Study|patient receiving other treatment for AML|0|||
130901759|NCT02353143|471275220|FG002|Overall Study|patient receiving other treatment for AML|1|||
130901760|NCT02353143|471275221|FG003|Overall Study|patient receiving other treatment for AML|0|||
130901761|NCT02353143|471275222|FG004|Overall Study|patient receiving other treatment for AML|0|||
130901762|NCT02353143|471275223|FG005|Overall Study|patient receiving other treatment for AML|0|||
130901763|NCT02353143|471275224|FG006|Overall Study|patient receiving other treatment for AML|0|||
130901764|NCT02353143|471275225|FG007|Overall Study|patient receiving other treatment for AML|0|||
130901765|NCT02353143|471275226|FG008|Overall Study|patient receiving other treatment for AML|0|||
130901766|NCT02353143|471275218|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
130901767|NCT02353143|471275219|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
130901768|NCT02353143|471275220|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
131112642|NCT04683731|472042461|FG001|Overall Study|Determined patient was not eligible|3|||
131112643|NCT04683731|472042462|FG002|Overall Study|Determined patient was not eligible|12|||
131112644|NCT04683731|472042463|FG003|Overall Study|Determined patient was not eligible|3|||
131026097|NCT04759833|471725386|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
131026098|NCT04759833|471725387|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
131026099|NCT04759833|471725388|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
131026100|NCT04759833|471725384|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
131026101|NCT04759833|471725385|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
131026102|NCT04759833|471725386|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
131026103|NCT04759833|471725387|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
131026104|NCT04759833|471725388|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
131026105|NCT04759833|471725384|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
131026106|NCT04759833|471725385|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
131026107|NCT04759833|471725386|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
131026108|NCT04759833|471725387|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
131026109|NCT04759833|471725388|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
131026110|NCT04711135|471725389|FG000|Overall Study|Physician Decision|0|||
131026111|NCT04711135|471725390|FG001|Overall Study|Physician Decision|1|||
131026112|NCT04711135|471725389|FG000|Overall Study|Ongoing treatment|0|||
131026113|NCT04711135|471725390|FG001|Overall Study|Ongoing treatment|1|||
131026114|NCT00998881|471725393|FG000|Overall Study|Adverse Event|2|||
131026115|NCT00998881|471725394|FG001|Overall Study|Adverse Event|2|||
131026116|NCT00998881|471725393|FG000|Overall Study|Lack of Efficacy|1|||
131026117|NCT00998881|471725394|FG001|Overall Study|Lack of Efficacy|0|||
131026118|NCT00998881|471725393|FG000|Overall Study|Physician Decision|3|||
131026119|NCT00998881|471725394|FG001|Overall Study|Physician Decision|0|||
131026120|NCT00998881|471725393|FG000|Overall Study|Withdrawal by Subject|1|||
131026121|NCT00998881|471725394|FG001|Overall Study|Withdrawal by Subject|0|||
131026122|NCT00998881|471725393|FG000|Overall Study|Personal matter|1|||
131026123|NCT00998881|471725394|FG001|Overall Study|Personal matter|0|||
131026124|NCT00818246|471725395|FG000|Overall Study|Impossible to match pictures|5|||
131026125|NCT01121991|471725396|FG000|Overall Study|Lack of Ovarian Response|2|||
131026126|NCT01121991|471725396|FG000|Overall Study|No Oocytes Retrieved|3|||
131112645|NCT01411839|472042465|FG000|Overall Study|Lost to Follow-up|4|||
131026127|NCT01121991|471725396|FG000|Overall Study|No Fertilization|1|||
130901769|NCT02353143|471275221|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
130901770|NCT02353143|471275222|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
131026128|NCT00409838|471725397|FG000|Short-term Period|Adverse Event|0|||
131026129|NCT00409838|471725398|FG001|Short-term Period|Adverse Event|1|||
131026130|NCT00409838|471725397|FG000|Short-term Period|Lost to Follow-up|0|||
131026131|NCT00409838|471725398|FG001|Short-term Period|Lost to Follow-up|1|||
130693685|NCT02554877|470505816|FG003|Overall Study|Did not meet entrance criteria|0|||
130901771|NCT02353143|471275223|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
130901772|NCT02353143|471275224|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
130901773|NCT02353143|471275225|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
130901774|NCT02353143|471275226|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
130901775|NCT03316911|471275236|FG000|Overall Study|Lost to Follow-up|33|||
130901776|NCT03316911|471275237|FG001|Overall Study|Lost to Follow-up|29|||
130901777|NCT01119937|471275238|FG000|Overall Study|Adverse Event|11|||
130901778|NCT01119937|471275239|FG001|Overall Study|Adverse Event|5|||
130901779|NCT01119937|471275238|FG000|Overall Study|Protocol deviation|3|||
130901780|NCT01119937|471275239|FG001|Overall Study|Protocol deviation|1|||
130901781|NCT01119937|471275238|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130901782|NCT01119937|471275239|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130901783|NCT01119937|471275238|FG000|Overall Study|Withdrawal by Subject|2|||
130901784|NCT01119937|471275239|FG001|Overall Study|Withdrawal by Subject|1|||
130901785|NCT04740905|471275240|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
130901786|NCT04740905|471275241|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
130901787|NCT04740905|471275240|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
130901788|NCT04740905|471275241|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
130901789|NCT04740905|471275240|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
130901790|NCT04740905|471275241|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
130901791|NCT04740905|471275240|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
130901792|NCT04740905|471275241|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
130901793|NCT04740905|471275240|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
130901794|NCT04740905|471275241|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
130901795|NCT04740905|471275240|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
130901796|NCT04740905|471275241|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
130901797|NCT04740905|471275240|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
130901798|NCT04740905|471275241|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
130901799|NCT04740905|471275240|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
130901800|NCT04740905|471275241|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
130901801|NCT04740905|471275240|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
130901802|NCT04740905|471275241|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
130901803|NCT04740905|471275240|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
130901804|NCT04740905|471275241|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
130901805|NCT04740905|471275240|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
130901806|NCT04740905|471275241|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
130901807|NCT04740905|471275240|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
130901808|NCT04740905|471275241|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
130901809|NCT04740905|471275240|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
130901810|NCT04740905|471275241|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
130901811|NCT04740905|471275240|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
130901812|NCT04740905|471275241|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
130901813|NCT00770146|471275242|FG000|Treatment Period|Withdrawal by Subject|6|||
130901814|NCT00770146|471275243|FG001|Treatment Period|Withdrawal by Subject|13|||
131112646|NCT01411839|472042466|FG001|Overall Study|Lost to Follow-up|3|||
131112647|NCT00458341|472042467|FG000|Cycle 1|Adverse Event|1|||
130901815|NCT00770146|471275242|FG000|Treatment Period|Adverse Event|2|||
130901816|NCT00770146|471275243|FG001|Treatment Period|Adverse Event|26|||
130901817|NCT00770146|471275242|FG000|Treatment Period|Other|1|||
130901818|NCT00770146|471275243|FG001|Treatment Period|Other|5|||
130901819|NCT00770146|471275242|FG000|Treatment Period|Protocol non-compliance|0|||
130901820|NCT00770146|471275243|FG001|Treatment Period|Protocol non-compliance|1|||
130901821|NCT00770146|471275242|FG000|Follow-up Period|Withdrawal by Subject|7|||
130901822|NCT00770146|471275243|FG001|Follow-up Period|Withdrawal by Subject|13|||
130901823|NCT00770146|471275242|FG000|Follow-up Period|Adverse Event|0|||
130901824|NCT00770146|471275243|FG001|Follow-up Period|Adverse Event|2|||
130901825|NCT00770146|471275242|FG000|Follow-up Period|Other|4|||
130901826|NCT00770146|471275243|FG001|Follow-up Period|Other|5|||
130901827|NCT00816023|471275247|FG000|Overall Study|Lost to Follow-up|1|||
130901828|NCT00816023|471275248|FG001|Overall Study|Lost to Follow-up|1|||
130693686|NCT02554877|470505813|FG000|Overall Study|No longer met eligibility criteria|1|||
130693687|NCT02554877|470505814|FG001|Overall Study|No longer met eligibility criteria|0|||
130693688|NCT02554877|470505815|FG002|Overall Study|No longer met eligibility criteria|1|||
130693689|NCT02554877|470505816|FG003|Overall Study|No longer met eligibility criteria|1|||
130901829|NCT00816023|471275249|FG002|Overall Study|Lost to Follow-up|0|||
130901830|NCT00816023|471275250|FG003|Overall Study|Lost to Follow-up|0|||
130901831|NCT00816023|471275247|FG000|Overall Study|Withdrawal by Subject|1|||
130901832|NCT00816023|471275248|FG001|Overall Study|Withdrawal by Subject|0|||
130901833|NCT00816023|471275249|FG002|Overall Study|Withdrawal by Subject|0|||
130693690|NCT02554877|470505813|FG000|Overall Study|Protocol Violation|3|||
130901834|NCT00816023|471275250|FG003|Overall Study|Withdrawal by Subject|0|||
131112648|NCT00458341|472042468|FG001|Cycle 1|Adverse Event|0|||
131112649|NCT05461794|472042471|FG000|Overall Study|Withdrawal by Subject|1|||
130693691|NCT02554877|470505814|FG001|Overall Study|Protocol Violation|1|||
130693692|NCT02554877|470505815|FG002|Overall Study|Protocol Violation|1|||
130693693|NCT02554877|470505816|FG003|Overall Study|Protocol Violation|0|||
130693694|NCT02554877|470505813|FG000|Overall Study|Other|1|||
130693695|NCT02554877|470505814|FG001|Overall Study|Other|3|||
130693696|NCT02554877|470505815|FG002|Overall Study|Other|0|||
130693697|NCT02554877|470505816|FG003|Overall Study|Other|3|||
130693698|NCT02554877|470505813|FG000|Overall Study|Insufficient clinical response|4|||
130768239|NCT01955109|470775505|FG001|Overall Study|Participant unwilling to continue|7|||
130768240|NCT01955109|470775504|FG000|Overall Study|Physician Decision|2|||
130768241|NCT01955109|470775505|FG001|Overall Study|Physician Decision|0|||
130768242|NCT01955109|470775504|FG000|Overall Study|Lost to Follow-up|3|||
130901835|NCT00816023|471275247|FG000|Overall Study|Physician Decision|0|||
130901836|NCT00816023|471275248|FG001|Overall Study|Physician Decision|0|||
130901837|NCT00816023|471275249|FG002|Overall Study|Physician Decision|1|||
130901838|NCT00816023|471275250|FG003|Overall Study|Physician Decision|0|||
130901839|NCT00816023|471275247|FG000|Overall Study|assessments complete prior to window|1|||
130901840|NCT00816023|471275248|FG001|Overall Study|assessments complete prior to window|1|||
130901841|NCT00816023|471275249|FG002|Overall Study|assessments complete prior to window|2|||
130901842|NCT00816023|471275250|FG003|Overall Study|assessments complete prior to window|1|||
130901843|NCT00816023|471275247|FG000|Overall Study|Randomized Not Treated|6|||
130901844|NCT00816023|471275248|FG001|Overall Study|Randomized Not Treated|4|||
130901845|NCT00816023|471275249|FG002|Overall Study|Randomized Not Treated|6|||
130901846|NCT00816023|471275250|FG003|Overall Study|Randomized Not Treated|11|||
130901847|NCT01525901|471275251|FG000|Period 2: 12 Weeks|Adverse Event|0|||
130901848|NCT01525901|471275252|FG001|Period 2: 12 Weeks|Adverse Event|1|||
130901849|NCT01525901|471275253|FG002|Period 2: 12 Weeks|Adverse Event|0|||
130901850|NCT01525901|471275254|FG003|Period 2: 12 Weeks|Adverse Event|0|||
130901851|NCT05027971|471275259|FG000|Overall Study|Physician Decision|7|||
130901852|NCT05027971|471275260|FG001|Overall Study|Physician Decision|3|||
130901853|NCT05027971|471275259|FG000|Overall Study|Lost to Follow-up|1|||
130901854|NCT05027971|471275260|FG001|Overall Study|Lost to Follow-up|1|||
130901855|NCT05027971|471275259|FG000|Overall Study|Withdrawal by Subject|0|||
130901856|NCT05027971|471275260|FG001|Overall Study|Withdrawal by Subject|2|||
130901857|NCT05027971|471275259|FG000|Overall Study|Non-study fiber used.|0|||
130901858|NCT05027971|471275260|FG001|Overall Study|Non-study fiber used.|1|||
130901859|NCT05027971|471275259|FG000|Overall Study|Protocol Violation|0|||
130901860|NCT05027971|471275260|FG001|Overall Study|Protocol Violation|2|||
130901861|NCT02486627|471275262|FG000|Overall Study|Death|1|||
130901862|NCT02486627|471275263|FG001|Overall Study|Death|0|||
130901863|NCT02486627|471275262|FG000|Overall Study|Other Unspecified|0|||
130901864|NCT02486627|471275263|FG001|Overall Study|Other Unspecified|2|||
130901865|NCT02486627|471275262|FG000|Overall Study|Consent Withdrawn by Participant|4|||
130901866|NCT02486627|471275263|FG001|Overall Study|Consent Withdrawn by Participant|3|||
130901867|NCT02486627|471275262|FG000|Overall Study|Significant Participant Noncompliance|1|||
130901868|NCT02486627|471275263|FG001|Overall Study|Significant Participant Noncompliance|1|||
130901869|NCT02486627|471275262|FG000|Overall Study|Lost to Follow-up|1|||
130901870|NCT02486627|471275263|FG001|Overall Study|Lost to Follow-up|3|||
130901871|NCT01073462|471275264|FG000|Overall Study|Death|14|||
130901872|NCT01073462|471275264|FG000|Overall Study|Kidney transplant|10|||
130901873|NCT01073462|471275264|FG000|Overall Study|Low parathyroid hormone levels|8|||
130901874|NCT01073462|471275264|FG000|Overall Study|Serious adverse event|2|||
130901875|NCT01073462|471275264|FG000|Overall Study|Lost to Follow-up|7|||
130901876|NCT01238588|471275265|FG000|Overall Study|Withdrawal by Subject|1|||
130901877|NCT01238588|471275265|FG000|Overall Study|Physician Decision|2|||
130901878|NCT05395091|471275268|FG000|Baseline to Month 12|Adverse Event|7|||
130901879|NCT05395091|471275269|FG001|Baseline to Month 12|Adverse Event|2|||
130901880|NCT05395091|471275270|FG002|Baseline to Month 12|Adverse Event|0|||
130901881|NCT05395091|471275268|FG000|Baseline to Month 12|Death|3|||
130901882|NCT05395091|471275269|FG001|Baseline to Month 12|Death|1|||
130901883|NCT05395091|471275270|FG002|Baseline to Month 12|Death|0|||
130901884|NCT05395091|471275268|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
131112650|NCT05461794|472042472|FG001|Overall Study|Withdrawal by Subject|1|||
131112651|NCT05461794|472042473|FG002|Overall Study|Withdrawal by Subject|3|||
130901885|NCT05395091|471275269|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
130901886|NCT05395091|471275270|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
130901887|NCT05395091|471275268|FG000|Baseline to Month 12|Protocol Violation|2|||
130901888|NCT05395091|471275269|FG001|Baseline to Month 12|Protocol Violation|3|||
130901889|NCT05395091|471275270|FG002|Baseline to Month 12|Protocol Violation|0|||
130901890|NCT05395091|471275268|FG000|Baseline to Month 12|Physician Decision|1|||
130901891|NCT05395091|471275269|FG001|Baseline to Month 12|Physician Decision|0|||
130901892|NCT05395091|471275270|FG002|Baseline to Month 12|Physician Decision|0|||
130901893|NCT05395091|471275268|FG000|Month 12 to Month 18|Death|1|||
130693699|NCT02554877|470505814|FG001|Overall Study|Insufficient clinical response|0|||
130901894|NCT05395091|471275269|FG001|Month 12 to Month 18|Death|0|||
130901895|NCT05395091|471275270|FG002|Month 12 to Month 18|Death|0|||
130693700|NCT02554877|470505815|FG002|Overall Study|Insufficient clinical response|0|||
130901896|NCT05395091|471275268|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
130901897|NCT05395091|471275269|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
130693701|NCT02554877|470505816|FG003|Overall Study|Insufficient clinical response|0|||
130693702|NCT02554877|470505813|FG000|Overall Study|No longer willing to participate|0|||
130693703|NCT02554877|470505814|FG001|Overall Study|No longer willing to participate|2|||
130693704|NCT02554877|470505815|FG002|Overall Study|No longer willing to participate|2|||
130693705|NCT02554877|470505816|FG003|Overall Study|No longer willing to participate|0|||
130693706|NCT04474405|470505817|FG000|Overall Study|Withdrawal by Subject|0|||
130901898|NCT05395091|471275270|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
130901899|NCT05395091|471275268|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
130901900|NCT05395091|471275269|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
130901901|NCT05395091|471275270|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
130901902|NCT05395091|471275268|FG000|Month 12 to Month 18|Other reasons|0|||
130901903|NCT05395091|471275269|FG001|Month 12 to Month 18|Other reasons|0|||
130901904|NCT05395091|471275270|FG002|Month 12 to Month 18|Other reasons|1|||
130901905|NCT03554486|471275271|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
130901906|NCT03554486|471275272|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
130901907|NCT03554486|471275273|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
130901908|NCT03554486|471275271|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
130901909|NCT03554486|471275272|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
130901910|NCT03554486|471275273|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
130901911|NCT03554486|471275271|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130901912|NCT03554486|471275272|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
130901913|NCT03554486|471275273|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
130901914|NCT01509053|471275274|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
130901915|NCT01509053|471275274|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
130901916|NCT01509053|471275274|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
130693707|NCT04474405|470505818|FG001|Overall Study|Withdrawal by Subject|0|||
130693708|NCT04474405|470505819|FG002|Overall Study|Withdrawal by Subject|1|||
130693709|NCT04474405|470505820|FG003|Overall Study|Withdrawal by Subject|0|||
130693710|NCT04474405|470505821|FG004|Overall Study|Withdrawal by Subject|1|||
130693711|NCT04474405|470505822|FG005|Overall Study|Withdrawal by Subject|0|||
130693712|NCT04474405|470505817|FG000|Overall Study|Other|0|||
130693713|NCT04474405|470505818|FG001|Overall Study|Other|0|||
130693714|NCT04474405|470505819|FG002|Overall Study|Other|0|||
130693715|NCT04474405|470505820|FG003|Overall Study|Other|0|||
130693716|NCT04474405|470505821|FG004|Overall Study|Other|3|||
130901917|NCT01509053|471275274|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
130693717|NCT04474405|470505822|FG005|Overall Study|Other|0|||
130901918|NCT01509053|471275274|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
130901919|NCT01509053|471275274|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
130901920|NCT01915303|471275275|FG000|Core Phase|Adverse Event|7|||
130901921|NCT01915303|471275275|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
130901922|NCT01915303|471275275|FG000|Core Phase|Death|2|||
131026132|NCT00409838|471725397|FG000|Short-term Period|Withdrawal by Subject|2|||
131026133|NCT00409838|471725398|FG001|Short-term Period|Withdrawal by Subject|3|||
131026134|NCT00409838|471725397|FG000|Short-term Period|Never Treated|1|||
131026135|NCT00409838|471725398|FG001|Short-term Period|Never Treated|0|||
131026136|NCT00409838|471725397|FG000|Long-term Extension Period|Adverse Event|10|||
130693718|NCT00274651|470505823|FG000|Overall Study|Adverse Event|6|||
130693719|NCT00274651|470505824|FG001|Overall Study|Adverse Event|3|||
130693720|NCT00274651|470505823|FG000|Overall Study|Lack of Efficacy|13|||
130693721|NCT00274651|470505824|FG001|Overall Study|Lack of Efficacy|6|||
130693722|NCT00274651|470505823|FG000|Overall Study|Death|1|||
130693723|NCT00274651|470505824|FG001|Overall Study|Death|3|||
130693724|NCT00274651|470505823|FG000|Overall Study|Withdrawal by Subject|0|||
130693725|NCT00274651|470505824|FG001|Overall Study|Withdrawal by Subject|1|||
130693726|NCT00274651|470505823|FG000|Overall Study|Physician Decision|8|||
130693727|NCT00274651|470505824|FG001|Overall Study|Physician Decision|7|||
130693728|NCT02157974|470505825|FG000|Overall Study|Withdrawal by Subject|0|||
130693729|NCT02157974|470505826|FG001|Overall Study|Withdrawal by Subject|1|||
130693730|NCT02157974|470505827|FG002|Overall Study|Withdrawal by Subject|0|||
130693731|NCT02157974|470505828|FG003|Overall Study|Withdrawal by Subject|0|||
130693732|NCT02157974|470505829|FG004|Overall Study|Withdrawal by Subject|0|||
130693733|NCT02157974|470505825|FG000|Overall Study|Screen Failure|0|||
130901923|NCT01915303|471275275|FG000|Core Phase|Protocol Violation|2|||
130901924|NCT01915303|471275275|FG000|Core Phase|Abnormal lab value|1|||
130901925|NCT01915303|471275275|FG000|Core Phase|Withdrawal by Subject|1|||
131026137|NCT00409838|471725398|FG001|Long-term Extension Period|Adverse Event|0|||
131026138|NCT00409838|471725397|FG000|Long-term Extension Period|Death|1|||
131026139|NCT00409838|471725398|FG001|Long-term Extension Period|Death|0|||
131026140|NCT00409838|471725397|FG000|Long-term Extension Period|Lack of Efficacy|2|||
130693734|NCT02157974|470505826|FG001|Overall Study|Screen Failure|1|||
130693735|NCT02157974|470505827|FG002|Overall Study|Screen Failure|0|||
130901926|NCT01915303|471275275|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
130901927|NCT01915303|471275275|FG000|Extension Phase|Withdrawal by Subject|4|||
130901928|NCT01915303|471275275|FG000|Extension Phase|Adverse Event|3|||
130901929|NCT01915303|471275275|FG000|Extension Phase|Death|1|||
130901930|NCT01915303|471275275|FG000|Extension Phase|Protocol Violation|1|||
130901931|NCT02925338|471275276|FG000|Overall Study|Death|0|||
130901932|NCT02925338|471275277|FG001|Overall Study|Death|2|||
130901933|NCT02925338|471275278|FG002|Overall Study|Death|1|||
130901934|NCT02925338|471275279|FG003|Overall Study|Death|0|||
130901935|NCT02925338|471275280|FG004|Overall Study|Death|0|||
130901936|NCT02925338|471275276|FG000|Overall Study|Lost to Follow-up|30|||
130901937|NCT02925338|471275277|FG001|Overall Study|Lost to Follow-up|10|||
130901938|NCT02925338|471275278|FG002|Overall Study|Lost to Follow-up|1|||
130901939|NCT02925338|471275279|FG003|Overall Study|Lost to Follow-up|16|||
130693736|NCT02157974|470505828|FG003|Overall Study|Screen Failure|0|||
130693737|NCT02157974|470505829|FG004|Overall Study|Screen Failure|0|||
130901940|NCT02925338|471275280|FG004|Overall Study|Lost to Follow-up|3|||
130901941|NCT02925338|471275276|FG000|Overall Study|Withdrawal by Subject|3|||
130901942|NCT02925338|471275277|FG001|Overall Study|Withdrawal by Subject|0|||
130901943|NCT02925338|471275278|FG002|Overall Study|Withdrawal by Subject|3|||
131026141|NCT00409838|471725398|FG001|Long-term Extension Period|Lack of Efficacy|0|||
131026142|NCT00409838|471725397|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
131026143|NCT00409838|471725398|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
131026144|NCT00409838|471725397|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
131026145|NCT00409838|471725398|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
131026146|NCT00409838|471725397|FG000|Long-term Extension Period|Pregnancy|1|||
131026147|NCT00409838|471725398|FG001|Long-term Extension Period|Pregnancy|0|||
131026148|NCT01619410|471725399|FG000|Overall Study|Lost to Follow-up|7|||
131026149|NCT01619410|471725400|FG001|Overall Study|Lost to Follow-up|4|||
131026150|NCT04788641|471725402|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
131026151|NCT04788641|471725403|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
131026152|NCT04788641|471725404|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
131026153|NCT04788641|471725405|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
131026154|NCT04788641|471725402|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
131026155|NCT04788641|471725403|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
131026156|NCT04788641|471725404|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
131026157|NCT04788641|471725405|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
131026158|NCT04788641|471725402|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
131026159|NCT04788641|471725403|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
131026160|NCT04788641|471725404|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
131026161|NCT04788641|471725405|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
131026162|NCT02462759|471725406|FG000|Part 1: Double Blind|Death|1|||
131026163|NCT02462759|471725407|FG001|Part 1: Double Blind|Death|0|||
131026164|NCT02462759|471725408|FG002|Part 1: Double Blind|Death|0|||
131026165|NCT02740231|471725409|FG000|Overall Study|Withdrawal by Subject|1|||
131026166|NCT02740231|471725410|FG001|Overall Study|Withdrawal by Subject|1|||
131026167|NCT02740231|471725411|FG002|Overall Study|Withdrawal by Subject|1|||
131026168|NCT02740231|471725412|FG003|Overall Study|Withdrawal by Subject|0|||
131026169|NCT02740231|471725409|FG000|Overall Study|Lack of Efficacy|0|||
131026170|NCT02740231|471725410|FG001|Overall Study|Lack of Efficacy|1|||
131026171|NCT02740231|471725411|FG002|Overall Study|Lack of Efficacy|0|||
131026172|NCT02740231|471725412|FG003|Overall Study|Lack of Efficacy|4|||
131026173|NCT02740231|471725409|FG000|Overall Study|Lost to Follow-up|1|||
131026174|NCT02740231|471725410|FG001|Overall Study|Lost to Follow-up|3|||
131026175|NCT02740231|471725411|FG002|Overall Study|Lost to Follow-up|0|||
131026176|NCT02740231|471725412|FG003|Overall Study|Lost to Follow-up|3|||
131026177|NCT02740231|471725409|FG000|Overall Study|Adverse Event|0|||
131026178|NCT02740231|471725410|FG001|Overall Study|Adverse Event|1|||
131026179|NCT02740231|471725411|FG002|Overall Study|Adverse Event|0|||
131026180|NCT02740231|471725412|FG003|Overall Study|Adverse Event|1|||
131026181|NCT01000480|471725413|FG000|Induction Phase|Adverse Event|2|||
131026182|NCT01000480|471725413|FG000|Induction Phase|Lost to Follow-up|1|||
131026183|NCT01000480|471725413|FG000|Induction Phase|Physician Decision|1|||
131026184|NCT01000480|471725413|FG000|Induction Phase|Entry Criteria Not Met|3|||
131026185|NCT01000480|471725413|FG000|Concurrent Therapy Phase|Adverse Event|4|||
130693738|NCT02157974|470505825|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
131026186|NCT01000480|471725413|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
131026187|NCT01000480|471725413|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
131026188|NCT01000480|471725413|FG000|Concurrent Therapy Phase|Physician Decision|1|||
130901944|NCT02925338|471275279|FG003|Overall Study|Withdrawal by Subject|2|||
130901945|NCT02925338|471275280|FG004|Overall Study|Withdrawal by Subject|2|||
130901946|NCT02925338|471275276|FG000|Overall Study|Missing|38|||
130901947|NCT02925338|471275277|FG001|Overall Study|Missing|27|||
130901948|NCT02925338|471275278|FG002|Overall Study|Missing|0|||
130901949|NCT02925338|471275279|FG003|Overall Study|Missing|3|||
130901950|NCT02925338|471275280|FG004|Overall Study|Missing|2|||
130901951|NCT02925338|471275276|FG000|Overall Study|Participant's Decision|11|||
130901952|NCT02925338|471275277|FG001|Overall Study|Participant's Decision|7|||
130901953|NCT02925338|471275278|FG002|Overall Study|Participant's Decision|3|||
130901954|NCT02925338|471275279|FG003|Overall Study|Participant's Decision|8|||
130901955|NCT02925338|471275280|FG004|Overall Study|Participant's Decision|1|||
130901956|NCT02925338|471275276|FG000|Overall Study|Treatment Discontinuation|144|||
130901957|NCT02925338|471275277|FG001|Overall Study|Treatment Discontinuation|65|||
130901958|NCT02925338|471275278|FG002|Overall Study|Treatment Discontinuation|56|||
130901959|NCT02925338|471275279|FG003|Overall Study|Treatment Discontinuation|131|||
130901960|NCT02925338|471275280|FG004|Overall Study|Treatment Discontinuation|22|||
130901961|NCT00636363|471275283|FG000|Overall Study|Conjunctivitis|0|||
131026189|NCT04600752|471725414|FG000|Overall Study|Physician Decision|0|||
130693739|NCT02157974|470505826|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
130693740|NCT02157974|470505827|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130693741|NCT02157974|470505828|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130693742|NCT02157974|470505829|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130693743|NCT01410227|470505830|FG000|Overall Study|Adverse Event|1|||
130693744|NCT01410227|470505831|FG001|Overall Study|Adverse Event|0|||
130693745|NCT01410227|470505832|FG002|Overall Study|Adverse Event|0|||
130693746|NCT01410227|470505833|FG003|Overall Study|Adverse Event|0|||
130693747|NCT01410227|470505830|FG000|Overall Study|Withdrawal by Subject|3|||
130693748|NCT01410227|470505831|FG001|Overall Study|Withdrawal by Subject|0|||
130693749|NCT01410227|470505832|FG002|Overall Study|Withdrawal by Subject|1|||
130693750|NCT01410227|470505833|FG003|Overall Study|Withdrawal by Subject|0|||
130693751|NCT01410227|470505830|FG000|Overall Study|Pregnancy|0|||
130693752|NCT01410227|470505831|FG001|Overall Study|Pregnancy|0|||
130693753|NCT01410227|470505832|FG002|Overall Study|Pregnancy|0|||
130693754|NCT01410227|470505833|FG003|Overall Study|Pregnancy|1|||
130693755|NCT01410227|470505830|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
130693756|NCT01410227|470505831|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
130693757|NCT01410227|470505832|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
130693758|NCT01410227|470505833|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
130693759|NCT01484912|470505834|FG000|Overall Study|Withdrawal by Subject|1|||
130693760|NCT01484912|470505835|FG001|Overall Study|Withdrawal by Subject|0|||
130693761|NCT01484912|470505834|FG000|Overall Study|Physician Decision|0|||
130693762|NCT01484912|470505835|FG001|Overall Study|Physician Decision|1|||
130693763|NCT03158727|470505836|FG000|Overall Study|Withdrawal by Subject|2|||
130693764|NCT03158727|470505837|FG001|Overall Study|Withdrawal by Subject|6|||
130693765|NCT03158727|470505836|FG000|Overall Study|Death|11|||
130693766|NCT03158727|470505837|FG001|Overall Study|Death|12|||
130693767|NCT03158727|470505836|FG000|Overall Study|Lost to Follow-up|1|||
130693768|NCT03158727|470505837|FG001|Overall Study|Lost to Follow-up|0|||
130693769|NCT03158727|470505836|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
130693770|NCT03158727|470505837|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
130693771|NCT03158727|470505836|FG000|Overall Study|Visit 11 not done by mistake|0|||
130693772|NCT03158727|470505837|FG001|Overall Study|Visit 11 not done by mistake|1|||
130693773|NCT03158727|470505836|FG000|Overall Study|Enrolled, not treated|1|||
130693774|NCT03158727|470505837|FG001|Overall Study|Enrolled, not treated|0|||
130693775|NCT00985439|470505838|FG000|Overall Study|Adverse Event|0|||
130693776|NCT00985439|470505839|FG001|Overall Study|Adverse Event|0|||
130693777|NCT00985439|470505840|FG002|Overall Study|Adverse Event|1|||
131026190|NCT04600752|471725415|FG001|Overall Study|Physician Decision|0|||
131026191|NCT04600752|471725416|FG002|Overall Study|Physician Decision|1|||
131026192|NCT04600752|471725414|FG000|Overall Study|Adverse Event|0|||
131026193|NCT04600752|471725415|FG001|Overall Study|Adverse Event|1|||
131026194|NCT04600752|471725416|FG002|Overall Study|Adverse Event|0|||
131026195|NCT04600752|471725414|FG000|Overall Study|Withdrawal by Subject|2|||
131026196|NCT04600752|471725415|FG001|Overall Study|Withdrawal by Subject|1|||
131026197|NCT04600752|471725416|FG002|Overall Study|Withdrawal by Subject|0|||
131026198|NCT04600752|471725414|FG000|Overall Study|Lack of Efficacy|1|||
131026199|NCT04600752|471725415|FG001|Overall Study|Lack of Efficacy|0|||
131026200|NCT04600752|471725416|FG002|Overall Study|Lack of Efficacy|0|||
131026201|NCT00999167|471725417|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
131026202|NCT00999167|471725418|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
131026203|NCT00999167|471725419|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
131026204|NCT00999167|471725417|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
130693778|NCT00985439|470505841|FG003|Overall Study|Adverse Event|0|||
130693779|NCT02462837|470505843|FG000|Overall Study|pt developed hives|1|||
130693780|NCT02462837|470505844|FG001|Overall Study|pt developed hives|0|||
130693781|NCT02462837|470505843|FG000|Overall Study|Withdrawal by Subject|1|||
130901962|NCT00636363|471275284|FG001|Overall Study|Conjunctivitis|0|||
130901963|NCT00636363|471275285|FG002|Overall Study|Conjunctivitis|1|||
130901964|NCT00636363|471275283|FG000|Overall Study|Adverse Event|0|||
130901965|NCT00636363|471275284|FG001|Overall Study|Adverse Event|0|||
130901966|NCT00636363|471275285|FG002|Overall Study|Adverse Event|1|||
130901967|NCT00636363|471275283|FG000|Overall Study|Positive slit lamp finding|0|||
130901968|NCT00636363|471275284|FG001|Overall Study|Positive slit lamp finding|2|||
130901969|NCT00636363|471275285|FG002|Overall Study|Positive slit lamp finding|1|||
130901970|NCT00636363|471275283|FG000|Overall Study|Study related symptoms/complaints|8|||
130901971|NCT00636363|471275284|FG001|Overall Study|Study related symptoms/complaints|7|||
130901972|NCT00636363|471275285|FG002|Overall Study|Study related symptoms/complaints|4|||
130901973|NCT00636363|471275283|FG000|Overall Study|Met ineligibility criteria|0|||
130901974|NCT00636363|471275284|FG001|Overall Study|Met ineligibility criteria|0|||
130901975|NCT00636363|471275285|FG002|Overall Study|Met ineligibility criteria|3|||
130693782|NCT02462837|470505844|FG001|Overall Study|Withdrawal by Subject|0|||
130693783|NCT05562011|470505852|FG000|Overall Study|Withdrawal by Subject|3|||
130693784|NCT05562011|470505852|FG000|Overall Study|Lost to Follow-up|1|||
130693785|NCT05562011|470505852|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
130693786|NCT05562011|470505852|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
130693787|NCT05562011|470505852|FG000|Overall Study|Device malfunction|13|||
130693788|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Refused|1|||
130693789|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Refused|3|||
130693790|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Medical|0|||
130693791|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Medical|1|||
130693792|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
130693793|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
130901976|NCT00636363|471275283|FG000|Overall Study|Missed > 1 visit|0|||
130901977|NCT00636363|471275284|FG001|Overall Study|Missed > 1 visit|1|||
130901978|NCT00636363|471275285|FG002|Overall Study|Missed > 1 visit|3|||
130901979|NCT00636363|471275283|FG000|Overall Study|Lack of motivation|1|||
130901980|NCT00636363|471275284|FG001|Overall Study|Lack of motivation|0|||
130901981|NCT00636363|471275285|FG002|Overall Study|Lack of motivation|1|||
131026205|NCT00999167|471725418|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
131026206|NCT00999167|471725419|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
131026207|NCT00999167|471725417|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
131026208|NCT00999167|471725418|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
131026209|NCT00999167|471725419|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
131026210|NCT00999167|471725417|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
131026211|NCT00999167|471725418|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
131026212|NCT00999167|471725419|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
131026213|NCT00999167|471725417|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
131026214|NCT00999167|471725418|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
131026215|NCT00999167|471725419|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
131026216|NCT00999167|471725417|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
131026217|NCT00999167|471725418|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
131026218|NCT00999167|471725419|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
131026219|NCT00999167|471725417|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
131026220|NCT00999167|471725418|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
131026221|NCT00999167|471725419|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
131026222|NCT00999167|471725417|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
131026223|NCT00999167|471725418|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
131026224|NCT00999167|471725419|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
131026225|NCT05052996|471725422|FG000|Overall Study|Still on study|0|||
131026226|NCT05052996|471725423|FG001|Overall Study|Still on study|0|||
131026227|NCT05052996|471725424|FG002|Overall Study|Still on study|47|||
131026228|NCT05052996|471725425|FG003|Overall Study|Still on study|44|||
131026229|NCT05052996|471725422|FG000|Overall Study|Cohort terminated by sponsor|21|||
131026230|NCT05052996|471725423|FG001|Overall Study|Cohort terminated by sponsor|12|||
131026231|NCT05052996|471725424|FG002|Overall Study|Cohort terminated by sponsor|0|||
131026232|NCT05052996|471725425|FG003|Overall Study|Cohort terminated by sponsor|0|||
131026233|NCT05052996|471725422|FG000|Overall Study|Withdrew consent|1|||
131026234|NCT05052996|471725423|FG001|Overall Study|Withdrew consent|0|||
131026235|NCT05052996|471725424|FG002|Overall Study|Withdrew consent|1|||
131026236|NCT05052996|471725425|FG003|Overall Study|Withdrew consent|2|||
131026237|NCT05052996|471725422|FG000|Overall Study|Lost to Follow-up|1|||
131026238|NCT05052996|471725423|FG001|Overall Study|Lost to Follow-up|0|||
131026239|NCT05052996|471725424|FG002|Overall Study|Lost to Follow-up|0|||
131026240|NCT05052996|471725425|FG003|Overall Study|Lost to Follow-up|2|||
131026241|NCT05052996|471725422|FG000|Overall Study|Adverse Event|0|||
131026242|NCT05052996|471725423|FG001|Overall Study|Adverse Event|0|||
131026243|NCT05052996|471725424|FG002|Overall Study|Adverse Event|2|||
130693794|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
130693795|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
130901982|NCT00636363|471275283|FG000|Overall Study|Protocol Violation|0|||
130901983|NCT00636363|471275284|FG001|Overall Study|Protocol Violation|3|||
130901984|NCT00636363|471275285|FG002|Overall Study|Protocol Violation|0|||
130693796|NCT02054715|470505853|FG000|Baseline/Follow-up 1|No Reason|0|||
130693797|NCT02054715|470505854|FG001|Baseline/Follow-up 1|No Reason|1|||
130693798|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
130693799|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
130693800|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Ineligible|3|||
130693801|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Ineligible|0|||
130693802|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Hospitalization|1|||
130693803|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Hospitalization|0|||
130693804|NCT02054715|470505853|FG000|Baseline/Follow-up 1|Changed Mind|1|||
130693805|NCT02054715|470505854|FG001|Baseline/Follow-up 1|Changed Mind|0|||
130693806|NCT02054715|470505853|FG000|Follow-up 2|Lost to Followup|3|||
130693807|NCT02054715|470505854|FG001|Follow-up 2|Lost to Followup|1|||
130693808|NCT02054715|470505853|FG000|Follow-up 2|Refused|3|||
130693809|NCT02054715|470505854|FG001|Follow-up 2|Refused|2|||
130693810|NCT02054715|470505853|FG000|Follow-up 2|Followup Not Completed|3|||
130693811|NCT02054715|470505854|FG001|Follow-up 2|Followup Not Completed|4|||
130693812|NCT02054715|470505853|FG000|Follow-up 2|Ineligible|4|||
130693813|NCT02054715|470505854|FG001|Follow-up 2|Ineligible|5|||
130693814|NCT02054715|470505853|FG000|Follow-up 2|Death|3|||
130693815|NCT02054715|470505854|FG001|Follow-up 2|Death|3|||
130693816|NCT02054715|470505853|FG000|Follow-up 2|Hospitalization|0|||
130693817|NCT02054715|470505854|FG001|Follow-up 2|Hospitalization|2|||
130693818|NCT02054715|470505853|FG000|Follow-up 2|Changed MD/Facility|0|||
130693819|NCT02054715|470505854|FG001|Follow-up 2|Changed MD/Facility|1|||
130693820|NCT02054715|470505853|FG000|Follow-up 2|Changed Mind|0|||
130693821|NCT02054715|470505854|FG001|Follow-up 2|Changed Mind|1|||
130693822|NCT02054715|470505853|FG000|Follow-up 2|No Reason|2|||
130693823|NCT02054715|470505854|FG001|Follow-up 2|No Reason|0|||
130693824|NCT02054715|470505853|FG000|Follow-up 2|Treatment Change or Delay|1|||
130693825|NCT02054715|470505854|FG001|Follow-up 2|Treatment Change or Delay|0|||
130693826|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
130693827|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
130693828|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
130693829|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
130693830|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
130693831|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
130693832|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
130693833|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
130693834|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
130693835|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
130693836|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
130693837|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
130693838|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
130693839|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
130693840|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
130693841|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
130693842|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
130693843|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
130693844|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
130693845|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
130693846|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
130693847|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
130901985|NCT00636363|471275283|FG000|Overall Study|Lost to Follow-up|3|||
130901986|NCT00636363|471275284|FG001|Overall Study|Lost to Follow-up|4|||
130901987|NCT00636363|471275285|FG002|Overall Study|Lost to Follow-up|2|||
130901988|NCT00636363|471275283|FG000|Overall Study|Withdrawal by Subject|1|||
130901989|NCT00636363|471275284|FG001|Overall Study|Withdrawal by Subject|3|||
130901990|NCT00636363|471275285|FG002|Overall Study|Withdrawal by Subject|2|||
130901991|NCT00280748|471275287|FG000|Overall Study|Decline in performance|3|||
130901992|NCT00280748|471275287|FG000|Overall Study|Extra-cranial disease progression|1|||
130901993|NCT01433250|471275288|FG000|Overall Study|Protocol Violation|0|||
130901994|NCT01433250|471275289|FG001|Overall Study|Protocol Violation|1|||
131026244|NCT05052996|471725425|FG003|Overall Study|Adverse Event|0|||
130693848|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
130693849|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
130693850|NCT00073307|470505862|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
130693851|NCT00073307|470505863|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
130693852|NCT00073307|470505864|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
130693853|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
130693854|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
130768243|NCT01955109|470775505|FG001|Overall Study|Lost to Follow-up|1|||
130901995|NCT01433250|471275288|FG000|Overall Study|Withdrawal by Subject|3|||
130901996|NCT01433250|471275289|FG001|Overall Study|Withdrawal by Subject|2|||
130901997|NCT00321646|471275292|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
130901998|NCT00321646|471275292|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
130901999|NCT00321646|471275292|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
130902000|NCT00392379|471275293|FG000|Overall Study|Withdrawal by Subject|17|||
130902001|NCT00392379|471275294|FG001|Overall Study|Withdrawal by Subject|28|||
130902002|NCT00392379|471275293|FG000|Overall Study|Lost to Follow-up|4|||
130902003|NCT00392379|471275294|FG001|Overall Study|Lost to Follow-up|9|||
130902004|NCT00392379|471275293|FG000|Overall Study|Adverse Event|1|||
130902005|NCT00392379|471275294|FG001|Overall Study|Adverse Event|1|||
130902006|NCT02730793|471275295|FG000|Overall Study|Physician Decision|0|||
130902007|NCT02730793|471275296|FG001|Overall Study|Physician Decision|1|||
130902008|NCT02730793|471275295|FG000|Overall Study|Withdrawal by Subject|0|||
131026245|NCT05052996|471725422|FG000|Overall Study|Randomized but never treated|0|||
131026246|NCT05052996|471725423|FG001|Overall Study|Randomized but never treated|0|||
131026247|NCT05052996|471725424|FG002|Overall Study|Randomized but never treated|1|||
131026248|NCT05052996|471725425|FG003|Overall Study|Randomized but never treated|1|||
131026249|NCT05052996|471725422|FG000|Overall Study|Protocol Violation|1|||
131026250|NCT05052996|471725423|FG001|Overall Study|Protocol Violation|0|||
131026251|NCT05052996|471725424|FG002|Overall Study|Protocol Violation|0|||
131026252|NCT05052996|471725425|FG003|Overall Study|Protocol Violation|0|||
131026253|NCT00522951|471725426|FG000|Period 1|body motion|0|||
131026254|NCT00522951|471725427|FG001|Period 1|body motion|1|||
131026255|NCT00522951|471725426|FG000|Washout Period|Adverse Event|0|||
131026256|NCT00522951|471725427|FG001|Washout Period|Adverse Event|1|||
131026257|NCT00522951|471725426|FG000|Washout Period|Death|0|||
131026258|NCT00522951|471725427|FG001|Washout Period|Death|1|||
131026259|NCT00522951|471725426|FG000|Period 2|Withdrawal by Subject|1|||
131026260|NCT00522951|471725427|FG001|Period 2|Withdrawal by Subject|0|||
131026261|NCT00522951|471725426|FG000|Period 2|residual contrast medium|1|||
131026262|NCT00522951|471725427|FG001|Period 2|residual contrast medium|1|||
131026263|NCT03101930|471725428|FG000|Overall Study|Withdrawal by Subject|2|||
131026264|NCT03101930|471725429|FG001|Overall Study|Withdrawal by Subject|1|||
131026265|NCT03101930|471725430|FG002|Overall Study|Withdrawal by Subject|2|||
131026266|NCT00976495|471725431|FG000|Overall Study|Withdrawal by Subject|0|||
131026267|NCT00976495|471725432|FG001|Overall Study|Withdrawal by Subject|1|||
131026268|NCT00976495|471725433|FG002|Overall Study|Withdrawal by Subject|0|||
131026269|NCT02538341|471725434|FG000|Overall Study|Lost to Follow-up|51|||
131026270|NCT02538341|471725435|FG001|Overall Study|Lost to Follow-up|46|||
131026271|NCT02538341|471725434|FG000|Overall Study|Withdrawal by Subject|3|||
131026272|NCT02538341|471725435|FG001|Overall Study|Withdrawal by Subject|1|||
131026273|NCT02538341|471725434|FG000|Overall Study|Death|2|||
131026274|NCT02538341|471725435|FG001|Overall Study|Death|0|||
131026275|NCT00331136|471725436|FG000|Overall Study|Adverse Event|3|||
131026276|NCT00331136|471725437|FG001|Overall Study|Adverse Event|5|||
131026277|NCT00331136|471725438|FG002|Overall Study|Adverse Event|0|||
131026278|NCT00331136|471725439|FG003|Overall Study|Adverse Event|1|||
131026279|NCT00331136|471725436|FG000|Overall Study|Withdrawal by Subject|0|||
131026280|NCT00331136|471725437|FG001|Overall Study|Withdrawal by Subject|1|||
131026281|NCT00331136|471725438|FG002|Overall Study|Withdrawal by Subject|0|||
131026282|NCT00331136|471725439|FG003|Overall Study|Withdrawal by Subject|0|||
131026283|NCT00331136|471725436|FG000|Overall Study|Lost to Follow-up|0|||
131026284|NCT00331136|471725437|FG001|Overall Study|Lost to Follow-up|1|||
131026285|NCT00331136|471725438|FG002|Overall Study|Lost to Follow-up|0|||
131026286|NCT00331136|471725439|FG003|Overall Study|Lost to Follow-up|0|||
131026287|NCT00331136|471725436|FG000|Overall Study|Protocol Violation|1|||
131026288|NCT00331136|471725437|FG001|Overall Study|Protocol Violation|0|||
131026289|NCT00331136|471725438|FG002|Overall Study|Protocol Violation|0|||
131026290|NCT00331136|471725439|FG003|Overall Study|Protocol Violation|0|||
131026291|NCT00331136|471725436|FG000|Overall Study|Not treated|1|||
131026292|NCT00331136|471725437|FG001|Overall Study|Not treated|0|||
131026293|NCT00331136|471725438|FG002|Overall Study|Not treated|0|||
131026294|NCT00331136|471725439|FG003|Overall Study|Not treated|0|||
131222731|NCT01333475|472443169|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
130768244|NCT01955109|470775504|FG000|Overall Study|Non-compliance|3|||
130768245|NCT01955109|470775505|FG001|Overall Study|Non-compliance|1|||
130768246|NCT00750919|470775516|FG000|Overall Study|Adverse Event|9|||
131026295|NCT02321514|471725440|FG000|Overall Study|Death|15|||
131026296|NCT02321514|471725440|FG000|Overall Study|Missed Visit|7|||
131026297|NCT02321514|471725440|FG000|Overall Study|Study Exit|3|||
131026298|NCT04484935|471725445|FG000|Overall Study|Other|0|||
130902009|NCT02730793|471275296|FG001|Overall Study|Withdrawal by Subject|1|||
131026299|NCT04484935|471725446|FG001|Overall Study|Other|1|||
131026300|NCT04484935|471725445|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131026301|NCT04484935|471725446|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131026302|NCT04484935|471725445|FG000|Overall Study|Lost to Follow-up|1|||
131026303|NCT04484935|471725446|FG001|Overall Study|Lost to Follow-up|0|||
130902010|NCT02365233|471275297|FG000|Overall Study|IRB withheld the data|1|||
130902011|NCT02365233|471275298|FG001|Overall Study|IRB withheld the data|2|||
130693855|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
130693856|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
130693857|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
130693858|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
130693859|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
130693860|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
130693861|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
130693862|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
130693863|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
130693864|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
130693865|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
130693866|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
130693867|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
130693868|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
130693869|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
130693870|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
130902012|NCT02365233|471275299|FG002|Overall Study|IRB withheld the data|2|||
130902013|NCT00534313|471275301|FG000|Short-term Period|Adverse Event|1|||
130902014|NCT00534313|471275302|FG001|Short-term Period|Adverse Event|2|||
130902015|NCT00534313|471275303|FG002|Short-term Period|Adverse Event|1|||
130693871|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
130693872|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
130693873|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
130693874|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
130693875|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
130693876|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
130693877|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
130693878|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
130693879|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
130693880|NCT00073307|470505862|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
130693881|NCT00073307|470505863|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
130693882|NCT00073307|470505864|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
130693883|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
130693884|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
130693885|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
130693886|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
130693887|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
130693888|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
130693889|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
130693890|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
130693891|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
130693892|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
130693893|NCT01438060|470505865|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
130693894|NCT01438060|470505866|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
130693895|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
130693896|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
130693897|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
130693898|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
130693899|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
130693900|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
130693901|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
130693902|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
130693903|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
130693904|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
130693905|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
130693906|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
130693907|NCT01438060|470505865|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
130693908|NCT01438060|470505866|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
130693909|NCT01438060|470505865|FG000|On Study Beyond Week 140|Adverse Event|0|||
130693910|NCT01438060|470505866|FG001|On Study Beyond Week 140|Adverse Event|2|||
130902016|NCT00534313|471275304|FG003|Short-term Period|Adverse Event|3|||
130693911|NCT01438060|470505865|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
130693912|NCT01438060|470505866|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
130693913|NCT01438060|470505865|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
130902017|NCT00534313|471275301|FG000|Short-term Period|Lack of Efficacy|3|||
130902018|NCT00534313|471275302|FG001|Short-term Period|Lack of Efficacy|4|||
130902019|NCT00534313|471275303|FG002|Short-term Period|Lack of Efficacy|0|||
130902020|NCT00534313|471275304|FG003|Short-term Period|Lack of Efficacy|3|||
130902021|NCT00534313|471275301|FG000|Short-term Period|Participant not meeting study criteria|0|||
130902022|NCT00534313|471275302|FG001|Short-term Period|Participant not meeting study criteria|0|||
130902023|NCT00534313|471275303|FG002|Short-term Period|Participant not meeting study criteria|0|||
131026304|NCT04484935|471725445|FG000|Overall Study|Death|2|||
131026305|NCT04484935|471725446|FG001|Overall Study|Death|1|||
130693914|NCT01438060|470505866|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
130693915|NCT01438060|470505865|FG000|On Study Beyond Week 140|Death|0|||
130693916|NCT01438060|470505866|FG001|On Study Beyond Week 140|Death|1|||
130693917|NCT01438060|470505865|FG000|On Study Beyond Week 140|Other Reason|0|||
130693918|NCT01438060|470505866|FG001|On Study Beyond Week 140|Other Reason|3|||
130693919|NCT01442376|470505867|FG000|Overall Study|Adverse Event|0|||
130693920|NCT01442376|470505868|FG001|Overall Study|Adverse Event|3|||
130693921|NCT01442376|470505869|FG002|Overall Study|Adverse Event|2|||
130693922|NCT01442376|470505867|FG000|Overall Study|Death|0|||
130693923|NCT01442376|470505868|FG001|Overall Study|Death|1|||
130693924|NCT01442376|470505869|FG002|Overall Study|Death|1|||
130693925|NCT01442376|470505867|FG000|Overall Study|Withdrawal of consent|0|||
130693926|NCT01442376|470505868|FG001|Overall Study|Withdrawal of consent|0|||
130693927|NCT01442376|470505869|FG002|Overall Study|Withdrawal of consent|1|||
130693928|NCT01442376|470505867|FG000|Overall Study|Patients not treated|2|||
130693929|NCT01442376|470505868|FG001|Overall Study|Patients not treated|3|||
130693930|NCT01442376|470505869|FG002|Overall Study|Patients not treated|1|||
130693931|NCT01442376|470505867|FG000|Overall Study|Not eligible for subsequent cycles|1|||
130693932|NCT01442376|470505868|FG001|Overall Study|Not eligible for subsequent cycles|2|||
130693933|NCT01442376|470505869|FG002|Overall Study|Not eligible for subsequent cycles|0|||
130693934|NCT03499873|470505870|FG000|Overall Study|Withdrawal by Subject|4|||
130693935|NCT03499873|470505871|FG001|Overall Study|Withdrawal by Subject|6|||
130693936|NCT03499873|470505872|FG002|Overall Study|Withdrawal by Subject|1|||
130693937|NCT03499873|470505870|FG000|Overall Study|Subjects condition worsened|0|||
130693938|NCT03499873|470505871|FG001|Overall Study|Subjects condition worsened|3|||
131026306|NCT03432858|471725448|FG000|Overall Study|Protocol Violation|2|||
131026307|NCT03432858|471725449|FG001|Overall Study|Protocol Violation|1|||
131026308|NCT03432858|471725450|FG002|Overall Study|Protocol Violation|9|||
131026309|NCT03432858|471725448|FG000|Overall Study|Withdrawal by Subject|0|||
131026310|NCT03432858|471725449|FG001|Overall Study|Withdrawal by Subject|1|||
131026311|NCT03432858|471725450|FG002|Overall Study|Withdrawal by Subject|1|||
131026312|NCT03432858|471725448|FG000|Overall Study|Procedure canceled/rescheduled|0|||
131026313|NCT03432858|471725449|FG001|Overall Study|Procedure canceled/rescheduled|9|||
131026314|NCT03432858|471725450|FG002|Overall Study|Procedure canceled/rescheduled|6|||
131026315|NCT03432858|471725448|FG000|Overall Study|Required postop mobilization with splinting|0|||
131026316|NCT03432858|471725449|FG001|Overall Study|Required postop mobilization with splinting|0|||
131026317|NCT03432858|471725450|FG002|Overall Study|Required postop mobilization with splinting|1|||
131026318|NCT01094184|471725453|FG000|Overall Study|Death|35|||
131026319|NCT01094184|471725454|FG001|Overall Study|Death|11|||
131026320|NCT03892564|471725455|FG000|Overall Study|Withdrawal by Subject|2|||
131026321|NCT04402294|471725456|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
131026322|NCT04402294|471725457|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
131026323|NCT04402294|471725456|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
131026324|NCT04402294|471725457|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
131026325|NCT01216176|471727561|FG000|Overall Study|Adverse Event|0|||
131026326|NCT01216176|471727562|FG001|Overall Study|Adverse Event|8|||
131026327|NCT01216176|471727563|FG002|Overall Study|Adverse Event|0|||
131026328|NCT01216176|471727561|FG000|Overall Study|Physician Decision|0|||
131026329|NCT01216176|471727562|FG001|Overall Study|Physician Decision|0|||
131026330|NCT01216176|471727563|FG002|Overall Study|Physician Decision|1|||
131026331|NCT03481660|471727566|FG000|Overall Study|Adverse Event|5|||
131026332|NCT03481660|471727567|FG001|Overall Study|Adverse Event|4|||
131112652|NCT05461794|472042471|FG000|Overall Study|Study Terminated By Sponsor|18|||
131112653|NCT05461794|472042472|FG001|Overall Study|Study Terminated By Sponsor|13|||
131112654|NCT05461794|472042473|FG002|Overall Study|Study Terminated By Sponsor|16|||
130693939|NCT03499873|470505872|FG002|Overall Study|Subjects condition worsened|11|||
130693940|NCT03499873|470505870|FG000|Overall Study|Adverse Event|8|||
130693941|NCT03499873|470505871|FG001|Overall Study|Adverse Event|3|||
130693942|NCT03499873|470505872|FG002|Overall Study|Adverse Event|6|||
130693943|NCT03499873|470505870|FG000|Overall Study|Physician Decision|1|||
130693944|NCT03499873|470505871|FG001|Overall Study|Physician Decision|0|||
130693945|NCT03499873|470505872|FG002|Overall Study|Physician Decision|0|||
130693946|NCT03499873|470505870|FG000|Overall Study|Administrative reasons|0|||
130693947|NCT03499873|470505871|FG001|Overall Study|Administrative reasons|1|||
131026333|NCT03481660|471727566|FG000|Overall Study|Death|13|||
131026334|NCT03481660|471727567|FG001|Overall Study|Death|9|||
131026335|NCT03481660|471727566|FG000|Overall Study|Lost to Follow-up|2|||
131026336|NCT03481660|471727567|FG001|Overall Study|Lost to Follow-up|2|||
131112655|NCT05461794|472042471|FG000|Overall Study|Death|20|||
131112656|NCT05461794|472042472|FG001|Overall Study|Death|5|||
131112657|NCT05461794|472042473|FG002|Overall Study|Death|19|||
131112658|NCT00467285|472042474|FG000|Overall Study|Lost to Follow-up|4|||
131112659|NCT00467285|472042475|FG001|Overall Study|Lost to Follow-up|4|||
131112660|NCT01658826|472042487|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
131112661|NCT01658826|472042488|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
131112662|NCT01658826|472042487|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
131112663|NCT01658826|472042488|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
131112664|NCT01658826|472042487|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
131112665|NCT01658826|472042488|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
131112666|NCT01658826|472042487|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
131112667|NCT01658826|472042488|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
131112668|NCT01658826|472042487|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
131112669|NCT01658826|472042488|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
131112670|NCT01658826|472042487|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
131112671|NCT01658826|472042488|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
131112672|NCT01658826|472042487|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
131112673|NCT01658826|472042488|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
131112674|NCT01658826|472042487|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
131112675|NCT01658826|472042488|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
131112676|NCT01658826|472042487|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
131112677|NCT01658826|472042488|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
131112678|NCT01422850|472042491|FG000|Overall Study|Physician Decision|3|||
131112679|NCT04484831|472042492|FG000|Overall Study|Withdrawal by Subject|1|||
131112680|NCT04484831|472042493|FG001|Overall Study|Withdrawal by Subject|0|||
131112681|NCT02244996|472042494|FG000|Overall Study|Lack of Efficacy|2|||
131112682|NCT02244996|472042495|FG001|Overall Study|Lack of Efficacy|6|||
131112683|NCT01335009|472042496|FG000|Overall Study|Too ill to travel to study sites|1|||
131112684|NCT01335009|472042497|FG001|Overall Study|Too ill to travel to study sites|0|||
131112685|NCT01335009|472042496|FG000|Overall Study|Death|28|||
131112686|NCT01335009|472042497|FG001|Overall Study|Death|32|||
131112687|NCT01335009|472042496|FG000|Overall Study|Withdrawal by Subject|1|||
131112688|NCT01335009|472042497|FG001|Overall Study|Withdrawal by Subject|1|||
131112689|NCT01335009|472042496|FG000|Overall Study|Lost to Follow-up|1|||
131112690|NCT01335009|472042497|FG001|Overall Study|Lost to Follow-up|0|||
131112691|NCT04821869|472042498|FG000|Overall Study|Adverse Event|4|||
131112692|NCT04821869|472042498|FG000|Overall Study|Withdrawal by Subject|2|||
131112693|NCT04821869|472042498|FG000|Overall Study|Did not meet FEV1 criteria|1|||
131112694|NCT00658684|472042499|FG000|Overall Study|Adverse Event|10|||
131112695|NCT00658684|472042500|FG001|Overall Study|Adverse Event|8|||
131112696|NCT00658684|472042501|FG002|Overall Study|Adverse Event|2|||
131112697|NCT00658684|472042502|FG003|Overall Study|Adverse Event|0|||
131026337|NCT03481660|471727566|FG000|Overall Study|Physician Decision|2|||
131026338|NCT03481660|471727567|FG001|Overall Study|Physician Decision|3|||
131026339|NCT03481660|471727566|FG000|Overall Study|Withdrawal by Subject|14|||
131026340|NCT03481660|471727567|FG001|Overall Study|Withdrawal by Subject|7|||
131026341|NCT01259401|471727568|FG000|4-month Follow-up|Death|0|||
131026342|NCT01259401|471727569|FG001|4-month Follow-up|Death|1|||
131026343|NCT01259401|471727568|FG000|4-month Follow-up|Lost to Follow-up|0|||
131026344|NCT01259401|471727569|FG001|4-month Follow-up|Lost to Follow-up|1|||
131026345|NCT00212355|471727570|FG000|Overall Study|Adverse Event|1|||
131026346|NCT00212355|471727570|FG000|Overall Study|Withdrawal by Subject|1|||
131026347|NCT00212355|471727570|FG000|Overall Study|A change of address|1|||
131026348|NCT00186992|471727574|FG000|Overall Study|Withdrawal by Subject|5|||
131026349|NCT00186992|471727574|FG000|Overall Study|Physician's discretion|13|||
131026350|NCT00186992|471727574|FG000|Overall Study|PI Discretion|4|||
131026351|NCT00186992|471727574|FG000|Overall Study|Ineligible|2|||
131026352|NCT00186992|471727574|FG000|Overall Study|Lost to Follow-up|2|||
131026353|NCT00186992|471727574|FG000|Overall Study|Still on Study|9|||
131026354|NCT03683069|471727575|FG000|Overall Study|see limitations|12|||
131026355|NCT03683069|471727576|FG001|Overall Study|see limitations|13|||
131112698|NCT00658684|472042499|FG000|Overall Study|Withdrawal by Subject|6|||
131112699|NCT00658684|472042500|FG001|Overall Study|Withdrawal by Subject|4|||
131112700|NCT00658684|472042501|FG002|Overall Study|Withdrawal by Subject|1|||
131112701|NCT00658684|472042502|FG003|Overall Study|Withdrawal by Subject|1|||
131112702|NCT00658684|472042499|FG000|Overall Study|Lack of Efficacy|1|||
131112703|NCT00658684|472042500|FG001|Overall Study|Lack of Efficacy|1|||
131112704|NCT00658684|472042501|FG002|Overall Study|Lack of Efficacy|0|||
131112705|NCT00658684|472042502|FG003|Overall Study|Lack of Efficacy|0|||
131112706|NCT00658684|472042499|FG000|Overall Study|Protocol Violation|1|||
131112707|NCT00658684|472042500|FG001|Overall Study|Protocol Violation|1|||
130902024|NCT00534313|471275304|FG003|Short-term Period|Participant not meeting study criteria|1|||
130902025|NCT00534313|471275301|FG000|Short-term Period|Participant withdrew consent|2|||
130902026|NCT00534313|471275302|FG001|Short-term Period|Participant withdrew consent|0|||
130902027|NCT00534313|471275303|FG002|Short-term Period|Participant withdrew consent|0|||
130902028|NCT00534313|471275304|FG003|Short-term Period|Participant withdrew consent|2|||
131112708|NCT00658684|472042501|FG002|Overall Study|Protocol Violation|0|||
131112709|NCT00658684|472042502|FG003|Overall Study|Protocol Violation|0|||
131112710|NCT00658684|472042499|FG000|Overall Study|Pregnancy|1|||
131112711|NCT00658684|472042500|FG001|Overall Study|Pregnancy|1|||
131112712|NCT00658684|472042501|FG002|Overall Study|Pregnancy|0|||
131112713|NCT00658684|472042502|FG003|Overall Study|Pregnancy|0|||
131112714|NCT00146328|472043948|FG000|Overall Study|Adverse Event|39|||
131112715|NCT00146328|472043949|FG001|Overall Study|Adverse Event|48|||
131112716|NCT00146328|472043950|FG002|Overall Study|Adverse Event|79|||
131026368|NCT03954184|471727581|FG000|Overall Study|Lost to Follow-up|500|||
131026369|NCT03954184|471727582|FG001|Overall Study|Lost to Follow-up|0|||
131026370|NCT03398200|471727583|FG000|Overall Study|Withdrawal by Subject|0|||
131026371|NCT03398200|471727584|FG001|Overall Study|Withdrawal by Subject|1|||
131026372|NCT04941287|471727585|FG000|Overall Study|Rapid decline before starting treatment|3|||
131026373|NCT04941287|471727586|FG001|Overall Study|Rapid decline before starting treatment|1|||
131026374|NCT01649271|471727587|FG000|Overall Study|Progressive disease|4|||
131026375|NCT01649271|471727588|FG001|Overall Study|Progressive disease|5|||
131026376|NCT01649271|471727587|FG000|Overall Study|Other Adverse Event|0|||
131026377|NCT01649271|471727588|FG001|Overall Study|Other Adverse Event|2|||
131026378|NCT01649271|471727587|FG000|Overall Study|Withdrawal by Subject|1|||
131026379|NCT01649271|471727588|FG001|Overall Study|Withdrawal by Subject|0|||
131026380|NCT01649271|471727587|FG000|Overall Study|Other than stated above|1|||
131026381|NCT01649271|471727588|FG001|Overall Study|Other than stated above|0|||
131026382|NCT05644002|471727589|FG000|Overall Study|Lost to Follow-up|1|||
131026383|NCT05644002|471727590|FG001|Overall Study|Lost to Follow-up|2|||
131026384|NCT05644002|471727589|FG000|Overall Study|Withdrawal by Subject|0|||
131026385|NCT05644002|471727590|FG001|Overall Study|Withdrawal by Subject|1|||
131026386|NCT04842500|471727591|FG000|Overall Study|Withdrawal by Subject|4|||
131026387|NCT04842500|471727592|FG001|Overall Study|Withdrawal by Subject|1|||
131026388|NCT04842500|471727593|FG002|Overall Study|Withdrawal by Subject|2|||
131026389|NCT04842500|471727594|FG003|Overall Study|Withdrawal by Subject|3|||
131026390|NCT04842500|471727591|FG000|Overall Study|Protocol Violation|1|||
131026391|NCT04842500|471727592|FG001|Overall Study|Protocol Violation|0|||
131026392|NCT04842500|471727593|FG002|Overall Study|Protocol Violation|0|||
131026393|NCT04842500|471727594|FG003|Overall Study|Protocol Violation|1|||
131026394|NCT05756075|471727597|FG000|Overall Study|Withdrawal by Subject|16|||
131026395|NCT05756075|471727598|FG001|Overall Study|Withdrawal by Subject|9|||
131026396|NCT03821844|471727599|FG000|Overall Study|Death|37|||
131026397|NCT03821844|471727600|FG001|Overall Study|Death|31|||
131026398|NCT03821844|471727599|FG000|Overall Study|Discharged|10|||
131026399|NCT03821844|471727600|FG001|Overall Study|Discharged|14|||
131026400|NCT03821844|471727599|FG000|Overall Study|Not present in facility at followup|2|||
131026401|NCT03821844|471727600|FG001|Overall Study|Not present in facility at followup|3|||
131026402|NCT04065048|471727601|FG000|Overall Study|Withdrawal by Subject|1|||
131026403|NCT04065048|471727602|FG001|Overall Study|Withdrawal by Subject|2|||
131026404|NCT04065048|471727603|FG002|Overall Study|Withdrawal by Subject|1|||
131026405|NCT04065048|471727604|FG003|Overall Study|Withdrawal by Subject|1|||
131026406|NCT04065048|471727601|FG000|Overall Study|Adverse Event|1|||
131026407|NCT04065048|471727602|FG001|Overall Study|Adverse Event|0|||
131026408|NCT04065048|471727603|FG002|Overall Study|Adverse Event|1|||
131026409|NCT04065048|471727604|FG003|Overall Study|Adverse Event|0|||
131026410|NCT05104697|471727606|FG000|Overall Study|Withdrawal by Subject|0|||
131026411|NCT05104697|471727607|FG001|Overall Study|Withdrawal by Subject|1|||
131026412|NCT03845465|471727608|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
131026413|NCT03845465|471727609|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
131026414|NCT03845465|471727608|FG000|6-month Data Collection|Withdrawal by Subject|0|||
131026415|NCT03845465|471727609|FG001|6-month Data Collection|Withdrawal by Subject|2|||
131026416|NCT03845465|471727608|FG000|12-month Data Collection|Withdrawal by Subject|0|||
131026417|NCT03845465|471727609|FG001|12-month Data Collection|Withdrawal by Subject|2|||
131026418|NCT03899961|471727621|FG000|Overall Study|-delivery prior to|2|||
131026419|NCT03899961|471727622|FG001|Overall Study|-delivery prior to|7|||
131026420|NCT03899961|471727621|FG000|Overall Study|req general anesth|1|||
131026421|NCT03899961|471727622|FG001|Overall Study|req general anesth|2|||
131026422|NCT03899961|471727621|FG000|Overall Study|capacity|5|||
131026423|NCT03899961|471727622|FG001|Overall Study|capacity|6|||
131026424|NCT03899961|471727621|FG000|Overall Study|Withdrawal by Subject|1|||
131026425|NCT03899961|471727622|FG001|Overall Study|Withdrawal by Subject|1|||
131026426|NCT04527146|471727623|FG000|Overall Study|Withdrawal by Subject|12|||
131026427|NCT04527146|471727624|FG001|Overall Study|Withdrawal by Subject|15|||
131026428|NCT04527146|471727625|FG002|Overall Study|Withdrawal by Subject|7|||
131026429|NCT04527146|471727626|FG003|Overall Study|Withdrawal by Subject|16|||
131112717|NCT00146328|472043948|FG000|Overall Study|Protocol Violation|11|||
130902029|NCT00534313|471275301|FG000|Short-term Period|Pregnancy|0|||
131026430|NCT04527146|471727623|FG000|Overall Study|Lost to Follow-up|13|||
130693948|NCT03499873|470505872|FG002|Overall Study|Administrative reasons|0|||
130693949|NCT03499873|470505870|FG000|Overall Study|Concomitant therapy|5|||
130693950|NCT03499873|470505871|FG001|Overall Study|Concomitant therapy|4|||
130693951|NCT03499873|470505872|FG002|Overall Study|Concomitant therapy|7|||
130693952|NCT03499873|470505870|FG000|Overall Study|Miscellaneous|1|||
131026431|NCT04527146|471727624|FG001|Overall Study|Lost to Follow-up|9|||
131026432|NCT04527146|471727625|FG002|Overall Study|Lost to Follow-up|16|||
131026433|NCT04527146|471727626|FG003|Overall Study|Lost to Follow-up|13|||
131026434|NCT04527146|471727623|FG000|Overall Study|Death|0|||
131026435|NCT04527146|471727624|FG001|Overall Study|Death|1|||
131026436|NCT04527146|471727625|FG002|Overall Study|Death|1|||
131026437|NCT04527146|471727626|FG003|Overall Study|Death|0|||
131026438|NCT04527146|471727623|FG000|Overall Study|Adverse Event|0|||
130902030|NCT00534313|471275302|FG001|Short-term Period|Pregnancy|0|||
130902031|NCT00534313|471275303|FG002|Short-term Period|Pregnancy|1|||
130902032|NCT00534313|471275304|FG003|Short-term Period|Pregnancy|0|||
130902033|NCT00534313|471275301|FG000|Long-term Period|Adverse Event|2|||
130902034|NCT00534313|471275302|FG001|Long-term Period|Adverse Event|1|||
130902035|NCT00534313|471275303|FG002|Long-term Period|Adverse Event|0|||
130902036|NCT00534313|471275304|FG003|Long-term Period|Adverse Event|1|||
130902037|NCT00534313|471275301|FG000|Long-term Period|Lack of Efficacy|14|||
130902038|NCT00534313|471275302|FG001|Long-term Period|Lack of Efficacy|10|||
130902039|NCT00534313|471275303|FG002|Long-term Period|Lack of Efficacy|14|||
130902040|NCT00534313|471275304|FG003|Long-term Period|Lack of Efficacy|12|||
131026439|NCT04527146|471727624|FG001|Overall Study|Adverse Event|0|||
131026440|NCT04527146|471727625|FG002|Overall Study|Adverse Event|1|||
131026441|NCT04527146|471727626|FG003|Overall Study|Adverse Event|0|||
131026442|NCT04527146|471727623|FG000|Overall Study|Ineligible after randomization|2|||
131026443|NCT04527146|471727624|FG001|Overall Study|Ineligible after randomization|0|||
131026444|NCT04527146|471727625|FG002|Overall Study|Ineligible after randomization|2|||
131026445|NCT04527146|471727626|FG003|Overall Study|Ineligible after randomization|2|||
131026446|NCT04527146|471727623|FG000|Overall Study|Moved to a different group|6|||
131026447|NCT04527146|471727624|FG001|Overall Study|Moved to a different group|3|||
131026448|NCT04527146|471727625|FG002|Overall Study|Moved to a different group|0|||
131026449|NCT04527146|471727626|FG003|Overall Study|Moved to a different group|2|||
131026450|NCT05107401|471727627|FG000|Overall Study|Lost to Follow-up|13|||
131026451|NCT05107401|471727628|FG001|Overall Study|Lost to Follow-up|12|||
131026452|NCT04468776|471727635|FG000|Overall Study|Lost to Follow-up|4|||
131026453|NCT04468776|471727636|FG001|Overall Study|Lost to Follow-up|3|||
131026454|NCT04468776|471727637|FG002|Overall Study|Lost to Follow-up|4|||
131026455|NCT04468776|471727635|FG000|Overall Study|Withdrawal by Subject|1|||
131026456|NCT04468776|471727636|FG001|Overall Study|Withdrawal by Subject|10|||
131026457|NCT04468776|471727637|FG002|Overall Study|Withdrawal by Subject|4|||
131026458|NCT04468776|471727635|FG000|Overall Study|Physician Decision|0|||
131026459|NCT04468776|471727636|FG001|Overall Study|Physician Decision|1|||
131026460|NCT04468776|471727637|FG002|Overall Study|Physician Decision|1|||
131026461|NCT05687903|471727638|FG000|Overall Study|Protocol Deviation|1|||
131026462|NCT05687903|471727639|FG001|Overall Study|Protocol Deviation|1|||
131026463|NCT05687903|471727640|FG002|Overall Study|Protocol Deviation|0|||
131026464|NCT05687903|471727641|FG003|Overall Study|Protocol Deviation|1|||
131026465|NCT05687903|471727642|FG004|Overall Study|Protocol Deviation|0|||
131026466|NCT05613205|471727643|FG000|Overall Study|Lost to Follow-up|0|||
131026467|NCT05613205|471727644|FG001|Overall Study|Lost to Follow-up|0|||
131026468|NCT05613205|471727645|FG002|Overall Study|Lost to Follow-up|1|||
131026469|NCT05613205|471727646|FG003|Overall Study|Lost to Follow-up|1|||
131026470|NCT05613205|471727647|FG004|Overall Study|Lost to Follow-up|0|||
131026471|NCT05613205|471727643|FG000|Overall Study|Withdrawal by Subject|0|||
131026472|NCT05613205|471727644|FG001|Overall Study|Withdrawal by Subject|0|||
131026473|NCT05613205|471727645|FG002|Overall Study|Withdrawal by Subject|1|||
131026474|NCT05613205|471727646|FG003|Overall Study|Withdrawal by Subject|1|||
130693953|NCT03499873|470505871|FG001|Overall Study|Miscellaneous|2|||
130693954|NCT03499873|470505872|FG002|Overall Study|Miscellaneous|2|||
130693955|NCT03499873|470505870|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
130693956|NCT03499873|470505871|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
131026475|NCT05613205|471727647|FG004|Overall Study|Withdrawal by Subject|0|||
131026476|NCT04440176|471727650|FG000|Overall Study|Withdrawal by Subject|5|||
131112718|NCT00146328|472043949|FG001|Overall Study|Protocol Violation|6|||
131026477|NCT04440176|471727651|FG001|Overall Study|Withdrawal by Subject|3|||
131026478|NCT04440176|471727650|FG000|Overall Study|Withdrawal by parent/guardian|4|||
131026479|NCT04440176|471727651|FG001|Overall Study|Withdrawal by parent/guardian|5|||
131026480|NCT04440176|471727650|FG000|Overall Study|Adverse Event|2|||
131026481|NCT04440176|471727651|FG001|Overall Study|Adverse Event|6|||
130902041|NCT00534313|471275301|FG000|Long-term Period|Lost to Follow-up|1|||
130902042|NCT00534313|471275302|FG001|Long-term Period|Lost to Follow-up|2|||
130902043|NCT00534313|471275303|FG002|Long-term Period|Lost to Follow-up|0|||
131026482|NCT04440176|471727650|FG000|Overall Study|Lost to Follow-up|22|||
130693957|NCT03499873|470505872|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
130693958|NCT04631562|470505883|FG000|Overall Study|Withdrawal by Subject|0|||
130693959|NCT04631562|470505884|FG001|Overall Study|Withdrawal by Subject|0|||
130693960|NCT04631562|470505885|FG002|Overall Study|Withdrawal by Subject|0|||
130693961|NCT04631562|470505886|FG003|Overall Study|Withdrawal by Subject|0|||
130693962|NCT04631562|470505887|FG004|Overall Study|Withdrawal by Subject|0|||
130693963|NCT04631562|470505888|FG005|Overall Study|Withdrawal by Subject|0|||
130693964|NCT04631562|470505889|FG006|Overall Study|Withdrawal by Subject|0|||
130693965|NCT04631562|470505890|FG007|Overall Study|Withdrawal by Subject|1|||
130693966|NCT04631562|470505891|FG008|Overall Study|Withdrawal by Subject|0|||
130902044|NCT00534313|471275304|FG003|Long-term Period|Lost to Follow-up|0|||
130902045|NCT00534313|471275301|FG000|Long-term Period|Withdrawal by Subject|2|||
130902046|NCT00534313|471275302|FG001|Long-term Period|Withdrawal by Subject|2|||
130902047|NCT00534313|471275303|FG002|Long-term Period|Withdrawal by Subject|0|||
130902048|NCT00534313|471275304|FG003|Long-term Period|Withdrawal by Subject|0|||
130902049|NCT00534313|471275301|FG000|Long-term Period|No longer meets study criteria|0|||
130902050|NCT00534313|471275302|FG001|Long-term Period|No longer meets study criteria|1|||
130902051|NCT00534313|471275303|FG002|Long-term Period|No longer meets study criteria|0|||
130902052|NCT00534313|471275304|FG003|Long-term Period|No longer meets study criteria|0|||
131026483|NCT04440176|471727651|FG001|Overall Study|Lost to Follow-up|23|||
131026484|NCT04440176|471727650|FG000|Overall Study|Medication error without associated adverse event|0|||
131026485|NCT04440176|471727651|FG001|Overall Study|Medication error without associated adverse event|1|||
131026486|NCT04440176|471727650|FG000|Overall Study|No longer met eligibility criteria|7|||
131026487|NCT04440176|471727651|FG001|Overall Study|No longer met eligibility criteria|1|||
131026488|NCT04440176|471727650|FG000|Overall Study|Other|1|||
131026489|NCT04440176|471727651|FG001|Overall Study|Other|2|||
131026490|NCT04440176|471727650|FG000|Overall Study|Protocol deviation|6|||
131026491|NCT04440176|471727651|FG001|Overall Study|Protocol deviation|8|||
131026492|NCT04440176|471727650|FG000|Overall Study|Randomized but not vaccinated|6|||
131026493|NCT04440176|471727651|FG001|Overall Study|Randomized but not vaccinated|3|||
131026494|NCT04608045|471727658|FG000|Overall Study|Physician Decision|1|||
131026495|NCT03103321|471727660|FG000|Overall Study|Protocol Violation|1|||
131026496|NCT03103321|471727661|FG001|Overall Study|Protocol Violation|1|||
131026497|NCT03103321|471727662|FG002|Overall Study|Protocol Violation|1|||
131026498|NCT03103321|471727663|FG003|Overall Study|Protocol Violation|0|||
131026499|NCT04247542|471727664|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
131026500|NCT04247542|471727665|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
131026501|NCT04247542|471727666|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
131026502|NCT04247542|471727664|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
131026503|NCT04247542|471727665|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
131026504|NCT04247542|471727666|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
131026505|NCT04118452|471727667|FG000|Overall Study|Lost to Follow-up|5|||
131026506|NCT04118452|471727668|FG001|Overall Study|Lost to Follow-up|5|||
131026507|NCT04118452|471727667|FG000|Overall Study|Withdrawal by Subject|17|||
131026508|NCT04118452|471727668|FG001|Overall Study|Withdrawal by Subject|17|||
131026509|NCT04847999|471727669|FG000|Overall Study|Lost to Follow-up|0|||
131026510|NCT04847999|471727670|FG001|Overall Study|Lost to Follow-up|1|||
131026511|NCT02879448|471727671|FG000|Overall Study|Death|251|||
131026512|NCT02879448|471727672|FG001|Overall Study|Death|263|||
131026513|NCT02879448|471727671|FG000|Overall Study|Lost to Follow-up|23|||
131026514|NCT02879448|471727672|FG001|Overall Study|Lost to Follow-up|28|||
131026515|NCT02879448|471727671|FG000|Overall Study|Withdrawal by Subject|42|||
131026516|NCT02879448|471727672|FG001|Overall Study|Withdrawal by Subject|79|||
131026517|NCT02879448|471727671|FG000|Overall Study|Other Reasons|8|||
131026518|NCT02879448|471727672|FG001|Overall Study|Other Reasons|12|||
131026519|NCT05952076|471727673|FG000|Overall Study|Death|1|||
131026520|NCT05952076|471727674|FG001|Overall Study|Death|1|||
131026521|NCT05952076|471727673|FG000|Overall Study|Lost to Follow-up|0|||
131026522|NCT05952076|471727674|FG001|Overall Study|Lost to Follow-up|1|||
131026523|NCT05288283|471727675|FG000|Overall Study|Study Terminated Early|1|||
131026524|NCT05288283|471727676|FG001|Overall Study|Study Terminated Early|1|||
130693967|NCT04631562|470505883|FG000|Overall Study|Other|0|||
130693968|NCT04631562|470505884|FG001|Overall Study|Other|0|||
130693969|NCT04631562|470505885|FG002|Overall Study|Other|0|||
131112719|NCT00146328|472043950|FG002|Overall Study|Protocol Violation|12|||
130693970|NCT04631562|470505886|FG003|Overall Study|Other|0|||
130693971|NCT04631562|470505887|FG004|Overall Study|Other|0|||
130693972|NCT04631562|470505888|FG005|Overall Study|Other|0|||
130693973|NCT04631562|470505889|FG006|Overall Study|Other|0|||
130693974|NCT04631562|470505890|FG007|Overall Study|Other|0|||
131112720|NCT00146328|472043948|FG000|Overall Study|Lost to Follow-up|7|||
131112721|NCT00146328|472043949|FG001|Overall Study|Lost to Follow-up|4|||
131112722|NCT00146328|472043950|FG002|Overall Study|Lost to Follow-up|7|||
131112723|NCT00146328|472043948|FG000|Overall Study|Withdrawal by Subject|16|||
130902053|NCT00534313|471275301|FG000|Long-term Period|Poor compliance/noncompliance|0|||
130902054|NCT00534313|471275302|FG001|Long-term Period|Poor compliance/noncompliance|1|||
130902055|NCT00534313|471275303|FG002|Long-term Period|Poor compliance/noncompliance|1|||
130902056|NCT00534313|471275304|FG003|Long-term Period|Poor compliance/noncompliance|0|||
130902057|NCT00534313|471275301|FG000|Long-term Period|Administrative reason by sponsor|17|||
130902058|NCT00534313|471275302|FG001|Long-term Period|Administrative reason by sponsor|15|||
130902059|NCT00534313|471275303|FG002|Long-term Period|Administrative reason by sponsor|26|||
130902060|NCT00534313|471275304|FG003|Long-term Period|Administrative reason by sponsor|18|||
130902061|NCT00534313|471275301|FG000|Long-term Period|Other|1|||
130902062|NCT00534313|471275302|FG001|Long-term Period|Other|2|||
130902063|NCT00534313|471275303|FG002|Long-term Period|Other|2|||
130902064|NCT00534313|471275304|FG003|Long-term Period|Other|2|||
130902065|NCT03007888|471275306|FG000|First Intervention (14 Days)|Adverse Event|1|||
130902066|NCT03007888|471275307|FG001|First Intervention (14 Days)|Adverse Event|0|||
130902067|NCT00927940|471275308|FG000|Overall Study|Death|1|||
130902068|NCT00043550|471275311|FG000|Overall Study|Withdrawal by Subject|22|||
130902069|NCT00043550|471275312|FG001|Overall Study|Withdrawal by Subject|12|||
130902070|NCT00043550|471275313|FG002|Overall Study|Withdrawal by Subject|20|||
130902071|NCT00827931|471275315|FG000|Overall Study|Death|3|||
130902072|NCT00827931|471275316|FG001|Overall Study|Death|5|||
130902073|NCT00827931|471275315|FG000|Overall Study|Adverse Event|1|||
130902074|NCT00827931|471275316|FG001|Overall Study|Adverse Event|0|||
130902075|NCT00827931|471275315|FG000|Overall Study|Lost to Follow-up|1|||
130902076|NCT00827931|471275316|FG001|Overall Study|Lost to Follow-up|0|||
130902077|NCT00827931|471275315|FG000|Overall Study|Withdrawal by Subject|0|||
130902078|NCT00827931|471275316|FG001|Overall Study|Withdrawal by Subject|1|||
130902079|NCT00827931|471275315|FG000|Overall Study|Other|1|||
130902080|NCT00827931|471275316|FG001|Overall Study|Other|0|||
130902081|NCT00995566|471275317|FG000|Overall Study|Adverse Event|2|||
130902082|NCT00995566|471275317|FG000|Overall Study|Early study termination|52|||
130902083|NCT00436501|471275320|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
130902084|NCT00436501|471275321|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
130902085|NCT00436501|471275320|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
130902086|NCT00436501|471275321|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
130902087|NCT03612856|471275324|FG000|Pre-dose Period|Physician Decision|0|||
130902088|NCT03612856|471275325|FG001|Pre-dose Period|Physician Decision|1|||
130902089|NCT03612856|471275326|FG002|Pre-dose Period|Physician Decision|1|||
130902090|NCT03612856|471275324|FG000|Pre-dose Period|Withdrawal by Subject|0|||
130902091|NCT03612856|471275325|FG001|Pre-dose Period|Withdrawal by Subject|1|||
131112724|NCT00146328|472043949|FG001|Overall Study|Withdrawal by Subject|16|||
131112725|NCT00146328|472043950|FG002|Overall Study|Withdrawal by Subject|22|||
131112726|NCT00146328|472043948|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
131112727|NCT00146328|472043949|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
131112728|NCT00146328|472043950|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
131112729|NCT00146328|472043948|FG000|Overall Study|Trial ended/site closed|8|||
131112730|NCT00146328|472043949|FG001|Overall Study|Trial ended/site closed|2|||
131112731|NCT00146328|472043950|FG002|Overall Study|Trial ended/site closed|19|||
131026539|NCT01704079|471727679|FG000|Overall Study|Withdrawal by Subject|5|||
131026540|NCT01704079|471727680|FG001|Overall Study|Withdrawal by Subject|7|||
131026541|NCT01704079|471727679|FG000|Overall Study|Lost to Follow-up|2|||
131026542|NCT01704079|471727680|FG001|Overall Study|Lost to Follow-up|5|||
131026543|NCT01704079|471727679|FG000|Overall Study|Adverse Event|4|||
131026544|NCT01704079|471727680|FG001|Overall Study|Adverse Event|7|||
131026545|NCT01704079|471727679|FG000|Overall Study|Protocol Violation|1|||
131026546|NCT01704079|471727680|FG001|Overall Study|Protocol Violation|0|||
131026547|NCT01704079|471727679|FG000|Overall Study|Subject noncompliance|2|||
131026548|NCT01704079|471727680|FG001|Overall Study|Subject noncompliance|3|||
131026549|NCT01704079|471727679|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
131026550|NCT01704079|471727680|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
131026551|NCT05986565|471727681|FG000|Overall Study|Lost to Follow-up|8|||
131026552|NCT05986565|471727682|FG001|Overall Study|Lost to Follow-up|3|||
130693975|NCT04631562|470505891|FG008|Overall Study|Other|1|||
130693976|NCT04631562|470505883|FG000|Overall Study|Lost to Follow-up|0|||
130693977|NCT04631562|470505884|FG001|Overall Study|Lost to Follow-up|0|||
130693978|NCT04631562|470505885|FG002|Overall Study|Lost to Follow-up|0|||
130693979|NCT04631562|470505886|FG003|Overall Study|Lost to Follow-up|1|||
130693980|NCT04631562|470505887|FG004|Overall Study|Lost to Follow-up|0|||
130693981|NCT04631562|470505888|FG005|Overall Study|Lost to Follow-up|0|||
130693982|NCT04631562|470505889|FG006|Overall Study|Lost to Follow-up|0|||
130693983|NCT04631562|470505890|FG007|Overall Study|Lost to Follow-up|0|||
130693984|NCT04631562|470505891|FG008|Overall Study|Lost to Follow-up|0|||
130693985|NCT04631562|470505883|FG000|Overall Study|Adverse Event|0|||
130693986|NCT04631562|470505884|FG001|Overall Study|Adverse Event|0|||
130693987|NCT04631562|470505885|FG002|Overall Study|Adverse Event|0|||
130902092|NCT03612856|471275326|FG002|Pre-dose Period|Withdrawal by Subject|0|||
130902093|NCT01576159|471275327|FG000|Overall Study|Withdrawal by Subject|0|||
130902094|NCT01576159|471275328|FG001|Overall Study|Withdrawal by Subject|1|||
130902095|NCT01576159|471275329|FG002|Overall Study|Withdrawal by Subject|0|||
130902096|NCT01576159|471275330|FG003|Overall Study|Withdrawal by Subject|0|||
130902097|NCT01576159|471275327|FG000|Overall Study|Physician Decision|0|||
130902098|NCT01576159|471275328|FG001|Overall Study|Physician Decision|0|||
130902099|NCT01576159|471275329|FG002|Overall Study|Physician Decision|1|||
130902100|NCT01576159|471275330|FG003|Overall Study|Physician Decision|0|||
131112732|NCT00146328|472043948|FG000|Overall Study|Patient decision to end|0|||
131112733|NCT00146328|472043949|FG001|Overall Study|Patient decision to end|1|||
131112734|NCT00146328|472043950|FG002|Overall Study|Patient decision to end|6|||
131112735|NCT00146328|472043948|FG000|Overall Study|Enroll into other trial|2|||
131112736|NCT00146328|472043949|FG001|Overall Study|Enroll into other trial|4|||
131112737|NCT00146328|472043950|FG002|Overall Study|Enroll into other trial|2|||
131112738|NCT00146328|472043948|FG000|Overall Study|Death|0|||
131112739|NCT00146328|472043949|FG001|Overall Study|Death|1|||
131112740|NCT00146328|472043950|FG002|Overall Study|Death|1|||
131112741|NCT00146328|472043948|FG000|Overall Study|Moved|2|||
131112742|NCT00146328|472043949|FG001|Overall Study|Moved|0|||
131112743|NCT00146328|472043950|FG002|Overall Study|Moved|0|||
131112744|NCT00146328|472043948|FG000|Overall Study|Interaction with other medication|2|||
131112745|NCT00146328|472043949|FG001|Overall Study|Interaction with other medication|0|||
131112746|NCT00146328|472043950|FG002|Overall Study|Interaction with other medication|1|||
131112747|NCT00300781|472043951|FG000|Overall Study|Disease Progression|55|||
131112748|NCT00300781|472043952|FG001|Overall Study|Disease Progression|52|||
131112749|NCT00300781|472043951|FG000|Overall Study|Adverse Event|5|||
131112750|NCT00300781|472043952|FG001|Overall Study|Adverse Event|6|||
131112751|NCT00300781|472043951|FG000|Overall Study|Withdrawal by Subject|1|||
131112752|NCT00300781|472043952|FG001|Overall Study|Withdrawal by Subject|2|||
131112753|NCT00300781|472043951|FG000|Overall Study|Physician Decision|1|||
131112754|NCT00300781|472043952|FG001|Overall Study|Physician Decision|0|||
131112755|NCT00300781|472043951|FG000|Overall Study|Not Recorded|0|||
131112756|NCT00300781|472043952|FG001|Overall Study|Not Recorded|1|||
131112757|NCT00300781|472043951|FG000|Overall Study|Symptomatic Deterioration|1|||
131112758|NCT00300781|472043952|FG001|Overall Study|Symptomatic Deterioration|0|||
131112759|NCT00300781|472043951|FG000|Overall Study|Lost to Follow-up|0|||
131112760|NCT00300781|472043952|FG001|Overall Study|Lost to Follow-up|1|||
131112761|NCT02072434|472043953|FG000|Overall Study|Protocol Violation|10|||
131112762|NCT02072434|472043954|FG001|Overall Study|Protocol Violation|9|||
130693988|NCT04631562|470505886|FG003|Overall Study|Adverse Event|0|||
130693989|NCT04631562|470505887|FG004|Overall Study|Adverse Event|0|||
130693990|NCT04631562|470505888|FG005|Overall Study|Adverse Event|0|||
130693991|NCT04631562|470505889|FG006|Overall Study|Adverse Event|1|||
130693992|NCT04631562|470505890|FG007|Overall Study|Adverse Event|0|||
130693993|NCT04631562|470505891|FG008|Overall Study|Adverse Event|0|||
130693994|NCT02436200|470505898|FG000|Overall Study|Significant outlier|1|||
130693995|NCT02471807|470505899|FG000|Overall Study|Death|14|||
130693996|NCT02471807|470505899|FG000|Overall Study|Withdrawal by Subject|2|||
130693997|NCT02471807|470505899|FG000|Overall Study|Explant|5|||
130693998|NCT02471807|470505899|FG000|Overall Study|Lost to Follow-up|1|||
130693999|NCT00957021|470505900|FG000|Overall Study|Death|5|||
130694000|NCT00957021|470505900|FG000|Overall Study|Lost to Follow-up|8|||
130694001|NCT00957021|470505900|FG000|Overall Study|Withdrawal by Subject|34|||
130694002|NCT00957021|470505900|FG000|Overall Study|No 2 yr ROM data|35|||
130694003|NCT00957021|470505900|FG000|Overall Study|Revised study component by 2 yr visit|8|||
130694004|NCT00957021|470505900|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
130694005|NCT00957021|470505900|FG000|Overall Study|Surgery Cancelled|9|||
130694006|NCT00957021|470505900|FG000|Overall Study|Termination due to language issue|2|||
130694007|NCT04025021|470505903|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
130694008|NCT04025021|470505904|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
130694009|NCT01986647|470505905|FG000|Overall Study|Lost to Follow-up|4|||
130694010|NCT01986647|470505906|FG001|Overall Study|Lost to Follow-up|1|||
130694011|NCT01986647|470505907|FG002|Overall Study|Lost to Follow-up|4|||
130694012|NCT01986647|470505908|FG003|Overall Study|Lost to Follow-up|4|||
130694013|NCT01986647|470505905|FG000|Overall Study|Withdrawal by Subject|1|||
130694014|NCT01986647|470505906|FG001|Overall Study|Withdrawal by Subject|3|||
130694015|NCT01986647|470505907|FG002|Overall Study|Withdrawal by Subject|2|||
130694016|NCT01986647|470505908|FG003|Overall Study|Withdrawal by Subject|3|||
130694017|NCT01986647|470505905|FG000|Overall Study|Health|5|||
130694018|NCT01986647|470505906|FG001|Overall Study|Health|3|||
130902101|NCT01576159|471275327|FG000|Overall Study|Lost to Follow-up|0|||
131112763|NCT02072434|472043953|FG000|Overall Study|Physician Decision|5|||
131112764|NCT02072434|472043954|FG001|Overall Study|Physician Decision|10|||
131112765|NCT02072434|472043953|FG000|Overall Study|Adverse event, serious fatal|1|||
131112766|NCT02072434|472043954|FG001|Overall Study|Adverse event, serious fatal|6|||
131112767|NCT02072434|472043953|FG000|Overall Study|Adverse Event|7|||
131112768|NCT02072434|472043954|FG001|Overall Study|Adverse Event|6|||
131112769|NCT02072434|472043953|FG000|Overall Study|Withdrawal by Subject|17|||
131112770|NCT02072434|472043954|FG001|Overall Study|Withdrawal by Subject|29|||
131112771|NCT02072434|472043953|FG000|Overall Study|Other|14|||
130902102|NCT01576159|471275328|FG001|Overall Study|Lost to Follow-up|0|||
130902103|NCT01576159|471275329|FG002|Overall Study|Lost to Follow-up|0|||
131112772|NCT02072434|472043954|FG001|Overall Study|Other|29|||
131112773|NCT02072434|472043953|FG000|Overall Study|Lost to Follow-up|0|||
131112774|NCT02072434|472043954|FG001|Overall Study|Lost to Follow-up|1|||
131112775|NCT02634346|472043955|FG000|Overall Study|Withdrawal by Subject|8|||
131112776|NCT02634346|472043956|FG001|Overall Study|Withdrawal by Subject|9|||
131112777|NCT02634346|472043957|FG002|Overall Study|Withdrawal by Subject|8|||
131112778|NCT02634346|472043955|FG000|Overall Study|Adverse Event|2|||
131112779|NCT02634346|472043956|FG001|Overall Study|Adverse Event|2|||
131112780|NCT02634346|472043957|FG002|Overall Study|Adverse Event|7|||
131112781|NCT02634346|472043955|FG000|Overall Study|Lack of Efficacy|1|||
131112782|NCT02634346|472043956|FG001|Overall Study|Lack of Efficacy|2|||
131112783|NCT02634346|472043957|FG002|Overall Study|Lack of Efficacy|8|||
131112784|NCT02634346|472043955|FG000|Overall Study|Lost to Follow-up|1|||
131112785|NCT02634346|472043956|FG001|Overall Study|Lost to Follow-up|0|||
131112786|NCT02634346|472043957|FG002|Overall Study|Lost to Follow-up|0|||
131112787|NCT02634346|472043955|FG000|Overall Study|Protocol Violation|0|||
131112788|NCT02634346|472043956|FG001|Overall Study|Protocol Violation|1|||
131112789|NCT02634346|472043957|FG002|Overall Study|Protocol Violation|0|||
131112790|NCT02175004|472043958|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
131112791|NCT02175004|472043959|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
131112792|NCT02175004|472043958|FG000|Overall Study|Investigator Judgment|1|||
131112793|NCT02175004|472043959|FG001|Overall Study|Investigator Judgment|4|||
131112794|NCT02175004|472043958|FG000|Overall Study|Voluntary Withdrawal|6|||
131112795|NCT02175004|472043959|FG001|Overall Study|Voluntary Withdrawal|19|||
131112796|NCT02175004|472043958|FG000|Overall Study|Liver Transplant|1|||
131112797|NCT02175004|472043959|FG001|Overall Study|Liver Transplant|0|||
131112798|NCT02175004|472043958|FG000|Overall Study|Disease Progression|1|||
131112799|NCT02175004|472043959|FG001|Overall Study|Disease Progression|0|||
131112800|NCT02175004|472043958|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
131112801|NCT02175004|472043959|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
131112802|NCT02960854|472043960|FG000|Overall Study|Not Disclosed|2|||
131112803|NCT02960854|472043961|FG001|Overall Study|Not Disclosed|2|||
131112804|NCT02960854|472043960|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
131112805|NCT02960854|472043961|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
131112806|NCT02960854|472043960|FG000|Overall Study|Subject Withdrew Consent|0|||
131112807|NCT02960854|472043961|FG001|Overall Study|Subject Withdrew Consent|1|||
131112808|NCT02960854|472043960|FG000|Overall Study|Death|4|||
131112809|NCT02960854|472043961|FG001|Overall Study|Death|6|||
131112810|NCT00221195|472043962|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
131112811|NCT00221195|472043963|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
131112812|NCT00221195|472043962|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
131112813|NCT00221195|472043963|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
131112814|NCT00221195|472043962|FG000|Washout Period (Months 7-9)|Death|0|||
131112815|NCT00221195|472043963|FG001|Washout Period (Months 7-9)|Death|1|||
131112816|NCT00221195|472043962|FG000|Therapy 2 (Months 10-15)|Death|1|||
131112817|NCT00221195|472043963|FG001|Therapy 2 (Months 10-15)|Death|0|||
130694019|NCT01986647|470505907|FG002|Overall Study|Health|6|||
130694020|NCT01986647|470505908|FG003|Overall Study|Health|4|||
130694021|NCT02905435|470505909|FG000|Overall Study|Death|2|||
130694022|NCT02905435|470505909|FG000|Overall Study|Physician Decision|1|||
130902104|NCT01576159|471275330|FG003|Overall Study|Lost to Follow-up|1|||
130902105|NCT01576159|471275327|FG000|Overall Study|Protocol Violation|1|||
130902106|NCT01576159|471275328|FG001|Overall Study|Protocol Violation|0|||
130902107|NCT01576159|471275329|FG002|Overall Study|Protocol Violation|0|||
130902108|NCT01576159|471275330|FG003|Overall Study|Protocol Violation|0|||
131112818|NCT00221195|472043962|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
131112819|NCT00221195|472043963|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
131112820|NCT00823901|472043964|FG000|Overall Study|Adverse Event|1|||
131112821|NCT00823901|472043965|FG001|Overall Study|Adverse Event|1|||
131112822|NCT00823901|472043964|FG000|Overall Study|Lack of Efficacy|1|||
131112823|NCT00823901|472043965|FG001|Overall Study|Lack of Efficacy|0|||
130694023|NCT02905435|470505909|FG000|Overall Study|Lost to Follow-up|4|||
130902109|NCT00169442|471275331|FG000|Overall Study|Withdrawal by Subject|0|||
131112824|NCT00823901|472043964|FG000|Overall Study|Lost to Follow-up|2|||
131112825|NCT00823901|472043965|FG001|Overall Study|Lost to Follow-up|1|||
131112826|NCT01369511|472043966|FG000|Overall Study|Adverse Event|1|||
131112827|NCT01369511|472043967|FG001|Overall Study|Adverse Event|1|||
131112828|NCT01369511|472043968|FG002|Overall Study|Adverse Event|5|||
131112829|NCT01369511|472043969|FG003|Overall Study|Adverse Event|0|||
131112830|NCT01369511|472043966|FG000|Overall Study|Entry criteria not met|2|||
131112831|NCT01369511|472043967|FG001|Overall Study|Entry criteria not met|0|||
131112832|NCT01369511|472043968|FG002|Overall Study|Entry criteria not met|0|||
131112833|NCT01369511|472043969|FG003|Overall Study|Entry criteria not met|1|||
131112834|NCT01369511|472043966|FG000|Overall Study|Lost to Follow-up|0|||
131112835|NCT01369511|472043967|FG001|Overall Study|Lost to Follow-up|1|||
130902110|NCT00169442|471275332|FG001|Overall Study|Withdrawal by Subject|0|||
130902111|NCT00169442|471275333|FG002|Overall Study|Withdrawal by Subject|1|||
130694024|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
130694025|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
130694026|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
130694027|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
130694028|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
130694029|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694030|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694031|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694032|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694033|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694034|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694035|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694036|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694037|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694038|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694039|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694040|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694041|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694042|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694043|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694044|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694045|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
130902112|NCT00169442|471275334|FG003|Overall Study|Withdrawal by Subject|0|||
130902113|NCT00169442|471275335|FG004|Overall Study|Withdrawal by Subject|0|||
130902114|NCT00169442|471275336|FG005|Overall Study|Withdrawal by Subject|0|||
130694046|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694047|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694048|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694049|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
130694050|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694051|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
130694052|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694053|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694054|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694055|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694056|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694057|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694058|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694059|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694060|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694061|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694062|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694063|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694064|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694065|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694066|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694067|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694068|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131026553|NCT05986565|471727681|FG000|Overall Study|Withdrawal by Subject|0|||
131026554|NCT05986565|471727682|FG001|Overall Study|Withdrawal by Subject|1|||
131026555|NCT02991807|471727684|FG000|Overall Study|Withdrawal by Subject|2|||
131026556|NCT02991807|471727685|FG001|Overall Study|Withdrawal by Subject|1|||
131026557|NCT02991807|471727684|FG000|Overall Study|Physician Decision|0|||
131026558|NCT02991807|471727685|FG001|Overall Study|Physician Decision|1|||
131026559|NCT02991807|471727684|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
131026560|NCT02991807|471727685|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
131026561|NCT00792636|471727687|FG000|Overall Study|Protocol Violation|17|||
131026562|NCT00792636|471727688|FG001|Overall Study|Protocol Violation|23|||
131026563|NCT00792636|471727689|FG002|Overall Study|Protocol Violation|20|||
131026564|NCT00792636|471727687|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
131026565|NCT00792636|471727688|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
131026566|NCT00792636|471727689|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
131026567|NCT00792636|471727687|FG000|Overall Study|Lost to Follow-up|13|||
130902115|NCT00169442|471275331|FG000|Overall Study|Migrated/moved from study area|0|||
131026568|NCT00792636|471727688|FG001|Overall Study|Lost to Follow-up|19|||
131026569|NCT00792636|471727689|FG002|Overall Study|Lost to Follow-up|14|||
130694069|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694070|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131026570|NCT00792636|471727687|FG000|Overall Study|Withdrew Consent|10|||
131026571|NCT00792636|471727688|FG001|Overall Study|Withdrew Consent|13|||
131026572|NCT00792636|471727689|FG002|Overall Study|Withdrew Consent|9|||
130694071|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694072|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
131112836|NCT01369511|472043968|FG002|Overall Study|Lost to Follow-up|1|||
131112837|NCT01369511|472043969|FG003|Overall Study|Lost to Follow-up|2|||
131112838|NCT01369511|472043966|FG000|Overall Study|Protocol Violation|0|||
131112839|NCT01369511|472043967|FG001|Overall Study|Protocol Violation|1|||
131112840|NCT01369511|472043968|FG002|Overall Study|Protocol Violation|0|||
131112841|NCT01369511|472043969|FG003|Overall Study|Protocol Violation|2|||
131112842|NCT01369511|472043966|FG000|Overall Study|Physician Decision|3|||
131112843|NCT01369511|472043967|FG001|Overall Study|Physician Decision|4|||
131112844|NCT01369511|472043968|FG002|Overall Study|Physician Decision|0|||
131112845|NCT01369511|472043969|FG003|Overall Study|Physician Decision|0|||
131112846|NCT01369511|472043966|FG000|Overall Study|Sponsor decision|2|||
131112847|NCT01369511|472043967|FG001|Overall Study|Sponsor decision|0|||
131112848|NCT01369511|472043968|FG002|Overall Study|Sponsor decision|1|||
131112849|NCT01369511|472043969|FG003|Overall Study|Sponsor decision|0|||
131112850|NCT01369511|472043966|FG000|Overall Study|Withdrawal by Subject|5|||
131112851|NCT01369511|472043967|FG001|Overall Study|Withdrawal by Subject|6|||
131112852|NCT01369511|472043968|FG002|Overall Study|Withdrawal by Subject|4|||
131112853|NCT01369511|472043969|FG003|Overall Study|Withdrawal by Subject|6|||
131112854|NCT01376349|472043972|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
131112855|NCT01376349|472043973|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
131112856|NCT01376349|472043974|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
131112857|NCT01376349|472043972|FG000|Raondomized Treatment|Adverse Event|13|||
131112858|NCT01376349|472043973|FG001|Raondomized Treatment|Adverse Event|17|||
131112859|NCT01376349|472043974|FG002|Raondomized Treatment|Adverse Event|14|||
131112860|NCT01376349|472043972|FG000|Raondomized Treatment|Unkown|1|||
131112861|NCT01376349|472043973|FG001|Raondomized Treatment|Unkown|2|||
131112862|NCT01376349|472043974|FG002|Raondomized Treatment|Unkown|1|||
131112863|NCT01376349|472043972|FG000|Raondomized Treatment|Alternative Treatment|0|||
131112864|NCT01376349|472043973|FG001|Raondomized Treatment|Alternative Treatment|0|||
131112865|NCT01376349|472043974|FG002|Raondomized Treatment|Alternative Treatment|1|||
131112866|NCT01180998|472043975|FG000|Overall Study|Poor Vision|0|||
131112867|NCT01180998|472043976|FG001|Overall Study|Poor Vision|2|||
131112868|NCT01180998|472043977|FG002|Overall Study|Poor Vision|2|||
131112869|NCT01180998|472043975|FG000|Overall Study|Lost to Follow-up|0|||
131112870|NCT01180998|472043976|FG001|Overall Study|Lost to Follow-up|0|||
130694073|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694074|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694075|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130694076|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694077|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
130694078|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
131026573|NCT00792636|471727687|FG000|Overall Study|Lack of Efficacy|3|||
131026574|NCT00792636|471727688|FG001|Overall Study|Lack of Efficacy|4|||
131026575|NCT00792636|471727689|FG002|Overall Study|Lack of Efficacy|13|||
131026576|NCT00792636|471727687|FG000|Overall Study|Adverse Event|4|||
131026577|NCT00792636|471727688|FG001|Overall Study|Adverse Event|2|||
131026578|NCT00792636|471727689|FG002|Overall Study|Adverse Event|3|||
131026579|NCT00792636|471727687|FG000|Overall Study|Investigator Discretion|2|||
131026580|NCT00792636|471727688|FG001|Overall Study|Investigator Discretion|0|||
131026581|NCT00792636|471727689|FG002|Overall Study|Investigator Discretion|2|||
131026582|NCT01046136|471727690|FG000|Overall Study|Withdrawal by Subject|0|||
131026583|NCT01046136|471727691|FG001|Overall Study|Withdrawal by Subject|4|||
131026584|NCT01046136|471727690|FG000|Overall Study|Physician Decision|1|||
131026585|NCT01046136|471727691|FG001|Overall Study|Physician Decision|1|||
131026586|NCT01046136|471727690|FG000|Overall Study|Lost to Follow-up|3|||
131026587|NCT01046136|471727691|FG001|Overall Study|Lost to Follow-up|3|||
131026588|NCT04579250|471727692|FG000|Overall Study|Withdrawal by Subject|1|||
131026589|NCT04579250|471727693|FG001|Overall Study|Withdrawal by Subject|1|||
131026590|NCT04579250|471727694|FG002|Overall Study|Withdrawal by Subject|0|||
131026591|NCT04579250|471727692|FG000|Overall Study|Lost to Follow-up|1|||
131026592|NCT04579250|471727693|FG001|Overall Study|Lost to Follow-up|1|||
131026593|NCT04579250|471727694|FG002|Overall Study|Lost to Follow-up|0|||
131026594|NCT04579250|471727692|FG000|Overall Study|Moved from area|0|||
131112871|NCT01180998|472043977|FG002|Overall Study|Lost to Follow-up|1|||
131112872|NCT01180998|472043975|FG000|Overall Study|Protocol Violation|1|||
131112873|NCT01180998|472043976|FG001|Overall Study|Protocol Violation|2|||
131112874|NCT01180998|472043977|FG002|Overall Study|Protocol Violation|0|||
131112875|NCT01180998|472043975|FG000|Overall Study|Withdrawal by Subject|0|||
131112876|NCT01180998|472043976|FG001|Overall Study|Withdrawal by Subject|0|||
131112877|NCT01180998|472043977|FG002|Overall Study|Withdrawal by Subject|1|||
131026595|NCT04579250|471727693|FG001|Overall Study|Moved from area|1|||
131026596|NCT04579250|471727694|FG002|Overall Study|Moved from area|2|||
131026597|NCT00727909|471727695|FG000|Overall Study|Withdrawal by Subject|5|||
131026598|NCT00727909|471727696|FG001|Overall Study|Withdrawal by Subject|11|||
131112878|NCT01180998|472043975|FG000|Overall Study|Poor comfort|3|||
131112879|NCT01180998|472043976|FG001|Overall Study|Poor comfort|0|||
130694079|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694080|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694081|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694082|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694083|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694084|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694085|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694086|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694087|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694088|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694089|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694090|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694091|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694092|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694093|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694094|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130902116|NCT00169442|471275332|FG001|Overall Study|Migrated/moved from study area|0|||
130694095|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694096|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694097|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694098|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694099|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694100|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130902117|NCT00169442|471275333|FG002|Overall Study|Migrated/moved from study area|0|||
130902118|NCT00169442|471275334|FG003|Overall Study|Migrated/moved from study area|0|||
130902119|NCT00169442|471275335|FG004|Overall Study|Migrated/moved from study area|0|||
130902120|NCT00169442|471275336|FG005|Overall Study|Migrated/moved from study area|2|||
130902121|NCT00169442|471275331|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130902122|NCT00169442|471275332|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130902123|NCT00169442|471275333|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130902124|NCT00169442|471275334|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130902125|NCT00169442|471275335|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
130902126|NCT00169442|471275336|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130902127|NCT00169442|471275331|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130902128|NCT00169442|471275332|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
130902129|NCT00169442|471275333|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130902130|NCT00169442|471275334|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130902131|NCT00169442|471275335|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
131026599|NCT00727909|471727697|FG002|Overall Study|Withdrawal by Subject|8|||
131026600|NCT00727909|471727698|FG003|Overall Study|Withdrawal by Subject|5|||
131026601|NCT00727909|471727695|FG000|Overall Study|Death|0|||
131026602|NCT00727909|471727696|FG001|Overall Study|Death|0|||
131026603|NCT00727909|471727697|FG002|Overall Study|Death|1|||
131026604|NCT00727909|471727698|FG003|Overall Study|Death|0|||
131026605|NCT03446157|471727699|FG000|Overall Study|Death|11|||
131026606|NCT03446157|471727700|FG001|Overall Study|Death|9|||
131026607|NCT03446157|471727699|FG000|Overall Study|Lost to Follow-up|0|||
131026608|NCT03446157|471727700|FG001|Overall Study|Lost to Follow-up|1|||
131026609|NCT03446157|471727699|FG000|Overall Study|Withdrawal by Subject|2|||
131026610|NCT03446157|471727700|FG001|Overall Study|Withdrawal by Subject|1|||
131026611|NCT00411151|471727701|FG000|Overall Study|Death|38|||
131026612|NCT00411151|471727701|FG000|Overall Study|Withdrawal by Subject|2|||
131026613|NCT00411151|471727701|FG000|Overall Study|Lost to Follow-up|2|||
131026614|NCT00411151|471727701|FG000|Overall Study|Protocol Violation|1|||
131026615|NCT00411151|471727701|FG000|Overall Study|Trial prematurely closed|4|||
131026616|NCT04110054|471727702|FG000|Overall Study|COVID-19 reason other than AE|0|||
131026617|NCT04110054|471727703|FG001|Overall Study|COVID-19 reason other than AE|0|||
131026618|NCT04110054|471727704|FG002|Overall Study|COVID-19 reason other than AE|2|||
131026619|NCT04110054|471727705|FG003|Overall Study|COVID-19 reason other than AE|0|||
131026620|NCT04110054|471727702|FG000|Overall Study|Withdrawal by Subject|0|||
131026621|NCT04110054|471727703|FG001|Overall Study|Withdrawal by Subject|3|||
131026622|NCT04110054|471727704|FG002|Overall Study|Withdrawal by Subject|2|||
131026623|NCT04110054|471727705|FG003|Overall Study|Withdrawal by Subject|0|||
131026624|NCT04110054|471727702|FG000|Overall Study|Adverse Event|1|||
131026625|NCT04110054|471727703|FG001|Overall Study|Adverse Event|1|||
131026626|NCT04110054|471727704|FG002|Overall Study|Adverse Event|4|||
130902132|NCT00169442|471275336|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130902133|NCT01181986|471275339|FG000|Phase 1|Lost to Follow-up|0|||
130902134|NCT01181986|471275340|FG001|Phase 1|Lost to Follow-up|1|||
131026627|NCT04110054|471727705|FG003|Overall Study|Adverse Event|3|||
131026628|NCT00093015|471727706|FG000|Overall Study|Withdrawal by Subject|194|||
131026629|NCT00093015|471727707|FG001|Overall Study|Withdrawal by Subject|171|||
131026630|NCT00093015|471727706|FG000|Overall Study|Lost to Follow-up|96|||
130902135|NCT01181986|471275341|FG002|Phase 1|Lost to Follow-up|1|||
131026631|NCT00093015|471727707|FG001|Overall Study|Lost to Follow-up|108|||
131026632|NCT00093015|471727706|FG000|Overall Study|Death|375|||
131026633|NCT00093015|471727707|FG001|Overall Study|Death|385|||
131026634|NCT00632203|471727709|FG000|Overall Study|Did not start study treatment|1|||
131026635|NCT00632203|471727710|FG001|Overall Study|Did not start study treatment|0|||
131112880|NCT01180998|472043977|FG002|Overall Study|Poor comfort|4|||
131112881|NCT01180998|472043975|FG000|Overall Study|Poor lens handling|0|||
131112882|NCT01180998|472043976|FG001|Overall Study|Poor lens handling|0|||
131112883|NCT01180998|472043977|FG002|Overall Study|Poor lens handling|2|||
131112884|NCT03871829|472043978|FG000|Overall Study|Lost to Follow-up|0|||
131112885|NCT03871829|472043979|FG001|Overall Study|Lost to Follow-up|1|||
131112886|NCT03871829|472043978|FG000|Overall Study|Withdrawal by Subject|1|||
131112887|NCT03871829|472043979|FG001|Overall Study|Withdrawal by Subject|1|||
131112888|NCT03871829|472043978|FG000|Overall Study|Death|12|||
131112889|NCT03871829|472043979|FG001|Overall Study|Death|8|||
131112890|NCT03871829|472043978|FG000|Overall Study|Study terminated by sponsor|31|||
131112891|NCT03871829|472043979|FG001|Overall Study|Study terminated by sponsor|34|||
131112892|NCT01106014|472043980|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
131112893|NCT01106014|472043981|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
131112894|NCT01106014|472043980|FG000|Overall Study|Adverse Event|78|||
131112895|NCT01106014|472043981|FG001|Overall Study|Adverse Event|42|||
131112896|NCT01106014|472043980|FG000|Overall Study|Withdrawal by Subject|43|||
131112897|NCT01106014|472043981|FG001|Overall Study|Withdrawal by Subject|37|||
131112898|NCT01106014|472043980|FG000|Overall Study|Administrative reason|7|||
131112899|NCT01106014|472043981|FG001|Overall Study|Administrative reason|6|||
131112900|NCT01106014|472043980|FG000|Overall Study|Lost to Follow-up|2|||
131112901|NCT01106014|472043981|FG001|Overall Study|Lost to Follow-up|3|||
131112902|NCT00784693|472043987|FG000|Overall Study|Lost to Follow-up|0|||
131112903|NCT00784693|472043988|FG001|Overall Study|Lost to Follow-up|1|||
131112904|NCT00784693|472043987|FG000|Overall Study|Lack of Efficacy|1|||
131112905|NCT00784693|472043988|FG001|Overall Study|Lack of Efficacy|1|||
131112906|NCT00784693|472043987|FG000|Overall Study|Withdrawal by Subject|0|||
131112907|NCT00784693|472043988|FG001|Overall Study|Withdrawal by Subject|4|||
131112908|NCT00784693|472043987|FG000|Overall Study|Randomized but not Treated|1|||
131112909|NCT00784693|472043988|FG001|Overall Study|Randomized but not Treated|0|||
131112910|NCT00784693|472043987|FG000|Overall Study|Other|1|||
131112911|NCT00784693|472043988|FG001|Overall Study|Other|0|||
131112912|NCT05458479|472043989|FG000|Overall Study|Lost to Follow-up|1|||
131112913|NCT00908232|472043990|FG000|Cycle 1 to 4|Death|5|||
131112914|NCT00908232|472043991|FG001|Cycle 1 to 4|Death|0|||
131112915|NCT00908232|472043992|FG002|Cycle 1 to 4|Death|0|||
130694101|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130694102|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
130694103|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694104|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
130694105|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
130694106|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
130694107|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694108|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694109|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694110|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694111|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694112|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694113|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694114|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694115|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
131026636|NCT02152137|471730339|FG000|Overall Study|Withdrawal by Subject|1|||
131026637|NCT02152137|471730339|FG000|Overall Study|Originally assigned to Arm B|3|||
131026638|NCT03358875|471730340|FG000|Overall Study|Death|409|||
131026639|NCT03358875|471730341|FG001|Overall Study|Death|223|||
131026640|NCT03358875|471730340|FG000|Overall Study|Study Closed by Sponsor|66|||
131026641|NCT03358875|471730341|FG001|Overall Study|Study Closed by Sponsor|29|||
131026642|NCT03358875|471730340|FG000|Overall Study|Withdrawal by Subject|13|||
131026643|NCT03358875|471730341|FG001|Overall Study|Withdrawal by Subject|16|||
131026644|NCT03358875|471730340|FG000|Overall Study|Lost to Follow-up|13|||
131026645|NCT03358875|471730341|FG001|Overall Study|Lost to Follow-up|2|||
131026646|NCT03358875|471730340|FG000|Overall Study|Miscellaneous|33|||
131026647|NCT03358875|471730341|FG001|Overall Study|Miscellaneous|0|||
131112916|NCT00908232|472043993|FG003|Cycle 1 to 4|Death|0|||
131112917|NCT00908232|472043990|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
131112918|NCT00908232|472043991|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
131112919|NCT00908232|472043992|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
131112920|NCT00908232|472043993|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
131112921|NCT00908232|472043990|FG000|Cycle 1 to 4|Progressive Disease|6|||
131112922|NCT00908232|472043991|FG001|Cycle 1 to 4|Progressive Disease|0|||
131112923|NCT00908232|472043992|FG002|Cycle 1 to 4|Progressive Disease|0|||
130902136|NCT01181986|471275339|FG000|Phase 1|Adverse Event|0|||
130902137|NCT01181986|471275340|FG001|Phase 1|Adverse Event|0|||
130902138|NCT01181986|471275341|FG002|Phase 1|Adverse Event|1|||
130902139|NCT01181986|471275339|FG000|Phase 1|Protocol Violation|1|||
130902140|NCT01181986|471275340|FG001|Phase 1|Protocol Violation|0|||
130902141|NCT01181986|471275341|FG002|Phase 1|Protocol Violation|0|||
130902142|NCT01181986|471275339|FG000|Phase 2|Adverse Event|0|||
130902143|NCT01181986|471275340|FG001|Phase 2|Adverse Event|3|||
130902144|NCT01181986|471275341|FG002|Phase 2|Adverse Event|0|||
130902145|NCT01181986|471275339|FG000|Phase 2|Medical condition|0|||
130694116|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694117|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694118|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694119|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694120|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694121|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694122|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694123|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694124|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694125|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694126|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694127|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130694128|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
130694129|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
130694130|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
130694131|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
130694132|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
130694133|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694134|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694135|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694136|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694137|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130768247|NCT00750919|470775516|FG000|Overall Study|Withdrawal by Subject|1|||
130768248|NCT00750919|470775516|FG000|Overall Study|Lack of Efficacy|8|||
130768249|NCT00750919|470775516|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
130768250|NCT00750919|470775516|FG000|Overall Study|Other|36|||
131026648|NCT03358875|471730340|FG000|Overall Study|Remained on Study|1|||
131026649|NCT03358875|471730341|FG001|Overall Study|Remained on Study|0|||
131026650|NCT06194214|471730345|FG000|Overall Study|Adverse Event|1|||
131026651|NCT03433339|471730346|FG000|Overall Study|Lost to Follow-up|2|||
131026652|NCT03433339|471730347|FG001|Overall Study|Lost to Follow-up|0|||
131026653|NCT03433339|471730346|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
131026654|NCT03433339|471730347|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
131026655|NCT03433339|471730346|FG000|Overall Study|Withdrawal by Subject|0|||
131026656|NCT03433339|471730347|FG001|Overall Study|Withdrawal by Subject|2|||
131026657|NCT04732494|471730358|FG000|Overall Study|Death|39|||
131026658|NCT04732494|471730359|FG001|Overall Study|Death|36|||
131026659|NCT04732494|471730358|FG000|Overall Study|Study Closed by Sponsor|20|||
131026660|NCT04732494|471730359|FG001|Overall Study|Study Closed by Sponsor|15|||
131026661|NCT04732494|471730358|FG000|Overall Study|Withdrawal by Subject|2|||
131026662|NCT04732494|471730359|FG001|Overall Study|Withdrawal by Subject|7|||
131026663|NCT04732494|471730358|FG000|Overall Study|Lost to Follow-up|1|||
131026664|NCT04732494|471730359|FG001|Overall Study|Lost to Follow-up|5|||
131026665|NCT05136404|471730360|FG000|Period 1|Adverse Event|0|||
131026666|NCT05136404|471730361|FG001|Period 1|Adverse Event|1|||
131026667|NCT05136404|471730362|FG002|Period 1|Adverse Event|1|||
131026668|NCT05136404|471730360|FG000|Period 2|Inappropriate Behavior|0|||
131026669|NCT05136404|471730361|FG001|Period 2|Inappropriate Behavior|0|||
131026670|NCT05136404|471730362|FG002|Period 2|Inappropriate Behavior|1|||
131026671|NCT05136404|471730360|FG000|Period 3|Adverse Event|0|||
131026672|NCT05136404|471730361|FG001|Period 3|Adverse Event|0|||
131026673|NCT05136404|471730362|FG002|Period 3|Adverse Event|1|||
131026674|NCT00448669|471730364|FG000|Overall Study|Lost to Follow-up|52|||
131026675|NCT00448669|471730365|FG001|Overall Study|Lost to Follow-up|63|||
131026676|NCT00448669|471730364|FG000|Overall Study|Withdrawal by Subject|90|||
130902146|NCT01181986|471275340|FG001|Phase 2|Medical condition|1|||
131026677|NCT00448669|471730365|FG001|Overall Study|Withdrawal by Subject|74|||
131112924|NCT00908232|472043993|FG003|Cycle 1 to 4|Progressive Disease|0|||
130694138|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694139|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130902147|NCT01181986|471275341|FG002|Phase 2|Medical condition|0|||
130902148|NCT00311584|471275342|FG000|Overall Study|Death|1|||
130902149|NCT00311584|471275343|FG001|Overall Study|Death|0|||
131026678|NCT00448669|471730364|FG000|Overall Study|Relocated|49|||
131026679|NCT00448669|471730365|FG001|Overall Study|Relocated|36|||
131026680|NCT00448669|471730364|FG000|Overall Study|Were withdrawn by investigator|10|||
131026681|NCT00448669|471730365|FG001|Overall Study|Were withdrawn by investigator|6|||
131026682|NCT00448669|471730364|FG000|Overall Study|Death|2|||
131026683|NCT00448669|471730365|FG001|Overall Study|Death|4|||
131026684|NCT00448669|471730364|FG000|Overall Study|Had other reasons|5|||
131026685|NCT00448669|471730365|FG001|Overall Study|Had other reasons|6|||
131026686|NCT00448669|471730364|FG000|Overall Study|HIV-infected at enrollment|1|||
131026687|NCT00448669|471730365|FG001|Overall Study|HIV-infected at enrollment|2|||
131026688|NCT00448669|471730364|FG000|Overall Study|Never started drug|9|||
131026689|NCT00448669|471730365|FG001|Overall Study|Never started drug|7|||
131026690|NCT04287985|471730366|FG000|Overall Study|Adverse Event|1|||
131112925|NCT00908232|472043990|FG000|Cycle 1 to 4|Adverse Event|12|||
131112926|NCT00908232|472043991|FG001|Cycle 1 to 4|Adverse Event|0|||
131112927|NCT00908232|472043992|FG002|Cycle 1 to 4|Adverse Event|0|||
131112928|NCT00908232|472043993|FG003|Cycle 1 to 4|Adverse Event|0|||
131112929|NCT00908232|472043990|FG000|Cycle 1 to 4|Other|1|||
131112930|NCT00908232|472043991|FG001|Cycle 1 to 4|Other|0|||
131112931|NCT00908232|472043992|FG002|Cycle 1 to 4|Other|0|||
131112932|NCT00908232|472043993|FG003|Cycle 1 to 4|Other|0|||
131112933|NCT00908232|472043990|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
131112934|NCT00908232|472043991|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
131112935|NCT00908232|472043992|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
131112936|NCT00908232|472043993|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
131112937|NCT00908232|472043990|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
131112938|NCT00908232|472043991|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
131112939|NCT00908232|472043992|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
131112940|NCT00908232|472043993|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
131112941|NCT00908232|472043990|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
131112942|NCT00908232|472043991|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
131112943|NCT00908232|472043992|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
131112944|NCT00908232|472043993|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
131026691|NCT04287985|471730367|FG001|Overall Study|Adverse Event|0|||
131026692|NCT04287985|471730368|FG002|Overall Study|Adverse Event|0|||
131026693|NCT04287985|471730369|FG003|Overall Study|Adverse Event|0|||
131026694|NCT04287985|471730366|FG000|Overall Study|Protocol Violation|0|||
131026695|NCT04287985|471730367|FG001|Overall Study|Protocol Violation|1|||
131026696|NCT04287985|471730368|FG002|Overall Study|Protocol Violation|0|||
131112945|NCT00908232|472043990|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
131112946|NCT00908232|472043991|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
131112947|NCT00908232|472043992|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
131112948|NCT00908232|472043993|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
131112949|NCT00908232|472043990|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
131112950|NCT00908232|472043991|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
131112951|NCT00908232|472043992|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
131112952|NCT00908232|472043993|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
131112953|NCT00908232|472043990|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
130694140|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694141|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694142|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694143|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
131026697|NCT04287985|471730369|FG003|Overall Study|Protocol Violation|0|||
131026698|NCT04287985|471730366|FG000|Overall Study|Physician Decision|0|||
131026699|NCT04287985|471730367|FG001|Overall Study|Physician Decision|0|||
131026700|NCT04287985|471730368|FG002|Overall Study|Physician Decision|0|||
130694144|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694145|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694146|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694147|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694148|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694149|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694150|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694151|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694152|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694153|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130694154|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|moved|0|||
130694155|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|moved|1|||
130694156|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|moved|1|||
130694157|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|moved|0|||
131026701|NCT04287985|471730369|FG003|Overall Study|Physician Decision|1|||
131112954|NCT00908232|472043991|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
131112955|NCT00908232|472043992|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
131112956|NCT00908232|472043993|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
131112957|NCT00908232|472043990|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
131112958|NCT00908232|472043991|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
131112959|NCT00908232|472043992|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
131112960|NCT00908232|472043993|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
131112961|NCT00908232|472043990|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
131112962|NCT00908232|472043991|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
131112963|NCT00908232|472043992|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
131112964|NCT00908232|472043993|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
131112965|NCT02260882|472043994|FG000|Overall Study|Protocol Violation|0|||
131112966|NCT02260882|472043995|FG001|Overall Study|Protocol Violation|1|||
131112967|NCT02119325|472043996|FG000|Washout Period 1|Adverse Event|0|||
131112968|NCT02119325|472043997|FG001|Washout Period 1|Adverse Event|1|||
131112969|NCT01386658|472043998|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
131112970|NCT01386658|472043999|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
131112971|NCT01386658|472043998|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
131112972|NCT01386658|472043999|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
131112973|NCT00954174|472044005|FG000|Overall Study|Adverse Event|28|||
131112974|NCT00954174|472044006|FG001|Overall Study|Adverse Event|23|||
131112975|NCT00954174|472044007|FG002|Overall Study|Adverse Event|4|||
131112976|NCT00954174|472044008|FG003|Overall Study|Adverse Event|9|||
131112977|NCT00954174|472044005|FG000|Overall Study|Death|4|||
131112978|NCT00954174|472044006|FG001|Overall Study|Death|2|||
131112979|NCT00954174|472044007|FG002|Overall Study|Death|0|||
131112980|NCT00954174|472044008|FG003|Overall Study|Death|0|||
131112981|NCT00954174|472044005|FG000|Overall Study|Lack of Efficacy|32|||
131112982|NCT00954174|472044006|FG001|Overall Study|Lack of Efficacy|22|||
131112983|NCT00954174|472044007|FG002|Overall Study|Lack of Efficacy|8|||
131112984|NCT00954174|472044008|FG003|Overall Study|Lack of Efficacy|6|||
131112985|NCT00954174|472044005|FG000|Overall Study|Withdrawal by Subject|14|||
131112986|NCT00954174|472044006|FG001|Overall Study|Withdrawal by Subject|10|||
131112987|NCT00954174|472044007|FG002|Overall Study|Withdrawal by Subject|4|||
131112988|NCT00954174|472044008|FG003|Overall Study|Withdrawal by Subject|3|||
131112989|NCT00954174|472044005|FG000|Overall Study|Medical Reason|4|||
131112990|NCT00954174|472044006|FG001|Overall Study|Medical Reason|2|||
131112991|NCT00954174|472044007|FG002|Overall Study|Medical Reason|1|||
131112992|NCT00954174|472044008|FG003|Overall Study|Medical Reason|0|||
131112993|NCT00954174|472044005|FG000|Overall Study|Ineligible|40|||
131112994|NCT00954174|472044006|FG001|Overall Study|Ineligible|47|||
131112995|NCT00954174|472044007|FG002|Overall Study|Ineligible|7|||
131112996|NCT00954174|472044008|FG003|Overall Study|Ineligible|4|||
131112997|NCT00954174|472044005|FG000|Overall Study|Never Treated|4|||
131112998|NCT00954174|472044006|FG001|Overall Study|Never Treated|17|||
131112999|NCT00954174|472044007|FG002|Overall Study|Never Treated|0|||
131113000|NCT00954174|472044008|FG003|Overall Study|Never Treated|3|||
131113001|NCT04209621|472044011|FG000|Overall Study|Death|1|||
131113002|NCT04209621|472044011|FG000|Overall Study|Study Terminated Early|2|||
131113003|NCT02249767|472044012|FG000|Overall Study|Did not use medication|8|||
131113004|NCT02249767|472044013|FG001|Overall Study|Did not use medication|9|||
131113005|NCT02249767|472044014|FG002|Overall Study|Did not use medication|8|||
131113006|NCT01372410|472044015|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
131113007|NCT01372410|472044016|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
131113008|NCT01372410|472044017|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
131113009|NCT01372410|472044018|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
131113010|NCT01372410|472044019|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
131113011|NCT01372410|472044020|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
131113012|NCT01372410|472044021|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
131113013|NCT01372410|472044022|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
131113014|NCT01372410|472044015|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
131113015|NCT01372410|472044016|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
131113016|NCT01372410|472044017|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
130694158|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|moved|0|||
130694159|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|moved|0|||
131113017|NCT01372410|472044018|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
131113018|NCT01372410|472044019|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
131113019|NCT01372410|472044020|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
130694160|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|moved|0|||
130694161|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|moved|0|||
131113020|NCT01372410|472044021|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
131113021|NCT01372410|472044022|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
131113022|NCT01372410|472044015|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131113023|NCT01372410|472044016|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130694162|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|moved|0|||
131113024|NCT01372410|472044017|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131113025|NCT01372410|472044018|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131113026|NCT01372410|472044019|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
131113027|NCT01372410|472044020|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131113028|NCT01372410|472044021|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130694163|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|moved|0|||
130694164|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|moved|0|||
130694165|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|moved|0|||
130902150|NCT00311584|471275342|FG000|Overall Study|Lack of Efficacy|12|||
130902151|NCT00311584|471275343|FG001|Overall Study|Lack of Efficacy|15|||
130694166|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|moved|0|||
130694167|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|moved|0|||
130902152|NCT00311584|471275342|FG000|Overall Study|Physician Decision|4|||
131026702|NCT04287985|471730366|FG000|Overall Study|Withdrawal by Subject|2|||
131026703|NCT04287985|471730367|FG001|Overall Study|Withdrawal by Subject|1|||
131026704|NCT04287985|471730368|FG002|Overall Study|Withdrawal by Subject|1|||
131026705|NCT04287985|471730369|FG003|Overall Study|Withdrawal by Subject|2|||
131026706|NCT01340066|471730374|FG000|Placebo Run in Period|Screen Failures|27|||
131026707|NCT01340066|471730375|FG001|Placebo Run in Period|Screen Failures|0|||
131026708|NCT01340066|471730376|FG002|Placebo Run in Period|Screen Failures|0|||
131026709|NCT01340066|471730374|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
131026710|NCT01340066|471730375|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
131026711|NCT01340066|471730376|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
131026712|NCT01340066|471730374|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
131026713|NCT01340066|471730375|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
131026714|NCT01340066|471730376|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
131026715|NCT01340066|471730374|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
131026716|NCT01340066|471730375|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
131026717|NCT01340066|471730376|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
131026718|NCT02789020|471730377|FG000|Overall Study|Withdrawal by Subject|6|||
131026719|NCT02789020|471730378|FG001|Overall Study|Withdrawal by Subject|5|||
131026720|NCT03771352|471730394|FG000|Overall Study|Screen failure|2|||
131026721|NCT03771352|471730394|FG000|Overall Study|Withdrawal by Subject|2|||
131026722|NCT03338816|471730399|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
131026723|NCT03338816|471730400|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
131026724|NCT03338816|471730401|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
131026725|NCT03338816|471730402|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
131026726|NCT03338816|471730399|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
131026727|NCT03338816|471730400|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
131026728|NCT03338816|471730401|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
131026729|NCT03338816|471730402|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
131026730|NCT03338816|471730399|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
131026731|NCT03338816|471730400|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
131026732|NCT03338816|471730401|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
131026733|NCT03338816|471730402|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
131026734|NCT03338816|471730399|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
131026735|NCT03338816|471730400|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
131026736|NCT03338816|471730401|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
131026737|NCT03338816|471730402|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
131026738|NCT03338816|471730399|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
131026739|NCT03338816|471730400|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
131026740|NCT03338816|471730401|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
131026741|NCT03338816|471730402|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
131026742|NCT03338816|471730399|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
131026743|NCT03338816|471730400|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
131026744|NCT03338816|471730401|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
131026745|NCT03338816|471730402|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
131026746|NCT03338816|471730399|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
131026747|NCT03338816|471730400|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
131026748|NCT03338816|471730401|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
131026749|NCT03338816|471730402|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
131026750|NCT04238247|471730408|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
131026751|NCT04238247|471730409|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
131026752|NCT04238247|471730410|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
131026753|NCT04238247|471730411|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
131026754|NCT04238247|471730408|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
131026755|NCT04238247|471730409|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
131026756|NCT04238247|471730410|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
131026757|NCT04238247|471730411|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
130694168|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|moved|0|||
130694169|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|moved|0|||
130694170|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|moved|0|||
130694171|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|moved|0|||
130694172|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|moved|0|||
130694173|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|moved|0|||
130694174|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|moved|0|||
130694175|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|moved|0|||
130694176|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|moved|0|||
130694177|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|moved|0|||
130694178|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|moved|0|||
130694179|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|moved|0|||
130694180|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694181|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694182|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130902153|NCT00311584|471275343|FG001|Overall Study|Physician Decision|5|||
131113029|NCT01372410|472044022|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
131113030|NCT01372410|472044015|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131113031|NCT01372410|472044016|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131113032|NCT01372410|472044017|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131113033|NCT01372410|472044018|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131113034|NCT01372410|472044019|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131113035|NCT01372410|472044020|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131113036|NCT01372410|472044021|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
131113037|NCT01372410|472044022|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
131113038|NCT01372410|472044015|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
131113039|NCT01372410|472044016|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131113040|NCT01372410|472044017|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131113041|NCT01372410|472044018|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131113042|NCT01372410|472044019|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
130902154|NCT00311584|471275342|FG000|Overall Study|Withdrawal by Subject|1|||
130902155|NCT00311584|471275343|FG001|Overall Study|Withdrawal by Subject|1|||
131113043|NCT01372410|472044020|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131113044|NCT01372410|472044021|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
131113045|NCT01372410|472044022|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
131113046|NCT01372410|472044015|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131113047|NCT01372410|472044016|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131113048|NCT01372410|472044017|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131113049|NCT01372410|472044018|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131113050|NCT01372410|472044019|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
131113051|NCT01372410|472044020|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131113052|NCT01372410|472044021|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131113053|NCT01372410|472044022|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
131113054|NCT01372410|472044015|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
131113055|NCT01372410|472044016|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
131113056|NCT01372410|472044017|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
131113057|NCT01372410|472044018|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
131113058|NCT01372410|472044019|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
131113059|NCT01372410|472044020|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
131113060|NCT01372410|472044021|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
131113061|NCT01372410|472044022|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
131113062|NCT01372410|472044015|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131113063|NCT01372410|472044016|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131113064|NCT01372410|472044017|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131113065|NCT01372410|472044018|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131113066|NCT01372410|472044019|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131113067|NCT01372410|472044020|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131113068|NCT01372410|472044021|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
131113069|NCT01372410|472044022|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
131113070|NCT01372410|472044015|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
131113071|NCT01372410|472044016|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
131113072|NCT01372410|472044017|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
131113073|NCT01372410|472044018|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
130694183|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
130694184|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694185|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694186|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694187|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130902156|NCT00311584|471275342|FG000|Overall Study|ineligible|2|||
130902157|NCT00311584|471275343|FG001|Overall Study|ineligible|2|||
130694188|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694189|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131113074|NCT01372410|472044019|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
131113075|NCT01372410|472044020|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
131113076|NCT01372410|472044021|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
131113077|NCT01372410|472044022|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
131113078|NCT01372410|472044015|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131113079|NCT01372410|472044016|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131113080|NCT01372410|472044017|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131113081|NCT01372410|472044018|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131113082|NCT01372410|472044019|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131113083|NCT01372410|472044020|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
131113084|NCT01372410|472044021|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131113085|NCT01372410|472044022|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
131113086|NCT04585646|472044023|FG000|First Intervention|Physician Decision|1|||
131113087|NCT04585646|472044024|FG001|First Intervention|Physician Decision|0|||
131113088|NCT04585646|472044023|FG000|First Intervention|Lost to Follow-up|0|||
131113089|NCT04585646|472044024|FG001|First Intervention|Lost to Follow-up|3|||
131113090|NCT04585646|472044023|FG000|First Intervention|Withdrawal by Subject|0|||
131113091|NCT04585646|472044024|FG001|First Intervention|Withdrawal by Subject|1|||
131113092|NCT02465463|472044026|FG000|Overall Study|Lost to Follow-up|2|||
131113093|NCT02465463|472044027|FG001|Overall Study|Lost to Follow-up|1|||
131113094|NCT02465463|472044026|FG000|Overall Study|Death|1|||
131113095|NCT02465463|472044027|FG001|Overall Study|Death|0|||
131113096|NCT02465463|472044026|FG000|Overall Study|Protocol Violation|1|||
131113097|NCT02465463|472044027|FG001|Overall Study|Protocol Violation|0|||
131113098|NCT01067326|472044030|FG000|Overall Study|Adverse Event|0|||
131113099|NCT01067326|472044031|FG001|Overall Study|Adverse Event|2|||
131113100|NCT01067326|472044030|FG000|Overall Study|Withdrawal by Subject|1|||
131113101|NCT01067326|472044031|FG001|Overall Study|Withdrawal by Subject|0|||
131113102|NCT01067326|472044030|FG000|Overall Study|Early Study Termination|1|||
131113103|NCT01067326|472044031|FG001|Overall Study|Early Study Termination|1|||
131113104|NCT01230788|472044036|FG000|Overall Study|Prescribed exclusion drug|1|||
131113105|NCT02411578|472044044|FG000|Crossover Trial Phase|Pregnancy|0|||
131113106|NCT02411578|472044045|FG001|Crossover Trial Phase|Pregnancy|1|||
131113107|NCT01557348|472044048|FG000|Overall Study|Adverse Event|6|||
131113108|NCT01557348|472044049|FG001|Overall Study|Adverse Event|16|||
131113109|NCT01557348|472044048|FG000|Overall Study|Infusion reaction event|5|||
131113110|NCT01557348|472044049|FG001|Overall Study|Infusion reaction event|5|||
131113111|NCT01557348|472044048|FG000|Overall Study|Death|7|||
131113112|NCT01557348|472044049|FG001|Overall Study|Death|4|||
131113113|NCT01557348|472044048|FG000|Overall Study|Insufficient Therapeutic Response|13|||
131113114|NCT01557348|472044049|FG001|Overall Study|Insufficient Therapeutic Response|28|||
131113115|NCT01557348|472044048|FG000|Overall Study|Withdrawal by Subject|5|||
131113116|NCT01557348|472044049|FG001|Overall Study|Withdrawal by Subject|4|||
131113117|NCT01557348|472044048|FG000|Overall Study|Lost to Follow-up|26|||
131113118|NCT01557348|472044049|FG001|Overall Study|Lost to Follow-up|22|||
131113119|NCT01557348|472044048|FG000|Overall Study|Administrative|18|||
131113120|NCT01557348|472044049|FG001|Overall Study|Administrative|11|||
131113121|NCT02000427|472044054|FG000|Overall Study|Death|22|||
131113122|NCT02708095|472044057|FG000|Overall Study|Adverse Event|4|||
131113123|NCT02708095|472044058|FG001|Overall Study|Adverse Event|10|||
131113124|NCT02708095|472044059|FG002|Overall Study|Adverse Event|11|||
131113125|NCT02708095|472044057|FG000|Overall Study|Lack of Efficacy|9|||
130694190|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694191|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694192|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131113126|NCT02708095|472044058|FG001|Overall Study|Lack of Efficacy|3|||
131113127|NCT02708095|472044059|FG002|Overall Study|Lack of Efficacy|0|||
131113128|NCT02708095|472044057|FG000|Overall Study|Lost to Follow-up|2|||
131113129|NCT02708095|472044058|FG001|Overall Study|Lost to Follow-up|0|||
131113130|NCT02708095|472044059|FG002|Overall Study|Lost to Follow-up|0|||
131113131|NCT02708095|472044057|FG000|Overall Study|Physician Decision|2|||
131113132|NCT02708095|472044058|FG001|Overall Study|Physician Decision|3|||
131113133|NCT02708095|472044059|FG002|Overall Study|Physician Decision|2|||
131113134|NCT02708095|472044057|FG000|Overall Study|Protocol Violation|0|||
131113135|NCT02708095|472044058|FG001|Overall Study|Protocol Violation|0|||
131113136|NCT02708095|472044059|FG002|Overall Study|Protocol Violation|1|||
131113137|NCT02708095|472044057|FG000|Overall Study|Withdrawal by Subject|5|||
131113138|NCT02708095|472044058|FG001|Overall Study|Withdrawal by Subject|3|||
131113139|NCT02708095|472044059|FG002|Overall Study|Withdrawal by Subject|4|||
131113140|NCT03891524|472044064|FG000|Overall Study|Death|0|||
131113141|NCT03891524|472044065|FG001|Overall Study|Death|0|||
131113142|NCT03891524|472044066|FG002|Overall Study|Death|0|||
131113143|NCT03891524|472044067|FG003|Overall Study|Death|0|||
131113144|NCT03891524|472044068|FG004|Overall Study|Death|0|||
131113145|NCT03891524|472044069|FG005|Overall Study|Death|0|||
131113146|NCT03891524|472044070|FG006|Overall Study|Death|0|||
131113147|NCT03891524|472044071|FG007|Overall Study|Death|1|||
131113148|NCT03891524|472044064|FG000|Overall Study|Withdrawal by Subject|0|||
131113149|NCT03891524|472044065|FG001|Overall Study|Withdrawal by Subject|1|||
131113150|NCT03891524|472044066|FG002|Overall Study|Withdrawal by Subject|2|||
131113151|NCT03891524|472044067|FG003|Overall Study|Withdrawal by Subject|1|||
131113152|NCT03891524|472044068|FG004|Overall Study|Withdrawal by Subject|2|||
131113153|NCT03891524|472044069|FG005|Overall Study|Withdrawal by Subject|2|||
131113154|NCT03891524|472044070|FG006|Overall Study|Withdrawal by Subject|2|||
131113155|NCT03891524|472044071|FG007|Overall Study|Withdrawal by Subject|1|||
131113156|NCT02958267|472044072|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
131113157|NCT02958267|472044073|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
131113158|NCT02958267|472044072|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
131113159|NCT02958267|472044073|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
131113160|NCT02958267|472044072|FG000|Follow-up Visits|Additional treatment pursued|2|||
131113161|NCT02958267|472044073|FG001|Follow-up Visits|Additional treatment pursued|1|||
131113162|NCT01210118|472044076|FG000|Overall Study|Lost to Follow-up|1|||
131113163|NCT01210118|472044077|FG001|Overall Study|Lost to Follow-up|1|||
131113164|NCT01210118|472044076|FG000|Overall Study|Protocol Violation|1|||
131113165|NCT01210118|472044077|FG001|Overall Study|Protocol Violation|1|||
131113166|NCT01210118|472044076|FG000|Overall Study|Spontaneous abortion|1|||
131113167|NCT01210118|472044077|FG001|Overall Study|Spontaneous abortion|3|||
131113168|NCT02684357|472044078|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
131113169|NCT02684357|472044079|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
131113170|NCT02684357|472044080|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
131113171|NCT02684357|472044081|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
131113172|NCT02684357|472044082|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
131113173|NCT02684357|472044083|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
131113174|NCT02684357|472044078|FG000|Part A|Lost to Follow-up|0|||
131113175|NCT02684357|472044079|FG001|Part A|Lost to Follow-up|2|||
131113176|NCT02684357|472044080|FG002|Part A|Lost to Follow-up|2|||
131113177|NCT02684357|472044081|FG003|Part A|Lost to Follow-up|0|||
131113178|NCT02684357|472044082|FG004|Part A|Lost to Follow-up|0|||
131113179|NCT02684357|472044083|FG005|Part A|Lost to Follow-up|0|||
131113180|NCT02684357|472044078|FG000|Part A|Withdrawal by Subject|3|||
131113181|NCT02684357|472044079|FG001|Part A|Withdrawal by Subject|0|||
131113182|NCT02684357|472044080|FG002|Part A|Withdrawal by Subject|0|||
131113183|NCT02684357|472044081|FG003|Part A|Withdrawal by Subject|0|||
131026758|NCT04238247|471730408|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
131026759|NCT04238247|471730409|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
131026760|NCT04238247|471730410|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
131026761|NCT04238247|471730411|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
131026762|NCT04238247|471730408|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
131026763|NCT04238247|471730409|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
131026764|NCT04238247|471730410|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
131026765|NCT04238247|471730411|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
131026766|NCT03092726|471730412|FG000|Overall Study|Adverse Event|3|||
131113184|NCT02684357|472044082|FG004|Part A|Withdrawal by Subject|0|||
131113185|NCT02684357|472044083|FG005|Part A|Withdrawal by Subject|0|||
131113186|NCT02684357|472044078|FG000|Part A|Other|0|||
130694193|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694194|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694195|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694196|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694197|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694198|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694199|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694200|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694201|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694202|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694203|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694204|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
131026767|NCT03092726|471730413|FG001|Overall Study|Adverse Event|10|||
131113187|NCT02684357|472044079|FG001|Part A|Other|1|||
131113188|NCT02684357|472044080|FG002|Part A|Other|0|||
131113189|NCT02684357|472044081|FG003|Part A|Other|0|||
131113190|NCT02684357|472044082|FG004|Part A|Other|0|||
131113191|NCT02684357|472044083|FG005|Part A|Other|0|||
131113192|NCT02684357|472044078|FG000|Part B|Adverse Event (Other)|0|||
131113193|NCT02684357|472044079|FG001|Part B|Adverse Event (Other)|0|||
131113194|NCT02684357|472044080|FG002|Part B|Adverse Event (Other)|0|||
131113195|NCT02684357|472044081|FG003|Part B|Adverse Event (Other)|1|||
131113196|NCT02684357|472044082|FG004|Part B|Adverse Event (Other)|1|||
130694205|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130694206|NCT00112437|470505916|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694207|NCT00112437|470505917|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694208|NCT00112437|470505918|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131026768|NCT03092726|471730412|FG000|Overall Study|Lack of Efficacy|0|||
131026769|NCT03092726|471730413|FG001|Overall Study|Lack of Efficacy|1|||
131026770|NCT03092726|471730412|FG000|Overall Study|Lost to Follow-up|1|||
131026771|NCT03092726|471730413|FG001|Overall Study|Lost to Follow-up|0|||
131026772|NCT03092726|471730412|FG000|Overall Study|Withdrawal by Subject|5|||
131026773|NCT03092726|471730413|FG001|Overall Study|Withdrawal by Subject|3|||
131026774|NCT04950127|471730414|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
131026775|NCT04950127|471730415|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
131026776|NCT04950127|471730416|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
131026777|NCT04950127|471730417|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
131026778|NCT04950127|471730418|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
131026779|NCT04950127|471730419|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
131026780|NCT04950127|471730414|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
131026781|NCT04950127|471730415|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
131026782|NCT04950127|471730416|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
131026783|NCT04950127|471730417|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
131026784|NCT04950127|471730418|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
131026785|NCT04950127|471730419|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
131026786|NCT04950127|471730414|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
131026787|NCT04950127|471730415|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
131026788|NCT04950127|471730416|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
131026789|NCT04950127|471730417|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
131026790|NCT04950127|471730418|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
131026791|NCT04950127|471730419|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
131026792|NCT04950127|471730414|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
131026793|NCT04950127|471730415|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
131026794|NCT04950127|471730416|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
131026795|NCT04950127|471730417|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
131026796|NCT04950127|471730418|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
131026797|NCT04950127|471730419|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
131026798|NCT04950127|471730414|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
131026799|NCT04950127|471730415|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
131026800|NCT04950127|471730416|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
131026801|NCT04950127|471730417|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
131026802|NCT04950127|471730418|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
131026803|NCT04950127|471730419|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
131026804|NCT03833167|471730424|FG000|Overall Study|Withdrawal by Subject|4|||
131026805|NCT03833167|471730425|FG001|Overall Study|Withdrawal by Subject|6|||
131026806|NCT03833167|471730424|FG000|Overall Study|Ongoing|186|||
131026807|NCT03833167|471730425|FG001|Overall Study|Ongoing|194|||
131026808|NCT03833167|471730424|FG000|Overall Study|Lost to Follow-up|1|||
131026809|NCT03833167|471730425|FG001|Overall Study|Lost to Follow-up|1|||
131026810|NCT03833167|471730424|FG000|Overall Study|Physician Decision|0|||
131026811|NCT03833167|471730425|FG001|Overall Study|Physician Decision|2|||
131026812|NCT03833167|471730424|FG000|Overall Study|Death|34|||
131026813|NCT03833167|471730425|FG001|Overall Study|Death|22|||
131026814|NCT01948661|471730427|FG000|Overall Study|Withdrawal by Subject|2|||
131026815|NCT01948661|471730428|FG001|Overall Study|Withdrawal by Subject|4|||
131026816|NCT03271489|471730429|FG000|Double-Blind (DB) Period|Adverse Event|4|||
131026817|NCT03271489|471730430|FG001|Double-Blind (DB) Period|Adverse Event|1|||
131026818|NCT03271489|471730429|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
131026819|NCT03271489|471730430|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
131026820|NCT03271489|471730429|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
131026821|NCT03271489|471730430|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
131026822|NCT03271489|471730429|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
131026823|NCT03271489|471730430|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
131026824|NCT03271489|471730429|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
131026825|NCT03271489|471730430|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
131026826|NCT03271489|471730429|FG000|Double-Blind (DB) Period|Other|6|||
131026827|NCT03271489|471730430|FG001|Double-Blind (DB) Period|Other|1|||
130694209|NCT00112437|470505919|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131026828|NCT03271489|471730429|FG000|Double-Blind (DB) Period|Missing|1|||
131026829|NCT03271489|471730430|FG001|Double-Blind (DB) Period|Missing|0|||
131026830|NCT03271489|471730429|FG000|Open-Label (OL) Period|Adverse Event|2|||
131113197|NCT02684357|472044083|FG005|Part B|Adverse Event (Other)|1|||
131113198|NCT02684357|472044078|FG000|Part B|Lost to Follow-up|0|||
130694210|NCT00112437|470505920|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
131026831|NCT03271489|471730430|FG001|Open-Label (OL) Period|Adverse Event|0|||
130902158|NCT03073733|471275344|FG000|Overall Study|Lost to Follow-up|1|||
130902159|NCT03073733|471275345|FG001|Overall Study|Lost to Follow-up|0|||
130902160|NCT03073733|471275346|FG002|Overall Study|Lost to Follow-up|0|||
130902161|NCT03073733|471275344|FG000|Overall Study|Physician Decision|0|||
130902162|NCT03073733|471275345|FG001|Overall Study|Physician Decision|1|||
130902163|NCT03073733|471275346|FG002|Overall Study|Physician Decision|0|||
130902164|NCT03073733|471275344|FG000|Overall Study|Withdrawal by Subject|0|||
130902165|NCT03073733|471275345|FG001|Overall Study|Withdrawal by Subject|0|||
131113199|NCT02684357|472044079|FG001|Part B|Lost to Follow-up|0|||
131113200|NCT02684357|472044080|FG002|Part B|Lost to Follow-up|0|||
131113201|NCT02684357|472044081|FG003|Part B|Lost to Follow-up|1|||
131113202|NCT02684357|472044082|FG004|Part B|Lost to Follow-up|1|||
131113203|NCT02684357|472044083|FG005|Part B|Lost to Follow-up|7|||
131113204|NCT02684357|472044078|FG000|Part B|Withdrawal by Subject|0|||
131113205|NCT02684357|472044079|FG001|Part B|Withdrawal by Subject|0|||
131113206|NCT02684357|472044080|FG002|Part B|Withdrawal by Subject|0|||
131113207|NCT02684357|472044081|FG003|Part B|Withdrawal by Subject|0|||
131113208|NCT02684357|472044082|FG004|Part B|Withdrawal by Subject|2|||
131113209|NCT02684357|472044083|FG005|Part B|Withdrawal by Subject|4|||
131113210|NCT02684357|472044078|FG000|Part B|Other|0|||
131113211|NCT02684357|472044079|FG001|Part B|Other|0|||
131113212|NCT02684357|472044080|FG002|Part B|Other|0|||
131113213|NCT02684357|472044081|FG003|Part B|Other|1|||
131113214|NCT02684357|472044082|FG004|Part B|Other|0|||
131113215|NCT02684357|472044083|FG005|Part B|Other|1|||
131113216|NCT01079130|472044084|FG000|Overall Study|Adverse Event|1|||
131113217|NCT01079130|472044085|FG001|Overall Study|Adverse Event|1|||
131113218|NCT01079130|472044086|FG002|Overall Study|Adverse Event|0|||
131113219|NCT01079130|472044087|FG003|Overall Study|Adverse Event|1|||
131113220|NCT01079130|472044088|FG004|Overall Study|Adverse Event|5|||
131113221|NCT01079130|472044089|FG005|Overall Study|Adverse Event|1|||
131113222|NCT01079130|472044084|FG000|Overall Study|Administrative problems|1|||
131113223|NCT01079130|472044085|FG001|Overall Study|Administrative problems|3|||
131113224|NCT01079130|472044086|FG002|Overall Study|Administrative problems|0|||
131113225|NCT01079130|472044087|FG003|Overall Study|Administrative problems|0|||
131113226|NCT01079130|472044088|FG004|Overall Study|Administrative problems|0|||
131113227|NCT01079130|472044089|FG005|Overall Study|Administrative problems|1|||
131113228|NCT01079130|472044084|FG000|Overall Study|Withdrawal by Subject|0|||
131113229|NCT01079130|472044085|FG001|Overall Study|Withdrawal by Subject|1|||
131113230|NCT01079130|472044086|FG002|Overall Study|Withdrawal by Subject|0|||
131113231|NCT01079130|472044087|FG003|Overall Study|Withdrawal by Subject|0|||
131113232|NCT01079130|472044088|FG004|Overall Study|Withdrawal by Subject|1|||
131113233|NCT01079130|472044089|FG005|Overall Study|Withdrawal by Subject|3|||
131113234|NCT01079130|472044084|FG000|Overall Study|Protocol deviation|0|||
131113235|NCT01079130|472044085|FG001|Overall Study|Protocol deviation|2|||
131113236|NCT01079130|472044086|FG002|Overall Study|Protocol deviation|1|||
131113237|NCT01079130|472044087|FG003|Overall Study|Protocol deviation|2|||
131113238|NCT01079130|472044088|FG004|Overall Study|Protocol deviation|0|||
131113239|NCT01079130|472044089|FG005|Overall Study|Protocol deviation|0|||
131113240|NCT01079130|472044084|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131113241|NCT01079130|472044085|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131113242|NCT01079130|472044086|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131113243|NCT01079130|472044087|FG003|Overall Study|Abnormal test procedure result(s)|0|||
131113244|NCT01079130|472044088|FG004|Overall Study|Abnormal test procedure result(s)|1|||
131113245|NCT01079130|472044089|FG005|Overall Study|Abnormal test procedure result(s)|0|||
130694211|NCT00112437|470505921|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694212|NCT00112437|470505922|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130902166|NCT03073733|471275346|FG002|Overall Study|Withdrawal by Subject|1|||
130902167|NCT00835731|471275347|FG000|Overall Study|Withdrawal by Subject|1|||
130902168|NCT00835731|471275348|FG001|Overall Study|Withdrawal by Subject|0|||
131113246|NCT01079130|472044084|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131113247|NCT01079130|472044085|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131113248|NCT01079130|472044086|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131113249|NCT01079130|472044087|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
131113250|NCT01079130|472044088|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
131113251|NCT01079130|472044089|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
131113252|NCT01079130|472044084|FG000|Overall Study|Lost to Follow-up|0|||
131113253|NCT01079130|472044085|FG001|Overall Study|Lost to Follow-up|0|||
131113254|NCT01079130|472044086|FG002|Overall Study|Lost to Follow-up|0|||
130694213|NCT00112437|470505923|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694214|NCT00112437|470505924|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130902169|NCT00835731|471275347|FG000|Overall Study|Physician Decision|1|||
130902170|NCT00835731|471275348|FG001|Overall Study|Physician Decision|1|||
131113255|NCT01079130|472044087|FG003|Overall Study|Lost to Follow-up|0|||
131113256|NCT01079130|472044088|FG004|Overall Study|Lost to Follow-up|1|||
131113257|NCT01079130|472044089|FG005|Overall Study|Lost to Follow-up|0|||
131113258|NCT01839487|472044090|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
131222732|NCT01333475|472443168|FG000|Overall Study|Toxicity|1|||
130694215|NCT00112437|470505925|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131026832|NCT03271489|471730429|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
131026833|NCT03271489|471730430|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
131026834|NCT03271489|471730429|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
131026835|NCT03271489|471730430|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
131026836|NCT03271489|471730429|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
131026837|NCT03271489|471730430|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
131026838|NCT03271489|471730429|FG000|Open-Label (OL) Period|No Specified|2|||
131026839|NCT03271489|471730430|FG001|Open-Label (OL) Period|No Specified|2|||
131026840|NCT03271489|471730429|FG000|Open-Label (OL) Period|Missing|2|||
131026841|NCT03271489|471730430|FG001|Open-Label (OL) Period|Missing|0|||
131026842|NCT03271489|471730429|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
131026843|NCT03271489|471730430|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
131026844|NCT03271489|471730429|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
131026845|NCT03271489|471730430|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
131026846|NCT03271489|471730429|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
131026847|NCT03271489|471730430|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
131026848|NCT03271489|471730429|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
131026849|NCT03271489|471730430|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
131026850|NCT03271489|471730429|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
131026851|NCT03271489|471730430|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
131026852|NCT03271489|471730429|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
131026853|NCT03271489|471730430|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
131026854|NCT03271489|471730429|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
131026855|NCT03271489|471730430|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
131026856|NCT03271489|471730429|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
131026857|NCT03271489|471730430|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
131026858|NCT03330795|471730431|FG000|Overall Study|Death|3|||
131026859|NCT03330795|471730431|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
131026860|NCT05064735|471730432|FG000|Overall Study|Withdrawal by Subject|7|||
131026861|NCT05064735|471730433|FG001|Overall Study|Withdrawal by Subject|8|||
131026862|NCT05064735|471730432|FG000|Overall Study|Lost to Follow-up|7|||
131026863|NCT05064735|471730433|FG001|Overall Study|Lost to Follow-up|2|||
131026864|NCT05064735|471730432|FG000|Overall Study|Physician Decision|2|||
131026865|NCT05064735|471730433|FG001|Overall Study|Physician Decision|1|||
131026866|NCT05064735|471730432|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
131026867|NCT05064735|471730433|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
131026868|NCT05064735|471730432|FG000|Overall Study|Site Closure|7|||
131026869|NCT05064735|471730433|FG001|Overall Study|Site Closure|2|||
131026870|NCT05575076|471730434|FG000|Overall Study|Adverse Event|24|||
131026871|NCT05575076|471730434|FG000|Overall Study|Death|7|||
131026872|NCT05575076|471730434|FG000|Overall Study|Lost to Follow-up|16|||
131026873|NCT05575076|471730434|FG000|Overall Study|Non-Compliance|3|||
131026874|NCT05575076|471730434|FG000|Overall Study|Physician Decision|6|||
131026875|NCT05575076|471730434|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
131222733|NCT01333475|472443169|FG001|Overall Study|Toxicity|3|||
131222734|NCT02981602|472443170|FG000|Overall Study|Adverse Event|0|||
131222735|NCT02981602|472443171|FG001|Overall Study|Adverse Event|0|||
131222736|NCT02981602|472443172|FG002|Overall Study|Adverse Event|0|||
131222737|NCT02981602|472443173|FG003|Overall Study|Adverse Event|1|||
131222738|NCT02981602|472443174|FG004|Overall Study|Adverse Event|0|||
131222739|NCT00386100|472443175|FG000|Overall Study|Did not receive study medication|6|||
131222740|NCT00386100|472443176|FG001|Overall Study|Did not receive study medication|4|||
131222741|NCT00386100|472443175|FG000|Overall Study|Adverse Event|15|||
131222742|NCT00386100|472443176|FG001|Overall Study|Adverse Event|25|||
131222743|NCT00386100|472443175|FG000|Overall Study|Death|0|||
131222744|NCT00386100|472443176|FG001|Overall Study|Death|1|||
131222745|NCT00386100|472443175|FG000|Overall Study|Insufficient therapeutic effect|30|||
131222746|NCT00386100|472443176|FG001|Overall Study|Insufficient therapeutic effect|6|||
131222747|NCT00386100|472443175|FG000|Overall Study|Lost to Follow-up|29|||
131222748|NCT00386100|472443176|FG001|Overall Study|Lost to Follow-up|29|||
131222749|NCT00386100|472443175|FG000|Overall Study|Non-compliance|18|||
131222750|NCT00386100|472443176|FG001|Overall Study|Non-compliance|19|||
130694216|NCT00112437|470505926|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131222751|NCT00386100|472443175|FG000|Overall Study|Protocol Violation|5|||
131222752|NCT00386100|472443176|FG001|Overall Study|Protocol Violation|3|||
131222753|NCT00386100|472443175|FG000|Overall Study|Withdrawal by Subject|32|||
131222754|NCT00386100|472443176|FG001|Overall Study|Withdrawal by Subject|31|||
131222755|NCT00386100|472443175|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
131222756|NCT00386100|472443176|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
131222757|NCT00386100|472443175|FG000|Overall Study|BMD <2.5|1|||
130902171|NCT01155167|471275349|FG000|Overall Study|Insufficient ultrasound data|2|||
131113259|NCT01839487|472044091|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
131113260|NCT01839487|472044092|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
131113261|NCT01839487|472044093|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
131113262|NCT01839487|472044094|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
131113263|NCT01839487|472044095|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
131113264|NCT01839487|472044090|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
131113265|NCT01839487|472044091|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
131113266|NCT01839487|472044092|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
131113267|NCT01839487|472044093|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
131113268|NCT01839487|472044094|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
131113269|NCT01839487|472044095|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
131113270|NCT01839487|472044090|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
131113271|NCT01839487|472044091|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
131113272|NCT01839487|472044092|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
131113273|NCT01839487|472044093|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
131113274|NCT01839487|472044094|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
130694217|NCT00112437|470505927|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694218|NCT00112437|470505928|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694219|NCT00112437|470505929|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
131113275|NCT01839487|472044095|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
131113276|NCT01839487|472044090|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
131113277|NCT01839487|472044091|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
131113278|NCT01839487|472044092|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
131113279|NCT01839487|472044093|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
130694220|NCT00112437|470505930|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694221|NCT00112437|470505931|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694222|NCT00112437|470505932|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694223|NCT00112437|470505933|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694224|NCT00112437|470505934|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694225|NCT00112437|470505935|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694226|NCT00112437|470505936|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694227|NCT00112437|470505937|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694228|NCT00112437|470505938|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694229|NCT00112437|470505939|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694230|NCT00112437|470505940|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694231|NCT00112437|470505941|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130694232|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
130694233|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
130694234|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
130694235|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
130694236|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
130694237|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
130694238|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
130694239|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
130694240|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
130694241|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
130694242|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
130694243|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
130694244|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
130694245|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
130694246|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
130694247|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
130694248|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
130694249|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
130694250|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
130694251|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
130694252|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
130694253|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
130694254|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
130902172|NCT01155167|471275350|FG001|Overall Study|Insufficient ultrasound data|0|||
130694255|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
130694256|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
130694257|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
130694258|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694259|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694260|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130768251|NCT02912455|470775522|FG000|Overall Study|Withdrawal by Subject|0|||
130768252|NCT02912455|470775523|FG001|Overall Study|Withdrawal by Subject|1|||
130768253|NCT02912455|470775522|FG000|Overall Study|Lack of Efficacy|0|||
130768254|NCT02912455|470775523|FG001|Overall Study|Lack of Efficacy|1|||
130768255|NCT02912455|470775522|FG000|Overall Study|Lost to Follow-up|2|||
130768256|NCT02912455|470775523|FG001|Overall Study|Lost to Follow-up|1|||
130768257|NCT01810783|470775528|FG000|Overall Study|Adverse Event|32|||
130768258|NCT01810783|470775528|FG000|Overall Study|Withdrawal by Subject|22|||
130768259|NCT01810783|470775528|FG000|Overall Study|Lack of Efficacy|12|||
130768260|NCT01810783|470775528|FG000|Overall Study|Lost to Follow-up|10|||
130768261|NCT01810783|470775528|FG000|Overall Study|Protocol Violation|5|||
130768262|NCT01810783|470775528|FG000|Overall Study|Non-compliance with IMP|4|||
130768263|NCT01810783|470775528|FG000|Overall Study|Adminstrative or other reason(s)|23|||
130768264|NCT01810783|470775528|FG000|Overall Study|Enrolled, not treated|1|||
130768265|NCT02134353|470775529|FG000|Overall Study|Adverse Event|10|||
130768266|NCT02134353|470775530|FG001|Overall Study|Adverse Event|6|||
130768267|NCT02134353|470775529|FG000|Overall Study|Lost to Follow-up|1|||
130768268|NCT02134353|470775530|FG001|Overall Study|Lost to Follow-up|1|||
130768269|NCT02134353|470775529|FG000|Overall Study|Lack of Efficacy|2|||
130768270|NCT02134353|470775530|FG001|Overall Study|Lack of Efficacy|1|||
130768271|NCT02134353|470775529|FG000|Overall Study|Withdrawal by Subject|12|||
130768272|NCT02134353|470775530|FG001|Overall Study|Withdrawal by Subject|13|||
130768273|NCT02134353|470775529|FG000|Overall Study|Death|0|||
130768274|NCT02134353|470775530|FG001|Overall Study|Death|1|||
130768275|NCT02134353|470775529|FG000|Overall Study|Pregnancy|0|||
130768276|NCT02134353|470775530|FG001|Overall Study|Pregnancy|1|||
130768277|NCT02134353|470775529|FG000|Overall Study|Relocation|1|||
130768278|NCT02134353|470775530|FG001|Overall Study|Relocation|0|||
130768279|NCT02134353|470775529|FG000|Overall Study|Other - Patient's Choice|0|||
130768280|NCT02134353|470775530|FG001|Overall Study|Other - Patient's Choice|1|||
130768281|NCT00477607|470775531|FG000|Overall Study|Lost to Follow-up|7|||
130768282|NCT00477607|470775532|FG001|Overall Study|Lost to Follow-up|7|||
130902173|NCT01155167|471275349|FG000|Overall Study|Access site changed to femoral artery|1|||
130902174|NCT01155167|471275350|FG001|Overall Study|Access site changed to femoral artery|0|||
130902175|NCT00167778|471275351|FG000|Overall Study|Withdrawal by Subject|1|||
130902176|NCT02654717|471275352|FG000|Overall Study|Adverse Event|2|||
130902177|NCT02654717|471275353|FG001|Overall Study|Adverse Event|2|||
130902178|NCT02654717|471275352|FG000|Overall Study|Protocol Violation|1|||
130902179|NCT02654717|471275353|FG001|Overall Study|Protocol Violation|2|||
130902180|NCT02654717|471275352|FG000|Overall Study|Withdrawal by Subject|0|||
130902181|NCT02654717|471275353|FG001|Overall Study|Withdrawal by Subject|1|||
130902182|NCT02654717|471275352|FG000|Overall Study|Non-permitted medication|3|||
130902183|NCT02654717|471275353|FG001|Overall Study|Non-permitted medication|0|||
130902184|NCT02880956|471275355|FG000|Overall Study|Adverse Event|3|||
130902185|NCT02880956|471275356|FG001|Overall Study|Adverse Event|6|||
130902186|NCT02880956|471275357|FG002|Overall Study|Adverse Event|5|||
130902187|NCT02880956|471275358|FG003|Overall Study|Adverse Event|4|||
130902188|NCT02880956|471275355|FG000|Overall Study|Withdrawal by Subject|9|||
130902189|NCT02880956|471275356|FG001|Overall Study|Withdrawal by Subject|4|||
130902190|NCT02880956|471275357|FG002|Overall Study|Withdrawal by Subject|6|||
130902191|NCT02880956|471275358|FG003|Overall Study|Withdrawal by Subject|11|||
130902192|NCT02880956|471275355|FG000|Overall Study|Lost to Follow-up|0|||
130902193|NCT02880956|471275356|FG001|Overall Study|Lost to Follow-up|1|||
130902194|NCT02880956|471275357|FG002|Overall Study|Lost to Follow-up|0|||
130902195|NCT02880956|471275358|FG003|Overall Study|Lost to Follow-up|0|||
130902196|NCT02880956|471275355|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
130902197|NCT02880956|471275356|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
130902198|NCT02880956|471275357|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
130902199|NCT02880956|471275358|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
130902200|NCT02880956|471275355|FG000|Overall Study|Other, Not Specified|4|||
130902201|NCT02880956|471275356|FG001|Overall Study|Other, Not Specified|2|||
130902202|NCT02880956|471275357|FG002|Overall Study|Other, Not Specified|0|||
130768283|NCT00358956|470775533|FG000|Overall Study|Adverse Event|3|||
130768284|NCT00358956|470775533|FG000|Overall Study|condition under investigation worsened|4|||
130768285|NCT00358956|470775533|FG000|Overall Study|Withdrawal by Subject|1|||
130768286|NCT04776018|470775534|FG000|Overall Study|Death|0|||
130768287|NCT04776018|470775535|FG001|Overall Study|Death|1|||
130768288|NCT04776018|470775536|FG002|Overall Study|Death|4|||
130768289|NCT04776018|470775537|FG003|Overall Study|Death|1|||
130768290|NCT04776018|470775538|FG004|Overall Study|Death|4|||
130768291|NCT04776018|470775539|FG005|Overall Study|Death|0|||
130768292|NCT04776018|470775540|FG006|Overall Study|Death|0|||
130902203|NCT02880956|471275358|FG003|Overall Study|Other, Not Specified|3|||
130902204|NCT00576420|471277424|FG000|Overall Study|Death|0|||
130902205|NCT00576420|471277425|FG001|Overall Study|Death|0|||
130902206|NCT00576420|471277426|FG002|Overall Study|Death|1|||
130902207|NCT01340872|471277428|FG000|Double-blind Phase|Adverse Event|6|||
130902208|NCT01340872|471277429|FG001|Double-blind Phase|Adverse Event|4|||
130902209|NCT01340872|471277430|FG002|Double-blind Phase|Adverse Event|0|||
130902210|NCT01340872|471277431|FG003|Double-blind Phase|Adverse Event|0|||
131113280|NCT01839487|472044094|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
130902211|NCT01340872|471277428|FG000|Double-blind Phase|Withdrawal by Subject|3|||
130902212|NCT01340872|471277429|FG001|Double-blind Phase|Withdrawal by Subject|5|||
130902213|NCT01340872|471277430|FG002|Double-blind Phase|Withdrawal by Subject|0|||
130902214|NCT01340872|471277431|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130902215|NCT01340872|471277428|FG000|Double-blind Phase|Lost to Follow-up|0|||
130694261|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694262|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694263|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
130694264|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
130694265|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694266|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694267|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
130694268|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694269|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694270|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694271|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694272|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694273|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694274|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130902216|NCT01340872|471277429|FG001|Double-blind Phase|Lost to Follow-up|1|||
130902217|NCT01340872|471277430|FG002|Double-blind Phase|Lost to Follow-up|0|||
130902218|NCT01340872|471277431|FG003|Double-blind Phase|Lost to Follow-up|0|||
130902219|NCT01340872|471277428|FG000|Double-blind Phase|Protocol Violation|0|||
130902220|NCT01340872|471277429|FG001|Double-blind Phase|Protocol Violation|1|||
130902221|NCT01340872|471277430|FG002|Double-blind Phase|Protocol Violation|0|||
130902222|NCT01340872|471277431|FG003|Double-blind Phase|Protocol Violation|0|||
130902223|NCT01340872|471277428|FG000|Open-label Phase|Physician Decision|0|||
130902224|NCT01340872|471277429|FG001|Open-label Phase|Physician Decision|0|||
130902225|NCT01340872|471277430|FG002|Open-label Phase|Physician Decision|2|||
130902226|NCT01340872|471277431|FG003|Open-label Phase|Physician Decision|1|||
130902227|NCT01340872|471277428|FG000|Open-label Phase|Pregnancy|0|||
130902228|NCT01340872|471277429|FG001|Open-label Phase|Pregnancy|0|||
130902229|NCT01340872|471277430|FG002|Open-label Phase|Pregnancy|1|||
130902230|NCT01340872|471277431|FG003|Open-label Phase|Pregnancy|0|||
130902231|NCT01340872|471277428|FG000|Open-label Phase|Adverse Event|0|||
130902232|NCT01340872|471277429|FG001|Open-label Phase|Adverse Event|0|||
130902233|NCT01340872|471277430|FG002|Open-label Phase|Adverse Event|8|||
130902234|NCT01340872|471277431|FG003|Open-label Phase|Adverse Event|4|||
130694275|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694276|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694277|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694278|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694279|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694280|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694281|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694282|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694283|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130694284|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694285|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694286|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694287|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694288|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694289|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694290|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694291|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130902235|NCT01340872|471277428|FG000|Open-label Phase|Withdrawal by Subject|0|||
130902236|NCT01340872|471277429|FG001|Open-label Phase|Withdrawal by Subject|0|||
130902237|NCT01340872|471277430|FG002|Open-label Phase|Withdrawal by Subject|1|||
130902238|NCT01340872|471277431|FG003|Open-label Phase|Withdrawal by Subject|6|||
130902239|NCT01340872|471277428|FG000|Open-label Phase|Worsening of IBD|0|||
130902240|NCT01340872|471277429|FG001|Open-label Phase|Worsening of IBD|0|||
131026876|NCT05575076|471730434|FG000|Overall Study|Withdrawal by Subject|71|||
130902241|NCT01340872|471277430|FG002|Open-label Phase|Worsening of IBD|1|||
130902242|NCT01340872|471277431|FG003|Open-label Phase|Worsening of IBD|0|||
131026877|NCT05575076|471730434|FG000|Overall Study|Study Terminated by Sponsor|630|||
131026878|NCT05575076|471730434|FG000|Overall Study|Other|17|||
131026879|NCT02886286|471730435|FG000|Overall Study|pump motor stall|0|||
131026880|NCT02886286|471730436|FG001|Overall Study|pump motor stall|1|||
131026881|NCT02376790|471730443|FG000|Overall Study|Withdrawal by Subject|43|||
131026882|NCT02376790|471730444|FG001|Overall Study|Withdrawal by Subject|36|||
131026883|NCT02376790|471730445|FG002|Overall Study|Withdrawal by Subject|37|||
131026884|NCT02376790|471730443|FG000|Overall Study|Decision by Sponsor|2|||
130902243|NCT01771809|471277434|FG000|Overall Study|Adverse Event|4|||
130902244|NCT01771809|471277435|FG001|Overall Study|Adverse Event|12|||
130902245|NCT01771809|471277434|FG000|Overall Study|Protocol Violation|0|||
130902246|NCT01771809|471277435|FG001|Overall Study|Protocol Violation|1|||
130902247|NCT01771809|471277434|FG000|Overall Study|Withdrawal by Subject|34|||
130902248|NCT01771809|471277435|FG001|Overall Study|Withdrawal by Subject|42|||
130902249|NCT01771809|471277434|FG000|Overall Study|Lost to Follow-up|1|||
130902250|NCT01771809|471277435|FG001|Overall Study|Lost to Follow-up|3|||
130902251|NCT01771809|471277434|FG000|Overall Study|Other (Insufficient clinical response)|22|||
130902252|NCT01771809|471277435|FG001|Overall Study|Other (Insufficient clinical response)|20|||
130902253|NCT01771809|471277434|FG000|Overall Study|Death|1|||
130902254|NCT01771809|471277435|FG001|Overall Study|Death|0|||
130902255|NCT01771809|471277434|FG000|Overall Study|Other (other)|9|||
130902256|NCT01771809|471277435|FG001|Overall Study|Other (other)|5|||
130902257|NCT01142089|471277447|FG000|Overall Study|Physician Decision|1|||
130902258|NCT01142089|471277448|FG001|Overall Study|Physician Decision|0|||
130902259|NCT01142089|471277447|FG000|Overall Study|Withdrawal by Subject|1|||
130902260|NCT01142089|471277448|FG001|Overall Study|Withdrawal by Subject|2|||
130902261|NCT01142089|471277447|FG000|Overall Study|Use of prohibited medications|0|||
130902262|NCT01142089|471277448|FG001|Overall Study|Use of prohibited medications|1|||
130902263|NCT01142089|471277447|FG000|Overall Study|Noncompliance with study procedures|2|||
130902264|NCT01142089|471277448|FG001|Overall Study|Noncompliance with study procedures|1|||
130902265|NCT01142089|471277447|FG000|Overall Study|Patient required rescue medication|8|||
130902266|NCT01142089|471277448|FG001|Overall Study|Patient required rescue medication|17|||
130902267|NCT02907892|471277453|FG000|Overall Study|Lost to Follow-up|27|||
130902268|NCT02907892|471277454|FG001|Overall Study|Lost to Follow-up|40|||
130694292|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
130694293|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130902269|NCT01974765|471277455|FG000|Overall Study|Withdrawal by Subject|1|||
130902270|NCT01974765|471277455|FG000|Overall Study|Death|1|||
130902271|NCT01974765|471277455|FG000|Overall Study|Adverse Event|2|||
131026885|NCT02376790|471730444|FG001|Overall Study|Decision by Sponsor|1|||
131026886|NCT02376790|471730445|FG002|Overall Study|Decision by Sponsor|4|||
131026887|NCT02376790|471730443|FG000|Overall Study|Lost to Follow-up|15|||
131026888|NCT02376790|471730444|FG001|Overall Study|Lost to Follow-up|10|||
131026889|NCT02376790|471730445|FG002|Overall Study|Lost to Follow-up|12|||
131026890|NCT03014453|471730446|FG000|Overall Study|Lost to Follow-up|12|||
131026891|NCT03014453|471730446|FG000|Overall Study|Discontinued GER|3|||
131026892|NCT03014453|471730446|FG000|Overall Study|Excluded|19|||
131026893|NCT03014453|471730446|FG000|Overall Study|Refused to take part in|37|||
131026894|NCT05450458|471730447|FG000|Overall Study|Lost to Follow-up|4|||
131026895|NCT01017146|471730448|FG000|Overall Study|Adverse Event|11|||
131026896|NCT01017146|471730449|FG001|Overall Study|Adverse Event|1|||
131026897|NCT01017146|471730448|FG000|Overall Study|Lost to Follow-up|14|||
131026898|NCT01017146|471730449|FG001|Overall Study|Lost to Follow-up|14|||
131026899|NCT01017146|471730448|FG000|Overall Study|Noncompliance with Study Product|1|||
131026900|NCT01017146|471730449|FG001|Overall Study|Noncompliance with Study Product|1|||
131026901|NCT01017146|471730448|FG000|Overall Study|Withdrawal by Subject|32|||
131026902|NCT01017146|471730449|FG001|Overall Study|Withdrawal by Subject|16|||
131026903|NCT01017146|471730448|FG000|Overall Study|Relocation|0|||
131026904|NCT01017146|471730449|FG001|Overall Study|Relocation|4|||
131026905|NCT01017146|471730448|FG000|Overall Study|Pregnancy|2|||
131026906|NCT01017146|471730449|FG001|Overall Study|Pregnancy|1|||
131026907|NCT01017146|471730448|FG000|Overall Study|Protocol Violation|2|||
131026908|NCT01017146|471730449|FG001|Overall Study|Protocol Violation|0|||
131026909|NCT01017146|471730448|FG000|Overall Study|Took Excluded Medication|2|||
131026910|NCT01017146|471730449|FG001|Overall Study|Took Excluded Medication|0|||
131026911|NCT01017146|471730448|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
131026912|NCT01017146|471730449|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
131026913|NCT01017146|471730448|FG000|Overall Study|Change in Work Situation|1|||
131026914|NCT01017146|471730449|FG001|Overall Study|Change in Work Situation|0|||
131026915|NCT01084707|471730453|FG000|Overall Study|Withdrawal by Subject|6|||
131026916|NCT00901901|471730454|FG000|Treatment Period|Adverse Event|120|||
131026917|NCT00901901|471730455|FG001|Treatment Period|Adverse Event|128|||
131026918|NCT00901901|471730454|FG000|Treatment Period|Withdrawal by Subject|26|||
131026919|NCT00901901|471730455|FG001|Treatment Period|Withdrawal by Subject|24|||
131026920|NCT00901901|471730454|FG000|Treatment Period|Physician Decision|2|||
131026921|NCT00901901|471730455|FG001|Treatment Period|Physician Decision|2|||
131026922|NCT00901901|471730454|FG000|Treatment Period|Lost to Follow-up|3|||
131026923|NCT00901901|471730455|FG001|Treatment Period|Lost to Follow-up|5|||
131026924|NCT00901901|471730454|FG000|Treatment Period|Noncompliance with study medication|4|||
131026925|NCT00901901|471730455|FG001|Treatment Period|Noncompliance with study medication|1|||
131026926|NCT00901901|471730454|FG000|Treatment Period|Missing|1|||
131026927|NCT00901901|471730455|FG001|Treatment Period|Missing|0|||
131026928|NCT00901901|471730454|FG000|Treatment Period|Never treated|0|||
131026929|NCT00901901|471730455|FG001|Treatment Period|Never treated|3|||
131113281|NCT01839487|472044095|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
131113282|NCT01839487|472044090|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
131113283|NCT01839487|472044091|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
131113284|NCT01839487|472044092|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
131113285|NCT01839487|472044093|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
131113286|NCT01839487|472044094|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
131113287|NCT01839487|472044095|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
131113288|NCT01839487|472044090|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
131113289|NCT01839487|472044091|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
131113290|NCT01839487|472044092|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
131113291|NCT01839487|472044093|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
131113292|NCT01839487|472044094|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
131113293|NCT01839487|472044095|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
131113294|NCT01839487|472044090|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
131113295|NCT01839487|472044091|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
131113296|NCT01839487|472044092|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
131113297|NCT01839487|472044093|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
131113298|NCT01839487|472044094|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
131113299|NCT01839487|472044095|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
131113300|NCT01839487|472044090|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
131113301|NCT01839487|472044091|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
131113302|NCT01839487|472044092|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
131113303|NCT01839487|472044093|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
131113304|NCT01839487|472044094|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
131113305|NCT01839487|472044095|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
131113306|NCT01839487|472044090|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
131113307|NCT01839487|472044091|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
131113308|NCT01839487|472044092|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
131113309|NCT01839487|472044093|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
131113310|NCT01839487|472044094|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
131113311|NCT01839487|472044095|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
131113312|NCT03471871|472044096|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
131113313|NCT03471871|472044097|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
131113314|NCT03471871|472044098|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
131113315|NCT03471871|472044099|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
131113316|NCT03471871|472044100|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
131113317|NCT03471871|472044096|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
131113318|NCT03471871|472044097|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
131113319|NCT03471871|472044098|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
131113320|NCT03471871|472044099|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
131113321|NCT03471871|472044100|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
131113322|NCT03471871|472044096|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
131113323|NCT03471871|472044097|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
131113324|NCT03471871|472044098|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
131113325|NCT03471871|472044099|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
130694294|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694295|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694296|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694297|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694298|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694299|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131113326|NCT03471871|472044100|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
131113327|NCT03471871|472044096|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
131113328|NCT03471871|472044097|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
131113329|NCT03471871|472044098|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
131113330|NCT03471871|472044099|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
131113331|NCT03471871|472044100|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
131113332|NCT03471871|472044096|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
131113333|NCT03471871|472044097|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
131113334|NCT03471871|472044098|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
131113335|NCT03471871|472044099|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
131113336|NCT03471871|472044100|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
131113337|NCT03144804|472044102|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
130694300|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131026930|NCT00901901|471730454|FG000|Treatment Period|Protocol driven decision point|0|||
130694301|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131113338|NCT03971422|472045510|FG000|Overall Study|Lost to Follow-up|0|||
131113339|NCT03971422|472045511|FG001|Overall Study|Lost to Follow-up|1|||
131113340|NCT03971422|472045512|FG002|Overall Study|Lost to Follow-up|0|||
131113341|NCT03971422|472045510|FG000|Overall Study|Lack of Efficacy|5|||
131113342|NCT03971422|472045511|FG001|Overall Study|Lack of Efficacy|1|||
131113343|NCT03971422|472045512|FG002|Overall Study|Lack of Efficacy|1|||
131113344|NCT03971422|472045510|FG000|Overall Study|Adverse event, not fatal|2|||
131113345|NCT03971422|472045511|FG001|Overall Study|Adverse event, not fatal|2|||
131113346|NCT03971422|472045512|FG002|Overall Study|Adverse event, not fatal|5|||
131113347|NCT03971422|472045510|FG000|Overall Study|Worsening of MG Symptoms|1|||
131113348|NCT03971422|472045511|FG001|Overall Study|Worsening of MG Symptoms|4|||
131113349|NCT03971422|472045512|FG002|Overall Study|Worsening of MG Symptoms|2|||
131113350|NCT03971422|472045510|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
131113351|NCT03971422|472045511|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
131113352|NCT03971422|472045512|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
131113353|NCT03971422|472045510|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
131113354|NCT03971422|472045511|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
131113355|NCT03971422|472045512|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
131113356|NCT03971422|472045510|FG000|Overall Study|Due to COVID-19 pandemic|0|||
131113357|NCT03971422|472045511|FG001|Overall Study|Due to COVID-19 pandemic|1|||
131113358|NCT03971422|472045512|FG002|Overall Study|Due to COVID-19 pandemic|1|||
131113359|NCT04751656|472045515|FG000|Overall Study|Lost to Follow-up|1|||
131113360|NCT03566810|472045516|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
131113361|NCT03566810|472045517|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
131026931|NCT00901901|471730455|FG001|Treatment Period|Protocol driven decision point|2|||
131026932|NCT00901901|471730454|FG000|Treatment Period|Study terminated by sponsor|2|||
130694302|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694303|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694304|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
131026933|NCT00901901|471730455|FG001|Treatment Period|Study terminated by sponsor|0|||
131026934|NCT00901901|471730454|FG000|Treatment Period|Protocol Violation|5|||
131026935|NCT00901901|471730455|FG001|Treatment Period|Protocol Violation|9|||
131026936|NCT00901901|471730454|FG000|Treatment Period|Switch to commercial drug|1|||
131026937|NCT00901901|471730455|FG001|Treatment Period|Switch to commercial drug|1|||
131026938|NCT00901901|471730454|FG000|Treatment Period|Transfer to treatment continuation study|5|||
131026939|NCT00901901|471730455|FG001|Treatment Period|Transfer to treatment continuation study|2|||
131026940|NCT00901901|471730454|FG000|Follow-up Period|Death|181|||
131026941|NCT00901901|471730455|FG001|Follow-up Period|Death|208|||
131026942|NCT00901901|471730454|FG000|Follow-up Period|Protocol driven decision point|47|||
131026943|NCT00901901|471730455|FG001|Follow-up Period|Protocol driven decision point|36|||
131026944|NCT00901901|471730454|FG000|Follow-up Period|Withdrawal by Subject|6|||
131026945|NCT00901901|471730455|FG001|Follow-up Period|Withdrawal by Subject|9|||
131026946|NCT00901901|471730454|FG000|Follow-up Period|Lost to Follow-up|12|||
131026947|NCT00901901|471730455|FG001|Follow-up Period|Lost to Follow-up|8|||
131026948|NCT00901901|471730454|FG000|Follow-up Period|Missing|94|||
131026949|NCT00901901|471730455|FG001|Follow-up Period|Missing|80|||
131026950|NCT05171777|471730458|FG000|Treatment Crossover Period|Adverse Event|9|||
131026951|NCT05171777|471730459|FG001|Treatment Crossover Period|Adverse Event|6|||
131026952|NCT05171777|471730460|FG002|Treatment Crossover Period|Adverse Event|0|||
131026953|NCT05171777|471730461|FG003|Treatment Crossover Period|Adverse Event|0|||
131026954|NCT05171777|471730458|FG000|Treatment Crossover Period|Death|5|||
131026955|NCT05171777|471730459|FG001|Treatment Crossover Period|Death|5|||
131026956|NCT05171777|471730460|FG002|Treatment Crossover Period|Death|0|||
131026957|NCT05171777|471730461|FG003|Treatment Crossover Period|Death|0|||
131026958|NCT05171777|471730458|FG000|Treatment Crossover Period|Disease Relapse|0|||
131026959|NCT05171777|471730459|FG001|Treatment Crossover Period|Disease Relapse|1|||
131026960|NCT05171777|471730460|FG002|Treatment Crossover Period|Disease Relapse|0|||
131026961|NCT05171777|471730461|FG003|Treatment Crossover Period|Disease Relapse|0|||
131026962|NCT05171777|471730458|FG000|Treatment Crossover Period|Reason not Specified|2|||
131026963|NCT05171777|471730459|FG001|Treatment Crossover Period|Reason not Specified|1|||
131026964|NCT05171777|471730460|FG002|Treatment Crossover Period|Reason not Specified|0|||
131026965|NCT05171777|471730461|FG003|Treatment Crossover Period|Reason not Specified|0|||
131113362|NCT03566810|472045518|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
131113363|NCT03566810|472045519|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
131026966|NCT05171777|471730458|FG000|Treatment Crossover Period|Physician Decision|0|||
131026967|NCT05171777|471730459|FG001|Treatment Crossover Period|Physician Decision|1|||
131113364|NCT01955122|472045527|FG000|Overall Study|Physician Decision|5|||
131113365|NCT01955122|472045528|FG001|Overall Study|Physician Decision|5|||
131113366|NCT00826111|472045529|FG000|Overall Study|Lost to Follow-up|0|||
131113367|NCT00826111|472045530|FG001|Overall Study|Lost to Follow-up|1|||
131113368|NCT00826111|472045529|FG000|Overall Study|Protocol Violation|1|||
131113369|NCT00826111|472045530|FG001|Overall Study|Protocol Violation|0|||
131026968|NCT05171777|471730460|FG002|Treatment Crossover Period|Physician Decision|0|||
131026969|NCT05171777|471730461|FG003|Treatment Crossover Period|Physician Decision|0|||
131026970|NCT05171777|471730458|FG000|Treatment Crossover Period|Progressive Disease|13|||
131026971|NCT05171777|471730459|FG001|Treatment Crossover Period|Progressive Disease|9|||
131026972|NCT05171777|471730460|FG002|Treatment Crossover Period|Progressive Disease|0|||
131026973|NCT05171777|471730461|FG003|Treatment Crossover Period|Progressive Disease|0|||
131026974|NCT05171777|471730458|FG000|Treatment Crossover Period|Protocol Violation|0|||
131026975|NCT05171777|471730459|FG001|Treatment Crossover Period|Protocol Violation|2|||
131026976|NCT05171777|471730460|FG002|Treatment Crossover Period|Protocol Violation|0|||
131026977|NCT05171777|471730461|FG003|Treatment Crossover Period|Protocol Violation|0|||
131026978|NCT05171777|471730458|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
131026979|NCT05171777|471730459|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
131026980|NCT05171777|471730460|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
131026981|NCT05171777|471730461|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
131026982|NCT05171777|471730458|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
131026983|NCT05171777|471730459|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
131026984|NCT05171777|471730460|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
131026985|NCT05171777|471730461|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
131026986|NCT05171777|471730458|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
131026987|NCT05171777|471730459|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
131026988|NCT05171777|471730460|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
131026989|NCT05171777|471730461|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
131026990|NCT05171777|471730458|FG000|Treatment Continuation Period|Death|0|||
131026991|NCT05171777|471730459|FG001|Treatment Continuation Period|Death|0|||
131026992|NCT05171777|471730460|FG002|Treatment Continuation Period|Death|1|||
131026993|NCT05171777|471730461|FG003|Treatment Continuation Period|Death|6|||
131026994|NCT05171777|471730458|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
131026995|NCT05171777|471730459|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
131026996|NCT05171777|471730460|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
131026997|NCT05171777|471730461|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
131026998|NCT02272816|471730462|FG000|Overall Study|Adverse Event|1|||
131026999|NCT00632749|471730463|FG000|Overall Study|Progressive disease|3|||
131027000|NCT00632749|471730464|FG001|Overall Study|Progressive disease|2|||
131027001|NCT00632749|471730465|FG002|Overall Study|Progressive disease|2|||
131027002|NCT00632749|471730466|FG003|Overall Study|Progressive disease|2|||
131027003|NCT00632749|471730467|FG004|Overall Study|Progressive disease|4|||
131027004|NCT00632749|471730468|FG005|Overall Study|Progressive disease|4|||
131027005|NCT00632749|471730469|FG006|Overall Study|Progressive disease|3|||
131027006|NCT00632749|471730470|FG007|Overall Study|Progressive disease|2|||
131027007|NCT00632749|471730471|FG008|Overall Study|Progressive disease|3|||
131027008|NCT00632749|471730472|FG009|Overall Study|Progressive disease|2|||
131027009|NCT00632749|471730473|FG010|Overall Study|Progressive disease|4|||
131027010|NCT00632749|471730474|FG011|Overall Study|Progressive disease|3|||
131027011|NCT00632749|471730475|FG012|Overall Study|Progressive disease|2|||
131027012|NCT00632749|471730476|FG013|Overall Study|Progressive disease|4|||
131027013|NCT00632749|471730463|FG000|Overall Study|Other Adverse event|1|||
131027014|NCT00632749|471730464|FG001|Overall Study|Other Adverse event|1|||
131027015|NCT00632749|471730465|FG002|Overall Study|Other Adverse event|1|||
131027016|NCT00632749|471730466|FG003|Overall Study|Other Adverse event|1|||
131027017|NCT00632749|471730467|FG004|Overall Study|Other Adverse event|2|||
131027018|NCT00632749|471730468|FG005|Overall Study|Other Adverse event|4|||
131027019|NCT00632749|471730469|FG006|Overall Study|Other Adverse event|1|||
131027020|NCT00632749|471730470|FG007|Overall Study|Other Adverse event|2|||
131027021|NCT00632749|471730471|FG008|Overall Study|Other Adverse event|2|||
131027022|NCT00632749|471730472|FG009|Overall Study|Other Adverse event|0|||
131027023|NCT00632749|471730473|FG010|Overall Study|Other Adverse event|1|||
131027024|NCT00632749|471730474|FG011|Overall Study|Other Adverse event|0|||
131027025|NCT00632749|471730475|FG012|Overall Study|Other Adverse event|1|||
131027026|NCT00632749|471730476|FG013|Overall Study|Other Adverse event|0|||
131027027|NCT00632749|471730463|FG000|Overall Study|Refuse to continue medication|0|||
131027028|NCT00632749|471730464|FG001|Overall Study|Refuse to continue medication|0|||
131027029|NCT00632749|471730465|FG002|Overall Study|Refuse to continue medication|0|||
131027030|NCT00632749|471730466|FG003|Overall Study|Refuse to continue medication|1|||
130694305|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694306|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694307|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694308|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694309|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130694310|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694311|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694312|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
131027031|NCT00632749|471730467|FG004|Overall Study|Refuse to continue medication|0|||
131027032|NCT00632749|471730468|FG005|Overall Study|Refuse to continue medication|0|||
130902272|NCT03860935|471277459|FG000|Overall Study|Withdrawal of Consent|15|||
130902273|NCT03860935|471277460|FG001|Overall Study|Withdrawal of Consent|6|||
131027033|NCT00632749|471730469|FG006|Overall Study|Refuse to continue medication|0|||
131027034|NCT00632749|471730470|FG007|Overall Study|Refuse to continue medication|0|||
131027035|NCT00632749|471730471|FG008|Overall Study|Refuse to continue medication|0|||
131027036|NCT00632749|471730472|FG009|Overall Study|Refuse to continue medication|1|||
131027037|NCT00632749|471730473|FG010|Overall Study|Refuse to continue medication|0|||
131027038|NCT00632749|471730474|FG011|Overall Study|Refuse to continue medication|0|||
131027039|NCT00632749|471730475|FG012|Overall Study|Refuse to continue medication|0|||
131027040|NCT00632749|471730476|FG013|Overall Study|Refuse to continue medication|0|||
131027041|NCT00632749|471730463|FG000|Overall Study|Reason other than those specified above|0|||
131027042|NCT00632749|471730464|FG001|Overall Study|Reason other than those specified above|2|||
131027043|NCT00632749|471730465|FG002|Overall Study|Reason other than those specified above|0|||
131027044|NCT00632749|471730466|FG003|Overall Study|Reason other than those specified above|0|||
131027045|NCT00632749|471730467|FG004|Overall Study|Reason other than those specified above|1|||
131027046|NCT00632749|471730468|FG005|Overall Study|Reason other than those specified above|0|||
131027047|NCT00632749|471730469|FG006|Overall Study|Reason other than those specified above|1|||
131027048|NCT00632749|471730470|FG007|Overall Study|Reason other than those specified above|0|||
131027049|NCT00632749|471730471|FG008|Overall Study|Reason other than those specified above|0|||
131027050|NCT00632749|471730472|FG009|Overall Study|Reason other than those specified above|0|||
131027051|NCT00632749|471730473|FG010|Overall Study|Reason other than those specified above|2|||
131027052|NCT00632749|471730474|FG011|Overall Study|Reason other than those specified above|1|||
131027053|NCT00632749|471730475|FG012|Overall Study|Reason other than those specified above|0|||
131027054|NCT00632749|471730476|FG013|Overall Study|Reason other than those specified above|2|||
131027055|NCT02671435|471730477|FG000|Overall Study|Death|1|||
131027056|NCT02671435|471730478|FG001|Overall Study|Death|3|||
131027057|NCT02671435|471730479|FG002|Overall Study|Death|0|||
131027058|NCT02671435|471730480|FG003|Overall Study|Death|16|||
131027059|NCT02671435|471730481|FG004|Overall Study|Death|14|||
131027060|NCT02671435|471730482|FG005|Overall Study|Death|29|||
131027061|NCT02671435|471730483|FG006|Overall Study|Death|34|||
131027062|NCT02671435|471730484|FG007|Overall Study|Death|28|||
131027063|NCT02671435|471730485|FG008|Overall Study|Death|19|||
131027064|NCT02671435|471730486|FG009|Overall Study|Death|10|||
131027065|NCT02671435|471730487|FG010|Overall Study|Death|8|||
131027066|NCT02671435|471730488|FG011|Overall Study|Death|29|||
131027067|NCT02671435|471730489|FG012|Overall Study|Death|29|||
131027068|NCT02671435|471730490|FG013|Overall Study|Death|29|||
131027069|NCT02671435|471730491|FG014|Overall Study|Death|27|||
131027070|NCT02671435|471730477|FG000|Overall Study|Lost to Follow-up|0|||
131027071|NCT02671435|471730478|FG001|Overall Study|Lost to Follow-up|0|||
131027072|NCT02671435|471730479|FG002|Overall Study|Lost to Follow-up|1|||
131027073|NCT02671435|471730480|FG003|Overall Study|Lost to Follow-up|0|||
131027074|NCT02671435|471730481|FG004|Overall Study|Lost to Follow-up|1|||
131027075|NCT02671435|471730482|FG005|Overall Study|Lost to Follow-up|1|||
131027076|NCT02671435|471730483|FG006|Overall Study|Lost to Follow-up|2|||
131027077|NCT02671435|471730484|FG007|Overall Study|Lost to Follow-up|2|||
131027078|NCT02671435|471730485|FG008|Overall Study|Lost to Follow-up|0|||
131027079|NCT02671435|471730486|FG009|Overall Study|Lost to Follow-up|2|||
131027080|NCT02671435|471730487|FG010|Overall Study|Lost to Follow-up|0|||
131027081|NCT02671435|471730488|FG011|Overall Study|Lost to Follow-up|3|||
130902274|NCT03860935|471277459|FG000|Overall Study|Death|75|||
130902275|NCT03860935|471277460|FG001|Overall Study|Death|51|||
130902276|NCT03086967|471277461|FG000|Overall Study|Screen Failure|2|||
130902277|NCT03086967|471277462|FG001|Overall Study|Screen Failure|2|||
130902278|NCT01430754|471277465|FG000|Run-In Phase|Circadian Period Ineligible|24|||
130902279|NCT01430754|471277466|FG001|Run-In Phase|Circadian Period Ineligible|0|||
130902280|NCT01430754|471277465|FG000|Run-In Phase|Protocol Violation|6|||
130902281|NCT01430754|471277466|FG001|Run-In Phase|Protocol Violation|0|||
130902282|NCT01430754|471277465|FG000|Run-In Phase|Adverse Event|2|||
130902283|NCT01430754|471277466|FG001|Run-In Phase|Adverse Event|0|||
130902284|NCT01430754|471277465|FG000|Run-In Phase|Other|2|||
130902285|NCT01430754|471277466|FG001|Run-In Phase|Other|0|||
130902286|NCT01430754|471277465|FG000|Run-In Phase|Withdrawal by Subject|2|||
130902287|NCT01430754|471277466|FG001|Run-In Phase|Withdrawal by Subject|0|||
130902288|NCT01430754|471277465|FG000|Run-In Phase|Lost to Follow-up|1|||
130902289|NCT01430754|471277466|FG001|Run-In Phase|Lost to Follow-up|0|||
130902290|NCT02230527|471277468|FG000|Overall Study|Withdrawal by Subject|1|||
130902291|NCT02230527|471277469|FG001|Overall Study|Withdrawal by Subject|1|||
130902292|NCT02230527|471277468|FG000|Overall Study|Death|1|||
130902293|NCT02230527|471277469|FG001|Overall Study|Death|0|||
130902294|NCT02230527|471277468|FG000|Overall Study|Lost to Follow-up|2|||
130902295|NCT02230527|471277469|FG001|Overall Study|Lost to Follow-up|1|||
130902296|NCT02230527|471277468|FG000|Overall Study|Other|1|||
130902297|NCT02230527|471277469|FG001|Overall Study|Other|0|||
130902298|NCT04461600|471277470|FG000|Overall Study|Death|6|||
130902299|NCT04461600|471277471|FG001|Overall Study|Death|5|||
130902300|NCT04461600|471277470|FG000|Overall Study|Withdrawal by Subject|0|||
130694313|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694314|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694315|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694316|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694317|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694318|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
130694319|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694320|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
130902301|NCT04461600|471277471|FG001|Overall Study|Withdrawal by Subject|1|||
130902302|NCT00775203|471277477|FG000|Overall Study|Adverse Event|25|||
130902303|NCT00775203|471277478|FG001|Overall Study|Adverse Event|6|||
130902304|NCT00775203|471277477|FG000|Overall Study|Lack of Efficacy|8|||
130902305|NCT00775203|471277478|FG001|Overall Study|Lack of Efficacy|9|||
130902306|NCT00775203|471277477|FG000|Overall Study|Withdrawal by Subject|11|||
131027082|NCT02671435|471730489|FG012|Overall Study|Lost to Follow-up|3|||
131027083|NCT02671435|471730490|FG013|Overall Study|Lost to Follow-up|2|||
131027084|NCT02671435|471730491|FG014|Overall Study|Lost to Follow-up|0|||
131027085|NCT02671435|471730477|FG000|Overall Study|Withdrawal by Subject|2|||
131027086|NCT02671435|471730478|FG001|Overall Study|Withdrawal by Subject|0|||
131027087|NCT02671435|471730479|FG002|Overall Study|Withdrawal by Subject|2|||
131027088|NCT02671435|471730480|FG003|Overall Study|Withdrawal by Subject|2|||
131027089|NCT02671435|471730481|FG004|Overall Study|Withdrawal by Subject|2|||
131027090|NCT02671435|471730482|FG005|Overall Study|Withdrawal by Subject|7|||
131027091|NCT02671435|471730483|FG006|Overall Study|Withdrawal by Subject|2|||
131027092|NCT02671435|471730484|FG007|Overall Study|Withdrawal by Subject|7|||
131027093|NCT02671435|471730485|FG008|Overall Study|Withdrawal by Subject|1|||
131027094|NCT02671435|471730486|FG009|Overall Study|Withdrawal by Subject|1|||
131027095|NCT02671435|471730487|FG010|Overall Study|Withdrawal by Subject|2|||
131027096|NCT02671435|471730488|FG011|Overall Study|Withdrawal by Subject|4|||
131027097|NCT02671435|471730489|FG012|Overall Study|Withdrawal by Subject|4|||
131027098|NCT02671435|471730490|FG013|Overall Study|Withdrawal by Subject|4|||
131027099|NCT02671435|471730491|FG014|Overall Study|Withdrawal by Subject|2|||
131027100|NCT02671435|471730477|FG000|Overall Study|Un-specified|0|||
131027101|NCT02671435|471730478|FG001|Overall Study|Un-specified|0|||
131027102|NCT02671435|471730479|FG002|Overall Study|Un-specified|0|||
131027103|NCT02671435|471730480|FG003|Overall Study|Un-specified|0|||
131027104|NCT02671435|471730481|FG004|Overall Study|Un-specified|1|||
131027105|NCT02671435|471730482|FG005|Overall Study|Un-specified|3|||
131027106|NCT02671435|471730483|FG006|Overall Study|Un-specified|2|||
131027107|NCT02671435|471730484|FG007|Overall Study|Un-specified|3|||
131027108|NCT02671435|471730485|FG008|Overall Study|Un-specified|0|||
131027109|NCT02671435|471730486|FG009|Overall Study|Un-specified|5|||
131027110|NCT02671435|471730487|FG010|Overall Study|Un-specified|8|||
131027111|NCT02671435|471730488|FG011|Overall Study|Un-specified|4|||
131027112|NCT02671435|471730489|FG012|Overall Study|Un-specified|5|||
131027113|NCT02671435|471730490|FG013|Overall Study|Un-specified|9|||
131027114|NCT02671435|471730491|FG014|Overall Study|Un-specified|8|||
131027115|NCT02412748|471730494|FG000|Overall Study|Lost to Follow-up|38|||
131027116|NCT02412748|471730495|FG001|Overall Study|Lost to Follow-up|39|||
131027117|NCT04128319|471730496|FG000|Overall Study|Death|3|||
131027118|NCT01011946|471730498|FG000|Overall Study|Transferred to another hospital|2|||
131027119|NCT01011946|471730498|FG000|Overall Study|No pathological lab value|1|||
131027120|NCT04820686|471730499|FG000|Overall Study|Withdrawal by Subject|5|||
131027121|NCT04820686|471730500|FG001|Overall Study|Withdrawal by Subject|2|||
131027122|NCT04820686|471730501|FG002|Overall Study|Withdrawal by Subject|3|||
131027123|NCT04820686|471730499|FG000|Overall Study|Study Termination|25|||
131027124|NCT04820686|471730500|FG001|Overall Study|Study Termination|13|||
131027125|NCT04820686|471730501|FG002|Overall Study|Study Termination|14|||
131027126|NCT04820686|471730499|FG000|Overall Study|Adverse Event|0|||
131027127|NCT04820686|471730500|FG001|Overall Study|Adverse Event|1|||
131027128|NCT04820686|471730501|FG002|Overall Study|Adverse Event|0|||
131027129|NCT01872078|471730502|FG000|Overall Study|Adverse Event|0|||
131027130|NCT01872078|471730503|FG001|Overall Study|Adverse Event|0|||
131027131|NCT01872078|471730504|FG002|Overall Study|Adverse Event|1|||
131027132|NCT01872078|471730505|FG003|Overall Study|Adverse Event|0|||
131027133|NCT01872078|471730502|FG000|Overall Study|Dose administration non-compliance|0|||
131027134|NCT01872078|471730503|FG001|Overall Study|Dose administration non-compliance|0|||
130902307|NCT00775203|471277478|FG001|Overall Study|Withdrawal by Subject|9|||
131027135|NCT01872078|471730504|FG002|Overall Study|Dose administration non-compliance|0|||
131027136|NCT01872078|471730505|FG003|Overall Study|Dose administration non-compliance|1|||
131027137|NCT01872078|471730502|FG000|Overall Study|Protocol Violation|0|||
130694321|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
131027138|NCT01872078|471730503|FG001|Overall Study|Protocol Violation|0|||
130902308|NCT00775203|471277477|FG000|Overall Study|Lost to Follow-up|11|||
131027139|NCT01872078|471730504|FG002|Overall Study|Protocol Violation|1|||
130902309|NCT00775203|471277478|FG001|Overall Study|Lost to Follow-up|15|||
131027140|NCT01872078|471730505|FG003|Overall Study|Protocol Violation|0|||
130768293|NCT04776018|470775534|FG000|Overall Study|Study terminated by sponsor|2|||
130768294|NCT04776018|470775535|FG001|Overall Study|Study terminated by sponsor|1|||
130768295|NCT04776018|470775536|FG002|Overall Study|Study terminated by sponsor|4|||
130768296|NCT04776018|470775537|FG003|Overall Study|Study terminated by sponsor|0|||
130768297|NCT04776018|470775538|FG004|Overall Study|Study terminated by sponsor|3|||
130768298|NCT04776018|470775539|FG005|Overall Study|Study terminated by sponsor|0|||
130768299|NCT04776018|470775540|FG006|Overall Study|Study terminated by sponsor|0|||
130768300|NCT04776018|470775534|FG000|Overall Study|Withdrawal by Subject|1|||
130768301|NCT04776018|470775535|FG001|Overall Study|Withdrawal by Subject|0|||
130768302|NCT04776018|470775536|FG002|Overall Study|Withdrawal by Subject|0|||
130768303|NCT04776018|470775537|FG003|Overall Study|Withdrawal by Subject|2|||
130768304|NCT04776018|470775538|FG004|Overall Study|Withdrawal by Subject|1|||
131027141|NCT01872078|471730502|FG000|Overall Study|Withdrawal by Subject|0|||
131027142|NCT01872078|471730503|FG001|Overall Study|Withdrawal by Subject|0|||
131027143|NCT01872078|471730504|FG002|Overall Study|Withdrawal by Subject|1|||
131027144|NCT01872078|471730505|FG003|Overall Study|Withdrawal by Subject|0|||
131027145|NCT01872078|471730502|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
131027146|NCT01872078|471730503|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
131027147|NCT01872078|471730504|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
131027148|NCT01872078|471730505|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
131027149|NCT01424670|471730506|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
131027150|NCT01424670|471730507|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
131027151|NCT01424670|471730506|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
131027152|NCT01424670|471730507|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
131027153|NCT01424670|471730506|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
131027154|NCT01424670|471730507|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
131027155|NCT01424670|471730506|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
131027156|NCT01424670|471730507|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
131027157|NCT01424670|471730506|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
131027158|NCT01424670|471730507|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
131027159|NCT01424670|471730506|FG000|Continuation Period|Adverse Event|13|||
131027160|NCT01424670|471730507|FG001|Continuation Period|Adverse Event|5|||
131027161|NCT01424670|471730506|FG000|Continuation Period|Lost to Follow-up|2|||
131027162|NCT01424670|471730507|FG001|Continuation Period|Lost to Follow-up|0|||
131027163|NCT01424670|471730506|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
131027164|NCT01424670|471730507|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
131027165|NCT01424670|471730506|FG000|Continuation Period|Physician Decision|5|||
131027166|NCT01424670|471730507|FG001|Continuation Period|Physician Decision|4|||
131027167|NCT01424670|471730506|FG000|Continuation Period|Withdrawal by Subject|13|||
131027168|NCT01424670|471730507|FG001|Continuation Period|Withdrawal by Subject|4|||
131027169|NCT00761189|471730508|FG000|Overall Study|Adverse Event|42|||
131027170|NCT00761189|471730508|FG000|Overall Study|Lack of Efficacy|45|||
131027171|NCT00761189|471730508|FG000|Overall Study|Lost to Follow-up|36|||
131027172|NCT00761189|471730508|FG000|Overall Study|Withdrawal by Subject|49|||
131027173|NCT00761189|471730508|FG000|Overall Study|Other|13|||
131027174|NCT03988842|471730511|FG000|Overall Study|Death|1|||
131027175|NCT00709098|471730514|FG000|Double-blind Period|Withdrawal of consent|3|||
131027176|NCT00709098|471730515|FG001|Double-blind Period|Withdrawal of consent|3|||
131027177|NCT00709098|471730516|FG002|Double-blind Period|Withdrawal of consent|0|||
131027178|NCT00709098|471730514|FG000|Double-blind Period|Administrative reason|1|||
131027179|NCT00709098|471730515|FG001|Double-blind Period|Administrative reason|3|||
131027180|NCT00709098|471730516|FG002|Double-blind Period|Administrative reason|0|||
131027181|NCT00709098|471730514|FG000|Double-blind Period|Death|1|||
131027182|NCT00709098|471730515|FG001|Double-blind Period|Death|1|||
131027183|NCT00709098|471730516|FG002|Double-blind Period|Death|0|||
131027184|NCT00709098|471730514|FG000|Double-blind Period|Lost to Follow-up|1|||
131027185|NCT00709098|471730515|FG001|Double-blind Period|Lost to Follow-up|1|||
131027186|NCT00709098|471730516|FG002|Double-blind Period|Lost to Follow-up|0|||
131027187|NCT00709098|471730514|FG000|Open-label Period|Withdrawal of consent|0|||
131027188|NCT00709098|471730515|FG001|Open-label Period|Withdrawal of consent|0|||
131027189|NCT00709098|471730516|FG002|Open-label Period|Withdrawal of consent|7|||
131027190|NCT00709098|471730514|FG000|Open-label Period|Administrative reason|0|||
131027191|NCT00709098|471730515|FG001|Open-label Period|Administrative reason|0|||
131027192|NCT00709098|471730516|FG002|Open-label Period|Administrative reason|5|||
131027193|NCT00709098|471730514|FG000|Open-label Period|Death|0|||
131027194|NCT00709098|471730515|FG001|Open-label Period|Death|0|||
131027195|NCT00709098|471730516|FG002|Open-label Period|Death|1|||
131027196|NCT00709098|471730514|FG000|Open-label Period|Lost to Follow-up|0|||
131027197|NCT00709098|471730515|FG001|Open-label Period|Lost to Follow-up|0|||
131027198|NCT00709098|471730516|FG002|Open-label Period|Lost to Follow-up|1|||
131027199|NCT01227265|471730518|FG000|Overall Study|Did Not Receive Treatment|1|||
131027200|NCT01227265|471730519|FG001|Overall Study|Did Not Receive Treatment|2|||
131027201|NCT01227265|471730520|FG002|Overall Study|Did Not Receive Treatment|0|||
131027202|NCT01227265|471730518|FG000|Overall Study|Administrative|1|||
131027203|NCT01227265|471730519|FG001|Overall Study|Administrative|0|||
130902310|NCT00775203|471277477|FG000|Overall Study|Administrative reason|2|||
130902311|NCT00775203|471277478|FG001|Overall Study|Administrative reason|0|||
131027204|NCT01227265|471730520|FG002|Overall Study|Administrative|2|||
131027205|NCT01227265|471730518|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
131027206|NCT01227265|471730519|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
131027207|NCT01227265|471730520|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
131027208|NCT01227265|471730518|FG000|Overall Study|Protocol Violation|2|||
131027209|NCT01227265|471730519|FG001|Overall Study|Protocol Violation|1|||
131027210|NCT01227265|471730520|FG002|Overall Study|Protocol Violation|0|||
131027211|NCT01227265|471730518|FG000|Overall Study|Withdrawal by Subject|7|||
131027212|NCT01227265|471730519|FG001|Overall Study|Withdrawal by Subject|7|||
131027213|NCT01227265|471730520|FG002|Overall Study|Withdrawal by Subject|3|||
131027214|NCT01227265|471730518|FG000|Overall Study|Lost to Follow-up|2|||
131027215|NCT01227265|471730519|FG001|Overall Study|Lost to Follow-up|0|||
131027216|NCT01227265|471730520|FG002|Overall Study|Lost to Follow-up|3|||
131027217|NCT01227265|471730518|FG000|Overall Study|Adverse Event|6|||
131027218|NCT01227265|471730519|FG001|Overall Study|Adverse Event|10|||
131027219|NCT01227265|471730520|FG002|Overall Study|Adverse Event|5|||
131027220|NCT03481816|471730522|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
131027221|NCT03481816|471730523|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
131027222|NCT03481816|471730522|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
131027223|NCT03481816|471730523|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
131027224|NCT03481816|471730522|FG000|Dose Expansion|Withdrawal by Subject|0|||
131027225|NCT03481816|471730523|FG001|Dose Expansion|Withdrawal by Subject|2|||
131027226|NCT03481816|471730522|FG000|Dose Expansion|Physician Decision|0|||
131027227|NCT03481816|471730523|FG001|Dose Expansion|Physician Decision|5|||
131027228|NCT03582722|471730531|FG000|Overall Study|Lost to Follow-up|1|||
131027229|NCT03582722|471730532|FG001|Overall Study|Lost to Follow-up|4|||
131027230|NCT03582722|471730531|FG000|Overall Study|Withdrawal by Subject|3|||
131027231|NCT03582722|471730532|FG001|Overall Study|Withdrawal by Subject|3|||
131027232|NCT03690206|471730533|FG000|Overall Study|Withdrawal by Subject|2|||
131027233|NCT03690206|471730534|FG001|Overall Study|Withdrawal by Subject|0|||
131027234|NCT03690206|471730535|FG002|Overall Study|Withdrawal by Subject|0|||
131027235|NCT03690206|471730533|FG000|Overall Study|ICF withdrawal|2|||
131027236|NCT03690206|471730534|FG001|Overall Study|ICF withdrawal|0|||
131027237|NCT03690206|471730535|FG002|Overall Study|ICF withdrawal|0|||
131027238|NCT06024174|471730536|FG000|Overall Study|Other Reasons|1|||
131027239|NCT06024174|471730536|FG000|Overall Study|Study terminated by Sponsor|4|||
131027240|NCT05028582|471730537|FG000|Overall Study|Lost to Follow-up|11|||
131027241|NCT05028582|471730538|FG001|Overall Study|Lost to Follow-up|9|||
131027242|NCT05028582|471730537|FG000|Overall Study|Withdrawal by Subject|9|||
131027243|NCT05028582|471730538|FG001|Overall Study|Withdrawal by Subject|10|||
131027244|NCT05028582|471730537|FG000|Overall Study|Adverse Event|5|||
131027245|NCT05028582|471730538|FG001|Overall Study|Adverse Event|2|||
131027246|NCT05028582|471730537|FG000|Overall Study|Miscellaneous|3|||
131027247|NCT05028582|471730538|FG001|Overall Study|Miscellaneous|2|||
131027248|NCT05028582|471730537|FG000|Overall Study|Lack of Efficacy|3|||
131027249|NCT05028582|471730538|FG001|Overall Study|Lack of Efficacy|1|||
131027250|NCT05028582|471730537|FG000|Overall Study|Physician Decision|0|||
131027251|NCT05028582|471730538|FG001|Overall Study|Physician Decision|1|||
131027252|NCT01959698|471730539|FG000|Overall Study|Adverse Event|0|||
131027253|NCT01959698|471730540|FG001|Overall Study|Adverse Event|0|||
131027254|NCT01959698|471730541|FG002|Overall Study|Adverse Event|0|||
131027255|NCT01959698|471730542|FG003|Overall Study|Adverse Event|0|||
131027256|NCT01959698|471730543|FG004|Overall Study|Adverse Event|0|||
131027257|NCT01959698|471730544|FG005|Overall Study|Adverse Event|0|||
131027258|NCT01959698|471730545|FG006|Overall Study|Adverse Event|1|||
131027259|NCT01959698|471730539|FG000|Overall Study|Physician Decision|1|||
131027260|NCT01959698|471730540|FG001|Overall Study|Physician Decision|0|||
131027261|NCT01959698|471730541|FG002|Overall Study|Physician Decision|1|||
131027262|NCT01959698|471730542|FG003|Overall Study|Physician Decision|2|||
131027263|NCT01959698|471730543|FG004|Overall Study|Physician Decision|0|||
131027264|NCT01959698|471730544|FG005|Overall Study|Physician Decision|3|||
131027265|NCT01959698|471730545|FG006|Overall Study|Physician Decision|3|||
131027266|NCT03012841|471732287|FG000|Overall Study|Protocol Violation|0|||
131027267|NCT03012841|471732288|FG001|Overall Study|Protocol Violation|10|||
131113370|NCT00826111|472045529|FG000|Overall Study|Withdrawal by Subject|5|||
130902312|NCT00775203|471277477|FG000|Overall Study|Noncompliance|4|||
131027268|NCT03012841|471732287|FG000|Overall Study|Lost to Follow-up|6|||
131027269|NCT03012841|471732288|FG001|Overall Study|Lost to Follow-up|1|||
131027270|NCT03012841|471732287|FG000|Overall Study|Withdrawal by Subject|6|||
131027271|NCT03012841|471732288|FG001|Overall Study|Withdrawal by Subject|0|||
131027272|NCT03012841|471732287|FG000|Overall Study|Unable to complete 12 month visit|6|||
131027273|NCT03012841|471732288|FG001|Overall Study|Unable to complete 12 month visit|0|||
131027274|NCT03012841|471732287|FG000|Overall Study|Subject relocation|1|||
131027275|NCT03012841|471732288|FG001|Overall Study|Subject relocation|0|||
131027276|NCT03012841|471732287|FG000|Overall Study|Seasonal winter travel|1|||
131027277|NCT03012841|471732288|FG001|Overall Study|Seasonal winter travel|0|||
131113371|NCT00826111|472045530|FG001|Overall Study|Withdrawal by Subject|0|||
131113372|NCT00826111|472045529|FG000|Overall Study|Physician Decision|1|||
131113373|NCT00826111|472045530|FG001|Overall Study|Physician Decision|1|||
131113374|NCT01672788|472045531|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
131113375|NCT01672788|472045532|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
131113376|NCT01672788|472045533|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
131113377|NCT01672788|472045534|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
131113378|NCT03511053|472045537|FG000|Overall Study|Withdrawal by Subject|1|||
131113379|NCT01128361|472045538|FG000|Overall Study|Lost to Follow-up|0|||
131113380|NCT01128361|472045539|FG001|Overall Study|Lost to Follow-up|1|||
131113381|NCT01128361|472045538|FG000|Overall Study|Withdrawal by Subject|5|||
131113382|NCT01128361|472045539|FG001|Overall Study|Withdrawal by Subject|2|||
131113383|NCT01929980|472045540|FG000|Overall Study|Physician Decision|1|||
131113384|NCT00985166|472045541|FG000|Overall Study|Lost to Follow-up|3|||
131113385|NCT00985166|472045542|FG001|Overall Study|Lost to Follow-up|2|||
131113386|NCT00985166|472045543|FG002|Overall Study|Lost to Follow-up|2|||
131113387|NCT00985166|472045541|FG000|Overall Study|Withdrawal by Subject|3|||
131113388|NCT00985166|472045542|FG001|Overall Study|Withdrawal by Subject|2|||
131113389|NCT00985166|472045543|FG002|Overall Study|Withdrawal by Subject|0|||
131113390|NCT00985166|472045541|FG000|Overall Study|Test not done|2|||
131113391|NCT00985166|472045542|FG001|Overall Study|Test not done|0|||
131113392|NCT00985166|472045543|FG002|Overall Study|Test not done|4|||
131113393|NCT00985166|472045541|FG000|Overall Study|Other|1|||
131113394|NCT00985166|472045542|FG001|Overall Study|Other|0|||
131113395|NCT00985166|472045543|FG002|Overall Study|Other|1|||
131113396|NCT01028222|472045544|FG000|Overall Study|Protocol deviation|1|||
131113397|NCT01028222|472045545|FG001|Overall Study|Protocol deviation|0|||
131113398|NCT01028222|472045544|FG000|Overall Study|Disease progression|33|||
131113399|NCT01028222|472045545|FG001|Overall Study|Disease progression|9|||
131113400|NCT01028222|472045544|FG000|Overall Study|Administrative problems|1|||
131113401|NCT01028222|472045545|FG001|Overall Study|Administrative problems|1|||
131113402|NCT01028222|472045544|FG000|Overall Study|Lost to Follow-up|0|||
131113403|NCT01028222|472045545|FG001|Overall Study|Lost to Follow-up|1|||
131113404|NCT01028222|472045544|FG000|Overall Study|Withdrawal by Subject|1|||
131113405|NCT01028222|472045545|FG001|Overall Study|Withdrawal by Subject|0|||
131113406|NCT01028222|472045544|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
131113407|NCT01028222|472045545|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
131113408|NCT01028222|472045544|FG000|Overall Study|Adverse Event|2|||
131113409|NCT01028222|472045545|FG001|Overall Study|Adverse Event|0|||
131113410|NCT03236246|472045548|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
131113411|NCT03236246|472045549|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
131113412|NCT03236246|472045548|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
131113413|NCT03236246|472045549|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
131113414|NCT03236246|472045548|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
131113415|NCT03236246|472045549|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
131113416|NCT03236246|472045548|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
131113417|NCT03236246|472045549|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
131113418|NCT03236246|472045548|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
131113419|NCT03236246|472045549|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
131113420|NCT03236246|472045548|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
131113421|NCT03236246|472045549|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
131113422|NCT03236246|472045548|FG000|24-Week Dose Titration Period|Death|3|||
131113423|NCT03236246|472045549|FG001|24-Week Dose Titration Period|Death|1|||
131113424|NCT03236246|472045548|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
131113425|NCT03236246|472045549|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
131113426|NCT03236246|472045548|FG000|24-Week Dose Titration Period|Adverse Event|7|||
131113427|NCT03236246|472045549|FG001|24-Week Dose Titration Period|Adverse Event|8|||
131113428|NCT03236246|472045548|FG000|24-Week Dose Titration Period|Captured as Other|1|||
131113429|NCT03236246|472045549|FG001|24-Week Dose Titration Period|Captured as Other|2|||
131113430|NCT03236246|472045548|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
131113431|NCT03236246|472045549|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
131113432|NCT03236246|472045548|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
131113433|NCT03236246|472045549|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
130694322|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
131113434|NCT03236246|472045548|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
131113435|NCT03236246|472045549|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
131113436|NCT03236246|472045548|FG000|24-Week Dose Maintenance Period|Death|0|||
131113437|NCT03236246|472045549|FG001|24-Week Dose Maintenance Period|Death|1|||
131113438|NCT03236246|472045548|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
131113439|NCT03236246|472045549|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
131113440|NCT01008696|472045550|FG000|Overall Study|Participant's evasion of hospital visit|5|||
131113441|NCT01008696|472045551|FG001|Overall Study|Participant's evasion of hospital visit|4|||
131113442|NCT01008696|472045550|FG000|Overall Study|Withdrawal by Subject|2|||
131113443|NCT01008696|472045551|FG001|Overall Study|Withdrawal by Subject|4|||
131113444|NCT01008696|472045550|FG000|Overall Study|Physician Decision|5|||
131113445|NCT01008696|472045551|FG001|Overall Study|Physician Decision|1|||
131113446|NCT01008696|472045550|FG000|Overall Study|Adverse Event|1|||
131113447|NCT01008696|472045551|FG001|Overall Study|Adverse Event|0|||
131113448|NCT01008696|472045550|FG000|Overall Study|Participants' non-cooperation|2|||
131113449|NCT01008696|472045551|FG001|Overall Study|Participants' non-cooperation|3|||
131113450|NCT01008696|472045550|FG000|Overall Study|Other|2|||
131113451|NCT01008696|472045551|FG001|Overall Study|Other|3|||
131113452|NCT01008696|472045550|FG000|Overall Study|Other|0|||
131113453|NCT01008696|472045551|FG001|Overall Study|Other|2|||
131113454|NCT02076113|472045552|FG000|Overall Study|Lost to Follow-up|4|||
131113455|NCT02076113|472045553|FG001|Overall Study|Lost to Follow-up|1|||
131113456|NCT02076113|472045552|FG000|Overall Study|Withdrawal by Subject|2|||
131113457|NCT02076113|472045553|FG001|Overall Study|Withdrawal by Subject|3|||
131113458|NCT02076113|472045552|FG000|Overall Study|Death|1|||
131113459|NCT02076113|472045553|FG001|Overall Study|Death|3|||
131113460|NCT04263909|472045554|FG000|Overall Study|Physician Decision|1|||
131113461|NCT04263909|472045555|FG001|Overall Study|Physician Decision|0|||
131113462|NCT04263909|472045556|FG002|Overall Study|Physician Decision|0|||
131113463|NCT04263909|472045554|FG000|Overall Study|Adverse Event|3|||
131113464|NCT04263909|472045555|FG001|Overall Study|Adverse Event|0|||
131113465|NCT04263909|472045556|FG002|Overall Study|Adverse Event|0|||
131113466|NCT04263909|472045554|FG000|Overall Study|Protocol Violation|5|||
131113467|NCT04263909|472045555|FG001|Overall Study|Protocol Violation|0|||
131113468|NCT04263909|472045556|FG002|Overall Study|Protocol Violation|0|||
131113469|NCT04288778|472045557|FG000|Overall Study|Withdrawal by Subject|2|||
131113470|NCT04288778|472045557|FG000|Overall Study|Adverse Event|5|||
131113471|NCT04288778|472045557|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131113472|NCT04288778|472045557|FG000|Overall Study|Other|1|||
131113473|NCT04288778|472045557|FG000|Overall Study|Started but not treated|2|||
131113474|NCT01324323|472045558|FG000|Overall Study|Withdrawal by Subject|1|||
131113475|NCT03153137|472045559|FG000|Overall Study|Lost to Follow-up|1|||
131113476|NCT03153137|472045560|FG001|Overall Study|Lost to Follow-up|0|||
131113477|NCT03153137|472045559|FG000|Overall Study|Withdrawal by Subject|2|||
131113478|NCT03153137|472045560|FG001|Overall Study|Withdrawal by Subject|1|||
131113479|NCT03153137|472045559|FG000|Overall Study|Physician Decision|0|||
131113480|NCT03153137|472045560|FG001|Overall Study|Physician Decision|3|||
131113481|NCT00528866|472045564|FG000|Overall Study|Protocol Violation|6|||
131113482|NCT00993915|472045568|FG000|Overall Study|Insufficient clinical response|3|||
131113483|NCT00993915|472045568|FG000|Overall Study|Withdrawal by Subject|2|||
131113484|NCT00993915|472045568|FG000|Overall Study|Other|1|||
131113485|NCT00993915|472045568|FG000|Overall Study|Ongoing|3|||
131113486|NCT00769860|472045569|FG000|Overall Study|Withdrawal by Subject|2|||
131113487|NCT00769860|472045570|FG001|Overall Study|Withdrawal by Subject|0|||
131113488|NCT01603082|472045571|FG000|Overall Study|Adverse Event|0|||
131113489|NCT01603082|472045572|FG001|Overall Study|Adverse Event|1|||
131113490|NCT01603082|472045571|FG000|Overall Study|Withdrawal by Subject|1|||
131113491|NCT01603082|472045572|FG001|Overall Study|Withdrawal by Subject|0|||
131113492|NCT01603082|472045571|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
131113493|NCT01603082|472045572|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
131113494|NCT01019317|472045576|FG000|Overall Study|Not Eligible|4|||
131113495|NCT03294109|472045578|FG000|Overall Study|Withdrawal by Subject|6|||
131113496|NCT03294109|472045579|FG001|Overall Study|Withdrawal by Subject|5|||
131113497|NCT04744285|472045580|FG000|Overall Study|Withdrawal by Subject|1|||
131113498|NCT04744285|472045581|FG001|Overall Study|Withdrawal by Subject|1|||
131113499|NCT04744285|472045582|FG002|Overall Study|Withdrawal by Subject|2|||
131113500|NCT04744285|472045583|FG003|Overall Study|Withdrawal by Subject|1|||
131113501|NCT01774084|472045584|FG000|Overall Study|Personal reasons|1|||
130902313|NCT00775203|471277478|FG001|Overall Study|Noncompliance|2|||
130902314|NCT00775203|471277477|FG000|Overall Study|Protocol Violation|0|||
130902315|NCT00775203|471277478|FG001|Overall Study|Protocol Violation|1|||
130902316|NCT00775203|471277477|FG000|Overall Study|Entered other study|1|||
130902317|NCT00775203|471277478|FG001|Overall Study|Entered other study|0|||
130902318|NCT00775203|471277477|FG000|Overall Study|Physician Decision|0|||
131113502|NCT01774084|472045585|FG001|Overall Study|Personal reasons|0|||
131113503|NCT00821431|472045586|FG000|Overall Study|Adverse Event|6|||
131113504|NCT00821431|472045587|FG001|Overall Study|Adverse Event|3|||
131113505|NCT00821431|472045586|FG000|Overall Study|Withdrawal by Subject|5|||
131113506|NCT00821431|472045587|FG001|Overall Study|Withdrawal by Subject|0|||
131113507|NCT00821431|472045586|FG000|Overall Study|Lost to Follow-up|1|||
131113508|NCT00821431|472045587|FG001|Overall Study|Lost to Follow-up|0|||
131113509|NCT00821431|472045586|FG000|Overall Study|Protocol Violation|3|||
131113510|NCT00821431|472045587|FG001|Overall Study|Protocol Violation|1|||
131113511|NCT00821431|472045586|FG000|Overall Study|Physician Decision|0|||
131113512|NCT00821431|472045587|FG001|Overall Study|Physician Decision|1|||
131113513|NCT01843218|472045590|FG000|Overall Study|Withdrawal by Subject|5|||
131113514|NCT04526197|472045591|FG000|Period 1|Adverse Event|0|||
131113515|NCT04526197|472045592|FG001|Period 1|Adverse Event|1|||
131113516|NCT04526197|472045591|FG000|Period 1|Withdrawal by Subject|1|||
131113517|NCT04526197|472045592|FG001|Period 1|Withdrawal by Subject|0|||
131113518|NCT04526197|472045591|FG000|Period 2|Adverse Event|0|||
131113519|NCT04526197|472045592|FG001|Period 2|Adverse Event|1|||
131113520|NCT04526197|472045591|FG000|Period 2|Withdrawal by Subject|0|||
131113521|NCT04526197|472045592|FG001|Period 2|Withdrawal by Subject|1|||
131113522|NCT00372385|472045593|FG000|Overall Study|Adverse Event|6|||
131113523|NCT00372385|472045594|FG001|Overall Study|Adverse Event|11|||
131113524|NCT00372385|472045595|FG002|Overall Study|Adverse Event|9|||
131113525|NCT00372385|472045596|FG003|Overall Study|Adverse Event|7|||
131113526|NCT00372385|472045593|FG000|Overall Study|Noncompliance|0|||
131113527|NCT00372385|472045594|FG001|Overall Study|Noncompliance|1|||
131113528|NCT00372385|472045595|FG002|Overall Study|Noncompliance|1|||
131113529|NCT00372385|472045596|FG003|Overall Study|Noncompliance|1|||
131113530|NCT00372385|472045593|FG000|Overall Study|Physician Decision|1|||
131113531|NCT00372385|472045594|FG001|Overall Study|Physician Decision|0|||
131113532|NCT00372385|472045595|FG002|Overall Study|Physician Decision|0|||
131113533|NCT00372385|472045596|FG003|Overall Study|Physician Decision|0|||
131113534|NCT00372385|472045593|FG000|Overall Study|Lost to Follow-up|2|||
131113535|NCT00372385|472045594|FG001|Overall Study|Lost to Follow-up|0|||
131113536|NCT00372385|472045595|FG002|Overall Study|Lost to Follow-up|0|||
131113537|NCT00372385|472045596|FG003|Overall Study|Lost to Follow-up|0|||
131113538|NCT00372385|472045593|FG000|Overall Study|Withdrawal by Subject|2|||
131113539|NCT00372385|472045594|FG001|Overall Study|Withdrawal by Subject|1|||
131113540|NCT00372385|472045595|FG002|Overall Study|Withdrawal by Subject|0|||
131113541|NCT00372385|472045596|FG003|Overall Study|Withdrawal by Subject|0|||
131113542|NCT00372385|472045593|FG000|Overall Study|Refusal of Treatment|3|||
131113543|NCT00372385|472045594|FG001|Overall Study|Refusal of Treatment|6|||
131113544|NCT00372385|472045595|FG002|Overall Study|Refusal of Treatment|0|||
131113545|NCT00372385|472045596|FG003|Overall Study|Refusal of Treatment|0|||
131113546|NCT00372385|472045593|FG000|Overall Study|No Response|1|||
131113547|NCT00372385|472045594|FG001|Overall Study|No Response|1|||
131113548|NCT00372385|472045595|FG002|Overall Study|No Response|0|||
131113549|NCT00372385|472045596|FG003|Overall Study|No Response|0|||
131113550|NCT00372385|472045593|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
131113551|NCT00372385|472045594|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
131113552|NCT00372385|472045595|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
131113553|NCT00372385|472045596|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
131113554|NCT00372385|472045593|FG000|Overall Study|Virologic Stopping Rule|17|||
131113555|NCT00372385|472045594|FG001|Overall Study|Virologic Stopping Rule|0|||
131113556|NCT00372385|472045595|FG002|Overall Study|Virologic Stopping Rule|0|||
131113557|NCT00372385|472045596|FG003|Overall Study|Virologic Stopping Rule|0|||
131113558|NCT01699789|472045597|FG000|Overall Study|Withdrawal by Subject|18|||
131113559|NCT01699789|472045598|FG001|Overall Study|Withdrawal by Subject|23|||
131113560|NCT01699789|472045597|FG000|Overall Study|Death|1|||
131113561|NCT01699789|472045598|FG001|Overall Study|Death|2|||
131113562|NCT01699789|472045597|FG000|Overall Study|Lost to Follow-up|83|||
131113563|NCT01699789|472045598|FG001|Overall Study|Lost to Follow-up|101|||
131113564|NCT01906346|472045599|FG000|Overall Study|AEs|1|||
131113565|NCT01323621|472045602|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
131113566|NCT01323621|472045603|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
131113567|NCT01323621|472045604|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
131113568|NCT01323621|472045602|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
131113569|NCT01323621|472045603|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
131113570|NCT01323621|472045604|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
131113571|NCT01323621|472045602|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
131113572|NCT01323621|472045603|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
131113573|NCT01323621|472045604|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
131113574|NCT01323621|472045602|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
131113575|NCT01323621|472045603|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
131113576|NCT01323621|472045604|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
131113577|NCT01323621|472045602|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
131113578|NCT01323621|472045603|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
131113579|NCT01323621|472045604|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
131113580|NCT01323621|472045602|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
131113581|NCT01323621|472045603|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
131113582|NCT01323621|472045604|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
130902319|NCT00775203|471277478|FG001|Overall Study|Physician Decision|1|||
130902320|NCT00704522|471277479|FG000|Overall Study|Lack of Efficacy|65|||
131113583|NCT01323621|472045602|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
131113584|NCT01323621|472045603|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
131113585|NCT01323621|472045604|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
131113586|NCT01323621|472045602|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
131222758|NCT00386100|472443176|FG001|Overall Study|BMD <2.5|0|||
131027278|NCT03012841|471732287|FG000|Overall Study|Physician Decision|0|||
131027279|NCT03012841|471732288|FG001|Overall Study|Physician Decision|2|||
131027280|NCT03012841|471732287|FG000|Overall Study|No ablation performed|0|||
131027281|NCT03012841|471732288|FG001|Overall Study|No ablation performed|2|||
131027282|NCT03012841|471732287|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
131027283|NCT03012841|471732288|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
131027284|NCT03012841|471732287|FG000|Overall Study|Insurance change|0|||
131027285|NCT03012841|471732288|FG001|Overall Study|Insurance change|1|||
131027286|NCT05096819|471732289|FG000|Overall Study|Withdrawal by Subject|3|||
131027287|NCT05096819|471732290|FG001|Overall Study|Withdrawal by Subject|0|||
131027288|NCT03547908|471732291|FG000|Blinded Phase|Lost to Follow-up|3|||
131027289|NCT03547908|471732292|FG001|Blinded Phase|Lost to Follow-up|3|||
131027290|NCT03547908|471732293|FG002|Blinded Phase|Lost to Follow-up|0|||
131027291|NCT03547908|471732294|FG003|Blinded Phase|Lost to Follow-up|0|||
131027292|NCT03547908|471732291|FG000|Blinded Phase|Withdrew Consent|2|||
131027293|NCT03547908|471732292|FG001|Blinded Phase|Withdrew Consent|3|||
131027294|NCT03547908|471732293|FG002|Blinded Phase|Withdrew Consent|0|||
131027295|NCT03547908|471732294|FG003|Blinded Phase|Withdrew Consent|0|||
131027296|NCT03547908|471732291|FG000|Blinded Phase|Investigator's Discretion|2|||
131027297|NCT03547908|471732292|FG001|Blinded Phase|Investigator's Discretion|1|||
131027298|NCT03547908|471732293|FG002|Blinded Phase|Investigator's Discretion|0|||
131027299|NCT03547908|471732294|FG003|Blinded Phase|Investigator's Discretion|0|||
131027300|NCT03547908|471732291|FG000|Blinded Phase|Death|2|||
131027301|NCT03547908|471732292|FG001|Blinded Phase|Death|0|||
131027302|NCT03547908|471732293|FG002|Blinded Phase|Death|0|||
131027303|NCT03547908|471732294|FG003|Blinded Phase|Death|0|||
131027304|NCT03547908|471732291|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
131027305|NCT03547908|471732292|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
131027306|NCT03547908|471732293|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
131027307|NCT03547908|471732294|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
131027308|NCT03547908|471732291|FG000|Blinded Phase|Adverse Event|1|||
131027309|NCT03547908|471732292|FG001|Blinded Phase|Adverse Event|0|||
131027310|NCT03547908|471732293|FG002|Blinded Phase|Adverse Event|0|||
131027311|NCT03547908|471732294|FG003|Blinded Phase|Adverse Event|0|||
131027312|NCT03547908|471732291|FG000|Blinded Phase|Randomized But Never Treated|1|||
131027313|NCT03547908|471732292|FG001|Blinded Phase|Randomized But Never Treated|0|||
131027314|NCT03547908|471732293|FG002|Blinded Phase|Randomized But Never Treated|0|||
131027315|NCT03547908|471732294|FG003|Blinded Phase|Randomized But Never Treated|0|||
131027316|NCT03547908|471732291|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
131027317|NCT03547908|471732292|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
131027318|NCT03547908|471732293|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
131027319|NCT03547908|471732294|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
131027320|NCT03547908|471732291|FG000|Open-label Extension Phase|Death|0|||
131027321|NCT03547908|471732292|FG001|Open-label Extension Phase|Death|0|||
131027322|NCT03547908|471732293|FG002|Open-label Extension Phase|Death|1|||
131027323|NCT03547908|471732294|FG003|Open-label Extension Phase|Death|0|||
131027324|NCT03416023|471732301|FG000|Overall Study|Exclusion criteria failure|1|||
131027325|NCT03416023|471732301|FG000|Overall Study|Withdrawal by Subject|6|||
131027326|NCT03416023|471732301|FG000|Overall Study|Explanted|7|||
131027327|NCT03416023|471732301|FG000|Overall Study|Physician Decision|1|||
131027328|NCT03416023|471732301|FG000|Overall Study|Lost to Follow-up|1|||
131027329|NCT03416023|471732301|FG000|Overall Study|Death|1|||
131027330|NCT04878354|471732302|FG000|Overall Study|Adverse Event|4|||
131027331|NCT04878354|471732303|FG001|Overall Study|Adverse Event|13|||
131027332|NCT04878354|471732302|FG000|Overall Study|Withdrawal by Subject|14|||
131027333|NCT04878354|471732303|FG001|Overall Study|Withdrawal by Subject|12|||
131027334|NCT04878354|471732302|FG000|Overall Study|Lost to Follow-up|4|||
131027335|NCT04878354|471732303|FG001|Overall Study|Lost to Follow-up|1|||
131027336|NCT04878354|471732302|FG000|Overall Study|Lack of Efficacy|1|||
131027337|NCT04878354|471732303|FG001|Overall Study|Lack of Efficacy|0|||
131027338|NCT04878354|471732302|FG000|Overall Study|Protocol Violation|0|||
131027339|NCT04878354|471732303|FG001|Overall Study|Protocol Violation|1|||
131027340|NCT04878354|471732302|FG000|Overall Study|"Reason stated as other in CRF"|2|||
131027341|NCT04878354|471732303|FG001|Overall Study|"Reason stated as other in CRF"|3|||
131027342|NCT04112316|471732313|FG000|First Period (8 Weeks)|Protocol Violation|1|||
131027343|NCT04112316|471732314|FG001|First Period (8 Weeks)|Protocol Violation|0|||
131027344|NCT04112316|471732313|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
131027345|NCT04112316|471732314|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
131027346|NCT03857620|471732315|FG000|Overall Study|Death|4|||
131027347|NCT03857620|471732316|FG001|Overall Study|Death|5|||
131027348|NCT03857620|471732317|FG002|Overall Study|Death|7|||
131027349|NCT03857620|471732315|FG000|Overall Study|Lost to Follow-up|2|||
131027350|NCT03857620|471732316|FG001|Overall Study|Lost to Follow-up|5|||
131027351|NCT03857620|471732317|FG002|Overall Study|Lost to Follow-up|3|||
131027352|NCT03857620|471732315|FG000|Overall Study|Disease progression or relapse after study registration|1|||
131027353|NCT03857620|471732316|FG001|Overall Study|Disease progression or relapse after study registration|5|||
131027354|NCT03857620|471732317|FG002|Overall Study|Disease progression or relapse after study registration|1|||
131113587|NCT01323621|472045603|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
131113588|NCT01323621|472045604|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
131113589|NCT01323621|472045602|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
131113590|NCT01323621|472045603|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
131113591|NCT01323621|472045604|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
131113592|NCT01323621|472045602|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131113593|NCT01323621|472045603|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
131113594|NCT01323621|472045604|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131113595|NCT01323621|472045602|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
131113596|NCT01323621|472045603|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
131113597|NCT01323621|472045604|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
131113598|NCT01323621|472045602|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131113599|NCT01323621|472045603|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
131113600|NCT01323621|472045604|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
131113601|NCT04226833|472045605|FG000|Overall Study|Death|0|||
131113602|NCT04226833|472045606|FG001|Overall Study|Death|0|||
131113603|NCT04226833|472045607|FG002|Overall Study|Death|1|||
131113604|NCT04226833|472045608|FG003|Overall Study|Death|0|||
131113605|NCT02876835|472045611|FG000|Treatment Period (51.1 Month)|Other|1|||
131113606|NCT02876835|472045612|FG001|Treatment Period (51.1 Month)|Other|0|||
131113607|NCT02876835|472045611|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
131113608|NCT02876835|472045612|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
131113609|NCT02876835|472045611|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
131113610|NCT02876835|472045612|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
131113611|NCT02876835|472045611|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
131113612|NCT02876835|472045612|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
131113613|NCT02540538|472045614|FG000|Overall Study|Pregnancy|0|||
131113614|NCT02540538|472045615|FG001|Overall Study|Pregnancy|1|||
131113615|NCT02540538|472045616|FG002|Overall Study|Pregnancy|0|||
131113616|NCT00364156|472045620|FG000|Overall Study|Withdrawal by Subject|73|||
131113617|NCT00364156|472045621|FG001|Overall Study|Withdrawal by Subject|80|||
131113618|NCT00364156|472045620|FG000|Overall Study|Protocol Violation|6|||
131113619|NCT00364156|472045621|FG001|Overall Study|Protocol Violation|1|||
131113620|NCT01891721|472045622|FG000|Overall Study|Lost to Follow-up|10|||
131113621|NCT01891721|472045623|FG001|Overall Study|Lost to Follow-up|5|||
131113622|NCT01891721|472045624|FG002|Overall Study|Lost to Follow-up|1|||
131113623|NCT04343248|472045625|FG000|Overall Study|Withdrawal by Subject|5|||
131113624|NCT04343248|472045626|FG001|Overall Study|Withdrawal by Subject|6|||
131113625|NCT04343248|472045625|FG000|Overall Study|Death|1|||
131113626|NCT04343248|472045626|FG001|Overall Study|Death|2|||
131113627|NCT04343248|472045625|FG000|Overall Study|Lost to Follow-up|9|||
131113628|NCT04343248|472045626|FG001|Overall Study|Lost to Follow-up|6|||
131113629|NCT04343248|472045625|FG000|Overall Study|Physician Decision|0|||
131113630|NCT04343248|472045626|FG001|Overall Study|Physician Decision|1|||
131113631|NCT04343248|472045625|FG000|Overall Study|Adverse Event|1|||
131113632|NCT04343248|472045626|FG001|Overall Study|Adverse Event|0|||
131113633|NCT01313650|472045629|FG000|Overall Study|Adverse Event|9|||
131113634|NCT01313650|472045630|FG001|Overall Study|Adverse Event|34|||
131113635|NCT01313650|472045631|FG002|Overall Study|Adverse Event|24|||
131113636|NCT01313650|472045632|FG003|Overall Study|Adverse Event|23|||
131113637|NCT01313650|472045629|FG000|Overall Study|Lack of Efficacy|37|||
131113638|NCT01313650|472045630|FG001|Overall Study|Lack of Efficacy|20|||
131113639|NCT01313650|472045631|FG002|Overall Study|Lack of Efficacy|32|||
131113640|NCT01313650|472045632|FG003|Overall Study|Lack of Efficacy|20|||
131113641|NCT01313650|472045629|FG000|Overall Study|Lost to Follow-up|1|||
131113642|NCT01313650|472045630|FG001|Overall Study|Lost to Follow-up|0|||
131113643|NCT01313650|472045631|FG002|Overall Study|Lost to Follow-up|3|||
131113644|NCT01313650|472045632|FG003|Overall Study|Lost to Follow-up|2|||
131113645|NCT01313650|472045629|FG000|Overall Study|Withdrawal by Subject|16|||
131113646|NCT01313650|472045630|FG001|Overall Study|Withdrawal by Subject|20|||
131113647|NCT01313650|472045631|FG002|Overall Study|Withdrawal by Subject|15|||
131113648|NCT01313650|472045632|FG003|Overall Study|Withdrawal by Subject|15|||
131113649|NCT01313650|472045629|FG000|Overall Study|Protocol Violation|4|||
131113650|NCT01313650|472045630|FG001|Overall Study|Protocol Violation|7|||
131113651|NCT01313650|472045631|FG002|Overall Study|Protocol Violation|5|||
131113652|NCT01313650|472045632|FG003|Overall Study|Protocol Violation|6|||
131113653|NCT01313650|472045629|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
131113654|NCT01313650|472045630|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
131113655|NCT01313650|472045631|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
131113656|NCT01313650|472045632|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
131113657|NCT05393037|472045633|FG000|Part A|Death|1|||
131113658|NCT05393037|472045634|FG001|Part A|Death|0|||
131113659|NCT05393037|472045633|FG000|Part A|Lost to Follow-up|1|||
131113660|NCT05393037|472045634|FG001|Part A|Lost to Follow-up|1|||
131113661|NCT05393037|472045633|FG000|Part A|Withdrawal by Subject|2|||
131113662|NCT05393037|472045634|FG001|Part A|Withdrawal by Subject|4|||
131113663|NCT05393037|472045633|FG000|Part B|Lost to Follow-up|1|||
131113664|NCT05393037|472045634|FG001|Part B|Lost to Follow-up|0|||
131113665|NCT04540133|472045635|FG000|Overall Study|Lost to Follow-up|1|||
131113666|NCT04540133|472045636|FG001|Overall Study|Lost to Follow-up|0|||
131113667|NCT03153111|472045637|FG000|Overall Study|Death|2|||
131113668|NCT03153111|472045638|FG001|Overall Study|Death|5|||
131113669|NCT03153111|472045637|FG000|Overall Study|Lost to Follow-up|1|||
131113670|NCT03153111|472045638|FG001|Overall Study|Lost to Follow-up|0|||
131113671|NCT03153111|472045637|FG000|Overall Study|Physician Decision|5|||
131113672|NCT03153111|472045638|FG001|Overall Study|Physician Decision|1|||
131113673|NCT03153111|472045637|FG000|Overall Study|Withdrawal by Subject|3|||
131113674|NCT03153111|472045638|FG001|Overall Study|Withdrawal by Subject|3|||
131113675|NCT00174265|472045642|FG000|Overall Study|Adverse Event|7|||
131113676|NCT00174265|472045643|FG001|Overall Study|Adverse Event|4|||
131113677|NCT00174265|472045642|FG000|Overall Study|Lack of Efficacy|2|||
131113678|NCT00174265|472045643|FG001|Overall Study|Lack of Efficacy|2|||
131113679|NCT00174265|472045642|FG000|Overall Study|Withdrawal by Subject|3|||
131113680|NCT00174265|472045643|FG001|Overall Study|Withdrawal by Subject|5|||
131113681|NCT00174265|472045642|FG000|Overall Study|Lost to Follow-up|1|||
131113682|NCT00174265|472045643|FG001|Overall Study|Lost to Follow-up|0|||
131113683|NCT00174265|472045642|FG000|Overall Study|Other (Not specified)|16|||
131113684|NCT00174265|472045643|FG001|Overall Study|Other (Not specified)|10|||
131113685|NCT01572922|472045645|FG000|Overall Study|Adverse Event|1|||
131113686|NCT01572922|472045645|FG000|Overall Study|Protocol Violation|1|||
131113687|NCT01572922|472045645|FG000|Overall Study|Death|1|||
131113688|NCT03040622|472045646|FG000|Overall Study|unable to implant device|3|||
131113689|NCT00445068|472045647|FG000|Overall Study|Disease progression|26|||
131113690|NCT00445068|472045647|FG000|Overall Study|Adverse Event|5|||
131113691|NCT00445068|472045647|FG000|Overall Study|Abnormal laboratory value|2|||
131113692|NCT00445068|472045647|FG000|Overall Study|Withdrawal by Subject|2|||
131113693|NCT00445068|472045647|FG000|Overall Study|Death|1|||
131113694|NCT04091451|472045651|FG000|Overall Study|Adverse Event|15|||
131113695|NCT04091451|472045652|FG001|Overall Study|Adverse Event|10|||
131113696|NCT04091451|472045651|FG000|Overall Study|Lost to Follow-up|8|||
131113697|NCT04091451|472045652|FG001|Overall Study|Lost to Follow-up|8|||
131113698|NCT04091451|472045651|FG000|Overall Study|Protocol Violation|5|||
131113699|NCT04091451|472045652|FG001|Overall Study|Protocol Violation|4|||
131113700|NCT04091451|472045651|FG000|Overall Study|Withdrawal by Subject|21|||
131113701|NCT04091451|472045652|FG001|Overall Study|Withdrawal by Subject|27|||
131113702|NCT04091451|472045651|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
131113703|NCT04091451|472045652|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
131113704|NCT04091451|472045651|FG000|Overall Study|Migrated/moved from the study area|3|||
131113705|NCT04091451|472045652|FG001|Overall Study|Migrated/moved from the study area|5|||
131113706|NCT04091451|472045651|FG000|Overall Study|Suspected HZ episode|1|||
131113707|NCT04091451|472045652|FG001|Overall Study|Suspected HZ episode|0|||
131113708|NCT02598557|472047210|FG000|Overall Study|Withdrawal by Subject|1|||
131113709|NCT02598557|472047211|FG001|Overall Study|Withdrawal by Subject|0|||
131113710|NCT02598557|472047212|FG002|Overall Study|Withdrawal by Subject|1|||
131113711|NCT02598557|472047210|FG000|Overall Study|Participant did not start treatment|2|||
131113712|NCT02598557|472047211|FG001|Overall Study|Participant did not start treatment|1|||
131113713|NCT02598557|472047212|FG002|Overall Study|Participant did not start treatment|1|||
131113714|NCT02598557|472047210|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
131113715|NCT02598557|472047211|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
131113716|NCT02598557|472047212|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
131113717|NCT02598557|472047210|FG000|Overall Study|Adverse Event|1|||
131113718|NCT02598557|472047211|FG001|Overall Study|Adverse Event|1|||
131113719|NCT02598557|472047212|FG002|Overall Study|Adverse Event|0|||
131113720|NCT01117454|472047215|FG000|Overall Study|Pregnancy|0|||
131113721|NCT01117454|472047216|FG001|Overall Study|Pregnancy|1|||
130694323|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694324|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694325|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694326|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
131113722|NCT00888433|472047217|FG000|Overall Study|Withdrawal by Subject|1|||
131113723|NCT00888433|472047218|FG001|Overall Study|Withdrawal by Subject|2|||
131113724|NCT00888433|472047217|FG000|Overall Study|Missed Visit|2|||
131113725|NCT00888433|472047218|FG001|Overall Study|Missed Visit|1|||
131113726|NCT01831544|472047219|FG000|Overall Study|Death|1|||
131113727|NCT01831544|472047219|FG000|Overall Study|Still on original MVAD device|2|||
130694327|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694328|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694329|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694330|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
131113728|NCT01681628|472047220|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
131113729|NCT01681628|472047221|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
131113730|NCT01681628|472047220|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
131027355|NCT03857620|471732315|FG000|Overall Study|Ineligible|5|||
131027356|NCT03857620|471732316|FG001|Overall Study|Ineligible|0|||
131027357|NCT03857620|471732317|FG002|Overall Study|Ineligible|2|||
131027358|NCT03857620|471732315|FG000|Overall Study|No malignancy|1|||
131027359|NCT03857620|471732316|FG001|Overall Study|No malignancy|0|||
131027360|NCT03857620|471732317|FG002|Overall Study|No malignancy|1|||
131027361|NCT03857620|471732315|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
131027362|NCT03857620|471732316|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
131027363|NCT03857620|471732317|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
131027364|NCT03857620|471732315|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
131027365|NCT03857620|471732316|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
131027366|NCT03857620|471732317|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
131027367|NCT03857620|471732315|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
131027368|NCT03857620|471732316|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
131027369|NCT03857620|471732317|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
131027370|NCT03857620|471732315|FG000|Overall Study|Surgery not performed, patient decision|0|||
131027371|NCT03857620|471732316|FG001|Overall Study|Surgery not performed, patient decision|3|||
131027372|NCT03857620|471732317|FG002|Overall Study|Surgery not performed, patient decision|1|||
131027373|NCT03857620|471732315|FG000|Overall Study|Surgery not performed, other reason|3|||
131027374|NCT03857620|471732316|FG001|Overall Study|Surgery not performed, other reason|1|||
131027375|NCT03857620|471732317|FG002|Overall Study|Surgery not performed, other reason|4|||
131027376|NCT03857620|471732315|FG000|Overall Study|Worsening performance status after surgery performed|0|||
131027377|NCT03857620|471732316|FG001|Overall Study|Worsening performance status after surgery performed|1|||
131027378|NCT03857620|471732317|FG002|Overall Study|Worsening performance status after surgery performed|1|||
131027379|NCT02473250|471732318|FG000|Overall Study|Lost to Follow-up|10|||
131027380|NCT02473250|471732318|FG000|Overall Study|Physician Decision|5|||
131027381|NCT02473250|471732318|FG000|Overall Study|Did not tolerate medication washout|3|||
131027382|NCT02473250|471732318|FG000|Overall Study|Antidepressant effect of divalproex|2|||
131027383|NCT00567398|471732319|FG000|Overall Study|Adverse Event|6|||
131027384|NCT00567398|471732320|FG001|Overall Study|Adverse Event|14|||
131027385|NCT00567398|471732319|FG000|Overall Study|Physician Decision|0|||
131027386|NCT00567398|471732320|FG001|Overall Study|Physician Decision|4|||
131027387|NCT00567398|471732319|FG000|Overall Study|Withdrawal by Subject|0|||
131027388|NCT00567398|471732320|FG001|Overall Study|Withdrawal by Subject|2|||
131027389|NCT00567398|471732319|FG000|Overall Study|Renal Transplantation|0|||
131027390|NCT00567398|471732320|FG001|Overall Study|Renal Transplantation|3|||
131027391|NCT00567398|471732319|FG000|Overall Study|Other|1|||
131027392|NCT00567398|471732320|FG001|Overall Study|Other|0|||
131027393|NCT03517553|471732321|FG000|Overall Study|Withdrawal by Subject|2|||
131027394|NCT03271151|471732322|FG000|Overall Study|Lost to Follow-up|1|||
131027395|NCT03271151|471732323|FG001|Overall Study|Lost to Follow-up|3|||
131113731|NCT01681628|472047221|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
131113732|NCT01681628|472047220|FG000|19 Months Follow-up|Death|1|||
131113733|NCT01681628|472047221|FG001|19 Months Follow-up|Death|0|||
131113734|NCT01681628|472047220|FG000|19 Months Follow-up|Lost to Follow-up|61|||
131113735|NCT01681628|472047221|FG001|19 Months Follow-up|Lost to Follow-up|43|||
131113736|NCT01637623|472047230|FG000|Overall Study|Lost to Follow-up|0|||
131113737|NCT01637623|472047231|FG001|Overall Study|Lost to Follow-up|0|||
131113738|NCT01637623|472047232|FG002|Overall Study|Lost to Follow-up|2|||
131113739|NCT01637623|472047230|FG000|Overall Study|Physician Decision|1|||
131113740|NCT01637623|472047231|FG001|Overall Study|Physician Decision|0|||
131113741|NCT01637623|472047232|FG002|Overall Study|Physician Decision|1|||
131113742|NCT02170389|472047235|FG000|Overall Study|Study terminated prior to start of treat|1|||
131113743|NCT01054144|472047241|FG000|Overall Study|Death|2|||
131113744|NCT03801902|472047243|FG000|Overall Study|Did not receive protocol treatment.|1|||
131113745|NCT03801902|472047244|FG001|Overall Study|Did not receive protocol treatment.|0|||
131113746|NCT03801902|472047245|FG002|Overall Study|Did not receive protocol treatment.|0|||
131113747|NCT03801902|472047246|FG003|Overall Study|Did not receive protocol treatment.|0|||
131027396|NCT03271151|471732322|FG000|Overall Study|Withdrawal by Subject|1|||
131027397|NCT03271151|471732323|FG001|Overall Study|Withdrawal by Subject|0|||
131113748|NCT02993523|472047249|FG000|Overall Study|Withdrew Consent|0|||
130902321|NCT00704522|471277480|FG001|Overall Study|Lack of Efficacy|17|||
131027398|NCT04093362|471732326|FG000|Overall Study|Study Termination|1|||
131027399|NCT04093362|471732327|FG001|Overall Study|Study Termination|1|||
131113749|NCT02993523|472047250|FG001|Overall Study|Withdrew Consent|0|||
131113750|NCT02993523|472047251|FG002|Overall Study|Withdrew Consent|2|||
131027400|NCT04093362|471732326|FG000|Overall Study|Withdrawal of Consent|1|||
131027401|NCT04093362|471732327|FG001|Overall Study|Withdrawal of Consent|0|||
131027402|NCT04093362|471732326|FG000|Overall Study|Death|1|||
131027403|NCT04093362|471732327|FG001|Overall Study|Death|3|||
131027404|NCT04093362|471732326|FG000|Overall Study|Reason not Specified|1|||
131027405|NCT04093362|471732327|FG001|Overall Study|Reason not Specified|2|||
131027406|NCT02201108|471732330|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
130902322|NCT00704522|471277479|FG000|Overall Study|Failure to appear again at hospital|56|||
130902323|NCT00704522|471277480|FG001|Overall Study|Failure to appear again at hospital|10|||
130902324|NCT00704522|471277479|FG000|Overall Study|Withdrawal by Subject|17|||
130902325|NCT00704522|471277480|FG001|Overall Study|Withdrawal by Subject|8|||
130902326|NCT00704522|471277479|FG000|Overall Study|Adverse Event|9|||
130902327|NCT00704522|471277480|FG001|Overall Study|Adverse Event|1|||
130902328|NCT00704522|471277479|FG000|Overall Study|Undefined causes|9|||
130902329|NCT00704522|471277480|FG001|Overall Study|Undefined causes|7|||
130902330|NCT00704522|471277479|FG000|Overall Study|No information on therapy end|27|||
130902331|NCT00704522|471277480|FG001|Overall Study|No information on therapy end|2|||
130902332|NCT00701662|471277481|FG000|Overall Study|Lack of Efficacy|1|||
131027407|NCT02201108|471732331|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
131027408|NCT02201108|471732332|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
131027409|NCT02201108|471732330|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
131027410|NCT02201108|471732331|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
131027411|NCT02201108|471732332|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
130694331|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694332|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
130902333|NCT00635024|471277482|FG000|Overall Study|Adverse Event|1|||
130902334|NCT01105065|471277483|FG000|Overall Study|Adverse Event|5|||
130902335|NCT01105065|471277483|FG000|Overall Study|Technical Problems|1|||
131027412|NCT02201108|471732330|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
131027413|NCT02201108|471732331|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
131027414|NCT02201108|471732332|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
130694333|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694334|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694335|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
130694336|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694337|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130902336|NCT02984943|471277484|FG000|Overall Study|Withdrawal by Subject|3|||
131027415|NCT02201108|471732330|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
131027416|NCT02201108|471732331|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
131027417|NCT02201108|471732332|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
131027418|NCT02201108|471732330|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
131027419|NCT02201108|471732331|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
131027420|NCT02201108|471732332|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
131027421|NCT02201108|471732330|FG000|Open Label Period (up to Week 192)|Other reason|4|||
131027422|NCT02201108|471732331|FG001|Open Label Period (up to Week 192)|Other reason|7|||
131027423|NCT02201108|471732332|FG002|Open Label Period (up to Week 192)|Other reason|0|||
131027424|NCT02201108|471732330|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
131027425|NCT02201108|471732331|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
131027426|NCT02201108|471732332|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
131027427|NCT02201108|471732330|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
131027428|NCT02201108|471732331|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
131027429|NCT02201108|471732332|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
131027430|NCT02201108|471732330|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
131027431|NCT02201108|471732331|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
131027432|NCT02201108|471732332|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
131027433|NCT03055377|471732342|FG000|Treatment Phase|Lost to Follow-up|28|||
131027434|NCT03055377|471732343|FG001|Treatment Phase|Lost to Follow-up|24|||
131027435|NCT03055377|471732342|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
131027436|NCT03055377|471732343|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
131027437|NCT01898494|471732350|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
131027438|NCT01898494|471732351|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
131027439|NCT01898494|471732352|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
131027440|NCT01898494|471732353|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
131027441|NCT01898494|471732354|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
131027442|NCT01898494|471732350|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
131027443|NCT01898494|471732351|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
131027444|NCT01898494|471732352|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
131027445|NCT01898494|471732353|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
131027446|NCT01898494|471732354|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
131027447|NCT01898494|471732350|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
131027448|NCT01898494|471732351|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
131027449|NCT01898494|471732352|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
131027450|NCT01898494|471732353|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
131027451|NCT01898494|471732354|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
131113751|NCT02993523|472047252|FG003|Overall Study|Withdrew Consent|9|||
130902337|NCT02984943|471277484|FG000|Overall Study|Physician Decision|1|||
130902338|NCT04575597|471277487|FG000|Overall Study|Death|0|||
130694338|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130768305|NCT04776018|470775539|FG005|Overall Study|Withdrawal by Subject|0|||
130768306|NCT04776018|470775540|FG006|Overall Study|Withdrawal by Subject|0|||
130768307|NCT04776018|470775534|FG000|Overall Study|Other|0|||
130768308|NCT04776018|470775535|FG001|Overall Study|Other|1|||
130768309|NCT04776018|470775536|FG002|Overall Study|Other|1|||
130768310|NCT04776018|470775537|FG003|Overall Study|Other|0|||
130768311|NCT04776018|470775538|FG004|Overall Study|Other|0|||
130768312|NCT04776018|470775539|FG005|Overall Study|Other|0|||
130768313|NCT04776018|470775540|FG006|Overall Study|Other|0|||
130768314|NCT04776018|470775534|FG000|Overall Study|Lost to Follow-up|0|||
130768315|NCT04776018|470775535|FG001|Overall Study|Lost to Follow-up|0|||
130768316|NCT04776018|470775536|FG002|Overall Study|Lost to Follow-up|1|||
130768317|NCT04776018|470775537|FG003|Overall Study|Lost to Follow-up|0|||
130768318|NCT04776018|470775538|FG004|Overall Study|Lost to Follow-up|0|||
130768319|NCT04776018|470775539|FG005|Overall Study|Lost to Follow-up|0|||
130768320|NCT04776018|470775540|FG006|Overall Study|Lost to Follow-up|0|||
130768321|NCT01900431|470775545|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
130768322|NCT01900431|470775546|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
130768323|NCT01900431|470775547|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
130768324|NCT01900431|470775545|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
130768325|NCT01900431|470775546|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
130768326|NCT01900431|470775547|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
130768327|NCT01900431|470775545|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
130768328|NCT01900431|470775546|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
130768329|NCT01900431|470775547|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
130768330|NCT01900431|470775545|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
130768331|NCT01900431|470775546|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
130768332|NCT01900431|470775547|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
130768333|NCT01900431|470775545|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
130768334|NCT01900431|470775546|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
130768335|NCT01900431|470775547|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
130768336|NCT01900431|470775545|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
130768337|NCT01900431|470775546|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
130768338|NCT01900431|470775547|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
130768339|NCT01900431|470775545|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
130768340|NCT01900431|470775546|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
130768341|NCT01900431|470775547|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
130768342|NCT01900431|470775545|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
130768343|NCT01900431|470775546|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
130768344|NCT01900431|470775547|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
130694339|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694340|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694341|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
130694342|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
130694343|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
130694344|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
130694345|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
130694346|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694347|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694348|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694349|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694350|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694351|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694352|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130768345|NCT01900431|470775545|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
130768346|NCT01900431|470775546|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
130768347|NCT01900431|470775547|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
130768348|NCT03172364|470775548|FG000|Overall Study|Adverse Event|1|||
130768349|NCT03172364|470775549|FG001|Overall Study|Adverse Event|1|||
130768350|NCT03172364|470775548|FG000|Overall Study|Protocol Violation|1|||
130768351|NCT03172364|470775549|FG001|Overall Study|Protocol Violation|0|||
130768352|NCT03755518|470775550|FG000|Overall Study|Lack of Efficacy|10|||
130768353|NCT03755518|470775550|FG000|Overall Study|Adverse Event|7|||
130768354|NCT03755518|470775550|FG000|Overall Study|Study Terminated by Sponsor|5|||
130768355|NCT03755518|470775550|FG000|Overall Study|Death|1|||
130902339|NCT04575597|471277488|FG001|Overall Study|Death|0|||
130694353|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694354|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694355|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130768356|NCT03755518|470775550|FG000|Overall Study|Withdrawal by Subject|3|||
130768357|NCT03755518|470775550|FG000|Overall Study|Progressive Disease|4|||
130902340|NCT04575597|471277489|FG002|Overall Study|Death|0|||
130902341|NCT04575597|471277490|FG003|Overall Study|Death|1|||
130902342|NCT04575597|471277491|FG004|Overall Study|Death|3|||
130902343|NCT04575597|471277492|FG005|Overall Study|Death|14|||
130902344|NCT04575597|471277487|FG000|Overall Study|Lost to Follow-up|2|||
130902345|NCT04575597|471277488|FG001|Overall Study|Lost to Follow-up|1|||
130902346|NCT04575597|471277489|FG002|Overall Study|Lost to Follow-up|1|||
130902347|NCT04575597|471277490|FG003|Overall Study|Lost to Follow-up|2|||
130902348|NCT04575597|471277491|FG004|Overall Study|Lost to Follow-up|10|||
130902349|NCT04575597|471277492|FG005|Overall Study|Lost to Follow-up|8|||
130902350|NCT04575597|471277487|FG000|Overall Study|Withdrawal by Subject|2|||
130902351|NCT04575597|471277488|FG001|Overall Study|Withdrawal by Subject|2|||
130902352|NCT04575597|471277489|FG002|Overall Study|Withdrawal by Subject|4|||
130902353|NCT04575597|471277490|FG003|Overall Study|Withdrawal by Subject|2|||
130902354|NCT04575597|471277491|FG004|Overall Study|Withdrawal by Subject|25|||
130902355|NCT04575597|471277492|FG005|Overall Study|Withdrawal by Subject|28|||
130902356|NCT04575597|471277487|FG000|Overall Study|Not Recorded|0|||
130902357|NCT04575597|471277488|FG001|Overall Study|Not Recorded|0|||
130902358|NCT04575597|471277489|FG002|Overall Study|Not Recorded|0|||
130902359|NCT04575597|471277490|FG003|Overall Study|Not Recorded|0|||
130902360|NCT04575597|471277491|FG004|Overall Study|Not Recorded|0|||
130902361|NCT04575597|471277492|FG005|Overall Study|Not Recorded|2|||
131113752|NCT02993523|472047253|FG004|Overall Study|Withdrew Consent|0|||
131113753|NCT02993523|472047249|FG000|Overall Study|Lost to Follow-up|0|||
131113754|NCT02993523|472047250|FG001|Overall Study|Lost to Follow-up|0|||
131113755|NCT02993523|472047251|FG002|Overall Study|Lost to Follow-up|3|||
131113756|NCT02993523|472047252|FG003|Overall Study|Lost to Follow-up|6|||
131113757|NCT02993523|472047253|FG004|Overall Study|Lost to Follow-up|0|||
131113758|NCT02993523|472047249|FG000|Overall Study|Death|1|||
131113759|NCT02993523|472047250|FG001|Overall Study|Death|1|||
131113760|NCT02993523|472047251|FG002|Overall Study|Death|138|||
131113761|NCT02993523|472047252|FG003|Overall Study|Death|222|||
131113762|NCT02993523|472047253|FG004|Overall Study|Death|6|||
131113763|NCT02993523|472047249|FG000|Overall Study|Reason not Specified|0|||
131113764|NCT02993523|472047250|FG001|Overall Study|Reason not Specified|0|||
131113765|NCT02993523|472047251|FG002|Overall Study|Reason not Specified|1|||
131113766|NCT02993523|472047252|FG003|Overall Study|Reason not Specified|1|||
131113767|NCT02993523|472047253|FG004|Overall Study|Reason not Specified|0|||
131113768|NCT03118674|472047254|FG000|Overall Study|Lost to Follow-up|2|||
131113769|NCT03118674|472047254|FG000|Overall Study|Screen Faliure|8|||
131113770|NCT03118674|472047254|FG000|Overall Study|Withdrawal by Subject|5|||
131113771|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
131113772|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
131113773|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
131113774|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
131113775|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
131113776|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
131113777|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
131113778|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
131113779|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Death|1|||
131113780|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Death|1|||
131113781|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
131113782|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
131113783|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
131113784|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
131113785|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
131113786|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
131113787|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
131113788|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
131113789|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
131113790|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
130768358|NCT03755518|470775550|FG000|Overall Study|Bone Marrow Transplant|4|||
130768359|NCT03755518|470775550|FG000|Overall Study|Physicians Decision|1|||
130768360|NCT03755518|470775550|FG000|Overall Study|Relapse|1|||
130902362|NCT04575597|471277487|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130902363|NCT04575597|471277488|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130902364|NCT04575597|471277489|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130902365|NCT04575597|471277490|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130902366|NCT04575597|471277491|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
131113791|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
131113792|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
131113793|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
131113794|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
130902367|NCT04575597|471277492|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
130902368|NCT02536404|471277502|FG000|Overall Study|Adverse Event|5|||
130902369|NCT02536404|471277503|FG001|Overall Study|Adverse Event|0|||
130902370|NCT02536404|471277502|FG000|Overall Study|Withdrawal by Subject|4|||
130902371|NCT02536404|471277503|FG001|Overall Study|Withdrawal by Subject|1|||
130694356|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694357|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130902372|NCT02536404|471277502|FG000|Overall Study|Physician Decision|10|||
130902373|NCT02536404|471277503|FG001|Overall Study|Physician Decision|0|||
130902374|NCT02536404|471277502|FG000|Overall Study|Sponsor decision|1|||
130902375|NCT02536404|471277503|FG001|Overall Study|Sponsor decision|0|||
130902376|NCT01587898|471277511|FG000|Overall Study|Adverse Event|1|||
130902377|NCT01587898|471277512|FG001|Overall Study|Adverse Event|1|||
130902378|NCT01587898|471277513|FG002|Overall Study|Adverse Event|0|||
130902379|NCT01587898|471277514|FG003|Overall Study|Adverse Event|0|||
130902380|NCT01587898|471277511|FG000|Overall Study|Protocol Violation|0|||
130902381|NCT01587898|471277512|FG001|Overall Study|Protocol Violation|2|||
130902382|NCT01587898|471277513|FG002|Overall Study|Protocol Violation|1|||
130902383|NCT01587898|471277514|FG003|Overall Study|Protocol Violation|1|||
130694358|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694359|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694360|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694361|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130694362|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694363|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694364|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694365|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694366|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694367|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694368|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694369|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694370|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694371|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
130694372|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694373|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694374|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694375|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694376|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694377|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694378|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694379|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694380|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694381|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694382|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694383|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694384|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694385|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694386|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694387|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130694388|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694389|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
130902384|NCT01587898|471277511|FG000|Overall Study|Lost to Follow-up|0|||
130902385|NCT01587898|471277512|FG001|Overall Study|Lost to Follow-up|0|||
130902386|NCT01587898|471277513|FG002|Overall Study|Lost to Follow-up|0|||
130902387|NCT01587898|471277514|FG003|Overall Study|Lost to Follow-up|1|||
130902388|NCT01587898|471277511|FG000|Overall Study|Withdrawal by Subject|2|||
130902389|NCT01587898|471277512|FG001|Overall Study|Withdrawal by Subject|1|||
130902390|NCT01587898|471277513|FG002|Overall Study|Withdrawal by Subject|0|||
130902391|NCT01587898|471277514|FG003|Overall Study|Withdrawal by Subject|0|||
130902392|NCT01587898|471277511|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
130694390|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694391|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694392|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
130902393|NCT01587898|471277512|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
130902394|NCT01587898|471277513|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
130902395|NCT01587898|471277514|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
130902396|NCT01738477|471277515|FG000|Overall Study|Lost to Follow-up|1|||
130902397|NCT01738477|471277516|FG001|Overall Study|Lost to Follow-up|4|||
130902398|NCT02576145|471277521|FG000|Overall Study|Adverse Event|1|||
130694393|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694394|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694395|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
130902399|NCT02576145|471277522|FG001|Overall Study|Adverse Event|0|||
130902400|NCT02576145|471277521|FG000|Overall Study|Withdrawal by Subject|1|||
130902401|NCT02576145|471277522|FG001|Overall Study|Withdrawal by Subject|0|||
130902402|NCT02576145|471277521|FG000|Overall Study|Acute rejection|1|||
130902403|NCT02576145|471277522|FG001|Overall Study|Acute rejection|0|||
130694396|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694397|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
130902404|NCT02576145|471277521|FG000|Overall Study|Tetanus Titers Decreased|0|||
130902405|NCT02576145|471277522|FG001|Overall Study|Tetanus Titers Decreased|1|||
130902406|NCT01227824|471277523|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
130902407|NCT01227824|471277524|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
130902408|NCT01227824|471277525|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
130902409|NCT01227824|471277523|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
130902410|NCT01227824|471277524|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
130902411|NCT01227824|471277525|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
130902412|NCT01227824|471277523|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
130902413|NCT01227824|471277524|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
130902414|NCT01227824|471277525|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
130902415|NCT01227824|471277523|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
130694398|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694399|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694400|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694401|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694402|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694403|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694404|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694405|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
130768361|NCT03755518|470775550|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
130902416|NCT01227824|471277524|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
130902417|NCT01227824|471277525|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
130902418|NCT01227824|471277523|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
130902419|NCT01227824|471277524|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
130902420|NCT01227824|471277525|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
130902421|NCT01227824|471277523|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
130902422|NCT01227824|471277524|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
130902423|NCT01227824|471277525|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
130902424|NCT01227824|471277523|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
130902425|NCT01227824|471277524|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
130902426|NCT01227824|471277525|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
130902427|NCT01227824|471277523|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
130902428|NCT01227824|471277524|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
130902429|NCT01227824|471277525|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
130902430|NCT01227824|471277523|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
130902431|NCT01227824|471277524|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
130902432|NCT01227824|471277525|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
130902433|NCT01227824|471277523|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
130902434|NCT01227824|471277524|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
130902435|NCT01227824|471277525|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
130902436|NCT01227824|471277523|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
130902437|NCT01227824|471277524|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
130902438|NCT01227824|471277525|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
130902439|NCT01227824|471277523|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
130902440|NCT01227824|471277524|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
130902441|NCT01227824|471277525|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
130902442|NCT01227824|471277523|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
130902443|NCT01227824|471277524|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
130902444|NCT01227824|471277525|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
130902445|NCT01227824|471277523|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
130902446|NCT01227824|471277524|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
130902447|NCT01227824|471277525|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
130902448|NCT01227824|471277523|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
130768362|NCT03755518|470775550|FG000|Overall Study|Withdrawal by PI|1|||
131113795|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
131113796|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
131113797|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
131113798|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
131113799|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
131113800|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
131113801|NCT00559585|472047255|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
131113802|NCT00559585|472047256|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
131113803|NCT00559585|472047255|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
131113804|NCT00559585|472047256|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
131113805|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
131113806|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
131113807|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
130694406|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694407|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694408|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694409|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694410|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694411|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694412|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694413|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
130694414|NCT00112437|470505916|FG000|Year 2 (12-Month Extension)|Moved|0|||
130694415|NCT00112437|470505917|FG001|Year 2 (12-Month Extension)|Moved|0|||
130694416|NCT00112437|470505918|FG002|Year 2 (12-Month Extension)|Moved|0|||
130694417|NCT00112437|470505919|FG003|Year 2 (12-Month Extension)|Moved|0|||
130694418|NCT00112437|470505920|FG004|Year 2 (12-Month Extension)|Moved|0|||
130694419|NCT00112437|470505921|FG005|Year 2 (12-Month Extension)|Moved|0|||
130694420|NCT00112437|470505922|FG006|Year 2 (12-Month Extension)|Moved|0|||
130694421|NCT00112437|470505923|FG007|Year 2 (12-Month Extension)|Moved|0|||
130694422|NCT00112437|470505924|FG008|Year 2 (12-Month Extension)|Moved|0|||
130694423|NCT00112437|470505925|FG009|Year 2 (12-Month Extension)|Moved|1|||
130694424|NCT00112437|470505926|FG010|Year 2 (12-Month Extension)|Moved|0|||
130694425|NCT00112437|470505927|FG011|Year 2 (12-Month Extension)|Moved|0|||
130694426|NCT00112437|470505928|FG012|Year 2 (12-Month Extension)|Moved|0|||
130694427|NCT00112437|470505929|FG013|Year 2 (12-Month Extension)|Moved|0|||
130694428|NCT00112437|470505930|FG014|Year 2 (12-Month Extension)|Moved|0|||
130694429|NCT00112437|470505931|FG015|Year 2 (12-Month Extension)|Moved|0|||
130694430|NCT00112437|470505932|FG016|Year 2 (12-Month Extension)|Moved|0|||
130694431|NCT00112437|470505933|FG017|Year 2 (12-Month Extension)|Moved|0|||
130694432|NCT00112437|470505934|FG018|Year 2 (12-Month Extension)|Moved|0|||
130694433|NCT00112437|470505935|FG019|Year 2 (12-Month Extension)|Moved|0|||
130694434|NCT00112437|470505936|FG020|Year 2 (12-Month Extension)|Moved|0|||
130694435|NCT00112437|470505937|FG021|Year 2 (12-Month Extension)|Moved|0|||
130694436|NCT00112437|470505938|FG022|Year 2 (12-Month Extension)|Moved|0|||
130694437|NCT00112437|470505939|FG023|Year 2 (12-Month Extension)|Moved|0|||
130694438|NCT00112437|470505940|FG024|Year 2 (12-Month Extension)|Moved|0|||
130694439|NCT00112437|470505941|FG025|Year 2 (12-Month Extension)|Moved|0|||
130694440|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
130694441|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
130694442|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
130694443|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
130694444|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
130694445|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
130694446|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
130694447|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
130694448|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
130694449|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
130694450|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
130694451|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
130694452|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
130694453|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
130694454|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
130694455|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
130694456|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
131113808|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
130694457|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
130694458|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
130694459|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
130694460|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
130694461|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
130694462|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
130694463|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
130694464|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
130768363|NCT02732327|470775551|FG000|Overall Study|Protocol Violation|0|||
130768364|NCT02732327|470775552|FG001|Overall Study|Protocol Violation|1|||
130768365|NCT04503668|470775553|FG000|Overall Study|Incomplete data|4|||
130768366|NCT04503668|470775554|FG001|Overall Study|Incomplete data|3|||
130768367|NCT04503668|470775553|FG000|Overall Study|Withdrawal by Subject|1|||
130768368|NCT04503668|470775554|FG001|Overall Study|Withdrawal by Subject|1|||
130768369|NCT04503668|470775553|FG000|Overall Study|Adverse Event|2|||
130694465|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
130694466|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694467|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694468|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694469|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694470|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694471|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694472|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694473|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694474|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694475|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130768370|NCT04503668|470775554|FG001|Overall Study|Adverse Event|0|||
130768371|NCT00603382|470775555|FG000|Overall Study|Adverse Event|0|||
130768372|NCT00603382|470775556|FG001|Overall Study|Adverse Event|1|||
130768373|NCT00603382|470775557|FG002|Overall Study|Adverse Event|1|||
130768374|NCT00603382|470775558|FG003|Overall Study|Adverse Event|2|||
130768375|NCT00603382|470775559|FG004|Overall Study|Adverse Event|1|||
130768376|NCT00603382|470775560|FG005|Overall Study|Adverse Event|2|||
130768377|NCT00603382|470775555|FG000|Overall Study|Lack of Efficacy|14|||
130902449|NCT01227824|471277524|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
130902450|NCT01227824|471277525|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
130902451|NCT02660138|471277527|FG000|Overall Study|Adverse Event|0|||
130902452|NCT02660138|471277528|FG001|Overall Study|Adverse Event|3|||
130902453|NCT02660138|471277529|FG002|Overall Study|Adverse Event|2|||
130902454|NCT02660138|471277527|FG000|Overall Study|Lack of Efficacy|1|||
130902455|NCT02660138|471277528|FG001|Overall Study|Lack of Efficacy|2|||
130902456|NCT02660138|471277529|FG002|Overall Study|Lack of Efficacy|1|||
130902457|NCT02660138|471277527|FG000|Overall Study|Withdrawal by Subject|7|||
130902458|NCT02660138|471277528|FG001|Overall Study|Withdrawal by Subject|6|||
130902459|NCT02660138|471277529|FG002|Overall Study|Withdrawal by Subject|6|||
130902460|NCT02660138|471277527|FG000|Overall Study|Lost to Follow-up|4|||
130768378|NCT00603382|470775556|FG001|Overall Study|Lack of Efficacy|9|||
130768379|NCT00603382|470775557|FG002|Overall Study|Lack of Efficacy|3|||
130768380|NCT00603382|470775558|FG003|Overall Study|Lack of Efficacy|6|||
130902461|NCT02660138|471277528|FG001|Overall Study|Lost to Follow-up|4|||
130902462|NCT02660138|471277529|FG002|Overall Study|Lost to Follow-up|1|||
130902463|NCT02660138|471277527|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
130902464|NCT02660138|471277528|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
130902465|NCT02660138|471277529|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
130902466|NCT02660138|471277527|FG000|Overall Study|Other|1|||
130902467|NCT02660138|471277528|FG001|Overall Study|Other|1|||
130902468|NCT02660138|471277529|FG002|Overall Study|Other|0|||
130902469|NCT02660138|471277527|FG000|Overall Study|Not treated|0|||
130902470|NCT02660138|471277528|FG001|Overall Study|Not treated|1|||
130902471|NCT02660138|471277529|FG002|Overall Study|Not treated|0|||
131027452|NCT01898494|471732350|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
131027453|NCT01898494|471732351|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
130694476|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694477|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
130694478|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694479|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
130902472|NCT02694757|471277530|FG000|Overall Study|Lack of Efficacy|3|||
130902473|NCT02650921|471277531|FG000|Overall Study|Withdrawal by Subject|4|||
130902474|NCT02650921|471277531|FG000|Overall Study|Lost to Follow-up|2|||
130902475|NCT02650921|471277531|FG000|Overall Study|Adverse Event|1|||
131027454|NCT01898494|471732352|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
131027455|NCT01898494|471732353|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
131027456|NCT01898494|471732354|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
130694480|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694481|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
130694482|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130768381|NCT00603382|470775559|FG004|Overall Study|Lack of Efficacy|6|||
130902476|NCT02650921|471277531|FG000|Overall Study|Due to Medical Condition|1|||
131027457|NCT01898494|471732350|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
130768382|NCT00603382|470775560|FG005|Overall Study|Lack of Efficacy|11|||
130768383|NCT00603382|470775555|FG000|Overall Study|Protocol Violation|1|||
130768384|NCT00603382|470775556|FG001|Overall Study|Protocol Violation|0|||
130902477|NCT00783302|471277532|FG000|Overall Study|Lost to Follow-up|17|||
130902478|NCT00783302|471277532|FG000|Overall Study|Technical Problems|11|||
130902479|NCT00783302|471277532|FG000|Overall Study|Protocol Violation|3|||
130902480|NCT00783302|471277532|FG000|Overall Study|Physician Decision|1|||
130902481|NCT00783302|471277532|FG000|Overall Study|Withdrawal by Subject|3|||
130902482|NCT04604132|471277533|FG000|Overall Study|Adverse Event|2|||
130902483|NCT04604132|471277534|FG001|Overall Study|Adverse Event|0|||
130902484|NCT04604132|471277535|FG002|Overall Study|Adverse Event|0|||
130902485|NCT04604132|471277536|FG003|Overall Study|Adverse Event|1|||
130902486|NCT04604132|471277537|FG004|Overall Study|Adverse Event|2|||
130902487|NCT04604132|471277533|FG000|Overall Study|Study terminated by sponsor|0|||
130902488|NCT04604132|471277534|FG001|Overall Study|Study terminated by sponsor|0|||
130902489|NCT04604132|471277535|FG002|Overall Study|Study terminated by sponsor|0|||
130902490|NCT04604132|471277536|FG003|Overall Study|Study terminated by sponsor|0|||
130902491|NCT04604132|471277537|FG004|Overall Study|Study terminated by sponsor|1|||
130902492|NCT04604132|471277533|FG000|Overall Study|Progressive disease: Clinical progression|0|||
130902493|NCT04604132|471277534|FG001|Overall Study|Progressive disease: Clinical progression|0|||
130902494|NCT04604132|471277535|FG002|Overall Study|Progressive disease: Clinical progression|1|||
130902495|NCT04604132|471277536|FG003|Overall Study|Progressive disease: Clinical progression|0|||
130902496|NCT04604132|471277537|FG004|Overall Study|Progressive disease: Clinical progression|0|||
130902497|NCT04604132|471277533|FG000|Overall Study|Progressive disease: Radiological progression|8|||
130902498|NCT04604132|471277534|FG001|Overall Study|Progressive disease: Radiological progression|7|||
130902499|NCT04604132|471277535|FG002|Overall Study|Progressive disease: Radiological progression|10|||
130902500|NCT04604132|471277536|FG003|Overall Study|Progressive disease: Radiological progression|4|||
130902501|NCT04604132|471277537|FG004|Overall Study|Progressive disease: Radiological progression|3|||
130902502|NCT04604132|471277533|FG000|Overall Study|Death|3|||
130902503|NCT04604132|471277534|FG001|Overall Study|Death|1|||
130902504|NCT04604132|471277535|FG002|Overall Study|Death|2|||
130902505|NCT04604132|471277536|FG003|Overall Study|Death|1|||
130902506|NCT04604132|471277537|FG004|Overall Study|Death|0|||
130902507|NCT00952380|471277538|FG000|Overall Study|Other|0|||
130902508|NCT00952380|471277539|FG001|Overall Study|Other|0|||
130902509|NCT00952380|471277540|FG002|Overall Study|Other|0|||
130902510|NCT00952380|471277541|FG003|Overall Study|Other|0|||
130902511|NCT00952380|471277542|FG004|Overall Study|Other|1|||
130902512|NCT00952380|471277538|FG000|Overall Study|Withdrawal by Subject|0|||
130902513|NCT00952380|471277539|FG001|Overall Study|Withdrawal by Subject|0|||
130902514|NCT00952380|471277540|FG002|Overall Study|Withdrawal by Subject|1|||
130902515|NCT00952380|471277541|FG003|Overall Study|Withdrawal by Subject|0|||
130902516|NCT00952380|471277542|FG004|Overall Study|Withdrawal by Subject|2|||
130902517|NCT00952380|471277538|FG000|Overall Study|Adverse Event|0|||
130902518|NCT00952380|471277539|FG001|Overall Study|Adverse Event|1|||
130902519|NCT00952380|471277540|FG002|Overall Study|Adverse Event|0|||
130902520|NCT00952380|471277541|FG003|Overall Study|Adverse Event|0|||
130902521|NCT00952380|471277542|FG004|Overall Study|Adverse Event|3|||
130902522|NCT00952380|471277538|FG000|Overall Study|Physician Decision|0|||
130902523|NCT00952380|471277539|FG001|Overall Study|Physician Decision|0|||
130902524|NCT00952380|471277540|FG002|Overall Study|Physician Decision|1|||
130902525|NCT00952380|471277541|FG003|Overall Study|Physician Decision|2|||
130902526|NCT00952380|471277542|FG004|Overall Study|Physician Decision|0|||
130902527|NCT00952380|471277538|FG000|Overall Study|Non-compliant to protocol|0|||
131113809|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
131113810|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
131113811|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
131113812|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
131113813|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
131113814|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
131113815|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
131113816|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
131113817|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
130902528|NCT00952380|471277539|FG001|Overall Study|Non-compliant to protocol|0|||
130902529|NCT00952380|471277540|FG002|Overall Study|Non-compliant to protocol|0|||
130902530|NCT00952380|471277541|FG003|Overall Study|Non-compliant to protocol|1|||
130902531|NCT00952380|471277542|FG004|Overall Study|Non-compliant to protocol|0|||
130902532|NCT03400956|471277543|FG000|Treatment Period 1|Adverse Event|0|||
130902533|NCT03400956|471277544|FG001|Treatment Period 1|Adverse Event|1|||
131113818|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
131113819|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
130694483|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694484|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
130694485|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694486|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694487|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694488|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694489|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130902534|NCT03400956|471277545|FG002|Treatment Period 1|Adverse Event|0|||
130902535|NCT03400956|471277543|FG000|Treatment Period 1|Lost to Follow-up|0|||
130902536|NCT03400956|471277544|FG001|Treatment Period 1|Lost to Follow-up|0|||
130902537|NCT03400956|471277545|FG002|Treatment Period 1|Lost to Follow-up|1|||
130902538|NCT03400956|471277543|FG000|Treatment Period 1|Protocol Violation|0|||
130902539|NCT03400956|471277544|FG001|Treatment Period 1|Protocol Violation|2|||
130902540|NCT03400956|471277545|FG002|Treatment Period 1|Protocol Violation|0|||
130902541|NCT03400956|471277543|FG000|Treatment Period 1|Study terminated by sponsor|3|||
130902542|NCT03400956|471277544|FG001|Treatment Period 1|Study terminated by sponsor|1|||
130902543|NCT03400956|471277545|FG002|Treatment Period 1|Study terminated by sponsor|1|||
130902544|NCT03400956|471277543|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130902545|NCT03400956|471277544|FG001|Treatment Period 1|Withdrawal by Subject|2|||
130902546|NCT03400956|471277545|FG002|Treatment Period 1|Withdrawal by Subject|4|||
130902547|NCT03400956|471277543|FG000|Treatment Period 1|Other|1|||
130902548|NCT03400956|471277544|FG001|Treatment Period 1|Other|2|||
130902549|NCT03400956|471277545|FG002|Treatment Period 1|Other|3|||
130902550|NCT03400956|471277543|FG000|Post-treatment Period 1|Adverse Event|0|||
130902551|NCT03400956|471277544|FG001|Post-treatment Period 1|Adverse Event|0|||
130902552|NCT03400956|471277545|FG002|Post-treatment Period 1|Adverse Event|1|||
130902553|NCT03400956|471277543|FG000|Post-treatment Period 1|Physician Decision|2|||
130902554|NCT03400956|471277544|FG001|Post-treatment Period 1|Physician Decision|3|||
130902555|NCT03400956|471277545|FG002|Post-treatment Period 1|Physician Decision|0|||
130902556|NCT03400956|471277543|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
130902557|NCT03400956|471277544|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
130902558|NCT03400956|471277545|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
130902559|NCT03400956|471277543|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
130902560|NCT03400956|471277544|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
130902561|NCT03400956|471277545|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
130902562|NCT03400956|471277543|FG000|Post-treatment Period 1|Other|4|||
130902563|NCT03400956|471277544|FG001|Post-treatment Period 1|Other|3|||
130902564|NCT03400956|471277545|FG002|Post-treatment Period 1|Other|4|||
130902565|NCT03400956|471277543|FG000|Treatment Period 2|Adverse Event|2|||
130902566|NCT03400956|471277544|FG001|Treatment Period 2|Adverse Event|1|||
130902567|NCT03400956|471277545|FG002|Treatment Period 2|Adverse Event|1|||
130902568|NCT03400956|471277543|FG000|Treatment Period 2|Lost to Follow-up|1|||
130902569|NCT03400956|471277544|FG001|Treatment Period 2|Lost to Follow-up|1|||
130902570|NCT03400956|471277545|FG002|Treatment Period 2|Lost to Follow-up|0|||
130902571|NCT03400956|471277543|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130902572|NCT03400956|471277544|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130902573|NCT03400956|471277545|FG002|Treatment Period 2|Withdrawal by Subject|3|||
130902574|NCT03400956|471277543|FG000|Treatment Period 2|Other|1|||
130902575|NCT03400956|471277544|FG001|Treatment Period 2|Other|1|||
130902576|NCT03400956|471277545|FG002|Treatment Period 2|Other|0|||
130902577|NCT03400956|471277543|FG000|Follow-up Period|Withdrawal by Subject|0|||
130902578|NCT03400956|471277544|FG001|Follow-up Period|Withdrawal by Subject|0|||
130902579|NCT03400956|471277545|FG002|Follow-up Period|Withdrawal by Subject|1|||
130902580|NCT03400956|471277543|FG000|Follow-up Period|Other|0|||
130902581|NCT03400956|471277544|FG001|Follow-up Period|Other|0|||
130902582|NCT03400956|471277545|FG002|Follow-up Period|Other|1|||
130902583|NCT00160667|471277546|FG000|Overall Study|Adverse Event|3|||
130902584|NCT00160667|471277547|FG001|Overall Study|Adverse Event|1|||
130902585|NCT00160667|471277548|FG002|Overall Study|Adverse Event|4|||
130902586|NCT00160667|471277546|FG000|Overall Study|Withdrawal by Subject|2|||
130902587|NCT00160667|471277547|FG001|Overall Study|Withdrawal by Subject|0|||
130902588|NCT00160667|471277548|FG002|Overall Study|Withdrawal by Subject|1|||
130902589|NCT00160667|471277546|FG000|Overall Study|Lack of Efficacy|0|||
130902590|NCT00160667|471277547|FG001|Overall Study|Lack of Efficacy|1|||
131027458|NCT01898494|471732351|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
131027459|NCT01898494|471732352|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
131027460|NCT01898494|471732353|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
131027461|NCT01898494|471732354|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
131027462|NCT01898494|471732350|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
131027463|NCT01898494|471732351|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
131027464|NCT01898494|471732352|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
130902591|NCT00160667|471277548|FG002|Overall Study|Lack of Efficacy|0|||
130902592|NCT00160667|471277546|FG000|Overall Study|Protocol Violation|0|||
130902593|NCT00160667|471277547|FG001|Overall Study|Protocol Violation|1|||
130902594|NCT00160667|471277548|FG002|Overall Study|Protocol Violation|0|||
130902595|NCT00160667|471277546|FG000|Overall Study|Patient decision|0|||
130902596|NCT00160667|471277547|FG001|Overall Study|Patient decision|0|||
130902597|NCT00160667|471277548|FG002|Overall Study|Patient decision|1|||
130902598|NCT01306929|471277553|FG000|Overall Study|Withdrawal by Subject|23|||
130902599|NCT01306929|471277553|FG000|Overall Study|Adverse Event|21|||
130902600|NCT01306929|471277553|FG000|Overall Study|Physician Decision|13|||
130902601|NCT01306929|471277553|FG000|Overall Study|Death|8|||
130902602|NCT01306929|471277553|FG000|Overall Study|Withdrawal by parent/guardian|5|||
130902603|NCT01306929|471277553|FG000|Overall Study|Protocol Violation|3|||
130902604|NCT01306929|471277553|FG000|Overall Study|Non-compliance with study drug|2|||
130902605|NCT01306929|471277553|FG000|Overall Study|Lost to Follow-up|2|||
130902606|NCT01306929|471277553|FG000|Overall Study|Various|17|||
130902607|NCT03709576|471277554|FG000|Overall Study|progression prior to enrollment|1|||
130902608|NCT00890045|471277562|FG000|Overall Study|Death|0|||
130902609|NCT00890045|471277563|FG001|Overall Study|Death|1|||
130902610|NCT00890045|471277562|FG000|Overall Study|Did not receive HeRO Graft|0|||
130902611|NCT00890045|471277563|FG001|Overall Study|Did not receive HeRO Graft|2|||
130902612|NCT00890045|471277562|FG000|Overall Study|Lost to Follow-up|5|||
130902613|NCT00890045|471277563|FG001|Overall Study|Lost to Follow-up|7|||
130902614|NCT00483756|471277566|FG000|Overall Study|Death|2|||
130902615|NCT00483756|471277567|FG001|Overall Study|Death|0|||
130902616|NCT00483756|471277568|FG002|Overall Study|Death|1|||
130902617|NCT00483756|471277566|FG000|Overall Study|Adverse Event|19|||
130902618|NCT00483756|471277567|FG001|Overall Study|Adverse Event|38|||
130902619|NCT00483756|471277568|FG002|Overall Study|Adverse Event|40|||
130902620|NCT00483756|471277566|FG000|Overall Study|Lack of Efficacy|1|||
130902621|NCT00483756|471277567|FG001|Overall Study|Lack of Efficacy|0|||
130902622|NCT00483756|471277568|FG002|Overall Study|Lack of Efficacy|0|||
130902623|NCT00483756|471277566|FG000|Overall Study|Lost to Follow-up|3|||
130902624|NCT00483756|471277567|FG001|Overall Study|Lost to Follow-up|1|||
130902625|NCT00483756|471277568|FG002|Overall Study|Lost to Follow-up|0|||
130902626|NCT00483756|471277566|FG000|Overall Study|Withdrawal by Subject|5|||
130902627|NCT00483756|471277567|FG001|Overall Study|Withdrawal by Subject|3|||
130902628|NCT00483756|471277568|FG002|Overall Study|Withdrawal by Subject|4|||
130902629|NCT00483756|471277566|FG000|Overall Study|Other|2|||
130902630|NCT00483756|471277567|FG001|Overall Study|Other|4|||
130902631|NCT00483756|471277568|FG002|Overall Study|Other|3|||
130902632|NCT00483756|471277566|FG000|Overall Study|Randomized, Not Treated|1|||
130902633|NCT00483756|471277567|FG001|Overall Study|Randomized, Not Treated|4|||
130902634|NCT00483756|471277568|FG002|Overall Study|Randomized, Not Treated|4|||
130902635|NCT00217464|471277570|FG000|Overall Study|Progression|15|||
131113820|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
131113821|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
131113822|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
131113823|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
131113824|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
131113825|NCT00559585|472047255|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
131113826|NCT00559585|472047256|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
131113827|NCT04614662|472047257|FG000|Overall Study|Withdrawal by Subject|0|||
131113828|NCT04614662|472047258|FG001|Overall Study|Withdrawal by Subject|1|||
131113829|NCT04195581|472047270|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
131113830|NCT04195581|472047270|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
131113831|NCT04195581|472047270|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
131113832|NCT04195581|472047270|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
131113833|NCT04195581|472047270|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
131113834|NCT04195581|472047270|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
131113835|NCT01237340|472047273|FG000|Overall Study|Adverse Event|3|||
131113836|NCT01237340|472047273|FG000|Overall Study|Withdrawal by Subject|1|||
131113837|NCT01237340|472047273|FG000|Overall Study|Early termination of the trial|36|||
131113838|NCT01136811|472047274|FG000|Overall Study|Physician Decision|11|||
131113839|NCT03829319|472047277|FG000|Overall Study|Sponsor's Decision|4|||
131113840|NCT03829319|472047278|FG001|Overall Study|Sponsor's Decision|90|||
131113841|NCT03829319|472047279|FG002|Overall Study|Sponsor's Decision|102|||
131113842|NCT03829319|472047277|FG000|Overall Study|Withdrawal by Subject|1|||
131113843|NCT03829319|472047278|FG001|Overall Study|Withdrawal by Subject|5|||
130768385|NCT00603382|470775557|FG002|Overall Study|Protocol Violation|1|||
130902636|NCT00217464|471277570|FG000|Overall Study|Other|2|||
130902637|NCT01089361|471277571|FG000|Overall Study|Death|1|||
130902638|NCT01089361|471277572|FG001|Overall Study|Death|0|||
130902639|NCT01426789|471277573|FG000|Part 1|Protocol deviation|0|||
130902640|NCT01426789|471277574|FG001|Part 1|Protocol deviation|1|||
130902641|NCT01426789|471277575|FG002|Part 1|Protocol deviation|0|||
130902642|NCT01426789|471277576|FG003|Part 1|Protocol deviation|0|||
130902643|NCT01426789|471277577|FG004|Part 1|Protocol deviation|0|||
130902644|NCT01426789|471277578|FG005|Part 1|Protocol deviation|0|||
130902645|NCT01426789|471277573|FG000|Part 1|Lost to Follow-up|1|||
130902646|NCT01426789|471277574|FG001|Part 1|Lost to Follow-up|2|||
130902647|NCT01426789|471277575|FG002|Part 1|Lost to Follow-up|0|||
130902648|NCT01426789|471277576|FG003|Part 1|Lost to Follow-up|0|||
130902649|NCT01426789|471277577|FG004|Part 1|Lost to Follow-up|0|||
130902650|NCT01426789|471277578|FG005|Part 1|Lost to Follow-up|0|||
130902651|NCT01426789|471277573|FG000|Part 1|Lack of Efficacy|2|||
130902652|NCT01426789|471277574|FG001|Part 1|Lack of Efficacy|1|||
130902653|NCT01426789|471277575|FG002|Part 1|Lack of Efficacy|0|||
130902654|NCT01426789|471277576|FG003|Part 1|Lack of Efficacy|0|||
130902655|NCT01426789|471277577|FG004|Part 1|Lack of Efficacy|0|||
130902656|NCT01426789|471277578|FG005|Part 1|Lack of Efficacy|0|||
130902657|NCT01426789|471277573|FG000|Part 1|Adverse Event|3|||
130902658|NCT01426789|471277574|FG001|Part 1|Adverse Event|0|||
130902659|NCT01426789|471277575|FG002|Part 1|Adverse Event|0|||
130902660|NCT01426789|471277576|FG003|Part 1|Adverse Event|0|||
130902661|NCT01426789|471277577|FG004|Part 1|Adverse Event|0|||
130902662|NCT01426789|471277578|FG005|Part 1|Adverse Event|0|||
130902663|NCT01426789|471277573|FG000|Part 2|Protocol deviation|0|||
130902664|NCT01426789|471277574|FG001|Part 2|Protocol deviation|0|||
130902665|NCT01426789|471277575|FG002|Part 2|Protocol deviation|1|||
130902666|NCT01426789|471277576|FG003|Part 2|Protocol deviation|0|||
130902667|NCT01426789|471277577|FG004|Part 2|Protocol deviation|0|||
130902668|NCT01426789|471277578|FG005|Part 2|Protocol deviation|0|||
130902669|NCT01426789|471277573|FG000|Part 2|Death|0|||
130902670|NCT01426789|471277574|FG001|Part 2|Death|0|||
130902671|NCT01426789|471277575|FG002|Part 2|Death|1|||
130902672|NCT01426789|471277576|FG003|Part 2|Death|0|||
130902673|NCT01426789|471277577|FG004|Part 2|Death|1|||
130902674|NCT01426789|471277578|FG005|Part 2|Death|0|||
130902675|NCT01426789|471277573|FG000|Part 2|Administrative problems|0|||
130902676|NCT01426789|471277574|FG001|Part 2|Administrative problems|0|||
130902677|NCT01426789|471277575|FG002|Part 2|Administrative problems|2|||
130902678|NCT01426789|471277576|FG003|Part 2|Administrative problems|0|||
130902679|NCT01426789|471277577|FG004|Part 2|Administrative problems|1|||
130902680|NCT01426789|471277578|FG005|Part 2|Administrative problems|0|||
130902681|NCT01426789|471277573|FG000|Part 2|Lost to Follow-up|0|||
130902682|NCT01426789|471277574|FG001|Part 2|Lost to Follow-up|0|||
130902683|NCT01426789|471277575|FG002|Part 2|Lost to Follow-up|4|||
130902684|NCT01426789|471277576|FG003|Part 2|Lost to Follow-up|0|||
130902685|NCT01426789|471277577|FG004|Part 2|Lost to Follow-up|1|||
130902686|NCT01426789|471277578|FG005|Part 2|Lost to Follow-up|0|||
130902687|NCT01426789|471277573|FG000|Part 2|Withdrawal by Subject|0|||
130902688|NCT01426789|471277574|FG001|Part 2|Withdrawal by Subject|0|||
130902689|NCT01426789|471277575|FG002|Part 2|Withdrawal by Subject|0|||
130902690|NCT01426789|471277576|FG003|Part 2|Withdrawal by Subject|1|||
130902691|NCT01426789|471277577|FG004|Part 2|Withdrawal by Subject|2|||
130902692|NCT01426789|471277578|FG005|Part 2|Withdrawal by Subject|0|||
130902693|NCT01426789|471277573|FG000|Part 2|Lack of Efficacy|0|||
130902694|NCT01426789|471277574|FG001|Part 2|Lack of Efficacy|0|||
130902695|NCT01426789|471277575|FG002|Part 2|Lack of Efficacy|5|||
131027465|NCT01898494|471732353|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
131027466|NCT01898494|471732354|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
131027467|NCT01898494|471732350|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
131027468|NCT01898494|471732351|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
131027469|NCT01898494|471732352|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
131027470|NCT01898494|471732353|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
131027471|NCT01898494|471732354|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
131027472|NCT01898494|471732350|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
131027473|NCT01898494|471732351|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
131027474|NCT01898494|471732352|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
131027475|NCT01898494|471732353|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
131027476|NCT01898494|471732354|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
131027477|NCT01898494|471732350|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
131027478|NCT01898494|471732351|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
131027479|NCT01898494|471732352|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
131027480|NCT01898494|471732353|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
131027481|NCT01898494|471732354|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
131027482|NCT01898494|471732350|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
131027483|NCT01898494|471732351|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
131027484|NCT01898494|471732352|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
130902696|NCT01426789|471277576|FG003|Part 2|Lack of Efficacy|0|||
130902697|NCT01426789|471277577|FG004|Part 2|Lack of Efficacy|2|||
130902698|NCT01426789|471277578|FG005|Part 2|Lack of Efficacy|0|||
130902699|NCT01426789|471277573|FG000|Part 2|Adverse Event|0|||
130902700|NCT01426789|471277574|FG001|Part 2|Adverse Event|0|||
130902701|NCT01426789|471277575|FG002|Part 2|Adverse Event|2|||
130902702|NCT01426789|471277576|FG003|Part 2|Adverse Event|0|||
130902703|NCT01426789|471277577|FG004|Part 2|Adverse Event|1|||
131027485|NCT01898494|471732353|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
131027486|NCT01898494|471732354|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
131027487|NCT01898494|471732350|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
131027488|NCT01898494|471732351|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
131027489|NCT01898494|471732352|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
131027490|NCT01898494|471732353|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
130902704|NCT01426789|471277578|FG005|Part 2|Adverse Event|0|||
130902705|NCT04463069|471277579|FG000|Overall Study|Withdrawal by Subject|2|||
130902706|NCT04463069|471277580|FG001|Overall Study|Withdrawal by Subject|10|||
130902707|NCT04463069|471277579|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
130902708|NCT04463069|471277580|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
130902709|NCT04531462|471279241|FG000|Overall Study|Withdrawal by Subject|3|||
130902710|NCT04531462|471279242|FG001|Overall Study|Withdrawal by Subject|1|||
130902711|NCT04531462|471279241|FG000|Overall Study|Adverse Event|3|||
130902712|NCT04531462|471279242|FG001|Overall Study|Adverse Event|3|||
130902713|NCT00504582|471279243|FG000|Overall Study|Lost to Follow-up|1|||
130902714|NCT00504582|471279244|FG001|Overall Study|Lost to Follow-up|0|||
130902715|NCT00504582|471279245|FG002|Overall Study|Lost to Follow-up|0|||
130902716|NCT00348933|471279248|FG000|Overall Study|Withdrawal by Subject|10|||
130902717|NCT00348933|471279248|FG000|Overall Study|Lost to Follow-up|6|||
130902718|NCT00348933|471279248|FG000|Overall Study|Protocol Violation|2|||
130902719|NCT00348933|471279248|FG000|Overall Study|Adverse Event|7|||
130902720|NCT01489111|471279249|FG000|Overall Study|Withdrawal criterion|1|||
130902721|NCT00711516|471279255|FG000|Overall Study|Adverse Event|1|||
130902722|NCT00711516|471279256|FG001|Overall Study|Adverse Event|1|||
130902723|NCT00711516|471279255|FG000|Overall Study|Withdrawal by Subject|0|||
130902724|NCT00711516|471279256|FG001|Overall Study|Withdrawal by Subject|1|||
130902725|NCT00711516|471279255|FG000|Overall Study|Protocol Violation|0|||
130902726|NCT00711516|471279256|FG001|Overall Study|Protocol Violation|1|||
130902727|NCT01029405|471279260|FG000|Overall Study|Withdrawal by Subject|0|||
130902728|NCT01029405|471279261|FG001|Overall Study|Withdrawal by Subject|1|||
130902729|NCT01029405|471279262|FG002|Overall Study|Withdrawal by Subject|2|||
130902730|NCT01029405|471279263|FG003|Overall Study|Withdrawal by Subject|0|||
130902731|NCT01029405|471279260|FG000|Overall Study|Protocol Violation|0|||
130902732|NCT01029405|471279261|FG001|Overall Study|Protocol Violation|0|||
130902733|NCT01029405|471279262|FG002|Overall Study|Protocol Violation|0|||
130902734|NCT01029405|471279263|FG003|Overall Study|Protocol Violation|1|||
130902735|NCT01029405|471279260|FG000|Overall Study|Adverse Event|0|||
130902736|NCT01029405|471279261|FG001|Overall Study|Adverse Event|0|||
130902737|NCT01029405|471279262|FG002|Overall Study|Adverse Event|1|||
130902738|NCT01029405|471279263|FG003|Overall Study|Adverse Event|1|||
130902739|NCT01029405|471279260|FG000|Overall Study|Lost to Follow-up|2|||
130902740|NCT01029405|471279261|FG001|Overall Study|Lost to Follow-up|1|||
130902741|NCT01029405|471279262|FG002|Overall Study|Lost to Follow-up|1|||
130902742|NCT01029405|471279263|FG003|Overall Study|Lost to Follow-up|2|||
130902743|NCT01029405|471279260|FG000|Overall Study|Other|0|||
130902744|NCT01029405|471279261|FG001|Overall Study|Other|1|||
130902745|NCT01029405|471279262|FG002|Overall Study|Other|0|||
130902746|NCT01029405|471279263|FG003|Overall Study|Other|1|||
130902747|NCT01534182|471279266|FG000|Overall Study|Administrative problems|1|||
130902748|NCT01534182|471279267|FG001|Overall Study|Administrative problems|0|||
130902749|NCT01534182|471279266|FG000|Overall Study|Withdrawal by Subject|4|||
130902750|NCT01534182|471279267|FG001|Overall Study|Withdrawal by Subject|7|||
130902751|NCT01534182|471279266|FG000|Overall Study|Adverse Event|7|||
130902752|NCT01534182|471279267|FG001|Overall Study|Adverse Event|3|||
130902753|NCT00924170|471279268|FG000|Overall Study|Refused further treatment|0|||
130902754|NCT00924170|471279269|FG001|Overall Study|Refused further treatment|1|||
131027491|NCT01898494|471732354|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
131027492|NCT01898494|471732350|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
131027493|NCT01898494|471732351|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
131027494|NCT01898494|471732352|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
131027495|NCT01898494|471732353|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
131027496|NCT01898494|471732354|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
131027497|NCT01898494|471732350|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
131027498|NCT01898494|471732351|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
131027499|NCT01898494|471732352|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
131027500|NCT01898494|471732353|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
131027501|NCT01898494|471732354|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
131027502|NCT01898494|471732350|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
131027503|NCT01898494|471732351|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
131027504|NCT01898494|471732352|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
131027505|NCT01898494|471732353|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
130902755|NCT00924170|471279268|FG000|Overall Study|Physician Decision|0|||
130902756|NCT00924170|471279269|FG001|Overall Study|Physician Decision|1|||
130902757|NCT00924170|471279268|FG000|Overall Study|Progressive disease|3|||
130902758|NCT00924170|471279269|FG001|Overall Study|Progressive disease|6|||
130902759|NCT00924170|471279268|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
131027506|NCT01898494|471732354|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
131027507|NCT03289039|471732355|FG000|Overall Study|Withdrawal by Subject|0|||
131027508|NCT03289039|471732356|FG001|Overall Study|Withdrawal by Subject|1|||
131027509|NCT03289039|471732355|FG000|Overall Study|Became ineligible prior to treatment start|0|||
131027510|NCT03289039|471732356|FG001|Overall Study|Became ineligible prior to treatment start|1|||
130902760|NCT00924170|471279269|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
130902761|NCT00924170|471279268|FG000|Overall Study|Death|1|||
130902762|NCT00924170|471279269|FG001|Overall Study|Death|0|||
130902763|NCT04449029|471279272|FG000|Overall Study|Adverse Event|0|||
130902764|NCT04449029|471279273|FG001|Overall Study|Adverse Event|1|||
130902765|NCT04449029|471279274|FG002|Overall Study|Adverse Event|1|||
130902766|NCT04449029|471279275|FG003|Overall Study|Adverse Event|0|||
130902767|NCT04449029|471279276|FG004|Overall Study|Adverse Event|1|||
130902768|NCT04449029|471279277|FG005|Overall Study|Adverse Event|0|||
130902769|NCT04449029|471279278|FG006|Overall Study|Adverse Event|1|||
130902770|NCT04449029|471279279|FG007|Overall Study|Adverse Event|0|||
130902771|NCT04449029|471279272|FG000|Overall Study|Lost to Follow-up|0|||
130902772|NCT04449029|471279273|FG001|Overall Study|Lost to Follow-up|1|||
130902773|NCT04449029|471279274|FG002|Overall Study|Lost to Follow-up|0|||
130902774|NCT04449029|471279275|FG003|Overall Study|Lost to Follow-up|0|||
130902775|NCT04449029|471279276|FG004|Overall Study|Lost to Follow-up|0|||
130902776|NCT04449029|471279277|FG005|Overall Study|Lost to Follow-up|0|||
130902777|NCT04449029|471279278|FG006|Overall Study|Lost to Follow-up|0|||
130902778|NCT04449029|471279279|FG007|Overall Study|Lost to Follow-up|0|||
130902779|NCT04449029|471279272|FG000|Overall Study|Protocol Violation|0|||
130902780|NCT04449029|471279273|FG001|Overall Study|Protocol Violation|1|||
130902781|NCT04449029|471279274|FG002|Overall Study|Protocol Violation|0|||
130902782|NCT04449029|471279275|FG003|Overall Study|Protocol Violation|0|||
130902783|NCT04449029|471279276|FG004|Overall Study|Protocol Violation|0|||
130902784|NCT04449029|471279277|FG005|Overall Study|Protocol Violation|0|||
130902785|NCT04449029|471279278|FG006|Overall Study|Protocol Violation|0|||
130902786|NCT04449029|471279279|FG007|Overall Study|Protocol Violation|0|||
130902787|NCT04449029|471279272|FG000|Overall Study|Physician Decision|0|||
130902788|NCT04449029|471279273|FG001|Overall Study|Physician Decision|0|||
130902789|NCT04449029|471279274|FG002|Overall Study|Physician Decision|0|||
130902790|NCT04449029|471279275|FG003|Overall Study|Physician Decision|0|||
130902791|NCT04449029|471279276|FG004|Overall Study|Physician Decision|0|||
130902792|NCT04449029|471279277|FG005|Overall Study|Physician Decision|1|||
130902793|NCT04449029|471279278|FG006|Overall Study|Physician Decision|0|||
130902794|NCT04449029|471279279|FG007|Overall Study|Physician Decision|0|||
130902795|NCT04449029|471279272|FG000|Overall Study|Withdrawal by Subject|3|||
130902796|NCT04449029|471279273|FG001|Overall Study|Withdrawal by Subject|0|||
130902797|NCT04449029|471279274|FG002|Overall Study|Withdrawal by Subject|1|||
130902798|NCT04449029|471279275|FG003|Overall Study|Withdrawal by Subject|1|||
130902799|NCT04449029|471279276|FG004|Overall Study|Withdrawal by Subject|5|||
130902800|NCT04449029|471279277|FG005|Overall Study|Withdrawal by Subject|1|||
130902801|NCT04449029|471279278|FG006|Overall Study|Withdrawal by Subject|4|||
130902802|NCT04449029|471279279|FG007|Overall Study|Withdrawal by Subject|0|||
130902803|NCT02025556|471279281|FG000|Overall Study|Adverse Event|0|||
130902804|NCT02025556|471279282|FG001|Overall Study|Adverse Event|4|||
130902805|NCT02025556|471279283|FG002|Overall Study|Adverse Event|2|||
130902806|NCT02025556|471279281|FG000|Overall Study|Lack of Efficacy|2|||
130768386|NCT00603382|470775558|FG003|Overall Study|Protocol Violation|2|||
130768387|NCT00603382|470775559|FG004|Overall Study|Protocol Violation|1|||
130902807|NCT02025556|471279282|FG001|Overall Study|Lack of Efficacy|1|||
130902808|NCT02025556|471279283|FG002|Overall Study|Lack of Efficacy|0|||
130902809|NCT02025556|471279281|FG000|Overall Study|Protocol Violation|2|||
130902810|NCT02025556|471279282|FG001|Overall Study|Protocol Violation|1|||
130902811|NCT02025556|471279283|FG002|Overall Study|Protocol Violation|0|||
130902812|NCT02025556|471279281|FG000|Overall Study|Withdrawal by Subject|0|||
130902813|NCT02025556|471279282|FG001|Overall Study|Withdrawal by Subject|3|||
130902814|NCT02025556|471279283|FG002|Overall Study|Withdrawal by Subject|6|||
130902815|NCT02025556|471279281|FG000|Overall Study|Lost to Follow-up|2|||
130902816|NCT02025556|471279282|FG001|Overall Study|Lost to Follow-up|4|||
130902817|NCT02025556|471279283|FG002|Overall Study|Lost to Follow-up|0|||
130902818|NCT02025556|471279281|FG000|Overall Study|Reason not reported|0|||
130902819|NCT02025556|471279282|FG001|Overall Study|Reason not reported|0|||
130902820|NCT02025556|471279283|FG002|Overall Study|Reason not reported|1|||
130902821|NCT00627445|471279284|FG000|Overall Study|Adverse Event|3|||
130902822|NCT00627445|471279285|FG001|Overall Study|Adverse Event|3|||
130902823|NCT00627445|471279284|FG000|Overall Study|Lack of Efficacy|0|||
130902824|NCT00627445|471279285|FG001|Overall Study|Lack of Efficacy|1|||
130902825|NCT00627445|471279284|FG000|Overall Study|Other|6|||
130902826|NCT00627445|471279285|FG001|Overall Study|Other|8|||
130902827|NCT04098224|471279286|FG000|Overall Study|Adverse Event|1|||
131027511|NCT03289039|471732355|FG000|Overall Study|progressed before treatment start|1|||
130902828|NCT04098224|471279287|FG001|Overall Study|Adverse Event|0|||
130902829|NCT04098224|471279286|FG000|Overall Study|Physician Decision|1|||
130902830|NCT04098224|471279287|FG001|Overall Study|Physician Decision|0|||
130768388|NCT00603382|470775560|FG005|Overall Study|Protocol Violation|0|||
130768389|NCT00603382|470775555|FG000|Overall Study|Lost to Follow-up|0|||
130902831|NCT04098224|471279286|FG000|Overall Study|Patient not required enteral feeding|1|||
130902832|NCT04098224|471279287|FG001|Overall Study|Patient not required enteral feeding|0|||
130902833|NCT04098224|471279286|FG000|Overall Study|Patient failure nasogastric tube|1|||
130902834|NCT04098224|471279287|FG001|Overall Study|Patient failure nasogastric tube|0|||
130902835|NCT04098224|471279286|FG000|Overall Study|Patient early extubation|1|||
130902836|NCT04098224|471279287|FG001|Overall Study|Patient early extubation|3|||
130902837|NCT01203852|471279291|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
130902838|NCT01203852|471279291|FG000|Washout 2 Weeks|Physician Decision|46|||
130902839|NCT00247611|471279297|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
130694490|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694491|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130694492|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694493|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694494|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694495|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694496|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694497|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694498|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694499|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694500|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694501|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694502|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694503|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694504|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694505|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694506|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694507|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
130694508|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694509|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694510|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694511|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694512|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694513|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694514|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694515|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694516|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694517|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130694518|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694519|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694520|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694521|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694522|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694523|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694524|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694525|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694526|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694527|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694528|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694529|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694530|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694531|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694532|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694533|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
130694534|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694535|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694536|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694537|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694538|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
131027512|NCT03289039|471732356|FG001|Overall Study|progressed before treatment start|0|||
131027513|NCT01718743|471732359|FG000|Overall Study|Physician Decision|7|||
131027514|NCT01718743|471732359|FG000|Overall Study|Withdrawal by Subject|14|||
131027515|NCT01718743|471732359|FG000|Overall Study|Progressive Disease|22|||
131027516|NCT01718743|471732359|FG000|Overall Study|Toxicity|1|||
131027517|NCT01718743|471732359|FG000|Overall Study|Malignancy|1|||
131027518|NCT03263026|471732363|FG000|Overall Study|Withdrawal by Subject|1|||
131027519|NCT03263026|471732364|FG001|Overall Study|Withdrawal by Subject|0|||
131027520|NCT03263026|471732363|FG000|Overall Study|Death|1|||
131027521|NCT03263026|471732364|FG001|Overall Study|Death|0|||
131027522|NCT03263026|471732363|FG000|Overall Study|Other/ Various|41|||
131027523|NCT03263026|471732364|FG001|Overall Study|Other/ Various|29|||
131027524|NCT03739996|471732367|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
131027525|NCT03739996|471732367|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
131027526|NCT03739996|471732367|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
131027527|NCT03739996|471732367|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
131027528|NCT03739996|471732367|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
131027529|NCT03739996|471732367|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
131027530|NCT03739996|471732367|FG000|Step 3 (SOC ART)|Death|1|||
131027531|NCT03739996|471732367|FG000|Step 3 (SOC ART)|Participant moved|1|||
131027532|NCT02553642|471732368|FG000|Overall Study|Withdrawal by Subject|0|||
131027533|NCT02553642|471732369|FG001|Overall Study|Withdrawal by Subject|3|||
130902840|NCT00247611|471279298|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
130902841|NCT00247611|471279297|FG000|Baselined|Completed baseline only|9|||
130902842|NCT00247611|471279298|FG001|Baselined|Completed baseline only|8|||
130902843|NCT02437110|471279301|FG000|Screening|Lost to Follow-up|3|||
130902844|NCT02437110|471279301|FG000|Screening|Physician Decision|1|||
130902845|NCT02437110|471279301|FG000|ART|Adverse Event|3|||
130902846|NCT02437110|471279301|FG000|ART|Protocol Violation|3|||
130902847|NCT02437110|471279301|FG000|ART|Withdrawal by Subject|4|||
130902848|NCT02437110|471279301|FG000|ART|Lost to follow-up prior to start of intervention|1|||
130902849|NCT02437110|471279301|FG000|ART|Physician decision prior to start of intervention|2|||
130902850|NCT02437110|471279301|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
130902851|NCT02437110|471279301|FG000|Post-ART|Lost to Follow-up|3|||
130902852|NCT02437110|471279301|FG000|Post-ART|Protocol Violation|4|||
130902853|NCT02437110|471279301|FG000|Post-ART|Withdrawal by Subject|3|||
130902854|NCT00308581|471279306|FG000|Induction Phase|Adverse Event|0|||
130902855|NCT00308581|471279307|FG001|Induction Phase|Adverse Event|0|||
130902856|NCT00308581|471279308|FG002|Induction Phase|Adverse Event|37|||
130902857|NCT00308581|471279306|FG000|Induction Phase|Lack of Efficacy|0|||
130902858|NCT00308581|471279307|FG001|Induction Phase|Lack of Efficacy|0|||
130902859|NCT00308581|471279308|FG002|Induction Phase|Lack of Efficacy|121|||
130902860|NCT00308581|471279306|FG000|Induction Phase|Withdrawal by Subject|0|||
130902861|NCT00308581|471279307|FG001|Induction Phase|Withdrawal by Subject|0|||
130902862|NCT00308581|471279308|FG002|Induction Phase|Withdrawal by Subject|5|||
130902863|NCT00308581|471279306|FG000|Induction Phase|Unknown reason|0|||
130902864|NCT00308581|471279307|FG001|Induction Phase|Unknown reason|0|||
130902865|NCT00308581|471279308|FG002|Induction Phase|Unknown reason|3|||
130902866|NCT00308581|471279306|FG000|Randomized Maintenance Phase|Adverse Event|10|||
130902867|NCT00308581|471279307|FG001|Randomized Maintenance Phase|Adverse Event|17|||
130902868|NCT00308581|471279308|FG002|Randomized Maintenance Phase|Adverse Event|0|||
130902869|NCT00308581|471279306|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
130902870|NCT00308581|471279307|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
130902871|NCT00308581|471279308|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
130902872|NCT00308581|471279306|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
130902873|NCT00308581|471279307|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
130902874|NCT00308581|471279308|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
130902875|NCT00308581|471279306|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
130902876|NCT00308581|471279307|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
130902877|NCT00308581|471279308|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
130902878|NCT00308581|471279306|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
130902879|NCT00308581|471279307|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
130902880|NCT00308581|471279308|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
130902881|NCT00308581|471279306|FG000|Randomized Maintenance Phase|Unknown reason|3|||
130902882|NCT00308581|471279307|FG001|Randomized Maintenance Phase|Unknown reason|0|||
130902883|NCT00308581|471279308|FG002|Randomized Maintenance Phase|Unknown reason|0|||
130902884|NCT00899353|471279309|FG000|Overall Study|Adverse Event|2|||
130902885|NCT00899353|471279309|FG000|Overall Study|Lost to Follow-up|1|||
130902886|NCT00899353|471279309|FG000|Overall Study|Withdrawal by Subject|2|||
130902887|NCT01284491|471279318|FG000|Overall Study|Study termination|13|||
130902888|NCT02395302|471279323|FG000|Overall Study|Screen Failure|3|||
130902889|NCT02395302|471279323|FG000|Overall Study|Run In Failure|7|||
130902890|NCT02395302|471279323|FG000|Overall Study|Withdrawal by Subject|2|||
130902891|NCT02395302|471279323|FG000|Overall Study|Physician Decision|2|||
130902892|NCT01087788|471279324|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
130902893|NCT01087788|471279325|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
130902894|NCT01087788|471279326|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
130902895|NCT01087788|471279324|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
130902896|NCT01087788|471279325|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
130902897|NCT01087788|471279326|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
130902898|NCT01087788|471279324|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
130902899|NCT01087788|471279325|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
130902900|NCT01087788|471279326|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
130902901|NCT01087788|471279324|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
130902902|NCT01087788|471279325|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
130902903|NCT01087788|471279326|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
130902904|NCT01087788|471279324|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
130902905|NCT01087788|471279325|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
130902906|NCT01087788|471279326|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
130902907|NCT01087788|471279324|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
130902908|NCT01087788|471279325|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
130902909|NCT01087788|471279326|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
130902910|NCT01087788|471279324|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
130902911|NCT01087788|471279325|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
131027534|NCT02553642|471732368|FG000|Overall Study|Physician Decision|0|||
131027535|NCT02553642|471732369|FG001|Overall Study|Physician Decision|1|||
131027536|NCT02553642|471732368|FG000|Overall Study|Additional cancer dx|0|||
131027537|NCT02553642|471732369|FG001|Overall Study|Additional cancer dx|1|||
131027538|NCT02553642|471732368|FG000|Overall Study|Never started treatment|0|||
131027539|NCT02553642|471732369|FG001|Overall Study|Never started treatment|1|||
131027540|NCT05444192|471732370|FG000|Overall Study|Lost to Follow-up|1|||
131027541|NCT05444192|471732371|FG001|Overall Study|Lost to Follow-up|0|||
131027542|NCT00894543|471732375|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
131027543|NCT00894543|471732376|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
131027544|NCT00894543|471732375|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
131027545|NCT00894543|471732376|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
131027546|NCT01532388|471732377|FG000|3-month Follow-up|Lost to Follow-up|68|||
131027547|NCT01532388|471732378|FG001|3-month Follow-up|Lost to Follow-up|68|||
131027548|NCT01532388|471732377|FG000|6-month Follow-up|Lost to Follow-up|74|||
131027549|NCT01532388|471732378|FG001|6-month Follow-up|Lost to Follow-up|66|||
131027550|NCT01532388|471732377|FG000|12-month Follow-up|Lost to Follow-up|69|||
131027551|NCT01532388|471732378|FG001|12-month Follow-up|Lost to Follow-up|67|||
131027552|NCT02919449|471732379|FG000|Overall Study|Withdrawal by Subject|1|||
131027553|NCT02919449|471732379|FG000|Overall Study|Investigator decision|1|||
131027554|NCT05623345|471732380|FG000|Overall Study|Withdrawal by Subject|14|||
131027555|NCT05623345|471732381|FG001|Overall Study|Withdrawal by Subject|0|||
131027556|NCT05623345|471732382|FG002|Overall Study|Withdrawal by Subject|9|||
131027557|NCT05623345|471732383|FG003|Overall Study|Withdrawal by Subject|20|||
131027558|NCT05623345|471732380|FG000|Overall Study|Lost to Follow-up|3|||
131027559|NCT05623345|471732381|FG001|Overall Study|Lost to Follow-up|0|||
131027560|NCT05623345|471732382|FG002|Overall Study|Lost to Follow-up|7|||
131027561|NCT05623345|471732383|FG003|Overall Study|Lost to Follow-up|2|||
131027562|NCT05623345|471732380|FG000|Overall Study|Termination of Study By Sponsor|37|||
130694539|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694540|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694541|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694542|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694543|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
130694544|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694545|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694546|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694547|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694548|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694549|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694550|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694551|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130902912|NCT01087788|471279326|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
130902913|NCT01087788|471279324|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
130902914|NCT01087788|471279325|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
130902915|NCT01087788|471279326|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
130902916|NCT01087788|471279324|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
130902917|NCT01087788|471279325|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
130902918|NCT01087788|471279326|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
130902919|NCT01087788|471279324|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
130902920|NCT01087788|471279325|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
130902921|NCT01087788|471279326|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
130902922|NCT01087788|471279324|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
130902923|NCT01087788|471279325|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
130902924|NCT01087788|471279326|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
130902925|NCT01087788|471279324|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
130902926|NCT01087788|471279325|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
130902927|NCT01087788|471279326|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
130902928|NCT01087788|471279324|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
130902929|NCT01087788|471279325|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
130902930|NCT01087788|471279326|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
130902931|NCT01087788|471279324|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
130902932|NCT01087788|471279325|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
130902933|NCT01087788|471279326|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
131027563|NCT05623345|471732381|FG001|Overall Study|Termination of Study By Sponsor|4|||
131027564|NCT05623345|471732382|FG002|Overall Study|Termination of Study By Sponsor|40|||
131027565|NCT05623345|471732383|FG003|Overall Study|Termination of Study By Sponsor|38|||
131027566|NCT01772472|471732385|FG000|Overall Study|Death|126|||
131027567|NCT01772472|471732386|FG001|Overall Study|Death|94|||
131027568|NCT01772472|471732385|FG000|Overall Study|Lost to Follow-up|51|||
131027569|NCT01772472|471732386|FG001|Overall Study|Lost to Follow-up|50|||
131027570|NCT01772472|471732385|FG000|Overall Study|Other|9|||
130902934|NCT01087788|471279324|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
130902935|NCT01087788|471279325|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
130902936|NCT01087788|471279326|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
130902937|NCT01087788|471279324|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
130902938|NCT01087788|471279325|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
130902939|NCT01087788|471279326|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
130902940|NCT01087788|471279324|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
130902941|NCT01087788|471279325|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
130902942|NCT01087788|471279326|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
130902943|NCT01087788|471279324|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
130902944|NCT01087788|471279325|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
130902945|NCT01087788|471279326|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
130902946|NCT01087788|471279324|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
130902947|NCT01087788|471279325|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
130902948|NCT01087788|471279326|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
130902949|NCT01087788|471279324|FG000|24-weeks Dose-blind Period|Patient moved|0|||
130902950|NCT01087788|471279325|FG001|24-weeks Dose-blind Period|Patient moved|0|||
130902951|NCT01087788|471279326|FG002|24-weeks Dose-blind Period|Patient moved|1|||
130902952|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
130902953|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
130902954|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
130902955|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
130902956|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
130902957|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
130902958|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
130902959|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
130902960|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
130902961|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
130902962|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
130902963|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
130902964|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
130902965|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
130902966|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
130902967|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
130902968|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
130902969|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
130902970|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
130902971|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
130902972|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
130902973|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
130902974|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
130902975|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
130902976|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
130902977|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
130902978|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
130902979|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
130902980|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
130902981|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
130902982|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
130902983|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
130902984|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
130902985|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
130902986|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
130902987|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
130902988|NCT01087788|471279324|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
130902989|NCT01087788|471279325|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
130902990|NCT01087788|471279326|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
130902991|NCT03044574|471279334|FG000|Overall Study|Lost to Follow-up|37|||
130902992|NCT03044574|471279335|FG001|Overall Study|Lost to Follow-up|45|||
130902993|NCT00710762|471279336|FG000|Overall Study|Progressive disease|27|||
130902994|NCT00710762|471279337|FG001|Overall Study|Progressive disease|30|||
130902995|NCT00710762|471279336|FG000|Overall Study|Adverse Event other disease worsening|2|||
130902996|NCT00710762|471279337|FG001|Overall Study|Adverse Event other disease worsening|1|||
130902997|NCT00710762|471279336|FG000|Overall Study|Other Adverse Event|7|||
130902998|NCT00710762|471279337|FG001|Overall Study|Other Adverse Event|7|||
130902999|NCT00710762|471279336|FG000|Overall Study|Lost to Follow-up|1|||
130903000|NCT00710762|471279337|FG001|Overall Study|Lost to Follow-up|0|||
130903001|NCT00710762|471279336|FG000|Overall Study|Reason other than listed above|2|||
130903002|NCT00710762|471279337|FG001|Overall Study|Reason other than listed above|2|||
130903003|NCT00495040|471279339|FG000|Overall Study|Withdrawal by Subject|3|||
130903004|NCT01700439|471279340|FG000|Overall Study|Lost to Follow-up|47|||
130903005|NCT01700439|471279340|FG000|Overall Study|Withdrawal by Subject|183|||
130903006|NCT01700439|471279340|FG000|Overall Study|Death|186|||
130903007|NCT00621621|471279349|FG000|Overall Study|Subjects were exited at EP study|30|||
130903008|NCT00621621|471279350|FG001|Overall Study|Subjects were exited at EP study|0|||
130903009|NCT01077375|471279365|FG000|Overall Study|Adverse Event|2|||
130903010|NCT01077375|471279366|FG001|Overall Study|Adverse Event|15|||
130903011|NCT01077375|471279365|FG000|Overall Study|Lack of Efficacy|6|||
130903012|NCT01077375|471279366|FG001|Overall Study|Lack of Efficacy|8|||
130903013|NCT01077375|471279365|FG000|Overall Study|Withdrawal by Subject|0|||
130903014|NCT01077375|471279366|FG001|Overall Study|Withdrawal by Subject|6|||
130903015|NCT01077375|471279365|FG000|Overall Study|Lost to Follow-up|2|||
130903016|NCT01077375|471279366|FG001|Overall Study|Lost to Follow-up|5|||
130903017|NCT01077375|471279365|FG000|Overall Study|Other Reason|0|||
130903018|NCT01077375|471279366|FG001|Overall Study|Other Reason|1|||
130903019|NCT01924429|471279369|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
130903020|NCT01924429|471279370|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
130903021|NCT00906971|471279371|FG000|Overall Study|Withdrawal by Subject|8|||
130903022|NCT00906971|471279372|FG001|Overall Study|Withdrawal by Subject|2|||
130903023|NCT00906971|471279371|FG000|Overall Study|Lost to Follow-up|0|||
130903024|NCT00906971|471279372|FG001|Overall Study|Lost to Follow-up|1|||
130903025|NCT00545129|471279373|FG000|Overall Study|Lack of Efficacy|2|||
131113844|NCT03829319|472047279|FG002|Overall Study|Withdrawal by Subject|4|||
131113845|NCT03829319|472047277|FG000|Overall Study|Physician Decision|0|||
131113846|NCT03829319|472047278|FG001|Overall Study|Physician Decision|3|||
131113847|NCT03829319|472047279|FG002|Overall Study|Physician Decision|0|||
131113848|NCT03829319|472047277|FG000|Overall Study|Lost to Follow-up|0|||
131113849|NCT03829319|472047278|FG001|Overall Study|Lost to Follow-up|0|||
131113850|NCT03829319|472047279|FG002|Overall Study|Lost to Follow-up|1|||
131113851|NCT03829319|472047277|FG000|Overall Study|Death|8|||
131113852|NCT03829319|472047278|FG001|Overall Study|Death|277|||
131113853|NCT03829319|472047279|FG002|Overall Study|Death|266|||
131113854|NCT04498832|472047280|FG000|Overall Study|Adverse Event|1|||
131113855|NCT04498832|472047281|FG001|Overall Study|Adverse Event|3|||
131113856|NCT04498832|472047280|FG000|Overall Study|Withdrawal by Subject|0|||
131113857|NCT04498832|472047281|FG001|Overall Study|Withdrawal by Subject|1|||
131113858|NCT01012739|472047282|FG000|Treatment Period 1|Adverse Event|0|||
131113859|NCT01012739|472047283|FG001|Treatment Period 1|Adverse Event|0|||
131113860|NCT01012739|472047284|FG002|Treatment Period 1|Adverse Event|0|||
131113861|NCT01012739|472047285|FG003|Treatment Period 1|Adverse Event|1|||
131113862|NCT01012739|472047282|FG000|Treatment Period 2|Abnormal test procedure results|0|||
131113863|NCT01012739|472047283|FG001|Treatment Period 2|Abnormal test procedure results|0|||
131113864|NCT01012739|472047284|FG002|Treatment Period 2|Abnormal test procedure results|0|||
131113865|NCT01012739|472047285|FG003|Treatment Period 2|Abnormal test procedure results|1|||
131113866|NCT03049735|472047288|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
131113867|NCT03049735|472047289|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
131113868|NCT03049735|472047290|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
131113869|NCT03049735|472047288|FG000|Overall Study|Other|5|||
131113870|NCT03049735|472047289|FG001|Overall Study|Other|3|||
131113871|NCT03049735|472047290|FG002|Overall Study|Other|1|||
131113872|NCT03049735|472047288|FG000|Overall Study|Lack of Efficacy|4|||
131113873|NCT03049735|472047289|FG001|Overall Study|Lack of Efficacy|0|||
131113874|NCT03049735|472047290|FG002|Overall Study|Lack of Efficacy|3|||
131113875|NCT03049735|472047288|FG000|Overall Study|Protocol deviation|1|||
131113876|NCT03049735|472047289|FG001|Overall Study|Protocol deviation|0|||
131113877|NCT03049735|472047290|FG002|Overall Study|Protocol deviation|0|||
131113878|NCT03049735|472047288|FG000|Overall Study|Pregnancy|0|||
131113879|NCT03049735|472047289|FG001|Overall Study|Pregnancy|0|||
131113880|NCT03049735|472047290|FG002|Overall Study|Pregnancy|1|||
131113881|NCT03049735|472047288|FG000|Overall Study|Adverse Event|7|||
131113882|NCT03049735|472047289|FG001|Overall Study|Adverse Event|18|||
131113883|NCT03049735|472047290|FG002|Overall Study|Adverse Event|5|||
131113884|NCT03049735|472047288|FG000|Overall Study|Withdrawal by Subject|10|||
131113885|NCT03049735|472047289|FG001|Overall Study|Withdrawal by Subject|3|||
131113886|NCT03049735|472047290|FG002|Overall Study|Withdrawal by Subject|7|||
131113887|NCT03049735|472047288|FG000|Overall Study|Lost to Follow-up|1|||
131113888|NCT03049735|472047289|FG001|Overall Study|Lost to Follow-up|5|||
130903026|NCT00545129|471279374|FG001|Overall Study|Lack of Efficacy|5|||
131113889|NCT03049735|472047290|FG002|Overall Study|Lost to Follow-up|5|||
131113890|NCT00390910|472047291|FG000|Overall Study|Adverse Event|1|||
131113891|NCT00390910|472047292|FG001|Overall Study|Adverse Event|0|||
130903027|NCT00545129|471279373|FG000|Overall Study|Death|2|||
130903028|NCT00545129|471279374|FG001|Overall Study|Death|1|||
130903029|NCT00545129|471279373|FG000|Overall Study|Adverse Event|1|||
130903030|NCT00545129|471279374|FG001|Overall Study|Adverse Event|1|||
131113892|NCT00390910|472047293|FG002|Overall Study|Adverse Event|0|||
131113893|NCT00390910|472047291|FG000|Overall Study|Lost to Follow-up|0|||
131113894|NCT00390910|472047292|FG001|Overall Study|Lost to Follow-up|1|||
131113895|NCT00390910|472047293|FG002|Overall Study|Lost to Follow-up|5|||
130903031|NCT00545129|471279373|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
130903032|NCT00545129|471279374|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
130903033|NCT00545129|471279373|FG000|Overall Study|Other|3|||
130903034|NCT00545129|471279374|FG001|Overall Study|Other|3|||
130903035|NCT01894568|471279375|FG000|Overall Study|Adverse Event|2|||
130903036|NCT01894568|471279376|FG001|Overall Study|Adverse Event|3|||
130903037|NCT01894568|471279375|FG000|Overall Study|Protocol required discontinuation|2|||
130903038|NCT01894568|471279376|FG001|Overall Study|Protocol required discontinuation|1|||
130903039|NCT01894568|471279375|FG000|Overall Study|Withdrawal by Subject|5|||
130903040|NCT01894568|471279376|FG001|Overall Study|Withdrawal by Subject|5|||
130903041|NCT01894568|471279375|FG000|Overall Study|Physician Decision|1|||
130903042|NCT01894568|471279376|FG001|Overall Study|Physician Decision|0|||
130903043|NCT01894568|471279375|FG000|Overall Study|Lost to Follow-up|0|||
130903044|NCT01894568|471279376|FG001|Overall Study|Lost to Follow-up|1|||
130903045|NCT00807573|471279377|FG000|Overall Study|Withdrawal by Subject|1|||
130903046|NCT00807573|471279377|FG000|Overall Study|Adverse Event|1|||
130903047|NCT01514370|471279380|FG000|Overall Study|Protocol Violation|2|||
130903048|NCT01514370|471279381|FG001|Overall Study|Protocol Violation|3|||
130903049|NCT01514370|471279380|FG000|Overall Study|Lost to Follow-up|0|||
130903050|NCT01514370|471279381|FG001|Overall Study|Lost to Follow-up|2|||
130903051|NCT01514370|471279380|FG000|Overall Study|Withdrawal by Subject|2|||
130903052|NCT01514370|471279381|FG001|Overall Study|Withdrawal by Subject|1|||
130903053|NCT01514370|471279380|FG000|Overall Study|Adverse Event|1|||
130903054|NCT01514370|471279381|FG001|Overall Study|Adverse Event|3|||
130903055|NCT01514370|471279380|FG000|Overall Study|Other|6|||
130903056|NCT01514370|471279381|FG001|Overall Study|Other|7|||
130903057|NCT01551420|471279382|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
130903058|NCT01551420|471279383|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
130903059|NCT01551420|471279382|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
130903060|NCT01551420|471279383|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
130903061|NCT01551420|471279382|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
130903062|NCT01551420|471279383|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
130903063|NCT01551420|471279382|FG000|Screened for Part B Eligibility|Declined participation|8|||
130903064|NCT01551420|471279383|FG001|Screened for Part B Eligibility|Declined participation|1|||
130903065|NCT01551420|471279382|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
130903066|NCT01551420|471279383|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
130903067|NCT01551420|471279382|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
130903068|NCT01551420|471279383|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
130903069|NCT01551420|471279382|FG000|Home Use (Part B)|Withdrawal by staff|0|||
130903070|NCT01551420|471279383|FG001|Home Use (Part B)|Withdrawal by staff|1|||
130903071|NCT04054947|471279384|FG000|Overall Study|Withdrawal by Subject|1|||
130903072|NCT04054947|471279385|FG001|Overall Study|Withdrawal by Subject|0|||
130903073|NCT04054947|471279384|FG000|Overall Study|Lost to Follow-up|2|||
130903074|NCT04054947|471279385|FG001|Overall Study|Lost to Follow-up|5|||
130903075|NCT00853970|471279390|FG000|Overall Study|Withdrawal by Subject|2|||
130903076|NCT00853970|471279391|FG001|Overall Study|Withdrawal by Subject|1|||
130903077|NCT00853970|471279390|FG000|Overall Study|Cancelled surgery|4|||
130903078|NCT00853970|471279391|FG001|Overall Study|Cancelled surgery|2|||
130903079|NCT02055365|471280944|FG000|Overall Study|Prematurely Withdrawn|1|||
130903080|NCT03603509|471280945|FG000|Overall Study|Lost to Follow-up|3|||
130903081|NCT03603509|471280946|FG001|Overall Study|Lost to Follow-up|4|||
130903082|NCT02656680|471280949|FG000|Overall Study|Lost to Follow-up|0|||
130903083|NCT02656680|471280950|FG001|Overall Study|Lost to Follow-up|1|||
130903084|NCT02656680|471280951|FG002|Overall Study|Lost to Follow-up|7|||
130903085|NCT01258998|471280952|FG000|Overall Study|Ineligible|1|||
130903086|NCT01143389|471280955|FG000|Overall Study|Lost to Follow-up|26|||
130903087|NCT01143389|471280956|FG001|Overall Study|Lost to Follow-up|25|||
130903088|NCT04966910|471280957|FG000|Baseline|Participant did not complete measure|0|||
130903089|NCT04966910|471280958|FG001|Baseline|Participant did not complete measure|0|||
130903090|NCT04966910|471280959|FG002|Baseline|Participant did not complete measure|1|||
130903091|NCT04966910|471280960|FG003|Baseline|Participant did not complete measure|0|||
130903092|NCT04966910|471280957|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
130903093|NCT04966910|471280958|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
130903094|NCT04966910|471280959|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
130903095|NCT04966910|471280960|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
130903096|NCT04966910|471280957|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
130903097|NCT04966910|471280958|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
130903098|NCT04966910|471280959|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
130903099|NCT04966910|471280960|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
130903100|NCT04966910|471280957|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
130903101|NCT04966910|471280958|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
130903102|NCT04966910|471280959|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
130903103|NCT04966910|471280960|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
130903104|NCT02276027|471280962|FG000|Overall Study|Death|1|||
130903105|NCT02276027|471280963|FG001|Overall Study|Death|0|||
130903106|NCT02276027|471280964|FG002|Overall Study|Death|0|||
130903107|NCT02276027|471280965|FG003|Overall Study|Death|2|||
130903108|NCT02276027|471280962|FG000|Overall Study|Physician Decision|0|||
130903109|NCT02276027|471280963|FG001|Overall Study|Physician Decision|0|||
130903110|NCT02276027|471280964|FG002|Overall Study|Physician Decision|0|||
130903111|NCT02276027|471280965|FG003|Overall Study|Physician Decision|1|||
130903112|NCT02276027|471280962|FG000|Overall Study|Progressive disease|1|||
130903113|NCT02276027|471280963|FG001|Overall Study|Progressive disease|13|||
130903114|NCT02276027|471280964|FG002|Overall Study|Progressive disease|12|||
130903115|NCT02276027|471280965|FG003|Overall Study|Progressive disease|14|||
130903116|NCT02276027|471280962|FG000|Overall Study|Subject/guardian decision|0|||
130903117|NCT02276027|471280963|FG001|Overall Study|Subject/guardian decision|1|||
130903118|NCT02276027|471280964|FG002|Overall Study|Subject/guardian decision|0|||
130903119|NCT02276027|471280965|FG003|Overall Study|Subject/guardian decision|3|||
130903120|NCT02276027|471280962|FG000|Overall Study|Adverse Event|0|||
130903121|NCT02276027|471280963|FG001|Overall Study|Adverse Event|2|||
130903122|NCT02276027|471280964|FG002|Overall Study|Adverse Event|8|||
130903123|NCT02276027|471280965|FG003|Overall Study|Adverse Event|2|||
130903124|NCT02446171|471280967|FG000|Overall Study|Withdrawal by Subject|0|||
130903125|NCT02446171|471280968|FG001|Overall Study|Withdrawal by Subject|0|||
130903126|NCT02446171|471280969|FG002|Overall Study|Withdrawal by Subject|2|||
130903127|NCT02446171|471280970|FG003|Overall Study|Withdrawal by Subject|0|||
130903128|NCT03811093|471280972|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
130903129|NCT03811093|471280973|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
130903130|NCT03811093|471280972|FG000|Overall Study|Unable to measure body fat percentage|2|||
130903131|NCT03811093|471280973|FG001|Overall Study|Unable to measure body fat percentage|0|||
130903132|NCT03188042|471280974|FG000|Overall Study|Withdrawal by Subject|1|||
130903133|NCT03188042|471280975|FG001|Overall Study|Withdrawal by Subject|1|||
130903134|NCT01475071|471280979|FG000|Overall Study|Physician Decision|1|||
130903135|NCT01475071|471280979|FG000|Overall Study|Withdrawal by Subject|6|||
130903136|NCT01475071|471280979|FG000|Overall Study|Lost to Follow-up|1|||
130903137|NCT01343823|471280980|FG000|Overall Study|Study Terminated|1|||
130903138|NCT01343823|471280981|FG001|Overall Study|Study Terminated|0|||
130903139|NCT01343823|471280982|FG002|Overall Study|Study Terminated|0|||
130903140|NCT01343823|471280983|FG003|Overall Study|Study Terminated|1|||
130903141|NCT01343823|471280980|FG000|Overall Study|Withdrawal by Subject|1|||
130903142|NCT01343823|471280981|FG001|Overall Study|Withdrawal by Subject|0|||
130903143|NCT01343823|471280982|FG002|Overall Study|Withdrawal by Subject|0|||
130903144|NCT01343823|471280983|FG003|Overall Study|Withdrawal by Subject|0|||
130903145|NCT00923364|471280984|FG000|Overall Study|Death|3|||
130903146|NCT00923364|471280985|FG001|Overall Study|Death|0|||
130903147|NCT00923364|471280984|FG000|Overall Study|Did not go to transplant|1|||
130903148|NCT00923364|471280985|FG001|Overall Study|Did not go to transplant|0|||
130903149|NCT01011478|471280986|FG000|Overall Study|No follow up data|12|||
130903150|NCT01011478|471280987|FG001|Overall Study|No follow up data|7|||
130903151|NCT04352127|471280989|FG000|Overall Study|Unable to obtain readings|4|||
130903152|NCT04352127|471280990|FG001|Overall Study|Unable to obtain readings|1|||
130903153|NCT05338671|471280991|FG000|Overall Study|Lost to Follow-up|2|||
130903154|NCT05338671|471280992|FG001|Overall Study|Lost to Follow-up|2|||
130903155|NCT05338671|471280991|FG000|Overall Study|Root canal completed in a single visit|1|||
130903156|NCT05338671|471280992|FG001|Overall Study|Root canal completed in a single visit|0|||
130903157|NCT04456673|471280993|FG000|Overall Study|Adverse Event|7|||
130903158|NCT04456673|471280994|FG001|Overall Study|Adverse Event|14|||
130903159|NCT04456673|471280993|FG000|Overall Study|Poor compliance to protocol|1|||
130903160|NCT04456673|471280994|FG001|Overall Study|Poor compliance to protocol|0|||
130903161|NCT04456673|471280993|FG000|Overall Study|Withdrawal by Subject|31|||
130903162|NCT04456673|471280994|FG001|Overall Study|Withdrawal by Subject|23|||
130903163|NCT04456673|471280993|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
130903164|NCT04456673|471280994|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
130903165|NCT04391049|471280995|FG000|Overall Study|Protocol Violation|1|||
130903166|NCT03874429|471280996|FG000|Overall Study|Adverse Event|2|||
130903167|NCT03874429|471280997|FG001|Overall Study|Adverse Event|2|||
130903168|NCT03874429|471280996|FG000|Overall Study|Lack of Efficacy|0|||
130903169|NCT03874429|471280997|FG001|Overall Study|Lack of Efficacy|1|||
130903170|NCT03874429|471280996|FG000|Overall Study|Covid-19 pandemic|4|||
130903171|NCT03874429|471280997|FG001|Overall Study|Covid-19 pandemic|2|||
130903172|NCT00992589|471281001|FG000|Open-Label Phase|Adverse Event|4|||
130903173|NCT00992589|471281002|FG001|Open-Label Phase|Adverse Event|0|||
130903174|NCT00992589|471281003|FG002|Open-Label Phase|Adverse Event|0|||
130903175|NCT00992589|471281004|FG003|Open-Label Phase|Adverse Event|0|||
130903176|NCT00992589|471281001|FG000|Open-Label Phase|Withdrawal by Subject|20|||
130903177|NCT00992589|471281002|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130903178|NCT00992589|471281003|FG002|Open-Label Phase|Withdrawal by Subject|0|||
130903179|NCT00992589|471281004|FG003|Open-Label Phase|Withdrawal by Subject|0|||
130903180|NCT00992589|471281001|FG000|Open-Label Phase|Lost to Follow-up|1|||
130903181|NCT00992589|471281002|FG001|Open-Label Phase|Lost to Follow-up|0|||
130903182|NCT00992589|471281003|FG002|Open-Label Phase|Lost to Follow-up|0|||
130903183|NCT00992589|471281004|FG003|Open-Label Phase|Lost to Follow-up|0|||
130903184|NCT00992589|471281001|FG000|Open-Label Phase|Protocol Violation|3|||
130903185|NCT00992589|471281002|FG001|Open-Label Phase|Protocol Violation|0|||
130903186|NCT00992589|471281003|FG002|Open-Label Phase|Protocol Violation|0|||
130903187|NCT00992589|471281004|FG003|Open-Label Phase|Protocol Violation|0|||
130903188|NCT00992589|471281001|FG000|Open-Label Phase|Physician Decision|4|||
130903189|NCT00992589|471281002|FG001|Open-Label Phase|Physician Decision|0|||
130903190|NCT00992589|471281003|FG002|Open-Label Phase|Physician Decision|0|||
130903191|NCT00992589|471281004|FG003|Open-Label Phase|Physician Decision|0|||
130903192|NCT00992589|471281001|FG000|Open-Label Phase|Other|45|||
130903193|NCT00992589|471281002|FG001|Open-Label Phase|Other|0|||
130903194|NCT00992589|471281003|FG002|Open-Label Phase|Other|0|||
130903195|NCT00992589|471281004|FG003|Open-Label Phase|Other|0|||
130903196|NCT00992589|471281001|FG000|Double-Blind Phase|Adverse Event|0|||
130903197|NCT00992589|471281002|FG001|Double-Blind Phase|Adverse Event|6|||
130903198|NCT00992589|471281003|FG002|Double-Blind Phase|Adverse Event|2|||
130903199|NCT00992589|471281004|FG003|Double-Blind Phase|Adverse Event|3|||
130903200|NCT00992589|471281001|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130903201|NCT00992589|471281002|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
130903202|NCT00992589|471281003|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
130903203|NCT00992589|471281004|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
130903204|NCT00992589|471281001|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130903205|NCT00992589|471281002|FG001|Double-Blind Phase|Lost to Follow-up|0|||
130903206|NCT00992589|471281003|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130903207|NCT00992589|471281004|FG003|Double-Blind Phase|Lost to Follow-up|2|||
130903208|NCT00992589|471281001|FG000|Double-Blind Phase|Other|0|||
130903209|NCT00992589|471281002|FG001|Double-Blind Phase|Other|1|||
130903210|NCT00992589|471281003|FG002|Double-Blind Phase|Other|6|||
130903211|NCT00992589|471281004|FG003|Double-Blind Phase|Other|3|||
130903212|NCT01215916|471281005|FG000|Overall Study|Progressive Disease|0|||
130903213|NCT01215916|471281006|FG001|Overall Study|Progressive Disease|2|||
130903214|NCT01215916|471281007|FG002|Overall Study|Progressive Disease|1|||
130903215|NCT01215916|471281008|FG003|Overall Study|Progressive Disease|2|||
130903216|NCT01215916|471281009|FG004|Overall Study|Progressive Disease|5|||
130903217|NCT01215916|471281010|FG005|Overall Study|Progressive Disease|4|||
130903218|NCT01215916|471281011|FG006|Overall Study|Progressive Disease|5|||
130903219|NCT01215916|471281012|FG007|Overall Study|Progressive Disease|3|||
130903220|NCT01215916|471281013|FG008|Overall Study|Progressive Disease|1|||
130903221|NCT01215916|471281005|FG000|Overall Study|Adverse Event|1|||
130903222|NCT01215916|471281006|FG001|Overall Study|Adverse Event|1|||
131027571|NCT01772472|471732386|FG001|Overall Study|Other|7|||
131027572|NCT01772472|471732385|FG000|Overall Study|Physician Decision|1|||
131027573|NCT01772472|471732386|FG001|Overall Study|Physician Decision|7|||
131027574|NCT01772472|471732385|FG000|Overall Study|Withdrawal by Subject|115|||
130694552|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694553|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694554|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694555|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
130694556|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131027575|NCT01772472|471732386|FG001|Overall Study|Withdrawal by Subject|90|||
131027576|NCT01772472|471732385|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
131027577|NCT01772472|471732386|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
131027578|NCT02697136|471732387|FG000|Overall Study|Adverse Event|3|||
131027579|NCT02697136|471732388|FG001|Overall Study|Adverse Event|0|||
131027580|NCT03578536|471732391|FG000|Overall Study|Lost to Follow-up|1|||
131027581|NCT02538900|471732392|FG000|Overall Study|Death|2|||
131027582|NCT02538900|471732393|FG001|Overall Study|Death|2|||
131027583|NCT02538900|471732394|FG002|Overall Study|Death|2|||
131027584|NCT02538900|471732392|FG000|Overall Study|Withdrawal by Subject|18|||
131027585|NCT02538900|471732393|FG001|Overall Study|Withdrawal by Subject|16|||
131027586|NCT02538900|471732394|FG002|Overall Study|Withdrawal by Subject|15|||
131113896|NCT00390910|472047291|FG000|Overall Study|Withdrawal by Subject|1|||
130694557|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694558|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
130903223|NCT01215916|471281007|FG002|Overall Study|Adverse Event|0|||
130903224|NCT01215916|471281008|FG003|Overall Study|Adverse Event|1|||
130903225|NCT01215916|471281009|FG004|Overall Study|Adverse Event|0|||
130903226|NCT01215916|471281010|FG005|Overall Study|Adverse Event|0|||
130903227|NCT01215916|471281011|FG006|Overall Study|Adverse Event|3|||
130903228|NCT01215916|471281012|FG007|Overall Study|Adverse Event|0|||
130903229|NCT01215916|471281013|FG008|Overall Study|Adverse Event|0|||
130903230|NCT01215916|471281005|FG000|Overall Study|Withdrawal by Subject|0|||
130903231|NCT01215916|471281006|FG001|Overall Study|Withdrawal by Subject|1|||
131027587|NCT02874534|471732395|FG000|Overall Study|Withdrawal by Subject|5|||
131027588|NCT02874534|471732396|FG001|Overall Study|Withdrawal by Subject|8|||
131027589|NCT02874534|471732395|FG000|Overall Study|Lost to Follow-up|2|||
131027590|NCT02874534|471732396|FG001|Overall Study|Lost to Follow-up|2|||
130903232|NCT01215916|471281007|FG002|Overall Study|Withdrawal by Subject|1|||
130903233|NCT01215916|471281008|FG003|Overall Study|Withdrawal by Subject|2|||
130903234|NCT01215916|471281009|FG004|Overall Study|Withdrawal by Subject|0|||
130903235|NCT01215916|471281010|FG005|Overall Study|Withdrawal by Subject|0|||
130903236|NCT01215916|471281011|FG006|Overall Study|Withdrawal by Subject|1|||
130903237|NCT01215916|471281012|FG007|Overall Study|Withdrawal by Subject|0|||
130903238|NCT01215916|471281013|FG008|Overall Study|Withdrawal by Subject|0|||
130903239|NCT01215916|471281005|FG000|Overall Study|Death|0|||
130903240|NCT01215916|471281006|FG001|Overall Study|Death|1|||
130903241|NCT01215916|471281007|FG002|Overall Study|Death|0|||
131113897|NCT00390910|472047292|FG001|Overall Study|Withdrawal by Subject|3|||
131113898|NCT00390910|472047293|FG002|Overall Study|Withdrawal by Subject|2|||
131113899|NCT00390910|472047291|FG000|Overall Study|Migrated/moved from study area|0|||
131113900|NCT00390910|472047292|FG001|Overall Study|Migrated/moved from study area|0|||
131113901|NCT00390910|472047293|FG002|Overall Study|Migrated/moved from study area|3|||
131113902|NCT03231943|472047298|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113903|NCT03231943|472047299|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
131113904|NCT03231943|472047300|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
131113905|NCT03231943|472047301|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113906|NCT03231943|472047302|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113907|NCT03231943|472047303|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113908|NCT03231943|472047304|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113909|NCT03231943|472047305|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113910|NCT03231943|472047306|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113911|NCT03231943|472047307|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113912|NCT03231943|472047308|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113913|NCT03231943|472047309|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113914|NCT03231943|472047310|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
131113915|NCT03231943|472047298|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113916|NCT03231943|472047299|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
131113917|NCT03231943|472047300|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113918|NCT03231943|472047301|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113919|NCT03231943|472047302|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113920|NCT03231943|472047303|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113921|NCT03231943|472047304|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113922|NCT03231943|472047305|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113923|NCT03231943|472047306|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113924|NCT03231943|472047307|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113925|NCT03231943|472047308|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113926|NCT03231943|472047309|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113927|NCT03231943|472047310|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
131113928|NCT03231943|472047298|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
131113929|NCT03231943|472047299|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131113930|NCT03231943|472047300|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131113931|NCT03231943|472047301|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131113932|NCT03231943|472047302|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131113933|NCT03231943|472047303|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131113934|NCT03231943|472047304|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131113935|NCT03231943|472047305|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131113936|NCT03231943|472047306|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131113937|NCT03231943|472047307|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130903242|NCT01215916|471281008|FG003|Overall Study|Death|0|||
130903243|NCT01215916|471281009|FG004|Overall Study|Death|1|||
131027591|NCT02874534|471732395|FG000|Overall Study|Ongoing in study|1|||
131027592|NCT02874534|471732396|FG001|Overall Study|Ongoing in study|1|||
131027594|NCT02923180|471732398|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
131027595|NCT02923180|471732398|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
131027596|NCT05198310|471732399|FG000|Overall Study|Lost to Follow-up|0|||
131027597|NCT05198310|471732400|FG001|Overall Study|Lost to Follow-up|1|||
131027598|NCT05198310|471732401|FG002|Overall Study|Lost to Follow-up|0|||
131027599|NCT05198310|471732402|FG003|Overall Study|Lost to Follow-up|0|||
131027600|NCT05198310|471732403|FG004|Overall Study|Lost to Follow-up|0|||
131113938|NCT03231943|472047308|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131113939|NCT03231943|472047309|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131113940|NCT03231943|472047310|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
131027601|NCT05198310|471732404|FG005|Overall Study|Lost to Follow-up|0|||
131027602|NCT05198310|471732405|FG006|Overall Study|Lost to Follow-up|0|||
131113941|NCT03231943|472047298|FG000|Part 2|Adverse Event|0|||
131113942|NCT03231943|472047299|FG001|Part 2|Adverse Event|0|||
130903244|NCT01215916|471281010|FG005|Overall Study|Death|0|||
130903245|NCT01215916|471281011|FG006|Overall Study|Death|0|||
130903246|NCT01215916|471281012|FG007|Overall Study|Death|0|||
130903247|NCT01215916|471281013|FG008|Overall Study|Death|1|||
130903248|NCT01215916|471281005|FG000|Overall Study|Physician Decision|0|||
130903249|NCT01215916|471281006|FG001|Overall Study|Physician Decision|0|||
130903250|NCT01215916|471281007|FG002|Overall Study|Physician Decision|1|||
130903251|NCT01215916|471281008|FG003|Overall Study|Physician Decision|1|||
130903252|NCT01215916|471281009|FG004|Overall Study|Physician Decision|0|||
130903253|NCT01215916|471281010|FG005|Overall Study|Physician Decision|0|||
130903254|NCT01215916|471281011|FG006|Overall Study|Physician Decision|0|||
130903255|NCT01215916|471281012|FG007|Overall Study|Physician Decision|0|||
130903256|NCT01215916|471281013|FG008|Overall Study|Physician Decision|0|||
130903257|NCT00045942|471281014|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
130903258|NCT00045942|471281015|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130903259|NCT00045942|471281016|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130903260|NCT00045942|471281017|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130903261|NCT00045942|471281018|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130903262|NCT00045942|471281019|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130903263|NCT00045942|471281020|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130903264|NCT00045942|471281021|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130903265|NCT00045942|471281022|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130903266|NCT00045942|471281014|FG000|PKC412A2104 (Core)|Adverse Event|5|||
130903267|NCT00045942|471281015|FG001|PKC412A2104 (Core)|Adverse Event|0|||
130903268|NCT00045942|471281016|FG002|PKC412A2104 (Core)|Adverse Event|0|||
130903269|NCT00045942|471281017|FG003|PKC412A2104 (Core)|Adverse Event|0|||
130903270|NCT00045942|471281018|FG004|PKC412A2104 (Core)|Adverse Event|0|||
130903271|NCT00045942|471281019|FG005|PKC412A2104 (Core)|Adverse Event|0|||
130903272|NCT00045942|471281020|FG006|PKC412A2104 (Core)|Adverse Event|0|||
130903273|NCT00045942|471281021|FG007|PKC412A2104 (Core)|Adverse Event|0|||
130903274|NCT00045942|471281022|FG008|PKC412A2104 (Core)|Adverse Event|0|||
130903275|NCT00045942|471281014|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
130903276|NCT00045942|471281015|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
130903277|NCT00045942|471281016|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
130903278|NCT00045942|471281017|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
130903279|NCT00045942|471281018|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
130903280|NCT00045942|471281019|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
130903281|NCT00045942|471281020|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
130903282|NCT00045942|471281021|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
130903283|NCT00045942|471281022|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
130903284|NCT00045942|471281014|FG000|PKC412A2104 (Core)|Death|1|||
130903285|NCT00045942|471281015|FG001|PKC412A2104 (Core)|Death|0|||
130903286|NCT00045942|471281016|FG002|PKC412A2104 (Core)|Death|0|||
130903287|NCT00045942|471281017|FG003|PKC412A2104 (Core)|Death|0|||
130903288|NCT00045942|471281018|FG004|PKC412A2104 (Core)|Death|0|||
130903289|NCT00045942|471281019|FG005|PKC412A2104 (Core)|Death|0|||
130903290|NCT00045942|471281020|FG006|PKC412A2104 (Core)|Death|0|||
130903291|NCT00045942|471281021|FG007|PKC412A2104 (Core)|Death|0|||
130903292|NCT00045942|471281022|FG008|PKC412A2104 (Core)|Death|0|||
130903293|NCT00045942|471281014|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
130903294|NCT00045942|471281015|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
130903295|NCT00045942|471281016|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
130903296|NCT00045942|471281017|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
130903297|NCT00045942|471281018|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
130903298|NCT00045942|471281019|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
130903299|NCT00045942|471281020|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
130903300|NCT00045942|471281021|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
130903301|NCT00045942|471281022|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
130903302|NCT00045942|471281014|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
130903303|NCT00045942|471281015|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
130903304|NCT00045942|471281016|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
130903305|NCT00045942|471281017|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
130903306|NCT00045942|471281018|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
130903307|NCT00045942|471281019|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
130903308|NCT00045942|471281020|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
130903309|NCT00045942|471281021|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
130903310|NCT00045942|471281022|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
130903311|NCT00045942|471281014|FG000|PKC412A2104E1|Lack of Efficacy|0|||
130768390|NCT00603382|470775556|FG001|Overall Study|Lost to Follow-up|1|||
130903312|NCT00045942|471281015|FG001|PKC412A2104E1|Lack of Efficacy|11|||
130903313|NCT00045942|471281016|FG002|PKC412A2104E1|Lack of Efficacy|11|||
130903314|NCT00045942|471281017|FG003|PKC412A2104E1|Lack of Efficacy|23|||
130903315|NCT00045942|471281018|FG004|PKC412A2104E1|Lack of Efficacy|17|||
130903316|NCT00045942|471281019|FG005|PKC412A2104E1|Lack of Efficacy|0|||
130903317|NCT00045942|471281020|FG006|PKC412A2104E1|Lack of Efficacy|0|||
130903318|NCT00045942|471281021|FG007|PKC412A2104E1|Lack of Efficacy|0|||
130903319|NCT00045942|471281022|FG008|PKC412A2104E1|Lack of Efficacy|0|||
130903320|NCT00045942|471281014|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
130903321|NCT00045942|471281015|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
131027603|NCT05198310|471732406|FG007|Overall Study|Lost to Follow-up|0|||
130903322|NCT00045942|471281016|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
130903323|NCT00045942|471281017|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
130903324|NCT00045942|471281018|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
130903325|NCT00045942|471281019|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
130903326|NCT00045942|471281020|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
130903327|NCT00045942|471281021|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
130903328|NCT00045942|471281022|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
130903329|NCT00045942|471281014|FG000|PKC412A2104E1|Adverse Event|0|||
130903330|NCT00045942|471281015|FG001|PKC412A2104E1|Adverse Event|1|||
130903331|NCT00045942|471281016|FG002|PKC412A2104E1|Adverse Event|1|||
130903332|NCT00045942|471281017|FG003|PKC412A2104E1|Adverse Event|3|||
130903333|NCT00045942|471281018|FG004|PKC412A2104E1|Adverse Event|6|||
130903334|NCT00045942|471281019|FG005|PKC412A2104E1|Adverse Event|0|||
130903335|NCT00045942|471281020|FG006|PKC412A2104E1|Adverse Event|0|||
130903336|NCT00045942|471281021|FG007|PKC412A2104E1|Adverse Event|0|||
130903337|NCT00045942|471281022|FG008|PKC412A2104E1|Adverse Event|0|||
130903338|NCT00045942|471281014|FG000|PKC412A2104E1|Death|0|||
130903339|NCT00045942|471281015|FG001|PKC412A2104E1|Death|4|||
130903340|NCT00045942|471281016|FG002|PKC412A2104E1|Death|1|||
130903341|NCT00045942|471281017|FG003|PKC412A2104E1|Death|1|||
130903342|NCT00045942|471281018|FG004|PKC412A2104E1|Death|1|||
130903343|NCT00045942|471281019|FG005|PKC412A2104E1|Death|0|||
130903344|NCT00045942|471281020|FG006|PKC412A2104E1|Death|0|||
130903345|NCT00045942|471281021|FG007|PKC412A2104E1|Death|0|||
130903346|NCT00045942|471281022|FG008|PKC412A2104E1|Death|0|||
130903347|NCT00045942|471281014|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130903348|NCT00045942|471281015|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130903349|NCT00045942|471281016|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
130903350|NCT00045942|471281017|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
130903351|NCT00045942|471281018|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130903352|NCT00045942|471281019|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130903353|NCT00045942|471281020|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130903354|NCT00045942|471281021|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130903355|NCT00045942|471281022|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130903356|NCT00045942|471281014|FG000|PKC412A2104E2|Lost to Follow-up|0|||
130903357|NCT00045942|471281015|FG001|PKC412A2104E2|Lost to Follow-up|0|||
130903358|NCT00045942|471281016|FG002|PKC412A2104E2|Lost to Follow-up|0|||
130903359|NCT00045942|471281017|FG003|PKC412A2104E2|Lost to Follow-up|0|||
130903360|NCT00045942|471281018|FG004|PKC412A2104E2|Lost to Follow-up|0|||
130903361|NCT00045942|471281019|FG005|PKC412A2104E2|Lost to Follow-up|0|||
130903362|NCT00045942|471281020|FG006|PKC412A2104E2|Lost to Follow-up|0|||
130694559|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694560|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130903363|NCT00045942|471281021|FG007|PKC412A2104E2|Lost to Follow-up|3|||
131027604|NCT05198310|471732399|FG000|Overall Study|Withdrawal by Subject|0|||
131027605|NCT05198310|471732400|FG001|Overall Study|Withdrawal by Subject|0|||
131027606|NCT05198310|471732401|FG002|Overall Study|Withdrawal by Subject|0|||
131027607|NCT05198310|471732402|FG003|Overall Study|Withdrawal by Subject|2|||
131027608|NCT05198310|471732403|FG004|Overall Study|Withdrawal by Subject|0|||
131027609|NCT05198310|471732404|FG005|Overall Study|Withdrawal by Subject|2|||
131027610|NCT05198310|471732405|FG006|Overall Study|Withdrawal by Subject|1|||
131027611|NCT05198310|471732406|FG007|Overall Study|Withdrawal by Subject|3|||
131027612|NCT01095796|471732407|FG000|Overall Study|Randomized but Not Treated|5|||
131027613|NCT01095796|471732408|FG001|Overall Study|Randomized but Not Treated|2|||
131027614|NCT01095796|471732407|FG000|Overall Study|Adverse Event|9|||
131027615|NCT01095796|471732408|FG001|Overall Study|Adverse Event|19|||
131027616|NCT01095796|471732407|FG000|Overall Study|Death|3|||
131027617|NCT01095796|471732408|FG001|Overall Study|Death|2|||
131027618|NCT01095796|471732407|FG000|Overall Study|Pregnancy|2|||
131027619|NCT01095796|471732408|FG001|Overall Study|Pregnancy|0|||
131027620|NCT01095796|471732407|FG000|Overall Study|Lack of Efficacy|5|||
131027621|NCT01095796|471732408|FG001|Overall Study|Lack of Efficacy|3|||
131027622|NCT01095796|471732407|FG000|Overall Study|Investigator's Discretion|7|||
131027623|NCT01095796|471732408|FG001|Overall Study|Investigator's Discretion|2|||
131027624|NCT01095796|471732407|FG000|Overall Study|Withdrew Consent|16|||
130903364|NCT00045942|471281022|FG008|PKC412A2104E2|Lost to Follow-up|0|||
130903365|NCT00045942|471281014|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
131027625|NCT01095796|471732408|FG001|Overall Study|Withdrew Consent|22|||
131027626|NCT01095796|471732407|FG000|Overall Study|Lost to Follow-up|27|||
130903366|NCT00045942|471281015|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
130903367|NCT00045942|471281016|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
130903368|NCT00045942|471281017|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
130903369|NCT00045942|471281018|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
130903370|NCT00045942|471281019|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
130903371|NCT00045942|471281020|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
131027627|NCT01095796|471732408|FG001|Overall Study|Lost to Follow-up|29|||
131027628|NCT01095796|471732407|FG000|Overall Study|Participant Noncompliance|5|||
131027629|NCT01095796|471732408|FG001|Overall Study|Participant Noncompliance|10|||
131027630|NCT01095796|471732407|FG000|Overall Study|Protocol Violation|1|||
130903372|NCT00045942|471281021|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
130903373|NCT00045942|471281022|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
130903374|NCT00045942|471281014|FG000|PKC412A2104E2|Lack of Efficacy|0|||
130903375|NCT00045942|471281015|FG001|PKC412A2104E2|Lack of Efficacy|0|||
130903376|NCT00045942|471281016|FG002|PKC412A2104E2|Lack of Efficacy|0|||
130903377|NCT00045942|471281017|FG003|PKC412A2104E2|Lack of Efficacy|0|||
130903378|NCT00045942|471281018|FG004|PKC412A2104E2|Lack of Efficacy|0|||
130903379|NCT00045942|471281019|FG005|PKC412A2104E2|Lack of Efficacy|3|||
130903380|NCT00045942|471281020|FG006|PKC412A2104E2|Lack of Efficacy|2|||
130903381|NCT00045942|471281021|FG007|PKC412A2104E2|Lack of Efficacy|2|||
130903382|NCT00045942|471281022|FG008|PKC412A2104E2|Lack of Efficacy|6|||
130903383|NCT00045942|471281014|FG000|PKC412A2104E2|Adverse Event|0|||
130903384|NCT00045942|471281015|FG001|PKC412A2104E2|Adverse Event|0|||
130903385|NCT00045942|471281016|FG002|PKC412A2104E2|Adverse Event|0|||
130903386|NCT00045942|471281017|FG003|PKC412A2104E2|Adverse Event|0|||
130903387|NCT00045942|471281018|FG004|PKC412A2104E2|Adverse Event|0|||
130903388|NCT00045942|471281019|FG005|PKC412A2104E2|Adverse Event|4|||
130903389|NCT00045942|471281020|FG006|PKC412A2104E2|Adverse Event|3|||
130903390|NCT00045942|471281021|FG007|PKC412A2104E2|Adverse Event|1|||
130903391|NCT00045942|471281022|FG008|PKC412A2104E2|Adverse Event|0|||
130903392|NCT00045942|471281014|FG000|PKC412A2104E2|Death|0|||
130903393|NCT00045942|471281015|FG001|PKC412A2104E2|Death|0|||
130903394|NCT00045942|471281016|FG002|PKC412A2104E2|Death|0|||
130903395|NCT00045942|471281017|FG003|PKC412A2104E2|Death|0|||
130903396|NCT00045942|471281018|FG004|PKC412A2104E2|Death|0|||
130903397|NCT00045942|471281019|FG005|PKC412A2104E2|Death|1|||
130903398|NCT00045942|471281020|FG006|PKC412A2104E2|Death|2|||
130903399|NCT00045942|471281021|FG007|PKC412A2104E2|Death|0|||
130903400|NCT00045942|471281022|FG008|PKC412A2104E2|Death|0|||
130903401|NCT02142387|471281023|FG000|Overall Study|<19 years old|49|||
130903402|NCT02142387|471281024|FG001|Overall Study|<19 years old|326|||
130903403|NCT02142387|471281023|FG000|Overall Study|non-cardiac etiology|504|||
130903404|NCT02142387|471281024|FG001|Overall Study|non-cardiac etiology|3431|||
130903405|NCT02142387|471281023|FG000|Overall Study|CPR not performed|74|||
130903406|NCT02142387|471281024|FG001|Overall Study|CPR not performed|473|||
130903407|NCT02142387|471281023|FG000|Overall Study|witnessed by paramedic|139|||
130903408|NCT02142387|471281024|FG001|Overall Study|witnessed by paramedic|917|||
130903409|NCT02142387|471281023|FG000|Overall Study|incomplete data|1|||
130903410|NCT02142387|471281024|FG001|Overall Study|incomplete data|9|||
130903411|NCT02142387|471281023|FG000|Overall Study|occurred not at home|298|||
130903412|NCT02142387|471281024|FG001|Overall Study|occurred not at home|2474|||
130903413|NCT05028361|471281025|FG000|Overall Study|Withdrawal by Subject|1|||
130903414|NCT05028361|471281026|FG001|Overall Study|Withdrawal by Subject|0|||
130903415|NCT00779259|471281027|FG000|Quinine Alone|Adverse Event|2|||
130903416|NCT02047318|471281031|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
130903417|NCT02047318|471281031|FG000|Core Study Period|Adverse Event|1|||
130903418|NCT02047318|471281031|FG000|Core Study Period|Withdrawal by caregiver|3|||
130903419|NCT02047318|471281031|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
130903420|NCT02095132|471281032|FG000|Overall Study|Adverse Event|0|||
130903421|NCT02095132|471281033|FG001|Overall Study|Adverse Event|0|||
130903422|NCT02095132|471281034|FG002|Overall Study|Adverse Event|0|||
130903423|NCT02095132|471281035|FG003|Overall Study|Adverse Event|0|||
130903424|NCT02095132|471281036|FG004|Overall Study|Adverse Event|1|||
130903425|NCT02095132|471281037|FG005|Overall Study|Adverse Event|0|||
130903426|NCT02095132|471281038|FG006|Overall Study|Adverse Event|1|||
130903427|NCT02095132|471281039|FG007|Overall Study|Adverse Event|0|||
130903428|NCT02095132|471281040|FG008|Overall Study|Adverse Event|0|||
130903429|NCT02095132|471281032|FG000|Overall Study|Death|0|||
131027631|NCT01095796|471732408|FG001|Overall Study|Protocol Violation|0|||
131027632|NCT01095796|471732407|FG000|Overall Study|Participant Transferred to Another Study|215|||
131027633|NCT01095796|471732408|FG001|Overall Study|Participant Transferred to Another Study|200|||
131027634|NCT01989455|471732413|FG000|Overall Study|Adverse Event|0|||
131027635|NCT01989455|471732414|FG001|Overall Study|Adverse Event|1|||
131027636|NCT01989455|471732415|FG002|Overall Study|Adverse Event|0|||
130903430|NCT02095132|471281033|FG001|Overall Study|Death|0|||
131027637|NCT01989455|471732416|FG003|Overall Study|Adverse Event|0|||
130903431|NCT02095132|471281034|FG002|Overall Study|Death|0|||
130903432|NCT02095132|471281035|FG003|Overall Study|Death|0|||
130903433|NCT02095132|471281036|FG004|Overall Study|Death|0|||
130903434|NCT02095132|471281037|FG005|Overall Study|Death|0|||
130903435|NCT02095132|471281038|FG006|Overall Study|Death|1|||
130903436|NCT02095132|471281039|FG007|Overall Study|Death|0|||
130903437|NCT02095132|471281040|FG008|Overall Study|Death|0|||
130903438|NCT02095132|471281032|FG000|Overall Study|Lack of Efficacy|3|||
130903439|NCT02095132|471281033|FG001|Overall Study|Lack of Efficacy|5|||
131027638|NCT01989455|471732417|FG004|Overall Study|Adverse Event|0|||
130903440|NCT02095132|471281034|FG002|Overall Study|Lack of Efficacy|2|||
130903441|NCT02095132|471281035|FG003|Overall Study|Lack of Efficacy|8|||
130903442|NCT02095132|471281036|FG004|Overall Study|Lack of Efficacy|3|||
131027639|NCT01989455|471732413|FG000|Overall Study|Withdrawal by Subject|0|||
131027640|NCT01989455|471732414|FG001|Overall Study|Withdrawal by Subject|1|||
130903443|NCT02095132|471281037|FG005|Overall Study|Lack of Efficacy|6|||
130903444|NCT02095132|471281038|FG006|Overall Study|Lack of Efficacy|10|||
130903445|NCT02095132|471281039|FG007|Overall Study|Lack of Efficacy|9|||
130903446|NCT02095132|471281040|FG008|Overall Study|Lack of Efficacy|8|||
130903447|NCT02095132|471281032|FG000|Overall Study|Physician Decision|1|||
130903448|NCT02095132|471281033|FG001|Overall Study|Physician Decision|0|||
130903449|NCT02095132|471281034|FG002|Overall Study|Physician Decision|0|||
130903450|NCT02095132|471281035|FG003|Overall Study|Physician Decision|0|||
130903451|NCT02095132|471281036|FG004|Overall Study|Physician Decision|0|||
130903452|NCT02095132|471281037|FG005|Overall Study|Physician Decision|0|||
130903453|NCT02095132|471281038|FG006|Overall Study|Physician Decision|1|||
130903454|NCT02095132|471281039|FG007|Overall Study|Physician Decision|0|||
130903455|NCT02095132|471281040|FG008|Overall Study|Physician Decision|2|||
130903456|NCT02095132|471281032|FG000|Overall Study|Withdrawal by Subject|0|||
130903457|NCT02095132|471281033|FG001|Overall Study|Withdrawal by Subject|0|||
130903458|NCT02095132|471281034|FG002|Overall Study|Withdrawal by Subject|2|||
130903459|NCT02095132|471281035|FG003|Overall Study|Withdrawal by Subject|2|||
130903460|NCT02095132|471281036|FG004|Overall Study|Withdrawal by Subject|3|||
130903461|NCT02095132|471281037|FG005|Overall Study|Withdrawal by Subject|0|||
130903462|NCT02095132|471281038|FG006|Overall Study|Withdrawal by Subject|5|||
130903463|NCT02095132|471281039|FG007|Overall Study|Withdrawal by Subject|0|||
130903464|NCT02095132|471281040|FG008|Overall Study|Withdrawal by Subject|0|||
130903465|NCT00409175|471281041|FG000|Overall Study|Adverse Event|4|||
130903466|NCT00409175|471281042|FG001|Overall Study|Adverse Event|3|||
130903467|NCT00409175|471281041|FG000|Overall Study|Withdrawal by Subject|1|||
130903468|NCT00409175|471281042|FG001|Overall Study|Withdrawal by Subject|2|||
130903469|NCT00409175|471281041|FG000|Overall Study|Negative genotype|0|||
130903470|NCT00409175|471281042|FG001|Overall Study|Negative genotype|1|||
130903471|NCT00409175|471281041|FG000|Overall Study|Liver transplantation|13|||
130903472|NCT00409175|471281042|FG001|Overall Study|Liver transplantation|13|||
130903473|NCT02108262|471281045|FG000|Overall Study|Non-compliance|0|||
130903474|NCT02108262|471281046|FG001|Overall Study|Non-compliance|2|||
130903475|NCT02108262|471281047|FG002|Overall Study|Non-compliance|1|||
130903476|NCT02108262|471281048|FG003|Overall Study|Non-compliance|1|||
130903477|NCT02108262|471281045|FG000|Overall Study|Randomized by error/screen failure|0|||
130903478|NCT02108262|471281046|FG001|Overall Study|Randomized by error/screen failure|0|||
130903479|NCT02108262|471281047|FG002|Overall Study|Randomized by error/screen failure|1|||
130903480|NCT02108262|471281048|FG003|Overall Study|Randomized by error/screen failure|0|||
130903481|NCT02108262|471281045|FG000|Overall Study|Distance to center|0|||
130903482|NCT02108262|471281046|FG001|Overall Study|Distance to center|1|||
130903483|NCT02108262|471281047|FG002|Overall Study|Distance to center|1|||
130903484|NCT02108262|471281048|FG003|Overall Study|Distance to center|0|||
130903485|NCT02108262|471281045|FG000|Overall Study|Adverse Event|0|||
130903486|NCT02108262|471281046|FG001|Overall Study|Adverse Event|11|||
130903487|NCT02108262|471281047|FG002|Overall Study|Adverse Event|6|||
130903488|NCT02108262|471281048|FG003|Overall Study|Adverse Event|12|||
130903489|NCT02108262|471281045|FG000|Overall Study|Death|0|||
130903490|NCT02108262|471281046|FG001|Overall Study|Death|2|||
130903491|NCT02108262|471281047|FG002|Overall Study|Death|2|||
130903492|NCT02108262|471281048|FG003|Overall Study|Death|1|||
130903493|NCT02108262|471281045|FG000|Overall Study|Lost to Follow-up|0|||
130903494|NCT02108262|471281046|FG001|Overall Study|Lost to Follow-up|0|||
130903495|NCT02108262|471281047|FG002|Overall Study|Lost to Follow-up|1|||
130903496|NCT02108262|471281048|FG003|Overall Study|Lost to Follow-up|0|||
130903497|NCT02108262|471281045|FG000|Overall Study|Physician Decision|0|||
130903498|NCT02108262|471281046|FG001|Overall Study|Physician Decision|0|||
130903499|NCT02108262|471281047|FG002|Overall Study|Physician Decision|2|||
131027641|NCT01989455|471732415|FG002|Overall Study|Withdrawal by Subject|0|||
130694561|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694562|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694563|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131027642|NCT01989455|471732416|FG003|Overall Study|Withdrawal by Subject|0|||
131027643|NCT01989455|471732417|FG004|Overall Study|Withdrawal by Subject|0|||
130694564|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130903500|NCT02108262|471281048|FG003|Overall Study|Physician Decision|0|||
130903501|NCT02108262|471281045|FG000|Overall Study|Withdrawal by Subject|0|||
130903502|NCT02108262|471281046|FG001|Overall Study|Withdrawal by Subject|7|||
130903503|NCT02108262|471281047|FG002|Overall Study|Withdrawal by Subject|3|||
130903504|NCT02108262|471281048|FG003|Overall Study|Withdrawal by Subject|4|||
130903505|NCT02108262|471281045|FG000|Overall Study|Due to key hepatic values|0|||
130903506|NCT02108262|471281046|FG001|Overall Study|Due to key hepatic values|1|||
130903507|NCT02108262|471281047|FG002|Overall Study|Due to key hepatic values|0|||
130903508|NCT02108262|471281048|FG003|Overall Study|Due to key hepatic values|0|||
130903509|NCT02108262|471281045|FG000|Overall Study|Unable to contact patient|0|||
130903510|NCT02108262|471281046|FG001|Overall Study|Unable to contact patient|3|||
130903511|NCT02108262|471281047|FG002|Overall Study|Unable to contact patient|1|||
130903512|NCT02108262|471281048|FG003|Overall Study|Unable to contact patient|2|||
131027644|NCT01989455|471732413|FG000|Overall Study|Technical problems with infusion|0|||
130903513|NCT02108262|471281045|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
130903514|NCT02108262|471281046|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
130903515|NCT02108262|471281047|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
130903516|NCT02108262|471281048|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
130903517|NCT02108262|471281045|FG000|Overall Study|Patient did not want another infusion|0|||
130903518|NCT02108262|471281046|FG001|Overall Study|Patient did not want another infusion|3|||
130903519|NCT02108262|471281047|FG002|Overall Study|Patient did not want another infusion|3|||
130903520|NCT02108262|471281048|FG003|Overall Study|Patient did not want another infusion|2|||
130903521|NCT02108262|471281045|FG000|Overall Study|Vacation|0|||
130903522|NCT02108262|471281046|FG001|Overall Study|Vacation|1|||
130903523|NCT02108262|471281047|FG002|Overall Study|Vacation|0|||
130903524|NCT02108262|471281048|FG003|Overall Study|Vacation|0|||
130903525|NCT02108262|471281045|FG000|Overall Study|Patient decision|0|||
130903526|NCT02108262|471281046|FG001|Overall Study|Patient decision|7|||
130903527|NCT02108262|471281047|FG002|Overall Study|Patient decision|9|||
130903528|NCT02108262|471281048|FG003|Overall Study|Patient decision|14|||
130903529|NCT02108262|471281045|FG000|Overall Study|Missed IV due to pharmacy error|0|||
130903530|NCT02108262|471281046|FG001|Overall Study|Missed IV due to pharmacy error|0|||
130903531|NCT02108262|471281047|FG002|Overall Study|Missed IV due to pharmacy error|1|||
130903532|NCT02108262|471281048|FG003|Overall Study|Missed IV due to pharmacy error|0|||
130903533|NCT01895361|471281049|FG000|Overall Study|Adverse Event|1|||
130903534|NCT01895361|471281050|FG001|Overall Study|Adverse Event|1|||
130903535|NCT01895361|471281051|FG002|Overall Study|Adverse Event|3|||
130903536|NCT01895361|471281049|FG000|Overall Study|Death|2|||
130903537|NCT01895361|471281050|FG001|Overall Study|Death|1|||
130903538|NCT01895361|471281051|FG002|Overall Study|Death|2|||
130903539|NCT01895361|471281049|FG000|Overall Study|Lost to Follow-up|4|||
130903540|NCT01895361|471281050|FG001|Overall Study|Lost to Follow-up|4|||
130903541|NCT01895361|471281051|FG002|Overall Study|Lost to Follow-up|6|||
130903542|NCT01895361|471281049|FG000|Overall Study|Non-compliance with study|1|||
130903543|NCT01895361|471281050|FG001|Overall Study|Non-compliance with study|3|||
130903544|NCT01895361|471281051|FG002|Overall Study|Non-compliance with study|1|||
130903545|NCT01895361|471281049|FG000|Overall Study|Physician Decision|2|||
130903546|NCT01895361|471281050|FG001|Overall Study|Physician Decision|2|||
130903547|NCT01895361|471281051|FG002|Overall Study|Physician Decision|2|||
130903548|NCT01895361|471281049|FG000|Overall Study|Withdrawal by Subject|7|||
130903549|NCT01895361|471281050|FG001|Overall Study|Withdrawal by Subject|6|||
130903550|NCT01895361|471281051|FG002|Overall Study|Withdrawal by Subject|6|||
130903551|NCT01895361|471281049|FG000|Overall Study|Lack of Efficacy|0|||
130903552|NCT01895361|471281050|FG001|Overall Study|Lack of Efficacy|1|||
130903553|NCT01895361|471281051|FG002|Overall Study|Lack of Efficacy|0|||
130903554|NCT01895361|471281049|FG000|Overall Study|Reasons different from categories above|7|||
130903555|NCT01895361|471281050|FG001|Overall Study|Reasons different from categories above|3|||
130903556|NCT01895361|471281051|FG002|Overall Study|Reasons different from categories above|4|||
130903557|NCT02586506|471281052|FG000|Overall Study|Protocol Violation|6|||
130903558|NCT02586506|471281052|FG000|Overall Study|Lost to Follow-up|1|||
130903559|NCT02586506|471281052|FG000|Overall Study|Other Reason|2|||
130903560|NCT00674154|471281053|FG000|Overall Study|Withdrawal by Subject|3|||
130903561|NCT00674154|471281054|FG001|Overall Study|Withdrawal by Subject|1|||
130903562|NCT00674154|471281053|FG000|Overall Study|Did not want parathyroidectomy|0|||
131027645|NCT01989455|471732414|FG001|Overall Study|Technical problems with infusion|0|||
131027646|NCT01989455|471732415|FG002|Overall Study|Technical problems with infusion|1|||
131027647|NCT01989455|471732416|FG003|Overall Study|Technical problems with infusion|0|||
131027648|NCT01989455|471732417|FG004|Overall Study|Technical problems with infusion|1|||
131027649|NCT02638337|471732418|FG000|Overall Study|Adverse Event|6|||
131027650|NCT02638337|471732419|FG001|Overall Study|Adverse Event|10|||
131027651|NCT02638337|471732418|FG000|Overall Study|Protocol Violation|3|||
131027652|NCT02638337|471732419|FG001|Overall Study|Protocol Violation|0|||
131027653|NCT02638337|471732418|FG000|Overall Study|Withdrawal by Subject|13|||
131027654|NCT02638337|471732419|FG001|Overall Study|Withdrawal by Subject|16|||
131027655|NCT02638337|471732418|FG000|Overall Study|Lost to Follow-up|7|||
131027656|NCT02638337|471732419|FG001|Overall Study|Lost to Follow-up|7|||
131027657|NCT02638337|471732418|FG000|Overall Study|Other - Miscellaneous|4|||
130903563|NCT00674154|471281054|FG001|Overall Study|Did not want parathyroidectomy|2|||
130903564|NCT05093790|471281055|FG000|Overall Study|Failure to meet continuation criteria|0|||
130903565|NCT05093790|471281056|FG001|Overall Study|Failure to meet continuation criteria|0|||
130903566|NCT05093790|471281057|FG002|Overall Study|Failure to meet continuation criteria|1|||
130903567|NCT05093790|471281058|FG003|Overall Study|Failure to meet continuation criteria|0|||
130903568|NCT05093790|471281055|FG000|Overall Study|Adverse Event|1|||
130903569|NCT05093790|471281056|FG001|Overall Study|Adverse Event|0|||
130903570|NCT05093790|471281057|FG002|Overall Study|Adverse Event|0|||
130903571|NCT05093790|471281058|FG003|Overall Study|Adverse Event|0|||
130903572|NCT01903252|471281060|FG000|Double-Blind Induction|Adverse Event|20|||
131027658|NCT02638337|471732419|FG001|Overall Study|Other - Miscellaneous|3|||
131027659|NCT04116736|471732420|FG000|Overall Study|Withdrew consent during study|3|||
130903573|NCT01903252|471281061|FG001|Double-Blind Induction|Adverse Event|18|||
130903574|NCT01903252|471281062|FG002|Double-Blind Induction|Adverse Event|0|||
130903575|NCT01903252|471281063|FG003|Double-Blind Induction|Adverse Event|0|||
130903576|NCT01903252|471281064|FG004|Double-Blind Induction|Adverse Event|0|||
130903577|NCT01903252|471281065|FG005|Double-Blind Induction|Adverse Event|0|||
130903578|NCT01903252|471281060|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
130903579|NCT01903252|471281061|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
130903580|NCT01903252|471281062|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
130903581|NCT01903252|471281063|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
130903582|NCT01903252|471281064|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
130903583|NCT01903252|471281065|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
130903584|NCT01903252|471281060|FG000|Double-Blind Induction|Physician Decision|2|||
130903585|NCT01903252|471281061|FG001|Double-Blind Induction|Physician Decision|3|||
130903586|NCT01903252|471281062|FG002|Double-Blind Induction|Physician Decision|0|||
130903587|NCT01903252|471281063|FG003|Double-Blind Induction|Physician Decision|0|||
130903588|NCT01903252|471281064|FG004|Double-Blind Induction|Physician Decision|0|||
130903589|NCT01903252|471281065|FG005|Double-Blind Induction|Physician Decision|0|||
130903590|NCT01903252|471281060|FG000|Double-Blind Induction|non-compliance,|7|||
130903591|NCT01903252|471281061|FG001|Double-Blind Induction|non-compliance,|7|||
130903592|NCT01903252|471281062|FG002|Double-Blind Induction|non-compliance,|0|||
130903593|NCT01903252|471281063|FG003|Double-Blind Induction|non-compliance,|0|||
130903594|NCT01903252|471281064|FG004|Double-Blind Induction|non-compliance,|0|||
130903595|NCT01903252|471281065|FG005|Double-Blind Induction|non-compliance,|0|||
130903596|NCT01903252|471281060|FG000|Extended Induction, Open-Label|Adverse Event|0|||
130903597|NCT01903252|471281061|FG001|Extended Induction, Open-Label|Adverse Event|0|||
130903598|NCT01903252|471281062|FG002|Extended Induction, Open-Label|Adverse Event|17|||
130903599|NCT01903252|471281063|FG003|Extended Induction, Open-Label|Adverse Event|0|||
130903600|NCT01903252|471281064|FG004|Extended Induction, Open-Label|Adverse Event|0|||
130903601|NCT01903252|471281065|FG005|Extended Induction, Open-Label|Adverse Event|0|||
130903602|NCT01903252|471281060|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130903603|NCT01903252|471281061|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130903604|NCT01903252|471281062|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
130903605|NCT01903252|471281063|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130903606|NCT01903252|471281064|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130903607|NCT01903252|471281065|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130903608|NCT01903252|471281060|FG000|Extended Induction, Open-Label|Physician Decision|0|||
130903609|NCT01903252|471281061|FG001|Extended Induction, Open-Label|Physician Decision|0|||
130903610|NCT01903252|471281062|FG002|Extended Induction, Open-Label|Physician Decision|1|||
130903611|NCT01903252|471281063|FG003|Extended Induction, Open-Label|Physician Decision|0|||
130903612|NCT01903252|471281064|FG004|Extended Induction, Open-Label|Physician Decision|0|||
130903613|NCT01903252|471281065|FG005|Extended Induction, Open-Label|Physician Decision|0|||
130903614|NCT01903252|471281060|FG000|Maintenance, Open-Label|Adverse Event|0|||
130903615|NCT01903252|471281061|FG001|Maintenance, Open-Label|Adverse Event|0|||
130903616|NCT01903252|471281062|FG002|Maintenance, Open-Label|Adverse Event|0|||
131027660|NCT04116736|471732421|FG001|Overall Study|Withdrew consent during study|1|||
131027661|NCT04116736|471732420|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
131027662|NCT04116736|471732421|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
131027663|NCT04116736|471732420|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
131027664|NCT04116736|471732421|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
131027665|NCT04116736|471732420|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
131027666|NCT04116736|471732421|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
131027667|NCT04116736|471732420|FG000|Overall Study|Subject was enrolled in error|2|||
131027668|NCT04116736|471732421|FG001|Overall Study|Subject was enrolled in error|0|||
131027669|NCT04116736|471732420|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
131027670|NCT04116736|471732421|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
131027671|NCT04116736|471732420|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
131027672|NCT04116736|471732421|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
131027673|NCT04116736|471732420|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
131027674|NCT04116736|471732421|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
131027675|NCT05512962|471732424|FG000|Overall Study|Withdrawal by Subject|1|||
131027676|NCT05512962|471732425|FG001|Overall Study|Withdrawal by Subject|0|||
131027677|NCT02860130|471732426|FG000|Overall Study|Adverse Event|2|||
130903617|NCT01903252|471281063|FG003|Maintenance, Open-Label|Adverse Event|3|||
130903618|NCT01903252|471281064|FG004|Maintenance, Open-Label|Adverse Event|9|||
130903619|NCT01903252|471281065|FG005|Maintenance, Open-Label|Adverse Event|14|||
130903620|NCT01903252|471281060|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
130903621|NCT01903252|471281061|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
130903622|NCT01903252|471281062|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
131113943|NCT03231943|472047300|FG002|Part 2|Adverse Event|0|||
131113944|NCT03231943|472047301|FG003|Part 2|Adverse Event|0|||
130903623|NCT01903252|471281063|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
130903624|NCT01903252|471281064|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
130903625|NCT01903252|471281065|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
130903626|NCT01903252|471281060|FG000|Maintenance, Open-Label|Other|0|||
130903627|NCT01903252|471281061|FG001|Maintenance, Open-Label|Other|0|||
130903628|NCT01903252|471281062|FG002|Maintenance, Open-Label|Other|0|||
130903629|NCT01903252|471281063|FG003|Maintenance, Open-Label|Other|2|||
130903630|NCT01903252|471281064|FG004|Maintenance, Open-Label|Other|6|||
130903631|NCT01903252|471281065|FG005|Maintenance, Open-Label|Other|2|||
130903632|NCT01381562|471281066|FG000|Overall Study|Adverse Event|0|||
130903633|NCT01381562|471281067|FG001|Overall Study|Adverse Event|1|||
130903634|NCT01381562|471281068|FG002|Overall Study|Adverse Event|0|||
130903635|NCT01642732|471281069|FG000|Overall Study|Withdrawal by Subject|1|||
130903636|NCT00592774|471281073|FG000|Overall Study|Adverse Event|5|||
130903637|NCT00592774|471281074|FG001|Overall Study|Adverse Event|19|||
130903638|NCT00592774|471281075|FG002|Overall Study|Adverse Event|2|||
130903639|NCT00592774|471281076|FG003|Overall Study|Adverse Event|14|||
130903640|NCT00592774|471281077|FG004|Overall Study|Adverse Event|8|||
130903641|NCT00592774|471281073|FG000|Overall Study|Protocol Violation|0|||
130903642|NCT00592774|471281074|FG001|Overall Study|Protocol Violation|1|||
130903643|NCT00592774|471281075|FG002|Overall Study|Protocol Violation|0|||
130903644|NCT00592774|471281076|FG003|Overall Study|Protocol Violation|0|||
130903645|NCT00592774|471281077|FG004|Overall Study|Protocol Violation|1|||
130903646|NCT00592774|471281073|FG000|Overall Study|Withdrawal by Subject|3|||
130903647|NCT00592774|471281074|FG001|Overall Study|Withdrawal by Subject|7|||
131027678|NCT02860130|471732427|FG001|Overall Study|Adverse Event|3|||
131027679|NCT02860130|471732426|FG000|Overall Study|Protocol Violation|1|||
131027680|NCT02860130|471732427|FG001|Overall Study|Protocol Violation|1|||
131027681|NCT02860130|471732426|FG000|Overall Study|Withdrawal by Subject|0|||
131027682|NCT02860130|471732427|FG001|Overall Study|Withdrawal by Subject|2|||
131027683|NCT02860130|471732426|FG000|Overall Study|Physician Decision|2|||
131027684|NCT02860130|471732427|FG001|Overall Study|Physician Decision|2|||
131027685|NCT02860130|471732426|FG000|Overall Study|Other|2|||
131027686|NCT02860130|471732427|FG001|Overall Study|Other|1|||
131027687|NCT03380390|471732429|FG000|Overall Study|Adverse Event|3|||
131027688|NCT01127373|471732430|FG000|Overall Study|Not Treated|3|||
131027689|NCT01127373|471732430|FG000|Overall Study|Lost to Follow-up|7|||
131027690|NCT01127373|471732430|FG000|Overall Study|Withdrawal by Subject|1|||
131027691|NCT01127373|471732430|FG000|Overall Study|Disease progression|1|||
131027692|NCT01426412|471732431|FG000|Overall Study|Withdrawal by Subject|1|||
131027693|NCT01426412|471732432|FG001|Overall Study|Withdrawal by Subject|0|||
131027694|NCT01426412|471732433|FG002|Overall Study|Withdrawal by Subject|0|||
131027695|NCT01426412|471732434|FG003|Overall Study|Withdrawal by Subject|0|||
131027696|NCT01426412|471732435|FG004|Overall Study|Withdrawal by Subject|1|||
131027697|NCT01426412|471732436|FG005|Overall Study|Withdrawal by Subject|0|||
131027698|NCT01426412|471732437|FG006|Overall Study|Withdrawal by Subject|0|||
131027699|NCT01426412|471732438|FG007|Overall Study|Withdrawal by Subject|3|||
131027700|NCT01426412|471732439|FG008|Overall Study|Withdrawal by Subject|1|||
131027701|NCT02794480|471732441|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
131027702|NCT02794480|471732442|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
131027703|NCT02794480|471732443|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
131027704|NCT02794480|471732444|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
131027705|NCT02794480|471732441|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
131027706|NCT02794480|471732442|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
131027707|NCT02794480|471732443|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
131027708|NCT02794480|471732444|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
131027709|NCT02794480|471732441|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131027710|NCT02794480|471732442|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131027711|NCT02794480|471732443|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131027712|NCT02794480|471732444|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
131027713|NCT02794480|471732441|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131027714|NCT02794480|471732442|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
131027715|NCT02794480|471732443|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131027716|NCT02794480|471732444|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
131027717|NCT02794480|471732441|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
131027718|NCT02794480|471732442|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131113945|NCT03231943|472047302|FG004|Part 2|Adverse Event|0|||
130903648|NCT00592774|471281075|FG002|Overall Study|Withdrawal by Subject|0|||
130903649|NCT00592774|471281076|FG003|Overall Study|Withdrawal by Subject|0|||
130903650|NCT00592774|471281077|FG004|Overall Study|Withdrawal by Subject|0|||
130903651|NCT00592774|471281073|FG000|Overall Study|Lack of Efficacy|3|||
130903652|NCT00592774|471281074|FG001|Overall Study|Lack of Efficacy|3|||
130903653|NCT00592774|471281075|FG002|Overall Study|Lack of Efficacy|0|||
130903654|NCT00592774|471281076|FG003|Overall Study|Lack of Efficacy|0|||
130903655|NCT00592774|471281077|FG004|Overall Study|Lack of Efficacy|2|||
130903656|NCT00592774|471281073|FG000|Overall Study|Physician Decision|0|||
130903657|NCT00592774|471281074|FG001|Overall Study|Physician Decision|1|||
130903658|NCT00592774|471281075|FG002|Overall Study|Physician Decision|1|||
130903659|NCT00592774|471281076|FG003|Overall Study|Physician Decision|0|||
130903660|NCT00592774|471281077|FG004|Overall Study|Physician Decision|1|||
130903661|NCT00592774|471281073|FG000|Overall Study|Other|0|||
130903662|NCT00592774|471281074|FG001|Overall Study|Other|1|||
130903663|NCT00592774|471281075|FG002|Overall Study|Other|1|||
130903664|NCT00592774|471281076|FG003|Overall Study|Other|0|||
130903665|NCT00592774|471281077|FG004|Overall Study|Other|2|||
130903666|NCT01892384|471281078|FG000|Overall Study|Withdrawal by Subject|1|||
130903667|NCT01892384|471281079|FG001|Overall Study|Withdrawal by Subject|1|||
130903668|NCT01892384|471281080|FG002|Overall Study|Withdrawal by Subject|0|||
130903669|NCT01892384|471281081|FG003|Overall Study|Withdrawal by Subject|0|||
130903670|NCT01829243|471281082|FG000|First Intervention|Screen Failure|4|||
130903671|NCT01829243|471281083|FG001|First Intervention|Screen Failure|2|||
130903672|NCT00053898|471281095|FG000|Overall Study|No follow-up data from any source|9|||
130903673|NCT00053898|471281096|FG001|Overall Study|No follow-up data from any source|12|||
130903674|NCT00053898|471281095|FG000|Overall Study|Follow-up from telephone contact only|5|||
130903675|NCT00053898|471281096|FG001|Overall Study|Follow-up from telephone contact only|1|||
130903676|NCT03039621|471282390|FG000|Overall Study|Violation of inclusion criteria|3|||
130903677|NCT03039621|471282391|FG001|Overall Study|Violation of inclusion criteria|2|||
130903678|NCT03039621|471282390|FG000|Overall Study|Non-compliance with protocol requirement|4|||
130903679|NCT03039621|471282391|FG001|Overall Study|Non-compliance with protocol requirement|5|||
130903680|NCT03039621|471282390|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
130903681|NCT03039621|471282391|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
130903682|NCT03039621|471282390|FG000|Overall Study|Violation of non-inclusion criteria|1|||
130903683|NCT03039621|471282391|FG001|Overall Study|Violation of non-inclusion criteria|2|||
130903684|NCT00002931|471282394|FG000|Overall Study|rapidly progressing disease during|2|||
130903685|NCT03224598|471282395|FG000|Overall Study|Lost to Follow-up|0|||
130903686|NCT03224598|471282396|FG001|Overall Study|Lost to Follow-up|2|||
130903687|NCT03224598|471282397|FG002|Overall Study|Lost to Follow-up|0|||
130903688|NCT03224598|471282395|FG000|Overall Study|Other|0|||
130903689|NCT03224598|471282396|FG001|Overall Study|Other|1|||
130903690|NCT03224598|471282397|FG002|Overall Study|Other|0|||
130903691|NCT01527357|471282399|FG000|Overall Study|Death|8|||
130903692|NCT01527357|471282400|FG001|Overall Study|Death|2|||
130903693|NCT01527357|471282399|FG000|Overall Study|Lost to Follow-up|6|||
130903694|NCT01527357|471282400|FG001|Overall Study|Lost to Follow-up|4|||
130903695|NCT01527357|471282399|FG000|Overall Study|Withdrew Consent|1|||
130903696|NCT01527357|471282400|FG001|Overall Study|Withdrew Consent|1|||
130903697|NCT01527357|471282399|FG000|Overall Study|Non-compliance|0|||
130903698|NCT01527357|471282400|FG001|Overall Study|Non-compliance|1|||
130903699|NCT01527357|471282399|FG000|Overall Study|No Day 29 Visit|0|||
130903700|NCT01527357|471282400|FG001|Overall Study|No Day 29 Visit|1|||
130903701|NCT01527357|471282399|FG000|Overall Study|Did Not Receive Treatment|2|||
130903702|NCT01527357|471282400|FG001|Overall Study|Did Not Receive Treatment|0|||
130903703|NCT01879579|471282401|FG000|Overall Study|Phone incompatible with texting platform|3|||
130903704|NCT01879579|471282402|FG001|Overall Study|Phone incompatible with texting platform|0|||
130903705|NCT01879579|471282401|FG000|Overall Study|Did not enroll in texting platform|1|||
130903706|NCT01879579|471282402|FG001|Overall Study|Did not enroll in texting platform|0|||
130903707|NCT01879579|471282401|FG000|Overall Study|Did not initiate insulin treatment|1|||
130903708|NCT01879579|471282402|FG001|Overall Study|Did not initiate insulin treatment|0|||
130903709|NCT01879579|471282401|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
130903710|NCT01879579|471282402|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
130903711|NCT01879579|471282401|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
130903712|NCT01879579|471282402|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
130903713|NCT02292784|471282403|FG000|Overall Study|Lost to Follow-up|1|||
130903714|NCT02292784|471282404|FG001|Overall Study|Lost to Follow-up|17|||
130903715|NCT02292784|471282405|FG002|Overall Study|Lost to Follow-up|18|||
130903716|NCT02292784|471282403|FG000|Overall Study|Withdrawal by Subject|0|||
130903717|NCT02292784|471282404|FG001|Overall Study|Withdrawal by Subject|3|||
130903718|NCT02292784|471282405|FG002|Overall Study|Withdrawal by Subject|3|||
130903719|NCT01264081|471282406|FG000|Participants Screened|Screening failures|30|||
130903720|NCT01264081|471282406|FG000|Started Treatment|Withdrawal by Subject|1|||
130903721|NCT01264081|471282406|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
130903722|NCT00134784|471282407|FG000|Overall Study|Withdrawal by Subject|2|||
130903723|NCT00134784|471282408|FG001|Overall Study|Withdrawal by Subject|2|||
130903724|NCT00134784|471282409|FG002|Overall Study|Withdrawal by Subject|2|||
130903725|NCT00134784|471282410|FG003|Overall Study|Withdrawal by Subject|1|||
130903726|NCT00464490|471282411|FG000|Overall Study|Physician Decision|11|||
130903727|NCT00464490|471282412|FG001|Overall Study|Physician Decision|11|||
130903728|NCT00603590|471282413|FG000|Overall Study|Did not attend study clinic|39|||
130903729|NCT00603590|471282414|FG001|Overall Study|Did not attend study clinic|30|||
130903730|NCT00603590|471282413|FG000|Overall Study|Refused blood test|5|||
130903731|NCT00603590|471282414|FG001|Overall Study|Refused blood test|1|||
130903732|NCT00603590|471282413|FG000|Overall Study|Patient discontinued study drug|22|||
130903733|NCT00603590|471282414|FG001|Overall Study|Patient discontinued study drug|15|||
130903734|NCT00603590|471282413|FG000|Overall Study|Adverse Event|2|||
130903735|NCT00603590|471282414|FG001|Overall Study|Adverse Event|0|||
130903736|NCT00603590|471282413|FG000|Overall Study|Lost to Follow-up|8|||
130903737|NCT00603590|471282414|FG001|Overall Study|Lost to Follow-up|4|||
130903738|NCT00603590|471282413|FG000|Overall Study|Cardiovascular event|0|||
130903739|NCT00603590|471282414|FG001|Overall Study|Cardiovascular event|1|||
130903740|NCT03565367|471282415|FG000|Overall Study|No scan due to technical issues|4|||
130903741|NCT03565367|471282416|FG001|Overall Study|No scan due to technical issues|0|||
130903742|NCT00137839|471282419|FG000|Overall Study|Adverse Event|7|||
130903743|NCT00137839|471282419|FG000|Overall Study|Physician Decision|7|||
130903744|NCT00137839|471282419|FG000|Overall Study|Death|8|||
130903745|NCT00137839|471282419|FG000|Overall Study|Disease Progression|60|||
130903746|NCT00137839|471282419|FG000|Overall Study|Not Start Treatment|1|||
130903747|NCT00137839|471282419|FG000|Overall Study|Prolonged Treatment Delay|1|||
130903748|NCT02882152|471282420|FG000|Overall Study|Lost to Follow-up|1|||
130903749|NCT02882152|471282421|FG001|Overall Study|Lost to Follow-up|0|||
130903750|NCT03468543|471282424|FG000|Overall Study|Protocol stopping rules met|3|||
130903751|NCT01437995|471282425|FG000|Overall Study|Lost to Follow-up|11|||
130903752|NCT01437995|471282426|FG001|Overall Study|Lost to Follow-up|18|||
130903753|NCT01437995|471282427|FG002|Overall Study|Lost to Follow-up|20|||
130903754|NCT00159822|471282428|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
130903755|NCT00159822|471282428|FG000|Voriconazole Treatment Period|Adverse Event|9|||
130903756|NCT00159822|471282428|FG000|Voriconazole Treatment Period|Death|4|||
130903757|NCT00159822|471282428|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
130903758|NCT00159822|471282428|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
130903759|NCT00159822|471282428|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
130903760|NCT00159822|471282428|FG000|Post-treatment Follow-up Period|Death|1|||
130903761|NCT00159822|471282428|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
130903762|NCT00159822|471282428|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
130768391|NCT00603382|470775557|FG002|Overall Study|Lost to Follow-up|1|||
130903763|NCT00275821|471282430|FG000|Overall Study|Adverse Event|4|||
130903764|NCT00275821|471282431|FG001|Overall Study|Adverse Event|12|||
130903765|NCT00275821|471282432|FG002|Overall Study|Adverse Event|5|||
130903766|NCT00275821|471282430|FG000|Overall Study|Administrative problems|3|||
130903767|NCT00275821|471282431|FG001|Overall Study|Administrative problems|4|||
130903768|NCT00275821|471282432|FG002|Overall Study|Administrative problems|4|||
130903769|NCT00275821|471282430|FG000|Overall Study|Withdrawal by Subject|0|||
130903770|NCT00275821|471282431|FG001|Overall Study|Withdrawal by Subject|2|||
130903771|NCT00275821|471282432|FG002|Overall Study|Withdrawal by Subject|1|||
130903772|NCT00275821|471282430|FG000|Overall Study|Lost to Follow-up|0|||
130903773|NCT00275821|471282431|FG001|Overall Study|Lost to Follow-up|1|||
130903774|NCT00275821|471282432|FG002|Overall Study|Lost to Follow-up|1|||
130903775|NCT00275821|471282430|FG000|Overall Study|Death|0|||
130903776|NCT00275821|471282431|FG001|Overall Study|Death|2|||
130903777|NCT00275821|471282432|FG002|Overall Study|Death|1|||
130903778|NCT00275821|471282430|FG000|Overall Study|Lack of Efficacy|2|||
130903779|NCT00275821|471282431|FG001|Overall Study|Lack of Efficacy|1|||
130903780|NCT00275821|471282432|FG002|Overall Study|Lack of Efficacy|0|||
130903781|NCT00275821|471282430|FG000|Overall Study|Protocol Violation|5|||
130903782|NCT00275821|471282431|FG001|Overall Study|Protocol Violation|1|||
130903783|NCT00275821|471282432|FG002|Overall Study|Protocol Violation|0|||
130903784|NCT00329901|471282433|FG000|Overall Study|Withdrawal by Subject|4|||
130903785|NCT00329901|471282434|FG001|Overall Study|Withdrawal by Subject|3|||
130903786|NCT00329901|471282435|FG002|Overall Study|Withdrawal by Subject|2|||
130903787|NCT00329901|471282433|FG000|Overall Study|Lost to Follow-up|2|||
130903788|NCT00329901|471282434|FG001|Overall Study|Lost to Follow-up|0|||
130903789|NCT00329901|471282435|FG002|Overall Study|Lost to Follow-up|1|||
130903790|NCT00329901|471282433|FG000|Overall Study|Protocol Violation|1|||
130903791|NCT00329901|471282434|FG001|Overall Study|Protocol Violation|0|||
130903792|NCT00329901|471282435|FG002|Overall Study|Protocol Violation|1|||
130903793|NCT00329901|471282433|FG000|Overall Study|Unable to classify|2|||
130903794|NCT00329901|471282434|FG001|Overall Study|Unable to classify|2|||
130903795|NCT00329901|471282435|FG002|Overall Study|Unable to classify|0|||
130903796|NCT02296138|471282436|FG000|Overall Study|Adverse Event|348|||
130903797|NCT02296138|471282437|FG001|Overall Study|Adverse Event|259|||
131113946|NCT03231943|472047303|FG005|Part 2|Adverse Event|0|||
130903798|NCT02296138|471282436|FG000|Overall Study|Lack of Efficacy|59|||
130903799|NCT02296138|471282437|FG001|Overall Study|Lack of Efficacy|37|||
131113947|NCT03231943|472047304|FG006|Part 2|Adverse Event|0|||
131113948|NCT03231943|472047305|FG007|Part 2|Adverse Event|0|||
130903800|NCT02296138|471282436|FG000|Overall Study|Protocol Violation|35|||
131113949|NCT03231943|472047306|FG008|Part 2|Adverse Event|0|||
131113950|NCT03231943|472047307|FG009|Part 2|Adverse Event|0|||
130903801|NCT02296138|471282437|FG001|Overall Study|Protocol Violation|36|||
131113951|NCT03231943|472047308|FG010|Part 2|Adverse Event|1|||
130903802|NCT02296138|471282436|FG000|Overall Study|Lost to Follow-up|9|||
130903803|NCT02296138|471282437|FG001|Overall Study|Lost to Follow-up|12|||
130694565|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130903804|NCT02296138|471282436|FG000|Overall Study|Withdrawal by Subject|184|||
130903805|NCT02296138|471282437|FG001|Overall Study|Withdrawal by Subject|131|||
130903806|NCT02296138|471282436|FG000|Overall Study|Not Treated|1|||
130903807|NCT02296138|471282437|FG001|Overall Study|Not Treated|1|||
130903808|NCT02296138|471282436|FG000|Overall Study|Patients with data irregularities|10|||
130903809|NCT02296138|471282437|FG001|Overall Study|Patients with data irregularities|11|||
130903810|NCT02296138|471282436|FG000|Overall Study|Other than specified|15|||
130903811|NCT02296138|471282437|FG001|Overall Study|Other than specified|13|||
130903812|NCT01209832|471282444|FG000|Period 1|Sponsor Decision and was not dosed|1|||
130903813|NCT01209832|471282444|FG000|Period 2|Sponsor Decision|1|||
130903814|NCT01268579|471282445|FG000|Overall Study|Adverse Event|1|||
130903815|NCT01268579|471282445|FG000|Overall Study|Withdrawal by Subject|2|||
130903816|NCT05463198|471282446|FG000|Overall Study|Withdrawal by Subject|19|||
130903817|NCT05463198|471282446|FG000|Overall Study|Procedure Notes Missing|18|||
130903818|NCT01860846|471282447|FG000|Overall Study|Lost to Follow-up|33|||
130903819|NCT02239120|471282450|FG000|Overall Study|Death|56|||
130903820|NCT02239120|471282451|FG001|Overall Study|Death|58|||
131027719|NCT02794480|471732443|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131027720|NCT02794480|471732444|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
131027721|NCT00262301|471732445|FG000|Double-blind Phase|Lost to Follow-up|1|||
131027722|NCT00262301|471732446|FG001|Double-blind Phase|Lost to Follow-up|0|||
131027723|NCT00262301|471732447|FG002|Double-blind Phase|Lost to Follow-up|0|||
131027724|NCT00262301|471732445|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
130903821|NCT02239120|471282450|FG000|Overall Study|Lost to Follow-up|19|||
130903822|NCT02239120|471282451|FG001|Overall Study|Lost to Follow-up|14|||
130903823|NCT00466687|471282452|FG000|Overall Study|Adverse Event|1|||
130903824|NCT00466687|471282452|FG000|Overall Study|Other complicating illness|3|||
130903825|NCT00466687|471282452|FG000|Overall Study|Withdrawal by Subject|1|||
130903826|NCT00466687|471282452|FG000|Overall Study|Disease progression|29|||
130903827|NCT01925989|471282453|FG000|Period 1|Sponsor Decision|1|||
130903828|NCT01925989|471282454|FG001|Period 1|Sponsor Decision|1|||
130903829|NCT01925989|471282455|FG002|Period 1|Sponsor Decision|0|||
130903830|NCT01925989|471282453|FG000|Period 1|Withdrawal by Subject|0|||
131027725|NCT00262301|471732446|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
131027726|NCT00262301|471732447|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
131027727|NCT01136876|471732450|FG000|Overall Study|Lost to Follow-up|0|||
131027728|NCT01136876|471732451|FG001|Overall Study|Lost to Follow-up|1|||
131027729|NCT01136876|471732450|FG000|Overall Study|Physician Decision|3|||
131027730|NCT01136876|471732451|FG001|Overall Study|Physician Decision|5|||
131027731|NCT01136876|471732450|FG000|Overall Study|Missing NGAL measurement|2|||
131027732|NCT01136876|471732451|FG001|Overall Study|Missing NGAL measurement|5|||
131027733|NCT00976937|471732454|FG000|Overall Study|Adverse Event|4|||
131027734|NCT00976937|471732455|FG001|Overall Study|Adverse Event|5|||
131027735|NCT00976937|471732454|FG000|Overall Study|Lost to Follow-up|2|||
131027736|NCT00976937|471732455|FG001|Overall Study|Lost to Follow-up|1|||
131027737|NCT00976937|471732454|FG000|Overall Study|Withdrawal by Subject|5|||
131027738|NCT00976937|471732455|FG001|Overall Study|Withdrawal by Subject|3|||
131027739|NCT00976937|471732454|FG000|Overall Study|Poor compliance to protocol|3|||
131027740|NCT00976937|471732455|FG001|Overall Study|Poor compliance to protocol|0|||
131027741|NCT00976937|471732454|FG000|Overall Study|Personal and Familial Reason|2|||
131027742|NCT00976937|471732455|FG001|Overall Study|Personal and Familial Reason|2|||
131027743|NCT03069313|471732456|FG000|Overall Study|Adverse Event|5|||
131027744|NCT03744312|471733766|FG000|Overall Study|Withdrawal by Subject|0|||
131027745|NCT03744312|471733767|FG001|Overall Study|Withdrawal by Subject|1|||
131027746|NCT03744312|471733766|FG000|Overall Study|Screen fail|0|||
131027747|NCT03744312|471733767|FG001|Overall Study|Screen fail|1|||
131027748|NCT04924062|471733768|FG000|Overall Study|Death|49|||
131027749|NCT04924062|471733769|FG001|Overall Study|Death|63|||
131027750|NCT04924062|471733768|FG000|Overall Study|Participant On-going|26|||
131027751|NCT04924062|471733769|FG001|Overall Study|Participant On-going|20|||
131027752|NCT04607044|471733776|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
131027753|NCT04607044|471733776|FG000|Overall Study|Adverse Event|1|||
131027754|NCT04607044|471733776|FG000|Overall Study|Did not receive study device|3|||
130903831|NCT01925989|471282454|FG001|Period 1|Withdrawal by Subject|1|||
130903832|NCT01925989|471282455|FG002|Period 1|Withdrawal by Subject|0|||
130903833|NCT00868517|471282460|FG000|Overall Study|Withdrawal by Subject|3|||
130903834|NCT00868517|471282461|FG001|Overall Study|Withdrawal by Subject|3|||
130903835|NCT00868517|471282462|FG002|Overall Study|Withdrawal by Subject|2|||
130903836|NCT00868517|471282460|FG000|Overall Study|Protocol Violation|1|||
131027755|NCT04607044|471733776|FG000|Overall Study|Death|1|||
131027756|NCT03651895|471733777|FG000|First Drug Assignment|Adverse Event|4|||
131027757|NCT03651895|471733778|FG001|First Drug Assignment|Adverse Event|5|||
131027758|NCT03651895|471733777|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
130903837|NCT00868517|471282461|FG001|Overall Study|Protocol Violation|1|||
131113952|NCT03231943|472047309|FG011|Part 2|Adverse Event|0|||
130903838|NCT00868517|471282462|FG002|Overall Study|Protocol Violation|0|||
130903839|NCT00420641|471282466|FG000|Overall Study|Adverse Event|3|||
130903840|NCT00420641|471282467|FG001|Overall Study|Adverse Event|25|||
130903841|NCT00420641|471282468|FG002|Overall Study|Adverse Event|10|||
130903842|NCT00420641|471282466|FG000|Overall Study|Lost to Follow-up|2|||
130903843|NCT00420641|471282467|FG001|Overall Study|Lost to Follow-up|4|||
130903844|NCT00420641|471282468|FG002|Overall Study|Lost to Follow-up|2|||
130903845|NCT00420641|471282466|FG000|Overall Study|Protocol Violation|8|||
130903846|NCT00420641|471282467|FG001|Overall Study|Protocol Violation|8|||
130903847|NCT00420641|471282468|FG002|Overall Study|Protocol Violation|7|||
130903848|NCT00420641|471282466|FG000|Overall Study|Withdrawal by Subject|15|||
130903849|NCT00420641|471282467|FG001|Overall Study|Withdrawal by Subject|21|||
130903850|NCT00420641|471282468|FG002|Overall Study|Withdrawal by Subject|14|||
130903851|NCT00420641|471282466|FG000|Overall Study|Lack of Efficacy|6|||
130903852|NCT00420641|471282467|FG001|Overall Study|Lack of Efficacy|5|||
130903853|NCT00420641|471282468|FG002|Overall Study|Lack of Efficacy|4|||
130903854|NCT00420641|471282466|FG000|Overall Study|Non-compliance|7|||
130903855|NCT00420641|471282467|FG001|Overall Study|Non-compliance|5|||
130903856|NCT00420641|471282468|FG002|Overall Study|Non-compliance|4|||
130903857|NCT00420641|471282466|FG000|Overall Study|Other|4|||
130903858|NCT00420641|471282467|FG001|Overall Study|Other|4|||
130903859|NCT00420641|471282468|FG002|Overall Study|Other|3|||
130903860|NCT03459690|471282470|FG000|Overall Study|Lost to Follow-up|0|||
130903861|NCT03459690|471282471|FG001|Overall Study|Lost to Follow-up|1|||
130903862|NCT03459690|471282470|FG000|Overall Study|Withdrawal by Subject|1|||
130903863|NCT03459690|471282471|FG001|Overall Study|Withdrawal by Subject|1|||
130903864|NCT02815280|471282472|FG000|Double-Blind Phase|Adverse Event|1|||
130903865|NCT02815280|471282473|FG001|Double-Blind Phase|Adverse Event|1|||
130903866|NCT02815280|471282472|FG000|Double-Blind Phase|Lost to Follow-up|10|||
130903867|NCT02815280|471282473|FG001|Double-Blind Phase|Lost to Follow-up|9|||
130903868|NCT02815280|471282472|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
130903869|NCT02815280|471282473|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
130903870|NCT02815280|471282472|FG000|Double-Blind Phase|Protocol Violation|2|||
130903871|NCT02815280|471282473|FG001|Double-Blind Phase|Protocol Violation|2|||
130903872|NCT02815280|471282472|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
130903873|NCT02815280|471282473|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
130903874|NCT02815280|471282472|FG000|Open-Label Phase|Adverse Event|2|||
130903875|NCT02815280|471282473|FG001|Open-Label Phase|Adverse Event|3|||
130903876|NCT02815280|471282472|FG000|Open-Label Phase|Lost to Follow-up|18|||
130903877|NCT02815280|471282473|FG001|Open-Label Phase|Lost to Follow-up|9|||
130903878|NCT02815280|471282472|FG000|Open-Label Phase|Withdrawal by Subject|33|||
130903879|NCT02815280|471282473|FG001|Open-Label Phase|Withdrawal by Subject|18|||
130903880|NCT02815280|471282472|FG000|Open-Label Phase|Protocol Violation|3|||
130903881|NCT02815280|471282473|FG001|Open-Label Phase|Protocol Violation|0|||
130903882|NCT02815280|471282472|FG000|Open-Label Phase|Administrative|26|||
130903883|NCT02815280|471282473|FG001|Open-Label Phase|Administrative|12|||
130903884|NCT02815280|471282472|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
130903885|NCT02815280|471282473|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
130903886|NCT02514473|471282488|FG000|Overall Study|Adverse Event|0|||
130903887|NCT02514473|471282489|FG001|Overall Study|Adverse Event|2|||
130903888|NCT02514473|471282488|FG000|Overall Study|Withdrawal by Subject|2|||
130903889|NCT02514473|471282489|FG001|Overall Study|Withdrawal by Subject|1|||
130903890|NCT02514473|471282488|FG000|Overall Study|Lost to Follow-up|0|||
130903891|NCT02514473|471282489|FG001|Overall Study|Lost to Follow-up|1|||
131027759|NCT03651895|471733778|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
130903892|NCT02514473|471282488|FG000|Overall Study|Other|1|||
130903893|NCT02514473|471282489|FG001|Overall Study|Other|1|||
130903894|NCT02158364|471282490|FG000|Overall Study|Case report forms uncollected|10|||
130903895|NCT02158364|471282490|FG000|Overall Study|Protocol Deviation|50|||
130903896|NCT01944839|471282491|FG000|Overall Study|Physician Decision|2|||
130903897|NCT01944839|471282492|FG001|Overall Study|Physician Decision|2|||
130903898|NCT01944839|471282491|FG000|Overall Study|Protocol Violation|0|||
130903899|NCT01944839|471282492|FG001|Overall Study|Protocol Violation|1|||
130903900|NCT01944839|471282491|FG000|Overall Study|Adverse Event|10|||
130903901|NCT01944839|471282492|FG001|Overall Study|Adverse Event|5|||
130903902|NCT01944839|471282491|FG000|Overall Study|Withdrawal by Subject|9|||
130903903|NCT01944839|471282492|FG001|Overall Study|Withdrawal by Subject|17|||
130903904|NCT01944839|471282491|FG000|Overall Study|Lost to Follow-up|1|||
130903905|NCT01944839|471282492|FG001|Overall Study|Lost to Follow-up|0|||
130903906|NCT01944839|471282491|FG000|Overall Study|Subject non-compliance|0|||
130903907|NCT01944839|471282492|FG001|Overall Study|Subject non-compliance|3|||
130903908|NCT02217527|471282493|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
130903909|NCT02217527|471282494|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
130903910|NCT02217527|471282493|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
131027760|NCT02525692|471733779|FG000|Overall Study|Withdrawal by Subject|1|||
130903911|NCT02217527|471282494|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
130903912|NCT01878149|471282495|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
130903913|NCT01878149|471282496|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
130903914|NCT00502203|471282504|FG000|Overall Study|Inevaluable|1|||
130903915|NCT02241889|471282507|FG000|Overall Study|device issues|0|||
130903916|NCT02241889|471282508|FG001|Overall Study|device issues|0|||
130903917|NCT02241889|471282509|FG002|Overall Study|device issues|1|||
130903918|NCT02241889|471282510|FG003|Overall Study|device issues|0|||
130903919|NCT02241889|471282511|FG004|Overall Study|device issues|0|||
130903920|NCT02241889|471282512|FG005|Overall Study|device issues|0|||
130903921|NCT02241889|471282507|FG000|Overall Study|Withdrawal by Subject|0|||
130903922|NCT02241889|471282508|FG001|Overall Study|Withdrawal by Subject|0|||
130903923|NCT02241889|471282509|FG002|Overall Study|Withdrawal by Subject|0|||
130903924|NCT02241889|471282510|FG003|Overall Study|Withdrawal by Subject|0|||
130903925|NCT02241889|471282511|FG004|Overall Study|Withdrawal by Subject|0|||
130903926|NCT02241889|471282512|FG005|Overall Study|Withdrawal by Subject|1|||
130903927|NCT03836001|471282513|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
130903928|NCT03836001|471282514|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
130903929|NCT03836001|471282515|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
130903930|NCT03836001|471282513|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
130903931|NCT03836001|471282514|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
130903932|NCT03836001|471282515|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
130903933|NCT03836001|471282513|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
130903934|NCT03836001|471282514|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
130903935|NCT03836001|471282515|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
130903936|NCT03836001|471282513|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
130903937|NCT03836001|471282514|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
130903938|NCT03836001|471282515|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
130903939|NCT01606878|471282524|FG000|Overall Study|Adverse Event|1|||
130903940|NCT01606878|471282525|FG001|Overall Study|Adverse Event|1|||
130903941|NCT01606878|471282526|FG002|Overall Study|Adverse Event|0|||
130903942|NCT01606878|471282527|FG003|Overall Study|Adverse Event|0|||
130903943|NCT01606878|471282528|FG004|Overall Study|Adverse Event|0|||
130903944|NCT01606878|471282529|FG005|Overall Study|Adverse Event|0|||
130903945|NCT01606878|471282530|FG006|Overall Study|Adverse Event|1|||
130903946|NCT01606878|471282531|FG007|Overall Study|Adverse Event|0|||
130903947|NCT01606878|471282532|FG008|Overall Study|Adverse Event|1|||
130903948|NCT01606878|471282533|FG009|Overall Study|Adverse Event|3|||
130903949|NCT01606878|471282534|FG010|Overall Study|Adverse Event|0|||
130903950|NCT01606878|471282524|FG000|Overall Study|Lack of Efficacy|1|||
130903951|NCT01606878|471282525|FG001|Overall Study|Lack of Efficacy|1|||
130903952|NCT01606878|471282526|FG002|Overall Study|Lack of Efficacy|1|||
130903953|NCT01606878|471282527|FG003|Overall Study|Lack of Efficacy|2|||
130903954|NCT01606878|471282528|FG004|Overall Study|Lack of Efficacy|1|||
130903955|NCT01606878|471282529|FG005|Overall Study|Lack of Efficacy|2|||
130903956|NCT01606878|471282530|FG006|Overall Study|Lack of Efficacy|1|||
130903957|NCT01606878|471282531|FG007|Overall Study|Lack of Efficacy|2|||
130903958|NCT01606878|471282532|FG008|Overall Study|Lack of Efficacy|2|||
130903959|NCT01606878|471282533|FG009|Overall Study|Lack of Efficacy|0|||
130903960|NCT01606878|471282534|FG010|Overall Study|Lack of Efficacy|1|||
130903961|NCT01606878|471282524|FG000|Overall Study|Physician Decision|1|||
130903962|NCT01606878|471282525|FG001|Overall Study|Physician Decision|0|||
130903963|NCT01606878|471282526|FG002|Overall Study|Physician Decision|2|||
130903964|NCT01606878|471282527|FG003|Overall Study|Physician Decision|1|||
130903965|NCT01606878|471282528|FG004|Overall Study|Physician Decision|1|||
130903966|NCT01606878|471282529|FG005|Overall Study|Physician Decision|1|||
130903967|NCT01606878|471282530|FG006|Overall Study|Physician Decision|2|||
130903968|NCT01606878|471282531|FG007|Overall Study|Physician Decision|0|||
130903969|NCT01606878|471282532|FG008|Overall Study|Physician Decision|1|||
130903970|NCT01606878|471282533|FG009|Overall Study|Physician Decision|0|||
130903971|NCT01606878|471282534|FG010|Overall Study|Physician Decision|0|||
130903972|NCT01606878|471282524|FG000|Overall Study|Withdrawal by Subject|3|||
130903973|NCT01606878|471282525|FG001|Overall Study|Withdrawal by Subject|2|||
130903974|NCT01606878|471282526|FG002|Overall Study|Withdrawal by Subject|2|||
130903975|NCT01606878|471282527|FG003|Overall Study|Withdrawal by Subject|0|||
130903976|NCT01606878|471282528|FG004|Overall Study|Withdrawal by Subject|1|||
130903977|NCT01606878|471282529|FG005|Overall Study|Withdrawal by Subject|1|||
130903978|NCT01606878|471282530|FG006|Overall Study|Withdrawal by Subject|2|||
130903979|NCT01606878|471282531|FG007|Overall Study|Withdrawal by Subject|1|||
130903980|NCT01606878|471282532|FG008|Overall Study|Withdrawal by Subject|2|||
130903981|NCT01606878|471282533|FG009|Overall Study|Withdrawal by Subject|0|||
130903982|NCT01606878|471282534|FG010|Overall Study|Withdrawal by Subject|2|||
130903983|NCT03353740|471282538|FG000|Overall Study|Images for these participants not viable|52|||
130903984|NCT01395784|471282539|FG000|Overall Study|Lost to Follow-up|7|||
130903985|NCT01395784|471282539|FG000|Overall Study|Withdrawal by Subject|3|||
130903986|NCT01395784|471282539|FG000|Overall Study|Physician Decision|5|||
130903987|NCT04268823|471282540|FG000|Overall Study|Adverse Event|1|||
130903988|NCT04268823|471282541|FG001|Overall Study|Adverse Event|0|||
130903989|NCT04268823|471282540|FG000|Overall Study|Participant Decision|1|||
130903990|NCT04268823|471282541|FG001|Overall Study|Participant Decision|0|||
130903991|NCT02716896|471284029|FG000|Overall Study|Physician Decision|0|||
130903992|NCT02716896|471284030|FG001|Overall Study|Physician Decision|1|||
130903993|NCT02519855|471284033|FG000|Overall Study|Adverse Event|0|||
130903994|NCT02519855|471284034|FG001|Overall Study|Adverse Event|1|||
130903995|NCT02519855|471284033|FG000|Overall Study|Lost to Follow-up|3|||
130903996|NCT02519855|471284034|FG001|Overall Study|Lost to Follow-up|3|||
130903997|NCT00003830|471284048|FG000|Overall Study|No follow up data|3|||
130903998|NCT00003830|471284049|FG001|Overall Study|No follow up data|0|||
130903999|NCT00003830|471284048|FG000|Overall Study|Sentinel node positive patients|829|||
130904000|NCT00003830|471284049|FG001|Overall Study|Sentinel node positive patients|793|||
130904001|NCT03699475|471284056|FG000|Overall Study|Death|1|||
130904002|NCT03739242|471284061|FG000|Overall Study|Withdrawal by Subject|1|||
130904003|NCT03739242|471284062|FG001|Overall Study|Withdrawal by Subject|1|||
130904004|NCT03739242|471284061|FG000|Overall Study|Protocol Violation|0|||
130904005|NCT03739242|471284062|FG001|Overall Study|Protocol Violation|1|||
130904006|NCT01752036|471284063|FG000|Overall Study|Death|2|||
130904007|NCT02278471|471284064|FG000|Overall Study|Lost to Follow-up|6|||
130904008|NCT02278471|471284065|FG001|Overall Study|Lost to Follow-up|15|||
130904009|NCT02278471|471284064|FG000|Overall Study|Death|2|||
130904010|NCT02278471|471284065|FG001|Overall Study|Death|2|||
130904011|NCT02278471|471284064|FG000|Overall Study|Withdrawal by Subject|0|||
130904012|NCT02278471|471284065|FG001|Overall Study|Withdrawal by Subject|3|||
130904013|NCT04535167|471284068|FG000|Treatment|Adverse Event|0|||
130904014|NCT04535167|471284069|FG001|Treatment|Adverse Event|0|||
130904015|NCT04535167|471284070|FG002|Treatment|Adverse Event|0|||
130904016|NCT04535167|471284071|FG003|Treatment|Adverse Event|0|||
130904017|NCT04535167|471284072|FG004|Treatment|Adverse Event|0|||
131113953|NCT03231943|472047310|FG012|Part 2|Adverse Event|0|||
131113954|NCT03231943|472047298|FG000|Part 2|Withdrawal by Subject|0|||
131113955|NCT03231943|472047299|FG001|Part 2|Withdrawal by Subject|0|||
131113956|NCT03231943|472047300|FG002|Part 2|Withdrawal by Subject|0|||
131113957|NCT03231943|472047301|FG003|Part 2|Withdrawal by Subject|0|||
131113958|NCT03231943|472047302|FG004|Part 2|Withdrawal by Subject|0|||
131113959|NCT03231943|472047303|FG005|Part 2|Withdrawal by Subject|0|||
131113960|NCT03231943|472047304|FG006|Part 2|Withdrawal by Subject|0|||
131113961|NCT03231943|472047305|FG007|Part 2|Withdrawal by Subject|0|||
131113962|NCT03231943|472047306|FG008|Part 2|Withdrawal by Subject|0|||
131113963|NCT03231943|472047307|FG009|Part 2|Withdrawal by Subject|0|||
131113964|NCT03231943|472047308|FG010|Part 2|Withdrawal by Subject|0|||
131113965|NCT03231943|472047309|FG011|Part 2|Withdrawal by Subject|1|||
131113966|NCT03231943|472047310|FG012|Part 2|Withdrawal by Subject|0|||
131113967|NCT02906787|472047312|FG000|Overall Study|Withdrawal by Subject|12|||
131113968|NCT02906787|472047313|FG001|Overall Study|Withdrawal by Subject|10|||
131113969|NCT02906787|472047312|FG000|Overall Study|Missed|24|||
131113970|NCT02906787|472047313|FG001|Overall Study|Missed|22|||
131113971|NCT02818920|472047314|FG000|Overall Study|Unresectable|4|||
131113972|NCT02818920|472047314|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
131113973|NCT02818920|472047314|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
131113974|NCT02818920|472047314|FG000|Overall Study|Adverse Event|3|||
131113975|NCT02818920|472047314|FG000|Overall Study|Developed Other Disease|1|||
131113976|NCT02818920|472047314|FG000|Overall Study|Refused Further Treatment|1|||
131113977|NCT03769181|472048955|FG000|Overall Study|Adverse Event|1|||
131113978|NCT03769181|472048956|FG001|Overall Study|Adverse Event|0|||
131113979|NCT03769181|472048957|FG002|Overall Study|Adverse Event|2|||
131113980|NCT03769181|472048958|FG003|Overall Study|Adverse Event|4|||
131113981|NCT03769181|472048955|FG000|Overall Study|Withdrawal by Subject|1|||
131113982|NCT03769181|472048956|FG001|Overall Study|Withdrawal by Subject|0|||
131113983|NCT03769181|472048957|FG002|Overall Study|Withdrawal by Subject|2|||
131113984|NCT03769181|472048958|FG003|Overall Study|Withdrawal by Subject|1|||
131113985|NCT03769181|472048955|FG000|Overall Study|Progressive disease|9|||
131113986|NCT03769181|472048956|FG001|Overall Study|Progressive disease|7|||
130904018|NCT04535167|471284073|FG005|Treatment|Adverse Event|0|||
131113987|NCT03769181|472048957|FG002|Overall Study|Progressive disease|13|||
131113988|NCT03769181|472048958|FG003|Overall Study|Progressive disease|6|||
130904019|NCT04535167|471284074|FG006|Treatment|Adverse Event|1|||
130904020|NCT04535167|471284068|FG000|Follow-Up|Death|0|||
130904021|NCT04535167|471284069|FG001|Follow-Up|Death|0|||
130904022|NCT04535167|471284070|FG002|Follow-Up|Death|0|||
130904023|NCT04535167|471284071|FG003|Follow-Up|Death|0|||
130904024|NCT04535167|471284072|FG004|Follow-Up|Death|0|||
130904025|NCT04535167|471284073|FG005|Follow-Up|Death|0|||
130904026|NCT04535167|471284074|FG006|Follow-Up|Death|1|||
130904027|NCT04535167|471284068|FG000|Follow-Up|Lost to Follow-up|0|||
130904028|NCT04535167|471284069|FG001|Follow-Up|Lost to Follow-up|0|||
131113989|NCT03769181|472048955|FG000|Overall Study|Other - Unspecified|2|||
131113990|NCT03769181|472048956|FG001|Overall Study|Other - Unspecified|1|||
131113991|NCT03769181|472048957|FG002|Overall Study|Other - Unspecified|0|||
131113992|NCT03769181|472048958|FG003|Overall Study|Other - Unspecified|0|||
130904029|NCT04535167|471284070|FG002|Follow-Up|Lost to Follow-up|0|||
130904030|NCT04535167|471284071|FG003|Follow-Up|Lost to Follow-up|1|||
130904031|NCT04535167|471284072|FG004|Follow-Up|Lost to Follow-up|0|||
130904032|NCT04535167|471284073|FG005|Follow-Up|Lost to Follow-up|0|||
130904033|NCT04535167|471284074|FG006|Follow-Up|Lost to Follow-up|0|||
130904034|NCT00978432|471284075|FG000|Overall Study|Withdrawal by Subject|0|||
130904035|NCT00978432|471284076|FG001|Overall Study|Withdrawal by Subject|0|||
130904036|NCT00978432|471284077|FG002|Overall Study|Withdrawal by Subject|1|||
130904037|NCT00978432|471284075|FG000|Overall Study|Lack of Efficacy|1|||
130904038|NCT00978432|471284076|FG001|Overall Study|Lack of Efficacy|1|||
130904039|NCT00978432|471284077|FG002|Overall Study|Lack of Efficacy|3|||
130904040|NCT00978432|471284075|FG000|Overall Study|Adverse Event|2|||
130904041|NCT00978432|471284076|FG001|Overall Study|Adverse Event|0|||
130904042|NCT00978432|471284077|FG002|Overall Study|Adverse Event|1|||
130904043|NCT04618770|471284078|FG000|Overall Study|Censored from Analysis|12|||
130904044|NCT04618770|471284078|FG000|Overall Study|Early Termination|25|||
130904045|NCT04972630|471284081|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
130904046|NCT04972630|471284082|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
130904047|NCT04972630|471284083|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
130904048|NCT00075270|471284086|FG000|Overall Study|Withdrawal by Subject|28|||
130904049|NCT00075270|471284087|FG001|Overall Study|Withdrawal by Subject|21|||
130904050|NCT00075270|471284086|FG000|Overall Study|Lost to Follow-up|25|||
130904051|NCT00075270|471284087|FG001|Overall Study|Lost to Follow-up|28|||
130904052|NCT00075270|471284086|FG000|Overall Study|Protocol Violation|0|||
130904053|NCT00075270|471284087|FG001|Overall Study|Protocol Violation|2|||
130904054|NCT00075270|471284086|FG000|Overall Study|Death|198|||
130904055|NCT00075270|471284087|FG001|Overall Study|Death|215|||
130904056|NCT00075270|471284086|FG000|Overall Study|Other/Unknown|9|||
130904057|NCT00075270|471284087|FG001|Overall Study|Other/Unknown|5|||
130904058|NCT00075270|471284086|FG000|Overall Study|Missing|26|||
130904059|NCT00075270|471284087|FG001|Overall Study|Missing|13|||
130904060|NCT02160002|471284088|FG000|Overall Study|Withdrawal by Subject|2|||
130904061|NCT02160002|471284089|FG001|Overall Study|Withdrawal by Subject|1|||
130904062|NCT04896229|471284090|FG000|Overall Study|Lost to Follow-up|113|||
130904063|NCT04896229|471284091|FG001|Overall Study|Lost to Follow-up|113|||
130904064|NCT04418661|471284092|FG000|Overall Study|Adverse Event|0|||
130904065|NCT04418661|471284093|FG001|Overall Study|Adverse Event|1|||
130904066|NCT04418661|471284094|FG002|Overall Study|Adverse Event|5|||
130904067|NCT04418661|471284095|FG003|Overall Study|Adverse Event|3|||
130904068|NCT04418661|471284096|FG004|Overall Study|Adverse Event|0|||
130904069|NCT04418661|471284097|FG005|Overall Study|Adverse Event|2|||
130904070|NCT04418661|471284092|FG000|Overall Study|Progressive disease|4|||
130904071|NCT04418661|471284093|FG001|Overall Study|Progressive disease|11|||
130904072|NCT04418661|471284094|FG002|Overall Study|Progressive disease|6|||
130904073|NCT04418661|471284095|FG003|Overall Study|Progressive disease|11|||
130904074|NCT04418661|471284096|FG004|Overall Study|Progressive disease|1|||
130904075|NCT04418661|471284097|FG005|Overall Study|Progressive disease|12|||
130904076|NCT04418661|471284092|FG000|Overall Study|Withdrawal by Subject|0|||
130904077|NCT04418661|471284093|FG001|Overall Study|Withdrawal by Subject|1|||
130904078|NCT04418661|471284094|FG002|Overall Study|Withdrawal by Subject|0|||
130904079|NCT04418661|471284095|FG003|Overall Study|Withdrawal by Subject|1|||
130904080|NCT04418661|471284096|FG004|Overall Study|Withdrawal by Subject|0|||
130904081|NCT04418661|471284097|FG005|Overall Study|Withdrawal by Subject|0|||
130904082|NCT04418661|471284092|FG000|Overall Study|Other|0|||
130904083|NCT04418661|471284093|FG001|Overall Study|Other|0|||
130904084|NCT04418661|471284094|FG002|Overall Study|Other|1|||
130904085|NCT04418661|471284095|FG003|Overall Study|Other|3|||
130904086|NCT04418661|471284096|FG004|Overall Study|Other|0|||
130904087|NCT04418661|471284097|FG005|Overall Study|Other|1|||
130904088|NCT00761150|471284100|FG000|Open-label Period|Adverse Event|36|||
130904089|NCT00761150|471284101|FG001|Open-label Period|Adverse Event|0|||
131027761|NCT02525692|471733780|FG001|Overall Study|Withdrawal by Subject|1|||
131027762|NCT02525692|471733781|FG002|Overall Study|Withdrawal by Subject|0|||
131027763|NCT02525692|471733782|FG003|Overall Study|Withdrawal by Subject|5|||
131027764|NCT02525692|471733783|FG004|Overall Study|Withdrawal by Subject|0|||
131027765|NCT02525692|471733784|FG005|Overall Study|Withdrawal by Subject|1|||
130768392|NCT00603382|470775558|FG003|Overall Study|Lost to Follow-up|1|||
130904090|NCT00761150|471284102|FG002|Open-label Period|Adverse Event|0|||
130904091|NCT00761150|471284100|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
130904092|NCT00761150|471284101|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
130904093|NCT00761150|471284102|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
131027766|NCT02525692|471733779|FG000|Overall Study|Death|16|||
131027767|NCT02525692|471733780|FG001|Overall Study|Death|18|||
131027768|NCT02525692|471733781|FG002|Overall Study|Death|7|||
130904094|NCT00761150|471284100|FG000|Open-label Period|Lost to Follow-up|7|||
130904095|NCT00761150|471284101|FG001|Open-label Period|Lost to Follow-up|0|||
130904096|NCT00761150|471284102|FG002|Open-label Period|Lost to Follow-up|0|||
130904097|NCT00761150|471284100|FG000|Open-label Period|Lack of Efficacy|4|||
131027769|NCT02525692|471733782|FG003|Overall Study|Death|20|||
130694566|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694567|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694568|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
131027770|NCT02525692|471733783|FG004|Overall Study|Death|3|||
131027771|NCT02525692|471733784|FG005|Overall Study|Death|6|||
131027772|NCT02525692|471733779|FG000|Overall Study|Lost to Follow-up|0|||
130694569|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130694570|NCT00112437|470505916|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694571|NCT00112437|470505917|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694572|NCT00112437|470505918|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694573|NCT00112437|470505919|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694574|NCT00112437|470505920|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694575|NCT00112437|470505921|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694576|NCT00112437|470505922|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694577|NCT00112437|470505923|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694578|NCT00112437|470505924|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694579|NCT00112437|470505925|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694580|NCT00112437|470505926|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
130694581|NCT00112437|470505927|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
130694582|NCT00112437|470505928|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694583|NCT00112437|470505929|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694584|NCT00112437|470505930|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694585|NCT00112437|470505931|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694586|NCT00112437|470505932|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694587|NCT00112437|470505933|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694588|NCT00112437|470505934|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694589|NCT00112437|470505935|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694590|NCT00112437|470505936|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694591|NCT00112437|470505937|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694592|NCT00112437|470505938|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694593|NCT00112437|470505939|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694594|NCT00112437|470505940|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694595|NCT00112437|470505941|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130694596|NCT00112437|470505916|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694597|NCT00112437|470505917|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694598|NCT00112437|470505918|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694599|NCT00112437|470505919|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694600|NCT00112437|470505920|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694601|NCT00112437|470505921|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694602|NCT00112437|470505922|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694603|NCT00112437|470505923|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694604|NCT00112437|470505924|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694605|NCT00112437|470505925|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694606|NCT00112437|470505926|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694607|NCT00112437|470505927|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694608|NCT00112437|470505928|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694609|NCT00112437|470505929|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694610|NCT00112437|470505930|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694611|NCT00112437|470505931|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694612|NCT00112437|470505932|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694613|NCT00112437|470505933|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694614|NCT00112437|470505934|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694615|NCT00112437|470505935|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694616|NCT00112437|470505936|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
130694617|NCT00112437|470505937|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
130694618|NCT00112437|470505938|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694619|NCT00112437|470505939|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694620|NCT00112437|470505940|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694621|NCT00112437|470505941|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130694622|NCT00112437|470505916|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694623|NCT00112437|470505917|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130768393|NCT00603382|470775559|FG004|Overall Study|Lost to Follow-up|0|||
131027773|NCT02525692|471733780|FG001|Overall Study|Lost to Follow-up|0|||
131027774|NCT02525692|471733781|FG002|Overall Study|Lost to Follow-up|1|||
131027775|NCT02525692|471733782|FG003|Overall Study|Lost to Follow-up|5|||
131027776|NCT02525692|471733783|FG004|Overall Study|Lost to Follow-up|0|||
131027777|NCT02525692|471733784|FG005|Overall Study|Lost to Follow-up|0|||
130694624|NCT00112437|470505918|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694625|NCT00112437|470505919|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694626|NCT00112437|470505920|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694627|NCT00112437|470505921|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694628|NCT00112437|470505922|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694629|NCT00112437|470505923|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694630|NCT00112437|470505924|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694631|NCT00112437|470505925|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694632|NCT00112437|470505926|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694633|NCT00112437|470505927|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694634|NCT00112437|470505928|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694635|NCT00112437|470505929|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694636|NCT00112437|470505930|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694637|NCT00112437|470505931|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694638|NCT00112437|470505932|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694639|NCT00112437|470505933|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694640|NCT00112437|470505934|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
131027778|NCT02396199|471733785|FG000|Overall Study|Lost to Follow-up|1|||
131027779|NCT02396199|471733785|FG000|Overall Study|Death|4|||
131027780|NCT05510232|471733786|FG000|Overall Study|Withdrawal by Subject|2|||
131027781|NCT05510232|471733787|FG001|Overall Study|Withdrawal by Subject|7|||
131027782|NCT05510232|471733788|FG002|Overall Study|Withdrawal by Subject|6|||
131027783|NCT02349412|471733799|FG000|Overall Study|Withdrawal by Subject|7|||
131027784|NCT02349412|471733800|FG001|Overall Study|Withdrawal by Subject|7|||
131027785|NCT04337372|471733801|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
131027786|NCT04337372|471733802|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
131027787|NCT04337372|471733803|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
131027788|NCT04337372|471733804|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
131027789|NCT04337372|471733801|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
131027790|NCT04337372|471733802|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
131027791|NCT04337372|471733803|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
131027792|NCT04337372|471733804|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
131027793|NCT04337372|471733801|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
131027794|NCT04337372|471733802|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
131027795|NCT04337372|471733803|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
131027796|NCT04337372|471733804|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
131027797|NCT04337372|471733801|FG000|Day 2: EEG Measures|Protocol Violation|6|||
131027798|NCT04337372|471733802|FG001|Day 2: EEG Measures|Protocol Violation|6|||
131027799|NCT04337372|471733803|FG002|Day 2: EEG Measures|Protocol Violation|5|||
131027800|NCT04337372|471733804|FG003|Day 2: EEG Measures|Protocol Violation|17|||
131027801|NCT05307783|471733805|FG000|Overall Study|Death|7|||
131027802|NCT05307783|471733805|FG000|Overall Study|Lost to Follow-up|4|||
131027803|NCT04883645|471733806|FG000|Overall Study|Death|1|||
131027804|NCT03460236|471733807|FG000|Overall Study|failed radiographic screening|16|||
131027805|NCT03460236|471733807|FG000|Overall Study|Withdrawal by Subject|11|||
131027806|NCT00979576|471733810|FG000|Combination Treatment Phase|Progressive disease|3|||
131027807|NCT00979576|471733811|FG001|Combination Treatment Phase|Progressive disease|1|||
131027808|NCT00979576|471733812|FG002|Combination Treatment Phase|Progressive disease|5|||
131027809|NCT00979576|471733810|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
131027810|NCT00979576|471733811|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
131027811|NCT00979576|471733812|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
131027812|NCT00979576|471733810|FG000|Combination Treatment Phase|Adverse Event|0|||
131027813|NCT00979576|471733811|FG001|Combination Treatment Phase|Adverse Event|2|||
131027814|NCT00979576|471733812|FG002|Combination Treatment Phase|Adverse Event|2|||
131027815|NCT00979576|471733810|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
131027816|NCT00979576|471733811|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
131027817|NCT00979576|471733812|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
131027818|NCT04855760|471733813|FG000|Overall Study|Adverse Event|21|||
131027819|NCT04855760|471733813|FG000|Overall Study|Withdrawal by Subject|116|||
131027820|NCT04855760|471733813|FG000|Overall Study|Lack of Efficacy|21|||
131027821|NCT04855760|471733813|FG000|Overall Study|Lost to Follow-up|49|||
131027822|NCT04855760|471733813|FG000|Overall Study|Protocol Violation|2|||
131027823|NCT04855760|471733813|FG000|Overall Study|Physician Decision|5|||
131027824|NCT04855760|471733813|FG000|Overall Study|Pregnancy|1|||
131027825|NCT04855760|471733813|FG000|Overall Study|Non-Compliance with Study Drug|11|||
130768394|NCT00603382|470775560|FG005|Overall Study|Lost to Follow-up|1|||
131027826|NCT04855760|471733813|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
131027827|NCT04855760|471733813|FG000|Overall Study|Study Completed by Sponsor|202|||
131027828|NCT04855760|471733813|FG000|Overall Study|Other|13|||
131027829|NCT04840199|471733816|FG000|Overall Study|Study Terminated by Sponsor|8|||
131027830|NCT04840199|471733817|FG001|Overall Study|Study Terminated by Sponsor|9|||
130904098|NCT00761150|471284101|FG001|Open-label Period|Lack of Efficacy|0|||
130904099|NCT00761150|471284102|FG002|Open-label Period|Lack of Efficacy|0|||
130904100|NCT00761150|471284100|FG000|Open-label Period|Withdrawal by Subject|5|||
130904101|NCT00761150|471284101|FG001|Open-label Period|Withdrawal by Subject|0|||
130904102|NCT00761150|471284102|FG002|Open-label Period|Withdrawal by Subject|0|||
130904103|NCT00761150|471284100|FG000|Open-label Period|Noncompliance|2|||
130904104|NCT00761150|471284101|FG001|Open-label Period|Noncompliance|0|||
130904105|NCT00761150|471284102|FG002|Open-label Period|Noncompliance|0|||
130904106|NCT00761150|471284100|FG000|Open-label Period|Other|5|||
130904107|NCT00761150|471284101|FG001|Open-label Period|Other|0|||
130904108|NCT00761150|471284102|FG002|Open-label Period|Other|0|||
130904109|NCT00761150|471284100|FG000|Double-blind Period|Lack of Efficacy|0|||
130904110|NCT00761150|471284101|FG001|Double-blind Period|Lack of Efficacy|2|||
130904111|NCT00761150|471284102|FG002|Double-blind Period|Lack of Efficacy|19|||
130904112|NCT00761150|471284100|FG000|Double-blind Period|Adverse Event|0|||
130904113|NCT00761150|471284101|FG001|Double-blind Period|Adverse Event|3|||
130904114|NCT00761150|471284102|FG002|Double-blind Period|Adverse Event|3|||
130904115|NCT00761150|471284100|FG000|Double-blind Period|Withdrawal by Subject|0|||
130904116|NCT00761150|471284101|FG001|Double-blind Period|Withdrawal by Subject|3|||
130904117|NCT00761150|471284102|FG002|Double-blind Period|Withdrawal by Subject|2|||
130904118|NCT00761150|471284100|FG000|Double-blind Period|Lost to Follow-up|0|||
130904119|NCT00761150|471284101|FG001|Double-blind Period|Lost to Follow-up|2|||
130904120|NCT00761150|471284102|FG002|Double-blind Period|Lost to Follow-up|1|||
130904121|NCT00761150|471284100|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
130904122|NCT00761150|471284101|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
130904123|NCT00761150|471284102|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
130904124|NCT00761150|471284100|FG000|Double-blind Period|Noncompliance|0|||
130904125|NCT00761150|471284101|FG001|Double-blind Period|Noncompliance|1|||
130904126|NCT00761150|471284102|FG002|Double-blind Period|Noncompliance|0|||
130904127|NCT00761150|471284100|FG000|Double-blind Period|Other|0|||
130904128|NCT00761150|471284101|FG001|Double-blind Period|Other|3|||
130904129|NCT00761150|471284102|FG002|Double-blind Period|Other|3|||
130904130|NCT02692651|471284103|FG000|Study Treatment|Death|7|||
130904131|NCT02692651|471284104|FG001|Study Treatment|Death|3|||
130904132|NCT02692651|471284103|FG000|Study Treatment|comfort care|1|||
130904133|NCT02692651|471284104|FG001|Study Treatment|comfort care|1|||
130904134|NCT02692651|471284103|FG000|Study Treatment|Protocol violation per treating team preference|8|||
130904135|NCT02692651|471284104|FG001|Study Treatment|Protocol violation per treating team preference|6|||
130904136|NCT02692651|471284103|FG000|Post Study Treatment Follow-up|Death|4|||
130904137|NCT02692651|471284104|FG001|Post Study Treatment Follow-up|Death|4|||
130904138|NCT02480712|471284105|FG000|Overall Study|Enrolled but Never Treated|1|||
130904139|NCT02480712|471284105|FG000|Overall Study|Lost to Follow-up|5|||
130904140|NCT02480712|471284105|FG000|Overall Study|Withdrew Consent|3|||
130904141|NCT02480712|471284105|FG000|Overall Study|Death|1|||
131027831|NCT04840199|471733816|FG000|Overall Study|Lost to Follow-up|0|||
131027832|NCT04840199|471733817|FG001|Overall Study|Lost to Follow-up|2|||
131027833|NCT04840199|471733816|FG000|Overall Study|Withdrawal by Subject|2|||
131027834|NCT04840199|471733817|FG001|Overall Study|Withdrawal by Subject|0|||
131027835|NCT04840199|471733816|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
131027836|NCT04840199|471733817|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
131027837|NCT04869982|471733820|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
131027838|NCT04869982|471733821|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
131027839|NCT04869982|471733820|FG000|Overall Study|Migrated / moved from the study area|1|||
131027840|NCT04869982|471733821|FG001|Overall Study|Migrated / moved from the study area|1|||
131027841|NCT04869982|471733820|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
131027842|NCT04869982|471733821|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
131027843|NCT04869982|471733820|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
131027844|NCT04869982|471733821|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
131027845|NCT04869982|471733820|FG000|Overall Study|Solicited adverse event|2|||
131027846|NCT04869982|471733821|FG001|Overall Study|Solicited adverse event|1|||
131027847|NCT01631214|471733822|FG000|Overall Study|Withdrawal by Subject|276|||
131027848|NCT01631214|471733823|FG001|Overall Study|Withdrawal by Subject|290|||
131027849|NCT01631214|471733822|FG000|Overall Study|Death|113|||
131027850|NCT01631214|471733823|FG001|Overall Study|Death|106|||
131027851|NCT01631214|471733822|FG000|Overall Study|Lost to Follow-up|54|||
131027852|NCT01631214|471733823|FG001|Overall Study|Lost to Follow-up|40|||
130904142|NCT02480712|471284105|FG000|Overall Study|Lack of Efficacy|1|||
130904143|NCT00475423|471284106|FG000|Overall Study|Protocol Violation|5|||
130904144|NCT00475423|471284106|FG000|Overall Study|Adverse Event|4|||
130904145|NCT00475423|471284106|FG000|Overall Study|Withdrawal by Subject|6|||
130904146|NCT00475423|471284106|FG000|Overall Study|Lack of Efficacy|8|||
130904147|NCT00475423|471284106|FG000|Overall Study|Death|1|||
131027853|NCT01631214|471733822|FG000|Overall Study|Adverse Event|45|||
131027854|NCT01631214|471733823|FG001|Overall Study|Adverse Event|45|||
131027855|NCT01631214|471733822|FG000|Overall Study|Other|22|||
131113993|NCT03078907|472048961|FG000|Overall Study|Adverse Event|2|||
130904148|NCT00475423|471284106|FG000|Overall Study|Reason not specified|1|||
130904149|NCT00475423|471284106|FG000|Overall Study|Lost to Follow-up|7|||
130904150|NCT00046891|471284107|FG000|Overall Study|Cancels|5|||
130904151|NCT00046891|471284108|FG001|Overall Study|Cancels|9|||
130904152|NCT00046891|471284107|FG000|Overall Study|Ineligible|1|||
130904153|NCT00046891|471284108|FG001|Overall Study|Ineligible|1|||
130904154|NCT00046891|471284107|FG000|Overall Study|Withdrawal by Subject|18|||
130904155|NCT00046891|471284108|FG001|Overall Study|Withdrawal by Subject|15|||
130904156|NCT00046891|471284107|FG000|Overall Study|Adverse Event|5|||
130904157|NCT00046891|471284108|FG001|Overall Study|Adverse Event|5|||
130904158|NCT02496676|471284109|FG000|Phase 1 - Period 1|Adverse Event|0|||
130904159|NCT02496676|471284110|FG001|Phase 1 - Period 1|Adverse Event|1|||
130904160|NCT02496676|471284109|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
130904161|NCT02496676|471284110|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
130904162|NCT04381988|471284121|FG000|Overall Study|The study was terminated|4|||
130904163|NCT04381988|471284122|FG001|Overall Study|The study was terminated|0|||
130904164|NCT01107379|471284123|FG000|Overall Study|Withdrawal by Subject|18|||
130904165|NCT01107379|471284123|FG000|Overall Study|Lost to Follow-up|3|||
130904166|NCT00609362|471284124|FG000|Overall Study|Withdrawal by Subject|2|||
130904167|NCT00609362|471284125|FG001|Overall Study|Withdrawal by Subject|1|||
130904168|NCT00609362|471284124|FG000|Overall Study|Adverse Event|1|||
130904169|NCT00609362|471284125|FG001|Overall Study|Adverse Event|0|||
130904170|NCT04559529|471284126|FG000|First Intervention (1 Day)|Adverse Event|0|||
130904171|NCT04559529|471284127|FG001|First Intervention (1 Day)|Adverse Event|0|||
130904172|NCT04559529|471284128|FG002|First Intervention (1 Day)|Adverse Event|0|||
130904173|NCT04559529|471284129|FG003|First Intervention (1 Day)|Adverse Event|1|||
130904174|NCT04559529|471284126|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
130904175|NCT04559529|471284127|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
130904176|NCT04559529|471284128|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
130904177|NCT04559529|471284129|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
130904178|NCT04559529|471284126|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
130904179|NCT04559529|471284127|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
130904180|NCT04559529|471284128|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
130904181|NCT04559529|471284129|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
130904182|NCT01009281|471284130|FG000|Overall Study|Administrative problems|7|||
130904183|NCT00548405|471284131|FG000|Overall Study|Adverse Event|6|||
130904184|NCT00548405|471284132|FG001|Overall Study|Adverse Event|2|||
130904185|NCT00548405|471284133|FG002|Overall Study|Adverse Event|0|||
130904186|NCT00548405|471284131|FG000|Overall Study|Lack of Efficacy|6|||
130904187|NCT00548405|471284132|FG001|Overall Study|Lack of Efficacy|0|||
130904188|NCT00548405|471284133|FG002|Overall Study|Lack of Efficacy|0|||
130904189|NCT00548405|471284131|FG000|Overall Study|Physician Decision|3|||
130904190|NCT00548405|471284132|FG001|Overall Study|Physician Decision|4|||
130904191|NCT00548405|471284133|FG002|Overall Study|Physician Decision|1|||
130904192|NCT00548405|471284131|FG000|Overall Study|Pregnancy|1|||
130904193|NCT00548405|471284132|FG001|Overall Study|Pregnancy|0|||
130904194|NCT00548405|471284133|FG002|Overall Study|Pregnancy|0|||
130904195|NCT00548405|471284131|FG000|Overall Study|Protocol Violation|1|||
130904196|NCT00548405|471284132|FG001|Overall Study|Protocol Violation|0|||
130904197|NCT00548405|471284133|FG002|Overall Study|Protocol Violation|0|||
130904198|NCT00548405|471284131|FG000|Overall Study|Withdrawal by Subject|36|||
130904199|NCT00548405|471284132|FG001|Overall Study|Withdrawal by Subject|12|||
130904200|NCT00548405|471284133|FG002|Overall Study|Withdrawal by Subject|5|||
130904201|NCT00548405|471284131|FG000|Overall Study|Lost to Follow-up|1|||
130904202|NCT00548405|471284132|FG001|Overall Study|Lost to Follow-up|1|||
131113994|NCT03078907|472048962|FG001|Overall Study|Adverse Event|0|||
131113995|NCT03078907|472048961|FG000|Overall Study|Other|1|||
131113996|NCT03078907|472048962|FG001|Overall Study|Other|0|||
131113997|NCT03078907|472048961|FG000|Overall Study|Protocol Violation|0|||
131113998|NCT03078907|472048962|FG001|Overall Study|Protocol Violation|1|||
130904203|NCT00548405|471284133|FG002|Overall Study|Lost to Follow-up|2|||
130904204|NCT00548405|471284131|FG000|Overall Study|Death|0|||
130904205|NCT00548405|471284132|FG001|Overall Study|Death|1|||
130904206|NCT00548405|471284133|FG002|Overall Study|Death|1|||
130904207|NCT00548405|471284131|FG000|Overall Study|Sponsor decision|1|||
130904208|NCT00548405|471284132|FG001|Overall Study|Sponsor decision|0|||
130904209|NCT00548405|471284133|FG002|Overall Study|Sponsor decision|0|||
130904210|NCT00548405|471284131|FG000|Overall Study|Randomized but not treated|1|||
130904211|NCT00548405|471284132|FG001|Overall Study|Randomized but not treated|0|||
130904212|NCT00548405|471284133|FG002|Overall Study|Randomized but not treated|0|||
130904213|NCT02582684|471284135|FG000|Overall Study|Unable to contact subject/parent|4|||
130904214|NCT02582684|471284135|FG000|Overall Study|Subject not able to get to clinic|10|||
130904215|NCT02582684|471284135|FG000|Overall Study|Subject withdrew consent|1|||
130904216|NCT02582684|471284135|FG000|Overall Study|Found to be ineligible after enrollment|2|||
130904217|NCT03025035|471284136|FG000|Overall Study|Death|2|||
130985458|NCT02889133|471572912|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
131113999|NCT03338192|472048963|FG000|Year One to Year Two|High Blood Pressure|7|||
130904218|NCT03025035|471284136|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
130904219|NCT02048241|471284137|FG000|Overall Study|Withdrawal by Subject|0|||
130904220|NCT02048241|471284138|FG001|Overall Study|Withdrawal by Subject|1|||
130904221|NCT00402233|471284139|FG000|Overall Study|Adverse Event|1|||
130904222|NCT00402233|471284140|FG001|Overall Study|Adverse Event|7|||
130904223|NCT00402233|471284141|FG002|Overall Study|Adverse Event|9|||
130904224|NCT00402233|471284142|FG003|Overall Study|Adverse Event|9|||
130904225|NCT00402233|471284139|FG000|Overall Study|Protocol Violation|0|||
130904226|NCT00402233|471284140|FG001|Overall Study|Protocol Violation|1|||
130904227|NCT00402233|471284141|FG002|Overall Study|Protocol Violation|0|||
130904228|NCT00402233|471284142|FG003|Overall Study|Protocol Violation|0|||
130904229|NCT00402233|471284139|FG000|Overall Study|Withdrawal by Subject|2|||
130904230|NCT00402233|471284140|FG001|Overall Study|Withdrawal by Subject|1|||
130904231|NCT00402233|471284141|FG002|Overall Study|Withdrawal by Subject|2|||
130904232|NCT00402233|471284142|FG003|Overall Study|Withdrawal by Subject|2|||
130904233|NCT00402233|471284139|FG000|Overall Study|Worsening of disease under study|2|||
130904234|NCT00402233|471284140|FG001|Overall Study|Worsening of disease under study|0|||
130904235|NCT00402233|471284141|FG002|Overall Study|Worsening of disease under study|0|||
130904236|NCT00402233|471284142|FG003|Overall Study|Worsening of disease under study|0|||
130904237|NCT00402233|471284139|FG000|Overall Study|Worsening of other pre-existing disease|0|||
130904238|NCT00402233|471284140|FG001|Overall Study|Worsening of other pre-existing disease|1|||
130904239|NCT00402233|471284141|FG002|Overall Study|Worsening of other pre-existing disease|0|||
130904240|NCT00402233|471284142|FG003|Overall Study|Worsening of other pre-existing disease|0|||
130904241|NCT04658940|471284143|FG000|Overall Study|Withdrawal by Subject|1|||
130904242|NCT03579602|471284144|FG000|Overall Study|Subject unable to receive study drug|0|||
130904243|NCT03579602|471284145|FG001|Overall Study|Subject unable to receive study drug|2|||
130904244|NCT03579602|471284144|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
130904245|NCT03579602|471284145|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
130904246|NCT02518464|471284146|FG000|Overall Study|Adverse Event|2|||
130904247|NCT01120067|471284147|FG000|Overall Study|Lost to Follow-up|3|||
130904248|NCT01120067|471284148|FG001|Overall Study|Lost to Follow-up|1|||
130904249|NCT01120067|471284147|FG000|Overall Study|fail to engage >3 sessions|2|||
130904250|NCT01120067|471284148|FG001|Overall Study|fail to engage >3 sessions|0|||
130904251|NCT00266877|471284149|FG000|Overall Study|Death|1|||
130904252|NCT00266877|471284150|FG001|Overall Study|Death|1|||
130904253|NCT00266877|471284151|FG002|Overall Study|Death|1|||
130904254|NCT00266877|471284149|FG000|Overall Study|Adverse Event|6|||
130904255|NCT00266877|471284150|FG001|Overall Study|Adverse Event|4|||
130904256|NCT00266877|471284151|FG002|Overall Study|Adverse Event|1|||
130904257|NCT00266877|471284149|FG000|Overall Study|Physician Decision|2|||
130904258|NCT00266877|471284150|FG001|Overall Study|Physician Decision|1|||
130904259|NCT00266877|471284151|FG002|Overall Study|Physician Decision|1|||
130904260|NCT00266877|471284149|FG000|Overall Study|Withdrawal by Subject|3|||
130904261|NCT00266877|471284150|FG001|Overall Study|Withdrawal by Subject|1|||
130904262|NCT00266877|471284151|FG002|Overall Study|Withdrawal by Subject|1|||
130904263|NCT00266877|471284149|FG000|Overall Study|Disease Progression|72|||
130904264|NCT00266877|471284150|FG001|Overall Study|Disease Progression|37|||
130904265|NCT00266877|471284151|FG002|Overall Study|Disease Progression|23|||
130904266|NCT00266877|471284149|FG000|Overall Study|Symptomatic Deterioration|6|||
130904267|NCT00266877|471284150|FG001|Overall Study|Symptomatic Deterioration|3|||
130904268|NCT00266877|471284151|FG002|Overall Study|Symptomatic Deterioration|1|||
130904269|NCT00266877|471284149|FG000|Overall Study|Hospitalization|1|||
131114000|NCT03338192|472048964|FG001|Year One to Year Two|High Blood Pressure|1|||
131114001|NCT03338192|472048963|FG000|Year One to Year Two|HIV +|1|||
131114002|NCT03338192|472048964|FG001|Year One to Year Two|HIV +|0|||
131114003|NCT03338192|472048963|FG000|Year Two to Year Four|High Blood Pressure|1|||
131114004|NCT03338192|472048964|FG001|Year Two to Year Four|High Blood Pressure|0|||
130904270|NCT00266877|471284150|FG001|Overall Study|Hospitalization|0|||
130904271|NCT00266877|471284151|FG002|Overall Study|Hospitalization|0|||
130904272|NCT00266877|471284149|FG000|Overall Study|Concomitant Radiotherapy|0|||
130904273|NCT00266877|471284150|FG001|Overall Study|Concomitant Radiotherapy|1|||
130904274|NCT00266877|471284151|FG002|Overall Study|Concomitant Radiotherapy|0|||
130904275|NCT03985878|471284153|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
130904276|NCT03985878|471284153|FG000|Overall Study|Study Terminated by Sponsor|12|||
130904277|NCT03985878|471284153|FG000|Overall Study|Withdrawal by Subject|1|||
130904278|NCT00278915|471284156|FG000|Overall Study|Disease progression|1|||
130904279|NCT02520089|471284157|FG000|Overall Study|Lost to Follow-up|3|||
130904280|NCT02520089|471284158|FG001|Overall Study|Lost to Follow-up|4|||
130904281|NCT03473548|471284161|FG000|Overall Study|Did not attempt HST testing|3|||
130904282|NCT03473548|471284162|FG001|Overall Study|Did not attempt HST testing|0|||
130904283|NCT00129311|471284164|FG000|Overall Study|Withdrawal by Subject|12|||
130904284|NCT00129311|471284165|FG001|Overall Study|Withdrawal by Subject|19|||
130904285|NCT02232880|471284166|FG000|Overall Study|study stopped prior to randomization|1|||
130904286|NCT02545543|471284167|FG000|Overall Study|Lost to Follow-up|67|||
130904287|NCT02545543|471284168|FG001|Overall Study|Lost to Follow-up|25|||
131027856|NCT01631214|471733823|FG001|Overall Study|Other|19|||
131027857|NCT01631214|471733822|FG000|Overall Study|Noncompliance|16|||
131027858|NCT01631214|471733823|FG001|Overall Study|Noncompliance|15|||
131027859|NCT01631214|471733822|FG000|Overall Study|Requirement for Alternative Therapy|8|||
131027860|NCT01631214|471733823|FG001|Overall Study|Requirement for Alternative Therapy|3|||
130904288|NCT02545543|471284167|FG000|Overall Study|Physician Decision|3|||
130904289|NCT02545543|471284168|FG001|Overall Study|Physician Decision|0|||
130904290|NCT02545543|471284167|FG000|Overall Study|Withdrawal by Subject|9|||
130904291|NCT02545543|471284168|FG001|Overall Study|Withdrawal by Subject|8|||
130904292|NCT02545543|471284167|FG000|Overall Study|Noncomplaince|1|||
130904293|NCT02545543|471284168|FG001|Overall Study|Noncomplaince|0|||
130904294|NCT02545543|471284167|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
131027861|NCT01631214|471733822|FG000|Overall Study|Protocol Deviation|4|||
131027862|NCT01631214|471733823|FG001|Overall Study|Protocol Deviation|3|||
130904295|NCT02545543|471284168|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
130904296|NCT02829944|471284172|FG000|Overall Study|Physician Decision|0|||
130904297|NCT02829944|471284173|FG001|Overall Study|Physician Decision|1|||
130904298|NCT02829944|471284172|FG000|Overall Study|Screen Failure|2|||
130904299|NCT02829944|471284173|FG001|Overall Study|Screen Failure|2|||
130904300|NCT02829944|471284172|FG000|Overall Study|Inadequate Neuraxial Block|1|||
130904301|NCT02829944|471284173|FG001|Overall Study|Inadequate Neuraxial Block|1|||
130904302|NCT02829944|471284172|FG000|Overall Study|Withdrawal by Subject|2|||
130904303|NCT02829944|471284173|FG001|Overall Study|Withdrawal by Subject|1|||
130904304|NCT02829944|471284172|FG000|Overall Study|Catheter Displacement|1|||
130904305|NCT02829944|471284173|FG001|Overall Study|Catheter Displacement|0|||
130904306|NCT02829944|471284172|FG000|Overall Study|Catheter broke|0|||
130904307|NCT02829944|471284173|FG001|Overall Study|Catheter broke|1|||
130904308|NCT02829944|471284172|FG000|Overall Study|Staff unavailable|0|||
131027863|NCT01631214|471733822|FG000|Overall Study|Ineligibility determined|5|||
130904309|NCT02829944|471284173|FG001|Overall Study|Staff unavailable|1|||
130904310|NCT00336583|471285468|FG000|Overall Study|Lost to Follow-up|1|||
130904311|NCT00336583|471285468|FG000|Overall Study|Death|1|||
130904312|NCT00910247|471285469|FG000|Overall Study|Adverse Event|15|||
130904313|NCT00910247|471285469|FG000|Overall Study|Death|2|||
131027864|NCT01631214|471733823|FG001|Overall Study|Ineligibility determined|2|||
131027865|NCT01631214|471733822|FG000|Overall Study|Administrative Decision|1|||
131027866|NCT01631214|471733823|FG001|Overall Study|Administrative Decision|0|||
131027867|NCT04143061|471733824|FG000|Overall Study|Protocol Deviation|0|||
131027868|NCT04143061|471733825|FG001|Overall Study|Protocol Deviation|0|||
131027869|NCT04143061|471733826|FG002|Overall Study|Protocol Deviation|0|||
131027870|NCT04143061|471733827|FG003|Overall Study|Protocol Deviation|0|||
131027871|NCT04143061|471733828|FG004|Overall Study|Protocol Deviation|0|||
131027872|NCT04143061|471733829|FG005|Overall Study|Protocol Deviation|0|||
131027873|NCT04143061|471733830|FG006|Overall Study|Protocol Deviation|5|||
131027874|NCT04143061|471733831|FG007|Overall Study|Protocol Deviation|5|||
131027875|NCT04143061|471733824|FG000|Overall Study|Withdrawal by Subject|2|||
131027876|NCT04143061|471733825|FG001|Overall Study|Withdrawal by Subject|0|||
131027877|NCT04143061|471733826|FG002|Overall Study|Withdrawal by Subject|0|||
131027878|NCT04143061|471733827|FG003|Overall Study|Withdrawal by Subject|0|||
131027879|NCT04143061|471733828|FG004|Overall Study|Withdrawal by Subject|0|||
131027880|NCT04143061|471733829|FG005|Overall Study|Withdrawal by Subject|1|||
131027881|NCT04143061|471733830|FG006|Overall Study|Withdrawal by Subject|0|||
131027882|NCT04143061|471733831|FG007|Overall Study|Withdrawal by Subject|0|||
131027883|NCT04143061|471733824|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131027884|NCT04143061|471733825|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131027885|NCT04143061|471733826|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131027886|NCT04143061|471733827|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131027887|NCT04143061|471733828|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
131027888|NCT04143061|471733829|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
131027889|NCT04143061|471733830|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
131027890|NCT04143061|471733831|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
131027891|NCT03602014|471733832|FG000|Overall Study|Lost to Follow-up|2|||
131027892|NCT03602014|471733833|FG001|Overall Study|Lost to Follow-up|0|||
131027893|NCT03602014|471733834|FG002|Overall Study|Lost to Follow-up|0|||
131027894|NCT06023082|471733838|FG000|Overall Study|Withdrawal by Subject|2|||
131027895|NCT06023082|471733838|FG000|Overall Study|Lost to Follow-up|15|||
131027896|NCT06023082|471733838|FG000|Overall Study|Side effects|5|||
130904314|NCT00910247|471285469|FG000|Overall Study|Lost to Follow-up|10|||
130904315|NCT00910247|471285469|FG000|Overall Study|Physician Decision|3|||
130904316|NCT00910247|471285469|FG000|Overall Study|Protocol Violation|10|||
130904317|NCT00910247|471285469|FG000|Overall Study|Withdrawal by Subject|25|||
130904318|NCT00910247|471285469|FG000|Overall Study|Not collected|4|||
130904319|NCT02927067|471285470|FG000|Overall Study|Withdrawn Consent|20|||
130904320|NCT02927067|471285471|FG001|Overall Study|Withdrawn Consent|12|||
130904321|NCT02927067|471285470|FG000|Overall Study|Death|18|||
130904322|NCT02927067|471285471|FG001|Overall Study|Death|31|||
130904323|NCT02927067|471285470|FG000|Overall Study|Adverse Event|13|||
130904324|NCT02927067|471285471|FG001|Overall Study|Adverse Event|10|||
130904325|NCT02927067|471285470|FG000|Overall Study|Noncompliance|5|||
130904326|NCT02927067|471285471|FG001|Overall Study|Noncompliance|2|||
130904327|NCT02927067|471285470|FG000|Overall Study|Reason not Specified|4|||
130904328|NCT02927067|471285471|FG001|Overall Study|Reason not Specified|6|||
130904329|NCT01727700|471285474|FG000|Overall Study|Adverse Event|0|||
130904330|NCT01727700|471285475|FG001|Overall Study|Adverse Event|7|||
130904331|NCT01727700|471285476|FG002|Overall Study|Adverse Event|1|||
130904332|NCT01727700|471285474|FG000|Overall Study|Particpant withdrew consent|0|||
130904333|NCT01727700|471285475|FG001|Overall Study|Particpant withdrew consent|3|||
130904334|NCT01727700|471285476|FG002|Overall Study|Particpant withdrew consent|1|||
130904335|NCT01727700|471285474|FG000|Overall Study|Protocol Violation|2|||
130904336|NCT01727700|471285475|FG001|Overall Study|Protocol Violation|0|||
130904337|NCT01727700|471285476|FG002|Overall Study|Protocol Violation|0|||
130904338|NCT01757691|471285480|FG000|Overall Study|Administrative problems|2|||
130904339|NCT01757691|471285481|FG001|Overall Study|Administrative problems|0|||
130904340|NCT02054481|471285484|FG000|Overall Study|Adverse Event|1|||
130904341|NCT02054481|471285485|FG001|Overall Study|Adverse Event|1|||
130904342|NCT02054481|471285486|FG002|Overall Study|Adverse Event|0|||
130904343|NCT02054481|471285487|FG003|Overall Study|Adverse Event|1|||
130904344|NCT02054481|471285484|FG000|Overall Study|Lost to Follow-up|1|||
130904345|NCT02054481|471285485|FG001|Overall Study|Lost to Follow-up|0|||
130904346|NCT02054481|471285486|FG002|Overall Study|Lost to Follow-up|0|||
130904347|NCT02054481|471285487|FG003|Overall Study|Lost to Follow-up|0|||
130904348|NCT02054481|471285484|FG000|Overall Study|Other reason|2|||
130904349|NCT02054481|471285485|FG001|Overall Study|Other reason|1|||
130904350|NCT02054481|471285486|FG002|Overall Study|Other reason|2|||
130904351|NCT02054481|471285487|FG003|Overall Study|Other reason|0|||
130904352|NCT02320903|471285488|FG000|Overall Study|Withdrawal by Subject|0|||
130904353|NCT02320903|471285489|FG001|Overall Study|Withdrawal by Subject|9|||
130904354|NCT02320903|471285490|FG002|Overall Study|Withdrawal by Subject|9|||
130904355|NCT02320903|471285488|FG000|Overall Study|Exited therapy; no longer eligible|8|||
130904356|NCT02320903|471285489|FG001|Overall Study|Exited therapy; no longer eligible|2|||
130904357|NCT02320903|471285490|FG002|Overall Study|Exited therapy; no longer eligible|2|||
130904358|NCT02320903|471285488|FG000|Overall Study|Lost to Follow-up|0|||
130904359|NCT02320903|471285489|FG001|Overall Study|Lost to Follow-up|5|||
130904360|NCT02320903|471285490|FG002|Overall Study|Lost to Follow-up|5|||
130904361|NCT03361176|471285495|FG000|Overall Study|Lost to Follow-up|1|||
130904362|NCT03361176|471285496|FG001|Overall Study|Lost to Follow-up|2|||
130904363|NCT03361176|471285495|FG000|Overall Study|Adverse Event|0|||
130694641|NCT00112437|470505935|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694642|NCT00112437|470505936|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
130694643|NCT00112437|470505937|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694644|NCT00112437|470505938|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694645|NCT00112437|470505939|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130904364|NCT03361176|471285496|FG001|Overall Study|Adverse Event|2|||
130904365|NCT03361176|471285495|FG000|Overall Study|Withdrawal by Subject|0|||
130904366|NCT03361176|471285496|FG001|Overall Study|Withdrawal by Subject|1|||
130904367|NCT03718299|471285497|FG000|Overall Study|Adverse Event|1|||
130904368|NCT03718299|471285497|FG000|Overall Study|Withdrawal by Subject|6|||
130904369|NCT03718299|471285497|FG000|Overall Study|Physician Decision|2|||
130904370|NCT03718299|471285497|FG000|Overall Study|Lost to Follow-up|1|||
130904371|NCT01992159|471285498|FG000|Overall Study|Withdrawal by Subject|4|||
130904372|NCT01992159|471285499|FG001|Overall Study|Withdrawal by Subject|7|||
130904373|NCT01992159|471285500|FG002|Overall Study|Withdrawal by Subject|0|||
130904374|NCT01992159|471285501|FG003|Overall Study|Withdrawal by Subject|3|||
130904375|NCT01992159|471285498|FG000|Overall Study|Adverse Event|0|||
130904376|NCT01992159|471285499|FG001|Overall Study|Adverse Event|1|||
130694646|NCT00112437|470505940|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130904377|NCT01992159|471285500|FG002|Overall Study|Adverse Event|0|||
130904378|NCT01992159|471285501|FG003|Overall Study|Adverse Event|1|||
130904379|NCT01992159|471285498|FG000|Overall Study|Death|0|||
130904380|NCT01992159|471285499|FG001|Overall Study|Death|0|||
130904381|NCT01992159|471285500|FG002|Overall Study|Death|1|||
130904382|NCT01992159|471285501|FG003|Overall Study|Death|0|||
130904383|NCT01205581|471285505|FG000|Overall Study|Withdrawal by Subject|1|||
130904384|NCT01205581|471285506|FG001|Overall Study|Withdrawal by Subject|0|||
130904385|NCT01205581|471285507|FG002|Overall Study|Withdrawal by Subject|0|||
130904386|NCT01205581|471285508|FG003|Overall Study|Withdrawal by Subject|0|||
130904387|NCT01205581|471285509|FG004|Overall Study|Withdrawal by Subject|0|||
130904388|NCT01205581|471285510|FG005|Overall Study|Withdrawal by Subject|0|||
130904389|NCT00640835|471285511|FG000|Overall Study|Adverse Event|5|||
130904390|NCT00640835|471285512|FG001|Overall Study|Adverse Event|3|||
130904391|NCT00640835|471285511|FG000|Overall Study|Withdrawal by Subject|12|||
130904392|NCT00640835|471285512|FG001|Overall Study|Withdrawal by Subject|14|||
130904393|NCT00640835|471285511|FG000|Overall Study|Physician Decision|10|||
130904394|NCT00640835|471285512|FG001|Overall Study|Physician Decision|14|||
130904395|NCT00640835|471285511|FG000|Overall Study|Sponsor's Decision|11|||
130904396|NCT00640835|471285512|FG001|Overall Study|Sponsor's Decision|7|||
130904397|NCT00640835|471285511|FG000|Overall Study|Protocol Violation|2|||
130904398|NCT00640835|471285512|FG001|Overall Study|Protocol Violation|2|||
130904399|NCT00640835|471285511|FG000|Overall Study|Lost to Follow-up|17|||
130904400|NCT00640835|471285512|FG001|Overall Study|Lost to Follow-up|13|||
130904401|NCT00640835|471285511|FG000|Overall Study|Other Reason|19|||
130904402|NCT00640835|471285512|FG001|Overall Study|Other Reason|4|||
130904403|NCT00713310|471285517|FG000|Overall Study|Adverse Event|5|||
130904404|NCT00713310|471285518|FG001|Overall Study|Adverse Event|2|||
130904405|NCT00713310|471285517|FG000|Overall Study|Lack of Efficacy|0|||
130904406|NCT00713310|471285518|FG001|Overall Study|Lack of Efficacy|2|||
130904407|NCT00713310|471285517|FG000|Overall Study|Withdrawal by Subject|0|||
130904408|NCT00713310|471285518|FG001|Overall Study|Withdrawal by Subject|2|||
130904409|NCT00686634|471285523|FG000|Overall Study|Protocol Violation|6|||
130904410|NCT02361580|471285526|FG000|Overall Study|Lost to Follow-up|6|||
130904411|NCT02361580|471285527|FG001|Overall Study|Lost to Follow-up|3|||
130904412|NCT00924781|471285528|FG000|Overall Study|Study terminated by sponsor|12|||
130904413|NCT00924781|471285529|FG001|Overall Study|Study terminated by sponsor|10|||
130904414|NCT00708201|471285530|FG000|Overall Study|Adverse Event|4|||
131114005|NCT03338192|472048963|FG000|Year Two to Year Four|HIV +|2|||
131114006|NCT03338192|472048964|FG001|Year Two to Year Four|HIV +|0|||
131114007|NCT03338192|472048963|FG000|Year Four to Year Six|High Blood Pressure|2|||
131114008|NCT03338192|472048964|FG001|Year Four to Year Six|High Blood Pressure|1|||
130768395|NCT00603382|470775555|FG000|Overall Study|Physician Decision|0|||
131114009|NCT03808688|472048965|FG000|Overall Study|Adverse Event|13|||
131114010|NCT03808688|472048966|FG001|Overall Study|Adverse Event|17|||
130694647|NCT00112437|470505941|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130694648|NCT00112437|470505916|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694649|NCT00112437|470505917|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694650|NCT00112437|470505918|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694651|NCT00112437|470505919|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131114011|NCT03808688|472048965|FG000|Overall Study|Lack of Efficacy|2|||
131114012|NCT03808688|472048966|FG001|Overall Study|Lack of Efficacy|0|||
131114013|NCT03808688|472048965|FG000|Overall Study|Lost to Follow-up|0|||
131114014|NCT03808688|472048966|FG001|Overall Study|Lost to Follow-up|2|||
131114015|NCT03808688|472048965|FG000|Overall Study|Withdrawal by Subject|1|||
131114016|NCT03808688|472048966|FG001|Overall Study|Withdrawal by Subject|0|||
131114017|NCT03808688|472048965|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
131114018|NCT03808688|472048966|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
131114019|NCT03808688|472048965|FG000|Overall Study|IOP Too High|1|||
131114020|NCT03808688|472048966|FG001|Overall Study|IOP Too High|1|||
131114021|NCT03808688|472048965|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
131114022|NCT03808688|472048966|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
131114023|NCT03808688|472048965|FG000|Overall Study|Visit Out of Window|0|||
131114024|NCT03808688|472048966|FG001|Overall Study|Visit Out of Window|1|||
131114025|NCT03808688|472048965|FG000|Overall Study|Medication Non-Compliance|0|||
131114026|NCT03808688|472048966|FG001|Overall Study|Medication Non-Compliance|1|||
130694652|NCT00112437|470505920|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
131222759|NCT00386100|472443175|FG000|Overall Study|Consecutive elevated Hba1C|1|||
130768396|NCT00603382|470775556|FG001|Overall Study|Physician Decision|0|||
130904415|NCT00708201|471285531|FG001|Overall Study|Adverse Event|4|||
130904416|NCT00708201|471285530|FG000|Overall Study|Withdrawal by Subject|1|||
130904417|NCT00708201|471285531|FG001|Overall Study|Withdrawal by Subject|1|||
130904418|NCT00708201|471285530|FG000|Overall Study|Lost to Follow-up|2|||
130904419|NCT00708201|471285531|FG001|Overall Study|Lost to Follow-up|0|||
130904420|NCT00708201|471285530|FG000|Overall Study|Protocol Violation|0|||
130694653|NCT00112437|470505921|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130768397|NCT00603382|470775557|FG002|Overall Study|Physician Decision|2|||
130904421|NCT00708201|471285531|FG001|Overall Study|Protocol Violation|1|||
130904422|NCT01653132|471285532|FG000|First Intervention|Protocol Violation|1|||
130904423|NCT01653132|471285533|FG001|First Intervention|Protocol Violation|0|||
130904424|NCT00761748|471285534|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
130904425|NCT00761748|471285535|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
130904426|NCT00761748|471285534|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
130904427|NCT00761748|471285535|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
130904428|NCT03312751|471285536|FG000|Overall Study|Death|7|||
130904429|NCT03312751|471285537|FG001|Overall Study|Death|9|||
130904430|NCT03312751|471285536|FG000|Overall Study|Study discontinuation due to other reason|0|||
130904431|NCT03312751|471285537|FG001|Overall Study|Study discontinuation due to other reason|1|||
130904432|NCT03490981|471285538|FG000|Overall Study|Lost to Follow-up|1|||
130904433|NCT03490981|471285539|FG001|Overall Study|Lost to Follow-up|2|||
130904434|NCT00282464|471285546|FG000|Overall Study|Adverse Event|26|||
130904435|NCT00282464|471285547|FG001|Overall Study|Adverse Event|20|||
130904436|NCT00282464|471285546|FG000|Overall Study|Lack of Efficacy|8|||
130904437|NCT00282464|471285547|FG001|Overall Study|Lack of Efficacy|8|||
130904438|NCT00282464|471285546|FG000|Overall Study|Lost to Follow-up|10|||
130904439|NCT00282464|471285547|FG001|Overall Study|Lost to Follow-up|10|||
130904440|NCT00282464|471285546|FG000|Overall Study|Withdrawal by Subject|24|||
130904441|NCT00282464|471285547|FG001|Overall Study|Withdrawal by Subject|10|||
130904442|NCT00282464|471285546|FG000|Overall Study|laboratory abnormality|1|||
130904443|NCT00282464|471285547|FG001|Overall Study|laboratory abnormality|2|||
130904444|NCT00282464|471285546|FG000|Overall Study|Protocol Violation|0|||
130904445|NCT00282464|471285547|FG001|Overall Study|Protocol Violation|7|||
130904446|NCT00282464|471285546|FG000|Overall Study|Patient moved|1|||
130904447|NCT00282464|471285547|FG001|Overall Study|Patient moved|0|||
130904448|NCT00282464|471285546|FG000|Overall Study|patient non-compliant|3|||
130904449|NCT00282464|471285547|FG001|Overall Study|patient non-compliant|0|||
130904450|NCT00282464|471285546|FG000|Overall Study|patient no show|0|||
130904451|NCT00282464|471285547|FG001|Overall Study|patient no show|1|||
130904452|NCT00282464|471285546|FG000|Overall Study|patient incarcerated|0|||
130904453|NCT00282464|471285547|FG001|Overall Study|patient incarcerated|1|||
130904454|NCT00282464|471285546|FG000|Overall Study|family crisis|0|||
130904455|NCT00282464|471285547|FG001|Overall Study|family crisis|1|||
130904456|NCT00282464|471285546|FG000|Overall Study|dispensed wrong kit|0|||
130904457|NCT00282464|471285547|FG001|Overall Study|dispensed wrong kit|1|||
130904458|NCT00282464|471285546|FG000|Overall Study|dropped due to missed visits|0|||
130904459|NCT00282464|471285547|FG001|Overall Study|dropped due to missed visits|1|||
130904460|NCT01624870|471285548|FG000|Overall Study|Death|19|||
130904461|NCT01624870|471285548|FG000|Overall Study|Withdrawal by Subject|1|||
130904462|NCT01624870|471285548|FG000|Overall Study|CoreValve not implanted|6|||
130904463|NCT01624870|471285548|FG000|Overall Study|Lost to follow up|1|||
130904464|NCT04672252|471285552|FG000|Overall Study|Protocol Violation|1|||
130904465|NCT04672252|471285553|FG001|Overall Study|Protocol Violation|0|||
130904466|NCT04391569|471285554|FG000|Overall Study|Death|15|||
130904467|NCT04391569|471285555|FG001|Overall Study|Death|10|||
130904468|NCT04391569|471285554|FG000|Overall Study|Withdrawal by Subject|1|||
130904469|NCT04391569|471285555|FG001|Overall Study|Withdrawal by Subject|0|||
130904470|NCT04391569|471285554|FG000|Overall Study|Lost to Follow-up|3|||
130904471|NCT04391569|471285555|FG001|Overall Study|Lost to Follow-up|2|||
130904472|NCT04391569|471285554|FG000|Overall Study|Lack of Efficacy|0|||
130904473|NCT04391569|471285555|FG001|Overall Study|Lack of Efficacy|1|||
130904474|NCT04391569|471285554|FG000|Overall Study|Participant discharged to hospice facility|0|||
130904475|NCT04391569|471285555|FG001|Overall Study|Participant discharged to hospice facility|1|||
130904476|NCT04391569|471285554|FG000|Overall Study|Participant family decision|1|||
130904477|NCT04391569|471285555|FG001|Overall Study|Participant family decision|0|||
130904478|NCT04391569|471285554|FG000|Overall Study|Participant discharged prematurely|1|||
130904479|NCT04391569|471285555|FG001|Overall Study|Participant discharged prematurely|0|||
130904480|NCT00899392|471285556|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
130904481|NCT00899392|471285557|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
130904482|NCT01431638|471285564|FG000|Overall Study|Adverse Event|1|||
130904483|NCT01431638|471285565|FG001|Overall Study|Adverse Event|3|||
130904484|NCT01431638|471285566|FG002|Overall Study|Adverse Event|1|||
130904485|NCT01431638|471285564|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130904486|NCT01431638|471285565|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130904487|NCT01431638|471285566|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
130904488|NCT01431638|471285564|FG000|Overall Study|Participants condition no longer requires study drug|0|||
130904489|NCT01431638|471285565|FG001|Overall Study|Participants condition no longer requires study drug|1|||
130904490|NCT01431638|471285566|FG002|Overall Study|Participants condition no longer requires study drug|0|||
130904491|NCT01431638|471285564|FG000|Overall Study|Participant withdrew consent|14|||
130904492|NCT01431638|471285565|FG001|Overall Study|Participant withdrew consent|5|||
130904493|NCT01431638|471285566|FG002|Overall Study|Participant withdrew consent|8|||
130904494|NCT01431638|471285564|FG000|Overall Study|Lost to Follow-up|7|||
130904495|NCT01431638|471285565|FG001|Overall Study|Lost to Follow-up|9|||
130904496|NCT01431638|471285566|FG002|Overall Study|Lost to Follow-up|7|||
130904497|NCT01431638|471285564|FG000|Overall Study|Administrative problems|1|||
130904498|NCT01431638|471285565|FG001|Overall Study|Administrative problems|4|||
130904499|NCT01431638|471285566|FG002|Overall Study|Administrative problems|6|||
130904500|NCT01431638|471285564|FG000|Overall Study|Death|1|||
130904501|NCT01431638|471285565|FG001|Overall Study|Death|0|||
130904502|NCT01431638|471285566|FG002|Overall Study|Death|0|||
130904503|NCT01431638|471285564|FG000|Overall Study|Protocol deviation|1|||
130904504|NCT01431638|471285565|FG001|Overall Study|Protocol deviation|1|||
130904505|NCT01431638|471285566|FG002|Overall Study|Protocol deviation|4|||
130904506|NCT01431638|471285564|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
130904507|NCT01431638|471285565|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
130904508|NCT01431638|471285566|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
130904509|NCT01239732|471285567|FG000|Overall Study|Termination of study per protocol|667|||
130904510|NCT01239732|471285567|FG000|Overall Study|Death|226|||
130904511|NCT01239732|471285567|FG000|Overall Study|Withdrawal by Subject|87|||
130904512|NCT01239732|471285567|FG000|Overall Study|Adverse Event|6|||
130904513|NCT01239732|471285567|FG000|Overall Study|Protocol Violation|3|||
130904514|NCT01239732|471285567|FG000|Overall Study|Participant non compliance|5|||
130904515|NCT01239732|471285567|FG000|Overall Study|Study termination by sponsor|2|||
130904516|NCT01239732|471285567|FG000|Overall Study|Investigator's decision|4|||
130904517|NCT01239732|471285567|FG000|Overall Study|Treatment failure|2|||
130904518|NCT01239732|471285567|FG000|Overall Study|Other|19|||
130904519|NCT02216812|471285585|FG000|Overall Study|Lost to Follow-up|10|||
130904520|NCT02216812|471285586|FG001|Overall Study|Lost to Follow-up|5|||
130904521|NCT00527488|471285591|FG000|Overall Study|Withdrawn prior to dosing|0|||
130904522|NCT00527488|471285592|FG001|Overall Study|Withdrawn prior to dosing|1|||
130904523|NCT00527488|471285593|FG002|Overall Study|Withdrawn prior to dosing|1|||
130904524|NCT00527488|471285594|FG003|Overall Study|Withdrawn prior to dosing|0|||
130904525|NCT00604214|471285599|FG000|Baseline to Day 28|Death|223|||
130904526|NCT00604214|471285600|FG001|Baseline to Day 28|Death|202|||
130904527|NCT00604214|471285599|FG000|Baseline to Day 28|Lost to Follow-up|2|||
130904528|NCT00604214|471285600|FG001|Baseline to Day 28|Lost to Follow-up|4|||
130904529|NCT00604214|471285599|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
130904530|NCT00604214|471285600|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
130904531|NCT00604214|471285599|FG000|Day 29 to Day 90|Death|64|||
130904532|NCT00604214|471285600|FG001|Day 29 to Day 90|Death|67|||
130904533|NCT00604214|471285599|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
130904534|NCT00604214|471285600|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
130904535|NCT00604214|471285599|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
130904536|NCT00604214|471285600|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
130904537|NCT00604214|471285599|FG000|Day 91 to Day 180|Death|19|||
130904538|NCT00604214|471285600|FG001|Day 91 to Day 180|Death|23|||
130904539|NCT00604214|471285599|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
130904540|NCT00604214|471285600|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
130904541|NCT00604214|471285599|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
131114027|NCT03329196|472048967|FG000|Overall Study|Adverse Event|10|||
131114028|NCT03329196|472048968|FG001|Overall Study|Adverse Event|5|||
131114029|NCT03329196|472048967|FG000|Overall Study|Physician Decision|2|||
131114030|NCT03329196|472048968|FG001|Overall Study|Physician Decision|2|||
131114031|NCT03329196|472048967|FG000|Overall Study|Withdrawal by Subject|11|||
131114032|NCT03329196|472048968|FG001|Overall Study|Withdrawal by Subject|3|||
131114033|NCT03329196|472048967|FG000|Overall Study|Hepatic function abnormalities|0|||
131114034|NCT03329196|472048968|FG001|Overall Study|Hepatic function abnormalities|1|||
130904542|NCT00604214|471285600|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
130904543|NCT03595124|471287004|FG000|Overall Study|Physician Decision|1|||
130904544|NCT03595124|471287005|FG001|Overall Study|Physician Decision|1|||
130904545|NCT03595124|471287006|FG002|Overall Study|Physician Decision|1|||
130904546|NCT03595124|471287004|FG000|Overall Study|Ineligible|1|||
130904547|NCT03595124|471287005|FG001|Overall Study|Ineligible|1|||
130904548|NCT03595124|471287006|FG002|Overall Study|Ineligible|0|||
130904549|NCT03595124|471287004|FG000|Overall Study|Disease Progression|4|||
131114035|NCT03329196|472048967|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
131114036|NCT03329196|472048968|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
130904550|NCT03595124|471287005|FG001|Overall Study|Disease Progression|1|||
130904551|NCT03595124|471287006|FG002|Overall Study|Disease Progression|4|||
130904552|NCT01095094|471287009|FG000|Overall Study|Withdrawal by Subject|1|||
130904553|NCT01095094|471287009|FG000|Overall Study|Death|1|||
130904554|NCT01095094|471287009|FG000|Overall Study|Physician Decision|1|||
130904555|NCT05347147|471287010|FG000|Overall Study|Lost to Follow-up|0|||
130904556|NCT05347147|471287011|FG001|Overall Study|Lost to Follow-up|1|||
130904557|NCT05347147|471287010|FG000|Overall Study|Sponsor request|3|||
130904558|NCT05347147|471287011|FG001|Overall Study|Sponsor request|3|||
130904559|NCT05347147|471287010|FG000|Overall Study|Study termination|2|||
130904560|NCT05347147|471287011|FG001|Overall Study|Study termination|1|||
130904561|NCT01122394|471287016|FG000|Overall Study|Withdrawal by Subject|1|||
130904562|NCT01122394|471287017|FG001|Overall Study|Withdrawal by Subject|1|||
130904563|NCT01122394|471287016|FG000|Overall Study|Lost to Follow-up|2|||
130904564|NCT01122394|471287017|FG001|Overall Study|Lost to Follow-up|2|||
130904565|NCT01122394|471287016|FG000|Overall Study|Adverse Event|0|||
130904566|NCT01122394|471287017|FG001|Overall Study|Adverse Event|1|||
130904567|NCT02446743|471287018|FG000|Overall Study|Withdrawal by Subject|1|||
130904568|NCT02446743|471287019|FG001|Overall Study|Withdrawal by Subject|1|||
130904569|NCT02446743|471287018|FG000|Overall Study|Lost to Follow-up|1|||
130904570|NCT02446743|471287019|FG001|Overall Study|Lost to Follow-up|0|||
130904571|NCT02446743|471287018|FG000|Overall Study|Adverse Event|1|||
130904572|NCT02446743|471287019|FG001|Overall Study|Adverse Event|1|||
130904573|NCT02446743|471287018|FG000|Overall Study|Other|2|||
130904574|NCT02446743|471287019|FG001|Overall Study|Other|3|||
130904575|NCT04389970|471287020|FG000|Overall Study|Lost to Follow-up|1|||
130904576|NCT01931670|471287022|FG000|Treatment Period|Exclusionary Medication Received|1|||
130904577|NCT01931670|471287023|FG001|Treatment Period|Exclusionary Medication Received|1|||
130904578|NCT01931670|471287024|FG002|Treatment Period|Exclusionary Medication Received|1|||
130904579|NCT01931670|471287022|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
130904580|NCT01931670|471287023|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
130904581|NCT01931670|471287024|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
130904582|NCT01931670|471287022|FG000|Treatment Period|Subject Noncompliant|4|||
130904583|NCT01931670|471287023|FG001|Treatment Period|Subject Noncompliant|9|||
130904584|NCT01931670|471287024|FG002|Treatment Period|Subject Noncompliant|5|||
130904585|NCT01931670|471287022|FG000|Treatment Period|Adverse Event|19|||
130904586|NCT01931670|471287023|FG001|Treatment Period|Adverse Event|8|||
130904587|NCT01931670|471287024|FG002|Treatment Period|Adverse Event|21|||
130904588|NCT01931670|471287022|FG000|Treatment Period|Lack of Efficacy|11|||
130904589|NCT01931670|471287023|FG001|Treatment Period|Lack of Efficacy|2|||
130904590|NCT01931670|471287024|FG002|Treatment Period|Lack of Efficacy|2|||
130904591|NCT01931670|471287022|FG000|Treatment Period|Pregnancy|7|||
130904592|NCT01931670|471287023|FG001|Treatment Period|Pregnancy|2|||
130904593|NCT01931670|471287024|FG002|Treatment Period|Pregnancy|0|||
130904594|NCT01931670|471287022|FG000|Treatment Period|Other|8|||
130904595|NCT01931670|471287023|FG001|Treatment Period|Other|7|||
130904596|NCT01931670|471287024|FG002|Treatment Period|Other|2|||
130904597|NCT01931670|471287022|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
130904598|NCT01931670|471287023|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
130904599|NCT01931670|471287024|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
130904600|NCT01931670|471287022|FG000|Treatment Period|Lost to Follow-up|19|||
130904601|NCT01931670|471287023|FG001|Treatment Period|Lost to Follow-up|5|||
130904602|NCT01931670|471287024|FG002|Treatment Period|Lost to Follow-up|7|||
130904603|NCT01931670|471287022|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
130904604|NCT01931670|471287023|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
130904605|NCT01931670|471287024|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
130904606|NCT01931670|471287022|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
130904607|NCT01931670|471287023|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
130904608|NCT01931670|471287024|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
130904609|NCT01931670|471287022|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
130904610|NCT01931670|471287023|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
130904611|NCT01931670|471287024|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
130904612|NCT01931670|471287022|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
130904613|NCT01931670|471287023|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
130904614|NCT01931670|471287024|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
130904615|NCT01931670|471287022|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
130904616|NCT01931670|471287023|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
130904617|NCT01931670|471287024|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
130904618|NCT01931670|471287022|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
130904619|NCT01931670|471287023|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
130904620|NCT01931670|471287024|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
130904621|NCT00976508|471287025|FG000|Overall Study|Death|7|||
130904622|NCT00976508|471287026|FG001|Overall Study|Death|1|||
130904623|NCT00976508|471287025|FG000|Overall Study|Lost to Follow-up|1|||
130904624|NCT00976508|471287026|FG001|Overall Study|Lost to Follow-up|0|||
130904625|NCT00976508|471287025|FG000|Overall Study|Withdrawal by Subject|1|||
130904626|NCT00976508|471287026|FG001|Overall Study|Withdrawal by Subject|0|||
130904627|NCT00976508|471287025|FG000|Overall Study|Disease Progression|4|||
130904628|NCT00976508|471287026|FG001|Overall Study|Disease Progression|4|||
130904629|NCT00976508|471287025|FG000|Overall Study|Subject Enrolled in Hospice|1|||
130904630|NCT00976508|471287026|FG001|Overall Study|Subject Enrolled in Hospice|0|||
130904631|NCT00976508|471287025|FG000|Overall Study|Terminated by the Sponsor|0|||
130904632|NCT00976508|471287026|FG001|Overall Study|Terminated by the Sponsor|1|||
130904633|NCT03023046|471287027|FG000|Overall Study|Withdrawal by Subject|1|||
130904634|NCT03404960|471287031|FG000|Overall Study|Adverse Event|0|||
130904635|NCT03404960|471287032|FG001|Overall Study|Adverse Event|2|||
130904636|NCT03404960|471287031|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
130904637|NCT03404960|471287032|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
130904638|NCT03404960|471287031|FG000|Overall Study|Bowel obstruction|0|||
130904639|NCT03404960|471287032|FG001|Overall Study|Bowel obstruction|1|||
130904640|NCT03404960|471287031|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
130904641|NCT03404960|471287032|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
130904642|NCT00246571|471287033|FG000|Overall Study|Adverse Event|7|||
130904643|NCT00246571|471287034|FG001|Overall Study|Adverse Event|0|||
130904644|NCT00246571|471287033|FG000|Overall Study|Protocol Violation|0|||
130904645|NCT00246571|471287034|FG001|Overall Study|Protocol Violation|1|||
130904646|NCT00246571|471287033|FG000|Overall Study|Withdrawal by Subject|2|||
130904647|NCT00246571|471287034|FG001|Overall Study|Withdrawal by Subject|3|||
130904648|NCT00246571|471287033|FG000|Overall Study|Lack of Efficacy|84|||
130904649|NCT00246571|471287034|FG001|Overall Study|Lack of Efficacy|21|||
130904650|NCT00246571|471287033|FG000|Overall Study|Death|17|||
130904651|NCT00246571|471287034|FG001|Overall Study|Death|3|||
130904652|NCT00246571|471287033|FG000|Overall Study|Sponsor|0|||
130904653|NCT00246571|471287034|FG001|Overall Study|Sponsor|1|||
130904654|NCT00246571|471287033|FG000|Overall Study|Did not meet entrance criteria|2|||
130904655|NCT00246571|471287034|FG001|Overall Study|Did not meet entrance criteria|1|||
130904656|NCT00246571|471287033|FG000|Overall Study|Laboratory abnormalities|1|||
130904657|NCT00246571|471287034|FG001|Overall Study|Laboratory abnormalities|0|||
130904658|NCT00246571|471287033|FG000|Overall Study|Crossover participants|0|||
130904659|NCT00246571|471287034|FG001|Overall Study|Crossover participants|74|||
130904660|NCT04395001|471287038|FG000|Overall Study|Lost to Follow-up|8|||
130904661|NCT04395001|471287039|FG001|Overall Study|Lost to Follow-up|9|||
130904662|NCT04395001|471287040|FG002|Overall Study|Lost to Follow-up|5|||
130904663|NCT04395001|471287038|FG000|Overall Study|Withdrawal by Subject|3|||
130904664|NCT04395001|471287039|FG001|Overall Study|Withdrawal by Subject|1|||
130904665|NCT04395001|471287040|FG002|Overall Study|Withdrawal by Subject|3|||
130904666|NCT04395001|471287038|FG000|Overall Study|missed appointment|7|||
130904667|NCT04395001|471287039|FG001|Overall Study|missed appointment|4|||
130904668|NCT04395001|471287040|FG002|Overall Study|missed appointment|1|||
130904669|NCT04251156|471287041|FG000|Overall Study|Lost to Follow-up|1|||
130904670|NCT04251156|471287042|FG001|Overall Study|Lost to Follow-up|1|||
130904671|NCT04251156|471287041|FG000|Overall Study|Withdrawal by Subject|4|||
130904672|NCT04251156|471287042|FG001|Overall Study|Withdrawal by Subject|4|||
130904673|NCT02455557|471287043|FG000|Overall Study|Withdrawal by Subject|2|||
130904674|NCT00807027|471287044|FG000|Overall Study|Withdrawal by Subject|13|||
130904675|NCT00807027|471287045|FG001|Overall Study|Withdrawal by Subject|14|||
130904676|NCT00807027|471287044|FG000|Overall Study|Protocol Violation|1|||
130904677|NCT00807027|471287045|FG001|Overall Study|Protocol Violation|1|||
130904678|NCT00807027|471287044|FG000|Overall Study|Adverse Event|2|||
130904679|NCT00807027|471287045|FG001|Overall Study|Adverse Event|2|||
130904680|NCT05508074|471287049|FG000|Overall Study|Death|2|||
130904681|NCT05508074|471287050|FG001|Overall Study|Death|5|||
130904682|NCT05508074|471287049|FG000|Overall Study|Withdrawal by Subject|1|||
130904683|NCT05508074|471287050|FG001|Overall Study|Withdrawal by Subject|2|||
130904684|NCT05508074|471287049|FG000|Overall Study|Adverse Event|0|||
130904685|NCT05508074|471287050|FG001|Overall Study|Adverse Event|1|||
130904686|NCT05508074|471287049|FG000|Overall Study|Physician Decision|0|||
130904687|NCT05508074|471287050|FG001|Overall Study|Physician Decision|1|||
130904688|NCT05508074|471287049|FG000|Overall Study|wrongly randomized|0|||
130904689|NCT05508074|471287050|FG001|Overall Study|wrongly randomized|1|||
130904690|NCT05508074|471287049|FG000|Overall Study|non-compliance|0|||
130904691|NCT05508074|471287050|FG001|Overall Study|non-compliance|1|||
130904692|NCT05040971|471287051|FG000|Overall Study|Withdrawal by Subject|0|||
130904693|NCT05040971|471287052|FG001|Overall Study|Withdrawal by Subject|2|||
130904694|NCT05040971|471287051|FG000|Overall Study|Lost to Follow-up|8|||
130904695|NCT05040971|471287052|FG001|Overall Study|Lost to Follow-up|3|||
130904696|NCT05040971|471287051|FG000|Overall Study|Death|2|||
130904697|NCT05040971|471287052|FG001|Overall Study|Death|0|||
130904698|NCT02720094|471287062|FG000|Overall Study|Ongoing|2210|||
130904699|NCT02720094|471287063|FG001|Overall Study|Ongoing|2203|||
130904700|NCT02720094|471287062|FG000|Overall Study|Scheduled exit visit/end of study|2|||
130904701|NCT02720094|471287063|FG001|Overall Study|Scheduled exit visit/end of study|1|||
130904702|NCT02720094|471287062|FG000|Overall Study|Death|4|||
130904703|NCT02720094|471287063|FG001|Overall Study|Death|7|||
130904704|NCT02720094|471287062|FG000|Overall Study|Withdrawal by Subject|55|||
130904705|NCT02720094|471287063|FG001|Overall Study|Withdrawal by Subject|56|||
130904706|NCT02720094|471287062|FG000|Overall Study|Lost to Follow-up|2|||
130904707|NCT02720094|471287063|FG001|Overall Study|Lost to Follow-up|7|||
130904708|NCT02720094|471287062|FG000|Overall Study|Physician Decision|1|||
130904709|NCT02720094|471287063|FG001|Overall Study|Physician Decision|3|||
130904710|NCT02720094|471287062|FG000|Overall Study|Inappropriate enrollment|1|||
130904711|NCT02720094|471287063|FG001|Overall Study|Inappropriate enrollment|3|||
130904712|NCT02720094|471287062|FG000|Overall Study|Relocation|1|||
130904713|NCT02720094|471287063|FG001|Overall Study|Relocation|1|||
130904714|NCT01302834|471287064|FG000|Overall Study|Protocol Violation|17|||
130904715|NCT01302834|471287065|FG001|Overall Study|Protocol Violation|23|||
130904716|NCT01302834|471287064|FG000|Overall Study|HIV positive|1|||
130904717|NCT01302834|471287065|FG001|Overall Study|HIV positive|3|||
130904718|NCT03735238|471287066|FG000|Overall Study|Did not want to participate in research|3|||
130904719|NCT03735238|471287066|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
130904720|NCT05214573|471287069|FG000|Overall Study|Physician Decision|5924|||
130904721|NCT05214573|471287070|FG001|Overall Study|Physician Decision|0|||
130904722|NCT02486718|471287071|FG000|Enrollment Phase|Death|19|||
130904723|NCT02486718|471287072|FG001|Enrollment Phase|Death|0|||
130904724|NCT02486718|471287073|FG002|Enrollment Phase|Death|0|||
130904725|NCT02486718|471287071|FG000|Enrollment Phase|Symptomatic deterioration|1|||
130904726|NCT02486718|471287072|FG001|Enrollment Phase|Symptomatic deterioration|0|||
130904727|NCT02486718|471287073|FG002|Enrollment Phase|Symptomatic deterioration|0|||
130904728|NCT02486718|471287071|FG000|Enrollment Phase|Withdrawal by Subject|86|||
130904729|NCT02486718|471287072|FG001|Enrollment Phase|Withdrawal by Subject|0|||
130904730|NCT02486718|471287073|FG002|Enrollment Phase|Withdrawal by Subject|0|||
130904731|NCT02486718|471287071|FG000|Enrollment Phase|Protocol Violation|18|||
130904732|NCT02486718|471287072|FG001|Enrollment Phase|Protocol Violation|0|||
130904733|NCT02486718|471287073|FG002|Enrollment Phase|Protocol Violation|0|||
130904734|NCT02486718|471287071|FG000|Enrollment Phase|Physician Decision|18|||
130904735|NCT02486718|471287072|FG001|Enrollment Phase|Physician Decision|0|||
130904736|NCT02486718|471287073|FG002|Enrollment Phase|Physician Decision|0|||
130904737|NCT02486718|471287071|FG000|Enrollment Phase|Reason not provided|41|||
130904738|NCT02486718|471287072|FG001|Enrollment Phase|Reason not provided|0|||
130904739|NCT02486718|471287073|FG002|Enrollment Phase|Reason not provided|0|||
130904740|NCT02486718|471287071|FG000|Enrollment Phase|Disease relapse|54|||
130904741|NCT02486718|471287072|FG001|Enrollment Phase|Disease relapse|0|||
130904742|NCT02486718|471287073|FG002|Enrollment Phase|Disease relapse|0|||
130904743|NCT02486718|471287071|FG000|Enrollment Phase|Lost to Follow-up|4|||
130904744|NCT02486718|471287072|FG001|Enrollment Phase|Lost to Follow-up|0|||
130904745|NCT02486718|471287073|FG002|Enrollment Phase|Lost to Follow-up|0|||
130904746|NCT02486718|471287071|FG000|Enrollment Phase|Adverse Event|34|||
131114037|NCT03329196|472048967|FG000|Overall Study|Difficult to control Hb|2|||
131114038|NCT03329196|472048968|FG001|Overall Study|Difficult to control Hb|3|||
131114039|NCT03329196|472048967|FG000|Overall Study|Dialysis or renal transplant|13|||
131114040|NCT03329196|472048968|FG001|Overall Study|Dialysis or renal transplant|15|||
130694654|NCT00112437|470505922|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694655|NCT00112437|470505923|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694656|NCT00112437|470505924|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694657|NCT00112437|470505925|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130904747|NCT02486718|471287072|FG001|Enrollment Phase|Adverse Event|0|||
130904748|NCT02486718|471287073|FG002|Enrollment Phase|Adverse Event|0|||
130904749|NCT02486718|471287071|FG000|Randomized Phase|Withdrawal by Subject|0|||
131114041|NCT03434353|472048975|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
130694658|NCT00112437|470505926|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694659|NCT00112437|470505927|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130904750|NCT02486718|471287072|FG001|Randomized Phase|Withdrawal by Subject|44|||
130904751|NCT02486718|471287073|FG002|Randomized Phase|Withdrawal by Subject|47|||
130904752|NCT02486718|471287071|FG000|Randomized Phase|Protocol Violation|0|||
130904753|NCT02486718|471287072|FG001|Randomized Phase|Protocol Violation|2|||
130904754|NCT02486718|471287073|FG002|Randomized Phase|Protocol Violation|0|||
130904755|NCT02486718|471287071|FG000|Randomized Phase|Physician Decision|0|||
130904756|NCT02486718|471287072|FG001|Randomized Phase|Physician Decision|0|||
130904757|NCT02486718|471287073|FG002|Randomized Phase|Physician Decision|3|||
130904758|NCT02486718|471287071|FG000|Randomized Phase|Lost to Follow-up|0|||
130904759|NCT02486718|471287072|FG001|Randomized Phase|Lost to Follow-up|5|||
130904760|NCT02486718|471287073|FG002|Randomized Phase|Lost to Follow-up|11|||
130904761|NCT02486718|471287071|FG000|Randomized Phase|Disease Relapse|0|||
130904762|NCT02486718|471287072|FG001|Randomized Phase|Disease Relapse|1|||
130904763|NCT02486718|471287073|FG002|Randomized Phase|Disease Relapse|0|||
130904764|NCT02486718|471287071|FG000|Randomized Phase|Death|0|||
130904765|NCT02486718|471287072|FG001|Randomized Phase|Death|154|||
130904766|NCT02486718|471287073|FG002|Randomized Phase|Death|155|||
130904767|NCT02486718|471287071|FG000|Randomized Phase|Ongoing|0|||
130904768|NCT02486718|471287072|FG001|Randomized Phase|Ongoing|301|||
130904769|NCT02486718|471287073|FG002|Randomized Phase|Ongoing|282|||
130904770|NCT01958827|471287074|FG000|Overall Study|Adverse Event|3|||
130904771|NCT01958827|471287074|FG000|Overall Study|Lack of Efficacy|6|||
130904772|NCT01958827|471287074|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
130904773|NCT04803214|471287075|FG000|Overall Study|Adverse Event|1|||
130904774|NCT04803214|471287076|FG001|Overall Study|Adverse Event|0|||
130904775|NCT04803214|471287075|FG000|Overall Study|Withdrawal by Subject|1|||
130904776|NCT04803214|471287076|FG001|Overall Study|Withdrawal by Subject|2|||
130904777|NCT04803214|471287075|FG000|Overall Study|Lost to Follow-up|2|||
130904778|NCT04803214|471287076|FG001|Overall Study|Lost to Follow-up|4|||
130904779|NCT04803214|471287075|FG000|Overall Study|Physician Decision|1|||
130904780|NCT04803214|471287076|FG001|Overall Study|Physician Decision|1|||
130904781|NCT04803214|471287075|FG000|Overall Study|Missed 12 month visit|0|||
130904782|NCT04803214|471287076|FG001|Overall Study|Missed 12 month visit|3|||
130904783|NCT03370276|471287077|FG000|Overall Study|Death|0|||
130904784|NCT03370276|471287078|FG001|Overall Study|Death|2|||
130904785|NCT03370276|471287079|FG002|Overall Study|Death|5|||
130904786|NCT04675151|471287081|FG000|Overall Study|Protocol Violation|1|||
130904787|NCT04675151|471287082|FG001|Overall Study|Protocol Violation|0|||
130904788|NCT04675151|471287083|FG002|Overall Study|Protocol Violation|0|||
130904789|NCT04675151|471287084|FG003|Overall Study|Protocol Violation|1|||
130904790|NCT04035486|471287085|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
130904791|NCT04035486|471287086|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
130904792|NCT04035486|471287087|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
130904793|NCT04035486|471287088|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
130904794|NCT04035486|471287085|FG000|Overall Study|Death|6|||
130904795|NCT04035486|471287086|FG001|Overall Study|Death|3|||
130904796|NCT04035486|471287087|FG002|Overall Study|Death|70|||
130904797|NCT04035486|471287088|FG003|Overall Study|Death|77|||
130904798|NCT04035486|471287085|FG000|Overall Study|Screen Failure|0|||
130904799|NCT04035486|471287086|FG001|Overall Study|Screen Failure|0|||
130904800|NCT04035486|471287087|FG002|Overall Study|Screen Failure|1|||
130904801|NCT04035486|471287088|FG003|Overall Study|Screen Failure|1|||
130904802|NCT04035486|471287085|FG000|Overall Study|Withdrawal by Subject|1|||
130904803|NCT04035486|471287086|FG001|Overall Study|Withdrawal by Subject|1|||
130904804|NCT04035486|471287087|FG002|Overall Study|Withdrawal by Subject|11|||
130904805|NCT04035486|471287088|FG003|Overall Study|Withdrawal by Subject|9|||
130904806|NCT01730937|471287089|FG000|Overall Study|Protocol Violation|5|||
130904807|NCT01730937|471287090|FG001|Overall Study|Protocol Violation|11|||
130904808|NCT03947684|471287093|FG000|Overall Study|Lost to Follow-up|13|||
130904809|NCT03947684|471287094|FG001|Overall Study|Lost to Follow-up|5|||
130904810|NCT03947684|471287095|FG002|Overall Study|Lost to Follow-up|1|||
130904811|NCT03947684|471287093|FG000|Overall Study|Withdrawal by Subject|11|||
130904812|NCT03947684|471287094|FG001|Overall Study|Withdrawal by Subject|4|||
130904813|NCT03947684|471287095|FG002|Overall Study|Withdrawal by Subject|0|||
130904814|NCT03947684|471287093|FG000|Overall Study|Physician Decision|1|||
130904815|NCT03947684|471287094|FG001|Overall Study|Physician Decision|0|||
130904816|NCT03947684|471287095|FG002|Overall Study|Physician Decision|0|||
130904817|NCT03947684|471287093|FG000|Overall Study|Lack of adherence to study protocol|2|||
130904818|NCT03947684|471287094|FG001|Overall Study|Lack of adherence to study protocol|0|||
130904819|NCT03947684|471287095|FG002|Overall Study|Lack of adherence to study protocol|0|||
130904820|NCT03875235|471287096|FG000|Overall Study|Ongoing study treatment|63|||
130904821|NCT03875235|471287097|FG001|Overall Study|Ongoing study treatment|20|||
130904822|NCT03875235|471287096|FG000|Overall Study|Off treatment|77|||
130904823|NCT03875235|471287097|FG001|Overall Study|Off treatment|91|||
130904824|NCT03875235|471287096|FG000|Overall Study|Withdrawal by Subject|3|||
130904825|NCT03875235|471287097|FG001|Overall Study|Withdrawal by Subject|10|||
130904826|NCT03875235|471287096|FG000|Overall Study|Death|198|||
130904827|NCT03875235|471287097|FG001|Overall Study|Death|223|||
130904828|NCT04526665|471287098|FG000|Overall Study|Withdrawal by Subject|6|||
130904829|NCT04526665|471287099|FG001|Overall Study|Withdrawal by Subject|3|||
130904830|NCT04526665|471287098|FG000|Overall Study|Adverse Event|4|||
130904831|NCT04526665|471287099|FG001|Overall Study|Adverse Event|1|||
130904832|NCT04526665|471287098|FG000|Overall Study|Physician Decision|2|||
130904833|NCT04526665|471287099|FG001|Overall Study|Physician Decision|2|||
130904834|NCT04526665|471287098|FG000|Overall Study|Death|2|||
130904835|NCT04526665|471287099|FG001|Overall Study|Death|0|||
130904836|NCT04526665|471287098|FG000|Overall Study|Other|0|||
130904837|NCT04526665|471287099|FG001|Overall Study|Other|1|||
130985459|NCT02889133|471572913|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
130985460|NCT02277990|471572914|FG000|Overall Study|Death|170|||
130985461|NCT02277990|471572915|FG001|Overall Study|Death|188|||
130985462|NCT02277990|471572914|FG000|Overall Study|Withdrawal by Subject|64|||
130985463|NCT02277990|471572915|FG001|Overall Study|Withdrawal by Subject|53|||
130985464|NCT02277990|471572914|FG000|Overall Study|Physician Decision|40|||
130985465|NCT02277990|471572915|FG001|Overall Study|Physician Decision|34|||
130985466|NCT02277990|471572914|FG000|Overall Study|Lost to Follow-up|66|||
130985467|NCT02277990|471572915|FG001|Overall Study|Lost to Follow-up|69|||
130985468|NCT02277990|471572914|FG000|Overall Study|Had other reason|26|||
130985469|NCT02277990|471572915|FG001|Overall Study|Had other reason|32|||
130985470|NCT04711603|471572916|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
130985471|NCT04711603|471572917|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
130985472|NCT04711603|471572918|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
130985473|NCT04711603|471572919|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
130985474|NCT04711603|471572916|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
130985475|NCT04711603|471572917|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
130985476|NCT04711603|471572918|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
130985477|NCT04711603|471572919|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
130985478|NCT04711603|471572916|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
130985479|NCT04711603|471572917|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
130985480|NCT04711603|471572918|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
130985481|NCT04711603|471572919|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
130985482|NCT04711603|471572916|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
130985483|NCT04711603|471572917|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
130985484|NCT04711603|471572918|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
130985485|NCT04711603|471572919|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
130985486|NCT04711603|471572916|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
130985487|NCT04711603|471572917|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
130985488|NCT04711603|471572918|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
130985489|NCT04711603|471572919|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
130985490|NCT04711603|471572916|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
130985491|NCT04711603|471572917|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
130985492|NCT04711603|471572918|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
130985493|NCT04711603|471572919|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
130985494|NCT04711603|471572916|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
130985495|NCT04711603|471572917|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
130985496|NCT04711603|471572918|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
130985497|NCT04711603|471572919|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
130985498|NCT04711603|471572916|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
130985499|NCT04711603|471572917|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
130985500|NCT04711603|471572918|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
130985501|NCT04711603|471572919|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
130985502|NCT04711603|471572916|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
130985503|NCT04711603|471572917|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
130985504|NCT04711603|471572918|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
130985505|NCT04711603|471572919|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
130985506|NCT04711603|471572916|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
130985507|NCT04711603|471572917|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
130985508|NCT04711603|471572918|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
130985509|NCT04711603|471572919|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
130985510|NCT04711603|471572916|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
130985511|NCT04711603|471572917|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
130985512|NCT04711603|471572918|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
130985513|NCT04711603|471572919|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
130985514|NCT04711603|471572916|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
130985515|NCT04711603|471572917|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
130904838|NCT03384693|471287943|FG000|Overall Study|Adverse Event|3|||
130904839|NCT01397825|471287949|FG000|Overall Study|Progressive Disease|10|||
130904840|NCT01397825|471287950|FG001|Overall Study|Progressive Disease|3|||
130904841|NCT01397825|471287951|FG002|Overall Study|Progressive Disease|11|||
130904842|NCT01397825|471287952|FG003|Overall Study|Progressive Disease|1|||
130904843|NCT01397825|471287953|FG004|Overall Study|Progressive Disease|0|||
130904844|NCT01397825|471287949|FG000|Overall Study|Symptomatic Deterioration|2|||
130904845|NCT01397825|471287950|FG001|Overall Study|Symptomatic Deterioration|0|||
130904846|NCT01397825|471287951|FG002|Overall Study|Symptomatic Deterioration|4|||
130904847|NCT01397825|471287952|FG003|Overall Study|Symptomatic Deterioration|0|||
130904848|NCT01397825|471287953|FG004|Overall Study|Symptomatic Deterioration|0|||
130904849|NCT01397825|471287949|FG000|Overall Study|Adverse Event|0|||
130904850|NCT01397825|471287950|FG001|Overall Study|Adverse Event|1|||
130904851|NCT01397825|471287951|FG002|Overall Study|Adverse Event|5|||
130904852|NCT01397825|471287952|FG003|Overall Study|Adverse Event|1|||
130904853|NCT01397825|471287953|FG004|Overall Study|Adverse Event|0|||
130904854|NCT01397825|471287949|FG000|Overall Study|Withdrawal by Subject|1|||
130904855|NCT01397825|471287950|FG001|Overall Study|Withdrawal by Subject|0|||
130904856|NCT01397825|471287951|FG002|Overall Study|Withdrawal by Subject|5|||
130904857|NCT01397825|471287952|FG003|Overall Study|Withdrawal by Subject|1|||
130904858|NCT01397825|471287953|FG004|Overall Study|Withdrawal by Subject|0|||
130904859|NCT00815516|471287954|FG000|Overall Study|Death|3|||
130904860|NCT00815516|471287955|FG001|Overall Study|Death|1|||
130904861|NCT00815516|471287954|FG000|Overall Study|Physician Decision|1|||
130904862|NCT00815516|471287955|FG001|Overall Study|Physician Decision|0|||
130904863|NCT00470158|471287961|FG000|Overall Study|Death|0|||
130904864|NCT00470158|471287962|FG001|Overall Study|Death|0|||
130904865|NCT00470158|471287963|FG002|Overall Study|Death|0|||
130904866|NCT00470158|471287964|FG003|Overall Study|Death|0|||
130904867|NCT00470158|471287965|FG004|Overall Study|Death|2|||
130904868|NCT00470158|471287961|FG000|Overall Study|Lost to Follow-up|7|||
130904869|NCT00470158|471287962|FG001|Overall Study|Lost to Follow-up|8|||
130904870|NCT00470158|471287963|FG002|Overall Study|Lost to Follow-up|8|||
130904871|NCT00470158|471287964|FG003|Overall Study|Lost to Follow-up|5|||
130904872|NCT00470158|471287965|FG004|Overall Study|Lost to Follow-up|4|||
130904873|NCT00470158|471287961|FG000|Overall Study|Protocol Violation|1|||
130904874|NCT00470158|471287962|FG001|Overall Study|Protocol Violation|0|||
130904875|NCT00470158|471287963|FG002|Overall Study|Protocol Violation|0|||
130904876|NCT00470158|471287964|FG003|Overall Study|Protocol Violation|0|||
130904877|NCT00470158|471287965|FG004|Overall Study|Protocol Violation|0|||
130904878|NCT01236118|471287966|FG000|Overall Study|Adverse Event|2|||
130904879|NCT01236118|471287967|FG001|Overall Study|Adverse Event|0|||
130904880|NCT01236118|471287968|FG002|Overall Study|Adverse Event|2|||
130904881|NCT01236118|471287966|FG000|Overall Study|Physician Decision|0|||
130904882|NCT01236118|471287967|FG001|Overall Study|Physician Decision|1|||
130904883|NCT01236118|471287968|FG002|Overall Study|Physician Decision|0|||
130904884|NCT01236118|471287966|FG000|Overall Study|Withdrawal by Subject|0|||
130904885|NCT01236118|471287967|FG001|Overall Study|Withdrawal by Subject|0|||
130904886|NCT01236118|471287968|FG002|Overall Study|Withdrawal by Subject|1|||
130904887|NCT01129024|471287970|FG000|Overall Study|Physician Decision|5|||
130904888|NCT01129024|471287970|FG000|Overall Study|Study Terminated by Sponsor|8|||
130904889|NCT01129024|471287970|FG000|Overall Study|Withdrawal by Subject|2|||
130904890|NCT01129024|471287970|FG000|Overall Study|Lack of Efficacy|3|||
130904891|NCT01129024|471287970|FG000|Overall Study|Needed a Platelet Transfusion|1|||
130904892|NCT01993836|471287971|FG000|Overall Study|Surgery Cancelled|3|||
130904893|NCT01993836|471287972|FG001|Overall Study|Surgery Cancelled|0|||
130904894|NCT01993836|471287973|FG002|Overall Study|Surgery Cancelled|0|||
130904895|NCT01993836|471287971|FG000|Overall Study|Physician Decision|2|||
130904896|NCT01993836|471287972|FG001|Overall Study|Physician Decision|1|||
130694660|NCT00112437|470505928|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694661|NCT00112437|470505929|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694662|NCT00112437|470505930|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130904897|NCT01993836|471287973|FG002|Overall Study|Physician Decision|0|||
130904898|NCT01993836|471287971|FG000|Overall Study|Death|0|||
130904899|NCT01993836|471287972|FG001|Overall Study|Death|2|||
130904900|NCT01993836|471287973|FG002|Overall Study|Death|0|||
130904901|NCT01993836|471287971|FG000|Overall Study|Withdrawal by Subject|12|||
130904902|NCT01993836|471287972|FG001|Overall Study|Withdrawal by Subject|10|||
130904903|NCT01993836|471287973|FG002|Overall Study|Withdrawal by Subject|5|||
130904904|NCT02195687|471287975|FG000|Overall Study|Personal Reasons|1|||
130904905|NCT02195687|471287976|FG001|Overall Study|Personal Reasons|1|||
130904906|NCT02195687|471287975|FG000|Overall Study|Lost to Follow-up|4|||
130904907|NCT02195687|471287976|FG001|Overall Study|Lost to Follow-up|1|||
130904908|NCT02677324|471287979|FG000|Overall Study|Disease Progression|6|||
130904909|NCT02677324|471287979|FG000|Overall Study|Inability to Swallow pills|1|||
130904910|NCT02677324|471287979|FG000|Overall Study|Non-compliance|1|||
130904911|NCT02677324|471287979|FG000|Overall Study|Lack of Efficacy|1|||
130904912|NCT02677324|471287979|FG000|Overall Study|Medical insurance coverage|1|||
130904913|NCT02677324|471287979|FG000|Overall Study|Adverse Event|1|||
130904914|NCT02677324|471287979|FG000|Overall Study|IgM Myeloma diagnosis|1|||
130904915|NCT02106923|471287980|FG000|Overall Study|Protocol Violation|0|||
130904916|NCT02106923|471287981|FG001|Overall Study|Protocol Violation|0|||
130904917|NCT02106923|471287982|FG002|Overall Study|Protocol Violation|0|||
130904918|NCT02106923|471287983|FG003|Overall Study|Protocol Violation|0|||
130904919|NCT02106923|471287984|FG004|Overall Study|Protocol Violation|0|||
130904920|NCT02106923|471287985|FG005|Overall Study|Protocol Violation|1|||
130904921|NCT03485495|471287986|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
130904922|NCT03485495|471287987|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
130904923|NCT01261780|471287989|FG000|Overall Study|Withdrawal by Subject|1|||
130904924|NCT01261780|471287990|FG001|Overall Study|Withdrawal by Subject|0|||
130904925|NCT01261780|471287989|FG000|Overall Study|Event not related to subject|1|||
130904926|NCT01261780|471287990|FG001|Overall Study|Event not related to subject|2|||
130904927|NCT03562767|471287991|FG000|Overall Study|Physician Decision|2|||
130904928|NCT03562767|471287992|FG001|Overall Study|Physician Decision|0|||
130904929|NCT03562767|471287993|FG002|Overall Study|Physician Decision|0|||
130904930|NCT03562767|471287991|FG000|Overall Study|Logistic Reason|1|||
130904931|NCT03562767|471287992|FG001|Overall Study|Logistic Reason|3|||
130904932|NCT03562767|471287993|FG002|Overall Study|Logistic Reason|0|||
130904933|NCT00938886|471287996|FG000|Overall Study|Death|0|||
130904934|NCT00938886|471287997|FG001|Overall Study|Death|1|||
130904935|NCT00938886|471287996|FG000|Overall Study|Withdrawal by Subject|4|||
130904936|NCT00938886|471287997|FG001|Overall Study|Withdrawal by Subject|7|||
130904937|NCT00938886|471287996|FG000|Overall Study|Lost to Follow-up|3|||
130904938|NCT00938886|471287997|FG001|Overall Study|Lost to Follow-up|2|||
130904939|NCT00913692|471288002|FG000|Screening (4 Months)|Physician Decision|3|||
130904940|NCT00913692|471288002|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
130904941|NCT00913692|471288002|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
130904942|NCT04231981|471288003|FG000|Overall Study|Adverse Event|1|||
130904943|NCT04231981|471288003|FG000|Overall Study|Death|16|||
130904944|NCT04231981|471288003|FG000|Overall Study|Lost to Follow-up|1|||
130904945|NCT02889562|471288004|FG000|Overall Study|Physician Decision|0|||
131114042|NCT03434353|472048976|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
131114043|NCT03434353|472048977|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
131114044|NCT03434353|472048978|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
131114045|NCT03434353|472048979|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
131114046|NCT03434353|472048975|FG000|Overall Study|Withdrew consent|1|||
130904946|NCT02889562|471288005|FG001|Overall Study|Physician Decision|1|||
131114047|NCT03434353|472048976|FG001|Overall Study|Withdrew consent|0|||
131114048|NCT03434353|472048977|FG002|Overall Study|Withdrew consent|3|||
131114049|NCT03434353|472048978|FG003|Overall Study|Withdrew consent|0|||
131114050|NCT03434353|472048979|FG004|Overall Study|Withdrew consent|0|||
131114051|NCT03434353|472048975|FG000|Overall Study|Adverse Event|1|||
131114052|NCT03434353|472048976|FG001|Overall Study|Adverse Event|0|||
131114053|NCT03434353|472048977|FG002|Overall Study|Adverse Event|0|||
131114054|NCT03434353|472048978|FG003|Overall Study|Adverse Event|0|||
131114055|NCT03434353|472048979|FG004|Overall Study|Adverse Event|1|||
131114056|NCT03434353|472048975|FG000|Overall Study|Lost to Follow-up|2|||
131114057|NCT03434353|472048976|FG001|Overall Study|Lost to Follow-up|0|||
131114058|NCT03434353|472048977|FG002|Overall Study|Lost to Follow-up|0|||
131114059|NCT03434353|472048978|FG003|Overall Study|Lost to Follow-up|0|||
131114060|NCT03434353|472048979|FG004|Overall Study|Lost to Follow-up|0|||
131114061|NCT01990534|472048982|FG000|Overall Study|Death|22|||
131114062|NCT01990534|472048982|FG000|Overall Study|Progressive disease|3|||
131114063|NCT01990534|472048982|FG000|Overall Study|Protocol Violation|1|||
131114064|NCT01990534|472048982|FG000|Overall Study|Withdrawal of Informed Consent|2|||
131114065|NCT01990534|472048982|FG000|Overall Study|Symptomatic Deterioration|1|||
130694663|NCT00112437|470505931|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694664|NCT00112437|470505932|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130904947|NCT02889562|471288004|FG000|Overall Study|Withdrawal by Subject|0|||
130904948|NCT02889562|471288005|FG001|Overall Study|Withdrawal by Subject|1|||
131114066|NCT01990534|472048982|FG000|Overall Study|Withdrawal by Subject|3|||
130904949|NCT01470989|471288008|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
130904950|NCT01470989|471288009|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
131114067|NCT01990534|472048982|FG000|Overall Study|Reason not Specified|2|||
131114068|NCT01990534|472048982|FG000|Overall Study|Lost to Follow-up|1|||
131114069|NCT00234494|472048983|FG000|Overall Study|Protocol Violation|2|||
131114070|NCT04175808|472048988|FG000|Part A|Miscellaneous|2|||
131114071|NCT04175808|472048989|FG001|Part A|Miscellaneous|0|||
131114072|NCT04175808|472048990|FG002|Part A|Miscellaneous|0|||
130904951|NCT01470989|471288008|FG000|Overall Study|Adverse Event|2|||
130904952|NCT01470989|471288009|FG001|Overall Study|Adverse Event|5|||
130904953|NCT01470989|471288008|FG000|Overall Study|Abnormal laboratory value|1|||
130904954|NCT01470989|471288009|FG001|Overall Study|Abnormal laboratory value|1|||
130904955|NCT01470989|471288008|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131114073|NCT04175808|472048991|FG003|Part A|Miscellaneous|0|||
130904956|NCT01470989|471288009|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130904957|NCT01470989|471288008|FG000|Overall Study|Withdrawal by Subject|19|||
130904958|NCT01470989|471288009|FG001|Overall Study|Withdrawal by Subject|17|||
130904959|NCT01470989|471288008|FG000|Overall Study|Lost to Follow-up|18|||
130904960|NCT01470989|471288009|FG001|Overall Study|Lost to Follow-up|13|||
130904961|NCT01470989|471288008|FG000|Overall Study|Administrative problems|2|||
130904962|NCT01470989|471288009|FG001|Overall Study|Administrative problems|4|||
130904963|NCT01470989|471288008|FG000|Overall Study|Death|2|||
130904964|NCT01470989|471288009|FG001|Overall Study|Death|2|||
130904965|NCT01470989|471288008|FG000|Overall Study|Protocol deviation|1|||
130904966|NCT01470989|471288009|FG001|Overall Study|Protocol deviation|2|||
130904967|NCT00969280|471288010|FG000|Overall Study|Protocol Violation|2|||
130904968|NCT00969280|471288011|FG001|Overall Study|Protocol Violation|1|||
130904969|NCT00969280|471288010|FG000|Overall Study|Withdrawal by Subject|0|||
130904970|NCT00969280|471288011|FG001|Overall Study|Withdrawal by Subject|1|||
130904971|NCT00969280|471288010|FG000|Overall Study|infection of influenza A(H1N1)|0|||
130904972|NCT00969280|471288011|FG001|Overall Study|infection of influenza A(H1N1)|1|||
130904973|NCT05985980|471288012|FG000|Overall Study|Withdrawal by Subject|1|||
130904974|NCT05985980|471288012|FG000|Overall Study|Withdrawal by Subject|1|||
130904975|NCT05985980|471288012|FG000|Overall Study|Withdrawal by Subject|1|||
130904976|NCT05985980|471288012|FG000|Overall Study|Withdrawal by Subject|1|||
130904977|NCT03587727|471288014|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
130904978|NCT03587727|471288014|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
130904979|NCT04102189|471288017|FG000|Overall Study|Withdrawal by Subject|1|||
130904980|NCT04102189|471288018|FG001|Overall Study|Withdrawal by Subject|2|||
130904981|NCT04102189|471288017|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130904982|NCT04102189|471288018|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130904983|NCT04102189|471288017|FG000|Overall Study|Lost to Follow-up|1|||
130904984|NCT04102189|471288018|FG001|Overall Study|Lost to Follow-up|0|||
130904985|NCT03576274|471288020|FG000|Overall Study|Lost to Follow-up|3|||
130904986|NCT03576274|471288021|FG001|Overall Study|Lost to Follow-up|2|||
130904987|NCT03576274|471288022|FG002|Overall Study|Lost to Follow-up|3|||
130904988|NCT03576274|471288023|FG003|Overall Study|Lost to Follow-up|1|||
130904989|NCT03576274|471288024|FG004|Overall Study|Lost to Follow-up|3|||
130904990|NCT03576274|471288020|FG000|Overall Study|Withdrawal by Subject|5|||
130904991|NCT03576274|471288021|FG001|Overall Study|Withdrawal by Subject|3|||
130904992|NCT03576274|471288022|FG002|Overall Study|Withdrawal by Subject|2|||
130904993|NCT03576274|471288023|FG003|Overall Study|Withdrawal by Subject|8|||
130904994|NCT03576274|471288024|FG004|Overall Study|Withdrawal by Subject|6|||
130904995|NCT03976323|471288025|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
130904996|NCT03976323|471288026|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
130904997|NCT03976323|471288027|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
130904998|NCT03976323|471288025|FG000|Induction Phase|Death|80|||
130904999|NCT03976323|471288026|FG001|Induction Phase|Death|0|||
130905000|NCT03976323|471288027|FG002|Induction Phase|Death|0|||
130905001|NCT03976323|471288025|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
130905002|NCT03976323|471288026|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
130905003|NCT03976323|471288027|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
130905004|NCT03976323|471288025|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130905005|NCT03976323|471288026|FG001|Maintenance Phase|Withdrawal by Subject|9|||
130905006|NCT03976323|471288027|FG002|Maintenance Phase|Withdrawal by Subject|3|||
130905007|NCT03976323|471288025|FG000|Maintenance Phase|Physician Decision|0|||
130905008|NCT03976323|471288026|FG001|Maintenance Phase|Physician Decision|0|||
130905009|NCT03976323|471288027|FG002|Maintenance Phase|Physician Decision|1|||
130905010|NCT03976323|471288025|FG000|Maintenance Phase|Death|0|||
130905011|NCT03976323|471288026|FG001|Maintenance Phase|Death|228|||
130905012|NCT03976323|471288027|FG002|Maintenance Phase|Death|234|||
130905013|NCT04085367|471289267|FG000|Overall Study|Adverse Event|1|||
130905014|NCT04085367|471289268|FG001|Overall Study|Adverse Event|1|||
130905015|NCT04085367|471289267|FG000|Overall Study|Withdrawal by Subject|13|||
130905016|NCT04085367|471289268|FG001|Overall Study|Withdrawal by Subject|4|||
130905017|NCT04085367|471289267|FG000|Overall Study|Lost to Follow-up|3|||
130905018|NCT04085367|471289268|FG001|Overall Study|Lost to Follow-up|1|||
130905019|NCT04085367|471289267|FG000|Overall Study|Other unspecified|2|||
130905020|NCT04085367|471289268|FG001|Overall Study|Other unspecified|1|||
130905021|NCT04085367|471289267|FG000|Overall Study|Status Unknown|1|||
130905022|NCT04085367|471289268|FG001|Overall Study|Status Unknown|1|||
130905023|NCT00130442|471289271|FG000|Overall Study|Withdrawal by Subject|0|||
130905024|NCT00130442|471289272|FG001|Overall Study|Withdrawal by Subject|1|||
130905025|NCT00130442|471289271|FG000|Overall Study|did not meet criteria|1|||
130905026|NCT00130442|471289272|FG001|Overall Study|did not meet criteria|1|||
130905027|NCT00814333|471289273|FG000|Enrollment|Lost to Follow-up|1|||
130905028|NCT00814333|471289274|FG001|Enrollment|Lost to Follow-up|0|||
130905029|NCT02233946|471289275|FG000|Baseline|Withdrawal by Subject|2|||
130905030|NCT02233946|471289276|FG001|Baseline|Withdrawal by Subject|0|||
130905031|NCT02233946|471289275|FG000|3-months Follow-up|Lost to Follow-up|53|||
130905032|NCT02233946|471289276|FG001|3-months Follow-up|Lost to Follow-up|29|||
130905033|NCT02233946|471289275|FG000|6-months Follow-up|Lost to Follow-up|21|||
130905034|NCT02233946|471289276|FG001|6-months Follow-up|Lost to Follow-up|2|||
130905035|NCT02233946|471289275|FG000|9-month Follow-up|Lost to Follow-up|20|||
130905036|NCT02233946|471289276|FG001|9-month Follow-up|Lost to Follow-up|11|||
130905037|NCT02233946|471289275|FG000|12-month Follow-up|Lost to Follow-up|28|||
130905038|NCT02233946|471289276|FG001|12-month Follow-up|Lost to Follow-up|11|||
130905039|NCT00773383|471289279|FG000|Overall Study|Adverse Event|4|||
130905040|NCT00773383|471289279|FG000|Overall Study|Death|1|||
130905041|NCT00773383|471289279|FG000|Overall Study|Progression of Disease|23|||
130905042|NCT00773383|471289279|FG000|Overall Study|Other|2|||
130905043|NCT00773383|471289279|FG000|Overall Study|No study dose received|1|||
130905044|NCT02919969|471289282|FG000|Overall Study|Lack of Efficacy|22|||
130905045|NCT02919969|471289282|FG000|Overall Study|Death|4|||
130905046|NCT02919969|471289282|FG000|Overall Study|Physician Decision|3|||
130905047|NCT02919969|471289282|FG000|Overall Study|Withdrawal by Subject|2|||
130905048|NCT03621475|471289283|FG000|Overall Study|No longer required restraints at initiation|0|||
130905049|NCT03621475|471289284|FG001|Overall Study|No longer required restraints at initiation|1|||
130905050|NCT01842633|471289285|FG000|Overall Study|Screen Failure|1|||
130905051|NCT01842633|471289286|FG001|Overall Study|Screen Failure|0|||
130905052|NCT01842633|471289287|FG002|Overall Study|Screen Failure|0|||
130905053|NCT01842633|471289285|FG000|Overall Study|Adverse Event|1|||
130905054|NCT01842633|471289286|FG001|Overall Study|Adverse Event|1|||
130905055|NCT01842633|471289287|FG002|Overall Study|Adverse Event|0|||
130905056|NCT01842633|471289285|FG000|Overall Study|Withdrawal by Subject|0|||
130905057|NCT01842633|471289286|FG001|Overall Study|Withdrawal by Subject|1|||
130905058|NCT01842633|471289287|FG002|Overall Study|Withdrawal by Subject|0|||
130905059|NCT01842633|471289285|FG000|Overall Study|Technical issues|1|||
130905060|NCT01842633|471289286|FG001|Overall Study|Technical issues|0|||
130905061|NCT01842633|471289287|FG002|Overall Study|Technical issues|0|||
130905062|NCT02093351|471289288|FG000|Part A|Adverse Event|0|||
130905063|NCT02093351|471289289|FG001|Part A|Adverse Event|1|||
130905064|NCT02093351|471289290|FG002|Part A|Adverse Event|1|||
130905065|NCT02093351|471289291|FG003|Part A|Adverse Event|0|||
130905066|NCT02093351|471289288|FG000|Part A|Condition under investigation worsened|2|||
130905067|NCT02093351|471289289|FG001|Part A|Condition under investigation worsened|0|||
130905068|NCT02093351|471289290|FG002|Part A|Condition under investigation worsened|2|||
130905069|NCT02093351|471289291|FG003|Part A|Condition under investigation worsened|0|||
130905070|NCT02093351|471289288|FG000|Part A|Death|0|||
130905071|NCT02093351|471289289|FG001|Part A|Death|1|||
130905072|NCT02093351|471289290|FG002|Part A|Death|0|||
130905073|NCT02093351|471289291|FG003|Part A|Death|0|||
130905074|NCT02093351|471289288|FG000|Part B|Patient decision|0|||
130905075|NCT02093351|471289289|FG001|Part B|Patient decision|0|||
130905076|NCT02093351|471289290|FG002|Part B|Patient decision|0|||
130905077|NCT02093351|471289291|FG003|Part B|Patient decision|3|||
130905078|NCT02093351|471289288|FG000|Part B|Disease progression|0|||
130905079|NCT02093351|471289289|FG001|Part B|Disease progression|0|||
130905080|NCT02093351|471289290|FG002|Part B|Disease progression|0|||
130905081|NCT02093351|471289291|FG003|Part B|Disease progression|4|||
130905082|NCT02093351|471289288|FG000|Part B|Complete response|0|||
130905083|NCT02093351|471289289|FG001|Part B|Complete response|0|||
130905084|NCT02093351|471289290|FG002|Part B|Complete response|0|||
130905085|NCT02093351|471289291|FG003|Part B|Complete response|1|||
130905086|NCT02093351|471289288|FG000|Part B|Adverse event + disease progression|0|||
130905087|NCT02093351|471289289|FG001|Part B|Adverse event + disease progression|0|||
130905088|NCT02093351|471289290|FG002|Part B|Adverse event + disease progression|0|||
130905089|NCT02093351|471289291|FG003|Part B|Adverse event + disease progression|1|||
130905090|NCT02093351|471289288|FG000|Part B|Lack of therapeutic response|0|||
130905091|NCT02093351|471289289|FG001|Part B|Lack of therapeutic response|0|||
130905092|NCT02093351|471289290|FG002|Part B|Lack of therapeutic response|0|||
130905093|NCT02093351|471289291|FG003|Part B|Lack of therapeutic response|12|||
130905094|NCT02093351|471289288|FG000|Part B|Condition under investigation worsened|0|||
130905095|NCT02093351|471289289|FG001|Part B|Condition under investigation worsened|0|||
130905096|NCT02093351|471289290|FG002|Part B|Condition under investigation worsened|0|||
130905097|NCT02093351|471289291|FG003|Part B|Condition under investigation worsened|39|||
130905098|NCT02093351|471289288|FG000|Part B|Adverse Event|0|||
130905099|NCT02093351|471289289|FG001|Part B|Adverse Event|0|||
130905100|NCT02093351|471289290|FG002|Part B|Adverse Event|0|||
130905101|NCT02093351|471289291|FG003|Part B|Adverse Event|2|||
130905102|NCT02093351|471289288|FG000|Part B|Death|0|||
130905103|NCT02093351|471289289|FG001|Part B|Death|0|||
130905104|NCT02093351|471289290|FG002|Part B|Death|0|||
130905105|NCT02093351|471289291|FG003|Part B|Death|1|||
130905106|NCT01099709|471289292|FG000|Period 1|Withdrawal by Subject|0|||
130905107|NCT01099709|471289293|FG001|Period 1|Withdrawal by Subject|1|||
130905108|NCT01099709|471289292|FG000|Period 1|Positive cotinine test|0|||
130905109|NCT01099709|471289293|FG001|Period 1|Positive cotinine test|1|||
130905110|NCT01099709|471289292|FG000|Period 1|Adverse Event|1|||
130905111|NCT01099709|471289293|FG001|Period 1|Adverse Event|0|||
130905112|NCT00706849|471289300|FG000|Treatment Period|Adverse Event|0|||
130905113|NCT00706849|471289301|FG001|Treatment Period|Adverse Event|9|||
130905114|NCT00706849|471289300|FG000|Treatment Period|Other|0|||
130905115|NCT00706849|471289301|FG001|Treatment Period|Other|1|||
130905116|NCT00706849|471289300|FG000|Follow-up Period|Withdrawal by Subject|0|||
130905117|NCT00706849|471289301|FG001|Follow-up Period|Withdrawal by Subject|2|||
130905118|NCT00706849|471289300|FG000|Follow-up Period|Protocol non-compliance|0|||
130905119|NCT00706849|471289301|FG001|Follow-up Period|Protocol non-compliance|1|||
130905120|NCT01611454|471289303|FG000|Overall Study|Lack of Efficacy|18|||
130905121|NCT01611454|471289304|FG001|Overall Study|Lack of Efficacy|10|||
130905122|NCT03269552|471289305|FG000|Overall Study|Adverse Event|2|||
130905123|NCT00920907|471289306|FG000|Induction Period|Adverse Event|0|||
130905124|NCT00920907|471289307|FG001|Induction Period|Adverse Event|2|||
130905125|NCT00920907|471289306|FG000|Induction Period|Death|1|||
130905126|NCT00920907|471289307|FG001|Induction Period|Death|1|||
130905127|NCT00920907|471289306|FG000|Induction Period|Disease Progression|12|||
130905128|NCT00920907|471289307|FG001|Induction Period|Disease Progression|11|||
130905129|NCT00920907|471289306|FG000|Induction Period|Study Drug Toxicity|8|||
130905130|NCT00920907|471289307|FG001|Induction Period|Study Drug Toxicity|6|||
130905131|NCT00920907|471289306|FG000|Induction Period|No longer meets study criteria|0|||
130905132|NCT00920907|471289307|FG001|Induction Period|No longer meets study criteria|1|||
130905133|NCT00920907|471289306|FG000|Induction Period|Withdrawal by Subject|1|||
130905134|NCT00920907|471289307|FG001|Induction Period|Withdrawal by Subject|1|||
130905135|NCT00920907|471289306|FG000|Maintenance Period|Disease Progression|3|||
130905136|NCT00920907|471289307|FG001|Maintenance Period|Disease Progression|7|||
130905137|NCT00920907|471289306|FG000|Maintenance Period|Administrative (study closure)|7|||
130768398|NCT00603382|470775558|FG003|Overall Study|Physician Decision|0|||
130768399|NCT00603382|470775559|FG004|Overall Study|Physician Decision|1|||
130768400|NCT00603382|470775560|FG005|Overall Study|Physician Decision|3|||
130768401|NCT00603382|470775555|FG000|Overall Study|Withdrawal by Subject|3|||
130768402|NCT00603382|470775556|FG001|Overall Study|Withdrawal by Subject|3|||
130768403|NCT00603382|470775557|FG002|Overall Study|Withdrawal by Subject|1|||
130768404|NCT00603382|470775558|FG003|Overall Study|Withdrawal by Subject|1|||
130768405|NCT00603382|470775559|FG004|Overall Study|Withdrawal by Subject|0|||
130768406|NCT00603382|470775560|FG005|Overall Study|Withdrawal by Subject|1|||
130768407|NCT03403621|470775561|FG000|Overall Study|Withdrawal by Subject|2|||
130768408|NCT03403621|470775562|FG001|Overall Study|Withdrawal by Subject|2|||
130768409|NCT00583102|470775563|FG000|Overall Study|Adverse Event|3|||
130768410|NCT02333383|470775564|FG000|Overall Study|Adalimumab discontinuation|21|||
130768411|NCT02333383|470775564|FG000|Overall Study|Lost to Follow-up|15|||
130768412|NCT02333383|470775564|FG000|Overall Study|Withdrawal by Subject|3|||
130768413|NCT02333383|470775564|FG000|Overall Study|Transfer to another hospital|2|||
130905138|NCT00920907|471289307|FG001|Maintenance Period|Administrative (study closure)|2|||
130905139|NCT00920907|471289306|FG000|Maintenance Period|Study Drug Toxicity|0|||
130905140|NCT00920907|471289307|FG001|Maintenance Period|Study Drug Toxicity|2|||
130905141|NCT00920907|471289306|FG000|Maintenance Period|Death|1|||
130905142|NCT00920907|471289307|FG001|Maintenance Period|Death|1|||
130905143|NCT00920907|471289306|FG000|Maintenance Period|Withdrawal by Subject|1|||
130905144|NCT00920907|471289307|FG001|Maintenance Period|Withdrawal by Subject|0|||
130905145|NCT00920907|471289306|FG000|Maintenance Period|Adverse Event|0|||
130905146|NCT00920907|471289307|FG001|Maintenance Period|Adverse Event|1|||
131027963|NCT04868110|471733845|FG000|Overall Study|Withdrawal by Subject|3|||
131027964|NCT04868110|471733846|FG001|Overall Study|Withdrawal by Subject|4|||
131027965|NCT04823611|471733847|FG000|Overall Study|Adverse Event|2|||
131027966|NCT04823611|471733848|FG001|Overall Study|Adverse Event|0|||
131027967|NCT04823611|471733849|FG002|Overall Study|Adverse Event|1|||
131027968|NCT04823611|471733850|FG003|Overall Study|Adverse Event|0|||
131027969|NCT04823611|471733851|FG004|Overall Study|Adverse Event|0|||
131027970|NCT04823611|471733852|FG005|Overall Study|Adverse Event|0|||
130905147|NCT02616601|471289308|FG000|Overall Study|Withdrawal by Subject|4|||
130905148|NCT02616601|471289309|FG001|Overall Study|Withdrawal by Subject|4|||
131114074|NCT04175808|472048992|FG004|Part A|Miscellaneous|0|||
131027971|NCT04823611|471733853|FG006|Overall Study|Adverse Event|0|||
130905149|NCT02616601|471289310|FG002|Overall Study|Withdrawal by Subject|3|||
130905150|NCT02616601|471289308|FG000|Overall Study|Adverse Event|2|||
130905151|NCT02616601|471289309|FG001|Overall Study|Adverse Event|0|||
130905152|NCT02616601|471289310|FG002|Overall Study|Adverse Event|2|||
130905153|NCT02616601|471289308|FG000|Overall Study|Death|1|||
130905154|NCT02616601|471289309|FG001|Overall Study|Death|0|||
130905155|NCT02616601|471289310|FG002|Overall Study|Death|0|||
130905156|NCT02616601|471289308|FG000|Overall Study|Lost to Follow-up|1|||
130905157|NCT02616601|471289309|FG001|Overall Study|Lost to Follow-up|0|||
130905158|NCT02616601|471289310|FG002|Overall Study|Lost to Follow-up|1|||
130905159|NCT02616601|471289308|FG000|Overall Study|Non-Compliance with Test Article|1|||
130905160|NCT02616601|471289309|FG001|Overall Study|Non-Compliance with Test Article|0|||
130905161|NCT02616601|471289310|FG002|Overall Study|Non-Compliance with Test Article|1|||
130905162|NCT00039871|471289311|FG000|Overall Study|Adverse Event|165|||
130905163|NCT00039871|471289311|FG000|Overall Study|Lost to Follow-up|18|||
130905164|NCT00039871|471289311|FG000|Overall Study|Protocol Violation|24|||
130905165|NCT00039871|471289311|FG000|Overall Study|Withdrawal by Subject|97|||
130905166|NCT00039871|471289311|FG000|Overall Study|Did not meet eligibility criteria|11|||
130905167|NCT00039871|471289311|FG000|Overall Study|Administrative|1|||
130905168|NCT00039871|471289311|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
130905169|NCT00039871|471289311|FG000|Overall Study|Never entered follow-up|7|||
130905170|NCT02186301|471289312|FG000|Overall Study|Progressive Disease|7|||
130905171|NCT02186301|471289313|FG001|Overall Study|Progressive Disease|22|||
130905172|NCT02186301|471289314|FG002|Overall Study|Progressive Disease|27|||
130905173|NCT02186301|471289312|FG000|Overall Study|Adverse Event|5|||
130905174|NCT02186301|471289313|FG001|Overall Study|Adverse Event|5|||
130905175|NCT02186301|471289314|FG002|Overall Study|Adverse Event|5|||
130905176|NCT02186301|471289312|FG000|Overall Study|Death|1|||
130905177|NCT02186301|471289313|FG001|Overall Study|Death|0|||
130905178|NCT02186301|471289314|FG002|Overall Study|Death|0|||
130905179|NCT02186301|471289312|FG000|Overall Study|Withdrawal by Subject|5|||
130905180|NCT02186301|471289313|FG001|Overall Study|Withdrawal by Subject|1|||
130905181|NCT02186301|471289314|FG002|Overall Study|Withdrawal by Subject|3|||
130905182|NCT02186301|471289312|FG000|Overall Study|Physician Decision|1|||
130905183|NCT02186301|471289313|FG001|Overall Study|Physician Decision|0|||
130905184|NCT02186301|471289314|FG002|Overall Study|Physician Decision|1|||
130905185|NCT02186301|471289312|FG000|Overall Study|Study Terminated by Sponsor|1|||
130905186|NCT02186301|471289313|FG001|Overall Study|Study Terminated by Sponsor|0|||
130905187|NCT02186301|471289314|FG002|Overall Study|Study Terminated by Sponsor|11|||
130905188|NCT02186301|471289312|FG000|Overall Study|Protocol Deviation|0|||
130905189|NCT02186301|471289313|FG001|Overall Study|Protocol Deviation|2|||
130905190|NCT02186301|471289314|FG002|Overall Study|Protocol Deviation|0|||
130905191|NCT02186301|471289312|FG000|Overall Study|Missing|0|||
130905192|NCT02186301|471289313|FG001|Overall Study|Missing|0|||
130905193|NCT02186301|471289314|FG002|Overall Study|Missing|2|||
130905194|NCT02186301|471289312|FG000|Overall Study|Other|0|||
130905195|NCT02186301|471289313|FG001|Overall Study|Other|0|||
130905196|NCT02186301|471289314|FG002|Overall Study|Other|1|||
130905197|NCT03560739|471289316|FG000|Overall Study|Adverse Event|0|||
130905198|NCT03560739|471289317|FG001|Overall Study|Adverse Event|1|||
130905199|NCT03560739|471289318|FG002|Overall Study|Adverse Event|0|||
130905200|NCT03560739|471289319|FG003|Overall Study|Adverse Event|0|||
130905201|NCT01275339|471289320|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
130905202|NCT01275339|471289321|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
130905203|NCT01275339|471289322|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
130905204|NCT01275339|471289323|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
130905205|NCT01275339|471289320|FG000|Overall Study|Withdrawal by Subject|0|||
130905206|NCT01275339|471289321|FG001|Overall Study|Withdrawal by Subject|0|||
131027972|NCT01894061|471733855|FG000|Overall Study|Screen failure|1|||
131114075|NCT04175808|472048993|FG005|Part A|Miscellaneous|0|||
130905207|NCT01275339|471289322|FG002|Overall Study|Withdrawal by Subject|1|||
130905208|NCT01275339|471289323|FG003|Overall Study|Withdrawal by Subject|0|||
130905209|NCT02478398|471289324|FG000|Overall Study|Adverse Event|20|||
130905210|NCT02478398|471289325|FG001|Overall Study|Adverse Event|5|||
131027973|NCT01894061|471733855|FG000|Overall Study|Withdrawal by Subject|1|||
131027974|NCT05384730|471733856|FG000|Overall Study|Adverse Event|1|||
131027975|NCT05384730|471733857|FG001|Overall Study|Adverse Event|0|||
131027976|NCT05384730|471733856|FG000|Overall Study|Lack of social support|2|||
131027977|NCT05384730|471733857|FG001|Overall Study|Lack of social support|0|||
131027978|NCT05384730|471733856|FG000|Overall Study|Hospital readmission|2|||
130905211|NCT02478398|471289324|FG000|Overall Study|Lost to Follow-up|5|||
130905212|NCT02478398|471289325|FG001|Overall Study|Lost to Follow-up|4|||
130905213|NCT02478398|471289324|FG000|Overall Study|Non-Compliance With Study Drug|5|||
131027979|NCT05384730|471733857|FG001|Overall Study|Hospital readmission|0|||
131027980|NCT05384730|471733856|FG000|Overall Study|Disease progression|5|||
131114076|NCT04175808|472048994|FG006|Part A|Miscellaneous|0|||
130905214|NCT02478398|471289325|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130905215|NCT02478398|471289324|FG000|Overall Study|Protocol Violation|3|||
131027981|NCT05384730|471733857|FG001|Overall Study|Disease progression|0|||
130905216|NCT02478398|471289325|FG001|Overall Study|Protocol Violation|1|||
130905217|NCT02478398|471289324|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
130905218|NCT02478398|471289325|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
130905219|NCT02478398|471289324|FG000|Overall Study|Withdrawal By Participant|10|||
130905220|NCT02478398|471289325|FG001|Overall Study|Withdrawal By Participant|4|||
130905221|NCT03123185|471289326|FG000|Overall Study|Withdrawal by Subject|0|||
130905222|NCT03123185|471289327|FG001|Overall Study|Withdrawal by Subject|0|||
130905223|NCT03123185|471289328|FG002|Overall Study|Withdrawal by Subject|0|||
130905224|NCT03123185|471289329|FG003|Overall Study|Withdrawal by Subject|0|||
130905225|NCT03123185|471289330|FG004|Overall Study|Withdrawal by Subject|0|||
130905226|NCT03123185|471289331|FG005|Overall Study|Withdrawal by Subject|0|||
130905227|NCT03123185|471289332|FG006|Overall Study|Withdrawal by Subject|0|||
130905228|NCT03123185|471289333|FG007|Overall Study|Withdrawal by Subject|0|||
130905229|NCT03123185|471289334|FG008|Overall Study|Withdrawal by Subject|0|||
130905230|NCT03123185|471289335|FG009|Overall Study|Withdrawal by Subject|0|||
130905231|NCT03123185|471289336|FG010|Overall Study|Withdrawal by Subject|0|||
130905232|NCT03123185|471289337|FG011|Overall Study|Withdrawal by Subject|0|||
130905233|NCT03123185|471289338|FG012|Overall Study|Withdrawal by Subject|1|||
130905234|NCT03123185|471289339|FG013|Overall Study|Withdrawal by Subject|0|||
130905235|NCT00718081|471289342|FG000|Overall Study|Adverse Event|0|||
130905236|NCT00718081|471289343|FG001|Overall Study|Adverse Event|1|||
130905237|NCT00718081|471289344|FG002|Overall Study|Adverse Event|0|||
130905238|NCT00718081|471289342|FG000|Overall Study|Lack of Efficacy|7|||
130905239|NCT00718081|471289343|FG001|Overall Study|Lack of Efficacy|3|||
130905240|NCT00718081|471289344|FG002|Overall Study|Lack of Efficacy|21|||
130905241|NCT01741012|471289346|FG000|Overall Study|Lost to Follow-up|1|||
130905242|NCT01741012|471289346|FG000|Overall Study|Withdrawal by Subject|2|||
130905243|NCT00880685|471289347|FG000|Memantine 10mg|Lost to Follow-up|2|||
130905244|NCT00880685|471289347|FG000|Memantine 20mg|Withdrawal by Subject|1|||
130905245|NCT01249118|471289348|FG000|First Washout Period|Physician Decision|0|||
130905246|NCT01249118|471289349|FG001|First Washout Period|Physician Decision|1|||
130905247|NCT01249118|471289350|FG002|First Washout Period|Physician Decision|0|||
130905248|NCT04179890|471289351|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
130905249|NCT04179890|471289352|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
130905250|NCT04179890|471289351|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
130905251|NCT04179890|471289352|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
130905252|NCT04179890|471289351|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
130905253|NCT04179890|471289352|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
130905254|NCT04179890|471289351|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
130905255|NCT04179890|471289352|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
130905256|NCT04179890|471289351|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
130905257|NCT04179890|471289352|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
130905258|NCT04179890|471289351|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
130905259|NCT04179890|471289352|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
130905260|NCT04179890|471289351|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
130905261|NCT04179890|471289352|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
130905262|NCT04179890|471289351|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
130905263|NCT04179890|471289352|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
130905264|NCT04179890|471289351|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
130905265|NCT04179890|471289352|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
130905266|NCT04369924|471289356|FG000|Overall Study|Lost to Follow-up|302|||
130905267|NCT04369924|471289357|FG001|Overall Study|Lost to Follow-up|339|||
130905268|NCT01323920|471289367|FG000|Overall Study|Death|5|||
130905269|NCT01323920|471289367|FG000|Overall Study|Withdrawal by Subject|1|||
130905270|NCT02915874|471289368|FG000|Overall Study|Lost to Follow-up|5|||
130905271|NCT02915874|471289369|FG001|Overall Study|Lost to Follow-up|4|||
130905272|NCT02915874|471289368|FG000|Overall Study|Withdrawal by Subject|1|||
130905273|NCT02915874|471289369|FG001|Overall Study|Withdrawal by Subject|1|||
130905274|NCT02915874|471289368|FG000|Overall Study|Started New Anxiety Medication|0|||
130905275|NCT02915874|471289369|FG001|Overall Study|Started New Anxiety Medication|1|||
130905276|NCT01056380|471289371|FG000|Overall Study|Lost to Follow-up|2|||
130905277|NCT01056380|471289372|FG001|Overall Study|Lost to Follow-up|3|||
130905278|NCT03901456|471289373|FG000|Overall Study|Withdrawal by Subject|0|||
130905279|NCT03901456|471289374|FG001|Overall Study|Withdrawal by Subject|0|||
130905280|NCT03901456|471289375|FG002|Overall Study|Withdrawal by Subject|1|||
130905281|NCT03901456|471289373|FG000|Overall Study|Lost to Follow-up|0|||
130905282|NCT03901456|471289374|FG001|Overall Study|Lost to Follow-up|1|||
130905283|NCT03901456|471289375|FG002|Overall Study|Lost to Follow-up|0|||
130905284|NCT00732940|471289376|FG000|Overall Study|Withdrawal by Subject|1|||
130905285|NCT00732940|471289377|FG001|Overall Study|Withdrawal by Subject|2|||
130905286|NCT00732940|471289376|FG000|Overall Study|Adverse Event|0|||
130905287|NCT00732940|471289377|FG001|Overall Study|Adverse Event|1|||
130905288|NCT00732940|471289376|FG000|Overall Study|Lost to Follow-up|1|||
130905289|NCT00732940|471289377|FG001|Overall Study|Lost to Follow-up|0|||
130905290|NCT00773838|471289378|FG000|Overall Study|Adverse Event|29|||
130905291|NCT00773838|471289378|FG000|Overall Study|Lost to Follow-up|1|||
130905292|NCT00773838|471289378|FG000|Overall Study|Physician Decision|8|||
130905293|NCT00773838|471289378|FG000|Overall Study|Progressive Disease|82|||
130905294|NCT00773838|471289378|FG000|Overall Study|Protocol Violation|2|||
130905295|NCT00773838|471289378|FG000|Overall Study|Withdrawal by Subject|21|||
130905296|NCT00509262|471289384|FG000|Overall Study|Adverse Event|16|||
130905297|NCT00509262|471289385|FG001|Overall Study|Adverse Event|18|||
130905298|NCT00509262|471289384|FG000|Overall Study|Other|2|||
130905299|NCT00509262|471289385|FG001|Overall Study|Other|2|||
130905300|NCT00509262|471289384|FG000|Overall Study|Lack of Efficacy|1|||
130905301|NCT00509262|471289385|FG001|Overall Study|Lack of Efficacy|0|||
130905302|NCT00509262|471289384|FG000|Overall Study|Lost to Follow-up|1|||
130905303|NCT00509262|471289385|FG001|Overall Study|Lost to Follow-up|6|||
130905304|NCT00509262|471289384|FG000|Overall Study|Physician Decision|1|||
130905305|NCT00509262|471289385|FG001|Overall Study|Physician Decision|3|||
130905306|NCT00509262|471289384|FG000|Overall Study|Protocol Violation|2|||
130905307|NCT00509262|471289385|FG001|Overall Study|Protocol Violation|2|||
130905308|NCT00509262|471289384|FG000|Overall Study|Withdrawal by Subject|24|||
130905309|NCT00509262|471289385|FG001|Overall Study|Withdrawal by Subject|11|||
130905310|NCT01589770|471289386|FG000|Overall Study|EGFR <60ml/min|6|||
130905311|NCT01589770|471289387|FG001|Overall Study|EGFR <60ml/min|4|||
130905312|NCT01589770|471289386|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
130905313|NCT01589770|471289387|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
130905314|NCT01658813|471289390|FG000|Overall Study|Disease progression|3|||
130905315|NCT02674854|471289391|FG000|Overall Study|Adverse Event|17|||
130905316|NCT02674854|471289392|FG001|Overall Study|Adverse Event|15|||
130905317|NCT02674854|471289393|FG002|Overall Study|Adverse Event|5|||
130905318|NCT02674854|471289391|FG000|Overall Study|Withdrawal by Subject|1|||
130905319|NCT02674854|471289392|FG001|Overall Study|Withdrawal by Subject|5|||
130905320|NCT02674854|471289393|FG002|Overall Study|Withdrawal by Subject|4|||
131114077|NCT02021292|472048998|FG000|Overall Study|Physician Decision|0|||
131114078|NCT02021292|472048999|FG001|Overall Study|Physician Decision|1|||
131114079|NCT02021292|472048998|FG000|Overall Study|Lost to Follow-up|0|||
131114080|NCT02021292|472048999|FG001|Overall Study|Lost to Follow-up|1|||
131114081|NCT02021292|472048998|FG000|Overall Study|Death|0|||
131114082|NCT02021292|472048999|FG001|Overall Study|Death|1|||
131114083|NCT05972733|472049000|FG000|Overall Study|Lost to Follow-up|2|||
131114084|NCT05972733|472049000|FG000|Overall Study|Withdrawal by Subject|1|||
131114085|NCT04982588|472049003|FG000|Overall Study|Withdrawal by Subject|2|||
130905321|NCT02674854|471289391|FG000|Overall Study|No-compliant subject|1|||
130905322|NCT02674854|471289392|FG001|Overall Study|No-compliant subject|0|||
130905323|NCT02674854|471289393|FG002|Overall Study|No-compliant subject|1|||
131114086|NCT02366728|472049005|FG000|Overall Study|Death|0|||
131114087|NCT02366728|472049006|FG001|Overall Study|Death|0|||
131114088|NCT02366728|472049007|FG002|Overall Study|Death|1|||
131114089|NCT02366728|472049005|FG000|Overall Study|Adverse Event|1|||
130905324|NCT02674854|471289391|FG000|Overall Study|Lost to Follow-up|1|||
130905325|NCT02674854|471289392|FG001|Overall Study|Lost to Follow-up|0|||
130905326|NCT02674854|471289393|FG002|Overall Study|Lost to Follow-up|2|||
130905327|NCT02674854|471289391|FG000|Overall Study|Lack of Efficacy|0|||
130905328|NCT02674854|471289392|FG001|Overall Study|Lack of Efficacy|3|||
130905329|NCT02674854|471289393|FG002|Overall Study|Lack of Efficacy|0|||
131114090|NCT02366728|472049006|FG001|Overall Study|Adverse Event|0|||
131114091|NCT02366728|472049007|FG002|Overall Study|Adverse Event|0|||
131114092|NCT02366728|472049005|FG000|Overall Study|Screen Failure|2|||
131114093|NCT02366728|472049006|FG001|Overall Study|Screen Failure|1|||
131114094|NCT02366728|472049007|FG002|Overall Study|Screen Failure|0|||
130905330|NCT02674854|471289391|FG000|Overall Study|Disallowed Concurrent Medication|2|||
130905331|NCT02674854|471289392|FG001|Overall Study|Disallowed Concurrent Medication|2|||
130905332|NCT02674854|471289393|FG002|Overall Study|Disallowed Concurrent Medication|0|||
130905333|NCT02674854|471289391|FG000|Overall Study|Protocol Violation|1|||
130905334|NCT02674854|471289392|FG001|Overall Study|Protocol Violation|1|||
130905335|NCT02674854|471289393|FG002|Overall Study|Protocol Violation|2|||
130905336|NCT02674854|471289391|FG000|Overall Study|Death|0|||
130905337|NCT02674854|471289392|FG001|Overall Study|Death|1|||
130905338|NCT02674854|471289393|FG002|Overall Study|Death|0|||
130905339|NCT02674854|471289391|FG000|Overall Study|Subject missed V6.2|1|||
130905340|NCT02674854|471289392|FG001|Overall Study|Subject missed V6.2|0|||
131114095|NCT02366728|472049005|FG000|Overall Study|Only yielded 2 vaccines|1|||
131114096|NCT02366728|472049006|FG001|Overall Study|Only yielded 2 vaccines|0|||
130768414|NCT04459598|470775567|FG000|Overall Study|Adverse Event|1|||
130905341|NCT02674854|471289393|FG002|Overall Study|Subject missed V6.2|0|||
131114097|NCT02366728|472049007|FG002|Overall Study|Only yielded 2 vaccines|0|||
130905342|NCT04738318|471289394|FG000|Overall Study|Protocol Violation|1|||
130905343|NCT04738318|471289395|FG001|Overall Study|Protocol Violation|0|||
130905344|NCT02290431|471289396|FG000|Overall Study|Adverse Event|20|||
130905345|NCT02290431|471289396|FG000|Overall Study|Progressive disease|4|||
130905346|NCT02290431|471289396|FG000|Overall Study|Study terminated by Sponsor|1|||
130905347|NCT02290431|471289396|FG000|Overall Study|Physician Decision|2|||
130905348|NCT00821327|471289397|FG000|Overall Study|Adverse Event|13|||
130905349|NCT00821327|471289397|FG000|Overall Study|Patient Request|1|||
130905350|NCT00821327|471289397|FG000|Overall Study|Investigator Request|2|||
130905351|NCT00821327|471289397|FG000|Overall Study|Sponsor Request|1|||
130905352|NCT00821327|471289397|FG000|Overall Study|Disease Progression|13|||
130905353|NCT00821327|471289397|FG000|Overall Study|Other/Unknown|5|||
130905354|NCT02119676|471289398|FG000|Overall Study|Adverse Event|9|||
130905355|NCT02119676|471289399|FG001|Overall Study|Adverse Event|17|||
130905356|NCT02119676|471289400|FG002|Overall Study|Adverse Event|10|||
130905357|NCT02119676|471289401|FG003|Overall Study|Adverse Event|10|||
130905358|NCT02119676|471289398|FG000|Overall Study|Disease progression|53|||
130905359|NCT02119676|471289399|FG001|Overall Study|Disease progression|55|||
130905360|NCT02119676|471289400|FG002|Overall Study|Disease progression|68|||
130905361|NCT02119676|471289401|FG003|Overall Study|Disease progression|73|||
130905362|NCT02119676|471289398|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
130905363|NCT02119676|471289399|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
130905364|NCT02119676|471289400|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
130905365|NCT02119676|471289401|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
130905366|NCT02119676|471289398|FG000|Overall Study|Physician Decision|4|||
130905367|NCT02119676|471289399|FG001|Overall Study|Physician Decision|2|||
130905368|NCT02119676|471289400|FG002|Overall Study|Physician Decision|3|||
130905369|NCT02119676|471289401|FG003|Overall Study|Physician Decision|2|||
130905370|NCT02119676|471289398|FG000|Overall Study|Death|9|||
130905371|NCT02119676|471289399|FG001|Overall Study|Death|3|||
130905372|NCT02119676|471289400|FG002|Overall Study|Death|2|||
130905373|NCT02119676|471289401|FG003|Overall Study|Death|1|||
130905374|NCT02119676|471289398|FG000|Overall Study|Noncompliance|0|||
130905375|NCT02119676|471289399|FG001|Overall Study|Noncompliance|1|||
130905376|NCT02119676|471289400|FG002|Overall Study|Noncompliance|0|||
130905377|NCT02119676|471289401|FG003|Overall Study|Noncompliance|0|||
130905378|NCT02119676|471289398|FG000|Overall Study|Lost to Follow-up|0|||
130905379|NCT02119676|471289399|FG001|Overall Study|Lost to Follow-up|0|||
130905380|NCT02119676|471289400|FG002|Overall Study|Lost to Follow-up|1|||
130905381|NCT02119676|471289401|FG003|Overall Study|Lost to Follow-up|0|||
130905382|NCT02119676|471289398|FG000|Overall Study|Protocol deviation|0|||
130905383|NCT02119676|471289399|FG001|Overall Study|Protocol deviation|0|||
130905384|NCT02119676|471289400|FG002|Overall Study|Protocol deviation|1|||
130905385|NCT02119676|471289401|FG003|Overall Study|Protocol deviation|0|||
130905386|NCT02119676|471289398|FG000|Overall Study|Other, unspecified|2|||
130905387|NCT02119676|471289399|FG001|Overall Study|Other, unspecified|1|||
130905388|NCT02119676|471289400|FG002|Overall Study|Other, unspecified|3|||
130905389|NCT02119676|471289401|FG003|Overall Study|Other, unspecified|4|||
130905390|NCT02119676|471289398|FG000|Overall Study|Did not receive study med|2|||
130905391|NCT02119676|471289399|FG001|Overall Study|Did not receive study med|2|||
130905392|NCT02119676|471289400|FG002|Overall Study|Did not receive study med|4|||
130905393|NCT02119676|471289401|FG003|Overall Study|Did not receive study med|5|||
130905394|NCT00219544|471289402|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
130905395|NCT00219544|471289403|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
130905396|NCT00219544|471289402|FG000|Single Blind Treatment Period|Adverse Event|9|||
130905397|NCT00219544|471289403|FG001|Single Blind Treatment Period|Adverse Event|0|||
130905398|NCT00219544|471289402|FG000|Single Blind Treatment Period|Protocol Violation|4|||
130905399|NCT00219544|471289403|FG001|Single Blind Treatment Period|Protocol Violation|0|||
130905400|NCT00219544|471289402|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
130905401|NCT00219544|471289403|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
130905402|NCT00219544|471289402|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
130905403|NCT00219544|471289403|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
130905404|NCT00219544|471289402|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
130905405|NCT00219544|471289403|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
130905406|NCT01007253|471289406|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
130905407|NCT01007253|471289407|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
130905408|NCT01007253|471289408|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
130768415|NCT04459598|470775568|FG001|Overall Study|Adverse Event|1|||
130905409|NCT01007253|471289409|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
130905410|NCT00814801|471289410|FG000|Overall Study|Adverse Event|15|||
130905411|NCT00814801|471289411|FG001|Overall Study|Adverse Event|16|||
130905412|NCT00814801|471289412|FG002|Overall Study|Adverse Event|19|||
130905413|NCT00814801|471289410|FG000|Overall Study|Withdrawal by Subject|9|||
130905414|NCT00814801|471289411|FG001|Overall Study|Withdrawal by Subject|11|||
130905415|NCT00814801|471289412|FG002|Overall Study|Withdrawal by Subject|14|||
130905416|NCT00814801|471289410|FG000|Overall Study|Inappropriate as a subject|1|||
130905417|NCT00814801|471289411|FG001|Overall Study|Inappropriate as a subject|1|||
130905418|NCT00814801|471289412|FG002|Overall Study|Inappropriate as a subject|1|||
130905419|NCT00814801|471289410|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
130905420|NCT00814801|471289411|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
130905421|NCT00814801|471289412|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
130905422|NCT00814801|471289410|FG000|Overall Study|Missing or change of caregiver|6|||
130905423|NCT00814801|471289411|FG001|Overall Study|Missing or change of caregiver|2|||
130905424|NCT00814801|471289412|FG002|Overall Study|Missing or change of caregiver|4|||
130905425|NCT00814801|471289410|FG000|Overall Study|Non-compliance|0|||
130905426|NCT00814801|471289411|FG001|Overall Study|Non-compliance|1|||
130905427|NCT00814801|471289412|FG002|Overall Study|Non-compliance|1|||
130905428|NCT00814801|471289410|FG000|Overall Study|Other|2|||
130905429|NCT00814801|471289411|FG001|Overall Study|Other|6|||
130905430|NCT00814801|471289412|FG002|Overall Study|Other|4|||
130905431|NCT00586664|471289413|FG000|Overall Study|Withdrawal by Subject|3|||
130905432|NCT00586664|471289414|FG001|Overall Study|Withdrawal by Subject|7|||
130905433|NCT00586664|471289415|FG002|Overall Study|Withdrawal by Subject|1|||
130905434|NCT00586664|471289413|FG000|Overall Study|Exclusion criteria met|2|||
130905435|NCT00586664|471289414|FG001|Overall Study|Exclusion criteria met|0|||
130905436|NCT00586664|471289415|FG002|Overall Study|Exclusion criteria met|0|||
130905437|NCT02751931|471289416|FG000|Overall Study|Adverse Event|3|||
130905438|NCT02751931|471289417|FG001|Overall Study|Adverse Event|0|||
130905439|NCT02751931|471289416|FG000|Overall Study|Other: Miscelleneous|10|||
130905440|NCT02751931|471289417|FG001|Overall Study|Other: Miscelleneous|8|||
130905441|NCT01037088|471289418|FG000|Overall Study|Withdrawal by Subject|3|||
130905442|NCT01585584|471289419|FG000|Overall Study|Lack of Efficacy|1|||
130905443|NCT01585584|471289419|FG000|Overall Study|Withdrawal by Subject|1|||
130905444|NCT01585584|471289419|FG000|Overall Study|Physician Decision|2|||
130905445|NCT00095238|471291179|FG000|Overall Study|Lack of Efficacy|9|||
130905446|NCT00095238|471291180|FG001|Overall Study|Lack of Efficacy|9|||
130905447|NCT00095238|471291179|FG000|Overall Study|Adverse Event|331|||
130905448|NCT00095238|471291180|FG001|Overall Study|Adverse Event|287|||
130905449|NCT00095238|471291179|FG000|Overall Study|Subject Withdrew Consent|208|||
130905450|NCT00095238|471291180|FG001|Overall Study|Subject Withdrew Consent|223|||
130905451|NCT00095238|471291179|FG000|Overall Study|Death|154|||
130905452|NCT00095238|471291180|FG001|Overall Study|Death|170|||
131114098|NCT00992511|472049008|FG000|Overall Study|Migrated/moved from study area|1|||
131114099|NCT00992511|472049009|FG001|Overall Study|Migrated/moved from study area|0|||
131114100|NCT00992511|472049010|FG002|Overall Study|Migrated/moved from study area|1|||
131114101|NCT00992511|472049011|FG003|Overall Study|Migrated/moved from study area|2|||
131114102|NCT00992511|472049008|FG000|Overall Study|Lost to Follow-up|1|||
131114103|NCT00992511|472049009|FG001|Overall Study|Lost to Follow-up|0|||
131114104|NCT00992511|472049010|FG002|Overall Study|Lost to Follow-up|0|||
131114105|NCT00992511|472049011|FG003|Overall Study|Lost to Follow-up|2|||
131114106|NCT00992511|472049008|FG000|Overall Study|Withdrawal by Subject|0|||
131114107|NCT00992511|472049009|FG001|Overall Study|Withdrawal by Subject|0|||
131114108|NCT00992511|472049010|FG002|Overall Study|Withdrawal by Subject|1|||
131114109|NCT00992511|472049011|FG003|Overall Study|Withdrawal by Subject|1|||
131114110|NCT04498169|472049012|FG000|Study Completion|Adverse Event|1|||
131114111|NCT04498169|472049013|FG001|Study Completion|Adverse Event|1|||
131114112|NCT04615247|472049014|FG000|Overall Study|Adverse Event|0|||
131114113|NCT04615247|472049015|FG001|Overall Study|Adverse Event|2|||
131114114|NCT04615247|472049014|FG000|Overall Study|Withdrawal by Subject|1|||
131114115|NCT04615247|472049015|FG001|Overall Study|Withdrawal by Subject|1|||
131114116|NCT01383161|472049020|FG000|Overall Study|Adverse Event|5|||
130694665|NCT00112437|470505933|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694666|NCT00112437|470505934|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694667|NCT00112437|470505935|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694668|NCT00112437|470505936|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694669|NCT00112437|470505937|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
130905453|NCT00095238|471291179|FG000|Overall Study|Lost to Follow-up|19|||
130905454|NCT00095238|471291180|FG001|Overall Study|Lost to Follow-up|24|||
130905455|NCT00095238|471291179|FG000|Overall Study|Noncompliance|44|||
130905456|NCT00095238|471291180|FG001|Overall Study|Noncompliance|45|||
130905457|NCT00095238|471291179|FG000|Overall Study|No longer met study criteria|4|||
130905458|NCT00095238|471291180|FG001|Overall Study|No longer met study criteria|5|||
130905459|NCT00095238|471291179|FG000|Overall Study|Study terminated by sponsor|0|||
131114117|NCT01383161|472049021|FG001|Overall Study|Adverse Event|1|||
130694670|NCT00112437|470505938|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130905460|NCT00095238|471291180|FG001|Overall Study|Study terminated by sponsor|1|||
130905461|NCT00095238|471291179|FG000|Overall Study|Missing|1|||
130905462|NCT00095238|471291180|FG001|Overall Study|Missing|0|||
130694671|NCT00112437|470505939|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130905463|NCT00095238|471291179|FG000|Overall Study|Other Reasons|87|||
131114118|NCT01383161|472049020|FG000|Overall Study|Withdrawal by Subject|0|||
131114119|NCT01383161|472049021|FG001|Overall Study|Withdrawal by Subject|2|||
131114120|NCT01383161|472049020|FG000|Overall Study|Lack of Efficacy|0|||
131114121|NCT01383161|472049021|FG001|Overall Study|Lack of Efficacy|1|||
130905464|NCT00095238|471291180|FG001|Overall Study|Other Reasons|88|||
130905465|NCT02038829|471291183|FG000|Washout Period 1|Death|0|||
130905466|NCT02038829|471291184|FG001|Washout Period 1|Death|0|||
130905467|NCT02038829|471291185|FG002|Washout Period 1|Death|0|||
130905468|NCT02038829|471291186|FG003|Washout Period 1|Death|0|||
130905469|NCT02038829|471291187|FG004|Washout Period 1|Death|1|||
130905470|NCT02038829|471291188|FG005|Washout Period 1|Death|0|||
130905471|NCT02038829|471291189|FG006|Washout Period 1|Death|0|||
130905472|NCT02038829|471291190|FG007|Washout Period 1|Death|0|||
130905473|NCT02038829|471291191|FG008|Washout Period 1|Death|0|||
130905474|NCT02038829|471291192|FG009|Washout Period 1|Death|0|||
130905475|NCT02038829|471291193|FG010|Washout Period 1|Death|0|||
130905476|NCT02038829|471291194|FG011|Washout Period 1|Death|0|||
130905477|NCT02038829|471291183|FG000|Treatment Period 2|Adverse Event|0|||
130905478|NCT02038829|471291184|FG001|Treatment Period 2|Adverse Event|0|||
130905479|NCT02038829|471291185|FG002|Treatment Period 2|Adverse Event|0|||
130905480|NCT02038829|471291186|FG003|Treatment Period 2|Adverse Event|0|||
130905481|NCT02038829|471291187|FG004|Treatment Period 2|Adverse Event|0|||
130905482|NCT02038829|471291188|FG005|Treatment Period 2|Adverse Event|0|||
130905483|NCT02038829|471291189|FG006|Treatment Period 2|Adverse Event|0|||
130905484|NCT02038829|471291190|FG007|Treatment Period 2|Adverse Event|0|||
130905485|NCT02038829|471291191|FG008|Treatment Period 2|Adverse Event|0|||
131027982|NCT05384730|471733856|FG000|Overall Study|Overwhelmed with College commitments|0|||
131027983|NCT05384730|471733857|FG001|Overall Study|Overwhelmed with College commitments|2|||
131027984|NCT04436107|471733861|FG000|Overall Study|Sponsor Ended Study|2|||
131027985|NCT04436107|471733862|FG001|Overall Study|Sponsor Ended Study|4|||
131027986|NCT04436107|471733863|FG002|Overall Study|Sponsor Ended Study|8|||
131027987|NCT04436107|471733864|FG003|Overall Study|Sponsor Ended Study|20|||
131027988|NCT04436107|471733861|FG000|Overall Study|Death|3|||
131027989|NCT04436107|471733862|FG001|Overall Study|Death|5|||
131027990|NCT04436107|471733863|FG002|Overall Study|Death|3|||
130768416|NCT01907217|470775569|FG000|Overall Study|Withdrawal by Subject|0|||
130905486|NCT02038829|471291192|FG009|Treatment Period 2|Adverse Event|0|||
130905487|NCT02038829|471291193|FG010|Treatment Period 2|Adverse Event|1|||
130905488|NCT02038829|471291194|FG011|Treatment Period 2|Adverse Event|0|||
130905489|NCT02038829|471291183|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130905490|NCT02038829|471291184|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130905491|NCT02038829|471291185|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130905492|NCT02038829|471291186|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130905493|NCT02038829|471291187|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130905494|NCT02038829|471291188|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130905495|NCT02038829|471291189|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130905496|NCT02038829|471291190|FG007|Treatment Period 2|Withdrawal by Subject|0|||
130905497|NCT02038829|471291191|FG008|Treatment Period 2|Withdrawal by Subject|0|||
130905498|NCT02038829|471291192|FG009|Treatment Period 2|Withdrawal by Subject|0|||
130905499|NCT02038829|471291193|FG010|Treatment Period 2|Withdrawal by Subject|0|||
130905500|NCT02038829|471291194|FG011|Treatment Period 2|Withdrawal by Subject|0|||
130905501|NCT02038829|471291183|FG000|Washout Period 2|Adverse Event|0|||
130905502|NCT02038829|471291184|FG001|Washout Period 2|Adverse Event|0|||
130905503|NCT02038829|471291185|FG002|Washout Period 2|Adverse Event|0|||
130905504|NCT02038829|471291186|FG003|Washout Period 2|Adverse Event|0|||
130905505|NCT02038829|471291187|FG004|Washout Period 2|Adverse Event|0|||
130768417|NCT01907217|470775570|FG001|Overall Study|Withdrawal by Subject|2|||
130905506|NCT02038829|471291188|FG005|Washout Period 2|Adverse Event|0|||
130905507|NCT02038829|471291189|FG006|Washout Period 2|Adverse Event|0|||
130905508|NCT02038829|471291190|FG007|Washout Period 2|Adverse Event|0|||
130905509|NCT02038829|471291191|FG008|Washout Period 2|Adverse Event|1|||
130905510|NCT02038829|471291192|FG009|Washout Period 2|Adverse Event|0|||
131027991|NCT04436107|471733864|FG003|Overall Study|Death|18|||
131027992|NCT04436107|471733861|FG000|Overall Study|Withdrawal by Subject|1|||
131027993|NCT04436107|471733862|FG001|Overall Study|Withdrawal by Subject|1|||
131027994|NCT04436107|471733863|FG002|Overall Study|Withdrawal by Subject|0|||
131027995|NCT04436107|471733864|FG003|Overall Study|Withdrawal by Subject|1|||
131114122|NCT03942406|472049028|FG000|Overall Study|Lost to Follow-up|4|||
131114123|NCT03942406|472049029|FG001|Overall Study|Lost to Follow-up|5|||
131114124|NCT03942406|472049030|FG002|Overall Study|Lost to Follow-up|3|||
131114125|NCT03942406|472049031|FG003|Overall Study|Lost to Follow-up|7|||
131114126|NCT03942406|472049032|FG004|Overall Study|Lost to Follow-up|1|||
130905511|NCT02038829|471291193|FG010|Washout Period 2|Adverse Event|0|||
131114127|NCT03942406|472049033|FG005|Overall Study|Lost to Follow-up|0|||
130905512|NCT02038829|471291194|FG011|Washout Period 2|Adverse Event|0|||
130905513|NCT02038829|471291183|FG000|Washout Period 2|Withdrawal by Subject|0|||
130905514|NCT02038829|471291184|FG001|Washout Period 2|Withdrawal by Subject|0|||
130905515|NCT02038829|471291185|FG002|Washout Period 2|Withdrawal by Subject|0|||
130905516|NCT02038829|471291186|FG003|Washout Period 2|Withdrawal by Subject|0|||
131114128|NCT03942406|472049034|FG006|Overall Study|Lost to Follow-up|0|||
130905517|NCT02038829|471291187|FG004|Washout Period 2|Withdrawal by Subject|0|||
130768418|NCT01078298|470775571|FG000|Overall Study|Lost to Follow-up|12|||
130905518|NCT02038829|471291188|FG005|Washout Period 2|Withdrawal by Subject|1|||
131114129|NCT03942406|472049028|FG000|Overall Study|Withdrawal by Subject|3|||
130905519|NCT02038829|471291189|FG006|Washout Period 2|Withdrawal by Subject|0|||
130905520|NCT02038829|471291190|FG007|Washout Period 2|Withdrawal by Subject|0|||
130905521|NCT02038829|471291191|FG008|Washout Period 2|Withdrawal by Subject|0|||
130905522|NCT02038829|471291192|FG009|Washout Period 2|Withdrawal by Subject|0|||
130905523|NCT02038829|471291193|FG010|Washout Period 2|Withdrawal by Subject|0|||
130905524|NCT02038829|471291194|FG011|Washout Period 2|Withdrawal by Subject|0|||
130905525|NCT02038829|471291183|FG000|Treatment Period 4|Adverse Event|0|||
130905526|NCT02038829|471291184|FG001|Treatment Period 4|Adverse Event|1|||
130905527|NCT02038829|471291185|FG002|Treatment Period 4|Adverse Event|0|||
130905528|NCT02038829|471291186|FG003|Treatment Period 4|Adverse Event|0|||
130905529|NCT02038829|471291187|FG004|Treatment Period 4|Adverse Event|0|||
130905530|NCT02038829|471291188|FG005|Treatment Period 4|Adverse Event|0|||
130905531|NCT02038829|471291189|FG006|Treatment Period 4|Adverse Event|0|||
130905532|NCT02038829|471291190|FG007|Treatment Period 4|Adverse Event|0|||
130905533|NCT02038829|471291191|FG008|Treatment Period 4|Adverse Event|0|||
130905534|NCT02038829|471291192|FG009|Treatment Period 4|Adverse Event|0|||
130905535|NCT02038829|471291193|FG010|Treatment Period 4|Adverse Event|0|||
130905536|NCT02038829|471291194|FG011|Treatment Period 4|Adverse Event|0|||
130905537|NCT02038829|471291183|FG000|Washout Period 4|Adverse Event|0|||
130905538|NCT02038829|471291184|FG001|Washout Period 4|Adverse Event|0|||
130905539|NCT02038829|471291185|FG002|Washout Period 4|Adverse Event|0|||
130905540|NCT02038829|471291186|FG003|Washout Period 4|Adverse Event|0|||
130905541|NCT02038829|471291187|FG004|Washout Period 4|Adverse Event|0|||
130905542|NCT02038829|471291188|FG005|Washout Period 4|Adverse Event|0|||
130905543|NCT02038829|471291189|FG006|Washout Period 4|Adverse Event|1|||
130905544|NCT02038829|471291190|FG007|Washout Period 4|Adverse Event|0|||
130905545|NCT02038829|471291191|FG008|Washout Period 4|Adverse Event|0|||
130905546|NCT02038829|471291192|FG009|Washout Period 4|Adverse Event|0|||
130905547|NCT02038829|471291193|FG010|Washout Period 4|Adverse Event|0|||
130905548|NCT02038829|471291194|FG011|Washout Period 4|Adverse Event|0|||
130905549|NCT02038829|471291183|FG000|Treatment Period 6|Adverse Event|0|||
130905550|NCT02038829|471291184|FG001|Treatment Period 6|Adverse Event|0|||
130905551|NCT02038829|471291185|FG002|Treatment Period 6|Adverse Event|1|||
130905552|NCT02038829|471291186|FG003|Treatment Period 6|Adverse Event|0|||
130905553|NCT02038829|471291187|FG004|Treatment Period 6|Adverse Event|0|||
130905554|NCT02038829|471291188|FG005|Treatment Period 6|Adverse Event|0|||
130905555|NCT02038829|471291189|FG006|Treatment Period 6|Adverse Event|0|||
130905556|NCT02038829|471291190|FG007|Treatment Period 6|Adverse Event|0|||
130905557|NCT02038829|471291191|FG008|Treatment Period 6|Adverse Event|0|||
130905558|NCT02038829|471291192|FG009|Treatment Period 6|Adverse Event|0|||
130905559|NCT02038829|471291193|FG010|Treatment Period 6|Adverse Event|0|||
130905560|NCT02038829|471291194|FG011|Treatment Period 6|Adverse Event|0|||
130905561|NCT02579928|471291195|FG000|Overall Study|Withdrawal by Subject|1|||
130905562|NCT02579928|471291196|FG001|Overall Study|Withdrawal by Subject|0|||
130905563|NCT04393298|471291199|FG000|Overall Study|Adverse Event|0|||
130905564|NCT04393298|471291200|FG001|Overall Study|Adverse Event|0|||
130905565|NCT04393298|471291201|FG002|Overall Study|Adverse Event|0|||
130905566|NCT04393298|471291202|FG003|Overall Study|Adverse Event|0|||
130905567|NCT04393298|471291203|FG004|Overall Study|Adverse Event|1|||
130905568|NCT04393298|471291204|FG005|Overall Study|Adverse Event|0|||
130905569|NCT04393298|471291205|FG006|Overall Study|Adverse Event|0|||
130905570|NCT04393298|471291206|FG007|Overall Study|Adverse Event|0|||
130905571|NCT04393298|471291207|FG008|Overall Study|Adverse Event|2|||
130905572|NCT04393298|471291208|FG009|Overall Study|Adverse Event|0|||
130905573|NCT04393298|471291209|FG010|Overall Study|Adverse Event|0|||
130905574|NCT04393298|471291210|FG011|Overall Study|Adverse Event|0|||
130905575|NCT04393298|471291211|FG012|Overall Study|Adverse Event|1|||
130905576|NCT04393298|471291212|FG013|Overall Study|Adverse Event|1|||
130905577|NCT04393298|471291213|FG014|Overall Study|Adverse Event|0|||
130905578|NCT04393298|471291199|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905579|NCT04393298|471291200|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905580|NCT04393298|471291201|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
130905581|NCT04393298|471291202|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905582|NCT04393298|471291203|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905583|NCT04393298|471291204|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905584|NCT04393298|471291205|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905585|NCT04393298|471291206|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905586|NCT04393298|471291207|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905587|NCT04393298|471291208|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905588|NCT04393298|471291209|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905589|NCT04393298|471291210|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905590|NCT04393298|471291211|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905591|NCT04393298|471291212|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130905592|NCT04393298|471291213|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
130905593|NCT04393298|471291199|FG000|Overall Study|Lack of Efficacy|0|||
130905594|NCT04393298|471291200|FG001|Overall Study|Lack of Efficacy|0|||
130905595|NCT04393298|471291201|FG002|Overall Study|Lack of Efficacy|0|||
130905596|NCT04393298|471291202|FG003|Overall Study|Lack of Efficacy|0|||
130905597|NCT04393298|471291203|FG004|Overall Study|Lack of Efficacy|0|||
130905598|NCT04393298|471291204|FG005|Overall Study|Lack of Efficacy|0|||
130905599|NCT04393298|471291205|FG006|Overall Study|Lack of Efficacy|0|||
130905600|NCT04393298|471291206|FG007|Overall Study|Lack of Efficacy|0|||
130905601|NCT04393298|471291207|FG008|Overall Study|Lack of Efficacy|0|||
130905602|NCT04393298|471291208|FG009|Overall Study|Lack of Efficacy|0|||
130905603|NCT04393298|471291209|FG010|Overall Study|Lack of Efficacy|0|||
130905604|NCT04393298|471291210|FG011|Overall Study|Lack of Efficacy|0|||
130905605|NCT04393298|471291211|FG012|Overall Study|Lack of Efficacy|0|||
130905606|NCT04393298|471291212|FG013|Overall Study|Lack of Efficacy|0|||
130905607|NCT04393298|471291213|FG014|Overall Study|Lack of Efficacy|1|||
130905608|NCT04393298|471291199|FG000|Overall Study|Progression|1|||
130905609|NCT04393298|471291200|FG001|Overall Study|Progression|0|||
130905610|NCT04393298|471291201|FG002|Overall Study|Progression|0|||
130905611|NCT04393298|471291202|FG003|Overall Study|Progression|0|||
130905612|NCT04393298|471291203|FG004|Overall Study|Progression|0|||
130905613|NCT04393298|471291204|FG005|Overall Study|Progression|0|||
130905614|NCT04393298|471291205|FG006|Overall Study|Progression|0|||
130905615|NCT04393298|471291206|FG007|Overall Study|Progression|0|||
130905616|NCT04393298|471291207|FG008|Overall Study|Progression|0|||
130905617|NCT04393298|471291208|FG009|Overall Study|Progression|0|||
130905618|NCT04393298|471291209|FG010|Overall Study|Progression|1|||
130905619|NCT04393298|471291210|FG011|Overall Study|Progression|1|||
130905620|NCT04393298|471291211|FG012|Overall Study|Progression|0|||
130905621|NCT04393298|471291212|FG013|Overall Study|Progression|0|||
130905622|NCT04393298|471291213|FG014|Overall Study|Progression|0|||
130905623|NCT04393298|471291199|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
130905624|NCT04393298|471291200|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905625|NCT04393298|471291201|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905626|NCT04393298|471291202|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905627|NCT04393298|471291203|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905628|NCT04393298|471291204|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905629|NCT04393298|471291205|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905630|NCT04393298|471291206|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905631|NCT04393298|471291207|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905632|NCT04393298|471291208|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905633|NCT04393298|471291209|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905634|NCT04393298|471291210|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905635|NCT04393298|471291211|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905636|NCT04393298|471291212|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905637|NCT04393298|471291213|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
130905638|NCT04393298|471291199|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905639|NCT04393298|471291200|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
130905640|NCT04393298|471291201|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905641|NCT04393298|471291202|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905642|NCT04393298|471291203|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905643|NCT04393298|471291204|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905644|NCT04393298|471291205|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905645|NCT04393298|471291206|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905646|NCT04393298|471291207|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905647|NCT04393298|471291208|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905648|NCT04393298|471291209|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905649|NCT04393298|471291210|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
131114130|NCT03942406|472049029|FG001|Overall Study|Withdrawal by Subject|1|||
131114131|NCT03942406|472049030|FG002|Overall Study|Withdrawal by Subject|1|||
130694672|NCT00112437|470505940|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130694673|NCT00112437|470505941|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130905650|NCT04393298|471291211|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905651|NCT04393298|471291212|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905652|NCT04393298|471291213|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
130905653|NCT04393298|471291199|FG000|Overall Study|Clinical Progression|0|||
130905654|NCT04393298|471291200|FG001|Overall Study|Clinical Progression|2|||
130905655|NCT04393298|471291201|FG002|Overall Study|Clinical Progression|0|||
130905656|NCT04393298|471291202|FG003|Overall Study|Clinical Progression|0|||
130694674|NCT00112437|470505916|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694675|NCT00112437|470505917|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694676|NCT00112437|470505918|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
130905657|NCT04393298|471291203|FG004|Overall Study|Clinical Progression|0|||
130905658|NCT04393298|471291204|FG005|Overall Study|Clinical Progression|0|||
130905659|NCT04393298|471291205|FG006|Overall Study|Clinical Progression|0|||
130905660|NCT04393298|471291206|FG007|Overall Study|Clinical Progression|0|||
130905661|NCT04393298|471291207|FG008|Overall Study|Clinical Progression|0|||
130905662|NCT04393298|471291208|FG009|Overall Study|Clinical Progression|0|||
130905663|NCT04393298|471291209|FG010|Overall Study|Clinical Progression|0|||
130905664|NCT04393298|471291210|FG011|Overall Study|Clinical Progression|0|||
130905665|NCT04393298|471291211|FG012|Overall Study|Clinical Progression|0|||
130905666|NCT04393298|471291212|FG013|Overall Study|Clinical Progression|0|||
130905667|NCT04393298|471291213|FG014|Overall Study|Clinical Progression|0|||
130905668|NCT04393298|471291199|FG000|Overall Study|Disease Progression|0|||
130905669|NCT04393298|471291200|FG001|Overall Study|Disease Progression|1|||
130905670|NCT04393298|471291201|FG002|Overall Study|Disease Progression|0|||
130905671|NCT04393298|471291202|FG003|Overall Study|Disease Progression|0|||
130905672|NCT04393298|471291203|FG004|Overall Study|Disease Progression|0|||
130905673|NCT04393298|471291204|FG005|Overall Study|Disease Progression|3|||
130905674|NCT04393298|471291205|FG006|Overall Study|Disease Progression|2|||
130905675|NCT04393298|471291206|FG007|Overall Study|Disease Progression|1|||
130905676|NCT04393298|471291207|FG008|Overall Study|Disease Progression|2|||
130905677|NCT04393298|471291208|FG009|Overall Study|Disease Progression|1|||
130905678|NCT04393298|471291209|FG010|Overall Study|Disease Progression|0|||
130905679|NCT04393298|471291210|FG011|Overall Study|Disease Progression|3|||
130905680|NCT04393298|471291211|FG012|Overall Study|Disease Progression|0|||
130905681|NCT04393298|471291212|FG013|Overall Study|Disease Progression|0|||
130905682|NCT04393298|471291213|FG014|Overall Study|Disease Progression|1|||
130905683|NCT04393298|471291199|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905684|NCT04393298|471291200|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905685|NCT04393298|471291201|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
130905686|NCT04393298|471291202|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905687|NCT04393298|471291203|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905688|NCT04393298|471291204|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905689|NCT04393298|471291205|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905690|NCT04393298|471291206|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905691|NCT04393298|471291207|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905692|NCT04393298|471291208|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905693|NCT04393298|471291209|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905694|NCT04393298|471291210|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905695|NCT04393298|471291211|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905696|NCT04393298|471291212|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905697|NCT04393298|471291213|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
130905698|NCT04393298|471291199|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905699|NCT04393298|471291200|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905700|NCT04393298|471291201|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
130905701|NCT04393298|471291202|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905702|NCT04393298|471291203|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905703|NCT04393298|471291204|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905704|NCT04393298|471291205|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905705|NCT04393298|471291206|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905706|NCT04393298|471291207|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905707|NCT04393298|471291208|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905708|NCT04393298|471291209|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905709|NCT04393298|471291210|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905710|NCT04393298|471291211|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905711|NCT04393298|471291212|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905712|NCT04393298|471291213|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
130905713|NCT04393298|471291199|FG000|Overall Study|Progressive Disease (PD)|0|||
131114132|NCT03942406|472049031|FG003|Overall Study|Withdrawal by Subject|3|||
131114133|NCT03942406|472049032|FG004|Overall Study|Withdrawal by Subject|0|||
131114134|NCT03942406|472049033|FG005|Overall Study|Withdrawal by Subject|0|||
131114135|NCT03942406|472049034|FG006|Overall Study|Withdrawal by Subject|0|||
131114136|NCT03942406|472049028|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
131114137|NCT03942406|472049029|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
131114138|NCT03942406|472049030|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
131028014|NCT04854096|471733867|FG000|Overall Study|Adverse Event|1|||
131028015|NCT04854096|471733868|FG001|Overall Study|Adverse Event|0|||
131028016|NCT04854096|471733867|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
130905714|NCT04393298|471291200|FG001|Overall Study|Progressive Disease (PD)|0|||
131028017|NCT04854096|471733868|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
130905715|NCT04393298|471291201|FG002|Overall Study|Progressive Disease (PD)|0|||
130905716|NCT04393298|471291202|FG003|Overall Study|Progressive Disease (PD)|3|||
131028018|NCT04854096|471733867|FG000|Overall Study|Withdrawal by Subject|1|||
130905717|NCT04393298|471291203|FG004|Overall Study|Progressive Disease (PD)|0|||
130905718|NCT04393298|471291204|FG005|Overall Study|Progressive Disease (PD)|0|||
130905719|NCT04393298|471291205|FG006|Overall Study|Progressive Disease (PD)|0|||
130905720|NCT04393298|471291206|FG007|Overall Study|Progressive Disease (PD)|0|||
130905721|NCT04393298|471291207|FG008|Overall Study|Progressive Disease (PD)|0|||
130905722|NCT04393298|471291208|FG009|Overall Study|Progressive Disease (PD)|0|||
130905723|NCT04393298|471291209|FG010|Overall Study|Progressive Disease (PD)|0|||
130905724|NCT04393298|471291210|FG011|Overall Study|Progressive Disease (PD)|0|||
130905725|NCT04393298|471291211|FG012|Overall Study|Progressive Disease (PD)|0|||
130905726|NCT04393298|471291212|FG013|Overall Study|Progressive Disease (PD)|0|||
130905727|NCT04393298|471291213|FG014|Overall Study|Progressive Disease (PD)|0|||
130905728|NCT04393298|471291199|FG000|Overall Study|Started a New Cancer Treatment|0|||
130905729|NCT04393298|471291200|FG001|Overall Study|Started a New Cancer Treatment|0|||
130905730|NCT04393298|471291201|FG002|Overall Study|Started a New Cancer Treatment|0|||
130905731|NCT04393298|471291202|FG003|Overall Study|Started a New Cancer Treatment|0|||
130905732|NCT04393298|471291203|FG004|Overall Study|Started a New Cancer Treatment|1|||
130905733|NCT04393298|471291204|FG005|Overall Study|Started a New Cancer Treatment|0|||
130905734|NCT04393298|471291205|FG006|Overall Study|Started a New Cancer Treatment|0|||
130905735|NCT04393298|471291206|FG007|Overall Study|Started a New Cancer Treatment|0|||
130905736|NCT04393298|471291207|FG008|Overall Study|Started a New Cancer Treatment|0|||
130905737|NCT04393298|471291208|FG009|Overall Study|Started a New Cancer Treatment|0|||
130905738|NCT04393298|471291209|FG010|Overall Study|Started a New Cancer Treatment|0|||
130905739|NCT04393298|471291210|FG011|Overall Study|Started a New Cancer Treatment|0|||
130905740|NCT04393298|471291211|FG012|Overall Study|Started a New Cancer Treatment|0|||
130905741|NCT04393298|471291212|FG013|Overall Study|Started a New Cancer Treatment|0|||
130905742|NCT04393298|471291213|FG014|Overall Study|Started a New Cancer Treatment|0|||
130905743|NCT04393298|471291199|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905744|NCT04393298|471291200|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905745|NCT04393298|471291201|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905746|NCT04393298|471291202|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905747|NCT04393298|471291203|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
130905748|NCT04393298|471291204|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905749|NCT04393298|471291205|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905750|NCT04393298|471291206|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905751|NCT04393298|471291207|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905752|NCT04393298|471291208|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905753|NCT04393298|471291209|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905754|NCT04393298|471291210|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905755|NCT04393298|471291211|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905756|NCT04393298|471291212|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905757|NCT04393298|471291213|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130905758|NCT04393298|471291199|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905759|NCT04393298|471291200|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905760|NCT04393298|471291201|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905761|NCT04393298|471291202|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905762|NCT04393298|471291203|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905763|NCT04393298|471291204|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
130905764|NCT04393298|471291205|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905765|NCT04393298|471291206|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905766|NCT04393298|471291207|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905767|NCT04393298|471291208|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905768|NCT04393298|471291209|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905769|NCT04393298|471291210|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905770|NCT04393298|471291211|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905771|NCT04393298|471291212|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905772|NCT04393298|471291213|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
130905773|NCT04393298|471291199|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905774|NCT04393298|471291200|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905775|NCT04393298|471291201|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905776|NCT04393298|471291202|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905777|NCT04393298|471291203|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905778|NCT04393298|471291204|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
130905779|NCT04393298|471291205|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905780|NCT04393298|471291206|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905781|NCT04393298|471291207|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905782|NCT04393298|471291208|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905783|NCT04393298|471291209|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905784|NCT04393298|471291210|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905785|NCT04393298|471291211|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905786|NCT04393298|471291212|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130905787|NCT04393298|471291213|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
130905788|NCT04393298|471291199|FG000|Overall Study|Death|0|||
130905789|NCT04393298|471291200|FG001|Overall Study|Death|0|||
130905790|NCT04393298|471291201|FG002|Overall Study|Death|0|||
130905791|NCT04393298|471291202|FG003|Overall Study|Death|0|||
130905792|NCT04393298|471291203|FG004|Overall Study|Death|0|||
130905793|NCT04393298|471291204|FG005|Overall Study|Death|1|||
130905794|NCT04393298|471291205|FG006|Overall Study|Death|1|||
130905795|NCT04393298|471291206|FG007|Overall Study|Death|0|||
130905796|NCT04393298|471291207|FG008|Overall Study|Death|1|||
130905797|NCT04393298|471291208|FG009|Overall Study|Death|1|||
130905798|NCT04393298|471291209|FG010|Overall Study|Death|0|||
130905799|NCT04393298|471291210|FG011|Overall Study|Death|1|||
130905800|NCT04393298|471291211|FG012|Overall Study|Death|1|||
130905801|NCT04393298|471291212|FG013|Overall Study|Death|0|||
130905802|NCT04393298|471291213|FG014|Overall Study|Death|1|||
130905803|NCT04393298|471291199|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905804|NCT04393298|471291200|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905805|NCT04393298|471291201|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905806|NCT04393298|471291202|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905807|NCT04393298|471291203|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905808|NCT04393298|471291204|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
130905809|NCT04393298|471291205|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905810|NCT04393298|471291206|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905811|NCT04393298|471291207|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905812|NCT04393298|471291208|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905813|NCT04393298|471291209|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905814|NCT04393298|471291210|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905815|NCT04393298|471291211|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905816|NCT04393298|471291212|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905817|NCT04393298|471291213|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130905818|NCT04393298|471291199|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
130905819|NCT04393298|471291200|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
130905820|NCT04393298|471291201|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
130905821|NCT04393298|471291202|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
130905822|NCT04393298|471291203|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
130905823|NCT04393298|471291204|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
130905824|NCT04393298|471291205|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
130905825|NCT04393298|471291206|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
130905826|NCT04393298|471291207|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
130905827|NCT04393298|471291208|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
130905828|NCT04393298|471291209|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
130905829|NCT04393298|471291210|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
130905830|NCT04393298|471291211|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
130905831|NCT04393298|471291212|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
130905832|NCT04393298|471291213|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
130905833|NCT04393298|471291199|FG000|Overall Study|Patient Passed Away|0|||
130905834|NCT04393298|471291200|FG001|Overall Study|Patient Passed Away|0|||
130905835|NCT04393298|471291201|FG002|Overall Study|Patient Passed Away|0|||
130905836|NCT04393298|471291202|FG003|Overall Study|Patient Passed Away|0|||
130905837|NCT04393298|471291203|FG004|Overall Study|Patient Passed Away|0|||
130905838|NCT04393298|471291204|FG005|Overall Study|Patient Passed Away|0|||
130905839|NCT04393298|471291205|FG006|Overall Study|Patient Passed Away|0|||
130905840|NCT04393298|471291206|FG007|Overall Study|Patient Passed Away|1|||
130905841|NCT04393298|471291207|FG008|Overall Study|Patient Passed Away|0|||
130905842|NCT04393298|471291208|FG009|Overall Study|Patient Passed Away|0|||
130905843|NCT04393298|471291209|FG010|Overall Study|Patient Passed Away|0|||
130905844|NCT04393298|471291210|FG011|Overall Study|Patient Passed Away|0|||
130905845|NCT04393298|471291211|FG012|Overall Study|Patient Passed Away|0|||
130905846|NCT04393298|471291212|FG013|Overall Study|Patient Passed Away|0|||
130905847|NCT04393298|471291213|FG014|Overall Study|Patient Passed Away|0|||
130905848|NCT04393298|471291199|FG000|Overall Study|Patient Deceased|0|||
130905849|NCT04393298|471291200|FG001|Overall Study|Patient Deceased|0|||
130905850|NCT04393298|471291201|FG002|Overall Study|Patient Deceased|0|||
130905851|NCT04393298|471291202|FG003|Overall Study|Patient Deceased|0|||
130905852|NCT04393298|471291203|FG004|Overall Study|Patient Deceased|0|||
130905853|NCT04393298|471291204|FG005|Overall Study|Patient Deceased|0|||
130905854|NCT04393298|471291205|FG006|Overall Study|Patient Deceased|0|||
130905855|NCT04393298|471291206|FG007|Overall Study|Patient Deceased|1|||
130905856|NCT04393298|471291207|FG008|Overall Study|Patient Deceased|0|||
130905857|NCT04393298|471291208|FG009|Overall Study|Patient Deceased|0|||
130905858|NCT04393298|471291209|FG010|Overall Study|Patient Deceased|0|||
130905859|NCT04393298|471291210|FG011|Overall Study|Patient Deceased|0|||
130905860|NCT04393298|471291211|FG012|Overall Study|Patient Deceased|0|||
130905861|NCT04393298|471291212|FG013|Overall Study|Patient Deceased|0|||
130905862|NCT04393298|471291213|FG014|Overall Study|Patient Deceased|0|||
130905863|NCT04393298|471291199|FG000|Overall Study|Patient Discharged to Hospice|0|||
130905864|NCT04393298|471291200|FG001|Overall Study|Patient Discharged to Hospice|0|||
130905865|NCT04393298|471291201|FG002|Overall Study|Patient Discharged to Hospice|0|||
130905866|NCT04393298|471291202|FG003|Overall Study|Patient Discharged to Hospice|0|||
130905867|NCT04393298|471291203|FG004|Overall Study|Patient Discharged to Hospice|0|||
130905868|NCT04393298|471291204|FG005|Overall Study|Patient Discharged to Hospice|0|||
130905869|NCT04393298|471291205|FG006|Overall Study|Patient Discharged to Hospice|0|||
130905870|NCT04393298|471291206|FG007|Overall Study|Patient Discharged to Hospice|0|||
130905871|NCT04393298|471291207|FG008|Overall Study|Patient Discharged to Hospice|1|||
130905872|NCT04393298|471291208|FG009|Overall Study|Patient Discharged to Hospice|0|||
130905873|NCT04393298|471291209|FG010|Overall Study|Patient Discharged to Hospice|0|||
130905874|NCT04393298|471291210|FG011|Overall Study|Patient Discharged to Hospice|0|||
130905875|NCT04393298|471291211|FG012|Overall Study|Patient Discharged to Hospice|0|||
130905876|NCT04393298|471291212|FG013|Overall Study|Patient Discharged to Hospice|0|||
130905877|NCT04393298|471291213|FG014|Overall Study|Patient Discharged to Hospice|0|||
130905878|NCT04393298|471291199|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905879|NCT04393298|471291200|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905880|NCT04393298|471291201|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905881|NCT04393298|471291202|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905882|NCT04393298|471291203|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905883|NCT04393298|471291204|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905884|NCT04393298|471291205|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905885|NCT04393298|471291206|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905886|NCT04393298|471291207|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905887|NCT04393298|471291208|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
130905888|NCT04393298|471291209|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905889|NCT04393298|471291210|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905890|NCT04393298|471291211|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905891|NCT04393298|471291212|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905892|NCT04393298|471291213|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
130905893|NCT04393298|471291199|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
130905894|NCT04393298|471291200|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
130905895|NCT04393298|471291201|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
130905896|NCT04393298|471291202|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
130905897|NCT04393298|471291203|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
130905898|NCT04393298|471291204|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
130905899|NCT04393298|471291205|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
130905900|NCT04393298|471291206|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
130905901|NCT04393298|471291207|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
130905902|NCT04393298|471291208|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
130905903|NCT04393298|471291209|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
130905904|NCT04393298|471291210|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
130905905|NCT04393298|471291211|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
130905906|NCT04393298|471291212|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
130905907|NCT04393298|471291213|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
130905908|NCT03754972|471291214|FG000|Overall Study|Protocol Violation|25|||
130905909|NCT02311582|471291215|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
130905910|NCT02311582|471291216|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
130905911|NCT02311582|471291217|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
130905912|NCT02311582|471291218|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
130905913|NCT02311582|471291219|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
130905914|NCT03422627|471291220|FG000|Overall Study|Protocol-specified Criteria|1|||
130905915|NCT03422627|471291221|FG001|Overall Study|Protocol-specified Criteria|1|||
130905916|NCT03422627|471291222|FG002|Overall Study|Protocol-specified Criteria|0|||
130905917|NCT03422627|471291223|FG003|Overall Study|Protocol-specified Criteria|0|||
130905918|NCT03422627|471291224|FG004|Overall Study|Protocol-specified Criteria|2|||
130905919|NCT03422627|471291220|FG000|Overall Study|Requirement for Alternative Therapy|1|||
130905920|NCT03422627|471291221|FG001|Overall Study|Requirement for Alternative Therapy|1|||
130905921|NCT03422627|471291222|FG002|Overall Study|Requirement for Alternative Therapy|2|||
130905922|NCT03422627|471291223|FG003|Overall Study|Requirement for Alternative Therapy|0|||
130905923|NCT03422627|471291224|FG004|Overall Study|Requirement for Alternative Therapy|0|||
130905924|NCT03422627|471291220|FG000|Overall Study|Disease Progression|1|||
130905925|NCT03422627|471291221|FG001|Overall Study|Disease Progression|0|||
130905926|NCT03422627|471291222|FG002|Overall Study|Disease Progression|1|||
130905927|NCT03422627|471291223|FG003|Overall Study|Disease Progression|2|||
130905928|NCT03422627|471291224|FG004|Overall Study|Disease Progression|0|||
130905929|NCT03422627|471291220|FG000|Overall Study|Adverse Event|2|||
130905930|NCT03422627|471291221|FG001|Overall Study|Adverse Event|1|||
130905931|NCT03422627|471291222|FG002|Overall Study|Adverse Event|0|||
130905932|NCT03422627|471291223|FG003|Overall Study|Adverse Event|0|||
130905933|NCT03422627|471291224|FG004|Overall Study|Adverse Event|2|||
130905934|NCT03422627|471291220|FG000|Overall Study|Ineligibility Determined|0|||
131028019|NCT04854096|471733868|FG001|Overall Study|Withdrawal by Subject|0|||
131028020|NCT04854096|471733867|FG000|Overall Study|Other reasons|1|||
131028021|NCT04854096|471733868|FG001|Overall Study|Other reasons|0|||
131028022|NCT04757610|471733869|FG000|Overall Study|Adverse Event|13|||
131028023|NCT04757610|471733870|FG001|Overall Study|Adverse Event|10|||
130905935|NCT03422627|471291221|FG001|Overall Study|Ineligibility Determined|1|||
130905936|NCT03422627|471291222|FG002|Overall Study|Ineligibility Determined|0|||
130905937|NCT03422627|471291223|FG003|Overall Study|Ineligibility Determined|0|||
130905938|NCT03422627|471291224|FG004|Overall Study|Ineligibility Determined|0|||
130905939|NCT03422627|471291220|FG000|Overall Study|Death|0|||
130905940|NCT03422627|471291221|FG001|Overall Study|Death|1|||
130905941|NCT03422627|471291222|FG002|Overall Study|Death|1|||
130905942|NCT03422627|471291223|FG003|Overall Study|Death|0|||
130905943|NCT03422627|471291224|FG004|Overall Study|Death|0|||
130905944|NCT03422627|471291220|FG000|Overall Study|Withdrawal by Subject|0|||
130905945|NCT03422627|471291221|FG001|Overall Study|Withdrawal by Subject|0|||
130905946|NCT03422627|471291222|FG002|Overall Study|Withdrawal by Subject|0|||
131028024|NCT04757610|471733871|FG002|Overall Study|Adverse Event|5|||
131028025|NCT04757610|471733869|FG000|Overall Study|Death|5|||
131028026|NCT04757610|471733870|FG001|Overall Study|Death|13|||
130905947|NCT03422627|471291223|FG003|Overall Study|Withdrawal by Subject|1|||
130905948|NCT03422627|471291224|FG004|Overall Study|Withdrawal by Subject|0|||
130905949|NCT04656275|471291227|FG000|Overall Study|Study terminated by sponsor|2|||
130905950|NCT04656275|471291228|FG001|Overall Study|Study terminated by sponsor|4|||
130905951|NCT00934648|471291231|FG000|Overall Study|Failure to return|8|||
130905952|NCT00934648|471291231|FG000|Overall Study|Withdrawal by Subject|1|||
130905953|NCT03828370|471291232|FG000|3 Month Follow-up|Lost to Follow-up|4|||
130905954|NCT03828370|471291233|FG001|3 Month Follow-up|Lost to Follow-up|12|||
130905955|NCT03828370|471291232|FG000|9 Month Follow up|Lost to Follow-up|12|||
130905956|NCT03828370|471291233|FG001|9 Month Follow up|Lost to Follow-up|20|||
130905957|NCT02554279|471291234|FG000|Overall Study|Adverse Event|2|||
130905958|NCT02554279|471291235|FG001|Overall Study|Adverse Event|5|||
130905959|NCT02554279|471291234|FG000|Overall Study|Lost to Follow-up|3|||
130905960|NCT02554279|471291235|FG001|Overall Study|Lost to Follow-up|2|||
130905961|NCT02554279|471291234|FG000|Overall Study|Withdrawal by Subject|6|||
130905962|NCT02554279|471291235|FG001|Overall Study|Withdrawal by Subject|4|||
130905963|NCT02554279|471291234|FG000|Overall Study|Protocol Violation|2|||
130905964|NCT02554279|471291235|FG001|Overall Study|Protocol Violation|1|||
130905965|NCT02554279|471291234|FG000|Overall Study|Other reason|19|||
130905966|NCT02554279|471291235|FG001|Overall Study|Other reason|6|||
130905967|NCT00812487|471291236|FG000|Overall Study|Lost to Follow-up|2|||
130905968|NCT00812487|471291237|FG001|Overall Study|Lost to Follow-up|0|||
130905969|NCT00812487|471291236|FG000|Overall Study|Withdrawal by Subject|3|||
130905970|NCT00812487|471291237|FG001|Overall Study|Withdrawal by Subject|2|||
130905971|NCT00812487|471291236|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
131028027|NCT04757610|471733871|FG002|Overall Study|Death|8|||
131028028|NCT04757610|471733869|FG000|Overall Study|Lack of Efficacy|1|||
130694677|NCT00112437|470505919|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694678|NCT00112437|470505920|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694679|NCT00112437|470505921|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694680|NCT00112437|470505922|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694681|NCT00112437|470505923|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694682|NCT00112437|470505924|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694683|NCT00112437|470505925|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
130905972|NCT00812487|471291237|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
130905973|NCT00812487|471291236|FG000|Overall Study|Protocol Violation|0|||
130905974|NCT00812487|471291237|FG001|Overall Study|Protocol Violation|1|||
130905975|NCT02360605|471291238|FG000|Overall Study|Withdrawal by Subject|4|||
131028029|NCT04757610|471733870|FG001|Overall Study|Lack of Efficacy|2|||
131028030|NCT04757610|471733871|FG002|Overall Study|Lack of Efficacy|3|||
131028031|NCT04757610|471733869|FG000|Overall Study|Lost to Follow-up|7|||
131028032|NCT04757610|471733870|FG001|Overall Study|Lost to Follow-up|2|||
131028033|NCT04757610|471733871|FG002|Overall Study|Lost to Follow-up|7|||
130694684|NCT00112437|470505926|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
130768419|NCT01078298|470775572|FG001|Overall Study|Lost to Follow-up|13|||
130905976|NCT02360605|471291239|FG001|Overall Study|Withdrawal by Subject|9|||
131028034|NCT04757610|471733869|FG000|Overall Study|Physician Decision|4|||
131028035|NCT04757610|471733870|FG001|Overall Study|Physician Decision|1|||
130905977|NCT02360605|471291238|FG000|Overall Study|Lost to Follow-up|7|||
130905978|NCT02360605|471291239|FG001|Overall Study|Lost to Follow-up|8|||
130905979|NCT02360605|471291238|FG000|Overall Study|Death|0|||
130905980|NCT02360605|471291239|FG001|Overall Study|Death|1|||
130905981|NCT00998764|471291240|FG000|Overall Study|Lack of Efficacy|3|||
130905982|NCT00998764|471291241|FG001|Overall Study|Lack of Efficacy|6|||
130905983|NCT00998764|471291240|FG000|Overall Study|Adverse Event|17|||
130905984|NCT00998764|471291241|FG001|Overall Study|Adverse Event|12|||
130905985|NCT00998764|471291240|FG000|Overall Study|Withdrawal by Subject|19|||
130905986|NCT00998764|471291241|FG001|Overall Study|Withdrawal by Subject|25|||
130905987|NCT00998764|471291240|FG000|Overall Study|Physician Decision|3|||
130905988|NCT00998764|471291241|FG001|Overall Study|Physician Decision|3|||
130905989|NCT00998764|471291240|FG000|Overall Study|Death|3|||
130905990|NCT00998764|471291241|FG001|Overall Study|Death|1|||
130905991|NCT00998764|471291240|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
130905992|NCT00998764|471291241|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
130905993|NCT00998764|471291240|FG000|Overall Study|Protocol Violation|0|||
130905994|NCT00998764|471291241|FG001|Overall Study|Protocol Violation|1|||
130905995|NCT00998764|471291240|FG000|Overall Study|Failed to Return|1|||
130905996|NCT00998764|471291241|FG001|Overall Study|Failed to Return|1|||
130905997|NCT00998764|471291240|FG000|Overall Study|Lost to Follow-up|1|||
130905998|NCT00998764|471291241|FG001|Overall Study|Lost to Follow-up|1|||
130905999|NCT00998764|471291240|FG000|Overall Study|Loss of Caregiver|0|||
130906000|NCT00998764|471291241|FG001|Overall Study|Loss of Caregiver|3|||
130906001|NCT00998764|471291240|FG000|Overall Study|Other|4|||
130906002|NCT00998764|471291241|FG001|Overall Study|Other|4|||
130906003|NCT00998764|471291240|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
130906004|NCT00998764|471291241|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
130906005|NCT01214174|471291242|FG000|Overall Study|Withdrawal by Subject|0|||
130906006|NCT01214174|471291243|FG001|Overall Study|Withdrawal by Subject|0|||
130906007|NCT01214174|471291244|FG002|Overall Study|Withdrawal by Subject|1|||
130906008|NCT00290407|471291245|FG000|Overall Study|Physician Decision|2|||
130906009|NCT01933789|471291254|FG000|Overall Study|Death|0|||
130906010|NCT01933789|471291255|FG001|Overall Study|Death|0|||
130906011|NCT01933789|471291256|FG002|Overall Study|Death|0|||
130906012|NCT01933789|471291257|FG003|Overall Study|Death|0|||
130906013|NCT01933789|471291258|FG004|Overall Study|Death|21|||
130906014|NCT01933789|471291259|FG005|Overall Study|Death|32|||
130906015|NCT01933789|471291260|FG006|Overall Study|Death|0|||
130906016|NCT01933789|471291261|FG007|Overall Study|Death|0|||
130906017|NCT01933789|471291262|FG008|Overall Study|Death|0|||
130906018|NCT01933789|471291254|FG000|Overall Study|Lost to Follow-up|0|||
130906019|NCT01933789|471291255|FG001|Overall Study|Lost to Follow-up|0|||
130906020|NCT01933789|471291256|FG002|Overall Study|Lost to Follow-up|0|||
130906021|NCT01933789|471291257|FG003|Overall Study|Lost to Follow-up|1|||
130906022|NCT01933789|471291258|FG004|Overall Study|Lost to Follow-up|8|||
130906023|NCT01933789|471291259|FG005|Overall Study|Lost to Follow-up|9|||
130906024|NCT01933789|471291260|FG006|Overall Study|Lost to Follow-up|1|||
130906025|NCT01933789|471291261|FG007|Overall Study|Lost to Follow-up|4|||
130906026|NCT01933789|471291262|FG008|Overall Study|Lost to Follow-up|0|||
130906027|NCT01933789|471291254|FG000|Overall Study|Withdrawal by Subject|2|||
130906028|NCT01933789|471291255|FG001|Overall Study|Withdrawal by Subject|1|||
130906029|NCT01933789|471291256|FG002|Overall Study|Withdrawal by Subject|0|||
130906030|NCT01933789|471291257|FG003|Overall Study|Withdrawal by Subject|0|||
130906031|NCT01933789|471291258|FG004|Overall Study|Withdrawal by Subject|17|||
130906032|NCT01933789|471291259|FG005|Overall Study|Withdrawal by Subject|16|||
130906033|NCT01933789|471291260|FG006|Overall Study|Withdrawal by Subject|1|||
130906034|NCT01933789|471291261|FG007|Overall Study|Withdrawal by Subject|4|||
130906035|NCT01933789|471291262|FG008|Overall Study|Withdrawal by Subject|0|||
130906036|NCT01933789|471291254|FG000|Overall Study|Became Ineligible|4|||
130906037|NCT01933789|471291255|FG001|Overall Study|Became Ineligible|0|||
130906038|NCT01933789|471291256|FG002|Overall Study|Became Ineligible|0|||
130906039|NCT01933789|471291257|FG003|Overall Study|Became Ineligible|0|||
130906040|NCT01933789|471291258|FG004|Overall Study|Became Ineligible|13|||
130906041|NCT01933789|471291259|FG005|Overall Study|Became Ineligible|10|||
130906042|NCT01933789|471291260|FG006|Overall Study|Became Ineligible|13|||
130906043|NCT01933789|471291261|FG007|Overall Study|Became Ineligible|6|||
130906044|NCT01933789|471291262|FG008|Overall Study|Became Ineligible|0|||
130906045|NCT01117792|471291268|FG000|Overall Study|Death|1|||
130906046|NCT01117792|471291268|FG000|Overall Study|Adverse Event|3|||
130906047|NCT00723203|471291269|FG000|Overall Study|Withdrawal by Subject|3|||
130906048|NCT01721577|471291270|FG000|Overall Study|Lack of Efficacy|1|||
130906049|NCT01721577|471291271|FG001|Overall Study|Lack of Efficacy|0|||
130906050|NCT01721577|471291270|FG000|Overall Study|Death|1|||
130906051|NCT01721577|471291271|FG001|Overall Study|Death|0|||
130906052|NCT01721577|471291270|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
130906053|NCT01721577|471291271|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
130906054|NCT01721577|471291270|FG000|Overall Study|Adverse Event|0|||
130906055|NCT01721577|471291271|FG001|Overall Study|Adverse Event|2|||
130906056|NCT02497976|471291274|FG000|Overall Study|Withdrawal by Subject|2|||
130906057|NCT02497976|471291275|FG001|Overall Study|Withdrawal by Subject|0|||
130906058|NCT02497976|471291274|FG000|Overall Study|Moved out of area|0|||
130906059|NCT02497976|471291275|FG001|Overall Study|Moved out of area|1|||
130906060|NCT00274924|471291278|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
130906061|NCT00274924|471291279|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
130906062|NCT00274924|471291280|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
130906063|NCT00274924|471291278|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
130906064|NCT00274924|471291279|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
130906065|NCT00274924|471291280|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
130906066|NCT00274924|471291278|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
130906067|NCT00274924|471291279|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
130906068|NCT00274924|471291280|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
130906069|NCT00274924|471291278|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
130906070|NCT00274924|471291279|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
130906071|NCT00274924|471291280|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
130906072|NCT00274924|471291278|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
130906073|NCT00274924|471291279|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
130906074|NCT00274924|471291280|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
130906075|NCT00274924|471291278|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
130906076|NCT00274924|471291279|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
130906077|NCT00274924|471291280|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
130906078|NCT00274924|471291278|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
130906079|NCT00274924|471291279|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
130906080|NCT00274924|471291280|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
130906081|NCT00274924|471291278|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
130906082|NCT00274924|471291279|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
130906083|NCT00274924|471291280|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
130906084|NCT00274924|471291278|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
130906085|NCT00274924|471291279|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
130906086|NCT00274924|471291280|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
130906087|NCT00274924|471291278|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
130906088|NCT00274924|471291279|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
130906089|NCT00274924|471291280|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
130906090|NCT00274924|471291278|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
130906091|NCT00274924|471291279|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
130906092|NCT00274924|471291280|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
130906093|NCT00274924|471291278|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
130906094|NCT00274924|471291279|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
130906095|NCT00274924|471291280|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
130906096|NCT00274924|471291278|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
130906097|NCT00274924|471291279|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
130906098|NCT00274924|471291280|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
130906099|NCT00740051|471291281|FG000|Overall Study|Lack of Efficacy|2|||
130906100|NCT00740051|471291282|FG001|Overall Study|Lack of Efficacy|5|||
130906101|NCT00740051|471291281|FG000|Overall Study|Adverse Event|1|||
130906102|NCT00740051|471291282|FG001|Overall Study|Adverse Event|4|||
130906103|NCT00740051|471291281|FG000|Overall Study|Protocol Violation|2|||
130906104|NCT00740051|471291282|FG001|Overall Study|Protocol Violation|6|||
130906105|NCT00740051|471291281|FG000|Overall Study|Lost to Follow-up|3|||
130906106|NCT00740051|471291282|FG001|Overall Study|Lost to Follow-up|8|||
130906107|NCT00740051|471291281|FG000|Overall Study|Withdrawal by Subject|6|||
130906108|NCT00740051|471291282|FG001|Overall Study|Withdrawal by Subject|8|||
130906109|NCT00740051|471291281|FG000|Overall Study|Other reason (not specified)|4|||
130906110|NCT00740051|471291282|FG001|Overall Study|Other reason (not specified)|1|||
130906111|NCT01966432|471291283|FG000|Overall Study|Lost to Follow-up|3|||
130906112|NCT01966432|471291284|FG001|Overall Study|Lost to Follow-up|2|||
130906113|NCT01966432|471291285|FG002|Overall Study|Lost to Follow-up|5|||
130906114|NCT01966432|471291283|FG000|Overall Study|Withdrawal by Subject|1|||
130906115|NCT01966432|471291284|FG001|Overall Study|Withdrawal by Subject|3|||
130906116|NCT01966432|471291285|FG002|Overall Study|Withdrawal by Subject|0|||
130906117|NCT01966432|471291283|FG000|Overall Study|Subject Incarcerated|0|||
130906118|NCT01966432|471291284|FG001|Overall Study|Subject Incarcerated|0|||
130906119|NCT01966432|471291285|FG002|Overall Study|Subject Incarcerated|1|||
130906120|NCT01966432|471291283|FG000|Overall Study|SBIRT program ended|1|||
130906121|NCT01966432|471291284|FG001|Overall Study|SBIRT program ended|8|||
130906122|NCT01966432|471291285|FG002|Overall Study|SBIRT program ended|20|||
130906123|NCT01055496|471291286|FG000|Overall Study|Withdrawal by Subject|2|||
130906124|NCT01055496|471291287|FG001|Overall Study|Withdrawal by Subject|4|||
130906125|NCT01055496|471291286|FG000|Overall Study|Death|13|||
130906126|NCT01055496|471291287|FG001|Overall Study|Death|23|||
130906127|NCT01055496|471291286|FG000|Overall Study|Lost to Follow-up|0|||
130906128|NCT01055496|471291287|FG001|Overall Study|Lost to Follow-up|2|||
130906129|NCT01055496|471291286|FG000|Overall Study|Other - Unspecified|0|||
130906130|NCT01055496|471291287|FG001|Overall Study|Other - Unspecified|1|||
130906131|NCT00584740|471291290|FG000|Overall Study|Adverse Event|1|||
130906132|NCT00584740|471291291|FG001|Overall Study|Adverse Event|1|||
130906133|NCT00584740|471291290|FG000|Overall Study|Lack of Efficacy|8|||
130906134|NCT00584740|471291291|FG001|Overall Study|Lack of Efficacy|2|||
130906135|NCT00584740|471291290|FG000|Overall Study|Withdrawal by Subject|3|||
130906136|NCT00584740|471291291|FG001|Overall Study|Withdrawal by Subject|2|||
130906137|NCT00584740|471291290|FG000|Overall Study|Lost to Follow-up|0|||
130906138|NCT00584740|471291291|FG001|Overall Study|Lost to Follow-up|1|||
130906139|NCT01903525|471291292|FG000|Overall Study|Lost to Follow-up|5|||
130906140|NCT01903525|471291293|FG001|Overall Study|Lost to Follow-up|9|||
130906141|NCT01903525|471291292|FG000|Overall Study|Adverse Event|0|||
130906142|NCT01903525|471291293|FG001|Overall Study|Adverse Event|1|||
130906143|NCT00930982|471291295|FG000|Overall Study|Adverse Event|19|||
130906144|NCT00930982|471291296|FG001|Overall Study|Adverse Event|23|||
130906145|NCT00930982|471291295|FG000|Overall Study|Protocol Violation|1|||
130906146|NCT00930982|471291296|FG001|Overall Study|Protocol Violation|5|||
130906147|NCT00930982|471291295|FG000|Overall Study|Withdrawal by Subject|1|||
130906148|NCT00930982|471291296|FG001|Overall Study|Withdrawal by Subject|1|||
130906149|NCT01673282|471291297|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
130906150|NCT01673282|471291298|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
130906151|NCT01673282|471291297|FG000|Overall Study|Lack of Efficacy|9|||
130906152|NCT01673282|471291298|FG001|Overall Study|Lack of Efficacy|2|||
130906153|NCT01673282|471291297|FG000|Overall Study|Lost to Follow-up|11|||
130906154|NCT01673282|471291298|FG001|Overall Study|Lost to Follow-up|10|||
130906155|NCT01673282|471291297|FG000|Overall Study|Withdrawal by Subject|3|||
130906156|NCT01673282|471291298|FG001|Overall Study|Withdrawal by Subject|3|||
130906157|NCT01673282|471291297|FG000|Overall Study|Other|1|||
130906158|NCT01673282|471291298|FG001|Overall Study|Other|6|||
130906159|NCT03915860|471291304|FG000|Overall Study|Adverse Event|3|||
130906160|NCT03915860|471291304|FG000|Overall Study|Withdrawal by Subject|6|||
130906161|NCT03915860|471291304|FG000|Overall Study|Lost to Follow-up|2|||
130906162|NCT03915860|471291304|FG000|Overall Study|Other than specified|3|||
130906163|NCT02195011|471291305|FG000|Overall Study|Adverse Event|4|||
130906164|NCT02195011|471291306|FG001|Overall Study|Adverse Event|0|||
130906165|NCT02195011|471291305|FG000|Overall Study|Progressive Disease|18|||
130906166|NCT02195011|471291306|FG001|Overall Study|Progressive Disease|1|||
130906167|NCT02195011|471291305|FG000|Overall Study|Withdrawal by Subject|3|||
130906168|NCT02195011|471291306|FG001|Overall Study|Withdrawal by Subject|0|||
130906169|NCT01853618|471291307|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
130906170|NCT01853618|471291308|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
130906171|NCT01853618|471291309|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
130906172|NCT01853618|471291310|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
130906173|NCT01853618|471291311|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
130906174|NCT01853618|471291307|FG000|Overall Study|Progressive disease|1|||
130906175|NCT01853618|471291308|FG001|Overall Study|Progressive disease|1|||
130906176|NCT01853618|471291309|FG002|Overall Study|Progressive disease|1|||
130906177|NCT01853618|471291310|FG003|Overall Study|Progressive disease|1|||
130906178|NCT01853618|471291311|FG004|Overall Study|Progressive disease|2|||
130906179|NCT01853618|471291307|FG000|Overall Study|Physician Decision|0|||
130906180|NCT01853618|471291308|FG001|Overall Study|Physician Decision|1|||
131028036|NCT04757610|471733871|FG002|Overall Study|Physician Decision|2|||
131222760|NCT00386100|472443176|FG001|Overall Study|Consecutive elevated Hba1C|0|||
130906181|NCT01853618|471291309|FG002|Overall Study|Physician Decision|1|||
130906182|NCT01853618|471291310|FG003|Overall Study|Physician Decision|0|||
130906183|NCT01853618|471291311|FG004|Overall Study|Physician Decision|0|||
130906184|NCT01853618|471291307|FG000|Overall Study|Refused further treatment|0|||
130906185|NCT01853618|471291308|FG001|Overall Study|Refused further treatment|0|||
130906186|NCT01853618|471291309|FG002|Overall Study|Refused further treatment|0|||
130906187|NCT01853618|471291310|FG003|Overall Study|Refused further treatment|0|||
130906188|NCT01853618|471291311|FG004|Overall Study|Refused further treatment|1|||
130906189|NCT01146860|471291314|FG000|Overall Study|Withdrawal by Subject|0|||
130906190|NCT01146860|471291315|FG001|Overall Study|Withdrawal by Subject|1|||
130906191|NCT01075191|471291316|FG000|Overall Study|Death|1|||
130906192|NCT01075191|471291316|FG000|Overall Study|Intensification|3|||
130906193|NCT01075191|471291316|FG000|Overall Study|Co-morbidities|1|||
130906194|NCT01075191|471291316|FG000|Overall Study|Adverse Event|4|||
130906195|NCT01075191|471291316|FG000|Overall Study|Noncompliance|3|||
130906196|NCT01075191|471291316|FG000|Overall Study|Therapy Break|3|||
130906197|NCT01075191|471291316|FG000|Overall Study|Patient's Wish|2|||
130906198|NCT01075191|471291316|FG000|Overall Study|Unknown Reasons|1|||
130906199|NCT00266864|471291321|FG000|Overall Study|Lost to Follow-up|4|||
130906200|NCT00266864|471291322|FG001|Overall Study|Lost to Follow-up|1|||
130906201|NCT00266864|471291321|FG000|Overall Study|Withdrawal by Subject|1|||
130906202|NCT00266864|471291322|FG001|Overall Study|Withdrawal by Subject|1|||
130906203|NCT03036800|471291323|FG000|Overall Study|Protocol Violation|1|||
130906204|NCT03036800|471291324|FG001|Overall Study|Protocol Violation|0|||
130906205|NCT03036800|471291323|FG000|Overall Study|Non-compliance|1|||
130906206|NCT03036800|471291324|FG001|Overall Study|Non-compliance|0|||
130906207|NCT03036800|471291323|FG000|Overall Study|Lost to Follow-up|1|||
130906208|NCT03036800|471291324|FG001|Overall Study|Lost to Follow-up|0|||
130906209|NCT03036800|471291323|FG000|Overall Study|Death|1|||
130906210|NCT03036800|471291324|FG001|Overall Study|Death|0|||
130906211|NCT03036800|471291323|FG000|Overall Study|Tolerance|5|||
130906212|NCT03036800|471291324|FG001|Overall Study|Tolerance|0|||
130906213|NCT03036800|471291323|FG000|Overall Study|Unknown/no reason given|50|||
130906214|NCT03036800|471291324|FG001|Overall Study|Unknown/no reason given|39|||
131028037|NCT04757610|471733869|FG000|Overall Study|Withdrawal by Subject|26|||
131028038|NCT04757610|471733870|FG001|Overall Study|Withdrawal by Subject|25|||
131028039|NCT04757610|471733871|FG002|Overall Study|Withdrawal by Subject|25|||
131028040|NCT04757610|471733869|FG000|Overall Study|Study Terminated by Sponsor|105|||
131028041|NCT04757610|471733870|FG001|Overall Study|Study Terminated by Sponsor|105|||
131028042|NCT04757610|471733871|FG002|Overall Study|Study Terminated by Sponsor|110|||
131028043|NCT04757610|471733869|FG000|Overall Study|Randomized in Error|1|||
131028044|NCT04757610|471733870|FG001|Overall Study|Randomized in Error|0|||
131028045|NCT04757610|471733871|FG002|Overall Study|Randomized in Error|0|||
131028046|NCT02965846|471733872|FG000|Overall Study|Lost to Follow-up|1|||
130906215|NCT01077154|471291328|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
130906216|NCT01077154|471291329|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
130906217|NCT01077154|471291328|FG000|Overall Study|Withdrawal by Subject|369|||
131028047|NCT02965846|471733873|FG001|Overall Study|Lost to Follow-up|0|||
131028048|NCT02965846|471733874|FG002|Overall Study|Lost to Follow-up|0|||
131028049|NCT02965846|471733872|FG000|Overall Study|Withdrawal by Subject|0|||
131028050|NCT02965846|471733873|FG001|Overall Study|Withdrawal by Subject|1|||
130906218|NCT01077154|471291329|FG001|Overall Study|Withdrawal by Subject|385|||
130906219|NCT01077154|471291328|FG000|Overall Study|Death|215|||
130906220|NCT01077154|471291329|FG001|Overall Study|Death|214|||
130906221|NCT01077154|471291328|FG000|Overall Study|Lost to Follow-up|43|||
130906222|NCT01077154|471291329|FG001|Overall Study|Lost to Follow-up|35|||
130906223|NCT01077154|471291328|FG000|Overall Study|Noncompliance|22|||
130906224|NCT01077154|471291329|FG001|Overall Study|Noncompliance|20|||
130906225|NCT01077154|471291328|FG000|Overall Study|Disease Progression|18|||
130906226|NCT01077154|471291329|FG001|Overall Study|Disease Progression|20|||
130906227|NCT01077154|471291328|FG000|Overall Study|Ineligibility Determined|10|||
130906228|NCT01077154|471291329|FG001|Overall Study|Ineligibility Determined|14|||
130906229|NCT01077154|471291328|FG000|Overall Study|Other|14|||
130906230|NCT01077154|471291329|FG001|Overall Study|Other|11|||
130906231|NCT01077154|471291328|FG000|Overall Study|Adverse Event|9|||
130906232|NCT01077154|471291329|FG001|Overall Study|Adverse Event|9|||
131028051|NCT02965846|471733874|FG002|Overall Study|Withdrawal by Subject|0|||
131028052|NCT02965846|471733872|FG000|Overall Study|Study Terminated By Sponsor|4|||
131028053|NCT02965846|471733873|FG001|Overall Study|Study Terminated By Sponsor|4|||
131028054|NCT02965846|471733874|FG002|Overall Study|Study Terminated By Sponsor|0|||
131028055|NCT02965846|471733872|FG000|Overall Study|Participants not randomized|0|||
131028056|NCT02965846|471733873|FG001|Overall Study|Participants not randomized|0|||
131028057|NCT02965846|471733874|FG002|Overall Study|Participants not randomized|33|||
131028058|NCT05048186|471733879|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
131028059|NCT05048186|471733880|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
131028060|NCT05048186|471733879|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
131028061|NCT05048186|471733880|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
131028062|NCT01091168|471733883|FG000|Overall Study|Progressive disease|250|||
131028063|NCT01091168|471733884|FG001|Overall Study|Progressive disease|234|||
131114139|NCT03942406|472049031|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
131114140|NCT03942406|472049032|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
131114141|NCT03942406|472049033|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
130694685|NCT00112437|470505927|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694686|NCT00112437|470505928|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694687|NCT00112437|470505929|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694688|NCT00112437|470505930|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694689|NCT00112437|470505931|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
130906233|NCT01077154|471291328|FG000|Overall Study|Administrative Decision|1|||
130906234|NCT01077154|471291329|FG001|Overall Study|Administrative Decision|6|||
130906235|NCT01077154|471291328|FG000|Overall Study|Protocol Deviation|1|||
130906236|NCT01077154|471291329|FG001|Overall Study|Protocol Deviation|0|||
130906237|NCT00686998|471291330|FG000|Overall Study|Adverse Event|3|||
130906238|NCT00686998|471291331|FG001|Overall Study|Adverse Event|2|||
130906239|NCT00686998|471291332|FG002|Overall Study|Adverse Event|1|||
130906240|NCT00686998|471291330|FG000|Overall Study|Withdrawal by Subject|2|||
130906241|NCT00686998|471291331|FG001|Overall Study|Withdrawal by Subject|1|||
130906242|NCT00686998|471291332|FG002|Overall Study|Withdrawal by Subject|2|||
130906243|NCT00686998|471291330|FG000|Overall Study|Lack of Efficacy|7|||
130906244|NCT00686998|471291331|FG001|Overall Study|Lack of Efficacy|5|||
130906245|NCT00686998|471291332|FG002|Overall Study|Lack of Efficacy|0|||
130906246|NCT00686998|471291330|FG000|Overall Study|Other|0|||
130906247|NCT00686998|471291331|FG001|Overall Study|Other|0|||
130906248|NCT00686998|471291332|FG002|Overall Study|Other|1|||
130906249|NCT00686998|471291330|FG000|Overall Study|Safety Reasons|1|||
130906250|NCT00686998|471291331|FG001|Overall Study|Safety Reasons|0|||
130906251|NCT00686998|471291332|FG002|Overall Study|Safety Reasons|0|||
130906252|NCT02207946|471291333|FG000|Overall Study|Lost to Follow-up|1|||
130906253|NCT02207946|471291334|FG001|Overall Study|Lost to Follow-up|0|||
130906254|NCT02207946|471291333|FG000|Overall Study|Adverse Event|0|||
130906255|NCT02207946|471291334|FG001|Overall Study|Adverse Event|1|||
130906256|NCT02361346|471291346|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
130906257|NCT02361346|471291347|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
130906258|NCT02361346|471291348|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
130906259|NCT02361346|471291349|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
130906260|NCT02361346|471291350|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
130906261|NCT02361346|471291351|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
130906262|NCT02361346|471291352|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
130906263|NCT02361346|471291353|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
130906264|NCT02361346|471291354|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
130906265|NCT02361346|471291346|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130906266|NCT02361346|471291347|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130906267|NCT02361346|471291348|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130906268|NCT02361346|471291349|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130906269|NCT02361346|471291350|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
130906270|NCT02361346|471291351|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130906271|NCT02361346|471291352|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130906272|NCT02361346|471291353|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130906273|NCT02361346|471291354|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
130906274|NCT02361346|471291346|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
130906275|NCT02361346|471291347|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
130906276|NCT02361346|471291348|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
130906277|NCT02361346|471291349|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
130906278|NCT02361346|471291350|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
130906279|NCT02361346|471291351|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
130906280|NCT02361346|471291352|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
130906281|NCT02361346|471291353|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
130906282|NCT02361346|471291354|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
130906283|NCT02361346|471291346|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130906284|NCT02361346|471291347|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130906285|NCT02361346|471291348|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130906286|NCT02361346|471291349|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130906287|NCT02361346|471291350|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130906288|NCT02361346|471291351|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130906289|NCT02361346|471291352|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130906290|NCT02361346|471291353|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
130906291|NCT02361346|471291354|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
130906292|NCT02361346|471291346|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130906293|NCT02361346|471291347|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130906294|NCT02361346|471291348|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130906295|NCT02361346|471291349|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130906296|NCT02361346|471291350|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130906297|NCT02361346|471291351|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130906298|NCT02361346|471291352|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130906299|NCT02361346|471291353|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
131028064|NCT01091168|471733883|FG000|Overall Study|Adverse Event|21|||
131028065|NCT01091168|471733884|FG001|Overall Study|Adverse Event|24|||
131028066|NCT01091168|471733883|FG000|Overall Study|Lost to Follow-up|0|||
131028067|NCT01091168|471733884|FG001|Overall Study|Lost to Follow-up|1|||
131028068|NCT01091168|471733883|FG000|Overall Study|Physician, patient's decision, other|27|||
131028069|NCT01091168|471733884|FG001|Overall Study|Physician, patient's decision, other|37|||
131028070|NCT04567615|471733889|FG000|Randomization|Participant withdrew consent|1|||
131028071|NCT04567615|471733890|FG001|Randomization|Participant withdrew consent|0|||
131028072|NCT04567615|471733891|FG002|Randomization|Participant withdrew consent|0|||
130906300|NCT02361346|471291354|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130906301|NCT02361346|471291346|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130906302|NCT02361346|471291347|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130906303|NCT02361346|471291348|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130906304|NCT02361346|471291349|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130906305|NCT02361346|471291350|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130906306|NCT02361346|471291351|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130906307|NCT02361346|471291352|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130906308|NCT02361346|471291353|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
130906309|NCT02361346|471291354|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
130906310|NCT01163318|471291355|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
130906311|NCT01163318|471291355|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
130906312|NCT01163318|471291355|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
130906313|NCT01163318|471291355|FG000|Overall Study|Participants Without Case Report Form|7|||
130906314|NCT01163318|471291355|FG000|Overall Study|Multiple Reasons Per Participant|224|||
130906315|NCT01006603|471291360|FG000|Overall Study|Withdrawal by Subject|17|||
130906316|NCT01006603|471291361|FG001|Overall Study|Withdrawal by Subject|19|||
130906317|NCT01006603|471291360|FG000|Overall Study|Lost to Follow-up|0|||
130906318|NCT01006603|471291361|FG001|Overall Study|Lost to Follow-up|1|||
130906319|NCT01006603|471291360|FG000|Overall Study|Safety reason|1|||
130906320|NCT01006603|471291361|FG001|Overall Study|Safety reason|1|||
130906321|NCT01006603|471291360|FG000|Overall Study|Protocol Violation|1|||
130906322|NCT01006603|471291361|FG001|Overall Study|Protocol Violation|3|||
130906323|NCT01006603|471291360|FG000|Overall Study|Incorrect enrolment|0|||
130906324|NCT01006603|471291361|FG001|Overall Study|Incorrect enrolment|2|||
130906325|NCT01006603|471291360|FG000|Overall Study|Adverse Event|15|||
130906326|NCT01006603|471291361|FG001|Overall Study|Adverse Event|7|||
130906327|NCT01006603|471291360|FG000|Overall Study|Death|1|||
130906328|NCT01006603|471291361|FG001|Overall Study|Death|1|||
130906329|NCT01006603|471291360|FG000|Overall Study|Study specific discontinuation criteria|33|||
130906330|NCT01006603|471291361|FG001|Overall Study|Study specific discontinuation criteria|34|||
130906331|NCT01006603|471291360|FG000|Overall Study|Other|3|||
130906332|NCT01006603|471291361|FG001|Overall Study|Other|7|||
130906333|NCT00622739|471292797|FG000|Overall Study|Physician Decision|1|||
130906334|NCT00622739|471292798|FG001|Overall Study|Physician Decision|0|||
130906335|NCT00622739|471292797|FG000|Overall Study|Adverse Event|1|||
130906336|NCT00622739|471292798|FG001|Overall Study|Adverse Event|2|||
130906337|NCT00622739|471292797|FG000|Overall Study|Lack of Efficacy|0|||
131028073|NCT04567615|471733889|FG000|Randomization|Adverse event unrelated to study drug|0|||
131028074|NCT04567615|471733890|FG001|Randomization|Adverse event unrelated to study drug|1|||
131028075|NCT04567615|471733891|FG002|Randomization|Adverse event unrelated to study drug|0|||
131028076|NCT04567615|471733889|FG000|Treatment Period|Participant Withdrew Consent|2|||
131028077|NCT04567615|471733890|FG001|Treatment Period|Participant Withdrew Consent|5|||
131028078|NCT04567615|471733891|FG002|Treatment Period|Participant Withdrew Consent|1|||
131028079|NCT04567615|471733889|FG000|Treatment Period|Death|1|||
131028080|NCT04567615|471733890|FG001|Treatment Period|Death|2|||
131028081|NCT04567615|471733891|FG002|Treatment Period|Death|0|||
131028082|NCT04567615|471733889|FG000|Treatment Period|Lost to Follow-up|0|||
131028083|NCT04567615|471733890|FG001|Treatment Period|Lost to Follow-up|1|||
131028084|NCT04567615|471733891|FG002|Treatment Period|Lost to Follow-up|0|||
131028085|NCT04567615|471733889|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
131028086|NCT04567615|471733890|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
131028087|NCT04567615|471733891|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
131028088|NCT04567615|471733889|FG000|Treatment Period|Disease Progression|85|||
131028089|NCT04567615|471733890|FG001|Treatment Period|Disease Progression|63|||
131028090|NCT04567615|471733891|FG002|Treatment Period|Disease Progression|16|||
131028091|NCT04567615|471733889|FG000|Treatment Period|Study Drug Toxicity|3|||
131028092|NCT04567615|471733890|FG001|Treatment Period|Study Drug Toxicity|10|||
131028093|NCT04567615|471733891|FG002|Treatment Period|Study Drug Toxicity|4|||
131028094|NCT04567615|471733889|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
131028095|NCT04567615|471733890|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
131028096|NCT04567615|471733891|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
131028097|NCT04567615|471733889|FG000|Treatment Period|Other Reasons|1|||
131028098|NCT04567615|471733890|FG001|Treatment Period|Other Reasons|2|||
131028099|NCT04567615|471733891|FG002|Treatment Period|Other Reasons|0|||
131028100|NCT04567615|471733889|FG000|Treatment Period|Still On-going Treatment|21|||
131028101|NCT04567615|471733890|FG001|Treatment Period|Still On-going Treatment|22|||
131028102|NCT04567615|471733891|FG002|Treatment Period|Still On-going Treatment|2|||
131028103|NCT05134337|471735203|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
131028104|NCT05134337|471735204|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
130906338|NCT00622739|471292798|FG001|Overall Study|Lack of Efficacy|2|||
130906339|NCT00622739|471292797|FG000|Overall Study|Withdrawal by Subject|0|||
130906340|NCT00622739|471292798|FG001|Overall Study|Withdrawal by Subject|1|||
130906341|NCT00622739|471292797|FG000|Overall Study|Lost to Follow-up|0|||
130906342|NCT00622739|471292798|FG001|Overall Study|Lost to Follow-up|1|||
130906343|NCT03387150|471292799|FG000|Overall Study|Withdrawal by Subject|3|||
130906344|NCT03387150|471292800|FG001|Overall Study|Withdrawal by Subject|0|||
130906345|NCT03387150|471292801|FG002|Overall Study|Withdrawal by Subject|3|||
130906346|NCT03387150|471292802|FG003|Overall Study|Withdrawal by Subject|4|||
130906347|NCT03387150|471292803|FG004|Overall Study|Withdrawal by Subject|1|||
130906348|NCT03387150|471292804|FG005|Overall Study|Withdrawal by Subject|2|||
130906349|NCT03387150|471292805|FG006|Overall Study|Withdrawal by Subject|0|||
130906350|NCT03387150|471292799|FG000|Overall Study|Lost to Follow-up|3|||
130906351|NCT03387150|471292800|FG001|Overall Study|Lost to Follow-up|2|||
130906352|NCT03387150|471292801|FG002|Overall Study|Lost to Follow-up|2|||
130906353|NCT03387150|471292802|FG003|Overall Study|Lost to Follow-up|3|||
130906354|NCT03387150|471292803|FG004|Overall Study|Lost to Follow-up|3|||
131114142|NCT03942406|472049034|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
130906355|NCT03387150|471292804|FG005|Overall Study|Lost to Follow-up|3|||
130906356|NCT03387150|471292805|FG006|Overall Study|Lost to Follow-up|0|||
131114143|NCT05628285|472049035|FG000|Overall Study|Lost to Follow-up|1|||
131114144|NCT03694418|472049036|FG000|Overall Study|Lost to Follow-up|115|||
131114145|NCT03694418|472049037|FG001|Overall Study|Lost to Follow-up|23|||
131114146|NCT03694418|472049038|FG002|Overall Study|Lost to Follow-up|12|||
131114147|NCT03694418|472049039|FG003|Overall Study|Lost to Follow-up|12|||
131114148|NCT03694418|472049040|FG004|Overall Study|Lost to Follow-up|13|||
131114149|NCT02310672|472049041|FG000|Overall Study|Death|1|||
131114150|NCT02310672|472049041|FG000|Overall Study|Lost to Follow-up|1|||
131114151|NCT02310672|472049041|FG000|Overall Study|Withdrawal by Subject|1|||
131114152|NCT02310672|472049041|FG000|Overall Study|Sponsor's decision|12|||
131114153|NCT01601847|472049049|FG000|Overall Study|Death|1|||
131114154|NCT01601847|472049050|FG001|Overall Study|Death|0|||
131114155|NCT01601847|472049049|FG000|Overall Study|Withdrawal by Subject|11|||
131114156|NCT01601847|472049050|FG001|Overall Study|Withdrawal by Subject|7|||
131114157|NCT01601847|472049049|FG000|Overall Study|Lost to Follow-up|1|||
131114158|NCT01601847|472049050|FG001|Overall Study|Lost to Follow-up|3|||
131114159|NCT01284062|472049051|FG000|Overall Study|Adverse Event|4|||
131114160|NCT01284062|472049052|FG001|Overall Study|Adverse Event|5|||
131114161|NCT01284062|472049053|FG002|Overall Study|Adverse Event|0|||
131114162|NCT01284062|472049054|FG003|Overall Study|Adverse Event|5|||
131114163|NCT01284062|472049051|FG000|Overall Study|Lack of Efficacy|3|||
131114164|NCT01284062|472049052|FG001|Overall Study|Lack of Efficacy|2|||
131114165|NCT01284062|472049053|FG002|Overall Study|Lack of Efficacy|2|||
131114166|NCT01284062|472049054|FG003|Overall Study|Lack of Efficacy|1|||
131114167|NCT01284062|472049051|FG000|Overall Study|Medication error without adverse event|0|||
131114168|NCT01284062|472049052|FG001|Overall Study|Medication error without adverse event|0|||
131114169|NCT01284062|472049053|FG002|Overall Study|Medication error without adverse event|1|||
131114170|NCT01284062|472049054|FG003|Overall Study|Medication error without adverse event|0|||
131114171|NCT01284062|472049051|FG000|Overall Study|Protocol Violation|1|||
131114172|NCT01284062|472049052|FG001|Overall Study|Protocol Violation|0|||
131114173|NCT01284062|472049053|FG002|Overall Study|Protocol Violation|0|||
131114174|NCT01284062|472049054|FG003|Overall Study|Protocol Violation|2|||
131114175|NCT01284062|472049051|FG000|Overall Study|Withdrawal by Subject|3|||
131114176|NCT01284062|472049052|FG001|Overall Study|Withdrawal by Subject|1|||
131114177|NCT01284062|472049053|FG002|Overall Study|Withdrawal by Subject|2|||
131114178|NCT01284062|472049054|FG003|Overall Study|Withdrawal by Subject|5|||
131114179|NCT01284062|472049051|FG000|Overall Study|Other|0|||
131114180|NCT01284062|472049052|FG001|Overall Study|Other|0|||
131114181|NCT01284062|472049053|FG002|Overall Study|Other|0|||
131114182|NCT01284062|472049054|FG003|Overall Study|Other|1|||
131114183|NCT01284062|472049051|FG000|Overall Study|Site Closed|0|||
131114184|NCT01284062|472049052|FG001|Overall Study|Site Closed|0|||
131114185|NCT01284062|472049053|FG002|Overall Study|Site Closed|1|||
131114186|NCT01284062|472049054|FG003|Overall Study|Site Closed|0|||
131114187|NCT02234323|472049055|FG000|All Enrolled|Not Treated: Completed study in database|2|||
131114188|NCT02234323|472049055|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
131114189|NCT02234323|472049055|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
131114190|NCT02234323|472049055|FG000|All Treated|Death|1|||
130906357|NCT03387150|471292799|FG000|Overall Study|Participant unable to adhere to visit|0|||
130906358|NCT03387150|471292800|FG001|Overall Study|Participant unable to adhere to visit|1|||
130906359|NCT03387150|471292801|FG002|Overall Study|Participant unable to adhere to visit|0|||
131114191|NCT02234323|472049055|FG000|All Treated|Physician Decision|5|||
131114192|NCT02234323|472049055|FG000|All Treated|Lack of Efficacy|3|||
131114193|NCT02234323|472049055|FG000|All Treated|Exceeded lab value limit|2|||
131114194|NCT02234323|472049055|FG000|All Treated|Other|7|||
131114195|NCT02644941|472049056|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
131114196|NCT02644941|472049057|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
131114197|NCT01717768|472049058|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131114198|NCT01717768|472049059|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
131114199|NCT01717768|472049060|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131114200|NCT01717768|472049061|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130906360|NCT03387150|471292802|FG003|Overall Study|Participant unable to adhere to visit|0|||
130906361|NCT03387150|471292803|FG004|Overall Study|Participant unable to adhere to visit|2|||
131114201|NCT01717768|472049062|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131114202|NCT01717768|472049063|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131114203|NCT01717768|472049064|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131114204|NCT01717768|472049065|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
130906362|NCT03387150|471292804|FG005|Overall Study|Participant unable to adhere to visit|2|||
130906363|NCT03387150|471292805|FG006|Overall Study|Participant unable to adhere to visit|0|||
130906364|NCT00371761|471292806|FG000|Overall Study|Adverse Event|1|||
130906365|NCT00371761|471292807|FG001|Overall Study|Adverse Event|1|||
130906366|NCT00371761|471292806|FG000|Overall Study|Withdrawal by Subject|1|||
130906367|NCT00371761|471292807|FG001|Overall Study|Withdrawal by Subject|3|||
130906368|NCT00371761|471292806|FG000|Overall Study|Investigator Judgment|2|||
130906369|NCT00371761|471292807|FG001|Overall Study|Investigator Judgment|3|||
130906370|NCT00371761|471292806|FG000|Overall Study|Study termination|4|||
130906371|NCT00371761|471292807|FG001|Overall Study|Study termination|3|||
130906372|NCT02448680|471292809|FG000|Overall Study|Physician Decision|1|||
130906373|NCT02448680|471292810|FG001|Overall Study|Physician Decision|1|||
131028105|NCT04059354|471735209|FG000|Overall Study|COVID-19 pandemic|3|||
131028106|NCT05403801|471735210|FG000|Overall Study|Withdrawal by Subject|2|||
131028107|NCT05215847|471735212|FG000|Overall Study|Lost to Follow-up|1|||
131028108|NCT02819843|471735219|FG000|Overall Study|Disease progression before RT|0|||
131028109|NCT02819843|471735220|FG001|Overall Study|Disease progression before RT|1|||
131028110|NCT03055858|471735222|FG000|Overall Study|Death|9|||
131028111|NCT03055858|471735222|FG000|Overall Study|Withdrawal by Subject|11|||
130906374|NCT02448680|471292809|FG000|Overall Study|Withdrawal by Subject|0|||
130906375|NCT02448680|471292810|FG001|Overall Study|Withdrawal by Subject|2|||
130906376|NCT01736657|471292817|FG000|Overall Study|insufficient vascular access|1|||
130906377|NCT00997438|471292828|FG000|Overall Study|Blood draw difficulty|2|||
130906378|NCT00997438|471292829|FG001|Overall Study|Blood draw difficulty|0|||
130906379|NCT00997438|471292830|FG002|Overall Study|Blood draw difficulty|1|||
130906380|NCT00997438|471292828|FG000|Overall Study|Withdrawal by Subject|1|||
131028112|NCT03055858|471735222|FG000|Overall Study|Lost to Follow-up|6|||
131028113|NCT03055858|471735222|FG000|Overall Study|Missed Follow-Up Visits|18|||
131028114|NCT04586920|471735223|FG000|Overall Study|Lost to Follow-up|0|||
131028115|NCT04586920|471735224|FG001|Overall Study|Lost to Follow-up|0|||
131028116|NCT04586920|471735225|FG002|Overall Study|Lost to Follow-up|0|||
131028117|NCT04586920|471735226|FG003|Overall Study|Lost to Follow-up|0|||
131028118|NCT04586920|471735227|FG004|Overall Study|Lost to Follow-up|0|||
131028119|NCT04586920|471735228|FG005|Overall Study|Lost to Follow-up|0|||
131028120|NCT04586920|471735229|FG006|Overall Study|Lost to Follow-up|1|||
131028121|NCT04586920|471735230|FG007|Overall Study|Lost to Follow-up|1|||
131028122|NCT04586920|471735231|FG008|Overall Study|Lost to Follow-up|0|||
131028123|NCT04586920|471735232|FG009|Overall Study|Lost to Follow-up|1|||
131028124|NCT04586920|471735233|FG010|Overall Study|Lost to Follow-up|0|||
131028125|NCT04586920|471735234|FG011|Overall Study|Lost to Follow-up|0|||
131028126|NCT04586920|471735235|FG012|Overall Study|Lost to Follow-up|0|||
131028127|NCT04586920|471735236|FG013|Overall Study|Lost to Follow-up|1|||
131028128|NCT04586920|471735237|FG014|Overall Study|Lost to Follow-up|0|||
131028129|NCT04586920|471735238|FG015|Overall Study|Lost to Follow-up|0|||
131028130|NCT04586920|471735239|FG016|Overall Study|Lost to Follow-up|0|||
131028131|NCT04586920|471735240|FG017|Overall Study|Lost to Follow-up|0|||
131028132|NCT04586920|471735223|FG000|Overall Study|Withdrawal by Subject|0|||
131028133|NCT04586920|471735224|FG001|Overall Study|Withdrawal by Subject|0|||
131028134|NCT04586920|471735225|FG002|Overall Study|Withdrawal by Subject|0|||
131028135|NCT04586920|471735226|FG003|Overall Study|Withdrawal by Subject|0|||
131028136|NCT04586920|471735227|FG004|Overall Study|Withdrawal by Subject|0|||
131028137|NCT04586920|471735228|FG005|Overall Study|Withdrawal by Subject|0|||
131028138|NCT04586920|471735229|FG006|Overall Study|Withdrawal by Subject|0|||
131028139|NCT04586920|471735230|FG007|Overall Study|Withdrawal by Subject|1|||
131028140|NCT04586920|471735231|FG008|Overall Study|Withdrawal by Subject|0|||
131114205|NCT01717768|472049066|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131114206|NCT01717768|472049067|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131114207|NCT01717768|472049068|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131114208|NCT01717768|472049069|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
131114209|NCT01717768|472049058|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131114210|NCT01717768|472049059|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131114211|NCT01717768|472049060|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131028141|NCT04586920|471735232|FG009|Overall Study|Withdrawal by Subject|1|||
131028142|NCT04586920|471735233|FG010|Overall Study|Withdrawal by Subject|0|||
131028143|NCT04586920|471735234|FG011|Overall Study|Withdrawal by Subject|1|||
131028144|NCT04586920|471735235|FG012|Overall Study|Withdrawal by Subject|0|||
131028145|NCT04586920|471735236|FG013|Overall Study|Withdrawal by Subject|0|||
131028146|NCT04586920|471735237|FG014|Overall Study|Withdrawal by Subject|0|||
131114212|NCT01717768|472049061|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131028147|NCT04586920|471735238|FG015|Overall Study|Withdrawal by Subject|0|||
130906381|NCT00997438|471292829|FG001|Overall Study|Withdrawal by Subject|1|||
130906382|NCT00997438|471292830|FG002|Overall Study|Withdrawal by Subject|0|||
130906383|NCT00997438|471292828|FG000|Overall Study|Exclusion criteria at visit 1|2|||
130906384|NCT00997438|471292829|FG001|Overall Study|Exclusion criteria at visit 1|2|||
130906385|NCT00997438|471292830|FG002|Overall Study|Exclusion criteria at visit 1|3|||
130694690|NCT00112437|470505932|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694691|NCT00112437|470505933|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694692|NCT00112437|470505934|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694693|NCT00112437|470505935|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694694|NCT00112437|470505936|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
130906386|NCT03505671|471292831|FG000|Overall Study|Withdrawal by Subject|2|||
130906387|NCT03505671|471292832|FG001|Overall Study|Withdrawal by Subject|1|||
130906388|NCT03505671|471292831|FG000|Overall Study|Lost to Follow-up|1|||
130906389|NCT03505671|471292832|FG001|Overall Study|Lost to Follow-up|0|||
130906390|NCT01857310|471292833|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
130906391|NCT01857310|471292834|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
130906392|NCT04761627|471292835|FG000|Run-in Period|Death|1|||
130906393|NCT04761627|471292836|FG001|Run-in Period|Death|0|||
130906394|NCT04761627|471292837|FG002|Run-in Period|Death|0|||
130906395|NCT04761627|471292835|FG000|Run-in Period|Required alternative therapy|2|||
130906396|NCT04761627|471292836|FG001|Run-in Period|Required alternative therapy|0|||
130906397|NCT04761627|471292837|FG002|Run-in Period|Required alternative therapy|0|||
130906398|NCT04761627|471292835|FG000|Run-in Period|Lost to Follow-up|2|||
130906399|NCT04761627|471292836|FG001|Run-in Period|Lost to Follow-up|0|||
130906400|NCT04761627|471292837|FG002|Run-in Period|Lost to Follow-up|0|||
130906401|NCT04761627|471292835|FG000|Run-in Period|Protocol Violation|3|||
130906402|NCT04761627|471292836|FG001|Run-in Period|Protocol Violation|0|||
130906403|NCT04761627|471292837|FG002|Run-in Period|Protocol Violation|0|||
130906404|NCT04761627|471292835|FG000|Run-in Period|Abnormal liver function|1|||
130906405|NCT04761627|471292836|FG001|Run-in Period|Abnormal liver function|0|||
130906406|NCT04761627|471292837|FG002|Run-in Period|Abnormal liver function|0|||
130906407|NCT04761627|471292835|FG000|Run-in Period|Adverse Event|6|||
130906408|NCT04761627|471292836|FG001|Run-in Period|Adverse Event|0|||
130906409|NCT04761627|471292837|FG002|Run-in Period|Adverse Event|0|||
130906410|NCT04761627|471292835|FG000|Run-in Period|Withdrawal by Subject|7|||
130906411|NCT04761627|471292836|FG001|Run-in Period|Withdrawal by Subject|0|||
130906412|NCT04761627|471292837|FG002|Run-in Period|Withdrawal by Subject|0|||
130906413|NCT04761627|471292835|FG000|Run-in Period|Did not meet PASI 50|15|||
130906414|NCT04761627|471292836|FG001|Run-in Period|Did not meet PASI 50|0|||
130906415|NCT04761627|471292837|FG002|Run-in Period|Did not meet PASI 50|0|||
130906416|NCT04761627|471292835|FG000|Run-in Period|Study site closure|2|||
130906417|NCT04761627|471292836|FG001|Run-in Period|Study site closure|0|||
130906418|NCT04761627|471292837|FG002|Run-in Period|Study site closure|0|||
130906419|NCT04761627|471292835|FG000|Run-in Period|Pregnancy|2|||
130906420|NCT04761627|471292836|FG001|Run-in Period|Pregnancy|0|||
130906421|NCT04761627|471292837|FG002|Run-in Period|Pregnancy|0|||
130906422|NCT04761627|471292835|FG000|Post-randomization Period|Military service|0|||
130906423|NCT04761627|471292836|FG001|Post-randomization Period|Military service|1|||
130906424|NCT04761627|471292837|FG002|Post-randomization Period|Military service|0|||
130906425|NCT04761627|471292835|FG000|Post-randomization Period|Adverse Event|0|||
130906426|NCT04761627|471292836|FG001|Post-randomization Period|Adverse Event|4|||
130906427|NCT04761627|471292837|FG002|Post-randomization Period|Adverse Event|2|||
130906428|NCT04761627|471292835|FG000|Post-randomization Period|Lost to Follow-up|0|||
130906429|NCT04761627|471292836|FG001|Post-randomization Period|Lost to Follow-up|6|||
130906430|NCT04761627|471292837|FG002|Post-randomization Period|Lost to Follow-up|6|||
130906431|NCT04761627|471292835|FG000|Post-randomization Period|Withdrawal by Subject|0|||
130906432|NCT04761627|471292836|FG001|Post-randomization Period|Withdrawal by Subject|7|||
130906433|NCT04761627|471292837|FG002|Post-randomization Period|Withdrawal by Subject|6|||
130906434|NCT04761627|471292835|FG000|Post-randomization Period|Pregnancy|0|||
130906435|NCT04761627|471292836|FG001|Post-randomization Period|Pregnancy|0|||
130906436|NCT04761627|471292837|FG002|Post-randomization Period|Pregnancy|1|||
130906437|NCT04761627|471292835|FG000|Post-randomization Period|Study site closure|0|||
130906438|NCT04761627|471292836|FG001|Post-randomization Period|Study site closure|0|||
130906439|NCT04761627|471292837|FG002|Post-randomization Period|Study site closure|1|||
131028148|NCT04586920|471735239|FG016|Overall Study|Withdrawal by Subject|0|||
131028149|NCT04586920|471735240|FG017|Overall Study|Withdrawal by Subject|0|||
131028150|NCT02728557|471735245|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
131028151|NCT02728557|471735246|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
131028152|NCT02728557|471735245|FG000|Overall Study|Dissatisfaction with research tasks|0|||
130694695|NCT00112437|470505937|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
130906440|NCT04761627|471292835|FG000|Post-randomization Period|Family planning|0|||
130906441|NCT04761627|471292836|FG001|Post-randomization Period|Family planning|1|||
130694696|NCT00112437|470505938|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
130906442|NCT04761627|471292837|FG002|Post-randomization Period|Family planning|0|||
130906443|NCT01634178|471292840|FG000|Treatment Period 1|Adverse Event|0|||
130906444|NCT01634178|471292841|FG001|Treatment Period 1|Adverse Event|1|||
130906445|NCT01634178|471292840|FG000|Treatment Period 2|Adverse Event|1|||
130906446|NCT01634178|471292841|FG001|Treatment Period 2|Adverse Event|0|||
130906447|NCT05867342|471292842|FG000|Overall Study|Investigator Decision|3|||
130906448|NCT05867342|471292843|FG001|Overall Study|Investigator Decision|3|||
130906449|NCT00991952|471292845|FG000|Overall Study|Adverse Event|0|||
130906450|NCT00991952|471292846|FG001|Overall Study|Adverse Event|1|||
130906451|NCT00582816|471292847|FG000|Overall Study|Engraftment Failure|3|||
130906452|NCT01609478|471292850|FG000|Overall Study|Adverse Event|3|||
130906453|NCT01609478|471292851|FG001|Overall Study|Adverse Event|1|||
130906454|NCT01609478|471292852|FG002|Overall Study|Adverse Event|5|||
130906455|NCT01609478|471292850|FG000|Overall Study|Protocol Deviation|0|||
130906456|NCT01609478|471292851|FG001|Overall Study|Protocol Deviation|1|||
130906457|NCT01609478|471292852|FG002|Overall Study|Protocol Deviation|1|||
130906458|NCT01609478|471292850|FG000|Overall Study|Non-Compliance with study treatment|1|||
130906459|NCT01609478|471292851|FG001|Overall Study|Non-Compliance with study treatment|0|||
130906460|NCT01609478|471292852|FG002|Overall Study|Non-Compliance with study treatment|0|||
130906461|NCT01609478|471292850|FG000|Overall Study|Physician Decision|1|||
130906462|NCT01609478|471292851|FG001|Overall Study|Physician Decision|0|||
130906463|NCT01609478|471292852|FG002|Overall Study|Physician Decision|1|||
130906464|NCT01609478|471292850|FG000|Overall Study|Withdrawal by Subject|2|||
130906465|NCT01609478|471292851|FG001|Overall Study|Withdrawal by Subject|0|||
130906466|NCT01609478|471292852|FG002|Overall Study|Withdrawal by Subject|2|||
130906467|NCT04966741|471292853|FG000|Overall Study|Lost to Follow-up|1|||
130906468|NCT04966741|471292854|FG001|Overall Study|Lost to Follow-up|0|||
130906469|NCT02635646|471292857|FG000|Overall Study|Lost to Follow-up|24|||
130906470|NCT02635646|471292858|FG001|Overall Study|Lost to Follow-up|25|||
131114213|NCT01717768|472049062|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131114214|NCT01717768|472049063|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131114215|NCT01717768|472049064|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131114216|NCT01717768|472049065|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131114217|NCT01717768|472049066|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131114218|NCT01717768|472049067|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131114219|NCT01717768|472049068|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
131114220|NCT01717768|472049069|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
131114221|NCT01717768|472049058|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114222|NCT01717768|472049059|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114223|NCT01717768|472049060|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114224|NCT01717768|472049061|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114225|NCT01717768|472049062|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114226|NCT01717768|472049063|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114227|NCT01717768|472049064|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114228|NCT01717768|472049065|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
131114229|NCT01717768|472049066|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114230|NCT01717768|472049067|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114231|NCT01717768|472049068|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114232|NCT01717768|472049069|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
131114233|NCT01717768|472049058|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114234|NCT01717768|472049059|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114235|NCT01717768|472049060|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114236|NCT01717768|472049061|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114237|NCT01717768|472049062|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114238|NCT01717768|472049063|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114239|NCT01717768|472049064|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114240|NCT01717768|472049065|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114241|NCT01717768|472049066|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114242|NCT01717768|472049067|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
131114243|NCT01717768|472049068|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114244|NCT01717768|472049069|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
131114245|NCT00448435|472049070|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
131114246|NCT00448435|472049071|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
131114247|NCT01387230|472049072|FG000|Overall Study|Adverse Event|0|||
130768420|NCT01078298|470775571|FG000|Overall Study|Withdrawal by Subject|31|||
130906471|NCT02635646|471292857|FG000|Overall Study|Pregnancy|1|||
130906472|NCT02635646|471292858|FG001|Overall Study|Pregnancy|1|||
130768421|NCT01078298|470775572|FG001|Overall Study|Withdrawal by Subject|33|||
130906473|NCT00645788|471292863|FG000|Overall Study|Did not receive study drug|1|||
130906474|NCT00645788|471292864|FG001|Overall Study|Did not receive study drug|1|||
130906475|NCT00645788|471292865|FG002|Overall Study|Did not receive study drug|0|||
130906476|NCT00645788|471292866|FG003|Overall Study|Did not receive study drug|0|||
130906477|NCT00645788|471292863|FG000|Overall Study|Adverse Event|4|||
130906478|NCT00645788|471292864|FG001|Overall Study|Adverse Event|9|||
130906479|NCT00645788|471292865|FG002|Overall Study|Adverse Event|5|||
130906480|NCT00645788|471292866|FG003|Overall Study|Adverse Event|3|||
130694697|NCT00112437|470505939|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694698|NCT00112437|470505940|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694699|NCT00112437|470505941|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
130694700|NCT00112437|470505916|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694701|NCT00112437|470505917|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694702|NCT00112437|470505918|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694703|NCT00112437|470505919|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694704|NCT00112437|470505920|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694705|NCT00112437|470505921|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694706|NCT00112437|470505922|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694707|NCT00112437|470505923|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694708|NCT00112437|470505924|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694709|NCT00112437|470505925|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694710|NCT00112437|470505926|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694711|NCT00112437|470505927|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694712|NCT00112437|470505928|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694713|NCT00112437|470505929|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694714|NCT00112437|470505930|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694715|NCT00112437|470505931|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694716|NCT00112437|470505932|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694717|NCT00112437|470505933|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694718|NCT00112437|470505934|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694719|NCT00112437|470505935|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694720|NCT00112437|470505936|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
130694721|NCT00112437|470505937|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
130694722|NCT00112437|470505938|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694723|NCT00112437|470505939|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694724|NCT00112437|470505940|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694725|NCT00112437|470505941|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130694726|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694727|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694728|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694729|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694730|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694731|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694732|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694733|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694734|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694735|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694736|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694737|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694738|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694739|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694740|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694741|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694742|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694743|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694744|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
131028153|NCT02728557|471735246|FG001|Overall Study|Dissatisfaction with research tasks|1|||
131028154|NCT02728557|471735245|FG000|Overall Study|Scheduling or change in availability|1|||
130694745|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694746|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694747|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694748|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
130694749|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
130694750|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130694751|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
130694752|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Death|0|||
130694753|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Death|0|||
130694754|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Death|0|||
130694755|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Death|0|||
130694756|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Death|0|||
130694757|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Death|0|||
130694758|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Death|0|||
130694759|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Death|0|||
130694760|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Death|0|||
130694761|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Death|0|||
130694762|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Death|0|||
131028155|NCT02728557|471735246|FG001|Overall Study|Scheduling or change in availability|1|||
130906481|NCT00645788|471292863|FG000|Overall Study|Lost to Follow-up|1|||
130906482|NCT00645788|471292864|FG001|Overall Study|Lost to Follow-up|0|||
130906483|NCT00645788|471292865|FG002|Overall Study|Lost to Follow-up|0|||
130906484|NCT00645788|471292866|FG003|Overall Study|Lost to Follow-up|0|||
131114248|NCT01387230|472049073|FG001|Overall Study|Adverse Event|1|||
131114249|NCT01387230|472049074|FG002|Overall Study|Adverse Event|3|||
131114250|NCT01387230|472049072|FG000|Overall Study|Lack of Efficacy|8|||
131114251|NCT01387230|472049073|FG001|Overall Study|Lack of Efficacy|5|||
131114252|NCT01387230|472049074|FG002|Overall Study|Lack of Efficacy|4|||
131114253|NCT01387230|472049072|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
131114254|NCT01387230|472049073|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
131114255|NCT01387230|472049074|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
131114256|NCT01387230|472049072|FG000|Overall Study|Lost to Follow-up|0|||
131114257|NCT01387230|472049073|FG001|Overall Study|Lost to Follow-up|0|||
131114258|NCT01387230|472049074|FG002|Overall Study|Lost to Follow-up|1|||
131114259|NCT01387230|472049072|FG000|Overall Study|Withdrawal by Subject|4|||
131114260|NCT01387230|472049073|FG001|Overall Study|Withdrawal by Subject|1|||
131114261|NCT01387230|472049074|FG002|Overall Study|Withdrawal by Subject|0|||
131114262|NCT00403754|472049075|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
131114263|NCT00403754|472049076|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
131114264|NCT00403754|472049077|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
131114265|NCT00403754|472049078|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
131114266|NCT00403754|472049075|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
131114267|NCT00403754|472049076|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
131114268|NCT00403754|472049077|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
131114269|NCT00403754|472049078|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
131114270|NCT02499770|472049083|FG000|Overall Study|Death|17|||
131114271|NCT02499770|472049084|FG001|Overall Study|Death|56|||
131114272|NCT02499770|472049083|FG000|Overall Study|Study completion|1|||
131114273|NCT02499770|472049084|FG001|Overall Study|Study completion|10|||
131114274|NCT02499770|472049083|FG000|Overall Study|Withdrawal by Subject|0|||
131114275|NCT02499770|472049084|FG001|Overall Study|Withdrawal by Subject|7|||
131114276|NCT02499770|472049083|FG000|Overall Study|Lost to Follow-up|0|||
131114277|NCT02499770|472049084|FG001|Overall Study|Lost to Follow-up|2|||
131114278|NCT02499770|472049083|FG000|Overall Study|Subject declined further treatment|1|||
131114279|NCT02499770|472049084|FG001|Overall Study|Subject declined further treatment|0|||
131114280|NCT02499770|472049083|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
131114281|NCT02499770|472049084|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
131114282|NCT02499770|472049083|FG000|Overall Study|Randomized but not enrolled|0|||
131114283|NCT02499770|472049084|FG001|Overall Study|Randomized but not enrolled|1|||
131114284|NCT00047320|472049085|FG000|Overall Study|Lack of Efficacy|8|||
131114285|NCT00047320|472049085|FG000|Overall Study|Lost to Follow-up|1|||
131114286|NCT00047320|472049085|FG000|Overall Study|Physician Decision|8|||
131114287|NCT00047320|472049085|FG000|Overall Study|Withdrawal by Subject|9|||
131114288|NCT00047320|472049085|FG000|Overall Study|Ineligible|2|||
131114289|NCT04275297|472049086|FG000|Overall Study|Lost to Follow-up|1|||
131114290|NCT04275297|472049087|FG001|Overall Study|Lost to Follow-up|1|||
131114291|NCT04824521|472049090|FG000|Overall Study|Lost to Follow-up|1|||
131114292|NCT00447382|472049091|FG000|Overall Study|Adverse Event|1|||
131114293|NCT00447382|472049092|FG001|Overall Study|Adverse Event|1|||
131114294|NCT00447382|472049091|FG000|Overall Study|Lack of Efficacy|1|||
131114295|NCT00447382|472049092|FG001|Overall Study|Lack of Efficacy|0|||
131114296|NCT00447382|472049091|FG000|Overall Study|Protocol Violation|2|||
131114297|NCT00447382|472049092|FG001|Overall Study|Protocol Violation|0|||
131114298|NCT00447382|472049091|FG000|Overall Study|Unclassified|2|||
131114299|NCT00447382|472049092|FG001|Overall Study|Unclassified|5|||
131114300|NCT02673619|472049093|FG000|Overall Study|Lost to Follow-up|1|||
131114301|NCT02673619|472049094|FG001|Overall Study|Lost to Follow-up|0|||
131114302|NCT02673619|472049095|FG002|Overall Study|Lost to Follow-up|0|||
131114303|NCT02673619|472049096|FG003|Overall Study|Lost to Follow-up|0|||
131114304|NCT02673619|472049093|FG000|Overall Study|Withdrawal by Subject|1|||
131114305|NCT02673619|472049094|FG001|Overall Study|Withdrawal by Subject|1|||
130694763|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Death|0|||
130694764|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Death|0|||
130694765|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Death|0|||
130694766|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Death|0|||
131114306|NCT02673619|472049095|FG002|Overall Study|Withdrawal by Subject|1|||
131114307|NCT02673619|472049096|FG003|Overall Study|Withdrawal by Subject|0|||
131114308|NCT02673619|472049093|FG000|Overall Study|Adverse Event|0|||
131114309|NCT02673619|472049094|FG001|Overall Study|Adverse Event|0|||
131114310|NCT02673619|472049095|FG002|Overall Study|Adverse Event|1|||
130694767|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Death|0|||
130694768|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Death|0|||
131222761|NCT00386100|472443175|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
130906485|NCT00645788|471292863|FG000|Overall Study|Protocol Violation|1|||
130906486|NCT00645788|471292864|FG001|Overall Study|Protocol Violation|0|||
130906487|NCT00645788|471292865|FG002|Overall Study|Protocol Violation|2|||
130694769|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Death|0|||
130694770|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Death|0|||
130694771|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Death|0|||
130694772|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Death|0|||
130694773|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Death|0|||
130694774|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Death|0|||
130694775|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Death|2|||
130694776|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Death|0|||
130694777|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Death|0|||
130694778|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694779|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694780|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694781|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694782|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694783|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694784|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694785|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694786|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694787|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694788|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694789|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694790|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694791|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694792|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694793|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694794|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694795|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694796|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694797|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694798|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694799|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694800|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694801|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694802|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130694803|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
130694804|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Other|0|||
130694805|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Other|0|||
130694806|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Other|0|||
130694807|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Other|0|||
130694808|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Other|0|||
130694809|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Other|0|||
130694810|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Other|0|||
130694811|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Other|0|||
130694812|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Other|0|||
130694813|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Other|0|||
130694814|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Other|0|||
130694815|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Other|0|||
130694816|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Other|0|||
130694817|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Other|0|||
130694818|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Other|0|||
130694819|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Other|0|||
130694820|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Other|0|||
130694821|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Other|0|||
130694822|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Other|0|||
130694823|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Other|0|||
130694824|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Other|0|||
130694825|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Other|0|||
130694826|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Other|0|||
130694827|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Other|0|||
130694828|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Other|1|||
130694829|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Other|0|||
130694830|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130768422|NCT01078298|470775571|FG000|Overall Study|Protocol Violation|6|||
130768423|NCT01078298|470775572|FG001|Overall Study|Protocol Violation|6|||
130694831|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694832|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694833|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694834|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694835|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694836|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694837|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694838|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694839|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694840|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694841|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694842|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694843|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694844|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694845|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694846|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694847|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694848|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694849|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694850|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694851|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694852|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694853|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
130694854|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694855|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130694856|NCT00112437|470505916|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694857|NCT00112437|470505917|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694858|NCT00112437|470505918|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694859|NCT00112437|470505919|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694860|NCT00112437|470505920|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694861|NCT00112437|470505921|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694862|NCT00112437|470505922|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694863|NCT00112437|470505923|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694864|NCT00112437|470505924|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694865|NCT00112437|470505925|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694866|NCT00112437|470505926|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694867|NCT00112437|470505927|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694868|NCT00112437|470505928|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694869|NCT00112437|470505929|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694870|NCT00112437|470505930|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694871|NCT00112437|470505931|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694872|NCT00112437|470505932|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694873|NCT00112437|470505933|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694874|NCT00112437|470505934|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694875|NCT00112437|470505935|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694876|NCT00112437|470505936|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694877|NCT00112437|470505937|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694878|NCT00112437|470505938|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
130694879|NCT00112437|470505939|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
130694880|NCT00112437|470505940|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130694881|NCT00112437|470505941|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
130694882|NCT03541252|470505942|FG000|Overall Study|Withdrawal by Subject|1|||
130694883|NCT00227370|470505943|FG000|Overall Study|Withdrawal by Subject|1|||
130694884|NCT00227370|470505944|FG001|Overall Study|Withdrawal by Subject|2|||
130694885|NCT00227370|470505943|FG000|Overall Study|Death|3|||
130694886|NCT00227370|470505944|FG001|Overall Study|Death|4|||
130694887|NCT00227370|470505943|FG000|Overall Study|Adverse Event|6|||
130694888|NCT00227370|470505944|FG001|Overall Study|Adverse Event|11|||
130694889|NCT00227370|470505943|FG000|Overall Study|Physician Decision|9|||
130694890|NCT00227370|470505944|FG001|Overall Study|Physician Decision|6|||
130694891|NCT00227370|470505943|FG000|Overall Study|Other reasons|2|||
130694892|NCT00227370|470505944|FG001|Overall Study|Other reasons|1|||
130694893|NCT03846193|470505945|FG000|Overall Study|Physician Decision|0|||
130694894|NCT03846193|470505946|FG001|Overall Study|Physician Decision|0|||
130694895|NCT03846193|470505947|FG002|Overall Study|Physician Decision|1|||
130694896|NCT03846193|470505948|FG003|Overall Study|Physician Decision|0|||
130768424|NCT01078298|470775571|FG000|Overall Study|Adverse Event|6|||
130906488|NCT00645788|471292866|FG003|Overall Study|Protocol Violation|0|||
130906489|NCT00645788|471292863|FG000|Overall Study|Withdrawal by Subject|0|||
130906490|NCT00645788|471292864|FG001|Overall Study|Withdrawal by Subject|1|||
130906491|NCT00645788|471292865|FG002|Overall Study|Withdrawal by Subject|0|||
130906492|NCT00645788|471292866|FG003|Overall Study|Withdrawal by Subject|2|||
131114311|NCT02673619|472049096|FG003|Overall Study|Adverse Event|0|||
130768425|NCT01078298|470775572|FG001|Overall Study|Adverse Event|5|||
130768426|NCT01078298|470775571|FG000|Overall Study|Death|2|||
130694897|NCT03846193|470505949|FG004|Overall Study|Physician Decision|0|||
130906493|NCT00645788|471292863|FG000|Overall Study|Pulmonary exacerbation|13|||
130906494|NCT00645788|471292864|FG001|Overall Study|Pulmonary exacerbation|16|||
131028156|NCT03897686|471735247|FG000|Overall Study|Protocol Violation|1|||
131028157|NCT03897686|471735248|FG001|Overall Study|Protocol Violation|1|||
131028158|NCT03897686|471735247|FG000|Overall Study|Withdrawal by Subject|1|||
131028159|NCT03897686|471735248|FG001|Overall Study|Withdrawal by Subject|1|||
131028160|NCT03416010|471735249|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
131114312|NCT02673619|472049093|FG000|Overall Study|Lack of Efficacy|0|||
131114313|NCT02673619|472049094|FG001|Overall Study|Lack of Efficacy|0|||
131114314|NCT02673619|472049095|FG002|Overall Study|Lack of Efficacy|1|||
131114315|NCT02673619|472049096|FG003|Overall Study|Lack of Efficacy|0|||
131114316|NCT04600336|472049099|FG000|Initial Treatment|Withdrawal by Subject|1|||
131114317|NCT04600336|472049100|FG001|Initial Treatment|Withdrawal by Subject|2|||
131114318|NCT04600336|472049101|FG002|Initial Treatment|Withdrawal by Subject|0|||
131114319|NCT04600336|472049102|FG003|Initial Treatment|Withdrawal by Subject|0|||
131114320|NCT04600336|472049099|FG000|Initial Treatment|Adverse Event|0|||
131114321|NCT04600336|472049100|FG001|Initial Treatment|Adverse Event|2|||
131114322|NCT04600336|472049101|FG002|Initial Treatment|Adverse Event|0|||
131114323|NCT04600336|472049102|FG003|Initial Treatment|Adverse Event|0|||
131114324|NCT04600336|472049099|FG000|Initial Treatment|Other complicating disease|0|||
131114325|NCT04600336|472049100|FG001|Initial Treatment|Other complicating disease|0|||
131114326|NCT04600336|472049101|FG002|Initial Treatment|Other complicating disease|1|||
131114327|NCT04600336|472049102|FG003|Initial Treatment|Other complicating disease|0|||
131114328|NCT04600336|472049099|FG000|Crossover Treatment|Withdrawal by Subject|0|||
131114329|NCT04600336|472049100|FG001|Crossover Treatment|Withdrawal by Subject|0|||
131114330|NCT04600336|472049101|FG002|Crossover Treatment|Withdrawal by Subject|2|||
131114331|NCT04600336|472049102|FG003|Crossover Treatment|Withdrawal by Subject|1|||
131114332|NCT04600336|472049099|FG000|Crossover Treatment|Adverse Event|0|||
131114333|NCT04600336|472049100|FG001|Crossover Treatment|Adverse Event|0|||
131114334|NCT04600336|472049101|FG002|Crossover Treatment|Adverse Event|1|||
131114335|NCT04600336|472049102|FG003|Crossover Treatment|Adverse Event|1|||
130694898|NCT03846193|470505945|FG000|Overall Study|Lost to Follow-up|0|||
130906495|NCT00645788|471292865|FG002|Overall Study|Pulmonary exacerbation|11|||
130906496|NCT00645788|471292866|FG003|Overall Study|Pulmonary exacerbation|9|||
130906497|NCT03149848|471292867|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
130906498|NCT03149848|471292867|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
130906499|NCT02581943|471292870|FG000|Overall Study|Death|5|||
130906500|NCT02581943|471292871|FG001|Overall Study|Death|2|||
130906501|NCT02581943|471292870|FG000|Overall Study|Disease Progression|12|||
130906502|NCT02581943|471292871|FG001|Overall Study|Disease Progression|15|||
130906503|NCT02581943|471292870|FG000|Overall Study|Withdrawal by Subject|1|||
130906504|NCT02581943|471292871|FG001|Overall Study|Withdrawal by Subject|2|||
130906505|NCT03021564|471292872|FG000|Overall Study|Death|84|||
130906506|NCT03021564|471292873|FG001|Overall Study|Death|466|||
130906507|NCT03021564|471292872|FG000|Overall Study|Lost to Follow-up|0|||
130906508|NCT03021564|471292873|FG001|Overall Study|Lost to Follow-up|2|||
130906509|NCT00459979|471292878|FG000|Overall Study|Withdrawal by Subject|1|||
131028161|NCT03416010|471735250|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
131028162|NCT03416010|471735249|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
131028163|NCT03416010|471735250|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
131028164|NCT03416010|471735249|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
131028165|NCT03416010|471735250|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
131028166|NCT03416010|471735249|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
131028167|NCT03416010|471735250|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
131028168|NCT03416010|471735249|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
131028169|NCT03416010|471735250|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
131028170|NCT03416010|471735249|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
131028171|NCT03416010|471735250|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
131028172|NCT03416010|471735249|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
131028173|NCT03416010|471735250|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
131028174|NCT05415436|471735254|FG000|Overall Study|Surgeon cancelled procedure|1|||
131028175|NCT05415436|471735255|FG001|Overall Study|Surgeon cancelled procedure|0|||
131028176|NCT05415436|471735254|FG000|Overall Study|Death|1|||
131028177|NCT05415436|471735255|FG001|Overall Study|Death|0|||
131028178|NCT03819686|471735262|FG000|Overall Study|Lost to Follow-up|2|||
131114336|NCT01521897|472050677|FG000|Overall Study|Protocol Violation|18|||
130694899|NCT03846193|470505946|FG001|Overall Study|Lost to Follow-up|0|||
130906510|NCT00459979|471292878|FG000|Overall Study|Protocol Violation|1|||
130906511|NCT00745615|471292883|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
130906512|NCT00745615|471292884|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
131028179|NCT03819686|471735263|FG001|Overall Study|Lost to Follow-up|3|||
131028180|NCT03157167|471735274|FG000|Overall Study|Withdrawal by Subject|1|||
131114337|NCT01521897|472050677|FG000|Overall Study|Lost to Follow-up|5|||
131114338|NCT02194062|472050684|FG000|Overall Study|Lost to Follow-up|2|||
131114339|NCT02194062|472050685|FG001|Overall Study|Lost to Follow-up|2|||
131114340|NCT02194062|472050686|FG002|Overall Study|Lost to Follow-up|5|||
131114341|NCT02276872|472050687|FG000|Overall Study|Adverse Event|1|||
131114342|NCT02276872|472050688|FG001|Overall Study|Adverse Event|0|||
131114343|NCT02276872|472050689|FG002|Overall Study|Adverse Event|0|||
131114344|NCT04147234|472050690|FG000|Overall Study|Clinical deterioration|0|||
131114345|NCT04147234|472050691|FG001|Overall Study|Clinical deterioration|0|||
131114346|NCT04147234|472050692|FG002|Overall Study|Clinical deterioration|1|||
131114347|NCT04147234|472050693|FG003|Overall Study|Clinical deterioration|0|||
131114348|NCT04147234|472050694|FG004|Overall Study|Clinical deterioration|0|||
131114349|NCT04147234|472050695|FG005|Overall Study|Clinical deterioration|0|||
131114350|NCT04147234|472050696|FG006|Overall Study|Clinical deterioration|0|||
131114351|NCT04147234|472050690|FG000|Overall Study|Withdrawal by Subject|0|||
131114352|NCT04147234|472050691|FG001|Overall Study|Withdrawal by Subject|1|||
131114353|NCT04147234|472050692|FG002|Overall Study|Withdrawal by Subject|1|||
131114354|NCT04147234|472050693|FG003|Overall Study|Withdrawal by Subject|0|||
131114355|NCT04147234|472050694|FG004|Overall Study|Withdrawal by Subject|0|||
131114356|NCT04147234|472050695|FG005|Overall Study|Withdrawal by Subject|0|||
131114357|NCT04147234|472050696|FG006|Overall Study|Withdrawal by Subject|0|||
131114358|NCT04147234|472050690|FG000|Overall Study|Clinical disease progression|1|||
131114359|NCT04147234|472050691|FG001|Overall Study|Clinical disease progression|3|||
131114360|NCT04147234|472050692|FG002|Overall Study|Clinical disease progression|1|||
131114361|NCT04147234|472050693|FG003|Overall Study|Clinical disease progression|1|||
131114362|NCT04147234|472050694|FG004|Overall Study|Clinical disease progression|0|||
131114363|NCT04147234|472050695|FG005|Overall Study|Clinical disease progression|1|||
131114364|NCT04147234|472050696|FG006|Overall Study|Clinical disease progression|0|||
131114365|NCT04147234|472050690|FG000|Overall Study|Objective disease progression|6|||
131114366|NCT04147234|472050691|FG001|Overall Study|Objective disease progression|4|||
131114367|NCT04147234|472050692|FG002|Overall Study|Objective disease progression|3|||
131114368|NCT04147234|472050693|FG003|Overall Study|Objective disease progression|3|||
131114369|NCT04147234|472050694|FG004|Overall Study|Objective disease progression|5|||
131114370|NCT04147234|472050695|FG005|Overall Study|Objective disease progression|2|||
131114371|NCT04147234|472050696|FG006|Overall Study|Objective disease progression|3|||
131114372|NCT04147234|472050690|FG000|Overall Study|Adverse Event|0|||
131114373|NCT04147234|472050691|FG001|Overall Study|Adverse Event|0|||
131114374|NCT04147234|472050692|FG002|Overall Study|Adverse Event|0|||
131114375|NCT04147234|472050693|FG003|Overall Study|Adverse Event|0|||
131114376|NCT04147234|472050694|FG004|Overall Study|Adverse Event|1|||
131114377|NCT04147234|472050695|FG005|Overall Study|Adverse Event|0|||
131114378|NCT04147234|472050696|FG006|Overall Study|Adverse Event|0|||
131114379|NCT02596620|472050697|FG000|Overall Study|Lost to Follow-up|1|||
131114380|NCT02596620|472050698|FG001|Overall Study|Lost to Follow-up|1|||
131114381|NCT00867113|472050699|FG000|Treatment Period|Adverse Event|15|||
131114382|NCT00867113|472050699|FG000|Treatment Period|Death|2|||
131114383|NCT00867113|472050699|FG000|Treatment Period|Withdrawal by Subject|19|||
131114384|NCT00867113|472050699|FG000|Treatment Period|Lost to Follow-up|3|||
131114385|NCT00867113|472050699|FG000|Treatment Period|Administrative problems|1|||
131114386|NCT00867113|472050699|FG000|Treatment Period|Disease progression/relapse|1|||
131114387|NCT00867113|472050699|FG000|Treatment Period|Protocol Violation|4|||
131114388|NCT00867113|472050699|FG000|Post Treatment After Survival Follow-up|Death|1|||
131114389|NCT00867113|472050699|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
131114390|NCT00867113|472050699|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
131114391|NCT00867113|472050699|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
131114392|NCT01886313|472050700|FG000|Overall Study|Adverse Event|1|||
131114393|NCT01886313|472050701|FG001|Overall Study|Adverse Event|1|||
131114394|NCT00634010|472050705|FG000|Overall Study|Adverse Event|2|||
131114395|NCT00634010|472050706|FG001|Overall Study|Adverse Event|5|||
131114396|NCT00634010|472050705|FG000|Overall Study|Withdrawal by Subject|5|||
131114397|NCT00634010|472050706|FG001|Overall Study|Withdrawal by Subject|6|||
131114398|NCT00634010|472050705|FG000|Overall Study|Physician Decision|1|||
131114399|NCT00634010|472050706|FG001|Overall Study|Physician Decision|1|||
131114400|NCT00634010|472050705|FG000|Overall Study|Disease Progression|1|||
131114401|NCT00634010|472050706|FG001|Overall Study|Disease Progression|1|||
131114402|NCT00634010|472050705|FG000|Overall Study|Non-Compliant|1|||
130768427|NCT01078298|470775572|FG001|Overall Study|Death|0|||
130906513|NCT00745615|471292885|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
130906514|NCT00745615|471292886|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
131114403|NCT00634010|472050706|FG001|Overall Study|Non-Compliant|1|||
130906515|NCT00745615|471292887|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
131114404|NCT02066051|472050712|FG000|Overall Study|Subject developed active GVHD|1|||
131114405|NCT03027557|472050716|FG000|Overall Study|Adverse Event|1|||
131114406|NCT03027557|472050717|FG001|Overall Study|Adverse Event|0|||
131114407|NCT03027557|472050718|FG002|Overall Study|Adverse Event|0|||
131114408|NCT01610687|472050723|FG000|Overall Study|Lack of Efficacy|26|||
130906516|NCT00745615|471292888|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
131114409|NCT01610687|472050723|FG000|Overall Study|Adverse Event|18|||
131114410|NCT01610687|472050723|FG000|Overall Study|Moved out of area|6|||
131114411|NCT01610687|472050723|FG000|Overall Study|Withdrawal by Subject|7|||
130694900|NCT03846193|470505947|FG002|Overall Study|Lost to Follow-up|0|||
130694901|NCT03846193|470505948|FG003|Overall Study|Lost to Follow-up|0|||
130694902|NCT03846193|470505949|FG004|Overall Study|Lost to Follow-up|1|||
130694903|NCT03846193|470505945|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130694904|NCT03846193|470505946|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130694905|NCT03846193|470505947|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130694906|NCT03846193|470505948|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
130694907|NCT03846193|470505949|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130694908|NCT02588339|470505951|FG000|Overall Study|Withdrawal by Subject|1|||
130694909|NCT02588339|470505951|FG000|Overall Study|GVHD Progression prior to treatment|2|||
130694910|NCT03679598|470507566|FG000|Overall Study|Adverse Event|2|||
130694911|NCT03679598|470507567|FG001|Overall Study|Adverse Event|0|||
130694912|NCT01701063|470507568|FG000|Overall Study|Lost to Follow-up|0|||
130694913|NCT01701063|470507569|FG001|Overall Study|Lost to Follow-up|1|||
130694914|NCT01701063|470507570|FG002|Overall Study|Lost to Follow-up|0|||
130694915|NCT01701063|470507568|FG000|Overall Study|Withdrawal by Subject|0|||
130694916|NCT01701063|470507569|FG001|Overall Study|Withdrawal by Subject|0|||
130694917|NCT01701063|470507570|FG002|Overall Study|Withdrawal by Subject|1|||
130694918|NCT01701063|470507568|FG000|Overall Study|Other|0|||
130906517|NCT00745615|471292883|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
130906518|NCT00745615|471292884|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
130906519|NCT00745615|471292885|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
130906520|NCT00745615|471292886|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
130906521|NCT00745615|471292887|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
130694919|NCT01701063|470507569|FG001|Overall Study|Other|0|||
130694920|NCT01701063|470507570|FG002|Overall Study|Other|1|||
130694921|NCT05387408|470507571|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
130694922|NCT01919112|470507572|FG000|Secondary Analysis-day 30|Death|1|||
130694923|NCT01919112|470507573|FG001|Secondary Analysis-day 30|Death|1|||
130694924|NCT01919112|470507574|FG002|Secondary Analysis-day 30|Death|1|||
130694925|NCT01919112|470507572|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
130694926|NCT01919112|470507573|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
130694927|NCT01919112|470507574|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
130694928|NCT02043132|470507575|FG000|Overall Study|Lost to Follow-up|1|||
130694929|NCT02043132|470507576|FG001|Overall Study|Lost to Follow-up|1|||
130694930|NCT02043132|470507575|FG000|Overall Study|screen failures|4|||
130694931|NCT02043132|470507576|FG001|Overall Study|screen failures|8|||
130694932|NCT00635648|470507577|FG000|Overall Study|Adverse Event|12|||
130694933|NCT00635648|470507577|FG000|Overall Study|Withdrawal by Subject|9|||
130694934|NCT00635648|470507577|FG000|Overall Study|Physician Decision|4|||
130694935|NCT00635648|470507577|FG000|Overall Study|Rapid progression of baseline disease|4|||
130694936|NCT00635648|470507577|FG000|Overall Study|Use of other antifungal agent needed|1|||
130694937|NCT00635648|470507577|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
130694938|NCT00635648|470507577|FG000|Overall Study|Noncompliance with protocol|1|||
130694939|NCT00635648|470507577|FG000|Overall Study|Other reason|2|||
130694940|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
130694941|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
130694942|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
130694943|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
130694944|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
130694945|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
130694946|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
130694947|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
130694948|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
130694949|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
130694950|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
130694951|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
130694952|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
130694953|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
130694954|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
130694955|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
130906522|NCT00745615|471292888|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
130906523|NCT00745615|471292883|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
130906524|NCT00745615|471292884|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
130906525|NCT00745615|471292885|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
130906526|NCT00745615|471292886|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
131114412|NCT01610687|472050723|FG000|Overall Study|Lost to Follow-up|4|||
130694956|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
130694957|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
130694958|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
130906527|NCT00745615|471292887|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
130906528|NCT00745615|471292888|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
130906529|NCT00745615|471292883|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
131114413|NCT01610687|472050723|FG000|Overall Study|Symptom control without study medication|2|||
131114414|NCT01610687|472050723|FG000|Overall Study|Unable to make journey|1|||
130906530|NCT00745615|471292884|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
131028181|NCT03157167|471735275|FG001|Overall Study|Withdrawal by Subject|0|||
131028182|NCT03157167|471735276|FG002|Overall Study|Withdrawal by Subject|0|||
131028183|NCT04905407|471735278|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
131028184|NCT04905407|471735279|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
131028185|NCT04905407|471735280|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
131028186|NCT04905407|471735281|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
131028187|NCT04905407|471735278|FG000|Part 1 and Part 2|Death|7|||
131028188|NCT04905407|471735279|FG001|Part 1 and Part 2|Death|7|||
131028189|NCT04905407|471735280|FG002|Part 1 and Part 2|Death|7|||
131028190|NCT04905407|471735281|FG003|Part 1 and Part 2|Death|0|||
131028191|NCT04905407|471735278|FG000|Part 1 and Part 2|Other than specified|0|||
131028192|NCT04905407|471735279|FG001|Part 1 and Part 2|Other than specified|0|||
131028193|NCT04905407|471735280|FG002|Part 1 and Part 2|Other than specified|1|||
131028194|NCT04905407|471735281|FG003|Part 1 and Part 2|Other than specified|0|||
131028195|NCT04905407|471735278|FG000|Part 3|Death|0|||
131028196|NCT04905407|471735279|FG001|Part 3|Death|0|||
131028197|NCT04905407|471735280|FG002|Part 3|Death|0|||
131028198|NCT04905407|471735281|FG003|Part 3|Death|2|||
131114415|NCT01610687|472050723|FG000|Overall Study|Death|1|||
131114416|NCT01610687|472050723|FG000|Overall Study|Cannabis affecting job|1|||
131028201|NCT01673984|471735289|FG000|Overall Study|Adverse Event|1|||
131028202|NCT01673984|471735290|FG001|Overall Study|Adverse Event|0|||
131028203|NCT01673984|471735289|FG000|Overall Study|Study termination|9|||
131028204|NCT01673984|471735290|FG001|Overall Study|Study termination|6|||
131028205|NCT04437433|471735294|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
131028206|NCT04437433|471735295|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
131028207|NCT04437433|471735294|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
131028208|NCT04437433|471735295|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
131028209|NCT04437433|471735294|FG000|Overall Study|Adverse Event|9|||
131028210|NCT04437433|471735295|FG001|Overall Study|Adverse Event|0|||
131028211|NCT04437433|471735294|FG000|Overall Study|Lack of Efficacy|4|||
131028212|NCT04437433|471735295|FG001|Overall Study|Lack of Efficacy|0|||
131028213|NCT04437433|471735294|FG000|Overall Study|Withdrawal by Subject|4|||
131028214|NCT04437433|471735295|FG001|Overall Study|Withdrawal by Subject|1|||
131028215|NCT04437433|471735294|FG000|Overall Study|Protocol Deviation|0|||
131028216|NCT04437433|471735295|FG001|Overall Study|Protocol Deviation|1|||
131028217|NCT04437433|471735294|FG000|Overall Study|Other, not specified|0|||
131028218|NCT04437433|471735295|FG001|Overall Study|Other, not specified|1|||
131028219|NCT04048681|471735296|FG000|Overall Study|family emergency|0|||
131028220|NCT04048681|471735297|FG001|Overall Study|family emergency|0|||
131028221|NCT04048681|471735298|FG002|Overall Study|family emergency|0|||
131028222|NCT04048681|471735299|FG003|Overall Study|family emergency|1|||
131028223|NCT04048681|471735300|FG004|Overall Study|family emergency|0|||
131028224|NCT01376700|471735301|FG000|Overall Study|Sponsor terminated study early|8|||
131028225|NCT01376700|471735301|FG000|Overall Study|Low or high titer inhibitor|8|||
131028226|NCT00879333|471735305|FG000|Overall Study|Adverse Event|94|||
131028227|NCT00879333|471735306|FG001|Overall Study|Adverse Event|34|||
131028228|NCT00879333|471735305|FG000|Overall Study|Abnormal Laboratory Value|1|||
131028229|NCT00879333|471735306|FG001|Overall Study|Abnormal Laboratory Value|0|||
131028230|NCT00879333|471735305|FG000|Overall Study|Withdrawal by Subject|20|||
131028231|NCT00879333|471735306|FG001|Overall Study|Withdrawal by Subject|7|||
131028232|NCT00879333|471735305|FG000|Overall Study|Lost to Follow-up|2|||
131028233|NCT00879333|471735306|FG001|Overall Study|Lost to Follow-up|1|||
131028234|NCT00879333|471735305|FG000|Overall Study|Administrative Problems|2|||
131028235|NCT00879333|471735306|FG001|Overall Study|Administrative Problems|0|||
131028236|NCT00879333|471735305|FG000|Overall Study|Death|16|||
131028237|NCT00879333|471735306|FG001|Overall Study|Death|5|||
131028238|NCT00879333|471735305|FG000|Overall Study|Disease Progression|292|||
131028239|NCT00879333|471735306|FG001|Overall Study|Disease Progression|169|||
131028240|NCT00879333|471735305|FG000|Overall Study|Protocol Violation|1|||
131028241|NCT00879333|471735306|FG001|Overall Study|Protocol Violation|1|||
131028242|NCT04154384|471735307|FG000|Overall Study|Lost to Follow-up|24|||
131028243|NCT04154384|471735308|FG001|Overall Study|Lost to Follow-up|33|||
131028244|NCT04154384|471735309|FG002|Overall Study|Lost to Follow-up|0|||
130906531|NCT00745615|471292885|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
131028245|NCT04154384|471735307|FG000|Overall Study|Withdrawal by Subject|7|||
131028246|NCT04154384|471735308|FG001|Overall Study|Withdrawal by Subject|18|||
131028247|NCT04154384|471735309|FG002|Overall Study|Withdrawal by Subject|0|||
131028248|NCT04154384|471735307|FG000|Overall Study|Missing outcome data|1|||
131028249|NCT04154384|471735308|FG001|Overall Study|Missing outcome data|0|||
131028250|NCT04154384|471735309|FG002|Overall Study|Missing outcome data|0|||
131028251|NCT00951379|471735310|FG000|Overall Study|Adverse Event|4|||
131114417|NCT01610687|472050723|FG000|Overall Study|Felt more alter without study medication|1|||
131114418|NCT03836807|472050724|FG000|Overall Study|Physician Decision|1|||
131114419|NCT03836807|472050725|FG001|Overall Study|Physician Decision|0|||
131114420|NCT02430051|472050726|FG000|Overall Study|Withdrawal by Subject|6|||
131114421|NCT02430051|472050727|FG001|Overall Study|Withdrawal by Subject|3|||
131114422|NCT02430051|472050726|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
131114423|NCT02430051|472050727|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
131114424|NCT02430051|472050726|FG000|Overall Study|Protocol Violation|1|||
131114425|NCT02430051|472050727|FG001|Overall Study|Protocol Violation|0|||
131114426|NCT01272947|472050728|FG000|Overall Study|Abnormal Laboratory Value|2|||
131114427|NCT01272947|472050729|FG001|Overall Study|Abnormal Laboratory Value|2|||
131114428|NCT02019420|472050731|FG000|Overall Study|Did not receive study drug|2|||
131114429|NCT02019420|472050732|FG001|Overall Study|Did not receive study drug|2|||
131114430|NCT02019420|472050731|FG000|Overall Study|Withdrawal by Subject|1|||
131114431|NCT02019420|472050732|FG001|Overall Study|Withdrawal by Subject|3|||
131114432|NCT02019420|472050731|FG000|Overall Study|At request of sponsor or investigator|0|||
131114433|NCT02019420|472050732|FG001|Overall Study|At request of sponsor or investigator|1|||
131114434|NCT02019420|472050731|FG000|Overall Study|Death|104|||
131114435|NCT02019420|472050732|FG001|Overall Study|Death|99|||
131114436|NCT02019420|472050731|FG000|Overall Study|Transferred to other care facility|1|||
131114437|NCT02019420|472050732|FG001|Overall Study|Transferred to other care facility|1|||
131114438|NCT02510560|472050733|FG000|Overall Study|Discontinued from Treatment|27|||
131114439|NCT02510560|472050734|FG001|Overall Study|Discontinued from Treatment|18|||
131114440|NCT02510560|472050735|FG002|Overall Study|Discontinued from Treatment|19|||
131114441|NCT02510560|472050733|FG000|Overall Study|Other|4|||
131114442|NCT02510560|472050734|FG001|Overall Study|Other|4|||
131114443|NCT02510560|472050735|FG002|Overall Study|Other|3|||
131114444|NCT00132496|472050736|FG000|Overall Study|Withdrawal by Subject|1|||
131114445|NCT00132496|472050737|FG001|Overall Study|Withdrawal by Subject|2|||
131114446|NCT00132496|472050736|FG000|Overall Study|Physician Decision|1|||
131114447|NCT00132496|472050737|FG001|Overall Study|Physician Decision|0|||
131114448|NCT01093625|472050742|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
131114449|NCT01093625|472050743|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
131114450|NCT01093625|472050742|FG000|2-Week Visit|Withdrawal by Subject|1|||
131114451|NCT01093625|472050743|FG001|2-Week Visit|Withdrawal by Subject|0|||
131114452|NCT01093625|472050742|FG000|1-Month Visit|Lost to Follow-up|2|||
131114453|NCT01093625|472050743|FG001|1-Month Visit|Lost to Follow-up|0|||
131114454|NCT01093625|472050742|FG000|3-Month Visit|Lost to Follow-up|2|||
131114455|NCT01093625|472050743|FG001|3-Month Visit|Lost to Follow-up|0|||
131114456|NCT01093625|472050742|FG000|6-Month Visit|Withdrawal by Subject|6|||
131114457|NCT01093625|472050743|FG001|6-Month Visit|Withdrawal by Subject|7|||
131114458|NCT01093625|472050742|FG000|6-Month Visit|Lost to Follow-up|2|||
131114459|NCT01093625|472050743|FG001|6-Month Visit|Lost to Follow-up|2|||
131114460|NCT01093625|472050742|FG000|1-Year Visit|Lost to Follow-up|5|||
131114461|NCT01093625|472050743|FG001|1-Year Visit|Lost to Follow-up|3|||
131114462|NCT01431534|472050746|FG000|Treatment Phase|Adverse Event|0|||
131114463|NCT01431534|472050747|FG001|Treatment Phase|Adverse Event|0|||
131114464|NCT01431534|472050748|FG002|Treatment Phase|Adverse Event|1|||
131114465|NCT01431534|472050746|FG000|Treatment Phase|Progressive Disease|4|||
131114466|NCT01431534|472050747|FG001|Treatment Phase|Progressive Disease|3|||
131114467|NCT01431534|472050748|FG002|Treatment Phase|Progressive Disease|10|||
131114468|NCT01009554|472050751|FG000|Overall Study|Adverse Event|1|||
131114469|NCT01009554|472050752|FG001|Overall Study|Adverse Event|1|||
131114470|NCT01009554|472050751|FG000|Overall Study|Withdrawal by Subject|1|||
131114471|NCT01009554|472050752|FG001|Overall Study|Withdrawal by Subject|3|||
131114472|NCT01009554|472050751|FG000|Overall Study|Noncompliant with Study Product|0|||
131114473|NCT01009554|472050752|FG001|Overall Study|Noncompliant with Study Product|3|||
131114474|NCT01605253|472050753|FG000|Overall Study|Physician Decision|3|||
131114475|NCT01605253|472050754|FG001|Overall Study|Physician Decision|2|||
131114476|NCT01605253|472050753|FG000|Overall Study|Lost to Follow-up|3|||
131114477|NCT01605253|472050754|FG001|Overall Study|Lost to Follow-up|1|||
131114478|NCT02554903|472050755|FG000|Overall Study|Death|1|||
131114479|NCT02554903|472050756|FG001|Overall Study|Death|1|||
131114480|NCT02554903|472050755|FG000|Overall Study|Physician Decision|2|||
131114481|NCT02554903|472050756|FG001|Overall Study|Physician Decision|2|||
131114482|NCT02554903|472050755|FG000|Overall Study|Heart Transplant|1|||
131114483|NCT02554903|472050756|FG001|Overall Study|Heart Transplant|2|||
131114484|NCT03951220|472050764|FG000|Overall Study|Withdrawal by Subject|9|||
131114485|NCT03951220|472050765|FG001|Overall Study|Withdrawal by Subject|2|||
131114486|NCT03951220|472050766|FG002|Overall Study|Withdrawal by Subject|0|||
131114487|NCT04598477|472050768|FG000|Overall Study|Adverse Event|2|||
131114488|NCT04598477|472050769|FG001|Overall Study|Adverse Event|0|||
131114489|NCT04598477|472050768|FG000|Overall Study|Death|0|||
131114490|NCT04598477|472050769|FG001|Overall Study|Death|1|||
131114491|NCT04598477|472050768|FG000|Overall Study|Lost to Follow-up|1|||
131114492|NCT04598477|472050769|FG001|Overall Study|Lost to Follow-up|0|||
131114493|NCT04598477|472050768|FG000|Overall Study|Physician Decision|7|||
131114494|NCT04598477|472050769|FG001|Overall Study|Physician Decision|2|||
130694959|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
130694960|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
130694961|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
130694962|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
130694963|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
130694964|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
130694965|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
130694966|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
130694967|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
130694968|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
130694969|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
130694970|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
130694971|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
130694972|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
130694973|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
130694974|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
130694975|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
130694976|NCT04194801|470507578|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
130694977|NCT04194801|470507579|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
130694978|NCT04194801|470507580|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
130694979|NCT04194801|470507578|FG000|Part Ib/II End of Study|Death|2|||
130694980|NCT04194801|470507579|FG001|Part Ib/II End of Study|Death|3|||
130694981|NCT04194801|470507580|FG002|Part Ib/II End of Study|Death|3|||
130694982|NCT04194801|470507578|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
130694983|NCT04194801|470507579|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
130694984|NCT04194801|470507580|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
130694985|NCT04194801|470507578|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
130694986|NCT04194801|470507579|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
130694987|NCT04194801|470507580|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
130694988|NCT04194801|470507578|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
130694989|NCT04194801|470507579|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
130694990|NCT04194801|470507580|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
130694991|NCT04194801|470507578|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
130694992|NCT04194801|470507579|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
130906532|NCT00745615|471292886|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
130906533|NCT00745615|471292887|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
130906534|NCT00745615|471292888|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
130906535|NCT00745615|471292883|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130906536|NCT00745615|471292884|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
130906537|NCT00745615|471292885|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130906538|NCT00745615|471292886|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130906539|NCT00745615|471292887|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130906540|NCT00745615|471292888|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130906541|NCT00745615|471292883|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
130906542|NCT00745615|471292884|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
130906543|NCT00745615|471292885|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
130906544|NCT00745615|471292886|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
130906545|NCT00745615|471292887|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
130906546|NCT00745615|471292888|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
130906547|NCT00745615|471292883|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
130906548|NCT00745615|471292884|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
130906549|NCT00745615|471292885|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
130906550|NCT00745615|471292886|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
130906551|NCT00745615|471292887|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
130906552|NCT00745615|471292888|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
130906553|NCT00745615|471292883|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
130906554|NCT00745615|471292884|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
130906555|NCT00745615|471292885|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
130906556|NCT00745615|471292886|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
131028252|NCT00951379|471735311|FG001|Overall Study|Adverse Event|1|||
131028253|NCT00951379|471735310|FG000|Overall Study|Withdrawal by Subject|1|||
131028254|NCT00951379|471735311|FG001|Overall Study|Withdrawal by Subject|0|||
130694993|NCT04194801|470507580|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
130694994|NCT03827395|470507581|FG000|Overall Study|Lost to Follow-up|1|||
130694995|NCT03827395|470507582|FG001|Overall Study|Lost to Follow-up|0|||
130694996|NCT03827395|470507581|FG000|Overall Study|Protocol Violation|1|||
130694997|NCT03827395|470507582|FG001|Overall Study|Protocol Violation|0|||
130694998|NCT03827395|470507581|FG000|Overall Study|Became ineligible after enrollment|1|||
130694999|NCT03827395|470507582|FG001|Overall Study|Became ineligible after enrollment|2|||
130695000|NCT01923740|470507583|FG000|Overall Study|Lost to Follow-up|4|||
130695001|NCT01923740|470507584|FG001|Overall Study|Lost to Follow-up|9|||
130695002|NCT01923740|470507583|FG000|Overall Study|Withdrawal by Subject|2|||
130695003|NCT01923740|470507584|FG001|Overall Study|Withdrawal by Subject|0|||
130695004|NCT00294047|470507585|FG000|Month 48|Adverse Event|28|||
130695005|NCT00294047|470507586|FG001|Month 48|Adverse Event|13|||
130695006|NCT00294047|470507585|FG000|Month 48|Protocol Violation|4|||
130695007|NCT00294047|470507586|FG001|Month 48|Protocol Violation|4|||
130695008|NCT00294047|470507585|FG000|Month 48|Withdrawal by Subject|111|||
130695009|NCT00294047|470507586|FG001|Month 48|Withdrawal by Subject|115|||
130695010|NCT00294047|470507585|FG000|Month 48|Lost to Follow-up|272|||
130695011|NCT00294047|470507586|FG001|Month 48|Lost to Follow-up|287|||
130695012|NCT00294047|470507585|FG000|Month 48|Other|10|||
130695013|NCT00294047|470507586|FG001|Month 48|Other|14|||
130695014|NCT00294047|470507585|FG000|Month 84|Adverse Event|4|||
130695015|NCT00294047|470507586|FG001|Month 84|Adverse Event|2|||
130695016|NCT00294047|470507585|FG000|Month 84|Protocol Violation|1|||
130695017|NCT00294047|470507586|FG001|Month 84|Protocol Violation|1|||
130695018|NCT00294047|470507585|FG000|Month 84|Withdrawal by Subject|33|||
130695019|NCT00294047|470507586|FG001|Month 84|Withdrawal by Subject|31|||
130695020|NCT00294047|470507585|FG000|Month 84|Lost to Follow-up|187|||
130695021|NCT00294047|470507586|FG001|Month 84|Lost to Follow-up|190|||
130695022|NCT00294047|470507585|FG000|Month 84|Absent Cervix|2|||
130695023|NCT00294047|470507586|FG001|Month 84|Absent Cervix|0|||
130695024|NCT00294047|470507585|FG000|Month 84|Work related reasons|4|||
130695025|NCT00294047|470507586|FG001|Month 84|Work related reasons|2|||
130695026|NCT00294047|470507585|FG000|Month 84|Center closed, subject did not transfer|1|||
130695027|NCT00294047|470507586|FG001|Month 84|Center closed, subject did not transfer|0|||
130695028|NCT00294047|470507585|FG000|Month 84|Family problems|2|||
130695029|NCT00294047|470507586|FG001|Month 84|Family problems|2|||
130695030|NCT00294047|470507585|FG000|Month 84|Lack of time|3|||
130695031|NCT00294047|470507586|FG001|Month 84|Lack of time|1|||
130695032|NCT00294047|470507585|FG000|Month 84|Personal reason|2|||
130695033|NCT00294047|470507586|FG001|Month 84|Personal reason|4|||
130695034|NCT00294047|470507585|FG000|Month 84|Subject does not want male physician|1|||
130695035|NCT00294047|470507586|FG001|Month 84|Subject does not want male physician|0|||
130695036|NCT00294047|470507585|FG000|Month 84|Transport reimbursement delayed|0|||
130695037|NCT00294047|470507586|FG001|Month 84|Transport reimbursement delayed|1|||
130695038|NCT00294047|470507585|FG000|Month 84|Unable to reach study site|1|||
130695039|NCT00294047|470507586|FG001|Month 84|Unable to reach study site|0|||
130695040|NCT00294047|470507585|FG000|Month 84|Under investigation locally|1|||
130695041|NCT00294047|470507586|FG001|Month 84|Under investigation locally|0|||
130695042|NCT00294047|470507585|FG000|Month 84|Visit missed|0|||
130695043|NCT00294047|470507586|FG001|Month 84|Visit missed|1|||
130695044|NCT00294047|470507585|FG000|Month 84|No consent for Month 84 Follow-up|731|||
130695045|NCT00294047|470507586|FG001|Month 84|No consent for Month 84 Follow-up|754|||
130695046|NCT00924638|470507592|FG000|Overall Study|Death|3|||
130695047|NCT00924638|470507593|FG001|Overall Study|Death|2|||
130695048|NCT00924638|470507592|FG000|Overall Study|Lost to Follow-up|1|||
130695049|NCT00924638|470507593|FG001|Overall Study|Lost to Follow-up|1|||
130695050|NCT00924638|470507592|FG000|Overall Study|Withdrawal by Subject|5|||
130695051|NCT00924638|470507593|FG001|Overall Study|Withdrawal by Subject|7|||
130695052|NCT00924638|470507592|FG000|Overall Study|Physician Decision|3|||
130695053|NCT00924638|470507593|FG001|Overall Study|Physician Decision|3|||
130695054|NCT00847535|470507594|FG000|Overall Study|Withdrawal by Subject|2|||
130695055|NCT00847535|470507595|FG001|Overall Study|Withdrawal by Subject|1|||
130695056|NCT00847535|470507596|FG002|Overall Study|Withdrawal by Subject|1|||
130695057|NCT00847535|470507594|FG000|Overall Study|Lost to Follow-up|0|||
130695058|NCT00847535|470507595|FG001|Overall Study|Lost to Follow-up|1|||
131114495|NCT04598477|472050768|FG000|Overall Study|Pregnancy|0|||
131114496|NCT04598477|472050769|FG001|Overall Study|Pregnancy|1|||
131114497|NCT04598477|472050768|FG000|Overall Study|Requires Prohibited Medication|0|||
131114498|NCT04598477|472050769|FG001|Overall Study|Requires Prohibited Medication|1|||
130695059|NCT00847535|470507596|FG002|Overall Study|Lost to Follow-up|0|||
131114499|NCT04598477|472050768|FG000|Overall Study|Study Terminated by Sponsor|18|||
130695060|NCT01252953|470507597|FG000|Overall Study|Withdrawal by Subject|16|||
130695061|NCT01252953|470507598|FG001|Overall Study|Withdrawal by Subject|17|||
130695062|NCT01252953|470507597|FG000|Overall Study|Lost to Follow-up|22|||
130695063|NCT01252953|470507598|FG001|Overall Study|Lost to Follow-up|21|||
130695064|NCT00958724|470507602|FG000|Overall Study|Disease Progression|6|||
130695065|NCT05604014|470507620|FG000|Overall Study|Lost to Follow-up|13|||
130695066|NCT00840203|470507621|FG000|First Intervention|Protocol Violation|1|||
130695067|NCT00840203|470507622|FG001|First Intervention|Protocol Violation|1|||
130695068|NCT00840203|470507621|FG000|Washout|Protocol Violation|1|||
130695069|NCT00840203|470507622|FG001|Washout|Protocol Violation|0|||
130695070|NCT02121184|470507623|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
130720849|NCT04126213|470601546|FG001|Overall Study|Withdrawal by Subject|2|||
130695071|NCT02121184|470507624|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
130695072|NCT02121184|470507623|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
130695073|NCT02121184|470507624|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
130695074|NCT02121184|470507623|FG000|Overall Study|Emergency cesarean section required|0|||
130695075|NCT02121184|470507624|FG001|Overall Study|Emergency cesarean section required|2|||
130695076|NCT02121184|470507623|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
130695077|NCT02121184|470507624|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
130695078|NCT04411680|470507629|FG000|Treatment Period|Adverse Event|3|||
130695079|NCT04411680|470507630|FG001|Treatment Period|Adverse Event|0|||
130695080|NCT04411680|470507629|FG000|Treatment Period|Discharged from hospital|18|||
130695081|NCT04411680|470507630|FG001|Treatment Period|Discharged from hospital|7|||
130695082|NCT04411680|470507629|FG000|Treatment Period|Missed 1 or more doses|8|||
130695083|NCT04411680|470507630|FG001|Treatment Period|Missed 1 or more doses|0|||
130695084|NCT04411680|470507629|FG000|Treatment Period|Transferred to another hospital|0|||
130695085|NCT04411680|470507630|FG001|Treatment Period|Transferred to another hospital|1|||
130695086|NCT04411680|470507629|FG000|Follow up Period|Withdrawal by Subject|2|||
130695087|NCT04411680|470507630|FG001|Follow up Period|Withdrawal by Subject|0|||
130695088|NCT04411680|470507629|FG000|Follow up Period|Lost to Follow-up|5|||
130695089|NCT04411680|470507630|FG001|Follow up Period|Lost to Follow-up|6|||
130695090|NCT04411680|470507629|FG000|Follow up Period|Death|11|||
130695091|NCT04411680|470507630|FG001|Follow up Period|Death|8|||
130695092|NCT00748566|470507631|FG000|Overall Study|Adverse Event|49|||
130695093|NCT00748566|470507631|FG000|Overall Study|Death|1|||
130695094|NCT00748566|470507631|FG000|Overall Study|Lack of Efficacy|12|||
130695095|NCT00748566|470507631|FG000|Overall Study|Lost to Follow-up|1|||
130695096|NCT00748566|470507631|FG000|Overall Study|Protocol Violation|13|||
130695097|NCT00748566|470507631|FG000|Overall Study|Withdrawal by Subject|22|||
130695098|NCT00748566|470507631|FG000|Overall Study|Study terminated by sponsor|5|||
130695099|NCT00748566|470507631|FG000|Overall Study|Other|9|||
130695100|NCT00841659|470507632|FG000|Washout: 2 Weeks|Protocol Violation|1|||
130695101|NCT00841659|470507633|FG001|Washout: 2 Weeks|Protocol Violation|0|||
130695102|NCT01964950|470507635|FG000|Overall Study|Protocol Violation|25|||
130695103|NCT00674128|470507638|FG000|Overall Study|Withdrawal by Subject|25|||
130695104|NCT00674128|470507639|FG001|Overall Study|Withdrawal by Subject|23|||
130695105|NCT00829452|470507640|FG000|First Intervention|Withdrawal by Subject|0|||
130695106|NCT00829452|470507641|FG001|First Intervention|Withdrawal by Subject|1|||
130695107|NCT00829452|470507640|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
130695108|NCT00829452|470507641|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
130695109|NCT00829452|470507640|FG000|Second Intervention|Physician Decision|0|||
130695110|NCT00829452|470507641|FG001|Second Intervention|Physician Decision|1|||
130695111|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
130695112|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
130695113|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
130695114|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
130695115|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
130695116|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
130695117|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
130695118|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
130906557|NCT00745615|471292887|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
130906558|NCT00745615|471292888|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
130906559|NCT00745615|471292883|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
130906560|NCT00745615|471292884|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
130906561|NCT00745615|471292885|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
130695119|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
130695120|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
130695121|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
130695122|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
130695123|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
130695124|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
130695125|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
130695126|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
130695127|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
131028255|NCT00951379|471735310|FG000|Overall Study|Noncompliance|1|||
131028256|NCT00951379|471735311|FG001|Overall Study|Noncompliance|0|||
131028257|NCT00951379|471735310|FG000|Overall Study|Disease Progression|0|||
131028258|NCT00951379|471735311|FG001|Overall Study|Disease Progression|1|||
131028259|NCT04218266|471735312|FG000|Overall Study|Death|1|||
131028260|NCT04218266|471735313|FG001|Overall Study|Death|2|||
131028261|NCT04218266|471735314|FG002|Overall Study|Death|3|||
131028262|NCT04218266|471735312|FG000|Overall Study|Adverse Event|13|||
131028263|NCT04218266|471735313|FG001|Overall Study|Adverse Event|14|||
130906562|NCT00745615|471292886|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
130906563|NCT00745615|471292887|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
130906564|NCT00745615|471292888|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
130906565|NCT00745615|471292883|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
130906566|NCT00745615|471292884|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
130906567|NCT00745615|471292885|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
130906568|NCT00745615|471292886|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
130906569|NCT00745615|471292887|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
130906570|NCT00745615|471292888|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
130906571|NCT00745615|471292883|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
130906572|NCT00745615|471292884|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
130906573|NCT00745615|471292885|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
130906574|NCT00745615|471292886|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
130906575|NCT00745615|471292887|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
130906576|NCT00745615|471292888|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
130906577|NCT00745615|471292883|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
130906578|NCT00745615|471292884|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
130906579|NCT00745615|471292885|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
130906580|NCT00745615|471292886|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
130906581|NCT00745615|471292887|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
130906582|NCT00745615|471292888|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
130906583|NCT00745615|471292883|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
130906584|NCT00745615|471292884|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
130906585|NCT00745615|471292885|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
130906586|NCT00745615|471292886|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
130906587|NCT00745615|471292887|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
130906588|NCT00745615|471292888|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
130906589|NCT00745615|471292883|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
130906590|NCT00745615|471292884|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
130906591|NCT00745615|471292885|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
130906592|NCT00745615|471292886|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
130906593|NCT00745615|471292887|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
130906594|NCT00745615|471292888|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
130906595|NCT00570232|471292891|FG000|Overall Study|Adverse Event|10|||
130906596|NCT00570232|471292891|FG000|Overall Study|discontinued due to medical condition|3|||
130906597|NCT00570232|471292891|FG000|Overall Study|discontinued due to recurrence|8|||
130906598|NCT00570232|471292891|FG000|Overall Study|discontinued due to noncompliance|2|||
130906599|NCT01163032|471292895|FG000|Randomization Phase|Withdrawal by Subject|2|||
130906600|NCT01163032|471292896|FG001|Randomization Phase|Withdrawal by Subject|3|||
130906601|NCT01163032|471292897|FG002|Randomization Phase|Withdrawal by Subject|0|||
130906602|NCT01163032|471292895|FG000|Randomization Phase|Adverse Event|3|||
130906603|NCT01163032|471292896|FG001|Randomization Phase|Adverse Event|3|||
130906604|NCT01163032|471292897|FG002|Randomization Phase|Adverse Event|0|||
130906605|NCT01163032|471292895|FG000|Randomization Phase|Protocol Violation|0|||
130906606|NCT01163032|471292896|FG001|Randomization Phase|Protocol Violation|1|||
130906607|NCT01163032|471292897|FG002|Randomization Phase|Protocol Violation|0|||
130906608|NCT01163032|471292895|FG000|Randomization Phase|Various*|5|||
130906609|NCT01163032|471292896|FG001|Randomization Phase|Various*|4|||
130906610|NCT01163032|471292897|FG002|Randomization Phase|Various*|0|||
130906611|NCT01163032|471292895|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
130906612|NCT01163032|471292896|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
130906613|NCT01163032|471292897|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
130906614|NCT01163032|471292895|FG000|Open Label Extension Phase|Adverse Event|0|||
130906615|NCT01163032|471292896|FG001|Open Label Extension Phase|Adverse Event|0|||
130906616|NCT01163032|471292897|FG002|Open Label Extension Phase|Adverse Event|3|||
130906617|NCT01163032|471292895|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
130906618|NCT01163032|471292896|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
130906619|NCT01163032|471292897|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
130906620|NCT01163032|471292895|FG000|Open Label Extension Phase|Protocol Violation|0|||
130906621|NCT01163032|471292896|FG001|Open Label Extension Phase|Protocol Violation|0|||
130906622|NCT01163032|471292897|FG002|Open Label Extension Phase|Protocol Violation|1|||
130906623|NCT01163032|471292895|FG000|Open Label Extension Phase|Study Termination|0|||
131028264|NCT04218266|471735314|FG002|Overall Study|Adverse Event|11|||
131028265|NCT04218266|471735312|FG000|Overall Study|Other|7|||
131028266|NCT04218266|471735313|FG001|Overall Study|Other|5|||
131028267|NCT04218266|471735314|FG002|Overall Study|Other|14|||
131028268|NCT04218266|471735312|FG000|Overall Study|Physician Decision|1|||
131028269|NCT04218266|471735313|FG001|Overall Study|Physician Decision|3|||
131028270|NCT04218266|471735314|FG002|Overall Study|Physician Decision|2|||
131028271|NCT04218266|471735312|FG000|Overall Study|Non-compliance with study drug|0|||
131028272|NCT04218266|471735313|FG001|Overall Study|Non-compliance with study drug|0|||
130906624|NCT01163032|471292896|FG001|Open Label Extension Phase|Study Termination|0|||
130906625|NCT01163032|471292897|FG002|Open Label Extension Phase|Study Termination|7|||
130906626|NCT01163032|471292895|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
130906627|NCT01163032|471292896|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
130906628|NCT01163032|471292897|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
130906629|NCT01307020|471292900|FG000|Overall Study|Lost to Follow-up|0|||
130906630|NCT01307020|471292901|FG001|Overall Study|Lost to Follow-up|0|||
130906631|NCT01307020|471292902|FG002|Overall Study|Lost to Follow-up|1|||
130906632|NCT01307020|471292903|FG003|Overall Study|Lost to Follow-up|1|||
130906633|NCT01307020|471292904|FG004|Overall Study|Lost to Follow-up|0|||
130906634|NCT01307020|471292905|FG005|Overall Study|Lost to Follow-up|0|||
130906635|NCT01307020|471292906|FG006|Overall Study|Lost to Follow-up|1|||
130906636|NCT01307020|471292907|FG007|Overall Study|Lost to Follow-up|0|||
130906637|NCT01307020|471292908|FG008|Overall Study|Lost to Follow-up|0|||
130906638|NCT01307020|471292909|FG009|Overall Study|Lost to Follow-up|0|||
130906639|NCT01307020|471292900|FG000|Overall Study|Electronic data capture failure|0|||
130906640|NCT01307020|471292901|FG001|Overall Study|Electronic data capture failure|1|||
130906641|NCT01307020|471292902|FG002|Overall Study|Electronic data capture failure|0|||
130906642|NCT01307020|471292903|FG003|Overall Study|Electronic data capture failure|0|||
130906643|NCT01307020|471292904|FG004|Overall Study|Electronic data capture failure|0|||
130906644|NCT01307020|471292905|FG005|Overall Study|Electronic data capture failure|0|||
130906645|NCT01307020|471292906|FG006|Overall Study|Electronic data capture failure|0|||
130906646|NCT01307020|471292907|FG007|Overall Study|Electronic data capture failure|0|||
130906647|NCT01307020|471292908|FG008|Overall Study|Electronic data capture failure|0|||
130906648|NCT01307020|471292909|FG009|Overall Study|Electronic data capture failure|0|||
130906649|NCT02380690|471292910|FG000|Overall Study|Lost to Follow-up|14|||
130906650|NCT02380690|471292911|FG001|Overall Study|Lost to Follow-up|4|||
130906651|NCT02380690|471292910|FG000|Overall Study|Withdrawal by Subject|20|||
130906652|NCT02380690|471292911|FG001|Overall Study|Withdrawal by Subject|8|||
130906653|NCT00727532|471292912|FG000|Overall Study|Adverse Event|1|||
130906654|NCT00727532|471292912|FG000|Overall Study|Withdrawal by Subject|1|||
130906655|NCT00829933|471292913|FG000|Overall Study|Adverse Event|2|||
130906656|NCT00829933|471292914|FG001|Overall Study|Adverse Event|3|||
130906657|NCT00829933|471292915|FG002|Overall Study|Adverse Event|2|||
130906658|NCT00829933|471292916|FG003|Overall Study|Adverse Event|1|||
130906659|NCT00829933|471292913|FG000|Overall Study|Death|0|||
130906660|NCT00829933|471292914|FG001|Overall Study|Death|0|||
130906661|NCT00829933|471292915|FG002|Overall Study|Death|1|||
130906662|NCT00829933|471292916|FG003|Overall Study|Death|1|||
130906663|NCT00829933|471292913|FG000|Overall Study|Lack of Efficacy|0|||
130906664|NCT00829933|471292914|FG001|Overall Study|Lack of Efficacy|1|||
130906665|NCT00829933|471292915|FG002|Overall Study|Lack of Efficacy|0|||
130906666|NCT00829933|471292916|FG003|Overall Study|Lack of Efficacy|0|||
130906667|NCT00829933|471292913|FG000|Overall Study|Physician Decision|5|||
130906668|NCT00829933|471292914|FG001|Overall Study|Physician Decision|7|||
130906669|NCT00829933|471292915|FG002|Overall Study|Physician Decision|8|||
130906670|NCT00829933|471292916|FG003|Overall Study|Physician Decision|1|||
130906671|NCT00829933|471292913|FG000|Overall Study|Pregnancy|0|||
130906672|NCT00829933|471292914|FG001|Overall Study|Pregnancy|0|||
130906673|NCT00829933|471292915|FG002|Overall Study|Pregnancy|0|||
130906674|NCT00829933|471292916|FG003|Overall Study|Pregnancy|2|||
130906675|NCT00829933|471292913|FG000|Overall Study|Protocol Violation|2|||
130906676|NCT00829933|471292914|FG001|Overall Study|Protocol Violation|1|||
130906677|NCT00829933|471292915|FG002|Overall Study|Protocol Violation|0|||
130906678|NCT00829933|471292916|FG003|Overall Study|Protocol Violation|0|||
130906679|NCT00829933|471292913|FG000|Overall Study|withdrew before treatment started|5|||
130906680|NCT00829933|471292914|FG001|Overall Study|withdrew before treatment started|1|||
130906681|NCT00829933|471292915|FG002|Overall Study|withdrew before treatment started|2|||
130906682|NCT00829933|471292916|FG003|Overall Study|withdrew before treatment started|9|||
131028273|NCT04218266|471735314|FG002|Overall Study|Non-compliance with study drug|1|||
131028274|NCT04218266|471735312|FG000|Overall Study|Withdrawal by Subject|1|||
131028275|NCT04218266|471735313|FG001|Overall Study|Withdrawal by Subject|3|||
130906683|NCT01986933|471292921|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
130906684|NCT01986933|471292922|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
130906685|NCT01986933|471292923|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
130906686|NCT01986933|471292924|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
130906687|NCT01986933|471292925|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
131028276|NCT04218266|471735314|FG002|Overall Study|Withdrawal by Subject|1|||
130906688|NCT01986933|471292921|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
131028277|NCT04218266|471735312|FG000|Overall Study|Study drug never administered|2|||
131028278|NCT04218266|471735313|FG001|Overall Study|Study drug never administered|0|||
131028279|NCT04218266|471735314|FG002|Overall Study|Study drug never administered|0|||
130906689|NCT01986933|471292922|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
130906690|NCT01986933|471292923|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
131028280|NCT01494922|471735316|FG000|Overall Study|Adverse Event|1|||
131028281|NCT02759016|471735317|FG000|Overall Study|Not treated with BI 836826|1|||
130768428|NCT01078298|470775571|FG000|Overall Study|Did not meet entrance criteria|0|||
130906691|NCT01986933|471292924|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
130906692|NCT01986933|471292925|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
130906693|NCT01986933|471292921|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
130906694|NCT01986933|471292922|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
130906695|NCT01986933|471292923|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
130906696|NCT01986933|471292924|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
130906697|NCT01986933|471292925|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
130906698|NCT01986933|471292921|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
130906699|NCT01986933|471292922|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
130906700|NCT01986933|471292923|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
130768429|NCT01078298|470775572|FG001|Overall Study|Did not meet entrance criteria|1|||
130768430|NCT01078298|470775571|FG000|Overall Study|Other|24|||
130768431|NCT01078298|470775572|FG001|Overall Study|Other|32|||
130768432|NCT00866333|470775574|FG000|Overall Study|Withdrawal of consent|0|||
130768433|NCT00866333|470775575|FG001|Overall Study|Withdrawal of consent|1|||
130768434|NCT00866333|470775576|FG002|Overall Study|Withdrawal of consent|2|||
130768435|NCT00866333|470775574|FG000|Overall Study|Reason not Specified|3|||
130906701|NCT01986933|471292924|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
130906702|NCT01986933|471292925|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
131028282|NCT02759016|471735318|FG001|Overall Study|Not treated with BI 836826|0|||
131028283|NCT02759016|471735317|FG000|Overall Study|Progressive disease|1|||
131028284|NCT02759016|471735318|FG001|Overall Study|Progressive disease|0|||
131028285|NCT02759016|471735317|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
131028286|NCT02759016|471735318|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
131028287|NCT02759016|471735317|FG000|Overall Study|Other not defined above|2|||
131028288|NCT02759016|471735318|FG001|Overall Study|Other not defined above|1|||
131028289|NCT03580369|471735319|FG000|Overall Study|No treatment due to mis-randomization|1|||
131028290|NCT03580369|471735320|FG001|Overall Study|No treatment due to mis-randomization|0|||
131028291|NCT03580369|471735321|FG002|Overall Study|No treatment due to mis-randomization|0|||
131028292|NCT03580369|471735322|FG003|Overall Study|No treatment due to mis-randomization|0|||
131028293|NCT03580369|471735323|FG004|Overall Study|No treatment due to mis-randomization|3|||
131028294|NCT03580369|471735324|FG005|Overall Study|No treatment due to mis-randomization|0|||
131028295|NCT03580369|471735325|FG006|Overall Study|No treatment due to mis-randomization|0|||
131028296|NCT03580369|471735326|FG007|Overall Study|No treatment due to mis-randomization|0|||
131028297|NCT03580369|471735319|FG000|Overall Study|Reason unknown|0|||
131028298|NCT03580369|471735320|FG001|Overall Study|Reason unknown|0|||
131028299|NCT03580369|471735321|FG002|Overall Study|Reason unknown|1|||
131028300|NCT03580369|471735322|FG003|Overall Study|Reason unknown|0|||
131028301|NCT03580369|471735323|FG004|Overall Study|Reason unknown|0|||
131028302|NCT03580369|471735324|FG005|Overall Study|Reason unknown|0|||
131028303|NCT03580369|471735325|FG006|Overall Study|Reason unknown|0|||
131028304|NCT03580369|471735326|FG007|Overall Study|Reason unknown|0|||
131028305|NCT03580369|471735319|FG000|Overall Study|Technical problems|0|||
131028306|NCT03580369|471735320|FG001|Overall Study|Technical problems|0|||
131028307|NCT03580369|471735321|FG002|Overall Study|Technical problems|0|||
131028308|NCT03580369|471735322|FG003|Overall Study|Technical problems|0|||
131028309|NCT03580369|471735323|FG004|Overall Study|Technical problems|1|||
131028310|NCT03580369|471735324|FG005|Overall Study|Technical problems|0|||
131028311|NCT03580369|471735325|FG006|Overall Study|Technical problems|2|||
131028312|NCT03580369|471735326|FG007|Overall Study|Technical problems|0|||
131028313|NCT03580369|471735319|FG000|Overall Study|Pregnancy|2|||
131028314|NCT03580369|471735320|FG001|Overall Study|Pregnancy|0|||
131028315|NCT03580369|471735321|FG002|Overall Study|Pregnancy|3|||
131028316|NCT03580369|471735322|FG003|Overall Study|Pregnancy|0|||
131028317|NCT03580369|471735323|FG004|Overall Study|Pregnancy|2|||
131028318|NCT03580369|471735324|FG005|Overall Study|Pregnancy|0|||
131028319|NCT03580369|471735325|FG006|Overall Study|Pregnancy|0|||
131028320|NCT03580369|471735326|FG007|Overall Study|Pregnancy|0|||
131028321|NCT03580369|471735319|FG000|Overall Study|Lost to Follow-up|2|||
131028322|NCT03580369|471735320|FG001|Overall Study|Lost to Follow-up|0|||
131028323|NCT03580369|471735321|FG002|Overall Study|Lost to Follow-up|2|||
131028324|NCT03580369|471735322|FG003|Overall Study|Lost to Follow-up|0|||
131028325|NCT03580369|471735323|FG004|Overall Study|Lost to Follow-up|3|||
131028326|NCT03580369|471735324|FG005|Overall Study|Lost to Follow-up|0|||
131028327|NCT03580369|471735325|FG006|Overall Study|Lost to Follow-up|1|||
131028328|NCT03580369|471735326|FG007|Overall Study|Lost to Follow-up|0|||
131028329|NCT03580369|471735319|FG000|Overall Study|Physician Decision|4|||
131028330|NCT03580369|471735320|FG001|Overall Study|Physician Decision|0|||
131028331|NCT03580369|471735321|FG002|Overall Study|Physician Decision|4|||
131028332|NCT03580369|471735322|FG003|Overall Study|Physician Decision|1|||
130906703|NCT01986933|471292921|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
131028333|NCT03580369|471735323|FG004|Overall Study|Physician Decision|1|||
131028334|NCT03580369|471735324|FG005|Overall Study|Physician Decision|0|||
131028335|NCT03580369|471735325|FG006|Overall Study|Physician Decision|0|||
131028336|NCT03580369|471735326|FG007|Overall Study|Physician Decision|0|||
131028337|NCT03580369|471735319|FG000|Overall Study|Lack of Efficacy|3|||
130695128|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
130695129|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
130695130|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
130695131|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
130695132|NCT02227238|470507647|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
130695133|NCT02227238|470507648|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
130695134|NCT02227238|470507649|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
130695135|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
130695136|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
130695137|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
130695138|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
130695139|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
130695140|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
130695141|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
130695142|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
130695143|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
130695144|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
130695145|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
130695146|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
130695147|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
130695148|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
130695149|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
130695150|NCT02227238|470507647|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
130695151|NCT02227238|470507648|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
130695152|NCT02227238|470507649|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
130695153|NCT03966911|470507651|FG000|Overall Study|Adverse Event|1|||
130695154|NCT03966911|470507652|FG001|Overall Study|Adverse Event|1|||
130695155|NCT03966911|470507651|FG000|Overall Study|Withdrawal by Subject|8|||
130695156|NCT03966911|470507652|FG001|Overall Study|Withdrawal by Subject|2|||
130695157|NCT03966911|470507651|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
130695158|NCT03966911|470507652|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
130695159|NCT03498560|470507653|FG000|Overall Study|Found Ineligible|2|||
130695160|NCT03498560|470507653|FG000|Overall Study|Withdrawal by Subject|14|||
130695161|NCT03498560|470507653|FG000|Overall Study|Lost to Follow-up|4|||
130695162|NCT03498560|470507653|FG000|Overall Study|Death|1|||
130695163|NCT01507662|470507654|FG000|Overall Study|Death|26|||
130695164|NCT01507662|470507655|FG001|Overall Study|Death|18|||
130695165|NCT01507662|470507654|FG000|Overall Study|Withdrawal by Subject|290|||
130906704|NCT01986933|471292922|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
130906705|NCT01986933|471292923|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
130906706|NCT01986933|471292924|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
130906707|NCT01986933|471292925|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
130906708|NCT01986933|471292921|FG000|Active-to-active (Part B)|Adverse Event|0|||
130906709|NCT01986933|471292922|FG001|Active-to-active (Part B)|Adverse Event|2|||
130906710|NCT01986933|471292923|FG002|Active-to-active (Part B)|Adverse Event|0|||
130906711|NCT01986933|471292924|FG003|Active-to-active (Part B)|Adverse Event|1|||
130906712|NCT01986933|471292925|FG004|Active-to-active (Part B)|Adverse Event|3|||
130695166|NCT01507662|470507655|FG001|Overall Study|Withdrawal by Subject|287|||
130695167|NCT01507662|470507654|FG000|Overall Study|Lost to Follow-up|498|||
130695168|NCT01507662|470507655|FG001|Overall Study|Lost to Follow-up|523|||
130695169|NCT01507662|470507654|FG000|Overall Study|Proxy interview done|2|||
130695170|NCT01507662|470507655|FG001|Overall Study|Proxy interview done|3|||
130695171|NCT01395017|470507660|FG000|Overall Study|Lost to Follow-up|1|||
130695172|NCT01395017|470507661|FG001|Overall Study|Lost to Follow-up|0|||
130695173|NCT01395017|470507660|FG000|Overall Study|Adverse Event|26|||
130695174|NCT01395017|470507661|FG001|Overall Study|Adverse Event|12|||
130695175|NCT01395017|470507660|FG000|Overall Study|Physician Decision|11|||
130695176|NCT01395017|470507661|FG001|Overall Study|Physician Decision|15|||
130695177|NCT01395017|470507660|FG000|Overall Study|Withdrawal by Subject|14|||
131114500|NCT04598477|472050769|FG001|Overall Study|Study Terminated by Sponsor|12|||
131114501|NCT04598477|472050768|FG000|Overall Study|Withdrawal by Subject|16|||
130695178|NCT01395017|470507661|FG001|Overall Study|Withdrawal by Subject|8|||
130695179|NCT01395017|470507660|FG000|Overall Study|Protocol deviation|1|||
130695180|NCT01395017|470507661|FG001|Overall Study|Protocol deviation|2|||
130695181|NCT01395017|470507660|FG000|Overall Study|Death|4|||
130695182|NCT01395017|470507661|FG001|Overall Study|Death|3|||
130695183|NCT01395017|470507660|FG000|Overall Study|Disease progression|42|||
130695184|NCT01395017|470507661|FG001|Overall Study|Disease progression|58|||
130906713|NCT01986933|471292921|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
130906714|NCT01986933|471292922|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
130695185|NCT01395017|470507660|FG000|Overall Study|Sponsor discontinued study|1|||
130695186|NCT01395017|470507661|FG001|Overall Study|Sponsor discontinued study|4|||
130695187|NCT01004510|470507662|FG000|Overall Study|Adverse Event|1|||
130695188|NCT01960296|470507665|FG000|Overall Study|Postponed surgery|1|||
130695189|NCT01960296|470507666|FG001|Overall Study|Postponed surgery|0|||
130695190|NCT01960296|470507665|FG000|Overall Study|Received different procedure|1|||
130695191|NCT01960296|470507666|FG001|Overall Study|Received different procedure|3|||
130695192|NCT02003391|470507667|FG000|Overall Study|Withdrawal by Subject|2|||
130695193|NCT02003391|470507668|FG001|Overall Study|Withdrawal by Subject|1|||
130695194|NCT02003391|470507667|FG000|Overall Study|Protocol Violation|0|||
130695195|NCT02003391|470507668|FG001|Overall Study|Protocol Violation|1|||
130695196|NCT02003391|470507667|FG000|Overall Study|Adverse Event|1|||
130695197|NCT02003391|470507668|FG001|Overall Study|Adverse Event|0|||
130695198|NCT02272803|470507669|FG000|Overall Study|Disease progression|16|||
130695199|NCT02272803|470507670|FG001|Overall Study|Disease progression|8|||
130695200|NCT02272803|470507669|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
130695201|NCT02272803|470507670|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
130906715|NCT01986933|471292923|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
130906716|NCT01986933|471292924|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
130906717|NCT01986933|471292925|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
130906718|NCT01986933|471292921|FG000|Active-to-active (Part B)|Pregnancy|0|||
130906719|NCT01986933|471292922|FG001|Active-to-active (Part B)|Pregnancy|0|||
130906720|NCT01986933|471292923|FG002|Active-to-active (Part B)|Pregnancy|0|||
130906721|NCT01986933|471292924|FG003|Active-to-active (Part B)|Pregnancy|0|||
130906722|NCT01986933|471292925|FG004|Active-to-active (Part B)|Pregnancy|1|||
130906723|NCT01986933|471292921|FG000|Active-to-active (Part B)|Physician Decision|0|||
130906724|NCT01986933|471292922|FG001|Active-to-active (Part B)|Physician Decision|0|||
130906725|NCT01986933|471292923|FG002|Active-to-active (Part B)|Physician Decision|1|||
130906726|NCT01986933|471292924|FG003|Active-to-active (Part B)|Physician Decision|1|||
130906727|NCT01986933|471292925|FG004|Active-to-active (Part B)|Physician Decision|0|||
130906728|NCT01986933|471292921|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
130906729|NCT01986933|471292922|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
130906730|NCT01986933|471292923|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
130906731|NCT01986933|471292924|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
130906732|NCT01986933|471292925|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
130906733|NCT01986933|471292921|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
130906734|NCT01986933|471292922|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
130906735|NCT01986933|471292923|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
130906736|NCT01986933|471292924|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
130906737|NCT01986933|471292925|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
131028338|NCT03580369|471735320|FG001|Overall Study|Lack of Efficacy|0|||
131028339|NCT03580369|471735321|FG002|Overall Study|Lack of Efficacy|7|||
131028340|NCT03580369|471735322|FG003|Overall Study|Lack of Efficacy|0|||
131028341|NCT03580369|471735323|FG004|Overall Study|Lack of Efficacy|2|||
131028342|NCT03580369|471735324|FG005|Overall Study|Lack of Efficacy|0|||
131028343|NCT03580369|471735325|FG006|Overall Study|Lack of Efficacy|3|||
131028344|NCT03580369|471735326|FG007|Overall Study|Lack of Efficacy|0|||
131028345|NCT03580369|471735319|FG000|Overall Study|Protocol Violation|6|||
131028346|NCT03580369|471735320|FG001|Overall Study|Protocol Violation|0|||
131028347|NCT03580369|471735321|FG002|Overall Study|Protocol Violation|6|||
131028348|NCT03580369|471735322|FG003|Overall Study|Protocol Violation|1|||
131028349|NCT03580369|471735323|FG004|Overall Study|Protocol Violation|8|||
131028350|NCT03580369|471735324|FG005|Overall Study|Protocol Violation|2|||
131028351|NCT03580369|471735325|FG006|Overall Study|Protocol Violation|1|||
131028352|NCT03580369|471735326|FG007|Overall Study|Protocol Violation|0|||
131028353|NCT03580369|471735319|FG000|Overall Study|Adverse Event|7|||
131028354|NCT03580369|471735320|FG001|Overall Study|Adverse Event|0|||
131028355|NCT03580369|471735321|FG002|Overall Study|Adverse Event|14|||
131028356|NCT03580369|471735322|FG003|Overall Study|Adverse Event|1|||
131028357|NCT03580369|471735323|FG004|Overall Study|Adverse Event|6|||
131028358|NCT03580369|471735324|FG005|Overall Study|Adverse Event|0|||
131028359|NCT03580369|471735325|FG006|Overall Study|Adverse Event|1|||
131028360|NCT03580369|471735326|FG007|Overall Study|Adverse Event|0|||
131028361|NCT03580369|471735319|FG000|Overall Study|Withdrawal by Subject|19|||
131028362|NCT03580369|471735320|FG001|Overall Study|Withdrawal by Subject|0|||
131028363|NCT03580369|471735321|FG002|Overall Study|Withdrawal by Subject|17|||
131028364|NCT03580369|471735322|FG003|Overall Study|Withdrawal by Subject|0|||
131028365|NCT03580369|471735323|FG004|Overall Study|Withdrawal by Subject|16|||
131028366|NCT03580369|471735324|FG005|Overall Study|Withdrawal by Subject|1|||
131028367|NCT03580369|471735325|FG006|Overall Study|Withdrawal by Subject|7|||
131028368|NCT03580369|471735326|FG007|Overall Study|Withdrawal by Subject|0|||
130695202|NCT02272803|470507669|FG000|Overall Study|Study drug toxicity|4|||
130695203|NCT02272803|470507670|FG001|Overall Study|Study drug toxicity|9|||
130906738|NCT01986933|471292921|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
131028369|NCT02891915|471735327|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
130695204|NCT02272803|470507669|FG000|Overall Study|Participant request to discontinue study treatment|3|||
130695205|NCT02272803|470507670|FG001|Overall Study|Participant request to discontinue study treatment|7|||
130695206|NCT02272803|470507669|FG000|Overall Study|Maximum clinical benefit|4|||
130695207|NCT02272803|470507670|FG001|Overall Study|Maximum clinical benefit|2|||
130695208|NCT02272803|470507669|FG000|Overall Study|Poor/non-compliance|2|||
130695209|NCT02272803|470507670|FG001|Overall Study|Poor/non-compliance|2|||
130695210|NCT02272803|470507669|FG000|Overall Study|Withdrawal by Subject|2|||
130695211|NCT02272803|470507670|FG001|Overall Study|Withdrawal by Subject|1|||
130695212|NCT02272803|470507669|FG000|Overall Study|Death|0|||
130695213|NCT02272803|470507670|FG001|Overall Study|Death|1|||
130695214|NCT02272803|470507669|FG000|Overall Study|Other reasons|1|||
130695215|NCT02272803|470507670|FG001|Overall Study|Other reasons|3|||
130695216|NCT02272803|470507669|FG000|Overall Study|Administrative reason by sponsor|5|||
130768436|NCT00866333|470775575|FG001|Overall Study|Reason not Specified|1|||
130768437|NCT00866333|470775576|FG002|Overall Study|Reason not Specified|1|||
130768438|NCT00866333|470775574|FG000|Overall Study|Study Terminated by Sponsor|2|||
130768439|NCT00866333|470775575|FG001|Overall Study|Study Terminated by Sponsor|5|||
130768440|NCT00866333|470775576|FG002|Overall Study|Study Terminated by Sponsor|9|||
130768441|NCT00350779|470775578|FG000|Overall Study|Adverse Event|4|||
130768442|NCT00350779|470775579|FG001|Overall Study|Adverse Event|2|||
130768443|NCT00350779|470775578|FG000|Overall Study|Lack of Efficacy|0|||
130768444|NCT00350779|470775579|FG001|Overall Study|Lack of Efficacy|4|||
130768445|NCT00350779|470775578|FG000|Overall Study|Lost to Follow-up|2|||
130768446|NCT00350779|470775579|FG001|Overall Study|Lost to Follow-up|0|||
130768447|NCT00350779|470775578|FG000|Overall Study|Physician Decision|2|||
130768448|NCT00350779|470775579|FG001|Overall Study|Physician Decision|4|||
130768449|NCT00350779|470775578|FG000|Overall Study|Protocol Violation|3|||
130768450|NCT00350779|470775579|FG001|Overall Study|Protocol Violation|1|||
130768451|NCT00350779|470775578|FG000|Overall Study|Withdrawal by Subject|9|||
130768452|NCT00350779|470775579|FG001|Overall Study|Withdrawal by Subject|8|||
130768453|NCT00350779|470775578|FG000|Overall Study|Patient Moved|2|||
130768454|NCT00350779|470775579|FG001|Overall Study|Patient Moved|1|||
130768455|NCT00350779|470775578|FG000|Overall Study|Non-compliance with study procedures|0|||
130768456|NCT00350779|470775579|FG001|Overall Study|Non-compliance with study procedures|1|||
130768457|NCT02012959|470775580|FG000|Treatment Phase A|Adverse Event|2|||
130768458|NCT02012959|470775581|FG001|Treatment Phase A|Adverse Event|0|||
130768459|NCT02012959|470775582|FG002|Treatment Phase A|Adverse Event|0|||
130768460|NCT02012959|470775583|FG003|Treatment Phase A|Adverse Event|0|||
130768461|NCT02012959|470775584|FG004|Treatment Phase A|Adverse Event|0|||
130768462|NCT03326518|470776666|FG000|Overall Study|Protocol Violation|1|||
130768463|NCT03326518|470776667|FG001|Overall Study|Protocol Violation|0|||
130695217|NCT02272803|470507670|FG001|Overall Study|Administrative reason by sponsor|4|||
130768464|NCT03326518|470776668|FG002|Overall Study|Protocol Violation|0|||
130768465|NCT03326518|470776666|FG000|Overall Study|Withdrawal by Subject|1|||
130768466|NCT03326518|470776667|FG001|Overall Study|Withdrawal by Subject|0|||
130768467|NCT03326518|470776668|FG002|Overall Study|Withdrawal by Subject|0|||
130768468|NCT03326518|470776666|FG000|Overall Study|Lost to Follow-up|1|||
131028370|NCT02891915|471735328|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
131028371|NCT02891915|471735327|FG000|Overall Study|Withdrawal by Subject|3|||
131028372|NCT02891915|471735328|FG001|Overall Study|Withdrawal by Subject|3|||
131028373|NCT02891915|471735327|FG000|Overall Study|Became Ineligible After Enrollment|2|||
131028374|NCT02891915|471735328|FG001|Overall Study|Became Ineligible After Enrollment|1|||
131028375|NCT02891915|471735327|FG000|Overall Study|Lost to Follow-up|1|||
131028376|NCT02891915|471735328|FG001|Overall Study|Lost to Follow-up|4|||
131028377|NCT02891915|471735327|FG000|Overall Study|Physician Decision|1|||
131028378|NCT02891915|471735328|FG001|Overall Study|Physician Decision|0|||
131028379|NCT03939312|471735331|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
131028380|NCT03939312|471735331|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
131028381|NCT03939312|471735331|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
131028382|NCT03939312|471735331|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
131028383|NCT03939312|471735331|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
131028384|NCT03939312|471735331|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
131028385|NCT03939312|471735331|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
131028386|NCT03939312|471735331|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
131028387|NCT03939312|471735331|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
131028388|NCT03939312|471735331|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
131028389|NCT03939312|471735331|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
131028390|NCT03939312|471735331|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
131028391|NCT02119650|471735332|FG000|Overall Study|Adverse Event|3|||
131028392|NCT02119650|471735333|FG001|Overall Study|Adverse Event|4|||
131028393|NCT02119650|471735332|FG000|Overall Study|Subject decision|2|||
130695218|NCT01566435|470507674|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
130768469|NCT03326518|470776667|FG001|Overall Study|Lost to Follow-up|0|||
131028394|NCT02119650|471735333|FG001|Overall Study|Subject decision|3|||
131028395|NCT02119650|471735332|FG000|Overall Study|Disease progression|11|||
130695219|NCT03684928|470507675|FG000|First Intervention|Lost to Follow-up|0|||
130695220|NCT03684928|470507676|FG001|First Intervention|Lost to Follow-up|1|||
130906739|NCT01986933|471292922|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
130906740|NCT01986933|471292923|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
130906741|NCT01986933|471292924|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
130906742|NCT01986933|471292925|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
130906743|NCT01986933|471292921|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
130906744|NCT01986933|471292922|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
130906745|NCT01986933|471292923|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
130906746|NCT01986933|471292924|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
130906747|NCT01986933|471292925|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
130906748|NCT01986933|471292921|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
130906749|NCT01986933|471292922|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
130906750|NCT01986933|471292923|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
130906751|NCT01986933|471292924|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
130906752|NCT01986933|471292925|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
130906753|NCT01986933|471292921|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
130906754|NCT01986933|471292922|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
130906755|NCT01986933|471292923|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
130906756|NCT01986933|471292924|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
130906757|NCT01986933|471292925|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
130906758|NCT01986933|471292921|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
130906759|NCT01986933|471292922|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
130906760|NCT01986933|471292923|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
130906761|NCT01986933|471292924|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
130906762|NCT01986933|471292925|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
130906763|NCT01986933|471292921|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
130906764|NCT01986933|471292922|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
130906765|NCT01986933|471292923|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
130906766|NCT01986933|471292924|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
130906767|NCT01986933|471292925|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
130906768|NCT03119701|471292926|FG000|6-day Dosing|Death|4|||
130906769|NCT03119701|471292927|FG001|6-day Dosing|Death|1|||
130906770|NCT03119701|471292926|FG000|6-day Dosing|Adverse Event|3|||
130906771|NCT03119701|471292927|FG001|6-day Dosing|Adverse Event|0|||
130906772|NCT03119701|471292926|FG000|6-day Dosing|Physician Decision|0|||
130906773|NCT03119701|471292927|FG001|6-day Dosing|Physician Decision|1|||
130906774|NCT03119701|471292926|FG000|6-day Dosing|Withdrawal by Subject|0|||
130906775|NCT03119701|471292927|FG001|6-day Dosing|Withdrawal by Subject|1|||
130906776|NCT03119701|471292926|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
130906777|NCT03119701|471292927|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
130906778|NCT00811642|471292936|FG000|Overall Study|Adverse Event|3|||
130906779|NCT00811642|471292936|FG000|Overall Study|Protocol Violation|1|||
130906780|NCT00811642|471292936|FG000|Overall Study|Death|2|||
130906781|NCT00811642|471292936|FG000|Overall Study|Withdrawal by Subject|7|||
130906782|NCT00811642|471292936|FG000|Overall Study|Cumulative use of antifungal agent|2|||
130906783|NCT05772702|471292944|FG000|Overall Study|Adverse Event|1|||
130906784|NCT00884377|471294708|FG000|Overall Study|Withdrawal by Subject|1|||
130906785|NCT00884377|471294709|FG001|Overall Study|Withdrawal by Subject|0|||
130906786|NCT00884377|471294708|FG000|Overall Study|Could not confirm diagnosis|1|||
130906787|NCT00884377|471294709|FG001|Overall Study|Could not confirm diagnosis|0|||
130906788|NCT00884377|471294708|FG000|Overall Study|Physician Decision|0|||
130906789|NCT00884377|471294709|FG001|Overall Study|Physician Decision|1|||
131114502|NCT04598477|472050769|FG001|Overall Study|Withdrawal by Subject|12|||
131114503|NCT04598477|472050768|FG000|Overall Study|Other|15|||
131114504|NCT04598477|472050769|FG001|Overall Study|Other|8|||
131114505|NCT05579990|472050772|FG000|Overall Study|Lost to Follow-up|3|||
131114506|NCT02038920|472050783|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
131114507|NCT02038920|472050784|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
131114508|NCT02038920|472050785|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
131114509|NCT02038920|472050786|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
131222762|NCT00386100|472443176|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
130695221|NCT03684928|470507675|FG000|First Intervention|Withdrawal by Subject|0|||
130906790|NCT02003365|471294710|FG000|Overall Study|Lost to Follow-up|0|||
130906791|NCT02003365|471294711|FG001|Overall Study|Lost to Follow-up|0|||
130906792|NCT02003365|471294712|FG002|Overall Study|Lost to Follow-up|1|||
130906793|NCT04854642|471294713|FG000|Overall Study|Adverse Event|1|||
130906794|NCT04854642|471294714|FG001|Overall Study|Adverse Event|2|||
130906795|NCT04854642|471294713|FG000|Overall Study|Withdrawal by Subject|0|||
130906796|NCT04854642|471294714|FG001|Overall Study|Withdrawal by Subject|1|||
130906797|NCT00562627|471294715|FG000|Overall Study|Protocol Violation|1|||
130906798|NCT00562627|471294716|FG001|Overall Study|Protocol Violation|1|||
130906799|NCT00562627|471294717|FG002|Overall Study|Protocol Violation|1|||
130906800|NCT00625742|471294718|FG000|Overall Study|Disease Progression|2|||
130906801|NCT00625742|471294718|FG000|Overall Study|Withdrawal by Subject|1|||
130906802|NCT00625742|471294718|FG000|Overall Study|Adverse Event|4|||
130906803|NCT00625742|471294718|FG000|Overall Study|Lost to Follow-up|4|||
130906804|NCT00625742|471294718|FG000|Overall Study|Ineligible|1|||
130906805|NCT01709578|471294719|FG000|Overall Study|Rescued and entered in long term safety|63|||
130906806|NCT01709578|471294720|FG001|Overall Study|Rescued and entered in long term safety|25|||
130906807|NCT01709578|471294721|FG002|Overall Study|Rescued and entered in long term safety|26|||
130906808|NCT01709578|471294719|FG000|Overall Study|Adverse Event|9|||
131114510|NCT02038920|472050787|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
131114511|NCT02038920|472050788|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
131114512|NCT02038920|472050783|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
131114513|NCT02038920|472050784|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
131114514|NCT02038920|472050785|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
131114515|NCT02038920|472050786|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
131114516|NCT02038920|472050787|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
131114517|NCT02038920|472050788|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
131114518|NCT02038920|472050783|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
131114519|NCT02038920|472050784|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
131114520|NCT02038920|472050785|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
131114521|NCT02038920|472050786|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
131114522|NCT02038920|472050787|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
131114523|NCT02038920|472050788|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
131114524|NCT02038920|472050783|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
131114525|NCT02038920|472050784|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
131114526|NCT02038920|472050785|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
131114527|NCT02038920|472050786|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
131114528|NCT02038920|472050787|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
131114529|NCT02038920|472050788|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
131114530|NCT02038920|472050783|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
131114531|NCT02038920|472050784|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
131114532|NCT02038920|472050785|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
131114533|NCT02038920|472050786|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
131114534|NCT02038920|472050787|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
131114535|NCT02038920|472050788|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
131114536|NCT02038920|472050783|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
131114537|NCT02038920|472050784|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
131114538|NCT02038920|472050785|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
131114539|NCT02038920|472050786|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
131114540|NCT02038920|472050787|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
131114541|NCT02038920|472050788|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
131114542|NCT02038920|472050783|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
131114543|NCT02038920|472050784|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
131114544|NCT02038920|472050785|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
131114545|NCT02038920|472050786|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
131114546|NCT02038920|472050787|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
131114547|NCT02038920|472050788|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
131114548|NCT02038920|472050783|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
131114549|NCT02038920|472050784|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
131114550|NCT02038920|472050785|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
131114551|NCT02038920|472050786|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
131114552|NCT02038920|472050787|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
131114553|NCT02038920|472050788|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
131114554|NCT02038920|472050783|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
131114555|NCT02038920|472050784|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
131114556|NCT02038920|472050785|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
131114557|NCT02038920|472050786|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
131114558|NCT02038920|472050787|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
131114559|NCT02038920|472050788|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
131114560|NCT02038920|472050783|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
131114561|NCT02038920|472050784|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
131114562|NCT02038920|472050785|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
130695222|NCT03684928|470507676|FG001|First Intervention|Withdrawal by Subject|2|||
130695223|NCT03684928|470507675|FG000|Second Intervention|Soft Tissue Injury|1|||
130906809|NCT01709578|471294720|FG001|Overall Study|Adverse Event|18|||
130906810|NCT01709578|471294721|FG002|Overall Study|Adverse Event|17|||
130906811|NCT01709578|471294719|FG000|Overall Study|Lack of Efficacy|5|||
131114563|NCT02038920|472050786|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
131114564|NCT02038920|472050787|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
131114565|NCT02038920|472050788|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
131114566|NCT02038920|472050783|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
131114567|NCT02038920|472050784|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
131114568|NCT02038920|472050785|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
131114569|NCT02038920|472050786|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
131114570|NCT02038920|472050787|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
131114571|NCT02038920|472050788|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
131114572|NCT02038920|472050783|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
131114573|NCT02038920|472050784|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
130906812|NCT01709578|471294720|FG001|Overall Study|Lack of Efficacy|4|||
130906813|NCT01709578|471294721|FG002|Overall Study|Lack of Efficacy|2|||
130906814|NCT01709578|471294719|FG000|Overall Study|Poor compliance to protocol|1|||
130906815|NCT01709578|471294720|FG001|Overall Study|Poor compliance to protocol|2|||
130906816|NCT01709578|471294721|FG002|Overall Study|Poor compliance to protocol|1|||
130906817|NCT01709578|471294719|FG000|Overall Study|Other, not related to safety or efficacy|2|||
130906818|NCT01709578|471294720|FG001|Overall Study|Other, not related to safety or efficacy|7|||
130906819|NCT01709578|471294721|FG002|Overall Study|Other, not related to safety or efficacy|5|||
131114574|NCT02038920|472050785|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
131114575|NCT02038920|472050786|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
131114576|NCT02038920|472050787|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
131114577|NCT02038920|472050788|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
131114578|NCT00866697|472050789|FG000|Overall Study|Study closed/terminated|156|||
131114579|NCT00866697|472050790|FG001|Overall Study|Study closed/terminated|138|||
131114580|NCT00866697|472050789|FG000|Overall Study|Lost to Follow-up|22|||
131114581|NCT00866697|472050790|FG001|Overall Study|Lost to Follow-up|28|||
131114582|NCT00866697|472050789|FG000|Overall Study|Physician Decision|3|||
131114583|NCT00866697|472050790|FG001|Overall Study|Physician Decision|5|||
131114584|NCT00866697|472050789|FG000|Overall Study|Withdrawal by Subject|33|||
131114585|NCT00866697|472050790|FG001|Overall Study|Withdrawal by Subject|57|||
131114586|NCT04376060|472050791|FG000|Overall Study|Physician Decision|1|||
131114587|NCT03739762|472052143|FG000|Overall Study|Lost to Follow-up|1|||
131114588|NCT03739762|472052144|FG001|Overall Study|Lost to Follow-up|1|||
131114589|NCT03739762|472052143|FG000|Overall Study|Withdrawal by Subject|2|||
131114590|NCT03739762|472052144|FG001|Overall Study|Withdrawal by Subject|6|||
131114591|NCT01423812|472052145|FG000|Overall Study|Lost to Follow-up|2|||
131114592|NCT01423812|472052146|FG001|Overall Study|Lost to Follow-up|2|||
131114593|NCT01423812|472052145|FG000|Overall Study|Withdrawal by Subject|1|||
131114594|NCT01423812|472052146|FG001|Overall Study|Withdrawal by Subject|2|||
131114595|NCT02748018|472052147|FG000|Study Period|Adverse Event|1|||
131114596|NCT02748018|472052148|FG001|Study Period|Adverse Event|3|||
131114597|NCT02748018|472052149|FG002|Study Period|Adverse Event|4|||
131114598|NCT02748018|472052150|FG003|Study Period|Adverse Event|0|||
131114599|NCT02748018|472052151|FG004|Study Period|Adverse Event|3|||
131114600|NCT02748018|472052152|FG005|Study Period|Adverse Event|3|||
131114601|NCT02748018|472052147|FG000|Study Period|Withdrawal by Subject|7|||
131114602|NCT02748018|472052148|FG001|Study Period|Withdrawal by Subject|4|||
131114603|NCT02748018|472052149|FG002|Study Period|Withdrawal by Subject|4|||
131114604|NCT02748018|472052150|FG003|Study Period|Withdrawal by Subject|11|||
131114605|NCT02748018|472052151|FG004|Study Period|Withdrawal by Subject|12|||
131114606|NCT02748018|472052152|FG005|Study Period|Withdrawal by Subject|10|||
131114607|NCT02748018|472052147|FG000|Study Period|Pregnancy|0|||
131114608|NCT02748018|472052148|FG001|Study Period|Pregnancy|1|||
131114609|NCT02748018|472052149|FG002|Study Period|Pregnancy|0|||
131114610|NCT02748018|472052150|FG003|Study Period|Pregnancy|0|||
131114611|NCT02748018|472052151|FG004|Study Period|Pregnancy|1|||
131114612|NCT02748018|472052152|FG005|Study Period|Pregnancy|0|||
131114613|NCT02748018|472052147|FG000|Study Period|Physician Decision|2|||
131114614|NCT02748018|472052148|FG001|Study Period|Physician Decision|2|||
131114615|NCT02748018|472052149|FG002|Study Period|Physician Decision|1|||
130695224|NCT03684928|470507676|FG001|Second Intervention|Soft Tissue Injury|0|||
130695225|NCT03733145|470507680|FG000|Overall Study|screenfail|3|||
131114616|NCT02748018|472052150|FG003|Study Period|Physician Decision|0|||
130695226|NCT03733145|470507681|FG001|Overall Study|screenfail|3|||
130906820|NCT04050371|471294722|FG000|Overall Study|Withdrawal by Subject|1|||
130906821|NCT04050371|471294723|FG001|Overall Study|Withdrawal by Subject|0|||
130906822|NCT00597701|471294724|FG000|Overall Study|Withdrawal by Subject|5|||
131114617|NCT02748018|472052151|FG004|Study Period|Physician Decision|2|||
131114618|NCT02748018|472052152|FG005|Study Period|Physician Decision|0|||
131114619|NCT02748018|472052147|FG000|Study Period|Lost to Follow-up|0|||
131114620|NCT02748018|472052148|FG001|Study Period|Lost to Follow-up|0|||
131114621|NCT02748018|472052149|FG002|Study Period|Lost to Follow-up|0|||
131114622|NCT02748018|472052150|FG003|Study Period|Lost to Follow-up|2|||
131114623|NCT02748018|472052151|FG004|Study Period|Lost to Follow-up|0|||
131114624|NCT02748018|472052152|FG005|Study Period|Lost to Follow-up|1|||
130695227|NCT03733145|470507682|FG002|Overall Study|screenfail|2|||
130695228|NCT02302716|470508952|FG000|Overall Study|Adverse Event|1|||
130695229|NCT02302716|470508953|FG001|Overall Study|Adverse Event|1|||
130695230|NCT02302716|470508952|FG000|Overall Study|Death|0|||
130695231|NCT02302716|470508953|FG001|Overall Study|Death|1|||
130695232|NCT02302716|470508952|FG000|Overall Study|Lack of Efficacy|0|||
130695233|NCT02302716|470508953|FG001|Overall Study|Lack of Efficacy|1|||
130695234|NCT02302716|470508952|FG000|Overall Study|Lost to Follow-up|2|||
130695235|NCT02302716|470508953|FG001|Overall Study|Lost to Follow-up|4|||
130695236|NCT02302716|470508952|FG000|Overall Study|Physician Decision|3|||
130695237|NCT02302716|470508953|FG001|Overall Study|Physician Decision|4|||
130695238|NCT02302716|470508952|FG000|Overall Study|Withdrawal by Subject|13|||
130695239|NCT02302716|470508953|FG001|Overall Study|Withdrawal by Subject|7|||
130695240|NCT02302716|470508952|FG000|Overall Study|Protocol Violation|0|||
130695241|NCT02302716|470508953|FG001|Overall Study|Protocol Violation|1|||
130695242|NCT00557245|470508957|FG000|Overall Study|Lost to Follow-up|7|||
130695243|NCT00557245|470508958|FG001|Overall Study|Lost to Follow-up|8|||
130695244|NCT00557245|470508959|FG002|Overall Study|Lost to Follow-up|10|||
130695245|NCT00557245|470508957|FG000|Overall Study|Ineligible|5|||
130695246|NCT00557245|470508958|FG001|Overall Study|Ineligible|4|||
130695247|NCT00557245|470508959|FG002|Overall Study|Ineligible|2|||
130695248|NCT00798603|470508961|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
130695249|NCT00798603|470508961|FG000|Overall Study|Withdrawal by Subject|10|||
130695250|NCT00798603|470508961|FG000|Overall Study|Adverse Event|22|||
130695251|NCT00798603|470508961|FG000|Overall Study|Physician Decision|1|||
130695252|NCT00798603|470508961|FG000|Overall Study|Lack of insurance coverage|1|||
130695253|NCT02316223|470508964|FG000|Overall Study|Lack of Efficacy|0|||
130695254|NCT02316223|470508965|FG001|Overall Study|Lack of Efficacy|1|||
130695255|NCT02316223|470508966|FG002|Overall Study|Lack of Efficacy|1|||
130695256|NCT02316223|470508964|FG000|Overall Study|Lost to Follow-up|27|||
130695257|NCT02316223|470508965|FG001|Overall Study|Lost to Follow-up|34|||
130695258|NCT02316223|470508966|FG002|Overall Study|Lost to Follow-up|36|||
130695259|NCT02316223|470508964|FG000|Overall Study|COPD Diagnosis|3|||
130695260|NCT02316223|470508965|FG001|Overall Study|COPD Diagnosis|2|||
130695261|NCT02316223|470508966|FG002|Overall Study|COPD Diagnosis|3|||
130695262|NCT02316223|470508964|FG000|Overall Study|Reside outside study area|1|||
130695263|NCT02316223|470508965|FG001|Overall Study|Reside outside study area|1|||
130695264|NCT02316223|470508966|FG002|Overall Study|Reside outside study area|1|||
130695265|NCT02316223|470508964|FG000|Overall Study|No asthma|2|||
130695266|NCT02316223|470508965|FG001|Overall Study|No asthma|0|||
130695267|NCT02316223|470508966|FG002|Overall Study|No asthma|0|||
130695268|NCT02316223|470508964|FG000|Overall Study|Discontinued by PI|11|||
130695269|NCT02316223|470508965|FG001|Overall Study|Discontinued by PI|19|||
130695270|NCT02316223|470508966|FG002|Overall Study|Discontinued by PI|3|||
130695271|NCT00529763|470508968|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
130695272|NCT00529763|470508969|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
130695273|NCT00529763|470508970|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130695274|NCT00529763|470508968|FG000|Overall Study|Death|1|||
130695275|NCT00529763|470508969|FG001|Overall Study|Death|1|||
130695276|NCT00529763|470508970|FG002|Overall Study|Death|1|||
130695277|NCT00529763|470508968|FG000|Overall Study|Disease Progression|10|||
130695278|NCT00529763|470508969|FG001|Overall Study|Disease Progression|16|||
130695279|NCT00529763|470508970|FG002|Overall Study|Disease Progression|11|||
130695280|NCT00529763|470508968|FG000|Overall Study|Lost to Follow-up|1|||
130768470|NCT03326518|470776668|FG002|Overall Study|Lost to Follow-up|1|||
130768471|NCT01375374|470776671|FG000|Overall Study|Adverse Event|1|||
130768472|NCT02065518|470776672|FG000|Overall Study|Lost to Follow-up|3|||
130768473|NCT02065518|470776673|FG001|Overall Study|Lost to Follow-up|4|||
130768474|NCT02065518|470776674|FG002|Overall Study|Lost to Follow-up|0|||
130768475|NCT02065518|470776675|FG003|Overall Study|Lost to Follow-up|3|||
130906823|NCT00597701|471294725|FG001|Overall Study|Withdrawal by Subject|5|||
130695281|NCT00529763|470508969|FG001|Overall Study|Lost to Follow-up|2|||
130695282|NCT00529763|470508970|FG002|Overall Study|Lost to Follow-up|3|||
130695283|NCT00529763|470508968|FG000|Overall Study|Stem Cell Transplant|0|||
130695284|NCT00529763|470508969|FG001|Overall Study|Stem Cell Transplant|3|||
130695285|NCT00529763|470508970|FG002|Overall Study|Stem Cell Transplant|1|||
130695286|NCT00529763|470508968|FG000|Overall Study|Study Drug Toxicity|3|||
130695287|NCT00529763|470508969|FG001|Overall Study|Study Drug Toxicity|6|||
130695288|NCT00529763|470508970|FG002|Overall Study|Study Drug Toxicity|4|||
130695289|NCT00529763|470508968|FG000|Overall Study|Participant Withdrew Consent|2|||
130695290|NCT00529763|470508969|FG001|Overall Study|Participant Withdrew Consent|3|||
130768476|NCT02065518|470776672|FG000|Overall Study|Withdrawal by Subject|3|||
130768477|NCT02065518|470776673|FG001|Overall Study|Withdrawal by Subject|4|||
130768478|NCT02065518|470776674|FG002|Overall Study|Withdrawal by Subject|9|||
130906824|NCT00597701|471294724|FG000|Overall Study|Death|0|||
130695291|NCT00529763|470508970|FG002|Overall Study|Participant Withdrew Consent|4|||
130695292|NCT00529763|470508968|FG000|Overall Study|Other reasons|2|||
130695293|NCT00529763|470508969|FG001|Overall Study|Other reasons|0|||
130695294|NCT00529763|470508970|FG002|Overall Study|Other reasons|2|||
130768479|NCT02065518|470776675|FG003|Overall Study|Withdrawal by Subject|2|||
131114625|NCT02748018|472052147|FG000|Continuation Period|Adverse Event|2|||
131114626|NCT02748018|472052148|FG001|Continuation Period|Adverse Event|0|||
131114627|NCT02748018|472052149|FG002|Continuation Period|Adverse Event|1|||
131114628|NCT02748018|472052150|FG003|Continuation Period|Adverse Event|1|||
131114629|NCT02748018|472052151|FG004|Continuation Period|Adverse Event|1|||
131114630|NCT02748018|472052152|FG005|Continuation Period|Adverse Event|4|||
131114631|NCT02748018|472052147|FG000|Continuation Period|Withdrawal by Subject|3|||
131114632|NCT02748018|472052148|FG001|Continuation Period|Withdrawal by Subject|5|||
131114633|NCT02748018|472052149|FG002|Continuation Period|Withdrawal by Subject|3|||
131114634|NCT02748018|472052150|FG003|Continuation Period|Withdrawal by Subject|9|||
131114635|NCT02748018|472052151|FG004|Continuation Period|Withdrawal by Subject|11|||
131114636|NCT02748018|472052152|FG005|Continuation Period|Withdrawal by Subject|1|||
131114637|NCT02748018|472052147|FG000|Continuation Period|Lost to Follow-up|0|||
131114638|NCT02748018|472052148|FG001|Continuation Period|Lost to Follow-up|2|||
131114639|NCT02748018|472052149|FG002|Continuation Period|Lost to Follow-up|1|||
131114640|NCT02748018|472052150|FG003|Continuation Period|Lost to Follow-up|0|||
131114641|NCT02748018|472052151|FG004|Continuation Period|Lost to Follow-up|1|||
131114642|NCT02748018|472052152|FG005|Continuation Period|Lost to Follow-up|0|||
131114643|NCT02748018|472052147|FG000|Continuation Period|Pregnancy|1|||
131114644|NCT02748018|472052148|FG001|Continuation Period|Pregnancy|2|||
131114645|NCT02748018|472052149|FG002|Continuation Period|Pregnancy|0|||
131114646|NCT02748018|472052150|FG003|Continuation Period|Pregnancy|0|||
131114647|NCT02748018|472052151|FG004|Continuation Period|Pregnancy|0|||
131114648|NCT02748018|472052152|FG005|Continuation Period|Pregnancy|0|||
131114649|NCT02748018|472052147|FG000|Continuation Period|Physician Decision|0|||
131114650|NCT02748018|472052148|FG001|Continuation Period|Physician Decision|1|||
131114651|NCT02748018|472052149|FG002|Continuation Period|Physician Decision|2|||
131114652|NCT02748018|472052150|FG003|Continuation Period|Physician Decision|0|||
131114653|NCT02748018|472052151|FG004|Continuation Period|Physician Decision|2|||
131114654|NCT02748018|472052152|FG005|Continuation Period|Physician Decision|1|||
131114655|NCT02748018|472052147|FG000|Continuation Period|Protocol Violation|0|||
131114656|NCT02748018|472052148|FG001|Continuation Period|Protocol Violation|1|||
131114657|NCT02748018|472052149|FG002|Continuation Period|Protocol Violation|0|||
131114658|NCT02748018|472052150|FG003|Continuation Period|Protocol Violation|0|||
131114659|NCT02748018|472052151|FG004|Continuation Period|Protocol Violation|0|||
131114660|NCT02748018|472052152|FG005|Continuation Period|Protocol Violation|0|||
131114661|NCT00537485|472052153|FG000|Overall Study|Adverse Event|10|||
131114662|NCT00537485|472052154|FG001|Overall Study|Adverse Event|5|||
131114663|NCT00537485|472052153|FG000|Overall Study|Withdrawal by Subject|3|||
131114664|NCT00537485|472052154|FG001|Overall Study|Withdrawal by Subject|2|||
131114665|NCT00537485|472052153|FG000|Overall Study|Withdrawal by Subject|1|||
131114666|NCT00537485|472052154|FG001|Overall Study|Withdrawal by Subject|3|||
131114667|NCT00537485|472052153|FG000|Overall Study|Physician Decision|1|||
131114668|NCT00537485|472052154|FG001|Overall Study|Physician Decision|0|||
131114669|NCT00312221|472052157|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
131114670|NCT00312221|472052158|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
131114671|NCT00312221|472052159|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
131114672|NCT00312221|472052160|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
131114673|NCT00312221|472052157|FG000|Open-label Run-in Period|Adverse Event|74|||
131114674|NCT00312221|472052158|FG001|Open-label Run-in Period|Adverse Event|0|||
131114675|NCT00312221|472052159|FG002|Open-label Run-in Period|Adverse Event|0|||
131114676|NCT00312221|472052160|FG003|Open-label Run-in Period|Adverse Event|0|||
131114677|NCT00312221|472052157|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
131114678|NCT00312221|472052158|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
131114679|NCT00312221|472052159|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
131114680|NCT00312221|472052160|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
131114681|NCT00312221|472052157|FG000|Open-label Run-in Period|Administrative|42|||
131114682|NCT00312221|472052158|FG001|Open-label Run-in Period|Administrative|0|||
131114683|NCT00312221|472052159|FG002|Open-label Run-in Period|Administrative|0|||
131114684|NCT00312221|472052160|FG003|Open-label Run-in Period|Administrative|0|||
131114685|NCT00312221|472052157|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
131114686|NCT00312221|472052158|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
131114687|NCT00312221|472052159|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
131114688|NCT00312221|472052160|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
131114689|NCT00312221|472052157|FG000|Open-label Run-in Period|Did not qualify|5|||
131114690|NCT00312221|472052158|FG001|Open-label Run-in Period|Did not qualify|0|||
131114691|NCT00312221|472052159|FG002|Open-label Run-in Period|Did not qualify|0|||
131114692|NCT00312221|472052160|FG003|Open-label Run-in Period|Did not qualify|0|||
131114693|NCT00312221|472052157|FG000|Double-blind Phase|Withdrawal by Subject|0|||
131114694|NCT00312221|472052158|FG001|Double-blind Phase|Withdrawal by Subject|6|||
131114695|NCT00312221|472052159|FG002|Double-blind Phase|Withdrawal by Subject|8|||
131114696|NCT00312221|472052160|FG003|Double-blind Phase|Withdrawal by Subject|7|||
131114697|NCT00312221|472052157|FG000|Double-blind Phase|Adverse Event|0|||
131114698|NCT00312221|472052158|FG001|Double-blind Phase|Adverse Event|10|||
131114699|NCT00312221|472052159|FG002|Double-blind Phase|Adverse Event|19|||
131114700|NCT00312221|472052160|FG003|Double-blind Phase|Adverse Event|18|||
130906825|NCT00597701|471294725|FG001|Overall Study|Death|1|||
130906826|NCT00597701|471294724|FG000|Overall Study|Physician Decision|2|||
130906827|NCT00597701|471294725|FG001|Overall Study|Physician Decision|0|||
130906828|NCT00597701|471294724|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
130906829|NCT00597701|471294725|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
130906830|NCT01107418|471294726|FG000|Overall Study|Disease Progression|45|||
130906831|NCT01107418|471294726|FG000|Overall Study|Adverse Event|3|||
130906832|NCT01107418|471294726|FG000|Overall Study|Withdrawal by Subject|1|||
130906833|NCT01107418|471294726|FG000|Overall Study|Study Closing|1|||
130906834|NCT01107418|471294726|FG000|Overall Study|Started Other Therapy|1|||
130906835|NCT01107418|471294726|FG000|Overall Study|Entered Extension Study|1|||
130906836|NCT00301821|471294733|FG000|Overall Study|Ineligible|25|||
130906837|NCT00301821|471294733|FG000|Overall Study|Cancel|1|||
130906838|NCT01314911|471294736|FG000|Overall Study|Lost to Follow-up|3|||
130906839|NCT01314911|471294737|FG001|Overall Study|Lost to Follow-up|2|||
130906840|NCT01314911|471294736|FG000|Overall Study|Withdrawal by Subject|1|||
130906841|NCT01314911|471294737|FG001|Overall Study|Withdrawal by Subject|3|||
130906842|NCT01314911|471294736|FG000|Overall Study|Received Non-randomized Study Drug|0|||
131028396|NCT02119650|471735333|FG001|Overall Study|Disease progression|14|||
131028397|NCT02119650|471735332|FG000|Overall Study|Death|5|||
131028398|NCT02119650|471735333|FG001|Overall Study|Death|1|||
131028399|NCT02119650|471735332|FG000|Overall Study|Noncompliance with study treatment|1|||
131028400|NCT02119650|471735333|FG001|Overall Study|Noncompliance with study treatment|1|||
131028401|NCT02119650|471735332|FG000|Overall Study|Study terminated by the sponsor|1|||
130695295|NCT00529763|470508968|FG000|Overall Study|Participant request to discontinue treatment|1|||
130695296|NCT00529763|470508969|FG001|Overall Study|Participant request to discontinue treatment|1|||
130695297|NCT00529763|470508970|FG002|Overall Study|Participant request to discontinue treatment|3|||
131028402|NCT02119650|471735333|FG001|Overall Study|Study terminated by the sponsor|0|||
131028403|NCT02119650|471735332|FG000|Overall Study|Physician Decision|0|||
131028404|NCT02119650|471735333|FG001|Overall Study|Physician Decision|2|||
131028405|NCT02119650|471735332|FG000|Overall Study|Multiple reasons for termination|2|||
131028406|NCT02119650|471735333|FG001|Overall Study|Multiple reasons for termination|1|||
131028407|NCT01721291|471735336|FG000|Overall Study|Withdrawal by Subject|1|||
131028408|NCT01721291|471735337|FG001|Overall Study|Withdrawal by Subject|0|||
131028409|NCT01721291|471735336|FG000|Overall Study|did not like the treatment|1|||
131028410|NCT01721291|471735337|FG001|Overall Study|did not like the treatment|0|||
131028411|NCT04442126|471735348|FG000|Overall Study|Withdrawal by Subject|0|||
131028412|NCT04442126|471735349|FG001|Overall Study|Withdrawal by Subject|0|||
131028413|NCT04442126|471735350|FG002|Overall Study|Withdrawal by Subject|0|||
131028414|NCT04442126|471735351|FG003|Overall Study|Withdrawal by Subject|2|||
131028415|NCT04442126|471735352|FG004|Overall Study|Withdrawal by Subject|1|||
130695298|NCT03669250|470508971|FG000|Overall Study|Adverse Event|0|||
130906843|NCT01314911|471294737|FG001|Overall Study|Received Non-randomized Study Drug|1|||
130906844|NCT01314911|471294736|FG000|Overall Study|Never Started Treatment|1|||
130906845|NCT01314911|471294737|FG001|Overall Study|Never Started Treatment|0|||
130906846|NCT01850602|471294750|FG000|Overall Study|Adverse Event|7|||
130906847|NCT01850602|471294751|FG001|Overall Study|Adverse Event|10|||
130906848|NCT01850602|471294750|FG000|Overall Study|Physician Decision|2|||
130906849|NCT01850602|471294751|FG001|Overall Study|Physician Decision|1|||
130906850|NCT01850602|471294750|FG000|Overall Study|Withdrawal by Subject|2|||
130906851|NCT01850602|471294751|FG001|Overall Study|Withdrawal by Subject|4|||
130906852|NCT01850602|471294750|FG000|Overall Study|Decrease in serum calcium|2|||
130906853|NCT01850602|471294751|FG001|Overall Study|Decrease in serum calcium|3|||
130906854|NCT01850602|471294750|FG000|Overall Study|Increase in serum ferritin|1|||
130906855|NCT01850602|471294751|FG001|Overall Study|Increase in serum ferritin|0|||
130906856|NCT00367770|471294752|FG000|Overall Study|Adverse Event|1|||
130906857|NCT00367770|471294752|FG000|Overall Study|Withdrawal by Subject|1|||
130906858|NCT01155479|471294753|FG000|Part I|Adverse Event|13|||
130906859|NCT01155479|471294754|FG001|Part I|Adverse Event|8|||
130906860|NCT01155479|471294755|FG002|Part I|Adverse Event|18|||
130906861|NCT01155479|471294756|FG003|Part I|Adverse Event|7|||
130906862|NCT01155479|471294757|FG004|Part I|Adverse Event|6|||
130906863|NCT01155479|471294753|FG000|Part I|Administrative|2|||
130906864|NCT01155479|471294754|FG001|Part I|Administrative|2|||
130906865|NCT01155479|471294755|FG002|Part I|Administrative|2|||
130906866|NCT01155479|471294756|FG003|Part I|Administrative|0|||
130906867|NCT01155479|471294757|FG004|Part I|Administrative|0|||
130906868|NCT01155479|471294753|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
130906869|NCT01155479|471294754|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
130906870|NCT01155479|471294755|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
130906871|NCT01155479|471294756|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
130906872|NCT01155479|471294757|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
130906873|NCT01155479|471294753|FG000|Part I|Withdrawal by Subject|11|||
130906874|NCT01155479|471294754|FG001|Part I|Withdrawal by Subject|13|||
130906875|NCT01155479|471294755|FG002|Part I|Withdrawal by Subject|8|||
131028416|NCT04442126|471735353|FG005|Overall Study|Withdrawal by Subject|0|||
131028417|NCT04442126|471735354|FG006|Overall Study|Withdrawal by Subject|1|||
130906876|NCT01155479|471294756|FG003|Part I|Withdrawal by Subject|8|||
130906877|NCT01155479|471294757|FG004|Part I|Withdrawal by Subject|9|||
130906878|NCT01155479|471294753|FG000|Part I|Lost to Follow-up|0|||
130906879|NCT01155479|471294754|FG001|Part I|Lost to Follow-up|0|||
130906880|NCT01155479|471294755|FG002|Part I|Lost to Follow-up|1|||
130906881|NCT01155479|471294756|FG003|Part I|Lost to Follow-up|1|||
130906882|NCT01155479|471294757|FG004|Part I|Lost to Follow-up|0|||
130906883|NCT01155479|471294753|FG000|Part I|Treatment Failure|3|||
130906884|NCT01155479|471294754|FG001|Part I|Treatment Failure|0|||
130906885|NCT01155479|471294755|FG002|Part I|Treatment Failure|3|||
130906886|NCT01155479|471294756|FG003|Part I|Treatment Failure|1|||
130906887|NCT01155479|471294757|FG004|Part I|Treatment Failure|2|||
130906888|NCT01155479|471294753|FG000|Part I|Did Not Receive Treatment|4|||
130906889|NCT01155479|471294754|FG001|Part I|Did Not Receive Treatment|2|||
130906890|NCT01155479|471294755|FG002|Part I|Did Not Receive Treatment|2|||
130906891|NCT01155479|471294756|FG003|Part I|Did Not Receive Treatment|6|||
130906892|NCT01155479|471294757|FG004|Part I|Did Not Receive Treatment|1|||
130906893|NCT01155479|471294753|FG000|Part I|Non-Compliance with Protocol|2|||
130906894|NCT01155479|471294754|FG001|Part I|Non-Compliance with Protocol|1|||
130906895|NCT01155479|471294755|FG002|Part I|Non-Compliance with Protocol|3|||
130906896|NCT01155479|471294756|FG003|Part I|Non-Compliance with Protocol|3|||
130906897|NCT01155479|471294757|FG004|Part I|Non-Compliance with Protocol|2|||
130906898|NCT01155479|471294753|FG000|Part II|Adverse Event|7|||
130906899|NCT01155479|471294754|FG001|Part II|Adverse Event|6|||
130906900|NCT01155479|471294755|FG002|Part II|Adverse Event|8|||
130906901|NCT01155479|471294756|FG003|Part II|Adverse Event|3|||
130906902|NCT01155479|471294757|FG004|Part II|Adverse Event|4|||
130906903|NCT01155479|471294753|FG000|Part II|Administrative|43|||
130906904|NCT01155479|471294754|FG001|Part II|Administrative|49|||
130906905|NCT01155479|471294755|FG002|Part II|Administrative|36|||
130906906|NCT01155479|471294756|FG003|Part II|Administrative|38|||
130906907|NCT01155479|471294757|FG004|Part II|Administrative|46|||
130906908|NCT01155479|471294753|FG000|Part II|Withdrawal by Subject|8|||
130906909|NCT01155479|471294754|FG001|Part II|Withdrawal by Subject|4|||
130906910|NCT01155479|471294755|FG002|Part II|Withdrawal by Subject|12|||
130906911|NCT01155479|471294756|FG003|Part II|Withdrawal by Subject|7|||
130906912|NCT01155479|471294757|FG004|Part II|Withdrawal by Subject|3|||
130906913|NCT01155479|471294753|FG000|Part II|Lost to Follow-up|1|||
130906914|NCT01155479|471294754|FG001|Part II|Lost to Follow-up|0|||
131114701|NCT00312221|472052157|FG000|Double-blind Phase|Lost to Follow-up|0|||
131114702|NCT00312221|472052158|FG001|Double-blind Phase|Lost to Follow-up|0|||
130906915|NCT01155479|471294755|FG002|Part II|Lost to Follow-up|0|||
130906916|NCT01155479|471294756|FG003|Part II|Lost to Follow-up|0|||
130906917|NCT01155479|471294757|FG004|Part II|Lost to Follow-up|1|||
130906918|NCT01155479|471294753|FG000|Part II|Treatment Failure|0|||
130906919|NCT01155479|471294754|FG001|Part II|Treatment Failure|1|||
130906920|NCT01155479|471294755|FG002|Part II|Treatment Failure|2|||
130906921|NCT01155479|471294756|FG003|Part II|Treatment Failure|0|||
130906922|NCT01155479|471294757|FG004|Part II|Treatment Failure|1|||
130906923|NCT01155479|471294753|FG000|Part II|Non-Compliance with Protocol|0|||
130906924|NCT01155479|471294754|FG001|Part II|Non-Compliance with Protocol|1|||
131028418|NCT04442126|471735355|FG007|Overall Study|Withdrawal by Subject|1|||
131028419|NCT04442126|471735356|FG008|Overall Study|Withdrawal by Subject|3|||
131028420|NCT04442126|471735348|FG000|Overall Study|Death|1|||
131028421|NCT04442126|471735349|FG001|Overall Study|Death|0|||
131028422|NCT04442126|471735350|FG002|Overall Study|Death|0|||
131028423|NCT04442126|471735351|FG003|Overall Study|Death|1|||
131028424|NCT04442126|471735352|FG004|Overall Study|Death|2|||
131028425|NCT04442126|471735353|FG005|Overall Study|Death|2|||
131028426|NCT04442126|471735354|FG006|Overall Study|Death|4|||
131028427|NCT04442126|471735355|FG007|Overall Study|Death|1|||
131028428|NCT04442126|471735356|FG008|Overall Study|Death|5|||
131114703|NCT00312221|472052159|FG002|Double-blind Phase|Lost to Follow-up|2|||
131114704|NCT00312221|472052160|FG003|Double-blind Phase|Lost to Follow-up|2|||
130695299|NCT03669250|470508972|FG001|Overall Study|Adverse Event|0|||
130695300|NCT03669250|470508973|FG002|Overall Study|Adverse Event|0|||
130695301|NCT03669250|470508974|FG003|Overall Study|Adverse Event|0|||
130906925|NCT01155479|471294755|FG002|Part II|Non-Compliance with Protocol|0|||
130906926|NCT01155479|471294756|FG003|Part II|Non-Compliance with Protocol|2|||
130906927|NCT01155479|471294757|FG004|Part II|Non-Compliance with Protocol|0|||
130906928|NCT00470184|471294758|FG000|Overall Study|Not Treated(became ineligible)|4|||
130906929|NCT00470184|471294758|FG000|Overall Study|Not treated (other)|1|||
130906930|NCT00470184|471294758|FG000|Overall Study|disease Progression|4|||
130906931|NCT00470184|471294758|FG000|Overall Study|Adverse Event|3|||
130906932|NCT00470184|471294758|FG000|Overall Study|Withdrawal by Subject|4|||
130906933|NCT00470184|471294758|FG000|Overall Study|other|5|||
130906934|NCT00470184|471294758|FG000|Overall Study|recurrence|1|||
130906935|NCT02483533|471294760|FG000|Overall Study|Lack of Efficacy|50|||
130906936|NCT02483533|471294761|FG001|Overall Study|Lack of Efficacy|50|||
130906937|NCT00768469|471294763|FG000|Overall Study|Adverse Event|0|||
131028429|NCT04442126|471735348|FG000|Overall Study|Study Terminated by Sponsor|0|||
131028430|NCT04442126|471735349|FG001|Overall Study|Study Terminated by Sponsor|0|||
131028431|NCT04442126|471735350|FG002|Overall Study|Study Terminated by Sponsor|0|||
130695302|NCT03669250|470508975|FG004|Overall Study|Adverse Event|1|||
130695303|NCT03669250|470508976|FG005|Overall Study|Adverse Event|0|||
130695304|NCT03669250|470508971|FG000|Overall Study|Withdrawal by Subject|0|||
130695305|NCT03669250|470508972|FG001|Overall Study|Withdrawal by Subject|1|||
130906938|NCT00768469|471294764|FG001|Overall Study|Adverse Event|2|||
130906939|NCT00768469|471294763|FG000|Overall Study|Disease Progression|3|||
130906940|NCT00768469|471294764|FG001|Overall Study|Disease Progression|4|||
130906941|NCT00768469|471294763|FG000|Overall Study|Withdrawal by Subject|0|||
130906942|NCT00768469|471294764|FG001|Overall Study|Withdrawal by Subject|1|||
130906943|NCT02953509|471294773|FG000|Overall Study|Death|1|||
130906944|NCT02953509|471294774|FG001|Overall Study|Death|3|||
130906945|NCT02953509|471294775|FG002|Overall Study|Death|3|||
130906946|NCT02953509|471294776|FG003|Overall Study|Death|4|||
130906947|NCT02953509|471294777|FG004|Overall Study|Death|12|||
130906948|NCT02953509|471294778|FG005|Overall Study|Death|3|||
130906949|NCT02953509|471294779|FG006|Overall Study|Death|25|||
130906950|NCT02953509|471294780|FG007|Overall Study|Death|10|||
130906951|NCT02953509|471294781|FG008|Overall Study|Death|21|||
130906952|NCT02953509|471294782|FG009|Overall Study|Death|20|||
130906953|NCT02953509|471294773|FG000|Overall Study|Reason Not Specified|0|||
130906954|NCT02953509|471294774|FG001|Overall Study|Reason Not Specified|2|||
130906955|NCT02953509|471294775|FG002|Overall Study|Reason Not Specified|8|||
130906956|NCT02953509|471294776|FG003|Overall Study|Reason Not Specified|2|||
130906957|NCT02953509|471294777|FG004|Overall Study|Reason Not Specified|11|||
130906958|NCT02953509|471294778|FG005|Overall Study|Reason Not Specified|4|||
130906959|NCT02953509|471294779|FG006|Overall Study|Reason Not Specified|12|||
130906960|NCT02953509|471294780|FG007|Overall Study|Reason Not Specified|2|||
130906961|NCT02953509|471294781|FG008|Overall Study|Reason Not Specified|7|||
130906962|NCT02953509|471294782|FG009|Overall Study|Reason Not Specified|2|||
130906963|NCT02953509|471294773|FG000|Overall Study|Consent Withdrawn|1|||
130906964|NCT02953509|471294774|FG001|Overall Study|Consent Withdrawn|1|||
130906965|NCT02953509|471294775|FG002|Overall Study|Consent Withdrawn|2|||
130906966|NCT02953509|471294776|FG003|Overall Study|Consent Withdrawn|1|||
130906967|NCT02953509|471294777|FG004|Overall Study|Consent Withdrawn|3|||
130906968|NCT02953509|471294778|FG005|Overall Study|Consent Withdrawn|0|||
130906969|NCT02953509|471294779|FG006|Overall Study|Consent Withdrawn|4|||
130906970|NCT02953509|471294780|FG007|Overall Study|Consent Withdrawn|1|||
130906971|NCT02953509|471294781|FG008|Overall Study|Consent Withdrawn|1|||
130906972|NCT02953509|471294782|FG009|Overall Study|Consent Withdrawn|4|||
130906973|NCT02953509|471294773|FG000|Overall Study|Lost to Follow-up|0|||
130906974|NCT02953509|471294774|FG001|Overall Study|Lost to Follow-up|0|||
130906975|NCT02953509|471294775|FG002|Overall Study|Lost to Follow-up|0|||
130906976|NCT02953509|471294776|FG003|Overall Study|Lost to Follow-up|0|||
130906977|NCT02953509|471294777|FG004|Overall Study|Lost to Follow-up|0|||
130906978|NCT02953509|471294778|FG005|Overall Study|Lost to Follow-up|0|||
130906979|NCT02953509|471294779|FG006|Overall Study|Lost to Follow-up|1|||
130906980|NCT02953509|471294780|FG007|Overall Study|Lost to Follow-up|1|||
130906981|NCT02953509|471294781|FG008|Overall Study|Lost to Follow-up|1|||
130906982|NCT02953509|471294782|FG009|Overall Study|Lost to Follow-up|1|||
130906983|NCT02953509|471294773|FG000|Overall Study|Study terminated by sponsor|1|||
130906984|NCT02953509|471294774|FG001|Overall Study|Study terminated by sponsor|0|||
130906985|NCT02953509|471294775|FG002|Overall Study|Study terminated by sponsor|0|||
130906986|NCT02953509|471294776|FG003|Overall Study|Study terminated by sponsor|0|||
130906987|NCT02953509|471294777|FG004|Overall Study|Study terminated by sponsor|0|||
130906988|NCT02953509|471294778|FG005|Overall Study|Study terminated by sponsor|0|||
130906989|NCT02953509|471294779|FG006|Overall Study|Study terminated by sponsor|1|||
130906990|NCT02953509|471294780|FG007|Overall Study|Study terminated by sponsor|0|||
130906991|NCT02953509|471294781|FG008|Overall Study|Study terminated by sponsor|1|||
130906992|NCT02953509|471294782|FG009|Overall Study|Study terminated by sponsor|1|||
130906993|NCT02522871|471294783|FG000|Overall Study|Protocol Violation|1|||
130906994|NCT02522871|471294784|FG001|Overall Study|Protocol Violation|4|||
130906995|NCT02522871|471294783|FG000|Overall Study|Treated without randomization|1|||
130906996|NCT02522871|471294784|FG001|Overall Study|Treated without randomization|0|||
130906997|NCT02522871|471294783|FG000|Overall Study|Death|9|||
130906998|NCT02522871|471294784|FG001|Overall Study|Death|9|||
130906999|NCT02522871|471294783|FG000|Overall Study|Died in operating room prior to transplant|0|||
130907000|NCT02522871|471294784|FG001|Overall Study|Died in operating room prior to transplant|1|||
130695306|NCT03669250|470508973|FG002|Overall Study|Withdrawal by Subject|0|||
130695307|NCT03669250|470508974|FG003|Overall Study|Withdrawal by Subject|1|||
130695308|NCT03669250|470508975|FG004|Overall Study|Withdrawal by Subject|0|||
130907001|NCT00725842|471294785|FG000|Overall Study|Lost to Follow-up|19|||
130907002|NCT00725842|471294785|FG000|Overall Study|Death|1|||
130907003|NCT00725842|471294785|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
130907004|NCT00725842|471294785|FG000|Overall Study|Consent date prior to study start date|5|||
130907005|NCT00725842|471294785|FG000|Overall Study|Inclusion criterion not met|1|||
130907006|NCT00725842|471294785|FG000|Overall Study|No Visit 1 data|1|||
130907007|NCT01715129|471294786|FG000|Overall Study|Adverse Event, fatal|1|||
130907008|NCT01715129|471294786|FG000|Overall Study|Lack of Efficacy|3|||
130907009|NCT01715129|471294786|FG000|Overall Study|Protocol Violation|1|||
130907010|NCT01715129|471294786|FG000|Overall Study|Consent Withdrawn|2|||
130907011|NCT01715129|471294786|FG000|Overall Study|Lost to Follow-up|1|||
130907012|NCT01715129|471294786|FG000|Overall Study|Other|1|||
130907013|NCT02793622|471294787|FG000|Overall Study|Lost to Follow-up|31|||
130907014|NCT02793622|471294788|FG001|Overall Study|Lost to Follow-up|19|||
130907015|NCT02793622|471294787|FG000|Overall Study|Withdrawal by Subject|21|||
130907016|NCT02793622|471294788|FG001|Overall Study|Withdrawal by Subject|17|||
130907017|NCT02793622|471294787|FG000|Overall Study|Adverse Event|0|||
131114705|NCT00312221|472052157|FG000|Double-blind Phase|Administrative|0|||
131114706|NCT00312221|472052158|FG001|Double-blind Phase|Administrative|26|||
131114707|NCT00312221|472052159|FG002|Double-blind Phase|Administrative|37|||
131114708|NCT00312221|472052160|FG003|Double-blind Phase|Administrative|33|||
131114709|NCT00312221|472052157|FG000|Double-blind Phase|Lack of Efficacy|0|||
131114710|NCT00312221|472052158|FG001|Double-blind Phase|Lack of Efficacy|17|||
131114711|NCT00312221|472052159|FG002|Double-blind Phase|Lack of Efficacy|6|||
131114712|NCT00312221|472052160|FG003|Double-blind Phase|Lack of Efficacy|10|||
131114713|NCT01003990|472052161|FG000|Overall Study|Adverse Event|8|||
131114714|NCT01003990|472052162|FG001|Overall Study|Adverse Event|5|||
131114715|NCT01003990|472052163|FG002|Overall Study|Adverse Event|11|||
131114716|NCT01003990|472052161|FG000|Overall Study|Death|0|||
130907018|NCT02793622|471294788|FG001|Overall Study|Adverse Event|1|||
131114717|NCT01003990|472052162|FG001|Overall Study|Death|8|||
131114718|NCT01003990|472052163|FG002|Overall Study|Death|1|||
131114719|NCT01003990|472052161|FG000|Overall Study|Lack of Efficacy|10|||
131114720|NCT01003990|472052162|FG001|Overall Study|Lack of Efficacy|2|||
131114721|NCT01003990|472052163|FG002|Overall Study|Lack of Efficacy|3|||
131114722|NCT01003990|472052161|FG000|Overall Study|Lost to Follow-up|30|||
131114723|NCT01003990|472052162|FG001|Overall Study|Lost to Follow-up|12|||
131114724|NCT01003990|472052163|FG002|Overall Study|Lost to Follow-up|7|||
131114725|NCT01003990|472052161|FG000|Overall Study|Reasons Not Identified|14|||
131114726|NCT01003990|472052162|FG001|Overall Study|Reasons Not Identified|13|||
131114727|NCT01003990|472052163|FG002|Overall Study|Reasons Not Identified|8|||
131114728|NCT01003990|472052161|FG000|Overall Study|Poor/Non-compliance|4|||
131114729|NCT01003990|472052162|FG001|Overall Study|Poor/Non-compliance|3|||
131114730|NCT01003990|472052163|FG002|Overall Study|Poor/Non-compliance|2|||
131114731|NCT01003990|472052161|FG000|Overall Study|Pregnancy|10|||
131114732|NCT01003990|472052162|FG001|Overall Study|Pregnancy|2|||
131114733|NCT01003990|472052163|FG002|Overall Study|Pregnancy|4|||
131114734|NCT01003990|472052161|FG000|Overall Study|No Longer Met Study Criteria|4|||
131114735|NCT01003990|472052162|FG001|Overall Study|No Longer Met Study Criteria|1|||
131114736|NCT01003990|472052163|FG002|Overall Study|No Longer Met Study Criteria|0|||
131114737|NCT01003990|472052161|FG000|Overall Study|Subject Withdrew Consent|12|||
131114738|NCT01003990|472052162|FG001|Overall Study|Subject Withdrew Consent|5|||
131114739|NCT01003990|472052163|FG002|Overall Study|Subject Withdrew Consent|7|||
131114740|NCT01641809|472052164|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
131114741|NCT01641809|472052165|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
131114742|NCT01641809|472052166|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
131114743|NCT01641809|472052167|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
131114744|NCT01641809|472052164|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
131114745|NCT01641809|472052165|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
131114746|NCT01641809|472052166|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
131114747|NCT01641809|472052167|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
131114748|NCT01641809|472052164|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
131114749|NCT01641809|472052165|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
131114750|NCT01641809|472052166|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
131114751|NCT01641809|472052167|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
131114752|NCT01641809|472052164|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
131114753|NCT01641809|472052165|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
131114754|NCT01641809|472052166|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
131114755|NCT01641809|472052167|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
131114756|NCT01641809|472052164|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
130907019|NCT02793622|471294787|FG000|Overall Study|Protocol Violation|1|||
131114757|NCT01641809|472052165|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
131114758|NCT01641809|472052166|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
131114759|NCT01641809|472052167|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
131114760|NCT01641809|472052164|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
131114761|NCT01641809|472052165|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
131114762|NCT01641809|472052166|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
131114763|NCT01641809|472052167|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
131114764|NCT01641809|472052164|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
131222763|NCT00386100|472443175|FG000|Overall Study|Laboratory findings|1|||
130768480|NCT00564278|470776676|FG000|Overall Study|Lost to Follow-up|35|||
130907020|NCT02793622|471294788|FG001|Overall Study|Protocol Violation|5|||
130907021|NCT01092832|471294789|FG000|Overall Study|Other|1|||
130907022|NCT01092832|471294790|FG001|Overall Study|Other|0|||
131114765|NCT01641809|472052165|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
131114766|NCT01641809|472052166|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
131114767|NCT01641809|472052167|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
131114768|NCT01641809|472052164|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
131114769|NCT01641809|472052165|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
131114770|NCT01641809|472052166|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
131114771|NCT01641809|472052167|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
131114772|NCT01641809|472052164|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
131114773|NCT01641809|472052165|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
131114774|NCT01641809|472052166|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
131114775|NCT01641809|472052167|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
131114776|NCT01641809|472052164|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
131114777|NCT01641809|472052165|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
131114778|NCT01641809|472052166|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
131114779|NCT01641809|472052167|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
131114780|NCT01641809|472052164|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
131114781|NCT01641809|472052165|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
131114782|NCT01641809|472052166|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
130907023|NCT00722371|471294791|FG000|Overall Study|Adverse Event|6|||
130907024|NCT00722371|471294792|FG001|Overall Study|Adverse Event|13|||
130907025|NCT00722371|471294793|FG002|Overall Study|Adverse Event|9|||
130907026|NCT00722371|471294794|FG003|Overall Study|Adverse Event|10|||
130907027|NCT00722371|471294795|FG004|Overall Study|Adverse Event|6|||
131028432|NCT04442126|471735351|FG003|Overall Study|Study Terminated by Sponsor|0|||
131028433|NCT04442126|471735352|FG004|Overall Study|Study Terminated by Sponsor|0|||
131028434|NCT04442126|471735353|FG005|Overall Study|Study Terminated by Sponsor|1|||
131028435|NCT04442126|471735354|FG006|Overall Study|Study Terminated by Sponsor|4|||
131028436|NCT04442126|471735355|FG007|Overall Study|Study Terminated by Sponsor|2|||
131028437|NCT04442126|471735356|FG008|Overall Study|Study Terminated by Sponsor|10|||
131028438|NCT04442126|471735348|FG000|Overall Study|Lost to Follow-up|0|||
131028439|NCT04442126|471735349|FG001|Overall Study|Lost to Follow-up|0|||
131028440|NCT04442126|471735350|FG002|Overall Study|Lost to Follow-up|0|||
131028441|NCT04442126|471735351|FG003|Overall Study|Lost to Follow-up|0|||
131028442|NCT04442126|471735352|FG004|Overall Study|Lost to Follow-up|0|||
131028443|NCT04442126|471735353|FG005|Overall Study|Lost to Follow-up|0|||
131028444|NCT04442126|471735354|FG006|Overall Study|Lost to Follow-up|0|||
131028445|NCT04442126|471735355|FG007|Overall Study|Lost to Follow-up|1|||
131028446|NCT04442126|471735356|FG008|Overall Study|Lost to Follow-up|2|||
131028447|NCT04442126|471735348|FG000|Overall Study|Progressive Disease|0|||
131028448|NCT04442126|471735349|FG001|Overall Study|Progressive Disease|1|||
131028449|NCT04442126|471735350|FG002|Overall Study|Progressive Disease|3|||
131028450|NCT04442126|471735351|FG003|Overall Study|Progressive Disease|0|||
131028451|NCT04442126|471735352|FG004|Overall Study|Progressive Disease|3|||
131028452|NCT04442126|471735353|FG005|Overall Study|Progressive Disease|0|||
131028453|NCT04442126|471735354|FG006|Overall Study|Progressive Disease|0|||
131028454|NCT04442126|471735355|FG007|Overall Study|Progressive Disease|0|||
131028455|NCT04442126|471735356|FG008|Overall Study|Progressive Disease|0|||
131028456|NCT04442126|471735348|FG000|Overall Study|Other|0|||
131028457|NCT04442126|471735349|FG001|Overall Study|Other|0|||
131028458|NCT04442126|471735350|FG002|Overall Study|Other|0|||
131028459|NCT04442126|471735351|FG003|Overall Study|Other|0|||
131028460|NCT04442126|471735352|FG004|Overall Study|Other|0|||
131028461|NCT04442126|471735353|FG005|Overall Study|Other|0|||
131028462|NCT04442126|471735354|FG006|Overall Study|Other|0|||
131028463|NCT04442126|471735355|FG007|Overall Study|Other|0|||
131028464|NCT04442126|471735356|FG008|Overall Study|Other|1|||
131028465|NCT06450405|471735357|FG000|Overall Study|Study funding terminated.|0|||
131028466|NCT06450405|471735358|FG001|Overall Study|Study funding terminated.|2|||
131028467|NCT03424811|471736530|FG000|Overall Study|Lost to Follow-up|9|||
131028468|NCT03424811|471736531|FG001|Overall Study|Lost to Follow-up|0|||
131028469|NCT03948763|471736532|FG000|Overall Study|Sponsor's decision|0|||
131114783|NCT01641809|472052167|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
131114784|NCT01641809|472052164|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
131114785|NCT01641809|472052165|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
131028470|NCT03948763|471736533|FG001|Overall Study|Sponsor's decision|2|||
131028471|NCT03948763|471736534|FG002|Overall Study|Sponsor's decision|6|||
131028472|NCT03948763|471736535|FG003|Overall Study|Sponsor's decision|4|||
131028473|NCT03948763|471736536|FG004|Overall Study|Sponsor's decision|0|||
130907028|NCT00722371|471294796|FG005|Overall Study|Adverse Event|8|||
131028474|NCT03948763|471736532|FG000|Overall Study|Physician Decision|0|||
131028475|NCT03948763|471736533|FG001|Overall Study|Physician Decision|0|||
131028476|NCT03948763|471736534|FG002|Overall Study|Physician Decision|1|||
131028477|NCT03948763|471736535|FG003|Overall Study|Physician Decision|0|||
131028478|NCT03948763|471736536|FG004|Overall Study|Physician Decision|0|||
131028479|NCT03948763|471736532|FG000|Overall Study|Lost to Follow-up|0|||
131028480|NCT03948763|471736533|FG001|Overall Study|Lost to Follow-up|0|||
130907029|NCT00722371|471294797|FG006|Overall Study|Adverse Event|4|||
130907030|NCT00722371|471294791|FG000|Overall Study|Contraindication|0|||
130907031|NCT00722371|471294792|FG001|Overall Study|Contraindication|0|||
130907032|NCT00722371|471294793|FG002|Overall Study|Contraindication|1|||
130907033|NCT00722371|471294794|FG003|Overall Study|Contraindication|0|||
130907034|NCT00722371|471294795|FG004|Overall Study|Contraindication|0|||
130907035|NCT00722371|471294796|FG005|Overall Study|Contraindication|0|||
130907036|NCT00722371|471294797|FG006|Overall Study|Contraindication|0|||
130907037|NCT00722371|471294791|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
130907038|NCT00722371|471294792|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
130907039|NCT00722371|471294793|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
130907040|NCT00722371|471294794|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
130907041|NCT00722371|471294795|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
130907042|NCT00722371|471294796|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
130907043|NCT00722371|471294797|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
130907044|NCT00722371|471294791|FG000|Overall Study|Excluded medication|0|||
130907045|NCT00722371|471294792|FG001|Overall Study|Excluded medication|1|||
130907046|NCT00722371|471294793|FG002|Overall Study|Excluded medication|1|||
130907047|NCT00722371|471294794|FG003|Overall Study|Excluded medication|0|||
130907048|NCT00722371|471294795|FG004|Overall Study|Excluded medication|0|||
130907049|NCT00722371|471294796|FG005|Overall Study|Excluded medication|0|||
130907050|NCT00722371|471294797|FG006|Overall Study|Excluded medication|1|||
130907051|NCT00722371|471294791|FG000|Overall Study|Hyperglycemia|2|||
130907052|NCT00722371|471294792|FG001|Overall Study|Hyperglycemia|6|||
130907053|NCT00722371|471294793|FG002|Overall Study|Hyperglycemia|4|||
130907054|NCT00722371|471294794|FG003|Overall Study|Hyperglycemia|2|||
130907055|NCT00722371|471294795|FG004|Overall Study|Hyperglycemia|5|||
130907056|NCT00722371|471294796|FG005|Overall Study|Hyperglycemia|1|||
130907057|NCT00722371|471294797|FG006|Overall Study|Hyperglycemia|1|||
130907058|NCT00722371|471294791|FG000|Overall Study|Hypoglycemia|1|||
130907059|NCT00722371|471294792|FG001|Overall Study|Hypoglycemia|0|||
130907060|NCT00722371|471294793|FG002|Overall Study|Hypoglycemia|0|||
130907061|NCT00722371|471294794|FG003|Overall Study|Hypoglycemia|0|||
130907062|NCT00722371|471294795|FG004|Overall Study|Hypoglycemia|0|||
130907063|NCT00722371|471294796|FG005|Overall Study|Hypoglycemia|0|||
130907064|NCT00722371|471294797|FG006|Overall Study|Hypoglycemia|0|||
130907065|NCT00722371|471294791|FG000|Overall Study|Lack of Efficacy|4|||
131028481|NCT03948763|471736534|FG002|Overall Study|Lost to Follow-up|0|||
131114786|NCT01641809|472052166|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
131114787|NCT01641809|472052167|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
131028482|NCT03948763|471736535|FG003|Overall Study|Lost to Follow-up|0|||
131028483|NCT03948763|471736536|FG004|Overall Study|Lost to Follow-up|1|||
131028484|NCT03948763|471736532|FG000|Overall Study|Death|2|||
131028485|NCT03948763|471736533|FG001|Overall Study|Death|12|||
131028486|NCT03948763|471736534|FG002|Overall Study|Death|13|||
131028487|NCT03948763|471736535|FG003|Overall Study|Death|10|||
131028488|NCT03948763|471736536|FG004|Overall Study|Death|11|||
131028489|NCT03948763|471736532|FG000|Overall Study|Withdrawal by Subject|1|||
131028490|NCT03948763|471736533|FG001|Overall Study|Withdrawal by Subject|1|||
131028491|NCT03948763|471736534|FG002|Overall Study|Withdrawal by Subject|0|||
131028492|NCT03948763|471736535|FG003|Overall Study|Withdrawal by Subject|2|||
131028493|NCT03948763|471736536|FG004|Overall Study|Withdrawal by Subject|4|||
131028494|NCT05038566|471736538|FG000|Overall Study|Technical Difficulties with the Device|0|||
131028495|NCT05038566|471736539|FG001|Overall Study|Technical Difficulties with the Device|1|||
131028502|NCT02840474|471736547|FG000|Overall Study|Lost to Follow-up|1|||
131028503|NCT02840474|471736548|FG001|Overall Study|Lost to Follow-up|0|||
131028504|NCT03192891|471736549|FG000|Overall Study|Lost to Follow-up|55|||
131028505|NCT04716634|471736551|FG000|Overall Study|Death|24|||
130907066|NCT00722371|471294792|FG001|Overall Study|Lack of Efficacy|6|||
130907067|NCT00722371|471294793|FG002|Overall Study|Lack of Efficacy|6|||
130907068|NCT00722371|471294794|FG003|Overall Study|Lack of Efficacy|6|||
130907069|NCT00722371|471294795|FG004|Overall Study|Lack of Efficacy|2|||
130907070|NCT00722371|471294796|FG005|Overall Study|Lack of Efficacy|3|||
131028506|NCT04716634|471736552|FG001|Overall Study|Death|24|||
131028507|NCT04716634|471736553|FG002|Overall Study|Death|8|||
131028508|NCT04716634|471736551|FG000|Overall Study|Closed by Sponsor|4|||
131028509|NCT04716634|471736552|FG001|Overall Study|Closed by Sponsor|4|||
130907071|NCT00722371|471294797|FG006|Overall Study|Lack of Efficacy|0|||
130907072|NCT00722371|471294791|FG000|Overall Study|Lost to Follow-up|11|||
130907073|NCT00722371|471294792|FG001|Overall Study|Lost to Follow-up|14|||
130907074|NCT00722371|471294793|FG002|Overall Study|Lost to Follow-up|21|||
131028510|NCT04716634|471736553|FG002|Overall Study|Closed by Sponsor|5|||
131028511|NCT04716634|471736551|FG000|Overall Study|Lost to Follow-up|1|||
130695309|NCT03669250|470508976|FG005|Overall Study|Withdrawal by Subject|0|||
130695310|NCT00828321|470508977|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
130695311|NCT00828321|470508978|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
130695312|NCT00828321|470508977|FG000|Second Intervention|Protocol Violation|0|||
130695313|NCT00828321|470508978|FG001|Second Intervention|Protocol Violation|1|||
130907075|NCT00722371|471294794|FG003|Overall Study|Lost to Follow-up|13|||
130907076|NCT00722371|471294795|FG004|Overall Study|Lost to Follow-up|8|||
130907077|NCT00722371|471294796|FG005|Overall Study|Lost to Follow-up|16|||
130907078|NCT00722371|471294797|FG006|Overall Study|Lost to Follow-up|13|||
130907079|NCT00722371|471294791|FG000|Overall Study|Physician Decision|5|||
130907080|NCT00722371|471294792|FG001|Overall Study|Physician Decision|2|||
130907081|NCT00722371|471294793|FG002|Overall Study|Physician Decision|2|||
130907082|NCT00722371|471294794|FG003|Overall Study|Physician Decision|5|||
130907083|NCT00722371|471294795|FG004|Overall Study|Physician Decision|2|||
130907084|NCT00722371|471294796|FG005|Overall Study|Physician Decision|3|||
130695314|NCT02034513|470508979|FG000|Overall Study|Adverse Event|11|||
130695315|NCT02034513|470508980|FG001|Overall Study|Adverse Event|10|||
130695316|NCT02034513|470508979|FG000|Overall Study|Lack of Efficacy|0|||
130695317|NCT02034513|470508980|FG001|Overall Study|Lack of Efficacy|1|||
130695318|NCT02034513|470508979|FG000|Overall Study|Lost to Follow-up|6|||
130695319|NCT02034513|470508980|FG001|Overall Study|Lost to Follow-up|7|||
130695320|NCT02034513|470508979|FG000|Overall Study|Pregnancy|0|||
130695321|NCT02034513|470508980|FG001|Overall Study|Pregnancy|3|||
130695322|NCT02034513|470508979|FG000|Overall Study|Protocol Violation|7|||
130695323|NCT02034513|470508980|FG001|Overall Study|Protocol Violation|10|||
130695324|NCT02034513|470508979|FG000|Overall Study|Withdrawal by Subject|25|||
130695325|NCT02034513|470508980|FG001|Overall Study|Withdrawal by Subject|25|||
130695326|NCT02034513|470508979|FG000|Overall Study|Unclassified|0|||
130695327|NCT02034513|470508980|FG001|Overall Study|Unclassified|1|||
130695328|NCT03119662|470508983|FG000|Overall Study|Withdrawal by Subject|0|||
130695329|NCT03119662|470508984|FG001|Overall Study|Withdrawal by Subject|1|||
130695330|NCT00660660|470508985|FG000|Overall Study|Adverse Event|1|||
130695331|NCT00660660|470508986|FG001|Overall Study|Adverse Event|0|||
130695332|NCT00660660|470508985|FG000|Overall Study|Lost to Follow-up|0|||
130695333|NCT00660660|470508986|FG001|Overall Study|Lost to Follow-up|6|||
130695334|NCT00660660|470508985|FG000|Overall Study|Lack of Efficacy|0|||
130695335|NCT00660660|470508986|FG001|Overall Study|Lack of Efficacy|2|||
130695336|NCT00660660|470508985|FG000|Overall Study|Withdrawal by Subject|3|||
130695337|NCT00660660|470508986|FG001|Overall Study|Withdrawal by Subject|0|||
130695338|NCT00660660|470508985|FG000|Overall Study|Incorrect enrollment and other|0|||
130695339|NCT00660660|470508986|FG001|Overall Study|Incorrect enrollment and other|1|||
130695340|NCT00660660|470508985|FG000|Overall Study|New medication after randomization|1|||
130695341|NCT00660660|470508986|FG001|Overall Study|New medication after randomization|0|||
130695342|NCT04158687|470508990|FG000|Overall Study|Adverse Event|2|||
130695343|NCT04158687|470508991|FG001|Overall Study|Adverse Event|3|||
130695344|NCT04158687|470508992|FG002|Overall Study|Adverse Event|0|||
130695345|NCT04158687|470508993|FG003|Overall Study|Adverse Event|3|||
130695346|NCT04158687|470508990|FG000|Overall Study|Lost to Follow-up|5|||
130695347|NCT04158687|470508991|FG001|Overall Study|Lost to Follow-up|12|||
130695348|NCT04158687|470508992|FG002|Overall Study|Lost to Follow-up|4|||
130907085|NCT00722371|471294797|FG006|Overall Study|Physician Decision|4|||
130907086|NCT00722371|471294791|FG000|Overall Study|Pregnancy|1|||
131028512|NCT04716634|471736552|FG001|Overall Study|Lost to Follow-up|0|||
131028513|NCT04716634|471736553|FG002|Overall Study|Lost to Follow-up|1|||
131028514|NCT04716634|471736551|FG000|Overall Study|Withdrawal by Subject|0|||
130695349|NCT04158687|470508993|FG003|Overall Study|Lost to Follow-up|5|||
130695350|NCT04158687|470508990|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
130695351|NCT04158687|470508991|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
130695352|NCT04158687|470508992|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
130695353|NCT04158687|470508993|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
130695354|NCT04158687|470508990|FG000|Overall Study|Non-Compliance with Study Medication|2|||
130695355|NCT04158687|470508991|FG001|Overall Study|Non-Compliance with Study Medication|2|||
130695356|NCT04158687|470508992|FG002|Overall Study|Non-Compliance with Study Medication|3|||
130695357|NCT04158687|470508993|FG003|Overall Study|Non-Compliance with Study Medication|0|||
130695358|NCT04158687|470508990|FG000|Overall Study|Investigator Decision|0|||
130695359|NCT04158687|470508991|FG001|Overall Study|Investigator Decision|0|||
130695360|NCT04158687|470508992|FG002|Overall Study|Investigator Decision|2|||
130695361|NCT04158687|470508993|FG003|Overall Study|Investigator Decision|0|||
130695362|NCT04158687|470508990|FG000|Overall Study|Protocol Violation|0|||
130695363|NCT04158687|470508991|FG001|Overall Study|Protocol Violation|2|||
130695364|NCT04158687|470508992|FG002|Overall Study|Protocol Violation|1|||
130695365|NCT04158687|470508993|FG003|Overall Study|Protocol Violation|0|||
130695366|NCT04158687|470508990|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
130695367|NCT04158687|470508991|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
130695368|NCT04158687|470508992|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
130907087|NCT00722371|471294792|FG001|Overall Study|Pregnancy|1|||
130907088|NCT00722371|471294793|FG002|Overall Study|Pregnancy|0|||
131114788|NCT01641809|472052164|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
131114789|NCT01641809|472052165|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
130695369|NCT04158687|470508993|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
130907089|NCT00722371|471294794|FG003|Overall Study|Pregnancy|0|||
130907090|NCT00722371|471294795|FG004|Overall Study|Pregnancy|0|||
130907091|NCT00722371|471294796|FG005|Overall Study|Pregnancy|1|||
130907092|NCT00722371|471294797|FG006|Overall Study|Pregnancy|0|||
130907093|NCT00722371|471294791|FG000|Overall Study|Protocol Violation|6|||
130907094|NCT00722371|471294792|FG001|Overall Study|Protocol Violation|1|||
130907095|NCT00722371|471294793|FG002|Overall Study|Protocol Violation|0|||
130907096|NCT00722371|471294794|FG003|Overall Study|Protocol Violation|1|||
130907097|NCT00722371|471294795|FG004|Overall Study|Protocol Violation|4|||
130907098|NCT00722371|471294796|FG005|Overall Study|Protocol Violation|2|||
130907099|NCT00722371|471294797|FG006|Overall Study|Protocol Violation|1|||
130907100|NCT00722371|471294791|FG000|Overall Study|Withdrawal by Subject|18|||
130907101|NCT00722371|471294792|FG001|Overall Study|Withdrawal by Subject|27|||
130907102|NCT00722371|471294793|FG002|Overall Study|Withdrawal by Subject|19|||
130907103|NCT00722371|471294794|FG003|Overall Study|Withdrawal by Subject|23|||
130907104|NCT00722371|471294795|FG004|Overall Study|Withdrawal by Subject|19|||
130907105|NCT00722371|471294796|FG005|Overall Study|Withdrawal by Subject|18|||
130907106|NCT00722371|471294797|FG006|Overall Study|Withdrawal by Subject|26|||
130907107|NCT02068768|471294798|FG000|Overall Study|Lost to Follow-up|5|||
130907108|NCT02068768|471294798|FG000|Overall Study|Early Termination by Sponsor|2|||
130907109|NCT00555425|471294799|FG000|Overall Study|Missed Medication > 1 wk|34|||
130907110|NCT00555425|471294800|FG001|Overall Study|Missed Medication > 1 wk|15|||
130907111|NCT00555425|471294799|FG000|Overall Study|Missed 3 physician management visits|1|||
130907112|NCT00555425|471294800|FG001|Overall Study|Missed 3 physician management visits|0|||
130907113|NCT00555425|471294799|FG000|Overall Study|Met criteria for protective transfer|16|||
130907114|NCT00555425|471294800|FG001|Overall Study|Met criteria for protective transfer|3|||
130907115|NCT00555425|471294799|FG000|Overall Study|Became pregnant and transferred care|0|||
130907116|NCT00555425|471294800|FG001|Overall Study|Became pregnant and transferred care|1|||
130907117|NCT03761797|471294801|FG000|Overall Study|Changing hospital|11|||
130907118|NCT03761797|471294801|FG000|Overall Study|Improvement/remission|6|||
130695370|NCT04158687|470508990|FG000|Overall Study|Reason not Specified|3|||
130695371|NCT04158687|470508991|FG001|Overall Study|Reason not Specified|2|||
130695372|NCT04158687|470508992|FG002|Overall Study|Reason not Specified|4|||
130907119|NCT03761797|471294801|FG000|Overall Study|Withdrawal by Subject|19|||
130907120|NCT03761797|471294801|FG000|Overall Study|Lost to Follow-up|33|||
131028515|NCT04716634|471736552|FG001|Overall Study|Withdrawal by Subject|0|||
131028516|NCT04716634|471736553|FG002|Overall Study|Withdrawal by Subject|1|||
131028517|NCT05387447|471736562|FG000|Overall Study|Participants changed their minds about study participation.|3|||
131028518|NCT05387447|471736563|FG001|Overall Study|Participants changed their minds about study participation.|5|||
131028519|NCT02630823|471736564|FG000|Overall Study|Withdrawal by Subject|1|||
131028520|NCT02630823|471736564|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
131028521|NCT03391466|471736567|FG000|Overall Study|Death|82|||
131028522|NCT03391466|471736568|FG001|Overall Study|Death|85|||
131028523|NCT03391466|471736567|FG000|Overall Study|Still on study|93|||
131028524|NCT03391466|471736568|FG001|Overall Study|Still on study|74|||
131028525|NCT03391466|471736567|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
131028526|NCT03391466|471736568|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
131028527|NCT03391466|471736567|FG000|Overall Study|Lost to Follow-up|5|||
131028528|NCT03391466|471736568|FG001|Overall Study|Lost to Follow-up|5|||
131028529|NCT03391466|471736567|FG000|Overall Study|Investigator decision|0|||
131028530|NCT03391466|471736568|FG001|Overall Study|Investigator decision|1|||
131028531|NCT03391466|471736567|FG000|Overall Study|Other|0|||
131028532|NCT03391466|471736568|FG001|Overall Study|Other|1|||
131028533|NCT03655132|471736571|FG000|Overall Study|Lost to Follow-up|2|||
131028534|NCT03655132|471736572|FG001|Overall Study|Lost to Follow-up|1|||
131028535|NCT03655132|471736571|FG000|Overall Study|Withdrawal by Subject|0|||
131028536|NCT03655132|471736572|FG001|Overall Study|Withdrawal by Subject|1|||
131028537|NCT03655132|471736571|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
131028538|NCT03655132|471736572|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
131028539|NCT05919082|471736574|FG000|Overall Study|Adverse Event|3|||
131028540|NCT05919082|471736575|FG001|Overall Study|Adverse Event|0|||
130907121|NCT03761797|471294801|FG000|Overall Study|Adverse Event|37|||
130907122|NCT03761797|471294801|FG000|Overall Study|Case report form (CRF) not collected|5|||
131028541|NCT05919082|471736574|FG000|Overall Study|Lost to Follow-up|0|||
131028542|NCT05919082|471736575|FG001|Overall Study|Lost to Follow-up|1|||
131028543|NCT05919082|471736574|FG000|Overall Study|Withdrawal by Subject|8|||
131028544|NCT05919082|471736575|FG001|Overall Study|Withdrawal by Subject|9|||
130695373|NCT04158687|470508993|FG003|Overall Study|Reason not Specified|4|||
130907123|NCT03761797|471294801|FG000|Overall Study|No patient visit after entry|13|||
130907124|NCT03761797|471294801|FG000|Overall Study|Switch to other diabetes medication|10|||
130695374|NCT04523480|470508996|FG000|Overall Study|Lost to Follow-up|30|||
130695375|NCT04523480|470508997|FG001|Overall Study|Lost to Follow-up|35|||
130695376|NCT04523480|470508998|FG002|Overall Study|Lost to Follow-up|0|||
130907125|NCT03761797|471294801|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
130907126|NCT03761797|471294801|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
130907127|NCT03761797|471294801|FG000|Overall Study|Insufficient effectives|2|||
130907128|NCT03761797|471294801|FG000|Overall Study|Excessive alcohol intake|1|||
130907129|NCT01244490|471294805|FG000|Overall Study|Lack of Efficacy|14|||
130907130|NCT01244490|471294806|FG001|Overall Study|Lack of Efficacy|5|||
130907131|NCT01244490|471294807|FG002|Overall Study|Lack of Efficacy|5|||
130907132|NCT01244490|471294805|FG000|Overall Study|Withdrawal by Subject|4|||
130907133|NCT01244490|471294806|FG001|Overall Study|Withdrawal by Subject|4|||
130907134|NCT01244490|471294807|FG002|Overall Study|Withdrawal by Subject|9|||
130907135|NCT01244490|471294805|FG000|Overall Study|Adverse Event|1|||
130907136|NCT01244490|471294806|FG001|Overall Study|Adverse Event|9|||
130907137|NCT01244490|471294807|FG002|Overall Study|Adverse Event|5|||
130907138|NCT01244490|471294805|FG000|Overall Study|Lost to Follow-up|0|||
130907139|NCT01244490|471294806|FG001|Overall Study|Lost to Follow-up|6|||
130907140|NCT01244490|471294807|FG002|Overall Study|Lost to Follow-up|3|||
130907141|NCT01244490|471294805|FG000|Overall Study|Other|0|||
130907142|NCT01244490|471294806|FG001|Overall Study|Other|0|||
130907143|NCT01244490|471294807|FG002|Overall Study|Other|1|||
130907144|NCT00400153|471294810|FG000|Overall Study|AE due to study disease worsening|14|||
130907145|NCT00400153|471294811|FG001|Overall Study|AE due to study disease worsening|19|||
130907146|NCT00400153|471294812|FG002|Overall Study|AE due to study disease worsening|20|||
130907147|NCT00400153|471294810|FG000|Overall Study|AE due to other disease worsening|2|||
130907148|NCT00400153|471294811|FG001|Overall Study|AE due to other disease worsening|1|||
130907149|NCT00400153|471294812|FG002|Overall Study|AE due to other disease worsening|0|||
130907150|NCT00400153|471294810|FG000|Overall Study|AE due to other condition|3|||
130907151|NCT00400153|471294811|FG001|Overall Study|AE due to other condition|14|||
130907152|NCT00400153|471294812|FG002|Overall Study|AE due to other condition|15|||
130907153|NCT00400153|471294810|FG000|Overall Study|Protocol Violation|7|||
130907154|NCT00400153|471294811|FG001|Overall Study|Protocol Violation|4|||
130907155|NCT00400153|471294812|FG002|Overall Study|Protocol Violation|9|||
130907156|NCT00400153|471294810|FG000|Overall Study|Lost to Follow-up|2|||
130907157|NCT00400153|471294811|FG001|Overall Study|Lost to Follow-up|1|||
130907158|NCT00400153|471294812|FG002|Overall Study|Lost to Follow-up|4|||
130907159|NCT00400153|471294810|FG000|Overall Study|Withdrawal by Subject|12|||
130907160|NCT00400153|471294811|FG001|Overall Study|Withdrawal by Subject|11|||
130907161|NCT00400153|471294812|FG002|Overall Study|Withdrawal by Subject|10|||
130907162|NCT00400153|471294810|FG000|Overall Study|Other reasons - not mentioned above|8|||
130907163|NCT00400153|471294811|FG001|Overall Study|Other reasons - not mentioned above|5|||
130907164|NCT00400153|471294812|FG002|Overall Study|Other reasons - not mentioned above|3|||
130907165|NCT00393042|471294813|FG000|First Intervention|Withdrawal by Subject|1|||
130907166|NCT00393042|471294814|FG001|First Intervention|Withdrawal by Subject|2|||
130907167|NCT00393042|471294813|FG000|First Intervention|Lost to Follow-up|3|||
130907168|NCT00393042|471294814|FG001|First Intervention|Lost to Follow-up|3|||
130907169|NCT00393042|471294813|FG000|First Intervention|Protocol Violation|1|||
130907170|NCT00393042|471294814|FG001|First Intervention|Protocol Violation|0|||
130907171|NCT00393042|471294813|FG000|First Intervention|Adverse Event|0|||
130907172|NCT00393042|471294814|FG001|First Intervention|Adverse Event|1|||
130907173|NCT00393042|471294813|FG000|Second Intervetion|Adverse Event|0|||
130907174|NCT00393042|471294814|FG001|Second Intervetion|Adverse Event|3|||
130907175|NCT00393042|471294813|FG000|Second Intervetion|Withdrawal by Subject|0|||
130907176|NCT00393042|471294814|FG001|Second Intervetion|Withdrawal by Subject|2|||
130907177|NCT00393042|471294813|FG000|Second Intervetion|Lack of Efficacy|1|||
130907178|NCT00393042|471294814|FG001|Second Intervetion|Lack of Efficacy|0|||
130907179|NCT00393042|471294813|FG000|Second Intervetion|Lost to Follow-up|0|||
130907180|NCT00393042|471294814|FG001|Second Intervetion|Lost to Follow-up|2|||
130907181|NCT00393042|471294813|FG000|Second Intervetion|Protocol Violation|1|||
130907182|NCT00393042|471294814|FG001|Second Intervetion|Protocol Violation|1|||
130907183|NCT01150474|471294819|FG000|Overall Study|Withdrawal by Subject|5|||
130907184|NCT01150474|471294820|FG001|Overall Study|Withdrawal by Subject|2|||
130907185|NCT01150474|471294819|FG000|Overall Study|Cancer found|1|||
130907186|NCT01150474|471294820|FG001|Overall Study|Cancer found|0|||
130907187|NCT01150474|471294819|FG000|Overall Study|Multiple Studies|0|||
130907188|NCT01150474|471294820|FG001|Overall Study|Multiple Studies|1|||
130907189|NCT01150474|471294819|FG000|Overall Study|Rectotomy|1|||
130907190|NCT01150474|471294820|FG001|Overall Study|Rectotomy|0|||
130907191|NCT01150474|471294819|FG000|Overall Study|Drug did not arrive in time|1|||
130907192|NCT01150474|471294820|FG001|Overall Study|Drug did not arrive in time|0|||
130907193|NCT01150474|471294819|FG000|Overall Study|Drug not administered|1|||
130907194|NCT01150474|471294820|FG001|Overall Study|Drug not administered|0|||
130907195|NCT01150474|471294819|FG000|Overall Study|Surgery Changed|1|||
130907196|NCT01150474|471294820|FG001|Overall Study|Surgery Changed|0|||
130907197|NCT01423604|471294821|FG000|Safety Run-In|Adverse Event|3|||
130907198|NCT01423604|471294822|FG001|Safety Run-In|Adverse Event|0|||
130695377|NCT00081653|470509004|FG000|Overall Study|Adverse Event|23|||
130695378|NCT00081653|470509005|FG001|Overall Study|Adverse Event|17|||
130695379|NCT00081653|470509004|FG000|Overall Study|Lost to Follow-up|2|||
130695380|NCT00081653|470509005|FG001|Overall Study|Lost to Follow-up|4|||
130695381|NCT00081653|470509004|FG000|Overall Study|Refused Treatment|18|||
130695382|NCT00081653|470509005|FG001|Overall Study|Refused Treatment|14|||
130695383|NCT00081653|470509004|FG000|Overall Study|Low bone mineral density|1|||
130695384|NCT00081653|470509005|FG001|Overall Study|Low bone mineral density|0|||
130695385|NCT00081653|470509004|FG000|Overall Study|Bone loss|2|||
130695386|NCT00081653|470509005|FG001|Overall Study|Bone loss|0|||
130695387|NCT00081653|470509004|FG000|Overall Study|Participant leaving country|1|||
130695388|NCT00081653|470509005|FG001|Overall Study|Participant leaving country|0|||
130695389|NCT00081653|470509004|FG000|Overall Study|Loss of bone mass|0|||
130695390|NCT00081653|470509005|FG001|Overall Study|Loss of bone mass|2|||
130695391|NCT02694536|470509008|FG000|Overall Study|Progressive Disease|40|||
130695392|NCT02694536|470509008|FG000|Overall Study|Lost to Follow-up|1|||
130695393|NCT02694536|470509008|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
130695394|NCT02694536|470509008|FG000|Overall Study|Withdrawal by Subject|8|||
130695395|NCT02694536|470509008|FG000|Overall Study|Death|8|||
130695396|NCT02694536|470509008|FG000|Overall Study|Other|22|||
130695397|NCT01911429|470509013|FG000|Overall Study|Adverse Event|5|||
130695398|NCT01911429|470509014|FG001|Overall Study|Adverse Event|3|||
130695399|NCT01911429|470509015|FG002|Overall Study|Adverse Event|9|||
130695400|NCT01911429|470509013|FG000|Overall Study|Lack of Efficacy|1|||
130695401|NCT01911429|470509014|FG001|Overall Study|Lack of Efficacy|2|||
130695402|NCT01911429|470509015|FG002|Overall Study|Lack of Efficacy|4|||
130695403|NCT01911429|470509013|FG000|Overall Study|Lost to Follow-up|0|||
130695404|NCT01911429|470509014|FG001|Overall Study|Lost to Follow-up|0|||
130695405|NCT01911429|470509015|FG002|Overall Study|Lost to Follow-up|1|||
130695406|NCT01911429|470509013|FG000|Overall Study|Protocol Violation|0|||
130695407|NCT01911429|470509014|FG001|Overall Study|Protocol Violation|0|||
130695408|NCT01911429|470509015|FG002|Overall Study|Protocol Violation|1|||
130695409|NCT01911429|470509013|FG000|Overall Study|Withdrawal by Subject|5|||
131114790|NCT01641809|472052166|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
131114791|NCT01641809|472052167|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
131114792|NCT01641809|472052164|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
131114793|NCT01641809|472052165|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
131114794|NCT01641809|472052166|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
131114795|NCT01641809|472052167|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
131114796|NCT01641809|472052164|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
131114797|NCT01641809|472052165|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
131114798|NCT01641809|472052166|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
131114799|NCT01641809|472052167|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
131114800|NCT01641809|472052164|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
131114801|NCT01641809|472052165|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
131114802|NCT01641809|472052166|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
131114803|NCT01641809|472052167|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
131114804|NCT01641809|472052164|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
131114805|NCT01641809|472052165|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
131114806|NCT01641809|472052166|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
131114807|NCT01641809|472052167|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
131114808|NCT01641809|472052164|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
131114809|NCT01641809|472052165|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
131114810|NCT01641809|472052166|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
131114811|NCT01641809|472052167|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
131114812|NCT03690141|472052168|FG000|Overall Study|Adverse Event|5|||
131114813|NCT03690141|472052168|FG000|Overall Study|Withdrawal by Subject|3|||
131114814|NCT03690141|472052168|FG000|Overall Study|Physician Decision|4|||
131114815|NCT03690141|472052168|FG000|Overall Study|Disease progression|4|||
131114816|NCT01807923|472052169|FG000|Overall Study|Adverse Event|2|||
131114817|NCT01807923|472052170|FG001|Overall Study|Adverse Event|1|||
131114818|NCT01807923|472052171|FG002|Overall Study|Adverse Event|2|||
131114819|NCT01807923|472052169|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130695410|NCT01911429|470509014|FG001|Overall Study|Withdrawal by Subject|5|||
130695411|NCT01911429|470509015|FG002|Overall Study|Withdrawal by Subject|4|||
130695412|NCT01911429|470509013|FG000|Overall Study|Accidental randomization|0|||
130695413|NCT01911429|470509014|FG001|Overall Study|Accidental randomization|0|||
131114820|NCT01807923|472052170|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
131114821|NCT01807923|472052171|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
131114822|NCT01807923|472052169|FG000|Overall Study|Physician Decision|0|||
130695414|NCT01911429|470509015|FG002|Overall Study|Accidental randomization|1|||
130695415|NCT01911429|470509013|FG000|Overall Study|subject left study|1|||
130695416|NCT01911429|470509014|FG001|Overall Study|subject left study|0|||
130695417|NCT01911429|470509015|FG002|Overall Study|subject left study|0|||
130695418|NCT01557751|470509021|FG000|Overall Study|Physician Decision|3|||
130695419|NCT01168856|470509028|FG000|Overall Study|Lost to Follow-up|4|||
130695420|NCT01168856|470509029|FG001|Overall Study|Lost to Follow-up|34|||
130695421|NCT01168856|470509028|FG000|Overall Study|Withdrawal by Subject|6|||
130695422|NCT01168856|470509029|FG001|Overall Study|Withdrawal by Subject|8|||
130695423|NCT01168856|470509028|FG000|Overall Study|Physician Decision|2|||
130695424|NCT01168856|470509029|FG001|Overall Study|Physician Decision|1|||
130695425|NCT01168856|470509028|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
130695426|NCT01168856|470509029|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
130695427|NCT01168856|470509028|FG000|Overall Study|Participant received anti-HCV treatment|1|||
130695428|NCT01168856|470509029|FG001|Overall Study|Participant received anti-HCV treatment|0|||
130695429|NCT01168856|470509028|FG000|Overall Study|Death|0|||
130695430|NCT01168856|470509029|FG001|Overall Study|Death|2|||
130695431|NCT01168856|470509028|FG000|Overall Study|Other|1|||
130695432|NCT01168856|470509029|FG001|Overall Study|Other|291|||
130695433|NCT01168856|470509028|FG000|Overall Study|Protocol Violation|4|||
130695434|NCT01168856|470509029|FG001|Overall Study|Protocol Violation|6|||
130695435|NCT04567329|470509034|FG000|Overall Study|Withdrawal by Subject|5|||
130695436|NCT04567329|470509035|FG001|Overall Study|Withdrawal by Subject|6|||
130695437|NCT04567329|470509034|FG000|Overall Study|Protocol Violation|2|||
130695438|NCT04567329|470509035|FG001|Overall Study|Protocol Violation|3|||
130695439|NCT04567329|470509034|FG000|Overall Study|Discontinued|2|||
130695440|NCT04567329|470509035|FG001|Overall Study|Discontinued|2|||
130695441|NCT04567329|470509034|FG000|Overall Study|Lost to Follow-up|0|||
130695442|NCT04567329|470509035|FG001|Overall Study|Lost to Follow-up|1|||
130695443|NCT04567329|470509034|FG000|Overall Study|Lack of Efficacy|0|||
130695444|NCT04567329|470509035|FG001|Overall Study|Lack of Efficacy|1|||
130768481|NCT00564278|470776677|FG001|Overall Study|Lost to Follow-up|33|||
130768482|NCT00564278|470776676|FG000|Overall Study|Physician Decision|1|||
130768483|NCT00564278|470776677|FG001|Overall Study|Physician Decision|2|||
130768484|NCT00564278|470776676|FG000|Overall Study|Withdrawal by Subject|11|||
130695449|NCT01559363|470509057|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
130695450|NCT01559363|470509058|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
130695451|NCT01559363|470509059|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
130695452|NCT01559363|470509060|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
130695453|NCT01559363|470509061|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
130695454|NCT01559363|470509062|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
130695455|NCT01559363|470509057|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
130695456|NCT01559363|470509058|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
130695457|NCT01559363|470509059|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
130695458|NCT01559363|470509060|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
130695459|NCT01559363|470509061|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
130695460|NCT01559363|470509062|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
130695461|NCT01559363|470509057|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
130695462|NCT01559363|470509058|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
130695463|NCT01559363|470509059|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130695464|NCT01559363|470509060|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130907199|NCT01423604|471294821|FG000|Safety Run-In|Death|1|||
130907200|NCT01423604|471294822|FG001|Safety Run-In|Death|0|||
130907201|NCT01423604|471294821|FG000|Safety Run-In|Physician Decision|1|||
130907202|NCT01423604|471294822|FG001|Safety Run-In|Physician Decision|0|||
130907203|NCT01423604|471294821|FG000|Safety Run-In|Disease progression|3|||
130907204|NCT01423604|471294822|FG001|Safety Run-In|Disease progression|0|||
130907205|NCT01423604|471294821|FG000|Safety Run-In|Patient decision|1|||
130907206|NCT01423604|471294822|FG001|Safety Run-In|Patient decision|0|||
130907207|NCT01423604|471294821|FG000|Randomized|Adverse Event|4|||
130907208|NCT01423604|471294822|FG001|Randomized|Adverse Event|10|||
130907209|NCT01423604|471294821|FG000|Randomized|Death|1|||
130907210|NCT01423604|471294822|FG001|Randomized|Death|0|||
130907211|NCT01423604|471294821|FG000|Randomized|Physician Decision|16|||
130907212|NCT01423604|471294822|FG001|Randomized|Physician Decision|13|||
130907213|NCT01423604|471294821|FG000|Randomized|Other - unspecified|37|||
130907214|NCT01423604|471294822|FG001|Randomized|Other - unspecified|31|||
131028545|NCT05919082|471736574|FG000|Overall Study|Lack of Efficacy|0|||
131028546|NCT05919082|471736575|FG001|Overall Study|Lack of Efficacy|1|||
131028547|NCT05919082|471736574|FG000|Overall Study|Investigator Decision|1|||
130695465|NCT01559363|470509061|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130695466|NCT01559363|470509062|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130695467|NCT01559363|470509057|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
130907215|NCT01423604|471294821|FG000|Randomized|Patient decision|5|||
130907216|NCT01423604|471294822|FG001|Randomized|Patient decision|9|||
130907217|NCT00424255|471294823|FG000|Overall Study|Death|115|||
131028548|NCT05919082|471736575|FG001|Overall Study|Investigator Decision|0|||
131028549|NCT01707030|471736579|FG000|Overall Study|Death|1|||
130695468|NCT01559363|470509058|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130695469|NCT01559363|470509059|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
130768485|NCT00564278|470776677|FG001|Overall Study|Withdrawal by Subject|7|||
130768486|NCT03341936|470776678|FG000|Overall Study|Ineligible|1|||
130695470|NCT01559363|470509060|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130695471|NCT01559363|470509061|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130695472|NCT01559363|470509062|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130695473|NCT01559363|470509057|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130695474|NCT01559363|470509058|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
130695475|NCT01559363|470509059|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130695476|NCT01559363|470509060|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130695477|NCT01559363|470509061|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130695478|NCT01559363|470509062|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130695479|NCT01559363|470509057|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130695480|NCT01559363|470509058|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130695481|NCT01559363|470509059|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130695482|NCT01559363|470509060|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
130695483|NCT01559363|470509061|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
130695484|NCT01559363|470509062|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130695485|NCT01559363|470509057|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130695486|NCT01559363|470509058|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130695487|NCT01559363|470509059|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130695488|NCT01559363|470509060|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
130695489|NCT01559363|470509061|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130695490|NCT01559363|470509062|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130695491|NCT00672984|470509063|FG000|First Intervention|Adverse Event|5|||
130695492|NCT00672984|470509064|FG001|First Intervention|Adverse Event|0|||
130695493|NCT00672984|470509065|FG002|First Intervention|Adverse Event|0|||
130695494|NCT00672984|470509063|FG000|First Intervention|Withdrawal by Subject|1|||
130768487|NCT03341936|470776678|FG000|Overall Study|Disease Progression|2|||
130907218|NCT00424255|471294824|FG001|Overall Study|Death|111|||
130907219|NCT00424255|471294823|FG000|Overall Study|Lost to Follow-up|26|||
130907220|NCT00424255|471294824|FG001|Overall Study|Lost to Follow-up|20|||
130907221|NCT00424255|471294823|FG000|Overall Study|Protocol Violation|0|||
130907222|NCT00424255|471294824|FG001|Overall Study|Protocol Violation|1|||
130907223|NCT00424255|471294823|FG000|Overall Study|Withdrawal by Subject|34|||
130907224|NCT00424255|471294824|FG001|Overall Study|Withdrawal by Subject|38|||
130907225|NCT00424255|471294823|FG000|Overall Study|Physician Decision|3|||
130907226|NCT00424255|471294824|FG001|Overall Study|Physician Decision|7|||
130907227|NCT00424255|471294823|FG000|Overall Study|Cognitive Disturbance|1|||
130907228|NCT00424255|471294824|FG001|Overall Study|Cognitive Disturbance|0|||
130907229|NCT00424255|471294823|FG000|Overall Study|Non-compliance by Participants|1|||
130907230|NCT00424255|471294824|FG001|Overall Study|Non-compliance by Participants|0|||
130695495|NCT00672984|470509064|FG001|First Intervention|Withdrawal by Subject|2|||
130768488|NCT03341936|470776678|FG000|Overall Study|Withdrew Consent|4|||
130907231|NCT00424255|471294823|FG000|Overall Study|Fatigue|1|||
130907232|NCT00424255|471294824|FG001|Overall Study|Fatigue|0|||
131028550|NCT01707030|471736580|FG001|Overall Study|Death|1|||
131028551|NCT01707030|471736579|FG000|Overall Study|Withdrawal by Subject|2|||
131028552|NCT01707030|471736580|FG001|Overall Study|Withdrawal by Subject|3|||
131028553|NCT01707030|471736579|FG000|Overall Study|Lost to Follow-up|8|||
131028554|NCT01707030|471736580|FG001|Overall Study|Lost to Follow-up|13|||
131028555|NCT04820855|471736581|FG000|Overall Study|Lost to Follow-up|6|||
131028556|NCT04820855|471736582|FG001|Overall Study|Lost to Follow-up|9|||
131028557|NCT00650104|471736584|FG000|Overall Study|Adverse Event|17|||
131028558|NCT00650104|471736584|FG000|Overall Study|Death|2|||
131028559|NCT00650104|471736584|FG000|Overall Study|Withdrawal by Subject|11|||
131028560|NCT00650104|471736584|FG000|Overall Study|Physician Decision|7|||
131028561|NCT00650104|471736584|FG000|Overall Study|Lost to Follow-up|1|||
131028562|NCT00650104|471736584|FG000|Overall Study|Non-compliance|2|||
131028563|NCT00650104|471736584|FG000|Overall Study|Sponsor Terminated Dosing|1|||
131028564|NCT00601900|471736596|FG000|Overall Study|Withdrawal by Subject|0|||
131028565|NCT00601900|471736597|FG001|Overall Study|Withdrawal by Subject|3|||
131028566|NCT02500758|471736606|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
131028567|NCT02500758|471736607|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
131028568|NCT02500758|471736606|FG000|Washout (1 Week)|Lost to Follow-up|2|||
131028569|NCT02500758|471736607|FG001|Washout (1 Week)|Lost to Follow-up|2|||
131028570|NCT02500758|471736606|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
131028571|NCT02500758|471736607|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
131028572|NCT02500758|471736606|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
131028573|NCT02500758|471736607|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
131028574|NCT02500758|471736606|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
130768489|NCT03341936|470776678|FG000|Overall Study|Non-Compliance|1|||
130768490|NCT03341936|470776678|FG000|Overall Study|Physician Decision|1|||
131028575|NCT02500758|471736607|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
131028576|NCT00274469|471736609|FG000|Overall Study|Death|63|||
131028577|NCT00274469|471736610|FG001|Overall Study|Death|74|||
131028578|NCT00274469|471736609|FG000|Overall Study|Did not consent to OS follow-up|16|||
130907233|NCT00424255|471294823|FG000|Overall Study|Disease Progression|0|||
130907234|NCT00424255|471294824|FG001|Overall Study|Disease Progression|2|||
130907235|NCT00424255|471294823|FG000|Overall Study|Sponsor Terminated Study|161|||
130907236|NCT00424255|471294824|FG001|Overall Study|Sponsor Terminated Study|167|||
130907237|NCT00327470|471294827|FG000|Overall Study|Randomized, but not treated|0|||
130907238|NCT00327470|471294828|FG001|Overall Study|Randomized, but not treated|2|||
130907239|NCT00327470|471294827|FG000|Overall Study|Adverse Event|9|||
130907240|NCT00327470|471294828|FG001|Overall Study|Adverse Event|14|||
130907241|NCT00327470|471294827|FG000|Overall Study|Lack of Efficacy|7|||
130907242|NCT00327470|471294828|FG001|Overall Study|Lack of Efficacy|19|||
130907243|NCT00327470|471294827|FG000|Overall Study|Other|5|||
130907244|NCT00327470|471294828|FG001|Overall Study|Other|9|||
130907245|NCT00327470|471294827|FG000|Overall Study|Lost to Follow-up|1|||
130907246|NCT00327470|471294828|FG001|Overall Study|Lost to Follow-up|3|||
130907247|NCT00327470|471294827|FG000|Overall Study|Withdrawal by Subject|6|||
130907248|NCT00327470|471294828|FG001|Overall Study|Withdrawal by Subject|12|||
130907249|NCT00327470|471294827|FG000|Overall Study|Death|1|||
130907250|NCT00327470|471294828|FG001|Overall Study|Death|4|||
130907251|NCT01226121|471294829|FG000|Overall Study|Lost to Follow-up|2|||
130907252|NCT01226121|471294830|FG001|Overall Study|Lost to Follow-up|0|||
130907253|NCT01226121|471294831|FG002|Overall Study|Lost to Follow-up|1|||
130907254|NCT00782795|471294832|FG000|Overall Study|Withdrawal by Subject|1|||
130907255|NCT00782795|471294833|FG001|Overall Study|Withdrawal by Subject|2|||
130907256|NCT03150485|471296405|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
130907257|NCT03150485|471296406|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
130907258|NCT03150485|471296407|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
130907259|NCT03150485|471296408|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
131028579|NCT00274469|471736610|FG001|Overall Study|Did not consent to OS follow-up|19|||
131028580|NCT04093752|471736614|FG000|Overall Study|Adverse Event|7|||
131028581|NCT04093752|471736615|FG001|Overall Study|Adverse Event|19|||
131028582|NCT04093752|471736616|FG002|Overall Study|Adverse Event|18|||
131028583|NCT04093752|471736617|FG003|Overall Study|Adverse Event|4|||
131028584|NCT04093752|471736614|FG000|Overall Study|Withdrawal by Subject|6|||
131028585|NCT04093752|471736615|FG001|Overall Study|Withdrawal by Subject|6|||
131028586|NCT04093752|471736616|FG002|Overall Study|Withdrawal by Subject|8|||
131028587|NCT04093752|471736617|FG003|Overall Study|Withdrawal by Subject|20|||
131028588|NCT04093752|471736614|FG000|Overall Study|Lost to Follow-up|2|||
131028589|NCT04093752|471736615|FG001|Overall Study|Lost to Follow-up|1|||
131028590|NCT04093752|471736616|FG002|Overall Study|Lost to Follow-up|1|||
131028591|NCT04093752|471736617|FG003|Overall Study|Lost to Follow-up|1|||
131028592|NCT04093752|471736614|FG000|Overall Study|Death|0|||
131028593|NCT04093752|471736615|FG001|Overall Study|Death|0|||
131028594|NCT04093752|471736616|FG002|Overall Study|Death|1|||
131028595|NCT04093752|471736617|FG003|Overall Study|Death|2|||
131028596|NCT04093752|471736614|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
131028597|NCT04093752|471736615|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
131028598|NCT04093752|471736616|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
131028599|NCT04093752|471736617|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
131028600|NCT04093752|471736614|FG000|Overall Study|Covid 19|0|||
131028601|NCT04093752|471736615|FG001|Overall Study|Covid 19|0|||
131028602|NCT04093752|471736616|FG002|Overall Study|Covid 19|0|||
131028603|NCT04093752|471736617|FG003|Overall Study|Covid 19|1|||
131028604|NCT04093752|471736614|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
131028605|NCT04093752|471736615|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
131028606|NCT04093752|471736616|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
131028607|NCT04093752|471736617|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
131028608|NCT04093752|471736614|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
131028609|NCT04093752|471736615|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
131028610|NCT04093752|471736616|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
131028611|NCT04093752|471736617|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
131028612|NCT04093752|471736614|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
131028613|NCT04093752|471736615|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
131028614|NCT04093752|471736616|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
131028615|NCT04093752|471736617|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
131028616|NCT02140645|471736619|FG000|Overall Study|Not linked|5489|||
131028617|NCT02140645|471736620|FG001|Overall Study|Not linked|61654|||
131028618|NCT02140645|471736621|FG002|Overall Study|Not linked|4236|||
131028619|NCT02140645|471736622|FG003|Overall Study|Not linked|13833|||
130907260|NCT03150485|471296409|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
130907261|NCT03150485|471296410|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
130907262|NCT01394718|471296414|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
130907263|NCT01394718|471296415|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
130907264|NCT01547780|471296416|FG000|Baseline PET Scan|Physician Decision|1|||
130907265|NCT01547780|471296417|FG001|Baseline PET Scan|Physician Decision|0|||
131028620|NCT02140645|471736623|FG004|Overall Study|Not linked|3286|||
130695496|NCT00672984|470509065|FG002|First Intervention|Withdrawal by Subject|2|||
130695497|NCT00672984|470509063|FG000|First Intervention|Sponsor decision|3|||
130695498|NCT00672984|470509064|FG001|First Intervention|Sponsor decision|0|||
130695499|NCT00672984|470509065|FG002|First Intervention|Sponsor decision|0|||
130695500|NCT00672984|470509063|FG000|Second Intervention|Non-compliance with facility policies|0|||
130695501|NCT00672984|470509064|FG001|Second Intervention|Non-compliance with facility policies|2|||
130695502|NCT00672984|470509065|FG002|Second Intervention|Non-compliance with facility policies|0|||
130695503|NCT00672984|470509063|FG000|Second Intervention|Withdrawal by Subject|0|||
130907266|NCT01547780|471296418|FG002|Baseline PET Scan|Physician Decision|1|||
130907267|NCT01547780|471296419|FG003|Baseline PET Scan|Physician Decision|0|||
130907268|NCT01547780|471296416|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
130907269|NCT01547780|471296417|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
130907270|NCT01547780|471296418|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
130907271|NCT01547780|471296419|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
130907272|NCT00588952|471296420|FG000|Overall Study|Adverse Event|0|||
130907273|NCT00588952|471296421|FG001|Overall Study|Adverse Event|2|||
130907274|NCT00588952|471296420|FG000|Overall Study|Withdrawal by Subject|3|||
130907275|NCT00588952|471296421|FG001|Overall Study|Withdrawal by Subject|5|||
130907276|NCT01362595|471296422|FG000|Overall Study|Screen failure|10|||
130907277|NCT01362595|471296422|FG000|Overall Study|Withdrawal by Subject|2|||
130907278|NCT02469038|471296423|FG000|Overall Study|Physician Decision|4|||
130907279|NCT02469038|471296424|FG001|Overall Study|Physician Decision|5|||
130907280|NCT00636987|471296425|FG000|Overall Study|Death|44|||
130907281|NCT00636987|471296425|FG000|Overall Study|Explanted|13|||
130907282|NCT00636987|471296425|FG000|Overall Study|Lost to Follow-up|63|||
130907283|NCT00636987|471296425|FG000|Overall Study|5 year visit window not complete|69|||
130907284|NCT01251146|471296426|FG000|Overall Study|Lost to Follow-up|3|||
130907285|NCT01251146|471296427|FG001|Overall Study|Lost to Follow-up|10|||
130907286|NCT01739400|471296428|FG000|Overall Study|Physician Decision|3|||
130907287|NCT01739400|471296429|FG001|Overall Study|Physician Decision|0|||
130907288|NCT01739400|471296428|FG000|Overall Study|Lost to Follow-up|2|||
130907289|NCT01739400|471296429|FG001|Overall Study|Lost to Follow-up|0|||
130907290|NCT01739400|471296428|FG000|Overall Study|Death|5|||
130907291|NCT01739400|471296429|FG001|Overall Study|Death|2|||
130907292|NCT01739400|471296428|FG000|Overall Study|Withdrawal by Subject|7|||
130907293|NCT01739400|471296429|FG001|Overall Study|Withdrawal by Subject|7|||
130907294|NCT02284178|471296431|FG000|Overall Study|Met exclusion criteria|49|||
130907295|NCT02284178|471296432|FG001|Overall Study|Met exclusion criteria|54|||
130907296|NCT01083173|471296445|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
130907297|NCT01083173|471296446|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
130907298|NCT01083173|471296445|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
130907299|NCT01083173|471296446|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
130907300|NCT01083173|471296445|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
130907301|NCT01083173|471296446|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
130907302|NCT01083173|471296445|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
130907303|NCT01083173|471296446|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
130907304|NCT01083173|471296445|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
130907305|NCT01083173|471296446|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
130907306|NCT01083173|471296445|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
130907307|NCT01083173|471296446|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
130907308|NCT01083173|471296445|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
130907309|NCT01083173|471296446|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
130907310|NCT01083173|471296445|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
130907311|NCT01083173|471296446|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
130907312|NCT01083173|471296445|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
130907313|NCT01083173|471296446|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
130907314|NCT01083173|471296445|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
130907315|NCT01083173|471296446|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
130907316|NCT01083173|471296445|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
130695504|NCT00672984|470509064|FG001|Second Intervention|Withdrawal by Subject|3|||
130907317|NCT01083173|471296446|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
130907318|NCT03410823|471296449|FG000|Overall Study|Death|1|||
130907319|NCT03410823|471296449|FG000|Overall Study|Withdrawal by Subject|2|||
130907320|NCT03410823|471296449|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
130907321|NCT05128929|471296451|FG000|Overall Study|Adverse Event|0|||
130907322|NCT05128929|471296452|FG001|Overall Study|Adverse Event|1|||
130907323|NCT02742246|471296453|FG000|Overall Study|Never initiated treatment|5|||
130907324|NCT02742246|471296454|FG001|Overall Study|Never initiated treatment|3|||
130907325|NCT02742246|471296455|FG002|Overall Study|Never initiated treatment|1|||
130695505|NCT00672984|470509065|FG002|Second Intervention|Withdrawal by Subject|0|||
130907326|NCT02742246|471296453|FG000|Overall Study|dropped out during treatment|7|||
130907327|NCT02742246|471296454|FG001|Overall Study|dropped out during treatment|13|||
130907328|NCT02742246|471296455|FG002|Overall Study|dropped out during treatment|10|||
130907329|NCT02742246|471296453|FG000|Overall Study|Death|1|||
130907330|NCT02742246|471296454|FG001|Overall Study|Death|0|||
130907331|NCT02742246|471296455|FG002|Overall Study|Death|0|||
130907332|NCT03553836|471296457|FG000|Overall Study|Ongoing in Study|460|||
130907333|NCT03553836|471296458|FG001|Overall Study|Ongoing in Study|459|||
130907334|NCT03553836|471296457|FG000|Overall Study|Withdrawal by Subject|9|||
130907335|NCT03553836|471296458|FG001|Overall Study|Withdrawal by Subject|10|||
130907336|NCT03553836|471296457|FG000|Overall Study|Lost to Follow-up|1|||
130907337|NCT03553836|471296458|FG001|Overall Study|Lost to Follow-up|3|||
130907338|NCT03553836|471296457|FG000|Overall Study|Death|17|||
130907339|NCT03553836|471296458|FG001|Overall Study|Death|17|||
130907340|NCT03220438|471296459|FG000|Overall Study|Lost to Follow-up|0|||
130907341|NCT03220438|471296460|FG001|Overall Study|Lost to Follow-up|0|||
130907342|NCT03220438|471296461|FG002|Overall Study|Lost to Follow-up|1|||
130907343|NCT03220438|471296462|FG003|Overall Study|Lost to Follow-up|0|||
130907344|NCT04062123|471296463|FG000|Overall Study|Withdrawal by Subject|0|||
130907345|NCT04062123|471296464|FG001|Overall Study|Withdrawal by Subject|1|||
130907346|NCT04062123|471296465|FG002|Overall Study|Withdrawal by Subject|0|||
130907347|NCT01041495|471296467|FG000|Overall Study|Withdrawal by Subject|2|||
130907348|NCT01041495|471296468|FG001|Overall Study|Withdrawal by Subject|5|||
130907349|NCT01041495|471296467|FG000|Overall Study|Adverse Event|2|||
130907350|NCT01041495|471296468|FG001|Overall Study|Adverse Event|1|||
130907351|NCT01041495|471296467|FG000|Overall Study|Lost to Follow-up|0|||
130907352|NCT01041495|471296468|FG001|Overall Study|Lost to Follow-up|1|||
130907353|NCT03584373|471296469|FG000|Overall Study|Lost to Follow-up|7|||
130907354|NCT03584373|471296470|FG001|Overall Study|Lost to Follow-up|8|||
130907355|NCT01487577|471296471|FG000|Overall Study|Became ineligible after signing consent|1|||
130907356|NCT03780400|471296475|FG000|Overall Study|Lost to Follow-up|5|||
130907357|NCT03780400|471296475|FG000|Overall Study|Withdrawal by Subject|2|||
130907358|NCT01479985|471296476|FG000|Overall Study|Tablet malfunction, no data saved|1|||
130907359|NCT01479985|471296477|FG001|Overall Study|Tablet malfunction, no data saved|1|||
130907360|NCT01479985|471296476|FG000|Overall Study|No decisional conflict scale responses|0|||
130907361|NCT01479985|471296477|FG001|Overall Study|No decisional conflict scale responses|2|||
130907362|NCT01479985|471296476|FG000|Overall Study|No post-visit survey|5|||
130907363|NCT01479985|471296477|FG001|Overall Study|No post-visit survey|3|||
130907364|NCT00662532|471296481|FG000|Overall Study|Adverse Event|0|||
130907365|NCT00662532|471296482|FG001|Overall Study|Adverse Event|1|||
130907366|NCT00662532|471296481|FG000|Overall Study|Lost to Follow-up|0|||
130907367|NCT00662532|471296482|FG001|Overall Study|Lost to Follow-up|1|||
130907368|NCT03823378|471296483|FG000|Overall Study|Adverse Event|2|||
130907369|NCT03823378|471296484|FG001|Overall Study|Adverse Event|2|||
130907370|NCT03823378|471296485|FG002|Overall Study|Adverse Event|0|||
130907371|NCT03823378|471296486|FG003|Overall Study|Adverse Event|0|||
130907372|NCT03823378|471296487|FG004|Overall Study|Adverse Event|0|||
130907373|NCT03823378|471296488|FG005|Overall Study|Adverse Event|0|||
130907374|NCT03823378|471296483|FG000|Overall Study|Lost to Follow-up|0|||
130907375|NCT03823378|471296484|FG001|Overall Study|Lost to Follow-up|1|||
130907376|NCT03823378|471296485|FG002|Overall Study|Lost to Follow-up|0|||
130907377|NCT03823378|471296486|FG003|Overall Study|Lost to Follow-up|0|||
130907378|NCT03823378|471296487|FG004|Overall Study|Lost to Follow-up|1|||
130907379|NCT03823378|471296488|FG005|Overall Study|Lost to Follow-up|0|||
131028621|NCT02140645|471736624|FG005|Overall Study|Not linked|70896|||
131028622|NCT01101451|471736625|FG000|Overall Study|Eligible and never treated|0|||
131028623|NCT01101451|471736626|FG001|Overall Study|Eligible and never treated|5|||
131028624|NCT01101451|471736625|FG000|Overall Study|Ineligible and treated|12|||
131028625|NCT01101451|471736626|FG001|Overall Study|Ineligible and treated|8|||
131028626|NCT01101451|471736625|FG000|Overall Study|Ineligible and never treated|2|||
131028627|NCT01101451|471736626|FG001|Overall Study|Ineligible and never treated|2|||
131222764|NCT00386100|472443176|FG001|Overall Study|Laboratory findings|0|||
130768491|NCT03341936|470776678|FG000|Overall Study|Withdrawal by Subject|1|||
130907380|NCT03823378|471296483|FG000|Overall Study|Withdrawal by Subject|0|||
130907381|NCT03823378|471296484|FG001|Overall Study|Withdrawal by Subject|1|||
130907382|NCT03823378|471296485|FG002|Overall Study|Withdrawal by Subject|4|||
130907383|NCT03823378|471296486|FG003|Overall Study|Withdrawal by Subject|2|||
130907384|NCT03823378|471296487|FG004|Overall Study|Withdrawal by Subject|0|||
130907385|NCT03823378|471296488|FG005|Overall Study|Withdrawal by Subject|1|||
130907386|NCT03823378|471296483|FG000|Overall Study|Other, not specified|19|||
130907387|NCT03823378|471296484|FG001|Overall Study|Other, not specified|12|||
130907388|NCT03823378|471296485|FG002|Overall Study|Other, not specified|6|||
130907389|NCT03823378|471296486|FG003|Overall Study|Other, not specified|8|||
130907390|NCT03823378|471296487|FG004|Overall Study|Other, not specified|17|||
130907391|NCT03823378|471296488|FG005|Overall Study|Other, not specified|7|||
130907392|NCT01282203|471296489|FG000|Overall Study|Adverse Event|1|||
131114823|NCT01807923|472052170|FG001|Overall Study|Physician Decision|0|||
130907393|NCT00058539|471296492|FG000|Overall Study|Disease progression|24|||
130907394|NCT00058539|471296492|FG000|Overall Study|Adverse Event|3|||
130907395|NCT00058539|471296492|FG000|Overall Study|Withdrawal by Subject|5|||
130907396|NCT00058539|471296492|FG000|Overall Study|Physician Decision|9|||
130907397|NCT00058539|471296492|FG000|Overall Study|Death|1|||
130907398|NCT02963831|471296493|FG000|Overall Study|Progressive Disease|3|||
130907399|NCT02963831|471296494|FG001|Overall Study|Progressive Disease|3|||
130907400|NCT02963831|471296495|FG002|Overall Study|Progressive Disease|16|||
130907401|NCT02963831|471296496|FG003|Overall Study|Progressive Disease|27|||
130907402|NCT02963831|471296493|FG000|Overall Study|Withdrawal by Subject|1|||
130907403|NCT02963831|471296494|FG001|Overall Study|Withdrawal by Subject|0|||
131114824|NCT01807923|472052171|FG002|Overall Study|Physician Decision|1|||
131114825|NCT01807923|472052169|FG000|Overall Study|Not Eligible (Genotype)|0|||
131114826|NCT01807923|472052170|FG001|Overall Study|Not Eligible (Genotype)|0|||
131114827|NCT01807923|472052171|FG002|Overall Study|Not Eligible (Genotype)|1|||
131114828|NCT01807923|472052169|FG000|Overall Study|Randomized But Not Treated|3|||
131114829|NCT01807923|472052170|FG001|Overall Study|Randomized But Not Treated|2|||
130695506|NCT00672984|470509063|FG000|Second Intervention|Protocol Violation|0|||
131114830|NCT01807923|472052171|FG002|Overall Study|Randomized But Not Treated|5|||
131114831|NCT02014740|472052175|FG000|Overall Study|Lost to Follow-up|4|||
131114832|NCT02014740|472052176|FG001|Overall Study|Lost to Follow-up|4|||
131114833|NCT02014740|472052175|FG000|Overall Study|Withdrawal by Subject|2|||
131114834|NCT02014740|472052176|FG001|Overall Study|Withdrawal by Subject|1|||
131114835|NCT02742766|472052177|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114836|NCT02742766|472052178|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114837|NCT02742766|472052179|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114838|NCT02742766|472052180|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114839|NCT02742766|472052181|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114840|NCT02742766|472052182|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114841|NCT02742766|472052183|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114842|NCT02742766|472052184|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114843|NCT02742766|472052185|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114844|NCT02742766|472052186|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114845|NCT02742766|472052187|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114846|NCT02742766|472052188|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114847|NCT02742766|472052189|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114848|NCT02742766|472052190|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
131114849|NCT02742766|472052191|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114850|NCT02742766|472052192|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114851|NCT02742766|472052193|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114852|NCT02742766|472052194|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114853|NCT02742766|472052195|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
131114854|NCT02742766|472052177|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114855|NCT02742766|472052178|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114856|NCT02742766|472052179|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
130695507|NCT00672984|470509064|FG001|Second Intervention|Protocol Violation|1|||
130695508|NCT00672984|470509065|FG002|Second Intervention|Protocol Violation|1|||
130695509|NCT00672984|470509063|FG000|Third Intervention|Adverse Event|1|||
130695510|NCT00672984|470509064|FG001|Third Intervention|Adverse Event|0|||
130695511|NCT00672984|470509065|FG002|Third Intervention|Adverse Event|1|||
130695512|NCT04060251|470509066|FG000|Overall Study|Study terminated due to low enrollment.|7|||
130695513|NCT04060251|470509067|FG001|Overall Study|Study terminated due to low enrollment.|5|||
130695514|NCT04060251|470509068|FG002|Overall Study|Study terminated due to low enrollment.|7|||
130695515|NCT04060251|470509066|FG000|Overall Study|Adverse Event|1|||
130695516|NCT04060251|470509067|FG001|Overall Study|Adverse Event|1|||
130695517|NCT04060251|470509068|FG002|Overall Study|Adverse Event|0|||
130695518|NCT00487435|470509069|FG000|Overall Study|Adverse Event|146|||
130695519|NCT00487435|470509069|FG000|Overall Study|Death|2|||
130695520|NCT00487435|470509069|FG000|Overall Study|Lack of Efficacy|33|||
130695521|NCT00487435|470509069|FG000|Overall Study|Lost to Follow-up|54|||
130695522|NCT00487435|470509069|FG000|Overall Study|Pregnancy|2|||
131114857|NCT02742766|472052180|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
130695523|NCT00487435|470509069|FG000|Overall Study|Withdrawal by Subject|132|||
130695524|NCT00487435|470509069|FG000|Overall Study|Resolution Of Pain|1|||
131114858|NCT02742766|472052181|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114859|NCT02742766|472052182|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114860|NCT02742766|472052183|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
130695525|NCT00487435|470509069|FG000|Overall Study|Study Medication Non-Compliant|32|||
130907404|NCT02963831|471296495|FG002|Overall Study|Withdrawal by Subject|2|||
130907405|NCT02963831|471296496|FG003|Overall Study|Withdrawal by Subject|4|||
130907406|NCT02963831|471296493|FG000|Overall Study|Adverse Event|0|||
131114861|NCT02742766|472052184|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114862|NCT02742766|472052185|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
130695526|NCT00487435|470509069|FG000|Overall Study|Other|83|||
130907407|NCT02963831|471296494|FG001|Overall Study|Adverse Event|1|||
130907408|NCT02963831|471296495|FG002|Overall Study|Adverse Event|1|||
130907409|NCT02963831|471296496|FG003|Overall Study|Adverse Event|2|||
130907410|NCT02963831|471296493|FG000|Overall Study|Death|0|||
130907411|NCT02963831|471296494|FG001|Overall Study|Death|0|||
130907412|NCT02963831|471296495|FG002|Overall Study|Death|0|||
130907413|NCT02963831|471296496|FG003|Overall Study|Death|2|||
130907414|NCT03977454|471296497|FG000|Overall Study|immediate postoperative revision|2|||
130907415|NCT03977454|471296498|FG001|Overall Study|immediate postoperative revision|2|||
130907416|NCT04365257|471296499|FG000|Overall Study|Physician Decision|1|||
130907417|NCT04365257|471296500|FG001|Overall Study|Physician Decision|0|||
130907418|NCT04365257|471296499|FG000|Overall Study|Patient Noncompliance|1|||
130907419|NCT04365257|471296500|FG001|Overall Study|Patient Noncompliance|0|||
130907420|NCT04365257|471296499|FG000|Overall Study|Withdrawal by Subject|0|||
130907421|NCT04365257|471296500|FG001|Overall Study|Withdrawal by Subject|1|||
130907422|NCT03452527|471296501|FG000|Overall Study|Withdrawal by Subject|1|||
130907423|NCT03452527|471296502|FG001|Overall Study|Withdrawal by Subject|1|||
130907424|NCT03452527|471296501|FG000|Overall Study|Study Terminated|2|||
130907425|NCT03452527|471296502|FG001|Overall Study|Study Terminated|3|||
130907426|NCT02129777|471296503|FG000|Double-Blind Period|Adverse Event|0|||
130907427|NCT02129777|471296504|FG001|Double-Blind Period|Adverse Event|0|||
130907428|NCT02129777|471296505|FG002|Double-Blind Period|Adverse Event|0|||
130907429|NCT02129777|471296506|FG003|Double-Blind Period|Adverse Event|0|||
130907430|NCT02129777|471296507|FG004|Double-Blind Period|Adverse Event|1|||
130907431|NCT02129777|471296508|FG005|Double-Blind Period|Adverse Event|0|||
130907432|NCT02129777|471296509|FG006|Double-Blind Period|Adverse Event|0|||
130907433|NCT02129777|471296503|FG000|Double-Blind Period|Lost to Follow-up|1|||
130907434|NCT02129777|471296504|FG001|Double-Blind Period|Lost to Follow-up|1|||
130907435|NCT02129777|471296505|FG002|Double-Blind Period|Lost to Follow-up|1|||
130907436|NCT02129777|471296506|FG003|Double-Blind Period|Lost to Follow-up|2|||
130907437|NCT02129777|471296507|FG004|Double-Blind Period|Lost to Follow-up|0|||
130907438|NCT02129777|471296508|FG005|Double-Blind Period|Lost to Follow-up|0|||
130907439|NCT02129777|471296509|FG006|Double-Blind Period|Lost to Follow-up|0|||
130907440|NCT02129777|471296503|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130907441|NCT02129777|471296504|FG001|Double-Blind Period|Withdrawal by Subject|4|||
130907442|NCT02129777|471296505|FG002|Double-Blind Period|Withdrawal by Subject|3|||
130907443|NCT02129777|471296506|FG003|Double-Blind Period|Withdrawal by Subject|2|||
130907444|NCT02129777|471296507|FG004|Double-Blind Period|Withdrawal by Subject|3|||
130907445|NCT02129777|471296508|FG005|Double-Blind Period|Withdrawal by Subject|0|||
130907446|NCT02129777|471296509|FG006|Double-Blind Period|Withdrawal by Subject|0|||
130907447|NCT02129777|471296503|FG000|Double-Blind Period|Pregnancy|0|||
130907448|NCT02129777|471296504|FG001|Double-Blind Period|Pregnancy|0|||
130907449|NCT02129777|471296505|FG002|Double-Blind Period|Pregnancy|0|||
130907450|NCT02129777|471296506|FG003|Double-Blind Period|Pregnancy|0|||
130907451|NCT02129777|471296507|FG004|Double-Blind Period|Pregnancy|1|||
130907452|NCT02129777|471296508|FG005|Double-Blind Period|Pregnancy|0|||
130907453|NCT02129777|471296509|FG006|Double-Blind Period|Pregnancy|0|||
130907454|NCT02129777|471296503|FG000|Double-Blind Period|Lack of Efficacy|3|||
130907455|NCT02129777|471296504|FG001|Double-Blind Period|Lack of Efficacy|1|||
130907456|NCT02129777|471296505|FG002|Double-Blind Period|Lack of Efficacy|0|||
130907457|NCT02129777|471296506|FG003|Double-Blind Period|Lack of Efficacy|3|||
130907458|NCT02129777|471296507|FG004|Double-Blind Period|Lack of Efficacy|2|||
130907459|NCT02129777|471296508|FG005|Double-Blind Period|Lack of Efficacy|0|||
130907460|NCT02129777|471296509|FG006|Double-Blind Period|Lack of Efficacy|0|||
130907461|NCT02129777|471296503|FG000|Double-Blind Period|Other|1|||
130907462|NCT02129777|471296504|FG001|Double-Blind Period|Other|2|||
130907463|NCT02129777|471296505|FG002|Double-Blind Period|Other|0|||
130907464|NCT02129777|471296506|FG003|Double-Blind Period|Other|0|||
130907465|NCT02129777|471296507|FG004|Double-Blind Period|Other|0|||
130907466|NCT02129777|471296508|FG005|Double-Blind Period|Other|0|||
131028628|NCT00593489|471736632|FG000|Allocation|did not attend workshop; allocation not|2|||
131028629|NCT00593489|471736633|FG001|Allocation|did not attend workshop; allocation not|1|||
131028630|NCT00073749|471736634|FG000|Overall Study|Disease Progression|2|||
131028631|NCT00073749|471736635|FG001|Overall Study|Disease Progression|0|||
130907467|NCT02129777|471296509|FG006|Double-Blind Period|Other|0|||
130907468|NCT02129777|471296503|FG000|Open-Label Period|Lack of Efficacy|0|||
130907469|NCT02129777|471296504|FG001|Open-Label Period|Lack of Efficacy|0|||
131028632|NCT00073749|471736636|FG002|Overall Study|Disease Progression|3|||
131028633|NCT00073749|471736637|FG003|Overall Study|Disease Progression|2|||
131028634|NCT00073749|471736638|FG004|Overall Study|Disease Progression|3|||
131028635|NCT00073749|471736639|FG005|Overall Study|Disease Progression|1|||
130907470|NCT02129777|471296505|FG002|Open-Label Period|Lack of Efficacy|0|||
130907471|NCT02129777|471296506|FG003|Open-Label Period|Lack of Efficacy|0|||
130907472|NCT02129777|471296507|FG004|Open-Label Period|Lack of Efficacy|0|||
130907473|NCT02129777|471296508|FG005|Open-Label Period|Lack of Efficacy|0|||
131028636|NCT00073749|471736640|FG006|Overall Study|Disease Progression|3|||
130907474|NCT02129777|471296509|FG006|Open-Label Period|Lack of Efficacy|5|||
130907475|NCT02129777|471296503|FG000|Open-Label Period|Lost to Follow-up|0|||
130907476|NCT02129777|471296504|FG001|Open-Label Period|Lost to Follow-up|0|||
130907477|NCT02129777|471296505|FG002|Open-Label Period|Lost to Follow-up|0|||
130907478|NCT02129777|471296506|FG003|Open-Label Period|Lost to Follow-up|0|||
130907479|NCT02129777|471296507|FG004|Open-Label Period|Lost to Follow-up|0|||
130907480|NCT02129777|471296508|FG005|Open-Label Period|Lost to Follow-up|1|||
130907481|NCT02129777|471296509|FG006|Open-Label Period|Lost to Follow-up|1|||
130907482|NCT02129777|471296503|FG000|Open-Label Period|Withdrawal by Subject|0|||
130907483|NCT02129777|471296504|FG001|Open-Label Period|Withdrawal by Subject|0|||
130907484|NCT02129777|471296505|FG002|Open-Label Period|Withdrawal by Subject|0|||
130907485|NCT02129777|471296506|FG003|Open-Label Period|Withdrawal by Subject|0|||
130907486|NCT02129777|471296507|FG004|Open-Label Period|Withdrawal by Subject|0|||
130907487|NCT02129777|471296508|FG005|Open-Label Period|Withdrawal by Subject|1|||
130907488|NCT02129777|471296509|FG006|Open-Label Period|Withdrawal by Subject|3|||
130907489|NCT02129777|471296503|FG000|Open-Label Period|Study Termination|0|||
130907490|NCT02129777|471296504|FG001|Open-Label Period|Study Termination|0|||
130907491|NCT02129777|471296505|FG002|Open-Label Period|Study Termination|0|||
130907492|NCT02129777|471296506|FG003|Open-Label Period|Study Termination|0|||
130907493|NCT02129777|471296507|FG004|Open-Label Period|Study Termination|0|||
130907494|NCT02129777|471296508|FG005|Open-Label Period|Study Termination|10|||
131114863|NCT02742766|472052186|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114864|NCT02742766|472052187|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114865|NCT02742766|472052188|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114866|NCT02742766|472052189|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
131114867|NCT02742766|472052190|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
131114868|NCT02742766|472052191|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114869|NCT02742766|472052192|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
131114870|NCT02742766|472052193|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114871|NCT02742766|472052194|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114872|NCT02742766|472052195|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
131114873|NCT04427501|472052196|FG000|Overall Study|Death|0|||
131114874|NCT04427501|472052197|FG001|Overall Study|Death|0|||
131114875|NCT04427501|472052198|FG002|Overall Study|Death|0|||
131114876|NCT04427501|472052199|FG003|Overall Study|Death|0|||
131114877|NCT04427501|472052200|FG004|Overall Study|Death|0|||
131114878|NCT04427501|472052201|FG005|Overall Study|Death|15|||
131114879|NCT04427501|472052202|FG006|Overall Study|Death|0|||
131114880|NCT04427501|472052203|FG007|Overall Study|Death|0|||
131114881|NCT04427501|472052204|FG008|Overall Study|Death|0|||
131114882|NCT04427501|472052205|FG009|Overall Study|Death|0|||
131114883|NCT04427501|472052206|FG010|Overall Study|Death|0|||
131114884|NCT04427501|472052207|FG011|Overall Study|Death|0|||
131114885|NCT04427501|472052196|FG000|Overall Study|Lost to Follow-up|5|||
131114886|NCT04427501|472052197|FG001|Overall Study|Lost to Follow-up|1|||
131114887|NCT04427501|472052198|FG002|Overall Study|Lost to Follow-up|2|||
131114888|NCT04427501|472052199|FG003|Overall Study|Lost to Follow-up|0|||
131114889|NCT04427501|472052200|FG004|Overall Study|Lost to Follow-up|2|||
131114890|NCT04427501|472052201|FG005|Overall Study|Lost to Follow-up|11|||
131114891|NCT04427501|472052202|FG006|Overall Study|Lost to Follow-up|10|||
131114892|NCT04427501|472052203|FG007|Overall Study|Lost to Follow-up|10|||
131114893|NCT04427501|472052204|FG008|Overall Study|Lost to Follow-up|2|||
131114894|NCT04427501|472052205|FG009|Overall Study|Lost to Follow-up|5|||
131114895|NCT04427501|472052206|FG010|Overall Study|Lost to Follow-up|2|||
131114896|NCT04427501|472052207|FG011|Overall Study|Lost to Follow-up|0|||
131114897|NCT04427501|472052196|FG000|Overall Study|Physician Decision|0|||
131114898|NCT04427501|472052197|FG001|Overall Study|Physician Decision|3|||
131114899|NCT04427501|472052198|FG002|Overall Study|Physician Decision|0|||
131114900|NCT04427501|472052199|FG003|Overall Study|Physician Decision|0|||
131114901|NCT04427501|472052200|FG004|Overall Study|Physician Decision|0|||
131114902|NCT04427501|472052201|FG005|Overall Study|Physician Decision|0|||
131114903|NCT04427501|472052202|FG006|Overall Study|Physician Decision|2|||
131114904|NCT04427501|472052203|FG007|Overall Study|Physician Decision|0|||
131114905|NCT04427501|472052204|FG008|Overall Study|Physician Decision|0|||
130907495|NCT02129777|471296509|FG006|Open-Label Period|Study Termination|39|||
130907496|NCT01001299|471296510|FG000|Overall Study|Insufficient Therapeutic Response|20|||
130907497|NCT01001299|471296510|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
130907498|NCT01001299|471296510|FG000|Overall Study|Death|1|||
130907499|NCT01001299|471296510|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
131114906|NCT04427501|472052205|FG009|Overall Study|Physician Decision|0|||
131114907|NCT04427501|472052206|FG010|Overall Study|Physician Decision|0|||
131114908|NCT04427501|472052207|FG011|Overall Study|Physician Decision|0|||
131114909|NCT04427501|472052196|FG000|Overall Study|Withdrawal by Subject|9|||
131114910|NCT04427501|472052197|FG001|Overall Study|Withdrawal by Subject|2|||
131114911|NCT04427501|472052198|FG002|Overall Study|Withdrawal by Subject|2|||
131114912|NCT04427501|472052199|FG003|Overall Study|Withdrawal by Subject|3|||
131114913|NCT04427501|472052200|FG004|Overall Study|Withdrawal by Subject|7|||
131114914|NCT04427501|472052201|FG005|Overall Study|Withdrawal by Subject|25|||
130907500|NCT01001299|471296510|FG000|Overall Study|Withdrew Consent|1|||
131114915|NCT04427501|472052202|FG006|Overall Study|Withdrawal by Subject|15|||
131114916|NCT04427501|472052203|FG007|Overall Study|Withdrawal by Subject|7|||
131114917|NCT04427501|472052204|FG008|Overall Study|Withdrawal by Subject|4|||
131114918|NCT04427501|472052205|FG009|Overall Study|Withdrawal by Subject|1|||
131114919|NCT04427501|472052206|FG010|Overall Study|Withdrawal by Subject|4|||
131114920|NCT04427501|472052207|FG011|Overall Study|Withdrawal by Subject|0|||
131114921|NCT04427501|472052196|FG000|Overall Study|Other - as reported by the investigator|1|||
131114922|NCT04427501|472052197|FG001|Overall Study|Other - as reported by the investigator|0|||
131114923|NCT04427501|472052198|FG002|Overall Study|Other - as reported by the investigator|0|||
131114924|NCT04427501|472052199|FG003|Overall Study|Other - as reported by the investigator|0|||
131114925|NCT04427501|472052200|FG004|Overall Study|Other - as reported by the investigator|0|||
131114926|NCT04427501|472052201|FG005|Overall Study|Other - as reported by the investigator|6|||
131114927|NCT04427501|472052202|FG006|Overall Study|Other - as reported by the investigator|6|||
131114928|NCT04427501|472052203|FG007|Overall Study|Other - as reported by the investigator|0|||
131114929|NCT04427501|472052204|FG008|Overall Study|Other - as reported by the investigator|0|||
131114930|NCT04427501|472052205|FG009|Overall Study|Other - as reported by the investigator|0|||
131114931|NCT04427501|472052206|FG010|Overall Study|Other - as reported by the investigator|0|||
130907501|NCT01565499|471296511|FG000|Overall Study|Physician Decision|1|||
130907502|NCT01565499|471296511|FG000|Overall Study|Adverse Event|5|||
130907503|NCT01565499|471296511|FG000|Overall Study|Withdrawal by Subject|2|||
130907504|NCT03116347|471296512|FG000|Overall Study|Withdrawal by Subject|1|||
130907505|NCT03116347|471296513|FG001|Overall Study|Withdrawal by Subject|2|||
130907506|NCT01255787|471296514|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
130907507|NCT01255787|471296515|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
130907508|NCT01255787|471296516|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
130907509|NCT01255787|471296517|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
130907510|NCT01255787|471296514|FG000|Overall Study|Major Protocol Deviation|1|||
130907511|NCT01255787|471296515|FG001|Overall Study|Major Protocol Deviation|1|||
130907512|NCT01255787|471296516|FG002|Overall Study|Major Protocol Deviation|0|||
130907513|NCT01255787|471296517|FG003|Overall Study|Major Protocol Deviation|4|||
130907514|NCT01255787|471296514|FG000|Overall Study|Lost to Follow-up|1|||
130907515|NCT01255787|471296515|FG001|Overall Study|Lost to Follow-up|2|||
130907516|NCT01255787|471296516|FG002|Overall Study|Lost to Follow-up|4|||
130907517|NCT01255787|471296517|FG003|Overall Study|Lost to Follow-up|2|||
130907518|NCT01255787|471296514|FG000|Overall Study|Withdrawal of Consent|3|||
130907519|NCT01255787|471296515|FG001|Overall Study|Withdrawal of Consent|9|||
130907520|NCT01255787|471296516|FG002|Overall Study|Withdrawal of Consent|3|||
130907521|NCT01255787|471296517|FG003|Overall Study|Withdrawal of Consent|4|||
130907522|NCT01255787|471296514|FG000|Overall Study|Pregnancy|0|||
130907523|NCT01255787|471296515|FG001|Overall Study|Pregnancy|0|||
130907524|NCT01255787|471296516|FG002|Overall Study|Pregnancy|0|||
130907525|NCT01255787|471296517|FG003|Overall Study|Pregnancy|1|||
130907526|NCT01255787|471296514|FG000|Overall Study|Lack of Efficacy|2|||
130907527|NCT01255787|471296515|FG001|Overall Study|Lack of Efficacy|2|||
130907528|NCT01255787|471296516|FG002|Overall Study|Lack of Efficacy|2|||
130907529|NCT01255787|471296517|FG003|Overall Study|Lack of Efficacy|2|||
130907530|NCT01255787|471296514|FG000|Overall Study|Noncompliance with Study Drug|3|||
130907531|NCT01255787|471296515|FG001|Overall Study|Noncompliance with Study Drug|1|||
130907532|NCT01255787|471296516|FG002|Overall Study|Noncompliance with Study Drug|0|||
130907533|NCT01255787|471296517|FG003|Overall Study|Noncompliance with Study Drug|0|||
130907534|NCT00476047|471296518|FG000|Overall Study|Lost to Follow-up|1|||
130907535|NCT03170232|471296519|FG000|Overall Study|Adverse Event|0|||
130907536|NCT03170232|471296520|FG001|Overall Study|Adverse Event|1|||
130907537|NCT03170232|471296519|FG000|Overall Study|Protocol Violation|0|||
130907538|NCT03170232|471296520|FG001|Overall Study|Protocol Violation|1|||
130907539|NCT03170232|471296519|FG000|Overall Study|Lack of Efficacy|0|||
130907540|NCT03170232|471296520|FG001|Overall Study|Lack of Efficacy|1|||
130907541|NCT03170232|471296519|FG000|Overall Study|Study closed/terminated|26|||
130907542|NCT03170232|471296520|FG001|Overall Study|Study closed/terminated|23|||
130907543|NCT03170232|471296519|FG000|Overall Study|Lost to Follow-up|1|||
130907544|NCT03170232|471296520|FG001|Overall Study|Lost to Follow-up|0|||
130907545|NCT03170232|471296519|FG000|Overall Study|Withdrawal by Subject|0|||
130907546|NCT03170232|471296520|FG001|Overall Study|Withdrawal by Subject|1|||
130907547|NCT00586326|471296521|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
131114932|NCT04427501|472052207|FG011|Overall Study|Other - as reported by the investigator|0|||
131114933|NCT04427501|472052196|FG000|Overall Study|Other|0|||
130907548|NCT00586326|471296521|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
130907549|NCT00586326|471296521|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
130907550|NCT00586326|471296521|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
130907551|NCT00586326|471296521|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
130907552|NCT00586326|471296521|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
130907553|NCT00586326|471296521|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
130907554|NCT00586326|471296521|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
131114934|NCT04427501|472052197|FG001|Overall Study|Other|0|||
130907555|NCT00586326|471296521|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
130907556|NCT00586326|471296521|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
130907557|NCT00586326|471296521|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
130907558|NCT00586326|471296521|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
130907559|NCT00586326|471296521|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
130907560|NCT00586326|471296521|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
130907561|NCT00586326|471296521|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
130907562|NCT00586326|471296521|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
130907563|NCT00586326|471296521|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
130907564|NCT03882008|471296522|FG000|Overall Study|Withdrawal by Subject|1|||
130907565|NCT03882008|471296522|FG000|Overall Study|Lost to Follow-up|1|||
130907566|NCT00484185|471296523|FG000|Overall Study|Lost to Follow-up|44|||
130907567|NCT00484185|471296523|FG000|Overall Study|Other|20|||
130907568|NCT00484185|471296523|FG000|Overall Study|Randomized but not treated|5|||
130907569|NCT00484185|471296523|FG000|Overall Study|Death|2|||
131114935|NCT04427501|472052198|FG002|Overall Study|Other|0|||
131114936|NCT04427501|472052199|FG003|Overall Study|Other|0|||
131114937|NCT04427501|472052200|FG004|Overall Study|Other|0|||
131114938|NCT04427501|472052201|FG005|Overall Study|Other|0|||
131114939|NCT04427501|472052202|FG006|Overall Study|Other|0|||
131114940|NCT04427501|472052203|FG007|Overall Study|Other|0|||
131114941|NCT04427501|472052204|FG008|Overall Study|Other|0|||
131114942|NCT04427501|472052205|FG009|Overall Study|Other|0|||
131114943|NCT04427501|472052206|FG010|Overall Study|Other|0|||
131114944|NCT04427501|472052207|FG011|Overall Study|Other|1|||
131114945|NCT00999713|472052208|FG000|Overall Study|Physician Decision|2|||
131114946|NCT00999713|472052209|FG001|Overall Study|Physician Decision|0|||
131114947|NCT00639223|472052210|FG000|Overall Study|Lost to Follow-up|0|||
131114948|NCT00639223|472052211|FG001|Overall Study|Lost to Follow-up|2|||
131114949|NCT04936841|472052212|FG000|Overall Study|Death|1|||
131114950|NCT03739437|472052214|FG000|Overall Study|Lost to Follow-up|2|||
131114951|NCT03739437|472052215|FG001|Overall Study|Lost to Follow-up|5|||
131114952|NCT01395316|472052218|FG000|Overall Study|Lost to Follow-up|2|||
131114953|NCT01395316|472052218|FG000|Overall Study|poor MRI quality|1|||
131114954|NCT03359590|472052219|FG000|First Intervention|Withdrawal by Subject|1|||
131114955|NCT03359590|472052220|FG001|First Intervention|Withdrawal by Subject|1|||
131114956|NCT03359590|472052219|FG000|First Intervention|Protocol Violation|0|||
131114957|NCT03359590|472052220|FG001|First Intervention|Protocol Violation|1|||
131114958|NCT02846532|472052221|FG000|Overall Study|Lost to Follow-up|0|||
131114959|NCT02846532|472052222|FG001|Overall Study|Lost to Follow-up|1|||
131114960|NCT02846532|472052223|FG002|Overall Study|Lost to Follow-up|1|||
131114961|NCT02846532|472052221|FG000|Overall Study|Withdrawal by Subject|1|||
131114962|NCT02846532|472052222|FG001|Overall Study|Withdrawal by Subject|2|||
131114963|NCT02846532|472052223|FG002|Overall Study|Withdrawal by Subject|0|||
131114964|NCT06132425|472052224|FG000|Overall Study|Withdrawal by Subject|3|||
131114965|NCT06132425|472052225|FG001|Overall Study|Withdrawal by Subject|0|||
131114966|NCT06132425|472052224|FG000|Overall Study|Did not follow study instructions|0|||
131114967|NCT06132425|472052225|FG001|Overall Study|Did not follow study instructions|2|||
131114968|NCT06132425|472052224|FG000|Overall Study|Lost to Follow-up|3|||
131114969|NCT06132425|472052225|FG001|Overall Study|Lost to Follow-up|5|||
131114970|NCT01019980|472052231|FG000|Overall Study|Drug not available.|2|||
131114971|NCT01019980|472052232|FG001|Overall Study|Drug not available.|0|||
131114972|NCT02383589|472052242|FG000|Treatment Period|Adverse Event|1|||
131114973|NCT02383589|472052243|FG001|Treatment Period|Adverse Event|3|||
131114974|NCT02383589|472052242|FG000|Treatment Period|Lost to Follow-up|0|||
131114975|NCT02383589|472052243|FG001|Treatment Period|Lost to Follow-up|1|||
131114976|NCT02383589|472052242|FG000|Treatment Period|Withdrawal by Subject|0|||
131114977|NCT02383589|472052243|FG001|Treatment Period|Withdrawal by Subject|5|||
131114978|NCT02383589|472052242|FG000|Treatment Period|Non-compliance with study drug|0|||
131114979|NCT02383589|472052243|FG001|Treatment Period|Non-compliance with study drug|1|||
131114980|NCT02383589|472052242|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
131114981|NCT02383589|472052243|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
130907570|NCT00459056|471296524|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
130907571|NCT00459056|471296525|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
130907572|NCT02283177|471296526|FG000|Overall Study|Withdrawal by Subject|1|||
130907573|NCT02283177|471296527|FG001|Overall Study|Withdrawal by Subject|1|||
130907574|NCT01101191|471296528|FG000|Period 1|Withdrawal by Subject|1|||
131114982|NCT02383589|472052242|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
131114983|NCT02383589|472052243|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
131114984|NCT02383589|472052242|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
131114985|NCT02383589|472052243|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
131114986|NCT03672461|472052244|FG000|Overall Study|COVID Related|4|||
131114987|NCT03672461|472052245|FG001|Overall Study|COVID Related|2|||
131114988|NCT03672461|472052244|FG000|Overall Study|Adverse Event|2|||
131114989|NCT03672461|472052245|FG001|Overall Study|Adverse Event|0|||
130907575|NCT01101191|471296529|FG001|Period 1|Withdrawal by Subject|0|||
131114990|NCT03672461|472052244|FG000|Overall Study|Serious Adverse Event|0|||
131114991|NCT03672461|472052245|FG001|Overall Study|Serious Adverse Event|1|||
131114992|NCT03672461|472052244|FG000|Overall Study|Too Busy|3|||
131114993|NCT03672461|472052245|FG001|Overall Study|Too Busy|1|||
130907576|NCT01101191|471296528|FG000|Period 1|Adverse Event|1|||
130907577|NCT01101191|471296529|FG001|Period 1|Adverse Event|2|||
130907578|NCT00879879|471296530|FG000|Overall Study|Death|1|||
130907579|NCT00879879|471296530|FG000|Overall Study|Withdrawal by Subject|1|||
130907580|NCT00879879|471296530|FG000|Overall Study|Physician Decision|1|||
130907581|NCT00989573|471296531|FG000|Overall Study|Adverse Event|8|||
130907582|NCT00989573|471296532|FG001|Overall Study|Adverse Event|12|||
130907583|NCT00989573|471296533|FG002|Overall Study|Adverse Event|4|||
130907584|NCT00989573|471296531|FG000|Overall Study|Physician Decision|0|||
130907585|NCT00989573|471296532|FG001|Overall Study|Physician Decision|2|||
130907586|NCT00989573|471296533|FG002|Overall Study|Physician Decision|0|||
130907587|NCT00989573|471296531|FG000|Overall Study|Protocol Violation|1|||
130907588|NCT00989573|471296532|FG001|Overall Study|Protocol Violation|1|||
130907589|NCT00989573|471296533|FG002|Overall Study|Protocol Violation|1|||
130907590|NCT00989573|471296531|FG000|Overall Study|Withdrawal by Subject|4|||
130907591|NCT00989573|471296532|FG001|Overall Study|Withdrawal by Subject|7|||
130907592|NCT00989573|471296533|FG002|Overall Study|Withdrawal by Subject|3|||
130907593|NCT03687970|471296535|FG000|Overall Study|visit scheduling conflicts|2|||
130907594|NCT03687970|471296536|FG001|Overall Study|visit scheduling conflicts|0|||
130907595|NCT00596362|471296537|FG000|Overall Study|Progressive Disease|1|||
130907596|NCT00817479|471296538|FG000|Overall Study|Physician Decision|1|||
130907597|NCT00817479|471296539|FG001|Overall Study|Physician Decision|1|||
130907598|NCT04030026|471296541|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
130907599|NCT04030026|471296542|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
130907600|NCT04030026|471296541|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
130907601|NCT04030026|471296542|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
130907602|NCT04030026|471296541|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
130907603|NCT04030026|471296542|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
130907604|NCT04030026|471296541|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
130907605|NCT04030026|471296542|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
130907606|NCT04030026|471296541|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
130907607|NCT04030026|471296542|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
130907608|NCT04030026|471296541|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
130907609|NCT04030026|471296542|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
130907610|NCT04030026|471296541|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
130907611|NCT04030026|471296542|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
130907612|NCT00523367|471296543|FG000|Overall Study|19 screen failures|19|||
130907613|NCT00523367|471296543|FG000|Overall Study|4 Withdrawn by PI|4|||
130907614|NCT04480424|471296544|FG000|Overall Study|Withdrawal by Subject|0|||
130907615|NCT04480424|471296545|FG001|Overall Study|Withdrawal by Subject|2|||
130907616|NCT04480424|471296544|FG000|Overall Study|Lost to Follow-up|3|||
130907617|NCT04480424|471296545|FG001|Overall Study|Lost to Follow-up|3|||
130907618|NCT04480424|471296544|FG000|Overall Study|Death|14|||
130907619|NCT04480424|471296545|FG001|Overall Study|Death|16|||
130907620|NCT04480424|471296544|FG000|Overall Study|Reason not Specified|5|||
130907621|NCT04480424|471296545|FG001|Overall Study|Reason not Specified|5|||
130907622|NCT02782923|471296546|FG000|Overall Study|Lost to Follow-up|15|||
130907623|NCT02418156|471296547|FG000|Overall Study|Lost to Follow-up|12|||
130907624|NCT02418156|471296547|FG000|Overall Study|Death|2|||
130907625|NCT02418156|471296547|FG000|Overall Study|Physician Decision|1|||
130907626|NCT02418156|471296547|FG000|Overall Study|Withdrawal by Subject|1|||
130907627|NCT02418156|471296547|FG000|Overall Study|Subject refused to return|1|||
130907628|NCT01909453|471296555|FG000|Overall Study|Ongoing|118|||
130907629|NCT01909453|471296556|FG001|Overall Study|Ongoing|103|||
130907630|NCT01909453|471296557|FG002|Overall Study|Ongoing|83|||
131028637|NCT00073749|471736634|FG000|Overall Study|Death|0|||
131028638|NCT00073749|471736635|FG001|Overall Study|Death|1|||
131028639|NCT00073749|471736636|FG002|Overall Study|Death|1|||
130907631|NCT01909453|471296558|FG003|Overall Study|Ongoing|164|||
130907632|NCT01909453|471296559|FG004|Overall Study|Ongoing|50|||
130907633|NCT01909453|471296555|FG000|Overall Study|Death|69|||
130907634|NCT01909453|471296556|FG001|Overall Study|Death|74|||
131028640|NCT00073749|471736637|FG003|Overall Study|Death|0|||
131028641|NCT00073749|471736638|FG004|Overall Study|Death|0|||
131028642|NCT00073749|471736639|FG005|Overall Study|Death|0|||
131028643|NCT00073749|471736640|FG006|Overall Study|Death|29|||
131028644|NCT00073749|471736634|FG000|Overall Study|Adverse Event|0|||
131028645|NCT00073749|471736635|FG001|Overall Study|Adverse Event|3|||
131028646|NCT00073749|471736636|FG002|Overall Study|Adverse Event|6|||
131028647|NCT00073749|471736637|FG003|Overall Study|Adverse Event|4|||
130907635|NCT01909453|471296557|FG002|Overall Study|Death|88|||
130907636|NCT01909453|471296558|FG003|Overall Study|Death|86|||
130907637|NCT01909453|471296559|FG004|Overall Study|Death|29|||
130907638|NCT01909453|471296555|FG000|Overall Study|Lost to Follow-up|3|||
130907639|NCT01909453|471296556|FG001|Overall Study|Lost to Follow-up|4|||
130907640|NCT01909453|471296557|FG002|Overall Study|Lost to Follow-up|4|||
130907641|NCT01909453|471296558|FG003|Overall Study|Lost to Follow-up|3|||
130907642|NCT01909453|471296559|FG004|Overall Study|Lost to Follow-up|3|||
131028648|NCT00073749|471736638|FG004|Overall Study|Adverse Event|2|||
130907643|NCT01909453|471296555|FG000|Overall Study|Withdrawal by Subject|2|||
130907644|NCT01909453|471296556|FG001|Overall Study|Withdrawal by Subject|13|||
130907645|NCT01909453|471296557|FG002|Overall Study|Withdrawal by Subject|16|||
130907646|NCT01909453|471296558|FG003|Overall Study|Withdrawal by Subject|5|||
130907647|NCT01909453|471296559|FG004|Overall Study|Withdrawal by Subject|4|||
130907648|NCT04078178|471298048|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
130907649|NCT04078178|471298049|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
130907650|NCT04078178|471298048|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
130907651|NCT04078178|471298049|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
130907652|NCT04078178|471298048|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
130907653|NCT04078178|471298049|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
130907654|NCT04078178|471298048|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
130907655|NCT04078178|471298049|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
130695527|NCT02705716|470509070|FG000|Overall Study|Adverse Event|0|||
130907656|NCT04078178|471298048|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
130907657|NCT04078178|471298049|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
130907658|NCT04006119|471298050|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
130907659|NCT04006119|471298050|FG000|End of Treatment Veledimex|Adverse Event|2|||
130907660|NCT04006119|471298050|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
130907661|NCT04006119|471298050|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
130907662|NCT04006119|471298050|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
130907663|NCT04006119|471298050|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
130907664|NCT04617795|471298051|FG000|Main Study|Lost to Follow-up|1|||
131028649|NCT00073749|471736639|FG005|Overall Study|Adverse Event|1|||
131028650|NCT00073749|471736640|FG006|Overall Study|Adverse Event|0|||
131028651|NCT00073749|471736634|FG000|Overall Study|Physician Decision|0|||
131028652|NCT00073749|471736635|FG001|Overall Study|Physician Decision|0|||
131028653|NCT00073749|471736636|FG002|Overall Study|Physician Decision|1|||
131028654|NCT00073749|471736637|FG003|Overall Study|Physician Decision|0|||
131028655|NCT00073749|471736638|FG004|Overall Study|Physician Decision|0|||
131028656|NCT00073749|471736639|FG005|Overall Study|Physician Decision|2|||
131028657|NCT00073749|471736640|FG006|Overall Study|Physician Decision|0|||
131028658|NCT00073749|471736634|FG000|Overall Study|Withdrawal by Subject|0|||
131028659|NCT00073749|471736635|FG001|Overall Study|Withdrawal by Subject|1|||
131028660|NCT00073749|471736636|FG002|Overall Study|Withdrawal by Subject|0|||
131028661|NCT00073749|471736637|FG003|Overall Study|Withdrawal by Subject|0|||
131028662|NCT00073749|471736638|FG004|Overall Study|Withdrawal by Subject|1|||
131028663|NCT00073749|471736639|FG005|Overall Study|Withdrawal by Subject|0|||
131028664|NCT00073749|471736640|FG006|Overall Study|Withdrawal by Subject|2|||
131028665|NCT00073749|471736634|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
131028666|NCT00073749|471736635|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
131028667|NCT00073749|471736636|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
131028668|NCT00073749|471736637|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
131028669|NCT00073749|471736638|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
131028670|NCT00073749|471736639|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
131028671|NCT00073749|471736640|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
131028672|NCT00073749|471736634|FG000|Overall Study|Lost to Follow-up|0|||
131028673|NCT00073749|471736635|FG001|Overall Study|Lost to Follow-up|0|||
131028674|NCT00073749|471736636|FG002|Overall Study|Lost to Follow-up|0|||
131028675|NCT00073749|471736637|FG003|Overall Study|Lost to Follow-up|0|||
131028676|NCT00073749|471736638|FG004|Overall Study|Lost to Follow-up|0|||
131028677|NCT00073749|471736639|FG005|Overall Study|Lost to Follow-up|0|||
131028678|NCT00073749|471736640|FG006|Overall Study|Lost to Follow-up|2|||
131028679|NCT00073749|471736634|FG000|Overall Study|Other|0|||
131028680|NCT00073749|471736635|FG001|Overall Study|Other|0|||
131028681|NCT00073749|471736636|FG002|Overall Study|Other|0|||
131028682|NCT00073749|471736637|FG003|Overall Study|Other|0|||
131028683|NCT00073749|471736638|FG004|Overall Study|Other|0|||
131028684|NCT00073749|471736639|FG005|Overall Study|Other|2|||
131028685|NCT00073749|471736640|FG006|Overall Study|Other|0|||
131028686|NCT04999592|471736641|FG000|Overall Study|Withdrawal by Subject|1|||
131028687|NCT04999592|471736642|FG001|Overall Study|Withdrawal by Subject|0|||
131028688|NCT02742519|471736643|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
131028689|NCT02742519|471736644|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
131028690|NCT02742519|471736645|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
131028691|NCT02742519|471736643|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
131028692|NCT02742519|471736644|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
131028693|NCT02742519|471736645|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
131028694|NCT02742519|471736643|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
131028695|NCT02742519|471736644|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
130907665|NCT04617795|471298052|FG001|Main Study|Lost to Follow-up|0|||
130907666|NCT00472459|471298053|FG000|Overall Study|Adverse Event|13|||
130907667|NCT00472459|471298054|FG001|Overall Study|Adverse Event|13|||
130907668|NCT00472459|471298053|FG000|Overall Study|Withdrawal by Subject|5|||
130907669|NCT00472459|471298054|FG001|Overall Study|Withdrawal by Subject|5|||
130907670|NCT00472459|471298053|FG000|Overall Study|Protocol Violation|3|||
130907671|NCT00472459|471298054|FG001|Overall Study|Protocol Violation|3|||
130907672|NCT00472459|471298053|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
130907673|NCT00472459|471298054|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
130907674|NCT00472459|471298053|FG000|Overall Study|Lost to Follow-up|1|||
130907675|NCT00472459|471298054|FG001|Overall Study|Lost to Follow-up|1|||
130907676|NCT03442764|471298055|FG000|Overall Study|Adverse Event|1|||
130907677|NCT03442764|471298056|FG001|Overall Study|Adverse Event|0|||
130907678|NCT03442764|471298057|FG002|Overall Study|Adverse Event|0|||
130907679|NCT04850313|471298058|FG000|Overall Study|Withdrawal by Subject|0|||
130907680|NCT04850313|471298059|FG001|Overall Study|Withdrawal by Subject|1|||
130907681|NCT02395016|471298060|FG000|Overall Study|Adverse Event|4|||
130907682|NCT02395016|471298061|FG001|Overall Study|Adverse Event|3|||
130907683|NCT02395016|471298060|FG000|Overall Study|Withdrawal by Subject|9|||
130907684|NCT02395016|471298061|FG001|Overall Study|Withdrawal by Subject|6|||
130907685|NCT02395016|471298060|FG000|Overall Study|Protocol Violation|2|||
130907686|NCT02395016|471298061|FG001|Overall Study|Protocol Violation|3|||
130907687|NCT00814879|471298063|FG000|By Week 24|Cancer Diagnosis|1|||
130907688|NCT00814879|471298064|FG001|By Week 24|Cancer Diagnosis|0|||
130907689|NCT00814879|471298063|FG000|By Week 24|Incarceration|0|||
130907690|NCT00814879|471298064|FG001|By Week 24|Incarceration|1|||
130907691|NCT00814879|471298063|FG000|By Week 48|Lost to Follow-up|2|||
130907692|NCT00814879|471298064|FG001|By Week 48|Lost to Follow-up|2|||
130907693|NCT00814879|471298063|FG000|By Week 48|Death|0|||
130907694|NCT00814879|471298064|FG001|By Week 48|Death|1|||
130907695|NCT01277042|471298065|FG000|Overall Study|Adverse Event|4|||
130907696|NCT01277042|471298066|FG001|Overall Study|Adverse Event|3|||
130907697|NCT01277042|471298065|FG000|Overall Study|Lost to Follow-up|2|||
130907698|NCT01277042|471298066|FG001|Overall Study|Lost to Follow-up|2|||
130907699|NCT01277042|471298065|FG000|Overall Study|Withdrawal by Subject|2|||
130907700|NCT01277042|471298066|FG001|Overall Study|Withdrawal by Subject|0|||
130907701|NCT01461057|471298067|FG000|Overall Study|Death|10|||
130907702|NCT01461057|471298068|FG001|Overall Study|Death|9|||
130907703|NCT01461057|471298067|FG000|Overall Study|Withdrawal by Subject|2|||
130907704|NCT01461057|471298068|FG001|Overall Study|Withdrawal by Subject|3|||
130907705|NCT01461057|471298067|FG000|Overall Study|Physician Decision|0|||
130907706|NCT01461057|471298068|FG001|Overall Study|Physician Decision|2|||
130907707|NCT01461057|471298067|FG000|Overall Study|Adverse Event|0|||
130907708|NCT01461057|471298068|FG001|Overall Study|Adverse Event|1|||
130907709|NCT01461057|471298067|FG000|Overall Study|Progression of Disease|1|||
130907710|NCT01461057|471298068|FG001|Overall Study|Progression of Disease|0|||
130907711|NCT01461057|471298067|FG000|Overall Study|Study Terminated by Sponsor|2|||
130907712|NCT01461057|471298068|FG001|Overall Study|Study Terminated by Sponsor|0|||
130907713|NCT01288976|471298069|FG000|Overall Study|Withdrawal by Subject|58|||
130907714|NCT01288976|471298070|FG001|Overall Study|Withdrawal by Subject|12|||
130907715|NCT01288976|471298071|FG002|Overall Study|Withdrawal by Subject|9|||
130907716|NCT01288976|471298069|FG000|Overall Study|Death|98|||
130907717|NCT01288976|471298070|FG001|Overall Study|Death|6|||
130907718|NCT01288976|471298071|FG002|Overall Study|Death|4|||
130907719|NCT01288976|471298069|FG000|Overall Study|Data unavailable|22|||
130907720|NCT01288976|471298070|FG001|Overall Study|Data unavailable|9|||
130907721|NCT01288976|471298071|FG002|Overall Study|Data unavailable|7|||
130907722|NCT00959374|471298074|FG000|Overall Study|Withdrawal by Subject|2|||
130907723|NCT00959374|471298074|FG000|Overall Study|Lost to Follow-up|14|||
130907724|NCT00959374|471298074|FG000|Overall Study|Death|1|||
130907725|NCT00959374|471298074|FG000|Overall Study|Protocol Violation|1|||
130907726|NCT00959374|471298074|FG000|Overall Study|Implant Removed/Not Replaced|4|||
131028696|NCT02742519|471736645|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
131028697|NCT04377308|471736647|FG000|Overall Study|Withdrawal by Subject|0|||
131028698|NCT04377308|471736648|FG001|Overall Study|Withdrawal by Subject|1|||
131028699|NCT04774237|471736649|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
131028700|NCT04774237|471736650|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
131028701|NCT04774237|471736651|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
130907727|NCT00959374|471298074|FG000|Overall Study|Physician Decision|1|||
130907728|NCT03350984|471298075|FG000|Overall Study|Death|1|||
131028702|NCT04774237|471736652|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
130768492|NCT03341936|470776678|FG000|Overall Study|Other|1|||
130907729|NCT03350984|471298076|FG001|Overall Study|Death|0|||
130907730|NCT03350984|471298075|FG000|Overall Study|Lost to Follow-up|5|||
130907731|NCT03350984|471298076|FG001|Overall Study|Lost to Follow-up|6|||
130907732|NCT03350984|471298075|FG000|Overall Study|Protocol Violation|1|||
130907733|NCT03350984|471298076|FG001|Overall Study|Protocol Violation|2|||
130907734|NCT03350984|471298075|FG000|Overall Study|Physician Decision|1|||
130907735|NCT03350984|471298076|FG001|Overall Study|Physician Decision|0|||
130907736|NCT00642473|471298077|FG000|Overall Study|Withdrawal by Subject|0|||
131028703|NCT04774237|471736653|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
131028704|NCT04774237|471736654|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
131028705|NCT03152786|471738012|FG000|Overall Study|Withdrawal by Subject|2|||
130907737|NCT00642473|471298078|FG001|Overall Study|Withdrawal by Subject|5|||
130907738|NCT00642473|471298077|FG000|Overall Study|Progression or death|2|||
130907739|NCT00642473|471298078|FG001|Overall Study|Progression or death|4|||
130907740|NCT00642473|471298077|FG000|Overall Study|Other|2|||
130907741|NCT00642473|471298078|FG001|Overall Study|Other|2|||
130907742|NCT01483690|471298082|FG000|Overall Study|Adverse Event|1|||
130907743|NCT01483690|471298083|FG001|Overall Study|Adverse Event|2|||
130907744|NCT01483690|471298082|FG000|Overall Study|clinical deterioration|1|||
130907745|NCT01483690|471298083|FG001|Overall Study|clinical deterioration|0|||
130907746|NCT01483690|471298082|FG000|Overall Study|Physician Decision|0|||
130907747|NCT01483690|471298083|FG001|Overall Study|Physician Decision|2|||
130907748|NCT01483690|471298082|FG000|Overall Study|exclusionary procedure|0|||
130907749|NCT01483690|471298083|FG001|Overall Study|exclusionary procedure|1|||
130907750|NCT00478881|471298084|FG000|Overall Study|Adverse Event|31|||
130907751|NCT00478881|471298085|FG001|Overall Study|Adverse Event|12|||
130907752|NCT00478881|471298084|FG000|Overall Study|Lack of Efficacy|0|||
130907753|NCT00478881|471298085|FG001|Overall Study|Lack of Efficacy|3|||
130907754|NCT00478881|471298084|FG000|Overall Study|Lost to Follow-up|0|||
130907755|NCT00478881|471298085|FG001|Overall Study|Lost to Follow-up|1|||
130907756|NCT00478881|471298084|FG000|Overall Study|Protocol Violation|2|||
130907757|NCT00478881|471298085|FG001|Overall Study|Protocol Violation|2|||
130907758|NCT00478881|471298084|FG000|Overall Study|Withdrawal by Subject|6|||
130907759|NCT00478881|471298085|FG001|Overall Study|Withdrawal by Subject|2|||
130907760|NCT00478881|471298084|FG000|Overall Study|Non-Compliance with Study Medication|0|||
130907761|NCT00478881|471298085|FG001|Overall Study|Non-Compliance with Study Medication|2|||
130907762|NCT00737464|471298086|FG000|Overall Study|Adverse Event|1|||
130907763|NCT00737464|471298086|FG000|Overall Study|Death|6|||
130907764|NCT00737464|471298086|FG000|Overall Study|Other - Failure to Return|1|||
130907765|NCT00737464|471298086|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
130907766|NCT00737464|471298086|FG000|Overall Study|Other reasons|4|||
130907767|NCT02987660|471298095|FG000|Overall Study|Study terminated by sponsor|10|||
130907768|NCT02987660|471298096|FG001|Overall Study|Study terminated by sponsor|10|||
130907769|NCT03707184|471298097|FG000|Overall Study|Withdrawal by Subject|2|||
130907770|NCT01653782|471298100|FG000|Overall Study|Withdrawal by Subject|9|||
130907771|NCT01653782|471298101|FG001|Overall Study|Withdrawal by Subject|15|||
130907772|NCT01653782|471298102|FG002|Overall Study|Withdrawal by Subject|4|||
130907773|NCT01653782|471298100|FG000|Overall Study|Lost to Follow-up|7|||
130695528|NCT02705716|470509071|FG001|Overall Study|Adverse Event|1|||
130695529|NCT02705716|470509070|FG000|Overall Study|Protocol Violation|3|||
130695530|NCT02705716|470509071|FG001|Overall Study|Protocol Violation|0|||
130695531|NCT02705716|470509070|FG000|Overall Study|Withdrawal of Consent|1|||
130695532|NCT02705716|470509071|FG001|Overall Study|Withdrawal of Consent|1|||
130907774|NCT01653782|471298101|FG001|Overall Study|Lost to Follow-up|3|||
130907775|NCT01653782|471298102|FG002|Overall Study|Lost to Follow-up|2|||
130907776|NCT05442775|471298105|FG000|Overall Study|Trial terminated|61|||
130907777|NCT05442775|471298105|FG000|Overall Study|Lack of Efficacy|4|||
131028706|NCT03152786|471738013|FG001|Overall Study|Withdrawal by Subject|1|||
131028707|NCT04923347|471738014|FG000|Overall Study|Withdrawal by Subject|14|||
131028708|NCT00753090|471738026|FG000|Overall Study|Withdrawal by Subject|10|||
131028709|NCT00753090|471738027|FG001|Overall Study|Withdrawal by Subject|10|||
131028710|NCT00753090|471738026|FG000|Overall Study|Death|17|||
131028711|NCT00753090|471738027|FG001|Overall Study|Death|6|||
131028712|NCT00753090|471738026|FG000|Overall Study|Study Prosthesis Removed|12|||
131028713|NCT00753090|471738027|FG001|Overall Study|Study Prosthesis Removed|3|||
131028714|NCT00753090|471738026|FG000|Overall Study|Lost to Follow-up|2|||
131028715|NCT00753090|471738027|FG001|Overall Study|Lost to Follow-up|2|||
131028716|NCT00753090|471738026|FG000|Overall Study|Other|127|||
131028717|NCT00753090|471738027|FG001|Overall Study|Other|75|||
131028718|NCT06066541|471738028|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
131028719|NCT06066541|471738029|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
131028720|NCT06066541|471738030|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
131028721|NCT06066541|471738031|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
131028722|NCT06066541|471738032|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
131028723|NCT06066541|471738033|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
131028724|NCT06066541|471738034|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
130907778|NCT05442775|471298105|FG000|Overall Study|Withdrawal by Subject|4|||
130907779|NCT05442775|471298105|FG000|Overall Study|Death|1|||
130907780|NCT05442775|471298105|FG000|Overall Study|Participant removed at Sponsor request|1|||
130907781|NCT01606254|471298106|FG000|Overall Study|Withdrawal by Subject|1|||
131028725|NCT06066541|471738028|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
130907782|NCT01606254|471298107|FG001|Overall Study|Withdrawal by Subject|3|||
130907783|NCT01606254|471298108|FG002|Overall Study|Withdrawal by Subject|0|||
130907784|NCT01606254|471298109|FG003|Overall Study|Withdrawal by Subject|2|||
130695533|NCT00562718|470509072|FG000|Overall Study|Death|1|||
130907785|NCT01606254|471298106|FG000|Overall Study|Adverse Event|1|||
131114994|NCT03672461|472052244|FG000|Overall Study|Lost to Follow-up|1|||
131114995|NCT03672461|472052245|FG001|Overall Study|Lost to Follow-up|2|||
131114996|NCT03672461|472052244|FG000|Overall Study|Family|2|||
131114997|NCT03672461|472052245|FG001|Overall Study|Family|2|||
131114998|NCT03672461|472052244|FG000|Overall Study|No remote technology access|0|||
131114999|NCT03672461|472052245|FG001|Overall Study|No remote technology access|1|||
131115000|NCT03672461|472052244|FG000|Overall Study|Withdrawal by Subject|1|||
131115001|NCT03672461|472052245|FG001|Overall Study|Withdrawal by Subject|0|||
131115002|NCT03672461|472052244|FG000|Overall Study|Cannot tolerate intervention|1|||
131115003|NCT03672461|472052245|FG001|Overall Study|Cannot tolerate intervention|0|||
131115004|NCT03672461|472052244|FG000|Overall Study|Incomplete outcome data|6|||
131115005|NCT03672461|472052245|FG001|Overall Study|Incomplete outcome data|1|||
131115006|NCT04225806|472052246|FG000|Overall Study|Trial termination|15|||
131115007|NCT02408861|472052249|FG000|Overall Study|Death|0|||
131115008|NCT02408861|472052250|FG001|Overall Study|Death|3|||
131115009|NCT02408861|472052251|FG002|Overall Study|Death|1|||
131115010|NCT02408861|472052252|FG003|Overall Study|Death|2|||
131115011|NCT02408861|472052253|FG004|Overall Study|Death|4|||
131115012|NCT02408861|472052254|FG005|Overall Study|Death|1|||
131115013|NCT02408861|472052255|FG006|Overall Study|Death|0|||
131115014|NCT02408861|472052249|FG000|Overall Study|Lost to Follow-up|0|||
131115015|NCT02408861|472052250|FG001|Overall Study|Lost to Follow-up|0|||
131115016|NCT02408861|472052251|FG002|Overall Study|Lost to Follow-up|1|||
131115017|NCT02408861|472052252|FG003|Overall Study|Lost to Follow-up|1|||
131115018|NCT02408861|472052253|FG004|Overall Study|Lost to Follow-up|4|||
131115019|NCT02408861|472052254|FG005|Overall Study|Lost to Follow-up|2|||
131115020|NCT02408861|472052255|FG006|Overall Study|Lost to Follow-up|1|||
130695534|NCT00562718|470509072|FG000|Overall Study|Withdrawal by Subject|3|||
130695535|NCT00562718|470509072|FG000|Overall Study|Adverse Event|4|||
130695536|NCT00562718|470509072|FG000|Overall Study|Lack of Efficacy|2|||
130695537|NCT00562718|470509072|FG000|Overall Study|not stated|1|||
130907786|NCT01606254|471298107|FG001|Overall Study|Adverse Event|1|||
131028726|NCT06066541|471738029|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
131028727|NCT06066541|471738030|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
131028728|NCT06066541|471738031|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
131028729|NCT06066541|471738032|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
131028730|NCT06066541|471738033|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
131028731|NCT06066541|471738034|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
131028732|NCT04533022|471738035|FG000|Overall Study|Withdrawal by Subject|15|||
131028733|NCT04533022|471738035|FG000|Overall Study|Adverse Event|6|||
131028734|NCT04533022|471738035|FG000|Overall Study|Death|1|||
131028735|NCT04533022|471738035|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
131028736|NCT04533022|471738035|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
131028737|NCT02163447|471738036|FG000|Overall Study|Withdrawal by Subject|2|||
131028738|NCT02163447|471738037|FG001|Overall Study|Withdrawal by Subject|0|||
131028739|NCT02163447|471738038|FG002|Overall Study|Withdrawal by Subject|1|||
131028740|NCT02163447|471738036|FG000|Overall Study|Lost to Follow-up|1|||
131028741|NCT02163447|471738037|FG001|Overall Study|Lost to Follow-up|3|||
131028742|NCT02163447|471738038|FG002|Overall Study|Lost to Follow-up|0|||
131028743|NCT02163447|471738036|FG000|Overall Study|Moved out of study area|2|||
131028744|NCT02163447|471738037|FG001|Overall Study|Moved out of study area|3|||
131028745|NCT02163447|471738038|FG002|Overall Study|Moved out of study area|2|||
131028746|NCT02163447|471738036|FG000|Overall Study|Became HIV infected at time of delivery|1|||
131028747|NCT02163447|471738037|FG001|Overall Study|Became HIV infected at time of delivery|0|||
131028748|NCT02163447|471738038|FG002|Overall Study|Became HIV infected at time of delivery|0|||
131028749|NCT04052516|471738040|FG000|Overall Study|Withdrawal by Subject|4|||
131028750|NCT04052516|471738041|FG001|Overall Study|Withdrawal by Subject|5|||
131028751|NCT04052516|471738042|FG002|Overall Study|Withdrawal by Subject|6|||
131028752|NCT04052516|471738040|FG000|Overall Study|Adverse Event|3|||
131028753|NCT04052516|471738041|FG001|Overall Study|Adverse Event|2|||
131028754|NCT04052516|471738042|FG002|Overall Study|Adverse Event|8|||
131028755|NCT04052516|471738040|FG000|Overall Study|Lost to Follow-up|2|||
131028756|NCT04052516|471738041|FG001|Overall Study|Lost to Follow-up|5|||
131028757|NCT04052516|471738042|FG002|Overall Study|Lost to Follow-up|3|||
131028758|NCT04052516|471738040|FG000|Overall Study|Protocol Violation|1|||
131115021|NCT02408861|472052249|FG000|Overall Study|Disease Progression|0|||
131115022|NCT02408861|472052250|FG001|Overall Study|Disease Progression|0|||
131028759|NCT04052516|471738041|FG001|Overall Study|Protocol Violation|1|||
131115023|NCT02408861|472052251|FG002|Overall Study|Disease Progression|1|||
131115024|NCT02408861|472052252|FG003|Overall Study|Disease Progression|0|||
131028760|NCT04052516|471738042|FG002|Overall Study|Protocol Violation|0|||
131028761|NCT04052516|471738040|FG000|Overall Study|Death|1|||
131115025|NCT02408861|472052253|FG004|Overall Study|Disease Progression|3|||
130695538|NCT01868243|470509073|FG000|Overall Study|Death|0|||
131115026|NCT02408861|472052254|FG005|Overall Study|Disease Progression|1|||
131115027|NCT02408861|472052255|FG006|Overall Study|Disease Progression|1|||
130695539|NCT01868243|470509074|FG001|Overall Study|Death|1|||
130907787|NCT01606254|471298108|FG002|Overall Study|Adverse Event|0|||
130907788|NCT01606254|471298109|FG003|Overall Study|Adverse Event|1|||
130907789|NCT04543409|471298110|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130907790|NCT04543409|471298111|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130907791|NCT04543409|471298110|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
130907792|NCT04543409|471298111|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
130907793|NCT04543409|471298110|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
130907794|NCT04543409|471298111|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
130907795|NCT04543409|471298110|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
131028762|NCT04052516|471738041|FG001|Overall Study|Death|0|||
131028763|NCT04052516|471738042|FG002|Overall Study|Death|0|||
131028764|NCT04052516|471738040|FG000|Overall Study|Physician Decision|0|||
131028765|NCT04052516|471738041|FG001|Overall Study|Physician Decision|1|||
131028766|NCT04052516|471738042|FG002|Overall Study|Physician Decision|0|||
131028767|NCT04052516|471738040|FG000|Overall Study|Pregnancy|1|||
131028768|NCT04052516|471738041|FG001|Overall Study|Pregnancy|0|||
131028769|NCT04052516|471738042|FG002|Overall Study|Pregnancy|0|||
131028770|NCT04052516|471738040|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
131028771|NCT04052516|471738041|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
131028772|NCT04052516|471738042|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
131028773|NCT04052516|471738040|FG000|Overall Study|Reason not recorded|0|||
131028774|NCT04052516|471738041|FG001|Overall Study|Reason not recorded|1|||
131028775|NCT04052516|471738042|FG002|Overall Study|Reason not recorded|0|||
131028776|NCT02597946|471738043|FG000|Overall Study|Withdrawal by Subject|1|||
131028777|NCT02597946|471738043|FG000|Overall Study|Progressive disease|16|||
131028778|NCT02597946|471738043|FG000|Overall Study|Other than above|1|||
131028779|NCT03625882|471738044|FG000|Overall Study|Protocol Violation|3|||
131028780|NCT05058391|471738049|FG000|Overall Study|Adverse Event|1|||
131028781|NCT00739648|471738052|FG000|Overall Study|Adverse Event|3|||
131028782|NCT00739648|471738053|FG001|Overall Study|Adverse Event|15|||
131028783|NCT00739648|471738052|FG000|Overall Study|Withdrawal by Subject|13|||
131028784|NCT00739648|471738053|FG001|Overall Study|Withdrawal by Subject|25|||
131028785|NCT00739648|471738052|FG000|Overall Study|Lost to Follow-up|4|||
131028786|NCT00739648|471738053|FG001|Overall Study|Lost to Follow-up|7|||
131028787|NCT00739648|471738052|FG000|Overall Study|Death|2|||
131028788|NCT00739648|471738053|FG001|Overall Study|Death|0|||
131028789|NCT00739648|471738052|FG000|Overall Study|Do not know|4|||
131028790|NCT00739648|471738053|FG001|Overall Study|Do not know|6|||
131028791|NCT05110495|471738054|FG000|Overall Study|Lost to Follow-up|1|||
131028792|NCT05110495|471738054|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
131028793|NCT05141903|471738055|FG000|Overall Study|Withdrawal by Subject|0|||
131028794|NCT05141903|471738056|FG001|Overall Study|Withdrawal by Subject|1|||
131028795|NCT05141903|471738057|FG002|Overall Study|Withdrawal by Subject|1|||
131028796|NCT05141903|471738058|FG003|Overall Study|Withdrawal by Subject|0|||
131028797|NCT05141903|471738059|FG004|Overall Study|Withdrawal by Subject|0|||
131028798|NCT05141903|471738055|FG000|Overall Study|Other|1|||
131028799|NCT05141903|471738056|FG001|Overall Study|Other|1|||
131028800|NCT05141903|471738057|FG002|Overall Study|Other|0|||
131028801|NCT05141903|471738058|FG003|Overall Study|Other|0|||
131028802|NCT05141903|471738059|FG004|Overall Study|Other|0|||
131028803|NCT03089398|471738067|FG000|Overall Study|Death|4|||
131028804|NCT03089398|471738068|FG001|Overall Study|Death|9|||
131028805|NCT03089398|471738067|FG000|Overall Study|Lost to Follow-up|21|||
131028806|NCT03089398|471738068|FG001|Overall Study|Lost to Follow-up|30|||
131028807|NCT03089398|471738067|FG000|Overall Study|Withdrawal by Subject|2|||
131028808|NCT03089398|471738068|FG001|Overall Study|Withdrawal by Subject|2|||
131028809|NCT05062265|471738069|FG000|Overall Study|Withdrawal by Subject|1|||
131028810|NCT05062265|471738070|FG001|Overall Study|Withdrawal by Subject|0|||
131028811|NCT05439603|471738071|FG000|Overall Study|met withdrawal criteria|2|||
131028812|NCT05461131|471738072|FG000|Overall Study|Lost to Follow-up|0|||
131028813|NCT05461131|471738073|FG001|Overall Study|Lost to Follow-up|2|||
131028814|NCT03101904|471738081|FG000|Wash Out (10 Days)|Adverse Event|1|||
131028815|NCT03101904|471738082|FG001|Wash Out (10 Days)|Adverse Event|0|||
131028816|NCT03101904|471738081|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
131028817|NCT03101904|471738082|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
131028818|NCT02682316|471738083|FG000|Overall Study|Benign Final Pathology|27|||
131028819|NCT02682316|471738084|FG001|Overall Study|Benign Final Pathology|26|||
131028820|NCT02682316|471738083|FG000|Overall Study|Reoperation before 30 days|7|||
131028821|NCT02682316|471738084|FG001|Overall Study|Reoperation before 30 days|6|||
131028822|NCT02682316|471738083|FG000|Overall Study|Ineligible|1|||
131028823|NCT02682316|471738084|FG001|Overall Study|Ineligible|0|||
131028824|NCT02682316|471738083|FG000|Overall Study|Death|1|||
131028825|NCT02682316|471738084|FG001|Overall Study|Death|0|||
131028826|NCT02682316|471738083|FG000|Overall Study|Lost to Follow-up|7|||
131028827|NCT02682316|471738084|FG001|Overall Study|Lost to Follow-up|3|||
131028828|NCT04538417|471738085|FG000|Overall Study|Withdrawal by Subject|2|||
131028829|NCT00150813|471738087|FG000|Overall Study|Adverse Event|1|||
131028830|NCT00150813|471738087|FG000|Overall Study|Lack of Efficacy|1|||
130695540|NCT00985751|470509075|FG000|Overall Study|Adverse Event|0|||
130695541|NCT00985751|470509076|FG001|Overall Study|Adverse Event|0|||
130695542|NCT00985751|470509077|FG002|Overall Study|Adverse Event|0|||
130695543|NCT00985751|470509078|FG003|Overall Study|Adverse Event|0|||
130695544|NCT00985751|470509079|FG004|Overall Study|Adverse Event|1|||
130695545|NCT00999687|470509088|FG000|First Intervention|Withdrawal by Subject|1|||
130695546|NCT00999687|470509088|FG000|Second Intervention|Withdrawal by Subject|2|||
130695547|NCT00999687|470509088|FG000|Second Intervention|Lack of Efficacy|1|||
130695548|NCT00474188|470509089|FG000|Overall Study|Withdrawal by Subject|1|||
130695549|NCT00474188|470509089|FG000|Overall Study|Study discontinued by sponsor|5|||
130695550|NCT00858403|470509091|FG000|Overall Study|Withdrawal by Subject|1|||
130695551|NCT00858403|470509091|FG000|Overall Study|Death|3|||
130695552|NCT00858403|470509091|FG000|Overall Study|Disease Progression|1|||
130695553|NCT03961204|470509096|FG000|Overall Study|Withdrawal by Subject|2|||
130695554|NCT03961204|470509096|FG000|Overall Study|Lost to Follow-up|3|||
130695555|NCT03961204|470509096|FG000|Overall Study|Other|1|||
130695556|NCT03961204|470509096|FG000|Overall Study|Missing|1|||
130695557|NCT03867760|470509097|FG000|Overall Study|Lost to Follow-up|2|||
130695558|NCT03867760|470509098|FG001|Overall Study|Lost to Follow-up|3|||
131028831|NCT00150813|471738087|FG000|Overall Study|Lost to Follow-up|5|||
131028832|NCT00150813|471738087|FG000|Overall Study|Withdrawal by Subject|5|||
131028833|NCT00150813|471738087|FG000|Overall Study|Remission|3|||
131028834|NCT00150813|471738087|FG000|Overall Study|Planned pregancy|1|||
131028835|NCT00150813|471738087|FG000|Overall Study|Switch to commercially available LEV|2|||
131028836|NCT03052608|471738089|FG000|Treatment Phase|Adverse Event|10|||
131028837|NCT03052608|471738090|FG001|Treatment Phase|Adverse Event|12|||
131028838|NCT03052608|471738089|FG000|Treatment Phase|Death|6|||
131028839|NCT03052608|471738090|FG001|Treatment Phase|Death|4|||
131028840|NCT03052608|471738089|FG000|Treatment Phase|Withdrawal by Subject|4|||
131028841|NCT03052608|471738090|FG001|Treatment Phase|Withdrawal by Subject|12|||
131028842|NCT03052608|471738089|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
131028843|NCT03052608|471738090|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
131028844|NCT03052608|471738089|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
131028845|NCT03052608|471738090|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
131028846|NCT03052608|471738089|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
131028847|NCT03052608|471738090|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
131028848|NCT03052608|471738089|FG000|Treatment Phase|Ongoing|103|||
131028849|NCT03052608|471738090|FG001|Treatment Phase|Ongoing|31|||
131028850|NCT03052608|471738089|FG000|Long-Term Follow-up Phase|Death|23|||
131028851|NCT03052608|471738090|FG001|Long-Term Follow-up Phase|Death|28|||
131028852|NCT03052608|471738089|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
131028853|NCT03052608|471738090|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
131028854|NCT03052608|471738089|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
131028855|NCT03052608|471738090|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
131028856|NCT03052608|471738089|FG000|Long-Term Follow-up Phase|Ongoing|122|||
131028857|NCT03052608|471738090|FG001|Long-Term Follow-up Phase|Ongoing|99|||
131028858|NCT03113500|471738091|FG000|Overall Study|Withdrawal by Subject|1|||
131028859|NCT05249439|471738093|FG000|Overall Study|Withdrawal by Subject|2|||
131028860|NCT05249439|471738094|FG001|Overall Study|Withdrawal by Subject|5|||
131028861|NCT05249439|471738093|FG000|Overall Study|Physician Decision|3|||
131028862|NCT05249439|471738094|FG001|Overall Study|Physician Decision|1|||
131028863|NCT03526861|471738099|FG000|Initial Treatment Period|Not dosed|1|||
131028864|NCT03526861|471738100|FG001|Initial Treatment Period|Not dosed|1|||
131028865|NCT03526861|471738101|FG002|Initial Treatment Period|Not dosed|1|||
131028866|NCT03526861|471738102|FG003|Initial Treatment Period|Not dosed|0|||
131028867|NCT03526861|471738103|FG004|Initial Treatment Period|Not dosed|0|||
131028868|NCT03526861|471738104|FG005|Initial Treatment Period|Not dosed|0|||
131028869|NCT03526861|471738105|FG006|Initial Treatment Period|Not dosed|0|||
131028870|NCT03526861|471738106|FG007|Initial Treatment Period|Not dosed|0|||
131028871|NCT03526861|471738107|FG008|Initial Treatment Period|Not dosed|0|||
131028872|NCT03526861|471738099|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
131028873|NCT03526861|471738100|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
131028874|NCT03526861|471738101|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
131028875|NCT03526861|471738102|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130695559|NCT03867760|470509097|FG000|Overall Study|Withdrawal by Subject|1|||
131028876|NCT03526861|471738103|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028877|NCT03526861|471738104|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
130695560|NCT03867760|470509098|FG001|Overall Study|Withdrawal by Subject|2|||
130695561|NCT03867760|470509097|FG000|Overall Study|subject could not meet study logistics|3|||
130695562|NCT03867760|470509098|FG001|Overall Study|subject could not meet study logistics|3|||
130768493|NCT04849416|470776679|FG000|Overall Study|Ongoing Treatment|12|||
131115028|NCT02408861|472052249|FG000|Overall Study|Adverse Event|1|||
131115029|NCT02408861|472052250|FG001|Overall Study|Adverse Event|0|||
131115030|NCT02408861|472052251|FG002|Overall Study|Adverse Event|1|||
131115031|NCT02408861|472052252|FG003|Overall Study|Adverse Event|0|||
131115032|NCT02408861|472052253|FG004|Overall Study|Adverse Event|2|||
131115033|NCT02408861|472052254|FG005|Overall Study|Adverse Event|0|||
131115034|NCT02408861|472052255|FG006|Overall Study|Adverse Event|0|||
131115035|NCT02408861|472052249|FG000|Overall Study|Physician Decision|1|||
131115036|NCT02408861|472052250|FG001|Overall Study|Physician Decision|1|||
131115037|NCT02408861|472052251|FG002|Overall Study|Physician Decision|1|||
131115038|NCT02408861|472052252|FG003|Overall Study|Physician Decision|0|||
131115039|NCT02408861|472052253|FG004|Overall Study|Physician Decision|0|||
131115040|NCT02408861|472052254|FG005|Overall Study|Physician Decision|1|||
131115041|NCT02408861|472052255|FG006|Overall Study|Physician Decision|0|||
131115042|NCT02408861|472052249|FG000|Overall Study|Protocol Violation|1|||
131115043|NCT02408861|472052250|FG001|Overall Study|Protocol Violation|0|||
131115044|NCT02408861|472052251|FG002|Overall Study|Protocol Violation|0|||
131115045|NCT02408861|472052252|FG003|Overall Study|Protocol Violation|0|||
131115046|NCT02408861|472052253|FG004|Overall Study|Protocol Violation|0|||
130907796|NCT04543409|471298111|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
130907797|NCT04543409|471298110|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
130907798|NCT04543409|471298111|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
130907799|NCT04543409|471298110|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
130907800|NCT04543409|471298111|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
130907801|NCT04543409|471298110|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
130907802|NCT04543409|471298111|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
130907803|NCT04543409|471298110|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
130907804|NCT04543409|471298111|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
130907805|NCT04543409|471298110|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
130907806|NCT04543409|471298111|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
130907807|NCT04543409|471298110|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
130907808|NCT04543409|471298111|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
130907809|NCT04543409|471298110|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
130907810|NCT04543409|471298111|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
130907811|NCT02093026|471298112|FG000|Overall Study|Adverse Event|26|||
130907812|NCT02093026|471298112|FG000|Overall Study|Death|10|||
130907813|NCT02093026|471298112|FG000|Overall Study|Other|157|||
131028878|NCT03526861|471738105|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028879|NCT03526861|471738106|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028880|NCT03526861|471738107|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028881|NCT03526861|471738099|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
131028882|NCT03526861|471738100|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
131028883|NCT03526861|471738101|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
131028884|NCT03526861|471738102|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131028885|NCT03526861|471738103|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131028886|NCT03526861|471738104|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131028887|NCT03526861|471738105|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131028888|NCT03526861|471738106|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131028889|NCT03526861|471738107|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
131028890|NCT03526861|471738099|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028891|NCT03526861|471738100|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028892|NCT03526861|471738101|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028893|NCT03526861|471738102|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
131028894|NCT03526861|471738103|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
131028895|NCT03526861|471738104|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028896|NCT03526861|471738105|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
131028897|NCT03526861|471738106|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028898|NCT03526861|471738107|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028899|NCT03526861|471738099|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
131028900|NCT03526861|471738100|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
131028901|NCT03526861|471738101|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
131115047|NCT02408861|472052254|FG005|Overall Study|Protocol Violation|0|||
131115048|NCT02408861|472052255|FG006|Overall Study|Protocol Violation|0|||
131115049|NCT02408861|472052249|FG000|Overall Study|Withdrawal by Subject|0|||
131115050|NCT02408861|472052250|FG001|Overall Study|Withdrawal by Subject|0|||
131115051|NCT02408861|472052251|FG002|Overall Study|Withdrawal by Subject|0|||
131115052|NCT02408861|472052252|FG003|Overall Study|Withdrawal by Subject|0|||
131115053|NCT02408861|472052253|FG004|Overall Study|Withdrawal by Subject|1|||
131115054|NCT02408861|472052254|FG005|Overall Study|Withdrawal by Subject|1|||
131115055|NCT02408861|472052255|FG006|Overall Study|Withdrawal by Subject|0|||
131115056|NCT02408861|472052249|FG000|Overall Study|Other Treatment|0|||
131115057|NCT02408861|472052250|FG001|Overall Study|Other Treatment|0|||
131115058|NCT02408861|472052251|FG002|Overall Study|Other Treatment|0|||
131115059|NCT02408861|472052252|FG003|Overall Study|Other Treatment|0|||
131115060|NCT02408861|472052253|FG004|Overall Study|Other Treatment|0|||
131115061|NCT02408861|472052254|FG005|Overall Study|Other Treatment|1|||
131115062|NCT02408861|472052255|FG006|Overall Study|Other Treatment|1|||
131115063|NCT07052682|472052256|FG000|Overall Study|Withdrawal by Subject|4|||
131115064|NCT05460273|472052257|FG000|Overall Study|Death|43|||
131115065|NCT05460273|472052258|FG001|Overall Study|Death|9|||
131115066|NCT05460273|472052257|FG000|Overall Study|Lost to Follow-up|7|||
131115067|NCT05460273|472052258|FG001|Overall Study|Lost to Follow-up|0|||
131115068|NCT05460273|472052257|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
131115069|NCT05460273|472052258|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
131115070|NCT04124614|472052259|FG000|Placebo Run-in Period|Not Randomized|34|||
131115071|NCT04124614|472052260|FG001|Placebo Run-in Period|Not Randomized|0|||
131115072|NCT04124614|472052261|FG002|Placebo Run-in Period|Not Randomized|0|||
131115073|NCT04124614|472052259|FG000|Double Blind Treatment Period|Adverse Event|0|||
131115074|NCT04124614|472052260|FG001|Double Blind Treatment Period|Adverse Event|7|||
131115075|NCT04124614|472052261|FG002|Double Blind Treatment Period|Adverse Event|22|||
131115076|NCT04124614|472052259|FG000|Double Blind Treatment Period|Death|0|||
131115077|NCT04124614|472052260|FG001|Double Blind Treatment Period|Death|0|||
131115078|NCT04124614|472052261|FG002|Double Blind Treatment Period|Death|1|||
131115079|NCT04124614|472052259|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
131115080|NCT04124614|472052260|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
131115081|NCT04124614|472052261|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
131115082|NCT04124614|472052259|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
131115083|NCT04124614|472052260|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
131115084|NCT04124614|472052261|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
131115085|NCT04124614|472052259|FG000|Double Blind Treatment Period|Physician Decision|0|||
131115086|NCT04124614|472052260|FG001|Double Blind Treatment Period|Physician Decision|0|||
131115087|NCT04124614|472052261|FG002|Double Blind Treatment Period|Physician Decision|3|||
131115088|NCT04124614|472052259|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
131115089|NCT04124614|472052260|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
131115090|NCT04124614|472052261|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
131115091|NCT04124614|472052259|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
131115092|NCT04124614|472052260|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
131115093|NCT04124614|472052261|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
131115094|NCT04124614|472052259|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
131115095|NCT04124614|472052260|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
131115096|NCT04124614|472052261|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
131115097|NCT04890054|472053556|FG000|Overall Study|Lost to Follow-up|202|||
131115098|NCT04890054|472053557|FG001|Overall Study|Lost to Follow-up|219|||
131115099|NCT01310803|472053561|FG000|Overall Study|Subject terminated by Sponsor|1|||
130695563|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Subject request|8|||
130907814|NCT00518973|471298113|FG000|Overall Study|Withdrawal by Subject|3|||
130907815|NCT00518973|471298114|FG001|Overall Study|Withdrawal by Subject|2|||
130907816|NCT00174291|471298125|FG000|Overall Study|Lost to Follow-up|1|||
130907817|NCT00174291|471298126|FG001|Overall Study|Lost to Follow-up|1|||
130907818|NCT00174291|471298125|FG000|Overall Study|Protocol Violation|0|||
130907819|NCT00174291|471298126|FG001|Overall Study|Protocol Violation|2|||
130907820|NCT00174291|471298125|FG000|Overall Study|Study terminated by sponsor|1|||
130907821|NCT00174291|471298126|FG001|Overall Study|Study terminated by sponsor|0|||
130907822|NCT00174291|471298125|FG000|Overall Study|Withdrawal by Subject|3|||
130907823|NCT00174291|471298126|FG001|Overall Study|Withdrawal by Subject|3|||
130907824|NCT01923168|471298129|FG000|Overall Study|Protocol Violation|1|||
130695564|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Subject request|11|||
130695565|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
130907825|NCT01923168|471298130|FG001|Overall Study|Protocol Violation|1|||
131115100|NCT01310803|472053562|FG001|Overall Study|Subject terminated by Sponsor|0|||
131115101|NCT01306890|472053563|FG000|Overall Study|Adverse Event|2|||
131115102|NCT01306890|472053563|FG000|Overall Study|Death|1223|||
131115103|NCT01306890|472053563|FG000|Overall Study|Lost to Follow-up|58|||
131115104|NCT01306890|472053563|FG000|Overall Study|Withdrawal by Subject|88|||
131115105|NCT01306890|472053563|FG000|Overall Study|Unspecified reasons|104|||
131115106|NCT01306890|472053563|FG000|Overall Study|Study Termination|3|||
130695566|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
130695567|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
130907826|NCT01923168|471298131|FG002|Overall Study|Protocol Violation|0|||
131115107|NCT01306890|472053563|FG000|Overall Study|No discontinuation documentation|41|||
130907827|NCT01923168|471298129|FG000|Overall Study|Subject/guardian decision|14|||
130907828|NCT01923168|471298130|FG001|Overall Study|Subject/guardian decision|14|||
130907829|NCT01923168|471298131|FG002|Overall Study|Subject/guardian decision|4|||
131028902|NCT03526861|471738102|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
131028903|NCT03526861|471738103|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
131028904|NCT03526861|471738104|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
131028905|NCT03526861|471738105|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
131028906|NCT03526861|471738106|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
131028907|NCT03526861|471738107|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
131028908|NCT03526861|471738099|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028909|NCT03526861|471738100|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028910|NCT03526861|471738101|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028911|NCT03526861|471738102|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
131028912|NCT03526861|471738103|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028913|NCT03526861|471738104|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028914|NCT03526861|471738105|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028915|NCT03526861|471738106|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028916|NCT03526861|471738107|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028917|NCT03526861|471738099|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028918|NCT03526861|471738100|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028919|NCT03526861|471738101|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028920|NCT03526861|471738102|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028921|NCT03526861|471738103|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028922|NCT03526861|471738104|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028923|NCT03526861|471738105|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028924|NCT03526861|471738106|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
131028925|NCT03526861|471738107|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
131028926|NCT03526861|471738099|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131028927|NCT03526861|471738100|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131028928|NCT03526861|471738101|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131028929|NCT03526861|471738102|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131028930|NCT03526861|471738103|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131028931|NCT03526861|471738104|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131028932|NCT03526861|471738105|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131028933|NCT03526861|471738106|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
131028934|NCT03526861|471738107|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
131028935|NCT03526861|471738099|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028936|NCT03526861|471738100|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028937|NCT03526861|471738101|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028938|NCT03526861|471738102|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028939|NCT03526861|471738103|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028940|NCT03526861|471738104|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028941|NCT03526861|471738105|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028942|NCT03526861|471738106|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
131028943|NCT03526861|471738107|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
131028944|NCT02814838|471738114|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
131028945|NCT02814838|471738115|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
131028946|NCT02814838|471738114|FG000|Overall Study|Consent withdrawal|1|||
130907830|NCT01923168|471298129|FG000|Overall Study|Adverse Event|12|||
130695568|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
130907831|NCT01923168|471298130|FG001|Overall Study|Adverse Event|12|||
130907832|NCT01923168|471298131|FG002|Overall Study|Adverse Event|0|||
130907833|NCT01923168|471298129|FG000|Overall Study|Physician Decision|6|||
130907834|NCT01923168|471298130|FG001|Overall Study|Physician Decision|9|||
130907835|NCT01923168|471298131|FG002|Overall Study|Physician Decision|5|||
130907836|NCT01923168|471298129|FG000|Overall Study|Progressive disease|4|||
130907837|NCT01923168|471298130|FG001|Overall Study|Progressive disease|3|||
130907838|NCT01923168|471298131|FG002|Overall Study|Progressive disease|7|||
130907839|NCT01923168|471298129|FG000|Overall Study|Death|0|||
130907840|NCT01923168|471298130|FG001|Overall Study|Death|0|||
130907841|NCT01923168|471298131|FG002|Overall Study|Death|1|||
130907842|NCT03418571|471298132|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
130907843|NCT03418571|471298133|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
130907844|NCT02376829|471298134|FG000|Overall Study|Withdrawal by Subject|27|||
130907845|NCT02376829|471298135|FG001|Overall Study|Withdrawal by Subject|44|||
130907846|NCT01439347|471298136|FG000|Overall Study|Death|10|||
130907847|NCT01439347|471298137|FG001|Overall Study|Death|9|||
130907848|NCT01439347|471298136|FG000|Overall Study|Withdrawal by Subject|0|||
130907849|NCT01439347|471298137|FG001|Overall Study|Withdrawal by Subject|1|||
130907850|NCT01439347|471298136|FG000|Overall Study|Physician Decision|1|||
130907851|NCT01439347|471298137|FG001|Overall Study|Physician Decision|0|||
130907852|NCT01439347|471298136|FG000|Overall Study|Sponsor Terminated Study|2|||
130907853|NCT01439347|471298137|FG001|Overall Study|Sponsor Terminated Study|3|||
130907854|NCT02009384|471298139|FG000|Overall Study|Death|2|||
130907855|NCT00718237|471298141|FG000|Overall Study|Adverse Event|1|||
130907856|NCT00718237|471298142|FG001|Overall Study|Adverse Event|3|||
130907857|NCT00718237|471298141|FG000|Overall Study|Lost to Follow-up|2|||
130907858|NCT00718237|471298142|FG001|Overall Study|Lost to Follow-up|2|||
130907859|NCT00718237|471298141|FG000|Overall Study|Physician Decision|1|||
130907860|NCT00718237|471298142|FG001|Overall Study|Physician Decision|0|||
130907861|NCT00718237|471298141|FG000|Overall Study|Withdrawal by Subject|9|||
130907862|NCT00718237|471298142|FG001|Overall Study|Withdrawal by Subject|10|||
130907863|NCT03189381|471298143|FG000|Overall Study|Death|1|||
130907864|NCT03189381|471298144|FG001|Overall Study|Death|0|||
130907865|NCT00251004|471298145|FG000|Overall Study|Withdrawal by Subject|23|||
130907866|NCT00251004|471298146|FG001|Overall Study|Withdrawal by Subject|16|||
130907867|NCT00251004|471298147|FG002|Overall Study|Withdrawal by Subject|14|||
130907868|NCT00251004|471298145|FG000|Overall Study|Death|9|||
130907869|NCT00251004|471298146|FG001|Overall Study|Death|10|||
130907870|NCT00251004|471298147|FG002|Overall Study|Death|8|||
130907871|NCT00251004|471298145|FG000|Overall Study|Lost to Follow-up|1|||
130907872|NCT00251004|471298146|FG001|Overall Study|Lost to Follow-up|2|||
130907873|NCT00251004|471298147|FG002|Overall Study|Lost to Follow-up|1|||
130907874|NCT00251004|471298145|FG000|Overall Study|Graft Loss|12|||
130907875|NCT00251004|471298146|FG001|Overall Study|Graft Loss|13|||
130907876|NCT00251004|471298147|FG002|Overall Study|Graft Loss|8|||
130907877|NCT00256282|471298149|FG000|Overall Study|Disease progression, relapse during acti|12|||
130907878|NCT00256282|471298149|FG000|Overall Study|Adverse Event|3|||
130907879|NCT00256282|471298149|FG000|Overall Study|Physician Decision|1|||
130907880|NCT00667446|471298150|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
130907881|NCT00667446|471298151|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
130907882|NCT00667446|471298150|FG000|Treatment Period (36 Months)|Other|2|||
130907883|NCT00667446|471298151|FG001|Treatment Period (36 Months)|Other|2|||
130907884|NCT00667446|471298150|FG000|Treatment Period (36 Months)|Personal reasons|2|||
130907885|NCT00667446|471298151|FG001|Treatment Period (36 Months)|Personal reasons|2|||
130907886|NCT00667446|471298150|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
130907887|NCT00667446|471298151|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
130907888|NCT00667446|471298150|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
130695569|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
130695570|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
130907889|NCT00667446|471298151|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
130907890|NCT00667446|471298150|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
130907891|NCT00667446|471298151|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
130907892|NCT00667446|471298150|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
130907893|NCT00667446|471298151|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
130907894|NCT00667446|471298150|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
130695571|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
130907895|NCT00667446|471298151|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
130907896|NCT00667446|471298150|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
130907897|NCT00667446|471298151|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
130907898|NCT00322153|471298154|FG000|Overall Study|Adverse Event|21|||
130907899|NCT00322153|471298155|FG001|Overall Study|Adverse Event|34|||
130907900|NCT00322153|471298154|FG000|Overall Study|Protocol Violation|6|||
130907901|NCT00322153|471298155|FG001|Overall Study|Protocol Violation|14|||
130695572|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
130695573|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
130695574|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
130695575|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Death|1|||
130695576|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Death|0|||
130695577|NCT00521586|470510569|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
130695578|NCT00521586|470510570|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
130695579|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
130695580|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
130695581|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
130695582|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
130695583|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
130695584|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
130695585|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
130695586|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
130907902|NCT00322153|471298154|FG000|Overall Study|Withdrawal by Subject|18|||
130907903|NCT00322153|471298155|FG001|Overall Study|Withdrawal by Subject|10|||
130695587|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
130695588|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
130695589|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
130695590|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
130695591|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
130695592|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
130695593|NCT00521586|470510569|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
130695594|NCT00521586|470510570|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
130695595|NCT00521586|470510569|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
130907904|NCT00322153|471298154|FG000|Overall Study|Lack of Efficacy|8|||
130907905|NCT00322153|471298155|FG001|Overall Study|Lack of Efficacy|3|||
130907906|NCT00322153|471298154|FG000|Overall Study|Lost to Follow-up|5|||
130907907|NCT00322153|471298155|FG001|Overall Study|Lost to Follow-up|4|||
130907908|NCT00322153|471298154|FG000|Overall Study|Withdrawn for other reasons|5|||
130907909|NCT00322153|471298155|FG001|Overall Study|Withdrawn for other reasons|4|||
130907910|NCT00591578|471298157|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
130907911|NCT00591578|471298158|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
130907912|NCT00591578|471298159|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
130907913|NCT00591578|471298157|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
130907914|NCT00591578|471298158|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
130907915|NCT00591578|471298159|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
130907916|NCT00591578|471298157|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
130907917|NCT00591578|471298158|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
130907918|NCT00591578|471298159|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
130907919|NCT00591578|471298157|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
130907920|NCT00591578|471298158|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
130907921|NCT00591578|471298159|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
130907922|NCT00591578|471298157|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
130907923|NCT00591578|471298158|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
130907924|NCT00591578|471298159|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
130907925|NCT00591578|471298157|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
130907926|NCT00591578|471298158|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
130907927|NCT00591578|471298159|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
130907928|NCT00591578|471298157|FG000|Double-Blind Treatment Phase|Other|4|||
130907929|NCT00591578|471298158|FG001|Double-Blind Treatment Phase|Other|9|||
130907930|NCT00591578|471298159|FG002|Double-Blind Treatment Phase|Other|4|||
130907931|NCT00591578|471298157|FG000|Open-Label Extension Phase|Adverse Event|3|||
130907932|NCT00591578|471298158|FG001|Open-Label Extension Phase|Adverse Event|5|||
130907933|NCT00591578|471298159|FG002|Open-Label Extension Phase|Adverse Event|0|||
130907934|NCT00591578|471298157|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
130907935|NCT00591578|471298158|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
130907936|NCT00591578|471298159|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130907937|NCT00591578|471298157|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
130907938|NCT00591578|471298158|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
130907939|NCT00591578|471298159|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
130907940|NCT00591578|471298157|FG000|Open-Label Extension Phase|Other|1|||
130907941|NCT00591578|471298158|FG001|Open-Label Extension Phase|Other|0|||
130768494|NCT04849416|470776680|FG001|Overall Study|Ongoing Treatment|5|||
130768495|NCT04849416|470776681|FG002|Overall Study|Ongoing Treatment|3|||
130768496|NCT04849416|470776679|FG000|Overall Study|On Post-Treatment Follow-up|8|||
130907942|NCT00591578|471298159|FG002|Open-Label Extension Phase|Other|0|||
130907943|NCT02632838|471298160|FG000|Overall Study|Withdrawal by Subject|3|||
130907944|NCT02632838|471298161|FG001|Overall Study|Withdrawal by Subject|0|||
130907945|NCT02632838|471298160|FG000|Overall Study|Lost to Follow-up|0|||
131115108|NCT03047551|472053568|FG000|Overall Study|Did not receive TAS|1|||
130907946|NCT02632838|471298161|FG001|Overall Study|Lost to Follow-up|2|||
130907947|NCT03945175|471298164|FG000|Overall Study|Did not meet inclusion criteria|31|||
130907948|NCT03945175|471298164|FG000|Overall Study|Withdrew consent|2|||
130907949|NCT03945175|471298164|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
130907950|NCT03945175|471298164|FG000|Overall Study|Early termination during Mydayis treatment|1|||
130907951|NCT00378079|471298168|FG000|Overall Study|Lost to Follow-up|6|||
130907952|NCT00378079|471298169|FG001|Overall Study|Lost to Follow-up|1|||
130907953|NCT00378079|471298170|FG002|Overall Study|Lost to Follow-up|0|||
130907954|NCT03455764|471298174|FG000|Overall Study|Adverse Event|1|||
130907955|NCT03455764|471298175|FG001|Overall Study|Adverse Event|0|||
130907956|NCT03455764|471298176|FG002|Overall Study|Adverse Event|0|||
130907957|NCT03455764|471298177|FG003|Overall Study|Adverse Event|0|||
130907958|NCT03455764|471298178|FG004|Overall Study|Adverse Event|0|||
130907959|NCT03455764|471298174|FG000|Overall Study|Disease Progression|4|||
130907960|NCT03455764|471298175|FG001|Overall Study|Disease Progression|0|||
130907961|NCT03455764|471298176|FG002|Overall Study|Disease Progression|0|||
130907962|NCT03455764|471298177|FG003|Overall Study|Disease Progression|0|||
130907963|NCT03455764|471298178|FG004|Overall Study|Disease Progression|0|||
130907964|NCT03455764|471298174|FG000|Overall Study|On Treatment|1|||
130907965|NCT03455764|471298175|FG001|Overall Study|On Treatment|0|||
130907966|NCT03455764|471298176|FG002|Overall Study|On Treatment|0|||
130907967|NCT03455764|471298177|FG003|Overall Study|On Treatment|0|||
130907968|NCT03455764|471298178|FG004|Overall Study|On Treatment|0|||
130907969|NCT01445886|471298180|FG000|Overall Study|Lost to Follow-up|2|||
130907970|NCT01445886|471298180|FG000|Overall Study|Protocol Violation|3|||
130907971|NCT00995865|471298181|FG000|Overall Study|Protocol Violation|2|||
130907972|NCT00995865|471298182|FG001|Overall Study|Protocol Violation|0|||
130907973|NCT00995865|471298183|FG002|Overall Study|Protocol Violation|0|||
130907974|NCT00995865|471298181|FG000|Overall Study|Lost to Follow-up|0|||
130907975|NCT00995865|471298182|FG001|Overall Study|Lost to Follow-up|0|||
130907976|NCT00995865|471298183|FG002|Overall Study|Lost to Follow-up|1|||
130907977|NCT05080660|471298185|FG000|Overall Study|Adverse Event|4|||
130907978|NCT05080660|471298186|FG001|Overall Study|Adverse Event|0|||
130907979|NCT05080660|471298185|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
130907980|NCT05080660|471298186|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
130907981|NCT05080660|471298185|FG000|Overall Study|Physician Decision|1|||
130907982|NCT05080660|471298186|FG001|Overall Study|Physician Decision|0|||
130907983|NCT05080660|471298185|FG000|Overall Study|Protocol Deviation|2|||
130907984|NCT05080660|471298186|FG001|Overall Study|Protocol Deviation|0|||
130907985|NCT05080660|471298185|FG000|Overall Study|Withdrawal by Subject|5|||
130907986|NCT05080660|471298186|FG001|Overall Study|Withdrawal by Subject|2|||
130907987|NCT04221230|471298196|FG000|Overall Study|Lost to Follow-up|12|||
130907988|NCT04221230|471298197|FG001|Overall Study|Lost to Follow-up|12|||
130907989|NCT04221230|471298196|FG000|Overall Study|Protocol Violation|2|||
130907990|NCT04221230|471298197|FG001|Overall Study|Protocol Violation|2|||
130907991|NCT04221230|471298196|FG000|Overall Study|Adverse Event|0|||
130907992|NCT04221230|471298197|FG001|Overall Study|Adverse Event|8|||
130907993|NCT04221230|471298196|FG000|Overall Study|Physician Decision|1|||
131028947|NCT02814838|471738115|FG001|Overall Study|Consent withdrawal|1|||
131028948|NCT00611559|471738117|FG000|Overall Study|Lost to Follow-up|0|||
131028949|NCT00611559|471738118|FG001|Overall Study|Lost to Follow-up|1|||
130695596|NCT00521586|470510570|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
130695597|NCT00521586|470510569|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
130695598|NCT00521586|470510570|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
131028950|NCT00611559|471738119|FG002|Overall Study|Lost to Follow-up|0|||
131028951|NCT00611559|471738117|FG000|Overall Study|Protocol Violation|1|||
131028952|NCT00611559|471738118|FG001|Overall Study|Protocol Violation|0|||
131028953|NCT00611559|471738119|FG002|Overall Study|Protocol Violation|1|||
130695599|NCT00521586|470510569|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
130695600|NCT00521586|470510570|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
130695601|NCT03234907|470510571|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
130695602|NCT03234907|470510572|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
130695603|NCT03234907|470510573|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130695604|NCT03234907|470510574|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130768497|NCT04849416|470776680|FG001|Overall Study|On Post-Treatment Follow-up|9|||
130768498|NCT04849416|470776681|FG002|Overall Study|On Post-Treatment Follow-up|10|||
130768499|NCT04849416|470776679|FG000|Overall Study|Withdrawal by Subject|0|||
130907994|NCT04221230|471298197|FG001|Overall Study|Physician Decision|0|||
130907995|NCT04221230|471298196|FG000|Overall Study|Withdrawal by Subject|13|||
130907996|NCT04221230|471298197|FG001|Overall Study|Withdrawal by Subject|11|||
130907997|NCT04221230|471298196|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130907998|NCT04221230|471298197|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130907999|NCT04221230|471298196|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130908000|NCT04221230|471298197|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130908001|NCT04221230|471298196|FG000|Overall Study|Pregnancy|0|||
131028954|NCT04095104|471738120|FG000|Overall Study|Withdrawal by Subject|0|||
130695605|NCT03234907|470510575|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130695606|NCT03234907|470510576|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130695607|NCT03234907|470510571|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
130695608|NCT03234907|470510572|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
130695609|NCT03234907|470510573|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130695610|NCT03234907|470510574|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130695611|NCT03234907|470510575|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130695612|NCT03234907|470510576|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130695613|NCT03234907|470510571|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
130695614|NCT03234907|470510572|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130695615|NCT03234907|470510573|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130695616|NCT03234907|470510574|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130695617|NCT03234907|470510575|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130695618|NCT03234907|470510576|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130695619|NCT03234907|470510571|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
130695620|NCT03234907|470510572|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
130695621|NCT03234907|470510573|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130695622|NCT03234907|470510574|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130695623|NCT03234907|470510575|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130695624|NCT03234907|470510576|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130695625|NCT03234907|470510571|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
130695626|NCT03234907|470510572|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
130695627|NCT03234907|470510573|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
130695628|NCT03234907|470510574|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
130695629|NCT03234907|470510575|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
130695630|NCT03234907|470510576|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
130695631|NCT03234907|470510571|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
130695632|NCT03234907|470510572|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
130695633|NCT03234907|470510573|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
130695634|NCT03234907|470510574|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
130695635|NCT03234907|470510575|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
130695636|NCT03234907|470510576|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
130695637|NCT03234907|470510571|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
130695638|NCT03234907|470510572|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
130695639|NCT03234907|470510573|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
130695640|NCT03234907|470510574|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
130695641|NCT03234907|470510575|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
130695642|NCT03234907|470510576|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
130695643|NCT00642993|470510577|FG000|Overall Study|Adverse Event|85|||
130695644|NCT00642993|470510578|FG001|Overall Study|Adverse Event|4|||
130695645|NCT00642993|470510577|FG000|Overall Study|Lost to Follow-up|8|||
130695646|NCT00642993|470510578|FG001|Overall Study|Lost to Follow-up|4|||
130695647|NCT00642993|470510577|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
130695648|NCT00642993|470510578|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
130695649|NCT00642993|470510577|FG000|Overall Study|Protocol Violation|1|||
130695650|NCT00642993|470510578|FG001|Overall Study|Protocol Violation|4|||
130695651|NCT00642993|470510577|FG000|Overall Study|Did not meet protocol eligibility|0|||
130695652|NCT00642993|470510578|FG001|Overall Study|Did not meet protocol eligibility|1|||
130695653|NCT00642993|470510577|FG000|Overall Study|Administrative|1|||
130695654|NCT00642993|470510578|FG001|Overall Study|Administrative|0|||
130695655|NCT02664415|470510579|FG000|Overall Study|Adverse Event|1|||
130695656|NCT02664415|470510580|FG001|Overall Study|Adverse Event|0|||
130695657|NCT02986139|470510584|FG000|Overall Study|Sponsor Decision|1|||
130695658|NCT02986139|470510585|FG001|Overall Study|Sponsor Decision|2|||
130695659|NCT02986139|470510584|FG000|Overall Study|Withdrawal by Subject|0|||
130695660|NCT02986139|470510585|FG001|Overall Study|Withdrawal by Subject|1|||
130695661|NCT02986139|470510584|FG000|Overall Study|Lost to Follow-up|0|||
130695662|NCT02986139|470510585|FG001|Overall Study|Lost to Follow-up|1|||
130768500|NCT04849416|470776680|FG001|Overall Study|Withdrawal by Subject|0|||
130768501|NCT04849416|470776681|FG002|Overall Study|Withdrawal by Subject|1|||
130908002|NCT04221230|471298197|FG001|Overall Study|Pregnancy|1|||
130908003|NCT04221230|471298196|FG000|Overall Study|Other|1|||
130908004|NCT04221230|471298197|FG001|Overall Study|Other|2|||
130908005|NCT02021656|471298198|FG000|Overall Study|Adverse Event|1|||
130908006|NCT02021656|471298198|FG000|Overall Study|Lack of Efficacy|2|||
130908007|NCT02021656|471298198|FG000|Overall Study|Lost to Follow-up|1|||
131115109|NCT03047551|472053569|FG001|Overall Study|Did not receive TAS|0|||
130908008|NCT02021656|471298198|FG000|Overall Study|Withdrew Consent|2|||
130908009|NCT00282347|471298201|FG000|Treatment Period|Death|2|||
130908010|NCT00282347|471298202|FG001|Treatment Period|Death|0|||
130908011|NCT00282347|471298201|FG000|Treatment Period|Lost to Follow-up|2|||
130908012|NCT00282347|471298202|FG001|Treatment Period|Lost to Follow-up|5|||
130908013|NCT00282347|471298201|FG000|Treatment Period|Withdrawal by Subject|1|||
130908014|NCT00282347|471298202|FG001|Treatment Period|Withdrawal by Subject|3|||
131115110|NCT03047551|472053568|FG000|Overall Study|Physician Decision|1|||
131115111|NCT03047551|472053569|FG001|Overall Study|Physician Decision|0|||
131115112|NCT03047551|472053568|FG000|Overall Study|Withdrawal by Subject|0|||
131115113|NCT03047551|472053569|FG001|Overall Study|Withdrawal by Subject|1|||
131115114|NCT03047551|472053568|FG000|Overall Study|Probe malfunction|0|||
131115115|NCT03047551|472053569|FG001|Overall Study|Probe malfunction|1|||
131115116|NCT03047551|472053568|FG000|Overall Study|Ineligible|0|||
131115117|NCT03047551|472053569|FG001|Overall Study|Ineligible|1|||
131115118|NCT00726622|472053570|FG000|Overall Study|Withdrawal by Subject|16|||
131115119|NCT00726622|472053571|FG001|Overall Study|Withdrawal by Subject|2|||
131115120|NCT00726622|472053570|FG000|Overall Study|Physician Decision|0|||
131115121|NCT00726622|472053571|FG001|Overall Study|Physician Decision|1|||
131115122|NCT00726622|472053570|FG000|Overall Study|Metastasis|2|||
131115123|NCT00726622|472053571|FG001|Overall Study|Metastasis|0|||
131115124|NCT01940354|472053572|FG000|Overall Study|Withdrawal by Subject|4|||
131115125|NCT01940354|472053573|FG001|Overall Study|Withdrawal by Subject|2|||
131115126|NCT03872453|472053574|FG000|Overall Study|Adverse Event|1|||
131115127|NCT03872453|472053575|FG001|Overall Study|Adverse Event|1|||
131115128|NCT03872453|472053576|FG002|Overall Study|Adverse Event|0|||
131115129|NCT03872453|472053577|FG003|Overall Study|Adverse Event|0|||
131115130|NCT03872453|472053574|FG000|Overall Study|Lost to Follow-up|8|||
131115131|NCT03872453|472053575|FG001|Overall Study|Lost to Follow-up|7|||
131115132|NCT03872453|472053576|FG002|Overall Study|Lost to Follow-up|4|||
131115133|NCT03872453|472053577|FG003|Overall Study|Lost to Follow-up|4|||
131115134|NCT03872453|472053574|FG000|Overall Study|Never Treated Migraine|19|||
131115135|NCT03872453|472053575|FG001|Overall Study|Never Treated Migraine|17|||
131115136|NCT03872453|472053576|FG002|Overall Study|Never Treated Migraine|13|||
131115137|NCT03872453|472053577|FG003|Overall Study|Never Treated Migraine|12|||
131115138|NCT03872453|472053574|FG000|Overall Study|Pregnancy|1|||
131115139|NCT03872453|472053575|FG001|Overall Study|Pregnancy|0|||
131115140|NCT03872453|472053576|FG002|Overall Study|Pregnancy|0|||
131115141|NCT03872453|472053577|FG003|Overall Study|Pregnancy|0|||
131115142|NCT03872453|472053574|FG000|Overall Study|Protocol Deviation|2|||
131115143|NCT03872453|472053575|FG001|Overall Study|Protocol Deviation|0|||
131115144|NCT03872453|472053576|FG002|Overall Study|Protocol Deviation|0|||
131115145|NCT03872453|472053577|FG003|Overall Study|Protocol Deviation|2|||
131115146|NCT03872453|472053574|FG000|Overall Study|Withdrawal by Subject|0|||
131115147|NCT03872453|472053575|FG001|Overall Study|Withdrawal by Subject|1|||
131115148|NCT03872453|472053576|FG002|Overall Study|Withdrawal by Subject|2|||
131115149|NCT03872453|472053577|FG003|Overall Study|Withdrawal by Subject|0|||
131115150|NCT03872453|472053574|FG000|Overall Study|Other Than Specified|1|||
131115151|NCT03872453|472053575|FG001|Overall Study|Other Than Specified|0|||
131115152|NCT03872453|472053576|FG002|Overall Study|Other Than Specified|0|||
131115153|NCT03872453|472053577|FG003|Overall Study|Other Than Specified|0|||
131115154|NCT00352885|472053578|FG000|Overall Study|Withdrawal by Subject|0|||
131115155|NCT00352885|472053579|FG001|Overall Study|Withdrawal by Subject|3|||
131115156|NCT00352885|472053578|FG000|Overall Study|Development of major depression|0|||
131115157|NCT00352885|472053579|FG001|Overall Study|Development of major depression|1|||
131115158|NCT00352885|472053578|FG000|Overall Study|Progression of metastatic melanoma|5|||
131115159|NCT00352885|472053579|FG001|Overall Study|Progression of metastatic melanoma|3|||
131115160|NCT00352885|472053578|FG000|Overall Study|Side effects of IL-2 administration|1|||
131115161|NCT00352885|472053579|FG001|Overall Study|Side effects of IL-2 administration|0|||
131115162|NCT03873493|472053580|FG000|Overall Study|Withdrawal by Subject|1|||
131115163|NCT03873493|472053580|FG000|Overall Study|Death|9|||
131115164|NCT03873493|472053580|FG000|Overall Study|Lost to Follow-up|1|||
131115165|NCT03873493|472053580|FG000|Overall Study|Study Terminated by Sponsor|1|||
130908015|NCT00282347|471298201|FG000|Treatment Period|Physician Decision|0|||
130908016|NCT00282347|471298202|FG001|Treatment Period|Physician Decision|1|||
130908017|NCT00282347|471298201|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
131115166|NCT03873493|472053580|FG000|Overall Study|Other|2|||
131115167|NCT03756350|472053582|FG000|Overall Study|Lost to Follow-up|1|||
131115168|NCT00440700|472053585|FG000|Overall Study|Withdrawal by Subject|8|||
130908018|NCT00282347|471298202|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
130908019|NCT00282347|471298201|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
130908020|NCT00282347|471298202|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
131115169|NCT00440700|472053586|FG001|Overall Study|Withdrawal by Subject|8|||
131115170|NCT00440700|472053587|FG002|Overall Study|Withdrawal by Subject|4|||
131115171|NCT01096342|472053588|FG000|Overall Study|Protocol Violation|1|||
131115172|NCT04906616|472053589|FG000|Overall Study|Divorce|3|||
130768502|NCT04849416|470776679|FG000|Overall Study|Lost to Follow-up|1|||
130908021|NCT00282347|471298201|FG000|Safety Follow-up Period|Physician Decision|1|||
130908022|NCT00282347|471298202|FG001|Safety Follow-up Period|Physician Decision|1|||
131115173|NCT04906616|472053590|FG001|Overall Study|Divorce|2|||
130908023|NCT00282347|471298201|FG000|Safety Follow-up Period|Protocol Deviation|0|||
130908024|NCT00282347|471298202|FG001|Safety Follow-up Period|Protocol Deviation|2|||
130908025|NCT00282347|471298201|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
130908026|NCT00282347|471298202|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
130908027|NCT00282347|471298201|FG000|B Cell Follow-up Period|Physician Decision|1|||
130908028|NCT00282347|471298202|FG001|B Cell Follow-up Period|Physician Decision|0|||
130908029|NCT00282347|471298201|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
130908030|NCT00282347|471298202|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
130908031|NCT00356122|471298203|FG000|TREATMENT|Lack of Efficacy|26|||
130908032|NCT00356122|471298203|FG000|TREATMENT|Adverse Event|10|||
130908033|NCT00356122|471298203|FG000|TREATMENT|Subject's request|4|||
130908034|NCT00356122|471298203|FG000|TREATMENT|Other|4|||
130908035|NCT00356122|471298203|FG000|TREATMENT|Did not receive study medication|1|||
130908036|NCT00356122|471298203|FG000|FOLLOW-UP|Death|37|||
130908037|NCT00356122|471298203|FG000|FOLLOW-UP|Lost to Follow-up|2|||
130908038|NCT00356122|471298203|FG000|FOLLOW-UP|Other|2|||
130908039|NCT00491556|471298204|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
130908040|NCT00491556|471298205|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
130908041|NCT00491556|471298204|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
130908042|NCT00491556|471298205|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
130908043|NCT00491556|471298204|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
130908044|NCT00491556|471298205|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
130908045|NCT00491556|471298204|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
130908046|NCT00491556|471298205|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
130908047|NCT00491556|471298204|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
130908048|NCT00491556|471298205|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
130908049|NCT00491556|471298204|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
130908050|NCT00491556|471298205|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
130908051|NCT00491556|471298204|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
130908052|NCT00491556|471298205|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
130908053|NCT00491556|471298204|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
130908054|NCT00491556|471298205|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
130908055|NCT00491556|471298204|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
130908056|NCT00491556|471298205|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
130908057|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
130908058|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
130908059|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
130908060|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
130908061|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
130908062|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
130908063|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
130908064|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
130908065|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
130908066|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
131028955|NCT04095104|471738121|FG001|Overall Study|Withdrawal by Subject|1|||
131028956|NCT03912831|471738123|FG000|Overall Study|Death|1|||
131028957|NCT03912831|471738124|FG001|Overall Study|Death|1|||
131028958|NCT03912831|471738125|FG002|Overall Study|Death|1|||
131028959|NCT03912831|471738126|FG003|Overall Study|Death|1|||
131028960|NCT03912831|471738127|FG004|Overall Study|Death|1|||
131028961|NCT03912831|471738128|FG005|Overall Study|Death|1|||
131028962|NCT03912831|471738123|FG000|Overall Study|Reason not Specified|0|||
131028963|NCT03912831|471738124|FG001|Overall Study|Reason not Specified|0|||
131028964|NCT03912831|471738125|FG002|Overall Study|Reason not Specified|0|||
131028965|NCT03912831|471738126|FG003|Overall Study|Reason not Specified|0|||
131028966|NCT03912831|471738127|FG004|Overall Study|Reason not Specified|1|||
131028967|NCT03912831|471738128|FG005|Overall Study|Reason not Specified|0|||
131028968|NCT03912831|471738123|FG000|Overall Study|Withdrawal by Participant|0|||
131028969|NCT03912831|471738124|FG001|Overall Study|Withdrawal by Participant|0|||
131028970|NCT03912831|471738125|FG002|Overall Study|Withdrawal by Participant|0|||
131028971|NCT03912831|471738126|FG003|Overall Study|Withdrawal by Participant|0|||
131028972|NCT03912831|471738127|FG004|Overall Study|Withdrawal by Participant|1|||
131028973|NCT03912831|471738128|FG005|Overall Study|Withdrawal by Participant|0|||
130768503|NCT04849416|470776680|FG001|Overall Study|Lost to Follow-up|0|||
130908067|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
131028974|NCT03527160|471738129|FG000|Overall Study|No urine collected|13|||
131028975|NCT03527160|471738129|FG000|Overall Study|No clinical serum creatinine collected|6|||
131028976|NCT03527160|471738129|FG000|Overall Study|Did not meet inclusion|2|||
131028977|NCT02910713|471738130|FG000|Overall Study|Protocol Violation|2|||
131028978|NCT02910713|471738130|FG000|Overall Study|Subject Choice|4|||
131028979|NCT02910713|471738130|FG000|Overall Study|Received One Application|10|||
130908068|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
130908069|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
130908070|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
130908071|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
130908072|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
130908073|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
130908074|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
130908075|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
130908076|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
130908077|NCT00491556|471298204|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
130908078|NCT00491556|471298205|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
130908079|NCT00993044|471298206|FG000|Irinotecan 50 mg|Physician Decision|1|||
130908080|NCT00734747|471298207|FG000|SRS Procedure|No staples placed|3|||
130908081|NCT00734747|471298207|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
130908082|NCT04285580|471300044|FG000|Overall Study|Protocol Violation|0|||
130908083|NCT04285580|471300045|FG001|Overall Study|Protocol Violation|1|||
130908084|NCT00076024|471300046|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
130908085|NCT00076024|471300047|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
130908086|NCT00076024|471300048|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
130908087|NCT00076024|471300049|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
130908088|NCT00076024|471300046|FG000|Phase 1, Lead-in|Adverse Event|1|||
130908089|NCT00076024|471300047|FG001|Phase 1, Lead-in|Adverse Event|0|||
130908090|NCT00076024|471300048|FG002|Phase 1, Lead-in|Adverse Event|0|||
130908091|NCT00076024|471300049|FG003|Phase 1, Lead-in|Adverse Event|0|||
130908092|NCT00076024|471300046|FG000|Phase 1, Lead-in|Clinical progression|1|||
130908093|NCT00076024|471300047|FG001|Phase 1, Lead-in|Clinical progression|0|||
130908094|NCT00076024|471300048|FG002|Phase 1, Lead-in|Clinical progression|0|||
130908095|NCT00076024|471300049|FG003|Phase 1, Lead-in|Clinical progression|0|||
130908096|NCT00076024|471300046|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
130908097|NCT00076024|471300047|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
130908098|NCT00076024|471300048|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
130908099|NCT00076024|471300049|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
130908100|NCT00076024|471300046|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
130908101|NCT00076024|471300047|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
130908102|NCT00076024|471300048|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
130908103|NCT00076024|471300049|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
130908104|NCT00076024|471300046|FG000|Phase 2, Double-blind|Adverse Event|0|||
130908105|NCT00076024|471300047|FG001|Phase 2, Double-blind|Adverse Event|25|||
130908106|NCT00076024|471300048|FG002|Phase 2, Double-blind|Adverse Event|6|||
130908107|NCT00076024|471300049|FG003|Phase 2, Double-blind|Adverse Event|0|||
130908108|NCT00076024|471300046|FG000|Phase 2, Double-blind|Un-specified|0|||
130908109|NCT00076024|471300047|FG001|Phase 2, Double-blind|Un-specified|14|||
131028980|NCT02910713|471738130|FG000|Overall Study|Received Neither Application|18|||
131028981|NCT02910713|471738130|FG000|Overall Study|Enrollment cap|7|||
131028982|NCT02910713|471738130|FG000|Overall Study|Investigator Discretion|1|||
131028983|NCT03767517|471738132|FG000|Overall Study|Lost to Follow-up|16|||
131028984|NCT03767517|471738133|FG001|Overall Study|Lost to Follow-up|10|||
131028985|NCT03767517|471738132|FG000|Overall Study|Death|2|||
131028986|NCT03767517|471738133|FG001|Overall Study|Death|3|||
131028987|NCT05338086|471739489|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
131028988|NCT05338086|471739490|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
131028989|NCT05338086|471739491|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
131028990|NCT05338086|471739492|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
131028991|NCT05338086|471739493|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
131028992|NCT05338086|471739489|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
131028993|NCT05338086|471739490|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
131028994|NCT05338086|471739491|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
130695663|NCT00414726|470510586|FG000|Overall Study|Withdrawal by Subject|0|||
130695664|NCT00414726|470510587|FG001|Overall Study|Withdrawal by Subject|1|||
130695665|NCT02107196|470510588|FG000|12-week Treatment Period|Adverse Event|6|||
130908110|NCT00076024|471300048|FG002|Phase 2, Double-blind|Un-specified|6|||
130908111|NCT00076024|471300049|FG003|Phase 2, Double-blind|Un-specified|0|||
130908112|NCT00076024|471300046|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
130908113|NCT00076024|471300047|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
130908114|NCT00076024|471300048|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
130908115|NCT00076024|471300049|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
130908116|NCT00076024|471300046|FG000|Phase 2, Open-label|Adverse Event|0|||
130908117|NCT00076024|471300047|FG001|Phase 2, Open-label|Adverse Event|0|||
130908118|NCT00076024|471300048|FG002|Phase 2, Open-label|Adverse Event|0|||
130908119|NCT00076024|471300049|FG003|Phase 2, Open-label|Adverse Event|2|||
130908120|NCT00076024|471300046|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
131028995|NCT05338086|471739492|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
131028996|NCT05338086|471739493|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
130695666|NCT02107196|470510589|FG001|12-week Treatment Period|Adverse Event|3|||
130695667|NCT02107196|470510588|FG000|12-week Treatment Period|Lack of Efficacy|2|||
130695668|NCT02107196|470510589|FG001|12-week Treatment Period|Lack of Efficacy|1|||
130695669|NCT02107196|470510588|FG000|12-week Treatment Period|Lost to Follow-up|3|||
130695670|NCT02107196|470510589|FG001|12-week Treatment Period|Lost to Follow-up|6|||
130695671|NCT02107196|470510588|FG000|12-week Treatment Period|Physician Decision|0|||
130695672|NCT02107196|470510589|FG001|12-week Treatment Period|Physician Decision|1|||
130695673|NCT02107196|470510588|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
130695674|NCT02107196|470510589|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
130695675|NCT02107196|470510588|FG000|12-week Treatment Period|Protocol Violation|7|||
130695676|NCT02107196|470510589|FG001|12-week Treatment Period|Protocol Violation|8|||
130695677|NCT02107196|470510588|FG000|12-week Treatment Period|Reason Missing|11|||
130695678|NCT02107196|470510589|FG001|12-week Treatment Period|Reason Missing|8|||
130695679|NCT02107196|470510588|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
130695680|NCT02107196|470510589|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
130695681|NCT02107196|470510588|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
130695682|NCT02107196|470510589|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
130695683|NCT02107196|470510588|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
130695684|NCT02107196|470510589|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
130695685|NCT02107196|470510588|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
130695686|NCT02107196|470510589|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
130695687|NCT00516295|470510590|FG000|Overall Study|Lack of Efficacy|2|||
130695688|NCT00516295|470510591|FG001|Overall Study|Lack of Efficacy|0|||
130695689|NCT00516295|470510592|FG002|Overall Study|Lack of Efficacy|0|||
130695690|NCT00516295|470510590|FG000|Overall Study|Ineligible|1|||
130695691|NCT00516295|470510591|FG001|Overall Study|Ineligible|0|||
130695692|NCT00516295|470510592|FG002|Overall Study|Ineligible|0|||
130695693|NCT01630616|470510597|FG000|Overall Study|Adverse Event|0|||
130908121|NCT00076024|471300047|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
130908122|NCT00076024|471300048|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
130908123|NCT00076024|471300049|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
130908124|NCT00076024|471300046|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
130908125|NCT00076024|471300047|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
130908126|NCT00076024|471300048|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
130908127|NCT00076024|471300049|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
130908128|NCT00076024|471300046|FG000|Phase 2, Open-label|Other|0|||
130908129|NCT00076024|471300047|FG001|Phase 2, Open-label|Other|0|||
130695694|NCT01630616|470510598|FG001|Overall Study|Adverse Event|0|||
130695695|NCT01630616|470510599|FG002|Overall Study|Adverse Event|0|||
130695696|NCT01630616|470510600|FG003|Overall Study|Adverse Event|1|||
130695697|NCT01630616|470510601|FG004|Overall Study|Adverse Event|0|||
130908130|NCT00076024|471300048|FG002|Phase 2, Open-label|Other|0|||
130908131|NCT00076024|471300049|FG003|Phase 2, Open-label|Other|2|||
130908132|NCT01155219|471300050|FG000|Overall Study|Adverse Event|3|||
130908133|NCT01155219|471300051|FG001|Overall Study|Adverse Event|1|||
130908134|NCT01155219|471300050|FG000|Overall Study|non-medical reason|1|||
130908135|NCT01155219|471300051|FG001|Overall Study|non-medical reason|2|||
130908136|NCT00719264|471300052|FG000|Overall Study|Adverse Event|41|||
130908137|NCT00719264|471300053|FG001|Overall Study|Adverse Event|49|||
131028997|NCT05338086|471739489|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
131028998|NCT05338086|471739490|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
131028999|NCT05338086|471739491|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
131029000|NCT05338086|471739492|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
131029001|NCT05338086|471739493|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
131029002|NCT05338086|471739489|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
131029003|NCT05338086|471739490|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
131029004|NCT05338086|471739491|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
131029005|NCT05338086|471739492|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
131029006|NCT05338086|471739493|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
131029007|NCT05338086|471739489|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
131045839|NCT03582033|471802286|FG008|Part C|Study terminated by sponsor|2|||
130695698|NCT01630616|470510602|FG005|Overall Study|Adverse Event|0|||
130695699|NCT01630616|470510597|FG000|Overall Study|Withdrawal by Subject|0|||
130908138|NCT00719264|471300052|FG000|Overall Study|Death|13|||
130908139|NCT00719264|471300053|FG001|Overall Study|Death|10|||
130908140|NCT00719264|471300052|FG000|Overall Study|Administrative Problems|6|||
130908141|NCT00719264|471300053|FG001|Overall Study|Administrative Problems|4|||
130908142|NCT00719264|471300052|FG000|Overall Study|Lost to Follow-up|1|||
130695700|NCT01630616|470510598|FG001|Overall Study|Withdrawal by Subject|0|||
130695701|NCT01630616|470510599|FG002|Overall Study|Withdrawal by Subject|0|||
130695702|NCT01630616|470510600|FG003|Overall Study|Withdrawal by Subject|2|||
130695703|NCT01630616|470510601|FG004|Overall Study|Withdrawal by Subject|0|||
130908143|NCT00719264|471300053|FG001|Overall Study|Lost to Follow-up|1|||
130908144|NCT00719264|471300052|FG000|Overall Study|Withdrawal by Subject|12|||
130908145|NCT00719264|471300053|FG001|Overall Study|Withdrawal by Subject|7|||
130908146|NCT00719264|471300052|FG000|Overall Study|Protocol Deviation|1|||
130908147|NCT00719264|471300053|FG001|Overall Study|Protocol Deviation|3|||
130908148|NCT00719264|471300052|FG000|Overall Study|New Cancer Therapy|4|||
130908149|NCT00719264|471300053|FG001|Overall Study|New Cancer Therapy|2|||
130908150|NCT00719264|471300052|FG000|Overall Study|Disease Progression|104|||
130908151|NCT00719264|471300053|FG001|Overall Study|Disease Progression|107|||
130908152|NCT03981822|471300055|FG000|Overall Study|Lost to Follow-up|0|||
130908153|NCT03981822|471300056|FG001|Overall Study|Lost to Follow-up|1|||
130908154|NCT03981822|471300057|FG002|Overall Study|Lost to Follow-up|1|||
130908155|NCT03981822|471300058|FG003|Overall Study|Lost to Follow-up|0|||
130908156|NCT03981822|471300059|FG004|Overall Study|Lost to Follow-up|6|||
130908157|NCT03981822|471300060|FG005|Overall Study|Lost to Follow-up|4|||
130908158|NCT03981822|471300061|FG006|Overall Study|Lost to Follow-up|4|||
130908159|NCT03981822|471300062|FG007|Overall Study|Lost to Follow-up|2|||
130908160|NCT03981822|471300055|FG000|Overall Study|Withdrawal by Subject|0|||
130908161|NCT03981822|471300056|FG001|Overall Study|Withdrawal by Subject|1|||
130908162|NCT03981822|471300057|FG002|Overall Study|Withdrawal by Subject|0|||
130908163|NCT03981822|471300058|FG003|Overall Study|Withdrawal by Subject|0|||
130908164|NCT03981822|471300059|FG004|Overall Study|Withdrawal by Subject|0|||
130908165|NCT03981822|471300060|FG005|Overall Study|Withdrawal by Subject|1|||
130908166|NCT03981822|471300061|FG006|Overall Study|Withdrawal by Subject|0|||
130908167|NCT03981822|471300062|FG007|Overall Study|Withdrawal by Subject|2|||
130908168|NCT03981822|471300055|FG000|Overall Study|COVID-19 Related|0|||
130908169|NCT03981822|471300056|FG001|Overall Study|COVID-19 Related|0|||
130908170|NCT03981822|471300057|FG002|Overall Study|COVID-19 Related|0|||
130908171|NCT03981822|471300058|FG003|Overall Study|COVID-19 Related|0|||
130908172|NCT03981822|471300059|FG004|Overall Study|COVID-19 Related|2|||
130908173|NCT03981822|471300060|FG005|Overall Study|COVID-19 Related|1|||
130908174|NCT03981822|471300061|FG006|Overall Study|COVID-19 Related|2|||
130908175|NCT03981822|471300062|FG007|Overall Study|COVID-19 Related|1|||
130908176|NCT06460493|471300063|FG000|Overall Study|Withdrawal by Subject|2|||
130908177|NCT04704154|471300064|FG000|Overall Study|Adverse Event|3|||
130908178|NCT04704154|471300065|FG001|Overall Study|Adverse Event|2|||
130908179|NCT04704154|471300066|FG002|Overall Study|Adverse Event|4|||
130908180|NCT04704154|471300067|FG003|Overall Study|Adverse Event|2|||
130908181|NCT04704154|471300068|FG004|Overall Study|Adverse Event|3|||
130908182|NCT04704154|471300069|FG005|Overall Study|Adverse Event|0|||
130908183|NCT04704154|471300064|FG000|Overall Study|Death|3|||
130908184|NCT04704154|471300065|FG001|Overall Study|Death|0|||
130908185|NCT04704154|471300066|FG002|Overall Study|Death|0|||
130908186|NCT04704154|471300067|FG003|Overall Study|Death|0|||
130908187|NCT04704154|471300068|FG004|Overall Study|Death|3|||
130908188|NCT04704154|471300069|FG005|Overall Study|Death|0|||
130908189|NCT04704154|471300064|FG000|Overall Study|Physician Decision|1|||
130908190|NCT04704154|471300065|FG001|Overall Study|Physician Decision|0|||
130908191|NCT04704154|471300066|FG002|Overall Study|Physician Decision|1|||
130908192|NCT04704154|471300067|FG003|Overall Study|Physician Decision|0|||
130908193|NCT04704154|471300068|FG004|Overall Study|Physician Decision|2|||
130908194|NCT04704154|471300069|FG005|Overall Study|Physician Decision|0|||
130908195|NCT04704154|471300064|FG000|Overall Study|Participant Decision|1|||
130908196|NCT04704154|471300065|FG001|Overall Study|Participant Decision|1|||
130908197|NCT04704154|471300066|FG002|Overall Study|Participant Decision|0|||
130908198|NCT04704154|471300067|FG003|Overall Study|Participant Decision|0|||
130908199|NCT04704154|471300068|FG004|Overall Study|Participant Decision|0|||
130908200|NCT04704154|471300069|FG005|Overall Study|Participant Decision|0|||
130908201|NCT04704154|471300064|FG000|Overall Study|Progressive Disease|19|||
130908202|NCT04704154|471300065|FG001|Overall Study|Progressive Disease|17|||
130908203|NCT04704154|471300066|FG002|Overall Study|Progressive Disease|20|||
130908204|NCT04704154|471300067|FG003|Overall Study|Progressive Disease|18|||
131029008|NCT05338086|471739490|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
130908205|NCT04704154|471300068|FG004|Overall Study|Progressive Disease|36|||
130908206|NCT04704154|471300069|FG005|Overall Study|Progressive Disease|30|||
130908207|NCT04704154|471300064|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
131029009|NCT05338086|471739491|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
130908208|NCT04704154|471300065|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
130908209|NCT04704154|471300066|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
130908210|NCT04704154|471300067|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
130908211|NCT04704154|471300068|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
130908212|NCT04704154|471300069|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
130908213|NCT04704154|471300064|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
130908214|NCT04704154|471300065|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
130908215|NCT04704154|471300066|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
130908216|NCT04704154|471300067|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
130908217|NCT04704154|471300068|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
130908218|NCT04704154|471300069|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
130908219|NCT02278341|471300070|FG000|Overall Study|Randomized but never received study drug|1|||
130908220|NCT02278341|471300071|FG001|Overall Study|Randomized but never received study drug|1|||
130908221|NCT02278341|471300070|FG000|Overall Study|Adverse Event|3|||
130908222|NCT02278341|471300071|FG001|Overall Study|Adverse Event|0|||
130908223|NCT02278341|471300070|FG000|Overall Study|Death|68|||
130908224|NCT02278341|471300071|FG001|Overall Study|Death|56|||
130908225|NCT02278341|471300070|FG000|Overall Study|Withdrawal by Subject|30|||
130908226|NCT02278341|471300071|FG001|Overall Study|Withdrawal by Subject|19|||
130908227|NCT02278341|471300070|FG000|Overall Study|Lost to Follow-up|0|||
130908228|NCT02278341|471300071|FG001|Overall Study|Lost to Follow-up|1|||
130908229|NCT02278341|471300070|FG000|Overall Study|Physician Decision|1|||
130908230|NCT02278341|471300071|FG001|Overall Study|Physician Decision|1|||
130908231|NCT02278341|471300070|FG000|Overall Study|Miscellaneous|15|||
130908232|NCT02278341|471300071|FG001|Overall Study|Miscellaneous|14|||
130908233|NCT04902326|471300072|FG000|Overall Study|Withdrawal by Subject|1|||
130908234|NCT04902326|471300073|FG001|Overall Study|Withdrawal by Subject|3|||
130908235|NCT04902326|471300074|FG002|Overall Study|Withdrawal by Subject|0|||
130908236|NCT04902326|471300075|FG003|Overall Study|Withdrawal by Subject|1|||
130908237|NCT04902326|471300072|FG000|Overall Study|Lost to Follow-up|14|||
130908238|NCT04902326|471300073|FG001|Overall Study|Lost to Follow-up|14|||
130908239|NCT04902326|471300074|FG002|Overall Study|Lost to Follow-up|14|||
130908240|NCT04902326|471300075|FG003|Overall Study|Lost to Follow-up|6|||
130908241|NCT02604017|471300076|FG000|Overall Study|Withdrew Consent|0|||
130908242|NCT02604017|471300077|FG001|Overall Study|Withdrew Consent|2|||
130908243|NCT02604017|471300076|FG000|Overall Study|Lost to Follow-up|5|||
130908244|NCT02604017|471300077|FG001|Overall Study|Lost to Follow-up|6|||
130908245|NCT02604017|471300076|FG000|Overall Study|Other|1|||
130908246|NCT02604017|471300077|FG001|Overall Study|Other|0|||
130908247|NCT00740246|471300078|FG000|Overall Study|Received Blood Transfusion|0|||
130908248|NCT00740246|471300079|FG001|Overall Study|Received Blood Transfusion|1|||
130908249|NCT00740246|471300078|FG000|Overall Study|Adverse Event|1|||
130908250|NCT00740246|471300079|FG001|Overall Study|Adverse Event|2|||
130908251|NCT00740246|471300078|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
130908252|NCT00740246|471300079|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
130908253|NCT00740246|471300078|FG000|Overall Study|Lost to Follow-up|2|||
130908254|NCT00740246|471300079|FG001|Overall Study|Lost to Follow-up|2|||
130908255|NCT00740246|471300078|FG000|Overall Study|Withdrawal by Subject|4|||
130908256|NCT00740246|471300079|FG001|Overall Study|Withdrawal by Subject|3|||
130908257|NCT00740246|471300078|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
130908258|NCT00740246|471300079|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
130908259|NCT00740246|471300078|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
130908260|NCT00740246|471300079|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
130908261|NCT00740246|471300078|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
130908262|NCT00740246|471300079|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
130908263|NCT00740246|471300078|FG000|Overall Study|Unable To Comply With Study Visits|2|||
130908264|NCT00740246|471300079|FG001|Overall Study|Unable To Comply With Study Visits|0|||
130908265|NCT00740246|471300078|FG000|Overall Study|Unable to Access Vein|0|||
130908266|NCT00740246|471300079|FG001|Overall Study|Unable to Access Vein|2|||
130908267|NCT00740246|471300078|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
130908268|NCT00740246|471300079|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
130908269|NCT01142128|471300080|FG000|Overall Study|Physician Decision|1|||
130908270|NCT01142128|471300080|FG000|Overall Study|Lost to Follow-up|1|||
130908271|NCT01142128|471300080|FG000|Overall Study|Withdrawal by Subject|2|||
130908272|NCT01315236|471300084|FG000|Double-blind Phase|Death|1|||
130908273|NCT01315236|471300085|FG001|Double-blind Phase|Death|0|||
130908274|NCT01315236|471300084|FG000|Double-blind Phase|Adverse Event|1|||
130908275|NCT01315236|471300085|FG001|Double-blind Phase|Adverse Event|0|||
130908276|NCT01315236|471300084|FG000|Double-blind Phase|Withdrawal of Consent|1|||
130908277|NCT01315236|471300085|FG001|Double-blind Phase|Withdrawal of Consent|0|||
130908278|NCT01315236|471300084|FG000|Double-blind Phase|Lost to Follow-up|1|||
130908279|NCT01315236|471300085|FG001|Double-blind Phase|Lost to Follow-up|0|||
130908280|NCT01315236|471300084|FG000|Open-label Phase|Death|1|||
130908281|NCT01315236|471300085|FG001|Open-label Phase|Death|0|||
130908282|NCT01315236|471300084|FG000|Open-label Phase|Adverse Event|0|||
130908283|NCT01315236|471300085|FG001|Open-label Phase|Adverse Event|1|||
130908284|NCT01315236|471300084|FG000|Open-label Phase|Other|0|||
130908285|NCT01315236|471300085|FG001|Open-label Phase|Other|1|||
130908286|NCT01315236|471300084|FG000|12-Month Follow-up Period|Death|0|||
130908287|NCT01315236|471300085|FG001|12-Month Follow-up Period|Death|1|||
130695704|NCT01630616|470510602|FG005|Overall Study|Withdrawal by Subject|0|||
130695705|NCT02218541|470510603|FG000|Overall Study|Lost to Follow-up|2|||
130695706|NCT02218541|470510604|FG001|Overall Study|Lost to Follow-up|1|||
130695707|NCT02218541|470510603|FG000|Overall Study|Implant Failure|4|||
130908288|NCT01315236|471300084|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
130908289|NCT01315236|471300085|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
130908290|NCT00442468|471300086|FG000|Overall Study|Adverse Event|4|||
130908291|NCT00442468|471300086|FG000|Overall Study|Withdrawal by Subject|91|||
130908292|NCT00442468|471300086|FG000|Overall Study|Did not complete all study procedures|88|||
130908293|NCT00589784|471300089|FG000|Overall Study|Withdrawal by Subject|0|||
130908294|NCT00589784|471300090|FG001|Overall Study|Withdrawal by Subject|6|||
130908295|NCT00589784|471300089|FG000|Overall Study|Patient inevaluable|1|||
130908296|NCT00589784|471300090|FG001|Overall Study|Patient inevaluable|0|||
130908297|NCT00589784|471300089|FG000|Overall Study|Adverse Event|0|||
130908298|NCT00589784|471300090|FG001|Overall Study|Adverse Event|4|||
130908299|NCT04341662|471300100|FG000|Overall Study|Did not have source-verified blood loss data|423|||
130908300|NCT04341662|471300101|FG001|Overall Study|Did not have source-verified blood loss data|514|||
131115174|NCT02464228|472053593|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
131115175|NCT02464228|472053594|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
131115176|NCT02464228|472053595|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
131115177|NCT02464228|472053596|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
131115178|NCT02464228|472053593|FG000|Overall Study|Physician Decision|2|||
131115179|NCT02464228|472053594|FG001|Overall Study|Physician Decision|0|||
131115180|NCT02464228|472053595|FG002|Overall Study|Physician Decision|1|||
131115181|NCT02464228|472053596|FG003|Overall Study|Physician Decision|0|||
131115182|NCT02464228|472053593|FG000|Overall Study|Miscellaneous|1|||
131115183|NCT02464228|472053594|FG001|Overall Study|Miscellaneous|0|||
131115184|NCT02464228|472053595|FG002|Overall Study|Miscellaneous|1|||
131115185|NCT02464228|472053596|FG003|Overall Study|Miscellaneous|0|||
130908301|NCT01582854|471300102|FG000|Overall Study|Death|8|||
130908302|NCT01582854|471300103|FG001|Overall Study|Death|5|||
130908303|NCT01582854|471300102|FG000|Overall Study|Adverse Event|2|||
130908304|NCT01582854|471300103|FG001|Overall Study|Adverse Event|3|||
130908305|NCT01582854|471300102|FG000|Overall Study|Withdrawal by Participant|8|||
130908306|NCT01582854|471300103|FG001|Overall Study|Withdrawal by Participant|11|||
130908307|NCT01582854|471300102|FG000|Overall Study|Lost to Follow-up|1|||
130908308|NCT01582854|471300103|FG001|Overall Study|Lost to Follow-up|2|||
130908309|NCT01582854|471300102|FG000|Overall Study|Physician Decision|0|||
130908310|NCT01582854|471300103|FG001|Overall Study|Physician Decision|1|||
130908311|NCT01582854|471300102|FG000|Overall Study|Recurrent Stroke|13|||
131115186|NCT02464228|472053593|FG000|Overall Study|Adverse Event|9|||
131115187|NCT02464228|472053594|FG001|Overall Study|Adverse Event|0|||
131115188|NCT02464228|472053595|FG002|Overall Study|Adverse Event|3|||
131115189|NCT02464228|472053596|FG003|Overall Study|Adverse Event|0|||
131115190|NCT02464228|472053593|FG000|Overall Study|Withdrawal by Subject|1|||
131115191|NCT02464228|472053594|FG001|Overall Study|Withdrawal by Subject|1|||
131115192|NCT02464228|472053595|FG002|Overall Study|Withdrawal by Subject|1|||
131115193|NCT02464228|472053596|FG003|Overall Study|Withdrawal by Subject|0|||
131115194|NCT02464228|472053593|FG000|Overall Study|Disease Progression|22|||
131115195|NCT02464228|472053594|FG001|Overall Study|Disease Progression|12|||
130695708|NCT02218541|470510604|FG001|Overall Study|Implant Failure|1|||
130695709|NCT01993186|470510605|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
130695710|NCT01993186|470510606|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
130695711|NCT01993186|470510605|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
130695712|NCT01993186|470510606|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
130695713|NCT01993186|470510605|FG000|Open-Label Extension Period|Other, Not Specified|0|||
130695714|NCT01993186|470510606|FG001|Open-Label Extension Period|Other, Not Specified|1|||
130695715|NCT01993186|470510605|FG000|Open-Label Extension Period|Adverse Event|1|||
130695716|NCT01993186|470510606|FG001|Open-Label Extension Period|Adverse Event|0|||
130695717|NCT01993186|470510605|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
130695718|NCT01993186|470510606|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
130695719|NCT01993186|470510605|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
130695720|NCT01993186|470510606|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
130695721|NCT01993186|470510605|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
131115196|NCT02464228|472053595|FG002|Overall Study|Disease Progression|5|||
131115197|NCT02464228|472053596|FG003|Overall Study|Disease Progression|2|||
130908312|NCT01582854|471300103|FG001|Overall Study|Recurrent Stroke|8|||
130908313|NCT01582854|471300102|FG000|Overall Study|Disallowed Concomitant Medication|3|||
130908314|NCT01582854|471300103|FG001|Overall Study|Disallowed Concomitant Medication|2|||
130908315|NCT01582854|471300102|FG000|Overall Study|Carotid or Neurosurgery|0|||
130908316|NCT01582854|471300103|FG001|Overall Study|Carotid or Neurosurgery|1|||
130908317|NCT01582854|471300102|FG000|Overall Study|General Anaesthesia|0|||
130908318|NCT01582854|471300103|FG001|Overall Study|General Anaesthesia|1|||
130695722|NCT01993186|470510606|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
130908319|NCT01582854|471300102|FG000|Overall Study|Other Miscellaneous Reason|1|||
130908320|NCT01582854|471300103|FG001|Overall Study|Other Miscellaneous Reason|0|||
130908321|NCT03101267|471300104|FG000|Primary Study Period|Withdrawal by Subject|1|||
130908322|NCT03101267|471300105|FG001|Primary Study Period|Withdrawal by Subject|2|||
130908323|NCT03101267|471300106|FG002|Primary Study Period|Withdrawal by Subject|3|||
130908324|NCT03101267|471300104|FG000|Primary Study Period|Miscellaneous|2|||
130908325|NCT03101267|471300105|FG001|Primary Study Period|Miscellaneous|0|||
130908326|NCT03101267|471300106|FG002|Primary Study Period|Miscellaneous|0|||
130908327|NCT04068896|471300107|FG000|Overall Study|Adverse Event|2|||
130908328|NCT04068896|471300108|FG001|Overall Study|Adverse Event|0|||
131115198|NCT00385203|472053599|FG000|Overall Study|Adverse Event|5|||
131115199|NCT00385203|472053600|FG001|Overall Study|Adverse Event|4|||
130908329|NCT04068896|471300109|FG002|Overall Study|Adverse Event|1|||
130908330|NCT04068896|471300110|FG003|Overall Study|Adverse Event|0|||
130908331|NCT04068896|471300111|FG004|Overall Study|Adverse Event|0|||
130908332|NCT04068896|471300112|FG005|Overall Study|Adverse Event|0|||
130908333|NCT04068896|471300107|FG000|Overall Study|Death|3|||
130908334|NCT04068896|471300108|FG001|Overall Study|Death|1|||
131115200|NCT00385203|472053599|FG000|Overall Study|Death|1|||
131115201|NCT00385203|472053600|FG001|Overall Study|Death|0|||
131115202|NCT00385203|472053599|FG000|Overall Study|Condition under investigation worsened|18|||
131115203|NCT00385203|472053600|FG001|Overall Study|Condition under investigation worsened|3|||
131115204|NCT00385203|472053599|FG000|Overall Study|Incorrect enrollment|2|||
131115205|NCT00385203|472053600|FG001|Overall Study|Incorrect enrollment|0|||
131115206|NCT03308942|472053601|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
131115207|NCT03308942|472053602|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
131115208|NCT03308942|472053603|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
131115209|NCT03308942|472053604|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
131115210|NCT03308942|472053605|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
131115211|NCT03308942|472053601|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
131115212|NCT03308942|472053602|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
131115213|NCT03308942|472053603|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
131115214|NCT03308942|472053604|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
131115215|NCT03308942|472053605|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
131115216|NCT03308942|472053601|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
131115217|NCT03308942|472053602|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
131115218|NCT03308942|472053603|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
131115219|NCT03308942|472053604|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
131115220|NCT03308942|472053605|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
131115221|NCT03308942|472053601|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
131115222|NCT03308942|472053602|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
131115223|NCT03308942|472053603|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
131115224|NCT03308942|472053604|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
131115225|NCT03308942|472053605|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
131115226|NCT03308942|472053601|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
131115227|NCT03308942|472053602|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
131115228|NCT03308942|472053603|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
131115229|NCT03308942|472053604|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
131115230|NCT03308942|472053605|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
131115231|NCT03308942|472053601|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
131115232|NCT03308942|472053602|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
131115233|NCT03308942|472053603|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
130695723|NCT00691704|470510607|FG000|Induction Therapy|Disease Progression|1|||
130695724|NCT00691704|470510607|FG000|Induction Therapy|Active Hepatitis|1|||
130695725|NCT00691704|470510607|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
130695726|NCT00691704|470510607|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
130695727|NCT00691704|470510607|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
130695728|NCT04661202|470510609|FG000|Overall Study|Withdrawal by Subject|1|||
130695729|NCT04661202|470510610|FG001|Overall Study|Withdrawal by Subject|1|||
130695730|NCT04661202|470510609|FG000|Overall Study|Lack of Efficacy|2|||
130695731|NCT04661202|470510610|FG001|Overall Study|Lack of Efficacy|0|||
130695732|NCT02313558|470510611|FG000|Overall Study|Withdrawal by Subject|2|||
130695733|NCT02313558|470510612|FG001|Overall Study|Withdrawal by Subject|0|||
130908335|NCT04068896|471300109|FG002|Overall Study|Death|3|||
130908336|NCT04068896|471300110|FG003|Overall Study|Death|19|||
130908337|NCT04068896|471300111|FG004|Overall Study|Death|17|||
130908338|NCT04068896|471300112|FG005|Overall Study|Death|0|||
130908339|NCT04068896|471300107|FG000|Overall Study|Physician Decision|0|||
130908340|NCT04068896|471300108|FG001|Overall Study|Physician Decision|0|||
130695734|NCT02313558|470510611|FG000|Overall Study|Lost to Follow-up|4|||
130695735|NCT02313558|470510612|FG001|Overall Study|Lost to Follow-up|4|||
130908341|NCT04068896|471300109|FG002|Overall Study|Physician Decision|0|||
131115234|NCT03308942|472053604|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
131115235|NCT03308942|472053605|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
131115236|NCT03308942|472053601|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
131115237|NCT03308942|472053602|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
131115238|NCT03308942|472053603|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
131115239|NCT03308942|472053604|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
131115240|NCT03308942|472053605|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
131115241|NCT01131351|472053606|FG000|Overall Study|Adverse Event|0|||
131115242|NCT01131351|472053607|FG001|Overall Study|Adverse Event|2|||
131115243|NCT01131351|472053606|FG000|Overall Study|Protocol Deviation|0|||
131115244|NCT01131351|472053607|FG001|Overall Study|Protocol Deviation|1|||
131115245|NCT02294682|472053608|FG000|Overall Study|Could not swallow pills|1|||
131115246|NCT02294682|472053609|FG001|Overall Study|Could not swallow pills|0|||
131115247|NCT03422172|472053612|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
131115248|NCT03422172|472053612|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
130768504|NCT04849416|470776681|FG002|Overall Study|Lost to Follow-up|0|||
130908342|NCT04068896|471300110|FG003|Overall Study|Physician Decision|1|||
130908343|NCT04068896|471300111|FG004|Overall Study|Physician Decision|0|||
130908344|NCT04068896|471300112|FG005|Overall Study|Physician Decision|0|||
130908345|NCT04068896|471300107|FG000|Overall Study|progressive disease|3|||
130908346|NCT04068896|471300108|FG001|Overall Study|progressive disease|5|||
130908347|NCT04068896|471300109|FG002|Overall Study|progressive disease|3|||
130908348|NCT04068896|471300110|FG003|Overall Study|progressive disease|2|||
130908349|NCT04068896|471300111|FG004|Overall Study|progressive disease|1|||
130908350|NCT04068896|471300112|FG005|Overall Study|progressive disease|2|||
130908351|NCT04068896|471300107|FG000|Overall Study|Study terminated by sponsor|0|||
130908352|NCT04068896|471300108|FG001|Overall Study|Study terminated by sponsor|0|||
130908353|NCT04068896|471300109|FG002|Overall Study|Study terminated by sponsor|1|||
130908354|NCT04068896|471300110|FG003|Overall Study|Study terminated by sponsor|2|||
130908355|NCT04068896|471300111|FG004|Overall Study|Study terminated by sponsor|1|||
130908356|NCT04068896|471300112|FG005|Overall Study|Study terminated by sponsor|4|||
130908357|NCT04068896|471300107|FG000|Overall Study|Protocol Violation|0|||
130908358|NCT04068896|471300108|FG001|Overall Study|Protocol Violation|0|||
130908359|NCT04068896|471300109|FG002|Overall Study|Protocol Violation|0|||
130908360|NCT04068896|471300110|FG003|Overall Study|Protocol Violation|1|||
130908361|NCT04068896|471300111|FG004|Overall Study|Protocol Violation|0|||
130908362|NCT04068896|471300112|FG005|Overall Study|Protocol Violation|0|||
130908363|NCT04068896|471300107|FG000|Overall Study|Withdrawal by Subject|0|||
130908364|NCT04068896|471300108|FG001|Overall Study|Withdrawal by Subject|3|||
130908365|NCT04068896|471300109|FG002|Overall Study|Withdrawal by Subject|0|||
130908366|NCT04068896|471300110|FG003|Overall Study|Withdrawal by Subject|2|||
130908367|NCT04068896|471300111|FG004|Overall Study|Withdrawal by Subject|1|||
130908368|NCT04068896|471300112|FG005|Overall Study|Withdrawal by Subject|0|||
130908369|NCT04068896|471300107|FG000|Overall Study|Symptomatic deterioration|2|||
130908370|NCT04068896|471300108|FG001|Overall Study|Symptomatic deterioration|0|||
130908371|NCT04068896|471300109|FG002|Overall Study|Symptomatic deterioration|0|||
130908372|NCT04068896|471300110|FG003|Overall Study|Symptomatic deterioration|0|||
130908373|NCT04068896|471300111|FG004|Overall Study|Symptomatic deterioration|0|||
130908374|NCT04068896|471300112|FG005|Overall Study|Symptomatic deterioration|0|||
130908375|NCT02398227|471300113|FG000|Overall Study|Lost to Follow-up|21|||
130908376|NCT02398227|471300114|FG001|Overall Study|Lost to Follow-up|12|||
130908377|NCT02398227|471300113|FG000|Overall Study|Withdrawal by Subject|5|||
130908378|NCT02398227|471300114|FG001|Overall Study|Withdrawal by Subject|6|||
130908379|NCT02398227|471300113|FG000|Overall Study|Removed from treatment and dropped out|1|||
130908380|NCT02398227|471300114|FG001|Overall Study|Removed from treatment and dropped out|0|||
130908381|NCT00107952|471300115|FG000|Overall Study|Death|75|||
130908382|NCT00107952|471300116|FG001|Overall Study|Death|61|||
130908383|NCT00107952|471300115|FG000|Overall Study|Lost to Follow-up|0|||
130908384|NCT00107952|471300116|FG001|Overall Study|Lost to Follow-up|3|||
131115249|NCT03422172|472053612|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
131115250|NCT00404066|472053616|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
131222765|NCT00386100|472443175|FG000|Overall Study|Participant's concern due to CPK levels|1|||
130908385|NCT00107952|471300115|FG000|Overall Study|Withdrawal by Subject|9|||
130908386|NCT00107952|471300116|FG001|Overall Study|Withdrawal by Subject|6|||
130908387|NCT00107952|471300115|FG000|Overall Study|Other|2|||
130908388|NCT00107952|471300116|FG001|Overall Study|Other|5|||
130908389|NCT00107952|471300115|FG000|Overall Study|Never received study treatment|9|||
130908390|NCT00107952|471300116|FG001|Overall Study|Never received study treatment|6|||
130908391|NCT01975831|471300117|FG000|Overall Study|Adverse Event|1|||
130908392|NCT01975831|471300118|FG001|Overall Study|Adverse Event|2|||
130908393|NCT01975831|471300119|FG002|Overall Study|Adverse Event|2|||
130908394|NCT01975831|471300120|FG003|Overall Study|Adverse Event|0|||
131115251|NCT00404066|472053616|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
131115252|NCT01179672|472053617|FG000|Overall Study|Adverse Event|17|||
131222766|NCT00386100|472443176|FG001|Overall Study|Participant's concern due to CPK levels|0|||
131222767|NCT00386100|472443175|FG000|Overall Study|Participant moving out of state|2|||
130695736|NCT04102345|470510613|FG000|Overall Study|Withdrawal by Subject|1|||
130695737|NCT04102345|470510614|FG001|Overall Study|Withdrawal by Subject|0|||
130695738|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
130695739|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
130695740|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
130695741|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
130695742|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
130695743|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
130695744|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
130695745|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
130695746|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
130695747|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
130695748|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
130695749|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
130695750|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
130695751|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
130695752|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
130695753|NCT00385736|470510615|FG000|Efficacy Analysis Set - Induction|Other|0|||
130695754|NCT00385736|470510616|FG001|Efficacy Analysis Set - Induction|Other|0|||
130695755|NCT00385736|470510617|FG002|Efficacy Analysis Set - Induction|Other|1|||
130695756|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
130695757|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
130695758|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
130695759|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
130695760|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
130695761|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
130908395|NCT01975831|471300121|FG004|Overall Study|Adverse Event|1|||
130908396|NCT01975831|471300122|FG005|Overall Study|Adverse Event|1|||
130908397|NCT01975831|471300123|FG006|Overall Study|Adverse Event|3|||
130908398|NCT01975831|471300124|FG007|Overall Study|Adverse Event|4|||
130908399|NCT01975831|471300125|FG008|Overall Study|Adverse Event|1|||
130908400|NCT01975831|471300117|FG000|Overall Study|Death|1|||
130908401|NCT01975831|471300118|FG001|Overall Study|Death|1|||
130908402|NCT01975831|471300119|FG002|Overall Study|Death|0|||
130908403|NCT01975831|471300120|FG003|Overall Study|Death|0|||
130908404|NCT01975831|471300121|FG004|Overall Study|Death|1|||
130908405|NCT01975831|471300122|FG005|Overall Study|Death|0|||
131029010|NCT05338086|471739492|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
131029011|NCT05338086|471739493|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
131029012|NCT05338086|471739489|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
131029013|NCT05338086|471739490|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
131029014|NCT05338086|471739491|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
131029015|NCT05338086|471739492|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
131029016|NCT05338086|471739493|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
131029017|NCT05338086|471739489|FG000|Transition Period (M12 to M18)|Death|0|||
131029018|NCT05338086|471739490|FG001|Transition Period (M12 to M18)|Death|0|||
131029019|NCT05338086|471739491|FG002|Transition Period (M12 to M18)|Death|1|||
131029020|NCT05338086|471739492|FG003|Transition Period (M12 to M18)|Death|0|||
131029021|NCT05338086|471739493|FG004|Transition Period (M12 to M18)|Death|0|||
131029022|NCT05338086|471739489|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
131029023|NCT05338086|471739490|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
131029024|NCT05338086|471739491|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
131029025|NCT05338086|471739492|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
131029026|NCT05338086|471739493|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
131029027|NCT05338086|471739489|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
131029028|NCT05338086|471739490|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
131029029|NCT05338086|471739491|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
131029030|NCT05338086|471739492|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
131029031|NCT05338086|471739493|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
131029032|NCT05338086|471739489|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
131029033|NCT05338086|471739490|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
130695762|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
130695763|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
130695764|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
130695765|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
130908406|NCT01975831|471300123|FG006|Overall Study|Death|1|||
130908407|NCT01975831|471300124|FG007|Overall Study|Death|0|||
131115253|NCT01179672|472053618|FG001|Overall Study|Adverse Event|8|||
130908408|NCT01975831|471300125|FG008|Overall Study|Death|0|||
130908409|NCT01975831|471300117|FG000|Overall Study|Progressive Disease|1|||
130695766|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
130695767|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
130695768|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
130695769|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
130695770|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
130695771|NCT00385736|470510615|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
130695772|NCT00385736|470510616|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
130695773|NCT00385736|470510617|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
130695774|NCT00385736|470510615|FG000|Safety Analysis Set|Adverse Event|23|||
130695775|NCT00385736|470510616|FG001|Safety Analysis Set|Adverse Event|15|||
130695776|NCT00385736|470510617|FG002|Safety Analysis Set|Adverse Event|23|||
130695777|NCT00385736|470510615|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
130695778|NCT00385736|470510616|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
130695779|NCT00385736|470510617|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
130695780|NCT00385736|470510615|FG000|Safety Analysis Set|Lost to Follow-up|0|||
130695781|NCT00385736|470510616|FG001|Safety Analysis Set|Lost to Follow-up|2|||
130695782|NCT00385736|470510617|FG002|Safety Analysis Set|Lost to Follow-up|2|||
130695783|NCT00385736|470510615|FG000|Safety Analysis Set|Lack of Efficacy|38|||
130695784|NCT00385736|470510616|FG001|Safety Analysis Set|Lack of Efficacy|16|||
130695785|NCT00385736|470510617|FG002|Safety Analysis Set|Lack of Efficacy|31|||
130695786|NCT00385736|470510615|FG000|Safety Analysis Set|Protocol Violation|2|||
130695787|NCT00385736|470510616|FG001|Safety Analysis Set|Protocol Violation|1|||
130695788|NCT00385736|470510617|FG002|Safety Analysis Set|Protocol Violation|6|||
130695789|NCT00385736|470510615|FG000|Safety Analysis Set|Other|1|||
130695790|NCT00385736|470510616|FG001|Safety Analysis Set|Other|4|||
130695791|NCT00385736|470510617|FG002|Safety Analysis Set|Other|4|||
130695792|NCT00198133|470510618|FG000|Overall Study|Disease progression|2|||
130695793|NCT00198133|470510619|FG001|Overall Study|Disease progression|5|||
130695794|NCT00198133|470510618|FG000|Overall Study|Adverse Event|1|||
130695795|NCT00198133|470510619|FG001|Overall Study|Adverse Event|3|||
130695796|NCT00198133|470510618|FG000|Overall Study|Withdrawal by Subject|1|||
130695797|NCT00198133|470510619|FG001|Overall Study|Withdrawal by Subject|0|||
130695798|NCT00198133|470510618|FG000|Overall Study|Physician Decision|1|||
130695799|NCT00198133|470510619|FG001|Overall Study|Physician Decision|0|||
130695800|NCT00835666|470510623|FG000|Washout|Protocol Violation|1|||
130695801|NCT00835666|470510624|FG001|Washout|Protocol Violation|0|||
130695802|NCT00835666|470510623|FG000|Washout|Withdrawal by Subject|1|||
130695803|NCT00835666|470510624|FG001|Washout|Withdrawal by Subject|0|||
130695804|NCT03599362|470510625|FG000|Overall Study|Screen Failure|3|||
130695805|NCT03707587|470510626|FG000|Overall Study|Death|0|||
130695806|NCT03707587|470510627|FG001|Overall Study|Death|1|||
130695807|NCT01537887|470510628|FG000|Period 1|Physician Decision|0|||
130695808|NCT01537887|470510629|FG001|Period 1|Physician Decision|0|||
130695809|NCT01537887|470510630|FG002|Period 1|Physician Decision|0|||
130695810|NCT01537887|470510631|FG003|Period 1|Physician Decision|0|||
130695811|NCT01537887|470510632|FG004|Period 1|Physician Decision|1|||
130695812|NCT01537887|470510633|FG005|Period 1|Physician Decision|1|||
130695813|NCT01537887|470510628|FG000|Period 1|Did not receive treatment|0|||
130695814|NCT01537887|470510629|FG001|Period 1|Did not receive treatment|0|||
130695815|NCT01537887|470510630|FG002|Period 1|Did not receive treatment|1|||
130695816|NCT01537887|470510631|FG003|Period 1|Did not receive treatment|0|||
130695817|NCT01537887|470510632|FG004|Period 1|Did not receive treatment|0|||
130695818|NCT01537887|470510633|FG005|Period 1|Did not receive treatment|0|||
130695819|NCT01537887|470510628|FG000|Period 2|Withdrawal by Subject|0|||
130695820|NCT01537887|470510629|FG001|Period 2|Withdrawal by Subject|1|||
130695821|NCT01537887|470510630|FG002|Period 2|Withdrawal by Subject|0|||
130768505|NCT01038752|470776697|FG000|Overall Study|Tumor Progression|2|||
130768506|NCT01038752|470776698|FG001|Overall Study|Tumor Progression|2|||
130768507|NCT01038752|470776697|FG000|Overall Study|Lost to Follow-up|3|||
130768508|NCT01038752|470776698|FG001|Overall Study|Lost to Follow-up|3|||
131115254|NCT01179672|472053617|FG000|Overall Study|Withdrawal by Subject|10|||
130695822|NCT01537887|470510631|FG003|Period 2|Withdrawal by Subject|0|||
130695823|NCT01537887|470510632|FG004|Period 2|Withdrawal by Subject|0|||
130695824|NCT01537887|470510633|FG005|Period 2|Withdrawal by Subject|0|||
130695825|NCT01537887|470510628|FG000|Period 3|Adverse Event|0|||
130695826|NCT01537887|470510629|FG001|Period 3|Adverse Event|0|||
130695827|NCT01537887|470510630|FG002|Period 3|Adverse Event|1|||
130695828|NCT01537887|470510631|FG003|Period 3|Adverse Event|0|||
130695829|NCT01537887|470510632|FG004|Period 3|Adverse Event|0|||
130695830|NCT01537887|470510633|FG005|Period 3|Adverse Event|0|||
130695831|NCT01537887|470510628|FG000|Period 3|Withdrawal by Subject|0|||
130695832|NCT01537887|470510629|FG001|Period 3|Withdrawal by Subject|1|||
130695833|NCT01537887|470510630|FG002|Period 3|Withdrawal by Subject|0|||
130695834|NCT01537887|470510631|FG003|Period 3|Withdrawal by Subject|0|||
130695835|NCT01537887|470510632|FG004|Period 3|Withdrawal by Subject|0|||
130695836|NCT01537887|470510633|FG005|Period 3|Withdrawal by Subject|0|||
130695837|NCT01634139|470510635|FG000|Overall Study|Non compliant with protocol|1|||
130695838|NCT01634139|470510636|FG001|Overall Study|Non compliant with protocol|0|||
130768509|NCT04165135|470776699|FG000|Overall Study|Protocol Violation|10|||
130695839|NCT01634139|470510637|FG002|Overall Study|Non compliant with protocol|0|||
130695840|NCT01634139|470510635|FG000|Overall Study|Consent withdrawn not due to AE|4|||
130695841|NCT01634139|470510636|FG001|Overall Study|Consent withdrawn not due to AE|3|||
130695842|NCT01634139|470510637|FG002|Overall Study|Consent withdrawn not due to AE|2|||
130695843|NCT01634139|470510635|FG000|Overall Study|Other|4|||
130695844|NCT01634139|470510636|FG001|Overall Study|Other|0|||
130695845|NCT01634139|470510637|FG002|Overall Study|Other|3|||
130695846|NCT01634139|470510635|FG000|Overall Study|Lost to Follow-up|0|||
130695847|NCT01634139|470510636|FG001|Overall Study|Lost to Follow-up|2|||
130695848|NCT01634139|470510637|FG002|Overall Study|Lost to Follow-up|0|||
130695849|NCT01634139|470510635|FG000|Overall Study|Not treated|1|||
130695850|NCT01634139|470510636|FG001|Overall Study|Not treated|1|||
130695851|NCT01634139|470510637|FG002|Overall Study|Not treated|0|||
130695852|NCT00425308|470510645|FG000|Overall Study|Adverse Event|2|||
130695853|NCT00425308|470510646|FG001|Overall Study|Adverse Event|1|||
130695854|NCT00425308|470510645|FG000|Overall Study|Withdrawal by Subject|1|||
130695855|NCT00425308|470510646|FG001|Overall Study|Withdrawal by Subject|0|||
130695856|NCT00425308|470510645|FG000|Overall Study|Death|1|||
130695857|NCT00425308|470510646|FG001|Overall Study|Death|0|||
130695858|NCT04442503|470510649|FG000|Overall Study|Adverse Event|1|||
130695859|NCT04442503|470510650|FG001|Overall Study|Adverse Event|1|||
130695860|NCT04442503|470510649|FG000|Overall Study|Lost to Follow-up|8|||
130695861|NCT04442503|470510650|FG001|Overall Study|Lost to Follow-up|6|||
130695862|NCT04442503|470510649|FG000|Overall Study|Physician Decision|0|||
130695863|NCT04442503|470510650|FG001|Overall Study|Physician Decision|2|||
130695864|NCT04442503|470510649|FG000|Overall Study|Withdrawal by Subject|3|||
130695865|NCT04442503|470510650|FG001|Overall Study|Withdrawal by Subject|4|||
130908410|NCT01975831|471300118|FG001|Overall Study|Progressive Disease|3|||
130908411|NCT01975831|471300119|FG002|Overall Study|Progressive Disease|2|||
130908412|NCT01975831|471300120|FG003|Overall Study|Progressive Disease|4|||
130908413|NCT01975831|471300121|FG004|Overall Study|Progressive Disease|13|||
130908414|NCT01975831|471300122|FG005|Overall Study|Progressive Disease|9|||
130908415|NCT01975831|471300123|FG006|Overall Study|Progressive Disease|10|||
130908416|NCT01975831|471300124|FG007|Overall Study|Progressive Disease|8|||
130695866|NCT04442503|470510649|FG000|Overall Study|Reason not Specified|0|||
130695867|NCT04442503|470510650|FG001|Overall Study|Reason not Specified|1|||
130695868|NCT04442503|470510649|FG000|Overall Study|Randomized but not Treated|3|||
130695869|NCT04442503|470510650|FG001|Overall Study|Randomized but not Treated|1|||
130695870|NCT02933060|470510651|FG000|Overall Study|Withdrawal by Subject|0|||
130695871|NCT02933060|470510652|FG001|Overall Study|Withdrawal by Subject|1|||
131029034|NCT05338086|471739491|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
131029035|NCT05338086|471739492|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
131029036|NCT05338086|471739493|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
131029037|NCT03940703|471739494|FG000|Overall Study|Still under treatment|31|||
131029038|NCT03940703|471739495|FG001|Overall Study|Still under treatment|0|||
131029039|NCT05113966|471739496|FG000|Overall Study|Death|21|||
131029040|NCT05113966|471739496|FG000|Overall Study|Study Terminated by Sponsor|9|||
131029041|NCT05386355|471739497|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
131029042|NCT05386355|471739498|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
131029043|NCT05386355|471739499|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
131029044|NCT05386355|471739500|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
131029045|NCT06143670|471739501|FG000|Overall Study|Lost to Follow-up|0|||
131029046|NCT06143670|471739502|FG001|Overall Study|Lost to Follow-up|1|||
131029047|NCT06143670|471739501|FG000|Overall Study|Withdrawal by Subject|3|||
131029048|NCT06143670|471739502|FG001|Overall Study|Withdrawal by Subject|0|||
131029049|NCT03747484|471739503|FG000|Overall Study|Lack of Efficacy|0|||
131029050|NCT03747484|471739504|FG001|Overall Study|Lack of Efficacy|1|||
131029051|NCT03747484|471739505|FG002|Overall Study|Lack of Efficacy|1|||
131029052|NCT03747484|471739506|FG003|Overall Study|Lack of Efficacy|2|||
131029053|NCT03747484|471739507|FG004|Overall Study|Lack of Efficacy|2|||
131029054|NCT04521478|471739514|FG000|Overall Study|Protocol Violation|2|||
131029055|NCT04521478|471739515|FG001|Overall Study|Protocol Violation|0|||
131029056|NCT04521478|471739516|FG002|Overall Study|Protocol Violation|1|||
130695872|NCT00989950|470510653|FG000|Randomized Phase|Protocol Violation|1|||
131029057|NCT04521478|471739517|FG003|Overall Study|Protocol Violation|0|||
131029058|NCT04521478|471739518|FG004|Overall Study|Protocol Violation|0|||
131029059|NCT04521478|471739519|FG005|Overall Study|Protocol Violation|0|||
130768510|NCT04165135|470776699|FG000|Overall Study|Participants withdrawal of consent|5|||
130908417|NCT01975831|471300125|FG008|Overall Study|Progressive Disease|10|||
131029060|NCT04521478|471739514|FG000|Overall Study|Technical Problems|0|||
131029061|NCT04521478|471739515|FG001|Overall Study|Technical Problems|0|||
130695873|NCT00989950|470510654|FG001|Randomized Phase|Protocol Violation|0|||
130695874|NCT00989950|470510655|FG002|Randomized Phase|Protocol Violation|0|||
130695875|NCT00989950|470510656|FG003|Randomized Phase|Protocol Violation|0|||
130695876|NCT00989950|470510653|FG000|Randomized Phase|Adverse Event|0|||
130695877|NCT00989950|470510654|FG001|Randomized Phase|Adverse Event|1|||
130695878|NCT00989950|470510655|FG002|Randomized Phase|Adverse Event|0|||
130695879|NCT00989950|470510656|FG003|Randomized Phase|Adverse Event|0|||
130908418|NCT01975831|471300117|FG000|Overall Study|Withdrawal by Subject|0|||
130908419|NCT01975831|471300118|FG001|Overall Study|Withdrawal by Subject|3|||
130908420|NCT01975831|471300119|FG002|Overall Study|Withdrawal by Subject|0|||
130908421|NCT01975831|471300120|FG003|Overall Study|Withdrawal by Subject|0|||
130908422|NCT01975831|471300121|FG004|Overall Study|Withdrawal by Subject|3|||
130908423|NCT01975831|471300122|FG005|Overall Study|Withdrawal by Subject|1|||
130908424|NCT01975831|471300123|FG006|Overall Study|Withdrawal by Subject|1|||
130908425|NCT01975831|471300124|FG007|Overall Study|Withdrawal by Subject|0|||
130908426|NCT01975831|471300125|FG008|Overall Study|Withdrawal by Subject|0|||
130908427|NCT01975831|471300117|FG000|Overall Study|Physician Decision|0|||
130908428|NCT01975831|471300118|FG001|Overall Study|Physician Decision|0|||
130908429|NCT01975831|471300119|FG002|Overall Study|Physician Decision|0|||
130908430|NCT01975831|471300120|FG003|Overall Study|Physician Decision|0|||
130908431|NCT01975831|471300121|FG004|Overall Study|Physician Decision|0|||
130908432|NCT01975831|471300122|FG005|Overall Study|Physician Decision|1|||
130908433|NCT01975831|471300123|FG006|Overall Study|Physician Decision|0|||
130908434|NCT01975831|471300124|FG007|Overall Study|Physician Decision|1|||
130908435|NCT01975831|471300125|FG008|Overall Study|Physician Decision|0|||
130908436|NCT01975831|471300117|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
130908437|NCT01975831|471300118|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
130908438|NCT01975831|471300119|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
130908439|NCT01975831|471300120|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
130908440|NCT01975831|471300121|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
130908441|NCT01975831|471300122|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
130908442|NCT01975831|471300123|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
130908443|NCT01975831|471300124|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
130908444|NCT01975831|471300125|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
130908445|NCT01975831|471300117|FG000|Overall Study|Entered Hospice|0|||
130908446|NCT01975831|471300118|FG001|Overall Study|Entered Hospice|0|||
130908447|NCT01975831|471300119|FG002|Overall Study|Entered Hospice|0|||
130908448|NCT01975831|471300120|FG003|Overall Study|Entered Hospice|0|||
130908449|NCT01975831|471300121|FG004|Overall Study|Entered Hospice|0|||
130908450|NCT01975831|471300122|FG005|Overall Study|Entered Hospice|1|||
130908451|NCT01975831|471300123|FG006|Overall Study|Entered Hospice|0|||
130908452|NCT01975831|471300124|FG007|Overall Study|Entered Hospice|0|||
130908453|NCT01975831|471300125|FG008|Overall Study|Entered Hospice|0|||
130908454|NCT01975831|471300117|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
130908455|NCT01975831|471300118|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
130908456|NCT01975831|471300119|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
130908457|NCT01975831|471300120|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
130908458|NCT01975831|471300121|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
130908459|NCT01975831|471300122|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
130908460|NCT01975831|471300123|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
130908461|NCT01975831|471300124|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
131029062|NCT04521478|471739516|FG002|Overall Study|Technical Problems|0|||
131029063|NCT04521478|471739517|FG003|Overall Study|Technical Problems|1|||
131029064|NCT04521478|471739518|FG004|Overall Study|Technical Problems|0|||
131029065|NCT04521478|471739519|FG005|Overall Study|Technical Problems|0|||
131029066|NCT04521478|471739514|FG000|Overall Study|Burden of Study Procedures|1|||
131029067|NCT04521478|471739515|FG001|Overall Study|Burden of Study Procedures|0|||
131029068|NCT04521478|471739516|FG002|Overall Study|Burden of Study Procedures|0|||
131029069|NCT04521478|471739517|FG003|Overall Study|Burden of Study Procedures|1|||
131029070|NCT04521478|471739518|FG004|Overall Study|Burden of Study Procedures|0|||
131029071|NCT04521478|471739519|FG005|Overall Study|Burden of Study Procedures|1|||
131029072|NCT04521478|471739514|FG000|Overall Study|Lack of Efficacy|0|||
131029073|NCT04521478|471739515|FG001|Overall Study|Lack of Efficacy|0|||
131029074|NCT04521478|471739516|FG002|Overall Study|Lack of Efficacy|0|||
131029075|NCT04521478|471739517|FG003|Overall Study|Lack of Efficacy|0|||
131029076|NCT04521478|471739518|FG004|Overall Study|Lack of Efficacy|1|||
131029077|NCT04521478|471739519|FG005|Overall Study|Lack of Efficacy|1|||
131029078|NCT04521478|471739514|FG000|Overall Study|Adverse Event|7|||
131029079|NCT04521478|471739515|FG001|Overall Study|Adverse Event|0|||
131029080|NCT04521478|471739516|FG002|Overall Study|Adverse Event|2|||
131029081|NCT04521478|471739517|FG003|Overall Study|Adverse Event|1|||
131029082|NCT04521478|471739518|FG004|Overall Study|Adverse Event|2|||
131029083|NCT04521478|471739519|FG005|Overall Study|Adverse Event|7|||
131029084|NCT04521478|471739514|FG000|Overall Study|No Reason Available|0|||
130908462|NCT01975831|471300125|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
130908463|NCT01401959|471300126|FG000|Enrolled|Withdrawal by Subject|1|||
130908464|NCT01401959|471300127|FG001|Enrolled|Withdrawal by Subject|0|||
130908465|NCT01401959|471300128|FG002|Enrolled|Withdrawal by Subject|0|||
131029085|NCT04521478|471739515|FG001|Overall Study|No Reason Available|2|||
131029086|NCT04521478|471739516|FG002|Overall Study|No Reason Available|0|||
130908466|NCT01401959|471300126|FG000|Treated|Disease Progression|2|||
130695880|NCT00101439|470510657|FG000|Period 2|Withdrawal by Subject|0|||
130695881|NCT00101439|470510658|FG001|Period 2|Withdrawal by Subject|2|||
130695882|NCT03101358|470510659|FG000|Overall Study|Non-compliance with study schedule|1|||
131029087|NCT04521478|471739517|FG003|Overall Study|No Reason Available|0|||
131029088|NCT04521478|471739518|FG004|Overall Study|No Reason Available|1|||
131029089|NCT04521478|471739519|FG005|Overall Study|No Reason Available|0|||
131029090|NCT04521478|471739514|FG000|Overall Study|Other than listed|3|||
131029091|NCT04521478|471739515|FG001|Overall Study|Other than listed|3|||
131029092|NCT04521478|471739516|FG002|Overall Study|Other than listed|3|||
131029093|NCT04521478|471739517|FG003|Overall Study|Other than listed|2|||
131029094|NCT04521478|471739518|FG004|Overall Study|Other than listed|3|||
131029095|NCT04521478|471739519|FG005|Overall Study|Other than listed|3|||
131029096|NCT04521478|471739514|FG000|Overall Study|Not treated|0|||
131029097|NCT04521478|471739515|FG001|Overall Study|Not treated|0|||
131029098|NCT04521478|471739516|FG002|Overall Study|Not treated|0|||
131029099|NCT04521478|471739517|FG003|Overall Study|Not treated|0|||
131029100|NCT04521478|471739518|FG004|Overall Study|Not treated|0|||
131029101|NCT04521478|471739519|FG005|Overall Study|Not treated|1|||
131029102|NCT03833245|471739523|FG000|Overall Study|Death|0|||
131029103|NCT03833245|471739524|FG001|Overall Study|Death|1|||
131029104|NCT03775109|471739526|FG000|Overall Study|Adverse Event|1|||
131029105|NCT03775109|471739527|FG001|Overall Study|Adverse Event|0|||
131029106|NCT03775109|471739526|FG000|Overall Study|COVID-19 outbreak|2|||
131029107|NCT03775109|471739527|FG001|Overall Study|COVID-19 outbreak|0|||
131029108|NCT03775109|471739526|FG000|Overall Study|Lost to Follow-up|0|||
131029109|NCT03775109|471739527|FG001|Overall Study|Lost to Follow-up|2|||
131029110|NCT03775109|471739526|FG000|Overall Study|Withdrawal by Subject|1|||
131029111|NCT03775109|471739527|FG001|Overall Study|Withdrawal by Subject|1|||
131029112|NCT03775109|471739526|FG000|Overall Study|Death|0|||
131029113|NCT03775109|471739527|FG001|Overall Study|Death|1|||
131029114|NCT03775109|471739526|FG000|Overall Study|Lack of Efficacy|1|||
131029115|NCT03775109|471739527|FG001|Overall Study|Lack of Efficacy|0|||
131029116|NCT03347383|471739528|FG000|Overall Study|Death|39|||
131029117|NCT03347383|471739528|FG000|Overall Study|Withdrawal by Subject|3|||
131029118|NCT03347383|471739528|FG000|Overall Study|Lost to Follow-up|9|||
131029119|NCT05691452|471739536|FG000|Overall Study|Withdrawal by Subject|1|||
131029120|NCT05691452|471739537|FG001|Overall Study|Withdrawal by Subject|1|||
131029121|NCT05691452|471739538|FG002|Overall Study|Withdrawal by Subject|0|||
131029122|NCT05691452|471739536|FG000|Overall Study|Physician Decision|1|||
131029123|NCT05691452|471739537|FG001|Overall Study|Physician Decision|0|||
131029124|NCT05691452|471739538|FG002|Overall Study|Physician Decision|0|||
131029125|NCT05691452|471739536|FG000|Overall Study|Lost to Follow-up|0|||
131029126|NCT05691452|471739537|FG001|Overall Study|Lost to Follow-up|0|||
131029127|NCT05691452|471739538|FG002|Overall Study|Lost to Follow-up|1|||
131029128|NCT05691452|471739536|FG000|Overall Study|Adverse Event|0|||
131029129|NCT05691452|471739537|FG001|Overall Study|Adverse Event|0|||
131029130|NCT05691452|471739538|FG002|Overall Study|Adverse Event|1|||
131029131|NCT01938547|471739541|FG000|Overall Study|Physician Decision|1|||
131029132|NCT05320432|471739544|FG000|Overall Study|Withdrawal by Subject|0|||
131029133|NCT05320432|471739545|FG001|Overall Study|Withdrawal by Subject|2|||
131029134|NCT04173663|471739549|FG000|Overall Study|Withdrawal by Subject|1|||
131029135|NCT04173663|471739550|FG001|Overall Study|Withdrawal by Subject|6|||
131029136|NCT04173663|471739549|FG000|Overall Study|Lost to Follow-up|17|||
131029137|NCT04173663|471739550|FG001|Overall Study|Lost to Follow-up|24|||
131029138|NCT01757665|471739553|FG000|Overall Study|Still on Study - Visit Completed|240|||
131029139|NCT01757665|471739554|FG001|Overall Study|Still on Study - Visit Completed|30|||
131029140|NCT01757665|471739553|FG000|Overall Study|Still on Study - Visit Pending|398|||
131029141|NCT01757665|471739554|FG001|Overall Study|Still on Study - Visit Pending|40|||
131029142|NCT01757665|471739553|FG000|Overall Study|Still on Study - Missed Visit|14|||
131029143|NCT01757665|471739554|FG001|Overall Study|Still on Study - Missed Visit|1|||
131029144|NCT01757665|471739553|FG000|Overall Study|Death|25|||
131029145|NCT01757665|471739554|FG001|Overall Study|Death|8|||
131029146|NCT01757665|471739553|FG000|Overall Study|Explant|1|||
131029147|NCT01757665|471739554|FG001|Overall Study|Explant|2|||
131029148|NCT01757665|471739553|FG000|Overall Study|Withdrawal by Subject|10|||
131029149|NCT01757665|471739554|FG001|Overall Study|Withdrawal by Subject|0|||
131029150|NCT01757665|471739553|FG000|Overall Study|Lost to Follow-up|1|||
131029151|NCT01757665|471739554|FG001|Overall Study|Lost to Follow-up|1|||
131029152|NCT01757665|471739553|FG000|Overall Study|Not Implanted with Device|5|||
131029153|NCT01757665|471739554|FG001|Overall Study|Not Implanted with Device|1|||
131029154|NCT05816551|471739557|FG000|Overall Study|Withdrawal by Subject|0|||
131029155|NCT05816551|471739558|FG001|Overall Study|Withdrawal by Subject|1|||
131029156|NCT05816551|471739557|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
131029157|NCT05816551|471739558|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
131029158|NCT04549168|471739565|FG000|Randomization Phase|Adverse Event|0|||
131029159|NCT04549168|471739566|FG001|Randomization Phase|Adverse Event|0|||
131029160|NCT04549168|471739567|FG002|Randomization Phase|Adverse Event|1|||
131029161|NCT04549168|471739565|FG000|Randomization Phase|Other|0|||
131029162|NCT04549168|471739566|FG001|Randomization Phase|Other|2|||
131029163|NCT04549168|471739567|FG002|Randomization Phase|Other|0|||
131115255|NCT01179672|472053618|FG001|Overall Study|Withdrawal by Subject|12|||
130768511|NCT01618916|470776700|FG000|Overall Study|Adverse Event|1|||
131029164|NCT04549168|471739565|FG000|Randomization Phase|Withdrawal by Subject|0|||
131029165|NCT04549168|471739566|FG001|Randomization Phase|Withdrawal by Subject|2|||
131029166|NCT04549168|471739567|FG002|Randomization Phase|Withdrawal by Subject|1|||
131029167|NCT02662062|471739571|FG000|Overall Study|Withdrawal by Subject|1|||
131029168|NCT06311084|471739572|FG000|Overall Study|Lost to Follow-up|14|||
131029169|NCT03988634|471739573|FG000|Double-Blind|Adverse Event|4|||
131029170|NCT03988634|471739574|FG001|Double-Blind|Adverse Event|0|||
131029171|NCT03988634|471739575|FG002|Double-Blind|Adverse Event|0|||
131029172|NCT03988634|471739573|FG000|Double-Blind|Death|18|||
131029173|NCT03988634|471739574|FG001|Double-Blind|Death|26|||
131029174|NCT03988634|471739575|FG002|Double-Blind|Death|0|||
131029175|NCT03988634|471739573|FG000|Double-Blind|Lost to Follow-up|6|||
131029176|NCT03988634|471739574|FG001|Double-Blind|Lost to Follow-up|7|||
131029177|NCT03988634|471739575|FG002|Double-Blind|Lost to Follow-up|0|||
131029178|NCT03988634|471739573|FG000|Double-Blind|Physician Decision|9|||
131029179|NCT03988634|471739574|FG001|Double-Blind|Physician Decision|5|||
131029180|NCT03988634|471739575|FG002|Double-Blind|Physician Decision|0|||
131029181|NCT03988634|471739573|FG000|Double-Blind|Subject decision|24|||
131029182|NCT03988634|471739574|FG001|Double-Blind|Subject decision|13|||
131029183|NCT03988634|471739575|FG002|Double-Blind|Subject decision|0|||
131029184|NCT03988634|471739573|FG000|Open-Label|Adverse Event|0|||
131029185|NCT03988634|471739574|FG001|Open-Label|Adverse Event|0|||
131029186|NCT03988634|471739575|FG002|Open-Label|Adverse Event|7|||
131029187|NCT03988634|471739573|FG000|Open-Label|Physician Decision|0|||
131029188|NCT03988634|471739574|FG001|Open-Label|Physician Decision|0|||
131029189|NCT03988634|471739575|FG002|Open-Label|Physician Decision|1|||
131029190|NCT03988634|471739573|FG000|Open-Label|Technical problems|0|||
131029191|NCT03988634|471739574|FG001|Open-Label|Technical problems|0|||
131029192|NCT03988634|471739575|FG002|Open-Label|Technical problems|1|||
131029193|NCT05458011|471739576|FG000|DB Period (12 Weeks)|Adverse Event|2|||
131029194|NCT05458011|471739577|FG001|DB Period (12 Weeks)|Adverse Event|1|||
131029195|NCT05458011|471739578|FG002|DB Period (12 Weeks)|Adverse Event|1|||
131029196|NCT05458011|471739576|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
131029197|NCT05458011|471739577|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
131029198|NCT05458011|471739578|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
131029199|NCT05458011|471739576|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
131029200|NCT05458011|471739577|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
131029201|NCT05458011|471739578|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
131029202|NCT05458011|471739576|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
131029203|NCT05458011|471739577|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
131029204|NCT05458011|471739578|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
131029205|NCT05458011|471739576|FG000|OL Period (12 Weeks)|Adverse Event|1|||
131029206|NCT05458011|471739577|FG001|OL Period (12 Weeks)|Adverse Event|2|||
131029207|NCT05458011|471739578|FG002|OL Period (12 Weeks)|Adverse Event|1|||
131029208|NCT05458011|471739576|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
131029209|NCT05458011|471739577|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
131029210|NCT05458011|471739578|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
131029211|NCT03385629|471739579|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
131029212|NCT03385629|471739580|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
131029213|NCT03385629|471739579|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
131029214|NCT03385629|471739580|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
131029215|NCT03385629|471739579|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
131029216|NCT03385629|471739580|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
131029217|NCT05633407|471739584|FG000|Overall Study|Physician Decision|2|||
131029218|NCT05633407|471739585|FG001|Overall Study|Physician Decision|0|||
131029219|NCT05633407|471739584|FG000|Overall Study|Adverse Event|1|||
131029220|NCT05633407|471739585|FG001|Overall Study|Adverse Event|0|||
131029221|NCT05633407|471739584|FG000|Overall Study|Withdrawal by Subject|1|||
131029222|NCT05633407|471739585|FG001|Overall Study|Withdrawal by Subject|0|||
131029223|NCT05633407|471739584|FG000|Overall Study|Other|1|||
131029224|NCT05633407|471739585|FG001|Overall Study|Other|1|||
131029225|NCT04842643|471740803|FG000|Overall Study|Physician Decision|1|||
131029226|NCT04842643|471740803|FG000|Overall Study|Other|1|||
131029227|NCT03484702|471740804|FG000|Treatment Period|Death|3|||
131029228|NCT03484702|471740805|FG001|Treatment Period|Death|1|||
131029229|NCT03484702|471740806|FG002|Treatment Period|Death|0|||
131029230|NCT03484702|471740807|FG003|Treatment Period|Death|0|||
131029231|NCT03484702|471740808|FG004|Treatment Period|Death|0|||
131029232|NCT03484702|471740809|FG005|Treatment Period|Death|0|||
131029233|NCT03484702|471740804|FG000|Treatment Period|Adverse Event|1|||
131029234|NCT03484702|471740805|FG001|Treatment Period|Adverse Event|0|||
131029235|NCT03484702|471740806|FG002|Treatment Period|Adverse Event|0|||
131029236|NCT03484702|471740807|FG003|Treatment Period|Adverse Event|0|||
131029237|NCT03484702|471740808|FG004|Treatment Period|Adverse Event|0|||
131029238|NCT03484702|471740809|FG005|Treatment Period|Adverse Event|0|||
131029239|NCT03484702|471740804|FG000|Treatment Period|Participant Withdrew from Study|0|||
130695883|NCT03101358|470510660|FG001|Overall Study|Non-compliance with study schedule|0|||
130695884|NCT03101358|470510661|FG002|Overall Study|Non-compliance with study schedule|0|||
130695885|NCT03101358|470510662|FG003|Overall Study|Non-compliance with study schedule|1|||
130695886|NCT03101358|470510659|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
130695887|NCT03101358|470510660|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
130695888|NCT03101358|470510661|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
130695889|NCT03101358|470510662|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
130695890|NCT03101358|470510659|FG000|Overall Study|Physician Decision|1|||
130695891|NCT03101358|470510660|FG001|Overall Study|Physician Decision|0|||
130695892|NCT03101358|470510661|FG002|Overall Study|Physician Decision|0|||
130695893|NCT03101358|470510662|FG003|Overall Study|Physician Decision|3|||
130695894|NCT03101358|470510659|FG000|Overall Study|Adverse Event|0|||
130695895|NCT03101358|470510660|FG001|Overall Study|Adverse Event|0|||
130695896|NCT03101358|470510661|FG002|Overall Study|Adverse Event|1|||
130695897|NCT03101358|470510662|FG003|Overall Study|Adverse Event|0|||
130695898|NCT03101358|470510659|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
130695899|NCT03101358|470510660|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
130695900|NCT03101358|470510661|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
130695901|NCT03101358|470510662|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
130695902|NCT03101358|470510659|FG000|Overall Study|Lost to Follow-up|1|||
130695903|NCT03101358|470510660|FG001|Overall Study|Lost to Follow-up|0|||
130695904|NCT03101358|470510661|FG002|Overall Study|Lost to Follow-up|0|||
130695905|NCT03101358|470510662|FG003|Overall Study|Lost to Follow-up|1|||
130695906|NCT00474058|470510663|FG000|Overall Study|Adverse Event|11|||
130695907|NCT00474058|470510664|FG001|Overall Study|Adverse Event|6|||
130695908|NCT00474058|470510663|FG000|Overall Study|Lack of Efficacy|0|||
130695909|NCT00474058|470510664|FG001|Overall Study|Lack of Efficacy|4|||
130695910|NCT00474058|470510663|FG000|Overall Study|Withdrawal by Subject|11|||
130695911|NCT00474058|470510664|FG001|Overall Study|Withdrawal by Subject|7|||
130695912|NCT00474058|470510663|FG000|Overall Study|Other|2|||
130695913|NCT00474058|470510664|FG001|Overall Study|Other|0|||
130695914|NCT02426918|470510665|FG000|Overall Study|Adverse Event|2|||
130695915|NCT02426918|470510666|FG001|Overall Study|Adverse Event|2|||
130695916|NCT02426918|470510667|FG002|Overall Study|Adverse Event|0|||
130695917|NCT02426918|470510665|FG000|Overall Study|Physician Decision|1|||
130695918|NCT02426918|470510666|FG001|Overall Study|Physician Decision|1|||
130908467|NCT01401959|471300127|FG001|Treated|Disease Progression|2|||
130908468|NCT01401959|471300128|FG002|Treated|Disease Progression|1|||
131115256|NCT01179672|472053617|FG000|Overall Study|Entry Criteria Not Met|0|||
131115257|NCT01179672|472053618|FG001|Overall Study|Entry Criteria Not Met|2|||
131115258|NCT01179672|472053617|FG000|Overall Study|Lost to Follow-up|0|||
130695919|NCT02426918|470510667|FG002|Overall Study|Physician Decision|1|||
130695920|NCT02426918|470510665|FG000|Overall Study|Withdrawal by Subject|5|||
130695921|NCT02426918|470510666|FG001|Overall Study|Withdrawal by Subject|5|||
130695922|NCT02426918|470510667|FG002|Overall Study|Withdrawal by Subject|4|||
130908469|NCT01401959|471300126|FG000|Treated|Adverse Event|4|||
131029240|NCT03484702|471740805|FG001|Treatment Period|Participant Withdrew from Study|1|||
131029241|NCT03484702|471740806|FG002|Treatment Period|Participant Withdrew from Study|0|||
131029242|NCT03484702|471740807|FG003|Treatment Period|Participant Withdrew from Study|0|||
131029243|NCT03484702|471740808|FG004|Treatment Period|Participant Withdrew from Study|0|||
131029244|NCT03484702|471740809|FG005|Treatment Period|Participant Withdrew from Study|0|||
131029245|NCT03484702|471740804|FG000|Treatment Period|Physician Decision|0|||
131029246|NCT03484702|471740805|FG001|Treatment Period|Physician Decision|1|||
131029247|NCT03484702|471740806|FG002|Treatment Period|Physician Decision|0|||
131029248|NCT03484702|471740807|FG003|Treatment Period|Physician Decision|0|||
131029249|NCT03484702|471740808|FG004|Treatment Period|Physician Decision|0|||
131029250|NCT03484702|471740809|FG005|Treatment Period|Physician Decision|1|||
131029251|NCT04850807|471740816|FG000|Overall Study|Death|50|||
131029252|NCT04850807|471740817|FG001|Overall Study|Death|55|||
131029253|NCT04850807|471740816|FG000|Overall Study|Discharged|17|||
131029254|NCT04850807|471740817|FG001|Overall Study|Discharged|13|||
131029255|NCT04850807|471740816|FG000|Overall Study|Incomplete baseline data|3|||
130695923|NCT02426918|470510665|FG000|Overall Study|Other|9|||
130695924|NCT02426918|470510666|FG001|Overall Study|Other|11|||
130908470|NCT01401959|471300127|FG001|Treated|Adverse Event|3|||
131029256|NCT04850807|471740817|FG001|Overall Study|Incomplete baseline data|2|||
131029257|NCT02651324|471740820|FG000|Overall Study|drug not administered, due dispensing issue|1|||
131029258|NCT02651324|471740821|FG001|Overall Study|drug not administered, due dispensing issue|0|||
131029259|NCT03896516|471740822|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
131115259|NCT01179672|472053618|FG001|Overall Study|Lost to Follow-up|1|||
130695925|NCT02426918|470510667|FG002|Overall Study|Other|9|||
130908471|NCT01401959|471300128|FG002|Treated|Adverse Event|2|||
130908472|NCT01401959|471300126|FG000|Treated|Withdrawal by Subject|1|||
131115260|NCT01179672|472053617|FG000|Overall Study|Protocol Violation|2|||
130695926|NCT01496118|470510668|FG000|Overall Study|Disease progression|3|||
130695927|NCT01496118|470510669|FG001|Overall Study|Disease progression|2|||
130695928|NCT01496118|470510670|FG002|Overall Study|Disease progression|3|||
130695929|NCT01496118|470510671|FG003|Overall Study|Disease progression|1|||
130695930|NCT01496118|470510672|FG004|Overall Study|Disease progression|2|||
130695931|NCT01496118|470510673|FG005|Overall Study|Disease progression|2|||
130695932|NCT01496118|470510674|FG006|Overall Study|Disease progression|14|||
130695933|NCT01496118|470510675|FG007|Overall Study|Disease progression|10|||
130695934|NCT01496118|470510668|FG000|Overall Study|Physician Decision|0|||
130695935|NCT01496118|470510669|FG001|Overall Study|Physician Decision|0|||
130695936|NCT01496118|470510670|FG002|Overall Study|Physician Decision|0|||
130695937|NCT01496118|470510671|FG003|Overall Study|Physician Decision|0|||
130695938|NCT01496118|470510672|FG004|Overall Study|Physician Decision|1|||
130695939|NCT01496118|470510673|FG005|Overall Study|Physician Decision|0|||
130695940|NCT01496118|470510674|FG006|Overall Study|Physician Decision|3|||
130695941|NCT01496118|470510675|FG007|Overall Study|Physician Decision|6|||
130695942|NCT01496118|470510668|FG000|Overall Study|Adverse Event|1|||
130695943|NCT01496118|470510669|FG001|Overall Study|Adverse Event|1|||
130695944|NCT01496118|470510670|FG002|Overall Study|Adverse Event|0|||
130695945|NCT01496118|470510671|FG003|Overall Study|Adverse Event|0|||
130695946|NCT01496118|470510672|FG004|Overall Study|Adverse Event|0|||
130695947|NCT01496118|470510673|FG005|Overall Study|Adverse Event|0|||
130695948|NCT01496118|470510674|FG006|Overall Study|Adverse Event|6|||
130695949|NCT01496118|470510675|FG007|Overall Study|Adverse Event|10|||
130695950|NCT01496118|470510668|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695951|NCT01496118|470510669|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695952|NCT01496118|470510670|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695953|NCT01496118|470510671|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695954|NCT01496118|470510672|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695955|NCT01496118|470510673|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695956|NCT01496118|470510674|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
130695957|NCT01496118|470510675|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130695958|NCT01496118|470510668|FG000|Overall Study|Death|0|||
130695959|NCT01496118|470510669|FG001|Overall Study|Death|0|||
130695960|NCT01496118|470510670|FG002|Overall Study|Death|0|||
130695961|NCT01496118|470510671|FG003|Overall Study|Death|0|||
130695962|NCT01496118|470510672|FG004|Overall Study|Death|0|||
130695963|NCT01496118|470510673|FG005|Overall Study|Death|0|||
130695964|NCT01496118|470510674|FG006|Overall Study|Death|1|||
130695965|NCT01496118|470510675|FG007|Overall Study|Death|1|||
130695966|NCT01496118|470510668|FG000|Overall Study|Withdrawal by Subject|0|||
130695967|NCT01496118|470510669|FG001|Overall Study|Withdrawal by Subject|0|||
130695968|NCT01496118|470510670|FG002|Overall Study|Withdrawal by Subject|0|||
130695969|NCT01496118|470510671|FG003|Overall Study|Withdrawal by Subject|2|||
130695970|NCT01496118|470510672|FG004|Overall Study|Withdrawal by Subject|0|||
130695971|NCT01496118|470510673|FG005|Overall Study|Withdrawal by Subject|1|||
130695972|NCT01496118|470510674|FG006|Overall Study|Withdrawal by Subject|6|||
130695973|NCT01496118|470510675|FG007|Overall Study|Withdrawal by Subject|3|||
130695974|NCT05616728|470510676|FG000|Overall Study|Lost to Follow-up|0|||
130695975|NCT05616728|470510677|FG001|Overall Study|Lost to Follow-up|0|||
130695976|NCT05616728|470510678|FG002|Overall Study|Lost to Follow-up|1|||
130695977|NCT05616728|470510676|FG000|Overall Study|Withdrawal by Subject|1|||
130695978|NCT05616728|470510677|FG001|Overall Study|Withdrawal by Subject|1|||
130695979|NCT05616728|470510678|FG002|Overall Study|Withdrawal by Subject|0|||
130695980|NCT05616728|470510676|FG000|Overall Study|Physician Decision|1|||
130695981|NCT05616728|470510677|FG001|Overall Study|Physician Decision|1|||
130695982|NCT05616728|470510678|FG002|Overall Study|Physician Decision|1|||
130695983|NCT05616728|470510676|FG000|Overall Study|Other|0|||
130695984|NCT05616728|470510677|FG001|Overall Study|Other|2|||
130695985|NCT05616728|470510678|FG002|Overall Study|Other|0|||
130695986|NCT01024855|470510681|FG000|Overall Study|Inclusion/exclusion criteria|1|||
130695987|NCT03306277|470510686|FG000|Overall Study|Death|1|||
130695988|NCT03306277|470510686|FG000|Overall Study|Adverse Event|1|||
130695989|NCT03306277|470510686|FG000|Overall Study|Withdrawal by Subject|1|||
130695990|NCT00881751|470510687|FG000|Overall Study|Physician Decision|0|||
130695991|NCT00881751|470510688|FG001|Overall Study|Physician Decision|1|||
130695992|NCT00881751|470510687|FG000|Overall Study|Adverse Event|0|||
130695993|NCT00881751|470510688|FG001|Overall Study|Adverse Event|2|||
130695994|NCT00881751|470510687|FG000|Overall Study|Withdrawal by Subject|0|||
130695995|NCT00881751|470510688|FG001|Overall Study|Withdrawal by Subject|2|||
130695996|NCT02385708|470510689|FG000|Overall Study|Withdrawal by Subject|0|||
130695997|NCT02385708|470510690|FG001|Overall Study|Withdrawal by Subject|2|||
130695998|NCT02385708|470510689|FG000|Overall Study|Withdrawn - surgery canceled|2|||
130695999|NCT02385708|470510690|FG001|Overall Study|Withdrawn - surgery canceled|5|||
130696000|NCT02385708|470510689|FG000|Overall Study|Investigator decision|5|||
130696001|NCT02385708|470510690|FG001|Overall Study|Investigator decision|7|||
130908473|NCT01401959|471300127|FG001|Treated|Withdrawal by Subject|2|||
130908474|NCT01401959|471300128|FG002|Treated|Withdrawal by Subject|2|||
130908475|NCT01401959|471300126|FG000|Treated|Protocol Violation|0|||
130908476|NCT01401959|471300127|FG001|Treated|Protocol Violation|1|||
130908477|NCT01401959|471300128|FG002|Treated|Protocol Violation|0|||
130908478|NCT02694718|471300129|FG000|Overall Study|Death|1|||
130908479|NCT02694718|471300129|FG000|Overall Study|Withdrawal by Subject|1|||
130908480|NCT02925793|471300130|FG000|Overall Study|Adverse Event|3|||
130908481|NCT02925793|471300131|FG001|Overall Study|Adverse Event|3|||
130908482|NCT02925793|471300132|FG002|Overall Study|Adverse Event|6|||
130908483|NCT02925793|471300130|FG000|Overall Study|Withdrawal by Subject|16|||
130908484|NCT02925793|471300131|FG001|Overall Study|Withdrawal by Subject|15|||
130908485|NCT02925793|471300132|FG002|Overall Study|Withdrawal by Subject|13|||
130908486|NCT02925793|471300130|FG000|Overall Study|Investigator Discretion|0|||
130908487|NCT02925793|471300131|FG001|Overall Study|Investigator Discretion|1|||
130908488|NCT02925793|471300132|FG002|Overall Study|Investigator Discretion|1|||
130908489|NCT02925793|471300130|FG000|Overall Study|Lost to Follow-up|2|||
130908490|NCT02925793|471300131|FG001|Overall Study|Lost to Follow-up|3|||
130908491|NCT02925793|471300132|FG002|Overall Study|Lost to Follow-up|1|||
130908492|NCT02925793|471300130|FG000|Overall Study|Lack of Efficacy|2|||
130908493|NCT02925793|471300131|FG001|Overall Study|Lack of Efficacy|6|||
130908494|NCT02925793|471300132|FG002|Overall Study|Lack of Efficacy|4|||
130908495|NCT02925793|471300130|FG000|Overall Study|Other:|2|||
130908496|NCT02925793|471300131|FG001|Overall Study|Other:|1|||
130908497|NCT02925793|471300132|FG002|Overall Study|Other:|3|||
130908498|NCT03063203|471300133|FG000|Overall Study|Chose alternative therapy|3|||
130908499|NCT03063203|471300133|FG000|Overall Study|Death|2|||
130908500|NCT03063203|471300133|FG000|Overall Study|Disease progression|4|||
130908501|NCT03063203|471300133|FG000|Overall Study|Physician Decision|5|||
130908502|NCT02045303|471300134|FG000|Overall Study|Protocol Violation|2|||
130908503|NCT02045303|471300135|FG001|Overall Study|Protocol Violation|1|||
130908504|NCT02045303|471300136|FG002|Overall Study|Protocol Violation|0|||
130908505|NCT02045303|471300134|FG000|Overall Study|Withdrawal by Subject|0|||
130908506|NCT02045303|471300135|FG001|Overall Study|Withdrawal by Subject|2|||
130908507|NCT02045303|471300136|FG002|Overall Study|Withdrawal by Subject|0|||
130908508|NCT04718103|471300137|FG000|Overall Study|Adverse Event|1|||
130908509|NCT04718103|471300138|FG001|Overall Study|Adverse Event|1|||
130908510|NCT04718103|471300137|FG000|Overall Study|Lack of Efficacy|4|||
130908511|NCT04718103|471300138|FG001|Overall Study|Lack of Efficacy|1|||
130908512|NCT04718103|471300137|FG000|Overall Study|Lost to Follow-up|2|||
130908513|NCT04718103|471300138|FG001|Overall Study|Lost to Follow-up|2|||
131029260|NCT03896516|471740823|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
131029261|NCT03896516|471740822|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
131029262|NCT03896516|471740823|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
131029263|NCT03896516|471740822|FG000|Washout Period|Physician Decision|3|||
131029264|NCT03896516|471740823|FG001|Washout Period|Physician Decision|1|||
131029265|NCT03896516|471740822|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
131029266|NCT03896516|471740823|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
131029267|NCT04725240|471740826|FG000|Overall Study|Adverse Event|2|||
131029268|NCT00676715|471740833|FG000|Treatment Period (TP)|Adverse Event|0|||
131029269|NCT00676715|471740834|FG001|Treatment Period (TP)|Adverse Event|3|||
131029270|NCT00676715|471740835|FG002|Treatment Period (TP)|Adverse Event|2|||
131029271|NCT00676715|471740836|FG003|Treatment Period (TP)|Adverse Event|2|||
131029272|NCT00676715|471740833|FG000|Treatment Period (TP)|Death|0|||
131029273|NCT00676715|471740834|FG001|Treatment Period (TP)|Death|0|||
131029274|NCT00676715|471740835|FG002|Treatment Period (TP)|Death|1|||
131029275|NCT00676715|471740836|FG003|Treatment Period (TP)|Death|0|||
131029276|NCT00676715|471740833|FG000|Treatment Period (TP)|Failure to return|1|||
131029277|NCT00676715|471740834|FG001|Treatment Period (TP)|Failure to return|0|||
131029278|NCT00676715|471740835|FG002|Treatment Period (TP)|Failure to return|0|||
131029279|NCT00676715|471740836|FG003|Treatment Period (TP)|Failure to return|0|||
131029280|NCT00676715|471740833|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
131029281|NCT00676715|471740834|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
131029282|NCT00676715|471740835|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
131029283|NCT00676715|471740836|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
130696002|NCT02385708|470510689|FG000|Overall Study|Protocol Violation|1|||
130696003|NCT02385708|470510690|FG001|Overall Study|Protocol Violation|1|||
130696004|NCT02761915|470510691|FG000|Overall Study|Death|3|||
130908514|NCT04718103|471300137|FG000|Overall Study|Physician Decision|2|||
130908515|NCT04718103|471300138|FG001|Overall Study|Physician Decision|0|||
130908516|NCT04718103|471300137|FG000|Overall Study|Pregnancy|0|||
130908517|NCT04718103|471300138|FG001|Overall Study|Pregnancy|1|||
130908518|NCT04718103|471300137|FG000|Overall Study|Withdrawal by Subject|10|||
130908519|NCT04718103|471300138|FG001|Overall Study|Withdrawal by Subject|6|||
130908520|NCT04718103|471300137|FG000|Overall Study|Randomized, not treated|4|||
130908521|NCT04718103|471300138|FG001|Overall Study|Randomized, not treated|1|||
130696005|NCT02761915|470510692|FG001|Overall Study|Death|1|||
130908522|NCT04718103|471300137|FG000|Overall Study|GCP violations|7|||
130908523|NCT04718103|471300138|FG001|Overall Study|GCP violations|5|||
130908524|NCT00136604|471300139|FG000|Overall Study|Lost to Follow-up|1|||
130908525|NCT00136604|471300140|FG001|Overall Study|Lost to Follow-up|0|||
130908526|NCT00136604|471300141|FG002|Overall Study|Lost to Follow-up|0|||
130908527|NCT00136604|471300142|FG003|Overall Study|Lost to Follow-up|0|||
130908528|NCT00136604|471300143|FG004|Overall Study|Lost to Follow-up|1|||
130908529|NCT00136604|471300139|FG000|Overall Study|Migrated/moved from study area|0|||
130908530|NCT00136604|471300140|FG001|Overall Study|Migrated/moved from study area|1|||
130908531|NCT00136604|471300141|FG002|Overall Study|Migrated/moved from study area|0|||
130908532|NCT00136604|471300142|FG003|Overall Study|Migrated/moved from study area|0|||
130908533|NCT00136604|471300143|FG004|Overall Study|Migrated/moved from study area|0|||
130908534|NCT01309893|471300145|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
130908535|NCT01309893|471300146|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
130908536|NCT01309893|471300145|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
130908537|NCT01309893|471300146|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
130908538|NCT01343901|471300147|FG000|Overall Study|Death|85|||
131029284|NCT00676715|471740833|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
131029285|NCT00676715|471740834|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
131029286|NCT00676715|471740835|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
130696006|NCT02761915|470510693|FG002|Overall Study|Death|1|||
130696007|NCT02761915|470510694|FG003|Overall Study|Death|1|||
130696008|NCT02761915|470510695|FG004|Overall Study|Death|0|||
130696009|NCT02761915|470510696|FG005|Overall Study|Death|1|||
130696010|NCT02761915|470510691|FG000|Overall Study|Withdrawal by Subject|1|||
130696011|NCT02761915|470510692|FG001|Overall Study|Withdrawal by Subject|0|||
130696012|NCT02761915|470510693|FG002|Overall Study|Withdrawal by Subject|0|||
130696013|NCT02761915|470510694|FG003|Overall Study|Withdrawal by Subject|0|||
130696014|NCT02761915|470510695|FG004|Overall Study|Withdrawal by Subject|1|||
130696015|NCT02761915|470510696|FG005|Overall Study|Withdrawal by Subject|2|||
130696016|NCT02761915|470510691|FG000|Overall Study|Disease Progression|0|||
130696017|NCT02761915|470510692|FG001|Overall Study|Disease Progression|0|||
131029287|NCT00676715|471740836|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
131029288|NCT00676715|471740833|FG000|Treatment Period (TP)|Withdrew consent|3|||
131029289|NCT00676715|471740834|FG001|Treatment Period (TP)|Withdrew consent|3|||
131029290|NCT00676715|471740835|FG002|Treatment Period (TP)|Withdrew consent|3|||
131029291|NCT00676715|471740836|FG003|Treatment Period (TP)|Withdrew consent|3|||
131029292|NCT00676715|471740833|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
131029293|NCT00676715|471740834|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
131029294|NCT00676715|471740835|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
131029295|NCT00676715|471740836|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
131029296|NCT00676715|471740833|FG000|Treatment Period (TP)|Administrative|0|||
131029297|NCT00676715|471740834|FG001|Treatment Period (TP)|Administrative|0|||
131029298|NCT00676715|471740835|FG002|Treatment Period (TP)|Administrative|0|||
131029299|NCT00676715|471740836|FG003|Treatment Period (TP)|Administrative|1|||
131029300|NCT00676715|471740833|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
131029301|NCT00676715|471740834|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
131029302|NCT00676715|471740835|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
131029303|NCT00676715|471740836|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
131029304|NCT00676715|471740833|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
131029305|NCT00676715|471740834|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
131029306|NCT00676715|471740835|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
131029307|NCT00676715|471740836|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
131029308|NCT00676715|471740833|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
131029309|NCT00676715|471740834|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
131029310|NCT00676715|471740835|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
131029311|NCT00676715|471740836|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
131029312|NCT00676715|471740833|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
131029313|NCT00676715|471740834|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
131029314|NCT00676715|471740835|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
131029315|NCT00676715|471740836|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
131029316|NCT00676715|471740833|FG000|Treatment-free Period (TFP)|Death|1|||
131029317|NCT00676715|471740834|FG001|Treatment-free Period (TFP)|Death|1|||
131029318|NCT00676715|471740835|FG002|Treatment-free Period (TFP)|Death|1|||
131029319|NCT00676715|471740836|FG003|Treatment-free Period (TFP)|Death|0|||
131029320|NCT00676715|471740833|FG000|Open Label Extension (OLE)|Reason not provided|3|||
131029321|NCT00676715|471740834|FG001|Open Label Extension (OLE)|Reason not provided|4|||
131029322|NCT00676715|471740835|FG002|Open Label Extension (OLE)|Reason not provided|1|||
131029323|NCT00676715|471740836|FG003|Open Label Extension (OLE)|Reason not provided|4|||
131029324|NCT00676715|471740833|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
130696018|NCT02761915|470510693|FG002|Overall Study|Disease Progression|0|||
130696019|NCT02761915|470510694|FG003|Overall Study|Disease Progression|2|||
130908539|NCT01343901|471300147|FG000|Overall Study|Physician Decision|4|||
130908540|NCT01343901|471300147|FG000|Overall Study|Lost to Follow-up|12|||
130908541|NCT01343901|471300147|FG000|Overall Study|Management by another medical team|11|||
130696020|NCT02761915|470510695|FG004|Overall Study|Disease Progression|2|||
130696021|NCT02761915|470510696|FG005|Overall Study|Disease Progression|2|||
130696022|NCT00645853|470510701|FG000|Overall Study|Adverse Event|18|||
130696023|NCT00645853|470510702|FG001|Overall Study|Adverse Event|7|||
130696024|NCT00645853|470510701|FG000|Overall Study|AZ study closure in Hungary|60|||
130696025|NCT00645853|470510702|FG001|Overall Study|AZ study closure in Hungary|40|||
130696026|NCT00645853|470510701|FG000|Overall Study|Withdrawal by Subject|5|||
130696027|NCT00645853|470510702|FG001|Overall Study|Withdrawal by Subject|2|||
130696028|NCT00645853|470510701|FG000|Overall Study|Protocol Violation|0|||
130696029|NCT00645853|470510702|FG001|Overall Study|Protocol Violation|2|||
130696030|NCT00645853|470510701|FG000|Overall Study|Discontinuation criteria|2|||
130696031|NCT00645853|470510702|FG001|Overall Study|Discontinuation criteria|2|||
130696032|NCT00645853|470510701|FG000|Overall Study|recall of ICF, planned operation, death|7|||
130696033|NCT00645853|470510702|FG001|Overall Study|recall of ICF, planned operation, death|4|||
130696034|NCT00380588|470510703|FG000|Overall Study|Unequivocal Disease Progression|25|||
130696035|NCT00380588|470510704|FG001|Overall Study|Unequivocal Disease Progression|34|||
130696036|NCT00380588|470510703|FG000|Overall Study|Next Cycle Not Started|4|||
130696037|NCT00380588|470510704|FG001|Overall Study|Next Cycle Not Started|0|||
130696038|NCT00380588|470510703|FG000|Overall Study|Adverse Event|7|||
130696039|NCT00380588|470510704|FG001|Overall Study|Adverse Event|3|||
130696040|NCT00380588|470510703|FG000|Overall Study|Withdrawal by Subject|1|||
130696041|NCT00380588|470510704|FG001|Overall Study|Withdrawal by Subject|3|||
130696042|NCT00380588|470510703|FG000|Overall Study|Physician Decision|2|||
130696043|NCT00380588|470510704|FG001|Overall Study|Physician Decision|0|||
130696044|NCT01120028|470510708|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
130696045|NCT01120028|470510709|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
130696046|NCT01120028|470510710|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
130696047|NCT01120028|470510711|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
130696048|NCT01120028|470510708|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
130696049|NCT01120028|470510709|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
130696050|NCT01120028|470510710|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
130696051|NCT01120028|470510711|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
131029325|NCT00676715|471740834|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
131029326|NCT00676715|471740835|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
131029327|NCT00676715|471740836|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
131029328|NCT00676715|471740833|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
131029329|NCT00676715|471740834|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
131029330|NCT00676715|471740835|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
131029331|NCT00676715|471740836|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
131029332|NCT00676715|471740833|FG000|Open Label Extension (OLE)|Adverse Event|0|||
131029333|NCT00676715|471740834|FG001|Open Label Extension (OLE)|Adverse Event|3|||
131029334|NCT00676715|471740835|FG002|Open Label Extension (OLE)|Adverse Event|1|||
131029335|NCT00676715|471740836|FG003|Open Label Extension (OLE)|Adverse Event|0|||
131029336|NCT00676715|471740833|FG000|Open Label Extension (OLE)|Death|2|||
131029337|NCT00676715|471740834|FG001|Open Label Extension (OLE)|Death|0|||
131029338|NCT00676715|471740835|FG002|Open Label Extension (OLE)|Death|2|||
131029339|NCT00676715|471740836|FG003|Open Label Extension (OLE)|Death|2|||
131029340|NCT01820260|471740837|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029341|NCT01820260|471740838|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029342|NCT01820260|471740839|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029343|NCT01820260|471740840|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029344|NCT01820260|471740841|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029345|NCT01820260|471740842|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029346|NCT01820260|471740843|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
131029347|NCT01820260|471740844|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029348|NCT01820260|471740845|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029349|NCT01820260|471740846|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029350|NCT01820260|471740847|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029351|NCT01820260|471740848|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029352|NCT01820260|471740849|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
130696052|NCT01401062|470510712|FG000|Overall Study|Death|9|||
130696053|NCT01401062|470510713|FG001|Overall Study|Death|7|||
130696054|NCT01401062|470510712|FG000|Overall Study|Physician Decision|1|||
130696055|NCT01401062|470510713|FG001|Overall Study|Physician Decision|0|||
130696056|NCT01401062|470510712|FG000|Overall Study|Withdrawal by Subject|1|||
131029353|NCT01820260|471740850|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
131029354|NCT01820260|471740837|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130696057|NCT01401062|470510713|FG001|Overall Study|Withdrawal by Subject|1|||
130696058|NCT01131260|470510716|FG000|Overall Study|Randomization error|5|||
130696059|NCT01131260|470510717|FG001|Overall Study|Randomization error|1|||
130696060|NCT01131260|470510716|FG000|Overall Study|Declined to continue participation|8|||
130696061|NCT01131260|470510717|FG001|Overall Study|Declined to continue participation|13|||
130696062|NCT01131260|470510716|FG000|Overall Study|Physician Decision|22|||
130696063|NCT01131260|470510717|FG001|Overall Study|Physician Decision|24|||
130696064|NCT01131260|470510716|FG000|Overall Study|Technical problems|7|||
130696065|NCT01131260|470510717|FG001|Overall Study|Technical problems|6|||
131029355|NCT01820260|471740838|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029356|NCT01820260|471740839|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029357|NCT01820260|471740840|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029358|NCT01820260|471740841|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029359|NCT01820260|471740842|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029360|NCT01820260|471740843|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029361|NCT01820260|471740844|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029362|NCT01820260|471740845|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029363|NCT01820260|471740846|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
131029364|NCT01820260|471740847|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029365|NCT01820260|471740848|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029366|NCT01820260|471740849|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029367|NCT01820260|471740850|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
131029368|NCT04831281|471740852|FG000|Overall Study|Adverse Event|1|||
131029369|NCT04831281|471740853|FG001|Overall Study|Adverse Event|0|||
131029370|NCT04831281|471740854|FG002|Overall Study|Adverse Event|3|||
131029371|NCT04831281|471740852|FG000|Overall Study|Withdrawal by Subject|0|||
131029372|NCT04831281|471740853|FG001|Overall Study|Withdrawal by Subject|1|||
131029373|NCT04831281|471740854|FG002|Overall Study|Withdrawal by Subject|2|||
131029374|NCT04831281|471740852|FG000|Overall Study|Undetermined|1|||
131029375|NCT04831281|471740853|FG001|Overall Study|Undetermined|1|||
131029376|NCT04831281|471740854|FG002|Overall Study|Undetermined|0|||
131029377|NCT02249949|471740855|FG000|Overall Study|Cancelled prior to treatment|2|||
131029378|NCT02097420|471740856|FG000|Overall Study|Death|6|||
131029379|NCT02097420|471740856|FG000|Overall Study|Valve explanted|13|||
131029380|NCT02097420|471740856|FG000|Overall Study|Other Reason|1|||
131029381|NCT03161379|471740864|FG000|Overall Study|Withdrawal by Subject|4|||
131029382|NCT03161379|471740864|FG000|Overall Study|disease progression during chemotherapy|5|||
131029383|NCT03161379|471740864|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
131029384|NCT03161379|471740864|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
131029385|NCT03453619|471740869|FG000|Core Study (Part A)|Physician Decision|0|||
131029386|NCT03453619|471740870|FG001|Core Study (Part A)|Physician Decision|0|||
131029387|NCT03453619|471740871|FG002|Core Study (Part A)|Physician Decision|2|||
131029388|NCT03453619|471740872|FG003|Core Study (Part A)|Physician Decision|0|||
131029389|NCT03453619|471740869|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
131029390|NCT03453619|471740870|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
131029391|NCT03453619|471740871|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
131029392|NCT03453619|471740872|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
131029393|NCT03453619|471740869|FG000|Core Study (Part A)|Other|0|||
131029394|NCT03453619|471740870|FG001|Core Study (Part A)|Other|1|||
131029395|NCT03453619|471740871|FG002|Core Study (Part A)|Other|0|||
131029396|NCT03453619|471740872|FG003|Core Study (Part A)|Other|0|||
131029397|NCT03453619|471740869|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
131029398|NCT03453619|471740870|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
131029399|NCT03453619|471740871|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
131029400|NCT03453619|471740872|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
131029401|NCT03453619|471740869|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
131029402|NCT03453619|471740870|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
131029403|NCT03453619|471740871|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
131029404|NCT03453619|471740872|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
131029405|NCT03453619|471740869|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
131029406|NCT03453619|471740870|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
131029407|NCT03453619|471740871|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
131029408|NCT03453619|471740872|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
131029409|NCT03453619|471740869|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
131029410|NCT03453619|471740870|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
131029411|NCT03453619|471740871|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
131029412|NCT03453619|471740872|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
131029413|NCT05229120|471740873|FG000|Overall Study|Withdrawal by Subject|8|||
131029414|NCT05862870|471740876|FG000|Overall Study|Lost to Follow-up|3|||
131029415|NCT02900924|471740877|FG000|Overall Study|Death|52|||
131029416|NCT02900924|471740877|FG000|Overall Study|Lost to Follow-up|4|||
131029417|NCT02900924|471740877|FG000|Overall Study|Withdrawal by Subject|20|||
131029418|NCT02900924|471740877|FG000|Overall Study|Missed Visit|33|||
131029419|NCT02365766|471740897|FG000|Overall Study|Withdrawal by Subject|0|||
131029420|NCT02365766|471740898|FG001|Overall Study|Withdrawal by Subject|0|||
130696066|NCT01131260|470510716|FG000|Overall Study|Staff error|2|||
130696067|NCT01131260|470510717|FG001|Overall Study|Staff error|1|||
130908542|NCT01343901|471300147|FG000|Overall Study|Participant decision|1|||
130908543|NCT02810340|471300148|FG000|Overall Study|Withdrawal by Subject|1|||
130908544|NCT02810340|471300149|FG001|Overall Study|Withdrawal by Subject|0|||
130908545|NCT02810340|471300150|FG002|Overall Study|Withdrawal by Subject|0|||
130908546|NCT02810340|471300148|FG000|Overall Study|Incarceration|0|||
130908547|NCT02810340|471300149|FG001|Overall Study|Incarceration|1|||
130908548|NCT02810340|471300150|FG002|Overall Study|Incarceration|0|||
130908549|NCT02810340|471300148|FG000|Overall Study|Lost to Follow-up|0|||
130908550|NCT02810340|471300149|FG001|Overall Study|Lost to Follow-up|0|||
130908551|NCT02810340|471300150|FG002|Overall Study|Lost to Follow-up|1|||
130908552|NCT00870233|471300151|FG000|Overall Study|Withdrawal by Subject|18|||
130908553|NCT00870233|471300151|FG000|Overall Study|Did not undergo laparotomy|3|||
130908554|NCT00870233|471300151|FG000|Overall Study|Incompatible internet browser|2|||
130908555|NCT00870233|471300151|FG000|Overall Study|Death|1|||
130908556|NCT01233687|471300152|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
130908557|NCT01233687|471300152|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
130908558|NCT01233687|471300152|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
130908559|NCT03324581|471300153|FG000|Overall Study|Adverse Event|18|||
130908560|NCT03324581|471300154|FG001|Overall Study|Adverse Event|11|||
130908561|NCT03324581|471300155|FG002|Overall Study|Adverse Event|7|||
130908562|NCT03324581|471300153|FG000|Overall Study|Lack of Efficacy|0|||
130908563|NCT03324581|471300154|FG001|Overall Study|Lack of Efficacy|1|||
130908564|NCT03324581|471300155|FG002|Overall Study|Lack of Efficacy|0|||
130908565|NCT03324581|471300153|FG000|Overall Study|Lost to Follow-up|5|||
130908566|NCT03324581|471300154|FG001|Overall Study|Lost to Follow-up|3|||
130908567|NCT03324581|471300155|FG002|Overall Study|Lost to Follow-up|6|||
130908568|NCT03324581|471300153|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
130908569|NCT03324581|471300154|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
130908570|NCT03324581|471300155|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
130908571|NCT03324581|471300153|FG000|Overall Study|Physician Decision|0|||
130908572|NCT03324581|471300154|FG001|Overall Study|Physician Decision|1|||
130908573|NCT03324581|471300155|FG002|Overall Study|Physician Decision|2|||
130908574|NCT03324581|471300153|FG000|Overall Study|Protocol Deviation|8|||
130908575|NCT03324581|471300154|FG001|Overall Study|Protocol Deviation|9|||
130908576|NCT03324581|471300155|FG002|Overall Study|Protocol Deviation|4|||
130908577|NCT03324581|471300153|FG000|Overall Study|Withdrawal by Subject|6|||
130908578|NCT03324581|471300154|FG001|Overall Study|Withdrawal by Subject|8|||
130908579|NCT03324581|471300155|FG002|Overall Study|Withdrawal by Subject|6|||
130908580|NCT03324581|471300153|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
130908581|NCT03324581|471300154|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
130908582|NCT03324581|471300155|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
130908583|NCT02274038|471300156|FG000|Overall Study|Death|1|||
130908584|NCT03783702|471300157|FG000|Overall Study|Lost to Follow-up|6|||
130908585|NCT03783702|471300158|FG001|Overall Study|Lost to Follow-up|8|||
131029421|NCT02365766|471740899|FG002|Overall Study|Withdrawal by Subject|1|||
131029422|NCT02365766|471740897|FG000|Overall Study|Eligibility Criteria Not Met|0|||
131029423|NCT02365766|471740898|FG001|Overall Study|Eligibility Criteria Not Met|0|||
131029424|NCT02365766|471740899|FG002|Overall Study|Eligibility Criteria Not Met|1|||
131029425|NCT03763708|471740903|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
131029426|NCT03763708|471740904|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131029427|NCT03763708|471740905|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131029428|NCT03763708|471740906|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131029429|NCT03763708|471740907|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131029430|NCT03763708|471740908|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131029431|NCT03763708|471740909|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131029432|NCT03763708|471740910|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131029433|NCT03763708|471740911|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
131029434|NCT03763708|471740903|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131029435|NCT03763708|471740904|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131029436|NCT03763708|471740905|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
131029437|NCT03763708|471740906|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131029438|NCT03763708|471740907|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131029439|NCT03763708|471740908|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131029440|NCT03763708|471740909|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
130908586|NCT03783702|471300157|FG000|Overall Study|Protocol Violation|1|||
130908587|NCT03783702|471300158|FG001|Overall Study|Protocol Violation|3|||
130908588|NCT04473482|471300159|FG000|Overall Study|Death|0|||
131029441|NCT03763708|471740910|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131115261|NCT01179672|472053618|FG001|Overall Study|Protocol Violation|2|||
130908589|NCT04473482|471300160|FG001|Overall Study|Death|3|||
131029442|NCT03763708|471740911|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
131115262|NCT01179672|472053617|FG000|Overall Study|Physician Decision|1|||
130908590|NCT04473482|471300159|FG000|Overall Study|Lost to Follow-up|9|||
130908591|NCT04473482|471300160|FG001|Overall Study|Lost to Follow-up|7|||
130768512|NCT01618916|470776701|FG001|Overall Study|Adverse Event|0|||
130768513|NCT01618916|470776702|FG002|Overall Study|Adverse Event|0|||
130768514|NCT01618916|470776703|FG003|Overall Study|Adverse Event|0|||
130768515|NCT01618916|470776704|FG004|Overall Study|Adverse Event|0|||
130768516|NCT01618916|470776705|FG005|Overall Study|Adverse Event|0|||
130768517|NCT01618916|470776700|FG000|Overall Study|Withdrawal by Subject|0|||
130768518|NCT01618916|470776701|FG001|Overall Study|Withdrawal by Subject|1|||
130768519|NCT01618916|470776702|FG002|Overall Study|Withdrawal by Subject|1|||
130768520|NCT01618916|470776703|FG003|Overall Study|Withdrawal by Subject|0|||
130768521|NCT01618916|470776704|FG004|Overall Study|Withdrawal by Subject|1|||
130768522|NCT01618916|470776705|FG005|Overall Study|Withdrawal by Subject|0|||
130768523|NCT01618916|470776700|FG000|Overall Study|Lost to Follow-up|1|||
130768524|NCT01618916|470776701|FG001|Overall Study|Lost to Follow-up|0|||
130768525|NCT01618916|470776702|FG002|Overall Study|Lost to Follow-up|0|||
130768526|NCT01618916|470776703|FG003|Overall Study|Lost to Follow-up|2|||
130768527|NCT01618916|470776704|FG004|Overall Study|Lost to Follow-up|0|||
130768528|NCT01618916|470776705|FG005|Overall Study|Lost to Follow-up|0|||
130768529|NCT04521114|470776706|FG000|Overall Study|Lost to Follow-up|1|||
130768530|NCT04521114|470776707|FG001|Overall Study|Lost to Follow-up|2|||
130768531|NCT04521114|470776708|FG002|Overall Study|Lost to Follow-up|0|||
130768532|NCT04521114|470776706|FG000|Overall Study|Withdrawal by Subject|1|||
130768533|NCT04521114|470776707|FG001|Overall Study|Withdrawal by Subject|2|||
130768534|NCT04521114|470776708|FG002|Overall Study|Withdrawal by Subject|2|||
130768535|NCT04521114|470776706|FG000|Overall Study|Adverse Event|1|||
130768536|NCT04521114|470776707|FG001|Overall Study|Adverse Event|0|||
130768537|NCT04521114|470776708|FG002|Overall Study|Adverse Event|0|||
130768538|NCT04521114|470776706|FG000|Overall Study|Sponsor Wish|1|||
130768539|NCT04521114|470776707|FG001|Overall Study|Sponsor Wish|0|||
130768540|NCT04521114|470776708|FG002|Overall Study|Sponsor Wish|0|||
130768541|NCT04521114|470776706|FG000|Overall Study|Withdrawal of Consent|2|||
130768542|NCT04521114|470776707|FG001|Overall Study|Withdrawal of Consent|2|||
130768543|NCT04521114|470776708|FG002|Overall Study|Withdrawal of Consent|0|||
130768544|NCT01084538|470776716|FG000|Overall Study|Drug not available|30|||
130768545|NCT01084538|470776716|FG000|Overall Study|Adverse Event|9|||
130768546|NCT01084538|470776716|FG000|Overall Study|Kidney transplant|6|||
130768547|NCT01084538|470776716|FG000|Overall Study|Serious Adverse Event|3|||
130768548|NCT01084538|470776716|FG000|Overall Study|Lack of effectiveness|2|||
130768549|NCT01084538|470776716|FG000|Overall Study|Patient noncompliance|2|||
130768550|NCT01084538|470776716|FG000|Overall Study|Hyperphosphatemia|2|||
130768551|NCT01084538|470776716|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
130768552|NCT01084538|470776716|FG000|Overall Study|Change of residence|2|||
130768553|NCT01084538|470776716|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
130768554|NCT01084538|470776716|FG000|Overall Study|Reason unknown|8|||
130768555|NCT02083653|470776721|FG000|Overall Study|Randomized but not Treated|0|||
130768556|NCT02083653|470776722|FG001|Overall Study|Randomized but not Treated|2|||
130768557|NCT02083653|470776723|FG002|Overall Study|Randomized but not Treated|7|||
130768558|NCT02083653|470776721|FG000|Overall Study|Adverse Event|12|||
130768559|NCT02083653|470776722|FG001|Overall Study|Adverse Event|5|||
130768560|NCT02083653|470776723|FG002|Overall Study|Adverse Event|4|||
130768561|NCT02083653|470776721|FG000|Overall Study|Lost to Follow-up|1|||
130768562|NCT02083653|470776722|FG001|Overall Study|Lost to Follow-up|0|||
130768563|NCT02083653|470776723|FG002|Overall Study|Lost to Follow-up|0|||
130768564|NCT02083653|470776721|FG000|Overall Study|Death|2|||
130768565|NCT02083653|470776722|FG001|Overall Study|Death|2|||
130768566|NCT02083653|470776723|FG002|Overall Study|Death|2|||
130768567|NCT02083653|470776721|FG000|Overall Study|Progressive Disease|65|||
130768568|NCT02083653|470776722|FG001|Overall Study|Progressive Disease|73|||
130768569|NCT02083653|470776723|FG002|Overall Study|Progressive Disease|63|||
130768570|NCT02083653|470776721|FG000|Overall Study|Withdrawal by Subject|2|||
130768571|NCT02083653|470776722|FG001|Overall Study|Withdrawal by Subject|1|||
130768572|NCT02083653|470776723|FG002|Overall Study|Withdrawal by Subject|2|||
130768573|NCT02083653|470776721|FG000|Overall Study|Other Events|0|||
130768574|NCT02083653|470776722|FG001|Overall Study|Other Events|2|||
130768575|NCT02083653|470776723|FG002|Overall Study|Other Events|2|||
130768576|NCT02083653|470776721|FG000|Overall Study|Reason Missing|0|||
130768577|NCT02083653|470776722|FG001|Overall Study|Reason Missing|0|||
130768578|NCT02083653|470776723|FG002|Overall Study|Reason Missing|4|||
130768579|NCT01625689|470776724|FG000|Overall Study|Migration|2|||
130768580|NCT01625689|470776725|FG001|Overall Study|Migration|1|||
130768581|NCT00106639|470776726|FG000|Overall Study|Adverse Event|3|||
130768582|NCT00106639|470776727|FG001|Overall Study|Adverse Event|4|||
130768583|NCT00106639|470776728|FG002|Overall Study|Adverse Event|1|||
130768584|NCT00106639|470776726|FG000|Overall Study|Protocol Violation|0|||
130768585|NCT00106639|470776727|FG001|Overall Study|Protocol Violation|1|||
130768586|NCT00106639|470776728|FG002|Overall Study|Protocol Violation|0|||
130768587|NCT00106639|470776726|FG000|Overall Study|Withdrawal by Subject|0|||
130768588|NCT00106639|470776727|FG001|Overall Study|Withdrawal by Subject|1|||
130768589|NCT00106639|470776728|FG002|Overall Study|Withdrawal by Subject|0|||
130768590|NCT00106639|470776726|FG000|Overall Study|Participant defaulted|0|||
130696068|NCT01131260|470510716|FG000|Overall Study|Ineligible|0|||
130696069|NCT01131260|470510717|FG001|Overall Study|Ineligible|2|||
130696070|NCT01018862|470510729|FG000|Overall Study|Adverse Event|2|||
130696071|NCT01018862|470510730|FG001|Overall Study|Adverse Event|0|||
130696072|NCT01018862|470510731|FG002|Overall Study|Adverse Event|6|||
130696073|NCT01018862|470510729|FG000|Overall Study|Lack of Efficacy|1|||
130696074|NCT01018862|470510730|FG001|Overall Study|Lack of Efficacy|0|||
130696075|NCT01018862|470510731|FG002|Overall Study|Lack of Efficacy|2|||
130696076|NCT01018862|470510729|FG000|Overall Study|Lost to Follow-up|3|||
130696077|NCT01018862|470510730|FG001|Overall Study|Lost to Follow-up|1|||
130696078|NCT01018862|470510731|FG002|Overall Study|Lost to Follow-up|0|||
130696079|NCT01018862|470510729|FG000|Overall Study|Protocol Violation|1|||
130696080|NCT01018862|470510730|FG001|Overall Study|Protocol Violation|3|||
130696081|NCT01018862|470510731|FG002|Overall Study|Protocol Violation|3|||
130696082|NCT01018862|470510729|FG000|Overall Study|Withdrawal by Subject|1|||
130696083|NCT01018862|470510730|FG001|Overall Study|Withdrawal by Subject|2|||
130696084|NCT01018862|470510731|FG002|Overall Study|Withdrawal by Subject|1|||
130696085|NCT01018862|470510729|FG000|Overall Study|administrative problems|5|||
130696086|NCT01018862|470510730|FG001|Overall Study|administrative problems|4|||
130768591|NCT00106639|470776727|FG001|Overall Study|Participant defaulted|1|||
130696087|NCT01018862|470510731|FG002|Overall Study|administrative problems|4|||
130696088|NCT01968031|470510732|FG000|Overall Study|Adverse Event|13|||
130696089|NCT01968031|470510733|FG001|Overall Study|Adverse Event|10|||
130696090|NCT01968031|470510734|FG002|Overall Study|Adverse Event|22|||
130696091|NCT01968031|470510732|FG000|Overall Study|Withdrawal by Subject|3|||
130696092|NCT01968031|470510733|FG001|Overall Study|Withdrawal by Subject|7|||
130696093|NCT01968031|470510734|FG002|Overall Study|Withdrawal by Subject|3|||
130696094|NCT01968031|470510732|FG000|Overall Study|Did not meet entry criteria|1|||
130696095|NCT01968031|470510733|FG001|Overall Study|Did not meet entry criteria|1|||
130696096|NCT01968031|470510734|FG002|Overall Study|Did not meet entry criteria|1|||
130696097|NCT01968031|470510732|FG000|Overall Study|Noncompliance|0|||
130696098|NCT01968031|470510733|FG001|Overall Study|Noncompliance|0|||
130696099|NCT01968031|470510734|FG002|Overall Study|Noncompliance|2|||
130696100|NCT01968031|470510732|FG000|Overall Study|Failed inclusion criteria|0|||
130696101|NCT01968031|470510733|FG001|Overall Study|Failed inclusion criteria|2|||
130696102|NCT01968031|470510734|FG002|Overall Study|Failed inclusion criteria|0|||
130696103|NCT01968031|470510732|FG000|Overall Study|Death|0|||
130696104|NCT01968031|470510733|FG001|Overall Study|Death|0|||
130696105|NCT01968031|470510734|FG002|Overall Study|Death|1|||
130696106|NCT01968031|470510732|FG000|Overall Study|Prohibited concomitant medication|1|||
130696107|NCT01968031|470510733|FG001|Overall Study|Prohibited concomitant medication|0|||
130696108|NCT01968031|470510734|FG002|Overall Study|Prohibited concomitant medication|0|||
130696109|NCT02583048|470512477|FG000|Overall Study|Withdrawal by Subject|0|||
130696110|NCT02583048|470512478|FG001|Overall Study|Withdrawal by Subject|1|||
130696111|NCT02583048|470512479|FG002|Overall Study|Withdrawal by Subject|0|||
130768592|NCT00106639|470776728|FG002|Overall Study|Participant defaulted|1|||
130768593|NCT01210144|470776730|FG000|Overall Study|Lack of ovarian response|1|||
130768594|NCT01210144|470776731|FG001|Overall Study|Lack of ovarian response|0|||
130768595|NCT01210144|470776730|FG000|Overall Study|No fertilization|1|||
130768596|NCT01210144|470776731|FG001|Overall Study|No fertilization|0|||
130768597|NCT01210144|470776730|FG000|Overall Study|No transfer|1|||
130768598|NCT01210144|470776731|FG001|Overall Study|No transfer|0|||
130768599|NCT00494221|470776734|FG000|Overall Study|Death|15|||
130768600|NCT00494221|470776735|FG001|Overall Study|Death|9|||
130768601|NCT00494221|470776736|FG002|Overall Study|Death|14|||
130768602|NCT00494221|470776734|FG000|Overall Study|Withdrawal by Subject|1|||
130768603|NCT00494221|470776735|FG001|Overall Study|Withdrawal by Subject|2|||
130768604|NCT00494221|470776736|FG002|Overall Study|Withdrawal by Subject|0|||
130768605|NCT01714609|470776741|FG000|Overall Study|Protocol Violation|1|||
130768606|NCT01714609|470776742|FG001|Overall Study|Protocol Violation|0|||
130768607|NCT00630747|470776743|FG000|Overall Study|Death|1|||
130768608|NCT00630747|470776743|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
130768609|NCT00630747|470776743|FG000|Overall Study|Returned to country of origin|1|||
130768610|NCT02306694|470776746|FG000|Overall Study|Withdrawal by Subject|3|||
130768611|NCT02306694|470776746|FG000|Overall Study|Lost to Follow-up|1|||
130696112|NCT02583048|470512477|FG000|Overall Study|Failed to meet eligibility criterion|0|||
130696113|NCT02583048|470512478|FG001|Overall Study|Failed to meet eligibility criterion|0|||
130696114|NCT02583048|470512479|FG002|Overall Study|Failed to meet eligibility criterion|1|||
130908592|NCT04473482|471300159|FG000|Overall Study|Withdrawal by Subject|2|||
130696115|NCT01151280|470512485|FG000|Overall Study|Adverse Event|1|||
131222768|NCT00386100|472443176|FG001|Overall Study|Participant moving out of state|0|||
130696116|NCT01151280|470512485|FG000|Overall Study|Lack of Efficacy|3|||
130696117|NCT01243151|470512486|FG000|Overall Study|Adverse Event|0|||
130696118|NCT01243151|470512487|FG001|Overall Study|Adverse Event|1|||
130768612|NCT03782974|470776747|FG000|Overall Study|Withdrawal by Subject|7|||
130768613|NCT03782974|470776748|FG001|Overall Study|Withdrawal by Subject|7|||
130768614|NCT03782974|470776747|FG000|Overall Study|Pregnancy|1|||
130768615|NCT03782974|470776748|FG001|Overall Study|Pregnancy|0|||
130768616|NCT00395642|470776749|FG000|Overall Study|Death|4|||
130768617|NCT00395642|470776749|FG000|Overall Study|Lost to Follow-up|1|||
130768618|NCT00395642|470776749|FG000|Overall Study|Physician Decision|7|||
130768619|NCT00395642|470776749|FG000|Overall Study|Withdrawal by Subject|1|||
130768620|NCT00659776|470776759|FG000|Overall Study|Withdrawal by Subject|12|||
130768621|NCT00659776|470776760|FG001|Overall Study|Withdrawal by Subject|2|||
130768622|NCT00659776|470776761|FG002|Overall Study|Withdrawal by Subject|0|||
130768623|NCT01180049|470776762|FG000|Overall Study|Other|9|||
130768624|NCT01180049|470776763|FG001|Overall Study|Other|7|||
130768625|NCT01180049|470776762|FG000|Overall Study|Lost to Follow-up|8|||
130768626|NCT01180049|470776763|FG001|Overall Study|Lost to Follow-up|6|||
130768627|NCT01180049|470776762|FG000|Overall Study|Death|36|||
130768628|NCT01180049|470776763|FG001|Overall Study|Death|35|||
130768629|NCT01905592|470776767|FG000|Overall Study|Disease Progression|51|||
130768630|NCT01905592|470776768|FG001|Overall Study|Disease Progression|110|||
130768631|NCT01905592|470776767|FG000|Overall Study|Toxicity|1|||
130768632|NCT01905592|470776768|FG001|Overall Study|Toxicity|16|||
130768633|NCT01905592|470776767|FG000|Overall Study|Physician Decision|0|||
130768634|NCT01905592|470776768|FG001|Overall Study|Physician Decision|2|||
130768635|NCT01905592|470776767|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
130768636|NCT01905592|470776768|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
130768637|NCT01905592|470776767|FG000|Overall Study|Protocol Violation|0|||
130768638|NCT01905592|470776768|FG001|Overall Study|Protocol Violation|1|||
130768639|NCT01905592|470776767|FG000|Overall Study|Sponsor's decision|1|||
130768640|NCT01905592|470776768|FG001|Overall Study|Sponsor's decision|1|||
130768641|NCT01905592|470776767|FG000|Overall Study|Not treated|7|||
130768642|NCT01905592|470776768|FG001|Overall Study|Not treated|3|||
130768643|NCT01905592|470776767|FG000|Overall Study|Withdrawal by Subject|10|||
130768644|NCT01905592|470776768|FG001|Overall Study|Withdrawal by Subject|2|||
130768645|NCT02732015|470778541|FG000|Overall Study|Lost to Follow-up|0|||
130768646|NCT02732015|470778542|FG001|Overall Study|Lost to Follow-up|1|||
130768647|NCT01980628|470778543|FG000|Overall Study|Adverse Event|12|||
130768648|NCT01980628|470778543|FG000|Overall Study|Physician Decision|5|||
130768649|NCT01980628|470778543|FG000|Overall Study|Withdrawal by Subject|4|||
130768650|NCT01980628|470778543|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
130768651|NCT03015194|470778544|FG000|Overall Study|Death|10|||
130768652|NCT03015194|470778544|FG000|Overall Study|Withdrawal by Subject|2|||
130768653|NCT02469168|470778547|FG000|Overall Study|Trial closed|1|||
130768654|NCT02469168|470778548|FG001|Overall Study|Trial closed|0|||
130768655|NCT00433017|470778549|FG000|Overall Study|Adverse Event|5|||
130768656|NCT00433017|470778550|FG001|Overall Study|Adverse Event|3|||
130768657|NCT00433017|470778549|FG000|Overall Study|Withdrawal by Subject|4|||
130768658|NCT00433017|470778550|FG001|Overall Study|Withdrawal by Subject|5|||
130768659|NCT00433017|470778549|FG000|Overall Study|Lost to Follow-up|3|||
130768660|NCT00433017|470778550|FG001|Overall Study|Lost to Follow-up|4|||
130768661|NCT00433017|470778549|FG000|Overall Study|Administrative problems|80|||
130768662|NCT00433017|470778550|FG001|Overall Study|Administrative problems|86|||
130908593|NCT04473482|471300160|FG001|Overall Study|Withdrawal by Subject|1|||
130908594|NCT00321893|471300162|FG000|Overall Study|Non-Compliance/Refusal|16|||
130908595|NCT00321893|471300163|FG001|Overall Study|Non-Compliance/Refusal|10|||
130908596|NCT00321893|471300162|FG000|Overall Study|Lost to Follow-up|2|||
130908597|NCT00321893|471300163|FG001|Overall Study|Lost to Follow-up|1|||
130908598|NCT00321893|471300162|FG000|Overall Study|Adverse Event|6|||
130908599|NCT00321893|471300163|FG001|Overall Study|Adverse Event|3|||
130908600|NCT00769483|471300164|FG000|Overall Study|Withdrawal by Subject|0|||
130908601|NCT00769483|471300165|FG001|Overall Study|Withdrawal by Subject|1|||
130908602|NCT00769483|471300166|FG002|Overall Study|Withdrawal by Subject|0|||
130908603|NCT00769483|471300167|FG003|Overall Study|Withdrawal by Subject|0|||
130908604|NCT00769483|471300168|FG004|Overall Study|Withdrawal by Subject|1|||
130908605|NCT00769483|471300169|FG005|Overall Study|Withdrawal by Subject|0|||
130908606|NCT01306877|471300170|FG000|Overall Study|Lost to Follow-up|3|||
130908607|NCT01306877|471300171|FG001|Overall Study|Lost to Follow-up|3|||
130908608|NCT01306877|471300170|FG000|Overall Study|Physician Decision|0|||
130908609|NCT01306877|471300171|FG001|Overall Study|Physician Decision|1|||
130768663|NCT00433017|470778549|FG000|Overall Study|Protocol Violation|1|||
130768664|NCT00433017|470778550|FG001|Overall Study|Protocol Violation|0|||
130768665|NCT00433017|470778549|FG000|Overall Study|Death|2|||
130768666|NCT00433017|470778550|FG001|Overall Study|Death|2|||
130768667|NCT00433017|470778549|FG000|Overall Study|Subject no longer requires study drug|1|||
130768668|NCT00433017|470778550|FG001|Overall Study|Subject no longer requires study drug|1|||
130768669|NCT03959488|470778553|FG000|Season 1|Other|6|||
130768670|NCT03959488|470778554|FG001|Season 1|Other|7|||
130768671|NCT03959488|470778555|FG002|Season 1|Other|0|||
130768672|NCT03959488|470778556|FG003|Season 1|Other|0|||
130768673|NCT03959488|470778557|FG004|Season 1|Other|0|||
130768674|NCT03959488|470778553|FG000|Season 1|Withdrawal by parent/guardian|43|||
130768675|NCT03959488|470778554|FG001|Season 1|Withdrawal by parent/guardian|28|||
130768676|NCT03959488|470778555|FG002|Season 1|Withdrawal by parent/guardian|0|||
130908610|NCT00006389|471300172|FG000|Overall Study|Adverse Event|1|||
130908611|NCT00999921|471300177|FG000|Overall Study|Lost to Follow-up|10|||
130908612|NCT00999921|471300178|FG001|Overall Study|Lost to Follow-up|19|||
130908613|NCT01076075|471300183|FG000|Overall Study|Adverse Event|3|||
130908614|NCT01076075|471300184|FG001|Overall Study|Adverse Event|9|||
130908615|NCT01076075|471300183|FG000|Overall Study|Lack of Efficacy|5|||
130908616|NCT01076075|471300184|FG001|Overall Study|Lack of Efficacy|4|||
130908617|NCT01076075|471300183|FG000|Overall Study|Lost to Follow-up|6|||
130908618|NCT01076075|471300184|FG001|Overall Study|Lost to Follow-up|5|||
130908619|NCT01076075|471300183|FG000|Overall Study|other|19|||
130908620|NCT01076075|471300184|FG001|Overall Study|other|9|||
130908621|NCT01076075|471300183|FG000|Overall Study|Protocol Violation|0|||
130908622|NCT01076075|471300184|FG001|Overall Study|Protocol Violation|1|||
130908623|NCT01076075|471300183|FG000|Overall Study|Withdrawal by Subject|8|||
130908624|NCT01076075|471300184|FG001|Overall Study|Withdrawal by Subject|19|||
130908625|NCT03500679|471300192|FG000|Overall Study|Lost to Follow-up|6|||
130908626|NCT03500679|471300193|FG001|Overall Study|Lost to Follow-up|3|||
130908627|NCT03500679|471300192|FG000|Overall Study|Withdrawal by Subject|3|||
130908628|NCT03500679|471300193|FG001|Overall Study|Withdrawal by Subject|0|||
130908629|NCT01962922|471300194|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
130908630|NCT01962922|471300195|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
130908631|NCT01962922|471300194|FG000|PK Portion Day 7|non-compliance|1|||
130908632|NCT01962922|471300195|FG001|PK Portion Day 7|non-compliance|0|||
130908633|NCT01962922|471300194|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
130908634|NCT01962922|471300195|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
130908635|NCT01962922|471300194|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
130908636|NCT01962922|471300195|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
130908637|NCT00495131|471300196|FG000|Overall Study|Adverse Event|6|||
130908638|NCT00495131|471300197|FG001|Overall Study|Adverse Event|2|||
130908639|NCT00495131|471300196|FG000|Overall Study|Lack of Efficacy|0|||
130908640|NCT00495131|471300197|FG001|Overall Study|Lack of Efficacy|2|||
130908641|NCT00495131|471300196|FG000|Overall Study|Lost to Follow-up|0|||
130908642|NCT00495131|471300197|FG001|Overall Study|Lost to Follow-up|2|||
130908643|NCT00495131|471300196|FG000|Overall Study|Withdrawal by Subject|1|||
130908644|NCT00495131|471300197|FG001|Overall Study|Withdrawal by Subject|0|||
130908645|NCT00744471|471300198|FG000|Overall Study|Randomized but not treated|1|||
130908646|NCT00744471|471300199|FG001|Overall Study|Randomized but not treated|1|||
130908647|NCT00744471|471300200|FG002|Overall Study|Randomized but not treated|4|||
130908648|NCT00744471|471300201|FG003|Overall Study|Randomized but not treated|0|||
130908649|NCT00744471|471300198|FG000|Overall Study|Death|0|||
130908650|NCT00744471|471300199|FG001|Overall Study|Death|0|||
130908651|NCT00744471|471300200|FG002|Overall Study|Death|0|||
130908652|NCT00744471|471300201|FG003|Overall Study|Death|1|||
130908653|NCT00744471|471300198|FG000|Overall Study|Adverse Event|6|||
130908654|NCT00744471|471300199|FG001|Overall Study|Adverse Event|7|||
130908655|NCT00744471|471300200|FG002|Overall Study|Adverse Event|5|||
130908656|NCT00744471|471300201|FG003|Overall Study|Adverse Event|9|||
130908657|NCT00744471|471300198|FG000|Overall Study|Withdrawal by Subject|9|||
130908658|NCT00744471|471300199|FG001|Overall Study|Withdrawal by Subject|9|||
130908659|NCT00744471|471300200|FG002|Overall Study|Withdrawal by Subject|15|||
130908660|NCT00744471|471300201|FG003|Overall Study|Withdrawal by Subject|12|||
130908661|NCT00744471|471300198|FG000|Overall Study|Protocol Violation|1|||
130908662|NCT00744471|471300199|FG001|Overall Study|Protocol Violation|4|||
130908663|NCT00744471|471300200|FG002|Overall Study|Protocol Violation|1|||
130908664|NCT00744471|471300201|FG003|Overall Study|Protocol Violation|2|||
130908665|NCT00744471|471300198|FG000|Overall Study|Entered extension study|41|||
130908666|NCT00744471|471300199|FG001|Overall Study|Entered extension study|84|||
130908667|NCT00744471|471300200|FG002|Overall Study|Entered extension study|100|||
130908668|NCT00744471|471300201|FG003|Overall Study|Entered extension study|91|||
130908669|NCT00744471|471300198|FG000|Overall Study|Other|2|||
130908670|NCT00744471|471300199|FG001|Overall Study|Other|3|||
130908671|NCT00744471|471300200|FG002|Overall Study|Other|6|||
130908672|NCT00744471|471300201|FG003|Overall Study|Other|2|||
130908673|NCT00744471|471300198|FG000|Overall Study|Lack of Efficacy|83|||
130908674|NCT00744471|471300199|FG001|Overall Study|Lack of Efficacy|37|||
130908675|NCT00744471|471300200|FG002|Overall Study|Lack of Efficacy|19|||
130908676|NCT00744471|471300201|FG003|Overall Study|Lack of Efficacy|31|||
130908677|NCT00744471|471300198|FG000|Overall Study|Lost to Follow-up|0|||
130908678|NCT00744471|471300199|FG001|Overall Study|Lost to Follow-up|0|||
130908679|NCT00744471|471300200|FG002|Overall Study|Lost to Follow-up|2|||
130908680|NCT00744471|471300201|FG003|Overall Study|Lost to Follow-up|0|||
130908681|NCT03224546|471300202|FG000|Overall Study|Lost to Follow-up|9|||
130908682|NCT03224546|471300203|FG001|Overall Study|Lost to Follow-up|8|||
130908683|NCT03224546|471300204|FG002|Overall Study|Lost to Follow-up|3|||
130908684|NCT03224546|471300202|FG000|Overall Study|Withdrawal by Subject|7|||
130908685|NCT03224546|471300203|FG001|Overall Study|Withdrawal by Subject|14|||
130908686|NCT03224546|471300204|FG002|Overall Study|Withdrawal by Subject|12|||
130908687|NCT00976573|471300207|FG000|Overall Study|Ineligible|0|||
130908688|NCT00976573|471300208|FG001|Overall Study|Ineligible|1|||
130908689|NCT00976573|471300207|FG000|Overall Study|Cancel prior to receiving treatment|4|||
130908690|NCT00976573|471300208|FG001|Overall Study|Cancel prior to receiving treatment|2|||
130696119|NCT01243151|470512488|FG002|Overall Study|Adverse Event|0|||
130696120|NCT01243151|470512489|FG003|Overall Study|Adverse Event|0|||
130696121|NCT01243151|470512490|FG004|Overall Study|Adverse Event|0|||
130696122|NCT01243151|470512486|FG000|Overall Study|Protocol Violation|0|||
130696123|NCT01243151|470512487|FG001|Overall Study|Protocol Violation|0|||
130696124|NCT01243151|470512488|FG002|Overall Study|Protocol Violation|1|||
130696125|NCT01243151|470512489|FG003|Overall Study|Protocol Violation|0|||
130696126|NCT01243151|470512490|FG004|Overall Study|Protocol Violation|0|||
130696127|NCT01243151|470512486|FG000|Overall Study|Other|0|||
130696128|NCT01243151|470512487|FG001|Overall Study|Other|0|||
130696129|NCT01243151|470512488|FG002|Overall Study|Other|0|||
130696130|NCT01243151|470512489|FG003|Overall Study|Other|1|||
130696131|NCT01243151|470512490|FG004|Overall Study|Other|0|||
130696132|NCT01243151|470512486|FG000|Overall Study|Randomized but not treated|0|||
130696133|NCT01243151|470512487|FG001|Overall Study|Randomized but not treated|0|||
130696134|NCT01243151|470512488|FG002|Overall Study|Randomized but not treated|0|||
130696135|NCT01243151|470512489|FG003|Overall Study|Randomized but not treated|1|||
130696136|NCT01243151|470512490|FG004|Overall Study|Randomized but not treated|0|||
130696137|NCT02308241|470512493|FG000|Overall Study|Withdrawal by Subject|3|||
130696138|NCT04408924|470512494|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
130908691|NCT03670836|471300211|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
130908692|NCT03670836|471300212|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
130908693|NCT03670836|471300211|FG000|Per Protocol Population (PP)|Physician Decision|9|||
130908694|NCT03670836|471300212|FG001|Per Protocol Population (PP)|Physician Decision|10|||
130908695|NCT03670836|471300211|FG000|Per Protocol Population (PP)|Physician Decision|4|||
130908696|NCT03670836|471300212|FG001|Per Protocol Population (PP)|Physician Decision|6|||
130908697|NCT03670836|471300211|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
130908698|NCT03670836|471300212|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
130908699|NCT01683019|471301776|FG000|Overall Study|Withdrawal by Subject|2|||
130908700|NCT01683019|471301777|FG001|Overall Study|Withdrawal by Subject|1|||
130908701|NCT01683019|471301778|FG002|Overall Study|Withdrawal by Subject|4|||
130908702|NCT03034200|471301780|FG000|Overall Study|Disease progression|8|||
130908703|NCT03034200|471301781|FG001|Overall Study|Disease progression|10|||
130908704|NCT03034200|471301782|FG002|Overall Study|Disease progression|4|||
130908705|NCT03034200|471301780|FG000|Overall Study|Physician Decision|2|||
130908706|NCT03034200|471301781|FG001|Overall Study|Physician Decision|0|||
130908707|NCT03034200|471301782|FG002|Overall Study|Physician Decision|3|||
130908708|NCT03034200|471301780|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
130908709|NCT03034200|471301781|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
130908710|NCT03034200|471301782|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
130908711|NCT03034200|471301780|FG000|Overall Study|Adjuvant Therapy|0|||
130908712|NCT03034200|471301781|FG001|Overall Study|Adjuvant Therapy|0|||
130908713|NCT03034200|471301782|FG002|Overall Study|Adjuvant Therapy|1|||
130908714|NCT01466179|471301784|FG000|Overall Study|Ongoing in core study|2|||
130908715|NCT01466179|471301784|FG000|Overall Study|Physician Decision|46|||
130696139|NCT04408924|470512494|FG000|Overall Study|Lost to Follow-up|3|||
130696140|NCT04408924|470512494|FG000|Overall Study|Withdrawal by Subject|5|||
130696141|NCT04408924|470512494|FG000|Overall Study|Sponsor Decision|2|||
130696142|NCT02578641|470512495|FG000|Overall Study|Adverse Event|5|||
130696143|NCT02578641|470512496|FG001|Overall Study|Adverse Event|15|||
130768677|NCT03959488|470778556|FG003|Season 1|Withdrawal by parent/guardian|0|||
130768678|NCT03959488|470778557|FG004|Season 1|Withdrawal by parent/guardian|0|||
130768679|NCT03959488|470778553|FG000|Season 1|Due to COVID-19 pandemic|2|||
130768680|NCT03959488|470778554|FG001|Season 1|Due to COVID-19 pandemic|3|||
130908716|NCT01466179|471301784|FG000|Overall Study|Progressive disease|43|||
130908717|NCT01466179|471301784|FG000|Overall Study|Adverse Event|32|||
130908718|NCT01466179|471301784|FG000|Overall Study|Disease relapse|23|||
130908719|NCT01466179|471301784|FG000|Overall Study|Lack of Efficacy|14|||
131029443|NCT03763708|471740903|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131029444|NCT03763708|471740904|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131029445|NCT03763708|471740905|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131029446|NCT03763708|471740906|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
131029447|NCT03763708|471740907|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131029448|NCT03763708|471740908|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131029449|NCT03763708|471740909|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
130696144|NCT02578641|470512495|FG000|Overall Study|Death|16|||
130696145|NCT02578641|470512496|FG001|Overall Study|Death|8|||
130696146|NCT02578641|470512495|FG000|Overall Study|Lost to Follow-up|0|||
130908720|NCT01466179|471301784|FG000|Overall Study|Death|7|||
130908721|NCT01466179|471301784|FG000|Overall Study|Withdrawal by Subject|7|||
130696147|NCT02578641|470512496|FG001|Overall Study|Lost to Follow-up|1|||
130696148|NCT02578641|470512495|FG000|Overall Study|Withdrawal by Subject|14|||
130696149|NCT02578641|470512496|FG001|Overall Study|Withdrawal by Subject|7|||
130908722|NCT01466179|471301784|FG000|Overall Study|Protocol Violation|2|||
130908723|NCT01466179|471301784|FG000|Overall Study|Other|3|||
130908724|NCT00749580|471301785|FG000|Overall Study|Lost to Follow-up|4|||
130908725|NCT00749580|471301786|FG001|Overall Study|Lost to Follow-up|8|||
130908726|NCT00749580|471301785|FG000|Overall Study|Adverse Event|0|||
130908727|NCT00749580|471301786|FG001|Overall Study|Adverse Event|1|||
130908728|NCT03489551|471301789|FG000|Overall Study|Withdrawal by Subject|2|||
130908729|NCT00054717|471301790|FG000|Overall Study|Randomized but not treated|2|||
130908730|NCT00054717|471301791|FG001|Overall Study|Randomized but not treated|8|||
130908731|NCT00054717|471301790|FG000|Overall Study|Adverse Event|70|||
130908732|NCT00054717|471301791|FG001|Overall Study|Adverse Event|22|||
130908733|NCT00054717|471301790|FG000|Overall Study|Protocol Violation|18|||
130908734|NCT00054717|471301791|FG001|Overall Study|Protocol Violation|19|||
130908735|NCT00054717|471301790|FG000|Overall Study|Lost to Follow-up|23|||
130908736|NCT00054717|471301791|FG001|Overall Study|Lost to Follow-up|13|||
130908737|NCT00054717|471301790|FG000|Overall Study|Withdrawal by Subject|32|||
130908738|NCT00054717|471301791|FG001|Overall Study|Withdrawal by Subject|20|||
131115263|NCT01179672|472053618|FG001|Overall Study|Physician Decision|1|||
131115264|NCT01187550|472053621|FG000|Overall Study|Protocol Violation|3|||
131115265|NCT01187550|472053622|FG001|Overall Study|Protocol Violation|1|||
131115266|NCT01187550|472053621|FG000|Overall Study|Other|3|||
131115267|NCT01187550|472053622|FG001|Overall Study|Other|0|||
131115268|NCT01187550|472053621|FG000|Overall Study|Randomized but not treated|8|||
131115269|NCT01187550|472053622|FG001|Overall Study|Randomized but not treated|0|||
131115270|NCT00129623|472053623|FG000|Overall Study|Adverse Event|3|||
131115271|NCT00129623|472053624|FG001|Overall Study|Adverse Event|7|||
131115272|NCT00129623|472053623|FG000|Overall Study|Refused Treatment|5|||
131115273|NCT00129623|472053624|FG001|Overall Study|Refused Treatment|3|||
131115274|NCT00129623|472053623|FG000|Overall Study|Failure to Return|1|||
131115275|NCT00129623|472053624|FG001|Overall Study|Failure to Return|1|||
131115276|NCT00129623|472053623|FG000|Overall Study|Relocated job out of state|1|||
130908739|NCT00054717|471301790|FG000|Overall Study|Other reason not defined above|117|||
130908740|NCT00054717|471301791|FG001|Overall Study|Other reason not defined above|217|||
130908741|NCT04565236|471301792|FG000|Overall Study|Patient/Guardian Decision|0|||
130908742|NCT04565236|471301793|FG001|Overall Study|Patient/Guardian Decision|0|||
130908743|NCT04565236|471301794|FG002|Overall Study|Patient/Guardian Decision|1|||
130908744|NCT04565236|471301795|FG003|Overall Study|Patient/Guardian Decision|0|||
130908745|NCT04423939|471301796|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
130908746|NCT04423939|471301797|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
130908747|NCT04423939|471301796|FG000|Overall Study|Death|3|||
130908748|NCT04423939|471301797|FG001|Overall Study|Death|0|||
130908749|NCT04423939|471301796|FG000|Overall Study|Withdrawal by Subject|3|||
130908750|NCT04423939|471301797|FG001|Overall Study|Withdrawal by Subject|0|||
130908751|NCT04423939|471301796|FG000|Overall Study|Caregiver to patient who died|0|||
130908752|NCT04423939|471301797|FG001|Overall Study|Caregiver to patient who died|3|||
130908753|NCT04423939|471301796|FG000|Overall Study|Caregiver to patient who withdrew|0|||
130908754|NCT04423939|471301797|FG001|Overall Study|Caregiver to patient who withdrew|3|||
130908755|NCT04626310|471301800|FG000|Overall Study|4-miss from treatment|6|||
130908756|NCT04626310|471301801|FG001|Overall Study|4-miss from treatment|5|||
130908757|NCT04626310|471301802|FG002|Overall Study|4-miss from treatment|5|||
130908758|NCT04626310|471301800|FG000|Overall Study|Withdrawal by Subject|1|||
130908759|NCT04626310|471301801|FG001|Overall Study|Withdrawal by Subject|0|||
130908760|NCT04626310|471301802|FG002|Overall Study|Withdrawal by Subject|3|||
130908761|NCT01117051|471301803|FG000|Overall Study|Withdrawal by Subject|5|||
130908762|NCT01117051|471301804|FG001|Overall Study|Withdrawal by Subject|3|||
130908763|NCT01117051|471301803|FG000|Overall Study|Adverse Event|4|||
130908764|NCT01117051|471301804|FG001|Overall Study|Adverse Event|3|||
130908765|NCT01117051|471301803|FG000|Overall Study|Lost to Follow-up|0|||
130908766|NCT01117051|471301804|FG001|Overall Study|Lost to Follow-up|1|||
130908767|NCT01117051|471301803|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
130908768|NCT01117051|471301804|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
130908769|NCT01117051|471301803|FG000|Overall Study|Sponsor's decision|3|||
131029450|NCT03763708|471740910|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131029451|NCT03763708|471740911|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
131029452|NCT03763708|471740903|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131029453|NCT03763708|471740904|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131029454|NCT03763708|471740905|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131029455|NCT03763708|471740906|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131029456|NCT03763708|471740907|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
131029457|NCT03763708|471740908|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131029458|NCT03763708|471740909|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131029459|NCT03763708|471740910|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131029460|NCT03763708|471740911|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
131115277|NCT00129623|472053624|FG001|Overall Study|Relocated job out of state|0|||
131115278|NCT00129623|472053623|FG000|Overall Study|Uncertainty to return|0|||
131115279|NCT00129623|472053624|FG001|Overall Study|Uncertainty to return|1|||
131115280|NCT02616614|472053625|FG000|Overall Study|Withdrawal by Subject|10|||
130696150|NCT02578641|470512495|FG000|Overall Study|Progressive Disease|69|||
130696151|NCT02578641|470512496|FG001|Overall Study|Progressive Disease|21|||
130696152|NCT02578641|470512495|FG000|Overall Study|No Study Drug|2|||
130908770|NCT01117051|471301804|FG001|Overall Study|Sponsor's decision|1|||
130908771|NCT01117051|471301803|FG000|Overall Study|Surgical procedure|0|||
130908772|NCT01117051|471301804|FG001|Overall Study|Surgical procedure|1|||
130908773|NCT01117051|471301803|FG000|Overall Study|Randomized by mistake|0|||
130908774|NCT01117051|471301804|FG001|Overall Study|Randomized by mistake|1|||
130908775|NCT01117051|471301803|FG000|Overall Study|Convenience issue|1|||
130908776|NCT01117051|471301804|FG001|Overall Study|Convenience issue|0|||
130908777|NCT00366340|471301805|FG000|Infant Series|Protocol Violation|3|||
130908778|NCT00366340|471301806|FG001|Infant Series|Protocol Violation|4|||
130908779|NCT00366340|471301805|FG000|Infant Series|Withdrawal by Subject|3|||
130908780|NCT00366340|471301806|FG001|Infant Series|Withdrawal by Subject|3|||
130908781|NCT00366340|471301805|FG000|Infant Series|Adverse Event|0|||
130908782|NCT00366340|471301806|FG001|Infant Series|Adverse Event|2|||
130908783|NCT00366340|471301805|FG000|Infant Series|Lost to Follow-up|1|||
130908784|NCT00366340|471301806|FG001|Infant Series|Lost to Follow-up|1|||
130908785|NCT00366340|471301805|FG000|Infant Series|Failure to return|1|||
130908786|NCT00366340|471301806|FG001|Infant Series|Failure to return|0|||
131029461|NCT03763708|471740903|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131029462|NCT03763708|471740904|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131029463|NCT03763708|471740905|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131029464|NCT03763708|471740906|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131029465|NCT03763708|471740907|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131029466|NCT03763708|471740908|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
131029467|NCT03763708|471740909|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131029468|NCT03763708|471740910|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131029469|NCT03763708|471740911|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
131029470|NCT03763708|471740903|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131029471|NCT03763708|471740904|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131029472|NCT03763708|471740905|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131029473|NCT03763708|471740906|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131029474|NCT03763708|471740907|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131029475|NCT03763708|471740908|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131029476|NCT03763708|471740909|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
131029477|NCT03763708|471740910|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131029478|NCT03763708|471740911|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
131029479|NCT03763708|471740903|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
131029480|NCT03763708|471740904|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
131029481|NCT03763708|471740905|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
131029482|NCT03763708|471740906|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
131029483|NCT03763708|471740907|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
131029484|NCT03763708|471740908|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
131029485|NCT03763708|471740909|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
131029486|NCT03763708|471740910|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
131029487|NCT03763708|471740911|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
131029488|NCT03763708|471740903|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
131029489|NCT03763708|471740904|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
131029490|NCT03763708|471740905|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
131029491|NCT03763708|471740906|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
131029492|NCT03763708|471740907|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
131029493|NCT03763708|471740908|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
131029494|NCT03763708|471740909|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
131029495|NCT03763708|471740910|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
131029496|NCT03763708|471740911|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
131029497|NCT03763708|471740903|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
131029498|NCT03763708|471740904|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
131029499|NCT03763708|471740905|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
131029500|NCT03763708|471740906|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
131029501|NCT03763708|471740907|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
131029502|NCT03763708|471740908|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
131029503|NCT03763708|471740909|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
131029504|NCT03763708|471740910|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
131029505|NCT03763708|471740911|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
131029506|NCT00931710|471740914|FG000|Overall Study|Adverse Event|16|||
131029507|NCT00931710|471740915|FG001|Overall Study|Adverse Event|10|||
131029508|NCT00931710|471740914|FG000|Overall Study|Abnormal test procedure results|2|||
131029509|NCT00931710|471740915|FG001|Overall Study|Abnormal test procedure results|0|||
131029510|NCT00931710|471740914|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
131029511|NCT00931710|471740915|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
131029512|NCT00931710|471740914|FG000|Overall Study|Patient withdrew consent|4|||
131029513|NCT00931710|471740915|FG001|Overall Study|Patient withdrew consent|9|||
131029514|NCT00931710|471740914|FG000|Overall Study|Lost to Follow-up|6|||
131029515|NCT00931710|471740915|FG001|Overall Study|Lost to Follow-up|5|||
131029516|NCT00931710|471740914|FG000|Overall Study|Protocol deviation|1|||
130908787|NCT00366340|471301805|FG000|After the Infant Series|Parent/legal guardian request|1|||
130908788|NCT00366340|471301806|FG001|After the Infant Series|Parent/legal guardian request|1|||
130908789|NCT00366340|471301805|FG000|After the Infant Series|Failed to return|0|||
130908790|NCT00366340|471301806|FG001|After the Infant Series|Failed to return|1|||
130908791|NCT00366340|471301805|FG000|After the Infant Series|Protocol Violation|2|||
130908792|NCT00366340|471301806|FG001|After the Infant Series|Protocol Violation|2|||
130908793|NCT00366340|471301805|FG000|After the Infant Series|Adverse Event|0|||
130908794|NCT00366340|471301806|FG001|After the Infant Series|Adverse Event|1|||
130908795|NCT00366340|471301805|FG000|After the Infant Series|Lost to Follow-up|0|||
130908796|NCT00366340|471301806|FG001|After the Infant Series|Lost to Follow-up|1|||
130908797|NCT00366340|471301805|FG000|Toddler Dose|Failed to return|1|||
130908798|NCT00366340|471301806|FG001|Toddler Dose|Failed to return|0|||
130908799|NCT00366340|471301805|FG000|Toddler Dose|Parent/legal guardian request|0|||
130908800|NCT00366340|471301806|FG001|Toddler Dose|Parent/legal guardian request|1|||
130908801|NCT00521001|471301808|FG000|Overall Study|Ineligible|1|||
130908802|NCT02821910|471301809|FG000|Overall Study|Withdrawal by Subject|0|||
130908803|NCT02821910|471301810|FG001|Overall Study|Withdrawal by Subject|0|||
130908804|NCT02821910|471301811|FG002|Overall Study|Withdrawal by Subject|1|||
130908805|NCT02821910|471301812|FG003|Overall Study|Withdrawal by Subject|0|||
131029517|NCT00931710|471740915|FG001|Overall Study|Protocol deviation|2|||
131029518|NCT02913872|471740916|FG000|Overall Study|Withdrawal by Subject|1|||
131029519|NCT02323321|471740917|FG000|Overall Study|Re-Transplant|1|||
131029520|NCT02323321|471740917|FG000|Overall Study|Death|12|||
131029521|NCT00446225|471740918|FG000|Overall Study|Protocol Violation|1|||
131029522|NCT00446225|471740919|FG001|Overall Study|Protocol Violation|0|||
131029523|NCT04450342|471740920|FG000|Overall Study|Adverse Event|1|||
131029524|NCT04450342|471740921|FG001|Overall Study|Adverse Event|1|||
131029525|NCT04450342|471740922|FG002|Overall Study|Adverse Event|0|||
131029526|NCT04450342|471740920|FG000|Overall Study|Device not used|1|||
131029527|NCT04450342|471740921|FG001|Overall Study|Device not used|0|||
131029528|NCT04450342|471740922|FG002|Overall Study|Device not used|0|||
131029529|NCT04450342|471740920|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
131029530|NCT04450342|471740921|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
131029531|NCT04450342|471740922|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
131029532|NCT04450342|471740920|FG000|Overall Study|Physician Decision|1|||
131029533|NCT04450342|471740921|FG001|Overall Study|Physician Decision|0|||
131029534|NCT04450342|471740922|FG002|Overall Study|Physician Decision|1|||
131029535|NCT04450342|471740920|FG000|Overall Study|Protocol Deviation|0|||
131029536|NCT04450342|471740921|FG001|Overall Study|Protocol Deviation|1|||
131029537|NCT04450342|471740922|FG002|Overall Study|Protocol Deviation|0|||
131029538|NCT04450342|471740920|FG000|Overall Study|Reoperation|1|||
131029539|NCT04450342|471740921|FG001|Overall Study|Reoperation|1|||
131029540|NCT04450342|471740922|FG002|Overall Study|Reoperation|0|||
131029541|NCT04450342|471740920|FG000|Overall Study|Screen Failures|0|||
131029542|NCT04450342|471740921|FG001|Overall Study|Screen Failures|0|||
131029543|NCT04450342|471740922|FG002|Overall Study|Screen Failures|2|||
131029544|NCT04450342|471740920|FG000|Overall Study|Site Terminated by Sponsor|1|||
131029545|NCT04450342|471740921|FG001|Overall Study|Site Terminated by Sponsor|1|||
131029546|NCT04450342|471740922|FG002|Overall Study|Site Terminated by Sponsor|1|||
131029547|NCT04450342|471740920|FG000|Overall Study|Study Terminated by Sponsor|31|||
131029548|NCT04450342|471740921|FG001|Overall Study|Study Terminated by Sponsor|29|||
131029549|NCT04450342|471740922|FG002|Overall Study|Study Terminated by Sponsor|6|||
131029550|NCT04450342|471740920|FG000|Overall Study|Withdrawal by Subject|0|||
131029551|NCT04450342|471740921|FG001|Overall Study|Withdrawal by Subject|1|||
131029552|NCT04450342|471740922|FG002|Overall Study|Withdrawal by Subject|2|||
131029553|NCT03361748|471740930|FG000|Overall Study|Death|77|||
131029554|NCT03361748|471740930|FG000|Overall Study|Lost to Follow-up|4|||
130908806|NCT02821910|471301813|FG004|Overall Study|Withdrawal by Subject|0|||
130908807|NCT02821910|471301814|FG005|Overall Study|Withdrawal by Subject|1|||
130908808|NCT02821910|471301809|FG000|Overall Study|Other than specified|1|||
130908809|NCT02821910|471301810|FG001|Overall Study|Other than specified|0|||
130908810|NCT02821910|471301811|FG002|Overall Study|Other than specified|1|||
131029555|NCT03361748|471740930|FG000|Overall Study|Withdrawal by Subject|20|||
131029556|NCT05792423|471740931|FG000|Overall Study|Withdrawal by Subject|2|||
131029557|NCT02471638|471740932|FG000|Overall Study|Early Term Withdrawal|10|||
131029558|NCT02187003|471742174|FG000|Overall Study|Adverse Event|2|||
130908811|NCT02821910|471301812|FG003|Overall Study|Other than specified|0|||
131029559|NCT02187003|471742175|FG001|Overall Study|Adverse Event|0|||
131029560|NCT02187003|471742174|FG000|Overall Study|Lost to Follow-up|14|||
131029561|NCT02187003|471742175|FG001|Overall Study|Lost to Follow-up|10|||
131029562|NCT02187003|471742174|FG000|Overall Study|Withdrawal by Subject|3|||
131029563|NCT02187003|471742175|FG001|Overall Study|Withdrawal by Subject|7|||
131029564|NCT02187003|471742174|FG000|Overall Study|Protocol Violation|2|||
131029565|NCT02187003|471742175|FG001|Overall Study|Protocol Violation|4|||
131029566|NCT02187003|471742174|FG000|Overall Study|Other|5|||
131029567|NCT02187003|471742175|FG001|Overall Study|Other|5|||
131029568|NCT02187003|471742174|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130908812|NCT02821910|471301813|FG004|Overall Study|Other than specified|0|||
131029569|NCT02187003|471742175|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
131029570|NCT04593472|471742176|FG000|Overall Study|Death|31|||
131029571|NCT04593472|471742177|FG001|Overall Study|Death|27|||
131029572|NCT04593472|471742176|FG000|Overall Study|Withdrawal by Subject|12|||
131029573|NCT04593472|471742177|FG001|Overall Study|Withdrawal by Subject|12|||
131029574|NCT04593472|471742176|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
131029575|NCT04593472|471742177|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
131029576|NCT04593472|471742176|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
131029577|NCT04593472|471742177|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
131029578|NCT04593472|471742176|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
131029579|NCT04593472|471742177|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
131029580|NCT04593472|471742176|FG000|Overall Study|Lost to Follow-up|0|||
131029581|NCT04593472|471742177|FG001|Overall Study|Lost to Follow-up|2|||
131029582|NCT04593472|471742176|FG000|Overall Study|Still collecting 24-month assessment|17|||
131029583|NCT04593472|471742177|FG001|Overall Study|Still collecting 24-month assessment|10|||
131029584|NCT04178733|471742178|FG000|Overall Study|Investigator Decision|0|||
131029585|NCT04178733|471742179|FG001|Overall Study|Investigator Decision|0|||
131029586|NCT04178733|471742180|FG002|Overall Study|Investigator Decision|0|||
131029587|NCT04178733|471742181|FG003|Overall Study|Investigator Decision|1|||
131029588|NCT04178733|471742182|FG004|Overall Study|Investigator Decision|2|||
131029589|NCT02287311|471742186|FG000|Cohort 1: Dose Level 1|Death|2|||
131029590|NCT02287311|471742187|FG001|Cohort 1: Dose Level 1|Death|0|||
131029591|NCT02287311|471742188|FG002|Cohort 1: Dose Level 1|Death|0|||
131029592|NCT02287311|471742189|FG003|Cohort 1: Dose Level 1|Death|3|||
131029593|NCT02287311|471742190|FG004|Cohort 1: Dose Level 1|Death|0|||
131029594|NCT02287311|471742191|FG005|Cohort 1: Dose Level 1|Death|0|||
131029595|NCT02287311|471742192|FG006|Cohort 1: Dose Level 1|Death|1|||
131029596|NCT02287311|471742193|FG007|Cohort 1: Dose Level 1|Death|0|||
131029597|NCT02287311|471742194|FG008|Cohort 1: Dose Level 1|Death|0|||
131029598|NCT02287311|471742186|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131029599|NCT02287311|471742187|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131029600|NCT02287311|471742188|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131029601|NCT02287311|471742189|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
131029602|NCT02287311|471742190|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131029603|NCT02287311|471742191|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131029604|NCT02287311|471742192|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
131029605|NCT02287311|471742193|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131029606|NCT02287311|471742194|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
131029607|NCT02287311|471742186|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
131029608|NCT02287311|471742187|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
131029609|NCT02287311|471742188|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
131029610|NCT02287311|471742189|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
131029611|NCT02287311|471742190|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
131029612|NCT02287311|471742191|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
131029613|NCT02287311|471742192|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
131029614|NCT02287311|471742193|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
131029615|NCT02287311|471742194|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
131029616|NCT02287311|471742186|FG000|Cohort 2: Dose Level 2|Death|0|||
131029617|NCT02287311|471742187|FG001|Cohort 2: Dose Level 2|Death|2|||
131029618|NCT02287311|471742188|FG002|Cohort 2: Dose Level 2|Death|0|||
131029619|NCT02287311|471742189|FG003|Cohort 2: Dose Level 2|Death|0|||
131029620|NCT02287311|471742190|FG004|Cohort 2: Dose Level 2|Death|2|||
131029621|NCT02287311|471742191|FG005|Cohort 2: Dose Level 2|Death|0|||
131029622|NCT02287311|471742192|FG006|Cohort 2: Dose Level 2|Death|0|||
131029623|NCT02287311|471742193|FG007|Cohort 2: Dose Level 2|Death|2|||
131029624|NCT02287311|471742194|FG008|Cohort 2: Dose Level 2|Death|0|||
131029625|NCT02287311|471742186|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131029626|NCT02287311|471742187|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131029627|NCT02287311|471742188|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131029628|NCT02287311|471742189|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131029629|NCT02287311|471742190|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
131029630|NCT02287311|471742191|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131029631|NCT02287311|471742192|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131029632|NCT02287311|471742193|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131029633|NCT02287311|471742194|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
131029634|NCT02287311|471742186|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
131029635|NCT02287311|471742187|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
131029636|NCT02287311|471742188|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
131029637|NCT02287311|471742189|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
131029638|NCT02287311|471742190|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
131029639|NCT02287311|471742191|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
131029640|NCT02287311|471742192|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
131029641|NCT02287311|471742193|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
131115281|NCT02616614|472053626|FG001|Overall Study|Withdrawal by Subject|5|||
131115282|NCT02616614|472053627|FG002|Overall Study|Withdrawal by Subject|6|||
131115283|NCT02616614|472053625|FG000|Overall Study|Physician Decision|2|||
131115284|NCT02616614|472053626|FG001|Overall Study|Physician Decision|1|||
131115285|NCT02616614|472053627|FG002|Overall Study|Physician Decision|0|||
131115286|NCT02616614|472053625|FG000|Overall Study|Adverse Event|1|||
131115287|NCT02616614|472053626|FG001|Overall Study|Adverse Event|4|||
131115288|NCT02616614|472053627|FG002|Overall Study|Adverse Event|1|||
131115289|NCT02616614|472053625|FG000|Overall Study|Protocol Violation|0|||
131115290|NCT02616614|472053626|FG001|Overall Study|Protocol Violation|3|||
131115291|NCT02616614|472053627|FG002|Overall Study|Protocol Violation|1|||
131115292|NCT02616614|472053625|FG000|Overall Study|Prohibited Medication|12|||
131115293|NCT02616614|472053626|FG001|Overall Study|Prohibited Medication|9|||
131115294|NCT02616614|472053627|FG002|Overall Study|Prohibited Medication|5|||
131115295|NCT02616614|472053625|FG000|Overall Study|More than 3 applications missed|6|||
131115296|NCT02616614|472053626|FG001|Overall Study|More than 3 applications missed|8|||
131115297|NCT02616614|472053627|FG002|Overall Study|More than 3 applications missed|1|||
130696153|NCT02578641|470512496|FG001|Overall Study|No Study Drug|0|||
130696154|NCT02578641|470512495|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
130696155|NCT02578641|470512496|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
130908813|NCT02821910|471301814|FG005|Overall Study|Other than specified|0|||
130908814|NCT00287079|471301815|FG000|Overall Study|Qualifying relapse|12|||
130908815|NCT00287079|471301816|FG001|Overall Study|Qualifying relapse|1|||
130908816|NCT00287079|471301815|FG000|Overall Study|Non-qualifying relapse|1|||
130908817|NCT00287079|471301816|FG001|Overall Study|Non-qualifying relapse|0|||
130908818|NCT00287079|471301815|FG000|Overall Study|Adverse Event|5|||
130908819|NCT00287079|471301816|FG001|Overall Study|Adverse Event|0|||
130908820|NCT00287079|471301815|FG000|Overall Study|Protocol Violation|1|||
130908821|NCT00287079|471301816|FG001|Overall Study|Protocol Violation|0|||
130908822|NCT00287079|471301815|FG000|Overall Study|Other|3|||
131115298|NCT02616614|472053625|FG000|Overall Study|Lost to Follow-up|31|||
131115299|NCT02616614|472053626|FG001|Overall Study|Lost to Follow-up|28|||
131115300|NCT02616614|472053627|FG002|Overall Study|Lost to Follow-up|13|||
131115301|NCT02616614|472053625|FG000|Overall Study|Pregnancy|2|||
131115302|NCT02616614|472053626|FG001|Overall Study|Pregnancy|0|||
131115303|NCT02616614|472053627|FG002|Overall Study|Pregnancy|1|||
131115304|NCT02616614|472053625|FG000|Overall Study|Other|1|||
131115305|NCT02616614|472053626|FG001|Overall Study|Other|2|||
131115306|NCT02616614|472053627|FG002|Overall Study|Other|1|||
131115307|NCT02315898|472053628|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
130696156|NCT02578641|470512495|FG000|Overall Study|Non-compliance with Study Schedule|1|||
130696157|NCT02578641|470512496|FG001|Overall Study|Non-compliance with Study Schedule|0|||
130696158|NCT02578641|470512495|FG000|Overall Study|Other|1|||
130696159|NCT02578641|470512496|FG001|Overall Study|Other|10|||
130696160|NCT02578641|470512495|FG000|Overall Study|Not treated|1|||
130696161|NCT02578641|470512496|FG001|Overall Study|Not treated|4|||
130696162|NCT00084864|470512499|FG000|Overall Study|Adverse Event|1|||
130696163|NCT00084864|470512500|FG001|Overall Study|Adverse Event|0|||
130696164|NCT00084864|470512501|FG002|Overall Study|Adverse Event|0|||
130696165|NCT00084864|470512502|FG003|Overall Study|Adverse Event|0|||
130696166|NCT01741545|470512503|FG000|Treatment Period|Lack of Efficacy|0|||
130696167|NCT01741545|470512504|FG001|Treatment Period|Lack of Efficacy|1|||
130696168|NCT01741545|470512503|FG000|Treatment Period|Adverse event, non-fatal|1|||
130696169|NCT01741545|470512504|FG001|Treatment Period|Adverse event, non-fatal|3|||
130696170|NCT01741545|470512503|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
130696171|NCT01741545|470512504|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
130696172|NCT01741545|470512503|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
131115308|NCT02315898|472053629|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
131115309|NCT02315898|472053630|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
131115310|NCT02315898|472053631|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
131115311|NCT02445755|472053632|FG000|Overall Study|Withdrawal by Subject|2|||
131115312|NCT02445755|472053632|FG000|Overall Study|Protocol Violation|6|||
131115313|NCT02445755|472053632|FG000|Overall Study|Screen Failure|5|||
131115314|NCT03239483|472053633|FG000|Overall Study|Lost to Follow-up|1|||
131115315|NCT03239483|472053634|FG001|Overall Study|Lost to Follow-up|0|||
130696173|NCT01741545|470512504|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
130696174|NCT01456962|470512505|FG000|Overall Study|Lost to Follow-up|2|||
130696175|NCT01456962|470512506|FG001|Overall Study|Lost to Follow-up|1|||
130908823|NCT00287079|471301816|FG001|Overall Study|Other|0|||
130696176|NCT01853176|470512507|FG000|Overall Study|Study terminated|4|||
130696177|NCT01853176|470512508|FG001|Overall Study|Study terminated|0|||
130696178|NCT01370083|470512511|FG000|Overall Study|Lost to Follow-up|2|||
130908824|NCT00423670|471301819|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
130908825|NCT00423670|471301820|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
131115316|NCT03239483|472053633|FG000|Overall Study|Withdrawal by Subject|1|||
131115317|NCT03239483|472053634|FG001|Overall Study|Withdrawal by Subject|0|||
130696179|NCT01370083|470512512|FG001|Overall Study|Lost to Follow-up|0|||
130696180|NCT01370083|470512511|FG000|Overall Study|Adverse Event|0|||
130696181|NCT01370083|470512512|FG001|Overall Study|Adverse Event|1|||
130696182|NCT00731939|470512514|FG000|Overall Study|Adverse Event|6|||
130696183|NCT00731939|470512514|FG000|Overall Study|Lost to Follow-up|15|||
130696184|NCT00731939|470512514|FG000|Overall Study|Not implanted with study device|9|||
130696185|NCT00731939|470512514|FG000|Overall Study|Withdrawal by Subject|2|||
130696186|NCT00731939|470512514|FG000|Overall Study|Did not meet enrollment criteria|2|||
130696187|NCT02072096|470512515|FG000|Overall Study|Lack of Efficacy|18|||
130696188|NCT02072096|470512516|FG001|Overall Study|Lack of Efficacy|29|||
130696189|NCT02072096|470512515|FG000|Overall Study|Protocol Violation|7|||
130696190|NCT02072096|470512516|FG001|Overall Study|Protocol Violation|7|||
130696191|NCT02072096|470512515|FG000|Overall Study|Withdrawal by Subject|5|||
130696192|NCT02072096|470512516|FG001|Overall Study|Withdrawal by Subject|7|||
130696193|NCT02072096|470512515|FG000|Overall Study|Adverse Event|5|||
130696194|NCT02072096|470512516|FG001|Overall Study|Adverse Event|2|||
130696195|NCT02072096|470512515|FG000|Overall Study|No Reason Provided|4|||
130696196|NCT02072096|470512516|FG001|Overall Study|No Reason Provided|2|||
130696197|NCT02072096|470512515|FG000|Overall Study|Death|2|||
130696198|NCT02072096|470512516|FG001|Overall Study|Death|0|||
130696199|NCT02072096|470512515|FG000|Overall Study|Physician Decision|0|||
130696200|NCT02072096|470512516|FG001|Overall Study|Physician Decision|1|||
130696201|NCT02072096|470512515|FG000|Overall Study|Study Terminated by Sponsor|43|||
130696202|NCT02072096|470512516|FG001|Overall Study|Study Terminated by Sponsor|30|||
130696203|NCT02072096|470512515|FG000|Overall Study|Lost to Follow-up|1|||
130696204|NCT02072096|470512516|FG001|Overall Study|Lost to Follow-up|0|||
130696205|NCT01266902|470512518|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
130696206|NCT01266902|470512519|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
130696207|NCT01266902|470512520|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
130696208|NCT01266902|470512518|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
130696209|NCT01266902|470512519|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
130696210|NCT01266902|470512520|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
130696211|NCT01266902|470512518|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
130696212|NCT01266902|470512519|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
130696213|NCT01266902|470512520|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
130696214|NCT01266902|470512518|FG000|Period 1 (Main Study)|Adverse Event|3|||
130696215|NCT01266902|470512519|FG001|Period 1 (Main Study)|Adverse Event|11|||
130696216|NCT01266902|470512520|FG002|Period 1 (Main Study)|Adverse Event|0|||
130696217|NCT01266902|470512518|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
131115318|NCT05352048|472053635|FG000|Overall Study|Lost to Follow-up|1|||
131115319|NCT05352048|472053635|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
131115320|NCT01233869|472053645|FG000|Initial Treatment Period (24 Months)|Death|1|||
131115321|NCT01233869|472053646|FG001|Initial Treatment Period (24 Months)|Death|0|||
131115322|NCT01233869|472053647|FG002|Initial Treatment Period (24 Months)|Death|0|||
131115323|NCT01233869|472053648|FG003|Initial Treatment Period (24 Months)|Death|0|||
131115324|NCT01233869|472053645|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
131115325|NCT01233869|472053646|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
131115326|NCT01233869|472053647|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
131115327|NCT01233869|472053648|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
131115328|NCT01233869|472053645|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
131115329|NCT01233869|472053646|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
131115330|NCT01233869|472053647|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
131115331|NCT01233869|472053648|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
131115332|NCT01233869|472053645|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
131115333|NCT01233869|472053646|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
131115334|NCT01233869|472053647|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
131115335|NCT01233869|472053648|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
131115336|NCT01233869|472053645|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
131115337|NCT01233869|472053646|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
131115338|NCT01233869|472053647|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
131115339|NCT01233869|472053648|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
131115340|NCT01233869|472053645|FG000|Extended Treatment Period (46 Months)|Other|3|||
131115341|NCT01233869|472053646|FG001|Extended Treatment Period (46 Months)|Other|0|||
130696218|NCT01266902|470512519|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
130696219|NCT01266902|470512520|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
130696220|NCT01266902|470512518|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
130696221|NCT01266902|470512519|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
130696222|NCT01266902|470512520|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
130696223|NCT01266902|470512518|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
130696224|NCT01266902|470512519|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
130696225|NCT01266902|470512520|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
130908826|NCT00423670|471301821|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
130908827|NCT00423670|471301822|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
130908828|NCT00423670|471301823|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
130908829|NCT00423670|471301824|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
130908830|NCT00423670|471301825|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
130908831|NCT00423670|471301826|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
130908832|NCT00423670|471301819|FG000|Treatment Period|Adverse Event|8|||
130908833|NCT00423670|471301820|FG001|Treatment Period|Adverse Event|12|||
130908834|NCT00423670|471301821|FG002|Treatment Period|Adverse Event|15|||
130908835|NCT00423670|471301822|FG003|Treatment Period|Adverse Event|20|||
130908836|NCT00423670|471301823|FG004|Treatment Period|Adverse Event|9|||
131115342|NCT01233869|472053647|FG002|Extended Treatment Period (46 Months)|Other|0|||
131115343|NCT01233869|472053648|FG003|Extended Treatment Period (46 Months)|Other|3|||
131115344|NCT01233869|472053645|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
131115345|NCT01233869|472053646|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
131115346|NCT01233869|472053647|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
130696226|NCT01266902|470512518|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
131115347|NCT01233869|472053648|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
131115348|NCT04464265|472053655|FG000|Overall Study|Physician Decision|2|||
131115349|NCT00974090|472053662|FG000|Period 1: Double Blind Period|Adverse Event|2|||
131115350|NCT00974090|472053663|FG001|Period 1: Double Blind Period|Adverse Event|1|||
131115351|NCT00974090|472053662|FG000|Period 1: Double Blind Period|Physician Decision|1|||
131115352|NCT00974090|472053663|FG001|Period 1: Double Blind Period|Physician Decision|0|||
131115353|NCT00974090|472053662|FG000|Period 2: Open-label Period|Adverse Event|4|||
131115354|NCT00974090|472053663|FG001|Period 2: Open-label Period|Adverse Event|6|||
131115355|NCT00974090|472053662|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
131115356|NCT00974090|472053663|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
131115357|NCT00974090|472053662|FG000|Period 2: Open-label Period|Physician Decision|0|||
131115358|NCT00974090|472053663|FG001|Period 2: Open-label Period|Physician Decision|3|||
131115359|NCT00974090|472053662|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
131115360|NCT00974090|472053663|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
131115361|NCT05696236|472053666|FG000|Overall Study|Lost to Follow-up|1|||
131115362|NCT05696236|472053667|FG001|Overall Study|Lost to Follow-up|0|||
131115363|NCT05696236|472053666|FG000|Overall Study|Later determined to not be eligible for participation|0|||
131115364|NCT05696236|472053667|FG001|Overall Study|Later determined to not be eligible for participation|1|||
131115365|NCT05696236|472053666|FG000|Overall Study|Withdrawal by Subject|2|||
131115366|NCT05696236|472053667|FG001|Overall Study|Withdrawal by Subject|2|||
131115367|NCT01145495|472053668|FG000|Overall Study|Adverse Event|6|||
131115368|NCT01145495|472053668|FG000|Overall Study|Withdrawal by Subject|6|||
131115369|NCT01145495|472053668|FG000|Overall Study|Disease progression after respone|2|||
131115370|NCT02060721|472053669|FG000|Overall Study|Lost to Follow-up|1|||
131115371|NCT02060721|472053669|FG000|Overall Study|Physician Decision|2|||
131115372|NCT02060721|472053669|FG000|Overall Study|Death|14|||
131115373|NCT02060721|472053669|FG000|Overall Study|Withdrawal by Subject|2|||
131115374|NCT02060721|472053669|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
131115375|NCT00117507|472053670|FG000|Overall Study|Adverse Event|4|||
131115376|NCT00117507|472053670|FG000|Overall Study|Abnormal laboratory values|3|||
131115377|NCT00117507|472053670|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131115378|NCT00117507|472053670|FG000|Overall Study|Patient withdrew consent|4|||
131115379|NCT00117507|472053670|FG000|Overall Study|Death|3|||
131115380|NCT05105789|472053671|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
131115381|NCT00323297|472053674|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
131115382|NCT00323297|472053675|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
131115383|NCT00323297|472053674|FG000|Part A (Double Blind Randomized)|Death|0|||
131115384|NCT00323297|472053675|FG001|Part A (Double Blind Randomized)|Death|1|||
131115385|NCT00323297|472053674|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
130696227|NCT01266902|470512519|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
130696228|NCT01266902|470512520|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
130908837|NCT00423670|471301824|FG005|Treatment Period|Adverse Event|4|||
130908838|NCT00423670|471301825|FG006|Treatment Period|Adverse Event|7|||
130908839|NCT00423670|471301826|FG007|Treatment Period|Adverse Event|2|||
131115386|NCT00323297|472053675|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
131115387|NCT00323297|472053674|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
131115388|NCT00323297|472053675|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
131115389|NCT00323297|472053674|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
131115390|NCT00323297|472053675|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
131115391|NCT00323297|472053674|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
131115392|NCT00323297|472053675|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
131115393|NCT00323297|472053674|FG000|Part B (Open-label)|Death|0|||
131115394|NCT00323297|472053675|FG001|Part B (Open-label)|Death|1|||
130908840|NCT00423670|471301819|FG000|Treatment Period|Protocol-defined clinical event|0|||
131115395|NCT00323297|472053674|FG000|Part B (Open-label)|Reason unspecified|0|||
131115396|NCT00323297|472053675|FG001|Part B (Open-label)|Reason unspecified|1|||
131115397|NCT00323297|472053674|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
131115398|NCT00323297|472053675|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
131115399|NCT00323297|472053674|FG000|Part B (Open-label)|Lack of Efficacy|3|||
131115400|NCT00323297|472053675|FG001|Part B (Open-label)|Lack of Efficacy|1|||
131115401|NCT00323297|472053674|FG000|Part B (Open-label)|Adverse Event|5|||
131115402|NCT00323297|472053675|FG001|Part B (Open-label)|Adverse Event|5|||
131115403|NCT00323297|472053674|FG000|Part B (Open-label)|Protocol Violation|0|||
131115404|NCT00323297|472053675|FG001|Part B (Open-label)|Protocol Violation|1|||
131115405|NCT04667247|472053680|FG000|Overall Study|Withdrawal by Subject|0|||
131115406|NCT04667247|472053681|FG001|Overall Study|Withdrawal by Subject|1|||
131115407|NCT01444651|472055434|FG000|Overall Study|Adverse Event|3|||
131115408|NCT01444651|472055435|FG001|Overall Study|Adverse Event|2|||
131115409|NCT01444651|472055434|FG000|Overall Study|Lost to Follow-up|5|||
131115410|NCT01444651|472055435|FG001|Overall Study|Lost to Follow-up|5|||
131115411|NCT01444651|472055434|FG000|Overall Study|Non-fasting|2|||
131115412|NCT01444651|472055435|FG001|Overall Study|Non-fasting|1|||
131115413|NCT01444651|472055434|FG000|Overall Study|Missing data|1|||
131115414|NCT01444651|472055435|FG001|Overall Study|Missing data|1|||
131115415|NCT01436071|472055436|FG000|Overall Study|Adverse Event|1|||
131115416|NCT01436071|472055437|FG001|Overall Study|Adverse Event|0|||
131115417|NCT01436071|472055436|FG000|Overall Study|Lack of Efficacy|16|||
131115418|NCT01436071|472055437|FG001|Overall Study|Lack of Efficacy|7|||
131115419|NCT01436071|472055436|FG000|Overall Study|Protocol Violation|0|||
131115420|NCT01436071|472055437|FG001|Overall Study|Protocol Violation|1|||
131115421|NCT01436071|472055436|FG000|Overall Study|Lost to Follow-up|3|||
131115422|NCT01436071|472055437|FG001|Overall Study|Lost to Follow-up|1|||
131115423|NCT01436071|472055436|FG000|Overall Study|Physician Decision|1|||
131115424|NCT01436071|472055437|FG001|Overall Study|Physician Decision|0|||
131115425|NCT01436071|472055436|FG000|Overall Study|Withdrawal by Subject|2|||
131115426|NCT01436071|472055437|FG001|Overall Study|Withdrawal by Subject|2|||
131115427|NCT01436071|472055436|FG000|Overall Study|Did Not Receive Trial Medication|3|||
131115428|NCT01436071|472055437|FG001|Overall Study|Did Not Receive Trial Medication|3|||
131115429|NCT01215175|472055440|FG000|Overall Study|Lost to Follow-up|0|||
131115430|NCT01215175|472055441|FG001|Overall Study|Lost to Follow-up|1|||
131115431|NCT01215175|472055442|FG002|Overall Study|Lost to Follow-up|0|||
131115432|NCT01215175|472055443|FG003|Overall Study|Lost to Follow-up|1|||
131115433|NCT01215175|472055444|FG004|Overall Study|Lost to Follow-up|0|||
131115434|NCT01296035|472055449|FG000|Overall Study|Withdrawal by Subject|1|||
131115435|NCT03189862|472055450|FG000|Overall Study|Withdrawal by Subject|1|||
131115436|NCT03189862|472055451|FG001|Overall Study|Withdrawal by Subject|0|||
131115437|NCT03189862|472055450|FG000|Overall Study|Lost to Follow-up|54|||
131115438|NCT03189862|472055451|FG001|Overall Study|Lost to Follow-up|62|||
131115439|NCT00056862|472055452|FG000|Overall Study|Protocol Violation|1|||
131115440|NCT00056862|472055453|FG001|Overall Study|Protocol Violation|0|||
131115441|NCT01829360|472055454|FG000|Overall Study|Protocol Violation|0|||
131115442|NCT01829360|472055455|FG001|Overall Study|Protocol Violation|0|||
131115443|NCT01829360|472055456|FG002|Overall Study|Protocol Violation|1|||
131115444|NCT01829360|472055457|FG003|Overall Study|Protocol Violation|0|||
131115445|NCT03838198|472055462|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
131115446|NCT03838198|472055463|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
131115447|NCT03838198|472055464|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
131115448|NCT03838198|472055465|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
131115449|NCT03838198|472055462|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
131115450|NCT03838198|472055463|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
131115451|NCT03838198|472055464|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
131115452|NCT03838198|472055465|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
131115453|NCT02378220|472055466|FG000|Overall Study|Death|6|||
131115454|NCT02378220|472055467|FG001|Overall Study|Death|1|||
131115455|NCT00578786|472055468|FG000|Overall Study|Adverse Event|27|||
131115456|NCT00578786|472055469|FG001|Overall Study|Adverse Event|37|||
131115457|NCT00578786|472055470|FG002|Overall Study|Adverse Event|17|||
131115458|NCT00578786|472055468|FG000|Overall Study|Lack of Efficacy|2|||
131115459|NCT00578786|472055469|FG001|Overall Study|Lack of Efficacy|5|||
131115460|NCT00578786|472055470|FG002|Overall Study|Lack of Efficacy|2|||
131115461|NCT00578786|472055468|FG000|Overall Study|Early Escape from Prior Study|2|||
131115462|NCT00578786|472055469|FG001|Overall Study|Early Escape from Prior Study|1|||
131115463|NCT00578786|472055470|FG002|Overall Study|Early Escape from Prior Study|2|||
131115464|NCT00578786|472055468|FG000|Overall Study|Withdrawal by Subject|7|||
131115465|NCT00578786|472055469|FG001|Overall Study|Withdrawal by Subject|8|||
131115466|NCT00578786|472055470|FG002|Overall Study|Withdrawal by Subject|5|||
131115467|NCT00578786|472055468|FG000|Overall Study|Protocol Violation|0|||
131115468|NCT00578786|472055469|FG001|Overall Study|Protocol Violation|3|||
131115469|NCT00578786|472055470|FG002|Overall Study|Protocol Violation|1|||
130908841|NCT00423670|471301820|FG001|Treatment Period|Protocol-defined clinical event|7|||
130908842|NCT00423670|471301821|FG002|Treatment Period|Protocol-defined clinical event|4|||
130908843|NCT00423670|471301822|FG003|Treatment Period|Protocol-defined clinical event|12|||
130908844|NCT00423670|471301823|FG004|Treatment Period|Protocol-defined clinical event|5|||
130908845|NCT00423670|471301824|FG005|Treatment Period|Protocol-defined clinical event|4|||
130908846|NCT00423670|471301825|FG006|Treatment Period|Protocol-defined clinical event|16|||
130908847|NCT00423670|471301826|FG007|Treatment Period|Protocol-defined clinical event|15|||
130908848|NCT00423670|471301819|FG000|Treatment Period|Lost to Follow-up|2|||
130908849|NCT00423670|471301820|FG001|Treatment Period|Lost to Follow-up|1|||
130908850|NCT00423670|471301821|FG002|Treatment Period|Lost to Follow-up|3|||
130908851|NCT00423670|471301822|FG003|Treatment Period|Lost to Follow-up|1|||
130908852|NCT00423670|471301823|FG004|Treatment Period|Lost to Follow-up|6|||
130908853|NCT00423670|471301824|FG005|Treatment Period|Lost to Follow-up|0|||
130908854|NCT00423670|471301825|FG006|Treatment Period|Lost to Follow-up|3|||
130908855|NCT00423670|471301826|FG007|Treatment Period|Lost to Follow-up|1|||
130908856|NCT00423670|471301819|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
130908857|NCT00423670|471301820|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
130908858|NCT00423670|471301821|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
130908859|NCT00423670|471301822|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
130908860|NCT00423670|471301823|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
130908861|NCT00423670|471301824|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
130908862|NCT00423670|471301825|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
130908863|NCT00423670|471301826|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
130908864|NCT00423670|471301819|FG000|Treatment Period|Investigator decision|0|||
130908865|NCT00423670|471301820|FG001|Treatment Period|Investigator decision|0|||
130908866|NCT00423670|471301821|FG002|Treatment Period|Investigator decision|0|||
130908867|NCT00423670|471301822|FG003|Treatment Period|Investigator decision|0|||
130908868|NCT00423670|471301823|FG004|Treatment Period|Investigator decision|0|||
130908869|NCT00423670|471301824|FG005|Treatment Period|Investigator decision|0|||
130908870|NCT00423670|471301825|FG006|Treatment Period|Investigator decision|0|||
130908871|NCT00423670|471301826|FG007|Treatment Period|Investigator decision|1|||
130908872|NCT00423670|471301819|FG000|Treatment Period|Non-compliance with protocol|3|||
130908873|NCT00423670|471301820|FG001|Treatment Period|Non-compliance with protocol|1|||
130908874|NCT00423670|471301821|FG002|Treatment Period|Non-compliance with protocol|1|||
130908875|NCT00423670|471301822|FG003|Treatment Period|Non-compliance with protocol|3|||
130908876|NCT00423670|471301823|FG004|Treatment Period|Non-compliance with protocol|2|||
130908877|NCT00423670|471301824|FG005|Treatment Period|Non-compliance with protocol|0|||
130908878|NCT00423670|471301825|FG006|Treatment Period|Non-compliance with protocol|2|||
130908879|NCT00423670|471301826|FG007|Treatment Period|Non-compliance with protocol|2|||
130908880|NCT00423670|471301819|FG000|Follow-up Period|Lost to Follow-up|0|||
130908881|NCT00423670|471301820|FG001|Follow-up Period|Lost to Follow-up|12|||
130908882|NCT00423670|471301821|FG002|Follow-up Period|Lost to Follow-up|8|||
130908883|NCT00423670|471301822|FG003|Follow-up Period|Lost to Follow-up|3|||
130908884|NCT00423670|471301823|FG004|Follow-up Period|Lost to Follow-up|1|||
130908885|NCT00423670|471301824|FG005|Follow-up Period|Lost to Follow-up|0|||
130908886|NCT00423670|471301825|FG006|Follow-up Period|Lost to Follow-up|5|||
130908887|NCT00423670|471301826|FG007|Follow-up Period|Lost to Follow-up|0|||
130908888|NCT00423670|471301819|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
130908889|NCT00423670|471301820|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
130908890|NCT00423670|471301821|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
130908891|NCT00423670|471301822|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
130908892|NCT00423670|471301823|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
130908893|NCT00423670|471301824|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
130908894|NCT00423670|471301825|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
130908895|NCT00423670|471301826|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
130908896|NCT00423670|471301819|FG000|Follow-up Period|Non-compliance with protocol|2|||
130908897|NCT00423670|471301820|FG001|Follow-up Period|Non-compliance with protocol|0|||
130908898|NCT00423670|471301821|FG002|Follow-up Period|Non-compliance with protocol|1|||
130908899|NCT00423670|471301822|FG003|Follow-up Period|Non-compliance with protocol|1|||
130908900|NCT00423670|471301823|FG004|Follow-up Period|Non-compliance with protocol|0|||
130908901|NCT00423670|471301824|FG005|Follow-up Period|Non-compliance with protocol|0|||
130908902|NCT00423670|471301825|FG006|Follow-up Period|Non-compliance with protocol|3|||
130908903|NCT00423670|471301826|FG007|Follow-up Period|Non-compliance with protocol|2|||
130908904|NCT01289782|471301827|FG000|Overall Study|Lost to Follow-up|14|||
131029642|NCT02287311|471742194|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
131029643|NCT02287311|471742186|FG000|Cohort 3: Dose Level 3|Death|0|||
131029644|NCT02287311|471742187|FG001|Cohort 3: Dose Level 3|Death|0|||
131029645|NCT02287311|471742188|FG002|Cohort 3: Dose Level 3|Death|4|||
131029646|NCT02287311|471742189|FG003|Cohort 3: Dose Level 3|Death|0|||
131029647|NCT02287311|471742190|FG004|Cohort 3: Dose Level 3|Death|0|||
131029648|NCT02287311|471742191|FG005|Cohort 3: Dose Level 3|Death|4|||
131029649|NCT02287311|471742192|FG006|Cohort 3: Dose Level 3|Death|0|||
130908905|NCT01289782|471301828|FG001|Overall Study|Lost to Follow-up|7|||
130908906|NCT01289782|471301827|FG000|Overall Study|Protocol Violation|1|||
130908907|NCT01289782|471301828|FG001|Overall Study|Protocol Violation|1|||
130908908|NCT01289782|471301827|FG000|Overall Study|Withdrawal by Subject|8|||
130908909|NCT01289782|471301828|FG001|Overall Study|Withdrawal by Subject|2|||
130908910|NCT01289782|471301827|FG000|Overall Study|Sponsor's Decision|1|||
130908911|NCT01289782|471301828|FG001|Overall Study|Sponsor's Decision|0|||
130908912|NCT01289782|471301827|FG000|Overall Study|Reason not specified|1|||
130908913|NCT01289782|471301828|FG001|Overall Study|Reason not specified|2|||
130908914|NCT01025154|471301832|FG000|Overall Study|Lost to Follow-up|1|||
130908915|NCT01025154|471301832|FG000|Overall Study|Withdrawal by Subject|1|||
130908916|NCT00542451|471301837|FG000|Overall Study|Adverse Event|31|||
130908917|NCT00542451|471301837|FG000|Overall Study|Withdrawal by Subject|30|||
130908918|NCT00542451|471301837|FG000|Overall Study|Physician Decision|4|||
130908919|NCT00542451|471301837|FG000|Overall Study|Recurrent disease|1|||
130908920|NCT00542451|471301837|FG000|Overall Study|unknown reason|1|||
130908921|NCT00542451|471301837|FG000|Overall Study|Death|2|||
130908922|NCT00542451|471301837|FG000|Overall Study|Lost to Follow-up|10|||
130908923|NCT03519386|471301838|FG000|Overall Study|Withdrawal by Subject|4|||
130908924|NCT03519386|471301839|FG001|Overall Study|Withdrawal by Subject|1|||
130908925|NCT03519386|471301840|FG002|Overall Study|Withdrawal by Subject|2|||
130908926|NCT03519386|471301838|FG000|Overall Study|Physician Decision|1|||
130908927|NCT03519386|471301839|FG001|Overall Study|Physician Decision|1|||
130908928|NCT03519386|471301840|FG002|Overall Study|Physician Decision|1|||
130908929|NCT03519386|471301838|FG000|Overall Study|Lost to Follow-up|0|||
130908930|NCT03519386|471301839|FG001|Overall Study|Lost to Follow-up|1|||
130908931|NCT03519386|471301840|FG002|Overall Study|Lost to Follow-up|1|||
130908932|NCT03519386|471301838|FG000|Overall Study|Death|1|||
130908933|NCT03519386|471301839|FG001|Overall Study|Death|0|||
130908934|NCT03519386|471301840|FG002|Overall Study|Death|4|||
130908935|NCT03519386|471301838|FG000|Overall Study|Adverse Event|2|||
130908936|NCT03519386|471301839|FG001|Overall Study|Adverse Event|1|||
130696229|NCT01266902|470512518|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
130908937|NCT03519386|471301840|FG002|Overall Study|Adverse Event|2|||
130908938|NCT03519386|471301838|FG000|Overall Study|Explanted|2|||
130908939|NCT03519386|471301839|FG001|Overall Study|Explanted|1|||
130908940|NCT03519386|471301840|FG002|Overall Study|Explanted|0|||
130908941|NCT03519386|471301838|FG000|Overall Study|Ongoing in study|190|||
130908942|NCT03519386|471301839|FG001|Overall Study|Ongoing in study|192|||
130908943|NCT03519386|471301840|FG002|Overall Study|Ongoing in study|183|||
130908944|NCT01222403|471301842|FG000|Overall Study|Inappropriate enrollment|0|||
130908945|NCT01222403|471301843|FG001|Overall Study|Inappropriate enrollment|2|||
130908946|NCT01028378|471301844|FG000|Overall Study|Lost to Follow-up|12|||
130908947|NCT01028378|471301844|FG000|Overall Study|Withdrawal by Subject|1|||
130908948|NCT01028378|471301844|FG000|Overall Study|Adminstrative Reasons|4|||
130908949|NCT01262352|471301845|FG000|Period 1|Illness after randomization|1|||
131029650|NCT02287311|471742193|FG007|Cohort 3: Dose Level 3|Death|0|||
131029651|NCT02287311|471742194|FG008|Cohort 3: Dose Level 3|Death|2|||
130696230|NCT01266902|470512519|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
130696231|NCT01266902|470512520|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
130696232|NCT01266902|470512518|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
131029652|NCT02287311|471742186|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
130696233|NCT01266902|470512519|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
130696234|NCT01266902|470512520|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
130908950|NCT01262352|471301846|FG001|Period 1|Illness after randomization|0|||
131029653|NCT02287311|471742187|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131029654|NCT02287311|471742188|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
131029655|NCT02287311|471742189|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131029656|NCT02287311|471742190|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131029657|NCT02287311|471742191|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
131029658|NCT02287311|471742192|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131029659|NCT02287311|471742193|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131029660|NCT02287311|471742194|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
131029661|NCT02287311|471742186|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131029662|NCT02287311|471742187|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131029663|NCT02287311|471742188|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
130696235|NCT00387153|470512521|FG000|Overall Study|Adverse Event|1|||
130908951|NCT01262352|471301845|FG000|Washout|Adverse Event|1|||
130908952|NCT01262352|471301846|FG001|Washout|Adverse Event|1|||
130908953|NCT01262352|471301845|FG000|Washout|Extended Washout|0|||
130908954|NCT01262352|471301846|FG001|Washout|Extended Washout|1|||
130908955|NCT01185834|471301850|FG000|Overall Study|Lost to Follow-up|2|||
130908956|NCT01185834|471301850|FG000|Overall Study|Discomfort|4|||
130908957|NCT01185834|471301850|FG000|Overall Study|Biomicroscopy|4|||
130908958|NCT01185834|471301850|FG000|Overall Study|Time/Job Conflict|2|||
130908959|NCT01185834|471301850|FG000|Overall Study|Early exit - Site error|2|||
130908960|NCT00887744|471301859|FG000|Overall Study|Adverse Event|3|||
130908961|NCT00887744|471301859|FG000|Overall Study|Death|1|||
130908962|NCT00887744|471301859|FG000|Overall Study|Lost to Follow-up|3|||
130908963|NCT00887744|471301859|FG000|Overall Study|Withdrawal by Subject|18|||
130908964|NCT00887744|471301859|FG000|Overall Study|Various reasons|9|||
130908965|NCT00450385|471301866|FG000|Overall Study|Death|3|||
130908966|NCT00450385|471301866|FG000|Overall Study|Protocol Violation|1|||
130908967|NCT00450385|471301866|FG000|Overall Study|Withdrawal by Subject|2|||
130908968|NCT00450385|471301866|FG000|Overall Study|Lack of Efficacy|2|||
130908969|NCT00450385|471301866|FG000|Overall Study|Adverse Event|1|||
130908970|NCT00450385|471301866|FG000|Overall Study|Physician Decision|1|||
130908971|NCT00450385|471301866|FG000|Overall Study|Other|3|||
130908972|NCT01390220|471301872|FG000|Test Dose Phase|Adverse Event|17|||
130908973|NCT01390220|471301873|FG001|Test Dose Phase|Adverse Event|0|||
130908974|NCT01390220|471301874|FG002|Test Dose Phase|Adverse Event|0|||
130908975|NCT01390220|471301872|FG000|Test Dose Phase|Withdrawal by Subject|8|||
130908976|NCT01390220|471301873|FG001|Test Dose Phase|Withdrawal by Subject|0|||
130908977|NCT01390220|471301874|FG002|Test Dose Phase|Withdrawal by Subject|0|||
130908978|NCT01390220|471301872|FG000|Test Dose Phase|Lost to Follow-up|2|||
130908979|NCT01390220|471301873|FG001|Test Dose Phase|Lost to Follow-up|0|||
130908980|NCT01390220|471301874|FG002|Test Dose Phase|Lost to Follow-up|0|||
130908981|NCT01390220|471301872|FG000|Test Dose Phase|Protocol Violation|8|||
130908982|NCT01390220|471301873|FG001|Test Dose Phase|Protocol Violation|0|||
130908983|NCT01390220|471301874|FG002|Test Dose Phase|Protocol Violation|0|||
130908984|NCT01390220|471301872|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
130908985|NCT01390220|471301873|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
130908986|NCT01390220|471301874|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
130908987|NCT01390220|471301872|FG000|Test Dose Phase|Study/Site closure|6|||
130908988|NCT01390220|471301873|FG001|Test Dose Phase|Study/Site closure|0|||
130908989|NCT01390220|471301874|FG002|Test Dose Phase|Study/Site closure|0|||
130908990|NCT01390220|471301872|FG000|Test Dose Phase|Caregiver no longer available|5|||
130908991|NCT01390220|471301873|FG001|Test Dose Phase|Caregiver no longer available|0|||
130908992|NCT01390220|471301874|FG002|Test Dose Phase|Caregiver no longer available|0|||
130908993|NCT01390220|471301872|FG000|Test Dose Phase|Noncompliance|2|||
130908994|NCT01390220|471301873|FG001|Test Dose Phase|Noncompliance|0|||
130908995|NCT01390220|471301874|FG002|Test Dose Phase|Noncompliance|0|||
130908996|NCT01390220|471301872|FG000|Test Dose Phase|Logistical|6|||
130908997|NCT01390220|471301873|FG001|Test Dose Phase|Logistical|0|||
130908998|NCT01390220|471301874|FG002|Test Dose Phase|Logistical|0|||
130908999|NCT01390220|471301872|FG000|Comparative Phase|Withdrawal by Subject|0|||
130909000|NCT01390220|471301873|FG001|Comparative Phase|Withdrawal by Subject|1|||
130909001|NCT01390220|471301874|FG002|Comparative Phase|Withdrawal by Subject|0|||
130909002|NCT01856023|471301875|FG000|Overall Study|Death|1|||
130909003|NCT01856023|471301876|FG001|Overall Study|Death|2|||
130909004|NCT01856023|471301875|FG000|Overall Study|Adverse Event|2|||
130909005|NCT01856023|471301876|FG001|Overall Study|Adverse Event|1|||
130909006|NCT01856023|471301875|FG000|Overall Study|Lack of Efficacy|5|||
130909007|NCT01856023|471301876|FG001|Overall Study|Lack of Efficacy|5|||
130909008|NCT01856023|471301875|FG000|Overall Study|non compliance, study closure|1|||
130909009|NCT01856023|471301876|FG001|Overall Study|non compliance, study closure|3|||
130909010|NCT01856023|471301875|FG000|Overall Study|Withdrawal by Subject|1|||
130909011|NCT01856023|471301876|FG001|Overall Study|Withdrawal by Subject|1|||
130909012|NCT00245583|471301879|FG000|Overall Study|Lost to Follow-up|1|||
130909013|NCT00245583|471301880|FG001|Overall Study|Lost to Follow-up|5|||
130909014|NCT00245583|471301879|FG000|Overall Study|Adverse Event|2|||
130909015|NCT00245583|471301880|FG001|Overall Study|Adverse Event|1|||
130909016|NCT00245583|471301879|FG000|Overall Study|Lack of Efficacy|1|||
130909017|NCT00245583|471301880|FG001|Overall Study|Lack of Efficacy|0|||
130909018|NCT00245583|471301879|FG000|Overall Study|Withdrawal by Subject|2|||
130909019|NCT00245583|471301880|FG001|Overall Study|Withdrawal by Subject|3|||
131115470|NCT00578786|472055468|FG000|Overall Study|Physician Decision|1|||
131115471|NCT00578786|472055469|FG001|Overall Study|Physician Decision|0|||
131115472|NCT00578786|472055470|FG002|Overall Study|Physician Decision|1|||
131115473|NCT00578786|472055468|FG000|Overall Study|Sponsor Decision|0|||
131115474|NCT00578786|472055469|FG001|Overall Study|Sponsor Decision|0|||
131115475|NCT00578786|472055470|FG002|Overall Study|Sponsor Decision|1|||
131115476|NCT00578786|472055468|FG000|Overall Study|Lost to Follow-up|0|||
131115477|NCT00578786|472055469|FG001|Overall Study|Lost to Follow-up|4|||
131115478|NCT00578786|472055470|FG002|Overall Study|Lost to Follow-up|0|||
130909020|NCT00829283|471301881|FG000|Overall Study|Lost to Follow-up|7|||
130909021|NCT00829283|471301882|FG001|Overall Study|Lost to Follow-up|25|||
130909022|NCT02414139|471301883|FG000|Treatment Period|Adverse Event|11|||
131222769|NCT00386100|472443175|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
130909023|NCT02414139|471301884|FG001|Treatment Period|Adverse Event|6|||
130909024|NCT02414139|471301885|FG002|Treatment Period|Adverse Event|8|||
130909025|NCT02414139|471301886|FG003|Treatment Period|Adverse Event|5|||
130909026|NCT02414139|471301887|FG004|Treatment Period|Adverse Event|14|||
130909027|NCT02414139|471301888|FG005|Treatment Period|Adverse Event|3|||
131115479|NCT00578786|472055468|FG000|Overall Study|Pregnancy|0|||
131115480|NCT00578786|472055469|FG001|Overall Study|Pregnancy|1|||
130696236|NCT00387153|470512521|FG000|Overall Study|Disease Progression|3|||
130696237|NCT00387153|470512521|FG000|Overall Study|Lack of Response|4|||
130696238|NCT01945580|470512524|FG000|Overall Study|Withdrawal by Subject|13|||
130696239|NCT01945580|470512525|FG001|Overall Study|Withdrawal by Subject|35|||
130909028|NCT02414139|471301889|FG006|Treatment Period|Adverse Event|6|||
130909029|NCT02414139|471301890|FG007|Treatment Period|Adverse Event|1|||
130909030|NCT02414139|471301891|FG008|Treatment Period|Adverse Event|6|||
130909031|NCT02414139|471301892|FG009|Treatment Period|Adverse Event|8|||
130909032|NCT02414139|471301883|FG000|Treatment Period|Death|0|||
130909033|NCT02414139|471301884|FG001|Treatment Period|Death|0|||
130909034|NCT02414139|471301885|FG002|Treatment Period|Death|1|||
130909035|NCT02414139|471301886|FG003|Treatment Period|Death|1|||
130909036|NCT02414139|471301887|FG004|Treatment Period|Death|0|||
130909037|NCT02414139|471301888|FG005|Treatment Period|Death|0|||
130909038|NCT02414139|471301889|FG006|Treatment Period|Death|0|||
130909039|NCT02414139|471301890|FG007|Treatment Period|Death|0|||
130909040|NCT02414139|471301891|FG008|Treatment Period|Death|0|||
130909041|NCT02414139|471301892|FG009|Treatment Period|Death|1|||
130909042|NCT02414139|471301883|FG000|Treatment Period|Physician Decision|5|||
130909043|NCT02414139|471301884|FG001|Treatment Period|Physician Decision|4|||
130909044|NCT02414139|471301885|FG002|Treatment Period|Physician Decision|6|||
130909045|NCT02414139|471301886|FG003|Treatment Period|Physician Decision|1|||
130909046|NCT02414139|471301887|FG004|Treatment Period|Physician Decision|4|||
130909047|NCT02414139|471301888|FG005|Treatment Period|Physician Decision|0|||
130909048|NCT02414139|471301889|FG006|Treatment Period|Physician Decision|2|||
130909049|NCT02414139|471301890|FG007|Treatment Period|Physician Decision|0|||
130909050|NCT02414139|471301891|FG008|Treatment Period|Physician Decision|1|||
130909051|NCT02414139|471301892|FG009|Treatment Period|Physician Decision|4|||
130909052|NCT02414139|471301883|FG000|Treatment Period|Progressive disease|48|||
130909053|NCT02414139|471301884|FG001|Treatment Period|Progressive disease|31|||
130909054|NCT02414139|471301885|FG002|Treatment Period|Progressive disease|37|||
131029664|NCT02287311|471742189|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131029665|NCT02287311|471742190|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131029666|NCT02287311|471742191|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
131029667|NCT02287311|471742192|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131029668|NCT02287311|471742193|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
131029669|NCT02287311|471742194|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
131029670|NCT05418296|471742199|FG000|Overall Study|Withdrawal by Subject|4|||
131029671|NCT05418296|471742200|FG001|Overall Study|Withdrawal by Subject|1|||
131029672|NCT01195831|471742205|FG000|Overall Study|Lost to Follow-up|2|||
131029673|NCT01195831|471742206|FG001|Overall Study|Lost to Follow-up|4|||
131029674|NCT01195831|471742205|FG000|Overall Study|Withdrawal by Subject|2|||
131029675|NCT01195831|471742206|FG001|Overall Study|Withdrawal by Subject|2|||
131029676|NCT01195831|471742205|FG000|Overall Study|Adverse Event|4|||
131029677|NCT01195831|471742206|FG001|Overall Study|Adverse Event|2|||
131029678|NCT01195831|471742205|FG000|Overall Study|Protocol Violation|0|||
131029679|NCT01195831|471742206|FG001|Overall Study|Protocol Violation|2|||
131029680|NCT04703322|471742207|FG000|Overall Study|Ongoing|8|||
131029681|NCT04703322|471742207|FG000|Overall Study|Withdrawal by Subject|1|||
131029682|NCT03713086|471742210|FG000|Overall Study|Withdrawal by Subject|0|||
131029683|NCT03713086|471742211|FG001|Overall Study|Withdrawal by Subject|2|||
131029684|NCT03713086|471742212|FG002|Overall Study|Withdrawal by Subject|1|||
131029685|NCT03713086|471742213|FG003|Overall Study|Withdrawal by Subject|0|||
131029686|NCT03713086|471742210|FG000|Overall Study|Lost to Follow-up|0|||
131029687|NCT03713086|471742211|FG001|Overall Study|Lost to Follow-up|1|||
131029688|NCT03713086|471742212|FG002|Overall Study|Lost to Follow-up|0|||
131029689|NCT03713086|471742213|FG003|Overall Study|Lost to Follow-up|1|||
131029690|NCT02312960|471742215|FG000|Overall Study|Death|24|||
131029691|NCT02312960|471742216|FG001|Overall Study|Death|32|||
131029692|NCT02312960|471742217|FG002|Overall Study|Death|25|||
131029693|NCT02312960|471742218|FG003|Overall Study|Death|11|||
131029694|NCT02312960|471742219|FG004|Overall Study|Death|5|||
131029695|NCT02312960|471742220|FG005|Overall Study|Death|5|||
131029696|NCT02312960|471742221|FG006|Overall Study|Death|8|||
131029697|NCT02312960|471742222|FG007|Overall Study|Death|5|||
131029698|NCT02312960|471742223|FG008|Overall Study|Death|7|||
131029699|NCT02312960|471742224|FG009|Overall Study|Death|3|||
131029700|NCT02312960|471742225|FG010|Overall Study|Death|3|||
131029701|NCT02312960|471742226|FG011|Overall Study|Death|1|||
131029702|NCT02312960|471742227|FG012|Overall Study|Death|25|||
130696240|NCT01945580|470512524|FG000|Overall Study|Physician Decision|3|||
130909055|NCT02414139|471301886|FG003|Treatment Period|Progressive disease|21|||
130909056|NCT02414139|471301887|FG004|Treatment Period|Progressive disease|43|||
130909057|NCT02414139|471301888|FG005|Treatment Period|Progressive disease|12|||
130909058|NCT02414139|471301889|FG006|Treatment Period|Progressive disease|16|||
131029703|NCT02312960|471742228|FG013|Overall Study|Death|19|||
131029704|NCT02312960|471742215|FG000|Overall Study|Missing|0|||
131029705|NCT02312960|471742216|FG001|Overall Study|Missing|0|||
131029706|NCT02312960|471742217|FG002|Overall Study|Missing|2|||
131029707|NCT02312960|471742218|FG003|Overall Study|Missing|0|||
130909059|NCT02414139|471301890|FG007|Treatment Period|Progressive disease|2|||
130909060|NCT02414139|471301891|FG008|Treatment Period|Progressive disease|20|||
130909061|NCT02414139|471301892|FG009|Treatment Period|Progressive disease|14|||
130909062|NCT02414139|471301883|FG000|Treatment Period|Protocol deviation|0|||
130909063|NCT02414139|471301884|FG001|Treatment Period|Protocol deviation|0|||
130909064|NCT02414139|471301885|FG002|Treatment Period|Protocol deviation|1|||
130909065|NCT02414139|471301886|FG003|Treatment Period|Protocol deviation|0|||
130909066|NCT02414139|471301887|FG004|Treatment Period|Protocol deviation|0|||
131115481|NCT00578786|472055470|FG002|Overall Study|Pregnancy|0|||
130909067|NCT02414139|471301888|FG005|Treatment Period|Protocol deviation|0|||
130909068|NCT02414139|471301889|FG006|Treatment Period|Protocol deviation|0|||
130909069|NCT02414139|471301890|FG007|Treatment Period|Protocol deviation|0|||
130909070|NCT02414139|471301891|FG008|Treatment Period|Protocol deviation|0|||
130909071|NCT02414139|471301892|FG009|Treatment Period|Protocol deviation|0|||
130909072|NCT02414139|471301883|FG000|Treatment Period|Subject/Guardian decision|5|||
130909073|NCT02414139|471301884|FG001|Treatment Period|Subject/Guardian decision|1|||
130909074|NCT02414139|471301885|FG002|Treatment Period|Subject/Guardian decision|1|||
130909075|NCT02414139|471301886|FG003|Treatment Period|Subject/Guardian decision|2|||
130909076|NCT02414139|471301887|FG004|Treatment Period|Subject/Guardian decision|5|||
130909077|NCT02414139|471301888|FG005|Treatment Period|Subject/Guardian decision|0|||
130909078|NCT02414139|471301889|FG006|Treatment Period|Subject/Guardian decision|2|||
130909079|NCT02414139|471301890|FG007|Treatment Period|Subject/Guardian decision|0|||
130909080|NCT02414139|471301891|FG008|Treatment Period|Subject/Guardian decision|1|||
130909081|NCT02414139|471301892|FG009|Treatment Period|Subject/Guardian decision|1|||
130909082|NCT02414139|471301883|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130909083|NCT02414139|471301884|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130909084|NCT02414139|471301885|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130909085|NCT02414139|471301886|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130909086|NCT02414139|471301887|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
130909087|NCT02414139|471301888|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130909088|NCT02414139|471301889|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
130909089|NCT02414139|471301890|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
130909090|NCT02414139|471301891|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
130909091|NCT02414139|471301892|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
130909092|NCT02414139|471301883|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
130909093|NCT02414139|471301884|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130909094|NCT02414139|471301885|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130909095|NCT02414139|471301886|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130909096|NCT02414139|471301887|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
131115482|NCT00578786|472055468|FG000|Overall Study|Not Otherwise Specified|0|||
131115483|NCT00578786|472055469|FG001|Overall Study|Not Otherwise Specified|4|||
131115484|NCT00578786|472055470|FG002|Overall Study|Not Otherwise Specified|1|||
131115485|NCT00578786|472055468|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
131115486|NCT00578786|472055469|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
131115487|NCT00578786|472055470|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
131115488|NCT00866723|472055471|FG000|Overall Study|Withdrawal by Subject|1|||
131115489|NCT00866723|472055471|FG000|Overall Study|Disease Progression|4|||
131115490|NCT01271803|472055472|FG000|Overall Study|Progressive disease|0|||
131115491|NCT01271803|472055473|FG001|Overall Study|Progressive disease|0|||
131115492|NCT01271803|472055474|FG002|Overall Study|Progressive disease|2|||
131115493|NCT01271803|472055472|FG000|Overall Study|Death|53|||
131115494|NCT01271803|472055473|FG001|Overall Study|Death|34|||
131115495|NCT01271803|472055474|FG002|Overall Study|Death|0|||
131115496|NCT01271803|472055472|FG000|Overall Study|Withdrawal by Subject|1|||
131115497|NCT01271803|472055473|FG001|Overall Study|Withdrawal by Subject|5|||
131115498|NCT01271803|472055474|FG002|Overall Study|Withdrawal by Subject|0|||
131115499|NCT01271803|472055472|FG000|Overall Study|Lost to Follow-up|1|||
131115500|NCT01271803|472055473|FG001|Overall Study|Lost to Follow-up|0|||
130909097|NCT02414139|471301888|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130909098|NCT02414139|471301889|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130909099|NCT02414139|471301890|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131115501|NCT01271803|472055474|FG002|Overall Study|Lost to Follow-up|0|||
131115502|NCT02178553|472055480|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
131115503|NCT02178553|472055481|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
131115504|NCT02178553|472055480|FG000|Overall Study|Physician Decision|0|||
131115505|NCT02178553|472055481|FG001|Overall Study|Physician Decision|4|||
131115506|NCT02178553|472055480|FG000|Overall Study|Technical problem with injection|1|||
131115507|NCT02178553|472055481|FG001|Overall Study|Technical problem with injection|3|||
131115508|NCT02187809|472055482|FG000|Overall Study|The study was terminated|3|||
131115509|NCT05085665|472055483|FG000|Overall Study|Physician Decision|2|||
131115510|NCT00778622|472055484|FG000|Overall Study|Adverse Event|5|||
131115511|NCT00778622|472055485|FG001|Overall Study|Adverse Event|4|||
130909100|NCT02414139|471301891|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130909101|NCT02414139|471301892|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130909102|NCT02414139|471301883|FG000|Post-treatment Efficacy Follow-up|Death|0|||
130909103|NCT02414139|471301884|FG001|Post-treatment Efficacy Follow-up|Death|1|||
130909104|NCT02414139|471301885|FG002|Post-treatment Efficacy Follow-up|Death|0|||
130909105|NCT02414139|471301886|FG003|Post-treatment Efficacy Follow-up|Death|0|||
130909106|NCT02414139|471301887|FG004|Post-treatment Efficacy Follow-up|Death|1|||
130909107|NCT02414139|471301888|FG005|Post-treatment Efficacy Follow-up|Death|0|||
130909108|NCT02414139|471301889|FG006|Post-treatment Efficacy Follow-up|Death|0|||
130909109|NCT02414139|471301890|FG007|Post-treatment Efficacy Follow-up|Death|0|||
130909110|NCT02414139|471301891|FG008|Post-treatment Efficacy Follow-up|Death|0|||
130909111|NCT02414139|471301892|FG009|Post-treatment Efficacy Follow-up|Death|1|||
130909112|NCT02414139|471301883|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
130909113|NCT02414139|471301884|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130909114|NCT02414139|471301885|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130909115|NCT02414139|471301886|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130909116|NCT02414139|471301887|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130909117|NCT02414139|471301888|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130909118|NCT02414139|471301889|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130909119|NCT02414139|471301890|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130909120|NCT02414139|471301891|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130909121|NCT02414139|471301892|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130909122|NCT02414139|471301883|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
130909123|NCT02414139|471301884|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
130909124|NCT02414139|471301885|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
130909125|NCT02414139|471301886|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
130909126|NCT02414139|471301887|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
130909127|NCT02414139|471301888|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
130909128|NCT02414139|471301889|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130909129|NCT02414139|471301890|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
130909130|NCT02414139|471301891|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
130909131|NCT02414139|471301892|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130909132|NCT02414139|471301883|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
130909133|NCT02414139|471301884|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
130909134|NCT02414139|471301885|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
130909135|NCT02414139|471301886|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
130909136|NCT02414139|471301887|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
130909137|NCT02414139|471301888|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
130909138|NCT02414139|471301889|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
130909139|NCT02414139|471301890|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
130909140|NCT02414139|471301891|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
130909141|NCT02414139|471301892|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
130909142|NCT02414139|471301883|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130909143|NCT02414139|471301884|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
130909144|NCT02414139|471301885|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130909145|NCT02414139|471301886|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130909146|NCT02414139|471301887|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130909147|NCT02414139|471301888|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130909148|NCT02414139|471301889|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130909149|NCT02414139|471301890|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130909150|NCT02414139|471301891|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130909151|NCT02414139|471301892|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
130909152|NCT02414139|471301883|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
130909153|NCT02414139|471301884|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
131029708|NCT02312960|471742219|FG004|Overall Study|Missing|0|||
131029709|NCT02312960|471742220|FG005|Overall Study|Missing|0|||
131029710|NCT02312960|471742221|FG006|Overall Study|Missing|0|||
131029711|NCT02312960|471742222|FG007|Overall Study|Missing|0|||
130696241|NCT01945580|470512525|FG001|Overall Study|Physician Decision|2|||
131029712|NCT02312960|471742223|FG008|Overall Study|Missing|0|||
131029713|NCT02312960|471742224|FG009|Overall Study|Missing|0|||
131029714|NCT02312960|471742225|FG010|Overall Study|Missing|0|||
131029715|NCT02312960|471742226|FG011|Overall Study|Missing|0|||
131029716|NCT02312960|471742227|FG012|Overall Study|Missing|0|||
131029717|NCT02312960|471742228|FG013|Overall Study|Missing|0|||
131029718|NCT02312960|471742215|FG000|Overall Study|Lost to Follow-up|0|||
131029719|NCT02312960|471742216|FG001|Overall Study|Lost to Follow-up|0|||
131029720|NCT02312960|471742217|FG002|Overall Study|Lost to Follow-up|1|||
131029721|NCT02312960|471742218|FG003|Overall Study|Lost to Follow-up|0|||
130909154|NCT02414139|471301885|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
130909155|NCT02414139|471301886|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
130909156|NCT02414139|471301887|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
130909157|NCT02414139|471301888|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
130909158|NCT02414139|471301889|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
130909159|NCT02414139|471301890|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
130909160|NCT02414139|471301891|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
130909161|NCT02414139|471301892|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130909162|NCT03631355|471301893|FG000|Overall Study|Lost to Follow-up|1|||
130909163|NCT03631355|471301894|FG001|Overall Study|Lost to Follow-up|2|||
130909164|NCT01369485|471301899|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
130909165|NCT01369485|471301900|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
130909166|NCT01369485|471301899|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
130909167|NCT01369485|471301900|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
130909168|NCT01369485|471301899|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
130909169|NCT01369485|471301900|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
130909170|NCT01369485|471301899|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
130909171|NCT01369485|471301900|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
130909172|NCT01369485|471301899|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
130909173|NCT01369485|471301900|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
130909174|NCT01369485|471301899|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
130909175|NCT01369485|471301900|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
130909176|NCT01369485|471301899|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
130909177|NCT01369485|471301900|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
130909178|NCT01369485|471301899|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
130909179|NCT01369485|471301900|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
130909180|NCT01369485|471301899|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
130909181|NCT01369485|471301900|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
130696242|NCT01945580|470512524|FG000|Overall Study|Lost to Follow-up|26|||
130909182|NCT01369485|471301899|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
130909183|NCT01369485|471301900|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
130909184|NCT04706416|471301905|FG000|Overall Study|Lost to Follow-up|2|||
130909185|NCT04706416|471301906|FG001|Overall Study|Lost to Follow-up|0|||
130909186|NCT02117427|471301914|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
130909187|NCT02117427|471301915|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
130909188|NCT02117427|471301916|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
130909189|NCT02117427|471301914|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
130909190|NCT02117427|471301915|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
130909191|NCT02117427|471301916|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
130909192|NCT02117427|471301914|FG000|Overall Study|Physician Decision|0|||
130909193|NCT02117427|471301915|FG001|Overall Study|Physician Decision|2|||
130909194|NCT02117427|471301916|FG002|Overall Study|Physician Decision|0|||
130909195|NCT02117427|471301914|FG000|Overall Study|No longer meets inclusion criteria|0|||
130909196|NCT02117427|471301915|FG001|Overall Study|No longer meets inclusion criteria|1|||
130909197|NCT02117427|471301916|FG002|Overall Study|No longer meets inclusion criteria|0|||
130909198|NCT02117427|471301914|FG000|Overall Study|Death|0|||
130909199|NCT02117427|471301915|FG001|Overall Study|Death|1|||
131029722|NCT02312960|471742219|FG004|Overall Study|Lost to Follow-up|0|||
131029723|NCT02312960|471742220|FG005|Overall Study|Lost to Follow-up|0|||
131029724|NCT02312960|471742221|FG006|Overall Study|Lost to Follow-up|1|||
131029725|NCT02312960|471742222|FG007|Overall Study|Lost to Follow-up|1|||
131029726|NCT02312960|471742223|FG008|Overall Study|Lost to Follow-up|0|||
131029727|NCT02312960|471742224|FG009|Overall Study|Lost to Follow-up|1|||
131029728|NCT02312960|471742225|FG010|Overall Study|Lost to Follow-up|0|||
131029729|NCT02312960|471742226|FG011|Overall Study|Lost to Follow-up|0|||
131029730|NCT02312960|471742227|FG012|Overall Study|Lost to Follow-up|1|||
131029731|NCT02312960|471742228|FG013|Overall Study|Lost to Follow-up|0|||
131029732|NCT02312960|471742215|FG000|Overall Study|Withdrawal by Subject|1|||
131029733|NCT02312960|471742216|FG001|Overall Study|Withdrawal by Subject|2|||
131029734|NCT02312960|471742217|FG002|Overall Study|Withdrawal by Subject|0|||
131029735|NCT02312960|471742218|FG003|Overall Study|Withdrawal by Subject|0|||
131029736|NCT02312960|471742219|FG004|Overall Study|Withdrawal by Subject|1|||
130696243|NCT01945580|470512525|FG001|Overall Study|Lost to Follow-up|39|||
130696244|NCT01945580|470512524|FG000|Overall Study|Death|7|||
130909200|NCT02117427|471301916|FG002|Overall Study|Death|0|||
131029737|NCT02312960|471742220|FG005|Overall Study|Withdrawal by Subject|0|||
130909201|NCT02730208|471301917|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
131029738|NCT02312960|471742221|FG006|Overall Study|Withdrawal by Subject|1|||
130909202|NCT02730208|471301918|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
131029739|NCT02312960|471742222|FG007|Overall Study|Withdrawal by Subject|2|||
131029740|NCT02312960|471742223|FG008|Overall Study|Withdrawal by Subject|2|||
131115512|NCT00778622|472055486|FG002|Overall Study|Adverse Event|7|||
131115513|NCT00778622|472055484|FG000|Overall Study|Withdrawal by Subject|4|||
131115514|NCT00778622|472055485|FG001|Overall Study|Withdrawal by Subject|5|||
131115515|NCT00778622|472055486|FG002|Overall Study|Withdrawal by Subject|5|||
131115516|NCT00778622|472055484|FG000|Overall Study|Lost to Follow-up|3|||
131115517|NCT00778622|472055485|FG001|Overall Study|Lost to Follow-up|3|||
131115518|NCT00778622|472055486|FG002|Overall Study|Lost to Follow-up|2|||
131115519|NCT00778622|472055484|FG000|Overall Study|Protocol Violation|0|||
131115520|NCT00778622|472055485|FG001|Overall Study|Protocol Violation|3|||
131115521|NCT00778622|472055486|FG002|Overall Study|Protocol Violation|0|||
131115522|NCT00778622|472055484|FG000|Overall Study|Lack of Efficacy|2|||
131115523|NCT00778622|472055485|FG001|Overall Study|Lack of Efficacy|0|||
131115524|NCT00778622|472055486|FG002|Overall Study|Lack of Efficacy|0|||
131115525|NCT00778622|472055484|FG000|Overall Study|immigration|1|||
131115526|NCT00778622|472055485|FG001|Overall Study|immigration|0|||
131115527|NCT00778622|472055486|FG002|Overall Study|immigration|0|||
131115528|NCT00778622|472055484|FG000|Overall Study|Other|1|||
131115529|NCT00778622|472055485|FG001|Overall Study|Other|0|||
131115530|NCT00778622|472055486|FG002|Overall Study|Other|1|||
131115531|NCT01251120|472055488|FG000|Overall Study|Lack of Efficacy|0|||
131115532|NCT01251120|472055489|FG001|Overall Study|Lack of Efficacy|1|||
131115533|NCT01822522|472055490|FG000|Overall Study|Adverse Event|1|||
131115534|NCT01822522|472055491|FG001|Overall Study|Adverse Event|1|||
131115535|NCT01822522|472055492|FG002|Overall Study|Adverse Event|1|||
131115536|NCT01822522|472055493|FG003|Overall Study|Adverse Event|0|||
131115537|NCT01822522|472055494|FG004|Overall Study|Adverse Event|0|||
131115538|NCT01822522|472055495|FG005|Overall Study|Adverse Event|1|||
131115539|NCT01822522|472055490|FG000|Overall Study|Death|3|||
131115540|NCT01822522|472055491|FG001|Overall Study|Death|0|||
131115541|NCT01822522|472055492|FG002|Overall Study|Death|2|||
131115542|NCT01822522|472055493|FG003|Overall Study|Death|0|||
131115543|NCT01822522|472055494|FG004|Overall Study|Death|0|||
131115544|NCT01822522|472055495|FG005|Overall Study|Death|0|||
131115545|NCT01822522|472055490|FG000|Overall Study|Lost to Follow-up|0|||
131115546|NCT01822522|472055491|FG001|Overall Study|Lost to Follow-up|0|||
131115547|NCT01822522|472055492|FG002|Overall Study|Lost to Follow-up|1|||
131115548|NCT01822522|472055493|FG003|Overall Study|Lost to Follow-up|1|||
131115549|NCT01822522|472055494|FG004|Overall Study|Lost to Follow-up|0|||
131115550|NCT01822522|472055495|FG005|Overall Study|Lost to Follow-up|1|||
131115551|NCT01822522|472055490|FG000|Overall Study|Withdrawal by Subject|0|||
131115552|NCT01822522|472055491|FG001|Overall Study|Withdrawal by Subject|0|||
131115553|NCT01822522|472055492|FG002|Overall Study|Withdrawal by Subject|0|||
131115554|NCT01822522|472055493|FG003|Overall Study|Withdrawal by Subject|1|||
131115555|NCT01822522|472055494|FG004|Overall Study|Withdrawal by Subject|0|||
131115556|NCT01822522|472055495|FG005|Overall Study|Withdrawal by Subject|0|||
131115557|NCT01822522|472055490|FG000|Overall Study|Lack of Efficacy|0|||
131115558|NCT01822522|472055491|FG001|Overall Study|Lack of Efficacy|0|||
131115559|NCT01822522|472055492|FG002|Overall Study|Lack of Efficacy|0|||
131115560|NCT01822522|472055493|FG003|Overall Study|Lack of Efficacy|0|||
131115561|NCT01822522|472055494|FG004|Overall Study|Lack of Efficacy|0|||
131115562|NCT01822522|472055495|FG005|Overall Study|Lack of Efficacy|2|||
131115563|NCT00890929|472055496|FG000|Overall Study|Death before treatment|2|||
131115564|NCT00890929|472055496|FG000|Overall Study|Withdrawal by Subject|3|||
131115565|NCT00890929|472055496|FG000|Overall Study|Physician Decision|1|||
131115566|NCT02558231|472055497|FG000|Overall Study|Death|4|||
131115567|NCT02558231|472055498|FG001|Overall Study|Death|12|||
131115568|NCT02558231|472055497|FG000|Overall Study|Lost to Follow-up|7|||
131115569|NCT02558231|472055498|FG001|Overall Study|Lost to Follow-up|4|||
131115570|NCT02558231|472055497|FG000|Overall Study|Withdrawal by Subject|7|||
131115571|NCT02558231|472055498|FG001|Overall Study|Withdrawal by Subject|4|||
131115572|NCT02558231|472055497|FG000|Overall Study|Physician Decision|7|||
131115573|NCT02558231|472055498|FG001|Overall Study|Physician Decision|5|||
131115574|NCT02558231|472055497|FG000|Overall Study|Sponsor Decision|0|||
131115575|NCT02558231|472055498|FG001|Overall Study|Sponsor Decision|1|||
131115576|NCT01006265|472055499|FG000|Overall Study|Lost to Follow-up|1|||
131115577|NCT01006265|472055500|FG001|Overall Study|Lost to Follow-up|0|||
131115578|NCT01006265|472055501|FG002|Overall Study|Lost to Follow-up|1|||
131115579|NCT01006265|472055502|FG003|Overall Study|Lost to Follow-up|0|||
131115580|NCT01006265|472055499|FG000|Overall Study|Withdrawal by Subject|4|||
131115581|NCT01006265|472055500|FG001|Overall Study|Withdrawal by Subject|7|||
131115582|NCT01006265|472055501|FG002|Overall Study|Withdrawal by Subject|5|||
131115583|NCT01006265|472055502|FG003|Overall Study|Withdrawal by Subject|5|||
131115584|NCT01006265|472055499|FG000|Overall Study|Administrative reason|1|||
131115585|NCT01006265|472055500|FG001|Overall Study|Administrative reason|2|||
131115586|NCT01006265|472055501|FG002|Overall Study|Administrative reason|3|||
131115587|NCT01006265|472055502|FG003|Overall Study|Administrative reason|0|||
131115588|NCT04233164|472055505|FG000|Overall Study|Unable to obtain specimen|0|||
131115589|NCT04233164|472055506|FG001|Overall Study|Unable to obtain specimen|1|||
131115590|NCT01840605|472055507|FG000|Overall Study|Adverse Event|0|||
131115591|NCT01840605|472055508|FG001|Overall Study|Adverse Event|1|||
130909203|NCT00510952|471301919|FG000|Overall Study|Adverse Event|1|||
131115592|NCT01840605|472055507|FG000|Overall Study|Physician Decision|2|||
131115593|NCT01840605|472055508|FG001|Overall Study|Physician Decision|1|||
131115594|NCT03065023|472055509|FG000|Overall Study|Progressive Disease|0|||
131115595|NCT03065023|472055510|FG001|Overall Study|Progressive Disease|1|||
131115596|NCT03065023|472055511|FG002|Overall Study|Progressive Disease|0|||
131115597|NCT03065023|472055512|FG003|Overall Study|Progressive Disease|0|||
131115598|NCT03065023|472055513|FG004|Overall Study|Progressive Disease|0|||
131115599|NCT03065023|472055509|FG000|Overall Study|Death|2|||
131115600|NCT03065023|472055510|FG001|Overall Study|Death|0|||
131115601|NCT03065023|472055511|FG002|Overall Study|Death|1|||
131115602|NCT03065023|472055512|FG003|Overall Study|Death|1|||
131115603|NCT03065023|472055513|FG004|Overall Study|Death|0|||
131115604|NCT03065023|472055509|FG000|Overall Study|Lost to Follow-up|0|||
130909204|NCT00510952|471301920|FG001|Overall Study|Adverse Event|0|||
130909205|NCT00510952|471301919|FG000|Overall Study|Entry Criteria Not Met|3|||
130909206|NCT00510952|471301920|FG001|Overall Study|Entry Criteria Not Met|1|||
130909207|NCT00510952|471301919|FG000|Overall Study|Lost to Follow-up|5|||
130909208|NCT00510952|471301920|FG001|Overall Study|Lost to Follow-up|3|||
130909209|NCT00510952|471301919|FG000|Overall Study|Physician Decision|1|||
130909210|NCT00510952|471301920|FG001|Overall Study|Physician Decision|1|||
130909211|NCT00510952|471301919|FG000|Overall Study|Protocol Violation|7|||
130909212|NCT00510952|471301920|FG001|Overall Study|Protocol Violation|4|||
130909213|NCT00510952|471301919|FG000|Overall Study|Sponsor Decision|1|||
130909214|NCT00510952|471301920|FG001|Overall Study|Sponsor Decision|0|||
130909215|NCT00510952|471301919|FG000|Overall Study|Withdrawal by Subject|6|||
130909216|NCT00510952|471301920|FG001|Overall Study|Withdrawal by Subject|7|||
130909217|NCT00510952|471301919|FG000|Overall Study|Did Not Receive Study Drug|2|||
130909218|NCT00510952|471301920|FG001|Overall Study|Did Not Receive Study Drug|0|||
130909219|NCT02793128|471301925|FG000|Overall Study|Death|4|||
130909220|NCT02793128|471301925|FG000|Overall Study|Withdrawal by Subject|2|||
130909221|NCT02793128|471301925|FG000|Overall Study|Physician Decision|1|||
130909222|NCT02793128|471301925|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
130909223|NCT02793128|471301925|FG000|Overall Study|Patient elected nephroureterectomy|1|||
130909224|NCT00055471|471301926|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
130909225|NCT00055471|471301927|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
130909226|NCT00055471|471301928|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
130909227|NCT00055471|471301926|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
130909228|NCT00055471|471301927|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
130909229|NCT00055471|471301928|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
130909230|NCT00055471|471301926|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
130909231|NCT00055471|471301927|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
130909232|NCT00055471|471301928|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
130909233|NCT04340063|471301929|FG000|Overall Study|Withdrawal by Subject|1|||
130909234|NCT04340063|471301930|FG001|Overall Study|Withdrawal by Subject|2|||
130909235|NCT04340063|471301929|FG000|Overall Study|Lost to Follow-up|3|||
130909236|NCT04340063|471301930|FG001|Overall Study|Lost to Follow-up|1|||
130909237|NCT04340063|471301929|FG000|Overall Study|Protocol Violation|0|||
130909238|NCT04340063|471301930|FG001|Overall Study|Protocol Violation|1|||
130909239|NCT01876810|471301931|FG000|Overall Study|Physician Decision|0|||
130909240|NCT01876810|471301932|FG001|Overall Study|Physician Decision|1|||
130909241|NCT00543855|471303214|FG000|Overall Study|Adverse Event|3|||
130909242|NCT00543855|471303215|FG001|Overall Study|Adverse Event|1|||
130909243|NCT00543855|471303216|FG002|Overall Study|Adverse Event|3|||
130909244|NCT00543855|471303217|FG003|Overall Study|Adverse Event|4|||
130909245|NCT00543855|471303214|FG000|Overall Study|Lost to Follow-up|0|||
130909246|NCT00543855|471303215|FG001|Overall Study|Lost to Follow-up|0|||
130909247|NCT00543855|471303216|FG002|Overall Study|Lost to Follow-up|1|||
130909248|NCT00543855|471303217|FG003|Overall Study|Lost to Follow-up|0|||
130909249|NCT00543855|471303214|FG000|Overall Study|Withdrawal by Subject|0|||
130909250|NCT00543855|471303215|FG001|Overall Study|Withdrawal by Subject|1|||
130909251|NCT00543855|471303216|FG002|Overall Study|Withdrawal by Subject|2|||
131115605|NCT03065023|472055510|FG001|Overall Study|Lost to Follow-up|1|||
131115606|NCT03065023|472055511|FG002|Overall Study|Lost to Follow-up|0|||
130909252|NCT00543855|471303217|FG003|Overall Study|Withdrawal by Subject|0|||
130909253|NCT00543855|471303214|FG000|Overall Study|Protocol Violation|1|||
130909254|NCT00543855|471303215|FG001|Overall Study|Protocol Violation|0|||
131115607|NCT03065023|472055512|FG003|Overall Study|Lost to Follow-up|0|||
130909255|NCT00543855|471303216|FG002|Overall Study|Protocol Violation|0|||
130909256|NCT00543855|471303217|FG003|Overall Study|Protocol Violation|0|||
130909257|NCT02582255|471303218|FG000|Overall Study|Protocol Violation|0|||
131115608|NCT03065023|472055513|FG004|Overall Study|Lost to Follow-up|0|||
131115609|NCT03065023|472055509|FG000|Overall Study|Participant Decision|0|||
131115610|NCT03065023|472055510|FG001|Overall Study|Participant Decision|0|||
131115611|NCT03065023|472055511|FG002|Overall Study|Participant Decision|0|||
130909258|NCT02582255|471303219|FG001|Overall Study|Protocol Violation|3|||
130909259|NCT05828095|471303224|FG000|Overall Study|Lost to Follow-up|1|||
131115612|NCT03065023|472055512|FG003|Overall Study|Participant Decision|1|||
130696245|NCT01945580|470512525|FG001|Overall Study|Death|2|||
130909260|NCT05828095|471303225|FG001|Overall Study|Lost to Follow-up|0|||
130909261|NCT05828095|471303224|FG000|Overall Study|Reactogenicity symptom|0|||
130909262|NCT05828095|471303225|FG001|Overall Study|Reactogenicity symptom|1|||
130909263|NCT03206073|471303226|FG000|Overall Study|Participant Noncompliance|0|||
130909264|NCT03206073|471303227|FG001|Overall Study|Participant Noncompliance|1|||
130909265|NCT03206073|471303228|FG002|Overall Study|Participant Noncompliance|0|||
130909266|NCT03206073|471303229|FG003|Overall Study|Participant Noncompliance|0|||
130909267|NCT03206073|471303226|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
130909268|NCT03206073|471303227|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
130909269|NCT03206073|471303228|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
130909270|NCT03206073|471303229|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
130909271|NCT03206073|471303226|FG000|Overall Study|Death|0|||
130909272|NCT03206073|471303227|FG001|Overall Study|Death|0|||
130909273|NCT03206073|471303228|FG002|Overall Study|Death|1|||
130909274|NCT03206073|471303229|FG003|Overall Study|Death|0|||
130909275|NCT03206073|471303226|FG000|Overall Study|Taken off active treatment|0|||
130909276|NCT03206073|471303227|FG001|Overall Study|Taken off active treatment|0|||
130909277|NCT03206073|471303228|FG002|Overall Study|Taken off active treatment|3|||
130909278|NCT03206073|471303229|FG003|Overall Study|Taken off active treatment|0|||
130909279|NCT03332771|471303230|FG000|Overall Study|Adverse Event|6|||
130909280|NCT03332771|471303231|FG001|Overall Study|Adverse Event|4|||
130909281|NCT03332771|471303232|FG002|Overall Study|Adverse Event|1|||
130909282|NCT03332771|471303233|FG003|Overall Study|Adverse Event|3|||
130909283|NCT03332771|471303230|FG000|Overall Study|Poor Compliance to Protocol|0|||
130909284|NCT03332771|471303231|FG001|Overall Study|Poor Compliance to Protocol|1|||
130909285|NCT03332771|471303232|FG002|Overall Study|Poor Compliance to Protocol|0|||
130909286|NCT03332771|471303233|FG003|Overall Study|Poor Compliance to Protocol|1|||
130909287|NCT03332771|471303230|FG000|Overall Study|Lost to Follow-up|2|||
130909288|NCT03332771|471303231|FG001|Overall Study|Lost to Follow-up|2|||
130909289|NCT03332771|471303232|FG002|Overall Study|Lost to Follow-up|1|||
130909290|NCT03332771|471303233|FG003|Overall Study|Lost to Follow-up|2|||
130909291|NCT03332771|471303230|FG000|Overall Study|At the Participant's own request|20|||
131029741|NCT02312960|471742224|FG009|Overall Study|Withdrawal by Subject|3|||
131029742|NCT02312960|471742225|FG010|Overall Study|Withdrawal by Subject|0|||
131029743|NCT02312960|471742226|FG011|Overall Study|Withdrawal by Subject|0|||
131029744|NCT02312960|471742227|FG012|Overall Study|Withdrawal by Subject|2|||
131029745|NCT02312960|471742228|FG013|Overall Study|Withdrawal by Subject|0|||
131029746|NCT02728076|471742229|FG000|Overall Study|Physician Decision|4|||
130696246|NCT01945580|470512524|FG000|Overall Study|Patient moved out of state|0|||
130909292|NCT03332771|471303231|FG001|Overall Study|At the Participant's own request|26|||
130909293|NCT03332771|471303232|FG002|Overall Study|At the Participant's own request|14|||
131029747|NCT05054374|471742230|FG000|Overall Study|Withdrawal by Subject|1|||
131029748|NCT05054374|471742231|FG001|Overall Study|Withdrawal by Subject|0|||
131029749|NCT05054374|471742232|FG002|Overall Study|Withdrawal by Subject|0|||
131029750|NCT05054374|471742233|FG003|Overall Study|Withdrawal by Subject|0|||
131029751|NCT05054374|471742230|FG000|Overall Study|Progressive Disease|5|||
131029752|NCT05054374|471742231|FG001|Overall Study|Progressive Disease|0|||
131029753|NCT05054374|471742232|FG002|Overall Study|Progressive Disease|0|||
131029754|NCT05054374|471742233|FG003|Overall Study|Progressive Disease|0|||
131029755|NCT03958955|471742235|FG000|Overall Study|Adverse Event|1|||
131029756|NCT04838262|471742236|FG000|Overall Study|Withdrawal by Subject|9|||
131029757|NCT04838262|471742237|FG001|Overall Study|Withdrawal by Subject|4|||
131029758|NCT04089371|471742246|FG000|Overall Study|Withdrawal by Subject|0|||
131029759|NCT04089371|471742247|FG001|Overall Study|Withdrawal by Subject|1|||
131029760|NCT04089371|471742246|FG000|Overall Study|Study terminated early|0|||
131029761|NCT04089371|471742247|FG001|Overall Study|Study terminated early|9|||
131029762|NCT04382898|471742248|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
131029763|NCT04382898|471742249|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
130909294|NCT03332771|471303233|FG003|Overall Study|At the Participant's own request|23|||
130909295|NCT03332771|471303230|FG000|Overall Study|Reason Not Specified|6|||
130909296|NCT03332771|471303231|FG001|Overall Study|Reason Not Specified|18|||
130909297|NCT03332771|471303232|FG002|Overall Study|Reason Not Specified|16|||
130909298|NCT03332771|471303233|FG003|Overall Study|Reason Not Specified|19|||
130909299|NCT00096954|471303234|FG000|Overall Study|Adverse Event|3|||
130909300|NCT00096954|471303235|FG001|Overall Study|Adverse Event|1|||
130909301|NCT00096954|471303234|FG000|Overall Study|Withdrawal by Subject|9|||
130909302|NCT00096954|471303235|FG001|Overall Study|Withdrawal by Subject|8|||
130909303|NCT00096954|471303234|FG000|Overall Study|Physician Decision|1|||
130909304|NCT00096954|471303235|FG001|Overall Study|Physician Decision|1|||
130909305|NCT00096954|471303234|FG000|Overall Study|Sponsors Decision|1|||
131029764|NCT04382898|471742250|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
131029765|NCT04382898|471742251|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
131029766|NCT04382898|471742252|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
131029767|NCT04382898|471742248|FG000|Part 1: Dose Titration|Death|6|||
131029768|NCT04382898|471742249|FG001|Part 1: Dose Titration|Death|0|||
130909306|NCT00096954|471303235|FG001|Overall Study|Sponsors Decision|1|||
130909307|NCT00096954|471303234|FG000|Overall Study|Pregnancy|1|||
130909308|NCT00096954|471303235|FG001|Overall Study|Pregnancy|1|||
130909309|NCT00096954|471303234|FG000|Overall Study|Initiation of immunotherapy|1|||
130909310|NCT00096954|471303235|FG001|Overall Study|Initiation of immunotherapy|0|||
130909311|NCT00096954|471303234|FG000|Overall Study|Non-compliance|0|||
130909312|NCT00096954|471303235|FG001|Overall Study|Non-compliance|3|||
130909313|NCT00096954|471303234|FG000|Overall Study|Lost to Follow-up|8|||
130909314|NCT00096954|471303235|FG001|Overall Study|Lost to Follow-up|5|||
130909315|NCT04533880|471303237|FG000|Overall Study|Lost to Follow-up|0|||
130909316|NCT04533880|471303238|FG001|Overall Study|Lost to Follow-up|1|||
130909317|NCT04533880|471303239|FG002|Overall Study|Lost to Follow-up|1|||
130909318|NCT01711879|471303244|FG000|Overall Study|Death|1|||
130909319|NCT01711879|471303245|FG001|Overall Study|Death|0|||
130909320|NCT02239224|471303248|FG000|Overall Study|Administrative|0|||
130909321|NCT02239224|471303249|FG001|Overall Study|Administrative|0|||
130909322|NCT02239224|471303250|FG002|Overall Study|Administrative|3|||
130909323|NCT02239224|471303251|FG003|Overall Study|Administrative|1|||
130909324|NCT03868124|471303253|FG000|Overall Study|Withdrawal by Subject|4|||
130909325|NCT03868124|471303254|FG001|Overall Study|Withdrawal by Subject|0|||
130909326|NCT03868124|471303255|FG002|Overall Study|Withdrawal by Subject|1|||
130909327|NCT03868124|471303253|FG000|Overall Study|Physician Decision|1|||
131115613|NCT03065023|472055513|FG004|Overall Study|Participant Decision|0|||
131115614|NCT03065023|472055509|FG000|Overall Study|Withdrawal by Subject|0|||
131115615|NCT03065023|472055510|FG001|Overall Study|Withdrawal by Subject|0|||
131115616|NCT03065023|472055511|FG002|Overall Study|Withdrawal by Subject|0|||
131115617|NCT03065023|472055512|FG003|Overall Study|Withdrawal by Subject|1|||
131115618|NCT03065023|472055513|FG004|Overall Study|Withdrawal by Subject|0|||
131115619|NCT04029961|472055514|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
131115620|NCT04029961|472055515|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
131115621|NCT04029961|472055514|FG000|Overall Study|Change in Treatment Course|0|||
131115622|NCT04029961|472055515|FG001|Overall Study|Change in Treatment Course|1|||
131115623|NCT03427125|472055516|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
131115624|NCT03427125|472055517|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
131115625|NCT03427125|472055518|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
131115626|NCT05975840|472055519|FG000|Overall Study|Other|1|||
131115627|NCT05975840|472055520|FG001|Overall Study|Other|0|||
130696247|NCT01945580|470512525|FG001|Overall Study|Patient moved out of state|1|||
130696248|NCT01945580|470512524|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
130696249|NCT01945580|470512525|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
130696250|NCT01945580|470512524|FG000|Overall Study|Family illness - unable to return|0|||
131115628|NCT05975840|472055521|FG002|Overall Study|Other|0|||
131115629|NCT05975840|472055522|FG003|Overall Study|Other|0|||
131115630|NCT05975840|472055523|FG004|Overall Study|Other|1|||
131115631|NCT05975840|472055524|FG005|Overall Study|Other|0|||
130696251|NCT01945580|470512525|FG001|Overall Study|Family illness - unable to return|1|||
131115632|NCT05975840|472055525|FG006|Overall Study|Other|0|||
131115633|NCT05975840|472055526|FG007|Overall Study|Other|0|||
131115634|NCT05975840|472055519|FG000|Overall Study|Lost to Follow-up|3|||
131115635|NCT05975840|472055520|FG001|Overall Study|Lost to Follow-up|6|||
131115636|NCT05975840|472055521|FG002|Overall Study|Lost to Follow-up|3|||
131115637|NCT05975840|472055522|FG003|Overall Study|Lost to Follow-up|1|||
131115638|NCT05975840|472055523|FG004|Overall Study|Lost to Follow-up|4|||
131115639|NCT05975840|472055524|FG005|Overall Study|Lost to Follow-up|1|||
131115640|NCT05975840|472055525|FG006|Overall Study|Lost to Follow-up|2|||
131115641|NCT05975840|472055526|FG007|Overall Study|Lost to Follow-up|4|||
131115642|NCT05975840|472055519|FG000|Overall Study|Migrated/moved from the study area|1|||
131115643|NCT05975840|472055520|FG001|Overall Study|Migrated/moved from the study area|0|||
131115644|NCT05975840|472055521|FG002|Overall Study|Migrated/moved from the study area|0|||
131115645|NCT05975840|472055522|FG003|Overall Study|Migrated/moved from the study area|0|||
131115646|NCT05975840|472055523|FG004|Overall Study|Migrated/moved from the study area|0|||
131115647|NCT05975840|472055524|FG005|Overall Study|Migrated/moved from the study area|0|||
131115648|NCT05975840|472055525|FG006|Overall Study|Migrated/moved from the study area|0|||
130909328|NCT03868124|471303254|FG001|Overall Study|Physician Decision|0|||
130909329|NCT03868124|471303255|FG002|Overall Study|Physician Decision|1|||
130909330|NCT03868124|471303253|FG000|Overall Study|Lost to Follow-up|1|||
130909331|NCT03868124|471303254|FG001|Overall Study|Lost to Follow-up|1|||
130696252|NCT01945580|470512524|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
130696253|NCT01945580|470512525|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
131115649|NCT05975840|472055526|FG007|Overall Study|Migrated/moved from the study area|0|||
130909332|NCT03868124|471303255|FG002|Overall Study|Lost to Follow-up|2|||
130909333|NCT03868124|471303253|FG000|Overall Study|Death|1|||
130909334|NCT03868124|471303254|FG001|Overall Study|Death|1|||
130696254|NCT01945580|470512524|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
130696255|NCT01945580|470512525|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
130696256|NCT01945580|470512524|FG000|Overall Study|Noncompliance with 36 month visit|1|||
130696257|NCT01945580|470512525|FG001|Overall Study|Noncompliance with 36 month visit|0|||
130696258|NCT01945580|470512524|FG000|Overall Study|The patient moved.|1|||
130696259|NCT01945580|470512525|FG001|Overall Study|The patient moved.|0|||
130696260|NCT01945580|470512524|FG000|Overall Study|No data available|0|||
130696261|NCT01945580|470512525|FG001|Overall Study|No data available|2|||
130696262|NCT05034874|470512528|FG000|Overall Study|Withdrawal by Subject|6|||
130909335|NCT03868124|471303255|FG002|Overall Study|Death|2|||
130909336|NCT03868124|471303253|FG000|Overall Study|Adverse Event|0|||
131029769|NCT04382898|471742250|FG002|Part 1: Dose Titration|Death|0|||
131029770|NCT04382898|471742251|FG003|Part 1: Dose Titration|Death|0|||
131029771|NCT04382898|471742252|FG004|Part 1: Dose Titration|Death|0|||
131029772|NCT04382898|471742248|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131029773|NCT04382898|471742249|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131029774|NCT04382898|471742250|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
131029775|NCT04382898|471742251|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131029776|NCT04382898|471742252|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131029777|NCT04382898|471742248|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
131029778|NCT04382898|471742249|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
131029779|NCT04382898|471742250|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
131029780|NCT04382898|471742251|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
131029781|NCT04382898|471742252|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
131029782|NCT04382898|471742248|FG000|Part 2: Dose Expansion|Death|0|||
131029783|NCT04382898|471742249|FG001|Part 2: Dose Expansion|Death|17|||
131029784|NCT04382898|471742250|FG002|Part 2: Dose Expansion|Death|13|||
131029785|NCT04382898|471742251|FG003|Part 2: Dose Expansion|Death|1|||
131029786|NCT04382898|471742252|FG004|Part 2: Dose Expansion|Death|0|||
131029787|NCT04382898|471742248|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
131029788|NCT04382898|471742249|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
131029789|NCT04382898|471742250|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
131029790|NCT04382898|471742251|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
131029791|NCT04382898|471742252|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
131029792|NCT04382898|471742248|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
131029793|NCT04382898|471742249|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
131029794|NCT04382898|471742250|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
131029795|NCT04382898|471742251|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
131029796|NCT04382898|471742252|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
131029797|NCT04382898|471742248|FG000|Part 2: Dose Expansion|Other|0|||
131029798|NCT04382898|471742249|FG001|Part 2: Dose Expansion|Other|0|||
131029799|NCT04382898|471742250|FG002|Part 2: Dose Expansion|Other|1|||
131029800|NCT04382898|471742251|FG003|Part 2: Dose Expansion|Other|0|||
131029801|NCT04382898|471742252|FG004|Part 2: Dose Expansion|Other|0|||
131029802|NCT03932682|471742253|FG000|Overall Study|Death|1|||
131029803|NCT03932682|471742254|FG001|Overall Study|Death|2|||
131029804|NCT03932682|471742253|FG000|Overall Study|Withdrawal by Subject|37|||
131029805|NCT03932682|471742254|FG001|Overall Study|Withdrawal by Subject|45|||
131029806|NCT03932682|471742253|FG000|Overall Study|Lost to Follow-up|19|||
131029807|NCT03932682|471742254|FG001|Overall Study|Lost to Follow-up|25|||
131029808|NCT03932682|471742253|FG000|Overall Study|Protocol Violation|0|||
131029809|NCT03932682|471742254|FG001|Overall Study|Protocol Violation|2|||
131029810|NCT03932682|471742253|FG000|Overall Study|Other|9|||
131029811|NCT03932682|471742254|FG001|Overall Study|Other|23|||
131029812|NCT02307565|471742256|FG000|Overall Study|Adverse Event|3|||
131029813|NCT02307565|471742257|FG001|Overall Study|Adverse Event|2|||
131029814|NCT02307565|471742256|FG000|Overall Study|Withdrawal by Subject|2|||
131029815|NCT02307565|471742257|FG001|Overall Study|Withdrawal by Subject|2|||
131029816|NCT04936035|471742264|FG000|Overall Study|Adverse Event|0|||
131029817|NCT04936035|471742265|FG001|Overall Study|Adverse Event|1|||
131029818|NCT04936035|471742266|FG002|Overall Study|Adverse Event|0|||
131029819|NCT04936035|471742267|FG003|Overall Study|Adverse Event|0|||
131029820|NCT04936035|471742268|FG004|Overall Study|Adverse Event|0|||
131029821|NCT04936035|471742264|FG000|Overall Study|Death|0|||
131029822|NCT04936035|471742265|FG001|Overall Study|Death|0|||
131029823|NCT04936035|471742266|FG002|Overall Study|Death|0|||
131029824|NCT04936035|471742267|FG003|Overall Study|Death|1|||
131029825|NCT04936035|471742268|FG004|Overall Study|Death|0|||
131029826|NCT04936035|471742264|FG000|Overall Study|Lost to Follow-up|0|||
131029827|NCT04936035|471742265|FG001|Overall Study|Lost to Follow-up|1|||
131029828|NCT04936035|471742266|FG002|Overall Study|Lost to Follow-up|1|||
130696263|NCT05034874|470512529|FG001|Overall Study|Withdrawal by Subject|6|||
131029829|NCT04936035|471742267|FG003|Overall Study|Lost to Follow-up|2|||
131029830|NCT04936035|471742268|FG004|Overall Study|Lost to Follow-up|1|||
130909337|NCT03868124|471303254|FG001|Overall Study|Adverse Event|0|||
131029831|NCT04936035|471742264|FG000|Overall Study|Physician Decision|0|||
131029832|NCT04936035|471742265|FG001|Overall Study|Physician Decision|1|||
130696264|NCT05034874|470512528|FG000|Overall Study|Lost to Follow-up|18|||
130696265|NCT05034874|470512529|FG001|Overall Study|Lost to Follow-up|8|||
130696266|NCT05034874|470512528|FG000|Overall Study|Physician Decision|0|||
130696267|NCT05034874|470512529|FG001|Overall Study|Physician Decision|1|||
130696268|NCT05034874|470512528|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
130909338|NCT03868124|471303255|FG002|Overall Study|Adverse Event|3|||
131029833|NCT04936035|471742266|FG002|Overall Study|Physician Decision|0|||
131029834|NCT04936035|471742267|FG003|Overall Study|Physician Decision|0|||
131029835|NCT04936035|471742268|FG004|Overall Study|Physician Decision|0|||
131029836|NCT04936035|471742264|FG000|Overall Study|Protocol Deviation|0|||
131029837|NCT04936035|471742265|FG001|Overall Study|Protocol Deviation|0|||
131029838|NCT04936035|471742266|FG002|Overall Study|Protocol Deviation|1|||
131029839|NCT04936035|471742267|FG003|Overall Study|Protocol Deviation|0|||
131029840|NCT04936035|471742268|FG004|Overall Study|Protocol Deviation|0|||
131029841|NCT04936035|471742264|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
131029842|NCT04936035|471742265|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
131029843|NCT04936035|471742266|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
131029844|NCT04936035|471742267|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
131029845|NCT04936035|471742268|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
131029846|NCT04936035|471742264|FG000|Overall Study|Reason Unknown|0|||
131029847|NCT04936035|471742265|FG001|Overall Study|Reason Unknown|0|||
131029848|NCT04936035|471742266|FG002|Overall Study|Reason Unknown|0|||
131029849|NCT04936035|471742267|FG003|Overall Study|Reason Unknown|0|||
131029850|NCT04936035|471742268|FG004|Overall Study|Reason Unknown|1|||
131029851|NCT04936035|471742264|FG000|Overall Study|Withdrawal by Subject|1|||
131029852|NCT04936035|471742265|FG001|Overall Study|Withdrawal by Subject|0|||
131029853|NCT04936035|471742266|FG002|Overall Study|Withdrawal by Subject|0|||
131029854|NCT04936035|471742267|FG003|Overall Study|Withdrawal by Subject|0|||
131029855|NCT04936035|471742268|FG004|Overall Study|Withdrawal by Subject|0|||
131029856|NCT04936035|471742264|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
131029857|NCT04936035|471742265|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
131029858|NCT04936035|471742266|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
131029859|NCT04936035|471742267|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
131029860|NCT04936035|471742268|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
131029861|NCT04936035|471742264|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
131029862|NCT04936035|471742265|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
131029863|NCT04936035|471742266|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
131029864|NCT04936035|471742267|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
131029865|NCT04936035|471742268|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
131029866|NCT04936035|471742264|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
131029867|NCT04936035|471742265|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
131029868|NCT04936035|471742266|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
131029869|NCT04936035|471742267|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
131029870|NCT04936035|471742268|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
131029871|NCT02811679|471742279|FG000|Overall Study|Adverse Event|1|||
131029872|NCT02811679|471742279|FG000|Overall Study|Lack of Efficacy|6|||
131029873|NCT02811679|471742279|FG000|Overall Study|Early study closure due to slow accrual|3|||
131029874|NCT05319860|471742281|FG000|Overall Study|Death|1|||
131029875|NCT05319860|471742282|FG001|Overall Study|Death|1|||
131029876|NCT05319860|471742281|FG000|Overall Study|Lost to Follow-up|3|||
131029877|NCT05319860|471742282|FG001|Overall Study|Lost to Follow-up|1|||
131029878|NCT05319860|471742281|FG000|Overall Study|Withdrawal by Subject|1|||
131029879|NCT05319860|471742282|FG001|Overall Study|Withdrawal by Subject|7|||
131029880|NCT04314895|471742283|FG000|Overall Study|Lost to Follow-up|1|||
131029881|NCT04314895|471742283|FG000|Overall Study|Death|10|||
131029882|NCT04314895|471742283|FG000|Overall Study|Physician Decision|2|||
131029883|NCT03941860|471742284|FG000|Overall Study|Withdrawal by Subject|0|||
131029884|NCT03941860|471742285|FG001|Overall Study|Withdrawal by Subject|1|||
131029885|NCT01361711|471742286|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
131029886|NCT01361711|471742286|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
131029887|NCT01361711|471742286|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
131029888|NCT01361711|471742286|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
131029889|NCT01361711|471742286|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
131029890|NCT01361711|471742286|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
131029891|NCT01361711|471742286|FG000|Completed Week 18 of Treatment|Other|9|||
131029892|NCT01361711|471742286|FG000|10 Year Follow-up|Still in follow-up|22|||
130909339|NCT03868124|471303253|FG000|Overall Study|Explanted|2|||
131115650|NCT05975840|472055519|FG000|Overall Study|Withdrawal by Subject|0|||
131115651|NCT05975840|472055520|FG001|Overall Study|Withdrawal by Subject|5|||
131115652|NCT05975840|472055521|FG002|Overall Study|Withdrawal by Subject|2|||
131115653|NCT05975840|472055522|FG003|Overall Study|Withdrawal by Subject|2|||
131115654|NCT05975840|472055523|FG004|Overall Study|Withdrawal by Subject|0|||
131115655|NCT05975840|472055524|FG005|Overall Study|Withdrawal by Subject|2|||
131115656|NCT05975840|472055525|FG006|Overall Study|Withdrawal by Subject|2|||
131115657|NCT05975840|472055526|FG007|Overall Study|Withdrawal by Subject|1|||
131115658|NCT05975840|472055519|FG000|Overall Study|Protocol Violation|0|||
131115659|NCT05975840|472055520|FG001|Overall Study|Protocol Violation|1|||
131115660|NCT05975840|472055521|FG002|Overall Study|Protocol Violation|0|||
131115661|NCT05975840|472055522|FG003|Overall Study|Protocol Violation|0|||
131115662|NCT05975840|472055523|FG004|Overall Study|Protocol Violation|0|||
131115663|NCT05975840|472055524|FG005|Overall Study|Protocol Violation|0|||
131115664|NCT05975840|472055525|FG006|Overall Study|Protocol Violation|0|||
131115665|NCT05975840|472055526|FG007|Overall Study|Protocol Violation|0|||
131115666|NCT05975840|472055519|FG000|Overall Study|Adverse Event|0|||
131115667|NCT05975840|472055520|FG001|Overall Study|Adverse Event|0|||
131115668|NCT05975840|472055521|FG002|Overall Study|Adverse Event|0|||
131115669|NCT05975840|472055522|FG003|Overall Study|Adverse Event|1|||
131115670|NCT05975840|472055523|FG004|Overall Study|Adverse Event|0|||
131115671|NCT05975840|472055524|FG005|Overall Study|Adverse Event|0|||
131115672|NCT05975840|472055525|FG006|Overall Study|Adverse Event|0|||
131115673|NCT05975840|472055526|FG007|Overall Study|Adverse Event|0|||
131115674|NCT05975840|472055519|FG000|Overall Study|Death|0|||
131115675|NCT05975840|472055520|FG001|Overall Study|Death|1|||
131115676|NCT05975840|472055521|FG002|Overall Study|Death|0|||
131115677|NCT05975840|472055522|FG003|Overall Study|Death|0|||
131115678|NCT05975840|472055523|FG004|Overall Study|Death|0|||
131115679|NCT05975840|472055524|FG005|Overall Study|Death|0|||
131115680|NCT05975840|472055525|FG006|Overall Study|Death|0|||
131115681|NCT05975840|472055526|FG007|Overall Study|Death|1|||
131115682|NCT04014361|472055529|FG000|Period 2|Physician Decision|0|||
131115683|NCT04014361|472055530|FG001|Period 2|Physician Decision|0|||
131115684|NCT04014361|472055531|FG002|Period 2|Physician Decision|0|||
131115685|NCT04014361|472055532|FG003|Period 2|Physician Decision|1|||
131115686|NCT04014361|472055533|FG004|Period 2|Physician Decision|0|||
131115687|NCT04014361|472055534|FG005|Period 2|Physician Decision|0|||
131115688|NCT04014361|472055535|FG006|Period 2|Physician Decision|0|||
131115689|NCT04014361|472055536|FG007|Period 2|Physician Decision|0|||
131115690|NCT02593786|472055538|FG000|Overall Study|Disease progression|12|||
131115691|NCT02593786|472055539|FG001|Overall Study|Disease progression|16|||
130696269|NCT05034874|470512529|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
130696270|NCT01867658|470512531|FG000|Overall Study|Withdrawal by Subject|6|||
130696271|NCT01867658|470512531|FG000|Overall Study|Death|2|||
130909340|NCT03868124|471303254|FG001|Overall Study|Explanted|1|||
131115692|NCT02593786|472055540|FG002|Overall Study|Disease progression|10|||
131115693|NCT02593786|472055541|FG003|Overall Study|Disease progression|7|||
131115694|NCT02593786|472055538|FG000|Overall Study|Study drug toxicity|1|||
131115695|NCT02593786|472055539|FG001|Overall Study|Study drug toxicity|0|||
131115696|NCT02593786|472055540|FG002|Overall Study|Study drug toxicity|0|||
131115697|NCT02593786|472055541|FG003|Overall Study|Study drug toxicity|0|||
131115698|NCT02593786|472055538|FG000|Overall Study|Adverse event unrelated to study drug|1|||
131115699|NCT02593786|472055539|FG001|Overall Study|Adverse event unrelated to study drug|1|||
131115700|NCT02593786|472055540|FG002|Overall Study|Adverse event unrelated to study drug|1|||
131115701|NCT02593786|472055541|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131115702|NCT02593786|472055538|FG000|Overall Study|Participant request to discontinue study therapy|0|||
131115703|NCT02593786|472055539|FG001|Overall Study|Participant request to discontinue study therapy|2|||
131115704|NCT02593786|472055540|FG002|Overall Study|Participant request to discontinue study therapy|0|||
131115705|NCT02593786|472055541|FG003|Overall Study|Participant request to discontinue study therapy|0|||
131115706|NCT02593786|472055538|FG000|Overall Study|Other reasons|1|||
131115707|NCT02593786|472055539|FG001|Overall Study|Other reasons|1|||
131115708|NCT02593786|472055540|FG002|Overall Study|Other reasons|0|||
131115709|NCT02593786|472055541|FG003|Overall Study|Other reasons|5|||
131115710|NCT01130051|472055542|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
131115711|NCT01130051|472055543|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
131115712|NCT01130051|472055542|FG000|Washout Period of 14 Days|Protocol Violation|1|||
131115713|NCT01130051|472055543|FG001|Washout Period of 14 Days|Protocol Violation|1|||
131115714|NCT04252287|472055547|FG000|Overall Study|Death|5|||
130696272|NCT01867658|470512531|FG000|Overall Study|Subject could not be contacted|1|||
130696273|NCT00840658|470512532|FG000|Overall Study|Death|2|||
130696274|NCT00840658|470512533|FG001|Overall Study|Death|2|||
131115715|NCT04252287|472055548|FG001|Overall Study|Death|3|||
131115716|NCT04252287|472055547|FG000|Overall Study|Lost to Follow-up|4|||
131115717|NCT04252287|472055548|FG001|Overall Study|Lost to Follow-up|6|||
131115718|NCT04252287|472055547|FG000|Overall Study|Withdrawal by Subject|19|||
131115719|NCT04252287|472055548|FG001|Overall Study|Withdrawal by Subject|16|||
130909341|NCT03868124|471303255|FG002|Overall Study|Explanted|0|||
131115720|NCT04252287|472055547|FG000|Overall Study|Protocol Violation|3|||
131115721|NCT04252287|472055548|FG001|Overall Study|Protocol Violation|4|||
131115722|NCT00835120|472055554|FG000|Overall Study|Lack of Efficacy|1|||
131115723|NCT00835120|472055554|FG000|Overall Study|Lost to Follow-up|3|||
131115724|NCT00835120|472055554|FG000|Overall Study|Adverse Event|2|||
131115725|NCT00835120|472055554|FG000|Overall Study|Withdrawal by Subject|2|||
131115726|NCT01298518|472055556|FG000|Overall Study|Withdrawal by Subject|0|||
131115727|NCT01298518|472055557|FG001|Overall Study|Withdrawal by Subject|0|||
131115728|NCT01298518|472055558|FG002|Overall Study|Withdrawal by Subject|1|||
131115729|NCT02273726|472055559|FG000|Overall Study|Death|70|||
131115730|NCT02273726|472055560|FG001|Overall Study|Death|62|||
131115731|NCT02273726|472055559|FG000|Overall Study|Withdrawal by Subject|41|||
131115732|NCT02273726|472055560|FG001|Overall Study|Withdrawal by Subject|29|||
131115733|NCT02273726|472055559|FG000|Overall Study|Kidney transplant|31|||
131115734|NCT02273726|472055560|FG001|Overall Study|Kidney transplant|39|||
131115735|NCT02273726|472055559|FG000|Overall Study|Physician Decision|30|||
131115736|NCT02273726|472055560|FG001|Overall Study|Physician Decision|15|||
131115737|NCT02273726|472055559|FG000|Overall Study|Adverse Event|27|||
131115738|NCT02273726|472055560|FG001|Overall Study|Adverse Event|9|||
131115739|NCT02273726|472055559|FG000|Overall Study|Lost to Follow-up|6|||
131115740|NCT02273726|472055560|FG001|Overall Study|Lost to Follow-up|3|||
131115741|NCT02273726|472055559|FG000|Overall Study|Lack of Efficacy|6|||
131115742|NCT02273726|472055560|FG001|Overall Study|Lack of Efficacy|1|||
131115743|NCT02273726|472055559|FG000|Overall Study|Protocol Violation|4|||
131115744|NCT02273726|472055560|FG001|Overall Study|Protocol Violation|0|||
131115745|NCT02273726|472055559|FG000|Overall Study|Other than specified|28|||
131115746|NCT02273726|472055560|FG001|Overall Study|Other than specified|30|||
131115747|NCT03610165|472055561|FG000|Overall Study|Device didn't work|0|||
131115748|NCT03610165|472055562|FG001|Overall Study|Device didn't work|1|||
131115749|NCT00671554|472055563|FG000|Overall Study|Disease progression|3|||
131115750|NCT02129205|472055564|FG000|Overall Study|Withdrawal by Subject|0|||
131115751|NCT02129205|472055565|FG001|Overall Study|Withdrawal by Subject|0|||
131115752|NCT02129205|472055566|FG002|Overall Study|Withdrawal by Subject|0|||
131115753|NCT02129205|472055567|FG003|Overall Study|Withdrawal by Subject|0|||
131115754|NCT02129205|472055568|FG004|Overall Study|Withdrawal by Subject|1|||
131115755|NCT02129205|472055569|FG005|Overall Study|Withdrawal by Subject|1|||
131115756|NCT02129205|472055570|FG006|Overall Study|Withdrawal by Subject|1|||
131115757|NCT02129205|472055571|FG007|Overall Study|Withdrawal by Subject|0|||
131115758|NCT02129205|472055572|FG008|Overall Study|Withdrawal by Subject|1|||
131115759|NCT02129205|472055573|FG009|Overall Study|Withdrawal by Subject|0|||
131115760|NCT02129205|472055564|FG000|Overall Study|Other|1|||
131115761|NCT02129205|472055565|FG001|Overall Study|Other|0|||
131115762|NCT02129205|472055566|FG002|Overall Study|Other|0|||
131115763|NCT02129205|472055567|FG003|Overall Study|Other|0|||
131115764|NCT02129205|472055568|FG004|Overall Study|Other|2|||
131115765|NCT02129205|472055569|FG005|Overall Study|Other|3|||
131115766|NCT02129205|472055570|FG006|Overall Study|Other|3|||
130696275|NCT00840658|470512534|FG002|Overall Study|Death|3|||
130696276|NCT00840658|470512535|FG003|Overall Study|Death|3|||
130696277|NCT00840658|470512532|FG000|Overall Study|Lost to Follow-up|3|||
130696278|NCT00840658|470512533|FG001|Overall Study|Lost to Follow-up|1|||
130696279|NCT00840658|470512534|FG002|Overall Study|Lost to Follow-up|2|||
130696280|NCT00840658|470512535|FG003|Overall Study|Lost to Follow-up|1|||
130696281|NCT02845336|470512540|FG000|Overall Study|Lost to Follow-up|3|||
130696282|NCT02845336|470512541|FG001|Overall Study|Lost to Follow-up|1|||
130696283|NCT02845336|470512540|FG000|Overall Study|Inability to get medication|2|||
130696284|NCT02845336|470512541|FG001|Overall Study|Inability to get medication|0|||
130696285|NCT02420353|470512548|FG000|Overall Study|Withdrawal by Subject|0|||
130696286|NCT02420353|470512549|FG001|Overall Study|Withdrawal by Subject|1|||
130696287|NCT01149057|470512550|FG000|Overall Study|Lack of Efficacy|16|||
130696288|NCT01149057|470512550|FG000|Overall Study|Adverse Event|13|||
130696289|NCT01149057|470512550|FG000|Overall Study|Withdrawal by Subject|9|||
131115767|NCT02129205|472055571|FG007|Overall Study|Other|2|||
130696290|NCT01149057|470512550|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
130696291|NCT01149057|470512550|FG000|Overall Study|B Cell Depletion|4|||
130696292|NCT01149057|470512550|FG000|Overall Study|Participant Non-Compliance|2|||
131115768|NCT02129205|472055572|FG008|Overall Study|Other|1|||
131115769|NCT02129205|472055573|FG009|Overall Study|Other|0|||
131115770|NCT02877927|472055574|FG000|Overall Study|Adverse Event|1|||
131115771|NCT02877927|472055575|FG001|Overall Study|Adverse Event|0|||
130696293|NCT01149057|470512550|FG000|Overall Study|Lost to Follow-up|1|||
130696294|NCT01149057|470512550|FG000|Overall Study|High Parathyroid Hormone Value|1|||
130696295|NCT01149057|470512550|FG000|Overall Study|Other|6|||
130696296|NCT04608448|470512551|FG000|Overall Study|Withdrawal by Subject|1|||
131115772|NCT02877927|472055574|FG000|Overall Study|Lost to Follow-up|37|||
131115773|NCT02877927|472055575|FG001|Overall Study|Lost to Follow-up|38|||
131115774|NCT02877927|472055574|FG000|Overall Study|Withdrawal by Subject|11|||
131115775|NCT02877927|472055575|FG001|Overall Study|Withdrawal by Subject|12|||
131115776|NCT02877927|472055574|FG000|Overall Study|Physician Decision|0|||
131115777|NCT02877927|472055575|FG001|Overall Study|Physician Decision|1|||
130909342|NCT03868124|471303253|FG000|Overall Study|Ongoing in study|176|||
131115778|NCT02877927|472055574|FG000|Overall Study|Missed EOT/PTE Visit|5|||
131115779|NCT02877927|472055575|FG001|Overall Study|Missed EOT/PTE Visit|6|||
131115780|NCT01810016|472055576|FG000|Overall Study|Progressive disease|1|||
131115781|NCT01810016|472055577|FG001|Overall Study|Progressive disease|1|||
131115782|NCT01810016|472055578|FG002|Overall Study|Progressive disease|0|||
131115783|NCT01810016|472055576|FG000|Overall Study|Death|0|||
131115784|NCT01810016|472055577|FG001|Overall Study|Death|0|||
131115785|NCT01810016|472055578|FG002|Overall Study|Death|1|||
131115786|NCT00708175|472055579|FG000|Overall Study|Adverse Event|4|||
131115787|NCT00708175|472055580|FG001|Overall Study|Adverse Event|5|||
131115788|NCT00708175|472055579|FG000|Overall Study|Protocol Violation|2|||
131115789|NCT00708175|472055580|FG001|Overall Study|Protocol Violation|3|||
131115790|NCT00708175|472055579|FG000|Overall Study|Lost to Follow-up|5|||
130909343|NCT03868124|471303254|FG001|Overall Study|Ongoing in study|180|||
130909344|NCT03868124|471303255|FG002|Overall Study|Ongoing in study|183|||
130909345|NCT04177355|471303256|FG000|Overall Study|Lost to Follow-up|0|||
130909346|NCT04177355|471303257|FG001|Overall Study|Lost to Follow-up|2|||
130909347|NCT04177355|471303258|FG002|Overall Study|Lost to Follow-up|0|||
130909348|NCT04177355|471303259|FG003|Overall Study|Lost to Follow-up|1|||
130909349|NCT04177355|471303260|FG004|Overall Study|Lost to Follow-up|2|||
130909350|NCT04177355|471303261|FG005|Overall Study|Lost to Follow-up|0|||
130909351|NCT04177355|471303262|FG006|Overall Study|Lost to Follow-up|1|||
130909352|NCT04177355|471303263|FG007|Overall Study|Lost to Follow-up|0|||
130909353|NCT04177355|471303264|FG008|Overall Study|Lost to Follow-up|0|||
131115791|NCT00708175|472055580|FG001|Overall Study|Lost to Follow-up|3|||
131115792|NCT00708175|472055579|FG000|Overall Study|Withdrawal by Subject|5|||
131115793|NCT00708175|472055580|FG001|Overall Study|Withdrawal by Subject|7|||
131115794|NCT00708175|472055579|FG000|Overall Study|BMD loss >7%|2|||
131115795|NCT00708175|472055580|FG001|Overall Study|BMD loss >7%|3|||
131115796|NCT04435782|472055588|FG000|Overall Study|Study terminated by sponsor|4|||
131115797|NCT06950879|472055592|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
131115798|NCT00594516|472057504|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
131115799|NCT00594516|472057505|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
131115800|NCT00594516|472057506|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
131115801|NCT00594516|472057504|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
131115802|NCT00594516|472057505|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
131115803|NCT00594516|472057506|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
131115804|NCT00594516|472057504|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
131115805|NCT00594516|472057505|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
131115806|NCT00594516|472057506|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
131115807|NCT00594516|472057504|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
131115808|NCT00594516|472057505|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
131115809|NCT00594516|472057506|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
131115810|NCT00594516|472057504|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
131115811|NCT00594516|472057505|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
131115812|NCT00594516|472057506|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
131115813|NCT00594516|472057504|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
131115814|NCT00594516|472057505|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
131115815|NCT00594516|472057506|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
131115816|NCT00594516|472057504|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
131115817|NCT00594516|472057505|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
131115818|NCT00594516|472057506|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
131115819|NCT00594516|472057504|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
131115820|NCT00594516|472057505|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
131115821|NCT00594516|472057506|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
131115822|NCT00594516|472057504|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
131115823|NCT00594516|472057505|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
131115824|NCT00594516|472057506|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
131115825|NCT02462928|472057507|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
131115826|NCT02462928|472057508|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
131115827|NCT02462928|472057509|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
131115828|NCT02462928|472057507|FG000|Overall Study|Adverse Event|47|||
130696297|NCT04608448|470512551|FG000|Overall Study|Adverse Event|1|||
131115829|NCT02462928|472057508|FG001|Overall Study|Adverse Event|51|||
131115830|NCT02462928|472057509|FG002|Overall Study|Adverse Event|25|||
131115831|NCT02462928|472057507|FG000|Overall Study|Lack of Efficacy|3|||
131115832|NCT02462928|472057508|FG001|Overall Study|Lack of Efficacy|8|||
131115833|NCT02462928|472057509|FG002|Overall Study|Lack of Efficacy|3|||
131115834|NCT02462928|472057507|FG000|Overall Study|Lost to Follow-up|4|||
130909354|NCT04177355|471303265|FG009|Overall Study|Lost to Follow-up|0|||
130909355|NCT04177355|471303266|FG010|Overall Study|Lost to Follow-up|0|||
130909356|NCT04177355|471303256|FG000|Overall Study|Withdrawal by Subject|0|||
130909357|NCT04177355|471303257|FG001|Overall Study|Withdrawal by Subject|0|||
130909358|NCT04177355|471303258|FG002|Overall Study|Withdrawal by Subject|0|||
131115835|NCT02462928|472057508|FG001|Overall Study|Lost to Follow-up|4|||
131115836|NCT02462928|472057509|FG002|Overall Study|Lost to Follow-up|1|||
131115837|NCT02462928|472057507|FG000|Overall Study|Withdrawal by Patient|31|||
131115838|NCT02462928|472057508|FG001|Overall Study|Withdrawal by Patient|21|||
131115839|NCT02462928|472057509|FG002|Overall Study|Withdrawal by Patient|21|||
131115840|NCT02462928|472057507|FG000|Overall Study|Protocol Violation|0|||
131115841|NCT02462928|472057508|FG001|Overall Study|Protocol Violation|1|||
131115842|NCT02462928|472057509|FG002|Overall Study|Protocol Violation|0|||
131115843|NCT02462928|472057507|FG000|Overall Study|Reason not Specified|4|||
131115844|NCT02462928|472057508|FG001|Overall Study|Reason not Specified|6|||
131115845|NCT02462928|472057509|FG002|Overall Study|Reason not Specified|5|||
131115846|NCT01493557|472057510|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
131115847|NCT01493557|472057511|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
131115848|NCT01493557|472057512|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
131115849|NCT01493557|472057510|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
131115850|NCT01493557|472057511|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
131115851|NCT01493557|472057512|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
131115852|NCT01493557|472057510|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
131115853|NCT01493557|472057511|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
131115854|NCT01493557|472057512|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
131115855|NCT01493557|472057510|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
131115856|NCT01493557|472057511|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
131115857|NCT01493557|472057512|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
131115858|NCT01493557|472057510|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
131115859|NCT01493557|472057511|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
131115860|NCT01493557|472057512|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
131115861|NCT01493557|472057510|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
131115862|NCT01493557|472057511|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
131115863|NCT01493557|472057512|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
131115864|NCT01493557|472057510|FG000|Not Randomized to Management Strategies|Early termination|0|||
131115865|NCT01493557|472057511|FG001|Not Randomized to Management Strategies|Early termination|0|||
131115866|NCT01493557|472057512|FG002|Not Randomized to Management Strategies|Early termination|34|||
131115867|NCT01493557|472057510|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
131115868|NCT01493557|472057511|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
131115869|NCT01493557|472057512|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
131115870|NCT01493557|472057510|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
131115871|NCT01493557|472057511|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
131115872|NCT01493557|472057512|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
131115873|NCT01493557|472057510|FG000|Randomized to Management Strategies|Other adverse event|8|||
131115874|NCT01493557|472057511|FG001|Randomized to Management Strategies|Other adverse event|5|||
131115875|NCT01493557|472057512|FG002|Randomized to Management Strategies|Other adverse event|0|||
131115876|NCT01493557|472057510|FG000|Randomized to Management Strategies|Protocol Violation|3|||
131115877|NCT01493557|472057511|FG001|Randomized to Management Strategies|Protocol Violation|0|||
131115878|NCT01493557|472057512|FG002|Randomized to Management Strategies|Protocol Violation|0|||
131115879|NCT01493557|472057510|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
131115880|NCT01493557|472057511|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
131115881|NCT01493557|472057512|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
131115882|NCT01493557|472057510|FG000|Randomized to Management Strategies|Other than stated above|1|||
131115883|NCT01493557|472057511|FG001|Randomized to Management Strategies|Other than stated above|3|||
131115884|NCT01493557|472057512|FG002|Randomized to Management Strategies|Other than stated above|0|||
131115885|NCT01493557|472057510|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
131115886|NCT01493557|472057511|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
131115887|NCT01493557|472057512|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
131115888|NCT01493557|472057510|FG000|Adding the Second Strategy|Other adverse event|1|||
131115889|NCT01493557|472057511|FG001|Adding the Second Strategy|Other adverse event|2|||
130909359|NCT04177355|471303259|FG003|Overall Study|Withdrawal by Subject|1|||
130909360|NCT04177355|471303260|FG004|Overall Study|Withdrawal by Subject|1|||
130909361|NCT04177355|471303261|FG005|Overall Study|Withdrawal by Subject|0|||
130909362|NCT04177355|471303262|FG006|Overall Study|Withdrawal by Subject|0|||
130909363|NCT04177355|471303263|FG007|Overall Study|Withdrawal by Subject|0|||
130909364|NCT04177355|471303264|FG008|Overall Study|Withdrawal by Subject|1|||
130909365|NCT04177355|471303265|FG009|Overall Study|Withdrawal by Subject|0|||
130909366|NCT04177355|471303266|FG010|Overall Study|Withdrawal by Subject|0|||
130909367|NCT00433511|471303267|FG000|Step 1|Adverse Event|50|||
130768681|NCT03959488|470778555|FG002|Season 1|Due to COVID-19 pandemic|0|||
131115890|NCT01493557|472057512|FG002|Adding the Second Strategy|Other adverse event|0|||
131115891|NCT01493557|472057510|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
131115892|NCT01493557|472057511|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
131115893|NCT01493557|472057512|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
131115894|NCT01890148|472057525|FG000|Overall Study|Adverse Event|1|||
131115895|NCT01678209|472057526|FG000|Overall Study|could not scan twice|1|||
131115896|NCT01678209|472057527|FG001|Overall Study|could not scan twice|1|||
131115897|NCT01678209|472057528|FG002|Overall Study|could not scan twice|1|||
131115898|NCT01678209|472057526|FG000|Overall Study|scheduling conflicts|0|||
131115899|NCT01678209|472057527|FG001|Overall Study|scheduling conflicts|0|||
131115900|NCT01678209|472057528|FG002|Overall Study|scheduling conflicts|1|||
131115901|NCT01678209|472057526|FG000|Overall Study|screen fail|16|||
131115902|NCT01678209|472057527|FG001|Overall Study|screen fail|17|||
131115903|NCT01678209|472057528|FG002|Overall Study|screen fail|16|||
131115904|NCT00702845|472057529|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
131115905|NCT00702845|472057530|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
131115906|NCT00702845|472057529|FG000|Overall Study|Too high ovarian response|5|||
131115907|NCT00702845|472057530|FG001|Overall Study|Too high ovarian response|1|||
131115908|NCT00702845|472057529|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
131115909|NCT00702845|472057530|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
131115910|NCT00702845|472057529|FG000|Overall Study|Insufficient ovarian response|1|||
131115911|NCT00702845|472057530|FG001|Overall Study|Insufficient ovarian response|0|||
131115912|NCT00702845|472057529|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
131115913|NCT00702845|472057530|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
131115914|NCT00702845|472057529|FG000|Overall Study|No or abnormal fertilization|4|||
131115915|NCT00702845|472057530|FG001|Overall Study|No or abnormal fertilization|2|||
131115916|NCT00702845|472057529|FG000|Overall Study|Patient's decision|2|||
131115917|NCT00702845|472057530|FG001|Overall Study|Patient's decision|1|||
131115918|NCT00702845|472057529|FG000|Overall Study|Not randomized|0|||
131115919|NCT00702845|472057530|FG001|Overall Study|Not randomized|1|||
131115920|NCT02973425|472057534|FG000|Overall Study|Lost to Follow-up|49|||
131115921|NCT02973425|472057535|FG001|Overall Study|Lost to Follow-up|53|||
131115922|NCT03876171|472057536|FG000|Overall Study|Withdrawal by Subject|3|||
131115923|NCT03876171|472057537|FG001|Overall Study|Withdrawal by Subject|3|||
131115924|NCT03876171|472057536|FG000|Overall Study|Re-arrest|0|||
131115925|NCT03876171|472057537|FG001|Overall Study|Re-arrest|4|||
131115926|NCT03503513|472057542|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
131115927|NCT03503513|472057542|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
131115928|NCT03503513|472057542|FG000|Overall Study|Physician Decision|3|||
131115929|NCT03503513|472057542|FG000|Overall Study|Withdrawal by Subject|2|||
131115930|NCT03503513|472057542|FG000|Overall Study|Lost to Follow-up|1|||
131115931|NCT00929656|472057543|FG000|Overall Study|Lost to Follow-up|0|||
131115932|NCT00929656|472057544|FG001|Overall Study|Lost to Follow-up|1|||
131115933|NCT00607880|472057545|FG000|Overall Study|Unable to place port due to occlusion|1|||
131115934|NCT00607880|472057546|FG001|Overall Study|Unable to place port due to occlusion|0|||
131115935|NCT01170039|472057547|FG000|Overall Study|Withdrawal by Subject|5|||
131115936|NCT01170039|472057548|FG001|Overall Study|Withdrawal by Subject|3|||
131115937|NCT01170039|472057547|FG000|Overall Study|Lack of funding, drug not available|3|||
131115938|NCT01170039|472057548|FG001|Overall Study|Lack of funding, drug not available|3|||
131115939|NCT00908583|472057549|FG000|Phase 1|Withdrawal by Subject|1|||
131115940|NCT00908583|472057549|FG000|Phase 1|Adverse Event|4|||
131115941|NCT00908583|472057549|FG000|Phase 2|Physician Decision|1|||
131115942|NCT00908583|472057549|FG000|Phase 2|Adverse Event|1|||
131115943|NCT00908583|472057549|FG000|Phase 3|Adverse Event|2|||
131115944|NCT00908583|472057549|FG000|Phase 4|Adverse Event|1|||
131115945|NCT00908583|472057549|FG000|Phase 4|Physician Decision|1|||
131115946|NCT00908583|472057549|FG000|Phase 5|Adverse Event|3|||
131115947|NCT00993954|472057550|FG000|Overall Study|Protocol Violation|21|||
131115948|NCT00993954|472057551|FG001|Overall Study|Protocol Violation|2|||
131115949|NCT00860951|472057552|FG000|Overall Study|Withdrawal by Subject|2|||
131115950|NCT00860951|472057552|FG000|Overall Study|Lost to Follow-up|5|||
131115951|NCT00727649|472057553|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
131115952|NCT00727649|472057554|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
131115953|NCT00727649|472057553|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
131115954|NCT00727649|472057554|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
131115955|NCT00727649|472057553|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
131115956|NCT00727649|472057554|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
131115957|NCT00727649|472057553|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
131115958|NCT00727649|472057554|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
131115959|NCT00727649|472057553|FG000|Second Intervention (4-weeks)|Death|1|||
131115960|NCT00727649|472057554|FG001|Second Intervention (4-weeks)|Death|0|||
131115961|NCT00727649|472057553|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
131115962|NCT00727649|472057554|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
131115963|NCT00727649|472057553|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
131115964|NCT00727649|472057554|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
131115965|NCT03823404|472057556|FG000|Overall Study|Lost to Follow-up|1|||
131115966|NCT03823404|472057557|FG001|Overall Study|Lost to Follow-up|2|||
131115967|NCT03823404|472057558|FG002|Overall Study|Lost to Follow-up|3|||
130696298|NCT00654186|470512552|FG000|Overall Study|Withdrawal by Subject|5|||
131029893|NCT01361711|471742286|FG000|10 Year Follow-up|Death|7|||
131029894|NCT01361711|471742286|FG000|10 Year Follow-up|Developed new cancer|1|||
131029895|NCT01361711|471742286|FG000|10 Year Follow-up|Lost to Follow-up|2|||
131029896|NCT01361711|471742286|FG000|10 Year Follow-up|New treatment started|6|||
131029897|NCT01361711|471742286|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
131029898|NCT01361711|471742286|FG000|10 Year Follow-up|Progressive Disease|1|||
131029899|NCT02596126|471742287|FG000|Overall Study|Lost to Follow-up|12|||
131029900|NCT02596126|471742288|FG001|Overall Study|Lost to Follow-up|21|||
131029901|NCT02596126|471742287|FG000|Overall Study|Protocol Violation|7|||
131029902|NCT02596126|471742288|FG001|Overall Study|Protocol Violation|9|||
131029903|NCT03396588|471742289|FG000|Overall Study|Physician Decision|2|||
131029904|NCT03396588|471742290|FG001|Overall Study|Physician Decision|3|||
131029905|NCT05179395|471742291|FG000|Overall Study|Lack of Efficacy|1|||
131029906|NCT00812461|471742292|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
131029907|NCT00812461|471742293|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
131029908|NCT00812461|471742292|FG000|All Treated Patients|Adverse Event|8|||
131029909|NCT00812461|471742293|FG001|All Treated Patients|Adverse Event|15|||
131029910|NCT00812461|471742292|FG000|All Treated Patients|Lack of Efficacy|13|||
131029911|NCT00812461|471742293|FG001|All Treated Patients|Lack of Efficacy|7|||
131029912|NCT00812461|471742292|FG000|All Treated Patients|Non-compliance|6|||
131029913|NCT00812461|471742293|FG001|All Treated Patients|Non-compliance|9|||
131029914|NCT00812461|471742292|FG000|All Treated Patients|Protocol Violation|36|||
131029915|NCT00812461|471742293|FG001|All Treated Patients|Protocol Violation|27|||
131029916|NCT00812461|471742292|FG000|All Treated Patients|Withdrawal by Subject|45|||
131029917|NCT00812461|471742293|FG001|All Treated Patients|Withdrawal by Subject|54|||
131029918|NCT00812461|471742292|FG000|All Treated Patients|Lost to Follow-up|11|||
131029919|NCT00812461|471742293|FG001|All Treated Patients|Lost to Follow-up|14|||
131029920|NCT00812461|471742292|FG000|All Treated Patients|Other Reason|13|||
131029921|NCT00812461|471742293|FG001|All Treated Patients|Other Reason|21|||
131029922|NCT04402489|471744354|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
131029923|NCT04402489|471744355|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
131029924|NCT04402489|471744356|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
131029925|NCT04402489|471744357|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
131029926|NCT04402489|471744358|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
131029927|NCT04402489|471744354|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
131029928|NCT04402489|471744355|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
131029929|NCT04402489|471744356|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
131029930|NCT04402489|471744357|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
131029931|NCT04402489|471744358|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
131029932|NCT04402489|471744354|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
131029933|NCT04402489|471744355|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
131029934|NCT04402489|471744356|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
131029935|NCT04402489|471744357|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
131029936|NCT04402489|471744358|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
131029937|NCT04402489|471744354|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
131029938|NCT04402489|471744355|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
131029939|NCT04402489|471744356|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
131029940|NCT04402489|471744357|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
131029941|NCT04402489|471744358|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
131029942|NCT04402489|471744354|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
131029943|NCT04402489|471744355|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
131029944|NCT04402489|471744356|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
131029945|NCT04402489|471744357|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
131029946|NCT04402489|471744358|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
131029947|NCT04402489|471744354|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
131029948|NCT04402489|471744355|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
131029949|NCT04402489|471744356|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
131029950|NCT04402489|471744357|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
131029951|NCT04402489|471744358|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
131029952|NCT04833777|471744364|FG000|Overall Study|Lost to Follow-up|1|||
131029953|NCT04833777|471744365|FG001|Overall Study|Lost to Follow-up|0|||
131029954|NCT03648840|471744374|FG000|First IV Infusion Session|Adverse Event|0|||
131029955|NCT03648840|471744375|FG001|First IV Infusion Session|Adverse Event|2|||
130909368|NCT00433511|471303268|FG001|Step 1|Adverse Event|157|||
130909369|NCT00433511|471303269|FG002|Step 1|Adverse Event|153|||
131029956|NCT03648840|471744374|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
131029957|NCT03648840|471744375|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
131029958|NCT03648840|471744374|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
131029959|NCT03648840|471744375|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
131029960|NCT03648840|471744374|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
131029961|NCT03648840|471744375|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
131029962|NCT05382936|471744379|FG000|Overall Study|Progressive Disease|3|||
131029963|NCT05382936|471744380|FG001|Overall Study|Progressive Disease|5|||
131029964|NCT05382936|471744381|FG002|Overall Study|Progressive Disease|2|||
131029965|NCT05382936|471744382|FG003|Overall Study|Progressive Disease|5|||
131029966|NCT05382936|471744379|FG000|Overall Study|Adverse Event|0|||
131029967|NCT05382936|471744380|FG001|Overall Study|Adverse Event|1|||
131029968|NCT05382936|471744381|FG002|Overall Study|Adverse Event|1|||
131029969|NCT05382936|471744382|FG003|Overall Study|Adverse Event|0|||
131029970|NCT05382936|471744379|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
131029971|NCT05382936|471744380|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
131029972|NCT05382936|471744381|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
131029973|NCT05382936|471744382|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
131029974|NCT05382936|471744379|FG000|Overall Study|Withdrawal by Subject|0|||
131029975|NCT05382936|471744380|FG001|Overall Study|Withdrawal by Subject|0|||
131029976|NCT05382936|471744381|FG002|Overall Study|Withdrawal by Subject|1|||
131029977|NCT05382936|471744382|FG003|Overall Study|Withdrawal by Subject|1|||
131029978|NCT05063994|471744385|FG000|Cortef Run-In|Withdrawal of Consent|1|||
131029979|NCT05063994|471744386|FG001|Cortef Run-In|Withdrawal of Consent|0|||
131029980|NCT05063994|471744387|FG002|Cortef Run-In|Withdrawal of Consent|0|||
131029981|NCT05063994|471744385|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
131029982|NCT05063994|471744386|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
131029983|NCT05063994|471744387|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
131029984|NCT05063994|471744385|FG000|Treatment|Physician Decision|0|||
131029985|NCT05063994|471744386|FG001|Treatment|Physician Decision|0|||
131029986|NCT05063994|471744387|FG002|Treatment|Physician Decision|1|||
131029987|NCT05063994|471744385|FG000|Treatment|Withdrawal by Subject|0|||
131029988|NCT05063994|471744386|FG001|Treatment|Withdrawal by Subject|0|||
131029989|NCT05063994|471744387|FG002|Treatment|Withdrawal by Subject|1|||
131029990|NCT05063994|471744385|FG000|Treatment|Withdrawal of Consent|0|||
131029991|NCT05063994|471744386|FG001|Treatment|Withdrawal of Consent|0|||
131029992|NCT05063994|471744387|FG002|Treatment|Withdrawal of Consent|1|||
131029993|NCT01857934|471744389|FG000|Overall Study|Relapse or progression|2|||
131029994|NCT01857934|471744389|FG000|Overall Study|Unacceptable toxicity|3|||
131029995|NCT01857934|471744389|FG000|Overall Study|Unwillingness or inability to comply|2|||
131029996|NCT01857934|471744389|FG000|Overall Study|Physician Decision|3|||
131029997|NCT03692676|471744394|FG000|Overall Study|exclude patients with prior use|4424|||
131029998|NCT03692676|471744395|FG001|Overall Study|exclude patients with prior use|24726|||
131029999|NCT03692676|471744396|FG002|Overall Study|exclude patients with prior use|0|||
131030000|NCT03692676|471744397|FG003|Overall Study|exclude patients with prior use|0|||
131030001|NCT03692676|471744394|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
131030002|NCT03692676|471744395|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
131030003|NCT03692676|471744396|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
131030004|NCT03692676|471744397|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
131030005|NCT03692676|471744394|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
131030006|NCT03692676|471744395|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
131030007|NCT03692676|471744396|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
131030008|NCT03692676|471744397|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
131030009|NCT03692676|471744394|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
131030010|NCT03692676|471744395|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
131030011|NCT03692676|471744396|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
131030012|NCT03692676|471744397|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
131030013|NCT03692676|471744394|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
131030014|NCT03692676|471744395|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
131030015|NCT03692676|471744396|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
131030016|NCT03692676|471744397|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
131030017|NCT03692676|471744394|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
131030018|NCT03692676|471744395|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
130909370|NCT00433511|471303267|FG000|Step 1|Withdrawal by Subject|45|||
130909371|NCT00433511|471303268|FG001|Step 1|Withdrawal by Subject|143|||
131115968|NCT03823404|472057556|FG000|Overall Study|Protocol Violation|2|||
131115969|NCT03823404|472057557|FG001|Overall Study|Protocol Violation|0|||
131115970|NCT03823404|472057558|FG002|Overall Study|Protocol Violation|2|||
131115971|NCT03823404|472057556|FG000|Overall Study|Adverse Event|35|||
131115972|NCT03823404|472057557|FG001|Overall Study|Adverse Event|38|||
131115973|NCT03823404|472057558|FG002|Overall Study|Adverse Event|8|||
131115974|NCT03823404|472057556|FG000|Overall Study|Withdrawal by Subject|38|||
131115975|NCT03823404|472057557|FG001|Overall Study|Withdrawal by Subject|40|||
131115976|NCT03823404|472057558|FG002|Overall Study|Withdrawal by Subject|35|||
131115977|NCT03823404|472057556|FG000|Overall Study|Death|4|||
131115978|NCT03823404|472057557|FG001|Overall Study|Death|0|||
131115979|NCT03823404|472057558|FG002|Overall Study|Death|0|||
131115980|NCT03823404|472057556|FG000|Overall Study|Other: Various reasons provided|5|||
131115981|NCT03823404|472057557|FG001|Overall Study|Other: Various reasons provided|5|||
131115982|NCT03823404|472057558|FG002|Overall Study|Other: Various reasons provided|6|||
131115983|NCT03383289|472057561|FG000|Overall Study|Death|83|||
131115984|NCT03383289|472057562|FG001|Overall Study|Death|78|||
131115985|NCT03383289|472057561|FG000|Overall Study|discharge from facility|84|||
131115986|NCT03383289|472057562|FG001|Overall Study|discharge from facility|84|||
131115987|NCT03383289|472057561|FG000|Overall Study|Withdrawal by Subject|4|||
131115988|NCT03383289|472057562|FG001|Overall Study|Withdrawal by Subject|1|||
131115989|NCT04439071|472057563|FG000|Overall Study|Lost to Follow-up|0|||
131115990|NCT04439071|472057564|FG001|Overall Study|Lost to Follow-up|3|||
131115991|NCT04439071|472057563|FG000|Overall Study|Withdrawal by Subject|3|||
131115992|NCT04439071|472057564|FG001|Overall Study|Withdrawal by Subject|8|||
131115993|NCT04439071|472057563|FG000|Overall Study|Death|6|||
131115994|NCT04439071|472057564|FG001|Overall Study|Death|4|||
131115995|NCT04439071|472057563|FG000|Overall Study|Other than specified|3|||
131115996|NCT04439071|472057564|FG001|Overall Study|Other than specified|3|||
131115997|NCT04439071|472057563|FG000|Overall Study|Randomized but not treated|2|||
131115998|NCT04439071|472057564|FG001|Overall Study|Randomized but not treated|0|||
131115999|NCT00832117|472057565|FG000|Overall Study|Death|1|||
131116000|NCT00832117|472057565|FG000|Overall Study|Disease Progression|11|||
131116001|NCT01524133|472057568|FG000|Treatment Phase|Withdrawal by Subject|13|||
131116002|NCT01524133|472057569|FG001|Treatment Phase|Withdrawal by Subject|28|||
131116003|NCT01524133|472057570|FG002|Treatment Phase|Withdrawal by Subject|31|||
131116004|NCT01524133|472057568|FG000|Treatment Phase|Physician Decision|6|||
131116005|NCT01524133|472057569|FG001|Treatment Phase|Physician Decision|3|||
131116006|NCT01524133|472057570|FG002|Treatment Phase|Physician Decision|3|||
131116007|NCT01524133|472057568|FG000|Treatment Phase|Lost to Follow-up|0|||
131116008|NCT01524133|472057569|FG001|Treatment Phase|Lost to Follow-up|1|||
131116009|NCT01524133|472057570|FG002|Treatment Phase|Lost to Follow-up|2|||
131116010|NCT01524133|472057568|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
131116011|NCT01524133|472057569|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
131116012|NCT01524133|472057570|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
131116013|NCT01524133|472057568|FG000|Overall Study 52 Weeks|Physician Decision|1|||
131116014|NCT01524133|472057569|FG001|Overall Study 52 Weeks|Physician Decision|0|||
131116015|NCT01524133|472057570|FG002|Overall Study 52 Weeks|Physician Decision|2|||
131116016|NCT01524133|472057568|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
131116017|NCT01524133|472057569|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
131116018|NCT01524133|472057570|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
131116019|NCT00059839|472057577|FG000|Overall Study|Death|1|||
131116020|NCT00059839|472057578|FG001|Overall Study|Death|1|||
131116021|NCT00059839|472057577|FG000|Overall Study|Lack of Efficacy|6|||
131116022|NCT00059839|472057578|FG001|Overall Study|Lack of Efficacy|5|||
131116023|NCT00059839|472057577|FG000|Overall Study|Lost to Follow-up|2|||
131116024|NCT00059839|472057578|FG001|Overall Study|Lost to Follow-up|0|||
131116025|NCT00059839|472057577|FG000|Overall Study|Physician Decision|1|||
131116026|NCT00059839|472057578|FG001|Overall Study|Physician Decision|2|||
131116027|NCT00059839|472057577|FG000|Overall Study|Withdrawal by Subject|1|||
131116028|NCT00059839|472057578|FG001|Overall Study|Withdrawal by Subject|6|||
131116029|NCT00059839|472057577|FG000|Overall Study|Ineligible|1|||
131116030|NCT00059839|472057578|FG001|Overall Study|Ineligible|3|||
131116031|NCT03842163|472057579|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
131116032|NCT03842163|472057579|FG000|Overall Study|Scintigraphy was not performed|44|||
131116033|NCT03829241|472057580|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
131116034|NCT03829241|472057581|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
131116035|NCT03829241|472057580|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
131116036|NCT03829241|472057581|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
131116037|NCT03829241|472057580|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
131116038|NCT03829241|472057581|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
131116039|NCT03829241|472057580|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
131116040|NCT03829241|472057581|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
131116041|NCT03829241|472057580|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
131116042|NCT03829241|472057581|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
131116043|NCT03829241|472057580|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
130696299|NCT00577655|470512553|FG000|Overall Study|Patient Request|0|||
130696300|NCT00577655|470512554|FG001|Overall Study|Patient Request|2|||
130696301|NCT00577655|470512553|FG000|Overall Study|Protocol Violation|0|||
130696302|NCT00577655|470512554|FG001|Overall Study|Protocol Violation|1|||
130696303|NCT00577655|470512553|FG000|Overall Study|Lost to Follow-up|1|||
130696304|NCT00577655|470512554|FG001|Overall Study|Lost to Follow-up|1|||
130696305|NCT00875524|470512556|FG000|Overall Study|Serious adverse event|0|||
130696306|NCT00875524|470512557|FG001|Overall Study|Serious adverse event|1|||
130696307|NCT00875524|470512556|FG000|Overall Study|Protocol Violation|4|||
130696308|NCT00875524|470512557|FG001|Overall Study|Protocol Violation|0|||
130696309|NCT00875524|470512556|FG000|Overall Study|Lost to Follow-up|1|||
130696310|NCT00875524|470512557|FG001|Overall Study|Lost to Follow-up|0|||
130696311|NCT00875524|470512556|FG000|Overall Study|Withdrawal by Subject|3|||
130696312|NCT00875524|470512557|FG001|Overall Study|Withdrawal by Subject|5|||
130696313|NCT01370863|470512558|FG000|Overall Study|Adverse Event|1|||
130696314|NCT01370863|470512559|FG001|Overall Study|Adverse Event|1|||
130696315|NCT01370863|470512558|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
130696316|NCT01370863|470512559|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
130696317|NCT01370863|470512558|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130696318|NCT01370863|470512559|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130696319|NCT01143337|470512560|FG000|Overall Study|Adverse Event|3|||
130696320|NCT01143337|470512561|FG001|Overall Study|Adverse Event|9|||
130696321|NCT01143337|470512562|FG002|Overall Study|Adverse Event|5|||
130696322|NCT01143337|470512560|FG000|Overall Study|Lack of Efficacy|6|||
130696323|NCT01143337|470512561|FG001|Overall Study|Lack of Efficacy|2|||
130696324|NCT01143337|470512562|FG002|Overall Study|Lack of Efficacy|1|||
130696325|NCT01143337|470512560|FG000|Overall Study|Protocol Violation|1|||
130696326|NCT01143337|470512561|FG001|Overall Study|Protocol Violation|0|||
130696327|NCT01143337|470512562|FG002|Overall Study|Protocol Violation|0|||
130696328|NCT01143337|470512560|FG000|Overall Study|Withdrawal by Subject|0|||
130696329|NCT01143337|470512561|FG001|Overall Study|Withdrawal by Subject|0|||
130696330|NCT01143337|470512562|FG002|Overall Study|Withdrawal by Subject|1|||
130696331|NCT01143337|470512560|FG000|Overall Study|Other reason|0|||
130909372|NCT00433511|471303269|FG002|Step 1|Withdrawal by Subject|154|||
130696332|NCT01143337|470512561|FG001|Overall Study|Other reason|0|||
130696333|NCT01143337|470512562|FG002|Overall Study|Other reason|5|||
130696334|NCT00406393|470512572|FG000|Overall Study|Did not undergo transplantation|2|||
130696335|NCT00406393|470512573|FG001|Overall Study|Did not undergo transplantation|1|||
130696336|NCT01597791|470512574|FG000|Overall Study|Physician Decision|2|||
130696337|NCT01597791|470512575|FG001|Overall Study|Physician Decision|1|||
130696338|NCT01597791|470512574|FG000|Overall Study|Cesarean Section|6|||
130909373|NCT00433511|471303267|FG000|Step 1|Death|3|||
130909374|NCT00433511|471303268|FG001|Step 1|Death|1|||
130909375|NCT00433511|471303269|FG002|Step 1|Death|1|||
130909376|NCT00433511|471303267|FG000|Step 1|Physician Decision|1|||
130909377|NCT00433511|471303268|FG001|Step 1|Physician Decision|4|||
131222770|NCT00386100|472443176|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
131030019|NCT03692676|471744396|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
130696339|NCT01597791|470512575|FG001|Overall Study|Cesarean Section|7|||
130696340|NCT01597791|470512574|FG000|Overall Study|Subject withdrawal|0|||
131222771|NCT00386100|472443175|FG000|Overall Study|Didn't meet entry criteria|1|||
131030020|NCT03692676|471744397|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
131030021|NCT03692676|471744394|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
131030022|NCT03692676|471744395|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
131030023|NCT03692676|471744396|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
131030024|NCT03692676|471744397|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
131030025|NCT03692676|471744394|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
131030026|NCT03692676|471744395|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
131030027|NCT03692676|471744396|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
131030028|NCT03692676|471744397|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
131030029|NCT03692676|471744394|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
131030030|NCT03692676|471744395|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
131030031|NCT03692676|471744396|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
131030032|NCT03692676|471744397|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
131222772|NCT00386100|472443176|FG001|Overall Study|Didn't meet entry criteria|1|||
131222773|NCT00386100|472443175|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
130696341|NCT01597791|470512575|FG001|Overall Study|Subject withdrawal|1|||
130696342|NCT01597791|470512574|FG000|Overall Study|Protocol Violation|0|||
130696343|NCT01597791|470512575|FG001|Overall Study|Protocol Violation|1|||
130696344|NCT01087502|470512576|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
130696345|NCT01087502|470512577|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
130696346|NCT01087502|470512576|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
130909378|NCT00433511|471303269|FG002|Step 1|Physician Decision|3|||
130696347|NCT01087502|470512577|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
130696348|NCT01087502|470512576|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
130696349|NCT01087502|470512577|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
130696350|NCT01087502|470512576|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
130696351|NCT01087502|470512577|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
130696352|NCT01087502|470512576|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
130696353|NCT01087502|470512577|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
130696354|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
130696355|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
130696356|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
130696357|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
130696358|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
130696359|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
130696360|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
130696361|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
130696362|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
130696363|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
130696364|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
130696365|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
130696366|NCT01087502|470512576|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
130696367|NCT01087502|470512577|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
130696368|NCT01151618|470512578|FG000|Overall Study|Adverse Event|2|||
130696369|NCT01151618|470512578|FG000|Overall Study|Withdrawal by Subject|7|||
130696370|NCT01632306|470512579|FG000|Overall Study|Protocol Violation|1|||
130696371|NCT01632306|470512580|FG001|Overall Study|Protocol Violation|0|||
130696372|NCT01632306|470512581|FG002|Overall Study|Protocol Violation|0|||
130696373|NCT01663896|470512584|FG000|Overall Study|Various reasons|43|||
130696374|NCT01451541|470512585|FG000|Overall Study|Adverse Event|4|||
130696375|NCT01451541|470512586|FG001|Overall Study|Adverse Event|3|||
130696376|NCT01451541|470512587|FG002|Overall Study|Adverse Event|6|||
130696377|NCT01451541|470512585|FG000|Overall Study|Lack of Efficacy|2|||
130696378|NCT01451541|470512586|FG001|Overall Study|Lack of Efficacy|0|||
130696379|NCT01451541|470512587|FG002|Overall Study|Lack of Efficacy|0|||
130696380|NCT01451541|470512585|FG000|Overall Study|Lost to Follow-up|4|||
130696381|NCT01451541|470512586|FG001|Overall Study|Lost to Follow-up|4|||
130696382|NCT01451541|470512587|FG002|Overall Study|Lost to Follow-up|7|||
130696383|NCT01451541|470512585|FG000|Overall Study|Withdrawal by Subject|15|||
130696384|NCT01451541|470512586|FG001|Overall Study|Withdrawal by Subject|8|||
130696385|NCT01451541|470512587|FG002|Overall Study|Withdrawal by Subject|6|||
130696386|NCT01451541|470512585|FG000|Overall Study|randomization error, noncompliance|11|||
131116044|NCT03829241|472057581|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
131116045|NCT03829241|472057580|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
131116046|NCT03829241|472057581|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
131116047|NCT03829241|472057580|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
131116048|NCT03829241|472057581|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
131116049|NCT03829241|472057580|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
131116050|NCT03829241|472057581|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
131116051|NCT03829241|472057580|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
131116052|NCT03829241|472057581|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
131116053|NCT03829241|472057580|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
131133721|NCT01661140|472117175|FG002|Open-Label Period|Sponsor termination|0|||
130696387|NCT01451541|470512586|FG001|Overall Study|randomization error, noncompliance|10|||
130696388|NCT01451541|470512587|FG002|Overall Study|randomization error, noncompliance|8|||
130696389|NCT03366428|470512588|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
130696390|NCT03366428|470512588|FG000|Overall Study|Adverse Event|12|||
130696391|NCT03366428|470512588|FG000|Overall Study|Clinical progression|2|||
130696392|NCT03366428|470512588|FG000|Overall Study|Withdrawal by Subject|4|||
130696393|NCT01046084|470512592|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
130696394|NCT01046084|470512593|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
130696395|NCT00379353|470512594|FG000|Overall Study|Hospitalization|3|||
130696396|NCT00379353|470512595|FG001|Overall Study|Hospitalization|3|||
130696397|NCT00379353|470512594|FG000|Overall Study|Withdrawal by Subject|5|||
130696398|NCT00379353|470512595|FG001|Overall Study|Withdrawal by Subject|2|||
130696399|NCT00379353|470512594|FG000|Overall Study|Death|1|||
130696400|NCT00379353|470512595|FG001|Overall Study|Death|0|||
130696401|NCT00379353|470512594|FG000|Overall Study|Cardiac Tamponade|1|||
130696402|NCT00379353|470512595|FG001|Overall Study|Cardiac Tamponade|0|||
130696403|NCT00379353|470512594|FG000|Overall Study|Non-compliance|1|||
130696404|NCT00379353|470512595|FG001|Overall Study|Non-compliance|0|||
130696405|NCT00379353|470512594|FG000|Overall Study|Conflicting drug treatment|0|||
130696406|NCT00379353|470512595|FG001|Overall Study|Conflicting drug treatment|1|||
130696407|NCT03614728|470512596|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
131222774|NCT00386100|472443176|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
131222775|NCT00386100|472443175|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
131222776|NCT00386100|472443176|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
131222777|NCT00386100|472443175|FG000|Overall Study|Bad metabolic control & patient security|1|||
131222778|NCT00386100|472443176|FG001|Overall Study|Bad metabolic control & patient security|0|||
131222779|NCT00386100|472443175|FG000|Overall Study|Bone loss by DXA bone scan|1|||
131222780|NCT00386100|472443176|FG001|Overall Study|Bone loss by DXA bone scan|0|||
131222781|NCT00386100|472443175|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
131222782|NCT00386100|472443176|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
131222783|NCT00386100|472443175|FG000|Overall Study|7.6% bone loss|1|||
131222784|NCT00386100|472443176|FG001|Overall Study|7.6% bone loss|0|||
131222785|NCT00386100|472443175|FG000|Overall Study|Osteoporosis|0|||
131222786|NCT00386100|472443176|FG001|Overall Study|Osteoporosis|1|||
131222787|NCT00386100|472443175|FG000|Overall Study|Positive pregnancy test|1|||
131222788|NCT00386100|472443176|FG001|Overall Study|Positive pregnancy test|3|||
131222789|NCT00386100|472443175|FG000|Overall Study|Out of country for 5 months|1|||
131222790|NCT00386100|472443176|FG001|Overall Study|Out of country for 5 months|0|||
131222791|NCT00386100|472443175|FG000|Overall Study|Hb1Ac >8%|0|||
131222792|NCT00386100|472443176|FG001|Overall Study|Hb1Ac >8%|1|||
131222793|NCT00386100|472443175|FG000|Overall Study|Participant randomized in error|1|||
131222794|NCT00386100|472443176|FG001|Overall Study|Participant randomized in error|0|||
131222795|NCT01706770|472443177|FG000|Overall Study|Lost to Follow-up|1|||
131222796|NCT01706770|472443178|FG001|Overall Study|Lost to Follow-up|0|||
131222797|NCT01706770|472443177|FG000|Overall Study|Physician Decision|1|||
131222798|NCT01706770|472443178|FG001|Overall Study|Physician Decision|0|||
131222799|NCT03636542|472443181|FG000|Overall Study|Lost to Follow-up|1|||
131222800|NCT03636542|472443182|FG001|Overall Study|Lost to Follow-up|1|||
131222801|NCT03636542|472443181|FG000|Overall Study|Physician Decision|0|||
131222802|NCT03636542|472443182|FG001|Overall Study|Physician Decision|1|||
131222803|NCT03636542|472443181|FG000|Overall Study|Withdrawal by Subject|1|||
131222804|NCT03636542|472443182|FG001|Overall Study|Withdrawal by Subject|0|||
131222805|NCT03674827|472443185|FG000|Treatment Phase|Adverse Event|0|||
131222806|NCT03674827|472443186|FG001|Treatment Phase|Adverse Event|0|||
130909379|NCT00433511|471303267|FG000|Step 1|Never started protocol therapy|28|||
130909380|NCT00433511|471303268|FG001|Step 1|Never started protocol therapy|64|||
131030033|NCT03692676|471744394|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
131030034|NCT03692676|471744395|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
131030035|NCT03692676|471744396|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
131030036|NCT03692676|471744397|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
131030037|NCT03692676|471744394|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
131030038|NCT03692676|471744395|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
131030039|NCT03692676|471744396|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
131030040|NCT03692676|471744397|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
131030041|NCT03692676|471744394|FG000|Overall Study|Other|0|||
131030042|NCT03692676|471744395|FG001|Overall Study|Other|805|||
131030043|NCT03692676|471744396|FG002|Overall Study|Other|758|||
131030044|NCT03692676|471744397|FG003|Overall Study|Other|277|||
131030045|NCT03692676|471744394|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
131116054|NCT03829241|472057581|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
131116055|NCT03829241|472057580|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
131116056|NCT03829241|472057581|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
131116057|NCT03829241|472057580|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
131116058|NCT03829241|472057581|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
131116059|NCT03829241|472057580|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
131116060|NCT03829241|472057581|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
131116061|NCT00698451|472057582|FG000|Overall Study|Adverse Event|22|||
131116062|NCT00698451|472057582|FG000|Overall Study|Physician Decision|2|||
131116063|NCT00698451|472057582|FG000|Overall Study|Protocol Violation|6|||
131116064|NCT00698451|472057582|FG000|Overall Study|Withdrawal by Subject|6|||
131116065|NCT00698451|472057582|FG000|Overall Study|Disease progression|3|||
131116066|NCT02224599|472057583|FG000|Overall Study|Physician Decision|1|||
131116067|NCT02224599|472057583|FG000|Overall Study|Progression of Disease|1|||
131116068|NCT00733304|472057584|FG000|Overall Study|Adverse Event|3|||
131116069|NCT00733304|472057585|FG001|Overall Study|Adverse Event|0|||
131116070|NCT00733304|472057586|FG002|Overall Study|Adverse Event|0|||
131116071|NCT00733304|472057584|FG000|Overall Study|Lack of Efficacy|0|||
131116072|NCT00733304|472057585|FG001|Overall Study|Lack of Efficacy|0|||
131222807|NCT03674827|472443187|FG002|Treatment Phase|Adverse Event|0|||
131222808|NCT03674827|472443188|FG003|Treatment Phase|Adverse Event|0|||
131222809|NCT03674827|472443189|FG004|Treatment Phase|Adverse Event|0|||
131222810|NCT03674827|472443190|FG005|Treatment Phase|Adverse Event|2|||
130768682|NCT03959488|470778556|FG003|Season 1|Due to COVID-19 pandemic|0|||
130909381|NCT00433511|471303269|FG002|Step 1|Never started protocol therapy|66|||
130909382|NCT00433511|471303267|FG000|Step 1|Alternative therapy|2|||
130909383|NCT00433511|471303268|FG001|Step 1|Alternative therapy|1|||
130909384|NCT00433511|471303269|FG002|Step 1|Alternative therapy|3|||
130909385|NCT00433511|471303267|FG000|Step 1|Disease progression, relapse|5|||
130909386|NCT00433511|471303268|FG001|Step 1|Disease progression, relapse|3|||
130909387|NCT00433511|471303269|FG002|Step 1|Disease progression, relapse|3|||
130909388|NCT00433511|471303267|FG000|Step 1|Other complicating disease|2|||
130909389|NCT00433511|471303268|FG001|Step 1|Other complicating disease|6|||
130909390|NCT00433511|471303269|FG002|Step 1|Other complicating disease|3|||
130909391|NCT00433511|471303267|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
130909392|NCT00433511|471303268|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
130909393|NCT00433511|471303269|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
130909394|NCT00433511|471303267|FG000|Step 1|Suspected recurrence|0|||
130909395|NCT00433511|471303268|FG001|Step 1|Suspected recurrence|1|||
130909396|NCT00433511|471303269|FG002|Step 1|Suspected recurrence|0|||
130909397|NCT00433511|471303267|FG000|Step 1|Insurance/drug distribution issues|0|||
130909398|NCT00433511|471303268|FG001|Step 1|Insurance/drug distribution issues|1|||
130909399|NCT00433511|471303269|FG002|Step 1|Insurance/drug distribution issues|2|||
130909400|NCT00433511|471303267|FG000|Step 1|Patient moved|0|||
130909401|NCT00433511|471303268|FG001|Step 1|Patient moved|0|||
130909402|NCT00433511|471303269|FG002|Step 1|Patient moved|1|||
130909403|NCT00433511|471303267|FG000|Step 2 (Arm D)|Adverse Event|0|||
130909404|NCT00433511|471303268|FG001|Step 2 (Arm D)|Adverse Event|0|||
130909405|NCT00433511|471303269|FG002|Step 2 (Arm D)|Adverse Event|135|||
130909406|NCT00433511|471303267|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
131030046|NCT03692676|471744395|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
131030047|NCT03692676|471744396|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
131030048|NCT03692676|471744397|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
131030049|NCT04638998|471744398|FG000|Overall Study|Withdrawal by Subject|1|||
131030050|NCT04638998|471744399|FG001|Overall Study|Withdrawal by Subject|3|||
131030051|NCT03692611|471744401|FG000|Overall Study|Found to be ineligible postrandomization|3|||
131030052|NCT03692611|471744402|FG001|Overall Study|Found to be ineligible postrandomization|0|||
131030053|NCT04490915|471744403|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
131030054|NCT04490915|471744404|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131030055|NCT04490915|471744403|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131030056|NCT04490915|471744404|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131030057|NCT04490915|471744403|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131030058|NCT04490915|471744404|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
131030059|NCT04490915|471744403|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
131030060|NCT04490915|471744404|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
131030061|NCT04490915|471744403|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
131030062|NCT04490915|471744404|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
131030063|NCT04490915|471744403|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
131030064|NCT04490915|471744404|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
131030065|NCT04490915|471744403|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
131030066|NCT04490915|471744404|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
131030067|NCT05374837|471744408|FG000|Overall Study|Lost to Follow-up|17|||
131030068|NCT05374837|471744409|FG001|Overall Study|Lost to Follow-up|18|||
131030069|NCT05406921|471744413|FG000|Overall Study|Withdrawal by Subject|25|||
131030070|NCT05406921|471744414|FG001|Overall Study|Withdrawal by Subject|0|||
131030071|NCT05406921|471744415|FG002|Overall Study|Withdrawal by Subject|25|||
131030072|NCT05406921|471744413|FG000|Overall Study|Protocol Violation|0|||
131030073|NCT05406921|471744414|FG001|Overall Study|Protocol Violation|12|||
131030074|NCT05406921|471744415|FG002|Overall Study|Protocol Violation|0|||
131030075|NCT02549339|471744423|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
131030076|NCT02549339|471744424|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
131030077|NCT02549339|471744423|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
131030078|NCT02549339|471744424|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
131030079|NCT02549339|471744423|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
131030080|NCT02549339|471744424|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
131030081|NCT02549339|471744423|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
131030082|NCT02549339|471744424|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
130909407|NCT00433511|471303268|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
130909408|NCT00433511|471303269|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
130909409|NCT00433511|471303267|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
130909410|NCT00433511|471303268|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
130909411|NCT00433511|471303269|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
130909412|NCT00433511|471303267|FG000|Step 2 (Arm D)|Physician Decision|0|||
130909413|NCT00433511|471303268|FG001|Step 2 (Arm D)|Physician Decision|0|||
130909414|NCT00433511|471303269|FG002|Step 2 (Arm D)|Physician Decision|9|||
130909415|NCT00433511|471303267|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
130909416|NCT00433511|471303268|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
130909417|NCT00433511|471303269|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
130909418|NCT00433511|471303267|FG000|Step 2 (Arm D)|Other complicating disease|0|||
130768683|NCT03959488|470778557|FG004|Season 1|Due to COVID-19 pandemic|0|||
130768684|NCT03959488|470778553|FG000|Season 1|Lost to Follow-up|17|||
130768685|NCT03959488|470778554|FG001|Season 1|Lost to Follow-up|7|||
130768686|NCT03959488|470778555|FG002|Season 1|Lost to Follow-up|0|||
130768687|NCT03959488|470778556|FG003|Season 1|Lost to Follow-up|0|||
130768688|NCT03959488|470778557|FG004|Season 1|Lost to Follow-up|0|||
130768689|NCT03959488|470778553|FG000|Season 1|Death|5|||
130768690|NCT03959488|470778554|FG001|Season 1|Death|1|||
130768691|NCT03959488|470778555|FG002|Season 1|Death|0|||
130909419|NCT00433511|471303268|FG001|Step 2 (Arm D)|Other complicating disease|0|||
130909420|NCT00433511|471303269|FG002|Step 2 (Arm D)|Other complicating disease|3|||
130909421|NCT00433511|471303267|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
130909422|NCT00433511|471303268|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
130909423|NCT00433511|471303269|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
130909424|NCT00433511|471303267|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
130909425|NCT00433511|471303268|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
130909426|NCT00433511|471303269|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
130909427|NCT00433511|471303267|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
130909428|NCT00433511|471303268|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
130909429|NCT00433511|471303269|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
130909430|NCT00433511|471303267|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
130909431|NCT00433511|471303268|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
130909432|NCT00433511|471303269|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
130909433|NCT02806973|471303271|FG000|Period 1|Withdrawal by Subject|0|||
130909434|NCT02806973|471303272|FG001|Period 1|Withdrawal by Subject|2|||
130909435|NCT02806973|471303273|FG002|Period 1|Withdrawal by Subject|1|||
130909436|NCT02806973|471303274|FG003|Period 1|Withdrawal by Subject|1|||
131030083|NCT02549339|471744423|FG000|12-month Follow-up|Lack of Efficacy|0|||
131030084|NCT02549339|471744424|FG001|12-month Follow-up|Lack of Efficacy|2|||
131030085|NCT02549339|471744423|FG000|12-month Follow-up|Withdrawal by Subject|8|||
131030086|NCT02549339|471744424|FG001|12-month Follow-up|Withdrawal by Subject|3|||
131030087|NCT02549339|471744423|FG000|12-month Follow-up|Lost to Follow-up|1|||
131030088|NCT02549339|471744424|FG001|12-month Follow-up|Lost to Follow-up|3|||
131030089|NCT02549339|471744423|FG000|12-month Follow-up|Other|0|||
131030090|NCT02549339|471744424|FG001|12-month Follow-up|Other|3|||
131030091|NCT03016169|471744425|FG000|Overall Study|Lost to Follow-up|4|||
131030092|NCT03016169|471744425|FG000|Overall Study|Death|54|||
131030093|NCT03016169|471744425|FG000|Overall Study|Device Explant|11|||
131030094|NCT03016169|471744425|FG000|Overall Study|Withdrawal by Subject|19|||
131030095|NCT03016169|471744425|FG000|Overall Study|Other Reasons|1|||
131030096|NCT05524233|471744442|FG000|Overall Study|Lost to Follow-up|2|||
131030097|NCT05524233|471744442|FG000|Overall Study|Adverse Event|2|||
131030098|NCT05524233|471744442|FG000|Overall Study|Withdrawal by Subject|1|||
131030099|NCT03126019|471744448|FG000|Overall Study|Death|5|||
131030100|NCT03126019|471744449|FG001|Overall Study|Death|27|||
131030101|NCT03126019|471744448|FG000|Overall Study|Lost to Follow-up|2|||
131030102|NCT03126019|471744449|FG001|Overall Study|Lost to Follow-up|4|||
131030103|NCT03126019|471744448|FG000|Overall Study|Withdrawal by Subject|1|||
131030104|NCT03126019|471744449|FG001|Overall Study|Withdrawal by Subject|9|||
131030105|NCT03126019|471744448|FG000|Overall Study|Physician Decision|1|||
131030106|NCT03126019|471744449|FG001|Overall Study|Physician Decision|0|||
131030107|NCT03126019|471744448|FG000|Overall Study|Transitioned to Rollover Study|0|||
131030108|NCT03126019|471744449|FG001|Overall Study|Transitioned to Rollover Study|11|||
131030109|NCT03126019|471744448|FG000|Overall Study|Did Not Return to Site for Care|0|||
131030110|NCT03126019|471744449|FG001|Overall Study|Did Not Return to Site for Care|1|||
131030111|NCT03126019|471744448|FG000|Overall Study|Site Closed|0|||
131030112|NCT03126019|471744449|FG001|Overall Study|Site Closed|1|||
131030113|NCT01566695|471744458|FG000|Overall Study|Lack of Efficacy|1|||
131030114|NCT01566695|471744459|FG001|Overall Study|Lack of Efficacy|0|||
131030115|NCT01566695|471744458|FG000|Overall Study|Adverse Event|3|||
131030116|NCT01566695|471744459|FG001|Overall Study|Adverse Event|0|||
131030117|NCT01566695|471744458|FG000|Overall Study|Death|79|||
131030118|NCT01566695|471744459|FG001|Overall Study|Death|86|||
131030119|NCT01566695|471744458|FG000|Overall Study|Withdrawal by Subject|13|||
131030120|NCT01566695|471744459|FG001|Overall Study|Withdrawal by Subject|12|||
131030121|NCT01566695|471744458|FG000|Overall Study|Lost to Follow-up|0|||
131030122|NCT01566695|471744459|FG001|Overall Study|Lost to Follow-up|3|||
131030123|NCT01566695|471744458|FG000|Overall Study|Other reasons|11|||
131030124|NCT01566695|471744459|FG001|Overall Study|Other reasons|8|||
131030125|NCT05956002|471744460|FG000|Treatment Period 3|Adverse Event|0|||
131030126|NCT05956002|471744461|FG001|Treatment Period 3|Adverse Event|0|||
131030127|NCT05956002|471744462|FG002|Treatment Period 3|Adverse Event|1|||
131030128|NCT05956002|471744463|FG003|Treatment Period 3|Adverse Event|0|||
131030129|NCT02281955|471744469|FG000|Overall Study|Death|1|||
130909437|NCT02806973|471303271|FG000|Period 1|Adverse Event|0|||
130909438|NCT02806973|471303272|FG001|Period 1|Adverse Event|0|||
130909439|NCT02806973|471303273|FG002|Period 1|Adverse Event|0|||
130909440|NCT02806973|471303274|FG003|Period 1|Adverse Event|1|||
130909441|NCT02806973|471303271|FG000|Period 3|Withdrawal by Subject|0|||
130909442|NCT02806973|471303272|FG001|Period 3|Withdrawal by Subject|0|||
130909443|NCT02806973|471303273|FG002|Period 3|Withdrawal by Subject|0|||
130909444|NCT02806973|471303274|FG003|Period 3|Withdrawal by Subject|3|||
130909445|NCT02806973|471303271|FG000|Period 3|Adverse Event|0|||
130909446|NCT02806973|471303272|FG001|Period 3|Adverse Event|0|||
130909447|NCT02806973|471303273|FG002|Period 3|Adverse Event|1|||
130909448|NCT02806973|471303274|FG003|Period 3|Adverse Event|0|||
130909449|NCT04209426|471303280|FG000|Overall Study|Lost to Follow-up|3|||
130909450|NCT04209426|471303281|FG001|Overall Study|Lost to Follow-up|2|||
130909451|NCT01082640|471303282|FG000|Overall Study|Adverse Event|9|||
130909452|NCT01082640|471303283|FG001|Overall Study|Adverse Event|5|||
130909453|NCT01082640|471303284|FG002|Overall Study|Adverse Event|3|||
130909454|NCT01082640|471303282|FG000|Overall Study|Withdrawal by Subject|3|||
130909455|NCT01082640|471303283|FG001|Overall Study|Withdrawal by Subject|3|||
130909456|NCT01082640|471303284|FG002|Overall Study|Withdrawal by Subject|2|||
130909457|NCT01082640|471303282|FG000|Overall Study|Major protocol deviation|3|||
130909458|NCT01082640|471303283|FG001|Overall Study|Major protocol deviation|3|||
130909459|NCT01082640|471303284|FG002|Overall Study|Major protocol deviation|0|||
130909460|NCT01082640|471303282|FG000|Overall Study|Lost to Follow-up|0|||
130909461|NCT01082640|471303283|FG001|Overall Study|Lost to Follow-up|3|||
130909462|NCT01082640|471303284|FG002|Overall Study|Lost to Follow-up|0|||
130909463|NCT01082640|471303282|FG000|Overall Study|Other|2|||
130909464|NCT01082640|471303283|FG001|Overall Study|Other|1|||
130909465|NCT01082640|471303284|FG002|Overall Study|Other|3|||
130909466|NCT03190369|471303289|FG000|Overall Study|Poor compliance to protocol|0|||
130909467|NCT03190369|471303290|FG001|Overall Study|Poor compliance to protocol|1|||
130909468|NCT03190369|471303289|FG000|Overall Study|Withdraw before treatment|1|||
130909469|NCT03190369|471303290|FG001|Overall Study|Withdraw before treatment|5|||
130909470|NCT03190369|471303289|FG000|Overall Study|Randomized but not treated|0|||
130909471|NCT03190369|471303290|FG001|Overall Study|Randomized but not treated|2|||
130909472|NCT02011893|471303291|FG000|Enrollment to Randomization|Adverse Event|2|||
130909473|NCT02011893|471303292|FG001|Enrollment to Randomization|Adverse Event|0|||
130909474|NCT02011893|471303293|FG002|Enrollment to Randomization|Adverse Event|0|||
130909475|NCT02011893|471303291|FG000|Enrollment to Randomization|Physician Decision|10|||
130696408|NCT03614728|470512597|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
130696409|NCT03614728|470512598|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
130696410|NCT03614728|470512599|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
130768692|NCT03959488|470778556|FG003|Season 1|Death|0|||
130909476|NCT02011893|471303292|FG001|Enrollment to Randomization|Physician Decision|0|||
130909477|NCT02011893|471303293|FG002|Enrollment to Randomization|Physician Decision|0|||
130909478|NCT02011893|471303291|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
130909479|NCT02011893|471303292|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
131030130|NCT02783300|471744470|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030131|NCT02783300|471744471|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030132|NCT02783300|471744472|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030133|NCT02783300|471744473|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030134|NCT02783300|471744474|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030135|NCT02783300|471744475|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030136|NCT02783300|471744476|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
131030137|NCT02783300|471744477|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030138|NCT02783300|471744478|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030139|NCT02783300|471744479|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030140|NCT02783300|471744480|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030141|NCT02783300|471744481|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030142|NCT02783300|471744482|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030143|NCT02783300|471744483|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030144|NCT02783300|471744484|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030145|NCT02783300|471744485|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030146|NCT02783300|471744486|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130909480|NCT02011893|471303293|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
130909481|NCT02011893|471303291|FG000|Enrollment to Randomization|Screening Failure|29|||
130909482|NCT02011893|471303292|FG001|Enrollment to Randomization|Screening Failure|0|||
131030147|NCT02783300|471744487|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030148|NCT02783300|471744488|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030149|NCT02783300|471744489|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030150|NCT02783300|471744490|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030151|NCT02783300|471744491|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030152|NCT02783300|471744492|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131116073|NCT00733304|472057586|FG002|Overall Study|Lack of Efficacy|2|||
130696411|NCT03614728|470512596|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
130696412|NCT03614728|470512597|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
130696413|NCT03614728|470512598|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
130696414|NCT03614728|470512599|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
130696415|NCT01958476|470512600|FG000|Overall Study|Parent requested exclusion from analysis|1|||
130696416|NCT01958476|470512601|FG001|Overall Study|Parent requested exclusion from analysis|0|||
130696417|NCT01824576|470512602|FG000|Overall Study|Device deficiency|2|||
130696418|NCT05412121|470512603|FG000|Overall Study|Withdrawal by Subject|4|||
130696419|NCT05412121|470512603|FG000|Overall Study|Physician Decision|1|||
130696420|NCT05412121|470512603|FG000|Overall Study|Lost to Follow-up|5|||
130696421|NCT03727139|470512604|FG000|Overall Study|Protocol Violation|60|||
130696422|NCT00757172|470512605|FG000|Overall Study|Withdrawal by Subject|4|||
130696423|NCT00757172|470512605|FG000|Overall Study|Physician Decision|3|||
130696424|NCT00757172|470512605|FG000|Overall Study|Progression|4|||
130696425|NCT00840879|470512606|FG000|Second Intervention|Withdrawal by Subject|1|||
130696426|NCT00840879|470512607|FG001|Second Intervention|Withdrawal by Subject|0|||
130696427|NCT04236596|470512608|FG000|Overall Study|Withdrawal by Subject|1|||
130696428|NCT04236596|470512608|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
130909483|NCT02011893|471303293|FG002|Enrollment to Randomization|Screening Failure|0|||
130909484|NCT02011893|471303291|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
130909485|NCT02011893|471303292|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
131030153|NCT02783300|471744493|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
130696429|NCT04236596|470512608|FG000|Overall Study|Participants did not receive implant at all|4|||
130696430|NCT02957331|470512613|FG000|Overall Study|Protocol Violation|1|||
130696431|NCT02957331|470512614|FG001|Overall Study|Protocol Violation|0|||
130696432|NCT03247686|470514386|FG000|Overall Study|Withdrawal by Subject|1|||
130696433|NCT03247686|470514387|FG001|Overall Study|Withdrawal by Subject|2|||
130696434|NCT00754052|470514399|FG000|Overall Study|Study terminated by Sponsor|5|||
130696435|NCT00754052|470514400|FG001|Overall Study|Study terminated by Sponsor|3|||
130696436|NCT02658019|470514402|FG000|Overall Study|Adverse Event|1|||
130696437|NCT04364854|470514406|FG000|Overall Study|Withdrawal by Subject|1|||
130696438|NCT04364854|470514407|FG001|Overall Study|Withdrawal by Subject|0|||
130696439|NCT04364854|470514408|FG002|Overall Study|Withdrawal by Subject|1|||
130696440|NCT04364854|470514409|FG003|Overall Study|Withdrawal by Subject|3|||
130696441|NCT04364854|470514406|FG000|Overall Study|Death|1|||
130696442|NCT04364854|470514407|FG001|Overall Study|Death|0|||
131030154|NCT02783300|471744494|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030155|NCT02783300|471744495|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030156|NCT02783300|471744496|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
131030157|NCT02783300|471744470|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030158|NCT02783300|471744471|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030159|NCT02783300|471744472|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030160|NCT02783300|471744473|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
131030161|NCT02783300|471744474|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030162|NCT02783300|471744475|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030163|NCT02783300|471744476|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030164|NCT02783300|471744477|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030165|NCT02783300|471744478|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030166|NCT02783300|471744479|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030167|NCT02783300|471744480|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030168|NCT02783300|471744481|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030169|NCT02783300|471744482|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030170|NCT02783300|471744483|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030171|NCT02783300|471744484|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130696443|NCT04364854|470514408|FG002|Overall Study|Death|0|||
130696444|NCT04364854|470514409|FG003|Overall Study|Death|0|||
130696445|NCT04364854|470514406|FG000|Overall Study|Lost to Follow-up|0|||
130696446|NCT04364854|470514407|FG001|Overall Study|Lost to Follow-up|0|||
130696447|NCT04364854|470514408|FG002|Overall Study|Lost to Follow-up|0|||
130696448|NCT04364854|470514409|FG003|Overall Study|Lost to Follow-up|1|||
130696449|NCT02435433|470514410|FG000|Overall Study|Withdrawal by Subject|2|||
130696450|NCT02435433|470514411|FG001|Overall Study|Withdrawal by Subject|3|||
130696451|NCT02435433|470514412|FG002|Overall Study|Withdrawal by Subject|1|||
131030172|NCT02783300|471744485|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030173|NCT02783300|471744486|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030174|NCT02783300|471744487|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030175|NCT02783300|471744488|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030176|NCT02783300|471744489|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030177|NCT02783300|471744490|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030178|NCT02783300|471744491|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030179|NCT02783300|471744492|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030180|NCT02783300|471744493|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030181|NCT02783300|471744494|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130909486|NCT02011893|471303293|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
130909487|NCT02011893|471303291|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
130909488|NCT02011893|471303292|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
130909489|NCT02011893|471303293|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
130909490|NCT02011893|471303291|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
130909491|NCT02011893|471303292|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
130909492|NCT02011893|471303293|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
130909493|NCT02011893|471303291|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
130909494|NCT02011893|471303292|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
130909495|NCT02011893|471303293|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
130909496|NCT02011893|471303291|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
130909497|NCT02011893|471303292|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
130909498|NCT02011893|471303293|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
130909499|NCT01241240|471303294|FG000|Overall Study|Adverse Event|5|||
130909500|NCT01241240|471303295|FG001|Overall Study|Adverse Event|4|||
130909501|NCT01241240|471303294|FG000|Overall Study|Lost to Follow-up|2|||
130909502|NCT01241240|471303295|FG001|Overall Study|Lost to Follow-up|4|||
130909503|NCT01241240|471303294|FG000|Overall Study|Personal Reasons|1|||
131030182|NCT02783300|471744495|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030183|NCT02783300|471744496|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
131030184|NCT02783300|471744470|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
131030185|NCT02783300|471744471|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
131030186|NCT02783300|471744472|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
131030187|NCT02783300|471744473|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
131030188|NCT02783300|471744474|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
131030189|NCT02783300|471744475|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
131030190|NCT02783300|471744476|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
131030191|NCT02783300|471744477|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
131030192|NCT02783300|471744478|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
131030193|NCT02783300|471744479|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
131030194|NCT02783300|471744480|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
131030195|NCT02783300|471744481|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
131030196|NCT02783300|471744482|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
131030197|NCT02783300|471744483|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
131030198|NCT02783300|471744484|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
131030199|NCT02783300|471744485|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
131030200|NCT02783300|471744486|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
131030201|NCT02783300|471744487|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
131030202|NCT02783300|471744488|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
131030203|NCT02783300|471744489|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
131030204|NCT02783300|471744490|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
131030205|NCT02783300|471744491|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
131030206|NCT02783300|471744492|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
131030207|NCT02783300|471744493|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
131030208|NCT02783300|471744494|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
131030209|NCT02783300|471744495|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
131030210|NCT02783300|471744496|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
131030211|NCT02783300|471744470|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030212|NCT02783300|471744471|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030213|NCT02783300|471744472|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030214|NCT02783300|471744473|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030215|NCT02783300|471744474|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030216|NCT02783300|471744475|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131116074|NCT00733304|472057584|FG000|Overall Study|Lost to Follow-up|0|||
131116075|NCT00733304|472057585|FG001|Overall Study|Lost to Follow-up|1|||
130768693|NCT03959488|470778557|FG004|Season 1|Death|0|||
130909504|NCT01241240|471303295|FG001|Overall Study|Personal Reasons|1|||
130909505|NCT00450112|471303296|FG000|Overall Study|Other Treatment Required|5|||
130909506|NCT00450112|471303297|FG001|Overall Study|Other Treatment Required|1|||
131030217|NCT02783300|471744476|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
131030218|NCT02783300|471744477|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030219|NCT02783300|471744478|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030220|NCT02783300|471744479|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030221|NCT02783300|471744480|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030222|NCT02783300|471744481|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030223|NCT02783300|471744482|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
131030224|NCT02783300|471744483|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030225|NCT02783300|471744484|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030226|NCT02783300|471744485|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130696452|NCT02435433|470514413|FG003|Overall Study|Withdrawal by Subject|0|||
130696453|NCT02435433|470514414|FG004|Overall Study|Withdrawal by Subject|0|||
130696454|NCT02435433|470514410|FG000|Overall Study|Lost to Follow-up|2|||
130696455|NCT02435433|470514411|FG001|Overall Study|Lost to Follow-up|2|||
130696456|NCT02435433|470514412|FG002|Overall Study|Lost to Follow-up|4|||
130696457|NCT02435433|470514413|FG003|Overall Study|Lost to Follow-up|1|||
130696458|NCT02435433|470514414|FG004|Overall Study|Lost to Follow-up|0|||
130696459|NCT00757705|470514415|FG000|Overall Study|Adverse Event|19|||
130696460|NCT00757705|470514415|FG000|Overall Study|Lost to Follow-up|16|||
130696461|NCT00757705|470514415|FG000|Overall Study|Withdrawal by Subject|25|||
130696462|NCT00757705|470514415|FG000|Overall Study|Insufficient Response|26|||
130696463|NCT00757705|470514415|FG000|Overall Study|Ineligible to continue|8|||
130696464|NCT00757705|470514415|FG000|Overall Study|Non-compliant|9|||
130696465|NCT00757705|470514415|FG000|Overall Study|Other|18|||
130696466|NCT00659815|470514416|FG000|Overall Study|Study related symptoms and complaints|2|||
130696467|NCT00659815|470514417|FG001|Overall Study|Study related symptoms and complaints|1|||
130696468|NCT00659815|470514416|FG000|Overall Study|Inability to maintain wearing schedule|1|||
130696469|NCT00659815|470514417|FG001|Overall Study|Inability to maintain wearing schedule|2|||
130696470|NCT00659815|470514416|FG000|Overall Study|Withdrawal by Subject|1|||
130696471|NCT00659815|470514417|FG001|Overall Study|Withdrawal by Subject|1|||
130696472|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
130696473|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
130696474|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
130696475|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
130696476|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
130696477|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
130696478|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
130696479|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
130696480|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
130696481|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
130696482|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
130696483|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
130696484|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
130696485|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
130696486|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
130696487|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
130696488|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
130696489|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
130696490|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
130696491|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
130696492|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
130696493|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
130696494|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
130696495|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
130696496|NCT01710358|470514418|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
130696497|NCT01710358|470514419|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
130696498|NCT01710358|470514420|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
130696499|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
130696500|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
130696501|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
130696502|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
130696503|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
130696504|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
130696505|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
130696506|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
130696507|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
130696508|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
130696509|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
130696510|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
130696511|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
130696512|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
130696513|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
130696514|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
130696515|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
130696516|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
130696517|NCT01710358|470514418|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
130696518|NCT01710358|470514419|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
130696519|NCT01710358|470514420|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
130696520|NCT01710358|470514418|FG000|Rescue Period|Adverse Event|0|||
130696521|NCT01710358|470514419|FG001|Rescue Period|Adverse Event|15|||
130696522|NCT01710358|470514420|FG002|Rescue Period|Adverse Event|0|||
130696523|NCT01710358|470514418|FG000|Rescue Period|Death|0|||
130696524|NCT01710358|470514419|FG001|Rescue Period|Death|1|||
130696525|NCT01710358|470514420|FG002|Rescue Period|Death|0|||
130696526|NCT01710358|470514418|FG000|Rescue Period|Lack of Efficacy|0|||
130696527|NCT01710358|470514419|FG001|Rescue Period|Lack of Efficacy|7|||
130696528|NCT01710358|470514420|FG002|Rescue Period|Lack of Efficacy|0|||
130696529|NCT01710358|470514418|FG000|Rescue Period|Withdrawal by Subject|0|||
130696530|NCT01710358|470514419|FG001|Rescue Period|Withdrawal by Subject|8|||
130696531|NCT01710358|470514420|FG002|Rescue Period|Withdrawal by Subject|0|||
130696532|NCT00640393|470514428|FG000|Part 1|Lost to Follow-up|2|||
130696533|NCT00640393|470514429|FG001|Part 1|Lost to Follow-up|0|||
131116076|NCT00733304|472057586|FG002|Overall Study|Lost to Follow-up|0|||
131116077|NCT00733304|472057584|FG000|Overall Study|Physician Decision|3|||
131116078|NCT00733304|472057585|FG001|Overall Study|Physician Decision|1|||
131116079|NCT00733304|472057586|FG002|Overall Study|Physician Decision|3|||
131116080|NCT00733304|472057584|FG000|Overall Study|Withdrawal by Subject|1|||
131116081|NCT00733304|472057585|FG001|Overall Study|Withdrawal by Subject|1|||
131116082|NCT00733304|472057586|FG002|Overall Study|Withdrawal by Subject|0|||
131116083|NCT03155373|472057596|FG000|Overall Study|No longer required surgery|1|||
131116084|NCT03155373|472057596|FG000|Overall Study|Protocol Violation|1|||
131116085|NCT03155373|472057596|FG000|Overall Study|Death|2|||
131116086|NCT03155373|472057596|FG000|Overall Study|Withdrawal by Subject|3|||
131116087|NCT00596934|472057597|FG000|Overall Study|Protocol Violation|1|||
131116088|NCT00596934|472057597|FG000|Overall Study|Withdrawal by Subject|1|||
131116089|NCT01214187|472057602|FG000|Overall Study|Adverse Event|6|||
131116090|NCT01214187|472057603|FG001|Overall Study|Adverse Event|2|||
131116091|NCT01214187|472057602|FG000|Overall Study|Death|1|||
131116092|NCT01214187|472057603|FG001|Overall Study|Death|1|||
131116093|NCT01214187|472057602|FG000|Overall Study|Withdrawal by Subject|0|||
131116094|NCT01214187|472057603|FG001|Overall Study|Withdrawal by Subject|3|||
131116095|NCT02308007|472057607|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
131116096|NCT02308007|472057608|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
131116097|NCT02308007|472057609|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
130696534|NCT00640393|470514430|FG002|Part 1|Lost to Follow-up|0|||
130696535|NCT00640393|470514428|FG000|Part 1|Withdrawal by Subject|3|||
130696536|NCT00640393|470514429|FG001|Part 1|Withdrawal by Subject|0|||
130696537|NCT00640393|470514430|FG002|Part 1|Withdrawal by Subject|0|||
130696538|NCT00640393|470514428|FG000|Randomization|Withdrawn per protocol|17|||
130696539|NCT00640393|470514429|FG001|Randomization|Withdrawn per protocol|0|||
130696540|NCT00640393|470514430|FG002|Randomization|Withdrawn per protocol|0|||
130696541|NCT00640393|470514428|FG000|Randomization|Never randomized by site|2|||
130696542|NCT00640393|470514429|FG001|Randomization|Never randomized by site|0|||
130696543|NCT00640393|470514430|FG002|Randomization|Never randomized by site|0|||
130696544|NCT00640393|470514428|FG000|Part 2|Lost to Follow-up|0|||
130696545|NCT00640393|470514429|FG001|Part 2|Lost to Follow-up|2|||
130696546|NCT00640393|470514430|FG002|Part 2|Lost to Follow-up|2|||
130696547|NCT00640393|470514428|FG000|Part 2|Withdrawal by Subject|0|||
130696548|NCT00640393|470514429|FG001|Part 2|Withdrawal by Subject|6|||
130696549|NCT00640393|470514430|FG002|Part 2|Withdrawal by Subject|1|||
130696550|NCT00640393|470514428|FG000|Part 2|Non-adherence|0|||
130696551|NCT00640393|470514429|FG001|Part 2|Non-adherence|1|||
130696552|NCT00640393|470514430|FG002|Part 2|Non-adherence|0|||
130696553|NCT00640393|470514428|FG000|Part 2|Adverse Event|0|||
130696554|NCT00640393|470514429|FG001|Part 2|Adverse Event|1|||
130696555|NCT00640393|470514430|FG002|Part 2|Adverse Event|0|||
130696556|NCT04406194|470514431|FG000|Period 1|Withdrawal by Subject|0|||
130696557|NCT04406194|470514432|FG001|Period 1|Withdrawal by Subject|1|||
130696558|NCT00396162|470514433|FG000|Overall Study|Withdrawal by Subject|2|||
130696559|NCT00396162|470514434|FG001|Overall Study|Withdrawal by Subject|3|||
130696560|NCT03540160|470514436|FG000|Overall Study|Protocol Violation|1|||
130696561|NCT03540160|470514436|FG000|Overall Study|Physician Decision|8|||
130696562|NCT03540160|470514436|FG000|Overall Study|Lack of Efficacy|60|||
130696563|NCT03540160|470514436|FG000|Overall Study|Pregnancy|1|||
130696564|NCT03540160|470514436|FG000|Overall Study|Adverse Event|20|||
130696565|NCT03540160|470514436|FG000|Overall Study|Withdrawal by Subject|68|||
130696566|NCT03540160|470514436|FG000|Overall Study|COVID-19|2|||
130696567|NCT03540160|470514436|FG000|Overall Study|Study Closure|10|||
130696568|NCT03540160|470514436|FG000|Overall Study|Lost to Follow-up|18|||
130696569|NCT03540160|470514436|FG000|Overall Study|Sponsor decision|191|||
130696570|NCT01664039|470514439|FG000|Overall Study|Adverse Event|3|||
130696571|NCT01664039|470514440|FG001|Overall Study|Adverse Event|4|||
130696572|NCT01664039|470514439|FG000|Overall Study|Lost to Follow-up|1|||
131116098|NCT02308007|472057607|FG000|Overall Study|Positive for STD at Baseline|7|||
131116099|NCT02308007|472057608|FG001|Overall Study|Positive for STD at Baseline|11|||
131116100|NCT02308007|472057609|FG002|Overall Study|Positive for STD at Baseline|7|||
131116101|NCT02308007|472057607|FG000|Overall Study|Lost to Follow-up|3|||
130909507|NCT00450112|471303296|FG000|Overall Study|Withdrawal by Subject|4|||
130909508|NCT00450112|471303297|FG001|Overall Study|Withdrawal by Subject|1|||
130909509|NCT00450112|471303296|FG000|Overall Study|Lost to Follow-up|2|||
130909510|NCT00450112|471303297|FG001|Overall Study|Lost to Follow-up|1|||
130909511|NCT00450112|471303296|FG000|Overall Study|Others|2|||
130909512|NCT00450112|471303297|FG001|Overall Study|Others|3|||
130909513|NCT05153473|471303298|FG000|Overall Study|Death|46|||
130909514|NCT05153473|471303298|FG000|Overall Study|Lost to Follow-up|3|||
130909515|NCT02962765|471303299|FG000|Overall Study|Protocol Violation|9|||
130909516|NCT02962765|471303299|FG000|Overall Study|Withdrawal by Subject|3|||
130909517|NCT02962765|471303299|FG000|Overall Study|Lost to Follow-up|1|||
130909518|NCT02962765|471303299|FG000|Overall Study|Death|1|||
130909519|NCT02962765|471303299|FG000|Overall Study|Limited access to study medication|3|||
130909520|NCT00064298|471303304|FG000|Overall Study|Withdrawal by Subject|2|||
130909521|NCT00064298|471303305|FG001|Overall Study|Withdrawal by Subject|1|||
130909522|NCT00064298|471303304|FG000|Overall Study|Lost to Follow-up|2|||
130909523|NCT00064298|471303305|FG001|Overall Study|Lost to Follow-up|2|||
130909524|NCT00064298|471303304|FG000|Overall Study|Death|0|||
130909525|NCT00064298|471303305|FG001|Overall Study|Death|1|||
130909526|NCT00064298|471303304|FG000|Overall Study|Disease Progression|2|||
130909527|NCT00064298|471303305|FG001|Overall Study|Disease Progression|1|||
130909528|NCT03614975|471303306|FG000|Overall Study|Physician Decision|7|||
130909529|NCT03614975|471303307|FG001|Overall Study|Physician Decision|5|||
130909530|NCT03614975|471303306|FG000|Overall Study|Withdrawal by Subject|2|||
130909531|NCT03614975|471303307|FG001|Overall Study|Withdrawal by Subject|2|||
130909532|NCT03614975|471303306|FG000|Overall Study|Specimens not in lab batch shipment|1|||
130909533|NCT03614975|471303307|FG001|Overall Study|Specimens not in lab batch shipment|1|||
130909534|NCT01569464|471303308|FG000|Overall Study|Adverse Event|4|||
130909535|NCT01569464|471303309|FG001|Overall Study|Adverse Event|0|||
130909536|NCT01569464|471303308|FG000|Overall Study|Lack of Efficacy|1|||
130909537|NCT01569464|471303309|FG001|Overall Study|Lack of Efficacy|0|||
130909538|NCT01569464|471303308|FG000|Overall Study|Protocol Violation|1|||
130909539|NCT01569464|471303309|FG001|Overall Study|Protocol Violation|0|||
130909540|NCT01569464|471303308|FG000|Overall Study|Lost to Follow-up|2|||
130909541|NCT01569464|471303309|FG001|Overall Study|Lost to Follow-up|3|||
130909542|NCT01569464|471303308|FG000|Overall Study|Withdrawal by Subject|1|||
130909543|NCT01569464|471303309|FG001|Overall Study|Withdrawal by Subject|1|||
130909544|NCT01569464|471303308|FG000|Overall Study|Other|1|||
130909545|NCT01569464|471303309|FG001|Overall Study|Other|1|||
131116102|NCT02308007|472057608|FG001|Overall Study|Lost to Follow-up|0|||
131116103|NCT02308007|472057609|FG002|Overall Study|Lost to Follow-up|1|||
131116104|NCT03678103|472057610|FG000|Overall Study|Withdrawn prior to completion|4|||
131116105|NCT01241552|472057615|FG000|Overall Study|Lack of Efficacy|1|||
131116106|NCT01241552|472057616|FG001|Overall Study|Lack of Efficacy|0|||
131116107|NCT01241552|472057617|FG002|Overall Study|Lack of Efficacy|0|||
131116108|NCT01241552|472057618|FG003|Overall Study|Lack of Efficacy|0|||
131222811|NCT03674827|472443185|FG000|Treatment Phase|Death|2|||
131222812|NCT03674827|472443186|FG001|Treatment Phase|Death|0|||
131222813|NCT03674827|472443187|FG002|Treatment Phase|Death|0|||
131222814|NCT03674827|472443188|FG003|Treatment Phase|Death|0|||
131222815|NCT03674827|472443189|FG004|Treatment Phase|Death|1|||
131222816|NCT03674827|472443190|FG005|Treatment Phase|Death|0|||
131222817|NCT03674827|472443185|FG000|Treatment Phase|Progressive Disease|0|||
131222818|NCT03674827|472443186|FG001|Treatment Phase|Progressive Disease|4|||
131222819|NCT03674827|472443187|FG002|Treatment Phase|Progressive Disease|3|||
131222820|NCT03674827|472443188|FG003|Treatment Phase|Progressive Disease|4|||
131222821|NCT03674827|472443189|FG004|Treatment Phase|Progressive Disease|4|||
130696573|NCT01664039|470514440|FG001|Overall Study|Lost to Follow-up|1|||
131116109|NCT01241552|472057615|FG000|Overall Study|Death|26|||
131116110|NCT01241552|472057616|FG001|Overall Study|Death|30|||
130909546|NCT03533686|471303310|FG000|Overall Study|Withdrawal by Subject|1|||
130909547|NCT03533686|471303311|FG001|Overall Study|Withdrawal by Subject|0|||
130909548|NCT03533686|471303312|FG002|Overall Study|Withdrawal by Subject|0|||
131116111|NCT01241552|472057617|FG002|Overall Study|Death|20|||
131116112|NCT01241552|472057618|FG003|Overall Study|Death|25|||
131116113|NCT01241552|472057615|FG000|Overall Study|Adverse Event|1|||
131116114|NCT01241552|472057616|FG001|Overall Study|Adverse Event|1|||
131116115|NCT01241552|472057617|FG002|Overall Study|Adverse Event|0|||
130696574|NCT01664039|470514439|FG000|Overall Study|Withdrawal by Subject|1|||
130909549|NCT03533686|471303313|FG003|Overall Study|Withdrawal by Subject|3|||
130909550|NCT03533686|471303314|FG004|Overall Study|Withdrawal by Subject|5|||
131116116|NCT01241552|472057618|FG003|Overall Study|Adverse Event|0|||
130909551|NCT03533686|471303315|FG005|Overall Study|Withdrawal by Subject|1|||
130909552|NCT03533686|471303310|FG000|Overall Study|Lost to Follow-up|0|||
130909553|NCT03533686|471303311|FG001|Overall Study|Lost to Follow-up|1|||
130909554|NCT03533686|471303312|FG002|Overall Study|Lost to Follow-up|0|||
130909555|NCT03533686|471303313|FG003|Overall Study|Lost to Follow-up|0|||
130909556|NCT03533686|471303314|FG004|Overall Study|Lost to Follow-up|2|||
130909557|NCT03533686|471303315|FG005|Overall Study|Lost to Follow-up|0|||
131116117|NCT01241552|472057615|FG000|Overall Study|Technical Problems|2|||
130909558|NCT03533686|471303310|FG000|Overall Study|Screen Failure|0|||
130909559|NCT03533686|471303311|FG001|Overall Study|Screen Failure|0|||
130909560|NCT03533686|471303312|FG002|Overall Study|Screen Failure|0|||
130909561|NCT03533686|471303313|FG003|Overall Study|Screen Failure|2|||
130909562|NCT03533686|471303314|FG004|Overall Study|Screen Failure|0|||
130909563|NCT03533686|471303315|FG005|Overall Study|Screen Failure|0|||
130909564|NCT00772070|471303316|FG000|Overall Study|Lost to Follow-up|0|||
130909565|NCT00772070|471303317|FG001|Overall Study|Lost to Follow-up|8|||
130909566|NCT00772070|471303316|FG000|Overall Study|Withdrawal by Subject|0|||
130909567|NCT00772070|471303317|FG001|Overall Study|Withdrawal by Subject|2|||
130909568|NCT00772070|471303316|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
130909569|NCT00772070|471303317|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
130909570|NCT01309308|471303318|FG000|Overall Study|Lost to Follow-up|6|||
130909571|NCT01309308|471303319|FG001|Overall Study|Lost to Follow-up|4|||
130909572|NCT01017575|471303320|FG000|Overall Study|Lack of Efficacy|0|||
130909573|NCT01017575|471303321|FG001|Overall Study|Lack of Efficacy|1|||
130909574|NCT01017575|471303322|FG002|Overall Study|Lack of Efficacy|0|||
130909575|NCT01017575|471303323|FG003|Overall Study|Lack of Efficacy|1|||
130909576|NCT01017575|471303324|FG004|Overall Study|Lack of Efficacy|1|||
130909577|NCT01017575|471303320|FG000|Overall Study|Adverse Event|0|||
130909578|NCT01017575|471303321|FG001|Overall Study|Adverse Event|1|||
130909579|NCT01017575|471303322|FG002|Overall Study|Adverse Event|0|||
130909580|NCT01017575|471303323|FG003|Overall Study|Adverse Event|0|||
130909581|NCT01017575|471303324|FG004|Overall Study|Adverse Event|2|||
130909582|NCT01017575|471303320|FG000|Overall Study|Withdrawal by Subject|1|||
131116118|NCT01241552|472057616|FG001|Overall Study|Technical Problems|0|||
131116119|NCT01241552|472057617|FG002|Overall Study|Technical Problems|2|||
131116120|NCT01241552|472057618|FG003|Overall Study|Technical Problems|2|||
131116121|NCT01241552|472057615|FG000|Overall Study|Progressive Disease|0|||
131116122|NCT01241552|472057616|FG001|Overall Study|Progressive Disease|0|||
131116123|NCT01241552|472057617|FG002|Overall Study|Progressive Disease|1|||
131116124|NCT01241552|472057618|FG003|Overall Study|Progressive Disease|2|||
131116125|NCT01241552|472057615|FG000|Overall Study|Protocol Violation|0|||
131116126|NCT01241552|472057616|FG001|Overall Study|Protocol Violation|2|||
131116127|NCT01241552|472057617|FG002|Overall Study|Protocol Violation|6|||
131116128|NCT01241552|472057618|FG003|Overall Study|Protocol Violation|1|||
131116129|NCT01241552|472057615|FG000|Overall Study|Withdrawal by Subject|7|||
131116130|NCT01241552|472057616|FG001|Overall Study|Withdrawal by Subject|15|||
131116131|NCT01241552|472057617|FG002|Overall Study|Withdrawal by Subject|14|||
131116132|NCT01241552|472057618|FG003|Overall Study|Withdrawal by Subject|15|||
131116133|NCT01241552|472057615|FG000|Overall Study|Physician Decision|2|||
131116134|NCT01241552|472057616|FG001|Overall Study|Physician Decision|4|||
131116135|NCT01241552|472057617|FG002|Overall Study|Physician Decision|2|||
131116136|NCT01241552|472057618|FG003|Overall Study|Physician Decision|3|||
131116137|NCT01241552|472057615|FG000|Overall Study|Lost to Follow-up|2|||
130909583|NCT01017575|471303321|FG001|Overall Study|Withdrawal by Subject|0|||
131116138|NCT01241552|472057616|FG001|Overall Study|Lost to Follow-up|11|||
131116139|NCT01241552|472057617|FG002|Overall Study|Lost to Follow-up|15|||
131116140|NCT01241552|472057618|FG003|Overall Study|Lost to Follow-up|16|||
131116141|NCT00528567|472057619|FG000|Overall Study|Death|4|||
131116142|NCT00528567|472057620|FG001|Overall Study|Death|5|||
131116143|NCT00528567|472057619|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
131116144|NCT00528567|472057620|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
131116145|NCT00528567|472057619|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
131116146|NCT00528567|472057620|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
131116147|NCT00528567|472057619|FG000|Overall Study|Violation Criteria at Entry|3|||
131116148|NCT00528567|472057620|FG001|Overall Study|Violation Criteria at Entry|17|||
131116149|NCT00528567|472057619|FG000|Overall Study|Withdrew Consent|59|||
131116150|NCT00528567|472057620|FG001|Overall Study|Withdrew Consent|55|||
131116151|NCT00528567|472057619|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
131116152|NCT00528567|472057620|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
131116153|NCT00528567|472057619|FG000|Overall Study|Failure to Return|1|||
130909584|NCT01017575|471303322|FG002|Overall Study|Withdrawal by Subject|0|||
130909585|NCT01017575|471303323|FG003|Overall Study|Withdrawal by Subject|0|||
131116154|NCT00528567|472057620|FG001|Overall Study|Failure to Return|4|||
130909586|NCT01017575|471303324|FG004|Overall Study|Withdrawal by Subject|0|||
130909587|NCT04271280|471303325|FG000|Overall Study|Lost to Follow-up|300|||
131116155|NCT00528567|472057619|FG000|Overall Study|Other Protocol Violation|5|||
131116156|NCT00528567|472057620|FG001|Overall Study|Other Protocol Violation|21|||
130909588|NCT04271280|471303325|FG000|Overall Study|Death|153|||
130909589|NCT04271280|471303325|FG000|Overall Study|Withdrawal of consent by patient|59|||
131116157|NCT00528567|472057619|FG000|Overall Study|Administrative/Other|22|||
131116158|NCT00528567|472057620|FG001|Overall Study|Administrative/Other|75|||
131116159|NCT00631189|472057623|FG000|Initial Phase|Protocol Violation|347|||
131116160|NCT00631189|472057624|FG001|Initial Phase|Protocol Violation|0|||
131222822|NCT03674827|472443190|FG005|Treatment Phase|Progressive Disease|9|||
130909590|NCT04271280|471303325|FG000|Overall Study|Other|51|||
130909591|NCT04271280|471303325|FG000|Overall Study|No end of study information|42|||
130909592|NCT01539317|471303326|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
130909593|NCT01539317|471303327|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
131116161|NCT00631189|472057625|FG002|Initial Phase|Protocol Violation|0|||
131116162|NCT00631189|472057626|FG003|Initial Phase|Protocol Violation|0|||
131116163|NCT00631189|472057623|FG000|Initial Phase|Withdrawal by Subject|4|||
131116164|NCT00631189|472057624|FG001|Initial Phase|Withdrawal by Subject|0|||
131116165|NCT00631189|472057625|FG002|Initial Phase|Withdrawal by Subject|0|||
131116166|NCT00631189|472057626|FG003|Initial Phase|Withdrawal by Subject|0|||
131116167|NCT00631189|472057623|FG000|Treatment Phase|Withdrawal by Subject|0|||
131116168|NCT00631189|472057624|FG001|Treatment Phase|Withdrawal by Subject|2|||
131116169|NCT00631189|472057625|FG002|Treatment Phase|Withdrawal by Subject|1|||
131116170|NCT00631189|472057626|FG003|Treatment Phase|Withdrawal by Subject|1|||
131116171|NCT00631189|472057623|FG000|Treatment Phase|Protocol Violation|0|||
131116172|NCT00631189|472057624|FG001|Treatment Phase|Protocol Violation|1|||
131116173|NCT00631189|472057625|FG002|Treatment Phase|Protocol Violation|6|||
131116174|NCT00631189|472057626|FG003|Treatment Phase|Protocol Violation|2|||
131116175|NCT00631189|472057623|FG000|Treatment Phase|Adverse Event|0|||
131116176|NCT00631189|472057624|FG001|Treatment Phase|Adverse Event|3|||
131116177|NCT00631189|472057625|FG002|Treatment Phase|Adverse Event|2|||
131116178|NCT00631189|472057626|FG003|Treatment Phase|Adverse Event|4|||
131116179|NCT00631189|472057623|FG000|Treatment Phase|Lost to Follow-up|0|||
131116180|NCT00631189|472057624|FG001|Treatment Phase|Lost to Follow-up|1|||
131116181|NCT00631189|472057625|FG002|Treatment Phase|Lost to Follow-up|0|||
131116182|NCT00631189|472057626|FG003|Treatment Phase|Lost to Follow-up|0|||
131116183|NCT00631189|472057623|FG000|Treatment Phase|Pregnancy|0|||
130909594|NCT02359851|471303344|FG000|Overall Study|Death|1|||
130909595|NCT02359851|471303344|FG000|Overall Study|Disease progression|1|||
131116184|NCT00631189|472057624|FG001|Treatment Phase|Pregnancy|0|||
131116185|NCT00631189|472057625|FG002|Treatment Phase|Pregnancy|1|||
131116186|NCT00631189|472057626|FG003|Treatment Phase|Pregnancy|0|||
131116187|NCT00631189|472057623|FG000|Treatment Phase|patient did not take pravastatin|0|||
131116188|NCT00631189|472057624|FG001|Treatment Phase|patient did not take pravastatin|0|||
131116189|NCT00631189|472057625|FG002|Treatment Phase|patient did not take pravastatin|1|||
131116190|NCT00631189|472057626|FG003|Treatment Phase|patient did not take pravastatin|0|||
131116191|NCT01132612|472057627|FG000|Overall Study|Death|0|||
131116192|NCT01132612|472057628|FG001|Overall Study|Death|0|||
131116193|NCT01132612|472057629|FG002|Overall Study|Death|1|||
131116194|NCT01132612|472057627|FG000|Overall Study|Protocol deviation|0|||
131116195|NCT01132612|472057628|FG001|Overall Study|Protocol deviation|0|||
131116196|NCT01132612|472057629|FG002|Overall Study|Protocol deviation|3|||
131116197|NCT01132612|472057627|FG000|Overall Study|Lost to Follow-up|2|||
131116198|NCT01132612|472057628|FG001|Overall Study|Lost to Follow-up|2|||
131116199|NCT01132612|472057629|FG002|Overall Study|Lost to Follow-up|7|||
131116200|NCT01132612|472057627|FG000|Overall Study|Adverse Event|5|||
131116201|NCT01132612|472057628|FG001|Overall Study|Adverse Event|2|||
131116202|NCT01132612|472057629|FG002|Overall Study|Adverse Event|15|||
131116203|NCT01132612|472057627|FG000|Overall Study|Withdrawal by Subject|5|||
131116204|NCT01132612|472057628|FG001|Overall Study|Withdrawal by Subject|8|||
131116205|NCT01132612|472057629|FG002|Overall Study|Withdrawal by Subject|19|||
131116206|NCT01132612|472057627|FG000|Overall Study|Administrative problems|5|||
131116207|NCT01132612|472057628|FG001|Overall Study|Administrative problems|1|||
131116208|NCT01132612|472057629|FG002|Overall Study|Administrative problems|52|||
131116209|NCT01132612|472057627|FG000|Overall Study|Lack of Efficacy|23|||
131116210|NCT01132612|472057628|FG001|Overall Study|Lack of Efficacy|22|||
131116211|NCT01132612|472057629|FG002|Overall Study|Lack of Efficacy|73|||
131116212|NCT02252536|472057630|FG000|Overall Study|Lost to Follow-up|5|||
131116213|NCT02252536|472057631|FG001|Overall Study|Lost to Follow-up|3|||
131116214|NCT01438151|472057633|FG000|Overall Study|study terminated|8|||
131116215|NCT01026142|472057644|FG000|Overall Study|Death|136|||
131116216|NCT01026142|472057645|FG001|Overall Study|Death|134|||
131116217|NCT01026142|472057644|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
131116218|NCT01026142|472057645|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
131116219|NCT04178967|472057648|FG000|Induction Period|Adverse Event|4|||
131116220|NCT04178967|472057649|FG001|Induction Period|Adverse Event|6|||
131116221|NCT04178967|472057650|FG002|Induction Period|Adverse Event|0|||
131116222|NCT04178967|472057651|FG003|Induction Period|Adverse Event|0|||
131116223|NCT04178967|472057652|FG004|Induction Period|Adverse Event|0|||
131116224|NCT04178967|472057653|FG005|Induction Period|Adverse Event|0|||
131116225|NCT04178967|472057654|FG006|Induction Period|Adverse Event|0|||
131116226|NCT04178967|472057655|FG007|Induction Period|Adverse Event|0|||
131116227|NCT04178967|472057656|FG008|Induction Period|Adverse Event|0|||
131116228|NCT04178967|472057657|FG009|Induction Period|Adverse Event|0|||
131116229|NCT04178967|472057658|FG010|Induction Period|Adverse Event|0|||
131116230|NCT04178967|472057648|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
131116231|NCT04178967|472057649|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
131116232|NCT04178967|472057650|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
131116233|NCT04178967|472057651|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
131116234|NCT04178967|472057652|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
131116235|NCT04178967|472057653|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
131116236|NCT04178967|472057654|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
130909596|NCT01888003|471303345|FG000|Overall Study|Study Terminated|5|||
130909597|NCT01888003|471303346|FG001|Overall Study|Study Terminated|6|||
130909598|NCT01888003|471303347|FG002|Overall Study|Study Terminated|40|||
130909599|NCT01854944|471303348|FG000|Overall Study|Withdrawal by Subject|0|||
130909600|NCT01854944|471303349|FG001|Overall Study|Withdrawal by Subject|0|||
130909601|NCT01854944|471303350|FG002|Overall Study|Withdrawal by Subject|1|||
130909602|NCT02101112|471303351|FG000|Overall Study|Adverse Event|0|||
130909603|NCT02101112|471303352|FG001|Overall Study|Adverse Event|0|||
130909604|NCT02101112|471303353|FG002|Overall Study|Adverse Event|1|||
130909605|NCT02101112|471303354|FG003|Overall Study|Adverse Event|0|||
130909606|NCT02101112|471303355|FG004|Overall Study|Adverse Event|0|||
130909607|NCT02101112|471303356|FG005|Overall Study|Adverse Event|0|||
130909608|NCT02101112|471303351|FG000|Overall Study|Withdrawal by Subject|0|||
130909609|NCT02101112|471303352|FG001|Overall Study|Withdrawal by Subject|0|||
130909610|NCT02101112|471303353|FG002|Overall Study|Withdrawal by Subject|0|||
130909611|NCT02101112|471303354|FG003|Overall Study|Withdrawal by Subject|0|||
130909612|NCT02101112|471303355|FG004|Overall Study|Withdrawal by Subject|1|||
130909613|NCT02101112|471303356|FG005|Overall Study|Withdrawal by Subject|0|||
130909614|NCT02125604|471303357|FG000|Overall Study|Other|4|||
130909615|NCT02125604|471303357|FG000|Overall Study|Investigator Decision|1|||
130909616|NCT02125604|471303357|FG000|Overall Study|Lost to Follow-up|2|||
130909617|NCT02125604|471303357|FG000|Overall Study|Consent Withdrawn|4|||
130909618|NCT02125604|471303357|FG000|Overall Study|Adverse Event|20|||
130909619|NCT01857583|471303360|FG000|Overall Study|Adverse Event|0|||
130909620|NCT01857583|471303361|FG001|Overall Study|Adverse Event|0|||
130909621|NCT01857583|471303362|FG002|Overall Study|Adverse Event|1|||
130909622|NCT01857583|471303363|FG003|Overall Study|Adverse Event|1|||
130909623|NCT01857583|471303360|FG000|Overall Study|Death|0|||
130909624|NCT01857583|471303361|FG001|Overall Study|Death|1|||
130909625|NCT01857583|471303362|FG002|Overall Study|Death|1|||
130909626|NCT01857583|471303363|FG003|Overall Study|Death|0|||
130909627|NCT01857583|471303360|FG000|Overall Study|Physician Decision|0|||
130909628|NCT01857583|471303361|FG001|Overall Study|Physician Decision|0|||
130909629|NCT01857583|471303362|FG002|Overall Study|Physician Decision|0|||
130909630|NCT01857583|471303363|FG003|Overall Study|Physician Decision|1|||
130909631|NCT01857583|471303360|FG000|Overall Study|Withdrawal by Subject|1|||
130909632|NCT01857583|471303361|FG001|Overall Study|Withdrawal by Subject|0|||
130909633|NCT01857583|471303362|FG002|Overall Study|Withdrawal by Subject|1|||
131030227|NCT02783300|471744486|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030228|NCT02783300|471744487|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030229|NCT02783300|471744488|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030230|NCT02783300|471744489|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030231|NCT02783300|471744490|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030232|NCT02783300|471744491|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030233|NCT02783300|471744492|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030234|NCT02783300|471744493|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030235|NCT02783300|471744494|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030236|NCT02783300|471744495|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030237|NCT02783300|471744496|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
131030238|NCT02783300|471744470|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030239|NCT02783300|471744471|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030240|NCT02783300|471744472|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030241|NCT02783300|471744473|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030242|NCT02783300|471744474|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
131030243|NCT02783300|471744475|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030244|NCT02783300|471744476|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
131030245|NCT02783300|471744477|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030246|NCT02783300|471744478|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030247|NCT02783300|471744479|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
131030248|NCT02783300|471744480|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131116237|NCT04178967|472057655|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
131116238|NCT04178967|472057656|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
130696575|NCT01664039|470514440|FG001|Overall Study|Withdrawal by Subject|3|||
130696576|NCT01664039|470514439|FG000|Overall Study|Noncompliance|1|||
130909634|NCT01857583|471303363|FG003|Overall Study|Withdrawal by Subject|2|||
130909635|NCT00458536|471303366|FG000|Overall Study|Disease progression prior to treatment|7|||
130909636|NCT00458536|471303366|FG000|Overall Study|Unable to make vaccine|3|||
130909637|NCT00458536|471303366|FG000|Overall Study|No measurable disease after surgery|2|||
130909638|NCT00458536|471303366|FG000|Overall Study|Did not have renal cell carcinoma|2|||
130909639|NCT00458536|471303366|FG000|Overall Study|Patient did not have surgery|1|||
130909640|NCT00458536|471303366|FG000|Overall Study|Ineligible due to toxicity|1|||
130909641|NCT00458536|471303366|FG000|Overall Study|Withdrawal by Subject|1|||
130909642|NCT00458536|471303366|FG000|Overall Study|Progressive disease during treatment|2|||
130909643|NCT03287635|471303369|FG000|Overall Study|Lost to Follow-up|5|||
130909644|NCT03287635|471303369|FG000|Overall Study|Withdrawal by Subject|1|||
130909645|NCT03287635|471303369|FG000|Overall Study|Physician Decision|1|||
130909646|NCT00323869|471303370|FG000|Overall Study|Death|1|||
130909647|NCT02294773|471305174|FG000|Overall Study|Withdrawal by Subject|0|||
130909648|NCT02294773|471305175|FG001|Overall Study|Withdrawal by Subject|2|||
130909649|NCT03052764|471305176|FG000|Double-Blind Treatment Period|Adverse Event|2|||
130909650|NCT03052764|471305177|FG001|Double-Blind Treatment Period|Adverse Event|0|||
131030249|NCT02783300|471744481|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030250|NCT02783300|471744482|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
131030251|NCT02783300|471744483|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030252|NCT02783300|471744484|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030253|NCT02783300|471744485|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030254|NCT02783300|471744486|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030255|NCT02783300|471744487|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030256|NCT02783300|471744488|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030257|NCT02783300|471744489|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030258|NCT02783300|471744490|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030259|NCT02783300|471744491|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030260|NCT02783300|471744492|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030261|NCT02783300|471744493|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030262|NCT02783300|471744494|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030263|NCT02783300|471744495|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030264|NCT02783300|471744496|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
131030265|NCT02783300|471744470|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030266|NCT02783300|471744471|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030267|NCT02783300|471744472|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030268|NCT02783300|471744473|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030269|NCT02783300|471744474|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030270|NCT02783300|471744475|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030271|NCT02783300|471744476|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030272|NCT02783300|471744477|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030273|NCT02783300|471744478|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030274|NCT02783300|471744479|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030275|NCT02783300|471744480|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030276|NCT02783300|471744481|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030277|NCT02783300|471744482|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030278|NCT02783300|471744483|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030279|NCT02783300|471744484|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030280|NCT02783300|471744485|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
131030281|NCT02783300|471744486|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030282|NCT02783300|471744487|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
131030283|NCT02783300|471744488|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
131030284|NCT02783300|471744489|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
131030285|NCT02783300|471744490|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030286|NCT02783300|471744491|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030287|NCT02783300|471744492|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030288|NCT02783300|471744493|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030289|NCT02783300|471744494|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
131030290|NCT02783300|471744495|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030291|NCT02783300|471744496|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
131030292|NCT02783300|471744470|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030293|NCT02783300|471744471|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030294|NCT02783300|471744472|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030295|NCT02783300|471744473|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030296|NCT02783300|471744474|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030297|NCT02783300|471744475|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030298|NCT02783300|471744476|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030299|NCT02783300|471744477|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030300|NCT02783300|471744478|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130909651|NCT03052764|471305176|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
130909652|NCT03052764|471305177|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
130909653|NCT03052764|471305176|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
130909654|NCT03052764|471305177|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
130909655|NCT03052764|471305176|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
130909656|NCT03052764|471305177|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130909657|NCT03052764|471305176|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
130909658|NCT03052764|471305177|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
130909659|NCT04478123|471305178|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
130909660|NCT04478123|471305178|FG000|Overall Study|NE|1|||
130909661|NCT04444895|471305179|FG000|Overall Study|Adverse Event|2|||
130909662|NCT04444895|471305179|FG000|Overall Study|Lost to Follow-up|2|||
130909663|NCT04444895|471305179|FG000|Overall Study|Withdrawal by Subject|5|||
130909664|NCT03581786|471305182|FG000|Overall Study|Death|67|||
130909665|NCT03581786|471305183|FG001|Overall Study|Death|47|||
130909666|NCT03581786|471305182|FG000|Overall Study|Withdrawal by Subject|2|||
130909667|NCT03581786|471305183|FG001|Overall Study|Withdrawal by Subject|5|||
130909668|NCT03581786|471305182|FG000|Overall Study|Lost to Follow-up|7|||
130909669|NCT03581786|471305183|FG001|Overall Study|Lost to Follow-up|4|||
130909670|NCT03581786|471305182|FG000|Overall Study|reason other than specified above|0|||
130909671|NCT03581786|471305183|FG001|Overall Study|reason other than specified above|1|||
130909672|NCT05523323|471305184|FG000|Overall Study|Death|26|||
130909673|NCT05523323|471305185|FG001|Overall Study|Death|21|||
130909674|NCT05523323|471305184|FG000|Overall Study|Ongoing participants|35|||
130909675|NCT05523323|471305185|FG001|Overall Study|Ongoing participants|30|||
130909676|NCT03435640|471305186|FG000|Overall Study|Withdrawal by Subject|0|||
130909677|NCT03435640|471305187|FG001|Overall Study|Withdrawal by Subject|1|||
130909678|NCT03435640|471305188|FG002|Overall Study|Withdrawal by Subject|0|||
130909679|NCT03435640|471305189|FG003|Overall Study|Withdrawal by Subject|2|||
130909680|NCT03435640|471305190|FG004|Overall Study|Withdrawal by Subject|0|||
130909681|NCT03435640|471305191|FG005|Overall Study|Withdrawal by Subject|0|||
131030301|NCT02783300|471744479|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030302|NCT02783300|471744480|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030303|NCT02783300|471744481|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030304|NCT02783300|471744482|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030305|NCT02783300|471744483|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030306|NCT02783300|471744484|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030307|NCT02783300|471744485|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030308|NCT02783300|471744486|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
131030309|NCT02783300|471744487|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030310|NCT02783300|471744488|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
131030311|NCT02783300|471744489|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
131030312|NCT02783300|471744490|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030313|NCT02783300|471744491|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030314|NCT02783300|471744492|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030315|NCT02783300|471744493|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030316|NCT02783300|471744494|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030317|NCT02783300|471744495|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030318|NCT02783300|471744496|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
131030319|NCT02783300|471744470|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030320|NCT02783300|471744471|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030321|NCT02783300|471744472|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030322|NCT02783300|471744473|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030323|NCT02783300|471744474|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030324|NCT02783300|471744475|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030325|NCT02783300|471744476|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030326|NCT02783300|471744477|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030327|NCT02783300|471744478|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030328|NCT02783300|471744479|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030329|NCT02783300|471744480|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030330|NCT02783300|471744481|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030331|NCT02783300|471744482|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030332|NCT02783300|471744483|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030333|NCT02783300|471744484|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130909682|NCT03435640|471305192|FG006|Overall Study|Withdrawal by Subject|3|||
130696577|NCT01664039|470514440|FG001|Overall Study|Noncompliance|1|||
130909683|NCT03435640|471305193|FG007|Overall Study|Withdrawal by Subject|0|||
130909684|NCT03435640|471305194|FG008|Overall Study|Withdrawal by Subject|0|||
130909685|NCT03435640|471305195|FG009|Overall Study|Withdrawal by Subject|2|||
130909686|NCT03435640|471305196|FG010|Overall Study|Withdrawal by Subject|3|||
130909687|NCT03435640|471305186|FG000|Overall Study|Lost to Follow-up|0|||
130909688|NCT03435640|471305187|FG001|Overall Study|Lost to Follow-up|0|||
130909689|NCT03435640|471305188|FG002|Overall Study|Lost to Follow-up|1|||
130909690|NCT03435640|471305189|FG003|Overall Study|Lost to Follow-up|0|||
130909691|NCT03435640|471305190|FG004|Overall Study|Lost to Follow-up|0|||
130909692|NCT03435640|471305191|FG005|Overall Study|Lost to Follow-up|0|||
130909693|NCT03435640|471305192|FG006|Overall Study|Lost to Follow-up|0|||
130909694|NCT03435640|471305193|FG007|Overall Study|Lost to Follow-up|0|||
130909695|NCT03435640|471305194|FG008|Overall Study|Lost to Follow-up|0|||
130909696|NCT03435640|471305195|FG009|Overall Study|Lost to Follow-up|0|||
130909697|NCT03435640|471305196|FG010|Overall Study|Lost to Follow-up|0|||
130909698|NCT01347307|471305199|FG000|Overall Study|Death|0|||
130909699|NCT01347307|471305200|FG001|Overall Study|Death|4|||
130909700|NCT01347307|471305199|FG000|Overall Study|Physician Decision|0|||
130909701|NCT01347307|471305200|FG001|Overall Study|Physician Decision|1|||
130909702|NCT00920829|471305210|FG000|Allocation|No post randomization data|3|||
130909703|NCT00920829|471305211|FG001|Allocation|No post randomization data|1|||
130909704|NCT00920829|471305212|FG002|Allocation|No post randomization data|0|||
130909705|NCT00920829|471305213|FG003|Allocation|No post randomization data|2|||
130909706|NCT00920829|471305210|FG000|Available for Analysis|Withdrawal by Subject|6|||
130909707|NCT00920829|471305211|FG001|Available for Analysis|Withdrawal by Subject|6|||
130909708|NCT00920829|471305212|FG002|Available for Analysis|Withdrawal by Subject|6|||
130909709|NCT00920829|471305213|FG003|Available for Analysis|Withdrawal by Subject|10|||
130909710|NCT00920829|471305210|FG000|Available for Analysis|Required Medical Treatment|0|||
130909711|NCT00920829|471305211|FG001|Available for Analysis|Required Medical Treatment|1|||
130909712|NCT00920829|471305212|FG002|Available for Analysis|Required Medical Treatment|2|||
130909713|NCT00920829|471305213|FG003|Available for Analysis|Required Medical Treatment|0|||
130909714|NCT00920829|471305210|FG000|Available for Analysis|Adverse Event|1|||
130909715|NCT00920829|471305211|FG001|Available for Analysis|Adverse Event|2|||
130909716|NCT00920829|471305212|FG002|Available for Analysis|Adverse Event|1|||
130909717|NCT00920829|471305213|FG003|Available for Analysis|Adverse Event|0|||
130909718|NCT00920829|471305210|FG000|Available for Analysis|Death|1|||
130909719|NCT00920829|471305211|FG001|Available for Analysis|Death|0|||
130909720|NCT00920829|471305212|FG002|Available for Analysis|Death|0|||
130909721|NCT00920829|471305213|FG003|Available for Analysis|Death|0|||
130909722|NCT00920829|471305210|FG000|Available for Analysis|Protocol Violation|0|||
130909723|NCT00920829|471305211|FG001|Available for Analysis|Protocol Violation|0|||
130909724|NCT00920829|471305212|FG002|Available for Analysis|Protocol Violation|1|||
130909725|NCT00920829|471305213|FG003|Available for Analysis|Protocol Violation|0|||
130909726|NCT00920829|471305210|FG000|Available for Analysis|Required more treatment|0|||
130909727|NCT00920829|471305211|FG001|Available for Analysis|Required more treatment|2|||
130909728|NCT00920829|471305212|FG002|Available for Analysis|Required more treatment|0|||
130909729|NCT00920829|471305213|FG003|Available for Analysis|Required more treatment|1|||
130909730|NCT04123665|471305214|FG000|Overall Study|Withdrawal by Subject|7|||
130909731|NCT04123665|471305215|FG001|Overall Study|Withdrawal by Subject|0|||
130909732|NCT04123665|471305214|FG000|Overall Study|Lost to Follow-up|1|||
130909733|NCT04123665|471305215|FG001|Overall Study|Lost to Follow-up|0|||
130909734|NCT03183778|471305218|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
131030334|NCT02783300|471744485|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030335|NCT02783300|471744486|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
131030336|NCT02783300|471744487|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030337|NCT02783300|471744488|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
131030338|NCT02783300|471744489|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
130768694|NCT03959488|470778553|FG000|Season 2|Other|0|||
130768695|NCT03959488|470778554|FG001|Season 2|Other|0|||
130768696|NCT03959488|470778555|FG002|Season 2|Other|2|||
130768697|NCT03959488|470778556|FG003|Season 2|Other|0|||
130768698|NCT03959488|470778557|FG004|Season 2|Other|0|||
130768699|NCT03959488|470778553|FG000|Season 2|Withdrawal by parent/guardian|0|||
130768700|NCT03959488|470778554|FG001|Season 2|Withdrawal by parent/guardian|0|||
130909735|NCT00721123|471305220|FG000|Overall Study|Adverse Event|96|||
130909736|NCT00721123|471305220|FG000|Overall Study|Death|10|||
130909737|NCT00721123|471305220|FG000|Overall Study|Insufficient Therapeutic Response|21|||
130909738|NCT00721123|471305220|FG000|Overall Study|Protocol Violation|1|||
130909739|NCT00721123|471305220|FG000|Overall Study|Refused Treatment|41|||
130909740|NCT00721123|471305220|FG000|Overall Study|Failure to Return|9|||
130909741|NCT00721123|471305220|FG000|Overall Study|Withdrawal by Subject|5|||
131030339|NCT02783300|471744490|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
130768701|NCT03959488|470778555|FG002|Season 2|Withdrawal by parent/guardian|3|||
130768702|NCT03959488|470778556|FG003|Season 2|Withdrawal by parent/guardian|1|||
130909742|NCT03954041|471305229|FG000|Overall Study|Lost to Follow-up|3|||
130909743|NCT03954041|471305230|FG001|Overall Study|Lost to Follow-up|3|||
130909744|NCT03954041|471305231|FG002|Overall Study|Lost to Follow-up|6|||
130909745|NCT03954041|471305229|FG000|Overall Study|Death|4|||
130909746|NCT03954041|471305230|FG001|Overall Study|Death|0|||
130909747|NCT03954041|471305231|FG002|Overall Study|Death|1|||
131116239|NCT04178967|472057657|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
131116240|NCT04178967|472057658|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
131116241|NCT04178967|472057648|FG000|Induction Period|Lack of Efficacy|4|||
131116242|NCT04178967|472057649|FG001|Induction Period|Lack of Efficacy|1|||
131116243|NCT04178967|472057650|FG002|Induction Period|Lack of Efficacy|0|||
131116244|NCT04178967|472057651|FG003|Induction Period|Lack of Efficacy|0|||
131116245|NCT04178967|472057652|FG004|Induction Period|Lack of Efficacy|0|||
131116246|NCT04178967|472057653|FG005|Induction Period|Lack of Efficacy|0|||
131116247|NCT04178967|472057654|FG006|Induction Period|Lack of Efficacy|0|||
131116248|NCT04178967|472057655|FG007|Induction Period|Lack of Efficacy|0|||
131116249|NCT04178967|472057656|FG008|Induction Period|Lack of Efficacy|0|||
131116250|NCT04178967|472057657|FG009|Induction Period|Lack of Efficacy|0|||
131116251|NCT04178967|472057658|FG010|Induction Period|Lack of Efficacy|0|||
131116252|NCT04178967|472057648|FG000|Induction Period|Protocol Violation|0|||
131116253|NCT04178967|472057649|FG001|Induction Period|Protocol Violation|6|||
131116254|NCT04178967|472057650|FG002|Induction Period|Protocol Violation|0|||
131116255|NCT04178967|472057651|FG003|Induction Period|Protocol Violation|0|||
131116256|NCT04178967|472057652|FG004|Induction Period|Protocol Violation|0|||
131116257|NCT04178967|472057653|FG005|Induction Period|Protocol Violation|0|||
131116258|NCT04178967|472057654|FG006|Induction Period|Protocol Violation|0|||
131116259|NCT04178967|472057655|FG007|Induction Period|Protocol Violation|0|||
131116260|NCT04178967|472057656|FG008|Induction Period|Protocol Violation|0|||
131116261|NCT04178967|472057657|FG009|Induction Period|Protocol Violation|0|||
131116262|NCT04178967|472057658|FG010|Induction Period|Protocol Violation|0|||
131116263|NCT04178967|472057648|FG000|Induction Period|Withdrawal by Subject|6|||
131116264|NCT04178967|472057649|FG001|Induction Period|Withdrawal by Subject|4|||
131116265|NCT04178967|472057650|FG002|Induction Period|Withdrawal by Subject|0|||
131116266|NCT04178967|472057651|FG003|Induction Period|Withdrawal by Subject|0|||
131116267|NCT04178967|472057652|FG004|Induction Period|Withdrawal by Subject|0|||
131116268|NCT04178967|472057653|FG005|Induction Period|Withdrawal by Subject|0|||
131116269|NCT04178967|472057654|FG006|Induction Period|Withdrawal by Subject|0|||
131116270|NCT04178967|472057655|FG007|Induction Period|Withdrawal by Subject|0|||
131116271|NCT04178967|472057656|FG008|Induction Period|Withdrawal by Subject|0|||
131116272|NCT04178967|472057657|FG009|Induction Period|Withdrawal by Subject|0|||
131116273|NCT04178967|472057658|FG010|Induction Period|Withdrawal by Subject|0|||
131116274|NCT04178967|472057648|FG000|Induction Period|Lost to Follow-up|2|||
131116275|NCT04178967|472057649|FG001|Induction Period|Lost to Follow-up|0|||
131116276|NCT04178967|472057650|FG002|Induction Period|Lost to Follow-up|0|||
131116277|NCT04178967|472057651|FG003|Induction Period|Lost to Follow-up|0|||
131116278|NCT04178967|472057652|FG004|Induction Period|Lost to Follow-up|0|||
131116279|NCT04178967|472057653|FG005|Induction Period|Lost to Follow-up|0|||
131116280|NCT04178967|472057654|FG006|Induction Period|Lost to Follow-up|0|||
131116281|NCT04178967|472057655|FG007|Induction Period|Lost to Follow-up|0|||
131116282|NCT04178967|472057656|FG008|Induction Period|Lost to Follow-up|0|||
131116283|NCT04178967|472057657|FG009|Induction Period|Lost to Follow-up|0|||
131116284|NCT04178967|472057658|FG010|Induction Period|Lost to Follow-up|0|||
131116285|NCT04178967|472057648|FG000|Induction Period|Participant Missed Study Visits|0|||
131116286|NCT04178967|472057649|FG001|Induction Period|Participant Missed Study Visits|1|||
131116287|NCT04178967|472057650|FG002|Induction Period|Participant Missed Study Visits|0|||
131116288|NCT04178967|472057651|FG003|Induction Period|Participant Missed Study Visits|0|||
131116289|NCT04178967|472057652|FG004|Induction Period|Participant Missed Study Visits|0|||
131116290|NCT04178967|472057653|FG005|Induction Period|Participant Missed Study Visits|0|||
131116291|NCT04178967|472057654|FG006|Induction Period|Participant Missed Study Visits|0|||
131116292|NCT04178967|472057655|FG007|Induction Period|Participant Missed Study Visits|0|||
130909748|NCT03954041|471305229|FG000|Overall Study|Death by neurologic criteria|0|||
131116293|NCT04178967|472057656|FG008|Induction Period|Participant Missed Study Visits|0|||
131116294|NCT04178967|472057657|FG009|Induction Period|Participant Missed Study Visits|0|||
131116295|NCT04178967|472057658|FG010|Induction Period|Participant Missed Study Visits|0|||
131116296|NCT04178967|472057648|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
131116297|NCT04178967|472057649|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
130696578|NCT03358147|470514446|FG000|Overall Study|Withdrawal by Subject|13|||
130696579|NCT03358147|470514447|FG001|Overall Study|Withdrawal by Subject|19|||
130696580|NCT03358147|470514448|FG002|Overall Study|Withdrawal by Subject|16|||
130696581|NCT03358147|470514449|FG003|Overall Study|Withdrawal by Subject|10|||
131116298|NCT04178967|472057650|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
131116299|NCT04178967|472057651|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
131116300|NCT04178967|472057652|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
131116301|NCT04178967|472057653|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
130909749|NCT03954041|471305230|FG001|Overall Study|Death by neurologic criteria|0|||
130909750|NCT03954041|471305231|FG002|Overall Study|Death by neurologic criteria|1|||
131116302|NCT04178967|472057654|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
130909751|NCT03954041|471305229|FG000|Overall Study|Reason not specified|7|||
131116303|NCT04178967|472057655|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
131116304|NCT04178967|472057656|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
130909752|NCT03954041|471305230|FG001|Overall Study|Reason not specified|4|||
130909753|NCT03954041|471305231|FG002|Overall Study|Reason not specified|2|||
130909754|NCT03954041|471305229|FG000|Overall Study|Withdrew prior to dosing|4|||
130909755|NCT03954041|471305230|FG001|Overall Study|Withdrew prior to dosing|2|||
130909756|NCT03954041|471305231|FG002|Overall Study|Withdrew prior to dosing|0|||
130909757|NCT00206076|471305235|FG000|Overall Study|Physician Decision|2|||
130909758|NCT00206076|471305236|FG001|Overall Study|Physician Decision|0|||
130909759|NCT00206076|471305235|FG000|Overall Study|Withdrawal by Subject|1|||
130909760|NCT00206076|471305236|FG001|Overall Study|Withdrawal by Subject|1|||
130909761|NCT03355664|471305239|FG000|Overall Study|Adverse Event|1|||
130909762|NCT03355664|471305240|FG001|Overall Study|Adverse Event|2|||
130909763|NCT03355664|471305239|FG000|Overall Study|Lost to Follow-up|11|||
130909764|NCT03355664|471305240|FG001|Overall Study|Lost to Follow-up|7|||
130909765|NCT03355664|471305239|FG000|Overall Study|Protocol Violation|1|||
130909766|NCT03355664|471305240|FG001|Overall Study|Protocol Violation|2|||
130909767|NCT03355664|471305239|FG000|Overall Study|Withdrawal by Subject|2|||
130909768|NCT03355664|471305240|FG001|Overall Study|Withdrawal by Subject|1|||
130909769|NCT01751802|471305243|FG000|Overall Study|Adverse Event|4|||
130909770|NCT01751802|471305244|FG001|Overall Study|Adverse Event|2|||
130909771|NCT00750880|471305247|FG000|Overall Study|Adverse Event|76|||
130909772|NCT00750880|471305247|FG000|Overall Study|Death|4|||
130909773|NCT00750880|471305247|FG000|Overall Study|Lack of Efficacy|46|||
130909774|NCT00750880|471305247|FG000|Overall Study|Lost to Follow-up|10|||
130909775|NCT00750880|471305247|FG000|Overall Study|Protocol Violation|15|||
130909776|NCT00750880|471305247|FG000|Overall Study|Withdrawal by Subject|33|||
130909777|NCT00750880|471305247|FG000|Overall Study|Physician Decision|20|||
130909778|NCT00750880|471305247|FG000|Overall Study|Administrative|11|||
130909779|NCT02964507|471305253|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
130909780|NCT02964507|471305254|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
130909781|NCT02964507|471305255|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
130909782|NCT02964507|471305256|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
130909783|NCT02964507|471305257|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
130909784|NCT02964507|471305258|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
130909785|NCT02964507|471305259|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
130909786|NCT02964507|471305260|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
130909787|NCT02964507|471305253|FG000|Overall Study|Study terminated by Sponsor|9|||
130909788|NCT02964507|471305254|FG001|Overall Study|Study terminated by Sponsor|1|||
130909789|NCT02964507|471305255|FG002|Overall Study|Study terminated by Sponsor|9|||
130909790|NCT02964507|471305256|FG003|Overall Study|Study terminated by Sponsor|3|||
130909791|NCT02964507|471305257|FG004|Overall Study|Study terminated by Sponsor|3|||
130909792|NCT02964507|471305258|FG005|Overall Study|Study terminated by Sponsor|2|||
130909793|NCT02964507|471305259|FG006|Overall Study|Study terminated by Sponsor|0|||
130909794|NCT02964507|471305260|FG007|Overall Study|Study terminated by Sponsor|0|||
130909795|NCT02964507|471305253|FG000|Overall Study|Other|3|||
130909796|NCT02964507|471305254|FG001|Overall Study|Other|0|||
130909797|NCT02964507|471305255|FG002|Overall Study|Other|0|||
130909798|NCT02964507|471305256|FG003|Overall Study|Other|0|||
130909799|NCT02964507|471305257|FG004|Overall Study|Other|1|||
130909800|NCT02964507|471305258|FG005|Overall Study|Other|0|||
130696582|NCT03358147|470514450|FG004|Overall Study|Withdrawal by Subject|5|||
130696583|NCT03358147|470514446|FG000|Overall Study|Adverse Event|3|||
130696584|NCT03358147|470514447|FG001|Overall Study|Adverse Event|9|||
130696585|NCT03358147|470514448|FG002|Overall Study|Adverse Event|7|||
130909801|NCT02964507|471305259|FG006|Overall Study|Other|0|||
130909802|NCT02964507|471305260|FG007|Overall Study|Other|0|||
130909803|NCT02964507|471305253|FG000|Overall Study|Death|11|||
130909804|NCT02964507|471305254|FG001|Overall Study|Death|9|||
130909805|NCT02964507|471305255|FG002|Overall Study|Death|12|||
130909806|NCT02964507|471305256|FG003|Overall Study|Death|2|||
130909807|NCT02964507|471305257|FG004|Overall Study|Death|10|||
130909808|NCT02964507|471305258|FG005|Overall Study|Death|5|||
131030340|NCT02783300|471744491|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030341|NCT02783300|471744492|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030342|NCT02783300|471744493|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030343|NCT02783300|471744494|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030344|NCT02783300|471744495|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030345|NCT02783300|471744496|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
131030346|NCT02783300|471744470|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030347|NCT02783300|471744471|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030348|NCT02783300|471744472|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030349|NCT02783300|471744473|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
130696586|NCT03358147|470514449|FG003|Overall Study|Adverse Event|5|||
130696587|NCT03358147|470514450|FG004|Overall Study|Adverse Event|2|||
130909809|NCT02964507|471305259|FG006|Overall Study|Death|0|||
130909810|NCT02964507|471305260|FG007|Overall Study|Death|0|||
130909811|NCT02964507|471305253|FG000|Overall Study|Withdrawal by Subject|1|||
130909812|NCT02964507|471305254|FG001|Overall Study|Withdrawal by Subject|0|||
130909813|NCT02964507|471305255|FG002|Overall Study|Withdrawal by Subject|1|||
130909814|NCT02964507|471305256|FG003|Overall Study|Withdrawal by Subject|1|||
130909815|NCT02964507|471305257|FG004|Overall Study|Withdrawal by Subject|0|||
131116305|NCT04178967|472057657|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
131116306|NCT04178967|472057658|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
131116307|NCT04178967|472057648|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131116308|NCT04178967|472057649|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131116309|NCT04178967|472057650|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131116310|NCT04178967|472057651|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131116311|NCT04178967|472057652|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131116312|NCT04178967|472057653|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
131116313|NCT04178967|472057654|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131116314|NCT04178967|472057655|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131116315|NCT04178967|472057656|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131116316|NCT04178967|472057657|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131116317|NCT04178967|472057658|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
131116318|NCT04178967|472057648|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131116319|NCT04178967|472057649|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131116320|NCT04178967|472057650|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131116321|NCT04178967|472057651|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
131116322|NCT04178967|472057652|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131116323|NCT04178967|472057653|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131116324|NCT04178967|472057654|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131116325|NCT04178967|472057655|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131116326|NCT04178967|472057656|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131116327|NCT04178967|472057657|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131116328|NCT04178967|472057658|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
131116329|NCT04178967|472057648|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
130909816|NCT02964507|471305258|FG005|Overall Study|Withdrawal by Subject|1|||
130909817|NCT02964507|471305259|FG006|Overall Study|Withdrawal by Subject|0|||
130909818|NCT02964507|471305260|FG007|Overall Study|Withdrawal by Subject|0|||
130909819|NCT02964507|471305253|FG000|Overall Study|Physician Decision|2|||
130909820|NCT02964507|471305254|FG001|Overall Study|Physician Decision|0|||
130909821|NCT02964507|471305255|FG002|Overall Study|Physician Decision|3|||
130909822|NCT02964507|471305256|FG003|Overall Study|Physician Decision|0|||
130909823|NCT02964507|471305257|FG004|Overall Study|Physician Decision|1|||
130909824|NCT02964507|471305258|FG005|Overall Study|Physician Decision|0|||
130909825|NCT02964507|471305259|FG006|Overall Study|Physician Decision|0|||
131116330|NCT04178967|472057649|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
131116331|NCT04178967|472057650|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
131116332|NCT04178967|472057651|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
131116333|NCT04178967|472057652|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
131116334|NCT04178967|472057653|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
131116335|NCT04178967|472057654|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
131116336|NCT04178967|472057655|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
131116337|NCT04178967|472057656|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
131116338|NCT04178967|472057657|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
131116339|NCT04178967|472057658|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
131116340|NCT04178967|472057648|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130696588|NCT03358147|470514446|FG000|Overall Study|Lost to Follow-up|4|||
130909826|NCT02964507|471305260|FG007|Overall Study|Physician Decision|0|||
130909827|NCT02495233|471305261|FG000|Overall Study|Miscellaneous|0|||
130909828|NCT02495233|471305262|FG001|Overall Study|Miscellaneous|1|||
130909829|NCT03880461|471305263|FG000|Overall Study|Determined ineligible after enrollment|45|||
130909830|NCT03880461|471305264|FG001|Overall Study|Determined ineligible after enrollment|44|||
130909831|NCT03880461|471305263|FG000|Overall Study|No weight measurement after enrollment|24|||
130909832|NCT03880461|471305264|FG001|Overall Study|No weight measurement after enrollment|17|||
130909833|NCT02652767|471305266|FG000|Overall Study|Death|2|||
130909834|NCT02652767|471305266|FG000|Overall Study|Lost to Follow-up|1|||
130909835|NCT02652767|471305266|FG000|Overall Study|Withdrawal by Subject|1|||
130909836|NCT01115803|471305268|FG000|Overall Study|Withdrawal by Subject|0|||
130909837|NCT01115803|471305269|FG001|Overall Study|Withdrawal by Subject|0|||
130909838|NCT01115803|471305270|FG002|Overall Study|Withdrawal by Subject|0|||
130909839|NCT01115803|471305271|FG003|Overall Study|Withdrawal by Subject|0|||
130909840|NCT01115803|471305272|FG004|Overall Study|Withdrawal by Subject|0|||
130909841|NCT01115803|471305273|FG005|Overall Study|Withdrawal by Subject|0|||
130909842|NCT01115803|471305274|FG006|Overall Study|Withdrawal by Subject|1|||
130909843|NCT01115803|471305268|FG000|Overall Study|Lost to Follow-up|0|||
130696589|NCT03358147|470514447|FG001|Overall Study|Lost to Follow-up|3|||
130909844|NCT01115803|471305269|FG001|Overall Study|Lost to Follow-up|0|||
130909845|NCT01115803|471305270|FG002|Overall Study|Lost to Follow-up|1|||
130909846|NCT01115803|471305271|FG003|Overall Study|Lost to Follow-up|0|||
130909847|NCT01115803|471305272|FG004|Overall Study|Lost to Follow-up|0|||
130909848|NCT01115803|471305273|FG005|Overall Study|Lost to Follow-up|0|||
130909849|NCT01115803|471305274|FG006|Overall Study|Lost to Follow-up|0|||
130909850|NCT01115803|471305268|FG000|Overall Study|Progressive Disease during Cycle1|0|||
130909851|NCT01115803|471305269|FG001|Overall Study|Progressive Disease during Cycle1|0|||
130909852|NCT01115803|471305270|FG002|Overall Study|Progressive Disease during Cycle1|0|||
130909853|NCT01115803|471305271|FG003|Overall Study|Progressive Disease during Cycle1|0|||
130909854|NCT01115803|471305272|FG004|Overall Study|Progressive Disease during Cycle1|0|||
130909855|NCT01115803|471305273|FG005|Overall Study|Progressive Disease during Cycle1|0|||
130909856|NCT01115803|471305274|FG006|Overall Study|Progressive Disease during Cycle1|1|||
130909857|NCT03475875|471305275|FG000|Period 1|Lost to Follow-up|1|||
130909858|NCT03475875|471305276|FG001|Period 1|Lost to Follow-up|0|||
130909859|NCT03475875|471305275|FG000|Period 1|Adverse Event|2|||
130909860|NCT03475875|471305276|FG001|Period 1|Adverse Event|1|||
130909861|NCT03475875|471305275|FG000|Period 2|Adverse Event|3|||
130909862|NCT03475875|471305276|FG001|Period 2|Adverse Event|0|||
130909863|NCT03475875|471305275|FG000|Period 2|Protocol Violation|0|||
130909864|NCT03475875|471305276|FG001|Period 2|Protocol Violation|1|||
130909865|NCT01642407|471305277|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
130909866|NCT01642407|471305277|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
130909867|NCT01642407|471305277|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
130909868|NCT04025710|471305278|FG000|Overall Study|Death|3|||
130909869|NCT04025710|471305278|FG000|Overall Study|Lost to Follow-up|5|||
131116341|NCT04178967|472057649|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131116342|NCT04178967|472057650|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131116343|NCT04178967|472057651|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131116344|NCT04178967|472057652|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
130909870|NCT04025710|471305278|FG000|Overall Study|Withdrawal by Subject|1|||
130909871|NCT04025710|471305278|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
130909872|NCT04025710|471305278|FG000|Overall Study|Drop-out according to protocol|34|||
130909873|NCT02431247|471305279|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
130909874|NCT02431247|471305280|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
130909875|NCT02431247|471305281|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
130909876|NCT02431247|471305279|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
130909877|NCT02431247|471305280|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
130909878|NCT02431247|471305281|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
130909879|NCT02431247|471305279|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
130909880|NCT02431247|471305280|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
130909881|NCT02431247|471305281|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
130909882|NCT02431247|471305279|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
130909883|NCT02431247|471305280|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
130909884|NCT02431247|471305281|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
130909885|NCT02431247|471305279|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
131116345|NCT04178967|472057653|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
131116346|NCT04178967|472057654|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131116347|NCT04178967|472057655|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
131116348|NCT04178967|472057656|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130909886|NCT02431247|471305280|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
130909887|NCT02431247|471305281|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
130909888|NCT02431247|471305279|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
130909889|NCT02431247|471305280|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
130909890|NCT02431247|471305281|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
130909891|NCT02431247|471305279|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
130909892|NCT02431247|471305280|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
131116349|NCT04178967|472057657|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131116350|NCT04178967|472057658|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
131116351|NCT04178967|472057648|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130909893|NCT02431247|471305281|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
130909894|NCT02431247|471305279|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
130909895|NCT02431247|471305280|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
130909896|NCT02431247|471305281|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
131116352|NCT04178967|472057649|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130768703|NCT03959488|470778557|FG004|Season 2|Withdrawal by parent/guardian|1|||
130768704|NCT03959488|470778553|FG000|Season 2|Lost to Follow-up|0|||
130768705|NCT03959488|470778554|FG001|Season 2|Lost to Follow-up|0|||
130909897|NCT02431247|471305279|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
130909898|NCT02431247|471305280|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
130909899|NCT02431247|471305281|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
130909900|NCT02431247|471305279|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
130909901|NCT02431247|471305280|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
130909902|NCT02431247|471305281|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
130909903|NCT02431247|471305279|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
130909904|NCT02431247|471305280|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
130909905|NCT02431247|471305281|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
130909906|NCT02431247|471305279|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
130909907|NCT02431247|471305280|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
130909908|NCT02431247|471305281|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
130909909|NCT02431247|471305279|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
130909910|NCT02431247|471305280|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
130909911|NCT02431247|471305281|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
130909912|NCT02431247|471305279|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
130909913|NCT02431247|471305280|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
130909914|NCT02431247|471305281|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
130909915|NCT01562873|471305282|FG000|Overall Study|Disease Progression per RECIST|10|||
130909916|NCT01562873|471305283|FG001|Overall Study|Disease Progression per RECIST|0|||
130909917|NCT01562873|471305282|FG000|Overall Study|Adverse Event|1|||
130909918|NCT01562873|471305283|FG001|Overall Study|Adverse Event|0|||
130909919|NCT01562873|471305282|FG000|Overall Study|Clinical Disease Progression|9|||
130909920|NCT01562873|471305283|FG001|Overall Study|Clinical Disease Progression|0|||
130909921|NCT01562873|471305282|FG000|Overall Study|Clinical PD and adverse event|1|||
130909922|NCT01562873|471305283|FG001|Overall Study|Clinical PD and adverse event|0|||
130909923|NCT01484938|471305284|FG000|Overall Study|Adverse Event|2|||
130909924|NCT01484938|471305284|FG000|Overall Study|Lost to Follow-up|1|||
130909925|NCT01484938|471305284|FG000|Overall Study|Noncompliance|1|||
130909926|NCT02942576|471305286|FG000|Overall Study|Adverse Event|28|||
130909927|NCT02942576|471305287|FG001|Overall Study|Adverse Event|6|||
130909928|NCT02942576|471305286|FG000|Overall Study|Withdrawal by Subject|7|||
130909929|NCT02942576|471305287|FG001|Overall Study|Withdrawal by Subject|5|||
130909930|NCT02942576|471305286|FG000|Overall Study|Physician Decision|1|||
130909931|NCT02942576|471305287|FG001|Overall Study|Physician Decision|4|||
130909932|NCT02942576|471305286|FG000|Overall Study|Other|10|||
130909933|NCT02942576|471305287|FG001|Overall Study|Other|8|||
130909934|NCT00938964|471305288|FG000|Overall Study|Death|3|||
130909935|NCT00938964|471305289|FG001|Overall Study|Death|3|||
130909936|NCT00938964|471305288|FG000|Overall Study|Lost to Follow-up|2|||
130909937|NCT00938964|471305289|FG001|Overall Study|Lost to Follow-up|3|||
130909938|NCT00938964|471305288|FG000|Overall Study|Withdrawal by Subject|22|||
130909939|NCT00938964|471305289|FG001|Overall Study|Withdrawal by Subject|18|||
130909940|NCT00938964|471305288|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
130909941|NCT00938964|471305289|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
130909942|NCT01858636|471305290|FG000|Overall Study|No Device Deployment Attempted|24|||
130909943|NCT01858636|471305290|FG000|Overall Study|Physician Decision|1|||
130909944|NCT01858636|471305290|FG000|Overall Study|Death|1|||
130909945|NCT01858636|471305290|FG000|Overall Study|Lost to Follow-up|1|||
130909946|NCT01858636|471305290|FG000|Overall Study|Withdrawal by Subject|1|||
130909947|NCT03523000|471305294|FG000|Overall Study|Withdrawal by Subject|3|||
130909948|NCT03523000|471305295|FG001|Overall Study|Withdrawal by Subject|0|||
130909949|NCT03523000|471305294|FG000|Overall Study|Unsuccessful trial|2|||
130909950|NCT03523000|471305295|FG001|Overall Study|Unsuccessful trial|0|||
130909951|NCT01227564|471305301|FG000|Overall Study|No Longer Willing to Participate|4|||
130909952|NCT01227564|471305302|FG001|Overall Study|No Longer Willing to Participate|2|||
130909953|NCT01227564|471305303|FG002|Overall Study|No Longer Willing to Participate|5|||
130909954|NCT01227564|471305301|FG000|Overall Study|Participant moved to another town|0|||
130909955|NCT01227564|471305302|FG001|Overall Study|Participant moved to another town|0|||
131116353|NCT04178967|472057650|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
131116354|NCT04178967|472057651|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
130909956|NCT01227564|471305303|FG002|Overall Study|Participant moved to another town|1|||
130909957|NCT02862600|471305312|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
130909958|NCT02862600|471305312|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
130909959|NCT02862600|471305312|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
130909960|NCT02862600|471305312|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
130909961|NCT00194675|471305324|FG000|Overall Study|Lost to Follow-up|1|||
131116355|NCT04178967|472057652|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
130909962|NCT00194675|471305325|FG001|Overall Study|Lost to Follow-up|1|||
130909963|NCT00194675|471305324|FG000|Overall Study|lack of interest|1|||
130909964|NCT00194675|471305325|FG001|Overall Study|lack of interest|1|||
130909965|NCT00194675|471305324|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
130909966|NCT00194675|471305325|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
130909967|NCT00194675|471305324|FG000|Overall Study|Protocol Violation|1|||
131116356|NCT04178967|472057653|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
131116357|NCT04178967|472057654|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
131116358|NCT04178967|472057655|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
131116359|NCT04178967|472057656|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
131116360|NCT04178967|472057657|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
131116361|NCT04178967|472057658|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
131116362|NCT04178967|472057648|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131116363|NCT04178967|472057649|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131116364|NCT04178967|472057650|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131116365|NCT04178967|472057651|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
131116366|NCT04178967|472057652|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130768706|NCT03959488|470778555|FG002|Season 2|Lost to Follow-up|1|||
130768707|NCT03959488|470778556|FG003|Season 2|Lost to Follow-up|0|||
130768708|NCT03959488|470778557|FG004|Season 2|Lost to Follow-up|1|||
130768709|NCT01760447|470778558|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
130768710|NCT01760447|470778559|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
130768711|NCT01760447|470778560|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
130768712|NCT01760447|470778561|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
130768713|NCT01760447|470778558|FG000|Weeks 0-20|Withdrawal by Subject|2|||
130768714|NCT01760447|470778559|FG001|Weeks 0-20|Withdrawal by Subject|0|||
130768715|NCT01760447|470778560|FG002|Weeks 0-20|Withdrawal by Subject|1|||
130768716|NCT01760447|470778561|FG003|Weeks 0-20|Withdrawal by Subject|0|||
130768717|NCT01760447|470778558|FG000|Weeks 0-20|Lost to Follow-up|1|||
130768718|NCT01760447|470778559|FG001|Weeks 0-20|Lost to Follow-up|0|||
130768719|NCT01760447|470778560|FG002|Weeks 0-20|Lost to Follow-up|1|||
130768720|NCT01760447|470778561|FG003|Weeks 0-20|Lost to Follow-up|1|||
130768721|NCT01760447|470778558|FG000|Weeks 0-20|Randomized but not treated|0|||
130768722|NCT01760447|470778559|FG001|Weeks 0-20|Randomized but not treated|0|||
130768723|NCT01760447|470778560|FG002|Weeks 0-20|Randomized but not treated|2|||
130768724|NCT01760447|470778561|FG003|Weeks 0-20|Randomized but not treated|0|||
130768725|NCT01760447|470778558|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
130768726|NCT01760447|470778559|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
130768727|NCT01760447|470778560|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
130768728|NCT01760447|470778561|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
130768729|NCT01760447|470778558|FG000|Weeks 20-54|Withdrawal by Subject|2|||
130768730|NCT01760447|470778559|FG001|Weeks 20-54|Withdrawal by Subject|1|||
130768731|NCT01760447|470778560|FG002|Weeks 20-54|Withdrawal by Subject|1|||
130768732|NCT01760447|470778561|FG003|Weeks 20-54|Withdrawal by Subject|2|||
130768733|NCT01760447|470778558|FG000|Weeks 20-54|Lost to Follow-up|0|||
130768734|NCT01760447|470778559|FG001|Weeks 20-54|Lost to Follow-up|0|||
130768735|NCT01760447|470778560|FG002|Weeks 20-54|Lost to Follow-up|1|||
130768736|NCT01760447|470778561|FG003|Weeks 20-54|Lost to Follow-up|2|||
130768737|NCT01108237|470778562|FG000|Overall Study|No alignment data|2|||
130768738|NCT01108237|470778563|FG001|Overall Study|No alignment data|15|||
130768739|NCT01108237|470778562|FG000|Overall Study|Did not meet criteria for analysis|7|||
130768740|NCT01108237|470778563|FG001|Overall Study|Did not meet criteria for analysis|0|||
130768741|NCT06439095|470778565|FG000|Overall Study|Lost to Follow-up|2|||
130768742|NCT02368886|470778566|FG000|Overall Study|Cancel|1|||
130768743|NCT02368886|470778567|FG001|Overall Study|Cancel|1|||
130768744|NCT02368886|470778568|FG002|Overall Study|Cancel|1|||
130768745|NCT02368886|470778569|FG003|Overall Study|Cancel|3|||
130768746|NCT02368886|470778566|FG000|Overall Study|Ineligible|0|||
130768747|NCT02368886|470778567|FG001|Overall Study|Ineligible|0|||
130768748|NCT02368886|470778568|FG002|Overall Study|Ineligible|0|||
130768749|NCT02368886|470778569|FG003|Overall Study|Ineligible|1|||
130768750|NCT02131636|470778571|FG000|Overall Study|Personal Reasons|4|||
130768751|NCT02131636|470778572|FG001|Overall Study|Personal Reasons|4|||
130768752|NCT02131636|470778571|FG000|Overall Study|Lost to Follow-up|4|||
130768753|NCT02131636|470778572|FG001|Overall Study|Lost to Follow-up|0|||
130768754|NCT02131636|470778571|FG000|Overall Study|Adverse Event|4|||
131116367|NCT04178967|472057653|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
130768755|NCT02131636|470778572|FG001|Overall Study|Adverse Event|1|||
131222823|NCT03674827|472443185|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
131222824|NCT03674827|472443186|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
130768756|NCT02173379|470778573|FG000|Overall Study|Lost to Follow-up|89|||
130768757|NCT02173379|470778574|FG001|Overall Study|Lost to Follow-up|81|||
130768758|NCT02173379|470778573|FG000|Overall Study|Withdrawal by Subject|24|||
130768759|NCT02173379|470778574|FG001|Overall Study|Withdrawal by Subject|29|||
130768760|NCT02173379|470778573|FG000|Overall Study|Physician Decision|8|||
130768761|NCT02173379|470778574|FG001|Overall Study|Physician Decision|8|||
130768762|NCT02173379|470778573|FG000|Overall Study|Death|75|||
130768763|NCT02173379|470778574|FG001|Overall Study|Death|72|||
130768764|NCT02173379|470778573|FG000|Overall Study|Other Reason|1|||
130768765|NCT02173379|470778574|FG001|Overall Study|Other Reason|0|||
130768766|NCT00715520|470778576|FG000|Overall Study|Screen failure|8|||
130768767|NCT00715520|470778577|FG001|Overall Study|Screen failure|1|||
130768768|NCT00715520|470778578|FG002|Overall Study|Screen failure|1|||
131116368|NCT04178967|472057654|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
131116369|NCT04178967|472057655|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
131116370|NCT04178967|472057656|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131116371|NCT04178967|472057657|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131116372|NCT04178967|472057658|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
131116373|NCT04178967|472057648|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
131116374|NCT04178967|472057649|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
131116375|NCT04178967|472057650|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
131116376|NCT04178967|472057651|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
131116377|NCT04178967|472057652|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
131116378|NCT04178967|472057653|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
131116379|NCT04178967|472057654|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
131116380|NCT04178967|472057655|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
131116381|NCT04178967|472057656|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
131116382|NCT04178967|472057657|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
131116383|NCT04178967|472057658|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
131116384|NCT04178967|472057648|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131116385|NCT04178967|472057649|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131116386|NCT04178967|472057650|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131116387|NCT04178967|472057651|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131116388|NCT04178967|472057652|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131116389|NCT04178967|472057653|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131116390|NCT04178967|472057654|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131116391|NCT04178967|472057655|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130909968|NCT00194675|471305325|FG001|Overall Study|Protocol Violation|0|||
130909969|NCT00194675|471305324|FG000|Overall Study|Death|1|||
130909970|NCT00194675|471305325|FG001|Overall Study|Death|0|||
130909971|NCT00704808|471305328|FG000|Overall Study|Discontinued prior to starting treatment|14|||
130909972|NCT00704808|471305328|FG000|Overall Study|Death|7|||
131116392|NCT04178967|472057656|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
131116393|NCT04178967|472057657|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
131116394|NCT04178967|472057658|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
131116395|NCT04178967|472057648|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131116396|NCT04178967|472057649|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131116397|NCT04178967|472057650|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131116398|NCT04178967|472057651|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131116399|NCT04178967|472057652|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131116400|NCT04178967|472057653|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131116401|NCT04178967|472057654|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131116402|NCT04178967|472057655|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131116403|NCT04178967|472057656|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131116404|NCT04178967|472057657|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
131116405|NCT04178967|472057658|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131116406|NCT04178967|472057648|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131116407|NCT04178967|472057649|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131116408|NCT04178967|472057650|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131116409|NCT04178967|472057651|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131116410|NCT04178967|472057652|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131116411|NCT04178967|472057653|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131116412|NCT04178967|472057654|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131116413|NCT04178967|472057655|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131116414|NCT04178967|472057656|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
131116415|NCT04178967|472057657|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
131116416|NCT04178967|472057658|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
130909973|NCT00704808|471305328|FG000|Overall Study|Tumor progression|80|||
130909974|NCT00704808|471305328|FG000|Overall Study|Patient's decision|11|||
130909975|NCT00704808|471305328|FG000|Overall Study|Early therapy discontinuation|16|||
130909976|NCT00704808|471305328|FG000|Overall Study|Adverse Event|1|||
130909977|NCT00704808|471305328|FG000|Overall Study|Lost to Follow-up|1|||
131116417|NCT04178967|472057648|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131116418|NCT04178967|472057649|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131116419|NCT04178967|472057650|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131116420|NCT04178967|472057651|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131116421|NCT04178967|472057652|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131116422|NCT04178967|472057653|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131116423|NCT04178967|472057654|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130909978|NCT00704808|471305328|FG000|Overall Study|Treatment change|1|||
130909979|NCT01285960|471305334|FG000|Overall Study|Withdrawal by Subject|2|||
131116424|NCT04178967|472057655|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131116425|NCT04178967|472057656|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131116426|NCT04178967|472057657|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
131116427|NCT04178967|472057658|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
131116428|NCT04178967|472057648|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131116429|NCT04178967|472057649|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131116430|NCT04178967|472057650|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130909980|NCT01285960|471305334|FG000|Overall Study|Lost to Follow-up|2|||
130909981|NCT01285960|471305334|FG000|Overall Study|2 subjects received less 10 sonications|2|||
130909982|NCT03194490|471305349|FG000|Overall Study|Lost to Follow-up|1|||
130909983|NCT03194490|471305350|FG001|Overall Study|Lost to Follow-up|3|||
130909984|NCT03194490|471305349|FG000|Overall Study|participant developed specific neck pain|1|||
130909985|NCT03194490|471305350|FG001|Overall Study|participant developed specific neck pain|0|||
130909986|NCT01758289|471305351|FG000|Overall Study|Premature Study Termination|44|||
130909987|NCT01758289|471305351|FG000|Overall Study|Adverse Event|9|||
130909988|NCT01574079|471305352|FG000|Overall Study|Physician Decision|0|||
130909989|NCT01574079|471305353|FG001|Overall Study|Physician Decision|2|||
131030350|NCT02783300|471744474|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030351|NCT02783300|471744475|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030352|NCT02783300|471744476|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030353|NCT02783300|471744477|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030354|NCT02783300|471744478|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030355|NCT02783300|471744479|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030356|NCT02783300|471744480|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030357|NCT02783300|471744481|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030358|NCT02783300|471744482|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030359|NCT02783300|471744483|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030360|NCT02783300|471744484|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030361|NCT02783300|471744485|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
131030362|NCT02783300|471744486|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030363|NCT02783300|471744487|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030364|NCT02783300|471744488|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030365|NCT02783300|471744489|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030366|NCT02783300|471744490|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030367|NCT02783300|471744491|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030368|NCT02783300|471744492|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
131030369|NCT02783300|471744493|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030370|NCT02783300|471744494|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030371|NCT02783300|471744495|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030372|NCT02783300|471744496|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
131030373|NCT02783300|471744470|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030374|NCT02783300|471744471|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030375|NCT02783300|471744472|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030376|NCT02783300|471744473|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030377|NCT02783300|471744474|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030378|NCT02783300|471744475|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030379|NCT02783300|471744476|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030380|NCT02783300|471744477|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030381|NCT02783300|471744478|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030382|NCT02783300|471744479|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030383|NCT02783300|471744480|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030384|NCT02783300|471744481|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030385|NCT02783300|471744482|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030386|NCT02783300|471744483|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
131030387|NCT02783300|471744484|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
131030388|NCT02783300|471744485|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
131030389|NCT02783300|471744486|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
131030390|NCT02783300|471744487|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030391|NCT02783300|471744488|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
131116431|NCT04178967|472057651|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131116432|NCT04178967|472057652|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130909990|NCT01574079|471305352|FG000|Overall Study|Lost to Follow-up|1|||
130909991|NCT01574079|471305353|FG001|Overall Study|Lost to Follow-up|0|||
130909992|NCT03640559|471305357|FG000|Overall Study|Physician Decision|1|||
130909993|NCT03640559|471305358|FG001|Overall Study|Physician Decision|1|||
130909994|NCT03640559|471305357|FG000|Overall Study|Withdrawal by Subject|1|||
130909995|NCT03640559|471305358|FG001|Overall Study|Withdrawal by Subject|0|||
130909996|NCT01436162|471305359|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
130909997|NCT01436162|471305360|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
130909998|NCT01436162|471305361|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
130909999|NCT01436162|471305359|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
130910000|NCT01436162|471305360|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
130910001|NCT01436162|471305361|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
130910002|NCT01436162|471305359|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
130910003|NCT01436162|471305360|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
130910004|NCT01436162|471305361|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
130910005|NCT01436162|471305359|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
130910006|NCT01436162|471305360|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
130910007|NCT01436162|471305361|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
130910008|NCT01436162|471305359|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
130910009|NCT01436162|471305360|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130910010|NCT01436162|471305361|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130910011|NCT01436162|471305359|FG000|Single-blind Lead-in Phase|Other|107|||
130910012|NCT01436162|471305360|FG001|Single-blind Lead-in Phase|Other|0|||
130910013|NCT01436162|471305361|FG002|Single-blind Lead-in Phase|Other|0|||
130910014|NCT01436162|471305359|FG000|Randomized Phase|Adverse Event|1|||
130910015|NCT01436162|471305360|FG001|Randomized Phase|Adverse Event|5|||
130910016|NCT01436162|471305361|FG002|Randomized Phase|Adverse Event|6|||
130910017|NCT01436162|471305359|FG000|Randomized Phase|Protocol Violation|4|||
130910018|NCT01436162|471305360|FG001|Randomized Phase|Protocol Violation|4|||
130910019|NCT01436162|471305361|FG002|Randomized Phase|Protocol Violation|2|||
130910020|NCT01436162|471305359|FG000|Randomized Phase|Withdrawal by Subject|16|||
130910021|NCT01436162|471305360|FG001|Randomized Phase|Withdrawal by Subject|9|||
130910022|NCT01436162|471305361|FG002|Randomized Phase|Withdrawal by Subject|8|||
130910023|NCT01436162|471305359|FG000|Randomized Phase|Lost to Follow-up|17|||
130910024|NCT01436162|471305360|FG001|Randomized Phase|Lost to Follow-up|5|||
130910025|NCT01436162|471305361|FG002|Randomized Phase|Lost to Follow-up|4|||
130910026|NCT01436162|471305359|FG000|Randomized Phase|Lack of Efficacy|0|||
130910027|NCT01436162|471305360|FG001|Randomized Phase|Lack of Efficacy|1|||
130910028|NCT01436162|471305361|FG002|Randomized Phase|Lack of Efficacy|1|||
130910029|NCT01436162|471305359|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
130910030|NCT01436162|471305360|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
130910031|NCT01436162|471305361|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
130910032|NCT01436162|471305359|FG000|Randomized Phase|Other|2|||
130910033|NCT01436162|471305360|FG001|Randomized Phase|Other|5|||
130910034|NCT01436162|471305361|FG002|Randomized Phase|Other|4|||
130910035|NCT01931202|471305362|FG000|Overall Study|Withdrawal by Subject|0|||
130910036|NCT01931202|471305363|FG001|Overall Study|Withdrawal by Subject|0|||
130910037|NCT01931202|471305364|FG002|Overall Study|Withdrawal by Subject|2|||
130910038|NCT01931202|471305362|FG000|Overall Study|Lost to Follow-up|0|||
130910039|NCT01931202|471305363|FG001|Overall Study|Lost to Follow-up|5|||
130910040|NCT01931202|471305364|FG002|Overall Study|Lost to Follow-up|2|||
130910041|NCT01994590|471306737|FG000|Overall Study|Adverse Event|1|||
130910042|NCT01994590|471306737|FG000|Overall Study|Trial Terminated|1|||
130910043|NCT02237911|471306738|FG000|Overall Study|Withdrawal by Subject|4|||
130910044|NCT02237911|471306739|FG001|Overall Study|Withdrawal by Subject|7|||
130910045|NCT02237911|471306740|FG002|Overall Study|Withdrawal by Subject|2|||
130910046|NCT02237911|471306738|FG000|Overall Study|Lost to Follow-up|3|||
130910047|NCT02237911|471306739|FG001|Overall Study|Lost to Follow-up|1|||
130910048|NCT02237911|471306740|FG002|Overall Study|Lost to Follow-up|1|||
130910049|NCT00053365|471306741|FG000|Overall Study|Incorrect cell type|1|||
130910050|NCT00053365|471306741|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
130910051|NCT00053365|471306741|FG000|Overall Study|Never treated|4|||
130910052|NCT00958789|471306746|FG000|Overall Study|Death|5|||
130910053|NCT00958789|471306746|FG000|Overall Study|Lost to Follow-up|14|||
130910054|NCT00958789|471306746|FG000|Overall Study|Withdrawal by Subject|17|||
131116433|NCT04178967|472057653|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130696590|NCT03358147|470514448|FG002|Overall Study|Lost to Follow-up|7|||
130910055|NCT00958789|471306746|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
130910056|NCT00958789|471306746|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
130910057|NCT00958789|471306746|FG000|Overall Study|Subject terminated|2|||
130910058|NCT00958789|471306746|FG000|Overall Study|Revision|7|||
130910059|NCT05007717|471306748|FG000|Overall Study|Death|3|||
130910060|NCT05007717|471306749|FG001|Overall Study|Death|2|||
130910061|NCT00427960|471306751|FG000|Overall Study|Adverse Event|2|||
130910062|NCT00427960|471306752|FG001|Overall Study|Adverse Event|0|||
130696591|NCT03358147|470514449|FG003|Overall Study|Lost to Follow-up|6|||
130910063|NCT00427960|471306751|FG000|Overall Study|Withdrawal by Subject|0|||
130910064|NCT00427960|471306752|FG001|Overall Study|Withdrawal by Subject|3|||
130910065|NCT00427960|471306751|FG000|Overall Study|Other|0|||
130910066|NCT00427960|471306752|FG001|Overall Study|Other|1|||
130910067|NCT03282565|471306755|FG000|Overall Study|COVID-19 Research Shutdown|0|||
130910068|NCT03282565|471306756|FG001|Overall Study|COVID-19 Research Shutdown|2|||
130910069|NCT03282565|471306757|FG002|Overall Study|COVID-19 Research Shutdown|2|||
130910070|NCT01143207|471306758|FG000|Overall Study|Lost to Follow-up|2|||
130910071|NCT01869725|471306759|FG000|Overall Study|ineligible after registration|1|||
130910072|NCT01869725|471306759|FG000|Overall Study|Death|1|||
130910073|NCT01869725|471306759|FG000|Overall Study|Lost to Follow-up|2|||
130910074|NCT04163718|471306764|FG000|Overall Study|Study terminated|12|||
130910075|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
130910076|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
130910077|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
130910078|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
130910079|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130910080|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
130910081|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130910082|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
130910083|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
130910084|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
130910085|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
130910086|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
130910087|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
130910088|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
130910089|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
130910090|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
130910091|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Program Termination|3|||
130910092|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Program Termination|0|||
130910093|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Program Termination|1|||
130910094|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Program Termination|1|||
130910095|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
130910096|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
130910097|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
130910098|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
130910099|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
130910100|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
130910101|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
130910102|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
130910103|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
130910104|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
131030392|NCT02783300|471744489|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
131030393|NCT02783300|471744490|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030394|NCT02783300|471744491|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030395|NCT02783300|471744492|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030396|NCT02783300|471744493|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030397|NCT02783300|471744494|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030398|NCT02783300|471744495|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030399|NCT02783300|471744496|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
131030400|NCT02783300|471744470|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030401|NCT02783300|471744471|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030402|NCT02783300|471744472|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030403|NCT02783300|471744473|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030404|NCT02783300|471744474|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030405|NCT02783300|471744475|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030406|NCT02783300|471744476|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030407|NCT02783300|471744477|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030408|NCT02783300|471744478|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030409|NCT02783300|471744479|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030410|NCT02783300|471744480|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030411|NCT02783300|471744481|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030412|NCT02783300|471744482|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
130910105|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
131030413|NCT02783300|471744483|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
131030414|NCT02783300|471744484|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
131030415|NCT02783300|471744485|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
131030416|NCT02783300|471744486|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
131030417|NCT02783300|471744487|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
130910106|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
130910107|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
130910108|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
130910109|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
130910110|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
130696592|NCT03358147|470514450|FG004|Overall Study|Lost to Follow-up|4|||
130696593|NCT03358147|470514446|FG000|Overall Study|Major Protocol Deviation|11|||
130910111|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
130910112|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
130910113|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
130910114|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
130910115|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
130910116|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
130910117|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
130910118|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
130910119|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
130910120|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
130910121|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
130910122|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
130910123|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
130910124|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
130910125|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
130910126|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
130910127|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
130696594|NCT03358147|470514447|FG001|Overall Study|Major Protocol Deviation|3|||
130910128|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
130910129|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
130910130|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
130910131|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
130910132|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
130910133|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
130910134|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
130910135|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
130910136|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
130910137|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
130910138|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
130910139|NCT03739840|471306767|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
130910140|NCT03739840|471306768|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
130910141|NCT03739840|471306769|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
130910142|NCT03739840|471306770|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
130910143|NCT03739840|471306767|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
130910144|NCT03739840|471306768|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
130910145|NCT03739840|471306769|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
130910146|NCT03739840|471306770|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
130910147|NCT03739840|471306767|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
130910148|NCT03739840|471306768|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
130910149|NCT03739840|471306769|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
130910150|NCT03739840|471306770|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
130910151|NCT03739840|471306767|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
130910152|NCT03739840|471306768|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
130910153|NCT03739840|471306769|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
130910154|NCT03739840|471306770|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
131030418|NCT02783300|471744488|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
131030419|NCT02783300|471744489|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
131030420|NCT02783300|471744490|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
131030421|NCT02783300|471744491|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
131030422|NCT02783300|471744492|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
130696595|NCT03358147|470514448|FG002|Overall Study|Major Protocol Deviation|2|||
130910155|NCT03739840|471306767|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
130910156|NCT03739840|471306768|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
131030423|NCT02783300|471744493|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
130696596|NCT03358147|470514449|FG003|Overall Study|Major Protocol Deviation|3|||
130910157|NCT03739840|471306769|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
130910158|NCT03739840|471306770|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
131030424|NCT02783300|471744494|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
131030425|NCT02783300|471744495|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
130910159|NCT03739840|471306767|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
130910160|NCT03739840|471306768|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
130910161|NCT03739840|471306769|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
130910162|NCT03739840|471306770|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
130910163|NCT03739840|471306767|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
130910164|NCT03739840|471306768|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
130910165|NCT03739840|471306769|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
130910166|NCT03739840|471306770|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
130910167|NCT03739840|471306767|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
130910168|NCT03739840|471306768|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
130910169|NCT03739840|471306769|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
130910170|NCT03739840|471306770|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
130910171|NCT03739840|471306767|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
130910172|NCT03739840|471306768|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
130910173|NCT03739840|471306769|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
130910174|NCT03739840|471306770|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
130910175|NCT01058265|471306773|FG000|Overall Study|Lost to Follow-up|11|||
130910176|NCT01058265|471306774|FG001|Overall Study|Lost to Follow-up|12|||
130910177|NCT00873860|471306775|FG000|Overall Study|Lost to Follow-up|1|||
130910178|NCT00873860|471306776|FG001|Overall Study|Lost to Follow-up|0|||
130910179|NCT00873860|471306777|FG002|Overall Study|Lost to Follow-up|0|||
130910180|NCT00873860|471306778|FG003|Overall Study|Lost to Follow-up|1|||
130910181|NCT00873860|471306775|FG000|Overall Study|Withdrawal by Subject|1|||
130910182|NCT00873860|471306776|FG001|Overall Study|Withdrawal by Subject|0|||
130910183|NCT00873860|471306777|FG002|Overall Study|Withdrawal by Subject|2|||
130910184|NCT00873860|471306778|FG003|Overall Study|Withdrawal by Subject|0|||
130910185|NCT00873860|471306775|FG000|Overall Study|Death|1|||
130910186|NCT00873860|471306776|FG001|Overall Study|Death|0|||
130910187|NCT00873860|471306777|FG002|Overall Study|Death|0|||
130910188|NCT00873860|471306778|FG003|Overall Study|Death|0|||
130910189|NCT00873860|471306775|FG000|Overall Study|Other|1|||
130910190|NCT00873860|471306776|FG001|Overall Study|Other|0|||
130910191|NCT00873860|471306777|FG002|Overall Study|Other|1|||
130910192|NCT00873860|471306778|FG003|Overall Study|Other|0|||
130910193|NCT01476644|471306796|FG000|Overall Study|Death|5|||
130910194|NCT01476644|471306796|FG000|Overall Study|moved to another state|2|||
130910195|NCT01476644|471306796|FG000|Overall Study|Lost to Follow-up|19|||
131030426|NCT02783300|471744496|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
131030427|NCT02783300|471744470|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030428|NCT02783300|471744471|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030429|NCT02783300|471744472|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030430|NCT02783300|471744473|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030431|NCT02783300|471744474|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030432|NCT02783300|471744475|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030433|NCT02783300|471744476|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030434|NCT02783300|471744477|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030435|NCT02783300|471744478|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030436|NCT02783300|471744479|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030437|NCT02783300|471744480|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030438|NCT02783300|471744481|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030439|NCT02783300|471744482|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030440|NCT02783300|471744483|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030441|NCT02783300|471744484|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030442|NCT02783300|471744485|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030443|NCT02783300|471744486|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030444|NCT02783300|471744487|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030445|NCT02783300|471744488|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030446|NCT02783300|471744489|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030447|NCT02783300|471744490|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030448|NCT02783300|471744491|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130910196|NCT01476644|471306796|FG000|Overall Study|Withdrawal by Subject|13|||
130910197|NCT00095628|471306797|FG000|Overall Study|Disease progression prior to treatment|1|||
131030449|NCT02783300|471744492|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030450|NCT02783300|471744493|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
130910198|NCT02280473|471306798|FG000|Overall Study|Adverse Event|1|||
130910199|NCT02280473|471306799|FG001|Overall Study|Adverse Event|1|||
130910200|NCT02280473|471306798|FG000|Overall Study|Lack of Efficacy|0|||
130910201|NCT02280473|471306799|FG001|Overall Study|Lack of Efficacy|1|||
130910202|NCT02280473|471306798|FG000|Overall Study|Lost to Follow-up|0|||
131116434|NCT04178967|472057654|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131116435|NCT04178967|472057655|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131116436|NCT04178967|472057656|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131116437|NCT04178967|472057657|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
131116438|NCT04178967|472057658|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
131116439|NCT01862640|472057659|FG000|Overall Study|Adverse Event|4|||
131116440|NCT01862640|472057660|FG001|Overall Study|Adverse Event|10|||
131116441|NCT01862640|472057661|FG002|Overall Study|Adverse Event|6|||
131116442|NCT01862640|472057662|FG003|Overall Study|Adverse Event|8|||
131116443|NCT01862640|472057659|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
131116444|NCT01862640|472057660|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
131116445|NCT01862640|472057661|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
131116446|NCT01862640|472057662|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
131116447|NCT01862640|472057659|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
131116448|NCT01862640|472057660|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
131116449|NCT01862640|472057661|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
131116450|NCT01862640|472057662|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
131116451|NCT01862640|472057659|FG000|Overall Study|Withdrawal by Subject|2|||
131116452|NCT01862640|472057660|FG001|Overall Study|Withdrawal by Subject|4|||
131116453|NCT01862640|472057661|FG002|Overall Study|Withdrawal by Subject|8|||
131116454|NCT01862640|472057662|FG003|Overall Study|Withdrawal by Subject|5|||
131116455|NCT01862640|472057659|FG000|Overall Study|Protocol Deviation|0|||
131116456|NCT01862640|472057660|FG001|Overall Study|Protocol Deviation|0|||
131116457|NCT01862640|472057661|FG002|Overall Study|Protocol Deviation|1|||
131116458|NCT01862640|472057662|FG003|Overall Study|Protocol Deviation|0|||
131116459|NCT00628251|472057663|FG000|Randomised Part|Withdrawal by Subject|0|||
131116460|NCT00628251|472057664|FG001|Randomised Part|Withdrawal by Subject|0|||
131116461|NCT00628251|472057665|FG002|Randomised Part|Withdrawal by Subject|1|||
131116462|NCT00628251|472057663|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
131116463|NCT00628251|472057664|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
131116464|NCT00628251|472057665|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
131116465|NCT00628251|472057663|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
131116466|NCT00628251|472057664|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
131116467|NCT00628251|472057665|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
131116468|NCT00628251|472057663|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
131116469|NCT00628251|472057664|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
131116470|NCT00628251|472057665|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
131116471|NCT00628251|472057663|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
131116472|NCT00628251|472057664|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
131116473|NCT00628251|472057665|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
131116474|NCT00628251|472057663|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
131116475|NCT00628251|472057664|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
131116476|NCT00628251|472057665|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
131116477|NCT01020448|472057666|FG000|Pre-assignment|Adverse Event|6|||
131116478|NCT01020448|472057666|FG000|Pre-assignment|Withdrawal by Subject|5|||
131116479|NCT01020448|472057666|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
131116480|NCT01020448|472057666|FG000|Treatment|Adverse Event|11|||
131116481|NCT01020448|472057666|FG000|Treatment|Consent Withdrawn|3|||
131116482|NCT01020448|472057666|FG000|Treatment|Disease Progression|2|||
131116483|NCT01020448|472057666|FG000|Treatment|Lack of Efficacy|8|||
131116484|NCT01020448|472057666|FG000|Treatment|Lost to Follow-up|2|||
131116485|NCT00728481|472057667|FG000|Overall Study|Withdrawal by Subject|0|||
131116486|NCT00728481|472057668|FG001|Overall Study|Withdrawal by Subject|1|||
131116487|NCT00728481|472057667|FG000|Overall Study|Adverse Event|0|||
131116488|NCT00728481|472057668|FG001|Overall Study|Adverse Event|1|||
131116489|NCT00728481|472057667|FG000|Overall Study|Study medication non-compliance|0|||
131116490|NCT00728481|472057668|FG001|Overall Study|Study medication non-compliance|2|||
131116491|NCT00728481|472057667|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
131116492|NCT00728481|472057668|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
131116493|NCT02545322|472057669|FG000|Overall Study|Withdrawal by Subject|3|||
131116494|NCT00041067|472057670|FG000|Overall Study|Adverse Event|20|||
131116495|NCT00041067|472057670|FG000|Overall Study|Progression|19|||
131116496|NCT00041067|472057670|FG000|Overall Study|Patient refusal|12|||
131116497|NCT00041067|472057670|FG000|Overall Study|Other reasons|23|||
131116498|NCT00041067|472057670|FG000|Overall Study|Ineligible|2|||
131116499|NCT01351623|472057672|FG000|Overall Study|Protocol Violation|2|||
131116500|NCT01351623|472057672|FG000|Overall Study|Adverse Event|4|||
131116501|NCT01351623|472057672|FG000|Overall Study|Withdrawal by Subject|1|||
131116502|NCT01351623|472057672|FG000|Overall Study|Death|2|||
131116503|NCT04201821|472057673|FG000|Overall Study|Withdrawal by Subject|2|||
131116504|NCT01130974|472057674|FG000|Overall Study|Protocol Violation|10|||
131116505|NCT01130974|472057675|FG001|Overall Study|Protocol Violation|10|||
131116506|NCT01130974|472057674|FG000|Overall Study|Withdrawal by Subject|0|||
131116507|NCT01130974|472057675|FG001|Overall Study|Withdrawal by Subject|1|||
131116508|NCT01130974|472057674|FG000|Overall Study|Ineligibility criteria|5|||
131116509|NCT01130974|472057675|FG001|Overall Study|Ineligibility criteria|2|||
131116510|NCT00387764|472057676|FG000|Overall Study|Adverse Event|12|||
131116511|NCT00387764|472057676|FG000|Overall Study|Withdrawal by Subject|8|||
130696597|NCT03358147|470514450|FG004|Overall Study|Major Protocol Deviation|1|||
130696598|NCT03358147|470514446|FG000|Overall Study|Protocol specified criteria|2|||
130910203|NCT02280473|471306799|FG001|Overall Study|Lost to Follow-up|1|||
130910204|NCT01484054|471306800|FG000|Period 1|Withdrawal by Subject|0|||
130910205|NCT01484054|471306801|FG001|Period 1|Withdrawal by Subject|1|||
130910206|NCT01610271|471306802|FG000|Overall Study|Surgery not complete|0|||
130910207|NCT01610271|471306803|FG001|Overall Study|Surgery not complete|1|||
130910208|NCT01610271|471306802|FG000|Overall Study|Prosthesis not implanted|2|||
130910209|NCT01610271|471306803|FG001|Overall Study|Prosthesis not implanted|3|||
130910210|NCT00364130|471306804|FG000|Intervention Period|Lost to Follow-up|4|||
130910211|NCT00364130|471306805|FG001|Intervention Period|Lost to Follow-up|3|||
130910212|NCT00364130|471306804|FG000|Intervention Period|Pregnancy|1|||
130910213|NCT00364130|471306805|FG001|Intervention Period|Pregnancy|0|||
130910214|NCT00364130|471306804|FG000|Intervention Period|Withdrawal by Subject|4|||
130910215|NCT00364130|471306805|FG001|Intervention Period|Withdrawal by Subject|5|||
130910216|NCT00364130|471306804|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
130910217|NCT00364130|471306805|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
130910218|NCT05281601|471306811|FG000|Overall Study|Physician Decision|2|||
130910219|NCT05281601|471306812|FG001|Overall Study|Physician Decision|0|||
130910220|NCT05281601|471306811|FG000|Overall Study|Lost to Follow-up|2|||
130910221|NCT05281601|471306812|FG001|Overall Study|Lost to Follow-up|0|||
130910222|NCT05281601|471306811|FG000|Overall Study|Death|1|||
130910223|NCT05281601|471306812|FG001|Overall Study|Death|0|||
130910224|NCT05281601|471306811|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130910225|NCT05281601|471306812|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130910226|NCT00586846|471306813|FG000|Overall Study|Physician Decision|1|||
130910227|NCT00586846|471306813|FG000|Overall Study|Death|1|||
130910228|NCT00586846|471306813|FG000|Overall Study|Evaluable for Toxicity Only|4|||
130910229|NCT00410202|471306817|FG000|On-Treatment|Continuing treatment|69|||
131030451|NCT02783300|471744494|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030452|NCT02783300|471744495|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
131030453|NCT02783300|471744496|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
131030454|NCT02783300|471744470|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030455|NCT02783300|471744471|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030456|NCT02783300|471744472|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030457|NCT02783300|471744473|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030458|NCT02783300|471744474|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030459|NCT02783300|471744475|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030460|NCT02783300|471744476|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030461|NCT02783300|471744477|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030462|NCT02783300|471744478|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030463|NCT02783300|471744479|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030464|NCT02783300|471744480|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030465|NCT02783300|471744481|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030466|NCT02783300|471744482|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030467|NCT02783300|471744483|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030468|NCT02783300|471744484|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030469|NCT02783300|471744485|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030470|NCT02783300|471744486|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030471|NCT02783300|471744487|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030472|NCT02783300|471744488|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030473|NCT02783300|471744489|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030474|NCT02783300|471744490|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030475|NCT02783300|471744491|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030476|NCT02783300|471744492|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
131116512|NCT00387764|472057676|FG000|Overall Study|Sponsor Terminated Study|1|||
130696599|NCT03358147|470514447|FG001|Overall Study|Protocol specified criteria|3|||
130696600|NCT03358147|470514448|FG002|Overall Study|Protocol specified criteria|0|||
130696601|NCT03358147|470514449|FG003|Overall Study|Protocol specified criteria|3|||
130910230|NCT00410202|471306818|FG001|On-Treatment|Continuing treatment|71|||
131116513|NCT00387764|472057676|FG000|Overall Study|Physician Decision|1|||
130910231|NCT00410202|471306819|FG002|On-Treatment|Continuing treatment|66|||
130910232|NCT00410202|471306817|FG000|On-Treatment|Adverse Event|1|||
130910233|NCT00410202|471306818|FG001|On-Treatment|Adverse Event|3|||
130696602|NCT03358147|470514450|FG004|Overall Study|Protocol specified criteria|1|||
130910234|NCT00410202|471306819|FG002|On-Treatment|Adverse Event|2|||
130910235|NCT00410202|471306817|FG000|On-Treatment|Death|1|||
130910236|NCT00410202|471306818|FG001|On-Treatment|Death|0|||
130910237|NCT00410202|471306819|FG002|On-Treatment|Death|0|||
130910238|NCT00410202|471306817|FG000|On-Treatment|Lost to Follow-up|1|||
130910239|NCT00410202|471306818|FG001|On-Treatment|Lost to Follow-up|0|||
130910240|NCT00410202|471306819|FG002|On-Treatment|Lost to Follow-up|1|||
130910241|NCT00410202|471306817|FG000|On-Treatment|Lack of Efficacy|1|||
130910242|NCT00410202|471306818|FG001|On-Treatment|Lack of Efficacy|4|||
130910243|NCT00410202|471306819|FG002|On-Treatment|Lack of Efficacy|0|||
130910244|NCT00410202|471306817|FG000|On-Treatment|Withdrawal by Subject|2|||
130910245|NCT00410202|471306818|FG001|On-Treatment|Withdrawal by Subject|1|||
130910246|NCT00410202|471306819|FG002|On-Treatment|Withdrawal by Subject|1|||
130910247|NCT00410202|471306817|FG000|On-Treatment|Other Reason|0|||
130910248|NCT00410202|471306818|FG001|On-Treatment|Other Reason|0|||
130910249|NCT00410202|471306819|FG002|On-Treatment|Other Reason|1|||
130910250|NCT00410202|471306817|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
130910251|NCT00410202|471306818|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
130910252|NCT00410202|471306819|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
130910253|NCT00410202|471306817|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
130910254|NCT00410202|471306818|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
130910255|NCT00410202|471306819|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
130910256|NCT00410202|471306817|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
130910257|NCT00410202|471306818|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
130910258|NCT00410202|471306819|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
130910259|NCT00144027|471306821|FG000|Overall Study|Lost to Follow-up|1|||
130910260|NCT00144027|471306822|FG001|Overall Study|Lost to Follow-up|3|||
130910261|NCT00144027|471306821|FG000|Overall Study|Withdrawal by Subject|2|||
130910262|NCT00144027|471306822|FG001|Overall Study|Withdrawal by Subject|2|||
130910263|NCT00144027|471306821|FG000|Overall Study|did not complete baseline assessment|0|||
130910264|NCT00144027|471306822|FG001|Overall Study|did not complete baseline assessment|6|||
130910265|NCT00937391|471306823|FG000|Stage 2|Withdrawal by Subject|1|||
130910266|NCT04597918|471306829|FG000|Overall Study|Withdrawal by Subject|6|||
130910267|NCT04597918|471306829|FG000|Overall Study|Lost to Follow-up|3|||
130910268|NCT04597918|471306829|FG000|Overall Study|Death|1|||
130910269|NCT00395538|471306830|FG000|Overall Study|Did not re-consent to revised protocol|1|||
130910270|NCT00395538|471306831|FG001|Overall Study|Did not re-consent to revised protocol|10|||
130910271|NCT00395538|471306832|FG002|Overall Study|Did not re-consent to revised protocol|0|||
130910272|NCT00395538|471306830|FG000|Overall Study|FDA partial hold on PTH|0|||
130910273|NCT00395538|471306831|FG001|Overall Study|FDA partial hold on PTH|0|||
130910274|NCT00395538|471306832|FG002|Overall Study|FDA partial hold on PTH|11|||
130910275|NCT00395538|471306830|FG000|Overall Study|Failed screening|0|||
130910276|NCT00395538|471306831|FG001|Overall Study|Failed screening|0|||
130910277|NCT00395538|471306832|FG002|Overall Study|Failed screening|4|||
130910278|NCT00395538|471306830|FG000|Overall Study|Switch to Natpara|0|||
130910279|NCT00395538|471306831|FG001|Overall Study|Switch to Natpara|0|||
130910280|NCT00395538|471306832|FG002|Overall Study|Switch to Natpara|3|||
131116514|NCT00387764|472057676|FG000|Overall Study|Other|2|||
131116515|NCT00387764|472057676|FG000|Overall Study|Death|7|||
131116516|NCT01184053|472057677|FG000|Overall Study|progression while on treatment|3|||
131116517|NCT04399122|472057678|FG000|Overall Study|Lost to Follow-up|2|||
131116518|NCT04399122|472057679|FG001|Overall Study|Lost to Follow-up|0|||
131116519|NCT04399122|472057678|FG000|Overall Study|Withdrawal by Subject|1|||
131116520|NCT04399122|472057679|FG001|Overall Study|Withdrawal by Subject|0|||
131116521|NCT02536755|472057682|FG000|Overall Study|Adverse Event|4|||
131116522|NCT02301936|472057683|FG000|Overall Study|Lost to Follow-up|1|||
131116523|NCT02301936|472057684|FG001|Overall Study|Lost to Follow-up|0|||
131116524|NCT01174238|472057685|FG000|Overall Study|Lost to Follow-up|2|||
131116525|NCT01102803|472057687|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
130910281|NCT00395538|471306830|FG000|Overall Study|Adverse Event|1|||
131116526|NCT01102803|472057688|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
130696603|NCT03358147|470514446|FG000|Overall Study|Physician Decision|1|||
130696604|NCT03358147|470514447|FG001|Overall Study|Physician Decision|0|||
130696605|NCT03358147|470514448|FG002|Overall Study|Physician Decision|1|||
130696606|NCT03358147|470514449|FG003|Overall Study|Physician Decision|6|||
130696607|NCT03358147|470514450|FG004|Overall Study|Physician Decision|1|||
130696608|NCT03358147|470514446|FG000|Overall Study|Administrative reasons|0|||
130696609|NCT03358147|470514447|FG001|Overall Study|Administrative reasons|1|||
130910282|NCT00395538|471306831|FG001|Overall Study|Adverse Event|0|||
130910283|NCT00395538|471306832|FG002|Overall Study|Adverse Event|2|||
130910284|NCT00395538|471306830|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
130910285|NCT00395538|471306831|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
130910286|NCT00395538|471306832|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
130910287|NCT00395538|471306830|FG000|Overall Study|Non-compliance with study protocol|0|||
130910288|NCT00395538|471306831|FG001|Overall Study|Non-compliance with study protocol|1|||
130910289|NCT00395538|471306832|FG002|Overall Study|Non-compliance with study protocol|0|||
130910290|NCT00395538|471306830|FG000|Overall Study|PTH resistance|0|||
131116527|NCT01102803|472057687|FG000|Post to Follow-Up|Lost to Follow-up|1|||
131116528|NCT01102803|472057688|FG001|Post to Follow-Up|Lost to Follow-up|3|||
131116529|NCT02684279|472057689|FG000|Overall Study|Adverse Event|87|||
131116530|NCT02684279|472057689|FG000|Overall Study|Lack of Efficacy|4|||
130910291|NCT00395538|471306831|FG001|Overall Study|PTH resistance|0|||
130910292|NCT00395538|471306832|FG002|Overall Study|PTH resistance|1|||
130910293|NCT00395538|471306830|FG000|Overall Study|Pregnancy|1|||
130910294|NCT00395538|471306831|FG001|Overall Study|Pregnancy|0|||
130910295|NCT00395538|471306832|FG002|Overall Study|Pregnancy|0|||
130910296|NCT00395538|471306830|FG000|Overall Study|Partial recovery of parathyroid function|0|||
130910297|NCT00395538|471306831|FG001|Overall Study|Partial recovery of parathyroid function|0|||
130910298|NCT00395538|471306832|FG002|Overall Study|Partial recovery of parathyroid function|1|||
130910299|NCT00395538|471306830|FG000|Overall Study|Participant elected to discontinue|0|||
130910300|NCT00395538|471306831|FG001|Overall Study|Participant elected to discontinue|0|||
130910301|NCT00395538|471306832|FG002|Overall Study|Participant elected to discontinue|1|||
130910302|NCT02211638|471306835|FG000|Overall Study|Case Report Forms Uncollected|291|||
130910303|NCT02211638|471306835|FG000|Overall Study|Protocol Violation|692|||
130910304|NCT02775903|471306838|FG000|Overall Study|Death|7|||
130910305|NCT02775903|471306839|FG001|Overall Study|Death|11|||
130910306|NCT02775903|471306840|FG002|Overall Study|Death|12|||
130910307|NCT02775903|471306841|FG003|Overall Study|Death|11|||
130910308|NCT02775903|471306838|FG000|Overall Study|Adverse Event|0|||
130910309|NCT02775903|471306839|FG001|Overall Study|Adverse Event|1|||
130910310|NCT02775903|471306840|FG002|Overall Study|Adverse Event|12|||
130910311|NCT02775903|471306841|FG003|Overall Study|Adverse Event|3|||
130910312|NCT02775903|471306838|FG000|Overall Study|Progressive disease|15|||
130910313|NCT02775903|471306839|FG001|Overall Study|Progressive disease|14|||
130910314|NCT02775903|471306840|FG002|Overall Study|Progressive disease|30|||
130910315|NCT02775903|471306841|FG003|Overall Study|Progressive disease|20|||
130910316|NCT02775903|471306838|FG000|Overall Study|Lack of Efficacy|2|||
130910317|NCT02775903|471306839|FG001|Overall Study|Lack of Efficacy|2|||
130910318|NCT02775903|471306840|FG002|Overall Study|Lack of Efficacy|2|||
130910319|NCT02775903|471306841|FG003|Overall Study|Lack of Efficacy|6|||
130910320|NCT02775903|471306838|FG000|Overall Study|Withdrawal by Subject|7|||
130910321|NCT02775903|471306839|FG001|Overall Study|Withdrawal by Subject|5|||
130910322|NCT02775903|471306840|FG002|Overall Study|Withdrawal by Subject|5|||
130910323|NCT02775903|471306841|FG003|Overall Study|Withdrawal by Subject|8|||
130910324|NCT02775903|471306838|FG000|Overall Study|Other reasons|7|||
130910325|NCT02775903|471306839|FG001|Overall Study|Other reasons|8|||
130910326|NCT02775903|471306840|FG002|Overall Study|Other reasons|2|||
130910327|NCT02775903|471306841|FG003|Overall Study|Other reasons|12|||
130910328|NCT04041700|471306842|FG000|Overall Study|Pregnancy|1|||
130910329|NCT04041700|471306842|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
130910330|NCT00285207|471306845|FG000|Overall Study|Lost to Follow-up|3|||
130910331|NCT00285207|471306846|FG001|Overall Study|Lost to Follow-up|2|||
130910332|NCT00285207|471306845|FG000|Overall Study|Withdrawal by Subject|5|||
130910333|NCT00285207|471306846|FG001|Overall Study|Withdrawal by Subject|2|||
130910334|NCT00285207|471306845|FG000|Overall Study|Pregnancy|1|||
130910335|NCT00285207|471306846|FG001|Overall Study|Pregnancy|1|||
130910336|NCT00285207|471306845|FG000|Overall Study|non-compliance|0|||
130910337|NCT00285207|471306846|FG001|Overall Study|non-compliance|1|||
130910338|NCT04571515|471306847|FG000|Overall Study|Physician Decision|0|||
130910339|NCT04571515|471306848|FG001|Overall Study|Physician Decision|0|||
130910340|NCT04571515|471306849|FG002|Overall Study|Physician Decision|0|||
130910341|NCT04571515|471306850|FG003|Overall Study|Physician Decision|0|||
130910342|NCT04571515|471306851|FG004|Overall Study|Physician Decision|1|||
130910343|NCT04571515|471306847|FG000|Overall Study|Withdrawal by Subject|0|||
130910344|NCT04571515|471306848|FG001|Overall Study|Withdrawal by Subject|0|||
130910345|NCT04571515|471306849|FG002|Overall Study|Withdrawal by Subject|0|||
130910346|NCT04571515|471306850|FG003|Overall Study|Withdrawal by Subject|0|||
131116531|NCT02684279|472057689|FG000|Overall Study|Lost to Follow-up|61|||
131116532|NCT02684279|472057689|FG000|Overall Study|Protocol Violation|6|||
131116533|NCT02684279|472057689|FG000|Overall Study|Pregnancy|8|||
130910347|NCT04571515|471306851|FG004|Overall Study|Withdrawal by Subject|1|||
131116534|NCT02684279|472057689|FG000|Overall Study|Withdrawal by Subject|92|||
130696610|NCT03358147|470514448|FG002|Overall Study|Administrative reasons|0|||
130696611|NCT03358147|470514449|FG003|Overall Study|Administrative reasons|3|||
130910348|NCT04571515|471306847|FG000|Overall Study|insufficient pain|1|||
130910349|NCT04571515|471306848|FG001|Overall Study|insufficient pain|0|||
130910350|NCT04571515|471306849|FG002|Overall Study|insufficient pain|0|||
130910351|NCT04571515|471306850|FG003|Overall Study|insufficient pain|0|||
130910352|NCT04571515|471306851|FG004|Overall Study|insufficient pain|1|||
130910353|NCT05140382|471306852|FG000|Overall Study|Death|3|||
130910354|NCT05140382|471306853|FG001|Overall Study|Death|0|||
130910355|NCT05140382|471306854|FG002|Overall Study|Death|0|||
130910356|NCT05140382|471306852|FG000|Overall Study|Investigator decision|1|||
131116535|NCT02684279|472057689|FG000|Overall Study|non-compliance with study drug|9|||
131116536|NCT02684279|472057689|FG000|Overall Study|non compliance with study visits|2|||
130910357|NCT05140382|471306853|FG001|Overall Study|Investigator decision|0|||
130910358|NCT05140382|471306854|FG002|Overall Study|Investigator decision|0|||
130696612|NCT03358147|470514450|FG004|Overall Study|Administrative reasons|0|||
130696613|NCT03358147|470514446|FG000|Overall Study|Lack of Efficacy|0|||
130696614|NCT03358147|470514447|FG001|Overall Study|Lack of Efficacy|1|||
130696615|NCT03358147|470514448|FG002|Overall Study|Lack of Efficacy|1|||
130696616|NCT03358147|470514449|FG003|Overall Study|Lack of Efficacy|0|||
130696617|NCT03358147|470514450|FG004|Overall Study|Lack of Efficacy|0|||
130696618|NCT02704091|470514451|FG000|Overall Study|Adverse Event|4|||
130696619|NCT02704091|470514452|FG001|Overall Study|Adverse Event|3|||
130696620|NCT02704091|470514451|FG000|Overall Study|Protocol Violation|5|||
130696621|NCT02704091|470514452|FG001|Overall Study|Protocol Violation|3|||
130696622|NCT02704091|470514451|FG000|Overall Study|Consent withdrawn|4|||
130696623|NCT02704091|470514452|FG001|Overall Study|Consent withdrawn|4|||
130696624|NCT02704091|470514451|FG000|Overall Study|Lost to Follow-up|13|||
130696625|NCT02704091|470514452|FG001|Overall Study|Lost to Follow-up|5|||
130696626|NCT02704091|470514451|FG000|Overall Study|Other|2|||
130696627|NCT02704091|470514452|FG001|Overall Study|Other|8|||
130696628|NCT03073798|470514455|FG000|Overall Study|Adverse Event|1|||
130696629|NCT03073798|470514455|FG000|Overall Study|Withdrawal by Subject|1|||
130696630|NCT01186458|470514459|FG000|Overall Study|Adverse Event|1|||
130696631|NCT02640235|470514460|FG000|Overall Study|Withdrawal by Subject|7|||
130696632|NCT02640235|470514461|FG001|Overall Study|Withdrawal by Subject|6|||
130696633|NCT02640235|470514460|FG000|Overall Study|Lost to Follow-up|4|||
130696634|NCT02640235|470514461|FG001|Overall Study|Lost to Follow-up|3|||
130696635|NCT02640235|470514460|FG000|Overall Study|Death|2|||
130696636|NCT02640235|470514461|FG001|Overall Study|Death|3|||
130696637|NCT02640235|470514460|FG000|Overall Study|Other|1|||
130696638|NCT02640235|470514461|FG001|Overall Study|Other|2|||
130696639|NCT00301964|470514462|FG000|Overall Study|Second primary|2|||
130696640|NCT00301964|470514462|FG000|Overall Study|Wrong primary|1|||
130696641|NCT00301964|470514462|FG000|Overall Study|Inadequate pathology|1|||
130696642|NCT01968551|470514467|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
130696643|NCT01968551|470514468|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
130696644|NCT01968551|470514469|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
130696645|NCT01968551|470514467|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
130696646|NCT01968551|470514468|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
130696647|NCT01968551|470514469|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
130696648|NCT01968551|470514467|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
130696649|NCT01968551|470514468|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
130696650|NCT01968551|470514469|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
130696651|NCT01968551|470514467|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
130696652|NCT01968551|470514468|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
130696653|NCT01968551|470514469|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
130696654|NCT01968551|470514467|FG000|Extension Phase|Adverse Event|0|||
130696655|NCT01968551|470514468|FG001|Extension Phase|Adverse Event|0|||
130696656|NCT01968551|470514469|FG002|Extension Phase|Adverse Event|2|||
130696657|NCT01968551|470514467|FG000|Extension Phase|Death|0|||
130696658|NCT01968551|470514468|FG001|Extension Phase|Death|1|||
131030477|NCT02783300|471744493|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030478|NCT02783300|471744494|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030479|NCT02783300|471744495|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
131030480|NCT02783300|471744496|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
131030481|NCT05192200|471744499|FG000|Treatment Period|Other|1|||
130696659|NCT01968551|470514469|FG002|Extension Phase|Death|0|||
130696660|NCT01968551|470514467|FG000|Extension Phase|Withdrew Consent|0|||
130696661|NCT01968551|470514468|FG001|Extension Phase|Withdrew Consent|0|||
130696662|NCT01968551|470514469|FG002|Extension Phase|Withdrew Consent|1|||
130696663|NCT01968551|470514467|FG000|Extension Phase|Lost to Follow-up|1|||
130696664|NCT01968551|470514468|FG001|Extension Phase|Lost to Follow-up|0|||
130696665|NCT01968551|470514469|FG002|Extension Phase|Lost to Follow-up|1|||
130696666|NCT00819169|470514470|FG000|Overall Study|Withdrawal by Subject|2|||
131030482|NCT05192200|471744499|FG000|Treatment Period|Lack of Efficacy|1|||
131030483|NCT05192200|471744499|FG000|Treatment Period|Withdrawal by Subject|1|||
131030484|NCT05192200|471744499|FG000|Follow-up|Withdrawal by Subject|1|||
130696667|NCT00819169|470514471|FG001|Overall Study|Withdrawal by Subject|0|||
130696668|NCT00819169|470514472|FG002|Overall Study|Withdrawal by Subject|0|||
131030485|NCT03978871|471744503|FG000|Overall Study|Lost to Follow-up|11|||
130696669|NCT00819169|470514473|FG003|Overall Study|Withdrawal by Subject|1|||
130696670|NCT00819169|470514474|FG004|Overall Study|Withdrawal by Subject|1|||
130696671|NCT00819169|470514475|FG005|Overall Study|Withdrawal by Subject|1|||
130696672|NCT00819169|470514476|FG006|Overall Study|Withdrawal by Subject|5|||
130696673|NCT00819169|470514477|FG007|Overall Study|Withdrawal by Subject|1|||
130696674|NCT00819169|470514478|FG008|Overall Study|Withdrawal by Subject|4|||
130696675|NCT00819169|470514470|FG000|Overall Study|Lost to Follow-up|0|||
131030486|NCT03978871|471744504|FG001|Overall Study|Lost to Follow-up|12|||
130696676|NCT00819169|470514471|FG001|Overall Study|Lost to Follow-up|2|||
130696677|NCT00819169|470514472|FG002|Overall Study|Lost to Follow-up|0|||
130696678|NCT00819169|470514473|FG003|Overall Study|Lost to Follow-up|1|||
130910359|NCT05140382|471306852|FG000|Overall Study|Other|4|||
130910360|NCT05140382|471306853|FG001|Overall Study|Other|0|||
130910361|NCT05140382|471306854|FG002|Overall Study|Other|1|||
130910362|NCT05140382|471306852|FG000|Overall Study|Progressive disease|20|||
130910363|NCT05140382|471306853|FG001|Overall Study|Progressive disease|1|||
130910364|NCT05140382|471306854|FG002|Overall Study|Progressive disease|12|||
130910365|NCT05140382|471306852|FG000|Overall Study|Subjective disease progression|2|||
130910366|NCT05140382|471306853|FG001|Overall Study|Subjective disease progression|1|||
130910367|NCT05140382|471306854|FG002|Overall Study|Subjective disease progression|0|||
130910368|NCT05140382|471306852|FG000|Overall Study|Unknown at data cut-off|0|||
130910369|NCT05140382|471306853|FG001|Overall Study|Unknown at data cut-off|0|||
130910370|NCT05140382|471306854|FG002|Overall Study|Unknown at data cut-off|1|||
130910371|NCT05140382|471306852|FG000|Overall Study|Withdrawal by Subject|1|||
130910372|NCT05140382|471306853|FG001|Overall Study|Withdrawal by Subject|0|||
130910373|NCT05140382|471306854|FG002|Overall Study|Withdrawal by Subject|4|||
130910374|NCT05140382|471306852|FG000|Overall Study|Withdrawal of consent|0|||
130910375|NCT05140382|471306853|FG001|Overall Study|Withdrawal of consent|0|||
130910376|NCT05140382|471306854|FG002|Overall Study|Withdrawal of consent|1|||
130910377|NCT05063318|471306859|FG000|Overall Study|Progressive disease|2|||
130910378|NCT05063318|471306860|FG001|Overall Study|Progressive disease|0|||
130910379|NCT05063318|471306861|FG002|Overall Study|Progressive disease|3|||
130910380|NCT05063318|471306859|FG000|Overall Study|Compassionate use|1|||
130910381|NCT05063318|471306860|FG001|Overall Study|Compassionate use|3|||
130910382|NCT05063318|471306861|FG002|Overall Study|Compassionate use|3|||
130910383|NCT05063318|471306859|FG000|Overall Study|Adverse Event|0|||
131116537|NCT02684279|472057689|FG000|Overall Study|subject to have surgery|1|||
131116538|NCT02684279|472057689|FG000|Overall Study|family emergency|1|||
130910384|NCT05063318|471306860|FG001|Overall Study|Adverse Event|1|||
130910385|NCT05063318|471306861|FG002|Overall Study|Adverse Event|0|||
130910386|NCT05063318|471306859|FG000|Overall Study|Withdrawal by Subject|0|||
130910387|NCT05063318|471306860|FG001|Overall Study|Withdrawal by Subject|1|||
130910388|NCT05063318|471306861|FG002|Overall Study|Withdrawal by Subject|0|||
131116539|NCT02684279|472057689|FG000|Overall Study|Site closures|7|||
131116540|NCT02684279|472057689|FG000|Overall Study|Physician Decision|1|||
131116541|NCT04752475|472059282|FG000|Overall Study|Withdrawal by Subject|1|||
131116542|NCT04752475|472059283|FG001|Overall Study|Withdrawal by Subject|1|||
131116543|NCT02113579|472059286|FG000|Overall Study|Adverse Event|1|||
131116544|NCT02113579|472059287|FG001|Overall Study|Adverse Event|0|||
131116545|NCT02113579|472059286|FG000|Overall Study|Withdrawal by Subject|3|||
131116546|NCT02113579|472059287|FG001|Overall Study|Withdrawal by Subject|2|||
131116547|NCT02113579|472059286|FG000|Overall Study|Lost to Follow-up|6|||
130910389|NCT03228420|471308447|FG000|Overall Study|Lost to Follow-up|5|||
130910390|NCT03228420|471308448|FG001|Overall Study|Lost to Follow-up|3|||
130910391|NCT03228420|471308447|FG000|Overall Study|Withdrawal by Subject|10|||
130910392|NCT03228420|471308448|FG001|Overall Study|Withdrawal by Subject|0|||
130910393|NCT03228420|471308447|FG000|Overall Study|Adverse Event|5|||
131116548|NCT02113579|472059287|FG001|Overall Study|Lost to Follow-up|2|||
131116549|NCT02217436|472059288|FG000|Overall Study|Protocol Violation|1|||
131116550|NCT02217436|472059289|FG001|Overall Study|Protocol Violation|1|||
131116551|NCT02217436|472059288|FG000|Overall Study|Incomplete data|0|||
131116552|NCT02217436|472059289|FG001|Overall Study|Incomplete data|1|||
131116553|NCT01016964|472059292|FG000|Overall Study|Lost to Follow-up|3|||
131116554|NCT01016964|472059293|FG001|Overall Study|Lost to Follow-up|3|||
131030487|NCT04072822|471744505|FG000|Treatment|Adverse Event|9|||
131030488|NCT04072822|471744506|FG001|Treatment|Adverse Event|5|||
131030489|NCT04072822|471744505|FG000|Treatment|Met Stopping Criteria|13|||
131030490|NCT04072822|471744506|FG001|Treatment|Met Stopping Criteria|24|||
131030491|NCT04072822|471744505|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
131030492|NCT04072822|471744506|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
131030493|NCT04072822|471744505|FG000|Treatment|Withdrawal by Subject|0|||
131116555|NCT00928564|472059294|FG000|Overall Study|Lost to Follow-up|6|||
131116556|NCT00928564|472059295|FG001|Overall Study|Lost to Follow-up|0|||
131116557|NCT01667081|472059297|FG000|Overall Study|Death|43|||
131116558|NCT01667081|472059298|FG001|Overall Study|Death|3|||
131116559|NCT01667081|472059297|FG000|Overall Study|Lost to Follow-up|99|||
131116560|NCT01667081|472059298|FG001|Overall Study|Lost to Follow-up|48|||
130696679|NCT00819169|470514474|FG004|Overall Study|Lost to Follow-up|0|||
130696680|NCT00819169|470514475|FG005|Overall Study|Lost to Follow-up|6|||
130696681|NCT00819169|470514476|FG006|Overall Study|Lost to Follow-up|2|||
130910394|NCT03228420|471308448|FG001|Overall Study|Adverse Event|2|||
130910395|NCT02428608|471308449|FG000|Overall Study|Pregnancy|2|||
130910396|NCT02428608|471308449|FG000|Overall Study|Lost to Follow-up|37|||
130910397|NCT02428608|471308449|FG000|Overall Study|Withdrawal by Subject|2|||
130910398|NCT02428608|471308449|FG000|Overall Study|scheduling conflicts|15|||
130910399|NCT02428608|471308449|FG000|Overall Study|moved away|10|||
130910400|NCT02428608|471308449|FG000|Overall Study|Death|1|||
130910401|NCT02428608|471308449|FG000|Overall Study|various|16|||
130910402|NCT03468985|471308450|FG000|Overall Study|Adverse Event|0|||
131030494|NCT04072822|471744506|FG001|Treatment|Withdrawal by Subject|2|||
131030495|NCT04072822|471744505|FG000|Treatment|Death|0|||
131116561|NCT01667081|472059297|FG000|Overall Study|Physician Decision|16|||
131116562|NCT01667081|472059298|FG001|Overall Study|Physician Decision|2|||
131116563|NCT01667081|472059297|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
131116564|NCT01667081|472059298|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
131116565|NCT01667081|472059297|FG000|Overall Study|Withdrawal by Subject|90|||
130696682|NCT00819169|470514477|FG007|Overall Study|Lost to Follow-up|2|||
130696683|NCT00819169|470514478|FG008|Overall Study|Lost to Follow-up|1|||
130696684|NCT00819169|470514470|FG000|Overall Study|Death|1|||
130696685|NCT00819169|470514471|FG001|Overall Study|Death|1|||
130696686|NCT00819169|470514472|FG002|Overall Study|Death|3|||
130696687|NCT00819169|470514473|FG003|Overall Study|Death|8|||
130696688|NCT00819169|470514474|FG004|Overall Study|Death|5|||
130696689|NCT00819169|470514475|FG005|Overall Study|Death|7|||
130696690|NCT00819169|470514476|FG006|Overall Study|Death|9|||
130696691|NCT00819169|470514477|FG007|Overall Study|Death|4|||
130696692|NCT00819169|470514478|FG008|Overall Study|Death|7|||
130696693|NCT00819169|470514470|FG000|Overall Study|Ineligibility determined|0|||
130910403|NCT03468985|471308451|FG001|Overall Study|Adverse Event|2|||
130910404|NCT03468985|471308452|FG002|Overall Study|Adverse Event|0|||
130910405|NCT03468985|471308453|FG003|Overall Study|Adverse Event|0|||
130910406|NCT03468985|471308450|FG000|Overall Study|Withdrawal by Subject|0|||
130910407|NCT03468985|471308451|FG001|Overall Study|Withdrawal by Subject|0|||
130910408|NCT03468985|471308452|FG002|Overall Study|Withdrawal by Subject|0|||
130910409|NCT03468985|471308453|FG003|Overall Study|Withdrawal by Subject|1|||
130910410|NCT00085709|471308454|FG000|Overall Study|Adverse Event|8|||
130910411|NCT00085709|471308455|FG001|Overall Study|Adverse Event|0|||
130910412|NCT00085709|471308454|FG000|Overall Study|Death|8|||
130910413|NCT00085709|471308455|FG001|Overall Study|Death|2|||
130910414|NCT00085709|471308454|FG000|Overall Study|Refusal unrelated to adverse events|1|||
130910415|NCT00085709|471308455|FG001|Overall Study|Refusal unrelated to adverse events|2|||
130910416|NCT00085709|471308454|FG000|Overall Study|Progression|3|||
130910417|NCT00085709|471308455|FG001|Overall Study|Progression|4|||
130910418|NCT00085709|471308454|FG000|Overall Study|Not protocol specified|12|||
130910419|NCT00085709|471308455|FG001|Overall Study|Not protocol specified|22|||
130910420|NCT00085709|471308454|FG000|Overall Study|Not eligible|19|||
130910421|NCT00085709|471308455|FG001|Overall Study|Not eligible|19|||
131116566|NCT01667081|472059298|FG001|Overall Study|Withdrawal by Subject|35|||
131116567|NCT03034460|472059299|FG000|Overall Study|Adverse Event|0|||
131116568|NCT03034460|472059300|FG001|Overall Study|Adverse Event|1|||
131116569|NCT03034460|472059299|FG000|Overall Study|Withdrawal by Subject|2|||
131116570|NCT03034460|472059300|FG001|Overall Study|Withdrawal by Subject|2|||
131116571|NCT03034460|472059299|FG000|Overall Study|Personal Reasons|1|||
131116572|NCT03034460|472059300|FG001|Overall Study|Personal Reasons|0|||
131116573|NCT01798992|472059301|FG000|Overall Study|Administrative withdrawal|0|||
130696694|NCT00819169|470514471|FG001|Overall Study|Ineligibility determined|0|||
130696695|NCT00819169|470514472|FG002|Overall Study|Ineligibility determined|0|||
130696696|NCT00819169|470514473|FG003|Overall Study|Ineligibility determined|2|||
130696697|NCT00819169|470514474|FG004|Overall Study|Ineligibility determined|0|||
130696698|NCT00819169|470514475|FG005|Overall Study|Ineligibility determined|0|||
130696699|NCT00819169|470514476|FG006|Overall Study|Ineligibility determined|0|||
130696700|NCT00819169|470514477|FG007|Overall Study|Ineligibility determined|0|||
130910422|NCT00085709|471308454|FG000|Overall Study|Withdrawal by Subject|2|||
130910423|NCT00085709|471308455|FG001|Overall Study|Withdrawal by Subject|1|||
131030496|NCT04072822|471744506|FG001|Treatment|Death|2|||
131030497|NCT04072822|471744505|FG000|Treatment|Lost to Follow-up|11|||
131030498|NCT04072822|471744506|FG001|Treatment|Lost to Follow-up|3|||
131030499|NCT04072822|471744505|FG000|Treatment|Physician Decision|1|||
131030500|NCT04072822|471744506|FG001|Treatment|Physician Decision|0|||
131030501|NCT04072822|471744505|FG000|Treatment|Other|7|||
131030502|NCT04072822|471744506|FG001|Treatment|Other|9|||
131030503|NCT04072822|471744505|FG000|Follow-up|Withdrawal by Subject|1|||
130696701|NCT00819169|470514478|FG008|Overall Study|Ineligibility determined|1|||
130696702|NCT00819169|470514470|FG000|Overall Study|Adverse Event|0|||
130910424|NCT00397943|471308456|FG000|Overall Study|Unspecified reasons|12|||
130696703|NCT00819169|470514471|FG001|Overall Study|Adverse Event|0|||
130696704|NCT00819169|470514472|FG002|Overall Study|Adverse Event|0|||
130696705|NCT00819169|470514473|FG003|Overall Study|Adverse Event|0|||
130696706|NCT00819169|470514474|FG004|Overall Study|Adverse Event|1|||
130696707|NCT00819169|470514475|FG005|Overall Study|Adverse Event|0|||
131030504|NCT04072822|471744506|FG001|Follow-up|Withdrawal by Subject|0|||
131030505|NCT04072822|471744505|FG000|Follow-up|Lost to Follow-up|5|||
130696708|NCT00819169|470514476|FG006|Overall Study|Adverse Event|0|||
130696709|NCT00819169|470514477|FG007|Overall Study|Adverse Event|0|||
130910425|NCT00397943|471308457|FG001|Overall Study|Unspecified reasons|9|||
130910426|NCT00397943|471308458|FG002|Overall Study|Unspecified reasons|0|||
130910427|NCT00397943|471308459|FG003|Overall Study|Unspecified reasons|0|||
130910428|NCT00397943|471308460|FG004|Overall Study|Unspecified reasons|0|||
131030506|NCT04072822|471744506|FG001|Follow-up|Lost to Follow-up|4|||
131030507|NCT04391894|471744508|FG000|Overall Study|Adverse Event|1|||
130696710|NCT00819169|470514478|FG008|Overall Study|Adverse Event|0|||
130696711|NCT00819169|470514470|FG000|Overall Study|Administrative Decision|0|||
130696712|NCT00819169|470514471|FG001|Overall Study|Administrative Decision|0|||
130696713|NCT00819169|470514472|FG002|Overall Study|Administrative Decision|0|||
130696714|NCT00819169|470514473|FG003|Overall Study|Administrative Decision|0|||
130696715|NCT00819169|470514474|FG004|Overall Study|Administrative Decision|1|||
130696716|NCT00819169|470514475|FG005|Overall Study|Administrative Decision|2|||
131030508|NCT04391894|471744509|FG001|Overall Study|Adverse Event|1|||
131030509|NCT04391894|471744510|FG002|Overall Study|Adverse Event|1|||
131030510|NCT04391894|471744511|FG003|Overall Study|Adverse Event|1|||
131030511|NCT04391894|471744512|FG004|Overall Study|Adverse Event|1|||
131030512|NCT04391894|471744508|FG000|Overall Study|Lost to Follow-up|1|||
131030513|NCT04391894|471744509|FG001|Overall Study|Lost to Follow-up|0|||
131030514|NCT04391894|471744510|FG002|Overall Study|Lost to Follow-up|0|||
131030515|NCT04391894|471744511|FG003|Overall Study|Lost to Follow-up|0|||
131030516|NCT04391894|471744512|FG004|Overall Study|Lost to Follow-up|0|||
131030517|NCT04391894|471744508|FG000|Overall Study|Protocol Violation|0|||
131030518|NCT04391894|471744509|FG001|Overall Study|Protocol Violation|0|||
131030519|NCT04391894|471744510|FG002|Overall Study|Protocol Violation|0|||
131030520|NCT04391894|471744511|FG003|Overall Study|Protocol Violation|1|||
131030521|NCT04391894|471744512|FG004|Overall Study|Protocol Violation|0|||
131030522|NCT04391894|471744508|FG000|Overall Study|Withdrawal by Subject|2|||
131030523|NCT04391894|471744509|FG001|Overall Study|Withdrawal by Subject|0|||
131030524|NCT04391894|471744510|FG002|Overall Study|Withdrawal by Subject|3|||
131030525|NCT04391894|471744511|FG003|Overall Study|Withdrawal by Subject|0|||
131030526|NCT04391894|471744512|FG004|Overall Study|Withdrawal by Subject|1|||
131030527|NCT04391894|471744508|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
131030528|NCT04391894|471744509|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
131030529|NCT04391894|471744510|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
131030530|NCT04391894|471744511|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
131030531|NCT04391894|471744512|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
131030532|NCT00220740|471744518|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
131030533|NCT00220740|471744519|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
131030534|NCT00220740|471744518|FG000|Efficacy Period|Adverse Event|1|||
131030535|NCT00220740|471744519|FG001|Efficacy Period|Adverse Event|1|||
131030536|NCT00220740|471744518|FG000|Efficacy Period|Withdrawal by Subject|1|||
131030537|NCT00220740|471744519|FG001|Efficacy Period|Withdrawal by Subject|0|||
131030538|NCT00220740|471744518|FG000|Efficacy Period|Protocol Violation|1|||
131030539|NCT00220740|471744519|FG001|Efficacy Period|Protocol Violation|0|||
131030540|NCT00220740|471744518|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
131030541|NCT00220740|471744519|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
131030542|NCT01057433|471744520|FG000|Overall Study|Adverse Event|1|||
131030543|NCT05268302|471744521|FG000|Overall Study|Death|0|||
131030544|NCT05268302|471744522|FG001|Overall Study|Death|1|||
131030545|NCT04630262|471746215|FG000|Overall Study|Intraoperative Screen Failure|5|||
131030546|NCT04630262|471746215|FG000|Overall Study|Study terminated prematurely|71|||
131030547|NCT04630262|471746215|FG000|Overall Study|Withdrawal by Subject|2|||
131030548|NCT04630262|471746215|FG000|Overall Study|Physician Decision|2|||
131030549|NCT01180634|471746217|FG000|Overall Study|Adverse Event|4|||
131030550|NCT01180634|471746218|FG001|Overall Study|Adverse Event|1|||
131030551|NCT01180634|471746217|FG000|Overall Study|Miscellaneous|2|||
131030552|NCT01180634|471746218|FG001|Overall Study|Miscellaneous|0|||
131030553|NCT01180634|471746217|FG000|Overall Study|Withdrawal by Subject|4|||
131030554|NCT01180634|471746218|FG001|Overall Study|Withdrawal by Subject|0|||
131030555|NCT04419168|471746219|FG000|Overall Study|Protocol Violation|1|||
131030556|NCT04419168|471746220|FG001|Overall Study|Protocol Violation|1|||
131030557|NCT04419168|471746219|FG000|Overall Study|Lost to Follow-up|7|||
131030558|NCT04419168|471746220|FG001|Overall Study|Lost to Follow-up|7|||
131030559|NCT04419168|471746219|FG000|Overall Study|Missed 6-month Visit|48|||
131030560|NCT04419168|471746220|FG001|Overall Study|Missed 6-month Visit|45|||
130696717|NCT00819169|470514476|FG006|Overall Study|Administrative Decision|0|||
131030561|NCT05009251|471746221|FG000|Overall Study|Protocol Violation|100|||
131030562|NCT05009251|471746222|FG001|Overall Study|Protocol Violation|105|||
131030563|NCT05009251|471746223|FG002|Overall Study|Protocol Violation|119|||
131030564|NCT05009251|471746224|FG003|Overall Study|Protocol Violation|120|||
131030565|NCT05009251|471746225|FG004|Overall Study|Protocol Violation|119|||
131030566|NCT05009251|471746221|FG000|Overall Study|Death|25|||
131030567|NCT05009251|471746222|FG001|Overall Study|Death|22|||
131030568|NCT05009251|471746223|FG002|Overall Study|Death|24|||
131030569|NCT05009251|471746224|FG003|Overall Study|Death|19|||
131030570|NCT05009251|471746225|FG004|Overall Study|Death|15|||
131030571|NCT00616967|471746232|FG000|Overall Study|Withdrawal by Subject|0|||
131030572|NCT00616967|471746233|FG001|Overall Study|Withdrawal by Subject|0|||
131030573|NCT00616967|471746234|FG002|Overall Study|Withdrawal by Subject|1|||
131030574|NCT02910583|471746235|FG000|Overall Study|Death|7|||
131030575|NCT02910583|471746236|FG001|Overall Study|Death|3|||
131030576|NCT02910583|471746235|FG000|Overall Study|Lost to Follow-up|1|||
131030577|NCT02910583|471746236|FG001|Overall Study|Lost to Follow-up|0|||
130696718|NCT00819169|470514477|FG007|Overall Study|Administrative Decision|2|||
130696719|NCT00819169|470514478|FG008|Overall Study|Administrative Decision|0|||
130696720|NCT00573313|470514481|FG000|Overall Study|Protocol Violation|5|||
130696721|NCT00573313|470514482|FG001|Overall Study|Protocol Violation|0|||
130696722|NCT00573313|470514483|FG002|Overall Study|Protocol Violation|6|||
131116574|NCT01798992|472059302|FG001|Overall Study|Administrative withdrawal|1|||
131116575|NCT01798992|472059303|FG002|Overall Study|Administrative withdrawal|0|||
131116576|NCT01798992|472059304|FG003|Overall Study|Administrative withdrawal|1|||
131116577|NCT01798992|472059301|FG000|Overall Study|Lost to Follow-up|0|||
131116578|NCT01798992|472059302|FG001|Overall Study|Lost to Follow-up|1|||
131116579|NCT01798992|472059303|FG002|Overall Study|Lost to Follow-up|1|||
131116580|NCT01798992|472059304|FG003|Overall Study|Lost to Follow-up|0|||
131116581|NCT01798992|472059301|FG000|Overall Study|Insufficient biopsy tissue|0|||
131116582|NCT01798992|472059302|FG001|Overall Study|Insufficient biopsy tissue|0|||
131116583|NCT01798992|472059303|FG002|Overall Study|Insufficient biopsy tissue|1|||
131116584|NCT01798992|472059304|FG003|Overall Study|Insufficient biopsy tissue|0|||
131116585|NCT03085758|472059319|FG000|Overall Study|Death|26|||
131116586|NCT03085758|472059320|FG001|Overall Study|Death|24|||
131116587|NCT03085758|472059321|FG002|Overall Study|Death|53|||
131116588|NCT03085758|472059319|FG000|Overall Study|Lost to Follow-up|1|||
131116589|NCT03085758|472059320|FG001|Overall Study|Lost to Follow-up|1|||
131116590|NCT03085758|472059321|FG002|Overall Study|Lost to Follow-up|1|||
131116591|NCT03085758|472059319|FG000|Overall Study|Withdrawal by Subject|2|||
131116592|NCT03085758|472059320|FG001|Overall Study|Withdrawal by Subject|2|||
131116593|NCT03085758|472059321|FG002|Overall Study|Withdrawal by Subject|1|||
130696723|NCT00573313|470514484|FG003|Overall Study|Protocol Violation|0|||
130696724|NCT00467597|470514493|FG000|Overall Study|Withdrawal by Subject|2|||
130696725|NCT00467597|470514494|FG001|Overall Study|Withdrawal by Subject|0|||
131116594|NCT03085758|472059319|FG000|Overall Study|Refusal to recall it up to day 90|0|||
131116595|NCT03085758|472059320|FG001|Overall Study|Refusal to recall it up to day 90|0|||
131116596|NCT03085758|472059321|FG002|Overall Study|Refusal to recall it up to day 90|1|||
131116597|NCT03085758|472059319|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
131116598|NCT03085758|472059320|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
131116599|NCT03085758|472059321|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
131116600|NCT04004429|472059322|FG000|Overall Study|Protocol Violation|1|||
131116601|NCT04004429|472059323|FG001|Overall Study|Protocol Violation|0|||
131116602|NCT04004429|472059324|FG002|Overall Study|Protocol Violation|0|||
131116603|NCT04004429|472059322|FG000|Overall Study|Physician Decision|0|||
131116604|NCT04004429|472059323|FG001|Overall Study|Physician Decision|1|||
131116605|NCT04004429|472059324|FG002|Overall Study|Physician Decision|1|||
131116606|NCT04004429|472059322|FG000|Overall Study|Withdrawal by Subject|1|||
131116607|NCT04004429|472059323|FG001|Overall Study|Withdrawal by Subject|1|||
131116608|NCT04004429|472059324|FG002|Overall Study|Withdrawal by Subject|1|||
131116609|NCT01122576|472059325|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
131116610|NCT01122576|472059326|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
131116611|NCT01122576|472059327|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
131116612|NCT01122576|472059325|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
131116613|NCT01122576|472059326|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
131116614|NCT01122576|472059327|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
131116615|NCT01122576|472059325|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
131116616|NCT01122576|472059326|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
131116617|NCT01122576|472059327|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
131116618|NCT00931944|472059328|FG000|Overall Study|Adverse Event|4|||
131116619|NCT00931944|472059328|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
131116620|NCT00931944|472059328|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
131116621|NCT00931944|472059328|FG000|Overall Study|Death|28|||
131116622|NCT00931944|472059328|FG000|Overall Study|Other|2|||
131116623|NCT02459769|472059332|FG000|Overall Study|Withdrawal by Subject|7|||
131116624|NCT02459769|472059333|FG001|Overall Study|Withdrawal by Subject|4|||
131116625|NCT02459769|472059334|FG002|Overall Study|Withdrawal by Subject|8|||
131116626|NCT02459769|472059335|FG003|Overall Study|Withdrawal by Subject|5|||
131116627|NCT02459769|472059332|FG000|Overall Study|Lost to Follow-up|1|||
130696726|NCT02096705|470514495|FG000|Treatment|Adverse Event|6|||
131116628|NCT02459769|472059333|FG001|Overall Study|Lost to Follow-up|0|||
131116629|NCT02459769|472059334|FG002|Overall Study|Lost to Follow-up|1|||
130696727|NCT02096705|470514496|FG001|Treatment|Adverse Event|3|||
131116630|NCT02459769|472059335|FG003|Overall Study|Lost to Follow-up|0|||
131116631|NCT01287364|472059336|FG000|Overall Study|Adverse Event|0|||
131116632|NCT01287364|472059337|FG001|Overall Study|Adverse Event|3|||
131116633|NCT01287364|472059336|FG000|Overall Study|Protocol Violation|5|||
130696728|NCT02096705|470514495|FG000|Treatment|Subject request to discontinue treatment|1|||
130696729|NCT02096705|470514496|FG001|Treatment|Subject request to discontinue treatment|1|||
130696730|NCT02096705|470514495|FG000|Treatment|Withdrawal by Subject|1|||
130696731|NCT02096705|470514496|FG001|Treatment|Withdrawal by Subject|0|||
130696732|NCT02096705|470514495|FG000|Treatment|Other|1|||
130696733|NCT02096705|470514496|FG001|Treatment|Other|1|||
131116634|NCT01287364|472059337|FG001|Overall Study|Protocol Violation|5|||
131116635|NCT01287364|472059336|FG000|Overall Study|Other Reason|4|||
131116636|NCT01287364|472059337|FG001|Overall Study|Other Reason|2|||
131116637|NCT05372653|472059344|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
131116638|NCT05372653|472059345|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
131116639|NCT05372653|472059344|FG000|Overall Study|Adverse Event|0|||
131116640|NCT05372653|472059345|FG001|Overall Study|Adverse Event|1|||
131116641|NCT00711529|472059346|FG000|Overall Study|Protocol Violation|2|||
131116642|NCT00711529|472059347|FG001|Overall Study|Protocol Violation|0|||
131116643|NCT00711529|472059346|FG000|Overall Study|Withdrawal by Subject|2|||
131116644|NCT00711529|472059347|FG001|Overall Study|Withdrawal by Subject|6|||
131116645|NCT03740997|472059350|FG000|Overall Study|Withdrawal by Subject|1|||
131116646|NCT03740997|472059351|FG001|Overall Study|Withdrawal by Subject|0|||
131116647|NCT03740997|472059350|FG000|Overall Study|Participant was unable to complete study procedures|1|||
131116648|NCT03740997|472059351|FG001|Overall Study|Participant was unable to complete study procedures|0|||
131116649|NCT01829425|472059352|FG000|Overall Study|Withdrawal by Subject|4|||
131116650|NCT01829425|472059353|FG001|Overall Study|Withdrawal by Subject|3|||
131116651|NCT01829425|472059352|FG000|Overall Study|Lost to Follow-up|2|||
131116652|NCT01829425|472059353|FG001|Overall Study|Lost to Follow-up|1|||
131116653|NCT05211739|472059354|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
131116654|NCT05211739|472059355|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
131116655|NCT05211739|472059354|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
131116656|NCT05211739|472059355|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
131116657|NCT05211739|472059354|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
131116658|NCT05211739|472059355|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
131116659|NCT05211739|472059354|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
131116660|NCT05211739|472059355|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
131116661|NCT03681951|472059356|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
131116662|NCT03681951|472059357|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131116663|NCT03681951|472059358|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131116664|NCT03681951|472059359|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131116665|NCT03681951|472059360|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131116666|NCT03681951|472059361|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131116667|NCT03681951|472059362|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131116668|NCT03681951|472059363|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
131116669|NCT03681951|472059356|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
131116670|NCT03681951|472059357|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131116671|NCT03681951|472059358|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131116672|NCT03681951|472059359|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131116673|NCT03681951|472059360|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131116674|NCT03681951|472059361|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131116675|NCT03681951|472059362|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131116676|NCT03681951|472059363|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
131116677|NCT03681951|472059356|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
131116678|NCT03681951|472059357|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131116679|NCT03681951|472059358|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131116680|NCT03681951|472059359|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131116681|NCT03681951|472059360|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131116682|NCT03681951|472059361|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131116683|NCT03681951|472059362|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131116684|NCT03681951|472059363|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
131116685|NCT01975428|472059364|FG000|Overall Study|Lost to Follow-up|17|||
131116686|NCT01975428|472059365|FG001|Overall Study|Lost to Follow-up|4|||
131116687|NCT01975428|472059364|FG000|Overall Study|Withdrawal by Subject|3|||
131116688|NCT01975428|472059365|FG001|Overall Study|Withdrawal by Subject|10|||
131116689|NCT01505010|472059366|FG000|Overall Study|Protocol Violation|0|||
131116690|NCT01505010|472059367|FG001|Overall Study|Protocol Violation|1|||
131116691|NCT01505010|472059366|FG000|Overall Study|Lost to Follow-up|0|||
131116692|NCT01505010|472059367|FG001|Overall Study|Lost to Follow-up|1|||
131116693|NCT01968070|472059374|FG000|Period 1|Withdrawal by Subject|0|||
131116694|NCT01968070|472059375|FG001|Period 1|Withdrawal by Subject|1|||
131116695|NCT01968070|472059376|FG002|Period 1|Withdrawal by Subject|0|||
131116696|NCT01968070|472059377|FG003|Period 1|Withdrawal by Subject|0|||
130696734|NCT02096705|470514495|FG000|Follow-up|Withdrawal by Subject|1|||
130696735|NCT02096705|470514496|FG001|Follow-up|Withdrawal by Subject|0|||
130696736|NCT02096705|470514495|FG000|Follow-up|Adverse Event|2|||
130696737|NCT02096705|470514496|FG001|Follow-up|Adverse Event|2|||
130696738|NCT02096705|470514495|FG000|Follow-up|Subjects not reporting status|1|||
131116697|NCT01968070|472059378|FG004|Period 1|Withdrawal by Subject|0|||
131116698|NCT01968070|472059379|FG005|Period 1|Withdrawal by Subject|0|||
130910429|NCT04521777|471308461|FG000|Overall Study|Death|2|||
130910430|NCT04521777|471308461|FG000|Overall Study|Withdrawal by Subject|2|||
130910431|NCT03139604|471308464|FG000|Overall Study|Other|7|||
130910432|NCT03139604|471308465|FG001|Overall Study|Other|3|||
130910433|NCT03139604|471308464|FG000|Overall Study|Withdrawal by Subject|16|||
130910434|NCT03139604|471308465|FG001|Overall Study|Withdrawal by Subject|17|||
130910435|NCT03139604|471308464|FG000|Overall Study|Physician Decision|1|||
130910436|NCT03139604|471308465|FG001|Overall Study|Physician Decision|2|||
130910437|NCT03139604|471308464|FG000|Overall Study|Lost to Follow-up|3|||
130910438|NCT03139604|471308465|FG001|Overall Study|Lost to Follow-up|1|||
130910439|NCT03139604|471308464|FG000|Overall Study|Death|65|||
130910440|NCT03139604|471308465|FG001|Overall Study|Death|67|||
130910441|NCT03139604|471308464|FG000|Overall Study|Study Terminated by Sponsor|122|||
130910442|NCT03139604|471308465|FG001|Overall Study|Study Terminated by Sponsor|127|||
130910443|NCT03139604|471308464|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
130910444|NCT03139604|471308465|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
130910445|NCT04950608|471308466|FG000|Overall Study|Withdrawal by Subject|2|||
130910446|NCT04950608|471308466|FG000|Overall Study|Physician Decision|3|||
131116699|NCT01968070|472059380|FG006|Period 1|Withdrawal by Subject|1|||
130910448|NCT02007512|471308468|FG000|Double Blind Treatment Period|Adverse Event|4|||
130910449|NCT02007512|471308469|FG001|Double Blind Treatment Period|Adverse Event|6|||
130910450|NCT02007512|471308470|FG002|Double Blind Treatment Period|Adverse Event|2|||
130910451|NCT02007512|471308471|FG003|Double Blind Treatment Period|Adverse Event|2|||
130910452|NCT02007512|471308468|FG000|Double Blind Treatment Period|Death|1|||
130910453|NCT02007512|471308469|FG001|Double Blind Treatment Period|Death|0|||
130910454|NCT02007512|471308470|FG002|Double Blind Treatment Period|Death|0|||
130910455|NCT02007512|471308471|FG003|Double Blind Treatment Period|Death|0|||
130910456|NCT02007512|471308468|FG000|Double Blind Treatment Period|Disease progression|51|||
130910457|NCT02007512|471308469|FG001|Double Blind Treatment Period|Disease progression|50|||
130910458|NCT02007512|471308470|FG002|Double Blind Treatment Period|Disease progression|57|||
130910459|NCT02007512|471308471|FG003|Double Blind Treatment Period|Disease progression|52|||
130910460|NCT02007512|471308468|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
130910461|NCT02007512|471308469|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
130910462|NCT02007512|471308470|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
131030578|NCT02910583|471746235|FG000|Overall Study|Withdrawal by Subject|12|||
131030579|NCT02910583|471746236|FG001|Overall Study|Withdrawal by Subject|8|||
131030580|NCT02910583|471746235|FG000|Overall Study|Other, Not Specified|6|||
131030581|NCT02910583|471746236|FG001|Overall Study|Other, Not Specified|3|||
131030582|NCT05059262|471746237|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
131030583|NCT05059262|471746238|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
131030584|NCT05059262|471746237|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
131030585|NCT05059262|471746238|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
131030586|NCT05059262|471746237|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
131030587|NCT05059262|471746238|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
131030588|NCT05059262|471746237|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
131030589|NCT05059262|471746238|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
131030590|NCT05059262|471746237|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
131030591|NCT05059262|471746238|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
131030592|NCT05059262|471746237|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
131030593|NCT05059262|471746238|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
131030594|NCT05059262|471746237|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
131030595|NCT05059262|471746238|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
131030596|NCT05059262|471746237|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
131030597|NCT05059262|471746238|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
131030598|NCT05059262|471746237|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
131030599|NCT05059262|471746238|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
131030600|NCT02029443|471746250|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
131030601|NCT02029443|471746251|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
131030602|NCT02029443|471746252|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
131030603|NCT02029443|471746253|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
131030604|NCT02029443|471746254|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
131030605|NCT02029443|471746250|FG000|Overall Study|Death|13|||
131030606|NCT02029443|471746251|FG001|Overall Study|Death|2|||
131030607|NCT02029443|471746252|FG002|Overall Study|Death|2|||
131030608|NCT02029443|471746253|FG003|Overall Study|Death|11|||
131030609|NCT02029443|471746254|FG004|Overall Study|Death|2|||
131030610|NCT02029443|471746250|FG000|Overall Study|Lost to Follow-up|1|||
131030611|NCT02029443|471746251|FG001|Overall Study|Lost to Follow-up|0|||
130910463|NCT02007512|471308471|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
131030612|NCT02029443|471746252|FG002|Overall Study|Lost to Follow-up|1|||
131030613|NCT02029443|471746253|FG003|Overall Study|Lost to Follow-up|1|||
130910464|NCT02007512|471308468|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130910465|NCT02007512|471308469|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130910466|NCT02007512|471308470|FG002|Double Blind Treatment Period|Protocol Violation|0|||
130910467|NCT02007512|471308471|FG003|Double Blind Treatment Period|Protocol Violation|1|||
130910468|NCT02007512|471308468|FG000|Double Blind Treatment Period|Other|2|||
130910469|NCT02007512|471308469|FG001|Double Blind Treatment Period|Other|1|||
131030614|NCT02029443|471746254|FG004|Overall Study|Lost to Follow-up|0|||
131030615|NCT02029443|471746250|FG000|Overall Study|Started other anti-cancer therapy|17|||
131030616|NCT02029443|471746251|FG001|Overall Study|Started other anti-cancer therapy|4|||
131030617|NCT02029443|471746252|FG002|Overall Study|Started other anti-cancer therapy|7|||
131030618|NCT02029443|471746253|FG003|Overall Study|Started other anti-cancer therapy|9|||
131030619|NCT02029443|471746254|FG004|Overall Study|Started other anti-cancer therapy|3|||
131030620|NCT02029443|471746250|FG000|Overall Study|Withdrawal by Subject|3|||
131030621|NCT02029443|471746251|FG001|Overall Study|Withdrawal by Subject|1|||
131030622|NCT02029443|471746252|FG002|Overall Study|Withdrawal by Subject|1|||
131030623|NCT02029443|471746253|FG003|Overall Study|Withdrawal by Subject|1|||
131030624|NCT02029443|471746254|FG004|Overall Study|Withdrawal by Subject|0|||
131030625|NCT02029443|471746250|FG000|Overall Study|Other|6|||
131030626|NCT02029443|471746251|FG001|Overall Study|Other|6|||
131030627|NCT02029443|471746252|FG002|Overall Study|Other|4|||
131030628|NCT02029443|471746253|FG003|Overall Study|Other|2|||
131030629|NCT02029443|471746254|FG004|Overall Study|Other|0|||
131030630|NCT03393975|471746256|FG000|Urgent Treatment Period|Physician Decision|0|||
131030631|NCT03393975|471746257|FG001|Urgent Treatment Period|Physician Decision|0|||
131030632|NCT03393975|471746258|FG002|Urgent Treatment Period|Physician Decision|0|||
131030633|NCT03393975|471746259|FG003|Urgent Treatment Period|Physician Decision|1|||
131030634|NCT03393975|471746256|FG000|Prophylaxis Period 1|Reason not Specified|0|||
131030635|NCT03393975|471746257|FG001|Prophylaxis Period 1|Reason not Specified|1|||
131030636|NCT03393975|471746258|FG002|Prophylaxis Period 1|Reason not Specified|0|||
131030637|NCT03393975|471746259|FG003|Prophylaxis Period 1|Reason not Specified|0|||
131030638|NCT03393975|471746256|FG000|Prophylaxis Period 2|Reason not Specified|0|||
131030639|NCT03393975|471746257|FG001|Prophylaxis Period 2|Reason not Specified|1|||
131030640|NCT03393975|471746258|FG002|Prophylaxis Period 2|Reason not Specified|0|||
131030641|NCT03393975|471746259|FG003|Prophylaxis Period 2|Reason not Specified|0|||
131030642|NCT04083235|471746263|FG000|Overall Study|Death|252|||
131030643|NCT04083235|471746264|FG001|Overall Study|Death|277|||
131030644|NCT04083235|471746263|FG000|Overall Study|Withdrawal by Subject|13|||
131030645|NCT04083235|471746264|FG001|Overall Study|Withdrawal by Subject|17|||
131030646|NCT04083235|471746263|FG000|Overall Study|Lost to Follow-up|1|||
131030647|NCT04083235|471746264|FG001|Overall Study|Lost to Follow-up|1|||
131030648|NCT04083235|471746263|FG000|Overall Study|Does not meet entry criteria|1|||
131030649|NCT04083235|471746264|FG001|Overall Study|Does not meet entry criteria|0|||
131030650|NCT04083235|471746263|FG000|Overall Study|Did not receive treatment|13|||
131030651|NCT04083235|471746264|FG001|Overall Study|Did not receive treatment|8|||
131030652|NCT04083235|471746263|FG000|Overall Study|Ongoing at the time of DCO|44|||
131030653|NCT04083235|471746264|FG001|Overall Study|Ongoing at the time of DCO|7|||
131030654|NCT05691309|471746267|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
131030655|NCT05691309|471746267|FG000|Overall Study|vancomycin levels not evaluable|2|||
131030656|NCT02724878|471746268|FG000|Overall Study|Still on Active Therapy|15|||
131030657|NCT02724878|471746268|FG000|Overall Study|Disease Progression|31|||
131030658|NCT02724878|471746268|FG000|Overall Study|Toxicity|5|||
131030659|NCT02724878|471746268|FG000|Overall Study|Death|1|||
131030660|NCT02724878|471746268|FG000|Overall Study|Withdrawal by Subject|4|||
131030661|NCT02724878|471746268|FG000|Overall Study|Lost to Follow-up|2|||
131030662|NCT02724878|471746268|FG000|Overall Study|Protocol Violation|1|||
131030663|NCT02724878|471746268|FG000|Overall Study|Ineligible for Study Drug|5|||
131030664|NCT02724878|471746268|FG000|Overall Study|not started|1|||
131030665|NCT01804816|471746269|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
131030666|NCT01804816|471746269|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
131030667|NCT04421378|471746275|FG000|Overall Study|Adverse Event|2|||
131030668|NCT04421378|471746276|FG001|Overall Study|Adverse Event|7|||
131030669|NCT04421378|471746277|FG002|Overall Study|Adverse Event|0|||
131030670|NCT04421378|471746278|FG003|Overall Study|Adverse Event|1|||
131030671|NCT04421378|471746279|FG004|Overall Study|Adverse Event|0|||
131030672|NCT04421378|471746275|FG000|Overall Study|Physician Decision|1|||
131030673|NCT04421378|471746276|FG001|Overall Study|Physician Decision|2|||
131030674|NCT04421378|471746277|FG002|Overall Study|Physician Decision|0|||
131030675|NCT04421378|471746278|FG003|Overall Study|Physician Decision|0|||
131030676|NCT04421378|471746279|FG004|Overall Study|Physician Decision|0|||
131030677|NCT04421378|471746275|FG000|Overall Study|Progressive Disease|16|||
131030678|NCT04421378|471746276|FG001|Overall Study|Progressive Disease|4|||
131030679|NCT04421378|471746277|FG002|Overall Study|Progressive Disease|18|||
131030680|NCT04421378|471746278|FG003|Overall Study|Progressive Disease|11|||
131030681|NCT04421378|471746279|FG004|Overall Study|Progressive Disease|3|||
131030682|NCT04421378|471746275|FG000|Overall Study|Study Terminated by Sponsor|0|||
131030683|NCT04421378|471746276|FG001|Overall Study|Study Terminated by Sponsor|1|||
131030684|NCT04421378|471746277|FG002|Overall Study|Study Terminated by Sponsor|1|||
131030685|NCT04421378|471746278|FG003|Overall Study|Study Terminated by Sponsor|0|||
130910470|NCT02007512|471308470|FG002|Double Blind Treatment Period|Other|1|||
130910471|NCT02007512|471308471|FG003|Double Blind Treatment Period|Other|2|||
131030686|NCT04421378|471746279|FG004|Overall Study|Study Terminated by Sponsor|0|||
131030687|NCT04421378|471746275|FG000|Overall Study|Withdrawal by Subject|3|||
131030688|NCT04421378|471746276|FG001|Overall Study|Withdrawal by Subject|1|||
131030689|NCT04421378|471746277|FG002|Overall Study|Withdrawal by Subject|0|||
131030690|NCT04421378|471746278|FG003|Overall Study|Withdrawal by Subject|2|||
131030691|NCT04421378|471746279|FG004|Overall Study|Withdrawal by Subject|0|||
131030692|NCT04421378|471746275|FG000|Overall Study|Other|1|||
131030693|NCT04421378|471746276|FG001|Overall Study|Other|0|||
131030694|NCT04421378|471746277|FG002|Overall Study|Other|0|||
131030695|NCT04421378|471746278|FG003|Overall Study|Other|0|||
131030696|NCT04421378|471746279|FG004|Overall Study|Other|0|||
131030697|NCT04263311|471746280|FG000|Overall Study|Lost to Follow-up|1|||
131030698|NCT04263311|471746281|FG001|Overall Study|Lost to Follow-up|2|||
131030699|NCT04263311|471746282|FG002|Overall Study|Lost to Follow-up|0|||
131030700|NCT04263311|471746280|FG000|Overall Study|Health Issues|1|||
131030701|NCT04263311|471746281|FG001|Overall Study|Health Issues|0|||
131030702|NCT04263311|471746282|FG002|Overall Study|Health Issues|0|||
131030703|NCT04263311|471746280|FG000|Overall Study|Left the country|1|||
131030704|NCT04263311|471746281|FG001|Overall Study|Left the country|0|||
131030705|NCT04263311|471746282|FG002|Overall Study|Left the country|0|||
131030706|NCT04263311|471746280|FG000|Overall Study|Unable to maintain time commitment|1|||
131030707|NCT04263311|471746281|FG001|Overall Study|Unable to maintain time commitment|0|||
131030708|NCT04263311|471746282|FG002|Overall Study|Unable to maintain time commitment|0|||
131030709|NCT04263311|471746280|FG000|Overall Study|No longer interested|1|||
131030710|NCT04263311|471746281|FG001|Overall Study|No longer interested|0|||
131030711|NCT04263311|471746282|FG002|Overall Study|No longer interested|0|||
131030712|NCT04263311|471746280|FG000|Overall Study|Ineligible post consent|0|||
131030713|NCT04263311|471746281|FG001|Overall Study|Ineligible post consent|0|||
131030714|NCT04263311|471746282|FG002|Overall Study|Ineligible post consent|5|||
131030715|NCT02592330|471746283|FG000|Overall Study|Withdrawal by Subject|1|||
131030716|NCT02592330|471746284|FG001|Overall Study|Withdrawal by Subject|0|||
131030717|NCT02592330|471746283|FG000|Overall Study|Failed Biopsy|1|||
131030718|NCT02592330|471746284|FG001|Overall Study|Failed Biopsy|0|||
131030719|NCT04673929|471746285|FG000|Overall Study|Death|73|||
131030720|NCT04673929|471746285|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
131030721|NCT02807636|471746289|FG000|Overall Study|Lost to Follow-up|10|||
131030722|NCT02807636|471746290|FG001|Overall Study|Lost to Follow-up|13|||
131030723|NCT02807636|471746291|FG002|Overall Study|Lost to Follow-up|6|||
131030724|NCT02807636|471746289|FG000|Overall Study|Protocol Deviation|1|||
131030725|NCT02807636|471746290|FG001|Overall Study|Protocol Deviation|0|||
131030726|NCT02807636|471746291|FG002|Overall Study|Protocol Deviation|0|||
131030727|NCT02807636|471746289|FG000|Overall Study|Symptomatic Deterioration|0|||
131030728|NCT02807636|471746290|FG001|Overall Study|Symptomatic Deterioration|1|||
131030729|NCT02807636|471746291|FG002|Overall Study|Symptomatic Deterioration|0|||
131030730|NCT02807636|471746289|FG000|Overall Study|Withdrawal by Subject|39|||
131030731|NCT02807636|471746290|FG001|Overall Study|Withdrawal by Subject|28|||
131030732|NCT02807636|471746291|FG002|Overall Study|Withdrawal by Subject|24|||
131030733|NCT02807636|471746289|FG000|Overall Study|Death|303|||
131030734|NCT02807636|471746290|FG001|Overall Study|Death|332|||
131030735|NCT02807636|471746291|FG002|Overall Study|Death|272|||
131030736|NCT02807636|471746289|FG000|Overall Study|Study Terminated By Sponsor|47|||
131030737|NCT02807636|471746290|FG001|Overall Study|Study Terminated By Sponsor|76|||
131030738|NCT02807636|471746291|FG002|Overall Study|Study Terminated By Sponsor|60|||
131030739|NCT02807636|471746289|FG000|Overall Study|Physician Decision|0|||
131030740|NCT02807636|471746290|FG001|Overall Study|Physician Decision|1|||
131030741|NCT02807636|471746291|FG002|Overall Study|Physician Decision|0|||
130696739|NCT02096705|470514496|FG001|Follow-up|Subjects not reporting status|2|||
130696740|NCT02166606|470514499|FG000|Overall Study|Adverse Event|3|||
130696741|NCT02166606|470514499|FG000|Overall Study|Death|31|||
130696742|NCT02166606|470514499|FG000|Overall Study|Protocol Violation|7|||
130696743|NCT02166606|470514499|FG000|Overall Study|Lost to Follow-up|30|||
130910472|NCT02007512|471308468|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
131030742|NCT05082909|471746292|FG000|Overall Study|Protocol Violation|0|||
131030743|NCT05082909|471746293|FG001|Overall Study|Protocol Violation|0|||
131030744|NCT05082909|471746294|FG002|Overall Study|Protocol Violation|1|||
131030745|NCT05082909|471746295|FG003|Overall Study|Protocol Violation|0|||
131030746|NCT05082909|471746296|FG004|Overall Study|Protocol Violation|0|||
131030747|NCT05082909|471746297|FG005|Overall Study|Protocol Violation|0|||
131030748|NCT04088630|471746298|FG000|Overall Study|Lost to Follow-up|3|||
131030749|NCT04088630|471746299|FG001|Overall Study|Lost to Follow-up|2|||
130696744|NCT02166606|470514499|FG000|Overall Study|Withdrawal by Subject|1|||
130696745|NCT02166606|470514499|FG000|Overall Study|Physician Decision|1|||
130696746|NCT02166606|470514499|FG000|Overall Study|Device upgrade|1|||
131030750|NCT04088630|471746300|FG002|Overall Study|Lost to Follow-up|6|||
131030751|NCT04088630|471746298|FG000|Overall Study|Death|3|||
131030752|NCT04088630|471746299|FG001|Overall Study|Death|1|||
131030753|NCT04088630|471746300|FG002|Overall Study|Death|1|||
131116700|NCT01968070|472059381|FG007|Period 1|Withdrawal by Subject|0|||
131116701|NCT01968070|472059382|FG008|Period 1|Withdrawal by Subject|0|||
131116702|NCT01968070|472059383|FG009|Period 1|Withdrawal by Subject|0|||
131116703|NCT01968070|472059384|FG010|Period 1|Withdrawal by Subject|0|||
131116704|NCT01968070|472059385|FG011|Period 1|Withdrawal by Subject|0|||
131116705|NCT01968070|472059386|FG012|Period 1|Withdrawal by Subject|0|||
131116706|NCT01968070|472059387|FG013|Period 1|Withdrawal by Subject|0|||
131116707|NCT01968070|472059388|FG014|Period 1|Withdrawal by Subject|0|||
131116708|NCT01968070|472059389|FG015|Period 1|Withdrawal by Subject|1|||
131116709|NCT01968070|472059390|FG016|Period 1|Withdrawal by Subject|0|||
131116710|NCT01968070|472059391|FG017|Period 1|Withdrawal by Subject|0|||
131116711|NCT01968070|472059374|FG000|Period 1|Protocol Violation|0|||
131116712|NCT01968070|472059375|FG001|Period 1|Protocol Violation|0|||
131116713|NCT01968070|472059376|FG002|Period 1|Protocol Violation|0|||
131116714|NCT01968070|472059377|FG003|Period 1|Protocol Violation|1|||
131116715|NCT01968070|472059378|FG004|Period 1|Protocol Violation|1|||
131116716|NCT01968070|472059379|FG005|Period 1|Protocol Violation|0|||
131116717|NCT01968070|472059380|FG006|Period 1|Protocol Violation|0|||
131116718|NCT01968070|472059381|FG007|Period 1|Protocol Violation|0|||
131116719|NCT01968070|472059382|FG008|Period 1|Protocol Violation|0|||
131116720|NCT01968070|472059383|FG009|Period 1|Protocol Violation|0|||
131116721|NCT01968070|472059384|FG010|Period 1|Protocol Violation|0|||
131116722|NCT01968070|472059385|FG011|Period 1|Protocol Violation|0|||
131116723|NCT01968070|472059386|FG012|Period 1|Protocol Violation|0|||
131116724|NCT01968070|472059387|FG013|Period 1|Protocol Violation|0|||
131116725|NCT01968070|472059388|FG014|Period 1|Protocol Violation|0|||
131116726|NCT01968070|472059389|FG015|Period 1|Protocol Violation|0|||
131116727|NCT01968070|472059390|FG016|Period 1|Protocol Violation|0|||
131116728|NCT01968070|472059391|FG017|Period 1|Protocol Violation|0|||
131116729|NCT01968070|472059374|FG000|Period 1|Lost to Follow-up|0|||
131116730|NCT01968070|472059375|FG001|Period 1|Lost to Follow-up|0|||
131116731|NCT01968070|472059376|FG002|Period 1|Lost to Follow-up|0|||
131116732|NCT01968070|472059377|FG003|Period 1|Lost to Follow-up|1|||
131116733|NCT01968070|472059378|FG004|Period 1|Lost to Follow-up|0|||
131116734|NCT01968070|472059379|FG005|Period 1|Lost to Follow-up|0|||
131116735|NCT01968070|472059380|FG006|Period 1|Lost to Follow-up|0|||
131116736|NCT01968070|472059381|FG007|Period 1|Lost to Follow-up|0|||
131116737|NCT01968070|472059382|FG008|Period 1|Lost to Follow-up|0|||
131116738|NCT01968070|472059383|FG009|Period 1|Lost to Follow-up|0|||
131116739|NCT01968070|472059384|FG010|Period 1|Lost to Follow-up|0|||
131116740|NCT01968070|472059385|FG011|Period 1|Lost to Follow-up|0|||
131116741|NCT01968070|472059386|FG012|Period 1|Lost to Follow-up|0|||
131116742|NCT01968070|472059387|FG013|Period 1|Lost to Follow-up|0|||
131116743|NCT01968070|472059388|FG014|Period 1|Lost to Follow-up|0|||
131116744|NCT01968070|472059389|FG015|Period 1|Lost to Follow-up|0|||
131116745|NCT01968070|472059390|FG016|Period 1|Lost to Follow-up|0|||
131116746|NCT01968070|472059391|FG017|Period 1|Lost to Follow-up|0|||
131116747|NCT01968070|472059374|FG000|Period 1|Adverse Event|0|||
131116748|NCT01968070|472059375|FG001|Period 1|Adverse Event|0|||
131116749|NCT01968070|472059376|FG002|Period 1|Adverse Event|0|||
131116750|NCT01968070|472059377|FG003|Period 1|Adverse Event|0|||
131116751|NCT01968070|472059378|FG004|Period 1|Adverse Event|0|||
131116752|NCT01968070|472059379|FG005|Period 1|Adverse Event|0|||
131116753|NCT01968070|472059380|FG006|Period 1|Adverse Event|1|||
131116754|NCT01968070|472059381|FG007|Period 1|Adverse Event|0|||
131116755|NCT01968070|472059382|FG008|Period 1|Adverse Event|0|||
131116756|NCT01968070|472059383|FG009|Period 1|Adverse Event|0|||
131116757|NCT01968070|472059384|FG010|Period 1|Adverse Event|0|||
131116758|NCT01968070|472059385|FG011|Period 1|Adverse Event|0|||
131116759|NCT01968070|472059386|FG012|Period 1|Adverse Event|0|||
131116760|NCT01968070|472059387|FG013|Period 1|Adverse Event|0|||
131116761|NCT01968070|472059388|FG014|Period 1|Adverse Event|0|||
131116762|NCT01968070|472059389|FG015|Period 1|Adverse Event|0|||
131116763|NCT01968070|472059390|FG016|Period 1|Adverse Event|0|||
131116764|NCT01968070|472059391|FG017|Period 1|Adverse Event|0|||
131116765|NCT01968070|472059374|FG000|Period 1|Physician Decision|0|||
131116766|NCT01968070|472059375|FG001|Period 1|Physician Decision|0|||
131116767|NCT01968070|472059376|FG002|Period 1|Physician Decision|0|||
131116768|NCT01968070|472059377|FG003|Period 1|Physician Decision|0|||
131116769|NCT01968070|472059378|FG004|Period 1|Physician Decision|0|||
131116770|NCT01968070|472059379|FG005|Period 1|Physician Decision|0|||
131116771|NCT01968070|472059380|FG006|Period 1|Physician Decision|0|||
131116772|NCT01968070|472059381|FG007|Period 1|Physician Decision|0|||
131116773|NCT01968070|472059382|FG008|Period 1|Physician Decision|0|||
131116774|NCT01968070|472059383|FG009|Period 1|Physician Decision|0|||
131116775|NCT01968070|472059384|FG010|Period 1|Physician Decision|0|||
131116776|NCT01968070|472059385|FG011|Period 1|Physician Decision|1|||
131116777|NCT01968070|472059386|FG012|Period 1|Physician Decision|0|||
131116778|NCT01968070|472059387|FG013|Period 1|Physician Decision|0|||
131116779|NCT01968070|472059388|FG014|Period 1|Physician Decision|0|||
131116780|NCT01968070|472059389|FG015|Period 1|Physician Decision|0|||
131116781|NCT01968070|472059390|FG016|Period 1|Physician Decision|0|||
131116782|NCT01968070|472059391|FG017|Period 1|Physician Decision|0|||
130910473|NCT02007512|471308469|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
130910474|NCT02007512|471308470|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
130910475|NCT02007512|471308471|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
130910476|NCT02007512|471308468|FG000|Open Label Treatment Period|Adverse Event|1|||
130910477|NCT02007512|471308469|FG001|Open Label Treatment Period|Adverse Event|0|||
130910478|NCT02007512|471308470|FG002|Open Label Treatment Period|Adverse Event|0|||
130910479|NCT02007512|471308471|FG003|Open Label Treatment Period|Adverse Event|0|||
130910480|NCT02007512|471308468|FG000|Open Label Treatment Period|Other|1|||
130910481|NCT02007512|471308469|FG001|Open Label Treatment Period|Other|1|||
130910482|NCT02007512|471308470|FG002|Open Label Treatment Period|Other|0|||
130910483|NCT02007512|471308471|FG003|Open Label Treatment Period|Other|0|||
130910484|NCT02007512|471308468|FG000|Open Label Treatment Period|Disease progression|23|||
131030754|NCT04088630|471746298|FG000|Overall Study|Physician Decision|0|||
131030755|NCT04088630|471746299|FG001|Overall Study|Physician Decision|1|||
131030756|NCT04088630|471746300|FG002|Overall Study|Physician Decision|1|||
131030757|NCT03175029|471746303|FG000|Overall Study|Withdrawal by Subject|2|||
131030758|NCT03175029|471746304|FG001|Overall Study|Withdrawal by Subject|1|||
131030759|NCT03175029|471746303|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
131030760|NCT03175029|471746304|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
131030761|NCT03315754|471746305|FG000|Overall Study|COVID-19 complications leading to death|1|||
131030762|NCT03315754|471746305|FG000|Overall Study|insurance coverage issue|1|||
131030763|NCT05227209|471746307|FG000|Overall Study|Adverse Event|11|||
131030764|NCT05227209|471746307|FG000|Overall Study|Lost to Follow-up|1|||
131030765|NCT05227209|471746307|FG000|Overall Study|Withdrawal by Subject|7|||
131030766|NCT05227209|471746307|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
131030767|NCT04245501|471746308|FG000|Overall Study|Adverse Event|2|||
131030768|NCT04245501|471746309|FG001|Overall Study|Adverse Event|0|||
131030769|NCT04245501|471746308|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
131030770|NCT04245501|471746309|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
131030771|NCT01426425|471746310|FG000|Overall Study|Exited prior to EP study|22|||
131030772|NCT01426425|471746310|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
131030773|NCT01426425|471746310|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
131030774|NCT03281291|471746316|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
131030775|NCT03281291|471746317|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
131030776|NCT03281291|471746318|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
131030777|NCT03281291|471746319|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
131030778|NCT03281291|471746320|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
131030779|NCT03281291|471746316|FG000|Overall Study|Protocol Deviation|2|||
131030780|NCT03281291|471746317|FG001|Overall Study|Protocol Deviation|0|||
131030781|NCT03281291|471746318|FG002|Overall Study|Protocol Deviation|1|||
131030782|NCT03281291|471746319|FG003|Overall Study|Protocol Deviation|2|||
131030783|NCT03281291|471746320|FG004|Overall Study|Protocol Deviation|1|||
131030784|NCT03281291|471746316|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
131030785|NCT03281291|471746317|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
131030786|NCT03281291|471746318|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
131030787|NCT03281291|471746319|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
131030788|NCT03281291|471746320|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
131030789|NCT03281291|471746316|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
131030790|NCT03281291|471746317|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
131030791|NCT03281291|471746318|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
131030792|NCT03281291|471746319|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
131030793|NCT03281291|471746320|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
131030794|NCT03281291|471746316|FG000|Overall Study|Lost to Follow-up|10|||
131030795|NCT03281291|471746317|FG001|Overall Study|Lost to Follow-up|10|||
131030796|NCT03281291|471746318|FG002|Overall Study|Lost to Follow-up|4|||
131030797|NCT03281291|471746319|FG003|Overall Study|Lost to Follow-up|6|||
131030798|NCT03281291|471746320|FG004|Overall Study|Lost to Follow-up|10|||
131030799|NCT03281291|471746316|FG000|Overall Study|Other|0|||
131030800|NCT03281291|471746317|FG001|Overall Study|Other|2|||
131030801|NCT03281291|471746318|FG002|Overall Study|Other|0|||
131030802|NCT03281291|471746319|FG003|Overall Study|Other|2|||
131030803|NCT03281291|471746320|FG004|Overall Study|Other|1|||
131030804|NCT00512070|471746323|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
131030805|NCT00512070|471746324|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
131030806|NCT00512070|471746325|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
131030807|NCT00512070|471746323|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
131030808|NCT00512070|471746324|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
131030809|NCT00512070|471746325|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
131030810|NCT00961571|471746326|FG000|Overall Study|Physician Decision|39|||
131030811|NCT02506959|471746328|FG000|Overall Study|Physician Decision|2|||
131030812|NCT02506959|471746329|FG001|Overall Study|Physician Decision|1|||
130910485|NCT02007512|471308469|FG001|Open Label Treatment Period|Disease progression|11|||
130910486|NCT02007512|471308470|FG002|Open Label Treatment Period|Disease progression|0|||
130910487|NCT02007512|471308471|FG003|Open Label Treatment Period|Disease progression|0|||
130910488|NCT00900601|471308476|FG000|Overall Study|Physician Decision|1|||
130910489|NCT03026088|471308477|FG000|Overall Study|Study termination|20|||
130910490|NCT01052844|471308485|FG000|Overall Study|Adverse Event|0|||
130910491|NCT01052844|471308486|FG001|Overall Study|Adverse Event|1|||
130910492|NCT03463031|471308487|FG000|Overall Study|Withdrawal by Subject|4|||
130910493|NCT03463031|471308488|FG001|Overall Study|Withdrawal by Subject|2|||
130910494|NCT03463031|471308487|FG000|Overall Study|Investigator/Sponsor Decision|0|||
130910495|NCT03463031|471308488|FG001|Overall Study|Investigator/Sponsor Decision|1|||
130910496|NCT03463031|471308487|FG000|Overall Study|Lost to Follow-up|1|||
130910497|NCT03463031|471308488|FG001|Overall Study|Lost to Follow-up|1|||
130910498|NCT03463031|471308487|FG000|Overall Study|Adverse Event|4|||
130910499|NCT03463031|471308488|FG001|Overall Study|Adverse Event|1|||
130910500|NCT03463031|471308487|FG000|Overall Study|Use of prohibited medication by subject|1|||
130910501|NCT03463031|471308488|FG001|Overall Study|Use of prohibited medication by subject|0|||
130910502|NCT02131532|471308489|FG000|Overall Study|Withdrawal by Subject|1|||
130910503|NCT02131532|471308489|FG000|Overall Study|Physician Decision|1|||
130910504|NCT02131532|471308489|FG000|Overall Study|Other health conditions|2|||
130910505|NCT03583164|471308495|FG000|Overall Study|Death in Main Phase|35|||
130910506|NCT03583164|471308495|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
130910507|NCT03583164|471308495|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
130910508|NCT03583164|471308495|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
130910509|NCT03583164|471308495|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
130910510|NCT03583164|471308495|FG000|Overall Study|Physician decision in Main Phase|1|||
130910511|NCT03583164|471308495|FG000|Overall Study|Physician decision in Extended Phase|2|||
130910512|NCT03583164|471308495|FG000|Overall Study|Death in Extended Phase|13|||
130910513|NCT03583164|471308495|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
130910514|NCT03583164|471308495|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
130910515|NCT03583164|471308495|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
130910516|NCT03583164|471308495|FG000|Overall Study|Treatment failure in Main Phase|2|||
130910517|NCT03583164|471308495|FG000|Overall Study|Treatment failure in Extended Phase|4|||
130910518|NCT03583164|471308495|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
130910519|NCT03583164|471308495|FG000|Overall Study|Other not specified reason in Main Phase|2|||
130910520|NCT01466595|471308496|FG000|Overall Study|Withdrawal by Subject|0|||
130910521|NCT01466595|471308497|FG001|Overall Study|Withdrawal by Subject|1|||
130910522|NCT00057954|471308498|FG000|Overall Study|Death|1|||
130910523|NCT00057954|471308498|FG000|Overall Study|Disease progression|1|||
130910524|NCT00559754|471308499|FG000|Overall Study|Disease progression|1|||
130910525|NCT00559754|471308499|FG000|Overall Study|Adverse Event|5|||
130910526|NCT00559754|471308499|FG000|Overall Study|Protocol Violation|1|||
130910527|NCT00559754|471308499|FG000|Overall Study|Investigator criteria|2|||
130910528|NCT00559754|471308499|FG000|Overall Study|Withdrawal by Subject|2|||
130910529|NCT01264016|471308500|FG000|Overall Study|Withdrawal by Subject|1|||
130910530|NCT01264016|471308500|FG000|Overall Study|Felt faint at sight of blood|1|||
130910531|NCT02147184|471308501|FG000|Overall Study|Lost to Follow-up|28|||
130910532|NCT02147184|471308502|FG001|Overall Study|Lost to Follow-up|15|||
130910533|NCT02147184|471308501|FG000|Overall Study|Study Burden|11|||
130910534|NCT02147184|471308502|FG001|Overall Study|Study Burden|7|||
130910535|NCT02147184|471308501|FG000|Overall Study|Pregnancy|6|||
130910536|NCT02147184|471308502|FG001|Overall Study|Pregnancy|0|||
130910537|NCT02147184|471308501|FG000|Overall Study|Moved out of state|3|||
130910538|NCT02147184|471308502|FG001|Overall Study|Moved out of state|3|||
130910539|NCT02147184|471308501|FG000|Overall Study|Physician Decision|0|||
130910540|NCT02147184|471308502|FG001|Overall Study|Physician Decision|2|||
130910541|NCT02147184|471308501|FG000|Overall Study|Other|1|||
130910542|NCT02147184|471308502|FG001|Overall Study|Other|0|||
130910543|NCT02117414|471308503|FG000|Overall Study|Death|5|||
130910544|NCT02117414|471308504|FG001|Overall Study|Death|2|||
130910545|NCT02117414|471308503|FG000|Overall Study|Withdrawal by Subject|10|||
130910546|NCT02117414|471308504|FG001|Overall Study|Withdrawal by Subject|4|||
130910547|NCT02537574|471308506|FG000|Overall Study|Adverse Event|1|||
130910548|NCT02537574|471308507|FG001|Overall Study|Adverse Event|3|||
130910549|NCT02537574|471308508|FG002|Overall Study|Adverse Event|2|||
130910550|NCT02537574|471308506|FG000|Overall Study|Lost to Follow-up|40|||
130910551|NCT02537574|471308507|FG001|Overall Study|Lost to Follow-up|51|||
130910552|NCT02537574|471308508|FG002|Overall Study|Lost to Follow-up|55|||
130910553|NCT02537574|471308506|FG000|Overall Study|Noncompliance with study drug|0|||
130910554|NCT02537574|471308507|FG001|Overall Study|Noncompliance with study drug|1|||
130910555|NCT02537574|471308508|FG002|Overall Study|Noncompliance with study drug|1|||
130910556|NCT02537574|471308506|FG000|Overall Study|Physician Decision|2|||
130910557|NCT02537574|471308507|FG001|Overall Study|Physician Decision|0|||
130910558|NCT02537574|471308508|FG002|Overall Study|Physician Decision|0|||
130910559|NCT02537574|471308506|FG000|Overall Study|Protocol Violation|4|||
130910560|NCT02537574|471308507|FG001|Overall Study|Protocol Violation|2|||
130910561|NCT02537574|471308508|FG002|Overall Study|Protocol Violation|3|||
130910562|NCT02537574|471308506|FG000|Overall Study|Withdrawal by Subject|37|||
130910563|NCT02537574|471308507|FG001|Overall Study|Withdrawal by Subject|27|||
130910564|NCT02537574|471308508|FG002|Overall Study|Withdrawal by Subject|29|||
130910565|NCT02537574|471308506|FG000|Overall Study|Lack of Efficacy|14|||
130910566|NCT02537574|471308507|FG001|Overall Study|Lack of Efficacy|16|||
130910567|NCT02537574|471308508|FG002|Overall Study|Lack of Efficacy|15|||
130910568|NCT02537574|471308506|FG000|Overall Study|Duplicate Patient|1|||
130910569|NCT02537574|471308507|FG001|Overall Study|Duplicate Patient|0|||
130910570|NCT02537574|471308508|FG002|Overall Study|Duplicate Patient|0|||
130910571|NCT02537574|471308506|FG000|Overall Study|Patient not Stable|0|||
130910572|NCT02537574|471308507|FG001|Overall Study|Patient not Stable|1|||
130910573|NCT02537574|471308508|FG002|Overall Study|Patient not Stable|0|||
130910574|NCT02537574|471308506|FG000|Overall Study|Incarceration|0|||
130910575|NCT02537574|471308507|FG001|Overall Study|Incarceration|1|||
130910576|NCT02537574|471308508|FG002|Overall Study|Incarceration|0|||
130910577|NCT02537574|471308506|FG000|Overall Study|Failed Naloxone Challenge|0|||
130910578|NCT02537574|471308507|FG001|Overall Study|Failed Naloxone Challenge|1|||
130910579|NCT02537574|471308508|FG002|Overall Study|Failed Naloxone Challenge|0|||
130910580|NCT02537574|471308506|FG000|Overall Study|Transportation Issues|0|||
130910581|NCT02537574|471308507|FG001|Overall Study|Transportation Issues|0|||
130910582|NCT02537574|471308508|FG002|Overall Study|Transportation Issues|1|||
130768769|NCT00715520|470778576|FG000|Overall Study|Withdrawal by Subject|2|||
130910583|NCT02537574|471308506|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
130910584|NCT02537574|471308507|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
130910585|NCT02537574|471308508|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
130910586|NCT02537574|471308506|FG000|Overall Study|Noncompliance with Protocol|0|||
130910587|NCT02537574|471308507|FG001|Overall Study|Noncompliance with Protocol|0|||
130910588|NCT02537574|471308508|FG002|Overall Study|Noncompliance with Protocol|1|||
130910589|NCT02663687|471308509|FG000|Overall Study|Adverse Event|1|||
130910590|NCT02663687|471308510|FG001|Overall Study|Adverse Event|0|||
130910591|NCT02663687|471308511|FG002|Overall Study|Adverse Event|0|||
130910592|NCT02663687|471308512|FG003|Overall Study|Adverse Event|0|||
130910593|NCT02663687|471308513|FG004|Overall Study|Adverse Event|0|||
130910594|NCT02663687|471308509|FG000|Overall Study|Other|1|||
130910595|NCT02663687|471308510|FG001|Overall Study|Other|0|||
130910596|NCT02663687|471308511|FG002|Overall Study|Other|1|||
130910597|NCT02663687|471308512|FG003|Overall Study|Other|0|||
130910598|NCT02663687|471308513|FG004|Overall Study|Other|0|||
130910599|NCT00417482|471308514|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
130910600|NCT00417482|471308515|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
130910601|NCT00417482|471308516|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
130910602|NCT00417482|471308514|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
130910603|NCT00417482|471308515|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
130910604|NCT00417482|471308516|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
130910605|NCT00417482|471308514|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
130910606|NCT00417482|471308515|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
130910607|NCT00417482|471308516|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
130910608|NCT00417482|471308514|FG000|Phase B 1st 16 Weeks|Death|1|||
130910609|NCT00417482|471308515|FG001|Phase B 1st 16 Weeks|Death|0|||
130910610|NCT00417482|471308516|FG002|Phase B 1st 16 Weeks|Death|0|||
130768770|NCT00715520|470778577|FG001|Overall Study|Withdrawal by Subject|0|||
130768771|NCT00715520|470778578|FG002|Overall Study|Withdrawal by Subject|1|||
130910611|NCT00417482|471308514|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
130910612|NCT00417482|471308515|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
130910613|NCT00417482|471308516|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
130910614|NCT00417482|471308514|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
130910615|NCT00417482|471308515|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
130910616|NCT00417482|471308516|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
130910617|NCT00417482|471308514|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
130910618|NCT00417482|471308515|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
130910619|NCT00417482|471308516|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
130910620|NCT00417482|471308514|FG000|Phase B 2nd 16 Weeks|Death|1|||
130910621|NCT00417482|471308515|FG001|Phase B 2nd 16 Weeks|Death|1|||
130910622|NCT00417482|471308516|FG002|Phase B 2nd 16 Weeks|Death|0|||
130910623|NCT06400979|471308519|FG000|Overall Study|Lost to Follow-up|29|||
130910624|NCT06400979|471308519|FG000|Overall Study|Withdrawal by Subject|1|||
130910625|NCT00117286|471308520|FG000|Overall Study|Adverse Event|12|||
130910626|NCT00117286|471308521|FG001|Overall Study|Adverse Event|6|||
130910627|NCT00117286|471308520|FG000|Overall Study|Lost to Follow-up|2|||
130768772|NCT02290925|470778580|FG000|First Period of Three Months|Lost to Follow-up|2|||
130910628|NCT00117286|471308521|FG001|Overall Study|Lost to Follow-up|0|||
130910629|NCT00117286|471308520|FG000|Overall Study|Protocol Violation|3|||
130910630|NCT00117286|471308521|FG001|Overall Study|Protocol Violation|3|||
130910631|NCT00117286|471308520|FG000|Overall Study|Withdrawal by Subject|6|||
130910632|NCT00117286|471308521|FG001|Overall Study|Withdrawal by Subject|2|||
130910633|NCT00117286|471308520|FG000|Overall Study|Physician Decision|3|||
130910634|NCT00117286|471308521|FG001|Overall Study|Physician Decision|7|||
130910635|NCT00117286|471308520|FG000|Overall Study|Lack of Efficacy|2|||
130910636|NCT00117286|471308521|FG001|Overall Study|Lack of Efficacy|1|||
130910637|NCT00117286|471308520|FG000|Overall Study|Research site closing|0|||
130910638|NCT00117286|471308521|FG001|Overall Study|Research site closing|2|||
130910639|NCT00048061|471308522|FG000|Overall Study|Adverse Event|41|||
130910640|NCT00048061|471308523|FG001|Overall Study|Adverse Event|32|||
130910641|NCT00048061|471308524|FG002|Overall Study|Adverse Event|44|||
130910642|NCT00048061|471308525|FG003|Overall Study|Adverse Event|37|||
130910643|NCT00048061|471308522|FG000|Overall Study|Lost to Follow-up|3|||
130910644|NCT00048061|471308523|FG001|Overall Study|Lost to Follow-up|2|||
130910645|NCT00048061|471308524|FG002|Overall Study|Lost to Follow-up|4|||
130910646|NCT00048061|471308525|FG003|Overall Study|Lost to Follow-up|5|||
130910647|NCT00048061|471308522|FG000|Overall Study|Withdrawal by Subject|20|||
130696747|NCT02166606|470514499|FG000|Overall Study|Enrolled after End of Enrollment|4|||
130696748|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
130696749|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
130696750|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
130696751|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
130696752|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|Death|3|||
130696753|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|Death|1|||
130696754|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
130696755|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
130696756|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
130696757|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
130696758|NCT00537095|470514504|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
130696759|NCT00537095|470514505|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
130696760|NCT00537095|470514504|FG000|Open-label Period (590 Days)|Adverse Event|2|||
130696761|NCT00537095|470514505|FG001|Open-label Period (590 Days)|Adverse Event|11|||
130696762|NCT00537095|470514504|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
130696763|NCT00537095|470514505|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
130696764|NCT00537095|470514504|FG000|Open-label Period (590 Days)|Death|2|||
130696765|NCT00537095|470514505|FG001|Open-label Period (590 Days)|Death|2|||
130696766|NCT00537095|470514504|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
130696767|NCT00537095|470514505|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
130696768|NCT00537095|470514504|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
130696769|NCT00537095|470514505|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
130696770|NCT00566722|470514506|FG000|Overall Study|Adverse Event|0|||
130696771|NCT00566722|470514507|FG001|Overall Study|Adverse Event|1|||
130696772|NCT00566722|470514508|FG002|Overall Study|Adverse Event|0|||
130696773|NCT00566722|470514506|FG000|Overall Study|Withdrawal by Subject|0|||
130696774|NCT00566722|470514507|FG001|Overall Study|Withdrawal by Subject|0|||
130696775|NCT00566722|470514508|FG002|Overall Study|Withdrawal by Subject|1|||
130696776|NCT00566722|470514506|FG000|Overall Study|Lost to Follow-up|1|||
130696777|NCT00566722|470514507|FG001|Overall Study|Lost to Follow-up|1|||
130696778|NCT00566722|470514508|FG002|Overall Study|Lost to Follow-up|1|||
130696779|NCT00566722|470514506|FG000|Overall Study|Lack of Efficacy|1|||
130696780|NCT00566722|470514507|FG001|Overall Study|Lack of Efficacy|2|||
130696781|NCT00566722|470514508|FG002|Overall Study|Lack of Efficacy|4|||
130696782|NCT00566722|470514506|FG000|Overall Study|Did not meet exclusion criteria|0|||
130696783|NCT00566722|470514507|FG001|Overall Study|Did not meet exclusion criteria|0|||
130696784|NCT00566722|470514508|FG002|Overall Study|Did not meet exclusion criteria|2|||
130696785|NCT00566722|470514506|FG000|Overall Study|Serious adverse event|0|||
130696786|NCT00566722|470514507|FG001|Overall Study|Serious adverse event|1|||
130696787|NCT00566722|470514508|FG002|Overall Study|Serious adverse event|0|||
130696788|NCT00566722|470514506|FG000|Overall Study|Noncompliant with drug administration|0|||
130696789|NCT00566722|470514507|FG001|Overall Study|Noncompliant with drug administration|0|||
130910648|NCT00048061|471308523|FG001|Overall Study|Withdrawal by Subject|29|||
130910649|NCT00048061|471308524|FG002|Overall Study|Withdrawal by Subject|29|||
130910650|NCT00048061|471308525|FG003|Overall Study|Withdrawal by Subject|32|||
130910651|NCT00048061|471308522|FG000|Overall Study|Did not follow-up|5|||
130910652|NCT00048061|471308523|FG001|Overall Study|Did not follow-up|5|||
130910653|NCT00048061|471308524|FG002|Overall Study|Did not follow-up|4|||
130910654|NCT00048061|471308525|FG003|Overall Study|Did not follow-up|5|||
130910655|NCT00048061|471308522|FG000|Overall Study|Early improvement|6|||
130910656|NCT00048061|471308523|FG001|Overall Study|Early improvement|5|||
131116783|NCT01968070|472059374|FG000|Period 2|Withdrawal by Subject|0|||
130696790|NCT00566722|470514508|FG002|Overall Study|Noncompliant with drug administration|1|||
130696791|NCT02611323|470514509|FG000|Overall Study|Death|3|||
130696792|NCT02611323|470514510|FG001|Overall Study|Death|1|||
130696793|NCT02611323|470514511|FG002|Overall Study|Death|0|||
130910657|NCT00048061|471308524|FG002|Overall Study|Early improvement|3|||
130910658|NCT00048061|471308525|FG003|Overall Study|Early improvement|0|||
130910659|NCT03555435|471308526|FG000|Overall Study|Lost to Follow-up|17|||
130910660|NCT03555435|471308527|FG001|Overall Study|Lost to Follow-up|19|||
130910661|NCT03555435|471308528|FG002|Overall Study|Lost to Follow-up|8|||
130910662|NCT01323946|471308529|FG000|Overall Study|Lost to Follow-up|0|||
130910663|NCT01323946|471308530|FG001|Overall Study|Lost to Follow-up|1|||
130910664|NCT01323946|471308531|FG002|Overall Study|Lost to Follow-up|0|||
130910665|NCT01323946|471308529|FG000|Overall Study|Parents refused the last blood draw|1|||
130910666|NCT01323946|471308530|FG001|Overall Study|Parents refused the last blood draw|0|||
130910667|NCT01323946|471308531|FG002|Overall Study|Parents refused the last blood draw|0|||
130910668|NCT01323946|471308529|FG000|Overall Study|Withdrawal by Subject|2|||
130910669|NCT01323946|471308530|FG001|Overall Study|Withdrawal by Subject|2|||
130910670|NCT01323946|471308531|FG002|Overall Study|Withdrawal by Subject|0|||
130910671|NCT01272661|471308534|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
130910672|NCT01272661|471308535|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
130910673|NCT01272661|471308536|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
130910674|NCT02869438|471308537|FG000|Overall Study|Lost to Follow-up|1|||
130910675|NCT02869438|471308538|FG001|Overall Study|Lost to Follow-up|0|||
130910676|NCT02869438|471308537|FG000|Overall Study|Adverse Event|1|||
130910677|NCT02869438|471308538|FG001|Overall Study|Adverse Event|0|||
130910678|NCT02869438|471308537|FG000|Overall Study|Withdrawal by Subject|1|||
130910679|NCT02869438|471308538|FG001|Overall Study|Withdrawal by Subject|2|||
130910680|NCT02169284|471308541|FG000|Overall Study|Physician Decision|0|||
130910681|NCT02169284|471308542|FG001|Overall Study|Physician Decision|1|||
130910682|NCT00984568|471308543|FG000|Overall Study|Withdrawal by Subject|1|||
130910683|NCT00984568|471308544|FG001|Overall Study|Withdrawal by Subject|2|||
130910684|NCT00984568|471308543|FG000|Overall Study|Lack of Efficacy|2|||
130910685|NCT00984568|471308544|FG001|Overall Study|Lack of Efficacy|0|||
130910686|NCT00984568|471308543|FG000|Overall Study|Adverse Event|2|||
130910687|NCT00984568|471308544|FG001|Overall Study|Adverse Event|0|||
130910688|NCT00984568|471308543|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
130910689|NCT00984568|471308544|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
130910690|NCT00984568|471308543|FG000|Overall Study|Lost to Follow-up|0|||
130910691|NCT00984568|471308544|FG001|Overall Study|Lost to Follow-up|1|||
130910692|NCT00984568|471308543|FG000|Overall Study|Opportunistic Infection|1|||
130910693|NCT00984568|471308544|FG001|Overall Study|Opportunistic Infection|0|||
130910694|NCT00984568|471308543|FG000|Overall Study|Unknown Reason|1|||
130910695|NCT00984568|471308544|FG001|Overall Study|Unknown Reason|3|||
130910696|NCT03583073|471308545|FG000|Overall Study|Lost to Follow-up|8|||
130910697|NCT03583073|471308546|FG001|Overall Study|Lost to Follow-up|12|||
130910698|NCT01367119|471308547|FG000|Overall Study|Adverse Event|1|||
130910699|NCT01367119|471308548|FG001|Overall Study|Adverse Event|0|||
130910700|NCT01367119|471308547|FG000|Overall Study|Withdrawal by Subject|1|||
130910701|NCT01367119|471308548|FG001|Overall Study|Withdrawal by Subject|1|||
130910702|NCT03180684|471308549|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
130910703|NCT03180684|471308550|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
130910704|NCT03180684|471308549|FG000|Overall Study|Physician Decision|1|||
130910705|NCT03180684|471308550|FG001|Overall Study|Physician Decision|0|||
130910706|NCT03180684|471308549|FG000|Overall Study|Lost to Follow-up|1|||
130910707|NCT03180684|471308550|FG001|Overall Study|Lost to Follow-up|0|||
130910708|NCT03180684|471308549|FG000|Overall Study|Progressive Disease|1|||
130910709|NCT03180684|471308550|FG001|Overall Study|Progressive Disease|0|||
130910710|NCT02675231|471308551|FG000|Overall Study|Withdrawal by Subject|2|||
130910711|NCT02675231|471308552|FG001|Overall Study|Withdrawal by Subject|4|||
130910712|NCT02675231|471308553|FG002|Overall Study|Withdrawal by Subject|2|||
130910713|NCT02675231|471308551|FG000|Overall Study|Lost to Follow-up|3|||
131030813|NCT04390048|471746330|FG000|Overall Study|Withdrawal by Subject|1|||
131030814|NCT04390048|471746331|FG001|Overall Study|Withdrawal by Subject|3|||
131030815|NCT00170573|471746333|FG000|Overall Study|Violation of inclusion criteria|13|||
130910714|NCT02675231|471308552|FG001|Overall Study|Lost to Follow-up|4|||
130910715|NCT02675231|471308553|FG002|Overall Study|Lost to Follow-up|3|||
130910716|NCT03370289|471308558|FG000|Overall Study|Screen Failure|1|||
130910717|NCT03370289|471308558|FG000|Overall Study|Sample Size Sufficient|4|||
130910718|NCT02220998|471308560|FG000|Overall Study|Randomized but Never Treated|1|||
130910719|NCT02220998|471308561|FG001|Overall Study|Randomized but Never Treated|2|||
130910720|NCT02220998|471308560|FG000|Overall Study|Death|2|||
130910721|NCT02220998|471308561|FG001|Overall Study|Death|0|||
130910722|NCT02220998|471308560|FG000|Overall Study|Lack of Efficacy|0|||
130910723|NCT02220998|471308561|FG001|Overall Study|Lack of Efficacy|5|||
131030816|NCT04556656|471746334|FG000|Overall Study|Withdrawal by Subject|14|||
131030817|NCT04556656|471746335|FG001|Overall Study|Withdrawal by Subject|12|||
131030818|NCT04556656|471746334|FG000|Overall Study|Physician Decision|1|||
131030819|NCT04556656|471746335|FG001|Overall Study|Physician Decision|0|||
130910724|NCT02220998|471308560|FG000|Overall Study|Lost to Follow-up|4|||
130910725|NCT02220998|471308561|FG001|Overall Study|Lost to Follow-up|4|||
130910726|NCT01659658|471310200|FG000|Overall Study|Withdrawal by Patient|18|||
131030820|NCT04556656|471746334|FG000|Overall Study|Adverse Event|4|||
130910727|NCT01659658|471310201|FG001|Overall Study|Withdrawal by Patient|4|||
130910728|NCT01659658|471310202|FG002|Overall Study|Withdrawal by Patient|2|||
130910729|NCT01659658|471310203|FG003|Overall Study|Withdrawal by Patient|0|||
130910730|NCT01659658|471310204|FG004|Overall Study|Withdrawal by Patient|11|||
130910731|NCT01659658|471310200|FG000|Overall Study|Study Terminated by Sponsor|9|||
130910732|NCT01659658|471310201|FG001|Overall Study|Study Terminated by Sponsor|7|||
130910733|NCT01659658|471310202|FG002|Overall Study|Study Terminated by Sponsor|0|||
130910734|NCT01659658|471310203|FG003|Overall Study|Study Terminated by Sponsor|1|||
130910735|NCT01659658|471310204|FG004|Overall Study|Study Terminated by Sponsor|4|||
130910736|NCT01659658|471310200|FG000|Overall Study|Reason not Specified|61|||
130910737|NCT01659658|471310201|FG001|Overall Study|Reason not Specified|15|||
130910738|NCT01659658|471310202|FG002|Overall Study|Reason not Specified|8|||
130910739|NCT01659658|471310203|FG003|Overall Study|Reason not Specified|1|||
130910740|NCT01659658|471310204|FG004|Overall Study|Reason not Specified|34|||
130910741|NCT01659658|471310200|FG000|Overall Study|Lost to Follow-up|2|||
130910742|NCT01659658|471310201|FG001|Overall Study|Lost to Follow-up|0|||
130910743|NCT01659658|471310202|FG002|Overall Study|Lost to Follow-up|0|||
130910744|NCT01659658|471310203|FG003|Overall Study|Lost to Follow-up|0|||
130910745|NCT01659658|471310204|FG004|Overall Study|Lost to Follow-up|0|||
130910746|NCT01083485|471310205|FG000|Overall Study|Adverse Event|0|||
130910747|NCT01083485|471310206|FG001|Overall Study|Adverse Event|1|||
130910748|NCT01083485|471310205|FG000|Overall Study|Protocol Violation|1|||
130910749|NCT01083485|471310206|FG001|Overall Study|Protocol Violation|0|||
130910750|NCT01083485|471310205|FG000|Overall Study|Withdrawal by Subject|5|||
130910751|NCT01083485|471310206|FG001|Overall Study|Withdrawal by Subject|2|||
130910752|NCT01083485|471310205|FG000|Overall Study|Other|1|||
130910753|NCT01083485|471310206|FG001|Overall Study|Other|0|||
130910754|NCT00451451|471310207|FG000|Overall Study|Adverse Event|11|||
130910755|NCT00451451|471310208|FG001|Overall Study|Adverse Event|21|||
130910756|NCT00451451|471310209|FG002|Overall Study|Adverse Event|26|||
130910757|NCT00451451|471310210|FG003|Overall Study|Adverse Event|10|||
130910758|NCT00451451|471310207|FG000|Overall Study|Lost to Follow-up|11|||
130910759|NCT00451451|471310208|FG001|Overall Study|Lost to Follow-up|9|||
130910760|NCT00451451|471310209|FG002|Overall Study|Lost to Follow-up|8|||
130910761|NCT00451451|471310210|FG003|Overall Study|Lost to Follow-up|11|||
130910762|NCT00451451|471310207|FG000|Overall Study|Consent Withdrawn|14|||
130910763|NCT00451451|471310208|FG001|Overall Study|Consent Withdrawn|9|||
130910764|NCT00451451|471310209|FG002|Overall Study|Consent Withdrawn|17|||
130910765|NCT00451451|471310210|FG003|Overall Study|Consent Withdrawn|17|||
130910766|NCT00451451|471310207|FG000|Overall Study|Investigator Decision|6|||
130910767|NCT00451451|471310208|FG001|Overall Study|Investigator Decision|2|||
130910768|NCT00451451|471310209|FG002|Overall Study|Investigator Decision|1|||
130910769|NCT00451451|471310210|FG003|Overall Study|Investigator Decision|2|||
130910770|NCT00451451|471310207|FG000|Overall Study|Subject Non-Compliance|8|||
130910771|NCT00451451|471310208|FG001|Overall Study|Subject Non-Compliance|4|||
130910772|NCT00451451|471310209|FG002|Overall Study|Subject Non-Compliance|3|||
130910773|NCT00451451|471310210|FG003|Overall Study|Subject Non-Compliance|3|||
130910774|NCT00451451|471310207|FG000|Overall Study|Death|1|||
130910775|NCT00451451|471310208|FG001|Overall Study|Death|0|||
130910776|NCT00451451|471310209|FG002|Overall Study|Death|0|||
130910777|NCT00451451|471310210|FG003|Overall Study|Death|1|||
130910778|NCT00451451|471310207|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
130910779|NCT00451451|471310208|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
130910780|NCT00451451|471310209|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
130910781|NCT00451451|471310210|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
130910782|NCT00084838|471310211|FG000|Overall Study|Death|1|||
130910783|NCT00084838|471310211|FG000|Overall Study|Adverse Event|2|||
130910784|NCT00084838|471310211|FG000|Overall Study|Withdrawal by Subject|1|||
130910785|NCT00084838|471310211|FG000|Overall Study|Progressive Disease|4|||
130910786|NCT00084838|471310211|FG000|Overall Study|Pt Non-Compliance|1|||
130910787|NCT00084838|471310211|FG000|Overall Study|Ineligible|4|||
130910788|NCT00122278|471310212|FG000|Overall Study|Lost to Follow-up|2|||
130910789|NCT00122278|471310213|FG001|Overall Study|Lost to Follow-up|0|||
130910790|NCT01002482|471310214|FG000|Overall Study|Withdrawal by Subject|14|||
130910791|NCT01002482|471310215|FG001|Overall Study|Withdrawal by Subject|21|||
130910792|NCT01002482|471310214|FG000|Overall Study|Included twice|1|||
130910793|NCT01002482|471310215|FG001|Overall Study|Included twice|0|||
130910794|NCT03607422|471310219|FG000|Overall Study|Adverse Event|7|||
130910795|NCT03607422|471310220|FG001|Overall Study|Adverse Event|3|||
130910796|NCT03607422|471310221|FG002|Overall Study|Adverse Event|2|||
130910797|NCT03607422|471310222|FG003|Overall Study|Adverse Event|0|||
130910798|NCT03607422|471310223|FG004|Overall Study|Adverse Event|2|||
130910799|NCT03607422|471310224|FG005|Overall Study|Adverse Event|0|||
130910800|NCT03607422|471310219|FG000|Overall Study|Withdrawal by Subject|11|||
130910801|NCT03607422|471310220|FG001|Overall Study|Withdrawal by Subject|3|||
130910802|NCT03607422|471310221|FG002|Overall Study|Withdrawal by Subject|6|||
130910803|NCT03607422|471310222|FG003|Overall Study|Withdrawal by Subject|2|||
130910804|NCT03607422|471310223|FG004|Overall Study|Withdrawal by Subject|0|||
130910805|NCT03607422|471310224|FG005|Overall Study|Withdrawal by Subject|0|||
130910806|NCT03607422|471310219|FG000|Overall Study|Lost to Follow-up|0|||
130910807|NCT03607422|471310220|FG001|Overall Study|Lost to Follow-up|0|||
130910808|NCT03607422|471310221|FG002|Overall Study|Lost to Follow-up|1|||
130910809|NCT03607422|471310222|FG003|Overall Study|Lost to Follow-up|0|||
130910810|NCT03607422|471310223|FG004|Overall Study|Lost to Follow-up|0|||
130910811|NCT03607422|471310224|FG005|Overall Study|Lost to Follow-up|0|||
130910812|NCT03607422|471310219|FG000|Overall Study|Other|12|||
130910813|NCT03607422|471310220|FG001|Overall Study|Other|4|||
130910814|NCT03607422|471310221|FG002|Overall Study|Other|1|||
130910815|NCT03607422|471310222|FG003|Overall Study|Other|2|||
130910816|NCT03607422|471310223|FG004|Overall Study|Other|0|||
130910817|NCT03607422|471310224|FG005|Overall Study|Other|2|||
130910818|NCT03607422|471310219|FG000|Overall Study|Ongoing at Time of Analysis|8|||
130910819|NCT03607422|471310220|FG001|Overall Study|Ongoing at Time of Analysis|0|||
130910820|NCT03607422|471310221|FG002|Overall Study|Ongoing at Time of Analysis|2|||
130910821|NCT03607422|471310222|FG003|Overall Study|Ongoing at Time of Analysis|1|||
130910822|NCT03607422|471310223|FG004|Overall Study|Ongoing at Time of Analysis|1|||
130910823|NCT03607422|471310224|FG005|Overall Study|Ongoing at Time of Analysis|1|||
130910824|NCT04060862|471310227|FG000|Overall Study|Symptomatic Deterioration|1|||
130910825|NCT04060862|471310227|FG000|Overall Study|Un-specified|6|||
130910826|NCT04060862|471310227|FG000|Overall Study|Progressive disease|12|||
130910827|NCT04060862|471310227|FG000|Overall Study|Physician Decision|1|||
130910828|NCT00608543|471310232|FG000|Overall Study|Adverse Event|4|||
130910829|NCT03416374|471310233|FG000|Between Treatment Period I and II|Other|0|||
130910830|NCT03416374|471310234|FG001|Between Treatment Period I and II|Other|9|||
130910831|NCT03416374|471310233|FG000|Treatment Period II|Lack of Efficacy|3|||
130910832|NCT03416374|471310234|FG001|Treatment Period II|Lack of Efficacy|11|||
130910833|NCT03416374|471310233|FG000|Treatment Period II|Adverse Event|1|||
130910834|NCT03416374|471310234|FG001|Treatment Period II|Adverse Event|4|||
130910835|NCT03416374|471310233|FG000|Treatment Period II|Death|0|||
130910836|NCT03416374|471310234|FG001|Treatment Period II|Death|1|||
130910837|NCT03416374|471310233|FG000|Treatment Period II|Other|0|||
130910838|NCT03416374|471310234|FG001|Treatment Period II|Other|2|||
130910839|NCT00214500|471310242|FG000|Treatment Period|Adverse Event|1|||
130910840|NCT00214500|471310242|FG000|Extension Period|Withdrawal by Subject|2|||
130910841|NCT00147251|471310243|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
130910842|NCT00147251|471310244|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
130910843|NCT01629706|471310245|FG000|Phase 1 PureVision|Screen Failure|4|||
130910844|NCT01629706|471310245|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
130910845|NCT01629706|471310245|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
130910846|NCT01629706|471310245|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
130910847|NCT01629706|471310245|FG000|Phase 2 Habitual|Screen Failure|6|||
130910848|NCT01629706|471310245|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
130910849|NCT01629706|471310245|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
130910850|NCT01629706|471310245|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
130910851|NCT01629706|471310245|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
130910852|NCT03595774|471310246|FG000|Overall Study|Adverse Event|1|||
130910853|NCT03595774|471310247|FG001|Overall Study|Adverse Event|0|||
130910854|NCT03595774|471310248|FG002|Overall Study|Adverse Event|1|||
130910855|NCT03595774|471310249|FG003|Overall Study|Adverse Event|0|||
130910856|NCT03595774|471310246|FG000|Overall Study|screen failure|0|||
130910857|NCT03595774|471310247|FG001|Overall Study|screen failure|1|||
130910858|NCT03595774|471310248|FG002|Overall Study|screen failure|0|||
130910859|NCT03595774|471310249|FG003|Overall Study|screen failure|1|||
130910860|NCT01151098|471310250|FG000|Overall Study|Adverse Event|82|||
130910861|NCT01151098|471310250|FG000|Overall Study|Lost to Follow-up|6|||
130910862|NCT01151098|471310250|FG000|Overall Study|Lack of Efficacy|15|||
130910863|NCT01151098|471310250|FG000|Overall Study|Protocol Violation|1|||
130910864|NCT01151098|471310250|FG000|Overall Study|Miscellaneous|13|||
130910865|NCT03343067|471310257|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
130910866|NCT03343067|471310258|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
130910867|NCT03343067|471310259|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
130910868|NCT00116168|471310260|FG000|Overall Study|Lost to Follow-up|6|||
130910869|NCT00116168|471310261|FG001|Overall Study|Lost to Follow-up|5|||
130910870|NCT00116168|471310262|FG002|Overall Study|Lost to Follow-up|0|||
130910871|NCT00116168|471310263|FG003|Overall Study|Lost to Follow-up|0|||
130910872|NCT02788474|471310264|FG000|Double Blind Treatment Period|Not treated|1|||
130910873|NCT02788474|471310265|FG001|Double Blind Treatment Period|Not treated|0|||
130910874|NCT02788474|471310264|FG000|Double Blind Treatment Period|Patient's refusal|3|||
130910875|NCT02788474|471310265|FG001|Double Blind Treatment Period|Patient's refusal|0|||
130910876|NCT02788474|471310264|FG000|Double Blind Treatment Period|Adverse Event|6|||
130910877|NCT02788474|471310265|FG001|Double Blind Treatment Period|Adverse Event|4|||
130910878|NCT02788474|471310264|FG000|Open Label Treatment Period|Adverse Event|29|||
130910879|NCT02788474|471310265|FG001|Open Label Treatment Period|Adverse Event|9|||
130910880|NCT02788474|471310264|FG000|Open Label Treatment Period|Other than reason specified|1|||
131030821|NCT04556656|471746335|FG001|Overall Study|Adverse Event|7|||
130910881|NCT02788474|471310265|FG001|Open Label Treatment Period|Other than reason specified|0|||
130910882|NCT02788474|471310264|FG000|Open Label Treatment Period|Patient's refusal|1|||
130910883|NCT02788474|471310265|FG001|Open Label Treatment Period|Patient's refusal|3|||
130910884|NCT02788474|471310264|FG000|Open Label Treatment Period|Non-compliance|1|||
130910885|NCT02788474|471310265|FG001|Open Label Treatment Period|Non-compliance|0|||
130910886|NCT01243671|471310267|FG000|Overall Study|Adverse Event|3|||
130910887|NCT01243671|471310267|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
130910888|NCT01243671|471310267|FG000|Overall Study|Other|1|||
130910889|NCT00573248|471310273|FG000|Overall Study|scheduling conflicts|15|||
130910890|NCT00573248|471310274|FG001|Overall Study|scheduling conflicts|11|||
130910891|NCT05342532|471310275|FG000|Overall Study|Adverse Event|5|||
130910892|NCT05342532|471310276|FG001|Overall Study|Adverse Event|20|||
130910893|NCT05342532|471310275|FG000|Overall Study|Lost to Follow-up|10|||
130910894|NCT05342532|471310276|FG001|Overall Study|Lost to Follow-up|15|||
130910895|NCT02057393|471310277|FG000|Overall Study|Withdrawal by Subject|1|||
130910896|NCT02057393|471310277|FG000|Overall Study|Patient did not meet criteria|1|||
130910897|NCT02273739|471310278|FG000|Overall Study|Progression of Disease|3|||
130910898|NCT02273739|471310279|FG001|Overall Study|Progression of Disease|4|||
130910899|NCT02273739|471310280|FG002|Overall Study|Progression of Disease|5|||
130910900|NCT02273739|471310281|FG003|Overall Study|Progression of Disease|2|||
130910901|NCT02273739|471310278|FG000|Overall Study|Death|0|||
130910902|NCT02273739|471310279|FG001|Overall Study|Death|0|||
130910903|NCT02273739|471310280|FG002|Overall Study|Death|0|||
130910904|NCT02273739|471310281|FG003|Overall Study|Death|2|||
130910905|NCT02273739|471310278|FG000|Overall Study|Adverse Event|0|||
130910906|NCT02273739|471310279|FG001|Overall Study|Adverse Event|0|||
130910907|NCT02273739|471310280|FG002|Overall Study|Adverse Event|0|||
130910908|NCT02273739|471310281|FG003|Overall Study|Adverse Event|1|||
130910909|NCT02273739|471310278|FG000|Overall Study|Withdrawal by Subject|0|||
130910910|NCT02273739|471310279|FG001|Overall Study|Withdrawal by Subject|0|||
130910911|NCT02273739|471310280|FG002|Overall Study|Withdrawal by Subject|2|||
130910912|NCT02273739|471310281|FG003|Overall Study|Withdrawal by Subject|1|||
130910913|NCT02273739|471310278|FG000|Overall Study|Physician Decision|0|||
130910914|NCT02273739|471310279|FG001|Overall Study|Physician Decision|0|||
130910915|NCT02273739|471310280|FG002|Overall Study|Physician Decision|0|||
130910916|NCT02273739|471310281|FG003|Overall Study|Physician Decision|1|||
130910917|NCT02017171|471310282|FG000|Overall Study|Death|10|||
130910918|NCT02017171|471310283|FG001|Overall Study|Death|4|||
130910919|NCT02017171|471310282|FG000|Overall Study|Withdrawal by Subject|23|||
130910920|NCT02017171|471310283|FG001|Overall Study|Withdrawal by Subject|17|||
130910921|NCT02017171|471310282|FG000|Overall Study|Lost to Follow-up|21|||
130910922|NCT02017171|471310283|FG001|Overall Study|Lost to Follow-up|20|||
130910923|NCT02017171|471310282|FG000|Overall Study|ESKD|6|||
130910924|NCT02017171|471310283|FG001|Overall Study|ESKD|2|||
130910925|NCT02017171|471310282|FG000|Overall Study|Miscellaneous|2|||
130910926|NCT02017171|471310283|FG001|Overall Study|Miscellaneous|3|||
130910927|NCT03091777|471310285|FG000|Overall Study|Pregnancy|2|||
130910928|NCT03091777|471310286|FG001|Overall Study|Pregnancy|1|||
130910929|NCT03091777|471310287|FG002|Overall Study|Pregnancy|0|||
130910930|NCT03091777|471310285|FG000|Overall Study|Adverse Event|2|||
130910931|NCT03091777|471310286|FG001|Overall Study|Adverse Event|1|||
130910932|NCT03091777|471310287|FG002|Overall Study|Adverse Event|4|||
130910933|NCT03091777|471310285|FG000|Overall Study|Withdrawal by Subject|4|||
130910934|NCT03091777|471310286|FG001|Overall Study|Withdrawal by Subject|2|||
130910935|NCT03091777|471310287|FG002|Overall Study|Withdrawal by Subject|6|||
130910936|NCT03091777|471310285|FG000|Overall Study|Protocol Violation|2|||
130910937|NCT03091777|471310286|FG001|Overall Study|Protocol Violation|1|||
130910938|NCT03091777|471310287|FG002|Overall Study|Protocol Violation|1|||
130910939|NCT03091777|471310285|FG000|Overall Study|Lost to Follow-up|12|||
130910940|NCT03091777|471310286|FG001|Overall Study|Lost to Follow-up|14|||
130910941|NCT03091777|471310287|FG002|Overall Study|Lost to Follow-up|7|||
130910942|NCT03091777|471310285|FG000|Overall Study|Lack of Efficacy|0|||
130910943|NCT03091777|471310286|FG001|Overall Study|Lack of Efficacy|0|||
130910944|NCT03091777|471310287|FG002|Overall Study|Lack of Efficacy|5|||
130910945|NCT03091777|471310285|FG000|Overall Study|Noncompliance with study drug|2|||
130910946|NCT03091777|471310286|FG001|Overall Study|Noncompliance with study drug|3|||
130910947|NCT03091777|471310287|FG002|Overall Study|Noncompliance with study drug|1|||
131030822|NCT04556656|471746334|FG000|Overall Study|Death|4|||
131030823|NCT04556656|471746335|FG001|Overall Study|Death|0|||
130910948|NCT03091777|471310285|FG000|Overall Study|Physician Decision|1|||
130910949|NCT03091777|471310286|FG001|Overall Study|Physician Decision|0|||
130910950|NCT03091777|471310287|FG002|Overall Study|Physician Decision|1|||
130910951|NCT03091777|471310285|FG000|Overall Study|Abnormal Laboratory Value|7|||
130910952|NCT03091777|471310286|FG001|Overall Study|Abnormal Laboratory Value|11|||
131030824|NCT04556656|471746334|FG000|Overall Study|Lost to Follow-up|3|||
130910953|NCT03091777|471310287|FG002|Overall Study|Abnormal Laboratory Value|12|||
130910954|NCT02536833|471310288|FG000|Overall Study|Discontinued Before Treatment|0|||
130910955|NCT02536833|471310289|FG001|Overall Study|Discontinued Before Treatment|0|||
131030825|NCT04556656|471746335|FG001|Overall Study|Lost to Follow-up|2|||
130910956|NCT02536833|471310290|FG002|Overall Study|Discontinued Before Treatment|1|||
130910957|NCT02536833|471310291|FG003|Overall Study|Discontinued Before Treatment|2|||
130910958|NCT02536833|471310288|FG000|Overall Study|Adverse Event|1|||
130910959|NCT02536833|471310289|FG001|Overall Study|Adverse Event|3|||
130910960|NCT02536833|471310290|FG002|Overall Study|Adverse Event|4|||
130910961|NCT02536833|471310291|FG003|Overall Study|Adverse Event|1|||
130910962|NCT02536833|471310288|FG000|Overall Study|Lost to Follow-up|2|||
130910963|NCT02536833|471310289|FG001|Overall Study|Lost to Follow-up|1|||
130910964|NCT02536833|471310290|FG002|Overall Study|Lost to Follow-up|2|||
130910965|NCT02536833|471310291|FG003|Overall Study|Lost to Follow-up|2|||
130910966|NCT02536833|471310288|FG000|Overall Study|Physician Decision|0|||
130910967|NCT02536833|471310289|FG001|Overall Study|Physician Decision|0|||
130910968|NCT02536833|471310290|FG002|Overall Study|Physician Decision|0|||
130910969|NCT02536833|471310291|FG003|Overall Study|Physician Decision|1|||
130910970|NCT02536833|471310288|FG000|Overall Study|Site Terminated by Sponsor|2|||
130910971|NCT02536833|471310289|FG001|Overall Study|Site Terminated by Sponsor|2|||
130910972|NCT02536833|471310290|FG002|Overall Study|Site Terminated by Sponsor|2|||
130910973|NCT02536833|471310291|FG003|Overall Study|Site Terminated by Sponsor|2|||
130910974|NCT02536833|471310288|FG000|Overall Study|Subject Non-Compliance|0|||
130910975|NCT02536833|471310289|FG001|Overall Study|Subject Non-Compliance|1|||
130910976|NCT02536833|471310290|FG002|Overall Study|Subject Non-Compliance|1|||
130910977|NCT02536833|471310291|FG003|Overall Study|Subject Non-Compliance|0|||
130910978|NCT02536833|471310288|FG000|Overall Study|Withdrawal by Subject|4|||
130910979|NCT02536833|471310289|FG001|Overall Study|Withdrawal by Subject|3|||
130910980|NCT02536833|471310290|FG002|Overall Study|Withdrawal by Subject|5|||
130910981|NCT02536833|471310291|FG003|Overall Study|Withdrawal by Subject|11|||
130910982|NCT02314143|471310292|FG000|Overall Study|Adverse Event|0|||
130910983|NCT02314143|471310293|FG001|Overall Study|Adverse Event|6|||
130910984|NCT02314143|471310294|FG002|Overall Study|Adverse Event|4|||
130910985|NCT02314143|471310292|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
130910986|NCT02314143|471310293|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
130910987|NCT02314143|471310294|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
130910988|NCT02314143|471310292|FG000|Overall Study|Physician Decision|2|||
130910989|NCT02314143|471310293|FG001|Overall Study|Physician Decision|1|||
130910990|NCT02314143|471310294|FG002|Overall Study|Physician Decision|0|||
130910991|NCT02314143|471310292|FG000|Overall Study|Withdrawal by Subject|1|||
130910992|NCT02314143|471310293|FG001|Overall Study|Withdrawal by Subject|0|||
130910993|NCT02314143|471310294|FG002|Overall Study|Withdrawal by Subject|1|||
130910994|NCT02764190|471310295|FG000|Overall Study|Lost to Follow-up|17|||
130910995|NCT02764190|471310296|FG001|Overall Study|Lost to Follow-up|13|||
130910996|NCT02140775|471310298|FG000|Overall Study|Withdrawal by Subject|30|||
130910997|NCT02140775|471310299|FG001|Overall Study|Withdrawal by Subject|7|||
130910998|NCT01172275|471310300|FG000|Overall Study|Lost to Follow-up|1|||
130910999|NCT01172275|471310301|FG001|Overall Study|Lost to Follow-up|0|||
130911000|NCT01172275|471310300|FG000|Overall Study|Protocol Violation|1|||
130911001|NCT01172275|471310301|FG001|Overall Study|Protocol Violation|0|||
130911002|NCT04650854|471310302|FG000|Overall Study|Adverse Event|1|||
130911003|NCT04650854|471310303|FG001|Overall Study|Adverse Event|12|||
130911004|NCT04650854|471310304|FG002|Overall Study|Adverse Event|14|||
130911005|NCT04650854|471310302|FG000|Overall Study|Lack of Efficacy|1|||
130911006|NCT04650854|471310303|FG001|Overall Study|Lack of Efficacy|3|||
130911007|NCT04650854|471310304|FG002|Overall Study|Lack of Efficacy|6|||
130911008|NCT04650854|471310302|FG000|Overall Study|Lost to Follow-up|1|||
130911009|NCT04650854|471310303|FG001|Overall Study|Lost to Follow-up|1|||
130911010|NCT04650854|471310304|FG002|Overall Study|Lost to Follow-up|0|||
130911011|NCT04650854|471310302|FG000|Overall Study|Withdrawal by Subject|2|||
130911012|NCT04650854|471310303|FG001|Overall Study|Withdrawal by Subject|17|||
130911013|NCT04650854|471310304|FG002|Overall Study|Withdrawal by Subject|9|||
130911014|NCT04650854|471310302|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
130911015|NCT04650854|471310303|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
130911016|NCT04650854|471310304|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
130911017|NCT04650854|471310302|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
130911018|NCT04650854|471310303|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
130911019|NCT04650854|471310304|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
130911020|NCT04650854|471310302|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
130911021|NCT04650854|471310303|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
130911022|NCT04650854|471310304|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
130911023|NCT04650854|471310302|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
130911024|NCT04650854|471310303|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
130911025|NCT04650854|471310304|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
130911026|NCT04650854|471310302|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
130911027|NCT04650854|471310303|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
130911028|NCT04650854|471310304|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
130911029|NCT04650854|471310302|FG000|Overall Study|Use of Rescue Medication|0|||
130911030|NCT04650854|471310303|FG001|Overall Study|Use of Rescue Medication|0|||
130911031|NCT04650854|471310304|FG002|Overall Study|Use of Rescue Medication|1|||
130911032|NCT04650854|471310302|FG000|Overall Study|Last Treatment Per Sponsor|0|||
130911033|NCT04650854|471310303|FG001|Overall Study|Last Treatment Per Sponsor|0|||
130911034|NCT04650854|471310304|FG002|Overall Study|Last Treatment Per Sponsor|2|||
130911035|NCT04650854|471310302|FG000|Overall Study|Rescue Medication|0|||
130911036|NCT04650854|471310303|FG001|Overall Study|Rescue Medication|0|||
130911037|NCT04650854|471310304|FG002|Overall Study|Rescue Medication|1|||
130911038|NCT04650854|471310302|FG000|Overall Study|Participant Want to Start a Family|0|||
130911039|NCT04650854|471310303|FG001|Overall Study|Participant Want to Start a Family|0|||
130911040|NCT04650854|471310304|FG002|Overall Study|Participant Want to Start a Family|1|||
130911041|NCT04650854|471310302|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
130911042|NCT04650854|471310303|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
130911043|NCT04650854|471310304|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
130911044|NCT04650854|471310302|FG000|Overall Study|Participant Screened For MG0020|0|||
130911045|NCT04650854|471310303|FG001|Overall Study|Participant Screened For MG0020|2|||
130911046|NCT04650854|471310304|FG002|Overall Study|Participant Screened For MG0020|3|||
130911047|NCT04650854|471310302|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
130911048|NCT04650854|471310303|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
130911049|NCT04650854|471310304|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
130911050|NCT04650854|471310302|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
130911051|NCT04650854|471310303|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
130911052|NCT04650854|471310304|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
130911053|NCT04650854|471310302|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
130911054|NCT04650854|471310303|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
130911055|NCT04650854|471310304|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
130911056|NCT04650854|471310302|FG000|Overall Study|End Of Study|0|||
130911057|NCT04650854|471310303|FG001|Overall Study|End Of Study|2|||
130911058|NCT04650854|471310304|FG002|Overall Study|End Of Study|1|||
130911059|NCT04650854|471310302|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
130911060|NCT04650854|471310303|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
130911061|NCT04650854|471310304|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
130911062|NCT04650854|471310302|FG000|Overall Study|Participant Received Rescue Medication|0|||
130911063|NCT04650854|471310303|FG001|Overall Study|Participant Received Rescue Medication|1|||
130911064|NCT04650854|471310304|FG002|Overall Study|Participant Received Rescue Medication|0|||
130911065|NCT04650854|471310302|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
130911066|NCT04650854|471310303|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
130911067|NCT04650854|471310304|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
130911068|NCT04650854|471310302|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
130911069|NCT04650854|471310303|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
130911070|NCT04650854|471310304|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
130911071|NCT04650854|471310302|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
130911072|NCT04650854|471310303|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
130911073|NCT04650854|471310304|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
130911074|NCT04650854|471310302|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
130911075|NCT04650854|471310303|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
130911076|NCT04650854|471310304|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
130911077|NCT04650854|471310302|FG000|Overall Study|Enrollment Cup|0|||
130911078|NCT04650854|471310303|FG001|Overall Study|Enrollment Cup|0|||
130911079|NCT04650854|471310304|FG002|Overall Study|Enrollment Cup|1|||
130911080|NCT05308290|471310305|FG000|Overall Study|Death|1|||
130911081|NCT05308290|471310306|FG001|Overall Study|Death|0|||
130911082|NCT05308290|471310305|FG000|Overall Study|Lost to Follow-up|2|||
130911083|NCT05308290|471310306|FG001|Overall Study|Lost to Follow-up|1|||
130911084|NCT05308290|471310305|FG000|Overall Study|still in study followup|0|||
130911085|NCT05308290|471310306|FG001|Overall Study|still in study followup|1|||
130911086|NCT04437368|471310307|FG000|Overall Study|Death|3|||
130911087|NCT04437368|471310308|FG001|Overall Study|Death|0|||
130911088|NCT04437368|471310309|FG002|Overall Study|Death|2|||
130911089|NCT04437368|471310307|FG000|Overall Study|Study terminated by sponsor|16|||
130911090|NCT04437368|471310308|FG001|Overall Study|Study terminated by sponsor|1|||
130911091|NCT04437368|471310309|FG002|Overall Study|Study terminated by sponsor|25|||
130911092|NCT04437368|471310307|FG000|Overall Study|Withdrawal by Subject|4|||
130911093|NCT04437368|471310308|FG001|Overall Study|Withdrawal by Subject|0|||
130911094|NCT04437368|471310309|FG002|Overall Study|Withdrawal by Subject|3|||
130911095|NCT04437368|471310307|FG000|Overall Study|Sponsor instructions|23|||
131116784|NCT01968070|472059375|FG001|Period 2|Withdrawal by Subject|0|||
130911096|NCT04437368|471310308|FG001|Overall Study|Sponsor instructions|0|||
131116785|NCT01968070|472059376|FG002|Period 2|Withdrawal by Subject|0|||
130911097|NCT04437368|471310309|FG002|Overall Study|Sponsor instructions|0|||
130911098|NCT01280955|471310319|FG000|Overall Study|Death|2|||
130911099|NCT01280955|471310319|FG000|Overall Study|Withdrawal by Subject|1|||
130911100|NCT04223232|471310320|FG000|Overall Study|Withdrawal by Subject|1|||
130911101|NCT02393690|471310322|FG000|Overall Study|Ineligible|0|||
130911102|NCT02393690|471310323|FG001|Overall Study|Ineligible|1|||
130911103|NCT01674634|471310324|FG000|Overall Study|Withdrawal by Subject|3|||
130911104|NCT01674634|471310324|FG000|Overall Study|Lost to Follow-up|3|||
130911105|NCT03187756|471310325|FG000|Overall Study|Termination of study|4|||
130911106|NCT02567552|471310326|FG000|Overall Study|Adverse Event|0|||
130911107|NCT02567552|471310327|FG001|Overall Study|Adverse Event|1|||
130911108|NCT01074047|471310328|FG000|Treatment Phase|Adverse Event|89|||
130911109|NCT01074047|471310329|FG001|Treatment Phase|Adverse Event|66|||
130911110|NCT01074047|471310328|FG000|Treatment Phase|Disease Progression|16|||
130911111|NCT01074047|471310329|FG001|Treatment Phase|Disease Progression|21|||
130911112|NCT01074047|471310328|FG000|Treatment Phase|Withdrawal by Subject|27|||
130911113|NCT01074047|471310329|FG001|Treatment Phase|Withdrawal by Subject|48|||
130911114|NCT01074047|471310328|FG000|Treatment Phase|Death|53|||
130911115|NCT01074047|471310329|FG001|Treatment Phase|Death|58|||
130911116|NCT01074047|471310328|FG000|Treatment Phase|Lost to Follow-up|0|||
130911117|NCT01074047|471310329|FG001|Treatment Phase|Lost to Follow-up|1|||
130911118|NCT01074047|471310328|FG000|Treatment Phase|Protocol Violation|0|||
130911119|NCT01074047|471310329|FG001|Treatment Phase|Protocol Violation|1|||
130911120|NCT01074047|471310328|FG000|Treatment Phase|Miscellaneous|32|||
130911121|NCT01074047|471310329|FG001|Treatment Phase|Miscellaneous|39|||
130911122|NCT01074047|471310328|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
130911123|NCT01074047|471310329|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
130911124|NCT01074047|471310328|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
130911125|NCT01074047|471310329|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
130911126|NCT01074047|471310328|FG000|Survival Follow-Up Phase|Death|116|||
130911127|NCT01074047|471310329|FG001|Survival Follow-Up Phase|Death|124|||
130911128|NCT01074047|471310328|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
130911129|NCT01074047|471310329|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
130911130|NCT01074047|471310328|FG000|Extension Phase|Physician Decision|1|||
130911131|NCT01074047|471310329|FG001|Extension Phase|Physician Decision|0|||
130911132|NCT01074047|471310328|FG000|Extension Phase|Adverse Event|5|||
130911133|NCT01074047|471310329|FG001|Extension Phase|Adverse Event|0|||
130911134|NCT01074047|471310328|FG000|Extension Phase|Disease Progression|9|||
130911135|NCT01074047|471310329|FG001|Extension Phase|Disease Progression|0|||
130911136|NCT01074047|471310328|FG000|Extension Phase|Withdrawal by Subject|2|||
130911137|NCT01074047|471310329|FG001|Extension Phase|Withdrawal by Subject|0|||
130911138|NCT01074047|471310328|FG000|Extension Phase|Death|5|||
130911139|NCT01074047|471310329|FG001|Extension Phase|Death|0|||
130911140|NCT03172910|471312069|FG000|Overall Study|Adverse Event|0|||
130911141|NCT03172910|471312070|FG001|Overall Study|Adverse Event|0|||
130911142|NCT03172910|471312071|FG002|Overall Study|Adverse Event|0|||
130911143|NCT03172910|471312072|FG003|Overall Study|Adverse Event|0|||
130911144|NCT03172910|471312073|FG004|Overall Study|Adverse Event|1|||
130911145|NCT01927341|471312077|FG000|Phase 1b|Lost to Follow-up|1|||
130911146|NCT01927341|471312078|FG001|Phase 1b|Lost to Follow-up|0|||
130911147|NCT01927341|471312079|FG002|Phase 1b|Lost to Follow-up|0|||
130911148|NCT01927341|471312080|FG003|Phase 1b|Lost to Follow-up|0|||
130911149|NCT01927341|471312081|FG004|Phase 1b|Lost to Follow-up|0|||
130911150|NCT01927341|471312077|FG000|Phase 1b|Death|2|||
130911151|NCT01927341|471312078|FG001|Phase 1b|Death|0|||
130911152|NCT01927341|471312079|FG002|Phase 1b|Death|0|||
130911153|NCT01927341|471312080|FG003|Phase 1b|Death|0|||
130911154|NCT01927341|471312081|FG004|Phase 1b|Death|0|||
130911155|NCT01927341|471312077|FG000|Phase 1b|Follow-up completed|7|||
130911156|NCT01927341|471312078|FG001|Phase 1b|Follow-up completed|0|||
130911157|NCT01927341|471312079|FG002|Phase 1b|Follow-up completed|0|||
130911158|NCT01927341|471312080|FG003|Phase 1b|Follow-up completed|0|||
130911159|NCT01927341|471312081|FG004|Phase 1b|Follow-up completed|0|||
130911160|NCT01927341|471312077|FG000|Phase 2|Lost to Follow-up|0|||
130696794|NCT02611323|470514512|FG003|Overall Study|Death|0|||
130696795|NCT02611323|470514513|FG004|Overall Study|Death|1|||
130911161|NCT01927341|471312078|FG001|Phase 2|Lost to Follow-up|1|||
130911162|NCT01927341|471312079|FG002|Phase 2|Lost to Follow-up|0|||
130911163|NCT01927341|471312080|FG003|Phase 2|Lost to Follow-up|0|||
130911164|NCT01927341|471312081|FG004|Phase 2|Lost to Follow-up|0|||
130911165|NCT01927341|471312077|FG000|Phase 2|Participant withdrew consent|0|||
130911166|NCT01927341|471312078|FG001|Phase 2|Participant withdrew consent|2|||
130911167|NCT01927341|471312079|FG002|Phase 2|Participant withdrew consent|1|||
130911168|NCT01927341|471312080|FG003|Phase 2|Participant withdrew consent|2|||
130911169|NCT01927341|471312081|FG004|Phase 2|Participant withdrew consent|3|||
131116786|NCT01968070|472059377|FG003|Period 2|Withdrawal by Subject|0|||
130696796|NCT02611323|470514514|FG005|Overall Study|Death|1|||
130911170|NCT01927341|471312077|FG000|Phase 2|Death|0|||
130911171|NCT01927341|471312078|FG001|Phase 2|Death|4|||
130911172|NCT01927341|471312079|FG002|Phase 2|Death|0|||
130911173|NCT01927341|471312080|FG003|Phase 2|Death|3|||
130911174|NCT01927341|471312081|FG004|Phase 2|Death|2|||
130911175|NCT01927341|471312077|FG000|Phase 2|New cancer therapy|0|||
130911176|NCT01927341|471312078|FG001|Phase 2|New cancer therapy|1|||
131116787|NCT01968070|472059378|FG004|Period 2|Withdrawal by Subject|1|||
131116788|NCT01968070|472059379|FG005|Period 2|Withdrawal by Subject|0|||
131116789|NCT01968070|472059380|FG006|Period 2|Withdrawal by Subject|0|||
131116790|NCT01968070|472059381|FG007|Period 2|Withdrawal by Subject|0|||
131116791|NCT01968070|472059382|FG008|Period 2|Withdrawal by Subject|0|||
131116792|NCT01968070|472059383|FG009|Period 2|Withdrawal by Subject|0|||
131116793|NCT01968070|472059384|FG010|Period 2|Withdrawal by Subject|0|||
131116794|NCT01968070|472059385|FG011|Period 2|Withdrawal by Subject|0|||
131116795|NCT01968070|472059386|FG012|Period 2|Withdrawal by Subject|0|||
131116796|NCT01968070|472059387|FG013|Period 2|Withdrawal by Subject|0|||
131116797|NCT01968070|472059388|FG014|Period 2|Withdrawal by Subject|0|||
131116798|NCT01968070|472059389|FG015|Period 2|Withdrawal by Subject|0|||
131116799|NCT01968070|472059390|FG016|Period 2|Withdrawal by Subject|0|||
131116800|NCT01968070|472059391|FG017|Period 2|Withdrawal by Subject|0|||
131116801|NCT00108069|472059396|FG000|Overall Study|Never rec'd study drug|0|||
130911177|NCT01927341|471312079|FG002|Phase 2|New cancer therapy|0|||
130911178|NCT01927341|471312080|FG003|Phase 2|New cancer therapy|4|||
130911179|NCT01927341|471312081|FG004|Phase 2|New cancer therapy|1|||
130911180|NCT01927341|471312077|FG000|Phase 2|Disease progression|0|||
130911181|NCT01927341|471312078|FG001|Phase 2|Disease progression|1|||
130911182|NCT01927341|471312079|FG002|Phase 2|Disease progression|1|||
130911183|NCT01927341|471312080|FG003|Phase 2|Disease progression|1|||
130911184|NCT01927341|471312081|FG004|Phase 2|Disease progression|0|||
130911185|NCT01927341|471312077|FG000|Phase 2|Follow-up completed|0|||
130911186|NCT01927341|471312078|FG001|Phase 2|Follow-up completed|6|||
130911187|NCT01927341|471312079|FG002|Phase 2|Follow-up completed|3|||
130911188|NCT01927341|471312080|FG003|Phase 2|Follow-up completed|5|||
130911189|NCT01927341|471312081|FG004|Phase 2|Follow-up completed|2|||
130911190|NCT01397201|471312082|FG000|Overall Study|Not treated|0|||
130911191|NCT01397201|471312083|FG001|Overall Study|Not treated|0|||
130911192|NCT01397201|471312084|FG002|Overall Study|Not treated|1|||
130911193|NCT01397201|471312085|FG003|Overall Study|Not treated|0|||
130911194|NCT01397201|471312086|FG004|Overall Study|Not treated|0|||
130911195|NCT01397201|471312082|FG000|Overall Study|Not yet defined|3|||
130911196|NCT01397201|471312083|FG001|Overall Study|Not yet defined|6|||
130911197|NCT01397201|471312084|FG002|Overall Study|Not yet defined|5|||
130911198|NCT01397201|471312085|FG003|Overall Study|Not yet defined|5|||
130911199|NCT01397201|471312086|FG004|Overall Study|Not yet defined|4|||
130911200|NCT01397201|471312082|FG000|Overall Study|Adverse Event|2|||
130911201|NCT01397201|471312083|FG001|Overall Study|Adverse Event|0|||
130911202|NCT01397201|471312084|FG002|Overall Study|Adverse Event|0|||
130911203|NCT01397201|471312085|FG003|Overall Study|Adverse Event|0|||
130911204|NCT01397201|471312086|FG004|Overall Study|Adverse Event|0|||
130911205|NCT00215683|471312087|FG000|Overall Study|Adverse Event|15|||
130911206|NCT00215683|471312088|FG001|Overall Study|Adverse Event|16|||
130911207|NCT00215683|471312089|FG002|Overall Study|Adverse Event|15|||
130911208|NCT00215683|471312087|FG000|Overall Study|Lack of Efficacy|5|||
130911209|NCT00215683|471312088|FG001|Overall Study|Lack of Efficacy|1|||
130911210|NCT00215683|471312089|FG002|Overall Study|Lack of Efficacy|2|||
130911211|NCT00215683|471312087|FG000|Overall Study|Lost to Follow-up|0|||
130911212|NCT00215683|471312088|FG001|Overall Study|Lost to Follow-up|2|||
130911213|NCT00215683|471312089|FG002|Overall Study|Lost to Follow-up|1|||
130911214|NCT00215683|471312087|FG000|Overall Study|Withdrawal by Subject|9|||
130911215|NCT00215683|471312088|FG001|Overall Study|Withdrawal by Subject|4|||
130911216|NCT00215683|471312089|FG002|Overall Study|Withdrawal by Subject|13|||
130911217|NCT00215683|471312087|FG000|Overall Study|Physician Decision|0|||
130911218|NCT00215683|471312088|FG001|Overall Study|Physician Decision|0|||
130911219|NCT00215683|471312089|FG002|Overall Study|Physician Decision|1|||
131030826|NCT04556656|471746334|FG000|Overall Study|Not further specified|2|||
131030827|NCT04556656|471746335|FG001|Overall Study|Not further specified|1|||
131030828|NCT03846505|471746337|FG000|Treatment Phase|Withdrawal by Subject|9|||
131030829|NCT03846505|471746338|FG001|Treatment Phase|Withdrawal by Subject|11|||
131030830|NCT03846505|471746337|FG000|Treatment Phase|Lost to Follow-up|6|||
131030831|NCT03846505|471746338|FG001|Treatment Phase|Lost to Follow-up|2|||
131030832|NCT03846505|471746337|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
131116802|NCT00108069|472059397|FG001|Overall Study|Never rec'd study drug|1|||
131116803|NCT00108069|472059396|FG000|Overall Study|Adverse Event|1|||
130911220|NCT00215683|471312087|FG000|Overall Study|Difficult to attend visits|0|||
130911221|NCT00215683|471312088|FG001|Overall Study|Difficult to attend visits|1|||
130911222|NCT00215683|471312089|FG002|Overall Study|Difficult to attend visits|0|||
130911223|NCT00215683|471312087|FG000|Overall Study|No study drug available|0|||
130911224|NCT00215683|471312088|FG001|Overall Study|No study drug available|1|||
131030833|NCT03846505|471746338|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
131116804|NCT00108069|472059397|FG001|Overall Study|Adverse Event|1|||
130911225|NCT00215683|471312089|FG002|Overall Study|No study drug available|0|||
130911226|NCT00215683|471312087|FG000|Overall Study|Intermittent therapy required|0|||
130911227|NCT00215683|471312088|FG001|Overall Study|Intermittent therapy required|1|||
130911228|NCT00215683|471312089|FG002|Overall Study|Intermittent therapy required|0|||
130911229|NCT04493333|471312096|FG000|Overall Study|Withdrawal by Subject|1|||
131030834|NCT03846505|471746337|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
131030835|NCT03846505|471746338|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
131030836|NCT03535272|471746339|FG000|Overall Study|Lost to Follow-up|71|||
131030837|NCT03535272|471746340|FG001|Overall Study|Lost to Follow-up|73|||
131030838|NCT03892616|471746341|FG000|Washout Period 2|Met discontinuation criterion|0|||
131030839|NCT03892616|471746342|FG001|Washout Period 2|Met discontinuation criterion|0|||
131030840|NCT03892616|471746343|FG002|Washout Period 2|Met discontinuation criterion|0|||
131030841|NCT03892616|471746344|FG003|Washout Period 2|Met discontinuation criterion|0|||
131030842|NCT03892616|471746345|FG004|Washout Period 2|Met discontinuation criterion|0|||
131030843|NCT03892616|471746346|FG005|Washout Period 2|Met discontinuation criterion|0|||
131030844|NCT03892616|471746347|FG006|Washout Period 2|Met discontinuation criterion|0|||
131030845|NCT03892616|471746348|FG007|Washout Period 2|Met discontinuation criterion|0|||
131030846|NCT03892616|471746349|FG008|Washout Period 2|Met discontinuation criterion|1|||
131030847|NCT03892616|471746350|FG009|Washout Period 2|Met discontinuation criterion|0|||
131030848|NCT03892616|471746351|FG010|Washout Period 2|Met discontinuation criterion|0|||
131030849|NCT03892616|471746352|FG011|Washout Period 2|Met discontinuation criterion|0|||
131030850|NCT00378105|471746353|FG000|Overall Study|Adverse Event|3|||
131030851|NCT00378105|471746354|FG001|Overall Study|Adverse Event|1|||
131030852|NCT00378105|471746353|FG000|Overall Study|Withdrawal by Subject|3|||
131030853|NCT00378105|471746354|FG001|Overall Study|Withdrawal by Subject|3|||
131030854|NCT00378105|471746353|FG000|Overall Study|Death|1|||
131030855|NCT00378105|471746354|FG001|Overall Study|Death|0|||
131030856|NCT00378105|471746353|FG000|Overall Study|Going to transplant|7|||
130911230|NCT04493333|471312097|FG001|Overall Study|Withdrawal by Subject|1|||
130911231|NCT04493333|471312096|FG000|Overall Study|Ineligible|0|||
131030857|NCT00378105|471746354|FG001|Overall Study|Going to transplant|8|||
131030858|NCT00378105|471746353|FG000|Overall Study|Progressive disease|3|||
131030859|NCT00378105|471746354|FG001|Overall Study|Progressive disease|3|||
131030860|NCT00378105|471746353|FG000|Overall Study|remain on study|3|||
131030861|NCT00378105|471746354|FG001|Overall Study|remain on study|11|||
131030862|NCT00378105|471746353|FG000|Overall Study|Physician Decision|0|||
131030863|NCT00378105|471746354|FG001|Overall Study|Physician Decision|2|||
131030864|NCT00378105|471746353|FG000|Overall Study|Going non-protocol therapy|0|||
130911232|NCT04493333|471312097|FG001|Overall Study|Ineligible|1|||
130911233|NCT04493333|471312096|FG000|Overall Study|Noncompliance|2|||
130911234|NCT04493333|471312097|FG001|Overall Study|Noncompliance|1|||
130911235|NCT01865084|471312100|FG000|Double Blind Period (DB)|Adverse Event|2|||
130911236|NCT01865084|471312101|FG001|Double Blind Period (DB)|Adverse Event|2|||
130911237|NCT01865084|471312102|FG002|Double Blind Period (DB)|Adverse Event|1|||
130911238|NCT01865084|471312100|FG000|Double Blind Period (DB)|Protocol Violation|0|||
130911239|NCT01865084|471312101|FG001|Double Blind Period (DB)|Protocol Violation|0|||
130911240|NCT01865084|471312102|FG002|Double Blind Period (DB)|Protocol Violation|1|||
130911241|NCT01865084|471312100|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
130911242|NCT01865084|471312101|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
130911243|NCT01865084|471312102|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
130911244|NCT01865084|471312100|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
130911245|NCT01865084|471312101|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
130911246|NCT01865084|471312102|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
130911247|NCT01865084|471312100|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
131030865|NCT00378105|471746354|FG001|Overall Study|Going non-protocol therapy|1|||
131030866|NCT00378105|471746353|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
131030867|NCT00378105|471746354|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
131030868|NCT04533347|471746358|FG000|Overall Study|Adverse Event|1|||
130911248|NCT01865084|471312101|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
131030869|NCT04533347|471746359|FG001|Overall Study|Adverse Event|2|||
131030870|NCT04533347|471746358|FG000|Overall Study|Lost to Follow-up|2|||
131030871|NCT04533347|471746359|FG001|Overall Study|Lost to Follow-up|0|||
130696797|NCT02611323|470514515|FG006|Overall Study|Death|8|||
130696798|NCT02611323|470514516|FG007|Overall Study|Death|0|||
130696799|NCT02611323|470514517|FG008|Overall Study|Death|4|||
130696800|NCT02611323|470514518|FG009|Overall Study|Death|6|||
130696801|NCT02611323|470514519|FG010|Overall Study|Death|26|||
130696802|NCT02611323|470514509|FG000|Overall Study|Lost to Follow-up|1|||
130696803|NCT02611323|470514510|FG001|Overall Study|Lost to Follow-up|0|||
130696804|NCT02611323|470514511|FG002|Overall Study|Lost to Follow-up|0|||
130696805|NCT02611323|470514512|FG003|Overall Study|Lost to Follow-up|0|||
130696806|NCT02611323|470514513|FG004|Overall Study|Lost to Follow-up|0|||
130696807|NCT02611323|470514514|FG005|Overall Study|Lost to Follow-up|0|||
130696808|NCT02611323|470514515|FG006|Overall Study|Lost to Follow-up|3|||
130696809|NCT02611323|470514516|FG007|Overall Study|Lost to Follow-up|0|||
130696810|NCT02611323|470514517|FG008|Overall Study|Lost to Follow-up|0|||
130696811|NCT02611323|470514518|FG009|Overall Study|Lost to Follow-up|0|||
130696812|NCT02611323|470514519|FG010|Overall Study|Lost to Follow-up|2|||
130911249|NCT01865084|471312102|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
130911250|NCT01865084|471312100|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
131030872|NCT04533347|471746358|FG000|Overall Study|Withdrawal by Subject|1|||
130911251|NCT01865084|471312101|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
130911252|NCT01865084|471312102|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
130911253|NCT01865084|471312100|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
130911254|NCT01865084|471312101|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
130911255|NCT01865084|471312102|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
130911256|NCT01865084|471312100|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
130911257|NCT01865084|471312101|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
130911258|NCT01865084|471312102|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
130911259|NCT01865084|471312100|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
130911260|NCT01865084|471312101|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
130911261|NCT01865084|471312102|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
130768773|NCT02290925|470778581|FG001|First Period of Three Months|Lost to Follow-up|1|||
130768774|NCT02290925|470778580|FG000|First Period of Three Months|Death|1|||
130768775|NCT02290925|470778581|FG001|First Period of Three Months|Death|0|||
130768776|NCT02290925|470778580|FG000|First Period of Three Months|Insulin Started|1|||
130768777|NCT02290925|470778581|FG001|First Period of Three Months|Insulin Started|1|||
130768778|NCT02290925|470778580|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
130768779|NCT02290925|470778581|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
130768780|NCT02290925|470778580|FG000|Second Period of 3 Months|insulin started|0|||
130911262|NCT01801072|471312103|FG000|Overall Study|Lost to Follow-up|17|||
130696813|NCT02611323|470514509|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
130768781|NCT02290925|470778581|FG001|Second Period of 3 Months|insulin started|1|||
130768782|NCT04942210|470778582|FG000|Overall Study|Adverse Event|0|||
130768783|NCT04942210|470778583|FG001|Overall Study|Adverse Event|1|||
130768784|NCT04942210|470778582|FG000|Overall Study|Protocol Deviation|4|||
130768785|NCT04942210|470778583|FG001|Overall Study|Protocol Deviation|1|||
130768786|NCT04942210|470778582|FG000|Overall Study|Withdrawal by Subject|5|||
130768787|NCT04942210|470778583|FG001|Overall Study|Withdrawal by Subject|2|||
130768788|NCT04942210|470778582|FG000|Overall Study|Lost to Follow-up|16|||
130768789|NCT04942210|470778583|FG001|Overall Study|Lost to Follow-up|7|||
130768790|NCT04942210|470778582|FG000|Overall Study|Ongoing at the time of DBL date|60|||
130768791|NCT04942210|470778583|FG001|Overall Study|Ongoing at the time of DBL date|25|||
130768792|NCT04942210|470778582|FG000|Overall Study|Randomized but did not receive vaccination|3|||
130768793|NCT04942210|470778583|FG001|Overall Study|Randomized but did not receive vaccination|0|||
130768794|NCT05697627|470778584|FG000|Overall Study|Adverse Event|1|||
130768795|NCT02570750|470778585|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
130768796|NCT02570750|470778586|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
130768797|NCT02570750|470778585|FG000|Overall Study|Protocol deviation|4|||
130768798|NCT02570750|470778586|FG001|Overall Study|Protocol deviation|2|||
130768799|NCT02570750|470778585|FG000|Overall Study|Withdrawal by Subject|5|||
130768800|NCT02570750|470778586|FG001|Overall Study|Withdrawal by Subject|0|||
130768801|NCT02570750|470778585|FG000|Overall Study|Lost to Follow-up|2|||
130768802|NCT02570750|470778586|FG001|Overall Study|Lost to Follow-up|2|||
130911263|NCT01801072|471312104|FG001|Overall Study|Lost to Follow-up|14|||
131030873|NCT04533347|471746359|FG001|Overall Study|Withdrawal by Subject|0|||
131030874|NCT03907397|471746360|FG000|Overall Study|Lost to Follow-up|0|||
130696814|NCT02611323|470514510|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696815|NCT02611323|470514511|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696816|NCT02611323|470514512|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696817|NCT02611323|470514513|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696818|NCT02611323|470514514|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696819|NCT02611323|470514515|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696820|NCT02611323|470514516|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696821|NCT02611323|470514517|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696822|NCT02611323|470514518|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
130696823|NCT02611323|470514519|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
130696824|NCT02611323|470514509|FG000|Overall Study|Progressive Disease|0|||
130696825|NCT02611323|470514510|FG001|Overall Study|Progressive Disease|0|||
130696826|NCT02611323|470514511|FG002|Overall Study|Progressive Disease|0|||
130696827|NCT02611323|470514512|FG003|Overall Study|Progressive Disease|0|||
130696828|NCT02611323|470514513|FG004|Overall Study|Progressive Disease|0|||
130768803|NCT02570750|470778585|FG000|Overall Study|Adverse Event|2|||
130768804|NCT02570750|470778586|FG001|Overall Study|Adverse Event|1|||
130768805|NCT04122625|470778587|FG000|Part A (up to 2.92 Years)|Death|2|||
130768806|NCT04122625|470778588|FG001|Part A (up to 2.92 Years)|Death|4|||
130768807|NCT04122625|470778589|FG002|Part A (up to 2.92 Years)|Death|0|||
131030875|NCT03907397|471746361|FG001|Overall Study|Lost to Follow-up|1|||
130911264|NCT01801072|471312103|FG000|Overall Study|Physician Decision|2|||
131030876|NCT03907397|471746360|FG000|Overall Study|Physician Decision|2|||
131030877|NCT03907397|471746361|FG001|Overall Study|Physician Decision|1|||
131030878|NCT03907397|471746360|FG000|Overall Study|Withdrawal by Subject|5|||
130768808|NCT04122625|470778590|FG003|Part A (up to 2.92 Years)|Death|0|||
130911265|NCT01801072|471312104|FG001|Overall Study|Physician Decision|3|||
130911266|NCT01801072|471312103|FG000|Overall Study|Withdrawal by Subject|1|||
130911267|NCT01801072|471312104|FG001|Overall Study|Withdrawal by Subject|0|||
130911268|NCT01801072|471312103|FG000|Overall Study|Protocol Violation|2|||
130911269|NCT01801072|471312104|FG001|Overall Study|Protocol Violation|0|||
130911270|NCT01801072|471312103|FG000|Overall Study|Death|7|||
130911271|NCT01801072|471312104|FG001|Overall Study|Death|8|||
130911272|NCT03693170|471312105|FG000|Overall Study|Disease Progression|48|||
130911273|NCT03693170|471312105|FG000|Overall Study|Adverse Event|16|||
130911274|NCT03693170|471312105|FG000|Overall Study|Physician Decision|6|||
130911275|NCT03693170|471312105|FG000|Overall Study|Protocol Violation|2|||
130911276|NCT03693170|471312105|FG000|Overall Study|Death|1|||
130911277|NCT03693170|471312105|FG000|Overall Study|Non compliance with study drug|1|||
130696829|NCT02611323|470514514|FG005|Overall Study|Progressive Disease|0|||
130911278|NCT03693170|471312105|FG000|Overall Study|Withdrawal by Subject|1|||
130911279|NCT02247531|471312106|FG000|Overall Study|Adverse Event|3|||
130911280|NCT02247531|471312107|FG001|Overall Study|Adverse Event|4|||
130911281|NCT02247531|471312108|FG002|Overall Study|Adverse Event|9|||
130911282|NCT02247531|471312106|FG000|Overall Study|Death|8|||
130911283|NCT02247531|471312107|FG001|Overall Study|Death|9|||
130911284|NCT02247531|471312108|FG002|Overall Study|Death|5|||
130911285|NCT02247531|471312106|FG000|Overall Study|Lost to Follow-up|1|||
130911286|NCT02247531|471312107|FG001|Overall Study|Lost to Follow-up|8|||
130911287|NCT02247531|471312108|FG002|Overall Study|Lost to Follow-up|3|||
130911288|NCT02247531|471312106|FG000|Overall Study|Non-compliance|2|||
130911289|NCT02247531|471312107|FG001|Overall Study|Non-compliance|2|||
130911290|NCT02247531|471312108|FG002|Overall Study|Non-compliance|0|||
130911291|NCT02247531|471312106|FG000|Overall Study|Withdrawal by Subject|26|||
130911292|NCT02247531|471312107|FG001|Overall Study|Withdrawal by Subject|31|||
130911293|NCT02247531|471312108|FG002|Overall Study|Withdrawal by Subject|25|||
130911294|NCT02247531|471312106|FG000|Overall Study|Study Terminated by Sponsor|64|||
130911295|NCT02247531|471312107|FG001|Overall Study|Study Terminated by Sponsor|66|||
130911296|NCT02247531|471312108|FG002|Overall Study|Study Terminated by Sponsor|62|||
130911297|NCT02247531|471312106|FG000|Overall Study|Physician Decision|0|||
130911298|NCT02247531|471312107|FG001|Overall Study|Physician Decision|2|||
130911299|NCT02247531|471312108|FG002|Overall Study|Physician Decision|2|||
130911300|NCT02247531|471312106|FG000|Overall Study|Unspecified Reason|2|||
130911301|NCT02247531|471312107|FG001|Overall Study|Unspecified Reason|3|||
130911302|NCT02247531|471312108|FG002|Overall Study|Unspecified Reason|4|||
130911303|NCT01442038|471312111|FG000|Overall Study|Death|35|||
130911304|NCT01442038|471312112|FG001|Overall Study|Death|29|||
130911305|NCT01442038|471312111|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
130911306|NCT01442038|471312112|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
130911307|NCT01442038|471312111|FG000|Overall Study|Participant Withdrew Consent|137|||
130911308|NCT01442038|471312112|FG001|Overall Study|Participant Withdrew Consent|102|||
130911309|NCT01442038|471312111|FG000|Overall Study|Lost to Follow-up|37|||
130911310|NCT01442038|471312112|FG001|Overall Study|Lost to Follow-up|51|||
130911311|NCT01442038|471312111|FG000|Overall Study|Adverse Event|26|||
130911312|NCT01442038|471312112|FG001|Overall Study|Adverse Event|15|||
130911313|NCT01442038|471312111|FG000|Overall Study|Protocol Deviation|9|||
130911314|NCT01442038|471312112|FG001|Overall Study|Protocol Deviation|20|||
130911315|NCT01442038|471312111|FG000|Overall Study|Investigator's Discretion|13|||
130911316|NCT01442038|471312112|FG001|Overall Study|Investigator's Discretion|16|||
130911317|NCT01442038|471312111|FG000|Overall Study|Study Terminated By Sponsor|2|||
130911318|NCT01442038|471312112|FG001|Overall Study|Study Terminated By Sponsor|3|||
131030879|NCT03907397|471746361|FG001|Overall Study|Withdrawal by Subject|4|||
130911319|NCT00089284|471312113|FG000|Overall Study|Adverse event before starting treatment|0|||
130911320|NCT00089284|471312114|FG001|Overall Study|Adverse event before starting treatment|0|||
130911321|NCT00089284|471312115|FG002|Overall Study|Adverse event before starting treatment|0|||
130911322|NCT00089284|471312116|FG003|Overall Study|Adverse event before starting treatment|0|||
131030880|NCT03907397|471746360|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
131030881|NCT03907397|471746361|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
131030882|NCT01331005|471747901|FG000|Overall Study|Lost to Follow-up|2|||
131030883|NCT01331005|471747902|FG001|Overall Study|Lost to Follow-up|1|||
131030884|NCT01331005|471747901|FG000|Overall Study|Withdrawal by Subject|2|||
130696830|NCT02611323|470514515|FG006|Overall Study|Progressive Disease|0|||
130696831|NCT02611323|470514516|FG007|Overall Study|Progressive Disease|0|||
130911323|NCT00089284|471312117|FG004|Overall Study|Adverse event before starting treatment|0|||
130911324|NCT00089284|471312118|FG005|Overall Study|Adverse event before starting treatment|0|||
130911325|NCT00089284|471312119|FG006|Overall Study|Adverse event before starting treatment|1|||
130911326|NCT02423109|471312128|FG000|Lens 1|Adverse Event|1|||
130911327|NCT02423109|471312129|FG001|Lens 1|Adverse Event|0|||
130911328|NCT03646643|471312130|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
130911329|NCT03646643|471312131|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
130911330|NCT03646643|471312130|FG000|Overall Study|Lost to Follow-up|0|||
130696832|NCT02611323|470514517|FG008|Overall Study|Progressive Disease|0|||
130911331|NCT03646643|471312131|FG001|Overall Study|Lost to Follow-up|1|||
130911332|NCT04131556|471312132|FG000|Overall Study|Adverse Event|1|||
130911333|NCT04131556|471312132|FG000|Overall Study|Withdrawal by Subject|1|||
130911334|NCT01229397|471312135|FG000|Overall Study|Withdrawal by Subject|3|||
130911335|NCT01229397|471312136|FG001|Overall Study|Withdrawal by Subject|3|||
130911336|NCT01229397|471312135|FG000|Overall Study|Lost to Follow-up|7|||
130911337|NCT01229397|471312136|FG001|Overall Study|Lost to Follow-up|6|||
130911338|NCT01229397|471312135|FG000|Overall Study|Migrated/moved from study area|1|||
130911339|NCT01229397|471312136|FG001|Overall Study|Migrated/moved from study area|0|||
130911340|NCT02545075|471312137|FG000|Randomization|Lost to Follow-up|0|||
130696833|NCT02611323|470514518|FG009|Overall Study|Progressive Disease|0|||
130696834|NCT02611323|470514519|FG010|Overall Study|Progressive Disease|1|||
130911341|NCT02545075|471312138|FG001|Randomization|Lost to Follow-up|1|||
130911342|NCT02545075|471312137|FG000|Randomization|Withdrawal by Subject|0|||
130911343|NCT02545075|471312138|FG001|Randomization|Withdrawal by Subject|6|||
130911344|NCT02545075|471312137|FG000|Treatment|Disease progression|71|||
130911345|NCT02545075|471312138|FG001|Treatment|Disease progression|32|||
130911346|NCT02545075|471312137|FG000|Treatment|Participant dicontinued study treatment|7|||
130911347|NCT02545075|471312138|FG001|Treatment|Participant dicontinued study treatment|9|||
130911348|NCT02545075|471312137|FG000|Treatment|Withdrawal by Subject|1|||
130911349|NCT02545075|471312138|FG001|Treatment|Withdrawal by Subject|0|||
130911350|NCT02545075|471312137|FG000|Treatment|Adverse event not related to study drug|1|||
130911351|NCT02545075|471312138|FG001|Treatment|Adverse event not related to study drug|0|||
130911352|NCT02545075|471312137|FG000|Treatment|Death|1|||
130911353|NCT02545075|471312138|FG001|Treatment|Death|0|||
130911354|NCT02545075|471312137|FG000|Treatment|Participant drug toxicity|1|||
130911355|NCT02545075|471312138|FG001|Treatment|Participant drug toxicity|0|||
130911356|NCT02545075|471312137|FG000|Treatment|Completed treatment|40|||
130911357|NCT02545075|471312138|FG001|Treatment|Completed treatment|12|||
130911358|NCT01810432|471312141|FG000|Washout|Protocol Violation|0|||
130911359|NCT01810432|471312142|FG001|Washout|Protocol Violation|1|||
130911360|NCT01810432|471312141|FG000|Washout|Adverse Event|1|||
130911361|NCT01810432|471312142|FG001|Washout|Adverse Event|0|||
130911362|NCT01810432|471312141|FG000|Period 2|Withdrawal by Subject|2|||
130911363|NCT01810432|471312142|FG001|Period 2|Withdrawal by Subject|1|||
130911364|NCT01810432|471312141|FG000|Period 2|Physician Decision|1|||
130911365|NCT01810432|471312142|FG001|Period 2|Physician Decision|0|||
130911366|NCT01810432|471312141|FG000|Period 2|Lost to Follow-up|1|||
130911367|NCT01810432|471312142|FG001|Period 2|Lost to Follow-up|1|||
130911368|NCT00736879|471312143|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
130911369|NCT00736879|471312144|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
130911370|NCT00736879|471312145|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
130911371|NCT00736879|471312146|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
130911372|NCT00736879|471312143|FG000|Double Blind Treatment Period|Adverse Event|0|||
130911373|NCT00736879|471312144|FG001|Double Blind Treatment Period|Adverse Event|1|||
130911374|NCT00736879|471312145|FG002|Double Blind Treatment Period|Adverse Event|1|||
130911375|NCT00736879|471312146|FG003|Double Blind Treatment Period|Adverse Event|0|||
130911376|NCT00736879|471312143|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
130911377|NCT00736879|471312144|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
130911378|NCT00736879|471312145|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
130911379|NCT00736879|471312146|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
130911380|NCT00736879|471312143|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
130911381|NCT00736879|471312144|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130911382|NCT00736879|471312145|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
130911383|NCT00736879|471312146|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
130911384|NCT00736879|471312143|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
130911385|NCT00736879|471312144|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
130911386|NCT00736879|471312145|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
130911387|NCT00736879|471312146|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
130911388|NCT00736879|471312143|FG000|Double Blind Treatment Period|No longer met criteria|0|||
130911389|NCT00736879|471312144|FG001|Double Blind Treatment Period|No longer met criteria|1|||
130911390|NCT00736879|471312145|FG002|Double Blind Treatment Period|No longer met criteria|0|||
130911391|NCT00736879|471312146|FG003|Double Blind Treatment Period|No longer met criteria|0|||
130911392|NCT00736879|471312143|FG000|Double Blind Treatment Period|non-specified|0|||
130911393|NCT00736879|471312144|FG001|Double Blind Treatment Period|non-specified|1|||
130911394|NCT00736879|471312145|FG002|Double Blind Treatment Period|non-specified|0|||
130911395|NCT00736879|471312146|FG003|Double Blind Treatment Period|non-specified|0|||
130911396|NCT00736879|471312143|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
130911397|NCT00736879|471312144|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
130911398|NCT00736879|471312145|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
130911399|NCT00736879|471312146|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
130911400|NCT00736879|471312143|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
130696835|NCT02611323|470514509|FG000|Overall Study|Withdrawal by Subject|1|||
130911401|NCT00736879|471312144|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
130911402|NCT00736879|471312145|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
130911403|NCT00736879|471312146|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
130911404|NCT02360111|471312147|FG000|Overall Study|Death|2|||
130911405|NCT01933217|471312150|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
130911406|NCT01933217|471312151|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
130911407|NCT01933217|471312150|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
130911408|NCT01933217|471312151|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
130911409|NCT03923738|471312152|FG000|Period 1|Adverse Event|1|||
130911410|NCT03923738|471312152|FG000|Period 1|Withdrawal by Subject|1|||
130911411|NCT05323656|471312160|FG000|Overall Study|Still On-Treatment|6|||
130911412|NCT05323656|471312161|FG001|Overall Study|Still On-Treatment|6|||
130911413|NCT05323656|471312160|FG000|Overall Study|Progressive Disease|15|||
130911414|NCT05323656|471312161|FG001|Overall Study|Progressive Disease|14|||
130911415|NCT05323656|471312160|FG000|Overall Study|Adverse Event|2|||
130911416|NCT05323656|471312161|FG001|Overall Study|Adverse Event|3|||
130911417|NCT05323656|471312160|FG000|Overall Study|Death|1|||
130911418|NCT05323656|471312161|FG001|Overall Study|Death|2|||
130911419|NCT05323656|471312160|FG000|Overall Study|Withdrawal by Subject|1|||
130911420|NCT05323656|471312161|FG001|Overall Study|Withdrawal by Subject|0|||
130911421|NCT05323656|471312160|FG000|Overall Study|Clinical disease progression|0|||
130911422|NCT05323656|471312161|FG001|Overall Study|Clinical disease progression|1|||
130911423|NCT05323656|471312160|FG000|Overall Study|Patient and Investigator decision|1|||
130911424|NCT05323656|471312161|FG001|Overall Study|Patient and Investigator decision|0|||
130911425|NCT05323656|471312160|FG000|Overall Study|Physician Decision|0|||
130911426|NCT05323656|471312161|FG001|Overall Study|Physician Decision|1|||
130911427|NCT03953183|471312162|FG000|Overall Study|Physician Decision|0|||
130911428|NCT03953183|471312163|FG001|Overall Study|Physician Decision|1|||
130911429|NCT03953183|471312162|FG000|Overall Study|Withdrawal by Subject|0|||
130911430|NCT03953183|471312163|FG001|Overall Study|Withdrawal by Subject|1|||
130911431|NCT04508140|471312164|FG000|Overall Study|Adverse Event|2|||
130911432|NCT04508140|471312165|FG001|Overall Study|Adverse Event|2|||
130911433|NCT04508140|471312164|FG000|Overall Study|Withdrawal by Subject|0|||
130911434|NCT04508140|471312165|FG001|Overall Study|Withdrawal by Subject|2|||
130911435|NCT04508140|471312164|FG000|Overall Study|progressive disease|9|||
130911436|NCT04508140|471312165|FG001|Overall Study|progressive disease|3|||
130911437|NCT01298193|471312166|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
130911438|NCT01298193|471312166|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
130911439|NCT01298193|471312166|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
130911440|NCT01298193|471312166|FG000|Efficacy Phase (Second Cycle)|Death|1|||
130911441|NCT04010539|471312167|FG000|Overall Study|Withdrawal by Subject|4|||
130911442|NCT04010539|471312168|FG001|Overall Study|Withdrawal by Subject|1|||
130911443|NCT04010539|471312167|FG000|Overall Study|Physician Decision|0|||
130911444|NCT04010539|471312168|FG001|Overall Study|Physician Decision|2|||
130911445|NCT04010539|471312167|FG000|Overall Study|Lost to Follow-up|10|||
130911446|NCT04010539|471312168|FG001|Overall Study|Lost to Follow-up|14|||
130911447|NCT04010539|471312167|FG000|Overall Study|Adverse Event|3|||
130911448|NCT04010539|471312168|FG001|Overall Study|Adverse Event|0|||
130911449|NCT04010539|471312167|FG000|Overall Study|Participant Did Not Receive IP|0|||
130911450|NCT04010539|471312168|FG001|Overall Study|Participant Did Not Receive IP|1|||
130911451|NCT04010539|471312167|FG000|Overall Study|Protocol Deviation|0|||
130911452|NCT04010539|471312168|FG001|Overall Study|Protocol Deviation|1|||
130911453|NCT04010539|471312167|FG000|Overall Study|Randomized in Error/ Mistake|2|||
130911454|NCT04010539|471312168|FG001|Overall Study|Randomized in Error/ Mistake|0|||
130911455|NCT04010539|471312167|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
130911456|NCT04010539|471312168|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
130911457|NCT00249288|471312169|FG000|Overall Study|Lost to Follow-up|3|||
131030885|NCT01331005|471747902|FG001|Overall Study|Withdrawal by Subject|3|||
131030886|NCT05021640|471747905|FG000|Overall Study|Lost to Follow-up|0|||
131030887|NCT05021640|471747906|FG001|Overall Study|Lost to Follow-up|0|||
131030888|NCT05021640|471747907|FG002|Overall Study|Lost to Follow-up|0|||
131030889|NCT05021640|471747908|FG003|Overall Study|Lost to Follow-up|0|||
131030890|NCT05021640|471747909|FG004|Overall Study|Lost to Follow-up|1|||
131030891|NCT04737772|471747910|FG000|Phase 2 Study|Lost to Follow-up|15|||
131030892|NCT04737772|471747911|FG001|Phase 2 Study|Lost to Follow-up|15|||
131030893|NCT04737772|471747910|FG000|Phase 2 Study|Withdrawal by Subject|0|||
130911458|NCT00249288|471312170|FG001|Overall Study|Lost to Follow-up|3|||
130911459|NCT00249288|471312169|FG000|Overall Study|Withdrawal by Subject|2|||
130911460|NCT00249288|471312170|FG001|Overall Study|Withdrawal by Subject|2|||
130911461|NCT03059446|471312171|FG000|Overall Study|Adverse Event|11|||
130911462|NCT03059446|471312171|FG000|Overall Study|Withdrawal of Consent|16|||
130911463|NCT03059446|471312171|FG000|Overall Study|Lost to Follow-up|3|||
130911464|NCT03059446|471312171|FG000|Overall Study|Protocol Violation|1|||
130911465|NCT03059446|471312171|FG000|Overall Study|Study Terminated by Sponsor|131|||
131030894|NCT04737772|471747911|FG001|Phase 2 Study|Withdrawal by Subject|1|||
130911466|NCT03059446|471312171|FG000|Overall Study|Reason not Specified|5|||
130911467|NCT04795622|471312172|FG000|Overall Study|Adverse Event|1|||
130911468|NCT04795622|471312173|FG001|Overall Study|Adverse Event|0|||
130911469|NCT04795622|471312172|FG000|Overall Study|Withdrawal by Subject|3|||
130911470|NCT04795622|471312173|FG001|Overall Study|Withdrawal by Subject|3|||
130911471|NCT04795622|471312172|FG000|Overall Study|Protocol Violation|0|||
130911472|NCT04795622|471312173|FG001|Overall Study|Protocol Violation|2|||
130911473|NCT04795622|471312172|FG000|Overall Study|Lost to Follow-up|2|||
130911474|NCT04795622|471312173|FG001|Overall Study|Lost to Follow-up|3|||
130911475|NCT04795622|471312172|FG000|Overall Study|Other|7|||
130911476|NCT04795622|471312173|FG001|Overall Study|Other|8|||
130911477|NCT00667420|471312180|FG000|Overall Study|Adverse Event|2|||
130911478|NCT00667420|471312180|FG000|Overall Study|Lack of Efficacy|5|||
130911479|NCT00667420|471312180|FG000|Overall Study|Physician Decision|1|||
130911480|NCT00667420|471312180|FG000|Overall Study|Withdrawal by Subject|2|||
130911481|NCT01982331|471312181|FG000|Received Vaccination 2|Adverse Event|1|||
130911482|NCT01982331|471312182|FG001|Received Vaccination 2|Adverse Event|2|||
130911483|NCT01982331|471312181|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
130911484|NCT01982331|471312182|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
130911485|NCT01982331|471312181|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
130911486|NCT01982331|471312182|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
131030895|NCT04737772|471747910|FG000|Phase 2 Study|Did not take any coaching calls|4|||
131030896|NCT04737772|471747911|FG001|Phase 2 Study|Did not take any coaching calls|0|||
131030897|NCT04737772|471747910|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
131030898|NCT04737772|471747911|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
131030899|NCT04737772|471747910|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
131030900|NCT04737772|471747911|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
131030901|NCT03090152|471747914|FG000|Overall Study|Withdrawal by Subject|0|||
131030902|NCT03090152|471747915|FG001|Overall Study|Withdrawal by Subject|2|||
131030903|NCT03090152|471747916|FG002|Overall Study|Withdrawal by Subject|1|||
131030904|NCT03090152|471747914|FG000|Overall Study|Surgery Canceled|1|||
131030905|NCT03090152|471747915|FG001|Overall Study|Surgery Canceled|0|||
131030906|NCT03090152|471747916|FG002|Overall Study|Surgery Canceled|0|||
131030907|NCT03090152|471747914|FG000|Overall Study|Epidural catheter could not be placed|0|||
131030908|NCT03090152|471747915|FG001|Overall Study|Epidural catheter could not be placed|2|||
131030909|NCT03090152|471747916|FG002|Overall Study|Epidural catheter could not be placed|0|||
131030910|NCT02927769|471747917|FG000|Induction Phase|Study drug toxicity|1|||
131030911|NCT02927769|471747918|FG001|Induction Phase|Study drug toxicity|1|||
131030912|NCT02927769|471747917|FG000|Induction Phase|Disease progression|0|||
131030913|NCT02927769|471747918|FG001|Induction Phase|Disease progression|1|||
131030914|NCT02927769|471747917|FG000|Intensification Phase|Study drug toxicity|1|||
131030915|NCT02927769|471747918|FG001|Intensification Phase|Study drug toxicity|0|||
131030916|NCT02954341|471747919|FG000|Overall Study|Attempted Implant unsuccessful|5|||
131030917|NCT02954341|471747919|FG000|Overall Study|Death|90|||
131030918|NCT02954341|471747919|FG000|Overall Study|Withdrawal by Subject|4|||
131030919|NCT02954341|471747919|FG000|Overall Study|Physician Decision|13|||
131030920|NCT02954341|471747919|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
131030921|NCT02954341|471747919|FG000|Overall Study|Not implanted due to physician's decision|1|||
131030922|NCT02954341|471747919|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
131030923|NCT04024813|471747922|FG000|Overall Study|Study terminated by Sponsor|1|||
131030924|NCT02729311|471747923|FG000|Overall Study|Withdrawal by Subject|8|||
131030925|NCT02729311|471747924|FG001|Overall Study|Withdrawal by Subject|2|||
131030926|NCT04321031|471747929|FG000|Overall Study|Adverse Event|0|||
131030927|NCT04321031|471747930|FG001|Overall Study|Adverse Event|2|||
131030928|NCT04321031|471747931|FG002|Overall Study|Adverse Event|2|||
131030929|NCT04321031|471747932|FG003|Overall Study|Adverse Event|2|||
131030930|NCT04321031|471747933|FG004|Overall Study|Adverse Event|2|||
131030931|NCT04321031|471747934|FG005|Overall Study|Adverse Event|2|||
131030932|NCT04321031|471747935|FG006|Overall Study|Adverse Event|0|||
131030933|NCT04321031|471747929|FG000|Overall Study|Lost to Follow-up|0|||
131030934|NCT04321031|471747930|FG001|Overall Study|Lost to Follow-up|0|||
131030935|NCT04321031|471747931|FG002|Overall Study|Lost to Follow-up|0|||
131030936|NCT04321031|471747932|FG003|Overall Study|Lost to Follow-up|1|||
131030937|NCT04321031|471747933|FG004|Overall Study|Lost to Follow-up|0|||
131030938|NCT04321031|471747934|FG005|Overall Study|Lost to Follow-up|2|||
131030939|NCT04321031|471747935|FG006|Overall Study|Lost to Follow-up|1|||
131030940|NCT04321031|471747929|FG000|Overall Study|Withdrawal by Subject|2|||
131030941|NCT04321031|471747930|FG001|Overall Study|Withdrawal by Subject|2|||
131030942|NCT04321031|471747931|FG002|Overall Study|Withdrawal by Subject|1|||
131030943|NCT04321031|471747932|FG003|Overall Study|Withdrawal by Subject|3|||
131030944|NCT04321031|471747933|FG004|Overall Study|Withdrawal by Subject|1|||
130911487|NCT00591266|471312183|FG000|Overall Study|Adverse Event|2|||
130911488|NCT00591266|471312184|FG001|Overall Study|Adverse Event|2|||
130911489|NCT00591266|471312185|FG002|Overall Study|Adverse Event|3|||
130911490|NCT00591266|471312183|FG000|Overall Study|Lost to Follow-up|0|||
131030945|NCT04321031|471747934|FG005|Overall Study|Withdrawal by Subject|0|||
131030946|NCT04321031|471747935|FG006|Overall Study|Withdrawal by Subject|1|||
130911491|NCT00591266|471312184|FG001|Overall Study|Lost to Follow-up|1|||
130911492|NCT00591266|471312185|FG002|Overall Study|Lost to Follow-up|0|||
130911493|NCT00591266|471312183|FG000|Overall Study|Protocol Violation|0|||
130911494|NCT00591266|471312184|FG001|Overall Study|Protocol Violation|0|||
130911495|NCT00591266|471312185|FG002|Overall Study|Protocol Violation|1|||
130911496|NCT00591266|471312183|FG000|Overall Study|Withdrawal by Subject|6|||
130911497|NCT00591266|471312184|FG001|Overall Study|Withdrawal by Subject|2|||
130911498|NCT00591266|471312185|FG002|Overall Study|Withdrawal by Subject|5|||
130911499|NCT00591266|471312183|FG000|Overall Study|Lack of Efficacy|0|||
130911500|NCT00591266|471312184|FG001|Overall Study|Lack of Efficacy|2|||
130911501|NCT00591266|471312185|FG002|Overall Study|Lack of Efficacy|0|||
130911502|NCT00591266|471312183|FG000|Overall Study|Other|1|||
130911503|NCT00591266|471312184|FG001|Overall Study|Other|4|||
130911504|NCT00591266|471312185|FG002|Overall Study|Other|5|||
130911505|NCT03488927|471312186|FG000|Overall Study|Withdrawal by Subject|44|||
130911506|NCT03488927|471312187|FG001|Overall Study|Withdrawal by Subject|118|||
130911507|NCT03488927|471312188|FG002|Overall Study|Withdrawal by Subject|217|||
130911508|NCT00901927|471312191|FG000|Overall Study|Lack of Efficacy|1|||
130911509|NCT00901927|471312191|FG000|Overall Study|Protocol Violation|3|||
130911510|NCT00901927|471312191|FG000|Overall Study|Withdrawal by Subject|2|||
130911511|NCT05298306|471312194|FG000|Overall Study|Physician Decision|0|||
130911512|NCT05298306|471312195|FG001|Overall Study|Physician Decision|0|||
130911513|NCT05298306|471312196|FG002|Overall Study|Physician Decision|0|||
130911514|NCT05298306|471312197|FG003|Overall Study|Physician Decision|1|||
130911515|NCT05298306|471312198|FG004|Overall Study|Physician Decision|0|||
130911516|NCT05298306|471312199|FG005|Overall Study|Physician Decision|0|||
130911517|NCT02676466|471312201|FG000|Overall Study|Death|0|||
130911518|NCT02676466|471312202|FG001|Overall Study|Death|2|||
130911519|NCT02676466|471312203|FG002|Overall Study|Death|1|||
130911520|NCT02676466|471312204|FG003|Overall Study|Death|0|||
130911521|NCT02676466|471312205|FG004|Overall Study|Death|0|||
130911522|NCT02676466|471312206|FG005|Overall Study|Death|0|||
130911523|NCT02676466|471312207|FG006|Overall Study|Death|0|||
130911524|NCT02676466|471312208|FG007|Overall Study|Death|0|||
130911525|NCT02676466|471312201|FG000|Overall Study|Withdrawal by Subject|4|||
130911526|NCT02676466|471312202|FG001|Overall Study|Withdrawal by Subject|3|||
130911527|NCT02676466|471312203|FG002|Overall Study|Withdrawal by Subject|1|||
130911528|NCT02676466|471312204|FG003|Overall Study|Withdrawal by Subject|0|||
130911529|NCT02676466|471312205|FG004|Overall Study|Withdrawal by Subject|3|||
130911530|NCT02676466|471312206|FG005|Overall Study|Withdrawal by Subject|1|||
130911531|NCT02676466|471312207|FG006|Overall Study|Withdrawal by Subject|1|||
130911532|NCT02676466|471312208|FG007|Overall Study|Withdrawal by Subject|1|||
130911533|NCT01178073|471312210|FG000|Overall Study|Adverse Event|34|||
130911534|NCT01178073|471312211|FG001|Overall Study|Adverse Event|27|||
130911535|NCT01178073|471312212|FG002|Overall Study|Adverse Event|24|||
130911536|NCT01178073|471312210|FG000|Overall Study|Protocol Violation|1|||
130911537|NCT01178073|471312211|FG001|Overall Study|Protocol Violation|1|||
130911538|NCT01178073|471312212|FG002|Overall Study|Protocol Violation|1|||
130911539|NCT01178073|471312210|FG000|Overall Study|Lost to Follow-up|2|||
130911540|NCT01178073|471312211|FG001|Overall Study|Lost to Follow-up|0|||
130911541|NCT01178073|471312212|FG002|Overall Study|Lost to Follow-up|3|||
130911542|NCT01178073|471312210|FG000|Overall Study|Physician Decision|14|||
131116805|NCT00108069|472059396|FG000|Overall Study|Withdrawal by Subject|1|||
131116806|NCT00108069|472059397|FG001|Overall Study|Withdrawal by Subject|0|||
131116807|NCT00108069|472059396|FG000|Overall Study|Death|1|||
131116808|NCT00108069|472059397|FG001|Overall Study|Death|0|||
131116809|NCT00108069|472059396|FG000|Overall Study|Progessive disease|27|||
131116810|NCT00108069|472059397|FG001|Overall Study|Progessive disease|11|||
131116811|NCT00995007|472059398|FG000|Overall Study|Withdrew consent|1|||
131116812|NCT00995007|472059399|FG001|Overall Study|Withdrew consent|0|||
131116813|NCT00995007|472059398|FG000|Overall Study|Refused further treatment|8|||
131116814|NCT00995007|472059399|FG001|Overall Study|Refused further treatment|2|||
130911543|NCT01178073|471312211|FG001|Overall Study|Physician Decision|10|||
130911544|NCT01178073|471312212|FG002|Overall Study|Physician Decision|10|||
130911545|NCT01178073|471312210|FG000|Overall Study|Withdrawal by Subject|10|||
130911546|NCT01178073|471312211|FG001|Overall Study|Withdrawal by Subject|6|||
130911547|NCT01178073|471312212|FG002|Overall Study|Withdrawal by Subject|8|||
131116815|NCT00995007|472059398|FG000|Overall Study|Toxicity|8|||
131116816|NCT00995007|472059399|FG001|Overall Study|Toxicity|0|||
131116817|NCT00882310|472059402|FG000|Overall Study|Screen Failure|10|||
130911548|NCT01178073|471312210|FG000|Overall Study|Missing Completion Status|1|||
130911549|NCT01178073|471312211|FG001|Overall Study|Missing Completion Status|0|||
130911550|NCT01178073|471312212|FG002|Overall Study|Missing Completion Status|0|||
130911551|NCT01721070|471312215|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
130911552|NCT03497676|471312216|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
130911553|NCT03497676|471312217|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
130911554|NCT03497676|471312218|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
130911555|NCT03497676|471312219|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
131116818|NCT00882310|472059402|FG000|Overall Study|Never received treatment|1|||
130911556|NCT03497676|471312216|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
130911557|NCT03497676|471312217|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
130911558|NCT03497676|471312218|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
130911559|NCT03497676|471312219|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
130911560|NCT03497676|471312216|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
130911561|NCT03497676|471312217|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
130911562|NCT03497676|471312218|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
130911563|NCT03497676|471312219|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
130911564|NCT03497676|471312216|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
130911565|NCT03497676|471312217|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
130911566|NCT03497676|471312218|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
130911567|NCT03497676|471312219|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
130911568|NCT03497676|471312216|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
130911569|NCT03497676|471312217|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
130911570|NCT03497676|471312218|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
130911571|NCT03497676|471312219|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
130911572|NCT03497676|471312216|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
130911573|NCT03497676|471312217|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
130911574|NCT03497676|471312218|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
130911575|NCT03497676|471312219|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
130911576|NCT03497676|471312216|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
130911577|NCT03497676|471312217|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
130911578|NCT03497676|471312218|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
130911579|NCT03497676|471312219|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
130911580|NCT03497676|471312216|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
130911581|NCT03497676|471312217|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
130911582|NCT03497676|471312218|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
130911583|NCT03497676|471312219|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
130911584|NCT01226043|471312229|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
130911585|NCT01226043|471312230|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
130911586|NCT01226043|471312231|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
130911587|NCT01226043|471312232|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
130911588|NCT01226043|471312229|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
130911589|NCT01226043|471312230|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
130911590|NCT01226043|471312231|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
130911591|NCT01226043|471312232|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
130911592|NCT01226043|471312229|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
130911593|NCT01226043|471312230|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
130911594|NCT01226043|471312231|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
130911595|NCT01226043|471312232|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
130911596|NCT01226043|471312229|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
130911597|NCT01226043|471312230|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
130911598|NCT01226043|471312231|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
130911599|NCT01226043|471312232|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
130911600|NCT01226043|471312229|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
130911601|NCT01226043|471312230|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
130911602|NCT01226043|471312231|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
130911603|NCT01226043|471312232|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
130911604|NCT01226043|471312229|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
130911605|NCT01226043|471312230|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
130911606|NCT01226043|471312231|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
130911607|NCT01226043|471312232|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
130911608|NCT01226043|471312229|FG000|6-week Re-randomization Phase|Adverse Event|0|||
130911609|NCT01226043|471312230|FG001|6-week Re-randomization Phase|Adverse Event|0|||
130911610|NCT01226043|471312231|FG002|6-week Re-randomization Phase|Adverse Event|1|||
130911611|NCT01226043|471312232|FG003|6-week Re-randomization Phase|Adverse Event|1|||
130911612|NCT01226043|471312229|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
130911613|NCT01226043|471312230|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
130911614|NCT01226043|471312231|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
130911615|NCT01226043|471312232|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
130911616|NCT01226043|471312229|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
130911617|NCT01226043|471312230|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
130911618|NCT01226043|471312231|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
131116819|NCT00882310|472059402|FG000|Overall Study|Death|6|||
131116820|NCT00882310|472059402|FG000|Overall Study|Progression of disease|4|||
130911619|NCT01226043|471312232|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
130911620|NCT01226043|471312229|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
130911621|NCT01226043|471312230|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
130911622|NCT01226043|471312231|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
130911623|NCT01226043|471312232|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
130911624|NCT01226043|471312229|FG000|6-week Re-randomization Phase|Physician Decision|0|||
130911625|NCT01226043|471312230|FG001|6-week Re-randomization Phase|Physician Decision|0|||
130911626|NCT01226043|471312231|FG002|6-week Re-randomization Phase|Physician Decision|3|||
130911627|NCT01226043|471312232|FG003|6-week Re-randomization Phase|Physician Decision|2|||
130911628|NCT01226043|471312229|FG000|6-week Re-randomization Phase|completed in error|0|||
130911629|NCT01226043|471312230|FG001|6-week Re-randomization Phase|completed in error|0|||
130911630|NCT01226043|471312231|FG002|6-week Re-randomization Phase|completed in error|0|||
130911631|NCT01226043|471312232|FG003|6-week Re-randomization Phase|completed in error|1|||
130911632|NCT01226043|471312229|FG000|30-week Observational Phase|Adverse Event|0|||
130911633|NCT01226043|471312230|FG001|30-week Observational Phase|Adverse Event|0|||
130911634|NCT01226043|471312231|FG002|30-week Observational Phase|Adverse Event|1|||
130911635|NCT01226043|471312232|FG003|30-week Observational Phase|Adverse Event|1|||
130911636|NCT01226043|471312229|FG000|30-week Observational Phase|Protocol Violation|0|||
130911637|NCT01226043|471312230|FG001|30-week Observational Phase|Protocol Violation|0|||
130911638|NCT01226043|471312231|FG002|30-week Observational Phase|Protocol Violation|0|||
130911639|NCT01226043|471312232|FG003|30-week Observational Phase|Protocol Violation|1|||
130911640|NCT01226043|471312229|FG000|30-week Observational Phase|Lost to Follow-up|0|||
130911641|NCT01226043|471312230|FG001|30-week Observational Phase|Lost to Follow-up|0|||
130911642|NCT01226043|471312231|FG002|30-week Observational Phase|Lost to Follow-up|2|||
130911643|NCT01226043|471312232|FG003|30-week Observational Phase|Lost to Follow-up|2|||
130911644|NCT01226043|471312229|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
130911645|NCT01226043|471312230|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
130911646|NCT01226043|471312231|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
130911647|NCT01226043|471312232|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
130911648|NCT01226043|471312229|FG000|30-week Observational Phase|Physician Decision|0|||
130911649|NCT01226043|471312230|FG001|30-week Observational Phase|Physician Decision|0|||
130911650|NCT01226043|471312231|FG002|30-week Observational Phase|Physician Decision|2|||
130911651|NCT01226043|471312232|FG003|30-week Observational Phase|Physician Decision|2|||
130911652|NCT03004443|471312233|FG000|Overall Study|Pregnancy|0|||
130911653|NCT03004443|471312234|FG001|Overall Study|Pregnancy|1|||
130911654|NCT00191646|471312235|FG000|Overall Study|Toxicity|26|||
130911655|NCT00191646|471312236|FG001|Overall Study|Toxicity|37|||
130911656|NCT00191646|471312235|FG000|Overall Study|Disease Progression|5|||
130911657|NCT00191646|471312236|FG001|Overall Study|Disease Progression|6|||
130911658|NCT00191646|471312235|FG000|Overall Study|Physician Decision|20|||
130911659|NCT00191646|471312236|FG001|Overall Study|Physician Decision|11|||
130911660|NCT00191646|471312235|FG000|Overall Study|Withdrawal by Subject|58|||
130911661|NCT00191646|471312236|FG001|Overall Study|Withdrawal by Subject|39|||
130911662|NCT00191646|471312235|FG000|Overall Study|Protocol Violation|5|||
130911663|NCT00191646|471312236|FG001|Overall Study|Protocol Violation|7|||
130911664|NCT00191646|471312235|FG000|Overall Study|Death|6|||
130911665|NCT00191646|471312236|FG001|Overall Study|Death|8|||
130911666|NCT00191646|471312235|FG000|Overall Study|Other|33|||
130911667|NCT00191646|471312236|FG001|Overall Study|Other|34|||
130911668|NCT00191646|471312235|FG000|Overall Study|Missing Data|18|||
130911669|NCT00191646|471312236|FG001|Overall Study|Missing Data|11|||
130911670|NCT05211284|471312241|FG000|Overall Study|Study Terminated|3|||
130911671|NCT05211284|471312242|FG001|Overall Study|Study Terminated|1|||
130911672|NCT03911843|471312243|FG000|Overall Study|Adverse Event|2|||
130911673|NCT03911843|471312244|FG001|Overall Study|Adverse Event|0|||
130911674|NCT03911843|471312243|FG000|Overall Study|Protocol Violation|2|||
130911675|NCT03911843|471312244|FG001|Overall Study|Protocol Violation|0|||
130911676|NCT03911843|471312243|FG000|Overall Study|Lost to Follow-up|0|||
130911677|NCT03911843|471312244|FG001|Overall Study|Lost to Follow-up|1|||
130911678|NCT01907100|471312245|FG000|Overall Study|PD based on modified RECIST criteria|31|||
130696836|NCT02611323|470514510|FG001|Overall Study|Withdrawal by Subject|0|||
130911679|NCT01907100|471312246|FG001|Overall Study|PD based on modified RECIST criteria|32|||
130911680|NCT01907100|471312247|FG002|Overall Study|PD based on modified RECIST criteria|95|||
130696837|NCT02611323|470514511|FG002|Overall Study|Withdrawal by Subject|0|||
130911681|NCT01907100|471312248|FG003|Overall Study|PD based on modified RECIST criteria|92|||
130911682|NCT01907100|471312245|FG000|Overall Study|Withdrawal by Subject|2|||
130911683|NCT01907100|471312246|FG001|Overall Study|Withdrawal by Subject|5|||
130911684|NCT01907100|471312247|FG002|Overall Study|Withdrawal by Subject|10|||
130696838|NCT02611323|470514512|FG003|Overall Study|Withdrawal by Subject|0|||
130911685|NCT01907100|471312248|FG003|Overall Study|Withdrawal by Subject|13|||
130911686|NCT01907100|471312245|FG000|Overall Study|Protocol Violation|0|||
130911687|NCT01907100|471312246|FG001|Overall Study|Protocol Violation|0|||
130911688|NCT01907100|471312247|FG002|Overall Study|Protocol Violation|1|||
130911689|NCT01907100|471312248|FG003|Overall Study|Protocol Violation|1|||
130768809|NCT04122625|470778591|FG004|Part A (up to 2.92 Years)|Death|0|||
130911690|NCT01907100|471312245|FG000|Overall Study|Lost to Follow-up|0|||
130911691|NCT01907100|471312246|FG001|Overall Study|Lost to Follow-up|0|||
130911692|NCT01907100|471312247|FG002|Overall Study|Lost to Follow-up|0|||
130911693|NCT01907100|471312248|FG003|Overall Study|Lost to Follow-up|1|||
130911694|NCT01907100|471312245|FG000|Overall Study|Not treated|2|||
130911695|NCT01907100|471312246|FG001|Overall Study|Not treated|0|||
130911696|NCT01907100|471312247|FG002|Overall Study|Not treated|1|||
130911697|NCT01907100|471312248|FG003|Overall Study|Not treated|2|||
130911698|NCT01907100|471312245|FG000|Overall Study|Other than reasons specified|1|||
130911699|NCT01907100|471312246|FG001|Overall Study|Other than reasons specified|0|||
130911700|NCT01907100|471312247|FG002|Overall Study|Other than reasons specified|10|||
130911701|NCT01907100|471312248|FG003|Overall Study|Other than reasons specified|6|||
130911702|NCT01907100|471312245|FG000|Overall Study|Adverse event (AE)|6|||
130911703|NCT01907100|471312246|FG001|Overall Study|Adverse event (AE)|3|||
130911704|NCT01907100|471312247|FG002|Overall Study|Adverse event (AE)|22|||
130911705|NCT01907100|471312248|FG003|Overall Study|Adverse event (AE)|23|||
130911706|NCT01907100|471312245|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
130911707|NCT01907100|471312246|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
130911708|NCT01907100|471312247|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
130911709|NCT01907100|471312248|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
130911710|NCT00644228|471312249|FG000|Randomization & Eligibility|Ineligible|31|||
130911711|NCT00644228|471312250|FG001|Randomization & Eligibility|Ineligible|21|||
130911712|NCT00644228|471312249|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
130911713|NCT00644228|471312250|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
130911714|NCT00644228|471312249|FG000|Randomization & Eligibility|Invalid Consent|0|||
130911715|NCT00644228|471312250|FG001|Randomization & Eligibility|Invalid Consent|1|||
130911716|NCT00644228|471312249|FG000|Induction Therapy|Adverse Event|22|||
130911717|NCT00644228|471312250|FG001|Induction Therapy|Adverse Event|55|||
130911718|NCT00644228|471312249|FG000|Induction Therapy|Withdrawal by Subject|10|||
130911719|NCT00644228|471312250|FG001|Induction Therapy|Withdrawal by Subject|3|||
130911720|NCT00644228|471312249|FG000|Induction Therapy|Progression/Relapse|24|||
130911721|NCT00644228|471312250|FG001|Induction Therapy|Progression/Relapse|12|||
130911722|NCT00644228|471312249|FG000|Induction Therapy|Death|3|||
130911723|NCT00644228|471312250|FG001|Induction Therapy|Death|7|||
130911724|NCT00644228|471312249|FG000|Induction Therapy|Not Protocol-Specified|24|||
130911725|NCT00644228|471312250|FG001|Induction Therapy|Not Protocol-Specified|28|||
130911726|NCT00644228|471312249|FG000|Maintenance|Adverse Event|27|||
130911727|NCT00644228|471312250|FG001|Maintenance|Adverse Event|31|||
130911728|NCT00644228|471312249|FG000|Maintenance|Withdrawal by Subject|6|||
130911729|NCT00644228|471312250|FG001|Maintenance|Withdrawal by Subject|4|||
130911730|NCT00644228|471312249|FG000|Maintenance|Progression/Relapse|67|||
130911731|NCT00644228|471312250|FG001|Maintenance|Progression/Relapse|42|||
130911732|NCT00644228|471312249|FG000|Maintenance|Death|3|||
130911733|NCT00644228|471312250|FG001|Maintenance|Death|3|||
130911734|NCT00644228|471312249|FG000|Maintenance|Not Protocol-Specified|14|||
130911735|NCT00644228|471312250|FG001|Maintenance|Not Protocol-Specified|15|||
130911736|NCT00644228|471312249|FG000|Maintenance|On Treatment|26|||
130911737|NCT00644228|471312250|FG001|Maintenance|On Treatment|40|||
130911738|NCT00760084|471312251|FG000|Overall Study|Physician Decision|5|||
130911739|NCT00760084|471312251|FG000|Overall Study|Withdrawal by Subject|2|||
130911740|NCT00760084|471312251|FG000|Overall Study|Progressive Disease|3|||
130911741|NCT05419908|471312253|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
130911742|NCT05419908|471312254|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
130911743|NCT05419908|471312253|FG000|Overall Study|Serious Adverse Event|0|||
130911744|NCT05419908|471312254|FG001|Overall Study|Serious Adverse Event|2|||
130911745|NCT05419908|471312253|FG000|Overall Study|Withdrawal by Subject|2|||
130911746|NCT05419908|471312254|FG001|Overall Study|Withdrawal by Subject|0|||
130911747|NCT05419908|471312253|FG000|Overall Study|Miscellaneous|1|||
130911748|NCT05419908|471312254|FG001|Overall Study|Miscellaneous|1|||
130911749|NCT03906461|471313814|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
130911750|NCT03906461|471313814|FG000|Completed 12-month Follow-up|Missed Visit|6|||
130911751|NCT04622735|471313815|FG000|Overall Study|Lost to Follow-up|1|||
130911752|NCT04622735|471313816|FG001|Overall Study|Lost to Follow-up|2|||
130911753|NCT04622735|471313817|FG002|Overall Study|Lost to Follow-up|1|||
130911754|NCT04622735|471313815|FG000|Overall Study|Adverse Event|0|||
130911755|NCT04622735|471313816|FG001|Overall Study|Adverse Event|0|||
130911756|NCT04622735|471313817|FG002|Overall Study|Adverse Event|1|||
130911757|NCT04622735|471313815|FG000|Overall Study|Protocol Violation|1|||
130911758|NCT04622735|471313816|FG001|Overall Study|Protocol Violation|0|||
130911759|NCT04622735|471313817|FG002|Overall Study|Protocol Violation|0|||
130911760|NCT04073368|471313818|FG000|Overall Study|Adverse Event|2|||
130911761|NCT04073368|471313819|FG001|Overall Study|Adverse Event|0|||
130911762|NCT04073368|471313820|FG002|Overall Study|Adverse Event|1|||
130911763|NCT04073368|471313821|FG003|Overall Study|Adverse Event|1|||
131030947|NCT04321031|471747929|FG000|Overall Study|Non-compliance with study drug|0|||
131030948|NCT04321031|471747930|FG001|Overall Study|Non-compliance with study drug|0|||
131030949|NCT04321031|471747931|FG002|Overall Study|Non-compliance with study drug|0|||
130911764|NCT04073368|471313818|FG000|Overall Study|Withdrawal by Subject|2|||
130911765|NCT04073368|471313819|FG001|Overall Study|Withdrawal by Subject|2|||
130911766|NCT04073368|471313820|FG002|Overall Study|Withdrawal by Subject|1|||
130911767|NCT04073368|471313821|FG003|Overall Study|Withdrawal by Subject|1|||
130911768|NCT04073368|471313818|FG000|Overall Study|Lost to Follow-up|1|||
130911769|NCT04073368|471313819|FG001|Overall Study|Lost to Follow-up|1|||
130911770|NCT04073368|471313820|FG002|Overall Study|Lost to Follow-up|1|||
130911771|NCT04073368|471313821|FG003|Overall Study|Lost to Follow-up|0|||
130911772|NCT04073368|471313818|FG000|Overall Study|Protocol Violation|0|||
130911773|NCT04073368|471313819|FG001|Overall Study|Protocol Violation|1|||
130911774|NCT04073368|471313820|FG002|Overall Study|Protocol Violation|0|||
130911775|NCT04073368|471313821|FG003|Overall Study|Protocol Violation|0|||
130911776|NCT04073368|471313818|FG000|Overall Study|Subject noncompliance|7|||
130911777|NCT04073368|471313819|FG001|Overall Study|Subject noncompliance|4|||
130911778|NCT04073368|471313820|FG002|Overall Study|Subject noncompliance|0|||
130911779|NCT04073368|471313821|FG003|Overall Study|Subject noncompliance|0|||
130911780|NCT01251744|471313825|FG000|Overall Study|Lost to Follow-up|1|||
130911781|NCT01251744|471313826|FG001|Overall Study|Lost to Follow-up|0|||
130911782|NCT01068652|471313827|FG000|Overall Study|Adverse Event|4|||
130911783|NCT01068652|471313828|FG001|Overall Study|Adverse Event|0|||
130911784|NCT01068652|471313827|FG000|Overall Study|Lack of Efficacy|0|||
130911785|NCT01068652|471313828|FG001|Overall Study|Lack of Efficacy|2|||
130911786|NCT01068652|471313827|FG000|Overall Study|Lost to Follow-up|2|||
130911787|NCT01068652|471313828|FG001|Overall Study|Lost to Follow-up|1|||
130911788|NCT01068652|471313827|FG000|Overall Study|Protocol Violation|3|||
130911789|NCT01068652|471313828|FG001|Overall Study|Protocol Violation|6|||
130911790|NCT01068652|471313827|FG000|Overall Study|Withdrawal criteria|1|||
130911791|NCT01068652|471313828|FG001|Overall Study|Withdrawal criteria|2|||
130911792|NCT01068652|471313827|FG000|Overall Study|Patient was not eligible|1|||
130911793|NCT01068652|471313828|FG001|Overall Study|Patient was not eligible|0|||
130911794|NCT01068652|471313827|FG000|Overall Study|Unclassified|7|||
130911795|NCT01068652|471313828|FG001|Overall Study|Unclassified|4|||
130911796|NCT02694523|471313829|FG000|Part A|Adverse Event|7|||
130911797|NCT02694523|471313830|FG001|Part A|Adverse Event|3|||
130911798|NCT02694523|471313831|FG002|Part A|Adverse Event|0|||
130911799|NCT02694523|471313832|FG003|Part A|Adverse Event|0|||
130911800|NCT02694523|471313833|FG004|Part A|Adverse Event|0|||
130911801|NCT02694523|471313834|FG005|Part A|Adverse Event|0|||
130911802|NCT02694523|471313835|FG006|Part A|Adverse Event|0|||
130911803|NCT02694523|471313829|FG000|Part A|Protocol Violation|1|||
130911804|NCT02694523|471313830|FG001|Part A|Protocol Violation|0|||
130911805|NCT02694523|471313831|FG002|Part A|Protocol Violation|0|||
130911806|NCT02694523|471313832|FG003|Part A|Protocol Violation|0|||
130911807|NCT02694523|471313833|FG004|Part A|Protocol Violation|0|||
130911808|NCT02694523|471313834|FG005|Part A|Protocol Violation|0|||
130911809|NCT02694523|471313835|FG006|Part A|Protocol Violation|0|||
130911810|NCT02694523|471313829|FG000|Part A|Lost to Follow-up|1|||
130911811|NCT02694523|471313830|FG001|Part A|Lost to Follow-up|2|||
130911812|NCT02694523|471313831|FG002|Part A|Lost to Follow-up|0|||
130911813|NCT02694523|471313832|FG003|Part A|Lost to Follow-up|0|||
130911814|NCT02694523|471313833|FG004|Part A|Lost to Follow-up|0|||
130911815|NCT02694523|471313834|FG005|Part A|Lost to Follow-up|0|||
130911816|NCT02694523|471313835|FG006|Part A|Lost to Follow-up|0|||
130696839|NCT02611323|470514513|FG004|Overall Study|Withdrawal by Subject|0|||
130696840|NCT02611323|470514514|FG005|Overall Study|Withdrawal by Subject|0|||
130696841|NCT02611323|470514515|FG006|Overall Study|Withdrawal by Subject|0|||
130696842|NCT02611323|470514516|FG007|Overall Study|Withdrawal by Subject|1|||
130696843|NCT02611323|470514517|FG008|Overall Study|Withdrawal by Subject|0|||
130696844|NCT02611323|470514518|FG009|Overall Study|Withdrawal by Subject|1|||
130696845|NCT02611323|470514519|FG010|Overall Study|Withdrawal by Subject|0|||
130696846|NCT02597049|470514520|FG000|Overall Study|Lost to Follow-up|0|||
130911817|NCT02694523|471313829|FG000|Part A|Withdrawal by Subject|3|||
130911818|NCT02694523|471313830|FG001|Part A|Withdrawal by Subject|1|||
130911819|NCT02694523|471313831|FG002|Part A|Withdrawal by Subject|0|||
130768810|NCT04122625|470778592|FG005|Part A (up to 2.92 Years)|Death|0|||
130911820|NCT02694523|471313832|FG003|Part A|Withdrawal by Subject|0|||
130911821|NCT02694523|471313833|FG004|Part A|Withdrawal by Subject|0|||
130911822|NCT02694523|471313834|FG005|Part A|Withdrawal by Subject|0|||
130911823|NCT02694523|471313835|FG006|Part A|Withdrawal by Subject|0|||
130911824|NCT02694523|471313829|FG000|Part A|Other|1|||
130911825|NCT02694523|471313830|FG001|Part A|Other|1|||
130911826|NCT02694523|471313831|FG002|Part A|Other|0|||
130911827|NCT02694523|471313832|FG003|Part A|Other|0|||
130911828|NCT02694523|471313833|FG004|Part A|Other|0|||
130911829|NCT02694523|471313834|FG005|Part A|Other|0|||
130911830|NCT02694523|471313835|FG006|Part A|Other|0|||
130696847|NCT02597049|470514521|FG001|Overall Study|Lost to Follow-up|3|||
130696848|NCT02597049|470514522|FG002|Overall Study|Lost to Follow-up|2|||
130911831|NCT02694523|471313829|FG000|Part B|Adverse Event|0|||
130911832|NCT02694523|471313830|FG001|Part B|Adverse Event|0|||
130911833|NCT02694523|471313831|FG002|Part B|Adverse Event|7|||
130911834|NCT02694523|471313832|FG003|Part B|Adverse Event|1|||
130911835|NCT02694523|471313833|FG004|Part B|Adverse Event|1|||
130911836|NCT02694523|471313834|FG005|Part B|Adverse Event|2|||
130911837|NCT02694523|471313835|FG006|Part B|Adverse Event|0|||
130911838|NCT02694523|471313829|FG000|Part B|Protocol Violation|0|||
130911839|NCT02694523|471313830|FG001|Part B|Protocol Violation|0|||
130911840|NCT02694523|471313831|FG002|Part B|Protocol Violation|1|||
130911841|NCT02694523|471313832|FG003|Part B|Protocol Violation|0|||
130911842|NCT02694523|471313833|FG004|Part B|Protocol Violation|0|||
130911843|NCT02694523|471313834|FG005|Part B|Protocol Violation|0|||
130911844|NCT02694523|471313835|FG006|Part B|Protocol Violation|0|||
130911845|NCT02694523|471313829|FG000|Part B|Lost to Follow-up|0|||
130911846|NCT02694523|471313830|FG001|Part B|Lost to Follow-up|0|||
130911847|NCT02694523|471313831|FG002|Part B|Lost to Follow-up|2|||
130911848|NCT02694523|471313832|FG003|Part B|Lost to Follow-up|3|||
130911849|NCT02694523|471313833|FG004|Part B|Lost to Follow-up|2|||
130911850|NCT02694523|471313834|FG005|Part B|Lost to Follow-up|0|||
130911851|NCT02694523|471313835|FG006|Part B|Lost to Follow-up|1|||
130911852|NCT02694523|471313829|FG000|Part B|Withdrawal by Subject|0|||
130911853|NCT02694523|471313830|FG001|Part B|Withdrawal by Subject|0|||
130911854|NCT02694523|471313831|FG002|Part B|Withdrawal by Subject|9|||
130911855|NCT02694523|471313832|FG003|Part B|Withdrawal by Subject|0|||
130911856|NCT02694523|471313833|FG004|Part B|Withdrawal by Subject|1|||
130911857|NCT02694523|471313834|FG005|Part B|Withdrawal by Subject|3|||
130911858|NCT02694523|471313835|FG006|Part B|Withdrawal by Subject|0|||
130911859|NCT02694523|471313829|FG000|Part B|Other|0|||
130911860|NCT02694523|471313830|FG001|Part B|Other|0|||
130911861|NCT02694523|471313831|FG002|Part B|Other|1|||
130911862|NCT02694523|471313832|FG003|Part B|Other|0|||
130911863|NCT02694523|471313833|FG004|Part B|Other|0|||
130911864|NCT02694523|471313834|FG005|Part B|Other|0|||
130911865|NCT02694523|471313835|FG006|Part B|Other|1|||
130911866|NCT04505540|471313838|FG000|Baseline|Protocol Violation|10|||
130911867|NCT04505540|471313838|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
130911868|NCT04505540|471313838|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
130911869|NCT04505540|471313838|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
130911870|NCT04505540|471313838|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
130911871|NCT04505540|471313838|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
130911872|NCT04505540|471313838|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
130911873|NCT04505540|471313838|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
130911874|NCT04505540|471313838|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
131116821|NCT00882310|472059402|FG000|Overall Study|Adverse Event|1|||
131116822|NCT02733185|472059408|FG000|Overall Study|Withdrawal by Subject|12|||
131116823|NCT02733185|472059409|FG001|Overall Study|Withdrawal by Subject|10|||
131116824|NCT02733185|472059410|FG002|Overall Study|Withdrawal by Subject|17|||
131116825|NCT02733185|472059411|FG003|Overall Study|Withdrawal by Subject|21|||
131116826|NCT02733185|472059408|FG000|Overall Study|Death|46|||
131116827|NCT02733185|472059409|FG001|Overall Study|Death|34|||
131116828|NCT02733185|472059410|FG002|Overall Study|Death|35|||
131116829|NCT02733185|472059411|FG003|Overall Study|Death|43|||
131116830|NCT02733185|472059408|FG000|Overall Study|Lost to Follow-up|17|||
131116831|NCT02733185|472059409|FG001|Overall Study|Lost to Follow-up|18|||
131116832|NCT02733185|472059410|FG002|Overall Study|Lost to Follow-up|16|||
131116833|NCT02733185|472059411|FG003|Overall Study|Lost to Follow-up|11|||
131116834|NCT01624259|472059412|FG000|Overall Study|Adverse Event|18|||
131116835|NCT01624259|472059413|FG001|Overall Study|Adverse Event|18|||
131116836|NCT01624259|472059412|FG000|Overall Study|Protocol Violation|1|||
131116837|NCT01624259|472059413|FG001|Overall Study|Protocol Violation|2|||
131116838|NCT01624259|472059412|FG000|Overall Study|Withdrawal by Subject|5|||
131116839|NCT01624259|472059413|FG001|Overall Study|Withdrawal by Subject|7|||
131116840|NCT01624259|472059412|FG000|Overall Study|Physician Decision|1|||
131116841|NCT01624259|472059413|FG001|Overall Study|Physician Decision|1|||
131116842|NCT01624259|472059412|FG000|Overall Study|Lost to Follow-up|2|||
131116843|NCT01624259|472059413|FG001|Overall Study|Lost to Follow-up|3|||
130911875|NCT04505540|471313838|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
131116844|NCT01624259|472059412|FG000|Overall Study|Abnormal laboratory measure|3|||
130911876|NCT04505540|471313838|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
130911877|NCT04505540|471313838|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
130911878|NCT04505540|471313838|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
130911879|NCT01698905|471313839|FG000|Overall Study|Adverse Event|4|||
130911880|NCT01698905|471313839|FG000|Overall Study|Physician Decision|2|||
130911881|NCT01698905|471313839|FG000|Overall Study|Pregnancy|1|||
130911882|NCT01698905|471313839|FG000|Overall Study|Protocol Violation|1|||
131116845|NCT01624259|472059413|FG001|Overall Study|Abnormal laboratory measure|0|||
130911883|NCT01698905|471313839|FG000|Overall Study|Subject/guardian decision|2|||
130911884|NCT01698905|471313839|FG000|Overall Study|Death|1|||
130911885|NCT05896748|471313840|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
130911886|NCT05896748|471313840|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
131116846|NCT03828292|472059414|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
131116847|NCT03828292|472059415|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
131116848|NCT03828292|472059416|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130911887|NCT05896748|471313840|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
130911888|NCT05896748|471313840|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
130911889|NCT05896748|471313840|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
130911890|NCT02325791|471313843|FG000|Overall Study|Adverse Event|0|||
130911891|NCT02325791|471313844|FG001|Overall Study|Adverse Event|1|||
130911892|NCT02325791|471313845|FG002|Overall Study|Adverse Event|1|||
130911893|NCT02325791|471313846|FG003|Overall Study|Adverse Event|0|||
130911894|NCT02325791|471313843|FG000|Overall Study|Death|0|||
130911895|NCT02325791|471313844|FG001|Overall Study|Death|3|||
130911896|NCT02325791|471313845|FG002|Overall Study|Death|0|||
130911897|NCT02325791|471313846|FG003|Overall Study|Death|1|||
130911898|NCT02325791|471313843|FG000|Overall Study|Lost to Follow-up|0|||
130911899|NCT02325791|471313844|FG001|Overall Study|Lost to Follow-up|15|||
130911900|NCT02325791|471313845|FG002|Overall Study|Lost to Follow-up|14|||
130911901|NCT02325791|471313846|FG003|Overall Study|Lost to Follow-up|9|||
130911902|NCT02325791|471313843|FG000|Overall Study|Physician Decision|0|||
130911903|NCT02325791|471313844|FG001|Overall Study|Physician Decision|1|||
130911904|NCT02325791|471313845|FG002|Overall Study|Physician Decision|1|||
130911905|NCT02325791|471313846|FG003|Overall Study|Physician Decision|0|||
130911906|NCT02325791|471313843|FG000|Overall Study|Protocol Violation|0|||
130911907|NCT02325791|471313844|FG001|Overall Study|Protocol Violation|0|||
130911908|NCT02325791|471313845|FG002|Overall Study|Protocol Violation|1|||
130911909|NCT02325791|471313846|FG003|Overall Study|Protocol Violation|0|||
130911910|NCT02325791|471313843|FG000|Overall Study|Withdrawal by Subject|0|||
130911911|NCT02325791|471313844|FG001|Overall Study|Withdrawal by Subject|5|||
130911912|NCT02325791|471313845|FG002|Overall Study|Withdrawal by Subject|8|||
130911913|NCT02325791|471313846|FG003|Overall Study|Withdrawal by Subject|16|||
130911914|NCT03309046|471313847|FG000|Overall Study|Withdrawal by Subject|4|||
130911915|NCT03309046|471313848|FG001|Overall Study|Withdrawal by Subject|17|||
130911916|NCT00089674|471313850|FG000|Overall Study|Physician Decision|4|||
130911917|NCT00089674|471313851|FG001|Overall Study|Physician Decision|2|||
130911918|NCT00089674|471313850|FG000|Overall Study|Adverse Event|23|||
130911919|NCT00089674|471313851|FG001|Overall Study|Adverse Event|29|||
130911920|NCT00089674|471313850|FG000|Overall Study|Withdrawal by Subject|143|||
130911921|NCT00089674|471313851|FG001|Overall Study|Withdrawal by Subject|127|||
130911922|NCT00089674|471313850|FG000|Overall Study|Death|43|||
130911923|NCT00089674|471313851|FG001|Overall Study|Death|43|||
130911924|NCT00089674|471313850|FG000|Overall Study|Disease progression|21|||
130911925|NCT00089674|471313851|FG001|Overall Study|Disease progression|23|||
130911926|NCT00089674|471313850|FG000|Overall Study|Ineligibility determined|8|||
130911927|NCT00089674|471313851|FG001|Overall Study|Ineligibility determined|10|||
130911928|NCT00089674|471313850|FG000|Overall Study|Lost to Follow-up|21|||
130911929|NCT00089674|471313851|FG001|Overall Study|Lost to Follow-up|17|||
130911930|NCT00089674|471313850|FG000|Overall Study|Noncompliance|7|||
130911931|NCT00089674|471313851|FG001|Overall Study|Noncompliance|3|||
130911932|NCT00089674|471313850|FG000|Overall Study|Other|5|||
130911933|NCT00089674|471313851|FG001|Overall Study|Other|9|||
130911934|NCT00089674|471313850|FG000|Overall Study|Requirement for alternative therapy|14|||
130911935|NCT00089674|471313851|FG001|Overall Study|Requirement for alternative therapy|4|||
130911936|NCT03963401|471313852|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
130911937|NCT03963401|471313853|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
130911938|NCT03963401|471313854|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
131116849|NCT03828292|472059417|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
131116850|NCT03828292|472059418|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
131116851|NCT03828292|472059419|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
131116852|NCT03828292|472059414|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
131116853|NCT03828292|472059415|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
131116854|NCT03828292|472059416|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
131116855|NCT03828292|472059417|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
131116856|NCT03828292|472059418|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
131116857|NCT03828292|472059419|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
131222825|NCT03674827|472443187|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
131222826|NCT03674827|472443188|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
130911939|NCT03963401|471313855|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
130911940|NCT03963401|471313856|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
130911941|NCT03963401|471313857|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
130911942|NCT03963401|471313852|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
130911943|NCT03963401|471313853|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
130911944|NCT03963401|471313854|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
130911945|NCT03963401|471313855|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
130911946|NCT03963401|471313856|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
130911947|NCT03963401|471313857|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
130911948|NCT03963401|471313852|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
131116858|NCT03828292|472059414|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130911949|NCT03963401|471313853|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
130911950|NCT03963401|471313854|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
130911951|NCT03963401|471313855|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
130911952|NCT03963401|471313856|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
130911953|NCT03963401|471313857|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
130911954|NCT03963401|471313852|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
130911955|NCT03963401|471313853|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
130911956|NCT03963401|471313854|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
130911957|NCT03963401|471313855|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
130911958|NCT03963401|471313856|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
130911959|NCT03963401|471313857|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
130911960|NCT03963401|471313852|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
130911961|NCT03963401|471313853|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
130911962|NCT03963401|471313854|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
130911963|NCT03963401|471313855|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
130911964|NCT03963401|471313856|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
130911965|NCT03963401|471313857|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
130911966|NCT03963401|471313852|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
130911967|NCT03963401|471313853|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
130911968|NCT03963401|471313854|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
130911969|NCT03963401|471313855|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
130911970|NCT03963401|471313856|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
130911971|NCT03963401|471313857|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
130911972|NCT03963401|471313852|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
130911973|NCT03963401|471313853|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
130911974|NCT03963401|471313854|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
130911975|NCT03963401|471313855|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
130911976|NCT03963401|471313856|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
130911977|NCT03963401|471313857|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
130911978|NCT03963401|471313852|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
130911979|NCT03963401|471313853|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
130911980|NCT03963401|471313854|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
130911981|NCT03963401|471313855|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
130911982|NCT03963401|471313856|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
130696849|NCT02597049|470514520|FG000|Overall Study|Withdrawal by Subject|2|||
130911983|NCT03963401|471313857|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
130911984|NCT03963401|471313852|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
130911985|NCT03963401|471313853|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
130911986|NCT03963401|471313854|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
130911987|NCT03963401|471313855|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
130911988|NCT03963401|471313856|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
130911989|NCT03963401|471313857|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
130911990|NCT03963401|471313852|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
130911991|NCT03963401|471313853|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
130911992|NCT03963401|471313854|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
130911993|NCT03963401|471313855|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
130911994|NCT03963401|471313856|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
130911995|NCT03963401|471313857|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
130911996|NCT03963401|471313852|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
130911997|NCT03963401|471313853|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
130911998|NCT03963401|471313854|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
130911999|NCT03963401|471313855|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
130912000|NCT03963401|471313856|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
131030950|NCT04321031|471747932|FG003|Overall Study|Non-compliance with study drug|0|||
131030951|NCT04321031|471747933|FG004|Overall Study|Non-compliance with study drug|0|||
131030952|NCT04321031|471747934|FG005|Overall Study|Non-compliance with study drug|1|||
131030953|NCT04321031|471747935|FG006|Overall Study|Non-compliance with study drug|0|||
131030954|NCT04321031|471747929|FG000|Overall Study|Other|0|||
131030955|NCT04321031|471747930|FG001|Overall Study|Other|0|||
131030956|NCT04321031|471747931|FG002|Overall Study|Other|0|||
131030957|NCT04321031|471747932|FG003|Overall Study|Other|1|||
131030958|NCT04321031|471747933|FG004|Overall Study|Other|0|||
130696850|NCT02597049|470514521|FG001|Overall Study|Withdrawal by Subject|2|||
130696851|NCT02597049|470514522|FG002|Overall Study|Withdrawal by Subject|1|||
130696852|NCT02597049|470514520|FG000|Overall Study|Adverse Event|2|||
130912001|NCT03963401|471313857|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
130912002|NCT01437878|471313858|FG000|Overall Study|Withdrawal by Subject|1|||
130912003|NCT01437878|471313859|FG001|Overall Study|Withdrawal by Subject|0|||
130912004|NCT01070043|471313860|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
130912005|NCT01070043|471313861|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
130912006|NCT01070043|471313862|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
130912007|NCT01070043|471313860|FG000|Double-Blind Treatment|Adverse Event|0|||
130912008|NCT01070043|471313861|FG001|Double-Blind Treatment|Adverse Event|0|||
130912009|NCT01070043|471313862|FG002|Double-Blind Treatment|Adverse Event|2|||
130912010|NCT00473746|471313864|FG000|Period 1 (Phase 1)|Adverse Event|1|||
130912011|NCT00473746|471313865|FG001|Period 1 (Phase 1)|Adverse Event|0|||
130912012|NCT00473746|471313866|FG002|Period 1 (Phase 1)|Adverse Event|0|||
130912013|NCT00473746|471313867|FG003|Period 1 (Phase 1)|Adverse Event|0|||
130912014|NCT00473746|471313868|FG004|Period 1 (Phase 1)|Adverse Event|0|||
130912015|NCT00473746|471313864|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
130912016|NCT00473746|471313865|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
130912017|NCT00473746|471313866|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
130912018|NCT00473746|471313867|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
131116859|NCT03828292|472059415|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130912019|NCT00473746|471313868|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
130912020|NCT00473746|471313864|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
130912021|NCT00473746|471313865|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
130912022|NCT00473746|471313866|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
131116860|NCT03828292|472059416|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
131116861|NCT03828292|472059417|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
131116862|NCT03828292|472059418|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
131116863|NCT03828292|472059419|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
131116864|NCT03828292|472059414|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
131116865|NCT03828292|472059415|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
131116866|NCT03828292|472059416|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
131116867|NCT03828292|472059417|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
130696853|NCT02597049|470514521|FG001|Overall Study|Adverse Event|0|||
130912023|NCT00473746|471313867|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
130912024|NCT00473746|471313868|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
130912025|NCT00473746|471313864|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
130912026|NCT00473746|471313865|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
130912027|NCT00473746|471313866|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
130912028|NCT00473746|471313867|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
130912029|NCT00473746|471313868|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
130912030|NCT00473746|471313864|FG000|Period 1 (Phase 1)|Reason not specified|0|||
130912031|NCT00473746|471313865|FG001|Period 1 (Phase 1)|Reason not specified|1|||
130912032|NCT00473746|471313866|FG002|Period 1 (Phase 1)|Reason not specified|0|||
130912033|NCT00473746|471313867|FG003|Period 1 (Phase 1)|Reason not specified|0|||
130912034|NCT00473746|471313868|FG004|Period 1 (Phase 1)|Reason not specified|0|||
130912035|NCT00473746|471313864|FG000|Period 2 (Phase 2)|Adverse Event|0|||
130912036|NCT00473746|471313865|FG001|Period 2 (Phase 2)|Adverse Event|0|||
130912037|NCT00473746|471313866|FG002|Period 2 (Phase 2)|Adverse Event|0|||
130912038|NCT00473746|471313867|FG003|Period 2 (Phase 2)|Adverse Event|0|||
130912039|NCT00473746|471313868|FG004|Period 2 (Phase 2)|Adverse Event|3|||
130912040|NCT00473746|471313864|FG000|Period 2 (Phase 2)|Death|0|||
130912041|NCT00473746|471313865|FG001|Period 2 (Phase 2)|Death|0|||
130912042|NCT00473746|471313866|FG002|Period 2 (Phase 2)|Death|0|||
130912043|NCT00473746|471313867|FG003|Period 2 (Phase 2)|Death|0|||
130912044|NCT00473746|471313868|FG004|Period 2 (Phase 2)|Death|1|||
130912045|NCT00473746|471313864|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
130912046|NCT00473746|471313865|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
130912047|NCT00473746|471313866|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
130912048|NCT00473746|471313867|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
130912049|NCT00473746|471313868|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
130912050|NCT00473746|471313864|FG000|Period 2 (Phase 2)|Reason not specified|0|||
130912051|NCT00473746|471313865|FG001|Period 2 (Phase 2)|Reason not specified|0|||
130912052|NCT00473746|471313866|FG002|Period 2 (Phase 2)|Reason not specified|0|||
131116868|NCT03828292|472059418|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
131116869|NCT03828292|472059419|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130696854|NCT02597049|470514522|FG002|Overall Study|Adverse Event|0|||
130912053|NCT00473746|471313867|FG003|Period 2 (Phase 2)|Reason not specified|0|||
130912054|NCT00473746|471313868|FG004|Period 2 (Phase 2)|Reason not specified|3|||
130912055|NCT02961218|471313872|FG000|Overall Study|Lost to Follow-up|0|||
130912056|NCT02961218|471313873|FG001|Overall Study|Lost to Follow-up|2|||
130912057|NCT02961218|471313872|FG000|Overall Study|Physician Decision|0|||
130912058|NCT02961218|471313873|FG001|Overall Study|Physician Decision|2|||
130912059|NCT02961218|471313872|FG000|Overall Study|Subject/Guardian Decision|3|||
130912060|NCT02961218|471313873|FG001|Overall Study|Subject/Guardian Decision|1|||
130912061|NCT00586066|471313876|FG000|Overall Study|Lost to Follow-up|6|||
130912062|NCT00586066|471313877|FG001|Overall Study|Lost to Follow-up|3|||
130912063|NCT00586066|471313876|FG000|Overall Study|Lack of Efficacy|5|||
130912064|NCT00586066|471313877|FG001|Overall Study|Lack of Efficacy|3|||
130912065|NCT00586066|471313876|FG000|Overall Study|Adverse Event|2|||
130912066|NCT00586066|471313877|FG001|Overall Study|Adverse Event|2|||
130912067|NCT00586066|471313876|FG000|Overall Study|Physician Decision|1|||
130912068|NCT00586066|471313877|FG001|Overall Study|Physician Decision|0|||
130912069|NCT00586066|471313876|FG000|Overall Study|Withdrawal of consent|4|||
130912070|NCT00586066|471313877|FG001|Overall Study|Withdrawal of consent|2|||
130912071|NCT02204007|471313880|FG000|Overall Study|Surgery Canceled|1|||
130912072|NCT02204007|471313881|FG001|Overall Study|Surgery Canceled|1|||
130912073|NCT00910988|471313882|FG000|Overall Study|Lost to Follow-up|2|||
130912074|NCT00910988|471313883|FG001|Overall Study|Lost to Follow-up|4|||
130912075|NCT00910988|471313884|FG002|Overall Study|Lost to Follow-up|3|||
130912076|NCT00910988|471313885|FG003|Overall Study|Lost to Follow-up|0|||
130912077|NCT00828854|471313886|FG000|Overall Study|Disease Progression|17|||
130912078|NCT00828854|471313886|FG000|Overall Study|Adverse Event|9|||
130912079|NCT00828854|471313886|FG000|Overall Study|Reason not Specified|1|||
130912080|NCT01505647|471313893|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
130912081|NCT01505647|471313894|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
130912082|NCT01505647|471313893|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
130912083|NCT01505647|471313894|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
130912084|NCT01505647|471313893|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
130912085|NCT01505647|471313894|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
130912086|NCT01505647|471313893|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
130912087|NCT01505647|471313894|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
130912088|NCT01505647|471313893|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
130912089|NCT01505647|471313894|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
130912090|NCT02059005|471313895|FG000|Overall Study|Death|1|||
130912091|NCT02059005|471313896|FG001|Overall Study|Death|3|||
130912092|NCT02059005|471313895|FG000|Overall Study|Lost to Follow-up|19|||
130912093|NCT02059005|471313896|FG001|Overall Study|Lost to Follow-up|19|||
130912094|NCT02059005|471313895|FG000|Overall Study|Incarceration|0|||
130912095|NCT02059005|471313896|FG001|Overall Study|Incarceration|1|||
130912096|NCT02059005|471313895|FG000|Overall Study|Inpatient|0|||
130912097|NCT02059005|471313896|FG001|Overall Study|Inpatient|1|||
130912098|NCT00739596|471313897|FG000|Overall Study|Adverse Event|12|||
130912099|NCT00739596|471313898|FG001|Overall Study|Adverse Event|6|||
130912100|NCT00739596|471313897|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
130912101|NCT00739596|471313898|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130912102|NCT00739596|471313897|FG000|Overall Study|Patient Withdrew Consent|8|||
130912103|NCT00739596|471313898|FG001|Overall Study|Patient Withdrew Consent|8|||
130912104|NCT00739596|471313897|FG000|Overall Study|Lost to Follow-up|0|||
130912105|NCT00739596|471313898|FG001|Overall Study|Lost to Follow-up|2|||
130912106|NCT00739596|471313897|FG000|Overall Study|Protocol Deviation|1|||
130912107|NCT00739596|471313898|FG001|Overall Study|Protocol Deviation|1|||
130912108|NCT00908011|471313903|FG000|Overall Study|Withdrawal by Subject|2|||
130912109|NCT00908011|471313904|FG001|Overall Study|Withdrawal by Subject|2|||
130912110|NCT02750943|471313905|FG000|Overall Study|Lost to Follow-up|1|||
130912111|NCT02750943|471313906|FG001|Overall Study|Lost to Follow-up|2|||
130912112|NCT02750943|471313905|FG000|Overall Study|Withdrawal by Subject|5|||
130912113|NCT02750943|471313906|FG001|Overall Study|Withdrawal by Subject|7|||
130912114|NCT00171054|471313907|FG000|Overall Study|Protocol Violation|1|||
130912115|NCT00171054|471313908|FG001|Overall Study|Protocol Violation|2|||
130912116|NCT00171054|471313907|FG000|Overall Study|Patient withdrew consent|1|||
130912117|NCT00171054|471313908|FG001|Overall Study|Patient withdrew consent|0|||
130912118|NCT00171054|471313907|FG000|Overall Study|Lost to Follow-up|0|||
130912119|NCT00171054|471313908|FG001|Overall Study|Lost to Follow-up|1|||
130912120|NCT00171054|471313907|FG000|Overall Study|Adverse Event|8|||
130912121|NCT00171054|471313908|FG001|Overall Study|Adverse Event|8|||
130912122|NCT00171054|471313907|FG000|Overall Study|Condition no longer required study drug|0|||
130912123|NCT00171054|471313908|FG001|Overall Study|Condition no longer required study drug|1|||
131116870|NCT03828292|472059414|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
131116871|NCT03828292|472059415|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
130912124|NCT03635788|471313912|FG000|Step 1|Death|1|||
130912125|NCT03635788|471313913|FG001|Step 1|Death|0|||
130912126|NCT03635788|471313914|FG002|Step 1|Death|0|||
130912127|NCT03635788|471313912|FG000|Step 1|Lost to Follow-up|31|||
130912128|NCT03635788|471313913|FG001|Step 1|Lost to Follow-up|0|||
130912129|NCT03635788|471313914|FG002|Step 1|Lost to Follow-up|0|||
130912130|NCT03635788|471313912|FG000|Step 1|Pregnancy|1|||
130912131|NCT03635788|471313913|FG001|Step 1|Pregnancy|0|||
130912132|NCT03635788|471313914|FG002|Step 1|Pregnancy|0|||
130912133|NCT03635788|471313912|FG000|Step 1|Protocol Violation|8|||
130912134|NCT03635788|471313913|FG001|Step 1|Protocol Violation|0|||
130912135|NCT03635788|471313914|FG002|Step 1|Protocol Violation|0|||
130912136|NCT03635788|471313912|FG000|Step 1|Withdrawal by Subject|13|||
130912137|NCT03635788|471313913|FG001|Step 1|Withdrawal by Subject|0|||
130912138|NCT03635788|471313914|FG002|Step 1|Withdrawal by Subject|0|||
130912139|NCT03635788|471313912|FG000|Step 1|Other reasons|12|||
130912140|NCT03635788|471313913|FG001|Step 1|Other reasons|0|||
130912141|NCT03635788|471313914|FG002|Step 1|Other reasons|0|||
130912142|NCT03635788|471313912|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
130912143|NCT03635788|471313913|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
130912144|NCT03635788|471313914|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
130912145|NCT03635788|471313912|FG000|Step 2|Lost to Follow-up|0|||
130912146|NCT03635788|471313913|FG001|Step 2|Lost to Follow-up|8|||
130912147|NCT03635788|471313914|FG002|Step 2|Lost to Follow-up|15|||
130912148|NCT03635788|471313912|FG000|Step 2|Withdrawal by Subject|0|||
130912149|NCT03635788|471313913|FG001|Step 2|Withdrawal by Subject|6|||
130912150|NCT03635788|471313914|FG002|Step 2|Withdrawal by Subject|6|||
130912151|NCT03635788|471313912|FG000|Step 2|Death|0|||
130912152|NCT03635788|471313913|FG001|Step 2|Death|2|||
130912153|NCT03635788|471313914|FG002|Step 2|Death|0|||
130912154|NCT03635788|471313912|FG000|Step 2|Incarceration|0|||
130912155|NCT03635788|471313913|FG001|Step 2|Incarceration|2|||
130912156|NCT03635788|471313914|FG002|Step 2|Incarceration|0|||
130912157|NCT03635788|471313912|FG000|Step 2|Non-Compliance With Study Requirements|0|||
130912158|NCT03635788|471313913|FG001|Step 2|Non-Compliance With Study Requirements|1|||
130912159|NCT03635788|471313914|FG002|Step 2|Non-Compliance With Study Requirements|1|||
130912160|NCT03635788|471313912|FG000|Step 2|Confounding Medical Condition|0|||
130912161|NCT03635788|471313913|FG001|Step 2|Confounding Medical Condition|0|||
130912162|NCT03635788|471313914|FG002|Step 2|Confounding Medical Condition|1|||
130912163|NCT03635788|471313912|FG000|Step 2|Out Of State With No Plan To Return|0|||
130912164|NCT03635788|471313913|FG001|Step 2|Out Of State With No Plan To Return|1|||
130912165|NCT03635788|471313914|FG002|Step 2|Out Of State With No Plan To Return|0|||
130912166|NCT03635788|471313912|FG000|Step 2|Switched To Injectables|0|||
130912167|NCT03635788|471313913|FG001|Step 2|Switched To Injectables|0|||
130912168|NCT03635788|471313914|FG002|Step 2|Switched To Injectables|1|||
130912169|NCT03635788|471313912|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
130912170|NCT03635788|471313913|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
130912171|NCT03635788|471313914|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
130912172|NCT04669535|471313915|FG000|Overall Study|Death|1|||
130912173|NCT04669535|471313916|FG001|Overall Study|Death|1|||
130912174|NCT04669535|471313917|FG002|Overall Study|Death|0|||
130912175|NCT04669535|471313918|FG003|Overall Study|Death|0|||
130912176|NCT02142803|471313919|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
130912177|NCT02142803|471313920|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
130912178|NCT02142803|471313921|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
130912179|NCT02142803|471313922|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
130912180|NCT02718300|471313928|FG000|Overall Study|Death|4|||
130912181|NCT02718300|471313929|FG001|Overall Study|Death|5|||
130912182|NCT02718300|471313930|FG002|Overall Study|Death|17|||
130912183|NCT02718300|471313928|FG000|Overall Study|Lost to Follow-up|1|||
130912184|NCT02718300|471313929|FG001|Overall Study|Lost to Follow-up|0|||
130912185|NCT02718300|471313930|FG002|Overall Study|Lost to Follow-up|2|||
130912186|NCT02718300|471313928|FG000|Overall Study|Physician Decision|1|||
130912187|NCT02718300|471313929|FG001|Overall Study|Physician Decision|0|||
130912188|NCT02718300|471313930|FG002|Overall Study|Physician Decision|2|||
130912189|NCT02718300|471313928|FG000|Overall Study|Study Terminated by Sponsor|6|||
130912190|NCT02718300|471313929|FG001|Overall Study|Study Terminated by Sponsor|3|||
130912191|NCT02718300|471313930|FG002|Overall Study|Study Terminated by Sponsor|4|||
130912192|NCT02718300|471313928|FG000|Overall Study|Withdrawal by Subject|0|||
130912193|NCT02718300|471313929|FG001|Overall Study|Withdrawal by Subject|4|||
130912194|NCT02718300|471313930|FG002|Overall Study|Withdrawal by Subject|3|||
130912195|NCT02718300|471313928|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
130912196|NCT02718300|471313929|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
130912197|NCT02718300|471313930|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
130912198|NCT02452697|471313932|FG000|Overall Study|Physician Decision|4|||
131030959|NCT04321031|471747934|FG005|Overall Study|Other|0|||
131030960|NCT04321031|471747935|FG006|Overall Study|Other|0|||
131030961|NCT03143153|471747938|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
131030962|NCT03143153|471747939|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
131030963|NCT03143153|471747940|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
131030964|NCT03143153|471747938|FG000|Pre-Treatment|Participant withdrew consent|0|||
130912199|NCT02452697|471313933|FG001|Overall Study|Physician Decision|4|||
130912200|NCT02452697|471313934|FG002|Overall Study|Physician Decision|3|||
130912201|NCT02452697|471313935|FG003|Overall Study|Physician Decision|2|||
130912202|NCT02452697|471313932|FG000|Overall Study|Withdrawal by Subject|1|||
130912203|NCT02452697|471313933|FG001|Overall Study|Withdrawal by Subject|0|||
130912204|NCT02452697|471313934|FG002|Overall Study|Withdrawal by Subject|0|||
130912205|NCT02452697|471313935|FG003|Overall Study|Withdrawal by Subject|0|||
130912206|NCT02452697|471313932|FG000|Overall Study|still in follow-up|2|||
130912207|NCT02452697|471313933|FG001|Overall Study|still in follow-up|2|||
130912208|NCT02452697|471313934|FG002|Overall Study|still in follow-up|1|||
130912209|NCT02452697|471313935|FG003|Overall Study|still in follow-up|3|||
130912210|NCT03552965|471313936|FG000|Overall Study|Death|1|||
130912211|NCT03552965|471313937|FG001|Overall Study|Death|1|||
130912212|NCT03552965|471313936|FG000|Overall Study|Lost to Follow-up|1|||
130912213|NCT03552965|471313937|FG001|Overall Study|Lost to Follow-up|1|||
130912214|NCT03552965|471313936|FG000|Overall Study|Physician Decision|1|||
130912215|NCT03552965|471313937|FG001|Overall Study|Physician Decision|1|||
130912216|NCT03552965|471313936|FG000|Overall Study|Withdrawal by Subject|0|||
130912217|NCT03552965|471313937|FG001|Overall Study|Withdrawal by Subject|2|||
130912218|NCT03552965|471313936|FG000|Overall Study|Continuation not in patient best interest|1|||
130912219|NCT03552965|471313937|FG001|Overall Study|Continuation not in patient best interest|0|||
130912220|NCT03552965|471313936|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
130912221|NCT03552965|471313937|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
130912222|NCT03120624|471313938|FG000|Overall Study|Withdrawal by Subject|0|||
130912223|NCT03120624|471313939|FG001|Overall Study|Withdrawal by Subject|1|||
130912224|NCT03120624|471313940|FG002|Overall Study|Withdrawal by Subject|0|||
130912225|NCT03120624|471313941|FG003|Overall Study|Withdrawal by Subject|0|||
130912226|NCT03120624|471313942|FG004|Overall Study|Withdrawal by Subject|0|||
130912227|NCT03120624|471313943|FG005|Overall Study|Withdrawal by Subject|0|||
130912228|NCT03120624|471313944|FG006|Overall Study|Withdrawal by Subject|0|||
130912229|NCT03120624|471313945|FG007|Overall Study|Withdrawal by Subject|0|||
130912230|NCT02477696|471313946|FG000|Overall Study|Death|89|||
130912231|NCT02477696|471313947|FG001|Overall Study|Death|106|||
130912232|NCT02477696|471313946|FG000|Overall Study|Lost to Follow-up|7|||
130912233|NCT02477696|471313947|FG001|Overall Study|Lost to Follow-up|5|||
130912234|NCT02477696|471313946|FG000|Overall Study|Withdrawal by Subject|37|||
130912235|NCT02477696|471313947|FG001|Overall Study|Withdrawal by Subject|34|||
130912236|NCT02477696|471313946|FG000|Overall Study|Physician Decision|7|||
130912237|NCT02477696|471313947|FG001|Overall Study|Physician Decision|9|||
130912238|NCT02477696|471313946|FG000|Overall Study|Study terminated by sponsor|103|||
130912239|NCT02477696|471313947|FG001|Overall Study|Study terminated by sponsor|99|||
130912240|NCT02477696|471313946|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
130912241|NCT02477696|471313947|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
130912242|NCT02477696|471313946|FG000|Overall Study|Missing/Unknown|2|||
131030965|NCT03143153|471747939|FG001|Pre-Treatment|Participant withdrew consent|1|||
131030966|NCT03143153|471747940|FG002|Pre-Treatment|Participant withdrew consent|12|||
131030967|NCT03143153|471747938|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
130696855|NCT02597049|470514520|FG000|Overall Study|Death|2|||
130696856|NCT02597049|470514521|FG001|Overall Study|Death|0|||
130696857|NCT02597049|470514522|FG002|Overall Study|Death|0|||
130696858|NCT02597049|470514520|FG000|Overall Study|Noncompliant with Study Visits|1|||
130696859|NCT02597049|470514521|FG001|Overall Study|Noncompliant with Study Visits|0|||
130696860|NCT02597049|470514522|FG002|Overall Study|Noncompliant with Study Visits|0|||
130696861|NCT00243347|470514525|FG000|Overall Study|Lack of Efficacy|4|||
130696862|NCT00243347|470514525|FG000|Overall Study|Adverse Event|2|||
130696863|NCT00243347|470514525|FG000|Overall Study|Death|1|||
130696864|NCT00243347|470514525|FG000|Overall Study|Withdrawal by Subject|5|||
130768811|NCT04122625|470778587|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
131030968|NCT03143153|471747939|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
131030969|NCT03143153|471747940|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
131030970|NCT03143153|471747938|FG000|Pre-Treatment|Other Reasons|1|||
131030971|NCT03143153|471747939|FG001|Pre-Treatment|Other Reasons|2|||
131030972|NCT03143153|471747940|FG002|Pre-Treatment|Other Reasons|1|||
131030973|NCT03143153|471747938|FG000|Pre-Treatment|Disease Progression|1|||
131030974|NCT03143153|471747939|FG001|Pre-Treatment|Disease Progression|1|||
131030975|NCT03143153|471747940|FG002|Pre-Treatment|Disease Progression|2|||
131030976|NCT03143153|471747938|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
131030977|NCT03143153|471747939|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
131030978|NCT03143153|471747940|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
131030979|NCT03143153|471747938|FG000|Treatment|Disease progression|174|||
131030980|NCT03143153|471747939|FG001|Treatment|Disease progression|184|||
131030981|NCT03143153|471747940|FG002|Treatment|Disease progression|193|||
131030982|NCT03143153|471747938|FG000|Treatment|Study drug toxicity|59|||
131030983|NCT03143153|471747939|FG001|Treatment|Study drug toxicity|33|||
131030984|NCT03143153|471747940|FG002|Treatment|Study drug toxicity|40|||
131030985|NCT03143153|471747938|FG000|Treatment|Death|5|||
131030986|NCT03143153|471747939|FG001|Treatment|Death|3|||
131030987|NCT03143153|471747940|FG002|Treatment|Death|4|||
130912243|NCT02477696|471313947|FG001|Overall Study|Missing/Unknown|0|||
131030988|NCT03143153|471747938|FG000|Treatment|Adverse event unrelated to study drug|19|||
131030989|NCT03143153|471747939|FG001|Treatment|Adverse event unrelated to study drug|28|||
130912244|NCT00401531|471314953|FG000|Overall Study|Adverse Event|2|||
130912245|NCT00401531|471314954|FG001|Overall Study|Adverse Event|0|||
130912246|NCT00401531|471314953|FG000|Overall Study|Protocol Violation|3|||
130912247|NCT00401531|471314954|FG001|Overall Study|Protocol Violation|7|||
130912248|NCT00401531|471314953|FG000|Overall Study|Lost to Follow-up|1|||
130696865|NCT00243347|470514525|FG000|Overall Study|Condition worsened|7|||
130696866|NCT01899053|470514528|FG000|Overall Study|Progressive Disease|4|||
130912249|NCT00401531|471314954|FG001|Overall Study|Lost to Follow-up|1|||
130912250|NCT00401531|471314953|FG000|Overall Study|Withdrawal by Subject|3|||
130912251|NCT00401531|471314954|FG001|Overall Study|Withdrawal by Subject|2|||
130912252|NCT00510874|471314955|FG000|Overall Study|Withdrawal by Subject|1|||
130912253|NCT00510874|471314956|FG001|Overall Study|Withdrawal by Subject|1|||
130912254|NCT00510874|471314957|FG002|Overall Study|Withdrawal by Subject|0|||
130912255|NCT00510874|471314958|FG003|Overall Study|Withdrawal by Subject|0|||
130912256|NCT00510874|471314959|FG004|Overall Study|Withdrawal by Subject|3|||
130912257|NCT00510874|471314960|FG005|Overall Study|Withdrawal by Subject|0|||
130912258|NCT00510874|471314961|FG006|Overall Study|Withdrawal by Subject|0|||
130912259|NCT00510874|471314955|FG000|Overall Study|Lost to Follow-up|2|||
130912260|NCT00510874|471314956|FG001|Overall Study|Lost to Follow-up|3|||
130912261|NCT00510874|471314957|FG002|Overall Study|Lost to Follow-up|1|||
130912262|NCT00510874|471314958|FG003|Overall Study|Lost to Follow-up|3|||
130912263|NCT00510874|471314959|FG004|Overall Study|Lost to Follow-up|4|||
130912264|NCT00510874|471314960|FG005|Overall Study|Lost to Follow-up|0|||
130912265|NCT00510874|471314961|FG006|Overall Study|Lost to Follow-up|1|||
130912266|NCT03956056|471314964|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
130912267|NCT03956056|471314964|FG000|Overall Study|Lack of Efficacy|1|||
130912268|NCT02360995|471314965|FG000|Overall Study|Lost to Follow-up|2|||
130912269|NCT02360995|471314966|FG001|Overall Study|Lost to Follow-up|0|||
130912270|NCT02360995|471314967|FG002|Overall Study|Lost to Follow-up|2|||
130912271|NCT02360995|471314965|FG000|Overall Study|Withdrawal by Subject|0|||
130912272|NCT02360995|471314966|FG001|Overall Study|Withdrawal by Subject|1|||
130912273|NCT02360995|471314967|FG002|Overall Study|Withdrawal by Subject|0|||
130912274|NCT02395666|471314968|FG000|Overall Study|Physician Decision|3|||
130912275|NCT02395666|471314969|FG001|Overall Study|Physician Decision|0|||
130912276|NCT02395666|471314968|FG000|Overall Study|Lost to Follow-up|1|||
130912277|NCT02395666|471314969|FG001|Overall Study|Lost to Follow-up|0|||
130912278|NCT02395666|471314968|FG000|Overall Study|Withdrawal by Subject|2|||
130912279|NCT02395666|471314969|FG001|Overall Study|Withdrawal by Subject|1|||
131030990|NCT03143153|471747940|FG002|Treatment|Adverse event unrelated to study drug|12|||
131030991|NCT03143153|471747938|FG000|Treatment|Participant request to discontinue study treatment|13|||
131030992|NCT03143153|471747939|FG001|Treatment|Participant request to discontinue study treatment|15|||
131030993|NCT03143153|471747940|FG002|Treatment|Participant request to discontinue study treatment|20|||
131030994|NCT03143153|471747938|FG000|Treatment|Participant withdrew consent|3|||
131030995|NCT03143153|471747939|FG001|Treatment|Participant withdrew consent|4|||
131030996|NCT03143153|471747940|FG002|Treatment|Participant withdrew consent|12|||
131030997|NCT03143153|471747938|FG000|Treatment|Pregnancy|1|||
131030998|NCT03143153|471747939|FG001|Treatment|Pregnancy|0|||
131030999|NCT03143153|471747940|FG002|Treatment|Pregnancy|0|||
131031000|NCT03143153|471747938|FG000|Treatment|Maximum clinical benefit|1|||
131031001|NCT03143153|471747939|FG001|Treatment|Maximum clinical benefit|3|||
131031002|NCT03143153|471747940|FG002|Treatment|Maximum clinical benefit|4|||
131031003|NCT03143153|471747938|FG000|Treatment|Completed treatment as per Protocol|13|||
131031004|NCT03143153|471747939|FG001|Treatment|Completed treatment as per Protocol|8|||
131031005|NCT03143153|471747940|FG002|Treatment|Completed treatment as per Protocol|0|||
131031006|NCT03143153|471747938|FG000|Treatment|Other reasons|12|||
131031007|NCT03143153|471747939|FG001|Treatment|Other reasons|7|||
131031008|NCT03143153|471747940|FG002|Treatment|Other reasons|15|||
131031009|NCT03143153|471747938|FG000|Treatment|Not reported|1|||
131031010|NCT03143153|471747939|FG001|Treatment|Not reported|0|||
131031011|NCT03143153|471747940|FG002|Treatment|Not reported|0|||
131031012|NCT02312557|471747941|FG000|Overall Study|Survival follow-up|4|||
131031013|NCT04237298|471747942|FG000|Overall Study|Lost to Follow-up|4|||
131031014|NCT04237298|471747943|FG001|Overall Study|Lost to Follow-up|5|||
131031015|NCT02530671|471747944|FG000|Overall Study|Lost to Follow-up|2|||
131031016|NCT02530671|471747945|FG001|Overall Study|Lost to Follow-up|0|||
131031017|NCT02530671|471747944|FG000|Overall Study|Withdrawal by Subject|1|||
131031018|NCT02530671|471747945|FG001|Overall Study|Withdrawal by Subject|0|||
130912280|NCT01409434|471314970|FG000|Overall Study|Protocol Violation|4|||
130912281|NCT04629508|471314971|FG000|Overall Study|Adverse Event|1|||
131031019|NCT01415154|471747946|FG000|Overall Study|Lack of Efficacy|4|||
131031020|NCT01415154|471747947|FG001|Overall Study|Lack of Efficacy|5|||
131031021|NCT01415154|471747946|FG000|Overall Study|Withdrawal by Subject|7|||
131031022|NCT01415154|471747947|FG001|Overall Study|Withdrawal by Subject|8|||
131031023|NCT01415154|471747946|FG000|Overall Study|Lost to Follow-up|1|||
131031024|NCT01415154|471747947|FG001|Overall Study|Lost to Follow-up|4|||
131031025|NCT01415154|471747946|FG000|Overall Study|Protocol Violation|0|||
131031026|NCT01415154|471747947|FG001|Overall Study|Protocol Violation|1|||
130912282|NCT04629508|471314971|FG000|Overall Study|Death|2|||
130912283|NCT04629508|471314971|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
130912284|NCT03960554|471314977|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
130912285|NCT03960554|471314978|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
130912286|NCT00735254|471314979|FG000|Overall Study|Protocol Violation|1|||
131031027|NCT01415154|471747946|FG000|Overall Study|Satisfactory Response|0|||
131031028|NCT01415154|471747947|FG001|Overall Study|Satisfactory Response|1|||
130912287|NCT00735254|471314980|FG001|Overall Study|Protocol Violation|1|||
130912288|NCT00735254|471314981|FG002|Overall Study|Protocol Violation|1|||
130912289|NCT00735254|471314982|FG003|Overall Study|Protocol Violation|0|||
130912290|NCT00751621|471314983|FG000|Overall Study|Adverse Event|1|||
130912291|NCT00751621|471314983|FG000|Overall Study|Withdrawal by Subject|1|||
130912292|NCT00751621|471314983|FG000|Overall Study|Subject moved to another country|1|||
130912293|NCT00751621|471314983|FG000|Overall Study|Poor adherence to asthma treatment|1|||
130912294|NCT02791594|471314984|FG000|Overall Study|Physician Decision|2|||
130912295|NCT02310321|471314985|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
130912296|NCT02310321|471314986|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
130912297|NCT02310321|471314987|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
130912298|NCT02310321|471314985|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
130912299|NCT02310321|471314986|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
130912300|NCT02310321|471314987|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
130912301|NCT02310321|471314985|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
130912302|NCT02310321|471314986|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
130912303|NCT02310321|471314987|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
130912304|NCT02310321|471314985|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
130912305|NCT02310321|471314986|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
130912306|NCT02310321|471314987|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
130912307|NCT02310321|471314985|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
130912308|NCT02310321|471314986|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
130912309|NCT02310321|471314987|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
130912310|NCT02310321|471314985|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
130912311|NCT02310321|471314986|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
130912312|NCT02310321|471314987|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
130912313|NCT02310321|471314985|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
130912314|NCT02310321|471314986|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
130912315|NCT02310321|471314987|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
130912316|NCT02310321|471314985|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
130912317|NCT02310321|471314986|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
130912318|NCT02310321|471314987|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
130912319|NCT02310321|471314985|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
130912320|NCT02310321|471314986|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
130912321|NCT02310321|471314987|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
130912322|NCT02310321|471314985|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
130912323|NCT02310321|471314986|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
130912324|NCT02310321|471314987|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
130912325|NCT02310321|471314985|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
130912326|NCT02310321|471314986|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
130912327|NCT02310321|471314987|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
130912328|NCT02310321|471314985|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
130912329|NCT02310321|471314986|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
130912330|NCT02310321|471314987|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
130912331|NCT02310321|471314985|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
130912332|NCT02310321|471314986|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
130912333|NCT02310321|471314987|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
130912334|NCT02310321|471314985|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
130912335|NCT02310321|471314986|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
130912336|NCT02310321|471314987|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
130912337|NCT02310321|471314985|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
130912338|NCT02310321|471314986|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
130912339|NCT02310321|471314987|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
130912340|NCT02310321|471314985|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
131031029|NCT01415154|471747946|FG000|Overall Study|Adverse Event|1|||
131031030|NCT01415154|471747947|FG001|Overall Study|Adverse Event|1|||
131031031|NCT06283173|471747963|FG000|Overall Study|Did not show for first visit|10|||
131031032|NCT06283173|471747963|FG000|Overall Study|Lost to Follow-up|12|||
131031033|NCT06283173|471747963|FG000|Overall Study|Physician Decision|7|||
131031034|NCT05470400|471747968|FG000|Overall Study|Lost to Follow-up|0|||
131031035|NCT05470400|471747969|FG001|Overall Study|Lost to Follow-up|0|||
131031036|NCT05470400|471747970|FG002|Overall Study|Lost to Follow-up|0|||
131031037|NCT05470400|471747971|FG003|Overall Study|Lost to Follow-up|0|||
131031038|NCT05470400|471747972|FG004|Overall Study|Lost to Follow-up|0|||
131031039|NCT05470400|471747973|FG005|Overall Study|Lost to Follow-up|0|||
130912341|NCT02310321|471314986|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
131031040|NCT05470400|471747974|FG006|Overall Study|Lost to Follow-up|0|||
131031041|NCT05470400|471747975|FG007|Overall Study|Lost to Follow-up|1|||
131116872|NCT03828292|472059416|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
131116873|NCT03828292|472059417|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
131116874|NCT03828292|472059418|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
131116875|NCT03828292|472059419|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
131116876|NCT01444456|472059420|FG000|Overall Study|Withdrawal by Subject|21|||
131116877|NCT01444456|472059420|FG000|Overall Study|Physician Decision|9|||
131116878|NCT01444456|472059420|FG000|Overall Study|Lost to Follow-up|37|||
131116879|NCT01444456|472059420|FG000|Overall Study|Death|73|||
131116880|NCT01444456|472059420|FG000|Overall Study|Ineligibility determined|23|||
131116881|NCT01444456|472059420|FG000|Overall Study|Other|18|||
131116882|NCT01444456|472059420|FG000|Overall Study|Not treated|104|||
131116883|NCT04313153|472060640|FG000|Overall Study|Adverse Event (includes Death)|14|||
131116884|NCT04313153|472060641|FG001|Overall Study|Adverse Event (includes Death)|19|||
131116885|NCT04313153|472060642|FG002|Overall Study|Adverse Event (includes Death)|10|||
131116886|NCT04313153|472060640|FG000|Overall Study|Physician Decision|4|||
131116887|NCT04313153|472060641|FG001|Overall Study|Physician Decision|2|||
131116888|NCT04313153|472060642|FG002|Overall Study|Physician Decision|1|||
131116889|NCT04313153|472060640|FG000|Overall Study|Withdrawal by Subject|7|||
131116890|NCT04313153|472060641|FG001|Overall Study|Withdrawal by Subject|6|||
131116891|NCT04313153|472060642|FG002|Overall Study|Withdrawal by Subject|2|||
131116892|NCT04313153|472060640|FG000|Overall Study|Lack of Efficacy|3|||
131116893|NCT04313153|472060641|FG001|Overall Study|Lack of Efficacy|3|||
131116894|NCT04313153|472060642|FG002|Overall Study|Lack of Efficacy|0|||
131116895|NCT04313153|472060640|FG000|Overall Study|Lost to Follow-up|1|||
131116896|NCT04313153|472060641|FG001|Overall Study|Lost to Follow-up|0|||
131116897|NCT04313153|472060642|FG002|Overall Study|Lost to Follow-up|2|||
131116898|NCT04313153|472060640|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
131116899|NCT04313153|472060641|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
131116900|NCT04313153|472060642|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
131116901|NCT04313153|472060640|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
131116902|NCT04313153|472060641|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
131116903|NCT04313153|472060642|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
131116904|NCT04313153|472060640|FG000|Overall Study|Change in Dialysis Modality|0|||
131116905|NCT04313153|472060641|FG001|Overall Study|Change in Dialysis Modality|1|||
131116906|NCT04313153|472060642|FG002|Overall Study|Change in Dialysis Modality|2|||
131116907|NCT04313153|472060640|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
131116908|NCT04313153|472060641|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
131116909|NCT04313153|472060642|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
131116910|NCT04313153|472060640|FG000|Overall Study|Other|5|||
131116911|NCT04313153|472060641|FG001|Overall Study|Other|3|||
131116912|NCT04313153|472060642|FG002|Overall Study|Other|2|||
131116913|NCT00332839|472060643|FG000|Core (Months 0 - 12)|Administrative problems|1|||
131116914|NCT00332839|472060644|FG001|Core (Months 0 - 12)|Administrative problems|1|||
131116915|NCT00332839|472060643|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
131116916|NCT00332839|472060644|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
131031042|NCT05470400|471747968|FG000|Overall Study|Withdrawal by Subject|1|||
131031043|NCT05470400|471747969|FG001|Overall Study|Withdrawal by Subject|0|||
131031044|NCT05470400|471747970|FG002|Overall Study|Withdrawal by Subject|0|||
131031045|NCT05470400|471747971|FG003|Overall Study|Withdrawal by Subject|0|||
131031046|NCT05470400|471747972|FG004|Overall Study|Withdrawal by Subject|0|||
131031047|NCT05470400|471747973|FG005|Overall Study|Withdrawal by Subject|1|||
131031048|NCT05470400|471747974|FG006|Overall Study|Withdrawal by Subject|0|||
131031049|NCT05470400|471747975|FG007|Overall Study|Withdrawal by Subject|2|||
131031050|NCT03138512|471747976|FG000|Randomization|Participants withdrew consent|0|||
131031051|NCT03138512|471747977|FG001|Randomization|Participants withdrew consent|1|||
131031052|NCT03138512|471747978|FG002|Randomization|Participants withdrew consent|1|||
131031053|NCT03138512|471747979|FG003|Randomization|Participants withdrew consent|0|||
131031054|NCT03138512|471747980|FG004|Randomization|Participants withdrew consent|0|||
131031055|NCT03138512|471747976|FG000|Randomization|Participant no longer meets study criteria|0|||
131031056|NCT03138512|471747977|FG001|Randomization|Participant no longer meets study criteria|3|||
131031057|NCT03138512|471747978|FG002|Randomization|Participant no longer meets study criteria|1|||
131031058|NCT03138512|471747979|FG003|Randomization|Participant no longer meets study criteria|1|||
131031059|NCT03138512|471747980|FG004|Randomization|Participant no longer meets study criteria|3|||
131031060|NCT03138512|471747976|FG000|Randomization|Other reasons|1|||
131031061|NCT03138512|471747977|FG001|Randomization|Other reasons|0|||
131031062|NCT03138512|471747978|FG002|Randomization|Other reasons|0|||
130696867|NCT01899053|470514529|FG001|Overall Study|Progressive Disease|0|||
130696868|NCT01899053|470514530|FG002|Overall Study|Progressive Disease|3|||
131031063|NCT03138512|471747979|FG003|Randomization|Other reasons|0|||
131031064|NCT03138512|471747980|FG004|Randomization|Other reasons|0|||
131031065|NCT03138512|471747976|FG000|Treatment Part A|Disease recurrence|10|||
131031066|NCT03138512|471747977|FG001|Treatment Part A|Disease recurrence|20|||
130912342|NCT02310321|471314987|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
130912343|NCT02310321|471314985|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
130912344|NCT02310321|471314986|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
130912345|NCT02310321|471314987|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
130912346|NCT02310321|471314985|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
130912347|NCT02310321|471314986|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
130912348|NCT02310321|471314987|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
130912349|NCT02310321|471314985|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
130912350|NCT02310321|471314986|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
130912351|NCT02310321|471314987|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
130912352|NCT02310321|471314985|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
130912353|NCT02310321|471314986|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
130912354|NCT02310321|471314987|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
130912355|NCT02310321|471314985|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
130912356|NCT02310321|471314986|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
130912357|NCT02310321|471314987|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
130912358|NCT02310321|471314985|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
130912359|NCT02310321|471314986|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
130912360|NCT02310321|471314987|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
130912361|NCT02310321|471314985|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
130912362|NCT02310321|471314986|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
130912363|NCT02310321|471314987|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
130912364|NCT01528215|471314988|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
130912365|NCT01528215|471314989|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
130912366|NCT01528215|471314988|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
130912367|NCT01528215|471314989|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
130912368|NCT01528215|471314988|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
130912369|NCT01528215|471314989|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
130912370|NCT01528215|471314988|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
130912371|NCT01528215|471314989|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
130912372|NCT01462227|471314991|FG000|Second Assignment|Lost to Follow-up|1|||
130912373|NCT01462227|471314992|FG001|Second Assignment|Lost to Follow-up|0|||
130912374|NCT01462227|471314993|FG002|Second Assignment|Lost to Follow-up|0|||
130912375|NCT01462227|471314994|FG003|Second Assignment|Lost to Follow-up|0|||
130912376|NCT01462227|471314991|FG000|Second Assignment|Protocol Violation|0|||
130912377|NCT01462227|471314992|FG001|Second Assignment|Protocol Violation|1|||
130912378|NCT01462227|471314993|FG002|Second Assignment|Protocol Violation|1|||
130912379|NCT01462227|471314994|FG003|Second Assignment|Protocol Violation|0|||
130912380|NCT00237185|471315000|FG000|Core|Adverse Event|3|||
130912381|NCT00237185|471315001|FG001|Core|Adverse Event|4|||
130912382|NCT00237185|471315000|FG000|Core|Abnormal laboratory value|0|||
130912383|NCT00237185|471315001|FG001|Core|Abnormal laboratory value|4|||
130912384|NCT00237185|471315000|FG000|Core|Abnormal test procedure results|1|||
130912385|NCT00237185|471315001|FG001|Core|Abnormal test procedure results|0|||
130912386|NCT00237185|471315000|FG000|Core|Lack of Efficacy|30|||
130912387|NCT00237185|471315001|FG001|Core|Lack of Efficacy|23|||
130912388|NCT00237185|471315000|FG000|Core|Protocol Violation|1|||
130912389|NCT00237185|471315001|FG001|Core|Protocol Violation|1|||
130912390|NCT00237185|471315000|FG000|Core|Withdrawal by Subject|4|||
130912391|NCT00237185|471315001|FG001|Core|Withdrawal by Subject|4|||
130912392|NCT00237185|471315000|FG000|Core|Administrative problems|0|||
130912393|NCT00237185|471315001|FG001|Core|Administrative problems|1|||
130912394|NCT00237185|471315000|FG000|Core|Death|4|||
130912395|NCT00237185|471315001|FG001|Core|Death|0|||
130912396|NCT00237185|471315000|FG000|Core|Determined ineligible post randomization|1|||
130912397|NCT00237185|471315001|FG001|Core|Determined ineligible post randomization|0|||
130912398|NCT00237185|471315000|FG000|Extension|Adverse Event|1|||
130912399|NCT00237185|471315001|FG001|Extension|Adverse Event|0|||
131031067|NCT03138512|471747978|FG002|Treatment Part A|Disease recurrence|0|||
131031068|NCT03138512|471747979|FG003|Treatment Part A|Disease recurrence|0|||
131031069|NCT03138512|471747980|FG004|Treatment Part A|Disease recurrence|0|||
131031070|NCT03138512|471747976|FG000|Treatment Part A|Study Drug Toxicity|132|||
131031071|NCT03138512|471747977|FG001|Treatment Part A|Study Drug Toxicity|5|||
131031072|NCT03138512|471747978|FG002|Treatment Part A|Study Drug Toxicity|0|||
130912400|NCT00237185|471315000|FG000|Extension|Abnormal laboratory value|0|||
130912401|NCT00237185|471315001|FG001|Extension|Abnormal laboratory value|1|||
130912402|NCT00237185|471315000|FG000|Extension|Lack of Efficacy|9|||
130912403|NCT00237185|471315001|FG001|Extension|Lack of Efficacy|14|||
130912404|NCT00237185|471315000|FG000|Extension|Condition no longer required study drug|0|||
130912405|NCT00237185|471315001|FG001|Extension|Condition no longer required study drug|1|||
130912406|NCT00237185|471315000|FG000|Extension|Withdrawal by Subject|3|||
130912407|NCT00237185|471315001|FG001|Extension|Withdrawal by Subject|2|||
130912408|NCT00237185|471315000|FG000|Extension|Lost to Follow-up|1|||
130912409|NCT00237185|471315001|FG001|Extension|Lost to Follow-up|0|||
130912410|NCT00237185|471315000|FG000|Extension|Administrative problems|1|||
130912411|NCT00237185|471315001|FG001|Extension|Administrative problems|0|||
130912412|NCT00237185|471315000|FG000|Extension|Death|1|||
130912413|NCT00237185|471315001|FG001|Extension|Death|1|||
130912414|NCT02035475|471315002|FG000|Overall Study|Withdrawal by Subject|4|||
130912415|NCT02035475|471315002|FG000|Overall Study|Physician Decision|1|||
130912416|NCT02035475|471315002|FG000|Overall Study|Equipment Error|1|||
130912417|NCT01702571|471315003|FG000|Overall Study|Death|1067|||
130912418|NCT01702571|471315004|FG001|Overall Study|Death|76|||
130912419|NCT01702571|471315003|FG000|Overall Study|Lost to Follow-up|144|||
130912420|NCT01702571|471315004|FG001|Overall Study|Lost to Follow-up|10|||
130912421|NCT01702571|471315003|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
130912422|NCT01702571|471315004|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
130912423|NCT01702571|471315003|FG000|Overall Study|Investigator Decision|5|||
130912424|NCT01702571|471315004|FG001|Overall Study|Investigator Decision|0|||
130912425|NCT01702571|471315003|FG000|Overall Study|Not Classifiable|1|||
130912426|NCT01702571|471315004|FG001|Overall Study|Not Classifiable|0|||
130912427|NCT01702571|471315003|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
130912428|NCT01702571|471315004|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
130912429|NCT01702571|471315003|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
130912430|NCT01702571|471315004|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
130912431|NCT01702571|471315003|FG000|Overall Study|Progressive Disease|3|||
130912432|NCT01702571|471315004|FG001|Overall Study|Progressive Disease|0|||
130912433|NCT01702571|471315003|FG000|Overall Study|Protocol Violation|2|||
130912434|NCT01702571|471315004|FG001|Overall Study|Protocol Violation|0|||
130912435|NCT01702571|471315003|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
130768812|NCT04122625|470778588|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
130768813|NCT04122625|470778589|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
130768814|NCT04122625|470778590|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
130768815|NCT04122625|470778591|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
130768816|NCT04122625|470778592|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
130912436|NCT01702571|471315004|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
130912437|NCT01702571|471315003|FG000|Overall Study|Termination By Sponsor|4|||
130912438|NCT01702571|471315004|FG001|Overall Study|Termination By Sponsor|0|||
130912439|NCT01702571|471315003|FG000|Overall Study|Withdrawal by Subject|177|||
130912440|NCT01702571|471315004|FG001|Overall Study|Withdrawal by Subject|29|||
130912441|NCT02047227|471315005|FG000|Overall Study|Adverse Event|2|||
130912442|NCT02047227|471315006|FG001|Overall Study|Adverse Event|4|||
130912443|NCT02047227|471315005|FG000|Overall Study|Lost to Follow-up|0|||
130912444|NCT02047227|471315006|FG001|Overall Study|Lost to Follow-up|3|||
130912445|NCT02047227|471315005|FG000|Overall Study|Protocol Violation|1|||
130912446|NCT02047227|471315006|FG001|Overall Study|Protocol Violation|0|||
130912447|NCT02047227|471315005|FG000|Overall Study|Spontaneous pregnancy|1|||
131031073|NCT03138512|471747979|FG003|Treatment Part A|Study Drug Toxicity|0|||
131031074|NCT03138512|471747980|FG004|Treatment Part A|Study Drug Toxicity|0|||
131031075|NCT03138512|471747976|FG000|Treatment Part A|Death|1|||
131031076|NCT03138512|471747977|FG001|Treatment Part A|Death|0|||
131031077|NCT03138512|471747978|FG002|Treatment Part A|Death|0|||
131031078|NCT03138512|471747979|FG003|Treatment Part A|Death|0|||
131031079|NCT03138512|471747980|FG004|Treatment Part A|Death|0|||
131031080|NCT03138512|471747976|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
131031081|NCT03138512|471747977|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
131031082|NCT03138512|471747978|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
131031083|NCT03138512|471747979|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
131031084|NCT03138512|471747980|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
131031085|NCT03138512|471747976|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
131031086|NCT03138512|471747977|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
131031087|NCT03138512|471747978|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
131031088|NCT03138512|471747979|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
131031089|NCT03138512|471747980|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
131031090|NCT03138512|471747976|FG000|Treatment Part A|Participant withdrew consent|2|||
131031091|NCT03138512|471747977|FG001|Treatment Part A|Participant withdrew consent|4|||
131031092|NCT03138512|471747978|FG002|Treatment Part A|Participant withdrew consent|0|||
131031093|NCT03138512|471747979|FG003|Treatment Part A|Participant withdrew consent|0|||
131031094|NCT03138512|471747980|FG004|Treatment Part A|Participant withdrew consent|0|||
131031095|NCT03138512|471747976|FG000|Treatment Part A|Lost to Follow-up|0|||
131031096|NCT03138512|471747977|FG001|Treatment Part A|Lost to Follow-up|1|||
131031097|NCT03138512|471747978|FG002|Treatment Part A|Lost to Follow-up|0|||
131031098|NCT03138512|471747979|FG003|Treatment Part A|Lost to Follow-up|0|||
131031099|NCT03138512|471747980|FG004|Treatment Part A|Lost to Follow-up|0|||
131031100|NCT03138512|471747976|FG000|Treatment Part A|Poor/non-compliance|1|||
131031101|NCT03138512|471747977|FG001|Treatment Part A|Poor/non-compliance|0|||
130912448|NCT02047227|471315006|FG001|Overall Study|Spontaneous pregnancy|0|||
130912449|NCT02047227|471315005|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
130912450|NCT02047227|471315006|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
130912451|NCT02047227|471315005|FG000|Overall Study|No oocytes retrieved|21|||
130912452|NCT02047227|471315006|FG001|Overall Study|No oocytes retrieved|20|||
130912453|NCT02047227|471315005|FG000|Overall Study|No fertilization|61|||
130912454|NCT02047227|471315006|FG001|Overall Study|No fertilization|51|||
130912455|NCT02047227|471315005|FG000|Overall Study|Intention to freeze all embryos|1|||
130912456|NCT02047227|471315006|FG001|Overall Study|Intention to freeze all embryos|0|||
130912457|NCT02047227|471315005|FG000|Overall Study|All embryos discarded|12|||
130912458|NCT02047227|471315006|FG001|Overall Study|All embryos discarded|11|||
130912459|NCT02047227|471315005|FG000|Overall Study|Other|10|||
130912460|NCT02047227|471315006|FG001|Overall Study|Other|9|||
130912461|NCT01977937|471315015|FG000|Overall Study|Withdrawal by Subject|2|||
130912462|NCT01977937|471315016|FG001|Overall Study|Withdrawal by Subject|1|||
130912463|NCT01977937|471315015|FG000|Overall Study|Adverse Event|1|||
130912464|NCT01977937|471315016|FG001|Overall Study|Adverse Event|0|||
130912465|NCT01977937|471315015|FG000|Overall Study|Physician Decision|0|||
130912466|NCT01977937|471315016|FG001|Overall Study|Physician Decision|1|||
130912467|NCT00915356|471315017|FG000|Overall Study|Withdrawal by Subject|1|||
130912468|NCT00915356|471315018|FG001|Overall Study|Withdrawal by Subject|0|||
130912469|NCT00915356|471315019|FG002|Overall Study|Withdrawal by Subject|0|||
130912470|NCT00915356|471315020|FG003|Overall Study|Withdrawal by Subject|0|||
130912471|NCT00915356|471315021|FG004|Overall Study|Withdrawal by Subject|0|||
130912472|NCT02819518|471315027|FG000|Overall Study|Death|9|||
130912473|NCT02819518|471315028|FG001|Overall Study|Death|12|||
130912474|NCT02819518|471315029|FG002|Overall Study|Death|9|||
130912475|NCT02819518|471315030|FG003|Overall Study|Death|475|||
130912476|NCT02819518|471315031|FG004|Overall Study|Death|244|||
130912477|NCT02819518|471315027|FG000|Overall Study|Withdrawal by Subject|0|||
130912478|NCT02819518|471315028|FG001|Overall Study|Withdrawal by Subject|0|||
130912479|NCT02819518|471315029|FG002|Overall Study|Withdrawal by Subject|0|||
130912480|NCT02819518|471315030|FG003|Overall Study|Withdrawal by Subject|25|||
130912481|NCT02819518|471315031|FG004|Overall Study|Withdrawal by Subject|8|||
130912482|NCT02819518|471315027|FG000|Overall Study|Lost to Follow-up|0|||
130912483|NCT02819518|471315028|FG001|Overall Study|Lost to Follow-up|0|||
130912484|NCT02819518|471315029|FG002|Overall Study|Lost to Follow-up|0|||
130912485|NCT02819518|471315030|FG003|Overall Study|Lost to Follow-up|0|||
130912486|NCT02819518|471315031|FG004|Overall Study|Lost to Follow-up|1|||
130912487|NCT02819518|471315027|FG000|Overall Study|Sponsor Decision|1|||
130912488|NCT02819518|471315028|FG001|Overall Study|Sponsor Decision|1|||
130912489|NCT02819518|471315029|FG002|Overall Study|Sponsor Decision|0|||
130912490|NCT02819518|471315030|FG003|Overall Study|Sponsor Decision|34|||
130912491|NCT02819518|471315031|FG004|Overall Study|Sponsor Decision|17|||
130912492|NCT02819518|471315027|FG000|Overall Study|Transferred to extension study|1|||
130912493|NCT02819518|471315028|FG001|Overall Study|Transferred to extension study|1|||
130912494|NCT02819518|471315029|FG002|Overall Study|Transferred to extension study|1|||
130912495|NCT02819518|471315030|FG003|Overall Study|Transferred to extension study|32|||
130912496|NCT02819518|471315031|FG004|Overall Study|Transferred to extension study|11|||
130912497|NCT00880165|471315032|FG000|Overall Study|Withdrawal by Subject|27|||
130912498|NCT00880165|471315033|FG001|Overall Study|Withdrawal by Subject|23|||
130912499|NCT00880165|471315032|FG000|Overall Study|Not diagnosed with OSA|14|||
130912500|NCT00880165|471315033|FG001|Overall Study|Not diagnosed with OSA|8|||
130912501|NCT00880165|471315032|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
130696869|NCT01899053|470514531|FG003|Overall Study|Progressive Disease|0|||
130696870|NCT01899053|470514532|FG004|Overall Study|Progressive Disease|3|||
130696871|NCT01899053|470514533|FG005|Overall Study|Progressive Disease|1|||
130696872|NCT01899053|470514534|FG006|Overall Study|Progressive Disease|1|||
130696873|NCT01899053|470514535|FG007|Overall Study|Progressive Disease|1|||
130696874|NCT01899053|470514536|FG008|Overall Study|Progressive Disease|4|||
130912502|NCT00880165|471315033|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
130912503|NCT00880165|471315032|FG000|Overall Study|Lost to follow|9|||
130912504|NCT00880165|471315033|FG001|Overall Study|Lost to follow|15|||
130912505|NCT00667602|471315034|FG000|Overall Study|Withdrawal by Subject|4|||
131116917|NCT00332839|472060643|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
130912506|NCT00667602|471315035|FG001|Overall Study|Withdrawal by Subject|9|||
130912507|NCT00667602|471315036|FG002|Overall Study|Withdrawal by Subject|10|||
130912508|NCT00667602|471315034|FG000|Overall Study|Lost to Follow-up|4|||
130912509|NCT00667602|471315035|FG001|Overall Study|Lost to Follow-up|5|||
130912510|NCT00667602|471315036|FG002|Overall Study|Lost to Follow-up|6|||
130912511|NCT00667602|471315034|FG000|Overall Study|Administrative reason|0|||
130912512|NCT00667602|471315035|FG001|Overall Study|Administrative reason|0|||
130912513|NCT00667602|471315036|FG002|Overall Study|Administrative reason|2|||
130696875|NCT01899053|470514537|FG009|Overall Study|Progressive Disease|3|||
130696876|NCT01899053|470514538|FG010|Overall Study|Progressive Disease|12|||
130912514|NCT00667602|471315034|FG000|Overall Study|Protocol Violation|0|||
130912515|NCT00667602|471315035|FG001|Overall Study|Protocol Violation|1|||
130912516|NCT00667602|471315036|FG002|Overall Study|Protocol Violation|0|||
131116918|NCT00332839|472060644|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
130696877|NCT01899053|470514539|FG011|Overall Study|Progressive Disease|5|||
130696878|NCT01899053|470514540|FG012|Overall Study|Progressive Disease|8|||
130696879|NCT01899053|470514541|FG013|Overall Study|Progressive Disease|17|||
130696880|NCT01899053|470514528|FG000|Overall Study|Adverse Event|1|||
130696881|NCT01899053|470514529|FG001|Overall Study|Adverse Event|1|||
130696882|NCT01899053|470514530|FG002|Overall Study|Adverse Event|1|||
130696883|NCT01899053|470514531|FG003|Overall Study|Adverse Event|3|||
130696884|NCT01899053|470514532|FG004|Overall Study|Adverse Event|1|||
130696885|NCT01899053|470514533|FG005|Overall Study|Adverse Event|1|||
130696886|NCT01899053|470514534|FG006|Overall Study|Adverse Event|1|||
130696887|NCT01899053|470514535|FG007|Overall Study|Adverse Event|0|||
130696888|NCT01899053|470514536|FG008|Overall Study|Adverse Event|2|||
130696889|NCT01899053|470514537|FG009|Overall Study|Adverse Event|0|||
130696890|NCT01899053|470514538|FG010|Overall Study|Adverse Event|3|||
130696891|NCT01899053|470514539|FG011|Overall Study|Adverse Event|1|||
130912517|NCT05169567|471315044|FG000|Overall Study|On study treatment|116|||
130912518|NCT05169567|471315045|FG001|Overall Study|On study treatment|128|||
130912519|NCT05169567|471315044|FG000|Overall Study|Lost to Follow-up|1|||
130912520|NCT05169567|471315045|FG001|Overall Study|Lost to Follow-up|0|||
130912521|NCT05169567|471315044|FG000|Overall Study|Withdrawal by Subject|25|||
130912522|NCT05169567|471315045|FG001|Overall Study|Withdrawal by Subject|21|||
130912523|NCT04382755|471315046|FG000|Overall Study|Withdrawal by Subject|1|||
130912524|NCT04382755|471315047|FG001|Overall Study|Withdrawal by Subject|0|||
130912525|NCT04382755|471315046|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
130912526|NCT04382755|471315047|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
130912527|NCT04382755|471315046|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
130912528|NCT04382755|471315047|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
130912529|NCT05069259|471315053|FG000|Overall Study|Withdrawal by Subject|1|||
130912530|NCT05069259|471315053|FG000|Overall Study|Sponsor decision|1|||
130912531|NCT03148275|471315054|FG000|Overall Study|Death|6|||
130912532|NCT03148275|471315054|FG000|Overall Study|Adverse Event|3|||
130912533|NCT03148275|471315054|FG000|Overall Study|Liver transplant|2|||
130912534|NCT03148275|471315054|FG000|Overall Study|Patient decision|5|||
130912535|NCT03148275|471315054|FG000|Overall Study|transition to commercial drug|1|||
130912536|NCT03148275|471315054|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
130912537|NCT05098938|471315055|FG000|Overall Study|Adverse Event|4|||
130696892|NCT01899053|470514540|FG012|Overall Study|Adverse Event|2|||
130696893|NCT01899053|470514541|FG013|Overall Study|Adverse Event|2|||
130696894|NCT01899053|470514528|FG000|Overall Study|Reason Not Specified|0|||
130696895|NCT01899053|470514529|FG001|Overall Study|Reason Not Specified|0|||
130696896|NCT01899053|470514530|FG002|Overall Study|Reason Not Specified|0|||
130696897|NCT01899053|470514531|FG003|Overall Study|Reason Not Specified|0|||
130912538|NCT05098938|471315056|FG001|Overall Study|Adverse Event|3|||
130912539|NCT05098938|471315055|FG000|Overall Study|inclusion/exclusion criteria change|11|||
130912540|NCT05098938|471315056|FG001|Overall Study|inclusion/exclusion criteria change|5|||
130912541|NCT05098938|471315055|FG000|Overall Study|lack of compliance|26|||
130912542|NCT05098938|471315056|FG001|Overall Study|lack of compliance|19|||
130912543|NCT05098938|471315055|FG000|Overall Study|Lost to Follow-up|37|||
130912544|NCT05098938|471315056|FG001|Overall Study|Lost to Follow-up|40|||
130912545|NCT05098938|471315055|FG000|Overall Study|Lost in treatment period|17|||
131031102|NCT03138512|471747978|FG002|Treatment Part A|Poor/non-compliance|0|||
131031103|NCT03138512|471747979|FG003|Treatment Part A|Poor/non-compliance|0|||
131031104|NCT03138512|471747980|FG004|Treatment Part A|Poor/non-compliance|0|||
131031105|NCT03138512|471747976|FG000|Treatment Part A|Pregnancy|0|||
131031106|NCT03138512|471747977|FG001|Treatment Part A|Pregnancy|1|||
131031107|NCT03138512|471747978|FG002|Treatment Part A|Pregnancy|0|||
131031108|NCT03138512|471747979|FG003|Treatment Part A|Pregnancy|0|||
131031109|NCT03138512|471747980|FG004|Treatment Part A|Pregnancy|0|||
131031110|NCT03138512|471747976|FG000|Treatment Part A|Other reasons|11|||
131031111|NCT03138512|471747977|FG001|Treatment Part A|Other reasons|8|||
131031112|NCT03138512|471747978|FG002|Treatment Part A|Other reasons|0|||
131031113|NCT03138512|471747979|FG003|Treatment Part A|Other reasons|0|||
131031114|NCT03138512|471747980|FG004|Treatment Part A|Other reasons|0|||
131031115|NCT03138512|471747976|FG000|Treatment Part B|Disease recurrence|0|||
131031116|NCT03138512|471747977|FG001|Treatment Part B|Disease recurrence|0|||
131031117|NCT03138512|471747978|FG002|Treatment Part B|Disease recurrence|6|||
131031118|NCT03138512|471747979|FG003|Treatment Part B|Disease recurrence|12|||
131031119|NCT03138512|471747980|FG004|Treatment Part B|Disease recurrence|10|||
131031120|NCT03138512|471747976|FG000|Treatment Part B|Study drug toxicity|0|||
130696898|NCT01899053|470514532|FG004|Overall Study|Reason Not Specified|0|||
130696899|NCT01899053|470514533|FG005|Overall Study|Reason Not Specified|0|||
130696900|NCT01899053|470514534|FG006|Overall Study|Reason Not Specified|1|||
130696901|NCT01899053|470514535|FG007|Overall Study|Reason Not Specified|0|||
130696902|NCT01899053|470514536|FG008|Overall Study|Reason Not Specified|0|||
130696903|NCT01899053|470514537|FG009|Overall Study|Reason Not Specified|0|||
130912546|NCT05098938|471315056|FG001|Overall Study|Lost in treatment period|13|||
130912547|NCT05098938|471315055|FG000|Overall Study|Met an exclusion criterion|0|||
130912548|NCT05098938|471315056|FG001|Overall Study|Met an exclusion criterion|3|||
130912549|NCT05098938|471315055|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
130912550|NCT05098938|471315056|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
130912551|NCT05098938|471315055|FG000|Overall Study|Physician Decision|25|||
130912552|NCT05098938|471315056|FG001|Overall Study|Physician Decision|32|||
130912553|NCT05098938|471315055|FG000|Overall Study|Run in failure in treatment phase|1|||
130912554|NCT05098938|471315056|FG001|Overall Study|Run in failure in treatment phase|1|||
130912555|NCT05098938|471315055|FG000|Overall Study|Withdrawal by Subject|0|||
130912556|NCT05098938|471315056|FG001|Overall Study|Withdrawal by Subject|3|||
130912557|NCT05098938|471315055|FG000|Overall Study|Run-in Failure in early study|505|||
130912558|NCT05098938|471315056|FG001|Overall Study|Run-in Failure in early study|514|||
130912559|NCT05098938|471315055|FG000|Overall Study|IMP delivery missed|1|||
130912560|NCT05098938|471315056|FG001|Overall Study|IMP delivery missed|5|||
130912561|NCT05098938|471315055|FG000|Overall Study|6 months visit was missed|2|||
130912562|NCT05098938|471315056|FG001|Overall Study|6 months visit was missed|0|||
130912563|NCT05098938|471315055|FG000|Overall Study|fit for use was not completed within window|3|||
130912564|NCT05098938|471315056|FG001|Overall Study|fit for use was not completed within window|0|||
130912565|NCT05098938|471315055|FG000|Overall Study|V2 visit was not completed within window|0|||
130912566|NCT05098938|471315056|FG001|Overall Study|V2 visit was not completed within window|1|||
130912567|NCT05098938|471315055|FG000|Overall Study|exclusionary medication use|1|||
130912568|NCT05098938|471315056|FG001|Overall Study|exclusionary medication use|2|||
130912569|NCT05098938|471315055|FG000|Overall Study|change in medication|1|||
130912570|NCT05098938|471315056|FG001|Overall Study|change in medication|0|||
131031121|NCT03138512|471747977|FG001|Treatment Part B|Study drug toxicity|0|||
131031122|NCT03138512|471747978|FG002|Treatment Part B|Study drug toxicity|63|||
131031123|NCT03138512|471747979|FG003|Treatment Part B|Study drug toxicity|3|||
131031124|NCT03138512|471747980|FG004|Treatment Part B|Study drug toxicity|45|||
131031125|NCT03138512|471747976|FG000|Treatment Part B|Death|0|||
131031126|NCT03138512|471747977|FG001|Treatment Part B|Death|0|||
131031127|NCT03138512|471747978|FG002|Treatment Part B|Death|1|||
131031128|NCT03138512|471747979|FG003|Treatment Part B|Death|0|||
131031129|NCT03138512|471747980|FG004|Treatment Part B|Death|0|||
131031130|NCT03138512|471747976|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
131031131|NCT03138512|471747977|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
131031132|NCT03138512|471747978|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
131031133|NCT03138512|471747979|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
131031134|NCT03138512|471747980|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
131031135|NCT03138512|471747976|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
131031136|NCT03138512|471747977|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
131031137|NCT03138512|471747978|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
131031138|NCT03138512|471747979|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
131031139|NCT03138512|471747980|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
131031140|NCT03138512|471747976|FG000|Treatment Part B|Participant withdrew consent|0|||
131031141|NCT03138512|471747977|FG001|Treatment Part B|Participant withdrew consent|0|||
131031142|NCT03138512|471747978|FG002|Treatment Part B|Participant withdrew consent|1|||
131031143|NCT03138512|471747979|FG003|Treatment Part B|Participant withdrew consent|1|||
131031144|NCT03138512|471747980|FG004|Treatment Part B|Participant withdrew consent|2|||
131031145|NCT03138512|471747976|FG000|Treatment Part B|Lost to Follow-up|0|||
131031146|NCT03138512|471747977|FG001|Treatment Part B|Lost to Follow-up|0|||
131031147|NCT03138512|471747978|FG002|Treatment Part B|Lost to Follow-up|0|||
131031148|NCT03138512|471747979|FG003|Treatment Part B|Lost to Follow-up|1|||
131031149|NCT03138512|471747980|FG004|Treatment Part B|Lost to Follow-up|0|||
131031150|NCT03138512|471747976|FG000|Treatment Part B|Poor/non-compliance|0|||
131031151|NCT03138512|471747977|FG001|Treatment Part B|Poor/non-compliance|0|||
131031152|NCT03138512|471747978|FG002|Treatment Part B|Poor/non-compliance|1|||
131031153|NCT03138512|471747979|FG003|Treatment Part B|Poor/non-compliance|1|||
131031154|NCT03138512|471747980|FG004|Treatment Part B|Poor/non-compliance|1|||
131031155|NCT03138512|471747976|FG000|Treatment Part B|Other reasons|0|||
131031156|NCT03138512|471747977|FG001|Treatment Part B|Other reasons|0|||
131031157|NCT03138512|471747978|FG002|Treatment Part B|Other reasons|3|||
131031158|NCT03138512|471747979|FG003|Treatment Part B|Other reasons|1|||
131031159|NCT03138512|471747980|FG004|Treatment Part B|Other reasons|5|||
131031160|NCT05687916|471747983|FG000|Overall Study|Adverse Event|1|||
131031161|NCT05687916|471747984|FG001|Overall Study|Adverse Event|2|||
131031162|NCT05687916|471747985|FG002|Overall Study|Adverse Event|0|||
131031163|NCT05687916|471747983|FG000|Overall Study|Withdrawal by Subject|1|||
131031164|NCT05687916|471747984|FG001|Overall Study|Withdrawal by Subject|0|||
131031165|NCT05687916|471747985|FG002|Overall Study|Withdrawal by Subject|1|||
131031166|NCT05687916|471747983|FG000|Overall Study|Protocol Violation|0|||
131031167|NCT05687916|471747984|FG001|Overall Study|Protocol Violation|2|||
131031168|NCT05687916|471747985|FG002|Overall Study|Protocol Violation|1|||
130912571|NCT05098938|471315055|FG000|Overall Study|treatment failure|2|||
130912572|NCT05098938|471315056|FG001|Overall Study|treatment failure|1|||
130912573|NCT01828320|471315057|FG000|Overall Study|Lost to Follow-up|1|||
130912574|NCT01828320|471315058|FG001|Overall Study|Lost to Follow-up|3|||
130912575|NCT01828320|471315057|FG000|Overall Study|Withdrawal by Subject|7|||
130912576|NCT01828320|471315058|FG001|Overall Study|Withdrawal by Subject|2|||
130912577|NCT02160782|471316440|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
130912578|NCT02160782|471316441|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
130912579|NCT02160782|471316442|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
130912580|NCT02160782|471316443|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
130912581|NCT02160782|471316444|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
130912582|NCT02160782|471316440|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
130912583|NCT02160782|471316441|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
131116919|NCT00332839|472060643|FG000|Core (Months 0 - 12)|Adverse Event|5|||
131116920|NCT00332839|472060644|FG001|Core (Months 0 - 12)|Adverse Event|15|||
131116921|NCT00332839|472060643|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
131116922|NCT00332839|472060644|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
131116923|NCT00332839|472060643|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
131116924|NCT00332839|472060644|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
131116925|NCT00332839|472060643|FG000|Follow-up (Months 12 - 60)|Death|1|||
131116926|NCT00332839|472060644|FG001|Follow-up (Months 12 - 60)|Death|1|||
131116927|NCT04641299|472060646|FG000|Overall Study|Adverse Event|0|||
131116928|NCT04641299|472060647|FG001|Overall Study|Adverse Event|0|||
131116929|NCT04641299|472060648|FG002|Overall Study|Adverse Event|2|||
131116930|NCT04641299|472060649|FG003|Overall Study|Adverse Event|0|||
131116931|NCT04641299|472060646|FG000|Overall Study|Lost to Follow-up|0|||
131116932|NCT04641299|472060647|FG001|Overall Study|Lost to Follow-up|1|||
131116933|NCT04641299|472060648|FG002|Overall Study|Lost to Follow-up|0|||
131116934|NCT04641299|472060649|FG003|Overall Study|Lost to Follow-up|0|||
131116935|NCT04641299|472060646|FG000|Overall Study|Withdrawal by Subject|1|||
131116936|NCT04641299|472060647|FG001|Overall Study|Withdrawal by Subject|0|||
131116937|NCT04641299|472060648|FG002|Overall Study|Withdrawal by Subject|0|||
131116938|NCT04641299|472060649|FG003|Overall Study|Withdrawal by Subject|0|||
131116939|NCT04641299|472060646|FG000|Overall Study|Reason not given|1|||
131116940|NCT04641299|472060647|FG001|Overall Study|Reason not given|0|||
131116941|NCT04641299|472060648|FG002|Overall Study|Reason not given|0|||
130768817|NCT04122625|470778587|FG000|Part B (up to 2.33 Years)|Death|0|||
130768818|NCT04122625|470778588|FG001|Part B (up to 2.33 Years)|Death|0|||
130768819|NCT04122625|470778589|FG002|Part B (up to 2.33 Years)|Death|5|||
130768820|NCT04122625|470778590|FG003|Part B (up to 2.33 Years)|Death|7|||
130768821|NCT04122625|470778591|FG004|Part B (up to 2.33 Years)|Death|6|||
130768822|NCT04122625|470778592|FG005|Part B (up to 2.33 Years)|Death|7|||
130768823|NCT01410240|470778593|FG000|Overall Study|Physician Decision|0|||
131116942|NCT04641299|472060649|FG003|Overall Study|Reason not given|0|||
131116943|NCT01920594|472060652|FG000|Overall Study|Adverse Event|4|||
131116944|NCT01920594|472060653|FG001|Overall Study|Adverse Event|2|||
131116945|NCT01920594|472060652|FG000|Overall Study|Lost to Follow-up|1|||
131116946|NCT01920594|472060653|FG001|Overall Study|Lost to Follow-up|0|||
131116947|NCT01920594|472060652|FG000|Overall Study|Recovery|2|||
131116948|NCT01920594|472060653|FG001|Overall Study|Recovery|0|||
131116949|NCT01920594|472060652|FG000|Overall Study|Investigator discretion|0|||
131116950|NCT01920594|472060653|FG001|Overall Study|Investigator discretion|1|||
131116951|NCT02460497|472060656|FG000|Overall Study|Participant Requested Withdrawal|4|||
131116952|NCT02460497|472060656|FG000|Overall Study|Non-Compliance|1|||
131116953|NCT02460497|472060656|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
131116954|NCT02460497|472060656|FG000|Overall Study|Lost to Follow-up|2|||
131116955|NCT02460497|472060656|FG000|Overall Study|Investigator Decision|1|||
131116956|NCT01448213|472060661|FG000|Overall Study|Lost to Follow-up|12|||
131116957|NCT01448213|472060662|FG001|Overall Study|Lost to Follow-up|10|||
131116958|NCT01448213|472060661|FG000|Overall Study|Adverse Event|4|||
131116959|NCT01448213|472060662|FG001|Overall Study|Adverse Event|10|||
131116960|NCT01448213|472060661|FG000|Overall Study|Protocol Violation|1|||
131116961|NCT01448213|472060662|FG001|Overall Study|Protocol Violation|2|||
131116962|NCT02012296|472060663|FG000|Overall Study|Lack of Efficacy|0|||
131116963|NCT02012296|472060664|FG001|Overall Study|Lack of Efficacy|0|||
131116964|NCT02012296|472060665|FG002|Overall Study|Lack of Efficacy|15|||
131116965|NCT02012296|472060663|FG000|Overall Study|Adverse Event|0|||
130768824|NCT01410240|470778594|FG001|Overall Study|Physician Decision|0|||
131116966|NCT02012296|472060664|FG001|Overall Study|Adverse Event|0|||
130768825|NCT01410240|470778595|FG002|Overall Study|Physician Decision|1|||
131116967|NCT02012296|472060665|FG002|Overall Study|Adverse Event|2|||
130768826|NCT01410240|470778593|FG000|Overall Study|Missed week 6 assessments|1|||
130768827|NCT01410240|470778594|FG001|Overall Study|Missed week 6 assessments|1|||
130912584|NCT02160782|471316442|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
130912585|NCT02160782|471316443|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
130768828|NCT01410240|470778595|FG002|Overall Study|Missed week 6 assessments|1|||
131116968|NCT02012296|472060663|FG000|Overall Study|Early study closure|0|||
131116969|NCT02012296|472060664|FG001|Overall Study|Early study closure|0|||
130768829|NCT02776670|470778596|FG000|Overall Study|Adverse Event|0|||
130768830|NCT02776670|470778597|FG001|Overall Study|Adverse Event|2|||
130768831|NCT02776670|470778596|FG000|Overall Study|Protocol Violation|0|||
130768832|NCT02776670|470778597|FG001|Overall Study|Protocol Violation|2|||
130768833|NCT02776670|470778596|FG000|Overall Study|Withdrawal by Subject|0|||
130768834|NCT02776670|470778597|FG001|Overall Study|Withdrawal by Subject|1|||
130768835|NCT02776670|470778596|FG000|Overall Study|Other - Reason not given|0|||
130768836|NCT02776670|470778597|FG001|Overall Study|Other - Reason not given|1|||
130768837|NCT02697591|470778600|FG000|Overall Study|Lost to Follow-up|0|||
130768838|NCT02697591|470778601|FG001|Overall Study|Lost to Follow-up|0|||
130768839|NCT02697591|470778602|FG002|Overall Study|Lost to Follow-up|0|||
130768840|NCT02697591|470778603|FG003|Overall Study|Lost to Follow-up|0|||
130768841|NCT02697591|470778604|FG004|Overall Study|Lost to Follow-up|0|||
131031169|NCT05687916|471747983|FG000|Overall Study|Reason not Specified|1|||
131031170|NCT05687916|471747984|FG001|Overall Study|Reason not Specified|0|||
131031171|NCT05687916|471747985|FG002|Overall Study|Reason not Specified|0|||
131031172|NCT03332017|471747986|FG000|Overall Study|Lost to Follow-up|1|||
131031173|NCT03332017|471747987|FG001|Overall Study|Lost to Follow-up|2|||
131031174|NCT03332017|471747986|FG000|Overall Study|Death|17|||
131031175|NCT03332017|471747987|FG001|Overall Study|Death|16|||
131031176|NCT03332017|471747986|FG000|Overall Study|Withdrawal by Subject|6|||
131031177|NCT03332017|471747987|FG001|Overall Study|Withdrawal by Subject|14|||
131031178|NCT03332017|471747986|FG000|Overall Study|Other|1|||
131031179|NCT03332017|471747987|FG001|Overall Study|Other|3|||
131031180|NCT03332017|471747986|FG000|Overall Study|Remained in Study (Ongoing)|47|||
131031181|NCT03332017|471747987|FG001|Overall Study|Remained in Study (Ongoing)|110|||
131031182|NCT03436745|471747988|FG000|Overall Study|Ineligible|0|||
131031183|NCT03436745|471747989|FG001|Overall Study|Ineligible|0|||
131031184|NCT03436745|471747990|FG002|Overall Study|Ineligible|1|||
131031185|NCT01809691|471747991|FG000|Overall Study|Currently on Treatment|192|||
131031186|NCT01809691|471747992|FG001|Overall Study|Currently on Treatment|100|||
131031187|NCT01809691|471747991|FG000|Overall Study|No Protocol Treatment|10|||
131031188|NCT01809691|471747992|FG001|Overall Study|No Protocol Treatment|11|||
131031189|NCT01809691|471747991|FG000|Overall Study|Adverse Event|80|||
131031190|NCT01809691|471747992|FG001|Overall Study|Adverse Event|21|||
131031191|NCT01809691|471747991|FG000|Overall Study|Disease Progression|226|||
131031192|NCT01809691|471747992|FG001|Overall Study|Disease Progression|372|||
131031193|NCT01809691|471747991|FG000|Overall Study|Death|26|||
131031194|NCT01809691|471747992|FG001|Overall Study|Death|13|||
131031195|NCT01809691|471747991|FG000|Overall Study|Participant Refusal|70|||
131031196|NCT01809691|471747992|FG001|Overall Study|Participant Refusal|72|||
131031197|NCT01809691|471747991|FG000|Overall Study|Other, Not Specified|34|||
131031198|NCT01809691|471747992|FG001|Overall Study|Other, Not Specified|52|||
131031199|NCT01580488|471747995|FG000|Overall Study|Withdrawal by Subject|1|||
131031200|NCT04401800|471747998|FG000|Overall Study|Death|17|||
131031201|NCT04401800|471747998|FG000|Overall Study|Lost to Follow-up|5|||
131031202|NCT04401800|471747998|FG000|Overall Study|Withdrawal by Subject|4|||
131031203|NCT03338790|471748005|FG000|Overall Study|Disease Progression|65|||
131031204|NCT03338790|471748006|FG001|Overall Study|Disease Progression|43|||
131031205|NCT03338790|471748007|FG002|Overall Study|Disease Progression|50|||
131031206|NCT03338790|471748008|FG003|Overall Study|Disease Progression|37|||
131031207|NCT03338790|471748005|FG000|Overall Study|Study Drug Toxicity|9|||
131031208|NCT03338790|471748006|FG001|Overall Study|Study Drug Toxicity|8|||
131031209|NCT03338790|471748007|FG002|Overall Study|Study Drug Toxicity|15|||
131031210|NCT03338790|471748008|FG003|Overall Study|Study Drug Toxicity|0|||
131031211|NCT03338790|471748005|FG000|Overall Study|Death|1|||
131031212|NCT03338790|471748006|FG001|Overall Study|Death|1|||
131031213|NCT03338790|471748007|FG002|Overall Study|Death|1|||
131031214|NCT03338790|471748008|FG003|Overall Study|Death|0|||
131031215|NCT03338790|471748005|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
131031216|NCT03338790|471748006|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
131031217|NCT03338790|471748007|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
131031218|NCT03338790|471748008|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
131031219|NCT03338790|471748005|FG000|Overall Study|Participant request to discontinue study treatment|3|||
131031220|NCT03338790|471748006|FG001|Overall Study|Participant request to discontinue study treatment|3|||
131031221|NCT03338790|471748007|FG002|Overall Study|Participant request to discontinue study treatment|2|||
131031222|NCT03338790|471748008|FG003|Overall Study|Participant request to discontinue study treatment|1|||
131031223|NCT03338790|471748005|FG000|Overall Study|Poor/non-compliance|0|||
131031224|NCT03338790|471748006|FG001|Overall Study|Poor/non-compliance|1|||
131031225|NCT03338790|471748007|FG002|Overall Study|Poor/non-compliance|0|||
131031226|NCT03338790|471748008|FG003|Overall Study|Poor/non-compliance|0|||
131031227|NCT03338790|471748005|FG000|Overall Study|Participant withdrew consent|1|||
131031228|NCT03338790|471748006|FG001|Overall Study|Participant withdrew consent|0|||
131031229|NCT03338790|471748007|FG002|Overall Study|Participant withdrew consent|1|||
131031230|NCT03338790|471748008|FG003|Overall Study|Participant withdrew consent|1|||
130768842|NCT02697591|470778605|FG005|Overall Study|Lost to Follow-up|1|||
130768843|NCT02697591|470778606|FG006|Overall Study|Lost to Follow-up|1|||
131031231|NCT03338790|471748005|FG000|Overall Study|Other reasons|0|||
131116970|NCT02012296|472060665|FG002|Overall Study|Early study closure|5|||
131116971|NCT02012296|472060663|FG000|Overall Study|Protocol Violation|0|||
131116972|NCT02012296|472060664|FG001|Overall Study|Protocol Violation|1|||
131116973|NCT02012296|472060665|FG002|Overall Study|Protocol Violation|0|||
131116974|NCT01330914|472060666|FG000|Overall Study|Withdrawal by Subject|4|||
131116975|NCT01330914|472060666|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
131116976|NCT03631667|472060671|FG000|Overall Study|Withdrawal by Subject|3|||
131116977|NCT00884325|472060672|FG000|Overall Study|Lost to Follow-up|1|||
131116978|NCT00884325|472060673|FG001|Overall Study|Lost to Follow-up|2|||
131116979|NCT00884325|472060672|FG000|Overall Study|Lack of Efficacy|0|||
131116980|NCT00884325|472060673|FG001|Overall Study|Lack of Efficacy|1|||
131116981|NCT00884325|472060672|FG000|Overall Study|Withdrawal by Subject|1|||
131116982|NCT00884325|472060673|FG001|Overall Study|Withdrawal by Subject|1|||
131116983|NCT00884325|472060672|FG000|Overall Study|Not provided|1|||
131116984|NCT00884325|472060673|FG001|Overall Study|Not provided|0|||
131116985|NCT00892177|472060674|FG000|Phase II|Ineligible|0|||
131116986|NCT00892177|472060675|FG001|Phase II|Ineligible|0|||
131116987|NCT00892177|472060676|FG002|Phase II|Ineligible|0|||
131116988|NCT00892177|472060677|FG003|Phase II|Ineligible|0|||
131116989|NCT00892177|472060678|FG004|Phase II|Ineligible|1|||
131116990|NCT00892177|472060679|FG005|Phase II|Ineligible|1|||
131116991|NCT00892177|472060674|FG000|Phase II|Withdrawal by Subject|0|||
131116992|NCT00892177|472060675|FG001|Phase II|Withdrawal by Subject|0|||
131116993|NCT00892177|472060676|FG002|Phase II|Withdrawal by Subject|0|||
131116994|NCT00892177|472060677|FG003|Phase II|Withdrawal by Subject|0|||
131116995|NCT00892177|472060678|FG004|Phase II|Withdrawal by Subject|4|||
131116996|NCT00892177|472060679|FG005|Phase II|Withdrawal by Subject|1|||
131116997|NCT00381563|472060685|FG000|Overall Study|Withdrawal by Subject|5|||
131116998|NCT00381563|472060686|FG001|Overall Study|Withdrawal by Subject|5|||
131116999|NCT00381563|472060685|FG000|Overall Study|Lost to Follow-up|2|||
131117000|NCT00381563|472060686|FG001|Overall Study|Lost to Follow-up|0|||
131117001|NCT00381563|472060685|FG000|Overall Study|Protocol Violation|0|||
131117002|NCT00381563|472060686|FG001|Overall Study|Protocol Violation|1|||
131117003|NCT01109173|472060688|FG000|Overall Study|Adverse Event|15|||
130912586|NCT02160782|471316444|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
130912587|NCT02160782|471316440|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
131031232|NCT03338790|471748006|FG001|Overall Study|Other reasons|5|||
131031233|NCT03338790|471748007|FG002|Overall Study|Other reasons|0|||
131031234|NCT03338790|471748008|FG003|Overall Study|Other reasons|2|||
131031235|NCT03338790|471748005|FG000|Overall Study|Not reported|0|||
131031236|NCT03338790|471748006|FG001|Overall Study|Not reported|0|||
131031237|NCT03338790|471748007|FG002|Overall Study|Not reported|1|||
131031238|NCT03338790|471748008|FG003|Overall Study|Not reported|0|||
131031239|NCT03338790|471748005|FG000|Overall Study|Completed treatment period|1|||
131031240|NCT03338790|471748006|FG001|Overall Study|Completed treatment period|2|||
131031241|NCT03338790|471748007|FG002|Overall Study|Completed treatment period|0|||
131031242|NCT03338790|471748008|FG003|Overall Study|Completed treatment period|0|||
131031243|NCT04588298|471748015|FG000|Overall Study|Adverse Event|0|||
131031244|NCT04588298|471748016|FG001|Overall Study|Adverse Event|0|||
131031245|NCT04588298|471748017|FG002|Overall Study|Adverse Event|1|||
131031246|NCT04588298|471748018|FG003|Overall Study|Adverse Event|0|||
131031247|NCT04588298|471748019|FG004|Overall Study|Adverse Event|2|||
131031248|NCT04588298|471748015|FG000|Overall Study|Withdrawal by Subject|1|||
131031249|NCT04588298|471748016|FG001|Overall Study|Withdrawal by Subject|0|||
131031250|NCT04588298|471748017|FG002|Overall Study|Withdrawal by Subject|0|||
131031251|NCT04588298|471748018|FG003|Overall Study|Withdrawal by Subject|1|||
131031252|NCT04588298|471748019|FG004|Overall Study|Withdrawal by Subject|0|||
131031253|NCT05592418|471748022|FG000|Overall Study|Adverse Event|1|||
131031254|NCT05592418|471748023|FG001|Overall Study|Adverse Event|0|||
131031255|NCT05592418|471748022|FG000|Overall Study|Lost to Follow-up|1|||
131031256|NCT05592418|471748023|FG001|Overall Study|Lost to Follow-up|3|||
131031257|NCT05592418|471748022|FG000|Overall Study|Withdrawal by Subject|2|||
131031258|NCT05592418|471748023|FG001|Overall Study|Withdrawal by Subject|7|||
131031259|NCT05569252|471748027|FG000|Overall Study|Adverse event (central vision loss)|1|||
131031260|NCT05569252|471748028|FG001|Overall Study|Adverse event (central vision loss)|0|||
131031261|NCT05569252|471748029|FG002|Overall Study|Adverse event (central vision loss)|0|||
131031262|NCT05569252|471748030|FG003|Overall Study|Adverse event (central vision loss)|0|||
131031263|NCT03665597|471748031|FG000|Period 1|Adverse Event|1|||
131031264|NCT03665597|471748032|FG001|Period 1|Adverse Event|0|||
131031265|NCT03665597|471748033|FG002|Period 1|Adverse Event|0|||
131031266|NCT03665597|471748034|FG003|Period 1|Adverse Event|1|||
131031267|NCT03665597|471748035|FG004|Period 1|Adverse Event|0|||
131031268|NCT03665597|471748036|FG005|Period 1|Adverse Event|0|||
131031269|NCT03665597|471748037|FG006|Period 1|Adverse Event|0|||
131117004|NCT01109173|472060689|FG001|Overall Study|Adverse Event|17|||
131031270|NCT03665597|471748031|FG000|Period 1|Screen Failure|0|||
131031271|NCT03665597|471748032|FG001|Period 1|Screen Failure|0|||
131117005|NCT01109173|472060690|FG002|Overall Study|Adverse Event|9|||
131117006|NCT01109173|472060691|FG003|Overall Study|Adverse Event|6|||
130768844|NCT02697591|470778607|FG007|Overall Study|Lost to Follow-up|0|||
131031272|NCT03665597|471748033|FG002|Period 1|Screen Failure|0|||
131031273|NCT03665597|471748034|FG003|Period 1|Screen Failure|1|||
131031274|NCT03665597|471748035|FG004|Period 1|Screen Failure|0|||
131031275|NCT03665597|471748036|FG005|Period 1|Screen Failure|0|||
131031276|NCT03665597|471748037|FG006|Period 1|Screen Failure|0|||
131031277|NCT03665597|471748031|FG000|Period 1|Death|0|||
131031278|NCT03665597|471748032|FG001|Period 1|Death|0|||
131031279|NCT03665597|471748033|FG002|Period 1|Death|0|||
131031280|NCT03665597|471748034|FG003|Period 1|Death|0|||
131031281|NCT03665597|471748035|FG004|Period 1|Death|0|||
131031282|NCT03665597|471748036|FG005|Period 1|Death|0|||
131031283|NCT03665597|471748037|FG006|Period 1|Death|45|||
131031284|NCT03665597|471748031|FG000|Period 1|Withdrawal by Subject|0|||
131031285|NCT03665597|471748032|FG001|Period 1|Withdrawal by Subject|0|||
131031286|NCT03665597|471748033|FG002|Period 1|Withdrawal by Subject|0|||
131031287|NCT03665597|471748034|FG003|Period 1|Withdrawal by Subject|0|||
131031288|NCT03665597|471748035|FG004|Period 1|Withdrawal by Subject|0|||
131031289|NCT03665597|471748036|FG005|Period 1|Withdrawal by Subject|0|||
131031290|NCT03665597|471748037|FG006|Period 1|Withdrawal by Subject|5|||
131031291|NCT03665597|471748031|FG000|Period 2|Adverse Event|0|||
131031292|NCT03665597|471748032|FG001|Period 2|Adverse Event|0|||
131031293|NCT03665597|471748033|FG002|Period 2|Adverse Event|0|||
131031294|NCT03665597|471748034|FG003|Period 2|Adverse Event|0|||
131031295|NCT03665597|471748035|FG004|Period 2|Adverse Event|0|||
131031296|NCT03665597|471748036|FG005|Period 2|Adverse Event|1|||
131031297|NCT03665597|471748037|FG006|Period 2|Adverse Event|0|||
131031298|NCT03665597|471748031|FG000|Period 3|Adverse Event|0|||
131031299|NCT03665597|471748032|FG001|Period 3|Adverse Event|1|||
130768845|NCT02697591|470778608|FG008|Overall Study|Lost to Follow-up|0|||
130768846|NCT02697591|470778609|FG009|Overall Study|Lost to Follow-up|1|||
130768847|NCT02697591|470778600|FG000|Overall Study|Withdrawal by Subject|1|||
130768848|NCT02697591|470778601|FG001|Overall Study|Withdrawal by Subject|1|||
130768849|NCT02697591|470778602|FG002|Overall Study|Withdrawal by Subject|2|||
130768850|NCT02697591|470778603|FG003|Overall Study|Withdrawal by Subject|1|||
130768851|NCT02697591|470778604|FG004|Overall Study|Withdrawal by Subject|7|||
130768852|NCT02697591|470778605|FG005|Overall Study|Withdrawal by Subject|6|||
130768853|NCT02697591|470778606|FG006|Overall Study|Withdrawal by Subject|9|||
130768854|NCT02697591|470778607|FG007|Overall Study|Withdrawal by Subject|1|||
130768855|NCT02697591|470778608|FG008|Overall Study|Withdrawal by Subject|6|||
130768856|NCT02697591|470778609|FG009|Overall Study|Withdrawal by Subject|10|||
130768857|NCT02697591|470778600|FG000|Overall Study|Physician Decision|1|||
130768858|NCT02697591|470778601|FG001|Overall Study|Physician Decision|0|||
130768859|NCT02697591|470778602|FG002|Overall Study|Physician Decision|0|||
130768860|NCT02697591|470778603|FG003|Overall Study|Physician Decision|0|||
130768861|NCT02697591|470778604|FG004|Overall Study|Physician Decision|1|||
130768862|NCT02697591|470778605|FG005|Overall Study|Physician Decision|2|||
130768863|NCT02697591|470778606|FG006|Overall Study|Physician Decision|0|||
130768864|NCT02697591|470778607|FG007|Overall Study|Physician Decision|0|||
130768865|NCT02697591|470778608|FG008|Overall Study|Physician Decision|1|||
130768866|NCT02697591|470778609|FG009|Overall Study|Physician Decision|1|||
130768867|NCT02697591|470778600|FG000|Overall Study|Death|2|||
130768868|NCT02697591|470778601|FG001|Overall Study|Death|3|||
130768869|NCT02697591|470778602|FG002|Overall Study|Death|1|||
130768870|NCT02697591|470778603|FG003|Overall Study|Death|1|||
130768871|NCT02697591|470778604|FG004|Overall Study|Death|4|||
130768872|NCT02697591|470778605|FG005|Overall Study|Death|5|||
130768873|NCT02697591|470778606|FG006|Overall Study|Death|3|||
130768874|NCT02697591|470778607|FG007|Overall Study|Death|1|||
130768875|NCT02697591|470778608|FG008|Overall Study|Death|1|||
130768876|NCT02697591|470778609|FG009|Overall Study|Death|5|||
130768877|NCT02697591|470778600|FG000|Overall Study|Reason not Specified|0|||
131031300|NCT03665597|471748033|FG002|Period 3|Adverse Event|0|||
131031301|NCT03665597|471748034|FG003|Period 3|Adverse Event|0|||
130768878|NCT02697591|470778601|FG001|Overall Study|Reason not Specified|0|||
130768879|NCT02697591|470778602|FG002|Overall Study|Reason not Specified|0|||
130768880|NCT02697591|470778603|FG003|Overall Study|Reason not Specified|1|||
130768881|NCT02697591|470778604|FG004|Overall Study|Reason not Specified|1|||
130768882|NCT02697591|470778605|FG005|Overall Study|Reason not Specified|2|||
130768883|NCT02697591|470778606|FG006|Overall Study|Reason not Specified|3|||
130768884|NCT02697591|470778607|FG007|Overall Study|Reason not Specified|1|||
130768885|NCT02697591|470778608|FG008|Overall Study|Reason not Specified|1|||
130768886|NCT02697591|470778609|FG009|Overall Study|Reason not Specified|3|||
131031302|NCT03665597|471748035|FG004|Period 3|Adverse Event|0|||
131031303|NCT03665597|471748036|FG005|Period 3|Adverse Event|0|||
131031304|NCT03665597|471748037|FG006|Period 3|Adverse Event|0|||
131031305|NCT03665597|471748031|FG000|Period 3|Death|0|||
131031306|NCT03665597|471748032|FG001|Period 3|Death|0|||
131031307|NCT03665597|471748033|FG002|Period 3|Death|0|||
131031308|NCT03665597|471748034|FG003|Period 3|Death|0|||
131031309|NCT03665597|471748035|FG004|Period 3|Death|1|||
131031310|NCT03665597|471748036|FG005|Period 3|Death|0|||
131031311|NCT03665597|471748037|FG006|Period 3|Death|0|||
131031312|NCT03665597|471748031|FG000|Period 4|Adverse Event|2|||
131117007|NCT01109173|472060688|FG000|Overall Study|Lost to Follow-up|0|||
131117008|NCT01109173|472060689|FG001|Overall Study|Lost to Follow-up|1|||
131117009|NCT01109173|472060690|FG002|Overall Study|Lost to Follow-up|0|||
131117010|NCT01109173|472060691|FG003|Overall Study|Lost to Follow-up|0|||
131117011|NCT01109173|472060688|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
131117012|NCT01109173|472060689|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
131117013|NCT01109173|472060690|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
131117014|NCT01109173|472060691|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
131117015|NCT01109173|472060688|FG000|Overall Study|Noncompliance|0|||
131117016|NCT01109173|472060689|FG001|Overall Study|Noncompliance|1|||
131117017|NCT01109173|472060690|FG002|Overall Study|Noncompliance|0|||
131117018|NCT01109173|472060691|FG003|Overall Study|Noncompliance|0|||
131117019|NCT01109173|472060688|FG000|Overall Study|Treatment Failure|25|||
131117020|NCT01109173|472060689|FG001|Overall Study|Treatment Failure|32|||
131117021|NCT01109173|472060690|FG002|Overall Study|Treatment Failure|69|||
131117022|NCT01109173|472060691|FG003|Overall Study|Treatment Failure|64|||
131117023|NCT01109173|472060688|FG000|Overall Study|Protocol Violation|4|||
131117024|NCT01109173|472060689|FG001|Overall Study|Protocol Violation|5|||
131117025|NCT01109173|472060690|FG002|Overall Study|Protocol Violation|1|||
131117026|NCT01109173|472060691|FG003|Overall Study|Protocol Violation|2|||
131117027|NCT01109173|472060688|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
131117028|NCT01109173|472060689|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
131117029|NCT01109173|472060690|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
131117030|NCT01109173|472060691|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
131117031|NCT01109173|472060688|FG000|Overall Study|Not Specifiied|5|||
131117032|NCT01109173|472060689|FG001|Overall Study|Not Specifiied|4|||
131117033|NCT01109173|472060690|FG002|Overall Study|Not Specifiied|9|||
131117034|NCT01109173|472060691|FG003|Overall Study|Not Specifiied|14|||
131117035|NCT00006392|472060699|FG000|Overall Study|Ineligible|11|||
131117036|NCT00006392|472060700|FG001|Overall Study|Ineligible|3|||
131117037|NCT00006392|472060701|FG002|Overall Study|Ineligible|5|||
131117038|NCT00006392|472060702|FG003|Overall Study|Ineligible|5|||
131117039|NCT00006392|472060699|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
131117040|NCT00006392|472060700|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
131117041|NCT00006392|472060701|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
131117042|NCT00006392|472060702|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
131117043|NCT01186796|472060703|FG000|Overall Study|Adverse Event|3|||
131117044|NCT01186796|472060704|FG001|Overall Study|Adverse Event|0|||
131117045|NCT01186796|472060703|FG000|Overall Study|Withdrawal by Subject|1|||
131117046|NCT01186796|472060704|FG001|Overall Study|Withdrawal by Subject|1|||
131117047|NCT01186796|472060703|FG000|Overall Study|Protocol Violation|0|||
131117048|NCT01186796|472060704|FG001|Overall Study|Protocol Violation|1|||
131117049|NCT03933397|472060708|FG000|Overall Study|No emergency department visit|65|||
131117050|NCT03933397|472060709|FG001|Overall Study|No emergency department visit|71|||
131117051|NCT03933397|472060708|FG000|Overall Study|Missed emergency department visit|25|||
131117052|NCT03933397|472060709|FG001|Overall Study|Missed emergency department visit|30|||
131117053|NCT03933397|472060708|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
131117054|NCT03933397|472060709|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
131117055|NCT03933397|472060708|FG000|Overall Study|Withdrawal by Subject|1|||
131117056|NCT03933397|472060709|FG001|Overall Study|Withdrawal by Subject|0|||
131117057|NCT03933397|472060708|FG000|Overall Study|Physician Decision|1|||
131117058|NCT03933397|472060709|FG001|Overall Study|Physician Decision|1|||
131117059|NCT03933397|472060708|FG000|Overall Study|missing pain score|1|||
131117060|NCT03933397|472060709|FG001|Overall Study|missing pain score|1|||
131117061|NCT03933397|472060708|FG000|Overall Study|Confirmed COVID-19|1|||
131117062|NCT03933397|472060709|FG001|Overall Study|Confirmed COVID-19|2|||
131117063|NCT01910116|472060710|FG000|Overall Study|Adverse Event|0|||
131117064|NCT01910116|472060711|FG001|Overall Study|Adverse Event|3|||
131117065|NCT01910116|472060710|FG000|Overall Study|Lack of Efficacy|3|||
131117066|NCT01910116|472060711|FG001|Overall Study|Lack of Efficacy|4|||
131117067|NCT01910116|472060710|FG000|Overall Study|Lost to Follow-up|1|||
131117068|NCT01910116|472060711|FG001|Overall Study|Lost to Follow-up|0|||
131117069|NCT01910116|472060710|FG000|Overall Study|Protocol Violation|1|||
131117070|NCT01910116|472060711|FG001|Overall Study|Protocol Violation|2|||
131117071|NCT01910116|472060710|FG000|Overall Study|Withdrawal by Subject|8|||
131117072|NCT01910116|472060711|FG001|Overall Study|Withdrawal by Subject|3|||
131117073|NCT01910116|472060710|FG000|Overall Study|uncertain allocation|1|||
131117074|NCT01910116|472060711|FG001|Overall Study|uncertain allocation|3|||
131117075|NCT01910116|472060710|FG000|Overall Study|incomplete data|0|||
131117076|NCT01910116|472060711|FG001|Overall Study|incomplete data|1|||
131117077|NCT04029116|472060712|FG000|Overall Study|Adverse Event|0|||
131117078|NCT04029116|472060713|FG001|Overall Study|Adverse Event|2|||
131117079|NCT04029116|472060712|FG000|Overall Study|Lost to Follow-up|3|||
131117080|NCT04029116|472060713|FG001|Overall Study|Lost to Follow-up|5|||
131117081|NCT04029116|472060712|FG000|Overall Study|Physician Decision|2|||
131117082|NCT04029116|472060713|FG001|Overall Study|Physician Decision|0|||
130696904|NCT01899053|470514538|FG010|Overall Study|Reason Not Specified|0|||
130696905|NCT01899053|470514539|FG011|Overall Study|Reason Not Specified|0|||
130696906|NCT01899053|470514540|FG012|Overall Study|Reason Not Specified|1|||
130696907|NCT01899053|470514541|FG013|Overall Study|Reason Not Specified|0|||
130696908|NCT01899053|470514528|FG000|Overall Study|Withdrawal by Subject|1|||
130696909|NCT01899053|470514529|FG001|Overall Study|Withdrawal by Subject|1|||
130696910|NCT01899053|470514530|FG002|Overall Study|Withdrawal by Subject|2|||
130696911|NCT01899053|470514531|FG003|Overall Study|Withdrawal by Subject|0|||
130696912|NCT01899053|470514532|FG004|Overall Study|Withdrawal by Subject|2|||
130696913|NCT01899053|470514533|FG005|Overall Study|Withdrawal by Subject|0|||
130696914|NCT01899053|470514534|FG006|Overall Study|Withdrawal by Subject|0|||
130696915|NCT01899053|470514535|FG007|Overall Study|Withdrawal by Subject|1|||
130696916|NCT01899053|470514536|FG008|Overall Study|Withdrawal by Subject|0|||
130696917|NCT01899053|470514537|FG009|Overall Study|Withdrawal by Subject|0|||
130696918|NCT01899053|470514538|FG010|Overall Study|Withdrawal by Subject|0|||
130696919|NCT01899053|470514539|FG011|Overall Study|Withdrawal by Subject|0|||
130696920|NCT01899053|470514540|FG012|Overall Study|Withdrawal by Subject|1|||
130696921|NCT01899053|470514541|FG013|Overall Study|Withdrawal by Subject|1|||
130696922|NCT01899053|470514528|FG000|Overall Study|Protocol Violation|0|||
130696923|NCT01899053|470514529|FG001|Overall Study|Protocol Violation|0|||
130696924|NCT01899053|470514530|FG002|Overall Study|Protocol Violation|1|||
130696925|NCT01899053|470514531|FG003|Overall Study|Protocol Violation|0|||
130696926|NCT01899053|470514532|FG004|Overall Study|Protocol Violation|0|||
130696927|NCT01899053|470514533|FG005|Overall Study|Protocol Violation|0|||
130696928|NCT01899053|470514534|FG006|Overall Study|Protocol Violation|0|||
130696929|NCT01899053|470514535|FG007|Overall Study|Protocol Violation|0|||
130696930|NCT01899053|470514536|FG008|Overall Study|Protocol Violation|0|||
130696931|NCT01899053|470514537|FG009|Overall Study|Protocol Violation|0|||
130696932|NCT01899053|470514538|FG010|Overall Study|Protocol Violation|0|||
130696933|NCT01899053|470514539|FG011|Overall Study|Protocol Violation|0|||
130696934|NCT01899053|470514540|FG012|Overall Study|Protocol Violation|0|||
130696935|NCT01899053|470514541|FG013|Overall Study|Protocol Violation|0|||
130696936|NCT01899053|470514528|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
130696937|NCT01899053|470514529|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
130696938|NCT01899053|470514530|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696939|NCT01899053|470514531|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696940|NCT01899053|470514532|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696941|NCT01899053|470514533|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696942|NCT01899053|470514534|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696943|NCT01899053|470514535|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696944|NCT01899053|470514536|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696945|NCT01899053|470514537|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696946|NCT01899053|470514538|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
130768887|NCT00624832|470778614|FG000|Overall Study|Adverse Event|0|||
131031313|NCT03665597|471748032|FG001|Period 4|Adverse Event|2|||
131031314|NCT03665597|471748033|FG002|Period 4|Adverse Event|2|||
131031315|NCT03665597|471748034|FG003|Period 4|Adverse Event|2|||
131031316|NCT03665597|471748035|FG004|Period 4|Adverse Event|1|||
131031317|NCT03665597|471748036|FG005|Period 4|Adverse Event|0|||
131031318|NCT03665597|471748037|FG006|Period 4|Adverse Event|0|||
131031319|NCT03665597|471748031|FG000|Period 4|Death|0|||
131031320|NCT03665597|471748032|FG001|Period 4|Death|0|||
131031321|NCT03665597|471748033|FG002|Period 4|Death|2|||
131031322|NCT03665597|471748034|FG003|Period 4|Death|0|||
131031323|NCT03665597|471748035|FG004|Period 4|Death|0|||
131031324|NCT03665597|471748036|FG005|Period 4|Death|0|||
131031325|NCT03665597|471748037|FG006|Period 4|Death|0|||
131031326|NCT03665597|471748031|FG000|Period 4|Physician Decision|1|||
131031327|NCT03665597|471748032|FG001|Period 4|Physician Decision|2|||
131031328|NCT03665597|471748033|FG002|Period 4|Physician Decision|0|||
131031329|NCT03665597|471748034|FG003|Period 4|Physician Decision|0|||
131031330|NCT03665597|471748035|FG004|Period 4|Physician Decision|0|||
131031331|NCT03665597|471748036|FG005|Period 4|Physician Decision|0|||
131031332|NCT03665597|471748037|FG006|Period 4|Physician Decision|0|||
131031333|NCT04831216|471748038|FG000|Overall Study|Lost to Follow-up|32|||
130696947|NCT01899053|470514539|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696948|NCT01899053|470514540|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696949|NCT01899053|470514541|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
130696950|NCT01899053|470514528|FG000|Overall Study|Symptomatic Deterioration|0|||
130696951|NCT01899053|470514529|FG001|Overall Study|Symptomatic Deterioration|0|||
130696952|NCT01899053|470514530|FG002|Overall Study|Symptomatic Deterioration|0|||
130696953|NCT01899053|470514531|FG003|Overall Study|Symptomatic Deterioration|0|||
130696954|NCT01899053|470514532|FG004|Overall Study|Symptomatic Deterioration|0|||
131031334|NCT03110315|471748045|FG000|Overall Study|Withdrawal by Subject|1|||
131031335|NCT03110315|471748046|FG001|Overall Study|Withdrawal by Subject|0|||
131031336|NCT04727554|471748048|FG000|Overall Study|Lost to Follow-up|0|||
131031337|NCT04727554|471748049|FG001|Overall Study|Lost to Follow-up|1|||
131031338|NCT04727554|471748048|FG000|Overall Study|Death|2|||
131031339|NCT04727554|471748049|FG001|Overall Study|Death|6|||
131222827|NCT03674827|472443189|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
130696955|NCT01899053|470514533|FG005|Overall Study|Symptomatic Deterioration|1|||
130696956|NCT01899053|470514534|FG006|Overall Study|Symptomatic Deterioration|0|||
130696957|NCT01899053|470514535|FG007|Overall Study|Symptomatic Deterioration|1|||
130696958|NCT01899053|470514536|FG008|Overall Study|Symptomatic Deterioration|0|||
130696959|NCT01899053|470514537|FG009|Overall Study|Symptomatic Deterioration|0|||
130696960|NCT01899053|470514538|FG010|Overall Study|Symptomatic Deterioration|0|||
131031340|NCT04727554|471748048|FG000|Overall Study|Withdrawal by Subject|1|||
131031341|NCT04727554|471748049|FG001|Overall Study|Withdrawal by Subject|0|||
131031342|NCT03930342|471748050|FG000|Overall Study|Lost to Follow-up|70|||
131031343|NCT03930342|471748051|FG001|Overall Study|Lost to Follow-up|77|||
131031344|NCT04060355|471749594|FG000|Overall Study|Lost to Follow-up|41|||
131031345|NCT01140880|471749595|FG000|Overall Study|Death|0|||
131031346|NCT01140880|471749596|FG001|Overall Study|Death|1|||
131031347|NCT01140880|471749595|FG000|Overall Study|Withdrawal by Subject|6|||
131031348|NCT01140880|471749596|FG001|Overall Study|Withdrawal by Subject|3|||
131031349|NCT01140880|471749595|FG000|Overall Study|Lost to Follow-up|8|||
131031350|NCT01140880|471749596|FG001|Overall Study|Lost to Follow-up|10|||
131031351|NCT01140880|471749595|FG000|Overall Study|Protocol Violation|0|||
131031352|NCT01140880|471749596|FG001|Overall Study|Protocol Violation|30|||
131031353|NCT05034952|471749598|FG000|Overall Study|Adverse Event|1|||
131031354|NCT05034952|471749599|FG001|Overall Study|Adverse Event|0|||
131031355|NCT05034952|471749600|FG002|Overall Study|Adverse Event|0|||
131031356|NCT05034952|471749601|FG003|Overall Study|Adverse Event|0|||
131031357|NCT05034952|471749598|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
131031358|NCT05034952|471749599|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
131031359|NCT05034952|471749600|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
131031360|NCT05034952|471749601|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
131031361|NCT05034952|471749598|FG000|Overall Study|Lost to Follow-up|1|||
131031362|NCT05034952|471749599|FG001|Overall Study|Lost to Follow-up|4|||
131031363|NCT05034952|471749600|FG002|Overall Study|Lost to Follow-up|3|||
131031364|NCT05034952|471749601|FG003|Overall Study|Lost to Follow-up|3|||
131031365|NCT05034952|471749598|FG000|Overall Study|Other|0|||
131031366|NCT05034952|471749599|FG001|Overall Study|Other|0|||
131031367|NCT05034952|471749600|FG002|Overall Study|Other|0|||
131031368|NCT05034952|471749601|FG003|Overall Study|Other|1|||
131031369|NCT04950660|471749602|FG000|Overall Study|Protocol Violation|4|||
131031370|NCT04950660|471749603|FG001|Overall Study|Protocol Violation|2|||
131031371|NCT04950660|471749602|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
131031372|NCT04950660|471749603|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
131031373|NCT04950660|471749602|FG000|Overall Study|Withdrawal by Subject|0|||
131031374|NCT04950660|471749603|FG001|Overall Study|Withdrawal by Subject|1|||
131031375|NCT04950660|471749602|FG000|Overall Study|Hypotension|1|||
131031376|NCT04950660|471749603|FG001|Overall Study|Hypotension|0|||
131031377|NCT02437318|471749610|FG000|Overall Study|Progressive disease|207|||
131031378|NCT02437318|471749611|FG001|Overall Study|Progressive disease|240|||
131031379|NCT02437318|471749610|FG000|Overall Study|Subject/guardian decision|24|||
131031380|NCT02437318|471749611|FG001|Overall Study|Subject/guardian decision|11|||
131031381|NCT02437318|471749610|FG000|Overall Study|Physician Decision|29|||
131031382|NCT02437318|471749611|FG001|Overall Study|Physician Decision|22|||
131031383|NCT02437318|471749610|FG000|Overall Study|Adverse Event|14|||
131031384|NCT02437318|471749611|FG001|Overall Study|Adverse Event|4|||
131031385|NCT02437318|471749610|FG000|Overall Study|Death|4|||
131031386|NCT02437318|471749611|FG001|Overall Study|Death|4|||
131031387|NCT02437318|471749610|FG000|Overall Study|Protocol deviation|5|||
131031388|NCT02437318|471749611|FG001|Overall Study|Protocol deviation|7|||
131031389|NCT02437318|471749610|FG000|Overall Study|Sponsor decision|1|||
131031390|NCT02437318|471749611|FG001|Overall Study|Sponsor decision|0|||
131031391|NCT00920621|471749613|FG000|Overall Study|Lost to Follow-up|16|||
131031392|NCT00920621|471749614|FG001|Overall Study|Lost to Follow-up|17|||
131031393|NCT00920621|471749615|FG002|Overall Study|Lost to Follow-up|19|||
131031394|NCT00920621|471749616|FG003|Overall Study|Lost to Follow-up|21|||
131031395|NCT00920621|471749613|FG000|Overall Study|Fetal/neonatal deaths|16|||
131031396|NCT00920621|471749614|FG001|Overall Study|Fetal/neonatal deaths|14|||
131031397|NCT00920621|471749615|FG002|Overall Study|Fetal/neonatal deaths|16|||
131222828|NCT03674827|472443190|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
130696961|NCT01899053|470514539|FG011|Overall Study|Symptomatic Deterioration|1|||
131031398|NCT00920621|471749616|FG003|Overall Study|Fetal/neonatal deaths|14|||
131031399|NCT00920621|471749613|FG000|Overall Study|Blood sample not collected|22|||
131031400|NCT00920621|471749614|FG001|Overall Study|Blood sample not collected|14|||
131031401|NCT00920621|471749615|FG002|Overall Study|Blood sample not collected|0|||
131031402|NCT00920621|471749616|FG003|Overall Study|Blood sample not collected|0|||
131031403|NCT02736409|471749617|FG000|Overall Study|Withdrawal by Subject|4|||
131031404|NCT02736409|471749618|FG001|Overall Study|Withdrawal by Subject|2|||
131031405|NCT02736409|471749619|FG002|Overall Study|Withdrawal by Subject|17|||
131031406|NCT02736409|471749620|FG003|Overall Study|Withdrawal by Subject|3|||
131031407|NCT02736409|471749617|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131031408|NCT02736409|471749618|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131031409|NCT02736409|471749619|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131031410|NCT02736409|471749620|FG003|Overall Study|Non-Compliance with Study Drug|1|||
131031411|NCT02736409|471749617|FG000|Overall Study|Adverse Event|0|||
131031412|NCT02736409|471749618|FG001|Overall Study|Adverse Event|1|||
131031413|NCT02736409|471749619|FG002|Overall Study|Adverse Event|5|||
131031414|NCT02736409|471749620|FG003|Overall Study|Adverse Event|4|||
131031415|NCT02736409|471749617|FG000|Overall Study|Other|0|||
131031416|NCT02736409|471749618|FG001|Overall Study|Other|0|||
131031417|NCT02736409|471749619|FG002|Overall Study|Other|1|||
131031418|NCT02736409|471749620|FG003|Overall Study|Other|1|||
131031419|NCT02736409|471749617|FG000|Overall Study|Pregnancy|0|||
131031420|NCT02736409|471749618|FG001|Overall Study|Pregnancy|0|||
131031421|NCT02736409|471749619|FG002|Overall Study|Pregnancy|1|||
131031422|NCT02736409|471749620|FG003|Overall Study|Pregnancy|0|||
131031423|NCT02736409|471749617|FG000|Overall Study|Lost to Follow-up|0|||
131031424|NCT02736409|471749618|FG001|Overall Study|Lost to Follow-up|0|||
131031425|NCT02736409|471749619|FG002|Overall Study|Lost to Follow-up|2|||
131031426|NCT02736409|471749620|FG003|Overall Study|Lost to Follow-up|1|||
131031427|NCT02736409|471749617|FG000|Overall Study|Physician Decision|0|||
131031428|NCT02736409|471749618|FG001|Overall Study|Physician Decision|0|||
131031429|NCT02736409|471749619|FG002|Overall Study|Physician Decision|0|||
131031430|NCT02736409|471749620|FG003|Overall Study|Physician Decision|2|||
131031431|NCT05536440|471749624|FG000|Overall Study|Adverse Event|0|||
131031432|NCT05536440|471749625|FG001|Overall Study|Adverse Event|0|||
131031433|NCT05536440|471749626|FG002|Overall Study|Adverse Event|0|||
131031434|NCT05536440|471749627|FG003|Overall Study|Adverse Event|0|||
131031435|NCT05536440|471749628|FG004|Overall Study|Adverse Event|0|||
131031436|NCT05536440|471749629|FG005|Overall Study|Adverse Event|0|||
131031437|NCT05536440|471749630|FG006|Overall Study|Adverse Event|0|||
131031438|NCT05536440|471749631|FG007|Overall Study|Adverse Event|0|||
131031439|NCT05536440|471749632|FG008|Overall Study|Adverse Event|1|||
131031440|NCT05323084|471749633|FG000|Period 2 - Washout|Lost to Follow-up|0|||
131031441|NCT05323084|471749634|FG001|Period 2 - Washout|Lost to Follow-up|1|||
131031442|NCT04382404|471749635|FG000|Overall Study|Adverse Event|1|||
131031443|NCT04382404|471749635|FG000|Overall Study|Lost to Follow-up|2|||
131031444|NCT01261312|471749637|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
131031445|NCT01261312|471749638|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
131031446|NCT01261312|471749639|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
131031447|NCT01261312|471749640|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131031448|NCT01261312|471749641|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131031449|NCT01261312|471749642|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131031450|NCT01261312|471749643|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131031451|NCT01261312|471749644|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131031452|NCT01261312|471749645|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131031453|NCT01261312|471749646|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131031454|NCT01261312|471749647|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131031455|NCT01261312|471749648|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131031456|NCT01261312|471749649|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
131031457|NCT01261312|471749637|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
131031458|NCT01261312|471749638|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
131031459|NCT01261312|471749639|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031460|NCT01261312|471749640|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031461|NCT01261312|471749641|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031462|NCT01261312|471749642|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031463|NCT01261312|471749643|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031464|NCT01261312|471749644|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031465|NCT01261312|471749645|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031466|NCT01261312|471749646|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031467|NCT01261312|471749647|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031468|NCT01261312|471749648|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031469|NCT01261312|471749649|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
131031470|NCT01261312|471749637|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
131031471|NCT01261312|471749638|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
131031472|NCT01261312|471749639|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131031473|NCT01261312|471749640|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131031474|NCT01261312|471749641|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131031475|NCT01261312|471749642|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131031476|NCT01261312|471749643|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131031477|NCT01261312|471749644|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131031478|NCT01261312|471749645|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131031479|NCT01261312|471749646|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
130696962|NCT01899053|470514540|FG012|Overall Study|Symptomatic Deterioration|2|||
130696963|NCT01899053|470514541|FG013|Overall Study|Symptomatic Deterioration|0|||
131031480|NCT01261312|471749647|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131031481|NCT01261312|471749648|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131031482|NCT01261312|471749649|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
131031483|NCT01261312|471749637|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
131031484|NCT01261312|471749638|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
131031485|NCT01261312|471749639|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031486|NCT01261312|471749640|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031487|NCT01261312|471749641|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031488|NCT01261312|471749642|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031489|NCT01261312|471749643|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031490|NCT01261312|471749644|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031491|NCT01261312|471749645|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031492|NCT01261312|471749646|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031493|NCT01261312|471749647|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031494|NCT01261312|471749648|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031495|NCT01261312|471749649|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
131031496|NCT01261312|471749637|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
131031497|NCT01261312|471749638|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
131031498|NCT01261312|471749639|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
131031499|NCT01261312|471749640|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131031500|NCT01261312|471749641|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131031501|NCT01261312|471749642|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131031502|NCT01261312|471749643|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131031503|NCT01261312|471749644|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131031504|NCT01261312|471749645|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131031505|NCT01261312|471749646|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131031506|NCT01261312|471749647|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131031507|NCT01261312|471749648|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131031508|NCT01261312|471749649|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
131031509|NCT01261312|471749637|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
131031510|NCT01261312|471749638|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
131031511|NCT01261312|471749639|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
131031512|NCT01261312|471749640|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131031513|NCT01261312|471749641|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131031514|NCT01261312|471749642|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131031515|NCT01261312|471749643|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131031516|NCT01261312|471749644|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131031517|NCT01261312|471749645|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131031518|NCT01261312|471749646|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131031519|NCT01261312|471749647|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131031520|NCT01261312|471749648|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131031521|NCT01261312|471749649|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
131031522|NCT01261312|471749637|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
131031523|NCT01261312|471749638|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031524|NCT01261312|471749639|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
131031525|NCT01261312|471749640|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031526|NCT01261312|471749641|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031527|NCT01261312|471749642|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031528|NCT01261312|471749643|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031529|NCT01261312|471749644|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031530|NCT01261312|471749645|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031531|NCT01261312|471749646|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031532|NCT01261312|471749647|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031533|NCT01261312|471749648|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031534|NCT01261312|471749649|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
131031535|NCT01261312|471749637|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131031536|NCT01261312|471749638|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131031537|NCT01261312|471749639|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131117083|NCT04029116|472060712|FG000|Overall Study|Pregnancy|1|||
131117084|NCT04029116|472060713|FG001|Overall Study|Pregnancy|2|||
131117085|NCT04029116|472060712|FG000|Overall Study|Withdrawal by Subject|4|||
131031538|NCT01261312|471749640|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
131031539|NCT01261312|471749641|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
131031540|NCT01261312|471749642|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
131031541|NCT01261312|471749643|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131031542|NCT01261312|471749644|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131031543|NCT01261312|471749645|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131031544|NCT01261312|471749646|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131031545|NCT01261312|471749647|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131031546|NCT01261312|471749648|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131031547|NCT01261312|471749649|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
131031548|NCT01261312|471749637|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031549|NCT01261312|471749638|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031550|NCT01261312|471749639|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031551|NCT01261312|471749640|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031552|NCT01261312|471749641|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
131031553|NCT01261312|471749642|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
131031554|NCT01261312|471749643|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031555|NCT01261312|471749644|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031556|NCT01261312|471749645|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031557|NCT01261312|471749646|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031558|NCT01261312|471749647|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031559|NCT01261312|471749648|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031560|NCT01261312|471749649|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
131031561|NCT01261312|471749637|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031562|NCT01261312|471749638|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031563|NCT01261312|471749639|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031564|NCT01261312|471749640|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031565|NCT01261312|471749641|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
131031566|NCT01261312|471749642|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
131031567|NCT01261312|471749643|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031568|NCT01261312|471749644|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031569|NCT01261312|471749645|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031570|NCT01261312|471749646|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031571|NCT01261312|471749647|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031572|NCT01261312|471749648|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031573|NCT01261312|471749649|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
131031574|NCT01261312|471749637|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
131031575|NCT01261312|471749638|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
131031576|NCT01261312|471749639|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
131031577|NCT01261312|471749640|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
131031578|NCT01261312|471749641|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
131031579|NCT01261312|471749642|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
131031580|NCT01261312|471749643|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
131031581|NCT01261312|471749644|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
131031582|NCT01261312|471749645|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
131031583|NCT01261312|471749646|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
131031584|NCT01261312|471749647|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
131031585|NCT01261312|471749648|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
131031586|NCT01261312|471749649|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
131031587|NCT01261312|471749637|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031588|NCT01261312|471749638|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031589|NCT01261312|471749639|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031590|NCT01261312|471749640|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031591|NCT01261312|471749641|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031592|NCT01261312|471749642|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
131031593|NCT01261312|471749643|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031594|NCT01261312|471749644|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031595|NCT01261312|471749645|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031596|NCT01261312|471749646|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031597|NCT01261312|471749647|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031598|NCT01261312|471749648|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031599|NCT01261312|471749649|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
131031600|NCT01261312|471749637|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131031601|NCT01261312|471749638|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131031602|NCT01261312|471749639|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131031603|NCT01261312|471749640|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
131031604|NCT01261312|471749641|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
131031605|NCT01261312|471749642|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
131031606|NCT01261312|471749643|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131031607|NCT01261312|471749644|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131117086|NCT04029116|472060713|FG001|Overall Study|Withdrawal by Subject|6|||
131117087|NCT04029116|472060712|FG000|Overall Study|Other|2|||
131117088|NCT04029116|472060713|FG001|Overall Study|Other|1|||
131117089|NCT03606980|472060714|FG000|Overall Study|Lost to Follow-up|3|||
131117090|NCT03606980|472060715|FG001|Overall Study|Lost to Follow-up|2|||
131117091|NCT03606980|472060716|FG002|Overall Study|Lost to Follow-up|3|||
131117092|NCT03606980|472060714|FG000|Overall Study|Withdrawal by Subject|1|||
131117093|NCT03606980|472060715|FG001|Overall Study|Withdrawal by Subject|0|||
131117094|NCT03606980|472060716|FG002|Overall Study|Withdrawal by Subject|4|||
131117095|NCT02469896|472060719|FG000|Overall Study|Withdrawal by Subject|2|||
131117096|NCT02469896|472060720|FG001|Overall Study|Withdrawal by Subject|0|||
131117097|NCT01294150|472060721|FG000|Overall Study|Physician Decision|2|||
131117098|NCT01294150|472060722|FG001|Overall Study|Physician Decision|2|||
131117099|NCT03675776|472060723|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
131117100|NCT03675776|472060724|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
131117101|NCT03675776|472060725|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
131117102|NCT03675776|472060723|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
131117103|NCT03675776|472060724|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
131117104|NCT03675776|472060725|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
131117105|NCT02401412|472060726|FG000|Overall Study|Lost to Follow-up|1|||
131117106|NCT02401412|472060727|FG001|Overall Study|Lost to Follow-up|0|||
131117107|NCT02401412|472060726|FG000|Overall Study|Discontinued Intervention|15|||
131117108|NCT02401412|472060727|FG001|Overall Study|Discontinued Intervention|21|||
131117109|NCT02401412|472060726|FG000|Overall Study|Withdrawal by Subject|4|||
131117110|NCT02401412|472060727|FG001|Overall Study|Withdrawal by Subject|4|||
131117111|NCT02401412|472060726|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
131117112|NCT02401412|472060727|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
131117113|NCT02401412|472060726|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
131117114|NCT02401412|472060727|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
131117115|NCT04513665|472060728|FG000|Overall Study|Adverse Event|2|||
131117116|NCT04513665|472060729|FG001|Overall Study|Adverse Event|0|||
131117117|NCT04513665|472060728|FG000|Overall Study|Lack of Efficacy|14|||
131117118|NCT04513665|472060729|FG001|Overall Study|Lack of Efficacy|0|||
131117119|NCT02608879|472060731|FG000|Overall Study|Lost to Follow-up|1|||
131117120|NCT02608879|472060732|FG001|Overall Study|Lost to Follow-up|0|||
131117121|NCT02608879|472060733|FG002|Overall Study|Lost to Follow-up|0|||
131117122|NCT02608879|472060731|FG000|Overall Study|Did not meet continuation criteria|0|||
131117123|NCT02608879|472060732|FG001|Overall Study|Did not meet continuation criteria|0|||
131117124|NCT02608879|472060733|FG002|Overall Study|Did not meet continuation criteria|3|||
131117125|NCT04246801|472060734|FG000|Overall Study|Adverse Event|1|||
131117126|NCT04246801|472060735|FG001|Overall Study|Adverse Event|1|||
131117127|NCT04246801|472060734|FG000|Overall Study|Protocol Violation|1|||
131117128|NCT04246801|472060735|FG001|Overall Study|Protocol Violation|1|||
131117129|NCT04246801|472060734|FG000|Overall Study|Lack of Efficacy|0|||
131117130|NCT04246801|472060735|FG001|Overall Study|Lack of Efficacy|2|||
131117131|NCT04246801|472060734|FG000|Overall Study|Lost to Follow-up|1|||
131117132|NCT04246801|472060735|FG001|Overall Study|Lost to Follow-up|1|||
131117133|NCT04246801|472060734|FG000|Overall Study|Withdrawal by Subject|2|||
131117134|NCT04246801|472060735|FG001|Overall Study|Withdrawal by Subject|1|||
131117135|NCT03684642|472060736|FG000|Overall Study|Adverse Event|6|||
131117136|NCT03684642|472060737|FG001|Overall Study|Adverse Event|15|||
131117137|NCT03684642|472060738|FG002|Overall Study|Adverse Event|11|||
131117138|NCT03684642|472060736|FG000|Overall Study|Withdrawal by Subject|35|||
131117139|NCT03684642|472060737|FG001|Overall Study|Withdrawal by Subject|53|||
131117140|NCT03684642|472060738|FG002|Overall Study|Withdrawal by Subject|23|||
131117141|NCT03684642|472060736|FG000|Overall Study|Lack of Efficacy|0|||
131117142|NCT03684642|472060737|FG001|Overall Study|Lack of Efficacy|0|||
131117143|NCT03684642|472060738|FG002|Overall Study|Lack of Efficacy|1|||
131117144|NCT03684642|472060736|FG000|Overall Study|Poor compliance to protocol|0|||
131117145|NCT03684642|472060737|FG001|Overall Study|Poor compliance to protocol|4|||
130696964|NCT03105297|470514542|FG000|Baseline Phase (Day 1)|Other|21|||
130696965|NCT03105297|470514542|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
131117146|NCT03684642|472060738|FG002|Overall Study|Poor compliance to protocol|1|||
130696966|NCT03105297|470514542|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
131117147|NCT03684642|472060736|FG000|Overall Study|Other than specified|62|||
130696967|NCT01390948|470514543|FG000|Overall Study|End of Study|1|||
130696968|NCT01390948|470514544|FG001|Overall Study|End of Study|0|||
130696969|NCT01390948|470514545|FG002|Overall Study|End of Study|0|||
131117148|NCT03684642|472060737|FG001|Overall Study|Other than specified|60|||
131117149|NCT03684642|472060738|FG002|Overall Study|Other than specified|67|||
131117150|NCT03684642|472060736|FG000|Overall Study|Randomized and not treated|0|||
131117151|NCT03684642|472060737|FG001|Overall Study|Randomized and not treated|0|||
131117152|NCT03684642|472060738|FG002|Overall Study|Randomized and not treated|1|||
131117153|NCT03684642|472060736|FG000|Overall Study|Missing completion status but alive at last contact|0|||
130696970|NCT01390948|470514543|FG000|Overall Study|Withdrew consent|2|||
130696971|NCT01390948|470514544|FG001|Overall Study|Withdrew consent|2|||
131117154|NCT03684642|472060737|FG001|Overall Study|Missing completion status but alive at last contact|1|||
131117155|NCT03684642|472060738|FG002|Overall Study|Missing completion status but alive at last contact|2|||
131117156|NCT02966223|472060746|FG000|Overall Study|Physician Decision|3|||
131117157|NCT02966223|472060746|FG000|Overall Study|Withdrawal by Subject|11|||
131117158|NCT02966223|472060746|FG000|Overall Study|Lost to Follow-up|1|||
131117159|NCT01326728|472060747|FG000|Overall Study|Death|13|||
131117160|NCT01326728|472060748|FG001|Overall Study|Death|0|||
131117161|NCT01326728|472060747|FG000|Overall Study|Early closure of study|34|||
131117162|NCT01326728|472060748|FG001|Overall Study|Early closure of study|9|||
131117163|NCT03785678|472060751|FG000|Overall Study|Death|44|||
131117164|NCT03785678|472060752|FG001|Overall Study|Death|42|||
131117165|NCT03785678|472060751|FG000|Overall Study|Lost to Follow-up|4|||
131117166|NCT03785678|472060752|FG001|Overall Study|Lost to Follow-up|2|||
131117167|NCT03785678|472060751|FG000|Overall Study|Physician Decision|0|||
131117168|NCT03785678|472060752|FG001|Overall Study|Physician Decision|2|||
131117169|NCT03785678|472060751|FG000|Overall Study|Withdrawal by Subject|5|||
131117170|NCT03785678|472060752|FG001|Overall Study|Withdrawal by Subject|3|||
131117171|NCT00805025|472060756|FG000|Overall Study|Screened but not enrolled/treated|42|||
131117172|NCT00805025|472060756|FG000|Overall Study|Adverse Event|4|||
131117173|NCT00805025|472060756|FG000|Overall Study|Withdrawal by Subject|2|||
131117174|NCT00805025|472060756|FG000|Overall Study|Physician Decision|1|||
131117175|NCT00375219|472060757|FG000|Overall Study|Failure to achieve a response|16|||
131117176|NCT00375219|472060758|FG001|Overall Study|Failure to achieve a response|2|||
131117177|NCT00375219|472060759|FG002|Overall Study|Failure to achieve a response|0|||
131117178|NCT00375219|472060757|FG000|Overall Study|Adverse Event|8|||
131117179|NCT00375219|472060758|FG001|Overall Study|Adverse Event|2|||
130912588|NCT02160782|471316441|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
130912589|NCT02160782|471316442|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
130912590|NCT02160782|471316443|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
131117180|NCT00375219|472060759|FG002|Overall Study|Adverse Event|1|||
131117181|NCT00375219|472060757|FG000|Overall Study|Protocol Violation|1|||
131117182|NCT00375219|472060758|FG001|Overall Study|Protocol Violation|0|||
131117183|NCT00375219|472060759|FG002|Overall Study|Protocol Violation|1|||
131117184|NCT00375219|472060757|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
131117185|NCT00375219|472060758|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
131117186|NCT00375219|472060759|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
131117187|NCT00375219|472060757|FG000|Overall Study|Lost to Follow-up|1|||
131117188|NCT00375219|472060758|FG001|Overall Study|Lost to Follow-up|1|||
131117189|NCT00375219|472060759|FG002|Overall Study|Lost to Follow-up|0|||
131117190|NCT00375219|472060757|FG000|Overall Study|Disease progression|18|||
131117191|NCT00375219|472060758|FG001|Overall Study|Disease progression|9|||
131117192|NCT00375219|472060759|FG002|Overall Study|Disease progression|12|||
131117193|NCT00375219|472060757|FG000|Overall Study|Death|4|||
131117194|NCT00375219|472060758|FG001|Overall Study|Death|3|||
131117195|NCT00375219|472060759|FG002|Overall Study|Death|7|||
131117196|NCT00375219|472060757|FG000|Overall Study|Hematologic resistance|1|||
131117197|NCT00375219|472060758|FG001|Overall Study|Hematologic resistance|0|||
131117198|NCT00375219|472060759|FG002|Overall Study|Hematologic resistance|0|||
131117199|NCT00375219|472060757|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
131117200|NCT00375219|472060758|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
131117201|NCT00375219|472060759|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
131117202|NCT00375219|472060757|FG000|Overall Study|Allograft|2|||
131117203|NCT00375219|472060758|FG001|Overall Study|Allograft|0|||
131117204|NCT00375219|472060759|FG002|Overall Study|Allograft|0|||
131117205|NCT00375219|472060757|FG000|Overall Study|Cord blood transplantation|1|||
131117206|NCT00375219|472060758|FG001|Overall Study|Cord blood transplantation|0|||
131117207|NCT00375219|472060759|FG002|Overall Study|Cord blood transplantation|0|||
131117208|NCT00375219|472060757|FG000|Overall Study|Withdrawal by Subject|1|||
131117209|NCT00375219|472060758|FG001|Overall Study|Withdrawal by Subject|0|||
131117210|NCT00375219|472060759|FG002|Overall Study|Withdrawal by Subject|0|||
130768888|NCT00624832|470778615|FG001|Overall Study|Adverse Event|1|||
130912591|NCT02160782|471316444|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
131117211|NCT01667107|472060760|FG000|Overall Study|Adverse Event|4|||
131117212|NCT01667107|472060761|FG001|Overall Study|Adverse Event|3|||
131117213|NCT01667107|472060760|FG000|Overall Study|Tolerability issues|0|||
131117214|NCT01667107|472060761|FG001|Overall Study|Tolerability issues|2|||
131117215|NCT01667107|472060760|FG000|Overall Study|Protocol Violation|0|||
131117216|NCT01667107|472060761|FG001|Overall Study|Protocol Violation|1|||
131117217|NCT01667107|472060760|FG000|Overall Study|Lack of Efficacy|0|||
131117218|NCT01667107|472060761|FG001|Overall Study|Lack of Efficacy|1|||
131117219|NCT01162239|472060764|FG000|Treatment Phase|Withdrawal by Subject|1|||
131117220|NCT01162239|472060765|FG001|Treatment Phase|Withdrawal by Subject|3|||
131117221|NCT01162239|472060766|FG002|Treatment Phase|Withdrawal by Subject|2|||
131222829|NCT03674827|472443185|FG000|Treatment Phase|Withdrawal by Subject|0|||
131117222|NCT01162239|472060767|FG003|Treatment Phase|Withdrawal by Subject|3|||
131117223|NCT01162239|472060764|FG000|Treatment Phase|Death|0|||
131117224|NCT01162239|472060765|FG001|Treatment Phase|Death|0|||
131117225|NCT01162239|472060766|FG002|Treatment Phase|Death|0|||
131031608|NCT01261312|471749645|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131031609|NCT01261312|471749646|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131031610|NCT01261312|471749647|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131031611|NCT01261312|471749648|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131031612|NCT01261312|471749649|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
131031613|NCT01261312|471749637|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131031614|NCT01261312|471749638|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131031615|NCT01261312|471749639|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131031616|NCT01261312|471749640|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
131031617|NCT01261312|471749641|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
131031618|NCT01261312|471749642|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
131031619|NCT01261312|471749643|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131031620|NCT01261312|471749644|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131031621|NCT01261312|471749645|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131031622|NCT01261312|471749646|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131031623|NCT01261312|471749647|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131031624|NCT01261312|471749648|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131031625|NCT01261312|471749649|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
131031626|NCT01261312|471749637|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131031627|NCT01261312|471749638|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131031628|NCT01261312|471749639|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131031629|NCT01261312|471749640|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131031630|NCT01261312|471749641|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131031631|NCT01261312|471749642|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131031632|NCT01261312|471749643|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
131031633|NCT01261312|471749644|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
131031634|NCT01261312|471749645|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
131031635|NCT01261312|471749646|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131031636|NCT01261312|471749647|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131031637|NCT01261312|471749648|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131031638|NCT01261312|471749649|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
131031639|NCT01261312|471749637|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031640|NCT01261312|471749638|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031641|NCT01261312|471749639|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031642|NCT01261312|471749640|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031643|NCT01261312|471749641|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031644|NCT01261312|471749642|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031645|NCT01261312|471749643|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031646|NCT01261312|471749644|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
131031647|NCT01261312|471749645|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
131031648|NCT01261312|471749646|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031649|NCT01261312|471749647|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031650|NCT01261312|471749648|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031651|NCT01261312|471749649|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
131031652|NCT01261312|471749637|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131031653|NCT01261312|471749638|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131031654|NCT01261312|471749639|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131031655|NCT01261312|471749640|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131031656|NCT01261312|471749641|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131031657|NCT01261312|471749642|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131031658|NCT01261312|471749643|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
131031659|NCT01261312|471749644|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
131031660|NCT01261312|471749645|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
131031661|NCT01261312|471749646|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131031662|NCT01261312|471749647|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131031663|NCT01261312|471749648|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131031664|NCT01261312|471749649|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
131031665|NCT01261312|471749637|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
131031666|NCT01261312|471749638|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
131031667|NCT01261312|471749639|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
131031668|NCT01261312|471749640|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
131117226|NCT01162239|472060767|FG003|Treatment Phase|Death|1|||
131031669|NCT01261312|471749641|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
131117227|NCT01162239|472060764|FG000|Treatment Phase|Lost to Follow-up|5|||
131031670|NCT01261312|471749642|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
131117228|NCT01162239|472060765|FG001|Treatment Phase|Lost to Follow-up|4|||
131117229|NCT01162239|472060766|FG002|Treatment Phase|Lost to Follow-up|2|||
131117230|NCT01162239|472060767|FG003|Treatment Phase|Lost to Follow-up|1|||
131117231|NCT01162239|472060764|FG000|Extended Follow-up|Lost to Follow-up|8|||
131117232|NCT01162239|472060765|FG001|Extended Follow-up|Lost to Follow-up|13|||
131117233|NCT01162239|472060766|FG002|Extended Follow-up|Lost to Follow-up|8|||
131117234|NCT01162239|472060767|FG003|Extended Follow-up|Lost to Follow-up|6|||
131117235|NCT00228566|472060768|FG000|Overall Study|Adverse Event|31|||
131117236|NCT00228566|472060768|FG000|Overall Study|Lack of Efficacy|14|||
131117237|NCT00228566|472060768|FG000|Overall Study|Lost to Follow-up|16|||
131117238|NCT00228566|472060768|FG000|Overall Study|Physician Decision|5|||
131031671|NCT01261312|471749643|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
131031672|NCT01261312|471749644|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
131031673|NCT01261312|471749645|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
131031674|NCT01261312|471749646|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
131031675|NCT01261312|471749647|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
131031676|NCT01261312|471749648|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
131031677|NCT01261312|471749649|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
131031678|NCT01261312|471749637|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131031679|NCT01261312|471749638|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131031680|NCT01261312|471749639|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131031681|NCT01261312|471749640|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131031682|NCT01261312|471749641|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131031683|NCT01261312|471749642|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131031684|NCT01261312|471749643|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
131031685|NCT01261312|471749644|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
131031686|NCT01261312|471749645|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
131031687|NCT01261312|471749646|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131031688|NCT01261312|471749647|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131031689|NCT01261312|471749648|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131031690|NCT01261312|471749649|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
131031691|NCT01261312|471749637|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131031692|NCT01261312|471749638|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131031693|NCT01261312|471749639|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131031694|NCT01261312|471749640|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131031695|NCT01261312|471749641|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131031696|NCT01261312|471749642|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131031697|NCT01261312|471749643|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
131031698|NCT01261312|471749644|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
131031699|NCT01261312|471749645|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
131031700|NCT01261312|471749646|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131031701|NCT01261312|471749647|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131031702|NCT01261312|471749648|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131031703|NCT01261312|471749649|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
131031704|NCT01261312|471749637|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131031705|NCT01261312|471749638|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131031706|NCT01261312|471749639|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131031707|NCT01261312|471749640|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131031708|NCT01261312|471749641|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131031709|NCT01261312|471749642|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131031710|NCT01261312|471749643|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
131031711|NCT01261312|471749644|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
131031712|NCT01261312|471749645|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
131031713|NCT01261312|471749646|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131031714|NCT01261312|471749647|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131031715|NCT01261312|471749648|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131031716|NCT01261312|471749649|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
131031717|NCT01261312|471749637|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131031718|NCT01261312|471749638|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131031719|NCT01261312|471749639|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131031720|NCT01261312|471749640|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131031721|NCT01261312|471749641|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131031722|NCT01261312|471749642|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131031723|NCT01261312|471749643|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131031724|NCT01261312|471749644|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131117239|NCT00228566|472060768|FG000|Overall Study|Withdrawal by Subject|4|||
131117240|NCT00228566|472060768|FG000|Overall Study|Miscellaneous|1|||
131117241|NCT04448756|472060769|FG000|Overall Study|Adverse Event|0|||
131117242|NCT04448756|472060770|FG001|Overall Study|Adverse Event|1|||
131117243|NCT04448756|472060771|FG002|Overall Study|Adverse Event|0|||
131117244|NCT04448756|472060769|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
131117245|NCT04448756|472060770|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
131117246|NCT04448756|472060771|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
131117247|NCT04448756|472060769|FG000|Overall Study|Withdrawal by Subject|0|||
131117248|NCT04448756|472060770|FG001|Overall Study|Withdrawal by Subject|3|||
131117249|NCT04448756|472060771|FG002|Overall Study|Withdrawal by Subject|1|||
131117250|NCT04448756|472060769|FG000|Overall Study|Death|2|||
130696972|NCT01390948|470514545|FG002|Overall Study|Withdrew consent|0|||
130696973|NCT01390948|470514543|FG000|Overall Study|Progressive Disease|2|||
130696974|NCT01390948|470514544|FG001|Overall Study|Progressive Disease|5|||
130696975|NCT01390948|470514545|FG002|Overall Study|Progressive Disease|0|||
131117251|NCT04448756|472060770|FG001|Overall Study|Death|1|||
131117252|NCT04448756|472060771|FG002|Overall Study|Death|0|||
131117253|NCT00232141|472060772|FG000|Overall Study|Adverse Event|9|||
131117254|NCT00232141|472060773|FG001|Overall Study|Adverse Event|4|||
131117255|NCT00232141|472060772|FG000|Overall Study|Lack of Efficacy|0|||
131117256|NCT00232141|472060773|FG001|Overall Study|Lack of Efficacy|3|||
131117257|NCT00232141|472060772|FG000|Overall Study|Lost to Follow-up|9|||
131117258|NCT00232141|472060773|FG001|Overall Study|Lost to Follow-up|6|||
131117259|NCT00232141|472060772|FG000|Overall Study|Other|8|||
131117260|NCT00232141|472060773|FG001|Overall Study|Other|10|||
131117261|NCT00232141|472060772|FG000|Overall Study|Withdrawal by Subject|5|||
131117262|NCT00232141|472060773|FG001|Overall Study|Withdrawal by Subject|3|||
131117263|NCT01479829|472060774|FG000|Overall Study|Withdrawal by Subject|8|||
131117264|NCT01479829|472060775|FG001|Overall Study|Withdrawal by Subject|10|||
131117265|NCT00601250|472060776|FG000|Overall Study|Adverse Event|3|||
131117266|NCT00601250|472060777|FG001|Overall Study|Adverse Event|9|||
131117267|NCT00601250|472060776|FG000|Overall Study|Protocol Violation|3|||
131117268|NCT00601250|472060777|FG001|Overall Study|Protocol Violation|2|||
131117269|NCT00601250|472060776|FG000|Overall Study|Lost to Follow-up|2|||
131117270|NCT00601250|472060777|FG001|Overall Study|Lost to Follow-up|6|||
131117271|NCT00601250|472060776|FG000|Overall Study|Withdrawal by Subject|4|||
131117272|NCT00601250|472060777|FG001|Overall Study|Withdrawal by Subject|13|||
131117273|NCT00601250|472060776|FG000|Overall Study|Other incl. lack of efficacy|2|||
131117274|NCT00601250|472060777|FG001|Overall Study|Other incl. lack of efficacy|9|||
131117275|NCT01791803|472060778|FG000|Overall Study|Withdrawal by Subject|0|||
131117276|NCT01791803|472060779|FG001|Overall Study|Withdrawal by Subject|0|||
131117277|NCT01791803|472060780|FG002|Overall Study|Withdrawal by Subject|0|||
131117278|NCT01791803|472060781|FG003|Overall Study|Withdrawal by Subject|2|||
131117279|NCT01791803|472060778|FG000|Overall Study|Physician Decision|0|||
131117280|NCT01791803|472060779|FG001|Overall Study|Physician Decision|2|||
131117281|NCT01791803|472060780|FG002|Overall Study|Physician Decision|0|||
131117282|NCT01791803|472060781|FG003|Overall Study|Physician Decision|1|||
131117283|NCT01791803|472060778|FG000|Overall Study|Death|0|||
131117284|NCT01791803|472060779|FG001|Overall Study|Death|0|||
131117285|NCT01791803|472060780|FG002|Overall Study|Death|2|||
131117286|NCT01791803|472060781|FG003|Overall Study|Death|2|||
131117287|NCT04572854|472060782|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
131117288|NCT04572854|472060783|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
131117289|NCT04572854|472060784|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
131117290|NCT04572854|472060785|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
131117291|NCT04572854|472060782|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
131117292|NCT04572854|472060783|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
131117293|NCT04572854|472060784|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
131117294|NCT04572854|472060785|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
131117295|NCT00523718|472062328|FG000|Overall Study|Withdrawal by Subject|1|||
131117296|NCT00523718|472062329|FG001|Overall Study|Withdrawal by Subject|0|||
131117297|NCT00523718|472062328|FG000|Overall Study|Protocol Violation|2|||
131117298|NCT00523718|472062329|FG001|Overall Study|Protocol Violation|0|||
131117299|NCT03441334|472062330|FG000|Overall Study|Withdrawal by Subject|1|||
131117300|NCT03441334|472062331|FG001|Overall Study|Withdrawal by Subject|0|||
131117301|NCT02615470|472062335|FG000|Overall Study|Lost to Follow-up|21|||
130696976|NCT01390948|470514543|FG000|Overall Study|Death during follow-up|10|||
131117302|NCT02615470|472062336|FG001|Overall Study|Lost to Follow-up|32|||
131117303|NCT01650285|472062339|FG000|Overall Study|Adverse Event|1|||
131117304|NCT00659529|472062340|FG000|Overall Study|Withdrawal by Subject|4|||
130696977|NCT01390948|470514544|FG001|Overall Study|Death during follow-up|11|||
130696978|NCT01390948|470514545|FG002|Overall Study|Death during follow-up|1|||
131117305|NCT00659529|472062340|FG000|Overall Study|Protocol Violation|3|||
131117306|NCT00659529|472062340|FG000|Overall Study|Screen failure|9|||
131117307|NCT03627767|472062345|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
131117308|NCT03627767|472062346|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
130696979|NCT05315713|470514547|FG000|Overall Study|Death|5|||
130696980|NCT05315713|470514547|FG000|Overall Study|Progressive disease|1|||
131117309|NCT03627767|472062347|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
131117310|NCT03627767|472062348|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
131117311|NCT03627767|472062349|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
131117312|NCT03627767|472062345|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
131117313|NCT03627767|472062346|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
131117314|NCT03627767|472062347|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
131117315|NCT03627767|472062348|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
131117316|NCT03627767|472062349|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
131117317|NCT03627767|472062345|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
131117318|NCT03627767|472062346|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
130696981|NCT05315713|470514547|FG000|Overall Study|Withdrawal by Subject|1|||
130696982|NCT05315713|470514547|FG000|Overall Study|Study terminated by sponsor|1|||
130696983|NCT03250117|470514550|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
130696984|NCT03250117|470514551|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
130696985|NCT03250117|470514552|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
130696986|NCT03250117|470514553|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
131031725|NCT01261312|471749645|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
131031726|NCT01261312|471749646|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
131031727|NCT01261312|471749647|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
131031728|NCT01261312|471749648|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
131031729|NCT01261312|471749649|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
131031730|NCT01261312|471749637|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131031731|NCT01261312|471749638|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131031732|NCT01261312|471749639|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131031733|NCT01261312|471749640|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131031734|NCT01261312|471749641|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131031735|NCT01261312|471749642|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131031736|NCT01261312|471749643|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131031737|NCT01261312|471749644|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131031738|NCT01261312|471749645|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131031739|NCT01261312|471749646|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
131031740|NCT01261312|471749647|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
131031741|NCT01261312|471749648|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
131031742|NCT01261312|471749649|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
131031743|NCT01261312|471749637|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131031744|NCT01261312|471749638|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131031745|NCT01261312|471749639|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131031746|NCT01261312|471749640|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131031747|NCT01261312|471749641|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131031748|NCT01261312|471749642|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131031749|NCT01261312|471749643|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131031750|NCT01261312|471749644|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131031751|NCT01261312|471749645|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
131031752|NCT01261312|471749646|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
131031753|NCT01261312|471749647|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
131031754|NCT01261312|471749648|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
131031755|NCT01261312|471749649|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
131031756|NCT01261312|471749637|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131031757|NCT01261312|471749638|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131031758|NCT01261312|471749639|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131031759|NCT01261312|471749640|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131031760|NCT01261312|471749641|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131031761|NCT01261312|471749642|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131031762|NCT01261312|471749643|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131031763|NCT01261312|471749644|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131031764|NCT01261312|471749645|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
131031765|NCT01261312|471749646|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
131031766|NCT01261312|471749647|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
131031767|NCT01261312|471749648|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
131031768|NCT01261312|471749649|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
131031769|NCT01261312|471749637|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131031770|NCT01261312|471749638|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131031771|NCT01261312|471749639|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131031772|NCT01261312|471749640|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131117319|NCT03627767|472062347|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
131031773|NCT01261312|471749641|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131031774|NCT01261312|471749642|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131031775|NCT01261312|471749643|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131031776|NCT01261312|471749644|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131031777|NCT01261312|471749645|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
131031778|NCT01261312|471749646|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
131031779|NCT01261312|471749647|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
131031780|NCT01261312|471749648|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
131031781|NCT01261312|471749649|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
131031782|NCT01261312|471749637|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131031783|NCT01261312|471749638|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131031784|NCT01261312|471749639|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131031785|NCT01261312|471749640|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131031786|NCT01261312|471749641|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131031787|NCT01261312|471749642|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131031788|NCT01261312|471749643|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131031789|NCT01261312|471749644|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131031790|NCT01261312|471749645|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
131031791|NCT01261312|471749646|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
131031792|NCT01261312|471749647|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
131031793|NCT01261312|471749648|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
131031794|NCT01261312|471749649|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
131031795|NCT01261312|471749637|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131031796|NCT01261312|471749638|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131031797|NCT01261312|471749639|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131031798|NCT01261312|471749640|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131031799|NCT01261312|471749641|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131031800|NCT01261312|471749642|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131031801|NCT01261312|471749643|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131031802|NCT01261312|471749644|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131031803|NCT01261312|471749645|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
131031804|NCT01261312|471749646|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
131031805|NCT01261312|471749647|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
131031806|NCT01261312|471749648|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
131031807|NCT01261312|471749649|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
131031808|NCT04812535|471749658|FG000|Overall Study|Withdrawal by Subject|0|||
131031809|NCT04812535|471749659|FG001|Overall Study|Withdrawal by Subject|0|||
131031810|NCT04812535|471749660|FG002|Overall Study|Withdrawal by Subject|0|||
131031811|NCT04812535|471749661|FG003|Overall Study|Withdrawal by Subject|1|||
131031812|NCT04812535|471749658|FG000|Overall Study|Death|7|||
131031813|NCT04812535|471749659|FG001|Overall Study|Death|2|||
131031814|NCT04812535|471749660|FG002|Overall Study|Death|4|||
131031815|NCT04812535|471749661|FG003|Overall Study|Death|1|||
131031816|NCT04812535|471749658|FG000|Overall Study|Due to premature study termination by sponsor|2|||
131031817|NCT04812535|471749659|FG001|Overall Study|Due to premature study termination by sponsor|0|||
131031818|NCT04812535|471749660|FG002|Overall Study|Due to premature study termination by sponsor|1|||
131031819|NCT04812535|471749661|FG003|Overall Study|Due to premature study termination by sponsor|3|||
131031820|NCT03336333|471749662|FG000|Overall Study|Remained on study at time of data cut-off|202|||
131031821|NCT03336333|471749663|FG001|Overall Study|Remained on study at time of data cut-off|219|||
131031822|NCT03336333|471749664|FG002|Overall Study|Remained on study at time of data cut-off|102|||
131031823|NCT03336333|471749662|FG000|Overall Study|Death|14|||
131031824|NCT03336333|471749663|FG001|Overall Study|Death|16|||
131031825|NCT03336333|471749664|FG002|Overall Study|Death|8|||
131031826|NCT03336333|471749662|FG000|Overall Study|Withdrawal by Subject|16|||
131031827|NCT03336333|471749663|FG001|Overall Study|Withdrawal by Subject|5|||
131031828|NCT03336333|471749664|FG002|Overall Study|Withdrawal by Subject|1|||
131031829|NCT03336333|471749662|FG000|Overall Study|Physician Decision|5|||
131031830|NCT03336333|471749663|FG001|Overall Study|Physician Decision|1|||
131031831|NCT03336333|471749664|FG002|Overall Study|Physician Decision|0|||
131031832|NCT03336333|471749662|FG000|Overall Study|Lost to Follow-up|1|||
131031833|NCT03336333|471749663|FG001|Overall Study|Lost to Follow-up|0|||
131031834|NCT03336333|471749664|FG002|Overall Study|Lost to Follow-up|0|||
131031835|NCT03792555|471749668|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
131031836|NCT03792555|471749669|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
131031837|NCT03792555|471749670|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
131031838|NCT03792555|471749668|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
130696987|NCT00556673|470514555|FG000|Overall Study|Protocol deviation|3|||
131117320|NCT03627767|472062348|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
131117321|NCT03627767|472062349|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
131117322|NCT03627767|472062345|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
130912592|NCT02160782|471316440|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
130912593|NCT02160782|471316441|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
130912594|NCT02160782|471316442|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
130912595|NCT02160782|471316443|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
130912596|NCT02160782|471316444|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
130912597|NCT02160782|471316440|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
130912598|NCT02160782|471316441|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
130912599|NCT02160782|471316442|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
130912600|NCT02160782|471316443|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
130912601|NCT02160782|471316444|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
130912602|NCT02160782|471316440|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
130912603|NCT02160782|471316441|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
130912604|NCT02160782|471316442|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
130912605|NCT02160782|471316443|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
130912606|NCT02160782|471316444|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
130912607|NCT02160782|471316440|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
130912608|NCT02160782|471316441|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
130912609|NCT02160782|471316442|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
130912610|NCT02160782|471316443|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
130912611|NCT02160782|471316444|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
130912612|NCT01104701|471316447|FG000|Overall Study|Withdrawal by Subject|0|||
130912613|NCT01104701|471316448|FG001|Overall Study|Withdrawal by Subject|1|||
130912614|NCT01104701|471316449|FG002|Overall Study|Withdrawal by Subject|2|||
130912615|NCT01104701|471316450|FG003|Overall Study|Withdrawal by Subject|1|||
130912616|NCT01104701|471316447|FG000|Overall Study|Adverse Event|0|||
130912617|NCT01104701|471316448|FG001|Overall Study|Adverse Event|0|||
130912618|NCT01104701|471316449|FG002|Overall Study|Adverse Event|0|||
130912619|NCT01104701|471316450|FG003|Overall Study|Adverse Event|1|||
130912620|NCT01104701|471316447|FG000|Overall Study|Physician Decision|0|||
130912621|NCT01104701|471316448|FG001|Overall Study|Physician Decision|2|||
130912622|NCT01104701|471316449|FG002|Overall Study|Physician Decision|0|||
130912623|NCT01104701|471316450|FG003|Overall Study|Physician Decision|0|||
130912624|NCT03437512|471316451|FG000|Randomized|Withdrawal by Subject|0|||
130912625|NCT03437512|471316452|FG001|Randomized|Withdrawal by Subject|2|||
130912626|NCT03437512|471316451|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
130912627|NCT03437512|471316452|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
130912628|NCT00674973|471316453|FG000|Overall Study|Insufficient Therapeutic Response|77|||
130912629|NCT00674973|471316454|FG001|Overall Study|Insufficient Therapeutic Response|72|||
130912630|NCT00674973|471316453|FG000|Overall Study|Refused Treatment|1|||
130912631|NCT00674973|471316454|FG001|Overall Study|Refused Treatment|5|||
130912632|NCT00674973|471316453|FG000|Overall Study|Failure to Return|1|||
130912633|NCT00674973|471316454|FG001|Overall Study|Failure to Return|0|||
130912634|NCT00674973|471316453|FG000|Overall Study|Adverse Event|2|||
130912635|NCT00674973|471316454|FG001|Overall Study|Adverse Event|9|||
130912636|NCT00674973|471316453|FG000|Overall Study|Death|19|||
130912637|NCT00674973|471316454|FG001|Overall Study|Death|15|||
130912638|NCT00674973|471316453|FG000|Overall Study|Protocol Violation|0|||
130912639|NCT00674973|471316454|FG001|Overall Study|Protocol Violation|1|||
131031839|NCT03792555|471749669|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
131031840|NCT03792555|471749670|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
131031841|NCT03792555|471749668|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
131031842|NCT03792555|471749669|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
131031843|NCT03792555|471749670|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
131031844|NCT04485039|471749671|FG000|TPOXX Only|Adverse Event|2|||
131031845|NCT04485039|471749671|FG000|TPOXX Only|Physician Decision|1|||
131117323|NCT03627767|472062346|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
131117324|NCT03627767|472062347|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
130768889|NCT00624832|470778616|FG002|Overall Study|Adverse Event|0|||
130912640|NCT05036369|471316457|FG000|Overall Study|Run In non compliance|1|||
130912641|NCT05036369|471316458|FG001|Overall Study|Run In non compliance|2|||
130912642|NCT05036369|471316457|FG000|Overall Study|Change in eligibility criteria|0|||
130912643|NCT05036369|471316458|FG001|Overall Study|Change in eligibility criteria|1|||
130912644|NCT01397162|471316461|FG000|Overall Study|Adverse Event|4|||
130912645|NCT01397162|471316462|FG001|Overall Study|Adverse Event|0|||
130768890|NCT00624832|470778617|FG003|Overall Study|Adverse Event|1|||
130912646|NCT01397162|471316463|FG002|Overall Study|Adverse Event|0|||
130912647|NCT01397162|471316464|FG003|Overall Study|Adverse Event|0|||
130912648|NCT01397162|471316465|FG004|Overall Study|Adverse Event|0|||
130912649|NCT01397162|471316461|FG000|Overall Study|Not yet defined|3|||
130912650|NCT01397162|471316462|FG001|Overall Study|Not yet defined|4|||
130912651|NCT01397162|471316463|FG002|Overall Study|Not yet defined|3|||
130912652|NCT01397162|471316464|FG003|Overall Study|Not yet defined|5|||
130912653|NCT01397162|471316465|FG004|Overall Study|Not yet defined|3|||
130912654|NCT01795638|471316470|FG000|Overall Study|Death|0|||
130912655|NCT01795638|471316471|FG001|Overall Study|Death|3|||
130912656|NCT01795638|471316470|FG000|Overall Study|transferred to quaternary hospital|2|||
130912657|NCT01795638|471316471|FG001|Overall Study|transferred to quaternary hospital|3|||
130912658|NCT01795638|471316470|FG000|Overall Study|Protocol Violation|3|||
130912659|NCT01795638|471316471|FG001|Overall Study|Protocol Violation|0|||
130912660|NCT01795638|471316470|FG000|Overall Study|discharged from hospital|7|||
130912661|NCT01795638|471316471|FG001|Overall Study|discharged from hospital|5|||
130912662|NCT01795638|471316470|FG000|Overall Study|Withdrawal by Subject|1|||
130912663|NCT01795638|471316471|FG001|Overall Study|Withdrawal by Subject|0|||
130912664|NCT03875118|471316472|FG000|Overall Study|Withdrawal by Subject|4|||
130912665|NCT03875118|471316473|FG001|Overall Study|Withdrawal by Subject|4|||
130912666|NCT03403374|471316474|FG000|Overall Study|Lost to Follow-up|1|||
130912667|NCT01298531|471316475|FG000|Overall Study|Lack of Efficacy|0|||
130912668|NCT01298531|471316476|FG001|Overall Study|Lack of Efficacy|1|||
130912669|NCT01298531|471316475|FG000|Overall Study|Lost to Follow-up|2|||
130912670|NCT01298531|471316476|FG001|Overall Study|Lost to Follow-up|0|||
130912671|NCT01298531|471316475|FG000|Overall Study|Protocol Violation|1|||
130912672|NCT01298531|471316476|FG001|Overall Study|Protocol Violation|1|||
130912673|NCT01298531|471316475|FG000|Overall Study|Adverse Event|4|||
130912674|NCT01298531|471316476|FG001|Overall Study|Adverse Event|3|||
130912675|NCT01298531|471316475|FG000|Overall Study|Does not meet entrance criteria|0|||
130912676|NCT01298531|471316476|FG001|Overall Study|Does not meet entrance criteria|1|||
130912677|NCT01298531|471316475|FG000|Overall Study|Other|2|||
130912678|NCT01298531|471316476|FG001|Overall Study|Other|1|||
130912679|NCT02611960|471316477|FG000|Overall Study|Adverse Event|7|||
130912680|NCT02611960|471316478|FG001|Overall Study|Adverse Event|8|||
130912681|NCT02611960|471316477|FG000|Overall Study|Death|98|||
130912682|NCT02611960|471316478|FG001|Overall Study|Death|92|||
130912683|NCT02611960|471316477|FG000|Overall Study|Withdrawal by Subject|1|||
131031846|NCT04485039|471749671|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
131031847|NCT04485039|471749671|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
131031848|NCT04005716|471749675|FG000|Overall Study|Death|175|||
131031849|NCT04005716|471749676|FG001|Overall Study|Death|196|||
131031850|NCT04005716|471749675|FG000|Overall Study|Withdrawal by Subject|1|||
131031851|NCT04005716|471749676|FG001|Overall Study|Withdrawal by Subject|6|||
131031852|NCT04005716|471749675|FG000|Overall Study|Lost to Follow-up|2|||
131031853|NCT04005716|471749676|FG001|Overall Study|Lost to Follow-up|2|||
131031854|NCT04021602|471749677|FG000|Overall Study|Lost to Follow-up|3|||
131031855|NCT04021602|471749678|FG001|Overall Study|Lost to Follow-up|3|||
131031856|NCT04021602|471749679|FG002|Overall Study|Lost to Follow-up|1|||
131031857|NCT04021602|471749677|FG000|Overall Study|Adverse Event|1|||
131031858|NCT04021602|471749678|FG001|Overall Study|Adverse Event|0|||
131031859|NCT04021602|471749679|FG002|Overall Study|Adverse Event|1|||
131031860|NCT03623321|471749680|FG000|Overall Study|Adverse Event|32|||
131031861|NCT03623321|471749680|FG000|Overall Study|Death|9|||
131031862|NCT03623321|471749680|FG000|Overall Study|Lack of Efficacy|9|||
131031863|NCT03623321|471749680|FG000|Overall Study|Lost to Follow-up|6|||
131031864|NCT03623321|471749680|FG000|Overall Study|Noncompliance with study drug|6|||
131031865|NCT03623321|471749680|FG000|Overall Study|Use of prohibited medication|3|||
131031866|NCT03623321|471749680|FG000|Overall Study|Physician Decision|5|||
131031867|NCT03623321|471749680|FG000|Overall Study|Protocol Violation|1|||
131031868|NCT03623321|471749680|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
130768891|NCT00624832|470778614|FG000|Overall Study|Abnormal Laboratory Value|2|||
130768892|NCT00624832|470778615|FG001|Overall Study|Abnormal Laboratory Value|0|||
130912684|NCT02611960|471316478|FG001|Overall Study|Withdrawal by Subject|5|||
130912685|NCT02611960|471316477|FG000|Overall Study|Sponsor Decision|11|||
130912686|NCT02611960|471316478|FG001|Overall Study|Sponsor Decision|11|||
131031869|NCT03623321|471749680|FG000|Overall Study|Not further specified|43|||
131031870|NCT02243709|471749681|FG000|Phase 1|Lost to Follow-up|0|||
131031871|NCT02243709|471749682|FG001|Phase 1|Lost to Follow-up|1|||
131031872|NCT02243709|471749681|FG000|Phase 1|Withdrawal by Subject|1|||
131031873|NCT02243709|471749682|FG001|Phase 1|Withdrawal by Subject|0|||
130912687|NCT02213042|471316481|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
130912688|NCT02213042|471316482|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
130912689|NCT02213042|471316483|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
130912690|NCT02213042|471316481|FG000|Overall Study|Adverse Event|2|||
130912691|NCT02213042|471316482|FG001|Overall Study|Adverse Event|1|||
130912692|NCT02213042|471316483|FG002|Overall Study|Adverse Event|0|||
131031874|NCT02243709|471749681|FG000|Phase 1|Protocol Violation|0|||
130912693|NCT02213042|471316481|FG000|Overall Study|Withdrawal by Subject|0|||
130912694|NCT02213042|471316482|FG001|Overall Study|Withdrawal by Subject|1|||
130912695|NCT02213042|471316483|FG002|Overall Study|Withdrawal by Subject|1|||
130912696|NCT02213042|471316481|FG000|Overall Study|Protocol Violation|1|||
130912697|NCT02213042|471316482|FG001|Overall Study|Protocol Violation|0|||
130912698|NCT02213042|471316483|FG002|Overall Study|Protocol Violation|0|||
130912699|NCT02213042|471316481|FG000|Overall Study|Investigator discretion|0|||
130912700|NCT02213042|471316482|FG001|Overall Study|Investigator discretion|0|||
130912701|NCT02213042|471316483|FG002|Overall Study|Investigator discretion|1|||
130912702|NCT05314478|471316484|FG000|Overall Study|Physician Decision|1|||
130912703|NCT02476422|471316485|FG000|Overall Study|Subject/guardian decision|0|||
130912704|NCT02476422|471316486|FG001|Overall Study|Subject/guardian decision|1|||
130912705|NCT00760214|471316488|FG000|Overall Study|Adverse Event|8|||
130912706|NCT00760214|471316489|FG001|Overall Study|Adverse Event|9|||
130912707|NCT00760214|471316490|FG002|Overall Study|Adverse Event|12|||
130912708|NCT00760214|471316488|FG000|Overall Study|Protocol Violation|3|||
130912709|NCT00760214|471316489|FG001|Overall Study|Protocol Violation|0|||
130912710|NCT00760214|471316490|FG002|Overall Study|Protocol Violation|3|||
130912711|NCT00760214|471316488|FG000|Overall Study|Lost to Follow-up|0|||
130912712|NCT00760214|471316489|FG001|Overall Study|Lost to Follow-up|0|||
131031875|NCT02243709|471749682|FG001|Phase 1|Protocol Violation|1|||
131031876|NCT02243709|471749681|FG000|Phase 1|Adverse Event|0|||
131031877|NCT02243709|471749682|FG001|Phase 1|Adverse Event|1|||
131031878|NCT04347161|471749685|FG000|Overall Study|Death|0|||
131031879|NCT04347161|471749686|FG001|Overall Study|Death|2|||
131031880|NCT04347161|471749685|FG000|Overall Study|Withdrawal by Subject|1|||
131031881|NCT04347161|471749686|FG001|Overall Study|Withdrawal by Subject|0|||
131031882|NCT04347161|471749685|FG000|Overall Study|Lost to Follow-up|0|||
131031883|NCT04347161|471749686|FG001|Overall Study|Lost to Follow-up|1|||
131031884|NCT04347161|471749685|FG000|Overall Study|No longer on study medication|1|||
131031885|NCT04347161|471749686|FG001|Overall Study|No longer on study medication|1|||
131031886|NCT04169373|471749687|FG000|Week 1 to Week 14|Adverse Event|1|||
131031887|NCT04169373|471749688|FG001|Week 1 to Week 14|Adverse Event|0|||
131031888|NCT04169373|471749689|FG002|Week 1 to Week 14|Adverse Event|1|||
131031889|NCT04169373|471749690|FG003|Week 1 to Week 14|Adverse Event|2|||
131031890|NCT04169373|471749687|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
131031891|NCT04169373|471749688|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
131031892|NCT04169373|471749689|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
131031893|NCT04169373|471749690|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
131031894|NCT04169373|471749687|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
131031895|NCT04169373|471749688|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
131031896|NCT04169373|471749689|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
131031897|NCT04169373|471749690|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
131031898|NCT04169373|471749687|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
131031899|NCT04169373|471749688|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
131031900|NCT04169373|471749689|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
131031901|NCT04169373|471749690|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
131031902|NCT04169373|471749687|FG000|Week 1 to Week 14|Other|1|||
131031903|NCT04169373|471749688|FG001|Week 1 to Week 14|Other|3|||
131031904|NCT04169373|471749689|FG002|Week 1 to Week 14|Other|3|||
131031905|NCT04169373|471749690|FG003|Week 1 to Week 14|Other|5|||
131031906|NCT04169373|471749687|FG000|Week 14 to Week 52|Adverse Event|1|||
131031907|NCT04169373|471749688|FG001|Week 14 to Week 52|Adverse Event|0|||
131031908|NCT04169373|471749689|FG002|Week 14 to Week 52|Adverse Event|0|||
131031909|NCT04169373|471749690|FG003|Week 14 to Week 52|Adverse Event|1|||
131031910|NCT04169373|471749687|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
131031911|NCT04169373|471749688|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
131031912|NCT04169373|471749689|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
131031913|NCT04169373|471749690|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
131031914|NCT04169373|471749687|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
131031915|NCT04169373|471749688|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
131031916|NCT04169373|471749689|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
131031917|NCT04169373|471749690|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
131031918|NCT04169373|471749687|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
131031919|NCT04169373|471749688|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
131031920|NCT04169373|471749689|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
131031921|NCT04169373|471749690|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
131031922|NCT04169373|471749687|FG000|Week 14 to Week 52|Other|4|||
131031923|NCT04169373|471749688|FG001|Week 14 to Week 52|Other|5|||
131031924|NCT04169373|471749689|FG002|Week 14 to Week 52|Other|4|||
131031925|NCT04169373|471749690|FG003|Week 14 to Week 52|Other|5|||
130912713|NCT00760214|471316490|FG002|Overall Study|Lost to Follow-up|1|||
130912714|NCT00760214|471316488|FG000|Overall Study|Withdrawal by Subject|12|||
130912715|NCT00760214|471316489|FG001|Overall Study|Withdrawal by Subject|14|||
131031926|NCT04169373|471749687|FG000|Week 14 to Week 52|Ongoing|0|||
131031927|NCT04169373|471749688|FG001|Week 14 to Week 52|Ongoing|1|||
131031928|NCT04169373|471749689|FG002|Week 14 to Week 52|Ongoing|0|||
131117325|NCT03627767|472062348|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
131117326|NCT03627767|472062349|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
131117327|NCT03627767|472062345|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
131117328|NCT03627767|472062346|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
131117329|NCT03627767|472062347|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
131117330|NCT03627767|472062348|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
131117331|NCT03627767|472062349|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
131117332|NCT03627767|472062345|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
131117333|NCT03627767|472062346|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
131117334|NCT03627767|472062347|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
131117335|NCT03627767|472062348|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
131117336|NCT03627767|472062349|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
131117337|NCT03627767|472062345|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
131117338|NCT03627767|472062346|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
131117339|NCT03627767|472062347|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
131117340|NCT03627767|472062348|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
131117341|NCT03627767|472062349|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
131117342|NCT03627767|472062345|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
131117343|NCT03627767|472062346|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
131117344|NCT03627767|472062347|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
131117345|NCT03627767|472062348|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
131117346|NCT03627767|472062349|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
131117347|NCT03627767|472062345|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
131117348|NCT03627767|472062346|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
131117349|NCT03627767|472062347|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
131117350|NCT03627767|472062348|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
131117351|NCT03627767|472062349|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
131117352|NCT03627767|472062345|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
131117353|NCT03627767|472062346|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
131117354|NCT03627767|472062347|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
131117355|NCT03627767|472062348|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
131117356|NCT03627767|472062349|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
131117357|NCT03627767|472062345|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
131117358|NCT03627767|472062346|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
131117359|NCT03627767|472062347|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
131117360|NCT03627767|472062348|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
131117361|NCT03627767|472062349|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
131117362|NCT03627767|472062345|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
131117363|NCT03627767|472062346|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130912716|NCT00760214|471316490|FG002|Overall Study|Withdrawal by Subject|13|||
130912717|NCT00760214|471316488|FG000|Overall Study|Lack of Efficacy|3|||
130912718|NCT00760214|471316489|FG001|Overall Study|Lack of Efficacy|2|||
130912719|NCT00760214|471316490|FG002|Overall Study|Lack of Efficacy|4|||
130912720|NCT00760214|471316488|FG000|Overall Study|Pregnancy|0|||
130912721|NCT00760214|471316489|FG001|Overall Study|Pregnancy|0|||
130912722|NCT00760214|471316490|FG002|Overall Study|Pregnancy|1|||
131031929|NCT04169373|471749690|FG003|Week 14 to Week 52|Ongoing|0|||
131117364|NCT03627767|472062347|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
131117365|NCT03627767|472062348|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
131117366|NCT03627767|472062349|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
131117367|NCT03627767|472062345|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
131031939|NCT03445988|471749702|FG000|Overall Study|Lost to Follow-up|14|||
131031940|NCT03445988|471749703|FG001|Overall Study|Lost to Follow-up|26|||
131031941|NCT03445988|471749704|FG002|Overall Study|Lost to Follow-up|27|||
131031942|NCT03445988|471749705|FG003|Overall Study|Lost to Follow-up|66|||
131031943|NCT03445988|471749702|FG000|Overall Study|Withdrawal by Subject|7|||
131031944|NCT03445988|471749703|FG001|Overall Study|Withdrawal by Subject|4|||
131031945|NCT03445988|471749704|FG002|Overall Study|Withdrawal by Subject|3|||
131031946|NCT03445988|471749705|FG003|Overall Study|Withdrawal by Subject|5|||
130696988|NCT00556673|470514556|FG001|Overall Study|Protocol deviation|2|||
130696989|NCT03555695|470514557|FG000|Overall Study|Withdrawal by Subject|1|||
130912723|NCT00760214|471316488|FG000|Overall Study|Physician Decision|1|||
131031947|NCT03445988|471749702|FG000|Overall Study|Death (unrelated to study)|5|||
131031948|NCT03445988|471749703|FG001|Overall Study|Death (unrelated to study)|1|||
131031949|NCT03445988|471749704|FG002|Overall Study|Death (unrelated to study)|2|||
130912724|NCT00760214|471316489|FG001|Overall Study|Physician Decision|1|||
130912725|NCT00760214|471316490|FG002|Overall Study|Physician Decision|1|||
130912726|NCT00760214|471316488|FG000|Overall Study|Other|3|||
130912727|NCT00760214|471316489|FG001|Overall Study|Other|4|||
130912728|NCT00760214|471316490|FG002|Overall Study|Other|6|||
130912729|NCT01134315|471316491|FG000|Overall Study|Adverse Event|1|||
130912730|NCT01134315|471316492|FG001|Overall Study|Adverse Event|2|||
130912731|NCT01134315|471316491|FG000|Overall Study|Other Reason|8|||
130912732|NCT01134315|471316492|FG001|Overall Study|Other Reason|17|||
130912733|NCT01086423|471316494|FG000|Overall Study|Protocol Violation|0|||
130912734|NCT01086423|471316495|FG001|Overall Study|Protocol Violation|0|||
130912735|NCT01086423|471316496|FG002|Overall Study|Protocol Violation|1|||
130912736|NCT01086423|471316494|FG000|Overall Study|Migrated/moved from study area|2|||
130912737|NCT01086423|471316495|FG001|Overall Study|Migrated/moved from study area|0|||
130912738|NCT01086423|471316496|FG002|Overall Study|Migrated/moved from study area|4|||
130912739|NCT01086423|471316494|FG000|Overall Study|Adverse event, fatal|1|||
130912740|NCT01086423|471316495|FG001|Overall Study|Adverse event, fatal|1|||
130912741|NCT01086423|471316496|FG002|Overall Study|Adverse event, fatal|0|||
130912742|NCT01086423|471316494|FG000|Overall Study|Adverse event, non-fatal|2|||
130912743|NCT01086423|471316495|FG001|Overall Study|Adverse event, non-fatal|1|||
130912744|NCT01086423|471316496|FG002|Overall Study|Adverse event, non-fatal|0|||
130912745|NCT01086423|471316494|FG000|Overall Study|Withdrawal by Subject|5|||
130912746|NCT01086423|471316495|FG001|Overall Study|Withdrawal by Subject|1|||
130912747|NCT01086423|471316496|FG002|Overall Study|Withdrawal by Subject|3|||
130912748|NCT01086423|471316494|FG000|Overall Study|Lost to Follow-up|0|||
130912749|NCT01086423|471316495|FG001|Overall Study|Lost to Follow-up|0|||
130912750|NCT01086423|471316496|FG002|Overall Study|Lost to Follow-up|1|||
130912751|NCT04950166|471316507|FG000|Overall Study|Withdrawal by Subject|1|||
130912752|NCT00857415|471316510|FG000|Overall Study|Image acquisition failure|2|||
130912753|NCT00857415|471316511|FG001|Overall Study|Image acquisition failure|0|||
130912754|NCT00857415|471316510|FG000|Overall Study|Invalid image or not imaged|3|||
130912755|NCT00857415|471316511|FG001|Overall Study|Invalid image or not imaged|0|||
130912756|NCT00857415|471316510|FG000|Overall Study|Subject still living at end of study|110|||
130912757|NCT00857415|471316511|FG001|Overall Study|Subject still living at end of study|0|||
130912758|NCT00857415|471316510|FG000|Overall Study|Deceased with no autopsy|2|||
130912759|NCT00857415|471316511|FG001|Overall Study|Deceased with no autopsy|0|||
130912760|NCT01130103|471316512|FG000|Randomized Treatment|Adverse Event|1|||
130912761|NCT01130103|471316513|FG001|Randomized Treatment|Adverse Event|1|||
130912762|NCT01130103|471316512|FG000|Randomized Treatment|Lost to Follow-up|1|||
130912763|NCT01130103|471316513|FG001|Randomized Treatment|Lost to Follow-up|0|||
130912764|NCT01130103|471316512|FG000|Randomized Treatment|Protocol Violation|3|||
130912765|NCT01130103|471316513|FG001|Randomized Treatment|Protocol Violation|2|||
130912766|NCT01130103|471316512|FG000|Randomized Treatment|Withdrawal by Subject|1|||
130912767|NCT01130103|471316513|FG001|Randomized Treatment|Withdrawal by Subject|2|||
130912768|NCT01130103|471316512|FG000|Maintenance Treatment|Lack of Efficacy|0|||
130912769|NCT01130103|471316513|FG001|Maintenance Treatment|Lack of Efficacy|1|||
130912770|NCT01130103|471316512|FG000|Maintenance Treatment|Lost to Follow-up|1|||
130912771|NCT01130103|471316513|FG001|Maintenance Treatment|Lost to Follow-up|1|||
130912772|NCT01130103|471316512|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
130912773|NCT01130103|471316513|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
130696990|NCT03555695|470514557|FG000|Overall Study|Lost to Follow-up|1|||
130696991|NCT03555695|470514557|FG000|Overall Study|appendicitis (unrelated)|1|||
130912774|NCT01822678|471316516|FG000|Overall Study|Withdrawal by Subject|5|||
130912775|NCT01822678|471316517|FG001|Overall Study|Withdrawal by Subject|4|||
130912776|NCT01822678|471316518|FG002|Overall Study|Withdrawal by Subject|4|||
130912777|NCT01822678|471316516|FG000|Overall Study|Adverse Event|4|||
130912778|NCT01822678|471316517|FG001|Overall Study|Adverse Event|3|||
130912779|NCT01822678|471316518|FG002|Overall Study|Adverse Event|1|||
130912780|NCT01822678|471316516|FG000|Overall Study|Lack of Efficacy|3|||
130912781|NCT01822678|471316517|FG001|Overall Study|Lack of Efficacy|6|||
130912782|NCT01822678|471316518|FG002|Overall Study|Lack of Efficacy|5|||
130912783|NCT01822678|471316516|FG000|Overall Study|Lost to Follow-up|0|||
130912784|NCT01822678|471316517|FG001|Overall Study|Lost to Follow-up|2|||
130912785|NCT01822678|471316518|FG002|Overall Study|Lost to Follow-up|1|||
130912786|NCT00764504|471316519|FG000|Overall Study|Death|12|||
130912787|NCT00764504|471316520|FG001|Overall Study|Death|6|||
130696992|NCT03555695|470514557|FG000|Overall Study|pre-existing sciatica|1|||
130696993|NCT04194151|470514558|FG000|Overall Study|Physician Decision|1|||
130912788|NCT00764504|471316521|FG002|Overall Study|Death|13|||
130912789|NCT00764504|471316519|FG000|Overall Study|Revision of Device|12|||
130912790|NCT00764504|471316520|FG001|Overall Study|Revision of Device|23|||
130912791|NCT00764504|471316521|FG002|Overall Study|Revision of Device|14|||
130912792|NCT00764504|471316519|FG000|Overall Study|Physician Decision|1|||
130912793|NCT00764504|471316520|FG001|Overall Study|Physician Decision|0|||
130912794|NCT00764504|471316521|FG002|Overall Study|Physician Decision|0|||
130912795|NCT00764504|471316519|FG000|Overall Study|Withdrawal by Subject|1|||
130912796|NCT00764504|471316520|FG001|Overall Study|Withdrawal by Subject|7|||
131031950|NCT03445988|471749705|FG003|Overall Study|Death (unrelated to study)|4|||
131031951|NCT02689284|471749709|FG000|Overall Study|Adverse Event|1|||
131031952|NCT02689284|471749710|FG001|Overall Study|Adverse Event|8|||
131031953|NCT02689284|471749709|FG000|Overall Study|Death|0|||
131031954|NCT02689284|471749710|FG001|Overall Study|Death|1|||
131031955|NCT02689284|471749709|FG000|Overall Study|Physician Decision|1|||
131031956|NCT02689284|471749710|FG001|Overall Study|Physician Decision|2|||
131031957|NCT02689284|471749709|FG000|Overall Study|Withdrawal by Subject|0|||
131031958|NCT02689284|471749710|FG001|Overall Study|Withdrawal by Subject|1|||
131031959|NCT02689284|471749709|FG000|Overall Study|progression of cancer|1|||
131031960|NCT02689284|471749710|FG001|Overall Study|progression of cancer|72|||
131031961|NCT02689284|471749709|FG000|Overall Study|decreased heart function|0|||
131031962|NCT02689284|471749710|FG001|Overall Study|decreased heart function|1|||
131031963|NCT02689284|471749709|FG000|Overall Study|concern for anemia|0|||
131031964|NCT02689284|471749710|FG001|Overall Study|concern for anemia|1|||
131031965|NCT02689284|471749709|FG000|Overall Study|no measurable cancer for evaluation|0|||
131031966|NCT02689284|471749710|FG001|Overall Study|no measurable cancer for evaluation|1|||
131031967|NCT03519581|471749713|FG000|Overall Study|Lost to Follow-up|3|||
131031968|NCT03519581|471749714|FG001|Overall Study|Lost to Follow-up|2|||
131031969|NCT03519581|471749713|FG000|Overall Study|Adverse Event|5|||
131031970|NCT03519581|471749714|FG001|Overall Study|Adverse Event|2|||
131031971|NCT03519581|471749713|FG000|Overall Study|Withdrawal by Subject|2|||
131031972|NCT03519581|471749714|FG001|Overall Study|Withdrawal by Subject|0|||
131031973|NCT03519581|471749713|FG000|Overall Study|Change to insurance|2|||
131031974|NCT03519581|471749714|FG001|Overall Study|Change to insurance|1|||
131031975|NCT03519581|471749713|FG000|Overall Study|Other|2|||
131031976|NCT03519581|471749714|FG001|Overall Study|Other|4|||
131031977|NCT05268393|471749715|FG000|Overall Study|Withdrawal by Subject|2|||
131031978|NCT05268393|471749716|FG001|Overall Study|Withdrawal by Subject|1|||
131031979|NCT05371652|471749717|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
131031980|NCT05371652|471749717|FG000|Overall Study|Withdrawal by Subject|12|||
131031981|NCT05371652|471749717|FG000|Overall Study|Adverse Event|1|||
131031982|NCT05371652|471749717|FG000|Overall Study|Other|11|||
131031983|NCT01494662|471749721|FG000|Overall Study|Withdrawal by Subject|0|||
131031984|NCT01494662|471749722|FG001|Overall Study|Withdrawal by Subject|0|||
131031985|NCT01494662|471749723|FG002|Overall Study|Withdrawal by Subject|1|||
131031986|NCT01494662|471749724|FG003|Overall Study|Withdrawal by Subject|0|||
131031987|NCT01494662|471749725|FG004|Overall Study|Withdrawal by Subject|0|||
131031988|NCT01494662|471749726|FG005|Overall Study|Withdrawal by Subject|0|||
131031989|NCT01494662|471749727|FG006|Overall Study|Withdrawal by Subject|0|||
131031990|NCT01494662|471749721|FG000|Overall Study|Physician Decision|0|||
131031991|NCT01494662|471749722|FG001|Overall Study|Physician Decision|0|||
131031992|NCT01494662|471749723|FG002|Overall Study|Physician Decision|1|||
131031993|NCT01494662|471749724|FG003|Overall Study|Physician Decision|0|||
131031994|NCT01494662|471749725|FG004|Overall Study|Physician Decision|0|||
131031995|NCT01494662|471749726|FG005|Overall Study|Physician Decision|0|||
131031996|NCT01494662|471749727|FG006|Overall Study|Physician Decision|0|||
131031997|NCT02724631|471749730|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
131031998|NCT05089734|471749735|FG000|Overall Study|Still on study|122|||
131031999|NCT05089734|471749736|FG001|Overall Study|Still on study|101|||
131032000|NCT05089734|471749735|FG000|Overall Study|Death|161|||
131032001|NCT05089734|471749736|FG001|Overall Study|Death|179|||
131032002|NCT05089734|471749735|FG000|Overall Study|Withdrew consent|11|||
131032003|NCT05089734|471749736|FG001|Overall Study|Withdrew consent|24|||
131032004|NCT05089734|471749735|FG000|Overall Study|Lost to Follow-up|5|||
131032005|NCT05089734|471749736|FG001|Overall Study|Lost to Follow-up|0|||
131032006|NCT02992925|471751321|FG000|Cohort 2|Physician Decision|0|||
131032007|NCT02992925|471751322|FG001|Cohort 2|Physician Decision|0|||
131032008|NCT02992925|471751323|FG002|Cohort 2|Physician Decision|1|||
131032009|NCT02992925|471751324|FG003|Cohort 2|Physician Decision|0|||
131032010|NCT02992925|471751321|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
130696994|NCT04194151|470514559|FG001|Overall Study|Physician Decision|1|||
130696995|NCT04194151|470514560|FG002|Overall Study|Physician Decision|1|||
130696996|NCT04194151|470514561|FG003|Overall Study|Physician Decision|1|||
130696997|NCT04194151|470514562|FG004|Overall Study|Physician Decision|0|||
130696998|NCT04194151|470514563|FG005|Overall Study|Physician Decision|1|||
131032011|NCT02992925|471751322|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
131032012|NCT02992925|471751323|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
131032013|NCT02992925|471751324|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
131032014|NCT03779204|471751325|FG000|Overall Study|Lost to Follow-up|2|||
131032015|NCT03779204|471751326|FG001|Overall Study|Lost to Follow-up|0|||
131032016|NCT04150718|471751327|FG000|Overall Study|Withdrawal by Subject|2|||
131032017|NCT04150718|471751328|FG001|Overall Study|Withdrawal by Subject|7|||
131032018|NCT04150718|471751329|FG002|Overall Study|Withdrawal by Subject|1|||
131032019|NCT04150718|471751327|FG000|Overall Study|Lost to Follow-up|1|||
131032020|NCT04150718|471751328|FG001|Overall Study|Lost to Follow-up|2|||
130696999|NCT04194151|470514558|FG000|Overall Study|Monitorization problem|0|||
130697000|NCT04194151|470514559|FG001|Overall Study|Monitorization problem|1|||
131032021|NCT04150718|471751329|FG002|Overall Study|Lost to Follow-up|0|||
130912797|NCT00764504|471316521|FG002|Overall Study|Withdrawal by Subject|4|||
130912798|NCT00764504|471316519|FG000|Overall Study|Lost to Follow-up|40|||
130912799|NCT00764504|471316520|FG001|Overall Study|Lost to Follow-up|34|||
130912800|NCT00764504|471316521|FG002|Overall Study|Lost to Follow-up|72|||
130912801|NCT01465191|471316525|FG000|Overall Study|Protocol Violation|6|||
130912802|NCT01465191|471316526|FG001|Overall Study|Protocol Violation|3|||
130912803|NCT01465191|471316527|FG002|Overall Study|Protocol Violation|3|||
130912804|NCT01465191|471316525|FG000|Overall Study|Lost to Follow-up|3|||
130912805|NCT01465191|471316526|FG001|Overall Study|Lost to Follow-up|6|||
130912806|NCT01465191|471316527|FG002|Overall Study|Lost to Follow-up|4|||
130912807|NCT02992132|471316528|FG000|Overall Study|Adverse Event|4|||
130912808|NCT02992132|471316529|FG001|Overall Study|Adverse Event|1|||
130912809|NCT02992132|471316530|FG002|Overall Study|Adverse Event|3|||
130912810|NCT02992132|471316528|FG000|Overall Study|Lack of Efficacy|2|||
130912811|NCT02992132|471316529|FG001|Overall Study|Lack of Efficacy|0|||
130912812|NCT02992132|471316530|FG002|Overall Study|Lack of Efficacy|0|||
130912813|NCT02992132|471316528|FG000|Overall Study|Non-compliance with study drug|2|||
130912814|NCT02992132|471316529|FG001|Overall Study|Non-compliance with study drug|0|||
130912815|NCT02992132|471316530|FG002|Overall Study|Non-compliance with study drug|0|||
130912816|NCT02992132|471316528|FG000|Overall Study|Progressive disease|1|||
130912817|NCT02992132|471316529|FG001|Overall Study|Progressive disease|0|||
130912818|NCT02992132|471316530|FG002|Overall Study|Progressive disease|0|||
130912819|NCT02992132|471316528|FG000|Overall Study|Protocol Violation|2|||
130912820|NCT02992132|471316529|FG001|Overall Study|Protocol Violation|2|||
130912821|NCT02992132|471316530|FG002|Overall Study|Protocol Violation|0|||
130912822|NCT02992132|471316528|FG000|Overall Study|Caregiver withdrew consent|2|||
131032022|NCT04150718|471751327|FG000|Overall Study|Ineligible|1|||
131032023|NCT04150718|471751328|FG001|Overall Study|Ineligible|0|||
131032024|NCT04150718|471751329|FG002|Overall Study|Ineligible|10|||
131032025|NCT05633953|471751330|FG000|Overall Study|Adverse Event|7|||
131032026|NCT05633953|471751330|FG000|Overall Study|Death|30|||
130912823|NCT02992132|471316529|FG001|Overall Study|Caregiver withdrew consent|3|||
130912824|NCT02992132|471316530|FG002|Overall Study|Caregiver withdrew consent|2|||
130912825|NCT02992132|471316528|FG000|Overall Study|Withdrawal by Subject|0|||
130912826|NCT02992132|471316529|FG001|Overall Study|Withdrawal by Subject|2|||
130912827|NCT02992132|471316530|FG002|Overall Study|Withdrawal by Subject|1|||
130912828|NCT02992132|471316528|FG000|Overall Study|Physician Decision|0|||
130912829|NCT02992132|471316529|FG001|Overall Study|Physician Decision|0|||
130912830|NCT02992132|471316530|FG002|Overall Study|Physician Decision|1|||
130912831|NCT00620464|471316538|FG000|Overall Study|Adverse Event|15|||
130912832|NCT00620464|471316539|FG001|Overall Study|Adverse Event|17|||
130912833|NCT00620464|471316538|FG000|Overall Study|Lost to Follow-up|1|||
130912834|NCT00620464|471316539|FG001|Overall Study|Lost to Follow-up|1|||
130912835|NCT00620464|471316538|FG000|Overall Study|Planning Pregnancy|1|||
130912836|NCT00620464|471316539|FG001|Overall Study|Planning Pregnancy|4|||
130912837|NCT00620464|471316538|FG000|Overall Study|Personal|2|||
130912838|NCT00620464|471316539|FG001|Overall Study|Personal|2|||
130912839|NCT00620464|471316538|FG000|Overall Study|Used prohibited medication|1|||
130912840|NCT00620464|471316539|FG001|Overall Study|Used prohibited medication|0|||
130912841|NCT00467610|471316540|FG000|Overall Study|Withdrawal by Subject|1|||
130912842|NCT01369615|471316541|FG000|Overall Study|Withdrawal by Subject|0|||
130912843|NCT01369615|471316542|FG001|Overall Study|Withdrawal by Subject|1|||
130912844|NCT01369615|471316541|FG000|Overall Study|Lost to Follow-up|0|||
130912845|NCT01369615|471316542|FG001|Overall Study|Lost to Follow-up|1|||
130912846|NCT04263454|471316543|FG000|Overall Study|Adverse Event|0|||
130912847|NCT04263454|471316544|FG001|Overall Study|Adverse Event|2|||
130912848|NCT04263454|471316543|FG000|Overall Study|Physician Decision|3|||
130912849|NCT04263454|471316544|FG001|Overall Study|Physician Decision|5|||
130912850|NCT04263454|471316543|FG000|Overall Study|Poor Data Quality|0|||
130912851|NCT04263454|471316544|FG001|Overall Study|Poor Data Quality|1|||
130912852|NCT00986479|471316545|FG000|Period 1|Improved mood|1|||
130912853|NCT00986479|471316546|FG001|Period 1|Improved mood|0|||
130912854|NCT00986479|471316545|FG000|Period 1|Administrative reasons|1|||
130912855|NCT00986479|471316546|FG001|Period 1|Administrative reasons|0|||
130912856|NCT01231347|471316547|FG000|Overall Study|Full Consent withdrawn|19|||
131032027|NCT05633953|471751330|FG000|Overall Study|Lost to Follow-up|1|||
130912857|NCT01231347|471316548|FG001|Overall Study|Full Consent withdrawn|19|||
130912858|NCT01231347|471316549|FG002|Overall Study|Full Consent withdrawn|11|||
130912859|NCT01231347|471316547|FG000|Overall Study|Lost to Follow-up|4|||
130912860|NCT01231347|471316548|FG001|Overall Study|Lost to Follow-up|2|||
130912861|NCT01231347|471316549|FG002|Overall Study|Lost to Follow-up|2|||
130912862|NCT01231347|471316547|FG000|Overall Study|Death|202|||
130912863|NCT01231347|471316548|FG001|Overall Study|Death|210|||
130912864|NCT01231347|471316549|FG002|Overall Study|Death|101|||
130912865|NCT01231347|471316547|FG000|Overall Study|other event|7|||
130912866|NCT01231347|471316548|FG001|Overall Study|other event|9|||
130912867|NCT01231347|471316549|FG002|Overall Study|other event|3|||
130912868|NCT02322021|471316550|FG000|Core Phase|Adverse Event|1|||
130912869|NCT02322021|471316551|FG001|Core Phase|Adverse Event|3|||
130912870|NCT02322021|471316552|FG002|Core Phase|Adverse Event|4|||
130912871|NCT02322021|471316553|FG003|Core Phase|Adverse Event|2|||
130912872|NCT02322021|471316554|FG004|Core Phase|Adverse Event|0|||
130912873|NCT02322021|471316550|FG000|Core Phase|Participant Choice|4|||
130912874|NCT02322021|471316551|FG001|Core Phase|Participant Choice|5|||
130912875|NCT02322021|471316552|FG002|Core Phase|Participant Choice|4|||
130912876|NCT02322021|471316553|FG003|Core Phase|Participant Choice|2|||
130912877|NCT02322021|471316554|FG004|Core Phase|Participant Choice|0|||
130912878|NCT02322021|471316550|FG000|Core Phase|Lost to Follow-up|0|||
130912879|NCT02322021|471316551|FG001|Core Phase|Lost to Follow-up|0|||
130912880|NCT02322021|471316552|FG002|Core Phase|Lost to Follow-up|0|||
130912881|NCT02322021|471316553|FG003|Core Phase|Lost to Follow-up|1|||
130912882|NCT02322021|471316554|FG004|Core Phase|Lost to Follow-up|0|||
130912883|NCT02322021|471316550|FG000|Core Phase|Other|0|||
130912884|NCT02322021|471316551|FG001|Core Phase|Other|0|||
130912885|NCT02322021|471316552|FG002|Core Phase|Other|1|||
130912886|NCT02322021|471316553|FG003|Core Phase|Other|0|||
130912887|NCT02322021|471316554|FG004|Core Phase|Other|0|||
130912888|NCT02322021|471316550|FG000|Extension Phase|Adverse Event|0|||
130912889|NCT02322021|471316551|FG001|Extension Phase|Adverse Event|0|||
130912890|NCT02322021|471316552|FG002|Extension Phase|Adverse Event|0|||
130912891|NCT02322021|471316553|FG003|Extension Phase|Adverse Event|0|||
130912892|NCT02322021|471316554|FG004|Extension Phase|Adverse Event|3|||
130912893|NCT02322021|471316550|FG000|Extension Phase|Participant Choice|0|||
130912894|NCT02322021|471316551|FG001|Extension Phase|Participant Choice|0|||
130912895|NCT02322021|471316552|FG002|Extension Phase|Participant Choice|0|||
130912896|NCT02322021|471316553|FG003|Extension Phase|Participant Choice|0|||
130912897|NCT02322021|471316554|FG004|Extension Phase|Participant Choice|6|||
130912898|NCT02322021|471316550|FG000|Extension Phase|Other|0|||
130912899|NCT02322021|471316551|FG001|Extension Phase|Other|0|||
130912900|NCT02322021|471316552|FG002|Extension Phase|Other|0|||
130912901|NCT02322021|471316553|FG003|Extension Phase|Other|0|||
130912902|NCT02322021|471316554|FG004|Extension Phase|Other|3|||
130912903|NCT02322021|471316550|FG000|Extension Phase|Lost to Follow-up|0|||
130912904|NCT02322021|471316551|FG001|Extension Phase|Lost to Follow-up|0|||
130912905|NCT02322021|471316552|FG002|Extension Phase|Lost to Follow-up|0|||
130912906|NCT02322021|471316553|FG003|Extension Phase|Lost to Follow-up|0|||
130912907|NCT02322021|471316554|FG004|Extension Phase|Lost to Follow-up|1|||
130912908|NCT02322021|471316550|FG000|Extension Phase|Study terminated by sponsor|0|||
130912909|NCT02322021|471316551|FG001|Extension Phase|Study terminated by sponsor|0|||
130912910|NCT02322021|471316552|FG002|Extension Phase|Study terminated by sponsor|0|||
130912911|NCT02322021|471316553|FG003|Extension Phase|Study terminated by sponsor|0|||
130912912|NCT02322021|471316554|FG004|Extension Phase|Study terminated by sponsor|28|||
130912913|NCT00973349|471316555|FG000|Overall Study|Adverse Event|0|||
130912914|NCT00973349|471316556|FG001|Overall Study|Adverse Event|0|||
130912915|NCT00973349|471316557|FG002|Overall Study|Adverse Event|0|||
130912916|NCT00973349|471316558|FG003|Overall Study|Adverse Event|0|||
130912917|NCT00973349|471316559|FG004|Overall Study|Adverse Event|1|||
130912918|NCT00973349|471316560|FG005|Overall Study|Adverse Event|0|||
130912919|NCT00973349|471316561|FG006|Overall Study|Adverse Event|0|||
130912920|NCT00973349|471316562|FG007|Overall Study|Adverse Event|0|||
130912921|NCT00973349|471316563|FG008|Overall Study|Adverse Event|1|||
130912922|NCT00973349|471316564|FG009|Overall Study|Adverse Event|0|||
130912923|NCT00973349|471316565|FG010|Overall Study|Adverse Event|0|||
130912924|NCT00973349|471316566|FG011|Overall Study|Adverse Event|0|||
130912925|NCT00973349|471316567|FG012|Overall Study|Adverse Event|0|||
130912926|NCT00973349|471316568|FG013|Overall Study|Adverse Event|0|||
130912927|NCT00973349|471316569|FG014|Overall Study|Adverse Event|1|||
130912928|NCT00973349|471316570|FG015|Overall Study|Adverse Event|0|||
130912929|NCT00973349|471316555|FG000|Overall Study|Withdrawal by Subject|1|||
130912930|NCT00973349|471316556|FG001|Overall Study|Withdrawal by Subject|2|||
130912931|NCT00973349|471316557|FG002|Overall Study|Withdrawal by Subject|2|||
130912932|NCT00973349|471316558|FG003|Overall Study|Withdrawal by Subject|3|||
130912933|NCT00973349|471316559|FG004|Overall Study|Withdrawal by Subject|2|||
130912934|NCT00973349|471316560|FG005|Overall Study|Withdrawal by Subject|0|||
130912935|NCT00973349|471316561|FG006|Overall Study|Withdrawal by Subject|2|||
130912936|NCT00973349|471316562|FG007|Overall Study|Withdrawal by Subject|2|||
130912937|NCT00973349|471316563|FG008|Overall Study|Withdrawal by Subject|0|||
130912938|NCT00973349|471316564|FG009|Overall Study|Withdrawal by Subject|2|||
130912939|NCT00973349|471316565|FG010|Overall Study|Withdrawal by Subject|0|||
130912940|NCT00973349|471316566|FG011|Overall Study|Withdrawal by Subject|1|||
130912941|NCT00973349|471316567|FG012|Overall Study|Withdrawal by Subject|0|||
130912942|NCT00973349|471316568|FG013|Overall Study|Withdrawal by Subject|0|||
130912943|NCT00973349|471316569|FG014|Overall Study|Withdrawal by Subject|0|||
130912944|NCT00973349|471316570|FG015|Overall Study|Withdrawal by Subject|0|||
130912945|NCT00973349|471316555|FG000|Overall Study|Lost to Follow-up|3|||
130912946|NCT00973349|471316556|FG001|Overall Study|Lost to Follow-up|1|||
130912947|NCT00973349|471316557|FG002|Overall Study|Lost to Follow-up|2|||
130912948|NCT00973349|471316558|FG003|Overall Study|Lost to Follow-up|2|||
130912949|NCT00973349|471316559|FG004|Overall Study|Lost to Follow-up|1|||
130912950|NCT00973349|471316560|FG005|Overall Study|Lost to Follow-up|3|||
130912951|NCT00973349|471316561|FG006|Overall Study|Lost to Follow-up|0|||
130912952|NCT00973349|471316562|FG007|Overall Study|Lost to Follow-up|1|||
130912953|NCT00973349|471316563|FG008|Overall Study|Lost to Follow-up|2|||
130912954|NCT00973349|471316564|FG009|Overall Study|Lost to Follow-up|1|||
130912955|NCT00973349|471316565|FG010|Overall Study|Lost to Follow-up|0|||
130912956|NCT00973349|471316566|FG011|Overall Study|Lost to Follow-up|1|||
130912957|NCT00973349|471316567|FG012|Overall Study|Lost to Follow-up|0|||
130912958|NCT00973349|471316568|FG013|Overall Study|Lost to Follow-up|0|||
130912959|NCT00973349|471316569|FG014|Overall Study|Lost to Follow-up|0|||
130912960|NCT00973349|471316570|FG015|Overall Study|Lost to Follow-up|1|||
130912961|NCT00973349|471316555|FG000|Overall Study|Inappropriate enrolment|0|||
130912962|NCT00973349|471316556|FG001|Overall Study|Inappropriate enrolment|0|||
130912963|NCT00973349|471316557|FG002|Overall Study|Inappropriate enrolment|1|||
130912964|NCT00973349|471316558|FG003|Overall Study|Inappropriate enrolment|0|||
130912965|NCT00973349|471316559|FG004|Overall Study|Inappropriate enrolment|0|||
130912966|NCT00973349|471316560|FG005|Overall Study|Inappropriate enrolment|0|||
130912967|NCT00973349|471316561|FG006|Overall Study|Inappropriate enrolment|0|||
130912968|NCT00973349|471316562|FG007|Overall Study|Inappropriate enrolment|0|||
130912969|NCT00973349|471316563|FG008|Overall Study|Inappropriate enrolment|0|||
130912970|NCT00973349|471316564|FG009|Overall Study|Inappropriate enrolment|2|||
130912971|NCT00973349|471316565|FG010|Overall Study|Inappropriate enrolment|0|||
130912972|NCT00973349|471316566|FG011|Overall Study|Inappropriate enrolment|0|||
130912973|NCT00973349|471316567|FG012|Overall Study|Inappropriate enrolment|1|||
130912974|NCT00973349|471316568|FG013|Overall Study|Inappropriate enrolment|0|||
130912975|NCT00973349|471316569|FG014|Overall Study|Inappropriate enrolment|1|||
130912976|NCT00973349|471316570|FG015|Overall Study|Inappropriate enrolment|1|||
130912977|NCT00973349|471316555|FG000|Overall Study|Protocol Violation|0|||
130912978|NCT00973349|471316556|FG001|Overall Study|Protocol Violation|0|||
130912979|NCT00973349|471316557|FG002|Overall Study|Protocol Violation|0|||
130912980|NCT00973349|471316558|FG003|Overall Study|Protocol Violation|0|||
130912981|NCT00973349|471316559|FG004|Overall Study|Protocol Violation|0|||
130912982|NCT00973349|471316560|FG005|Overall Study|Protocol Violation|0|||
130912983|NCT00973349|471316561|FG006|Overall Study|Protocol Violation|0|||
130912984|NCT00973349|471316562|FG007|Overall Study|Protocol Violation|0|||
130912985|NCT00973349|471316563|FG008|Overall Study|Protocol Violation|1|||
130912986|NCT00973349|471316564|FG009|Overall Study|Protocol Violation|0|||
130912987|NCT00973349|471316565|FG010|Overall Study|Protocol Violation|0|||
130912988|NCT00973349|471316566|FG011|Overall Study|Protocol Violation|0|||
130912989|NCT00973349|471316567|FG012|Overall Study|Protocol Violation|0|||
130912990|NCT00973349|471316568|FG013|Overall Study|Protocol Violation|0|||
130912991|NCT00973349|471316569|FG014|Overall Study|Protocol Violation|0|||
130912992|NCT00973349|471316570|FG015|Overall Study|Protocol Violation|0|||
130912993|NCT00973349|471316555|FG000|Overall Study|Unable to classify|0|||
130912994|NCT00973349|471316556|FG001|Overall Study|Unable to classify|0|||
130912995|NCT00973349|471316557|FG002|Overall Study|Unable to classify|0|||
130912996|NCT00973349|471316558|FG003|Overall Study|Unable to classify|0|||
130912997|NCT00973349|471316559|FG004|Overall Study|Unable to classify|1|||
130912998|NCT00973349|471316560|FG005|Overall Study|Unable to classify|1|||
130912999|NCT00973349|471316561|FG006|Overall Study|Unable to classify|0|||
130913000|NCT00973349|471316562|FG007|Overall Study|Unable to classify|0|||
130913001|NCT00973349|471316563|FG008|Overall Study|Unable to classify|0|||
131117368|NCT03627767|472062346|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
130913002|NCT00973349|471316564|FG009|Overall Study|Unable to classify|1|||
130913003|NCT00973349|471316565|FG010|Overall Study|Unable to classify|0|||
131032028|NCT05633953|471751330|FG000|Overall Study|Osilodrostat discontinued|4|||
131032029|NCT05633953|471751330|FG000|Overall Study|Physician Decision|1|||
131032030|NCT05633953|471751330|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
131032031|NCT05633953|471751330|FG000|Overall Study|Progressive disease|2|||
131032032|NCT04034251|471751331|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
131032033|NCT04034251|471751332|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
131032034|NCT04034251|471751333|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
131032035|NCT04783935|471751346|FG000|Overall Study|Withdrawal by Subject|6|||
131032036|NCT04783935|471751346|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
131032037|NCT04783935|471751346|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
131032038|NCT04783935|471751346|FG000|Overall Study|Lost to Follow-up|3|||
131032039|NCT04783935|471751346|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
131032040|NCT06074523|471751350|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
131032041|NCT06074523|471751350|FG000|Overall Study|Withdrawal by Subject|1|||
131117369|NCT03627767|472062347|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
130913004|NCT00973349|471316566|FG011|Overall Study|Unable to classify|0|||
130913005|NCT00973349|471316567|FG012|Overall Study|Unable to classify|0|||
130913006|NCT00973349|471316568|FG013|Overall Study|Unable to classify|0|||
130913007|NCT00973349|471316569|FG014|Overall Study|Unable to classify|0|||
130913008|NCT00973349|471316570|FG015|Overall Study|Unable to classify|0|||
130913009|NCT02301988|471316571|FG000|Overall Study|Withdrawal by Subject|2|||
130913010|NCT02301988|471316572|FG001|Overall Study|Withdrawal by Subject|1|||
130913011|NCT02301988|471316571|FG000|Overall Study|Physician Decision|2|||
130913012|NCT02301988|471316572|FG001|Overall Study|Physician Decision|2|||
130913013|NCT02301988|471316571|FG000|Overall Study|Unknown Reason|1|||
130913014|NCT02301988|471316572|FG001|Overall Study|Unknown Reason|3|||
130913015|NCT02301988|471316571|FG000|Overall Study|Lack of Efficacy|3|||
130913016|NCT02301988|471316572|FG001|Overall Study|Lack of Efficacy|2|||
130913017|NCT02301988|471316571|FG000|Overall Study|Death|1|||
130913018|NCT02301988|471316572|FG001|Overall Study|Death|0|||
130913019|NCT02301988|471316571|FG000|Overall Study|Adverse Event|1|||
130913020|NCT02301988|471316572|FG001|Overall Study|Adverse Event|1|||
130913021|NCT02898116|471316573|FG000|Overall Study|Adverse Event|1|||
130913022|NCT02898116|471316573|FG000|Overall Study|Progressive disease|1|||
130913023|NCT02891161|471316580|FG000|Study Treatment|Disease Progression|2|||
130913024|NCT02891161|471316581|FG001|Study Treatment|Disease Progression|4|||
130913025|NCT02891161|471316580|FG000|Study Treatment|AE/Side Effects/Complications|1|||
130913026|NCT02891161|471316581|FG001|Study Treatment|AE/Side Effects/Complications|5|||
130913027|NCT02891161|471316580|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
130913028|NCT02891161|471316581|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
130913029|NCT02891161|471316580|FG000|Follow up|Death|4|||
130913030|NCT02891161|471316581|FG001|Follow up|Death|8|||
130913031|NCT02891161|471316580|FG000|Follow up|Refused to Follow up|0|||
130913032|NCT02891161|471316581|FG001|Follow up|Refused to Follow up|2|||
130913033|NCT02891161|471316580|FG000|Follow up|Symptomatic deterioration|0|||
130913034|NCT02891161|471316581|FG001|Follow up|Symptomatic deterioration|1|||
130913035|NCT02891161|471316580|FG000|Follow up|Study terminated|0|||
130913036|NCT02891161|471316581|FG001|Follow up|Study terminated|6|||
130913037|NCT04755283|471316582|FG000|Overall Study|Withdrawal by Subject|14|||
131117370|NCT03627767|472062348|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
130697001|NCT04194151|470514560|FG002|Overall Study|Monitorization problem|0|||
130697002|NCT04194151|470514561|FG003|Overall Study|Monitorization problem|0|||
130697003|NCT04194151|470514562|FG004|Overall Study|Monitorization problem|0|||
130697004|NCT04194151|470514563|FG005|Overall Study|Monitorization problem|0|||
130697005|NCT00874276|470514564|FG000|Overall Study|Withdrawal by Subject|1|||
130697006|NCT00874276|470514565|FG001|Overall Study|Withdrawal by Subject|1|||
130697007|NCT01109849|470516024|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
130697008|NCT01109849|470516025|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
130697009|NCT01109849|470516026|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
131117371|NCT03627767|472062349|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
131117372|NCT03627767|472062345|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
131117373|NCT03627767|472062346|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
131117374|NCT03627767|472062347|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
131117375|NCT03627767|472062348|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
131117376|NCT03627767|472062349|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
131117377|NCT03627767|472062345|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
131117378|NCT03627767|472062346|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
131117379|NCT03627767|472062347|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
131117380|NCT03627767|472062348|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
131117381|NCT03627767|472062349|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
131117382|NCT03627767|472062345|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
131117383|NCT03627767|472062346|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
130697010|NCT01109849|470516027|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
130697011|NCT01109849|470516028|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
130697012|NCT01109849|470516024|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
130697013|NCT01109849|470516025|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130697014|NCT01109849|470516026|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130697015|NCT01109849|470516027|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130697016|NCT01109849|470516028|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130697017|NCT01109849|470516024|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
130697018|NCT01109849|470516025|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
130697019|NCT01109849|470516026|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
130697020|NCT01109849|470516027|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
130697021|NCT01109849|470516028|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
130697022|NCT01109849|470516024|FG000|Initial Randomization: ADHD Treatment|move away|2|||
130697023|NCT01109849|470516025|FG001|Initial Randomization: ADHD Treatment|move away|7|||
130913038|NCT04755283|471316583|FG001|Overall Study|Withdrawal by Subject|3|||
130913039|NCT04755283|471316584|FG002|Overall Study|Withdrawal by Subject|6|||
130913040|NCT04755283|471316582|FG000|Overall Study|Lost to Follow-up|0|||
130913041|NCT04755283|471316583|FG001|Overall Study|Lost to Follow-up|0|||
130913042|NCT04755283|471316584|FG002|Overall Study|Lost to Follow-up|1|||
130913043|NCT04755283|471316582|FG000|Overall Study|Death|31|||
130913044|NCT04755283|471316583|FG001|Overall Study|Death|36|||
130697024|NCT01109849|470516026|FG002|Initial Randomization: ADHD Treatment|move away|0|||
130697025|NCT01109849|470516027|FG003|Initial Randomization: ADHD Treatment|move away|0|||
130697026|NCT01109849|470516028|FG004|Initial Randomization: ADHD Treatment|move away|0|||
130697027|NCT01109849|470516024|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
130697028|NCT01109849|470516025|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
130697029|NCT01109849|470516026|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
130697030|NCT01109849|470516027|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
130697031|NCT01109849|470516028|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
130697032|NCT01109849|470516024|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
130697033|NCT01109849|470516025|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
130697034|NCT01109849|470516026|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
130697035|NCT01109849|470516027|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
130697036|NCT01109849|470516028|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
130697037|NCT03969641|470516029|FG000|Overall Study|Lost to Follow-up|5|||
130697038|NCT03969641|470516030|FG001|Overall Study|Lost to Follow-up|3|||
130697039|NCT03969641|470516029|FG000|Overall Study|Withdrawal by Subject|1|||
130697040|NCT03969641|470516030|FG001|Overall Study|Withdrawal by Subject|2|||
130697041|NCT03969641|470516029|FG000|Overall Study|Found to be ineligible|1|||
130697042|NCT03969641|470516030|FG001|Overall Study|Found to be ineligible|1|||
130697043|NCT03969641|470516029|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
130697044|NCT03969641|470516030|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
130697045|NCT03969641|470516029|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
130697046|NCT03969641|470516030|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
130697047|NCT03969641|470516029|FG000|Overall Study|Elective termination|0|||
130697048|NCT03969641|470516030|FG001|Overall Study|Elective termination|1|||
131117384|NCT03627767|472062347|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
131117385|NCT03627767|472062348|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
131117386|NCT03627767|472062349|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
131117387|NCT03627767|472062345|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
131117388|NCT03627767|472062346|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
131117389|NCT03627767|472062347|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
131117390|NCT03627767|472062348|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
131117391|NCT03627767|472062349|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
131117392|NCT03627767|472062345|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
131117393|NCT03627767|472062346|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
131117394|NCT03627767|472062347|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
131117395|NCT03627767|472062348|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
131117396|NCT03627767|472062349|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
131117397|NCT03627767|472062345|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
131117398|NCT03627767|472062346|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
131117399|NCT03627767|472062347|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
131117400|NCT03627767|472062348|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
131117401|NCT03627767|472062349|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
131117402|NCT03627767|472062345|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
131117403|NCT03627767|472062346|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
131117404|NCT03627767|472062347|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
130697049|NCT00354835|470516031|FG000|Overall Study|Death|1|||
130697050|NCT00354835|470516032|FG001|Overall Study|Death|1|||
130697051|NCT00354835|470516031|FG000|Overall Study|Physician Decision|8|||
130697052|NCT00354835|470516032|FG001|Overall Study|Physician Decision|13|||
130697053|NCT00354835|470516031|FG000|Overall Study|Withdrawal by Subject|2|||
130697054|NCT00354835|470516032|FG001|Overall Study|Withdrawal by Subject|1|||
130697055|NCT00354835|470516031|FG000|Overall Study|Ineligible|17|||
130697056|NCT00354835|470516032|FG001|Overall Study|Ineligible|16|||
130697057|NCT00354835|470516031|FG000|Overall Study|Disease progression or relapse|15|||
130697058|NCT00354835|470516032|FG001|Overall Study|Disease progression or relapse|22|||
130697059|NCT00354835|470516031|FG000|Overall Study|Adverse Event|6|||
130697060|NCT00354835|470516032|FG001|Overall Study|Adverse Event|0|||
130697061|NCT00354835|470516031|FG000|Overall Study|Refusal of further therapy|3|||
130697062|NCT00354835|470516032|FG001|Overall Study|Refusal of further therapy|8|||
130697063|NCT03141151|470516033|FG000|Overall Study|Lost to Follow-up|3|||
130697064|NCT03141151|470516034|FG001|Overall Study|Lost to Follow-up|2|||
130913045|NCT04755283|471316584|FG002|Overall Study|Death|34|||
131117405|NCT03627767|472062348|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
131117406|NCT03627767|472062349|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
131117407|NCT04163900|472062352|FG000|Overall Study|Radiological disease progression|112|||
130697065|NCT03141151|470516033|FG000|Overall Study|Withdrawal by Subject|3|||
130697066|NCT03141151|470516034|FG001|Overall Study|Withdrawal by Subject|2|||
130697067|NCT00884390|470516035|FG000|Overall Study|Adverse Event|0|||
130697068|NCT00884390|470516036|FG001|Overall Study|Adverse Event|1|||
130697069|NCT00884390|470516035|FG000|Overall Study|Lost to Follow-up|0|||
130697070|NCT00884390|470516036|FG001|Overall Study|Lost to Follow-up|1|||
130697071|NCT00884390|470516035|FG000|Overall Study|Physician Decision|2|||
130697072|NCT00884390|470516036|FG001|Overall Study|Physician Decision|1|||
130697073|NCT00884390|470516035|FG000|Overall Study|Protocol Violation|4|||
130697074|NCT00884390|470516036|FG001|Overall Study|Protocol Violation|1|||
130697075|NCT00884390|470516035|FG000|Overall Study|Withdrawal by Subject|4|||
130697076|NCT00884390|470516036|FG001|Overall Study|Withdrawal by Subject|1|||
130697077|NCT00884390|470516035|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
130697078|NCT00884390|470516036|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
130697079|NCT00884390|470516035|FG000|Overall Study|Other|11|||
130697080|NCT00884390|470516036|FG001|Overall Study|Other|1|||
130697081|NCT02670551|470516037|FG000|Overall Study|Adverse Event|4|||
130697082|NCT02670551|470516038|FG001|Overall Study|Adverse Event|7|||
130697083|NCT02670551|470516039|FG002|Overall Study|Adverse Event|9|||
130697084|NCT02670551|470516037|FG000|Overall Study|Lack of Efficacy|2|||
130697085|NCT02670551|470516038|FG001|Overall Study|Lack of Efficacy|0|||
130697086|NCT02670551|470516039|FG002|Overall Study|Lack of Efficacy|3|||
130697087|NCT02670551|470516037|FG000|Overall Study|Withdrawal of Consent|6|||
130697088|NCT02670551|470516038|FG001|Overall Study|Withdrawal of Consent|3|||
130697089|NCT02670551|470516039|FG002|Overall Study|Withdrawal of Consent|8|||
130697090|NCT02670551|470516037|FG000|Overall Study|Lost to Follow-up|5|||
130697091|NCT02670551|470516038|FG001|Overall Study|Lost to Follow-up|7|||
130697092|NCT02670551|470516039|FG002|Overall Study|Lost to Follow-up|6|||
130697093|NCT02670551|470516037|FG000|Overall Study|Protocol Violation|1|||
130697094|NCT02670551|470516038|FG001|Overall Study|Protocol Violation|0|||
130697095|NCT02670551|470516039|FG002|Overall Study|Protocol Violation|0|||
130697096|NCT02670551|470516037|FG000|Overall Study|Noncompliance with study drug|3|||
130697097|NCT02670551|470516038|FG001|Overall Study|Noncompliance with study drug|3|||
130697098|NCT02670551|470516039|FG002|Overall Study|Noncompliance with study drug|2|||
130697099|NCT02670551|470516037|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130697100|NCT02670551|470516038|FG001|Overall Study|Other Miscellaneous Reasons|3|||
130697101|NCT02670551|470516039|FG002|Overall Study|Other Miscellaneous Reasons|3|||
130697102|NCT02670551|470516037|FG000|Overall Study|Did Not Receive Treatment|5|||
130697103|NCT02670551|470516038|FG001|Overall Study|Did Not Receive Treatment|3|||
130697104|NCT02670551|470516039|FG002|Overall Study|Did Not Receive Treatment|0|||
130697105|NCT01971645|470516041|FG000|Overall Study|Adverse Event|1|||
130697106|NCT01971645|470516042|FG001|Overall Study|Adverse Event|0|||
130697107|NCT01971645|470516043|FG002|Overall Study|Adverse Event|0|||
130913046|NCT05597020|471316592|FG000|Washout|Forbidden medication|2|||
130913047|NCT05597020|471316593|FG001|Washout|Forbidden medication|0|||
130913048|NCT05597020|471316592|FG000|Treatment Period II|Advice from primary care physician|1|||
130913049|NCT05597020|471316593|FG001|Treatment Period II|Advice from primary care physician|0|||
130913050|NCT05597020|471316592|FG000|Treatment Period II|Subject lost investigational product|1|||
130913051|NCT05597020|471316593|FG001|Treatment Period II|Subject lost investigational product|0|||
130913052|NCT05597020|471316592|FG000|Treatment Period II|Private reasons|0|||
130913053|NCT05597020|471316593|FG001|Treatment Period II|Private reasons|1|||
130913054|NCT01015131|471316594|FG000|Overall Study|Physician Decision|1|||
130913055|NCT01015131|471316594|FG000|Overall Study|Protocol Violation|1|||
130913056|NCT01015131|471316594|FG000|Overall Study|Withdrawal by Subject|2|||
131032042|NCT04956861|471751355|FG000|Overall Study|Withdrawal by Subject|4|||
131032043|NCT04956861|471751356|FG001|Overall Study|Withdrawal by Subject|4|||
131032044|NCT04956861|471751357|FG002|Overall Study|Withdrawal by Subject|2|||
131032045|NCT04956861|471751355|FG000|Overall Study|Physician Decision|4|||
131032046|NCT04956861|471751356|FG001|Overall Study|Physician Decision|5|||
131032047|NCT04956861|471751357|FG002|Overall Study|Physician Decision|1|||
131032048|NCT05337748|471751361|FG000|Overall Study|Withdrawal by Subject|1|||
131032049|NCT05337748|471751362|FG001|Overall Study|Withdrawal by Subject|0|||
131032050|NCT05337748|471751361|FG000|Overall Study|Death|1|||
131032051|NCT05337748|471751362|FG001|Overall Study|Death|0|||
131032052|NCT02543281|471751368|FG000|Overall Study|Lost to Follow-up|0|||
130697108|NCT01971645|470516041|FG000|Overall Study|Lost to Follow-up|1|||
130697109|NCT01971645|470516042|FG001|Overall Study|Lost to Follow-up|0|||
130697110|NCT01971645|470516043|FG002|Overall Study|Lost to Follow-up|1|||
130697111|NCT01971645|470516041|FG000|Overall Study|Protocol Violation|0|||
130697112|NCT01971645|470516042|FG001|Overall Study|Protocol Violation|0|||
130697113|NCT01971645|470516043|FG002|Overall Study|Protocol Violation|1|||
130697114|NCT04476277|470516044|FG000|Overall Study|Withdrawal by Subject|0|||
130697115|NCT04476277|470516045|FG001|Overall Study|Withdrawal by Subject|0|||
130697116|NCT04476277|470516046|FG002|Overall Study|Withdrawal by Subject|1|||
130697117|NCT04476277|470516047|FG003|Overall Study|Withdrawal by Subject|0|||
130697118|NCT01962298|470516048|FG000|Overall Study|Protocol Violation|1|||
130697119|NCT01962298|470516049|FG001|Overall Study|Protocol Violation|0|||
130697120|NCT01962298|470516050|FG002|Overall Study|Protocol Violation|1|||
131032053|NCT02543281|471751369|FG001|Overall Study|Lost to Follow-up|0|||
131032054|NCT02543281|471751370|FG002|Overall Study|Lost to Follow-up|1|||
130697121|NCT01962298|470516051|FG003|Overall Study|Protocol Violation|1|||
130697122|NCT01962298|470516052|FG004|Overall Study|Protocol Violation|0|||
130697123|NCT01962298|470516048|FG000|Overall Study|Data quality insufficient|2|||
130697124|NCT01962298|470516049|FG001|Overall Study|Data quality insufficient|0|||
130697125|NCT01962298|470516050|FG002|Overall Study|Data quality insufficient|3|||
130913057|NCT01015131|471316594|FG000|Overall Study|Other Protocol Specified Criteria|4|||
130913058|NCT05430022|471316595|FG000|Overall Study|Withdrawal by Subject|4|||
130913059|NCT05430022|471316596|FG001|Overall Study|Withdrawal by Subject|4|||
130913060|NCT00560885|471316603|FG000|Overall Study|Death|7|||
130913061|NCT00560885|471316603|FG000|Overall Study|Withdrawal by Subject|1|||
130913062|NCT03803683|471316607|FG000|Overall Study|Lost to Follow-up|41|||
130913063|NCT03803683|471316608|FG001|Overall Study|Lost to Follow-up|18|||
130913064|NCT03803683|471316609|FG002|Overall Study|Lost to Follow-up|12|||
130913065|NCT03803683|471316607|FG000|Overall Study|Withdrawal by Subject|9|||
130913066|NCT03803683|471316608|FG001|Overall Study|Withdrawal by Subject|1|||
130913067|NCT03803683|471316609|FG002|Overall Study|Withdrawal by Subject|4|||
130913068|NCT00492050|471316610|FG000|Overall Study|Adverse Event|1|||
130913069|NCT00492050|471316610|FG000|Overall Study|Lack of Efficacy|1|||
130913070|NCT00492050|471316610|FG000|Overall Study|Withdrawal by Subject|3|||
130913071|NCT00492050|471316610|FG000|Overall Study|Unable to collect SCT|2|||
130913072|NCT00492050|471316610|FG000|Overall Study|Progressive Disease|2|||
130913073|NCT00282412|471318199|FG000|Overall Study|Death|2|||
130913074|NCT01507298|471318200|FG000|Overall Study|Protocol Violation|0|||
130913075|NCT01507298|471318201|FG001|Overall Study|Protocol Violation|6|||
130913076|NCT00537238|471318202|FG000|Overall Study|Death|1|||
130913077|NCT00537238|471318203|FG001|Overall Study|Death|2|||
130913078|NCT00537238|471318202|FG000|Overall Study|Adverse Event|31|||
130913079|NCT00537238|471318203|FG001|Overall Study|Adverse Event|22|||
130913080|NCT00537238|471318202|FG000|Overall Study|Lack of Efficacy|20|||
130913081|NCT00537238|471318203|FG001|Overall Study|Lack of Efficacy|21|||
130913082|NCT00537238|471318202|FG000|Overall Study|Lost to Follow-up|12|||
130913083|NCT00537238|471318203|FG001|Overall Study|Lost to Follow-up|8|||
130913084|NCT00537238|471318202|FG000|Overall Study|Withdrawal by Subject|51|||
130913085|NCT00537238|471318203|FG001|Overall Study|Withdrawal by Subject|47|||
130913086|NCT00537238|471318202|FG000|Overall Study|Protocol Violation|15|||
130913087|NCT00537238|471318203|FG001|Overall Study|Protocol Violation|19|||
130913088|NCT00537238|471318202|FG000|Overall Study|Does not meet entrance criteria|0|||
131117408|NCT04163900|472062353|FG001|Overall Study|Radiological disease progression|127|||
130697126|NCT01962298|470516051|FG003|Overall Study|Data quality insufficient|1|||
130697127|NCT01962298|470516052|FG004|Overall Study|Data quality insufficient|4|||
130697128|NCT01962298|470516048|FG000|Overall Study|Insufficient data|0|||
130697129|NCT01962298|470516049|FG001|Overall Study|Insufficient data|2|||
130697130|NCT01962298|470516050|FG002|Overall Study|Insufficient data|1|||
130697131|NCT01962298|470516051|FG003|Overall Study|Insufficient data|0|||
130697132|NCT01962298|470516052|FG004|Overall Study|Insufficient data|1|||
130697133|NCT01962298|470516048|FG000|Overall Study|Incorrect data recorded|0|||
130697134|NCT01962298|470516049|FG001|Overall Study|Incorrect data recorded|1|||
131117409|NCT04163900|472062352|FG000|Overall Study|Study closure|98|||
131117410|NCT04163900|472062353|FG001|Overall Study|Study closure|133|||
130697135|NCT01962298|470516050|FG002|Overall Study|Incorrect data recorded|0|||
130697136|NCT01962298|470516051|FG003|Overall Study|Incorrect data recorded|0|||
130697137|NCT01962298|470516052|FG004|Overall Study|Incorrect data recorded|0|||
130697138|NCT01962298|470516048|FG000|Overall Study|Physician Decision|0|||
131117411|NCT04163900|472062352|FG000|Overall Study|Adverse Event|78|||
131117412|NCT04163900|472062353|FG001|Overall Study|Adverse Event|32|||
131117413|NCT04163900|472062352|FG000|Overall Study|Withdrawal by Subject|37|||
131117414|NCT04163900|472062353|FG001|Overall Study|Withdrawal by Subject|34|||
131117415|NCT04163900|472062352|FG000|Overall Study|Death|29|||
131117416|NCT04163900|472062353|FG001|Overall Study|Death|16|||
131117417|NCT04163900|472062352|FG000|Overall Study|Physician Decision|17|||
131117418|NCT04163900|472062353|FG001|Overall Study|Physician Decision|25|||
130697139|NCT01962298|470516049|FG001|Overall Study|Physician Decision|1|||
130697140|NCT01962298|470516050|FG002|Overall Study|Physician Decision|0|||
130913089|NCT00537238|471318203|FG001|Overall Study|Does not meet entrance criteria|2|||
130913090|NCT00537238|471318202|FG000|Overall Study|Other|44|||
130913091|NCT00537238|471318203|FG001|Overall Study|Other|52|||
130913092|NCT00426231|471318206|FG000|Overall Study|Withdrawal by Subject|9|||
130913093|NCT00426231|471318207|FG001|Overall Study|Withdrawal by Subject|12|||
130913094|NCT02437513|471318208|FG000|Overall Study|Withdrawal by Subject|2|||
130697141|NCT01962298|470516051|FG003|Overall Study|Physician Decision|0|||
130697142|NCT01962298|470516052|FG004|Overall Study|Physician Decision|1|||
130697143|NCT00533507|470516053|FG000|Overall Study|Withdrawal by Subject|1|||
130697144|NCT01576705|470516054|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
130697145|NCT01576705|470516055|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
130697146|NCT01576705|470516056|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
130697147|NCT01576705|470516057|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
130697148|NCT01576705|470516054|FG000|Overall Study|invalid ICF|0|||
130697149|NCT01576705|470516055|FG001|Overall Study|invalid ICF|1|||
130697150|NCT01576705|470516056|FG002|Overall Study|invalid ICF|0|||
130697151|NCT01576705|470516057|FG003|Overall Study|invalid ICF|0|||
130697152|NCT02896296|470516058|FG000|Overall Study|Adverse Event|1|||
130913095|NCT00736957|471318209|FG000|Overall Study|Adverse Event|43|||
130913096|NCT00736957|471318209|FG000|Overall Study|Withdrawal by Subject|49|||
130913097|NCT00736957|471318209|FG000|Overall Study|violation of eligibility criteria|2|||
130768893|NCT00624832|470778616|FG002|Overall Study|Abnormal Laboratory Value|0|||
130697153|NCT02896296|470516058|FG000|Overall Study|Lost to Follow-up|19|||
130697154|NCT02896296|470516058|FG000|Overall Study|Pregnancy|1|||
130697155|NCT02896296|470516058|FG000|Overall Study|Physician Decision|2|||
130697156|NCT02896296|470516058|FG000|Overall Study|Withdrawal by Subject|10|||
130697157|NCT02896296|470516058|FG000|Overall Study|Site closing|7|||
130697158|NCT02896296|470516058|FG000|Overall Study|Incarceration|1|||
130697159|NCT02896296|470516058|FG000|Overall Study|Relocation|1|||
130697160|NCT01874535|470516059|FG000|Overall Study|Lost to Follow-up|10|||
130697161|NCT01874535|470516060|FG001|Overall Study|Lost to Follow-up|9|||
130697162|NCT01874535|470516059|FG000|Overall Study|incomplete symptom resolution|45|||
130697163|NCT01874535|470516060|FG001|Overall Study|incomplete symptom resolution|35|||
130697164|NCT01215721|470516061|FG000|Overall Study|Adverse Event|2|||
131117419|NCT04163900|472062352|FG000|Overall Study|Clinical disease progression|14|||
131117420|NCT04163900|472062353|FG001|Overall Study|Clinical disease progression|13|||
131117421|NCT04163900|472062352|FG000|Overall Study|Protocol Violation|3|||
131117422|NCT04163900|472062353|FG001|Overall Study|Protocol Violation|4|||
131117423|NCT04163900|472062352|FG000|Overall Study|Lost to Follow-up|0|||
131117424|NCT04163900|472062353|FG001|Overall Study|Lost to Follow-up|1|||
131117425|NCT01873417|472062354|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
131117426|NCT01873417|472062354|FG000|Overall Study|Adverse Event|24|||
131117427|NCT01873417|472062354|FG000|Overall Study|Lost to Follow-up|2|||
131117428|NCT01873417|472062354|FG000|Overall Study|Withdrawal by Subject|2|||
131117429|NCT01873417|472062354|FG000|Overall Study|Physician Decision|3|||
130768894|NCT00624832|470778617|FG003|Overall Study|Abnormal Laboratory Value|0|||
130768895|NCT04379700|470778618|FG000|Overall Study|Withdrawal by Subject|10|||
130697165|NCT00045162|470516062|FG000|Overall Study|Ineligible|12|||
130697166|NCT00045162|470516063|FG001|Overall Study|Ineligible|8|||
130697167|NCT00045162|470516062|FG000|Overall Study|Not treated|7|||
130697168|NCT00045162|470516063|FG001|Overall Study|Not treated|2|||
130697169|NCT00045162|470516062|FG000|Overall Study|Adverse Event|55|||
130697170|NCT00045162|470516063|FG001|Overall Study|Adverse Event|50|||
130697171|NCT00045162|470516062|FG000|Overall Study|Lack of Efficacy|32|||
130697172|NCT00045162|470516063|FG001|Overall Study|Lack of Efficacy|29|||
130697173|NCT00045162|470516062|FG000|Overall Study|Death|10|||
130697174|NCT00045162|470516063|FG001|Overall Study|Death|10|||
130697175|NCT00045162|470516062|FG000|Overall Study|Withdrawal by Subject|5|||
130697176|NCT00045162|470516063|FG001|Overall Study|Withdrawal by Subject|3|||
130697177|NCT00045162|470516062|FG000|Overall Study|Other|21|||
130697178|NCT00045162|470516063|FG001|Overall Study|Other|16|||
130697179|NCT01044433|470516064|FG000|Overall Study|Lost to Follow-up|3|||
130697180|NCT01044433|470516064|FG000|Overall Study|Withdrawal by Subject|3|||
130697181|NCT02943096|470516065|FG000|Overall Study|Lack of Efficacy|0|||
130697182|NCT02943096|470516066|FG001|Overall Study|Lack of Efficacy|1|||
130697183|NCT05065619|470516067|FG000|Up to Day 42|Lost to Follow-up|1|||
130697184|NCT05065619|470516068|FG001|Up to Day 42|Lost to Follow-up|0|||
130697185|NCT05065619|470516067|FG000|Up to Day 42|Withdrawal by Subject|1|||
130697186|NCT05065619|470516068|FG001|Up to Day 42|Withdrawal by Subject|0|||
131117430|NCT00785044|472062355|FG000|Overall Study|Dosed at non-participating sites|152|||
131117431|NCT00785044|472062355|FG000|Overall Study|Death|77|||
131117432|NCT00785044|472062355|FG000|Overall Study|Lost to Follow-up|266|||
130768896|NCT04379700|470778618|FG000|Overall Study|Screen Fail|4|||
130768897|NCT04379700|470778618|FG000|Overall Study|Lost to Follow-up|3|||
130768898|NCT00592592|470778619|FG000|Overall Study|Patient found ineligible upon chart review|1|||
130768899|NCT02700698|470778620|FG000|Overall Study|Withdrawal by Subject|1|||
130768900|NCT02700698|470778621|FG001|Overall Study|Withdrawal by Subject|0|||
130768901|NCT00530790|470778622|FG000|Overall Study|Adverse Event|2|||
130768902|NCT00530790|470778622|FG000|Overall Study|Withdrawal by Subject|2|||
130768903|NCT00530790|470778622|FG000|Overall Study|Physician Decision|1|||
130768904|NCT05053035|470778625|FG000|Overall Study|Withdrawal by Subject|1|||
131117433|NCT00785044|472062355|FG000|Overall Study|Withdrawal by Subject|1|||
130768905|NCT05053035|470778626|FG001|Overall Study|Withdrawal by Subject|0|||
130768906|NCT00938587|470778629|FG000|Overall Study|Adverse Event|2|||
131117434|NCT01628107|472062356|FG000|Overall Study|Withdrawal by Subject|17|||
131117435|NCT01628107|472062356|FG000|Overall Study|Lost to Follow-up|4|||
130697187|NCT05065619|470516067|FG000|After Day 43|Lost to Follow-up|1|||
130697188|NCT05065619|470516068|FG001|After Day 43|Lost to Follow-up|0|||
130697189|NCT05065619|470516067|FG000|After Day 43|Physician Decision|3|||
130697190|NCT05065619|470516068|FG001|After Day 43|Physician Decision|0|||
130697191|NCT05065619|470516067|FG000|After Day 43|Withdrawal by Subject|1|||
130697192|NCT05065619|470516068|FG001|After Day 43|Withdrawal by Subject|2|||
130697193|NCT05065619|470516067|FG000|After Day 43|Public vaccination|6|||
130697194|NCT05065619|470516068|FG001|After Day 43|Public vaccination|8|||
130697195|NCT05065619|470516067|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
130697196|NCT05065619|470516068|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
130697197|NCT05065619|470516067|FG000|After Day 43|Study Terminated by Sponsor|88|||
130768907|NCT00938587|470778630|FG001|Overall Study|Adverse Event|0|||
130768908|NCT00938587|470778631|FG002|Overall Study|Adverse Event|0|||
131117436|NCT01628107|472062356|FG000|Overall Study|Adverse Event|33|||
130697198|NCT05065619|470516068|FG001|After Day 43|Study Terminated by Sponsor|16|||
130697199|NCT00714051|470516074|FG000|Overall Study|Withdrawal by Subject|1|||
130697200|NCT00714051|470516075|FG001|Overall Study|Withdrawal by Subject|0|||
130697201|NCT00714051|470516074|FG000|Overall Study|Death|0|||
130697202|NCT00714051|470516075|FG001|Overall Study|Death|1|||
130697203|NCT02119936|470516084|FG000|Overall Study|Lost to Follow-up|10|||
130697204|NCT00570128|470516085|FG000|Overall Study|Adverse Event|1|||
130697205|NCT00570128|470516086|FG001|Overall Study|Adverse Event|0|||
130697206|NCT00570128|470516085|FG000|Overall Study|Lost to Follow-up|1|||
130697207|NCT00570128|470516086|FG001|Overall Study|Lost to Follow-up|0|||
130697208|NCT00570128|470516085|FG000|Overall Study|Withdrawal by Subject|2|||
130913098|NCT00736957|471318209|FG000|Overall Study|did not attend hospital appointments|1|||
130913099|NCT00736957|471318209|FG000|Overall Study|not eligible for Treatment Period I|22|||
130697209|NCT00570128|470516086|FG001|Overall Study|Withdrawal by Subject|0|||
130913100|NCT00736957|471318209|FG000|Overall Study|Physician Decision|5|||
131032055|NCT05247489|471751371|FG000|Overall Study|Lost to Follow-up|5|||
131032056|NCT05247489|471751372|FG001|Overall Study|Lost to Follow-up|1|||
131032057|NCT05247489|471751371|FG000|Overall Study|Withdrawal by Subject|6|||
131032058|NCT05247489|471751372|FG001|Overall Study|Withdrawal by Subject|7|||
131032059|NCT05247489|471751371|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
131032060|NCT05247489|471751372|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
131032061|NCT05247489|471751371|FG000|Overall Study|Left Country|1|||
131032062|NCT05247489|471751372|FG001|Overall Study|Left Country|0|||
131032063|NCT05247489|471751371|FG000|Overall Study|Noncompliance with Investigational Product|1|||
131032064|NCT05247489|471751372|FG001|Overall Study|Noncompliance with Investigational Product|0|||
131032065|NCT05247489|471751371|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
131032066|NCT05247489|471751372|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
131032067|NCT04541706|471751373|FG000|Overall Study|Withdrawal by Subject|3|||
131032068|NCT04541706|471751373|FG000|Overall Study|Progressive disease|33|||
131032069|NCT04541706|471751373|FG000|Overall Study|Physician Decision|1|||
131032070|NCT04541706|471751373|FG000|Overall Study|Lost to Follow-up|2|||
131032071|NCT04541706|471751373|FG000|Overall Study|Death|5|||
131032072|NCT04541706|471751373|FG000|Overall Study|Adverse Event|1|||
131032073|NCT05563246|471751374|FG000|Overall Study|Withdrawal by Subject|1|||
131032074|NCT05563246|471751375|FG001|Overall Study|Withdrawal by Subject|2|||
131032075|NCT05563246|471751376|FG002|Overall Study|Withdrawal by Subject|0|||
131032076|NCT05563246|471751377|FG003|Overall Study|Withdrawal by Subject|0|||
131032077|NCT05563246|471751374|FG000|Overall Study|Protocol Deviation|0|||
131032078|NCT05563246|471751375|FG001|Overall Study|Protocol Deviation|1|||
131032079|NCT05563246|471751376|FG002|Overall Study|Protocol Deviation|0|||
131032080|NCT05563246|471751377|FG003|Overall Study|Protocol Deviation|0|||
131032081|NCT05563246|471751374|FG000|Overall Study|Physician Decision|0|||
131032082|NCT05563246|471751375|FG001|Overall Study|Physician Decision|1|||
131032083|NCT05563246|471751376|FG002|Overall Study|Physician Decision|0|||
131032084|NCT05563246|471751377|FG003|Overall Study|Physician Decision|0|||
131032085|NCT05563246|471751374|FG000|Overall Study|Adverse Event|0|||
131032086|NCT05563246|471751375|FG001|Overall Study|Adverse Event|0|||
131032087|NCT05563246|471751376|FG002|Overall Study|Adverse Event|2|||
131032088|NCT05563246|471751377|FG003|Overall Study|Adverse Event|0|||
131032089|NCT05563246|471751374|FG000|Overall Study|Lost to Follow-up|0|||
131032090|NCT05563246|471751375|FG001|Overall Study|Lost to Follow-up|0|||
131032091|NCT05563246|471751376|FG002|Overall Study|Lost to Follow-up|1|||
131032092|NCT05563246|471751377|FG003|Overall Study|Lost to Follow-up|0|||
131032093|NCT04294225|471751384|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
131032094|NCT04294225|471751384|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
131032095|NCT04294225|471751384|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
131032096|NCT04294225|471751384|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
131032097|NCT04294225|471751384|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
131032098|NCT04927065|471751386|FG000|First Booster|Adverse Event|1|||
131032099|NCT04927065|471751387|FG001|First Booster|Adverse Event|0|||
131032100|NCT04927065|471751388|FG002|First Booster|Adverse Event|0|||
131032101|NCT04927065|471751389|FG003|First Booster|Adverse Event|0|||
131032102|NCT04927065|471751390|FG004|First Booster|Adverse Event|0|||
131032103|NCT04927065|471751391|FG005|First Booster|Adverse Event|0|||
131032104|NCT04927065|471751392|FG006|First Booster|Adverse Event|0|||
131032105|NCT04927065|471751393|FG007|First Booster|Adverse Event|1|||
131032106|NCT04927065|471751394|FG008|First Booster|Adverse Event|0|||
131032107|NCT04927065|471751395|FG009|First Booster|Adverse Event|0|||
131032108|NCT04927065|471751396|FG010|First Booster|Adverse Event|0|||
131032109|NCT04927065|471751397|FG011|First Booster|Adverse Event|0|||
131032110|NCT04927065|471751398|FG012|First Booster|Adverse Event|0|||
130697210|NCT03868631|470516087|FG000|Baseline to Week 6|Adverse Event|0|||
130697211|NCT03868631|470516088|FG001|Baseline to Week 6|Adverse Event|3|||
130697212|NCT03868631|470516087|FG000|Baseline to Week 6|Protocol Violation|1|||
131032111|NCT04927065|471751399|FG013|First Booster|Adverse Event|0|||
131032112|NCT04927065|471751400|FG014|First Booster|Adverse Event|0|||
131032113|NCT04927065|471751401|FG015|First Booster|Adverse Event|0|||
131032114|NCT04927065|471751386|FG000|First Booster|Death|1|||
131117437|NCT01628107|472062356|FG000|Overall Study|Physician Decision|2|||
131117438|NCT01628107|472062356|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
131117439|NCT01628107|472062356|FG000|Overall Study|Non-compliant with Study Procedures|10|||
131117440|NCT01628107|472062356|FG000|Overall Study|Not Treated|8|||
131117441|NCT01628107|472062356|FG000|Overall Study|Sponsor Decision|11|||
131117442|NCT01628107|472062356|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
131117443|NCT01628107|472062356|FG000|Overall Study|Relocated|8|||
131117444|NCT01628107|472062356|FG000|Overall Study|Kidney Transplant|9|||
131117445|NCT01628107|472062356|FG000|Overall Study|Use of Standard of Care|9|||
130697213|NCT03868631|470516088|FG001|Baseline to Week 6|Protocol Violation|1|||
130697214|NCT03868631|470516087|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
130697215|NCT03868631|470516088|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
130697216|NCT03868631|470516087|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
130697217|NCT03868631|470516088|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
130697218|NCT03868631|470516087|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
130697219|NCT03868631|470516088|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
130697220|NCT03868631|470516087|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
130697221|NCT03868631|470516088|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
130697222|NCT01929681|470516090|FG000|Overall Study|Withdrawal by Subject|1|||
130697223|NCT01929681|470516091|FG001|Overall Study|Withdrawal by Subject|0|||
130697224|NCT01929681|470516090|FG000|Overall Study|Physician Decision|1|||
130697225|NCT01929681|470516091|FG001|Overall Study|Physician Decision|1|||
130697226|NCT02218216|470516092|FG000|Overall Study|Study terminated before completed|6|||
130697227|NCT02218216|470516093|FG001|Overall Study|Study terminated before completed|0|||
130697228|NCT02218216|470516094|FG002|Overall Study|Study terminated before completed|0|||
130697229|NCT02452463|470516099|FG000|Overall Study|Death|1|||
130697230|NCT02452463|470516100|FG001|Overall Study|Death|0|||
130697231|NCT02452463|470516101|FG002|Overall Study|Death|0|||
130697232|NCT02452463|470516099|FG000|Overall Study|Study Suspended|1|||
130697233|NCT02452463|470516100|FG001|Overall Study|Study Suspended|0|||
130697234|NCT02452463|470516101|FG002|Overall Study|Study Suspended|0|||
130697235|NCT02452463|470516099|FG000|Overall Study|Recommended by DSMB|0|||
130697236|NCT02452463|470516100|FG001|Overall Study|Recommended by DSMB|1|||
130697237|NCT02452463|470516101|FG002|Overall Study|Recommended by DSMB|0|||
130697238|NCT02452463|470516099|FG000|Overall Study|Withdrawal by Subject|0|||
130697239|NCT02452463|470516100|FG001|Overall Study|Withdrawal by Subject|1|||
130697240|NCT02452463|470516101|FG002|Overall Study|Withdrawal by Subject|0|||
130697241|NCT05740098|470516102|FG000|Overall Study|Lost to Follow-up|26|||
130697242|NCT05740098|470516103|FG001|Overall Study|Lost to Follow-up|17|||
130697243|NCT05740098|470516104|FG002|Overall Study|Lost to Follow-up|21|||
130697244|NCT01073631|470516105|FG000|Overall Study|Death|82|||
130697245|NCT01073631|470516105|FG000|Overall Study|Adverse Event|24|||
130697246|NCT01073631|470516105|FG000|Overall Study|Other|63|||
130697247|NCT01528735|470516106|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
130697248|NCT01528735|470516107|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
130697249|NCT01528735|470516106|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
130697250|NCT01528735|470516107|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
130697251|NCT01426854|470516110|FG000|Overall Study|Adverse Event|1|||
130697252|NCT01426854|470516111|FG001|Overall Study|Adverse Event|5|||
130697253|NCT01426854|470516110|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
130913101|NCT00422097|471318210|FG000|Dose Level 2|Still on treatment|0|||
131117446|NCT02953639|472062357|FG000|Overall Study|Adverse Event|2|||
131117447|NCT02953639|472062358|FG001|Overall Study|Adverse Event|0|||
131117448|NCT02953639|472062359|FG002|Overall Study|Adverse Event|1|||
131117449|NCT02953639|472062357|FG000|Overall Study|Lost to Follow-up|8|||
131117450|NCT02953639|472062358|FG001|Overall Study|Lost to Follow-up|4|||
131117451|NCT02953639|472062359|FG002|Overall Study|Lost to Follow-up|3|||
131117452|NCT02953639|472062357|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131117453|NCT02953639|472062358|FG001|Overall Study|Non-Compliance With Study Drug|2|||
131117454|NCT02953639|472062359|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131117455|NCT02953639|472062357|FG000|Overall Study|Multiple Reasons|1|||
131117456|NCT02953639|472062358|FG001|Overall Study|Multiple Reasons|0|||
131117457|NCT02953639|472062359|FG002|Overall Study|Multiple Reasons|1|||
131117458|NCT02953639|472062357|FG000|Overall Study|Physician Decision|1|||
130697254|NCT01426854|470516111|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
130697255|NCT01426854|470516110|FG000|Overall Study|Lost to Follow-up|3|||
130697256|NCT01426854|470516111|FG001|Overall Study|Lost to Follow-up|0|||
131117459|NCT02953639|472062358|FG001|Overall Study|Physician Decision|0|||
130697257|NCT01426854|470516110|FG000|Overall Study|Noncompliance|0|||
130913102|NCT00422097|471318211|FG001|Dose Level 2|Still on treatment|1|||
131117460|NCT02953639|472062359|FG002|Overall Study|Physician Decision|0|||
131117461|NCT02953639|472062357|FG000|Overall Study|Withdrawal by Subject|7|||
130697258|NCT01426854|470516111|FG001|Overall Study|Noncompliance|1|||
130697259|NCT01426854|470516110|FG000|Overall Study|Treatment Failure|0|||
130697260|NCT01426854|470516111|FG001|Overall Study|Treatment Failure|16|||
130697261|NCT01426854|470516110|FG000|Overall Study|Protocol Deviation|0|||
130697262|NCT01426854|470516111|FG001|Overall Study|Protocol Deviation|1|||
130697263|NCT01426854|470516110|FG000|Overall Study|Other|3|||
130697264|NCT01426854|470516111|FG001|Overall Study|Other|2|||
130697265|NCT01971554|470516112|FG000|Overall Study|Lost to Follow-up|1|||
130697266|NCT01971554|470516113|FG001|Overall Study|Lost to Follow-up|0|||
131117462|NCT02953639|472062358|FG001|Overall Study|Withdrawal by Subject|8|||
131117463|NCT02953639|472062359|FG002|Overall Study|Withdrawal by Subject|10|||
131117464|NCT02953639|472062357|FG000|Overall Study|Completed or Discontinued information is missing|1|||
131117465|NCT02953639|472062358|FG001|Overall Study|Completed or Discontinued information is missing|0|||
131117466|NCT02953639|472062359|FG002|Overall Study|Completed or Discontinued information is missing|0|||
131117467|NCT01830855|472062360|FG000|Overall Study|Other|7|||
131117468|NCT01830855|472062361|FG001|Overall Study|Other|1|||
131117469|NCT01830855|472062362|FG002|Overall Study|Other|4|||
131117470|NCT01830855|472062363|FG003|Overall Study|Other|4|||
131117471|NCT01830855|472062360|FG000|Overall Study|Medication error without associated AE|1|||
131117472|NCT01830855|472062361|FG001|Overall Study|Medication error without associated AE|0|||
131117473|NCT01830855|472062362|FG002|Overall Study|Medication error without associated AE|0|||
131117474|NCT01830855|472062363|FG003|Overall Study|Medication error without associated AE|1|||
131117475|NCT01830855|472062360|FG000|Overall Study|Pregnancy|3|||
131117476|NCT01830855|472062361|FG001|Overall Study|Pregnancy|1|||
131117477|NCT01830855|472062362|FG002|Overall Study|Pregnancy|2|||
131117478|NCT01830855|472062363|FG003|Overall Study|Pregnancy|1|||
131117479|NCT01830855|472062360|FG000|Overall Study|No longer meets eligibility criteria|11|||
131117480|NCT01830855|472062361|FG001|Overall Study|No longer meets eligibility criteria|2|||
131117481|NCT01830855|472062362|FG002|Overall Study|No longer meets eligibility criteria|3|||
131117482|NCT01830855|472062363|FG003|Overall Study|No longer meets eligibility criteria|5|||
131117483|NCT01830855|472062360|FG000|Overall Study|Adverse Event|11|||
131117484|NCT01830855|472062361|FG001|Overall Study|Adverse Event|5|||
131117485|NCT01830855|472062362|FG002|Overall Study|Adverse Event|6|||
131117486|NCT01830855|472062363|FG003|Overall Study|Adverse Event|3|||
131117487|NCT01830855|472062360|FG000|Overall Study|Protocol deviation|10|||
131117488|NCT01830855|472062361|FG001|Overall Study|Protocol deviation|5|||
131117489|NCT01830855|472062362|FG002|Overall Study|Protocol deviation|6|||
131117490|NCT01830855|472062363|FG003|Overall Study|Protocol deviation|6|||
131117491|NCT01830855|472062360|FG000|Overall Study|Withdrawal by Subject|33|||
131117492|NCT01830855|472062361|FG001|Overall Study|Withdrawal by Subject|14|||
131117493|NCT01830855|472062362|FG002|Overall Study|Withdrawal by Subject|10|||
131117494|NCT01830855|472062363|FG003|Overall Study|Withdrawal by Subject|12|||
131117495|NCT01830855|472062360|FG000|Overall Study|No longer willing to participate|32|||
131117496|NCT01830855|472062361|FG001|Overall Study|No longer willing to participate|13|||
131117497|NCT01830855|472062362|FG002|Overall Study|No longer willing to participate|12|||
131117498|NCT01830855|472062363|FG003|Overall Study|No longer willing to participate|17|||
131117499|NCT01830855|472062360|FG000|Overall Study|Lost to Follow-up|47|||
131117500|NCT01830855|472062361|FG001|Overall Study|Lost to Follow-up|20|||
131117501|NCT01830855|472062362|FG002|Overall Study|Lost to Follow-up|23|||
131117502|NCT01830855|472062363|FG003|Overall Study|Lost to Follow-up|33|||
131117503|NCT03523728|472062364|FG000|Stage 1 (24 Months)|Adverse Event|2|||
131117504|NCT03523728|472062365|FG001|Stage 1 (24 Months)|Adverse Event|2|||
131117505|NCT03523728|472062366|FG002|Stage 1 (24 Months)|Adverse Event|4|||
131117506|NCT03523728|472062367|FG003|Stage 1 (24 Months)|Adverse Event|0|||
131117507|NCT03523728|472062368|FG004|Stage 1 (24 Months)|Adverse Event|0|||
131117508|NCT03523728|472062364|FG000|Stage 1 (24 Months)|Progressive disease|0|||
131117509|NCT03523728|472062365|FG001|Stage 1 (24 Months)|Progressive disease|0|||
131117510|NCT03523728|472062366|FG002|Stage 1 (24 Months)|Progressive disease|1|||
131117511|NCT03523728|472062367|FG003|Stage 1 (24 Months)|Progressive disease|0|||
131117512|NCT03523728|472062368|FG004|Stage 1 (24 Months)|Progressive disease|0|||
131117513|NCT03523728|472062364|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
131117514|NCT03523728|472062365|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
130697267|NCT01971554|470516114|FG002|Overall Study|Lost to Follow-up|0|||
130697268|NCT01971554|470516115|FG003|Overall Study|Lost to Follow-up|0|||
130913103|NCT00422097|471318212|FG002|Dose Level 2|Still on treatment|0|||
131117515|NCT03523728|472062366|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
131117516|NCT03523728|472062367|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
131117517|NCT03523728|472062368|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
131117518|NCT03523728|472062364|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
131117519|NCT03523728|472062365|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
131117520|NCT03523728|472062366|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
131117521|NCT03523728|472062367|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
131117522|NCT03523728|472062368|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
131117523|NCT03523728|472062364|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
131117524|NCT03523728|472062365|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
131117525|NCT03523728|472062366|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
131117526|NCT03523728|472062367|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
131117527|NCT03523728|472062368|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
130697269|NCT01942135|470516119|FG000|Overall Study|Adverse Event|21|||
130913104|NCT00422097|471318213|FG003|Dose Level 2|Still on treatment|0|||
130697270|NCT01942135|470516120|FG001|Overall Study|Adverse Event|7|||
130697271|NCT01942135|470516119|FG000|Overall Study|Global Deterioration of Health Status|9|||
130697272|NCT01942135|470516120|FG001|Overall Study|Global Deterioration of Health Status|6|||
130697273|NCT01942135|470516119|FG000|Overall Study|Randomized Not Treated|2|||
130697274|NCT01942135|470516120|FG001|Overall Study|Randomized Not Treated|2|||
130697275|NCT01942135|470516119|FG000|Overall Study|Death|2|||
130697276|NCT01942135|470516120|FG001|Overall Study|Death|1|||
130697277|NCT01942135|470516119|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
130697278|NCT01942135|470516120|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
130697279|NCT01942135|470516119|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
130697280|NCT01942135|470516120|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
130697281|NCT01942135|470516119|FG000|Overall Study|Withdrawal by Subject|4|||
130697282|NCT01942135|470516120|FG001|Overall Study|Withdrawal by Subject|3|||
130697283|NCT01942135|470516119|FG000|Overall Study|Protocol Violation|1|||
130697284|NCT01942135|470516120|FG001|Overall Study|Protocol Violation|0|||
130697285|NCT01942135|470516119|FG000|Overall Study|Other|19|||
130697286|NCT01942135|470516120|FG001|Overall Study|Other|4|||
130697287|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
130697288|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
130768909|NCT00938587|470778632|FG003|Overall Study|Adverse Event|2|||
130913105|NCT00422097|471318214|FG004|Dose Level 2|Still on treatment|0|||
130913106|NCT00422097|471318215|FG005|Dose Level 2|Still on treatment|0|||
130913107|NCT00422097|471318216|FG006|Dose Level 2|Still on treatment|0|||
130913108|NCT00422097|471318217|FG007|Dose Level 2|Still on treatment|0|||
130913109|NCT00331864|471318218|FG000|Overall Study|Adverse Event|30|||
130913110|NCT00331864|471318219|FG001|Overall Study|Adverse Event|1|||
130913111|NCT00331864|471318218|FG000|Overall Study|Lack of Efficacy|4|||
130913112|NCT00331864|471318219|FG001|Overall Study|Lack of Efficacy|0|||
130913113|NCT00331864|471318218|FG000|Overall Study|Protocol Violation|3|||
130913114|NCT00331864|471318219|FG001|Overall Study|Protocol Violation|0|||
130913115|NCT00331864|471318218|FG000|Overall Study|Withdrawal by Subject|10|||
130913116|NCT00331864|471318219|FG001|Overall Study|Withdrawal by Subject|0|||
130913117|NCT00331864|471318218|FG000|Overall Study|Lost to Follow-up|4|||
130913118|NCT00331864|471318219|FG001|Overall Study|Lost to Follow-up|3|||
130913119|NCT00331864|471318218|FG000|Overall Study|Administrative Problems|1|||
130913120|NCT00331864|471318219|FG001|Overall Study|Administrative Problems|0|||
130913121|NCT00331864|471318218|FG000|Overall Study|Death|6|||
130913122|NCT00331864|471318219|FG001|Overall Study|Death|0|||
130913123|NCT01092507|471318220|FG000|Overall Study|Withdrawal by Subject|2|||
130913124|NCT01092507|471318221|FG001|Overall Study|Withdrawal by Subject|0|||
130913125|NCT00293215|471318232|FG000|Overall Study|Progressive disease|3|||
130913126|NCT00293215|471318233|FG001|Overall Study|Progressive disease|1|||
130913127|NCT00293215|471318232|FG000|Overall Study|Adverse Event|2|||
130913128|NCT00293215|471318233|FG001|Overall Study|Adverse Event|2|||
130913129|NCT01229371|471318234|FG000|Overall Study|Withdrawal by Subject|0|||
130913130|NCT01229371|471318235|FG001|Overall Study|Withdrawal by Subject|1|||
130913131|NCT01229371|471318236|FG002|Overall Study|Withdrawal by Subject|0|||
130913132|NCT01229371|471318237|FG003|Overall Study|Withdrawal by Subject|0|||
130913133|NCT00145600|471318238|FG000|Overall Study|Death|1|||
130913134|NCT00145600|471318239|FG001|Overall Study|Death|2|||
130913135|NCT00145600|471318240|FG002|Overall Study|Death|2|||
130913136|NCT00145600|471318241|FG003|Overall Study|Death|6|||
130913137|NCT00145600|471318238|FG000|Overall Study|Ineligible|3|||
130913138|NCT00145600|471318239|FG001|Overall Study|Ineligible|0|||
130913139|NCT00145600|471318240|FG002|Overall Study|Ineligible|1|||
130913140|NCT00145600|471318241|FG003|Overall Study|Ineligible|5|||
130913141|NCT00145600|471318238|FG000|Overall Study|Lost to Follow-up|2|||
130913142|NCT00145600|471318239|FG001|Overall Study|Lost to Follow-up|6|||
130913143|NCT00145600|471318240|FG002|Overall Study|Lost to Follow-up|2|||
130913144|NCT00145600|471318241|FG003|Overall Study|Lost to Follow-up|4|||
130913145|NCT00145600|471318238|FG000|Overall Study|Noncompliance|1|||
130913146|NCT00145600|471318239|FG001|Overall Study|Noncompliance|0|||
130913147|NCT00145600|471318240|FG002|Overall Study|Noncompliance|0|||
130913148|NCT00145600|471318241|FG003|Overall Study|Noncompliance|0|||
130913149|NCT00145600|471318238|FG000|Overall Study|Withdrawal by Subject|1|||
130913150|NCT00145600|471318239|FG001|Overall Study|Withdrawal by Subject|2|||
130913151|NCT00145600|471318240|FG002|Overall Study|Withdrawal by Subject|0|||
130913152|NCT00145600|471318241|FG003|Overall Study|Withdrawal by Subject|1|||
130913153|NCT01539642|471318243|FG000|Overall Study|Lack of Efficacy|20|||
130913154|NCT01539642|471318244|FG001|Overall Study|Lack of Efficacy|18|||
130913155|NCT01539642|471318243|FG000|Overall Study|Patient ready for early discharge|8|||
130913156|NCT01539642|471318244|FG001|Overall Study|Patient ready for early discharge|7|||
130913157|NCT01539642|471318243|FG000|Overall Study|Adverse Event|6|||
130913158|NCT01539642|471318244|FG001|Overall Study|Adverse Event|4|||
130913159|NCT01539642|471318243|FG000|Overall Study|Withdrawal by Subject|2|||
130913160|NCT01539642|471318244|FG001|Overall Study|Withdrawal by Subject|2|||
130913161|NCT00761579|471318245|FG000|Overall Study|Adverse Event|10|||
130697289|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
130697290|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
130697291|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
130697292|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
130697293|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
130697294|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
130697295|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
130697296|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
130697297|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
130697298|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
130697299|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
130697300|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
130697301|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
130697302|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
130697303|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
130697304|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
130697305|NCT00950300|470516121|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
130697306|NCT00950300|470516122|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
130697307|NCT00950300|470516121|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
130913162|NCT00761579|471318245|FG000|Overall Study|Death|2|||
131117528|NCT03523728|472062364|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
131117529|NCT03523728|472062365|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
131117530|NCT03523728|472062366|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
131117531|NCT03523728|472062367|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
131117532|NCT03523728|472062368|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
131117533|NCT03523728|472062364|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
131117534|NCT03523728|472062365|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
131117535|NCT03523728|472062366|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
131117536|NCT03523728|472062367|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
131117537|NCT03523728|472062368|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
131117538|NCT03523728|472062364|FG000|Stage 2 (24 Months)|Adverse Event|0|||
131117539|NCT03523728|472062365|FG001|Stage 2 (24 Months)|Adverse Event|0|||
131117540|NCT03523728|472062366|FG002|Stage 2 (24 Months)|Adverse Event|0|||
131117541|NCT03523728|472062367|FG003|Stage 2 (24 Months)|Adverse Event|1|||
131117542|NCT03523728|472062368|FG004|Stage 2 (24 Months)|Adverse Event|2|||
131117543|NCT03523728|472062364|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
131117544|NCT03523728|472062365|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
131117545|NCT03523728|472062366|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
131117546|NCT03523728|472062367|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
131117547|NCT03523728|472062368|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
131117548|NCT03523728|472062364|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
131117549|NCT03523728|472062365|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
131117550|NCT03523728|472062366|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
131117551|NCT03523728|472062367|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
131117552|NCT03523728|472062368|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
131117553|NCT03523728|472062364|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
131117554|NCT03523728|472062365|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
131117555|NCT03523728|472062366|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
131117556|NCT03523728|472062367|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
131117557|NCT03523728|472062368|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
131117558|NCT03523728|472062364|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
131117559|NCT03523728|472062365|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
131117560|NCT03523728|472062366|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
131117561|NCT03523728|472062367|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
131117562|NCT03523728|472062368|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
131117563|NCT00621751|472062369|FG000|Overall Study|Adverse Event|0|||
131117564|NCT00621751|472062370|FG001|Overall Study|Adverse Event|1|||
131117565|NCT00295633|472062371|FG000|Overall Study|Lack of Efficacy|19|||
130697308|NCT00950300|470516122|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
130697309|NCT00950300|470516121|FG000|TFFU Period|Death|4|||
130697310|NCT00950300|470516122|FG001|TFFU Period|Death|1|||
130697311|NCT00950300|470516121|FG000|TFFU Period|Refused Treatment|10|||
130697312|NCT00950300|470516122|FG001|TFFU Period|Refused Treatment|11|||
130697313|NCT00950300|470516121|FG000|TFFU Period|Failure to Return|16|||
130913163|NCT00761579|471318245|FG000|Overall Study|Lack of Efficacy|21|||
130913164|NCT00761579|471318245|FG000|Overall Study|Lost to Follow-up|16|||
131117566|NCT00295633|472062372|FG001|Overall Study|Lack of Efficacy|7|||
131117567|NCT00295633|472062373|FG002|Overall Study|Lack of Efficacy|16|||
131117568|NCT00295633|472062371|FG000|Overall Study|Withdrawal of consent by subject|16|||
131117569|NCT00295633|472062372|FG001|Overall Study|Withdrawal of consent by subject|16|||
131117570|NCT00295633|472062373|FG002|Overall Study|Withdrawal of consent by subject|26|||
131117571|NCT00295633|472062371|FG000|Overall Study|Adverse Event|9|||
130697314|NCT00950300|470516122|FG001|TFFU Period|Failure to Return|16|||
130697315|NCT00950300|470516121|FG000|TFFU Period|Recurrence of Disease|63|||
130697316|NCT00950300|470516122|FG001|TFFU Period|Recurrence of Disease|72|||
130697317|NCT00950300|470516121|FG000|TFFU Period|Other|4|||
130697318|NCT00950300|470516122|FG001|TFFU Period|Other|3|||
130697319|NCT00950300|470516121|FG000|SFU Period|Death|44|||
130697320|NCT00950300|470516122|FG001|SFU Period|Death|42|||
130913165|NCT00761579|471318245|FG000|Overall Study|Pregnancy|1|||
130913166|NCT00761579|471318245|FG000|Overall Study|Withdrawal by Subject|34|||
130913167|NCT00761579|471318245|FG000|Overall Study|Lack of compliance|2|||
130913168|NCT00761579|471318245|FG000|Overall Study|Protocol deviation|1|||
130913169|NCT00761579|471318245|FG000|Overall Study|Drug overdose|1|||
130913170|NCT00761579|471318245|FG000|Overall Study|Aggravation of depression|1|||
130913171|NCT00761579|471318245|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
130913172|NCT00761579|471318245|FG000|Overall Study|Lost survey form|1|||
130697321|NCT00950300|470516121|FG000|SFU Period|Lost to Follow-up|30|||
130697322|NCT00950300|470516122|FG001|SFU Period|Lost to Follow-up|28|||
130697323|NCT00950300|470516121|FG000|SFU Period|Withdrawal by Subject|4|||
130697324|NCT00950300|470516122|FG001|SFU Period|Withdrawal by Subject|8|||
130697325|NCT01717040|470516123|FG000|Overall Study|Lost to Follow-up|2|||
130697326|NCT01717040|470516124|FG001|Overall Study|Lost to Follow-up|3|||
130697327|NCT01717040|470516123|FG000|Overall Study|Lack of Efficacy|1|||
130697328|NCT01717040|470516124|FG001|Overall Study|Lack of Efficacy|1|||
130697329|NCT01717040|470516123|FG000|Overall Study|Adverse Event|1|||
130697330|NCT01717040|470516124|FG001|Overall Study|Adverse Event|0|||
130697331|NCT01717040|470516123|FG000|Overall Study|Required Medication Change|0|||
130697332|NCT01717040|470516124|FG001|Overall Study|Required Medication Change|1|||
130697333|NCT01717040|470516123|FG000|Overall Study|New Substance Use Disorder|1|||
130697334|NCT01717040|470516124|FG001|Overall Study|New Substance Use Disorder|0|||
130697335|NCT00494013|470516125|FG000|Overall Study|Adverse Event|0|||
130697336|NCT00494013|470516126|FG001|Overall Study|Adverse Event|1|||
130913173|NCT00761579|471318245|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
130913174|NCT03611010|471318246|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
130913175|NCT03611010|471318247|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
130913176|NCT03611010|471318248|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
130913177|NCT03611010|471318249|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
130913178|NCT00950911|471318250|FG000|Overall Study|Adverse Event|0|||
130913179|NCT00950911|471318251|FG001|Overall Study|Adverse Event|2|||
130913180|NCT00950911|471318250|FG000|Overall Study|Death|4|||
130913181|NCT00950911|471318251|FG001|Overall Study|Death|6|||
130913182|NCT00950911|471318250|FG000|Overall Study|Disease progression|2|||
130913183|NCT00950911|471318251|FG001|Overall Study|Disease progression|2|||
130913184|NCT00950911|471318250|FG000|Overall Study|Consent withdrawn|1|||
130913185|NCT00950911|471318251|FG001|Overall Study|Consent withdrawn|3|||
130913186|NCT00950911|471318250|FG000|Overall Study|Administrative decision|3|||
130913187|NCT00950911|471318251|FG001|Overall Study|Administrative decision|1|||
130913188|NCT00950911|471318250|FG000|Overall Study|Ineligibility determined|1|||
130913189|NCT00950911|471318251|FG001|Overall Study|Ineligibility determined|0|||
130913190|NCT00950911|471318250|FG000|Overall Study|Noncompliance|1|||
130913191|NCT00950911|471318251|FG001|Overall Study|Noncompliance|0|||
130913192|NCT00950911|471318250|FG000|Overall Study|Poor performance status|0|||
130913193|NCT00950911|471318251|FG001|Overall Study|Poor performance status|1|||
131032115|NCT04927065|471751387|FG001|First Booster|Death|0|||
131032116|NCT04927065|471751388|FG002|First Booster|Death|0|||
131117572|NCT00295633|472062372|FG001|Overall Study|Adverse Event|17|||
131117573|NCT00295633|472062373|FG002|Overall Study|Adverse Event|9|||
130913194|NCT02600351|471318254|FG000|Overall Study|Lack of Efficacy|3|||
131032117|NCT04927065|471751389|FG003|First Booster|Death|1|||
131032118|NCT04927065|471751390|FG004|First Booster|Death|0|||
131032119|NCT04927065|471751391|FG005|First Booster|Death|1|||
131032120|NCT04927065|471751392|FG006|First Booster|Death|0|||
131032121|NCT04927065|471751393|FG007|First Booster|Death|0|||
131032122|NCT04927065|471751394|FG008|First Booster|Death|0|||
131117574|NCT00295633|472062371|FG000|Overall Study|Lost to Follow-up|6|||
130697337|NCT00494013|470516125|FG000|Overall Study|Entry Criteria Not Met|1|||
131032123|NCT04927065|471751395|FG009|First Booster|Death|0|||
131032124|NCT04927065|471751396|FG010|First Booster|Death|0|||
131032125|NCT04927065|471751397|FG011|First Booster|Death|0|||
131117575|NCT00295633|472062372|FG001|Overall Study|Lost to Follow-up|11|||
130697338|NCT00494013|470516126|FG001|Overall Study|Entry Criteria Not Met|4|||
130697339|NCT00494013|470516125|FG000|Overall Study|Lost to Follow-up|5|||
131117576|NCT00295633|472062373|FG002|Overall Study|Lost to Follow-up|7|||
130697340|NCT00494013|470516126|FG001|Overall Study|Lost to Follow-up|6|||
130697341|NCT00494013|470516125|FG000|Overall Study|Physician Decision|3|||
130697342|NCT00494013|470516126|FG001|Overall Study|Physician Decision|5|||
130697343|NCT00494013|470516125|FG000|Overall Study|Protocol Violation|8|||
130697344|NCT00494013|470516126|FG001|Overall Study|Protocol Violation|5|||
130697345|NCT00494013|470516125|FG000|Overall Study|Withdrawal by Subject|13|||
130913195|NCT02600351|471318255|FG001|Overall Study|Lack of Efficacy|0|||
131032126|NCT04927065|471751398|FG012|First Booster|Death|0|||
131032127|NCT04927065|471751399|FG013|First Booster|Death|0|||
130913196|NCT02600351|471318256|FG002|Overall Study|Lack of Efficacy|5|||
130913197|NCT02600351|471318257|FG003|Overall Study|Lack of Efficacy|2|||
130913198|NCT02600351|471318254|FG000|Overall Study|Lost to Follow-up|1|||
130697346|NCT00494013|470516126|FG001|Overall Study|Withdrawal by Subject|14|||
130697347|NCT00494013|470516125|FG000|Overall Study|Sponsor Decision|0|||
130697348|NCT00494013|470516126|FG001|Overall Study|Sponsor Decision|1|||
130697349|NCT04203823|470516127|FG000|Overall Study|Withdrawal by Subject|2|||
130697350|NCT04203823|470516128|FG001|Overall Study|Withdrawal by Subject|2|||
130697351|NCT04203823|470516127|FG000|Overall Study|Adverse Event|1|||
130697352|NCT04203823|470516128|FG001|Overall Study|Adverse Event|1|||
130697353|NCT04203823|470516127|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130697354|NCT04203823|470516128|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
130697355|NCT01499043|470516129|FG000|Overall Study|Progressive disease (radiographic)|2|||
130913199|NCT02600351|471318255|FG001|Overall Study|Lost to Follow-up|0|||
130913200|NCT02600351|471318256|FG002|Overall Study|Lost to Follow-up|0|||
130913201|NCT02600351|471318257|FG003|Overall Study|Lost to Follow-up|0|||
130913202|NCT02600351|471318254|FG000|Overall Study|Randomized but Not Treated|1|||
130913203|NCT02600351|471318255|FG001|Overall Study|Randomized but Not Treated|0|||
130913204|NCT02600351|471318256|FG002|Overall Study|Randomized but Not Treated|1|||
130913205|NCT02600351|471318257|FG003|Overall Study|Randomized but Not Treated|3|||
130913206|NCT02063880|471318258|FG000|Overall Study|Death|21|||
130913207|NCT02063880|471318259|FG001|Overall Study|Death|18|||
130913208|NCT02063880|471318258|FG000|Overall Study|Lost to Follow-up|7|||
130697356|NCT01499043|470516129|FG000|Overall Study|Progressive disease (clinical)|1|||
130697357|NCT01499043|470516129|FG000|Overall Study|Withdrawal by Subject|2|||
130697358|NCT01499043|470516129|FG000|Overall Study|Adverse Event|1|||
130697359|NCT00438633|470516131|FG000|Overall Study|Withdrawal by Subject|1|||
130697360|NCT00438633|470516132|FG001|Overall Study|Withdrawal by Subject|0|||
130697361|NCT00438633|470516131|FG000|Overall Study|Lost to Follow-up|15|||
130768910|NCT00938587|470778629|FG000|Overall Study|Did not meet entrance criteria|0|||
130768911|NCT00938587|470778630|FG001|Overall Study|Did not meet entrance criteria|0|||
130768912|NCT00938587|470778631|FG002|Overall Study|Did not meet entrance criteria|1|||
130768913|NCT00938587|470778632|FG003|Overall Study|Did not meet entrance criteria|0|||
130768914|NCT00938587|470778629|FG000|Overall Study|Withdrawal by Subject|1|||
130768915|NCT00938587|470778630|FG001|Overall Study|Withdrawal by Subject|1|||
130768916|NCT00938587|470778631|FG002|Overall Study|Withdrawal by Subject|0|||
130768917|NCT00938587|470778632|FG003|Overall Study|Withdrawal by Subject|0|||
130768918|NCT02191046|470778636|FG000|Overall Study|low compliance|5|||
130768919|NCT02191046|470778637|FG001|Overall Study|low compliance|1|||
130768920|NCT00048997|470778640|FG000|Overall Study|Protocol Violation|7|||
130768921|NCT00048997|470778641|FG001|Overall Study|Protocol Violation|2|||
130768922|NCT00048997|470778640|FG000|Overall Study|Withdrawal by Subject|6|||
130768923|NCT00048997|470778641|FG001|Overall Study|Withdrawal by Subject|1|||
130768924|NCT02819440|470778642|FG000|Overall Study|Adverse Event|3|||
130913209|NCT02063880|471318259|FG001|Overall Study|Lost to Follow-up|7|||
130913210|NCT02063880|471318258|FG000|Overall Study|Ineligible|0|||
130913211|NCT02063880|471318259|FG001|Overall Study|Ineligible|2|||
131032128|NCT04927065|471751400|FG014|First Booster|Death|0|||
131032129|NCT04927065|471751401|FG015|First Booster|Death|0|||
131032130|NCT04927065|471751386|FG000|First Booster|Lost to Follow-up|8|||
131032131|NCT04927065|471751387|FG001|First Booster|Lost to Follow-up|20|||
131032132|NCT04927065|471751388|FG002|First Booster|Lost to Follow-up|0|||
131032133|NCT04927065|471751389|FG003|First Booster|Lost to Follow-up|11|||
131032134|NCT04927065|471751390|FG004|First Booster|Lost to Follow-up|43|||
131032135|NCT04927065|471751391|FG005|First Booster|Lost to Follow-up|30|||
131032136|NCT04927065|471751392|FG006|First Booster|Lost to Follow-up|28|||
131032137|NCT04927065|471751393|FG007|First Booster|Lost to Follow-up|23|||
131032138|NCT04927065|471751394|FG008|First Booster|Lost to Follow-up|4|||
131032139|NCT04927065|471751395|FG009|First Booster|Lost to Follow-up|15|||
131032140|NCT04927065|471751396|FG010|First Booster|Lost to Follow-up|0|||
130697362|NCT00438633|470516132|FG001|Overall Study|Lost to Follow-up|17|||
130697363|NCT03193021|470516133|FG000|Overall Study|Lost to Follow-up|1|||
130697364|NCT03193021|470516134|FG001|Overall Study|Lost to Follow-up|1|||
130768925|NCT02819440|470778643|FG001|Overall Study|Adverse Event|1|||
130913212|NCT00567593|471318260|FG000|Overall Study|Adverse Event|1|||
130913213|NCT00567593|471318260|FG000|Overall Study|Physician Decision|1|||
131032141|NCT04927065|471751397|FG011|First Booster|Lost to Follow-up|0|||
131032142|NCT04927065|471751398|FG012|First Booster|Lost to Follow-up|0|||
131032143|NCT04927065|471751399|FG013|First Booster|Lost to Follow-up|0|||
130697365|NCT02286466|470516135|FG000|Overall Study|Death|1|||
130697366|NCT02286466|470516136|FG001|Overall Study|Death|3|||
130697367|NCT02286466|470516135|FG000|Overall Study|Withdrawal by Subject|5|||
130697368|NCT02286466|470516136|FG001|Overall Study|Withdrawal by Subject|2|||
130697369|NCT02286466|470516135|FG000|Overall Study|Lost to Follow-up|1|||
130697370|NCT02286466|470516136|FG001|Overall Study|Lost to Follow-up|4|||
130913214|NCT04087213|471318263|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
130913215|NCT04087213|471318263|FG000|In-Facility Introduction|Adverse Event|1|||
131032144|NCT04927065|471751400|FG014|First Booster|Lost to Follow-up|0|||
131032145|NCT04927065|471751401|FG015|First Booster|Lost to Follow-up|0|||
130913216|NCT04087213|471318263|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
130913217|NCT04087213|471318263|FG000|Assisted Evaluable Period|Personal reasons|3|||
130913218|NCT04087213|471318263|FG000|Transition Period B|Renal Transplantation|1|||
130913219|NCT01859143|471318264|FG000|Overall Study|Lost to Follow-up|2|||
130913220|NCT01859143|471318265|FG001|Overall Study|Lost to Follow-up|0|||
130913221|NCT02413372|471318269|FG000|Treatment|Lost to Follow-up|0|||
130913222|NCT02413372|471318270|FG001|Treatment|Lost to Follow-up|2|||
130913223|NCT02413372|471318271|FG002|Treatment|Lost to Follow-up|1|||
130913224|NCT02413372|471318269|FG000|Treatment|Withdrawal by Subject|1|||
130913225|NCT02413372|471318270|FG001|Treatment|Withdrawal by Subject|0|||
130768926|NCT02819440|470778642|FG000|Overall Study|Lost to Follow-up|1|||
130768927|NCT02819440|470778643|FG001|Overall Study|Lost to Follow-up|3|||
130913226|NCT02413372|471318271|FG002|Treatment|Withdrawal by Subject|0|||
130913227|NCT02413372|471318269|FG000|Follow-up|Lost to Follow-up|1|||
130913228|NCT02413372|471318270|FG001|Follow-up|Lost to Follow-up|1|||
131032146|NCT04927065|471751386|FG000|First Booster|Physician Decision|1|||
130768928|NCT02819440|470778642|FG000|Overall Study|Withdrawal by Subject|9|||
130768929|NCT02819440|470778643|FG001|Overall Study|Withdrawal by Subject|8|||
130768930|NCT00575510|470778646|FG000|Overall Study|Lost to Follow-up|4|||
131032147|NCT04927065|471751387|FG001|First Booster|Physician Decision|0|||
131032148|NCT04927065|471751388|FG002|First Booster|Physician Decision|0|||
130697371|NCT02286466|470516135|FG000|Overall Study|Declined Clinician Assessment|0|||
130697372|NCT02286466|470516136|FG001|Overall Study|Declined Clinician Assessment|1|||
130697373|NCT00835081|470516137|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130697374|NCT00835081|470516138|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130697375|NCT00421304|470516139|FG000|Overall Study|Lost to Follow-up|5|||
130697376|NCT00421304|470516140|FG001|Overall Study|Lost to Follow-up|2|||
130697377|NCT00421304|470516141|FG002|Overall Study|Lost to Follow-up|5|||
130697378|NCT00421304|470516139|FG000|Overall Study|Withdrawal by Subject|2|||
130697379|NCT00421304|470516140|FG001|Overall Study|Withdrawal by Subject|2|||
130697380|NCT00421304|470516141|FG002|Overall Study|Withdrawal by Subject|2|||
130697381|NCT00421304|470516139|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
130697382|NCT00421304|470516140|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
130697383|NCT00421304|470516141|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
130697384|NCT00421304|470516139|FG000|Overall Study|Did not attend Day 360 visit|0|||
130697385|NCT00421304|470516140|FG001|Overall Study|Did not attend Day 360 visit|0|||
130697386|NCT00421304|470516141|FG002|Overall Study|Did not attend Day 360 visit|1|||
131032149|NCT04927065|471751389|FG003|First Booster|Physician Decision|3|||
131032150|NCT04927065|471751390|FG004|First Booster|Physician Decision|1|||
131032151|NCT04927065|471751391|FG005|First Booster|Physician Decision|1|||
131032152|NCT04927065|471751392|FG006|First Booster|Physician Decision|0|||
131032153|NCT04927065|471751393|FG007|First Booster|Physician Decision|3|||
131032154|NCT04927065|471751394|FG008|First Booster|Physician Decision|0|||
131032155|NCT04927065|471751395|FG009|First Booster|Physician Decision|0|||
131032156|NCT04927065|471751396|FG010|First Booster|Physician Decision|0|||
131032157|NCT04927065|471751397|FG011|First Booster|Physician Decision|0|||
131032158|NCT04927065|471751398|FG012|First Booster|Physician Decision|0|||
131032159|NCT04927065|471751399|FG013|First Booster|Physician Decision|0|||
131032160|NCT04927065|471751400|FG014|First Booster|Physician Decision|0|||
131032161|NCT04927065|471751401|FG015|First Booster|Physician Decision|0|||
131032162|NCT04927065|471751386|FG000|First Booster|Protocol Violation|4|||
131032163|NCT04927065|471751387|FG001|First Booster|Protocol Violation|4|||
131032164|NCT04927065|471751388|FG002|First Booster|Protocol Violation|0|||
131032165|NCT04927065|471751389|FG003|First Booster|Protocol Violation|3|||
131032166|NCT04927065|471751390|FG004|First Booster|Protocol Violation|0|||
131032167|NCT04927065|471751391|FG005|First Booster|Protocol Violation|0|||
131032168|NCT04927065|471751392|FG006|First Booster|Protocol Violation|0|||
131032169|NCT04927065|471751393|FG007|First Booster|Protocol Violation|2|||
131032170|NCT04927065|471751394|FG008|First Booster|Protocol Violation|0|||
131032171|NCT04927065|471751395|FG009|First Booster|Protocol Violation|0|||
130697387|NCT03196284|470516142|FG000|Main Part|Withdrawal by Subject|0|||
130697388|NCT03196284|470516143|FG001|Main Part|Withdrawal by Subject|1|||
130697389|NCT03196284|470516144|FG002|Main Part|Withdrawal by Subject|0|||
130697390|NCT03196284|470516142|FG000|Extension Part|Lack of Efficacy|0|||
130768931|NCT00575510|470778647|FG001|Overall Study|Lost to Follow-up|6|||
130913229|NCT02413372|471318271|FG002|Follow-up|Lost to Follow-up|0|||
131032172|NCT04927065|471751396|FG010|First Booster|Protocol Violation|0|||
131032173|NCT04927065|471751397|FG011|First Booster|Protocol Violation|0|||
131032174|NCT04927065|471751398|FG012|First Booster|Protocol Violation|0|||
130913230|NCT02413372|471318269|FG000|Follow-up|Subject Withdrew Consent|1|||
130913231|NCT02413372|471318270|FG001|Follow-up|Subject Withdrew Consent|0|||
131032175|NCT04927065|471751399|FG013|First Booster|Protocol Violation|0|||
131032176|NCT04927065|471751400|FG014|First Booster|Protocol Violation|0|||
131032177|NCT04927065|471751401|FG015|First Booster|Protocol Violation|0|||
131032178|NCT04927065|471751386|FG000|First Booster|Withdrawal by Subject|8|||
130697391|NCT03196284|470516143|FG001|Extension Part|Lack of Efficacy|0|||
130697392|NCT03196284|470516144|FG002|Extension Part|Lack of Efficacy|1|||
130697393|NCT03196284|470516142|FG000|Extension Part|Withdrawal by Subject|0|||
130697394|NCT03196284|470516143|FG001|Extension Part|Withdrawal by Subject|0|||
130697395|NCT03196284|470516144|FG002|Extension Part|Withdrawal by Subject|1|||
130697396|NCT03196284|470516142|FG000|Extension Part|Physician Decision|0|||
130697397|NCT03196284|470516143|FG001|Extension Part|Physician Decision|0|||
130697398|NCT03196284|470516144|FG002|Extension Part|Physician Decision|1|||
130697399|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
130697400|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
130697401|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
130697402|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
130697403|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
130697404|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
130697405|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
131117577|NCT00295633|472062371|FG000|Overall Study|Physician Decision|9|||
131117578|NCT00295633|472062372|FG001|Overall Study|Physician Decision|10|||
131117579|NCT00295633|472062373|FG002|Overall Study|Physician Decision|8|||
131117580|NCT00295633|472062371|FG000|Overall Study|Poor/Noncompliance|2|||
131117581|NCT00295633|472062372|FG001|Overall Study|Poor/Noncompliance|2|||
131117582|NCT00295633|472062373|FG002|Overall Study|Poor/Noncompliance|6|||
131117583|NCT00295633|472062371|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
131117584|NCT00295633|472062372|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
131117585|NCT00295633|472062373|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
131117586|NCT00295633|472062371|FG000|Overall Study|Death|1|||
131117587|NCT00295633|472062372|FG001|Overall Study|Death|1|||
131117588|NCT00295633|472062373|FG002|Overall Study|Death|0|||
131117589|NCT00295633|472062371|FG000|Overall Study|Administrative reason by sponsor|0|||
131117590|NCT00295633|472062372|FG001|Overall Study|Administrative reason by sponsor|0|||
131117591|NCT00295633|472062373|FG002|Overall Study|Administrative reason by sponsor|1|||
131117592|NCT00419120|472062375|FG000|Long Term Follow up Period|study ongoing|10|||
131117593|NCT01950247|472062376|FG000|Overall Study|Withdrawal by Subject|28|||
131117594|NCT01950247|472062377|FG001|Overall Study|Withdrawal by Subject|13|||
131117595|NCT01950247|472062376|FG000|Overall Study|Lost to Follow-up|18|||
131117596|NCT01950247|472062377|FG001|Overall Study|Lost to Follow-up|16|||
131117597|NCT01950247|472062376|FG000|Overall Study|Physician Decision|3|||
131117598|NCT01950247|472062377|FG001|Overall Study|Physician Decision|4|||
131117599|NCT01950247|472062376|FG000|Overall Study|Adverse Event|3|||
131117600|NCT01950247|472062377|FG001|Overall Study|Adverse Event|2|||
131117601|NCT01950247|472062376|FG000|Overall Study|Death|1|||
131117602|NCT01950247|472062377|FG001|Overall Study|Death|1|||
131117603|NCT01950247|472062376|FG000|Overall Study|Not Defined|4|||
131117604|NCT01950247|472062377|FG001|Overall Study|Not Defined|10|||
131117605|NCT00763971|472062378|FG000|Overall Study|Adverse Event|5|||
131117606|NCT00763971|472062379|FG001|Overall Study|Adverse Event|2|||
131117607|NCT00763971|472062380|FG002|Overall Study|Adverse Event|4|||
131117608|NCT00763971|472062378|FG000|Overall Study|Protocol Violation|3|||
131117609|NCT00763971|472062379|FG001|Overall Study|Protocol Violation|3|||
131117610|NCT00763971|472062380|FG002|Overall Study|Protocol Violation|2|||
131117611|NCT00763971|472062378|FG000|Overall Study|Withdrawal by Subject|4|||
131117612|NCT00763971|472062379|FG001|Overall Study|Withdrawal by Subject|5|||
131117613|NCT00763971|472062380|FG002|Overall Study|Withdrawal by Subject|5|||
131117614|NCT00763971|472062378|FG000|Overall Study|Lost to Follow-up|0|||
131117615|NCT00763971|472062379|FG001|Overall Study|Lost to Follow-up|1|||
131117616|NCT00763971|472062380|FG002|Overall Study|Lost to Follow-up|0|||
131117617|NCT00763971|472062378|FG000|Overall Study|Lack of Efficacy|11|||
131117618|NCT00763971|472062379|FG001|Overall Study|Lack of Efficacy|22|||
131117619|NCT00763971|472062380|FG002|Overall Study|Lack of Efficacy|54|||
131117620|NCT00763971|472062378|FG000|Overall Study|Unable to swallow capsule|2|||
130697406|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
130697407|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
130697408|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
130697409|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
130697410|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
131117621|NCT00763971|472062379|FG001|Overall Study|Unable to swallow capsule|1|||
131117622|NCT00763971|472062380|FG002|Overall Study|Unable to swallow capsule|1|||
131117623|NCT00763971|472062378|FG000|Overall Study|Personal reason|3|||
131117624|NCT00763971|472062379|FG001|Overall Study|Personal reason|0|||
131117625|NCT00763971|472062380|FG002|Overall Study|Personal reason|0|||
131117626|NCT00763971|472062378|FG000|Overall Study|Exclusion criteria met|1|||
131117627|NCT00763971|472062379|FG001|Overall Study|Exclusion criteria met|0|||
131117628|NCT00763971|472062380|FG002|Overall Study|Exclusion criteria met|0|||
130697411|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
130697412|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
131117629|NCT00763971|472062378|FG000|Overall Study|Sponsor decision|1|||
131117630|NCT00763971|472062379|FG001|Overall Study|Sponsor decision|0|||
131117631|NCT00763971|472062380|FG002|Overall Study|Sponsor decision|0|||
131117632|NCT00763971|472062378|FG000|Overall Study|Due to holiday season|2|||
131117633|NCT00763971|472062379|FG001|Overall Study|Due to holiday season|0|||
130697413|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
130697414|NCT01139762|470516145|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
130697415|NCT01139762|470516146|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
130697416|NCT01139762|470516147|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
130697417|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
130697418|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
130697419|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
131032179|NCT04927065|471751387|FG001|First Booster|Withdrawal by Subject|23|||
131032180|NCT04927065|471751388|FG002|First Booster|Withdrawal by Subject|0|||
131032181|NCT04927065|471751389|FG003|First Booster|Withdrawal by Subject|19|||
131032182|NCT04927065|471751390|FG004|First Booster|Withdrawal by Subject|20|||
131032183|NCT04927065|471751391|FG005|First Booster|Withdrawal by Subject|15|||
131032184|NCT04927065|471751392|FG006|First Booster|Withdrawal by Subject|6|||
131032185|NCT04927065|471751393|FG007|First Booster|Withdrawal by Subject|24|||
131032186|NCT04927065|471751394|FG008|First Booster|Withdrawal by Subject|0|||
131032187|NCT04927065|471751395|FG009|First Booster|Withdrawal by Subject|4|||
131032188|NCT04927065|471751396|FG010|First Booster|Withdrawal by Subject|0|||
131032189|NCT04927065|471751397|FG011|First Booster|Withdrawal by Subject|0|||
131032190|NCT04927065|471751398|FG012|First Booster|Withdrawal by Subject|0|||
131032191|NCT04927065|471751399|FG013|First Booster|Withdrawal by Subject|0|||
131032192|NCT04927065|471751400|FG014|First Booster|Withdrawal by Subject|0|||
131032193|NCT04927065|471751401|FG015|First Booster|Withdrawal by Subject|0|||
131032194|NCT04927065|471751386|FG000|First Booster|Other Than Specified|1|||
131032195|NCT04927065|471751387|FG001|First Booster|Other Than Specified|1|||
131032196|NCT04927065|471751388|FG002|First Booster|Other Than Specified|0|||
131032197|NCT04927065|471751389|FG003|First Booster|Other Than Specified|1|||
131032198|NCT04927065|471751390|FG004|First Booster|Other Than Specified|2|||
131032199|NCT04927065|471751391|FG005|First Booster|Other Than Specified|3|||
131032200|NCT04927065|471751392|FG006|First Booster|Other Than Specified|2|||
131032201|NCT04927065|471751393|FG007|First Booster|Other Than Specified|6|||
131032202|NCT04927065|471751394|FG008|First Booster|Other Than Specified|0|||
131032203|NCT04927065|471751395|FG009|First Booster|Other Than Specified|4|||
131032204|NCT04927065|471751396|FG010|First Booster|Other Than Specified|0|||
131032205|NCT04927065|471751397|FG011|First Booster|Other Than Specified|0|||
131032206|NCT04927065|471751398|FG012|First Booster|Other Than Specified|0|||
131032207|NCT04927065|471751399|FG013|First Booster|Other Than Specified|0|||
131032208|NCT04927065|471751400|FG014|First Booster|Other Than Specified|0|||
131032209|NCT04927065|471751401|FG015|First Booster|Other Than Specified|0|||
131032210|NCT04927065|471751386|FG000|Second Booster|Death|0|||
131032211|NCT04927065|471751387|FG001|Second Booster|Death|0|||
131032212|NCT04927065|471751388|FG002|Second Booster|Death|0|||
131032213|NCT04927065|471751389|FG003|Second Booster|Death|0|||
131032214|NCT04927065|471751390|FG004|Second Booster|Death|0|||
131032215|NCT04927065|471751391|FG005|Second Booster|Death|0|||
131032216|NCT04927065|471751392|FG006|Second Booster|Death|0|||
131032217|NCT04927065|471751393|FG007|Second Booster|Death|0|||
131032218|NCT04927065|471751394|FG008|Second Booster|Death|0|||
131032219|NCT04927065|471751395|FG009|Second Booster|Death|0|||
131032220|NCT04927065|471751396|FG010|Second Booster|Death|2|||
131032221|NCT04927065|471751397|FG011|Second Booster|Death|0|||
131032222|NCT04927065|471751398|FG012|Second Booster|Death|2|||
131032223|NCT04927065|471751399|FG013|Second Booster|Death|2|||
131032224|NCT04927065|471751400|FG014|Second Booster|Death|0|||
131032225|NCT04927065|471751401|FG015|Second Booster|Death|0|||
131032226|NCT04927065|471751386|FG000|Second Booster|Lost to Follow-up|0|||
131032227|NCT04927065|471751387|FG001|Second Booster|Lost to Follow-up|0|||
130697420|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Death|0|||
130697421|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Death|1|||
130697422|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Death|1|||
130697423|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
130697424|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
130913232|NCT02413372|471318271|FG002|Follow-up|Subject Withdrew Consent|1|||
131032228|NCT04927065|471751388|FG002|Second Booster|Lost to Follow-up|3|||
130697425|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
131032229|NCT04927065|471751389|FG003|Second Booster|Lost to Follow-up|0|||
131032230|NCT04927065|471751390|FG004|Second Booster|Lost to Follow-up|0|||
131032231|NCT04927065|471751391|FG005|Second Booster|Lost to Follow-up|0|||
131032232|NCT04927065|471751392|FG006|Second Booster|Lost to Follow-up|0|||
131032233|NCT04927065|471751393|FG007|Second Booster|Lost to Follow-up|0|||
131032234|NCT04927065|471751394|FG008|Second Booster|Lost to Follow-up|0|||
131032235|NCT04927065|471751395|FG009|Second Booster|Lost to Follow-up|0|||
131032236|NCT04927065|471751396|FG010|Second Booster|Lost to Follow-up|14|||
131032237|NCT04927065|471751397|FG011|Second Booster|Lost to Follow-up|10|||
131032238|NCT04927065|471751398|FG012|Second Booster|Lost to Follow-up|13|||
131032239|NCT04927065|471751399|FG013|Second Booster|Lost to Follow-up|16|||
131032240|NCT04927065|471751400|FG014|Second Booster|Lost to Follow-up|0|||
131117634|NCT00763971|472062380|FG002|Overall Study|Due to holiday season|1|||
131117635|NCT00763971|472062378|FG000|Overall Study|Randomization error|0|||
131117636|NCT00763971|472062379|FG001|Overall Study|Randomization error|0|||
131117637|NCT00763971|472062380|FG002|Overall Study|Randomization error|1|||
131117638|NCT00763971|472062378|FG000|Overall Study|Medical monitor decision|0|||
131117639|NCT00763971|472062379|FG001|Overall Study|Medical monitor decision|0|||
131117640|NCT00763971|472062380|FG002|Overall Study|Medical monitor decision|1|||
131117641|NCT00763971|472062378|FG000|Overall Study|Moved to another country|0|||
131117642|NCT00763971|472062379|FG001|Overall Study|Moved to another country|1|||
131117643|NCT00763971|472062380|FG002|Overall Study|Moved to another country|0|||
131117644|NCT00763971|472062378|FG000|Overall Study|Subject wanted dose reduction|0|||
131117645|NCT00763971|472062379|FG001|Overall Study|Subject wanted dose reduction|1|||
131117646|NCT00763971|472062380|FG002|Overall Study|Subject wanted dose reduction|0|||
131117647|NCT00763971|472062378|FG000|Overall Study|Lack of availability|0|||
131117648|NCT00763971|472062379|FG001|Overall Study|Lack of availability|1|||
131117649|NCT00763971|472062380|FG002|Overall Study|Lack of availability|0|||
131117650|NCT00763971|472062378|FG000|Overall Study|Performed final visit on phone|0|||
131117651|NCT00763971|472062379|FG001|Overall Study|Performed final visit on phone|1|||
131117652|NCT00763971|472062380|FG002|Overall Study|Performed final visit on phone|0|||
131117653|NCT00763971|472062378|FG000|Overall Study|Participation in 489-326 required|1|||
131117654|NCT00763971|472062379|FG001|Overall Study|Participation in 489-326 required|0|||
131117655|NCT00763971|472062380|FG002|Overall Study|Participation in 489-326 required|0|||
131117656|NCT00710879|472062382|FG000|Overall Study|Lost to Follow-up|2|||
130768932|NCT00575510|470778648|FG002|Overall Study|Lost to Follow-up|9|||
130768933|NCT00575510|470778646|FG000|Overall Study|Withdrawal by Subject|1|||
130768934|NCT00575510|470778647|FG001|Overall Study|Withdrawal by Subject|0|||
130768935|NCT00575510|470778648|FG002|Overall Study|Withdrawal by Subject|0|||
130768936|NCT00575510|470778646|FG000|Overall Study|Clinic Called Patient|7|||
130768937|NCT00575510|470778647|FG001|Overall Study|Clinic Called Patient|7|||
130768938|NCT00575510|470778648|FG002|Overall Study|Clinic Called Patient|7|||
130768939|NCT00575510|470778646|FG000|Overall Study|Pregnancy|0|||
130768940|NCT00575510|470778647|FG001|Overall Study|Pregnancy|0|||
130768941|NCT00575510|470778648|FG002|Overall Study|Pregnancy|1|||
130768942|NCT02697734|470778653|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
130768943|NCT02697734|470778654|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
130768944|NCT02697734|470778653|FG000|Core Phase - up to Week 48|Adverse Event|1|||
131117657|NCT00710879|472062383|FG001|Overall Study|Lost to Follow-up|1|||
131117658|NCT00710879|472062382|FG000|Overall Study|Protocol Violation|0|||
131117659|NCT00710879|472062383|FG001|Overall Study|Protocol Violation|3|||
131117660|NCT01809132|472062384|FG000|Overall Study|Withdrawal by Subject|0|||
131117661|NCT01809132|472062385|FG001|Overall Study|Withdrawal by Subject|0|||
131117662|NCT01809132|472062386|FG002|Overall Study|Withdrawal by Subject|1|||
131117663|NCT03349775|472062387|FG000|Overall Study|Side Effects|1|||
131117664|NCT03349775|472062388|FG001|Overall Study|Side Effects|2|||
131117665|NCT03349775|472062387|FG000|Overall Study|Withdrawal by Subject|1|||
131117666|NCT03349775|472062388|FG001|Overall Study|Withdrawal by Subject|1|||
131117667|NCT03349775|472062387|FG000|Overall Study|No primary outcome measurements|0|||
131117668|NCT03349775|472062388|FG001|Overall Study|No primary outcome measurements|1|||
131117669|NCT01516970|472062389|FG000|Overall Study|Lost to Follow-up|7|||
131117670|NCT01516970|472062390|FG001|Overall Study|Lost to Follow-up|8|||
131117671|NCT01516970|472062389|FG000|Overall Study|Adverse Event|1|||
131117672|NCT01516970|472062390|FG001|Overall Study|Adverse Event|5|||
131117673|NCT01516970|472062389|FG000|Overall Study|Withdrawal by Subject|1|||
131117674|NCT01516970|472062390|FG001|Overall Study|Withdrawal by Subject|1|||
131117675|NCT01516970|472062389|FG000|Overall Study|Other|9|||
131117676|NCT01516970|472062390|FG001|Overall Study|Other|7|||
131117677|NCT00434421|472062391|FG000|Overall Study|Withdrawal by Subject|1|||
131117678|NCT00434421|472062391|FG000|Overall Study|Non-compliance with study treatment|1|||
131117679|NCT01756040|472062392|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
131117680|NCT01756040|472062392|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
131117681|NCT01756040|472062392|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
131117682|NCT01205438|472062393|FG000|Overall Study|Adverse Event|19|||
131117683|NCT01205438|472062394|FG001|Overall Study|Adverse Event|17|||
131117684|NCT01205438|472062395|FG002|Overall Study|Adverse Event|24|||
130768945|NCT02697734|470778654|FG001|Core Phase - up to Week 48|Adverse Event|2|||
130913233|NCT02413372|471318269|FG000|Follow-up|Subject unable to return for visit|0|||
131117685|NCT01205438|472062393|FG000|Overall Study|Death|1|||
131117686|NCT01205438|472062394|FG001|Overall Study|Death|1|||
131117687|NCT01205438|472062395|FG002|Overall Study|Death|3|||
131117688|NCT01205438|472062393|FG000|Overall Study|Entry Criteria Not Met|16|||
131117689|NCT01205438|472062394|FG001|Overall Study|Entry Criteria Not Met|15|||
131117690|NCT01205438|472062395|FG002|Overall Study|Entry Criteria Not Met|13|||
131117691|NCT01205438|472062393|FG000|Overall Study|Lack of Efficacy|14|||
131117692|NCT01205438|472062394|FG001|Overall Study|Lack of Efficacy|11|||
131117693|NCT01205438|472062395|FG002|Overall Study|Lack of Efficacy|14|||
131117694|NCT01205438|472062393|FG000|Overall Study|Lost to Follow-up|6|||
131117695|NCT01205438|472062394|FG001|Overall Study|Lost to Follow-up|7|||
130697426|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
130697427|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
130697428|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
130697429|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
130697430|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
130697431|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
130697432|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
130697433|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
130697434|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
130697435|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
130697436|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
130697437|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
130697438|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
130697439|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
130697440|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
130697441|NCT01139762|470516145|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
130697442|NCT01139762|470516146|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
130697443|NCT01139762|470516147|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
130697444|NCT01912807|470516148|FG000|Overall Study|Did not meet elegibility criteria|6|||
130697445|NCT01912807|470516149|FG001|Overall Study|Did not meet elegibility criteria|4|||
130697446|NCT01912807|470516148|FG000|Overall Study|Lost to Follow-up|36|||
130697447|NCT01912807|470516149|FG001|Overall Study|Lost to Follow-up|37|||
130697448|NCT04750239|470516150|FG000|Overall Study|Withdrawal by Subject|2|||
130697449|NCT04750239|470516150|FG000|Overall Study|Trial terminated by sponsor|1|||
130697450|NCT00919711|470516151|FG000|Overall Study|Withdrawal by Subject|15|||
130697451|NCT00919711|470516152|FG001|Overall Study|Withdrawal by Subject|7|||
130697452|NCT00919711|470516151|FG000|Overall Study|Adverse Event|13|||
130697453|NCT00919711|470516152|FG001|Overall Study|Adverse Event|3|||
130697454|NCT00919711|470516151|FG000|Overall Study|Other|1|||
130697455|NCT00919711|470516152|FG001|Overall Study|Other|2|||
130697456|NCT00919711|470516151|FG000|Overall Study|Administrative Decision|0|||
130697457|NCT00919711|470516152|FG001|Overall Study|Administrative Decision|1|||
130697458|NCT00919711|470516151|FG000|Overall Study|Lost to Follow-up|2|||
130697459|NCT00919711|470516152|FG001|Overall Study|Lost to Follow-up|0|||
130697460|NCT00919711|470516151|FG000|Overall Study|Death|1|||
130697461|NCT00919711|470516152|FG001|Overall Study|Death|0|||
130697462|NCT00919711|470516151|FG000|Overall Study|Noncompliance|1|||
130697463|NCT00919711|470516152|FG001|Overall Study|Noncompliance|0|||
130697464|NCT00903877|470516153|FG000|Overall Study|Did not meet study criteria|33|||
130697465|NCT00903877|470516153|FG000|Overall Study|Withdrawal by Subject|3|||
130697466|NCT00903877|470516153|FG000|Overall Study|Adverse Event|2|||
130697467|NCT00903877|470516153|FG000|Overall Study|Lost to Follow-up|1|||
130697468|NCT00903877|470516153|FG000|Overall Study|Participation put on hold|4|||
130697469|NCT00087529|470516155|FG000|Overall Study|Death|1|||
130697470|NCT00087529|470516156|FG001|Overall Study|Death|0|||
130697471|NCT00087529|470516155|FG000|Overall Study|Adverse Event|0|||
130697472|NCT00087529|470516156|FG001|Overall Study|Adverse Event|8|||
130697473|NCT00087529|470516155|FG000|Overall Study|Pregnancy|0|||
130697474|NCT00087529|470516156|FG001|Overall Study|Pregnancy|1|||
130697475|NCT00087529|470516155|FG000|Overall Study|Lost to Follow-up|2|||
130697476|NCT00087529|470516156|FG001|Overall Study|Lost to Follow-up|3|||
130697477|NCT00087529|470516155|FG000|Overall Study|Participant Decision|14|||
130697478|NCT00087529|470516156|FG001|Overall Study|Participant Decision|37|||
130697479|NCT00087529|470516155|FG000|Overall Study|Physician Decision|4|||
130697480|NCT00087529|470516156|FG001|Overall Study|Physician Decision|8|||
130697481|NCT00087529|470516155|FG000|Overall Study|Initiation of Excluded Therapy|0|||
130697482|NCT00087529|470516156|FG001|Overall Study|Initiation of Excluded Therapy|1|||
130697483|NCT00087529|470516155|FG000|Overall Study|Participant Noncompliance|0|||
130697484|NCT00087529|470516156|FG001|Overall Study|Participant Noncompliance|1|||
130697485|NCT00087529|470516155|FG000|Overall Study|Disease Progression|5|||
130913234|NCT02413372|471318270|FG001|Follow-up|Subject unable to return for visit|0|||
130913235|NCT02413372|471318271|FG002|Follow-up|Subject unable to return for visit|1|||
130913236|NCT04587271|471318278|FG000|Overall Study|Lost to Follow-up|2|||
130913237|NCT04587271|471318279|FG001|Overall Study|Lost to Follow-up|2|||
130697486|NCT00087529|470516156|FG001|Overall Study|Disease Progression|4|||
130697487|NCT00087529|470516155|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
130913238|NCT04587271|471318280|FG002|Overall Study|Lost to Follow-up|0|||
130697488|NCT00087529|470516156|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
130697489|NCT02535923|470516157|FG000|Overall Study|Lost to Follow-up|5|||
130697490|NCT02535923|470516158|FG001|Overall Study|Lost to Follow-up|5|||
130697491|NCT02535923|470516157|FG000|Overall Study|Withdrawal by Subject|4|||
130697492|NCT02535923|470516158|FG001|Overall Study|Withdrawal by Subject|3|||
130697493|NCT00685334|470516166|FG000|Overall Study|Withdrawal by Subject|5|||
130697494|NCT00685334|470516167|FG001|Overall Study|Withdrawal by Subject|6|||
130697495|NCT00685334|470516166|FG000|Overall Study|Lost to Follow-up|4|||
130697496|NCT00685334|470516167|FG001|Overall Study|Lost to Follow-up|0|||
130697497|NCT00685334|470516166|FG000|Overall Study|Chose to enter hospital|1|||
130697498|NCT00685334|470516167|FG001|Overall Study|Chose to enter hospital|1|||
130697499|NCT01891357|470516168|FG000|Overall Study|Protocol Violation|3|||
130697500|NCT01253564|470516169|FG000|Overall Study|Disease Progression|22|||
130697501|NCT01253564|470516169|FG000|Overall Study|Withdrawal by Subject|1|||
130697502|NCT01253564|470516169|FG000|Overall Study|Serious Adverse Event|1|||
130697503|NCT03694197|470516172|FG000|Overall Study|Adverse Event|9|||
130697504|NCT03694197|470516172|FG000|Overall Study|Protocol became inconvenient to participate|1|||
130697505|NCT03694197|470516172|FG000|Overall Study|Physician Decision|4|||
130697506|NCT03694197|470516172|FG000|Overall Study|Study terminated by sponsor|1350|||
130697507|NCT03694197|470516172|FG000|Overall Study|Participant moved|5|||
130697508|NCT03694197|470516172|FG000|Overall Study|Participant withdrew consent|10|||
130697509|NCT03694197|470516172|FG000|Overall Study|Related to IMP administration|1|||
130697510|NCT03694197|470516172|FG000|Overall Study|Not disclosed|5|||
130697511|NCT03506633|470517855|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
130697512|NCT03506633|470517856|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
130697513|NCT04573309|470517858|FG000|Overall Study|Protocol Violation|1|||
130697514|NCT04573309|470517859|FG001|Overall Study|Protocol Violation|0|||
130697515|NCT01541215|470517862|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
130697516|NCT01541215|470517863|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
130697517|NCT01541215|470517862|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
130768946|NCT02697734|470778653|FG000|Core Phase - up to Week 48|Physician Decision|1|||
130768947|NCT02697734|470778654|FG001|Core Phase - up to Week 48|Physician Decision|0|||
130913239|NCT04587271|471318281|FG003|Overall Study|Lost to Follow-up|2|||
130913240|NCT04587271|471318282|FG004|Overall Study|Lost to Follow-up|2|||
130913241|NCT04587271|471318283|FG005|Overall Study|Lost to Follow-up|0|||
130913242|NCT04587271|471318278|FG000|Overall Study|Caregiver brought child to visits|0|||
130913243|NCT04587271|471318279|FG001|Overall Study|Caregiver brought child to visits|0|||
130913244|NCT04587271|471318280|FG002|Overall Study|Caregiver brought child to visits|0|||
130913245|NCT04587271|471318281|FG003|Overall Study|Caregiver brought child to visits|1|||
130913246|NCT04587271|471318282|FG004|Overall Study|Caregiver brought child to visits|0|||
130913247|NCT04587271|471318283|FG005|Overall Study|Caregiver brought child to visits|0|||
130913248|NCT02180165|471318285|FG000|Overall Study|Not Treated|0|||
130913249|NCT02180165|471318286|FG001|Overall Study|Not Treated|0|||
130913250|NCT02180165|471318287|FG002|Overall Study|Not Treated|1|||
130913251|NCT02180165|471318288|FG003|Overall Study|Not Treated|0|||
130913252|NCT02180165|471318285|FG000|Overall Study|Adverse Event|7|||
130913253|NCT02180165|471318286|FG001|Overall Study|Adverse Event|0|||
130913254|NCT02180165|471318287|FG002|Overall Study|Adverse Event|18|||
130913255|NCT02180165|471318288|FG003|Overall Study|Adverse Event|3|||
130913256|NCT02180165|471318285|FG000|Overall Study|Lack of Efficacy|0|||
130913257|NCT02180165|471318286|FG001|Overall Study|Lack of Efficacy|1|||
130913258|NCT02180165|471318287|FG002|Overall Study|Lack of Efficacy|3|||
130913259|NCT02180165|471318288|FG003|Overall Study|Lack of Efficacy|2|||
130913260|NCT02180165|471318285|FG000|Overall Study|Physician Decision|1|||
130913261|NCT02180165|471318286|FG001|Overall Study|Physician Decision|0|||
130913262|NCT02180165|471318287|FG002|Overall Study|Physician Decision|5|||
130913263|NCT02180165|471318288|FG003|Overall Study|Physician Decision|0|||
130913264|NCT02180165|471318285|FG000|Overall Study|Withdrawal by Subject|3|||
130913265|NCT02180165|471318286|FG001|Overall Study|Withdrawal by Subject|0|||
130913266|NCT02180165|471318287|FG002|Overall Study|Withdrawal by Subject|2|||
130913267|NCT02180165|471318288|FG003|Overall Study|Withdrawal by Subject|1|||
130913268|NCT02943460|471318290|FG000|Blinded Study Phase|Adverse Event|3|||
130913269|NCT02943460|471318291|FG001|Blinded Study Phase|Adverse Event|0|||
130913270|NCT02943460|471318292|FG002|Blinded Study Phase|Adverse Event|0|||
130913271|NCT02943460|471318290|FG000|Blinded Study Phase|Withdrew Consent|0|||
130913272|NCT02943460|471318291|FG001|Blinded Study Phase|Withdrew Consent|1|||
130913273|NCT02943460|471318292|FG002|Blinded Study Phase|Withdrew Consent|0|||
130913274|NCT02943460|471318290|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
130913275|NCT02943460|471318291|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
130913276|NCT02943460|471318292|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
131032241|NCT04927065|471751401|FG015|Second Booster|Lost to Follow-up|0|||
131032242|NCT04927065|471751386|FG000|Second Booster|Physician Decision|0|||
131032243|NCT04927065|471751387|FG001|Second Booster|Physician Decision|0|||
130913277|NCT02943460|471318290|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
130913278|NCT02943460|471318291|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
130913279|NCT02943460|471318292|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
130913280|NCT02943460|471318290|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
130913281|NCT02943460|471318291|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
130697518|NCT01541215|470517863|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
130697519|NCT01541215|470517862|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
130697520|NCT01541215|470517863|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
130697521|NCT01541215|470517862|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
130697522|NCT01541215|470517863|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
130913282|NCT02943460|471318292|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
130913283|NCT01031381|471318293|FG000|Overall Study|Physician Decision|3|||
130913284|NCT01031381|471318293|FG000|Overall Study|Withdrawal by Subject|6|||
130913285|NCT00723398|471318294|FG000|Overall Study|Withdrawal by Subject|2|||
130913286|NCT00723398|471318295|FG001|Overall Study|Withdrawal by Subject|6|||
130913287|NCT00723398|471318296|FG002|Overall Study|Withdrawal by Subject|4|||
130913288|NCT00723398|471318297|FG003|Overall Study|Withdrawal by Subject|4|||
130913289|NCT00723398|471318298|FG004|Overall Study|Withdrawal by Subject|4|||
130913290|NCT00723398|471318294|FG000|Overall Study|Protocol Violation|2|||
130913291|NCT00723398|471318295|FG001|Overall Study|Protocol Violation|1|||
130913292|NCT00723398|471318296|FG002|Overall Study|Protocol Violation|5|||
130913293|NCT00723398|471318297|FG003|Overall Study|Protocol Violation|0|||
130913294|NCT00723398|471318298|FG004|Overall Study|Protocol Violation|0|||
130913295|NCT00723398|471318294|FG000|Overall Study|Physician Decision|2|||
130913296|NCT00723398|471318295|FG001|Overall Study|Physician Decision|2|||
130913297|NCT00723398|471318296|FG002|Overall Study|Physician Decision|5|||
130913298|NCT00723398|471318297|FG003|Overall Study|Physician Decision|0|||
130913299|NCT00723398|471318298|FG004|Overall Study|Physician Decision|1|||
130913300|NCT00723398|471318294|FG000|Overall Study|Adverse Event|0|||
130913301|NCT00723398|471318295|FG001|Overall Study|Adverse Event|5|||
130913302|NCT00723398|471318296|FG002|Overall Study|Adverse Event|3|||
130913303|NCT00723398|471318297|FG003|Overall Study|Adverse Event|1|||
130913304|NCT00723398|471318298|FG004|Overall Study|Adverse Event|4|||
130913305|NCT00723398|471318294|FG000|Overall Study|Lost to Follow-up|0|||
130913306|NCT00723398|471318295|FG001|Overall Study|Lost to Follow-up|1|||
130913307|NCT00723398|471318296|FG002|Overall Study|Lost to Follow-up|0|||
130913308|NCT00723398|471318297|FG003|Overall Study|Lost to Follow-up|0|||
130913309|NCT00723398|471318298|FG004|Overall Study|Lost to Follow-up|0|||
130913310|NCT00122109|471318299|FG000|Overall Study|Did not meet criteria|6|||
130913311|NCT00122109|471318300|FG001|Overall Study|Did not meet criteria|7|||
130913312|NCT00267189|471318306|FG000|Overall Study|Patient withdrew consent|1|||
130913313|NCT00267189|471318307|FG001|Overall Study|Patient withdrew consent|1|||
130913314|NCT00267189|471318306|FG000|Overall Study|Death|1|||
130913315|NCT00267189|471318307|FG001|Overall Study|Death|0|||
130913316|NCT00267189|471318306|FG000|Overall Study|Missing|3|||
130913317|NCT00267189|471318307|FG001|Overall Study|Missing|0|||
130913318|NCT01578330|471318312|FG000|Overall Study|Adverse Event|2|||
130913319|NCT01578330|471318312|FG000|Overall Study|Protocol Violation|5|||
130913320|NCT03114488|471318315|FG000|Time Period 2|Withdrawal by Subject|1|||
130913321|NCT03114488|471318316|FG001|Time Period 2|Withdrawal by Subject|3|||
130913322|NCT04137224|471318317|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
130913323|NCT04137224|471318318|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
130913324|NCT04137224|471318317|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
130913325|NCT04137224|471318318|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
130913326|NCT04137224|471318317|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
130913327|NCT04137224|471318318|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
131032244|NCT04927065|471751388|FG002|Second Booster|Physician Decision|0|||
131032245|NCT04927065|471751389|FG003|Second Booster|Physician Decision|0|||
131032246|NCT04927065|471751390|FG004|Second Booster|Physician Decision|0|||
131032247|NCT04927065|471751391|FG005|Second Booster|Physician Decision|0|||
131032248|NCT04927065|471751392|FG006|Second Booster|Physician Decision|0|||
131032249|NCT04927065|471751393|FG007|Second Booster|Physician Decision|0|||
131032250|NCT04927065|471751394|FG008|Second Booster|Physician Decision|0|||
130913328|NCT01225887|471318319|FG000|Overall Study|Ineligible:required test not done|2|||
130913329|NCT01225887|471318319|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
130913330|NCT01225887|471318319|FG000|Overall Study|Ineligible:inadequate pathology|2|||
130913331|NCT01669928|471318320|FG000|First Intervention|Withdrawal by Subject|3|||
130913332|NCT01669928|471318321|FG001|First Intervention|Withdrawal by Subject|5|||
130913333|NCT00566501|471318324|FG000|Overall Study|Adverse Event|68|||
130913334|NCT00566501|471318325|FG001|Overall Study|Adverse Event|59|||
130913335|NCT00566501|471318324|FG000|Overall Study|Medication Non-compliance|5|||
130913336|NCT00566501|471318325|FG001|Overall Study|Medication Non-compliance|0|||
130913337|NCT00566501|471318324|FG000|Overall Study|Protocol Violation|2|||
131032251|NCT04927065|471751395|FG009|Second Booster|Physician Decision|0|||
131032252|NCT04927065|471751396|FG010|Second Booster|Physician Decision|0|||
131032253|NCT04927065|471751397|FG011|Second Booster|Physician Decision|3|||
131032254|NCT04927065|471751398|FG012|Second Booster|Physician Decision|0|||
131032255|NCT04927065|471751399|FG013|Second Booster|Physician Decision|1|||
131032256|NCT04927065|471751400|FG014|Second Booster|Physician Decision|0|||
131032257|NCT04927065|471751401|FG015|Second Booster|Physician Decision|0|||
131032258|NCT04927065|471751386|FG000|Second Booster|Withdrawal by Subject|0|||
131032259|NCT04927065|471751387|FG001|Second Booster|Withdrawal by Subject|0|||
131032260|NCT04927065|471751388|FG002|Second Booster|Withdrawal by Subject|4|||
131032261|NCT04927065|471751389|FG003|Second Booster|Withdrawal by Subject|0|||
131032262|NCT04927065|471751390|FG004|Second Booster|Withdrawal by Subject|0|||
131032263|NCT04927065|471751391|FG005|Second Booster|Withdrawal by Subject|0|||
131032264|NCT04927065|471751392|FG006|Second Booster|Withdrawal by Subject|0|||
130913338|NCT00566501|471318325|FG001|Overall Study|Protocol Violation|2|||
130913339|NCT00566501|471318324|FG000|Overall Study|Request of Investigator or Sponsor|6|||
130913340|NCT00566501|471318325|FG001|Overall Study|Request of Investigator or Sponsor|7|||
130913341|NCT00566501|471318324|FG000|Overall Study|Withdrawal by Subject|33|||
130913342|NCT00566501|471318325|FG001|Overall Study|Withdrawal by Subject|30|||
130913343|NCT00566501|471318324|FG000|Overall Study|Lack of Efficacy|8|||
130913344|NCT00566501|471318325|FG001|Overall Study|Lack of Efficacy|3|||
130913345|NCT00566501|471318324|FG000|Overall Study|Other|25|||
130913346|NCT00566501|471318325|FG001|Overall Study|Other|21|||
130913347|NCT00925990|471318328|FG000|Overall Study|Adverse Event|1|||
130913348|NCT00925990|471318329|FG001|Overall Study|Adverse Event|3|||
131117696|NCT01205438|472062395|FG002|Overall Study|Lost to Follow-up|8|||
131117697|NCT01205438|472062393|FG000|Overall Study|Withdrawal by Subject|19|||
131117698|NCT01205438|472062394|FG001|Overall Study|Withdrawal by Subject|25|||
131117699|NCT01205438|472062395|FG002|Overall Study|Withdrawal by Subject|19|||
131117700|NCT01205438|472062393|FG000|Overall Study|Physician Decision|0|||
131117701|NCT01205438|472062394|FG001|Overall Study|Physician Decision|3|||
131117702|NCT01205438|472062395|FG002|Overall Study|Physician Decision|2|||
131117703|NCT01205438|472062393|FG000|Overall Study|Protocol Violation|2|||
131117704|NCT01205438|472062394|FG001|Overall Study|Protocol Violation|7|||
131117705|NCT01205438|472062395|FG002|Overall Study|Protocol Violation|4|||
131117706|NCT01205438|472062393|FG000|Overall Study|Sponsor Decision|0|||
131117707|NCT01205438|472062394|FG001|Overall Study|Sponsor Decision|1|||
131117708|NCT01205438|472062395|FG002|Overall Study|Sponsor Decision|1|||
131117709|NCT01446016|472062396|FG000|Overall Study|Lost to Follow-up|3|||
131117710|NCT01446016|472062396|FG000|Overall Study|Withdrawal by Subject|1|||
131117711|NCT01446016|472062396|FG000|Overall Study|Toxicity|3|||
131117712|NCT01087957|472062403|FG000|Overall Study|Death|2|||
131117713|NCT01087957|472062404|FG001|Overall Study|Death|2|||
131117714|NCT01087957|472062403|FG000|Overall Study|Lost to Follow-up|3|||
131117715|NCT01087957|472062404|FG001|Overall Study|Lost to Follow-up|4|||
131117716|NCT01087957|472062403|FG000|Overall Study|Protocol Violation|13|||
131117717|NCT01087957|472062404|FG001|Overall Study|Protocol Violation|25|||
131117718|NCT01087957|472062403|FG000|Overall Study|Withdrawal by Subject|18|||
131117719|NCT01087957|472062404|FG001|Overall Study|Withdrawal by Subject|15|||
131117720|NCT01087957|472062403|FG000|Overall Study|Physician Decision|5|||
130697523|NCT01541215|470517862|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
130913349|NCT00925990|471318328|FG000|Overall Study|Withdrawal by Subject|2|||
130913350|NCT00925990|471318329|FG001|Overall Study|Withdrawal by Subject|2|||
130913351|NCT00925990|471318328|FG000|Overall Study|Lost to Follow-up|1|||
130913352|NCT00925990|471318329|FG001|Overall Study|Lost to Follow-up|3|||
130913353|NCT00925990|471318328|FG000|Overall Study|Physician Decision|1|||
130913354|NCT00925990|471318329|FG001|Overall Study|Physician Decision|1|||
130913355|NCT00925990|471318328|FG000|Overall Study|moved out of state, missed medication|0|||
130913356|NCT00925990|471318329|FG001|Overall Study|moved out of state, missed medication|2|||
130913357|NCT00679055|471318330|FG000|Overall Study|Adverse Event|0|||
130913358|NCT00679055|471318331|FG001|Overall Study|Adverse Event|1|||
130913359|NCT00679055|471318330|FG000|Overall Study|Other|0|||
131032265|NCT04927065|471751393|FG007|Second Booster|Withdrawal by Subject|0|||
131032266|NCT04927065|471751394|FG008|Second Booster|Withdrawal by Subject|0|||
131032267|NCT04927065|471751395|FG009|Second Booster|Withdrawal by Subject|0|||
131032268|NCT04927065|471751396|FG010|Second Booster|Withdrawal by Subject|3|||
131032269|NCT04927065|471751397|FG011|Second Booster|Withdrawal by Subject|16|||
131032270|NCT04927065|471751398|FG012|Second Booster|Withdrawal by Subject|13|||
131032271|NCT04927065|471751399|FG013|Second Booster|Withdrawal by Subject|9|||
131032272|NCT04927065|471751400|FG014|Second Booster|Withdrawal by Subject|0|||
131032273|NCT04927065|471751401|FG015|Second Booster|Withdrawal by Subject|0|||
131032274|NCT04927065|471751386|FG000|Second Booster|Other Than Specified|0|||
131032275|NCT04927065|471751387|FG001|Second Booster|Other Than Specified|0|||
131032276|NCT04927065|471751388|FG002|Second Booster|Other Than Specified|0|||
131032277|NCT04927065|471751389|FG003|Second Booster|Other Than Specified|0|||
131032278|NCT04927065|471751390|FG004|Second Booster|Other Than Specified|0|||
131032279|NCT04927065|471751391|FG005|Second Booster|Other Than Specified|0|||
131032280|NCT04927065|471751392|FG006|Second Booster|Other Than Specified|0|||
131032281|NCT04927065|471751393|FG007|Second Booster|Other Than Specified|0|||
131032282|NCT04927065|471751394|FG008|Second Booster|Other Than Specified|0|||
131032283|NCT04927065|471751395|FG009|Second Booster|Other Than Specified|0|||
131032284|NCT04927065|471751396|FG010|Second Booster|Other Than Specified|1|||
131032285|NCT04927065|471751397|FG011|Second Booster|Other Than Specified|1|||
131032286|NCT04927065|471751398|FG012|Second Booster|Other Than Specified|4|||
131117721|NCT01087957|472062404|FG001|Overall Study|Physician Decision|9|||
131117722|NCT01186939|472062405|FG000|Overall Study|Death|7|||
131117723|NCT01186939|472062405|FG000|Overall Study|Withdrawal by Subject|2|||
131117724|NCT01186939|472062405|FG000|Overall Study|No longer receiving clinical benefit|17|||
131117725|NCT01186939|472062405|FG000|Overall Study|Program closed|5|||
131117726|NCT01186939|472062405|FG000|Overall Study|Sponsor decision|4|||
131117727|NCT01186939|472062405|FG000|Overall Study|Started additional treatment|1|||
131117728|NCT01186939|472062405|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
130913360|NCT00679055|471318331|FG001|Overall Study|Other|3|||
130913361|NCT00679055|471318330|FG000|Overall Study|Study Terminated|2|||
130913362|NCT00679055|471318331|FG001|Overall Study|Study Terminated|1|||
130913363|NCT01368432|471318334|FG000|Overall Study|Lost to Follow-up|0|||
130913364|NCT01368432|471318335|FG001|Overall Study|Lost to Follow-up|1|||
130913365|NCT01008150|471318336|FG000|Overall Study|did not receive study drug|1|||
130913366|NCT01008150|471318337|FG001|Overall Study|did not receive study drug|1|||
130913367|NCT01008150|471318338|FG002|Overall Study|did not receive study drug|1|||
130913368|NCT01008150|471318339|FG003|Overall Study|did not receive study drug|0|||
130913369|NCT00737438|471318340|FG000|Overall Study|Withdrawal by Subject|2|||
130913370|NCT00737438|471318340|FG000|Overall Study|Patient ineligible|1|||
130697524|NCT01541215|470517863|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
130697525|NCT01541215|470517862|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
130697526|NCT01541215|470517863|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
130697527|NCT02817828|470517869|FG000|Overall Study|Lost to Follow-up|41|||
130697528|NCT02817828|470517869|FG000|Overall Study|Adverse event not related to bleeding|104|||
130697529|NCT02817828|470517869|FG000|Overall Study|Adverse event related to bleeding|53|||
130697530|NCT02817828|470517869|FG000|Overall Study|Protocol Violation|11|||
130697531|NCT02817828|470517869|FG000|Overall Study|Pregnancy|7|||
130697532|NCT02817828|470517869|FG000|Overall Study|Pregnancy wish|15|||
130697533|NCT02817828|470517869|FG000|Overall Study|Withdrawal by Subject|78|||
130697534|NCT02817828|470517869|FG000|Overall Study|Other|26|||
130697535|NCT02651987|470517870|FG000|Overall Study|Adverse Event|2|||
130697536|NCT02651987|470517871|FG001|Overall Study|Adverse Event|2|||
130697537|NCT02651987|470517870|FG000|Overall Study|Consent Withdrawn|2|||
130697538|NCT02651987|470517871|FG001|Overall Study|Consent Withdrawn|0|||
130697539|NCT02651987|470517870|FG000|Overall Study|Local PD|0|||
130913371|NCT03845543|471318342|FG000|Overall Study|Death|25|||
130913372|NCT03845543|471318342|FG000|Overall Study|Withdrawal by Subject|2|||
130913373|NCT03845543|471318342|FG000|Overall Study|Lost to Follow-up|12|||
130913374|NCT03845543|471318342|FG000|Overall Study|Adverse Event|17|||
130913375|NCT01400815|471318345|FG000|Overall Study|Adverse Event|3|||
130913376|NCT01400815|471318346|FG001|Overall Study|Adverse Event|0|||
131117729|NCT01186939|472062405|FG000|Overall Study|Myocardial infarction|1|||
131117730|NCT01186939|472062405|FG000|Overall Study|Bone marrow transplant|1|||
130697540|NCT02651987|470517871|FG001|Overall Study|Local PD|2|||
130697541|NCT02651987|470517870|FG000|Overall Study|Investigator Decision|1|||
130697542|NCT02651987|470517871|FG001|Overall Study|Investigator Decision|1|||
130697543|NCT00486434|470517872|FG000|Overall Study|Withdrawal by Subject|34|||
130697544|NCT00486434|470517873|FG001|Overall Study|Withdrawal by Subject|39|||
130697545|NCT00486434|470517872|FG000|Overall Study|Adverse Event|118|||
130697546|NCT00486434|470517873|FG001|Overall Study|Adverse Event|44|||
130697547|NCT00486434|470517872|FG000|Overall Study|Protocol Violation|22|||
130697548|NCT00486434|470517873|FG001|Overall Study|Protocol Violation|21|||
130697549|NCT00486434|470517872|FG000|Overall Study|Lack of Efficacy|12|||
130697550|NCT00486434|470517873|FG001|Overall Study|Lack of Efficacy|19|||
130697551|NCT00486434|470517872|FG000|Overall Study|Lost to Follow-up|2|||
130697552|NCT00486434|470517873|FG001|Overall Study|Lost to Follow-up|3|||
130697553|NCT00486434|470517872|FG000|Overall Study|Death|1|||
130697554|NCT00486434|470517873|FG001|Overall Study|Death|2|||
130697555|NCT00486434|470517872|FG000|Overall Study|Personal reasons|5|||
130697556|NCT00486434|470517873|FG001|Overall Study|Personal reasons|6|||
130697557|NCT00522041|470517874|FG000|Overall Study|Adverse Event|9|||
130697558|NCT00522041|470517875|FG001|Overall Study|Adverse Event|3|||
130697559|NCT00522041|470517874|FG000|Overall Study|Protocol Violation|2|||
130697560|NCT00522041|470517875|FG001|Overall Study|Protocol Violation|0|||
130697561|NCT00522041|470517874|FG000|Overall Study|Lost to Follow-up|1|||
130697562|NCT00522041|470517875|FG001|Overall Study|Lost to Follow-up|4|||
130697563|NCT00522041|470517874|FG000|Overall Study|Voluntary withdrawal|5|||
131117731|NCT01186939|472062405|FG000|Overall Study|Transformation to AML|1|||
131117732|NCT00616434|472062410|FG000|Overall Study|Adverse Event|5|||
131117733|NCT00616434|472062411|FG001|Overall Study|Adverse Event|2|||
130697564|NCT00522041|470517875|FG001|Overall Study|Voluntary withdrawal|4|||
130913377|NCT01400815|471318345|FG000|Overall Study|Death|0|||
130913378|NCT01400815|471318346|FG001|Overall Study|Death|1|||
130697565|NCT00522041|470517874|FG000|Overall Study|Did not receive treatment|0|||
130697566|NCT00522041|470517875|FG001|Overall Study|Did not receive treatment|1|||
130697567|NCT00735696|470517877|FG000|Overall Study|Withdrawal by Subject|1|||
130913379|NCT01400815|471318345|FG000|Overall Study|Lost to Follow-up|18|||
130913380|NCT01400815|471318346|FG001|Overall Study|Lost to Follow-up|11|||
130913381|NCT01400815|471318345|FG000|Overall Study|Protocol Violation|0|||
130697568|NCT00735696|470517877|FG000|Overall Study|Enrolled but never Treated|1|||
130697569|NCT02998541|470517881|FG000|Overall Study|Adverse Event|4|||
130697570|NCT02998541|470517882|FG001|Overall Study|Adverse Event|5|||
130697571|NCT02998541|470517883|FG002|Overall Study|Adverse Event|1|||
130697572|NCT02998541|470517881|FG000|Overall Study|Protocol Violation|1|||
130697573|NCT02998541|470517882|FG001|Overall Study|Protocol Violation|0|||
130913382|NCT01400815|471318346|FG001|Overall Study|Protocol Violation|1|||
130913383|NCT01400815|471318345|FG000|Overall Study|Physician Decision|1|||
131117734|NCT00616434|472062410|FG000|Overall Study|Physician Decision|0|||
130697574|NCT02998541|470517883|FG002|Overall Study|Protocol Violation|0|||
130697575|NCT02998541|470517881|FG000|Overall Study|Withdrawal by Subject|3|||
130697576|NCT02998541|470517882|FG001|Overall Study|Withdrawal by Subject|1|||
130697577|NCT02998541|470517883|FG002|Overall Study|Withdrawal by Subject|0|||
130697578|NCT02998541|470517881|FG000|Overall Study|Lost to Follow-up|0|||
130697579|NCT02998541|470517882|FG001|Overall Study|Lost to Follow-up|3|||
130697580|NCT02998541|470517883|FG002|Overall Study|Lost to Follow-up|1|||
130697581|NCT02998541|470517881|FG000|Overall Study|Physician Decision|0|||
130697582|NCT02998541|470517882|FG001|Overall Study|Physician Decision|0|||
130697583|NCT02998541|470517883|FG002|Overall Study|Physician Decision|3|||
130697584|NCT02998541|470517881|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130697585|NCT02998541|470517882|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130697586|NCT02998541|470517883|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
130697587|NCT03387462|470517889|FG000|Overall Study|Lost to Follow-up|1|||
130913384|NCT01400815|471318346|FG001|Overall Study|Physician Decision|0|||
130913385|NCT01400815|471318345|FG000|Overall Study|Withdrawal by Subject|15|||
130913386|NCT01400815|471318346|FG001|Overall Study|Withdrawal by Subject|8|||
131032287|NCT04927065|471751399|FG013|Second Booster|Other Than Specified|0|||
131032288|NCT04927065|471751400|FG014|Second Booster|Other Than Specified|0|||
130697588|NCT01944722|470517894|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
130697589|NCT01944722|470517894|FG000|Overall Study|Specimen Shipping Issues|34|||
130697590|NCT01944722|470517894|FG000|Overall Study|Improper Storage/Transport|5|||
130697591|NCT01944722|470517894|FG000|Overall Study|Insufficient Volume for Test|1|||
130697592|NCT01944722|470517894|FG000|Overall Study|Missing Specimens|3|||
130697593|NCT01944722|470517894|FG000|Overall Study|Specimens Mislabeled|2|||
130697594|NCT01944722|470517894|FG000|Overall Study|Withdrawal by Subject|8|||
130697595|NCT01944722|470517894|FG000|Overall Study|NILM Subjects <30 years old|8106|||
130697596|NCT01944722|470517894|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
130697597|NCT01944722|470517894|FG000|Overall Study|>ASCUS Cytology|1122|||
130697598|NCT02906917|470517896|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
130697599|NCT02906917|470517897|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
130697600|NCT02906917|470517896|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
130697601|NCT02906917|470517897|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
130697602|NCT02906917|470517896|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
130697603|NCT02906917|470517897|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
130697604|NCT02906917|470517896|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
130697605|NCT02906917|470517897|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
130697606|NCT02906917|470517896|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
130697607|NCT02906917|470517897|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
130697608|NCT02906917|470517896|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
130697609|NCT02906917|470517897|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
130697610|NCT02906917|470517896|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
130697611|NCT02906917|470517897|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
130697612|NCT02906917|470517896|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
130697613|NCT02906917|470517897|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
130697614|NCT00210639|470517898|FG000|Overall Study|Lost to Follow-up|37|||
130913387|NCT01400815|471318345|FG000|Overall Study|Subject in jail|1|||
131032289|NCT04927065|471751401|FG015|Second Booster|Other Than Specified|0|||
131032290|NCT04927065|471751386|FG000|Third Booster|Lost to Follow-up|0|||
131032291|NCT04927065|471751387|FG001|Third Booster|Lost to Follow-up|0|||
131032292|NCT04927065|471751388|FG002|Third Booster|Lost to Follow-up|0|||
131032293|NCT04927065|471751389|FG003|Third Booster|Lost to Follow-up|0|||
131032294|NCT04927065|471751390|FG004|Third Booster|Lost to Follow-up|0|||
131032295|NCT04927065|471751391|FG005|Third Booster|Lost to Follow-up|0|||
131032296|NCT04927065|471751392|FG006|Third Booster|Lost to Follow-up|0|||
131032297|NCT04927065|471751393|FG007|Third Booster|Lost to Follow-up|0|||
131032298|NCT04927065|471751394|FG008|Third Booster|Lost to Follow-up|0|||
131032299|NCT04927065|471751395|FG009|Third Booster|Lost to Follow-up|0|||
131032300|NCT04927065|471751396|FG010|Third Booster|Lost to Follow-up|0|||
131032301|NCT04927065|471751397|FG011|Third Booster|Lost to Follow-up|0|||
131032302|NCT04927065|471751398|FG012|Third Booster|Lost to Follow-up|0|||
131032303|NCT04927065|471751399|FG013|Third Booster|Lost to Follow-up|0|||
131032304|NCT04927065|471751400|FG014|Third Booster|Lost to Follow-up|0|||
130697615|NCT00210639|470517899|FG001|Overall Study|Lost to Follow-up|29|||
130913388|NCT01400815|471318346|FG001|Overall Study|Subject in jail|0|||
131032305|NCT04927065|471751401|FG015|Third Booster|Lost to Follow-up|1|||
131032306|NCT04927065|471751386|FG000|Third Booster|Withdrawal by Subject|0|||
131032307|NCT04927065|471751387|FG001|Third Booster|Withdrawal by Subject|0|||
131032308|NCT04927065|471751388|FG002|Third Booster|Withdrawal by Subject|0|||
130697616|NCT00210639|470517898|FG000|Overall Study|Withdrawal by Subject|8|||
130697617|NCT00210639|470517899|FG001|Overall Study|Withdrawal by Subject|1|||
130697618|NCT00210639|470517898|FG000|Overall Study|Other|18|||
130697619|NCT00210639|470517899|FG001|Overall Study|Other|12|||
130697620|NCT00874822|470517903|FG000|Overall Study|excluded by criteria|8|||
130913389|NCT01123850|471318350|FG000|Overall Study|Slow enrollment|45|||
131032309|NCT04927065|471751389|FG003|Third Booster|Withdrawal by Subject|0|||
130697621|NCT02854800|470517904|FG000|Overall Study|Protocol Violation|16|||
130697622|NCT02854800|470517905|FG001|Overall Study|Protocol Violation|11|||
130697623|NCT02854800|470517906|FG002|Overall Study|Protocol Violation|3|||
130697624|NCT02854800|470517904|FG000|Overall Study|Withdrawal by Subject|4|||
130697625|NCT02854800|470517905|FG001|Overall Study|Withdrawal by Subject|2|||
130697626|NCT02854800|470517906|FG002|Overall Study|Withdrawal by Subject|3|||
130697627|NCT02627963|470517913|FG000|Overall Study|Randomized but not treated|2|||
130697628|NCT02627963|470517914|FG001|Overall Study|Randomized but not treated|6|||
130768948|NCT02697734|470778653|FG000|Optional Extension Phase|Adverse Event|5|||
130768949|NCT02697734|470778654|FG001|Optional Extension Phase|Adverse Event|1|||
130768950|NCT02697734|470778653|FG000|Optional Extension Phase|Physician Decision|0|||
130768951|NCT02697734|470778654|FG001|Optional Extension Phase|Physician Decision|1|||
130697633|NCT05278858|470517916|FG000|Overall Study|Withdrawal by Subject|1|||
130697634|NCT00503867|470517921|FG000|Overall Study|Lost to Follow-up|1|||
130697635|NCT00503867|470517921|FG000|Overall Study|Adverse Event|1|||
130697636|NCT04697173|470517925|FG000|Overall Study|Withdrawal by Subject|34|||
130697637|NCT04697173|470517926|FG001|Overall Study|Withdrawal by Subject|38|||
130697638|NCT03807440|470517927|FG000|Overall Study|No documentation of index date 2|320|||
130697639|NCT03807440|470517927|FG000|Overall Study|No informed consent for index date 2|117|||
130697640|NCT00323258|470517928|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
130697641|NCT00323258|470517929|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
130697642|NCT00323258|470517928|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
130697643|NCT00323258|470517929|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
130697644|NCT00323258|470517928|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
130697645|NCT00323258|470517929|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
130697646|NCT00323258|470517928|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
130697647|NCT00323258|470517929|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
130697648|NCT00323258|470517928|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
130697649|NCT00323258|470517929|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
130697650|NCT00323258|470517928|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
130697651|NCT00323258|470517929|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
130697652|NCT00323258|470517928|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
130697653|NCT00323258|470517929|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
130697654|NCT02372006|470517939|FG000|Overall Study|Progressive disease|8|||
130697655|NCT02372006|470517940|FG001|Overall Study|Progressive disease|7|||
130697656|NCT02372006|470517941|FG002|Overall Study|Progressive disease|34|||
130697657|NCT02372006|470517939|FG000|Overall Study|Dose limiting toxicity|0|||
130697658|NCT02372006|470517940|FG001|Overall Study|Dose limiting toxicity|1|||
130697659|NCT02372006|470517941|FG002|Overall Study|Dose limiting toxicity|0|||
130697660|NCT02372006|470517939|FG000|Overall Study|Adverse Event|0|||
130697661|NCT02372006|470517940|FG001|Overall Study|Adverse Event|0|||
130697662|NCT02372006|470517941|FG002|Overall Study|Adverse Event|3|||
130697663|NCT02372006|470517939|FG000|Overall Study|Withdrawal by Subject|0|||
130697664|NCT02372006|470517940|FG001|Overall Study|Withdrawal by Subject|1|||
130697665|NCT02372006|470517941|FG002|Overall Study|Withdrawal by Subject|1|||
130697666|NCT02372006|470517939|FG000|Overall Study|Other reason for not completing|0|||
130697667|NCT02372006|470517940|FG001|Overall Study|Other reason for not completing|0|||
130697668|NCT02372006|470517941|FG002|Overall Study|Other reason for not completing|1|||
130697669|NCT03504085|470517944|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
130697670|NCT03504085|470517945|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
130697671|NCT03504085|470517944|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
130768952|NCT02651688|470778655|FG000|Overall Study|Non-compliance|0|||
131032310|NCT04927065|471751390|FG004|Third Booster|Withdrawal by Subject|0|||
131032311|NCT04927065|471751391|FG005|Third Booster|Withdrawal by Subject|0|||
131032312|NCT04927065|471751392|FG006|Third Booster|Withdrawal by Subject|0|||
131032313|NCT04927065|471751393|FG007|Third Booster|Withdrawal by Subject|0|||
131032314|NCT04927065|471751394|FG008|Third Booster|Withdrawal by Subject|0|||
131032315|NCT04927065|471751395|FG009|Third Booster|Withdrawal by Subject|0|||
131032316|NCT04927065|471751396|FG010|Third Booster|Withdrawal by Subject|0|||
131032317|NCT04927065|471751397|FG011|Third Booster|Withdrawal by Subject|0|||
131032318|NCT04927065|471751398|FG012|Third Booster|Withdrawal by Subject|0|||
131032319|NCT04927065|471751399|FG013|Third Booster|Withdrawal by Subject|0|||
131032320|NCT04927065|471751400|FG014|Third Booster|Withdrawal by Subject|0|||
131032321|NCT04927065|471751401|FG015|Third Booster|Withdrawal by Subject|1|||
131032322|NCT03366649|471751408|FG000|Overall Study|Failed preoperative screening|4|||
131032323|NCT03366649|471751409|FG001|Overall Study|Failed preoperative screening|0|||
131032324|NCT03366649|471751410|FG002|Overall Study|Failed preoperative screening|0|||
131032325|NCT03366649|471751408|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
131032326|NCT03366649|471751409|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
131032327|NCT03366649|471751410|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
131032328|NCT03673111|471751411|FG000|Overall Study|Protocol Violation|0|||
130697672|NCT03504085|470517945|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
130697673|NCT04133311|470517946|FG000|Period 1 Double Masked Treatment Period|Death|1|||
130697674|NCT04133311|470517947|FG001|Period 1 Double Masked Treatment Period|Death|0|||
130697675|NCT04133311|470517948|FG002|Period 1 Double Masked Treatment Period|Death|0|||
130697676|NCT04133311|470517949|FG003|Period 1 Double Masked Treatment Period|Death|0|||
130697677|NCT04133311|470517946|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
130697678|NCT04133311|470517947|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
130697679|NCT04133311|470517948|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
130697680|NCT04133311|470517949|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
130697681|NCT04133311|470517946|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
130697682|NCT04133311|470517947|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
130697683|NCT04133311|470517948|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
130697684|NCT04133311|470517949|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
130697685|NCT04133311|470517946|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
130697686|NCT04133311|470517947|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
130697687|NCT04133311|470517948|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
130697688|NCT04133311|470517949|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
130697689|NCT04133311|470517946|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
130697690|NCT04133311|470517947|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
130697691|NCT04133311|470517948|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
130697692|NCT04133311|470517949|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
130697693|NCT04133311|470517946|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
130697694|NCT04133311|470517947|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
130697695|NCT04133311|470517948|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
130697696|NCT04133311|470517949|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
130697697|NCT04133311|470517946|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
130697698|NCT04133311|470517947|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
130697699|NCT04133311|470517948|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
130697700|NCT04133311|470517949|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
130697701|NCT04133311|470517946|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
130697702|NCT04133311|470517947|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
130697703|NCT04133311|470517948|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
130697704|NCT04133311|470517949|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
130697705|NCT01926119|470517952|FG000|Overall Study|Withdrawal by Subject|1|||
130697706|NCT01859598|470517953|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
131032329|NCT03673111|471751412|FG001|Overall Study|Protocol Violation|0|||
131032330|NCT03673111|471751413|FG002|Overall Study|Protocol Violation|0|||
131032331|NCT03673111|471751414|FG003|Overall Study|Protocol Violation|0|||
131032332|NCT03673111|471751415|FG004|Overall Study|Protocol Violation|0|||
131032333|NCT03673111|471751416|FG005|Overall Study|Protocol Violation|0|||
131032334|NCT03673111|471751417|FG006|Overall Study|Protocol Violation|0|||
131032335|NCT03673111|471751418|FG007|Overall Study|Protocol Violation|0|||
131032336|NCT03673111|471751419|FG008|Overall Study|Protocol Violation|0|||
131032337|NCT03673111|471751420|FG009|Overall Study|Protocol Violation|0|||
131032338|NCT03673111|471751421|FG010|Overall Study|Protocol Violation|1|||
131032339|NCT03673111|471751422|FG011|Overall Study|Protocol Violation|0|||
131032340|NCT03673111|471751423|FG012|Overall Study|Protocol Violation|0|||
131032341|NCT03673111|471751424|FG013|Overall Study|Protocol Violation|0|||
131032342|NCT03673111|471751411|FG000|Overall Study|Adverse Event|1|||
131032343|NCT03673111|471751412|FG001|Overall Study|Adverse Event|0|||
131032344|NCT03673111|471751413|FG002|Overall Study|Adverse Event|0|||
131032345|NCT03673111|471751414|FG003|Overall Study|Adverse Event|0|||
131032346|NCT03673111|471751415|FG004|Overall Study|Adverse Event|0|||
131032347|NCT03673111|471751416|FG005|Overall Study|Adverse Event|0|||
131032348|NCT03673111|471751417|FG006|Overall Study|Adverse Event|0|||
131032349|NCT03673111|471751418|FG007|Overall Study|Adverse Event|0|||
131032350|NCT03673111|471751419|FG008|Overall Study|Adverse Event|0|||
131032351|NCT03673111|471751420|FG009|Overall Study|Adverse Event|0|||
131032352|NCT03673111|471751421|FG010|Overall Study|Adverse Event|0|||
131032353|NCT03673111|471751422|FG011|Overall Study|Adverse Event|0|||
131032354|NCT03673111|471751423|FG012|Overall Study|Adverse Event|0|||
131032355|NCT03673111|471751424|FG013|Overall Study|Adverse Event|0|||
131032356|NCT01744782|471751428|FG000|Overall Study|Death|1|||
131032357|NCT02120456|471751429|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131032358|NCT02120456|471751430|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131032359|NCT02120456|471751431|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131032360|NCT02120456|471751432|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131117735|NCT00616434|472062411|FG001|Overall Study|Physician Decision|4|||
131117736|NCT00616434|472062410|FG000|Overall Study|Withdrawal by Subject|1|||
131032361|NCT02120456|471751433|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131032362|NCT02120456|471751434|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
130697707|NCT03255980|470517958|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
130697708|NCT03255980|470517959|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
130697709|NCT03255980|470517960|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
130697710|NCT03255980|470517961|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
130697711|NCT03255980|470517958|FG000|Overall Study|Adverse Event|1|||
130697712|NCT03255980|470517959|FG001|Overall Study|Adverse Event|1|||
130697713|NCT03255980|470517960|FG002|Overall Study|Adverse Event|0|||
130697714|NCT03255980|470517961|FG003|Overall Study|Adverse Event|1|||
130697715|NCT03255980|470517958|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
130697716|NCT03255980|470517959|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
130697717|NCT03255980|470517960|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
130697718|NCT03255980|470517961|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
130697719|NCT03255980|470517958|FG000|Overall Study|Lost to Follow-up|1|||
130697720|NCT03255980|470517959|FG001|Overall Study|Lost to Follow-up|1|||
130697721|NCT03255980|470517960|FG002|Overall Study|Lost to Follow-up|0|||
130697722|NCT03255980|470517961|FG003|Overall Study|Lost to Follow-up|3|||
130697723|NCT03255980|470517958|FG000|Overall Study|Withdrawal by Subject|0|||
130697724|NCT03255980|470517959|FG001|Overall Study|Withdrawal by Subject|1|||
130697725|NCT03255980|470517960|FG002|Overall Study|Withdrawal by Subject|0|||
130697726|NCT03255980|470517961|FG003|Overall Study|Withdrawal by Subject|3|||
130697727|NCT02611362|470517962|FG000|Overall Study|Withdrawal by Subject|7|||
130697728|NCT02611362|470517963|FG001|Overall Study|Withdrawal by Subject|2|||
130697729|NCT02611362|470517962|FG000|Overall Study|Lost to Follow-up|2|||
130697730|NCT02611362|470517963|FG001|Overall Study|Lost to Follow-up|4|||
130697731|NCT01155531|470517964|FG000|Overall Study|Adverse Event|0|||
130697732|NCT01155531|470517965|FG001|Overall Study|Adverse Event|0|||
130697733|NCT01155531|470517966|FG002|Overall Study|Adverse Event|1|||
130697734|NCT01155531|470517967|FG003|Overall Study|Adverse Event|0|||
130697735|NCT01155531|470517964|FG000|Overall Study|Lost to Follow-up|0|||
130697736|NCT01155531|470517965|FG001|Overall Study|Lost to Follow-up|0|||
130697737|NCT01155531|470517966|FG002|Overall Study|Lost to Follow-up|0|||
130697738|NCT01155531|470517967|FG003|Overall Study|Lost to Follow-up|1|||
130697739|NCT01155531|470517964|FG000|Overall Study|Withdrawal by Subject|1|||
130697740|NCT01155531|470517965|FG001|Overall Study|Withdrawal by Subject|0|||
130697741|NCT01155531|470517966|FG002|Overall Study|Withdrawal by Subject|1|||
130697742|NCT01155531|470517967|FG003|Overall Study|Withdrawal by Subject|0|||
130697743|NCT00354159|470517968|FG000|Randomized Study Period|Withdrawal by Subject|5|||
130697744|NCT00354159|470517969|FG001|Randomized Study Period|Withdrawal by Subject|3|||
130697745|NCT00354159|470517968|FG000|Randomized Study Period|Physician Decision|6|||
130697746|NCT00354159|470517969|FG001|Randomized Study Period|Physician Decision|10|||
130697747|NCT00354159|470517968|FG000|Randomized Study Period|Lost to Follow-up|4|||
130697748|NCT00354159|470517969|FG001|Randomized Study Period|Lost to Follow-up|0|||
130697749|NCT00354159|470517968|FG000|Randomized Study Period|Death|7|||
130697750|NCT00354159|470517969|FG001|Randomized Study Period|Death|9|||
130697751|NCT00354159|470517968|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
130697752|NCT00354159|470517969|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
130697753|NCT00354159|470517968|FG000|Long-term Follow-up|Physician Decision|127|||
130697754|NCT00354159|470517969|FG001|Long-term Follow-up|Physician Decision|122|||
130697755|NCT00354159|470517968|FG000|Long-term Follow-up|Lost to Follow-up|1|||
130913390|NCT01638819|471318357|FG000|Overall Study|Lost to Follow-up|1|||
130913391|NCT01638819|471318358|FG001|Overall Study|Lost to Follow-up|0|||
130913392|NCT03538431|471318359|FG000|Overall Study|Physician Decision|0|||
130913393|NCT03538431|471318360|FG001|Overall Study|Physician Decision|1|||
130913394|NCT03538431|471318359|FG000|Overall Study|Withdrawal by Subject|1|||
130913395|NCT03538431|471318360|FG001|Overall Study|Withdrawal by Subject|0|||
130913396|NCT03911154|471318361|FG000|Overall Study|Withdrawal by Subject|1|||
130913397|NCT01278160|471318365|FG000|Overall Study|Adverse Event|1|||
130913398|NCT01278160|471318366|FG001|Overall Study|Adverse Event|1|||
130913399|NCT01278160|471318365|FG000|Overall Study|Lost to Follow-up|0|||
130697756|NCT00354159|470517969|FG001|Long-term Follow-up|Lost to Follow-up|0|||
130697757|NCT00354159|470517968|FG000|Long-term Follow-up|Death|14|||
130697758|NCT00354159|470517969|FG001|Long-term Follow-up|Death|11|||
130697759|NCT00354159|470517968|FG000|Long-term Follow-up|Study Closed|29|||
130697760|NCT00354159|470517969|FG001|Long-term Follow-up|Study Closed|34|||
130697761|NCT01653704|470517971|FG000|Overall Study|Technical failure during recording|1|||
130913400|NCT01278160|471318366|FG001|Overall Study|Lost to Follow-up|1|||
130697762|NCT01653704|470517972|FG001|Overall Study|Technical failure during recording|1|||
130697763|NCT01653704|470517971|FG000|Overall Study|Performance not reflective of training|1|||
130697764|NCT01653704|470517972|FG001|Overall Study|Performance not reflective of training|0|||
130913401|NCT01278160|471318365|FG000|Overall Study|Withdrawal by Subject|3|||
130913402|NCT01278160|471318366|FG001|Overall Study|Withdrawal by Subject|2|||
130913403|NCT01278160|471318365|FG000|Overall Study|Unclassified|1|||
130697765|NCT01728116|470517973|FG000|Overall Study|Sponsor Terminated Study|106|||
130697766|NCT01728116|470517974|FG001|Overall Study|Sponsor Terminated Study|35|||
130697767|NCT01728116|470517973|FG000|Overall Study|Withdrawal by Subject|16|||
130697768|NCT01728116|470517974|FG001|Overall Study|Withdrawal by Subject|9|||
130697769|NCT01728116|470517973|FG000|Overall Study|Adverse Event|13|||
130697770|NCT01728116|470517974|FG001|Overall Study|Adverse Event|0|||
130697771|NCT01728116|470517973|FG000|Overall Study|Procedure/device failure|7|||
130697772|NCT01728116|470517974|FG001|Overall Study|Procedure/device failure|0|||
130697773|NCT01728116|470517973|FG000|Overall Study|Lost to Follow-up|9|||
130697774|NCT01728116|470517974|FG001|Overall Study|Lost to Follow-up|2|||
130697775|NCT01728116|470517973|FG000|Overall Study|Physician Decision|2|||
130697776|NCT01728116|470517974|FG001|Overall Study|Physician Decision|0|||
130697777|NCT01728116|470517973|FG000|Overall Study|Subject Non-Compliance|2|||
130697778|NCT01728116|470517974|FG001|Overall Study|Subject Non-Compliance|0|||
130697779|NCT01728116|470517973|FG000|Overall Study|Inter-current finding at procedure|1|||
130697780|NCT01728116|470517974|FG001|Overall Study|Inter-current finding at procedure|0|||
130697781|NCT01728116|470517973|FG000|Overall Study|Incorrectly enrolled in Study|0|||
130697782|NCT01728116|470517974|FG001|Overall Study|Incorrectly enrolled in Study|1|||
130697783|NCT01728116|470517973|FG000|Overall Study|various not noted previously|5|||
130697784|NCT01728116|470517974|FG001|Overall Study|various not noted previously|0|||
130697785|NCT03277248|470517987|FG000|Overall Study|Adverse Event|3|||
130697786|NCT03277248|470517988|FG001|Overall Study|Adverse Event|1|||
130697787|NCT03277248|470517987|FG000|Overall Study|Subject Withdrawal of Consent|6|||
130697788|NCT03277248|470517988|FG001|Overall Study|Subject Withdrawal of Consent|23|||
130697789|NCT03277248|470517987|FG000|Overall Study|Investigator/Sponsor Decision|2|||
130697790|NCT03277248|470517988|FG001|Overall Study|Investigator/Sponsor Decision|2|||
130697791|NCT03277248|470517987|FG000|Overall Study|Pregnancy|4|||
130697792|NCT03277248|470517988|FG001|Overall Study|Pregnancy|1|||
130697793|NCT03277248|470517987|FG000|Overall Study|Lost to Follow-up|0|||
130697794|NCT03277248|470517988|FG001|Overall Study|Lost to Follow-up|2|||
130697795|NCT03277248|470517987|FG000|Overall Study|Lack of Efficacy|0|||
130697796|NCT03277248|470517988|FG001|Overall Study|Lack of Efficacy|2|||
130697797|NCT03277248|470517987|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
130697798|NCT03277248|470517988|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
130697799|NCT01691612|470517993|FG000|Overall Study|deemed ineligible after 1st visit|6|||
130697800|NCT01691612|470517993|FG000|Overall Study|Adverse Event|1|||
130697801|NCT00640341|470519059|FG000|Overall Study|Adverse Event|0|||
130913404|NCT01278160|471318366|FG001|Overall Study|Unclassified|2|||
130913405|NCT00406718|471318370|FG000|Overall Study|Withdrawal by Subject|2|||
130913406|NCT00406718|471318371|FG001|Overall Study|Withdrawal by Subject|9|||
131032363|NCT02120456|471751435|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
131032364|NCT02120456|471751436|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
130697802|NCT00640341|470519060|FG001|Overall Study|Adverse Event|0|||
130697803|NCT00640341|470519061|FG002|Overall Study|Adverse Event|1|||
130697804|NCT00640341|470519059|FG000|Overall Study|Positive Slit Lamp Findings|0|||
130697805|NCT00640341|470519060|FG001|Overall Study|Positive Slit Lamp Findings|0|||
130697806|NCT00640341|470519061|FG002|Overall Study|Positive Slit Lamp Findings|1|||
130697807|NCT00640341|470519059|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
130697808|NCT00640341|470519060|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
130697809|NCT00640341|470519061|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
130697810|NCT00640341|470519059|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
130697811|NCT00640341|470519060|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
130697812|NCT00640341|470519061|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
130697813|NCT00640341|470519059|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
130697814|NCT00640341|470519060|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
130697815|NCT00640341|470519061|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
130768953|NCT02651688|470778656|FG001|Overall Study|Non-compliance|0|||
131032365|NCT02120456|471751437|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
131032366|NCT02120456|471751429|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131032367|NCT02120456|471751430|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131032368|NCT02120456|471751431|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131032369|NCT02120456|471751432|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131032370|NCT02120456|471751433|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131032371|NCT02120456|471751434|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131032372|NCT02120456|471751435|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
131032373|NCT02120456|471751436|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
130697816|NCT00640341|470519059|FG000|Overall Study|Lost to Follow-up|2|||
130697817|NCT00640341|470519060|FG001|Overall Study|Lost to Follow-up|0|||
130697818|NCT00640341|470519061|FG002|Overall Study|Lost to Follow-up|0|||
130768954|NCT02651688|470778657|FG002|Overall Study|Non-compliance|1|||
130768955|NCT02651688|470778655|FG000|Overall Study|Principal Investigator (PI) decision|0|||
131032374|NCT02120456|471751437|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
131032375|NCT02120456|471751429|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131032376|NCT02120456|471751430|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
130697819|NCT00640341|470519059|FG000|Overall Study|Withdrawal by Subject|4|||
130697820|NCT00640341|470519060|FG001|Overall Study|Withdrawal by Subject|0|||
130697821|NCT00640341|470519061|FG002|Overall Study|Withdrawal by Subject|1|||
130697822|NCT00640341|470519059|FG000|Overall Study|Unacceptable Lens Movement|1|||
130697823|NCT00640341|470519060|FG001|Overall Study|Unacceptable Lens Movement|0|||
130697824|NCT00640341|470519061|FG002|Overall Study|Unacceptable Lens Movement|0|||
130697825|NCT00640341|470519059|FG000|Overall Study|Poor fit/Uncomfortable|4|||
130697826|NCT00640341|470519060|FG001|Overall Study|Poor fit/Uncomfortable|0|||
130913407|NCT00406718|471318372|FG002|Overall Study|Withdrawal by Subject|4|||
130913408|NCT00406718|471318370|FG000|Overall Study|Lost to Follow-up|2|||
130913409|NCT00406718|471318371|FG001|Overall Study|Lost to Follow-up|5|||
130913410|NCT00406718|471318372|FG002|Overall Study|Lost to Follow-up|4|||
130913411|NCT02445391|471318377|FG000|Overall Study|No active protocol treatment|3|||
130913412|NCT02445391|471318378|FG001|Overall Study|No active protocol treatment|0|||
130913413|NCT02445391|471318379|FG002|Overall Study|No active protocol treatment|0|||
130913414|NCT02445391|471318377|FG000|Overall Study|Adverse Event|0|||
130913415|NCT02445391|471318378|FG001|Overall Study|Adverse Event|21|||
130913416|NCT02445391|471318379|FG002|Overall Study|Adverse Event|12|||
130913417|NCT02445391|471318377|FG000|Overall Study|Alternative therapy|0|||
130913418|NCT02445391|471318378|FG001|Overall Study|Alternative therapy|0|||
130913419|NCT02445391|471318379|FG002|Overall Study|Alternative therapy|1|||
130913420|NCT02445391|471318377|FG000|Overall Study|Disease progression|0|||
130913421|NCT02445391|471318378|FG001|Overall Study|Disease progression|7|||
130913422|NCT02445391|471318379|FG002|Overall Study|Disease progression|22|||
130913423|NCT02445391|471318377|FG000|Overall Study|Complicating disease|0|||
130913424|NCT02445391|471318378|FG001|Overall Study|Complicating disease|2|||
130913425|NCT02445391|471318379|FG002|Overall Study|Complicating disease|1|||
130913426|NCT02445391|471318377|FG000|Overall Study|Withdrawal by Subject|0|||
130913427|NCT02445391|471318378|FG001|Overall Study|Withdrawal by Subject|4|||
130913428|NCT02445391|471318379|FG002|Overall Study|Withdrawal by Subject|9|||
130913429|NCT02445391|471318377|FG000|Overall Study|Financial issue|0|||
130913430|NCT02445391|471318378|FG001|Overall Study|Financial issue|0|||
130697827|NCT00640341|470519061|FG002|Overall Study|Poor fit/Uncomfortable|0|||
130697828|NCT00640341|470519059|FG000|Overall Study|Ineligable at Baseline|5|||
130697829|NCT00640341|470519060|FG001|Overall Study|Ineligable at Baseline|3|||
130697830|NCT00640341|470519061|FG002|Overall Study|Ineligable at Baseline|2|||
130697831|NCT00640341|470519059|FG000|Overall Study|Adverse event and positive slit lamp|1|||
130697832|NCT00640341|470519060|FG001|Overall Study|Adverse event and positive slit lamp|0|||
130697833|NCT00640341|470519061|FG002|Overall Study|Adverse event and positive slit lamp|0|||
130697834|NCT01894230|470519062|FG000|Overall Study|Lost to Follow-up|2|||
130697835|NCT01894230|470519063|FG001|Overall Study|Lost to Follow-up|2|||
130697836|NCT01894230|470519062|FG000|Overall Study|Withdrawal by Subject|4|||
130697837|NCT01894230|470519063|FG001|Overall Study|Withdrawal by Subject|4|||
130697838|NCT01894230|470519062|FG000|Overall Study|Non-adherent|0|||
130697839|NCT01894230|470519063|FG001|Overall Study|Non-adherent|1|||
130697840|NCT01894230|470519062|FG000|Overall Study|Death|1|||
130697841|NCT01894230|470519063|FG001|Overall Study|Death|0|||
130697842|NCT02300987|470519064|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
130697843|NCT02300987|470519065|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
130697844|NCT02300987|470519064|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
130913431|NCT02445391|471318379|FG002|Overall Study|Financial issue|2|||
130913432|NCT02445391|471318377|FG000|Overall Study|Still on treatment|0|||
130913433|NCT02445391|471318378|FG001|Overall Study|Still on treatment|7|||
130913434|NCT02445391|471318379|FG002|Overall Study|Still on treatment|16|||
130913435|NCT02445391|471318377|FG000|Overall Study|Not start protocol therapy|0|||
130913436|NCT02445391|471318378|FG001|Overall Study|Not start protocol therapy|12|||
130913437|NCT02445391|471318379|FG002|Overall Study|Not start protocol therapy|9|||
130913438|NCT01897714|471319844|FG000|Phase I (Dose Escalation)|Disease progression|3|||
130913439|NCT01897714|471319845|FG001|Phase I (Dose Escalation)|Disease progression|5|||
130913440|NCT01897714|471319846|FG002|Phase I (Dose Escalation)|Disease progression|1|||
130913441|NCT01897714|471319847|FG003|Phase I (Dose Escalation)|Disease progression|3|||
130913442|NCT01897714|471319848|FG004|Phase I (Dose Escalation)|Disease progression|0|||
130913443|NCT01897714|471319849|FG005|Phase I (Dose Escalation)|Disease progression|0|||
130913444|NCT01897714|471319844|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
130913445|NCT01897714|471319845|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
130913446|NCT01897714|471319846|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
130913447|NCT01897714|471319847|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
130913448|NCT01897714|471319848|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
130913449|NCT01897714|471319849|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
130697845|NCT02300987|470519065|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
130913450|NCT01897714|471319844|FG000|Phase I (Dose Escalation)|Other|0|||
130913451|NCT01897714|471319845|FG001|Phase I (Dose Escalation)|Other|1|||
130913452|NCT01897714|471319846|FG002|Phase I (Dose Escalation)|Other|0|||
130913453|NCT01897714|471319847|FG003|Phase I (Dose Escalation)|Other|0|||
131117737|NCT00616434|472062411|FG001|Overall Study|Withdrawal by Subject|1|||
130697846|NCT02300987|470519064|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
130697847|NCT02300987|470519065|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
130697848|NCT02300987|470519064|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
131032377|NCT02120456|471751431|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131032378|NCT02120456|471751432|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131032379|NCT02120456|471751433|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131032380|NCT02120456|471751434|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
130768956|NCT02651688|470778656|FG001|Overall Study|Principal Investigator (PI) decision|2|||
130768957|NCT02651688|470778657|FG002|Overall Study|Principal Investigator (PI) decision|0|||
130768958|NCT02651688|470778655|FG000|Overall Study|Lost to Follow-up|1|||
130768959|NCT02651688|470778656|FG001|Overall Study|Lost to Follow-up|3|||
130768960|NCT02651688|470778657|FG002|Overall Study|Lost to Follow-up|0|||
130768961|NCT02651688|470778655|FG000|Overall Study|Withdrawal by Subject|1|||
130768962|NCT02651688|470778656|FG001|Overall Study|Withdrawal by Subject|0|||
130768963|NCT02651688|470778657|FG002|Overall Study|Withdrawal by Subject|2|||
130768964|NCT00731731|470778658|FG000|Overall Study|Protocol Violation|0|||
130768965|NCT00731731|470778659|FG001|Overall Study|Protocol Violation|0|||
130768966|NCT00731731|470778660|FG002|Overall Study|Protocol Violation|1|||
130768967|NCT00731731|470778658|FG000|Overall Study|Cancel prior to treatment|0|||
130768968|NCT00731731|470778659|FG001|Overall Study|Cancel prior to treatment|0|||
130768969|NCT00731731|470778660|FG002|Overall Study|Cancel prior to treatment|2|||
130768970|NCT03970200|470778661|FG000|Overall Study|Death|2|||
130768971|NCT03970200|470778662|FG001|Overall Study|Death|2|||
130768972|NCT03970200|470778663|FG002|Overall Study|Death|1|||
130768973|NCT03970200|470778661|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
130768974|NCT03970200|470778662|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
130768975|NCT03970200|470778663|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
130768976|NCT01693185|470778664|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
130768977|NCT01693185|470778665|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
130768978|NCT01429441|470778666|FG000|Overall Study|Adverse Event|5|||
130768979|NCT01429441|470778667|FG001|Overall Study|Adverse Event|1|||
130768980|NCT01429441|470778666|FG000|Overall Study|Death|0|||
130768981|NCT01429441|470778667|FG001|Overall Study|Death|2|||
130768982|NCT01429441|470778666|FG000|Overall Study|Lost to Follow-up|5|||
130768983|NCT01429441|470778667|FG001|Overall Study|Lost to Follow-up|2|||
130768984|NCT01429441|470778666|FG000|Overall Study|Physician Decision|1|||
130768985|NCT01429441|470778667|FG001|Overall Study|Physician Decision|0|||
130768986|NCT01429441|470778666|FG000|Overall Study|Withdrawal by Subject|27|||
130768987|NCT01429441|470778667|FG001|Overall Study|Withdrawal by Subject|18|||
130768988|NCT02279745|470778668|FG000|Overall Study|Adverse Event|7|||
130768989|NCT02279745|470778668|FG000|Overall Study|Death|6|||
130768990|NCT02279745|470778668|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
130768991|NCT02279745|470778668|FG000|Overall Study|Withdrawal by Subject|2|||
130768992|NCT02279745|470778668|FG000|Overall Study|Pregnancy|1|||
130768993|NCT02279745|470778668|FG000|Overall Study|Study Non-compliance|1|||
130768994|NCT02279745|470778668|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
130768995|NCT00380718|470778669|FG000|Overall Study|Adverse Event|1|||
130768996|NCT00380718|470778669|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
130768997|NCT01606748|470778670|FG000|Overall Study|Adverse Event|1|||
130768998|NCT01606748|470778671|FG001|Overall Study|Adverse Event|0|||
130768999|NCT01606748|470778670|FG000|Overall Study|Progressive Disease|1|||
130769000|NCT01606748|470778671|FG001|Overall Study|Progressive Disease|0|||
130769001|NCT01606748|470778670|FG000|Overall Study|Withdrawal by Subject|1|||
130769002|NCT01606748|470778671|FG001|Overall Study|Withdrawal by Subject|0|||
130769003|NCT03742258|470778675|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
130769004|NCT03742258|470778676|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
130769005|NCT03742258|470778677|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
130769006|NCT03742258|470778675|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
130769007|NCT03742258|470778676|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
130769008|NCT03742258|470778677|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
130769009|NCT03742258|470778675|FG000|Survival Follow-Up|Still in Follow-up|0|||
130769010|NCT03742258|470778676|FG001|Survival Follow-Up|Still in Follow-up|0|||
130769011|NCT03742258|470778677|FG002|Survival Follow-Up|Still in Follow-up|2|||
130769012|NCT03084315|470778678|FG000|Overall Study|Lost to Follow-up|8|||
130769013|NCT03084315|470778679|FG001|Overall Study|Lost to Follow-up|7|||
131032381|NCT02120456|471751435|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131032382|NCT02120456|471751436|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
131032383|NCT02120456|471751437|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
131032384|NCT01785719|471751439|FG000|4-week Baseline Evaluation|Physician Decision|1|||
130769014|NCT03084315|470778678|FG000|Overall Study|Withdrawal by Subject|2|||
130769015|NCT03084315|470778679|FG001|Overall Study|Withdrawal by Subject|2|||
130769016|NCT01952080|470778681|FG000|Overall Study|Withdrawal by Subject|0|||
131032385|NCT01785719|471751440|FG001|4-week Baseline Evaluation|Physician Decision|0|||
130769017|NCT01952080|470778682|FG001|Overall Study|Withdrawal by Subject|0|||
130769018|NCT01952080|470778683|FG002|Overall Study|Withdrawal by Subject|0|||
130769019|NCT01952080|470778684|FG003|Overall Study|Withdrawal by Subject|1|||
130769020|NCT01952080|470778681|FG000|Overall Study|Protocol Non-compliance|0|||
130913454|NCT01897714|471319848|FG004|Phase I (Dose Escalation)|Other|0|||
130913455|NCT01897714|471319849|FG005|Phase I (Dose Escalation)|Other|0|||
130913456|NCT01897714|471319844|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
130913457|NCT01897714|471319845|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
130913458|NCT01897714|471319846|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
130913459|NCT01897714|471319847|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
131117738|NCT00616434|472062410|FG000|Overall Study|Protocol deviation|0|||
131117739|NCT00616434|472062411|FG001|Overall Study|Protocol deviation|1|||
131117740|NCT01118325|472062414|FG000|Overall Study|Adverse Event|1|||
131117741|NCT01118325|472062415|FG001|Overall Study|Adverse Event|0|||
131117742|NCT01118325|472062416|FG002|Overall Study|Adverse Event|1|||
131117743|NCT03334409|472062417|FG000|Overall Study|Did not meet inclusion criteria|1|||
131117744|NCT03334409|472062418|FG001|Overall Study|Did not meet inclusion criteria|0|||
131117745|NCT00975715|472062419|FG000|Titration Period|Adverse Event|6|||
131117746|NCT00975715|472062420|FG001|Titration Period|Adverse Event|0|||
131117747|NCT00975715|472062419|FG000|Titration Period|Protocol Violation|1|||
131117748|NCT00975715|472062420|FG001|Titration Period|Protocol Violation|0|||
131117749|NCT00975715|472062419|FG000|Maintenance Period|Adverse Event|2|||
131117750|NCT00975715|472062420|FG001|Maintenance Period|Adverse Event|1|||
131117751|NCT01674712|472062427|FG000|Overall Study|Adverse Event|5|||
131117752|NCT01674712|472062428|FG001|Overall Study|Adverse Event|6|||
131117753|NCT01674712|472062429|FG002|Overall Study|Adverse Event|3|||
131117754|NCT01674712|472062430|FG003|Overall Study|Adverse Event|4|||
131117755|NCT01674712|472062431|FG004|Overall Study|Adverse Event|6|||
131117756|NCT01674712|472062427|FG000|Overall Study|Lost to Follow-up|1|||
131117757|NCT01674712|472062428|FG001|Overall Study|Lost to Follow-up|0|||
131117758|NCT01674712|472062429|FG002|Overall Study|Lost to Follow-up|0|||
131117759|NCT01674712|472062430|FG003|Overall Study|Lost to Follow-up|0|||
131117760|NCT01674712|472062431|FG004|Overall Study|Lost to Follow-up|0|||
131117761|NCT01674712|472062427|FG000|Overall Study|Protocol Violation|2|||
131117762|NCT01674712|472062428|FG001|Overall Study|Protocol Violation|0|||
131117763|NCT01674712|472062429|FG002|Overall Study|Protocol Violation|0|||
131117764|NCT01674712|472062430|FG003|Overall Study|Protocol Violation|0|||
131117765|NCT01674712|472062431|FG004|Overall Study|Protocol Violation|0|||
131117766|NCT01674712|472062427|FG000|Overall Study|Withdrawal by Subject|2|||
131117767|NCT01674712|472062428|FG001|Overall Study|Withdrawal by Subject|2|||
131117768|NCT01674712|472062429|FG002|Overall Study|Withdrawal by Subject|5|||
130697849|NCT02300987|470519065|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
130697850|NCT02300987|470519064|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
130697851|NCT02300987|470519065|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
130697852|NCT02488109|470519069|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
130697853|NCT02488109|470519070|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
130697854|NCT02488109|470519069|FG000|12-month Follow-Up|Lost to Follow-up|4|||
130697855|NCT02488109|470519070|FG001|12-month Follow-Up|Lost to Follow-up|7|||
130697856|NCT00660387|470519071|FG000|Overall Study|Adverse Event|1|||
130697857|NCT00660387|470519072|FG001|Overall Study|Adverse Event|2|||
130697858|NCT00660387|470519071|FG000|Overall Study|Lack of Efficacy|0|||
130697859|NCT00660387|470519072|FG001|Overall Study|Lack of Efficacy|1|||
130697860|NCT00660387|470519071|FG000|Overall Study|Protocol Violation|1|||
130697861|NCT00660387|470519072|FG001|Overall Study|Protocol Violation|0|||
130697862|NCT03086135|470519077|FG000|Overall Study|Adverse Event|1|||
130697863|NCT03086135|470519077|FG000|Overall Study|Lost to Follow-up|2|||
130697864|NCT01023061|470519080|FG000|Overall Study|Withdrawal prior to treatment|2|||
130697865|NCT02966340|470519081|FG000|Overall Study|Adverse Event|0|||
130697866|NCT02966340|470519082|FG001|Overall Study|Adverse Event|1|||
130697867|NCT02966340|470519081|FG000|Overall Study|Lost to Follow-up|0|||
130697868|NCT02966340|470519082|FG001|Overall Study|Lost to Follow-up|1|||
130697869|NCT02966340|470519081|FG000|Overall Study|Withdrawal by Subject|1|||
130697870|NCT02966340|470519082|FG001|Overall Study|Withdrawal by Subject|0|||
130697871|NCT02966340|470519081|FG000|Overall Study|data acquisition error|1|||
130913460|NCT01897714|471319848|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
131117769|NCT01674712|472062430|FG003|Overall Study|Withdrawal by Subject|4|||
131117770|NCT01674712|472062431|FG004|Overall Study|Withdrawal by Subject|3|||
131117771|NCT01674712|472062427|FG000|Overall Study|Administrative|0|||
131117772|NCT01674712|472062428|FG001|Overall Study|Administrative|1|||
130697872|NCT02966340|470519082|FG001|Overall Study|data acquisition error|0|||
130697873|NCT02966340|470519081|FG000|Overall Study|startle non-responder|1|||
130697874|NCT02966340|470519082|FG001|Overall Study|startle non-responder|1|||
130697875|NCT01622660|470519083|FG000|Overall Study|Adverse Event|1|||
130697876|NCT04556734|470519084|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
130697877|NCT04556734|470519085|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130697878|NCT04556734|470519086|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
131117773|NCT01674712|472062429|FG002|Overall Study|Administrative|0|||
131117774|NCT01674712|472062430|FG003|Overall Study|Administrative|0|||
131117775|NCT01674712|472062431|FG004|Overall Study|Administrative|1|||
131117776|NCT01674712|472062427|FG000|Overall Study|Lack of Efficacy|0|||
131117777|NCT01674712|472062428|FG001|Overall Study|Lack of Efficacy|0|||
130697879|NCT04556734|470519087|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130697880|NCT04556734|470519088|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130697881|NCT04556734|470519089|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130697882|NCT04556734|470519090|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130697883|NCT04556734|470519091|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130697884|NCT04556734|470519084|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
130697885|NCT04556734|470519085|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697886|NCT04556734|470519086|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697887|NCT04556734|470519087|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697888|NCT04556734|470519088|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697889|NCT04556734|470519089|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697890|NCT04556734|470519090|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697891|NCT04556734|470519091|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130697892|NCT04556734|470519084|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130913461|NCT01897714|471319849|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
130697893|NCT04556734|470519085|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130913462|NCT01897714|471319844|FG000|Phase II (MTD)|Lost to Follow-up|0|||
131117778|NCT01674712|472062429|FG002|Overall Study|Lack of Efficacy|1|||
131117779|NCT01674712|472062430|FG003|Overall Study|Lack of Efficacy|0|||
131117780|NCT01674712|472062431|FG004|Overall Study|Lack of Efficacy|1|||
131117781|NCT00874770|472062432|FG000|Overall Study|Lack of Efficacy|2|||
131117782|NCT00874770|472062433|FG001|Overall Study|Lack of Efficacy|0|||
131117783|NCT00874770|472062434|FG002|Overall Study|Lack of Efficacy|0|||
131117784|NCT00874770|472062435|FG003|Overall Study|Lack of Efficacy|2|||
131117785|NCT00874770|472062432|FG000|Overall Study|Adverse Event|1|||
131117786|NCT00874770|472062433|FG001|Overall Study|Adverse Event|1|||
131117787|NCT00874770|472062434|FG002|Overall Study|Adverse Event|4|||
131117788|NCT00874770|472062435|FG003|Overall Study|Adverse Event|2|||
131117789|NCT00874770|472062432|FG000|Overall Study|Lost to Follow-up|1|||
131117790|NCT00874770|472062433|FG001|Overall Study|Lost to Follow-up|0|||
131117791|NCT00874770|472062434|FG002|Overall Study|Lost to Follow-up|0|||
131117792|NCT00874770|472062435|FG003|Overall Study|Lost to Follow-up|1|||
131117793|NCT00874770|472062432|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
131117794|NCT00874770|472062433|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
131117795|NCT00874770|472062434|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
131117796|NCT00874770|472062435|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
131117797|NCT05395104|472062436|FG000|Overall Study|Met Liver Stopping Criteria|1|||
131117798|NCT05395104|472062436|FG000|Overall Study|Withdrawal by Subject|1|||
131117799|NCT03974334|472062437|FG000|Overall Study|Lost to Follow-up|1|||
131117800|NCT00024167|472062438|FG000|Overall Study|Death|53|||
131117801|NCT00024167|472062439|FG001|Overall Study|Death|47|||
131117802|NCT00770770|472062454|FG000|Overall Study|Lost to Follow-up|1|||
131117803|NCT00770770|472062455|FG001|Overall Study|Lost to Follow-up|0|||
131117804|NCT00770770|472062454|FG000|Overall Study|Withdrawal by Subject|1|||
131117805|NCT00770770|472062455|FG001|Overall Study|Withdrawal by Subject|0|||
131117806|NCT00770770|472062454|FG000|Overall Study|Death|0|||
131117807|NCT00770770|472062455|FG001|Overall Study|Death|1|||
131117808|NCT00770770|472062454|FG000|Overall Study|Study Terminated|8|||
131117809|NCT00770770|472062455|FG001|Overall Study|Study Terminated|0|||
131117810|NCT01230554|472062463|FG000|Overall Study|Lost to Follow-up|2|||
131117811|NCT01230554|472062463|FG000|Overall Study|Inability to maintain visit schedule|1|||
131117812|NCT00685685|472062464|FG000|Washout Period of 7 Days|Adverse Event|2|||
131117813|NCT00685685|472062465|FG001|Washout Period of 7 Days|Adverse Event|0|||
130697894|NCT04556734|470519086|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130697895|NCT04556734|470519087|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130697896|NCT04556734|470519088|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130697897|NCT04556734|470519089|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130697898|NCT04556734|470519090|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130697899|NCT04556734|470519091|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130913463|NCT01897714|471319845|FG001|Phase II (MTD)|Lost to Follow-up|0|||
130913464|NCT01897714|471319846|FG002|Phase II (MTD)|Lost to Follow-up|0|||
130913465|NCT01897714|471319847|FG003|Phase II (MTD)|Lost to Follow-up|0|||
131117814|NCT00685685|472062464|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
131117815|NCT00685685|472062465|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131117816|NCT02374021|472062466|FG000|Overall Study|Adverse Event|1|||
130769021|NCT01952080|470778682|FG001|Overall Study|Protocol Non-compliance|1|||
130913466|NCT01897714|471319848|FG004|Phase II (MTD)|Lost to Follow-up|1|||
130913467|NCT01897714|471319849|FG005|Phase II (MTD)|Lost to Follow-up|0|||
131117817|NCT02374021|472062467|FG001|Overall Study|Adverse Event|0|||
131117818|NCT02374021|472062466|FG000|Overall Study|Lost to Follow-up|3|||
131117819|NCT02374021|472062467|FG001|Overall Study|Lost to Follow-up|2|||
130913468|NCT01897714|471319844|FG000|Phase II (MTD)|Death|0|||
131117820|NCT02374021|472062466|FG000|Overall Study|Physician Decision|0|||
131117821|NCT02374021|472062467|FG001|Overall Study|Physician Decision|3|||
131117822|NCT02374021|472062466|FG000|Overall Study|Withdrawal by Subject|6|||
131117823|NCT02374021|472062467|FG001|Overall Study|Withdrawal by Subject|5|||
131117824|NCT02374021|472062466|FG000|Overall Study|Poor Adherence|0|||
131117825|NCT02374021|472062467|FG001|Overall Study|Poor Adherence|1|||
131117826|NCT02374021|472062466|FG000|Overall Study|Scan protocol not followed|0|||
131117827|NCT02374021|472062467|FG001|Overall Study|Scan protocol not followed|1|||
131117828|NCT02374021|472062466|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
131117829|NCT02374021|472062467|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
131117830|NCT00504153|472062468|FG000|Overall Study|Withdrawal by Subject|1|||
131117831|NCT00504153|472062468|FG000|Overall Study|Adverse Event|4|||
131117832|NCT00504153|472062468|FG000|Overall Study|Death|1|||
131117833|NCT02281357|472062472|FG000|Overall Study|Adverse Event|2|||
131117834|NCT02281357|472062473|FG001|Overall Study|Adverse Event|1|||
131117835|NCT02281357|472062472|FG000|Overall Study|Lost to Follow-up|1|||
131117836|NCT02281357|472062473|FG001|Overall Study|Lost to Follow-up|0|||
131117837|NCT02281357|472062472|FG000|Overall Study|Withdrawal by Subject|4|||
131117838|NCT02281357|472062473|FG001|Overall Study|Withdrawal by Subject|3|||
131117839|NCT03007979|472062476|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
131117840|NCT00972777|472062484|FG000|Overall Study|Adverse Event|3|||
131117841|NCT00972777|472062485|FG001|Overall Study|Adverse Event|2|||
131117842|NCT00972777|472062484|FG000|Overall Study|Lost to Follow-up|0|||
131117843|NCT00972777|472062485|FG001|Overall Study|Lost to Follow-up|4|||
131117844|NCT00972777|472062484|FG000|Overall Study|Withdrawal by Subject|4|||
131117845|NCT00972777|472062485|FG001|Overall Study|Withdrawal by Subject|5|||
130913469|NCT01897714|471319845|FG001|Phase II (MTD)|Death|0|||
130913470|NCT01897714|471319846|FG002|Phase II (MTD)|Death|0|||
130913471|NCT01897714|471319847|FG003|Phase II (MTD)|Death|0|||
130913472|NCT01897714|471319848|FG004|Phase II (MTD)|Death|25|||
130913473|NCT01897714|471319849|FG005|Phase II (MTD)|Death|10|||
130913474|NCT01897714|471319844|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
130913475|NCT01897714|471319845|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
130913476|NCT01897714|471319846|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
130913477|NCT01897714|471319847|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
130913478|NCT01897714|471319848|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
130913479|NCT01897714|471319849|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
131117846|NCT00972777|472062484|FG000|Overall Study|Physician Decision|4|||
131117847|NCT00972777|472062485|FG001|Overall Study|Physician Decision|0|||
131117848|NCT00972777|472062484|FG000|Overall Study|Protocol Violation|0|||
130697900|NCT04556734|470519084|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
130697901|NCT04556734|470519085|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697902|NCT04556734|470519086|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697903|NCT04556734|470519087|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697904|NCT04556734|470519088|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697905|NCT04556734|470519089|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697906|NCT04556734|470519090|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697907|NCT04556734|470519091|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130697908|NCT04556734|470519084|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697909|NCT04556734|470519085|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697910|NCT04556734|470519086|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
130697911|NCT04556734|470519087|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697912|NCT04556734|470519088|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697913|NCT04556734|470519089|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697914|NCT04556734|470519090|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697915|NCT04556734|470519091|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130697916|NCT04556734|470519084|FG000|OLE Period (28 Weeks)|Not reported|0|||
130697917|NCT04556734|470519085|FG001|OLE Period (28 Weeks)|Not reported|0|||
130697918|NCT04556734|470519086|FG002|OLE Period (28 Weeks)|Not reported|0|||
130697919|NCT04556734|470519087|FG003|OLE Period (28 Weeks)|Not reported|0|||
130697920|NCT04556734|470519088|FG004|OLE Period (28 Weeks)|Not reported|0|||
130697921|NCT04556734|470519089|FG005|OLE Period (28 Weeks)|Not reported|1|||
130697922|NCT04556734|470519090|FG006|OLE Period (28 Weeks)|Not reported|0|||
130697923|NCT04556734|470519091|FG007|OLE Period (28 Weeks)|Not reported|0|||
130913480|NCT01897714|471319844|FG000|Phase II (MTD)|Other|0|||
130913481|NCT01897714|471319845|FG001|Phase II (MTD)|Other|0|||
131117849|NCT00972777|472062485|FG001|Overall Study|Protocol Violation|2|||
131117850|NCT00972777|472062484|FG000|Overall Study|Screening Failure|2|||
131117851|NCT00972777|472062485|FG001|Overall Study|Screening Failure|1|||
131117852|NCT00972777|472062484|FG000|Overall Study|Missed visit|1|||
131117853|NCT00972777|472062485|FG001|Overall Study|Missed visit|0|||
130697924|NCT04556734|470519084|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697925|NCT04556734|470519085|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697926|NCT04556734|470519086|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697927|NCT04556734|470519087|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697928|NCT04556734|470519088|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
131117854|NCT01093326|472062486|FG000|Overall Study|Death|0|||
131117855|NCT01093326|472062487|FG001|Overall Study|Death|1|||
131117856|NCT01093326|472062488|FG002|Overall Study|Death|0|||
130697929|NCT04556734|470519089|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697930|NCT04556734|470519090|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130697931|NCT04556734|470519091|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
130697932|NCT04556734|470519084|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
130697933|NCT04556734|470519085|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
130697934|NCT04556734|470519086|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
130697935|NCT04556734|470519087|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
130697936|NCT04556734|470519088|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
130697937|NCT04556734|470519089|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
130697938|NCT04556734|470519090|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
130697939|NCT04556734|470519091|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
130697940|NCT04556734|470519084|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130697941|NCT04556734|470519085|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130697942|NCT04556734|470519086|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130697943|NCT04556734|470519087|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
130697944|NCT04556734|470519088|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
130697945|NCT04556734|470519089|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
130697946|NCT04556734|470519090|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
130697947|NCT04556734|470519091|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130697948|NCT01120899|470519094|FG000|Overall Study|Withdrawal by Subject|3|||
130697949|NCT00820599|470519095|FG000|Overall Study|Death|129|||
130697950|NCT00820599|470519095|FG000|Overall Study|Withdrawal by Subject|2|||
130697951|NCT00202839|470519096|FG000|Overall Study|Adverse Event|1|||
130697952|NCT00202839|470519097|FG001|Overall Study|Adverse Event|5|||
130913482|NCT01897714|471319846|FG002|Phase II (MTD)|Other|0|||
130913483|NCT01897714|471319847|FG003|Phase II (MTD)|Other|0|||
131032386|NCT01785719|471751439|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
131032387|NCT01785719|471751440|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
131032388|NCT01785719|471751439|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
131032389|NCT01785719|471751440|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
131032390|NCT01785719|471751439|FG000|4-week Baseline Evaluation|Pregnancy|0|||
131032391|NCT01785719|471751440|FG001|4-week Baseline Evaluation|Pregnancy|2|||
131032392|NCT01785719|471751439|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
131032393|NCT01785719|471751440|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
131032394|NCT01785719|471751439|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
131032395|NCT01785719|471751440|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
131032396|NCT01785719|471751439|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
131032397|NCT01785719|471751440|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
131032398|NCT01785719|471751439|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
131032399|NCT01785719|471751440|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
131032400|NCT01785719|471751439|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
131032401|NCT01785719|471751440|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
131032402|NCT01785719|471751439|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
131032403|NCT01785719|471751440|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
131032404|NCT01785719|471751439|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
131032405|NCT01785719|471751440|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
131032406|NCT01785719|471751439|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
131032407|NCT01785719|471751440|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
131032408|NCT01785719|471751439|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
131032409|NCT01785719|471751440|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
131032410|NCT01785719|471751439|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
131032411|NCT01785719|471751440|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
131032412|NCT01785719|471751439|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
131032413|NCT01785719|471751440|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
131032414|NCT03443323|471751441|FG000|Overall Study|Lost to Follow-up|2|||
131032415|NCT03443323|471751442|FG001|Overall Study|Lost to Follow-up|2|||
131032416|NCT03443323|471751441|FG000|Overall Study|PI withdrawal|1|||
131032417|NCT03443323|471751442|FG001|Overall Study|PI withdrawal|0|||
131032418|NCT04610892|471751450|FG000|Overall Study|Adverse Event|1|||
131032419|NCT04610892|471751451|FG001|Overall Study|Adverse Event|0|||
131032420|NCT04610892|471751452|FG002|Overall Study|Adverse Event|0|||
131032421|NCT04610892|471751453|FG003|Overall Study|Adverse Event|1|||
131032422|NCT04610892|471751454|FG004|Overall Study|Adverse Event|3|||
131032423|NCT04610892|471751450|FG000|Overall Study|Death|0|||
131032424|NCT04610892|471751451|FG001|Overall Study|Death|1|||
131032425|NCT04610892|471751452|FG002|Overall Study|Death|0|||
131032426|NCT04610892|471751453|FG003|Overall Study|Death|1|||
131032427|NCT04610892|471751454|FG004|Overall Study|Death|0|||
131117857|NCT01093326|472062486|FG000|Overall Study|Lack of Efficacy|7|||
131117858|NCT01093326|472062487|FG001|Overall Study|Lack of Efficacy|6|||
131117859|NCT01093326|472062488|FG002|Overall Study|Lack of Efficacy|3|||
131117860|NCT01093326|472062486|FG000|Overall Study|Lost to Follow-up|2|||
131117861|NCT01093326|472062487|FG001|Overall Study|Lost to Follow-up|5|||
131117862|NCT01093326|472062488|FG002|Overall Study|Lost to Follow-up|4|||
131117863|NCT01093326|472062486|FG000|Overall Study|Physician Decision|3|||
131117864|NCT01093326|472062487|FG001|Overall Study|Physician Decision|1|||
131117865|NCT01093326|472062488|FG002|Overall Study|Physician Decision|3|||
131117866|NCT01093326|472062486|FG000|Overall Study|Withdrawal by Subject|30|||
131117867|NCT01093326|472062487|FG001|Overall Study|Withdrawal by Subject|27|||
131117868|NCT01093326|472062488|FG002|Overall Study|Withdrawal by Subject|26|||
131117869|NCT01093326|472062486|FG000|Overall Study|Adverse Event|2|||
131117870|NCT01093326|472062487|FG001|Overall Study|Adverse Event|1|||
131117871|NCT01093326|472062488|FG002|Overall Study|Adverse Event|4|||
131117872|NCT01093326|472062486|FG000|Overall Study|Other|0|||
131117873|NCT01093326|472062487|FG001|Overall Study|Other|0|||
131117874|NCT01093326|472062488|FG002|Overall Study|Other|1|||
131117875|NCT04263896|472062489|FG000|Overall Study|Withdrawal by Subject|2|||
131117876|NCT04263896|472062490|FG001|Overall Study|Withdrawal by Subject|4|||
131117877|NCT04263896|472062489|FG000|Overall Study|converted to open procedure|0|||
131117878|NCT04263896|472062490|FG001|Overall Study|converted to open procedure|1|||
131117879|NCT04263896|472062489|FG000|Overall Study|Lost to Follow-up|9|||
131117880|NCT04263896|472062490|FG001|Overall Study|Lost to Follow-up|11|||
131117881|NCT04263896|472062489|FG000|Overall Study|surveys lost in mail|5|||
131117882|NCT04263896|472062490|FG001|Overall Study|surveys lost in mail|3|||
131117883|NCT04263896|472062489|FG000|Overall Study|excluded from analysis|1|||
131117884|NCT04263896|472062490|FG001|Overall Study|excluded from analysis|0|||
131117885|NCT05586269|472064044|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
130697953|NCT00202839|470519096|FG000|Overall Study|Physician Decision|12|||
130697954|NCT00202839|470519097|FG001|Overall Study|Physician Decision|0|||
130697955|NCT00202839|470519096|FG000|Overall Study|Withdrawal by Subject|6|||
131117886|NCT05586269|472064045|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
131117887|NCT05586269|472064046|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
131117888|NCT05586269|472064047|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
131117889|NCT05586269|472064044|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
131117890|NCT05586269|472064045|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
131117891|NCT05586269|472064046|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
131117892|NCT05586269|472064047|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
131117893|NCT00088907|472064049|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
130697956|NCT00202839|470519097|FG001|Overall Study|Withdrawal by Subject|2|||
130697957|NCT00202839|470519096|FG000|Overall Study|Protocol Violation|2|||
130697958|NCT00202839|470519097|FG001|Overall Study|Protocol Violation|1|||
130697959|NCT00202839|470519096|FG000|Overall Study|Lost to Follow-up|3|||
130697960|NCT00202839|470519097|FG001|Overall Study|Lost to Follow-up|2|||
130697961|NCT00442351|470519098|FG000|Overall Study|Administrative|6|||
130697962|NCT00442351|470519099|FG001|Overall Study|Administrative|5|||
130697963|NCT00442351|470519098|FG000|Overall Study|Did not meet protocol eligibility|1|||
130697964|NCT00442351|470519099|FG001|Overall Study|Did not meet protocol eligibility|0|||
130697965|NCT00442351|470519098|FG000|Overall Study|Other|0|||
130697966|NCT00442351|470519099|FG001|Overall Study|Other|1|||
130697967|NCT00544167|470519103|FG000|Overall Study|Adverse Event|21|||
130697968|NCT00544167|470519103|FG000|Overall Study|Physician Decision|8|||
130697969|NCT04281472|470519108|FG000|Stage A|Lack of Efficacy|8|||
130697970|NCT04281472|470519109|FG001|Stage A|Lack of Efficacy|0|||
130697971|NCT04281472|470519110|FG002|Stage A|Lack of Efficacy|0|||
130697972|NCT04281472|470519108|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
130697973|NCT04281472|470519109|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
130697974|NCT04281472|470519110|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
130697975|NCT04281472|470519108|FG000|Stage A|Adverse Event|20|||
130697976|NCT04281472|470519109|FG001|Stage A|Adverse Event|0|||
130697977|NCT04281472|470519110|FG002|Stage A|Adverse Event|0|||
130697978|NCT04281472|470519108|FG000|Stage A|Death|1|||
130697979|NCT04281472|470519109|FG001|Stage A|Death|0|||
130697980|NCT04281472|470519110|FG002|Stage A|Death|0|||
130697981|NCT04281472|470519108|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
130697982|NCT04281472|470519109|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
130697983|NCT04281472|470519110|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
130697984|NCT04281472|470519108|FG000|Stage A|Lost to Follow-up|2|||
130697985|NCT04281472|470519109|FG001|Stage A|Lost to Follow-up|0|||
130697986|NCT04281472|470519110|FG002|Stage A|Lost to Follow-up|0|||
130697987|NCT04281472|470519108|FG000|Stage A|Non-compliance with study drug|1|||
131117894|NCT00088907|472064050|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
131117895|NCT00088907|472064049|FG000|Randomized Study (Step 1)|Adverse Event|14|||
131117896|NCT00088907|472064050|FG001|Randomized Study (Step 1)|Adverse Event|19|||
131117897|NCT00088907|472064049|FG000|Randomized Study (Step 1)|Death|11|||
131117898|NCT00088907|472064050|FG001|Randomized Study (Step 1)|Death|12|||
131117899|NCT00088907|472064049|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
131117900|NCT00088907|472064050|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
131117901|NCT00088907|472064049|FG000|Randomized Study (Step 1)|complicating disease|3|||
131117902|NCT00088907|472064050|FG001|Randomized Study (Step 1)|complicating disease|1|||
131117903|NCT00088907|472064049|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
131117904|NCT00088907|472064050|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
131117905|NCT00088907|472064049|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
131117906|NCT00088907|472064050|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
131117907|NCT00088907|472064049|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
131117908|NCT00088907|472064050|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
130697988|NCT04281472|470519109|FG001|Stage A|Non-compliance with study drug|0|||
131117909|NCT00088907|472064049|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
131117910|NCT00088907|472064050|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
131117911|NCT00088907|472064049|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
131117912|NCT00088907|472064050|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
130697989|NCT04281472|470519110|FG002|Stage A|Non-compliance with study drug|0|||
130697990|NCT04281472|470519108|FG000|Stage A|Physician Decision|1|||
130697991|NCT04281472|470519109|FG001|Stage A|Physician Decision|0|||
130697992|NCT04281472|470519110|FG002|Stage A|Physician Decision|0|||
130697993|NCT04281472|470519108|FG000|Stage A|Prohibited medications|2|||
130697994|NCT04281472|470519109|FG001|Stage A|Prohibited medications|0|||
130697995|NCT04281472|470519110|FG002|Stage A|Prohibited medications|0|||
130697996|NCT04281472|470519108|FG000|Stage A|Withdrawal by Subject|11|||
130697997|NCT04281472|470519109|FG001|Stage A|Withdrawal by Subject|0|||
130697998|NCT04281472|470519110|FG002|Stage A|Withdrawal by Subject|0|||
130697999|NCT04281472|470519108|FG000|Stage A|Other|5|||
130698000|NCT04281472|470519109|FG001|Stage A|Other|0|||
130698001|NCT04281472|470519110|FG002|Stage A|Other|0|||
130698002|NCT04281472|470519108|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
130698003|NCT04281472|470519109|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
130698004|NCT04281472|470519110|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
130698005|NCT04281472|470519108|FG000|Stage B|Adverse Event|0|||
130698006|NCT04281472|470519109|FG001|Stage B|Adverse Event|3|||
130698007|NCT04281472|470519110|FG002|Stage B|Adverse Event|0|||
130698008|NCT04281472|470519108|FG000|Stage B|Death|0|||
130698009|NCT04281472|470519109|FG001|Stage B|Death|0|||
130698010|NCT04281472|470519110|FG002|Stage B|Death|1|||
130698011|NCT04281472|470519108|FG000|Stage B|Lack of Efficacy|0|||
130698012|NCT04281472|470519109|FG001|Stage B|Lack of Efficacy|0|||
130698013|NCT04281472|470519110|FG002|Stage B|Lack of Efficacy|1|||
130698014|NCT04281472|470519108|FG000|Stage B|Lost to Follow-up|0|||
130698015|NCT04281472|470519109|FG001|Stage B|Lost to Follow-up|0|||
130698016|NCT04281472|470519110|FG002|Stage B|Lost to Follow-up|2|||
130698017|NCT04281472|470519108|FG000|Stage B|Prohibited medications|0|||
130698018|NCT04281472|470519109|FG001|Stage B|Prohibited medications|2|||
130698019|NCT04281472|470519110|FG002|Stage B|Prohibited medications|1|||
130698020|NCT04281472|470519108|FG000|Stage B|Protocol Violation|0|||
130698021|NCT04281472|470519109|FG001|Stage B|Protocol Violation|1|||
130698022|NCT04281472|470519110|FG002|Stage B|Protocol Violation|1|||
130698023|NCT04281472|470519108|FG000|Stage B|Sponsor decision|0|||
130698024|NCT04281472|470519109|FG001|Stage B|Sponsor decision|0|||
130698025|NCT04281472|470519110|FG002|Stage B|Sponsor decision|1|||
130698026|NCT04281472|470519108|FG000|Stage B|Withdrawal by Subject|0|||
130698027|NCT04281472|470519109|FG001|Stage B|Withdrawal by Subject|3|||
130698028|NCT04281472|470519110|FG002|Stage B|Withdrawal by Subject|3|||
130698029|NCT04281472|470519108|FG000|Stage B|Other|0|||
130698030|NCT04281472|470519109|FG001|Stage B|Other|3|||
130698031|NCT04281472|470519110|FG002|Stage B|Other|0|||
130698032|NCT00152451|470519111|FG000|Overall Study|Adverse Event|4|||
130698033|NCT01055834|470519118|FG000|Treatment Period I|Adverse Event|1|||
130698034|NCT01055834|470519119|FG001|Treatment Period I|Adverse Event|0|||
130698035|NCT05004649|470519120|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
130698036|NCT05004649|470519120|FG000|Overall Study|Lost to Follow-up|1|||
130698037|NCT05004649|470519120|FG000|Overall Study|Withdrawal by Subject|2|||
130698038|NCT05004649|470519120|FG000|Overall Study|COVID-19|1|||
131117913|NCT00088907|472064049|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
131117914|NCT00088907|472064050|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
131117915|NCT03426787|472064055|FG000|Overall Study|Withdrawal by Subject|6|||
130698039|NCT01717313|470519121|FG000|Phase A (Weeks 0 to 24)|Death|0|||
130698040|NCT01717313|470519122|FG001|Phase A (Weeks 0 to 24)|Death|1|||
130698041|NCT01717313|470519121|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
130698042|NCT01717313|470519122|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
130698043|NCT01717313|470519121|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
130698044|NCT01717313|470519122|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
131117916|NCT03426787|472064055|FG000|Overall Study|Lost to Follow-up|7|||
130698045|NCT01717313|470519121|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
130698046|NCT01717313|470519122|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
130698047|NCT01717313|470519121|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
130698048|NCT01717313|470519122|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
130698049|NCT01717313|470519121|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
131117917|NCT03426787|472064055|FG000|Overall Study|Unrelated to intervention death|1|||
131117918|NCT02592551|472064056|FG000|Overall Study|Not evaluable|1|||
131117919|NCT02592551|472064057|FG001|Overall Study|Not evaluable|3|||
131117920|NCT02592551|472064058|FG002|Overall Study|Not evaluable|0|||
131117921|NCT02020863|472064059|FG000|Overall Study|Discovery of Metastatic disease|4|||
131117922|NCT02020863|472064059|FG000|Overall Study|Team chose not to place an a line|1|||
131117923|NCT00907257|472064060|FG000|Overall Study|Adverse Event|0|||
131117924|NCT00907257|472064061|FG001|Overall Study|Adverse Event|4|||
130698050|NCT01717313|470519122|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
130698051|NCT01717313|470519121|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
130698052|NCT01717313|470519122|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
130698053|NCT01717313|470519121|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
130698054|NCT01717313|470519122|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
130698055|NCT01717313|470519121|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
130698056|NCT01717313|470519122|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
130698057|NCT00728754|470519123|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
130698058|NCT00728754|470519124|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
130698059|NCT00728754|470519123|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
130698060|NCT00728754|470519124|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
130698061|NCT00728754|470519123|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
130698062|NCT00728754|470519124|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
130698063|NCT00009945|470519125|FG000|Overall Study|no follow up data|7|||
130698064|NCT00009945|470519126|FG001|Overall Study|no follow up data|5|||
130698065|NCT02654145|470519127|FG000|Overall Study|Lack of Efficacy|1|||
130698066|NCT02654145|470519127|FG000|Overall Study|Protocol Violation|1|||
130698067|NCT02654145|470519127|FG000|Overall Study|Withdrawal by Subject|5|||
130698068|NCT01943435|470519135|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
130698069|NCT01943435|470519136|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
130698070|NCT01943435|470519137|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
130698071|NCT01943435|470519135|FG000|Intervention Period|Withdrawal by Subject|3|||
130698072|NCT01943435|470519136|FG001|Intervention Period|Withdrawal by Subject|3|||
130698073|NCT01943435|470519137|FG002|Intervention Period|Withdrawal by Subject|4|||
130698074|NCT01943435|470519135|FG000|2 Month Follow up|Lost to Follow-up|2|||
130698075|NCT01943435|470519136|FG001|2 Month Follow up|Lost to Follow-up|3|||
130698076|NCT01943435|470519137|FG002|2 Month Follow up|Lost to Follow-up|0|||
130698077|NCT01943435|470519135|FG000|6 Month Follow up|Lost to Follow-up|12|||
130698078|NCT01943435|470519136|FG001|6 Month Follow up|Lost to Follow-up|7|||
130698079|NCT01943435|470519137|FG002|6 Month Follow up|Lost to Follow-up|15|||
130698080|NCT00295490|470519138|FG000|Overall Study|Protocol Violation|0|||
130698081|NCT00295490|470519139|FG001|Overall Study|Protocol Violation|0|||
130698082|NCT00295490|470519140|FG002|Overall Study|Protocol Violation|3|||
130698083|NCT00295490|470519141|FG003|Overall Study|Protocol Violation|3|||
130698084|NCT00295490|470519138|FG000|Overall Study|Withdrawal by Subject|0|||
130698085|NCT00295490|470519139|FG001|Overall Study|Withdrawal by Subject|2|||
130698086|NCT00295490|470519140|FG002|Overall Study|Withdrawal by Subject|0|||
130698087|NCT00295490|470519141|FG003|Overall Study|Withdrawal by Subject|1|||
130698088|NCT00295490|470519138|FG000|Overall Study|Lost to Follow-up|0|||
130698089|NCT00295490|470519139|FG001|Overall Study|Lost to Follow-up|0|||
130698090|NCT00295490|470519140|FG002|Overall Study|Lost to Follow-up|1|||
130698091|NCT00295490|470519141|FG003|Overall Study|Lost to Follow-up|0|||
130698092|NCT00295490|470519138|FG000|Overall Study|Adverse Event|1|||
130698093|NCT00295490|470519139|FG001|Overall Study|Adverse Event|0|||
130698094|NCT00295490|470519140|FG002|Overall Study|Adverse Event|0|||
130698095|NCT00295490|470519141|FG003|Overall Study|Adverse Event|0|||
130698096|NCT00295490|470519138|FG000|Overall Study|Other|0|||
130698097|NCT00295490|470519139|FG001|Overall Study|Other|2|||
130698098|NCT00295490|470519140|FG002|Overall Study|Other|0|||
130698099|NCT00295490|470519141|FG003|Overall Study|Other|1|||
130698100|NCT01617096|470519142|FG000|Overall Study|Withdrawal by Subject|96|||
130698101|NCT01617096|470519143|FG001|Overall Study|Withdrawal by Subject|81|||
130698102|NCT01617096|470519142|FG000|Overall Study|Lost to Follow-up|37|||
130698103|NCT01617096|470519143|FG001|Overall Study|Lost to Follow-up|32|||
130698104|NCT01617096|470519142|FG000|Overall Study|Physician Decision|10|||
130698105|NCT01617096|470519143|FG001|Overall Study|Physician Decision|18|||
130698106|NCT01617096|470519142|FG000|Overall Study|Death|4|||
130698107|NCT01617096|470519143|FG001|Overall Study|Death|3|||
130698108|NCT01617096|470519142|FG000|Overall Study|Other|1|||
130698109|NCT01617096|470519143|FG001|Overall Study|Other|3|||
130698110|NCT01196390|470519146|FG000|Overall Study|Protocol Violation|4|||
130698111|NCT01196390|470519147|FG001|Overall Study|Protocol Violation|5|||
130698112|NCT04610580|470519148|FG000|Two-way Crossover Period|Adverse Event|1|||
130698113|NCT04610580|470519149|FG001|Two-way Crossover Period|Adverse Event|0|||
130698114|NCT04610580|470519150|FG002|Two-way Crossover Period|Adverse Event|0|||
130698115|NCT04610580|470519151|FG003|Two-way Crossover Period|Adverse Event|0|||
130698116|NCT04610580|470519152|FG004|Two-way Crossover Period|Adverse Event|0|||
130698117|NCT04610580|470519153|FG005|Two-way Crossover Period|Adverse Event|0|||
131117925|NCT00907257|472064060|FG000|Overall Study|Protocol Violation|1|||
131117926|NCT00907257|472064061|FG001|Overall Study|Protocol Violation|2|||
131117927|NCT00907257|472064060|FG000|Overall Study|Lost to Follow-up|3|||
131117928|NCT00907257|472064061|FG001|Overall Study|Lost to Follow-up|3|||
131117929|NCT00907257|472064060|FG000|Overall Study|Withdrawal by Subject|1|||
131117930|NCT00907257|472064061|FG001|Overall Study|Withdrawal by Subject|2|||
131117931|NCT00907257|472064060|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
131117932|NCT00907257|472064061|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
131117933|NCT00907257|472064060|FG000|Overall Study|Moved|1|||
131117934|NCT00907257|472064061|FG001|Overall Study|Moved|0|||
131117935|NCT00907257|472064060|FG000|Overall Study|Personal Reasons|6|||
131117936|NCT00907257|472064061|FG001|Overall Study|Personal Reasons|1|||
131117937|NCT00283049|472064062|FG000|Overall Study|Adverse Event|6|||
131117938|NCT00283049|472064063|FG001|Overall Study|Adverse Event|1|||
131117939|NCT00283049|472064064|FG002|Overall Study|Adverse Event|4|||
131117940|NCT00283049|472064062|FG000|Overall Study|Protocol Violation|3|||
131117941|NCT00283049|472064063|FG001|Overall Study|Protocol Violation|0|||
131117942|NCT00283049|472064064|FG002|Overall Study|Protocol Violation|3|||
131117943|NCT00283049|472064062|FG000|Overall Study|Death|1|||
131117944|NCT00283049|472064063|FG001|Overall Study|Death|1|||
131117945|NCT00283049|472064064|FG002|Overall Study|Death|1|||
131117946|NCT00283049|472064062|FG000|Overall Study|Lack of Efficacy|0|||
131117947|NCT00283049|472064063|FG001|Overall Study|Lack of Efficacy|1|||
131117948|NCT00283049|472064064|FG002|Overall Study|Lack of Efficacy|1|||
131117949|NCT00283049|472064062|FG000|Overall Study|Lost to Follow-up|4|||
131117950|NCT00283049|472064063|FG001|Overall Study|Lost to Follow-up|2|||
131117951|NCT00283049|472064064|FG002|Overall Study|Lost to Follow-up|5|||
131117952|NCT00283049|472064062|FG000|Overall Study|Withdrawal by Subject|26|||
131117953|NCT00283049|472064063|FG001|Overall Study|Withdrawal by Subject|24|||
131117954|NCT00283049|472064064|FG002|Overall Study|Withdrawal by Subject|19|||
131117955|NCT00283049|472064062|FG000|Overall Study|Discontinuation of Study|18|||
131117956|NCT00283049|472064063|FG001|Overall Study|Discontinuation of Study|16|||
130698118|NCT04610580|470519148|FG000|Two-way Crossover Period|Physician Decision|1|||
130698119|NCT04610580|470519149|FG001|Two-way Crossover Period|Physician Decision|0|||
130698120|NCT04610580|470519150|FG002|Two-way Crossover Period|Physician Decision|0|||
130698121|NCT04610580|470519151|FG003|Two-way Crossover Period|Physician Decision|0|||
130698122|NCT04610580|470519152|FG004|Two-way Crossover Period|Physician Decision|0|||
130698123|NCT04610580|470519153|FG005|Two-way Crossover Period|Physician Decision|0|||
130698124|NCT04610580|470519148|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
130698125|NCT04610580|470519149|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
130698126|NCT04610580|470519150|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
130698127|NCT04610580|470519151|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
130698128|NCT04610580|470519152|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
130698129|NCT04610580|470519153|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
130698130|NCT04610580|470519148|FG000|Two-way Crossover Period|Other than specified|0|||
130698131|NCT04610580|470519149|FG001|Two-way Crossover Period|Other than specified|1|||
130698132|NCT04610580|470519150|FG002|Two-way Crossover Period|Other than specified|0|||
130698133|NCT04610580|470519151|FG003|Two-way Crossover Period|Other than specified|0|||
130698134|NCT04610580|470519152|FG004|Two-way Crossover Period|Other than specified|0|||
130698135|NCT04610580|470519153|FG005|Two-way Crossover Period|Other than specified|0|||
130698136|NCT04610580|470519148|FG000|Washout Before Extension Period|Other than specified|0|||
130698137|NCT04610580|470519149|FG001|Washout Before Extension Period|Other than specified|1|||
130698138|NCT04610580|470519150|FG002|Washout Before Extension Period|Other than specified|0|||
130698139|NCT04610580|470519151|FG003|Washout Before Extension Period|Other than specified|0|||
130698140|NCT04610580|470519152|FG004|Washout Before Extension Period|Other than specified|0|||
130698141|NCT04610580|470519153|FG005|Washout Before Extension Period|Other than specified|0|||
130698142|NCT04610580|470519148|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
130698143|NCT04610580|470519149|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
131117957|NCT00283049|472064064|FG002|Overall Study|Discontinuation of Study|20|||
131117958|NCT00283049|472064062|FG000|Overall Study|No longer requires study treatment|0|||
131117959|NCT00283049|472064063|FG001|Overall Study|No longer requires study treatment|0|||
131117960|NCT00283049|472064064|FG002|Overall Study|No longer requires study treatment|1|||
131117961|NCT01086410|472064065|FG000|Overall Study|Adverse Event|1|||
131117962|NCT01086410|472064066|FG001|Overall Study|Adverse Event|0|||
131117963|NCT01086410|472064067|FG002|Overall Study|Adverse Event|0|||
131117964|NCT01086410|472064068|FG003|Overall Study|Adverse Event|2|||
130698144|NCT04610580|470519150|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
130698145|NCT04610580|470519151|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
130698146|NCT04610580|470519152|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
130698147|NCT04610580|470519153|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
130698148|NCT04610580|470519148|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
131117965|NCT01086410|472064065|FG000|Overall Study|Lack of Efficacy|1|||
131117966|NCT01086410|472064066|FG001|Overall Study|Lack of Efficacy|1|||
131117967|NCT01086410|472064067|FG002|Overall Study|Lack of Efficacy|0|||
131117968|NCT01086410|472064068|FG003|Overall Study|Lack of Efficacy|0|||
131117969|NCT01086410|472064065|FG000|Overall Study|Protocol Violation|1|||
131117970|NCT01086410|472064066|FG001|Overall Study|Protocol Violation|1|||
130698149|NCT04610580|470519149|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130698150|NCT04610580|470519150|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130698151|NCT04610580|470519151|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130698152|NCT04610580|470519152|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
130698153|NCT04610580|470519153|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130698154|NCT01097694|470519154|FG000|Overall Study|Adverse Event|5|||
130698155|NCT01097694|470519155|FG001|Overall Study|Adverse Event|0|||
130698156|NCT01097694|470519154|FG000|Overall Study|Lost to Follow-up|0|||
130698157|NCT01097694|470519155|FG001|Overall Study|Lost to Follow-up|3|||
130698158|NCT01097694|470519154|FG000|Overall Study|Withdrawal by Subject|3|||
130698159|NCT01097694|470519155|FG001|Overall Study|Withdrawal by Subject|1|||
130698160|NCT02179190|470519156|FG000|Enrollment|Exit Prior to Device Attempt|11|||
130698161|NCT02179190|470519156|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
130698162|NCT02179190|470519156|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
130698163|NCT02179190|470519156|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
130698164|NCT02179190|470519156|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
130698165|NCT02179190|470519156|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
130698166|NCT02377349|470519157|FG000|Overall Study|Serious Adverse Event|1|||
130698167|NCT02377349|470519158|FG001|Overall Study|Serious Adverse Event|0|||
130698168|NCT02377349|470519157|FG000|Overall Study|Protocol Violation|3|||
130698169|NCT02377349|470519158|FG001|Overall Study|Protocol Violation|2|||
130698170|NCT02377349|470519157|FG000|Overall Study|Withdrawal by Subject|5|||
130698171|NCT02377349|470519158|FG001|Overall Study|Withdrawal by Subject|3|||
130698172|NCT02377349|470519157|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
130698173|NCT02377349|470519158|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
130698174|NCT02377349|470519157|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
130698175|NCT02377349|470519158|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
130698176|NCT02377349|470519157|FG000|Overall Study|Other|0|||
130698177|NCT02377349|470519158|FG001|Overall Study|Other|1|||
130698178|NCT01993940|470519161|FG000|Overall Study|Adverse Event|16|||
130698179|NCT01993940|470519162|FG001|Overall Study|Adverse Event|11|||
130698180|NCT01993940|470519161|FG000|Overall Study|Withdrawal by Subject|15|||
130698181|NCT01993940|470519162|FG001|Overall Study|Withdrawal by Subject|19|||
130698182|NCT01993940|470519161|FG000|Overall Study|Lost to Follow-up|2|||
130698183|NCT01993940|470519162|FG001|Overall Study|Lost to Follow-up|5|||
130698184|NCT01993940|470519161|FG000|Overall Study|Protocol Violation|5|||
130769022|NCT01952080|470778683|FG002|Overall Study|Protocol Non-compliance|0|||
130769023|NCT01952080|470778684|FG003|Overall Study|Protocol Non-compliance|0|||
130769024|NCT00564395|470778685|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
130769025|NCT00564395|470778686|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
130769026|NCT00564395|470778685|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
130769027|NCT00564395|470778686|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
130769028|NCT00594386|470778687|FG000|Overall Study|Major protocol violation|2|||
130769029|NCT00594386|470778687|FG000|Overall Study|Lack of Efficacy|12|||
130769030|NCT00594386|470778687|FG000|Overall Study|Adverse Event|68|||
130769031|NCT00594386|470778687|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
130769032|NCT00594386|470778687|FG000|Overall Study|Subject withdrew consent|35|||
130769033|NCT00594386|470778687|FG000|Overall Study|Study ended per sponsor|115|||
130769034|NCT00594386|470778687|FG000|Overall Study|Lost to Follow-up|6|||
130769035|NCT00594386|470778687|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
130769036|NCT00594386|470778687|FG000|Overall Study|Other: Subject moved to Seattle|1|||
130769037|NCT00594386|470778687|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
130769038|NCT00594386|470778687|FG000|Overall Study|Other: Study terminated per investigator|2|||
130769039|NCT00594386|470778687|FG000|Overall Study|Other: Sponsor closure of study|1|||
130769040|NCT00594386|470778687|FG000|Overall Study|Other: Site terminated participation|1|||
130769041|NCT00594386|470778687|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
130769042|NCT00594386|470778687|FG000|Overall Study|Other: Loss of drivers license|1|||
130769043|NCT00094536|470778688|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
131117971|NCT01086410|472064067|FG002|Overall Study|Protocol Violation|0|||
131117972|NCT01086410|472064068|FG003|Overall Study|Protocol Violation|0|||
130698185|NCT01993940|470519162|FG001|Overall Study|Protocol Violation|8|||
130698186|NCT01993940|470519161|FG000|Overall Study|Death|1|||
130698187|NCT01993940|470519162|FG001|Overall Study|Death|0|||
130698188|NCT01993940|470519161|FG000|Overall Study|Other - Miscellaneous|1|||
130698189|NCT01993940|470519162|FG001|Overall Study|Other - Miscellaneous|1|||
130698190|NCT03259165|470519163|FG000|Overall Study|COVID 19 pandemic|1|||
130698191|NCT03259165|470519164|FG001|Overall Study|COVID 19 pandemic|1|||
130698192|NCT01949532|470519165|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
130698193|NCT01949532|470519166|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
130698194|NCT00939523|470519171|FG000|Overall Study|Lack of Efficacy|1|||
130698195|NCT00939523|470519171|FG000|Overall Study|Physician Decision|2|||
130698196|NCT00024258|470519172|FG000|Overall Study|Withdrawal by Subject|1|||
130698197|NCT00024258|470519172|FG000|Overall Study|Disease Progression|8|||
130698198|NCT01050764|470519173|FG000|Overall Study|Death, before HSCT|1|||
130698199|NCT01050764|470519173|FG000|Overall Study|Donor mobilization failure, death|1|||
130698200|NCT01050764|470519173|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
130698201|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Adverse Event|8|||
130698202|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Adverse Event|5|||
130698203|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Adverse Event|9|||
130698204|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Adverse Event|0|||
130698205|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Adverse Event|0|||
130698206|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Adverse Event|0|||
130698207|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
130698208|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
130698209|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
130698210|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
130698211|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
130698212|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
130698213|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
130698214|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
130698215|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
130698216|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
130698217|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
130698218|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
130698219|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Physician Decision|4|||
130698220|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Physician Decision|0|||
130698221|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Physician Decision|2|||
130698222|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Physician Decision|0|||
130698223|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Physician Decision|0|||
130698224|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Physician Decision|0|||
130698225|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Pregnancy|1|||
130698226|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Pregnancy|2|||
130698227|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Pregnancy|0|||
130698228|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Pregnancy|0|||
130698229|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Pregnancy|0|||
130698230|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Pregnancy|0|||
130698231|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
130698232|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
130698233|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
130698234|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
130698235|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
130698236|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
130698237|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
130698238|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
130698239|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
130698240|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
130698241|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
130698242|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
130698243|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
130698244|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
130698245|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
130698246|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
130698247|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130698248|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130698249|NCT02614196|470519176|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
130698250|NCT02614196|470519177|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
130698251|NCT02614196|470519178|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
130698252|NCT02614196|470519179|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
130698253|NCT02614196|470519180|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
131032428|NCT04610892|471751450|FG000|Overall Study|Withdrawal by Subject|3|||
131032429|NCT04610892|471751451|FG001|Overall Study|Withdrawal by Subject|2|||
131032430|NCT04610892|471751452|FG002|Overall Study|Withdrawal by Subject|0|||
131032431|NCT04610892|471751453|FG003|Overall Study|Withdrawal by Subject|6|||
130698254|NCT02614196|470519181|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
130769044|NCT00094536|470778688|FG000|Treatment and Follow-up|Adverse Event|4|||
130698255|NCT02614196|470519176|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
130769045|NCT00094536|470778688|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
130698256|NCT02614196|470519177|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
130698257|NCT02614196|470519178|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
130698258|NCT02614196|470519179|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
131032432|NCT04610892|471751454|FG004|Overall Study|Withdrawal by Subject|6|||
131032433|NCT04610892|471751450|FG000|Overall Study|Subjects who did not receive treatment|1|||
131032434|NCT04610892|471751451|FG001|Overall Study|Subjects who did not receive treatment|0|||
131032435|NCT04610892|471751452|FG002|Overall Study|Subjects who did not receive treatment|0|||
131032436|NCT04610892|471751453|FG003|Overall Study|Subjects who did not receive treatment|0|||
131032437|NCT04610892|471751454|FG004|Overall Study|Subjects who did not receive treatment|2|||
131032438|NCT05520190|471751455|FG000|Overall Study|Lost to Follow-up|7|||
131032439|NCT05520190|471751455|FG000|Overall Study|Withdrawal by Subject|2|||
131032440|NCT01999075|471751456|FG000|Overall Study|Lost to Follow-up|0|||
131032441|NCT01999075|471751457|FG001|Overall Study|Lost to Follow-up|2|||
131032442|NCT01999075|471751456|FG000|Overall Study|Withdrawal by Subject|2|||
131032443|NCT01999075|471751457|FG001|Overall Study|Withdrawal by Subject|7|||
131032444|NCT01999075|471751456|FG000|Overall Study|Enrolled in drug trial|3|||
131032445|NCT01999075|471751457|FG001|Overall Study|Enrolled in drug trial|1|||
131032446|NCT01999075|471751456|FG000|Overall Study|Became ineligible|0|||
131032447|NCT01999075|471751457|FG001|Overall Study|Became ineligible|2|||
131032448|NCT03683719|471751458|FG000|Overall Study|Lack of Efficacy|1|||
131032449|NCT03683719|471751459|FG001|Overall Study|Lack of Efficacy|3|||
131032450|NCT03683719|471751460|FG002|Overall Study|Lack of Efficacy|4|||
131032451|NCT03683719|471751461|FG003|Overall Study|Lack of Efficacy|0|||
131032452|NCT03683719|471751462|FG004|Overall Study|Lack of Efficacy|4|||
131032453|NCT03683719|471751458|FG000|Overall Study|Adverse Event|6|||
131032454|NCT03683719|471751459|FG001|Overall Study|Adverse Event|6|||
131032455|NCT03683719|471751460|FG002|Overall Study|Adverse Event|0|||
131032456|NCT03683719|471751461|FG003|Overall Study|Adverse Event|1|||
131032457|NCT03683719|471751462|FG004|Overall Study|Adverse Event|3|||
130698259|NCT02614196|470519180|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
130698260|NCT02614196|470519181|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
130698261|NCT02614196|470519176|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
130698262|NCT02614196|470519177|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
130698263|NCT02614196|470519178|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
130698264|NCT02614196|470519179|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
131032458|NCT03683719|471751458|FG000|Overall Study|Withdrawal by Subject|4|||
131032459|NCT03683719|471751459|FG001|Overall Study|Withdrawal by Subject|4|||
131032460|NCT03683719|471751460|FG002|Overall Study|Withdrawal by Subject|3|||
131032461|NCT03683719|471751461|FG003|Overall Study|Withdrawal by Subject|5|||
131032462|NCT03683719|471751462|FG004|Overall Study|Withdrawal by Subject|5|||
131032463|NCT03683719|471751458|FG000|Overall Study|Lost to Follow-up|1|||
131032464|NCT03683719|471751459|FG001|Overall Study|Lost to Follow-up|0|||
131032465|NCT03683719|471751460|FG002|Overall Study|Lost to Follow-up|0|||
131032466|NCT03683719|471751461|FG003|Overall Study|Lost to Follow-up|1|||
130698265|NCT02614196|470519180|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
130698266|NCT02614196|470519181|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
130698267|NCT02614196|470519176|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
130698268|NCT02614196|470519177|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
130698269|NCT02614196|470519178|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
130698270|NCT02614196|470519179|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
130698271|NCT02614196|470519180|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
130698272|NCT02614196|470519181|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
130698273|NCT02614196|470519176|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
130698274|NCT02614196|470519177|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
130698275|NCT02614196|470519178|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
130698276|NCT02614196|470519179|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
130698277|NCT02614196|470519180|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
130698278|NCT02614196|470519181|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
130698279|NCT00258856|470520780|FG000|Overall Study|Lost to Follow-up|1|||
130698280|NCT00258856|470520781|FG001|Overall Study|Lost to Follow-up|0|||
130698281|NCT00258856|470520782|FG002|Overall Study|Lost to Follow-up|2|||
130698282|NCT00258856|470520783|FG003|Overall Study|Lost to Follow-up|0|||
130698283|NCT00258856|470520780|FG000|Overall Study|Non-compliance|2|||
130698284|NCT00258856|470520781|FG001|Overall Study|Non-compliance|0|||
130698285|NCT00258856|470520782|FG002|Overall Study|Non-compliance|0|||
130698286|NCT00258856|470520783|FG003|Overall Study|Non-compliance|1|||
130698287|NCT01691430|470520784|FG000|Overall Study|Death|17|||
130698288|NCT01691430|470520785|FG001|Overall Study|Death|16|||
130698289|NCT01691430|470520784|FG000|Overall Study|Withdrawal by Subject|5|||
130698290|NCT01691430|470520785|FG001|Overall Study|Withdrawal by Subject|1|||
131032467|NCT03683719|471751462|FG004|Overall Study|Lost to Follow-up|1|||
131117973|NCT01086410|472064065|FG000|Overall Study|Lost to Follow-up|0|||
131032468|NCT03683719|471751458|FG000|Overall Study|Other personal reasons|0|||
131032469|NCT03683719|471751459|FG001|Overall Study|Other personal reasons|0|||
131032470|NCT03683719|471751460|FG002|Overall Study|Other personal reasons|1|||
131032471|NCT03683719|471751461|FG003|Overall Study|Other personal reasons|0|||
131117974|NCT01086410|472064066|FG001|Overall Study|Lost to Follow-up|0|||
130698291|NCT01691430|470520784|FG000|Overall Study|Lost to Follow-up|0|||
130698292|NCT01691430|470520785|FG001|Overall Study|Lost to Follow-up|3|||
131117975|NCT01086410|472064067|FG002|Overall Study|Lost to Follow-up|1|||
131117976|NCT01086410|472064068|FG003|Overall Study|Lost to Follow-up|0|||
131117977|NCT04196803|472064069|FG000|Overall Study|Withdrawal by Subject|1|||
131117978|NCT04196803|472064070|FG001|Overall Study|Withdrawal by Subject|3|||
131117979|NCT04196803|472064069|FG000|Overall Study|Adverse Event|4|||
131117980|NCT04196803|472064070|FG001|Overall Study|Adverse Event|2|||
131117981|NCT04196803|472064069|FG000|Overall Study|Lost to Follow-up|0|||
131117982|NCT04196803|472064070|FG001|Overall Study|Lost to Follow-up|1|||
131117983|NCT01022996|472064071|FG000|Overall Study|Adverse Event|14|||
131117984|NCT01022996|472064071|FG000|Overall Study|Withdrawal by Subject|3|||
131117985|NCT01022996|472064071|FG000|Overall Study|Lost to Follow-up|1|||
131117986|NCT01022996|472064071|FG000|Overall Study|Administrative problems|6|||
131117987|NCT01022996|472064071|FG000|Overall Study|Disease Progression|32|||
131117988|NCT01022996|472064071|FG000|Overall Study|Protocol Violation|1|||
131117989|NCT00930722|472064072|FG000|Overall Study|Lost to Follow-up|16|||
131117990|NCT00930722|472064072|FG000|Overall Study|No longer willing to participate|9|||
130698293|NCT02219009|470520788|FG000|Overall Study|Withdrawal by Subject|5|||
130698294|NCT02219009|470520789|FG001|Overall Study|Withdrawal by Subject|1|||
130698295|NCT02219009|470520788|FG000|Overall Study|Adverse Event|2|||
130698296|NCT02219009|470520789|FG001|Overall Study|Adverse Event|4|||
130698297|NCT02219009|470520788|FG000|Overall Study|Lost to Follow-up|2|||
130698298|NCT02219009|470520789|FG001|Overall Study|Lost to Follow-up|2|||
130698299|NCT02219009|470520788|FG000|Overall Study|Protocol deviation|1|||
130698300|NCT02219009|470520789|FG001|Overall Study|Protocol deviation|0|||
130698301|NCT02219009|470520788|FG000|Overall Study|Physician Decision|0|||
130698302|NCT02219009|470520789|FG001|Overall Study|Physician Decision|1|||
130698303|NCT00762411|470520790|FG000|Initial Treatment|Death|7|||
130698304|NCT00762411|470520791|FG001|Initial Treatment|Death|6|||
130698305|NCT00762411|470520790|FG000|Initial Treatment|Adverse Event|132|||
130698306|NCT00762411|470520791|FG001|Initial Treatment|Adverse Event|40|||
130698307|NCT00762411|470520790|FG000|Initial Treatment|Protocol Violation|4|||
130698308|NCT00762411|470520791|FG001|Initial Treatment|Protocol Violation|1|||
130698309|NCT00762411|470520790|FG000|Initial Treatment|Withdrawal by Subject|65|||
130698310|NCT00762411|470520791|FG001|Initial Treatment|Withdrawal by Subject|52|||
130698311|NCT00762411|470520790|FG000|Initial Treatment|Physician Decision|1|||
130698312|NCT00762411|470520791|FG001|Initial Treatment|Physician Decision|0|||
130698313|NCT00762411|470520790|FG000|Initial Treatment|Sponsor Decision|293|||
130698314|NCT00762411|470520791|FG001|Initial Treatment|Sponsor Decision|401|||
130698315|NCT00762411|470520790|FG000|Initial Treatment|Lost to Follow-up|5|||
130698316|NCT00762411|470520791|FG001|Initial Treatment|Lost to Follow-up|0|||
130698317|NCT00762411|470520790|FG000|Initial Treatment|Caregiver Decision|21|||
130698318|NCT00762411|470520791|FG001|Initial Treatment|Caregiver Decision|16|||
130698319|NCT00762411|470520790|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
130698320|NCT00762411|470520791|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
130698321|NCT00762411|470520790|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
130698322|NCT00762411|470520791|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
130698323|NCT00762411|470520790|FG000|Delayed Start|Adverse Event|0|||
130698324|NCT00762411|470520791|FG001|Delayed Start|Adverse Event|4|||
130698325|NCT00762411|470520790|FG000|Delayed Start|Protocol Violation|0|||
130698326|NCT00762411|470520791|FG001|Delayed Start|Protocol Violation|1|||
130698327|NCT00762411|470520790|FG000|Delayed Start|Sponsor Decision|16|||
130698328|NCT00762411|470520791|FG001|Delayed Start|Sponsor Decision|20|||
130698329|NCT00762411|470520790|FG000|Delayed Start|Caregiver Decision|1|||
130698330|NCT00762411|470520791|FG001|Delayed Start|Caregiver Decision|1|||
130698331|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
130698332|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
130913484|NCT01897714|471319848|FG004|Phase II (MTD)|Other|3|||
130913485|NCT01897714|471319849|FG005|Phase II (MTD)|Other|0|||
130913486|NCT00423722|471319850|FG000|Overall Study|Death|4|||
130913487|NCT00423722|471319851|FG001|Overall Study|Death|4|||
130913488|NCT00423722|471319850|FG000|Overall Study|Declined to participate|2|||
130913489|NCT00423722|471319851|FG001|Overall Study|Declined to participate|3|||
130913490|NCT00423722|471319850|FG000|Overall Study|Unable to complete questionnaires|4|||
130913491|NCT00423722|471319851|FG001|Overall Study|Unable to complete questionnaires|4|||
131117991|NCT00930722|472064072|FG000|Overall Study|Study terminated by sponsor|2|||
131117992|NCT01069120|472064073|FG000|Overall Study|Study prematurely terminated|27|||
131117993|NCT05097716|472064074|FG000|Period 1|Adverse Event|1|||
131117994|NCT05097716|472064074|FG000|Period 1|Close contact with highly-transmissible infection|1|||
131117995|NCT01754857|472064077|FG000|Overall Study|Adverse Event|7|||
131117996|NCT01754857|472064077|FG000|Overall Study|Disease progression|3|||
130698333|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
130698334|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
130698335|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
130913492|NCT00423722|471319850|FG000|Overall Study|Withdrawal by Subject|4|||
131117997|NCT01754857|472064077|FG000|Overall Study|Physician Decision|2|||
131117998|NCT01754857|472064077|FG000|Overall Study|Withdrawal by Subject|3|||
131117999|NCT01754857|472064077|FG000|Overall Study|other complicating disease|1|||
130913493|NCT00423722|471319851|FG001|Overall Study|Withdrawal by Subject|2|||
130913494|NCT00518687|471319853|FG000|Overall Study|Adverse Event|201|||
130913495|NCT00518687|471319854|FG001|Overall Study|Adverse Event|177|||
130913496|NCT00518687|471319853|FG000|Overall Study|Lost to Follow-up|144|||
131032472|NCT03683719|471751462|FG004|Overall Study|Other personal reasons|1|||
131032473|NCT03056040|471751469|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
131032474|NCT03056040|471751470|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
131032475|NCT03056040|471751469|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
131032476|NCT03056040|471751470|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
131032477|NCT03056040|471751469|FG000|Primary Evaluation Period|Pregnancy|0|||
131032478|NCT03056040|471751470|FG001|Primary Evaluation Period|Pregnancy|1|||
131032479|NCT03056040|471751469|FG000|Primary Evaluation Period|Randomized, not treated|1|||
131032480|NCT03056040|471751470|FG001|Primary Evaluation Period|Randomized, not treated|1|||
131032481|NCT03056040|471751469|FG000|Extension Period|Physician Decision|3|||
131032482|NCT03056040|471751470|FG001|Extension Period|Physician Decision|3|||
131032483|NCT03056040|471751469|FG000|Extension Period|Lost to Follow-up|0|||
131032484|NCT03056040|471751470|FG001|Extension Period|Lost to Follow-up|1|||
131032485|NCT03056040|471751469|FG000|Extension Period|Death|0|||
131032486|NCT03056040|471751470|FG001|Extension Period|Death|3|||
131032487|NCT03056040|471751469|FG000|Extension Period|Withdrawal by Subject|1|||
131032488|NCT03056040|471751470|FG001|Extension Period|Withdrawal by Subject|0|||
131032489|NCT03988608|471751471|FG000|Overall Study|Adverse Event|1|||
131032490|NCT03988608|471751471|FG000|Overall Study|Lost to Follow-up|1|||
131032491|NCT03988608|471751471|FG000|Overall Study|Withdrawal by Subject|3|||
131032492|NCT03988608|471751471|FG000|Overall Study|Death|1|||
131032493|NCT03396926|471751478|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
131032494|NCT03396926|471751479|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
131032495|NCT00450658|471751480|FG000|Overall Study|Adverse Event|24|||
131032496|NCT00450658|471751481|FG001|Overall Study|Adverse Event|15|||
131032497|NCT00450658|471751480|FG000|Overall Study|Withdrawal by Subject|43|||
131032498|NCT00450658|471751481|FG001|Overall Study|Withdrawal by Subject|26|||
131032499|NCT00450658|471751480|FG000|Overall Study|Lost to Follow-up|22|||
131032500|NCT00450658|471751481|FG001|Overall Study|Lost to Follow-up|5|||
131032501|NCT00450658|471751480|FG000|Overall Study|UGI ulcer|33|||
131032502|NCT00450658|471751481|FG001|Overall Study|UGI ulcer|34|||
131032503|NCT00450658|471751480|FG000|Overall Study|misc|21|||
131032504|NCT00450658|471751481|FG001|Overall Study|misc|10|||
131032505|NCT05763823|471751482|FG000|Overall Study|Death|6|||
131032506|NCT05763823|471751482|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131032507|NCT05763823|471751482|FG000|Overall Study|Withdrawal by Subject|6|||
131032508|NCT04410042|471751485|FG000|Overall Study|Not Eligible|1|||
131032509|NCT04410042|471751486|FG001|Overall Study|Not Eligible|1|||
131032510|NCT03720795|471751490|FG000|Phase 1|Lost to Follow-up|4|||
131032511|NCT03720795|471751490|FG000|Phase 1|Withdrawal by Subject|6|||
131032512|NCT03720795|471751490|FG000|Phase 1|Protocol Violation|1|||
130698336|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
130698337|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
130698338|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
130698339|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
130698340|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
130698341|NCT00762411|470520790|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
130698342|NCT00762411|470520791|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
130698343|NCT02259348|470520794|FG000|Overall Study|Donors|6|||
130698344|NCT02259348|470520794|FG000|Overall Study|Death|4|||
130698345|NCT04211766|470520795|FG000|Overall Study|Withdrawal by Subject|5|||
130698346|NCT04211766|470520796|FG001|Overall Study|Withdrawal by Subject|1|||
130698347|NCT04590781|470520798|FG000|Overall Study|Death|0|||
130698348|NCT04590781|470520799|FG001|Overall Study|Death|2|||
130698349|NCT04590781|470520798|FG000|Overall Study|Withdrawal by Subject|2|||
130698350|NCT04590781|470520799|FG001|Overall Study|Withdrawal by Subject|0|||
130698351|NCT01680016|470520802|FG000|Overall Study|Adverse Event|0|||
130698352|NCT01680016|470520803|FG001|Overall Study|Adverse Event|0|||
130698353|NCT01680016|470520804|FG002|Overall Study|Adverse Event|1|||
130698354|NCT01680016|470520805|FG003|Overall Study|Adverse Event|4|||
130698355|NCT01680016|470520802|FG000|Overall Study|The Subject went out of The Trial|1|||
131032513|NCT03720795|471751490|FG000|Phase 1|Other|1|||
130698356|NCT01680016|470520803|FG001|Overall Study|The Subject went out of The Trial|0|||
131032514|NCT03720795|471751490|FG000|Phase 2|Lost to Follow-up|5|||
131118000|NCT01754857|472064077|FG000|Overall Study|ineligible to continue onto maintenance|1|||
131133722|NCT01661140|472117173|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
130698357|NCT01680016|470520804|FG002|Overall Study|The Subject went out of The Trial|3|||
130698358|NCT01680016|470520805|FG003|Overall Study|The Subject went out of The Trial|0|||
130913497|NCT00518687|471319854|FG001|Overall Study|Lost to Follow-up|155|||
131032515|NCT03720795|471751490|FG000|Phase 2|Withdrawal by Subject|10|||
131032516|NCT03720795|471751490|FG000|Phase 2|Protocol Violation|2|||
131032517|NCT03720795|471751490|FG000|3 Month Follow Up|Lost to Follow-up|2|||
130913498|NCT00518687|471319853|FG000|Overall Study|Physician Decision|42|||
130913499|NCT00518687|471319854|FG001|Overall Study|Physician Decision|48|||
130913500|NCT00518687|471319853|FG000|Overall Study|Progressive disease|2|||
130913501|NCT00518687|471319854|FG001|Overall Study|Progressive disease|2|||
130913502|NCT00518687|471319853|FG000|Overall Study|Protocol Violation|8|||
130913503|NCT00518687|471319854|FG001|Overall Study|Protocol Violation|10|||
130913504|NCT00518687|471319853|FG000|Overall Study|Study terminated by sponsor|930|||
130913505|NCT00518687|471319854|FG001|Overall Study|Study terminated by sponsor|918|||
130913506|NCT00518687|471319853|FG000|Overall Study|Withdrawal by Subject|110|||
130913507|NCT00518687|471319854|FG001|Overall Study|Withdrawal by Subject|110|||
130913508|NCT05108922|471319855|FG000|Overall Study|Adverse Event|2|||
130913509|NCT05108922|471319856|FG001|Overall Study|Adverse Event|3|||
130698359|NCT01680016|470520802|FG000|Overall Study|Protocol Violation|0|||
130698360|NCT01680016|470520803|FG001|Overall Study|Protocol Violation|1|||
130698361|NCT01680016|470520804|FG002|Overall Study|Protocol Violation|0|||
130698362|NCT01680016|470520805|FG003|Overall Study|Protocol Violation|0|||
130698363|NCT01680016|470520802|FG000|Overall Study|Withdrawal by Subject|5|||
130698364|NCT01680016|470520803|FG001|Overall Study|Withdrawal by Subject|7|||
130698365|NCT01680016|470520804|FG002|Overall Study|Withdrawal by Subject|1|||
130698366|NCT01680016|470520805|FG003|Overall Study|Withdrawal by Subject|1|||
130698367|NCT03686215|470520806|FG000|Overall Study|Adverse Event|0|||
130698368|NCT03686215|470520807|FG001|Overall Study|Adverse Event|0|||
130698369|NCT03686215|470520808|FG002|Overall Study|Adverse Event|7|||
130698370|NCT03686215|470520806|FG000|Overall Study|Physician Decision|0|||
130698371|NCT03686215|470520807|FG001|Overall Study|Physician Decision|0|||
130698372|NCT03686215|470520808|FG002|Overall Study|Physician Decision|1|||
130698373|NCT03686215|470520806|FG000|Overall Study|Protocol Violation|0|||
130698374|NCT03686215|470520807|FG001|Overall Study|Protocol Violation|0|||
130698375|NCT03686215|470520808|FG002|Overall Study|Protocol Violation|4|||
130698376|NCT03686215|470520806|FG000|Overall Study|Device issue|1|||
130698377|NCT03686215|470520807|FG001|Overall Study|Device issue|0|||
130698378|NCT03686215|470520808|FG002|Overall Study|Device issue|2|||
130698379|NCT02485158|470520811|FG000|Overall Study|Withdrawal by Subject|3|||
130698380|NCT02485158|470520811|FG000|Overall Study|expected drug side effect|1|||
130698381|NCT02846883|470520812|FG000|Overall Study|Death|0|||
130698382|NCT02846883|470520813|FG001|Overall Study|Death|1|||
130698383|NCT02846883|470520814|FG002|Overall Study|Death|1|||
130698384|NCT02846883|470520812|FG000|Overall Study|Lost to Follow-up|0|||
130698385|NCT02846883|470520813|FG001|Overall Study|Lost to Follow-up|0|||
130698386|NCT02846883|470520814|FG002|Overall Study|Lost to Follow-up|1|||
130698387|NCT02846883|470520812|FG000|Overall Study|Withdrawal by Subject|1|||
130698388|NCT02846883|470520813|FG001|Overall Study|Withdrawal by Subject|0|||
130698389|NCT02846883|470520814|FG002|Overall Study|Withdrawal by Subject|0|||
130698390|NCT02846883|470520812|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
130698391|NCT02846883|470520813|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
130698392|NCT02846883|470520814|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
130698393|NCT02846883|470520812|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
130698394|NCT02846883|470520813|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
130698395|NCT02846883|470520814|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
130698396|NCT01098851|470520817|FG000|Overall Study|Equipment failure|1|||
130698397|NCT01098851|470520818|FG001|Overall Study|Equipment failure|0|||
130698398|NCT00927251|470520819|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
130698399|NCT01813435|470520827|FG000|Overall Study|did not finish experimental regimen|1902|||
130698400|NCT01813435|470520828|FG001|Overall Study|did not finish experimental regimen|770|||
130698401|NCT01813435|470520827|FG000|Overall Study|Lost to Follow-up|268|||
130698402|NCT01813435|470520828|FG001|Overall Study|Lost to Follow-up|237|||
130698403|NCT03035890|470520829|FG000|Overall Study|Death|1|||
130698404|NCT00452348|470520831|FG000|Overall Study|Adverse Event|6|||
130698405|NCT00452348|470520832|FG001|Overall Study|Adverse Event|9|||
130698406|NCT00452348|470520831|FG000|Overall Study|Lack of Efficacy|10|||
130698407|NCT00452348|470520832|FG001|Overall Study|Lack of Efficacy|9|||
130698408|NCT00452348|470520831|FG000|Overall Study|Lost to Follow-up|14|||
130698409|NCT00452348|470520832|FG001|Overall Study|Lost to Follow-up|8|||
130698410|NCT00452348|470520831|FG000|Overall Study|Protocol Violation|22|||
130698411|NCT00452348|470520832|FG001|Overall Study|Protocol Violation|28|||
130698412|NCT00452348|470520831|FG000|Overall Study|Withdrawal by Subject|18|||
130698413|NCT00452348|470520832|FG001|Overall Study|Withdrawal by Subject|21|||
130913510|NCT05108922|471319855|FG000|Overall Study|Lost to Follow-up|2|||
130913511|NCT05108922|471319856|FG001|Overall Study|Lost to Follow-up|1|||
130698414|NCT00452348|470520831|FG000|Overall Study|Other|9|||
130698415|NCT00452348|470520832|FG001|Overall Study|Other|9|||
130698416|NCT01490190|470520833|FG000|Overall Study|Withdrawal by Subject|9|||
130698417|NCT01490190|470520833|FG000|Overall Study|Adverse Event|17|||
130698418|NCT01490190|470520833|FG000|Overall Study|Protocol Violation|5|||
130698419|NCT01490190|470520833|FG000|Overall Study|Lost to Follow-up|13|||
130913512|NCT05108922|471319855|FG000|Overall Study|Inadvertent enrollment|0|||
130913513|NCT05108922|471319856|FG001|Overall Study|Inadvertent enrollment|1|||
130913514|NCT05108922|471319855|FG000|Overall Study|Physician Decision|2|||
131118001|NCT01754857|472064077|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
131118002|NCT01754857|472064077|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
131118003|NCT01509079|472064078|FG000|Overall Study|Lack of Efficacy|0|||
131118004|NCT01509079|472064079|FG001|Overall Study|Lack of Efficacy|2|||
131118005|NCT01509079|472064078|FG000|Overall Study|started an excluded medication|0|||
131118006|NCT01509079|472064079|FG001|Overall Study|started an excluded medication|1|||
131118007|NCT01399190|472064082|FG000|Overall Study|Not Eligible for Final Analysis|5|||
131118008|NCT01399190|472064082|FG000|Overall Study|Adverse Event|8|||
131118009|NCT01399190|472064082|FG000|Overall Study|Participant's Request|5|||
131118010|NCT01399190|472064082|FG000|Overall Study|Physician Decision|2|||
131118011|NCT00436618|472064086|FG000|Overall Study|Withdrawal by Subject|5|||
131118012|NCT00436618|472064087|FG001|Overall Study|Withdrawal by Subject|8|||
131118013|NCT00436618|472064088|FG002|Overall Study|Withdrawal by Subject|11|||
131118014|NCT00436618|472064086|FG000|Overall Study|Adverse Event|8|||
131118015|NCT00436618|472064087|FG001|Overall Study|Adverse Event|8|||
131118016|NCT00436618|472064088|FG002|Overall Study|Adverse Event|9|||
131118017|NCT00436618|472064086|FG000|Overall Study|Alternate Treatment|3|||
131118018|NCT00436618|472064087|FG001|Overall Study|Alternate Treatment|4|||
131118019|NCT00436618|472064088|FG002|Overall Study|Alternate Treatment|12|||
131118020|NCT00436618|472064086|FG000|Overall Study|Other Medical Problems|3|||
131118021|NCT00436618|472064087|FG001|Overall Study|Other Medical Problems|1|||
131118022|NCT00436618|472064088|FG002|Overall Study|Other Medical Problems|7|||
131118023|NCT00436618|472064086|FG000|Overall Study|Death|4|||
131118024|NCT00436618|472064087|FG001|Overall Study|Death|2|||
131118025|NCT00436618|472064088|FG002|Overall Study|Death|3|||
131118026|NCT00436618|472064086|FG000|Overall Study|New Primary or Other Reasons|6|||
131118027|NCT00436618|472064087|FG001|Overall Study|New Primary or Other Reasons|2|||
131118028|NCT00436618|472064088|FG002|Overall Study|New Primary or Other Reasons|12|||
131118029|NCT00436618|472064086|FG000|Overall Study|Still on treatment|1|||
131118030|NCT00436618|472064087|FG001|Overall Study|Still on treatment|2|||
131118031|NCT00436618|472064088|FG002|Overall Study|Still on treatment|7|||
130698420|NCT01490190|470520833|FG000|Overall Study|Relocation|1|||
130698421|NCT01490190|470520833|FG000|Overall Study|Inconvenience|1|||
130698422|NCT01490190|470520833|FG000|Overall Study|Ring expulsion|2|||
131118032|NCT00698204|472064089|FG000|Overall Study|Withdrawal by Subject|1|||
131118033|NCT00698204|472064090|FG001|Overall Study|Withdrawal by Subject|0|||
131118034|NCT03083847|472064091|FG000|Main|Physician Decision|0|||
131118035|NCT03083847|472064092|FG001|Main|Physician Decision|0|||
131118036|NCT03083847|472064093|FG002|Main|Physician Decision|0|||
131118037|NCT03083847|472064094|FG003|Main|Physician Decision|0|||
131118038|NCT03083847|472064095|FG004|Main|Physician Decision|0|||
131118039|NCT03083847|472064096|FG005|Main|Physician Decision|1|||
131118040|NCT03083847|472064097|FG006|Main|Physician Decision|0|||
131118041|NCT03083847|472064098|FG007|Main|Physician Decision|0|||
131118042|NCT03083847|472064099|FG008|Main|Physician Decision|0|||
131118043|NCT03083847|472064100|FG009|Main|Physician Decision|0|||
131118044|NCT03083847|472064091|FG000|Main|Pregnancy|0|||
131118045|NCT03083847|472064092|FG001|Main|Pregnancy|0|||
131118046|NCT03083847|472064093|FG002|Main|Pregnancy|0|||
131118047|NCT03083847|472064094|FG003|Main|Pregnancy|0|||
131118048|NCT03083847|472064095|FG004|Main|Pregnancy|0|||
131118049|NCT03083847|472064096|FG005|Main|Pregnancy|0|||
131118050|NCT03083847|472064097|FG006|Main|Pregnancy|0|||
131118051|NCT03083847|472064098|FG007|Main|Pregnancy|1|||
131118052|NCT03083847|472064099|FG008|Main|Pregnancy|0|||
131118053|NCT03083847|472064100|FG009|Main|Pregnancy|0|||
131118054|NCT03083847|472064091|FG000|Main|Adverse Event|0|||
130698423|NCT00960154|470520839|FG000|Overall Study|Study termination|25|||
130698424|NCT00960154|470520840|FG001|Overall Study|Study termination|25|||
131118055|NCT03083847|472064092|FG001|Main|Adverse Event|0|||
131118056|NCT03083847|472064093|FG002|Main|Adverse Event|0|||
130698425|NCT00377156|470520841|FG000|Overall Study|Death|23|||
130698426|NCT00377156|470520842|FG001|Overall Study|Death|19|||
130698427|NCT00377156|470520841|FG000|Overall Study|Withdrawal by Subject|16|||
131118057|NCT03083847|472064094|FG003|Main|Adverse Event|0|||
131118058|NCT03083847|472064095|FG004|Main|Adverse Event|0|||
131118059|NCT03083847|472064096|FG005|Main|Adverse Event|0|||
130698428|NCT00377156|470520842|FG001|Overall Study|Withdrawal by Subject|24|||
131118060|NCT03083847|472064097|FG006|Main|Adverse Event|0|||
131118061|NCT03083847|472064098|FG007|Main|Adverse Event|2|||
131118062|NCT03083847|472064099|FG008|Main|Adverse Event|0|||
131118063|NCT03083847|472064100|FG009|Main|Adverse Event|0|||
131118064|NCT03083847|472064091|FG000|Main|Withdrawal by Subject|0|||
131118065|NCT03083847|472064092|FG001|Main|Withdrawal by Subject|0|||
131118066|NCT03083847|472064093|FG002|Main|Withdrawal by Subject|0|||
131118067|NCT03083847|472064094|FG003|Main|Withdrawal by Subject|0|||
131118068|NCT03083847|472064095|FG004|Main|Withdrawal by Subject|0|||
131118069|NCT03083847|472064096|FG005|Main|Withdrawal by Subject|0|||
131118070|NCT03083847|472064097|FG006|Main|Withdrawal by Subject|1|||
131118071|NCT03083847|472064098|FG007|Main|Withdrawal by Subject|1|||
130698429|NCT00377156|470520841|FG000|Overall Study|Had follow-up <90 d|3|||
131118072|NCT03083847|472064099|FG008|Main|Withdrawal by Subject|0|||
130698430|NCT00377156|470520842|FG001|Overall Study|Had follow-up <90 d|6|||
130698431|NCT00377156|470520841|FG000|Overall Study|Cancellation|1|||
130698432|NCT00377156|470520842|FG001|Overall Study|Cancellation|0|||
130698433|NCT00377156|470520841|FG000|Overall Study|Refused testing|0|||
130698434|NCT00377156|470520842|FG001|Overall Study|Refused testing|1|||
130698435|NCT00377156|470520841|FG000|Overall Study|Ineligible|0|||
130698436|NCT00377156|470520842|FG001|Overall Study|Ineligible|1|||
130698437|NCT00377156|470520841|FG000|Overall Study|Disability or language problem|0|||
130698438|NCT00377156|470520842|FG001|Overall Study|Disability or language problem|1|||
130698439|NCT00377156|470520841|FG000|Overall Study|Other|5|||
130698440|NCT00377156|470520842|FG001|Overall Study|Other|2|||
130698441|NCT00856349|470520843|FG000|Overall Study|Death|418|||
130698442|NCT00856349|470520843|FG000|Overall Study|Withdrawal by Subject|116|||
130698443|NCT00856349|470520843|FG000|Overall Study|Lost to Follow-up|91|||
130698444|NCT00856349|470520843|FG000|Overall Study|Protocol Violation|38|||
130698445|NCT00856349|470520843|FG000|Overall Study|Physician Decision|13|||
130698446|NCT00856349|470520843|FG000|Overall Study|Subject relocation|104|||
130698447|NCT00856349|470520843|FG000|Overall Study|Device explant|33|||
130698448|NCT00856349|470520843|FG000|Overall Study|Site closure|78|||
130698449|NCT00856349|470520843|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
130698450|NCT02725515|470520844|FG000|Overall Study|Refused infusion (no study treatment)|1|||
130698451|NCT02725515|470520845|FG001|Overall Study|Refused infusion (no study treatment)|0|||
130698452|NCT02725515|470520844|FG000|Overall Study|Loss of Improvement per Protocol|14|||
130698453|NCT02725515|470520845|FG001|Overall Study|Loss of Improvement per Protocol|25|||
130698454|NCT02725515|470520844|FG000|Overall Study|Withdrawal by Subject|2|||
130698455|NCT02725515|470520845|FG001|Overall Study|Withdrawal by Subject|1|||
130698456|NCT02725515|470520844|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130698457|NCT02725515|470520845|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130698458|NCT02725515|470520844|FG000|Overall Study|Lost to Follow-up|1|||
130698459|NCT02725515|470520845|FG001|Overall Study|Lost to Follow-up|1|||
130698460|NCT02725515|470520844|FG000|Overall Study|Adverse Event|7|||
130698461|NCT02725515|470520845|FG001|Overall Study|Adverse Event|2|||
130698462|NCT02725515|470520844|FG000|Overall Study|No Documented Disease Improvement|0|||
130698463|NCT02725515|470520845|FG001|Overall Study|No Documented Disease Improvement|1|||
130698464|NCT02725515|470520844|FG000|Overall Study|Completed Study Under Original Protocol|0|||
130698465|NCT02725515|470520845|FG001|Overall Study|Completed Study Under Original Protocol|1|||
130698466|NCT02725515|470520844|FG000|Overall Study|Lack of Response|0|||
130698467|NCT02725515|470520845|FG001|Overall Study|Lack of Response|1|||
130698468|NCT00874549|470520846|FG000|Overall Study|Adverse Event|0|||
130698469|NCT00874549|470520847|FG001|Overall Study|Adverse Event|0|||
130698470|NCT00874549|470520848|FG002|Overall Study|Adverse Event|1|||
130698471|NCT00874549|470520849|FG003|Overall Study|Adverse Event|0|||
130698472|NCT00874549|470520846|FG000|Overall Study|Protocol Violation|1|||
130698473|NCT00874549|470520847|FG001|Overall Study|Protocol Violation|0|||
130698474|NCT00874549|470520848|FG002|Overall Study|Protocol Violation|2|||
130698475|NCT00874549|470520849|FG003|Overall Study|Protocol Violation|1|||
130698476|NCT00874549|470520846|FG000|Overall Study|Lost to Follow-up|0|||
130698477|NCT00874549|470520847|FG001|Overall Study|Lost to Follow-up|0|||
130698478|NCT00874549|470520848|FG002|Overall Study|Lost to Follow-up|1|||
130698479|NCT00874549|470520849|FG003|Overall Study|Lost to Follow-up|0|||
130698480|NCT00874549|470520846|FG000|Overall Study|Withdrawal by Subject|0|||
131032518|NCT05311384|471751491|FG000|Overall Study|Uncontrolled health conditions|2|||
131032519|NCT05311384|471751491|FG000|Overall Study|Withdrawal by Subject|1|||
131032520|NCT03302494|471751492|FG000|Overall Study|Other|7|||
131032521|NCT03302494|471751493|FG001|Overall Study|Other|4|||
131032522|NCT03302494|471751494|FG002|Overall Study|Other|6|||
131032523|NCT03302494|471751492|FG000|Overall Study|Withdrawal by Subject|10|||
131032524|NCT03302494|471751493|FG001|Overall Study|Withdrawal by Subject|2|||
131032525|NCT03302494|471751494|FG002|Overall Study|Withdrawal by Subject|9|||
131032526|NCT03302494|471751492|FG000|Overall Study|Study Terminated by Sponsor|32|||
131032527|NCT03302494|471751493|FG001|Overall Study|Study Terminated by Sponsor|29|||
131032528|NCT03302494|471751494|FG002|Overall Study|Study Terminated by Sponsor|30|||
131032529|NCT03302494|471751492|FG000|Overall Study|Physician Decision|1|||
131032530|NCT03302494|471751493|FG001|Overall Study|Physician Decision|0|||
131032531|NCT03302494|471751494|FG002|Overall Study|Physician Decision|1|||
131032532|NCT03302494|471751492|FG000|Overall Study|Lost to Follow-up|1|||
131032533|NCT03302494|471751493|FG001|Overall Study|Lost to Follow-up|3|||
130698481|NCT00874549|470520847|FG001|Overall Study|Withdrawal by Subject|1|||
131032534|NCT03302494|471751494|FG002|Overall Study|Lost to Follow-up|3|||
131032535|NCT03302494|471751492|FG000|Overall Study|Death|13|||
131032536|NCT03302494|471751493|FG001|Overall Study|Death|11|||
130698482|NCT00874549|470520848|FG002|Overall Study|Withdrawal by Subject|0|||
130698483|NCT00874549|470520849|FG003|Overall Study|Withdrawal by Subject|1|||
130698484|NCT00517192|470520856|FG000|Overall Study|Adverse Event|1|||
130698485|NCT00517192|470520857|FG001|Overall Study|Adverse Event|1|||
130698486|NCT00517192|470520856|FG000|Overall Study|Lost to Follow-up|1|||
131032537|NCT03302494|471751494|FG002|Overall Study|Death|4|||
131032538|NCT03302494|471751492|FG000|Overall Study|Adverse Event|1|||
131118073|NCT03083847|472064100|FG009|Main|Withdrawal by Subject|0|||
130698487|NCT00517192|470520857|FG001|Overall Study|Lost to Follow-up|1|||
130698488|NCT00517192|470520856|FG000|Overall Study|Withdrawal by Subject|1|||
130698489|NCT00517192|470520857|FG001|Overall Study|Withdrawal by Subject|0|||
130698490|NCT00517192|470520856|FG000|Overall Study|Early termination of the trial|16|||
130698491|NCT00517192|470520857|FG001|Overall Study|Early termination of the trial|18|||
130698492|NCT02733627|470520859|FG000|Overall Study|Adverse Event|0|||
130698493|NCT02733627|470520860|FG001|Overall Study|Adverse Event|1|||
130698494|NCT02733627|470520861|FG002|Overall Study|Adverse Event|1|||
130698495|NCT02733627|470520862|FG003|Overall Study|Adverse Event|0|||
130698496|NCT02733627|470520859|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
130698497|NCT02733627|470520860|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
130698498|NCT02733627|470520861|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
130698499|NCT02733627|470520862|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
130698500|NCT00183196|470520863|FG000|Overall Study|Withdrawal by Subject|18|||
130698501|NCT00183196|470520864|FG001|Overall Study|Withdrawal by Subject|11|||
130698502|NCT00183196|470520865|FG002|Overall Study|Withdrawal by Subject|13|||
130698503|NCT00183196|470520863|FG000|Overall Study|Adverse Event|1|||
130698504|NCT00183196|470520864|FG001|Overall Study|Adverse Event|2|||
130698505|NCT00183196|470520865|FG002|Overall Study|Adverse Event|2|||
130698506|NCT00183196|470520863|FG000|Overall Study|Legal event|1|||
130698507|NCT00183196|470520864|FG001|Overall Study|Legal event|1|||
130698508|NCT00183196|470520865|FG002|Overall Study|Legal event|1|||
130698509|NCT00183196|470520863|FG000|Overall Study|Required more intensive care|0|||
130698510|NCT00183196|470520864|FG001|Overall Study|Required more intensive care|1|||
130698511|NCT00183196|470520865|FG002|Overall Study|Required more intensive care|2|||
130698512|NCT01513239|470520866|FG000|Period 1: Main Phase|Adverse Event|1|||
130698513|NCT01513239|470520867|FG001|Period 1: Main Phase|Adverse Event|1|||
130698514|NCT01513239|470520868|FG002|Period 1: Main Phase|Adverse Event|2|||
130698515|NCT01513239|470520869|FG003|Period 1: Main Phase|Adverse Event|0|||
130698516|NCT01513239|470520870|FG004|Period 1: Main Phase|Adverse Event|0|||
130698517|NCT01513239|470520871|FG005|Period 1: Main Phase|Adverse Event|0|||
130698518|NCT01513239|470520866|FG000|Period 1: Main Phase|Death|29|||
130698519|NCT01513239|470520867|FG001|Period 1: Main Phase|Death|22|||
130698520|NCT01513239|470520868|FG002|Period 1: Main Phase|Death|32|||
130698521|NCT01513239|470520869|FG003|Period 1: Main Phase|Death|0|||
130698522|NCT01513239|470520870|FG004|Period 1: Main Phase|Death|0|||
130698523|NCT01513239|470520871|FG005|Period 1: Main Phase|Death|0|||
130698524|NCT01513239|470520866|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
130698525|NCT01513239|470520867|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
130698526|NCT01513239|470520868|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
130698527|NCT01513239|470520869|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
130698528|NCT01513239|470520870|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
130698529|NCT01513239|470520871|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
130698530|NCT01513239|470520866|FG000|Period 1: Main Phase|Physician Decision|4|||
130698531|NCT01513239|470520867|FG001|Period 1: Main Phase|Physician Decision|4|||
130698532|NCT01513239|470520868|FG002|Period 1: Main Phase|Physician Decision|4|||
130698533|NCT01513239|470520869|FG003|Period 1: Main Phase|Physician Decision|0|||
130698534|NCT01513239|470520870|FG004|Period 1: Main Phase|Physician Decision|0|||
130698535|NCT01513239|470520871|FG005|Period 1: Main Phase|Physician Decision|0|||
130698536|NCT01513239|470520866|FG000|Period 1: Main Phase|Protocol Violation|2|||
130698537|NCT01513239|470520867|FG001|Period 1: Main Phase|Protocol Violation|2|||
130698538|NCT01513239|470520868|FG002|Period 1: Main Phase|Protocol Violation|2|||
130698539|NCT01513239|470520869|FG003|Period 1: Main Phase|Protocol Violation|0|||
130698540|NCT01513239|470520870|FG004|Period 1: Main Phase|Protocol Violation|0|||
130698541|NCT01513239|470520871|FG005|Period 1: Main Phase|Protocol Violation|0|||
130698542|NCT01513239|470520866|FG000|Period 1: Main Phase|Technical Problems|1|||
130698543|NCT01513239|470520867|FG001|Period 1: Main Phase|Technical Problems|2|||
130698544|NCT01513239|470520868|FG002|Period 1: Main Phase|Technical Problems|0|||
130698545|NCT01513239|470520869|FG003|Period 1: Main Phase|Technical Problems|0|||
130698546|NCT01513239|470520870|FG004|Period 1: Main Phase|Technical Problems|0|||
130698547|NCT01513239|470520871|FG005|Period 1: Main Phase|Technical Problems|0|||
130698548|NCT01513239|470520866|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
131118074|NCT01949155|472064102|FG000|Overall Study|Lost to Follow-up|1|||
131118075|NCT01949155|472064103|FG001|Overall Study|Lost to Follow-up|0|||
131118076|NCT01949155|472064102|FG000|Overall Study|Protocol Violation|1|||
130698549|NCT01513239|470520867|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
130698550|NCT01513239|470520868|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
130698551|NCT01513239|470520869|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
130698552|NCT01513239|470520870|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
130769046|NCT00094536|470778688|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
131118077|NCT01949155|472064103|FG001|Overall Study|Protocol Violation|0|||
131118078|NCT00314249|472064104|FG000|Overall Study|Adverse Event|73|||
130913515|NCT05108922|471319856|FG001|Overall Study|Physician Decision|3|||
130698553|NCT01513239|470520871|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
130698554|NCT01513239|470520866|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
130698555|NCT01513239|470520867|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
130698556|NCT01513239|470520868|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
130698557|NCT01513239|470520869|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
130698558|NCT01513239|470520870|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
130698559|NCT01513239|470520871|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
130698560|NCT01513239|470520866|FG000|Period 2: 9 Month Extension Phase|Death|0|||
130698561|NCT01513239|470520867|FG001|Period 2: 9 Month Extension Phase|Death|0|||
130698562|NCT01513239|470520868|FG002|Period 2: 9 Month Extension Phase|Death|0|||
130698563|NCT01513239|470520869|FG003|Period 2: 9 Month Extension Phase|Death|2|||
130698564|NCT01513239|470520870|FG004|Period 2: 9 Month Extension Phase|Death|5|||
130698565|NCT01513239|470520871|FG005|Period 2: 9 Month Extension Phase|Death|2|||
130698566|NCT01513239|470520866|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130698567|NCT01513239|470520867|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130698568|NCT01513239|470520868|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130698569|NCT01513239|470520869|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
130698570|NCT01513239|470520870|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
130698571|NCT01513239|470520871|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130698572|NCT01513239|470520866|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130698573|NCT01513239|470520867|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130698574|NCT01513239|470520868|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130698575|NCT01513239|470520869|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
130698576|NCT01513239|470520870|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130698577|NCT01513239|470520871|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130698578|NCT01513239|470520866|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130698579|NCT01513239|470520867|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130698580|NCT01513239|470520868|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130698581|NCT01513239|470520869|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130698582|NCT01513239|470520870|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
130698583|NCT01513239|470520871|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
130698584|NCT03167606|470520874|FG000|Overall Study|Lost to Follow-up|73|||
130698585|NCT03167606|470520875|FG001|Overall Study|Lost to Follow-up|64|||
130698586|NCT03167606|470520874|FG000|Overall Study|Withdrawal by Subject|6|||
130698587|NCT03167606|470520875|FG001|Overall Study|Withdrawal by Subject|5|||
130698588|NCT03167606|470520874|FG000|Overall Study|Withdrawal by Investigator|0|||
130698589|NCT03167606|470520875|FG001|Overall Study|Withdrawal by Investigator|2|||
130698590|NCT00059332|470520876|FG000|Overall Study|Withdrawal by Subject|2|||
130698591|NCT00059332|470520877|FG001|Overall Study|Withdrawal by Subject|1|||
130698592|NCT00059332|470520876|FG000|Overall Study|Lost to Follow-up|1|||
130698593|NCT00059332|470520877|FG001|Overall Study|Lost to Follow-up|1|||
130698594|NCT00413049|470520879|FG000|Overall Study|Adverse Event|10|||
130698595|NCT00413049|470520880|FG001|Overall Study|Adverse Event|8|||
130698596|NCT00413049|470520879|FG000|Overall Study|Withdrawal by Subject|7|||
130698597|NCT00413049|470520880|FG001|Overall Study|Withdrawal by Subject|5|||
130698598|NCT00413049|470520879|FG000|Overall Study|Lost to Follow-up|2|||
130698599|NCT00413049|470520880|FG001|Overall Study|Lost to Follow-up|3|||
130698600|NCT00413049|470520879|FG000|Overall Study|Protocol Violation|3|||
130698601|NCT00413049|470520880|FG001|Overall Study|Protocol Violation|1|||
130698602|NCT00413049|470520879|FG000|Overall Study|Subject no longer requires study drug|0|||
130698603|NCT00413049|470520880|FG001|Overall Study|Subject no longer requires study drug|1|||
130698604|NCT00413049|470520879|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130698605|NCT00413049|470520880|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130698606|NCT00413049|470520879|FG000|Overall Study|Lack of Efficacy|1|||
130698607|NCT00413049|470520880|FG001|Overall Study|Lack of Efficacy|0|||
130698608|NCT01460628|470520881|FG000|Overall Study|Adverse Event|3|||
130698609|NCT01460628|470520881|FG000|Overall Study|Withdrawal by Subject|2|||
130698610|NCT02587143|470520882|FG000|Overall Study|Adverse Event|1|||
130698611|NCT02587143|470520883|FG001|Overall Study|Adverse Event|0|||
130698612|NCT03314857|470520886|FG000|Overall Study|Death|4|||
130698613|NCT03314857|470520886|FG000|Overall Study|Physician Decision|1|||
130698614|NCT01119625|470520887|FG000|Overall Study|Lost to Follow-up|1|||
130698615|NCT01119625|470520888|FG001|Overall Study|Lost to Follow-up|2|||
130698616|NCT01119625|470520887|FG000|Overall Study|Withdrawal by Subject|2|||
130698617|NCT01119625|470520888|FG001|Overall Study|Withdrawal by Subject|1|||
130698618|NCT01119625|470520887|FG000|Overall Study|Other|0|||
130698619|NCT01119625|470520888|FG001|Overall Study|Other|1|||
130698620|NCT01721772|470520895|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
130698621|NCT01721772|470520896|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
130698622|NCT01721772|470520895|FG000|Pre-Treatment|Poor/non-compliance|0|||
130698623|NCT01721772|470520896|FG001|Pre-Treatment|Poor/non-compliance|1|||
130698624|NCT01721772|470520895|FG000|Pre-Treatment|Participant withdrew consent|0|||
130698625|NCT01721772|470520896|FG001|Pre-Treatment|Participant withdrew consent|1|||
130698626|NCT01721772|470520895|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
130698627|NCT01721772|470520896|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
130698628|NCT01721772|470520895|FG000|Treatment|Disease progression|119|||
130698629|NCT01721772|470520896|FG001|Treatment|Disease progression|168|||
130698630|NCT01721772|470520895|FG000|Treatment|Study drug toxicity|19|||
130698631|NCT01721772|470520896|FG001|Treatment|Study drug toxicity|10|||
130698632|NCT01721772|470520895|FG000|Treatment|Adverse event unrelated to study drug|7|||
130698633|NCT01721772|470520896|FG001|Treatment|Adverse event unrelated to study drug|7|||
130698634|NCT01721772|470520895|FG000|Treatment|Maximum clinical benefit|16|||
130698635|NCT01721772|470520896|FG001|Treatment|Maximum clinical benefit|4|||
130698636|NCT01721772|470520895|FG000|Treatment|Other|19|||
130698637|NCT01721772|470520896|FG001|Treatment|Other|2|||
130698638|NCT01721772|470520895|FG000|Treatment|Participant withdrew consent|2|||
130698639|NCT01721772|470520896|FG001|Treatment|Participant withdrew consent|5|||
130698640|NCT01721772|470520895|FG000|Treatment|Participant request to discontinue study treatment|21|||
130698641|NCT01721772|470520896|FG001|Treatment|Participant request to discontinue study treatment|8|||
130698642|NCT01721772|470520895|FG000|Treatment|Death|1|||
130698643|NCT01721772|470520896|FG001|Treatment|Death|0|||
130698644|NCT01721772|470520895|FG000|Treatment|Not reported|1|||
130698645|NCT01721772|470520896|FG001|Treatment|Not reported|0|||
130698646|NCT01721772|470520895|FG000|Treatment|Poor/non-compliance|1|||
130698647|NCT01721772|470520896|FG001|Treatment|Poor/non-compliance|0|||
130698648|NCT01721772|470520895|FG000|Treatment|Lost to Follow-up|0|||
130698649|NCT01721772|470520896|FG001|Treatment|Lost to Follow-up|1|||
130698650|NCT00397254|470520904|FG000|Overall Study|Lost to Follow-up|2|||
130698651|NCT00397254|470520905|FG001|Overall Study|Lost to Follow-up|2|||
130698652|NCT02340780|470520906|FG000|Overall Study|Ineligible|1|||
130698653|NCT02637141|470520908|FG000|Overall Study|Adverse Event|1|||
130698654|NCT02637141|470520909|FG001|Overall Study|Adverse Event|1|||
130698655|NCT02637141|470520910|FG002|Overall Study|Adverse Event|0|||
130698656|NCT02637141|470520908|FG000|Overall Study|Withdrawal by Subject|1|||
130698657|NCT02637141|470520909|FG001|Overall Study|Withdrawal by Subject|1|||
130698658|NCT02637141|470520910|FG002|Overall Study|Withdrawal by Subject|1|||
130698659|NCT03885934|470520915|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
130698660|NCT03885934|470520916|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
130698661|NCT03885934|470520917|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
130698662|NCT03885934|470520918|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
130698663|NCT03885934|470520919|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
130698664|NCT03885934|470520920|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
130698665|NCT04473326|470520925|FG000|Overall Study|Death|0|||
130698666|NCT04473326|470520926|FG001|Overall Study|Death|1|||
130698667|NCT04473326|470520925|FG000|Overall Study|Withdrawal by Subject|1|||
130698668|NCT04473326|470520926|FG001|Overall Study|Withdrawal by Subject|2|||
130698669|NCT02046122|470520927|FG000|Overall Study|Physician Decision|8|||
130698670|NCT02046122|470520927|FG000|Overall Study|Withdrawal by Subject|1|||
130698671|NCT01559116|470520928|FG000|Overall Study|Adverse Event|10|||
130698672|NCT01559116|470520928|FG000|Overall Study|Lack of Efficacy|1|||
130698673|NCT01559116|470520928|FG000|Overall Study|Lost to Follow-up|1|||
130698674|NCT01559116|470520928|FG000|Overall Study|Protocol Violation|1|||
130698675|NCT01559116|470520928|FG000|Overall Study|Withdrawal by Subject|4|||
130698676|NCT01559116|470520928|FG000|Overall Study|other than stated above|9|||
130698677|NCT01532908|470520929|FG000|Overall Study|Not Transplanted|1|||
130698678|NCT01532908|470520930|FG001|Overall Study|Not Transplanted|0|||
130698679|NCT00021541|470520931|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
130698680|NCT00021541|470520932|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
130698681|NCT00021541|470520931|FG000|Period 1-First Treatment|Adverse Event|2|||
130698682|NCT00021541|470520932|FG001|Period 1-First Treatment|Adverse Event|1|||
130698683|NCT00021541|470520931|FG000|Period 1-First Treatment|non-adherence|3|||
130769047|NCT00094536|470778688|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
131032539|NCT03302494|471751493|FG001|Overall Study|Adverse Event|2|||
131032540|NCT03302494|471751494|FG002|Overall Study|Adverse Event|0|||
131032541|NCT03302494|471751492|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
131032542|NCT03302494|471751493|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
130698684|NCT00021541|470520932|FG001|Period 1-First Treatment|non-adherence|0|||
130698685|NCT00021541|470520931|FG000|Period 1-First Treatment|Death|1|||
130698686|NCT00021541|470520932|FG001|Period 1-First Treatment|Death|0|||
130698687|NCT00021541|470520931|FG000|Period 1-First Treatment|Pts that did not progress|2|||
130698688|NCT00021541|470520932|FG001|Period 1-First Treatment|Pts that did not progress|2|||
130698689|NCT00021541|470520931|FG000|Period 1-First Treatment|Ineligible|0|||
130698690|NCT00021541|470520932|FG001|Period 1-First Treatment|Ineligible|2|||
130698691|NCT00021541|470520931|FG000|Period 2-crossover|refused phase B|2|||
130698692|NCT00021541|470520932|FG001|Period 2-crossover|refused phase B|2|||
130698693|NCT00021541|470520931|FG000|Period 2-crossover|Withdrawal by Subject|3|||
130698694|NCT00021541|470520932|FG001|Period 2-crossover|Withdrawal by Subject|4|||
130698695|NCT00021541|470520931|FG000|Period 2-crossover|Adverse Event|2|||
130698696|NCT00021541|470520932|FG001|Period 2-crossover|Adverse Event|2|||
131118079|NCT00314249|472064105|FG001|Overall Study|Adverse Event|94|||
131118080|NCT00314249|472064104|FG000|Overall Study|Lack of Efficacy|33|||
131118081|NCT00314249|472064105|FG001|Overall Study|Lack of Efficacy|24|||
131118082|NCT00314249|472064104|FG000|Overall Study|Withdrawal by Subject|21|||
131118083|NCT00314249|472064105|FG001|Overall Study|Withdrawal by Subject|28|||
131118084|NCT00314249|472064104|FG000|Overall Study|Lost to Follow-up|15|||
131118085|NCT00314249|472064105|FG001|Overall Study|Lost to Follow-up|9|||
131118086|NCT00314249|472064104|FG000|Overall Study|Physician Decision|1|||
131118087|NCT00314249|472064105|FG001|Overall Study|Physician Decision|1|||
131118088|NCT00314249|472064104|FG000|Overall Study|Withdrawn for other reasons|4|||
131118089|NCT00314249|472064105|FG001|Overall Study|Withdrawn for other reasons|1|||
131118090|NCT00314249|472064104|FG000|Overall Study|Non-Compliant|5|||
131118091|NCT00314249|472064105|FG001|Overall Study|Non-Compliant|6|||
131118092|NCT00210184|472064106|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
131118093|NCT01353508|472064107|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
131118094|NCT01353508|472064108|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
131118095|NCT01353508|472064109|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
130698697|NCT00021541|470520931|FG000|Period 2-crossover|non-adherence|1|||
130698698|NCT00021541|470520932|FG001|Period 2-crossover|non-adherence|0|||
130698699|NCT00021541|470520931|FG000|Period 2-crossover|Pts that did not progress|2|||
130698700|NCT00021541|470520932|FG001|Period 2-crossover|Pts that did not progress|3|||
131118096|NCT01353508|472064110|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
131118097|NCT01353508|472064107|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
131118098|NCT01353508|472064108|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
131118099|NCT01353508|472064109|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
131118100|NCT01353508|472064110|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
130698701|NCT00826241|470520933|FG000|Overall Study|Withdrawal from Follow-up|1|||
130698702|NCT00826241|470520933|FG000|Overall Study|Withdrew consent|2|||
130698703|NCT00826241|470520933|FG000|Overall Study|Death|4|||
130698704|NCT00826241|470520933|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
130698705|NCT00826241|470520933|FG000|Overall Study|Non-compliance|1|||
130698706|NCT00826241|470520933|FG000|Overall Study|Progression of disease|1|||
130698707|NCT00826241|470520933|FG000|Overall Study|Patient refused follow-up|3|||
130698708|NCT00826241|470520933|FG000|Overall Study|Lost to Follow-up|9|||
130698709|NCT00826241|470520933|FG000|Overall Study|Could not obtain records|1|||
130698710|NCT00826241|470520933|FG000|Overall Study|Screen failure|2|||
130698711|NCT00826241|470520933|FG000|Overall Study|Pt unable to proceed to registration|1|||
130698712|NCT00826241|470520933|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
130698713|NCT01675596|470520936|FG000|Overall Study|Death|6|||
130698714|NCT01675596|470520936|FG000|Overall Study|Exit with other reason|1|||
130698715|NCT01675596|470520936|FG000|Overall Study|Missed Visit|1|||
130698716|NCT01539239|470520937|FG000|Overall Study|Death|5|||
130698717|NCT01539239|470520938|FG001|Overall Study|Death|5|||
130698718|NCT01539239|470520937|FG000|Overall Study|Lost to Follow-up|7|||
130698719|NCT01539239|470520938|FG001|Overall Study|Lost to Follow-up|12|||
130698720|NCT03201003|470520940|FG000|Overall Study|Adverse Event|14|||
130698721|NCT03201003|470520941|FG001|Overall Study|Adverse Event|1|||
130698722|NCT03201003|470520940|FG000|Overall Study|Other reasons|5|||
130698723|NCT03201003|470520941|FG001|Overall Study|Other reasons|1|||
130698724|NCT03201003|470520940|FG000|Overall Study|Withdrawal by Subject|4|||
130698725|NCT03201003|470520941|FG001|Overall Study|Withdrawal by Subject|1|||
130698726|NCT03201003|470520940|FG000|Overall Study|Lost to Follow-up|2|||
130698727|NCT03201003|470520941|FG001|Overall Study|Lost to Follow-up|0|||
130698728|NCT03201003|470520940|FG000|Overall Study|Protocol Violation|1|||
130698729|NCT03201003|470520941|FG001|Overall Study|Protocol Violation|0|||
130698730|NCT00834613|470520942|FG000|First Intervention|Protocol Violation|1|||
130698731|NCT00834613|470520943|FG001|First Intervention|Protocol Violation|0|||
130698732|NCT01751087|470520944|FG000|Overall Study|Withdrawal by Subject|1|||
130698733|NCT01751087|470520945|FG001|Overall Study|Withdrawal by Subject|0|||
130698734|NCT01751087|470520946|FG002|Overall Study|Withdrawal by Subject|0|||
130698735|NCT01751087|470520944|FG000|Overall Study|Physician Decision|0|||
131118101|NCT02606461|472064111|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
131118102|NCT02606461|472064112|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
131118103|NCT02606461|472064113|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
131118104|NCT02606461|472064114|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
131118105|NCT02606461|472064115|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130698736|NCT01751087|470520945|FG001|Overall Study|Physician Decision|0|||
130698737|NCT01751087|470520946|FG002|Overall Study|Physician Decision|1|||
130698738|NCT00697619|470520947|FG000|Overall Study|Lack of Efficacy|2|||
130698739|NCT00697619|470520948|FG001|Overall Study|Lack of Efficacy|2|||
130698740|NCT00697619|470520947|FG000|Overall Study|Adverse Event|4|||
130698741|NCT00697619|470520948|FG001|Overall Study|Adverse Event|6|||
130698742|NCT02005562|470522688|FG000|Overall Study|Death|2|||
130698743|NCT02005562|470522689|FG001|Overall Study|Death|2|||
131118106|NCT02606461|472064116|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
131118107|NCT02092350|472064117|FG000|Overall Study|Adverse Event|0|||
131118108|NCT02092350|472064118|FG001|Overall Study|Adverse Event|3|||
131118109|NCT02092350|472064117|FG000|Overall Study|Death|2|||
131118110|NCT02092350|472064118|FG001|Overall Study|Death|5|||
131118111|NCT02092350|472064117|FG000|Overall Study|Lost to Follow-up|3|||
131118112|NCT02092350|472064118|FG001|Overall Study|Lost to Follow-up|1|||
131118113|NCT02092350|472064117|FG000|Overall Study|Protocol Violation|1|||
131118114|NCT02092350|472064118|FG001|Overall Study|Protocol Violation|0|||
131118115|NCT02092350|472064117|FG000|Overall Study|Physician Decision|1|||
131118116|NCT02092350|472064118|FG001|Overall Study|Physician Decision|1|||
131118117|NCT02092350|472064117|FG000|Overall Study|Screen Failure|1|||
131118118|NCT02092350|472064118|FG001|Overall Study|Screen Failure|0|||
131118119|NCT02092350|472064117|FG000|Overall Study|Withdrawal by Subject|2|||
131118120|NCT02092350|472064118|FG001|Overall Study|Withdrawal by Subject|2|||
131118121|NCT00239226|472064119|FG000|Overall Study|permAF during stabilization period|0|||
131118122|NCT00239226|472064120|FG001|Overall Study|permAF during stabilization period|0|||
131118123|NCT00239226|472064121|FG002|Overall Study|permAF during stabilization period|0|||
131118124|NCT00239226|472064122|FG003|Overall Study|permAF during stabilization period|3|||
131118125|NCT00239226|472064119|FG000|Overall Study|Lost to Follow-up|1|||
131118126|NCT00239226|472064120|FG001|Overall Study|Lost to Follow-up|0|||
131118127|NCT00239226|472064121|FG002|Overall Study|Lost to Follow-up|1|||
131118128|NCT00239226|472064122|FG003|Overall Study|Lost to Follow-up|0|||
131118129|NCT00646906|472064123|FG000|Crossover Period 1|Withdrawal by Subject|1|||
131118130|NCT00646906|472064124|FG001|Crossover Period 1|Withdrawal by Subject|0|||
131118131|NCT00646906|472064125|FG002|Crossover Period 1|Withdrawal by Subject|0|||
131118132|NCT00646906|472064126|FG003|Crossover Period 1|Withdrawal by Subject|0|||
131118133|NCT00646906|472064127|FG004|Crossover Period 1|Withdrawal by Subject|0|||
131118134|NCT00646906|472064128|FG005|Crossover Period 1|Withdrawal by Subject|1|||
131118135|NCT00646906|472064129|FG006|Crossover Period 1|Withdrawal by Subject|0|||
131118136|NCT00646906|472064123|FG000|Crossover Period 2|Withdrawal by Subject|0|||
131118137|NCT00646906|472064124|FG001|Crossover Period 2|Withdrawal by Subject|1|||
131118138|NCT00646906|472064125|FG002|Crossover Period 2|Withdrawal by Subject|2|||
131118139|NCT00646906|472064126|FG003|Crossover Period 2|Withdrawal by Subject|1|||
131118140|NCT00646906|472064127|FG004|Crossover Period 2|Withdrawal by Subject|0|||
131118141|NCT00646906|472064128|FG005|Crossover Period 2|Withdrawal by Subject|0|||
131118142|NCT00646906|472064129|FG006|Crossover Period 2|Withdrawal by Subject|0|||
131118143|NCT00646906|472064123|FG000|Crossover Period 2|Physician Decision|0|||
131118144|NCT00646906|472064124|FG001|Crossover Period 2|Physician Decision|0|||
131118145|NCT00646906|472064125|FG002|Crossover Period 2|Physician Decision|0|||
130769048|NCT00094536|470778688|FG000|Treatment and Follow-up|Subject non-compliance|9|||
130769049|NCT00094536|470778688|FG000|Treatment and Follow-up|Unable to attend visits|1|||
130769050|NCT01687283|470780483|FG000|Overall Study|Adverse Event|11|||
130769051|NCT01687283|470780484|FG001|Overall Study|Adverse Event|4|||
130769052|NCT01687283|470780483|FG000|Overall Study|Lack of Efficacy|3|||
130769053|NCT01687283|470780484|FG001|Overall Study|Lack of Efficacy|1|||
130769054|NCT01687283|470780483|FG000|Overall Study|Protocol Violation|1|||
130769055|NCT01687283|470780484|FG001|Overall Study|Protocol Violation|3|||
130769056|NCT01687283|470780483|FG000|Overall Study|protocol defined stopping criteria|8|||
130769057|NCT01687283|470780484|FG001|Overall Study|protocol defined stopping criteria|10|||
130769058|NCT01687283|470780483|FG000|Overall Study|Lost to Follow-up|1|||
130769059|NCT01687283|470780484|FG001|Overall Study|Lost to Follow-up|1|||
130769060|NCT01687283|470780483|FG000|Overall Study|Investigator discretion|2|||
131118146|NCT00646906|472064126|FG003|Crossover Period 2|Physician Decision|0|||
131118147|NCT00646906|472064127|FG004|Crossover Period 2|Physician Decision|0|||
131118148|NCT00646906|472064128|FG005|Crossover Period 2|Physician Decision|0|||
131118149|NCT00646906|472064129|FG006|Crossover Period 2|Physician Decision|1|||
131118150|NCT04060563|472064132|FG000|Overall Study|Lost to Follow-up|1|||
131118151|NCT04060563|472064133|FG001|Overall Study|Lost to Follow-up|1|||
131118152|NCT04060563|472064132|FG000|Overall Study|Physician Decision|0|||
131118153|NCT04060563|472064133|FG001|Overall Study|Physician Decision|1|||
130913516|NCT05108922|471319855|FG000|Overall Study|Protocol deviation|1|||
130913517|NCT05108922|471319856|FG001|Overall Study|Protocol deviation|0|||
131118154|NCT00851682|472064134|FG000|Overall Study|screen failure|5|||
131118155|NCT00851682|472064135|FG001|Overall Study|screen failure|0|||
131118156|NCT01379573|472064139|FG000|Overall Study|Lost to Follow-up|1|||
131118157|NCT01379573|472064139|FG000|Overall Study|Screen Failure|10|||
131118158|NCT00962390|472064140|FG000|Overall Study|Adverse Event|0|||
131118159|NCT00962390|472064141|FG001|Overall Study|Adverse Event|0|||
131118160|NCT00962390|472064142|FG002|Overall Study|Adverse Event|3|||
130769061|NCT01687283|470780484|FG001|Overall Study|Investigator discretion|0|||
131118161|NCT00962390|472064143|FG003|Overall Study|Adverse Event|1|||
131118162|NCT00962390|472064140|FG000|Overall Study|Lost to Follow-up|2|||
131118163|NCT00962390|472064141|FG001|Overall Study|Lost to Follow-up|2|||
131118164|NCT00962390|472064142|FG002|Overall Study|Lost to Follow-up|0|||
130769062|NCT01687283|470780483|FG000|Overall Study|Withdrawal by Subject|9|||
130913518|NCT05108922|471319855|FG000|Overall Study|Screen failure|1|||
131118165|NCT00962390|472064143|FG003|Overall Study|Lost to Follow-up|0|||
131032543|NCT03302494|471751494|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
131032544|NCT05134233|471751495|FG000|Overall Study|Pregnancy|1|||
131032545|NCT05134233|471751495|FG000|Overall Study|MEP value too low|2|||
131032546|NCT05134233|471751495|FG000|Overall Study|Lost to Follow-up|1|||
131032547|NCT04763265|471751496|FG000|Overall Study|Adverse Event|1|||
131032548|NCT04763265|471751497|FG001|Overall Study|Adverse Event|0|||
131032549|NCT04763265|471751496|FG000|Overall Study|Lost to Follow-up|2|||
130698744|NCT02005562|470522688|FG000|Overall Study|Graft loss|7|||
130698745|NCT02005562|470522689|FG001|Overall Study|Graft loss|6|||
130698746|NCT02005562|470522688|FG000|Overall Study|Withdrawal by Subject|2|||
130698747|NCT02005562|470522689|FG001|Overall Study|Withdrawal by Subject|2|||
130698748|NCT02005562|470522688|FG000|Overall Study|No transplant|1|||
130698749|NCT02005562|470522689|FG001|Overall Study|No transplant|4|||
130698750|NCT02005562|470522688|FG000|Overall Study|Physician Decision|0|||
130698751|NCT02005562|470522689|FG001|Overall Study|Physician Decision|1|||
130698752|NCT00288704|470522692|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
130698753|NCT00288704|470522693|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
130698754|NCT00288704|470522694|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
130698755|NCT00288704|470522692|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
130698756|NCT00288704|470522693|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
130698757|NCT00288704|470522694|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
130698758|NCT00288704|470522692|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
130698759|NCT00288704|470522693|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
130698760|NCT00288704|470522694|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
130698761|NCT00288704|470522692|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
130698762|NCT00288704|470522693|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
130698763|NCT00288704|470522694|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
130698764|NCT00288704|470522692|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
130698765|NCT00288704|470522693|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
130698766|NCT00288704|470522694|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
130698767|NCT00288704|470522692|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
130698768|NCT00288704|470522693|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
130698769|NCT00288704|470522694|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
130698770|NCT00288704|470522692|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
130698771|NCT00288704|470522693|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
130698772|NCT00288704|470522694|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
130698773|NCT01579006|470522695|FG000|Overall Study|Lack of Efficacy|10|||
130698774|NCT01579006|470522695|FG000|Overall Study|Adverse Event|13|||
130698775|NCT01579006|470522695|FG000|Overall Study|Withdrawal by Subject|5|||
130698776|NCT01579006|470522695|FG000|Overall Study|Non-compliance|3|||
130698777|NCT01579006|470522695|FG000|Overall Study|Due to participant's health fund|1|||
130698778|NCT01579006|470522695|FG000|Overall Study|Scheduled surgery|1|||
130698779|NCT00799708|470522698|FG000|Overall Study|non-compliance|1|||
130698780|NCT00799708|470522699|FG001|Overall Study|non-compliance|0|||
130698781|NCT00799708|470522700|FG002|Overall Study|non-compliance|0|||
130913519|NCT05108922|471319856|FG001|Overall Study|Screen failure|0|||
131032550|NCT04763265|471751497|FG001|Overall Study|Lost to Follow-up|4|||
131032551|NCT04763265|471751496|FG000|Overall Study|Withdrawal by Subject|0|||
131032552|NCT04763265|471751497|FG001|Overall Study|Withdrawal by Subject|1|||
131032553|NCT05609760|471751507|FG000|Overall Study|Lost to Follow-up|0|||
131032554|NCT05609760|471751508|FG001|Overall Study|Lost to Follow-up|1|||
131032555|NCT05609760|471751507|FG000|Overall Study|Withdrawal by Subject|1|||
131032556|NCT05609760|471751508|FG001|Overall Study|Withdrawal by Subject|0|||
131032557|NCT05302596|471751509|FG000|Overall Study|Withdrawal by Subject|1|||
131032558|NCT05302596|471751510|FG001|Overall Study|Withdrawal by Subject|1|||
131032559|NCT02671903|471753059|FG000|Period 0 (Run-In)|Death|0|||
131032560|NCT02671903|471753060|FG001|Period 0 (Run-In)|Death|0|||
131032561|NCT02671903|471753061|FG002|Period 0 (Run-In)|Death|3|||
130698782|NCT03343639|470522701|FG000|Overall Study|Withdrawal by Subject|10|||
130698783|NCT03343639|470522702|FG001|Overall Study|Withdrawal by Subject|6|||
130698784|NCT03343639|470522701|FG000|Overall Study|Lost to Follow-up|4|||
130698785|NCT03343639|470522702|FG001|Overall Study|Lost to Follow-up|5|||
130698786|NCT03343639|470522701|FG000|Overall Study|Protocol Violation|0|||
130698787|NCT03343639|470522702|FG001|Overall Study|Protocol Violation|1|||
131032562|NCT02671903|471753059|FG000|Period 0 (Run-In)|Physician Decision|0|||
131032563|NCT02671903|471753060|FG001|Period 0 (Run-In)|Physician Decision|0|||
131032564|NCT02671903|471753061|FG002|Period 0 (Run-In)|Physician Decision|4|||
131032565|NCT02671903|471753059|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
131032566|NCT02671903|471753060|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
131032567|NCT02671903|471753061|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
131032568|NCT02671903|471753059|FG000|Period 0 (Run-In)|Protocol Violation|0|||
131032569|NCT02671903|471753060|FG001|Period 0 (Run-In)|Protocol Violation|0|||
131032570|NCT02671903|471753061|FG002|Period 0 (Run-In)|Protocol Violation|1|||
131032571|NCT02671903|471753059|FG000|Period 0 (Run-In)|Adverse Event|0|||
131032572|NCT02671903|471753060|FG001|Period 0 (Run-In)|Adverse Event|0|||
131032573|NCT02671903|471753061|FG002|Period 0 (Run-In)|Adverse Event|1|||
131032574|NCT02671903|471753059|FG000|Period 0 (Run-In)|Implantation Failure|0|||
131032575|NCT02671903|471753060|FG001|Period 0 (Run-In)|Implantation Failure|0|||
131032576|NCT02671903|471753061|FG002|Period 0 (Run-In)|Implantation Failure|2|||
131032577|NCT02671903|471753059|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
131032578|NCT02671903|471753060|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
131032579|NCT02671903|471753061|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
131032580|NCT03376321|471753062|FG000|Overall Study|Other|5|||
131118166|NCT00962390|472064140|FG000|Overall Study|Protocol Violation|1|||
131118167|NCT00962390|472064141|FG001|Overall Study|Protocol Violation|0|||
131118168|NCT00962390|472064142|FG002|Overall Study|Protocol Violation|0|||
131118169|NCT00962390|472064143|FG003|Overall Study|Protocol Violation|0|||
131118170|NCT00962390|472064140|FG000|Overall Study|Withdrawal by Subject|1|||
131118171|NCT00962390|472064141|FG001|Overall Study|Withdrawal by Subject|1|||
131118172|NCT00962390|472064142|FG002|Overall Study|Withdrawal by Subject|1|||
131118173|NCT00962390|472064143|FG003|Overall Study|Withdrawal by Subject|0|||
131118174|NCT02613884|472064144|FG000|Overall Study|Death|1|||
131118175|NCT02613884|472064144|FG000|Overall Study|Lost to Follow-up|1|||
130698788|NCT02697617|470522706|FG000|Overall Study|Withdrawal by Subject|0|||
130698789|NCT02697617|470522707|FG001|Overall Study|Withdrawal by Subject|2|||
130698790|NCT02697617|470522706|FG000|Overall Study|Pregnancy|1|||
130698791|NCT02697617|470522707|FG001|Overall Study|Pregnancy|0|||
130698792|NCT02460835|470522710|FG000|Overall Study|Disease progression prior to treatment|3|||
130698793|NCT02460835|470522710|FG000|Overall Study|Unable to complete planning scans|2|||
130698794|NCT02460835|470522710|FG000|Overall Study|Decrease in performance status|1|||
130698795|NCT02460835|470522710|FG000|Overall Study|Withdrawal by Subject|3|||
130698796|NCT02460835|470522710|FG000|Overall Study|Underwent fractionated RT|10|||
130698797|NCT02460835|470522710|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
130698798|NCT01157234|470522711|FG000|Overall Study|Withdrawal by Subject|1|||
130698799|NCT01157234|470522712|FG001|Overall Study|Withdrawal by Subject|0|||
130698800|NCT00876265|470522719|FG000|Overall Study|Miscellaneous reasons|4|||
130698801|NCT00876265|470522719|FG000|Overall Study|Lost to Follow-up|6|||
130698802|NCT00876265|470522719|FG000|Overall Study|Withdrawal by Subject|2|||
130698803|NCT03433703|470522722|FG000|Overall Study|Study terminated by Sponsor|2|||
130698804|NCT02786953|470522725|FG000|Overall Study|Withdrawal by Subject|3|||
130698805|NCT02786953|470522726|FG001|Overall Study|Withdrawal by Subject|0|||
130698806|NCT02786953|470522725|FG000|Overall Study|Physician Decision|0|||
130698807|NCT02786953|470522726|FG001|Overall Study|Physician Decision|1|||
130698808|NCT01698554|470522730|FG000|Overall Study|Adverse Event|2|||
130698809|NCT01698554|470522731|FG001|Overall Study|Adverse Event|5|||
130698810|NCT01698554|470522732|FG002|Overall Study|Adverse Event|0|||
130698811|NCT01698554|470522733|FG003|Overall Study|Adverse Event|1|||
130698812|NCT01698554|470522730|FG000|Overall Study|Lost to Follow-up|1|||
130698813|NCT01698554|470522731|FG001|Overall Study|Lost to Follow-up|0|||
130698814|NCT01698554|470522732|FG002|Overall Study|Lost to Follow-up|0|||
130698815|NCT01698554|470522733|FG003|Overall Study|Lost to Follow-up|0|||
130698816|NCT01698554|470522730|FG000|Overall Study|Personal Reasons|0|||
130698817|NCT01698554|470522731|FG001|Overall Study|Personal Reasons|5|||
130698818|NCT01698554|470522732|FG002|Overall Study|Personal Reasons|1|||
130698819|NCT01698554|470522733|FG003|Overall Study|Personal Reasons|1|||
130698820|NCT01698554|470522730|FG000|Overall Study|Protocol Violation|2|||
130698821|NCT01698554|470522731|FG001|Overall Study|Protocol Violation|0|||
130698822|NCT01698554|470522732|FG002|Overall Study|Protocol Violation|1|||
130698823|NCT01698554|470522733|FG003|Overall Study|Protocol Violation|0|||
130698824|NCT01698554|470522730|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130698825|NCT01698554|470522731|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130698826|NCT01698554|470522732|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130698827|NCT01698554|470522733|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130698828|NCT02229084|470522734|FG000|Overall Study|Adverse Event|1|||
130769063|NCT01687283|470780484|FG001|Overall Study|Withdrawal by Subject|8|||
130769064|NCT04003623|470780488|FG000|Overall Study|Withdrawal by Subject|1|||
131032581|NCT03376321|471753063|FG001|Overall Study|Other|1|||
131118176|NCT01514136|472064145|FG000|Test Period 1; Test A|Protocol Violation|1|||
130698829|NCT02229084|470522735|FG001|Overall Study|Adverse Event|0|||
130698830|NCT02229084|470522736|FG002|Overall Study|Adverse Event|0|||
131118177|NCT01514136|472064146|FG001|Test Period 1; Test A|Protocol Violation|0|||
130698831|NCT02229084|470522737|FG003|Overall Study|Adverse Event|0|||
130698832|NCT02229084|470522738|FG004|Overall Study|Adverse Event|0|||
130698833|NCT02229084|470522739|FG005|Overall Study|Adverse Event|0|||
130698834|NCT02229084|470522740|FG006|Overall Study|Adverse Event|0|||
130698835|NCT02229084|470522734|FG000|Overall Study|Lost to Follow-up|0|||
130698836|NCT02229084|470522735|FG001|Overall Study|Lost to Follow-up|0|||
130698837|NCT02229084|470522736|FG002|Overall Study|Lost to Follow-up|1|||
130698838|NCT02229084|470522737|FG003|Overall Study|Lost to Follow-up|1|||
130698839|NCT02229084|470522738|FG004|Overall Study|Lost to Follow-up|0|||
130698840|NCT02229084|470522739|FG005|Overall Study|Lost to Follow-up|0|||
131118178|NCT01514136|472064147|FG002|Test Period 1; Test A|Protocol Violation|0|||
131118179|NCT01514136|472064148|FG003|Test Period 1; Test A|Protocol Violation|0|||
131118180|NCT01514136|472064149|FG004|Test Period 1; Test A|Protocol Violation|0|||
131118181|NCT01514136|472064150|FG005|Test Period 1; Test A|Protocol Violation|0|||
131118182|NCT01514136|472064151|FG006|Test Period 1; Test A|Protocol Violation|0|||
131118183|NCT01514136|472064152|FG007|Test Period 1; Test A|Protocol Violation|0|||
131118184|NCT01514136|472064145|FG000|Test Period 1; Test A|Break from study holiday|2|||
131118185|NCT01514136|472064146|FG001|Test Period 1; Test A|Break from study holiday|0|||
131118186|NCT01514136|472064147|FG002|Test Period 1; Test A|Break from study holiday|0|||
131118187|NCT01514136|472064148|FG003|Test Period 1; Test A|Break from study holiday|0|||
131118188|NCT01514136|472064149|FG004|Test Period 1; Test A|Break from study holiday|0|||
131118189|NCT01514136|472064150|FG005|Test Period 1; Test A|Break from study holiday|0|||
131118190|NCT01514136|472064151|FG006|Test Period 1; Test A|Break from study holiday|0|||
131118191|NCT01514136|472064152|FG007|Test Period 1; Test A|Break from study holiday|0|||
131118192|NCT01514136|472064145|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
131118193|NCT01514136|472064146|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
131118194|NCT01514136|472064147|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
131118195|NCT01514136|472064148|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
131118196|NCT01514136|472064149|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
131118197|NCT01514136|472064150|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
131118198|NCT01514136|472064151|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
131118199|NCT01514136|472064152|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
131118200|NCT01514136|472064145|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
131118201|NCT01514136|472064146|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
131118202|NCT01514136|472064147|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
131118203|NCT01514136|472064148|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
131118204|NCT01514136|472064149|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
131118205|NCT01514136|472064150|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
130698841|NCT02229084|470522740|FG006|Overall Study|Lost to Follow-up|1|||
130698842|NCT02229084|470522734|FG000|Overall Study|Physician Decision|0|||
130698843|NCT02229084|470522735|FG001|Overall Study|Physician Decision|0|||
130698844|NCT02229084|470522736|FG002|Overall Study|Physician Decision|0|||
130698845|NCT02229084|470522737|FG003|Overall Study|Physician Decision|1|||
130698846|NCT02229084|470522738|FG004|Overall Study|Physician Decision|3|||
130698847|NCT02229084|470522739|FG005|Overall Study|Physician Decision|0|||
130698848|NCT02229084|470522740|FG006|Overall Study|Physician Decision|1|||
130698849|NCT02229084|470522734|FG000|Overall Study|Withdrawal by Subject|0|||
130698850|NCT02229084|470522735|FG001|Overall Study|Withdrawal by Subject|0|||
130698851|NCT02229084|470522736|FG002|Overall Study|Withdrawal by Subject|1|||
130698852|NCT02229084|470522737|FG003|Overall Study|Withdrawal by Subject|0|||
130698853|NCT02229084|470522738|FG004|Overall Study|Withdrawal by Subject|1|||
130698854|NCT02229084|470522739|FG005|Overall Study|Withdrawal by Subject|1|||
130698855|NCT02229084|470522740|FG006|Overall Study|Withdrawal by Subject|1|||
130698856|NCT02229084|470522734|FG000|Overall Study|Death|0|||
130698857|NCT02229084|470522735|FG001|Overall Study|Death|0|||
130698858|NCT02229084|470522736|FG002|Overall Study|Death|0|||
130698859|NCT02229084|470522737|FG003|Overall Study|Death|0|||
130698860|NCT02229084|470522738|FG004|Overall Study|Death|0|||
130698861|NCT02229084|470522739|FG005|Overall Study|Death|0|||
130698862|NCT02229084|470522740|FG006|Overall Study|Death|1|||
130698863|NCT04535986|470522749|FG000|Overall Study|Death|4|||
130698864|NCT04535986|470522750|FG001|Overall Study|Death|5|||
130698865|NCT04535986|470522749|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
130698866|NCT04535986|470522750|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
130698867|NCT04535986|470522749|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
130698868|NCT04535986|470522750|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
130698869|NCT04535986|470522749|FG000|Overall Study|Adverse Event|10|||
130698870|NCT04535986|470522750|FG001|Overall Study|Adverse Event|1|||
130698871|NCT04535986|470522749|FG000|Overall Study|Lack of Efficacy|3|||
130698872|NCT04535986|470522750|FG001|Overall Study|Lack of Efficacy|2|||
130698873|NCT04535986|470522749|FG000|Overall Study|Investigator discretion|3|||
131118206|NCT01514136|472064151|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
131118207|NCT01514136|472064152|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
131118208|NCT01514136|472064145|FG000|Test Period 2; Test A*|Adverse Event|0|||
131118209|NCT01514136|472064146|FG001|Test Period 2; Test A*|Adverse Event|0|||
130698874|NCT04535986|470522750|FG001|Overall Study|Investigator discretion|0|||
130769065|NCT04003623|470780489|FG001|Overall Study|Withdrawal by Subject|0|||
130698875|NCT04535986|470522749|FG000|Overall Study|Withdrawal by Subject|32|||
130698876|NCT04535986|470522750|FG001|Overall Study|Withdrawal by Subject|14|||
130698877|NCT04535986|470522749|FG000|Overall Study|Lost to Follow-up|5|||
130698878|NCT04535986|470522750|FG001|Overall Study|Lost to Follow-up|3|||
130698879|NCT04535986|470522749|FG000|Overall Study|Other|7|||
130698880|NCT04535986|470522750|FG001|Overall Study|Other|3|||
130698881|NCT04561115|470522753|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
130698882|NCT04561115|470522754|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
130698883|NCT04561115|470522753|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
130698884|NCT04561115|470522754|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
130698885|NCT04561115|470522753|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
130698886|NCT04561115|470522754|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
130698887|NCT00743145|470522755|FG000|Overall Study|Withdrawal by Subject|1|||
130698888|NCT00743145|470522755|FG000|Overall Study|Adverse Event|2|||
130698889|NCT00743145|470522755|FG000|Overall Study|Pregnancy|1|||
130698890|NCT01745094|470522756|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
130698891|NCT01745094|470522757|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
130698892|NCT01745094|470522758|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
130698893|NCT01745094|470522759|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
130698894|NCT01745094|470522756|FG000|Overall Study|Adverse Event|0|||
130698895|NCT01745094|470522757|FG001|Overall Study|Adverse Event|0|||
130698896|NCT01745094|470522758|FG002|Overall Study|Adverse Event|3|||
130698897|NCT01745094|470522759|FG003|Overall Study|Adverse Event|0|||
130698898|NCT01745094|470522756|FG000|Overall Study|Withdrawal by Subject|2|||
130698899|NCT01745094|470522757|FG001|Overall Study|Withdrawal by Subject|0|||
130698900|NCT01745094|470522758|FG002|Overall Study|Withdrawal by Subject|1|||
130698901|NCT01745094|470522759|FG003|Overall Study|Withdrawal by Subject|2|||
130698902|NCT01745094|470522756|FG000|Overall Study|Protocol Violation|1|||
130698903|NCT01745094|470522757|FG001|Overall Study|Protocol Violation|0|||
130698904|NCT01745094|470522758|FG002|Overall Study|Protocol Violation|3|||
130698905|NCT01745094|470522759|FG003|Overall Study|Protocol Violation|1|||
130698906|NCT01745094|470522756|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
130698907|NCT01745094|470522757|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
130698908|NCT01745094|470522758|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
130698909|NCT01745094|470522759|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
130698910|NCT01745094|470522756|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
130698911|NCT01745094|470522757|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
130698912|NCT01745094|470522758|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
130698913|NCT01745094|470522759|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
130698914|NCT01745094|470522756|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
130698915|NCT01745094|470522757|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
130698916|NCT01745094|470522758|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
130698917|NCT01745094|470522759|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
130698918|NCT02416180|470522760|FG000|Overall Study|Withdrawal by Subject|1|||
130698919|NCT00881569|470522764|FG000|Overall Study|Disease progression|1|||
130698920|NCT00881569|470522765|FG001|Overall Study|Disease progression|1|||
130698921|NCT01567527|470522776|FG000|Conversion Phase.|Protocol deviation|3|||
130698922|NCT01567527|470522777|FG001|Conversion Phase.|Protocol deviation|0|||
130698923|NCT01567527|470522778|FG002|Conversion Phase.|Protocol deviation|0|||
130698924|NCT01567527|470522779|FG003|Conversion Phase.|Protocol deviation|0|||
130698925|NCT01567527|470522780|FG004|Conversion Phase.|Protocol deviation|0|||
130698926|NCT01567527|470522776|FG000|Conversion Phase.|Met withdrawal criteria|10|||
130698927|NCT01567527|470522777|FG001|Conversion Phase.|Met withdrawal criteria|0|||
130698928|NCT01567527|470522778|FG002|Conversion Phase.|Met withdrawal criteria|0|||
130698929|NCT01567527|470522779|FG003|Conversion Phase.|Met withdrawal criteria|0|||
130698930|NCT01567527|470522780|FG004|Conversion Phase.|Met withdrawal criteria|0|||
130698931|NCT01567527|470522776|FG000|Conversion Phase.|Withdrawal by Subject|32|||
130698932|NCT01567527|470522777|FG001|Conversion Phase.|Withdrawal by Subject|0|||
130698933|NCT01567527|470522778|FG002|Conversion Phase.|Withdrawal by Subject|0|||
130698934|NCT01567527|470522779|FG003|Conversion Phase.|Withdrawal by Subject|0|||
130698935|NCT01567527|470522780|FG004|Conversion Phase.|Withdrawal by Subject|0|||
130698936|NCT01567527|470522776|FG000|Conversion Phase.|Lost to Follow-up|16|||
130698937|NCT01567527|470522777|FG001|Conversion Phase.|Lost to Follow-up|0|||
130698938|NCT01567527|470522778|FG002|Conversion Phase.|Lost to Follow-up|0|||
130698939|NCT01567527|470522779|FG003|Conversion Phase.|Lost to Follow-up|0|||
130698940|NCT01567527|470522780|FG004|Conversion Phase.|Lost to Follow-up|0|||
130698941|NCT01567527|470522776|FG000|Conversion Phase.|Lack of Efficacy|2|||
130698942|NCT01567527|470522777|FG001|Conversion Phase.|Lack of Efficacy|0|||
130698943|NCT01567527|470522778|FG002|Conversion Phase.|Lack of Efficacy|0|||
130769066|NCT00703326|470780491|FG000|Overall Study|Lost to Follow-up|47|||
130698944|NCT01567527|470522779|FG003|Conversion Phase.|Lack of Efficacy|0|||
130698945|NCT01567527|470522780|FG004|Conversion Phase.|Lack of Efficacy|0|||
130698946|NCT01567527|470522776|FG000|Conversion Phase.|Adverse Event|33|||
130698947|NCT01567527|470522777|FG001|Conversion Phase.|Adverse Event|0|||
130698948|NCT01567527|470522778|FG002|Conversion Phase.|Adverse Event|0|||
130698949|NCT01567527|470522779|FG003|Conversion Phase.|Adverse Event|0|||
130698950|NCT01567527|470522780|FG004|Conversion Phase.|Adverse Event|0|||
130698951|NCT01567527|470522776|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
130698952|NCT01567527|470522777|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
130698953|NCT01567527|470522778|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
130698954|NCT01567527|470522779|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
130698955|NCT01567527|470522780|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
130698956|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130698957|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
130698958|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130698959|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130698960|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130698961|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130698962|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
130698963|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130698964|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130698965|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130698966|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130698967|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
130698968|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130698969|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130698970|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130698971|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
130698972|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
130698973|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
130698974|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
131032582|NCT03376321|471753062|FG000|Overall Study|Withdrawal by Subject|8|||
131032583|NCT03376321|471753063|FG001|Overall Study|Withdrawal by Subject|14|||
131032584|NCT03376321|471753062|FG000|Overall Study|Lost to Follow-up|1|||
131032585|NCT03376321|471753063|FG001|Overall Study|Lost to Follow-up|7|||
131032586|NCT03376321|471753062|FG000|Overall Study|Death|4|||
131032587|NCT03376321|471753063|FG001|Overall Study|Death|0|||
131032588|NCT03376321|471753062|FG000|Overall Study|Randomized, not treated|5|||
131032589|NCT03376321|471753063|FG001|Overall Study|Randomized, not treated|3|||
131032590|NCT04258709|471753064|FG000|Overall Study|Lost to Follow-up|10|||
131032591|NCT04258709|471753065|FG001|Overall Study|Lost to Follow-up|4|||
131032592|NCT04258709|471753064|FG000|Overall Study|Withdrawal by Subject|1|||
131032593|NCT04258709|471753065|FG001|Overall Study|Withdrawal by Subject|0|||
131032594|NCT04258709|471753064|FG000|Overall Study|Fetal demise|0|||
131032595|NCT04258709|471753065|FG001|Overall Study|Fetal demise|1|||
131032596|NCT04258709|471753064|FG000|Overall Study|Protocol Violation|1|||
131032597|NCT04258709|471753065|FG001|Overall Study|Protocol Violation|1|||
131032598|NCT02287610|471753066|FG000|Overall Study|Lost to Follow-up|3|||
131032599|NCT02287610|471753066|FG000|Overall Study|Withdrawal by Subject|8|||
131032600|NCT02287610|471753066|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
131032601|NCT05273749|471753067|FG000|Overall Study|Adverse Event|14|||
131032602|NCT05273749|471753068|FG001|Overall Study|Adverse Event|8|||
131032603|NCT05273749|471753067|FG000|Overall Study|Lack of Efficacy|2|||
131032604|NCT05273749|471753068|FG001|Overall Study|Lack of Efficacy|8|||
131032605|NCT05273749|471753067|FG000|Overall Study|Physician Decision|0|||
131032606|NCT05273749|471753068|FG001|Overall Study|Physician Decision|2|||
131032607|NCT05273749|471753067|FG000|Overall Study|Withdrawal by Subject|14|||
131032608|NCT05273749|471753068|FG001|Overall Study|Withdrawal by Subject|16|||
131032609|NCT05273749|471753067|FG000|Overall Study|Lost to Follow-up|10|||
131032610|NCT05273749|471753068|FG001|Overall Study|Lost to Follow-up|10|||
131032611|NCT05273749|471753067|FG000|Overall Study|Pregnancy|1|||
131032612|NCT05273749|471753068|FG001|Overall Study|Pregnancy|0|||
131032613|NCT05273749|471753067|FG000|Overall Study|Non-Compliance|3|||
131032614|NCT05273749|471753068|FG001|Overall Study|Non-Compliance|2|||
131032615|NCT05273749|471753067|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
131032616|NCT05273749|471753068|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
131032617|NCT04806594|471753069|FG000|Overall Study|Withdrawal by Subject|2|||
131032618|NCT04806594|471753069|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
131032619|NCT04318548|471753072|FG000|Overall Study|Adverse Event|0|||
131032620|NCT04318548|471753073|FG001|Overall Study|Adverse Event|0|||
131032621|NCT04318548|471753074|FG002|Overall Study|Adverse Event|1|||
130698975|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
131032622|NCT04318548|471753072|FG000|Overall Study|Lost to Follow-up|6|||
131032623|NCT04318548|471753073|FG001|Overall Study|Lost to Follow-up|13|||
130698976|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130698977|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
131032624|NCT04318548|471753074|FG002|Overall Study|Lost to Follow-up|9|||
131032625|NCT04318548|471753072|FG000|Overall Study|Protocol Violation|1|||
131032626|NCT04318548|471753073|FG001|Overall Study|Protocol Violation|0|||
131032627|NCT04318548|471753074|FG002|Overall Study|Protocol Violation|2|||
131032628|NCT04318548|471753072|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
130769067|NCT00703326|470780492|FG001|Overall Study|Lost to Follow-up|18|||
130769068|NCT00703326|470780491|FG000|Overall Study|Withdrawal by Subject|54|||
130769069|NCT00703326|470780492|FG001|Overall Study|Withdrawal by Subject|20|||
130769070|NCT00703326|470780491|FG000|Overall Study|Adverse Event|1|||
130769071|NCT00703326|470780492|FG001|Overall Study|Adverse Event|0|||
130769072|NCT01393106|470780495|FG000|Overall Study|Adverse Event|3|||
130769073|NCT01393106|470780495|FG000|Overall Study|Withdrawal by Subject|1|||
130769074|NCT01393106|470780495|FG000|Overall Study|Lack of Efficacy|1|||
130769075|NCT01744483|470780496|FG000|Overall Study|Death|9|||
130769076|NCT01744483|470780497|FG001|Overall Study|Death|4|||
130769077|NCT01744483|470780498|FG002|Overall Study|Death|11|||
130769078|NCT01744483|470780496|FG000|Overall Study|Lost to Follow-up|8|||
130769079|NCT01744483|470780497|FG001|Overall Study|Lost to Follow-up|9|||
130769080|NCT01744483|470780498|FG002|Overall Study|Lost to Follow-up|11|||
130769081|NCT01744483|470780496|FG000|Overall Study|Protocol Violation|1|||
130769082|NCT01744483|470780497|FG001|Overall Study|Protocol Violation|2|||
130769083|NCT01744483|470780498|FG002|Overall Study|Protocol Violation|1|||
130769084|NCT01744483|470780496|FG000|Overall Study|Withdrawal by Subject|4|||
130769085|NCT01744483|470780497|FG001|Overall Study|Withdrawal by Subject|6|||
130769086|NCT01744483|470780498|FG002|Overall Study|Withdrawal by Subject|2|||
130769087|NCT01744483|470780496|FG000|Overall Study|No ICU Admit|5|||
130769088|NCT01744483|470780497|FG001|Overall Study|No ICU Admit|1|||
130769089|NCT01744483|470780498|FG002|Overall Study|No ICU Admit|2|||
130769090|NCT01744483|470780496|FG000|Overall Study|Routed to OSH|2|||
130769091|NCT01744483|470780497|FG001|Overall Study|Routed to OSH|0|||
130769092|NCT01744483|470780498|FG002|Overall Study|Routed to OSH|1|||
130769093|NCT03041467|470780499|FG000|Overall Study|Death|46|||
130769094|NCT03041467|470780500|FG001|Overall Study|Death|39|||
131032629|NCT04318548|471753073|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
130698978|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
131032630|NCT04318548|471753074|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
130698979|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130698980|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130698981|NCT01567527|470522776|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130698982|NCT01567527|470522777|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
130698983|NCT01567527|470522778|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130698984|NCT01567527|470522779|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130698985|NCT01567527|470522780|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
131032631|NCT04318548|471753072|FG000|Overall Study|Migrated / moved from the study area|0|||
131032632|NCT04318548|471753073|FG001|Overall Study|Migrated / moved from the study area|0|||
131032633|NCT04318548|471753074|FG002|Overall Study|Migrated / moved from the study area|1|||
131032634|NCT04318548|471753072|FG000|Overall Study|Other|1|||
131032635|NCT04318548|471753073|FG001|Overall Study|Other|2|||
131032636|NCT04318548|471753074|FG002|Overall Study|Other|3|||
131118210|NCT01514136|472064147|FG002|Test Period 2; Test A*|Adverse Event|0|||
131118211|NCT01514136|472064148|FG003|Test Period 2; Test A*|Adverse Event|0|||
131118212|NCT01514136|472064149|FG004|Test Period 2; Test A*|Adverse Event|1|||
131118213|NCT01514136|472064150|FG005|Test Period 2; Test A*|Adverse Event|0|||
131118214|NCT01514136|472064151|FG006|Test Period 2; Test A*|Adverse Event|0|||
131118215|NCT01514136|472064152|FG007|Test Period 2; Test A*|Adverse Event|0|||
131118216|NCT01514136|472064145|FG000|Test Period 2; Test A*|Holiday|0|||
131118217|NCT01514136|472064146|FG001|Test Period 2; Test A*|Holiday|0|||
131118218|NCT01514136|472064147|FG002|Test Period 2; Test A*|Holiday|0|||
131118219|NCT01514136|472064148|FG003|Test Period 2; Test A*|Holiday|0|||
131118220|NCT01514136|472064149|FG004|Test Period 2; Test A*|Holiday|1|||
131118221|NCT01514136|472064150|FG005|Test Period 2; Test A*|Holiday|0|||
131118222|NCT01514136|472064151|FG006|Test Period 2; Test A*|Holiday|0|||
131118223|NCT01514136|472064152|FG007|Test Period 2; Test A*|Holiday|0|||
131118224|NCT01514136|472064145|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
131118225|NCT01514136|472064146|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
131118226|NCT01514136|472064147|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
130698986|NCT01567527|470522776|FG000|IM Depot Stabilization.|Protocol deviation|0|||
130698987|NCT01567527|470522777|FG001|IM Depot Stabilization.|Protocol deviation|0|||
130769095|NCT03041467|470780499|FG000|Overall Study|Withdrawal by Subject|36|||
130769096|NCT03041467|470780500|FG001|Overall Study|Withdrawal by Subject|37|||
130769097|NCT03041467|470780499|FG000|Overall Study|Lost to Follow-up|6|||
131118227|NCT01514136|472064148|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
130769098|NCT03041467|470780500|FG001|Overall Study|Lost to Follow-up|8|||
130769099|NCT03041467|470780499|FG000|Overall Study|Declined consent for study extension|21|||
131118228|NCT01514136|472064149|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
131118229|NCT01514136|472064150|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
131032657|NCT01416831|471753081|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
131032658|NCT01416831|471753082|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
131032659|NCT05215314|471753083|FG000|Overall Study|Lost to Follow-up|2|||
131118230|NCT01514136|472064151|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
130698988|NCT01567527|470522778|FG002|IM Depot Stabilization.|Protocol deviation|5|||
130698989|NCT01567527|470522779|FG003|IM Depot Stabilization.|Protocol deviation|0|||
130698990|NCT01567527|470522780|FG004|IM Depot Stabilization.|Protocol deviation|0|||
130698991|NCT01567527|470522776|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
130698992|NCT01567527|470522777|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
130698993|NCT01567527|470522778|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
130698994|NCT01567527|470522779|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
130698995|NCT01567527|470522780|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
130698996|NCT01567527|470522776|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
130698997|NCT01567527|470522777|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
130698998|NCT01567527|470522778|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
130698999|NCT01567527|470522779|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
130699000|NCT01567527|470522780|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
130699001|NCT01567527|470522776|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
130699002|NCT01567527|470522777|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
130913520|NCT05108922|471319855|FG000|Overall Study|Withdrawal by Subject|11|||
130913521|NCT05108922|471319856|FG001|Overall Study|Withdrawal by Subject|8|||
130913522|NCT01846104|471319861|FG000|Overall Study|Withdrawal by Subject|1|||
130913523|NCT00851630|471319865|FG000|Overall Study|Death|2|||
130699003|NCT01567527|470522778|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
130699004|NCT01567527|470522779|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
130699005|NCT01567527|470522780|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
130699006|NCT01567527|470522776|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
130699007|NCT01567527|470522777|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
130699008|NCT01567527|470522778|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
130699009|NCT01567527|470522779|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
130699010|NCT01567527|470522780|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
130913524|NCT00851630|471319866|FG001|Overall Study|Death|1|||
130913525|NCT00851630|471319865|FG000|Overall Study|Clinical failure|0|||
130913526|NCT00851630|471319866|FG001|Overall Study|Clinical failure|1|||
130913527|NCT02349061|471319868|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
130913528|NCT02349061|471319869|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
130913529|NCT02349061|471319870|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
130913530|NCT02349061|471319868|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
130913531|NCT02349061|471319869|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
131032660|NCT05215314|471753084|FG001|Overall Study|Lost to Follow-up|2|||
131032661|NCT05215314|471753083|FG000|Overall Study|Withdrawal by Subject|2|||
131032662|NCT05215314|471753084|FG001|Overall Study|Withdrawal by Subject|0|||
131032663|NCT05215314|471753083|FG000|Overall Study|Physician Decision|1|||
131032664|NCT05215314|471753084|FG001|Overall Study|Physician Decision|0|||
131032665|NCT04784559|471753085|FG000|Overall Study|Withdrawal by Subject|3|||
131032666|NCT04784559|471753086|FG001|Overall Study|Withdrawal by Subject|2|||
131032667|NCT04784559|471753087|FG002|Overall Study|Withdrawal by Subject|1|||
131032668|NCT04784559|471753085|FG000|Overall Study|Death|2|||
131032669|NCT04784559|471753086|FG001|Overall Study|Death|1|||
131032670|NCT04784559|471753087|FG002|Overall Study|Death|2|||
131032671|NCT04784559|471753085|FG000|Overall Study|Lost to Follow-up|0|||
131032672|NCT04784559|471753086|FG001|Overall Study|Lost to Follow-up|0|||
131032673|NCT04784559|471753087|FG002|Overall Study|Lost to Follow-up|2|||
131032674|NCT04784559|471753085|FG000|Overall Study|Participant worsened, PI decision|1|||
131032675|NCT04784559|471753086|FG001|Overall Study|Participant worsened, PI decision|0|||
131032676|NCT04784559|471753087|FG002|Overall Study|Participant worsened, PI decision|0|||
131032677|NCT04784559|471753085|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
131032678|NCT04784559|471753086|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
131032679|NCT04784559|471753087|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
131032680|NCT04784559|471753085|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
131032681|NCT04784559|471753086|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
131032682|NCT04784559|471753087|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
131032683|NCT04784559|471753085|FG000|Overall Study|Did not meet all inclusion criteria|0|||
131032684|NCT04784559|471753086|FG001|Overall Study|Did not meet all inclusion criteria|1|||
131032685|NCT04784559|471753087|FG002|Overall Study|Did not meet all inclusion criteria|0|||
131032686|NCT04784559|471753085|FG000|Overall Study|The participant was transferred to IRCU|0|||
131032687|NCT04784559|471753086|FG001|Overall Study|The participant was transferred to IRCU|1|||
131032688|NCT04784559|471753087|FG002|Overall Study|The participant was transferred to IRCU|0|||
131032689|NCT04784559|471753085|FG000|Overall Study|SAE|0|||
130699011|NCT01567527|470522776|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
130699012|NCT01567527|470522777|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
130699013|NCT01567527|470522778|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
130913532|NCT02349061|471319870|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
130913533|NCT02349061|471319868|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
130913534|NCT02349061|471319869|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
130769100|NCT03041467|470780500|FG001|Overall Study|Declined consent for study extension|33|||
130769101|NCT03041467|470780499|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
131118231|NCT01514136|472064152|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
130769102|NCT03041467|470780500|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
130769103|NCT01190189|470780501|FG000|Overall Study|Lost to Follow-up|4|||
130769104|NCT01190189|470780501|FG000|Overall Study|Withdrawal by Subject|1|||
130769105|NCT01190189|470780501|FG000|Overall Study|Migrated/moved from study area|1|||
130769106|NCT00255840|470780508|FG000|Overall Study|Lost to Follow-up|10|||
130769107|NCT00255840|470780509|FG001|Overall Study|Lost to Follow-up|14|||
130769108|NCT00255840|470780508|FG000|Overall Study|Discontinued intervention|53|||
130769109|NCT00255840|470780509|FG001|Overall Study|Discontinued intervention|56|||
130769110|NCT04278924|470780511|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
130769111|NCT04278924|470780512|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
130769112|NCT04278924|470780513|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130769113|NCT04278924|470780514|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
130769114|NCT04278924|470780515|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130769115|NCT04278924|470780516|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130769116|NCT04278924|470780517|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130769117|NCT04278924|470780511|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
130769118|NCT04278924|470780512|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
130769119|NCT04278924|470780513|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
130769120|NCT04278924|470780514|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
130769121|NCT04278924|470780515|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
130769122|NCT04278924|470780516|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
130769123|NCT04278924|470780517|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
130769124|NCT06226649|470780518|FG000|Overall Study|Withdrawal by Subject|4|||
130769125|NCT06226649|470780519|FG001|Overall Study|Withdrawal by Subject|1|||
130769126|NCT04847232|470780520|FG000|Overall Study|Death|123|||
130769127|NCT04847232|470780521|FG001|Overall Study|Death|115|||
130769128|NCT04847232|470780520|FG000|Overall Study|Lost to Follow-up|3|||
130769129|NCT04847232|470780521|FG001|Overall Study|Lost to Follow-up|10|||
130769130|NCT04847232|470780520|FG000|Overall Study|Withdrawal by Subject|73|||
130769131|NCT04847232|470780521|FG001|Overall Study|Withdrawal by Subject|101|||
130769132|NCT04847232|470780520|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
130769133|NCT04847232|470780521|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
130769134|NCT00631163|470780522|FG000|Number of Participants in Year 1|Adverse Event|12|||
130769135|NCT00631163|470780522|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
130769136|NCT00631163|470780522|FG000|Number of Participants in Year 1|Death|6|||
130769137|NCT00631163|470780522|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
130769138|NCT00631163|470780522|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
130769139|NCT00631163|470780522|FG000|Number of Participants in Year 1|Administrative problems|6|||
130769140|NCT00631163|470780522|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
130769141|NCT00631163|470780522|FG000|Number of Participants in Year 2|Adverse Event|1|||
130769142|NCT00631163|470780522|FG000|Number of Participants in Year 2|Protocol Violation|1|||
130769143|NCT00631163|470780522|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
130769144|NCT04348500|470780525|FG000|Overall Study|Death|2|||
130769145|NCT04348500|470780526|FG001|Overall Study|Death|2|||
130769146|NCT04348500|470780525|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
130769147|NCT04348500|470780526|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
130769148|NCT03699540|470780527|FG000|Overall Study|Lost to Follow-up|1|||
131118232|NCT01514136|472064145|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
131118233|NCT01514136|472064146|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
131118234|NCT01514136|472064147|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
131118235|NCT01514136|472064148|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
131118236|NCT01514136|472064149|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
131118237|NCT01514136|472064150|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
131118238|NCT01514136|472064151|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
131118239|NCT01514136|472064152|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
131118240|NCT01514136|472064145|FG000|Test Period 2; Test C*|holiday|0|||
131118241|NCT01514136|472064146|FG001|Test Period 2; Test C*|holiday|0|||
131118242|NCT01514136|472064147|FG002|Test Period 2; Test C*|holiday|0|||
130769149|NCT03517449|470780534|FG000|Overall Study|Death|184|||
130769150|NCT03517449|470780535|FG001|Overall Study|Death|236|||
130769151|NCT03517449|470780534|FG000|Overall Study|Lost to Follow-up|0|||
130769152|NCT03517449|470780535|FG001|Overall Study|Lost to Follow-up|2|||
130769153|NCT03517449|470780534|FG000|Overall Study|Withdrawal by Subject|7|||
130769154|NCT03517449|470780535|FG001|Overall Study|Withdrawal by Subject|26|||
130769155|NCT03517449|470780534|FG000|Overall Study|Participants Ongoing|220|||
131118243|NCT01514136|472064148|FG003|Test Period 2; Test C*|holiday|0|||
131118244|NCT01514136|472064149|FG004|Test Period 2; Test C*|holiday|0|||
131118245|NCT01514136|472064150|FG005|Test Period 2; Test C*|holiday|0|||
130913535|NCT02349061|471319870|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
130913536|NCT02349061|471319868|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
130913537|NCT02349061|471319869|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
130913538|NCT02349061|471319870|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
130913539|NCT02349061|471319868|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
130913540|NCT02349061|471319869|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
130913541|NCT02349061|471319870|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
130913542|NCT02349061|471319868|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
130913543|NCT02349061|471319869|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
130913544|NCT02349061|471319870|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
130913545|NCT02349061|471319868|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
130913546|NCT02349061|471319869|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
130913547|NCT02349061|471319870|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
130913548|NCT02349061|471319868|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
130913549|NCT02349061|471319869|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
130913550|NCT02349061|471319870|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
130913551|NCT02349061|471319868|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
130913552|NCT02349061|471319869|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
130913553|NCT02349061|471319870|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
130913554|NCT02349061|471319868|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
130913555|NCT02349061|471319869|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
130913556|NCT02349061|471319870|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
130913557|NCT02349061|471319868|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
130913558|NCT02349061|471319869|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
130913559|NCT02349061|471319870|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
130913560|NCT02349061|471319868|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
130913561|NCT02349061|471319869|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
130913562|NCT02349061|471319870|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
130913563|NCT02349061|471319868|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
130913564|NCT02349061|471319869|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
130913565|NCT02349061|471319870|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
130913566|NCT00398411|471319871|FG000|Overall Study|Death|0|||
130913567|NCT00398411|471319872|FG001|Overall Study|Death|1|||
130913568|NCT02095223|471319873|FG000|Overall Study|Withdrawal by Subject|1|||
130913569|NCT02095223|471319874|FG001|Overall Study|Withdrawal by Subject|0|||
130913570|NCT02339285|471319875|FG000|Overall Study|Withdrawal by Subject|0|||
130913571|NCT02339285|471319876|FG001|Overall Study|Withdrawal by Subject|1|||
130913572|NCT02339285|471319877|FG002|Overall Study|Withdrawal by Subject|1|||
130913573|NCT02339285|471319875|FG000|Overall Study|Lost to Follow-up|1|||
130913574|NCT02339285|471319876|FG001|Overall Study|Lost to Follow-up|1|||
130913575|NCT02339285|471319877|FG002|Overall Study|Lost to Follow-up|1|||
130913576|NCT02339285|471319875|FG000|Overall Study|Protocol Deviation|0|||
130913577|NCT02339285|471319876|FG001|Overall Study|Protocol Deviation|1|||
130913578|NCT02339285|471319877|FG002|Overall Study|Protocol Deviation|0|||
130913579|NCT03061097|471319878|FG000|Overall Study|Withdrawal by Subject|0|||
130913580|NCT03061097|471319879|FG001|Overall Study|Withdrawal by Subject|3|||
130913581|NCT03911713|471319880|FG000|Overall Study|Lost to Follow-up|0|||
130913582|NCT03911713|471319881|FG001|Overall Study|Lost to Follow-up|2|||
130913583|NCT03911713|471319882|FG002|Overall Study|Lost to Follow-up|0|||
130913584|NCT03911713|471319883|FG003|Overall Study|Lost to Follow-up|0|||
130913585|NCT03911713|471319884|FG004|Overall Study|Lost to Follow-up|0|||
130913586|NCT03911713|471319880|FG000|Overall Study|Other|0|||
130913587|NCT03911713|471319881|FG001|Overall Study|Other|0|||
130913588|NCT03911713|471319882|FG002|Overall Study|Other|0|||
130913589|NCT03911713|471319883|FG003|Overall Study|Other|1|||
130913590|NCT03911713|471319884|FG004|Overall Study|Other|0|||
130913591|NCT03911713|471319880|FG000|Overall Study|Randomized, Never Dosed|1|||
130913592|NCT03911713|471319881|FG001|Overall Study|Randomized, Never Dosed|0|||
130913593|NCT03911713|471319882|FG002|Overall Study|Randomized, Never Dosed|0|||
130913594|NCT03911713|471319883|FG003|Overall Study|Randomized, Never Dosed|1|||
130913595|NCT03911713|471319884|FG004|Overall Study|Randomized, Never Dosed|0|||
130913596|NCT01614600|471319885|FG000|Overall Study|Unacceptable fit|1|||
130913597|NCT01614600|471319885|FG000|Overall Study|Discomfort|1|||
130913598|NCT01614600|471319885|FG000|Overall Study|Unable to remove lens at the end of day|1|||
130913599|NCT01614600|471319885|FG000|Overall Study|Protocol deviation|1|||
130913600|NCT03347188|471319886|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
130913601|NCT03347188|471319887|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
130913602|NCT03347188|471319886|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
130913603|NCT03347188|471319887|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
130913604|NCT03347188|471319886|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
130913605|NCT03347188|471319887|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
130913606|NCT03347188|471319886|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
130913607|NCT03347188|471319887|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
130913608|NCT03347188|471319886|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
130913609|NCT03347188|471319887|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
130913610|NCT03347188|471319886|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
130913611|NCT03347188|471319887|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
130913612|NCT03347188|471319886|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
130913613|NCT03347188|471319887|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
130913614|NCT03347188|471319886|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
130913615|NCT03347188|471319887|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
130913616|NCT01845818|471319888|FG000|Overall Study|Withdrawal by Subject|0|||
130913617|NCT01845818|471319889|FG001|Overall Study|Withdrawal by Subject|1|||
130913618|NCT01845818|471319888|FG000|Overall Study|Lost to Follow-up|7|||
130913619|NCT01845818|471319889|FG001|Overall Study|Lost to Follow-up|5|||
130913620|NCT01845818|471319888|FG000|Overall Study|Administrative Reasons|3|||
130913621|NCT01845818|471319889|FG001|Overall Study|Administrative Reasons|1|||
130913622|NCT01845818|471319888|FG000|Overall Study|Serious Adverse Event|1|||
130913623|NCT01845818|471319889|FG001|Overall Study|Serious Adverse Event|1|||
130913624|NCT01845818|471319888|FG000|Overall Study|Other|25|||
130913625|NCT01845818|471319889|FG001|Overall Study|Other|8|||
130913626|NCT01845818|471319888|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
130913627|NCT01845818|471319889|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
130913628|NCT01845818|471319888|FG000|Overall Study|No Follow-Up Data Available|4|||
130913629|NCT01845818|471319889|FG001|Overall Study|No Follow-Up Data Available|1|||
130913630|NCT02186873|471319890|FG000|Overall Study|Adverse Event|1|||
130913631|NCT02186873|471319891|FG001|Overall Study|Adverse Event|3|||
130913632|NCT02186873|471319890|FG000|Overall Study|Lack of Efficacy|0|||
130913633|NCT02186873|471319891|FG001|Overall Study|Lack of Efficacy|1|||
130913634|NCT02186873|471319890|FG000|Overall Study|Lost to Follow-up|1|||
130913635|NCT02186873|471319891|FG001|Overall Study|Lost to Follow-up|2|||
130913636|NCT02186873|471319890|FG000|Overall Study|Withdrawal by Subject|7|||
130913637|NCT02186873|471319891|FG001|Overall Study|Withdrawal by Subject|2|||
130913638|NCT00107783|471319892|FG000|Overall Study|Adverse Event|0|||
130913639|NCT00107783|471319893|FG001|Overall Study|Adverse Event|2|||
130913640|NCT00107783|471319892|FG000|Overall Study|Death|0|||
130913641|NCT00107783|471319893|FG001|Overall Study|Death|1|||
130913642|NCT00107783|471319892|FG000|Overall Study|Withdrawal by Subject|2|||
130913643|NCT00107783|471319893|FG001|Overall Study|Withdrawal by Subject|0|||
130913644|NCT00107783|471319892|FG000|Overall Study|Second hip replacement|1|||
130913645|NCT00107783|471319893|FG001|Overall Study|Second hip replacement|1|||
131118246|NCT01514136|472064151|FG006|Test Period 2; Test C*|holiday|1|||
131118247|NCT01514136|472064152|FG007|Test Period 2; Test C*|holiday|0|||
131118248|NCT01514136|472064145|FG000|Test Period 2; Test C*|Protocol Violation|0|||
131118249|NCT01514136|472064146|FG001|Test Period 2; Test C*|Protocol Violation|0|||
131118250|NCT01514136|472064147|FG002|Test Period 2; Test C*|Protocol Violation|0|||
131118251|NCT01514136|472064148|FG003|Test Period 2; Test C*|Protocol Violation|0|||
131118252|NCT01514136|472064149|FG004|Test Period 2; Test C*|Protocol Violation|0|||
131118253|NCT01514136|472064150|FG005|Test Period 2; Test C*|Protocol Violation|0|||
130913646|NCT01051466|471319894|FG000|Overall Study|Adverse Event|1|||
131118254|NCT01514136|472064151|FG006|Test Period 2; Test C*|Protocol Violation|1|||
131118255|NCT01514136|472064152|FG007|Test Period 2; Test C*|Protocol Violation|0|||
131118256|NCT02729740|472064153|FG000|Overall Study|Early Termination|130|||
131118257|NCT02729740|472064153|FG000|Overall Study|Other|1|||
131118258|NCT00601705|472064157|FG000|Overall Study|Withdrawal by Subject|1|||
131118259|NCT02101021|472064160|FG000|Overall Study|Death|4|||
131118260|NCT02101021|472064161|FG001|Overall Study|Death|3|||
131118261|NCT02101021|472064162|FG002|Overall Study|Death|6|||
131118262|NCT02101021|472064163|FG003|Overall Study|Death|0|||
131118263|NCT02101021|472064164|FG004|Overall Study|Death|3|||
131118264|NCT02101021|472064160|FG000|Overall Study|Withdrew Consent from study|1|||
131118265|NCT02101021|472064161|FG001|Overall Study|Withdrew Consent from study|1|||
130913647|NCT01051466|471319895|FG001|Overall Study|Adverse Event|0|||
131118266|NCT02101021|472064162|FG002|Overall Study|Withdrew Consent from study|0|||
131118267|NCT02101021|472064163|FG003|Overall Study|Withdrew Consent from study|2|||
130913648|NCT01051466|471319894|FG000|Overall Study|Lost to Follow-up|1|||
130913649|NCT01051466|471319895|FG001|Overall Study|Lost to Follow-up|1|||
131118268|NCT02101021|472064164|FG004|Overall Study|Withdrew Consent from study|0|||
130913650|NCT01051466|471319894|FG000|Overall Study|Withdrawal by Subject|5|||
130913651|NCT01051466|471319895|FG001|Overall Study|Withdrawal by Subject|1|||
131118269|NCT02101021|472064160|FG000|Overall Study|Lost to Follow-up|1|||
131118270|NCT02101021|472064161|FG001|Overall Study|Lost to Follow-up|0|||
131118271|NCT02101021|472064162|FG002|Overall Study|Lost to Follow-up|0|||
131118272|NCT02101021|472064163|FG003|Overall Study|Lost to Follow-up|0|||
130913652|NCT01051466|471319894|FG000|Overall Study|Entry Criteria Not Met|0|||
130913653|NCT01051466|471319895|FG001|Overall Study|Entry Criteria Not Met|3|||
130913654|NCT01051466|471319894|FG000|Overall Study|Physician Decision|1|||
131118273|NCT02101021|472064164|FG004|Overall Study|Lost to Follow-up|0|||
131118274|NCT02101021|472064160|FG000|Overall Study|Study Terminated by Sponsor|1|||
130699014|NCT01567527|470522779|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
131118275|NCT02101021|472064161|FG001|Overall Study|Study Terminated by Sponsor|0|||
131118276|NCT02101021|472064162|FG002|Overall Study|Study Terminated by Sponsor|1|||
131118277|NCT02101021|472064163|FG003|Overall Study|Study Terminated by Sponsor|1|||
130699015|NCT01567527|470522780|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
130699016|NCT01567527|470522776|FG000|IM Depot Stabilization.|Adverse Event|0|||
130699017|NCT01567527|470522777|FG001|IM Depot Stabilization.|Adverse Event|0|||
130699018|NCT01567527|470522778|FG002|IM Depot Stabilization.|Adverse Event|37|||
130699019|NCT01567527|470522779|FG003|IM Depot Stabilization.|Adverse Event|0|||
130699020|NCT01567527|470522780|FG004|IM Depot Stabilization.|Adverse Event|0|||
130699021|NCT01567527|470522776|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130699022|NCT01567527|470522777|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130699023|NCT01567527|470522778|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
130699024|NCT01567527|470522779|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130699025|NCT01567527|470522780|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130699026|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
130699027|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
130699028|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
130699029|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
130699030|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
130699031|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
130699032|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
130699033|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
130699034|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
130699035|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
130699036|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
130699037|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
130699038|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
130699039|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
130699040|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
130699041|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
130699042|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
130699043|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
130699044|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
130699045|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
130699046|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130699047|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130699048|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130699049|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
130699050|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
130699051|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
130699052|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
130699053|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
130699054|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
130699055|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
130699056|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
130699057|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
130699058|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
130699059|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
130699060|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
130699061|NCT01567527|470522776|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130699062|NCT01567527|470522777|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130699063|NCT01567527|470522778|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130699064|NCT01567527|470522779|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
130699065|NCT01567527|470522780|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
130699066|NCT02004691|470522781|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
130699067|NCT02004691|470522782|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
130699068|NCT02004691|470522781|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
130699069|NCT02004691|470522782|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
130699070|NCT02004691|470522781|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
131118278|NCT02101021|472064164|FG004|Overall Study|Study Terminated by Sponsor|1|||
131118279|NCT01368042|472064165|FG000|Overall Study|Death|14|||
131118280|NCT01368042|472064165|FG000|Overall Study|Protocol Violation|11|||
131118281|NCT01368042|472064165|FG000|Overall Study|Lost to Follow-up|4|||
130913655|NCT01051466|471319895|FG001|Overall Study|Physician Decision|0|||
130913656|NCT02231918|471319896|FG000|Overall Study|Withdrawal by Subject|0|||
130913657|NCT02231918|471319897|FG001|Overall Study|Withdrawal by Subject|1|||
130913658|NCT02231918|471319898|FG002|Overall Study|Withdrawal by Subject|0|||
130913659|NCT02231918|471319896|FG000|Overall Study|Adverse Event|0|||
130913660|NCT02231918|471319897|FG001|Overall Study|Adverse Event|0|||
130913661|NCT02231918|471319898|FG002|Overall Study|Adverse Event|1|||
130913662|NCT05061966|471319900|FG000|Overall Study|Lost to Follow-up|13|||
130913663|NCT05061966|471319901|FG001|Overall Study|Lost to Follow-up|13|||
130913664|NCT02923427|471319908|FG000|Overall Study|convert to laparatomy|2|||
130913665|NCT02923427|471319909|FG001|Overall Study|convert to laparatomy|2|||
130913666|NCT02923427|471319908|FG000|Overall Study|destaturation|1|||
130913667|NCT02923427|471319909|FG001|Overall Study|destaturation|0|||
130913668|NCT02923427|471319908|FG000|Overall Study|can not replace LMA|1|||
130913669|NCT02923427|471319909|FG001|Overall Study|can not replace LMA|0|||
130913670|NCT01325623|471319910|FG000|Overall Study|Withdrawal by Subject|3|||
130913671|NCT02556203|471319911|FG000|Overall Study|Withdrawal by Subject|21|||
130913672|NCT02556203|471319912|FG001|Overall Study|Withdrawal by Subject|21|||
130913673|NCT02556203|471319911|FG000|Overall Study|Lost to Follow-up|5|||
130913674|NCT02556203|471319912|FG001|Overall Study|Lost to Follow-up|5|||
130913675|NCT02556203|471319911|FG000|Overall Study|Adverse Event|1|||
130913676|NCT02556203|471319912|FG001|Overall Study|Adverse Event|0|||
130913677|NCT05246397|471319917|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
130913678|NCT03875768|471319918|FG000|Overall Study|Lost to Follow-up|16|||
130913679|NCT03875768|471319919|FG001|Overall Study|Lost to Follow-up|13|||
130913680|NCT03875768|471319918|FG000|Overall Study|Withdrawal by Subject|10|||
130913681|NCT03875768|471319919|FG001|Overall Study|Withdrawal by Subject|21|||
130913682|NCT03875768|471319918|FG000|Overall Study|Did not complete assessment|21|||
130913683|NCT03875768|471319919|FG001|Overall Study|Did not complete assessment|12|||
130913684|NCT03875768|471319918|FG000|Overall Study|Became ineligible|1|||
130913685|NCT03875768|471319919|FG001|Overall Study|Became ineligible|0|||
130913686|NCT01925274|471319922|FG000|Overall Study|Death|1|||
130913687|NCT01925274|471319923|FG001|Overall Study|Death|0|||
130913688|NCT01925274|471319924|FG002|Overall Study|Death|0|||
130913689|NCT01925274|471319922|FG000|Overall Study|Lost to Follow-up|0|||
130913690|NCT01925274|471319923|FG001|Overall Study|Lost to Follow-up|1|||
130913691|NCT01925274|471319924|FG002|Overall Study|Lost to Follow-up|0|||
130913692|NCT01925274|471319922|FG000|Overall Study|Withdrawal by Subject|1|||
130913693|NCT01925274|471319923|FG001|Overall Study|Withdrawal by Subject|2|||
130913694|NCT01925274|471319924|FG002|Overall Study|Withdrawal by Subject|0|||
130913695|NCT01925274|471319922|FG000|Overall Study|Study terminated by sponsor|4|||
130913696|NCT01925274|471319923|FG001|Overall Study|Study terminated by sponsor|0|||
130913697|NCT01925274|471319924|FG002|Overall Study|Study terminated by sponsor|0|||
130913698|NCT01925274|471319922|FG000|Overall Study|Protocol amendment|1|||
130913699|NCT01925274|471319923|FG001|Overall Study|Protocol amendment|3|||
130913700|NCT01925274|471319924|FG002|Overall Study|Protocol amendment|6|||
130913701|NCT00777205|471319927|FG000|Overall Study|Lost to Follow-up|25|||
130913702|NCT00777205|471319928|FG001|Overall Study|Lost to Follow-up|9|||
130913703|NCT00777205|471319927|FG000|Overall Study|Withdrawal by Subject|6|||
130913704|NCT00777205|471319928|FG001|Overall Study|Withdrawal by Subject|4|||
130913705|NCT00777205|471319927|FG000|Overall Study|Death|0|||
130913706|NCT00777205|471319928|FG001|Overall Study|Death|2|||
130913707|NCT00777205|471319927|FG000|Overall Study|Protocol Violation|0|||
130913708|NCT00777205|471319928|FG001|Overall Study|Protocol Violation|56|||
130913709|NCT00100178|471319929|FG000|Overall Study|Lost to Follow-up|0|||
130913710|NCT00100178|471319930|FG001|Overall Study|Lost to Follow-up|6|||
130913711|NCT00100178|471319931|FG002|Overall Study|Lost to Follow-up|5|||
130913712|NCT00100178|471319929|FG000|Overall Study|Adverse Event|2|||
130913713|NCT00100178|471319930|FG001|Overall Study|Adverse Event|2|||
130913714|NCT00100178|471319931|FG002|Overall Study|Adverse Event|1|||
130913715|NCT00100178|471319929|FG000|Overall Study|Withdrawal by Subject|1|||
130913716|NCT00100178|471319930|FG001|Overall Study|Withdrawal by Subject|1|||
130913717|NCT00100178|471319931|FG002|Overall Study|Withdrawal by Subject|1|||
130913718|NCT00100178|471319929|FG000|Overall Study|Physician Decision|6|||
130913719|NCT00100178|471319930|FG001|Overall Study|Physician Decision|1|||
130913720|NCT00100178|471319931|FG002|Overall Study|Physician Decision|3|||
130913721|NCT02477839|471319934|FG000|Overall Study|Adverse Event|0|||
130913722|NCT02477839|471319935|FG001|Overall Study|Adverse Event|1|||
130913723|NCT02477839|471319934|FG000|Overall Study|Protocol Violation|0|||
130913724|NCT02477839|471319935|FG001|Overall Study|Protocol Violation|2|||
130913725|NCT02477839|471319934|FG000|Overall Study|Withdrawal by Subject|3|||
130913726|NCT02477839|471319935|FG001|Overall Study|Withdrawal by Subject|3|||
130913727|NCT02477839|471319934|FG000|Overall Study|Participant had PGS during V6|0|||
130913728|NCT02477839|471319935|FG001|Overall Study|Participant had PGS during V6|1|||
130913729|NCT02477839|471319934|FG000|Overall Study|Parents decided to stop medication|0|||
130913730|NCT02477839|471319935|FG001|Overall Study|Parents decided to stop medication|1|||
130913731|NCT02477839|471319934|FG000|Overall Study|Lack of tolerability|0|||
130913732|NCT02477839|471319935|FG001|Overall Study|Lack of tolerability|1|||
130913733|NCT02477839|471319934|FG000|Overall Study|Exclusion criterion|0|||
130913734|NCT02477839|471319935|FG001|Overall Study|Exclusion criterion|1|||
130913735|NCT00631696|471319936|FG000|Overall Study|Entered, not randomized to treatment|1|||
130913736|NCT00631696|471319937|FG001|Overall Study|Entered, not randomized to treatment|1|||
130913737|NCT00631696|471319936|FG000|Overall Study|Discontinued after database release date|1|||
130913738|NCT00631696|471319937|FG001|Overall Study|Discontinued after database release date|0|||
130913739|NCT00631696|471319936|FG000|Overall Study|Follow up after database release date|1|||
130913740|NCT00631696|471319937|FG001|Overall Study|Follow up after database release date|0|||
130913741|NCT00631696|471319936|FG000|Overall Study|Lost to Follow-up|7|||
130913742|NCT00631696|471319937|FG001|Overall Study|Lost to Follow-up|10|||
130913743|NCT00631696|471319936|FG000|Overall Study|Withdrawal by Subject|2|||
130913744|NCT00631696|471319937|FG001|Overall Study|Withdrawal by Subject|9|||
130913745|NCT00631696|471319936|FG000|Overall Study|Other|8|||
130913746|NCT00631696|471319937|FG001|Overall Study|Other|8|||
130913747|NCT00631696|471319936|FG000|Overall Study|Protocol Violation|9|||
130913748|NCT00631696|471319937|FG001|Overall Study|Protocol Violation|9|||
130913749|NCT00631696|471319936|FG000|Overall Study|Study terminated by sponsor|3|||
130913750|NCT00631696|471319937|FG001|Overall Study|Study terminated by sponsor|3|||
130913751|NCT00631696|471319936|FG000|Overall Study|Adverse Event|5|||
130913752|NCT00631696|471319937|FG001|Overall Study|Adverse Event|0|||
130913753|NCT01439568|471319940|FG000|Overall Study|Lost to Follow-up|1|||
130913754|NCT01439568|471319941|FG001|Overall Study|Lost to Follow-up|0|||
130913755|NCT01439568|471319940|FG000|Overall Study|Withdrawal by Subject|2|||
130913756|NCT01439568|471319941|FG001|Overall Study|Withdrawal by Subject|2|||
130913757|NCT01676727|471319942|FG000|Overall Study|Death|18|||
130913758|NCT01676727|471319942|FG000|Overall Study|Withdrawal by Subject|6|||
130913759|NCT01676727|471319942|FG000|Overall Study|Screening failure|5|||
130913760|NCT01676727|471319942|FG000|Overall Study|Not willing to attend 1-year visit|2|||
130913761|NCT01676727|471319942|FG000|Overall Study|Valve explanted|1|||
130913762|NCT03053271|471319943|FG000|Overall Study|Did not meet randomization criteria|3|||
130913763|NCT03053271|471319943|FG000|Overall Study|Withdrawal by Subject|1|||
130913764|NCT00580970|471319944|FG000|Pre-treatment|Non-compliance|1|||
130913765|NCT00580970|471319944|FG000|Treatment (Lovastatin)|Non-compliance|6|||
130913766|NCT00580970|471319944|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
130913767|NCT00580970|471319944|FG000|Treatment (Lovastatin)|Physician Decision|4|||
130913768|NCT00580970|471319944|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
130913769|NCT00580970|471319944|FG000|Treatment (Lovastatin)|Death|1|||
130913770|NCT01938573|471319946|FG000|Overall Study|Lack of Efficacy|1|||
130913771|NCT01938573|471319947|FG001|Overall Study|Lack of Efficacy|0|||
130913772|NCT01938573|471319946|FG000|Overall Study|Operation at other hospital|1|||
130913773|NCT01938573|471319947|FG001|Overall Study|Operation at other hospital|0|||
130913774|NCT01199731|471319951|FG000|Overall Study|Adverse Event|0|||
130913775|NCT01199731|471319952|FG001|Overall Study|Adverse Event|1|||
130913776|NCT01199731|471319953|FG002|Overall Study|Adverse Event|0|||
130913777|NCT01199731|471319951|FG000|Overall Study|Study closed/terminated|7|||
130913778|NCT01199731|471319952|FG001|Overall Study|Study closed/terminated|9|||
130913779|NCT01199731|471319953|FG002|Overall Study|Study closed/terminated|7|||
130913780|NCT01199731|471319951|FG000|Overall Study|Lost to Follow-up|0|||
130913781|NCT01199731|471319952|FG001|Overall Study|Lost to Follow-up|0|||
130913782|NCT01199731|471319953|FG002|Overall Study|Lost to Follow-up|2|||
130913783|NCT01199731|471319951|FG000|Overall Study|Physician Decision|0|||
130913784|NCT01199731|471319952|FG001|Overall Study|Physician Decision|1|||
130913785|NCT01199731|471319953|FG002|Overall Study|Physician Decision|1|||
130913786|NCT01199731|471319951|FG000|Overall Study|Withdrawal by Subject|2|||
131032690|NCT04784559|471753086|FG001|Overall Study|SAE|1|||
131032691|NCT04784559|471753087|FG002|Overall Study|SAE|0|||
131032692|NCT04784559|471753085|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
131032693|NCT04784559|471753086|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
131032694|NCT04784559|471753087|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
131032695|NCT03406871|471753088|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
131032696|NCT03406871|471753089|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
131032697|NCT03406871|471753090|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
131032698|NCT03406871|471753088|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
131032699|NCT03406871|471753089|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
130913787|NCT01199731|471319952|FG001|Overall Study|Withdrawal by Subject|0|||
130913788|NCT01199731|471319953|FG002|Overall Study|Withdrawal by Subject|0|||
130913789|NCT00943124|471319954|FG000|Period 1|Withdrawal by Subject|1|||
130699071|NCT02004691|470522782|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
130913790|NCT00943124|471319955|FG001|Period 1|Withdrawal by Subject|1|||
130913791|NCT00943124|471319954|FG000|Period 1|Did Not Follow Study Procedures|1|||
130913792|NCT00943124|471319955|FG001|Period 1|Did Not Follow Study Procedures|0|||
130913793|NCT00943124|471319954|FG000|Period 1|Personal Reasons|0|||
130913794|NCT00943124|471319955|FG001|Period 1|Personal Reasons|1|||
130913795|NCT02448810|471319957|FG000|Overall Study|Adverse Event|0|||
130699072|NCT02004691|470522781|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
130913796|NCT02448810|471319958|FG001|Overall Study|Adverse Event|0|||
130913797|NCT02448810|471319959|FG002|Overall Study|Adverse Event|1|||
130913798|NCT02448810|471319960|FG003|Overall Study|Adverse Event|0|||
130913799|NCT02448810|471319961|FG004|Overall Study|Adverse Event|0|||
130913800|NCT02448810|471319962|FG005|Overall Study|Adverse Event|0|||
130913801|NCT02448810|471319963|FG006|Overall Study|Adverse Event|0|||
130913802|NCT02448810|471319964|FG007|Overall Study|Adverse Event|0|||
130913803|NCT02448810|471319957|FG000|Overall Study|Withdrawal by Subject|0|||
130913804|NCT02448810|471319958|FG001|Overall Study|Withdrawal by Subject|0|||
130913805|NCT02448810|471319959|FG002|Overall Study|Withdrawal by Subject|1|||
130913806|NCT02448810|471319960|FG003|Overall Study|Withdrawal by Subject|0|||
130769156|NCT03517449|470780535|FG001|Overall Study|Participants Ongoing|152|||
130913807|NCT02448810|471319961|FG004|Overall Study|Withdrawal by Subject|3|||
130913808|NCT02448810|471319962|FG005|Overall Study|Withdrawal by Subject|5|||
130913809|NCT02448810|471319963|FG006|Overall Study|Withdrawal by Subject|0|||
130913810|NCT02448810|471319964|FG007|Overall Study|Withdrawal by Subject|2|||
130913811|NCT02448810|471319957|FG000|Overall Study|Other (study terminated by sponsor)|0|||
130913812|NCT02448810|471319958|FG001|Overall Study|Other (study terminated by sponsor)|0|||
130913813|NCT02448810|471319959|FG002|Overall Study|Other (study terminated by sponsor)|0|||
130913814|NCT02448810|471319960|FG003|Overall Study|Other (study terminated by sponsor)|0|||
130913815|NCT02448810|471319961|FG004|Overall Study|Other (study terminated by sponsor)|4|||
130913816|NCT02448810|471319962|FG005|Overall Study|Other (study terminated by sponsor)|2|||
130913817|NCT02448810|471319963|FG006|Overall Study|Other (study terminated by sponsor)|2|||
130913818|NCT02448810|471319964|FG007|Overall Study|Other (study terminated by sponsor)|1|||
130913819|NCT02448810|471319957|FG000|Overall Study|Death|1|||
130913820|NCT02448810|471319958|FG001|Overall Study|Death|0|||
130913821|NCT02448810|471319959|FG002|Overall Study|Death|1|||
130913822|NCT02448810|471319960|FG003|Overall Study|Death|0|||
130913823|NCT02448810|471319961|FG004|Overall Study|Death|1|||
130913824|NCT02448810|471319962|FG005|Overall Study|Death|0|||
130913825|NCT02448810|471319963|FG006|Overall Study|Death|0|||
130913826|NCT02448810|471319964|FG007|Overall Study|Death|0|||
130913827|NCT02448810|471319957|FG000|Overall Study|Other (Progressive disease)|2|||
130913828|NCT02448810|471319958|FG001|Overall Study|Other (Progressive disease)|2|||
130913829|NCT02448810|471319959|FG002|Overall Study|Other (Progressive disease)|0|||
130913830|NCT02448810|471319960|FG003|Overall Study|Other (Progressive disease)|3|||
130913831|NCT02448810|471319961|FG004|Overall Study|Other (Progressive disease)|23|||
130913832|NCT02448810|471319962|FG005|Overall Study|Other (Progressive disease)|9|||
130913833|NCT02448810|471319963|FG006|Overall Study|Other (Progressive disease)|14|||
130913834|NCT02448810|471319964|FG007|Overall Study|Other (Progressive disease)|5|||
130913835|NCT02448810|471319957|FG000|Overall Study|Lost to Follow-up|0|||
130913836|NCT02448810|471319958|FG001|Overall Study|Lost to Follow-up|1|||
130913837|NCT02448810|471319959|FG002|Overall Study|Lost to Follow-up|0|||
130913838|NCT02448810|471319960|FG003|Overall Study|Lost to Follow-up|0|||
130913839|NCT02448810|471319961|FG004|Overall Study|Lost to Follow-up|0|||
130913840|NCT02448810|471319962|FG005|Overall Study|Lost to Follow-up|0|||
130913841|NCT02448810|471319963|FG006|Overall Study|Lost to Follow-up|0|||
130913842|NCT02448810|471319964|FG007|Overall Study|Lost to Follow-up|0|||
130913843|NCT02448810|471319957|FG000|Overall Study|Other (unspecified)|0|||
130913844|NCT02448810|471319958|FG001|Overall Study|Other (unspecified)|0|||
130913845|NCT02448810|471319959|FG002|Overall Study|Other (unspecified)|0|||
130913846|NCT02448810|471319960|FG003|Overall Study|Other (unspecified)|0|||
130913847|NCT02448810|471319961|FG004|Overall Study|Other (unspecified)|0|||
130913848|NCT02448810|471319962|FG005|Overall Study|Other (unspecified)|0|||
130913849|NCT02448810|471319963|FG006|Overall Study|Other (unspecified)|2|||
130913850|NCT02448810|471319964|FG007|Overall Study|Other (unspecified)|0|||
130913851|NCT00470847|471319967|FG000|Overall Study|Pt still receiving treatment|1|||
130913852|NCT00381381|471319968|FG000|Overall Study|Adverse Event|3|||
130913853|NCT00381381|471319968|FG000|Overall Study|Lost to Follow-up|52|||
130913854|NCT00381381|471319968|FG000|Overall Study|Withdrawal by Subject|9|||
130913855|NCT01147172|471319971|FG000|Overall Study|Withdrawal by Subject|2|||
130913856|NCT01147172|471319971|FG000|Overall Study|Lost to Follow-up|2|||
130913857|NCT02787551|471319972|FG000|Core Period: 26 Weeks|Adverse Event|10|||
130913858|NCT02787551|471319973|FG001|Core Period: 26 Weeks|Adverse Event|0|||
131032700|NCT03406871|471753090|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
131032701|NCT03406871|471753088|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
131032702|NCT03406871|471753089|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
130913859|NCT02787551|471319972|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
130913860|NCT02787551|471319973|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
130913861|NCT02787551|471319972|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
130913862|NCT02787551|471319973|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
130913863|NCT02787551|471319972|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
130769157|NCT02005627|470780540|FG000|Overall Study|Lost to Follow-up|1|||
130913864|NCT02787551|471319973|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
130913865|NCT02787551|471319972|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
130913866|NCT02787551|471319973|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
130913867|NCT02787551|471319972|FG000|Core Period: 26 Weeks|Other than specified|3|||
130913868|NCT02787551|471319973|FG001|Core Period: 26 Weeks|Other than specified|1|||
130913869|NCT02787551|471319972|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
130913870|NCT02787551|471319973|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
130913871|NCT02787551|471319972|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
130913872|NCT02787551|471319973|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
130913873|NCT02787551|471319972|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
130913874|NCT02787551|471319973|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
130913875|NCT02001181|471319975|FG000|Overall Study|Adverse Event|0|||
130913876|NCT02001181|471319976|FG001|Overall Study|Adverse Event|2|||
130913877|NCT02001181|471319975|FG000|Overall Study|Lost to Follow-up|1|||
130913878|NCT02001181|471319976|FG001|Overall Study|Lost to Follow-up|0|||
130913879|NCT02001181|471319975|FG000|Overall Study|Withdrawal by Subject|0|||
130913880|NCT02001181|471319976|FG001|Overall Study|Withdrawal by Subject|1|||
130913881|NCT00292318|471319978|FG000|Overall Study|Study terminated by officials|2|||
130913882|NCT00292318|471319979|FG001|Overall Study|Study terminated by officials|1|||
130913883|NCT00771316|471319980|FG000|Overall Study|Adverse Event|0|||
130913884|NCT00771316|471319981|FG001|Overall Study|Adverse Event|1|||
130913885|NCT00771316|471319980|FG000|Overall Study|Patient withdrew consent|1|||
130913886|NCT00771316|471319981|FG001|Overall Study|Patient withdrew consent|0|||
130913887|NCT00771316|471319980|FG000|Overall Study|Discontinued due to early termination|1|||
130913888|NCT00771316|471319981|FG001|Overall Study|Discontinued due to early termination|0|||
130913889|NCT02027376|471319982|FG000|Overall Study|Death|1|||
130913890|NCT02027376|471319983|FG001|Overall Study|Death|0|||
130913891|NCT02027376|471319984|FG002|Overall Study|Death|0|||
130913892|NCT00843726|471319985|FG000|Overall Study|Death|1|||
130913893|NCT00843726|471319986|FG001|Overall Study|Death|0|||
130913894|NCT00843726|471319985|FG000|Overall Study|Withdrawal by Subject|0|||
130913895|NCT00843726|471319986|FG001|Overall Study|Withdrawal by Subject|1|||
130913896|NCT05521906|471319988|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
130913897|NCT05521906|471319989|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
130913898|NCT00257608|471322235|FG000|Chemotherapy Phase|Adverse Event|138|||
130913899|NCT00257608|471322236|FG001|Chemotherapy Phase|Adverse Event|0|||
130913900|NCT00257608|471322237|FG002|Chemotherapy Phase|Adverse Event|0|||
130913901|NCT00257608|471322235|FG000|Chemotherapy Phase|Disease progression|139|||
130913902|NCT00257608|471322236|FG001|Chemotherapy Phase|Disease progression|0|||
130913903|NCT00257608|471322237|FG002|Chemotherapy Phase|Disease progression|0|||
130913904|NCT00257608|471322235|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
130913905|NCT00257608|471322236|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
130913906|NCT00257608|471322237|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
130913907|NCT00257608|471322235|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
130699073|NCT02004691|470522782|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
130699074|NCT02004691|470522781|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
130913908|NCT00257608|471322236|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
130913909|NCT00257608|471322237|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
130913910|NCT00257608|471322235|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
130913911|NCT00257608|471322236|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
130913912|NCT00257608|471322237|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
130913913|NCT00257608|471322235|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
130913914|NCT00257608|471322236|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
130913915|NCT00257608|471322237|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
131032703|NCT03406871|471753090|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
131032704|NCT03406871|471753088|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
131032705|NCT03406871|471753089|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
131032706|NCT03406871|471753090|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
131032707|NCT03406871|471753088|FG000|Expansion Cohort(Final Analysis)|Death|0|||
131032708|NCT03406871|471753089|FG001|Expansion Cohort(Final Analysis)|Death|1|||
131032709|NCT03406871|471753090|FG002|Expansion Cohort(Final Analysis)|Death|0|||
131032710|NCT03406871|471753088|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
131032711|NCT03406871|471753089|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
131032712|NCT03406871|471753090|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
131032713|NCT04241068|471753096|FG000|Core Treatment Period|Adverse Event|91|||
131032714|NCT04241068|471753096|FG000|Core Treatment Period|Change of Treatment|4|||
131032715|NCT04241068|471753096|FG000|Core Treatment Period|Consent Withdrawn|143|||
131032716|NCT04241068|471753096|FG000|Core Treatment Period|Death|26|||
131032717|NCT04241068|471753096|FG000|Core Treatment Period|Disease Progression|67|||
131032718|NCT04241068|471753096|FG000|Core Treatment Period|Investigator Decision|40|||
131032719|NCT04241068|471753096|FG000|Core Treatment Period|Loss of Capacity|9|||
131032720|NCT04241068|471753096|FG000|Core Treatment Period|Lost to Follow-up|11|||
131032721|NCT04241068|471753096|FG000|Core Treatment Period|Relocation|4|||
130699075|NCT02004691|470522782|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
131118282|NCT01368042|472064165|FG000|Overall Study|Transplanted|1|||
130913916|NCT00257608|471322235|FG000|Chemotherapy Phase|Physician Decision|28|||
130913917|NCT00257608|471322236|FG001|Chemotherapy Phase|Physician Decision|0|||
130913918|NCT00257608|471322237|FG002|Chemotherapy Phase|Physician Decision|0|||
130913919|NCT00257608|471322235|FG000|Post Chemotherapy Phase|Adverse Event|0|||
130913920|NCT00257608|471322236|FG001|Post Chemotherapy Phase|Adverse Event|34|||
130913921|NCT00257608|471322237|FG002|Post Chemotherapy Phase|Adverse Event|38|||
130913922|NCT00257608|471322235|FG000|Post Chemotherapy Phase|Disease progression|0|||
130913923|NCT00257608|471322236|FG001|Post Chemotherapy Phase|Disease progression|204|||
130913924|NCT00257608|471322237|FG002|Post Chemotherapy Phase|Disease progression|168|||
130913925|NCT00257608|471322235|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
130913926|NCT00257608|471322236|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
130913927|NCT00257608|471322237|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
130913928|NCT00257608|471322235|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
130913929|NCT00257608|471322236|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
130913930|NCT00257608|471322237|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
130913931|NCT00257608|471322235|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
130913932|NCT00257608|471322236|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
130913933|NCT00257608|471322237|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
130913934|NCT00257608|471322235|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
130913935|NCT00257608|471322236|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
130913936|NCT00257608|471322237|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
130913937|NCT00257608|471322235|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
130913938|NCT00257608|471322236|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
130913939|NCT00257608|471322237|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
130913940|NCT00257608|471322235|FG000|Post Chemotherapy Phase|Physician Decision|0|||
130913941|NCT00257608|471322236|FG001|Post Chemotherapy Phase|Physician Decision|8|||
130913942|NCT00257608|471322237|FG002|Post Chemotherapy Phase|Physician Decision|11|||
130913943|NCT00257608|471322235|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
130913944|NCT00257608|471322236|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
130913945|NCT00257608|471322237|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
130913946|NCT00257608|471322235|FG000|Post Chemotherapy Phase|Not treated|0|||
130913947|NCT00257608|471322236|FG001|Post Chemotherapy Phase|Not treated|4|||
130913948|NCT00257608|471322237|FG002|Post Chemotherapy Phase|Not treated|7|||
130913949|NCT02171065|471322238|FG000|Overall Study|Withdrawal by Subject|1|||
130913950|NCT02171065|471322239|FG001|Overall Study|Withdrawal by Subject|0|||
130913951|NCT02171065|471322240|FG002|Overall Study|Withdrawal by Subject|0|||
130913952|NCT02171065|471322238|FG000|Overall Study|Lost to Follow-up|0|||
130913953|NCT02171065|471322239|FG001|Overall Study|Lost to Follow-up|0|||
130913954|NCT02171065|471322240|FG002|Overall Study|Lost to Follow-up|1|||
130913955|NCT02598960|471322241|FG000|Treatment Period|Disease Progression|4|||
130913956|NCT02598960|471322242|FG001|Treatment Period|Disease Progression|4|||
130913957|NCT02598960|471322243|FG002|Treatment Period|Disease Progression|4|||
130913958|NCT02598960|471322244|FG003|Treatment Period|Disease Progression|6|||
130913959|NCT02598960|471322245|FG004|Treatment Period|Disease Progression|8|||
130913960|NCT02598960|471322246|FG005|Treatment Period|Disease Progression|2|||
130913961|NCT02598960|471322247|FG006|Treatment Period|Disease Progression|2|||
130913962|NCT02598960|471322248|FG007|Treatment Period|Disease Progression|3|||
130913963|NCT02598960|471322249|FG008|Treatment Period|Disease Progression|7|||
130913964|NCT02598960|471322250|FG009|Treatment Period|Disease Progression|9|||
130913965|NCT02598960|471322251|FG010|Treatment Period|Disease Progression|7|||
130913966|NCT02598960|471322252|FG011|Treatment Period|Disease Progression|143|||
130913967|NCT02598960|471322253|FG012|Treatment Period|Disease Progression|23|||
130913968|NCT02598960|471322241|FG000|Treatment Period|Study drug toxicity|0|||
130913969|NCT02598960|471322242|FG001|Treatment Period|Study drug toxicity|0|||
130913970|NCT02598960|471322243|FG002|Treatment Period|Study drug toxicity|0|||
130769158|NCT02005627|470780541|FG001|Overall Study|Lost to Follow-up|2|||
130913971|NCT02598960|471322244|FG003|Treatment Period|Study drug toxicity|0|||
130913972|NCT02598960|471322245|FG004|Treatment Period|Study drug toxicity|0|||
130913973|NCT02598960|471322246|FG005|Treatment Period|Study drug toxicity|0|||
130913974|NCT02598960|471322247|FG006|Treatment Period|Study drug toxicity|0|||
130913975|NCT02598960|471322248|FG007|Treatment Period|Study drug toxicity|0|||
130913976|NCT02598960|471322249|FG008|Treatment Period|Study drug toxicity|0|||
130913977|NCT02598960|471322250|FG009|Treatment Period|Study drug toxicity|1|||
130913978|NCT02598960|471322251|FG010|Treatment Period|Study drug toxicity|0|||
130913979|NCT02598960|471322252|FG011|Treatment Period|Study drug toxicity|3|||
130913980|NCT02598960|471322253|FG012|Treatment Period|Study drug toxicity|0|||
130913981|NCT02598960|471322241|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
130913982|NCT02598960|471322242|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
131032722|NCT04241068|471753096|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
131032723|NCT04241068|471753096|FG000|Core Treatment Period|Study Visit Burden|40|||
131032724|NCT04241068|471753096|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
131032725|NCT04241068|471753096|FG000|Core Treatment Period|Missing|2|||
131118283|NCT01621542|472064166|FG000|Overall Study|Adverse Event|0|||
130699076|NCT02004691|470522781|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
131118284|NCT01621542|472064167|FG001|Overall Study|Adverse Event|0|||
131118285|NCT01621542|472064168|FG002|Overall Study|Adverse Event|1|||
131118286|NCT01621542|472064169|FG003|Overall Study|Adverse Event|3|||
131118287|NCT01621542|472064170|FG004|Overall Study|Adverse Event|0|||
131118288|NCT01621542|472064171|FG005|Overall Study|Adverse Event|0|||
131118289|NCT01621542|472064166|FG000|Overall Study|Death|0|||
131118290|NCT01621542|472064167|FG001|Overall Study|Death|1|||
131118291|NCT01621542|472064168|FG002|Overall Study|Death|0|||
131118292|NCT01621542|472064169|FG003|Overall Study|Death|0|||
131118293|NCT01621542|472064170|FG004|Overall Study|Death|0|||
131118294|NCT01621542|472064171|FG005|Overall Study|Death|0|||
131118295|NCT01621542|472064166|FG000|Overall Study|Physician Decision|1|||
131118296|NCT01621542|472064167|FG001|Overall Study|Physician Decision|0|||
131118297|NCT01621542|472064168|FG002|Overall Study|Physician Decision|1|||
131118298|NCT01621542|472064169|FG003|Overall Study|Physician Decision|13|||
131118299|NCT01621542|472064170|FG004|Overall Study|Physician Decision|3|||
131118300|NCT01621542|472064171|FG005|Overall Study|Physician Decision|1|||
131118301|NCT01621542|472064166|FG000|Overall Study|Withdrawal by Subject|2|||
131118302|NCT01621542|472064167|FG001|Overall Study|Withdrawal by Subject|0|||
131118303|NCT01621542|472064168|FG002|Overall Study|Withdrawal by Subject|1|||
131118304|NCT01621542|472064169|FG003|Overall Study|Withdrawal by Subject|3|||
131118305|NCT01621542|472064170|FG004|Overall Study|Withdrawal by Subject|3|||
131118306|NCT01621542|472064171|FG005|Overall Study|Withdrawal by Subject|3|||
131118307|NCT01621542|472064166|FG000|Overall Study|progression/treatment failure|2|||
131118308|NCT01621542|472064167|FG001|Overall Study|progression/treatment failure|4|||
131118309|NCT01621542|472064168|FG002|Overall Study|progression/treatment failure|3|||
131118310|NCT01621542|472064169|FG003|Overall Study|progression/treatment failure|7|||
131118311|NCT01621542|472064170|FG004|Overall Study|progression/treatment failure|3|||
131118312|NCT01621542|472064171|FG005|Overall Study|progression/treatment failure|5|||
131118313|NCT01621542|472064166|FG000|Overall Study|Protocol Violation|0|||
131118314|NCT01621542|472064167|FG001|Overall Study|Protocol Violation|0|||
131118315|NCT01621542|472064168|FG002|Overall Study|Protocol Violation|0|||
131118316|NCT01621542|472064169|FG003|Overall Study|Protocol Violation|1|||
131118317|NCT01621542|472064170|FG004|Overall Study|Protocol Violation|0|||
131118318|NCT01621542|472064171|FG005|Overall Study|Protocol Violation|0|||
131118319|NCT01621542|472064166|FG000|Overall Study|study stopped by sponsor|0|||
131118320|NCT01621542|472064167|FG001|Overall Study|study stopped by sponsor|0|||
131118321|NCT01621542|472064168|FG002|Overall Study|study stopped by sponsor|0|||
131118322|NCT01621542|472064169|FG003|Overall Study|study stopped by sponsor|1|||
131118323|NCT01621542|472064170|FG004|Overall Study|study stopped by sponsor|0|||
131118324|NCT01621542|472064171|FG005|Overall Study|study stopped by sponsor|0|||
131118325|NCT00760669|472064172|FG000|Overall Study|Not assessed for overall improvement|18|||
131118326|NCT00760669|472064172|FG000|Overall Study|Participants missing efficacy assessment|6|||
131118327|NCT00760669|472064172|FG000|Overall Study|Participants with overlapping cases|1|||
131118328|NCT00760669|472064172|FG000|Overall Study|Took drug before entering in contract|5|||
131118329|NCT02663271|472064173|FG000|Overall Study|Withdrawal by Subject|5|||
131118330|NCT02663271|472064173|FG000|Overall Study|Lack of Efficacy|1|||
131118331|NCT01572675|472064174|FG000|Overall Study|End of prescribed treatment|140|||
131118332|NCT01572675|472064175|FG001|Overall Study|End of prescribed treatment|118|||
131118333|NCT01572675|472064174|FG000|Overall Study|Recovery|16|||
131118334|NCT01572675|472064175|FG001|Overall Study|Recovery|23|||
131118335|NCT01572675|472064174|FG000|Overall Study|Lack of Efficacy|31|||
131118336|NCT01572675|472064175|FG001|Overall Study|Lack of Efficacy|31|||
131118337|NCT01572675|472064174|FG000|Overall Study|Intolerance|6|||
131118338|NCT01572675|472064175|FG001|Overall Study|Intolerance|5|||
131118339|NCT01572675|472064174|FG000|Overall Study|Improved symptoms|8|||
131118340|NCT01572675|472064175|FG001|Overall Study|Improved symptoms|2|||
131118341|NCT01572675|472064174|FG000|Overall Study|Surgical intervention|3|||
130699077|NCT02004691|470522782|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
130699078|NCT02623218|470522783|FG000|Overall Study|Lost to Follow-up|0|||
131118342|NCT01572675|472064175|FG001|Overall Study|Surgical intervention|6|||
131118343|NCT01572675|472064174|FG000|Overall Study|Withdrawal by Subject|5|||
131118344|NCT01572675|472064175|FG001|Overall Study|Withdrawal by Subject|1|||
131118345|NCT01572675|472064174|FG000|Overall Study|Physician Decision|2|||
131118346|NCT01572675|472064175|FG001|Overall Study|Physician Decision|2|||
131118347|NCT01572675|472064174|FG000|Overall Study|Death unrelated to coxibs|1|||
131118348|NCT01572675|472064175|FG001|Overall Study|Death unrelated to coxibs|1|||
131118349|NCT01572675|472064174|FG000|Overall Study|Other disease detected|1|||
131118350|NCT01572675|472064175|FG001|Overall Study|Other disease detected|1|||
131118351|NCT01572675|472064174|FG000|Overall Study|Unknown reason|1|||
131118352|NCT01572675|472064175|FG001|Overall Study|Unknown reason|1|||
131118353|NCT01572675|472064174|FG000|Overall Study|Rheumatologist new evaluation|0|||
131118354|NCT01572675|472064175|FG001|Overall Study|Rheumatologist new evaluation|1|||
131118355|NCT01572675|472064174|FG000|Overall Study|Missing data|1|||
131118356|NCT01572675|472064175|FG001|Overall Study|Missing data|4|||
131118357|NCT01572675|472064174|FG000|Overall Study|Lost to Follow-up|22|||
130699079|NCT02623218|470522784|FG001|Overall Study|Lost to Follow-up|1|||
130913983|NCT02598960|471322243|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
130913984|NCT02598960|471322244|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
130913985|NCT02598960|471322245|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
130913986|NCT02598960|471322246|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
130913987|NCT02598960|471322247|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
130913988|NCT02598960|471322248|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
130913989|NCT02598960|471322249|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
130913990|NCT02598960|471322250|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
130913991|NCT02598960|471322251|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
130913992|NCT02598960|471322252|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
130913993|NCT02598960|471322253|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
130913994|NCT02598960|471322241|FG000|Treatment Period|participant request to discontinue|0|||
130913995|NCT02598960|471322242|FG001|Treatment Period|participant request to discontinue|1|||
130913996|NCT02598960|471322243|FG002|Treatment Period|participant request to discontinue|0|||
130913997|NCT02598960|471322244|FG003|Treatment Period|participant request to discontinue|0|||
130913998|NCT02598960|471322245|FG004|Treatment Period|participant request to discontinue|1|||
130913999|NCT02598960|471322246|FG005|Treatment Period|participant request to discontinue|0|||
130914000|NCT02598960|471322247|FG006|Treatment Period|participant request to discontinue|0|||
130914001|NCT02598960|471322248|FG007|Treatment Period|participant request to discontinue|0|||
130914002|NCT02598960|471322249|FG008|Treatment Period|participant request to discontinue|0|||
130914003|NCT02598960|471322250|FG009|Treatment Period|participant request to discontinue|0|||
130914004|NCT02598960|471322251|FG010|Treatment Period|participant request to discontinue|1|||
130914005|NCT02598960|471322252|FG011|Treatment Period|participant request to discontinue|4|||
130914006|NCT02598960|471322253|FG012|Treatment Period|participant request to discontinue|0|||
130914007|NCT02598960|471322241|FG000|Treatment Period|participant withdrew consent|0|||
130914008|NCT02598960|471322242|FG001|Treatment Period|participant withdrew consent|0|||
130914009|NCT02598960|471322243|FG002|Treatment Period|participant withdrew consent|0|||
130914010|NCT02598960|471322244|FG003|Treatment Period|participant withdrew consent|0|||
130914011|NCT02598960|471322245|FG004|Treatment Period|participant withdrew consent|0|||
130914012|NCT02598960|471322246|FG005|Treatment Period|participant withdrew consent|0|||
130914013|NCT02598960|471322247|FG006|Treatment Period|participant withdrew consent|0|||
130914014|NCT02598960|471322248|FG007|Treatment Period|participant withdrew consent|0|||
130914015|NCT02598960|471322249|FG008|Treatment Period|participant withdrew consent|0|||
130914016|NCT02598960|471322250|FG009|Treatment Period|participant withdrew consent|0|||
130914017|NCT02598960|471322251|FG010|Treatment Period|participant withdrew consent|0|||
130914018|NCT02598960|471322252|FG011|Treatment Period|participant withdrew consent|3|||
130914019|NCT02598960|471322253|FG012|Treatment Period|participant withdrew consent|0|||
130914020|NCT02598960|471322241|FG000|Treatment Period|No longer meets study criteria|0|||
130914021|NCT02598960|471322242|FG001|Treatment Period|No longer meets study criteria|0|||
130914022|NCT02598960|471322243|FG002|Treatment Period|No longer meets study criteria|0|||
130914023|NCT02598960|471322244|FG003|Treatment Period|No longer meets study criteria|0|||
130914024|NCT02598960|471322245|FG004|Treatment Period|No longer meets study criteria|0|||
131032726|NCT04241068|471753096|FG000|Core Treatment Period|Reason Not Specified|41|||
131032727|NCT04241068|471753096|FG000|LTE Period|Adverse Event|19|||
131032728|NCT04241068|471753096|FG000|LTE Period|Change of Treatment|1|||
131032729|NCT04241068|471753096|FG000|LTE Period|Consent Withdrawn|71|||
131032730|NCT04241068|471753096|FG000|LTE Period|Death|8|||
131032731|NCT04241068|471753096|FG000|LTE Period|Disease Progression|11|||
131032732|NCT04241068|471753096|FG000|LTE Period|Investigator Decision|12|||
131032733|NCT04241068|471753096|FG000|LTE Period|Loss of Capacity|2|||
131032734|NCT04241068|471753096|FG000|LTE Period|Lost to Follow-up|7|||
131032735|NCT04241068|471753096|FG000|LTE Period|Relocation|6|||
131032736|NCT04241068|471753096|FG000|LTE Period|Site Terminated by Sponsor|26|||
131032737|NCT04241068|471753096|FG000|LTE Period|Study Terminated by Sponsor|276|||
131032738|NCT04241068|471753096|FG000|LTE Period|Study Visit Burden|10|||
131032739|NCT04241068|471753096|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
131032740|NCT04241068|471753096|FG000|LTE Period|Reason Not Specified|65|||
131032741|NCT01413100|471753097|FG000|Overall Study|Withdrawal by Subject|1|||
131032742|NCT05369403|471753098|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
131032743|NCT05369403|471753099|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
131032744|NCT05369403|471753100|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
131032745|NCT05369403|471753098|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
131032746|NCT05369403|471753099|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
131032747|NCT05369403|471753100|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
131032748|NCT05369403|471753098|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
131032749|NCT05369403|471753099|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
130914025|NCT02598960|471322246|FG005|Treatment Period|No longer meets study criteria|0|||
130914026|NCT02598960|471322247|FG006|Treatment Period|No longer meets study criteria|0|||
131032750|NCT05369403|471753100|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
130914027|NCT02598960|471322248|FG007|Treatment Period|No longer meets study criteria|0|||
130914028|NCT02598960|471322249|FG008|Treatment Period|No longer meets study criteria|0|||
130914029|NCT02598960|471322250|FG009|Treatment Period|No longer meets study criteria|0|||
130914030|NCT02598960|471322251|FG010|Treatment Period|No longer meets study criteria|0|||
130914031|NCT02598960|471322252|FG011|Treatment Period|No longer meets study criteria|1|||
130914032|NCT02598960|471322253|FG012|Treatment Period|No longer meets study criteria|0|||
130914033|NCT02598960|471322241|FG000|Treatment Period|Other Reasons|0|||
130914034|NCT02598960|471322242|FG001|Treatment Period|Other Reasons|0|||
130914035|NCT02598960|471322243|FG002|Treatment Period|Other Reasons|0|||
130914036|NCT02598960|471322244|FG003|Treatment Period|Other Reasons|0|||
130914037|NCT02598960|471322245|FG004|Treatment Period|Other Reasons|0|||
130914038|NCT02598960|471322246|FG005|Treatment Period|Other Reasons|0|||
130914039|NCT02598960|471322247|FG006|Treatment Period|Other Reasons|0|||
130914040|NCT02598960|471322248|FG007|Treatment Period|Other Reasons|0|||
130914041|NCT02598960|471322249|FG008|Treatment Period|Other Reasons|0|||
130914042|NCT02598960|471322250|FG009|Treatment Period|Other Reasons|0|||
130914043|NCT02598960|471322251|FG010|Treatment Period|Other Reasons|0|||
130914044|NCT02598960|471322252|FG011|Treatment Period|Other Reasons|0|||
130914045|NCT02598960|471322253|FG012|Treatment Period|Other Reasons|1|||
130914046|NCT02598960|471322241|FG000|Participants Entering Follow Up Period|Death|1|||
130914047|NCT02598960|471322242|FG001|Participants Entering Follow Up Period|Death|0|||
130914048|NCT02598960|471322243|FG002|Participants Entering Follow Up Period|Death|0|||
130914049|NCT02598960|471322244|FG003|Participants Entering Follow Up Period|Death|0|||
130914050|NCT02598960|471322245|FG004|Participants Entering Follow Up Period|Death|0|||
130914051|NCT02598960|471322246|FG005|Participants Entering Follow Up Period|Death|0|||
130914052|NCT02598960|471322247|FG006|Participants Entering Follow Up Period|Death|0|||
130914053|NCT02598960|471322248|FG007|Participants Entering Follow Up Period|Death|0|||
130914054|NCT02598960|471322249|FG008|Participants Entering Follow Up Period|Death|0|||
130914055|NCT02598960|471322250|FG009|Participants Entering Follow Up Period|Death|1|||
130914056|NCT02598960|471322251|FG010|Participants Entering Follow Up Period|Death|0|||
130914057|NCT02598960|471322252|FG011|Participants Entering Follow Up Period|Death|11|||
130914058|NCT02598960|471322253|FG012|Participants Entering Follow Up Period|Death|2|||
130914059|NCT02598960|471322241|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
130914060|NCT02598960|471322242|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
130914061|NCT02598960|471322243|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
130914062|NCT02598960|471322244|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
131032751|NCT05369403|471753098|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
131032752|NCT05369403|471753099|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
131032753|NCT05369403|471753100|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
131032754|NCT05369403|471753098|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
131032755|NCT05369403|471753099|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
131032756|NCT05369403|471753100|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
131118358|NCT01572675|472064175|FG001|Overall Study|Lost to Follow-up|27|||
131118359|NCT02921269|472064179|FG000|Overall Study|Did not complete DLT period|1|||
131118360|NCT02322229|472064189|FG000|Overall Study|Physician Decision|2|||
131118361|NCT00705432|472064190|FG000|Treatment Period|Adverse Event|45|||
131118362|NCT00705432|472064191|FG001|Treatment Period|Adverse Event|37|||
131118363|NCT00705432|472064192|FG002|Treatment Period|Adverse Event|51|||
131118364|NCT00705432|472064193|FG003|Treatment Period|Adverse Event|12|||
131118365|NCT00705432|472064194|FG004|Treatment Period|Adverse Event|8|||
131118366|NCT00705432|472064195|FG005|Treatment Period|Adverse Event|9|||
131118367|NCT00705432|472064190|FG000|Treatment Period|Treatment failure|92|||
131118368|NCT00705432|472064191|FG001|Treatment Period|Treatment failure|42|||
131118369|NCT00705432|472064192|FG002|Treatment Period|Treatment failure|33|||
131118370|NCT00705432|472064193|FG003|Treatment Period|Treatment failure|25|||
131118371|NCT00705432|472064194|FG004|Treatment Period|Treatment failure|13|||
131118372|NCT00705432|472064195|FG005|Treatment Period|Treatment failure|14|||
131118373|NCT00705432|472064190|FG000|Treatment Period|Non medical reason|26|||
131118374|NCT00705432|472064191|FG001|Treatment Period|Non medical reason|32|||
131118375|NCT00705432|472064192|FG002|Treatment Period|Non medical reason|37|||
130769159|NCT02005627|470780540|FG000|Overall Study|Withdrawal by Subject|1|||
130914063|NCT02598960|471322245|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
131032757|NCT05369403|471753098|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
130914064|NCT02598960|471322246|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
130914065|NCT02598960|471322247|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
130914066|NCT02598960|471322248|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
131118376|NCT00705432|472064193|FG003|Treatment Period|Non medical reason|4|||
131118377|NCT00705432|472064194|FG004|Treatment Period|Non medical reason|7|||
131118378|NCT00705432|472064195|FG005|Treatment Period|Non medical reason|7|||
131118379|NCT00705432|472064190|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
130769160|NCT02005627|470780541|FG001|Overall Study|Withdrawal by Subject|2|||
131118380|NCT00705432|472064191|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
131118381|NCT00705432|472064192|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
131118382|NCT00705432|472064193|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
131118383|NCT00705432|472064194|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
131118384|NCT00705432|472064195|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
131118385|NCT00705432|472064190|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
131118386|NCT00705432|472064191|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
131118387|NCT00705432|472064192|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
131118388|NCT00705432|472064193|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
131118389|NCT00705432|472064194|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
131118390|NCT00705432|472064195|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
131118391|NCT00521053|472064196|FG000|Observation Phase|Disease Progression|55|||
131118392|NCT00521053|472064196|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
131118393|NCT00521053|472064196|FG000|Observation Phase|Death|2|||
131118394|NCT00521053|472064196|FG000|Observation Phase|Adverse Event|1|||
131118395|NCT00521053|472064196|FG000|Observation Phase|Other non-study melanoma treatment|1|||
131118396|NCT00521053|472064196|FG000|Observation Phase|Physician Decision|1|||
131118397|NCT00482703|472064197|FG000|Overall Study|Poor compliance|1|||
131118398|NCT00482703|472064198|FG001|Overall Study|Poor compliance|0|||
130914067|NCT02598960|471322249|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
130914068|NCT02598960|471322250|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
130914069|NCT02598960|471322251|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
130914070|NCT02598960|471322252|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
130914071|NCT02598960|471322253|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
130914072|NCT02598960|471322241|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
130914073|NCT02598960|471322242|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
131118399|NCT04223791|472064200|FG000|Overall Study|Lost to Follow-up|0|||
131118400|NCT04223791|472064201|FG001|Overall Study|Lost to Follow-up|4|||
131118401|NCT04223791|472064200|FG000|Overall Study|Physician Decision|5|||
131118402|NCT04223791|472064201|FG001|Overall Study|Physician Decision|1|||
131118403|NCT04223791|472064200|FG000|Overall Study|Protocol Violation|1|||
131118404|NCT04223791|472064201|FG001|Overall Study|Protocol Violation|1|||
131118405|NCT04223791|472064200|FG000|Overall Study|Withdrawal by Subject|10|||
131118406|NCT04223791|472064201|FG001|Overall Study|Withdrawal by Subject|12|||
131118407|NCT04223791|472064200|FG000|Overall Study|Pregnancy|1|||
131118408|NCT04223791|472064201|FG001|Overall Study|Pregnancy|1|||
131118409|NCT04223791|472064200|FG000|Overall Study|Ongoing in Study|305|||
131118410|NCT04223791|472064201|FG001|Overall Study|Ongoing in Study|302|||
131118411|NCT00729378|472065565|FG000|Baseline|Did not complete study measurements|72|||
131118412|NCT00729378|472065566|FG001|Baseline|Did not complete study measurements|33|||
131118413|NCT00729378|472065565|FG000|Baseline|Withdrawal by Subject|66|||
131118414|NCT00729378|472065566|FG001|Baseline|Withdrawal by Subject|59|||
131118415|NCT00729378|472065565|FG000|12-months|Lost to Follow-up|100|||
130699080|NCT02623218|470522785|FG002|Overall Study|Lost to Follow-up|0|||
130699081|NCT02623218|470522786|FG003|Overall Study|Lost to Follow-up|0|||
130699082|NCT02623218|470522787|FG004|Overall Study|Lost to Follow-up|0|||
130699083|NCT01726803|470522788|FG000|Overall Study|Lost to Follow-up|6|||
130699084|NCT01726803|470522789|FG001|Overall Study|Lost to Follow-up|1|||
130699085|NCT01726803|470522788|FG000|Overall Study|Withdrawal by Subject|1|||
130699086|NCT01726803|470522789|FG001|Overall Study|Withdrawal by Subject|0|||
130699087|NCT01685008|470522791|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
130699088|NCT01685008|470522792|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
130699089|NCT01685008|470522793|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
130699090|NCT01685008|470522794|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
130699091|NCT01685008|470522791|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
130699092|NCT01685008|470522792|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
130699093|NCT01685008|470522793|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
130699094|NCT01685008|470522794|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
130699095|NCT01685008|470522791|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
130699096|NCT01685008|470522792|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
130699097|NCT01685008|470522793|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
130699098|NCT01685008|470522794|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
130699099|NCT01685008|470522791|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
130699100|NCT01685008|470522792|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
130699101|NCT01685008|470522793|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
130699102|NCT01685008|470522794|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
130699103|NCT01685008|470522791|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
130699104|NCT01685008|470522792|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
130699105|NCT01685008|470522793|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
130699106|NCT01685008|470522794|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
130699107|NCT01970592|470522795|FG000|Overall Study|Withdrawal by Subject|4|||
130914074|NCT02598960|471322243|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
130914075|NCT02598960|471322244|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
130914076|NCT02598960|471322245|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
130914077|NCT02598960|471322246|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
130914078|NCT02598960|471322247|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
130914079|NCT02598960|471322248|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
130914080|NCT02598960|471322249|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
130914081|NCT02598960|471322250|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
130914082|NCT02598960|471322251|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
130914083|NCT02598960|471322252|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
130914084|NCT02598960|471322253|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
130914085|NCT02598960|471322241|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914086|NCT02598960|471322242|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914087|NCT02598960|471322243|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914088|NCT02598960|471322244|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914089|NCT02598960|471322245|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914090|NCT02598960|471322246|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914091|NCT02598960|471322247|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914092|NCT02598960|471322248|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914093|NCT02598960|471322249|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914094|NCT02598960|471322250|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914095|NCT02598960|471322251|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914096|NCT02598960|471322252|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
130914097|NCT02598960|471322253|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
130914098|NCT02598960|471322241|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
130914099|NCT02598960|471322242|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
130914100|NCT02598960|471322243|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
130914101|NCT02598960|471322244|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
130914102|NCT02598960|471322245|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
130914103|NCT02598960|471322246|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
130914104|NCT02598960|471322247|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
130914105|NCT02598960|471322248|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
130914106|NCT02598960|471322249|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
130914107|NCT02598960|471322250|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
130914108|NCT02598960|471322251|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
130914109|NCT02598960|471322252|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
130914110|NCT02598960|471322253|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
130914111|NCT03265665|471322258|FG000|24-week Data Collection|Withdrawal by Subject|2|||
130914112|NCT03265665|471322259|FG001|24-week Data Collection|Withdrawal by Subject|2|||
131118416|NCT00729378|472065566|FG001|12-months|Lost to Follow-up|65|||
131118417|NCT00729378|472065565|FG000|24-months|Lost to Follow-up|72|||
131118418|NCT00729378|472065566|FG001|24-months|Lost to Follow-up|51|||
131118419|NCT00729378|472065565|FG000|36-months|Lost to Follow-up|15|||
131118420|NCT00729378|472065566|FG001|36-months|Lost to Follow-up|6|||
131118421|NCT02246582|472065569|FG000|Overall Study|Withdrawal by Subject|3|||
131118422|NCT02246582|472065570|FG001|Overall Study|Withdrawal by Subject|4|||
131118423|NCT02060383|472065571|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
131118424|NCT02060383|472065572|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
131118425|NCT02060383|472065573|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
131118426|NCT02060383|472065574|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
131118427|NCT02060383|472065575|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
131118428|NCT02060383|472065571|FG000|Core Phase|Adverse Event|2|||
131118429|NCT02060383|472065572|FG001|Core Phase|Adverse Event|0|||
131118430|NCT02060383|472065573|FG002|Core Phase|Adverse Event|0|||
131118431|NCT02060383|472065574|FG003|Core Phase|Adverse Event|2|||
131118432|NCT02060383|472065575|FG004|Core Phase|Adverse Event|6|||
131118433|NCT02060383|472065571|FG000|Core Phase|Administrative problems|0|||
131118434|NCT02060383|472065572|FG001|Core Phase|Administrative problems|1|||
131118435|NCT02060383|472065573|FG002|Core Phase|Administrative problems|0|||
131118436|NCT02060383|472065574|FG003|Core Phase|Administrative problems|0|||
131118437|NCT02060383|472065575|FG004|Core Phase|Administrative problems|0|||
131118438|NCT02060383|472065571|FG000|Core Phase|Protocol Violation|0|||
131118439|NCT02060383|472065572|FG001|Core Phase|Protocol Violation|0|||
131118440|NCT02060383|472065573|FG002|Core Phase|Protocol Violation|0|||
131118441|NCT02060383|472065574|FG003|Core Phase|Protocol Violation|1|||
131118442|NCT02060383|472065575|FG004|Core Phase|Protocol Violation|0|||
131118443|NCT02060383|472065571|FG000|Core Phase|Withdrawal by Subject|0|||
131118444|NCT02060383|472065572|FG001|Core Phase|Withdrawal by Subject|0|||
130914113|NCT03265665|471322258|FG000|24-week Data Collection|Lost to Follow-up|4|||
130914114|NCT03265665|471322259|FG001|24-week Data Collection|Lost to Follow-up|5|||
130914115|NCT03265665|471322258|FG000|36-week Data Collection|Lost to Follow-up|6|||
130914116|NCT03265665|471322259|FG001|36-week Data Collection|Lost to Follow-up|8|||
130914117|NCT01193660|471322260|FG000|Overall Study|Withdrawal by Subject|2|||
130914118|NCT01193660|471322261|FG001|Overall Study|Withdrawal by Subject|3|||
130914119|NCT01193660|471322262|FG002|Overall Study|Withdrawal by Subject|1|||
130914120|NCT01193660|471322260|FG000|Overall Study|Death|1|||
130914121|NCT01193660|471322261|FG001|Overall Study|Death|0|||
130914122|NCT01193660|471322262|FG002|Overall Study|Death|0|||
130914123|NCT01193660|471322260|FG000|Overall Study|Physician Decision|1|||
130914124|NCT01193660|471322261|FG001|Overall Study|Physician Decision|0|||
130914125|NCT01193660|471322262|FG002|Overall Study|Physician Decision|1|||
130914126|NCT00195273|471322263|FG000|Overall Study|Adverse Event|9|||
130914127|NCT00195273|471322264|FG001|Overall Study|Adverse Event|9|||
130914128|NCT00195273|471322263|FG000|Overall Study|Protocol deviation|0|||
130914129|NCT00195273|471322264|FG001|Overall Study|Protocol deviation|1|||
130914130|NCT00195273|471322263|FG000|Overall Study|Lack of Efficacy|3|||
130914131|NCT00195273|471322264|FG001|Overall Study|Lack of Efficacy|1|||
130914132|NCT00195273|471322263|FG000|Overall Study|Procedural complications|9|||
130914133|NCT00195273|471322264|FG001|Overall Study|Procedural complications|3|||
130914134|NCT01680965|471322265|FG000|Overall Study|Death|0|||
130914135|NCT01680965|471322266|FG001|Overall Study|Death|0|||
130914136|NCT01680965|471322267|FG002|Overall Study|Death|0|||
130914137|NCT01680965|471322268|FG003|Overall Study|Death|6|||
130914138|NCT00595465|471322269|FG000|Overall Study|Adverse Event|4|||
130914139|NCT00595465|471322270|FG001|Overall Study|Adverse Event|3|||
130914140|NCT00595465|471322271|FG002|Overall Study|Adverse Event|3|||
130914141|NCT00595465|471322269|FG000|Overall Study|Pregnancy|0|||
130914142|NCT00595465|471322270|FG001|Overall Study|Pregnancy|0|||
130914143|NCT00595465|471322271|FG002|Overall Study|Pregnancy|1|||
130914144|NCT00595465|471322269|FG000|Overall Study|Protocol Violation|2|||
130914145|NCT00595465|471322270|FG001|Overall Study|Protocol Violation|1|||
130914146|NCT00595465|471322271|FG002|Overall Study|Protocol Violation|0|||
130914147|NCT00595465|471322269|FG000|Overall Study|Lost to Follow-up|0|||
130914148|NCT00595465|471322270|FG001|Overall Study|Lost to Follow-up|0|||
130914149|NCT00595465|471322271|FG002|Overall Study|Lost to Follow-up|2|||
130914150|NCT00595465|471322269|FG000|Overall Study|administrative reason|0|||
130914151|NCT00595465|471322270|FG001|Overall Study|administrative reason|0|||
130914152|NCT00595465|471322271|FG002|Overall Study|administrative reason|1|||
130914153|NCT02595970|471322272|FG000|Overall Study|Withdrawal by Subject|2|||
130914154|NCT02595970|471322272|FG000|Overall Study|Physician Decision|2|||
130914155|NCT02595970|471322272|FG000|Overall Study|Protocol Violation|4|||
130914156|NCT02595970|471322272|FG000|Overall Study|Adverse Event|5|||
130914157|NCT02595970|471322272|FG000|Overall Study|Lack of Efficacy|7|||
130914158|NCT04879225|471322273|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
131032758|NCT05369403|471753099|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
131032759|NCT05369403|471753100|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
131032760|NCT05369403|471753098|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
131032761|NCT05369403|471753099|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
131032762|NCT05369403|471753100|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
131118445|NCT02060383|472065573|FG002|Core Phase|Withdrawal by Subject|0|||
130699108|NCT01970592|470522795|FG000|Overall Study|Physician Decision|1|||
130699109|NCT01970592|470522795|FG000|Overall Study|Adverse Event|1|||
130699110|NCT01320722|470522798|FG000|Overall Study|Did not Receive Intervention|3|||
130699111|NCT01320722|470522799|FG001|Overall Study|Did not Receive Intervention|2|||
130699112|NCT01320722|470522800|FG002|Overall Study|Did not Receive Intervention|1|||
130699113|NCT01320722|470522801|FG003|Overall Study|Did not Receive Intervention|1|||
130914159|NCT04879225|471322273|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
130914160|NCT02367131|471322276|FG000|Overall Study|Adverse Event|64|||
130914161|NCT02367131|471322276|FG000|Overall Study|No visit since the first visit|3|||
130914162|NCT02367131|471322276|FG000|Overall Study|Request by patient|53|||
130914163|NCT02367131|471322276|FG000|Overall Study|Improvement/remission|2|||
130914164|NCT02367131|471322276|FG000|Overall Study|No change/progressive disease|78|||
130699114|NCT01320722|470522802|FG004|Overall Study|Did not Receive Intervention|2|||
130914165|NCT02367131|471322276|FG000|Overall Study|Other than stated above|20|||
130914166|NCT02367131|471322276|FG000|Overall Study|Not treated|2|||
130914167|NCT02572388|471322277|FG000|Overall Study|Withdrawal by Subject|1|||
130914168|NCT02572388|471322278|FG001|Overall Study|Withdrawal by Subject|1|||
130914169|NCT02572388|471322279|FG002|Overall Study|Withdrawal by Subject|2|||
130914170|NCT02572388|471322280|FG003|Overall Study|Withdrawal by Subject|2|||
130914171|NCT01973569|471322281|FG000|Overall Study|Adverse Event|9|||
130699115|NCT01320722|470522798|FG000|Overall Study|Lost to Follow-up|0|||
130914172|NCT01973569|471322282|FG001|Overall Study|Adverse Event|2|||
130914173|NCT01973569|471322283|FG002|Overall Study|Adverse Event|4|||
130914174|NCT01973569|471322281|FG000|Overall Study|Protocol Violation|2|||
130914175|NCT01973569|471322282|FG001|Overall Study|Protocol Violation|1|||
130914176|NCT01973569|471322283|FG002|Overall Study|Protocol Violation|3|||
130914177|NCT01973569|471322281|FG000|Overall Study|Withdrawal by Subject|7|||
130914178|NCT01973569|471322282|FG001|Overall Study|Withdrawal by Subject|5|||
130914179|NCT01973569|471322283|FG002|Overall Study|Withdrawal by Subject|2|||
130914180|NCT01973569|471322281|FG000|Overall Study|Invasive dental treatment|3|||
130914181|NCT01973569|471322282|FG001|Overall Study|Invasive dental treatment|5|||
130914182|NCT01973569|471322283|FG002|Overall Study|Invasive dental treatment|6|||
130914183|NCT01973569|471322281|FG000|Overall Study|Prohibited concomitant d|1|||
130914184|NCT01973569|471322282|FG001|Overall Study|Prohibited concomitant d|5|||
130914185|NCT01973569|471322283|FG002|Overall Study|Prohibited concomitant d|0|||
130914186|NCT01973569|471322281|FG000|Overall Study|Disease progression|0|||
130914187|NCT01973569|471322282|FG001|Overall Study|Disease progression|3|||
131118446|NCT02060383|472065574|FG003|Core Phase|Withdrawal by Subject|4|||
131118447|NCT02060383|472065575|FG004|Core Phase|Withdrawal by Subject|2|||
131118448|NCT02060383|472065571|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
131118449|NCT02060383|472065572|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
131118450|NCT02060383|472065573|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
131118451|NCT02060383|472065574|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
131118452|NCT02060383|472065575|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
131118453|NCT02060383|472065571|FG000|Extension Phase|Adverse Event|1|||
131118454|NCT02060383|472065572|FG001|Extension Phase|Adverse Event|1|||
131118455|NCT02060383|472065573|FG002|Extension Phase|Adverse Event|2|||
131118456|NCT02060383|472065574|FG003|Extension Phase|Adverse Event|0|||
131118457|NCT02060383|472065575|FG004|Extension Phase|Adverse Event|1|||
131118458|NCT02060383|472065571|FG000|Extension Phase|Withdrawal by Subject|0|||
131118459|NCT02060383|472065572|FG001|Extension Phase|Withdrawal by Subject|1|||
131118460|NCT02060383|472065573|FG002|Extension Phase|Withdrawal by Subject|0|||
131118461|NCT02060383|472065574|FG003|Extension Phase|Withdrawal by Subject|0|||
131118462|NCT02060383|472065575|FG004|Extension Phase|Withdrawal by Subject|2|||
131118463|NCT02060383|472065571|FG000|Extension Phase|Administrative problems|1|||
131118464|NCT02060383|472065572|FG001|Extension Phase|Administrative problems|0|||
131118465|NCT02060383|472065573|FG002|Extension Phase|Administrative problems|0|||
131118466|NCT02060383|472065574|FG003|Extension Phase|Administrative problems|0|||
131118467|NCT02060383|472065575|FG004|Extension Phase|Administrative problems|0|||
131118468|NCT02060383|472065571|FG000|Extension Phase|Death|0|||
131118469|NCT02060383|472065572|FG001|Extension Phase|Death|0|||
131118470|NCT02060383|472065573|FG002|Extension Phase|Death|1|||
131118471|NCT02060383|472065574|FG003|Extension Phase|Death|0|||
131118472|NCT02060383|472065575|FG004|Extension Phase|Death|1|||
131118473|NCT02060383|472065571|FG000|Extension Phase|Protocol Violation|0|||
131118474|NCT02060383|472065572|FG001|Extension Phase|Protocol Violation|0|||
131118475|NCT02060383|472065573|FG002|Extension Phase|Protocol Violation|0|||
131118476|NCT02060383|472065574|FG003|Extension Phase|Protocol Violation|0|||
131118477|NCT02060383|472065575|FG004|Extension Phase|Protocol Violation|1|||
131118478|NCT00395863|472065578|FG000|Overall Study|Patients did not complete both exams|2|||
131118479|NCT00395863|472065579|FG001|Overall Study|Patients did not complete both exams|3|||
131118480|NCT01876251|472065582|FG000|Overall Study|Clinical progression|1|||
131118481|NCT01876251|472065583|FG001|Overall Study|Clinical progression|0|||
131118482|NCT01876251|472065584|FG002|Overall Study|Clinical progression|0|||
131118483|NCT01876251|472065582|FG000|Overall Study|Death|2|||
131118484|NCT01876251|472065583|FG001|Overall Study|Death|0|||
131118485|NCT01876251|472065584|FG002|Overall Study|Death|1|||
131118486|NCT01876251|472065582|FG000|Overall Study|Participant started new treatment|1|||
131118487|NCT01876251|472065583|FG001|Overall Study|Participant started new treatment|0|||
131118488|NCT01876251|472065584|FG002|Overall Study|Participant started new treatment|1|||
130914188|NCT01973569|471322283|FG002|Overall Study|Disease progression|0|||
130914189|NCT01973569|471322281|FG000|Overall Study|Other|1|||
130914190|NCT01973569|471322282|FG001|Overall Study|Other|1|||
131118489|NCT01876251|472065582|FG000|Overall Study|Participant refused further follow-up|0|||
130914191|NCT01973569|471322283|FG002|Overall Study|Other|0|||
130914192|NCT01973569|471322281|FG000|Overall Study|Did not receive study drug|6|||
130914193|NCT01973569|471322282|FG001|Overall Study|Did not receive study drug|3|||
130914194|NCT01973569|471322283|FG002|Overall Study|Did not receive study drug|3|||
130914195|NCT00810108|471322287|FG000|Overall Study|Withdrawal by Subject|1|||
131118490|NCT01876251|472065583|FG001|Overall Study|Participant refused further follow-up|0|||
131118491|NCT01876251|472065584|FG002|Overall Study|Participant refused further follow-up|1|||
131118492|NCT01876251|472065582|FG000|Overall Study|Study terminated|1|||
131118493|NCT01876251|472065583|FG001|Overall Study|Study terminated|0|||
131118494|NCT01876251|472065584|FG002|Overall Study|Study terminated|0|||
131118495|NCT01876251|472065582|FG000|Overall Study|Objective progression or relapse|10|||
131118496|NCT01876251|472065583|FG001|Overall Study|Objective progression or relapse|3|||
131118497|NCT01876251|472065584|FG002|Overall Study|Objective progression or relapse|8|||
131118498|NCT00268437|472065585|FG000|Overall Study|Ineligible|1|||
130699116|NCT01320722|470522799|FG001|Overall Study|Lost to Follow-up|1|||
130699117|NCT01320722|470522800|FG002|Overall Study|Lost to Follow-up|0|||
130699118|NCT01320722|470522801|FG003|Overall Study|Lost to Follow-up|1|||
130914196|NCT00810108|471322288|FG001|Overall Study|Withdrawal by Subject|0|||
131118499|NCT03335163|472065588|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
131118500|NCT03335163|472065588|FG000|Overall Study|Withdrawal by Subject|18|||
131118501|NCT03945591|472065590|FG000|Overall Study|Participant not transplanted|1|||
131118502|NCT03945591|472065590|FG000|Overall Study|Change in treatment plan|3|||
131118503|NCT03945591|472065590|FG000|Overall Study|Adverse Event|1|||
131118504|NCT01986920|472065593|FG000|A- 101 25%|Withdrawal by Subject|1|||
131118505|NCT01986920|472065594|FG001|A- 101 25%|Withdrawal by Subject|0|||
131118506|NCT01986920|472065595|FG002|A- 101 25%|Withdrawal by Subject|0|||
131118507|NCT01986920|472065596|FG003|A- 101 25%|Withdrawal by Subject|0|||
131118508|NCT01986920|472065593|FG000|A-101 32.5%|Withdrawal by Subject|0|||
131118509|NCT01986920|472065594|FG001|A-101 32.5%|Withdrawal by Subject|1|||
131118510|NCT01986920|472065595|FG002|A-101 32.5%|Withdrawal by Subject|0|||
131118511|NCT01986920|472065596|FG003|A-101 32.5%|Withdrawal by Subject|0|||
131118512|NCT01986920|472065593|FG000|A-101 40%|Withdrawal by Subject|0|||
131118513|NCT01986920|472065594|FG001|A-101 40%|Withdrawal by Subject|0|||
131118514|NCT01986920|472065595|FG002|A-101 40%|Withdrawal by Subject|1|||
131118515|NCT01986920|472065596|FG003|A-101 40%|Withdrawal by Subject|0|||
131118516|NCT01986920|472065593|FG000|Placebo|Withdrawal by Subject|0|||
131118517|NCT01986920|472065594|FG001|Placebo|Withdrawal by Subject|0|||
131118518|NCT01986920|472065595|FG002|Placebo|Withdrawal by Subject|0|||
131118519|NCT01986920|472065596|FG003|Placebo|Withdrawal by Subject|1|||
131118520|NCT01338415|472065597|FG000|Core + Extension|Adverse Event|8|||
131118521|NCT01338415|472065598|FG001|Core + Extension|Adverse Event|6|||
131118522|NCT01338415|472065599|FG002|Core + Extension|Adverse Event|0|||
131118523|NCT01338415|472065597|FG000|Core + Extension|Withdrawal by Subject|1|||
131118524|NCT01338415|472065598|FG001|Core + Extension|Withdrawal by Subject|1|||
131118525|NCT01338415|472065599|FG002|Core + Extension|Withdrawal by Subject|0|||
131118526|NCT01338415|472065597|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
131118527|NCT01338415|472065598|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
131118528|NCT01338415|472065599|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
131118529|NCT01338415|472065597|FG000|Core + Extension|Other (administrative reason)|1|||
131118530|NCT01338415|472065598|FG001|Core + Extension|Other (administrative reason)|0|||
131118531|NCT01338415|472065599|FG002|Core + Extension|Other (administrative reason)|0|||
131118532|NCT01338415|472065597|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
131118533|NCT01338415|472065598|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
131118534|NCT01338415|472065599|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
131118535|NCT01338415|472065597|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
131118536|NCT01338415|472065598|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
131118537|NCT01338415|472065599|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
131118538|NCT01338415|472065597|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
131118539|NCT01338415|472065598|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
131118540|NCT01338415|472065599|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
131118541|NCT01338415|472065597|FG000|Exceptional Use Treatment Period|Death|0|||
131118542|NCT01338415|472065598|FG001|Exceptional Use Treatment Period|Death|0|||
131118543|NCT01338415|472065599|FG002|Exceptional Use Treatment Period|Death|1|||
131118544|NCT05215262|472065602|FG000|Overall Study|Lost to Follow-up|12|||
131118545|NCT05215262|472065603|FG001|Overall Study|Lost to Follow-up|0|||
131118546|NCT04880447|472065605|FG000|Overall Study|No vaccination information|1|||
131118547|NCT04880447|472065605|FG000|Overall Study|No adverse event information (missing information)|1|||
131118548|NCT04880447|472065605|FG000|Overall Study|Disease not covered in this study|35|||
131118549|NCT00718549|472065606|FG000|Induction Phase|Disease Progression|1|||
131118550|NCT00718549|472065607|FG001|Induction Phase|Disease Progression|0|||
131118551|NCT00718549|472065608|FG002|Induction Phase|Disease Progression|0|||
131118552|NCT00718549|472065606|FG000|Induction Phase|Eligibility Criteria Violation|2|||
131118553|NCT00718549|472065607|FG001|Induction Phase|Eligibility Criteria Violation|0|||
131118554|NCT00718549|472065608|FG002|Induction Phase|Eligibility Criteria Violation|0|||
131118555|NCT00718549|472065606|FG000|Induction Phase|Early Termination - No Additional Info|59|||
131118556|NCT00718549|472065607|FG001|Induction Phase|Early Termination - No Additional Info|0|||
131118557|NCT00718549|472065608|FG002|Induction Phase|Early Termination - No Additional Info|0|||
131118558|NCT00718549|472065606|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
131118559|NCT00718549|472065607|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
131118560|NCT00718549|472065608|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
131118561|NCT00718549|472065606|FG000|Maintenance/ Observation Phase|Death|0|||
130699119|NCT01320722|470522802|FG004|Overall Study|Lost to Follow-up|3|||
131118562|NCT00718549|472065607|FG001|Maintenance/ Observation Phase|Death|1|||
131118563|NCT00718549|472065608|FG002|Maintenance/ Observation Phase|Death|2|||
130699120|NCT01320722|470522798|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
131118564|NCT00718549|472065606|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
131118565|NCT00718549|472065607|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
131118566|NCT00718549|472065608|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
131118567|NCT00718549|472065606|FG000|Maintenance/ Observation Phase|Progression|0|||
130914197|NCT00137631|471322296|FG000|Overall Study|Lost to Follow-up|37|||
130914198|NCT00137631|471322297|FG001|Overall Study|Lost to Follow-up|41|||
130914199|NCT02486302|471322299|FG000|Overall Study|Discontinued prematurely|410|||
130914200|NCT02486302|471322299|FG000|Overall Study|Documentation not completed|255|||
130914201|NCT02486302|471322299|FG000|Overall Study|Excluded due to legal reasons|8|||
130914202|NCT02486302|471322299|FG000|Overall Study|Not treated|3|||
130914203|NCT01871142|471322300|FG000|Overall Study|Adverse Event|1|||
130914204|NCT00598702|471322309|FG000|Overall Study|Other|0|||
130914205|NCT00598702|471322310|FG001|Overall Study|Other|2|||
130914206|NCT00598702|471322311|FG002|Overall Study|Other|0|||
130914207|NCT00598702|471322312|FG003|Overall Study|Other|0|||
130914208|NCT00598702|471322313|FG004|Overall Study|Other|0|||
131032763|NCT05369403|471753098|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
131032764|NCT05369403|471753099|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
131032765|NCT05369403|471753100|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
131032766|NCT05369403|471753098|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
131032767|NCT05369403|471753099|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
131032768|NCT05369403|471753100|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
131032769|NCT05369403|471753098|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
131032770|NCT05369403|471753099|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
131032771|NCT05369403|471753100|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
131032772|NCT05369403|471753098|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
131032773|NCT05369403|471753099|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
131032774|NCT05369403|471753100|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
131032775|NCT04896476|471753112|FG000|Overall Study|Withdrawal by Subject|1|||
131032776|NCT04896476|471753112|FG000|Overall Study|Lost to Follow-up|2|||
131032777|NCT03476187|471753113|FG000|Overall Study|Protocol Violation|7|||
131032778|NCT03476187|471753113|FG000|Overall Study|Physician Decision|5|||
131032779|NCT03924986|471753114|FG000|Overall Study|Death|57|||
131032780|NCT03924986|471753115|FG001|Overall Study|Death|66|||
131032781|NCT03924986|471753114|FG000|Overall Study|Study Concluded by Sponsor|51|||
131032782|NCT03924986|471753115|FG001|Overall Study|Study Concluded by Sponsor|41|||
131032783|NCT03924986|471753114|FG000|Overall Study|Withdrawal by Subject|15|||
131032784|NCT03924986|471753115|FG001|Overall Study|Withdrawal by Subject|20|||
131032785|NCT03924986|471753114|FG000|Overall Study|Lost to Follow-up|7|||
131032786|NCT03924986|471753115|FG001|Overall Study|Lost to Follow-up|5|||
131032787|NCT03924986|471753114|FG000|Overall Study|Miscellaneous|1|||
131032788|NCT03924986|471753115|FG001|Overall Study|Miscellaneous|0|||
131032789|NCT05948670|471753117|FG000|Overall Study|Protocol Violation|6|||
131032790|NCT05948670|471753118|FG001|Overall Study|Protocol Violation|8|||
131032791|NCT05948670|471753117|FG000|Overall Study|Withdrawal by Subject|0|||
131032792|NCT05948670|471753118|FG001|Overall Study|Withdrawal by Subject|1|||
131032793|NCT03699709|471753119|FG000|Overall Study|Death|1|||
131032794|NCT03699709|471753120|FG001|Overall Study|Death|2|||
131032795|NCT03699709|471753119|FG000|Overall Study|Lost to Follow-up|10|||
131032796|NCT03699709|471753120|FG001|Overall Study|Lost to Follow-up|3|||
131032797|NCT03699709|471753119|FG000|Overall Study|Withdrawal by Subject|5|||
131032798|NCT03699709|471753120|FG001|Overall Study|Withdrawal by Subject|0|||
131032799|NCT03699709|471753119|FG000|Overall Study|incarcerated|1|||
131032800|NCT03699709|471753120|FG001|Overall Study|incarcerated|0|||
131032801|NCT03699709|471753119|FG000|Overall Study|scheduled, but no show|0|||
131032802|NCT03699709|471753120|FG001|Overall Study|scheduled, but no show|1|||
131032803|NCT04562649|471753122|FG000|Overall Study|Withdrawal by Subject|11|||
131032804|NCT04562649|471753123|FG001|Overall Study|Withdrawal by Subject|8|||
131032805|NCT04562649|471753122|FG000|Overall Study|Lost to Follow-up|26|||
131032806|NCT04562649|471753123|FG001|Overall Study|Lost to Follow-up|20|||
131032807|NCT04029688|471753127|FG000|Overall Study|Death|8|||
131032808|NCT04029688|471753128|FG001|Overall Study|Death|3|||
131032809|NCT04029688|471753129|FG002|Overall Study|Death|6|||
131032810|NCT04029688|471753130|FG003|Overall Study|Death|2|||
131032811|NCT04029688|471753131|FG004|Overall Study|Death|5|||
131032812|NCT04029688|471753132|FG005|Overall Study|Death|0|||
131032813|NCT04029688|471753133|FG006|Overall Study|Death|2|||
131032814|NCT04029688|471753134|FG007|Overall Study|Death|3|||
131032815|NCT04029688|471753127|FG000|Overall Study|Study Terminated by Sponsor|0|||
131032816|NCT04029688|471753128|FG001|Overall Study|Study Terminated by Sponsor|0|||
131032817|NCT04029688|471753129|FG002|Overall Study|Study Terminated by Sponsor|0|||
131032818|NCT04029688|471753130|FG003|Overall Study|Study Terminated by Sponsor|0|||
131032819|NCT04029688|471753131|FG004|Overall Study|Study Terminated by Sponsor|1|||
131032820|NCT04029688|471753132|FG005|Overall Study|Study Terminated by Sponsor|3|||
131032821|NCT04029688|471753133|FG006|Overall Study|Study Terminated by Sponsor|1|||
131032822|NCT04029688|471753134|FG007|Overall Study|Study Terminated by Sponsor|3|||
131032823|NCT04029688|471753127|FG000|Overall Study|Withdrawal by Subject|0|||
131032824|NCT04029688|471753128|FG001|Overall Study|Withdrawal by Subject|0|||
130914209|NCT00598702|471322314|FG005|Overall Study|Other|1|||
130914210|NCT00598702|471322315|FG006|Overall Study|Other|0|||
130914211|NCT00598702|471322316|FG007|Overall Study|Other|0|||
130699121|NCT01320722|470522799|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
130914212|NCT00598702|471322309|FG000|Overall Study|Early discharge from hospital|0|||
130914213|NCT00598702|471322310|FG001|Overall Study|Early discharge from hospital|0|||
130914214|NCT00598702|471322311|FG002|Overall Study|Early discharge from hospital|2|||
130914215|NCT00598702|471322312|FG003|Overall Study|Early discharge from hospital|5|||
130914216|NCT00598702|471322313|FG004|Overall Study|Early discharge from hospital|0|||
130914217|NCT00598702|471322314|FG005|Overall Study|Early discharge from hospital|10|||
130914218|NCT00598702|471322315|FG006|Overall Study|Early discharge from hospital|1|||
130914219|NCT00598702|471322316|FG007|Overall Study|Early discharge from hospital|0|||
130914220|NCT00598702|471322309|FG000|Overall Study|Adverse Event|0|||
130914221|NCT00598702|471322310|FG001|Overall Study|Adverse Event|0|||
130914222|NCT00598702|471322311|FG002|Overall Study|Adverse Event|0|||
130914223|NCT00598702|471322312|FG003|Overall Study|Adverse Event|1|||
130914224|NCT00598702|471322313|FG004|Overall Study|Adverse Event|0|||
130914225|NCT00598702|471322314|FG005|Overall Study|Adverse Event|0|||
130699122|NCT01320722|470522800|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
130699123|NCT01320722|470522801|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
130914226|NCT00598702|471322315|FG006|Overall Study|Adverse Event|0|||
130914227|NCT00598702|471322316|FG007|Overall Study|Adverse Event|0|||
130914228|NCT00598702|471322309|FG000|Overall Study|Withdrawal by Subject|0|||
130914229|NCT00598702|471322310|FG001|Overall Study|Withdrawal by Subject|0|||
130914230|NCT00598702|471322311|FG002|Overall Study|Withdrawal by Subject|0|||
130914231|NCT00598702|471322312|FG003|Overall Study|Withdrawal by Subject|1|||
130914232|NCT00598702|471322313|FG004|Overall Study|Withdrawal by Subject|1|||
130914233|NCT00598702|471322314|FG005|Overall Study|Withdrawal by Subject|0|||
130914234|NCT00598702|471322315|FG006|Overall Study|Withdrawal by Subject|0|||
130914235|NCT00598702|471322316|FG007|Overall Study|Withdrawal by Subject|0|||
130914236|NCT00598702|471322309|FG000|Overall Study|Physician Decision|0|||
130914237|NCT00598702|471322310|FG001|Overall Study|Physician Decision|0|||
130914238|NCT00598702|471322311|FG002|Overall Study|Physician Decision|0|||
130914239|NCT00598702|471322312|FG003|Overall Study|Physician Decision|0|||
130914240|NCT00598702|471322313|FG004|Overall Study|Physician Decision|1|||
130914241|NCT00598702|471322314|FG005|Overall Study|Physician Decision|0|||
130914242|NCT00598702|471322315|FG006|Overall Study|Physician Decision|0|||
130914243|NCT00598702|471322316|FG007|Overall Study|Physician Decision|0|||
130914244|NCT00598702|471322309|FG000|Overall Study|Dose limiting toxicity|0|||
130914245|NCT00598702|471322310|FG001|Overall Study|Dose limiting toxicity|0|||
130914246|NCT00598702|471322311|FG002|Overall Study|Dose limiting toxicity|0|||
130914247|NCT00598702|471322312|FG003|Overall Study|Dose limiting toxicity|1|||
131032825|NCT04029688|471753129|FG002|Overall Study|Withdrawal by Subject|0|||
131032826|NCT04029688|471753130|FG003|Overall Study|Withdrawal by Subject|1|||
131032827|NCT04029688|471753131|FG004|Overall Study|Withdrawal by Subject|0|||
131032828|NCT04029688|471753132|FG005|Overall Study|Withdrawal by Subject|0|||
131032829|NCT04029688|471753133|FG006|Overall Study|Withdrawal by Subject|0|||
131032830|NCT04029688|471753134|FG007|Overall Study|Withdrawal by Subject|0|||
131032831|NCT05784662|471753135|FG000|Overall Study|Lost to Follow-up|21|||
131032832|NCT05784662|471753136|FG001|Overall Study|Lost to Follow-up|17|||
131032833|NCT04739956|471753144|FG000|Overall Study|Withdrawal by Subject|1|||
131032834|NCT04739956|471753145|FG001|Overall Study|Withdrawal by Subject|1|||
131032835|NCT03920111|471753146|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
131032836|NCT03920111|471753147|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
131032837|NCT03920111|471753148|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
131032838|NCT03853746|471753152|FG000|Overall Study|Withdrawal by Subject|1|||
131032839|NCT00999804|471753153|FG000|Overall Study|Lack of Efficacy|9|||
131032840|NCT00999804|471753154|FG001|Overall Study|Lack of Efficacy|2|||
131032841|NCT00999804|471753153|FG000|Overall Study|Adverse Event|4|||
131032842|NCT00999804|471753154|FG001|Overall Study|Adverse Event|3|||
131032843|NCT00999804|471753153|FG000|Overall Study|Withdrawal by Subject|4|||
131032844|NCT00999804|471753154|FG001|Overall Study|Withdrawal by Subject|0|||
131032845|NCT00999804|471753153|FG000|Overall Study|Death|1|||
131032846|NCT00999804|471753154|FG001|Overall Study|Death|0|||
131032847|NCT00999804|471753153|FG000|Overall Study|Ineligible|3|||
131032848|NCT00999804|471753154|FG001|Overall Study|Ineligible|0|||
131032849|NCT01997840|471753156|FG000|Overall Study|Lost to Follow-up|0|||
131032850|NCT01997840|471753157|FG001|Overall Study|Lost to Follow-up|0|||
130699124|NCT01320722|470522802|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
131032851|NCT01997840|471753158|FG002|Overall Study|Lost to Follow-up|1|||
131032852|NCT01997840|471753159|FG003|Overall Study|Lost to Follow-up|0|||
131032853|NCT01997840|471753156|FG000|Overall Study|Withdrawal by participant|0|||
131032854|NCT01997840|471753157|FG001|Overall Study|Withdrawal by participant|0|||
130914248|NCT00598702|471322313|FG004|Overall Study|Dose limiting toxicity|1|||
130914249|NCT00598702|471322314|FG005|Overall Study|Dose limiting toxicity|1|||
130914250|NCT00598702|471322315|FG006|Overall Study|Dose limiting toxicity|0|||
130914251|NCT00598702|471322316|FG007|Overall Study|Dose limiting toxicity|0|||
130914252|NCT02106910|471322319|FG000|Overall Study|Lost to Follow-up|1|||
130914253|NCT02106910|471322320|FG001|Overall Study|Lost to Follow-up|1|||
130914254|NCT01675427|471322321|FG000|Overall Study|Withdrawal by Subject|7|||
130914255|NCT01675427|471322321|FG000|Overall Study|Participant Refused Sample Collection|18|||
130914256|NCT01675427|471322321|FG000|Overall Study|Sample not Collected by Mistake|2|||
130699125|NCT01320722|470522798|FG000|Overall Study|Participant Developed a Rash|0|||
130914257|NCT01675427|471322321|FG000|Overall Study|Lost to Follow-up|5|||
130914258|NCT01675427|471322321|FG000|Overall Study|Other|2|||
130914259|NCT00700570|471322322|FG000|Overall Study|Adverse Event|2|||
130914260|NCT00700570|471322323|FG001|Overall Study|Adverse Event|6|||
130914261|NCT00700570|471322322|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
130914262|NCT00700570|471322323|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
130914263|NCT00700570|471322322|FG000|Overall Study|Disease Progression|8|||
130914264|NCT00700570|471322323|FG001|Overall Study|Disease Progression|11|||
130914265|NCT00700570|471322322|FG000|Overall Study|Withdrawal by Subject|1|||
130914266|NCT00700570|471322323|FG001|Overall Study|Withdrawal by Subject|6|||
130914267|NCT00611533|471322324|FG000|First Intervention (6 Weeks)|Never started study|0|||
130914268|NCT00611533|471322325|FG001|First Intervention (6 Weeks)|Never started study|1|||
130914269|NCT00611533|471322324|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
130914270|NCT00611533|471322325|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
130914271|NCT00611533|471322324|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
130914272|NCT00611533|471322325|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
130914273|NCT04327674|471322333|FG000|Overall Study|Protocol Violation|19|||
130914274|NCT01461980|471322334|FG000|Overall Study|Other|9|||
130914275|NCT01461980|471322335|FG001|Overall Study|Other|8|||
130914276|NCT01461980|471322336|FG002|Overall Study|Other|6|||
130914277|NCT01461980|471322334|FG000|Overall Study|Medication error|7|||
130914278|NCT01461980|471322335|FG001|Overall Study|Medication error|5|||
130914279|NCT01461980|471322336|FG002|Overall Study|Medication error|6|||
130914280|NCT01461980|471322334|FG000|Overall Study|Adverse Event|12|||
130914281|NCT01461980|471322335|FG001|Overall Study|Adverse Event|5|||
130914282|NCT01461980|471322336|FG002|Overall Study|Adverse Event|6|||
130914283|NCT01461980|471322334|FG000|Overall Study|Protocol Violation|12|||
130914284|NCT01461980|471322335|FG001|Overall Study|Protocol Violation|19|||
130914285|NCT01461980|471322336|FG002|Overall Study|Protocol Violation|16|||
130914286|NCT01461980|471322334|FG000|Overall Study|No longer meets eligibility criteria|18|||
130914287|NCT01461980|471322335|FG001|Overall Study|No longer meets eligibility criteria|9|||
130914288|NCT01461980|471322336|FG002|Overall Study|No longer meets eligibility criteria|19|||
130914289|NCT01461980|471322334|FG000|Overall Study|Lost to Follow-up|52|||
130914290|NCT01461980|471322335|FG001|Overall Study|Lost to Follow-up|53|||
130914291|NCT01461980|471322336|FG002|Overall Study|Lost to Follow-up|51|||
130914292|NCT01461980|471322334|FG000|Overall Study|No longer willing to participate|52|||
130699126|NCT01320722|470522799|FG001|Overall Study|Participant Developed a Rash|0|||
130699127|NCT01320722|470522800|FG002|Overall Study|Participant Developed a Rash|2|||
131032855|NCT01997840|471753158|FG002|Overall Study|Withdrawal by participant|8|||
131032856|NCT01997840|471753159|FG003|Overall Study|Withdrawal by participant|1|||
131032857|NCT01997840|471753156|FG000|Overall Study|Physician Decision|0|||
131032858|NCT01997840|471753157|FG001|Overall Study|Physician Decision|0|||
131032859|NCT01997840|471753158|FG002|Overall Study|Physician Decision|3|||
131032860|NCT01997840|471753159|FG003|Overall Study|Physician Decision|0|||
131032861|NCT01997840|471753156|FG000|Overall Study|Progressive disease|3|||
131032862|NCT01997840|471753157|FG001|Overall Study|Progressive disease|4|||
131032863|NCT01997840|471753158|FG002|Overall Study|Progressive disease|57|||
131032864|NCT01997840|471753159|FG003|Overall Study|Progressive disease|8|||
131032865|NCT01997840|471753156|FG000|Overall Study|Other reasons|0|||
131032866|NCT01997840|471753157|FG001|Overall Study|Other reasons|0|||
131032867|NCT01997840|471753158|FG002|Overall Study|Other reasons|1|||
131032868|NCT01997840|471753159|FG003|Overall Study|Other reasons|0|||
131032869|NCT01997840|471753156|FG000|Overall Study|Adverse Event|0|||
131032870|NCT01997840|471753157|FG001|Overall Study|Adverse Event|0|||
131032871|NCT01997840|471753158|FG002|Overall Study|Adverse Event|15|||
131032872|NCT01997840|471753159|FG003|Overall Study|Adverse Event|2|||
131032873|NCT05256706|471753160|FG000|Overall Study|Lost to Follow-up|9|||
131032874|NCT05256706|471753161|FG001|Overall Study|Lost to Follow-up|3|||
131032875|NCT05256706|471753160|FG000|Overall Study|Withdrawal by Subject|7|||
131032876|NCT05256706|471753161|FG001|Overall Study|Withdrawal by Subject|11|||
131118568|NCT00718549|472065607|FG001|Maintenance/ Observation Phase|Progression|5|||
131118569|NCT00718549|472065608|FG002|Maintenance/ Observation Phase|Progression|14|||
131118570|NCT00718549|472065606|FG000|Maintenance/ Observation Phase|Relapse|0|||
130914293|NCT01461980|471322335|FG001|Overall Study|No longer willing to participate|38|||
130914294|NCT01461980|471322336|FG002|Overall Study|No longer willing to participate|54|||
130914295|NCT01461980|471322334|FG000|Overall Study|Randomized but not vaccinated|4|||
130914296|NCT01461980|471322335|FG001|Overall Study|Randomized but not vaccinated|8|||
131032877|NCT05256706|471753160|FG000|Overall Study|Screen Failures|3|||
131032878|NCT05256706|471753161|FG001|Overall Study|Screen Failures|0|||
131032879|NCT03850678|471753162|FG000|Overall Study|Withdrawal by Subject|3|||
131032880|NCT03850678|471753163|FG001|Overall Study|Withdrawal by Subject|0|||
131032881|NCT03850678|471753162|FG000|Overall Study|Experimenter Error|1|||
130914297|NCT01461980|471322336|FG002|Overall Study|Randomized but not vaccinated|7|||
130914298|NCT04171765|471322337|FG000|Overall Study|Adverse Event|2|||
130914299|NCT04171765|471322338|FG001|Overall Study|Adverse Event|0|||
130914300|NCT04171765|471322339|FG002|Overall Study|Adverse Event|1|||
130914301|NCT04171765|471322340|FG003|Overall Study|Adverse Event|0|||
130914302|NCT04171765|471322337|FG000|Overall Study|Lost to Follow-up|0|||
131118571|NCT00718549|472065607|FG001|Maintenance/ Observation Phase|Relapse|3|||
131118572|NCT00718549|472065608|FG002|Maintenance/ Observation Phase|Relapse|2|||
131118573|NCT01970488|472065613|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
131118574|NCT01970488|472065614|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
131118575|NCT01970488|472065615|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
131118576|NCT01970488|472065616|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
131118577|NCT01970488|472065617|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
131118578|NCT01970488|472065613|FG000|Part 1: Through Week 16|Protocol Violation|1|||
130914303|NCT04171765|471322338|FG001|Overall Study|Lost to Follow-up|2|||
130914304|NCT04171765|471322339|FG002|Overall Study|Lost to Follow-up|2|||
130914305|NCT04171765|471322340|FG003|Overall Study|Lost to Follow-up|2|||
130914306|NCT04171765|471322337|FG000|Overall Study|Week 58 visit missed|0|||
130914307|NCT04171765|471322338|FG001|Overall Study|Week 58 visit missed|0|||
130914308|NCT04171765|471322339|FG002|Overall Study|Week 58 visit missed|1|||
130914309|NCT04171765|471322340|FG003|Overall Study|Week 58 visit missed|0|||
130914310|NCT04171765|471322337|FG000|Overall Study|Study terminated by sponsor|2|||
130914311|NCT04171765|471322338|FG001|Overall Study|Study terminated by sponsor|0|||
130914312|NCT04171765|471322339|FG002|Overall Study|Study terminated by sponsor|0|||
130914313|NCT04171765|471322340|FG003|Overall Study|Study terminated by sponsor|0|||
130914314|NCT04171765|471322337|FG000|Overall Study|Withdrawal by Subject|1|||
131032882|NCT03850678|471753163|FG001|Overall Study|Experimenter Error|1|||
131032883|NCT03850678|471753162|FG000|Overall Study|Did Not Condition To Experiment|7|||
131032884|NCT03850678|471753163|FG001|Overall Study|Did Not Condition To Experiment|2|||
131032885|NCT01573442|471753166|FG000|Overall Study|Cancels|9|||
131032886|NCT01573442|471753167|FG001|Overall Study|Cancels|10|||
130914315|NCT04171765|471322338|FG001|Overall Study|Withdrawal by Subject|0|||
130914316|NCT04171765|471322339|FG002|Overall Study|Withdrawal by Subject|0|||
131032887|NCT05710107|471753169|FG000|Overall Study|Withdrawal by Subject|1|||
131032888|NCT05710107|471753170|FG001|Overall Study|Withdrawal by Subject|1|||
131032889|NCT05710107|471753169|FG000|Overall Study|Lost to Follow-up|8|||
131032890|NCT05710107|471753170|FG001|Overall Study|Lost to Follow-up|9|||
131032891|NCT05710107|471753169|FG000|Overall Study|Unable to place assigned block|2|||
131032892|NCT05710107|471753170|FG001|Overall Study|Unable to place assigned block|0|||
131032893|NCT05710107|471753169|FG000|Overall Study|Withdrawn by study team|0|||
131032894|NCT05710107|471753170|FG001|Overall Study|Withdrawn by study team|1|||
131032895|NCT04166773|471753171|FG000|Overall Study|Adverse Event|2|||
131032896|NCT04166773|471753172|FG001|Overall Study|Adverse Event|0|||
131032897|NCT04166773|471753173|FG002|Overall Study|Adverse Event|2|||
131032898|NCT04166773|471753174|FG003|Overall Study|Adverse Event|1|||
131032899|NCT04166773|471753171|FG000|Overall Study|Lost to Follow-up|4|||
131032900|NCT04166773|471753172|FG001|Overall Study|Lost to Follow-up|2|||
131032901|NCT04166773|471753173|FG002|Overall Study|Lost to Follow-up|1|||
131032902|NCT04166773|471753174|FG003|Overall Study|Lost to Follow-up|3|||
131032903|NCT04166773|471753171|FG000|Overall Study|Physician Decision|0|||
131032904|NCT04166773|471753172|FG001|Overall Study|Physician Decision|0|||
131032905|NCT04166773|471753173|FG002|Overall Study|Physician Decision|0|||
131032906|NCT04166773|471753174|FG003|Overall Study|Physician Decision|1|||
131032907|NCT04166773|471753171|FG000|Overall Study|Withdrawal by Subject|1|||
131032908|NCT04166773|471753172|FG001|Overall Study|Withdrawal by Subject|1|||
131032909|NCT04166773|471753173|FG002|Overall Study|Withdrawal by Subject|2|||
131032910|NCT04166773|471753174|FG003|Overall Study|Withdrawal by Subject|5|||
131032911|NCT04717492|471753176|FG000|Overall Study|Withdrawal by Subject|2|||
131032912|NCT04717492|471753177|FG001|Overall Study|Withdrawal by Subject|13|||
131032913|NCT04717492|471753176|FG000|Overall Study|Lost to Follow-up|2|||
131032914|NCT04717492|471753177|FG001|Overall Study|Lost to Follow-up|9|||
131032915|NCT04456517|471753178|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
131032916|NCT04456517|471753179|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
131032917|NCT05071807|471753180|FG000|Overall Study|Withdrawal by Subject|4|||
131032918|NCT05071807|471753181|FG001|Overall Study|Withdrawal by Subject|0|||
131032919|NCT05071807|471753180|FG000|Overall Study|Unrelated medical issues|3|||
131032920|NCT05071807|471753181|FG001|Overall Study|Unrelated medical issues|0|||
131032921|NCT05071807|471753180|FG000|Overall Study|Relocated|0|||
131032922|NCT05071807|471753181|FG001|Overall Study|Relocated|1|||
131032923|NCT04176965|471753183|FG000|Overall Study|Death|1|||
131118579|NCT01970488|472065614|FG001|Part 1: Through Week 16|Protocol Violation|2|||
130914317|NCT04171765|471322340|FG003|Overall Study|Withdrawal by Subject|3|||
130914318|NCT00809354|471322341|FG000|Overall Study|Adverse Event|32|||
130914319|NCT00809354|471322342|FG001|Overall Study|Adverse Event|45|||
131032924|NCT04176965|471753184|FG001|Overall Study|Death|2|||
131032925|NCT04176965|471753183|FG000|Overall Study|Lost to Follow-up|10|||
131032926|NCT04176965|471753184|FG001|Overall Study|Lost to Follow-up|2|||
131118580|NCT01970488|472065615|FG002|Part 1: Through Week 16|Protocol Violation|0|||
131118581|NCT01970488|472065616|FG003|Part 1: Through Week 16|Protocol Violation|0|||
131118582|NCT01970488|472065617|FG004|Part 1: Through Week 16|Protocol Violation|0|||
131118583|NCT01970488|472065613|FG000|Part 1: Through Week 16|Adverse Event|6|||
131118584|NCT01970488|472065614|FG001|Part 1: Through Week 16|Adverse Event|5|||
131118585|NCT01970488|472065615|FG002|Part 1: Through Week 16|Adverse Event|0|||
131118586|NCT01970488|472065616|FG003|Part 1: Through Week 16|Adverse Event|0|||
131118587|NCT01970488|472065617|FG004|Part 1: Through Week 16|Adverse Event|0|||
131118588|NCT01970488|472065613|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
131118589|NCT01970488|472065614|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
131118590|NCT01970488|472065615|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
131118591|NCT01970488|472065616|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
131118592|NCT01970488|472065617|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
131118593|NCT01970488|472065613|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
131118594|NCT01970488|472065614|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
131118595|NCT01970488|472065615|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
131118596|NCT01970488|472065616|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
131118597|NCT01970488|472065617|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
131118598|NCT01970488|472065613|FG000|Part 2: Post Week 16|Physician Decision|0|||
131118599|NCT01970488|472065614|FG001|Part 2: Post Week 16|Physician Decision|0|||
131118600|NCT01970488|472065615|FG002|Part 2: Post Week 16|Physician Decision|0|||
131118601|NCT01970488|472065616|FG003|Part 2: Post Week 16|Physician Decision|0|||
131118602|NCT01970488|472065617|FG004|Part 2: Post Week 16|Physician Decision|1|||
131118603|NCT01970488|472065613|FG000|Part 2: Post Week 16|Non-compliance|0|||
131118604|NCT01970488|472065614|FG001|Part 2: Post Week 16|Non-compliance|0|||
131118605|NCT01970488|472065615|FG002|Part 2: Post Week 16|Non-compliance|1|||
131118606|NCT01970488|472065616|FG003|Part 2: Post Week 16|Non-compliance|0|||
131118607|NCT01970488|472065617|FG004|Part 2: Post Week 16|Non-compliance|0|||
131118608|NCT01970488|472065613|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
131118609|NCT01970488|472065614|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
131118610|NCT01970488|472065615|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
131118611|NCT01970488|472065616|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
131118612|NCT01970488|472065617|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
131118613|NCT01970488|472065613|FG000|Part 2: Post Week 16|Adverse Event|0|||
131118614|NCT01970488|472065614|FG001|Part 2: Post Week 16|Adverse Event|0|||
131118615|NCT01970488|472065615|FG002|Part 2: Post Week 16|Adverse Event|5|||
131118616|NCT01970488|472065616|FG003|Part 2: Post Week 16|Adverse Event|1|||
131118617|NCT01970488|472065617|FG004|Part 2: Post Week 16|Adverse Event|1|||
131118618|NCT01970488|472065613|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
131118619|NCT01970488|472065614|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
131118620|NCT01970488|472065615|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
131118621|NCT01970488|472065616|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
131118622|NCT01970488|472065617|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
131118623|NCT01970488|472065613|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
131118624|NCT01970488|472065614|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
131118625|NCT01970488|472065615|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
131118626|NCT01970488|472065616|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
131118627|NCT01970488|472065617|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
131118628|NCT02448225|472065619|FG000|Overall Study|Withdrawal by Subject|1|||
131118629|NCT02448225|472065619|FG000|Overall Study|Did not get FSPG scan|18|||
131118630|NCT02448225|472065619|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
131118631|NCT02486653|472065622|FG000|Overall Study|Withdrawal by Subject|1|||
131118632|NCT02486653|472065623|FG001|Overall Study|Withdrawal by Subject|3|||
131118633|NCT02486653|472065622|FG000|Overall Study|Protocol Violation|1|||
131118634|NCT02486653|472065623|FG001|Overall Study|Protocol Violation|0|||
131118635|NCT02486653|472065622|FG000|Overall Study|surgery cancelled|4|||
131118636|NCT02486653|472065623|FG001|Overall Study|surgery cancelled|1|||
131118637|NCT01177384|472065625|FG000|Overall Study|Adverse Event|6|||
131118638|NCT01177384|472065626|FG001|Overall Study|Adverse Event|4|||
131118639|NCT01177384|472065625|FG000|Overall Study|Lack of Efficacy|0|||
131118640|NCT01177384|472065626|FG001|Overall Study|Lack of Efficacy|1|||
131118641|NCT01177384|472065625|FG000|Overall Study|Lost to Follow-up|3|||
131118642|NCT01177384|472065626|FG001|Overall Study|Lost to Follow-up|4|||
131118643|NCT01177384|472065625|FG000|Overall Study|Physician Decision|0|||
131118644|NCT01177384|472065626|FG001|Overall Study|Physician Decision|3|||
131118645|NCT01177384|472065625|FG000|Overall Study|Protocol Violation|0|||
131118646|NCT01177384|472065626|FG001|Overall Study|Protocol Violation|2|||
131118647|NCT01177384|472065625|FG000|Overall Study|Withdrawal by Subject|5|||
131118648|NCT01177384|472065626|FG001|Overall Study|Withdrawal by Subject|12|||
131118649|NCT01849497|472065627|FG000|Overall Study|Withdrawal by Subject|1|||
131118650|NCT01849497|472065628|FG001|Overall Study|Withdrawal by Subject|2|||
131118651|NCT01849497|472065627|FG000|Overall Study|Sponsor Decision|0|||
131118652|NCT01849497|472065628|FG001|Overall Study|Sponsor Decision|1|||
131118653|NCT01849497|472065627|FG000|Overall Study|Lost to Follow-up|0|||
131118654|NCT01849497|472065628|FG001|Overall Study|Lost to Follow-up|1|||
130914320|NCT00809354|471322343|FG002|Overall Study|Adverse Event|37|||
130914321|NCT00809354|471322344|FG003|Overall Study|Adverse Event|53|||
130914322|NCT00809354|471322345|FG004|Overall Study|Adverse Event|26|||
130914323|NCT00809354|471322346|FG005|Overall Study|Adverse Event|33|||
130914324|NCT00809354|471322347|FG006|Overall Study|Adverse Event|44|||
131032927|NCT04176965|471753183|FG000|Overall Study|Withdrawal by Subject|6|||
131032928|NCT04176965|471753184|FG001|Overall Study|Withdrawal by Subject|1|||
131032929|NCT03903146|471753185|FG000|Overall Study|Lost to Follow-up|6|||
131032930|NCT03903146|471753186|FG001|Overall Study|Lost to Follow-up|4|||
131032931|NCT03903146|471753185|FG000|Overall Study|Withdrawal by Subject|0|||
131032932|NCT03903146|471753186|FG001|Overall Study|Withdrawal by Subject|1|||
131032933|NCT02919683|471753187|FG000|Post-Surgery Follow-Up|Death|2|||
131032934|NCT02919683|471753188|FG001|Post-Surgery Follow-Up|Death|2|||
131032935|NCT02919683|471753187|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
131032936|NCT02919683|471753188|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
131032937|NCT04072380|471753190|FG000|Overall Study|Adverse Event|4|||
131032938|NCT04072380|471753191|FG001|Overall Study|Adverse Event|6|||
131032939|NCT04072380|471753192|FG002|Overall Study|Adverse Event|0|||
131032940|NCT04072380|471753190|FG000|Overall Study|Withdrawal by Subject|3|||
131032941|NCT04072380|471753191|FG001|Overall Study|Withdrawal by Subject|1|||
131032942|NCT04072380|471753192|FG002|Overall Study|Withdrawal by Subject|1|||
131032943|NCT04072380|471753190|FG000|Overall Study|Physician Decision|2|||
131032944|NCT04072380|471753191|FG001|Overall Study|Physician Decision|0|||
131032945|NCT04072380|471753192|FG002|Overall Study|Physician Decision|0|||
131032946|NCT04072380|471753190|FG000|Overall Study|Protocol Violation|0|||
131032947|NCT04072380|471753191|FG001|Overall Study|Protocol Violation|2|||
131032948|NCT04072380|471753192|FG002|Overall Study|Protocol Violation|3|||
131032949|NCT04072380|471753190|FG000|Overall Study|Intercurrent Illness and Others|3|||
131032950|NCT04072380|471753191|FG001|Overall Study|Intercurrent Illness and Others|5|||
131032951|NCT04072380|471753192|FG002|Overall Study|Intercurrent Illness and Others|6|||
131032952|NCT04049643|471753195|FG000|Overall Study|Lack of Efficacy|1|||
131032953|NCT04049643|471753196|FG001|Overall Study|Lack of Efficacy|1|||
131032954|NCT04049643|471753197|FG002|Overall Study|Lack of Efficacy|0|||
131032955|NCT04049643|471753195|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
131032956|NCT04049643|471753196|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
131032957|NCT04049643|471753197|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
131032958|NCT03131648|471755280|FG000|Initial Treatment Period|Not dosed|2|||
131032959|NCT03131648|471755281|FG001|Initial Treatment Period|Not dosed|2|||
131032960|NCT03131648|471755282|FG002|Initial Treatment Period|Not dosed|0|||
131032961|NCT03131648|471755283|FG003|Initial Treatment Period|Not dosed|0|||
131032962|NCT03131648|471755284|FG004|Initial Treatment Period|Not dosed|0|||
131032963|NCT03131648|471755285|FG005|Initial Treatment Period|Not dosed|0|||
131032964|NCT03131648|471755286|FG006|Initial Treatment Period|Not dosed|0|||
131032965|NCT03131648|471755287|FG007|Initial Treatment Period|Not dosed|0|||
131032966|NCT03131648|471755280|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
131032967|NCT03131648|471755281|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
130914325|NCT00809354|471322348|FG007|Overall Study|Adverse Event|40|||
130914326|NCT00809354|471322349|FG008|Overall Study|Adverse Event|46|||
131032968|NCT03131648|471755282|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131032969|NCT03131648|471755283|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131032970|NCT03131648|471755284|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131032971|NCT03131648|471755285|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131032972|NCT03131648|471755286|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131032973|NCT03131648|471755287|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131032974|NCT03131648|471755280|FG000|Open-label Treatment|Discontinued IMP|0|||
131032975|NCT03131648|471755281|FG001|Open-label Treatment|Discontinued IMP|0|||
131032976|NCT03131648|471755282|FG002|Open-label Treatment|Discontinued IMP|0|||
131032977|NCT03131648|471755283|FG003|Open-label Treatment|Discontinued IMP|0|||
131032978|NCT03131648|471755284|FG004|Open-label Treatment|Discontinued IMP|0|||
131032979|NCT03131648|471755285|FG005|Open-label Treatment|Discontinued IMP|0|||
131032980|NCT03131648|471755286|FG006|Open-label Treatment|Discontinued IMP|112|||
131032981|NCT03131648|471755287|FG007|Open-label Treatment|Discontinued IMP|0|||
131032982|NCT03131648|471755280|FG000|Open-label Treatment|Completed Week 50|0|||
131032983|NCT03131648|471755281|FG001|Open-label Treatment|Completed Week 50|0|||
131032984|NCT03131648|471755282|FG002|Open-label Treatment|Completed Week 50|0|||
131032985|NCT03131648|471755283|FG003|Open-label Treatment|Completed Week 50|0|||
131032986|NCT03131648|471755284|FG004|Open-label Treatment|Completed Week 50|0|||
131032987|NCT03131648|471755285|FG005|Open-label Treatment|Completed Week 50|0|||
131032988|NCT03131648|471755286|FG006|Open-label Treatment|Completed Week 50|6|||
131032989|NCT03131648|471755287|FG007|Open-label Treatment|Completed Week 50|0|||
131032990|NCT03131648|471755280|FG000|Maintenance Treatment Period|Not dosed|0|||
131032991|NCT03131648|471755281|FG001|Maintenance Treatment Period|Not dosed|0|||
130914327|NCT00809354|471322350|FG009|Overall Study|Adverse Event|26|||
130914328|NCT00809354|471322341|FG000|Overall Study|Lack of Efficacy|23|||
131118655|NCT02941926|472065629|FG000|Core Phase|Progressive disease|1109|||
131118656|NCT02941926|472065629|FG000|Core Phase|Adverse Event|504|||
131118657|NCT02941926|472065629|FG000|Core Phase|Subject/guardian decision|127|||
131118658|NCT02941926|472065629|FG000|Core Phase|Physician Decision|112|||
131118659|NCT02941926|472065629|FG000|Core Phase|Death|46|||
131118660|NCT02941926|472065629|FG000|Core Phase|Protocol deviation|34|||
131118661|NCT02941926|472065629|FG000|Core Phase|Lost to Follow-up|8|||
131118662|NCT02941926|472065629|FG000|Core Phase|Technical problems|5|||
131118663|NCT02941926|472065629|FG000|Extension Phase|Physician Decision|155|||
131118664|NCT02941926|472065629|FG000|Extension Phase|Progressive disease|115|||
131118665|NCT02941926|472065629|FG000|Extension Phase|Adverse Event|13|||
131118666|NCT02941926|472065629|FG000|Extension Phase|Subject/Guardian decision|12|||
131118667|NCT02941926|472065629|FG000|Extension Phase|Death|6|||
131118668|NCT00307333|472065630|FG000|Overall Study|Lost to Follow-up|11|||
131118669|NCT00307333|472065631|FG001|Overall Study|Lost to Follow-up|3|||
131118670|NCT00698932|472065632|FG000|Overall Study|Adverse Event|0|||
131118671|NCT00698932|472065633|FG001|Overall Study|Adverse Event|2|||
131118672|NCT00698932|472065632|FG000|Overall Study|Incorrect enrollment|0|||
131118673|NCT00698932|472065633|FG001|Overall Study|Incorrect enrollment|2|||
131118674|NCT00698932|472065632|FG000|Overall Study|Study specific discontinuation criteria|3|||
131118675|NCT00698932|472065633|FG001|Overall Study|Study specific discontinuation criteria|4|||
131118676|NCT00698932|472065632|FG000|Overall Study|Withdrawal by Subject|11|||
131118677|NCT00698932|472065633|FG001|Overall Study|Withdrawal by Subject|23|||
131118678|NCT00698932|472065632|FG000|Overall Study|Lost to Follow-up|6|||
131118679|NCT00698932|472065633|FG001|Overall Study|Lost to Follow-up|1|||
131118680|NCT00698932|472065632|FG000|Overall Study|Severe non-compliance to protocol|1|||
131118681|NCT00698932|472065633|FG001|Overall Study|Severe non-compliance to protocol|2|||
131118682|NCT00698932|472065632|FG000|Overall Study|Safety reasons|0|||
131118683|NCT00698932|472065633|FG001|Overall Study|Safety reasons|2|||
131118684|NCT00698932|472065632|FG000|Overall Study|Death|1|||
131118685|NCT00698932|472065633|FG001|Overall Study|Death|0|||
131118686|NCT03044249|472065638|FG000|Overall Study|Adverse Event|4|||
131118687|NCT03044249|472065639|FG001|Overall Study|Adverse Event|9|||
131118688|NCT03044249|472065638|FG000|Overall Study|Lost to Follow-up|1|||
131118689|NCT03044249|472065639|FG001|Overall Study|Lost to Follow-up|0|||
131118690|NCT03044249|472065638|FG000|Overall Study|Non-compliance with Study Drug|1|||
131118691|NCT03044249|472065639|FG001|Overall Study|Non-compliance with Study Drug|0|||
131118692|NCT03044249|472065638|FG000|Overall Study|Study Terminated by Sponsor|2|||
131118693|NCT03044249|472065639|FG001|Overall Study|Study Terminated by Sponsor|0|||
131118694|NCT03044249|472065638|FG000|Overall Study|Withdrawal by Subject|2|||
131118695|NCT03044249|472065639|FG001|Overall Study|Withdrawal by Subject|5|||
131118696|NCT00955279|472065640|FG000|Overall Study|Other|0|||
131118697|NCT00955279|472065641|FG001|Overall Study|Other|0|||
131118698|NCT00955279|472065642|FG002|Overall Study|Other|3|||
131118699|NCT00955279|472065640|FG000|Overall Study|Death|1|||
131118700|NCT00955279|472065641|FG001|Overall Study|Death|1|||
131118701|NCT00955279|472065642|FG002|Overall Study|Death|1|||
131118702|NCT00955279|472065640|FG000|Overall Study|Lost to Follow-up|0|||
131118703|NCT00955279|472065641|FG001|Overall Study|Lost to Follow-up|3|||
131118704|NCT00955279|472065642|FG002|Overall Study|Lost to Follow-up|1|||
131118705|NCT00955279|472065640|FG000|Overall Study|Withdrawal by Subject|2|||
131118706|NCT00955279|472065641|FG001|Overall Study|Withdrawal by Subject|0|||
131118707|NCT00955279|472065642|FG002|Overall Study|Withdrawal by Subject|3|||
131118708|NCT02632721|472065644|FG000|Overall Study|Adverse Event|0|||
131118709|NCT02632721|472065645|FG001|Overall Study|Adverse Event|0|||
131118710|NCT02632721|472065646|FG002|Overall Study|Adverse Event|2|||
131118711|NCT02632721|472065647|FG003|Overall Study|Adverse Event|5|||
131118712|NCT02632721|472065648|FG004|Overall Study|Adverse Event|3|||
131118713|NCT02632721|472065644|FG000|Overall Study|Dose limiting toxicity|0|||
131118714|NCT02632721|472065645|FG001|Overall Study|Dose limiting toxicity|0|||
131118715|NCT02632721|472065646|FG002|Overall Study|Dose limiting toxicity|0|||
131118716|NCT02632721|472065647|FG003|Overall Study|Dose limiting toxicity|1|||
131118717|NCT02632721|472065648|FG004|Overall Study|Dose limiting toxicity|0|||
131118718|NCT02632721|472065644|FG000|Overall Study|Progressive disease|3|||
131118719|NCT02632721|472065645|FG001|Overall Study|Progressive disease|0|||
131118720|NCT02632721|472065646|FG002|Overall Study|Progressive disease|4|||
131118721|NCT02632721|472065647|FG003|Overall Study|Progressive disease|6|||
131118722|NCT02632721|472065648|FG004|Overall Study|Progressive disease|5|||
131118723|NCT02632721|472065644|FG000|Overall Study|Refused to continue taking trial medication|0|||
131118724|NCT02632721|472065645|FG001|Overall Study|Refused to continue taking trial medication|1|||
131118725|NCT02632721|472065646|FG002|Overall Study|Refused to continue taking trial medication|1|||
131118726|NCT02632721|472065647|FG003|Overall Study|Refused to continue taking trial medication|1|||
131118727|NCT02632721|472065648|FG004|Overall Study|Refused to continue taking trial medication|2|||
131118728|NCT02632721|472065644|FG000|Overall Study|Inadequate clinical condition|0|||
131118729|NCT02632721|472065645|FG001|Overall Study|Inadequate clinical condition|0|||
131118730|NCT02632721|472065646|FG002|Overall Study|Inadequate clinical condition|0|||
130914329|NCT00809354|471322342|FG001|Overall Study|Lack of Efficacy|23|||
131118731|NCT02632721|472065647|FG003|Overall Study|Inadequate clinical condition|0|||
131118732|NCT02632721|472065648|FG004|Overall Study|Inadequate clinical condition|1|||
131118733|NCT02632721|472065644|FG000|Overall Study|No meet eligibility|0|||
131118734|NCT02632721|472065645|FG001|Overall Study|No meet eligibility|0|||
131118735|NCT02632721|472065646|FG002|Overall Study|No meet eligibility|0|||
131118736|NCT02632721|472065647|FG003|Overall Study|No meet eligibility|0|||
131118737|NCT02632721|472065648|FG004|Overall Study|No meet eligibility|1|||
131118738|NCT02632721|472065644|FG000|Overall Study|Allergic reaction|0|||
131118739|NCT02632721|472065645|FG001|Overall Study|Allergic reaction|0|||
131118740|NCT02632721|472065646|FG002|Overall Study|Allergic reaction|0|||
131118741|NCT02632721|472065647|FG003|Overall Study|Allergic reaction|1|||
131118742|NCT02632721|472065648|FG004|Overall Study|Allergic reaction|0|||
131118743|NCT02632721|472065644|FG000|Overall Study|Receiving Decitabine locally|0|||
131118744|NCT02632721|472065645|FG001|Overall Study|Receiving Decitabine locally|0|||
131118745|NCT02632721|472065646|FG002|Overall Study|Receiving Decitabine locally|1|||
131118746|NCT02632721|472065647|FG003|Overall Study|Receiving Decitabine locally|0|||
131118747|NCT02632721|472065648|FG004|Overall Study|Receiving Decitabine locally|0|||
131118748|NCT02632721|472065644|FG000|Overall Study|No benefit from study treatment|1|||
131118749|NCT02632721|472065645|FG001|Overall Study|No benefit from study treatment|1|||
131118750|NCT02632721|472065646|FG002|Overall Study|No benefit from study treatment|0|||
131118751|NCT02632721|472065647|FG003|Overall Study|No benefit from study treatment|0|||
131118752|NCT02632721|472065648|FG004|Overall Study|No benefit from study treatment|1|||
131118753|NCT02632721|472065644|FG000|Overall Study|Patient wish for other treatment|0|||
131118754|NCT02632721|472065645|FG001|Overall Study|Patient wish for other treatment|1|||
131118755|NCT02632721|472065646|FG002|Overall Study|Patient wish for other treatment|0|||
131118756|NCT02632721|472065647|FG003|Overall Study|Patient wish for other treatment|0|||
131118757|NCT02632721|472065648|FG004|Overall Study|Patient wish for other treatment|0|||
131118758|NCT02632721|472065644|FG000|Overall Study|Relapsed Pneumonia|0|||
131118759|NCT02632721|472065645|FG001|Overall Study|Relapsed Pneumonia|0|||
131118760|NCT02632721|472065646|FG002|Overall Study|Relapsed Pneumonia|0|||
131118761|NCT02632721|472065647|FG003|Overall Study|Relapsed Pneumonia|0|||
131118762|NCT02632721|472065648|FG004|Overall Study|Relapsed Pneumonia|1|||
131118763|NCT02632721|472065644|FG000|Overall Study|Therapy refractory AML|0|||
131118764|NCT02632721|472065645|FG001|Overall Study|Therapy refractory AML|0|||
131118765|NCT02632721|472065646|FG002|Overall Study|Therapy refractory AML|0|||
131118766|NCT02632721|472065647|FG003|Overall Study|Therapy refractory AML|0|||
131118767|NCT02632721|472065648|FG004|Overall Study|Therapy refractory AML|1|||
131118768|NCT02632721|472065644|FG000|Overall Study|Increase of white blood cell count|0|||
131118769|NCT02632721|472065645|FG001|Overall Study|Increase of white blood cell count|0|||
131118770|NCT02632721|472065646|FG002|Overall Study|Increase of white blood cell count|0|||
131118771|NCT02632721|472065647|FG003|Overall Study|Increase of white blood cell count|0|||
131118772|NCT02632721|472065648|FG004|Overall Study|Increase of white blood cell count|1|||
131118773|NCT02632721|472065644|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
131118774|NCT02632721|472065645|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
131118775|NCT02632721|472065646|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
131118776|NCT02632721|472065647|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
131118777|NCT02632721|472065648|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
131118778|NCT00544648|472065651|FG000|Overall Study|Withdrawal by Subject|1|||
131118779|NCT00544648|472065652|FG001|Overall Study|Withdrawal by Subject|0|||
131118780|NCT00544648|472065651|FG000|Overall Study|Adverse Event|1|||
131118781|NCT00544648|472065652|FG001|Overall Study|Adverse Event|1|||
131118782|NCT00544648|472065651|FG000|Overall Study|progression of disease|1|||
131118783|NCT00544648|472065652|FG001|Overall Study|progression of disease|0|||
131118784|NCT04166383|472065654|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
131118785|NCT04166383|472065654|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
131118786|NCT04166383|472065654|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
131118787|NCT03346057|472065655|FG000|Overall Study|Death|1|||
131118788|NCT03346057|472065656|FG001|Overall Study|Death|2|||
131118789|NCT03346057|472065657|FG002|Overall Study|Death|0|||
131118790|NCT03346057|472065658|FG003|Overall Study|Death|0|||
130699128|NCT01320722|470522801|FG003|Overall Study|Participant Developed a Rash|1|||
130699129|NCT01320722|470522802|FG004|Overall Study|Participant Developed a Rash|1|||
130699130|NCT01320722|470522798|FG000|Overall Study|Non-compliant with Medication|0|||
131118791|NCT03346057|472065655|FG000|Overall Study|Lost to Follow-up|0|||
131118792|NCT03346057|472065656|FG001|Overall Study|Lost to Follow-up|2|||
130699131|NCT01320722|470522799|FG001|Overall Study|Non-compliant with Medication|0|||
130699132|NCT01320722|470522800|FG002|Overall Study|Non-compliant with Medication|1|||
130699133|NCT01320722|470522801|FG003|Overall Study|Non-compliant with Medication|0|||
130699134|NCT01320722|470522802|FG004|Overall Study|Non-compliant with Medication|0|||
130699135|NCT01320722|470522798|FG000|Overall Study|Adverse Event|0|||
130699136|NCT01320722|470522799|FG001|Overall Study|Adverse Event|0|||
130914330|NCT00809354|471322343|FG002|Overall Study|Lack of Efficacy|22|||
131118793|NCT03346057|472065657|FG002|Overall Study|Lost to Follow-up|1|||
131118794|NCT03346057|472065658|FG003|Overall Study|Lost to Follow-up|0|||
131118795|NCT03346057|472065655|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
131118796|NCT03346057|472065656|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
131118797|NCT03346057|472065657|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
131118798|NCT03346057|472065658|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
131118799|NCT03346057|472065655|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
131118800|NCT03346057|472065656|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
131118801|NCT03346057|472065657|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
131118802|NCT03346057|472065658|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
131118803|NCT03346057|472065655|FG000|Overall Study|Physician Decision|3|||
131118804|NCT03346057|472065656|FG001|Overall Study|Physician Decision|2|||
131118805|NCT03346057|472065657|FG002|Overall Study|Physician Decision|0|||
131118806|NCT03346057|472065658|FG003|Overall Study|Physician Decision|2|||
131118807|NCT03346057|472065655|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
131118808|NCT03346057|472065656|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
131118809|NCT03346057|472065657|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
131118810|NCT03346057|472065658|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
131118811|NCT03346057|472065655|FG000|Overall Study|Withdrawal by Subject|1|||
131118812|NCT03346057|472065656|FG001|Overall Study|Withdrawal by Subject|0|||
131118813|NCT03346057|472065657|FG002|Overall Study|Withdrawal by Subject|0|||
131118814|NCT03346057|472065658|FG003|Overall Study|Withdrawal by Subject|0|||
131118815|NCT03044886|472065659|FG000|Overall Study|Lost to Follow-up|15|||
131118816|NCT03044886|472065660|FG001|Overall Study|Lost to Follow-up|10|||
131118817|NCT03044886|472065661|FG002|Overall Study|Lost to Follow-up|12|||
131118818|NCT02003014|472065662|FG000|Overall Study|Case report forms uncollected|9|||
131118819|NCT02003014|472065662|FG000|Overall Study|Treatment started after contract period|1|||
131118820|NCT02003014|472065662|FG000|Overall Study|Patient did not visit the study site|5|||
131118821|NCT02003014|472065662|FG000|Overall Study|Investigator's transfer|4|||
131118822|NCT01660451|472065663|FG000|Overall Study|Protocol Violation|0|||
131118823|NCT01660451|472065664|FG001|Overall Study|Protocol Violation|1|||
131118824|NCT01660451|472065665|FG002|Overall Study|Protocol Violation|1|||
131118825|NCT01660451|472065663|FG000|Overall Study|AE not associated with clinical disease progression|13|||
131118826|NCT01660451|472065664|FG001|Overall Study|AE not associated with clinical disease progression|10|||
131118827|NCT01660451|472065665|FG002|Overall Study|AE not associated with clinical disease progression|40|||
131118828|NCT01660451|472065663|FG000|Overall Study|AE associated with clinical disease progression|1|||
131118829|NCT01660451|472065664|FG001|Overall Study|AE associated with clinical disease progression|3|||
131118830|NCT01660451|472065665|FG002|Overall Study|AE associated with clinical disease progression|11|||
131118831|NCT01660451|472065663|FG000|Overall Study|Sponsor Decision|0|||
131118832|NCT01660451|472065664|FG001|Overall Study|Sponsor Decision|0|||
131118833|NCT01660451|472065665|FG002|Overall Study|Sponsor Decision|1|||
131118834|NCT01660451|472065663|FG000|Overall Study|Protocol Deviation|0|||
131118835|NCT01660451|472065664|FG001|Overall Study|Protocol Deviation|0|||
131118836|NCT01660451|472065665|FG002|Overall Study|Protocol Deviation|1|||
131118837|NCT01660451|472065663|FG000|Overall Study|Physician Decision|1|||
131118838|NCT01660451|472065664|FG001|Overall Study|Physician Decision|2|||
131118839|NCT01660451|472065665|FG002|Overall Study|Physician Decision|5|||
131118840|NCT01660451|472065663|FG000|Overall Study|Withdrawal by Subject|1|||
131118841|NCT01660451|472065664|FG001|Overall Study|Withdrawal by Subject|1|||
131118842|NCT01660451|472065665|FG002|Overall Study|Withdrawal by Subject|20|||
131118843|NCT01660451|472065663|FG000|Overall Study|Trial closure.|0|||
131118844|NCT01660451|472065664|FG001|Overall Study|Trial closure.|0|||
131118845|NCT01660451|472065665|FG002|Overall Study|Trial closure.|1|||
131118846|NCT01660451|472065663|FG000|Overall Study|Switching to other therapy|0|||
131118847|NCT01660451|472065664|FG001|Overall Study|Switching to other therapy|1|||
131118848|NCT01660451|472065665|FG002|Overall Study|Switching to other therapy|1|||
131118849|NCT01660451|472065663|FG000|Overall Study|Progressive disease - clinical progression|4|||
131118850|NCT01660451|472065664|FG001|Overall Study|Progressive disease - clinical progression|10|||
131118851|NCT01660451|472065665|FG002|Overall Study|Progressive disease - clinical progression|9|||
131118852|NCT01660451|472065663|FG000|Overall Study|Progressive disease - radiological progression|12|||
131118853|NCT01660451|472065664|FG001|Overall Study|Progressive disease - radiological progression|23|||
131118854|NCT01660451|472065665|FG002|Overall Study|Progressive disease - radiological progression|50|||
131118855|NCT01660451|472065663|FG000|Overall Study|Death|1|||
131118856|NCT01660451|472065664|FG001|Overall Study|Death|0|||
131118857|NCT01660451|472065665|FG002|Overall Study|Death|1|||
131118858|NCT01660451|472065663|FG000|Overall Study|Other|0|||
131118859|NCT01660451|472065664|FG001|Overall Study|Other|0|||
131118860|NCT01660451|472065665|FG002|Overall Study|Other|1|||
131118861|NCT02456662|472065667|FG000|Overall Study|Lost to Follow-up|2|||
131118862|NCT02456662|472065668|FG001|Overall Study|Lost to Follow-up|1|||
131118863|NCT00074581|472065670|FG000|Overall Study|Death|15|||
131118864|NCT00074581|472065671|FG001|Overall Study|Death|16|||
131118865|NCT00074581|472065670|FG000|Overall Study|Withdrawal by Subject|50|||
131118866|NCT00074581|472065671|FG001|Overall Study|Withdrawal by Subject|49|||
131118867|NCT00074581|472065670|FG000|Overall Study|Unable to adhere to visit schedule|13|||
131118868|NCT00074581|472065671|FG001|Overall Study|Unable to adhere to visit schedule|14|||
131118869|NCT00074581|472065670|FG000|Overall Study|Relocated|14|||
131118870|NCT00074581|472065671|FG001|Overall Study|Relocated|9|||
130914331|NCT00809354|471322344|FG003|Overall Study|Lack of Efficacy|15|||
130914332|NCT00809354|471322345|FG004|Overall Study|Lack of Efficacy|40|||
130914333|NCT00809354|471322346|FG005|Overall Study|Lack of Efficacy|19|||
130914334|NCT00809354|471322347|FG006|Overall Study|Lack of Efficacy|21|||
130914335|NCT00809354|471322348|FG007|Overall Study|Lack of Efficacy|15|||
130914336|NCT00809354|471322349|FG008|Overall Study|Lack of Efficacy|18|||
131118871|NCT00074581|472065670|FG000|Overall Study|Were withdrawn by investigator|5|||
131118872|NCT00074581|472065671|FG001|Overall Study|Were withdrawn by investigator|2|||
130914337|NCT00809354|471322350|FG009|Overall Study|Lack of Efficacy|38|||
130914338|NCT00809354|471322341|FG000|Overall Study|Lost to Follow-up|10|||
130914339|NCT00809354|471322342|FG001|Overall Study|Lost to Follow-up|11|||
130914340|NCT00809354|471322343|FG002|Overall Study|Lost to Follow-up|8|||
130914341|NCT00809354|471322344|FG003|Overall Study|Lost to Follow-up|13|||
130914342|NCT00809354|471322345|FG004|Overall Study|Lost to Follow-up|6|||
130914343|NCT00809354|471322346|FG005|Overall Study|Lost to Follow-up|2|||
131118873|NCT00074581|472065670|FG000|Overall Study|Lost to Follow-up|16|||
131118874|NCT00074581|472065671|FG001|Overall Study|Lost to Follow-up|11|||
131118875|NCT00074581|472065670|FG000|Overall Study|Ended relationship w. index participant|117|||
131118876|NCT00074581|472065671|FG001|Overall Study|Ended relationship w. index participant|106|||
131118877|NCT00074581|472065670|FG000|Overall Study|Other|14|||
131118878|NCT00074581|472065671|FG001|Overall Study|Other|19|||
131118879|NCT04411628|472065676|FG000|Overall Study|Withdrawal by Subject|1|||
131118880|NCT04411628|472065677|FG001|Overall Study|Withdrawal by Subject|1|||
131118881|NCT04411628|472065678|FG002|Overall Study|Withdrawal by Subject|2|||
131118882|NCT04411628|472065679|FG003|Overall Study|Withdrawal by Subject|0|||
131118883|NCT04411628|472065676|FG000|Overall Study|Lost to Follow-up|0|||
131118884|NCT04411628|472065677|FG001|Overall Study|Lost to Follow-up|1|||
131118885|NCT04411628|472065678|FG002|Overall Study|Lost to Follow-up|0|||
131118886|NCT04411628|472065679|FG003|Overall Study|Lost to Follow-up|0|||
131118887|NCT00732251|472065680|FG000|Overall Study|Lost to Follow-up|3|||
131118888|NCT00732251|472065680|FG000|Overall Study|Withdrawal by Subject|3|||
131118889|NCT00732251|472065680|FG000|Overall Study|Early Term due to Site Closure|1|||
130914344|NCT00809354|471322347|FG006|Overall Study|Lost to Follow-up|0|||
130914345|NCT00809354|471322348|FG007|Overall Study|Lost to Follow-up|5|||
130914346|NCT00809354|471322349|FG008|Overall Study|Lost to Follow-up|4|||
130914347|NCT00809354|471322350|FG009|Overall Study|Lost to Follow-up|0|||
130914348|NCT00809354|471322341|FG000|Overall Study|Protocol Violation|7|||
130914349|NCT00809354|471322342|FG001|Overall Study|Protocol Violation|14|||
130914350|NCT00809354|471322343|FG002|Overall Study|Protocol Violation|14|||
131118890|NCT01034540|472065681|FG000|Overall Study|Adverse Event|0|||
131118891|NCT01034540|472065682|FG001|Overall Study|Adverse Event|1|||
131118892|NCT03519867|472065685|FG000|Overall Study|Adverse Event|1|||
131118893|NCT03519867|472065686|FG001|Overall Study|Adverse Event|1|||
131118894|NCT03519867|472065687|FG002|Overall Study|Adverse Event|0|||
131118895|NCT03519867|472065688|FG003|Overall Study|Adverse Event|0|||
131118896|NCT03519867|472065689|FG004|Overall Study|Adverse Event|0|||
131118897|NCT03519867|472065690|FG005|Overall Study|Adverse Event|0|||
131118898|NCT03519867|472065691|FG006|Overall Study|Adverse Event|0|||
131118899|NCT03519867|472065692|FG007|Overall Study|Adverse Event|0|||
131118900|NCT03519867|472065693|FG008|Overall Study|Adverse Event|0|||
131118901|NCT03519867|472065694|FG009|Overall Study|Adverse Event|0|||
131118902|NCT03519867|472065685|FG000|Overall Study|Protocol Violation|0|||
131118903|NCT03519867|472065686|FG001|Overall Study|Protocol Violation|0|||
130914351|NCT00809354|471322344|FG003|Overall Study|Protocol Violation|12|||
131118904|NCT03519867|472065687|FG002|Overall Study|Protocol Violation|0|||
131118905|NCT03519867|472065688|FG003|Overall Study|Protocol Violation|0|||
131118906|NCT03519867|472065689|FG004|Overall Study|Protocol Violation|0|||
131118907|NCT03519867|472065690|FG005|Overall Study|Protocol Violation|1|||
131118908|NCT03519867|472065691|FG006|Overall Study|Protocol Violation|0|||
131118909|NCT03519867|472065692|FG007|Overall Study|Protocol Violation|0|||
131118910|NCT03519867|472065693|FG008|Overall Study|Protocol Violation|0|||
130914352|NCT00809354|471322345|FG004|Overall Study|Protocol Violation|14|||
130914353|NCT00809354|471322346|FG005|Overall Study|Protocol Violation|6|||
130914354|NCT00809354|471322347|FG006|Overall Study|Protocol Violation|4|||
130914355|NCT00809354|471322348|FG007|Overall Study|Protocol Violation|6|||
131118911|NCT03519867|472065694|FG009|Overall Study|Protocol Violation|0|||
131118912|NCT03519867|472065685|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131118913|NCT03519867|472065686|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131118914|NCT03519867|472065687|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131118915|NCT03519867|472065688|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130769161|NCT00548249|470780542|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
130914356|NCT00809354|471322349|FG008|Overall Study|Protocol Violation|9|||
130914357|NCT00809354|471322350|FG009|Overall Study|Protocol Violation|3|||
130914358|NCT00809354|471322341|FG000|Overall Study|Withdrawal by Subject|32|||
130914359|NCT00809354|471322342|FG001|Overall Study|Withdrawal by Subject|27|||
130914360|NCT00809354|471322343|FG002|Overall Study|Withdrawal by Subject|31|||
130914361|NCT00809354|471322344|FG003|Overall Study|Withdrawal by Subject|33|||
130914362|NCT00809354|471322345|FG004|Overall Study|Withdrawal by Subject|34|||
130914363|NCT00809354|471322346|FG005|Overall Study|Withdrawal by Subject|29|||
130914364|NCT00809354|471322347|FG006|Overall Study|Withdrawal by Subject|27|||
130914365|NCT00809354|471322348|FG007|Overall Study|Withdrawal by Subject|19|||
130914366|NCT00809354|471322349|FG008|Overall Study|Withdrawal by Subject|18|||
130914367|NCT00809354|471322350|FG009|Overall Study|Withdrawal by Subject|20|||
130914368|NCT00809354|471322341|FG000|Overall Study|Other|10|||
130914369|NCT00809354|471322342|FG001|Overall Study|Other|2|||
130914370|NCT00809354|471322343|FG002|Overall Study|Other|7|||
130914371|NCT00809354|471322344|FG003|Overall Study|Other|10|||
130914372|NCT00809354|471322345|FG004|Overall Study|Other|5|||
130914373|NCT00809354|471322346|FG005|Overall Study|Other|3|||
130914374|NCT00809354|471322347|FG006|Overall Study|Other|2|||
130914375|NCT00809354|471322348|FG007|Overall Study|Other|3|||
130914376|NCT00809354|471322349|FG008|Overall Study|Other|4|||
130914377|NCT00809354|471322350|FG009|Overall Study|Other|3|||
130914378|NCT00809354|471322341|FG000|Overall Study|Study terminated by sponsor|138|||
130914379|NCT00809354|471322342|FG001|Overall Study|Study terminated by sponsor|134|||
130914380|NCT00809354|471322343|FG002|Overall Study|Study terminated by sponsor|129|||
130914381|NCT00809354|471322344|FG003|Overall Study|Study terminated by sponsor|120|||
130914382|NCT00809354|471322345|FG004|Overall Study|Study terminated by sponsor|126|||
130914383|NCT00809354|471322346|FG005|Overall Study|Study terminated by sponsor|133|||
130914384|NCT00809354|471322347|FG006|Overall Study|Study terminated by sponsor|124|||
130914385|NCT00809354|471322348|FG007|Overall Study|Study terminated by sponsor|148|||
130914386|NCT00809354|471322349|FG008|Overall Study|Study terminated by sponsor|127|||
130914387|NCT00809354|471322350|FG009|Overall Study|Study terminated by sponsor|135|||
130914388|NCT00809354|471322341|FG000|Overall Study|Withdrawn due to pregnancy|0|||
130914389|NCT00809354|471322342|FG001|Overall Study|Withdrawn due to pregnancy|1|||
130914390|NCT00809354|471322343|FG002|Overall Study|Withdrawn due to pregnancy|0|||
130914391|NCT00809354|471322344|FG003|Overall Study|Withdrawn due to pregnancy|0|||
130914392|NCT00809354|471322345|FG004|Overall Study|Withdrawn due to pregnancy|0|||
130914393|NCT00809354|471322346|FG005|Overall Study|Withdrawn due to pregnancy|0|||
130914394|NCT00809354|471322347|FG006|Overall Study|Withdrawn due to pregnancy|0|||
130914395|NCT00809354|471322348|FG007|Overall Study|Withdrawn due to pregnancy|0|||
130914396|NCT00809354|471322349|FG008|Overall Study|Withdrawn due to pregnancy|0|||
130914397|NCT00809354|471322350|FG009|Overall Study|Withdrawn due to pregnancy|0|||
130914398|NCT00809354|471322341|FG000|Overall Study|Randomized but not Treated|3|||
130914399|NCT00809354|471322342|FG001|Overall Study|Randomized but not Treated|1|||
130914400|NCT00809354|471322343|FG002|Overall Study|Randomized but not Treated|6|||
130914401|NCT00809354|471322344|FG003|Overall Study|Randomized but not Treated|0|||
130914402|NCT00809354|471322345|FG004|Overall Study|Randomized but not Treated|5|||
130914403|NCT00809354|471322346|FG005|Overall Study|Randomized but not Treated|0|||
130914404|NCT00809354|471322347|FG006|Overall Study|Randomized but not Treated|1|||
130914405|NCT00809354|471322348|FG007|Overall Study|Randomized but not Treated|1|||
130914406|NCT00809354|471322349|FG008|Overall Study|Randomized but not Treated|2|||
130914407|NCT00809354|471322350|FG009|Overall Study|Randomized but not Treated|1|||
130914408|NCT00809354|471322341|FG000|Overall Study|Death|0|||
130914409|NCT00809354|471322342|FG001|Overall Study|Death|0|||
130914410|NCT00809354|471322343|FG002|Overall Study|Death|0|||
130914411|NCT00809354|471322344|FG003|Overall Study|Death|0|||
130914412|NCT00809354|471322345|FG004|Overall Study|Death|0|||
130914413|NCT00809354|471322346|FG005|Overall Study|Death|0|||
130914414|NCT00809354|471322347|FG006|Overall Study|Death|0|||
130914415|NCT00809354|471322348|FG007|Overall Study|Death|1|||
130914416|NCT00809354|471322349|FG008|Overall Study|Death|0|||
130914417|NCT00809354|471322350|FG009|Overall Study|Death|0|||
130914418|NCT03257371|471322353|FG000|Overall Study|Lost to Follow-up|1|||
130914419|NCT03198078|471322359|FG000|Overall Study|Adverse Event|0|||
130914420|NCT03198078|471322360|FG001|Overall Study|Adverse Event|1|||
131118916|NCT03519867|472065689|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130914421|NCT03198078|471322361|FG002|Overall Study|Adverse Event|2|||
130914422|NCT03198078|471322359|FG000|Overall Study|Lack of Efficacy|0|||
130914423|NCT03198078|471322360|FG001|Overall Study|Lack of Efficacy|0|||
130914424|NCT03198078|471322361|FG002|Overall Study|Lack of Efficacy|3|||
130914425|NCT03198078|471322359|FG000|Overall Study|Lost to Follow-up|1|||
130914426|NCT03198078|471322360|FG001|Overall Study|Lost to Follow-up|0|||
130914427|NCT03198078|471322361|FG002|Overall Study|Lost to Follow-up|0|||
130914428|NCT03198078|471322359|FG000|Overall Study|Pregnancy|0|||
130914429|NCT03198078|471322360|FG001|Overall Study|Pregnancy|1|||
130914430|NCT03198078|471322361|FG002|Overall Study|Pregnancy|0|||
130914431|NCT03198078|471322359|FG000|Overall Study|Withdrawal by Subject|1|||
130914432|NCT03198078|471322360|FG001|Overall Study|Withdrawal by Subject|0|||
130914433|NCT03198078|471322361|FG002|Overall Study|Withdrawal by Subject|2|||
130914434|NCT03198078|471322359|FG000|Overall Study|Withdrawal by Caregiver|1|||
130914435|NCT03198078|471322360|FG001|Overall Study|Withdrawal by Caregiver|3|||
130914436|NCT03198078|471322361|FG002|Overall Study|Withdrawal by Caregiver|5|||
130699137|NCT01320722|470522800|FG002|Overall Study|Adverse Event|3|||
130699138|NCT01320722|470522801|FG003|Overall Study|Adverse Event|6|||
130699139|NCT01320722|470522802|FG004|Overall Study|Adverse Event|0|||
130699140|NCT01320722|470522798|FG000|Overall Study|Not Compliant with Study Procedures|0|||
130699141|NCT01320722|470522799|FG001|Overall Study|Not Compliant with Study Procedures|0|||
130699142|NCT01320722|470522800|FG002|Overall Study|Not Compliant with Study Procedures|0|||
130699143|NCT01320722|470522801|FG003|Overall Study|Not Compliant with Study Procedures|4|||
130699144|NCT01320722|470522802|FG004|Overall Study|Not Compliant with Study Procedures|0|||
130699145|NCT01320722|470522798|FG000|Overall Study|Pregnancy|0|||
130699146|NCT01320722|470522799|FG001|Overall Study|Pregnancy|0|||
130699147|NCT01320722|470522800|FG002|Overall Study|Pregnancy|0|||
130699148|NCT01320722|470522801|FG003|Overall Study|Pregnancy|1|||
130699149|NCT01320722|470522802|FG004|Overall Study|Pregnancy|0|||
130699150|NCT01320722|470522798|FG000|Overall Study|Started an Exclusionary Medication|0|||
130699151|NCT01320722|470522799|FG001|Overall Study|Started an Exclusionary Medication|0|||
130699152|NCT01320722|470522800|FG002|Overall Study|Started an Exclusionary Medication|0|||
130914437|NCT02607930|471322362|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
130914438|NCT02607930|471322363|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
130914439|NCT02607930|471322364|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
130914440|NCT02607930|471322365|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
130914441|NCT02607930|471322362|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
130914442|NCT02607930|471322363|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
130914443|NCT02607930|471322364|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
130914444|NCT02607930|471322365|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
130914445|NCT02607930|471322362|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
130914446|NCT02607930|471322363|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
130914447|NCT02607930|471322364|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
130914448|NCT02607930|471322365|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
130914449|NCT02607930|471322362|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
130914450|NCT02607930|471322363|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
130914451|NCT02607930|471322364|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
130914452|NCT02607930|471322365|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
130914453|NCT02607930|471322362|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
130914454|NCT02607930|471322363|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
130914455|NCT02607930|471322364|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
130914456|NCT02607930|471322365|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
130914457|NCT02607930|471322362|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
130914458|NCT02607930|471322363|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
130914459|NCT02607930|471322364|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
130914460|NCT02607930|471322365|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
130914461|NCT02607930|471322362|FG000|Double-Blinded Treatment Phase|Death|2|||
130914462|NCT02607930|471322363|FG001|Double-Blinded Treatment Phase|Death|1|||
130914463|NCT02607930|471322364|FG002|Double-Blinded Treatment Phase|Death|0|||
130914464|NCT02607930|471322365|FG003|Double-Blinded Treatment Phase|Death|0|||
130914465|NCT02607930|471322362|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
130914466|NCT02607930|471322363|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
130914467|NCT02607930|471322364|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
130914468|NCT02607930|471322365|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
130914469|NCT02607930|471322362|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
130914470|NCT02607930|471322363|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
130914471|NCT02607930|471322364|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
130914472|NCT02607930|471322365|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
130914473|NCT02607930|471322362|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
130914474|NCT02607930|471322363|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
130914475|NCT02607930|471322364|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
130914476|NCT02607930|471322365|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
130914477|NCT02607930|471322362|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
130914478|NCT02607930|471322363|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
130914479|NCT02607930|471322364|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
130914480|NCT02607930|471322365|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
130914481|NCT02607930|471322362|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
130914482|NCT02607930|471322363|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
130914483|NCT02607930|471322364|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
130914484|NCT02607930|471322365|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
130699153|NCT01320722|470522801|FG003|Overall Study|Started an Exclusionary Medication|0|||
130699154|NCT01320722|470522802|FG004|Overall Study|Started an Exclusionary Medication|1|||
130699155|NCT01320722|470522798|FG000|Overall Study|Withdrew due to Health Condition|0|||
130699156|NCT01320722|470522799|FG001|Overall Study|Withdrew due to Health Condition|0|||
130699157|NCT01320722|470522800|FG002|Overall Study|Withdrew due to Health Condition|0|||
130914485|NCT02607930|471322362|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
130914486|NCT02607930|471322363|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
130914487|NCT02607930|471322364|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
130914488|NCT02607930|471322365|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
130914489|NCT02607930|471322362|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
130914490|NCT02607930|471322363|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
130914491|NCT02607930|471322364|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
130914492|NCT02607930|471322365|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
130914493|NCT02607930|471322362|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
130914494|NCT02607930|471322363|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
130914495|NCT02607930|471322364|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
130914496|NCT02607930|471322365|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
130914497|NCT02607930|471322362|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
130914498|NCT02607930|471322363|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
130914499|NCT02607930|471322364|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
130914500|NCT02607930|471322365|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
130914501|NCT01050543|471322368|FG000|Overall Study|Withdrawal by Subject|0|||
130914502|NCT01050543|471322369|FG001|Overall Study|Withdrawal by Subject|2|||
130914503|NCT01050543|471322368|FG000|Overall Study|Protocol Violation|0|||
130914504|NCT01050543|471322369|FG001|Overall Study|Protocol Violation|1|||
130914505|NCT01050543|471322368|FG000|Overall Study|Administrative|4|||
130914506|NCT01050543|471322369|FG001|Overall Study|Administrative|1|||
130914507|NCT00570765|471322370|FG000|DB Phase|Withdrawal by Subject|1|||
130914508|NCT00570765|471322371|FG001|DB Phase|Withdrawal by Subject|0|||
130914509|NCT00570765|471322372|FG002|DB Phase|Withdrawal by Subject|0|||
130914510|NCT00570765|471322373|FG003|DB Phase|Withdrawal by Subject|0|||
130914511|NCT00570765|471322370|FG000|DB Phase|Protocol Violation|0|||
130914512|NCT00570765|471322371|FG001|DB Phase|Protocol Violation|1|||
130914513|NCT00570765|471322372|FG002|DB Phase|Protocol Violation|0|||
130914514|NCT00570765|471322373|FG003|DB Phase|Protocol Violation|0|||
130914515|NCT00570765|471322370|FG000|DB Phase|Adverse Event|3|||
130914516|NCT00570765|471322371|FG001|DB Phase|Adverse Event|6|||
130914517|NCT00570765|471322372|FG002|DB Phase|Adverse Event|0|||
130914518|NCT00570765|471322373|FG003|DB Phase|Adverse Event|0|||
130914519|NCT00570765|471322370|FG000|DB Phase|Did Not Receive Study Drug|0|||
130914520|NCT00570765|471322371|FG001|DB Phase|Did Not Receive Study Drug|0|||
130914521|NCT00570765|471322372|FG002|DB Phase|Did Not Receive Study Drug|1|||
130914522|NCT00570765|471322373|FG003|DB Phase|Did Not Receive Study Drug|0|||
130914523|NCT00570765|471322370|FG000|LTSE Phase|Withdrawal by Subject|0|||
130914524|NCT00570765|471322371|FG001|LTSE Phase|Withdrawal by Subject|0|||
130914525|NCT00570765|471322372|FG002|LTSE Phase|Withdrawal by Subject|0|||
130914526|NCT00570765|471322373|FG003|LTSE Phase|Withdrawal by Subject|1|||
130914527|NCT00570765|471322370|FG000|LTSE Phase|Adverse Event|0|||
130914528|NCT00570765|471322371|FG001|LTSE Phase|Adverse Event|0|||
130914529|NCT00570765|471322372|FG002|LTSE Phase|Adverse Event|0|||
130914530|NCT00570765|471322373|FG003|LTSE Phase|Adverse Event|7|||
130914531|NCT00570765|471322370|FG000|LTSE Phase|Physician Decision|0|||
130914532|NCT00570765|471322371|FG001|LTSE Phase|Physician Decision|0|||
130914533|NCT00570765|471322372|FG002|LTSE Phase|Physician Decision|0|||
130914534|NCT00570765|471322373|FG003|LTSE Phase|Physician Decision|4|||
130914535|NCT03711266|471322374|FG000|Overall Study|Lost to Follow-up|10|||
130914536|NCT00057876|471322375|FG000|Overall Study|Adverse Event|8|||
130914537|NCT00057876|471322376|FG001|Overall Study|Adverse Event|8|||
130914538|NCT00057876|471322375|FG000|Overall Study|Death|2|||
130914539|NCT00057876|471322376|FG001|Overall Study|Death|1|||
130914540|NCT00057876|471322375|FG000|Overall Study|Withdrawal by Subject|5|||
130914541|NCT00057876|471322376|FG001|Overall Study|Withdrawal by Subject|6|||
130914542|NCT00057876|471322375|FG000|Overall Study|Lack of Efficacy|10|||
130914543|NCT00057876|471322376|FG001|Overall Study|Lack of Efficacy|8|||
130914544|NCT00057876|471322375|FG000|Overall Study|Ineligible|1|||
131032992|NCT03131648|471755282|FG002|Maintenance Treatment Period|Not dosed|3|||
131032993|NCT03131648|471755283|FG003|Maintenance Treatment Period|Not dosed|2|||
130699158|NCT01320722|470522801|FG003|Overall Study|Withdrew due to Health Condition|0|||
130699159|NCT01320722|470522802|FG004|Overall Study|Withdrew due to Health Condition|1|||
130699160|NCT00160524|470522803|FG000|Overall Study|Adverse Event|119|||
130914545|NCT00057876|471322376|FG001|Overall Study|Ineligible|2|||
130914546|NCT00057876|471322375|FG000|Overall Study|other reason|2|||
130914547|NCT00057876|471322376|FG001|Overall Study|other reason|2|||
130914548|NCT00057876|471322375|FG000|Overall Study|other complicating disease|1|||
130914549|NCT00057876|471322376|FG001|Overall Study|other complicating disease|0|||
130914550|NCT00437320|471322379|FG000|Overall Study|Participant request|2|||
130914551|NCT00437320|471322380|FG001|Overall Study|Participant request|1|||
130914552|NCT00437320|471322381|FG002|Overall Study|Participant request|4|||
130914553|NCT01649804|471322388|FG000|Overall Study|Administrative/Other|8|||
130914554|NCT02456103|471322389|FG000|Overall Study|Study Closure|207|||
130914555|NCT02456103|471322389|FG000|Overall Study|Physician Decision|1|||
130914556|NCT02456103|471322389|FG000|Overall Study|Required prohibited medications|5|||
130914557|NCT02456103|471322389|FG000|Overall Study|Protocol Violation|1|||
130914558|NCT02456103|471322389|FG000|Overall Study|Adverse Event|5|||
130914559|NCT02456103|471322389|FG000|Overall Study|Abnormal Laboratory Value|2|||
130914560|NCT02456103|471322389|FG000|Overall Study|Lost to Follow-up|1|||
130914561|NCT02456103|471322389|FG000|Overall Study|Withdrawal by Subject|24|||
130914562|NCT01912963|471322396|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
130914563|NCT01912963|471322397|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
130914564|NCT01912963|471322398|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
130914565|NCT01912963|471322396|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
130914566|NCT01912963|471322397|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
130914567|NCT01912963|471322398|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
130914568|NCT01912963|471322396|FG000|Overall Study|Adverse Event|0|||
130914569|NCT01912963|471322397|FG001|Overall Study|Adverse Event|1|||
130914570|NCT01912963|471322398|FG002|Overall Study|Adverse Event|1|||
130914571|NCT01912963|471322396|FG000|Overall Study|Withdrawal by Subject|0|||
131032994|NCT03131648|471755284|FG004|Maintenance Treatment Period|Not dosed|1|||
131032995|NCT03131648|471755285|FG005|Maintenance Treatment Period|Not dosed|0|||
131032996|NCT03131648|471755286|FG006|Maintenance Treatment Period|Not dosed|0|||
131032997|NCT03131648|471755287|FG007|Maintenance Treatment Period|Not dosed|0|||
131032998|NCT03131648|471755280|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
131032999|NCT03131648|471755281|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
131033000|NCT03131648|471755282|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
131033001|NCT03131648|471755283|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
131033002|NCT03131648|471755284|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
131033003|NCT03131648|471755285|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
131033004|NCT03131648|471755286|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
131033005|NCT03131648|471755287|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
131033006|NCT03131648|471755280|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131033007|NCT03131648|471755281|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131033008|NCT03131648|471755282|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
131033009|NCT03131648|471755283|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
131033010|NCT03131648|471755284|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
131033011|NCT03131648|471755285|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
131033012|NCT03131648|471755286|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131033013|NCT03131648|471755287|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131033014|NCT03131648|471755280|FG000|Maintenance Treatment Period|Completed Week 50|0|||
131033015|NCT03131648|471755281|FG001|Maintenance Treatment Period|Completed Week 50|0|||
131033016|NCT03131648|471755282|FG002|Maintenance Treatment Period|Completed Week 50|0|||
131033017|NCT03131648|471755283|FG003|Maintenance Treatment Period|Completed Week 50|0|||
131033018|NCT03131648|471755284|FG004|Maintenance Treatment Period|Completed Week 50|1|||
131033019|NCT03131648|471755285|FG005|Maintenance Treatment Period|Completed Week 50|0|||
131033020|NCT03131648|471755286|FG006|Maintenance Treatment Period|Completed Week 50|0|||
131033021|NCT03131648|471755287|FG007|Maintenance Treatment Period|Completed Week 50|0|||
131033022|NCT03131648|471755280|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
131033023|NCT03131648|471755281|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
131033024|NCT03131648|471755282|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
131033025|NCT03131648|471755283|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
131033026|NCT03131648|471755284|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
131033027|NCT03131648|471755285|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
131033028|NCT03131648|471755286|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
131033029|NCT03131648|471755287|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
131033030|NCT05324124|471755288|FG000|Period 1|Withdrawal by Subject|1|||
131033031|NCT05324124|471755289|FG001|Period 1|Withdrawal by Subject|0|||
131033032|NCT05324124|471755288|FG000|Period 1|Physician Decision|0|||
130914572|NCT01912963|471322397|FG001|Overall Study|Withdrawal by Subject|1|||
130914573|NCT01912963|471322398|FG002|Overall Study|Withdrawal by Subject|0|||
131033033|NCT05324124|471755289|FG001|Period 1|Physician Decision|1|||
131033034|NCT04760678|471755292|FG000|Overall Study|Death|13|||
131033035|NCT04760678|471755292|FG000|Overall Study|Lost to Follow-up|48|||
131033036|NCT04760678|471755292|FG000|Overall Study|Withdrawal by Subject|1|||
131033037|NCT01748448|471755295|FG000|Treatment Period|Consent withdrawn by subject|1|||
131033038|NCT01748448|471755296|FG001|Treatment Period|Consent withdrawn by subject|0|||
131033039|NCT01748448|471755295|FG000|Treatment Period|Adverse Event|1|||
131033040|NCT01748448|471755296|FG001|Treatment Period|Adverse Event|0|||
131033041|NCT01748448|471755295|FG000|Treatment Period|Personal|0|||
131033042|NCT01748448|471755296|FG001|Treatment Period|Personal|1|||
131033043|NCT02907099|471755297|FG000|Overall Study|Adverse Event|1|||
131033044|NCT02907099|471755297|FG000|Overall Study|Withdrawal by Subject|2|||
130914574|NCT01912963|471322396|FG000|Overall Study|Sought treatment locally|0|||
131033045|NCT02907099|471755297|FG000|Overall Study|Screen Fail|2|||
131033046|NCT05368103|471755298|FG000|Overall Study|Withdrawal by Subject|4|||
131033047|NCT05368103|471755298|FG000|Overall Study|Lost to Follow-up|1|||
130914575|NCT01912963|471322397|FG001|Overall Study|Sought treatment locally|1|||
130914576|NCT01912963|471322398|FG002|Overall Study|Sought treatment locally|0|||
130914577|NCT03112590|471322403|FG000|Overall Study|Adverse Event|0|||
130914578|NCT03112590|471322404|FG001|Overall Study|Adverse Event|1|||
130914579|NCT03112590|471322405|FG002|Overall Study|Adverse Event|0|||
130914580|NCT05156073|471322406|FG000|Overall Study|Patient canceled appointment with PCP|1|||
130914581|NCT02734433|471322407|FG000|Overall Study|Disease progression|1|||
130914582|NCT02734433|471322408|FG001|Overall Study|Disease progression|5|||
130914583|NCT02734433|471322407|FG000|Overall Study|Clinical progression|0|||
130914584|NCT02734433|471322408|FG001|Overall Study|Clinical progression|1|||
130914585|NCT02734433|471322407|FG000|Overall Study|Withdrawal by Subject|1|||
131118917|NCT03519867|472065690|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131118918|NCT03519867|472065691|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
131118919|NCT03519867|472065692|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131118920|NCT03519867|472065693|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
131118921|NCT03519867|472065694|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130914586|NCT02734433|471322408|FG001|Overall Study|Withdrawal by Subject|2|||
130914587|NCT03805646|471322409|FG000|Overall Study|Death|40|||
130914588|NCT03805646|471322410|FG001|Overall Study|Death|49|||
130914589|NCT03805646|471322409|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
130914590|NCT03805646|471322410|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
130914591|NCT00891462|471323590|FG000|Overall Study|Withdrawal by Subject|9|||
130914592|NCT00891462|471323591|FG001|Overall Study|Withdrawal by Subject|6|||
130914593|NCT00891462|471323592|FG002|Overall Study|Withdrawal by Subject|7|||
130914594|NCT00891462|471323590|FG000|Overall Study|Adverse Event|7|||
130914595|NCT00891462|471323591|FG001|Overall Study|Adverse Event|8|||
130914596|NCT00891462|471323592|FG002|Overall Study|Adverse Event|7|||
130914597|NCT00891462|471323590|FG000|Overall Study|Lack of Efficacy|10|||
130914598|NCT00891462|471323591|FG001|Overall Study|Lack of Efficacy|5|||
130914599|NCT00891462|471323592|FG002|Overall Study|Lack of Efficacy|1|||
130914600|NCT00891462|471323590|FG000|Overall Study|COPD exacerbation|7|||
130914601|NCT00891462|471323591|FG001|Overall Study|COPD exacerbation|4|||
130914602|NCT00891462|471323592|FG002|Overall Study|COPD exacerbation|1|||
130914603|NCT00891462|471323590|FG000|Overall Study|Other Reason|2|||
130914604|NCT00891462|471323591|FG001|Overall Study|Other Reason|5|||
130914605|NCT00891462|471323592|FG002|Overall Study|Other Reason|3|||
130914606|NCT00891462|471323590|FG000|Overall Study|Protocol Violation|2|||
130914607|NCT00891462|471323591|FG001|Overall Study|Protocol Violation|1|||
130914608|NCT00891462|471323592|FG002|Overall Study|Protocol Violation|3|||
130914609|NCT00891462|471323590|FG000|Overall Study|Inclusion/exclusion criteria|0|||
130914610|NCT00891462|471323591|FG001|Overall Study|Inclusion/exclusion criteria|2|||
131118922|NCT03519867|472065685|FG000|Overall Study|Admin. of other reversal agent|1|||
131118923|NCT03519867|472065686|FG001|Overall Study|Admin. of other reversal agent|1|||
131118924|NCT03519867|472065687|FG002|Overall Study|Admin. of other reversal agent|0|||
131118925|NCT03519867|472065688|FG003|Overall Study|Admin. of other reversal agent|0|||
131118926|NCT03519867|472065689|FG004|Overall Study|Admin. of other reversal agent|0|||
131118927|NCT03519867|472065690|FG005|Overall Study|Admin. of other reversal agent|1|||
131118928|NCT03519867|472065691|FG006|Overall Study|Admin. of other reversal agent|0|||
131118929|NCT03519867|472065692|FG007|Overall Study|Admin. of other reversal agent|0|||
131118930|NCT03519867|472065693|FG008|Overall Study|Admin. of other reversal agent|0|||
131118931|NCT03519867|472065694|FG009|Overall Study|Admin. of other reversal agent|0|||
131118932|NCT03519867|472065685|FG000|Overall Study|Reason not provided|1|||
131118933|NCT03519867|472065686|FG001|Overall Study|Reason not provided|1|||
131118934|NCT03519867|472065687|FG002|Overall Study|Reason not provided|1|||
130914611|NCT00891462|471323592|FG002|Overall Study|Inclusion/exclusion criteria|2|||
130914612|NCT00891462|471323590|FG000|Overall Study|Lost to Follow-up|0|||
130914613|NCT00891462|471323591|FG001|Overall Study|Lost to Follow-up|2|||
130914614|NCT00891462|471323592|FG002|Overall Study|Lost to Follow-up|0|||
130914615|NCT01920555|471323595|FG000|Overall Study|Physician Decision|1|||
130914616|NCT01920555|471323596|FG001|Overall Study|Physician Decision|2|||
130914617|NCT01920555|471323597|FG002|Overall Study|Physician Decision|1|||
130914618|NCT01920555|471323598|FG003|Overall Study|Physician Decision|2|||
130914619|NCT01920555|471323599|FG004|Overall Study|Physician Decision|0|||
130914620|NCT01920555|471323595|FG000|Overall Study|Lack of Efficacy|2|||
130914621|NCT01920555|471323596|FG001|Overall Study|Lack of Efficacy|0|||
130914622|NCT01920555|471323597|FG002|Overall Study|Lack of Efficacy|0|||
130914623|NCT01920555|471323598|FG003|Overall Study|Lack of Efficacy|0|||
130914624|NCT01920555|471323599|FG004|Overall Study|Lack of Efficacy|0|||
130914625|NCT01920555|471323595|FG000|Overall Study|Travel Difficulties|1|||
131118935|NCT03519867|472065688|FG003|Overall Study|Reason not provided|1|||
131118936|NCT03519867|472065689|FG004|Overall Study|Reason not provided|0|||
131118937|NCT03519867|472065690|FG005|Overall Study|Reason not provided|1|||
130914626|NCT01920555|471323596|FG001|Overall Study|Travel Difficulties|1|||
130914627|NCT01920555|471323597|FG002|Overall Study|Travel Difficulties|0|||
130914628|NCT01920555|471323598|FG003|Overall Study|Travel Difficulties|0|||
130914629|NCT01920555|471323599|FG004|Overall Study|Travel Difficulties|1|||
130914630|NCT01920555|471323595|FG000|Overall Study|Lost to Follow-up|0|||
130914631|NCT01920555|471323596|FG001|Overall Study|Lost to Follow-up|1|||
130914632|NCT01920555|471323597|FG002|Overall Study|Lost to Follow-up|0|||
130914633|NCT01920555|471323598|FG003|Overall Study|Lost to Follow-up|1|||
130914634|NCT01920555|471323599|FG004|Overall Study|Lost to Follow-up|0|||
130914635|NCT05447897|471323600|FG000|Overall Study|Did not participate in survey|2|||
130914636|NCT02028871|471323603|FG000|Overall Study|Positive urine drug screen|1|||
130914637|NCT02028871|471323604|FG001|Overall Study|Positive urine drug screen|1|||
130914638|NCT02028871|471323603|FG000|Overall Study|Withdrawal by Subject|1|||
130914639|NCT02028871|471323604|FG001|Overall Study|Withdrawal by Subject|2|||
130914640|NCT02028871|471323603|FG000|Overall Study|IV placement difficulty|1|||
130914641|NCT02028871|471323604|FG001|Overall Study|IV placement difficulty|0|||
130914642|NCT02028871|471323603|FG000|Overall Study|Current Illness|1|||
130914643|NCT02028871|471323604|FG001|Overall Study|Current Illness|0|||
130914644|NCT01916967|471323610|FG000|Overall Study|Adverse Event|0|||
130914645|NCT01916967|471323611|FG001|Overall Study|Adverse Event|0|||
130914646|NCT01916967|471323612|FG002|Overall Study|Adverse Event|2|||
130914647|NCT01916967|471323610|FG000|Overall Study|Lack of Efficacy|0|||
130914648|NCT01916967|471323611|FG001|Overall Study|Lack of Efficacy|0|||
130914649|NCT01916967|471323612|FG002|Overall Study|Lack of Efficacy|6|||
130914650|NCT01916967|471323610|FG000|Overall Study|Physician Decision|0|||
130914651|NCT01916967|471323611|FG001|Overall Study|Physician Decision|0|||
130914652|NCT01916967|471323612|FG002|Overall Study|Physician Decision|1|||
130914653|NCT01916967|471323610|FG000|Overall Study|Protocol Violation|0|||
130914654|NCT01916967|471323611|FG001|Overall Study|Protocol Violation|1|||
130914655|NCT01916967|471323612|FG002|Overall Study|Protocol Violation|0|||
130914656|NCT01104155|471323613|FG000|Overall Study|Adverse Event|15|||
130914657|NCT01104155|471323614|FG001|Overall Study|Adverse Event|8|||
130914658|NCT01104155|471323613|FG000|Overall Study|Participant choice|6|||
130914659|NCT01104155|471323614|FG001|Overall Study|Participant choice|5|||
130914660|NCT01104155|471323613|FG000|Overall Study|Withdrawal of consent|1|||
130914661|NCT01104155|471323614|FG001|Overall Study|Withdrawal of consent|1|||
130914662|NCT01104155|471323613|FG000|Overall Study|Other|3|||
130914663|NCT01104155|471323614|FG001|Overall Study|Other|4|||
130914664|NCT01484132|471323620|FG000|Overall Study|Lost to Follow-up|8|||
130914665|NCT01484132|471323620|FG000|Overall Study|Difficulty with time commitment|2|||
130914666|NCT01484132|471323620|FG000|Overall Study|Ineligible|1|||
130914667|NCT01484132|471323620|FG000|Overall Study|No pre-treatment urine sample collected|1|||
130914668|NCT01484132|471323620|FG000|Overall Study|No post-treatment urine sample collected|10|||
130914669|NCT00568685|471323621|FG000|Overall Study|Adverse Event|2|||
130914670|NCT00568685|471323622|FG001|Overall Study|Adverse Event|3|||
130914671|NCT00568685|471323623|FG002|Overall Study|Adverse Event|3|||
130914672|NCT00568685|471323621|FG000|Overall Study|Withdrawal by Subject|7|||
130914673|NCT00568685|471323622|FG001|Overall Study|Withdrawal by Subject|2|||
130914674|NCT00568685|471323623|FG002|Overall Study|Withdrawal by Subject|2|||
130914675|NCT00568685|471323621|FG000|Overall Study|Protocol Violation|1|||
130914676|NCT00568685|471323622|FG001|Overall Study|Protocol Violation|0|||
130914677|NCT00568685|471323623|FG002|Overall Study|Protocol Violation|0|||
130914678|NCT02038452|471323624|FG000|Overall Study|Withdrawal by Subject|7|||
130914679|NCT02038452|471323625|FG001|Overall Study|Withdrawal by Subject|9|||
130914680|NCT02038452|471323624|FG000|Overall Study|Lost to Follow-up|31|||
130914681|NCT02038452|471323625|FG001|Overall Study|Lost to Follow-up|28|||
130914682|NCT01090973|471323630|FG000|Overall Study|Disease progression|1|||
130914683|NCT01626495|471323632|FG000|Overall Study|Adverse Event|3|||
130914684|NCT01626495|471323632|FG000|Overall Study|Disease progression|27|||
130914685|NCT01626495|471323632|FG000|Overall Study|Withdrawal by Subject|1|||
130914686|NCT01626495|471323632|FG000|Overall Study|Administrative problem|1|||
130914687|NCT01626495|471323632|FG000|Overall Study|Death|2|||
130914688|NCT01626495|471323632|FG000|Overall Study|Physician Decision|1|||
130914689|NCT01626495|471323632|FG000|Overall Study|New cancer therapy|16|||
130914690|NCT01626495|471323632|FG000|Overall Study|Manufacturing failure|1|||
130914691|NCT01934972|471323633|FG000|Overall Study|Withdrawal by Subject|9|||
130914692|NCT01934972|471323634|FG001|Overall Study|Withdrawal by Subject|6|||
130914693|NCT03131453|471323635|FG000|Overall Study|Study terminated by Sponsor|424|||
130914694|NCT03131453|471323636|FG001|Overall Study|Study terminated by Sponsor|222|||
130914695|NCT03131453|471323637|FG002|Overall Study|Study terminated by Sponsor|438|||
130914696|NCT03131453|471323635|FG000|Overall Study|Withdrawal by Subject|18|||
130914697|NCT03131453|471323636|FG001|Overall Study|Withdrawal by Subject|7|||
130914698|NCT03131453|471323637|FG002|Overall Study|Withdrawal by Subject|13|||
130914699|NCT03131453|471323635|FG000|Overall Study|Adverse Event|10|||
130914700|NCT03131453|471323636|FG001|Overall Study|Adverse Event|3|||
130914701|NCT03131453|471323637|FG002|Overall Study|Adverse Event|3|||
130914702|NCT03131453|471323635|FG000|Overall Study|Lost to Follow-up|1|||
130914703|NCT03131453|471323636|FG001|Overall Study|Lost to Follow-up|0|||
130914704|NCT03131453|471323637|FG002|Overall Study|Lost to Follow-up|1|||
130914705|NCT03131453|471323635|FG000|Overall Study|Physician Decision|1|||
130914706|NCT03131453|471323636|FG001|Overall Study|Physician Decision|0|||
130914707|NCT03131453|471323637|FG002|Overall Study|Physician Decision|1|||
130914708|NCT03131453|471323635|FG000|Overall Study|Non-compliance with study treatment|1|||
131033048|NCT05368103|471755298|FG000|Overall Study|Lack of Efficacy|3|||
130699161|NCT00160524|470522803|FG000|Overall Study|Adverse Event and Other|94|||
130699162|NCT00160524|470522803|FG000|Overall Study|Protocol Violation|16|||
130699163|NCT00160524|470522803|FG000|Overall Study|Protocol Violation and Other|2|||
130699164|NCT00160524|470522803|FG000|Overall Study|Withdrawal by Subject|141|||
130699165|NCT00160524|470522803|FG000|Overall Study|Withdrawal by Subject and Other|17|||
130914709|NCT03131453|471323636|FG001|Overall Study|Non-compliance with study treatment|0|||
130914710|NCT03131453|471323637|FG002|Overall Study|Non-compliance with study treatment|0|||
130914711|NCT03131453|471323635|FG000|Overall Study|Technical problems|1|||
130914712|NCT03131453|471323636|FG001|Overall Study|Technical problems|0|||
130914713|NCT03131453|471323637|FG002|Overall Study|Technical problems|0|||
130914714|NCT03131453|471323635|FG000|Overall Study|Protocol deviation|0|||
130914715|NCT03131453|471323636|FG001|Overall Study|Protocol deviation|1|||
130914716|NCT03131453|471323637|FG002|Overall Study|Protocol deviation|0|||
131118938|NCT03519867|472065691|FG006|Overall Study|Reason not provided|0|||
131118939|NCT03519867|472065692|FG007|Overall Study|Reason not provided|1|||
131118940|NCT03519867|472065693|FG008|Overall Study|Reason not provided|1|||
131118941|NCT03519867|472065694|FG009|Overall Study|Reason not provided|0|||
131118942|NCT01252810|472065695|FG000|Overall Study|Withdrawal by Subject|4|||
131118943|NCT01252810|472065696|FG001|Overall Study|Withdrawal by Subject|1|||
131118944|NCT01252810|472065695|FG000|Overall Study|Lost to Follow-up|0|||
131118945|NCT01252810|472065696|FG001|Overall Study|Lost to Follow-up|1|||
131118946|NCT01252810|472065695|FG000|Overall Study|Physician Decision|2|||
131118947|NCT01252810|472065696|FG001|Overall Study|Physician Decision|1|||
131118948|NCT01252810|472065695|FG000|Overall Study|Various reasons|8|||
131118949|NCT01252810|472065696|FG001|Overall Study|Various reasons|0|||
131118950|NCT04376827|472065701|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
131118951|NCT04376827|472065702|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
131118952|NCT04376827|472065701|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
131118953|NCT04376827|472065702|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
131118954|NCT04376827|472065701|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
131118955|NCT04376827|472065702|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
130914737|NCT00445978|471323644|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
130914738|NCT00445978|471323644|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
130914739|NCT00445978|471323644|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
130914740|NCT00445978|471323644|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
130914741|NCT00445978|471323644|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
130914742|NCT00445978|471323644|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
130699166|NCT00160524|470522803|FG000|Overall Study|Physician Decision|27|||
130699167|NCT00160524|470522803|FG000|Overall Study|Physician Decision and Other|6|||
130699168|NCT00160524|470522803|FG000|Overall Study|Lost to Follow-up|13|||
130699169|NCT00160524|470522803|FG000|Overall Study|Lost to Follow-up and Other|1|||
130699170|NCT00160524|470522803|FG000|Overall Study|Lack of Efficacy|21|||
130699171|NCT00160524|470522803|FG000|Overall Study|Lack of Efficacy and Other|1|||
130699172|NCT00160524|470522803|FG000|Overall Study|Other|20|||
130699173|NCT01547728|470522815|FG000|Overall Study|Change in procedure and equipment|1|||
130914743|NCT00445978|471323644|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
130914744|NCT00445978|471323644|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
130914745|NCT00445978|471323644|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
130914746|NCT01822496|471323647|FG000|Overall Study|Protocol Violation|2|||
130914747|NCT01822496|471323648|FG001|Overall Study|Protocol Violation|2|||
130914748|NCT01822496|471323649|FG002|Overall Study|Protocol Violation|0|||
130914749|NCT01822496|471323650|FG003|Overall Study|Protocol Violation|1|||
130914750|NCT01822496|471323647|FG000|Overall Study|Withdrawal by Subject|0|||
130914751|NCT01822496|471323648|FG001|Overall Study|Withdrawal by Subject|0|||
130914752|NCT01822496|471323649|FG002|Overall Study|Withdrawal by Subject|0|||
130914753|NCT01822496|471323650|FG003|Overall Study|Withdrawal by Subject|3|||
130914754|NCT00304239|471323651|FG000|Overall Study|Protocol Deviations/Violations|15|||
130914755|NCT00304239|471323652|FG001|Overall Study|Protocol Deviations/Violations|0|||
130914756|NCT00304239|471323651|FG000|Overall Study|Adverse Event|2|||
130914757|NCT00304239|471323652|FG001|Overall Study|Adverse Event|0|||
130914758|NCT02979197|471323653|FG000|Overall Study|Adverse Event|4|||
130914759|NCT02979197|471323654|FG001|Overall Study|Adverse Event|2|||
131033049|NCT03675282|471755299|FG000|Overall Study|Lost to Follow-up|4|||
131033050|NCT03675282|471755300|FG001|Overall Study|Lost to Follow-up|8|||
131033051|NCT03675282|471755301|FG002|Overall Study|Lost to Follow-up|1|||
131033052|NCT03675282|471755302|FG003|Overall Study|Lost to Follow-up|0|||
131033053|NCT03675282|471755303|FG004|Overall Study|Lost to Follow-up|2|||
131033054|NCT03675282|471755304|FG005|Overall Study|Lost to Follow-up|7|||
131033055|NCT03675282|471755299|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
131033056|NCT03675282|471755300|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
131033057|NCT03675282|471755301|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
131033058|NCT03675282|471755302|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
131033059|NCT03675282|471755303|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
130914760|NCT02979197|471323655|FG002|Overall Study|Adverse Event|0|||
130914761|NCT02979197|471323653|FG000|Overall Study|Protocol Violation|0|||
130914762|NCT02979197|471323654|FG001|Overall Study|Protocol Violation|1|||
130914763|NCT02979197|471323655|FG002|Overall Study|Protocol Violation|0|||
130914764|NCT02979197|471323653|FG000|Overall Study|Subject unable to commit to study dates|0|||
130914765|NCT02979197|471323654|FG001|Overall Study|Subject unable to commit to study dates|1|||
130914766|NCT02979197|471323655|FG002|Overall Study|Subject unable to commit to study dates|0|||
130914767|NCT03643159|471323656|FG000|Overall Study|Adverse Event|1|||
130914768|NCT03643159|471323656|FG000|Overall Study|Withdrawal by Subject|1|||
130914769|NCT03438383|471323657|FG000|Overall Study|Protocol Violation|9|||
130914770|NCT03438383|471323658|FG001|Overall Study|Protocol Violation|3|||
130914771|NCT02766465|471323659|FG000|Overall Study|Withdrawal by Subject|0|||
130914772|NCT02766465|471323660|FG001|Overall Study|Withdrawal by Subject|10|||
130914773|NCT01631812|471323661|FG000|Overall Study|Adverse Event|25|||
130914774|NCT01631812|471323661|FG000|Overall Study|Lack of Efficacy|5|||
130914775|NCT01631812|471323661|FG000|Overall Study|Withdrawal by Subject|4|||
130914776|NCT01631812|471323661|FG000|Overall Study|Physician Decision|3|||
130914777|NCT02435069|471323662|FG000|Dose Response - First Intervention|Adverse Event|0|||
130914778|NCT02435069|471323663|FG001|Dose Response - First Intervention|Adverse Event|1|||
130914779|NCT02435069|471323664|FG002|Dose Response - First Intervention|Adverse Event|1|||
130914780|NCT02435069|471323665|FG003|Dose Response - First Intervention|Adverse Event|0|||
130914781|NCT02435069|471323666|FG004|Dose Response - First Intervention|Adverse Event|0|||
130914782|NCT02435069|471323662|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
130914783|NCT02435069|471323663|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
130914784|NCT02435069|471323664|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
130914785|NCT02435069|471323665|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
130914786|NCT02435069|471323666|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
130914787|NCT01528033|471323667|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
130914788|NCT01528033|471323668|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
130914789|NCT01528033|471323667|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
130914790|NCT01528033|471323668|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
130914791|NCT01528033|471323667|FG000|Primary Endpoint Assessment ITT|Death|2|||
130914792|NCT01528033|471323668|FG001|Primary Endpoint Assessment ITT|Death|2|||
130914793|NCT01528033|471323667|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
130914794|NCT01528033|471323668|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
130914795|NCT01528033|471323667|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
130914796|NCT01528033|471323668|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
130914797|NCT01528033|471323667|FG000|Follow Up|No data available|46|||
130914798|NCT01528033|471323668|FG001|Follow Up|No data available|44|||
131118956|NCT04376827|472065701|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
131118957|NCT04376827|472065702|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
131118958|NCT04376827|472065701|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
131118959|NCT04376827|472065702|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
131118960|NCT00761306|472067216|FG000|Overall Study|Adverse Event|5|||
131118961|NCT00761306|472067216|FG000|Overall Study|Lack of Efficacy|4|||
130769162|NCT00548249|470780543|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
131118962|NCT00761306|472067216|FG000|Overall Study|Protocol Violation|2|||
131118963|NCT00761306|472067216|FG000|Overall Study|Withdrawal of Consent|3|||
131118964|NCT00761306|472067216|FG000|Overall Study|Lost to Follow-up|1|||
131118965|NCT00761306|472067216|FG000|Overall Study|Administrative or Other Reasons|5|||
131118966|NCT05162027|472067217|FG000|Overall Study|Adverse Event|1|||
131118967|NCT05162027|472067218|FG001|Overall Study|Adverse Event|0|||
131118968|NCT03713034|472067219|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
131118969|NCT03713034|472067220|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
131118970|NCT02982239|472067223|FG000|Overall Study|Lost to Follow-up|3|||
130769163|NCT00548249|470780544|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
130769164|NCT00548249|470780545|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
130769165|NCT00548249|470780546|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
130914799|NCT02436681|471323671|FG000|Overall Study|Lost to Follow-up|10|||
130914800|NCT02436681|471323671|FG000|Overall Study|Withdrawal by Subject|2|||
130914801|NCT02436681|471323671|FG000|Overall Study|Death|2|||
130914802|NCT02030938|471323674|FG000|Overall Study|Lost to Follow-up|4|||
130914803|NCT02030938|471323674|FG000|Overall Study|Withdrawal by Subject|1|||
130914804|NCT02520661|471323676|FG000|Overall Study|Lost to Follow-up|7|||
130914805|NCT02520661|471323677|FG001|Overall Study|Lost to Follow-up|3|||
130914806|NCT02520661|471323676|FG000|Overall Study|Admitted from ED|49|||
130914807|NCT02520661|471323677|FG001|Overall Study|Admitted from ED|48|||
130914808|NCT02520661|471323676|FG000|Overall Study|ED greater than 24 hours|29|||
130914809|NCT02520661|471323677|FG001|Overall Study|ED greater than 24 hours|38|||
130914810|NCT02520661|471323676|FG000|Overall Study|other ineligibility|14|||
130914811|NCT02520661|471323677|FG001|Overall Study|other ineligibility|22|||
131118971|NCT02982239|472067224|FG001|Overall Study|Lost to Follow-up|2|||
130914812|NCT02520661|471323676|FG000|Overall Study|Withdrawal by Subject|7|||
130914813|NCT02520661|471323677|FG001|Overall Study|Withdrawal by Subject|16|||
130914814|NCT03954132|471323678|FG000|Overall Study|Adverse Event|2|||
130914815|NCT03954132|471323679|FG001|Overall Study|Adverse Event|0|||
130914816|NCT03954132|471323678|FG000|Overall Study|Patient's wish|5|||
130914817|NCT03954132|471323679|FG001|Overall Study|Patient's wish|0|||
130914818|NCT03954132|471323678|FG000|Overall Study|Lost to Follow-up|10|||
130914819|NCT03954132|471323679|FG001|Overall Study|Lost to Follow-up|0|||
130914820|NCT03954132|471323678|FG000|Overall Study|Screening failure|0|||
130914821|NCT03954132|471323679|FG001|Overall Study|Screening failure|1|||
130914822|NCT03954132|471323678|FG000|Overall Study|No registration after Visit 1|5|||
130914823|NCT03954132|471323679|FG001|Overall Study|No registration after Visit 1|2|||
130914824|NCT03954132|471323678|FG000|Overall Study|Other reason than listed|2|||
130914825|NCT03954132|471323679|FG001|Overall Study|Other reason than listed|2|||
130914826|NCT03954132|471323678|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
130914827|NCT03954132|471323679|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
130914828|NCT03954132|471323678|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
130914829|NCT03954132|471323679|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
130914830|NCT00072176|471323682|FG000|Overall Study|Withdrawal by Subject|1|||
130914831|NCT00072176|471323683|FG001|Overall Study|Withdrawal by Subject|0|||
130914832|NCT00072176|471323682|FG000|Overall Study|Protocol Violation|0|||
130914833|NCT00072176|471323683|FG001|Overall Study|Protocol Violation|1|||
130914834|NCT04502979|471323689|FG000|Overall Study|Lost to Follow-up|1|||
130914835|NCT04502979|471323690|FG001|Overall Study|Lost to Follow-up|3|||
130914836|NCT04502979|471323689|FG000|Overall Study|Withdrawal by Subject|2|||
130914837|NCT04502979|471323690|FG001|Overall Study|Withdrawal by Subject|1|||
130914838|NCT02887859|471323700|FG000|Overall Study|Ongoing|6|||
130914839|NCT02887859|471323700|FG000|Overall Study|Adverse Event|7|||
130914840|NCT02887859|471323700|FG000|Overall Study|Death|1|||
130914841|NCT02887859|471323700|FG000|Overall Study|Physician Decision|1|||
130914842|NCT00697073|471325276|FG000|Overall Study|Withdrawal by Subject|2|||
130914843|NCT00697073|471325276|FG000|Overall Study|Pregnancy|1|||
130914844|NCT00697073|471325276|FG000|Overall Study|non compliance and other|6|||
130914845|NCT01858376|471325277|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
130914846|NCT01886716|471325282|FG000|Week 1|Lost to Follow-up|0|||
130914847|NCT01886716|471325283|FG001|Week 1|Lost to Follow-up|0|||
130914848|NCT01886716|471325284|FG002|Week 1|Lost to Follow-up|2|||
130914849|NCT01886716|471325285|FG003|Week 1|Lost to Follow-up|2|||
130914850|NCT01886716|471325282|FG000|Week 2|Lost to Follow-up|3|||
130914851|NCT01886716|471325283|FG001|Week 2|Lost to Follow-up|2|||
130914852|NCT01886716|471325284|FG002|Week 2|Lost to Follow-up|1|||
130914853|NCT01886716|471325285|FG003|Week 2|Lost to Follow-up|3|||
130914854|NCT01886716|471325282|FG000|Week 3|Lost to Follow-up|1|||
130914855|NCT01886716|471325283|FG001|Week 3|Lost to Follow-up|1|||
130914856|NCT01886716|471325284|FG002|Week 3|Lost to Follow-up|0|||
131033060|NCT03675282|471755304|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
131033061|NCT03675282|471755299|FG000|Overall Study|Physician Decision|1|||
131033062|NCT03675282|471755300|FG001|Overall Study|Physician Decision|0|||
131033063|NCT03675282|471755301|FG002|Overall Study|Physician Decision|0|||
131033064|NCT03675282|471755302|FG003|Overall Study|Physician Decision|0|||
131033065|NCT03675282|471755303|FG004|Overall Study|Physician Decision|0|||
131033066|NCT03675282|471755304|FG005|Overall Study|Physician Decision|0|||
131033067|NCT05875142|471755305|FG000|Overall Study|Lost to Follow-up|0|||
131033068|NCT05875142|471755306|FG001|Overall Study|Lost to Follow-up|1|||
131033069|NCT05875142|471755307|FG002|Overall Study|Lost to Follow-up|1|||
131033070|NCT03232138|471755309|FG000|Overall Study|Physician Decision|1|||
131033071|NCT03232138|471755310|FG001|Overall Study|Physician Decision|0|||
131033072|NCT03232138|471755309|FG000|Overall Study|Adverse Event|2|||
131033073|NCT03232138|471755310|FG001|Overall Study|Adverse Event|0|||
131033074|NCT03232138|471755309|FG000|Overall Study|Withdrawal by Subject|1|||
131033075|NCT03232138|471755310|FG001|Overall Study|Withdrawal by Subject|2|||
131033076|NCT05076708|471755312|FG000|Overall Study|Withdrawal by Subject|4|||
131033077|NCT05076708|471755312|FG000|Overall Study|Lost to study during switch phase|8|||
131033078|NCT03269136|471755315|FG000|Part 1: Dose Escalation|Other|0|||
131033079|NCT03269136|471755316|FG001|Part 1: Dose Escalation|Other|0|||
131033080|NCT03269136|471755317|FG002|Part 1: Dose Escalation|Other|0|||
131033081|NCT03269136|471755318|FG003|Part 1: Dose Escalation|Other|0|||
131033082|NCT03269136|471755319|FG004|Part 1: Dose Escalation|Other|0|||
130914857|NCT01886716|471325285|FG003|Week 3|Lost to Follow-up|1|||
130914858|NCT03894046|471325286|FG000|Overall Study|Protocol Violation|1|||
130914859|NCT03894046|471325287|FG001|Overall Study|Protocol Violation|0|||
130914860|NCT03894046|471325288|FG002|Overall Study|Protocol Violation|0|||
130914861|NCT03894046|471325286|FG000|Overall Study|Adverse Event|0|||
131033083|NCT03269136|471755320|FG005|Part 1: Dose Escalation|Other|0|||
131033084|NCT03269136|471755321|FG006|Part 1: Dose Escalation|Other|0|||
131033085|NCT03269136|471755322|FG007|Part 1: Dose Escalation|Other|0|||
130914862|NCT03894046|471325287|FG001|Overall Study|Adverse Event|1|||
131033086|NCT03269136|471755323|FG008|Part 1: Dose Escalation|Other|0|||
131033087|NCT03269136|471755324|FG009|Part 1: Dose Escalation|Other|0|||
130914863|NCT03894046|471325288|FG002|Overall Study|Adverse Event|0|||
130914864|NCT03894046|471325286|FG000|Overall Study|Withdrawal by Subject|2|||
130914865|NCT03894046|471325287|FG001|Overall Study|Withdrawal by Subject|3|||
130914866|NCT03894046|471325288|FG002|Overall Study|Withdrawal by Subject|1|||
130914867|NCT03894046|471325286|FG000|Overall Study|Death|15|||
130914868|NCT03894046|471325287|FG001|Overall Study|Death|21|||
130914869|NCT03894046|471325288|FG002|Overall Study|Death|4|||
130914870|NCT03894046|471325286|FG000|Overall Study|No growth of ABC|2|||
130914871|NCT03894046|471325287|FG001|Overall Study|No growth of ABC|1|||
130914872|NCT03894046|471325288|FG002|Overall Study|No growth of ABC|0|||
130914873|NCT03894046|471325286|FG000|Overall Study|Physician Decision|1|||
130914874|NCT03894046|471325287|FG001|Overall Study|Physician Decision|1|||
130914875|NCT03894046|471325288|FG002|Overall Study|Physician Decision|1|||
130914876|NCT03894046|471325286|FG000|Overall Study|Prohibited concomitant medication|1|||
130914877|NCT03894046|471325287|FG001|Overall Study|Prohibited concomitant medication|0|||
130914878|NCT03894046|471325288|FG002|Overall Study|Prohibited concomitant medication|0|||
130914879|NCT03894046|471325286|FG000|Overall Study|Transferred to other arm/group|1|||
130914880|NCT03894046|471325287|FG001|Overall Study|Transferred to other arm/group|1|||
130914881|NCT03894046|471325288|FG002|Overall Study|Transferred to other arm/group|0|||
130914882|NCT04416633|471325292|FG000|Overall Study|Death|1|||
130914883|NCT04416633|471325292|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
130914884|NCT04416633|471325292|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
130914885|NCT04416633|471325292|FG000|Overall Study|Adverse Event|6|||
130914886|NCT04416633|471325292|FG000|Overall Study|Withdrawal by Subject|6|||
130914887|NCT04612790|471325293|FG000|DB Period (Up to 36 Weeks)|Death|1|||
130914888|NCT04612790|471325294|FG001|DB Period (Up to 36 Weeks)|Death|1|||
130914889|NCT04612790|471325295|FG002|DB Period (Up to 36 Weeks)|Death|0|||
130914890|NCT04612790|471325296|FG003|DB Period (Up to 36 Weeks)|Death|0|||
130914891|NCT04612790|471325293|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
130914892|NCT04612790|471325294|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
130914893|NCT04612790|471325295|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
130914894|NCT04612790|471325296|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
130914895|NCT04612790|471325293|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
130914896|NCT04612790|471325294|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
130914897|NCT04612790|471325295|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
130914898|NCT04612790|471325296|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
130914899|NCT04612790|471325293|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
130914900|NCT04612790|471325294|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
130914901|NCT04612790|471325295|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
130914902|NCT04612790|471325296|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
130914903|NCT04612790|471325293|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
130914904|NCT04612790|471325294|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
130914905|NCT04612790|471325295|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
130914906|NCT04612790|471325296|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
130914907|NCT04612790|471325293|FG000|DB Period (Up to 36 Weeks)|Other|1|||
130914908|NCT04612790|471325294|FG001|DB Period (Up to 36 Weeks)|Other|0|||
130914909|NCT04612790|471325295|FG002|DB Period (Up to 36 Weeks)|Other|0|||
130914910|NCT04612790|471325296|FG003|DB Period (Up to 36 Weeks)|Other|0|||
130914911|NCT04612790|471325293|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
130914912|NCT04612790|471325294|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
130914913|NCT04612790|471325295|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
130914914|NCT04612790|471325296|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
130914915|NCT04612790|471325293|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
130914916|NCT04612790|471325294|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
130914917|NCT04612790|471325295|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
130914918|NCT04612790|471325296|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
130914919|NCT04612790|471325293|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
130914920|NCT04612790|471325294|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
130914921|NCT04612790|471325295|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
130914922|NCT04612790|471325296|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
130914923|NCT04612790|471325293|FG000|OLE Period (Up to 1 Year)|Other|0|||
130914924|NCT04612790|471325294|FG001|OLE Period (Up to 1 Year)|Other|0|||
131033088|NCT03269136|471755325|FG010|Part 1: Dose Escalation|Other|1|||
131033089|NCT03269136|471755326|FG011|Part 1: Dose Escalation|Other|1|||
131033090|NCT03269136|471755327|FG012|Part 1: Dose Escalation|Other|1|||
131033091|NCT03269136|471755328|FG013|Part 1: Dose Escalation|Other|0|||
131033092|NCT03269136|471755329|FG014|Part 1: Dose Escalation|Other|3|||
131033093|NCT03269136|471755330|FG015|Part 1: Dose Escalation|Other|1|||
131033094|NCT03269136|471755331|FG016|Part 1: Dose Escalation|Other|1|||
130914925|NCT04612790|471325295|FG002|OLE Period (Up to 1 Year)|Other|0|||
130914926|NCT04612790|471325296|FG003|OLE Period (Up to 1 Year)|Other|1|||
130914927|NCT00785928|471325297|FG000|Treatment Phase|Adverse Event|1|||
131033095|NCT03269136|471755332|FG017|Part 1: Dose Escalation|Other|0|||
131033096|NCT03269136|471755315|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
130914928|NCT00785928|471325298|FG001|Treatment Phase|Adverse Event|1|||
130914929|NCT00785928|471325299|FG002|Treatment Phase|Adverse Event|2|||
130914930|NCT00785928|471325300|FG003|Treatment Phase|Adverse Event|0|||
130914931|NCT00785928|471325301|FG004|Treatment Phase|Adverse Event|0|||
130914932|NCT00785928|471325302|FG005|Treatment Phase|Adverse Event|0|||
130914933|NCT00785928|471325303|FG006|Treatment Phase|Adverse Event|2|||
130914934|NCT00785928|471325297|FG000|Treatment Phase|Inadequate Response|0|||
130914935|NCT00785928|471325298|FG001|Treatment Phase|Inadequate Response|1|||
130914936|NCT00785928|471325299|FG002|Treatment Phase|Inadequate Response|0|||
130914937|NCT00785928|471325300|FG003|Treatment Phase|Inadequate Response|0|||
130914938|NCT00785928|471325301|FG004|Treatment Phase|Inadequate Response|0|||
130914939|NCT00785928|471325302|FG005|Treatment Phase|Inadequate Response|0|||
130914940|NCT00785928|471325303|FG006|Treatment Phase|Inadequate Response|0|||
130914941|NCT00785928|471325297|FG000|Treatment Phase|Lack of Efficacy|0|||
130914942|NCT00785928|471325298|FG001|Treatment Phase|Lack of Efficacy|1|||
130914943|NCT00785928|471325299|FG002|Treatment Phase|Lack of Efficacy|1|||
130914944|NCT00785928|471325300|FG003|Treatment Phase|Lack of Efficacy|0|||
130914945|NCT00785928|471325301|FG004|Treatment Phase|Lack of Efficacy|0|||
130914946|NCT00785928|471325302|FG005|Treatment Phase|Lack of Efficacy|0|||
130914947|NCT00785928|471325303|FG006|Treatment Phase|Lack of Efficacy|0|||
130914948|NCT00785928|471325297|FG000|Treatment Phase|Physician Decision|0|||
130914949|NCT00785928|471325298|FG001|Treatment Phase|Physician Decision|0|||
130914950|NCT00785928|471325299|FG002|Treatment Phase|Physician Decision|0|||
130914951|NCT00785928|471325300|FG003|Treatment Phase|Physician Decision|0|||
130914952|NCT00785928|471325301|FG004|Treatment Phase|Physician Decision|1|||
130914953|NCT00785928|471325302|FG005|Treatment Phase|Physician Decision|0|||
130914954|NCT00785928|471325303|FG006|Treatment Phase|Physician Decision|0|||
130914955|NCT00785928|471325297|FG000|Treatment Phase|Sponsor Decision|1|||
130914956|NCT00785928|471325298|FG001|Treatment Phase|Sponsor Decision|0|||
130914957|NCT00785928|471325299|FG002|Treatment Phase|Sponsor Decision|0|||
130914958|NCT00785928|471325300|FG003|Treatment Phase|Sponsor Decision|0|||
130914959|NCT00785928|471325301|FG004|Treatment Phase|Sponsor Decision|0|||
130914960|NCT00785928|471325302|FG005|Treatment Phase|Sponsor Decision|0|||
130914961|NCT00785928|471325303|FG006|Treatment Phase|Sponsor Decision|1|||
130914962|NCT00785928|471325297|FG000|Treatment Phase|Withdrawal by Subject|1|||
130914963|NCT00785928|471325298|FG001|Treatment Phase|Withdrawal by Subject|2|||
130914964|NCT00785928|471325299|FG002|Treatment Phase|Withdrawal by Subject|0|||
130914965|NCT00785928|471325300|FG003|Treatment Phase|Withdrawal by Subject|0|||
130914966|NCT00785928|471325301|FG004|Treatment Phase|Withdrawal by Subject|1|||
130914967|NCT00785928|471325302|FG005|Treatment Phase|Withdrawal by Subject|0|||
130914968|NCT00785928|471325303|FG006|Treatment Phase|Withdrawal by Subject|0|||
130914969|NCT05021081|471325307|FG000|Phase 2|Subject enrolled in error|1|||
130914970|NCT05021081|471325308|FG001|Phase 2|Subject enrolled in error|1|||
130914971|NCT05021081|471325309|FG002|Phase 2|Subject enrolled in error|0|||
130914972|NCT00369122|471325310|FG000|Overall Study|Ineligible|10|||
130914973|NCT00369122|471325310|FG000|Overall Study|No protocol treatment|1|||
130914974|NCT00408629|471325311|FG000|Overall Study|Adverse Event|13|||
130914975|NCT00408629|471325312|FG001|Overall Study|Adverse Event|27|||
130914976|NCT00408629|471325311|FG000|Overall Study|Withdrawal by Subject|8|||
130914977|NCT00408629|471325312|FG001|Overall Study|Withdrawal by Subject|4|||
130914978|NCT00408629|471325311|FG000|Overall Study|Lost to Follow-up|1|||
130914979|NCT00408629|471325312|FG001|Overall Study|Lost to Follow-up|1|||
130914980|NCT00408629|471325311|FG000|Overall Study|Lack of Efficacy|63|||
130914981|NCT00408629|471325312|FG001|Overall Study|Lack of Efficacy|73|||
130914982|NCT00408629|471325311|FG000|Overall Study|Protocol Violation|1|||
130914983|NCT00408629|471325312|FG001|Overall Study|Protocol Violation|5|||
130914984|NCT00408629|471325311|FG000|Overall Study|Miscellaneous|11|||
130914985|NCT00408629|471325312|FG001|Overall Study|Miscellaneous|15|||
130914986|NCT00191906|471325313|FG000|Study Period II|Adverse Event|0|||
130914987|NCT00191906|471325314|FG001|Study Period II|Adverse Event|1|||
130914988|NCT00191906|471325315|FG002|Study Period II|Adverse Event|0|||
130914989|NCT00191906|471325316|FG003|Study Period II|Adverse Event|0|||
130914990|NCT00191906|471325313|FG000|Study Period II|Withdrawal by Subject|0|||
130914991|NCT00191906|471325314|FG001|Study Period II|Withdrawal by Subject|3|||
131118972|NCT02767323|472067231|FG000|Overall Study|Withdrawal by Subject|17|||
130914992|NCT00191906|471325315|FG002|Study Period II|Withdrawal by Subject|0|||
130914993|NCT00191906|471325316|FG003|Study Period II|Withdrawal by Subject|0|||
130914994|NCT00191906|471325313|FG000|Study Period II|Parent/Caregiver Decision|0|||
130914995|NCT00191906|471325314|FG001|Study Period II|Parent/Caregiver Decision|1|||
130914996|NCT00191906|471325315|FG002|Study Period II|Parent/Caregiver Decision|0|||
130914997|NCT00191906|471325316|FG003|Study Period II|Parent/Caregiver Decision|0|||
130914998|NCT00191906|471325313|FG000|Study Period II|Entry Criteria Exclusion|0|||
130914999|NCT00191906|471325314|FG001|Study Period II|Entry Criteria Exclusion|0|||
130915000|NCT00191906|471325315|FG002|Study Period II|Entry Criteria Exclusion|1|||
130915001|NCT00191906|471325316|FG003|Study Period II|Entry Criteria Exclusion|0|||
130915002|NCT00191906|471325313|FG000|Study Period III|Adverse Event|1|||
130915003|NCT00191906|471325314|FG001|Study Period III|Adverse Event|0|||
130915004|NCT00191906|471325315|FG002|Study Period III|Adverse Event|0|||
130915005|NCT00191906|471325316|FG003|Study Period III|Adverse Event|0|||
130915006|NCT00191906|471325313|FG000|Study Period III|Lost to Follow-up|0|||
130915007|NCT00191906|471325314|FG001|Study Period III|Lost to Follow-up|1|||
130915008|NCT00191906|471325315|FG002|Study Period III|Lost to Follow-up|0|||
130915009|NCT00191906|471325316|FG003|Study Period III|Lost to Follow-up|0|||
130915010|NCT00191906|471325313|FG000|Study Period III|Parent/Caregiver Decision|1|||
130915011|NCT00191906|471325314|FG001|Study Period III|Parent/Caregiver Decision|0|||
130915012|NCT00191906|471325315|FG002|Study Period III|Parent/Caregiver Decision|0|||
130915013|NCT00191906|471325316|FG003|Study Period III|Parent/Caregiver Decision|0|||
130915014|NCT00191906|471325313|FG000|Study Period III|Lack of Efficacy|3|||
130915015|NCT00191906|471325314|FG001|Study Period III|Lack of Efficacy|3|||
130915016|NCT00191906|471325315|FG002|Study Period III|Lack of Efficacy|0|||
130915017|NCT00191906|471325316|FG003|Study Period III|Lack of Efficacy|0|||
130915018|NCT00573937|471325317|FG000|Overall Study|Study Terminated|0|||
130915019|NCT00573937|471325318|FG001|Overall Study|Study Terminated|1|||
130915020|NCT00333801|471325319|FG000|Overall Study|Moved to another state|5|||
130915021|NCT00333801|471325320|FG001|Overall Study|Moved to another state|3|||
130915022|NCT00333801|471325319|FG000|Overall Study|Lost to Follow-up|2|||
130915023|NCT00333801|471325320|FG001|Overall Study|Lost to Follow-up|0|||
130915024|NCT00333801|471325319|FG000|Overall Study|Incarcerated|1|||
130915025|NCT00333801|471325320|FG001|Overall Study|Incarcerated|2|||
130915026|NCT00333801|471325319|FG000|Overall Study|Withdrawal by Subject|0|||
130915027|NCT00333801|471325320|FG001|Overall Study|Withdrawal by Subject|1|||
130915028|NCT03387683|471325323|FG000|Overall Study|In receipt of disallowed medication|1|||
130915029|NCT03387683|471325324|FG001|Overall Study|In receipt of disallowed medication|0|||
130915030|NCT03387683|471325323|FG000|Overall Study|Did not receive treatment|1|||
130915031|NCT03387683|471325324|FG001|Overall Study|Did not receive treatment|0|||
130915032|NCT01954342|471325325|FG000|Overall Study|Missing data from 13-16week study visit|0|||
130915033|NCT01954342|471325326|FG001|Overall Study|Missing data from 13-16week study visit|0|||
130915034|NCT01954342|471325327|FG002|Overall Study|Missing data from 13-16week study visit|0|||
130915035|NCT01954342|471325328|FG003|Overall Study|Missing data from 13-16week study visit|1|||
130915036|NCT01954342|471325325|FG000|Overall Study|Miscarriage|0|||
130915037|NCT01954342|471325326|FG001|Overall Study|Miscarriage|0|||
130915038|NCT01954342|471325327|FG002|Overall Study|Miscarriage|0|||
130915039|NCT01954342|471325328|FG003|Overall Study|Miscarriage|3|||
130915040|NCT01954342|471325325|FG000|Overall Study|Lost to Follow-up|0|||
130915041|NCT01954342|471325326|FG001|Overall Study|Lost to Follow-up|0|||
130915042|NCT01954342|471325327|FG002|Overall Study|Lost to Follow-up|0|||
130915043|NCT01954342|471325328|FG003|Overall Study|Lost to Follow-up|5|||
130915044|NCT01954342|471325325|FG000|Overall Study|Preterm delivery|0|||
130915045|NCT01954342|471325326|FG001|Overall Study|Preterm delivery|0|||
130915046|NCT01954342|471325327|FG002|Overall Study|Preterm delivery|0|||
130915047|NCT01954342|471325328|FG003|Overall Study|Preterm delivery|3|||
130915048|NCT01954342|471325325|FG000|Overall Study|Pre-eclampsia|0|||
130915049|NCT01954342|471325326|FG001|Overall Study|Pre-eclampsia|0|||
130915050|NCT01954342|471325327|FG002|Overall Study|Pre-eclampsia|0|||
130915051|NCT01954342|471325328|FG003|Overall Study|Pre-eclampsia|4|||
131033097|NCT03269136|471755316|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
131033098|NCT03269136|471755317|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
130699174|NCT01547728|470522815|FG000|Overall Study|Drug not ready for subject|1|||
130699175|NCT01547728|470522815|FG000|Overall Study|Screen failure|39|||
130699176|NCT03828539|470522816|FG000|Overall Study|Adverse Event|3|||
130699177|NCT03828539|470522817|FG001|Overall Study|Adverse Event|12|||
130699178|NCT03828539|470522816|FG000|Overall Study|Patient's/guardian's decision|3|||
130699179|NCT03828539|470522817|FG001|Overall Study|Patient's/guardian's decision|5|||
130699180|NCT03828539|470522816|FG000|Overall Study|Lost to Follow-up|4|||
130699181|NCT03828539|470522817|FG001|Overall Study|Lost to Follow-up|2|||
130699182|NCT03828539|470522816|FG000|Overall Study|Protocol Violation|3|||
130699183|NCT03828539|470522817|FG001|Overall Study|Protocol Violation|2|||
130699184|NCT03828539|470522816|FG000|Overall Study|Withdrawal of informed consent|2|||
130699185|NCT03828539|470522817|FG001|Overall Study|Withdrawal of informed consent|1|||
130699186|NCT03828539|470522816|FG000|Overall Study|New therapy for study indication|1|||
130699187|NCT03828539|470522817|FG001|Overall Study|New therapy for study indication|0|||
130915052|NCT01954342|471325325|FG000|Overall Study|Unreliable Data|0|||
130915053|NCT01954342|471325326|FG001|Overall Study|Unreliable Data|0|||
130915054|NCT01954342|471325327|FG002|Overall Study|Unreliable Data|0|||
130915055|NCT01954342|471325328|FG003|Overall Study|Unreliable Data|2|||
130915056|NCT01646073|471325329|FG000|Period A (12 Weeks)|Adverse Event|0|||
130915057|NCT01646073|471325330|FG001|Period A (12 Weeks)|Adverse Event|2|||
130915058|NCT01646073|471325329|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
130915059|NCT01646073|471325330|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
130915060|NCT01646073|471325329|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
130915061|NCT01646073|471325330|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
130699188|NCT01341405|470522818|FG000|Overall Study|Adverse Event|0|||
130699189|NCT01341405|470522819|FG001|Overall Study|Adverse Event|1|||
130915062|NCT01646073|471325329|FG000|Period A (12 Weeks)|Protocol Violation|0|||
130915063|NCT01646073|471325330|FG001|Period A (12 Weeks)|Protocol Violation|1|||
130915064|NCT01646073|471325329|FG000|Period A (12 Weeks)|Other|0|||
130915065|NCT01646073|471325330|FG001|Period A (12 Weeks)|Other|1|||
130915066|NCT01646073|471325329|FG000|Period B (12 Weeks)|Adverse Event|0|||
130915067|NCT01646073|471325330|FG001|Period B (12 Weeks)|Adverse Event|7|||
130915068|NCT01646073|471325329|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
130915069|NCT01646073|471325330|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
130915070|NCT01646073|471325329|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
130915071|NCT01646073|471325330|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
130769166|NCT00548249|470780542|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
130769167|NCT00548249|470780543|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
130769168|NCT00548249|470780544|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
130769169|NCT00548249|470780545|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
130769170|NCT00548249|470780546|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
130769171|NCT00548249|470780542|FG000|Overall Study|Protocol Violation|1|||
130915072|NCT01999114|471325331|FG000|Overall Study|Adverse Event|8|||
130915073|NCT01999114|471325332|FG001|Overall Study|Adverse Event|7|||
130915074|NCT01999114|471325333|FG002|Overall Study|Adverse Event|2|||
130699190|NCT01341405|470522820|FG002|Overall Study|Adverse Event|1|||
130699191|NCT01341405|470522818|FG000|Overall Study|Withdrawal by Subject|3|||
130699192|NCT01341405|470522819|FG001|Overall Study|Withdrawal by Subject|2|||
130699193|NCT01341405|470522820|FG002|Overall Study|Withdrawal by Subject|1|||
130699194|NCT00057941|470522821|FG000|Overall Study|Death|1|||
130699195|NCT00057941|470522822|FG001|Overall Study|Death|2|||
130699196|NCT00057941|470522821|FG000|Overall Study|Adverse Event|7|||
130699197|NCT00057941|470522822|FG001|Overall Study|Adverse Event|9|||
130699198|NCT00057941|470522821|FG000|Overall Study|Lack of Efficacy|54|||
130699199|NCT00057941|470522822|FG001|Overall Study|Lack of Efficacy|53|||
130699200|NCT00057941|470522821|FG000|Overall Study|Withdrawal by Subject|6|||
130699201|NCT00057941|470522822|FG001|Overall Study|Withdrawal by Subject|1|||
130699202|NCT00057941|470522821|FG000|Overall Study|still on treatment|3|||
130699203|NCT00057941|470522822|FG001|Overall Study|still on treatment|1|||
130699204|NCT00057941|470522821|FG000|Overall Study|insurance, symptomatic deterioration|1|||
130699205|NCT00057941|470522822|FG001|Overall Study|insurance, symptomatic deterioration|3|||
130699206|NCT00057941|470522821|FG000|Overall Study|Ineligible|2|||
130699207|NCT00057941|470522822|FG001|Overall Study|Ineligible|5|||
130699208|NCT04142658|470522824|FG000|Overall Study|Death|2|||
130699209|NCT04142658|470522825|FG001|Overall Study|Death|1|||
130699210|NCT04142658|470522824|FG000|Overall Study|Lost to Follow-up|4|||
130699211|NCT04142658|470522825|FG001|Overall Study|Lost to Follow-up|13|||
130699212|NCT04142658|470522824|FG000|Overall Study|Withdrawal by Subject|9|||
130699213|NCT04142658|470522825|FG001|Overall Study|Withdrawal by Subject|16|||
130699214|NCT00830167|470522830|FG000|Overall Study|Lack of Efficacy|26|||
130699215|NCT00830167|470522831|FG001|Overall Study|Lack of Efficacy|10|||
130699216|NCT00830167|470522830|FG000|Overall Study|Adverse Event|8|||
130699217|NCT00830167|470522831|FG001|Overall Study|Adverse Event|24|||
130699218|NCT00830167|470522830|FG000|Overall Study|Not meeting entrance criteria|2|||
130699219|NCT00830167|470522831|FG001|Overall Study|Not meeting entrance criteria|5|||
130699220|NCT00830167|470522830|FG000|Overall Study|Withdrawal by Subject|2|||
130699221|NCT00830167|470522831|FG001|Overall Study|Withdrawal by Subject|0|||
130699222|NCT00830167|470522830|FG000|Overall Study|Lost to Follow-up|0|||
130699223|NCT00830167|470522831|FG001|Overall Study|Lost to Follow-up|1|||
130699224|NCT00830167|470522830|FG000|Overall Study|Protocol Violation|0|||
130699225|NCT00830167|470522831|FG001|Overall Study|Protocol Violation|1|||
130699226|NCT00830167|470522830|FG000|Overall Study|Other|2|||
130699227|NCT00830167|470522831|FG001|Overall Study|Other|2|||
130699228|NCT02224053|470522832|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
130699229|NCT02224053|470522832|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
130699230|NCT02224053|470522832|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
130699231|NCT02224053|470522832|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
130699232|NCT02224053|470522832|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
130699233|NCT01898598|470522836|FG000|Overall Study|Adverse Event|1|||
130699234|NCT01898598|470522837|FG001|Overall Study|Adverse Event|0|||
130699235|NCT01898598|470522836|FG000|Overall Study|Withdrawal by Subject|3|||
130699236|NCT01898598|470522837|FG001|Overall Study|Withdrawal by Subject|0|||
130699237|NCT01898598|470522836|FG000|Overall Study|Lost to Follow-up|0|||
130915075|NCT01999114|471325334|FG003|Overall Study|Adverse Event|2|||
130915076|NCT01999114|471325335|FG004|Overall Study|Adverse Event|1|||
130699238|NCT01898598|470522837|FG001|Overall Study|Lost to Follow-up|1|||
130699239|NCT01898598|470522836|FG000|Overall Study|Other|0|||
130699240|NCT01898598|470522837|FG001|Overall Study|Other|1|||
130699241|NCT04194008|470522838|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
130699242|NCT04194008|470522838|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
130769172|NCT00548249|470780543|FG001|Overall Study|Protocol Violation|1|||
130915077|NCT01999114|471325331|FG000|Overall Study|Withdrawal by Subject|0|||
130699243|NCT04194008|470522838|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
130769173|NCT00548249|470780544|FG002|Overall Study|Protocol Violation|4|||
130915078|NCT01999114|471325332|FG001|Overall Study|Withdrawal by Subject|0|||
130915079|NCT01999114|471325333|FG002|Overall Study|Withdrawal by Subject|1|||
130915080|NCT01999114|471325334|FG003|Overall Study|Withdrawal by Subject|0|||
130915081|NCT01999114|471325335|FG004|Overall Study|Withdrawal by Subject|1|||
130915082|NCT01999114|471325331|FG000|Overall Study|Lost to Follow-up|0|||
130915083|NCT01999114|471325332|FG001|Overall Study|Lost to Follow-up|0|||
130915084|NCT01999114|471325333|FG002|Overall Study|Lost to Follow-up|1|||
130915085|NCT01999114|471325334|FG003|Overall Study|Lost to Follow-up|0|||
130915086|NCT01999114|471325335|FG004|Overall Study|Lost to Follow-up|0|||
130915087|NCT01999114|471325331|FG000|Overall Study|Administrative|0|||
130915088|NCT01999114|471325332|FG001|Overall Study|Administrative|0|||
130915089|NCT01999114|471325333|FG002|Overall Study|Administrative|1|||
130915090|NCT01999114|471325334|FG003|Overall Study|Administrative|1|||
130915091|NCT01999114|471325335|FG004|Overall Study|Administrative|2|||
130915092|NCT01497275|471325338|FG000|Overall Study|Death|1|||
130915093|NCT01497275|471325338|FG000|Overall Study|Adverse Event|1|||
130915094|NCT01950169|471325339|FG000|Overall Study|Withdrawal by Subject|2|||
130915095|NCT01950169|471325340|FG001|Overall Study|Withdrawal by Subject|8|||
130915096|NCT01950169|471325341|FG002|Overall Study|Withdrawal by Subject|1|||
130915097|NCT01950169|471325339|FG000|Overall Study|Death|1|||
130915098|NCT01950169|471325340|FG001|Overall Study|Death|0|||
130915099|NCT01950169|471325341|FG002|Overall Study|Death|0|||
130915100|NCT02410551|471325344|FG000|Overall Study|Adverse Event|1|||
130915101|NCT02410551|471325344|FG000|Overall Study|Withdrawal by Subject|1|||
130915102|NCT02410551|471325344|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
130915103|NCT01739309|471325345|FG000|Overall Study|Adverse Event|1|||
130915104|NCT01739309|471325345|FG000|Overall Study|Withdrawal by Subject|1|||
130915105|NCT01495975|471325346|FG000|Overall Study|Lost to Follow-up|1|||
130915106|NCT01495975|471325347|FG001|Overall Study|Lost to Follow-up|0|||
130915107|NCT01254292|471325354|FG000|Comparative Phase|Adverse Event|25|||
130915108|NCT01254292|471325355|FG001|Comparative Phase|Adverse Event|25|||
130915109|NCT01254292|471325354|FG000|Comparative Phase|Lost to Follow-up|3|||
130915110|NCT01254292|471325355|FG001|Comparative Phase|Lost to Follow-up|21|||
130915111|NCT01254292|471325354|FG000|Comparative Phase|Pregnancy|2|||
130915112|NCT01254292|471325355|FG001|Comparative Phase|Pregnancy|6|||
130915113|NCT01254292|471325354|FG000|Comparative Phase|Withdrawal by Subject|20|||
130915114|NCT01254292|471325355|FG001|Comparative Phase|Withdrawal by Subject|21|||
130915115|NCT01254292|471325354|FG000|Comparative Phase|Protocol Violation|1|||
130915116|NCT01254292|471325355|FG001|Comparative Phase|Protocol Violation|2|||
130915117|NCT01254292|471325354|FG000|Comparative Phase|Wish for pregnancy|4|||
130915118|NCT01254292|471325355|FG001|Comparative Phase|Wish for pregnancy|6|||
130915119|NCT01254292|471325354|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
130915120|NCT01254292|471325355|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
130915121|NCT01254292|471325354|FG000|LCS12 Extension Phase|Adverse Event|9|||
130915122|NCT01254292|471325355|FG001|LCS12 Extension Phase|Adverse Event|0|||
130915123|NCT01254292|471325354|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
130915124|NCT01254292|471325355|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
130915125|NCT01254292|471325354|FG000|LCS12 Extension Phase|Other unknown|4|||
130915126|NCT01254292|471325355|FG001|LCS12 Extension Phase|Other unknown|0|||
130915127|NCT01254292|471325354|FG000|LCS12 Extension Phase|Pregnancy|2|||
130915128|NCT01254292|471325355|FG001|LCS12 Extension Phase|Pregnancy|0|||
130915129|NCT01254292|471325354|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
130915130|NCT01254292|471325355|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
130915131|NCT02083081|471325356|FG000|Overall Study|Lost to Follow-up|31|||
130699244|NCT04194008|470522838|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
130699245|NCT04194008|470522838|FG000|Treatment Phase With Nerivio|Missing data|4|||
130915132|NCT02083081|471325357|FG001|Overall Study|Lost to Follow-up|9|||
130915133|NCT03799211|471325358|FG000|Overall Study|Lost to Follow-up|2|||
130915134|NCT03799211|471325359|FG001|Overall Study|Lost to Follow-up|13|||
130915135|NCT03799211|471325358|FG000|Overall Study|Withdrawal by Subject|2|||
130915136|NCT03799211|471325359|FG001|Overall Study|Withdrawal by Subject|0|||
130915137|NCT00764491|471325360|FG000|Overall Study|Lost to Follow-up|35|||
130915138|NCT00764491|471325361|FG001|Overall Study|Lost to Follow-up|17|||
130915139|NCT03139279|471325364|FG000|Overall Study|Physician Decision|2|||
130915140|NCT03139279|471325365|FG001|Overall Study|Physician Decision|0|||
130915141|NCT03139279|471325364|FG000|Overall Study|Protocol Violation|5|||
130699246|NCT04194008|470522838|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
130699247|NCT00860262|470522839|FG000|Overall Study|Adverse Event|9|||
130699248|NCT00860262|470522840|FG001|Overall Study|Adverse Event|6|||
130915142|NCT03139279|471325365|FG001|Overall Study|Protocol Violation|4|||
130915143|NCT03139279|471325364|FG000|Overall Study|Withdrawal by Subject|0|||
130915144|NCT03139279|471325365|FG001|Overall Study|Withdrawal by Subject|2|||
130915145|NCT01336569|471325366|FG000|Overall Study|Lost to Follow-up|4|||
130915146|NCT02337738|471325367|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
130915147|NCT02337738|471325368|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
130915148|NCT02337738|471325369|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
130915149|NCT02337738|471325367|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
130699249|NCT00860262|470522841|FG002|Overall Study|Adverse Event|7|||
130699250|NCT00860262|470522839|FG000|Overall Study|Protocol Violation|0|||
130699251|NCT00860262|470522840|FG001|Overall Study|Protocol Violation|1|||
130699252|NCT00860262|470522841|FG002|Overall Study|Protocol Violation|0|||
130699253|NCT00860262|470522839|FG000|Overall Study|Lost to Follow-up|2|||
130699254|NCT00860262|470522840|FG001|Overall Study|Lost to Follow-up|0|||
130915150|NCT02337738|471325368|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
130915151|NCT02337738|471325369|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
130915152|NCT02337738|471325367|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
130915153|NCT02337738|471325368|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
130915154|NCT02337738|471325369|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
130915155|NCT02337738|471325367|FG000|Overall Study|Voluntary Withdrawal|10|||
130915156|NCT02337738|471325368|FG001|Overall Study|Voluntary Withdrawal|5|||
130915157|NCT02337738|471325369|FG002|Overall Study|Voluntary Withdrawal|2|||
130915158|NCT02337738|471325367|FG000|Overall Study|Lack of Efficacy|2|||
130915159|NCT02337738|471325368|FG001|Overall Study|Lack of Efficacy|4|||
130915160|NCT02337738|471325369|FG002|Overall Study|Lack of Efficacy|0|||
130915161|NCT02337738|471325367|FG000|Overall Study|Investigator's Judgment|1|||
130915162|NCT02337738|471325368|FG001|Overall Study|Investigator's Judgment|1|||
130915163|NCT02337738|471325369|FG002|Overall Study|Investigator's Judgment|3|||
130915164|NCT00406354|471325370|FG000|All Randomized Patients|Protocol Violation|0|||
130915165|NCT00406354|471325371|FG001|All Randomized Patients|Protocol Violation|0|||
130915166|NCT00406354|471325372|FG002|All Randomized Patients|Protocol Violation|1|||
130915167|NCT00406354|471325370|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
130915168|NCT00406354|471325371|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
130915169|NCT00406354|471325372|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
130915170|NCT00406354|471325370|FG000|All Randomized and Treated Patients|Adverse Event|6|||
130915171|NCT00406354|471325371|FG001|All Randomized and Treated Patients|Adverse Event|2|||
130915172|NCT00406354|471325372|FG002|All Randomized and Treated Patients|Adverse Event|1|||
130915173|NCT00406354|471325370|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
130915174|NCT00406354|471325371|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
130699255|NCT00860262|470522841|FG002|Overall Study|Lost to Follow-up|1|||
130699256|NCT00860262|470522839|FG000|Overall Study|Withdrawal by Subject|4|||
130699257|NCT00860262|470522840|FG001|Overall Study|Withdrawal by Subject|8|||
130769174|NCT00548249|470780545|FG003|Overall Study|Protocol Violation|0|||
131033099|NCT03269136|471755318|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
131033100|NCT03269136|471755319|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
131033101|NCT03269136|471755320|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
130915175|NCT00406354|471325372|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
130915176|NCT00406354|471325370|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
130915177|NCT00406354|471325371|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
130915178|NCT00406354|471325372|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
130915179|NCT00406354|471325370|FG000|All Randomized and Treated Patients|Physician Decision|0|||
130915180|NCT00406354|471325371|FG001|All Randomized and Treated Patients|Physician Decision|0|||
130915181|NCT00406354|471325372|FG002|All Randomized and Treated Patients|Physician Decision|1|||
131033102|NCT03269136|471755321|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
131033103|NCT03269136|471755322|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
130769175|NCT00548249|470780546|FG004|Overall Study|Protocol Violation|3|||
130915182|NCT00747461|471325373|FG000|Overall Study|study terminated by sponsor|5|||
130915183|NCT00299182|471325388|FG000|Overall Study|Withdrawal by Subject|0|||
130915184|NCT00299182|471325389|FG001|Overall Study|Withdrawal by Subject|0|||
130915185|NCT00299182|471325390|FG002|Overall Study|Withdrawal by Subject|1|||
130915186|NCT00299182|471325391|FG003|Overall Study|Withdrawal by Subject|0|||
130915187|NCT00299182|471325392|FG004|Overall Study|Withdrawal by Subject|1|||
130915188|NCT00299182|471325393|FG005|Overall Study|Withdrawal by Subject|2|||
130915189|NCT00299182|471325394|FG006|Overall Study|Withdrawal by Subject|0|||
130915190|NCT00299182|471325388|FG000|Overall Study|Chemotherapy Changed|0|||
130915191|NCT00299182|471325389|FG001|Overall Study|Chemotherapy Changed|0|||
130915192|NCT00299182|471325390|FG002|Overall Study|Chemotherapy Changed|1|||
130915193|NCT00299182|471325391|FG003|Overall Study|Chemotherapy Changed|0|||
130915194|NCT00299182|471325392|FG004|Overall Study|Chemotherapy Changed|1|||
130915195|NCT00299182|471325393|FG005|Overall Study|Chemotherapy Changed|0|||
130915196|NCT00299182|471325394|FG006|Overall Study|Chemotherapy Changed|1|||
130915197|NCT00299182|471325388|FG000|Overall Study|Adverse Event|0|||
131033104|NCT03269136|471755323|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
130915198|NCT00299182|471325389|FG001|Overall Study|Adverse Event|0|||
130915199|NCT00299182|471325390|FG002|Overall Study|Adverse Event|0|||
130915200|NCT00299182|471325391|FG003|Overall Study|Adverse Event|0|||
131033105|NCT03269136|471755324|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
130699258|NCT00860262|470522841|FG002|Overall Study|Withdrawal by Subject|6|||
130699259|NCT00860262|470522839|FG000|Overall Study|Lack of Efficacy|0|||
130769176|NCT00548249|470780542|FG000|Overall Study|Miscellaneous|2|||
130915201|NCT00299182|471325392|FG004|Overall Study|Adverse Event|0|||
131033106|NCT03269136|471755325|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
130699260|NCT00860262|470522840|FG001|Overall Study|Lack of Efficacy|4|||
130915202|NCT00299182|471325393|FG005|Overall Study|Adverse Event|1|||
130915203|NCT00299182|471325394|FG006|Overall Study|Adverse Event|0|||
130915204|NCT00299182|471325388|FG000|Overall Study|Not Eligible|0|||
130915205|NCT00299182|471325389|FG001|Overall Study|Not Eligible|0|||
130915206|NCT00299182|471325390|FG002|Overall Study|Not Eligible|0|||
130915207|NCT00299182|471325391|FG003|Overall Study|Not Eligible|0|||
130915208|NCT00299182|471325392|FG004|Overall Study|Not Eligible|1|||
130915209|NCT00299182|471325393|FG005|Overall Study|Not Eligible|0|||
130915210|NCT00299182|471325394|FG006|Overall Study|Not Eligible|0|||
130915211|NCT00932737|471325401|FG000|Overall Study|Not treated in second episode|1|||
130915212|NCT00932737|471325402|FG001|Overall Study|Not treated in second episode|0|||
130915213|NCT00932737|471325401|FG000|Overall Study|Adverse Event|0|||
130915214|NCT00932737|471325402|FG001|Overall Study|Adverse Event|1|||
130699261|NCT00860262|470522841|FG002|Overall Study|Lack of Efficacy|3|||
130699262|NCT00860262|470522839|FG000|Overall Study|Other|5|||
130699263|NCT00860262|470522840|FG001|Overall Study|Other|3|||
130699264|NCT00860262|470522841|FG002|Overall Study|Other|1|||
130699265|NCT00124618|470522842|FG000|Overall Study|Ineligible|1|||
130915215|NCT02906332|471325407|FG000|Overall Study|Withdrawal by Subject|1|||
130915216|NCT02949700|471325408|FG000|Phase I|Withdrawal by Subject|1|||
130915217|NCT02949700|471325409|FG001|Phase I|Withdrawal by Subject|1|||
130915218|NCT02949700|471325410|FG002|Phase I|Withdrawal by Subject|0|||
130915219|NCT02949700|471325411|FG003|Phase I|Withdrawal by Subject|0|||
130915220|NCT02949700|471325408|FG000|Phase I|Protocol Violation|1|||
130915221|NCT02949700|471325409|FG001|Phase I|Protocol Violation|0|||
130915222|NCT02949700|471325410|FG002|Phase I|Protocol Violation|0|||
130915223|NCT02949700|471325411|FG003|Phase I|Protocol Violation|0|||
130915224|NCT02949700|471325408|FG000|Phase II|Withdrawal by Subject|0|||
130915225|NCT02949700|471325409|FG001|Phase II|Withdrawal by Subject|0|||
130915226|NCT02949700|471325410|FG002|Phase II|Withdrawal by Subject|0|||
130915227|NCT02949700|471325411|FG003|Phase II|Withdrawal by Subject|2|||
130915228|NCT02949700|471325408|FG000|Phase II|Protocol Violation|0|||
131033107|NCT03269136|471755326|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
131033108|NCT03269136|471755327|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
131033109|NCT03269136|471755328|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
131033110|NCT03269136|471755329|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
131033111|NCT03269136|471755330|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
131033112|NCT03269136|471755331|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
131033113|NCT03269136|471755332|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
131033114|NCT03269136|471755315|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033115|NCT03269136|471755316|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033116|NCT03269136|471755317|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033117|NCT03269136|471755318|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033118|NCT03269136|471755319|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033119|NCT03269136|471755320|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033120|NCT03269136|471755321|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033121|NCT03269136|471755322|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
131033122|NCT03269136|471755323|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033123|NCT03269136|471755324|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033124|NCT03269136|471755325|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033125|NCT03269136|471755326|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033126|NCT03269136|471755327|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033127|NCT03269136|471755328|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033128|NCT03269136|471755329|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033129|NCT03269136|471755330|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033130|NCT03269136|471755331|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033131|NCT03269136|471755332|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
131033132|NCT03269136|471755315|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033133|NCT03269136|471755316|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
130699266|NCT01596127|470522843|FG000|Overall Study|Patient Ineligible|1|||
130915229|NCT02949700|471325409|FG001|Phase II|Protocol Violation|0|||
130915230|NCT02949700|471325410|FG002|Phase II|Protocol Violation|1|||
130915231|NCT02949700|471325411|FG003|Phase II|Protocol Violation|3|||
130915240|NCT02628769|471325430|FG000|First Intervention|Adverse Event|1|||
130915241|NCT02628769|471325431|FG001|First Intervention|Adverse Event|0|||
131118973|NCT02767323|472067232|FG001|Overall Study|Withdrawal by Subject|5|||
131118974|NCT02767323|472067233|FG002|Overall Study|Withdrawal by Subject|13|||
131118975|NCT02767323|472067234|FG003|Overall Study|Withdrawal by Subject|0|||
131118976|NCT02767323|472067231|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
131118977|NCT02767323|472067232|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
131118978|NCT02767323|472067233|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
131118979|NCT02767323|472067234|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
130699267|NCT00633022|470522844|FG000|Overall Study|Adverse Event|1|||
130699268|NCT00633022|470522845|FG001|Overall Study|Adverse Event|0|||
130699269|NCT00633022|470522846|FG002|Overall Study|Adverse Event|5|||
130699270|NCT00633022|470522844|FG000|Overall Study|Physician Decision|0|||
130699271|NCT00633022|470522845|FG001|Overall Study|Physician Decision|1|||
130699272|NCT00633022|470522846|FG002|Overall Study|Physician Decision|0|||
130915242|NCT02628769|471325430|FG000|First Intervention|Withdrawal by Subject|0|||
130915243|NCT02628769|471325431|FG001|First Intervention|Withdrawal by Subject|1|||
130915244|NCT02628769|471325430|FG000|Second Intervention|Adverse Event|2|||
130915245|NCT02628769|471325431|FG001|Second Intervention|Adverse Event|0|||
130915246|NCT02628769|471325430|FG000|Second Intervention|Physician Decision|0|||
130915247|NCT02628769|471325431|FG001|Second Intervention|Physician Decision|1|||
130915248|NCT02024555|471325432|FG000|Overall Study|Lost to Follow-up|1|||
130915249|NCT02024555|471325433|FG001|Overall Study|Lost to Follow-up|1|||
130915250|NCT02024555|471325432|FG000|Overall Study|Withdrawal by Subject|5|||
130915251|NCT02024555|471325433|FG001|Overall Study|Withdrawal by Subject|1|||
130915252|NCT02719327|471325436|FG000|Overall Study|Withdrawal by Subject|11|||
130915253|NCT02719327|471325437|FG001|Overall Study|Withdrawal by Subject|8|||
130915254|NCT03350620|471325438|FG000|Stage 2|Adverse Event|0|||
130915255|NCT03350620|471325439|FG001|Stage 2|Adverse Event|1|||
130915256|NCT03350620|471325440|FG002|Stage 2|Adverse Event|1|||
130915257|NCT03350620|471325438|FG000|Stage 2|Lack of Efficacy|0|||
130915258|NCT03350620|471325439|FG001|Stage 2|Lack of Efficacy|2|||
130915259|NCT03350620|471325440|FG002|Stage 2|Lack of Efficacy|0|||
130915260|NCT03350620|471325438|FG000|Stage 2|Lost to Follow-up|1|||
130915261|NCT03350620|471325439|FG001|Stage 2|Lost to Follow-up|2|||
130915262|NCT03350620|471325440|FG002|Stage 2|Lost to Follow-up|2|||
130915263|NCT03350620|471325438|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
130915264|NCT03350620|471325439|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
130915265|NCT03350620|471325440|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
131033134|NCT03269136|471755317|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033135|NCT03269136|471755318|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033136|NCT03269136|471755319|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033137|NCT03269136|471755320|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033138|NCT03269136|471755321|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033139|NCT03269136|471755322|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033140|NCT03269136|471755323|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033141|NCT03269136|471755324|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
131033142|NCT03269136|471755325|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033143|NCT03269136|471755326|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033144|NCT03269136|471755327|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033145|NCT03269136|471755328|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033146|NCT03269136|471755329|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033147|NCT03269136|471755330|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033148|NCT03269136|471755331|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033149|NCT03269136|471755332|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
131033150|NCT03269136|471755315|FG000|Part 1: Dose Escalation|Death|0|||
131033151|NCT03269136|471755316|FG001|Part 1: Dose Escalation|Death|0|||
131033152|NCT03269136|471755317|FG002|Part 1: Dose Escalation|Death|0|||
131033153|NCT03269136|471755318|FG003|Part 1: Dose Escalation|Death|0|||
131033154|NCT03269136|471755319|FG004|Part 1: Dose Escalation|Death|0|||
131033155|NCT03269136|471755320|FG005|Part 1: Dose Escalation|Death|0|||
131033156|NCT03269136|471755321|FG006|Part 1: Dose Escalation|Death|0|||
131033157|NCT03269136|471755322|FG007|Part 1: Dose Escalation|Death|0|||
131033158|NCT03269136|471755323|FG008|Part 1: Dose Escalation|Death|0|||
131033159|NCT03269136|471755324|FG009|Part 1: Dose Escalation|Death|1|||
131033160|NCT03269136|471755325|FG010|Part 1: Dose Escalation|Death|0|||
131033161|NCT03269136|471755326|FG011|Part 1: Dose Escalation|Death|1|||
130915266|NCT01066000|471325443|FG000|Overall Study|Protocol Violation|4|||
130915267|NCT01066000|471325443|FG000|Overall Study|Death|3|||
130915268|NCT01066000|471325443|FG000|Overall Study|Withdrawal by Subject|1|||
131033162|NCT03269136|471755327|FG012|Part 1: Dose Escalation|Death|0|||
131033163|NCT03269136|471755328|FG013|Part 1: Dose Escalation|Death|1|||
131033164|NCT03269136|471755329|FG014|Part 1: Dose Escalation|Death|0|||
131033165|NCT03269136|471755330|FG015|Part 1: Dose Escalation|Death|0|||
131033166|NCT03269136|471755331|FG016|Part 1: Dose Escalation|Death|2|||
131033167|NCT03269136|471755332|FG017|Part 1: Dose Escalation|Death|0|||
131033168|NCT03269136|471755315|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
130699273|NCT04388787|470522847|FG000|Blinded Period|Patient could not follow instructions|1|||
130699274|NCT04388787|470522847|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
130699275|NCT00688844|470522848|FG000|Overall Study|Lost to Follow-up|10|||
131118980|NCT04479436|472067244|FG000|Overall Study|Progressive disease|26|||
131118981|NCT04479436|472067245|FG001|Overall Study|Progressive disease|1|||
131118982|NCT04479436|472067244|FG000|Overall Study|Adverse Event|6|||
131118983|NCT04479436|472067245|FG001|Overall Study|Adverse Event|0|||
131118984|NCT04479436|472067244|FG000|Overall Study|Withdrawal by Subject|5|||
131118985|NCT04479436|472067245|FG001|Overall Study|Withdrawal by Subject|0|||
131118986|NCT04479436|472067244|FG000|Overall Study|Clinical progression|1|||
131118987|NCT04479436|472067245|FG001|Overall Study|Clinical progression|0|||
131118988|NCT04479436|472067244|FG000|Overall Study|Physician Decision|1|||
131118989|NCT04479436|472067245|FG001|Overall Study|Physician Decision|0|||
131118990|NCT00791258|472067252|FG000|Overall Study|Adverse Event|87|||
131118991|NCT00791258|472067252|FG000|Overall Study|Lost to Follow-up|18|||
131118992|NCT00791258|472067252|FG000|Overall Study|Protocol Violation|109|||
131118993|NCT00791258|472067252|FG000|Overall Study|Withdrawal by Subject|40|||
131118994|NCT00791258|472067252|FG000|Overall Study|Did not take medication for >3 days|1|||
131118995|NCT00791258|472067252|FG000|Overall Study|subject left area|2|||
131118996|NCT00791258|472067252|FG000|Overall Study|non-compliance|3|||
131118997|NCT00791258|472067252|FG000|Overall Study|Subject incarcerated|1|||
131118998|NCT00791258|472067252|FG000|Overall Study|Subject required restricted medication|1|||
131118999|NCT00791258|472067252|FG000|Overall Study|Lack of Efficacy|1|||
131119000|NCT00058552|472067253|FG000|Overall Study|Died prior to receiving treatment|4|||
131119001|NCT00058552|472067254|FG001|Overall Study|Died prior to receiving treatment|2|||
131119002|NCT00058552|472067253|FG000|Overall Study|Disease progression|52|||
131119003|NCT00058552|472067254|FG001|Overall Study|Disease progression|44|||
131119004|NCT00058552|472067253|FG000|Overall Study|Adverse Event|4|||
131119005|NCT00058552|472067254|FG001|Overall Study|Adverse Event|2|||
131119006|NCT00058552|472067253|FG000|Overall Study|Withdrawal by Subject|3|||
131119007|NCT00058552|472067254|FG001|Overall Study|Withdrawal by Subject|5|||
131119008|NCT00058552|472067253|FG000|Overall Study|Physician Decision|2|||
131119009|NCT00058552|472067254|FG001|Overall Study|Physician Decision|5|||
131119010|NCT00058552|472067253|FG000|Overall Study|Clinical disease progression|0|||
131119011|NCT00058552|472067254|FG001|Overall Study|Clinical disease progression|4|||
131119012|NCT02319668|472067255|FG000|Overall Study|Other (Not specified)|0|||
131119013|NCT02319668|472067256|FG001|Overall Study|Other (Not specified)|2|||
131119014|NCT01372150|472067257|FG000|Overall Study|Lack of Efficacy|3|||
131119015|NCT01372150|472067258|FG001|Overall Study|Lack of Efficacy|0|||
131119016|NCT01372150|472067259|FG002|Overall Study|Lack of Efficacy|1|||
131119017|NCT01372150|472067257|FG000|Overall Study|Lost to Follow-up|4|||
131119018|NCT01372150|472067258|FG001|Overall Study|Lost to Follow-up|5|||
131119019|NCT01372150|472067259|FG002|Overall Study|Lost to Follow-up|6|||
131119020|NCT01372150|472067257|FG000|Overall Study|Protocol Violation|1|||
131119021|NCT01372150|472067258|FG001|Overall Study|Protocol Violation|0|||
131119022|NCT01372150|472067259|FG002|Overall Study|Protocol Violation|3|||
131119023|NCT01372150|472067257|FG000|Overall Study|Withdrawal by Subject|2|||
131119024|NCT01372150|472067258|FG001|Overall Study|Withdrawal by Subject|7|||
131119025|NCT01372150|472067259|FG002|Overall Study|Withdrawal by Subject|2|||
131119026|NCT01372150|472067257|FG000|Overall Study|Other|1|||
131119027|NCT01372150|472067258|FG001|Overall Study|Other|0|||
131119028|NCT01372150|472067259|FG002|Overall Study|Other|2|||
131119029|NCT01372150|472067257|FG000|Overall Study|Adverse Event|2|||
131119030|NCT01372150|472067258|FG001|Overall Study|Adverse Event|1|||
131119031|NCT01372150|472067259|FG002|Overall Study|Adverse Event|2|||
131119032|NCT01372150|472067257|FG000|Overall Study|Randomized but not treated|0|||
131119033|NCT01372150|472067258|FG001|Overall Study|Randomized but not treated|1|||
131119034|NCT01372150|472067259|FG002|Overall Study|Randomized but not treated|0|||
131119035|NCT02316340|472067260|FG000|First Progression|Clinical progression|2|||
131119036|NCT02316340|472067261|FG001|First Progression|Clinical progression|1|||
131119037|NCT02316340|472067260|FG000|First Progression|Withdrawal by Subject|1|||
131119038|NCT02316340|472067261|FG001|First Progression|Withdrawal by Subject|0|||
131119039|NCT03781323|472067262|FG000|Overall Study|Withdrawal by Subject|1|||
131119040|NCT01526551|472067263|FG000|Overall Study|Lack of returned parental consent form|424|||
131119041|NCT04422990|472067268|FG000|Overall Study|Withdrawal by Subject|0|||
131119042|NCT04422990|472067269|FG001|Overall Study|Withdrawal by Subject|1|||
131119043|NCT04422990|472067268|FG000|Overall Study|Travel|3|||
131119044|NCT04422990|472067269|FG001|Overall Study|Travel|0|||
131119045|NCT00433914|472067273|FG000|Overall Study|Withdrawal by Subject|0|||
131119046|NCT00433914|472067274|FG001|Overall Study|Withdrawal by Subject|2|||
131119047|NCT00433914|472067273|FG000|Overall Study|Lost to Follow-up|0|||
131119048|NCT00433914|472067274|FG001|Overall Study|Lost to Follow-up|1|||
130699276|NCT01374451|470522849|FG000|Overall Study|Administrative problems|1|||
131119049|NCT02844920|472067277|FG000|Overall Study|Lost to Follow-up|2|||
131119050|NCT00766090|472067288|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131119051|NCT00766090|472067289|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131119052|NCT00766090|472067290|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130915269|NCT01066000|471325443|FG000|Overall Study|Adverse Event|1|||
130915270|NCT05268055|471325444|FG000|Overall Study|Lost to Follow-up|68|||
130915271|NCT05268055|471325445|FG001|Overall Study|Lost to Follow-up|68|||
130915272|NCT05268055|471325444|FG000|Overall Study|Withdrawal by Subject|12|||
130915273|NCT05268055|471325445|FG001|Overall Study|Withdrawal by Subject|8|||
130915274|NCT01854658|471327327|FG000|Overall Study|Protocol Violation|6|||
130915275|NCT01854658|471327328|FG001|Overall Study|Protocol Violation|2|||
130915276|NCT01854658|471327329|FG002|Overall Study|Protocol Violation|2|||
130915277|NCT01854658|471327330|FG003|Overall Study|Protocol Violation|1|||
130915278|NCT01854658|471327327|FG000|Overall Study|Physician Decision|7|||
130915279|NCT01854658|471327328|FG001|Overall Study|Physician Decision|5|||
130915280|NCT01854658|471327329|FG002|Overall Study|Physician Decision|2|||
130915281|NCT01854658|471327330|FG003|Overall Study|Physician Decision|4|||
130915282|NCT01854658|471327327|FG000|Overall Study|Lost to Follow-up|8|||
130915283|NCT01854658|471327328|FG001|Overall Study|Lost to Follow-up|9|||
130915284|NCT01854658|471327329|FG002|Overall Study|Lost to Follow-up|8|||
130915285|NCT01854658|471327330|FG003|Overall Study|Lost to Follow-up|4|||
130915286|NCT01854658|471327327|FG000|Overall Study|Withdrawal by Subject|28|||
130915287|NCT01854658|471327328|FG001|Overall Study|Withdrawal by Subject|21|||
130915288|NCT01854658|471327329|FG002|Overall Study|Withdrawal by Subject|29|||
130915289|NCT01854658|471327330|FG003|Overall Study|Withdrawal by Subject|15|||
130915290|NCT01854658|471327327|FG000|Overall Study|Protocol-specified criteria|15|||
130915291|NCT01854658|471327328|FG001|Overall Study|Protocol-specified criteria|15|||
130915292|NCT01854658|471327329|FG002|Overall Study|Protocol-specified criteria|10|||
130915293|NCT01854658|471327330|FG003|Overall Study|Protocol-specified criteria|7|||
130915294|NCT01854658|471327327|FG000|Overall Study|Lack of Efficacy|3|||
130915295|NCT01854658|471327328|FG001|Overall Study|Lack of Efficacy|8|||
130915296|NCT01854658|471327329|FG002|Overall Study|Lack of Efficacy|4|||
130915297|NCT01854658|471327330|FG003|Overall Study|Lack of Efficacy|7|||
130915298|NCT01854658|471327327|FG000|Overall Study|Adverse Event|21|||
130915299|NCT01854658|471327328|FG001|Overall Study|Adverse Event|14|||
130915300|NCT01854658|471327329|FG002|Overall Study|Adverse Event|23|||
130699277|NCT01374451|470522850|FG001|Overall Study|Administrative problems|0|||
130699278|NCT01223027|470522851|FG000|Overall Study|Adverse Event|20|||
130699279|NCT01223027|470522852|FG001|Overall Study|Adverse Event|10|||
130699280|NCT01223027|470522851|FG000|Overall Study|Death|42|||
130699281|NCT01223027|470522852|FG001|Overall Study|Death|42|||
130699282|NCT01223027|470522851|FG000|Overall Study|Lost to Follow-up|2|||
130699283|NCT01223027|470522852|FG001|Overall Study|Lost to Follow-up|1|||
130699284|NCT01223027|470522851|FG000|Overall Study|Physician Decision|4|||
130699285|NCT01223027|470522852|FG001|Overall Study|Physician Decision|8|||
130699286|NCT01223027|470522851|FG000|Overall Study|Progressive Disease|167|||
130699287|NCT01223027|470522852|FG001|Overall Study|Progressive Disease|183|||
130699288|NCT01223027|470522851|FG000|Overall Study|Protocol Violation|2|||
130699289|NCT01223027|470522852|FG001|Overall Study|Protocol Violation|1|||
130699290|NCT01223027|470522851|FG000|Overall Study|Subject/guardian decicion|18|||
130699291|NCT01223027|470522852|FG001|Overall Study|Subject/guardian decicion|16|||
130699292|NCT01223027|470522851|FG000|Overall Study|New therapy for study indication|17|||
130699293|NCT01223027|470522852|FG001|Overall Study|New therapy for study indication|8|||
130699294|NCT01223027|470522851|FG000|Overall Study|Study terminated by sponsor|2|||
130699295|NCT01223027|470522852|FG001|Overall Study|Study terminated by sponsor|8|||
130699296|NCT00724958|470522856|FG000|Overall Study|Adverse Event|28|||
130699297|NCT00724958|470522856|FG000|Overall Study|Loss of Response|40|||
130699298|NCT00724958|470522856|FG000|Overall Study|No Response|18|||
130699299|NCT00724958|470522856|FG000|Overall Study|Remission|7|||
130699300|NCT00724958|470522856|FG000|Overall Study|Other Reason|76|||
130699301|NCT00724958|470522856|FG000|Overall Study|No documentation for end of therapy|13|||
130699302|NCT01520987|470524611|FG000|Overall Study|Withdrawal by Subject|1|||
130699303|NCT01520987|470524612|FG001|Overall Study|Withdrawal by Subject|0|||
130699304|NCT01520987|470524613|FG002|Overall Study|Withdrawal by Subject|0|||
130699305|NCT01520987|470524614|FG003|Overall Study|Withdrawal by Subject|0|||
130699306|NCT01520987|470524615|FG004|Overall Study|Withdrawal by Subject|0|||
130699307|NCT01520987|470524616|FG005|Overall Study|Withdrawal by Subject|1|||
130699308|NCT01520987|470524617|FG006|Overall Study|Withdrawal by Subject|0|||
130699309|NCT01520987|470524618|FG007|Overall Study|Withdrawal by Subject|0|||
130699310|NCT04729101|470524619|FG000|Overall Study|Adverse Event|1|||
130699311|NCT04729101|470524620|FG001|Overall Study|Adverse Event|0|||
130699312|NCT04729101|470524619|FG000|Overall Study|Physician Decision|1|||
130699313|NCT04729101|470524620|FG001|Overall Study|Physician Decision|0|||
130699314|NCT04729101|470524619|FG000|Overall Study|Withdrawal by Subject|1|||
130699315|NCT04729101|470524620|FG001|Overall Study|Withdrawal by Subject|0|||
130699316|NCT02940522|470524621|FG000|Overall Study|Lost to Follow-up|1|||
130699317|NCT02940522|470524622|FG001|Overall Study|Lost to Follow-up|2|||
130699318|NCT02940522|470524621|FG000|Overall Study|Withdrawal by Subject|1|||
130699319|NCT02940522|470524622|FG001|Overall Study|Withdrawal by Subject|0|||
130699320|NCT00274625|470524623|FG000|Overall Study|Lost to Follow-up|46|||
130699321|NCT00274625|470524624|FG001|Overall Study|Lost to Follow-up|54|||
130915301|NCT01854658|471327330|FG003|Overall Study|Adverse Event|19|||
130915302|NCT01854658|471327327|FG000|Overall Study|Administrative reasons|5|||
130915303|NCT01854658|471327328|FG001|Overall Study|Administrative reasons|1|||
130915304|NCT01854658|471327329|FG002|Overall Study|Administrative reasons|2|||
130915305|NCT01854658|471327330|FG003|Overall Study|Administrative reasons|2|||
130915306|NCT02203071|471327331|FG000|Overall Study|Lost to Follow-up|3|||
130915307|NCT02203071|471327332|FG001|Overall Study|Lost to Follow-up|1|||
130915308|NCT02570074|471327340|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
130915309|NCT02570074|471327341|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
130915310|NCT02436304|471327342|FG000|Overall Study|Lost to Follow-up|0|||
130915311|NCT02436304|471327343|FG001|Overall Study|Lost to Follow-up|1|||
130915312|NCT02436304|471327344|FG002|Overall Study|Lost to Follow-up|0|||
130915313|NCT02436304|471327342|FG000|Overall Study|Withdrawal by Subject|0|||
130915314|NCT02436304|471327343|FG001|Overall Study|Withdrawal by Subject|1|||
130915315|NCT02436304|471327344|FG002|Overall Study|Withdrawal by Subject|0|||
130915316|NCT02436304|471327342|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
130915317|NCT02436304|471327343|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
130915318|NCT02436304|471327344|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
130915319|NCT03793556|471327345|FG000|Overall Study|Withdrawal by Subject|12|||
130915320|NCT03793556|471327346|FG001|Overall Study|Withdrawal by Subject|1|||
130915321|NCT03793556|471327345|FG000|Overall Study|Lost to Follow-up|1|||
130915322|NCT03793556|471327346|FG001|Overall Study|Lost to Follow-up|1|||
130915323|NCT00004635|471327348|FG000|Period One|refused|2|||
130915324|NCT00004635|471327349|FG001|Period One|refused|1|||
130915325|NCT00004635|471327348|FG000|Period One|Withdrawal by Subject|1|||
130915326|NCT00004635|471327349|FG001|Period One|Withdrawal by Subject|1|||
130915327|NCT00004635|471327348|FG000|Period One|Protocol Violation|1|||
130915328|NCT00004635|471327349|FG001|Period One|Protocol Violation|0|||
130915329|NCT00004635|471327348|FG000|Period One|PSA did not go <5 ng/mL|1|||
130915330|NCT00004635|471327349|FG001|Period One|PSA did not go <5 ng/mL|0|||
130915331|NCT00004635|471327348|FG000|Period One|second malignancy|1|||
130915332|NCT00004635|471327349|FG001|Period One|second malignancy|0|||
130915333|NCT00004635|471327348|FG000|Period One|progressed|0|||
130915334|NCT00004635|471327349|FG001|Period One|progressed|2|||
130915335|NCT00004635|471327348|FG000|Period One|health problem|0|||
130915336|NCT00004635|471327349|FG001|Period One|health problem|1|||
130915337|NCT00004635|471327348|FG000|Period One|discrepancy in data entry|0|||
130915338|NCT00004635|471327349|FG001|Period One|discrepancy in data entry|1|||
130915339|NCT00004635|471327348|FG000|Period Two|progression|2|||
130915340|NCT00004635|471327349|FG001|Period Two|progression|3|||
130915341|NCT00004635|471327348|FG000|Period Two|Adverse Event|1|||
130915342|NCT00004635|471327349|FG001|Period Two|Adverse Event|0|||
130915343|NCT00004635|471327348|FG000|Period Two|refused|0|||
130915344|NCT00004635|471327349|FG001|Period Two|refused|2|||
130915345|NCT00004635|471327348|FG000|Period Two|health problem|1|||
130915346|NCT00004635|471327349|FG001|Period Two|health problem|1|||
130915347|NCT00004635|471327348|FG000|Period Two|travel issues|0|||
130915348|NCT00004635|471327349|FG001|Period Two|travel issues|1|||
130915349|NCT00004635|471327348|FG000|Period Two|secondary malignancy|1|||
130915350|NCT00004635|471327349|FG001|Period Two|secondary malignancy|1|||
130915351|NCT00004635|471327348|FG000|Period Two|Lost to Follow-up|1|||
130915352|NCT00004635|471327349|FG001|Period Two|Lost to Follow-up|0|||
130915353|NCT00004635|471327348|FG000|Period Two|discrepancy in data entry|0|||
130915354|NCT00004635|471327349|FG001|Period Two|discrepancy in data entry|1|||
130915355|NCT03633617|471327350|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
130915356|NCT03633617|471327351|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
130915357|NCT03633617|471327352|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130915358|NCT03633617|471327353|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130915359|NCT03633617|471327354|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130915360|NCT03633617|471327355|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130915361|NCT03633617|471327356|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130915362|NCT03633617|471327357|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130915363|NCT03633617|471327358|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130915364|NCT03633617|471327359|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130915365|NCT03633617|471327360|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
130915366|NCT03633617|471327350|FG000|Part A|Unconfirmed early termination visit|1|||
130915367|NCT03633617|471327351|FG001|Part A|Unconfirmed early termination visit|0|||
130915368|NCT03633617|471327352|FG002|Part A|Unconfirmed early termination visit|0|||
130915369|NCT03633617|471327353|FG003|Part A|Unconfirmed early termination visit|0|||
130915370|NCT03633617|471327354|FG004|Part A|Unconfirmed early termination visit|0|||
130915371|NCT03633617|471327355|FG005|Part A|Unconfirmed early termination visit|0|||
130915372|NCT03633617|471327356|FG006|Part A|Unconfirmed early termination visit|0|||
130915373|NCT03633617|471327357|FG007|Part A|Unconfirmed early termination visit|0|||
131119053|NCT00766090|472067291|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130915374|NCT03633617|471327358|FG008|Part A|Unconfirmed early termination visit|0|||
130915375|NCT03633617|471327359|FG009|Part A|Unconfirmed early termination visit|0|||
130915376|NCT03633617|471327360|FG010|Part A|Unconfirmed early termination visit|0|||
130915377|NCT03633617|471327350|FG000|Part A|Adverse Event|0|||
130915378|NCT03633617|471327351|FG001|Part A|Adverse Event|1|||
130915379|NCT03633617|471327352|FG002|Part A|Adverse Event|0|||
130915380|NCT03633617|471327353|FG003|Part A|Adverse Event|0|||
130915381|NCT03633617|471327354|FG004|Part A|Adverse Event|0|||
130915382|NCT03633617|471327355|FG005|Part A|Adverse Event|0|||
130915383|NCT03633617|471327356|FG006|Part A|Adverse Event|0|||
130915384|NCT03633617|471327357|FG007|Part A|Adverse Event|0|||
130915385|NCT03633617|471327358|FG008|Part A|Adverse Event|0|||
130915386|NCT03633617|471327359|FG009|Part A|Adverse Event|0|||
130915387|NCT03633617|471327360|FG010|Part A|Adverse Event|0|||
130915388|NCT03633617|471327350|FG000|Part A|Pregnancy|1|||
130915389|NCT03633617|471327351|FG001|Part A|Pregnancy|0|||
130915390|NCT03633617|471327352|FG002|Part A|Pregnancy|0|||
130915391|NCT03633617|471327353|FG003|Part A|Pregnancy|0|||
130915392|NCT03633617|471327354|FG004|Part A|Pregnancy|0|||
130915393|NCT03633617|471327355|FG005|Part A|Pregnancy|0|||
130915394|NCT03633617|471327356|FG006|Part A|Pregnancy|0|||
130915395|NCT03633617|471327357|FG007|Part A|Pregnancy|0|||
130915396|NCT03633617|471327358|FG008|Part A|Pregnancy|0|||
130915397|NCT03633617|471327359|FG009|Part A|Pregnancy|0|||
130915398|NCT03633617|471327360|FG010|Part A|Pregnancy|0|||
130915399|NCT03633617|471327350|FG000|Part A|Withdrawal by Subject|0|||
130915400|NCT03633617|471327351|FG001|Part A|Withdrawal by Subject|1|||
130915401|NCT03633617|471327352|FG002|Part A|Withdrawal by Subject|0|||
130915402|NCT03633617|471327353|FG003|Part A|Withdrawal by Subject|0|||
130915403|NCT03633617|471327354|FG004|Part A|Withdrawal by Subject|0|||
130915404|NCT03633617|471327355|FG005|Part A|Withdrawal by Subject|0|||
130915405|NCT03633617|471327356|FG006|Part A|Withdrawal by Subject|0|||
130915406|NCT03633617|471327357|FG007|Part A|Withdrawal by Subject|0|||
130915407|NCT03633617|471327358|FG008|Part A|Withdrawal by Subject|0|||
130915408|NCT03633617|471327359|FG009|Part A|Withdrawal by Subject|0|||
130915409|NCT03633617|471327360|FG010|Part A|Withdrawal by Subject|0|||
130915410|NCT03633617|471327350|FG000|Part B|Adverse Event|0|||
130915411|NCT03633617|471327351|FG001|Part B|Adverse Event|0|||
130915412|NCT03633617|471327352|FG002|Part B|Adverse Event|2|||
130915413|NCT03633617|471327353|FG003|Part B|Adverse Event|2|||
130915414|NCT03633617|471327354|FG004|Part B|Adverse Event|1|||
130915415|NCT03633617|471327355|FG005|Part B|Adverse Event|0|||
130915416|NCT03633617|471327356|FG006|Part B|Adverse Event|0|||
130915417|NCT03633617|471327357|FG007|Part B|Adverse Event|0|||
130915418|NCT03633617|471327358|FG008|Part B|Adverse Event|0|||
130915419|NCT03633617|471327359|FG009|Part B|Adverse Event|0|||
130915420|NCT03633617|471327360|FG010|Part B|Adverse Event|0|||
130915421|NCT03633617|471327350|FG000|Part B|Withdrawal by Subject|0|||
130915422|NCT03633617|471327351|FG001|Part B|Withdrawal by Subject|0|||
130915423|NCT03633617|471327352|FG002|Part B|Withdrawal by Subject|1|||
130915424|NCT03633617|471327353|FG003|Part B|Withdrawal by Subject|0|||
130915425|NCT03633617|471327354|FG004|Part B|Withdrawal by Subject|2|||
130915426|NCT03633617|471327355|FG005|Part B|Withdrawal by Subject|0|||
130915427|NCT03633617|471327356|FG006|Part B|Withdrawal by Subject|0|||
130915428|NCT03633617|471327357|FG007|Part B|Withdrawal by Subject|0|||
130915429|NCT03633617|471327358|FG008|Part B|Withdrawal by Subject|0|||
130915430|NCT03633617|471327359|FG009|Part B|Withdrawal by Subject|0|||
130915431|NCT03633617|471327360|FG010|Part B|Withdrawal by Subject|0|||
130915432|NCT03633617|471327350|FG000|Part B|Lost to Follow-up|0|||
130915433|NCT03633617|471327351|FG001|Part B|Lost to Follow-up|0|||
130915434|NCT03633617|471327352|FG002|Part B|Lost to Follow-up|0|||
130915435|NCT03633617|471327353|FG003|Part B|Lost to Follow-up|0|||
130915436|NCT03633617|471327354|FG004|Part B|Lost to Follow-up|1|||
130915437|NCT03633617|471327355|FG005|Part B|Lost to Follow-up|0|||
130915438|NCT03633617|471327356|FG006|Part B|Lost to Follow-up|0|||
130915439|NCT03633617|471327357|FG007|Part B|Lost to Follow-up|0|||
130915440|NCT03633617|471327358|FG008|Part B|Lost to Follow-up|0|||
130915441|NCT03633617|471327359|FG009|Part B|Lost to Follow-up|0|||
130915442|NCT03633617|471327360|FG010|Part B|Lost to Follow-up|0|||
130915443|NCT03633617|471327350|FG000|Part B|Physician Decision|0|||
130915444|NCT03633617|471327351|FG001|Part B|Physician Decision|0|||
131119054|NCT00766090|472067292|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130915445|NCT03633617|471327352|FG002|Part B|Physician Decision|0|||
131119055|NCT00766090|472067293|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130915446|NCT03633617|471327353|FG003|Part B|Physician Decision|0|||
130915447|NCT03633617|471327354|FG004|Part B|Physician Decision|1|||
130915448|NCT03633617|471327355|FG005|Part B|Physician Decision|0|||
130915449|NCT03633617|471327356|FG006|Part B|Physician Decision|0|||
130915450|NCT03633617|471327357|FG007|Part B|Physician Decision|0|||
130915451|NCT03633617|471327358|FG008|Part B|Physician Decision|0|||
130915452|NCT03633617|471327359|FG009|Part B|Physician Decision|0|||
130915453|NCT03633617|471327360|FG010|Part B|Physician Decision|0|||
130915454|NCT03633617|471327350|FG000|Part B|COVID-19 Restrictions|0|||
130915455|NCT03633617|471327351|FG001|Part B|COVID-19 Restrictions|0|||
130915456|NCT03633617|471327352|FG002|Part B|COVID-19 Restrictions|1|||
130915457|NCT03633617|471327353|FG003|Part B|COVID-19 Restrictions|0|||
130915458|NCT03633617|471327354|FG004|Part B|COVID-19 Restrictions|0|||
130915459|NCT03633617|471327355|FG005|Part B|COVID-19 Restrictions|0|||
130915460|NCT03633617|471327356|FG006|Part B|COVID-19 Restrictions|0|||
130915461|NCT03633617|471327357|FG007|Part B|COVID-19 Restrictions|0|||
130915462|NCT03633617|471327358|FG008|Part B|COVID-19 Restrictions|0|||
130915463|NCT03633617|471327359|FG009|Part B|COVID-19 Restrictions|0|||
130915464|NCT03633617|471327360|FG010|Part B|COVID-19 Restrictions|0|||
130915465|NCT03633617|471327350|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130915466|NCT03633617|471327351|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130915467|NCT03633617|471327352|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
130915468|NCT03633617|471327353|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130915469|NCT03633617|471327354|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130915470|NCT03633617|471327355|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130915471|NCT03633617|471327356|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130915472|NCT03633617|471327357|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130915473|NCT03633617|471327358|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130915474|NCT03633617|471327359|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130915475|NCT03633617|471327360|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
130915476|NCT03633617|471327350|FG000|Part C (& Follow-up)|Adverse Event|0|||
130915477|NCT03633617|471327351|FG001|Part C (& Follow-up)|Adverse Event|0|||
130915478|NCT03633617|471327352|FG002|Part C (& Follow-up)|Adverse Event|0|||
130915479|NCT03633617|471327353|FG003|Part C (& Follow-up)|Adverse Event|0|||
131033169|NCT03269136|471755316|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
131033170|NCT03269136|471755317|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
131033171|NCT03269136|471755318|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
131033172|NCT03269136|471755319|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
131033173|NCT03269136|471755320|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
131033174|NCT03269136|471755321|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
131033175|NCT03269136|471755322|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
131033176|NCT03269136|471755323|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
131033177|NCT03269136|471755324|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
131033178|NCT03269136|471755325|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
131033179|NCT03269136|471755326|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
131033180|NCT03269136|471755327|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
131033181|NCT03269136|471755328|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
131033182|NCT03269136|471755329|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
131033183|NCT03269136|471755330|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
131033184|NCT03269136|471755331|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
131033185|NCT03269136|471755332|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
131033186|NCT03269136|471755315|FG000|Part 1: Dose Escalation|Adverse Event|0|||
131033187|NCT03269136|471755316|FG001|Part 1: Dose Escalation|Adverse Event|0|||
131033188|NCT03269136|471755317|FG002|Part 1: Dose Escalation|Adverse Event|0|||
131033189|NCT03269136|471755318|FG003|Part 1: Dose Escalation|Adverse Event|0|||
131033190|NCT03269136|471755319|FG004|Part 1: Dose Escalation|Adverse Event|0|||
131033191|NCT03269136|471755320|FG005|Part 1: Dose Escalation|Adverse Event|0|||
131033192|NCT03269136|471755321|FG006|Part 1: Dose Escalation|Adverse Event|2|||
131033193|NCT03269136|471755322|FG007|Part 1: Dose Escalation|Adverse Event|0|||
131033194|NCT03269136|471755323|FG008|Part 1: Dose Escalation|Adverse Event|0|||
131033195|NCT03269136|471755324|FG009|Part 1: Dose Escalation|Adverse Event|0|||
131033196|NCT03269136|471755325|FG010|Part 1: Dose Escalation|Adverse Event|1|||
131033197|NCT03269136|471755326|FG011|Part 1: Dose Escalation|Adverse Event|2|||
131033198|NCT03269136|471755327|FG012|Part 1: Dose Escalation|Adverse Event|0|||
131033199|NCT03269136|471755328|FG013|Part 1: Dose Escalation|Adverse Event|1|||
131033200|NCT03269136|471755329|FG014|Part 1: Dose Escalation|Adverse Event|0|||
131033201|NCT03269136|471755330|FG015|Part 1: Dose Escalation|Adverse Event|0|||
131033202|NCT03269136|471755331|FG016|Part 1: Dose Escalation|Adverse Event|1|||
131033203|NCT03269136|471755332|FG017|Part 1: Dose Escalation|Adverse Event|0|||
131033204|NCT03269136|471755315|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
131033205|NCT03269136|471755316|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
131033206|NCT03269136|471755317|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
131033207|NCT03269136|471755318|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
131033208|NCT03269136|471755319|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
131033209|NCT03269136|471755320|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
131033210|NCT03269136|471755321|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
131033211|NCT03269136|471755322|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
131033212|NCT03269136|471755323|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
131033213|NCT03269136|471755324|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
131033214|NCT03269136|471755325|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
131033215|NCT03269136|471755326|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
131033216|NCT03269136|471755327|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
131033217|NCT03269136|471755328|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
131033218|NCT03269136|471755329|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
130915480|NCT03633617|471327354|FG004|Part C (& Follow-up)|Adverse Event|0|||
130915481|NCT03633617|471327355|FG005|Part C (& Follow-up)|Adverse Event|1|||
130915482|NCT03633617|471327356|FG006|Part C (& Follow-up)|Adverse Event|0|||
130915483|NCT03633617|471327357|FG007|Part C (& Follow-up)|Adverse Event|1|||
130915484|NCT03633617|471327358|FG008|Part C (& Follow-up)|Adverse Event|0|||
130915485|NCT03633617|471327359|FG009|Part C (& Follow-up)|Adverse Event|0|||
130915486|NCT03633617|471327360|FG010|Part C (& Follow-up)|Adverse Event|0|||
130915487|NCT03633617|471327350|FG000|Part C (& Follow-up)|Pregnancy|0|||
130915488|NCT03633617|471327351|FG001|Part C (& Follow-up)|Pregnancy|0|||
130915489|NCT03633617|471327352|FG002|Part C (& Follow-up)|Pregnancy|0|||
130915490|NCT03633617|471327353|FG003|Part C (& Follow-up)|Pregnancy|0|||
130915491|NCT03633617|471327354|FG004|Part C (& Follow-up)|Pregnancy|0|||
130915492|NCT03633617|471327355|FG005|Part C (& Follow-up)|Pregnancy|0|||
130915493|NCT03633617|471327356|FG006|Part C (& Follow-up)|Pregnancy|0|||
130915494|NCT03633617|471327357|FG007|Part C (& Follow-up)|Pregnancy|0|||
130915495|NCT03633617|471327358|FG008|Part C (& Follow-up)|Pregnancy|0|||
130915496|NCT03633617|471327359|FG009|Part C (& Follow-up)|Pregnancy|1|||
130915497|NCT03633617|471327360|FG010|Part C (& Follow-up)|Pregnancy|0|||
130915498|NCT03633617|471327350|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
130915499|NCT03633617|471327351|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
130915500|NCT03633617|471327352|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
130915501|NCT03633617|471327353|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
130915502|NCT03633617|471327354|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
130915503|NCT03633617|471327355|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
130915504|NCT03633617|471327356|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
130915505|NCT03633617|471327357|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
130915506|NCT03633617|471327358|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
130915507|NCT03633617|471327359|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
130915508|NCT03633617|471327360|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
130915509|NCT03633617|471327350|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
130915510|NCT03633617|471327351|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
130915511|NCT03633617|471327352|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
130915512|NCT03633617|471327353|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
130915513|NCT03633617|471327354|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
130915514|NCT03633617|471327355|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
130915515|NCT03633617|471327356|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
130915516|NCT03633617|471327357|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
130915517|NCT03633617|471327358|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
130915518|NCT03633617|471327359|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
130915519|NCT03633617|471327360|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
130915520|NCT03633617|471327350|FG000|Part C (& Follow-up)|Physician Decision|0|||
130915521|NCT03633617|471327351|FG001|Part C (& Follow-up)|Physician Decision|0|||
130915522|NCT03633617|471327352|FG002|Part C (& Follow-up)|Physician Decision|0|||
130915523|NCT03633617|471327353|FG003|Part C (& Follow-up)|Physician Decision|0|||
130915524|NCT03633617|471327354|FG004|Part C (& Follow-up)|Physician Decision|0|||
130915525|NCT03633617|471327355|FG005|Part C (& Follow-up)|Physician Decision|0|||
130915526|NCT03633617|471327356|FG006|Part C (& Follow-up)|Physician Decision|0|||
130915527|NCT03633617|471327357|FG007|Part C (& Follow-up)|Physician Decision|1|||
130915528|NCT03633617|471327358|FG008|Part C (& Follow-up)|Physician Decision|0|||
130915529|NCT03633617|471327359|FG009|Part C (& Follow-up)|Physician Decision|0|||
130915530|NCT03633617|471327360|FG010|Part C (& Follow-up)|Physician Decision|1|||
130915531|NCT03633617|471327350|FG000|Part C (& Follow-up)|COVID-19 related|0|||
130915532|NCT03633617|471327351|FG001|Part C (& Follow-up)|COVID-19 related|0|||
130915533|NCT03633617|471327352|FG002|Part C (& Follow-up)|COVID-19 related|0|||
130699322|NCT00274625|470524623|FG000|Overall Study|Excluded from analysis|14|||
130699323|NCT00274625|470524624|FG001|Overall Study|Excluded from analysis|8|||
130699324|NCT01754376|470524628|FG000|Overall Study|Adverse Event|1|||
130699325|NCT01754376|470524628|FG000|Overall Study|Lack of Efficacy|2|||
130699326|NCT04264819|470524629|FG000|Overall Study|Physician Decision|19|||
130699327|NCT04264819|470524629|FG000|Overall Study|Adverse Event|12|||
130699328|NCT04264819|470524629|FG000|Overall Study|Withdrawal by Subject|11|||
130699329|NCT04264819|470524629|FG000|Overall Study|Lost to Follow-up|2|||
130699330|NCT04264819|470524629|FG000|Overall Study|Death|2|||
130699331|NCT04768296|470524630|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
130699332|NCT04768296|470524631|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
130699333|NCT03087786|470524632|FG000|Overall Study|Withdrawal by Subject|2|||
130699334|NCT03087786|470524633|FG001|Overall Study|Withdrawal by Subject|0|||
130699335|NCT01453153|470524638|FG000|Overall Study|Physician Decision|0|||
130699336|NCT01453153|470524639|FG001|Overall Study|Physician Decision|0|||
130699337|NCT01453153|470524640|FG002|Overall Study|Physician Decision|1|||
130699338|NCT01453153|470524638|FG000|Overall Study|Progressive Disease|3|||
130699339|NCT01453153|470524639|FG001|Overall Study|Progressive Disease|2|||
130699340|NCT01453153|470524640|FG002|Overall Study|Progressive Disease|16|||
130699341|NCT01453153|470524638|FG000|Overall Study|Withdrawal by Subject|0|||
130699342|NCT01453153|470524639|FG001|Overall Study|Withdrawal by Subject|1|||
130699343|NCT01453153|470524640|FG002|Overall Study|Withdrawal by Subject|2|||
130915534|NCT03633617|471327353|FG003|Part C (& Follow-up)|COVID-19 related|0|||
130915535|NCT03633617|471327354|FG004|Part C (& Follow-up)|COVID-19 related|0|||
130915536|NCT03633617|471327355|FG005|Part C (& Follow-up)|COVID-19 related|1|||
130915537|NCT03633617|471327356|FG006|Part C (& Follow-up)|COVID-19 related|0|||
130915538|NCT03633617|471327357|FG007|Part C (& Follow-up)|COVID-19 related|0|||
130915539|NCT03633617|471327358|FG008|Part C (& Follow-up)|COVID-19 related|0|||
130915540|NCT03633617|471327359|FG009|Part C (& Follow-up)|COVID-19 related|0|||
130915541|NCT03633617|471327360|FG010|Part C (& Follow-up)|COVID-19 related|0|||
130915542|NCT03633617|471327350|FG000|Part C (& Follow-up)|Protocol Violation|0|||
130915543|NCT03633617|471327351|FG001|Part C (& Follow-up)|Protocol Violation|0|||
130915544|NCT03633617|471327352|FG002|Part C (& Follow-up)|Protocol Violation|0|||
130915545|NCT03633617|471327353|FG003|Part C (& Follow-up)|Protocol Violation|0|||
130915546|NCT03633617|471327354|FG004|Part C (& Follow-up)|Protocol Violation|0|||
130915547|NCT03633617|471327355|FG005|Part C (& Follow-up)|Protocol Violation|0|||
130915548|NCT03633617|471327356|FG006|Part C (& Follow-up)|Protocol Violation|0|||
130915549|NCT03633617|471327357|FG007|Part C (& Follow-up)|Protocol Violation|0|||
130915550|NCT03633617|471327358|FG008|Part C (& Follow-up)|Protocol Violation|0|||
130915551|NCT03633617|471327359|FG009|Part C (& Follow-up)|Protocol Violation|3|||
130915552|NCT03633617|471327360|FG010|Part C (& Follow-up)|Protocol Violation|1|||
130915553|NCT03633617|471327350|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
130915554|NCT03633617|471327351|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
130915555|NCT03633617|471327352|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
130915556|NCT03633617|471327353|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
130915557|NCT03633617|471327354|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
130915558|NCT03633617|471327355|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
130915559|NCT03633617|471327356|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
130915560|NCT03633617|471327357|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
130915561|NCT03633617|471327358|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
130915562|NCT03633617|471327359|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
130915563|NCT03633617|471327360|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
130915564|NCT00629772|471327365|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
130915565|NCT00629772|471327366|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
130915566|NCT00629772|471327365|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
130915567|NCT00629772|471327366|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
130915568|NCT01393301|471327367|FG000|Overall Study|Lost to Follow-up|5|||
130915569|NCT01393301|471327368|FG001|Overall Study|Lost to Follow-up|3|||
130915570|NCT01393301|471327367|FG000|Overall Study|Withdrawal by Subject|2|||
130915571|NCT01393301|471327368|FG001|Overall Study|Withdrawal by Subject|0|||
130915572|NCT01393301|471327367|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
130915573|NCT01393301|471327368|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
130915574|NCT02758171|471327369|FG000|Wash-out|Withdrawal by Subject|1|||
130915575|NCT02758171|471327370|FG001|Wash-out|Withdrawal by Subject|0|||
130915576|NCT02758171|471327369|FG000|Wash-out|Other reason|1|||
130915577|NCT02758171|471327370|FG001|Wash-out|Other reason|0|||
130915578|NCT00853073|471327371|FG000|Overall Study|Withdrawal by Subject|3|||
130915579|NCT00853073|471327372|FG001|Overall Study|Withdrawal by Subject|2|||
130915580|NCT00722423|471327373|FG000|Overall Study|Protocol Violation|0|||
130915581|NCT00722423|471327374|FG001|Overall Study|Protocol Violation|1|||
130915582|NCT01309165|471327375|FG000|Overall Study|Lost to Follow-up|4|||
130915583|NCT01309165|471327376|FG001|Overall Study|Lost to Follow-up|3|||
130915584|NCT01309165|471327375|FG000|Overall Study|Return to work|1|||
130915585|NCT01309165|471327376|FG001|Overall Study|Return to work|2|||
130915586|NCT01309165|471327375|FG000|Overall Study|Left country|0|||
130915587|NCT01309165|471327376|FG001|Overall Study|Left country|1|||
130915588|NCT01309165|471327375|FG000|Overall Study|No transportation|0|||
130915589|NCT01309165|471327376|FG001|Overall Study|No transportation|1|||
130915590|NCT01309165|471327375|FG000|Overall Study|Admitted to hospital for second stroke|1|||
130915591|NCT01309165|471327376|FG001|Overall Study|Admitted to hospital for second stroke|0|||
130915592|NCT05085730|471327378|FG000|Overall Study|Withdrawal by Subject|4|||
130915593|NCT05085730|471327378|FG000|Overall Study|Physician Decision|1|||
131033219|NCT03269136|471755330|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
131033220|NCT03269136|471755331|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
131033221|NCT03269136|471755332|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
130915594|NCT02038881|471327379|FG000|Overall Study|Withdrawal by Subject|0|||
130915595|NCT02038881|471327380|FG001|Overall Study|Withdrawal by Subject|0|||
130915596|NCT02038881|471327381|FG002|Overall Study|Withdrawal by Subject|1|||
130915597|NCT02038881|471327379|FG000|Overall Study|Lost to Follow-up|2|||
131033222|NCT03269136|471755315|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033223|NCT03269136|471755316|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130915598|NCT02038881|471327380|FG001|Overall Study|Lost to Follow-up|0|||
130915599|NCT02038881|471327381|FG002|Overall Study|Lost to Follow-up|0|||
130915600|NCT02038881|471327379|FG000|Overall Study|incarcerated|1|||
130915601|NCT02038881|471327380|FG001|Overall Study|incarcerated|0|||
130915602|NCT02038881|471327381|FG002|Overall Study|incarcerated|0|||
130915603|NCT00333840|471327382|FG000|First-line Treatment Period|Adverse Event|38|||
130915604|NCT00333840|471327383|FG001|First-line Treatment Period|Adverse Event|37|||
130915605|NCT00333840|471327384|FG002|First-line Treatment Period|Adverse Event|0|||
131119056|NCT00766090|472067294|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131119057|NCT00766090|472067295|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130915606|NCT00333840|471327385|FG003|First-line Treatment Period|Adverse Event|0|||
130915607|NCT00333840|471327382|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
130915608|NCT00333840|471327383|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
131119058|NCT00766090|472067296|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
131119059|NCT00766090|472067297|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131119060|NCT00766090|472067298|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131119061|NCT00766090|472067299|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131119062|NCT00766090|472067288|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
131119063|NCT00766090|472067289|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131119064|NCT00766090|472067290|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131119065|NCT00766090|472067291|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131119066|NCT00766090|472067292|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131119067|NCT00766090|472067293|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131119068|NCT00766090|472067294|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131119069|NCT00766090|472067295|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130915609|NCT00333840|471327384|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
130915610|NCT00333840|471327385|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
130915611|NCT00333840|471327382|FG000|First-line Treatment Period|Abnormal procedure|2|||
130915612|NCT00333840|471327383|FG001|First-line Treatment Period|Abnormal procedure|0|||
130915613|NCT00333840|471327384|FG002|First-line Treatment Period|Abnormal procedure|0|||
130915614|NCT00333840|471327385|FG003|First-line Treatment Period|Abnormal procedure|0|||
130915615|NCT00333840|471327382|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
130915616|NCT00333840|471327383|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
130915617|NCT00333840|471327384|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
130915618|NCT00333840|471327385|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
130915619|NCT00333840|471327382|FG000|First-line Treatment Period|No longer required study drug|21|||
130915620|NCT00333840|471327383|FG001|First-line Treatment Period|No longer required study drug|8|||
130915621|NCT00333840|471327384|FG002|First-line Treatment Period|No longer required study drug|0|||
130915622|NCT00333840|471327385|FG003|First-line Treatment Period|No longer required study drug|0|||
130915623|NCT00333840|471327382|FG000|First-line Treatment Period|Protocol Violation|17|||
131119070|NCT00766090|472067296|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131119071|NCT00766090|472067297|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131119072|NCT00766090|472067298|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131119073|NCT00766090|472067299|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
131119074|NCT00766090|472067288|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
131119075|NCT00766090|472067289|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131119076|NCT00766090|472067290|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131119077|NCT00766090|472067291|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
131119078|NCT00766090|472067292|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131119079|NCT00766090|472067293|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130915624|NCT00333840|471327383|FG001|First-line Treatment Period|Protocol Violation|17|||
130915625|NCT00333840|471327384|FG002|First-line Treatment Period|Protocol Violation|0|||
130915626|NCT00333840|471327385|FG003|First-line Treatment Period|Protocol Violation|0|||
130915627|NCT00333840|471327382|FG000|First-line Treatment Period|Subject withdrew consent|57|||
130915628|NCT00333840|471327383|FG001|First-line Treatment Period|Subject withdrew consent|77|||
130915629|NCT00333840|471327384|FG002|First-line Treatment Period|Subject withdrew consent|0|||
130915630|NCT00333840|471327385|FG003|First-line Treatment Period|Subject withdrew consent|0|||
130915631|NCT00333840|471327382|FG000|First-line Treatment Period|Lost to Follow-up|15|||
130915632|NCT00333840|471327383|FG001|First-line Treatment Period|Lost to Follow-up|6|||
130915633|NCT00333840|471327384|FG002|First-line Treatment Period|Lost to Follow-up|0|||
130915634|NCT00333840|471327385|FG003|First-line Treatment Period|Lost to Follow-up|0|||
130915635|NCT00333840|471327382|FG000|First-line Treatment Period|Administrative problems|12|||
130915636|NCT00333840|471327383|FG001|First-line Treatment Period|Administrative problems|6|||
130915637|NCT00333840|471327384|FG002|First-line Treatment Period|Administrative problems|0|||
130915638|NCT00333840|471327385|FG003|First-line Treatment Period|Administrative problems|0|||
130915639|NCT00333840|471327382|FG000|First-line Treatment Period|Death|19|||
130915640|NCT00333840|471327383|FG001|First-line Treatment Period|Death|2|||
130915641|NCT00333840|471327384|FG002|First-line Treatment Period|Death|0|||
130915642|NCT00333840|471327385|FG003|First-line Treatment Period|Death|0|||
131119080|NCT00766090|472067294|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131119081|NCT00766090|472067295|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130915643|NCT00333840|471327382|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
130915644|NCT00333840|471327383|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
131119082|NCT00766090|472067296|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130915645|NCT00333840|471327384|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
130915646|NCT00333840|471327385|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
130915647|NCT00333840|471327382|FG000|Second-line Treatment Period|Adverse Event|0|||
130915648|NCT00333840|471327383|FG001|Second-line Treatment Period|Adverse Event|0|||
130915649|NCT00333840|471327384|FG002|Second-line Treatment Period|Adverse Event|3|||
130915650|NCT00333840|471327385|FG003|Second-line Treatment Period|Adverse Event|34|||
130915651|NCT00333840|471327382|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
130915652|NCT00333840|471327383|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
130915653|NCT00333840|471327384|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
130915654|NCT00333840|471327385|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
130915655|NCT00333840|471327382|FG000|Second-line Treatment Period|Abnormal procedure|0|||
130915656|NCT00333840|471327383|FG001|Second-line Treatment Period|Abnormal procedure|0|||
130915657|NCT00333840|471327384|FG002|Second-line Treatment Period|Abnormal procedure|0|||
130915658|NCT00333840|471327385|FG003|Second-line Treatment Period|Abnormal procedure|1|||
130915659|NCT00333840|471327382|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
130915660|NCT00333840|471327383|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
130915661|NCT00333840|471327384|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
130915662|NCT00333840|471327385|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
130915663|NCT00333840|471327382|FG000|Second-line Treatment Period|No longer required study drug|0|||
130915664|NCT00333840|471327383|FG001|Second-line Treatment Period|No longer required study drug|0|||
130915665|NCT00333840|471327384|FG002|Second-line Treatment Period|No longer required study drug|1|||
130915666|NCT00333840|471327385|FG003|Second-line Treatment Period|No longer required study drug|14|||
130915667|NCT00333840|471327382|FG000|Second-line Treatment Period|Protocol Violation|0|||
130915668|NCT00333840|471327383|FG001|Second-line Treatment Period|Protocol Violation|0|||
130915669|NCT00333840|471327384|FG002|Second-line Treatment Period|Protocol Violation|1|||
130915670|NCT00333840|471327385|FG003|Second-line Treatment Period|Protocol Violation|10|||
130915671|NCT00333840|471327382|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
130915672|NCT00333840|471327383|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
130915673|NCT00333840|471327384|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
130915674|NCT00333840|471327385|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
130915675|NCT00333840|471327382|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
130915676|NCT00333840|471327383|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
130915677|NCT00333840|471327384|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
130915678|NCT00333840|471327385|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
130915679|NCT00333840|471327382|FG000|Second-line Treatment Period|Administrative problems|0|||
130915680|NCT00333840|471327383|FG001|Second-line Treatment Period|Administrative problems|0|||
130915681|NCT00333840|471327384|FG002|Second-line Treatment Period|Administrative problems|0|||
130915682|NCT00333840|471327385|FG003|Second-line Treatment Period|Administrative problems|7|||
130915683|NCT00333840|471327382|FG000|Second-line Treatment Period|Death|0|||
130915684|NCT00333840|471327383|FG001|Second-line Treatment Period|Death|0|||
130915685|NCT00333840|471327384|FG002|Second-line Treatment Period|Death|0|||
130915686|NCT00333840|471327385|FG003|Second-line Treatment Period|Death|9|||
130915687|NCT01453725|471327386|FG000|Overall Study|Adverse Event|3|||
130915688|NCT01453725|471327387|FG001|Overall Study|Adverse Event|3|||
130915689|NCT01453725|471327386|FG000|Overall Study|Lost to Follow-up|4|||
130915690|NCT01453725|471327387|FG001|Overall Study|Lost to Follow-up|0|||
130915691|NCT01453725|471327386|FG000|Overall Study|Non-compliance With Protocol|1|||
130915692|NCT01453725|471327387|FG001|Overall Study|Non-compliance With Protocol|2|||
130915693|NCT01453725|471327386|FG000|Overall Study|Protocol Violation|1|||
130915694|NCT01453725|471327387|FG001|Overall Study|Protocol Violation|0|||
130915695|NCT01453725|471327386|FG000|Overall Study|Withdrawal by Subject|2|||
130915696|NCT01453725|471327387|FG001|Overall Study|Withdrawal by Subject|3|||
130915697|NCT01453725|471327386|FG000|Overall Study|Pregnancy Wish|0|||
130915698|NCT01453725|471327387|FG001|Overall Study|Pregnancy Wish|2|||
130915699|NCT01453725|471327386|FG000|Overall Study|Pregnancy|1|||
131033224|NCT03269136|471755317|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033225|NCT03269136|471755318|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033226|NCT03269136|471755319|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033227|NCT03269136|471755320|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033228|NCT03269136|471755321|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033229|NCT03269136|471755322|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033230|NCT03269136|471755323|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033231|NCT03269136|471755324|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033232|NCT03269136|471755325|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130915700|NCT01453725|471327387|FG001|Overall Study|Pregnancy|0|||
130915701|NCT01453725|471327386|FG000|Overall Study|Physician Decision|1|||
130915702|NCT01453725|471327387|FG001|Overall Study|Physician Decision|1|||
130915703|NCT00875979|471327396|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
131033233|NCT03269136|471755326|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033234|NCT03269136|471755327|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
130915704|NCT00875979|471327397|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
130915705|NCT00875979|471327396|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
130915706|NCT00875979|471327397|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
130915707|NCT00875979|471327396|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
130915708|NCT00875979|471327397|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
130915709|NCT00875979|471327396|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
130915710|NCT00875979|471327397|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
130915711|NCT00875979|471327396|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
130915712|NCT00875979|471327397|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
130915713|NCT00875979|471327396|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
130915714|NCT00875979|471327397|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
130915715|NCT00875979|471327396|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
130915716|NCT00875979|471327397|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
130915717|NCT00875979|471327396|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
130915718|NCT00875979|471327397|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
130915719|NCT00875979|471327396|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
130915720|NCT00875979|471327397|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
130915721|NCT03719586|471327398|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
130915722|NCT03719586|471327399|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
130915723|NCT03719586|471327400|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
130915724|NCT03719586|471327401|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
130915725|NCT00178633|471327402|FG000|Overall Study|Lost to Follow-up|6|||
131033235|NCT03269136|471755328|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
131033236|NCT03269136|471755329|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
131033237|NCT03269136|471755330|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033238|NCT03269136|471755331|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
131033239|NCT03269136|471755332|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131033240|NCT03269136|471755315|FG000|Part 2A: Dose Expansion|Other|0|||
131033241|NCT03269136|471755316|FG001|Part 2A: Dose Expansion|Other|0|||
131033242|NCT03269136|471755317|FG002|Part 2A: Dose Expansion|Other|0|||
131033243|NCT03269136|471755318|FG003|Part 2A: Dose Expansion|Other|0|||
131033244|NCT03269136|471755319|FG004|Part 2A: Dose Expansion|Other|0|||
130915726|NCT04810481|471327404|FG000|Overall Study|Disqualified data sets|10|||
130915727|NCT04810481|471327405|FG001|Overall Study|Disqualified data sets|28|||
130915728|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
130915729|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
130915730|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Death|1|||
130915731|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Death|0|||
130915732|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
130915733|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
130915734|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
130915735|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
130915736|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
130915737|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
130915738|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
130915739|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
131033245|NCT03269136|471755320|FG005|Part 2A: Dose Expansion|Other|0|||
131033246|NCT03269136|471755321|FG006|Part 2A: Dose Expansion|Other|0|||
131033247|NCT03269136|471755322|FG007|Part 2A: Dose Expansion|Other|0|||
131033248|NCT03269136|471755323|FG008|Part 2A: Dose Expansion|Other|0|||
130915740|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
130915741|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
130915742|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
130915743|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
130915744|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
131033249|NCT03269136|471755324|FG009|Part 2A: Dose Expansion|Other|0|||
131033250|NCT03269136|471755325|FG010|Part 2A: Dose Expansion|Other|0|||
131033251|NCT03269136|471755326|FG011|Part 2A: Dose Expansion|Other|0|||
130915745|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
131033252|NCT03269136|471755327|FG012|Part 2A: Dose Expansion|Other|0|||
131033253|NCT03269136|471755328|FG013|Part 2A: Dose Expansion|Other|0|||
130769177|NCT00548249|470780543|FG001|Overall Study|Miscellaneous|3|||
130915746|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
131033254|NCT03269136|471755329|FG014|Part 2A: Dose Expansion|Other|0|||
131033255|NCT03269136|471755330|FG015|Part 2A: Dose Expansion|Other|0|||
131119083|NCT00766090|472067297|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130915747|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
130915748|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
130915749|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
130915750|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
130915751|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
130915752|NCT02927262|471327406|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
130915753|NCT02927262|471327407|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
130915754|NCT02927262|471327406|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
130915755|NCT02927262|471327407|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
130915756|NCT02927262|471327406|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
130915757|NCT02927262|471327407|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
130915758|NCT02927262|471327406|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
130915759|NCT02927262|471327407|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
130915760|NCT00923936|471327408|FG000|Overall Study|progressive disease on study|2|||
130915761|NCT00923936|471327409|FG001|Overall Study|progressive disease on study|1|||
130915762|NCT00923936|471327408|FG000|Overall Study|Adverse Event|2|||
130915763|NCT00923936|471327409|FG001|Overall Study|Adverse Event|1|||
130915764|NCT00923936|471327408|FG000|Overall Study|Lost to follow up|2|||
130915765|NCT00923936|471327409|FG001|Overall Study|Lost to follow up|0|||
130915766|NCT00923936|471327408|FG000|Overall Study|Continuing in follow up period|2|||
130915767|NCT00923936|471327409|FG001|Overall Study|Continuing in follow up period|1|||
130915768|NCT01697358|471327410|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
130915769|NCT01697358|471327411|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
130915770|NCT01697358|471327410|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
130915771|NCT01697358|471327411|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
130915772|NCT01697358|471327410|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
130915773|NCT01697358|471327411|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
130915774|NCT01697358|471327410|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
130915775|NCT01697358|471327411|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
130915776|NCT01697358|471327410|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
130915777|NCT01697358|471327411|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
130915778|NCT01697358|471327410|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
130915779|NCT01697358|471327411|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
130915780|NCT01697358|471327410|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
130915781|NCT01697358|471327411|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
130915782|NCT01697358|471327410|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
130915783|NCT01697358|471327411|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
130915784|NCT01697358|471327410|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
130915785|NCT01697358|471327411|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
130915786|NCT01697358|471327410|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
130915787|NCT01697358|471327411|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
130915788|NCT00471146|471327412|FG000|Overall Study|Adverse Event|32|||
130915789|NCT00471146|471327413|FG001|Overall Study|Adverse Event|33|||
130915790|NCT00471146|471327412|FG000|Overall Study|Withdrawal by Subject|14|||
130915791|NCT00471146|471327413|FG001|Overall Study|Withdrawal by Subject|11|||
130915792|NCT00471146|471327412|FG000|Overall Study|Death|11|||
130915793|NCT00471146|471327413|FG001|Overall Study|Death|12|||
130915794|NCT00471146|471327412|FG000|Overall Study|Lost to Follow-up|4|||
130915795|NCT00471146|471327413|FG001|Overall Study|Lost to Follow-up|2|||
130915796|NCT00471146|471327412|FG000|Overall Study|Protocol Violation|2|||
130915797|NCT00471146|471327413|FG001|Overall Study|Protocol Violation|2|||
130915798|NCT00471146|471327412|FG000|Overall Study|Objective progression or relapse|84|||
130915799|NCT00471146|471327413|FG001|Overall Study|Objective progression or relapse|87|||
130915800|NCT00471146|471327412|FG000|Overall Study|Global deterioration of health status|12|||
130915801|NCT00471146|471327413|FG001|Overall Study|Global deterioration of health status|14|||
130915802|NCT00471146|471327412|FG000|Overall Study|Randomized but not treated|9|||
130915803|NCT00471146|471327413|FG001|Overall Study|Randomized but not treated|8|||
130915804|NCT00471146|471327412|FG000|Overall Study|Other|4|||
130915805|NCT00471146|471327413|FG001|Overall Study|Other|5|||
131033256|NCT03269136|471755331|FG016|Part 2A: Dose Expansion|Other|0|||
130915806|NCT05394350|471327414|FG000|Overall Study|Death|2|||
131033257|NCT03269136|471755332|FG017|Part 2A: Dose Expansion|Other|1|||
131033258|NCT03269136|471755315|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131033259|NCT03269136|471755316|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130915807|NCT05394350|471327415|FG001|Overall Study|Death|2|||
130915808|NCT05394350|471327416|FG002|Overall Study|Death|4|||
130915809|NCT05394350|471327417|FG003|Overall Study|Death|0|||
130915810|NCT05394350|471327418|FG004|Overall Study|Death|1|||
130915811|NCT05394350|471327419|FG005|Overall Study|Death|0|||
130915812|NCT05394350|471327414|FG000|Overall Study|Study terminated by sponsor|1|||
130915813|NCT05394350|471327415|FG001|Overall Study|Study terminated by sponsor|1|||
130915814|NCT05394350|471327416|FG002|Overall Study|Study terminated by sponsor|7|||
130915815|NCT05394350|471327417|FG003|Overall Study|Study terminated by sponsor|3|||
130915816|NCT05394350|471327418|FG004|Overall Study|Study terminated by sponsor|2|||
130915817|NCT05394350|471327419|FG005|Overall Study|Study terminated by sponsor|4|||
130915818|NCT02963935|471327422|FG000|Overall Study|Adverse Event|12|||
130915819|NCT02963935|471327423|FG001|Overall Study|Adverse Event|6|||
130915820|NCT02963935|471327422|FG000|Overall Study|Protocol Violation|2|||
130915821|NCT02963935|471327423|FG001|Overall Study|Protocol Violation|1|||
130915822|NCT02963935|471327422|FG000|Overall Study|Lack of Efficacy|0|||
130915823|NCT02963935|471327423|FG001|Overall Study|Lack of Efficacy|2|||
130915824|NCT02963935|471327422|FG000|Overall Study|Lost to Follow-up|1|||
130915825|NCT02963935|471327423|FG001|Overall Study|Lost to Follow-up|6|||
130915826|NCT02963935|471327422|FG000|Overall Study|Unclassified|13|||
130915827|NCT02963935|471327423|FG001|Overall Study|Unclassified|22|||
130915828|NCT00464269|471327424|FG000|Overall Study|Lack of Efficacy|1|||
130915829|NCT00464269|471327425|FG001|Overall Study|Lack of Efficacy|0|||
130915830|NCT00464269|471327426|FG002|Overall Study|Lack of Efficacy|0|||
130915831|NCT00464269|471327427|FG003|Overall Study|Lack of Efficacy|0|||
130915832|NCT00464269|471327424|FG000|Overall Study|Lost to Follow-up|0|||
130915833|NCT00464269|471327425|FG001|Overall Study|Lost to Follow-up|4|||
130915834|NCT00464269|471327426|FG002|Overall Study|Lost to Follow-up|0|||
130915835|NCT00464269|471327427|FG003|Overall Study|Lost to Follow-up|1|||
130915836|NCT00464269|471327424|FG000|Overall Study|Withdrawal by Subject|0|||
130915837|NCT00464269|471327425|FG001|Overall Study|Withdrawal by Subject|2|||
130915838|NCT00464269|471327426|FG002|Overall Study|Withdrawal by Subject|1|||
130915839|NCT00464269|471327427|FG003|Overall Study|Withdrawal by Subject|1|||
130915840|NCT00464269|471327424|FG000|Overall Study|Other reason|3|||
130915841|NCT00464269|471327425|FG001|Overall Study|Other reason|3|||
130915842|NCT00464269|471327426|FG002|Overall Study|Other reason|1|||
130915843|NCT00464269|471327427|FG003|Overall Study|Other reason|1|||
130915844|NCT00464269|471327424|FG000|Overall Study|AE, serious fatal|0|||
130915845|NCT00464269|471327425|FG001|Overall Study|AE, serious fatal|0|||
130915846|NCT00464269|471327426|FG002|Overall Study|AE, serious fatal|1|||
130915847|NCT00464269|471327427|FG003|Overall Study|AE, serious fatal|1|||
130915848|NCT00464269|471327424|FG000|Overall Study|SAE, non-fatal|0|||
130915849|NCT00464269|471327425|FG001|Overall Study|SAE, non-fatal|0|||
130915850|NCT00464269|471327426|FG002|Overall Study|SAE, non-fatal|0|||
130915851|NCT00464269|471327427|FG003|Overall Study|SAE, non-fatal|1|||
130915852|NCT00464269|471327424|FG000|Overall Study|AE, non-serious non-fatal|2|||
130915853|NCT00464269|471327425|FG001|Overall Study|AE, non-serious non-fatal|8|||
130915854|NCT00464269|471327426|FG002|Overall Study|AE, non-serious non-fatal|3|||
130915855|NCT00464269|471327427|FG003|Overall Study|AE, non-serious non-fatal|4|||
130915856|NCT00464269|471327424|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130915857|NCT00464269|471327425|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130915858|NCT00464269|471327426|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
130915859|NCT00464269|471327427|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130915860|NCT05055128|471327428|FG000|Overall Study|Adverse Event|0|||
130915861|NCT05055128|471327429|FG001|Overall Study|Adverse Event|0|||
130915862|NCT05055128|471327430|FG002|Overall Study|Adverse Event|0|||
130915863|NCT05055128|471327431|FG003|Overall Study|Adverse Event|1|||
130915864|NCT05055128|471327432|FG004|Overall Study|Adverse Event|1|||
130699344|NCT01453153|470524638|FG000|Overall Study|Adverse Event|1|||
130699345|NCT01453153|470524639|FG001|Overall Study|Adverse Event|1|||
130699346|NCT01453153|470524640|FG002|Overall Study|Adverse Event|1|||
130699347|NCT01802216|470524642|FG000|4 Month Visit|Participant did not show to visit|3|||
130699348|NCT01802216|470524643|FG001|4 Month Visit|Participant did not show to visit|4|||
130699349|NCT01802216|470524642|FG000|8 Month Visit|Participant did not show to visit|3|||
130699350|NCT01802216|470524643|FG001|8 Month Visit|Participant did not show to visit|5|||
130699351|NCT01802216|470524642|FG000|12 Month Visit|Participant did not show to visit|3|||
130699352|NCT01802216|470524643|FG001|12 Month Visit|Participant did not show to visit|4|||
130699353|NCT00880334|470524644|FG000|Randomized Phase|Physician Decision|1|||
130699354|NCT00880334|470524645|FG001|Randomized Phase|Physician Decision|0|||
130699355|NCT00880334|470524644|FG000|Randomized Phase|Withdrawal by Subject|2|||
130699356|NCT00880334|470524645|FG001|Randomized Phase|Withdrawal by Subject|1|||
130699357|NCT00880334|470524644|FG000|Randomized Phase|Inadequate Labs|1|||
130699358|NCT00880334|470524645|FG001|Randomized Phase|Inadequate Labs|1|||
130699359|NCT00880334|470524644|FG000|Randomized Phase|Brain Metastasis|0|||
130699360|NCT00880334|470524645|FG001|Randomized Phase|Brain Metastasis|1|||
130699361|NCT00880334|470524644|FG000|Randomized Phase|Crossover Participants|0|||
130699362|NCT00880334|470524645|FG001|Randomized Phase|Crossover Participants|37|||
130699363|NCT05061992|470524650|FG000|Overall Study|Excess bowel movements|1|||
130699364|NCT05061992|470524651|FG001|Overall Study|Excess bowel movements|0|||
130699365|NCT05061992|470524650|FG000|Overall Study|Complications of Medical Care|1|||
130699366|NCT05061992|470524651|FG001|Overall Study|Complications of Medical Care|0|||
130699367|NCT05061992|470524650|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
130915865|NCT05055128|471327428|FG000|Overall Study|Protocol Violation|0|||
130915866|NCT05055128|471327429|FG001|Overall Study|Protocol Violation|0|||
130915867|NCT05055128|471327430|FG002|Overall Study|Protocol Violation|0|||
130915868|NCT05055128|471327431|FG003|Overall Study|Protocol Violation|1|||
130915869|NCT05055128|471327432|FG004|Overall Study|Protocol Violation|0|||
130915870|NCT05055128|471327428|FG000|Overall Study|Withdrawal by Subject|5|||
130915871|NCT05055128|471327429|FG001|Overall Study|Withdrawal by Subject|2|||
130915872|NCT05055128|471327430|FG002|Overall Study|Withdrawal by Subject|2|||
130915873|NCT05055128|471327431|FG003|Overall Study|Withdrawal by Subject|4|||
130915874|NCT05055128|471327432|FG004|Overall Study|Withdrawal by Subject|2|||
130915875|NCT05055128|471327428|FG000|Overall Study|Randomized By Mistake|0|||
130915876|NCT05055128|471327429|FG001|Overall Study|Randomized By Mistake|1|||
130915877|NCT05055128|471327430|FG002|Overall Study|Randomized By Mistake|0|||
130915878|NCT05055128|471327431|FG003|Overall Study|Randomized By Mistake|0|||
130915879|NCT05055128|471327432|FG004|Overall Study|Randomized By Mistake|0|||
130915880|NCT05055128|471327428|FG000|Overall Study|Other|1|||
130915881|NCT05055128|471327429|FG001|Overall Study|Other|0|||
130915882|NCT05055128|471327430|FG002|Overall Study|Other|0|||
130915883|NCT05055128|471327431|FG003|Overall Study|Other|0|||
130915884|NCT05055128|471327432|FG004|Overall Study|Other|0|||
130915885|NCT01460368|471327433|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130915886|NCT01460368|471327434|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130915887|NCT01460368|471327435|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130915888|NCT01460368|471327436|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130915889|NCT01460368|471327437|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
130915890|NCT01460368|471327438|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130915891|NCT01460368|471327439|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
130915892|NCT01460368|471327433|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
130915893|NCT01460368|471327434|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
130915894|NCT01460368|471327435|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
130915895|NCT01460368|471327436|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
130915896|NCT01460368|471327437|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
130915897|NCT01460368|471327438|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
130915898|NCT01460368|471327439|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
130915899|NCT01460368|471327433|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130915900|NCT01460368|471327434|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
130915901|NCT01460368|471327435|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130915902|NCT01460368|471327436|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130915903|NCT01460368|471327437|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130915904|NCT01460368|471327438|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130915905|NCT01460368|471327439|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
130915906|NCT01460368|471327433|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130915907|NCT01460368|471327434|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130915908|NCT01460368|471327435|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
130915909|NCT01460368|471327436|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130915910|NCT01460368|471327437|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130915911|NCT01460368|471327438|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130915912|NCT01460368|471327439|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130915913|NCT01460368|471327433|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
130915914|NCT01460368|471327434|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
130915915|NCT01460368|471327435|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
130915916|NCT01460368|471327436|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
130915917|NCT01460368|471327437|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
130915918|NCT01460368|471327438|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
130915919|NCT01460368|471327439|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
130915920|NCT02149875|471327446|FG000|Overall Study|Lost to Follow-up|3|||
130915921|NCT02149875|471327447|FG001|Overall Study|Lost to Follow-up|4|||
130915922|NCT02149875|471327448|FG002|Overall Study|Lost to Follow-up|5|||
130915923|NCT02149875|471327446|FG000|Overall Study|Withdrawal by Subject|3|||
130915924|NCT02149875|471327447|FG001|Overall Study|Withdrawal by Subject|2|||
130915925|NCT02149875|471327448|FG002|Overall Study|Withdrawal by Subject|2|||
130915926|NCT02149875|471327446|FG000|Overall Study|Physician Decision|1|||
131119084|NCT00766090|472067298|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131119085|NCT00766090|472067299|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131119086|NCT00766090|472067288|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
131119087|NCT00766090|472067289|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
130915927|NCT02149875|471327447|FG001|Overall Study|Physician Decision|2|||
130915928|NCT02149875|471327448|FG002|Overall Study|Physician Decision|2|||
130915929|NCT01385371|471327449|FG000|Overall Study|Adverse Event|54|||
130699368|NCT05061992|470524651|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
131119088|NCT00766090|472067290|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
131119089|NCT00766090|472067291|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
131119090|NCT00766090|472067292|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
131119091|NCT00766090|472067293|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
131119092|NCT00766090|472067294|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
131119093|NCT00766090|472067295|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
130699369|NCT05061992|470524650|FG000|Overall Study|Withdrawal by Subject|0|||
130915930|NCT01385371|471327450|FG001|Overall Study|Adverse Event|19|||
130915931|NCT01385371|471327449|FG000|Overall Study|Lost to Follow-up|16|||
130915932|NCT01385371|471327450|FG001|Overall Study|Lost to Follow-up|16|||
130915933|NCT01385371|471327449|FG000|Overall Study|Withdrawal by Subject|52|||
130915934|NCT01385371|471327450|FG001|Overall Study|Withdrawal by Subject|39|||
130915935|NCT01385371|471327449|FG000|Overall Study|Protocol Violation|25|||
130915936|NCT01385371|471327450|FG001|Overall Study|Protocol Violation|21|||
130915937|NCT01385371|471327449|FG000|Overall Study|Administrative|2|||
130915938|NCT01385371|471327450|FG001|Overall Study|Administrative|2|||
130915939|NCT02478372|471327451|FG000|Overall Study|Protocol Violation|12|||
130915940|NCT02478372|471327452|FG001|Overall Study|Protocol Violation|8|||
130915941|NCT02478372|471327451|FG000|Overall Study|Lost to Follow-up|1|||
130915942|NCT02478372|471327452|FG001|Overall Study|Lost to Follow-up|4|||
130915943|NCT02478372|471327451|FG000|Overall Study|Death|0|||
130915944|NCT02478372|471327452|FG001|Overall Study|Death|2|||
130915945|NCT01565642|471327454|FG000|Overall Study|Withdrawal by Subject|2|||
130915946|NCT01565642|471327455|FG001|Overall Study|Withdrawal by Subject|1|||
130915947|NCT02955797|471327456|FG000|Overall Study|Protocol Violation|1|||
130915948|NCT02955797|471327457|FG001|Overall Study|Protocol Violation|0|||
130915949|NCT02955797|471327458|FG002|Overall Study|Protocol Violation|0|||
130915950|NCT02955797|471327459|FG003|Overall Study|Protocol Violation|1|||
130915951|NCT02955797|471327456|FG000|Overall Study|Withdrawal by Subject|2|||
130915952|NCT02955797|471327457|FG001|Overall Study|Withdrawal by Subject|2|||
130915953|NCT02955797|471327458|FG002|Overall Study|Withdrawal by Subject|0|||
130915954|NCT02955797|471327459|FG003|Overall Study|Withdrawal by Subject|1|||
130915955|NCT02955797|471327456|FG000|Overall Study|Lost to Follow-up|0|||
130915956|NCT02955797|471327457|FG001|Overall Study|Lost to Follow-up|1|||
130915957|NCT02955797|471327458|FG002|Overall Study|Lost to Follow-up|0|||
130915958|NCT02955797|471327459|FG003|Overall Study|Lost to Follow-up|0|||
130915959|NCT01898208|471327462|FG000|Overall Study|Positive blood culture|17|||
130915960|NCT01898208|471327463|FG001|Overall Study|Positive blood culture|23|||
130915961|NCT01898208|471327464|FG002|Overall Study|Positive blood culture|15|||
130915962|NCT01898208|471327462|FG000|Overall Study|Death/comfort care within 24 hours|10|||
130915963|NCT01898208|471327463|FG001|Overall Study|Death/comfort care within 24 hours|9|||
130915964|NCT01898208|471327464|FG002|Overall Study|Death/comfort care within 24 hours|8|||
130915965|NCT01898208|471327462|FG000|Overall Study|Negative Gram Stain|6|||
130915966|NCT01898208|471327463|FG001|Overall Study|Negative Gram Stain|9|||
130915967|NCT01898208|471327464|FG002|Overall Study|Negative Gram Stain|6|||
130915968|NCT01898208|471327462|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
130915969|NCT01898208|471327463|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
130915970|NCT01898208|471327464|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
130915971|NCT01898208|471327462|FG000|Overall Study|System/Technical Error|1|||
130915972|NCT01898208|471327463|FG001|Overall Study|System/Technical Error|2|||
130915973|NCT01898208|471327464|FG002|Overall Study|System/Technical Error|3|||
130915974|NCT01898208|471327462|FG000|Overall Study|Lost to Follow-up|3|||
130915975|NCT01898208|471327463|FG001|Overall Study|Lost to Follow-up|1|||
130915976|NCT01898208|471327464|FG002|Overall Study|Lost to Follow-up|1|||
131119094|NCT00766090|472067296|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
130699370|NCT05061992|470524651|FG001|Overall Study|Withdrawal by Subject|1|||
130699371|NCT02473393|470524652|FG000|Overall Study|Adverse Event|0|||
130699372|NCT02473393|470524653|FG001|Overall Study|Adverse Event|0|||
130699373|NCT02473393|470524654|FG002|Overall Study|Adverse Event|1|||
130699374|NCT02473393|470524655|FG003|Overall Study|Adverse Event|0|||
130915977|NCT03001882|471327470|FG000|Overall Study|Death|1|||
131119095|NCT00766090|472067297|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
131119096|NCT00766090|472067298|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
130699375|NCT02473393|470524652|FG000|Overall Study|Withdrawal by Subject|0|||
130699376|NCT02473393|470524653|FG001|Overall Study|Withdrawal by Subject|0|||
130699377|NCT02473393|470524654|FG002|Overall Study|Withdrawal by Subject|1|||
130699378|NCT02473393|470524655|FG003|Overall Study|Withdrawal by Subject|1|||
130915978|NCT03001882|471327471|FG001|Overall Study|Death|0|||
130915979|NCT03001882|471327472|FG002|Overall Study|Death|0|||
130915980|NCT03001882|471327473|FG003|Overall Study|Death|3|||
130915981|NCT03001882|471327470|FG000|Overall Study|Participant withdrew consent|0|||
130915982|NCT03001882|471327471|FG001|Overall Study|Participant withdrew consent|1|||
130915983|NCT03001882|471327472|FG002|Overall Study|Participant withdrew consent|0|||
130915984|NCT03001882|471327473|FG003|Overall Study|Participant withdrew consent|5|||
130915985|NCT03001882|471327470|FG000|Overall Study|Other reasons|1|||
130915986|NCT03001882|471327471|FG001|Overall Study|Other reasons|2|||
130915987|NCT03001882|471327472|FG002|Overall Study|Other reasons|0|||
130915988|NCT03001882|471327473|FG003|Overall Study|Other reasons|5|||
130915989|NCT03001882|471327470|FG000|Overall Study|Administrative reason by sponsor|0|||
130915990|NCT03001882|471327471|FG001|Overall Study|Administrative reason by sponsor|0|||
130915991|NCT03001882|471327472|FG002|Overall Study|Administrative reason by sponsor|0|||
130915992|NCT03001882|471327473|FG003|Overall Study|Administrative reason by sponsor|1|||
130915993|NCT03001882|471327470|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
130915994|NCT03001882|471327471|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
130915995|NCT03001882|471327472|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
130915996|NCT03001882|471327473|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
130915997|NCT03001882|471327470|FG000|Overall Study|Not reported|0|||
130915998|NCT03001882|471327471|FG001|Overall Study|Not reported|0|||
130915999|NCT03001882|471327472|FG002|Overall Study|Not reported|0|||
130916000|NCT03001882|471327473|FG003|Overall Study|Not reported|6|||
130916001|NCT03001882|471327470|FG000|Overall Study|Maximum clinical benefit|2|||
130916002|NCT03001882|471327471|FG001|Overall Study|Maximum clinical benefit|3|||
130916003|NCT03001882|471327472|FG002|Overall Study|Maximum clinical benefit|0|||
130916004|NCT03001882|471327473|FG003|Overall Study|Maximum clinical benefit|10|||
130916005|NCT03001882|471327470|FG000|Overall Study|AE unrelated to study drug|3|||
130916006|NCT03001882|471327471|FG001|Overall Study|AE unrelated to study drug|3|||
130916007|NCT03001882|471327472|FG002|Overall Study|AE unrelated to study drug|0|||
130916008|NCT03001882|471327473|FG003|Overall Study|AE unrelated to study drug|11|||
130916009|NCT03001882|471327470|FG000|Overall Study|Study Drug Toxicity|8|||
130916010|NCT03001882|471327471|FG001|Overall Study|Study Drug Toxicity|5|||
130916011|NCT03001882|471327472|FG002|Overall Study|Study Drug Toxicity|0|||
130916012|NCT03001882|471327473|FG003|Overall Study|Study Drug Toxicity|37|||
130916013|NCT03001882|471327470|FG000|Overall Study|Disease progression|16|||
130916014|NCT03001882|471327471|FG001|Overall Study|Disease progression|14|||
130916015|NCT03001882|471327472|FG002|Overall Study|Disease progression|1|||
130916016|NCT03001882|471327473|FG003|Overall Study|Disease progression|90|||
130916017|NCT00589290|471327474|FG000|Overall Study|Withdrawal by Subject|1|||
130916018|NCT01067976|471327475|FG000|Overall Study|Study drug never administered|20|||
130916019|NCT01067976|471327475|FG000|Overall Study|Study prematurely discontinued|2|||
130916020|NCT00566111|471327476|FG000|Overall Study|Adverse Event|0|||
130916021|NCT00566111|471327477|FG001|Overall Study|Adverse Event|2|||
130916022|NCT01554397|471327480|FG000|Overall Study|Withdrawal by Subject|1|||
130916023|NCT01554397|471327481|FG001|Overall Study|Withdrawal by Subject|0|||
130916024|NCT01554397|471327480|FG000|Overall Study|Ineligible|7|||
130916025|NCT01554397|471327481|FG001|Overall Study|Ineligible|0|||
130916026|NCT02497612|471329617|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
130916027|NCT02497612|471329618|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
130916028|NCT02497612|471329619|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
130916029|NCT02497612|471329620|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
130916030|NCT02497612|471329617|FG000|Overall Study|Participant's request|2|||
130916031|NCT02497612|471329618|FG001|Overall Study|Participant's request|3|||
130916032|NCT02497612|471329619|FG002|Overall Study|Participant's request|4|||
130916033|NCT02497612|471329620|FG003|Overall Study|Participant's request|1|||
130916034|NCT02497612|471329617|FG000|Overall Study|Investigator's judgement|1|||
130916035|NCT02497612|471329618|FG001|Overall Study|Investigator's judgement|0|||
130916036|NCT02497612|471329619|FG002|Overall Study|Investigator's judgement|0|||
130916037|NCT02497612|471329620|FG003|Overall Study|Investigator's judgement|2|||
130916038|NCT02497612|471329617|FG000|Overall Study|Adverse Event|3|||
130916039|NCT02497612|471329618|FG001|Overall Study|Adverse Event|1|||
130916040|NCT02497612|471329619|FG002|Overall Study|Adverse Event|4|||
130916041|NCT02497612|471329620|FG003|Overall Study|Adverse Event|1|||
130916042|NCT02497612|471329617|FG000|Overall Study|Lost to Follow-up|1|||
130916043|NCT02497612|471329618|FG001|Overall Study|Lost to Follow-up|1|||
130916044|NCT02497612|471329619|FG002|Overall Study|Lost to Follow-up|0|||
130916045|NCT02497612|471329620|FG003|Overall Study|Lost to Follow-up|1|||
130916046|NCT02497612|471329617|FG000|Overall Study|Other unspecified|1|||
130916047|NCT02497612|471329618|FG001|Overall Study|Other unspecified|1|||
130916048|NCT02497612|471329619|FG002|Overall Study|Other unspecified|2|||
130916049|NCT02497612|471329620|FG003|Overall Study|Other unspecified|0|||
130916050|NCT02497612|471329617|FG000|Overall Study|Not eligible|1|||
130916051|NCT02497612|471329618|FG001|Overall Study|Not eligible|0|||
130916052|NCT02497612|471329619|FG002|Overall Study|Not eligible|0|||
130916053|NCT02497612|471329620|FG003|Overall Study|Not eligible|1|||
130916054|NCT02651467|471329621|FG000|Overall Study|Withdrawal by Subject|0|||
130916055|NCT02651467|471329622|FG001|Overall Study|Withdrawal by Subject|0|||
130916056|NCT02651467|471329623|FG002|Overall Study|Withdrawal by Subject|2|||
130916057|NCT02651467|471329621|FG000|Overall Study|Other (Not specified)|1|||
130916058|NCT02651467|471329622|FG001|Overall Study|Other (Not specified)|0|||
130916059|NCT02651467|471329623|FG002|Overall Study|Other (Not specified)|2|||
130916060|NCT02024529|471329624|FG000|Overall Study|Withdrawal by Subject|11|||
130916061|NCT02024529|471329625|FG001|Overall Study|Withdrawal by Subject|21|||
130916062|NCT02024529|471329624|FG000|Overall Study|Lost to Follow-up|2|||
130916063|NCT02024529|471329625|FG001|Overall Study|Lost to Follow-up|4|||
131119097|NCT00766090|472067299|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
131119098|NCT00766090|472067288|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119099|NCT00766090|472067289|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119100|NCT00766090|472067290|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119101|NCT00766090|472067291|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119102|NCT00766090|472067292|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
131119103|NCT00766090|472067293|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119104|NCT00766090|472067294|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119105|NCT00766090|472067295|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119106|NCT00766090|472067296|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119107|NCT00766090|472067297|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119108|NCT00766090|472067298|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119109|NCT00766090|472067299|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131119110|NCT00766090|472067288|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119111|NCT00766090|472067289|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119112|NCT00766090|472067290|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
131119113|NCT00766090|472067291|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119114|NCT00766090|472067292|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119115|NCT00766090|472067293|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119116|NCT00766090|472067294|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119117|NCT00766090|472067295|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119118|NCT00766090|472067296|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119119|NCT00766090|472067297|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119120|NCT00766090|472067298|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119121|NCT00766090|472067299|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
131119122|NCT00766090|472067288|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
131119123|NCT00766090|472067289|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
131119124|NCT00766090|472067290|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
131119125|NCT00766090|472067291|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
131119126|NCT00766090|472067292|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
131119127|NCT00766090|472067293|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
131119128|NCT00766090|472067294|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
131119129|NCT00766090|472067295|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
131119130|NCT00766090|472067296|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
131119131|NCT00766090|472067297|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
131119132|NCT00766090|472067298|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
131119133|NCT00766090|472067299|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
131119134|NCT00766090|472067288|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119135|NCT00766090|472067289|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119136|NCT00766090|472067290|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119137|NCT00766090|472067291|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119138|NCT00766090|472067292|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119139|NCT00766090|472067293|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
131119140|NCT00766090|472067294|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119141|NCT00766090|472067295|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119142|NCT00766090|472067296|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119143|NCT00766090|472067297|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119144|NCT00766090|472067298|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119145|NCT00766090|472067299|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
131119146|NCT00766090|472067288|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131119147|NCT00766090|472067289|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
131119148|NCT00766090|472067290|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131119149|NCT00766090|472067291|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
131119150|NCT00766090|472067292|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131119151|NCT00766090|472067293|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131119152|NCT00766090|472067294|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131119153|NCT00766090|472067295|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130699379|NCT02274558|470524656|FG000|Overall Study|Adverse Event|2|||
130699380|NCT02274558|470524657|FG001|Overall Study|Adverse Event|4|||
130699381|NCT02274558|470524658|FG002|Overall Study|Adverse Event|2|||
130699382|NCT02274558|470524656|FG000|Overall Study|Non-compliance|2|||
130699383|NCT02274558|470524657|FG001|Overall Study|Non-compliance|1|||
130916064|NCT00354614|471329626|FG000|Overall Study|Lack of Efficacy|28|||
130699384|NCT02274558|470524658|FG002|Overall Study|Non-compliance|0|||
131119154|NCT00766090|472067296|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131119155|NCT00766090|472067297|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131119156|NCT00766090|472067298|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
131119157|NCT00766090|472067299|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
131119158|NCT00766090|472067288|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131119159|NCT00766090|472067289|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131119160|NCT00766090|472067290|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130916065|NCT01890746|471329627|FG000|Overall Study|Death|39|||
130916066|NCT01890746|471329628|FG001|Overall Study|Death|30|||
130916067|NCT01890746|471329627|FG000|Overall Study|Adverse Event|1|||
130916068|NCT01890746|471329628|FG001|Overall Study|Adverse Event|0|||
130916069|NCT01890746|471329627|FG000|Overall Study|Lost to Follow-up|4|||
130916070|NCT01890746|471329628|FG001|Overall Study|Lost to Follow-up|1|||
130916071|NCT01890746|471329627|FG000|Overall Study|Physician Decision|3|||
130916072|NCT01890746|471329628|FG001|Overall Study|Physician Decision|2|||
130916073|NCT01890746|471329627|FG000|Overall Study|Withdrawal by Subject|5|||
130916074|NCT01890746|471329628|FG001|Overall Study|Withdrawal by Subject|8|||
130916075|NCT02642029|471329629|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
130916076|NCT02642029|471329630|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
130916077|NCT02642029|471329631|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
130916078|NCT02642029|471329632|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
130916079|NCT02642029|471329633|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
130916080|NCT02642029|471329634|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
130916081|NCT02642029|471329629|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
130916082|NCT02642029|471329630|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
130916083|NCT02642029|471329631|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
130916084|NCT02642029|471329632|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
130916085|NCT02642029|471329633|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
130916086|NCT02642029|471329634|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
130916087|NCT02642029|471329629|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
130916088|NCT02642029|471329630|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
130916089|NCT02642029|471329631|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
130916090|NCT02642029|471329632|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
130916091|NCT02642029|471329633|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
130916092|NCT02642029|471329634|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
130916093|NCT02642029|471329629|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
130916094|NCT02642029|471329630|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
130916095|NCT02642029|471329631|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
130916096|NCT02642029|471329632|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
130916097|NCT02642029|471329633|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
130916098|NCT02642029|471329634|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
130916099|NCT02642029|471329629|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
130916100|NCT02642029|471329630|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
130916101|NCT02642029|471329631|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
130916102|NCT02642029|471329632|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
130916103|NCT02642029|471329633|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
130916104|NCT02642029|471329634|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
130916105|NCT02642029|471329629|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
130916106|NCT02642029|471329630|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130916107|NCT02642029|471329631|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130916108|NCT02642029|471329632|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130916109|NCT02642029|471329633|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130916110|NCT02642029|471329634|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130916111|NCT01134731|471329636|FG000|Overall Study|Adverse Event|3|||
130916112|NCT01134731|471329637|FG001|Overall Study|Adverse Event|2|||
130916113|NCT01134731|471329638|FG002|Overall Study|Adverse Event|1|||
130916114|NCT01134731|471329636|FG000|Overall Study|Physician Decision|2|||
130916115|NCT01134731|471329637|FG001|Overall Study|Physician Decision|2|||
130916116|NCT01134731|471329638|FG002|Overall Study|Physician Decision|2|||
130916117|NCT01134731|471329636|FG000|Overall Study|Lack of Efficacy|0|||
130916118|NCT01134731|471329637|FG001|Overall Study|Lack of Efficacy|0|||
130916119|NCT01134731|471329638|FG002|Overall Study|Lack of Efficacy|1|||
130916120|NCT01134731|471329636|FG000|Overall Study|Withdrawal by Subject|3|||
130916121|NCT01134731|471329637|FG001|Overall Study|Withdrawal by Subject|3|||
130916122|NCT01134731|471329638|FG002|Overall Study|Withdrawal by Subject|1|||
130916123|NCT01134731|471329636|FG000|Overall Study|Lost to Follow-up|5|||
131033260|NCT03269136|471755317|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131033261|NCT03269136|471755318|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131033262|NCT03269136|471755319|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131033263|NCT03269136|471755320|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131033264|NCT03269136|471755321|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130916124|NCT01134731|471329637|FG001|Overall Study|Lost to Follow-up|4|||
130916125|NCT01134731|471329638|FG002|Overall Study|Lost to Follow-up|3|||
130916126|NCT00676338|471329639|FG000|Overall Study|Adverse Event|6|||
130916127|NCT00676338|471329640|FG001|Overall Study|Adverse Event|6|||
130916128|NCT00676338|471329641|FG002|Overall Study|Adverse Event|5|||
131033265|NCT03269136|471755322|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131033266|NCT03269136|471755323|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130916129|NCT00676338|471329642|FG003|Overall Study|Adverse Event|1|||
130916130|NCT00676338|471329639|FG000|Overall Study|Lost to Follow-up|4|||
130916131|NCT00676338|471329640|FG001|Overall Study|Lost to Follow-up|1|||
130916132|NCT00676338|471329641|FG002|Overall Study|Lost to Follow-up|3|||
130916133|NCT00676338|471329642|FG003|Overall Study|Lost to Follow-up|4|||
130916134|NCT00676338|471329639|FG000|Overall Study|Physician Decision|3|||
130916135|NCT00676338|471329640|FG001|Overall Study|Physician Decision|3|||
130916136|NCT00676338|471329641|FG002|Overall Study|Physician Decision|2|||
130916137|NCT00676338|471329642|FG003|Overall Study|Physician Decision|3|||
130916138|NCT00676338|471329639|FG000|Overall Study|Protocol Violation|5|||
130916139|NCT00676338|471329640|FG001|Overall Study|Protocol Violation|9|||
130916140|NCT00676338|471329641|FG002|Overall Study|Protocol Violation|2|||
130916141|NCT00676338|471329642|FG003|Overall Study|Protocol Violation|5|||
130916142|NCT00676338|471329639|FG000|Overall Study|Withdrawal by Subject|17|||
130916143|NCT00676338|471329640|FG001|Overall Study|Withdrawal by Subject|9|||
130916144|NCT00676338|471329641|FG002|Overall Study|Withdrawal by Subject|12|||
130916145|NCT00676338|471329642|FG003|Overall Study|Withdrawal by Subject|6|||
130916146|NCT00676338|471329639|FG000|Overall Study|Entry Criteria Not Met|0|||
130916147|NCT00676338|471329640|FG001|Overall Study|Entry Criteria Not Met|2|||
130916148|NCT00676338|471329641|FG002|Overall Study|Entry Criteria Not Met|1|||
130916149|NCT00676338|471329642|FG003|Overall Study|Entry Criteria Not Met|1|||
130916150|NCT00676338|471329639|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
130916151|NCT00676338|471329640|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
130916152|NCT00676338|471329641|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
130916153|NCT00676338|471329642|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
130916154|NCT02122458|471329643|FG000|Overall Study|Withdrawal by Subject|0|||
130916155|NCT02122458|471329644|FG001|Overall Study|Withdrawal by Subject|0|||
130916156|NCT02122458|471329645|FG002|Overall Study|Withdrawal by Subject|0|||
130916157|NCT02122458|471329646|FG003|Overall Study|Withdrawal by Subject|4|||
130916158|NCT02122458|471329647|FG004|Overall Study|Withdrawal by Subject|4|||
130916159|NCT02122458|471329648|FG005|Overall Study|Withdrawal by Subject|4|||
130916160|NCT02122458|471329649|FG006|Overall Study|Withdrawal by Subject|0|||
130916161|NCT02122458|471329643|FG000|Overall Study|Lost to Follow-up|1|||
130916162|NCT02122458|471329644|FG001|Overall Study|Lost to Follow-up|3|||
130916163|NCT02122458|471329645|FG002|Overall Study|Lost to Follow-up|0|||
130916164|NCT02122458|471329646|FG003|Overall Study|Lost to Follow-up|7|||
130916165|NCT02122458|471329647|FG004|Overall Study|Lost to Follow-up|5|||
130916166|NCT02122458|471329648|FG005|Overall Study|Lost to Follow-up|15|||
130916167|NCT02122458|471329649|FG006|Overall Study|Lost to Follow-up|1|||
130916168|NCT02122458|471329643|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
130916169|NCT02122458|471329644|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
130916170|NCT02122458|471329645|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
130916171|NCT02122458|471329646|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
130916172|NCT02122458|471329647|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
130916173|NCT02122458|471329648|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
130916174|NCT02122458|471329649|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
130916175|NCT02122458|471329643|FG000|Overall Study|Adverse Event|1|||
130916176|NCT02122458|471329644|FG001|Overall Study|Adverse Event|0|||
130916177|NCT02122458|471329645|FG002|Overall Study|Adverse Event|0|||
130916178|NCT02122458|471329646|FG003|Overall Study|Adverse Event|0|||
130916179|NCT02122458|471329647|FG004|Overall Study|Adverse Event|0|||
131033267|NCT03269136|471755324|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130699385|NCT02274558|470524656|FG000|Overall Study|Withdrawal by Subject|1|||
130699386|NCT02274558|470524657|FG001|Overall Study|Withdrawal by Subject|5|||
130699387|NCT02274558|470524658|FG002|Overall Study|Withdrawal by Subject|4|||
130699388|NCT02274558|470524656|FG000|Overall Study|Death|0|||
130699389|NCT02274558|470524657|FG001|Overall Study|Death|0|||
130699390|NCT02274558|470524658|FG002|Overall Study|Death|1|||
130699391|NCT02274558|470524656|FG000|Overall Study|Lost to Follow-up|2|||
130699392|NCT02274558|470524657|FG001|Overall Study|Lost to Follow-up|1|||
130699393|NCT02274558|470524658|FG002|Overall Study|Lost to Follow-up|1|||
130916180|NCT02122458|471329648|FG005|Overall Study|Adverse Event|0|||
130916181|NCT02122458|471329649|FG006|Overall Study|Adverse Event|0|||
130916182|NCT02122458|471329643|FG000|Overall Study|Experimental Error|0|||
130916183|NCT02122458|471329644|FG001|Overall Study|Experimental Error|0|||
130916184|NCT02122458|471329645|FG002|Overall Study|Experimental Error|0|||
130916185|NCT02122458|471329646|FG003|Overall Study|Experimental Error|0|||
130916186|NCT02122458|471329647|FG004|Overall Study|Experimental Error|3|||
130916187|NCT02122458|471329648|FG005|Overall Study|Experimental Error|0|||
130916188|NCT02122458|471329649|FG006|Overall Study|Experimental Error|0|||
130916189|NCT02122458|471329643|FG000|Overall Study|Deployed or Moved|0|||
130916190|NCT02122458|471329644|FG001|Overall Study|Deployed or Moved|0|||
130916191|NCT02122458|471329645|FG002|Overall Study|Deployed or Moved|0|||
130916192|NCT02122458|471329646|FG003|Overall Study|Deployed or Moved|0|||
131033268|NCT03269136|471755325|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131033269|NCT03269136|471755326|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131119161|NCT00766090|472067291|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131119162|NCT00766090|472067292|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
131119163|NCT00766090|472067293|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131119164|NCT00766090|472067294|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131119165|NCT00766090|472067295|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131119166|NCT00766090|472067296|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131119167|NCT00766090|472067297|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131119168|NCT00766090|472067298|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131119169|NCT00766090|472067299|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
131119170|NCT00800436|472067300|FG000|Overall Study|Withdrawal by Subject|0|||
131119171|NCT00800436|472067301|FG001|Overall Study|Withdrawal by Subject|0|||
131119172|NCT00800436|472067302|FG002|Overall Study|Withdrawal by Subject|1|||
131119173|NCT00800436|472067303|FG003|Overall Study|Withdrawal by Subject|1|||
131119174|NCT00800436|472067304|FG004|Overall Study|Withdrawal by Subject|0|||
131119175|NCT00800436|472067305|FG005|Overall Study|Withdrawal by Subject|0|||
131119176|NCT00800436|472067306|FG006|Overall Study|Withdrawal by Subject|0|||
131119177|NCT01106027|472067313|FG000|Overall Study|Lost graft early, discontinued|1|||
131119178|NCT02871778|472067314|FG000|Part A: Treatment Period 1|Adverse Event|1|||
131119179|NCT02871778|472067315|FG001|Part A: Treatment Period 1|Adverse Event|1|||
131119180|NCT02871778|472067316|FG002|Part A: Treatment Period 1|Adverse Event|1|||
131119181|NCT02871778|472067317|FG003|Part A: Treatment Period 1|Adverse Event|0|||
131119182|NCT02871778|472067318|FG004|Part A: Treatment Period 1|Adverse Event|0|||
131119183|NCT02871778|472067319|FG005|Part A: Treatment Period 1|Adverse Event|0|||
131119184|NCT02871778|472067320|FG006|Part A: Treatment Period 1|Adverse Event|0|||
131119185|NCT02871778|472067321|FG007|Part A: Treatment Period 1|Adverse Event|0|||
131119186|NCT02871778|472067314|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
131119187|NCT02871778|472067315|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
131119188|NCT02871778|472067316|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
131119189|NCT02871778|472067317|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
131119190|NCT02871778|472067318|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
131119191|NCT02871778|472067319|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
131119192|NCT02871778|472067320|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
131119193|NCT02871778|472067321|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130916193|NCT02122458|471329647|FG004|Overall Study|Deployed or Moved|1|||
130916194|NCT02122458|471329648|FG005|Overall Study|Deployed or Moved|0|||
130916195|NCT02122458|471329649|FG006|Overall Study|Deployed or Moved|0|||
130916196|NCT02122458|471329643|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
130916197|NCT02122458|471329644|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
130916198|NCT02122458|471329645|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
130916199|NCT02122458|471329646|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
130916200|NCT02122458|471329647|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
130916201|NCT02122458|471329648|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
130916202|NCT02122458|471329649|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
130916203|NCT02122458|471329643|FG000|Overall Study|Noncompliance|0|||
130916204|NCT02122458|471329644|FG001|Overall Study|Noncompliance|1|||
130916205|NCT02122458|471329645|FG002|Overall Study|Noncompliance|0|||
130916206|NCT02122458|471329646|FG003|Overall Study|Noncompliance|0|||
131119194|NCT02871778|472067314|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131119195|NCT02871778|472067315|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131119196|NCT02871778|472067316|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
131119197|NCT02871778|472067317|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131119198|NCT02871778|472067318|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131119199|NCT02871778|472067319|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131119200|NCT02871778|472067320|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131119201|NCT02871778|472067321|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
131119202|NCT02871778|472067314|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131119203|NCT02871778|472067315|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131119204|NCT02871778|472067316|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
131119205|NCT02871778|472067317|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131119206|NCT02871778|472067318|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131119207|NCT02871778|472067319|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131119208|NCT02871778|472067320|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131119209|NCT02871778|472067321|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
131119210|NCT02871778|472067314|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
131119211|NCT02871778|472067315|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
130699394|NCT02274558|470524656|FG000|Overall Study|Physician Decision|0|||
130916207|NCT02122458|471329647|FG004|Overall Study|Noncompliance|0|||
130916208|NCT02122458|471329648|FG005|Overall Study|Noncompliance|0|||
130916209|NCT02122458|471329649|FG006|Overall Study|Noncompliance|0|||
130916210|NCT00412542|471329650|FG000|Overall Study|Withdrawal by Subject|0|||
130916211|NCT00412542|471329651|FG001|Overall Study|Withdrawal by Subject|2|||
130916212|NCT00412542|471329650|FG000|Overall Study|Not Eligible|0|||
130916213|NCT00412542|471329651|FG001|Overall Study|Not Eligible|1|||
130916214|NCT03161093|471329652|FG000|Overall Study|Protocol Violation|11|||
130699395|NCT02274558|470524657|FG001|Overall Study|Physician Decision|2|||
130699396|NCT02274558|470524658|FG002|Overall Study|Physician Decision|1|||
130699397|NCT05393271|470524664|FG000|Overall Study|Physician Decision|0|||
130699398|NCT05393271|470524665|FG001|Overall Study|Physician Decision|0|||
130699399|NCT05393271|470524666|FG002|Overall Study|Physician Decision|0|||
130699400|NCT05393271|470524667|FG003|Overall Study|Physician Decision|0|||
130916215|NCT03161093|471329653|FG001|Overall Study|Protocol Violation|14|||
130916216|NCT03161093|471329654|FG002|Overall Study|Protocol Violation|6|||
130916217|NCT03161093|471329655|FG003|Overall Study|Protocol Violation|13|||
130916218|NCT03161093|471329656|FG004|Overall Study|Protocol Violation|1|||
130916219|NCT03161093|471329657|FG005|Overall Study|Protocol Violation|0|||
130916220|NCT03161093|471329652|FG000|Overall Study|Adverse Event|5|||
130916221|NCT03161093|471329653|FG001|Overall Study|Adverse Event|21|||
130916222|NCT03161093|471329654|FG002|Overall Study|Adverse Event|16|||
130916223|NCT03161093|471329655|FG003|Overall Study|Adverse Event|35|||
130916224|NCT03161093|471329656|FG004|Overall Study|Adverse Event|2|||
130916225|NCT03161093|471329657|FG005|Overall Study|Adverse Event|1|||
130916226|NCT03161093|471329652|FG000|Overall Study|Lack of Efficacy|9|||
130916227|NCT03161093|471329653|FG001|Overall Study|Lack of Efficacy|13|||
130916228|NCT03161093|471329654|FG002|Overall Study|Lack of Efficacy|9|||
130916229|NCT03161093|471329655|FG003|Overall Study|Lack of Efficacy|24|||
130916230|NCT03161093|471329656|FG004|Overall Study|Lack of Efficacy|4|||
130916231|NCT03161093|471329657|FG005|Overall Study|Lack of Efficacy|1|||
130916232|NCT03161093|471329652|FG000|Overall Study|Physician Decision|0|||
130916233|NCT03161093|471329653|FG001|Overall Study|Physician Decision|1|||
130916234|NCT03161093|471329654|FG002|Overall Study|Physician Decision|0|||
130916235|NCT03161093|471329655|FG003|Overall Study|Physician Decision|2|||
130916236|NCT03161093|471329656|FG004|Overall Study|Physician Decision|17|||
130916237|NCT03161093|471329657|FG005|Overall Study|Physician Decision|15|||
130916238|NCT03161093|471329652|FG000|Overall Study|Withdrawal by Subject|24|||
130916239|NCT03161093|471329653|FG001|Overall Study|Withdrawal by Subject|73|||
130916240|NCT03161093|471329654|FG002|Overall Study|Withdrawal by Subject|44|||
130916241|NCT03161093|471329655|FG003|Overall Study|Withdrawal by Subject|97|||
130916242|NCT03161093|471329656|FG004|Overall Study|Withdrawal by Subject|11|||
130916243|NCT03161093|471329657|FG005|Overall Study|Withdrawal by Subject|10|||
130916244|NCT03161093|471329652|FG000|Overall Study|Lost to Follow-up|3|||
130916245|NCT03161093|471329653|FG001|Overall Study|Lost to Follow-up|12|||
130916246|NCT03161093|471329654|FG002|Overall Study|Lost to Follow-up|4|||
130916247|NCT03161093|471329655|FG003|Overall Study|Lost to Follow-up|7|||
130916248|NCT03161093|471329656|FG004|Overall Study|Lost to Follow-up|8|||
130916249|NCT03161093|471329657|FG005|Overall Study|Lost to Follow-up|13|||
130916250|NCT03161093|471329652|FG000|Overall Study|Death|3|||
130916251|NCT03161093|471329653|FG001|Overall Study|Death|9|||
130916252|NCT03161093|471329654|FG002|Overall Study|Death|7|||
130916253|NCT03161093|471329655|FG003|Overall Study|Death|9|||
130916254|NCT03161093|471329656|FG004|Overall Study|Death|0|||
130916255|NCT03161093|471329657|FG005|Overall Study|Death|0|||
130916256|NCT03161093|471329652|FG000|Overall Study|Unknown - Not reported|0|||
130916257|NCT03161093|471329653|FG001|Overall Study|Unknown - Not reported|1|||
130916258|NCT03161093|471329654|FG002|Overall Study|Unknown - Not reported|0|||
130916259|NCT03161093|471329655|FG003|Overall Study|Unknown - Not reported|0|||
130916260|NCT03161093|471329656|FG004|Overall Study|Unknown - Not reported|0|||
130916261|NCT03161093|471329657|FG005|Overall Study|Unknown - Not reported|1|||
130916262|NCT01031706|471329658|FG000|Overall Study|Adverse Event|1|||
130916263|NCT01031706|471329659|FG001|Overall Study|Adverse Event|0|||
130699401|NCT05393271|470524668|FG004|Overall Study|Physician Decision|0|||
130699402|NCT05393271|470524669|FG005|Overall Study|Physician Decision|0|||
130699403|NCT05393271|470524670|FG006|Overall Study|Physician Decision|1|||
130699404|NCT05393271|470524671|FG007|Overall Study|Physician Decision|0|||
130916264|NCT01031706|471329658|FG000|Overall Study|Withdrawal by Subject|1|||
130916265|NCT01031706|471329659|FG001|Overall Study|Withdrawal by Subject|1|||
130916266|NCT02124161|471329660|FG000|Overall Study|Other unspecified|0|||
130916267|NCT02124161|471329661|FG001|Overall Study|Other unspecified|1|||
130916268|NCT02124161|471329660|FG000|Overall Study|Death|1|||
130916269|NCT02124161|471329661|FG001|Overall Study|Death|0|||
130916270|NCT02124161|471329660|FG000|Overall Study|Protocol Violation|2|||
130916271|NCT02124161|471329661|FG001|Overall Study|Protocol Violation|1|||
130916272|NCT02124161|471329660|FG000|Overall Study|Withdrawal by Subject|1|||
130916273|NCT02124161|471329661|FG001|Overall Study|Withdrawal by Subject|2|||
130916274|NCT02124161|471329660|FG000|Overall Study|Adverse Event|2|||
130916275|NCT02124161|471329661|FG001|Overall Study|Adverse Event|0|||
130916276|NCT02124161|471329660|FG000|Overall Study|Does not meet entrance criteria|2|||
130916277|NCT02124161|471329661|FG001|Overall Study|Does not meet entrance criteria|3|||
130916278|NCT02124161|471329660|FG000|Overall Study|No longer meets eligibility criteria|5|||
130916279|NCT02124161|471329661|FG001|Overall Study|No longer meets eligibility criteria|4|||
130916280|NCT02124161|471329660|FG000|Overall Study|Lost to Follow-up|3|||
130916281|NCT02124161|471329661|FG001|Overall Study|Lost to Follow-up|4|||
130916282|NCT02517866|471329662|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
130916283|NCT02517866|471329663|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
130916284|NCT02517866|471329664|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130916285|NCT02517866|471329662|FG000|Overall Study|Significant Protocol Deviation|4|||
130916286|NCT02517866|471329663|FG001|Overall Study|Significant Protocol Deviation|1|||
130916287|NCT02517866|471329664|FG002|Overall Study|Significant Protocol Deviation|0|||
130916288|NCT02517866|471329662|FG000|Overall Study|Lost to Follow-up|1|||
130916289|NCT02517866|471329663|FG001|Overall Study|Lost to Follow-up|0|||
130916290|NCT02517866|471329664|FG002|Overall Study|Lost to Follow-up|0|||
130916291|NCT02517866|471329662|FG000|Overall Study|Voluntary Withdrawal|2|||
130916292|NCT02517866|471329663|FG001|Overall Study|Voluntary Withdrawal|2|||
130916293|NCT02517866|471329664|FG002|Overall Study|Voluntary Withdrawal|0|||
130916294|NCT02517866|471329662|FG000|Overall Study|Investigator Decision|2|||
130916295|NCT02517866|471329663|FG001|Overall Study|Investigator Decision|1|||
130916296|NCT02517866|471329664|FG002|Overall Study|Investigator Decision|0|||
130916297|NCT02517866|471329662|FG000|Overall Study|Reason not specified|2|||
130916298|NCT02517866|471329663|FG001|Overall Study|Reason not specified|0|||
130916299|NCT02517866|471329664|FG002|Overall Study|Reason not specified|0|||
130916300|NCT01147640|471329666|FG000|Overall Study|Adverse Event|2|||
130916301|NCT01147640|471329667|FG001|Overall Study|Adverse Event|0|||
130916302|NCT01147640|471329666|FG000|Overall Study|Physician Decision|1|||
130916303|NCT01147640|471329667|FG001|Overall Study|Physician Decision|0|||
130916304|NCT01147640|471329666|FG000|Overall Study|Withdrawal by Subject|1|||
130916305|NCT01147640|471329667|FG001|Overall Study|Withdrawal by Subject|0|||
130916306|NCT01147640|471329666|FG000|Overall Study|Lost to Follow-up|0|||
130916307|NCT01147640|471329667|FG001|Overall Study|Lost to Follow-up|1|||
130916308|NCT01147640|471329666|FG000|Overall Study|Didn't meet eligibility criteria|1|||
130916309|NCT01147640|471329667|FG001|Overall Study|Didn't meet eligibility criteria|0|||
130916310|NCT00369707|471329671|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
130916311|NCT00369707|471329671|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
130916312|NCT00369707|471329671|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
130916313|NCT00369707|471329671|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
130916314|NCT00369707|471329671|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
130916315|NCT00369707|471329671|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
130916316|NCT00369707|471329671|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
130916317|NCT00369707|471329671|FG000|Follow up for 2 Years After Treatment|Death|1|||
130916318|NCT00369707|471329671|FG000|Follow up for 2 Years After Treatment|Other|2|||
130916319|NCT04674644|471329681|FG000|Overall Study|with missing data|37|||
130916320|NCT01230710|471329687|FG000|Overall Study|Disease Progression|41|||
130916321|NCT01230710|471329687|FG000|Overall Study|Lost to Follow-up|3|||
130916322|NCT01230710|471329687|FG000|Overall Study|Death|4|||
130916323|NCT01230710|471329687|FG000|Overall Study|Withdrawal of Consent|1|||
130916324|NCT03277690|471329688|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
130916325|NCT03277690|471329689|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
130916326|NCT03277690|471329688|FG000|Dose Titration and Maintenance|Physician Decision|1|||
130916327|NCT03277690|471329689|FG001|Dose Titration and Maintenance|Physician Decision|0|||
130916328|NCT03277690|471329688|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
130916329|NCT03277690|471329689|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
130916330|NCT03277690|471329688|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
130916331|NCT03277690|471329689|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
130916332|NCT03277690|471329688|FG000|Dose Titration and Maintenance|Adverse Event|15|||
130916333|NCT03277690|471329689|FG001|Dose Titration and Maintenance|Adverse Event|0|||
130916334|NCT03277690|471329688|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
130916335|NCT03277690|471329689|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
130916336|NCT03277690|471329688|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
130916337|NCT03277690|471329689|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
130916338|NCT01691898|471329690|FG000|Overall Study|Death|34|||
131119212|NCT02871778|472067316|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
131119213|NCT02871778|472067317|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
130916339|NCT01691898|471329691|FG001|Overall Study|Death|32|||
130916340|NCT01691898|471329692|FG002|Overall Study|Death|6|||
130916341|NCT01691898|471329693|FG003|Overall Study|Death|3|||
130916342|NCT01691898|471329694|FG004|Overall Study|Death|8|||
130916343|NCT01691898|471329695|FG005|Overall Study|Death|31|||
130916344|NCT01691898|471329690|FG000|Overall Study|Adverse Event|0|||
130916345|NCT01691898|471329691|FG001|Overall Study|Adverse Event|1|||
130916346|NCT01691898|471329692|FG002|Overall Study|Adverse Event|0|||
130916347|NCT01691898|471329693|FG003|Overall Study|Adverse Event|1|||
130916348|NCT01691898|471329694|FG004|Overall Study|Adverse Event|1|||
130916349|NCT01691898|471329695|FG005|Overall Study|Adverse Event|0|||
130916350|NCT01691898|471329690|FG000|Overall Study|Progression of Disease|1|||
130916351|NCT01691898|471329691|FG001|Overall Study|Progression of Disease|2|||
130916352|NCT01691898|471329692|FG002|Overall Study|Progression of Disease|1|||
130916353|NCT01691898|471329693|FG003|Overall Study|Progression of Disease|0|||
130916354|NCT01691898|471329694|FG004|Overall Study|Progression of Disease|0|||
130916355|NCT01691898|471329695|FG005|Overall Study|Progression of Disease|1|||
130916356|NCT01691898|471329690|FG000|Overall Study|Lost to Follow-up|3|||
130916357|NCT01691898|471329691|FG001|Overall Study|Lost to Follow-up|1|||
130916358|NCT01691898|471329692|FG002|Overall Study|Lost to Follow-up|0|||
130916359|NCT01691898|471329693|FG003|Overall Study|Lost to Follow-up|0|||
130916360|NCT01691898|471329694|FG004|Overall Study|Lost to Follow-up|1|||
130916361|NCT01691898|471329695|FG005|Overall Study|Lost to Follow-up|0|||
130916362|NCT01691898|471329690|FG000|Overall Study|Withdrawal by Subject|9|||
130916363|NCT01691898|471329691|FG001|Overall Study|Withdrawal by Subject|8|||
130916364|NCT01691898|471329692|FG002|Overall Study|Withdrawal by Subject|2|||
130916365|NCT01691898|471329693|FG003|Overall Study|Withdrawal by Subject|1|||
130916366|NCT01691898|471329694|FG004|Overall Study|Withdrawal by Subject|3|||
130916367|NCT01691898|471329695|FG005|Overall Study|Withdrawal by Subject|3|||
130916368|NCT01691898|471329690|FG000|Overall Study|Non-Compliance|0|||
130916369|NCT01691898|471329691|FG001|Overall Study|Non-Compliance|0|||
130916370|NCT01691898|471329692|FG002|Overall Study|Non-Compliance|0|||
130916371|NCT01691898|471329693|FG003|Overall Study|Non-Compliance|0|||
130916372|NCT01691898|471329694|FG004|Overall Study|Non-Compliance|1|||
130916373|NCT01691898|471329695|FG005|Overall Study|Non-Compliance|0|||
130916374|NCT00747812|471329696|FG000|Overall Study|Research Site Staff Relocation|5|||
130916375|NCT00747812|471329697|FG001|Overall Study|Research Site Staff Relocation|3|||
130916376|NCT01708161|471329698|FG000|Overall Study|Adverse Event|1|||
130916377|NCT01708161|471329699|FG001|Overall Study|Adverse Event|3|||
130916378|NCT01708161|471329700|FG002|Overall Study|Adverse Event|4|||
130916379|NCT01708161|471329701|FG003|Overall Study|Adverse Event|2|||
130916380|NCT01708161|471329702|FG004|Overall Study|Adverse Event|3|||
130916381|NCT01708161|471329703|FG005|Overall Study|Adverse Event|0|||
130916382|NCT01708161|471329698|FG000|Overall Study|Death|0|||
130916383|NCT01708161|471329699|FG001|Overall Study|Death|0|||
130916384|NCT01708161|471329700|FG002|Overall Study|Death|0|||
130916385|NCT01708161|471329701|FG003|Overall Study|Death|1|||
130916386|NCT01708161|471329702|FG004|Overall Study|Death|0|||
130916387|NCT01708161|471329703|FG005|Overall Study|Death|1|||
130916388|NCT01708161|471329698|FG000|Overall Study|Withdrawal by Subject|0|||
130916389|NCT01708161|471329699|FG001|Overall Study|Withdrawal by Subject|1|||
130916390|NCT01708161|471329700|FG002|Overall Study|Withdrawal by Subject|1|||
130916391|NCT01708161|471329701|FG003|Overall Study|Withdrawal by Subject|0|||
130916392|NCT01708161|471329702|FG004|Overall Study|Withdrawal by Subject|0|||
130916393|NCT01708161|471329703|FG005|Overall Study|Withdrawal by Subject|0|||
130916394|NCT01708161|471329698|FG000|Overall Study|Administrative problems|0|||
130916395|NCT01708161|471329699|FG001|Overall Study|Administrative problems|1|||
130916396|NCT01708161|471329700|FG002|Overall Study|Administrative problems|0|||
130916397|NCT01708161|471329701|FG003|Overall Study|Administrative problems|0|||
130916398|NCT01708161|471329702|FG004|Overall Study|Administrative problems|0|||
130916399|NCT01708161|471329703|FG005|Overall Study|Administrative problems|0|||
130916400|NCT01708161|471329698|FG000|Overall Study|Disease progression|3|||
130916401|NCT01708161|471329699|FG001|Overall Study|Disease progression|5|||
130916402|NCT01708161|471329700|FG002|Overall Study|Disease progression|5|||
130916403|NCT01708161|471329701|FG003|Overall Study|Disease progression|13|||
130916404|NCT01708161|471329702|FG004|Overall Study|Disease progression|3|||
130916405|NCT01708161|471329703|FG005|Overall Study|Disease progression|0|||
130916406|NCT02019277|471329704|FG000|Overall Study|Withdrawal by Subject|3|||
130916407|NCT02019277|471329704|FG000|Overall Study|Death|7|||
130916408|NCT02019277|471329704|FG000|Overall Study|Did no Cooperate|1|||
130916409|NCT02019277|471329704|FG000|Overall Study|Adverse Event|1|||
130916410|NCT02633501|471329706|FG000|Overall Study|Adverse Event|0|||
130916411|NCT02633501|471329707|FG001|Overall Study|Adverse Event|0|||
130916412|NCT02633501|471329708|FG002|Overall Study|Adverse Event|1|||
130916413|NCT02633501|471329709|FG003|Overall Study|Adverse Event|0|||
130916414|NCT02633501|471329710|FG004|Overall Study|Adverse Event|1|||
130916415|NCT02633501|471329711|FG005|Overall Study|Adverse Event|1|||
130916416|NCT02633501|471329706|FG000|Overall Study|Withdrawal by Subject|2|||
130916417|NCT02633501|471329707|FG001|Overall Study|Withdrawal by Subject|1|||
130916418|NCT02633501|471329708|FG002|Overall Study|Withdrawal by Subject|2|||
130916419|NCT02633501|471329709|FG003|Overall Study|Withdrawal by Subject|2|||
130916420|NCT02633501|471329710|FG004|Overall Study|Withdrawal by Subject|1|||
130916421|NCT02633501|471329711|FG005|Overall Study|Withdrawal by Subject|3|||
130916422|NCT02633501|471329706|FG000|Overall Study|Various other reasons|0|||
130916423|NCT02633501|471329707|FG001|Overall Study|Various other reasons|2|||
130916424|NCT02633501|471329708|FG002|Overall Study|Various other reasons|4|||
130916425|NCT02633501|471329709|FG003|Overall Study|Various other reasons|1|||
130916426|NCT02633501|471329710|FG004|Overall Study|Various other reasons|7|||
130916427|NCT02633501|471329711|FG005|Overall Study|Various other reasons|11|||
130916428|NCT02633501|471329706|FG000|Overall Study|Lost to Follow-up|0|||
130916429|NCT02633501|471329707|FG001|Overall Study|Lost to Follow-up|0|||
130916430|NCT02633501|471329708|FG002|Overall Study|Lost to Follow-up|0|||
130916431|NCT02633501|471329709|FG003|Overall Study|Lost to Follow-up|1|||
130916432|NCT02633501|471329710|FG004|Overall Study|Lost to Follow-up|2|||
130769178|NCT00548249|470780544|FG002|Overall Study|Miscellaneous|2|||
130769179|NCT00548249|470780545|FG003|Overall Study|Miscellaneous|0|||
130769180|NCT00548249|470780546|FG004|Overall Study|Miscellaneous|2|||
130769181|NCT00548249|470780542|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
130769182|NCT00548249|470780543|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
130769183|NCT00548249|470780544|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
130769184|NCT00548249|470780545|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
130769185|NCT00548249|470780546|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
130769186|NCT00548249|470780542|FG000|Overall Study|Adverse Event|2|||
130769187|NCT00548249|470780543|FG001|Overall Study|Adverse Event|2|||
130769188|NCT00548249|470780544|FG002|Overall Study|Adverse Event|0|||
130769189|NCT00548249|470780545|FG003|Overall Study|Adverse Event|1|||
130769190|NCT00548249|470780546|FG004|Overall Study|Adverse Event|1|||
130769191|NCT00548249|470780542|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
130769192|NCT00548249|470780543|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
130769193|NCT00548249|470780544|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
130769194|NCT00548249|470780545|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
130769195|NCT00548249|470780546|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
130769196|NCT00548249|470780542|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
130769197|NCT00548249|470780543|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
130769198|NCT00548249|470780544|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
130769199|NCT00548249|470780545|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
130769200|NCT00548249|470780546|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
130769201|NCT00548249|470780542|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130769202|NCT00548249|470780543|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130769203|NCT00548249|470780544|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130769204|NCT00548249|470780545|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130769205|NCT00548249|470780546|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
130769206|NCT00548249|470780542|FG000|Overall Study|Prolonged hospitalization|0|||
130769207|NCT00548249|470780543|FG001|Overall Study|Prolonged hospitalization|0|||
130769208|NCT00548249|470780544|FG002|Overall Study|Prolonged hospitalization|2|||
130769209|NCT00548249|470780545|FG003|Overall Study|Prolonged hospitalization|1|||
130916433|NCT02633501|471329711|FG005|Overall Study|Lost to Follow-up|0|||
130916434|NCT01986140|471329713|FG000|Overall Study|Withdrawal by Subject|31|||
130916435|NCT01986140|471329714|FG001|Overall Study|Withdrawal by Subject|25|||
130699405|NCT05393271|470524672|FG008|Overall Study|Physician Decision|0|||
130699406|NCT05393271|470524673|FG009|Overall Study|Physician Decision|0|||
130699407|NCT05393271|470524674|FG010|Overall Study|Physician Decision|0|||
130699408|NCT02943993|470524675|FG000|Overall Study|Withdrawal by Subject|52|||
130699409|NCT02943993|470524675|FG000|Overall Study|Transfer to another institution|6|||
130699410|NCT02943993|470524675|FG000|Overall Study|Lost to Follow-up|135|||
130699411|NCT02943993|470524675|FG000|Overall Study|Death|98|||
130699412|NCT02943993|470524675|FG000|Overall Study|Other reason for premature termination|32|||
130699413|NCT02943993|470524675|FG000|Overall Study|Missing reason for termination|7|||
130699414|NCT02483416|470524679|FG000|Overall Study|Other reason|0|||
130699415|NCT02483416|470524680|FG001|Overall Study|Other reason|1|||
130699416|NCT02483416|470524679|FG000|Overall Study|Treatment stop|3|||
130699417|NCT02483416|470524680|FG001|Overall Study|Treatment stop|0|||
130699418|NCT04968925|470524681|FG000|Phase I- Period 1|COVID-19 related|0|||
130699419|NCT04968925|470524682|FG001|Phase I- Period 1|COVID-19 related|1|||
130699420|NCT04968925|470524683|FG002|Phase I- Period 1|COVID-19 related|0|||
130699421|NCT04968925|470524684|FG003|Phase I- Period 1|COVID-19 related|0|||
130699422|NCT04968925|470524681|FG000|Phase I- Period 1|Subject enrolled in error|1|||
130699423|NCT04968925|470524682|FG001|Phase I- Period 1|Subject enrolled in error|1|||
130699424|NCT04968925|470524683|FG002|Phase I- Period 1|Subject enrolled in error|0|||
130699425|NCT04968925|470524684|FG003|Phase I- Period 1|Subject enrolled in error|0|||
130699426|NCT04968925|470524681|FG000|Phase II- Period 1|COVID-19 Related|0|||
130699427|NCT04968925|470524682|FG001|Phase II- Period 1|COVID-19 Related|0|||
130699428|NCT04968925|470524683|FG002|Phase II- Period 1|COVID-19 Related|6|||
130699429|NCT04968925|470524684|FG003|Phase II- Period 1|COVID-19 Related|6|||
130699430|NCT04968925|470524681|FG000|Phase II- Period 1|Subject enrolled in error|0|||
130769210|NCT00548249|470780546|FG004|Overall Study|Prolonged hospitalization|0|||
130769211|NCT00548249|470780542|FG000|Overall Study|Withdrawal by Subject|2|||
130769212|NCT00548249|470780543|FG001|Overall Study|Withdrawal by Subject|0|||
130916436|NCT01986140|471329713|FG000|Overall Study|alternative treatment|1|||
130916437|NCT01986140|471329714|FG001|Overall Study|alternative treatment|1|||
130916438|NCT01986140|471329713|FG000|Overall Study|found not eligible|3|||
130699431|NCT04968925|470524682|FG001|Phase II- Period 1|Subject enrolled in error|0|||
130699432|NCT04968925|470524683|FG002|Phase II- Period 1|Subject enrolled in error|1|||
130699433|NCT04968925|470524684|FG003|Phase II- Period 1|Subject enrolled in error|0|||
130699434|NCT04968925|470524681|FG000|Phase II -Period 2|COVID-19 related|0|||
130916439|NCT01986140|471329714|FG001|Overall Study|found not eligible|0|||
130916440|NCT01986140|471329713|FG000|Overall Study|Adverse Event|0|||
130916441|NCT01986140|471329714|FG001|Overall Study|Adverse Event|1|||
130916442|NCT01986140|471329713|FG000|Overall Study|progression disease|0|||
130916443|NCT01986140|471329714|FG001|Overall Study|progression disease|1|||
130916444|NCT02808650|471329720|FG000|Overall Study|Death|0|||
130916445|NCT02808650|471329721|FG001|Overall Study|Death|0|||
130916446|NCT02808650|471329722|FG002|Overall Study|Death|0|||
130916447|NCT02808650|471329723|FG003|Overall Study|Death|0|||
130916448|NCT02808650|471329724|FG004|Overall Study|Death|1|||
130916449|NCT02808650|471329720|FG000|Overall Study|Lack of Efficacy|5|||
130916450|NCT02808650|471329721|FG001|Overall Study|Lack of Efficacy|5|||
130916451|NCT02808650|471329722|FG002|Overall Study|Lack of Efficacy|6|||
130916452|NCT02808650|471329723|FG003|Overall Study|Lack of Efficacy|5|||
130916453|NCT02808650|471329724|FG004|Overall Study|Lack of Efficacy|4|||
130916454|NCT02808650|471329720|FG000|Overall Study|Physician Decision|1|||
130916455|NCT02808650|471329721|FG001|Overall Study|Physician Decision|1|||
130916456|NCT02808650|471329722|FG002|Overall Study|Physician Decision|0|||
130916457|NCT02808650|471329723|FG003|Overall Study|Physician Decision|0|||
130916458|NCT02808650|471329724|FG004|Overall Study|Physician Decision|0|||
130916459|NCT02808650|471329720|FG000|Overall Study|Withdrawal by Subject|0|||
130916460|NCT02808650|471329721|FG001|Overall Study|Withdrawal by Subject|0|||
130916461|NCT02808650|471329722|FG002|Overall Study|Withdrawal by Subject|0|||
130916462|NCT02808650|471329723|FG003|Overall Study|Withdrawal by Subject|1|||
130916463|NCT02808650|471329724|FG004|Overall Study|Withdrawal by Subject|1|||
130916464|NCT01069627|471329727|FG000|Overall Study|Disease progression|7|||
130916465|NCT01069627|471329727|FG000|Overall Study|Adverse Event|12|||
130916466|NCT01069627|471329727|FG000|Overall Study|Protocol Violation|1|||
130916467|NCT02939079|471329731|FG000|Overall Study|Adverse Event|2|||
130916468|NCT02939079|471329732|FG001|Overall Study|Adverse Event|1|||
130916469|NCT02939079|471329731|FG000|Overall Study|Lost to Follow-up|0|||
130916470|NCT02939079|471329732|FG001|Overall Study|Lost to Follow-up|2|||
130916471|NCT02939079|471329731|FG000|Overall Study|Protocol Violation|1|||
130916472|NCT02939079|471329732|FG001|Overall Study|Protocol Violation|0|||
130916473|NCT02939079|471329731|FG000|Overall Study|Withdrawal by Subject|0|||
130916474|NCT02939079|471329732|FG001|Overall Study|Withdrawal by Subject|1|||
130916475|NCT02939079|471329731|FG000|Overall Study|relapse during the study|1|||
130916476|NCT02939079|471329732|FG001|Overall Study|relapse during the study|1|||
130916477|NCT04093414|471329733|FG000|3 Month Follow up|Physician Decision|0|||
130916478|NCT04093414|471329734|FG001|3 Month Follow up|Physician Decision|1|||
130916479|NCT04093414|471329733|FG000|6month Follow up|Physician Decision|1|||
130916480|NCT04093414|471329734|FG001|6month Follow up|Physician Decision|3|||
130916481|NCT04209348|471329735|FG000|Overall Study|Lost to Follow-up|1|||
130916482|NCT04209348|471329736|FG001|Overall Study|Lost to Follow-up|0|||
130916483|NCT00961649|471329739|FG000|Overall Study|Adverse Event|4|||
130916484|NCT00961649|471329740|FG001|Overall Study|Adverse Event|0|||
130916485|NCT00961649|471329741|FG002|Overall Study|Adverse Event|0|||
130916486|NCT00961649|471329742|FG003|Overall Study|Adverse Event|2|||
130916487|NCT00961649|471329739|FG000|Overall Study|Inadequate control of IOP|0|||
130916488|NCT00961649|471329740|FG001|Overall Study|Inadequate control of IOP|0|||
130916489|NCT00961649|471329741|FG002|Overall Study|Inadequate control of IOP|0|||
130916490|NCT00961649|471329742|FG003|Overall Study|Inadequate control of IOP|1|||
130916491|NCT00961649|471329739|FG000|Overall Study|Patient has travel plans during holidays|0|||
130916492|NCT00961649|471329740|FG001|Overall Study|Patient has travel plans during holidays|0|||
130916493|NCT00961649|471329741|FG002|Overall Study|Patient has travel plans during holidays|1|||
130916494|NCT00961649|471329742|FG003|Overall Study|Patient has travel plans during holidays|0|||
130916495|NCT00961649|471329739|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
130916496|NCT00961649|471329740|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
130916497|NCT00961649|471329741|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
130916498|NCT00961649|471329742|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
130916499|NCT00961649|471329739|FG000|Overall Study|Study terminated by sponsor|4|||
130916500|NCT00961649|471329740|FG001|Overall Study|Study terminated by sponsor|4|||
131033270|NCT03269136|471755327|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131033271|NCT03269136|471755328|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130916501|NCT00961649|471329741|FG002|Overall Study|Study terminated by sponsor|4|||
131033272|NCT03269136|471755329|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
131033273|NCT03269136|471755330|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130916502|NCT00961649|471329742|FG003|Overall Study|Study terminated by sponsor|1|||
130916503|NCT02711345|471329743|FG000|Overall Study|Adverse Event|0|||
130916504|NCT02711345|471329744|FG001|Overall Study|Adverse Event|0|||
130916505|NCT02711345|471329745|FG002|Overall Study|Adverse Event|0|||
130916506|NCT02711345|471329746|FG003|Overall Study|Adverse Event|1|||
130916507|NCT02711345|471329747|FG004|Overall Study|Adverse Event|1|||
130916508|NCT02711345|471329748|FG005|Overall Study|Adverse Event|2|||
130916509|NCT02711345|471329749|FG006|Overall Study|Adverse Event|1|||
131033274|NCT03269136|471755331|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
130916510|NCT02711345|471329750|FG007|Overall Study|Adverse Event|0|||
130916511|NCT02711345|471329751|FG008|Overall Study|Adverse Event|0|||
130916512|NCT02711345|471329752|FG009|Overall Study|Adverse Event|2|||
130916513|NCT02711345|471329743|FG000|Overall Study|Physician Decision|0|||
130916514|NCT02711345|471329744|FG001|Overall Study|Physician Decision|0|||
130916515|NCT02711345|471329745|FG002|Overall Study|Physician Decision|1|||
130916516|NCT02711345|471329746|FG003|Overall Study|Physician Decision|0|||
130916517|NCT02711345|471329747|FG004|Overall Study|Physician Decision|0|||
130916518|NCT02711345|471329748|FG005|Overall Study|Physician Decision|0|||
130916519|NCT02711345|471329749|FG006|Overall Study|Physician Decision|0|||
130916520|NCT02711345|471329750|FG007|Overall Study|Physician Decision|0|||
130916521|NCT02711345|471329751|FG008|Overall Study|Physician Decision|1|||
130916522|NCT02711345|471329752|FG009|Overall Study|Physician Decision|0|||
130916523|NCT02711345|471329743|FG000|Overall Study|Progressive disease|1|||
130916524|NCT02711345|471329744|FG001|Overall Study|Progressive disease|3|||
130916525|NCT02711345|471329745|FG002|Overall Study|Progressive disease|5|||
130916526|NCT02711345|471329746|FG003|Overall Study|Progressive disease|3|||
130916527|NCT02711345|471329747|FG004|Overall Study|Progressive disease|7|||
130916528|NCT02711345|471329748|FG005|Overall Study|Progressive disease|2|||
130916529|NCT02711345|471329749|FG006|Overall Study|Progressive disease|8|||
130916530|NCT02711345|471329750|FG007|Overall Study|Progressive disease|4|||
130916531|NCT02711345|471329751|FG008|Overall Study|Progressive disease|5|||
130916532|NCT02711345|471329752|FG009|Overall Study|Progressive disease|6|||
130916533|NCT02711345|471329743|FG000|Overall Study|Subject/guardian decision|0|||
130916534|NCT02711345|471329744|FG001|Overall Study|Subject/guardian decision|0|||
130916535|NCT02711345|471329745|FG002|Overall Study|Subject/guardian decision|0|||
130916536|NCT02711345|471329746|FG003|Overall Study|Subject/guardian decision|0|||
130916537|NCT02711345|471329747|FG004|Overall Study|Subject/guardian decision|0|||
130916538|NCT02711345|471329748|FG005|Overall Study|Subject/guardian decision|2|||
130916539|NCT02711345|471329749|FG006|Overall Study|Subject/guardian decision|3|||
130916540|NCT02711345|471329750|FG007|Overall Study|Subject/guardian decision|1|||
130916541|NCT02711345|471329751|FG008|Overall Study|Subject/guardian decision|0|||
130916542|NCT02711345|471329752|FG009|Overall Study|Subject/guardian decision|4|||
130916543|NCT02711345|471329743|FG000|Overall Study|Death|1|||
130916544|NCT02711345|471329744|FG001|Overall Study|Death|0|||
130916545|NCT02711345|471329745|FG002|Overall Study|Death|0|||
130916546|NCT02711345|471329746|FG003|Overall Study|Death|0|||
130916547|NCT02711345|471329747|FG004|Overall Study|Death|0|||
130916548|NCT02711345|471329748|FG005|Overall Study|Death|0|||
130916549|NCT02711345|471329749|FG006|Overall Study|Death|0|||
130916550|NCT02711345|471329750|FG007|Overall Study|Death|1|||
130916551|NCT02711345|471329751|FG008|Overall Study|Death|0|||
130916552|NCT02711345|471329752|FG009|Overall Study|Death|0|||
130916553|NCT00543543|471329755|FG000|Base Study|Adverse Event|1|||
130916554|NCT00543543|471329756|FG001|Base Study|Adverse Event|11|||
130916555|NCT00543543|471329757|FG002|Base Study|Adverse Event|0|||
130916556|NCT00543543|471329758|FG003|Base Study|Adverse Event|5|||
130916557|NCT00543543|471329755|FG000|Base Study|Lost to Follow-up|12|||
130916558|NCT00543543|471329756|FG001|Base Study|Lost to Follow-up|749|||
130916559|NCT00543543|471329757|FG002|Base Study|Lost to Follow-up|9|||
130916560|NCT00543543|471329758|FG003|Base Study|Lost to Follow-up|701|||
130916561|NCT00543543|471329755|FG000|Base Study|Physician Decision|0|||
130916562|NCT00543543|471329756|FG001|Base Study|Physician Decision|4|||
130916563|NCT00543543|471329757|FG002|Base Study|Physician Decision|0|||
130916564|NCT00543543|471329758|FG003|Base Study|Physician Decision|7|||
130916565|NCT00543543|471329755|FG000|Base Study|Protocol Violation|0|||
130916566|NCT00543543|471329756|FG001|Base Study|Protocol Violation|6|||
130916567|NCT00543543|471329757|FG002|Base Study|Protocol Violation|0|||
131033275|NCT03269136|471755332|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
131033276|NCT03269136|471755315|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
130916568|NCT00543543|471329758|FG003|Base Study|Protocol Violation|6|||
130916569|NCT00543543|471329755|FG000|Base Study|Withdrawal by Subject|7|||
131033277|NCT03269136|471755316|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
130916570|NCT00543543|471329756|FG001|Base Study|Withdrawal by Subject|482|||
130916571|NCT00543543|471329757|FG002|Base Study|Withdrawal by Subject|5|||
130916572|NCT00543543|471329758|FG003|Base Study|Withdrawal by Subject|503|||
130916573|NCT00543543|471329755|FG000|Extension Study|Adverse Event|0|||
131033278|NCT03269136|471755317|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
131033279|NCT03269136|471755318|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
130916574|NCT00543543|471329756|FG001|Extension Study|Adverse Event|0|||
130916575|NCT00543543|471329757|FG002|Extension Study|Adverse Event|0|||
130916576|NCT00543543|471329758|FG003|Extension Study|Adverse Event|5|||
130916577|NCT00543543|471329755|FG000|Extension Study|Lost to Follow-up|0|||
130916578|NCT00543543|471329756|FG001|Extension Study|Lost to Follow-up|0|||
130916579|NCT00543543|471329757|FG002|Extension Study|Lost to Follow-up|0|||
131033280|NCT03269136|471755319|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
131033281|NCT03269136|471755320|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
130916580|NCT00543543|471329758|FG003|Extension Study|Lost to Follow-up|77|||
130916581|NCT00543543|471329755|FG000|Extension Study|Physician Decision|0|||
130916582|NCT00543543|471329756|FG001|Extension Study|Physician Decision|0|||
130916583|NCT00543543|471329757|FG002|Extension Study|Physician Decision|0|||
130916584|NCT00543543|471329758|FG003|Extension Study|Physician Decision|7|||
130916585|NCT00543543|471329755|FG000|Extension Study|Pregnancy|0|||
130916586|NCT00543543|471329756|FG001|Extension Study|Pregnancy|0|||
130916587|NCT00543543|471329757|FG002|Extension Study|Pregnancy|0|||
130916588|NCT00543543|471329758|FG003|Extension Study|Pregnancy|6|||
130916589|NCT00543543|471329755|FG000|Extension Study|Protocol Violation|0|||
130916590|NCT00543543|471329756|FG001|Extension Study|Protocol Violation|0|||
130916591|NCT00543543|471329757|FG002|Extension Study|Protocol Violation|0|||
130916592|NCT00543543|471329758|FG003|Extension Study|Protocol Violation|11|||
130699435|NCT04968925|470524682|FG001|Phase II -Period 2|COVID-19 related|0|||
130699436|NCT04968925|470524683|FG002|Phase II -Period 2|COVID-19 related|4|||
130699437|NCT04968925|470524684|FG003|Phase II -Period 2|COVID-19 related|3|||
130699438|NCT04968925|470524681|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
130699439|NCT04968925|470524682|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
130699440|NCT04968925|470524683|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
130699441|NCT04968925|470524684|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
130699442|NCT00487695|470524689|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
130699443|NCT00487695|470524690|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
130699444|NCT00487695|470524689|FG000|First Procedure|active wheezing (did not have procedure)|1|||
130699445|NCT00487695|470524690|FG001|First Procedure|active wheezing (did not have procedure)|0|||
130699446|NCT00487695|470524689|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
130699447|NCT00487695|470524690|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
130699448|NCT00487695|470524689|FG000|Second Procedure|active wheezing|0|||
130699449|NCT00487695|470524690|FG001|Second Procedure|active wheezing|1|||
130699450|NCT00487695|470524689|FG000|Second Procedure|Withdrawal by Subject|1|||
130769213|NCT00548249|470780544|FG002|Overall Study|Withdrawal by Subject|0|||
130916593|NCT00543543|471329755|FG000|Extension Study|Withdrawal by Subject|0|||
130916594|NCT00543543|471329756|FG001|Extension Study|Withdrawal by Subject|0|||
130769214|NCT00548249|470780545|FG003|Overall Study|Withdrawal by Subject|0|||
130769215|NCT00548249|470780546|FG004|Overall Study|Withdrawal by Subject|0|||
130769216|NCT00548249|470780542|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
130769217|NCT00548249|470780543|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
130769218|NCT00548249|470780544|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
130769219|NCT00548249|470780545|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
130769220|NCT00548249|470780546|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
130769221|NCT00548249|470780542|FG000|Overall Study|Sponsor's request|0|||
130769222|NCT00548249|470780543|FG001|Overall Study|Sponsor's request|0|||
130769223|NCT00548249|470780544|FG002|Overall Study|Sponsor's request|0|||
130769224|NCT00548249|470780545|FG003|Overall Study|Sponsor's request|1|||
130769225|NCT00548249|470780546|FG004|Overall Study|Sponsor's request|0|||
130769226|NCT03003000|470780547|FG000|Overall Study|Adverse Event|1|||
130769227|NCT03003000|470780548|FG001|Overall Study|Adverse Event|2|||
130769228|NCT03003000|470780549|FG002|Overall Study|Adverse Event|3|||
130769229|NCT03003000|470780547|FG000|Overall Study|Lack of Efficacy|1|||
130769230|NCT03003000|470780548|FG001|Overall Study|Lack of Efficacy|0|||
130769231|NCT03003000|470780549|FG002|Overall Study|Lack of Efficacy|0|||
130769232|NCT03003000|470780547|FG000|Overall Study|Non-compliant with protocol|0|||
130769233|NCT03003000|470780548|FG001|Overall Study|Non-compliant with protocol|1|||
130769234|NCT03003000|470780549|FG002|Overall Study|Non-compliant with protocol|1|||
130769235|NCT03003000|470780547|FG000|Overall Study|Refused to continue medication|2|||
130769236|NCT03003000|470780548|FG001|Overall Study|Refused to continue medication|0|||
130769237|NCT03003000|470780549|FG002|Overall Study|Refused to continue medication|0|||
130916595|NCT00543543|471329757|FG002|Extension Study|Withdrawal by Subject|0|||
131119214|NCT02871778|472067318|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
131119215|NCT02871778|472067319|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
131119216|NCT02871778|472067320|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
131119217|NCT02871778|472067321|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
131119218|NCT02871778|472067314|FG000|Part A: Treatment Period 2|Adverse Event|2|||
131119219|NCT02871778|472067315|FG001|Part A: Treatment Period 2|Adverse Event|2|||
131119220|NCT02871778|472067316|FG002|Part A: Treatment Period 2|Adverse Event|0|||
131119221|NCT02871778|472067317|FG003|Part A: Treatment Period 2|Adverse Event|0|||
131119222|NCT02871778|472067318|FG004|Part A: Treatment Period 2|Adverse Event|0|||
131119223|NCT02871778|472067319|FG005|Part A: Treatment Period 2|Adverse Event|0|||
131119224|NCT02871778|472067320|FG006|Part A: Treatment Period 2|Adverse Event|0|||
131119225|NCT02871778|472067321|FG007|Part A: Treatment Period 2|Adverse Event|0|||
130699451|NCT00487695|470524690|FG001|Second Procedure|Withdrawal by Subject|2|||
130769238|NCT03003000|470780547|FG000|Overall Study|Other than listed|1|||
130769239|NCT03003000|470780548|FG001|Overall Study|Other than listed|1|||
130916596|NCT00543543|471329758|FG003|Extension Study|Withdrawal by Subject|120|||
130916597|NCT02919696|471329759|FG000|Overall Study|Adverse Event|1|||
130916598|NCT02919696|471329760|FG001|Overall Study|Adverse Event|2|||
130699452|NCT04542694|470524691|FG000|Overall Study|The need for prohibited therapy|2|||
130699453|NCT04542694|470524692|FG001|Overall Study|The need for prohibited therapy|0|||
130699454|NCT04542694|470524691|FG000|Overall Study|Adverse Event|1|||
130699455|NCT04542694|470524692|FG001|Overall Study|Adverse Event|0|||
130916599|NCT02919696|471329759|FG000|Overall Study|Withdrawal by Subject|2|||
131033282|NCT03269136|471755321|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
131033283|NCT03269136|471755322|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
131033284|NCT03269136|471755323|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
131033285|NCT03269136|471755324|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
131033286|NCT03269136|471755325|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
131033287|NCT03269136|471755326|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
131033288|NCT03269136|471755327|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
131033289|NCT03269136|471755328|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
131033290|NCT03269136|471755329|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
131033291|NCT03269136|471755330|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
131033292|NCT03269136|471755331|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
131033293|NCT03269136|471755332|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
131033294|NCT03269136|471755315|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
131033295|NCT03269136|471755316|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
131033296|NCT03269136|471755317|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
131033297|NCT03269136|471755318|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
131033298|NCT03269136|471755319|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
131033299|NCT03269136|471755320|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
131033300|NCT03269136|471755321|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
131033301|NCT03269136|471755322|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
131033302|NCT03269136|471755323|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
131033303|NCT03269136|471755324|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
131033304|NCT03269136|471755325|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
131033305|NCT03269136|471755326|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
131033306|NCT03269136|471755327|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
130916600|NCT02919696|471329760|FG001|Overall Study|Withdrawal by Subject|1|||
130916601|NCT02919696|471329759|FG000|Overall Study|Sponsor Decision|1|||
130916602|NCT02919696|471329760|FG001|Overall Study|Sponsor Decision|1|||
130916603|NCT02919696|471329759|FG000|Overall Study|Never Treated|0|||
130916604|NCT02919696|471329760|FG001|Overall Study|Never Treated|1|||
130916605|NCT04308304|471329761|FG000|Overall Study|Withdrawal by Subject|4|||
130916606|NCT04308304|471329762|FG001|Overall Study|Withdrawal by Subject|0|||
130916607|NCT04308304|471329761|FG000|Overall Study|Protocol Violation|1|||
130916608|NCT04308304|471329762|FG001|Overall Study|Protocol Violation|0|||
130916609|NCT00945555|471329763|FG000|Overall Study|Referred to another hospital|5|||
130916610|NCT00945555|471329763|FG000|Overall Study|Worsening condition, intensive care unit|1|||
130916611|NCT00945555|471329763|FG000|Overall Study|Withdrawal by Subject|2|||
130916612|NCT00945555|471329763|FG000|Overall Study|Participant continued treatment at home|1|||
130916613|NCT00945555|471329763|FG000|Overall Study|Death|18|||
130916614|NCT00945555|471329763|FG000|Overall Study|Other|1|||
130916615|NCT00484094|471329764|FG000|Overall Study|Discontinued|39|||
130916616|NCT00484094|471329764|FG000|Overall Study|Other|3|||
130916617|NCT01686828|471329765|FG000|Overall Study|Physician Decision|1|||
130916618|NCT01686828|471329766|FG001|Overall Study|Physician Decision|0|||
130916619|NCT01686828|471329767|FG002|Overall Study|Physician Decision|0|||
130916620|NCT01686828|471329768|FG003|Overall Study|Physician Decision|0|||
130916621|NCT01686828|471329765|FG000|Overall Study|New Job|0|||
130916622|NCT01686828|471329766|FG001|Overall Study|New Job|1|||
130916623|NCT01686828|471329767|FG002|Overall Study|New Job|0|||
130916624|NCT01686828|471329768|FG003|Overall Study|New Job|0|||
130916625|NCT01686828|471329765|FG000|Overall Study|Weight Loss|0|||
130916626|NCT01686828|471329766|FG001|Overall Study|Weight Loss|0|||
130916627|NCT01686828|471329767|FG002|Overall Study|Weight Loss|1|||
130916628|NCT01686828|471329768|FG003|Overall Study|Weight Loss|0|||
131033307|NCT03269136|471755328|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
131033308|NCT03269136|471755329|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
131033309|NCT03269136|471755330|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
131033310|NCT03269136|471755331|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
130699456|NCT04542694|470524691|FG000|Overall Study|Protocol Violation|1|||
130699457|NCT04542694|470524692|FG001|Overall Study|Protocol Violation|0|||
130699458|NCT00969124|470524693|FG000|Overall Study|Protocol Violation|2|||
130699459|NCT00969124|470524693|FG000|Overall Study|Inadequate bowel preparation|15|||
130699460|NCT00969124|470524693|FG000|Overall Study|Inability to reach cecum|9|||
130769240|NCT03003000|470780549|FG002|Overall Study|Other than listed|1|||
130916629|NCT01558739|471329769|FG000|Overall Study|Adverse Event|7|||
130916630|NCT01558739|471329769|FG000|Overall Study|Withdrawal by Subject|2|||
130916631|NCT01558739|471329769|FG000|Overall Study|Death|3|||
130916632|NCT01558739|471329769|FG000|Overall Study|Disease Progression|4|||
130916633|NCT01558739|471329769|FG000|Overall Study|Protocol Violation|1|||
130916634|NCT04176705|471329770|FG000|Overall Study|Withdrawal by Subject|4|||
130916635|NCT04176705|471329771|FG001|Overall Study|Withdrawal by Subject|4|||
130916636|NCT04176705|471329770|FG000|Overall Study|Death|1|||
130916637|NCT04176705|471329771|FG001|Overall Study|Death|1|||
130916638|NCT04176705|471329770|FG000|Overall Study|Lost to Follow-up|3|||
130916639|NCT04176705|471329771|FG001|Overall Study|Lost to Follow-up|3|||
130916640|NCT03698331|471329773|FG000|Overall Study|Adverse Event|2|||
130916641|NCT03698331|471329774|FG001|Overall Study|Adverse Event|3|||
130916642|NCT03698331|471329773|FG000|Overall Study|Withdrawal by Subject|1|||
130916643|NCT03698331|471329774|FG001|Overall Study|Withdrawal by Subject|1|||
130916644|NCT03698331|471329773|FG000|Overall Study|Lost to Follow-up|0|||
130916645|NCT03698331|471329774|FG001|Overall Study|Lost to Follow-up|2|||
130916646|NCT03698331|471329773|FG000|Overall Study|Non-compliance with study drug|1|||
130916647|NCT03698331|471329774|FG001|Overall Study|Non-compliance with study drug|0|||
130916648|NCT01467583|471329775|FG000|Overall Study|Death|1|||
130916649|NCT01467583|471329776|FG001|Overall Study|Death|1|||
130916650|NCT01467583|471329777|FG002|Overall Study|Death|0|||
130916651|NCT01467583|471329775|FG000|Overall Study|Withdrawal by Subject|1|||
130916652|NCT01467583|471329776|FG001|Overall Study|Withdrawal by Subject|0|||
130916653|NCT01467583|471329777|FG002|Overall Study|Withdrawal by Subject|0|||
130916654|NCT01467583|471329775|FG000|Overall Study|Protocol Violation|0|||
130916655|NCT01467583|471329776|FG001|Overall Study|Protocol Violation|0|||
130916656|NCT01467583|471329777|FG002|Overall Study|Protocol Violation|2|||
130916657|NCT02130024|471329778|FG000|Overall Study|Adverse Event|10|||
130916658|NCT02130024|471329779|FG001|Overall Study|Adverse Event|11|||
130916659|NCT02130024|471329778|FG000|Overall Study|Death|2|||
130916660|NCT02130024|471329779|FG001|Overall Study|Death|2|||
130916661|NCT02130024|471329778|FG000|Overall Study|Lost to Follow-up|1|||
130916662|NCT02130024|471329779|FG001|Overall Study|Lost to Follow-up|1|||
130916663|NCT02130024|471329778|FG000|Overall Study|Physician Decision|1|||
130916664|NCT02130024|471329779|FG001|Overall Study|Physician Decision|3|||
130916665|NCT02130024|471329778|FG000|Overall Study|Protocol Deviation|4|||
130916666|NCT02130024|471329779|FG001|Overall Study|Protocol Deviation|0|||
130916667|NCT02130024|471329778|FG000|Overall Study|Site Administration Problems|1|||
130769241|NCT04933617|470780551|FG000|Dose Escalation|Early closure of study|0|||
130769242|NCT04933617|470780552|FG001|Dose Escalation|Early closure of study|3|||
130769243|NCT04933617|470780553|FG002|Dose Escalation|Early closure of study|0|||
130769244|NCT04933617|470780554|FG003|Dose Escalation|Early closure of study|0|||
130769245|NCT04933617|470780555|FG004|Dose Escalation|Early closure of study|0|||
130769246|NCT03760458|470780556|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
130769247|NCT03760458|470780557|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
130769248|NCT03760458|470780558|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
130769249|NCT03760458|470780559|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
130769250|NCT03760458|470780560|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
130769251|NCT02007278|470780574|FG000|Overall Study|Failure to comply with an eligibility|0|||
130769252|NCT02007278|470780575|FG001|Overall Study|Failure to comply with an eligibility|1|||
130769253|NCT02007278|470780574|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
130769254|NCT02007278|470780575|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
130769255|NCT02007278|470780574|FG000|Overall Study|Incorrect medication administration|1|||
130769256|NCT02007278|470780575|FG001|Overall Study|Incorrect medication administration|0|||
130769257|NCT02007278|470780574|FG000|Overall Study|Mis-randomization|1|||
130769258|NCT02007278|470780575|FG001|Overall Study|Mis-randomization|1|||
130769259|NCT00002525|470780576|FG000|Overall Study|Adverse Event|36|||
130916668|NCT02130024|471329779|FG001|Overall Study|Site Administration Problems|0|||
130916669|NCT02130024|471329778|FG000|Overall Study|Subject Withdrew Consent|6|||
130916670|NCT02130024|471329779|FG001|Overall Study|Subject Withdrew Consent|14|||
130916671|NCT04916769|471329783|FG000|Period 1|Physician Decision|0|||
130916672|NCT04916769|471329784|FG001|Period 1|Physician Decision|0|||
130916673|NCT04916769|471329785|FG002|Period 1|Physician Decision|0|||
130916674|NCT04916769|471329786|FG003|Period 1|Physician Decision|0|||
131119226|NCT02871778|472067314|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
131119227|NCT02871778|472067315|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
131119228|NCT02871778|472067316|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
131119229|NCT02871778|472067317|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
131119230|NCT02871778|472067318|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
130916675|NCT04916769|471329787|FG004|Period 1|Physician Decision|0|||
130916676|NCT04916769|471329788|FG005|Period 1|Physician Decision|1|||
130916677|NCT04916769|471329783|FG000|Period 2|Physician Decision|0|||
130916678|NCT04916769|471329784|FG001|Period 2|Physician Decision|1|||
130916679|NCT04916769|471329785|FG002|Period 2|Physician Decision|0|||
130916680|NCT04916769|471329786|FG003|Period 2|Physician Decision|0|||
130916681|NCT04916769|471329787|FG004|Period 2|Physician Decision|0|||
130916682|NCT04916769|471329788|FG005|Period 2|Physician Decision|0|||
131119231|NCT02871778|472067319|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
130769260|NCT00002525|470780577|FG001|Overall Study|Adverse Event|0|||
130769261|NCT00002525|470780576|FG000|Overall Study|Death|5|||
130916683|NCT03672643|471329801|FG000|Overall Study|Adverse Event|3|||
130916684|NCT03672643|471329801|FG000|Overall Study|Death|2|||
130916685|NCT03672643|471329801|FG000|Overall Study|Withdrawal by Subject|1|||
130916686|NCT03672643|471329801|FG000|Overall Study|Progressive disease|11|||
130916687|NCT03672643|471329801|FG000|Overall Study|Global deterioration of health status|1|||
130916688|NCT03672643|471329801|FG000|Overall Study|Refused further treatment|7|||
130916689|NCT03672643|471329801|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
130985516|NCT04711603|471572918|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
130916690|NCT04526509|471329802|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
130916691|NCT04526509|471329803|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130916692|NCT04526509|471329804|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130916693|NCT04526509|471329805|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130916694|NCT04526509|471329806|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130916695|NCT04526509|471329807|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130916696|NCT04526509|471329808|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
130916697|NCT04526509|471329802|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
130916698|NCT04526509|471329803|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130916699|NCT04526509|471329804|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130916700|NCT04526509|471329805|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130916701|NCT04526509|471329806|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130916702|NCT04526509|471329807|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130916703|NCT04526509|471329808|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130916704|NCT04526509|471329802|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
130916705|NCT04526509|471329803|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130916706|NCT04526509|471329804|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130916707|NCT04526509|471329805|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130916708|NCT04526509|471329806|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130916709|NCT04526509|471329807|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130916710|NCT04526509|471329808|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
130916711|NCT04526509|471329802|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
130916712|NCT04526509|471329803|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130916713|NCT04526509|471329804|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130916714|NCT04526509|471329805|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130916715|NCT04526509|471329806|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130916716|NCT04526509|471329807|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130916717|NCT04526509|471329808|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
130916718|NCT04526509|471329802|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
130916719|NCT04526509|471329803|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130916720|NCT04526509|471329804|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130916721|NCT04526509|471329805|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130916722|NCT04526509|471329806|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130916723|NCT04526509|471329807|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130916724|NCT04526509|471329808|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
130916725|NCT04526509|471329802|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
130916726|NCT04526509|471329803|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130985517|NCT04711603|471572919|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
130985518|NCT05479604|471572924|FG000|Overall Study|Lost to Follow-up|1|||
130985519|NCT05479604|471572925|FG001|Overall Study|Lost to Follow-up|5|||
130985520|NCT00946296|471572927|FG000|Overall Study|Physician Decision|3|||
130985521|NCT00946296|471572928|FG001|Overall Study|Physician Decision|0|||
130985522|NCT02068495|471572932|FG000|Overall Study|Case Report Forms Uncollected|60|||
130985523|NCT02068495|471572932|FG000|Overall Study|Protocol Deviation|49|||
130985524|NCT00689026|471572933|FG000|Overall Study|Withdrawal by Subject|13|||
130985525|NCT00689026|471572934|FG001|Overall Study|Withdrawal by Subject|6|||
130985526|NCT02703922|471572936|FG000|Overall Study|Death|5|||
130985527|NCT02703922|471572937|FG001|Overall Study|Death|8|||
130985528|NCT02703922|471572936|FG000|Overall Study|Lost to Follow-up|10|||
130985529|NCT02703922|471572937|FG001|Overall Study|Lost to Follow-up|10|||
130985530|NCT00394355|471572939|FG000|Overall Study|Adverse Event|10|||
130985531|NCT00394355|471572940|FG001|Overall Study|Adverse Event|6|||
130985532|NCT00394355|471572941|FG002|Overall Study|Adverse Event|7|||
130985533|NCT00394355|471572942|FG003|Overall Study|Adverse Event|8|||
130916727|NCT04526509|471329804|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130916728|NCT04526509|471329805|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130916729|NCT04526509|471329806|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130916730|NCT04526509|471329807|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130916731|NCT04526509|471329808|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130916732|NCT04526509|471329802|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
130916733|NCT04526509|471329803|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130916734|NCT04526509|471329804|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130916735|NCT04526509|471329805|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130916736|NCT04526509|471329806|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130916737|NCT04526509|471329807|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130916738|NCT04526509|471329808|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130916739|NCT04526509|471329802|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
130916740|NCT04526509|471329803|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130916741|NCT04526509|471329804|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130916742|NCT04526509|471329805|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130916743|NCT04526509|471329806|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130916744|NCT04526509|471329807|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130916745|NCT04526509|471329808|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
130916746|NCT04526509|471329802|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
130916747|NCT04526509|471329803|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130916748|NCT04526509|471329804|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130916749|NCT04526509|471329805|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130916750|NCT04526509|471329806|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130916751|NCT04526509|471329807|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130916752|NCT04526509|471329808|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
130916753|NCT04526509|471329802|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
130916754|NCT04526509|471329803|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130916755|NCT04526509|471329804|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130916756|NCT04526509|471329805|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130916757|NCT04526509|471329806|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130916758|NCT04526509|471329807|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130916759|NCT04526509|471329808|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
130916760|NCT04526509|471329802|FG000|Enrolled|Study Terminated by Sponsor|0|||
130916761|NCT04526509|471329803|FG001|Enrolled|Study Terminated by Sponsor|0|||
130916762|NCT04526509|471329804|FG002|Enrolled|Study Terminated by Sponsor|0|||
130916763|NCT04526509|471329805|FG003|Enrolled|Study Terminated by Sponsor|0|||
130916764|NCT04526509|471329806|FG004|Enrolled|Study Terminated by Sponsor|0|||
130916765|NCT04526509|471329807|FG005|Enrolled|Study Terminated by Sponsor|0|||
130916766|NCT04526509|471329808|FG006|Enrolled|Study Terminated by Sponsor|1|||
130916767|NCT04526509|471329802|FG000|Enrolled|Death prior to lymphodepletion|0|||
130916768|NCT04526509|471329803|FG001|Enrolled|Death prior to lymphodepletion|0|||
130916769|NCT04526509|471329804|FG002|Enrolled|Death prior to lymphodepletion|0|||
130916770|NCT04526509|471329805|FG003|Enrolled|Death prior to lymphodepletion|1|||
130916771|NCT04526509|471329806|FG004|Enrolled|Death prior to lymphodepletion|0|||
130916772|NCT04526509|471329807|FG005|Enrolled|Death prior to lymphodepletion|0|||
131119232|NCT02871778|472067320|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
131119233|NCT02871778|472067321|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
131119234|NCT02871778|472067314|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
131119235|NCT02871778|472067315|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130916773|NCT04526509|471329808|FG006|Enrolled|Death prior to lymphodepletion|0|||
130916774|NCT04526509|471329802|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130916775|NCT04526509|471329803|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130916776|NCT04526509|471329804|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130916777|NCT04526509|471329805|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
130916778|NCT04526509|471329806|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130916779|NCT04526509|471329807|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130916780|NCT04526509|471329808|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130916781|NCT04526509|471329802|FG000|Enrolled|Physician Decision|0|||
130916782|NCT04526509|471329803|FG001|Enrolled|Physician Decision|1|||
130916783|NCT04526509|471329804|FG002|Enrolled|Physician Decision|0|||
130916784|NCT04526509|471329805|FG003|Enrolled|Physician Decision|0|||
130916785|NCT04526509|471329806|FG004|Enrolled|Physician Decision|0|||
130916786|NCT04526509|471329807|FG005|Enrolled|Physician Decision|0|||
130699461|NCT00969124|470524693|FG000|Overall Study|Previously unrecognized disease|3|||
130699462|NCT00969124|470524693|FG000|Overall Study|Technical error|1|||
130699463|NCT00687739|470524694|FG000|Overall Study|Lost to Follow-up|2|||
130699464|NCT00687739|470524695|FG001|Overall Study|Lost to Follow-up|2|||
130699465|NCT00687739|470524696|FG002|Overall Study|Lost to Follow-up|1|||
130699466|NCT00687739|470524697|FG003|Overall Study|Lost to Follow-up|2|||
130699467|NCT00687739|470524694|FG000|Overall Study|Adverse Event|0|||
130699468|NCT00687739|470524695|FG001|Overall Study|Adverse Event|1|||
130699469|NCT00687739|470524696|FG002|Overall Study|Adverse Event|1|||
130699470|NCT00687739|470524697|FG003|Overall Study|Adverse Event|0|||
130699471|NCT01957150|470524699|FG000|Overall Study|Adverse Event|23|||
130699472|NCT01957150|470524700|FG001|Overall Study|Adverse Event|20|||
130699473|NCT01957150|470524699|FG000|Overall Study|Withdrawal by Subject|13|||
130699474|NCT01957150|470524700|FG001|Overall Study|Withdrawal by Subject|17|||
130699475|NCT01957150|470524699|FG000|Overall Study|Physician Decision|3|||
130699476|NCT01957150|470524700|FG001|Overall Study|Physician Decision|6|||
130699477|NCT01957150|470524699|FG000|Overall Study|Lost to Follow-up|4|||
130699478|NCT01957150|470524700|FG001|Overall Study|Lost to Follow-up|4|||
130699479|NCT01957150|470524699|FG000|Overall Study|Protocol Violation|1|||
130699480|NCT01957150|470524700|FG001|Overall Study|Protocol Violation|0|||
130699481|NCT01957150|470524699|FG000|Overall Study|Lack of Efficacy|11|||
130699482|NCT01957150|470524700|FG001|Overall Study|Lack of Efficacy|11|||
130699483|NCT02451358|470524703|FG000|Overall Study|Withdrawal by Subject|1|||
130699484|NCT02451358|470524704|FG001|Overall Study|Withdrawal by Subject|1|||
130699485|NCT02451358|470524705|FG002|Overall Study|Withdrawal by Subject|0|||
130699486|NCT02451358|470524706|FG003|Overall Study|Withdrawal by Subject|0|||
130699487|NCT02451358|470524703|FG000|Overall Study|Protocol Violation|0|||
130699488|NCT02451358|470524704|FG001|Overall Study|Protocol Violation|1|||
130699489|NCT02451358|470524705|FG002|Overall Study|Protocol Violation|1|||
130699490|NCT02451358|470524706|FG003|Overall Study|Protocol Violation|0|||
130699491|NCT00252564|470524711|FG000|Overall Study|Adverse Event|17|||
130699492|NCT00252564|470524712|FG001|Overall Study|Adverse Event|13|||
130699493|NCT00252564|470524711|FG000|Overall Study|Unrelated Complication|2|||
130699494|NCT00252564|470524712|FG001|Overall Study|Unrelated Complication|1|||
130699495|NCT00252564|470524711|FG000|Overall Study|Disease Progression|14|||
130699496|NCT00252564|470524712|FG001|Overall Study|Disease Progression|20|||
130699497|NCT00252564|470524711|FG000|Overall Study|Death|0|||
130699498|NCT00252564|470524712|FG001|Overall Study|Death|3|||
130699499|NCT00252564|470524711|FG000|Overall Study|Physician Decision|1|||
130699500|NCT00252564|470524712|FG001|Overall Study|Physician Decision|0|||
130699501|NCT00252564|470524711|FG000|Overall Study|Lost to Follow-up|1|||
130699502|NCT00252564|470524712|FG001|Overall Study|Lost to Follow-up|0|||
130699503|NCT00252564|470524711|FG000|Overall Study|Patient Request|4|||
130699504|NCT00252564|470524712|FG001|Overall Study|Patient Request|5|||
130699505|NCT00252564|470524711|FG000|Overall Study|Withdrawal by Subject|0|||
130769262|NCT00002525|470780577|FG001|Overall Study|Death|0|||
131033311|NCT03269136|471755332|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
131033312|NCT03269136|471755315|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
130699506|NCT00252564|470524712|FG001|Overall Study|Withdrawal by Subject|2|||
130699507|NCT03414034|470524716|FG000|Overall Study|Adverse Event|6|||
131033313|NCT03269136|471755316|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
131033314|NCT03269136|471755317|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
130699508|NCT03414034|470524717|FG001|Overall Study|Adverse Event|1|||
130699509|NCT03414034|470524718|FG002|Overall Study|Adverse Event|1|||
130699510|NCT03414034|470524716|FG000|Overall Study|Death|0|||
130699511|NCT03414034|470524717|FG001|Overall Study|Death|0|||
130699512|NCT03414034|470524718|FG002|Overall Study|Death|1|||
130699513|NCT03414034|470524716|FG000|Overall Study|Non-compliance With Study Drug|0|||
130699514|NCT03414034|470524717|FG001|Overall Study|Non-compliance With Study Drug|0|||
130699515|NCT03414034|470524718|FG002|Overall Study|Non-compliance With Study Drug|1|||
130699516|NCT03414034|470524716|FG000|Overall Study|Physician Decision|1|||
130699517|NCT03414034|470524717|FG001|Overall Study|Physician Decision|3|||
130916787|NCT04526509|471329808|FG006|Enrolled|Physician Decision|0|||
130699518|NCT03414034|470524718|FG002|Overall Study|Physician Decision|2|||
130916788|NCT04340193|471329810|FG000|Overall Study|Other reason|0|||
130916789|NCT04340193|471329811|FG001|Overall Study|Other reason|0|||
130916790|NCT04340193|471329812|FG002|Overall Study|Other reason|1|||
130916791|NCT04340193|471329810|FG000|Overall Study|Disease recurrence|0|||
130916792|NCT04340193|471329811|FG001|Overall Study|Disease recurrence|1|||
130916793|NCT04340193|471329812|FG002|Overall Study|Disease recurrence|0|||
130916794|NCT04340193|471329810|FG000|Overall Study|Study drug toxicity|1|||
130916795|NCT04340193|471329811|FG001|Overall Study|Study drug toxicity|0|||
130916796|NCT04340193|471329812|FG002|Overall Study|Study drug toxicity|0|||
130916797|NCT04340193|471329810|FG000|Overall Study|Disease progression|1|||
130916798|NCT04340193|471329811|FG001|Overall Study|Disease progression|2|||
130916799|NCT04340193|471329812|FG002|Overall Study|Disease progression|3|||
130916800|NCT04340193|471329810|FG000|Overall Study|Administrative reasons by sponsor|0|||
130916801|NCT04340193|471329811|FG001|Overall Study|Administrative reasons by sponsor|1|||
130916802|NCT04340193|471329812|FG002|Overall Study|Administrative reasons by sponsor|0|||
130916803|NCT04340193|471329810|FG000|Overall Study|Adverse Event|1|||
130916804|NCT04340193|471329811|FG001|Overall Study|Adverse Event|1|||
130916805|NCT04340193|471329812|FG002|Overall Study|Adverse Event|0|||
130916806|NCT01386008|471329813|FG000|Overall Study|exited w/o incident /study discontinued|17|||
130916807|NCT01386008|471329813|FG000|Overall Study|Adverse Event|3|||
130916808|NCT04449861|471329814|FG000|Overall Study|Withdrawal by Subject|4|||
130916809|NCT04449861|471329814|FG000|Overall Study|Lost to Follow-up|5|||
130916810|NCT04449861|471329814|FG000|Overall Study|Death|112|||
130916811|NCT00976677|471329815|FG000|Overall Study|Adverse Event|1|||
130916812|NCT00976677|471329816|FG001|Overall Study|Adverse Event|0|||
130916813|NCT00976677|471329815|FG000|Overall Study|Withdrawal by Subject|0|||
130916814|NCT00976677|471329816|FG001|Overall Study|Withdrawal by Subject|2|||
130916815|NCT00976677|471329815|FG000|Overall Study|Disease progression|1|||
130916816|NCT00976677|471329816|FG001|Overall Study|Disease progression|1|||
130916817|NCT00976677|471329815|FG000|Overall Study|Trial unblinded|2|||
130916818|NCT00976677|471329816|FG001|Overall Study|Trial unblinded|2|||
130916819|NCT00976677|471329815|FG000|Overall Study|Unknown/Missing|1|||
130916820|NCT00976677|471329816|FG001|Overall Study|Unknown/Missing|0|||
130916821|NCT03507400|471329817|FG000|Overall Study|discontinued|5|||
130916822|NCT03507400|471329818|FG001|Overall Study|discontinued|1|||
130916823|NCT03507400|471329817|FG000|Overall Study|Lost to Follow-up|8|||
130916824|NCT03507400|471329818|FG001|Overall Study|Lost to Follow-up|6|||
130916825|NCT03507400|471329817|FG000|Overall Study|Protocol Violation|0|||
130916826|NCT03507400|471329818|FG001|Overall Study|Protocol Violation|1|||
130916827|NCT01555983|471329823|FG000|Overall Study|Withdrawal by Subject|1|||
130916828|NCT01555983|471329824|FG001|Overall Study|Withdrawal by Subject|0|||
130916829|NCT01555983|471329825|FG002|Overall Study|Withdrawal by Subject|0|||
130916830|NCT01555983|471329826|FG003|Overall Study|Withdrawal by Subject|0|||
130916831|NCT01555983|471329827|FG004|Overall Study|Withdrawal by Subject|1|||
130916832|NCT01555983|471329828|FG005|Overall Study|Withdrawal by Subject|1|||
130916833|NCT00108433|471331544|FG000|Overall Study|Lack of Efficacy|1|||
130916834|NCT00108433|471331545|FG001|Overall Study|Lack of Efficacy|2|||
130916835|NCT00108433|471331544|FG000|Overall Study|Death|3|||
130916836|NCT00108433|471331545|FG001|Overall Study|Death|0|||
130916837|NCT00108433|471331544|FG000|Overall Study|Adverse Event|3|||
130699519|NCT03414034|470524716|FG000|Overall Study|Withdrawal of Informed Consent|2|||
130916838|NCT00108433|471331545|FG001|Overall Study|Adverse Event|1|||
130916839|NCT00108433|471331544|FG000|Overall Study|Other|14|||
130916840|NCT00108433|471331545|FG001|Overall Study|Other|14|||
130916841|NCT04806503|471331549|FG000|Overall Study|Lost to Follow-up|0|||
130916842|NCT04806503|471331550|FG001|Overall Study|Lost to Follow-up|0|||
130916843|NCT04806503|471331551|FG002|Overall Study|Lost to Follow-up|1|||
130916844|NCT04806503|471331552|FG003|Overall Study|Lost to Follow-up|0|||
131033315|NCT03269136|471755318|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
131033316|NCT03269136|471755319|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
131033317|NCT03269136|471755320|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
131033318|NCT03269136|471755321|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
131033319|NCT03269136|471755322|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
131033320|NCT03269136|471755323|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
131033321|NCT03269136|471755324|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
131033322|NCT03269136|471755325|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
131033323|NCT03269136|471755326|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
131033324|NCT03269136|471755327|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
131033325|NCT03269136|471755328|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
130916845|NCT04806503|471331553|FG004|Overall Study|Lost to Follow-up|0|||
130916846|NCT04806503|471331549|FG000|Overall Study|Withdrawal by Subject|1|||
130916847|NCT04806503|471331550|FG001|Overall Study|Withdrawal by Subject|0|||
130916848|NCT04806503|471331551|FG002|Overall Study|Withdrawal by Subject|1|||
130916849|NCT04806503|471331552|FG003|Overall Study|Withdrawal by Subject|1|||
130916850|NCT04806503|471331553|FG004|Overall Study|Withdrawal by Subject|1|||
130916851|NCT04806503|471331549|FG000|Overall Study|Adverse Event|1|||
130916852|NCT04806503|471331550|FG001|Overall Study|Adverse Event|1|||
130916853|NCT04806503|471331551|FG002|Overall Study|Adverse Event|0|||
130916854|NCT04806503|471331552|FG003|Overall Study|Adverse Event|1|||
130916855|NCT04806503|471331553|FG004|Overall Study|Adverse Event|0|||
130916856|NCT00734474|471331563|FG000|Overall Study|Entry Criteria Not Met|0|||
130916857|NCT00734474|471331564|FG001|Overall Study|Entry Criteria Not Met|0|||
130916858|NCT00734474|471331565|FG002|Overall Study|Entry Criteria Not Met|5|||
130916859|NCT00734474|471331566|FG003|Overall Study|Entry Criteria Not Met|0|||
130916860|NCT00734474|471331567|FG004|Overall Study|Entry Criteria Not Met|3|||
130916861|NCT00734474|471331568|FG005|Overall Study|Entry Criteria Not Met|1|||
130916862|NCT00734474|471331569|FG006|Overall Study|Entry Criteria Not Met|0|||
130916863|NCT00734474|471331570|FG007|Overall Study|Entry Criteria Not Met|1|||
130916864|NCT00734474|471331571|FG008|Overall Study|Entry Criteria Not Met|1|||
130916865|NCT00734474|471331563|FG000|Overall Study|Lost to Follow-up|1|||
130916866|NCT00734474|471331564|FG001|Overall Study|Lost to Follow-up|0|||
130916867|NCT00734474|471331565|FG002|Overall Study|Lost to Follow-up|13|||
130916868|NCT00734474|471331566|FG003|Overall Study|Lost to Follow-up|0|||
130916869|NCT00734474|471331567|FG004|Overall Study|Lost to Follow-up|11|||
130916870|NCT00734474|471331568|FG005|Overall Study|Lost to Follow-up|1|||
130916871|NCT00734474|471331569|FG006|Overall Study|Lost to Follow-up|0|||
130916872|NCT00734474|471331570|FG007|Overall Study|Lost to Follow-up|9|||
130916873|NCT00734474|471331571|FG008|Overall Study|Lost to Follow-up|4|||
130916874|NCT00734474|471331563|FG000|Overall Study|Withdrawal by Subject|2|||
130916875|NCT00734474|471331564|FG001|Overall Study|Withdrawal by Subject|1|||
130916876|NCT00734474|471331565|FG002|Overall Study|Withdrawal by Subject|18|||
130916877|NCT00734474|471331566|FG003|Overall Study|Withdrawal by Subject|0|||
130916878|NCT00734474|471331567|FG004|Overall Study|Withdrawal by Subject|24|||
130916879|NCT00734474|471331568|FG005|Overall Study|Withdrawal by Subject|2|||
130916880|NCT00734474|471331569|FG006|Overall Study|Withdrawal by Subject|0|||
130916881|NCT00734474|471331570|FG007|Overall Study|Withdrawal by Subject|36|||
130916882|NCT00734474|471331571|FG008|Overall Study|Withdrawal by Subject|21|||
130916883|NCT00734474|471331563|FG000|Overall Study|Physician Decision|0|||
130916884|NCT00734474|471331564|FG001|Overall Study|Physician Decision|0|||
130916885|NCT00734474|471331565|FG002|Overall Study|Physician Decision|4|||
130916886|NCT00734474|471331566|FG003|Overall Study|Physician Decision|1|||
130916887|NCT00734474|471331567|FG004|Overall Study|Physician Decision|11|||
130916888|NCT00734474|471331568|FG005|Overall Study|Physician Decision|0|||
130916889|NCT00734474|471331569|FG006|Overall Study|Physician Decision|0|||
130916890|NCT00734474|471331570|FG007|Overall Study|Physician Decision|9|||
130916891|NCT00734474|471331571|FG008|Overall Study|Physician Decision|9|||
130916892|NCT00734474|471331563|FG000|Overall Study|Adverse Event|4|||
130916893|NCT00734474|471331564|FG001|Overall Study|Adverse Event|4|||
130916894|NCT00734474|471331565|FG002|Overall Study|Adverse Event|63|||
130916895|NCT00734474|471331566|FG003|Overall Study|Adverse Event|1|||
130916896|NCT00734474|471331567|FG004|Overall Study|Adverse Event|64|||
130916897|NCT00734474|471331568|FG005|Overall Study|Adverse Event|0|||
130916898|NCT00734474|471331569|FG006|Overall Study|Adverse Event|1|||
130916899|NCT00734474|471331570|FG007|Overall Study|Adverse Event|65|||
130916900|NCT00734474|471331571|FG008|Overall Study|Adverse Event|39|||
130699520|NCT03414034|470524717|FG001|Overall Study|Withdrawal of Informed Consent|1|||
130699521|NCT03414034|470524718|FG002|Overall Study|Withdrawal of Informed Consent|4|||
130699522|NCT03414034|470524716|FG000|Overall Study|Progressive Disease|15|||
130699523|NCT03414034|470524717|FG001|Overall Study|Progressive Disease|15|||
130699524|NCT03414034|470524718|FG002|Overall Study|Progressive Disease|17|||
130699525|NCT03414034|470524716|FG000|Overall Study|Miscellaneous|0|||
130916901|NCT00734474|471331563|FG000|Overall Study|Protocol Violation|0|||
130916902|NCT00734474|471331564|FG001|Overall Study|Protocol Violation|0|||
130916903|NCT00734474|471331565|FG002|Overall Study|Protocol Violation|4|||
130916904|NCT00734474|471331566|FG003|Overall Study|Protocol Violation|0|||
130916905|NCT00734474|471331567|FG004|Overall Study|Protocol Violation|3|||
130916906|NCT00734474|471331568|FG005|Overall Study|Protocol Violation|0|||
130916907|NCT00734474|471331569|FG006|Overall Study|Protocol Violation|0|||
130916908|NCT00734474|471331570|FG007|Overall Study|Protocol Violation|3|||
130916909|NCT00734474|471331571|FG008|Overall Study|Protocol Violation|1|||
130916910|NCT00734474|471331563|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
130916911|NCT00734474|471331564|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
130916912|NCT00734474|471331565|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
130916913|NCT00734474|471331566|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
130916914|NCT00734474|471331567|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
130916915|NCT00734474|471331568|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
130916916|NCT00734474|471331569|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
131119236|NCT02871778|472067316|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
131119237|NCT02871778|472067317|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130699526|NCT03414034|470524717|FG001|Overall Study|Miscellaneous|0|||
130699527|NCT03414034|470524718|FG002|Overall Study|Miscellaneous|2|||
130916917|NCT00734474|471331570|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
130916918|NCT00734474|471331571|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
130916919|NCT00734474|471331563|FG000|Overall Study|Sponsor Decision|0|||
130916920|NCT00734474|471331564|FG001|Overall Study|Sponsor Decision|0|||
130916921|NCT00734474|471331565|FG002|Overall Study|Sponsor Decision|0|||
131119238|NCT02871778|472067318|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
131119239|NCT02871778|472067319|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
131119240|NCT02871778|472067320|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
131119241|NCT02871778|472067321|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
131119242|NCT02871778|472067314|FG000|Part B: Treatment Period 3|Adverse Event|0|||
131119243|NCT02871778|472067315|FG001|Part B: Treatment Period 3|Adverse Event|0|||
131119244|NCT02871778|472067316|FG002|Part B: Treatment Period 3|Adverse Event|0|||
131119245|NCT02871778|472067317|FG003|Part B: Treatment Period 3|Adverse Event|0|||
131119246|NCT02871778|472067318|FG004|Part B: Treatment Period 3|Adverse Event|1|||
131119247|NCT02871778|472067319|FG005|Part B: Treatment Period 3|Adverse Event|1|||
131119248|NCT02871778|472067320|FG006|Part B: Treatment Period 3|Adverse Event|1|||
131119249|NCT02871778|472067321|FG007|Part B: Treatment Period 3|Adverse Event|0|||
131119250|NCT02653300|472067323|FG000|Overall Study|Withdrawal by Subject|2|||
131119251|NCT00800683|472067343|FG000|Overall Study|Adverse Event|11|||
131119252|NCT00800683|472067344|FG001|Overall Study|Adverse Event|8|||
131119253|NCT00800683|472067343|FG000|Overall Study|Lost to Follow-up|3|||
131119254|NCT00800683|472067344|FG001|Overall Study|Lost to Follow-up|1|||
131119255|NCT00800683|472067343|FG000|Overall Study|Withdrawal by Subject|1|||
131119256|NCT00800683|472067344|FG001|Overall Study|Withdrawal by Subject|7|||
131119257|NCT00800683|472067343|FG000|Overall Study|Lack of Efficacy|1|||
131119258|NCT00800683|472067344|FG001|Overall Study|Lack of Efficacy|1|||
131119259|NCT00800683|472067343|FG000|Overall Study|Other|1|||
131119260|NCT00800683|472067344|FG001|Overall Study|Other|2|||
131119261|NCT01478360|472067345|FG000|Overall Study|Lost to Follow-up|1|||
131119262|NCT01478360|472067346|FG001|Overall Study|Lost to Follow-up|0|||
131119263|NCT01478360|472067345|FG000|Overall Study|Adverse Event|0|||
131119264|NCT01478360|472067346|FG001|Overall Study|Adverse Event|1|||
131119265|NCT01478360|472067345|FG000|Overall Study|Administrative problems|1|||
131119266|NCT01478360|472067346|FG001|Overall Study|Administrative problems|2|||
131119267|NCT02289352|472067347|FG000|Overall Study|Withdrawal by Subject|1|||
131119268|NCT02289352|472067348|FG001|Overall Study|Withdrawal by Subject|1|||
131119269|NCT02289352|472067349|FG002|Overall Study|Withdrawal by Subject|0|||
131119270|NCT00911625|472067350|FG000|Overall Study|Lost to Follow-up|7|||
131119271|NCT00911625|472067351|FG001|Overall Study|Lost to Follow-up|0|||
131119272|NCT01289821|472067352|FG000|Treatment Period|Withdrawal by Subject|1|||
131119273|NCT01289821|472067352|FG000|Treatment Period|Physician Decision|3|||
131119274|NCT01289821|472067352|FG000|Treatment Period|Adverse Event|4|||
131119275|NCT01289821|472067352|FG000|Treatment Period|Radiological Progression|43|||
131119276|NCT01289821|472067352|FG000|Treatment Period|Clinical Progression|2|||
131119277|NCT01289821|472067352|FG000|Treatment Period|Therapeutic procedure required|1|||
131119278|NCT01289821|472067352|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
131119279|NCT01289821|472067352|FG000|Safety Follow-up Period|Protocol Violation|3|||
131119280|NCT01289821|472067352|FG000|Safety Follow-up Period|Unspecified reason|1|||
131119281|NCT01289821|472067352|FG000|Survival Follow-up Period|Protocol Violation|1|||
131119282|NCT01289821|472067352|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
131119283|NCT01289821|472067352|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
131119284|NCT02463071|472067359|FG000|Overall Study|Adverse Event|3|||
131119285|NCT02463071|472067360|FG001|Overall Study|Adverse Event|5|||
131119286|NCT02463071|472067361|FG002|Overall Study|Adverse Event|1|||
131119287|NCT02463071|472067359|FG000|Overall Study|Death|1|||
131119288|NCT02463071|472067360|FG001|Overall Study|Death|0|||
131119289|NCT02463071|472067361|FG002|Overall Study|Death|0|||
131119290|NCT02463071|472067359|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
131119291|NCT02463071|472067360|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131119292|NCT02463071|472067361|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
131119293|NCT02463071|472067359|FG000|Overall Study|Reason not specified|7|||
131119294|NCT02463071|472067360|FG001|Overall Study|Reason not specified|9|||
131119295|NCT02463071|472067361|FG002|Overall Study|Reason not specified|4|||
131119296|NCT02463071|472067359|FG000|Overall Study|Protocol Violation|0|||
130916922|NCT00734474|471331566|FG003|Overall Study|Sponsor Decision|0|||
131119297|NCT02463071|472067360|FG001|Overall Study|Protocol Violation|2|||
131119298|NCT02463071|472067361|FG002|Overall Study|Protocol Violation|0|||
131119299|NCT02463071|472067359|FG000|Overall Study|Lost to Follow-up|0|||
131119300|NCT02463071|472067360|FG001|Overall Study|Lost to Follow-up|0|||
131119301|NCT02463071|472067361|FG002|Overall Study|Lost to Follow-up|1|||
131119302|NCT01245387|472067362|FG000|Overall Study|Lost to Follow-up|106|||
131119303|NCT01245387|472067362|FG000|Overall Study|Lack of Efficacy|195|||
131119304|NCT01245387|472067362|FG000|Overall Study|Adverse Event|9|||
131119305|NCT01245387|472067362|FG000|Overall Study|Death|3|||
131119306|NCT01245387|472067362|FG000|Overall Study|Other|131|||
131119307|NCT01245387|472067362|FG000|Overall Study|Missing discontinuation status|369|||
131119308|NCT00757003|472067363|FG000|Overall Study|Death|33|||
131119309|NCT00757003|472067363|FG000|Overall Study|Lost to Follow-up|9|||
131119310|NCT00757003|472067363|FG000|Overall Study|Withdrawal by Subject|4|||
131119311|NCT00757003|472067363|FG000|Overall Study|Surgically explanted|2|||
131119312|NCT00757003|472067363|FG000|Overall Study|Not implanted|1|||
131119313|NCT02146599|472067379|FG000|Overall Study|Failed to meet inclusion criteria|5|||
130916923|NCT00734474|471331567|FG004|Overall Study|Sponsor Decision|2|||
130916924|NCT00734474|471331568|FG005|Overall Study|Sponsor Decision|0|||
130916925|NCT00734474|471331569|FG006|Overall Study|Sponsor Decision|0|||
130916926|NCT00734474|471331570|FG007|Overall Study|Sponsor Decision|0|||
130916927|NCT00734474|471331571|FG008|Overall Study|Sponsor Decision|0|||
130916928|NCT00734474|471331563|FG000|Overall Study|Death|0|||
130916929|NCT00734474|471331564|FG001|Overall Study|Death|0|||
130916930|NCT00734474|471331565|FG002|Overall Study|Death|1|||
130916931|NCT00734474|471331566|FG003|Overall Study|Death|0|||
130916932|NCT00734474|471331567|FG004|Overall Study|Death|0|||
130916933|NCT00734474|471331568|FG005|Overall Study|Death|0|||
130916934|NCT00734474|471331569|FG006|Overall Study|Death|0|||
130916935|NCT00734474|471331570|FG007|Overall Study|Death|2|||
130916936|NCT00734474|471331571|FG008|Overall Study|Death|1|||
130916937|NCT00734474|471331563|FG000|Overall Study|Lack of Efficacy|0|||
130916938|NCT00734474|471331564|FG001|Overall Study|Lack of Efficacy|0|||
130916939|NCT00734474|471331565|FG002|Overall Study|Lack of Efficacy|4|||
130916940|NCT00734474|471331566|FG003|Overall Study|Lack of Efficacy|0|||
130916941|NCT00734474|471331567|FG004|Overall Study|Lack of Efficacy|0|||
130916942|NCT00734474|471331568|FG005|Overall Study|Lack of Efficacy|0|||
130916943|NCT00734474|471331569|FG006|Overall Study|Lack of Efficacy|0|||
130916944|NCT00734474|471331570|FG007|Overall Study|Lack of Efficacy|4|||
130916945|NCT00734474|471331571|FG008|Overall Study|Lack of Efficacy|6|||
130916946|NCT01797731|471331580|FG000|Overall Study|Didn't have proper radiographs required|3|||
130916947|NCT01797731|471331581|FG001|Overall Study|Didn't have proper radiographs required|3|||
130916948|NCT00091442|471331583|FG000|Overall Study|Progressive Disease|220|||
130916949|NCT00091442|471331584|FG001|Overall Study|Progressive Disease|189|||
130916950|NCT00091442|471331583|FG000|Overall Study|Physician Decision|61|||
130916951|NCT00091442|471331584|FG001|Overall Study|Physician Decision|58|||
131119314|NCT03061175|472067383|FG000|Baseline|Participant was deemed ineligible|1|||
131119315|NCT03061175|472067384|FG001|Baseline|Participant was deemed ineligible|0|||
131119316|NCT03061175|472067383|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
131119317|NCT03061175|472067384|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
131119318|NCT03061175|472067383|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
131119319|NCT03061175|472067384|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
131119320|NCT03061175|472067383|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
131119321|NCT03061175|472067384|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
131119322|NCT02243865|472067385|FG000|Overall Study|Protocol Violation|1|||
131119323|NCT02243865|472067386|FG001|Overall Study|Protocol Violation|3|||
131119324|NCT02243865|472067385|FG000|Overall Study|Lost to Follow-up|1|||
131119325|NCT02243865|472067386|FG001|Overall Study|Lost to Follow-up|1|||
131119326|NCT02243865|472067385|FG000|Overall Study|Withdrawal by Subject|1|||
131119327|NCT02243865|472067386|FG001|Overall Study|Withdrawal by Subject|0|||
131119328|NCT02243865|472067385|FG000|Overall Study|Adverse Event|1|||
131119329|NCT02243865|472067386|FG001|Overall Study|Adverse Event|1|||
131119330|NCT01235793|472067390|FG000|Overall Study|Death|6|||
131119331|NCT01159912|472067394|FG000|Overall Study|Adverse Event|2|||
131119332|NCT01159912|472067395|FG001|Overall Study|Adverse Event|2|||
131119333|NCT01159912|472067396|FG002|Overall Study|Adverse Event|3|||
131119334|NCT01159912|472067394|FG000|Overall Study|Lack of Efficacy|23|||
131119335|NCT01159912|472067395|FG001|Overall Study|Lack of Efficacy|15|||
131119336|NCT01159912|472067396|FG002|Overall Study|Lack of Efficacy|14|||
131119337|NCT01159912|472067394|FG000|Overall Study|Protocol Violation|1|||
131119338|NCT01159912|472067395|FG001|Overall Study|Protocol Violation|2|||
131119339|NCT01159912|472067396|FG002|Overall Study|Protocol Violation|3|||
131119340|NCT01159912|472067394|FG000|Overall Study|Lost to Follow-up|4|||
131119341|NCT01159912|472067395|FG001|Overall Study|Lost to Follow-up|0|||
131119342|NCT01159912|472067396|FG002|Overall Study|Lost to Follow-up|0|||
131119343|NCT01159912|472067394|FG000|Overall Study|Physician Decision|0|||
131119344|NCT01159912|472067395|FG001|Overall Study|Physician Decision|0|||
131119345|NCT01159912|472067396|FG002|Overall Study|Physician Decision|3|||
131119346|NCT01159912|472067394|FG000|Overall Study|Withdrawal by Subject|10|||
131119347|NCT01159912|472067395|FG001|Overall Study|Withdrawal by Subject|3|||
131119348|NCT01159912|472067396|FG002|Overall Study|Withdrawal by Subject|3|||
131119349|NCT01428661|472067404|FG000|Double-Masked Phase|Protocol Violation|9|||
131119350|NCT01428661|472067405|FG001|Double-Masked Phase|Protocol Violation|4|||
131119351|NCT01428661|472067406|FG002|Double-Masked Phase|Protocol Violation|0|||
131119352|NCT01428661|472067404|FG000|Double-Masked Phase|Adverse Event|13|||
131119353|NCT01428661|472067405|FG001|Double-Masked Phase|Adverse Event|4|||
130916952|NCT00091442|471331583|FG000|Overall Study|Withdrawal by Subject|38|||
130916953|NCT00091442|471331584|FG001|Overall Study|Withdrawal by Subject|46|||
130916954|NCT00091442|471331583|FG000|Overall Study|Adverse Event|29|||
130916955|NCT00091442|471331584|FG001|Overall Study|Adverse Event|48|||
130916956|NCT00091442|471331583|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
130916957|NCT00091442|471331584|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
130916958|NCT00091442|471331583|FG000|Overall Study|Death|9|||
130916959|NCT00091442|471331584|FG001|Overall Study|Death|7|||
131119354|NCT01428661|472067406|FG002|Double-Masked Phase|Adverse Event|0|||
130916960|NCT00091442|471331583|FG000|Overall Study|Lost to Follow-up|1|||
130916961|NCT00091442|471331584|FG001|Overall Study|Lost to Follow-up|3|||
130916962|NCT00091442|471331583|FG000|Overall Study|Other|2|||
130916963|NCT00091442|471331584|FG001|Overall Study|Other|6|||
130916964|NCT05095454|471331589|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
130916965|NCT05095454|471331590|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
130916966|NCT03342963|471331591|FG000|Overall Study|Adverse Event|1|||
130916967|NCT03342963|471331592|FG001|Overall Study|Adverse Event|2|||
130916968|NCT03342963|471331593|FG002|Overall Study|Adverse Event|0|||
130916969|NCT03342963|471331594|FG003|Overall Study|Adverse Event|0|||
130916970|NCT03342963|471331591|FG000|Overall Study|Withdrawal by Subject|1|||
130916971|NCT03342963|471331592|FG001|Overall Study|Withdrawal by Subject|0|||
130916972|NCT03342963|471331593|FG002|Overall Study|Withdrawal by Subject|0|||
130916973|NCT03342963|471331594|FG003|Overall Study|Withdrawal by Subject|0|||
130916974|NCT00986830|471331595|FG000|Overall Study|Death|1|||
130916975|NCT00986830|471331595|FG000|Overall Study|Lost to Follow-up|1|||
130916976|NCT00986830|471331595|FG000|Overall Study|Lack of Efficacy|1|||
130916977|NCT00986830|471331595|FG000|Overall Study|Unable to access sinus with device|5|||
130916978|NCT01332331|471331597|FG000|Overall Study|Lost to Follow-up|0|||
130916979|NCT01332331|471331598|FG001|Overall Study|Lost to Follow-up|1|||
130916980|NCT01332331|471331597|FG000|Overall Study|Adverse Event|1|||
130916981|NCT01332331|471331598|FG001|Overall Study|Adverse Event|1|||
130916982|NCT01332331|471331597|FG000|Overall Study|Physician Decision|1|||
130916983|NCT01332331|471331598|FG001|Overall Study|Physician Decision|0|||
130916984|NCT03605212|471331603|FG000|Treatment Period|Adverse Event|1|||
130916985|NCT03605212|471331604|FG001|Treatment Period|Adverse Event|0|||
130916986|NCT03605212|471331605|FG002|Treatment Period|Adverse Event|0|||
130916987|NCT03605212|471331606|FG003|Treatment Period|Adverse Event|0|||
130916988|NCT03605212|471331607|FG004|Treatment Period|Adverse Event|0|||
130916989|NCT03605212|471331603|FG000|Treatment Period|Physician Decision|0|||
130916990|NCT03605212|471331604|FG001|Treatment Period|Physician Decision|0|||
130916991|NCT03605212|471331605|FG002|Treatment Period|Physician Decision|0|||
130916992|NCT03605212|471331606|FG003|Treatment Period|Physician Decision|0|||
130916993|NCT03605212|471331607|FG004|Treatment Period|Physician Decision|1|||
130916994|NCT01756053|471331608|FG000|Period 1 (10 Days)|Protocol Violation|1|||
130916995|NCT01756053|471331609|FG001|Period 1 (10 Days)|Protocol Violation|1|||
130916996|NCT01756053|471331608|FG000|Period 2 (10 Days)|Protocol Violation|0|||
130916997|NCT01756053|471331609|FG001|Period 2 (10 Days)|Protocol Violation|2|||
130916998|NCT00285818|471331610|FG000|Overall Study|Withdrawal by Subject|3|||
130916999|NCT00285818|471331611|FG001|Overall Study|Withdrawal by Subject|2|||
130917000|NCT00285818|471331610|FG000|Overall Study|Lost to Follow-up|1|||
130917001|NCT00285818|471331611|FG001|Overall Study|Lost to Follow-up|0|||
130917002|NCT04041375|471331612|FG000|Intervention Phase|Withdrawal by Subject|2|||
130917003|NCT04041375|471331613|FG001|Intervention Phase|Withdrawal by Subject|2|||
130917004|NCT04041375|471331612|FG000|Follow-up Phase|Death|2|||
130917005|NCT04041375|471331613|FG001|Follow-up Phase|Death|0|||
130917006|NCT04041375|471331612|FG000|Follow-up Phase|Lost to Follow-up|2|||
130917007|NCT04041375|471331613|FG001|Follow-up Phase|Lost to Follow-up|1|||
130917008|NCT04041375|471331612|FG000|Follow-up Phase|Too ill|3|||
130917009|NCT04041375|471331613|FG001|Follow-up Phase|Too ill|0|||
130917010|NCT01672736|471331618|FG000|Overall Study|Available drug expired on 31 May 16|3|||
130917011|NCT01262573|471331619|FG000|Overall Study|Withdrawal by Subject|0|||
130917012|NCT01262573|471331620|FG001|Overall Study|Withdrawal by Subject|1|||
130917013|NCT03800173|471331627|FG000|Overall Study|Lost to Follow-up|0|||
130917014|NCT03800173|471331628|FG001|Overall Study|Lost to Follow-up|0|||
131033326|NCT03269136|471755329|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
131033327|NCT03269136|471755330|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
131033328|NCT03269136|471755331|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
131033329|NCT03269136|471755332|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
131033330|NCT03150810|471755333|FG000|Overall Study|Death|4|||
131033331|NCT03150810|471755334|FG001|Overall Study|Death|8|||
131033332|NCT03150810|471755335|FG002|Overall Study|Death|7|||
131033333|NCT03150810|471755336|FG003|Overall Study|Death|2|||
131033334|NCT03150810|471755337|FG004|Overall Study|Death|2|||
131033335|NCT03150810|471755338|FG005|Overall Study|Death|10|||
131033336|NCT03150810|471755339|FG006|Overall Study|Death|8|||
130917015|NCT03800173|471331629|FG002|Overall Study|Lost to Follow-up|0|||
130917016|NCT03800173|471331630|FG003|Overall Study|Lost to Follow-up|0|||
130917017|NCT03800173|471331631|FG004|Overall Study|Lost to Follow-up|1|||
130917018|NCT00936611|471331632|FG000|Overall Study|Progressive Disease|3|||
130917019|NCT00936611|471331632|FG000|Overall Study|New Systemic Therapy|22|||
130917020|NCT00936611|471331632|FG000|Overall Study|Lost to Follow-up|1|||
130917021|NCT00936611|471331632|FG000|Overall Study|Withdrawal by Subject|2|||
130917022|NCT00936611|471331632|FG000|Overall Study|Still on Follow-up|1|||
130699528|NCT01332968|470524719|FG000|Induction Period|Adverse Event|23|||
130917023|NCT00936611|471331632|FG000|Overall Study|Still on Active Therapy|7|||
130917024|NCT00936611|471331632|FG000|Overall Study|Ineligible for Study Drug|3|||
130917025|NCT02507973|471331633|FG000|Overall Study|Adverse Event|1|||
131033337|NCT03150810|471755340|FG007|Overall Study|Death|6|||
130917026|NCT02081183|471331635|FG000|Overall Study|Lost to Follow-up|0|||
130917027|NCT02081183|471331636|FG001|Overall Study|Lost to Follow-up|1|||
130917028|NCT02081183|471331635|FG000|Overall Study|Protocol Violation|1|||
130917029|NCT02081183|471331636|FG001|Overall Study|Protocol Violation|0|||
130917030|NCT02081183|471331635|FG000|Overall Study|Other|3|||
130917031|NCT02081183|471331636|FG001|Overall Study|Other|3|||
130917032|NCT00910273|471331641|FG000|Overall Study|Lack of Efficacy|6|||
130917033|NCT00910273|471331642|FG001|Overall Study|Lack of Efficacy|9|||
130917034|NCT00910273|471331641|FG000|Overall Study|Adverse Event|1|||
130917035|NCT00910273|471331642|FG001|Overall Study|Adverse Event|1|||
130917036|NCT00910273|471331641|FG000|Overall Study|Withdrawal by Subject|1|||
130917037|NCT00910273|471331642|FG001|Overall Study|Withdrawal by Subject|0|||
130917038|NCT00910273|471331641|FG000|Overall Study|Discontinuation of study by sponsor|8|||
130917039|NCT00910273|471331642|FG001|Overall Study|Discontinuation of study by sponsor|2|||
130917040|NCT00910273|471331641|FG000|Overall Study|Protocol Violation|1|||
130917041|NCT00910273|471331642|FG001|Overall Study|Protocol Violation|0|||
130917042|NCT00910273|471331641|FG000|Overall Study|Lost to Follow-up|1|||
130917043|NCT00910273|471331642|FG001|Overall Study|Lost to Follow-up|1|||
130917044|NCT04043728|471331643|FG000|Overall Study|Lost to Follow-up|1|||
130917045|NCT04043728|471331644|FG001|Overall Study|Lost to Follow-up|2|||
130917046|NCT04043728|471331645|FG002|Overall Study|Lost to Follow-up|0|||
130917047|NCT01033851|471331646|FG000|Overall Study|Withdrawal by Subject|3|||
130917048|NCT01033851|471331647|FG001|Overall Study|Withdrawal by Subject|7|||
130917049|NCT02349542|471331648|FG000|Overall Study|Withdrawal by Subject|5|||
130917050|NCT01011738|471331649|FG000|Overall Study|Death|12|||
130917051|NCT01011738|471331650|FG001|Overall Study|Death|3|||
130917052|NCT01011738|471331651|FG002|Overall Study|Death|0|||
130917053|NCT01011738|471331649|FG000|Overall Study|Unknown reasons|312|||
130917054|NCT01011738|471331650|FG001|Overall Study|Unknown reasons|291|||
130917055|NCT01011738|471331651|FG002|Overall Study|Unknown reasons|17|||
130917056|NCT03841448|471331652|FG000|Double-blind Treatment (DBT) Period|Death|1|||
130917057|NCT03841448|471331653|FG001|Double-blind Treatment (DBT) Period|Death|1|||
130917058|NCT03841448|471331654|FG002|Double-blind Treatment (DBT) Period|Death|0|||
130917059|NCT03841448|471331655|FG003|Double-blind Treatment (DBT) Period|Death|0|||
130917060|NCT03841448|471331652|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
130917061|NCT03841448|471331653|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
130917062|NCT03841448|471331654|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
130917063|NCT03841448|471331655|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
130917064|NCT03841448|471331652|FG000|Open-Label Extension (OLE) Period|Death|0|||
130917065|NCT03841448|471331653|FG001|Open-Label Extension (OLE) Period|Death|0|||
130917066|NCT03841448|471331654|FG002|Open-Label Extension (OLE) Period|Death|0|||
130917067|NCT03841448|471331655|FG003|Open-Label Extension (OLE) Period|Death|1|||
130917068|NCT03841448|471331652|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
130917069|NCT03841448|471331653|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
130917070|NCT03841448|471331654|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
130917071|NCT03841448|471331655|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
130917072|NCT03841448|471331652|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
130917073|NCT03841448|471331653|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
130917074|NCT03841448|471331654|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
130917075|NCT03841448|471331655|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
130917076|NCT03841448|471331652|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
130917077|NCT03841448|471331653|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
130917078|NCT03841448|471331654|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
130917079|NCT03841448|471331655|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
130917080|NCT01163266|471331656|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
130917081|NCT01163266|471331657|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
130917082|NCT01163266|471331658|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
130917083|NCT01163266|471331656|FG000|Overall Study|Lack of Efficacy|1|||
130917084|NCT01163266|471331657|FG001|Overall Study|Lack of Efficacy|3|||
130917085|NCT01163266|471331658|FG002|Overall Study|Lack of Efficacy|1|||
130917086|NCT01163266|471331656|FG000|Overall Study|Noncompliance with Study Drug|0|||
131033338|NCT03150810|471755341|FG008|Overall Study|Death|18|||
130917087|NCT01163266|471331657|FG001|Overall Study|Noncompliance with Study Drug|2|||
130917088|NCT01163266|471331658|FG002|Overall Study|Noncompliance with Study Drug|0|||
130917089|NCT01163266|471331656|FG000|Overall Study|Protocol Deviations|2|||
130917090|NCT01163266|471331657|FG001|Overall Study|Protocol Deviations|2|||
130917091|NCT01163266|471331658|FG002|Overall Study|Protocol Deviations|5|||
130917092|NCT01163266|471331656|FG000|Overall Study|Withdrawal of Consent|5|||
130917093|NCT01163266|471331657|FG001|Overall Study|Withdrawal of Consent|7|||
130917094|NCT01163266|471331658|FG002|Overall Study|Withdrawal of Consent|3|||
130917095|NCT01163266|471331656|FG000|Overall Study|Lost to Follow-up|7|||
130917096|NCT01163266|471331657|FG001|Overall Study|Lost to Follow-up|7|||
130917097|NCT01163266|471331658|FG002|Overall Study|Lost to Follow-up|10|||
130917098|NCT01163266|471331656|FG000|Overall Study|Other|1|||
130917099|NCT01163266|471331657|FG001|Overall Study|Other|1|||
131119355|NCT01428661|472067404|FG000|Double-Masked Phase|Lost to Follow-up|14|||
131119356|NCT01428661|472067405|FG001|Double-Masked Phase|Lost to Follow-up|14|||
131119357|NCT01428661|472067406|FG002|Double-Masked Phase|Lost to Follow-up|0|||
131119358|NCT01428661|472067404|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
131119359|NCT01428661|472067405|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
131119360|NCT01428661|472067406|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
131119361|NCT01428661|472067404|FG000|Double-Masked Phase|Lack of Efficacy|2|||
131119362|NCT01428661|472067405|FG001|Double-Masked Phase|Lack of Efficacy|1|||
131119363|NCT01428661|472067406|FG002|Double-Masked Phase|Lack of Efficacy|0|||
131119364|NCT01428661|472067404|FG000|Double-Masked Phase|*Various|1|||
131119365|NCT01428661|472067405|FG001|Double-Masked Phase|*Various|6|||
131119366|NCT01428661|472067406|FG002|Double-Masked Phase|*Various|0|||
131119367|NCT01428661|472067404|FG000|Open Label Extension|Protocol Violation|0|||
131119368|NCT01428661|472067405|FG001|Open Label Extension|Protocol Violation|0|||
131119369|NCT01428661|472067406|FG002|Open Label Extension|Protocol Violation|9|||
131119370|NCT01428661|472067404|FG000|Open Label Extension|Adverse Event|0|||
131119371|NCT01428661|472067405|FG001|Open Label Extension|Adverse Event|0|||
131119372|NCT01428661|472067406|FG002|Open Label Extension|Adverse Event|15|||
131119373|NCT01428661|472067404|FG000|Open Label Extension|Lost to Follow-up|0|||
131119374|NCT01428661|472067405|FG001|Open Label Extension|Lost to Follow-up|0|||
131119375|NCT01428661|472067406|FG002|Open Label Extension|Lost to Follow-up|38|||
131119376|NCT01428661|472067404|FG000|Open Label Extension|Withdrawal by Subject|0|||
131119377|NCT01428661|472067405|FG001|Open Label Extension|Withdrawal by Subject|0|||
131119378|NCT01428661|472067406|FG002|Open Label Extension|Withdrawal by Subject|49|||
131119379|NCT01428661|472067404|FG000|Open Label Extension|Lack of Efficacy|0|||
131119380|NCT01428661|472067405|FG001|Open Label Extension|Lack of Efficacy|0|||
130699529|NCT01332968|470524720|FG001|Induction Period|Adverse Event|26|||
130699530|NCT01332968|470524721|FG002|Induction Period|Adverse Event|0|||
130699531|NCT01332968|470524722|FG003|Induction Period|Adverse Event|0|||
130699532|NCT01332968|470524723|FG004|Induction Period|Adverse Event|0|||
130699533|NCT01332968|470524724|FG005|Induction Period|Adverse Event|0|||
130699534|NCT01332968|470524725|FG006|Induction Period|Adverse Event|0|||
131119381|NCT01428661|472067406|FG002|Open Label Extension|Lack of Efficacy|24|||
131119382|NCT01428661|472067404|FG000|Open Label Extension|**Various|0|||
131119383|NCT01428661|472067405|FG001|Open Label Extension|**Various|0|||
131119384|NCT01428661|472067406|FG002|Open Label Extension|**Various|185|||
131119385|NCT02229539|472070133|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
131119386|NCT02229539|472070134|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
131119387|NCT02229539|472070135|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
131119388|NCT02229539|472070133|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
131119389|NCT02229539|472070134|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
131119390|NCT02229539|472070135|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
131119391|NCT02229539|472070133|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
131119392|NCT02229539|472070134|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
131119393|NCT02229539|472070135|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
131119394|NCT02229539|472070133|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
131119395|NCT02229539|472070134|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
131119396|NCT02229539|472070135|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
131119397|NCT02229539|472070133|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
131119398|NCT02229539|472070134|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
131119399|NCT02229539|472070135|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
131119400|NCT02229539|472070133|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
131119401|NCT02229539|472070134|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
131119402|NCT02229539|472070135|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
131119403|NCT04050670|472070138|FG000|Period 3|Physician Decision|0|||
131119404|NCT04050670|472070139|FG001|Period 3|Physician Decision|1|||
131119405|NCT04050670|472070140|FG002|Period 3|Physician Decision|0|||
131119406|NCT00880555|472070151|FG000|Overall Study|Physician Decision|0|||
131119407|NCT00880555|472070152|FG001|Overall Study|Physician Decision|8|||
131119408|NCT00880555|472070153|FG002|Overall Study|Physician Decision|0|||
131119409|NCT00880555|472070154|FG003|Overall Study|Physician Decision|2|||
131119410|NCT00880555|472070155|FG004|Overall Study|Physician Decision|1|||
131119411|NCT00880555|472070156|FG005|Overall Study|Physician Decision|0|||
131119412|NCT00880555|472070151|FG000|Overall Study|Withdrawal by Subject|1|||
130699535|NCT01332968|470524726|FG007|Induction Period|Adverse Event|0|||
130699536|NCT01332968|470524719|FG000|Induction Period|Death|1|||
130699537|NCT01332968|470524720|FG001|Induction Period|Death|4|||
130699538|NCT01332968|470524721|FG002|Induction Period|Death|0|||
130699539|NCT01332968|470524722|FG003|Induction Period|Death|0|||
131119413|NCT00880555|472070152|FG001|Overall Study|Withdrawal by Subject|1|||
131119414|NCT00880555|472070153|FG002|Overall Study|Withdrawal by Subject|0|||
131119415|NCT00880555|472070154|FG003|Overall Study|Withdrawal by Subject|0|||
131119416|NCT00880555|472070155|FG004|Overall Study|Withdrawal by Subject|0|||
131119417|NCT00880555|472070156|FG005|Overall Study|Withdrawal by Subject|0|||
130917100|NCT01163266|471331658|FG002|Overall Study|Other|2|||
130917101|NCT02586064|471331659|FG000|Overall Study|Other Obligations|6|||
130917102|NCT02586064|471331660|FG001|Overall Study|Other Obligations|6|||
130699540|NCT01332968|470524723|FG004|Induction Period|Death|0|||
130699541|NCT01332968|470524724|FG005|Induction Period|Death|0|||
130917103|NCT02586064|471331659|FG000|Overall Study|Other|3|||
130699542|NCT01332968|470524725|FG006|Induction Period|Death|0|||
130699543|NCT01332968|470524726|FG007|Induction Period|Death|0|||
130699544|NCT01332968|470524719|FG000|Induction Period|Non-compliance|1|||
130917104|NCT02586064|471331660|FG001|Overall Study|Other|7|||
130917105|NCT02586064|471331659|FG000|Overall Study|Never Started|3|||
130917106|NCT02586064|471331660|FG001|Overall Study|Never Started|3|||
130917107|NCT02586064|471331659|FG000|Overall Study|Lost Interest|1|||
130917108|NCT02586064|471331660|FG001|Overall Study|Lost Interest|4|||
130917109|NCT02586064|471331659|FG000|Overall Study|Miscellaneous Life Issues|0|||
130917110|NCT02586064|471331660|FG001|Overall Study|Miscellaneous Life Issues|5|||
130917111|NCT02586064|471331659|FG000|Overall Study|Infrequent Attendance|2|||
131033339|NCT03150810|471755342|FG009|Overall Study|Death|3|||
131033340|NCT03150810|471755343|FG010|Overall Study|Death|19|||
131033341|NCT03150810|471755344|FG011|Overall Study|Death|1|||
131033342|NCT03150810|471755345|FG012|Overall Study|Death|19|||
131033343|NCT03150810|471755333|FG000|Overall Study|Withdrawal by Subject|0|||
131033344|NCT03150810|471755334|FG001|Overall Study|Withdrawal by Subject|1|||
131033345|NCT03150810|471755335|FG002|Overall Study|Withdrawal by Subject|1|||
131033346|NCT03150810|471755336|FG003|Overall Study|Withdrawal by Subject|1|||
131033347|NCT03150810|471755337|FG004|Overall Study|Withdrawal by Subject|0|||
131033348|NCT03150810|471755338|FG005|Overall Study|Withdrawal by Subject|0|||
131033349|NCT03150810|471755339|FG006|Overall Study|Withdrawal by Subject|2|||
131033350|NCT03150810|471755340|FG007|Overall Study|Withdrawal by Subject|0|||
131033351|NCT03150810|471755341|FG008|Overall Study|Withdrawal by Subject|2|||
131033352|NCT03150810|471755342|FG009|Overall Study|Withdrawal by Subject|0|||
131033353|NCT03150810|471755343|FG010|Overall Study|Withdrawal by Subject|1|||
131033354|NCT03150810|471755344|FG011|Overall Study|Withdrawal by Subject|0|||
131033355|NCT03150810|471755345|FG012|Overall Study|Withdrawal by Subject|1|||
131033356|NCT03150810|471755333|FG000|Overall Study|Sponsor Decision|0|||
131033357|NCT03150810|471755334|FG001|Overall Study|Sponsor Decision|2|||
131033358|NCT03150810|471755335|FG002|Overall Study|Sponsor Decision|0|||
131033359|NCT03150810|471755336|FG003|Overall Study|Sponsor Decision|0|||
131033360|NCT03150810|471755337|FG004|Overall Study|Sponsor Decision|1|||
131033361|NCT03150810|471755338|FG005|Overall Study|Sponsor Decision|1|||
131033362|NCT03150810|471755339|FG006|Overall Study|Sponsor Decision|0|||
131033363|NCT03150810|471755340|FG007|Overall Study|Sponsor Decision|0|||
131033364|NCT03150810|471755341|FG008|Overall Study|Sponsor Decision|1|||
131033365|NCT03150810|471755342|FG009|Overall Study|Sponsor Decision|0|||
131033366|NCT03150810|471755343|FG010|Overall Study|Sponsor Decision|0|||
131033367|NCT03150810|471755344|FG011|Overall Study|Sponsor Decision|0|||
131033368|NCT03150810|471755345|FG012|Overall Study|Sponsor Decision|5|||
131033369|NCT03150810|471755333|FG000|Overall Study|Lost to Follow-up|0|||
131033370|NCT03150810|471755334|FG001|Overall Study|Lost to Follow-up|1|||
131033371|NCT03150810|471755335|FG002|Overall Study|Lost to Follow-up|1|||
131033372|NCT03150810|471755336|FG003|Overall Study|Lost to Follow-up|0|||
131033373|NCT03150810|471755337|FG004|Overall Study|Lost to Follow-up|0|||
131033374|NCT03150810|471755338|FG005|Overall Study|Lost to Follow-up|0|||
131033375|NCT03150810|471755339|FG006|Overall Study|Lost to Follow-up|1|||
131033376|NCT03150810|471755340|FG007|Overall Study|Lost to Follow-up|0|||
131033377|NCT03150810|471755341|FG008|Overall Study|Lost to Follow-up|0|||
131033378|NCT03150810|471755342|FG009|Overall Study|Lost to Follow-up|0|||
131033379|NCT03150810|471755343|FG010|Overall Study|Lost to Follow-up|1|||
131033380|NCT03150810|471755344|FG011|Overall Study|Lost to Follow-up|0|||
131033381|NCT03150810|471755345|FG012|Overall Study|Lost to Follow-up|0|||
131033382|NCT03150810|471755333|FG000|Overall Study|Physician Decision|0|||
131033383|NCT03150810|471755334|FG001|Overall Study|Physician Decision|0|||
131033384|NCT03150810|471755335|FG002|Overall Study|Physician Decision|0|||
131033385|NCT03150810|471755336|FG003|Overall Study|Physician Decision|0|||
131033386|NCT03150810|471755337|FG004|Overall Study|Physician Decision|0|||
131033387|NCT03150810|471755338|FG005|Overall Study|Physician Decision|1|||
131033388|NCT03150810|471755339|FG006|Overall Study|Physician Decision|1|||
131033389|NCT03150810|471755340|FG007|Overall Study|Physician Decision|0|||
130917112|NCT02586064|471331660|FG001|Overall Study|Infrequent Attendance|1|||
131033390|NCT03150810|471755341|FG008|Overall Study|Physician Decision|0|||
131033391|NCT03150810|471755342|FG009|Overall Study|Physician Decision|0|||
130917113|NCT02586064|471331659|FG000|Overall Study|Timed Out|2|||
130917114|NCT02586064|471331660|FG001|Overall Study|Timed Out|0|||
131033392|NCT03150810|471755343|FG010|Overall Study|Physician Decision|0|||
131033393|NCT03150810|471755344|FG011|Overall Study|Physician Decision|0|||
131033394|NCT03150810|471755345|FG012|Overall Study|Physician Decision|0|||
131033395|NCT03150810|471755333|FG000|Overall Study|Site withdrawal from study|0|||
130699545|NCT01332968|470524720|FG001|Induction Period|Non-compliance|0|||
131033396|NCT03150810|471755334|FG001|Overall Study|Site withdrawal from study|1|||
131033397|NCT03150810|471755335|FG002|Overall Study|Site withdrawal from study|0|||
130917115|NCT02586064|471331659|FG000|Overall Study|AUD relapse|0|||
130699546|NCT01332968|470524721|FG002|Induction Period|Non-compliance|0|||
130699547|NCT01332968|470524722|FG003|Induction Period|Non-compliance|0|||
130699548|NCT01332968|470524723|FG004|Induction Period|Non-compliance|0|||
130699549|NCT01332968|470524724|FG005|Induction Period|Non-compliance|0|||
130699550|NCT01332968|470524725|FG006|Induction Period|Non-compliance|0|||
130699551|NCT01332968|470524726|FG007|Induction Period|Non-compliance|0|||
130699552|NCT01332968|470524719|FG000|Induction Period|Other|2|||
130699553|NCT01332968|470524720|FG001|Induction Period|Other|2|||
130699554|NCT01332968|470524721|FG002|Induction Period|Other|0|||
130699555|NCT01332968|470524722|FG003|Induction Period|Other|0|||
130699556|NCT01332968|470524723|FG004|Induction Period|Other|0|||
130699557|NCT01332968|470524724|FG005|Induction Period|Other|0|||
130699558|NCT01332968|470524725|FG006|Induction Period|Other|0|||
130699559|NCT01332968|470524726|FG007|Induction Period|Other|0|||
130699560|NCT01332968|470524719|FG000|Induction Period|Physician Decision|6|||
130699561|NCT01332968|470524720|FG001|Induction Period|Physician Decision|1|||
130699562|NCT01332968|470524721|FG002|Induction Period|Physician Decision|0|||
130699563|NCT01332968|470524722|FG003|Induction Period|Physician Decision|0|||
130699564|NCT01332968|470524723|FG004|Induction Period|Physician Decision|0|||
130917116|NCT02586064|471331660|FG001|Overall Study|AUD relapse|2|||
130917117|NCT02586064|471331659|FG000|Overall Study|Legal Issue|1|||
130917118|NCT02586064|471331660|FG001|Overall Study|Legal Issue|0|||
130917119|NCT03181893|471331661|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130917120|NCT03181893|471331662|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
130917121|NCT03181893|471331663|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130917122|NCT03181893|471331664|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130917123|NCT03181893|471331665|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130917124|NCT03181893|471331666|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130917125|NCT03181893|471331667|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130917126|NCT03181893|471331668|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130917127|NCT03181893|471331669|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130917128|NCT03181893|471331670|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130917129|NCT03181893|471331671|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130917130|NCT03181893|471331661|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
130917131|NCT03181893|471331662|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
130917132|NCT03181893|471331663|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130917133|NCT03181893|471331664|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130917134|NCT03181893|471331665|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130917135|NCT03181893|471331666|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130917136|NCT03181893|471331667|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130917137|NCT03181893|471331668|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130917138|NCT03181893|471331669|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130917139|NCT03181893|471331670|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131119418|NCT00880555|472070151|FG000|Overall Study|Lack of resources (hired rater)|9|||
131119419|NCT00880555|472070152|FG001|Overall Study|Lack of resources (hired rater)|7|||
131119420|NCT00880555|472070153|FG002|Overall Study|Lack of resources (hired rater)|5|||
131119421|NCT00880555|472070154|FG003|Overall Study|Lack of resources (hired rater)|0|||
131119422|NCT00880555|472070155|FG004|Overall Study|Lack of resources (hired rater)|0|||
131119423|NCT00880555|472070156|FG005|Overall Study|Lack of resources (hired rater)|0|||
131119424|NCT00880555|472070151|FG000|Overall Study|Death|0|||
131119425|NCT00880555|472070152|FG001|Overall Study|Death|0|||
131119426|NCT00880555|472070153|FG002|Overall Study|Death|0|||
131119427|NCT00880555|472070154|FG003|Overall Study|Death|0|||
131119428|NCT00880555|472070155|FG004|Overall Study|Death|0|||
131119429|NCT00880555|472070156|FG005|Overall Study|Death|1|||
131119430|NCT00880555|472070151|FG000|Overall Study|Lost to Follow-up|0|||
131119431|NCT00880555|472070152|FG001|Overall Study|Lost to Follow-up|1|||
131119432|NCT00880555|472070153|FG002|Overall Study|Lost to Follow-up|0|||
131119433|NCT00880555|472070154|FG003|Overall Study|Lost to Follow-up|0|||
131119434|NCT00880555|472070155|FG004|Overall Study|Lost to Follow-up|0|||
131119435|NCT00880555|472070156|FG005|Overall Study|Lost to Follow-up|0|||
130699565|NCT01332968|470524724|FG005|Induction Period|Physician Decision|0|||
130699566|NCT01332968|470524725|FG006|Induction Period|Physician Decision|0|||
130699567|NCT01332968|470524726|FG007|Induction Period|Physician Decision|0|||
130699568|NCT01332968|470524719|FG000|Induction Period|Progressive Disease|15|||
130699569|NCT01332968|470524720|FG001|Induction Period|Progressive Disease|7|||
130699570|NCT01332968|470524721|FG002|Induction Period|Progressive Disease|0|||
130917140|NCT03181893|471331671|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
131119436|NCT02982590|472070158|FG000|Overall Study|Lost to Follow-up|0|||
131119437|NCT02982590|472070159|FG001|Overall Study|Lost to Follow-up|1|||
131119438|NCT02982590|472070158|FG000|Overall Study|Death|4|||
131119439|NCT02982590|472070159|FG001|Overall Study|Death|0|||
131119440|NCT01168973|472070160|FG000|Overall Study|Progressive Disease|341|||
130699571|NCT01332968|470524722|FG003|Induction Period|Progressive Disease|0|||
130699572|NCT01332968|470524723|FG004|Induction Period|Progressive Disease|0|||
130699573|NCT01332968|470524724|FG005|Induction Period|Progressive Disease|0|||
131222830|NCT03674827|472443186|FG001|Treatment Phase|Withdrawal by Subject|0|||
131222831|NCT03674827|472443187|FG002|Treatment Phase|Withdrawal by Subject|0|||
131222832|NCT03674827|472443188|FG003|Treatment Phase|Withdrawal by Subject|0|||
131222833|NCT03674827|472443189|FG004|Treatment Phase|Withdrawal by Subject|0|||
131222834|NCT03674827|472443190|FG005|Treatment Phase|Withdrawal by Subject|1|||
131222835|NCT03674827|472443185|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
131222836|NCT03674827|472443186|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
131222837|NCT03674827|472443187|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
131222838|NCT03674827|472443188|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
131222839|NCT03674827|472443189|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
131222840|NCT03674827|472443190|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
131222841|NCT03674827|472443185|FG000|Treatment Phase|Other|0|||
131222842|NCT03674827|472443186|FG001|Treatment Phase|Other|1|||
131222843|NCT03674827|472443187|FG002|Treatment Phase|Other|0|||
131222844|NCT03674827|472443188|FG003|Treatment Phase|Other|0|||
131222845|NCT03674827|472443189|FG004|Treatment Phase|Other|0|||
131222846|NCT03674827|472443190|FG005|Treatment Phase|Other|1|||
131222847|NCT03674827|472443185|FG000|Long-Term Follow-up Phase|Death|2|||
131222848|NCT03674827|472443186|FG001|Long-Term Follow-up Phase|Death|4|||
131222849|NCT03674827|472443187|FG002|Long-Term Follow-up Phase|Death|2|||
131222850|NCT03674827|472443188|FG003|Long-Term Follow-up Phase|Death|3|||
131222851|NCT03674827|472443189|FG004|Long-Term Follow-up Phase|Death|2|||
131222852|NCT03674827|472443190|FG005|Long-Term Follow-up Phase|Death|6|||
131222853|NCT03674827|472443185|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
131222854|NCT03674827|472443186|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
131222855|NCT03674827|472443187|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
131222856|NCT03674827|472443188|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
131222857|NCT03674827|472443189|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
131222858|NCT03674827|472443190|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
131222859|NCT03674827|472443185|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
131222860|NCT03674827|472443186|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
131222861|NCT03674827|472443187|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
131222862|NCT03674827|472443188|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
131222863|NCT03674827|472443189|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
131222864|NCT03674827|472443190|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
131222865|NCT00527397|472443191|FG000|Overall Study|Adverse Event|3|||
131222866|NCT00527397|472443191|FG000|Overall Study|Lack of Efficacy|1|||
131222867|NCT00527397|472443191|FG000|Overall Study|Protocol Violation|1|||
131222868|NCT00527397|472443191|FG000|Overall Study|Withdrawal by Subject|6|||
131222869|NCT00527397|472443191|FG000|Overall Study|Study terminated by sponsor|13|||
131222870|NCT01783483|472443192|FG000|Overall Study|Death|3|||
131222871|NCT01783483|472443193|FG001|Overall Study|Death|3|||
131222872|NCT01783483|472443192|FG000|Overall Study|Lost to Follow-up|14|||
131222873|NCT01783483|472443193|FG001|Overall Study|Lost to Follow-up|10|||
131222874|NCT01783483|472443192|FG000|Overall Study|Withdrawal by Subject|2|||
131222875|NCT01783483|472443193|FG001|Overall Study|Withdrawal by Subject|1|||
131222876|NCT01783483|472443192|FG000|Overall Study|Physician Decision|1|||
131222877|NCT01783483|472443193|FG001|Overall Study|Physician Decision|1|||
131222878|NCT04130919|472443199|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
131222879|NCT04130919|472443200|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
130699574|NCT01332968|470524725|FG006|Induction Period|Progressive Disease|0|||
130699575|NCT01332968|470524726|FG007|Induction Period|Progressive Disease|0|||
130699576|NCT01332968|470524719|FG000|Induction Period|Protocol Violation|3|||
130699577|NCT01332968|470524720|FG001|Induction Period|Protocol Violation|4|||
130917141|NCT03181893|471331661|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130917142|NCT03181893|471331662|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131033398|NCT03150810|471755336|FG003|Overall Study|Site withdrawal from study|0|||
130917143|NCT03181893|471331663|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130917144|NCT03181893|471331664|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130917145|NCT03181893|471331665|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130917146|NCT03181893|471331666|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130917147|NCT03181893|471331667|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
131033399|NCT03150810|471755337|FG004|Overall Study|Site withdrawal from study|0|||
131033400|NCT03150810|471755338|FG005|Overall Study|Site withdrawal from study|0|||
131033401|NCT03150810|471755339|FG006|Overall Study|Site withdrawal from study|0|||
131033402|NCT03150810|471755340|FG007|Overall Study|Site withdrawal from study|0|||
131222880|NCT04130919|472443201|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
131222881|NCT04130919|472443202|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
131222882|NCT04130919|472443203|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
131222883|NCT04130919|472443204|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
131222884|NCT04130919|472443199|FG000|Blinded Treatment Phase|Adverse Event|0|||
131222885|NCT04130919|472443200|FG001|Blinded Treatment Phase|Adverse Event|0|||
131222886|NCT04130919|472443201|FG002|Blinded Treatment Phase|Adverse Event|1|||
131222887|NCT04130919|472443202|FG003|Blinded Treatment Phase|Adverse Event|0|||
130917148|NCT03181893|471331668|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
130917149|NCT03181893|471331669|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
130917150|NCT03181893|471331670|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130917151|NCT03181893|471331671|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
130917152|NCT03181893|471331661|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130917153|NCT03181893|471331662|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130917154|NCT03181893|471331663|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130917155|NCT03181893|471331664|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130917156|NCT03181893|471331665|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130917157|NCT03181893|471331666|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130917158|NCT03181893|471331667|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130917159|NCT03181893|471331668|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130917160|NCT03181893|471331669|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130917161|NCT03181893|471331670|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
130917162|NCT03181893|471331671|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130917163|NCT03181893|471331661|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130917164|NCT03181893|471331662|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130917165|NCT03181893|471331663|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130917166|NCT03181893|471331664|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130917167|NCT03181893|471331665|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130917168|NCT03181893|471331666|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130917169|NCT03181893|471331667|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130917170|NCT03181893|471331668|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130917171|NCT03181893|471331669|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130917172|NCT03181893|471331670|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130917173|NCT03181893|471331671|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
130917174|NCT00968864|471331673|FG000|Overall Study|Protocol exception/ not evaluable|1|||
130917175|NCT04815031|471331674|FG000|Overall Study|No adverse event information (missing information)|33|||
130917176|NCT00586625|471331675|FG000|Overall Study|Adverse Event|6|||
130917177|NCT00586625|471331676|FG001|Overall Study|Adverse Event|6|||
130917178|NCT00586625|471331675|FG000|Overall Study|Protocol Violation|3|||
130917179|NCT00586625|471331676|FG001|Overall Study|Protocol Violation|0|||
130917180|NCT00586625|471331675|FG000|Overall Study|Withdrawal by Subject|32|||
130917181|NCT00586625|471331676|FG001|Overall Study|Withdrawal by Subject|10|||
130917182|NCT00586625|471331675|FG000|Overall Study|Subject non-compliance|0|||
130917183|NCT00586625|471331676|FG001|Overall Study|Subject non-compliance|1|||
130917184|NCT00586625|471331675|FG000|Overall Study|Subject unable to return for visit|2|||
130917185|NCT00586625|471331676|FG001|Overall Study|Subject unable to return for visit|0|||
130917186|NCT02728596|471331677|FG000|Overall Study|Refusal unrelated to adverse event|3|||
130917187|NCT02728596|471331678|FG001|Overall Study|Refusal unrelated to adverse event|6|||
130917188|NCT02728596|471331679|FG002|Overall Study|Refusal unrelated to adverse event|7|||
130917189|NCT02728596|471331680|FG003|Overall Study|Refusal unrelated to adverse event|7|||
130917190|NCT02728596|471331677|FG000|Overall Study|Death|44|||
130917191|NCT02728596|471331678|FG001|Overall Study|Death|42|||
130917192|NCT02728596|471331679|FG002|Overall Study|Death|123|||
130917193|NCT02728596|471331680|FG003|Overall Study|Death|68|||
130917194|NCT04032652|471331687|FG000|Overall Study|The study was terminated and the PI has|1|||
130917195|NCT04032652|471331688|FG001|Overall Study|The study was terminated and the PI has|1|||
130917196|NCT00165984|471331689|FG000|Overall Study|Death|15|||
130917197|NCT01414608|471331690|FG000|Overall Study|Ineligible|5|||
130917198|NCT01414608|471331691|FG001|Overall Study|Ineligible|2|||
130917199|NCT03945266|471331692|FG000|Overall Study|Withdrawal by Subject|1|||
130917200|NCT03945266|471331693|FG001|Overall Study|Withdrawal by Subject|0|||
130917201|NCT03945266|471331692|FG000|Overall Study|Miscarriage|0|||
130917202|NCT03945266|471331693|FG001|Overall Study|Miscarriage|2|||
130917203|NCT03945266|471331692|FG000|Overall Study|Lost to Follow-up|1|||
130917204|NCT03945266|471331693|FG001|Overall Study|Lost to Follow-up|0|||
130917205|NCT01736124|471331696|FG000|Post-intervention Assessment|Death|2|||
130917206|NCT01736124|471331697|FG001|Post-intervention Assessment|Death|2|||
130917207|NCT01736124|471331696|FG000|Post-intervention Assessment|lost computer access|1|||
130917208|NCT01736124|471331697|FG001|Post-intervention Assessment|lost computer access|1|||
130917209|NCT01736124|471331696|FG000|Post-intervention Assessment|Moved away|3|||
130917210|NCT01736124|471331697|FG001|Post-intervention Assessment|Moved away|1|||
130917211|NCT01736124|471331696|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
130917212|NCT01736124|471331697|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
130699578|NCT01332968|470524721|FG002|Induction Period|Protocol Violation|0|||
130917213|NCT01736124|471331696|FG000|Post-intervention Assessment|Illness|3|||
130917214|NCT01736124|471331697|FG001|Post-intervention Assessment|Illness|2|||
130917215|NCT01736124|471331696|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
131119441|NCT01168973|472070161|FG001|Overall Study|Progressive Disease|429|||
130699579|NCT01332968|470524722|FG003|Induction Period|Protocol Violation|0|||
130917216|NCT01736124|471331697|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
130917217|NCT01736124|471331696|FG000|Post-intervention Assessment|Temporarily away|3|||
130917218|NCT01736124|471331697|FG001|Post-intervention Assessment|Temporarily away|1|||
130917219|NCT01736124|471331696|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
130917220|NCT01736124|471331697|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
130917221|NCT01736124|471331696|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
130917222|NCT01736124|471331697|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
130917223|NCT01736124|471331696|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
130917224|NCT01736124|471331697|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
130917225|NCT01736124|471331696|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
130917226|NCT01736124|471331697|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
130917227|NCT01736124|471331696|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
131119442|NCT01168973|472070160|FG000|Overall Study|Adverse Event|94|||
131119443|NCT01168973|472070161|FG001|Overall Study|Adverse Event|55|||
131119444|NCT01168973|472070160|FG000|Overall Study|Withdrawal by Subject|90|||
131119445|NCT01168973|472070161|FG001|Overall Study|Withdrawal by Subject|53|||
131119446|NCT01168973|472070160|FG000|Overall Study|Death|42|||
131119447|NCT01168973|472070161|FG001|Overall Study|Death|45|||
131119448|NCT01168973|472070160|FG000|Overall Study|Physician Decision|37|||
131119449|NCT01168973|472070161|FG001|Overall Study|Physician Decision|19|||
131119450|NCT01168973|472070160|FG000|Overall Study|Sponsor Decision|2|||
131119451|NCT01168973|472070161|FG001|Overall Study|Sponsor Decision|1|||
131119452|NCT01168973|472070160|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
131119453|NCT01168973|472070161|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
131119454|NCT02230254|472070162|FG000|Overall Study|Lost to Follow-up|3|||
131119455|NCT02023242|472070163|FG000|Overall Study|Lost to Follow-up|3|||
131119456|NCT02023242|472070164|FG001|Overall Study|Lost to Follow-up|1|||
131119457|NCT02023242|472070163|FG000|Overall Study|Death|0|||
131119458|NCT02023242|472070164|FG001|Overall Study|Death|1|||
131119459|NCT00388505|472070167|FG000|Overall Study|Adverse Event or Death|43|||
131119460|NCT00388505|472070168|FG001|Overall Study|Adverse Event or Death|17|||
131119461|NCT00388505|472070167|FG000|Overall Study|Withdrawal by Subject|24|||
131119462|NCT00388505|472070168|FG001|Overall Study|Withdrawal by Subject|9|||
131119463|NCT00388505|472070167|FG000|Overall Study|Lost to Follow-up|5|||
131119464|NCT00388505|472070168|FG001|Overall Study|Lost to Follow-up|3|||
131119465|NCT00388505|472070167|FG000|Overall Study|Inappropriate Enrollment|0|||
131119466|NCT00388505|472070168|FG001|Overall Study|Inappropriate Enrollment|1|||
131119467|NCT00388505|472070167|FG000|Overall Study|Administrative Reason|1|||
131119468|NCT00388505|472070168|FG001|Overall Study|Administrative Reason|0|||
131119469|NCT00388505|472070167|FG000|Overall Study|Protocol Violation|6|||
131119470|NCT00388505|472070168|FG001|Overall Study|Protocol Violation|5|||
131119471|NCT00388505|472070167|FG000|Overall Study|Unable to classify|4|||
131119472|NCT00388505|472070168|FG001|Overall Study|Unable to classify|3|||
131119473|NCT04854434|472070172|FG000|Overall Study|Death|1|||
131119474|NCT04854434|472070173|FG001|Overall Study|Death|3|||
131119475|NCT04854434|472070174|FG002|Overall Study|Death|4|||
131119476|NCT04854434|472070172|FG000|Overall Study|Study Terminated by Sponsor|2|||
131119477|NCT04854434|472070173|FG001|Overall Study|Study Terminated by Sponsor|0|||
131119478|NCT04854434|472070174|FG002|Overall Study|Study Terminated by Sponsor|0|||
131119479|NCT04854434|472070172|FG000|Overall Study|Other|1|||
131119480|NCT04854434|472070173|FG001|Overall Study|Other|1|||
131119481|NCT04854434|472070174|FG002|Overall Study|Other|0|||
131119482|NCT01274715|472070175|FG000|Overall Study|Lost to Follow-up|1|||
131119483|NCT01274715|472070175|FG000|Overall Study|After consent, met exclusion criteria.|1|||
131119484|NCT01274715|472070175|FG000|Overall Study|After consent, met exclusion criteria.|1|||
131119485|NCT01274715|472070175|FG000|Overall Study|After consent, met exclusion criteria.|1|||
131119486|NCT02285920|472070177|FG000|Overall Study|Kidney transplantation|2|||
131119487|NCT02285920|472070178|FG001|Overall Study|Kidney transplantation|2|||
131119488|NCT02285920|472070179|FG002|Overall Study|Kidney transplantation|2|||
131119489|NCT02285920|472070180|FG003|Overall Study|Kidney transplantation|0|||
131119490|NCT02285920|472070177|FG000|Overall Study|Change to peritoneal dialysis|0|||
131119491|NCT02285920|472070178|FG001|Overall Study|Change to peritoneal dialysis|0|||
131119492|NCT02285920|472070179|FG002|Overall Study|Change to peritoneal dialysis|1|||
131119493|NCT02285920|472070180|FG003|Overall Study|Change to peritoneal dialysis|0|||
131119494|NCT02285920|472070177|FG000|Overall Study|Transfer to non-participating unit|0|||
131119495|NCT02285920|472070178|FG001|Overall Study|Transfer to non-participating unit|1|||
131119496|NCT02285920|472070179|FG002|Overall Study|Transfer to non-participating unit|0|||
130917228|NCT01736124|471331697|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
130917229|NCT01736124|471331696|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
131119497|NCT02285920|472070180|FG003|Overall Study|Transfer to non-participating unit|0|||
131119498|NCT02285920|472070177|FG000|Overall Study|Dialysis discontinuation|0|||
131119499|NCT02285920|472070178|FG001|Overall Study|Dialysis discontinuation|1|||
131119500|NCT02285920|472070179|FG002|Overall Study|Dialysis discontinuation|0|||
131119501|NCT02285920|472070180|FG003|Overall Study|Dialysis discontinuation|0|||
131119502|NCT02285920|472070177|FG000|Overall Study|Death|2|||
131119503|NCT02285920|472070178|FG001|Overall Study|Death|0|||
130917230|NCT01736124|471331697|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
130917231|NCT01736124|471331696|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
130917232|NCT01736124|471331697|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
130917233|NCT01736124|471331696|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
130917234|NCT01736124|471331697|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
130917235|NCT01736124|471331696|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
130917236|NCT01736124|471331697|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
130917237|NCT02423772|471331698|FG000|Overall Study|Lost to Follow-up|3|||
130917238|NCT02423772|471331699|FG001|Overall Study|Lost to Follow-up|3|||
130917239|NCT02423772|471331698|FG000|Overall Study|Did not begin intervention|2|||
130917240|NCT02423772|471331699|FG001|Overall Study|Did not begin intervention|5|||
130917241|NCT01193842|471331700|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
130917242|NCT01193842|471331701|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
130917243|NCT01193842|471331702|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
130917244|NCT01193842|471331703|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
130917245|NCT01193842|471331704|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
130917246|NCT01193842|471331700|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
130917247|NCT01193842|471331701|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
130917248|NCT01193842|471331702|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
130917249|NCT01193842|471331703|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
130917250|NCT01193842|471331704|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
130917251|NCT01193842|471331700|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
130917252|NCT01193842|471331701|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
130917253|NCT01193842|471331702|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
130917254|NCT01193842|471331703|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
130917255|NCT01193842|471331704|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
130917256|NCT01193842|471331700|FG000|Phase II: Randomized Groups|Death|0|||
130917257|NCT01193842|471331701|FG001|Phase II: Randomized Groups|Death|0|||
130917258|NCT01193842|471331702|FG002|Phase II: Randomized Groups|Death|0|||
130917259|NCT01193842|471331703|FG003|Phase II: Randomized Groups|Death|1|||
130917260|NCT01193842|471331704|FG004|Phase II: Randomized Groups|Death|1|||
130917261|NCT01193842|471331700|FG000|Phase II: Randomized Groups|Adverse Event|0|||
130917262|NCT01193842|471331701|FG001|Phase II: Randomized Groups|Adverse Event|0|||
130917263|NCT01193842|471331702|FG002|Phase II: Randomized Groups|Adverse Event|0|||
130917264|NCT01193842|471331703|FG003|Phase II: Randomized Groups|Adverse Event|5|||
130917265|NCT01193842|471331704|FG004|Phase II: Randomized Groups|Adverse Event|3|||
130917266|NCT01193842|471331700|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
130917267|NCT01193842|471331701|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
130917268|NCT01193842|471331702|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
130917269|NCT01193842|471331703|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
130917270|NCT01193842|471331704|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
130917271|NCT01193842|471331700|FG000|Phase II: Randomized Groups|Ineligible|0|||
130917272|NCT01193842|471331701|FG001|Phase II: Randomized Groups|Ineligible|0|||
130917273|NCT01193842|471331702|FG002|Phase II: Randomized Groups|Ineligible|0|||
130917274|NCT01193842|471331703|FG003|Phase II: Randomized Groups|Ineligible|0|||
130917275|NCT01193842|471331704|FG004|Phase II: Randomized Groups|Ineligible|1|||
130917276|NCT01193842|471331700|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
130917277|NCT01193842|471331701|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
130917278|NCT01193842|471331702|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
130917279|NCT01193842|471331703|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
130917280|NCT01193842|471331704|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
130917281|NCT05274165|471331706|FG000|Overall Study|Withdrawal by Subject|3|||
130917282|NCT05274165|471331707|FG001|Overall Study|Withdrawal by Subject|3|||
130917283|NCT02484690|471331708|FG000|Overall Study|Adverse Event|1|||
130917284|NCT02484690|471331709|FG001|Overall Study|Adverse Event|3|||
130917285|NCT02484690|471331710|FG002|Overall Study|Adverse Event|0|||
130917286|NCT02484690|471331711|FG003|Overall Study|Adverse Event|0|||
130917287|NCT02484690|471331712|FG004|Overall Study|Adverse Event|5|||
130917288|NCT02484690|471331708|FG000|Overall Study|Death|0|||
130917289|NCT02484690|471331709|FG001|Overall Study|Death|0|||
130917290|NCT02484690|471331710|FG002|Overall Study|Death|0|||
130917291|NCT02484690|471331711|FG003|Overall Study|Death|0|||
130917292|NCT02484690|471331712|FG004|Overall Study|Death|1|||
130917293|NCT02484690|471331708|FG000|Overall Study|Withdrawal by Subject|1|||
130917294|NCT02484690|471331709|FG001|Overall Study|Withdrawal by Subject|3|||
130917295|NCT02484690|471331710|FG002|Overall Study|Withdrawal by Subject|1|||
130917296|NCT02484690|471331711|FG003|Overall Study|Withdrawal by Subject|2|||
130917297|NCT02484690|471331712|FG004|Overall Study|Withdrawal by Subject|0|||
130917298|NCT02484690|471331708|FG000|Overall Study|Physician Decision|2|||
130917299|NCT02484690|471331709|FG001|Overall Study|Physician Decision|0|||
130917300|NCT02484690|471331710|FG002|Overall Study|Physician Decision|1|||
130917301|NCT02484690|471331711|FG003|Overall Study|Physician Decision|0|||
130917302|NCT02484690|471331712|FG004|Overall Study|Physician Decision|0|||
131222888|NCT04130919|472443203|FG004|Blinded Treatment Phase|Adverse Event|0|||
131222889|NCT04130919|472443204|FG005|Blinded Treatment Phase|Adverse Event|0|||
131222890|NCT04130919|472443199|FG000|Blinded Treatment Phase|Disease worsening|0|||
131222891|NCT04130919|472443200|FG001|Blinded Treatment Phase|Disease worsening|0|||
131222892|NCT04130919|472443201|FG002|Blinded Treatment Phase|Disease worsening|1|||
131222893|NCT04130919|472443202|FG003|Blinded Treatment Phase|Disease worsening|0|||
131222894|NCT04130919|472443203|FG004|Blinded Treatment Phase|Disease worsening|0|||
131222895|NCT04130919|472443204|FG005|Blinded Treatment Phase|Disease worsening|0|||
131222896|NCT04130919|472443199|FG000|Blinded Treatment Phase|Investigator's decision|0|||
131222897|NCT04130919|472443200|FG001|Blinded Treatment Phase|Investigator's decision|1|||
131222898|NCT04130919|472443201|FG002|Blinded Treatment Phase|Investigator's decision|0|||
131222899|NCT04130919|472443202|FG003|Blinded Treatment Phase|Investigator's decision|0|||
131222900|NCT04130919|472443203|FG004|Blinded Treatment Phase|Investigator's decision|0|||
131222901|NCT04130919|472443204|FG005|Blinded Treatment Phase|Investigator's decision|0|||
131222902|NCT04130919|472443199|FG000|Blinded Treatment Phase|Withdrew consent|1|||
131222903|NCT04130919|472443200|FG001|Blinded Treatment Phase|Withdrew consent|0|||
131222904|NCT04130919|472443201|FG002|Blinded Treatment Phase|Withdrew consent|0|||
131222905|NCT04130919|472443202|FG003|Blinded Treatment Phase|Withdrew consent|0|||
131222906|NCT04130919|472443203|FG004|Blinded Treatment Phase|Withdrew consent|0|||
131222907|NCT04130919|472443204|FG005|Blinded Treatment Phase|Withdrew consent|0|||
131222908|NCT04130919|472443199|FG000|Open-label Treatment Phase|Withdrew consent|0|||
131222909|NCT04130919|472443200|FG001|Open-label Treatment Phase|Withdrew consent|0|||
131222910|NCT04130919|472443201|FG002|Open-label Treatment Phase|Withdrew consent|0|||
131222911|NCT04130919|472443202|FG003|Open-label Treatment Phase|Withdrew consent|1|||
131222912|NCT04130919|472443203|FG004|Open-label Treatment Phase|Withdrew consent|1|||
131222913|NCT04130919|472443204|FG005|Open-label Treatment Phase|Withdrew consent|1|||
131222914|NCT04130919|472443199|FG000|Open-label Treatment Phase|Disease worsening|0|||
131222915|NCT04130919|472443200|FG001|Open-label Treatment Phase|Disease worsening|0|||
131222916|NCT04130919|472443201|FG002|Open-label Treatment Phase|Disease worsening|0|||
131222917|NCT04130919|472443202|FG003|Open-label Treatment Phase|Disease worsening|1|||
131222918|NCT04130919|472443203|FG004|Open-label Treatment Phase|Disease worsening|0|||
131222919|NCT04130919|472443204|FG005|Open-label Treatment Phase|Disease worsening|1|||
131222920|NCT04130919|472443199|FG000|Open-label Treatment Phase|Investigator's decision|0|||
131222921|NCT04130919|472443200|FG001|Open-label Treatment Phase|Investigator's decision|0|||
130699580|NCT01332968|470524723|FG004|Induction Period|Protocol Violation|0|||
130699581|NCT01332968|470524724|FG005|Induction Period|Protocol Violation|0|||
130917303|NCT02484690|471331708|FG000|Overall Study|Lost to Follow-up|0|||
130917304|NCT02484690|471331709|FG001|Overall Study|Lost to Follow-up|0|||
130917305|NCT02484690|471331710|FG002|Overall Study|Lost to Follow-up|1|||
130917306|NCT02484690|471331711|FG003|Overall Study|Lost to Follow-up|0|||
130917307|NCT02484690|471331712|FG004|Overall Study|Lost to Follow-up|0|||
130917308|NCT03693300|471333207|FG000|Overall Study|Withdrawal by Subject|6|||
130917309|NCT03693300|471333208|FG001|Overall Study|Withdrawal by Subject|0|||
130917310|NCT03693300|471333207|FG000|Overall Study|Death|50|||
130917311|NCT03693300|471333208|FG001|Overall Study|Death|2|||
130917312|NCT03693300|471333207|FG000|Overall Study|Lost to Follow-up|2|||
130917313|NCT03693300|471333208|FG001|Overall Study|Lost to Follow-up|0|||
130917314|NCT02206048|471333209|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
130917315|NCT03589469|471333212|FG000|Overall Study|Withdrawal by Subject|8|||
130917316|NCT03589469|471333212|FG000|Overall Study|Physician Decision|20|||
130917317|NCT03589469|471333212|FG000|Overall Study|Death|97|||
130917318|NCT03589469|471333212|FG000|Overall Study|Lost to Follow-up|8|||
130917319|NCT03589469|471333212|FG000|Overall Study|Miscellaneous|1|||
130917320|NCT04195906|471333214|FG000|Part 1|Adverse Event|3|||
130917321|NCT04195906|471333215|FG001|Part 1|Adverse Event|7|||
130917322|NCT04195906|471333214|FG000|Part 1|Withdrawal by Subject|0|||
130917323|NCT04195906|471333215|FG001|Part 1|Withdrawal by Subject|1|||
130917324|NCT04195906|471333214|FG000|Part 2|Adverse Event|1|||
130917325|NCT04195906|471333215|FG001|Part 2|Adverse Event|1|||
130917326|NCT04195906|471333214|FG000|Part 2|Withdrawal by Subject|0|||
130917327|NCT04195906|471333215|FG001|Part 2|Withdrawal by Subject|3|||
130917328|NCT04195906|471333214|FG000|Part 2|Other|1|||
130917329|NCT04195906|471333215|FG001|Part 2|Other|3|||
130917330|NCT02008318|471333216|FG000|Overall Study|Adverse Event|4|||
130917331|NCT02008318|471333217|FG001|Overall Study|Adverse Event|0|||
131033403|NCT03150810|471755341|FG008|Overall Study|Site withdrawal from study|0|||
131033404|NCT03150810|471755342|FG009|Overall Study|Site withdrawal from study|1|||
131033405|NCT03150810|471755343|FG010|Overall Study|Site withdrawal from study|1|||
131222922|NCT04130919|472443201|FG002|Open-label Treatment Phase|Investigator's decision|0|||
131222923|NCT04130919|472443202|FG003|Open-label Treatment Phase|Investigator's decision|1|||
131222924|NCT04130919|472443203|FG004|Open-label Treatment Phase|Investigator's decision|0|||
131222925|NCT04130919|472443204|FG005|Open-label Treatment Phase|Investigator's decision|0|||
130699582|NCT01332968|470524725|FG006|Induction Period|Protocol Violation|0|||
130917332|NCT02008318|471333216|FG000|Overall Study|Physician Decision|2|||
130917333|NCT02008318|471333217|FG001|Overall Study|Physician Decision|0|||
130699583|NCT01332968|470524726|FG007|Induction Period|Protocol Violation|0|||
130699584|NCT01332968|470524719|FG000|Induction Period|Withdrawal by Subject|3|||
130699585|NCT01332968|470524720|FG001|Induction Period|Withdrawal by Subject|5|||
130699586|NCT01332968|470524721|FG002|Induction Period|Withdrawal by Subject|0|||
130699587|NCT01332968|470524722|FG003|Induction Period|Withdrawal by Subject|0|||
130917334|NCT02008318|471333216|FG000|Overall Study|Progressive Disease|2|||
130917335|NCT02008318|471333217|FG001|Overall Study|Progressive Disease|0|||
130917336|NCT02008318|471333216|FG000|Overall Study|Protocol Violation|1|||
130917337|NCT02008318|471333217|FG001|Overall Study|Protocol Violation|1|||
130917338|NCT02008318|471333216|FG000|Overall Study|Withdrawal by Subject|3|||
130917339|NCT02008318|471333217|FG001|Overall Study|Withdrawal by Subject|0|||
130917340|NCT00371826|471333224|FG000|Core Phase (12 Months)|Adverse Event|15|||
130917341|NCT00371826|471333225|FG001|Core Phase (12 Months)|Adverse Event|4|||
130917342|NCT00371826|471333226|FG002|Core Phase (12 Months)|Adverse Event|9|||
130917343|NCT00371826|471333224|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
130917344|NCT00371826|471333225|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
130917345|NCT00371826|471333226|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
130917346|NCT00371826|471333224|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
130917347|NCT00371826|471333225|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
130917348|NCT00371826|471333226|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
130917349|NCT00371826|471333224|FG000|Core Phase (12 Months)|Protocol Violation|1|||
130917350|NCT00371826|471333225|FG001|Core Phase (12 Months)|Protocol Violation|0|||
130917351|NCT00371826|471333226|FG002|Core Phase (12 Months)|Protocol Violation|1|||
130917352|NCT00371826|471333224|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
130917353|NCT00371826|471333225|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
130917354|NCT00371826|471333226|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
130917355|NCT00371826|471333224|FG000|Core Phase (12 Months)|Administrative problems|1|||
130917356|NCT00371826|471333225|FG001|Core Phase (12 Months)|Administrative problems|0|||
130917357|NCT00371826|471333226|FG002|Core Phase (12 Months)|Administrative problems|8|||
130917358|NCT00371826|471333224|FG000|Core Phase (12 Months)|Graft Loss|0|||
130917359|NCT00371826|471333225|FG001|Core Phase (12 Months)|Graft Loss|1|||
130917360|NCT00371826|471333226|FG002|Core Phase (12 Months)|Graft Loss|0|||
130917361|NCT00371826|471333224|FG000|Extension Phase (24 Months)|Adverse Event|4|||
130917362|NCT00371826|471333225|FG001|Extension Phase (24 Months)|Adverse Event|5|||
130917363|NCT00371826|471333226|FG002|Extension Phase (24 Months)|Adverse Event|0|||
130917364|NCT00371826|471333224|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
130917365|NCT00371826|471333225|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
130917366|NCT00371826|471333226|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
130917367|NCT00371826|471333224|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
130917368|NCT00371826|471333225|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
130917369|NCT00371826|471333226|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
130917370|NCT00371826|471333224|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
130917371|NCT00371826|471333225|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
130917372|NCT00371826|471333226|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
130917373|NCT00371826|471333224|FG000|Extension Phase (24 Months)|Administrative problems|0|||
130917374|NCT00371826|471333225|FG001|Extension Phase (24 Months)|Administrative problems|0|||
130917375|NCT00371826|471333226|FG002|Extension Phase (24 Months)|Administrative problems|2|||
130917376|NCT00385762|471333227|FG000|Overall Study|Adverse Event|1|||
130917377|NCT00385762|471333227|FG000|Overall Study|Lost to Follow-up|1|||
130917378|NCT00573183|471333228|FG000|Overall Study|Lost to Follow-up|52|||
130917379|NCT00573183|471333229|FG001|Overall Study|Lost to Follow-up|50|||
130917380|NCT00573183|471333228|FG000|Overall Study|Withdrawal by Subject|8|||
130917381|NCT00573183|471333229|FG001|Overall Study|Withdrawal by Subject|2|||
130917382|NCT00573183|471333228|FG000|Overall Study|Death|0|||
130917383|NCT00573183|471333229|FG001|Overall Study|Death|1|||
130917384|NCT00573183|471333228|FG000|Overall Study|Adverse Event|2|||
130917385|NCT00573183|471333229|FG001|Overall Study|Adverse Event|0|||
130917386|NCT00573183|471333228|FG000|Overall Study|Incarceration|5|||
130917387|NCT00573183|471333229|FG001|Overall Study|Incarceration|8|||
130917388|NCT00573183|471333228|FG000|Overall Study|Other|5|||
130699588|NCT01332968|470524723|FG004|Induction Period|Withdrawal by Subject|0|||
130699589|NCT01332968|470524724|FG005|Induction Period|Withdrawal by Subject|0|||
130769263|NCT00002525|470780576|FG000|Overall Study|Withdrawal by Subject|11|||
130917389|NCT00573183|471333229|FG001|Overall Study|Other|2|||
130917390|NCT00231842|471333230|FG000|Overall Study|Withdrawal by Subject|3|||
130917391|NCT00231842|471333230|FG000|Overall Study|Did not complete the last 3 cycle|8|||
130917392|NCT02422303|471333231|FG000|Overall Study|Lost to Follow-up|1|||
131119504|NCT02285920|472070179|FG002|Overall Study|Death|2|||
130699590|NCT01332968|470524725|FG006|Induction Period|Withdrawal by Subject|0|||
130699591|NCT01332968|470524726|FG007|Induction Period|Withdrawal by Subject|0|||
130917393|NCT02422303|471333232|FG001|Overall Study|Lost to Follow-up|1|||
130917394|NCT00428792|471333235|FG000|Overall Study|Lack of Efficacy|1|||
130917395|NCT00428792|471333236|FG001|Overall Study|Lack of Efficacy|3|||
130917396|NCT00428792|471333235|FG000|Overall Study|Lost to Follow-up|0|||
130917397|NCT00428792|471333236|FG001|Overall Study|Lost to Follow-up|1|||
130917398|NCT01926015|471333237|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130917399|NCT01926015|471333238|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130917400|NCT01926015|471333237|FG000|Overall Study|Randomized not treated|2|||
130917401|NCT01926015|471333238|FG001|Overall Study|Randomized not treated|0|||
130917402|NCT00639678|471333239|FG000|Overall Study|Withdrawal by Subject|3|||
130917403|NCT00639678|471333240|FG001|Overall Study|Withdrawal by Subject|0|||
130917404|NCT00639678|471333241|FG002|Overall Study|Withdrawal by Subject|4|||
130917405|NCT00639678|471333242|FG003|Overall Study|Withdrawal by Subject|0|||
130917406|NCT00639678|471333239|FG000|Overall Study|Lost to Follow-up|1|||
131033406|NCT03150810|471755344|FG011|Overall Study|Site withdrawal from study|0|||
131033407|NCT03150810|471755345|FG012|Overall Study|Site withdrawal from study|0|||
131033408|NCT03150810|471755333|FG000|Overall Study|Hospice|0|||
131033409|NCT03150810|471755334|FG001|Overall Study|Hospice|0|||
131033410|NCT03150810|471755335|FG002|Overall Study|Hospice|0|||
131033411|NCT03150810|471755336|FG003|Overall Study|Hospice|0|||
131033412|NCT03150810|471755337|FG004|Overall Study|Hospice|0|||
131033413|NCT03150810|471755338|FG005|Overall Study|Hospice|1|||
131033414|NCT03150810|471755339|FG006|Overall Study|Hospice|0|||
131033415|NCT03150810|471755340|FG007|Overall Study|Hospice|0|||
131033416|NCT03150810|471755341|FG008|Overall Study|Hospice|0|||
131033417|NCT03150810|471755342|FG009|Overall Study|Hospice|0|||
131033418|NCT03150810|471755343|FG010|Overall Study|Hospice|0|||
131033419|NCT03150810|471755344|FG011|Overall Study|Hospice|0|||
131033420|NCT03150810|471755345|FG012|Overall Study|Hospice|0|||
131033421|NCT03150810|471755333|FG000|Overall Study|Participant relocated abroad.|0|||
131033422|NCT03150810|471755334|FG001|Overall Study|Participant relocated abroad.|0|||
131033423|NCT03150810|471755335|FG002|Overall Study|Participant relocated abroad.|0|||
131033424|NCT03150810|471755336|FG003|Overall Study|Participant relocated abroad.|0|||
131033425|NCT03150810|471755337|FG004|Overall Study|Participant relocated abroad.|0|||
131033426|NCT03150810|471755338|FG005|Overall Study|Participant relocated abroad.|1|||
131033427|NCT03150810|471755339|FG006|Overall Study|Participant relocated abroad.|0|||
131033428|NCT03150810|471755340|FG007|Overall Study|Participant relocated abroad.|0|||
131033429|NCT03150810|471755341|FG008|Overall Study|Participant relocated abroad.|0|||
131033430|NCT03150810|471755342|FG009|Overall Study|Participant relocated abroad.|0|||
131033431|NCT03150810|471755343|FG010|Overall Study|Participant relocated abroad.|0|||
131033432|NCT03150810|471755344|FG011|Overall Study|Participant relocated abroad.|0|||
131033433|NCT03150810|471755345|FG012|Overall Study|Participant relocated abroad.|0|||
131033434|NCT03150810|471755333|FG000|Overall Study|Transferred care to oncologist|0|||
131033435|NCT03150810|471755334|FG001|Overall Study|Transferred care to oncologist|0|||
131033436|NCT03150810|471755335|FG002|Overall Study|Transferred care to oncologist|0|||
131033437|NCT03150810|471755336|FG003|Overall Study|Transferred care to oncologist|0|||
131033438|NCT03150810|471755337|FG004|Overall Study|Transferred care to oncologist|0|||
131033439|NCT03150810|471755338|FG005|Overall Study|Transferred care to oncologist|0|||
131033440|NCT03150810|471755339|FG006|Overall Study|Transferred care to oncologist|2|||
131033441|NCT03150810|471755340|FG007|Overall Study|Transferred care to oncologist|0|||
131033442|NCT03150810|471755341|FG008|Overall Study|Transferred care to oncologist|0|||
131033443|NCT03150810|471755342|FG009|Overall Study|Transferred care to oncologist|0|||
131033444|NCT03150810|471755343|FG010|Overall Study|Transferred care to oncologist|0|||
131033445|NCT03150810|471755344|FG011|Overall Study|Transferred care to oncologist|0|||
131033446|NCT03150810|471755345|FG012|Overall Study|Transferred care to oncologist|0|||
131033447|NCT05116787|471755346|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
131033448|NCT05116787|471755347|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
131033449|NCT05116787|471755346|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
131033450|NCT05116787|471755347|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
131033451|NCT05116787|471755346|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
131033452|NCT05116787|471755347|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
131033453|NCT05116787|471755346|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
131033454|NCT05116787|471755347|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
131033455|NCT04359108|471755348|FG000|Overall Study|Withdrawal by Subject|1|||
131033456|NCT04359108|471755349|FG001|Overall Study|Withdrawal by Subject|0|||
131033457|NCT04359108|471755348|FG000|Overall Study|Unable or too feeble to walk independently|0|||
131033458|NCT04359108|471755349|FG001|Overall Study|Unable or too feeble to walk independently|2|||
131033459|NCT04359108|471755348|FG000|Overall Study|Argus II system stopped functioning|0|||
131033460|NCT04359108|471755349|FG001|Overall Study|Argus II system stopped functioning|1|||
131033461|NCT04359108|471755348|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
131033462|NCT04359108|471755349|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
131033463|NCT06393088|471755351|FG000|Overall Study|Withdrawal by Subject|0|||
131033464|NCT06393088|471755352|FG001|Overall Study|Withdrawal by Subject|2|||
131033465|NCT02515773|471755353|FG000|Overall Study|Withdrawal by Subject|12|||
131033466|NCT02515773|471755354|FG001|Overall Study|Withdrawal by Subject|2|||
130917407|NCT00639678|471333240|FG001|Overall Study|Lost to Follow-up|0|||
130917408|NCT00639678|471333241|FG002|Overall Study|Lost to Follow-up|6|||
130917409|NCT00639678|471333242|FG003|Overall Study|Lost to Follow-up|0|||
130917410|NCT00639678|471333239|FG000|Overall Study|Adverse Event|0|||
130917411|NCT00639678|471333240|FG001|Overall Study|Adverse Event|1|||
130917412|NCT00639678|471333241|FG002|Overall Study|Adverse Event|0|||
130917413|NCT00639678|471333242|FG003|Overall Study|Adverse Event|0|||
130917414|NCT00639678|471333239|FG000|Overall Study|Lack of Compliance|0|||
130917415|NCT00639678|471333240|FG001|Overall Study|Lack of Compliance|0|||
130917416|NCT00639678|471333241|FG002|Overall Study|Lack of Compliance|1|||
130917417|NCT00639678|471333242|FG003|Overall Study|Lack of Compliance|0|||
130917418|NCT01364649|471333243|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
130917419|NCT01364649|471333244|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
130917420|NCT01364649|471333243|FG000|Overall Study|Lack of Efficacy|6|||
130917421|NCT01364649|471333244|FG001|Overall Study|Lack of Efficacy|0|||
130917422|NCT01364649|471333243|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
130917423|NCT01364649|471333244|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
130917424|NCT01364649|471333243|FG000|Overall Study|Protocol Deviations|4|||
130917425|NCT01364649|471333244|FG001|Overall Study|Protocol Deviations|8|||
130917426|NCT01364649|471333243|FG000|Overall Study|Withdrawal of Consent|9|||
130917427|NCT01364649|471333244|FG001|Overall Study|Withdrawal of Consent|7|||
130917428|NCT01364649|471333243|FG000|Overall Study|Lost to Follow-up|12|||
130917429|NCT01364649|471333244|FG001|Overall Study|Lost to Follow-up|13|||
130917430|NCT01364649|471333243|FG000|Overall Study|Other|4|||
130917431|NCT01364649|471333244|FG001|Overall Study|Other|1|||
130917432|NCT03270644|471333263|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
130917433|NCT03270644|471333263|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
130917434|NCT00902668|471333267|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
130917435|NCT01914757|471333268|FG000|Overall Study|Severe non-compliance to protocol|3|||
130917436|NCT01914757|471333269|FG001|Overall Study|Severe non-compliance to protocol|1|||
130917437|NCT01914757|471333270|FG002|Overall Study|Severe non-compliance to protocol|2|||
130917438|NCT01914757|471333268|FG000|Overall Study|Lost to Follow-up|5|||
130917439|NCT01914757|471333269|FG001|Overall Study|Lost to Follow-up|8|||
130917440|NCT01914757|471333270|FG002|Overall Study|Lost to Follow-up|6|||
130917441|NCT01914757|471333268|FG000|Overall Study|Withdrawal by Subject|15|||
130917442|NCT01914757|471333269|FG001|Overall Study|Withdrawal by Subject|27|||
130917443|NCT01914757|471333270|FG002|Overall Study|Withdrawal by Subject|19|||
130917444|NCT01914757|471333268|FG000|Overall Study|Death|2|||
130917445|NCT01914757|471333269|FG001|Overall Study|Death|2|||
130917446|NCT01914757|471333270|FG002|Overall Study|Death|1|||
130917447|NCT01914757|471333268|FG000|Overall Study|Adverse Event|4|||
130917448|NCT01914757|471333269|FG001|Overall Study|Adverse Event|3|||
130917449|NCT01914757|471333270|FG002|Overall Study|Adverse Event|4|||
130917450|NCT01914757|471333268|FG000|Overall Study|Study specific withdrawal criteria|0|||
130917451|NCT01914757|471333269|FG001|Overall Study|Study specific withdrawal criteria|1|||
130917452|NCT01914757|471333270|FG002|Overall Study|Study specific withdrawal criteria|0|||
130917453|NCT01914757|471333268|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130917454|NCT01914757|471333269|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130917455|NCT01914757|471333270|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
130917456|NCT01914757|471333268|FG000|Overall Study|Other reasons|5|||
130917457|NCT01914757|471333269|FG001|Overall Study|Other reasons|9|||
130917458|NCT01914757|471333270|FG002|Overall Study|Other reasons|4|||
130917459|NCT00615108|471333271|FG000|Overall Study|Adverse Event|122|||
130917460|NCT00615108|471333271|FG000|Overall Study|Other|370|||
130917461|NCT00615108|471333271|FG000|Overall Study|Lost to Follow-up|15|||
130917462|NCT01426438|471333280|FG000|Overall Study|Lost to Follow-up|1|||
130917463|NCT01426438|471333281|FG001|Overall Study|Lost to Follow-up|3|||
130917464|NCT01426438|471333280|FG000|Overall Study|Off study Treatment|9|||
130917465|NCT01426438|471333281|FG001|Overall Study|Off study Treatment|3|||
130917466|NCT01426438|471333280|FG000|Overall Study|Poor scan quality|3|||
131033467|NCT02515773|471755353|FG000|Overall Study|Lost to Follow-up|119|||
131033468|NCT02515773|471755354|FG001|Overall Study|Lost to Follow-up|126|||
131033469|NCT02515773|471755353|FG000|Overall Study|Discharged from Clinic Services|53|||
131033470|NCT02515773|471755354|FG001|Overall Study|Discharged from Clinic Services|84|||
131033471|NCT02515773|471755353|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
131033472|NCT02515773|471755354|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
130917467|NCT01426438|471333281|FG001|Overall Study|Poor scan quality|2|||
130917468|NCT01426438|471333280|FG000|Overall Study|Missed Scan|2|||
130917469|NCT01426438|471333281|FG001|Overall Study|Missed Scan|2|||
130917470|NCT02833350|471333282|FG000|Overall Study|Adverse Event|0|||
130917471|NCT02833350|471333283|FG001|Overall Study|Adverse Event|3|||
130917472|NCT02833350|471333284|FG002|Overall Study|Adverse Event|4|||
130917473|NCT02833350|471333285|FG003|Overall Study|Adverse Event|4|||
130917474|NCT02833350|471333286|FG004|Overall Study|Adverse Event|1|||
130917475|NCT02833350|471333287|FG005|Overall Study|Adverse Event|0|||
130917476|NCT02833350|471333288|FG006|Overall Study|Adverse Event|1|||
130917477|NCT02833350|471333282|FG000|Overall Study|Death|0|||
130917478|NCT02833350|471333283|FG001|Overall Study|Death|0|||
131033473|NCT02515773|471755353|FG000|Overall Study|Follow-up at non-study site|8|||
130917479|NCT02833350|471333284|FG002|Overall Study|Death|1|||
130699592|NCT01332968|470524719|FG000|Induction Period|Randomised but not treated|4|||
130699593|NCT01332968|470524720|FG001|Induction Period|Randomised but not treated|7|||
130699594|NCT01332968|470524721|FG002|Induction Period|Randomised but not treated|0|||
130917480|NCT02833350|471333285|FG003|Overall Study|Death|0|||
130917481|NCT02833350|471333286|FG004|Overall Study|Death|0|||
130917482|NCT02833350|471333287|FG005|Overall Study|Death|0|||
130917483|NCT02833350|471333288|FG006|Overall Study|Death|0|||
130917484|NCT02833350|471333282|FG000|Overall Study|Lack of Efficacy|0|||
130917485|NCT02833350|471333283|FG001|Overall Study|Lack of Efficacy|2|||
130917486|NCT02833350|471333284|FG002|Overall Study|Lack of Efficacy|1|||
130917487|NCT02833350|471333285|FG003|Overall Study|Lack of Efficacy|4|||
130917488|NCT02833350|471333286|FG004|Overall Study|Lack of Efficacy|0|||
130917489|NCT02833350|471333287|FG005|Overall Study|Lack of Efficacy|1|||
130917490|NCT02833350|471333288|FG006|Overall Study|Lack of Efficacy|1|||
130917491|NCT02833350|471333282|FG000|Overall Study|Lost to Follow-up|0|||
130917492|NCT02833350|471333283|FG001|Overall Study|Lost to Follow-up|1|||
130917493|NCT02833350|471333284|FG002|Overall Study|Lost to Follow-up|0|||
130917494|NCT02833350|471333285|FG003|Overall Study|Lost to Follow-up|0|||
130917495|NCT02833350|471333286|FG004|Overall Study|Lost to Follow-up|0|||
130917496|NCT02833350|471333287|FG005|Overall Study|Lost to Follow-up|0|||
130917497|NCT02833350|471333288|FG006|Overall Study|Lost to Follow-up|1|||
130917498|NCT02833350|471333282|FG000|Overall Study|Withdrawal by Subject|3|||
130917499|NCT02833350|471333283|FG001|Overall Study|Withdrawal by Subject|3|||
130917500|NCT02833350|471333284|FG002|Overall Study|Withdrawal by Subject|2|||
130917501|NCT02833350|471333285|FG003|Overall Study|Withdrawal by Subject|0|||
130917502|NCT02833350|471333286|FG004|Overall Study|Withdrawal by Subject|2|||
130917503|NCT02833350|471333287|FG005|Overall Study|Withdrawal by Subject|0|||
130917504|NCT02833350|471333288|FG006|Overall Study|Withdrawal by Subject|2|||
130917505|NCT01500031|471333291|FG000|Overall Study|Death|1|||
130917506|NCT01500031|471333291|FG000|Overall Study|Withdrawal by Subject|4|||
130917507|NCT03643575|471333292|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
130917508|NCT03643575|471333293|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
130917509|NCT03643575|471333294|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
130917510|NCT03643575|471333295|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
130917511|NCT03643575|471333296|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
130917512|NCT03643575|471333297|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
130917513|NCT03643575|471333292|FG000|Washout: 7 Days|Adverse Event|1|||
130917514|NCT03643575|471333293|FG001|Washout: 7 Days|Adverse Event|0|||
130917515|NCT03643575|471333294|FG002|Washout: 7 Days|Adverse Event|0|||
130917516|NCT03643575|471333295|FG003|Washout: 7 Days|Adverse Event|0|||
130917517|NCT03643575|471333296|FG004|Washout: 7 Days|Adverse Event|0|||
130917518|NCT03643575|471333297|FG005|Washout: 7 Days|Adverse Event|0|||
130917519|NCT03643575|471333292|FG000|Washout: 7 Days|Non compliance check in|0|||
130917520|NCT03643575|471333293|FG001|Washout: 7 Days|Non compliance check in|1|||
130917521|NCT03643575|471333294|FG002|Washout: 7 Days|Non compliance check in|0|||
130917522|NCT03643575|471333295|FG003|Washout: 7 Days|Non compliance check in|0|||
130917523|NCT03643575|471333296|FG004|Washout: 7 Days|Non compliance check in|0|||
130917524|NCT03643575|471333297|FG005|Washout: 7 Days|Non compliance check in|0|||
130917525|NCT01189604|471333298|FG000|Overall Study|Impossible to visit|0|||
130917526|NCT01189604|471333299|FG001|Overall Study|Impossible to visit|0|||
130917527|NCT01189604|471333300|FG002|Overall Study|Impossible to visit|0|||
130917528|NCT01189604|471333301|FG003|Overall Study|Impossible to visit|0|||
130917529|NCT01189604|471333302|FG004|Overall Study|Impossible to visit|0|||
130917530|NCT01189604|471333303|FG005|Overall Study|Impossible to visit|1|||
130917531|NCT01189604|471333304|FG006|Overall Study|Impossible to visit|0|||
130917532|NCT01189604|471333298|FG000|Overall Study|Adverse Event|0|||
130917533|NCT01189604|471333299|FG001|Overall Study|Adverse Event|1|||
131119505|NCT02285920|472070180|FG003|Overall Study|Death|1|||
131119506|NCT01480284|472070181|FG000|Overall Study|Withdrawal by Subject|2|||
130699595|NCT01332968|470524722|FG003|Induction Period|Randomised but not treated|0|||
130699596|NCT01332968|470524723|FG004|Induction Period|Randomised but not treated|0|||
130699597|NCT01332968|470524724|FG005|Induction Period|Randomised but not treated|0|||
130699598|NCT01332968|470524725|FG006|Induction Period|Randomised but not treated|0|||
130699599|NCT01332968|470524726|FG007|Induction Period|Randomised but not treated|0|||
130917534|NCT01189604|471333300|FG002|Overall Study|Adverse Event|0|||
130917535|NCT01189604|471333301|FG003|Overall Study|Adverse Event|0|||
130917536|NCT01189604|471333302|FG004|Overall Study|Adverse Event|2|||
130917537|NCT01189604|471333303|FG005|Overall Study|Adverse Event|0|||
130917538|NCT01189604|471333304|FG006|Overall Study|Adverse Event|1|||
130917539|NCT01189604|471333298|FG000|Overall Study|Withdrawal by Subject|1|||
130917540|NCT01189604|471333299|FG001|Overall Study|Withdrawal by Subject|0|||
130917541|NCT01189604|471333300|FG002|Overall Study|Withdrawal by Subject|0|||
130917542|NCT01189604|471333301|FG003|Overall Study|Withdrawal by Subject|0|||
130917543|NCT01189604|471333302|FG004|Overall Study|Withdrawal by Subject|0|||
130917544|NCT01189604|471333303|FG005|Overall Study|Withdrawal by Subject|0|||
130917545|NCT01189604|471333304|FG006|Overall Study|Withdrawal by Subject|0|||
131119507|NCT01480284|472070182|FG001|Overall Study|Withdrawal by Subject|0|||
130917546|NCT03945214|471333307|FG000|Overall Study|Lost to Follow-up|3|||
130917547|NCT03945214|471333308|FG001|Overall Study|Lost to Follow-up|4|||
130917548|NCT03945214|471333309|FG002|Overall Study|Lost to Follow-up|7|||
130917549|NCT03945214|471333310|FG003|Overall Study|Lost to Follow-up|4|||
130917550|NCT01772160|471333312|FG000|Overall Study|Death|3|||
130917551|NCT01772160|471333312|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
130917552|NCT01772160|471333312|FG000|Overall Study|Consent withdrawal|3|||
130917553|NCT01772160|471333312|FG000|Overall Study|Migrated / moved from the study area|4|||
130917554|NCT01772160|471333312|FG000|Overall Study|Lost to Follow-up|30|||
130917555|NCT01772160|471333312|FG000|Overall Study|Other|5|||
130917556|NCT00538291|471333313|FG000|Overall Study|Adverse Event|2|||
130917557|NCT00538291|471333313|FG000|Overall Study|Withdrawal by Subject|1|||
130917558|NCT00591344|471333314|FG000|Overall Study|Transportation issues|1|||
130917559|NCT00591344|471333315|FG001|Overall Study|Transportation issues|0|||
130917560|NCT00591344|471333314|FG000|Overall Study|Moved out of state|1|||
130917561|NCT00591344|471333315|FG001|Overall Study|Moved out of state|0|||
130917562|NCT00591344|471333314|FG000|Overall Study|Medical complications|1|||
130917563|NCT00591344|471333315|FG001|Overall Study|Medical complications|3|||
130917564|NCT00591344|471333314|FG000|Overall Study|Underwent DBS|2|||
130917565|NCT00591344|471333315|FG001|Overall Study|Underwent DBS|2|||
130917566|NCT00591344|471333314|FG000|Overall Study|Death|0|||
130917567|NCT00591344|471333315|FG001|Overall Study|Death|1|||
130917568|NCT00591344|471333314|FG000|Overall Study|Lost to Follow-up|0|||
130917569|NCT00591344|471333315|FG001|Overall Study|Lost to Follow-up|1|||
130917570|NCT00591344|471333314|FG000|Overall Study|Did not want to come off medication|0|||
130917571|NCT00591344|471333315|FG001|Overall Study|Did not want to come off medication|1|||
130917572|NCT00331422|471333318|FG000|Overall Study|Did not receive entire study regimen|5|||
130917573|NCT04128371|471333319|FG000|Overall Study|Lack of Efficacy|1|||
130917574|NCT03553927|471333323|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
130917575|NCT03553927|471333324|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
130917576|NCT03553927|471333323|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
130917577|NCT03553927|471333324|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
130917578|NCT03360747|471333330|FG000|Overall Study|Voluntary Withdrawal|1|||
130917579|NCT01759511|471333331|FG000|Overall Study|Adverse Event|4|||
130917580|NCT01759511|471333331|FG000|Overall Study|Death|2|||
130917581|NCT01759511|471333331|FG000|Overall Study|Lack of Efficacy|2|||
130917582|NCT01759511|471333331|FG000|Overall Study|Physician Decision|1|||
130917583|NCT01759511|471333331|FG000|Overall Study|Progressive Disease|5|||
130917584|NCT01759511|471333331|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
130917585|NCT01759511|471333331|FG000|Overall Study|Study Terminated by Sponsor|13|||
130917586|NCT01759511|471333331|FG000|Overall Study|Withdrawal by Subject|3|||
130917587|NCT05736224|471333332|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
130917588|NCT03673046|471334951|FG000|Overall Study|Adverse Event|1|||
130917589|NCT03673046|471334952|FG001|Overall Study|Adverse Event|1|||
130917590|NCT03673046|471334951|FG000|Overall Study|Withdrawal by Subject|8|||
130917591|NCT03673046|471334952|FG001|Overall Study|Withdrawal by Subject|2|||
130917592|NCT03817879|471334953|FG000|Overall Study|Drop out|5|||
130917593|NCT03817879|471334954|FG001|Overall Study|Drop out|12|||
130917594|NCT03817879|471334953|FG000|Overall Study|Withdrawal by Subject|0|||
131033474|NCT02515773|471755354|FG001|Overall Study|Follow-up at non-study site|16|||
131033475|NCT02515773|471755353|FG000|Overall Study|Moved from area|9|||
131033476|NCT02515773|471755354|FG001|Overall Study|Moved from area|14|||
131033477|NCT05551637|471755355|FG000|Overall Study|Lack of Efficacy|0|||
131033478|NCT05551637|471755356|FG001|Overall Study|Lack of Efficacy|6|||
131033479|NCT05551637|471755355|FG000|Overall Study|Lost to Follow-up|1|||
131033480|NCT05551637|471755356|FG001|Overall Study|Lost to Follow-up|1|||
131033481|NCT03033576|471755359|FG000|Overall Study|Ineligible|1|||
131033482|NCT03033576|471755360|FG001|Overall Study|Ineligible|1|||
131033483|NCT03033576|471755359|FG000|Overall Study|Adverse Event|4|||
131033484|NCT03033576|471755360|FG001|Overall Study|Adverse Event|20|||
131119508|NCT01480284|472070181|FG000|Overall Study|Adverse Event|1|||
131119509|NCT01480284|472070182|FG001|Overall Study|Adverse Event|0|||
131119510|NCT01480284|472070181|FG000|Overall Study|Study closed/terminated|3|||
131119511|NCT01480284|472070182|FG001|Overall Study|Study closed/terminated|0|||
131119512|NCT01480284|472070181|FG000|Overall Study|Lost to Follow-up|1|||
130917595|NCT03817879|471334954|FG001|Overall Study|Withdrawal by Subject|1|||
130917596|NCT00866788|471334955|FG000|Overall Study|Adverse Event|0|||
130917597|NCT00866788|471334956|FG001|Overall Study|Adverse Event|2|||
130917598|NCT00866788|471334957|FG002|Overall Study|Adverse Event|0|||
130917599|NCT00866788|471334958|FG003|Overall Study|Adverse Event|1|||
130917600|NCT00866788|471334955|FG000|Overall Study|Lost to Follow-up|1|||
130917601|NCT00866788|471334956|FG001|Overall Study|Lost to Follow-up|1|||
130917602|NCT00866788|471334957|FG002|Overall Study|Lost to Follow-up|0|||
130917603|NCT00866788|471334958|FG003|Overall Study|Lost to Follow-up|2|||
131033485|NCT03033576|471755359|FG000|Overall Study|Progression/relapse|9|||
131033486|NCT03033576|471755360|FG001|Overall Study|Progression/relapse|36|||
131033487|NCT03033576|471755359|FG000|Overall Study|Death|1|||
131033488|NCT03033576|471755360|FG001|Overall Study|Death|1|||
130917604|NCT00866788|471334955|FG000|Overall Study|Withdrawal by Subject|2|||
130917605|NCT00866788|471334956|FG001|Overall Study|Withdrawal by Subject|1|||
130917606|NCT00866788|471334957|FG002|Overall Study|Withdrawal by Subject|0|||
130917607|NCT00866788|471334958|FG003|Overall Study|Withdrawal by Subject|1|||
130917608|NCT00866788|471334955|FG000|Overall Study|Pregnancy|0|||
130917609|NCT00866788|471334956|FG001|Overall Study|Pregnancy|1|||
130917610|NCT00866788|471334957|FG002|Overall Study|Pregnancy|0|||
130917611|NCT00866788|471334958|FG003|Overall Study|Pregnancy|0|||
130917612|NCT00866788|471334955|FG000|Overall Study|Disease progression|3|||
130917613|NCT00866788|471334956|FG001|Overall Study|Disease progression|1|||
130917614|NCT00866788|471334957|FG002|Overall Study|Disease progression|1|||
130917615|NCT00866788|471334958|FG003|Overall Study|Disease progression|0|||
130917616|NCT00866788|471334955|FG000|Overall Study|Physician Decision|0|||
130917617|NCT00866788|471334956|FG001|Overall Study|Physician Decision|0|||
130917618|NCT00866788|471334957|FG002|Overall Study|Physician Decision|1|||
130917619|NCT00866788|471334958|FG003|Overall Study|Physician Decision|1|||
130917620|NCT02742441|471334959|FG000|Overall Study|Lost to Follow-up|4|||
130917621|NCT02742441|471334960|FG001|Overall Study|Lost to Follow-up|4|||
130917622|NCT02742441|471334959|FG000|Overall Study|Withdrawal by Subject|2|||
130917623|NCT02742441|471334960|FG001|Overall Study|Withdrawal by Subject|2|||
130917624|NCT02742441|471334959|FG000|Overall Study|Adverse Event|0|||
130917625|NCT02742441|471334960|FG001|Overall Study|Adverse Event|2|||
130917626|NCT02202837|471334961|FG000|Overall Study|Enbrel treatment discontinued|36|||
130917627|NCT02202837|471334962|FG001|Overall Study|Enbrel treatment discontinued|4|||
130917628|NCT02202837|471334961|FG000|Overall Study|Other|10|||
130917629|NCT02202837|471334962|FG001|Overall Study|Other|0|||
130917630|NCT02202837|471334961|FG000|Overall Study|Lost to Follow-up|7|||
130917631|NCT02202837|471334962|FG001|Overall Study|Lost to Follow-up|1|||
130917632|NCT02281773|471334963|FG000|Overall Study|Adverse Event|6|||
130917633|NCT02281773|471334964|FG001|Overall Study|Adverse Event|1|||
130917634|NCT02281773|471334965|FG002|Overall Study|Adverse Event|4|||
130917635|NCT02281773|471334966|FG003|Overall Study|Adverse Event|8|||
130917636|NCT02281773|471334967|FG004|Overall Study|Adverse Event|9|||
130917637|NCT02281773|471334963|FG000|Overall Study|Protocol Violation|1|||
130917638|NCT02281773|471334964|FG001|Overall Study|Protocol Violation|0|||
130917639|NCT02281773|471334965|FG002|Overall Study|Protocol Violation|0|||
130917640|NCT02281773|471334966|FG003|Overall Study|Protocol Violation|2|||
130917641|NCT02281773|471334967|FG004|Overall Study|Protocol Violation|2|||
130917642|NCT02281773|471334963|FG000|Overall Study|Lost to Follow-up|2|||
130917643|NCT02281773|471334964|FG001|Overall Study|Lost to Follow-up|2|||
130917644|NCT02281773|471334965|FG002|Overall Study|Lost to Follow-up|6|||
130917645|NCT02281773|471334966|FG003|Overall Study|Lost to Follow-up|2|||
130917646|NCT02281773|471334967|FG004|Overall Study|Lost to Follow-up|10|||
130917647|NCT02281773|471334963|FG000|Overall Study|Withdrawal by Subject|2|||
130917648|NCT02281773|471334964|FG001|Overall Study|Withdrawal by Subject|8|||
130917649|NCT02281773|471334965|FG002|Overall Study|Withdrawal by Subject|6|||
130917650|NCT02281773|471334966|FG003|Overall Study|Withdrawal by Subject|6|||
130917651|NCT02281773|471334967|FG004|Overall Study|Withdrawal by Subject|8|||
130917652|NCT02281773|471334963|FG000|Overall Study|Other Reason|0|||
130917653|NCT02281773|471334964|FG001|Overall Study|Other Reason|4|||
130917654|NCT02281773|471334965|FG002|Overall Study|Other Reason|2|||
130917655|NCT02281773|471334966|FG003|Overall Study|Other Reason|3|||
130917656|NCT02281773|471334967|FG004|Overall Study|Other Reason|1|||
130917657|NCT02104752|471334968|FG000|Overall Study|Withdrawal by Subject|1|||
130917658|NCT02104752|471334969|FG001|Overall Study|Withdrawal by Subject|0|||
130917659|NCT02104752|471334968|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
130917660|NCT02104752|471334969|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
130917661|NCT05439941|471334970|FG000|Overall Study|Lack of Efficacy|8|||
130917662|NCT05439941|471334971|FG001|Overall Study|Lack of Efficacy|5|||
130917663|NCT05439941|471334972|FG002|Overall Study|Lack of Efficacy|3|||
131119513|NCT01480284|472070182|FG001|Overall Study|Lost to Follow-up|0|||
131119514|NCT01480284|472070181|FG000|Overall Study|Physician Decision|1|||
131119515|NCT01480284|472070182|FG001|Overall Study|Physician Decision|0|||
131119516|NCT01641237|472070195|FG000|Period II|Withdrawal by Subject|1|||
131119517|NCT01641237|472070196|FG001|Period II|Withdrawal by Subject|0|||
131119518|NCT01641237|472070197|FG002|Period II|Withdrawal by Subject|0|||
131119519|NCT01641237|472070198|FG003|Period II|Withdrawal by Subject|0|||
130917664|NCT05439941|471334970|FG000|Overall Study|Treatment Failure|0|||
130917665|NCT05439941|471334971|FG001|Overall Study|Treatment Failure|1|||
130917666|NCT05439941|471334972|FG002|Overall Study|Treatment Failure|0|||
130917667|NCT05439941|471334970|FG000|Overall Study|Adverse Event|1|||
130917668|NCT05439941|471334971|FG001|Overall Study|Adverse Event|3|||
130917669|NCT05439941|471334972|FG002|Overall Study|Adverse Event|0|||
130917670|NCT05439941|471334970|FG000|Overall Study|Adverse Event - Parent Study|1|||
131119520|NCT01641237|472070195|FG000|Period III|Lost to Follow-up|1|||
131119521|NCT01641237|472070196|FG001|Period III|Lost to Follow-up|0|||
130917671|NCT05439941|471334971|FG001|Overall Study|Adverse Event - Parent Study|0|||
130917672|NCT05439941|471334972|FG002|Overall Study|Adverse Event - Parent Study|0|||
130917673|NCT05439941|471334970|FG000|Overall Study|Pregnancy|1|||
131119522|NCT01641237|472070197|FG002|Period III|Lost to Follow-up|0|||
130917674|NCT05439941|471334971|FG001|Overall Study|Pregnancy|0|||
130917675|NCT05439941|471334972|FG002|Overall Study|Pregnancy|0|||
130917676|NCT05439941|471334970|FG000|Overall Study|Withdrawal by Subject|9|||
130917677|NCT05439941|471334971|FG001|Overall Study|Withdrawal by Subject|6|||
130917678|NCT05439941|471334972|FG002|Overall Study|Withdrawal by Subject|10|||
130917679|NCT05439941|471334970|FG000|Overall Study|Non-Compliance|1|||
130917680|NCT05439941|471334971|FG001|Overall Study|Non-Compliance|1|||
130917681|NCT05439941|471334972|FG002|Overall Study|Non-Compliance|1|||
130917682|NCT05439941|471334970|FG000|Overall Study|Lost to Follow-up|2|||
130917683|NCT05439941|471334971|FG001|Overall Study|Lost to Follow-up|2|||
130917684|NCT05439941|471334972|FG002|Overall Study|Lost to Follow-up|0|||
130917685|NCT05439941|471334970|FG000|Overall Study|Physician Decision|1|||
130917686|NCT05439941|471334971|FG001|Overall Study|Physician Decision|0|||
130917687|NCT05439941|471334972|FG002|Overall Study|Physician Decision|0|||
130917688|NCT05439941|471334970|FG000|Overall Study|Trial Termination by Sponsor|78|||
130917689|NCT05439941|471334971|FG001|Overall Study|Trial Termination by Sponsor|83|||
130917690|NCT05439941|471334972|FG002|Overall Study|Trial Termination by Sponsor|65|||
130917691|NCT05439941|471334970|FG000|Overall Study|Other than Reasons Listed|2|||
130917692|NCT05439941|471334971|FG001|Overall Study|Other than Reasons Listed|1|||
130917693|NCT05439941|471334972|FG002|Overall Study|Other than Reasons Listed|0|||
130917694|NCT02336373|471334973|FG000|Overall Study|Protocol closed early|4|||
130917695|NCT02336373|471334973|FG000|Overall Study|Physician Decision|14|||
130917696|NCT01856907|471334985|FG000|Overall Study|Pregnancy|0|||
130917697|NCT01856907|471334986|FG001|Overall Study|Pregnancy|1|||
130917698|NCT01856907|471334987|FG002|Overall Study|Pregnancy|0|||
130917699|NCT01856907|471334985|FG000|Overall Study|Pregnancy|0|||
130917700|NCT01856907|471334986|FG001|Overall Study|Pregnancy|1|||
130917701|NCT01856907|471334987|FG002|Overall Study|Pregnancy|0|||
130917702|NCT01856907|471334985|FG000|Overall Study|Withdrawal by Subject|0|||
130917703|NCT01856907|471334986|FG001|Overall Study|Withdrawal by Subject|1|||
130917704|NCT01856907|471334987|FG002|Overall Study|Withdrawal by Subject|0|||
130917705|NCT01604408|471334990|FG000|Treatment Period 1|Protocol Violation|0|||
130917706|NCT01604408|471334991|FG001|Treatment Period 1|Protocol Violation|1|||
130917707|NCT01604408|471334990|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130917708|NCT01604408|471334991|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130917709|NCT01604408|471334990|FG000|Treatment Period 2|Protocol Violation|1|||
130917710|NCT01604408|471334991|FG001|Treatment Period 2|Protocol Violation|0|||
130917711|NCT01604408|471334990|FG000|Treatment Period 2|Adverse Event|0|||
130917712|NCT01604408|471334991|FG001|Treatment Period 2|Adverse Event|1|||
130917713|NCT01604408|471334990|FG000|Treatment Period 3|Protocol Violation|1|||
130917714|NCT01604408|471334991|FG001|Treatment Period 3|Protocol Violation|1|||
130917715|NCT01604408|471334990|FG000|Treatment Period 3|Adverse Event|0|||
130917716|NCT01604408|471334991|FG001|Treatment Period 3|Adverse Event|3|||
130917717|NCT01604408|471334990|FG000|Treatment Period 3|Withdrawal by Subject|3|||
130917718|NCT01604408|471334991|FG001|Treatment Period 3|Withdrawal by Subject|1|||
130917719|NCT01604408|471334990|FG000|Treatment Period 3|Sponsor Decision|1|||
130917720|NCT01604408|471334991|FG001|Treatment Period 3|Sponsor Decision|0|||
130917721|NCT01604408|471334990|FG000|Treatment Period 4|Death|1|||
130917722|NCT01604408|471334991|FG001|Treatment Period 4|Death|0|||
130917723|NCT01604408|471334990|FG000|Treatment Period 4|Withdrawal by Subject|2|||
130917724|NCT01604408|471334991|FG001|Treatment Period 4|Withdrawal by Subject|1|||
130917725|NCT01604408|471334990|FG000|Treatment Period 4|Adverse Event|0|||
130917726|NCT01604408|471334991|FG001|Treatment Period 4|Adverse Event|1|||
130917727|NCT01604408|471334990|FG000|Treatment Period 5|Adverse Event|4|||
130917728|NCT01604408|471334991|FG001|Treatment Period 5|Adverse Event|0|||
130917729|NCT01604408|471334990|FG000|Treatment Period 6|Lost to Follow-up|0|||
130917730|NCT01604408|471334991|FG001|Treatment Period 6|Lost to Follow-up|1|||
130917731|NCT01604408|471334990|FG000|Treatment Period 6|Adverse Event|2|||
130917732|NCT01604408|471334991|FG001|Treatment Period 6|Adverse Event|0|||
130917733|NCT01604408|471334990|FG000|Treatment Period 6|Sponsor decision|0|||
130917734|NCT01604408|471334991|FG001|Treatment Period 6|Sponsor decision|1|||
130917735|NCT01604408|471334990|FG000|Observation Period|Adverse Event|1|||
130917736|NCT01604408|471334991|FG001|Observation Period|Adverse Event|1|||
130917737|NCT01604408|471334990|FG000|Observation Period|Withdrawal by Subject|0|||
130917738|NCT01604408|471334991|FG001|Observation Period|Withdrawal by Subject|2|||
130917739|NCT00917501|471334992|FG000|Overall Study|Lost to Follow-up|4|||
130917740|NCT00917501|471334993|FG001|Overall Study|Lost to Follow-up|1|||
130917741|NCT00917501|471334992|FG000|Overall Study|Withdrawal by Subject|3|||
130917742|NCT00917501|471334993|FG001|Overall Study|Withdrawal by Subject|1|||
130917743|NCT00917501|471334992|FG000|Overall Study|Lack of Efficacy|1|||
130917744|NCT00917501|471334993|FG001|Overall Study|Lack of Efficacy|2|||
130917745|NCT00917501|471334992|FG000|Overall Study|trouble swollowing capsules|0|||
130917746|NCT00917501|471334993|FG001|Overall Study|trouble swollowing capsules|1|||
130917747|NCT03626168|471334994|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130917748|NCT03626168|471334995|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130917749|NCT03626168|471334994|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
130917750|NCT03626168|471334995|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
130917751|NCT03626168|471334994|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130917752|NCT03626168|471334995|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
130917753|NCT00808483|471334996|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
130917754|NCT00808483|471334997|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
130917755|NCT00808483|471334996|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
130917756|NCT00808483|471334997|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
130917757|NCT00808483|471334996|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
130917758|NCT00808483|471334997|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
130917759|NCT04553679|471334998|FG000|Overall Study|Withdrawal by Subject|2|||
130917760|NCT04553679|471334999|FG001|Overall Study|Withdrawal by Subject|0|||
130917761|NCT04553679|471334998|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
130917762|NCT04553679|471334999|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
130917763|NCT02357979|471335000|FG000|Overall Study|Lost to Follow-up|5|||
130917764|NCT02357979|471335001|FG001|Overall Study|Lost to Follow-up|5|||
130917765|NCT00850070|471335005|FG000|Overall Study|Lack of Efficacy|1|||
130917766|NCT00850070|471335006|FG001|Overall Study|Lack of Efficacy|1|||
130917767|NCT00850070|471335005|FG000|Overall Study|Adverse Event|2|||
130917768|NCT00850070|471335006|FG001|Overall Study|Adverse Event|0|||
130917769|NCT05047770|471335007|FG000|Overall Study|Withdrawal by Subject|15|||
130917770|NCT05047770|471335008|FG001|Overall Study|Withdrawal by Subject|10|||
130917771|NCT05047770|471335009|FG002|Overall Study|Withdrawal by Subject|6|||
130917772|NCT05047770|471335010|FG003|Overall Study|Withdrawal by Subject|12|||
130917773|NCT05047770|471335007|FG000|Overall Study|Lost to Follow-up|7|||
130917774|NCT05047770|471335008|FG001|Overall Study|Lost to Follow-up|5|||
130917775|NCT05047770|471335009|FG002|Overall Study|Lost to Follow-up|12|||
130917776|NCT05047770|471335010|FG003|Overall Study|Lost to Follow-up|13|||
130917777|NCT05047770|471335007|FG000|Overall Study|Other|1|||
130917778|NCT05047770|471335008|FG001|Overall Study|Other|0|||
130917779|NCT05047770|471335009|FG002|Overall Study|Other|1|||
130917780|NCT05047770|471335010|FG003|Overall Study|Other|0|||
130917781|NCT00074984|471335013|FG000|Overall Study|Death|1|||
130917782|NCT00074984|471335014|FG001|Overall Study|Death|2|||
130917783|NCT00074984|471335013|FG000|Overall Study|Withdrawal by Subject|2|||
130917784|NCT00074984|471335014|FG001|Overall Study|Withdrawal by Subject|3|||
130917785|NCT00074984|471335013|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
130917786|NCT00074984|471335014|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
130917787|NCT01522248|471335017|FG000|Overall Study|Lost to Follow-up|1|||
130917788|NCT01522248|471335018|FG001|Overall Study|Lost to Follow-up|0|||
130917789|NCT00694707|471335023|FG000|Overall Study|Did Not Receive Treatment|0|||
130917790|NCT00694707|471335024|FG001|Overall Study|Did Not Receive Treatment|0|||
130917791|NCT00694707|471335025|FG002|Overall Study|Did Not Receive Treatment|1|||
130917792|NCT00694707|471335026|FG003|Overall Study|Did Not Receive Treatment|1|||
130917793|NCT00694707|471335027|FG004|Overall Study|Did Not Receive Treatment|1|||
130917794|NCT00694707|471335023|FG000|Overall Study|Adverse Event|22|||
130917795|NCT00694707|471335024|FG001|Overall Study|Adverse Event|14|||
130917796|NCT00694707|471335025|FG002|Overall Study|Adverse Event|8|||
130917797|NCT00694707|471335026|FG003|Overall Study|Adverse Event|12|||
130917798|NCT00694707|471335027|FG004|Overall Study|Adverse Event|13|||
130917799|NCT00694707|471335023|FG000|Overall Study|Insufficient Therapeutic Response|33|||
130917800|NCT00694707|471335024|FG001|Overall Study|Insufficient Therapeutic Response|18|||
130917801|NCT00694707|471335025|FG002|Overall Study|Insufficient Therapeutic Response|17|||
130917802|NCT00694707|471335026|FG003|Overall Study|Insufficient Therapeutic Response|15|||
130917803|NCT00694707|471335027|FG004|Overall Study|Insufficient Therapeutic Response|10|||
130917804|NCT00694707|471335023|FG000|Overall Study|Protocol Violation|1|||
130917805|NCT00694707|471335024|FG001|Overall Study|Protocol Violation|2|||
130917806|NCT00694707|471335025|FG002|Overall Study|Protocol Violation|1|||
130917807|NCT00694707|471335026|FG003|Overall Study|Protocol Violation|3|||
130917808|NCT00694707|471335027|FG004|Overall Study|Protocol Violation|1|||
130917809|NCT00694707|471335023|FG000|Overall Study|Withdrawal of Consent|14|||
130917810|NCT00694707|471335024|FG001|Overall Study|Withdrawal of Consent|18|||
130917811|NCT00694707|471335025|FG002|Overall Study|Withdrawal of Consent|22|||
130917812|NCT00694707|471335026|FG003|Overall Study|Withdrawal of Consent|16|||
130917813|NCT00694707|471335027|FG004|Overall Study|Withdrawal of Consent|15|||
130917814|NCT00694707|471335023|FG000|Overall Study|Lost to Follow-up|0|||
130917815|NCT00694707|471335024|FG001|Overall Study|Lost to Follow-up|1|||
130917816|NCT00694707|471335025|FG002|Overall Study|Lost to Follow-up|2|||
130917817|NCT00694707|471335026|FG003|Overall Study|Lost to Follow-up|0|||
130917818|NCT00694707|471335027|FG004|Overall Study|Lost to Follow-up|0|||
130917819|NCT00694707|471335023|FG000|Overall Study|Jeopardizing Parole Status|1|||
130917820|NCT00694707|471335024|FG001|Overall Study|Jeopardizing Parole Status|0|||
130917821|NCT00694707|471335025|FG002|Overall Study|Jeopardizing Parole Status|0|||
130769264|NCT00002525|470780577|FG001|Overall Study|Withdrawal by Subject|0|||
130917822|NCT00694707|471335026|FG003|Overall Study|Jeopardizing Parole Status|0|||
130917823|NCT00694707|471335027|FG004|Overall Study|Jeopardizing Parole Status|0|||
130917824|NCT00694707|471335023|FG000|Overall Study|Death in the Family|1|||
130917825|NCT00694707|471335024|FG001|Overall Study|Death in the Family|0|||
130917826|NCT00694707|471335025|FG002|Overall Study|Death in the Family|0|||
130917827|NCT00694707|471335026|FG003|Overall Study|Death in the Family|0|||
130917828|NCT00694707|471335027|FG004|Overall Study|Death in the Family|0|||
130917829|NCT00694707|471335023|FG000|Overall Study|Arrest by Police|0|||
130917830|NCT00694707|471335024|FG001|Overall Study|Arrest by Police|1|||
130917831|NCT00694707|471335025|FG002|Overall Study|Arrest by Police|0|||
130917832|NCT00694707|471335026|FG003|Overall Study|Arrest by Police|0|||
130917833|NCT00694707|471335027|FG004|Overall Study|Arrest by Police|0|||
130917834|NCT00694707|471335023|FG000|Overall Study|Administrative Reasons|0|||
130917835|NCT00694707|471335024|FG001|Overall Study|Administrative Reasons|1|||
130917836|NCT00694707|471335025|FG002|Overall Study|Administrative Reasons|0|||
130917837|NCT00694707|471335026|FG003|Overall Study|Administrative Reasons|2|||
130917838|NCT00694707|471335027|FG004|Overall Study|Administrative Reasons|0|||
130917839|NCT00694707|471335023|FG000|Overall Study|Notification of Past Head Injury|0|||
130917840|NCT00694707|471335024|FG001|Overall Study|Notification of Past Head Injury|0|||
130917841|NCT00694707|471335025|FG002|Overall Study|Notification of Past Head Injury|0|||
130917842|NCT00694707|471335026|FG003|Overall Study|Notification of Past Head Injury|1|||
130917843|NCT00694707|471335027|FG004|Overall Study|Notification of Past Head Injury|0|||
130917844|NCT01904058|471335032|FG000|Overall Study|Adverse Event|2|||
130917845|NCT01904058|471335033|FG001|Overall Study|Adverse Event|0|||
130917846|NCT01904058|471335034|FG002|Overall Study|Adverse Event|0|||
130917847|NCT01904058|471335035|FG003|Overall Study|Adverse Event|0|||
130917848|NCT01904058|471335032|FG000|Overall Study|Withdrawal by Subject|1|||
130917849|NCT01904058|471335033|FG001|Overall Study|Withdrawal by Subject|0|||
130917850|NCT01904058|471335034|FG002|Overall Study|Withdrawal by Subject|1|||
130917851|NCT01904058|471335035|FG003|Overall Study|Withdrawal by Subject|0|||
130917852|NCT01904058|471335032|FG000|Overall Study|Pregnancy|0|||
130917853|NCT01904058|471335033|FG001|Overall Study|Pregnancy|0|||
130917854|NCT01904058|471335034|FG002|Overall Study|Pregnancy|0|||
130917855|NCT01904058|471335035|FG003|Overall Study|Pregnancy|1|||
130917856|NCT03096483|471335037|FG000|Overall Study|Withdrawal by site|1|||
130917857|NCT02046733|471335038|FG000|Overall Study|never initiated 'treatment visits'|6|||
130917858|NCT02046733|471335039|FG001|Overall Study|never initiated 'treatment visits'|0|||
130917859|NCT00199875|471335049|FG000|Overall Study|Withdrawal by Subject|0|||
130917860|NCT00199875|471335050|FG001|Overall Study|Withdrawal by Subject|0|||
130917861|NCT00199875|471335051|FG002|Overall Study|Withdrawal by Subject|0|||
130917862|NCT00199875|471335052|FG003|Overall Study|Withdrawal by Subject|0|||
130917863|NCT00199875|471335053|FG004|Overall Study|Withdrawal by Subject|1|||
130917864|NCT01024231|471335056|FG000|Overall Study|Other Reasons|1|||
130917865|NCT01024231|471335057|FG001|Overall Study|Other Reasons|2|||
130917866|NCT01024231|471335058|FG002|Overall Study|Other Reasons|0|||
130917867|NCT01024231|471335059|FG003|Overall Study|Other Reasons|0|||
130917868|NCT01024231|471335060|FG004|Overall Study|Other Reasons|2|||
130917869|NCT01024231|471335061|FG005|Overall Study|Other Reasons|0|||
130917870|NCT01024231|471335062|FG006|Overall Study|Other Reasons|1|||
130917871|NCT01024231|471335056|FG000|Overall Study|Maximum Clinical Benefit|1|||
130917872|NCT01024231|471335057|FG001|Overall Study|Maximum Clinical Benefit|2|||
130917873|NCT01024231|471335058|FG002|Overall Study|Maximum Clinical Benefit|0|||
130917874|NCT01024231|471335059|FG003|Overall Study|Maximum Clinical Benefit|1|||
130917875|NCT01024231|471335060|FG004|Overall Study|Maximum Clinical Benefit|1|||
130917876|NCT01024231|471335061|FG005|Overall Study|Maximum Clinical Benefit|0|||
130917877|NCT01024231|471335062|FG006|Overall Study|Maximum Clinical Benefit|0|||
130917878|NCT01024231|471335056|FG000|Overall Study|Disease Progression|3|||
130917879|NCT01024231|471335057|FG001|Overall Study|Disease Progression|1|||
130917880|NCT01024231|471335058|FG002|Overall Study|Disease Progression|3|||
130917881|NCT01024231|471335059|FG003|Overall Study|Disease Progression|0|||
130917882|NCT01024231|471335060|FG004|Overall Study|Disease Progression|4|||
130917883|NCT01024231|471335061|FG005|Overall Study|Disease Progression|11|||
130917884|NCT01024231|471335062|FG006|Overall Study|Disease Progression|6|||
130917885|NCT01024231|471335056|FG000|Overall Study|AE unrelated to Study Drug|0|||
130917886|NCT01024231|471335057|FG001|Overall Study|AE unrelated to Study Drug|1|||
130917887|NCT01024231|471335058|FG002|Overall Study|AE unrelated to Study Drug|0|||
130917888|NCT01024231|471335059|FG003|Overall Study|AE unrelated to Study Drug|0|||
130917889|NCT01024231|471335060|FG004|Overall Study|AE unrelated to Study Drug|0|||
130917890|NCT01024231|471335061|FG005|Overall Study|AE unrelated to Study Drug|0|||
131033489|NCT03033576|471755359|FG000|Overall Study|Patient refusal|1|||
131033490|NCT03033576|471755360|FG001|Overall Study|Patient refusal|6|||
131033491|NCT03033576|471755359|FG000|Overall Study|Other, unspecified reasons|0|||
131033492|NCT03033576|471755360|FG001|Overall Study|Other, unspecified reasons|4|||
131033493|NCT03033576|471755359|FG000|Overall Study|Currently on protocol therapy|0|||
131033494|NCT03033576|471755360|FG001|Overall Study|Currently on protocol therapy|2|||
130917891|NCT01024231|471335062|FG006|Overall Study|AE unrelated to Study Drug|0|||
130917892|NCT01024231|471335056|FG000|Overall Study|No longer meets criteria|0|||
130917893|NCT01024231|471335057|FG001|Overall Study|No longer meets criteria|0|||
130917894|NCT01024231|471335058|FG002|Overall Study|No longer meets criteria|0|||
130917895|NCT01024231|471335059|FG003|Overall Study|No longer meets criteria|0|||
131033495|NCT05179837|471755361|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
130917896|NCT01024231|471335060|FG004|Overall Study|No longer meets criteria|1|||
130917897|NCT01024231|471335061|FG005|Overall Study|No longer meets criteria|0|||
130917898|NCT01024231|471335062|FG006|Overall Study|No longer meets criteria|1|||
130699600|NCT01332968|470524719|FG000|Maintenance/Observation Period|Adverse Event|0|||
130699601|NCT01332968|470524720|FG001|Maintenance/Observation Period|Adverse Event|0|||
130917899|NCT01024231|471335056|FG000|Overall Study|Study Drug Toxicity|1|||
130917900|NCT01024231|471335057|FG001|Overall Study|Study Drug Toxicity|6|||
130917901|NCT01024231|471335058|FG002|Overall Study|Study Drug Toxicity|6|||
130917902|NCT01024231|471335059|FG003|Overall Study|Study Drug Toxicity|4|||
130917903|NCT01024231|471335060|FG004|Overall Study|Study Drug Toxicity|2|||
130917904|NCT01024231|471335061|FG005|Overall Study|Study Drug Toxicity|0|||
130917905|NCT01024231|471335062|FG006|Overall Study|Study Drug Toxicity|7|||
130917906|NCT01024231|471335056|FG000|Overall Study|Death|6|||
130917907|NCT01024231|471335057|FG001|Overall Study|Death|2|||
130917908|NCT01024231|471335058|FG002|Overall Study|Death|1|||
130917909|NCT01024231|471335059|FG003|Overall Study|Death|0|||
130917910|NCT01024231|471335060|FG004|Overall Study|Death|4|||
130917911|NCT01024231|471335061|FG005|Overall Study|Death|3|||
130917912|NCT01024231|471335062|FG006|Overall Study|Death|5|||
130917913|NCT01024231|471335056|FG000|Overall Study|Lost to Follow-up|0|||
130917914|NCT01024231|471335057|FG001|Overall Study|Lost to Follow-up|0|||
130917915|NCT01024231|471335058|FG002|Overall Study|Lost to Follow-up|0|||
130917916|NCT01024231|471335059|FG003|Overall Study|Lost to Follow-up|0|||
130917917|NCT01024231|471335060|FG004|Overall Study|Lost to Follow-up|0|||
130917918|NCT01024231|471335061|FG005|Overall Study|Lost to Follow-up|0|||
130917919|NCT01024231|471335062|FG006|Overall Study|Lost to Follow-up|1|||
130699602|NCT01332968|470524721|FG002|Maintenance/Observation Period|Adverse Event|53|||
130699603|NCT01332968|470524722|FG003|Maintenance/Observation Period|Adverse Event|66|||
130917920|NCT01024231|471335056|FG000|Overall Study|Withdrew Consent|0|||
130917921|NCT01024231|471335057|FG001|Overall Study|Withdrew Consent|1|||
130917922|NCT01024231|471335058|FG002|Overall Study|Withdrew Consent|0|||
130917923|NCT01024231|471335059|FG003|Overall Study|Withdrew Consent|0|||
130917924|NCT01024231|471335060|FG004|Overall Study|Withdrew Consent|0|||
130917925|NCT01024231|471335061|FG005|Overall Study|Withdrew Consent|0|||
130917926|NCT01024231|471335062|FG006|Overall Study|Withdrew Consent|0|||
130917927|NCT01024231|471335056|FG000|Overall Study|Continuing on Treatment|0|||
130917928|NCT01024231|471335057|FG001|Overall Study|Continuing on Treatment|0|||
130917929|NCT01024231|471335058|FG002|Overall Study|Continuing on Treatment|0|||
130917930|NCT01024231|471335059|FG003|Overall Study|Continuing on Treatment|0|||
130699604|NCT01332968|470524723|FG004|Maintenance/Observation Period|Adverse Event|0|||
130699605|NCT01332968|470524724|FG005|Maintenance/Observation Period|Adverse Event|0|||
130917931|NCT01024231|471335060|FG004|Overall Study|Continuing on Treatment|3|||
130917932|NCT01024231|471335061|FG005|Overall Study|Continuing on Treatment|2|||
130917933|NCT01024231|471335062|FG006|Overall Study|Continuing on Treatment|0|||
130917934|NCT01013350|471335063|FG000|Overall Study|Lost to Follow-up|15|||
130917935|NCT01013350|471335064|FG001|Overall Study|Lost to Follow-up|95|||
130917936|NCT01013350|471335063|FG000|Overall Study|Adverse Event|0|||
130917937|NCT01013350|471335064|FG001|Overall Study|Adverse Event|1|||
130917938|NCT01013350|471335063|FG000|Overall Study|Physician Decision|4|||
130917939|NCT01013350|471335064|FG001|Overall Study|Physician Decision|20|||
130917940|NCT01013350|471335063|FG000|Overall Study|Withdrawal by Subject|15|||
130917941|NCT01013350|471335064|FG001|Overall Study|Withdrawal by Subject|38|||
130917942|NCT01013350|471335063|FG000|Overall Study|Death|3|||
130917943|NCT01013350|471335064|FG001|Overall Study|Death|5|||
130917944|NCT01013350|471335063|FG000|Overall Study|Participant entered interventional study|0|||
130917945|NCT01013350|471335064|FG001|Overall Study|Participant entered interventional study|8|||
130917946|NCT01013350|471335063|FG000|Overall Study|Other|1|||
130917947|NCT01013350|471335064|FG001|Overall Study|Other|25|||
130917948|NCT01268150|471335065|FG000|Treatment Phase|Progression of disease|18|||
130917949|NCT01268150|471335065|FG000|Treatment Phase|Adverse Event|3|||
130917950|NCT01268150|471335065|FG000|Treatment Phase|Withdrawal by Subject|3|||
130917951|NCT01268150|471335065|FG000|Treatment Phase|Other|4|||
130917952|NCT01268150|471335065|FG000|Extension Phase|Adverse Event|3|||
130917953|NCT01268150|471335065|FG000|Extension Phase|Disease progression|18|||
130917954|NCT01268150|471335065|FG000|Extension Phase|Other|6|||
130699606|NCT01332968|470524725|FG006|Maintenance/Observation Period|Adverse Event|0|||
130699607|NCT01332968|470524726|FG007|Maintenance/Observation Period|Adverse Event|0|||
130917955|NCT00395733|471335066|FG000|Period 2|Withdrawal by Subject|1|||
130917956|NCT00395733|471335067|FG001|Period 2|Withdrawal by Subject|2|||
130917957|NCT00395733|471335066|FG000|Period 2|Protocol Violation|0|||
130917958|NCT00395733|471335067|FG001|Period 2|Protocol Violation|1|||
130917959|NCT00395733|471335066|FG000|Period 2|Adverse Event|0|||
130917960|NCT00395733|471335067|FG001|Period 2|Adverse Event|2|||
130917961|NCT00395733|471335066|FG000|Period 2|Technical problems|1|||
130917962|NCT00395733|471335067|FG001|Period 2|Technical problems|0|||
130917963|NCT03725852|471335068|FG000|Overall Study|Death|1|||
130917964|NCT03725852|471335069|FG001|Overall Study|Death|0|||
130917965|NCT03725852|471335068|FG000|Overall Study|Withdrawal by Subject|1|||
130917966|NCT03725852|471335069|FG001|Overall Study|Withdrawal by Subject|0|||
130917967|NCT03725852|471335068|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
130917968|NCT03725852|471335069|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
130917969|NCT04738734|471335072|FG000|Overall Study|Withdrawal by Subject|2|||
130917970|NCT04738734|471335073|FG001|Overall Study|Withdrawal by Subject|4|||
130917971|NCT04738734|471335072|FG000|Overall Study|Lost to Follow-up|5|||
130917972|NCT04738734|471335073|FG001|Overall Study|Lost to Follow-up|2|||
130917973|NCT04738734|471335072|FG000|Overall Study|Physician Decision|0|||
130917974|NCT04738734|471335073|FG001|Overall Study|Physician Decision|1|||
130917975|NCT04738734|471335072|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
130917976|NCT04738734|471335073|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
130917977|NCT02435147|471335077|FG000|Overall Study|non-evaluable DXA scan|11|||
130917978|NCT03452228|471335080|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130917979|NCT03452228|471335081|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
130917980|NCT03452228|471335082|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130699608|NCT01332968|470524719|FG000|Maintenance/Observation Period|Death|0|||
130699609|NCT01332968|470524720|FG001|Maintenance/Observation Period|Death|0|||
130699610|NCT01332968|470524721|FG002|Maintenance/Observation Period|Death|5|||
130699611|NCT01332968|470524722|FG003|Maintenance/Observation Period|Death|6|||
130699612|NCT01332968|470524723|FG004|Maintenance/Observation Period|Death|0|||
130699613|NCT01332968|470524724|FG005|Maintenance/Observation Period|Death|0|||
130699614|NCT01332968|470524725|FG006|Maintenance/Observation Period|Death|0|||
130699615|NCT01332968|470524726|FG007|Maintenance/Observation Period|Death|0|||
130699616|NCT01332968|470524719|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
130699617|NCT01332968|470524720|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
130699618|NCT01332968|470524721|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
130699619|NCT01332968|470524722|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
130699620|NCT01332968|470524723|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
130699621|NCT01332968|470524724|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
130699622|NCT01332968|470524725|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
130699623|NCT01332968|470524726|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
130699624|NCT01332968|470524719|FG000|Maintenance/Observation Period|Non-compliance|0|||
130699625|NCT01332968|470524720|FG001|Maintenance/Observation Period|Non-compliance|0|||
130699626|NCT01332968|470524721|FG002|Maintenance/Observation Period|Non-compliance|4|||
130699627|NCT01332968|470524722|FG003|Maintenance/Observation Period|Non-compliance|3|||
130699628|NCT01332968|470524723|FG004|Maintenance/Observation Period|Non-compliance|0|||
130699629|NCT01332968|470524724|FG005|Maintenance/Observation Period|Non-compliance|0|||
130699630|NCT01332968|470524725|FG006|Maintenance/Observation Period|Non-compliance|0|||
130699631|NCT01332968|470524726|FG007|Maintenance/Observation Period|Non-compliance|0|||
130699632|NCT01332968|470524719|FG000|Maintenance/Observation Period|Other|0|||
130699633|NCT01332968|470524720|FG001|Maintenance/Observation Period|Other|0|||
130699634|NCT01332968|470524721|FG002|Maintenance/Observation Period|Other|4|||
130699635|NCT01332968|470524722|FG003|Maintenance/Observation Period|Other|7|||
130699636|NCT01332968|470524723|FG004|Maintenance/Observation Period|Other|0|||
130699637|NCT01332968|470524724|FG005|Maintenance/Observation Period|Other|0|||
130699638|NCT01332968|470524725|FG006|Maintenance/Observation Period|Other|0|||
130699639|NCT01332968|470524726|FG007|Maintenance/Observation Period|Other|0|||
130699640|NCT01332968|470524719|FG000|Maintenance/Observation Period|Physician Decision|0|||
130699641|NCT01332968|470524720|FG001|Maintenance/Observation Period|Physician Decision|0|||
130699642|NCT01332968|470524721|FG002|Maintenance/Observation Period|Physician Decision|14|||
130699643|NCT01332968|470524722|FG003|Maintenance/Observation Period|Physician Decision|19|||
130699644|NCT01332968|470524723|FG004|Maintenance/Observation Period|Physician Decision|0|||
130699645|NCT01332968|470524724|FG005|Maintenance/Observation Period|Physician Decision|1|||
130699646|NCT01332968|470524725|FG006|Maintenance/Observation Period|Physician Decision|0|||
130699647|NCT01332968|470524726|FG007|Maintenance/Observation Period|Physician Decision|0|||
130699648|NCT01332968|470524719|FG000|Maintenance/Observation Period|Progressive Disease|0|||
130699649|NCT01332968|470524720|FG001|Maintenance/Observation Period|Progressive Disease|0|||
130699650|NCT01332968|470524721|FG002|Maintenance/Observation Period|Progressive Disease|72|||
130699651|NCT01332968|470524722|FG003|Maintenance/Observation Period|Progressive Disease|40|||
130699652|NCT01332968|470524723|FG004|Maintenance/Observation Period|Progressive Disease|0|||
130699653|NCT01332968|470524724|FG005|Maintenance/Observation Period|Progressive Disease|0|||
130699654|NCT01332968|470524725|FG006|Maintenance/Observation Period|Progressive Disease|0|||
130699655|NCT01332968|470524726|FG007|Maintenance/Observation Period|Progressive Disease|0|||
130917981|NCT03452228|471335080|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130699656|NCT01332968|470524719|FG000|Maintenance/Observation Period|Protocol Violation|0|||
130699657|NCT01332968|470524720|FG001|Maintenance/Observation Period|Protocol Violation|0|||
130699658|NCT01332968|470524721|FG002|Maintenance/Observation Period|Protocol Violation|1|||
130699659|NCT01332968|470524722|FG003|Maintenance/Observation Period|Protocol Violation|1|||
130699660|NCT01332968|470524723|FG004|Maintenance/Observation Period|Protocol Violation|0|||
130769265|NCT00002525|470780576|FG000|Overall Study|Start non-protocol therapy|1|||
130917982|NCT03452228|471335081|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
131119523|NCT01641237|472070198|FG003|Period III|Lost to Follow-up|0|||
130917983|NCT03452228|471335082|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130917984|NCT03452228|471335080|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
130917985|NCT03452228|471335081|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
130917986|NCT03452228|471335082|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
130917987|NCT03452228|471335080|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130917988|NCT03452228|471335081|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130917989|NCT03452228|471335082|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130917990|NCT04251273|471335083|FG000|Overall Study|Lost to Follow-up|331|||
130917991|NCT04251273|471335084|FG001|Overall Study|Lost to Follow-up|290|||
130917992|NCT00810693|471335085|FG000|Treatment Period|Adverse Event|8|||
130917993|NCT00810693|471335086|FG001|Treatment Period|Adverse Event|1|||
130917994|NCT00810693|471335087|FG002|Treatment Period|Adverse Event|7|||
130917995|NCT00810693|471335085|FG000|Treatment Period|Death|0|||
130917996|NCT00810693|471335086|FG001|Treatment Period|Death|1|||
130917997|NCT00810693|471335087|FG002|Treatment Period|Death|2|||
130917998|NCT00810693|471335085|FG000|Treatment Period|Lack of Efficacy|0|||
130917999|NCT00810693|471335086|FG001|Treatment Period|Lack of Efficacy|0|||
130918000|NCT00810693|471335087|FG002|Treatment Period|Lack of Efficacy|1|||
130918001|NCT00810693|471335085|FG000|Treatment Period|Lost to Follow-up|1|||
130918002|NCT00810693|471335086|FG001|Treatment Period|Lost to Follow-up|0|||
130918003|NCT00810693|471335087|FG002|Treatment Period|Lost to Follow-up|0|||
130918004|NCT00810693|471335085|FG000|Treatment Period|Non-compliance|1|||
130918005|NCT00810693|471335086|FG001|Treatment Period|Non-compliance|0|||
130918006|NCT00810693|471335087|FG002|Treatment Period|Non-compliance|0|||
130918007|NCT00810693|471335085|FG000|Treatment Period|Protocol Violation|1|||
130918008|NCT00810693|471335086|FG001|Treatment Period|Protocol Violation|2|||
130918009|NCT00810693|471335087|FG002|Treatment Period|Protocol Violation|2|||
130918010|NCT00810693|471335085|FG000|Treatment Period|Withdrawal by Subject|6|||
130918011|NCT00810693|471335086|FG001|Treatment Period|Withdrawal by Subject|2|||
130918012|NCT00810693|471335087|FG002|Treatment Period|Withdrawal by Subject|3|||
130918013|NCT00810693|471335085|FG000|Treatment Period|Not treated|0|||
130918014|NCT00810693|471335086|FG001|Treatment Period|Not treated|1|||
130918015|NCT00810693|471335087|FG002|Treatment Period|Not treated|1|||
130918016|NCT00810693|471335085|FG000|Follow-up Period (FUP)|Adverse Event|3|||
130918017|NCT00810693|471335086|FG001|Follow-up Period (FUP)|Adverse Event|1|||
130918018|NCT00810693|471335087|FG002|Follow-up Period (FUP)|Adverse Event|1|||
130918019|NCT00810693|471335085|FG000|Follow-up Period (FUP)|Death|2|||
130918020|NCT00810693|471335086|FG001|Follow-up Period (FUP)|Death|0|||
130918021|NCT00810693|471335087|FG002|Follow-up Period (FUP)|Death|1|||
130918022|NCT00810693|471335085|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
130918023|NCT00810693|471335086|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
130918024|NCT00810693|471335087|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
130918025|NCT00810693|471335085|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
130918026|NCT00810693|471335086|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
130918027|NCT00810693|471335087|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
130918028|NCT00810693|471335085|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
130918029|NCT00810693|471335086|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
130918030|NCT00810693|471335087|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
130918031|NCT01297920|471335088|FG000|Overall Study|Adverse Event|42|||
131119524|NCT02716675|472070199|FG000|Overall Study|Death|2|||
131119525|NCT02716675|472070200|FG001|Overall Study|Death|3|||
131119526|NCT02716675|472070201|FG002|Overall Study|Death|0|||
131119527|NCT02716675|472070199|FG000|Overall Study|Physician Decision|2|||
131119528|NCT02716675|472070200|FG001|Overall Study|Physician Decision|1|||
131119529|NCT02716675|472070201|FG002|Overall Study|Physician Decision|1|||
131119530|NCT02716675|472070199|FG000|Overall Study|Lost to Follow-up|100|||
131119531|NCT02716675|472070200|FG001|Overall Study|Lost to Follow-up|87|||
131119532|NCT02716675|472070201|FG002|Overall Study|Lost to Follow-up|99|||
131119533|NCT02716675|472070199|FG000|Overall Study|Withdrawal by Subject|22|||
131119534|NCT02716675|472070200|FG001|Overall Study|Withdrawal by Subject|25|||
131119535|NCT02716675|472070201|FG002|Overall Study|Withdrawal by Subject|20|||
131119536|NCT02716675|472070199|FG000|Overall Study|Protocol Violation|0|||
131119537|NCT02716675|472070200|FG001|Overall Study|Protocol Violation|3|||
131119538|NCT02716675|472070201|FG002|Overall Study|Protocol Violation|1|||
131119539|NCT02716675|472070199|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
130769266|NCT00002525|470780577|FG001|Overall Study|Start non-protocol therapy|0|||
131119540|NCT02716675|472070200|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
130918032|NCT01297920|471335089|FG001|Overall Study|Adverse Event|10|||
130918033|NCT01297920|471335090|FG002|Overall Study|Adverse Event|38|||
130918034|NCT01297920|471335088|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
130918035|NCT01297920|471335089|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
130918036|NCT01297920|471335090|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
130918037|NCT01297920|471335088|FG000|Overall Study|Noncompliance|1|||
131119541|NCT02716675|472070201|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
131119542|NCT02716675|472070199|FG000|Overall Study|Other|38|||
131119543|NCT02716675|472070200|FG001|Overall Study|Other|47|||
130918038|NCT01297920|471335089|FG001|Overall Study|Noncompliance|0|||
130918039|NCT01297920|471335090|FG002|Overall Study|Noncompliance|0|||
130918040|NCT01297920|471335088|FG000|Overall Study|Protocol Violation|1|||
130918041|NCT01297920|471335089|FG001|Overall Study|Protocol Violation|3|||
130918042|NCT01297920|471335090|FG002|Overall Study|Protocol Violation|0|||
130918043|NCT01297920|471335088|FG000|Overall Study|Inadequate Control of IOP|7|||
130918044|NCT01297920|471335089|FG001|Overall Study|Inadequate Control of IOP|9|||
130918045|NCT01297920|471335090|FG002|Overall Study|Inadequate Control of IOP|17|||
130918046|NCT01297920|471335088|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
130918047|NCT01297920|471335089|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
130918048|NCT01297920|471335090|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
130918049|NCT03212690|471335091|FG000|Overall Study|Protocol Violation|1|||
130918050|NCT00474760|471335092|FG000|Overall Study|Death|0|||
130918051|NCT00474760|471335093|FG001|Overall Study|Death|0|||
130918052|NCT00474760|471335094|FG002|Overall Study|Death|0|||
130918053|NCT00474760|471335095|FG003|Overall Study|Death|0|||
130918054|NCT00474760|471335096|FG004|Overall Study|Death|2|||
130918055|NCT00474760|471335097|FG005|Overall Study|Death|0|||
130918056|NCT00474760|471335098|FG006|Overall Study|Death|0|||
130918057|NCT00474760|471335092|FG000|Overall Study|Adverse Event|0|||
131119544|NCT02716675|472070201|FG002|Overall Study|Other|48|||
130918058|NCT00474760|471335093|FG001|Overall Study|Adverse Event|0|||
130918059|NCT00474760|471335094|FG002|Overall Study|Adverse Event|0|||
130918060|NCT00474760|471335095|FG003|Overall Study|Adverse Event|0|||
130918061|NCT00474760|471335096|FG004|Overall Study|Adverse Event|1|||
130918062|NCT00474760|471335097|FG005|Overall Study|Adverse Event|7|||
130918063|NCT00474760|471335098|FG006|Overall Study|Adverse Event|0|||
130918064|NCT00474760|471335092|FG000|Overall Study|Laboratory abnormality|0|||
130918065|NCT00474760|471335093|FG001|Overall Study|Laboratory abnormality|0|||
130918066|NCT00474760|471335094|FG002|Overall Study|Laboratory abnormality|0|||
130918067|NCT00474760|471335095|FG003|Overall Study|Laboratory abnormality|0|||
130918068|NCT00474760|471335096|FG004|Overall Study|Laboratory abnormality|0|||
130918069|NCT00474760|471335097|FG005|Overall Study|Laboratory abnormality|1|||
130918070|NCT00474760|471335098|FG006|Overall Study|Laboratory abnormality|0|||
130918071|NCT00474760|471335092|FG000|Overall Study|Withdrawal by Subject|0|||
130918072|NCT00474760|471335093|FG001|Overall Study|Withdrawal by Subject|0|||
130918073|NCT00474760|471335094|FG002|Overall Study|Withdrawal by Subject|0|||
130918074|NCT00474760|471335095|FG003|Overall Study|Withdrawal by Subject|1|||
130918075|NCT00474760|471335096|FG004|Overall Study|Withdrawal by Subject|0|||
130918076|NCT00474760|471335097|FG005|Overall Study|Withdrawal by Subject|1|||
130918077|NCT00474760|471335098|FG006|Overall Study|Withdrawal by Subject|1|||
130918078|NCT00474760|471335092|FG000|Overall Study|Other|0|||
130918079|NCT00474760|471335093|FG001|Overall Study|Other|1|||
130918080|NCT00474760|471335094|FG002|Overall Study|Other|0|||
130918081|NCT00474760|471335095|FG003|Overall Study|Other|0|||
130918082|NCT00474760|471335096|FG004|Overall Study|Other|1|||
130918083|NCT00474760|471335097|FG005|Overall Study|Other|0|||
130918084|NCT00474760|471335098|FG006|Overall Study|Other|0|||
130918085|NCT00474760|471335092|FG000|Overall Study|Progressive disease|3|||
130918086|NCT00474760|471335093|FG001|Overall Study|Progressive disease|2|||
130918087|NCT00474760|471335094|FG002|Overall Study|Progressive disease|3|||
130918088|NCT00474760|471335095|FG003|Overall Study|Progressive disease|2|||
130918089|NCT00474760|471335096|FG004|Overall Study|Progressive disease|8|||
130918090|NCT00474760|471335097|FG005|Overall Study|Progressive disease|20|||
130918091|NCT00474760|471335098|FG006|Overall Study|Progressive disease|7|||
130918092|NCT00474760|471335092|FG000|Overall Study|Terminated by sponsor|0|||
130918093|NCT00474760|471335093|FG001|Overall Study|Terminated by sponsor|0|||
130918094|NCT00474760|471335094|FG002|Overall Study|Terminated by sponsor|0|||
130918095|NCT00474760|471335095|FG003|Overall Study|Terminated by sponsor|0|||
130918096|NCT00474760|471335096|FG004|Overall Study|Terminated by sponsor|0|||
130918097|NCT00474760|471335097|FG005|Overall Study|Terminated by sponsor|0|||
130918098|NCT00474760|471335098|FG006|Overall Study|Terminated by sponsor|2|||
131119545|NCT00709111|472070202|FG000|Overall Study|Withdrawal by Subject|1|||
131119546|NCT00709111|472070202|FG000|Overall Study|Unable to attend clinic visits|1|||
130918099|NCT02345226|471335099|FG000|Double-Blind Phase|Adverse Event|5|||
130918100|NCT02345226|471335100|FG001|Double-Blind Phase|Adverse Event|6|||
130918101|NCT02345226|471335099|FG000|Double-Blind Phase|Death|3|||
130918102|NCT02345226|471335100|FG001|Double-Blind Phase|Death|0|||
130918103|NCT02345226|471335099|FG000|Double-Blind Phase|Pregnancy|0|||
130918104|NCT02345226|471335100|FG001|Double-Blind Phase|Pregnancy|1|||
130918105|NCT02345226|471335099|FG000|Double-Blind Phase|Lack of Efficacy|1|||
130918106|NCT02345226|471335100|FG001|Double-Blind Phase|Lack of Efficacy|0|||
130918107|NCT02345226|471335099|FG000|Double-Blind Phase|Investigator's Discretion|4|||
130918108|NCT02345226|471335100|FG001|Double-Blind Phase|Investigator's Discretion|3|||
130918109|NCT02345226|471335099|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
130918110|NCT02345226|471335100|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
131119547|NCT01301456|472070207|FG000|Stage 1|Withdrawal by Subject|0|||
130918111|NCT02345226|471335099|FG000|Double-Blind Phase|Withdrew Consent|41|||
130918112|NCT02345226|471335100|FG001|Double-Blind Phase|Withdrew Consent|39|||
130699661|NCT01332968|470524724|FG005|Maintenance/Observation Period|Protocol Violation|0|||
130699662|NCT01332968|470524725|FG006|Maintenance/Observation Period|Protocol Violation|0|||
130699663|NCT01332968|470524726|FG007|Maintenance/Observation Period|Protocol Violation|0|||
130699664|NCT01332968|470524719|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
130699665|NCT01332968|470524720|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
130699666|NCT01332968|470524721|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
130699667|NCT01332968|470524722|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
130918113|NCT02345226|471335099|FG000|Double-Blind Phase|Lost to Follow-up|12|||
130918114|NCT02345226|471335100|FG001|Double-Blind Phase|Lost to Follow-up|16|||
130918115|NCT02345226|471335099|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
130918116|NCT02345226|471335100|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
130918117|NCT02345226|471335099|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130918118|NCT02345226|471335100|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
130918119|NCT01710046|471335103|FG000|Overall Study|Lost to Follow-up|1|||
130918120|NCT01710046|471335104|FG001|Overall Study|Lost to Follow-up|0|||
130918121|NCT02282358|471335105|FG000|Overall Study|Nonevaluable|1|||
130918122|NCT02158975|471335108|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
130918123|NCT01346969|471335109|FG000|Overall Study|Withdrawal by Subject|0|||
130918124|NCT01346969|471335110|FG001|Overall Study|Withdrawal by Subject|0|||
130918125|NCT01346969|471335111|FG002|Overall Study|Withdrawal by Subject|1|||
130918126|NCT01346969|471335112|FG003|Overall Study|Withdrawal by Subject|0|||
130918127|NCT01346969|471335109|FG000|Overall Study|Lost to Follow-up|1|||
130918128|NCT01346969|471335110|FG001|Overall Study|Lost to Follow-up|0|||
130918129|NCT01346969|471335111|FG002|Overall Study|Lost to Follow-up|2|||
130918130|NCT01346969|471335112|FG003|Overall Study|Lost to Follow-up|0|||
130918131|NCT01346969|471335109|FG000|Overall Study|Physician Decision|0|||
130918132|NCT01346969|471335110|FG001|Overall Study|Physician Decision|0|||
130918133|NCT01346969|471335111|FG002|Overall Study|Physician Decision|0|||
130918134|NCT01346969|471335112|FG003|Overall Study|Physician Decision|1|||
130918135|NCT01346969|471335109|FG000|Overall Study|Randomized but not treated|1|||
130918136|NCT01346969|471335110|FG001|Overall Study|Randomized but not treated|0|||
130918137|NCT01346969|471335111|FG002|Overall Study|Randomized but not treated|0|||
130918138|NCT01346969|471335112|FG003|Overall Study|Randomized but not treated|0|||
130918139|NCT02557295|471335113|FG000|Overall Study|Withdrawal by Subject|9|||
130918140|NCT02557295|471335114|FG001|Overall Study|Withdrawal by Subject|2|||
130918141|NCT02557295|471335115|FG002|Overall Study|Withdrawal by Subject|4|||
130918142|NCT02557295|471335116|FG003|Overall Study|Withdrawal by Subject|0|||
130918143|NCT02557295|471335117|FG004|Overall Study|Withdrawal by Subject|0|||
130918144|NCT02557295|471335118|FG005|Overall Study|Withdrawal by Subject|0|||
131119548|NCT01301456|472070208|FG001|Stage 1|Withdrawal by Subject|0|||
131119549|NCT01301456|472070209|FG002|Stage 1|Withdrawal by Subject|1|||
131119550|NCT01301456|472070210|FG003|Stage 1|Withdrawal by Subject|0|||
131119551|NCT01301456|472070211|FG004|Stage 1|Withdrawal by Subject|1|||
131119552|NCT01301456|472070212|FG005|Stage 1|Withdrawal by Subject|0|||
131119553|NCT01301456|472070213|FG006|Stage 1|Withdrawal by Subject|0|||
131119554|NCT01301456|472070214|FG007|Stage 1|Withdrawal by Subject|0|||
131119555|NCT01301456|472070215|FG008|Stage 1|Withdrawal by Subject|0|||
131119556|NCT01301456|472070216|FG009|Stage 1|Withdrawal by Subject|0|||
131119557|NCT01301456|472070217|FG010|Stage 1|Withdrawal by Subject|0|||
131119558|NCT01301456|472070218|FG011|Stage 1|Withdrawal by Subject|0|||
131119559|NCT01301456|472070207|FG000|Stage 1|Randomized but not treated|0|||
131119560|NCT01301456|472070208|FG001|Stage 1|Randomized but not treated|0|||
131119561|NCT01301456|472070209|FG002|Stage 1|Randomized but not treated|0|||
131119562|NCT01301456|472070210|FG003|Stage 1|Randomized but not treated|0|||
131119563|NCT01301456|472070211|FG004|Stage 1|Randomized but not treated|0|||
131119564|NCT01301456|472070212|FG005|Stage 1|Randomized but not treated|0|||
131119565|NCT01301456|472070213|FG006|Stage 1|Randomized but not treated|1|||
131119566|NCT01301456|472070214|FG007|Stage 1|Randomized but not treated|0|||
130699668|NCT01332968|470524723|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
130769267|NCT00002525|470780576|FG000|Overall Study|Other complicating disease|1|||
130918145|NCT02557295|471335119|FG006|Overall Study|Withdrawal by Subject|15|||
131119567|NCT01301456|472070215|FG008|Stage 1|Randomized but not treated|0|||
131119568|NCT01301456|472070216|FG009|Stage 1|Randomized but not treated|0|||
131119569|NCT01301456|472070217|FG010|Stage 1|Randomized but not treated|0|||
131119570|NCT01301456|472070218|FG011|Stage 1|Randomized but not treated|0|||
131119571|NCT01301456|472070207|FG000|Stage 2|Adverse Event|0|||
131119572|NCT01301456|472070208|FG001|Stage 2|Adverse Event|0|||
130769268|NCT00002525|470780577|FG001|Overall Study|Other complicating disease|0|||
131119573|NCT01301456|472070209|FG002|Stage 2|Adverse Event|0|||
130918146|NCT02557295|471335120|FG007|Overall Study|Withdrawal by Subject|1|||
130918147|NCT02557295|471335121|FG008|Overall Study|Withdrawal by Subject|3|||
130918148|NCT02557295|471335113|FG000|Overall Study|Disease Progression|0|||
130918149|NCT02557295|471335114|FG001|Overall Study|Disease Progression|0|||
131119574|NCT01301456|472070210|FG003|Stage 2|Adverse Event|0|||
130699669|NCT01332968|470524724|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
130769269|NCT00002525|470780576|FG000|Overall Study|Duke's A, B1, D disease|92|||
131222926|NCT04130919|472443199|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
130769270|NCT00002525|470780577|FG001|Overall Study|Duke's A, B1, D disease|0|||
130769271|NCT00002525|470780576|FG000|Overall Study|Error|6|||
130769272|NCT00002525|470780577|FG001|Overall Study|Error|0|||
130769273|NCT00002525|470780576|FG000|Overall Study|Other|26|||
130769274|NCT00002525|470780577|FG001|Overall Study|Other|0|||
130769275|NCT00002525|470780576|FG000|Overall Study|Never start protocol therapy|8|||
130769276|NCT00002525|470780577|FG001|Overall Study|Never start protocol therapy|0|||
130769277|NCT02886884|470780578|FG000|Follow-up|Withdrawal by Subject|0|||
130769278|NCT02886884|470780579|FG001|Follow-up|Withdrawal by Subject|0|||
130769279|NCT02886884|470780580|FG002|Follow-up|Withdrawal by Subject|0|||
130769280|NCT02886884|470780581|FG003|Follow-up|Withdrawal by Subject|1|||
130769281|NCT03230838|470780582|FG000|Overall Study|Withdrawal by Subject|3|||
130769282|NCT03230838|470780583|FG001|Overall Study|Withdrawal by Subject|0|||
130769283|NCT03230838|470780582|FG000|Overall Study|Temperature excursion|1|||
130769284|NCT03230838|470780583|FG001|Overall Study|Temperature excursion|0|||
130918150|NCT02557295|471335115|FG002|Overall Study|Disease Progression|0|||
130918151|NCT02557295|471335116|FG003|Overall Study|Disease Progression|0|||
130918152|NCT02557295|471335117|FG004|Overall Study|Disease Progression|0|||
130918153|NCT02557295|471335118|FG005|Overall Study|Disease Progression|0|||
130918154|NCT02557295|471335119|FG006|Overall Study|Disease Progression|1|||
131222927|NCT04130919|472443200|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
131222928|NCT04130919|472443201|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
131222929|NCT04130919|472443202|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
131222930|NCT04130919|472443203|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
131222931|NCT04130919|472443204|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
131222932|NCT04130919|472443199|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
131222933|NCT04130919|472443200|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
131222934|NCT04130919|472443201|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
131222935|NCT04130919|472443202|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
131222936|NCT04130919|472443203|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
131222937|NCT04130919|472443204|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
131222938|NCT02624518|472443205|FG000|Overall Study|Physician Decision|1|||
131222939|NCT00370396|472443208|FG000|Overall Study|Withdrawal by Subject|0|||
131222940|NCT00370396|472443209|FG001|Overall Study|Withdrawal by Subject|0|||
131222941|NCT00370396|472443210|FG002|Overall Study|Withdrawal by Subject|1|||
131222942|NCT00370396|472443208|FG000|Overall Study|Lost to Follow-up|11|||
131222943|NCT00370396|472443209|FG001|Overall Study|Lost to Follow-up|1|||
131222944|NCT00370396|472443210|FG002|Overall Study|Lost to Follow-up|0|||
130918155|NCT02557295|471335120|FG007|Overall Study|Disease Progression|0|||
130918156|NCT02557295|471335121|FG008|Overall Study|Disease Progression|0|||
130918157|NCT02557295|471335113|FG000|Overall Study|Lack of Efficacy|24|||
130918158|NCT02557295|471335114|FG001|Overall Study|Lack of Efficacy|1|||
130918159|NCT02557295|471335115|FG002|Overall Study|Lack of Efficacy|3|||
130918160|NCT02557295|471335116|FG003|Overall Study|Lack of Efficacy|0|||
130918161|NCT02557295|471335117|FG004|Overall Study|Lack of Efficacy|0|||
130918162|NCT02557295|471335118|FG005|Overall Study|Lack of Efficacy|0|||
130918163|NCT02557295|471335119|FG006|Overall Study|Lack of Efficacy|12|||
130918164|NCT02557295|471335120|FG007|Overall Study|Lack of Efficacy|1|||
130918165|NCT02557295|471335121|FG008|Overall Study|Lack of Efficacy|0|||
130918166|NCT02557295|471335113|FG000|Overall Study|Adverse Event|16|||
131222945|NCT01462695|472443211|FG000|Overall Study|Adverse Event|1|||
131222946|NCT01462695|472443212|FG001|Overall Study|Adverse Event|1|||
130769285|NCT00435188|470780589|FG000|Overall Study|Death|1|||
130769286|NCT00435188|470780590|FG001|Overall Study|Death|6|||
130769287|NCT00435188|470780589|FG000|Overall Study|Withdrawal by Subject|16|||
130769288|NCT00435188|470780590|FG001|Overall Study|Withdrawal by Subject|11|||
130769289|NCT00435188|470780589|FG000|Overall Study|Lost to Follow-up|5|||
130769290|NCT00435188|470780590|FG001|Overall Study|Lost to Follow-up|6|||
130918167|NCT02557295|471335114|FG001|Overall Study|Adverse Event|2|||
130918168|NCT02557295|471335115|FG002|Overall Study|Adverse Event|3|||
130918169|NCT02557295|471335116|FG003|Overall Study|Adverse Event|0|||
130918170|NCT02557295|471335117|FG004|Overall Study|Adverse Event|0|||
130918171|NCT02557295|471335118|FG005|Overall Study|Adverse Event|0|||
130918172|NCT02557295|471335119|FG006|Overall Study|Adverse Event|2|||
130918173|NCT02557295|471335120|FG007|Overall Study|Adverse Event|1|||
131222947|NCT01462695|472443211|FG000|Overall Study|Death|2|||
131222948|NCT01462695|472443212|FG001|Overall Study|Death|0|||
131222949|NCT01462695|472443211|FG000|Overall Study|Lack of Efficacy|6|||
130918174|NCT02557295|471335121|FG008|Overall Study|Adverse Event|1|||
130918175|NCT02557295|471335113|FG000|Overall Study|Lost to Follow-up|4|||
130918176|NCT02557295|471335114|FG001|Overall Study|Lost to Follow-up|0|||
130918177|NCT02557295|471335115|FG002|Overall Study|Lost to Follow-up|0|||
130918178|NCT02557295|471335116|FG003|Overall Study|Lost to Follow-up|0|||
130769291|NCT01915771|470780591|FG000|Day 1|Withdrawal by Subject|1|||
130769292|NCT01915771|470780591|FG000|Day 15|Withdrawal by Subject|1|||
130769293|NCT03420222|470780594|FG000|Overall Study|Withdrawal by Subject|5|||
130699670|NCT01332968|470524725|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
130699671|NCT01332968|470524726|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
130699672|NCT01332968|470524719|FG000|Follow-Up Period|Adverse Event|0|||
130699673|NCT01332968|470524720|FG001|Follow-Up Period|Adverse Event|0|||
130699674|NCT01332968|470524721|FG002|Follow-Up Period|Adverse Event|0|||
130699675|NCT01332968|470524722|FG003|Follow-Up Period|Adverse Event|0|||
130699676|NCT01332968|470524723|FG004|Follow-Up Period|Adverse Event|0|||
130918179|NCT02557295|471335117|FG004|Overall Study|Lost to Follow-up|0|||
130918180|NCT02557295|471335118|FG005|Overall Study|Lost to Follow-up|0|||
130918181|NCT02557295|471335119|FG006|Overall Study|Lost to Follow-up|9|||
130918182|NCT02557295|471335120|FG007|Overall Study|Lost to Follow-up|0|||
130918183|NCT02557295|471335121|FG008|Overall Study|Lost to Follow-up|0|||
130918184|NCT02557295|471335113|FG000|Overall Study|Study Close|54|||
130918185|NCT02557295|471335114|FG001|Overall Study|Study Close|3|||
130918186|NCT02557295|471335115|FG002|Overall Study|Study Close|5|||
130918187|NCT02557295|471335116|FG003|Overall Study|Study Close|3|||
130918188|NCT02557295|471335117|FG004|Overall Study|Study Close|0|||
130918189|NCT02557295|471335118|FG005|Overall Study|Study Close|0|||
130918190|NCT02557295|471335119|FG006|Overall Study|Study Close|37|||
130918191|NCT02557295|471335120|FG007|Overall Study|Study Close|3|||
130918192|NCT02557295|471335121|FG008|Overall Study|Study Close|19|||
130918193|NCT02557295|471335113|FG000|Overall Study|except for study close|4|||
130918194|NCT02557295|471335114|FG001|Overall Study|except for study close|0|||
130918195|NCT02557295|471335115|FG002|Overall Study|except for study close|0|||
130918196|NCT02557295|471335116|FG003|Overall Study|except for study close|0|||
130918197|NCT02557295|471335117|FG004|Overall Study|except for study close|0|||
130918198|NCT02557295|471335118|FG005|Overall Study|except for study close|0|||
130918199|NCT02557295|471335119|FG006|Overall Study|except for study close|5|||
131033496|NCT05179837|471755361|FG000|Overall Study|Device malfunctioned|1|||
131033497|NCT05179837|471755361|FG000|Overall Study|Image quality too low|2|||
131033498|NCT05051124|471755362|FG000|Overall Study|Lost to Follow-up|2|||
131033499|NCT05051124|471755362|FG000|Overall Study|Withdrawal by Subject|1|||
131033500|NCT05051124|471755362|FG000|Overall Study|Residential relocation|2|||
131033501|NCT05051124|471755362|FG000|Overall Study|Death|1|||
131033502|NCT04782973|471755363|FG000|Overall Study|Withdrawal by Subject|5|||
131033503|NCT04782973|471755363|FG000|Overall Study|Protocol Violation|6|||
131033504|NCT04782973|471755363|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
131033505|NCT03557697|471755364|FG000|Overall Study|Withdrawal by Subject|2|||
131033506|NCT03557697|471755365|FG001|Overall Study|Withdrawal by Subject|4|||
131033507|NCT06491433|471755366|FG000|Overall Study|Protocol Violation|51|||
131033508|NCT06491433|471755366|FG000|Overall Study|consent withdrawal|2|||
131033509|NCT06491433|471755366|FG000|Overall Study|screen failure|1|||
131033510|NCT04749615|471755367|FG000|Overall Study|Lost to Follow-up|6|||
131033511|NCT04749615|471755368|FG001|Overall Study|Lost to Follow-up|10|||
131033512|NCT03611491|471755369|FG000|Overall Study|Lost to Follow-up|1|||
131033513|NCT05478499|471755388|FG000|Overall Study|Adverse Event|4|||
131033514|NCT05478499|471755389|FG001|Overall Study|Adverse Event|2|||
131033515|NCT05478499|471755388|FG000|Overall Study|Withdrawal by Subject|3|||
131033516|NCT05478499|471755389|FG001|Overall Study|Withdrawal by Subject|2|||
131033517|NCT05478499|471755388|FG000|Overall Study|Lack of Efficacy|1|||
131033518|NCT05478499|471755389|FG001|Overall Study|Lack of Efficacy|0|||
131033519|NCT05478499|471755388|FG000|Overall Study|Lost to Follow-up|1|||
131033520|NCT05478499|471755389|FG001|Overall Study|Lost to Follow-up|0|||
131033521|NCT05478499|471755388|FG000|Overall Study|Other reasons|0|||
131033522|NCT05478499|471755389|FG001|Overall Study|Other reasons|1|||
131033523|NCT02962895|471755390|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
131033524|NCT02962895|471755391|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
131033525|NCT02962895|471755392|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
131033526|NCT02962895|471755393|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
131033527|NCT02962895|471755394|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
131033528|NCT02962895|471755395|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
131033529|NCT02962895|471755396|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
131033530|NCT02962895|471755390|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
130769294|NCT03420222|470780595|FG001|Overall Study|Withdrawal by Subject|0|||
131033531|NCT02962895|471755391|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
131033532|NCT02962895|471755392|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131119575|NCT01301456|472070211|FG004|Stage 2|Adverse Event|0|||
130699677|NCT01332968|470524724|FG005|Follow-Up Period|Adverse Event|0|||
130699678|NCT01332968|470524725|FG006|Follow-Up Period|Adverse Event|0|||
130918200|NCT02557295|471335120|FG007|Overall Study|except for study close|1|||
130918201|NCT02557295|471335121|FG008|Overall Study|except for study close|0|||
130918202|NCT01896050|471336713|FG000|Overall Study|Adverse Event|37|||
130918203|NCT01896050|471336714|FG001|Overall Study|Adverse Event|2|||
130918204|NCT01896050|471336713|FG000|Overall Study|Death|1|||
130918205|NCT01896050|471336714|FG001|Overall Study|Death|0|||
131119576|NCT01301456|472070212|FG005|Stage 2|Adverse Event|0|||
131119577|NCT01301456|472070213|FG006|Stage 2|Adverse Event|0|||
130699679|NCT01332968|470524726|FG007|Follow-Up Period|Adverse Event|4|||
130699680|NCT01332968|470524719|FG000|Follow-Up Period|Death|0|||
130699681|NCT01332968|470524720|FG001|Follow-Up Period|Death|0|||
130699682|NCT01332968|470524721|FG002|Follow-Up Period|Death|0|||
130699683|NCT01332968|470524722|FG003|Follow-Up Period|Death|0|||
130699684|NCT01332968|470524723|FG004|Follow-Up Period|Death|0|||
130769295|NCT03420222|470780594|FG000|Overall Study|Physician Decision|0|||
130918206|NCT00392015|471336715|FG000|Overall Study|Lost to Follow-up|2|||
130918207|NCT00392015|471336716|FG001|Overall Study|Lost to Follow-up|0|||
130918208|NCT00392015|471336717|FG002|Overall Study|Lost to Follow-up|2|||
130918209|NCT00392015|471336718|FG003|Overall Study|Lost to Follow-up|1|||
130918210|NCT00392015|471336719|FG004|Overall Study|Lost to Follow-up|1|||
130918211|NCT00392015|471336720|FG005|Overall Study|Lost to Follow-up|0|||
130918212|NCT00392015|471336715|FG000|Overall Study|Withdrawal by Subject|0|||
130918213|NCT00392015|471336716|FG001|Overall Study|Withdrawal by Subject|0|||
130918214|NCT00392015|471336717|FG002|Overall Study|Withdrawal by Subject|2|||
130918215|NCT00392015|471336718|FG003|Overall Study|Withdrawal by Subject|0|||
130918216|NCT00392015|471336719|FG004|Overall Study|Withdrawal by Subject|0|||
130918217|NCT00392015|471336720|FG005|Overall Study|Withdrawal by Subject|0|||
130918218|NCT00392015|471336715|FG000|Overall Study|Adverse Event|0|||
130918219|NCT00392015|471336716|FG001|Overall Study|Adverse Event|0|||
130918220|NCT00392015|471336717|FG002|Overall Study|Adverse Event|0|||
130918221|NCT00392015|471336718|FG003|Overall Study|Adverse Event|0|||
130918222|NCT00392015|471336719|FG004|Overall Study|Adverse Event|1|||
130918223|NCT00392015|471336720|FG005|Overall Study|Adverse Event|0|||
130918224|NCT00392015|471336715|FG000|Overall Study|Previous trial recipient|0|||
130918225|NCT00392015|471336716|FG001|Overall Study|Previous trial recipient|0|||
130918226|NCT00392015|471336717|FG002|Overall Study|Previous trial recipient|0|||
130918227|NCT00392015|471336718|FG003|Overall Study|Previous trial recipient|0|||
130918228|NCT00392015|471336719|FG004|Overall Study|Previous trial recipient|1|||
130918229|NCT00392015|471336720|FG005|Overall Study|Previous trial recipient|0|||
130918240|NCT02925923|471336726|FG000|Overall Study|blood samples hemolyzed|0|||
130918241|NCT02925923|471336727|FG001|Overall Study|blood samples hemolyzed|2|||
130918242|NCT01863953|471336732|FG000|Overall Study|Adverse Event|0|||
130918243|NCT01863953|471336733|FG001|Overall Study|Adverse Event|0|||
130918244|NCT01863953|471336734|FG002|Overall Study|Adverse Event|1|||
130918245|NCT01824342|471336736|FG000|Overall Study|Withdrawal by Subject|0|||
130918246|NCT01824342|471336737|FG001|Overall Study|Withdrawal by Subject|3|||
130918247|NCT01824342|471336736|FG000|Overall Study|Adverse Event|1|||
131119578|NCT01301456|472070214|FG007|Stage 2|Adverse Event|0|||
131119579|NCT01301456|472070215|FG008|Stage 2|Adverse Event|0|||
131119580|NCT01301456|472070216|FG009|Stage 2|Adverse Event|0|||
131119581|NCT01301456|472070217|FG010|Stage 2|Adverse Event|1|||
131119582|NCT01301456|472070218|FG011|Stage 2|Adverse Event|0|||
131119583|NCT00915772|472070219|FG000|Overall Study|Adverse Event|12|||
131119584|NCT00915772|472070220|FG001|Overall Study|Adverse Event|13|||
131119585|NCT00915772|472070221|FG002|Overall Study|Adverse Event|11|||
131119586|NCT00915772|472070219|FG000|Overall Study|Protocol Violation|4|||
131119587|NCT00915772|472070220|FG001|Overall Study|Protocol Violation|1|||
131119588|NCT00915772|472070221|FG002|Overall Study|Protocol Violation|2|||
131119589|NCT00915772|472070219|FG000|Overall Study|Lost to Follow-up|1|||
131119590|NCT00915772|472070220|FG001|Overall Study|Lost to Follow-up|2|||
131119591|NCT00915772|472070221|FG002|Overall Study|Lost to Follow-up|2|||
131119592|NCT00915772|472070219|FG000|Overall Study|Lack of Efficacy|9|||
131119593|NCT00915772|472070220|FG001|Overall Study|Lack of Efficacy|15|||
131119594|NCT00915772|472070221|FG002|Overall Study|Lack of Efficacy|3|||
131119595|NCT00915772|472070219|FG000|Overall Study|Refused to continue trial medication|6|||
131119596|NCT00915772|472070220|FG001|Overall Study|Refused to continue trial medication|8|||
131119597|NCT00915772|472070221|FG002|Overall Study|Refused to continue trial medication|4|||
130699685|NCT01332968|470524724|FG005|Follow-Up Period|Death|0|||
130918248|NCT01824342|471336737|FG001|Overall Study|Adverse Event|1|||
130918249|NCT01824342|471336736|FG000|Overall Study|Disease Progression|1|||
131119598|NCT00915772|472070219|FG000|Overall Study|Any other reason|4|||
131119599|NCT00915772|472070220|FG001|Overall Study|Any other reason|7|||
131119600|NCT00915772|472070221|FG002|Overall Study|Any other reason|7|||
130699686|NCT01332968|470524725|FG006|Follow-Up Period|Death|27|||
130699687|NCT01332968|470524726|FG007|Follow-Up Period|Death|30|||
130918250|NCT01824342|471336737|FG001|Overall Study|Disease Progression|1|||
130918251|NCT01824342|471336736|FG000|Overall Study|Physician Decision|5|||
130918252|NCT01824342|471336737|FG001|Overall Study|Physician Decision|0|||
130699688|NCT01332968|470524719|FG000|Follow-Up Period|Lost to Follow-up|0|||
130699689|NCT01332968|470524720|FG001|Follow-Up Period|Lost to Follow-up|0|||
130918253|NCT01824342|471336736|FG000|Overall Study|Death|2|||
130918254|NCT01824342|471336737|FG001|Overall Study|Death|0|||
130918255|NCT00313300|471336740|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
130918256|NCT00313300|471336741|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
130918257|NCT00313300|471336742|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
130918258|NCT00313300|471336743|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
130918259|NCT00313300|471336744|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
130918260|NCT00313300|471336740|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
130918261|NCT00313300|471336741|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
130918262|NCT00313300|471336742|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
130918263|NCT00313300|471336743|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
130918264|NCT00313300|471336744|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
130918265|NCT00313300|471336740|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
130918266|NCT00313300|471336741|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
130918267|NCT00313300|471336742|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
130918268|NCT00313300|471336743|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
130918269|NCT00313300|471336744|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
130918270|NCT00313300|471336740|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
130918271|NCT00313300|471336741|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
130918272|NCT00313300|471336742|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
130918273|NCT00313300|471336743|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
130918274|NCT00313300|471336744|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
131119601|NCT01383096|472070224|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
131119602|NCT01383096|472070225|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
131119603|NCT01383096|472070226|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
131119604|NCT01383096|472070224|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
131119605|NCT01383096|472070225|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
131119606|NCT01383096|472070226|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
131119607|NCT01383096|472070224|FG000|Third Intervention (8 Days)|Elevated AST|0|||
131119608|NCT01383096|472070225|FG001|Third Intervention (8 Days)|Elevated AST|1|||
131119609|NCT01383096|472070226|FG002|Third Intervention (8 Days)|Elevated AST|0|||
131119610|NCT01383096|472070224|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
131119611|NCT01383096|472070225|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
131119612|NCT01383096|472070226|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
131119613|NCT01383096|472070224|FG000|Third Intervention (8 Days)|Adverse Event|1|||
131119614|NCT01383096|472070225|FG001|Third Intervention (8 Days)|Adverse Event|0|||
131119615|NCT01383096|472070226|FG002|Third Intervention (8 Days)|Adverse Event|0|||
131119616|NCT01383096|472070224|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
131119617|NCT01383096|472070225|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
131119618|NCT01383096|472070226|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
131119619|NCT01383096|472070224|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
131119620|NCT01383096|472070225|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
131119621|NCT01383096|472070226|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
131119622|NCT01383096|472070224|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
131119623|NCT01383096|472070225|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
131119624|NCT01383096|472070226|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
131119625|NCT01383096|472070224|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
131119626|NCT01383096|472070225|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
131119627|NCT01383096|472070226|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
131119628|NCT01383096|472070224|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
131119629|NCT01383096|472070225|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
131119630|NCT01383096|472070226|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
131119631|NCT01383096|472070224|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
131119632|NCT01383096|472070225|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
131119633|NCT01383096|472070226|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
131119634|NCT01211535|472070227|FG000|Overall Study|Adverse Event|0|||
131119635|NCT01211535|472070228|FG001|Overall Study|Adverse Event|1|||
131119636|NCT03593850|472070231|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
131119637|NCT03593850|472070232|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
131119638|NCT01735279|472070233|FG000|Overall Study|Lost to Follow-up|11|||
131119639|NCT01735279|472070234|FG001|Overall Study|Lost to Follow-up|8|||
131119640|NCT00233363|472070239|FG000|Overall Study|Adverse Event|1|||
130699690|NCT01332968|470524721|FG002|Follow-Up Period|Lost to Follow-up|0|||
130918275|NCT00313300|471336740|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
130699691|NCT01332968|470524722|FG003|Follow-Up Period|Lost to Follow-up|0|||
130699692|NCT01332968|470524723|FG004|Follow-Up Period|Lost to Follow-up|0|||
130918276|NCT00313300|471336741|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
130918277|NCT00313300|471336742|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
130918278|NCT00313300|471336743|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
130918279|NCT00313300|471336744|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
130918280|NCT00313300|471336740|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
130918281|NCT00313300|471336741|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
130918282|NCT00313300|471336742|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
130918283|NCT00313300|471336743|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
130918284|NCT00313300|471336744|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
130918285|NCT00313300|471336740|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
130918286|NCT00313300|471336741|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
130918287|NCT00313300|471336742|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
130918288|NCT00313300|471336743|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
130918289|NCT00313300|471336744|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
130918290|NCT00313300|471336740|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
130918291|NCT00313300|471336741|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
130918292|NCT00313300|471336742|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
130918293|NCT00313300|471336743|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
130918294|NCT00313300|471336744|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
130918295|NCT00313300|471336740|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
130918296|NCT00313300|471336741|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
130918297|NCT00313300|471336742|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
130918298|NCT00313300|471336743|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
130918299|NCT00313300|471336744|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
130918300|NCT00313300|471336740|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
130918301|NCT00313300|471336741|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
130918302|NCT00313300|471336742|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
130918303|NCT00313300|471336743|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
130918304|NCT00313300|471336744|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
130918305|NCT00313300|471336740|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
130918306|NCT00313300|471336741|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
130918307|NCT00313300|471336742|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
130918308|NCT00313300|471336743|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
130918309|NCT00313300|471336744|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
130918310|NCT00313300|471336740|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
131033533|NCT02962895|471755393|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131033534|NCT02962895|471755394|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131033535|NCT02962895|471755395|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131033536|NCT02962895|471755396|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
131033537|NCT02962895|471755390|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
131033538|NCT02962895|471755391|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
131033539|NCT02962895|471755392|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
131033540|NCT02962895|471755393|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
131033541|NCT02962895|471755394|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
131033542|NCT02962895|471755395|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
131033543|NCT02962895|471755396|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
131033544|NCT02962895|471755390|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
131033545|NCT02962895|471755391|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131033546|NCT02962895|471755392|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131033547|NCT02962895|471755393|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131033548|NCT02962895|471755394|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131033549|NCT02962895|471755395|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131033550|NCT02962895|471755396|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
131033551|NCT02962895|471755390|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131033552|NCT02962895|471755391|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
131033553|NCT02962895|471755392|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131033554|NCT02962895|471755393|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131033555|NCT02962895|471755394|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131033556|NCT02962895|471755395|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131033557|NCT02962895|471755396|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
131119641|NCT00233363|472070240|FG001|Overall Study|Adverse Event|2|||
131119642|NCT00233363|472070239|FG000|Overall Study|Lack of Efficacy|0|||
130918311|NCT00313300|471336741|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
130918312|NCT00313300|471336742|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
130699693|NCT01332968|470524724|FG005|Follow-Up Period|Lost to Follow-up|0|||
130918313|NCT00313300|471336743|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
130918314|NCT00313300|471336744|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
130918315|NCT00313300|471336740|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
130918316|NCT00313300|471336741|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
130918317|NCT00313300|471336742|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
130918318|NCT00313300|471336743|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
130918319|NCT00313300|471336744|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
130918320|NCT00313300|471336740|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
130918321|NCT00313300|471336741|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
130918322|NCT00313300|471336742|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
130918323|NCT00313300|471336743|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
130918324|NCT00313300|471336744|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
130918325|NCT00313300|471336740|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
130918326|NCT00313300|471336741|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
130918327|NCT00313300|471336742|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
130918328|NCT00313300|471336743|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
130918329|NCT00313300|471336744|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
130918330|NCT00313300|471336740|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
130918331|NCT00313300|471336741|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
130918332|NCT00313300|471336742|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
130918333|NCT00313300|471336743|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
130918334|NCT00313300|471336744|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
130918335|NCT00313300|471336740|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
130918336|NCT00313300|471336741|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
130918337|NCT00313300|471336742|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
130918338|NCT00313300|471336743|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
130918339|NCT00313300|471336744|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
130918340|NCT00313300|471336740|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
130918341|NCT00313300|471336741|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
130918342|NCT00313300|471336742|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
130918343|NCT00313300|471336743|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
130918344|NCT00313300|471336744|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
130918345|NCT00313300|471336740|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
130918346|NCT00313300|471336741|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
130918347|NCT00313300|471336742|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
130918348|NCT00313300|471336743|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
130918349|NCT00313300|471336744|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
130918350|NCT00313300|471336740|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
130918351|NCT00313300|471336741|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
130918352|NCT00313300|471336742|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
130918353|NCT00313300|471336743|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
130918354|NCT00313300|471336744|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
130918355|NCT00313300|471336740|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
130918356|NCT00313300|471336741|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
130918357|NCT00313300|471336742|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
130918358|NCT00313300|471336743|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
131033558|NCT02962895|471755390|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131033559|NCT02962895|471755391|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131033560|NCT02962895|471755392|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131033561|NCT02962895|471755393|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
131033562|NCT02962895|471755394|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131033563|NCT02962895|471755395|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131033564|NCT02962895|471755396|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
131033565|NCT02962895|471755390|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131033566|NCT02962895|471755391|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131033567|NCT02962895|471755392|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131033568|NCT02962895|471755393|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131033569|NCT02962895|471755394|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131033570|NCT02962895|471755395|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
131033571|NCT02962895|471755396|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
131033572|NCT02962895|471755390|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
131033573|NCT02962895|471755391|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
130699694|NCT01332968|470524725|FG006|Follow-Up Period|Lost to Follow-up|11|||
131222950|NCT01462695|472443212|FG001|Overall Study|Lack of Efficacy|12|||
131222951|NCT01462695|472443211|FG000|Overall Study|Physician Decision|5|||
131222952|NCT01462695|472443212|FG001|Overall Study|Physician Decision|0|||
131222953|NCT01462695|472443211|FG000|Overall Study|Withdrawal by Subject|2|||
131222954|NCT01462695|472443212|FG001|Overall Study|Withdrawal by Subject|0|||
131222955|NCT01462695|472443211|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
131222956|NCT01462695|472443212|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
131222957|NCT01364298|472443214|FG000|Overall Study|Adverse Event|3|||
131222958|NCT01364298|472443215|FG001|Overall Study|Adverse Event|4|||
131222959|NCT01364298|472443214|FG000|Overall Study|Lack of adherence to treatment|1|||
131222960|NCT01364298|472443215|FG001|Overall Study|Lack of adherence to treatment|3|||
131222961|NCT01364298|472443214|FG000|Overall Study|Lack of Efficacy|1|||
131222962|NCT01364298|472443215|FG001|Overall Study|Lack of Efficacy|0|||
131222963|NCT01364298|472443214|FG000|Overall Study|Lost to Follow-up|5|||
131222964|NCT01364298|472443215|FG001|Overall Study|Lost to Follow-up|10|||
131222965|NCT01364298|472443214|FG000|Overall Study|Withdrawal by Subject|3|||
131222966|NCT01364298|472443215|FG001|Overall Study|Withdrawal by Subject|3|||
131222967|NCT01364298|472443214|FG000|Overall Study|Other|1|||
131222968|NCT01364298|472443215|FG001|Overall Study|Other|3|||
131222969|NCT03797222|472443218|FG000|Overall Study|Withdrawal by Subject|1|||
131222970|NCT00659581|472443221|FG000|Overall Study|Adverse Event|1006|||
131222971|NCT00659581|472443221|FG000|Overall Study|Lack of Efficacy|1183|||
131222972|NCT00659581|472443221|FG000|Overall Study|Other|6393|||
131222973|NCT00725725|472443222|FG000|Overall Study|Adverse Event|1|||
131222974|NCT00725725|472443223|FG001|Overall Study|Adverse Event|3|||
131222975|NCT00725725|472443224|FG002|Overall Study|Adverse Event|2|||
131222976|NCT00725725|472443222|FG000|Overall Study|Lost to Follow-up|2|||
131222977|NCT00725725|472443223|FG001|Overall Study|Lost to Follow-up|0|||
131222978|NCT00725725|472443224|FG002|Overall Study|Lost to Follow-up|2|||
131222979|NCT00725725|472443222|FG000|Overall Study|Withdrawal by Subject|1|||
131222980|NCT00725725|472443223|FG001|Overall Study|Withdrawal by Subject|0|||
131222981|NCT00725725|472443224|FG002|Overall Study|Withdrawal by Subject|1|||
131222982|NCT00725725|472443222|FG000|Overall Study|Protocol Violation|0|||
131222983|NCT00725725|472443223|FG001|Overall Study|Protocol Violation|1|||
131222984|NCT00725725|472443224|FG002|Overall Study|Protocol Violation|0|||
131222985|NCT01619085|472443228|FG000|Overall Study|Adverse Event|231|||
131222986|NCT01619085|472443228|FG000|Overall Study|Protocol Violation|4|||
131222987|NCT01619085|472443228|FG000|Overall Study|Lost to Follow-up|3|||
131222988|NCT01619085|472443228|FG000|Overall Study|Withdrawal by Subject|45|||
131222989|NCT01619085|472443228|FG000|Overall Study|Other than specified|96|||
131222990|NCT01619085|472443228|FG000|Overall Study|Not treated|1|||
131222991|NCT01619085|472443228|FG000|Overall Study|Death|145|||
131222992|NCT03125629|472443229|FG000|Overall Study|Withdrawal by Subject|2|||
131222993|NCT03125629|472443229|FG000|Overall Study|Equipment malfunction|1|||
131222994|NCT03909971|472443230|FG000|Overall Study|Other Reasons Not Specified|0|||
131222995|NCT03909971|472443231|FG001|Overall Study|Other Reasons Not Specified|1|||
131222996|NCT03909971|472443230|FG000|Overall Study|Global Deterioration of Health Status|2|||
131222997|NCT03909971|472443231|FG001|Overall Study|Global Deterioration of Health Status|1|||
131222998|NCT03909971|472443230|FG000|Overall Study|Progressive Disease|6|||
131222999|NCT03909971|472443231|FG001|Overall Study|Progressive Disease|14|||
131223000|NCT03909971|472443230|FG000|Overall Study|Death|2|||
131223001|NCT03909971|472443231|FG001|Overall Study|Death|6|||
131223002|NCT04523831|472443234|FG000|Overall Study|Lost to Follow-up|15|||
131223003|NCT04523831|472443235|FG001|Overall Study|Lost to Follow-up|17|||
131223004|NCT04523831|472443234|FG000|Overall Study|Death|0|||
131223005|NCT04523831|472443235|FG001|Overall Study|Death|3|||
131223006|NCT04523831|472443234|FG000|Overall Study|Adverse Event|2|||
131223007|NCT04523831|472443235|FG001|Overall Study|Adverse Event|0|||
131223008|NCT04556838|472443236|FG000|Overall Study|Withdrawal by Subject|3|||
131223009|NCT04556838|472443237|FG001|Overall Study|Withdrawal by Subject|1|||
131223010|NCT04556838|472443238|FG002|Overall Study|Withdrawal by Subject|2|||
131223011|NCT04556838|472443236|FG000|Overall Study|Adverse Event|0|||
131223012|NCT04556838|472443237|FG001|Overall Study|Adverse Event|1|||
131223013|NCT04556838|472443238|FG002|Overall Study|Adverse Event|1|||
131223014|NCT04556838|472443236|FG000|Overall Study|Lost to Follow-up|0|||
131223015|NCT04556838|472443237|FG001|Overall Study|Lost to Follow-up|0|||
131223016|NCT04556838|472443238|FG002|Overall Study|Lost to Follow-up|2|||
131223017|NCT04556838|472443236|FG000|Overall Study|Subject travel|0|||
131223018|NCT04556838|472443237|FG001|Overall Study|Subject travel|1|||
131223019|NCT04556838|472443238|FG002|Overall Study|Subject travel|0|||
131223020|NCT04556838|472443236|FG000|Overall Study|Physician Decision|1|||
131223021|NCT04556838|472443237|FG001|Overall Study|Physician Decision|0|||
131223022|NCT04556838|472443238|FG002|Overall Study|Physician Decision|0|||
131223023|NCT03185949|472443241|FG000|ITT Analysis|Withdrawal by Subject|4|||
131223024|NCT03185949|472443242|FG001|ITT Analysis|Withdrawal by Subject|3|||
131223025|NCT03185949|472443241|FG000|PP Analysis|Protocol Violation|2|||
131223026|NCT03185949|472443242|FG001|PP Analysis|Protocol Violation|2|||
131223027|NCT03185949|472443241|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
131223028|NCT03185949|472443242|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
131223029|NCT03053622|472444921|FG000|Overall Study|Lost to Follow-up|0|||
131223030|NCT03053622|472444922|FG001|Overall Study|Lost to Follow-up|0|||
131223031|NCT03053622|472444923|FG002|Overall Study|Lost to Follow-up|0|||
131223032|NCT03053622|472444924|FG003|Overall Study|Lost to Follow-up|1|||
131223033|NCT02598622|472444925|FG000|Overall Study|Withdrawal by Subject|3|||
131223034|NCT02598622|472444926|FG001|Overall Study|Withdrawal by Subject|0|||
131223035|NCT02598622|472444925|FG000|Overall Study|Physician Decision|3|||
131223036|NCT02598622|472444926|FG001|Overall Study|Physician Decision|0|||
131223037|NCT01355523|472444930|FG000|Overall Study|Withdrawal by Subject|1|||
131223038|NCT01355523|472444931|FG001|Overall Study|Withdrawal by Subject|4|||
131223039|NCT01355523|472444930|FG000|Overall Study|Lost to Follow-up|0|||
131223040|NCT01355523|472444931|FG001|Overall Study|Lost to Follow-up|2|||
131223041|NCT01355523|472444930|FG000|Overall Study|Protocol Violation|0|||
131223042|NCT01355523|472444931|FG001|Overall Study|Protocol Violation|2|||
131223043|NCT01355523|472444930|FG000|Overall Study|Adverse Event|0|||
131223044|NCT01355523|472444931|FG001|Overall Study|Adverse Event|2|||
131223045|NCT01835470|472444932|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
131223046|NCT01835470|472444932|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
131223047|NCT01272193|472444933|FG000|Overall Study|Adverse Event|1|||
131223048|NCT01272193|472444934|FG001|Overall Study|Adverse Event|1|||
131223049|NCT01272193|472444933|FG000|Overall Study|Lack of Efficacy|0|||
131223050|NCT01272193|472444934|FG001|Overall Study|Lack of Efficacy|3|||
131223051|NCT01272193|472444933|FG000|Overall Study|Withdrawal Criteria|1|||
131223052|NCT01272193|472444934|FG001|Overall Study|Withdrawal Criteria|1|||
131223053|NCT01272193|472444933|FG000|Overall Study|Unclassified|8|||
131223054|NCT01272193|472444934|FG001|Overall Study|Unclassified|7|||
131223055|NCT01440647|472444939|FG000|Overall Study|Death|2|||
130918359|NCT00313300|471336744|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
130918360|NCT00850343|471336745|FG000|Overall Study|Withdrawal by Subject|11|||
130918361|NCT00850343|471336746|FG001|Overall Study|Withdrawal by Subject|0|||
130918362|NCT00850343|471336747|FG002|Overall Study|Withdrawal by Subject|3|||
130918363|NCT00850343|471336748|FG003|Overall Study|Withdrawal by Subject|2|||
130918364|NCT00850343|471336745|FG000|Overall Study|Adverse Event|15|||
130918365|NCT00850343|471336746|FG001|Overall Study|Adverse Event|2|||
130918366|NCT00850343|471336747|FG002|Overall Study|Adverse Event|6|||
130918367|NCT00850343|471336748|FG003|Overall Study|Adverse Event|6|||
130918368|NCT00850343|471336745|FG000|Overall Study|Pregnancy|0|||
130918369|NCT00850343|471336746|FG001|Overall Study|Pregnancy|0|||
131119643|NCT00233363|472070240|FG001|Overall Study|Lack of Efficacy|2|||
131119644|NCT00233363|472070239|FG000|Overall Study|Withdrawal by Subject|1|||
131119645|NCT00233363|472070240|FG001|Overall Study|Withdrawal by Subject|1|||
131119646|NCT00233363|472070239|FG000|Overall Study|Aggravation of complication|1|||
131119647|NCT00233363|472070240|FG001|Overall Study|Aggravation of complication|0|||
131119648|NCT02170779|472070241|FG000|Overall Study|Withdrawal by Subject|1|||
131119649|NCT02170779|472070242|FG001|Overall Study|Withdrawal by Subject|0|||
131119650|NCT02170779|472070241|FG000|Overall Study|Lost to Follow-up|0|||
131119651|NCT02170779|472070242|FG001|Overall Study|Lost to Follow-up|1|||
131119652|NCT00369785|472070243|FG000|Overall Study|Physician Decision|3|||
130918370|NCT00850343|471336747|FG002|Overall Study|Pregnancy|0|||
130918371|NCT00850343|471336748|FG003|Overall Study|Pregnancy|1|||
130918372|NCT00850343|471336745|FG000|Overall Study|Lack of Efficacy|17|||
130918373|NCT00850343|471336746|FG001|Overall Study|Lack of Efficacy|0|||
130918374|NCT00850343|471336747|FG002|Overall Study|Lack of Efficacy|3|||
130918375|NCT00850343|471336748|FG003|Overall Study|Lack of Efficacy|2|||
130918376|NCT00850343|471336745|FG000|Overall Study|Non-compliance with Study Procedures|1|||
130918377|NCT00850343|471336746|FG001|Overall Study|Non-compliance with Study Procedures|0|||
130918378|NCT00850343|471336747|FG002|Overall Study|Non-compliance with Study Procedures|1|||
130918379|NCT00850343|471336748|FG003|Overall Study|Non-compliance with Study Procedures|1|||
131223056|NCT01440647|472444940|FG001|Overall Study|Death|3|||
131223057|NCT03627195|472444969|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
131223058|NCT03627195|472444970|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
131223059|NCT03627195|472444971|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130918380|NCT00850343|471336745|FG000|Overall Study|Physician Decision|2|||
131223060|NCT03627195|472444972|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
131223061|NCT03627195|472444973|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130699695|NCT01332968|470524726|FG007|Follow-Up Period|Lost to Follow-up|15|||
130918381|NCT00850343|471336746|FG001|Overall Study|Physician Decision|1|||
130918382|NCT00850343|471336747|FG002|Overall Study|Physician Decision|1|||
130918383|NCT00850343|471336748|FG003|Overall Study|Physician Decision|1|||
130918384|NCT02764333|471336750|FG000|Overall Study|Ineligible|1|||
131223062|NCT03627195|472444974|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
131119653|NCT00369785|472070244|FG001|Overall Study|Physician Decision|2|||
131223063|NCT04335110|472444975|FG000|Overall Study|Withdrawal by Subject|1|||
131223064|NCT04335110|472444976|FG001|Overall Study|Withdrawal by Subject|1|||
131223065|NCT04335110|472444975|FG000|Overall Study|Death|0|||
131223066|NCT04335110|472444976|FG001|Overall Study|Death|1|||
130918385|NCT01788046|471336754|FG000|Overall Study|Withdrawal by Subject|12|||
130918386|NCT01788046|471336755|FG001|Overall Study|Withdrawal by Subject|12|||
131119654|NCT00369785|472070243|FG000|Overall Study|Death|1|||
131119655|NCT00369785|472070244|FG001|Overall Study|Death|2|||
131119656|NCT00369785|472070243|FG000|Overall Study|Withdrawal by Subject|7|||
131119657|NCT00369785|472070244|FG001|Overall Study|Withdrawal by Subject|6|||
131119658|NCT00369785|472070243|FG000|Overall Study|Toxicity|6|||
131119659|NCT00369785|472070244|FG001|Overall Study|Toxicity|4|||
131119660|NCT00369785|472070243|FG000|Overall Study|Never started|0|||
131119661|NCT00369785|472070244|FG001|Overall Study|Never started|2|||
131119662|NCT00369785|472070243|FG000|Overall Study|Progression|4|||
131119663|NCT00369785|472070244|FG001|Overall Study|Progression|4|||
131119664|NCT00369785|472070243|FG000|Overall Study|Multiple reasons|6|||
131119665|NCT00369785|472070244|FG001|Overall Study|Multiple reasons|5|||
131119666|NCT02678416|472070252|FG000|Part 1|Withdrawal by Subject|1|||
131119667|NCT02678416|472070252|FG000|Part 2|Adverse Event|2|||
131119668|NCT02678416|472070252|FG000|Part 2|Withdrawal by Subject|1|||
131119669|NCT04556136|472070253|FG000|Overall Study|Lost to Follow-up|6|||
131119670|NCT04556136|472070254|FG001|Overall Study|Lost to Follow-up|6|||
131119671|NCT04556136|472070253|FG000|Overall Study|Physician Decision|2|||
131119672|NCT04556136|472070254|FG001|Overall Study|Physician Decision|1|||
131119673|NCT04556136|472070253|FG000|Overall Study|Withdrawal by Subject|2|||
131119674|NCT04556136|472070254|FG001|Overall Study|Withdrawal by Subject|1|||
131119675|NCT01848353|472070255|FG000|Phase 1|Withdrawal by Subject|3|||
131119676|NCT01848353|472070256|FG001|Phase 1|Withdrawal by Subject|1|||
131119677|NCT01848353|472070257|FG002|Phase 1|Withdrawal by Subject|0|||
131119678|NCT01848353|472070258|FG003|Phase 1|Withdrawal by Subject|0|||
131119679|NCT01848353|472070255|FG000|Phase 2|Withdrawal by Subject|3|||
131119680|NCT01848353|472070256|FG001|Phase 2|Withdrawal by Subject|2|||
131119681|NCT01848353|472070257|FG002|Phase 2|Withdrawal by Subject|0|||
131119682|NCT01848353|472070258|FG003|Phase 2|Withdrawal by Subject|0|||
131119683|NCT01848353|472070255|FG000|Phase 3|Withdrawal by Subject|1|||
131119684|NCT01848353|472070256|FG001|Phase 3|Withdrawal by Subject|1|||
131119685|NCT01848353|472070257|FG002|Phase 3|Withdrawal by Subject|0|||
131119686|NCT01848353|472070258|FG003|Phase 3|Withdrawal by Subject|0|||
131119687|NCT00935272|472070261|FG000|Overall Study|Lost to Follow-up|10|||
131119688|NCT00935272|472070262|FG001|Overall Study|Lost to Follow-up|3|||
131119689|NCT00935272|472070261|FG000|Overall Study|Withdrawal by Subject|8|||
131119690|NCT00935272|472070262|FG001|Overall Study|Withdrawal by Subject|2|||
131119691|NCT00935272|472070261|FG000|Overall Study|Physician Decision|1|||
131119692|NCT00935272|472070262|FG001|Overall Study|Physician Decision|0|||
131119693|NCT00935272|472070261|FG000|Overall Study|Protocol Violation|0|||
131119694|NCT00935272|472070262|FG001|Overall Study|Protocol Violation|1|||
131119695|NCT03492554|472070270|FG000|Overall Study|Protocol Violation|0|||
131119696|NCT03492554|472070271|FG001|Overall Study|Protocol Violation|14|||
131119697|NCT04340557|472070274|FG000|Overall Study|Transferred to ICU and/or death|1|||
131119698|NCT04340557|472070275|FG001|Overall Study|Transferred to ICU and/or death|2|||
131119699|NCT01221727|472070276|FG000|Overall Study|Physician Decision|2|||
130699696|NCT01332968|470524719|FG000|Follow-Up Period|Non-compliance|0|||
130699697|NCT01332968|470524720|FG001|Follow-Up Period|Non-compliance|0|||
130699698|NCT01332968|470524721|FG002|Follow-Up Period|Non-compliance|0|||
130918387|NCT01788046|471336754|FG000|Overall Study|Lost to Follow-up|12|||
130918388|NCT01788046|471336755|FG001|Overall Study|Lost to Follow-up|19|||
130918389|NCT01788046|471336754|FG000|Overall Study|Death|7|||
130918390|NCT01788046|471336755|FG001|Overall Study|Death|5|||
130918391|NCT01788046|471336754|FG000|Overall Study|Protocol Specified Criteria|25|||
130918392|NCT01788046|471336755|FG001|Overall Study|Protocol Specified Criteria|1|||
130918393|NCT02713204|471336758|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
130918394|NCT02713204|471336759|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130918395|NCT02713204|471336760|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
130918396|NCT02713204|471336761|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130918397|NCT02713204|471336762|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130918398|NCT02713204|471336763|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130918399|NCT02713204|471336764|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130918400|NCT02713204|471336765|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
130918401|NCT02713204|471336758|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131119700|NCT01221727|472070277|FG001|Overall Study|Physician Decision|0|||
131119701|NCT01221727|472070276|FG000|Overall Study|Withdrawal by Subject|1|||
131119702|NCT01221727|472070277|FG001|Overall Study|Withdrawal by Subject|1|||
131119703|NCT00529451|472070305|FG000|Overall Study|Subject withdrew consent|16|||
131119704|NCT00529451|472070306|FG001|Overall Study|Subject withdrew consent|21|||
130918402|NCT02713204|471336759|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131119705|NCT00529451|472070307|FG002|Overall Study|Subject withdrew consent|13|||
131119706|NCT00529451|472070308|FG003|Overall Study|Subject withdrew consent|12|||
131119707|NCT00529451|472070305|FG000|Overall Study|Adverse Event|9|||
131119708|NCT00529451|472070306|FG001|Overall Study|Adverse Event|16|||
130699699|NCT01332968|470524722|FG003|Follow-Up Period|Non-compliance|0|||
131119709|NCT00529451|472070307|FG002|Overall Study|Adverse Event|14|||
131119710|NCT00529451|472070308|FG003|Overall Study|Adverse Event|8|||
131119711|NCT00529451|472070305|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
131223067|NCT00350519|472444977|FG000|Overall Study|Death|0|||
130918403|NCT02713204|471336760|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
130918404|NCT02713204|471336761|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130918405|NCT02713204|471336762|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130918406|NCT02713204|471336763|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130918407|NCT02713204|471336764|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130918408|NCT02713204|471336765|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130918409|NCT02713204|471336758|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130918410|NCT02713204|471336759|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
130918411|NCT02713204|471336760|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130918412|NCT02713204|471336761|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130918413|NCT02713204|471336762|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130918414|NCT02713204|471336763|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130918415|NCT02713204|471336764|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130918416|NCT02713204|471336765|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130918417|NCT02713204|471336758|FG000|From Week 12 up to Week 36|Adverse Event|1|||
130918418|NCT02713204|471336759|FG001|From Week 12 up to Week 36|Adverse Event|0|||
130918419|NCT02713204|471336760|FG002|From Week 12 up to Week 36|Adverse Event|0|||
130918420|NCT02713204|471336761|FG003|From Week 12 up to Week 36|Adverse Event|1|||
130918421|NCT02713204|471336762|FG004|From Week 12 up to Week 36|Adverse Event|1|||
130918422|NCT02713204|471336763|FG005|From Week 12 up to Week 36|Adverse Event|0|||
130699700|NCT01332968|470524723|FG004|Follow-Up Period|Non-compliance|0|||
130918423|NCT02713204|471336764|FG006|From Week 12 up to Week 36|Adverse Event|2|||
130918424|NCT02713204|471336765|FG007|From Week 12 up to Week 36|Adverse Event|1|||
130918425|NCT02713204|471336758|FG000|From Week 12 up to Week 36|Death|0|||
130918426|NCT02713204|471336759|FG001|From Week 12 up to Week 36|Death|0|||
130918427|NCT02713204|471336760|FG002|From Week 12 up to Week 36|Death|0|||
130918428|NCT02713204|471336761|FG003|From Week 12 up to Week 36|Death|1|||
130918429|NCT02713204|471336762|FG004|From Week 12 up to Week 36|Death|0|||
130918430|NCT02713204|471336763|FG005|From Week 12 up to Week 36|Death|1|||
130918431|NCT02713204|471336764|FG006|From Week 12 up to Week 36|Death|0|||
130918432|NCT02713204|471336765|FG007|From Week 12 up to Week 36|Death|3|||
130918433|NCT02713204|471336758|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
130918434|NCT02713204|471336759|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
130918435|NCT02713204|471336760|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
130918436|NCT02713204|471336761|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
130918437|NCT02713204|471336762|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
130918438|NCT02713204|471336763|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
130918439|NCT02713204|471336764|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
130918440|NCT02713204|471336765|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
130918441|NCT02713204|471336758|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
130918442|NCT02713204|471336759|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
130918443|NCT02713204|471336760|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
130918444|NCT02713204|471336761|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
130918445|NCT02713204|471336762|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
130918446|NCT02713204|471336763|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
130918447|NCT02713204|471336764|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
130918448|NCT02713204|471336765|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
131033574|NCT02962895|471755392|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
131033575|NCT02962895|471755393|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
131033576|NCT02962895|471755394|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
131033577|NCT02962895|471755395|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
131033578|NCT02962895|471755396|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
131033579|NCT02962895|471755390|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131033580|NCT02962895|471755391|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131033581|NCT02962895|471755392|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131033582|NCT02962895|471755393|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131033583|NCT02962895|471755394|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131033584|NCT02962895|471755395|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
131223068|NCT00350519|472444978|FG001|Overall Study|Death|1|||
130699701|NCT01332968|470524724|FG005|Follow-Up Period|Non-compliance|0|||
130699702|NCT01332968|470524725|FG006|Follow-Up Period|Non-compliance|4|||
130918449|NCT00669396|471336766|FG000|Overall Study|Lost to Follow-up|10|||
130918450|NCT00669396|471336767|FG001|Overall Study|Lost to Follow-up|12|||
130918451|NCT04402060|471336768|FG000|Overall Study|Death|1|||
130918452|NCT04402060|471336769|FG001|Overall Study|Death|12|||
130918453|NCT04402060|471336770|FG002|Overall Study|Death|7|||
130918454|NCT04402060|471336768|FG000|Overall Study|Adverse Event|0|||
130918455|NCT04402060|471336769|FG001|Overall Study|Adverse Event|0|||
130918456|NCT04402060|471336770|FG002|Overall Study|Adverse Event|1|||
130918457|NCT04402060|471336768|FG000|Overall Study|Withdrawal by Subject|0|||
130918458|NCT04402060|471336769|FG001|Overall Study|Withdrawal by Subject|1|||
130918459|NCT04402060|471336770|FG002|Overall Study|Withdrawal by Subject|2|||
130918460|NCT04402060|471336768|FG000|Overall Study|Sponsor Request|0|||
130918461|NCT04402060|471336769|FG001|Overall Study|Sponsor Request|2|||
130918462|NCT04402060|471336770|FG002|Overall Study|Sponsor Request|0|||
130918463|NCT04402060|471336768|FG000|Overall Study|Physician Decision|0|||
130918464|NCT04402060|471336769|FG001|Overall Study|Physician Decision|0|||
130918465|NCT04402060|471336770|FG002|Overall Study|Physician Decision|1|||
130918466|NCT04402060|471336768|FG000|Overall Study|Other|0|||
130918467|NCT04402060|471336769|FG001|Overall Study|Other|1|||
130918468|NCT04402060|471336770|FG002|Overall Study|Other|0|||
130918469|NCT03386474|471336784|FG000|Overall Study|Death|1|||
130918470|NCT03386474|471336785|FG001|Overall Study|Death|0|||
130918471|NCT03386474|471336784|FG000|Overall Study|Adverse Event|0|||
130918472|NCT03386474|471336785|FG001|Overall Study|Adverse Event|1|||
130918473|NCT02155881|471336786|FG000|Overall Study|Withdrawal by Subject|0|||
130918474|NCT02155881|471336787|FG001|Overall Study|Withdrawal by Subject|2|||
130918475|NCT02155881|471336786|FG000|Overall Study|Inappropriately randomized|2|||
130918476|NCT02155881|471336787|FG001|Overall Study|Inappropriately randomized|2|||
130918477|NCT04357782|471336788|FG000|Overall Study|Discharged from hospital|1|||
130918478|NCT04357782|471336789|FG001|Overall Study|Discharged from hospital|0|||
130918479|NCT04357782|471336788|FG000|Overall Study|Death|0|||
130918480|NCT04357782|471336789|FG001|Overall Study|Death|2|||
130918481|NCT01786148|471336790|FG000|Overall Study|Lost to Follow-up|21|||
130918482|NCT01786148|471336791|FG001|Overall Study|Lost to Follow-up|13|||
130918483|NCT01786148|471336790|FG000|Overall Study|Death|0|||
130918484|NCT01786148|471336791|FG001|Overall Study|Death|1|||
130918485|NCT01786148|471336790|FG000|Overall Study|Withdrawal by Subject|0|||
130918486|NCT01786148|471336791|FG001|Overall Study|Withdrawal by Subject|7|||
130918487|NCT01786148|471336790|FG000|Overall Study|Incarceration|1|||
130918488|NCT01786148|471336791|FG001|Overall Study|Incarceration|1|||
130918489|NCT03780543|471336793|FG000|Overall Study|Adverse Event|1|||
130918490|NCT03780543|471336794|FG001|Overall Study|Adverse Event|0|||
130918491|NCT03780543|471336795|FG002|Overall Study|Adverse Event|2|||
130918492|NCT03780543|471336793|FG000|Overall Study|Lost to Follow-up|2|||
130918493|NCT03780543|471336794|FG001|Overall Study|Lost to Follow-up|0|||
130918494|NCT03780543|471336795|FG002|Overall Study|Lost to Follow-up|1|||
130918495|NCT03780543|471336793|FG000|Overall Study|Study terminated by Sponsor|8|||
130918496|NCT03780543|471336794|FG001|Overall Study|Study terminated by Sponsor|7|||
130918497|NCT03780543|471336795|FG002|Overall Study|Study terminated by Sponsor|13|||
130918498|NCT03780543|471336793|FG000|Overall Study|Withdrawal by Subject|1|||
130918499|NCT03780543|471336794|FG001|Overall Study|Withdrawal by Subject|8|||
130918500|NCT03780543|471336795|FG002|Overall Study|Withdrawal by Subject|1|||
130918501|NCT03780543|471336793|FG000|Overall Study|Noncompliance with study drug|1|||
130918502|NCT03780543|471336794|FG001|Overall Study|Noncompliance with study drug|0|||
130918503|NCT03780543|471336795|FG002|Overall Study|Noncompliance with study drug|0|||
130918504|NCT00066729|471336801|FG000|Overall Study|Lost to Follow-up|1|||
130918505|NCT00066729|471336801|FG000|Overall Study|Disease progression|1|||
130918506|NCT03896165|471336804|FG000|Overall Study|Withdrawal by Subject|2|||
130918507|NCT01811225|471336805|FG000|Treatment Period 1|Adverse Event|2|||
131119712|NCT00529451|472070306|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
131119713|NCT00529451|472070307|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
131119714|NCT00529451|472070308|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
131119715|NCT00529451|472070305|FG000|Overall Study|Lost to Follow-up|4|||
131119716|NCT00529451|472070306|FG001|Overall Study|Lost to Follow-up|7|||
131119717|NCT00529451|472070307|FG002|Overall Study|Lost to Follow-up|4|||
131119718|NCT00529451|472070308|FG003|Overall Study|Lost to Follow-up|4|||
131119719|NCT00529451|472070305|FG000|Overall Study|Protocol deviation|1|||
131119720|NCT00529451|472070306|FG001|Overall Study|Protocol deviation|1|||
131119721|NCT00529451|472070307|FG002|Overall Study|Protocol deviation|4|||
131119722|NCT00529451|472070308|FG003|Overall Study|Protocol deviation|1|||
131119723|NCT00529451|472070305|FG000|Overall Study|Administrative problems|1|||
131119724|NCT00529451|472070306|FG001|Overall Study|Administrative problems|1|||
131119725|NCT00529451|472070307|FG002|Overall Study|Administrative problems|0|||
131119726|NCT00529451|472070308|FG003|Overall Study|Administrative problems|2|||
130699703|NCT01332968|470524726|FG007|Follow-Up Period|Non-compliance|9|||
130699704|NCT01332968|470524719|FG000|Follow-Up Period|Other|0|||
130699705|NCT01332968|470524720|FG001|Follow-Up Period|Other|0|||
130699706|NCT01332968|470524721|FG002|Follow-Up Period|Other|0|||
130699707|NCT01332968|470524722|FG003|Follow-Up Period|Other|0|||
130918508|NCT01811225|471336806|FG001|Treatment Period 1|Adverse Event|3|||
130699708|NCT01332968|470524723|FG004|Follow-Up Period|Other|0|||
130918509|NCT01811225|471336805|FG000|Treatment Period 1|Lost to Follow-up|12|||
130918510|NCT01811225|471336806|FG001|Treatment Period 1|Lost to Follow-up|8|||
130918511|NCT01811225|471336805|FG000|Treatment Period 1|transporation|1|||
130918512|NCT01811225|471336806|FG001|Treatment Period 1|transporation|0|||
130918513|NCT01811225|471336805|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
130918514|NCT01811225|471336806|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
130918515|NCT01811225|471336805|FG000|Treatment Period 2|Lost to Follow-up|1|||
130918516|NCT01811225|471336806|FG001|Treatment Period 2|Lost to Follow-up|2|||
131119727|NCT00590044|472070311|FG000|Overall Study|Withdrawal by Subject|2|||
131119728|NCT00590044|472070312|FG001|Overall Study|Withdrawal by Subject|2|||
130918517|NCT01811225|471336805|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
130918518|NCT01811225|471336806|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
130918519|NCT00287365|471336807|FG000|Overall Study|sample not acquired|13|||
130918520|NCT03000569|471336808|FG000|Overall Study|Withdrawal by Subject|1|||
130918521|NCT03000569|471336809|FG001|Overall Study|Withdrawal by Subject|0|||
130918522|NCT02298023|471336812|FG000|Overall Study|Withdrawal by Subject|1|||
130918523|NCT02298023|471336813|FG001|Overall Study|Withdrawal by Subject|0|||
130918524|NCT02298023|471336814|FG002|Overall Study|Withdrawal by Subject|0|||
130918525|NCT01967173|471336815|FG000|Overall Study|Lost to Follow-up|5|||
130699709|NCT01332968|470524724|FG005|Follow-Up Period|Other|0|||
130699710|NCT01332968|470524725|FG006|Follow-Up Period|Other|18|||
130699711|NCT01332968|470524726|FG007|Follow-Up Period|Other|21|||
130918526|NCT01967173|471336816|FG001|Overall Study|Lost to Follow-up|3|||
130918527|NCT01967173|471336817|FG002|Overall Study|Lost to Follow-up|2|||
130918528|NCT01967173|471336818|FG003|Overall Study|Lost to Follow-up|4|||
130918529|NCT01967173|471336819|FG004|Overall Study|Lost to Follow-up|8|||
130918530|NCT01967173|471336820|FG005|Overall Study|Lost to Follow-up|12|||
130918531|NCT01967173|471336821|FG006|Overall Study|Lost to Follow-up|6|||
130918532|NCT01967173|471336822|FG007|Overall Study|Lost to Follow-up|8|||
130918533|NCT01967173|471336815|FG000|Overall Study|Physician Decision|2|||
130699712|NCT01332968|470524719|FG000|Follow-Up Period|Physician Decision|0|||
130699713|NCT01332968|470524720|FG001|Follow-Up Period|Physician Decision|0|||
130699714|NCT01332968|470524721|FG002|Follow-Up Period|Physician Decision|0|||
130918534|NCT01967173|471336816|FG001|Overall Study|Physician Decision|0|||
130918535|NCT01967173|471336817|FG002|Overall Study|Physician Decision|2|||
130918536|NCT01967173|471336818|FG003|Overall Study|Physician Decision|1|||
130918537|NCT01967173|471336819|FG004|Overall Study|Physician Decision|1|||
131033585|NCT02962895|471755396|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
131033586|NCT02962895|471755390|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131033587|NCT02962895|471755391|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
131033588|NCT02962895|471755392|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131033589|NCT02962895|471755393|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131033590|NCT02962895|471755394|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131033591|NCT02962895|471755395|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131033592|NCT02962895|471755396|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
131033593|NCT02962895|471755390|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131033594|NCT02962895|471755391|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131033595|NCT02962895|471755392|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131033596|NCT02962895|471755393|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131033597|NCT02962895|471755394|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
131033598|NCT02962895|471755395|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131033599|NCT02962895|471755396|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
131033600|NCT02962895|471755390|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131033601|NCT02962895|471755391|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131033602|NCT02962895|471755392|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131033603|NCT02962895|471755393|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131033604|NCT02962895|471755394|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
131033605|NCT02962895|471755395|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131033606|NCT02962895|471755396|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
131033607|NCT02962895|471755390|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
131033608|NCT02962895|471755391|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
131033609|NCT02962895|471755392|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
131033610|NCT02962895|471755393|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
131033611|NCT02962895|471755394|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
131033612|NCT02962895|471755395|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
131033613|NCT02962895|471755396|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
131033614|NCT02962895|471755390|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
131033615|NCT02962895|471755391|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
131033616|NCT02962895|471755392|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
131033617|NCT02962895|471755393|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
131033618|NCT02962895|471755394|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
131033619|NCT02962895|471755395|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
131033620|NCT02962895|471755396|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
131033621|NCT05894577|471755397|FG000|Overall Study|No receipt of study drug|14|||
131033622|NCT05894577|471755398|FG001|Overall Study|No receipt of study drug|13|||
131033623|NCT05894577|471755397|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
131033624|NCT05894577|471755398|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
131033625|NCT05894577|471755397|FG000|Overall Study|Screen Fail|2|||
130699715|NCT01332968|470524722|FG003|Follow-Up Period|Physician Decision|0|||
130699716|NCT01332968|470524723|FG004|Follow-Up Period|Physician Decision|0|||
130699717|NCT01332968|470524724|FG005|Follow-Up Period|Physician Decision|0|||
130918538|NCT01967173|471336820|FG005|Overall Study|Physician Decision|1|||
130918539|NCT01967173|471336821|FG006|Overall Study|Physician Decision|1|||
130918540|NCT01967173|471336822|FG007|Overall Study|Physician Decision|0|||
130918541|NCT01967173|471336815|FG000|Overall Study|Lack of Efficacy|2|||
130918542|NCT01967173|471336816|FG001|Overall Study|Lack of Efficacy|0|||
130918543|NCT01967173|471336817|FG002|Overall Study|Lack of Efficacy|2|||
130918544|NCT01967173|471336818|FG003|Overall Study|Lack of Efficacy|2|||
130918545|NCT01967173|471336819|FG004|Overall Study|Lack of Efficacy|0|||
130918546|NCT01967173|471336820|FG005|Overall Study|Lack of Efficacy|1|||
130918547|NCT01967173|471336821|FG006|Overall Study|Lack of Efficacy|0|||
130918548|NCT01967173|471336822|FG007|Overall Study|Lack of Efficacy|2|||
130918549|NCT01967173|471336815|FG000|Overall Study|Pregnancy|0|||
130918550|NCT01967173|471336816|FG001|Overall Study|Pregnancy|0|||
130918551|NCT01967173|471336817|FG002|Overall Study|Pregnancy|0|||
130918552|NCT01967173|471336818|FG003|Overall Study|Pregnancy|0|||
130918553|NCT01967173|471336819|FG004|Overall Study|Pregnancy|0|||
130918554|NCT01967173|471336820|FG005|Overall Study|Pregnancy|0|||
130918555|NCT01967173|471336821|FG006|Overall Study|Pregnancy|1|||
130918556|NCT01967173|471336822|FG007|Overall Study|Pregnancy|1|||
130918557|NCT01967173|471336815|FG000|Overall Study|Adverse Event|0|||
130918558|NCT01967173|471336816|FG001|Overall Study|Adverse Event|0|||
130918559|NCT01967173|471336817|FG002|Overall Study|Adverse Event|0|||
130918560|NCT01967173|471336818|FG003|Overall Study|Adverse Event|0|||
130918561|NCT01967173|471336819|FG004|Overall Study|Adverse Event|0|||
130918562|NCT01967173|471336820|FG005|Overall Study|Adverse Event|0|||
130918563|NCT01967173|471336821|FG006|Overall Study|Adverse Event|0|||
130918564|NCT01967173|471336822|FG007|Overall Study|Adverse Event|1|||
130918565|NCT01967173|471336815|FG000|Overall Study|Withdrawal by Subject|15|||
130918566|NCT01967173|471336816|FG001|Overall Study|Withdrawal by Subject|14|||
130918567|NCT01967173|471336817|FG002|Overall Study|Withdrawal by Subject|10|||
130918568|NCT01967173|471336818|FG003|Overall Study|Withdrawal by Subject|7|||
130918569|NCT01967173|471336819|FG004|Overall Study|Withdrawal by Subject|8|||
130699718|NCT01332968|470524725|FG006|Follow-Up Period|Physician Decision|12|||
130699719|NCT01332968|470524726|FG007|Follow-Up Period|Physician Decision|15|||
130918570|NCT01967173|471336820|FG005|Overall Study|Withdrawal by Subject|9|||
130918571|NCT01967173|471336821|FG006|Overall Study|Withdrawal by Subject|10|||
130918572|NCT01967173|471336822|FG007|Overall Study|Withdrawal by Subject|12|||
130918573|NCT04122534|471336828|FG000|Overall Study|Lost to Follow-up|4|||
130918574|NCT00397215|471336836|FG000|Month 0 (Day 0)|Adverse Event|0|||
130918575|NCT00397215|471336837|FG001|Month 0 (Day 0)|Adverse Event|1|||
130918576|NCT00397215|471336838|FG002|Month 0 (Day 0)|Adverse Event|0|||
130918577|NCT00397215|471336839|FG003|Month 0 (Day 0)|Adverse Event|0|||
130918578|NCT00397215|471336836|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
130918579|NCT00397215|471336837|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
130918580|NCT00397215|471336838|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
130918581|NCT00397215|471336839|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
130918582|NCT00397215|471336836|FG000|Month 0 (Day 0)|Other|4|||
130918583|NCT00397215|471336837|FG001|Month 0 (Day 0)|Other|1|||
130918584|NCT00397215|471336838|FG002|Month 0 (Day 0)|Other|3|||
130918585|NCT00397215|471336839|FG003|Month 0 (Day 0)|Other|3|||
130918586|NCT00397215|471336836|FG000|Month 6 (Day 180)|Adverse Event|0|||
131033626|NCT05894577|471755398|FG001|Overall Study|Screen Fail|0|||
131033627|NCT05894577|471755397|FG000|Overall Study|Study drug recall|86|||
131033628|NCT05894577|471755398|FG001|Overall Study|Study drug recall|63|||
131033629|NCT05481320|471755399|FG000|Overall Study|Withdrawal by Subject|1|||
131033630|NCT05481320|471755400|FG001|Overall Study|Withdrawal by Subject|1|||
131033631|NCT05481320|471755399|FG000|Overall Study|Care recipent passed away|0|||
131033632|NCT05481320|471755400|FG001|Overall Study|Care recipent passed away|1|||
131033633|NCT05481320|471755399|FG000|Overall Study|Out-of-window assessment|0|||
131033634|NCT05481320|471755400|FG001|Overall Study|Out-of-window assessment|1|||
131033635|NCT05481320|471755399|FG000|Overall Study|No longer a primary caregiver|3|||
131033636|NCT05481320|471755400|FG001|Overall Study|No longer a primary caregiver|0|||
131033637|NCT05481320|471755399|FG000|Overall Study|Unable to contact|1|||
131033638|NCT05481320|471755400|FG001|Overall Study|Unable to contact|0|||
131033639|NCT05282173|471755403|FG000|Overall Study|Missed|3|||
131033640|NCT05282173|471755404|FG001|Overall Study|Missed|2|||
131033641|NCT05282173|471755405|FG002|Overall Study|Missed|4|||
131033642|NCT03364647|471755407|FG000|Overall Study|Withdrawal by Subject|3|||
131033643|NCT03364647|471755408|FG001|Overall Study|Withdrawal by Subject|1|||
131033644|NCT03476460|471755411|FG000|Overall Study|Withdrawal by Subject|3|||
131033645|NCT03476460|471755412|FG001|Overall Study|Withdrawal by Subject|2|||
131033646|NCT03476460|471755411|FG000|Overall Study|Non-compliance with treatment|3|||
131033647|NCT03476460|471755412|FG001|Overall Study|Non-compliance with treatment|0|||
131033648|NCT03476460|471755411|FG000|Overall Study|Missing laboratory tests|5|||
131033649|NCT03476460|471755412|FG001|Overall Study|Missing laboratory tests|5|||
131033650|NCT03476460|471755411|FG000|Overall Study|Adverse Event|0|||
131033651|NCT03476460|471755412|FG001|Overall Study|Adverse Event|1|||
131033652|NCT01606215|471755417|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
131033653|NCT01606215|471755418|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
130918587|NCT00397215|471336837|FG001|Month 6 (Day 180)|Adverse Event|3|||
130918588|NCT00397215|471336838|FG002|Month 6 (Day 180)|Adverse Event|2|||
130918589|NCT00397215|471336839|FG003|Month 6 (Day 180)|Adverse Event|0|||
130918590|NCT00397215|471336836|FG000|Month 6 (Day 180)|Other|2|||
130918591|NCT00397215|471336837|FG001|Month 6 (Day 180)|Other|0|||
130918592|NCT00397215|471336838|FG002|Month 6 (Day 180)|Other|3|||
130918593|NCT00397215|471336839|FG003|Month 6 (Day 180)|Other|0|||
130918594|NCT02128932|471336840|FG000|Overall Study|Withdrawal by Subject|11|||
130918595|NCT02128932|471336841|FG001|Overall Study|Withdrawal by Subject|7|||
130918596|NCT02128932|471336842|FG002|Overall Study|Withdrawal by Subject|8|||
130918597|NCT02128932|471336840|FG000|Overall Study|Death|2|||
130918598|NCT02128932|471336841|FG001|Overall Study|Death|0|||
130918599|NCT02128932|471336842|FG002|Overall Study|Death|2|||
130918600|NCT02128932|471336840|FG000|Overall Study|Lost to Follow-up|2|||
130918601|NCT02128932|471336841|FG001|Overall Study|Lost to Follow-up|1|||
130918602|NCT02128932|471336842|FG002|Overall Study|Lost to Follow-up|1|||
130918603|NCT02128932|471336840|FG000|Overall Study|No reason for withdrawal|12|||
130918604|NCT02128932|471336841|FG001|Overall Study|No reason for withdrawal|11|||
130918605|NCT02128932|471336842|FG002|Overall Study|No reason for withdrawal|7|||
130918606|NCT01361568|471336843|FG000|Overall Study|Adverse Event|0|||
130918607|NCT01361568|471336844|FG001|Overall Study|Adverse Event|0|||
130918608|NCT01361568|471336845|FG002|Overall Study|Adverse Event|0|||
130918609|NCT01361568|471336846|FG003|Overall Study|Adverse Event|0|||
130918610|NCT01361568|471336847|FG004|Overall Study|Adverse Event|1|||
130918611|NCT01361568|471336848|FG005|Overall Study|Adverse Event|0|||
130918612|NCT01361568|471336843|FG000|Overall Study|Physician Decision|0|||
130918613|NCT01361568|471336844|FG001|Overall Study|Physician Decision|0|||
130918614|NCT01361568|471336845|FG002|Overall Study|Physician Decision|0|||
130918615|NCT01361568|471336846|FG003|Overall Study|Physician Decision|0|||
130918616|NCT01361568|471336847|FG004|Overall Study|Physician Decision|0|||
130918617|NCT01361568|471336848|FG005|Overall Study|Physician Decision|1|||
130918618|NCT01361568|471336843|FG000|Overall Study|Withdrawal by Subject|2|||
130918619|NCT01361568|471336844|FG001|Overall Study|Withdrawal by Subject|1|||
130918620|NCT01361568|471336845|FG002|Overall Study|Withdrawal by Subject|0|||
130918621|NCT01361568|471336846|FG003|Overall Study|Withdrawal by Subject|0|||
130918622|NCT01361568|471336847|FG004|Overall Study|Withdrawal by Subject|0|||
130918623|NCT01361568|471336848|FG005|Overall Study|Withdrawal by Subject|1|||
130918624|NCT00657358|471336853|FG000|Overall Study|Lack of Efficacy|6|||
130918625|NCT01254630|471336854|FG000|Overall Study|Adverse Event|36|||
130918626|NCT01254630|471336855|FG001|Overall Study|Adverse Event|15|||
130918627|NCT01254630|471336856|FG002|Overall Study|Adverse Event|40|||
130918628|NCT01254630|471336857|FG003|Overall Study|Adverse Event|8|||
130918629|NCT01254630|471336854|FG000|Overall Study|Death|461|||
130918630|NCT01254630|471336855|FG001|Overall Study|Death|151|||
130918631|NCT01254630|471336856|FG002|Overall Study|Death|478|||
130918632|NCT01254630|471336857|FG003|Overall Study|Death|139|||
130918633|NCT01254630|471336854|FG000|Overall Study|Lost to Follow-up|80|||
130918634|NCT01254630|471336855|FG001|Overall Study|Lost to Follow-up|26|||
130918635|NCT01254630|471336856|FG002|Overall Study|Lost to Follow-up|89|||
130918636|NCT01254630|471336857|FG003|Overall Study|Lost to Follow-up|32|||
130918637|NCT01254630|471336854|FG000|Overall Study|Physician Decision|24|||
130918638|NCT01254630|471336855|FG001|Overall Study|Physician Decision|8|||
130918639|NCT01254630|471336856|FG002|Overall Study|Physician Decision|16|||
130918640|NCT01254630|471336857|FG003|Overall Study|Physician Decision|7|||
130918641|NCT01254630|471336854|FG000|Overall Study|Withdrawal by Subject|201|||
130918642|NCT01254630|471336855|FG001|Overall Study|Withdrawal by Subject|94|||
130918643|NCT01254630|471336856|FG002|Overall Study|Withdrawal by Subject|188|||
130918644|NCT01254630|471336857|FG003|Overall Study|Withdrawal by Subject|89|||
130918645|NCT01254630|471336854|FG000|Overall Study|Study terminated by sponsor|0|||
130918646|NCT01254630|471336855|FG001|Overall Study|Study terminated by sponsor|994|||
130918647|NCT01254630|471336856|FG002|Overall Study|Study terminated by sponsor|0|||
130918648|NCT01254630|471336857|FG003|Overall Study|Study terminated by sponsor|1010|||
130918649|NCT01254630|471336854|FG000|Overall Study|Status not recorded|0|||
131033654|NCT04592549|471755419|FG000|Overall Study|Withdrawal by Subject|0|||
131033655|NCT04592549|471755420|FG001|Overall Study|Withdrawal by Subject|1|||
130918650|NCT01254630|471336855|FG001|Overall Study|Status not recorded|0|||
130918651|NCT01254630|471336856|FG002|Overall Study|Status not recorded|1|||
130918652|NCT01254630|471336857|FG003|Overall Study|Status not recorded|0|||
130918653|NCT02959983|471336858|FG000|Overall Study|Protocol Violation|0|||
130918654|NCT02959983|471336859|FG001|Overall Study|Protocol Violation|1|||
131033656|NCT04592549|471755421|FG002|Overall Study|Withdrawal by Subject|0|||
130918655|NCT02959983|471336858|FG000|Overall Study|Lack of Efficacy|0|||
130918656|NCT02959983|471336859|FG001|Overall Study|Lack of Efficacy|1|||
131033657|NCT04592549|471755422|FG003|Overall Study|Withdrawal by Subject|1|||
130918657|NCT02959983|471336858|FG000|Overall Study|Lost to Follow-up|12|||
130918658|NCT02959983|471336859|FG001|Overall Study|Lost to Follow-up|9|||
130918659|NCT02959983|471336858|FG000|Overall Study|Other|1|||
131033658|NCT04592549|471755423|FG004|Overall Study|Withdrawal by Subject|1|||
131033659|NCT04592549|471755424|FG005|Overall Study|Withdrawal by Subject|0|||
131033660|NCT04592549|471755419|FG000|Overall Study|Lost to Follow-up|2|||
130918660|NCT02959983|471336859|FG001|Overall Study|Other|1|||
130918661|NCT02959983|471336858|FG000|Overall Study|Physician Decision|1|||
130918662|NCT02959983|471336859|FG001|Overall Study|Physician Decision|0|||
130918663|NCT02959983|471336858|FG000|Overall Study|Adverse Event|5|||
130918664|NCT02959983|471336859|FG001|Overall Study|Adverse Event|1|||
130918665|NCT02959983|471336858|FG000|Overall Study|Withdrawal by Subject|7|||
130918666|NCT02959983|471336859|FG001|Overall Study|Withdrawal by Subject|12|||
130918667|NCT02020577|471336860|FG000|Overall Study|Progressive disease|3|||
130918668|NCT02020577|471336861|FG001|Overall Study|Progressive disease|38|||
130918669|NCT02020577|471336860|FG000|Overall Study|Other AE or clinical progression|0|||
130918670|NCT02020577|471336861|FG001|Overall Study|Other AE or clinical progression|15|||
130918671|NCT02020577|471336860|FG000|Overall Study|Withdrawal by Subject|0|||
130918672|NCT02020577|471336861|FG001|Overall Study|Withdrawal by Subject|1|||
130918673|NCT02020577|471336860|FG000|Overall Study|Other than stated above|0|||
130918674|NCT02020577|471336861|FG001|Overall Study|Other than stated above|1|||
130918675|NCT00241358|471336862|FG000|Overall Study|Determined to be not ineligible|0|||
130918676|NCT00241358|471336863|FG001|Overall Study|Determined to be not ineligible|1|||
130918677|NCT00241358|471336864|FG002|Overall Study|Determined to be not ineligible|1|||
130918678|NCT02663908|471336865|FG000|Overall Study|Withdrawal by Subject|8|||
130918679|NCT02663908|471336866|FG001|Overall Study|Withdrawal by Subject|5|||
130918680|NCT02663908|471336865|FG000|Overall Study|Lost to Follow-up|1|||
130918681|NCT02663908|471336866|FG001|Overall Study|Lost to Follow-up|5|||
130918682|NCT02663908|471336865|FG000|Overall Study|Adverse Event|13|||
130918683|NCT02663908|471336866|FG001|Overall Study|Adverse Event|11|||
130918684|NCT02663908|471336865|FG000|Overall Study|Protocol Violation|1|||
130918685|NCT02663908|471336866|FG001|Overall Study|Protocol Violation|2|||
130918686|NCT02663908|471336865|FG000|Overall Study|Lack of therapeutic response|2|||
130918687|NCT02663908|471336866|FG001|Overall Study|Lack of therapeutic response|0|||
130918688|NCT02663908|471336865|FG000|Overall Study|COVID-19|1|||
130918689|NCT02663908|471336866|FG001|Overall Study|COVID-19|0|||
130918690|NCT02663908|471336865|FG000|Overall Study|Site closed|1|||
130918691|NCT02663908|471336866|FG001|Overall Study|Site closed|0|||
130918692|NCT02663908|471336865|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
130918693|NCT02663908|471336866|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
130918694|NCT02663908|471336865|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
130918695|NCT02663908|471336866|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
130918696|NCT02663908|471336865|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
130918697|NCT02663908|471336866|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
130918698|NCT02663908|471336865|FG000|Overall Study|Death|1|||
130918699|NCT02663908|471336866|FG001|Overall Study|Death|0|||
130918700|NCT02663908|471336865|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
130918701|NCT02663908|471336866|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
130918702|NCT02663908|471336865|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
130918703|NCT02663908|471336866|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
130918704|NCT03308786|471336867|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
130918705|NCT06238362|471336871|FG000|Overall Study|Insufficient total sleep time|1|||
130918706|NCT06238362|471336872|FG001|Overall Study|Insufficient total sleep time|0|||
130918707|NCT06238362|471336871|FG000|Overall Study|Inadequate signal quality|1|||
130918708|NCT06238362|471336872|FG001|Overall Study|Inadequate signal quality|0|||
130918709|NCT05136690|471336873|FG000|Period 1|Withdrawal by Subject|0|||
130918710|NCT05136690|471336874|FG001|Period 1|Withdrawal by Subject|1|||
130918711|NCT05136690|471336873|FG000|Period 2|Lost to Follow-up|0|||
130918712|NCT05136690|471336874|FG001|Period 2|Lost to Follow-up|3|||
130918713|NCT05136690|471336873|FG000|Period 2|Withdrawal by Subject|0|||
130918714|NCT05136690|471336874|FG001|Period 2|Withdrawal by Subject|1|||
130918715|NCT01313858|471338587|FG000|Overall Study|Premature Treatment Termination|251|||
130918716|NCT01313858|471338588|FG001|Overall Study|Premature Treatment Termination|219|||
130918717|NCT01313858|471338589|FG002|Overall Study|Premature Treatment Termination|191|||
130918718|NCT01313858|471338587|FG000|Overall Study|Lost to Follow-up|35|||
131119729|NCT00590044|472070311|FG000|Overall Study|wrong insulin arm assigned|1|||
131119730|NCT00590044|472070312|FG001|Overall Study|wrong insulin arm assigned|0|||
131119731|NCT00590044|472070311|FG000|Overall Study|Protocol Violation|1|||
131119732|NCT00590044|472070312|FG001|Overall Study|Protocol Violation|0|||
131119733|NCT00773136|472070316|FG000|Overall Study|Physician Decision|2|||
131119734|NCT01010633|472070317|FG000|Overall Study|Adverse Event|1|||
131119735|NCT01010633|472070318|FG001|Overall Study|Adverse Event|1|||
131119736|NCT01010633|472070317|FG000|Overall Study|Protocol Violation|1|||
131119737|NCT01010633|472070318|FG001|Overall Study|Protocol Violation|2|||
131119738|NCT01010633|472070317|FG000|Overall Study|Withdrawal by Subject|2|||
130918719|NCT01313858|471338588|FG001|Overall Study|Lost to Follow-up|51|||
130918720|NCT01313858|471338589|FG002|Overall Study|Lost to Follow-up|47|||
131119739|NCT01010633|472070318|FG001|Overall Study|Withdrawal by Subject|1|||
131119740|NCT01010633|472070317|FG000|Overall Study|Investigator decision|0|||
131223069|NCT00350519|472444977|FG000|Overall Study|Physician Decision|0|||
130918721|NCT02899299|471338591|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
130918722|NCT02899299|471338592|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
130918723|NCT02899299|471338591|FG000|Pre-treatment|Participant withdrew consent|1|||
130918724|NCT02899299|471338592|FG001|Pre-treatment|Participant withdrew consent|11|||
130918725|NCT02899299|471338591|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
130918726|NCT02899299|471338592|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
130918727|NCT02899299|471338591|FG000|Pre-treatment|Not reported|0|||
130918728|NCT02899299|471338592|FG001|Pre-treatment|Not reported|1|||
130918729|NCT02899299|471338591|FG000|Treatment|Disease Progression|182|||
130918730|NCT02899299|471338592|FG001|Treatment|Disease Progression|43|||
130918731|NCT02899299|471338591|FG000|Treatment|Study Drug Toxicity|60|||
130918732|NCT02899299|471338592|FG001|Treatment|Study Drug Toxicity|24|||
130918733|NCT02899299|471338591|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
130918734|NCT02899299|471338592|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
130918735|NCT02899299|471338591|FG000|Treatment|Participant request to discontinue Study treatment|4|||
130918736|NCT02899299|471338592|FG001|Treatment|Participant request to discontinue Study treatment|10|||
130918737|NCT02899299|471338591|FG000|Treatment|Participant withdrew consent|6|||
130918738|NCT02899299|471338592|FG001|Treatment|Participant withdrew consent|3|||
130918739|NCT02899299|471338591|FG000|Treatment|Lost to Follow-up|0|||
130918740|NCT02899299|471338592|FG001|Treatment|Lost to Follow-up|2|||
130918741|NCT02899299|471338591|FG000|Treatment|Maximum Clinical Benefit|11|||
130918742|NCT02899299|471338592|FG001|Treatment|Maximum Clinical Benefit|2|||
130918743|NCT02899299|471338591|FG000|Treatment|Poor/Non-compliance|1|||
130918744|NCT02899299|471338592|FG001|Treatment|Poor/Non-compliance|0|||
130918745|NCT02899299|471338591|FG000|Treatment|Participant no longer meets Study criteria|4|||
130918746|NCT02899299|471338592|FG001|Treatment|Participant no longer meets Study criteria|0|||
130918747|NCT02899299|471338591|FG000|Treatment|Administrative reason by Sponsor|2|||
130918748|NCT02899299|471338592|FG001|Treatment|Administrative reason by Sponsor|0|||
130769296|NCT03420222|470780595|FG001|Overall Study|Physician Decision|1|||
130769297|NCT02334384|470780596|FG000|Overall Study|Lost to Follow-up|1|||
130769298|NCT02334384|470780597|FG001|Overall Study|Lost to Follow-up|1|||
130769299|NCT00055497|470780598|FG000|Overall Study|Adverse Event|1|||
130918749|NCT02899299|471338591|FG000|Treatment|Other reasons|12|||
131033661|NCT04592549|471755420|FG001|Overall Study|Lost to Follow-up|0|||
130769300|NCT00055497|470780599|FG001|Overall Study|Adverse Event|1|||
130769301|NCT00055497|470780600|FG002|Overall Study|Adverse Event|1|||
130769302|NCT00055497|470780601|FG003|Overall Study|Adverse Event|28|||
131033662|NCT04592549|471755421|FG002|Overall Study|Lost to Follow-up|0|||
131033663|NCT04592549|471755422|FG003|Overall Study|Lost to Follow-up|1|||
131033664|NCT04592549|471755423|FG004|Overall Study|Lost to Follow-up|1|||
131033665|NCT04592549|471755424|FG005|Overall Study|Lost to Follow-up|1|||
131033666|NCT05184192|471755425|FG000|Overall Study|Lost to Follow-up|4|||
131033667|NCT05184192|471755426|FG001|Overall Study|Lost to Follow-up|7|||
131033668|NCT05184192|471755425|FG000|Overall Study|Adverse Event|1|||
131033669|NCT05184192|471755426|FG001|Overall Study|Adverse Event|4|||
131033670|NCT05184192|471755425|FG000|Overall Study|PI withdrawal|1|||
131033671|NCT05184192|471755426|FG001|Overall Study|PI withdrawal|2|||
131033672|NCT05184192|471755425|FG000|Overall Study|Withdrew due to adverse effect|1|||
131033673|NCT05184192|471755426|FG001|Overall Study|Withdrew due to adverse effect|0|||
131033674|NCT05184192|471755425|FG000|Overall Study|Medication schedule|1|||
131033675|NCT05184192|471755426|FG001|Overall Study|Medication schedule|0|||
131033676|NCT05184192|471755425|FG000|Overall Study|Concern for adverse effects|0|||
131033677|NCT05184192|471755426|FG001|Overall Study|Concern for adverse effects|4|||
131033678|NCT04015167|471755440|FG000|Overall Study|Lost to Follow-up|40|||
131033679|NCT04015167|471755440|FG000|Overall Study|Adverse Event|5|||
131033680|NCT04015167|471755440|FG000|Overall Study|Withdrawal by Subject|2|||
131033681|NCT04015167|471755440|FG000|Overall Study|Subject went to jail|1|||
131033682|NCT03640312|471755441|FG000|Overall Study|Lost to Follow-up|3|||
131033683|NCT03640312|471755442|FG001|Overall Study|Lost to Follow-up|6|||
131033684|NCT06037369|471755451|FG000|Overall Study|Lost to Follow-up|0|||
131033685|NCT06037369|471755452|FG001|Overall Study|Lost to Follow-up|1|||
131033686|NCT04876118|471755457|FG000|Overall Study|Pregnancy|1|||
131033687|NCT04876118|471755457|FG000|Overall Study|Withdrawal by Subject|14|||
131033688|NCT05351554|471755460|FG000|Overall Study|Study terminated by sponsor|1|||
130769303|NCT00055497|470780598|FG000|Overall Study|Withdrawal by Subject|3|||
130769304|NCT00055497|470780599|FG001|Overall Study|Withdrawal by Subject|1|||
130769305|NCT00055497|470780600|FG002|Overall Study|Withdrawal by Subject|1|||
130769306|NCT00055497|470780601|FG003|Overall Study|Withdrawal by Subject|15|||
130918750|NCT02899299|471338592|FG001|Treatment|Other reasons|2|||
130918751|NCT02899299|471338591|FG000|Treatment|Not reported|7|||
131033689|NCT03774082|471755461|FG000|Overall Study|Death|6|||
131033690|NCT03774082|471755462|FG001|Overall Study|Death|3|||
131033691|NCT03774082|471755463|FG002|Overall Study|Death|2|||
131033692|NCT03774082|471755461|FG000|Overall Study|Subject decision|0|||
131033693|NCT03774082|471755462|FG001|Overall Study|Subject decision|3|||
131033694|NCT03774082|471755463|FG002|Overall Study|Subject decision|0|||
131033695|NCT03774082|471755461|FG000|Overall Study|Lost to Follow-up|2|||
130918752|NCT02899299|471338592|FG001|Treatment|Not reported|0|||
130918753|NCT02468232|471338602|FG000|Core Part of Study|Adverse Event|0|||
130918754|NCT02468232|471338603|FG001|Core Part of Study|Adverse Event|1|||
130918755|NCT02468232|471338604|FG002|Core Part of Study|Adverse Event|0|||
130918756|NCT02468232|471338605|FG003|Core Part of Study|Adverse Event|0|||
130918757|NCT02468232|471338602|FG000|Core Part of Study|Death|20|||
130918758|NCT02468232|471338603|FG001|Core Part of Study|Death|17|||
130918759|NCT02468232|471338604|FG002|Core Part of Study|Death|0|||
130918760|NCT02468232|471338605|FG003|Core Part of Study|Death|0|||
131033696|NCT03774082|471755462|FG001|Overall Study|Lost to Follow-up|0|||
131033697|NCT03774082|471755463|FG002|Overall Study|Lost to Follow-up|0|||
131033698|NCT03774082|471755461|FG000|Overall Study|Guardian decision|0|||
131033699|NCT03774082|471755462|FG001|Overall Study|Guardian decision|0|||
131033700|NCT03774082|471755463|FG002|Overall Study|Guardian decision|1|||
131033701|NCT03774082|471755461|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
131033702|NCT03774082|471755462|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
131033703|NCT03774082|471755463|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
131033704|NCT05093829|471755464|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
131033705|NCT05093829|471755465|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
131033706|NCT05093829|471755466|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
131033707|NCT05093829|471755467|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
131033708|NCT05093829|471755468|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
131033709|NCT04353661|471757252|FG000|Overall Study|Protocol Violation|0|||
131033710|NCT04353661|471757253|FG001|Overall Study|Protocol Violation|0|||
131033711|NCT04353661|471757254|FG002|Overall Study|Protocol Violation|1|||
131033712|NCT04353661|471757252|FG000|Overall Study|Study termination by the Sponsor|1|||
131033713|NCT04353661|471757253|FG001|Overall Study|Study termination by the Sponsor|1|||
131033714|NCT04353661|471757254|FG002|Overall Study|Study termination by the Sponsor|1|||
131033715|NCT00667251|471757255|FG000|Overall Study|Disease progression|232|||
131033716|NCT00667251|471757256|FG001|Overall Study|Disease progression|203|||
131033717|NCT00667251|471757255|FG000|Overall Study|Toxicity|44|||
131033718|NCT00667251|471757256|FG001|Overall Study|Toxicity|23|||
131033719|NCT00667251|471757255|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
131033720|NCT00667251|471757256|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
131033721|NCT00667251|471757255|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
131033722|NCT00667251|471757256|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
131033723|NCT00667251|471757255|FG000|Overall Study|Symptomatic progression|8|||
131033724|NCT00667251|471757256|FG001|Overall Study|Symptomatic progression|4|||
131033725|NCT00667251|471757255|FG000|Overall Study|Death|6|||
131033726|NCT00667251|471757256|FG001|Overall Study|Death|11|||
131033727|NCT00667251|471757255|FG000|Overall Study|Intercurrent illness|5|||
131033728|NCT00667251|471757256|FG001|Overall Study|Intercurrent illness|6|||
131033729|NCT00667251|471757255|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
131033730|NCT00667251|471757256|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
131033731|NCT00667251|471757255|FG000|Overall Study|Randomized not Treated|4|||
131033732|NCT00667251|471757256|FG001|Overall Study|Randomized not Treated|1|||
131033733|NCT02727699|471757257|FG000|Overall Study|Adverse Event|2|||
131033734|NCT02727699|471757258|FG001|Overall Study|Adverse Event|0|||
131033735|NCT02727699|471757257|FG000|Overall Study|Withdrawal by Subject|5|||
131033736|NCT02727699|471757258|FG001|Overall Study|Withdrawal by Subject|3|||
131033737|NCT02727699|471757257|FG000|Overall Study|Protocol Violation|0|||
131033738|NCT02727699|471757258|FG001|Overall Study|Protocol Violation|1|||
131033739|NCT02727699|471757257|FG000|Overall Study|Physician Decision|0|||
131033740|NCT02727699|471757258|FG001|Overall Study|Physician Decision|1|||
131033741|NCT02727699|471757257|FG000|Overall Study|Lost to Follow-up|1|||
131033742|NCT02727699|471757258|FG001|Overall Study|Lost to Follow-up|0|||
131033743|NCT02727699|471757257|FG000|Overall Study|Sponsor Decision|1|||
131033744|NCT02727699|471757258|FG001|Overall Study|Sponsor Decision|0|||
131033745|NCT02995434|471757263|FG000|Overall Study|Adverse Event|1|||
131033746|NCT02995434|471757264|FG001|Overall Study|Adverse Event|0|||
131033747|NCT02995434|471757263|FG000|Overall Study|Withdrawal by Subject|6|||
131033748|NCT02995434|471757264|FG001|Overall Study|Withdrawal by Subject|3|||
131033749|NCT03047928|471757265|FG000|Overall Study|Adverse Event|0|||
130918761|NCT02468232|471338602|FG000|Core Part of Study|Technical Problems|1|||
130918762|NCT02468232|471338603|FG001|Core Part of Study|Technical Problems|1|||
130918763|NCT02468232|471338604|FG002|Core Part of Study|Technical Problems|0|||
131033750|NCT03047928|471757266|FG001|Overall Study|Adverse Event|2|||
131033751|NCT03047928|471757267|FG002|Overall Study|Adverse Event|0|||
131033752|NCT03047928|471757265|FG000|Overall Study|Protocol Violation|0|||
131033753|NCT03047928|471757266|FG001|Overall Study|Protocol Violation|1|||
131033754|NCT03047928|471757267|FG002|Overall Study|Protocol Violation|0|||
131033755|NCT03047928|471757265|FG000|Overall Study|included in another protocol|0|||
131223070|NCT00350519|472444978|FG001|Overall Study|Physician Decision|1|||
130918764|NCT02468232|471338605|FG003|Core Part of Study|Technical Problems|0|||
130918765|NCT02468232|471338602|FG000|OLE Part of Study|Adverse Event|0|||
131223071|NCT00350519|472444977|FG000|Overall Study|Protocol Violation|1|||
131223072|NCT00350519|472444978|FG001|Overall Study|Protocol Violation|2|||
131223073|NCT00350519|472444977|FG000|Overall Study|Withdrawal by Subject|3|||
131033756|NCT03047928|471757266|FG001|Overall Study|included in another protocol|1|||
131033757|NCT03047928|471757267|FG002|Overall Study|included in another protocol|0|||
131033758|NCT04179500|471757268|FG000|Treatment|Withdrawal by Subject|1|||
131033759|NCT04179500|471757268|FG000|Treatment|Adverse Event|2|||
131033760|NCT04179500|471757268|FG000|Treatment|pyrazinamide resistance|1|||
131033761|NCT04492007|471757269|FG000|Overall Study|Lost to Follow-up|1|||
131033762|NCT04492007|471757270|FG001|Overall Study|Lost to Follow-up|1|||
131033763|NCT04492007|471757271|FG002|Overall Study|Lost to Follow-up|2|||
131033764|NCT04492007|471757272|FG003|Overall Study|Lost to Follow-up|2|||
131033765|NCT04492007|471757269|FG000|Overall Study|Protocol Violation|1|||
131033766|NCT04492007|471757270|FG001|Overall Study|Protocol Violation|1|||
131033767|NCT04492007|471757271|FG002|Overall Study|Protocol Violation|1|||
131033768|NCT04492007|471757272|FG003|Overall Study|Protocol Violation|1|||
131033769|NCT04492007|471757269|FG000|Overall Study|Withdrawal by Subject|0|||
131033770|NCT04492007|471757270|FG001|Overall Study|Withdrawal by Subject|0|||
131033771|NCT04492007|471757271|FG002|Overall Study|Withdrawal by Subject|1|||
131033772|NCT04492007|471757272|FG003|Overall Study|Withdrawal by Subject|1|||
131033773|NCT04177823|471757275|FG000|Overall Study|Physician Decision|1|||
131033774|NCT04177823|471757275|FG000|Overall Study|Withdrawal by Subject|1|||
131033775|NCT05178316|471757278|FG000|Overall Study|Adverse Event|5|||
131033776|NCT05178316|471757279|FG001|Overall Study|Adverse Event|4|||
131033777|NCT05178316|471757280|FG002|Overall Study|Adverse Event|9|||
131033778|NCT05178316|471757278|FG000|Overall Study|Enrolled in Error|1|||
131033779|NCT05178316|471757279|FG001|Overall Study|Enrolled in Error|2|||
131033780|NCT05178316|471757280|FG002|Overall Study|Enrolled in Error|1|||
131033781|NCT05178316|471757278|FG000|Overall Study|Lost to Follow-up|3|||
131033782|NCT05178316|471757279|FG001|Overall Study|Lost to Follow-up|15|||
131033783|NCT05178316|471757280|FG002|Overall Study|Lost to Follow-up|11|||
131033784|NCT05178316|471757278|FG000|Overall Study|Noncompliance|1|||
131033785|NCT05178316|471757279|FG001|Overall Study|Noncompliance|3|||
131033786|NCT05178316|471757280|FG002|Overall Study|Noncompliance|1|||
131033787|NCT05178316|471757278|FG000|Overall Study|Other|0|||
131033788|NCT05178316|471757279|FG001|Overall Study|Other|1|||
131033789|NCT05178316|471757280|FG002|Overall Study|Other|0|||
131033790|NCT05178316|471757278|FG000|Overall Study|Physician Decision|0|||
131033791|NCT05178316|471757279|FG001|Overall Study|Physician Decision|3|||
131033792|NCT05178316|471757280|FG002|Overall Study|Physician Decision|2|||
131033793|NCT05178316|471757278|FG000|Overall Study|Protocol deviation|1|||
131033794|NCT05178316|471757279|FG001|Overall Study|Protocol deviation|0|||
131033795|NCT05178316|471757280|FG002|Overall Study|Protocol deviation|1|||
131033796|NCT05178316|471757278|FG000|Overall Study|Sponsor decision|1|||
131033797|NCT05178316|471757279|FG001|Overall Study|Sponsor decision|0|||
131033798|NCT05178316|471757280|FG002|Overall Study|Sponsor decision|1|||
131033799|NCT05178316|471757278|FG000|Overall Study|Withdrawal by Subject|5|||
131033800|NCT05178316|471757279|FG001|Overall Study|Withdrawal by Subject|11|||
131033801|NCT05178316|471757280|FG002|Overall Study|Withdrawal by Subject|5|||
131033802|NCT03457142|471757281|FG000|Overall Study|Death|1|||
131033803|NCT04060654|471757282|FG000|Overall Study|Withdrawal by Subject|1|||
131033804|NCT04060654|471757282|FG000|Overall Study|Lost to Follow-up|5|||
131033805|NCT03707951|471757283|FG000|Overall Study|Lost to Follow-up|8|||
131033806|NCT03707951|471757284|FG001|Overall Study|Lost to Follow-up|17|||
131033807|NCT03707951|471757283|FG000|Overall Study|Withdrawal by Subject|6|||
131033808|NCT03707951|471757284|FG001|Overall Study|Withdrawal by Subject|6|||
131033809|NCT04887129|471757285|FG000|Overall Study|Lost to Follow-up|0|||
131033810|NCT04887129|471757286|FG001|Overall Study|Lost to Follow-up|24|||
131033811|NCT04887129|471757285|FG000|Overall Study|Withdrawal by Subject|9|||
131033812|NCT04887129|471757286|FG001|Overall Study|Withdrawal by Subject|57|||
131033813|NCT04887129|471757285|FG000|Overall Study|Other|2|||
131033814|NCT04887129|471757286|FG001|Overall Study|Other|9|||
131033815|NCT03792256|471757289|FG000|Overall Study|Death|0|||
131033816|NCT03792256|471757290|FG001|Overall Study|Death|1|||
131033817|NCT03792256|471757289|FG000|Overall Study|Lack of Efficacy|0|||
131033818|NCT03792256|471757290|FG001|Overall Study|Lack of Efficacy|1|||
131033819|NCT03792256|471757289|FG000|Overall Study|Withdrawal by Subject|0|||
131033820|NCT03792256|471757290|FG001|Overall Study|Withdrawal by Subject|1|||
131033821|NCT04977947|471757291|FG000|Overall Study|Lost to Follow-up|1|||
131033822|NCT04977947|471757292|FG001|Overall Study|Lost to Follow-up|1|||
131033823|NCT03436290|471757293|FG000|Overall Study|Post-randomization Exclusion|1|||
131033824|NCT03436290|471757294|FG001|Overall Study|Post-randomization Exclusion|0|||
131033825|NCT03436290|471757293|FG000|Overall Study|Death|6|||
131033826|NCT03436290|471757294|FG001|Overall Study|Death|0|||
131033827|NCT03436290|471757293|FG000|Overall Study|Withdrawal by Subject|4|||
131033828|NCT03436290|471757294|FG001|Overall Study|Withdrawal by Subject|0|||
131223074|NCT00350519|472444978|FG001|Overall Study|Withdrawal by Subject|2|||
130769307|NCT00055497|470780598|FG000|Overall Study|Lost to Follow-up|0|||
131033829|NCT03436290|471757293|FG000|Overall Study|Protocol Violation|30|||
131033830|NCT03436290|471757294|FG001|Overall Study|Protocol Violation|0|||
130918766|NCT02468232|471338603|FG001|OLE Part of Study|Adverse Event|0|||
130918767|NCT02468232|471338604|FG002|OLE Part of Study|Adverse Event|4|||
130918768|NCT02468232|471338605|FG003|OLE Part of Study|Adverse Event|5|||
130918769|NCT02468232|471338602|FG000|OLE Part of Study|Death|0|||
130918770|NCT02468232|471338603|FG001|OLE Part of Study|Death|0|||
130918771|NCT02468232|471338604|FG002|OLE Part of Study|Death|4|||
130918772|NCT02468232|471338605|FG003|OLE Part of Study|Death|2|||
131119741|NCT01010633|472070318|FG001|Overall Study|Investigator decision|1|||
131119742|NCT00888381|472070322|FG000|Overall Study|Lost to Follow-up|0|||
131119743|NCT00888381|472070323|FG001|Overall Study|Lost to Follow-up|1|||
131119744|NCT00097773|472070324|FG000|Overall Study|Lost to Follow-up|2|||
131119745|NCT00097773|472070325|FG001|Overall Study|Lost to Follow-up|2|||
131119746|NCT00097773|472070326|FG002|Overall Study|Lost to Follow-up|0|||
131119747|NCT00097773|472070327|FG003|Overall Study|Lost to Follow-up|1|||
131119748|NCT00097773|472070324|FG000|Overall Study|Physician Decision|2|||
131119749|NCT00097773|472070325|FG001|Overall Study|Physician Decision|2|||
131119750|NCT00097773|472070326|FG002|Overall Study|Physician Decision|3|||
131119751|NCT00097773|472070327|FG003|Overall Study|Physician Decision|1|||
131119752|NCT00097773|472070324|FG000|Overall Study|Withdrawal by Subject|3|||
131119753|NCT00097773|472070325|FG001|Overall Study|Withdrawal by Subject|3|||
131119754|NCT00097773|472070326|FG002|Overall Study|Withdrawal by Subject|3|||
131119755|NCT00097773|472070327|FG003|Overall Study|Withdrawal by Subject|1|||
131119756|NCT00097773|472070324|FG000|Overall Study|Adverse Event|0|||
131119757|NCT00097773|472070325|FG001|Overall Study|Adverse Event|1|||
131119758|NCT00097773|472070326|FG002|Overall Study|Adverse Event|0|||
131119759|NCT00097773|472070327|FG003|Overall Study|Adverse Event|0|||
131119760|NCT00097773|472070324|FG000|Overall Study|Other|1|||
131119761|NCT00097773|472070325|FG001|Overall Study|Other|0|||
131119762|NCT00097773|472070326|FG002|Overall Study|Other|2|||
131119763|NCT00097773|472070327|FG003|Overall Study|Other|0|||
131119764|NCT00003702|472070328|FG000|Overall Study|Ineligible cell types|2|||
131119765|NCT00003702|472070329|FG001|Overall Study|Ineligible cell types|2|||
131119766|NCT00003702|472070328|FG000|Overall Study|Did not meet criteria for persistence|8|||
131119767|NCT00003702|472070329|FG001|Overall Study|Did not meet criteria for persistence|5|||
131119768|NCT00003702|472070328|FG000|Overall Study|WHO score > 6|2|||
131119769|NCT00003702|472070329|FG001|Overall Study|WHO score > 6|1|||
131119770|NCT00003702|472070328|FG000|Overall Study|Inadequate documentation of disease|1|||
131119771|NCT00003702|472070329|FG001|Overall Study|Inadequate documentation of disease|3|||
131119772|NCT01009034|472070330|FG000|Overall Study|Lost to Follow-up|2|||
131119773|NCT01009034|472070330|FG000|Overall Study|Withdrawal by Subject|2|||
131119774|NCT01494350|472070331|FG000|Overall Study|Worsening of lesion|1|||
131119775|NCT02054325|472070333|FG000|Overall Study|Lost to Follow-up|8|||
131119776|NCT02054325|472070334|FG001|Overall Study|Lost to Follow-up|5|||
131119777|NCT00617604|472070335|FG000|Overall Study|Death|2|||
131119778|NCT00617604|472070336|FG001|Overall Study|Death|1|||
131119779|NCT00617604|472070335|FG000|Overall Study|Lost to Follow-up|1|||
131119780|NCT00617604|472070336|FG001|Overall Study|Lost to Follow-up|0|||
131119781|NCT00617604|472070335|FG000|Overall Study|Miscellaneous Reasons|8|||
131119782|NCT00617604|472070336|FG001|Overall Study|Miscellaneous Reasons|10|||
131119783|NCT00617604|472070335|FG000|Overall Study|Withdrawal by Subject|4|||
131119784|NCT00617604|472070336|FG001|Overall Study|Withdrawal by Subject|6|||
131119785|NCT00617604|472070335|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
131119786|NCT00617604|472070336|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
131119787|NCT03250832|472070337|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
131119788|NCT03250832|472070338|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
131119789|NCT03250832|472070339|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
131119790|NCT03250832|472070340|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
131119791|NCT03250832|472070341|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
131119792|NCT03250832|472070342|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
131119793|NCT03250832|472070343|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
131119794|NCT03250832|472070344|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
131119795|NCT03250832|472070345|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
131119796|NCT03250832|472070346|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
131119797|NCT03250832|472070347|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
131119798|NCT03250832|472070348|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
131119799|NCT03250832|472070337|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
131119800|NCT03250832|472070338|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
131119801|NCT03250832|472070339|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
131119802|NCT03250832|472070340|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
131119803|NCT03250832|472070341|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
131119804|NCT03250832|472070342|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
131119805|NCT03250832|472070343|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
131119806|NCT03250832|472070344|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
131119807|NCT03250832|472070345|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130918773|NCT02468232|471338602|FG000|OLE Part of Study|Physician Decision|0|||
130918774|NCT02468232|471338603|FG001|OLE Part of Study|Physician Decision|0|||
130918775|NCT02468232|471338604|FG002|OLE Part of Study|Physician Decision|4|||
130918776|NCT02468232|471338605|FG003|OLE Part of Study|Physician Decision|0|||
130918777|NCT02468232|471338602|FG000|OLE Part of Study|Subject/Guardian decision|0|||
130918778|NCT02468232|471338603|FG001|OLE Part of Study|Subject/Guardian decision|0|||
130918779|NCT02468232|471338604|FG002|OLE Part of Study|Subject/Guardian decision|2|||
131119808|NCT03250832|472070346|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
131119809|NCT03250832|472070347|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
131119810|NCT03250832|472070348|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
131119811|NCT03250832|472070337|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119812|NCT03250832|472070338|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119813|NCT03250832|472070339|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
131119814|NCT03250832|472070340|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119815|NCT03250832|472070341|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119816|NCT03250832|472070342|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119817|NCT03250832|472070343|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119818|NCT03250832|472070344|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119819|NCT03250832|472070345|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119820|NCT03250832|472070346|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119821|NCT03250832|472070347|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119822|NCT03250832|472070348|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
131119823|NCT03250832|472070337|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119824|NCT03250832|472070338|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119825|NCT03250832|472070339|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119826|NCT03250832|472070340|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119827|NCT03250832|472070341|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119828|NCT03250832|472070342|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119829|NCT03250832|472070343|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119830|NCT03250832|472070344|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
131119831|NCT03250832|472070345|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119832|NCT03250832|472070346|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119833|NCT03250832|472070347|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119834|NCT03250832|472070348|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
131119835|NCT03250832|472070337|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119836|NCT03250832|472070338|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119837|NCT03250832|472070339|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119838|NCT03250832|472070340|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119839|NCT03250832|472070341|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119840|NCT03250832|472070342|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119841|NCT03250832|472070343|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119842|NCT03250832|472070344|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
131119843|NCT03250832|472070345|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119844|NCT03250832|472070346|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119845|NCT03250832|472070347|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119846|NCT03250832|472070348|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
131119847|NCT03250832|472070337|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131119848|NCT03250832|472070338|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131119849|NCT03250832|472070339|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131119850|NCT03250832|472070340|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131119851|NCT03250832|472070341|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130918780|NCT02468232|471338605|FG003|OLE Part of Study|Subject/Guardian decision|5|||
130918781|NCT00506662|471338606|FG000|Overall Study|Adverse Event|0|||
130918782|NCT00506662|471338607|FG001|Overall Study|Adverse Event|2|||
130918783|NCT00506662|471338606|FG000|Overall Study|Lack of Efficacy|1|||
130918784|NCT00506662|471338607|FG001|Overall Study|Lack of Efficacy|0|||
130918785|NCT00506662|471338606|FG000|Overall Study|Protocol Violation|2|||
130918786|NCT00506662|471338607|FG001|Overall Study|Protocol Violation|4|||
130918787|NCT00506662|471338606|FG000|Overall Study|Trial terminated|10|||
130918788|NCT00506662|471338607|FG001|Overall Study|Trial terminated|16|||
130918789|NCT00506662|471338606|FG000|Overall Study|Not recorded|4|||
131119852|NCT03250832|472070342|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131119853|NCT03250832|472070343|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131119854|NCT03250832|472070344|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
131119855|NCT03250832|472070345|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130918790|NCT00506662|471338607|FG001|Overall Study|Not recorded|6|||
130918791|NCT00246753|471338610|FG000|Overall Study|Withdrawal by Subject|2|||
130918792|NCT00246753|471338610|FG000|Overall Study|Physician Decision|2|||
130918793|NCT00246753|471338610|FG000|Overall Study|Adverse Event|2|||
130918794|NCT00246753|471338610|FG000|Overall Study|Unacceptable toxicity|2|||
130918795|NCT00617851|471338614|FG000|Overall Study|Death|0|||
130918796|NCT00617851|471338615|FG001|Overall Study|Death|0|||
130918797|NCT00617851|471338616|FG002|Overall Study|Death|0|||
130918798|NCT00617851|471338617|FG003|Overall Study|Death|1|||
130918799|NCT00617851|471338614|FG000|Overall Study|Withdrawal by Subject|14|||
130918800|NCT00617851|471338615|FG001|Overall Study|Withdrawal by Subject|7|||
130918801|NCT00617851|471338616|FG002|Overall Study|Withdrawal by Subject|12|||
130918802|NCT00617851|471338617|FG003|Overall Study|Withdrawal by Subject|4|||
130918803|NCT00617851|471338614|FG000|Overall Study|Lost to Follow-up|27|||
130918804|NCT00617851|471338615|FG001|Overall Study|Lost to Follow-up|29|||
130918805|NCT00617851|471338616|FG002|Overall Study|Lost to Follow-up|31|||
130918806|NCT00617851|471338617|FG003|Overall Study|Lost to Follow-up|19|||
130918807|NCT00617851|471338614|FG000|Overall Study|Inappropriate Enrollment|5|||
130918808|NCT00617851|471338615|FG001|Overall Study|Inappropriate Enrollment|4|||
130918809|NCT00617851|471338616|FG002|Overall Study|Inappropriate Enrollment|1|||
130918810|NCT00617851|471338617|FG003|Overall Study|Inappropriate Enrollment|1|||
130918811|NCT00617851|471338614|FG000|Overall Study|Unable to classify|1|||
130918812|NCT00617851|471338615|FG001|Overall Study|Unable to classify|0|||
130918813|NCT00617851|471338616|FG002|Overall Study|Unable to classify|1|||
130918814|NCT00617851|471338617|FG003|Overall Study|Unable to classify|0|||
130918815|NCT01200524|471338618|FG000|Overall Study|Withdrawal by Subject|1|||
130918816|NCT01200524|471338619|FG001|Overall Study|Withdrawal by Subject|1|||
130918817|NCT01200524|471338620|FG002|Overall Study|Withdrawal by Subject|3|||
131033831|NCT04274764|471757295|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
131033832|NCT04274764|471757296|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
131033833|NCT02677298|471757301|FG000|Double Blind Phase|Adverse Event|2|||
131033834|NCT02677298|471757302|FG001|Double Blind Phase|Adverse Event|1|||
131033835|NCT02677298|471757303|FG002|Double Blind Phase|Adverse Event|0|||
131033836|NCT02677298|471757301|FG000|Double Blind Phase|Physician Decision|5|||
131033837|NCT02677298|471757302|FG001|Double Blind Phase|Physician Decision|0|||
131033838|NCT02677298|471757303|FG002|Double Blind Phase|Physician Decision|0|||
131033839|NCT02677298|471757301|FG000|Double Blind Phase|Lost to Follow-up|11|||
131033840|NCT02677298|471757302|FG001|Double Blind Phase|Lost to Follow-up|7|||
131033841|NCT02677298|471757303|FG002|Double Blind Phase|Lost to Follow-up|0|||
131033842|NCT02677298|471757301|FG000|Double Blind Phase|Withdrawal by Subject|11|||
131033843|NCT02677298|471757302|FG001|Double Blind Phase|Withdrawal by Subject|8|||
131033844|NCT02677298|471757303|FG002|Double Blind Phase|Withdrawal by Subject|0|||
131033845|NCT02677298|471757301|FG000|Double Blind Phase|No study drug available at site|0|||
131033846|NCT02677298|471757302|FG001|Double Blind Phase|No study drug available at site|1|||
131033847|NCT02677298|471757303|FG002|Double Blind Phase|No study drug available at site|0|||
131033848|NCT02677298|471757301|FG000|Open Label Phase|Adverse Event|0|||
131033849|NCT02677298|471757302|FG001|Open Label Phase|Adverse Event|0|||
131033850|NCT02677298|471757303|FG002|Open Label Phase|Adverse Event|4|||
131033851|NCT02677298|471757301|FG000|Open Label Phase|Physician Decision|0|||
131033852|NCT02677298|471757302|FG001|Open Label Phase|Physician Decision|0|||
131033853|NCT02677298|471757303|FG002|Open Label Phase|Physician Decision|1|||
131033854|NCT02677298|471757301|FG000|Open Label Phase|Lost to Follow-up|0|||
131033855|NCT02677298|471757302|FG001|Open Label Phase|Lost to Follow-up|0|||
131033856|NCT02677298|471757303|FG002|Open Label Phase|Lost to Follow-up|17|||
131033857|NCT02677298|471757301|FG000|Open Label Phase|Withdrawal by Subject|0|||
131033858|NCT02677298|471757302|FG001|Open Label Phase|Withdrawal by Subject|0|||
131033859|NCT02677298|471757303|FG002|Open Label Phase|Withdrawal by Subject|38|||
131033860|NCT03611621|471757317|FG000|Overall Study|Graft loss|3|||
131033861|NCT03611621|471757317|FG000|Overall Study|Death|3|||
131033862|NCT03611621|471757317|FG000|Overall Study|Lost to Follow-up|1|||
131033863|NCT03039023|471757318|FG000|Overall Study|Withdrawal by Subject|1|||
131033864|NCT03039023|471757319|FG001|Overall Study|Withdrawal by Subject|0|||
131033865|NCT03039023|471757320|FG002|Overall Study|Withdrawal by Subject|1|||
131033866|NCT03039023|471757321|FG003|Overall Study|Withdrawal by Subject|1|||
131033867|NCT03039023|471757322|FG004|Overall Study|Withdrawal by Subject|0|||
131033868|NCT03039023|471757318|FG000|Overall Study|Physician Decision|0|||
131033869|NCT03039023|471757319|FG001|Overall Study|Physician Decision|0|||
131033870|NCT03039023|471757320|FG002|Overall Study|Physician Decision|0|||
131033871|NCT03039023|471757321|FG003|Overall Study|Physician Decision|1|||
131033872|NCT03039023|471757322|FG004|Overall Study|Physician Decision|0|||
130918818|NCT01200524|471338618|FG000|Overall Study|Adverse Event|1|||
131033873|NCT04130438|471757323|FG000|Overall Study|Lost to Follow-up|0|||
131033874|NCT04130438|471757324|FG001|Overall Study|Lost to Follow-up|0|||
131033875|NCT04130438|471757325|FG002|Overall Study|Lost to Follow-up|1|||
131033876|NCT04142788|471757327|FG000|Overall Study|Trial terminated prematurely|2|||
131033877|NCT04142788|471757328|FG001|Overall Study|Trial terminated prematurely|2|||
130918819|NCT01200524|471338619|FG001|Overall Study|Adverse Event|0|||
130918820|NCT01200524|471338620|FG002|Overall Study|Adverse Event|0|||
130918821|NCT01200524|471338618|FG000|Overall Study|Non availability of study nurse|0|||
130918822|NCT01200524|471338619|FG001|Overall Study|Non availability of study nurse|0|||
130918823|NCT01200524|471338620|FG002|Overall Study|Non availability of study nurse|1|||
130918824|NCT01303861|471338621|FG000|Overall Study|Lost to Follow-up|34|||
130918825|NCT01303861|471338622|FG001|Overall Study|Lost to Follow-up|14|||
130918826|NCT01303861|471338623|FG002|Overall Study|Lost to Follow-up|27|||
130918827|NCT01303861|471338624|FG003|Overall Study|Lost to Follow-up|31|||
130918828|NCT01303861|471338621|FG000|Overall Study|Lack of Efficacy|3|||
130918829|NCT01303861|471338622|FG001|Overall Study|Lack of Efficacy|2|||
130918830|NCT01303861|471338623|FG002|Overall Study|Lack of Efficacy|1|||
130918831|NCT01303861|471338624|FG003|Overall Study|Lack of Efficacy|0|||
130918832|NCT01303861|471338621|FG000|Overall Study|Withdrawal by Subject|16|||
130918833|NCT01303861|471338622|FG001|Overall Study|Withdrawal by Subject|8|||
130918834|NCT01303861|471338623|FG002|Overall Study|Withdrawal by Subject|8|||
130918835|NCT01303861|471338624|FG003|Overall Study|Withdrawal by Subject|23|||
130918836|NCT01303861|471338621|FG000|Overall Study|Adverse Event|4|||
130918837|NCT01303861|471338622|FG001|Overall Study|Adverse Event|1|||
130918838|NCT01303861|471338623|FG002|Overall Study|Adverse Event|0|||
130918839|NCT01303861|471338624|FG003|Overall Study|Adverse Event|5|||
131119856|NCT03250832|472070346|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130918840|NCT01303861|471338621|FG000|Overall Study|Pregnancy|1|||
130918841|NCT01303861|471338622|FG001|Overall Study|Pregnancy|0|||
130918842|NCT01303861|471338623|FG002|Overall Study|Pregnancy|0|||
130918843|NCT01303861|471338624|FG003|Overall Study|Pregnancy|0|||
131033878|NCT05516147|471757334|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
131033879|NCT04764448|471757336|FG000|Overall Study|Study terminated by sponsor|2|||
131033880|NCT04764448|471757337|FG001|Overall Study|Study terminated by sponsor|2|||
131033881|NCT04764448|471757338|FG002|Overall Study|Study terminated by sponsor|5|||
131033882|NCT04764448|471757336|FG000|Overall Study|Withdrawal by Subject|3|||
131033883|NCT04764448|471757337|FG001|Overall Study|Withdrawal by Subject|3|||
131033884|NCT04764448|471757338|FG002|Overall Study|Withdrawal by Subject|1|||
131033885|NCT04322643|471757348|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
131033886|NCT03891667|471757353|FG000|Overall Study|Physician Decision|1|||
131033887|NCT03891667|471757354|FG001|Overall Study|Physician Decision|1|||
131033888|NCT03891667|471757353|FG000|Overall Study|COVID related pause|1|||
131033889|NCT03891667|471757354|FG001|Overall Study|COVID related pause|0|||
131033890|NCT03891667|471757353|FG000|Overall Study|Withdrawal by Subject|0|||
131033891|NCT03891667|471757354|FG001|Overall Study|Withdrawal by Subject|1|||
131033892|NCT03891667|471757353|FG000|Overall Study|Adverse Event|0|||
131033893|NCT03891667|471757354|FG001|Overall Study|Adverse Event|1|||
131033894|NCT02924272|471757367|FG000|Overall Study|Site Terminated by Sponsor|4|||
131033895|NCT02924272|471757368|FG001|Overall Study|Site Terminated by Sponsor|1|||
131033896|NCT02924272|471757367|FG000|Overall Study|Withdrawal by Subject|2|||
131033897|NCT02924272|471757368|FG001|Overall Study|Withdrawal by Subject|0|||
131033898|NCT02924272|471757367|FG000|Overall Study|Adverse Event|3|||
131033899|NCT02924272|471757368|FG001|Overall Study|Adverse Event|0|||
131033900|NCT02924272|471757367|FG000|Overall Study|Progressive Disease|11|||
131033901|NCT02924272|471757368|FG001|Overall Study|Progressive Disease|8|||
131033902|NCT02924272|471757367|FG000|Overall Study|Clinical Deterioration|1|||
131033903|NCT02924272|471757368|FG001|Overall Study|Clinical Deterioration|0|||
131033904|NCT02924272|471757367|FG000|Overall Study|Death|1|||
131033905|NCT02924272|471757368|FG001|Overall Study|Death|0|||
131033906|NCT02924272|471757367|FG000|Overall Study|Reason Not Specified|1|||
131033907|NCT02924272|471757368|FG001|Overall Study|Reason Not Specified|0|||
131033908|NCT04952909|471757375|FG000|Overall Study|Death|3|||
131033909|NCT05308004|471757376|FG000|Overall Study|Not seen by Palliative Care NP|0|||
131033910|NCT05308004|471757377|FG001|Overall Study|Not seen by Palliative Care NP|1|||
131033911|NCT03575897|471757378|FG000|Overall Study|Lost to Follow-up|12|||
131033912|NCT03575897|471757379|FG001|Overall Study|Lost to Follow-up|13|||
131033913|NCT03652688|471757386|FG000|Baseline|Withdrawal by Subject|0|||
131033914|NCT03652688|471757387|FG001|Baseline|Withdrawal by Subject|3|||
131033915|NCT03652688|471757386|FG000|Follow-up|Lost to Follow-up|56|||
131033916|NCT03652688|471757387|FG001|Follow-up|Lost to Follow-up|54|||
131033917|NCT03468218|471757388|FG000|Overall Study|Adverse Event|5|||
131033918|NCT03468218|471757388|FG000|Overall Study|Progressive Disease|16|||
131033919|NCT03468218|471757388|FG000|Overall Study|Death|1|||
131033920|NCT03468218|471757388|FG000|Overall Study|Alternate therapy|1|||
131033921|NCT03468218|471757388|FG000|Overall Study|Withdrawal by Subject|2|||
131033922|NCT03719443|471757389|FG000|Overall Study|Lost to Follow-up|0|||
131033923|NCT03719443|471757390|FG001|Overall Study|Lost to Follow-up|0|||
131033924|NCT03719443|471757391|FG002|Overall Study|Lost to Follow-up|1|||
131033925|NCT03719443|471757392|FG003|Overall Study|Lost to Follow-up|0|||
131033926|NCT03719443|471757393|FG004|Overall Study|Lost to Follow-up|1|||
131033927|NCT03719443|471757394|FG005|Overall Study|Lost to Follow-up|0|||
131033928|NCT03719443|471757395|FG006|Overall Study|Lost to Follow-up|1|||
131033929|NCT03719443|471757389|FG000|Overall Study|Withdrawal by Subject|0|||
131033930|NCT03719443|471757390|FG001|Overall Study|Withdrawal by Subject|0|||
131033931|NCT03719443|471757391|FG002|Overall Study|Withdrawal by Subject|1|||
131033932|NCT03719443|471757392|FG003|Overall Study|Withdrawal by Subject|0|||
130918844|NCT02476201|471338627|FG000|Overall Study|Unable to program MPP|9|||
131223075|NCT02595528|472444979|FG000|Overall Study|Withdrawal by Subject|1|||
131223076|NCT02595528|472444980|FG001|Overall Study|Withdrawal by Subject|2|||
131223077|NCT02595528|472444981|FG002|Overall Study|Withdrawal by Subject|1|||
131223078|NCT02595528|472444982|FG003|Overall Study|Withdrawal by Subject|3|||
130918845|NCT02476201|471338627|FG000|Overall Study|Study echo not performed|5|||
130918846|NCT02476201|471338627|FG000|Overall Study|Adverse Event|4|||
130918847|NCT02476201|471338627|FG000|Overall Study|Death|2|||
130918848|NCT02476201|471338627|FG000|Overall Study|Lost to Follow-up|2|||
130918849|NCT02476201|471338627|FG000|Overall Study|MPP programmed to OFF|2|||
130918850|NCT02476201|471338627|FG000|Overall Study|Withdrawal by Subject|1|||
131223079|NCT02595528|472444979|FG000|Overall Study|Lost to Follow-up|1|||
131223080|NCT02595528|472444980|FG001|Overall Study|Lost to Follow-up|1|||
131223081|NCT02595528|472444981|FG002|Overall Study|Lost to Follow-up|0|||
131223082|NCT02595528|472444982|FG003|Overall Study|Lost to Follow-up|1|||
131223083|NCT00096382|472444983|FG000|Overall Study|Not treated|1|||
131223084|NCT00096382|472444984|FG001|Overall Study|Not treated|0|||
131223085|NCT00096382|472444983|FG000|Overall Study|Death during treatment|1|||
131223086|NCT00096382|472444984|FG001|Overall Study|Death during treatment|0|||
131223087|NCT03862625|472444994|FG000|Overall Study|Lost to Follow-up|0|||
131223088|NCT03862625|472444995|FG001|Overall Study|Lost to Follow-up|1|||
131223089|NCT01326702|472444996|FG000|Overall Study|Other|1|||
131223090|NCT01326702|472444997|FG001|Overall Study|Other|0|||
131223091|NCT01326702|472444998|FG002|Overall Study|Other|0|||
131223092|NCT01326702|472444999|FG003|Overall Study|Other|0|||
131223093|NCT01326702|472445000|FG004|Overall Study|Other|0|||
131223094|NCT01326702|472445001|FG005|Overall Study|Other|1|||
131223095|NCT01326702|472445002|FG006|Overall Study|Other|0|||
131223096|NCT01326702|472444996|FG000|Overall Study|progressive disease|1|||
131223097|NCT01326702|472444997|FG001|Overall Study|progressive disease|1|||
131223098|NCT01326702|472444998|FG002|Overall Study|progressive disease|3|||
131223099|NCT01326702|472444999|FG003|Overall Study|progressive disease|1|||
131223100|NCT01326702|472445000|FG004|Overall Study|progressive disease|3|||
131223101|NCT01326702|472445001|FG005|Overall Study|progressive disease|2|||
131223102|NCT01326702|472445002|FG006|Overall Study|progressive disease|3|||
131223103|NCT01326702|472444996|FG000|Overall Study|Death|0|||
131223104|NCT01326702|472444997|FG001|Overall Study|Death|1|||
131223105|NCT01326702|472444998|FG002|Overall Study|Death|0|||
131223106|NCT01326702|472444999|FG003|Overall Study|Death|0|||
131223107|NCT01326702|472445000|FG004|Overall Study|Death|0|||
131223108|NCT01326702|472445001|FG005|Overall Study|Death|0|||
131223109|NCT01326702|472445002|FG006|Overall Study|Death|0|||
131223110|NCT01326702|472444996|FG000|Overall Study|Adverse Event|0|||
131223111|NCT01326702|472444997|FG001|Overall Study|Adverse Event|0|||
131223112|NCT01326702|472444998|FG002|Overall Study|Adverse Event|1|||
131223113|NCT01326702|472444999|FG003|Overall Study|Adverse Event|1|||
131223114|NCT01326702|472445000|FG004|Overall Study|Adverse Event|0|||
131223115|NCT01326702|472445001|FG005|Overall Study|Adverse Event|3|||
131223116|NCT01326702|472445002|FG006|Overall Study|Adverse Event|1|||
131223117|NCT01326702|472444996|FG000|Overall Study|Withdrawal by Subject|0|||
131223118|NCT01326702|472444997|FG001|Overall Study|Withdrawal by Subject|0|||
130918851|NCT02476201|471338627|FG000|Overall Study|Unsuccessful implant|1|||
130918852|NCT00691301|471338628|FG000|Overall Study|Adverse Event|10|||
130918853|NCT00691301|471338628|FG000|Overall Study|Death|2|||
130918854|NCT00691301|471338628|FG000|Overall Study|Lack of Efficacy|32|||
130918855|NCT00691301|471338628|FG000|Overall Study|Withdrawal by Subject|4|||
130918856|NCT00691301|471338628|FG000|Overall Study|Concurrent illness|2|||
131223119|NCT01326702|472444998|FG002|Overall Study|Withdrawal by Subject|1|||
131223120|NCT01326702|472444999|FG003|Overall Study|Withdrawal by Subject|0|||
131223121|NCT01326702|472445000|FG004|Overall Study|Withdrawal by Subject|1|||
131223122|NCT01326702|472445001|FG005|Overall Study|Withdrawal by Subject|1|||
130918857|NCT00691301|471338628|FG000|Overall Study|other reason|3|||
130918858|NCT00691301|471338628|FG000|Overall Study|Did not initiate study treatment|1|||
130918859|NCT01823146|471338629|FG000|Overall Study|Withdrawal by Subject|0|||
131223123|NCT01326702|472445002|FG006|Overall Study|Withdrawal by Subject|3|||
130769308|NCT00055497|470780599|FG001|Overall Study|Lost to Follow-up|1|||
131223124|NCT01326702|472444996|FG000|Overall Study|Not Treated|0|||
131223125|NCT01326702|472444997|FG001|Overall Study|Not Treated|0|||
131223126|NCT01326702|472444998|FG002|Overall Study|Not Treated|0|||
131223127|NCT01326702|472444999|FG003|Overall Study|Not Treated|1|||
131223128|NCT01326702|472445000|FG004|Overall Study|Not Treated|0|||
131223129|NCT01326702|472445001|FG005|Overall Study|Not Treated|1|||
131223130|NCT01326702|472445002|FG006|Overall Study|Not Treated|0|||
131223131|NCT00856778|472445011|FG000|Overall Study|Adverse Event|7|||
131223132|NCT00856778|472445011|FG000|Overall Study|Withdrawal by Subject|10|||
130769309|NCT00055497|470780600|FG002|Overall Study|Lost to Follow-up|0|||
130918860|NCT01823146|471338630|FG001|Overall Study|Withdrawal by Subject|1|||
130918861|NCT01823146|471338629|FG000|Overall Study|Lost to Follow-up|2|||
130918862|NCT01823146|471338630|FG001|Overall Study|Lost to Follow-up|1|||
131223133|NCT00856778|472445011|FG000|Overall Study|Study deviation|2|||
131223134|NCT00856778|472445011|FG000|Overall Study|Lost to Follow-up|5|||
131223135|NCT03333382|472445014|FG000|Overall Study|Lost to Follow-up|1|||
130918863|NCT00463580|471338631|FG000|Overall Study|Lost to Follow-up|1|||
130918864|NCT00463580|471338632|FG001|Overall Study|Lost to Follow-up|0|||
130918865|NCT00463580|471338631|FG000|Overall Study|Schedule conflict|2|||
130918866|NCT00463580|471338632|FG001|Overall Study|Schedule conflict|0|||
130918867|NCT00463580|471338631|FG000|Overall Study|Medical/psychiatric complications|0|||
130918868|NCT00463580|471338632|FG001|Overall Study|Medical/psychiatric complications|2|||
130918869|NCT03917459|471338634|FG000|Overall Study|Adverse Event|1|||
130918870|NCT03917459|471338635|FG001|Overall Study|Adverse Event|0|||
130918871|NCT03917459|471338634|FG000|Overall Study|Withdrawal by Subject|0|||
130918872|NCT03917459|471338635|FG001|Overall Study|Withdrawal by Subject|1|||
130918873|NCT00491764|471338636|FG000|Overall Study|Adverse Event|1|||
130918874|NCT00491764|471338637|FG001|Overall Study|Adverse Event|2|||
130918875|NCT00491764|471338638|FG002|Overall Study|Adverse Event|4|||
130918876|NCT00491764|471338639|FG003|Overall Study|Adverse Event|4|||
130918877|NCT00491764|471338640|FG004|Overall Study|Adverse Event|0|||
130918878|NCT00491764|471338641|FG005|Overall Study|Adverse Event|1|||
130918879|NCT00491764|471338636|FG000|Overall Study|Lost to Follow-up|0|||
130918880|NCT00491764|471338637|FG001|Overall Study|Lost to Follow-up|1|||
130918881|NCT00491764|471338638|FG002|Overall Study|Lost to Follow-up|0|||
130918882|NCT00491764|471338639|FG003|Overall Study|Lost to Follow-up|1|||
130918883|NCT00491764|471338640|FG004|Overall Study|Lost to Follow-up|0|||
130918884|NCT00491764|471338641|FG005|Overall Study|Lost to Follow-up|3|||
130918885|NCT00491764|471338636|FG000|Overall Study|Withdrawal by Subject|2|||
130918886|NCT00491764|471338637|FG001|Overall Study|Withdrawal by Subject|3|||
130918887|NCT00491764|471338638|FG002|Overall Study|Withdrawal by Subject|1|||
130918888|NCT00491764|471338639|FG003|Overall Study|Withdrawal by Subject|2|||
130918889|NCT00491764|471338640|FG004|Overall Study|Withdrawal by Subject|2|||
130918890|NCT00491764|471338641|FG005|Overall Study|Withdrawal by Subject|4|||
130918891|NCT00491764|471338636|FG000|Overall Study|Non Compliance with the Protocol|1|||
130918892|NCT00491764|471338637|FG001|Overall Study|Non Compliance with the Protocol|0|||
130918893|NCT00491764|471338638|FG002|Overall Study|Non Compliance with the Protocol|0|||
130918894|NCT00491764|471338639|FG003|Overall Study|Non Compliance with the Protocol|0|||
130918895|NCT00491764|471338640|FG004|Overall Study|Non Compliance with the Protocol|0|||
130918896|NCT00491764|471338641|FG005|Overall Study|Non Compliance with the Protocol|0|||
130918897|NCT00491764|471338636|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
130918898|NCT00491764|471338637|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
130918899|NCT00491764|471338638|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
130918900|NCT00491764|471338639|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
130918901|NCT00491764|471338640|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
130918902|NCT00491764|471338641|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
130918903|NCT00491764|471338636|FG000|Overall Study|Administrative|1|||
130918904|NCT00491764|471338637|FG001|Overall Study|Administrative|0|||
130918905|NCT00491764|471338638|FG002|Overall Study|Administrative|2|||
130918906|NCT00491764|471338639|FG003|Overall Study|Administrative|1|||
130918907|NCT00491764|471338640|FG004|Overall Study|Administrative|0|||
130918908|NCT00491764|471338641|FG005|Overall Study|Administrative|0|||
130918909|NCT00697788|471338644|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130918910|NCT00697788|471338645|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
130918911|NCT00697788|471338646|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130918912|NCT00697788|471338647|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130918913|NCT00697788|471338648|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130918914|NCT00697788|471338649|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130918915|NCT00697788|471338650|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130918916|NCT00697788|471338651|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
130918917|NCT00697788|471338644|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130918918|NCT00697788|471338645|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130918919|NCT00697788|471338646|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130918920|NCT00697788|471338647|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130918921|NCT00697788|471338648|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
130918922|NCT00697788|471338649|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130918923|NCT00697788|471338650|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130918924|NCT00697788|471338651|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
130918925|NCT00075218|471338660|FG000|Double-Blind Treatment|Adverse Event|23|||
130918926|NCT00075218|471338661|FG001|Double-Blind Treatment|Adverse Event|4|||
130918927|NCT00075218|471338662|FG002|Double-Blind Treatment|Adverse Event|0|||
130918928|NCT00075218|471338660|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
130918929|NCT00075218|471338661|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
130918930|NCT00075218|471338662|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
130918931|NCT00075218|471338660|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
130918932|NCT00075218|471338661|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
130918933|NCT00075218|471338662|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
130918934|NCT00075218|471338660|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
130918935|NCT00075218|471338661|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
130918936|NCT00075218|471338662|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
130918937|NCT00075218|471338660|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
130918938|NCT00075218|471338661|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
130918939|NCT00075218|471338662|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
130918940|NCT00075218|471338660|FG000|Double-Blind Treatment|No study medication taken|2|||
130918941|NCT00075218|471338661|FG001|Double-Blind Treatment|No study medication taken|0|||
130918942|NCT00075218|471338662|FG002|Double-Blind Treatment|No study medication taken|0|||
130918943|NCT00075218|471338660|FG000|Open-Label Treatment|Lack of Efficacy|0|||
130918944|NCT00075218|471338661|FG001|Open-Label Treatment|Lack of Efficacy|0|||
130918945|NCT00075218|471338662|FG002|Open-Label Treatment|Lack of Efficacy|174|||
130918946|NCT00075218|471338660|FG000|Open-Label Treatment|Adverse Event|0|||
130918947|NCT00075218|471338661|FG001|Open-Label Treatment|Adverse Event|0|||
130918948|NCT00075218|471338662|FG002|Open-Label Treatment|Adverse Event|51|||
130918949|NCT00075218|471338660|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
130918950|NCT00075218|471338661|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
130918951|NCT00075218|471338662|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
130918952|NCT00075218|471338660|FG000|Open-Label Treatment|Decision of Sponsor|0|||
130918953|NCT00075218|471338661|FG001|Open-Label Treatment|Decision of Sponsor|0|||
130918954|NCT00075218|471338662|FG002|Open-Label Treatment|Decision of Sponsor|8|||
130918955|NCT00075218|471338660|FG000|Open-Label Treatment|Protocol Violation|0|||
130918956|NCT00075218|471338661|FG001|Open-Label Treatment|Protocol Violation|0|||
130918957|NCT00075218|471338662|FG002|Open-Label Treatment|Protocol Violation|1|||
130918958|NCT00075218|471338660|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
130918959|NCT00075218|471338661|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
130918960|NCT00075218|471338662|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
130918961|NCT03840174|471338665|FG000|Overall Study|Withdrawal by Subject|1|||
130918962|NCT03840174|471338666|FG001|Overall Study|Withdrawal by Subject|0|||
130918963|NCT03840174|471338667|FG002|Overall Study|Withdrawal by Subject|0|||
130918964|NCT03840174|471338668|FG003|Overall Study|Withdrawal by Subject|0|||
130918965|NCT00131508|471338671|FG000|Overall Study|Disease progression|0|||
130918966|NCT00131508|471338672|FG001|Overall Study|Disease progression|2|||
130918967|NCT00131508|471338671|FG000|Overall Study|Non-Compliance|2|||
130918968|NCT00131508|471338672|FG001|Overall Study|Non-Compliance|4|||
130918969|NCT00131508|471338671|FG000|Overall Study|Withdrawal by Subject|1|||
130918970|NCT00131508|471338672|FG001|Overall Study|Withdrawal by Subject|2|||
130918971|NCT02248701|471338674|FG000|Overall Study|Withdrawal by Subject|2|||
130918972|NCT02248701|471338675|FG001|Overall Study|Withdrawal by Subject|1|||
130918973|NCT02248701|471338674|FG000|Overall Study|Physician Decision|0|||
130918974|NCT02248701|471338675|FG001|Overall Study|Physician Decision|1|||
130918975|NCT02248701|471338674|FG000|Overall Study|Adverse Event|1|||
130918976|NCT02248701|471338675|FG001|Overall Study|Adverse Event|0|||
130918977|NCT02248701|471338674|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
130918978|NCT02248701|471338675|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
130918979|NCT00845858|471338676|FG000|Overall Study|Withdrawal by Subject|5|||
130918980|NCT00845858|471338677|FG001|Overall Study|Withdrawal by Subject|1|||
130918981|NCT00845858|471338678|FG002|Overall Study|Withdrawal by Subject|1|||
130918982|NCT00845858|471338676|FG000|Overall Study|Adverse Event|3|||
131033933|NCT03719443|471757393|FG004|Overall Study|Withdrawal by Subject|0|||
131033934|NCT03719443|471757394|FG005|Overall Study|Withdrawal by Subject|0|||
131033935|NCT03719443|471757395|FG006|Overall Study|Withdrawal by Subject|0|||
131033936|NCT04924660|471757396|FG000|United States|Death|29|||
131033937|NCT04924660|471757397|FG001|United States|Death|32|||
131033938|NCT04924660|471757398|FG002|United States|Death|34|||
131033939|NCT04924660|471757399|FG003|United States|Death|25|||
131033940|NCT04924660|471757400|FG004|United States|Death|26|||
131033941|NCT04924660|471757401|FG005|United States|Death|23|||
131033942|NCT04924660|471757396|FG000|United States|Lost to Follow-up|15|||
131033943|NCT04924660|471757397|FG001|United States|Lost to Follow-up|10|||
131033944|NCT04924660|471757398|FG002|United States|Lost to Follow-up|13|||
131033945|NCT04924660|471757399|FG003|United States|Lost to Follow-up|5|||
131033946|NCT04924660|471757400|FG004|United States|Lost to Follow-up|19|||
131033947|NCT04924660|471757401|FG005|United States|Lost to Follow-up|20|||
131033948|NCT04924660|471757396|FG000|United States|Withdrawal by Subject|8|||
131033949|NCT04924660|471757397|FG001|United States|Withdrawal by Subject|3|||
131033950|NCT04924660|471757398|FG002|United States|Withdrawal by Subject|3|||
131033951|NCT04924660|471757399|FG003|United States|Withdrawal by Subject|3|||
131033952|NCT04924660|471757400|FG004|United States|Withdrawal by Subject|8|||
131033953|NCT04924660|471757401|FG005|United States|Withdrawal by Subject|4|||
131033954|NCT04924660|471757396|FG000|Spain|Death|0|||
131223136|NCT03333382|472445015|FG001|Overall Study|Lost to Follow-up|0|||
131033955|NCT04924660|471757397|FG001|Spain|Death|0|||
131033956|NCT04924660|471757398|FG002|Spain|Death|0|||
131033957|NCT04924660|471757399|FG003|Spain|Death|0|||
131033958|NCT04924660|471757400|FG004|Spain|Death|0|||
131033959|NCT04924660|471757401|FG005|Spain|Death|2|||
131033960|NCT04924660|471757396|FG000|Spain|Lost to Follow-up|0|||
131033961|NCT04924660|471757397|FG001|Spain|Lost to Follow-up|0|||
130918983|NCT00845858|471338677|FG001|Overall Study|Adverse Event|8|||
130918984|NCT00845858|471338678|FG002|Overall Study|Adverse Event|4|||
130918985|NCT00845858|471338676|FG000|Overall Study|Protocol Violation|0|||
130918986|NCT00845858|471338677|FG001|Overall Study|Protocol Violation|0|||
130918987|NCT00845858|471338678|FG002|Overall Study|Protocol Violation|1|||
130918988|NCT00845858|471338676|FG000|Overall Study|not eligible|0|||
130918989|NCT00845858|471338677|FG001|Overall Study|not eligible|3|||
130918990|NCT00845858|471338678|FG002|Overall Study|not eligible|2|||
130918991|NCT00880542|471338679|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
130918992|NCT00880542|471338679|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
130918993|NCT00880542|471338679|FG000|REP: Surgical Resection|progressive disease|1|||
130918994|NCT04289623|471338680|FG000|Wave 1 Emails|Email was not delivered|268|||
130918995|NCT04289623|471338681|FG001|Wave 1 Emails|Email was not delivered|257|||
130918996|NCT04289623|471338682|FG002|Wave 1 Emails|Email was not delivered|0|||
130918997|NCT04289623|471338683|FG003|Wave 1 Emails|Email was not delivered|0|||
130918998|NCT04289623|471338684|FG004|Wave 1 Emails|Email was not delivered|0|||
130918999|NCT04289623|471338685|FG005|Wave 1 Emails|Email was not delivered|0|||
130919000|NCT03758443|471338686|FG000|Induction Period|Adverse Event|2|||
130919001|NCT03758443|471338687|FG001|Induction Period|Adverse Event|4|||
130919002|NCT03758443|471338688|FG002|Induction Period|Adverse Event|2|||
130919003|NCT03758443|471338689|FG003|Induction Period|Adverse Event|3|||
130919004|NCT03758443|471338686|FG000|Induction Period|Physician Decision|1|||
130919005|NCT03758443|471338687|FG001|Induction Period|Physician Decision|1|||
130919006|NCT03758443|471338688|FG002|Induction Period|Physician Decision|3|||
130919007|NCT03758443|471338689|FG003|Induction Period|Physician Decision|0|||
130919008|NCT03758443|471338686|FG000|Induction Period|Protocol Violation|0|||
130919009|NCT03758443|471338687|FG001|Induction Period|Protocol Violation|0|||
130919010|NCT03758443|471338688|FG002|Induction Period|Protocol Violation|0|||
130919011|NCT03758443|471338689|FG003|Induction Period|Protocol Violation|1|||
130919012|NCT03758443|471338686|FG000|Induction Period|Withdrawal by Subject|3|||
130919013|NCT03758443|471338687|FG001|Induction Period|Withdrawal by Subject|2|||
130919014|NCT03758443|471338688|FG002|Induction Period|Withdrawal by Subject|2|||
130919015|NCT03758443|471338689|FG003|Induction Period|Withdrawal by Subject|4|||
130919016|NCT03758443|471338686|FG000|Extended Induction Period|Adverse Event|1|||
130919017|NCT03758443|471338687|FG001|Extended Induction Period|Adverse Event|1|||
130919018|NCT03758443|471338688|FG002|Extended Induction Period|Adverse Event|0|||
130919019|NCT03758443|471338689|FG003|Extended Induction Period|Adverse Event|1|||
130919020|NCT03758443|471338686|FG000|Extended Induction Period|Lost to Follow-up|1|||
130919021|NCT03758443|471338687|FG001|Extended Induction Period|Lost to Follow-up|0|||
130919022|NCT03758443|471338688|FG002|Extended Induction Period|Lost to Follow-up|0|||
130919023|NCT03758443|471338689|FG003|Extended Induction Period|Lost to Follow-up|0|||
130919024|NCT03758443|471338686|FG000|Extended Induction Period|Physician Decision|2|||
130919025|NCT03758443|471338687|FG001|Extended Induction Period|Physician Decision|1|||
130919026|NCT03758443|471338688|FG002|Extended Induction Period|Physician Decision|2|||
130919027|NCT03758443|471338689|FG003|Extended Induction Period|Physician Decision|2|||
130919028|NCT03758443|471338686|FG000|Extended Induction Period|Protocol Violation|0|||
130919029|NCT03758443|471338687|FG001|Extended Induction Period|Protocol Violation|0|||
130919030|NCT03758443|471338688|FG002|Extended Induction Period|Protocol Violation|0|||
130919031|NCT03758443|471338689|FG003|Extended Induction Period|Protocol Violation|1|||
131033962|NCT04924660|471757398|FG002|Spain|Lost to Follow-up|0|||
131033963|NCT04924660|471757399|FG003|Spain|Lost to Follow-up|0|||
131033964|NCT04924660|471757400|FG004|Spain|Lost to Follow-up|1|||
131033965|NCT04924660|471757401|FG005|Spain|Lost to Follow-up|0|||
131033966|NCT04924660|471757396|FG000|Brazil|Death|0|||
131033967|NCT04924660|471757397|FG001|Brazil|Death|0|||
131033968|NCT04924660|471757398|FG002|Brazil|Death|0|||
131033969|NCT04924660|471757399|FG003|Brazil|Death|0|||
131033970|NCT04924660|471757400|FG004|Brazil|Death|1|||
131033971|NCT04924660|471757401|FG005|Brazil|Death|0|||
131033972|NCT04924660|471757396|FG000|Italy|Lost to Follow-up|0|||
131033973|NCT04924660|471757397|FG001|Italy|Lost to Follow-up|0|||
131033974|NCT04924660|471757398|FG002|Italy|Lost to Follow-up|0|||
131033975|NCT04924660|471757399|FG003|Italy|Lost to Follow-up|0|||
131033976|NCT04924660|471757400|FG004|Italy|Lost to Follow-up|0|||
131033977|NCT04924660|471757401|FG005|Italy|Lost to Follow-up|1|||
131033978|NCT04924660|471757396|FG000|South Africa|Death|0|||
130919032|NCT03758443|471338686|FG000|Extended Induction Period|Withdrawal by Subject|8|||
130919033|NCT03758443|471338687|FG001|Extended Induction Period|Withdrawal by Subject|1|||
130919034|NCT03758443|471338688|FG002|Extended Induction Period|Withdrawal by Subject|7|||
131033979|NCT04924660|471757397|FG001|South Africa|Death|0|||
130919035|NCT03758443|471338689|FG003|Extended Induction Period|Withdrawal by Subject|3|||
130919036|NCT03758443|471338686|FG000|Extended Induction Period|Miscellaneous|1|||
131033980|NCT04924660|471757398|FG002|South Africa|Death|0|||
131033981|NCT04924660|471757399|FG003|South Africa|Death|0|||
131033982|NCT04924660|471757400|FG004|South Africa|Death|0|||
131033983|NCT04924660|471757401|FG005|South Africa|Death|1|||
131033984|NCT04924660|471757396|FG000|South Africa|Lost to Follow-up|0|||
131033985|NCT04924660|471757397|FG001|South Africa|Lost to Follow-up|0|||
131119857|NCT03250832|472070347|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131119858|NCT03250832|472070348|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
131119859|NCT03250832|472070337|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131119860|NCT03250832|472070338|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131119861|NCT03250832|472070339|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131119862|NCT03250832|472070340|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130699720|NCT01332968|470524719|FG000|Follow-Up Period|Progressive Disease|0|||
130699721|NCT01332968|470524720|FG001|Follow-Up Period|Progressive Disease|0|||
130699722|NCT01332968|470524721|FG002|Follow-Up Period|Progressive Disease|0|||
130919037|NCT03758443|471338687|FG001|Extended Induction Period|Miscellaneous|0|||
130919038|NCT03758443|471338688|FG002|Extended Induction Period|Miscellaneous|0|||
130919039|NCT03758443|471338689|FG003|Extended Induction Period|Miscellaneous|0|||
130919040|NCT03758443|471338686|FG000|Maintenance Period|Adverse Event|1|||
130919041|NCT03758443|471338687|FG001|Maintenance Period|Adverse Event|2|||
130919042|NCT03758443|471338688|FG002|Maintenance Period|Adverse Event|0|||
130919043|NCT03758443|471338689|FG003|Maintenance Period|Adverse Event|0|||
130919044|NCT03758443|471338686|FG000|Maintenance Period|Lost to Follow-up|0|||
130919045|NCT03758443|471338687|FG001|Maintenance Period|Lost to Follow-up|0|||
130919046|NCT03758443|471338688|FG002|Maintenance Period|Lost to Follow-up|0|||
130919047|NCT03758443|471338689|FG003|Maintenance Period|Lost to Follow-up|1|||
130919048|NCT03758443|471338686|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
130919049|NCT03758443|471338687|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
130919050|NCT03758443|471338688|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
130919051|NCT03758443|471338689|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
130919052|NCT03758443|471338686|FG000|Maintenance Period|Protocol Violation|0|||
130919053|NCT03758443|471338687|FG001|Maintenance Period|Protocol Violation|1|||
130919054|NCT03758443|471338688|FG002|Maintenance Period|Protocol Violation|0|||
130919055|NCT03758443|471338689|FG003|Maintenance Period|Protocol Violation|0|||
130919056|NCT03758443|471338686|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
130919057|NCT03758443|471338687|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
130919058|NCT03758443|471338688|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
130919059|NCT03758443|471338689|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
130919060|NCT03758443|471338686|FG000|Maintenance Period|Withdrawal by Subject|1|||
130919061|NCT03758443|471338687|FG001|Maintenance Period|Withdrawal by Subject|0|||
130919062|NCT03758443|471338688|FG002|Maintenance Period|Withdrawal by Subject|1|||
130919063|NCT03758443|471338689|FG003|Maintenance Period|Withdrawal by Subject|1|||
130919064|NCT03758443|471338686|FG000|Maintenance Period|Miscellaneous|0|||
130919065|NCT03758443|471338687|FG001|Maintenance Period|Miscellaneous|0|||
130919066|NCT03758443|471338688|FG002|Maintenance Period|Miscellaneous|1|||
130919067|NCT03758443|471338689|FG003|Maintenance Period|Miscellaneous|0|||
130919068|NCT01436396|471338690|FG000|Overall Study|Protocol Violation|7|||
130919069|NCT01436396|471338691|FG001|Overall Study|Protocol Violation|5|||
130919070|NCT01436396|471338690|FG000|Overall Study|Adverse Event|1|||
130919071|NCT01436396|471338691|FG001|Overall Study|Adverse Event|2|||
130919072|NCT01436396|471338690|FG000|Overall Study|Withdrawal by Subject|19|||
130919073|NCT01436396|471338691|FG001|Overall Study|Withdrawal by Subject|29|||
130919074|NCT01436396|471338690|FG000|Overall Study|Serious adverse event|2|||
130919075|NCT01436396|471338691|FG001|Overall Study|Serious adverse event|3|||
130919076|NCT01436396|471338690|FG000|Overall Study|Lost to Follow-up|3|||
130919077|NCT01436396|471338691|FG001|Overall Study|Lost to Follow-up|3|||
130919078|NCT03080454|471338692|FG000|Baseline|Adverse Event|2|||
130919079|NCT03080454|471338692|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
130919080|NCT03080454|471338692|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
130919081|NCT00216476|471338693|FG000|Overall Study|Withdrawal by Subject|59|||
130919082|NCT00216476|471338694|FG001|Overall Study|Withdrawal by Subject|72|||
130919083|NCT00216476|471338695|FG002|Overall Study|Withdrawal by Subject|9|||
131119863|NCT03250832|472070341|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131119864|NCT03250832|472070342|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131119865|NCT03250832|472070343|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130699723|NCT01332968|470524722|FG003|Follow-Up Period|Progressive Disease|0|||
130699724|NCT01332968|470524723|FG004|Follow-Up Period|Progressive Disease|0|||
130919084|NCT00216476|471338693|FG000|Overall Study|Lost to Follow-up|10|||
130919085|NCT00216476|471338694|FG001|Overall Study|Lost to Follow-up|9|||
130919086|NCT00216476|471338695|FG002|Overall Study|Lost to Follow-up|1|||
130919087|NCT00216476|471338693|FG000|Overall Study|Adverse Event|6|||
130919088|NCT00216476|471338694|FG001|Overall Study|Adverse Event|10|||
130919089|NCT00216476|471338695|FG002|Overall Study|Adverse Event|1|||
130919090|NCT00216476|471338693|FG000|Overall Study|Lack of Efficacy|4|||
130919091|NCT00216476|471338694|FG001|Overall Study|Lack of Efficacy|3|||
130919092|NCT00216476|471338695|FG002|Overall Study|Lack of Efficacy|0|||
130919093|NCT00216476|471338693|FG000|Overall Study|Death|2|||
130919094|NCT00216476|471338694|FG001|Overall Study|Death|0|||
130919095|NCT00216476|471338695|FG002|Overall Study|Death|0|||
130919096|NCT00216476|471338693|FG000|Overall Study|Pregnancy|0|||
130699725|NCT01332968|470524724|FG005|Follow-Up Period|Progressive Disease|0|||
130919097|NCT00216476|471338694|FG001|Overall Study|Pregnancy|1|||
130919098|NCT00216476|471338695|FG002|Overall Study|Pregnancy|1|||
130919099|NCT00216476|471338693|FG000|Overall Study|Other|0|||
130919100|NCT00216476|471338694|FG001|Overall Study|Other|0|||
130919101|NCT00216476|471338695|FG002|Overall Study|Other|1|||
130919102|NCT00216476|471338693|FG000|Overall Study|Refuses Injection|11|||
130919103|NCT00216476|471338694|FG001|Overall Study|Refuses Injection|0|||
130919104|NCT00216476|471338695|FG002|Overall Study|Refuses Injection|0|||
130919105|NCT00216476|471338693|FG000|Overall Study|No Further Need for Treatment|3|||
130919106|NCT00216476|471338694|FG001|Overall Study|No Further Need for Treatment|4|||
130919107|NCT00216476|471338695|FG002|Overall Study|No Further Need for Treatment|1|||
130919108|NCT00216476|471338693|FG000|Overall Study|Non-compliance|0|||
130919109|NCT00216476|471338694|FG001|Overall Study|Non-compliance|4|||
130919110|NCT00216476|471338695|FG002|Overall Study|Non-compliance|1|||
130919111|NCT00216476|471338693|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
130919112|NCT00216476|471338694|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
130919113|NCT00216476|471338695|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
130919114|NCT00216476|471338693|FG000|Overall Study|Administrative Reasons|1|||
130919115|NCT00216476|471338694|FG001|Overall Study|Administrative Reasons|1|||
130919116|NCT00216476|471338695|FG002|Overall Study|Administrative Reasons|0|||
130919117|NCT00216476|471338693|FG000|Overall Study|Protocol Deviation|5|||
130919118|NCT00216476|471338694|FG001|Overall Study|Protocol Deviation|1|||
130919119|NCT00216476|471338695|FG002|Overall Study|Protocol Deviation|0|||
130919120|NCT00216476|471338693|FG000|Overall Study|Patient Moved|2|||
130919121|NCT00216476|471338694|FG001|Overall Study|Patient Moved|2|||
130919122|NCT00216476|471338695|FG002|Overall Study|Patient Moved|0|||
130919123|NCT02191137|471338696|FG000|Treatment|Death|4|||
130919124|NCT02191137|471338696|FG000|Treatment|Withdrawal by Subject|3|||
130919125|NCT02191137|471338696|FG000|Treatment|Adverse Event|2|||
130919126|NCT02191137|471338696|FG000|Treatment|Other|1|||
130919127|NCT02191137|471338696|FG000|Follow-up|Lost to Follow-up|2|||
130919128|NCT02191137|471338696|FG000|Follow-up|Ongoing/unknown|2|||
130919129|NCT02191137|471338696|FG000|Follow-up|Adverse Event|1|||
130919130|NCT00696800|471338697|FG000|Overall Study|Adverse Event|16|||
130919131|NCT00696800|471338698|FG001|Overall Study|Adverse Event|3|||
130919132|NCT00696800|471338697|FG000|Overall Study|Insufficient compliance with medication|2|||
130919133|NCT00696800|471338698|FG001|Overall Study|Insufficient compliance with medication|1|||
130919134|NCT00696800|471338697|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
130919135|NCT00696800|471338698|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
130919136|NCT00696800|471338697|FG000|Overall Study|Insufficient ovarian response|4|||
130919137|NCT00696800|471338698|FG001|Overall Study|Insufficient ovarian response|1|||
130919138|NCT00696800|471338697|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
130919139|NCT00696800|471338698|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
130919140|NCT00696800|471338697|FG000|Overall Study|Too high ovarian response|6|||
130919141|NCT00696800|471338698|FG001|Overall Study|Too high ovarian response|1|||
131119866|NCT03250832|472070344|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
131119867|NCT03250832|472070345|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131119868|NCT03250832|472070346|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130919142|NCT00696800|471338697|FG000|Overall Study|No/too few/bad quality oocytes|4|||
130919143|NCT00696800|471338698|FG001|Overall Study|No/too few/bad quality oocytes|3|||
130919144|NCT00696800|471338697|FG000|Overall Study|No/abnormal fertilization|11|||
130919145|NCT00696800|471338698|FG001|Overall Study|No/abnormal fertilization|13|||
130919146|NCT00696800|471338697|FG000|Overall Study|No/too few/bad quality embryos|24|||
130919147|NCT00696800|471338698|FG001|Overall Study|No/too few/bad quality embryos|18|||
130919148|NCT00696800|471338697|FG000|Overall Study|Other Reasons|5|||
130919149|NCT00696800|471338698|FG001|Overall Study|Other Reasons|3|||
130919150|NCT00696800|471338697|FG000|Overall Study|Not treated|1|||
130919151|NCT00696800|471338698|FG001|Overall Study|Not treated|2|||
130919152|NCT05224141|471338699|FG000|Overall Study|Ongoing|75|||
130919153|NCT05224141|471338700|FG001|Overall Study|Ongoing|88|||
130919154|NCT05224141|471338699|FG000|Overall Study|Withdrawal by Subject|2|||
130919155|NCT05224141|471338700|FG001|Overall Study|Withdrawal by Subject|4|||
130919156|NCT05224141|471338699|FG000|Overall Study|Death|153|||
131119869|NCT03250832|472070347|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131119870|NCT03250832|472070348|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
131119871|NCT03250832|472070337|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
130919157|NCT05224141|471338700|FG001|Overall Study|Death|138|||
130919158|NCT03469934|471338705|FG000|Overall Study|Withdrawal by Subject|0|||
130919159|NCT03469934|471338706|FG001|Overall Study|Withdrawal by Subject|1|||
130919160|NCT04889222|471338708|FG000|Overall Study|Did not meet eligibility criteria|8|||
130919161|NCT04889222|471338708|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
130919162|NCT04889222|471338708|FG000|Overall Study|Did not proceed due to time constraints|5|||
130919163|NCT02853344|471338717|FG000|Overall Study|Lost to Follow-up|1|||
130919164|NCT02853344|471338718|FG001|Overall Study|Lost to Follow-up|1|||
130919165|NCT02853344|471338717|FG000|Overall Study|Withdrawal by Subject|2|||
130919166|NCT02853344|471338718|FG001|Overall Study|Withdrawal by Subject|4|||
131033986|NCT04924660|471757398|FG002|South Africa|Lost to Follow-up|0|||
131033987|NCT04924660|471757399|FG003|South Africa|Lost to Follow-up|0|||
130919167|NCT02853344|471338717|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
130919168|NCT02853344|471338718|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
130919169|NCT02853344|471338717|FG000|Overall Study|Death|70|||
130919170|NCT02853344|471338718|FG001|Overall Study|Death|112|||
130919171|NCT02913612|471338719|FG000|Overall Study|Lost to Follow-up|6|||
130919172|NCT02913612|471338720|FG001|Overall Study|Lost to Follow-up|5|||
130919173|NCT02913612|471338721|FG002|Overall Study|Lost to Follow-up|2|||
130919174|NCT02913612|471338722|FG003|Overall Study|Lost to Follow-up|0|||
130919175|NCT02913612|471338719|FG000|Overall Study|Physician Decision|1|||
130919176|NCT02913612|471338720|FG001|Overall Study|Physician Decision|4|||
131033988|NCT04924660|471757400|FG004|South Africa|Lost to Follow-up|0|||
131033989|NCT04924660|471757401|FG005|South Africa|Lost to Follow-up|1|||
131033990|NCT06205407|471757402|FG000|Period 2|Withdrawal by Subject|0|||
131033991|NCT06205407|471757403|FG001|Period 2|Withdrawal by Subject|1|||
131033992|NCT06205407|471757402|FG000|Period 2|Adverse Event|2|||
131033993|NCT06205407|471757403|FG001|Period 2|Adverse Event|1|||
131033994|NCT04229992|471759036|FG000|Overall Study|Withdrawal by Subject|0|||
131033995|NCT04229992|471759037|FG001|Overall Study|Withdrawal by Subject|2|||
131033996|NCT04229992|471759038|FG002|Overall Study|Withdrawal by Subject|1|||
130919177|NCT02913612|471338721|FG002|Overall Study|Physician Decision|1|||
130919178|NCT02913612|471338722|FG003|Overall Study|Physician Decision|0|||
131033997|NCT04229992|471759039|FG003|Overall Study|Withdrawal by Subject|1|||
131119872|NCT03250832|472070338|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
131119873|NCT03250832|472070339|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
130919179|NCT02913612|471338719|FG000|Overall Study|Withdrawal by Subject|2|||
131119874|NCT03250832|472070340|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
131119875|NCT03250832|472070341|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
131119876|NCT03250832|472070342|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
130919180|NCT02913612|471338720|FG001|Overall Study|Withdrawal by Subject|4|||
130919181|NCT02913612|471338721|FG002|Overall Study|Withdrawal by Subject|0|||
130919182|NCT02913612|471338722|FG003|Overall Study|Withdrawal by Subject|0|||
130919183|NCT02913612|471338719|FG000|Overall Study|Hemangioma resolved|1|||
130919184|NCT02913612|471338720|FG001|Overall Study|Hemangioma resolved|0|||
130919185|NCT02913612|471338721|FG002|Overall Study|Hemangioma resolved|0|||
130919186|NCT02913612|471338722|FG003|Overall Study|Hemangioma resolved|0|||
130919187|NCT02913612|471338719|FG000|Overall Study|Local IRB decision|1|||
130919188|NCT02913612|471338720|FG001|Overall Study|Local IRB decision|0|||
131033998|NCT04229992|471759036|FG000|Overall Study|Adverse Event|1|||
131119877|NCT03250832|472070343|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
131119878|NCT03250832|472070344|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
131119879|NCT03250832|472070345|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
131119880|NCT03250832|472070346|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
131119881|NCT03250832|472070347|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
131119882|NCT03250832|472070348|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
131119883|NCT03250832|472070337|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
131119884|NCT03250832|472070338|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
131119885|NCT03250832|472070339|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
131119886|NCT03250832|472070340|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
131119887|NCT03250832|472070341|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
131119888|NCT03250832|472070342|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
131119889|NCT03250832|472070343|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
131119890|NCT03250832|472070344|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
131119891|NCT03250832|472070345|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
131119892|NCT03250832|472070346|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
131119893|NCT03250832|472070347|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
131119894|NCT03250832|472070348|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
131119895|NCT03250832|472070337|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131119896|NCT03250832|472070338|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131119897|NCT03250832|472070339|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131223137|NCT00550420|472445016|FG000|Overall Study|Adverse Event|28|||
130919189|NCT02913612|471338721|FG002|Overall Study|Local IRB decision|0|||
130919190|NCT02913612|471338722|FG003|Overall Study|Local IRB decision|0|||
131033999|NCT04229992|471759037|FG001|Overall Study|Adverse Event|1|||
131034000|NCT04229992|471759038|FG002|Overall Study|Adverse Event|3|||
131034001|NCT04229992|471759039|FG003|Overall Study|Adverse Event|1|||
131034002|NCT04229992|471759036|FG000|Overall Study|Lost to Follow-up|0|||
131034003|NCT04229992|471759037|FG001|Overall Study|Lost to Follow-up|0|||
131034004|NCT04229992|471759038|FG002|Overall Study|Lost to Follow-up|0|||
131034005|NCT04229992|471759039|FG003|Overall Study|Lost to Follow-up|1|||
130919191|NCT02913612|471338719|FG000|Overall Study|Study drug non-compliance|1|||
130919192|NCT02913612|471338720|FG001|Overall Study|Study drug non-compliance|1|||
130919193|NCT02913612|471338721|FG002|Overall Study|Study drug non-compliance|0|||
131034006|NCT03770273|471759040|FG000|Overall Study|Adverse Event|2|||
131034007|NCT03770273|471759041|FG001|Overall Study|Adverse Event|0|||
131034008|NCT03770273|471759040|FG000|Overall Study|Lost to Follow-up|1|||
131034009|NCT03770273|471759041|FG001|Overall Study|Lost to Follow-up|1|||
131034010|NCT00418886|471759042|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
131034011|NCT00418886|471759043|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
131034012|NCT00418886|471759042|FG000|Randomized Period|Death|122|||
131034013|NCT00418886|471759043|FG001|Randomized Period|Death|147|||
131034014|NCT00418886|471759042|FG000|Randomized Period|Withdrawal by Subject|9|||
131034015|NCT00418886|471759043|FG001|Randomized Period|Withdrawal by Subject|10|||
131034016|NCT00418886|471759042|FG000|Randomized Period|Lost to Follow-up|4|||
131034017|NCT00418886|471759043|FG001|Randomized Period|Lost to Follow-up|6|||
131034018|NCT00418886|471759042|FG000|Randomized Period|withdrawn due to other reason|1|||
131034019|NCT00418886|471759043|FG001|Randomized Period|withdrawn due to other reason|0|||
131034020|NCT00418886|471759042|FG000|Randomized Period|randomised but no treatment received|0|||
131034021|NCT00418886|471759043|FG001|Randomized Period|randomised but no treatment received|1|||
131034022|NCT05177848|471759044|FG000|Overall Study|Lost to Follow-up|1|||
131034023|NCT05177848|471759045|FG001|Overall Study|Lost to Follow-up|4|||
131034024|NCT05177848|471759044|FG000|Overall Study|Discontinued|2|||
131034025|NCT05177848|471759045|FG001|Overall Study|Discontinued|1|||
131034026|NCT02035787|471759046|FG000|Overall Study- 12 Months|Adverse Event|3|||
131034027|NCT02035787|471759047|FG001|Overall Study- 12 Months|Adverse Event|0|||
131034028|NCT02035787|471759046|FG000|Overall Study- 12 Months|Complete response|4|||
131034029|NCT02035787|471759047|FG001|Overall Study- 12 Months|Complete response|1|||
131034030|NCT02035787|471759046|FG000|Overall Study- 12 Months|Protocol Violation|1|||
131034031|NCT02035787|471759047|FG001|Overall Study- 12 Months|Protocol Violation|1|||
131034032|NCT06414213|471759048|FG000|Overall Study|Lost to Follow-up|1|||
131034033|NCT06414213|471759049|FG001|Overall Study|Lost to Follow-up|1|||
131034034|NCT06414213|471759050|FG002|Overall Study|Lost to Follow-up|3|||
131034035|NCT03338933|471759051|FG000|Screening Visit|Lost to Follow-up|1|||
131034036|NCT03338933|471759052|FG001|Screening Visit|Lost to Follow-up|3|||
131034037|NCT03338933|471759053|FG002|Screening Visit|Lost to Follow-up|1|||
131034038|NCT03338933|471759054|FG003|Screening Visit|Lost to Follow-up|4|||
131034039|NCT03338933|471759051|FG000|Screening Visit|Screen fail after consent|2|||
131034040|NCT03338933|471759052|FG001|Screening Visit|Screen fail after consent|7|||
131034041|NCT03338933|471759053|FG002|Screening Visit|Screen fail after consent|1|||
131034042|NCT03338933|471759054|FG003|Screening Visit|Screen fail after consent|4|||
131034043|NCT03338933|471759051|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
131034044|NCT03338933|471759052|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
131034045|NCT03338933|471759053|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
131119898|NCT03250832|472070340|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131119899|NCT03250832|472070341|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131119900|NCT03250832|472070342|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131119901|NCT03250832|472070343|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131119902|NCT03250832|472070344|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131119903|NCT03250832|472070345|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
131119904|NCT03250832|472070346|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
131119905|NCT03250832|472070347|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130699726|NCT01332968|470524725|FG006|Follow-Up Period|Progressive Disease|126|||
130699727|NCT01332968|470524726|FG007|Follow-Up Period|Progressive Disease|106|||
130699728|NCT01332968|470524719|FG000|Follow-Up Period|Protocol Violation|0|||
130699729|NCT01332968|470524720|FG001|Follow-Up Period|Protocol Violation|0|||
131034046|NCT03338933|471759054|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
131034047|NCT03338933|471759051|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
131034048|NCT03338933|471759052|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
131034049|NCT03338933|471759053|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
131034050|NCT03338933|471759054|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
131034051|NCT03338933|471759051|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
131034052|NCT03338933|471759052|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
131034053|NCT03338933|471759053|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
131034054|NCT03338933|471759054|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
131034055|NCT01084876|471759056|FG000|Main Study Treatment Period|Adverse Event|12|||
131034056|NCT01084876|471759057|FG001|Main Study Treatment Period|Adverse Event|7|||
131034057|NCT01084876|471759056|FG000|Main Study Treatment Period|Disease Progression|41|||
131034058|NCT01084876|471759057|FG001|Main Study Treatment Period|Disease Progression|24|||
131034059|NCT01084876|471759056|FG000|Main Study Treatment Period|Physician Decision|2|||
131119906|NCT03250832|472070348|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
131119907|NCT03250832|472070337|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130699730|NCT01332968|470524721|FG002|Follow-Up Period|Protocol Violation|0|||
130919194|NCT02913612|471338722|FG003|Overall Study|Study drug non-compliance|0|||
130919195|NCT02913612|471338719|FG000|Overall Study|Insurance issues|0|||
130919196|NCT02913612|471338720|FG001|Overall Study|Insurance issues|1|||
130919197|NCT02913612|471338721|FG002|Overall Study|Insurance issues|0|||
130919198|NCT02913612|471338722|FG003|Overall Study|Insurance issues|0|||
130919199|NCT02913612|471338719|FG000|Overall Study|Needed to treat second hemangioma|0|||
130919200|NCT02913612|471338720|FG001|Overall Study|Needed to treat second hemangioma|1|||
130919201|NCT02913612|471338721|FG002|Overall Study|Needed to treat second hemangioma|0|||
130919202|NCT02913612|471338722|FG003|Overall Study|Needed to treat second hemangioma|0|||
130919203|NCT02913612|471338719|FG000|Overall Study|Study completion criteria not met|0|||
130919204|NCT02913612|471338720|FG001|Overall Study|Study completion criteria not met|1|||
130919205|NCT02913612|471338721|FG002|Overall Study|Study completion criteria not met|0|||
130919206|NCT02913612|471338722|FG003|Overall Study|Study completion criteria not met|0|||
130919207|NCT02913612|471338719|FG000|Overall Study|Ineligible|0|||
130919208|NCT02913612|471338720|FG001|Overall Study|Ineligible|1|||
130919209|NCT02913612|471338721|FG002|Overall Study|Ineligible|0|||
130919210|NCT02913612|471338722|FG003|Overall Study|Ineligible|0|||
130919211|NCT00973674|471338725|FG000|Overall Study|Protocol Violation|2|||
130919212|NCT00973674|471338726|FG001|Overall Study|Protocol Violation|0|||
130919213|NCT00071396|471338727|FG000|Overall Study|Withdrawal by Subject|1|||
130919214|NCT00071396|471338727|FG000|Overall Study|Physician Decision|2|||
130919215|NCT02639546|471338728|FG000|Overall Study|Death|2|||
130919216|NCT02639546|471338729|FG001|Overall Study|Death|2|||
130919217|NCT02639546|471338730|FG002|Overall Study|Death|1|||
130919218|NCT02639546|471338731|FG003|Overall Study|Death|2|||
130919219|NCT02639546|471338732|FG004|Overall Study|Death|2|||
130919220|NCT02639546|471338733|FG005|Overall Study|Death|2|||
130919221|NCT02639546|471338734|FG006|Overall Study|Death|0|||
130919222|NCT02639546|471338735|FG007|Overall Study|Death|0|||
130919223|NCT02639546|471338728|FG000|Overall Study|Lost to Follow-up|0|||
130919224|NCT02639546|471338729|FG001|Overall Study|Lost to Follow-up|0|||
130919225|NCT02639546|471338730|FG002|Overall Study|Lost to Follow-up|1|||
130919226|NCT02639546|471338731|FG003|Overall Study|Lost to Follow-up|0|||
130919227|NCT02639546|471338732|FG004|Overall Study|Lost to Follow-up|1|||
130919228|NCT02639546|471338733|FG005|Overall Study|Lost to Follow-up|1|||
130919229|NCT02639546|471338734|FG006|Overall Study|Lost to Follow-up|0|||
130919230|NCT02639546|471338735|FG007|Overall Study|Lost to Follow-up|1|||
130919231|NCT02639546|471338728|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
130919232|NCT02639546|471338729|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
130919233|NCT02639546|471338730|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
130919234|NCT02639546|471338731|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
130919235|NCT02639546|471338732|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
130919236|NCT02639546|471338733|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
130919237|NCT02639546|471338734|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
130919238|NCT02639546|471338735|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
130919239|NCT02639546|471338728|FG000|Overall Study|Study Terminated By Sponsor|0|||
130919240|NCT02639546|471338729|FG001|Overall Study|Study Terminated By Sponsor|2|||
130919241|NCT02639546|471338730|FG002|Overall Study|Study Terminated By Sponsor|3|||
130919242|NCT02639546|471338731|FG003|Overall Study|Study Terminated By Sponsor|4|||
130919243|NCT02639546|471338732|FG004|Overall Study|Study Terminated By Sponsor|4|||
130919244|NCT02639546|471338733|FG005|Overall Study|Study Terminated By Sponsor|3|||
130919245|NCT02639546|471338734|FG006|Overall Study|Study Terminated By Sponsor|3|||
130919246|NCT02639546|471338735|FG007|Overall Study|Study Terminated By Sponsor|9|||
130919247|NCT02639546|471338728|FG000|Overall Study|Withdrawal by Subject|2|||
130919248|NCT02639546|471338729|FG001|Overall Study|Withdrawal by Subject|2|||
130919249|NCT02639546|471338730|FG002|Overall Study|Withdrawal by Subject|1|||
130919250|NCT02639546|471338731|FG003|Overall Study|Withdrawal by Subject|0|||
130919251|NCT02639546|471338732|FG004|Overall Study|Withdrawal by Subject|0|||
130919252|NCT02639546|471338733|FG005|Overall Study|Withdrawal by Subject|1|||
130919253|NCT02639546|471338734|FG006|Overall Study|Withdrawal by Subject|2|||
130919254|NCT02639546|471338735|FG007|Overall Study|Withdrawal by Subject|1|||
131119908|NCT03250832|472070338|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131119909|NCT03250832|472070339|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131119910|NCT03250832|472070340|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130919255|NCT00116428|471338736|FG000|Overall Study|Withdrawal by Subject|2|||
130919256|NCT00116428|471338737|FG001|Overall Study|Withdrawal by Subject|5|||
130919257|NCT00116428|471338736|FG000|Overall Study|Did not meet inclusion criteria|1|||
130919258|NCT00116428|471338737|FG001|Overall Study|Did not meet inclusion criteria|0|||
130919259|NCT00113087|471338738|FG000|Overall Study|Death or Transplant|14|||
130919260|NCT00113087|471338739|FG001|Overall Study|Death or Transplant|16|||
131119911|NCT03250832|472070341|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131119912|NCT03250832|472070342|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130919261|NCT00113087|471338738|FG000|Overall Study|Family or MD withdrew subject|10|||
130919262|NCT00113087|471338739|FG001|Overall Study|Family or MD withdrew subject|5|||
130919263|NCT02215096|471338740|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
131034060|NCT01084876|471759057|FG001|Main Study Treatment Period|Physician Decision|0|||
131034061|NCT01084876|471759056|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
131034062|NCT01084876|471759057|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
131034063|NCT01084876|471759056|FG000|Main Study Treatment Period|Other Reason|0|||
131034064|NCT01084876|471759057|FG001|Main Study Treatment Period|Other Reason|1|||
131034065|NCT01084876|471759056|FG000|Main Study Treatment Period|Other|0|||
131034066|NCT01084876|471759057|FG001|Main Study Treatment Period|Other|1|||
131034067|NCT01084876|471759056|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
131034068|NCT01084876|471759057|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
131034069|NCT01084876|471759056|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
131034070|NCT01084876|471759057|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
131034071|NCT01084876|471759056|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
131034072|NCT01084876|471759057|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
131034073|NCT01084876|471759056|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
131034074|NCT01084876|471759057|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
131034075|NCT01084876|471759056|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
131034076|NCT01084876|471759057|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
131034077|NCT01084876|471759056|FG000|Treatment Period Beyond Cycle 8|Other|6|||
131034078|NCT01084876|471759057|FG001|Treatment Period Beyond Cycle 8|Other|9|||
131034079|NCT05434078|471759070|FG000|Overall Study|Lost to Follow-up|2|||
131034080|NCT05434078|471759071|FG001|Overall Study|Lost to Follow-up|1|||
131034081|NCT05434078|471759070|FG000|Overall Study|Withdrawal by Subject|1|||
131034082|NCT05434078|471759071|FG001|Overall Study|Withdrawal by Subject|0|||
131034083|NCT03829410|471759076|FG000|Overall Study|Adverse Event|1|||
131034084|NCT03829410|471759077|FG001|Overall Study|Adverse Event|0|||
131034085|NCT03829410|471759078|FG002|Overall Study|Adverse Event|1|||
131034086|NCT03829410|471759079|FG003|Overall Study|Adverse Event|4|||
131034087|NCT03829410|471759076|FG000|Overall Study|Physician Decision|0|||
131034088|NCT03829410|471759077|FG001|Overall Study|Physician Decision|0|||
131034089|NCT03829410|471759078|FG002|Overall Study|Physician Decision|0|||
131034090|NCT03829410|471759079|FG003|Overall Study|Physician Decision|2|||
131034091|NCT03829410|471759076|FG000|Overall Study|Disease Progressing|3|||
131034092|NCT03829410|471759077|FG001|Overall Study|Disease Progressing|4|||
131034093|NCT03829410|471759078|FG002|Overall Study|Disease Progressing|2|||
131034094|NCT03829410|471759079|FG003|Overall Study|Disease Progressing|31|||
131034095|NCT03829410|471759076|FG000|Overall Study|Miscellaneous|2|||
131034096|NCT03829410|471759077|FG001|Overall Study|Miscellaneous|4|||
131034097|NCT03829410|471759078|FG002|Overall Study|Miscellaneous|3|||
131034098|NCT03829410|471759079|FG003|Overall Study|Miscellaneous|10|||
131034099|NCT02577835|471759080|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
131034100|NCT04676022|471759081|FG000|Overall Study|Screen Failure/|1|||
131034101|NCT04676022|471759082|FG001|Overall Study|Screen Failure/|1|||
131034102|NCT04676022|471759083|FG002|Overall Study|Screen Failure/|85|||
131034103|NCT04676022|471759081|FG000|Overall Study|Lost to Follow-up|1|||
131119913|NCT03250832|472070343|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131119914|NCT03250832|472070344|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131119915|NCT03250832|472070345|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
130699731|NCT01332968|470524722|FG003|Follow-Up Period|Protocol Violation|0|||
130699732|NCT01332968|470524723|FG004|Follow-Up Period|Protocol Violation|0|||
130699733|NCT01332968|470524724|FG005|Follow-Up Period|Protocol Violation|0|||
130699734|NCT01332968|470524725|FG006|Follow-Up Period|Protocol Violation|1|||
130699735|NCT01332968|470524726|FG007|Follow-Up Period|Protocol Violation|0|||
130699736|NCT01332968|470524719|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130699737|NCT01332968|470524720|FG001|Follow-Up Period|Withdrawal by Subject|0|||
130699738|NCT01332968|470524721|FG002|Follow-Up Period|Withdrawal by Subject|0|||
130699739|NCT01332968|470524722|FG003|Follow-Up Period|Withdrawal by Subject|0|||
130699740|NCT01332968|470524723|FG004|Follow-Up Period|Withdrawal by Subject|0|||
130699741|NCT01332968|470524724|FG005|Follow-Up Period|Withdrawal by Subject|0|||
130699742|NCT01332968|470524725|FG006|Follow-Up Period|Withdrawal by Subject|29|||
130699743|NCT01332968|470524726|FG007|Follow-Up Period|Withdrawal by Subject|32|||
130699744|NCT01332968|470524719|FG000|Follow-Up Period|No reason provided|0|||
130699745|NCT01332968|470524720|FG001|Follow-Up Period|No reason provided|0|||
130769310|NCT00055497|470780601|FG003|Overall Study|Lost to Follow-up|5|||
131034104|NCT04676022|471759082|FG001|Overall Study|Lost to Follow-up|1|||
131119916|NCT03250832|472070346|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
130699746|NCT01332968|470524721|FG002|Follow-Up Period|No reason provided|0|||
130699747|NCT01332968|470524722|FG003|Follow-Up Period|No reason provided|0|||
130699748|NCT01332968|470524723|FG004|Follow-Up Period|No reason provided|0|||
131034105|NCT04676022|471759083|FG002|Overall Study|Lost to Follow-up|0|||
131034106|NCT04676022|471759081|FG000|Overall Study|Adverse Event|2|||
131034107|NCT04676022|471759082|FG001|Overall Study|Adverse Event|0|||
131034108|NCT04676022|471759083|FG002|Overall Study|Adverse Event|1|||
131034109|NCT04676022|471759081|FG000|Overall Study|Physician Decision|2|||
131034110|NCT04676022|471759082|FG001|Overall Study|Physician Decision|0|||
131034111|NCT04676022|471759083|FG002|Overall Study|Physician Decision|1|||
130919264|NCT02215096|471338741|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
130919265|NCT02215096|471338742|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
130919266|NCT02215096|471338743|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
130919267|NCT02215096|471338744|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
130919268|NCT02215096|471338740|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
130919269|NCT02215096|471338741|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
130919270|NCT02215096|471338742|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
130919271|NCT02215096|471338743|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
130699749|NCT01332968|470524724|FG005|Follow-Up Period|No reason provided|0|||
130699750|NCT01332968|470524725|FG006|Follow-Up Period|No reason provided|2|||
130699751|NCT01332968|470524726|FG007|Follow-Up Period|No reason provided|3|||
130919272|NCT02215096|471338744|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
130919273|NCT02215096|471338740|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
130919274|NCT02215096|471338741|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
130919275|NCT02215096|471338742|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
130919276|NCT02215096|471338743|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
130919277|NCT02215096|471338744|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
130919278|NCT02215096|471338740|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
130919279|NCT02215096|471338741|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
130919280|NCT02215096|471338742|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
130919281|NCT02215096|471338743|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
130919282|NCT02215096|471338744|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
130919283|NCT02840721|471338745|FG000|Treatment Period|Adverse Event|1|||
130919284|NCT02840721|471338745|FG000|Follow-Up|Lack of Efficacy|1|||
130919285|NCT02840721|471338745|FG000|Follow-Up|Withdrawal by Subject|4|||
130919286|NCT02840721|471338745|FG000|Follow-Up|Withdrawal of Consent|2|||
130919287|NCT00423514|471338747|FG000|Overall Study|Ineligible|1|||
130699752|NCT03480022|470524727|FG000|Overall Study|Pregnancy|2|||
130919288|NCT00423514|471338748|FG001|Overall Study|Ineligible|0|||
130919289|NCT03685123|471338749|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
130699753|NCT03480022|470524728|FG001|Overall Study|Pregnancy|0|||
130699754|NCT03480022|470524727|FG000|Overall Study|Adverse Event|6|||
130699755|NCT03480022|470524728|FG001|Overall Study|Adverse Event|0|||
130699756|NCT03480022|470524727|FG000|Overall Study|Lack of Efficacy|0|||
130699757|NCT03480022|470524728|FG001|Overall Study|Lack of Efficacy|2|||
130699758|NCT03480022|470524727|FG000|Overall Study|Physician Decision|0|||
130699759|NCT03480022|470524728|FG001|Overall Study|Physician Decision|1|||
130769311|NCT00055497|470780598|FG000|Overall Study|Protocol Violation|0|||
130769312|NCT00055497|470780599|FG001|Overall Study|Protocol Violation|0|||
130919290|NCT03685123|471338750|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
130919291|NCT03685123|471338751|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
130919292|NCT03685123|471338749|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
130919293|NCT03685123|471338750|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
130919294|NCT03685123|471338751|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
130919295|NCT03685123|471338749|FG000|Weight Loss Phase|Lost to Follow-up|1|||
130919296|NCT03685123|471338750|FG001|Weight Loss Phase|Lost to Follow-up|0|||
130919297|NCT03685123|471338751|FG002|Weight Loss Phase|Lost to Follow-up|0|||
130919298|NCT03685123|471338749|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
130919299|NCT03685123|471338750|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
130919300|NCT03685123|471338751|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
130919301|NCT03685123|471338749|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
130919302|NCT03685123|471338750|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
130919303|NCT03685123|471338751|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
130919304|NCT03685123|471338749|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
130919305|NCT03685123|471338750|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
130919306|NCT03685123|471338751|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
130919307|NCT01402011|471338752|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
130919308|NCT01402011|471338753|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
130919309|NCT01402011|471338754|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
131034112|NCT04676022|471759081|FG000|Overall Study|Withdrawal by Subject|3|||
131034113|NCT04676022|471759082|FG001|Overall Study|Withdrawal by Subject|1|||
131034114|NCT04676022|471759083|FG002|Overall Study|Withdrawal by Subject|6|||
131223138|NCT00550420|472445016|FG000|Overall Study|Lost to Follow-up|8|||
130699760|NCT03480022|470524727|FG000|Overall Study|Withdrawal by Subject|2|||
130699761|NCT03480022|470524728|FG001|Overall Study|Withdrawal by Subject|0|||
130699762|NCT03480022|470524727|FG000|Overall Study|Medication concerns|1|||
130699763|NCT03480022|470524728|FG001|Overall Study|Medication concerns|0|||
130699764|NCT03480022|470524727|FG000|Overall Study|Family member COVID exposure|0|||
130919310|NCT01402011|471338752|FG000|Active Treatment Period|Withdrawal by Subject|1|||
130919311|NCT01402011|471338753|FG001|Active Treatment Period|Withdrawal by Subject|3|||
130919312|NCT01402011|471338754|FG002|Active Treatment Period|Withdrawal by Subject|0|||
130699765|NCT03480022|470524728|FG001|Overall Study|Family member COVID exposure|1|||
130919313|NCT01402011|471338752|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
130919314|NCT01402011|471338753|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
130919315|NCT01402011|471338754|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
130919316|NCT00717093|471340699|FG000|Overall Study|Adverse Event|19|||
130919317|NCT00717093|471340700|FG001|Overall Study|Adverse Event|9|||
130919318|NCT00717093|471340699|FG000|Overall Study|Lack of Efficacy|3|||
130919319|NCT00717093|471340700|FG001|Overall Study|Lack of Efficacy|13|||
130919320|NCT00717093|471340699|FG000|Overall Study|Lost to Follow-up|9|||
130919321|NCT00717093|471340700|FG001|Overall Study|Lost to Follow-up|6|||
130919322|NCT00717093|471340699|FG000|Overall Study|Withdrawal by Subject|12|||
130919323|NCT00717093|471340700|FG001|Overall Study|Withdrawal by Subject|19|||
130919324|NCT00717093|471340699|FG000|Overall Study|Other|0|||
130919325|NCT00717093|471340700|FG001|Overall Study|Other|1|||
130919326|NCT00717093|471340699|FG000|Overall Study|Randomized but not treated|1|||
130919327|NCT00717093|471340700|FG001|Overall Study|Randomized but not treated|0|||
130919328|NCT00531934|471340701|FG000|Overall Study|Adverse Event|4|||
130919329|NCT00531934|471340702|FG001|Overall Study|Adverse Event|8|||
130919330|NCT00531934|471340701|FG000|Overall Study|Progression|52|||
130919331|NCT00531934|471340702|FG001|Overall Study|Progression|42|||
130919332|NCT00531934|471340701|FG000|Overall Study|Death|7|||
130919333|NCT00531934|471340702|FG001|Overall Study|Death|10|||
130919334|NCT00531934|471340701|FG000|Overall Study|Withdrawal by Subject|1|||
130919335|NCT00531934|471340702|FG001|Overall Study|Withdrawal by Subject|1|||
130919336|NCT00531934|471340701|FG000|Overall Study|Other|2|||
130919337|NCT00531934|471340702|FG001|Overall Study|Other|2|||
130919338|NCT01543698|471340707|FG000|Phase 1b|Disease progression|2|||
130919339|NCT01543698|471340708|FG001|Phase 1b|Disease progression|4|||
130919340|NCT01543698|471340709|FG002|Phase 1b|Disease progression|3|||
130919341|NCT01543698|471340710|FG003|Phase 1b|Disease progression|2|||
130919342|NCT01543698|471340711|FG004|Phase 1b|Disease progression|10|||
130919343|NCT01543698|471340712|FG005|Phase 1b|Disease progression|6|||
130919344|NCT01543698|471340713|FG006|Phase 1b|Disease progression|5|||
130919345|NCT01543698|471340714|FG007|Phase 1b|Disease progression|3|||
130919346|NCT01543698|471340715|FG008|Phase 1b|Disease progression|4|||
130919347|NCT01543698|471340716|FG009|Phase 1b|Disease progression|5|||
130919348|NCT01543698|471340717|FG010|Phase 1b|Disease progression|1|||
130919349|NCT01543698|471340718|FG011|Phase 1b|Disease progression|0|||
130919350|NCT01543698|471340719|FG012|Phase 1b|Disease progression|0|||
130919351|NCT01543698|471340720|FG013|Phase 1b|Disease progression|0|||
130919352|NCT01543698|471340721|FG014|Phase 1b|Disease progression|0|||
130919353|NCT01543698|471340707|FG000|Phase 1b|Death|0|||
130919354|NCT01543698|471340708|FG001|Phase 1b|Death|0|||
130919355|NCT01543698|471340709|FG002|Phase 1b|Death|1|||
130919356|NCT01543698|471340710|FG003|Phase 1b|Death|1|||
130919357|NCT01543698|471340711|FG004|Phase 1b|Death|0|||
130919358|NCT01543698|471340712|FG005|Phase 1b|Death|0|||
130919359|NCT01543698|471340713|FG006|Phase 1b|Death|0|||
131119917|NCT03250832|472070347|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131119918|NCT03250832|472070348|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
131119919|NCT03250832|472070337|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131119920|NCT03250832|472070338|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131119921|NCT03250832|472070339|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131119922|NCT03250832|472070340|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131119923|NCT03250832|472070341|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131119924|NCT03250832|472070342|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131119925|NCT03250832|472070343|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131119926|NCT03250832|472070344|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131119927|NCT03250832|472070345|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131119928|NCT03250832|472070346|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130919360|NCT01543698|471340714|FG007|Phase 1b|Death|0|||
130919361|NCT01543698|471340715|FG008|Phase 1b|Death|0|||
130919362|NCT01543698|471340716|FG009|Phase 1b|Death|0|||
130919363|NCT01543698|471340717|FG010|Phase 1b|Death|1|||
131119929|NCT03250832|472070347|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
131119930|NCT03250832|472070348|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
131119931|NCT02303704|472070349|FG000|Overall Study|Protocol Violation|5|||
131119932|NCT02303704|472070350|FG001|Overall Study|Protocol Violation|9|||
130769313|NCT00055497|470780600|FG002|Overall Study|Protocol Violation|0|||
130919364|NCT01543698|471340718|FG011|Phase 1b|Death|0|||
130919365|NCT01543698|471340719|FG012|Phase 1b|Death|0|||
130919366|NCT01543698|471340720|FG013|Phase 1b|Death|0|||
130919367|NCT01543698|471340721|FG014|Phase 1b|Death|0|||
130919368|NCT01543698|471340707|FG000|Phase 1b|Withdrawal by Subject|0|||
130919369|NCT01543698|471340708|FG001|Phase 1b|Withdrawal by Subject|1|||
130919370|NCT01543698|471340709|FG002|Phase 1b|Withdrawal by Subject|0|||
130919371|NCT01543698|471340710|FG003|Phase 1b|Withdrawal by Subject|1|||
130919372|NCT01543698|471340711|FG004|Phase 1b|Withdrawal by Subject|0|||
130919373|NCT01543698|471340712|FG005|Phase 1b|Withdrawal by Subject|0|||
130919374|NCT01543698|471340713|FG006|Phase 1b|Withdrawal by Subject|1|||
130919375|NCT01543698|471340714|FG007|Phase 1b|Withdrawal by Subject|0|||
130919376|NCT01543698|471340715|FG008|Phase 1b|Withdrawal by Subject|0|||
130919377|NCT01543698|471340716|FG009|Phase 1b|Withdrawal by Subject|0|||
130919378|NCT01543698|471340717|FG010|Phase 1b|Withdrawal by Subject|0|||
130919379|NCT01543698|471340718|FG011|Phase 1b|Withdrawal by Subject|0|||
130919380|NCT01543698|471340719|FG012|Phase 1b|Withdrawal by Subject|0|||
130919381|NCT01543698|471340720|FG013|Phase 1b|Withdrawal by Subject|0|||
130919382|NCT01543698|471340721|FG014|Phase 1b|Withdrawal by Subject|0|||
130919383|NCT01543698|471340707|FG000|Phase 1b|Adverse Event|1|||
130699766|NCT00640926|470524729|FG000|Overall Study|Adverse Event|2|||
130699767|NCT00640926|470524730|FG001|Overall Study|Adverse Event|3|||
130699768|NCT00640926|470524731|FG002|Overall Study|Adverse Event|2|||
130699769|NCT00640926|470524729|FG000|Overall Study|Lack of Efficacy|0|||
130699770|NCT00640926|470524730|FG001|Overall Study|Lack of Efficacy|2|||
130699771|NCT00640926|470524731|FG002|Overall Study|Lack of Efficacy|1|||
130699772|NCT00640926|470524729|FG000|Overall Study|Protocol Violation|2|||
130699773|NCT00640926|470524730|FG001|Overall Study|Protocol Violation|0|||
130699774|NCT00640926|470524731|FG002|Overall Study|Protocol Violation|2|||
130699775|NCT00640926|470524729|FG000|Overall Study|Lost to Follow-up|3|||
130699776|NCT00640926|470524730|FG001|Overall Study|Lost to Follow-up|1|||
130699777|NCT00640926|470524731|FG002|Overall Study|Lost to Follow-up|2|||
130919384|NCT01543698|471340708|FG001|Phase 1b|Adverse Event|0|||
130919385|NCT01543698|471340709|FG002|Phase 1b|Adverse Event|0|||
130919386|NCT01543698|471340710|FG003|Phase 1b|Adverse Event|1|||
130919387|NCT01543698|471340711|FG004|Phase 1b|Adverse Event|2|||
130919388|NCT01543698|471340712|FG005|Phase 1b|Adverse Event|2|||
130919389|NCT01543698|471340713|FG006|Phase 1b|Adverse Event|0|||
130919390|NCT01543698|471340714|FG007|Phase 1b|Adverse Event|0|||
130919391|NCT01543698|471340715|FG008|Phase 1b|Adverse Event|1|||
130919392|NCT01543698|471340716|FG009|Phase 1b|Adverse Event|1|||
130919393|NCT01543698|471340717|FG010|Phase 1b|Adverse Event|2|||
130919394|NCT01543698|471340718|FG011|Phase 1b|Adverse Event|0|||
130919395|NCT01543698|471340719|FG012|Phase 1b|Adverse Event|0|||
130919396|NCT01543698|471340720|FG013|Phase 1b|Adverse Event|0|||
130919397|NCT01543698|471340721|FG014|Phase 1b|Adverse Event|0|||
130919398|NCT01543698|471340707|FG000|Phase 1b|Administrative problems|1|||
130919399|NCT01543698|471340708|FG001|Phase 1b|Administrative problems|0|||
130919400|NCT01543698|471340709|FG002|Phase 1b|Administrative problems|0|||
130919401|NCT01543698|471340710|FG003|Phase 1b|Administrative problems|0|||
130919402|NCT01543698|471340711|FG004|Phase 1b|Administrative problems|1|||
130919403|NCT01543698|471340712|FG005|Phase 1b|Administrative problems|0|||
130919404|NCT01543698|471340713|FG006|Phase 1b|Administrative problems|0|||
130919405|NCT01543698|471340714|FG007|Phase 1b|Administrative problems|1|||
130919406|NCT01543698|471340715|FG008|Phase 1b|Administrative problems|0|||
130919407|NCT01543698|471340716|FG009|Phase 1b|Administrative problems|0|||
130919408|NCT01543698|471340717|FG010|Phase 1b|Administrative problems|2|||
130919409|NCT01543698|471340718|FG011|Phase 1b|Administrative problems|0|||
130919410|NCT01543698|471340719|FG012|Phase 1b|Administrative problems|0|||
130919411|NCT01543698|471340720|FG013|Phase 1b|Administrative problems|0|||
130919412|NCT01543698|471340721|FG014|Phase 1b|Administrative problems|0|||
130919413|NCT01543698|471340707|FG000|Phase 1b|Protocol Violation|2|||
130919414|NCT01543698|471340708|FG001|Phase 1b|Protocol Violation|0|||
130919415|NCT01543698|471340709|FG002|Phase 1b|Protocol Violation|0|||
130919416|NCT01543698|471340710|FG003|Phase 1b|Protocol Violation|0|||
130919417|NCT01543698|471340711|FG004|Phase 1b|Protocol Violation|0|||
130919418|NCT01543698|471340712|FG005|Phase 1b|Protocol Violation|0|||
130919419|NCT01543698|471340713|FG006|Phase 1b|Protocol Violation|0|||
130919420|NCT01543698|471340714|FG007|Phase 1b|Protocol Violation|0|||
130919421|NCT01543698|471340715|FG008|Phase 1b|Protocol Violation|0|||
131034115|NCT04676022|471759081|FG000|Overall Study|Will not move forward with permanent implant|6|||
130919422|NCT01543698|471340716|FG009|Phase 1b|Protocol Violation|0|||
130919423|NCT01543698|471340717|FG010|Phase 1b|Protocol Violation|0|||
130919424|NCT01543698|471340718|FG011|Phase 1b|Protocol Violation|0|||
131034116|NCT04676022|471759082|FG001|Overall Study|Will not move forward with permanent implant|0|||
131034117|NCT04676022|471759083|FG002|Overall Study|Will not move forward with permanent implant|0|||
131034118|NCT04676022|471759081|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
131034119|NCT04676022|471759082|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
130699778|NCT00640926|470524729|FG000|Overall Study|Withdrawal by Subject|1|||
130699779|NCT00640926|470524730|FG001|Overall Study|Withdrawal by Subject|0|||
130699780|NCT00640926|470524731|FG002|Overall Study|Withdrawal by Subject|1|||
130699781|NCT03922750|470524732|FG000|Overall Study|Unclassified|0|||
130699782|NCT03922750|470524733|FG001|Overall Study|Unclassified|0|||
130699783|NCT03922750|470524734|FG002|Overall Study|Unclassified|1|||
130919425|NCT01543698|471340719|FG012|Phase 1b|Protocol Violation|0|||
130919426|NCT01543698|471340720|FG013|Phase 1b|Protocol Violation|0|||
130919427|NCT01543698|471340721|FG014|Phase 1b|Protocol Violation|0|||
130919428|NCT01543698|471340707|FG000|Phase 2|Protocol Violation|0|||
130919429|NCT01543698|471340708|FG001|Phase 2|Protocol Violation|0|||
130919430|NCT01543698|471340709|FG002|Phase 2|Protocol Violation|0|||
130919431|NCT01543698|471340710|FG003|Phase 2|Protocol Violation|0|||
130919432|NCT01543698|471340711|FG004|Phase 2|Protocol Violation|0|||
130919433|NCT01543698|471340712|FG005|Phase 2|Protocol Violation|0|||
130919434|NCT01543698|471340713|FG006|Phase 2|Protocol Violation|0|||
130919435|NCT01543698|471340714|FG007|Phase 2|Protocol Violation|0|||
130919436|NCT01543698|471340715|FG008|Phase 2|Protocol Violation|0|||
130919437|NCT01543698|471340716|FG009|Phase 2|Protocol Violation|0|||
130919438|NCT01543698|471340717|FG010|Phase 2|Protocol Violation|0|||
130919439|NCT01543698|471340718|FG011|Phase 2|Protocol Violation|0|||
130919440|NCT01543698|471340719|FG012|Phase 2|Protocol Violation|1|||
130919441|NCT01543698|471340720|FG013|Phase 2|Protocol Violation|0|||
130919442|NCT01543698|471340721|FG014|Phase 2|Protocol Violation|0|||
130919443|NCT01543698|471340707|FG000|Phase 2|Disease progression|0|||
130919444|NCT01543698|471340708|FG001|Phase 2|Disease progression|0|||
130919445|NCT01543698|471340709|FG002|Phase 2|Disease progression|0|||
130919446|NCT01543698|471340710|FG003|Phase 2|Disease progression|0|||
130919447|NCT01543698|471340711|FG004|Phase 2|Disease progression|0|||
130919448|NCT01543698|471340712|FG005|Phase 2|Disease progression|0|||
131034120|NCT04676022|471759083|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
131034121|NCT05409183|471759087|FG000|Complete Study|Adverse Event|1|||
131034122|NCT05409183|471759088|FG001|Complete Study|Adverse Event|2|||
131034123|NCT05409183|471759087|FG000|Complete Study|Withdrawal by Subject|3|||
131034124|NCT05409183|471759088|FG001|Complete Study|Withdrawal by Subject|0|||
131034125|NCT02274662|471759089|FG000|Overall Study|Death|1|||
131034126|NCT02274662|471759089|FG000|Overall Study|Lost to Follow-up|3|||
131034127|NCT03194217|471759090|FG000|Overall Study|Adverse Event|0|||
131034128|NCT03194217|471759091|FG001|Overall Study|Adverse Event|2|||
131034129|NCT03194217|471759092|FG002|Overall Study|Adverse Event|3|||
131034130|NCT03194217|471759093|FG003|Overall Study|Adverse Event|3|||
131034131|NCT03194217|471759090|FG000|Overall Study|Failure to meet randomisation criteria|0|||
131034132|NCT03194217|471759091|FG001|Overall Study|Failure to meet randomisation criteria|0|||
131034133|NCT03194217|471759092|FG002|Overall Study|Failure to meet randomisation criteria|0|||
131034134|NCT03194217|471759093|FG003|Overall Study|Failure to meet randomisation criteria|1|||
131034135|NCT03194217|471759090|FG000|Overall Study|Other|0|||
131034136|NCT03194217|471759091|FG001|Overall Study|Other|1|||
131034137|NCT03194217|471759092|FG002|Overall Study|Other|1|||
131034138|NCT03194217|471759093|FG003|Overall Study|Other|0|||
131034139|NCT02936752|471759094|FG000|Overall Study|Death|2|||
131034140|NCT02936752|471759095|FG001|Overall Study|Death|1|||
130699784|NCT03922750|470524732|FG000|Overall Study|Adverse Event|0|||
130699785|NCT03922750|470524733|FG001|Overall Study|Adverse Event|1|||
130699786|NCT03922750|470524734|FG002|Overall Study|Adverse Event|0|||
130699787|NCT02985398|470524735|FG000|Overall Study|Adverse Event|1|||
130699788|NCT02985398|470524735|FG000|Overall Study|Lost to Follow-up|4|||
130699789|NCT02985398|470524735|FG000|Overall Study|Withdrawal by Subject|8|||
130699790|NCT02985398|470524735|FG000|Overall Study|Study Burden|9|||
130699791|NCT04164758|470524740|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
130699792|NCT04164758|470524741|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
130699793|NCT04164758|470524742|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
130699794|NCT04164758|470524740|FG000|Overall Study|Adverse Event|0|||
130699795|NCT04164758|470524741|FG001|Overall Study|Adverse Event|1|||
130699796|NCT04164758|470524742|FG002|Overall Study|Adverse Event|0|||
130699797|NCT01670097|470524743|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
130699798|NCT01670097|470524744|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
130699799|NCT01670097|470524743|FG000|Overall Study|Study burden|1|||
130699800|NCT01670097|470524744|FG001|Overall Study|Study burden|0|||
130699801|NCT01670097|470524743|FG000|Overall Study|COPD exacerbation|0|||
130699802|NCT01670097|470524744|FG001|Overall Study|COPD exacerbation|1|||
130699803|NCT01670097|470524743|FG000|Overall Study|Neutropenia|0|||
130699804|NCT01670097|470524744|FG001|Overall Study|Neutropenia|1|||
130699805|NCT01670097|470524743|FG000|Overall Study|Clinical deterioration|0|||
130699806|NCT01670097|470524744|FG001|Overall Study|Clinical deterioration|1|||
130769314|NCT00055497|470780601|FG003|Overall Study|Protocol Violation|3|||
130919449|NCT01543698|471340713|FG006|Phase 2|Disease progression|0|||
130919450|NCT01543698|471340714|FG007|Phase 2|Disease progression|0|||
130919451|NCT01543698|471340715|FG008|Phase 2|Disease progression|0|||
130919452|NCT01543698|471340716|FG009|Phase 2|Disease progression|0|||
130919453|NCT01543698|471340717|FG010|Phase 2|Disease progression|0|||
131034141|NCT02936752|471759094|FG000|Overall Study|Physician Decision|4|||
131034142|NCT02936752|471759095|FG001|Overall Study|Physician Decision|0|||
130699807|NCT01670097|470524743|FG000|Overall Study|Disease progression|0|||
130699808|NCT01670097|470524744|FG001|Overall Study|Disease progression|1|||
130699809|NCT00697827|470524745|FG000|Overall Study|enrolled but not treated|2|||
130699810|NCT00697827|470524746|FG001|Overall Study|enrolled but not treated|1|||
130699811|NCT05665387|470524749|FG000|Overall Study|Withdrawal by Subject|1|||
130699812|NCT05665387|470524750|FG001|Overall Study|Withdrawal by Subject|0|||
130919454|NCT01543698|471340718|FG011|Phase 2|Disease progression|10|||
130919455|NCT01543698|471340719|FG012|Phase 2|Disease progression|21|||
130919456|NCT01543698|471340720|FG013|Phase 2|Disease progression|30|||
131034143|NCT02936752|471759094|FG000|Overall Study|Withdrawal by Subject|0|||
130919457|NCT01543698|471340721|FG014|Phase 2|Disease progression|25|||
130919458|NCT01543698|471340707|FG000|Phase 2|Death|0|||
130919459|NCT01543698|471340708|FG001|Phase 2|Death|0|||
130919460|NCT01543698|471340709|FG002|Phase 2|Death|0|||
130919461|NCT01543698|471340710|FG003|Phase 2|Death|0|||
130919462|NCT01543698|471340711|FG004|Phase 2|Death|0|||
130919463|NCT01543698|471340712|FG005|Phase 2|Death|0|||
130919464|NCT01543698|471340713|FG006|Phase 2|Death|0|||
130919465|NCT01543698|471340714|FG007|Phase 2|Death|0|||
130919466|NCT01543698|471340715|FG008|Phase 2|Death|0|||
130919467|NCT01543698|471340716|FG009|Phase 2|Death|0|||
130919468|NCT01543698|471340717|FG010|Phase 2|Death|0|||
130919469|NCT01543698|471340718|FG011|Phase 2|Death|0|||
130919470|NCT01543698|471340719|FG012|Phase 2|Death|1|||
130919471|NCT01543698|471340720|FG013|Phase 2|Death|1|||
130919472|NCT01543698|471340721|FG014|Phase 2|Death|1|||
130919473|NCT01543698|471340707|FG000|Phase 2|Administrative problems|0|||
130919474|NCT01543698|471340708|FG001|Phase 2|Administrative problems|0|||
130919475|NCT01543698|471340709|FG002|Phase 2|Administrative problems|0|||
130919476|NCT01543698|471340710|FG003|Phase 2|Administrative problems|0|||
130919477|NCT01543698|471340711|FG004|Phase 2|Administrative problems|0|||
130919478|NCT01543698|471340712|FG005|Phase 2|Administrative problems|0|||
130919479|NCT01543698|471340713|FG006|Phase 2|Administrative problems|0|||
130919480|NCT01543698|471340714|FG007|Phase 2|Administrative problems|0|||
130919481|NCT01543698|471340715|FG008|Phase 2|Administrative problems|0|||
130919482|NCT01543698|471340716|FG009|Phase 2|Administrative problems|0|||
130919483|NCT01543698|471340717|FG010|Phase 2|Administrative problems|0|||
130919484|NCT01543698|471340718|FG011|Phase 2|Administrative problems|0|||
130919485|NCT01543698|471340719|FG012|Phase 2|Administrative problems|0|||
130919486|NCT01543698|471340720|FG013|Phase 2|Administrative problems|3|||
130919487|NCT01543698|471340721|FG014|Phase 2|Administrative problems|1|||
130919488|NCT01543698|471340707|FG000|Phase 2|Withdrawal by Subject|0|||
130919489|NCT01543698|471340708|FG001|Phase 2|Withdrawal by Subject|0|||
130919490|NCT01543698|471340709|FG002|Phase 2|Withdrawal by Subject|0|||
130919491|NCT01543698|471340710|FG003|Phase 2|Withdrawal by Subject|0|||
130919492|NCT01543698|471340711|FG004|Phase 2|Withdrawal by Subject|0|||
130919493|NCT01543698|471340712|FG005|Phase 2|Withdrawal by Subject|0|||
130919494|NCT01543698|471340713|FG006|Phase 2|Withdrawal by Subject|0|||
130919495|NCT01543698|471340714|FG007|Phase 2|Withdrawal by Subject|0|||
130919496|NCT01543698|471340715|FG008|Phase 2|Withdrawal by Subject|0|||
130919497|NCT01543698|471340716|FG009|Phase 2|Withdrawal by Subject|0|||
130919498|NCT01543698|471340717|FG010|Phase 2|Withdrawal by Subject|0|||
130919499|NCT01543698|471340718|FG011|Phase 2|Withdrawal by Subject|0|||
130919500|NCT01543698|471340719|FG012|Phase 2|Withdrawal by Subject|0|||
130919501|NCT01543698|471340720|FG013|Phase 2|Withdrawal by Subject|3|||
130919502|NCT01543698|471340721|FG014|Phase 2|Withdrawal by Subject|1|||
130919503|NCT01543698|471340707|FG000|Phase 2|Adverse Event|0|||
130919504|NCT01543698|471340708|FG001|Phase 2|Adverse Event|0|||
130919505|NCT01543698|471340709|FG002|Phase 2|Adverse Event|0|||
130919506|NCT01543698|471340710|FG003|Phase 2|Adverse Event|0|||
130919507|NCT01543698|471340711|FG004|Phase 2|Adverse Event|0|||
130919508|NCT01543698|471340712|FG005|Phase 2|Adverse Event|0|||
130919509|NCT01543698|471340713|FG006|Phase 2|Adverse Event|0|||
130919510|NCT01543698|471340714|FG007|Phase 2|Adverse Event|0|||
131223139|NCT00550420|472445016|FG000|Overall Study|Protocol Violation|11|||
131223140|NCT00550420|472445016|FG000|Overall Study|Withdrawal by Subject|30|||
131223141|NCT00550420|472445016|FG000|Overall Study|Still in study at termination|206|||
131223142|NCT00550420|472445016|FG000|Overall Study|Missing|2|||
131223143|NCT00550420|472445016|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
131223144|NCT00550420|472445016|FG000|Overall Study|Investigators opinion|1|||
130699813|NCT05665387|470524751|FG002|Overall Study|Withdrawal by Subject|1|||
130699814|NCT03732833|470524754|FG000|Overall Study|Adverse Event|0|||
130919511|NCT01543698|471340715|FG008|Phase 2|Adverse Event|0|||
130919512|NCT01543698|471340716|FG009|Phase 2|Adverse Event|0|||
130919513|NCT01543698|471340717|FG010|Phase 2|Adverse Event|0|||
130919514|NCT01543698|471340718|FG011|Phase 2|Adverse Event|1|||
130919515|NCT01543698|471340719|FG012|Phase 2|Adverse Event|3|||
130919516|NCT01543698|471340720|FG013|Phase 2|Adverse Event|5|||
130919517|NCT01543698|471340721|FG014|Phase 2|Adverse Event|14|||
130919518|NCT00217620|471340722|FG000|Overall Study|Adverse Event|2|||
130919519|NCT00217620|471340722|FG000|Overall Study|Progression|31|||
130919520|NCT00217620|471340722|FG000|Overall Study|Not Protocol Specified|4|||
130919521|NCT00217620|471340722|FG000|Overall Study|Ineligible|13|||
131223145|NCT00550420|472445016|FG000|Overall Study|Lack of curative effect|1|||
131223146|NCT00550420|472445016|FG000|Overall Study|Unethical stop of enrollment|2|||
130919522|NCT00217620|471340722|FG000|Overall Study|Never received treatment|1|||
130699815|NCT03732833|470524755|FG001|Overall Study|Adverse Event|3|||
130919523|NCT00150709|471340723|FG000|Overall Study|Protocol Violation|7|||
130919524|NCT00150709|471340724|FG001|Overall Study|Protocol Violation|8|||
130919525|NCT00150709|471340725|FG002|Overall Study|Protocol Violation|3|||
130919526|NCT00150709|471340726|FG003|Overall Study|Protocol Violation|1|||
130919527|NCT00150709|471340723|FG000|Overall Study|Adverse Event|8|||
130919528|NCT00150709|471340724|FG001|Overall Study|Adverse Event|2|||
130919529|NCT00150709|471340725|FG002|Overall Study|Adverse Event|2|||
130919530|NCT00150709|471340726|FG003|Overall Study|Adverse Event|3|||
130919531|NCT00150709|471340723|FG000|Overall Study|Lack of Efficacy|6|||
130919532|NCT00150709|471340724|FG001|Overall Study|Lack of Efficacy|11|||
130919533|NCT00150709|471340725|FG002|Overall Study|Lack of Efficacy|9|||
130919534|NCT00150709|471340726|FG003|Overall Study|Lack of Efficacy|0|||
130919535|NCT00150709|471340723|FG000|Overall Study|Withdrawal by Subject|7|||
130919536|NCT00150709|471340724|FG001|Overall Study|Withdrawal by Subject|10|||
130919537|NCT00150709|471340725|FG002|Overall Study|Withdrawal by Subject|5|||
130919538|NCT00150709|471340726|FG003|Overall Study|Withdrawal by Subject|0|||
130919539|NCT00150709|471340723|FG000|Overall Study|Lost to Follow-up|3|||
130919540|NCT00150709|471340724|FG001|Overall Study|Lost to Follow-up|2|||
130919541|NCT00150709|471340725|FG002|Overall Study|Lost to Follow-up|0|||
130919542|NCT00150709|471340726|FG003|Overall Study|Lost to Follow-up|0|||
130919543|NCT00150709|471340723|FG000|Overall Study|Sponsor decision|0|||
130919544|NCT00150709|471340724|FG001|Overall Study|Sponsor decision|0|||
130919545|NCT00150709|471340725|FG002|Overall Study|Sponsor decision|0|||
130919546|NCT00150709|471340726|FG003|Overall Study|Sponsor decision|1|||
130919547|NCT00150709|471340723|FG000|Overall Study|Site/Investigator discontinued the study|5|||
130919548|NCT00150709|471340724|FG001|Overall Study|Site/Investigator discontinued the study|5|||
130919549|NCT00150709|471340725|FG002|Overall Study|Site/Investigator discontinued the study|2|||
130919550|NCT00150709|471340726|FG003|Overall Study|Site/Investigator discontinued the study|0|||
130919551|NCT00150709|471340723|FG000|Overall Study|Decision of parent(s)|1|||
130919552|NCT00150709|471340724|FG001|Overall Study|Decision of parent(s)|2|||
130919553|NCT00150709|471340725|FG002|Overall Study|Decision of parent(s)|0|||
130919554|NCT00150709|471340726|FG003|Overall Study|Decision of parent(s)|0|||
130919555|NCT00150709|471340723|FG000|Overall Study|Decision of parent(s) and investigator|3|||
130919556|NCT00150709|471340724|FG001|Overall Study|Decision of parent(s) and investigator|0|||
130919557|NCT00150709|471340725|FG002|Overall Study|Decision of parent(s) and investigator|0|||
130919558|NCT00150709|471340726|FG003|Overall Study|Decision of parent(s) and investigator|0|||
130919559|NCT00150709|471340723|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
130919560|NCT00150709|471340724|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
130919561|NCT00150709|471340725|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
130919562|NCT00150709|471340726|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
130919563|NCT00150709|471340723|FG000|Overall Study|Investigator decision|1|||
130919564|NCT00150709|471340724|FG001|Overall Study|Investigator decision|0|||
130919565|NCT00150709|471340725|FG002|Overall Study|Investigator decision|0|||
130919566|NCT00150709|471340726|FG003|Overall Study|Investigator decision|1|||
130919567|NCT00150709|471340723|FG000|Overall Study|Subject relocated|2|||
130919568|NCT00150709|471340724|FG001|Overall Study|Subject relocated|2|||
130919569|NCT00150709|471340725|FG002|Overall Study|Subject relocated|1|||
130919570|NCT00150709|471340726|FG003|Overall Study|Subject relocated|0|||
130919571|NCT00150709|471340723|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
130919572|NCT00150709|471340724|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
130919573|NCT00150709|471340725|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
130919574|NCT00150709|471340726|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
130919575|NCT00150709|471340723|FG000|Overall Study|Convenience|0|||
130919576|NCT00150709|471340724|FG001|Overall Study|Convenience|1|||
130919577|NCT00150709|471340725|FG002|Overall Study|Convenience|0|||
130919578|NCT00150709|471340726|FG003|Overall Study|Convenience|0|||
130919579|NCT00150709|471340723|FG000|Overall Study|Subject entered new drug study|0|||
130919580|NCT00150709|471340724|FG001|Overall Study|Subject entered new drug study|1|||
130919581|NCT00150709|471340725|FG002|Overall Study|Subject entered new drug study|0|||
130919582|NCT00150709|471340726|FG003|Overall Study|Subject entered new drug study|0|||
130919583|NCT00150709|471340723|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
130919584|NCT00150709|471340724|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
130919585|NCT00150709|471340725|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
130919586|NCT00150709|471340726|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
130919587|NCT00150709|471340723|FG000|Overall Study|Lack of ease of swallowing|0|||
130919588|NCT00150709|471340724|FG001|Overall Study|Lack of ease of swallowing|1|||
130919589|NCT00150709|471340725|FG002|Overall Study|Lack of ease of swallowing|0|||
130919590|NCT00150709|471340726|FG003|Overall Study|Lack of ease of swallowing|0|||
130919591|NCT01626456|471340732|FG000|Overall Study|Withdrawal by Subject|21|||
130699816|NCT03732833|470524756|FG002|Overall Study|Adverse Event|1|||
130699817|NCT03732833|470524754|FG000|Overall Study|Withdrawal by Subject|11|||
130919592|NCT01626456|471340733|FG001|Overall Study|Withdrawal by Subject|46|||
130919593|NCT01626456|471340732|FG000|Overall Study|Adverse Event|2|||
130919594|NCT01626456|471340733|FG001|Overall Study|Adverse Event|27|||
130919595|NCT01626456|471340732|FG000|Overall Study|Lost to Follow-up|2|||
130919596|NCT01626456|471340733|FG001|Overall Study|Lost to Follow-up|27|||
130919597|NCT01626456|471340732|FG000|Overall Study|Lack of Efficacy|6|||
130919598|NCT01626456|471340733|FG001|Overall Study|Lack of Efficacy|7|||
130919599|NCT01626456|471340732|FG000|Overall Study|Physician Decision|1|||
130919600|NCT01626456|471340733|FG001|Overall Study|Physician Decision|4|||
130769315|NCT00055497|470780598|FG000|Overall Study|Lack of Efficacy|1|||
130919601|NCT01626456|471340732|FG000|Overall Study|Protocol Violation|1|||
130919602|NCT01626456|471340733|FG001|Overall Study|Protocol Violation|1|||
130919603|NCT01626456|471340732|FG000|Overall Study|Site Closure|2|||
130919604|NCT01626456|471340733|FG001|Overall Study|Site Closure|3|||
130919605|NCT01626456|471340732|FG000|Overall Study|Incarceration|0|||
130919606|NCT01626456|471340733|FG001|Overall Study|Incarceration|2|||
130919607|NCT04015336|471340734|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
130919608|NCT01816074|471340737|FG000|Phase 1|Time commitment issues|0|||
130919609|NCT01816074|471340738|FG001|Phase 1|Time commitment issues|0|||
130919610|NCT01816074|471340739|FG002|Phase 1|Time commitment issues|1|||
130919611|NCT01816074|471340740|FG003|Phase 1|Time commitment issues|0|||
130919612|NCT01816074|471340737|FG000|Phase 2|Time commitment Issues|0|||
130919613|NCT01816074|471340738|FG001|Phase 2|Time commitment Issues|2|||
130919614|NCT01816074|471340739|FG002|Phase 2|Time commitment Issues|0|||
130919615|NCT01816074|471340740|FG003|Phase 2|Time commitment Issues|0|||
130919616|NCT01816074|471340737|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
130919617|NCT01816074|471340738|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
130919618|NCT01816074|471340739|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
130919619|NCT01816074|471340740|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
130919620|NCT01816074|471340737|FG000|Phase 2|Physician Decision|0|||
130919621|NCT01816074|471340738|FG001|Phase 2|Physician Decision|0|||
130919622|NCT01816074|471340739|FG002|Phase 2|Physician Decision|0|||
130919623|NCT01816074|471340740|FG003|Phase 2|Physician Decision|1|||
130919624|NCT01816074|471340737|FG000|Phase 2|Withdrawal by Subject|1|||
130919625|NCT01816074|471340738|FG001|Phase 2|Withdrawal by Subject|0|||
130919626|NCT01816074|471340739|FG002|Phase 2|Withdrawal by Subject|0|||
130919627|NCT01816074|471340740|FG003|Phase 2|Withdrawal by Subject|0|||
130919628|NCT01868503|471340741|FG000|Overall Study|Withdrawal by Subject|1|||
130919629|NCT01868503|471340741|FG000|Overall Study|Protocol Violation|1|||
130919630|NCT03650556|471340742|FG000|Overall Study|Death|2|||
130919631|NCT03650556|471340742|FG000|Overall Study|Withdrawal by Subject|20|||
130919632|NCT03650556|471340742|FG000|Overall Study|Physician Decision|2|||
130919633|NCT03650556|471340742|FG000|Overall Study|Lost to Follow-up|8|||
130919634|NCT03650556|471340742|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
130919635|NCT03650556|471340742|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
130919636|NCT03228433|471340745|FG000|Overall Study|Lost to Follow-up|1|||
130919637|NCT03228433|471340746|FG001|Overall Study|Lost to Follow-up|0|||
130919638|NCT03228433|471340747|FG002|Overall Study|Lost to Follow-up|0|||
130919639|NCT03228433|471340748|FG003|Overall Study|Lost to Follow-up|0|||
130919640|NCT03228433|471340749|FG004|Overall Study|Lost to Follow-up|0|||
130919641|NCT03228433|471340750|FG005|Overall Study|Lost to Follow-up|0|||
130919642|NCT03228433|471340745|FG000|Overall Study|Positive alcohol test|0|||
130919643|NCT03228433|471340746|FG001|Overall Study|Positive alcohol test|0|||
130919644|NCT03228433|471340747|FG002|Overall Study|Positive alcohol test|0|||
130919645|NCT03228433|471340748|FG003|Overall Study|Positive alcohol test|1|||
130919646|NCT03228433|471340749|FG004|Overall Study|Positive alcohol test|0|||
130919647|NCT03228433|471340750|FG005|Overall Study|Positive alcohol test|0|||
130919648|NCT01030536|471340751|FG000|Overall Study|Withdrawal by Subject|0|||
130919649|NCT01030536|471340752|FG001|Overall Study|Withdrawal by Subject|0|||
130919650|NCT01030536|471340753|FG002|Overall Study|Withdrawal by Subject|1|||
130919651|NCT01030536|471340754|FG003|Overall Study|Withdrawal by Subject|0|||
130919652|NCT01030536|471340755|FG004|Overall Study|Withdrawal by Subject|0|||
130919653|NCT01030536|471340751|FG000|Overall Study|undefined|1|||
130919654|NCT01030536|471340752|FG001|Overall Study|undefined|0|||
130919655|NCT01030536|471340753|FG002|Overall Study|undefined|1|||
130919656|NCT01030536|471340754|FG003|Overall Study|undefined|1|||
130919657|NCT01030536|471340755|FG004|Overall Study|undefined|0|||
130919658|NCT01030536|471340751|FG000|Overall Study|Adverse Event|0|||
130919659|NCT01030536|471340752|FG001|Overall Study|Adverse Event|3|||
130919660|NCT01030536|471340753|FG002|Overall Study|Adverse Event|1|||
130919661|NCT01030536|471340754|FG003|Overall Study|Adverse Event|0|||
131034144|NCT02936752|471759095|FG001|Overall Study|Withdrawal by Subject|2|||
131034145|NCT04489771|471759096|FG000|Overall Study|Death|27|||
130919662|NCT01030536|471340755|FG004|Overall Study|Adverse Event|1|||
130919663|NCT01030536|471340751|FG000|Overall Study|Progressive disease|6|||
130919664|NCT01030536|471340752|FG001|Overall Study|Progressive disease|2|||
130919665|NCT01030536|471340753|FG002|Overall Study|Progressive disease|3|||
130919666|NCT01030536|471340754|FG003|Overall Study|Progressive disease|2|||
130919667|NCT01030536|471340755|FG004|Overall Study|Progressive disease|0|||
130919668|NCT01030536|471340751|FG000|Overall Study|Death|0|||
131034146|NCT04489771|471759097|FG001|Overall Study|Death|25|||
131034147|NCT04489771|471759096|FG000|Overall Study|Withdrawal by Subject|1|||
131034148|NCT04489771|471759097|FG001|Overall Study|Withdrawal by Subject|0|||
130919669|NCT01030536|471340752|FG001|Overall Study|Death|1|||
130919670|NCT01030536|471340753|FG002|Overall Study|Death|0|||
130919671|NCT01030536|471340754|FG003|Overall Study|Death|0|||
130919672|NCT01030536|471340755|FG004|Overall Study|Death|0|||
130919673|NCT03666624|471340760|FG000|Overall Study|participant grieving over recent death of parent|1|||
131034149|NCT04489771|471759096|FG000|Overall Study|Participants Ongoing in Study|50|||
130769316|NCT00055497|470780599|FG001|Overall Study|Lack of Efficacy|0|||
130769317|NCT00055497|470780600|FG002|Overall Study|Lack of Efficacy|0|||
130769318|NCT00055497|470780601|FG003|Overall Study|Lack of Efficacy|27|||
130769319|NCT00055497|470780598|FG000|Overall Study|Administrative Reasons|0|||
130769320|NCT00055497|470780599|FG001|Overall Study|Administrative Reasons|0|||
130769321|NCT00055497|470780600|FG002|Overall Study|Administrative Reasons|0|||
130769322|NCT00055497|470780601|FG003|Overall Study|Administrative Reasons|1|||
130769323|NCT00055497|470780598|FG000|Overall Study|Other|0|||
130919674|NCT03666624|471340761|FG001|Overall Study|participant grieving over recent death of parent|0|||
130919675|NCT03021304|471340766|FG000|Overall Study|Lack of Efficacy|1|||
130919676|NCT00569270|471340768|FG000|Period: First Intervention|Protocol Violation|0|||
130919677|NCT00569270|471340769|FG001|Period: First Intervention|Protocol Violation|1|||
130919678|NCT00492531|471340770|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
130919679|NCT00492531|471340771|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
130919680|NCT03822182|471340772|FG000|Overall Study|Protocol Violation|0|||
130919681|NCT03822182|471340773|FG001|Overall Study|Protocol Violation|1|||
130919682|NCT03822182|471340774|FG002|Overall Study|Protocol Violation|1|||
130919683|NCT00810355|471340775|FG000|Overall Study|Lost to Follow-up|13|||
130919684|NCT00810355|471340776|FG001|Overall Study|Lost to Follow-up|17|||
130919685|NCT00810355|471340777|FG002|Overall Study|Lost to Follow-up|11|||
130919686|NCT00810355|471340775|FG000|Overall Study|Withdrawal by Subject|1|||
130769324|NCT00055497|470780599|FG001|Overall Study|Other|0|||
130769325|NCT00055497|470780600|FG002|Overall Study|Other|0|||
130919687|NCT00810355|471340776|FG001|Overall Study|Withdrawal by Subject|0|||
130919688|NCT00810355|471340777|FG002|Overall Study|Withdrawal by Subject|0|||
130919689|NCT00400764|471340778|FG000|Phase Ib|Adverse Event|1|||
130919690|NCT00400764|471340779|FG001|Phase Ib|Adverse Event|0|||
130919691|NCT00400764|471340780|FG002|Phase Ib|Adverse Event|0|||
130919692|NCT00400764|471340781|FG003|Phase Ib|Adverse Event|0|||
130769326|NCT00055497|470780601|FG003|Overall Study|Other|11|||
130769327|NCT00048165|470780602|FG000|Completed 6 Months Study|Administration/Other|8|||
130769328|NCT00048165|470780603|FG001|Completed 6 Months Study|Administration/Other|8|||
130919693|NCT00400764|471340782|FG004|Phase Ib|Adverse Event|0|||
130769329|NCT00048165|470780602|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
130769330|NCT00048165|470780603|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
130769331|NCT00048165|470780602|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
130769332|NCT00048165|470780603|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
130919694|NCT00400764|471340778|FG000|Phase Ib|Death|1|||
130919695|NCT00400764|471340779|FG001|Phase Ib|Death|0|||
130919696|NCT00400764|471340780|FG002|Phase Ib|Death|0|||
130919697|NCT00400764|471340781|FG003|Phase Ib|Death|0|||
130919698|NCT00400764|471340782|FG004|Phase Ib|Death|0|||
130919699|NCT00400764|471340778|FG000|Phase Ib|Disease Progression|4|||
130919700|NCT00400764|471340779|FG001|Phase Ib|Disease Progression|4|||
131034150|NCT04489771|471759097|FG001|Overall Study|Participants Ongoing in Study|51|||
131034151|NCT02979522|471759104|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
130769333|NCT00048165|470780602|FG000|Completed 6 Months Study|Death|12|||
130769334|NCT00048165|470780603|FG001|Completed 6 Months Study|Death|6|||
130769335|NCT00048165|470780602|FG000|Completed 6 Months Study|Insufficient therapy|1|||
130769336|NCT00048165|470780603|FG001|Completed 6 Months Study|Insufficient therapy|4|||
130769337|NCT00048165|470780602|FG000|Completed 6 Months Study|Other violation|4|||
130769338|NCT00048165|470780603|FG001|Completed 6 Months Study|Other violation|6|||
130769339|NCT00048165|470780602|FG000|Completed 6 Months Study|Refused treatment|5|||
130769340|NCT00048165|470780603|FG001|Completed 6 Months Study|Refused treatment|5|||
130769341|NCT00048165|470780602|FG000|Completed 6 Months Study|Violation criteria|0|||
130769342|NCT00048165|470780603|FG001|Completed 6 Months Study|Violation criteria|2|||
130769343|NCT00048165|470780602|FG000|Completed 6 Months Study|Did not receive study drug|6|||
130769344|NCT00048165|470780603|FG001|Completed 6 Months Study|Did not receive study drug|6|||
130769345|NCT00048165|470780602|FG000|Completed 12 Months Study|Administration/Other|0|||
130769346|NCT00048165|470780603|FG001|Completed 12 Months Study|Administration/Other|2|||
130769347|NCT00048165|470780602|FG000|Completed 12 Months Study|Death|2|||
130769348|NCT00048165|470780603|FG001|Completed 12 Months Study|Death|1|||
131034152|NCT02979522|471759105|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
130769349|NCT00048165|470780602|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
130919701|NCT00400764|471340780|FG002|Phase Ib|Disease Progression|0|||
130919702|NCT00400764|471340781|FG003|Phase Ib|Disease Progression|0|||
130919703|NCT00400764|471340782|FG004|Phase Ib|Disease Progression|0|||
130919704|NCT00400764|471340778|FG000|Phase II|Death|0|||
131034153|NCT02979522|471759104|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
130769350|NCT00048165|470780603|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
130769351|NCT02112877|470780604|FG000|Overall Study|Withdrawal by Subject|1|||
130919705|NCT00400764|471340779|FG001|Phase II|Death|0|||
130919706|NCT00400764|471340780|FG002|Phase II|Death|1|||
130919707|NCT00400764|471340781|FG003|Phase II|Death|2|||
130919708|NCT00400764|471340782|FG004|Phase II|Death|0|||
130919709|NCT00400764|471340778|FG000|Phase II|Lost to Follow-up|0|||
130919710|NCT00400764|471340779|FG001|Phase II|Lost to Follow-up|0|||
130919711|NCT00400764|471340780|FG002|Phase II|Lost to Follow-up|1|||
130919712|NCT00400764|471340781|FG003|Phase II|Lost to Follow-up|0|||
130919713|NCT00400764|471340782|FG004|Phase II|Lost to Follow-up|0|||
130919714|NCT00400764|471340778|FG000|Phase II|Physician Decision|0|||
130919715|NCT00400764|471340779|FG001|Phase II|Physician Decision|0|||
130919716|NCT00400764|471340780|FG002|Phase II|Physician Decision|1|||
130769352|NCT02112877|470780605|FG001|Overall Study|Withdrawal by Subject|7|||
130919717|NCT00400764|471340781|FG003|Phase II|Physician Decision|1|||
130919718|NCT00400764|471340782|FG004|Phase II|Physician Decision|0|||
130919719|NCT00400764|471340778|FG000|Phase II|Sponsor's decision to terminate|0|||
130919720|NCT00400764|471340779|FG001|Phase II|Sponsor's decision to terminate|0|||
130919721|NCT00400764|471340780|FG002|Phase II|Sponsor's decision to terminate|18|||
130919722|NCT00400764|471340781|FG003|Phase II|Sponsor's decision to terminate|22|||
130919723|NCT00400764|471340782|FG004|Phase II|Sponsor's decision to terminate|11|||
130919724|NCT00400764|471340778|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
130919725|NCT00400764|471340779|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
130919726|NCT00400764|471340780|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
130919727|NCT00400764|471340781|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
130919728|NCT00400764|471340782|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
130919729|NCT00400764|471340778|FG000|Phase II|Withdrawal by Subject|0|||
130919730|NCT00400764|471340779|FG001|Phase II|Withdrawal by Subject|0|||
130919731|NCT00400764|471340780|FG002|Phase II|Withdrawal by Subject|1|||
130919732|NCT00400764|471340781|FG003|Phase II|Withdrawal by Subject|1|||
130919733|NCT00400764|471340782|FG004|Phase II|Withdrawal by Subject|0|||
130919734|NCT02628938|471340783|FG000|Overall Study|Did not attend the follow up recall|2|||
130919735|NCT02628938|471340784|FG001|Overall Study|Did not attend the follow up recall|2|||
130919736|NCT02628938|471340785|FG002|Overall Study|Did not attend the follow up recall|1|||
130919737|NCT02628938|471340783|FG000|Overall Study|Failure to comply with the instructions|3|||
130919738|NCT02628938|471340784|FG001|Overall Study|Failure to comply with the instructions|0|||
130919739|NCT02628938|471340785|FG002|Overall Study|Failure to comply with the instructions|3|||
130919740|NCT03113916|471340788|FG000|Overall Study|Withdrawal by Subject|9|||
130919741|NCT03113916|471340789|FG001|Overall Study|Withdrawal by Subject|7|||
130919742|NCT03113916|471340788|FG000|Overall Study|Pregnancy|1|||
130919743|NCT03113916|471340789|FG001|Overall Study|Pregnancy|3|||
130919744|NCT03113916|471340788|FG000|Overall Study|Lost to Follow-up|1|||
130919745|NCT03113916|471340789|FG001|Overall Study|Lost to Follow-up|2|||
131034154|NCT02979522|471759105|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
131034155|NCT04509674|471759106|FG000|Overall Study|Not treated|33|||
131034156|NCT04509674|471759107|FG001|Overall Study|Not treated|26|||
131034157|NCT04509674|471759106|FG000|Overall Study|Protocol Violation|9|||
131034158|NCT04509674|471759107|FG001|Overall Study|Protocol Violation|10|||
131034159|NCT04509674|471759106|FG000|Overall Study|Lost to Follow-up|31|||
131034160|NCT04509674|471759107|FG001|Overall Study|Lost to Follow-up|39|||
131034161|NCT04509674|471759106|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
131034162|NCT04509674|471759107|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
131034163|NCT04509674|471759106|FG000|Overall Study|Adverse event, serious fatal event|11|||
131034164|NCT04509674|471759107|FG001|Overall Study|Adverse event, serious fatal event|4|||
131034165|NCT04509674|471759106|FG000|Overall Study|Adverse event, non-fatal event|107|||
131034166|NCT04509674|471759107|FG001|Overall Study|Adverse event, non-fatal event|118|||
131034167|NCT04509674|471759106|FG000|Overall Study|Other reason than listed|106|||
131034168|NCT04509674|471759107|FG001|Overall Study|Other reason than listed|95|||
131034169|NCT03197662|471759108|FG000|Overall Study|Withdrawn by family|0|||
131034170|NCT03197662|471759109|FG001|Overall Study|Withdrawn by family|2|||
131034171|NCT01214616|471759110|FG000|Overall Study|Progressive disease|2|||
131034172|NCT01214616|471759111|FG001|Overall Study|Progressive disease|2|||
131034173|NCT01214616|471759112|FG002|Overall Study|Progressive disease|2|||
131034174|NCT01214616|471759113|FG003|Overall Study|Progressive disease|4|||
131034175|NCT01214616|471759110|FG000|Overall Study|Dose limiting toxicity|0|||
131034176|NCT01214616|471759111|FG001|Overall Study|Dose limiting toxicity|2|||
131034177|NCT01214616|471759112|FG002|Overall Study|Dose limiting toxicity|0|||
131034178|NCT01214616|471759113|FG003|Overall Study|Dose limiting toxicity|0|||
131034179|NCT01214616|471759110|FG000|Overall Study|Other adverse events|0|||
131034180|NCT01214616|471759111|FG001|Overall Study|Other adverse events|1|||
131034181|NCT01214616|471759112|FG002|Overall Study|Other adverse events|1|||
131223147|NCT00550420|472445016|FG000|Overall Study|Caregiver's decision to withdraw|1|||
130919746|NCT00843856|471340790|FG000|Overall Study|Lost to Follow-up|1|||
130919747|NCT00843856|471340791|FG001|Overall Study|Lost to Follow-up|2|||
130919748|NCT00621959|471340792|FG000|Overall Study|Adverse Event|4|||
130919749|NCT00621959|471340793|FG001|Overall Study|Adverse Event|2|||
131034182|NCT01214616|471759113|FG003|Overall Study|Other adverse events|1|||
131034183|NCT01214616|471759110|FG000|Overall Study|Withdrawal by Subject|1|||
131034184|NCT01214616|471759111|FG001|Overall Study|Withdrawal by Subject|0|||
131034185|NCT01214616|471759112|FG002|Overall Study|Withdrawal by Subject|0|||
130769353|NCT02112877|470780604|FG000|Overall Study|Visit Missed|1|||
130919750|NCT00621959|471340792|FG000|Overall Study|Lack of Efficacy|1|||
131119933|NCT00397033|472070355|FG000|Overall Study|Adverse Event|7|||
131119934|NCT00397033|472070356|FG001|Overall Study|Adverse Event|10|||
131119935|NCT00397033|472070357|FG002|Overall Study|Adverse Event|4|||
131119936|NCT00397033|472070355|FG000|Overall Study|Lack of Efficacy|22|||
131119937|NCT00397033|472070356|FG001|Overall Study|Lack of Efficacy|12|||
131119938|NCT00397033|472070357|FG002|Overall Study|Lack of Efficacy|9|||
131119939|NCT00397033|472070355|FG000|Overall Study|Lost to Follow-up|3|||
131119940|NCT00397033|472070356|FG001|Overall Study|Lost to Follow-up|3|||
131119941|NCT00397033|472070357|FG002|Overall Study|Lost to Follow-up|3|||
131119942|NCT00397033|472070355|FG000|Overall Study|Withdrawal by Subject|12|||
131119943|NCT00397033|472070356|FG001|Overall Study|Withdrawal by Subject|7|||
130919751|NCT00621959|471340793|FG001|Overall Study|Lack of Efficacy|1|||
130919752|NCT00621959|471340792|FG000|Overall Study|Lost to Follow-up|0|||
130919753|NCT00621959|471340793|FG001|Overall Study|Lost to Follow-up|2|||
130919754|NCT00621959|471340792|FG000|Overall Study|Withdrawal by Subject|1|||
130919755|NCT00621959|471340793|FG001|Overall Study|Withdrawal by Subject|1|||
130919756|NCT00621959|471340792|FG000|Overall Study|Other|1|||
130919757|NCT00621959|471340793|FG001|Overall Study|Other|3|||
130919758|NCT01758523|471340794|FG000|Overall Study|Adverse Event|2|||
130919759|NCT01758523|471340795|FG001|Overall Study|Adverse Event|1|||
130919760|NCT01758523|471340794|FG000|Overall Study|Lack of Efficacy|4|||
130919761|NCT01758523|471340795|FG001|Overall Study|Lack of Efficacy|2|||
130919762|NCT01758523|471340794|FG000|Overall Study|Lost to Follow-up|3|||
130919763|NCT01758523|471340795|FG001|Overall Study|Lost to Follow-up|4|||
130919764|NCT01758523|471340794|FG000|Overall Study|Withdrawal by Subject|12|||
130919765|NCT01758523|471340795|FG001|Overall Study|Withdrawal by Subject|7|||
130919766|NCT01893203|471340796|FG000|Overall Study|Withdrawal by Subject|1|||
130919767|NCT00590135|471340797|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
130919768|NCT04729621|471340798|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
130919769|NCT04729621|471340799|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
130919770|NCT04729621|471340800|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
130919771|NCT04729621|471340801|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
130919772|NCT04729621|471340802|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
130919773|NCT04729621|471340798|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
130919774|NCT04729621|471340799|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
130919775|NCT04729621|471340800|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
130919776|NCT04729621|471340801|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
130919777|NCT04729621|471340802|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
130919778|NCT04729621|471340798|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
130919779|NCT04729621|471340799|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
130919780|NCT04729621|471340800|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
130919781|NCT04729621|471340801|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
130919782|NCT04729621|471340802|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
130919783|NCT04729621|471340798|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130919784|NCT04729621|471340799|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130919785|NCT04729621|471340800|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
130919786|NCT04729621|471340801|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
130919787|NCT04729621|471340802|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
130919788|NCT04729621|471340798|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
130919789|NCT04729621|471340799|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
130919790|NCT04729621|471340800|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
130919791|NCT04729621|471340801|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
130919792|NCT04729621|471340802|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
130919793|NCT04729621|471340798|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
130919794|NCT04729621|471340799|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
130919795|NCT04729621|471340800|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
130919796|NCT04729621|471340801|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
130919797|NCT04729621|471340802|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
130919798|NCT03439657|471340803|FG000|Overall Study|Adverse Event|2|||
130919799|NCT03439657|471340804|FG001|Overall Study|Adverse Event|3|||
131119944|NCT00397033|472070357|FG002|Overall Study|Withdrawal by Subject|5|||
131119945|NCT00397033|472070355|FG000|Overall Study|Other|0|||
131119946|NCT00397033|472070356|FG001|Overall Study|Other|5|||
130919800|NCT03439657|471340803|FG000|Overall Study|Lost to Follow-up|1|||
130919801|NCT03439657|471340804|FG001|Overall Study|Lost to Follow-up|0|||
130919802|NCT03439657|471340803|FG000|Overall Study|Protocol Violation|1|||
130919803|NCT03439657|471340804|FG001|Overall Study|Protocol Violation|1|||
131119947|NCT00397033|472070357|FG002|Overall Study|Other|2|||
131119948|NCT01984164|472070358|FG000|Overall Study|Withdrawal by Subject|4|||
131119949|NCT01984164|472070359|FG001|Overall Study|Withdrawal by Subject|3|||
131119950|NCT01984164|472070358|FG000|Overall Study|Adverse Event|5|||
131119951|NCT01984164|472070359|FG001|Overall Study|Adverse Event|19|||
130919804|NCT03439657|471340803|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
130919805|NCT03439657|471340804|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
130919806|NCT00370071|471340808|FG000|Overall Study|Withdrawal by Subject|2|||
130919807|NCT00761631|471340810|FG000|Overall Study|Parent/legal guardian request|8|||
130919808|NCT00761631|471340811|FG001|Overall Study|Parent/legal guardian request|3|||
130919809|NCT00761631|471340812|FG002|Overall Study|Parent/legal guardian request|8|||
130919810|NCT00761631|471340813|FG003|Overall Study|Parent/legal guardian request|0|||
130919811|NCT00761631|471340814|FG004|Overall Study|Parent/legal guardian request|5|||
130919812|NCT00761631|471340815|FG005|Overall Study|Parent/legal guardian request|0|||
130919813|NCT00761631|471340810|FG000|Overall Study|Lost to Follow-up|2|||
130919814|NCT00761631|471340811|FG001|Overall Study|Lost to Follow-up|4|||
130919815|NCT00761631|471340812|FG002|Overall Study|Lost to Follow-up|7|||
130919816|NCT00761631|471340813|FG003|Overall Study|Lost to Follow-up|1|||
130919817|NCT00761631|471340814|FG004|Overall Study|Lost to Follow-up|6|||
130919818|NCT00761631|471340815|FG005|Overall Study|Lost to Follow-up|1|||
130919819|NCT00761631|471340810|FG000|Overall Study|Protocol Violation|2|||
130919820|NCT00761631|471340811|FG001|Overall Study|Protocol Violation|0|||
130919821|NCT00761631|471340812|FG002|Overall Study|Protocol Violation|0|||
130919822|NCT00761631|471340813|FG003|Overall Study|Protocol Violation|1|||
130919823|NCT00761631|471340814|FG004|Overall Study|Protocol Violation|5|||
130919824|NCT00761631|471340815|FG005|Overall Study|Protocol Violation|1|||
130919825|NCT00761631|471340810|FG000|Overall Study|Randomized, not treated|1|||
130919826|NCT00761631|471340811|FG001|Overall Study|Randomized, not treated|0|||
130919827|NCT00761631|471340812|FG002|Overall Study|Randomized, not treated|0|||
130919828|NCT00761631|471340813|FG003|Overall Study|Randomized, not treated|0|||
130919829|NCT00761631|471340814|FG004|Overall Study|Randomized, not treated|0|||
130919830|NCT00761631|471340815|FG005|Overall Study|Randomized, not treated|0|||
130919831|NCT00761631|471340810|FG000|Overall Study|Failed to return|1|||
130919832|NCT00761631|471340811|FG001|Overall Study|Failed to return|0|||
130919833|NCT00761631|471340812|FG002|Overall Study|Failed to return|1|||
130919834|NCT00761631|471340813|FG003|Overall Study|Failed to return|1|||
130919835|NCT00761631|471340814|FG004|Overall Study|Failed to return|5|||
130919836|NCT00761631|471340815|FG005|Overall Study|Failed to return|2|||
130919837|NCT00761631|471340810|FG000|Overall Study|Physician Decision|1|||
130919838|NCT00761631|471340811|FG001|Overall Study|Physician Decision|0|||
130919839|NCT00761631|471340812|FG002|Overall Study|Physician Decision|0|||
130919840|NCT00761631|471340813|FG003|Overall Study|Physician Decision|0|||
130919841|NCT00761631|471340814|FG004|Overall Study|Physician Decision|0|||
130919842|NCT00761631|471340815|FG005|Overall Study|Physician Decision|0|||
130919843|NCT00761631|471340810|FG000|Overall Study|Other|0|||
130919844|NCT00761631|471340811|FG001|Overall Study|Other|0|||
130919845|NCT00761631|471340812|FG002|Overall Study|Other|0|||
130919846|NCT00761631|471340813|FG003|Overall Study|Other|0|||
130919847|NCT00761631|471340814|FG004|Overall Study|Other|1|||
130919848|NCT00761631|471340815|FG005|Overall Study|Other|1|||
130919849|NCT01999868|471340816|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
130919850|NCT01999868|471340817|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
130919851|NCT01999868|471340818|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
130919852|NCT01999868|471340816|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
130919853|NCT01999868|471340817|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
130919854|NCT01999868|471340818|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
130919855|NCT01999868|471340816|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
130919856|NCT01999868|471340817|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
130699818|NCT03732833|470524755|FG001|Overall Study|Withdrawal by Subject|13|||
130699819|NCT03732833|470524756|FG002|Overall Study|Withdrawal by Subject|8|||
130919857|NCT01999868|471340818|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
130919858|NCT01999868|471340816|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
130919859|NCT01999868|471340817|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
130919860|NCT01999868|471340818|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
130919861|NCT01999868|471340816|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
130919862|NCT01999868|471340817|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
130919863|NCT01999868|471340818|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
130919864|NCT01999868|471340816|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
131034186|NCT01214616|471759113|FG003|Overall Study|Withdrawal by Subject|1|||
131034187|NCT03721952|471759114|FG000|Overall Study|Lost to Follow-up|0|||
131034188|NCT03721952|471759115|FG001|Overall Study|Lost to Follow-up|0|||
131034189|NCT03721952|471759116|FG002|Overall Study|Lost to Follow-up|2|||
131034190|NCT03721952|471759117|FG003|Overall Study|Lost to Follow-up|0|||
131034191|NCT03721952|471759118|FG004|Overall Study|Lost to Follow-up|0|||
131034192|NCT03721952|471759114|FG000|Overall Study|Protocol Violation|0|||
131034193|NCT03721952|471759115|FG001|Overall Study|Protocol Violation|1|||
131034194|NCT03721952|471759116|FG002|Overall Study|Protocol Violation|0|||
131034195|NCT03721952|471759117|FG003|Overall Study|Protocol Violation|0|||
131034196|NCT03721952|471759118|FG004|Overall Study|Protocol Violation|0|||
131034197|NCT03721952|471759114|FG000|Overall Study|Withdrawal by Subject|1|||
130919865|NCT01999868|471340817|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
130919866|NCT01999868|471340818|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
130919867|NCT01999868|471340816|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
130919868|NCT01999868|471340817|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
130919869|NCT01999868|471340818|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
130919870|NCT01999868|471340816|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
130919871|NCT01999868|471340817|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
130919872|NCT01999868|471340818|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
130919873|NCT01999868|471340816|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
130919874|NCT01999868|471340817|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
130919875|NCT01999868|471340818|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
130919876|NCT01999868|471340816|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
130919877|NCT01999868|471340817|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
130919878|NCT01999868|471340818|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
130919879|NCT01999868|471340816|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
130919880|NCT01999868|471340817|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
130919881|NCT01999868|471340818|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
130919882|NCT01999868|471340816|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
130919883|NCT01999868|471340817|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
130919884|NCT01999868|471340818|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
130919885|NCT01999868|471340816|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
130919886|NCT01999868|471340817|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
130919887|NCT01999868|471340818|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
130919888|NCT01999868|471340816|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
130919889|NCT01999868|471340817|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
130919890|NCT01999868|471340818|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
130919891|NCT01999868|471340816|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
130919892|NCT01999868|471340817|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
130919893|NCT01999868|471340818|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
130919894|NCT00289016|471340823|FG000|Overall Study|Disease Progression|29|||
130919895|NCT00289016|471340823|FG000|Overall Study|Death|2|||
130919896|NCT00289016|471340823|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
130919897|NCT00289016|471340823|FG000|Overall Study|Withdrawal by Subject|2|||
130919898|NCT00289016|471340823|FG000|Overall Study|Adverse Event|1|||
130919899|NCT00289016|471340823|FG000|Overall Study|Other|1|||
130919900|NCT00319501|471340824|FG000|Double-blind Period|Withdrawal by Subject|0|||
130919901|NCT00319501|471340825|FG001|Double-blind Period|Withdrawal by Subject|3|||
130919902|NCT00319501|471340824|FG000|Double-blind Period|Sponsor Request|1|||
130919903|NCT00319501|471340825|FG001|Double-blind Period|Sponsor Request|0|||
130919904|NCT00319501|471340824|FG000|Double-blind Period|Did not receive treatment|42|||
130919905|NCT00319501|471340825|FG001|Double-blind Period|Did not receive treatment|29|||
130919906|NCT00319501|471340824|FG000|Open-label Period|Adverse Event|5|||
130919907|NCT00319501|471340825|FG001|Open-label Period|Adverse Event|0|||
130919908|NCT00319501|471340824|FG000|Open-label Period|Protocol Violation|6|||
130919909|NCT00319501|471340825|FG001|Open-label Period|Protocol Violation|0|||
130919910|NCT00319501|471340824|FG000|Open-label Period|Withdrawal by Subject|38|||
130919911|NCT00319501|471340825|FG001|Open-label Period|Withdrawal by Subject|0|||
130919912|NCT00319501|471340824|FG000|Open-label Period|Principal Investigator decision|6|||
130919913|NCT00319501|471340825|FG001|Open-label Period|Principal Investigator decision|0|||
131034198|NCT03721952|471759115|FG001|Overall Study|Withdrawal by Subject|0|||
131034199|NCT03721952|471759116|FG002|Overall Study|Withdrawal by Subject|40|||
131034200|NCT03721952|471759117|FG003|Overall Study|Withdrawal by Subject|28|||
131034201|NCT03721952|471759118|FG004|Overall Study|Withdrawal by Subject|0|||
131034202|NCT05292365|471759121|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
131034203|NCT05292365|471759122|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
131034204|NCT05292365|471759123|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
131034205|NCT05292365|471759124|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
131034206|NCT04495894|471759133|FG000|Overall Study|Withdrawal by Subject|2|||
131034207|NCT04495894|471759134|FG001|Overall Study|Withdrawal by Subject|0|||
131034208|NCT04495894|471759135|FG002|Overall Study|Withdrawal by Subject|2|||
131034209|NCT04495894|471759136|FG003|Overall Study|Withdrawal by Subject|3|||
131034210|NCT04495894|471759133|FG000|Overall Study|Early termination|0|||
130769354|NCT02112877|470780605|FG001|Overall Study|Visit Missed|6|||
130919914|NCT00319501|471340824|FG000|Open-label Period|Sponsor request|12|||
131034211|NCT04495894|471759134|FG001|Overall Study|Early termination|0|||
130919915|NCT00319501|471340825|FG001|Open-label Period|Sponsor request|0|||
130699820|NCT03732833|470524754|FG000|Overall Study|Lost to Follow-up|3|||
130699821|NCT03732833|470524755|FG001|Overall Study|Lost to Follow-up|5|||
130699822|NCT03732833|470524756|FG002|Overall Study|Lost to Follow-up|4|||
130699823|NCT03732833|470524754|FG000|Overall Study|Pregnancy|0|||
130699824|NCT03732833|470524755|FG001|Overall Study|Pregnancy|2|||
130919916|NCT00319501|471340824|FG000|Open-label Period|Lost to Follow-up|5|||
130919917|NCT00319501|471340825|FG001|Open-label Period|Lost to Follow-up|0|||
130919918|NCT00319501|471340824|FG000|Open-label Period|Did not receive treatment|33|||
130919919|NCT00319501|471340825|FG001|Open-label Period|Did not receive treatment|0|||
130919920|NCT00319501|471340824|FG000|Open-label Period|Other|11|||
130919921|NCT00319501|471340825|FG001|Open-label Period|Other|0|||
130919922|NCT00319501|471340824|FG000|Open-label Extension Period|Adverse Event|2|||
130919923|NCT00319501|471340825|FG001|Open-label Extension Period|Adverse Event|0|||
130919924|NCT00319501|471340824|FG000|Open-label Extension Period|Did not receive treatment|18|||
130919925|NCT00319501|471340825|FG001|Open-label Extension Period|Did not receive treatment|0|||
130919926|NCT00319501|471340824|FG000|Open-label Extension Period|Other|1|||
130919927|NCT00319501|471340825|FG001|Open-label Extension Period|Other|0|||
130919928|NCT00319501|471340824|FG000|Open-label Extension Period|Principal investigator decision|2|||
130919929|NCT00319501|471340825|FG001|Open-label Extension Period|Principal investigator decision|0|||
130919930|NCT00319501|471340824|FG000|Open-label Extension Period|Sponsor request|26|||
130919931|NCT00319501|471340825|FG001|Open-label Extension Period|Sponsor request|0|||
130919932|NCT00319501|471340824|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
130919933|NCT00319501|471340825|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
130919934|NCT02764697|471340832|FG000|Overall Study|Lack of Efficacy|3|||
130919935|NCT00302107|471340833|FG000|Overall Study|Lost to Follow-up|6|||
130919936|NCT00302107|471340834|FG001|Overall Study|Lost to Follow-up|5|||
130919937|NCT00302107|471340833|FG000|Overall Study|Protocol Violation|1|||
130919938|NCT00302107|471340834|FG001|Overall Study|Protocol Violation|0|||
130919939|NCT00302107|471340833|FG000|Overall Study|Relocation|0|||
131119952|NCT01984164|472070358|FG000|Overall Study|Lost to Follow-up|1|||
131119953|NCT01984164|472070359|FG001|Overall Study|Lost to Follow-up|3|||
131119954|NCT05293743|472070360|FG000|Overall Study|Withdrawal by Subject|1|||
131119955|NCT05293743|472070361|FG001|Overall Study|Withdrawal by Subject|0|||
131119956|NCT00667823|472070362|FG000|Overall Study|Lost to Follow-up|5|||
131119957|NCT00667823|472070362|FG000|Overall Study|Adverse Event|7|||
131119958|NCT00667823|472070362|FG000|Overall Study|Death|182|||
131119959|NCT00667823|472070362|FG000|Overall Study|Withdrawal by Subject|12|||
131119960|NCT00667823|472070362|FG000|Overall Study|Other|8|||
131119961|NCT00667823|472070362|FG000|Overall Study|Missing (completion page missing)|2|||
131119962|NCT00583024|472070363|FG000|Overall Study|Lost to Follow-up|4|||
131119963|NCT02553265|472072284|FG000|Enrollment|Death|0|||
131119964|NCT02553265|472072285|FG001|Enrollment|Death|0|||
131119965|NCT02553265|472072286|FG002|Enrollment|Death|1|||
131119966|NCT02553265|472072284|FG000|First Intervention (28 Days)|Adverse Event|1|||
131119967|NCT02553265|472072285|FG001|First Intervention (28 Days)|Adverse Event|0|||
131119968|NCT02553265|472072286|FG002|First Intervention (28 Days)|Adverse Event|0|||
131119969|NCT02553265|472072284|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
131119970|NCT02553265|472072285|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
131119971|NCT02553265|472072286|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
131119972|NCT02553265|472072284|FG000|Second Intervention (28 Days)|Adverse Event|1|||
131119973|NCT02553265|472072285|FG001|Second Intervention (28 Days)|Adverse Event|0|||
131119974|NCT02553265|472072286|FG002|Second Intervention (28 Days)|Adverse Event|0|||
131119975|NCT02553265|472072284|FG000|Third Intervention (28 Days)|Adverse Event|1|||
131119976|NCT02553265|472072285|FG001|Third Intervention (28 Days)|Adverse Event|0|||
131119977|NCT02553265|472072286|FG002|Third Intervention (28 Days)|Adverse Event|0|||
131119978|NCT02553265|472072284|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
131119979|NCT02553265|472072285|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
131119980|NCT02553265|472072286|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
131119981|NCT02667275|472072287|FG000|Overall Study|Protocol Violation|11|||
130919940|NCT00302107|471340834|FG001|Overall Study|Relocation|1|||
131119982|NCT02667275|472072288|FG001|Overall Study|Protocol Violation|7|||
130699825|NCT03732833|470524756|FG002|Overall Study|Pregnancy|0|||
130919941|NCT00302107|471340833|FG000|Overall Study|Withdrawal by Subject|0|||
130919942|NCT00302107|471340834|FG001|Overall Study|Withdrawal by Subject|3|||
130919943|NCT00302107|471340833|FG000|Overall Study|Adverse Event|1|||
130919944|NCT00302107|471340834|FG001|Overall Study|Adverse Event|0|||
130919945|NCT01790932|471340835|FG000|Overall Study|Disease Progression|41|||
130919946|NCT01790932|471340835|FG000|Overall Study|Adverse Event|7|||
130919947|NCT01790932|471340835|FG000|Overall Study|Physician Decision|1|||
131119983|NCT02667275|472072287|FG000|Overall Study|Lost to Follow-up|0|||
131119984|NCT02667275|472072288|FG001|Overall Study|Lost to Follow-up|2|||
131119985|NCT02667275|472072287|FG000|Overall Study|Withdrawal by Subject|0|||
131119986|NCT02667275|472072288|FG001|Overall Study|Withdrawal by Subject|5|||
131119987|NCT02667275|472072287|FG000|Overall Study|Discontinued early without completing|0|||
130699826|NCT03732833|470524754|FG000|Overall Study|Physician Decision|2|||
130699827|NCT03732833|470524755|FG001|Overall Study|Physician Decision|3|||
130919948|NCT01790932|471340835|FG000|Overall Study|Withdrawal by Subject|1|||
130919949|NCT04223973|471340836|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
130919950|NCT04223973|471340837|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
130919951|NCT04223973|471340836|FG000|Overall Study|Adverse Event|4|||
130919952|NCT04223973|471340837|FG001|Overall Study|Adverse Event|0|||
130919953|NCT04223973|471340836|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
130919954|NCT04223973|471340837|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
131034212|NCT04495894|471759135|FG002|Overall Study|Early termination|3|||
131223148|NCT00550420|472445016|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
130699828|NCT03732833|470524756|FG002|Overall Study|Physician Decision|1|||
130699829|NCT03732833|470524754|FG000|Overall Study|Covid-19 related and other reasons|2|||
130699830|NCT03732833|470524755|FG001|Overall Study|Covid-19 related and other reasons|7|||
130699831|NCT03732833|470524756|FG002|Overall Study|Covid-19 related and other reasons|3|||
130699832|NCT00550147|470524757|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
130699833|NCT00550147|470524757|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
130699834|NCT00550147|470524757|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
130699835|NCT00550147|470524757|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
130699836|NCT00550147|470524757|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
130699837|NCT02311894|470524759|FG000|Overall Study|Discontinued in error|1|||
130699838|NCT02311894|470524759|FG000|Overall Study|Lost to Follow-up|1|||
130699839|NCT02311894|470524759|FG000|Overall Study|Adverse Event|1|||
130699840|NCT02311894|470524759|FG000|Overall Study|Withdrawal by Subject|1|||
130699841|NCT00751023|470524760|FG000|Overall Study|Lost to Follow-up|11|||
130699842|NCT00751023|470524761|FG001|Overall Study|Lost to Follow-up|7|||
130699843|NCT02616380|470524764|FG000|Overall Study|Lost to Follow-up|1|||
130699844|NCT02616380|470524764|FG000|Overall Study|Other|2|||
130699845|NCT03407729|470524765|FG000|Overall Study|Lost to Follow-up|2|||
130699846|NCT03407729|470524766|FG001|Overall Study|Lost to Follow-up|0|||
130699847|NCT03407729|470524765|FG000|Overall Study|Unable to schedule|0|||
130699848|NCT03407729|470524766|FG001|Overall Study|Unable to schedule|3|||
130699849|NCT03950674|470524767|FG000|Overall Study|Death|16|||
130699850|NCT03950674|470524768|FG001|Overall Study|Death|15|||
130699851|NCT03950674|470524767|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
130699852|NCT03950674|470524768|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
130699853|NCT00609154|470524771|FG000|Overall Study|Protocol Violation|1|||
130699854|NCT00609154|470524772|FG001|Overall Study|Protocol Violation|2|||
130699855|NCT00609154|470524771|FG000|Overall Study|Unable to establish IV access|0|||
130699856|NCT00609154|470524772|FG001|Overall Study|Unable to establish IV access|4|||
130699857|NCT00609154|470524771|FG000|Overall Study|Adverse Event|0|||
130699858|NCT00609154|470524772|FG001|Overall Study|Adverse Event|2|||
130699859|NCT03833427|470524773|FG000|Overall Study|Death|4|||
130699860|NCT03833427|470524774|FG001|Overall Study|Death|2|||
130699861|NCT03833427|470524775|FG002|Overall Study|Death|9|||
130699862|NCT03833427|470524776|FG003|Overall Study|Death|11|||
130699863|NCT03833427|470524777|FG004|Overall Study|Death|0|||
130699864|NCT03833427|470524778|FG005|Overall Study|Death|0|||
130699865|NCT03833427|470524779|FG006|Overall Study|Death|0|||
130699866|NCT03833427|470524773|FG000|Overall Study|Withdrawal by Subject|0|||
130699867|NCT03833427|470524774|FG001|Overall Study|Withdrawal by Subject|1|||
130699868|NCT03833427|470524775|FG002|Overall Study|Withdrawal by Subject|1|||
130699869|NCT03833427|470524776|FG003|Overall Study|Withdrawal by Subject|0|||
130699870|NCT03833427|470524777|FG004|Overall Study|Withdrawal by Subject|0|||
130699871|NCT03833427|470524778|FG005|Overall Study|Withdrawal by Subject|0|||
130699872|NCT03833427|470524779|FG006|Overall Study|Withdrawal by Subject|0|||
130699873|NCT03833427|470524773|FG000|Overall Study|Sponsor Decision|0|||
130699874|NCT03833427|470524774|FG001|Overall Study|Sponsor Decision|0|||
130699875|NCT03833427|470524775|FG002|Overall Study|Sponsor Decision|1|||
130699876|NCT03833427|470524776|FG003|Overall Study|Sponsor Decision|3|||
130699877|NCT03833427|470524777|FG004|Overall Study|Sponsor Decision|0|||
130699878|NCT03833427|470524778|FG005|Overall Study|Sponsor Decision|0|||
130699879|NCT03833427|470524779|FG006|Overall Study|Sponsor Decision|0|||
130699880|NCT01499160|470524784|FG000|Overall Study|Adverse Event|1|||
130699881|NCT01499160|470524784|FG000|Overall Study|Withdrawal by Subject|1|||
130699882|NCT03448692|470524785|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
130699883|NCT03448692|470524786|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
130699884|NCT03448692|470524785|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
130699885|NCT03448692|470524786|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
130699886|NCT03448692|470524785|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
130699887|NCT03448692|470524786|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
130699888|NCT03448692|470524785|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
130699889|NCT03448692|470524786|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
130699890|NCT03448692|470524785|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
130769355|NCT00621517|470780616|FG000|Overall Study|Lost to Follow-up|3|||
130919955|NCT04223973|471340836|FG000|Overall Study|Physician Decision|1|||
130919956|NCT04223973|471340837|FG001|Overall Study|Physician Decision|1|||
130919957|NCT04223973|471340836|FG000|Overall Study|Withdrawal by Subject|0|||
130919958|NCT04223973|471340837|FG001|Overall Study|Withdrawal by Subject|1|||
130919959|NCT01441180|471340843|FG000|Overall Study|Lost to Follow-up|1|||
130919960|NCT01441180|471340844|FG001|Overall Study|Lost to Follow-up|1|||
130769356|NCT00621517|470780617|FG001|Overall Study|Lost to Follow-up|3|||
130769357|NCT00621517|470780616|FG000|Overall Study|Withdrawal by Subject|3|||
130919961|NCT01441180|471340845|FG002|Overall Study|Lost to Follow-up|1|||
130919962|NCT01441180|471340843|FG000|Overall Study|Discontinued|0|||
130919963|NCT01441180|471340844|FG001|Overall Study|Discontinued|0|||
130919964|NCT01441180|471340845|FG002|Overall Study|Discontinued|2|||
130919965|NCT02569671|471340848|FG000|Overall Study|Lost to Follow-up|2|||
130919966|NCT02569671|471340849|FG001|Overall Study|Lost to Follow-up|1|||
130919967|NCT02569671|471340848|FG000|Overall Study|Withdrawal by Subject|1|||
130919968|NCT02569671|471340849|FG001|Overall Study|Withdrawal by Subject|3|||
130919969|NCT02612129|471340850|FG000|Single Dose Treatment Period|Screening Failure|1|||
130919970|NCT02612129|471340851|FG001|Single Dose Treatment Period|Screening Failure|0|||
130919971|NCT02612129|471340852|FG002|Single Dose Treatment Period|Screening Failure|0|||
130919972|NCT02612129|471340850|FG000|Continuous Treatment Period|Early Escape|0|||
130919973|NCT02612129|471340851|FG001|Continuous Treatment Period|Early Escape|2|||
130919974|NCT02612129|471340852|FG002|Continuous Treatment Period|Early Escape|0|||
130919975|NCT02612129|471340850|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
130919976|NCT02612129|471340851|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
130919977|NCT02612129|471340852|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
130919978|NCT02612129|471340850|FG000|Continuous Treatment Period|Safety Reasons|0|||
130919979|NCT02612129|471340851|FG001|Continuous Treatment Period|Safety Reasons|3|||
130919980|NCT02612129|471340852|FG002|Continuous Treatment Period|Safety Reasons|0|||
130919981|NCT02612129|471340850|FG000|Continuous Treatment Period|Death|0|||
130919982|NCT02612129|471340851|FG001|Continuous Treatment Period|Death|1|||
130919983|NCT02612129|471340852|FG002|Continuous Treatment Period|Death|0|||
130919984|NCT02612129|471340850|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
130919985|NCT02612129|471340851|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
130919986|NCT02612129|471340852|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
130919987|NCT03487549|471340853|FG000|Overall Study|Protocol Violation|0|||
130919988|NCT03487549|471340854|FG001|Overall Study|Protocol Violation|1|||
130919989|NCT03487549|471340853|FG000|Overall Study|Lost to Follow-up|2|||
130919990|NCT03487549|471340854|FG001|Overall Study|Lost to Follow-up|1|||
130919991|NCT03487549|471340853|FG000|Overall Study|Withdrawal by Subject|2|||
130919992|NCT03487549|471340854|FG001|Overall Study|Withdrawal by Subject|0|||
130919993|NCT00825682|471342482|FG000|Overall Study|personal reasons/ inconvenience|13|||
130919994|NCT00825682|471342483|FG001|Overall Study|personal reasons/ inconvenience|5|||
130919995|NCT01644565|471342486|FG000|Overall Study|Undisclosed Medical History|1|||
130919996|NCT01644565|471342487|FG001|Overall Study|Undisclosed Medical History|0|||
130919997|NCT01644565|471342488|FG002|Overall Study|Undisclosed Medical History|0|||
130919998|NCT01644565|471342489|FG003|Overall Study|Undisclosed Medical History|0|||
130919999|NCT01644565|471342490|FG004|Overall Study|Undisclosed Medical History|0|||
130920000|NCT01644565|471342491|FG005|Overall Study|Undisclosed Medical History|0|||
130920001|NCT01644565|471342492|FG006|Overall Study|Undisclosed Medical History|0|||
130920002|NCT01644565|471342493|FG007|Overall Study|Undisclosed Medical History|0|||
130920003|NCT01644565|471342494|FG008|Overall Study|Undisclosed Medical History|0|||
130920004|NCT01644565|471342486|FG000|Overall Study|Lost to Follow-up|0|||
130920005|NCT01644565|471342487|FG001|Overall Study|Lost to Follow-up|0|||
130920006|NCT01644565|471342488|FG002|Overall Study|Lost to Follow-up|0|||
130920007|NCT01644565|471342489|FG003|Overall Study|Lost to Follow-up|1|||
130920008|NCT01644565|471342490|FG004|Overall Study|Lost to Follow-up|0|||
130920009|NCT01644565|471342491|FG005|Overall Study|Lost to Follow-up|0|||
130920010|NCT01644565|471342492|FG006|Overall Study|Lost to Follow-up|0|||
130920011|NCT01644565|471342493|FG007|Overall Study|Lost to Follow-up|2|||
130920012|NCT01644565|471342494|FG008|Overall Study|Lost to Follow-up|0|||
130920013|NCT01644565|471342486|FG000|Overall Study|Family emergency|0|||
130920014|NCT01644565|471342487|FG001|Overall Study|Family emergency|0|||
130920015|NCT01644565|471342488|FG002|Overall Study|Family emergency|0|||
131223149|NCT00550420|472445016|FG000|Overall Study|Exclusion criteria|1|||
130699891|NCT03448692|470524786|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
130699892|NCT00593827|470524788|FG000|Overall Study|On Active Treatment/Pending|0|||
130699893|NCT00593827|470524789|FG001|Overall Study|On Active Treatment/Pending|2|||
130699894|NCT00663234|470524790|FG000|Overall Study|Not willing to adhere to requirements|1|||
130920016|NCT01644565|471342489|FG003|Overall Study|Family emergency|0|||
130920017|NCT01644565|471342490|FG004|Overall Study|Family emergency|1|||
130920018|NCT01644565|471342491|FG005|Overall Study|Family emergency|0|||
130920019|NCT01644565|471342492|FG006|Overall Study|Family emergency|0|||
130920020|NCT01644565|471342493|FG007|Overall Study|Family emergency|0|||
130920021|NCT01644565|471342494|FG008|Overall Study|Family emergency|0|||
130920022|NCT01644565|471342486|FG000|Overall Study|Relocation|0|||
130920023|NCT01644565|471342487|FG001|Overall Study|Relocation|0|||
130920024|NCT01644565|471342488|FG002|Overall Study|Relocation|0|||
130920025|NCT01644565|471342489|FG003|Overall Study|Relocation|0|||
130920026|NCT01644565|471342490|FG004|Overall Study|Relocation|0|||
130920027|NCT01644565|471342491|FG005|Overall Study|Relocation|0|||
130920028|NCT01644565|471342492|FG006|Overall Study|Relocation|0|||
130920029|NCT01644565|471342493|FG007|Overall Study|Relocation|0|||
130920030|NCT01644565|471342494|FG008|Overall Study|Relocation|1|||
130920031|NCT01550289|471342495|FG000|Overall Study|Protocol Violation|1|||
130920032|NCT01550289|471342496|FG001|Overall Study|Protocol Violation|0|||
130920033|NCT01550289|471342495|FG000|Overall Study|Lost to Follow-up|1|||
130920034|NCT01550289|471342496|FG001|Overall Study|Lost to Follow-up|1|||
130920035|NCT01550289|471342495|FG000|Overall Study|Withdrawal by Subject|11|||
130920036|NCT01550289|471342496|FG001|Overall Study|Withdrawal by Subject|3|||
130920037|NCT02975336|471342497|FG000|DBPC (52 Weeks)|Adverse Event|16|||
130920038|NCT02975336|471342498|FG001|DBPC (52 Weeks)|Adverse Event|17|||
130920039|NCT02975336|471342499|FG002|DBPC (52 Weeks)|Adverse Event|13|||
130920040|NCT02975336|471342500|FG003|DBPC (52 Weeks)|Adverse Event|18|||
130920041|NCT02975336|471342501|FG004|DBPC (52 Weeks)|Adverse Event|0|||
130920042|NCT02975336|471342502|FG005|DBPC (52 Weeks)|Adverse Event|0|||
130920043|NCT02975336|471342503|FG006|DBPC (52 Weeks)|Adverse Event|0|||
130920044|NCT02975336|471342504|FG007|DBPC (52 Weeks)|Adverse Event|0|||
130920045|NCT02975336|471342497|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
130920046|NCT02975336|471342498|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
130920047|NCT02975336|471342499|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
130920048|NCT02975336|471342500|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
130920049|NCT02975336|471342501|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
130920050|NCT02975336|471342502|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
130920051|NCT02975336|471342503|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
130920052|NCT02975336|471342504|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
130920053|NCT02975336|471342497|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
130920054|NCT02975336|471342498|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
130920055|NCT02975336|471342499|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
130920056|NCT02975336|471342500|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
130920057|NCT02975336|471342501|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
130920058|NCT02975336|471342502|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
130920059|NCT02975336|471342503|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
130920060|NCT02975336|471342504|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
130920061|NCT02975336|471342497|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
130920062|NCT02975336|471342498|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
130920063|NCT02975336|471342499|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
130920064|NCT02975336|471342500|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
130920065|NCT02975336|471342501|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
130920066|NCT02975336|471342502|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
130920067|NCT02975336|471342503|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
130920068|NCT02975336|471342504|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
130920069|NCT02975336|471342497|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
130920070|NCT02975336|471342498|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
130920071|NCT02975336|471342499|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
130920072|NCT02975336|471342500|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
130920073|NCT02975336|471342501|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
130920074|NCT02975336|471342502|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
130920075|NCT02975336|471342503|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
130920076|NCT02975336|471342504|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
130920077|NCT02975336|471342497|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
130920078|NCT02975336|471342498|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
130920079|NCT02975336|471342499|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
130920080|NCT02975336|471342500|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
130920081|NCT02975336|471342501|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
130920082|NCT02975336|471342502|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
130920083|NCT02975336|471342503|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
130920084|NCT02975336|471342504|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
130920085|NCT02975336|471342497|FG000|LTE (104 Weeks)|Adverse Event|0|||
130920086|NCT02975336|471342498|FG001|LTE (104 Weeks)|Adverse Event|0|||
131223150|NCT00550420|472445016|FG000|Overall Study|Prohibited medicine|1|||
130699895|NCT01709903|470524793|FG000|Overall Study|administrative problems|2|||
130699896|NCT01709903|470524794|FG001|Overall Study|administrative problems|6|||
130699897|NCT01709903|470524793|FG000|Overall Study|Abnormal test procedure results|1|||
130699898|NCT01709903|470524794|FG001|Overall Study|Abnormal test procedure results|0|||
130699899|NCT01709903|470524793|FG000|Overall Study|In ability to use device|1|||
130699900|NCT01709903|470524794|FG001|Overall Study|In ability to use device|1|||
130699901|NCT01709903|470524793|FG000|Overall Study|no longer needed study drug|0|||
130699902|NCT01709903|470524794|FG001|Overall Study|no longer needed study drug|1|||
130699903|NCT01709903|470524793|FG000|Overall Study|Lost to Follow-up|0|||
130920087|NCT02975336|471342499|FG002|LTE (104 Weeks)|Adverse Event|0|||
130920088|NCT02975336|471342500|FG003|LTE (104 Weeks)|Adverse Event|0|||
130699904|NCT01709903|470524794|FG001|Overall Study|Lost to Follow-up|2|||
130699905|NCT01709903|470524793|FG000|Overall Study|Death|2|||
130699906|NCT01709903|470524794|FG001|Overall Study|Death|0|||
130699907|NCT01709903|470524793|FG000|Overall Study|Protocol Violation|3|||
130699908|NCT01709903|470524794|FG001|Overall Study|Protocol Violation|2|||
130920089|NCT02975336|471342501|FG004|LTE (104 Weeks)|Adverse Event|7|||
130920090|NCT02975336|471342502|FG005|LTE (104 Weeks)|Adverse Event|4|||
130920091|NCT02975336|471342503|FG006|LTE (104 Weeks)|Adverse Event|2|||
130920092|NCT02975336|471342504|FG007|LTE (104 Weeks)|Adverse Event|0|||
130920093|NCT02975336|471342497|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
131223151|NCT02773446|472445018|FG000|First Admission|Withdrawal by Subject|0|||
130699909|NCT01709903|470524793|FG000|Overall Study|Lack of Efficacy|3|||
130920094|NCT02975336|471342498|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
130920095|NCT02975336|471342499|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
130920096|NCT02975336|471342500|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
130920097|NCT02975336|471342501|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
130920098|NCT02975336|471342502|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
130920099|NCT02975336|471342503|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
130920100|NCT02975336|471342504|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
130920101|NCT02975336|471342497|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
130920102|NCT02975336|471342498|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
130920103|NCT02975336|471342499|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
130920104|NCT02975336|471342500|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
130920105|NCT02975336|471342501|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
130920106|NCT02975336|471342502|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
130920107|NCT02975336|471342503|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
130920108|NCT02975336|471342504|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
130920109|NCT02975336|471342497|FG000|LTE (104 Weeks)|Other|0|||
130920110|NCT02975336|471342498|FG001|LTE (104 Weeks)|Other|0|||
130920111|NCT02975336|471342499|FG002|LTE (104 Weeks)|Other|0|||
130920112|NCT02975336|471342500|FG003|LTE (104 Weeks)|Other|0|||
130920113|NCT02975336|471342501|FG004|LTE (104 Weeks)|Other|55|||
130920114|NCT02975336|471342502|FG005|LTE (104 Weeks)|Other|63|||
130920115|NCT02975336|471342503|FG006|LTE (104 Weeks)|Other|76|||
130920116|NCT02975336|471342504|FG007|LTE (104 Weeks)|Other|72|||
130920117|NCT01897454|471342505|FG000|Overall Study|Withdrawal by Subject|1|||
130920118|NCT00094172|471342508|FG000|Overall Study|Adverse Event|0|||
130920119|NCT00094172|471342509|FG001|Overall Study|Adverse Event|1|||
130920120|NCT00094172|471342508|FG000|Overall Study|Lost to Follow-up|2|||
130920121|NCT00094172|471342509|FG001|Overall Study|Lost to Follow-up|0|||
130920122|NCT00094172|471342508|FG000|Overall Study|Protocol Violation|0|||
130920123|NCT00094172|471342509|FG001|Overall Study|Protocol Violation|1|||
130920124|NCT00094172|471342508|FG000|Overall Study|Withdrawal by Subject|10|||
130920125|NCT00094172|471342509|FG001|Overall Study|Withdrawal by Subject|5|||
130920126|NCT00094172|471342508|FG000|Overall Study|Primary endpoint met.|1|||
130920127|NCT00094172|471342509|FG001|Overall Study|Primary endpoint met.|0|||
130920128|NCT00094172|471342508|FG000|Overall Study|Started other MS therapy due to disease|1|||
130920129|NCT00094172|471342509|FG001|Overall Study|Started other MS therapy due to disease|0|||
130699910|NCT01709903|470524794|FG001|Overall Study|Lack of Efficacy|3|||
130699911|NCT01709903|470524793|FG000|Overall Study|Withdrawal by Subject|6|||
130699912|NCT01709903|470524794|FG001|Overall Study|Withdrawal by Subject|6|||
130699913|NCT01709903|470524793|FG000|Overall Study|Adverse Event|11|||
130699914|NCT01709903|470524794|FG001|Overall Study|Adverse Event|18|||
130699915|NCT02061280|470524795|FG000|Overall Study|Protocol Violation|12|||
130699916|NCT02061280|470524796|FG001|Overall Study|Protocol Violation|8|||
130699917|NCT02061280|470524795|FG000|Overall Study|moved out of state|0|||
130699918|NCT02061280|470524796|FG001|Overall Study|moved out of state|1|||
130699919|NCT02061280|470524795|FG000|Overall Study|Withdrawal by Subject|1|||
130699920|NCT02061280|470524796|FG001|Overall Study|Withdrawal by Subject|2|||
130699921|NCT02061280|470524795|FG000|Overall Study|Lost to Follow-up|5|||
130699922|NCT02061280|470524796|FG001|Overall Study|Lost to Follow-up|1|||
130699923|NCT05135273|470526328|FG000|Overall Study|Recruited into the army|0|||
130699924|NCT05135273|470526329|FG001|Overall Study|Recruited into the army|0|||
130699925|NCT05135273|470526330|FG002|Overall Study|Recruited into the army|0|||
130699926|NCT05135273|470526331|FG003|Overall Study|Recruited into the army|0|||
130699927|NCT05135273|470526332|FG004|Overall Study|Recruited into the army|1|||
130699928|NCT05135273|470526333|FG005|Overall Study|Recruited into the army|0|||
130699929|NCT05135273|470526334|FG006|Overall Study|Recruited into the army|0|||
130699930|NCT05135273|470526335|FG007|Overall Study|Recruited into the army|0|||
130920130|NCT01392443|471342514|FG000|Overall Study|Disease progression|30|||
130920131|NCT01392443|471342514|FG000|Overall Study|Adverse Event|24|||
130920132|NCT01392443|471342514|FG000|Overall Study|Death|7|||
130920133|NCT01392443|471342514|FG000|Overall Study|Withdrawal by Subject|5|||
130920134|NCT01392443|471342514|FG000|Overall Study|Lost to Follow-up|1|||
130920135|NCT01392443|471342514|FG000|Overall Study|Protocol Violation|1|||
130920136|NCT01977794|471342517|FG000|Overall Study|Adverse Event|2|||
130920137|NCT01977794|471342518|FG001|Overall Study|Adverse Event|2|||
130920138|NCT01977794|471342517|FG000|Overall Study|Lost to Follow-up|2|||
130920139|NCT01977794|471342518|FG001|Overall Study|Lost to Follow-up|1|||
130920140|NCT01977794|471342517|FG000|Overall Study|Protocol Violation|1|||
130769358|NCT00621517|470780617|FG001|Overall Study|Withdrawal by Subject|4|||
130769359|NCT00621517|470780616|FG000|Overall Study|Adverse Event|1|||
130769360|NCT00621517|470780617|FG001|Overall Study|Adverse Event|0|||
130769361|NCT00073008|470780618|FG000|Overall Study|Missing|6|||
130769362|NCT00073008|470780619|FG001|Overall Study|Missing|6|||
130769363|NCT00073008|470780618|FG000|Overall Study|Withdrawal by Subject|2|||
130769364|NCT00073008|470780619|FG001|Overall Study|Withdrawal by Subject|2|||
130769365|NCT00073008|470780618|FG000|Overall Study|Lost to Follow-up|1|||
130769366|NCT00073008|470780619|FG001|Overall Study|Lost to Follow-up|3|||
130769367|NCT00073008|470780618|FG000|Overall Study|Death|46|||
130769368|NCT00073008|470780619|FG001|Overall Study|Death|47|||
130769369|NCT00073008|470780618|FG000|Overall Study|"Other selected on Case Report Form"|7|||
130769370|NCT00073008|470780619|FG001|Overall Study|"Other selected on Case Report Form"|5|||
130769371|NCT02669667|470780620|FG000|Overall Study|Lost to Follow-up|0|||
130769372|NCT02669667|470780621|FG001|Overall Study|Lost to Follow-up|0|||
130769373|NCT02669667|470780622|FG002|Overall Study|Lost to Follow-up|0|||
130769374|NCT02669667|470780623|FG003|Overall Study|Lost to Follow-up|0|||
130769375|NCT02669667|470780624|FG004|Overall Study|Lost to Follow-up|0|||
130769376|NCT02669667|470780625|FG005|Overall Study|Lost to Follow-up|1|||
130769377|NCT02669667|470780626|FG006|Overall Study|Lost to Follow-up|0|||
130769378|NCT02839876|470780627|FG000|Overall Study|Protocol Violation|10|||
130769379|NCT02839876|470780628|FG001|Overall Study|Protocol Violation|11|||
130699931|NCT05135273|470526328|FG000|Overall Study|Moved away from study site|0|||
130699932|NCT05135273|470526329|FG001|Overall Study|Moved away from study site|0|||
130699933|NCT05135273|470526330|FG002|Overall Study|Moved away from study site|0|||
130699934|NCT05135273|470526331|FG003|Overall Study|Moved away from study site|0|||
130699935|NCT05135273|470526332|FG004|Overall Study|Moved away from study site|0|||
130699936|NCT05135273|470526333|FG005|Overall Study|Moved away from study site|1|||
130699937|NCT05135273|470526334|FG006|Overall Study|Moved away from study site|1|||
130699938|NCT05135273|470526335|FG007|Overall Study|Moved away from study site|0|||
130699939|NCT05135273|470526328|FG000|Overall Study|Travel|0|||
130699940|NCT05135273|470526329|FG001|Overall Study|Travel|0|||
130699941|NCT05135273|470526330|FG002|Overall Study|Travel|0|||
130769380|NCT01156051|470780631|FG000|Overall Study|Lost to Follow-up|1|||
130769381|NCT01156051|470780632|FG001|Overall Study|Lost to Follow-up|0|||
130769382|NCT01156051|470780631|FG000|Overall Study|patient not compliant with protocol|0|||
130769383|NCT01156051|470780632|FG001|Overall Study|patient not compliant with protocol|1|||
130769384|NCT02071082|470780639|FG000|Overall Study|Enrolled and Never Treated|1|||
130769385|NCT02071082|470780640|FG001|Overall Study|Enrolled and Never Treated|1|||
130769386|NCT02071082|470780639|FG000|Overall Study|Adverse Event|0|||
130769387|NCT02071082|470780640|FG001|Overall Study|Adverse Event|1|||
130769388|NCT02071082|470780639|FG000|Overall Study|Withdrew Consent|0|||
130769389|NCT02071082|470780640|FG001|Overall Study|Withdrew Consent|4|||
130769390|NCT02071082|470780639|FG000|Overall Study|Lost to Follow-up|1|||
130769391|NCT02071082|470780640|FG001|Overall Study|Lost to Follow-up|1|||
130769392|NCT00958412|470780644|FG000|Overall Study|Study prematurely terminated|18|||
130769393|NCT02227368|470782425|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
130769394|NCT02227368|470782426|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
130769395|NCT02227368|470782425|FG000|Overall Study|Lost to Follow-up|1|||
130769396|NCT02227368|470782426|FG001|Overall Study|Lost to Follow-up|0|||
130769397|NCT02227368|470782425|FG000|Overall Study|Adverse Event|1|||
130769398|NCT02227368|470782426|FG001|Overall Study|Adverse Event|0|||
130769399|NCT02510820|470782430|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130769400|NCT02510820|470782431|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130769401|NCT02510820|470782430|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130769402|NCT02510820|470782431|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130769403|NCT03046056|470782432|FG000|Overall Study|Non-responder at Week 10|6|||
130769404|NCT03046056|470782433|FG001|Overall Study|Non-responder at Week 10|6|||
130769405|NCT03046056|470782434|FG002|Overall Study|Non-responder at Week 10|4|||
130769406|NCT03046056|470782432|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
131223152|NCT02773446|472445019|FG001|First Admission|Withdrawal by Subject|0|||
130699942|NCT05135273|470526331|FG003|Overall Study|Travel|0|||
130769407|NCT03046056|470782433|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
130769408|NCT03046056|470782434|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
130769409|NCT03046056|470782432|FG000|Overall Study|Adverse Event|1|||
130769410|NCT03046056|470782433|FG001|Overall Study|Adverse Event|5|||
130769411|NCT03046056|470782434|FG002|Overall Study|Adverse Event|0|||
130769412|NCT03046056|470782432|FG000|Overall Study|Non-compliance With Study Drug|0|||
130769413|NCT03046056|470782433|FG001|Overall Study|Non-compliance With Study Drug|0|||
130769414|NCT03046056|470782434|FG002|Overall Study|Non-compliance With Study Drug|2|||
130699943|NCT05135273|470526332|FG004|Overall Study|Travel|0|||
130699944|NCT05135273|470526333|FG005|Overall Study|Travel|0|||
130769415|NCT03046056|470782432|FG000|Overall Study|Protocol Violation|1|||
130769416|NCT03046056|470782433|FG001|Overall Study|Protocol Violation|1|||
130769417|NCT03046056|470782434|FG002|Overall Study|Protocol Violation|0|||
131223153|NCT02773446|472445020|FG002|First Admission|Withdrawal by Subject|0|||
130699945|NCT05135273|470526334|FG006|Overall Study|Travel|0|||
130699946|NCT05135273|470526335|FG007|Overall Study|Travel|1|||
130699947|NCT02710214|470526336|FG000|Overall Study|Lost to Follow-up|1|||
130699948|NCT02710214|470526337|FG001|Overall Study|Lost to Follow-up|0|||
130699949|NCT02710214|470526336|FG000|Overall Study|Lack of Efficacy|0|||
130699950|NCT02710214|470526337|FG001|Overall Study|Lack of Efficacy|1|||
130699951|NCT02710214|470526336|FG000|Overall Study|Death|0|||
130699952|NCT02710214|470526337|FG001|Overall Study|Death|1|||
130699953|NCT01705717|470526347|FG000|Overall Study|Adverse Event|2|||
130699954|NCT01705717|470526348|FG001|Overall Study|Adverse Event|2|||
130699955|NCT01705717|470526347|FG000|Overall Study|Lack of Efficacy|0|||
130699956|NCT01705717|470526348|FG001|Overall Study|Lack of Efficacy|1|||
130699957|NCT01705717|470526347|FG000|Overall Study|Other|0|||
130699958|NCT01705717|470526348|FG001|Overall Study|Other|2|||
130699959|NCT01188226|470526354|FG000|Overall Study|Withdrawal by Subject|4|||
130699960|NCT01662024|470526355|FG000|Overall Study|Pregnancy|2|||
130699961|NCT01662024|470526355|FG000|Overall Study|Withdrawal by Subject|3|||
130699962|NCT04980456|470526356|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
130699963|NCT04980456|470526357|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
130699964|NCT04980456|470526356|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
130699965|NCT04980456|470526357|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
130699966|NCT04980456|470526356|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
130699967|NCT04980456|470526357|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
130699968|NCT04980456|470526356|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
130699969|NCT04980456|470526357|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
130699970|NCT04832971|470526358|FG000|Overall Study|Death|1|||
130699971|NCT04832971|470526359|FG001|Overall Study|Death|0|||
130699972|NCT04832971|470526360|FG002|Overall Study|Death|0|||
130699973|NCT04832971|470526361|FG003|Overall Study|Death|0|||
130699974|NCT04832971|470526358|FG000|Overall Study|Lost to Follow-up|1|||
130699975|NCT04832971|470526359|FG001|Overall Study|Lost to Follow-up|1|||
130699976|NCT04832971|470526360|FG002|Overall Study|Lost to Follow-up|1|||
130699977|NCT04832971|470526361|FG003|Overall Study|Lost to Follow-up|0|||
130699978|NCT04832971|470526358|FG000|Overall Study|Withdrawal by Subject|1|||
130699979|NCT04832971|470526359|FG001|Overall Study|Withdrawal by Subject|3|||
130699980|NCT04832971|470526360|FG002|Overall Study|Withdrawal by Subject|2|||
130920141|NCT01977794|471342518|FG001|Overall Study|Protocol Violation|0|||
130920142|NCT01977794|471342517|FG000|Overall Study|Death|1|||
130920143|NCT01977794|471342518|FG001|Overall Study|Death|1|||
130920144|NCT01977794|471342517|FG000|Overall Study|Withdrew consent|2|||
130920145|NCT01977794|471342518|FG001|Overall Study|Withdrew consent|1|||
130920146|NCT01977794|471342517|FG000|Overall Study|Other|0|||
130920147|NCT01977794|471342518|FG001|Overall Study|Other|1|||
130920148|NCT00533897|471342520|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
130920149|NCT00533897|471342521|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
130920150|NCT00533897|471342522|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
130920151|NCT00533897|471342523|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
130920152|NCT00533897|471342524|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
130920153|NCT00533897|471342525|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
130920154|NCT00533897|471342526|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
130920155|NCT00533897|471342527|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
130920156|NCT00533897|471342520|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
130920157|NCT00533897|471342521|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130920158|NCT00533897|471342522|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130920159|NCT00533897|471342523|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130920160|NCT00533897|471342524|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130920161|NCT00533897|471342525|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130920162|NCT00533897|471342526|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130920163|NCT00533897|471342527|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
130920164|NCT00533897|471342520|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
130920165|NCT00533897|471342521|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130920166|NCT00533897|471342522|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130920167|NCT00533897|471342523|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130699981|NCT04832971|470526361|FG003|Overall Study|Withdrawal by Subject|2|||
130699982|NCT04832971|470526358|FG000|Overall Study|Other, Not Specified|0|||
130699983|NCT04832971|470526359|FG001|Overall Study|Other, Not Specified|0|||
130699984|NCT04832971|470526360|FG002|Overall Study|Other, Not Specified|1|||
130699985|NCT04832971|470526361|FG003|Overall Study|Other, Not Specified|0|||
130699986|NCT02293460|470526362|FG000|Overall Study|Protocol Violation|1|||
130699987|NCT02293460|470526362|FG000|Overall Study|Lack of Efficacy|2|||
130920168|NCT00533897|471342524|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130920169|NCT00533897|471342525|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130920170|NCT00533897|471342526|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130920171|NCT00533897|471342527|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
130920172|NCT00533897|471342520|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
130920173|NCT00533897|471342521|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130920174|NCT00533897|471342522|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130699988|NCT02293460|470526362|FG000|Overall Study|Adverse Event|2|||
130699989|NCT02293460|470526362|FG000|Overall Study|Withdrawal by Subject|1|||
130699990|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
130699991|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
130699992|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
130920175|NCT00533897|471342523|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130920176|NCT00533897|471342524|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130920177|NCT00533897|471342525|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130920178|NCT00533897|471342526|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130920179|NCT00533897|471342527|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
130920180|NCT00533897|471342520|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
130920181|NCT00533897|471342521|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130920182|NCT00533897|471342522|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130920183|NCT00533897|471342523|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130920184|NCT00533897|471342524|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130920185|NCT00533897|471342525|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130920186|NCT00533897|471342526|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130920187|NCT00533897|471342527|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
130920188|NCT00533897|471342520|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
130920189|NCT00533897|471342521|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130920190|NCT00533897|471342522|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130920191|NCT00533897|471342523|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130920192|NCT00533897|471342524|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130920193|NCT00533897|471342525|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130920194|NCT00533897|471342526|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130920195|NCT00533897|471342527|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
130920196|NCT00533897|471342520|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130920197|NCT00533897|471342521|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
130920198|NCT00533897|471342522|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
130920199|NCT00533897|471342523|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130920200|NCT00533897|471342524|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130920201|NCT00533897|471342525|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130920202|NCT00533897|471342526|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130920203|NCT00533897|471342527|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
130920204|NCT00533897|471342520|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130920205|NCT00533897|471342521|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130920206|NCT00533897|471342522|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
130920207|NCT00533897|471342523|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130920208|NCT00533897|471342524|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130920209|NCT00533897|471342525|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130920210|NCT00533897|471342526|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130920211|NCT00533897|471342527|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
130920212|NCT00533897|471342520|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130920213|NCT00533897|471342521|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130920214|NCT00533897|471342522|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130920215|NCT00533897|471342523|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130920216|NCT00533897|471342524|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130920217|NCT00533897|471342525|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
130920218|NCT00533897|471342526|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130920219|NCT00533897|471342527|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
130920220|NCT00533897|471342520|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130920221|NCT00533897|471342521|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130920222|NCT00533897|471342522|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130920223|NCT00533897|471342523|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
131034213|NCT04495894|471759136|FG003|Overall Study|Early termination|0|||
130699993|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
130699994|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
130699995|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
130699996|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
130699997|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
130699998|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
130699999|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
130700000|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
130700001|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
130700002|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
130920224|NCT00533897|471342524|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130920225|NCT00533897|471342525|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
130920226|NCT00533897|471342526|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130920227|NCT00533897|471342527|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
130920228|NCT00533897|471342520|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130920229|NCT00533897|471342521|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130920230|NCT00533897|471342522|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130920231|NCT00533897|471342523|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130920232|NCT00533897|471342524|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130920233|NCT00533897|471342525|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
130920234|NCT00533897|471342526|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
130920235|NCT00533897|471342527|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
130920236|NCT00533897|471342520|FG000|Long Term Extension (LTE)|Death|0|||
130920237|NCT00533897|471342521|FG001|Long Term Extension (LTE)|Death|0|||
130920238|NCT00533897|471342522|FG002|Long Term Extension (LTE)|Death|0|||
130920239|NCT00533897|471342523|FG003|Long Term Extension (LTE)|Death|0|||
130769418|NCT03046056|470782432|FG000|Overall Study|Investigator's Discretion|0|||
130920240|NCT00533897|471342524|FG004|Long Term Extension (LTE)|Death|0|||
130920241|NCT00533897|471342525|FG005|Long Term Extension (LTE)|Death|0|||
130920242|NCT00533897|471342526|FG006|Long Term Extension (LTE)|Death|1|||
130920243|NCT00533897|471342527|FG007|Long Term Extension (LTE)|Death|3|||
130920244|NCT00533897|471342520|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
130920245|NCT00533897|471342521|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
130920246|NCT00533897|471342522|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
130920247|NCT00533897|471342523|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
130920248|NCT00533897|471342524|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
130920249|NCT00533897|471342525|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
130920250|NCT00533897|471342526|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
130920251|NCT00533897|471342527|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
130920252|NCT00533897|471342520|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130920253|NCT00533897|471342521|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130920254|NCT00533897|471342522|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130920255|NCT00533897|471342523|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130920256|NCT00533897|471342524|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130920257|NCT00533897|471342525|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130920258|NCT00533897|471342526|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
130920259|NCT00533897|471342527|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
130920260|NCT00533897|471342520|FG000|Long Term Extension (LTE)|Adverse Event|0|||
130920261|NCT00533897|471342521|FG001|Long Term Extension (LTE)|Adverse Event|0|||
130920262|NCT00533897|471342522|FG002|Long Term Extension (LTE)|Adverse Event|0|||
130920263|NCT00533897|471342523|FG003|Long Term Extension (LTE)|Adverse Event|0|||
130920264|NCT00533897|471342524|FG004|Long Term Extension (LTE)|Adverse Event|0|||
130920265|NCT00533897|471342525|FG005|Long Term Extension (LTE)|Adverse Event|0|||
130920266|NCT00533897|471342526|FG006|Long Term Extension (LTE)|Adverse Event|2|||
130920267|NCT00533897|471342527|FG007|Long Term Extension (LTE)|Adverse Event|5|||
130920268|NCT00533897|471342520|FG000|Long Term Extension (LTE)|Pregnancy|0|||
130920269|NCT00533897|471342521|FG001|Long Term Extension (LTE)|Pregnancy|0|||
130920270|NCT00533897|471342522|FG002|Long Term Extension (LTE)|Pregnancy|0|||
130920271|NCT00533897|471342523|FG003|Long Term Extension (LTE)|Pregnancy|0|||
130920272|NCT00533897|471342524|FG004|Long Term Extension (LTE)|Pregnancy|0|||
130920273|NCT00533897|471342525|FG005|Long Term Extension (LTE)|Pregnancy|0|||
130920274|NCT00533897|471342526|FG006|Long Term Extension (LTE)|Pregnancy|0|||
130920275|NCT00533897|471342527|FG007|Long Term Extension (LTE)|Pregnancy|2|||
130920276|NCT00533897|471342520|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
130920277|NCT00533897|471342521|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
130920278|NCT00533897|471342522|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
130920279|NCT00533897|471342523|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
130700003|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
130700004|NCT04592419|470526366|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
130700005|NCT04592419|470526367|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
130700006|NCT04592419|470526366|FG000|Open-Label Extension Period|Adverse Event|1|||
130700007|NCT04592419|470526367|FG001|Open-Label Extension Period|Adverse Event|2|||
130700008|NCT04592419|470526366|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
130700009|NCT04592419|470526367|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
130700010|NCT04592419|470526366|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
130769419|NCT03046056|470782433|FG001|Overall Study|Investigator's Discretion|1|||
130920280|NCT00533897|471342524|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
130920281|NCT00533897|471342525|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
130920282|NCT00533897|471342526|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
130920283|NCT00533897|471342527|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
130920284|NCT00533897|471342520|FG000|Long Term Extension (LTE)|Other|0|||
130920285|NCT00533897|471342521|FG001|Long Term Extension (LTE)|Other|0|||
130920286|NCT00533897|471342522|FG002|Long Term Extension (LTE)|Other|0|||
130920287|NCT00533897|471342523|FG003|Long Term Extension (LTE)|Other|0|||
130920288|NCT00533897|471342524|FG004|Long Term Extension (LTE)|Other|0|||
130920289|NCT00533897|471342525|FG005|Long Term Extension (LTE)|Other|0|||
130920290|NCT00533897|471342526|FG006|Long Term Extension (LTE)|Other|1|||
130920291|NCT00533897|471342527|FG007|Long Term Extension (LTE)|Other|6|||
130920292|NCT00827502|471342528|FG000|Overall Study|randomized but not treated|11|||
130920293|NCT00827502|471342528|FG000|Overall Study|Adverse Event|1|||
130920294|NCT00827502|471342528|FG000|Overall Study|Lost to Follow-up|4|||
130920295|NCT00827502|471342528|FG000|Overall Study|Withdrawal by Subject|5|||
130920296|NCT02478632|471342529|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
130920297|NCT02478632|471342530|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
130920298|NCT02478632|471342529|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
130920299|NCT02478632|471342530|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
130920300|NCT02478632|471342529|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
130920301|NCT02478632|471342530|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
130920302|NCT03019185|471342531|FG000|Overall Study|Lost to Follow-up|3|||
130920303|NCT03019185|471342532|FG001|Overall Study|Lost to Follow-up|0|||
130920304|NCT03019185|471342533|FG002|Overall Study|Lost to Follow-up|2|||
130920305|NCT03019185|471342531|FG000|Overall Study|Withdrawal by Subject|1|||
130920306|NCT03019185|471342532|FG001|Overall Study|Withdrawal by Subject|1|||
130920307|NCT03019185|471342533|FG002|Overall Study|Withdrawal by Subject|0|||
130920308|NCT03019185|471342531|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
130920309|NCT03019185|471342532|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
130920310|NCT03019185|471342533|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
130920311|NCT03019185|471342531|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
130920312|NCT03019185|471342532|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
130920313|NCT03019185|471342533|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
130920314|NCT03355365|471342534|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
130920315|NCT03355365|471342535|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
130920316|NCT03355365|471342534|FG000|Year 1, First Intervention|Protocol Violation|1|||
130920317|NCT03355365|471342535|FG001|Year 1, First Intervention|Protocol Violation|0|||
130920318|NCT03355365|471342534|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
130920319|NCT03355365|471342535|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
130920320|NCT03355365|471342534|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
130920321|NCT03355365|471342535|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
130920322|NCT03355365|471342534|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
130920323|NCT03355365|471342535|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
130920324|NCT03355365|471342534|FG000|Year 2, Crossover Intervention|severe COVID|0|||
130920325|NCT03355365|471342535|FG001|Year 2, Crossover Intervention|severe COVID|1|||
130920326|NCT03355365|471342534|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
130920327|NCT03355365|471342535|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
130920328|NCT02110238|471342536|FG000|12 Week Pivotal Phase|Adverse Event|3|||
130920329|NCT02110238|471342537|FG001|12 Week Pivotal Phase|Adverse Event|0|||
130920330|NCT02110238|471342536|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
130920331|NCT02110238|471342537|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
130920332|NCT02110238|471342536|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
130920333|NCT02110238|471342537|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
130920334|NCT02110238|471342536|FG000|12 Week Pivotal Phase|Physician Decision|0|||
130920335|NCT02110238|471342537|FG001|12 Week Pivotal Phase|Physician Decision|2|||
130920336|NCT02110238|471342536|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
130920337|NCT02110238|471342537|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
130920338|NCT02110238|471342536|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
130920339|NCT02110238|471342537|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
130920340|NCT02110238|471342536|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
130920341|NCT02110238|471342537|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
130920342|NCT02110238|471342536|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
130920343|NCT02110238|471342537|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
131119988|NCT02667275|472072288|FG001|Overall Study|Discontinued early without completing|1|||
131119989|NCT02357134|472072289|FG000|Overall Study|Lost to Follow-up|1|||
130920344|NCT02110238|471342536|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
130920345|NCT02110238|471342537|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
130920346|NCT02110238|471342536|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
130920347|NCT02110238|471342537|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
130920348|NCT02110238|471342536|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
130920349|NCT02110238|471342537|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
130920350|NCT00142935|471342540|FG000|Overall Study|Other reason|1|||
130769420|NCT03046056|470782434|FG002|Overall Study|Investigator's Discretion|0|||
130920351|NCT00142935|471342541|FG001|Overall Study|Other reason|1|||
130920352|NCT00142935|471342542|FG002|Overall Study|Other reason|1|||
130920353|NCT00142935|471342540|FG000|Overall Study|Lost to Follow-up|2|||
130920354|NCT00142935|471342541|FG001|Overall Study|Lost to Follow-up|5|||
130920355|NCT00142935|471342542|FG002|Overall Study|Lost to Follow-up|5|||
130920356|NCT00142935|471342540|FG000|Overall Study|Death|0|||
130920357|NCT00142935|471342541|FG001|Overall Study|Death|2|||
130920358|NCT00142935|471342542|FG002|Overall Study|Death|1|||
130920359|NCT01330030|471342549|FG000|Overall Study|Lost to Follow-up|16|||
130920360|NCT01330030|471342550|FG001|Overall Study|Lost to Follow-up|17|||
130920361|NCT01419626|471342551|FG000|Overall Study|Protocol Violation|3|||
130920362|NCT01419626|471342552|FG001|Overall Study|Protocol Violation|2|||
130920363|NCT01419626|471342553|FG002|Overall Study|Protocol Violation|2|||
130920364|NCT01419626|471342551|FG000|Overall Study|Withdrawal by Subject|1|||
130920365|NCT01419626|471342552|FG001|Overall Study|Withdrawal by Subject|0|||
130920366|NCT01419626|471342553|FG002|Overall Study|Withdrawal by Subject|0|||
130920367|NCT01419626|471342551|FG000|Overall Study|Lost to Follow-up|0|||
130920368|NCT01419626|471342552|FG001|Overall Study|Lost to Follow-up|1|||
130920369|NCT01419626|471342553|FG002|Overall Study|Lost to Follow-up|1|||
130920370|NCT01365052|471342554|FG000|Overall Study|Adverse Event|4|||
130920371|NCT01365052|471342555|FG001|Overall Study|Adverse Event|4|||
130920372|NCT01146912|471342556|FG000|Overall Study|Already received influenza vaccination|817|||
130920373|NCT01146912|471342557|FG001|Overall Study|Already received influenza vaccination|822|||
130920374|NCT01146912|471342558|FG002|Overall Study|Already received influenza vaccination|13|||
130920375|NCT01146912|471342559|FG003|Overall Study|Already received influenza vaccination|15|||
130920376|NCT01146912|471342560|FG004|Overall Study|Already received influenza vaccination|41|||
130920377|NCT01146912|471342561|FG005|Overall Study|Already received influenza vaccination|61|||
130920378|NCT01146912|471342562|FG006|Overall Study|Already received influenza vaccination|56|||
130920379|NCT01146912|471342563|FG007|Overall Study|Already received influenza vaccination|0|||
130920380|NCT01146912|471342556|FG000|Overall Study|< 14 weeks gestational age|0|||
130920381|NCT01146912|471342557|FG001|Overall Study|< 14 weeks gestational age|0|||
130920382|NCT01146912|471342558|FG002|Overall Study|< 14 weeks gestational age|3|||
130920383|NCT01146912|471342559|FG003|Overall Study|< 14 weeks gestational age|2|||
130920384|NCT01146912|471342560|FG004|Overall Study|< 14 weeks gestational age|0|||
130920385|NCT01146912|471342561|FG005|Overall Study|< 14 weeks gestational age|0|||
130920386|NCT01146912|471342562|FG006|Overall Study|< 14 weeks gestational age|0|||
130920387|NCT01146912|471342563|FG007|Overall Study|< 14 weeks gestational age|0|||
130920388|NCT01146912|471342556|FG000|Overall Study|Duplicate patient|0|||
130920389|NCT01146912|471342557|FG001|Overall Study|Duplicate patient|0|||
130920390|NCT01146912|471342558|FG002|Overall Study|Duplicate patient|1|||
130920391|NCT01146912|471342559|FG003|Overall Study|Duplicate patient|0|||
130920392|NCT01146912|471342560|FG004|Overall Study|Duplicate patient|0|||
130920393|NCT01146912|471342561|FG005|Overall Study|Duplicate patient|0|||
130920394|NCT01146912|471342562|FG006|Overall Study|Duplicate patient|0|||
130920395|NCT01146912|471342563|FG007|Overall Study|Duplicate patient|0|||
130920396|NCT01145625|471342566|FG000|Overall Study|Lost to Follow-up|8|||
130920397|NCT01145625|471342567|FG001|Overall Study|Lost to Follow-up|9|||
130920398|NCT01145625|471342566|FG000|Overall Study|Adverse Event|6|||
130920399|NCT01145625|471342567|FG001|Overall Study|Adverse Event|4|||
130920400|NCT01145625|471342566|FG000|Overall Study|Protocol Violation|3|||
130920401|NCT01145625|471342567|FG001|Overall Study|Protocol Violation|1|||
130920402|NCT01145625|471342566|FG000|Overall Study|Withdrawal by Subject|7|||
130920403|NCT01145625|471342567|FG001|Overall Study|Withdrawal by Subject|16|||
130920404|NCT01145625|471342566|FG000|Overall Study|Pregnancy|0|||
130920405|NCT01145625|471342567|FG001|Overall Study|Pregnancy|1|||
130920406|NCT02980783|471342568|FG000|Overall Study|Lost to Follow-up|1|||
130920407|NCT02202980|471342571|FG000|Overall Study|Lack of Efficacy|1|||
130920408|NCT02202980|471342572|FG001|Overall Study|Lack of Efficacy|0|||
130920409|NCT02202980|471342573|FG002|Overall Study|Lack of Efficacy|7|||
130920410|NCT02202980|471342574|FG003|Overall Study|Lack of Efficacy|0|||
130920411|NCT02202980|471342575|FG004|Overall Study|Lack of Efficacy|3|||
130920412|NCT02202980|471342576|FG005|Overall Study|Lack of Efficacy|1|||
130920413|NCT02202980|471342577|FG006|Overall Study|Lack of Efficacy|11|||
130920414|NCT02202980|471342578|FG007|Overall Study|Lack of Efficacy|2|||
130920415|NCT02202980|471342579|FG008|Overall Study|Lack of Efficacy|2|||
130920416|NCT02202980|471342580|FG009|Overall Study|Lack of Efficacy|0|||
130920417|NCT02202980|471342581|FG010|Overall Study|Lack of Efficacy|0|||
130920418|NCT02202980|471342582|FG011|Overall Study|Lack of Efficacy|3|||
130920419|NCT02202980|471342583|FG012|Overall Study|Lack of Efficacy|10|||
130920420|NCT02202980|471342584|FG013|Overall Study|Lack of Efficacy|0|||
130920421|NCT02202980|471342571|FG000|Overall Study|Protocol Violation|0|||
130920422|NCT02202980|471342572|FG001|Overall Study|Protocol Violation|0|||
130920423|NCT02202980|471342573|FG002|Overall Study|Protocol Violation|0|||
130920424|NCT02202980|471342574|FG003|Overall Study|Protocol Violation|3|||
130920425|NCT02202980|471342575|FG004|Overall Study|Protocol Violation|3|||
130920426|NCT02202980|471342576|FG005|Overall Study|Protocol Violation|0|||
130920427|NCT02202980|471342577|FG006|Overall Study|Protocol Violation|0|||
130920428|NCT02202980|471342578|FG007|Overall Study|Protocol Violation|0|||
130920429|NCT02202980|471342579|FG008|Overall Study|Protocol Violation|0|||
130920430|NCT02202980|471342580|FG009|Overall Study|Protocol Violation|0|||
130920431|NCT02202980|471342581|FG010|Overall Study|Protocol Violation|0|||
130920432|NCT02202980|471342582|FG011|Overall Study|Protocol Violation|0|||
130920433|NCT02202980|471342583|FG012|Overall Study|Protocol Violation|0|||
130920434|NCT02202980|471342584|FG013|Overall Study|Protocol Violation|0|||
130920435|NCT02202980|471342571|FG000|Overall Study|Lost to Follow-up|0|||
130920436|NCT02202980|471342572|FG001|Overall Study|Lost to Follow-up|1|||
130920437|NCT02202980|471342573|FG002|Overall Study|Lost to Follow-up|1|||
130920438|NCT02202980|471342574|FG003|Overall Study|Lost to Follow-up|1|||
130920439|NCT02202980|471342575|FG004|Overall Study|Lost to Follow-up|0|||
130920440|NCT02202980|471342576|FG005|Overall Study|Lost to Follow-up|0|||
130920441|NCT02202980|471342577|FG006|Overall Study|Lost to Follow-up|0|||
130920442|NCT02202980|471342578|FG007|Overall Study|Lost to Follow-up|1|||
130920443|NCT02202980|471342579|FG008|Overall Study|Lost to Follow-up|1|||
130920444|NCT02202980|471342580|FG009|Overall Study|Lost to Follow-up|0|||
130920445|NCT02202980|471342581|FG010|Overall Study|Lost to Follow-up|0|||
130920446|NCT02202980|471342582|FG011|Overall Study|Lost to Follow-up|0|||
130920447|NCT02202980|471342583|FG012|Overall Study|Lost to Follow-up|1|||
130920448|NCT02202980|471342584|FG013|Overall Study|Lost to Follow-up|0|||
130920449|NCT02202980|471342571|FG000|Overall Study|Withdrew Consent|0|||
130920450|NCT02202980|471342572|FG001|Overall Study|Withdrew Consent|1|||
130920451|NCT02202980|471342573|FG002|Overall Study|Withdrew Consent|2|||
130920452|NCT02202980|471342574|FG003|Overall Study|Withdrew Consent|0|||
130920453|NCT02202980|471342575|FG004|Overall Study|Withdrew Consent|0|||
130920454|NCT02202980|471342576|FG005|Overall Study|Withdrew Consent|0|||
130920455|NCT02202980|471342577|FG006|Overall Study|Withdrew Consent|0|||
130920456|NCT02202980|471342578|FG007|Overall Study|Withdrew Consent|0|||
130920457|NCT02202980|471342579|FG008|Overall Study|Withdrew Consent|1|||
130920458|NCT02202980|471342580|FG009|Overall Study|Withdrew Consent|0|||
130920459|NCT02202980|471342581|FG010|Overall Study|Withdrew Consent|0|||
130920460|NCT02202980|471342582|FG011|Overall Study|Withdrew Consent|0|||
130920461|NCT02202980|471342583|FG012|Overall Study|Withdrew Consent|0|||
130920462|NCT02202980|471342584|FG013|Overall Study|Withdrew Consent|0|||
130920463|NCT02130570|471342586|FG000|Overall Study|Death|3|||
130920464|NCT02130570|471342587|FG001|Overall Study|Death|5|||
130920465|NCT02130570|471342586|FG000|Overall Study|Withdrawal by Subject|6|||
130920466|NCT02130570|471342587|FG001|Overall Study|Withdrawal by Subject|3|||
130920467|NCT02130570|471342586|FG000|Overall Study|Part of practice that discontinued study|0|||
130920468|NCT02130570|471342587|FG001|Overall Study|Part of practice that discontinued study|5|||
130920469|NCT01696695|471342590|FG000|Overall Study|Disease progression|373|||
130920470|NCT01696695|471342590|FG000|Overall Study|Death|29|||
130920471|NCT01696695|471342590|FG000|Overall Study|Adverse Event|74|||
130920472|NCT01696695|471342590|FG000|Overall Study|Withdrawal by Subject|92|||
130920473|NCT01696695|471342590|FG000|Overall Study|Lost to Follow-up|48|||
130920474|NCT01696695|471342590|FG000|Overall Study|Other|74|||
130920475|NCT01696695|471342590|FG000|Overall Study|Major Protocol Violation|192|||
130920476|NCT01781975|471342606|FG000|Overall Study|Death|1|||
130920477|NCT01781975|471342607|FG001|Overall Study|Death|0|||
130920478|NCT01781975|471342606|FG000|Overall Study|Withdrawal by Subject|1|||
130920479|NCT01781975|471342607|FG001|Overall Study|Withdrawal by Subject|1|||
130920480|NCT02404220|471342608|FG000|Overall Study|Adverse Event|0|||
130920481|NCT02404220|471342609|FG001|Overall Study|Adverse Event|0|||
130920482|NCT02404220|471342610|FG002|Overall Study|Adverse Event|1|||
130920483|NCT02404220|471342611|FG003|Overall Study|Adverse Event|0|||
130920484|NCT02404220|471342608|FG000|Overall Study|Death|5|||
130920485|NCT02404220|471342609|FG001|Overall Study|Death|5|||
130920486|NCT02404220|471342610|FG002|Overall Study|Death|3|||
130920487|NCT02404220|471342611|FG003|Overall Study|Death|8|||
131119990|NCT02357134|472072290|FG001|Overall Study|Lost to Follow-up|0|||
131119991|NCT02357134|472072291|FG002|Overall Study|Lost to Follow-up|0|||
131119992|NCT02357134|472072292|FG003|Overall Study|Lost to Follow-up|0|||
131119993|NCT03583450|472072293|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
130920488|NCT02404220|471342608|FG000|Overall Study|Progressive Disease|0|||
130920489|NCT02404220|471342609|FG001|Overall Study|Progressive Disease|0|||
130920490|NCT02404220|471342610|FG002|Overall Study|Progressive Disease|1|||
130920491|NCT02404220|471342611|FG003|Overall Study|Progressive Disease|1|||
130920492|NCT02404220|471342608|FG000|Overall Study|Study Terminated by Sponsor|0|||
130920493|NCT02404220|471342609|FG001|Overall Study|Study Terminated by Sponsor|0|||
130920494|NCT02404220|471342610|FG002|Overall Study|Study Terminated by Sponsor|2|||
130920495|NCT02404220|471342611|FG003|Overall Study|Study Terminated by Sponsor|1|||
130920496|NCT02404220|471342608|FG000|Overall Study|Withdrawal by Subject|0|||
130920497|NCT02404220|471342609|FG001|Overall Study|Withdrawal by Subject|1|||
130920498|NCT02404220|471342610|FG002|Overall Study|Withdrawal by Subject|0|||
130920499|NCT02404220|471342611|FG003|Overall Study|Withdrawal by Subject|0|||
130920500|NCT02404220|471342608|FG000|Overall Study|Enrolled but Never Treated|0|||
130920501|NCT02404220|471342609|FG001|Overall Study|Enrolled but Never Treated|2|||
130920502|NCT02404220|471342610|FG002|Overall Study|Enrolled but Never Treated|0|||
130920503|NCT02404220|471342611|FG003|Overall Study|Enrolled but Never Treated|0|||
130920504|NCT02905149|471342612|FG000|Overall Study|Lost to Follow-up|2|||
130920505|NCT02905149|471342613|FG001|Overall Study|Lost to Follow-up|0|||
130920506|NCT01180647|471342622|FG000|Overall Study|Lost to Follow-up|5|||
130920507|NCT01180647|471342623|FG001|Overall Study|Lost to Follow-up|6|||
130920508|NCT00386607|471342624|FG000|Core|Adverse Event|40|||
130920509|NCT00386607|471342625|FG001|Core|Adverse Event|0|||
130920510|NCT00386607|471342624|FG000|Core|Abnormal laboratory value(s)|3|||
130920511|NCT00386607|471342625|FG001|Core|Abnormal laboratory value(s)|0|||
130920512|NCT00386607|471342624|FG000|Core|Unsatisfactory therapeutic effect|23|||
130920513|NCT00386607|471342625|FG001|Core|Unsatisfactory therapeutic effect|0|||
130920514|NCT00386607|471342624|FG000|Core|Condition no longer requires study drug|4|||
130920515|NCT00386607|471342625|FG001|Core|Condition no longer requires study drug|0|||
130920516|NCT00386607|471342624|FG000|Core|Patient withdrew consent|15|||
130920517|NCT00386607|471342625|FG001|Core|Patient withdrew consent|0|||
130920518|NCT00386607|471342624|FG000|Core|Lost to Follow-up|23|||
130920519|NCT00386607|471342625|FG001|Core|Lost to Follow-up|0|||
130920520|NCT00386607|471342624|FG000|Core|Administrative problems|1|||
130920521|NCT00386607|471342625|FG001|Core|Administrative problems|0|||
130920522|NCT00386607|471342624|FG000|Core|Protocol Deviation|6|||
130920523|NCT00386607|471342625|FG001|Core|Protocol Deviation|0|||
130920524|NCT00386607|471342624|FG000|Extension|Adverse Event|0|||
130920525|NCT00386607|471342625|FG001|Extension|Adverse Event|6|||
130920526|NCT00386607|471342624|FG000|Extension|Abnormal laboratory value(s)|0|||
130920527|NCT00386607|471342625|FG001|Extension|Abnormal laboratory value(s)|1|||
130920528|NCT00386607|471342624|FG000|Extension|Administrative problems|0|||
130920529|NCT00386607|471342625|FG001|Extension|Administrative problems|1|||
130920530|NCT00386607|471342624|FG000|Extension|Lost to Follow-up|0|||
130920531|NCT00386607|471342625|FG001|Extension|Lost to Follow-up|3|||
130920532|NCT00386607|471342624|FG000|Extension|Patient withdrew consent|0|||
130920533|NCT00386607|471342625|FG001|Extension|Patient withdrew consent|5|||
130920534|NCT00386607|471342624|FG000|Extension|Unsatisfactory therapeutic effect|0|||
130920535|NCT00386607|471342625|FG001|Extension|Unsatisfactory therapeutic effect|1|||
130920536|NCT01927627|471342627|FG000|Overall Study|Adverse Event|3|||
130920537|NCT01927627|471342627|FG000|Overall Study|Lack of Efficacy|1|||
130920538|NCT01927627|471342627|FG000|Overall Study|Financial Concerns|1|||
130920539|NCT00467857|471342628|FG000|Overall Study|Adverse Event|1|||
130920540|NCT00467857|471342629|FG001|Overall Study|Adverse Event|0|||
130920541|NCT00467857|471342628|FG000|Overall Study|Withdrew consent|2|||
130920542|NCT00467857|471342629|FG001|Overall Study|Withdrew consent|0|||
130920543|NCT00467857|471342628|FG000|Overall Study|Death|0|||
130920544|NCT00467857|471342629|FG001|Overall Study|Death|1|||
130920545|NCT00467857|471342628|FG000|Overall Study|Discharged from court service|0|||
130920546|NCT00467857|471342629|FG001|Overall Study|Discharged from court service|1|||
130920547|NCT00467857|471342628|FG000|Overall Study|Emergency care required|0|||
130920548|NCT00467857|471342629|FG001|Overall Study|Emergency care required|1|||
130920549|NCT00467857|471342628|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
130920550|NCT00467857|471342629|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
130920551|NCT00467857|471342628|FG000|Overall Study|Discontinuation reason missing|0|||
130920552|NCT00467857|471342629|FG001|Overall Study|Discontinuation reason missing|3|||
130920553|NCT03208127|471342632|FG000|Overall Study|Death|1|||
130920554|NCT00579098|471342637|FG000|Overall Study|Lost to Follow-up|2|||
130920555|NCT00579098|471342638|FG001|Overall Study|Lost to Follow-up|0|||
130920556|NCT00579098|471342637|FG000|Overall Study|Adverse Event|2|||
130920557|NCT00579098|471342638|FG001|Overall Study|Adverse Event|3|||
130920558|NCT00579098|471342637|FG000|Overall Study|Withdrawal by Subject|2|||
130920559|NCT00579098|471342638|FG001|Overall Study|Withdrawal by Subject|3|||
130920560|NCT00579098|471342637|FG000|Overall Study|AF returned after ablation|3|||
130920561|NCT00579098|471342638|FG001|Overall Study|AF returned after ablation|2|||
130700011|NCT04592419|470526367|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
130700012|NCT04592419|470526366|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
130920562|NCT02121522|471342639|FG000|Overall Study|Adverse Event|1|||
130920563|NCT00338104|471342641|FG000|Overall Study|Protocol Violation|2|||
130920564|NCT00338104|471342642|FG001|Overall Study|Protocol Violation|1|||
130920565|NCT00338104|471342643|FG002|Overall Study|Protocol Violation|3|||
130920566|NCT00633750|471342645|FG000|Overall Study|Adverse Event|2|||
130920567|NCT00633750|471342645|FG000|Overall Study|Withdrawal by Subject|3|||
131034214|NCT05579899|471759138|FG000|Overall Study|Lost to Follow-up|3|||
131034215|NCT05579899|471759139|FG001|Overall Study|Lost to Follow-up|1|||
131034216|NCT05579899|471759138|FG000|Overall Study|Adverse Event|0|||
131034217|NCT05579899|471759139|FG001|Overall Study|Adverse Event|3|||
131034218|NCT05579899|471759138|FG000|Overall Study|Pregnancy|0|||
131034219|NCT05579899|471759139|FG001|Overall Study|Pregnancy|1|||
131034220|NCT05579899|471759138|FG000|Overall Study|Withdrawal by Subject|0|||
131034221|NCT05579899|471759139|FG001|Overall Study|Withdrawal by Subject|3|||
130920568|NCT02004522|471342650|FG000|Overall Study|Adverse Event|55|||
130920569|NCT02004522|471342651|FG001|Overall Study|Adverse Event|6|||
130920570|NCT02004522|471342650|FG000|Overall Study|Withdrawal by Subject|13|||
130920571|NCT02004522|471342651|FG001|Overall Study|Withdrawal by Subject|7|||
130920572|NCT02004522|471342650|FG000|Overall Study|Death|12|||
131034222|NCT04064164|471759142|FG000|Overall Study|Withdrawal by Subject|8|||
130920573|NCT02004522|471342651|FG001|Overall Study|Death|3|||
130920574|NCT02004522|471342650|FG000|Overall Study|Physician Decision|3|||
130920575|NCT02004522|471342651|FG001|Overall Study|Physician Decision|4|||
130920576|NCT02004522|471342650|FG000|Overall Study|Protocol Violation|1|||
130920577|NCT02004522|471342651|FG001|Overall Study|Protocol Violation|0|||
130920578|NCT02004522|471342650|FG000|Overall Study|Other is reason listed by PI|4|||
130920579|NCT02004522|471342651|FG001|Overall Study|Other is reason listed by PI|1|||
130920580|NCT02004522|471342650|FG000|Overall Study|Never Dosed|2|||
130920581|NCT02004522|471342651|FG001|Overall Study|Never Dosed|4|||
130920582|NCT02004522|471342650|FG000|Overall Study|Disease Progression|35|||
130920583|NCT02004522|471342651|FG001|Overall Study|Disease Progression|31|||
130920584|NCT02004522|471342650|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
130920585|NCT02004522|471342651|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
130920586|NCT01787331|471342652|FG000|Overall Study|Physician Decision|1|||
130920587|NCT01787331|471342652|FG000|Overall Study|Withdrawal by Subject|1|||
130920588|NCT00667875|471342653|FG000|Overall Study|Adverse Event|0|||
130920589|NCT00667875|471342654|FG001|Overall Study|Adverse Event|2|||
130920590|NCT00667875|471342655|FG002|Overall Study|Adverse Event|6|||
130920591|NCT00667875|471342653|FG000|Overall Study|Withdrawal by Subject|10|||
130920592|NCT00667875|471342654|FG001|Overall Study|Withdrawal by Subject|9|||
130920593|NCT00667875|471342655|FG002|Overall Study|Withdrawal by Subject|7|||
130920594|NCT00450255|471342656|FG000|Overall Study|Prior RFA ablation of liver|1|||
130920595|NCT01696071|471342657|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
130920596|NCT01696071|471342658|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
130920597|NCT01757535|471342659|FG000|Overall Study|Disease Relapse|151|||
130920598|NCT01757535|471342660|FG001|Overall Study|Disease Relapse|181|||
130920599|NCT01757535|471342659|FG000|Overall Study|Other Reasons|28|||
130920600|NCT01757535|471342660|FG001|Overall Study|Other Reasons|27|||
130920601|NCT01757535|471342659|FG000|Overall Study|Adverse Event|31|||
130920602|NCT01757535|471342660|FG001|Overall Study|Adverse Event|11|||
130920603|NCT01757535|471342659|FG000|Overall Study|Withdrew Consent|19|||
130920604|NCT01757535|471342660|FG001|Overall Study|Withdrew Consent|13|||
130920605|NCT01757535|471342659|FG000|Overall Study|Physician Decision|7|||
130920606|NCT01757535|471342660|FG001|Overall Study|Physician Decision|0|||
130920607|NCT01757535|471342659|FG000|Overall Study|Death|2|||
130920608|NCT01757535|471342660|FG001|Overall Study|Death|2|||
130920609|NCT04622306|471344102|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
130920610|NCT04622306|471344103|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
130920611|NCT04622306|471344104|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
130920612|NCT04622306|471344105|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
131119994|NCT03583450|472072294|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
131119995|NCT03374995|472072295|FG000|Overall Study|Withdrawal by Subject|0|||
131119996|NCT03374995|472072296|FG001|Overall Study|Withdrawal by Subject|1|||
131119997|NCT01380730|472072299|FG000|Overall Study|Death|0|||
131119998|NCT01380730|472072300|FG001|Overall Study|Death|0|||
131119999|NCT01380730|472072301|FG002|Overall Study|Death|0|||
131120000|NCT01380730|472072302|FG003|Overall Study|Death|0|||
131120001|NCT01380730|472072303|FG004|Overall Study|Death|1|||
131120002|NCT01380730|472072304|FG005|Overall Study|Death|0|||
131120003|NCT01380730|472072305|FG006|Overall Study|Death|0|||
131120004|NCT01380730|472072306|FG007|Overall Study|Death|0|||
131120005|NCT00467779|472072311|FG000|Stage 1|Adverse Event|1|||
131120006|NCT00467779|472072312|FG001|Stage 1|Adverse Event|0|||
131120007|NCT00467779|472072313|FG002|Stage 1|Adverse Event|0|||
131120008|NCT00467779|472072314|FG003|Stage 1|Adverse Event|0|||
131120009|NCT00467779|472072315|FG004|Stage 1|Adverse Event|0|||
131120010|NCT00467779|472072316|FG005|Stage 1|Adverse Event|1|||
131120011|NCT00467779|472072317|FG006|Stage 1|Adverse Event|2|||
131120012|NCT00467779|472072318|FG007|Stage 1|Adverse Event|1|||
131120013|NCT00467779|472072319|FG008|Stage 1|Adverse Event|0|||
130920613|NCT04622306|471344106|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
131120014|NCT00467779|472072320|FG009|Stage 1|Adverse Event|0|||
131120015|NCT00467779|472072321|FG010|Stage 1|Adverse Event|0|||
131120016|NCT00467779|472072322|FG011|Stage 1|Adverse Event|0|||
131120017|NCT00467779|472072323|FG012|Stage 1|Adverse Event|0|||
130920614|NCT04622306|471344107|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
130920615|NCT04622306|471344102|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
130920616|NCT04622306|471344103|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
131120018|NCT00467779|472072324|FG013|Stage 1|Adverse Event|0|||
131120019|NCT00467779|472072325|FG014|Stage 1|Adverse Event|0|||
131120020|NCT00467779|472072311|FG000|Stage 1|Disease Progression|2|||
131223154|NCT02773446|472445021|FG003|First Admission|Withdrawal by Subject|1|||
130920617|NCT04622306|471344104|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
130920618|NCT04622306|471344105|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
130920619|NCT04622306|471344106|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
131120021|NCT00467779|472072312|FG001|Stage 1|Disease Progression|2|||
131120022|NCT00467779|472072313|FG002|Stage 1|Disease Progression|2|||
131120023|NCT00467779|472072314|FG003|Stage 1|Disease Progression|3|||
130920620|NCT04622306|471344107|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
130920621|NCT00736944|471344108|FG000|Induction|Death|1|||
130920622|NCT00736944|471344108|FG000|Definitive Treatment|Physician Decision|1|||
130920623|NCT01601132|471344109|FG000|Overall Study|Patient withdrew consent|1|||
130920624|NCT01601132|471344109|FG000|Overall Study|Protocol deviation|1|||
130920625|NCT01952145|471344113|FG000|Overall Study|Protocol Violation|2|||
130920626|NCT01952145|471344114|FG001|Overall Study|Protocol Violation|1|||
130920627|NCT01952145|471344113|FG000|Overall Study|Death|0|||
130920628|NCT01952145|471344114|FG001|Overall Study|Death|1|||
130920629|NCT01952145|471344113|FG000|Overall Study|Adverse Event|9|||
130920630|NCT01952145|471344114|FG001|Overall Study|Adverse Event|0|||
130920631|NCT01952145|471344113|FG000|Overall Study|Withdrawal Criteria|16|||
130920632|NCT01952145|471344114|FG001|Overall Study|Withdrawal Criteria|11|||
130920633|NCT01952145|471344113|FG000|Overall Study|Unclassified|1|||
130920634|NCT01952145|471344114|FG001|Overall Study|Unclassified|1|||
130920635|NCT04138810|471344118|FG000|Overall Study|Withdrawal by Subject|0|||
130920636|NCT04138810|471344119|FG001|Overall Study|Withdrawal by Subject|1|||
130920637|NCT04138810|471344118|FG000|Overall Study|Subject cancelled surgery|1|||
130920638|NCT04138810|471344119|FG001|Overall Study|Subject cancelled surgery|0|||
130920639|NCT01622231|471344122|FG000|Overall Study|Physician Decision|1|||
130700013|NCT04592419|470526367|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
130700014|NCT04592419|470526366|FG000|Open-Label Extension Period|Sponsor Request|73|||
130700015|NCT04592419|470526367|FG001|Open-Label Extension Period|Sponsor Request|84|||
130700016|NCT04129944|470526370|FG000|Overall Study|Death|0|||
130700017|NCT04129944|470526371|FG001|Overall Study|Death|0|||
130700018|NCT04129944|470526372|FG002|Overall Study|Death|0|||
130700019|NCT04129944|470526373|FG003|Overall Study|Death|1|||
130700020|NCT04129944|470526370|FG000|Overall Study|Lost to Follow-up|1|||
130700021|NCT04129944|470526371|FG001|Overall Study|Lost to Follow-up|0|||
130700022|NCT04129944|470526372|FG002|Overall Study|Lost to Follow-up|0|||
130700023|NCT04129944|470526373|FG003|Overall Study|Lost to Follow-up|0|||
130700024|NCT04129944|470526370|FG000|Overall Study|Withdrawal by Subject|1|||
130700025|NCT04129944|470526371|FG001|Overall Study|Withdrawal by Subject|0|||
130700026|NCT04129944|470526372|FG002|Overall Study|Withdrawal by Subject|1|||
130700027|NCT04129944|470526373|FG003|Overall Study|Withdrawal by Subject|2|||
130920640|NCT01622231|471344122|FG000|Overall Study|Withdrawal by Subject|1|||
130920641|NCT02329080|471344124|FG000|Overall Study|Adverse Event|1|||
130920642|NCT02329080|471344124|FG000|Overall Study|Death|4|||
130920643|NCT02329080|471344124|FG000|Overall Study|Lack of Efficacy|22|||
130920644|NCT02329080|471344124|FG000|Overall Study|Lost to Follow-up|1|||
130920645|NCT02329080|471344124|FG000|Overall Study|Physician Decision|2|||
130920646|NCT02329080|471344124|FG000|Overall Study|Partial response|4|||
130920647|NCT02329080|471344124|FG000|Overall Study|Complete response|4|||
130920648|NCT04545060|471344125|FG000|Overall Study|Adverse Event|0|||
130920649|NCT04545060|471344126|FG001|Overall Study|Adverse Event|1|||
130920650|NCT04545060|471344125|FG000|Overall Study|Death|0|||
130920651|NCT04545060|471344126|FG001|Overall Study|Death|5|||
130920652|NCT04545060|471344125|FG000|Overall Study|Lost to Follow-up|10|||
130920653|NCT04545060|471344126|FG001|Overall Study|Lost to Follow-up|13|||
130920654|NCT04545060|471344125|FG000|Overall Study|Physician Decision|3|||
130920655|NCT04545060|471344126|FG001|Overall Study|Physician Decision|0|||
130920656|NCT04545060|471344125|FG000|Overall Study|Withdrawal by Subject|17|||
130920657|NCT04545060|471344126|FG001|Overall Study|Withdrawal by Subject|22|||
130920658|NCT00619177|471344129|FG000|Overall Study|Adverse Event|18|||
130920659|NCT00619177|471344129|FG000|Overall Study|Lost to Follow-up|2|||
130920660|NCT00619177|471344129|FG000|Overall Study|Lack of Efficacy|1|||
130920661|NCT00619177|471344129|FG000|Overall Study|Missing termination information|481|||
130920662|NCT00619177|471344129|FG000|Overall Study|Not specified reasons|6|||
130920663|NCT01609231|471344130|FG000|Overall Study|Adverse Event|1|||
130920664|NCT01609231|471344131|FG001|Overall Study|Adverse Event|3|||
130920665|NCT01609231|471344130|FG000|Overall Study|Physician Decision|1|||
130920666|NCT01609231|471344131|FG001|Overall Study|Physician Decision|0|||
131223155|NCT02773446|472445022|FG004|First Admission|Withdrawal by Subject|0|||
130700028|NCT02419573|470526374|FG000|Overall Study|Lost to Follow-up|3|||
130700029|NCT02419573|470526375|FG001|Overall Study|Lost to Follow-up|0|||
130700030|NCT02419573|470526374|FG000|Overall Study|Withdrawal by Subject|1|||
130920667|NCT01609231|471344130|FG000|Overall Study|Withdrawal by Subject|1|||
131223156|NCT02773446|472445023|FG005|First Admission|Withdrawal by Subject|0|||
130920668|NCT01609231|471344131|FG001|Overall Study|Withdrawal by Subject|0|||
130920669|NCT03082261|471344134|FG000|Overall Study|Death|4|||
130920670|NCT03082261|471344134|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
130920671|NCT03082261|471344134|FG000|Overall Study|Insurance denial|1|||
130920672|NCT03082261|471344134|FG000|Overall Study|Peripheral lead added|1|||
130920673|NCT03082261|471344134|FG000|Overall Study|Withdrawal by Subject|40|||
130920674|NCT03082261|471344134|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
130920675|NCT03082261|471344134|FG000|Overall Study|Subject implanted with device other than study device|1|||
130920676|NCT03082261|471344134|FG000|Overall Study|Lost to Follow-up|14|||
130920677|NCT03082261|471344134|FG000|Overall Study|Subject moved to a different state|1|||
130700031|NCT02419573|470526375|FG001|Overall Study|Withdrawal by Subject|0|||
130700032|NCT00493792|470526376|FG000|Overall Study|Death|55|||
130920678|NCT03082261|471344134|FG000|Overall Study|Subject non-compliance|2|||
130920679|NCT03082261|471344134|FG000|Overall Study|Subject participation terminated by investigator|9|||
130920680|NCT03082261|471344134|FG000|Overall Study|Subject participation terminated by sponsor|4|||
130920681|NCT03082261|471344134|FG000|Overall Study|System explant|19|||
130920682|NCT03082261|471344134|FG000|Overall Study|Unable to place lead(s)|2|||
130920683|NCT03082261|471344134|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
130920684|NCT00702689|471344136|FG000|Overall Study|Withdrawal by Subject|4|||
130920685|NCT00702689|471344136|FG000|Overall Study|Recurrent malignancy|1|||
130920686|NCT00702689|471344136|FG000|Overall Study|Adverse Event|1|||
130920687|NCT01281137|471344139|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
130920688|NCT01281137|471344140|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
130920689|NCT01281137|471344139|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
130920690|NCT01281137|471344140|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
130920691|NCT01281137|471344139|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
130920692|NCT01281137|471344140|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
130920693|NCT01281137|471344139|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
130920694|NCT01281137|471344140|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
130920695|NCT01281137|471344139|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
130920696|NCT01281137|471344140|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
130920697|NCT02761733|471344143|FG000|Overall Study|Death|3|||
130920698|NCT02761733|471344144|FG001|Overall Study|Death|5|||
130920699|NCT02761733|471344145|FG002|Overall Study|Death|1|||
130920700|NCT02761733|471344146|FG003|Overall Study|Death|1|||
130920701|NCT02761733|471344143|FG000|Overall Study|Lost to Follow-up|6|||
130920702|NCT02761733|471344144|FG001|Overall Study|Lost to Follow-up|7|||
130920703|NCT02761733|471344145|FG002|Overall Study|Lost to Follow-up|0|||
130920704|NCT02761733|471344146|FG003|Overall Study|Lost to Follow-up|3|||
130920705|NCT02761733|471344143|FG000|Overall Study|Physician Decision|4|||
130920706|NCT02761733|471344144|FG001|Overall Study|Physician Decision|0|||
130920707|NCT02761733|471344145|FG002|Overall Study|Physician Decision|0|||
130920708|NCT02761733|471344146|FG003|Overall Study|Physician Decision|0|||
130920709|NCT02761733|471344143|FG000|Overall Study|Withdrawal by Subject|2|||
130920710|NCT02761733|471344144|FG001|Overall Study|Withdrawal by Subject|0|||
130920711|NCT02761733|471344145|FG002|Overall Study|Withdrawal by Subject|0|||
130920712|NCT02761733|471344146|FG003|Overall Study|Withdrawal by Subject|0|||
130920713|NCT02761733|471344143|FG000|Overall Study|Discharged from Study Site|10|||
130920714|NCT02761733|471344144|FG001|Overall Study|Discharged from Study Site|9|||
130920715|NCT02761733|471344145|FG002|Overall Study|Discharged from Study Site|25|||
130920716|NCT02761733|471344146|FG003|Overall Study|Discharged from Study Site|11|||
130920717|NCT02761733|471344143|FG000|Overall Study|Cognitive Impairment|5|||
130920718|NCT02761733|471344144|FG001|Overall Study|Cognitive Impairment|0|||
130920719|NCT02761733|471344145|FG002|Overall Study|Cognitive Impairment|1|||
130920720|NCT02761733|471344146|FG003|Overall Study|Cognitive Impairment|0|||
130920721|NCT01986907|471344149|FG000|Overall Study|Adverse Event|11|||
130920722|NCT01986907|471344149|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
130920723|NCT01986907|471344149|FG000|Overall Study|Protocol Violation|4|||
130920724|NCT01986907|471344149|FG000|Overall Study|Withdrawal by Subject|76|||
130920725|NCT01986907|471344149|FG000|Overall Study|Lost to Follow-up|38|||
130920726|NCT01986907|471344149|FG000|Overall Study|Death|9|||
130920727|NCT04295772|471344153|FG000|Overall Study|Protocol Violation|1|||
130920728|NCT04295772|471344154|FG001|Overall Study|Protocol Violation|0|||
130920729|NCT04295772|471344153|FG000|Overall Study|Ongoing for safety monitoring|14|||
130920730|NCT04295772|471344154|FG001|Overall Study|Ongoing for safety monitoring|1|||
130920731|NCT04295772|471344153|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
130920732|NCT04295772|471344154|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
130920733|NCT02846324|471344155|FG000|Overall Study|Other|1|||
130700033|NCT00493792|470526377|FG001|Overall Study|Death|50|||
130700034|NCT00493792|470526376|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
130700035|NCT00493792|470526377|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
130700036|NCT02246764|470526390|FG000|Overall Study|Adverse Event|15|||
130920734|NCT02846324|471344156|FG001|Overall Study|Other|0|||
130920735|NCT02846324|471344157|FG002|Overall Study|Other|0|||
130920736|NCT02846324|471344158|FG003|Overall Study|Other|0|||
130920737|NCT02846324|471344155|FG000|Overall Study|Withdrawal by Subject|1|||
130920738|NCT02846324|471344156|FG001|Overall Study|Withdrawal by Subject|0|||
130700037|NCT02246764|470526391|FG001|Overall Study|Adverse Event|29|||
130700038|NCT02246764|470526392|FG002|Overall Study|Adverse Event|1|||
130700039|NCT02246764|470526390|FG000|Overall Study|Withdrawal by Subject|0|||
130920739|NCT02846324|471344157|FG002|Overall Study|Withdrawal by Subject|4|||
130920740|NCT02846324|471344158|FG003|Overall Study|Withdrawal by Subject|0|||
130920741|NCT03576495|471344175|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
130920742|NCT03576495|471344176|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
130920743|NCT03608254|471344178|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
130920744|NCT03608254|471344178|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
130920745|NCT04203797|471344179|FG000|Overall Study|Adverse Event|1|||
130920746|NCT04203797|471344180|FG001|Overall Study|Adverse Event|0|||
130920747|NCT04203797|471344179|FG000|Overall Study|Did not complete End of Study follow-up|1|||
130920748|NCT04203797|471344180|FG001|Overall Study|Did not complete End of Study follow-up|0|||
130920749|NCT00516074|471344181|FG000|Overall Study|Adverse Event|0|||
130920750|NCT00516074|471344182|FG001|Overall Study|Adverse Event|1|||
130920751|NCT00516074|471344181|FG000|Overall Study|Subject Decision|4|||
130920752|NCT00516074|471344182|FG001|Overall Study|Subject Decision|2|||
130920753|NCT00516074|471344181|FG000|Overall Study|Loss of Glucose Control|2|||
130920754|NCT00516074|471344182|FG001|Overall Study|Loss of Glucose Control|0|||
130920755|NCT01903031|471344183|FG000|Overall Study|Not Able to Attend Clinic|1|||
130920756|NCT01903031|471344184|FG001|Overall Study|Not Able to Attend Clinic|1|||
130920757|NCT01903031|471344185|FG002|Overall Study|Not Able to Attend Clinic|0|||
130920758|NCT01903031|471344183|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
130920759|NCT01903031|471344184|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
130920760|NCT01903031|471344185|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
130920761|NCT01903031|471344183|FG000|Overall Study|Adverse Event|0|||
130920762|NCT01903031|471344184|FG001|Overall Study|Adverse Event|1|||
130920763|NCT01903031|471344185|FG002|Overall Study|Adverse Event|0|||
130920764|NCT01903031|471344183|FG000|Overall Study|Withdrawal by Subject|0|||
130920765|NCT01903031|471344184|FG001|Overall Study|Withdrawal by Subject|1|||
130920766|NCT01903031|471344185|FG002|Overall Study|Withdrawal by Subject|1|||
130920767|NCT01903031|471344183|FG000|Overall Study|Protocol Violation|0|||
130920768|NCT01903031|471344184|FG001|Overall Study|Protocol Violation|0|||
130920769|NCT01903031|471344185|FG002|Overall Study|Protocol Violation|2|||
130920770|NCT01903031|471344183|FG000|Overall Study|Lost to Follow-up|0|||
130920771|NCT01903031|471344184|FG001|Overall Study|Lost to Follow-up|0|||
130920772|NCT01903031|471344185|FG002|Overall Study|Lost to Follow-up|1|||
130920773|NCT01903031|471344183|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
130920774|NCT01903031|471344184|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
130920775|NCT01903031|471344185|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
130920776|NCT03540030|471344186|FG000|Overall Study|Withdrawal by Subject|2|||
130920777|NCT03540030|471344187|FG001|Overall Study|Withdrawal by Subject|1|||
130920778|NCT03540030|471344186|FG000|Overall Study|screen fail|7|||
130920779|NCT03540030|471344187|FG001|Overall Study|screen fail|1|||
130920780|NCT03540030|471344186|FG000|Overall Study|never had surgery after signing consent|9|||
130920781|NCT03540030|471344187|FG001|Overall Study|never had surgery after signing consent|1|||
130920782|NCT00447005|471344189|FG000|Overall Study|Adverse Event|1|||
130920783|NCT00447005|471344189|FG000|Overall Study|Lack of Efficacy|11|||
130920784|NCT01484275|471344193|FG000|Overall Study|Study terminated by sponsor|28|||
130920785|NCT01484275|471344194|FG001|Overall Study|Study terminated by sponsor|32|||
130920786|NCT01484275|471344193|FG000|Overall Study|Other|10|||
130920787|NCT01484275|471344194|FG001|Overall Study|Other|0|||
130920788|NCT01484275|471344193|FG000|Overall Study|Death|3|||
130920789|NCT01484275|471344194|FG001|Overall Study|Death|4|||
130920790|NCT01484275|471344193|FG000|Overall Study|Withdrawal by Subject|1|||
131120024|NCT00467779|472072315|FG004|Stage 1|Disease Progression|2|||
131120025|NCT00467779|472072316|FG005|Stage 1|Disease Progression|2|||
131120026|NCT00467779|472072317|FG006|Stage 1|Disease Progression|4|||
131120027|NCT00467779|472072318|FG007|Stage 1|Disease Progression|5|||
131120028|NCT00467779|472072319|FG008|Stage 1|Disease Progression|0|||
131120029|NCT00467779|472072320|FG009|Stage 1|Disease Progression|0|||
131120030|NCT00467779|472072321|FG010|Stage 1|Disease Progression|0|||
131120031|NCT00467779|472072322|FG011|Stage 1|Disease Progression|0|||
131120032|NCT00467779|472072323|FG012|Stage 1|Disease Progression|0|||
130920791|NCT01484275|471344194|FG001|Overall Study|Withdrawal by Subject|5|||
130920792|NCT01484275|471344193|FG000|Overall Study|Lost to Follow-up|1|||
130920793|NCT01484275|471344194|FG001|Overall Study|Lost to Follow-up|1|||
130920794|NCT00003487|471344195|FG000|Overall Study|Not evaluable|2|||
130920795|NCT03855228|471344202|FG000|Overall Study|Adverse Event|2|||
130920796|NCT03855228|471344203|FG001|Overall Study|Adverse Event|4|||
130920797|NCT03855228|471344204|FG002|Overall Study|Adverse Event|4|||
130920798|NCT03855228|471344205|FG003|Overall Study|Adverse Event|8|||
130920799|NCT03855228|471344202|FG000|Overall Study|Treatment Failure|1|||
131120033|NCT00467779|472072324|FG013|Stage 1|Disease Progression|0|||
131120034|NCT00467779|472072325|FG014|Stage 1|Disease Progression|0|||
131120035|NCT00467779|472072311|FG000|Stage 1|Unspecified Reason|1|||
130920800|NCT03855228|471344203|FG001|Overall Study|Treatment Failure|2|||
130920801|NCT03855228|471344204|FG002|Overall Study|Treatment Failure|1|||
130920802|NCT03855228|471344205|FG003|Overall Study|Treatment Failure|8|||
131120036|NCT00467779|472072312|FG001|Stage 1|Unspecified Reason|0|||
130920803|NCT03855228|471344202|FG000|Overall Study|Lost to Follow-up|0|||
130920804|NCT03855228|471344203|FG001|Overall Study|Lost to Follow-up|0|||
130920805|NCT03855228|471344204|FG002|Overall Study|Lost to Follow-up|0|||
130920806|NCT03855228|471344205|FG003|Overall Study|Lost to Follow-up|1|||
130920807|NCT03855228|471344202|FG000|Overall Study|Protocol Violation|0|||
130920808|NCT03855228|471344203|FG001|Overall Study|Protocol Violation|1|||
130920809|NCT03855228|471344204|FG002|Overall Study|Protocol Violation|2|||
130920810|NCT03855228|471344205|FG003|Overall Study|Protocol Violation|1|||
130920811|NCT03855228|471344202|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
130920812|NCT03855228|471344203|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
130920813|NCT03855228|471344204|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
130920814|NCT03855228|471344205|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
130920815|NCT00722800|471344207|FG000|Overall Study|Withdrawal by Subject|1|||
130920816|NCT00722800|471344208|FG001|Overall Study|Withdrawal by Subject|0|||
130920817|NCT00722800|471344207|FG000|Overall Study|Physician Decision|1|||
130920818|NCT00722800|471344208|FG001|Overall Study|Physician Decision|0|||
130920819|NCT02130297|471344212|FG000|Overall Study|Lost to Follow-up|4|||
130920820|NCT00913380|471344226|FG000|Clinical Outcomes|Lost to Follow-up|6|||
130920821|NCT00913380|471344227|FG001|Clinical Outcomes|Lost to Follow-up|6|||
130920822|NCT00806351|471344228|FG000|Overall Study|Death|5|||
130920823|NCT00806351|471344229|FG001|Overall Study|Death|4|||
130920824|NCT00142298|471344238|FG000|Overall Study|Adverse Event|10|||
130920825|NCT00142298|471344239|FG001|Overall Study|Adverse Event|10|||
130920826|NCT00142298|471344240|FG002|Overall Study|Adverse Event|1|||
130920827|NCT00142298|471344241|FG003|Overall Study|Adverse Event|5|||
130920828|NCT00142298|471344242|FG004|Overall Study|Adverse Event|2|||
130920829|NCT00142298|471344243|FG005|Overall Study|Adverse Event|2|||
130920830|NCT00142298|471344244|FG006|Overall Study|Adverse Event|0|||
130920831|NCT00142298|471344245|FG007|Overall Study|Adverse Event|0|||
130920832|NCT00142298|471344246|FG008|Overall Study|Adverse Event|0|||
130920833|NCT00142298|471344247|FG009|Overall Study|Adverse Event|0|||
130920834|NCT00142298|471344238|FG000|Overall Study|Clinical disease progression|1|||
130920835|NCT00142298|471344239|FG001|Overall Study|Clinical disease progression|0|||
130920836|NCT00142298|471344240|FG002|Overall Study|Clinical disease progression|0|||
130920837|NCT00142298|471344241|FG003|Overall Study|Clinical disease progression|0|||
130920838|NCT00142298|471344242|FG004|Overall Study|Clinical disease progression|0|||
130920839|NCT00142298|471344243|FG005|Overall Study|Clinical disease progression|0|||
130920840|NCT00142298|471344244|FG006|Overall Study|Clinical disease progression|0|||
130920841|NCT00142298|471344245|FG007|Overall Study|Clinical disease progression|0|||
130920842|NCT00142298|471344246|FG008|Overall Study|Clinical disease progression|0|||
130920843|NCT00142298|471344247|FG009|Overall Study|Clinical disease progression|0|||
130920844|NCT00142298|471344238|FG000|Overall Study|Death|1|||
130920845|NCT00142298|471344239|FG001|Overall Study|Death|1|||
130920846|NCT00142298|471344240|FG002|Overall Study|Death|1|||
130920847|NCT00142298|471344241|FG003|Overall Study|Death|0|||
130920848|NCT00142298|471344242|FG004|Overall Study|Death|0|||
130920849|NCT00142298|471344243|FG005|Overall Study|Death|6|||
130920850|NCT00142298|471344244|FG006|Overall Study|Death|0|||
130920851|NCT00142298|471344245|FG007|Overall Study|Death|0|||
130920852|NCT00142298|471344246|FG008|Overall Study|Death|0|||
131034223|NCT04064164|471759143|FG001|Overall Study|Withdrawal by Subject|8|||
130700040|NCT02246764|470526391|FG001|Overall Study|Withdrawal by Subject|0|||
130700041|NCT02246764|470526392|FG002|Overall Study|Withdrawal by Subject|1|||
130700042|NCT02246764|470526390|FG000|Overall Study|Disallowed Concomitant Medication|1|||
130700043|NCT02246764|470526391|FG001|Overall Study|Disallowed Concomitant Medication|0|||
130700044|NCT02246764|470526392|FG002|Overall Study|Disallowed Concomitant Medication|0|||
130700045|NCT02246764|470526390|FG000|Overall Study|Physician Decision|0|||
130700046|NCT02246764|470526391|FG001|Overall Study|Physician Decision|2|||
130700047|NCT02246764|470526392|FG002|Overall Study|Physician Decision|1|||
130700048|NCT02246764|470526390|FG000|Overall Study|Protocol Violation|2|||
130700049|NCT02246764|470526391|FG001|Overall Study|Protocol Violation|1|||
130769421|NCT03046056|470782432|FG000|Overall Study|Withdrew Consent|1|||
130920853|NCT00142298|471344247|FG009|Overall Study|Death|0|||
130920854|NCT00142298|471344238|FG000|Overall Study|Lack of Efficacy|44|||
130920855|NCT00142298|471344239|FG001|Overall Study|Lack of Efficacy|62|||
130920856|NCT00142298|471344240|FG002|Overall Study|Lack of Efficacy|9|||
130920857|NCT00142298|471344241|FG003|Overall Study|Lack of Efficacy|12|||
130920858|NCT00142298|471344242|FG004|Overall Study|Lack of Efficacy|1|||
130920859|NCT00142298|471344243|FG005|Overall Study|Lack of Efficacy|0|||
130920860|NCT00142298|471344244|FG006|Overall Study|Lack of Efficacy|0|||
130920861|NCT00142298|471344245|FG007|Overall Study|Lack of Efficacy|1|||
130920862|NCT00142298|471344246|FG008|Overall Study|Lack of Efficacy|0|||
130920863|NCT00142298|471344247|FG009|Overall Study|Lack of Efficacy|0|||
130920864|NCT00142298|471344238|FG000|Overall Study|Non-compliance|15|||
130920865|NCT00142298|471344239|FG001|Overall Study|Non-compliance|13|||
130920866|NCT00142298|471344240|FG002|Overall Study|Non-compliance|0|||
130920867|NCT00142298|471344241|FG003|Overall Study|Non-compliance|6|||
130700050|NCT02246764|470526392|FG002|Overall Study|Protocol Violation|1|||
130920868|NCT00142298|471344242|FG004|Overall Study|Non-compliance|1|||
130700051|NCT02754492|470526395|FG000|Overall Study|Protocol Violation|2|||
130700052|NCT02754492|470526396|FG001|Overall Study|Protocol Violation|2|||
130920869|NCT00142298|471344243|FG005|Overall Study|Non-compliance|0|||
130920870|NCT00142298|471344244|FG006|Overall Study|Non-compliance|0|||
130920871|NCT00142298|471344245|FG007|Overall Study|Non-compliance|3|||
130920872|NCT00142298|471344246|FG008|Overall Study|Non-compliance|3|||
130920873|NCT00142298|471344247|FG009|Overall Study|Non-compliance|0|||
130920874|NCT00142298|471344238|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
130920875|NCT00142298|471344239|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
130920876|NCT00142298|471344240|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
130920877|NCT00142298|471344241|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
130920878|NCT00142298|471344242|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
130920879|NCT00142298|471344243|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
130920880|NCT00142298|471344244|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
130920881|NCT00142298|471344245|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
130920882|NCT00142298|471344246|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
130920883|NCT00142298|471344247|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
130920884|NCT00142298|471344238|FG000|Overall Study|Pregnancy|4|||
130920885|NCT00142298|471344239|FG001|Overall Study|Pregnancy|4|||
130920886|NCT00142298|471344240|FG002|Overall Study|Pregnancy|2|||
130920887|NCT00142298|471344241|FG003|Overall Study|Pregnancy|3|||
130920888|NCT00142298|471344242|FG004|Overall Study|Pregnancy|0|||
130920889|NCT00142298|471344243|FG005|Overall Study|Pregnancy|0|||
130920890|NCT00142298|471344244|FG006|Overall Study|Pregnancy|0|||
130920891|NCT00142298|471344245|FG007|Overall Study|Pregnancy|0|||
130920892|NCT00142298|471344246|FG008|Overall Study|Pregnancy|1|||
130920893|NCT00142298|471344247|FG009|Overall Study|Pregnancy|0|||
130920894|NCT00142298|471344238|FG000|Overall Study|Virologic breakthrough|19|||
130920895|NCT00142298|471344239|FG001|Overall Study|Virologic breakthrough|23|||
130920896|NCT00142298|471344240|FG002|Overall Study|Virologic breakthrough|9|||
130920897|NCT00142298|471344241|FG003|Overall Study|Virologic breakthrough|7|||
130920898|NCT00142298|471344242|FG004|Overall Study|Virologic breakthrough|2|||
130920899|NCT00142298|471344243|FG005|Overall Study|Virologic breakthrough|3|||
130920900|NCT00142298|471344244|FG006|Overall Study|Virologic breakthrough|3|||
130920901|NCT00142298|471344245|FG007|Overall Study|Virologic breakthrough|0|||
130920902|NCT00142298|471344246|FG008|Overall Study|Virologic breakthrough|0|||
130920903|NCT00142298|471344247|FG009|Overall Study|Virologic breakthrough|0|||
130920904|NCT00142298|471344238|FG000|Overall Study|Other- not specified|0|||
130920905|NCT00142298|471344239|FG001|Overall Study|Other- not specified|3|||
130920906|NCT00142298|471344240|FG002|Overall Study|Other- not specified|0|||
130920907|NCT00142298|471344241|FG003|Overall Study|Other- not specified|1|||
130920908|NCT00142298|471344242|FG004|Overall Study|Other- not specified|0|||
130920909|NCT00142298|471344243|FG005|Overall Study|Other- not specified|0|||
130920910|NCT00142298|471344244|FG006|Overall Study|Other- not specified|0|||
130920911|NCT00142298|471344245|FG007|Overall Study|Other- not specified|0|||
130920912|NCT00142298|471344246|FG008|Overall Study|Other- not specified|0|||
130920913|NCT00142298|471344247|FG009|Overall Study|Other- not specified|0|||
130920914|NCT00142298|471344238|FG000|Overall Study|Lost to Follow-up|0|||
130920915|NCT00142298|471344239|FG001|Overall Study|Lost to Follow-up|0|||
130920916|NCT00142298|471344240|FG002|Overall Study|Lost to Follow-up|0|||
130920917|NCT00142298|471344241|FG003|Overall Study|Lost to Follow-up|0|||
130920918|NCT00142298|471344242|FG004|Overall Study|Lost to Follow-up|0|||
130920919|NCT00142298|471344243|FG005|Overall Study|Lost to Follow-up|0|||
130920920|NCT00142298|471344244|FG006|Overall Study|Lost to Follow-up|2|||
130920921|NCT00142298|471344245|FG007|Overall Study|Lost to Follow-up|0|||
130920922|NCT00142298|471344246|FG008|Overall Study|Lost to Follow-up|0|||
130920923|NCT00142298|471344247|FG009|Overall Study|Lost to Follow-up|0|||
131120037|NCT00467779|472072313|FG002|Stage 1|Unspecified Reason|1|||
131120038|NCT00467779|472072314|FG003|Stage 1|Unspecified Reason|0|||
131120039|NCT00467779|472072315|FG004|Stage 1|Unspecified Reason|1|||
131120040|NCT00467779|472072316|FG005|Stage 1|Unspecified Reason|2|||
131120041|NCT00467779|472072317|FG006|Stage 1|Unspecified Reason|0|||
131120042|NCT00467779|472072318|FG007|Stage 1|Unspecified Reason|0|||
130700053|NCT02754492|470526397|FG002|Overall Study|Protocol Violation|0|||
130700054|NCT02754492|470526398|FG003|Overall Study|Protocol Violation|1|||
130700055|NCT02754492|470526395|FG000|Overall Study|Withdrawal by Subject|2|||
130700056|NCT02754492|470526396|FG001|Overall Study|Withdrawal by Subject|0|||
130920924|NCT00142298|471344238|FG000|Overall Study|Treatment Failure|0|||
130920925|NCT00142298|471344239|FG001|Overall Study|Treatment Failure|0|||
130920926|NCT00142298|471344240|FG002|Overall Study|Treatment Failure|0|||
130920927|NCT00142298|471344241|FG003|Overall Study|Treatment Failure|0|||
130920928|NCT00142298|471344242|FG004|Overall Study|Treatment Failure|0|||
130920929|NCT00142298|471344243|FG005|Overall Study|Treatment Failure|2|||
130920930|NCT00142298|471344244|FG006|Overall Study|Treatment Failure|2|||
130920931|NCT00142298|471344245|FG007|Overall Study|Treatment Failure|0|||
130920932|NCT00142298|471344246|FG008|Overall Study|Treatment Failure|0|||
130920933|NCT00142298|471344247|FG009|Overall Study|Treatment Failure|0|||
131120043|NCT00467779|472072319|FG008|Stage 1|Unspecified Reason|0|||
131120044|NCT00467779|472072320|FG009|Stage 1|Unspecified Reason|0|||
131120045|NCT00467779|472072321|FG010|Stage 1|Unspecified Reason|0|||
131120046|NCT00467779|472072322|FG011|Stage 1|Unspecified Reason|0|||
131120047|NCT00467779|472072323|FG012|Stage 1|Unspecified Reason|0|||
131120048|NCT00467779|472072324|FG013|Stage 1|Unspecified Reason|0|||
131120049|NCT00467779|472072325|FG014|Stage 1|Unspecified Reason|0|||
131120050|NCT00467779|472072311|FG000|Stage 1|Physician Decision|0|||
131120051|NCT00467779|472072312|FG001|Stage 1|Physician Decision|1|||
131120052|NCT00467779|472072313|FG002|Stage 1|Physician Decision|0|||
131120053|NCT00467779|472072314|FG003|Stage 1|Physician Decision|0|||
131120054|NCT00467779|472072315|FG004|Stage 1|Physician Decision|0|||
131120055|NCT00467779|472072316|FG005|Stage 1|Physician Decision|0|||
131120056|NCT00467779|472072317|FG006|Stage 1|Physician Decision|0|||
131120057|NCT00467779|472072318|FG007|Stage 1|Physician Decision|0|||
131120058|NCT00467779|472072319|FG008|Stage 1|Physician Decision|0|||
131120059|NCT00467779|472072320|FG009|Stage 1|Physician Decision|0|||
131120060|NCT00467779|472072321|FG010|Stage 1|Physician Decision|0|||
131120061|NCT00467779|472072322|FG011|Stage 1|Physician Decision|0|||
131120062|NCT00467779|472072323|FG012|Stage 1|Physician Decision|0|||
131120063|NCT00467779|472072324|FG013|Stage 1|Physician Decision|0|||
131120064|NCT00467779|472072325|FG014|Stage 1|Physician Decision|0|||
131120065|NCT00467779|472072311|FG000|Stage 1|Withdrawal by Subject|0|||
131120066|NCT00467779|472072312|FG001|Stage 1|Withdrawal by Subject|0|||
131120067|NCT00467779|472072313|FG002|Stage 1|Withdrawal by Subject|0|||
131120068|NCT00467779|472072314|FG003|Stage 1|Withdrawal by Subject|0|||
131120069|NCT00467779|472072315|FG004|Stage 1|Withdrawal by Subject|0|||
131120070|NCT00467779|472072316|FG005|Stage 1|Withdrawal by Subject|0|||
131120071|NCT00467779|472072317|FG006|Stage 1|Withdrawal by Subject|1|||
131120072|NCT00467779|472072318|FG007|Stage 1|Withdrawal by Subject|1|||
131120073|NCT00467779|472072319|FG008|Stage 1|Withdrawal by Subject|0|||
131120074|NCT00467779|472072320|FG009|Stage 1|Withdrawal by Subject|0|||
131120075|NCT00467779|472072321|FG010|Stage 1|Withdrawal by Subject|0|||
131120076|NCT00467779|472072322|FG011|Stage 1|Withdrawal by Subject|0|||
131120077|NCT00467779|472072323|FG012|Stage 1|Withdrawal by Subject|0|||
131120078|NCT00467779|472072324|FG013|Stage 1|Withdrawal by Subject|0|||
131120079|NCT00467779|472072325|FG014|Stage 1|Withdrawal by Subject|0|||
131120080|NCT00467779|472072311|FG000|Stage 1A|Adverse Event|0|||
131120081|NCT00467779|472072312|FG001|Stage 1A|Adverse Event|0|||
131120082|NCT00467779|472072313|FG002|Stage 1A|Adverse Event|0|||
131120083|NCT00467779|472072314|FG003|Stage 1A|Adverse Event|0|||
131120084|NCT00467779|472072315|FG004|Stage 1A|Adverse Event|0|||
131120085|NCT00467779|472072316|FG005|Stage 1A|Adverse Event|0|||
131120086|NCT00467779|472072317|FG006|Stage 1A|Adverse Event|0|||
131120087|NCT00467779|472072318|FG007|Stage 1A|Adverse Event|0|||
131120088|NCT00467779|472072319|FG008|Stage 1A|Adverse Event|0|||
131120089|NCT00467779|472072320|FG009|Stage 1A|Adverse Event|0|||
131120090|NCT00467779|472072321|FG010|Stage 1A|Adverse Event|0|||
131120091|NCT00467779|472072322|FG011|Stage 1A|Adverse Event|0|||
131120092|NCT00467779|472072323|FG012|Stage 1A|Adverse Event|1|||
131120093|NCT00467779|472072324|FG013|Stage 1A|Adverse Event|0|||
131120094|NCT00467779|472072325|FG014|Stage 1A|Adverse Event|0|||
131120095|NCT00467779|472072311|FG000|Stage 1A|Death|0|||
131120096|NCT00467779|472072312|FG001|Stage 1A|Death|0|||
130920934|NCT00300274|471344248|FG000|Overall Study|Withdrawal by Subject|12|||
130920935|NCT00300274|471344249|FG001|Overall Study|Withdrawal by Subject|3|||
130920936|NCT00300274|471344250|FG002|Overall Study|Withdrawal by Subject|14|||
130920937|NCT00300274|471344248|FG000|Overall Study|Lost to Follow-up|3|||
130920938|NCT00300274|471344249|FG001|Overall Study|Lost to Follow-up|4|||
130920939|NCT00300274|471344250|FG002|Overall Study|Lost to Follow-up|5|||
130920940|NCT00300274|471344248|FG000|Overall Study|Death|31|||
130920941|NCT00300274|471344249|FG001|Overall Study|Death|20|||
130920942|NCT00300274|471344250|FG002|Overall Study|Death|25|||
130920943|NCT00300274|471344248|FG000|Overall Study|Re-transplant|0|||
131120097|NCT00467779|472072313|FG002|Stage 1A|Death|0|||
131120098|NCT00467779|472072314|FG003|Stage 1A|Death|0|||
131120099|NCT00467779|472072315|FG004|Stage 1A|Death|0|||
131120100|NCT00467779|472072316|FG005|Stage 1A|Death|0|||
131120101|NCT00467779|472072317|FG006|Stage 1A|Death|0|||
131120102|NCT00467779|472072318|FG007|Stage 1A|Death|0|||
130920944|NCT00300274|471344249|FG001|Overall Study|Re-transplant|0|||
130920945|NCT00300274|471344250|FG002|Overall Study|Re-transplant|1|||
131120103|NCT00467779|472072319|FG008|Stage 1A|Death|0|||
131120104|NCT00467779|472072320|FG009|Stage 1A|Death|0|||
131120105|NCT00467779|472072321|FG010|Stage 1A|Death|0|||
130920946|NCT04439201|471344251|FG000|Overall Study|Ineligible|2|||
130920947|NCT04439201|471344251|FG000|Overall Study|Never start protocol therapy|1|||
131120106|NCT00467779|472072322|FG011|Stage 1A|Death|1|||
131120107|NCT00467779|472072323|FG012|Stage 1A|Death|1|||
131120108|NCT00467779|472072324|FG013|Stage 1A|Death|0|||
131120109|NCT00467779|472072325|FG014|Stage 1A|Death|0|||
131120110|NCT00467779|472072311|FG000|Stage 1A|Disease Progression|0|||
131120111|NCT00467779|472072312|FG001|Stage 1A|Disease Progression|0|||
131120112|NCT00467779|472072313|FG002|Stage 1A|Disease Progression|0|||
131120113|NCT00467779|472072314|FG003|Stage 1A|Disease Progression|0|||
131120114|NCT00467779|472072315|FG004|Stage 1A|Disease Progression|0|||
130920948|NCT04439201|471344251|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
130920949|NCT04439201|471344251|FG000|Overall Study|Mutation status not confirmed|4|||
130920950|NCT04439201|471344251|FG000|Overall Study|Adverse Event|1|||
130920951|NCT04439201|471344251|FG000|Overall Study|Death|7|||
130920952|NCT04439201|471344251|FG000|Overall Study|Withdrawal by Subject|2|||
131120115|NCT00467779|472072316|FG005|Stage 1A|Disease Progression|0|||
131120116|NCT00467779|472072317|FG006|Stage 1A|Disease Progression|0|||
131120117|NCT00467779|472072318|FG007|Stage 1A|Disease Progression|0|||
131120118|NCT00467779|472072319|FG008|Stage 1A|Disease Progression|0|||
131120119|NCT00467779|472072320|FG009|Stage 1A|Disease Progression|2|||
131120120|NCT00467779|472072321|FG010|Stage 1A|Disease Progression|2|||
131120121|NCT00467779|472072322|FG011|Stage 1A|Disease Progression|5|||
131120122|NCT00467779|472072323|FG012|Stage 1A|Disease Progression|2|||
131120123|NCT00467779|472072324|FG013|Stage 1A|Disease Progression|0|||
131120124|NCT00467779|472072325|FG014|Stage 1A|Disease Progression|0|||
131120125|NCT00467779|472072311|FG000|Stage 1A|Physician Decision|0|||
131120126|NCT00467779|472072312|FG001|Stage 1A|Physician Decision|0|||
131120127|NCT00467779|472072313|FG002|Stage 1A|Physician Decision|0|||
131120128|NCT00467779|472072314|FG003|Stage 1A|Physician Decision|0|||
131120129|NCT00467779|472072315|FG004|Stage 1A|Physician Decision|0|||
131120130|NCT00467779|472072316|FG005|Stage 1A|Physician Decision|0|||
131120131|NCT00467779|472072317|FG006|Stage 1A|Physician Decision|0|||
130920953|NCT04439201|471344251|FG000|Overall Study|Disease progression|20|||
130920954|NCT04439201|471344251|FG000|Overall Study|Alternative therapy|1|||
130920955|NCT04439201|471344251|FG000|Overall Study|Physician Decision|1|||
130920956|NCT05147428|471344254|FG000|Overall Study|Removed prior to mailing|289|||
130920957|NCT05147428|471344255|FG001|Overall Study|Removed prior to mailing|306|||
130920958|NCT05147428|471344256|FG002|Overall Study|Removed prior to mailing|270|||
130920959|NCT05147428|471344254|FG000|Overall Study|Died or disenrolled during blackout period|239|||
130920960|NCT05147428|471344255|FG001|Overall Study|Died or disenrolled during blackout period|278|||
131120132|NCT00467779|472072318|FG007|Stage 1A|Physician Decision|0|||
131120133|NCT00467779|472072319|FG008|Stage 1A|Physician Decision|0|||
131120134|NCT00467779|472072320|FG009|Stage 1A|Physician Decision|1|||
131120135|NCT00467779|472072321|FG010|Stage 1A|Physician Decision|0|||
130920961|NCT05147428|471344256|FG002|Overall Study|Died or disenrolled during blackout period|273|||
130920962|NCT04680052|471345406|FG000|Overall Study|Ongoing|244|||
130920963|NCT04680052|471345407|FG001|Overall Study|Ongoing|229|||
130920964|NCT04680052|471345408|FG002|Overall Study|Ongoing|39|||
130920965|NCT04680052|471345409|FG003|Overall Study|Ongoing|46|||
130920966|NCT04680052|471345406|FG000|Overall Study|Death|15|||
130920967|NCT04680052|471345407|FG001|Overall Study|Death|22|||
130920968|NCT04680052|471345408|FG002|Overall Study|Death|7|||
130920969|NCT04680052|471345409|FG003|Overall Study|Death|1|||
130920970|NCT04680052|471345406|FG000|Overall Study|Lost to Follow-up|3|||
130920971|NCT04680052|471345407|FG001|Overall Study|Lost to Follow-up|2|||
130920972|NCT04680052|471345408|FG002|Overall Study|Lost to Follow-up|0|||
130920973|NCT04680052|471345409|FG003|Overall Study|Lost to Follow-up|1|||
130920974|NCT04680052|471345406|FG000|Overall Study|Withdrawal by Subject|11|||
130920975|NCT04680052|471345407|FG001|Overall Study|Withdrawal by Subject|19|||
130920976|NCT04680052|471345408|FG002|Overall Study|Withdrawal by Subject|7|||
130920977|NCT04680052|471345409|FG003|Overall Study|Withdrawal by Subject|5|||
130920978|NCT04680052|471345406|FG000|Overall Study|Missing|0|||
130920979|NCT04680052|471345407|FG001|Overall Study|Missing|1|||
130920980|NCT04680052|471345408|FG002|Overall Study|Missing|0|||
130920981|NCT04680052|471345409|FG003|Overall Study|Missing|0|||
130920982|NCT04680052|471345406|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
130920983|NCT04680052|471345407|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
130920984|NCT04680052|471345408|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
130920985|NCT04680052|471345409|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
130920986|NCT04680052|471345406|FG000|Overall Study|Physician Decision|0|||
130920987|NCT04680052|471345407|FG001|Overall Study|Physician Decision|1|||
130920988|NCT04680052|471345408|FG002|Overall Study|Physician Decision|0|||
130920989|NCT04680052|471345409|FG003|Overall Study|Physician Decision|0|||
130920990|NCT01367002|471345410|FG000|Overall Study|Withdrawal by Subject|1|||
130920991|NCT01367002|471345411|FG001|Overall Study|Withdrawal by Subject|0|||
131120136|NCT00467779|472072322|FG011|Stage 1A|Physician Decision|0|||
131223157|NCT02773446|472445018|FG000|First Admission|Lost to Follow-up|1|||
130920992|NCT01367002|471345410|FG000|Overall Study|Physician Decision|0|||
130920993|NCT01367002|471345411|FG001|Overall Study|Physician Decision|2|||
130920994|NCT02468674|471345414|FG000|Overall Study|Adverse Event|0|||
130920995|NCT02468674|471345415|FG001|Overall Study|Adverse Event|0|||
130920996|NCT02468674|471345416|FG002|Overall Study|Adverse Event|0|||
130920997|NCT02468674|471345417|FG003|Overall Study|Adverse Event|1|||
130920998|NCT02468674|471345418|FG004|Overall Study|Adverse Event|0|||
130920999|NCT02468674|471345419|FG005|Overall Study|Adverse Event|1|||
130921000|NCT02468674|471345420|FG006|Overall Study|Adverse Event|0|||
131120137|NCT00467779|472072323|FG012|Stage 1A|Physician Decision|0|||
131120138|NCT00467779|472072324|FG013|Stage 1A|Physician Decision|0|||
131120139|NCT00467779|472072325|FG014|Stage 1A|Physician Decision|0|||
130921001|NCT02468674|471345421|FG007|Overall Study|Adverse Event|0|||
130921002|NCT02468674|471345422|FG008|Overall Study|Adverse Event|0|||
130921003|NCT02468674|471345414|FG000|Overall Study|Lost to Follow-up|1|||
130921004|NCT02468674|471345415|FG001|Overall Study|Lost to Follow-up|0|||
130921005|NCT02468674|471345416|FG002|Overall Study|Lost to Follow-up|0|||
130921006|NCT02468674|471345417|FG003|Overall Study|Lost to Follow-up|0|||
130921007|NCT02468674|471345418|FG004|Overall Study|Lost to Follow-up|0|||
130921008|NCT02468674|471345419|FG005|Overall Study|Lost to Follow-up|0|||
130921009|NCT02468674|471345420|FG006|Overall Study|Lost to Follow-up|0|||
130921010|NCT02468674|471345421|FG007|Overall Study|Lost to Follow-up|1|||
130921011|NCT02468674|471345422|FG008|Overall Study|Lost to Follow-up|1|||
130921012|NCT02468674|471345414|FG000|Overall Study|Physician Decision|0|||
130921013|NCT02468674|471345415|FG001|Overall Study|Physician Decision|0|||
130921014|NCT02468674|471345416|FG002|Overall Study|Physician Decision|0|||
130921015|NCT02468674|471345417|FG003|Overall Study|Physician Decision|0|||
130921016|NCT02468674|471345418|FG004|Overall Study|Physician Decision|0|||
130921017|NCT02468674|471345419|FG005|Overall Study|Physician Decision|0|||
130921018|NCT02468674|471345420|FG006|Overall Study|Physician Decision|1|||
130921019|NCT02468674|471345421|FG007|Overall Study|Physician Decision|0|||
130921020|NCT02468674|471345422|FG008|Overall Study|Physician Decision|0|||
130921021|NCT02468674|471345414|FG000|Overall Study|Patient/Guardian Decision|0|||
130921022|NCT02468674|471345415|FG001|Overall Study|Patient/Guardian Decision|0|||
130921023|NCT02468674|471345416|FG002|Overall Study|Patient/Guardian Decision|0|||
130921024|NCT02468674|471345417|FG003|Overall Study|Patient/Guardian Decision|0|||
130921025|NCT02468674|471345418|FG004|Overall Study|Patient/Guardian Decision|1|||
130921026|NCT02468674|471345419|FG005|Overall Study|Patient/Guardian Decision|0|||
130921027|NCT02468674|471345420|FG006|Overall Study|Patient/Guardian Decision|0|||
130921028|NCT02468674|471345421|FG007|Overall Study|Patient/Guardian Decision|2|||
130921029|NCT02468674|471345422|FG008|Overall Study|Patient/Guardian Decision|1|||
130921030|NCT02468674|471345414|FG000|Overall Study|Protocol Deviation|0|||
130921031|NCT02468674|471345415|FG001|Overall Study|Protocol Deviation|0|||
130921032|NCT02468674|471345416|FG002|Overall Study|Protocol Deviation|0|||
130921033|NCT02468674|471345417|FG003|Overall Study|Protocol Deviation|0|||
130921034|NCT02468674|471345418|FG004|Overall Study|Protocol Deviation|0|||
131034224|NCT04059484|471759145|FG000|Overall Study|Adverse Event|2|||
130921035|NCT02468674|471345419|FG005|Overall Study|Protocol Deviation|0|||
130921036|NCT02468674|471345420|FG006|Overall Study|Protocol Deviation|0|||
130921037|NCT02468674|471345421|FG007|Overall Study|Protocol Deviation|1|||
131034225|NCT04059484|471759146|FG001|Overall Study|Adverse Event|5|||
131034226|NCT04059484|471759145|FG000|Overall Study|Withdrawal by Subject|5|||
131034227|NCT04059484|471759146|FG001|Overall Study|Withdrawal by Subject|3|||
131034228|NCT04059484|471759145|FG000|Overall Study|Progressive disease|112|||
131034229|NCT04059484|471759146|FG001|Overall Study|Progressive disease|112|||
131034230|NCT04059484|471759145|FG000|Overall Study|Other|8|||
131034231|NCT04059484|471759146|FG001|Overall Study|Other|3|||
131034232|NCT04059484|471759145|FG000|Overall Study|Ongoing|20|||
131034233|NCT04059484|471759146|FG001|Overall Study|Ongoing|20|||
131034234|NCT01000961|471759147|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
131034235|NCT01000961|471759148|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131034236|NCT01000961|471759147|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
131034237|NCT01000961|471759148|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
131034238|NCT02949362|471759149|FG000|Retrospective Period|Inform consent not signed by participant|4|||
131034239|NCT02949362|471759150|FG001|Retrospective Period|Inform consent not signed by participant|1|||
130700057|NCT02754492|470526397|FG002|Overall Study|Withdrawal by Subject|0|||
130700058|NCT02754492|470526398|FG003|Overall Study|Withdrawal by Subject|0|||
130700059|NCT02754492|470526395|FG000|Overall Study|Equipment malfuntion|0|||
130700060|NCT02754492|470526396|FG001|Overall Study|Equipment malfuntion|0|||
130700061|NCT02754492|470526397|FG002|Overall Study|Equipment malfuntion|2|||
130700062|NCT02754492|470526398|FG003|Overall Study|Equipment malfuntion|5|||
130700063|NCT02754492|470526395|FG000|Overall Study|Adverse Event|0|||
130700064|NCT02754492|470526396|FG001|Overall Study|Adverse Event|0|||
130700065|NCT02754492|470526397|FG002|Overall Study|Adverse Event|0|||
130700066|NCT02754492|470526398|FG003|Overall Study|Adverse Event|13|||
130700067|NCT02754492|470526395|FG000|Overall Study|Venous access issues not resulting in AE|0|||
130700068|NCT02754492|470526396|FG001|Overall Study|Venous access issues not resulting in AE|0|||
130700069|NCT02754492|470526397|FG002|Overall Study|Venous access issues not resulting in AE|0|||
130700070|NCT02754492|470526398|FG003|Overall Study|Venous access issues not resulting in AE|4|||
130700071|NCT01408888|470526399|FG000|First Intervention|Adverse Event|0|||
130700072|NCT01408888|470526400|FG001|First Intervention|Adverse Event|1|||
130700073|NCT01408888|470526399|FG000|First Intervention|Withdrawal by Subject|0|||
130921038|NCT02468674|471345422|FG008|Overall Study|Protocol Deviation|1|||
130921039|NCT02280304|471345424|FG000|Overall Study|Lost to Follow-up|7|||
130921040|NCT02280304|471345425|FG001|Overall Study|Lost to Follow-up|8|||
130921041|NCT03689530|471345433|FG000|Overall Study|Withdrawal by Subject|53|||
130921042|NCT03689530|471345434|FG001|Overall Study|Withdrawal by Subject|16|||
130921043|NCT01546207|471345438|FG000|Overall Study|Death|1|||
130921044|NCT00713323|471345439|FG000|Overall Study|Adverse Event|75|||
130921045|NCT00713323|471345439|FG000|Overall Study|Withdrawal by Subject|15|||
130921046|NCT00713323|471345439|FG000|Overall Study|Lost to Follow-up|11|||
130921047|NCT00713323|471345439|FG000|Overall Study|Lack of Efficacy|36|||
130921048|NCT00713323|471345439|FG000|Overall Study|Low creatine clearance at screening|1|||
130921049|NCT00713323|471345439|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
130921050|NCT00713323|471345439|FG000|Overall Study|Surgery cured allodynic pain|1|||
130921051|NCT00713323|471345439|FG000|Overall Study|Pain free|1|||
130921052|NCT00713323|471345439|FG000|Overall Study|Non-compliance|1|||
130921053|NCT00713323|471345439|FG000|Overall Study|Pain resolved|1|||
130921054|NCT00713323|471345439|FG000|Overall Study|Subject travelling to USA|1|||
130921055|NCT00713323|471345439|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
130921056|NCT00713323|471345439|FG000|Overall Study|Treatment that may interact with Sativex|1|||
130921057|NCT01947582|471345445|FG000|Overall Study|Withdrawal by Subject|1|||
130921058|NCT01826604|471345446|FG000|Overall Study|Lost to Follow-up|8|||
130921059|NCT01826604|471345447|FG001|Overall Study|Lost to Follow-up|9|||
130921060|NCT00491075|471345448|FG000|Overall Study|Withdrawal by Subject|1|||
130921061|NCT00491075|471345448|FG000|Overall Study|Physician Decision|1|||
130921062|NCT01603355|471345449|FG000|Overall Study|Lack of Efficacy|2|||
130921063|NCT05350410|471345452|FG000|Overall Study|Withdrawal by Subject|1|||
130921064|NCT02589405|471345453|FG000|Overall Study|Adverse Event|3|||
130921065|NCT02589405|471345453|FG000|Overall Study|Withdrawal by Subject|1|||
130921066|NCT01032174|471345460|FG000|Overall Study|Adverse Event|0|||
130921067|NCT01032174|471345461|FG001|Overall Study|Adverse Event|1|||
130921068|NCT02635776|471345465|FG000|Overall Study|Physician Decision|1|||
130921069|NCT02635776|471345466|FG001|Overall Study|Physician Decision|0|||
130921070|NCT02635776|471345465|FG000|Overall Study|Adverse Event|51|||
130921071|NCT02635776|471345466|FG001|Overall Study|Adverse Event|3|||
130921072|NCT02635776|471345465|FG000|Overall Study|Withdrawal by Subject|41|||
130921073|NCT02635776|471345466|FG001|Overall Study|Withdrawal by Subject|7|||
130921074|NCT02635776|471345465|FG000|Overall Study|Lost to Follow-up|4|||
130921075|NCT02635776|471345466|FG001|Overall Study|Lost to Follow-up|0|||
130921076|NCT02635776|471345465|FG000|Overall Study|Other reasons|5|||
130921077|NCT02635776|471345466|FG001|Overall Study|Other reasons|1|||
130921078|NCT00788073|471345467|FG000|STX209 Then Placebo|Adverse Event|1|||
130921079|NCT00788073|471345468|FG001|STX209 Then Placebo|Adverse Event|0|||
130921080|NCT00788073|471345467|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
130921081|NCT00788073|471345468|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
130921082|NCT00788073|471345467|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
130921083|NCT00788073|471345468|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
130921084|NCT00788073|471345467|FG000|STX209 Then Placebo|unable to return due to travel|0|||
131034240|NCT02949362|471759151|FG002|Retrospective Period|Inform consent not signed by participant|0|||
131034241|NCT02949362|471759152|FG003|Retrospective Period|Inform consent not signed by participant|0|||
131034242|NCT02949362|471759149|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
131034243|NCT02949362|471759150|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
131034244|NCT02949362|471759151|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
131120140|NCT00467779|472072311|FG000|Stage 1A|Withdrawal by Subject|0|||
130700074|NCT01408888|470526400|FG001|First Intervention|Withdrawal by Subject|2|||
130700075|NCT01408888|470526399|FG000|Second Intervention|Withdrawal by Subject|1|||
130700076|NCT01408888|470526400|FG001|Second Intervention|Withdrawal by Subject|0|||
130700077|NCT01408888|470526399|FG000|Second Intervention|Adverse Event|1|||
130700078|NCT01408888|470526400|FG001|Second Intervention|Adverse Event|0|||
130700079|NCT00695110|470526403|FG000|Treatment Period 1|Adverse Event|1|||
130700080|NCT00695110|470526403|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130700081|NCT00695110|470526403|FG000|Treatment Period 3|Withdrawal by Subject|1|||
130700082|NCT00695110|470526403|FG000|Treatment Period 4|Adverse Event|1|||
130700083|NCT00611884|470526406|FG000|Overall Study|Adverse Event|1|||
130700084|NCT00611884|470526407|FG001|Overall Study|Adverse Event|0|||
130700085|NCT00611884|470526408|FG002|Overall Study|Adverse Event|0|||
130700086|NCT00611884|470526409|FG003|Overall Study|Adverse Event|1|||
130700087|NCT00611884|470526406|FG000|Overall Study|Non-Compliance|1|||
130700088|NCT00611884|470526407|FG001|Overall Study|Non-Compliance|4|||
130700089|NCT00611884|470526408|FG002|Overall Study|Non-Compliance|2|||
130700090|NCT00611884|470526409|FG003|Overall Study|Non-Compliance|2|||
130921085|NCT00788073|471345468|FG001|STX209 Then Placebo|unable to return due to travel|1|||
130921086|NCT00788073|471345467|FG000|Placebo Then STX209|Adverse Event|2|||
130921087|NCT00788073|471345468|FG001|Placebo Then STX209|Adverse Event|0|||
130921088|NCT00788073|471345467|FG000|Placebo Then STX209|Protocol Violation|0|||
130921089|NCT00788073|471345468|FG001|Placebo Then STX209|Protocol Violation|1|||
130700091|NCT00611884|470526406|FG000|Overall Study|Lack of Efficacy|0|||
130921090|NCT00239590|471345470|FG000|Randomized|Lost to Follow-up|0|||
130921091|NCT00239590|471345471|FG001|Randomized|Lost to Follow-up|1|||
130921092|NCT00239590|471345470|FG000|Randomized|Withdrawal by Subject|0|||
130921093|NCT00239590|471345471|FG001|Randomized|Withdrawal by Subject|1|||
130921094|NCT00239590|471345470|FG000|Completed Study Protocol|Adverse Event|1|||
130921095|NCT00239590|471345471|FG001|Completed Study Protocol|Adverse Event|1|||
130921096|NCT00239590|471345470|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
130921097|NCT00239590|471345471|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
130921098|NCT02362269|471345474|FG000|Overall Study|Moved|1|||
130921099|NCT02362269|471345475|FG001|Overall Study|Moved|0|||
130921100|NCT02362269|471345474|FG000|Overall Study|Lost to Follow-up|0|||
130921101|NCT02362269|471345475|FG001|Overall Study|Lost to Follow-up|6|||
130921102|NCT04154930|471345478|FG000|Overall Study|Withdrawal by Subject|15|||
130921103|NCT04154930|471345479|FG001|Overall Study|Withdrawal by Subject|6|||
130921104|NCT04154930|471345478|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
130921105|NCT04154930|471345479|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
130921106|NCT04154930|471345478|FG000|Overall Study|Lost to Follow-up|14|||
130921107|NCT04154930|471345479|FG001|Overall Study|Lost to Follow-up|6|||
130921108|NCT04154930|471345478|FG000|Overall Study|Other|6|||
130921109|NCT04154930|471345479|FG001|Overall Study|Other|0|||
130921110|NCT02058693|471345480|FG000|Phase 1|Withdrawal by Subject|3|||
130921111|NCT02058693|471345481|FG001|Phase 1|Withdrawal by Subject|2|||
130921112|NCT02058693|471345480|FG000|Phase 1|Adverse Event|0|||
130921113|NCT02058693|471345481|FG001|Phase 1|Adverse Event|1|||
130921114|NCT02058693|471345480|FG000|Phase 1|Lack of Efficacy|1|||
130921115|NCT02058693|471345481|FG001|Phase 1|Lack of Efficacy|0|||
130921116|NCT02058693|471345480|FG000|Phase 1|Physician Decision|1|||
130921117|NCT02058693|471345481|FG001|Phase 1|Physician Decision|1|||
130921118|NCT02058693|471345480|FG000|Phase 2|Withdrawal by Subject|0|||
130921119|NCT02058693|471345481|FG001|Phase 2|Withdrawal by Subject|2|||
130921120|NCT00347360|471345484|FG000|Overall Study|Adverse Event|1|||
130921121|NCT00347360|471345485|FG001|Overall Study|Adverse Event|2|||
130921122|NCT00347360|471345486|FG002|Overall Study|Adverse Event|0|||
130921123|NCT00347360|471345487|FG003|Overall Study|Adverse Event|4|||
130921124|NCT00347360|471345488|FG004|Overall Study|Adverse Event|1|||
130921125|NCT00347360|471345489|FG005|Overall Study|Adverse Event|2|||
130921126|NCT00347360|471345490|FG006|Overall Study|Adverse Event|2|||
130921127|NCT00347360|471345491|FG007|Overall Study|Adverse Event|0|||
130921128|NCT00347360|471345492|FG008|Overall Study|Adverse Event|2|||
130921129|NCT00347360|471345493|FG009|Overall Study|Adverse Event|3|||
130921130|NCT00347360|471345494|FG010|Overall Study|Adverse Event|3|||
130921131|NCT00347360|471345495|FG011|Overall Study|Adverse Event|1|||
130921132|NCT00347360|471345496|FG012|Overall Study|Adverse Event|3|||
130921133|NCT00347360|471345497|FG013|Overall Study|Adverse Event|2|||
130921134|NCT00347360|471345498|FG014|Overall Study|Adverse Event|2|||
130921135|NCT00347360|471345484|FG000|Overall Study|Lost to Follow-up|0|||
130921136|NCT00347360|471345485|FG001|Overall Study|Lost to Follow-up|0|||
130921137|NCT00347360|471345486|FG002|Overall Study|Lost to Follow-up|0|||
130921138|NCT00347360|471345487|FG003|Overall Study|Lost to Follow-up|2|||
130921139|NCT00347360|471345488|FG004|Overall Study|Lost to Follow-up|1|||
130921140|NCT00347360|471345489|FG005|Overall Study|Lost to Follow-up|1|||
130921141|NCT00347360|471345490|FG006|Overall Study|Lost to Follow-up|0|||
130921142|NCT00347360|471345491|FG007|Overall Study|Lost to Follow-up|1|||
130921143|NCT00347360|471345492|FG008|Overall Study|Lost to Follow-up|1|||
130921144|NCT00347360|471345493|FG009|Overall Study|Lost to Follow-up|2|||
130921145|NCT00347360|471345494|FG010|Overall Study|Lost to Follow-up|0|||
130921146|NCT00347360|471345495|FG011|Overall Study|Lost to Follow-up|0|||
130921147|NCT00347360|471345496|FG012|Overall Study|Lost to Follow-up|1|||
130921148|NCT00347360|471345497|FG013|Overall Study|Lost to Follow-up|0|||
130921149|NCT00347360|471345498|FG014|Overall Study|Lost to Follow-up|0|||
130921150|NCT00347360|471345484|FG000|Overall Study|Protocol Violation|2|||
130921151|NCT00347360|471345485|FG001|Overall Study|Protocol Violation|3|||
130921152|NCT00347360|471345486|FG002|Overall Study|Protocol Violation|1|||
130921153|NCT00347360|471345487|FG003|Overall Study|Protocol Violation|2|||
130921154|NCT00347360|471345488|FG004|Overall Study|Protocol Violation|1|||
130921155|NCT00347360|471345489|FG005|Overall Study|Protocol Violation|2|||
130921156|NCT00347360|471345490|FG006|Overall Study|Protocol Violation|0|||
130700092|NCT00611884|470526407|FG001|Overall Study|Lack of Efficacy|1|||
130921157|NCT00347360|471345491|FG007|Overall Study|Protocol Violation|0|||
130921158|NCT00347360|471345492|FG008|Overall Study|Protocol Violation|1|||
130921159|NCT00347360|471345493|FG009|Overall Study|Protocol Violation|2|||
130921160|NCT00347360|471345494|FG010|Overall Study|Protocol Violation|0|||
130921161|NCT00347360|471345495|FG011|Overall Study|Protocol Violation|0|||
130921162|NCT00347360|471345496|FG012|Overall Study|Protocol Violation|0|||
130921163|NCT00347360|471345497|FG013|Overall Study|Protocol Violation|1|||
130921164|NCT00347360|471345498|FG014|Overall Study|Protocol Violation|0|||
130921165|NCT00347360|471345484|FG000|Overall Study|Withdrawal by Subject|0|||
131120141|NCT00467779|472072312|FG001|Stage 1A|Withdrawal by Subject|0|||
130700093|NCT00611884|470526408|FG002|Overall Study|Lack of Efficacy|0|||
130700094|NCT00611884|470526409|FG003|Overall Study|Lack of Efficacy|0|||
130700095|NCT00611884|470526406|FG000|Overall Study|Unclassified|7|||
130700096|NCT00611884|470526407|FG001|Overall Study|Unclassified|4|||
130700097|NCT00611884|470526408|FG002|Overall Study|Unclassified|2|||
130700098|NCT00611884|470526409|FG003|Overall Study|Unclassified|3|||
130700099|NCT00981799|470526410|FG000|Overall Study|Adverse Event|1|||
130700100|NCT00981799|470526411|FG001|Overall Study|Adverse Event|1|||
130700101|NCT00981799|470526412|FG002|Overall Study|Adverse Event|0|||
130700102|NCT00981799|470526413|FG003|Overall Study|Adverse Event|0|||
130921166|NCT00347360|471345485|FG001|Overall Study|Withdrawal by Subject|1|||
130921167|NCT00347360|471345486|FG002|Overall Study|Withdrawal by Subject|2|||
130921168|NCT00347360|471345487|FG003|Overall Study|Withdrawal by Subject|4|||
130921169|NCT00347360|471345488|FG004|Overall Study|Withdrawal by Subject|1|||
130921170|NCT00347360|471345489|FG005|Overall Study|Withdrawal by Subject|2|||
130921171|NCT00347360|471345490|FG006|Overall Study|Withdrawal by Subject|1|||
130769422|NCT03046056|470782433|FG001|Overall Study|Withdrew Consent|0|||
130921172|NCT00347360|471345491|FG007|Overall Study|Withdrawal by Subject|1|||
130921173|NCT00347360|471345492|FG008|Overall Study|Withdrawal by Subject|1|||
130921174|NCT00347360|471345493|FG009|Overall Study|Withdrawal by Subject|1|||
130921175|NCT00347360|471345494|FG010|Overall Study|Withdrawal by Subject|0|||
130921176|NCT00347360|471345495|FG011|Overall Study|Withdrawal by Subject|3|||
130921177|NCT00347360|471345496|FG012|Overall Study|Withdrawal by Subject|4|||
130921178|NCT00347360|471345497|FG013|Overall Study|Withdrawal by Subject|2|||
130921179|NCT00347360|471345498|FG014|Overall Study|Withdrawal by Subject|1|||
130921180|NCT00347360|471345484|FG000|Overall Study|Lack of Efficacy|1|||
130769423|NCT03046056|470782434|FG002|Overall Study|Withdrew Consent|0|||
130769424|NCT02913105|470782435|FG000|Overall Study|Adverse Event|11|||
130769425|NCT02913105|470782436|FG001|Overall Study|Adverse Event|0|||
130769426|NCT02913105|470782437|FG002|Overall Study|Adverse Event|4|||
130769427|NCT02913105|470782435|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130769428|NCT02913105|470782436|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130769429|NCT02913105|470782437|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130769430|NCT02913105|470782435|FG000|Overall Study|Reason Not Specified|3|||
130769431|NCT02913105|470782436|FG001|Overall Study|Reason Not Specified|1|||
130769432|NCT02913105|470782437|FG002|Overall Study|Reason Not Specified|1|||
130769433|NCT02913105|470782435|FG000|Overall Study|Physician Decision|1|||
130769434|NCT02913105|470782436|FG001|Overall Study|Physician Decision|1|||
130769435|NCT02913105|470782437|FG002|Overall Study|Physician Decision|0|||
130769436|NCT02913105|470782435|FG000|Overall Study|Withdrawal by Subject|0|||
130769437|NCT02913105|470782436|FG001|Overall Study|Withdrawal by Subject|3|||
130769438|NCT02913105|470782437|FG002|Overall Study|Withdrawal by Subject|1|||
130769439|NCT01317004|470782438|FG000|Overall Study|Withdrawal by Subject|1|||
130769440|NCT01317004|470782439|FG001|Overall Study|Withdrawal by Subject|4|||
130769441|NCT01317004|470782438|FG000|Overall Study|Protocol Violation|0|||
130769442|NCT01317004|470782439|FG001|Overall Study|Protocol Violation|2|||
130769443|NCT01317004|470782438|FG000|Overall Study|Adverse Event|3|||
130769444|NCT01317004|470782439|FG001|Overall Study|Adverse Event|3|||
130769445|NCT01859949|470782445|FG000|Overall Study|Family Matters|0|||
130769446|NCT01859949|470782446|FG001|Overall Study|Family Matters|1|||
130769447|NCT01859949|470782445|FG000|Overall Study|Physician Decision|2|||
130769448|NCT01859949|470782446|FG001|Overall Study|Physician Decision|4|||
130769449|NCT01859949|470782445|FG000|Overall Study|Withdrawal by Subject|11|||
130769450|NCT01859949|470782446|FG001|Overall Study|Withdrawal by Subject|10|||
130769451|NCT01859949|470782445|FG000|Overall Study|Protocol Violation|1|||
130769452|NCT01859949|470782446|FG001|Overall Study|Protocol Violation|1|||
130769453|NCT01859949|470782445|FG000|Overall Study|Adverse Event|0|||
130769454|NCT01859949|470782446|FG001|Overall Study|Adverse Event|1|||
130769455|NCT01890759|470782447|FG000|Overall Study|Protocol Violation|0|||
130769456|NCT01890759|470782448|FG001|Overall Study|Protocol Violation|2|||
130769457|NCT01890759|470782447|FG000|Overall Study|Lost to Follow-up|0|||
130769458|NCT01890759|470782448|FG001|Overall Study|Lost to Follow-up|2|||
130769459|NCT01890759|470782447|FG000|Overall Study|Withdrawal by Subject|2|||
130769460|NCT01890759|470782448|FG001|Overall Study|Withdrawal by Subject|8|||
130769461|NCT01344759|470782449|FG000|Overall Study|Patients failed to reach sedation level|0|||
130769462|NCT01344759|470782450|FG001|Overall Study|Patients failed to reach sedation level|2|||
130769463|NCT01153009|470782451|FG000|Overall Study|Adverse Event|4|||
130769464|NCT01153009|470782452|FG001|Overall Study|Adverse Event|14|||
130769465|NCT01153009|470782453|FG002|Overall Study|Adverse Event|14|||
130769466|NCT01153009|470782454|FG003|Overall Study|Adverse Event|10|||
130769467|NCT01153009|470782451|FG000|Overall Study|Lack of Efficacy|9|||
130769468|NCT01153009|470782452|FG001|Overall Study|Lack of Efficacy|0|||
130769469|NCT01153009|470782453|FG002|Overall Study|Lack of Efficacy|2|||
130769470|NCT01153009|470782454|FG003|Overall Study|Lack of Efficacy|1|||
130769471|NCT01153009|470782451|FG000|Overall Study|Noncompliance with Study Medication|1|||
130769472|NCT01153009|470782452|FG001|Overall Study|Noncompliance with Study Medication|3|||
130769473|NCT01153009|470782453|FG002|Overall Study|Noncompliance with Study Medication|4|||
130769474|NCT01153009|470782454|FG003|Overall Study|Noncompliance with Study Medication|1|||
130769475|NCT01153009|470782451|FG000|Overall Study|Protocol Deviations|4|||
130769476|NCT01153009|470782452|FG001|Overall Study|Protocol Deviations|3|||
130769477|NCT01153009|470782453|FG002|Overall Study|Protocol Deviations|3|||
130769478|NCT01153009|470782454|FG003|Overall Study|Protocol Deviations|2|||
130769479|NCT01153009|470782451|FG000|Overall Study|Withdrawal of Consent|5|||
130769480|NCT01153009|470782452|FG001|Overall Study|Withdrawal of Consent|5|||
130769481|NCT01153009|470782453|FG002|Overall Study|Withdrawal of Consent|4|||
130769482|NCT01153009|470782454|FG003|Overall Study|Withdrawal of Consent|6|||
130921181|NCT00347360|471345485|FG001|Overall Study|Lack of Efficacy|1|||
130700103|NCT01190930|470526414|FG000|Induction|Adverse Event|17|||
130700104|NCT01190930|470526415|FG001|Induction|Adverse Event|0|||
130700105|NCT01190930|470526416|FG002|Induction|Adverse Event|0|||
130700106|NCT01190930|470526417|FG003|Induction|Adverse Event|0|||
130700107|NCT01190930|470526418|FG004|Induction|Adverse Event|0|||
130700108|NCT01190930|470526419|FG005|Induction|Adverse Event|0|||
130700109|NCT01190930|470526420|FG006|Induction|Adverse Event|0|||
130700110|NCT01190930|470526421|FG007|Induction|Adverse Event|0|||
130700111|NCT01190930|470526422|FG008|Induction|Adverse Event|0|||
130700112|NCT01190930|470526423|FG009|Induction|Adverse Event|0|||
130700113|NCT01190930|470526414|FG000|Induction|Death|34|||
130700114|NCT01190930|470526415|FG001|Induction|Death|0|||
130700115|NCT01190930|470526416|FG002|Induction|Death|0|||
130700116|NCT01190930|470526417|FG003|Induction|Death|0|||
130700117|NCT01190930|470526418|FG004|Induction|Death|0|||
130700118|NCT01190930|470526419|FG005|Induction|Death|0|||
130700119|NCT01190930|470526420|FG006|Induction|Death|0|||
130700120|NCT01190930|470526421|FG007|Induction|Death|0|||
130700121|NCT01190930|470526422|FG008|Induction|Death|0|||
130700122|NCT01190930|470526423|FG009|Induction|Death|0|||
130700123|NCT01190930|470526414|FG000|Induction|Lost to Follow-up|1|||
130700124|NCT01190930|470526415|FG001|Induction|Lost to Follow-up|0|||
130700125|NCT01190930|470526416|FG002|Induction|Lost to Follow-up|0|||
130700126|NCT01190930|470526417|FG003|Induction|Lost to Follow-up|0|||
130700127|NCT01190930|470526418|FG004|Induction|Lost to Follow-up|0|||
130700128|NCT01190930|470526419|FG005|Induction|Lost to Follow-up|0|||
130700129|NCT01190930|470526420|FG006|Induction|Lost to Follow-up|0|||
130700130|NCT01190930|470526421|FG007|Induction|Lost to Follow-up|0|||
130700131|NCT01190930|470526422|FG008|Induction|Lost to Follow-up|0|||
130700132|NCT01190930|470526423|FG009|Induction|Lost to Follow-up|0|||
130700133|NCT01190930|470526414|FG000|Induction|Physician Decision|125|||
130700134|NCT01190930|470526415|FG001|Induction|Physician Decision|3|||
130700135|NCT01190930|470526416|FG002|Induction|Physician Decision|0|||
130700136|NCT01190930|470526417|FG003|Induction|Physician Decision|0|||
130700137|NCT01190930|470526418|FG004|Induction|Physician Decision|0|||
130700138|NCT01190930|470526419|FG005|Induction|Physician Decision|0|||
130700139|NCT01190930|470526420|FG006|Induction|Physician Decision|0|||
130700140|NCT01190930|470526421|FG007|Induction|Physician Decision|0|||
130700141|NCT01190930|470526422|FG008|Induction|Physician Decision|0|||
130700142|NCT01190930|470526423|FG009|Induction|Physician Decision|0|||
130700143|NCT01190930|470526414|FG000|Induction|Withdrawal by Subject|9|||
130700144|NCT01190930|470526415|FG001|Induction|Withdrawal by Subject|0|||
130700145|NCT01190930|470526416|FG002|Induction|Withdrawal by Subject|0|||
130700146|NCT01190930|470526417|FG003|Induction|Withdrawal by Subject|0|||
130700147|NCT01190930|470526418|FG004|Induction|Withdrawal by Subject|0|||
130700148|NCT01190930|470526419|FG005|Induction|Withdrawal by Subject|0|||
130700149|NCT01190930|470526420|FG006|Induction|Withdrawal by Subject|0|||
130700150|NCT01190930|470526421|FG007|Induction|Withdrawal by Subject|0|||
130700151|NCT01190930|470526422|FG008|Induction|Withdrawal by Subject|0|||
130700152|NCT01190930|470526423|FG009|Induction|Withdrawal by Subject|0|||
130700153|NCT01190930|470526414|FG000|Induction|Refusal|235|||
130700154|NCT01190930|470526415|FG001|Induction|Refusal|0|||
130700155|NCT01190930|470526416|FG002|Induction|Refusal|0|||
130700156|NCT01190930|470526417|FG003|Induction|Refusal|0|||
130700157|NCT01190930|470526418|FG004|Induction|Refusal|0|||
130700158|NCT01190930|470526419|FG005|Induction|Refusal|0|||
130700159|NCT01190930|470526420|FG006|Induction|Refusal|0|||
130700160|NCT01190930|470526421|FG007|Induction|Refusal|0|||
130700161|NCT01190930|470526422|FG008|Induction|Refusal|0|||
130700162|NCT01190930|470526423|FG009|Induction|Refusal|0|||
130700163|NCT01190930|470526414|FG000|Induction|Inevaluable|23|||
130700164|NCT01190930|470526415|FG001|Induction|Inevaluable|1|||
130700165|NCT01190930|470526416|FG002|Induction|Inevaluable|0|||
130700166|NCT01190930|470526417|FG003|Induction|Inevaluable|0|||
130700167|NCT01190930|470526418|FG004|Induction|Inevaluable|0|||
130700168|NCT01190930|470526419|FG005|Induction|Inevaluable|0|||
130700169|NCT01190930|470526420|FG006|Induction|Inevaluable|0|||
130700170|NCT01190930|470526421|FG007|Induction|Inevaluable|0|||
130700171|NCT01190930|470526422|FG008|Induction|Inevaluable|0|||
130921182|NCT00347360|471345486|FG002|Overall Study|Lack of Efficacy|3|||
130921183|NCT00347360|471345487|FG003|Overall Study|Lack of Efficacy|1|||
130700172|NCT01190930|470526423|FG009|Induction|Inevaluable|0|||
130700173|NCT01190930|470526414|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
130700174|NCT01190930|470526415|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700175|NCT01190930|470526416|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700176|NCT01190930|470526417|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700177|NCT01190930|470526418|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700178|NCT01190930|470526419|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700179|NCT01190930|470526420|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700180|NCT01190930|470526421|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700181|NCT01190930|470526422|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700182|NCT01190930|470526423|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130700183|NCT01190930|470526414|FG000|Induction|High Risk Downs|80|||
130700184|NCT01190930|470526415|FG001|Induction|High Risk Downs|0|||
130700185|NCT01190930|470526416|FG002|Induction|High Risk Downs|0|||
130769483|NCT01153009|470782451|FG000|Overall Study|Lost to Follow-up|8|||
130769484|NCT01153009|470782452|FG001|Overall Study|Lost to Follow-up|8|||
130769485|NCT01153009|470782453|FG002|Overall Study|Lost to Follow-up|11|||
130769486|NCT01153009|470782454|FG003|Overall Study|Lost to Follow-up|15|||
130769487|NCT01153009|470782451|FG000|Overall Study|Other|1|||
130769488|NCT01153009|470782452|FG001|Overall Study|Other|1|||
130769489|NCT01153009|470782453|FG002|Overall Study|Other|3|||
130769490|NCT01153009|470782454|FG003|Overall Study|Other|2|||
130769491|NCT04494425|470782459|FG000|Overall Study|Death|160|||
130769492|NCT04494425|470782460|FG001|Overall Study|Death|166|||
130769493|NCT04494425|470782459|FG000|Overall Study|Withdrawal by Subject|10|||
130769494|NCT04494425|470782460|FG001|Overall Study|Withdrawal by Subject|40|||
130769495|NCT04494425|470782459|FG000|Overall Study|Other|1|||
130769496|NCT04494425|470782460|FG001|Overall Study|Other|1|||
130769497|NCT04494425|470782459|FG000|Overall Study|Ongoing at the time of PCD|265|||
130769498|NCT04494425|470782460|FG001|Overall Study|Ongoing at the time of PCD|223|||
130769499|NCT01270321|470782462|FG000|Overall Study|Death|3|||
130769500|NCT01270321|470782463|FG001|Overall Study|Death|1|||
130769501|NCT01270321|470782464|FG002|Overall Study|Death|4|||
130769502|NCT01270321|470782462|FG000|Overall Study|Adverse Event|7|||
130769503|NCT01270321|470782463|FG001|Overall Study|Adverse Event|9|||
130769504|NCT01270321|470782464|FG002|Overall Study|Adverse Event|5|||
130769505|NCT05437640|470782465|FG000|Washout (1 Week)|Adverse Event|1|||
130769506|NCT05437640|470782466|FG001|Washout (1 Week)|Adverse Event|0|||
130769507|NCT04228965|470782469|FG000|Overall Study|Lost to Follow-up|26|||
130769508|NCT04228965|470782470|FG001|Overall Study|Lost to Follow-up|11|||
130769509|NCT04228965|470782469|FG000|Overall Study|Withdrawal by Subject|18|||
130769510|NCT04228965|470782470|FG001|Overall Study|Withdrawal by Subject|5|||
130769511|NCT00734656|470782473|FG000|Lab Session 1|Withdrawal by Subject|2|||
130769512|NCT00734656|470782474|FG001|Lab Session 1|Withdrawal by Subject|0|||
130769513|NCT00734656|470782475|FG002|Lab Session 1|Withdrawal by Subject|0|||
130769514|NCT00734656|470782476|FG003|Lab Session 1|Withdrawal by Subject|0|||
130769515|NCT00734656|470782473|FG000|Washout 1|Withdrawal by Subject|1|||
130769516|NCT00734656|470782474|FG001|Washout 1|Withdrawal by Subject|5|||
130769517|NCT00734656|470782475|FG002|Washout 1|Withdrawal by Subject|2|||
130769518|NCT00734656|470782476|FG003|Washout 1|Withdrawal by Subject|3|||
130769519|NCT00734656|470782473|FG000|Lab Session 2|Withdrawal by Subject|1|||
130769520|NCT00734656|470782474|FG001|Lab Session 2|Withdrawal by Subject|0|||
130769521|NCT00734656|470782475|FG002|Lab Session 2|Withdrawal by Subject|0|||
130921184|NCT00347360|471345488|FG004|Overall Study|Lack of Efficacy|0|||
130921185|NCT00347360|471345489|FG005|Overall Study|Lack of Efficacy|1|||
130921186|NCT00347360|471345490|FG006|Overall Study|Lack of Efficacy|0|||
130921187|NCT00347360|471345491|FG007|Overall Study|Lack of Efficacy|1|||
130921188|NCT00347360|471345492|FG008|Overall Study|Lack of Efficacy|1|||
130921189|NCT00347360|471345493|FG009|Overall Study|Lack of Efficacy|0|||
130921190|NCT00347360|471345494|FG010|Overall Study|Lack of Efficacy|0|||
130921191|NCT00347360|471345495|FG011|Overall Study|Lack of Efficacy|0|||
130921192|NCT00347360|471345496|FG012|Overall Study|Lack of Efficacy|0|||
130921193|NCT00347360|471345497|FG013|Overall Study|Lack of Efficacy|0|||
130921194|NCT00347360|471345498|FG014|Overall Study|Lack of Efficacy|0|||
130921195|NCT00347360|471345484|FG000|Overall Study|Reason not listed/blank|1|||
130921196|NCT00347360|471345485|FG001|Overall Study|Reason not listed/blank|0|||
130921197|NCT00347360|471345486|FG002|Overall Study|Reason not listed/blank|0|||
130921198|NCT00347360|471345487|FG003|Overall Study|Reason not listed/blank|0|||
130921199|NCT00347360|471345488|FG004|Overall Study|Reason not listed/blank|0|||
130921200|NCT00347360|471345489|FG005|Overall Study|Reason not listed/blank|0|||
130921201|NCT00347360|471345490|FG006|Overall Study|Reason not listed/blank|1|||
130921202|NCT00347360|471345491|FG007|Overall Study|Reason not listed/blank|0|||
130769522|NCT00734656|470782476|FG003|Lab Session 2|Withdrawal by Subject|1|||
130769523|NCT00734656|470782473|FG000|Washout 2|Withdrawal by Subject|1|||
130769524|NCT00734656|470782474|FG001|Washout 2|Withdrawal by Subject|1|||
130769525|NCT00734656|470782475|FG002|Washout 2|Withdrawal by Subject|1|||
130769526|NCT00734656|470782476|FG003|Washout 2|Withdrawal by Subject|0|||
130769527|NCT00734656|470782473|FG000|Washout 3|Withdrawal by Subject|1|||
130769528|NCT00734656|470782474|FG001|Washout 3|Withdrawal by Subject|0|||
130769529|NCT00734656|470782475|FG002|Washout 3|Withdrawal by Subject|0|||
130921203|NCT00347360|471345492|FG008|Overall Study|Reason not listed/blank|0|||
130921204|NCT00347360|471345493|FG009|Overall Study|Reason not listed/blank|0|||
130921205|NCT00347360|471345494|FG010|Overall Study|Reason not listed/blank|0|||
131034245|NCT02949362|471759152|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
130769530|NCT00734656|470782476|FG003|Washout 3|Withdrawal by Subject|1|||
130769531|NCT00734656|470782473|FG000|Lab Session 4|Withdrawal by Subject|0|||
130769532|NCT00734656|470782474|FG001|Lab Session 4|Withdrawal by Subject|0|||
130769533|NCT00734656|470782475|FG002|Lab Session 4|Withdrawal by Subject|0|||
130769534|NCT00734656|470782476|FG003|Lab Session 4|Withdrawal by Subject|1|||
130921206|NCT00347360|471345495|FG011|Overall Study|Reason not listed/blank|0|||
130921207|NCT00347360|471345496|FG012|Overall Study|Reason not listed/blank|0|||
130921208|NCT00347360|471345497|FG013|Overall Study|Reason not listed/blank|1|||
130921209|NCT00347360|471345498|FG014|Overall Study|Reason not listed/blank|0|||
130700186|NCT01190930|470526417|FG003|Induction|High Risk Downs|0|||
130921210|NCT00347360|471345484|FG000|Overall Study|Per sponsors instruction|0|||
130921211|NCT00347360|471345485|FG001|Overall Study|Per sponsors instruction|1|||
130921212|NCT00347360|471345486|FG002|Overall Study|Per sponsors instruction|0|||
130921213|NCT00347360|471345487|FG003|Overall Study|Per sponsors instruction|0|||
130921214|NCT00347360|471345488|FG004|Overall Study|Per sponsors instruction|0|||
130921215|NCT00347360|471345489|FG005|Overall Study|Per sponsors instruction|0|||
130921216|NCT00347360|471345490|FG006|Overall Study|Per sponsors instruction|0|||
130921217|NCT00347360|471345491|FG007|Overall Study|Per sponsors instruction|0|||
130921218|NCT00347360|471345492|FG008|Overall Study|Per sponsors instruction|0|||
130921219|NCT00347360|471345493|FG009|Overall Study|Per sponsors instruction|0|||
130921220|NCT00347360|471345494|FG010|Overall Study|Per sponsors instruction|0|||
130921221|NCT00347360|471345495|FG011|Overall Study|Per sponsors instruction|0|||
130921222|NCT00347360|471345496|FG012|Overall Study|Per sponsors instruction|0|||
130921223|NCT00347360|471345497|FG013|Overall Study|Per sponsors instruction|0|||
130921224|NCT00347360|471345498|FG014|Overall Study|Per sponsors instruction|0|||
130921225|NCT00347360|471345484|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
130921226|NCT00347360|471345485|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
130921227|NCT00347360|471345486|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
130921228|NCT00347360|471345487|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
130921229|NCT00347360|471345488|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
130921230|NCT00347360|471345489|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
130921231|NCT00347360|471345490|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
130921232|NCT00347360|471345491|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
130921233|NCT00347360|471345492|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
130921234|NCT00347360|471345493|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
130921235|NCT00347360|471345494|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
130921236|NCT00347360|471345495|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
130921237|NCT00347360|471345496|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
130921238|NCT00347360|471345497|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
130921239|NCT00347360|471345498|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
130921240|NCT00347360|471345484|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
130921241|NCT00347360|471345485|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
130921242|NCT00347360|471345486|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
130921243|NCT00347360|471345487|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
130921244|NCT00347360|471345488|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
130921245|NCT00347360|471345489|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
130921246|NCT00347360|471345490|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
130921247|NCT00347360|471345491|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
130921248|NCT00347360|471345492|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
130921249|NCT00347360|471345493|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
130921250|NCT00347360|471345494|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
130921251|NCT00347360|471345495|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
130921252|NCT00347360|471345496|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
130921253|NCT00347360|471345497|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
130921254|NCT00347360|471345498|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
130921255|NCT00347360|471345484|FG000|Overall Study|Abnormal lab values|0|||
130921256|NCT00347360|471345485|FG001|Overall Study|Abnormal lab values|0|||
130921257|NCT00347360|471345486|FG002|Overall Study|Abnormal lab values|0|||
130921258|NCT00347360|471345487|FG003|Overall Study|Abnormal lab values|0|||
130921259|NCT00347360|471345488|FG004|Overall Study|Abnormal lab values|0|||
130921260|NCT00347360|471345489|FG005|Overall Study|Abnormal lab values|0|||
130921261|NCT00347360|471345490|FG006|Overall Study|Abnormal lab values|1|||
130921262|NCT00347360|471345491|FG007|Overall Study|Abnormal lab values|0|||
130921263|NCT00347360|471345492|FG008|Overall Study|Abnormal lab values|0|||
130921264|NCT00347360|471345493|FG009|Overall Study|Abnormal lab values|0|||
130921265|NCT00347360|471345494|FG010|Overall Study|Abnormal lab values|0|||
130921266|NCT00347360|471345495|FG011|Overall Study|Abnormal lab values|0|||
130921267|NCT00347360|471345496|FG012|Overall Study|Abnormal lab values|0|||
130921268|NCT00347360|471345497|FG013|Overall Study|Abnormal lab values|0|||
130921269|NCT00347360|471345498|FG014|Overall Study|Abnormal lab values|0|||
130921270|NCT00347360|471345484|FG000|Overall Study|PI recommended early withdrawal|0|||
130700187|NCT01190930|470526418|FG004|Induction|High Risk Downs|0|||
130700188|NCT01190930|470526419|FG005|Induction|High Risk Downs|0|||
130921271|NCT00347360|471345485|FG001|Overall Study|PI recommended early withdrawal|0|||
130921272|NCT00347360|471345486|FG002|Overall Study|PI recommended early withdrawal|0|||
130921273|NCT00347360|471345487|FG003|Overall Study|PI recommended early withdrawal|0|||
130921274|NCT00347360|471345488|FG004|Overall Study|PI recommended early withdrawal|0|||
130700189|NCT01190930|470526420|FG006|Induction|High Risk Downs|0|||
130700190|NCT01190930|470526421|FG007|Induction|High Risk Downs|0|||
130700191|NCT01190930|470526422|FG008|Induction|High Risk Downs|0|||
130700192|NCT01190930|470526423|FG009|Induction|High Risk Downs|0|||
130921275|NCT00347360|471345489|FG005|Overall Study|PI recommended early withdrawal|0|||
130921276|NCT00347360|471345490|FG006|Overall Study|PI recommended early withdrawal|0|||
130921277|NCT00347360|471345491|FG007|Overall Study|PI recommended early withdrawal|0|||
130921278|NCT00347360|471345492|FG008|Overall Study|PI recommended early withdrawal|0|||
130921279|NCT00347360|471345493|FG009|Overall Study|PI recommended early withdrawal|1|||
130921280|NCT00347360|471345494|FG010|Overall Study|PI recommended early withdrawal|0|||
130921281|NCT00347360|471345495|FG011|Overall Study|PI recommended early withdrawal|0|||
130921282|NCT00347360|471345496|FG012|Overall Study|PI recommended early withdrawal|0|||
130921283|NCT00347360|471345497|FG013|Overall Study|PI recommended early withdrawal|0|||
130921284|NCT00347360|471345498|FG014|Overall Study|PI recommended early withdrawal|0|||
130921285|NCT00347360|471345484|FG000|Overall Study|Did not meet criteria before ABPM|0|||
130921286|NCT00347360|471345485|FG001|Overall Study|Did not meet criteria before ABPM|0|||
130921287|NCT00347360|471345486|FG002|Overall Study|Did not meet criteria before ABPM|0|||
130921288|NCT00347360|471345487|FG003|Overall Study|Did not meet criteria before ABPM|0|||
130921289|NCT00347360|471345488|FG004|Overall Study|Did not meet criteria before ABPM|0|||
130921290|NCT00347360|471345489|FG005|Overall Study|Did not meet criteria before ABPM|0|||
130921291|NCT00347360|471345490|FG006|Overall Study|Did not meet criteria before ABPM|0|||
130921292|NCT00347360|471345491|FG007|Overall Study|Did not meet criteria before ABPM|0|||
130921293|NCT00347360|471345492|FG008|Overall Study|Did not meet criteria before ABPM|0|||
130921294|NCT00347360|471345493|FG009|Overall Study|Did not meet criteria before ABPM|0|||
130921295|NCT00347360|471345494|FG010|Overall Study|Did not meet criteria before ABPM|1|||
130921296|NCT00347360|471345495|FG011|Overall Study|Did not meet criteria before ABPM|0|||
130921297|NCT00347360|471345496|FG012|Overall Study|Did not meet criteria before ABPM|0|||
130921298|NCT00347360|471345497|FG013|Overall Study|Did not meet criteria before ABPM|0|||
130921299|NCT00347360|471345498|FG014|Overall Study|Did not meet criteria before ABPM|0|||
130921300|NCT00347360|471345484|FG000|Overall Study|Randomized in error|0|||
130921301|NCT00347360|471345485|FG001|Overall Study|Randomized in error|0|||
130921302|NCT00347360|471345486|FG002|Overall Study|Randomized in error|0|||
130921303|NCT00347360|471345487|FG003|Overall Study|Randomized in error|0|||
130921304|NCT00347360|471345488|FG004|Overall Study|Randomized in error|0|||
130921305|NCT00347360|471345489|FG005|Overall Study|Randomized in error|0|||
130921306|NCT00347360|471345490|FG006|Overall Study|Randomized in error|0|||
130921307|NCT00347360|471345491|FG007|Overall Study|Randomized in error|0|||
130921308|NCT00347360|471345492|FG008|Overall Study|Randomized in error|0|||
130921309|NCT00347360|471345493|FG009|Overall Study|Randomized in error|0|||
130921310|NCT00347360|471345494|FG010|Overall Study|Randomized in error|0|||
130921311|NCT00347360|471345495|FG011|Overall Study|Randomized in error|1|||
130921312|NCT00347360|471345496|FG012|Overall Study|Randomized in error|0|||
130921313|NCT00347360|471345497|FG013|Overall Study|Randomized in error|0|||
130921314|NCT00347360|471345498|FG014|Overall Study|Randomized in error|0|||
130921315|NCT00347360|471345484|FG000|Overall Study|Failed inclusion criteria #4|0|||
130921316|NCT00347360|471345485|FG001|Overall Study|Failed inclusion criteria #4|0|||
130921317|NCT00347360|471345486|FG002|Overall Study|Failed inclusion criteria #4|0|||
130921318|NCT00347360|471345487|FG003|Overall Study|Failed inclusion criteria #4|0|||
130921319|NCT00347360|471345488|FG004|Overall Study|Failed inclusion criteria #4|0|||
130921320|NCT00347360|471345489|FG005|Overall Study|Failed inclusion criteria #4|0|||
130921321|NCT00347360|471345490|FG006|Overall Study|Failed inclusion criteria #4|0|||
130921322|NCT00347360|471345491|FG007|Overall Study|Failed inclusion criteria #4|0|||
130921323|NCT00347360|471345492|FG008|Overall Study|Failed inclusion criteria #4|0|||
130921324|NCT00347360|471345493|FG009|Overall Study|Failed inclusion criteria #4|0|||
130921325|NCT00347360|471345494|FG010|Overall Study|Failed inclusion criteria #4|0|||
130921326|NCT00347360|471345495|FG011|Overall Study|Failed inclusion criteria #4|1|||
130921327|NCT00347360|471345496|FG012|Overall Study|Failed inclusion criteria #4|0|||
130921328|NCT00347360|471345497|FG013|Overall Study|Failed inclusion criteria #4|0|||
130921329|NCT00347360|471345498|FG014|Overall Study|Failed inclusion criteria #4|0|||
130921330|NCT00347360|471345484|FG000|Overall Study|Prolonged duration between visits|0|||
130921331|NCT00347360|471345485|FG001|Overall Study|Prolonged duration between visits|0|||
130921332|NCT00347360|471345486|FG002|Overall Study|Prolonged duration between visits|0|||
130921333|NCT00347360|471345487|FG003|Overall Study|Prolonged duration between visits|0|||
130921334|NCT00347360|471345488|FG004|Overall Study|Prolonged duration between visits|0|||
130921335|NCT00347360|471345489|FG005|Overall Study|Prolonged duration between visits|0|||
130921336|NCT00347360|471345490|FG006|Overall Study|Prolonged duration between visits|0|||
130921337|NCT00347360|471345491|FG007|Overall Study|Prolonged duration between visits|0|||
130921338|NCT00347360|471345492|FG008|Overall Study|Prolonged duration between visits|0|||
130921339|NCT00347360|471345493|FG009|Overall Study|Prolonged duration between visits|0|||
130921340|NCT00347360|471345494|FG010|Overall Study|Prolonged duration between visits|0|||
130921341|NCT00347360|471345495|FG011|Overall Study|Prolonged duration between visits|0|||
130921342|NCT00347360|471345496|FG012|Overall Study|Prolonged duration between visits|1|||
131034246|NCT02949362|471759149|FG000|Prospective Period|Other|0|||
130921343|NCT00347360|471345497|FG013|Overall Study|Prolonged duration between visits|0|||
130921344|NCT00347360|471345498|FG014|Overall Study|Prolonged duration between visits|0|||
130921345|NCT00347360|471345484|FG000|Overall Study|Subject left town, ran out of study drug|0|||
130921346|NCT00347360|471345485|FG001|Overall Study|Subject left town, ran out of study drug|0|||
130921347|NCT00347360|471345486|FG002|Overall Study|Subject left town, ran out of study drug|0|||
130921348|NCT00347360|471345487|FG003|Overall Study|Subject left town, ran out of study drug|0|||
130921349|NCT00347360|471345488|FG004|Overall Study|Subject left town, ran out of study drug|0|||
130921350|NCT00347360|471345489|FG005|Overall Study|Subject left town, ran out of study drug|0|||
130921351|NCT00347360|471345490|FG006|Overall Study|Subject left town, ran out of study drug|0|||
130921352|NCT00347360|471345491|FG007|Overall Study|Subject left town, ran out of study drug|0|||
130921353|NCT00347360|471345492|FG008|Overall Study|Subject left town, ran out of study drug|0|||
130921354|NCT00347360|471345493|FG009|Overall Study|Subject left town, ran out of study drug|0|||
130921355|NCT00347360|471345494|FG010|Overall Study|Subject left town, ran out of study drug|0|||
130921356|NCT00347360|471345495|FG011|Overall Study|Subject left town, ran out of study drug|0|||
130921357|NCT00347360|471345496|FG012|Overall Study|Subject left town, ran out of study drug|0|||
130921358|NCT00347360|471345497|FG013|Overall Study|Subject left town, ran out of study drug|1|||
130921359|NCT00347360|471345498|FG014|Overall Study|Subject left town, ran out of study drug|0|||
130921360|NCT00347360|471345484|FG000|Overall Study|Subject refuse to sign updated consent|0|||
130921361|NCT00347360|471345485|FG001|Overall Study|Subject refuse to sign updated consent|0|||
130921362|NCT00347360|471345486|FG002|Overall Study|Subject refuse to sign updated consent|0|||
130921363|NCT00347360|471345487|FG003|Overall Study|Subject refuse to sign updated consent|0|||
130921364|NCT00347360|471345488|FG004|Overall Study|Subject refuse to sign updated consent|0|||
130921365|NCT00347360|471345489|FG005|Overall Study|Subject refuse to sign updated consent|0|||
130921366|NCT00347360|471345490|FG006|Overall Study|Subject refuse to sign updated consent|0|||
130921367|NCT00347360|471345491|FG007|Overall Study|Subject refuse to sign updated consent|0|||
130921368|NCT00347360|471345492|FG008|Overall Study|Subject refuse to sign updated consent|0|||
130921369|NCT00347360|471345493|FG009|Overall Study|Subject refuse to sign updated consent|0|||
130921370|NCT00347360|471345494|FG010|Overall Study|Subject refuse to sign updated consent|0|||
130921371|NCT00347360|471345495|FG011|Overall Study|Subject refuse to sign updated consent|0|||
130921372|NCT00347360|471345496|FG012|Overall Study|Subject refuse to sign updated consent|0|||
130921373|NCT00347360|471345497|FG013|Overall Study|Subject refuse to sign updated consent|0|||
130921374|NCT00347360|471345498|FG014|Overall Study|Subject refuse to sign updated consent|1|||
130921375|NCT00347360|471345484|FG000|Overall Study|Visits conflicted with new job|0|||
130921376|NCT00347360|471345485|FG001|Overall Study|Visits conflicted with new job|0|||
130921377|NCT00347360|471345486|FG002|Overall Study|Visits conflicted with new job|0|||
130921378|NCT00347360|471345487|FG003|Overall Study|Visits conflicted with new job|0|||
130921379|NCT00347360|471345488|FG004|Overall Study|Visits conflicted with new job|0|||
130921380|NCT00347360|471345489|FG005|Overall Study|Visits conflicted with new job|0|||
130921381|NCT00347360|471345490|FG006|Overall Study|Visits conflicted with new job|1|||
130921382|NCT00347360|471345491|FG007|Overall Study|Visits conflicted with new job|0|||
130921383|NCT00347360|471345492|FG008|Overall Study|Visits conflicted with new job|0|||
130921384|NCT00347360|471345493|FG009|Overall Study|Visits conflicted with new job|0|||
130921385|NCT00347360|471345494|FG010|Overall Study|Visits conflicted with new job|0|||
130921386|NCT00347360|471345495|FG011|Overall Study|Visits conflicted with new job|0|||
130921387|NCT00347360|471345496|FG012|Overall Study|Visits conflicted with new job|0|||
130921388|NCT00347360|471345497|FG013|Overall Study|Visits conflicted with new job|0|||
130921389|NCT00347360|471345498|FG014|Overall Study|Visits conflicted with new job|0|||
130921390|NCT01449539|471345499|FG000|Overall Study|Withdrawal by Subject|3|||
130921391|NCT01449539|471345499|FG000|Overall Study|Toxicity not study related|1|||
130921392|NCT01387789|471345500|FG000|Overall Study|Adverse Event|5|||
131120142|NCT00467779|472072313|FG002|Stage 1A|Withdrawal by Subject|0|||
131120143|NCT00467779|472072314|FG003|Stage 1A|Withdrawal by Subject|0|||
131120144|NCT00467779|472072315|FG004|Stage 1A|Withdrawal by Subject|0|||
131120145|NCT00467779|472072316|FG005|Stage 1A|Withdrawal by Subject|0|||
131120146|NCT00467779|472072317|FG006|Stage 1A|Withdrawal by Subject|0|||
130921393|NCT01387789|471345500|FG000|Overall Study|Lack of Efficacy|2|||
130921394|NCT01387789|471345500|FG000|Overall Study|Lost to Follow-up|1|||
130921395|NCT00508755|471345507|FG000|Overall Study|Withdrawal by Subject|1|||
130921396|NCT00945893|471345508|FG000|Overall Study|Lost to Follow-up|2|||
131120147|NCT00467779|472072318|FG007|Stage 1A|Withdrawal by Subject|0|||
131120148|NCT00467779|472072319|FG008|Stage 1A|Withdrawal by Subject|0|||
131120149|NCT00467779|472072320|FG009|Stage 1A|Withdrawal by Subject|0|||
131120150|NCT00467779|472072321|FG010|Stage 1A|Withdrawal by Subject|1|||
131120151|NCT00467779|472072322|FG011|Stage 1A|Withdrawal by Subject|1|||
131223158|NCT02773446|472445019|FG001|First Admission|Lost to Follow-up|0|||
131120152|NCT00467779|472072323|FG012|Stage 1A|Withdrawal by Subject|1|||
131223159|NCT02773446|472445020|FG002|First Admission|Lost to Follow-up|0|||
131223160|NCT02773446|472445021|FG003|First Admission|Lost to Follow-up|0|||
131223161|NCT02773446|472445022|FG004|First Admission|Lost to Follow-up|0|||
130700193|NCT01190930|470526414|FG000|Induction|Enrollment onto another COG Protocol|1|||
130700194|NCT01190930|470526415|FG001|Induction|Enrollment onto another COG Protocol|0|||
130700195|NCT01190930|470526416|FG002|Induction|Enrollment onto another COG Protocol|0|||
131120153|NCT00467779|472072324|FG013|Stage 1A|Withdrawal by Subject|0|||
131120154|NCT00467779|472072325|FG014|Stage 1A|Withdrawal by Subject|0|||
130921397|NCT00945893|471345509|FG001|Overall Study|Lost to Follow-up|8|||
130921398|NCT00945893|471345508|FG000|Overall Study|Withdrawal of consent|1|||
130921399|NCT00945893|471345509|FG001|Overall Study|Withdrawal of consent|2|||
130921400|NCT03113071|471345510|FG000|Overall Study|Withdrawal by Subject|1|||
130921401|NCT03113071|471345511|FG001|Overall Study|Withdrawal by Subject|0|||
130921402|NCT01602120|471345512|FG000|Overall Study|Adverse Event|3|||
130921403|NCT01602120|471345513|FG001|Overall Study|Adverse Event|6|||
130921404|NCT01602120|471345514|FG002|Overall Study|Adverse Event|0|||
130921405|NCT01602120|471345515|FG003|Overall Study|Adverse Event|2|||
130921406|NCT01602120|471345512|FG000|Overall Study|Death|0|||
130921407|NCT01602120|471345513|FG001|Overall Study|Death|4|||
130921408|NCT01602120|471345514|FG002|Overall Study|Death|0|||
130921409|NCT01602120|471345515|FG003|Overall Study|Death|0|||
130921410|NCT01602120|471345512|FG000|Overall Study|Lost to Follow-up|0|||
130921411|NCT01602120|471345513|FG001|Overall Study|Lost to Follow-up|1|||
130921412|NCT01602120|471345514|FG002|Overall Study|Lost to Follow-up|0|||
130921413|NCT01602120|471345515|FG003|Overall Study|Lost to Follow-up|1|||
130921414|NCT01602120|471345512|FG000|Overall Study|Protocol Violation|1|||
130921415|NCT01602120|471345513|FG001|Overall Study|Protocol Violation|1|||
130921416|NCT01602120|471345514|FG002|Overall Study|Protocol Violation|0|||
130921417|NCT01602120|471345515|FG003|Overall Study|Protocol Violation|0|||
130921418|NCT01602120|471345512|FG000|Overall Study|Non-compliance|0|||
130921419|NCT01602120|471345513|FG001|Overall Study|Non-compliance|3|||
130921420|NCT01602120|471345514|FG002|Overall Study|Non-compliance|0|||
130921421|NCT01602120|471345515|FG003|Overall Study|Non-compliance|1|||
130921422|NCT01602120|471345512|FG000|Overall Study|Withdrawal by Subject|8|||
130921423|NCT01602120|471345513|FG001|Overall Study|Withdrawal by Subject|17|||
130921424|NCT01602120|471345514|FG002|Overall Study|Withdrawal by Subject|0|||
130921425|NCT01602120|471345515|FG003|Overall Study|Withdrawal by Subject|3|||
130921426|NCT01602120|471345512|FG000|Overall Study|Study Terminated by Sponsor|12|||
130921427|NCT01602120|471345513|FG001|Overall Study|Study Terminated by Sponsor|24|||
130921428|NCT01602120|471345514|FG002|Overall Study|Study Terminated by Sponsor|17|||
130921429|NCT01602120|471345515|FG003|Overall Study|Study Terminated by Sponsor|44|||
130921430|NCT01602120|471345512|FG000|Overall Study|Physician Decision|2|||
130921431|NCT01602120|471345513|FG001|Overall Study|Physician Decision|3|||
130921432|NCT01602120|471345514|FG002|Overall Study|Physician Decision|0|||
130921433|NCT01602120|471345515|FG003|Overall Study|Physician Decision|0|||
130921434|NCT01602120|471345512|FG000|Overall Study|Unspecified Reason|3|||
130921435|NCT01602120|471345513|FG001|Overall Study|Unspecified Reason|1|||
130921436|NCT01602120|471345514|FG002|Overall Study|Unspecified Reason|0|||
130921437|NCT01602120|471345515|FG003|Overall Study|Unspecified Reason|2|||
130921438|NCT01187433|471345522|FG000|Overall Study|Protocol Violation|6|||
130921439|NCT01187433|471345523|FG001|Overall Study|Protocol Violation|2|||
130921440|NCT01187433|471345522|FG000|Overall Study|Withdrawal by Subject|5|||
130921441|NCT01187433|471345523|FG001|Overall Study|Withdrawal by Subject|2|||
130921442|NCT00437983|471345525|FG000|Overall Study|Adverse Event|6|||
130921443|NCT00437983|471345526|FG001|Overall Study|Adverse Event|6|||
130921444|NCT00437983|471345525|FG000|Overall Study|Protocol Violation|2|||
130921445|NCT00437983|471345526|FG001|Overall Study|Protocol Violation|1|||
130921446|NCT00437983|471345525|FG000|Overall Study|Withdrawal by Subject|5|||
130921447|NCT00437983|471345526|FG001|Overall Study|Withdrawal by Subject|6|||
130921448|NCT00672646|471345529|FG000|Overall Study|Lost to Follow-up|0|||
130921449|NCT00672646|471345530|FG001|Overall Study|Lost to Follow-up|1|||
130921450|NCT00672646|471345531|FG002|Overall Study|Lost to Follow-up|2|||
131120155|NCT00467779|472072311|FG000|Stage 1A|Unspecified Reason|0|||
130700196|NCT01190930|470526417|FG003|Induction|Enrollment onto another COG Protocol|0|||
130921451|NCT00672646|471345529|FG000|Overall Study|Withdrawal by Subject|0|||
130921452|NCT00672646|471345530|FG001|Overall Study|Withdrawal by Subject|0|||
130921453|NCT00672646|471345531|FG002|Overall Study|Withdrawal by Subject|1|||
130921454|NCT00242216|471345532|FG000|Overall Study|Lost to Follow-up|12|||
130921455|NCT00242216|471345533|FG001|Overall Study|Lost to Follow-up|17|||
130921456|NCT00242216|471345532|FG000|Overall Study|Death|4|||
130700197|NCT01190930|470526418|FG004|Induction|Enrollment onto another COG Protocol|0|||
130700198|NCT01190930|470526419|FG005|Induction|Enrollment onto another COG Protocol|0|||
130921457|NCT00242216|471345533|FG001|Overall Study|Death|2|||
130921458|NCT00242216|471345532|FG000|Overall Study|Lack of Efficacy|1|||
130700199|NCT01190930|470526420|FG006|Induction|Enrollment onto another COG Protocol|0|||
130700200|NCT01190930|470526421|FG007|Induction|Enrollment onto another COG Protocol|0|||
130921459|NCT00242216|471345533|FG001|Overall Study|Lack of Efficacy|2|||
130921460|NCT00242216|471345532|FG000|Overall Study|no medicaiton dispensed|1|||
130921461|NCT00242216|471345533|FG001|Overall Study|no medicaiton dispensed|1|||
130921462|NCT00678080|471345534|FG000|Overall Study|Physician Decision|2|||
130921463|NCT00678080|471345535|FG001|Overall Study|Physician Decision|0|||
130921464|NCT00678080|471345534|FG000|Overall Study|Lost to Follow-up|1|||
130921465|NCT00678080|471345535|FG001|Overall Study|Lost to Follow-up|0|||
130921466|NCT00678080|471345534|FG000|Overall Study|Withdrawal by Subject|0|||
130921467|NCT00678080|471345535|FG001|Overall Study|Withdrawal by Subject|1|||
130921468|NCT03730012|471345536|FG000|Overall Study|Adverse Event|0|||
130921469|NCT03730012|471345537|FG001|Overall Study|Adverse Event|1|||
130921470|NCT03730012|471345536|FG000|Overall Study|Lack of Efficacy|1|||
130921471|NCT03730012|471345537|FG001|Overall Study|Lack of Efficacy|5|||
130921472|NCT03730012|471345536|FG000|Overall Study|Withdrawal by Subject|0|||
130921473|NCT03730012|471345537|FG001|Overall Study|Withdrawal by Subject|1|||
130921474|NCT03730012|471345536|FG000|Overall Study|Miscellaneous|2|||
130921475|NCT03730012|471345537|FG001|Overall Study|Miscellaneous|1|||
130921476|NCT03320057|471347510|FG000|Overall Study|Lost to Follow-up|4|||
130921477|NCT03320057|471347511|FG001|Overall Study|Lost to Follow-up|17|||
130921478|NCT03320057|471347510|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
130921479|NCT03320057|471347511|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
130921480|NCT06956170|471347512|FG000|Overall Study|Death|2|||
130921481|NCT06956170|471347513|FG001|Overall Study|Death|1|||
130921482|NCT06956170|471347512|FG000|Overall Study|Withdrawal by Subject|1|||
130921483|NCT06956170|471347513|FG001|Overall Study|Withdrawal by Subject|0|||
130921484|NCT06956170|471347512|FG000|Overall Study|Ongoing|7|||
130921485|NCT06956170|471347513|FG001|Overall Study|Ongoing|10|||
130921486|NCT01516437|471347514|FG000|Overall Study|Reason not specified|0|||
130921487|NCT01516437|471347515|FG001|Overall Study|Reason not specified|0|||
130921488|NCT01516437|471347516|FG002|Overall Study|Reason not specified|1|||
130921489|NCT01516437|471347517|FG003|Overall Study|Reason not specified|1|||
130921490|NCT00316719|471347518|FG000|Overall Study|Adverse Event|0|||
130921491|NCT00316719|471347519|FG001|Overall Study|Adverse Event|6|||
130921492|NCT00316719|471347518|FG000|Overall Study|Consent withdrawn|2|||
130921493|NCT00316719|471347519|FG001|Overall Study|Consent withdrawn|0|||
130921494|NCT02400333|471347522|FG000|Overall Study|Withdrawal by Subject|0|||
130921495|NCT02400333|471347523|FG001|Overall Study|Withdrawal by Subject|1|||
130921496|NCT02400333|471347524|FG002|Overall Study|Withdrawal by Subject|0|||
130921497|NCT02400333|471347525|FG003|Overall Study|Withdrawal by Subject|1|||
130921498|NCT02400333|471347522|FG000|Overall Study|Protocol Violation|1|||
130921499|NCT02400333|471347523|FG001|Overall Study|Protocol Violation|0|||
130921500|NCT02400333|471347524|FG002|Overall Study|Protocol Violation|2|||
130921501|NCT02400333|471347525|FG003|Overall Study|Protocol Violation|1|||
130921502|NCT01890473|471347529|FG000|Overall Study|Lost to Follow-up|1|||
130921503|NCT01890473|471347530|FG001|Overall Study|Lost to Follow-up|0|||
130921504|NCT01890473|471347529|FG000|Overall Study|Poor/non-compliance|1|||
130921505|NCT01890473|471347530|FG001|Overall Study|Poor/non-compliance|0|||
130921506|NCT00934089|471347531|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
130921507|NCT00934089|471347532|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
130921508|NCT00934089|471347531|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
130921509|NCT00934089|471347532|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
130921510|NCT00003473|471347533|FG000|Overall Study|Three patients were not evaluable.|3|||
130921511|NCT05154578|471347539|FG000|Overall Study|Withdrawal by Subject|2|||
130921512|NCT05154578|471347540|FG001|Overall Study|Withdrawal by Subject|3|||
130921513|NCT05154578|471347541|FG002|Overall Study|Withdrawal by Subject|2|||
130921514|NCT05154578|471347542|FG003|Overall Study|Withdrawal by Subject|4|||
130921515|NCT05154578|471347543|FG004|Overall Study|Withdrawal by Subject|0|||
130921516|NCT05154578|471347539|FG000|Overall Study|Lost to Follow-up|0|||
130921517|NCT05154578|471347540|FG001|Overall Study|Lost to Follow-up|1|||
130921518|NCT05154578|471347541|FG002|Overall Study|Lost to Follow-up|0|||
130921519|NCT05154578|471347542|FG003|Overall Study|Lost to Follow-up|3|||
130921520|NCT05154578|471347543|FG004|Overall Study|Lost to Follow-up|0|||
130921521|NCT05154578|471347539|FG000|Overall Study|Adverse Event|0|||
130921522|NCT05154578|471347540|FG001|Overall Study|Adverse Event|0|||
130921523|NCT05154578|471347541|FG002|Overall Study|Adverse Event|0|||
130921524|NCT05154578|471347542|FG003|Overall Study|Adverse Event|1|||
130921525|NCT05154578|471347543|FG004|Overall Study|Adverse Event|0|||
130921526|NCT05154578|471347539|FG000|Overall Study|Relocated to another province|0|||
130921527|NCT05154578|471347540|FG001|Overall Study|Relocated to another province|0|||
130921528|NCT05154578|471347541|FG002|Overall Study|Relocated to another province|1|||
130921529|NCT05154578|471347542|FG003|Overall Study|Relocated to another province|0|||
130921530|NCT05154578|471347543|FG004|Overall Study|Relocated to another province|1|||
130921531|NCT05154578|471347539|FG000|Overall Study|Baby loss|0|||
130921532|NCT05154578|471347540|FG001|Overall Study|Baby loss|1|||
130921533|NCT05154578|471347541|FG002|Overall Study|Baby loss|0|||
130921534|NCT05154578|471347542|FG003|Overall Study|Baby loss|0|||
130921535|NCT05154578|471347543|FG004|Overall Study|Baby loss|0|||
130921536|NCT00705289|471347549|FG000|Overall Study|Subject or treating physician's choice|131|||
131034247|NCT02949362|471759150|FG001|Prospective Period|Other|0|||
131034248|NCT02949362|471759151|FG002|Prospective Period|Other|0|||
131034249|NCT02949362|471759152|FG003|Prospective Period|Other|4|||
131034250|NCT04633122|471759159|FG000|Overall Study|Remained on treatment|19|||
131034251|NCT04633122|471759160|FG001|Overall Study|Remained on treatment|14|||
131034252|NCT04633122|471759159|FG000|Overall Study|Survival follow-up stopped|22|||
131034253|NCT04633122|471759160|FG001|Overall Study|Survival follow-up stopped|25|||
131034254|NCT03307343|471759161|FG000|Overall Study|Withdrawal by Subject|1|||
130921537|NCT02601027|471347550|FG000|Registration to Surgery|Withdrawal by Subject|20|||
130921538|NCT02601027|471347551|FG001|Registration to Surgery|Withdrawal by Subject|10|||
130921539|NCT02609828|471347552|FG000|Overall Study|Adverse Event|8|||
130921540|NCT02609828|471347553|FG001|Overall Study|Adverse Event|1|||
130921541|NCT02609828|471347554|FG002|Overall Study|Adverse Event|0|||
130921542|NCT02609828|471347555|FG003|Overall Study|Adverse Event|6|||
130921543|NCT02609828|471347552|FG000|Overall Study|Death|15|||
130921544|NCT02609828|471347553|FG001|Overall Study|Death|1|||
130921545|NCT02609828|471347554|FG002|Overall Study|Death|1|||
130921546|NCT02609828|471347555|FG003|Overall Study|Death|19|||
130921547|NCT02609828|471347552|FG000|Overall Study|Insufficient clinical response|2|||
130921548|NCT02609828|471347553|FG001|Overall Study|Insufficient clinical response|1|||
130921549|NCT02609828|471347554|FG002|Overall Study|Insufficient clinical response|0|||
130921550|NCT02609828|471347555|FG003|Overall Study|Insufficient clinical response|0|||
130921551|NCT02609828|471347552|FG000|Overall Study|Lost to Follow-up|0|||
130921552|NCT02609828|471347553|FG001|Overall Study|Lost to Follow-up|0|||
130921553|NCT02609828|471347554|FG002|Overall Study|Lost to Follow-up|0|||
130921554|NCT02609828|471347555|FG003|Overall Study|Lost to Follow-up|1|||
130921555|NCT02609828|471347552|FG000|Overall Study|Protocol Violation|2|||
130921556|NCT02609828|471347553|FG001|Overall Study|Protocol Violation|0|||
130921557|NCT02609828|471347554|FG002|Overall Study|Protocol Violation|0|||
130921558|NCT02609828|471347555|FG003|Overall Study|Protocol Violation|1|||
130921559|NCT02609828|471347552|FG000|Overall Study|Withdrawal by Subject|12|||
130921560|NCT02609828|471347553|FG001|Overall Study|Withdrawal by Subject|1|||
130921561|NCT02609828|471347554|FG002|Overall Study|Withdrawal by Subject|0|||
130921562|NCT02609828|471347555|FG003|Overall Study|Withdrawal by Subject|10|||
130921563|NCT02609828|471347552|FG000|Overall Study|Other|3|||
130921564|NCT02609828|471347553|FG001|Overall Study|Other|0|||
130921565|NCT02609828|471347554|FG002|Overall Study|Other|0|||
130921566|NCT02609828|471347555|FG003|Overall Study|Other|6|||
130921567|NCT02609828|471347552|FG000|Overall Study|Randomized but not treated|1|||
130921568|NCT02609828|471347553|FG001|Overall Study|Randomized but not treated|0|||
130921569|NCT02609828|471347554|FG002|Overall Study|Randomized but not treated|0|||
130921570|NCT02609828|471347555|FG003|Overall Study|Randomized but not treated|0|||
130921571|NCT03758066|471347556|FG000|Overall Study|Lost to Follow-up|14|||
130921572|NCT01540838|471347557|FG000|Overall Study|Open nasogastric tube|9|||
130921573|NCT01540838|471347558|FG001|Overall Study|Open nasogastric tube|7|||
130921574|NCT01540838|471347557|FG000|Overall Study|Treatment doses missing|8|||
130921575|NCT01540838|471347558|FG001|Overall Study|Treatment doses missing|12|||
130921576|NCT01540838|471347557|FG000|Overall Study|Additional antibiotic treatment|1|||
130921577|NCT01540838|471347558|FG001|Overall Study|Additional antibiotic treatment|2|||
130921578|NCT01540838|471347557|FG000|Overall Study|Died before treatment initiation|1|||
130921579|NCT01540838|471347558|FG001|Overall Study|Died before treatment initiation|1|||
130921580|NCT01540838|471347557|FG000|Overall Study|Not BM. Other treatment|3|||
130921581|NCT01540838|471347558|FG001|Overall Study|Not BM. Other treatment|1|||
130921582|NCT03641339|471347559|FG000|Overall Study|Physician Decision|1|||
130700201|NCT01190930|470526422|FG008|Induction|Enrollment onto another COG Protocol|0|||
130700202|NCT01190930|470526423|FG009|Induction|Enrollment onto another COG Protocol|0|||
130700203|NCT01190930|470526414|FG000|Induction|Average Risk|1847|||
130700204|NCT01190930|470526415|FG001|Induction|Average Risk|0|||
130700205|NCT01190930|470526416|FG002|Induction|Average Risk|0|||
130700206|NCT01190930|470526417|FG003|Induction|Average Risk|0|||
130700207|NCT01190930|470526418|FG004|Induction|Average Risk|0|||
130700208|NCT01190930|470526419|FG005|Induction|Average Risk|0|||
130700209|NCT01190930|470526420|FG006|Induction|Average Risk|0|||
130700210|NCT01190930|470526421|FG007|Induction|Average Risk|0|||
130700211|NCT01190930|470526422|FG008|Induction|Average Risk|0|||
130700212|NCT01190930|470526423|FG009|Induction|Average Risk|0|||
130700213|NCT01190930|470526414|FG000|Induction|High Risk|1227|||
130700214|NCT01190930|470526415|FG001|Induction|High Risk|0|||
130700215|NCT01190930|470526416|FG002|Induction|High Risk|0|||
130700216|NCT01190930|470526417|FG003|Induction|High Risk|0|||
130700217|NCT01190930|470526418|FG004|Induction|High Risk|0|||
130700218|NCT01190930|470526419|FG005|Induction|High Risk|0|||
130700219|NCT01190930|470526420|FG006|Induction|High Risk|0|||
130700220|NCT01190930|470526421|FG007|Induction|High Risk|0|||
130700221|NCT01190930|470526422|FG008|Induction|High Risk|0|||
130700222|NCT01190930|470526423|FG009|Induction|High Risk|0|||
130700223|NCT01190930|470526414|FG000|Induction|Low Risk|443|||
130700224|NCT01190930|470526415|FG001|Induction|Low Risk|0|||
130700225|NCT01190930|470526416|FG002|Induction|Low Risk|0|||
130921583|NCT03641339|471347560|FG001|Overall Study|Physician Decision|0|||
130700226|NCT01190930|470526417|FG003|Induction|Low Risk|0|||
130700227|NCT01190930|470526418|FG004|Induction|Low Risk|0|||
130700228|NCT01190930|470526419|FG005|Induction|Low Risk|0|||
130700229|NCT01190930|470526420|FG006|Induction|Low Risk|0|||
130921584|NCT03641339|471347561|FG002|Overall Study|Physician Decision|0|||
130921585|NCT03641339|471347562|FG003|Overall Study|Physician Decision|0|||
130700230|NCT01190930|470526421|FG007|Induction|Low Risk|0|||
130700231|NCT01190930|470526422|FG008|Induction|Low Risk|0|||
130700232|NCT01190930|470526423|FG009|Induction|Low Risk|0|||
130700233|NCT01190930|470526414|FG000|Induction|Very High Risk|1012|||
130700234|NCT01190930|470526415|FG001|Induction|Very High Risk|0|||
130921586|NCT03641339|471347563|FG004|Overall Study|Physician Decision|0|||
130700235|NCT01190930|470526416|FG002|Induction|Very High Risk|0|||
130700236|NCT01190930|470526417|FG003|Induction|Very High Risk|0|||
130700237|NCT01190930|470526418|FG004|Induction|Very High Risk|0|||
130921587|NCT03641339|471347564|FG005|Overall Study|Physician Decision|0|||
130921588|NCT03641339|471347559|FG000|Overall Study|Withdrawal by Subject|0|||
130921589|NCT03641339|471347560|FG001|Overall Study|Withdrawal by Subject|2|||
130921590|NCT03641339|471347561|FG002|Overall Study|Withdrawal by Subject|0|||
130921591|NCT03641339|471347562|FG003|Overall Study|Withdrawal by Subject|2|||
130921592|NCT03641339|471347563|FG004|Overall Study|Withdrawal by Subject|0|||
130921593|NCT03641339|471347564|FG005|Overall Study|Withdrawal by Subject|1|||
130921594|NCT03863197|471347565|FG000|Overall Study|Lost to Follow-up|2|||
130921595|NCT03863197|471347566|FG001|Overall Study|Lost to Follow-up|3|||
130921596|NCT03863197|471347565|FG000|Overall Study|Withdrawal by Subject|4|||
130921597|NCT03863197|471347566|FG001|Overall Study|Withdrawal by Subject|0|||
130921598|NCT03863197|471347565|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
130921599|NCT03863197|471347566|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
130921600|NCT00413244|471347569|FG000|Overall Study|Withdrawal by Subject|10|||
130921601|NCT00413244|471347570|FG001|Overall Study|Withdrawal by Subject|1|||
130921602|NCT00446251|471347571|FG000|Overall Study|On-study Transplants|2|||
130921603|NCT00446251|471347571|FG000|Overall Study|Rituximab Infusion Reaction|2|||
130921604|NCT00446251|471347571|FG000|Overall Study|Lost to Follow-up|1|||
130921605|NCT02264639|471347573|FG000|Overall Study|Death (after completing single-dose phase)|1|||
130921606|NCT02264639|471347574|FG001|Overall Study|Death (after completing single-dose phase)|0|||
130921607|NCT02264639|471347575|FG002|Overall Study|Death (after completing single-dose phase)|0|||
130921608|NCT02264639|471347576|FG003|Overall Study|Death (after completing single-dose phase)|0|||
130921609|NCT02264639|471347577|FG004|Overall Study|Death (after completing single-dose phase)|0|||
130921610|NCT02264639|471347573|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
130921611|NCT02264639|471347574|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
130921612|NCT02264639|471347575|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
131034255|NCT03307343|471759162|FG001|Overall Study|Withdrawal by Subject|2|||
131034256|NCT03307343|471759161|FG000|Overall Study|Pregnancy|0|||
131034257|NCT03307343|471759162|FG001|Overall Study|Pregnancy|2|||
131034258|NCT03307343|471759161|FG000|Overall Study|Physician Decision|1|||
131034259|NCT03307343|471759162|FG001|Overall Study|Physician Decision|0|||
131034260|NCT03307343|471759161|FG000|Overall Study|Lost to Follow-up|0|||
131034261|NCT03307343|471759162|FG001|Overall Study|Lost to Follow-up|2|||
131034262|NCT03382652|471759165|FG000|Overall Study|Lost to Follow-up|6|||
131034263|NCT03382652|471759165|FG000|Overall Study|Death|4|||
131034264|NCT03382652|471759165|FG000|Overall Study|Revision|5|||
131034265|NCT03382652|471759165|FG000|Overall Study|Patient withdrew|3|||
131034266|NCT03382652|471759165|FG000|Overall Study|Other reasons|21|||
131034267|NCT05794243|471759168|FG000|Overall Study|Withdrawal by Subject|1|||
131034268|NCT05794243|471759169|FG001|Overall Study|Withdrawal by Subject|0|||
131034269|NCT05794243|471759170|FG002|Overall Study|Withdrawal by Subject|1|||
131034270|NCT05794243|471759168|FG000|Overall Study|Physician Decision|0|||
131034271|NCT05794243|471759169|FG001|Overall Study|Physician Decision|3|||
131034272|NCT05794243|471759170|FG002|Overall Study|Physician Decision|1|||
131034273|NCT02761057|471759171|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
131034274|NCT02761057|471759172|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
131034275|NCT02761057|471759173|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
131034276|NCT02761057|471759174|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
131034277|NCT02761057|471759171|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
131034278|NCT02761057|471759172|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
131034279|NCT02761057|471759173|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
131034280|NCT02761057|471759174|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
131034281|NCT02761057|471759171|FG000|Overall Study|Currently On Study Treatment|0|||
131034282|NCT02761057|471759172|FG001|Overall Study|Currently On Study Treatment|3|||
131034283|NCT02761057|471759173|FG002|Overall Study|Currently On Study Treatment|0|||
131034284|NCT02761057|471759174|FG003|Overall Study|Currently On Study Treatment|0|||
131034285|NCT02761057|471759171|FG000|Overall Study|Adverse Event|11|||
131034286|NCT02761057|471759172|FG001|Overall Study|Adverse Event|9|||
131034287|NCT02761057|471759173|FG002|Overall Study|Adverse Event|5|||
131034288|NCT02761057|471759174|FG003|Overall Study|Adverse Event|3|||
131034289|NCT02761057|471759171|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
131034290|NCT02761057|471759172|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
131034291|NCT02761057|471759173|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
131034292|NCT02761057|471759174|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
131034293|NCT02761057|471759171|FG000|Overall Study|Progression/Relapse|29|||
131034294|NCT02761057|471759172|FG001|Overall Study|Progression/Relapse|27|||
131034295|NCT02761057|471759173|FG002|Overall Study|Progression/Relapse|20|||
131034296|NCT02761057|471759174|FG003|Overall Study|Progression/Relapse|23|||
131034297|NCT02761057|471759171|FG000|Overall Study|Death|2|||
131034298|NCT02761057|471759172|FG001|Overall Study|Death|2|||
131034299|NCT02761057|471759173|FG002|Overall Study|Death|1|||
130921613|NCT02264639|471347576|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
130921614|NCT02264639|471347577|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
130921615|NCT02264639|471347573|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
130921616|NCT02264639|471347574|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
130921617|NCT02264639|471347575|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
130921618|NCT02264639|471347576|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
130921619|NCT02264639|471347577|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
130921620|NCT02264639|471347573|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
130921621|NCT02264639|471347574|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
130921622|NCT02264639|471347575|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
130921623|NCT02264639|471347576|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
130921624|NCT02264639|471347577|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
130921625|NCT01058655|471347578|FG000|Overall Study|Withdrawal by Subject|1|||
130921626|NCT01058655|471347579|FG001|Overall Study|Withdrawal by Subject|0|||
130921627|NCT01058655|471347580|FG002|Overall Study|Withdrawal by Subject|3|||
130921628|NCT01058655|471347581|FG003|Overall Study|Withdrawal by Subject|4|||
130921629|NCT01058655|471347578|FG000|Overall Study|Prolonged Treatment Delay|0|||
130921630|NCT01058655|471347579|FG001|Overall Study|Prolonged Treatment Delay|0|||
130921631|NCT01058655|471347580|FG002|Overall Study|Prolonged Treatment Delay|0|||
130921632|NCT01058655|471347581|FG003|Overall Study|Prolonged Treatment Delay|2|||
130921633|NCT01058655|471347578|FG000|Overall Study|Symptomatic Deterioration|0|||
130921634|NCT01058655|471347579|FG001|Overall Study|Symptomatic Deterioration|0|||
130921635|NCT01058655|471347580|FG002|Overall Study|Symptomatic Deterioration|0|||
130921636|NCT01058655|471347581|FG003|Overall Study|Symptomatic Deterioration|1|||
130921637|NCT01058655|471347578|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
130921638|NCT01058655|471347579|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
130921639|NCT01058655|471347580|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
130921640|NCT01058655|471347581|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
130921641|NCT01058655|471347578|FG000|Overall Study|Death|0|||
130921642|NCT01058655|471347579|FG001|Overall Study|Death|1|||
130921643|NCT01058655|471347580|FG002|Overall Study|Death|1|||
130921644|NCT01058655|471347581|FG003|Overall Study|Death|0|||
130921645|NCT01058655|471347578|FG000|Overall Study|Disease Progression|1|||
130921646|NCT01058655|471347579|FG001|Overall Study|Disease Progression|2|||
130921647|NCT01058655|471347580|FG002|Overall Study|Disease Progression|4|||
130921648|NCT01058655|471347581|FG003|Overall Study|Disease Progression|24|||
130921649|NCT01058655|471347578|FG000|Overall Study|Other|0|||
130921650|NCT01058655|471347579|FG001|Overall Study|Other|0|||
130921651|NCT01058655|471347580|FG002|Overall Study|Other|0|||
130921652|NCT01058655|471347581|FG003|Overall Study|Other|4|||
130921653|NCT04472429|471347582|FG000|Randomized Period|Ongoing|90|||
130921654|NCT04472429|471347583|FG001|Randomized Period|Ongoing|40|||
130921655|NCT04472429|471347584|FG002|Randomized Period|Ongoing|0|||
130921656|NCT04472429|471347582|FG000|Randomized Period|Death|52|||
130700238|NCT01190930|470526419|FG005|Induction|Very High Risk|0|||
130700239|NCT01190930|470526420|FG006|Induction|Very High Risk|0|||
130921657|NCT04472429|471347583|FG001|Randomized Period|Death|37|||
130921658|NCT04472429|471347584|FG002|Randomized Period|Death|0|||
130921659|NCT04472429|471347582|FG000|Randomized Period|Lost to Follow-up|4|||
130921660|NCT04472429|471347583|FG001|Randomized Period|Lost to Follow-up|0|||
130921661|NCT04472429|471347584|FG002|Randomized Period|Lost to Follow-up|0|||
130921662|NCT04472429|471347582|FG000|Randomized Period|Physician Decision|1|||
130921663|NCT04472429|471347583|FG001|Randomized Period|Physician Decision|2|||
130921664|NCT04472429|471347584|FG002|Randomized Period|Physician Decision|0|||
131034300|NCT02761057|471759174|FG003|Overall Study|Death|1|||
130700240|NCT01190930|470526421|FG007|Induction|Very High Risk|0|||
130700241|NCT01190930|470526422|FG008|Induction|Very High Risk|0|||
130700242|NCT01190930|470526423|FG009|Induction|Very High Risk|0|||
130700243|NCT01190930|470526414|FG000|Induction|Philadelphia chromosome-positive|99|||
130700244|NCT01190930|470526415|FG001|Induction|Philadelphia chromosome-positive|0|||
130700245|NCT01190930|470526416|FG002|Induction|Philadelphia chromosome-positive|0|||
130700246|NCT01190930|470526417|FG003|Induction|Philadelphia chromosome-positive|0|||
130700247|NCT01190930|470526418|FG004|Induction|Philadelphia chromosome-positive|0|||
130700248|NCT01190930|470526419|FG005|Induction|Philadelphia chromosome-positive|0|||
130700249|NCT01190930|470526420|FG006|Induction|Philadelphia chromosome-positive|0|||
130700250|NCT01190930|470526421|FG007|Induction|Philadelphia chromosome-positive|0|||
130700251|NCT01190930|470526422|FG008|Induction|Philadelphia chromosome-positive|0|||
130700252|NCT01190930|470526423|FG009|Induction|Philadelphia chromosome-positive|0|||
130700253|NCT01190930|470526414|FG000|Induction|Incomplete Induction data|63|||
130921665|NCT04472429|471347582|FG000|Randomized Period|Withdrawal by Subject|6|||
130921666|NCT04472429|471347583|FG001|Randomized Period|Withdrawal by Subject|5|||
131120156|NCT00467779|472072312|FG001|Stage 1A|Unspecified Reason|0|||
130700254|NCT01190930|470526415|FG001|Induction|Incomplete Induction data|0|||
130700255|NCT01190930|470526416|FG002|Induction|Incomplete Induction data|0|||
130700256|NCT01190930|470526417|FG003|Induction|Incomplete Induction data|0|||
130921667|NCT04472429|471347584|FG002|Randomized Period|Withdrawal by Subject|0|||
130921668|NCT04472429|471347582|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
130921669|NCT04472429|471347583|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
130921670|NCT04472429|471347584|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
130921671|NCT04472429|471347582|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
130921672|NCT04472429|471347583|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
130921673|NCT04472429|471347584|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
130921674|NCT04472429|471347582|FG000|Open-label Monotherapy Period|Ongoing|0|||
130921675|NCT04472429|471347583|FG001|Open-label Monotherapy Period|Ongoing|0|||
130921676|NCT04472429|471347584|FG002|Open-label Monotherapy Period|Ongoing|32|||
130921677|NCT04472429|471347582|FG000|Open-label Monotherapy Period|Death|0|||
130921678|NCT04472429|471347583|FG001|Open-label Monotherapy Period|Death|0|||
130921679|NCT04472429|471347584|FG002|Open-label Monotherapy Period|Death|35|||
130921680|NCT04472429|471347582|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
130769535|NCT03214679|470782478|FG000|Overall Study|Lost to Follow-up|12|||
130921681|NCT04472429|471347583|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
130921682|NCT04472429|471347584|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
130921683|NCT00753766|471347587|FG000|Overall Study|Physician Decision|1|||
130921684|NCT00753766|471347588|FG001|Overall Study|Physician Decision|0|||
130921685|NCT00839852|471347589|FG000|Overall Study|Adverse Event|10|||
130921686|NCT00839852|471347589|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130921687|NCT00839852|471347589|FG000|Overall Study|Protocol Violation|9|||
130921688|NCT00839852|471347589|FG000|Overall Study|Withdrawal of Consent|16|||
130921689|NCT00839852|471347589|FG000|Overall Study|Lost to Follow-up|7|||
130921690|NCT00839852|471347589|FG000|Overall Study|Lack of Compliance While in Jail|1|||
130921691|NCT00839852|471347589|FG000|Overall Study|Pregnancy|1|||
130921692|NCT00494299|471347590|FG000|Overall Study|Adverse Event|93|||
130921693|NCT00494299|471347591|FG001|Overall Study|Adverse Event|13|||
130921694|NCT00494299|471347590|FG000|Overall Study|Lost to Follow-up|1|||
130921695|NCT00494299|471347591|FG001|Overall Study|Lost to Follow-up|0|||
130921696|NCT00494299|471347590|FG000|Overall Study|Physician Decision|0|||
130921697|NCT00494299|471347591|FG001|Overall Study|Physician Decision|2|||
130921698|NCT00494299|471347590|FG000|Overall Study|Protocol Violation|1|||
130921699|NCT00494299|471347591|FG001|Overall Study|Protocol Violation|2|||
130921700|NCT00494299|471347590|FG000|Overall Study|Withdrawal by Subject|8|||
130921701|NCT00494299|471347591|FG001|Overall Study|Withdrawal by Subject|3|||
130921702|NCT00494299|471347590|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
130921703|NCT00494299|471347591|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
130921704|NCT00494299|471347590|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
130921705|NCT00494299|471347591|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
130921706|NCT00494299|471347590|FG000|Overall Study|Site Closed by Sponsor|6|||
130921707|NCT00494299|471347591|FG001|Overall Study|Site Closed by Sponsor|0|||
130921708|NCT00494299|471347590|FG000|Overall Study|Protocol Driven Decision Point|11|||
130921709|NCT00494299|471347591|FG001|Overall Study|Protocol Driven Decision Point|22|||
130921710|NCT02805972|471347596|FG000|Washout Period|Lost to Follow-up|3|||
130921711|NCT02805972|471347597|FG001|Washout Period|Lost to Follow-up|0|||
130921712|NCT01206166|471347599|FG000|Overall Study|No evaluable data|2|||
130921713|NCT01206166|471347600|FG001|Overall Study|No evaluable data|3|||
130921714|NCT00932126|471347601|FG000|Overall Study|Adverse Event|0|||
130921715|NCT00932126|471347602|FG001|Overall Study|Adverse Event|0|||
130921716|NCT00932126|471347603|FG002|Overall Study|Adverse Event|0|||
130921717|NCT00932126|471347604|FG003|Overall Study|Adverse Event|0|||
130921718|NCT00932126|471347605|FG004|Overall Study|Adverse Event|0|||
130921719|NCT00932126|471347606|FG005|Overall Study|Adverse Event|0|||
130921720|NCT00932126|471347607|FG006|Overall Study|Adverse Event|1|||
130921721|NCT00932126|471347608|FG007|Overall Study|Adverse Event|2|||
130921722|NCT00932126|471347601|FG000|Overall Study|Protocol Violation|0|||
130921723|NCT00932126|471347602|FG001|Overall Study|Protocol Violation|0|||
130769536|NCT03214679|470782479|FG001|Overall Study|Lost to Follow-up|14|||
130921724|NCT00932126|471347603|FG002|Overall Study|Protocol Violation|0|||
130921725|NCT00932126|471347604|FG003|Overall Study|Protocol Violation|0|||
130921726|NCT00932126|471347605|FG004|Overall Study|Protocol Violation|1|||
130921727|NCT00932126|471347606|FG005|Overall Study|Protocol Violation|0|||
130921728|NCT00932126|471347607|FG006|Overall Study|Protocol Violation|0|||
130921729|NCT00932126|471347608|FG007|Overall Study|Protocol Violation|0|||
130921730|NCT00932126|471347601|FG000|Overall Study|Withdrawal by Subject|0|||
130921731|NCT00932126|471347602|FG001|Overall Study|Withdrawal by Subject|0|||
130921732|NCT00932126|471347603|FG002|Overall Study|Withdrawal by Subject|1|||
130921733|NCT00932126|471347604|FG003|Overall Study|Withdrawal by Subject|0|||
130921734|NCT00932126|471347605|FG004|Overall Study|Withdrawal by Subject|0|||
130921735|NCT00932126|471347606|FG005|Overall Study|Withdrawal by Subject|0|||
130921736|NCT00932126|471347607|FG006|Overall Study|Withdrawal by Subject|0|||
130921737|NCT00932126|471347608|FG007|Overall Study|Withdrawal by Subject|1|||
131120157|NCT00467779|472072313|FG002|Stage 1A|Unspecified Reason|0|||
130921738|NCT00932126|471347601|FG000|Overall Study|Objective progression or relapse|3|||
130769537|NCT03214679|470782478|FG000|Overall Study|not eligible|2|||
130921739|NCT00932126|471347602|FG001|Overall Study|Objective progression or relapse|3|||
130921740|NCT00932126|471347603|FG002|Overall Study|Objective progression or relapse|2|||
130921741|NCT00932126|471347604|FG003|Overall Study|Objective progression or relapse|3|||
130921742|NCT00932126|471347605|FG004|Overall Study|Objective progression or relapse|3|||
130921743|NCT00932126|471347606|FG005|Overall Study|Objective progression or relapse|3|||
130921744|NCT00932126|471347607|FG006|Overall Study|Objective progression or relapse|3|||
130921745|NCT00932126|471347608|FG007|Overall Study|Objective progression or relapse|5|||
130921746|NCT00932126|471347601|FG000|Overall Study|Other|0|||
130921747|NCT00932126|471347602|FG001|Overall Study|Other|0|||
130921748|NCT00932126|471347603|FG002|Overall Study|Other|0|||
130921749|NCT00932126|471347604|FG003|Overall Study|Other|0|||
130921750|NCT00932126|471347605|FG004|Overall Study|Other|1|||
130921751|NCT00932126|471347606|FG005|Overall Study|Other|0|||
130921752|NCT00932126|471347607|FG006|Overall Study|Other|1|||
130921753|NCT00932126|471347608|FG007|Overall Study|Other|2|||
130921754|NCT02716805|471347609|FG000|Overall Study|Progressive disease|2|||
130921755|NCT02716805|471347610|FG001|Overall Study|Progressive disease|0|||
130921756|NCT02716805|471347611|FG002|Overall Study|Progressive disease|0|||
130921757|NCT02716805|471347612|FG003|Overall Study|Progressive disease|0|||
130921758|NCT00066365|471347613|FG000|Overall Study|Adverse Event|1|||
130921759|NCT00066365|471347614|FG001|Overall Study|Adverse Event|0|||
130921760|NCT00066365|471347613|FG000|Overall Study|Lack of Efficacy|15|||
130921761|NCT00066365|471347614|FG001|Overall Study|Lack of Efficacy|12|||
130921762|NCT00066365|471347613|FG000|Overall Study|Physician Decision|1|||
130921763|NCT00066365|471347614|FG001|Overall Study|Physician Decision|0|||
130921764|NCT00066365|471347613|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
130921765|NCT00066365|471347614|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
130921766|NCT00066365|471347613|FG000|Overall Study|Ineligible|4|||
130921767|NCT00066365|471347614|FG001|Overall Study|Ineligible|2|||
130921768|NCT00660673|471347616|FG000|Overall Study|Adverse Event|84|||
130921769|NCT00660673|471347616|FG000|Overall Study|Lack of Efficacy|7|||
130921770|NCT00660673|471347616|FG000|Overall Study|Withdrawal by Subject|22|||
130921771|NCT00660673|471347616|FG000|Overall Study|Administrative|2|||
130921772|NCT00660673|471347616|FG000|Overall Study|Protocol Violation|2|||
130921773|NCT00415168|471347620|FG000|Overall Study|Death|26|||
130921774|NCT00415168|471347620|FG000|Overall Study|Lost to Follow-up|3|||
130921775|NCT00415168|471347620|FG000|Overall Study|Physician Decision|13|||
130921776|NCT00415168|471347620|FG000|Overall Study|Sponsor Decision|4|||
130921777|NCT00415168|471347620|FG000|Overall Study|Withdrawal by Subject|6|||
130921778|NCT02925117|471347623|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
130921779|NCT02925117|471347624|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
130921780|NCT02925117|471347625|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
130921781|NCT02925117|471347626|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
130921782|NCT02925117|471347627|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130921783|NCT02925117|471347628|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130921784|NCT02925117|471347629|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130921785|NCT02925117|471347630|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130921786|NCT02925117|471347631|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130921787|NCT02925117|471347632|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130921788|NCT02925117|471347633|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130921789|NCT02925117|471347634|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
130921790|NCT02925117|471347623|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
130921791|NCT02925117|471347624|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
130921792|NCT02925117|471347625|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
130921793|NCT02925117|471347626|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130921794|NCT02925117|471347627|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130921795|NCT02925117|471347628|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130921796|NCT02925117|471347629|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130921797|NCT02925117|471347630|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130921798|NCT02925117|471347631|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130921799|NCT02925117|471347632|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130921800|NCT02925117|471347633|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130921801|NCT02925117|471347634|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
130769538|NCT03214679|470782479|FG001|Overall Study|not eligible|0|||
130921802|NCT02925117|471347623|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
130921803|NCT02925117|471347624|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
130921804|NCT02925117|471347625|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130921805|NCT02925117|471347626|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130921806|NCT02925117|471347627|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130921807|NCT02925117|471347628|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130921808|NCT02925117|471347629|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130921809|NCT02925117|471347630|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130921810|NCT02925117|471347631|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130921811|NCT02925117|471347632|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130921812|NCT02925117|471347633|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130921813|NCT02925117|471347634|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
130700257|NCT01190930|470526418|FG004|Induction|Incomplete Induction data|0|||
130700258|NCT01190930|470526419|FG005|Induction|Incomplete Induction data|0|||
130700259|NCT01190930|470526420|FG006|Induction|Incomplete Induction data|0|||
130700260|NCT01190930|470526421|FG007|Induction|Incomplete Induction data|0|||
130700261|NCT01190930|470526422|FG008|Induction|Incomplete Induction data|0|||
130700262|NCT01190930|470526423|FG009|Induction|Incomplete Induction data|0|||
130700263|NCT01190930|470526414|FG000|Induction|Progressive disease|0|||
130700264|NCT01190930|470526415|FG001|Induction|Progressive disease|1|||
130700265|NCT01190930|470526416|FG002|Induction|Progressive disease|0|||
130700266|NCT01190930|470526417|FG003|Induction|Progressive disease|0|||
130700267|NCT01190930|470526418|FG004|Induction|Progressive disease|0|||
130700268|NCT01190930|470526419|FG005|Induction|Progressive disease|0|||
130700269|NCT01190930|470526420|FG006|Induction|Progressive disease|0|||
130700270|NCT01190930|470526421|FG007|Induction|Progressive disease|0|||
130700271|NCT01190930|470526422|FG008|Induction|Progressive disease|0|||
130700272|NCT01190930|470526423|FG009|Induction|Progressive disease|0|||
130921814|NCT02925117|471347623|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
130921815|NCT02925117|471347624|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
130921816|NCT02925117|471347625|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
130921817|NCT02925117|471347626|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
130921818|NCT02925117|471347627|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
130921819|NCT02925117|471347628|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
130921820|NCT02925117|471347629|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
130921821|NCT02925117|471347630|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
130700273|NCT01190930|470526414|FG000|Induction|No treatment|3|||
130700274|NCT01190930|470526415|FG001|Induction|No treatment|0|||
130700275|NCT01190930|470526416|FG002|Induction|No treatment|0|||
130700276|NCT01190930|470526417|FG003|Induction|No treatment|0|||
130700277|NCT01190930|470526418|FG004|Induction|No treatment|0|||
130700278|NCT01190930|470526419|FG005|Induction|No treatment|0|||
130700279|NCT01190930|470526420|FG006|Induction|No treatment|0|||
130700280|NCT01190930|470526421|FG007|Induction|No treatment|0|||
130700281|NCT01190930|470526422|FG008|Induction|No treatment|0|||
130700282|NCT01190930|470526423|FG009|Induction|No treatment|0|||
130700283|NCT01190930|470526414|FG000|Induction|Ineligible|69|||
130700284|NCT01190930|470526415|FG001|Induction|Ineligible|4|||
130700285|NCT01190930|470526416|FG002|Induction|Ineligible|0|||
130700286|NCT01190930|470526417|FG003|Induction|Ineligible|0|||
130700287|NCT01190930|470526418|FG004|Induction|Ineligible|0|||
130700288|NCT01190930|470526419|FG005|Induction|Ineligible|0|||
130700289|NCT01190930|470526420|FG006|Induction|Ineligible|0|||
130700290|NCT01190930|470526421|FG007|Induction|Ineligible|0|||
130700291|NCT01190930|470526422|FG008|Induction|Ineligible|0|||
130700292|NCT01190930|470526423|FG009|Induction|Ineligible|0|||
130700293|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
130700294|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
130700295|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
130700296|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
130700297|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
130700298|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
130700299|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
130700300|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
130700301|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
130921822|NCT02925117|471347631|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
130921823|NCT02925117|471347632|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
130921824|NCT02925117|471347633|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
130921825|NCT02925117|471347634|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
130921826|NCT02925117|471347623|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
131034301|NCT02761057|471759171|FG000|Overall Study|Other - Not Protocol Specified|2|||
131034302|NCT02761057|471759172|FG001|Overall Study|Other - Not Protocol Specified|1|||
131034303|NCT02761057|471759173|FG002|Overall Study|Other - Not Protocol Specified|2|||
131034304|NCT02761057|471759174|FG003|Overall Study|Other - Not Protocol Specified|0|||
131034305|NCT04209465|471759175|FG000|Overall Study|Adverse Event|0|||
130700302|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
130700303|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Death|0|||
130700304|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Death|0|||
130700305|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Death|8|||
130700306|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Death|4|||
130700307|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Death|0|||
130700308|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Death|0|||
130700309|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Death|0|||
130700310|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Death|0|||
130700311|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Death|0|||
130700312|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Death|0|||
130700313|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
130700314|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
130700315|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
130700316|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
131034306|NCT04209465|471759176|FG001|Overall Study|Adverse Event|0|||
130921827|NCT02925117|471347624|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130921828|NCT02925117|471347625|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130921829|NCT02925117|471347626|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130921830|NCT02925117|471347627|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130921831|NCT02925117|471347628|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
130921832|NCT02925117|471347629|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130921833|NCT02925117|471347630|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130921834|NCT02925117|471347631|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130921835|NCT02925117|471347632|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
130921836|NCT02925117|471347633|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
130921837|NCT02925117|471347634|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
130921838|NCT02925117|471347623|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
130921839|NCT02925117|471347624|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
130921840|NCT02925117|471347625|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
130921841|NCT02925117|471347626|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
130921842|NCT02925117|471347627|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
130921843|NCT02925117|471347628|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
130921844|NCT02925117|471347629|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
130921845|NCT02925117|471347630|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
130921846|NCT02925117|471347631|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
130921847|NCT02925117|471347632|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
130921848|NCT02925117|471347633|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
130921849|NCT02925117|471347634|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
130921850|NCT02925117|471347623|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130921851|NCT02925117|471347624|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130921852|NCT02925117|471347625|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130921853|NCT02925117|471347626|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130921854|NCT02925117|471347627|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
130921855|NCT02925117|471347628|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
130921856|NCT02925117|471347629|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
130921857|NCT02925117|471347630|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
130921858|NCT02925117|471347631|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
130921859|NCT02925117|471347632|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130921860|NCT02925117|471347633|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
130921861|NCT02925117|471347634|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
130921862|NCT02925117|471347623|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
130921863|NCT02925117|471347624|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
130921864|NCT02925117|471347625|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
130921865|NCT02925117|471347626|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
130921866|NCT02925117|471347627|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
130921867|NCT02925117|471347628|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
130921868|NCT02925117|471347629|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
130921869|NCT02925117|471347630|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
130921870|NCT02925117|471347631|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
130921871|NCT02925117|471347632|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
130921872|NCT02925117|471347633|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
130921873|NCT02925117|471347634|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
130921874|NCT02187744|471347639|FG000|Study|Participant refused further follow-up|1|||
130921875|NCT02187744|471347640|FG001|Study|Participant refused further follow-up|0|||
130921876|NCT02187744|471347639|FG000|Study|Other|2|||
130921877|NCT02187744|471347640|FG001|Study|Other|1|||
130921878|NCT02187744|471347639|FG000|Study|Lost to Follow-up|0|||
130921879|NCT02187744|471347640|FG001|Study|Lost to Follow-up|2|||
130921880|NCT02187744|471347639|FG000|Study|Related adverse event, not serious|0|||
130921881|NCT02187744|471347640|FG001|Study|Related adverse event, not serious|2|||
130921882|NCT02187744|471347639|FG000|Study|Death|1|||
130921883|NCT02187744|471347640|FG001|Study|Death|0|||
130921884|NCT02187744|471347639|FG000|Study|Related adverse event, serious non-fatal|0|||
131034307|NCT04209465|471759177|FG002|Overall Study|Adverse Event|0|||
131034308|NCT04209465|471759178|FG003|Overall Study|Adverse Event|0|||
131034309|NCT04209465|471759179|FG004|Overall Study|Adverse Event|0|||
131034310|NCT04209465|471759180|FG005|Overall Study|Adverse Event|1|||
131034311|NCT04209465|471759181|FG006|Overall Study|Adverse Event|0|||
131034312|NCT04209465|471759182|FG007|Overall Study|Adverse Event|0|||
131034313|NCT04209465|471759183|FG008|Overall Study|Adverse Event|1|||
130921885|NCT02187744|471347640|FG001|Study|Related adverse event, serious non-fatal|1|||
130921886|NCT02187744|471347639|FG000|Treatment|Death|1|||
130921887|NCT02187744|471347640|FG001|Treatment|Death|0|||
130921888|NCT02187744|471347639|FG000|Treatment|Related adverse event, serious non-fatal|0|||
130921889|NCT02187744|471347640|FG001|Treatment|Related adverse event, serious non-fatal|1|||
130921890|NCT02187744|471347639|FG000|Treatment|Related adverse event, not serious|0|||
130921891|NCT02187744|471347640|FG001|Treatment|Related adverse event, not serious|2|||
130921892|NCT02187744|471347639|FG000|Treatment|Lost to Follow-up|0|||
130921893|NCT02187744|471347640|FG001|Treatment|Lost to Follow-up|1|||
131034314|NCT04209465|471759184|FG009|Overall Study|Adverse Event|0|||
131034315|NCT04209465|471759185|FG010|Overall Study|Adverse Event|2|||
131223162|NCT02773446|472445023|FG005|First Admission|Lost to Follow-up|0|||
131223163|NCT04378010|472445024|FG000|Overall Study|Adverse Event|8|||
131223164|NCT04378010|472445025|FG001|Overall Study|Adverse Event|14|||
131223165|NCT04378010|472445026|FG002|Overall Study|Adverse Event|4|||
131223166|NCT04378010|472445024|FG000|Overall Study|Withdrawal by Subject|0|||
131223167|NCT04378010|472445025|FG001|Overall Study|Withdrawal by Subject|2|||
131223168|NCT04378010|472445026|FG002|Overall Study|Withdrawal by Subject|1|||
131223169|NCT04378010|472445024|FG000|Overall Study|Protocol Violation|2|||
131223170|NCT04378010|472445025|FG001|Overall Study|Protocol Violation|1|||
131223171|NCT04378010|472445026|FG002|Overall Study|Protocol Violation|4|||
131223172|NCT04378010|472445024|FG000|Overall Study|Study terminated by Sponsor|22|||
131223173|NCT04378010|472445025|FG001|Overall Study|Study terminated by Sponsor|16|||
131223174|NCT04378010|472445026|FG002|Overall Study|Study terminated by Sponsor|22|||
131223175|NCT04378010|472445024|FG000|Overall Study|Subject inability to complete study visit|0|||
131223176|NCT04378010|472445025|FG001|Overall Study|Subject inability to complete study visit|0|||
131223177|NCT04378010|472445026|FG002|Overall Study|Subject inability to complete study visit|1|||
131223178|NCT04378010|472445024|FG000|Overall Study|Subject never dosed|0|||
131223179|NCT04378010|472445025|FG001|Overall Study|Subject never dosed|1|||
131223180|NCT04378010|472445026|FG002|Overall Study|Subject never dosed|0|||
131223181|NCT03237611|472445027|FG000|Overall Study|Withdrawal by Subject|1|||
131223182|NCT03237611|472445027|FG000|Overall Study|Ineligible|1|||
131223183|NCT04023994|472445028|FG000|Overall Study|Lost to Follow-up|0|||
131223184|NCT04023994|472445029|FG001|Overall Study|Lost to Follow-up|1|||
131223185|NCT04023994|472445030|FG002|Overall Study|Lost to Follow-up|2|||
131223186|NCT04023994|472445031|FG003|Overall Study|Lost to Follow-up|0|||
131223187|NCT04023994|472445032|FG004|Overall Study|Lost to Follow-up|0|||
131223188|NCT04023994|472445033|FG005|Overall Study|Lost to Follow-up|0|||
131223189|NCT04023994|472445028|FG000|Overall Study|Withdrawal by Subject|0|||
131223190|NCT04023994|472445029|FG001|Overall Study|Withdrawal by Subject|0|||
131223191|NCT04023994|472445030|FG002|Overall Study|Withdrawal by Subject|0|||
131223192|NCT04023994|472445031|FG003|Overall Study|Withdrawal by Subject|1|||
131223193|NCT04023994|472445032|FG004|Overall Study|Withdrawal by Subject|0|||
131223194|NCT04023994|472445033|FG005|Overall Study|Withdrawal by Subject|0|||
131223195|NCT00923195|472445034|FG000|Overall Study|Death|0|||
131223196|NCT00923195|472445035|FG001|Overall Study|Death|1|||
131223197|NCT01613131|472445036|FG000|Overall Study|Withdrawal by Subject|3|||
131223198|NCT01613131|472445037|FG001|Overall Study|Withdrawal by Subject|5|||
131223199|NCT00787566|472445038|FG000|Overall Study|AE related to chemotherapy|0|||
131223200|NCT00787566|472445039|FG001|Overall Study|AE related to chemotherapy|1|||
131223201|NCT00787566|472445040|FG002|Overall Study|AE related to chemotherapy|0|||
131223202|NCT01814761|472445041|FG000|Overall Study|Other Reasons|1|||
131223203|NCT01814761|472445042|FG001|Overall Study|Other Reasons|10|||
131223204|NCT01814761|472445041|FG000|Overall Study|Ocular Adverse Event|6|||
131223205|NCT01814761|472445042|FG001|Overall Study|Ocular Adverse Event|15|||
131223206|NCT01814761|472445041|FG000|Overall Study|Lost to Follow-up|1|||
131223207|NCT01814761|472445042|FG001|Overall Study|Lost to Follow-up|5|||
131223208|NCT01169987|472445045|FG000|Overall Study|Withdrawal by Subject|3|||
131223209|NCT01169987|472445045|FG000|Overall Study|Lost to Follow-up|24|||
131223210|NCT01169987|472445045|FG000|Overall Study|Other|4|||
131223211|NCT01896700|472445046|FG000|Overall Study|Adverse Event|4|||
131223212|NCT01896700|472445047|FG001|Overall Study|Adverse Event|5|||
131223213|NCT01896700|472445046|FG000|Overall Study|Withdrawal by Subject|0|||
131223214|NCT01896700|472445047|FG001|Overall Study|Withdrawal by Subject|1|||
131223215|NCT00423488|472445048|FG000|Overall Study|No evidence of study drug intake|2|||
131223216|NCT00423488|472445049|FG001|Overall Study|No evidence of study drug intake|1|||
131223217|NCT00423488|472445048|FG000|Overall Study|No post baseline data|3|||
131223218|NCT00423488|472445049|FG001|Overall Study|No post baseline data|0|||
131223219|NCT00886782|472445052|FG000|Overall Study|Disease progression|3|||
131223220|NCT00886782|472445053|FG001|Overall Study|Disease progression|3|||
131223221|NCT00886782|472445054|FG002|Overall Study|Disease progression|3|||
130921894|NCT02187744|471347639|FG000|Treatment|Other|2|||
130921895|NCT02187744|471347640|FG001|Treatment|Other|0|||
131223222|NCT00886782|472445052|FG000|Overall Study|Study drug toxicity|0|||
131223223|NCT00886782|472445053|FG001|Overall Study|Study drug toxicity|0|||
131223224|NCT00886782|472445054|FG002|Overall Study|Study drug toxicity|1|||
130921896|NCT02187744|471347639|FG000|Treatment|Participant refused continued treatment|1|||
130921897|NCT02187744|471347640|FG001|Treatment|Participant refused continued treatment|1|||
131223225|NCT00886782|472445052|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
131223226|NCT00886782|472445053|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
131223227|NCT00886782|472445054|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
131223228|NCT03118765|472445055|FG000|Overall Study|Withdrawal by Subject|0|||
131223229|NCT03118765|472445056|FG001|Overall Study|Withdrawal by Subject|0|||
131223230|NCT03118765|472445057|FG002|Overall Study|Withdrawal by Subject|1|||
131223231|NCT03118765|472445058|FG003|Overall Study|Withdrawal by Subject|0|||
131223232|NCT03118765|472445059|FG004|Overall Study|Withdrawal by Subject|0|||
131223233|NCT03118765|472445055|FG000|Overall Study|Adverse Event|1|||
131223234|NCT03118765|472445056|FG001|Overall Study|Adverse Event|1|||
130700317|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
130700318|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
130921898|NCT01972568|471347641|FG000|Overall Study|Other events|3|||
130921899|NCT01972568|471347642|FG001|Overall Study|Other events|0|||
130921900|NCT01972568|471347643|FG002|Overall Study|Other events|0|||
130921901|NCT01972568|471347641|FG000|Overall Study|Lack of Efficacy|0|||
130921902|NCT01972568|471347642|FG001|Overall Study|Lack of Efficacy|1|||
130921903|NCT01972568|471347643|FG002|Overall Study|Lack of Efficacy|2|||
131223235|NCT03118765|472445057|FG002|Overall Study|Adverse Event|1|||
131223236|NCT03118765|472445058|FG003|Overall Study|Adverse Event|1|||
131223237|NCT03118765|472445059|FG004|Overall Study|Adverse Event|1|||
131223238|NCT03118765|472445055|FG000|Overall Study|Non compliance with Study Procedures|0|||
131223239|NCT03118765|472445056|FG001|Overall Study|Non compliance with Study Procedures|0|||
131223240|NCT03118765|472445057|FG002|Overall Study|Non compliance with Study Procedures|0|||
131223241|NCT03118765|472445058|FG003|Overall Study|Non compliance with Study Procedures|1|||
131223242|NCT03118765|472445059|FG004|Overall Study|Non compliance with Study Procedures|0|||
131223243|NCT03118765|472445055|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
131223244|NCT03118765|472445056|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
131223245|NCT03118765|472445057|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
131223246|NCT03118765|472445058|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
131223247|NCT03118765|472445059|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
131223248|NCT03118765|472445055|FG000|Overall Study|COPD Exacerbation|1|||
131223249|NCT03118765|472445056|FG001|Overall Study|COPD Exacerbation|0|||
131223250|NCT03118765|472445057|FG002|Overall Study|COPD Exacerbation|0|||
131223251|NCT03118765|472445058|FG003|Overall Study|COPD Exacerbation|1|||
131223252|NCT03118765|472445059|FG004|Overall Study|COPD Exacerbation|0|||
131223253|NCT03118765|472445055|FG000|Overall Study|Lost to Follow-up|1|||
131223254|NCT03118765|472445056|FG001|Overall Study|Lost to Follow-up|0|||
131223255|NCT03118765|472445057|FG002|Overall Study|Lost to Follow-up|1|||
131223256|NCT03118765|472445058|FG003|Overall Study|Lost to Follow-up|0|||
131223257|NCT03118765|472445059|FG004|Overall Study|Lost to Follow-up|0|||
131223258|NCT03118765|472445055|FG000|Overall Study|Sponsor Decision|1|||
131223259|NCT03118765|472445056|FG001|Overall Study|Sponsor Decision|0|||
131223260|NCT03118765|472445057|FG002|Overall Study|Sponsor Decision|1|||
131223261|NCT03118765|472445058|FG003|Overall Study|Sponsor Decision|0|||
131223262|NCT03118765|472445059|FG004|Overall Study|Sponsor Decision|1|||
131223263|NCT00879970|472445060|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
131223264|NCT00879970|472445061|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
131223265|NCT00879970|472445062|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
131223266|NCT00879970|472445063|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
131223267|NCT00879970|472445064|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
131223268|NCT00879970|472445060|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
131223269|NCT00879970|472445061|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
131223270|NCT00879970|472445062|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
131223271|NCT00879970|472445063|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
131223272|NCT00879970|472445064|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
131223273|NCT00879970|472445060|FG000|Period 1 TZD Randomization|Death|2|||
131223274|NCT00879970|472445061|FG001|Period 1 TZD Randomization|Death|1|||
131223275|NCT00879970|472445062|FG002|Period 1 TZD Randomization|Death|0|||
131223276|NCT00879970|472445063|FG003|Period 1 TZD Randomization|Death|0|||
131223277|NCT00879970|472445064|FG004|Period 1 TZD Randomization|Death|0|||
130700319|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
130700320|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
130700321|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
130700322|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
130700323|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700324|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
130700325|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
130700326|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
130921904|NCT01972568|471347641|FG000|Overall Study|Protocol Violation|1|||
130921905|NCT01972568|471347642|FG001|Overall Study|Protocol Violation|2|||
130921906|NCT01972568|471347643|FG002|Overall Study|Protocol Violation|2|||
130921907|NCT01972568|471347641|FG000|Overall Study|Withdrawal by Subject|6|||
130921908|NCT01972568|471347642|FG001|Overall Study|Withdrawal by Subject|3|||
130921909|NCT01972568|471347643|FG002|Overall Study|Withdrawal by Subject|7|||
131034316|NCT04209465|471759186|FG011|Overall Study|Adverse Event|1|||
131223278|NCT00879970|472445060|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
131223279|NCT00879970|472445061|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
131223280|NCT00879970|472445062|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
131223281|NCT00879970|472445063|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
131223282|NCT00879970|472445064|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
131223283|NCT00879970|472445060|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
130921910|NCT01972568|471347641|FG000|Overall Study|Lost to Follow-up|1|||
130921911|NCT01972568|471347642|FG001|Overall Study|Lost to Follow-up|0|||
130921912|NCT01972568|471347643|FG002|Overall Study|Lost to Follow-up|0|||
130921913|NCT01972568|471347641|FG000|Overall Study|Adverse Event|5|||
130921914|NCT01972568|471347642|FG001|Overall Study|Adverse Event|6|||
130921915|NCT01972568|471347643|FG002|Overall Study|Adverse Event|5|||
130921916|NCT02572401|471347646|FG000|Overall Study|Lost to Follow-up|5|||
130921917|NCT02572401|471347647|FG001|Overall Study|Lost to Follow-up|8|||
130921918|NCT02572401|471347648|FG002|Overall Study|Lost to Follow-up|9|||
130921919|NCT02572401|471347649|FG003|Overall Study|Lost to Follow-up|9|||
130921920|NCT02572401|471347646|FG000|Overall Study|Death|0|||
130921921|NCT02572401|471347647|FG001|Overall Study|Death|0|||
130921922|NCT02572401|471347648|FG002|Overall Study|Death|0|||
130921923|NCT02572401|471347649|FG003|Overall Study|Death|1|||
130921924|NCT00306189|471347650|FG000|Overall Study|Physician Decision|0|||
130921925|NCT00306189|471347651|FG001|Overall Study|Physician Decision|0|||
130921926|NCT00306189|471347652|FG002|Overall Study|Physician Decision|0|||
130921927|NCT00306189|471347653|FG003|Overall Study|Physician Decision|1|||
130921928|NCT00306189|471347650|FG000|Overall Study|Adverse Event|3|||
130921929|NCT00306189|471347651|FG001|Overall Study|Adverse Event|3|||
130921930|NCT00306189|471347652|FG002|Overall Study|Adverse Event|2|||
130921931|NCT00306189|471347653|FG003|Overall Study|Adverse Event|2|||
130921932|NCT00306189|471347650|FG000|Overall Study|Withdrawal by Subject|4|||
130921933|NCT00306189|471347651|FG001|Overall Study|Withdrawal by Subject|2|||
130700327|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700328|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700329|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700330|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700331|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700332|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130700333|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Refusal|0|||
130921934|NCT00306189|471347652|FG002|Overall Study|Withdrawal by Subject|8|||
130921935|NCT00306189|471347653|FG003|Overall Study|Withdrawal by Subject|1|||
130921936|NCT00306189|471347650|FG000|Overall Study|Ineligibility determined|1|||
130921937|NCT00306189|471347651|FG001|Overall Study|Ineligibility determined|1|||
130921938|NCT00306189|471347652|FG002|Overall Study|Ineligibility determined|1|||
130921939|NCT00306189|471347653|FG003|Overall Study|Ineligibility determined|1|||
130921940|NCT00306189|471347650|FG000|Overall Study|Other|1|||
130921941|NCT00306189|471347651|FG001|Overall Study|Other|0|||
130921942|NCT00306189|471347652|FG002|Overall Study|Other|0|||
130921943|NCT00306189|471347653|FG003|Overall Study|Other|0|||
130921944|NCT02059408|471347654|FG000|Overall Study|Did not get tested|0|||
130921945|NCT02059408|471347655|FG001|Overall Study|Did not get tested|330|||
130921946|NCT02059408|471347656|FG002|Overall Study|Did not get tested|358|||
130921947|NCT02993757|471347657|FG000|Overall Study|Non compliance with the protocol|155|||
130921948|NCT02993757|471347658|FG001|Overall Study|Non compliance with the protocol|170|||
130921949|NCT02993757|471347657|FG000|Overall Study|Lost to Follow-up|1|||
130921950|NCT02993757|471347658|FG001|Overall Study|Lost to Follow-up|0|||
130921951|NCT02993757|471347657|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
130921952|NCT02993757|471347658|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
130921953|NCT00957580|471347661|FG000|Overall Study|Ongoing at data cut-off|0|||
130921954|NCT00957580|471347662|FG001|Overall Study|Ongoing at data cut-off|1|||
130921955|NCT00957580|471347663|FG002|Overall Study|Ongoing at data cut-off|0|||
130921956|NCT00957580|471347661|FG000|Overall Study|Enrolled but not treated|0|||
130921957|NCT00957580|471347662|FG001|Overall Study|Enrolled but not treated|1|||
130921958|NCT00957580|471347663|FG002|Overall Study|Enrolled but not treated|0|||
130921959|NCT01090492|471347664|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
130921960|NCT01090492|471347665|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
130921961|NCT01090492|471347666|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
130700334|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Refusal|2|||
130700335|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Refusal|694|||
130921962|NCT01090492|471347667|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
130921963|NCT01090492|471347668|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
130921964|NCT01090492|471347669|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
130921965|NCT01090492|471347670|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
130921966|NCT01090492|471347671|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
130921967|NCT01090492|471347664|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130921968|NCT01090492|471347665|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
130921969|NCT01090492|471347666|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130921970|NCT01090492|471347667|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130700336|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Refusal|4|||
130921971|NCT01090492|471347668|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130921972|NCT01090492|471347669|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130700337|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Refusal|0|||
130921973|NCT01090492|471347670|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
130921974|NCT01090492|471347671|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
130921975|NCT01090492|471347664|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130921976|NCT01090492|471347665|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130921977|NCT01090492|471347666|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
130921978|NCT01090492|471347667|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130921979|NCT01090492|471347668|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130921980|NCT01090492|471347669|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130921981|NCT01090492|471347670|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130921982|NCT01090492|471347671|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130921983|NCT01090492|471347664|FG000|First Intervention Period (4 Weeks)|Other|0|||
130921984|NCT01090492|471347665|FG001|First Intervention Period (4 Weeks)|Other|0|||
130921985|NCT01090492|471347666|FG002|First Intervention Period (4 Weeks)|Other|1|||
130921986|NCT01090492|471347667|FG003|First Intervention Period (4 Weeks)|Other|1|||
130921987|NCT01090492|471347668|FG004|First Intervention Period (4 Weeks)|Other|2|||
130921988|NCT01090492|471347669|FG005|First Intervention Period (4 Weeks)|Other|0|||
130921989|NCT01090492|471347670|FG006|First Intervention Period (4 Weeks)|Other|0|||
130921990|NCT01090492|471347671|FG007|First Intervention Period (4 Weeks)|Other|0|||
130921991|NCT01090492|471347664|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
130921992|NCT01090492|471347665|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
130921993|NCT01090492|471347666|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
130921994|NCT01090492|471347667|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
130921995|NCT01090492|471347668|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
130921996|NCT01090492|471347669|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
130921997|NCT01090492|471347670|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
130921998|NCT01090492|471347671|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
130921999|NCT01090492|471347664|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
130922000|NCT01090492|471347665|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
130922001|NCT01090492|471347666|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
130922002|NCT01090492|471347667|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
130922003|NCT01090492|471347668|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
130922004|NCT01090492|471347669|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
130922005|NCT01090492|471347670|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
130922006|NCT01090492|471347671|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
130922007|NCT01090492|471347664|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
130922008|NCT01090492|471347665|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
130922009|NCT01090492|471347666|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
130922010|NCT01090492|471347667|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
130922011|NCT01090492|471347668|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
130922012|NCT01090492|471347669|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
130922013|NCT01090492|471347670|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
130922014|NCT01090492|471347671|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
130922015|NCT01090492|471347664|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130922016|NCT01090492|471347665|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
130922017|NCT01090492|471347666|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130922018|NCT01090492|471347667|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130922019|NCT01090492|471347668|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130922020|NCT01090492|471347669|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130922021|NCT01090492|471347670|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130922022|NCT01090492|471347671|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
130922023|NCT01090492|471347664|FG000|Second Intervention Period (4 Weeks)|Other|0|||
130922024|NCT01090492|471347665|FG001|Second Intervention Period (4 Weeks)|Other|1|||
130922025|NCT01090492|471347666|FG002|Second Intervention Period (4 Weeks)|Other|1|||
130922026|NCT01090492|471347667|FG003|Second Intervention Period (4 Weeks)|Other|0|||
130922027|NCT01090492|471347668|FG004|Second Intervention Period (4 Weeks)|Other|0|||
130922028|NCT01090492|471347669|FG005|Second Intervention Period (4 Weeks)|Other|0|||
130922029|NCT01090492|471347670|FG006|Second Intervention Period (4 Weeks)|Other|0|||
130922030|NCT01090492|471347671|FG007|Second Intervention Period (4 Weeks)|Other|0|||
130922031|NCT01090492|471347664|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
130922032|NCT01090492|471347665|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
130922033|NCT01090492|471347666|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
130922034|NCT01090492|471347667|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
130922035|NCT01090492|471347668|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
130922036|NCT01090492|471347669|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
130922037|NCT01090492|471347670|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
130922038|NCT01090492|471347671|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
130922039|NCT01090492|471347664|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130922040|NCT01090492|471347665|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
131223284|NCT00879970|472445061|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
131223285|NCT00879970|472445062|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
131223286|NCT00879970|472445063|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
131223287|NCT00879970|472445064|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
131223288|NCT00879970|472445060|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
131223289|NCT00879970|472445061|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
131223290|NCT00879970|472445062|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
131223291|NCT00879970|472445063|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
131223292|NCT00879970|472445064|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
131223293|NCT00879970|472445060|FG000|Period 2 Vitamin D Randomization|Death|0|||
131223294|NCT00879970|472445061|FG001|Period 2 Vitamin D Randomization|Death|0|||
131223295|NCT00879970|472445062|FG002|Period 2 Vitamin D Randomization|Death|0|||
131223296|NCT00879970|472445063|FG003|Period 2 Vitamin D Randomization|Death|2|||
131223297|NCT00879970|472445064|FG004|Period 2 Vitamin D Randomization|Death|0|||
131223298|NCT01749033|472445067|FG000|Overall Study|Did not receive allocated intervention|3|||
131223299|NCT01749033|472445068|FG001|Overall Study|Did not receive allocated intervention|3|||
131223300|NCT01749033|472445069|FG002|Overall Study|Did not receive allocated intervention|0|||
131223301|NCT01749033|472445067|FG000|Overall Study|Lost to Follow-up|0|||
131223302|NCT01749033|472445068|FG001|Overall Study|Lost to Follow-up|2|||
131223303|NCT01749033|472445069|FG002|Overall Study|Lost to Follow-up|1|||
131223304|NCT00068237|472445070|FG000|Overall Study|Ineligible|3|||
131223305|NCT00068237|472445070|FG000|Overall Study|No protocol treatment received|2|||
131223306|NCT00363129|472445071|FG000|Overall Study|Withdrawal by Subject|11|||
130922041|NCT01090492|471347666|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130922042|NCT01090492|471347667|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130922043|NCT01090492|471347668|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130922044|NCT01090492|471347669|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130922045|NCT01090492|471347670|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
130922046|NCT01090492|471347671|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
130922047|NCT01681472|471347672|FG000|Overall Study|Adverse Event|0|||
130922048|NCT01681472|471347673|FG001|Overall Study|Adverse Event|1|||
130922049|NCT01681472|471347674|FG002|Overall Study|Adverse Event|0|||
130922050|NCT01681472|471347675|FG003|Overall Study|Adverse Event|0|||
130922051|NCT01999179|471347686|FG000|Overall Study|Adverse Event|1|||
130922052|NCT01999179|471347686|FG000|Overall Study|Lost to Follow-up|1|||
130922053|NCT01999179|471347686|FG000|Overall Study|Change in Therapy|3|||
130922054|NCT01999179|471347686|FG000|Overall Study|New catheter|2|||
130922055|NCT03128411|471347690|FG000|Treatment Phase|Adverse Event|21|||
130922056|NCT03128411|471347690|FG000|Treatment Phase|Physician Decision|1|||
130922057|NCT03128411|471347690|FG000|Treatment Phase|Other|2|||
130922058|NCT03128411|471347690|FG000|Long Term Follow-up Phase|Death|2|||
130922059|NCT02900976|471347695|FG000|Overall Study|Adverse Event|0|||
130922060|NCT02900976|471347696|FG001|Overall Study|Adverse Event|1|||
130922061|NCT02900976|471347695|FG000|Overall Study|Physician Decision|0|||
130922062|NCT02900976|471347696|FG001|Overall Study|Physician Decision|2|||
130922063|NCT02900976|471347695|FG000|Overall Study|Progressive disease|0|||
130922064|NCT02900976|471347696|FG001|Overall Study|Progressive disease|6|||
130922065|NCT06934993|471347697|FG000|Overall Study|Withdrawal by Subject|29|||
130922066|NCT06934993|471347697|FG000|Overall Study|elevated postoperative creatinine level|11|||
130922067|NCT06934993|471347697|FG000|Overall Study|Death|3|||
130922068|NCT01995825|471349092|FG000|Overall Study|Withdrawal by Subject|1|||
130922069|NCT01995825|471349093|FG001|Overall Study|Withdrawal by Subject|0|||
130922070|NCT00403234|471349096|FG000|Overall Study|Withdrawal by Subject|0|||
130922071|NCT00403234|471349097|FG001|Overall Study|Withdrawal by Subject|1|||
130922072|NCT00403234|471349098|FG002|Overall Study|Withdrawal by Subject|0|||
130922073|NCT00403234|471349099|FG003|Overall Study|Withdrawal by Subject|0|||
130922074|NCT00403234|471349096|FG000|Overall Study|Adverse Event|1|||
130922075|NCT00403234|471349097|FG001|Overall Study|Adverse Event|0|||
130922076|NCT00403234|471349098|FG002|Overall Study|Adverse Event|1|||
130922077|NCT00403234|471349099|FG003|Overall Study|Adverse Event|0|||
130922078|NCT00739674|471349106|FG000|Overall Study|Screening failures|19|||
130922079|NCT00739674|471349107|FG001|Overall Study|Screening failures|17|||
130922080|NCT00739674|471349106|FG000|Overall Study|Site 212 removal|19|||
130922081|NCT00739674|471349107|FG001|Overall Study|Site 212 removal|13|||
130922082|NCT00739674|471349106|FG000|Overall Study|No follow-up data|33|||
130922083|NCT00739674|471349107|FG001|Overall Study|No follow-up data|18|||
130922084|NCT00739674|471349106|FG000|Overall Study|Dietician consultation >30 days|1|||
130922085|NCT00739674|471349107|FG001|Overall Study|Dietician consultation >30 days|9|||
130922086|NCT00739674|471349106|FG000|Overall Study|Adverse Event|22|||
130922087|NCT00739674|471349107|FG001|Overall Study|Adverse Event|13|||
130922088|NCT00739674|471349106|FG000|Overall Study|Death|1|||
130922089|NCT00739674|471349107|FG001|Overall Study|Death|0|||
131223307|NCT00363129|472445072|FG001|Overall Study|Withdrawal by Subject|18|||
131223308|NCT00363129|472445071|FG000|Overall Study|Adverse Event|8|||
131223309|NCT00363129|472445072|FG001|Overall Study|Adverse Event|3|||
130922090|NCT00739674|471349106|FG000|Overall Study|Lack of Efficacy|1|||
130922091|NCT00739674|471349107|FG001|Overall Study|Lack of Efficacy|0|||
130922092|NCT00739674|471349106|FG000|Overall Study|Lost to Follow-up|52|||
130922093|NCT00739674|471349107|FG001|Overall Study|Lost to Follow-up|30|||
130922094|NCT00739674|471349106|FG000|Overall Study|Protocol Violation|5|||
130922095|NCT00739674|471349107|FG001|Overall Study|Protocol Violation|5|||
130922096|NCT00739674|471349106|FG000|Overall Study|Withdrawal by Subject|9|||
130922097|NCT00739674|471349107|FG001|Overall Study|Withdrawal by Subject|9|||
130922098|NCT00739674|471349106|FG000|Overall Study|Reason missing|2|||
130922099|NCT00739674|471349107|FG001|Overall Study|Reason missing|0|||
130922100|NCT00739674|471349106|FG000|Overall Study|Clinic closed|6|||
130922101|NCT00739674|471349107|FG001|Overall Study|Clinic closed|4|||
130922102|NCT00739674|471349106|FG000|Overall Study|Patient moved|3|||
130922103|NCT00739674|471349107|FG001|Overall Study|Patient moved|2|||
130922104|NCT00739674|471349106|FG000|Overall Study|Non compliant|4|||
130922105|NCT00739674|471349107|FG001|Overall Study|Non compliant|0|||
130922106|NCT00739674|471349106|FG000|Overall Study|Unable to attend visit|3|||
130922107|NCT00739674|471349107|FG001|Overall Study|Unable to attend visit|1|||
130922108|NCT00739674|471349106|FG000|Overall Study|Home monitoring off meds|1|||
130922109|NCT00739674|471349107|FG001|Overall Study|Home monitoring off meds|0|||
130769539|NCT01754766|470782485|FG000|Overall Study|Personal reasons|1|||
130769540|NCT01754766|470782486|FG001|Overall Study|Personal reasons|1|||
130769541|NCT01754766|470782487|FG002|Overall Study|Personal reasons|0|||
130769542|NCT01709409|470782490|FG000|Overall Study|Protocol Violation|1|||
130769543|NCT01709409|470782491|FG001|Overall Study|Protocol Violation|0|||
130769544|NCT02412878|470782492|FG000|Overall Study|Withdrawal by Subject|19|||
130769545|NCT02412878|470782493|FG001|Overall Study|Withdrawal by Subject|10|||
130769546|NCT02412878|470782492|FG000|Overall Study|Lost to Follow-up|2|||
130769547|NCT02412878|470782493|FG001|Overall Study|Lost to Follow-up|3|||
130769548|NCT04571385|470782494|FG000|Overall Study|Participant non-compliance|1|||
130769549|NCT04571385|470782495|FG001|Overall Study|Participant non-compliance|0|||
130769550|NCT04571385|470782496|FG002|Overall Study|Participant non-compliance|0|||
130769551|NCT04571385|470782494|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
130769552|NCT04571385|470782495|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
130769553|NCT04571385|470782496|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
130769554|NCT04571385|470782494|FG000|Overall Study|Screen failure|0|||
130769555|NCT04571385|470782495|FG001|Overall Study|Screen failure|0|||
130769556|NCT04571385|470782496|FG002|Overall Study|Screen failure|1|||
130769557|NCT02263729|470782497|FG000|Overall Study|Lost to Follow-up|1|||
130769558|NCT02263729|470782498|FG001|Overall Study|Lost to Follow-up|1|||
130769559|NCT01212159|470782499|FG000|Overall Study|Withdrawal by Subject|12|||
130769560|NCT01212159|470782500|FG001|Overall Study|Withdrawal by Subject|12|||
130769561|NCT01306214|470782501|FG000|Overall Study|Death|0|||
130769562|NCT01306214|470782502|FG001|Overall Study|Death|0|||
130769563|NCT01306214|470782503|FG002|Overall Study|Death|1|||
130769564|NCT01306214|470782501|FG000|Overall Study|Lost to Follow-up|3|||
130769565|NCT01306214|470782502|FG001|Overall Study|Lost to Follow-up|5|||
130769566|NCT01306214|470782503|FG002|Overall Study|Lost to Follow-up|4|||
130769567|NCT01306214|470782501|FG000|Overall Study|Withdrawal by Subject|24|||
130769568|NCT01306214|470782502|FG001|Overall Study|Withdrawal by Subject|22|||
130769569|NCT01306214|470782503|FG002|Overall Study|Withdrawal by Subject|16|||
130769570|NCT01306214|470782501|FG000|Overall Study|Not treated|1|||
130769571|NCT01306214|470782502|FG001|Overall Study|Not treated|1|||
130769572|NCT01306214|470782503|FG002|Overall Study|Not treated|1|||
130769573|NCT01026818|470782504|FG000|Screening Period|Entry Criteria Not Met|105|||
130769574|NCT01026818|470782505|FG001|Screening Period|Entry Criteria Not Met|0|||
130769575|NCT01026818|470782506|FG002|Screening Period|Entry Criteria Not Met|0|||
130769576|NCT01026818|470782507|FG003|Screening Period|Entry Criteria Not Met|0|||
130769577|NCT01026818|470782504|FG000|Screening Period|Withdrawal by Subject|49|||
130922110|NCT00739674|471349106|FG000|Overall Study|Erectile dysfunction|0|||
130922111|NCT00739674|471349107|FG001|Overall Study|Erectile dysfunction|1|||
130922112|NCT01594281|471349108|FG000|Interventional Core Phase|Protocol Deviation|1|||
130922113|NCT01594281|471349109|FG001|Interventional Core Phase|Protocol Deviation|0|||
130922114|NCT01594281|471349110|FG002|Interventional Core Phase|Protocol Deviation|0|||
130922115|NCT01594281|471349108|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
130922116|NCT01594281|471349109|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
130922117|NCT01594281|471349110|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
130922118|NCT01594281|471349108|FG000|Interventional Core Phase|Death|1|||
130922119|NCT01594281|471349109|FG001|Interventional Core Phase|Death|1|||
130922120|NCT01594281|471349110|FG002|Interventional Core Phase|Death|2|||
130922121|NCT01594281|471349108|FG000|Interventional Core Phase|Lost to Follow-up|1|||
130922122|NCT01594281|471349109|FG001|Interventional Core Phase|Lost to Follow-up|4|||
130922123|NCT01594281|471349110|FG002|Interventional Core Phase|Lost to Follow-up|1|||
130769578|NCT01026818|470782505|FG001|Screening Period|Withdrawal by Subject|0|||
130769579|NCT01026818|470782506|FG002|Screening Period|Withdrawal by Subject|0|||
130769580|NCT01026818|470782507|FG003|Screening Period|Withdrawal by Subject|0|||
130769581|NCT01026818|470782504|FG000|Screening Period|Protocol Deviation|3|||
130922124|NCT01594281|471349108|FG000|Interventional Core Phase|Adverse Event|4|||
130922125|NCT01594281|471349109|FG001|Interventional Core Phase|Adverse Event|4|||
130922126|NCT01594281|471349110|FG002|Interventional Core Phase|Adverse Event|4|||
130922127|NCT01594281|471349108|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
130922128|NCT01594281|471349109|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
130922129|NCT01594281|471349110|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
130922130|NCT01594281|471349108|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
130922131|NCT01594281|471349109|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
130922132|NCT01594281|471349110|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
130922133|NCT01594281|471349108|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
130922134|NCT01594281|471349109|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
130922135|NCT01594281|471349110|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
130922136|NCT01034631|471349112|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
130922137|NCT01034631|471349113|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
130922138|NCT01034631|471349114|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
130922139|NCT01034631|471349112|FG000|Phase II|Not Evaluable per protocol|0|||
130922140|NCT01034631|471349113|FG001|Phase II|Not Evaluable per protocol|0|||
130922141|NCT01034631|471349114|FG002|Phase II|Not Evaluable per protocol|2|||
130922142|NCT01034631|471349112|FG000|Phase II|Determined Ineligible per protocol|0|||
130922143|NCT01034631|471349113|FG001|Phase II|Determined Ineligible per protocol|1|||
130922144|NCT01034631|471349114|FG002|Phase II|Determined Ineligible per protocol|0|||
130922145|NCT04019288|471349115|FG000|Overall Study|Death|1|||
130922146|NCT04019288|471349116|FG001|Overall Study|Death|0|||
130922147|NCT04019288|471349117|FG002|Overall Study|Death|0|||
130922148|NCT03166735|471349118|FG000|Overall Study|Not Treated|1|||
130922149|NCT03166735|471349119|FG001|Overall Study|Not Treated|0|||
130922150|NCT03166735|471349120|FG002|Overall Study|Not Treated|0|||
130922151|NCT03166735|471349121|FG003|Overall Study|Not Treated|0|||
130922152|NCT03166735|471349122|FG004|Overall Study|Not Treated|0|||
130922153|NCT03166735|471349118|FG000|Overall Study|follow-up not completed as planned|0|||
130922154|NCT03166735|471349119|FG001|Overall Study|follow-up not completed as planned|1|||
130922155|NCT03166735|471349120|FG002|Overall Study|follow-up not completed as planned|1|||
130922156|NCT03166735|471349121|FG003|Overall Study|follow-up not completed as planned|0|||
130922157|NCT03166735|471349122|FG004|Overall Study|follow-up not completed as planned|1|||
130922158|NCT03166735|471349118|FG000|Overall Study|Withdrawal by Subject|0|||
130922159|NCT03166735|471349119|FG001|Overall Study|Withdrawal by Subject|0|||
130922160|NCT03166735|471349120|FG002|Overall Study|Withdrawal by Subject|1|||
130922161|NCT03166735|471349121|FG003|Overall Study|Withdrawal by Subject|1|||
130922162|NCT03166735|471349122|FG004|Overall Study|Withdrawal by Subject|2|||
130922163|NCT03166735|471349118|FG000|Overall Study|Lost to Follow-up|0|||
130922164|NCT03166735|471349119|FG001|Overall Study|Lost to Follow-up|2|||
130922165|NCT03166735|471349120|FG002|Overall Study|Lost to Follow-up|1|||
130922166|NCT03166735|471349121|FG003|Overall Study|Lost to Follow-up|0|||
130922167|NCT03166735|471349122|FG004|Overall Study|Lost to Follow-up|1|||
130922168|NCT01543958|471349123|FG000|Overall Study|Loss to follow-up|3|||
130922169|NCT01543958|471349123|FG000|Overall Study|ART initiation|1|||
130922170|NCT04401423|471349124|FG000|Overall Study|Withdrawal by Subject|3|||
130922171|NCT04401423|471349125|FG001|Overall Study|Withdrawal by Subject|1|||
130922172|NCT04401423|471349124|FG000|Overall Study|Physician Decision|2|||
130922173|NCT04401423|471349125|FG001|Overall Study|Physician Decision|1|||
130922174|NCT03372096|471349131|FG000|Overall Study|Study Closed|8|||
130922175|NCT00680017|471349132|FG000|Overall Study|Adverse Event|13|||
130922176|NCT00680017|471349133|FG001|Overall Study|Adverse Event|7|||
130922177|NCT00680017|471349132|FG000|Overall Study|Withdrawal by Subject|2|||
130922178|NCT00680017|471349133|FG001|Overall Study|Withdrawal by Subject|5|||
130922179|NCT00680017|471349132|FG000|Overall Study|Lost to Follow-up|2|||
130922180|NCT00680017|471349133|FG001|Overall Study|Lost to Follow-up|0|||
130922181|NCT02555683|471349134|FG000|Overall Study|Physician Decision|1|||
130922182|NCT02555683|471349135|FG001|Overall Study|Physician Decision|0|||
130922183|NCT02555683|471349136|FG002|Overall Study|Physician Decision|2|||
130922184|NCT02555683|471349134|FG000|Overall Study|Lost to Follow-up|2|||
130922185|NCT02555683|471349135|FG001|Overall Study|Lost to Follow-up|1|||
130922186|NCT02555683|471349136|FG002|Overall Study|Lost to Follow-up|2|||
130922187|NCT02555683|471349134|FG000|Overall Study|Technical Problems|1|||
130922188|NCT02555683|471349135|FG001|Overall Study|Technical Problems|1|||
130922189|NCT02555683|471349136|FG002|Overall Study|Technical Problems|0|||
130922190|NCT02555683|471349134|FG000|Overall Study|Protocol deviation|0|||
130922191|NCT02555683|471349135|FG001|Overall Study|Protocol deviation|1|||
130922192|NCT02555683|471349136|FG002|Overall Study|Protocol deviation|0|||
130922193|NCT02555683|471349134|FG000|Overall Study|Lack of Efficacy|2|||
130922194|NCT02555683|471349135|FG001|Overall Study|Lack of Efficacy|0|||
130922195|NCT02555683|471349136|FG002|Overall Study|Lack of Efficacy|0|||
130922196|NCT02555683|471349134|FG000|Overall Study|Death|0|||
130922197|NCT02555683|471349135|FG001|Overall Study|Death|1|||
130922198|NCT02555683|471349136|FG002|Overall Study|Death|2|||
130922199|NCT02555683|471349134|FG000|Overall Study|Adverse Event|1|||
130922200|NCT02555683|471349135|FG001|Overall Study|Adverse Event|0|||
130922201|NCT02555683|471349136|FG002|Overall Study|Adverse Event|1|||
130922202|NCT02555683|471349134|FG000|Overall Study|Subject/guardian decision|12|||
130922203|NCT02555683|471349135|FG001|Overall Study|Subject/guardian decision|12|||
130922204|NCT02555683|471349136|FG002|Overall Study|Subject/guardian decision|22|||
130922205|NCT02555683|471349134|FG000|Overall Study|Death post Treatment/safety period|0|||
130922206|NCT02555683|471349135|FG001|Overall Study|Death post Treatment/safety period|1|||
130922207|NCT02555683|471349136|FG002|Overall Study|Death post Treatment/safety period|0|||
130922208|NCT05074667|471349137|FG000|Overall Study|Death|1|||
130922209|NCT05074667|471349137|FG000|Overall Study|Withdrawal by Subject|4|||
130922210|NCT05074667|471349137|FG000|Overall Study|Lost to Follow-up|10|||
130922211|NCT00434954|471349141|FG000|Overall Study|Adverse Event|17|||
130922212|NCT00434954|471349142|FG001|Overall Study|Adverse Event|2|||
130922213|NCT00434954|471349141|FG000|Overall Study|Entry criteria not met|14|||
130922214|NCT00434954|471349142|FG001|Overall Study|Entry criteria not met|16|||
130922215|NCT00434954|471349141|FG000|Overall Study|Lost to Follow-up|0|||
130922216|NCT00434954|471349142|FG001|Overall Study|Lost to Follow-up|1|||
130922217|NCT00434954|471349141|FG000|Overall Study|Physician Decision|6|||
130922218|NCT00434954|471349142|FG001|Overall Study|Physician Decision|3|||
130922219|NCT00434954|471349141|FG000|Overall Study|Protocol Violation|36|||
130922220|NCT00434954|471349142|FG001|Overall Study|Protocol Violation|27|||
130922221|NCT00434954|471349141|FG000|Overall Study|Sponsor decision|1|||
130922222|NCT00434954|471349142|FG001|Overall Study|Sponsor decision|0|||
130922223|NCT00434954|471349141|FG000|Overall Study|Subject decision|8|||
130922224|NCT00434954|471349142|FG001|Overall Study|Subject decision|22|||
130922225|NCT00864721|471349143|FG000|Overall Study|Patient request|11|||
130922226|NCT00864721|471349143|FG000|Overall Study|Hospitalized|1|||
130922227|NCT00864721|471349143|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
130922228|NCT00864721|471349143|FG000|Overall Study|Adverse Event|21|||
130922229|NCT03750955|471349145|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
130922230|NCT03750955|471349146|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
130922231|NCT03750955|471349145|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
130922232|NCT03750955|471349146|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
130922233|NCT01705730|471349149|FG000|Overall Study|Lack of Efficacy|1|||
130922234|NCT01705730|471349149|FG000|Overall Study|Adverse Event|3|||
130922235|NCT01705730|471349149|FG000|Overall Study|Lost to Follow-up|1|||
130922236|NCT01705730|471349149|FG000|Overall Study|Reason not Specified|4|||
130922237|NCT01773733|471349150|FG000|Overall Study|Adverse Event|3286|||
130922238|NCT01773733|471349151|FG001|Overall Study|Adverse Event|540|||
130922239|NCT01773733|471349150|FG000|Overall Study|Pregnancy|28|||
131034317|NCT04209465|471759187|FG012|Overall Study|Adverse Event|1|||
131034318|NCT04209465|471759175|FG000|Overall Study|Death|1|||
131034319|NCT04209465|471759176|FG001|Overall Study|Death|0|||
131034320|NCT04209465|471759177|FG002|Overall Study|Death|0|||
131034321|NCT04209465|471759178|FG003|Overall Study|Death|0|||
131034322|NCT04209465|471759179|FG004|Overall Study|Death|2|||
131034323|NCT04209465|471759180|FG005|Overall Study|Death|7|||
131034324|NCT04209465|471759181|FG006|Overall Study|Death|2|||
131034325|NCT04209465|471759182|FG007|Overall Study|Death|2|||
131034326|NCT04209465|471759183|FG008|Overall Study|Death|1|||
131034327|NCT04209465|471759184|FG009|Overall Study|Death|1|||
131034328|NCT04209465|471759185|FG010|Overall Study|Death|1|||
131034329|NCT04209465|471759186|FG011|Overall Study|Death|0|||
130922240|NCT01773733|471349151|FG001|Overall Study|Pregnancy|0|||
130922241|NCT01773733|471349150|FG000|Overall Study|Other different categories of not compl|55415|||
130922242|NCT01773733|471349151|FG001|Overall Study|Other different categories of not compl|7781|||
130922243|NCT01180985|471349152|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
130922244|NCT01180985|471349153|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
130922245|NCT00129272|471349158|FG000|Overall Study|Lost to Follow-up|12|||
130922246|NCT00129272|471349159|FG001|Overall Study|Lost to Follow-up|11|||
130922247|NCT00129272|471349158|FG000|Overall Study|Withdrawal by Subject|5|||
130922248|NCT00129272|471349159|FG001|Overall Study|Withdrawal by Subject|11|||
130922249|NCT03345914|471349160|FG000|Overall Study|Transition to another study at week 16|80|||
130922250|NCT03345914|471349161|FG001|Overall Study|Transition to another study at week 16|86|||
130922251|NCT03345914|471349162|FG002|Overall Study|Transition to another study at week 16|78|||
130922252|NCT03345914|471349160|FG000|Overall Study|Transition to OLE during follow-up|37|||
130922253|NCT03345914|471349161|FG001|Overall Study|Transition to OLE during follow-up|33|||
130922254|NCT03345914|471349162|FG002|Overall Study|Transition to OLE during follow-up|39|||
130922255|NCT03345914|471349160|FG000|Overall Study|Physician Decision|0|||
130922256|NCT03345914|471349161|FG001|Overall Study|Physician Decision|1|||
130922257|NCT03345914|471349162|FG002|Overall Study|Physician Decision|1|||
130922258|NCT03345914|471349160|FG000|Overall Study|Withdrawal by Subject|5|||
130922259|NCT03345914|471349161|FG001|Overall Study|Withdrawal by Subject|1|||
131034330|NCT04209465|471759187|FG012|Overall Study|Death|10|||
131034331|NCT04209465|471759175|FG000|Overall Study|Physician Decision|0|||
131034332|NCT04209465|471759176|FG001|Overall Study|Physician Decision|1|||
131034333|NCT04209465|471759177|FG002|Overall Study|Physician Decision|0|||
131034334|NCT04209465|471759178|FG003|Overall Study|Physician Decision|0|||
130700338|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Refusal|3|||
130700339|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Refusal|0|||
130700340|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Refusal|0|||
130700341|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Refusal|0|||
130700342|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Refusal|0|||
130700343|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
130700344|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
130700345|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
130700346|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
130700347|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
130700348|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
130700349|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
130700350|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
130700351|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
130700352|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
130700353|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700354|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
130700355|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700356|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700357|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700358|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700359|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700360|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700361|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700362|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130700363|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
130700364|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
130700365|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
130700366|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
130700367|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
130700368|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
130700369|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
130700370|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
130700371|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
130700372|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
130700373|NCT01190930|470526414|FG000|Post Induction Pre-Maintenance|Relapse|0|||
130700374|NCT01190930|470526415|FG001|Post Induction Pre-Maintenance|Relapse|0|||
130700375|NCT01190930|470526416|FG002|Post Induction Pre-Maintenance|Relapse|1|||
130700376|NCT01190930|470526417|FG003|Post Induction Pre-Maintenance|Relapse|0|||
130700377|NCT01190930|470526418|FG004|Post Induction Pre-Maintenance|Relapse|0|||
130700378|NCT01190930|470526419|FG005|Post Induction Pre-Maintenance|Relapse|0|||
130769582|NCT01026818|470782505|FG001|Screening Period|Protocol Deviation|0|||
130769583|NCT01026818|470782506|FG002|Screening Period|Protocol Deviation|0|||
130922260|NCT03345914|471349162|FG002|Overall Study|Withdrawal by Subject|2|||
130922261|NCT03345914|471349160|FG000|Overall Study|Other|1|||
130922262|NCT03345914|471349161|FG001|Overall Study|Other|1|||
130922263|NCT03345914|471349162|FG002|Overall Study|Other|1|||
130922264|NCT03345914|471349160|FG000|Overall Study|Ongoing|0|||
130922265|NCT03345914|471349161|FG001|Overall Study|Ongoing|0|||
130922266|NCT03345914|471349162|FG002|Overall Study|Ongoing|1|||
130922267|NCT00885846|471349165|FG000|Overall Study|Withdrawal by Subject|2|||
130922268|NCT00885846|471349166|FG001|Overall Study|Withdrawal by Subject|5|||
130922269|NCT00885846|471349167|FG002|Overall Study|Withdrawal by Subject|2|||
130922270|NCT00762385|471349171|FG000|First Intervention|Lens Issue|1|||
130922271|NCT00762385|471349172|FG001|First Intervention|Lens Issue|1|||
130922272|NCT00762385|471349171|FG000|First Intervention|Lost to Follow-up|0|||
130922273|NCT00762385|471349172|FG001|First Intervention|Lost to Follow-up|2|||
130922274|NCT00762385|471349171|FG000|First Intervention|Ineligible|1|||
130922275|NCT00762385|471349172|FG001|First Intervention|Ineligible|0|||
130922276|NCT00762385|471349171|FG000|First Intervention|Protocol Violation|0|||
130922277|NCT00762385|471349172|FG001|First Intervention|Protocol Violation|1|||
130922278|NCT00762385|471349171|FG000|Second Intervention|Protocol Violation|3|||
130922279|NCT00762385|471349172|FG001|Second Intervention|Protocol Violation|3|||
130922280|NCT04891978|471349173|FG000|Baseline|Protocol Violation|2|||
130922281|NCT04891978|471349174|FG001|Baseline|Protocol Violation|1|||
130922282|NCT04891978|471349175|FG002|Baseline|Protocol Violation|0|||
130922283|NCT04891978|471349173|FG000|Baseline|Missing AIRQ|1|||
130700379|NCT01190930|470526420|FG006|Post Induction Pre-Maintenance|Relapse|0|||
130700380|NCT01190930|470526421|FG007|Post Induction Pre-Maintenance|Relapse|0|||
130700381|NCT01190930|470526422|FG008|Post Induction Pre-Maintenance|Relapse|0|||
130700382|NCT01190930|470526423|FG009|Post Induction Pre-Maintenance|Relapse|0|||
130922284|NCT04891978|471349174|FG001|Baseline|Missing AIRQ|0|||
130922285|NCT04891978|471349175|FG002|Baseline|Missing AIRQ|0|||
130922286|NCT04891978|471349173|FG000|Baseline|Did not attend a baseline visit|0|||
130922287|NCT04891978|471349174|FG001|Baseline|Did not attend a baseline visit|0|||
130922288|NCT04891978|471349175|FG002|Baseline|Did not attend a baseline visit|9|||
130922289|NCT00493025|471349176|FG000|Overall Study|Physician Decision|19|||
130922290|NCT01876420|471349177|FG000|Overall Study|Missed 30 day visit|1|||
130922291|NCT05338216|471349178|FG000|Overall Study|Withdrawal by Subject|1|||
130922292|NCT05338216|471349179|FG001|Overall Study|Withdrawal by Subject|1|||
130922293|NCT04515394|471349180|FG000|Overall Study|Participant did not receive treatment|1|||
130922294|NCT01065597|471349181|FG000|Overall Study|Adverse Event|1|||
130922295|NCT01416272|471349183|FG000|Overall Study|Unacceptable distance visual acuity|2|||
130922296|NCT01416272|471349183|FG000|Overall Study|Lost to Follow-up|1|||
130922297|NCT01416272|471349183|FG000|Overall Study|Study related complaints|1|||
130922298|NCT02319837|471349184|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
130922299|NCT02319837|471349185|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
130922300|NCT02319837|471349186|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
130922301|NCT02319837|471349184|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
130922302|NCT02319837|471349185|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
130922303|NCT02319837|471349186|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
130922304|NCT02319837|471349184|FG000|Study Treatment Phase|Adverse Event|73|||
130922305|NCT02319837|471349185|FG001|Study Treatment Phase|Adverse Event|36|||
130922306|NCT02319837|471349186|FG002|Study Treatment Phase|Adverse Event|63|||
130922307|NCT02319837|471349184|FG000|Study Treatment Phase|Development of castration resistance|0|||
130922308|NCT02319837|471349185|FG001|Study Treatment Phase|Development of castration resistance|2|||
130922309|NCT02319837|471349186|FG002|Study Treatment Phase|Development of castration resistance|0|||
130922310|NCT02319837|471349184|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
130922311|NCT02319837|471349185|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
130922312|NCT02319837|471349186|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
130922313|NCT02319837|471349184|FG000|Study Treatment Phase|Protocol Violation|2|||
131034335|NCT04209465|471759179|FG004|Overall Study|Physician Decision|0|||
131034336|NCT04209465|471759180|FG005|Overall Study|Physician Decision|0|||
131034337|NCT04209465|471759181|FG006|Overall Study|Physician Decision|0|||
131034338|NCT04209465|471759182|FG007|Overall Study|Physician Decision|0|||
131034339|NCT04209465|471759183|FG008|Overall Study|Physician Decision|0|||
131034340|NCT04209465|471759184|FG009|Overall Study|Physician Decision|0|||
131034341|NCT04209465|471759185|FG010|Overall Study|Physician Decision|0|||
131034342|NCT04209465|471759186|FG011|Overall Study|Physician Decision|0|||
131034343|NCT04209465|471759187|FG012|Overall Study|Physician Decision|0|||
131034344|NCT04209465|471759175|FG000|Overall Study|Progressive Disease|0|||
131034345|NCT04209465|471759176|FG001|Overall Study|Progressive Disease|0|||
131034346|NCT04209465|471759177|FG002|Overall Study|Progressive Disease|1|||
131034347|NCT04209465|471759178|FG003|Overall Study|Progressive Disease|2|||
131034348|NCT04209465|471759179|FG004|Overall Study|Progressive Disease|8|||
131034349|NCT04209465|471759180|FG005|Overall Study|Progressive Disease|5|||
131034350|NCT04209465|471759181|FG006|Overall Study|Progressive Disease|3|||
131034351|NCT04209465|471759182|FG007|Overall Study|Progressive Disease|4|||
131034352|NCT04209465|471759183|FG008|Overall Study|Progressive Disease|1|||
131034353|NCT04209465|471759184|FG009|Overall Study|Progressive Disease|3|||
131034354|NCT04209465|471759185|FG010|Overall Study|Progressive Disease|2|||
131034355|NCT04209465|471759186|FG011|Overall Study|Progressive Disease|1|||
131034356|NCT04209465|471759187|FG012|Overall Study|Progressive Disease|0|||
131034357|NCT04209465|471759175|FG000|Overall Study|Withdrawal by Subject|0|||
131034358|NCT04209465|471759176|FG001|Overall Study|Withdrawal by Subject|0|||
131034359|NCT04209465|471759177|FG002|Overall Study|Withdrawal by Subject|0|||
131034360|NCT04209465|471759178|FG003|Overall Study|Withdrawal by Subject|0|||
131034361|NCT04209465|471759179|FG004|Overall Study|Withdrawal by Subject|0|||
131034362|NCT04209465|471759180|FG005|Overall Study|Withdrawal by Subject|1|||
131034363|NCT04209465|471759181|FG006|Overall Study|Withdrawal by Subject|2|||
131034364|NCT04209465|471759182|FG007|Overall Study|Withdrawal by Subject|0|||
131034365|NCT04209465|471759183|FG008|Overall Study|Withdrawal by Subject|1|||
131034366|NCT04209465|471759184|FG009|Overall Study|Withdrawal by Subject|0|||
131034367|NCT04209465|471759185|FG010|Overall Study|Withdrawal by Subject|0|||
131034368|NCT04209465|471759186|FG011|Overall Study|Withdrawal by Subject|2|||
131034369|NCT04209465|471759187|FG012|Overall Study|Withdrawal by Subject|2|||
131034370|NCT04209465|471759175|FG000|Overall Study|Lost to Follow-up|0|||
131034371|NCT04209465|471759176|FG001|Overall Study|Lost to Follow-up|0|||
131034372|NCT04209465|471759177|FG002|Overall Study|Lost to Follow-up|0|||
131034373|NCT04209465|471759178|FG003|Overall Study|Lost to Follow-up|0|||
131034374|NCT04209465|471759179|FG004|Overall Study|Lost to Follow-up|0|||
131034375|NCT04209465|471759180|FG005|Overall Study|Lost to Follow-up|1|||
131034376|NCT04209465|471759181|FG006|Overall Study|Lost to Follow-up|0|||
131034377|NCT04209465|471759182|FG007|Overall Study|Lost to Follow-up|0|||
131034378|NCT04209465|471759183|FG008|Overall Study|Lost to Follow-up|1|||
131034379|NCT04209465|471759184|FG009|Overall Study|Lost to Follow-up|0|||
131034380|NCT04209465|471759185|FG010|Overall Study|Lost to Follow-up|0|||
130922314|NCT02319837|471349185|FG001|Study Treatment Phase|Protocol Violation|2|||
130922315|NCT02319837|471349186|FG002|Study Treatment Phase|Protocol Violation|1|||
130922316|NCT02319837|471349184|FG000|Study Treatment Phase|Lost to Follow-up|0|||
130922317|NCT02319837|471349185|FG001|Study Treatment Phase|Lost to Follow-up|1|||
130922318|NCT02319837|471349186|FG002|Study Treatment Phase|Lost to Follow-up|0|||
130922319|NCT02319837|471349184|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
130922320|NCT02319837|471349185|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
130922321|NCT02319837|471349186|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
130922322|NCT02319837|471349184|FG000|Study Treatment Phase|Other|0|||
130922323|NCT02319837|471349185|FG001|Study Treatment Phase|Other|1|||
130922324|NCT02319837|471349186|FG002|Study Treatment Phase|Other|0|||
130922325|NCT02319837|471349184|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
130922326|NCT02319837|471349185|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
130922327|NCT02319837|471349186|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
130922328|NCT02319837|471349184|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
130922329|NCT02319837|471349185|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
130922330|NCT02319837|471349186|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
130922331|NCT02319837|471349184|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
130922332|NCT02319837|471349185|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
130922333|NCT02319837|471349186|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
130922334|NCT02319837|471349184|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
130922335|NCT02319837|471349185|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
130922336|NCT02319837|471349186|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
130922337|NCT02319837|471349184|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
130922338|NCT02319837|471349185|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
130922339|NCT02319837|471349186|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
131034381|NCT04209465|471759186|FG011|Overall Study|Lost to Follow-up|1|||
131034382|NCT04209465|471759187|FG012|Overall Study|Lost to Follow-up|0|||
131034383|NCT04209465|471759175|FG000|Overall Study|Started new therapy|0|||
131034384|NCT04209465|471759176|FG001|Overall Study|Started new therapy|0|||
131034385|NCT04209465|471759177|FG002|Overall Study|Started new therapy|0|||
131034386|NCT04209465|471759178|FG003|Overall Study|Started new therapy|0|||
131034387|NCT04209465|471759179|FG004|Overall Study|Started new therapy|0|||
131034388|NCT04209465|471759180|FG005|Overall Study|Started new therapy|1|||
131034389|NCT04209465|471759181|FG006|Overall Study|Started new therapy|0|||
131034390|NCT04209465|471759182|FG007|Overall Study|Started new therapy|0|||
131034391|NCT04209465|471759183|FG008|Overall Study|Started new therapy|0|||
131034392|NCT04209465|471759184|FG009|Overall Study|Started new therapy|0|||
131034393|NCT04209465|471759185|FG010|Overall Study|Started new therapy|0|||
131034394|NCT04209465|471759186|FG011|Overall Study|Started new therapy|0|||
131034395|NCT04209465|471759187|FG012|Overall Study|Started new therapy|0|||
131034396|NCT04209465|471759175|FG000|Overall Study|Study terminated early by sponsor|0|||
131034397|NCT04209465|471759176|FG001|Overall Study|Study terminated early by sponsor|0|||
131034398|NCT04209465|471759177|FG002|Overall Study|Study terminated early by sponsor|0|||
131034399|NCT04209465|471759178|FG003|Overall Study|Study terminated early by sponsor|0|||
131034400|NCT04209465|471759179|FG004|Overall Study|Study terminated early by sponsor|0|||
131034401|NCT04209465|471759180|FG005|Overall Study|Study terminated early by sponsor|0|||
131034402|NCT04209465|471759181|FG006|Overall Study|Study terminated early by sponsor|3|||
131034403|NCT04209465|471759182|FG007|Overall Study|Study terminated early by sponsor|0|||
131034404|NCT04209465|471759183|FG008|Overall Study|Study terminated early by sponsor|0|||
131034405|NCT04209465|471759184|FG009|Overall Study|Study terminated early by sponsor|0|||
131034406|NCT04209465|471759185|FG010|Overall Study|Study terminated early by sponsor|0|||
131034407|NCT04209465|471759186|FG011|Overall Study|Study terminated early by sponsor|0|||
131034408|NCT04209465|471759187|FG012|Overall Study|Study terminated early by sponsor|3|||
131034409|NCT04209465|471759175|FG000|Overall Study|Other|0|||
131034410|NCT04209465|471759176|FG001|Overall Study|Other|0|||
131034411|NCT04209465|471759177|FG002|Overall Study|Other|0|||
131034412|NCT04209465|471759178|FG003|Overall Study|Other|0|||
131034413|NCT04209465|471759179|FG004|Overall Study|Other|0|||
131034414|NCT04209465|471759180|FG005|Overall Study|Other|0|||
131034415|NCT04209465|471759181|FG006|Overall Study|Other|0|||
131034416|NCT04209465|471759182|FG007|Overall Study|Other|0|||
131034417|NCT04209465|471759183|FG008|Overall Study|Other|1|||
131034418|NCT04209465|471759184|FG009|Overall Study|Other|0|||
131034419|NCT04209465|471759185|FG010|Overall Study|Other|0|||
131034420|NCT04209465|471759186|FG011|Overall Study|Other|0|||
131034421|NCT04209465|471759187|FG012|Overall Study|Other|0|||
131034422|NCT03097549|471759188|FG000|Overall Study|Withdrawal by Subject|1|||
130922340|NCT02319837|471349184|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
130922341|NCT02319837|471349185|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
130922342|NCT02319837|471349186|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
130922343|NCT02319837|471349184|FG000|Long-Term Follow-Up Phase|Death|33|||
130922344|NCT02319837|471349185|FG001|Long-Term Follow-Up Phase|Death|54|||
130922345|NCT02319837|471349186|FG002|Long-Term Follow-Up Phase|Death|42|||
130922346|NCT04545554|471349191|FG000|Overall Study|Withdrawal by Subject|0|||
130922347|NCT04545554|471349192|FG001|Overall Study|Withdrawal by Subject|0|||
130922348|NCT04545554|471349193|FG002|Overall Study|Withdrawal by Subject|0|||
130922349|NCT04545554|471349194|FG003|Overall Study|Withdrawal by Subject|1|||
130922350|NCT04545554|471349195|FG004|Overall Study|Withdrawal by Subject|0|||
130922351|NCT04545554|471349196|FG005|Overall Study|Withdrawal by Subject|0|||
130922352|NCT01313312|471349197|FG000|Overall Study|Adverse Event|5|||
130922353|NCT01313312|471349197|FG000|Overall Study|Withdrawal by Subject|18|||
130922354|NCT01313312|471349197|FG000|Overall Study|Lack of Efficacy|3|||
130922355|NCT01313312|471349197|FG000|Overall Study|Investigator Decision|1|||
130922356|NCT01313312|471349197|FG000|Overall Study|Observational Phase|1|||
130922357|NCT01313312|471349197|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
130922358|NCT01313312|471349197|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
130922359|NCT01254331|471349199|FG000|Initial Phase|Adverse Event|3|||
130922360|NCT01254331|471349199|FG000|Initial Phase|Withdrawal by Subject|1|||
130922361|NCT01254331|471349199|FG000|Initial Phase|Pregnancy|1|||
130922362|NCT01254331|471349199|FG000|Extension Phase|Lack of Efficacy|1|||
130922363|NCT01254331|471349199|FG000|Extension Phase|Lost to Follow-up|3|||
130922364|NCT00892047|471349201|FG000|Overall Study|Adverse Event|2|||
130922365|NCT00892047|471349202|FG001|Overall Study|Adverse Event|2|||
130922366|NCT00892047|471349201|FG000|Overall Study|subject burden|2|||
130922367|NCT00892047|471349202|FG001|Overall Study|subject burden|3|||
130922368|NCT00892047|471349201|FG000|Overall Study|Lack of Efficacy|0|||
130922369|NCT00892047|471349202|FG001|Overall Study|Lack of Efficacy|2|||
130922370|NCT05306977|471349203|FG000|Overall Study|Withdrawal by Subject|1|||
130922371|NCT05213481|471349208|FG000|Overall Study|Adverse Event|3|||
130922372|NCT05213481|471349208|FG000|Overall Study|Lost to Follow-up|1|||
130922373|NCT01612858|471349209|FG000|Overall Study|Withdrawal by Subject|5|||
130922374|NCT01612858|471349210|FG001|Overall Study|Withdrawal by Subject|1|||
130922375|NCT00660699|471349215|FG000|Overall Study|Withdrawal by Subject|2|||
130922376|NCT01752985|471349216|FG000|Treatment Period|Subject request to discontinue treatment|1|||
130922377|NCT01752985|471349217|FG001|Treatment Period|Subject request to discontinue treatment|0|||
130922378|NCT01752985|471349218|FG002|Treatment Period|Subject request to discontinue treatment|1|||
130922379|NCT01752985|471349216|FG000|Treatment Period|Subject no longer meets study criteria|0|||
130922380|NCT01752985|471349217|FG001|Treatment Period|Subject no longer meets study criteria|1|||
130922381|NCT01752985|471349218|FG002|Treatment Period|Subject no longer meets study criteria|1|||
130922382|NCT01752985|471349216|FG000|Treatment Period|Adverse Event|2|||
130922383|NCT01752985|471349217|FG001|Treatment Period|Adverse Event|1|||
130922384|NCT01752985|471349218|FG002|Treatment Period|Adverse Event|2|||
130922385|NCT01752985|471349216|FG000|Treatment Period|Withdrawal by Subject|1|||
130922386|NCT01752985|471349217|FG001|Treatment Period|Withdrawal by Subject|1|||
130922387|NCT01752985|471349218|FG002|Treatment Period|Withdrawal by Subject|0|||
130922388|NCT01752985|471349216|FG000|Treatment Period|Lost to Follow-up|0|||
130922389|NCT01752985|471349217|FG001|Treatment Period|Lost to Follow-up|0|||
130922390|NCT01752985|471349218|FG002|Treatment Period|Lost to Follow-up|1|||
130922391|NCT03128047|471349219|FG000|Overall Study|Withdrawal by Subject|1|||
130922392|NCT01385566|471350807|FG000|Overall Study|Lost to Follow-up|1|||
130922393|NCT01385566|471350808|FG001|Overall Study|Lost to Follow-up|0|||
130922394|NCT01385566|471350809|FG002|Overall Study|Lost to Follow-up|0|||
130922395|NCT01385566|471350810|FG003|Overall Study|Lost to Follow-up|0|||
130922396|NCT01385566|471350811|FG004|Overall Study|Lost to Follow-up|0|||
130922397|NCT01385566|471350812|FG005|Overall Study|Lost to Follow-up|0|||
131034423|NCT03097549|471759189|FG001|Overall Study|Withdrawal by Subject|0|||
131034424|NCT03097549|471759188|FG000|Overall Study|Lost to Follow-up|1|||
131034425|NCT03097549|471759189|FG001|Overall Study|Lost to Follow-up|0|||
131034426|NCT04505904|471759190|FG000|Overall Study|Withdrawal by Subject|1|||
131034427|NCT04505904|471759191|FG001|Overall Study|Withdrawal by Subject|2|||
131034428|NCT04505904|471759192|FG002|Overall Study|Withdrawal by Subject|0|||
131034429|NCT04505904|471759193|FG003|Overall Study|Withdrawal by Subject|0|||
131034430|NCT04505904|471759190|FG000|Overall Study|Physician Decision|1|||
131034431|NCT04505904|471759191|FG001|Overall Study|Physician Decision|0|||
130922398|NCT01385566|471350807|FG000|Overall Study|Withdrawal by Subject|0|||
130922399|NCT01385566|471350808|FG001|Overall Study|Withdrawal by Subject|0|||
130922400|NCT01385566|471350809|FG002|Overall Study|Withdrawal by Subject|0|||
130922401|NCT01385566|471350810|FG003|Overall Study|Withdrawal by Subject|1|||
130922402|NCT01385566|471350811|FG004|Overall Study|Withdrawal by Subject|0|||
130922403|NCT01385566|471350812|FG005|Overall Study|Withdrawal by Subject|0|||
130922404|NCT04092582|471350813|FG000|Overall Study|Death|1|||
131034432|NCT04505904|471759192|FG002|Overall Study|Physician Decision|0|||
130922405|NCT04092582|471350814|FG001|Overall Study|Death|1|||
131034433|NCT04505904|471759193|FG003|Overall Study|Physician Decision|0|||
130922406|NCT04092582|471350813|FG000|Overall Study|Withdrawal by Subject|4|||
130922407|NCT04092582|471350814|FG001|Overall Study|Withdrawal by Subject|1|||
130922408|NCT04092582|471350813|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
130922409|NCT04092582|471350814|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
130922410|NCT02025621|471350815|FG000|Overall Study|Withdrawal by Subject|1|||
130922411|NCT02025621|471350816|FG001|Overall Study|Withdrawal by Subject|0|||
130922412|NCT02025621|471350815|FG000|Overall Study|Death|0|||
130922413|NCT02025621|471350816|FG001|Overall Study|Death|1|||
130922414|NCT02025621|471350815|FG000|Overall Study|No longer eligible|10|||
130922415|NCT02025621|471350816|FG001|Overall Study|No longer eligible|15|||
130922416|NCT02025621|471350815|FG000|Overall Study|Surgery initiated before infusion|3|||
130922417|NCT02025621|471350816|FG001|Overall Study|Surgery initiated before infusion|3|||
130922418|NCT04805541|471350818|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
130922419|NCT00283400|471350822|FG000|Overall Study|Withdrawal by Subject|1|||
130922420|NCT00283400|471350823|FG001|Overall Study|Withdrawal by Subject|1|||
130922421|NCT00283400|471350824|FG002|Overall Study|Withdrawal by Subject|0|||
130922422|NCT00283400|471350825|FG003|Overall Study|Withdrawal by Subject|0|||
130922423|NCT00283400|471350822|FG000|Overall Study|Death|1|||
130922424|NCT00283400|471350823|FG001|Overall Study|Death|0|||
130922425|NCT00283400|471350824|FG002|Overall Study|Death|1|||
130922426|NCT00283400|471350825|FG003|Overall Study|Death|0|||
130922427|NCT02195583|471350826|FG000|Overall Study|Lost to Follow-up|1|||
130922428|NCT02195583|471350826|FG000|Overall Study|Withdrawal by Subject|4|||
130922429|NCT02195583|471350826|FG000|Overall Study|Adverse Event|2|||
130922430|NCT02195583|471350826|FG000|Overall Study|Other Reason|2|||
130922431|NCT01709513|471350827|FG000|Overall Study|Randomized but not treated|0|||
130922432|NCT01709513|471350828|FG001|Overall Study|Randomized but not treated|1|||
130922433|NCT01709513|471350829|FG002|Overall Study|Randomized but not treated|0|||
130922434|NCT01709513|471350827|FG000|Overall Study|Adverse Event|16|||
130922435|NCT01709513|471350828|FG001|Overall Study|Adverse Event|31|||
130922436|NCT01709513|471350829|FG002|Overall Study|Adverse Event|23|||
130922437|NCT01709513|471350827|FG000|Overall Study|Poor compliance to protocol|2|||
130922438|NCT01709513|471350828|FG001|Overall Study|Poor compliance to protocol|0|||
130922439|NCT01709513|471350829|FG002|Overall Study|Poor compliance to protocol|0|||
130922440|NCT01709513|471350827|FG000|Overall Study|Other|3|||
130922441|NCT01709513|471350828|FG001|Overall Study|Other|11|||
130922442|NCT01709513|471350829|FG002|Overall Study|Other|7|||
130922443|NCT01560403|471350830|FG000|Overall Study|Lost to Follow-up|0|||
130922444|NCT01560403|471350831|FG001|Overall Study|Lost to Follow-up|1|||
130922445|NCT04218695|471350832|FG000|Overall Study|Adverse Event|1|||
130922446|NCT04218695|471350833|FG001|Overall Study|Adverse Event|0|||
130922447|NCT01020981|471350834|FG000|Overall Study|Did not return mailed survey|74|||
130922448|NCT01020981|471350835|FG001|Overall Study|Did not return mailed survey|58|||
130922449|NCT01020981|471350834|FG000|Overall Study|Survey returned undeliverable|8|||
130922450|NCT01020981|471350835|FG001|Overall Study|Survey returned undeliverable|32|||
130922451|NCT01020981|471350834|FG000|Overall Study|Participant declined to complete survey|2|||
130922452|NCT01020981|471350835|FG001|Overall Study|Participant declined to complete survey|0|||
130922453|NCT00040365|471350836|FG000|Overall Study|Death|1|||
130922454|NCT00040365|471350836|FG000|Overall Study|Progressive disease|7|||
130922455|NCT00040365|471350836|FG000|Overall Study|Lost to Follow-up|3|||
130922456|NCT00541931|471350837|FG000|Overall Study|Adverse Event|1|||
130922457|NCT00541931|471350838|FG001|Overall Study|Adverse Event|0|||
130922458|NCT00541931|471350837|FG000|Overall Study|Lost to Follow-up|3|||
130922459|NCT00541931|471350838|FG001|Overall Study|Lost to Follow-up|3|||
130922460|NCT00541931|471350837|FG000|Overall Study|Withdrawal by Subject|1|||
130922461|NCT00541931|471350838|FG001|Overall Study|Withdrawal by Subject|0|||
130922462|NCT00541931|471350837|FG000|Overall Study|Transportation Issue|0|||
130922463|NCT00541931|471350838|FG001|Overall Study|Transportation Issue|1|||
130922464|NCT01086033|471350841|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
130922465|NCT01086033|471350841|FG000|Overall Study|Lost to Follow-up|86|||
130922466|NCT01086033|471350841|FG000|Overall Study|Adverse Event|42|||
130922467|NCT01086033|471350841|FG000|Overall Study|Withdrawal by Subject|41|||
130922468|NCT01086033|471350841|FG000|Overall Study|Other|14|||
130922469|NCT01086033|471350841|FG000|Overall Study|Other|13|||
130922470|NCT01086033|471350841|FG000|Overall Study|AE and Withdrew Consent|5|||
130922471|NCT01086033|471350841|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
130922472|NCT01086033|471350841|FG000|Overall Study|Withdrew consent and Other Reason|4|||
130922473|NCT01086033|471350841|FG000|Overall Study|AE and Lack of Efficacy|4|||
130922474|NCT01086033|471350841|FG000|Overall Study|Death|1|||
130922475|NCT01086033|471350841|FG000|Overall Study|AE and Lost to Follow-up|1|||
130922476|NCT01086033|471350841|FG000|Overall Study|AE and Other Reason|1|||
130922477|NCT01086033|471350841|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
130922478|NCT04572633|471350842|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
130922479|NCT02924571|471350843|FG000|Overall Study|Lost to Follow-up|1|||
130922480|NCT02924571|471350844|FG001|Overall Study|Lost to Follow-up|1|||
130922481|NCT02924571|471350845|FG002|Overall Study|Lost to Follow-up|0|||
130700383|NCT01190930|470526414|FG000|Maintenance|Adverse Event|0|||
130700384|NCT01190930|470526415|FG001|Maintenance|Adverse Event|0|||
130700385|NCT01190930|470526416|FG002|Maintenance|Adverse Event|0|||
130700386|NCT01190930|470526417|FG003|Maintenance|Adverse Event|0|||
130700387|NCT01190930|470526418|FG004|Maintenance|Adverse Event|0|||
130700388|NCT01190930|470526419|FG005|Maintenance|Adverse Event|1|||
130700389|NCT01190930|470526420|FG006|Maintenance|Adverse Event|1|||
130700390|NCT01190930|470526421|FG007|Maintenance|Adverse Event|3|||
130700391|NCT01190930|470526422|FG008|Maintenance|Adverse Event|3|||
130700392|NCT01190930|470526423|FG009|Maintenance|Adverse Event|0|||
130700393|NCT01190930|470526414|FG000|Maintenance|Death|0|||
130700394|NCT01190930|470526415|FG001|Maintenance|Death|0|||
130700395|NCT01190930|470526416|FG002|Maintenance|Death|0|||
130700396|NCT01190930|470526417|FG003|Maintenance|Death|1|||
130700397|NCT01190930|470526418|FG004|Maintenance|Death|0|||
130700398|NCT01190930|470526419|FG005|Maintenance|Death|0|||
130700399|NCT01190930|470526420|FG006|Maintenance|Death|2|||
130700400|NCT01190930|470526421|FG007|Maintenance|Death|2|||
130700401|NCT01190930|470526422|FG008|Maintenance|Death|2|||
130700402|NCT01190930|470526423|FG009|Maintenance|Death|2|||
130700403|NCT01190930|470526414|FG000|Maintenance|Lost to Follow-up|0|||
130700404|NCT01190930|470526415|FG001|Maintenance|Lost to Follow-up|0|||
130700405|NCT01190930|470526416|FG002|Maintenance|Lost to Follow-up|0|||
130700406|NCT01190930|470526417|FG003|Maintenance|Lost to Follow-up|0|||
130700407|NCT01190930|470526418|FG004|Maintenance|Lost to Follow-up|0|||
130700408|NCT01190930|470526419|FG005|Maintenance|Lost to Follow-up|0|||
130700409|NCT01190930|470526420|FG006|Maintenance|Lost to Follow-up|1|||
130700410|NCT01190930|470526421|FG007|Maintenance|Lost to Follow-up|1|||
130700411|NCT01190930|470526422|FG008|Maintenance|Lost to Follow-up|1|||
130700412|NCT01190930|470526423|FG009|Maintenance|Lost to Follow-up|0|||
130700413|NCT01190930|470526414|FG000|Maintenance|Physician Decision|0|||
130700414|NCT01190930|470526415|FG001|Maintenance|Physician Decision|1|||
130700415|NCT01190930|470526416|FG002|Maintenance|Physician Decision|0|||
130700416|NCT01190930|470526417|FG003|Maintenance|Physician Decision|5|||
130700417|NCT01190930|470526418|FG004|Maintenance|Physician Decision|9|||
130700418|NCT01190930|470526419|FG005|Maintenance|Physician Decision|4|||
130700419|NCT01190930|470526420|FG006|Maintenance|Physician Decision|8|||
130700420|NCT01190930|470526421|FG007|Maintenance|Physician Decision|8|||
130700421|NCT01190930|470526422|FG008|Maintenance|Physician Decision|10|||
130700422|NCT01190930|470526423|FG009|Maintenance|Physician Decision|17|||
130700423|NCT01190930|470526414|FG000|Maintenance|Withdrawal by Subject|0|||
130700424|NCT01190930|470526415|FG001|Maintenance|Withdrawal by Subject|0|||
130700425|NCT01190930|470526416|FG002|Maintenance|Withdrawal by Subject|0|||
130700426|NCT01190930|470526417|FG003|Maintenance|Withdrawal by Subject|0|||
130700427|NCT01190930|470526418|FG004|Maintenance|Withdrawal by Subject|0|||
130700428|NCT01190930|470526419|FG005|Maintenance|Withdrawal by Subject|0|||
130700429|NCT01190930|470526420|FG006|Maintenance|Withdrawal by Subject|2|||
130700430|NCT01190930|470526421|FG007|Maintenance|Withdrawal by Subject|1|||
130700431|NCT01190930|470526422|FG008|Maintenance|Withdrawal by Subject|4|||
130700432|NCT01190930|470526423|FG009|Maintenance|Withdrawal by Subject|1|||
130700433|NCT01190930|470526414|FG000|Maintenance|Refusal|0|||
130700434|NCT01190930|470526415|FG001|Maintenance|Refusal|1|||
130700435|NCT01190930|470526416|FG002|Maintenance|Refusal|0|||
130700436|NCT01190930|470526417|FG003|Maintenance|Refusal|2|||
130700437|NCT01190930|470526418|FG004|Maintenance|Refusal|0|||
130700438|NCT01190930|470526419|FG005|Maintenance|Refusal|4|||
130700439|NCT01190930|470526420|FG006|Maintenance|Refusal|5|||
130700440|NCT01190930|470526421|FG007|Maintenance|Refusal|17|||
130700441|NCT01190930|470526422|FG008|Maintenance|Refusal|13|||
130700442|NCT01190930|470526423|FG009|Maintenance|Refusal|6|||
130700443|NCT01190930|470526414|FG000|Maintenance|second malignant neoplasm|0|||
130700444|NCT01190930|470526415|FG001|Maintenance|second malignant neoplasm|0|||
130700445|NCT01190930|470526416|FG002|Maintenance|second malignant neoplasm|0|||
130922482|NCT00894166|471350846|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
130922483|NCT00894166|471350847|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
130700446|NCT01190930|470526417|FG003|Maintenance|second malignant neoplasm|1|||
130700447|NCT01190930|470526418|FG004|Maintenance|second malignant neoplasm|0|||
130700448|NCT01190930|470526419|FG005|Maintenance|second malignant neoplasm|1|||
130700449|NCT01190930|470526420|FG006|Maintenance|second malignant neoplasm|0|||
130700450|NCT01190930|470526421|FG007|Maintenance|second malignant neoplasm|0|||
130700451|NCT01190930|470526422|FG008|Maintenance|second malignant neoplasm|1|||
130700452|NCT01190930|470526423|FG009|Maintenance|second malignant neoplasm|0|||
130700453|NCT01190930|470526414|FG000|Maintenance|Inevaluable|0|||
130700454|NCT01190930|470526415|FG001|Maintenance|Inevaluable|0|||
130700455|NCT01190930|470526416|FG002|Maintenance|Inevaluable|0|||
130700456|NCT01190930|470526417|FG003|Maintenance|Inevaluable|0|||
130700457|NCT01190930|470526418|FG004|Maintenance|Inevaluable|0|||
130700458|NCT01190930|470526419|FG005|Maintenance|Inevaluable|1|||
130700459|NCT01190930|470526420|FG006|Maintenance|Inevaluable|1|||
130700460|NCT01190930|470526421|FG007|Maintenance|Inevaluable|1|||
130700461|NCT01190930|470526422|FG008|Maintenance|Inevaluable|0|||
130700462|NCT01190930|470526423|FG009|Maintenance|Inevaluable|0|||
130700463|NCT01190930|470526414|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
130700464|NCT01190930|470526415|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
130922484|NCT00894166|471350848|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
130922485|NCT00894166|471350849|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
130922486|NCT00894166|471350850|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
130922487|NCT00894166|471350851|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
130922488|NCT00894166|471350852|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
130922489|NCT00894166|471350853|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
130922490|NCT00894166|471350846|FG000|Overall Study|Death|0|||
130922491|NCT00894166|471350847|FG001|Overall Study|Death|0|||
130922492|NCT00894166|471350848|FG002|Overall Study|Death|0|||
130922493|NCT00894166|471350849|FG003|Overall Study|Death|1|||
130922494|NCT00894166|471350850|FG004|Overall Study|Death|0|||
130922495|NCT00894166|471350851|FG005|Overall Study|Death|0|||
130922496|NCT00894166|471350852|FG006|Overall Study|Death|0|||
130922497|NCT00894166|471350853|FG007|Overall Study|Death|0|||
130922498|NCT02747875|471350865|FG000|Overall Study|Physician Decision|1|||
130922499|NCT02747875|471350866|FG001|Overall Study|Physician Decision|0|||
130922500|NCT02747875|471350865|FG000|Overall Study|Adverse Event|0|||
130922501|NCT02747875|471350866|FG001|Overall Study|Adverse Event|1|||
130922502|NCT03478657|471350867|FG000|Overall Study|Withdrawal by Subject|0|||
130922503|NCT03478657|471350868|FG001|Overall Study|Withdrawal by Subject|1|||
130922504|NCT01786668|471350869|FG000|Overall Study|Adverse Event|0|||
130922505|NCT01786668|471350870|FG001|Overall Study|Adverse Event|1|||
130922506|NCT01786668|471350871|FG002|Overall Study|Adverse Event|1|||
130922507|NCT01786668|471350872|FG003|Overall Study|Adverse Event|2|||
130922508|NCT01786668|471350869|FG000|Overall Study|Withdrawal by Subject|0|||
130922509|NCT01786668|471350870|FG001|Overall Study|Withdrawal by Subject|0|||
130922510|NCT01786668|471350871|FG002|Overall Study|Withdrawal by Subject|3|||
130922511|NCT01786668|471350872|FG003|Overall Study|Withdrawal by Subject|1|||
130922512|NCT01786668|471350869|FG000|Overall Study|Pregnancy|0|||
130922513|NCT01786668|471350870|FG001|Overall Study|Pregnancy|0|||
130922514|NCT01786668|471350871|FG002|Overall Study|Pregnancy|0|||
130922515|NCT01786668|471350872|FG003|Overall Study|Pregnancy|1|||
130922516|NCT01786668|471350869|FG000|Overall Study|Lost to Follow-up|1|||
130922517|NCT01786668|471350870|FG001|Overall Study|Lost to Follow-up|0|||
130922518|NCT01786668|471350871|FG002|Overall Study|Lost to Follow-up|1|||
130922519|NCT01786668|471350872|FG003|Overall Study|Lost to Follow-up|0|||
130922520|NCT01702805|471350874|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
130922521|NCT01702805|471350875|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
130922522|NCT01702805|471350874|FG000|Overall Study|Incomplete Follow-up|18|||
130922523|NCT01702805|471350875|FG001|Overall Study|Incomplete Follow-up|15|||
130922524|NCT01702805|471350874|FG000|Overall Study|Vital Status Assessment Only|40|||
130922525|NCT01702805|471350875|FG001|Overall Study|Vital Status Assessment Only|39|||
130922526|NCT01702805|471350874|FG000|Overall Study|Lost to Follow-up|5|||
130922527|NCT01702805|471350875|FG001|Overall Study|Lost to Follow-up|5|||
130922528|NCT03570697|471350876|FG000|Overall Study|Lost to Follow-up|0|||
130922529|NCT03570697|471350877|FG001|Overall Study|Lost to Follow-up|1|||
130922530|NCT03570697|471350876|FG000|Overall Study|Death|2|||
130922531|NCT03570697|471350877|FG001|Overall Study|Death|0|||
130922532|NCT03570697|471350876|FG000|Overall Study|Withdrawal by Subject|4|||
130922533|NCT03570697|471350877|FG001|Overall Study|Withdrawal by Subject|2|||
130922534|NCT01776840|471350878|FG000|Overall Study|Lost to Follow-up|12|||
130922535|NCT01776840|471350879|FG001|Overall Study|Lost to Follow-up|7|||
130922536|NCT01776840|471350878|FG000|Overall Study|Withdrawal by Subject|32|||
130922537|NCT01776840|471350879|FG001|Overall Study|Withdrawal by Subject|48|||
130922538|NCT01776840|471350878|FG000|Overall Study|Sponsor decision|89|||
130922539|NCT01776840|471350879|FG001|Overall Study|Sponsor decision|87|||
130922540|NCT03068455|471350883|FG000|Pre-treatment Period|Disease progression|0|||
130922541|NCT03068455|471350884|FG001|Pre-treatment Period|Disease progression|1|||
130922542|NCT03068455|471350883|FG000|Pre-treatment Period|Participant withdrew consent|1|||
130922543|NCT03068455|471350884|FG001|Pre-treatment Period|Participant withdrew consent|1|||
130922544|NCT03068455|471350883|FG000|Pre-treatment Period|Poor/non-compliance|0|||
130922545|NCT03068455|471350884|FG001|Pre-treatment Period|Poor/non-compliance|1|||
130922546|NCT03068455|471350883|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
130922547|NCT03068455|471350884|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
130922548|NCT03068455|471350883|FG000|Pre-treatment Period|Not reported|2|||
130922549|NCT03068455|471350884|FG001|Pre-treatment Period|Not reported|1|||
130922550|NCT03068455|471350883|FG000|Treatment Period|Disease progression|166|||
130922551|NCT03068455|471350884|FG001|Treatment Period|Disease progression|208|||
130922552|NCT03068455|471350883|FG000|Treatment Period|Study drug toxicity|317|||
130922553|NCT03068455|471350884|FG001|Treatment Period|Study drug toxicity|104|||
130922554|NCT03068455|471350883|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
130922555|NCT03068455|471350884|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
130922556|NCT03068455|471350883|FG000|Treatment Period|Participant request to stop therapy|33|||
130922557|NCT03068455|471350884|FG001|Treatment Period|Participant request to stop therapy|20|||
130922558|NCT03068455|471350883|FG000|Treatment Period|Participant withdrew consent|5|||
130922559|NCT03068455|471350884|FG001|Treatment Period|Participant withdrew consent|10|||
130922560|NCT03068455|471350883|FG000|Treatment Period|Poor/non-compliance|3|||
130700465|NCT01190930|470526416|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
130700466|NCT01190930|470526417|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
130700467|NCT01190930|470526418|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
130700468|NCT01190930|470526419|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
130700469|NCT01190930|470526420|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
130700470|NCT01190930|470526421|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
130922561|NCT03068455|471350884|FG001|Treatment Period|Poor/non-compliance|0|||
130922562|NCT03068455|471350883|FG000|Treatment Period|Participant no longer meets study criteria|1|||
130922563|NCT03068455|471350884|FG001|Treatment Period|Participant no longer meets study criteria|3|||
130922564|NCT03068455|471350883|FG000|Treatment Period|Other reasons|12|||
130700471|NCT01190930|470526422|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
130922565|NCT03068455|471350884|FG001|Treatment Period|Other reasons|4|||
130922566|NCT03173313|471350886|FG000|Overall Study|Lost to Follow-up|2|||
130922567|NCT03173313|471350887|FG001|Overall Study|Lost to Follow-up|3|||
130922568|NCT03173313|471350886|FG000|Overall Study|Withdrawal by Subject|0|||
130922569|NCT03173313|471350887|FG001|Overall Study|Withdrawal by Subject|1|||
130922570|NCT03173313|471350886|FG000|Overall Study|Death|5|||
130922571|NCT03173313|471350887|FG001|Overall Study|Death|0|||
130922572|NCT03173313|471350886|FG000|Overall Study|Physician Decision|1|||
130922573|NCT03173313|471350887|FG001|Overall Study|Physician Decision|0|||
130922574|NCT03173313|471350886|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
130700472|NCT01190930|470526423|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
130700473|NCT01190930|470526414|FG000|Maintenance|Relapse|0|||
130700474|NCT01190930|470526415|FG001|Maintenance|Relapse|0|||
130700475|NCT01190930|470526416|FG002|Maintenance|Relapse|0|||
130700476|NCT01190930|470526417|FG003|Maintenance|Relapse|2|||
130700477|NCT01190930|470526418|FG004|Maintenance|Relapse|0|||
130700478|NCT01190930|470526419|FG005|Maintenance|Relapse|1|||
130700479|NCT01190930|470526420|FG006|Maintenance|Relapse|6|||
130700480|NCT01190930|470526421|FG007|Maintenance|Relapse|13|||
130700481|NCT01190930|470526422|FG008|Maintenance|Relapse|11|||
130700482|NCT01190930|470526423|FG009|Maintenance|Relapse|11|||
130700483|NCT01190930|470526414|FG000|Maintenance|Still on therapy|0|||
130700484|NCT01190930|470526415|FG001|Maintenance|Still on therapy|8|||
130700485|NCT01190930|470526416|FG002|Maintenance|Still on therapy|0|||
130700486|NCT01190930|470526417|FG003|Maintenance|Still on therapy|29|||
130700487|NCT01190930|470526418|FG004|Maintenance|Still on therapy|0|||
130700488|NCT01190930|470526419|FG005|Maintenance|Still on therapy|0|||
130700489|NCT01190930|470526420|FG006|Maintenance|Still on therapy|0|||
130700490|NCT01190930|470526421|FG007|Maintenance|Still on therapy|0|||
130700491|NCT01190930|470526422|FG008|Maintenance|Still on therapy|0|||
130700492|NCT01190930|470526423|FG009|Maintenance|Still on therapy|0|||
130700493|NCT02167594|470526424|FG000|Overall Study|Withdrawal by Subject|2|||
130700494|NCT02167594|470526425|FG001|Overall Study|Withdrawal by Subject|0|||
130700495|NCT02167594|470526426|FG002|Overall Study|Withdrawal by Subject|0|||
130700496|NCT02167594|470526424|FG000|Overall Study|Death|0|||
130700497|NCT02167594|470526425|FG001|Overall Study|Death|1|||
130700498|NCT02167594|470526426|FG002|Overall Study|Death|0|||
130700499|NCT02161549|470526427|FG000|Overall Study|Physician Decision|6|||
130700500|NCT02161549|470526428|FG001|Overall Study|Physician Decision|2|||
130700501|NCT01583530|470526429|FG000|Overall Study|Adverse Event|0|||
130700502|NCT01583530|470526430|FG001|Overall Study|Adverse Event|0|||
130700503|NCT01583530|470526431|FG002|Overall Study|Adverse Event|0|||
130700504|NCT01583530|470526432|FG003|Overall Study|Adverse Event|0|||
130700505|NCT01583530|470526433|FG004|Overall Study|Adverse Event|0|||
130700506|NCT01583530|470526434|FG005|Overall Study|Adverse Event|1|||
130700507|NCT01583530|470526429|FG000|Overall Study|Withdrawal by Subject|0|||
130700508|NCT01583530|470526430|FG001|Overall Study|Withdrawal by Subject|3|||
130700509|NCT01583530|470526431|FG002|Overall Study|Withdrawal by Subject|0|||
130700510|NCT01583530|470526432|FG003|Overall Study|Withdrawal by Subject|1|||
130700511|NCT01583530|470526433|FG004|Overall Study|Withdrawal by Subject|1|||
130700512|NCT01583530|470526434|FG005|Overall Study|Withdrawal by Subject|2|||
130700513|NCT01583530|470526429|FG000|Overall Study|Lost to Follow-up|0|||
130700514|NCT01583530|470526430|FG001|Overall Study|Lost to Follow-up|0|||
130700515|NCT01583530|470526431|FG002|Overall Study|Lost to Follow-up|0|||
130700516|NCT01583530|470526432|FG003|Overall Study|Lost to Follow-up|0|||
130700517|NCT01583530|470526433|FG004|Overall Study|Lost to Follow-up|3|||
130700518|NCT01583530|470526434|FG005|Overall Study|Lost to Follow-up|0|||
130700519|NCT01583530|470526429|FG000|Overall Study|Lack of compliance|0|||
130700520|NCT01583530|470526430|FG001|Overall Study|Lack of compliance|0|||
130700521|NCT01583530|470526431|FG002|Overall Study|Lack of compliance|0|||
130922575|NCT03173313|471350887|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
130922576|NCT03173313|471350886|FG000|Overall Study|Bone Fracture|1|||
130922577|NCT03173313|471350887|FG001|Overall Study|Bone Fracture|0|||
130700522|NCT01583530|470526432|FG003|Overall Study|Lack of compliance|0|||
130700523|NCT01583530|470526433|FG004|Overall Study|Lack of compliance|1|||
130700524|NCT01583530|470526434|FG005|Overall Study|Lack of compliance|0|||
130700525|NCT04010227|470526435|FG000|Overall Study|Death|1|||
130700526|NCT04010227|470526436|FG001|Overall Study|Death|2|||
130922578|NCT01042678|471350891|FG000|Overall Study|Physician Decision|1|||
130922579|NCT01042678|471350892|FG001|Overall Study|Physician Decision|0|||
130922580|NCT01042678|471350893|FG002|Overall Study|Physician Decision|0|||
130922581|NCT01042678|471350894|FG003|Overall Study|Physician Decision|0|||
130922582|NCT01042678|471350895|FG004|Overall Study|Physician Decision|0|||
130922583|NCT01042678|471350896|FG005|Overall Study|Physician Decision|0|||
130922584|NCT01788228|471350904|FG000|Overall Study|Migrated/moved from study area|1|||
130922585|NCT01788228|471350905|FG001|Overall Study|Migrated/moved from study area|0|||
130922586|NCT00259610|471350909|FG000|Overall Study|Withdrawal by Subject|33|||
130922587|NCT00259610|471350910|FG001|Overall Study|Withdrawal by Subject|25|||
130922588|NCT00259610|471350911|FG002|Overall Study|Withdrawal by Subject|29|||
130922589|NCT00259610|471350912|FG003|Overall Study|Withdrawal by Subject|19|||
130922590|NCT00259610|471350909|FG000|Overall Study|Lost to Follow-up|19|||
130922591|NCT00259610|471350910|FG001|Overall Study|Lost to Follow-up|8|||
130922592|NCT00259610|471350911|FG002|Overall Study|Lost to Follow-up|18|||
130922593|NCT00259610|471350912|FG003|Overall Study|Lost to Follow-up|15|||
130922594|NCT00259610|471350909|FG000|Overall Study|Physician Decision|6|||
130922595|NCT00259610|471350910|FG001|Overall Study|Physician Decision|4|||
130922596|NCT00259610|471350911|FG002|Overall Study|Physician Decision|7|||
130922597|NCT00259610|471350912|FG003|Overall Study|Physician Decision|2|||
130922598|NCT00259610|471350909|FG000|Overall Study|Death|1|||
130922599|NCT00259610|471350910|FG001|Overall Study|Death|1|||
130922600|NCT00259610|471350911|FG002|Overall Study|Death|2|||
130922601|NCT00259610|471350912|FG003|Overall Study|Death|0|||
130922602|NCT00259610|471350909|FG000|Overall Study|non medical reason|6|||
130922603|NCT00259610|471350910|FG001|Overall Study|non medical reason|2|||
130922604|NCT00259610|471350911|FG002|Overall Study|non medical reason|10|||
130922605|NCT00259610|471350912|FG003|Overall Study|non medical reason|3|||
130922606|NCT00259610|471350909|FG000|Overall Study|Adverse Event|3|||
130922607|NCT00259610|471350910|FG001|Overall Study|Adverse Event|4|||
130922608|NCT00259610|471350911|FG002|Overall Study|Adverse Event|5|||
130922609|NCT00259610|471350912|FG003|Overall Study|Adverse Event|2|||
130922610|NCT00259610|471350909|FG000|Overall Study|Serious Adverse Event|8|||
130922611|NCT00259610|471350910|FG001|Overall Study|Serious Adverse Event|2|||
130922612|NCT00259610|471350911|FG002|Overall Study|Serious Adverse Event|2|||
130922613|NCT00259610|471350912|FG003|Overall Study|Serious Adverse Event|2|||
130922614|NCT03344796|471350915|FG000|Overall Study|Lost to Follow-up|0|||
130922615|NCT03344796|471350916|FG001|Overall Study|Lost to Follow-up|0|||
130922616|NCT03344796|471350917|FG002|Overall Study|Lost to Follow-up|0|||
130922617|NCT03344796|471350918|FG003|Overall Study|Lost to Follow-up|0|||
130769584|NCT01026818|470782507|FG003|Screening Period|Protocol Deviation|0|||
130769585|NCT01026818|470782504|FG000|Screening Period|Adverse Event|2|||
130769586|NCT01026818|470782505|FG001|Screening Period|Adverse Event|0|||
130769587|NCT01026818|470782506|FG002|Screening Period|Adverse Event|0|||
130769588|NCT01026818|470782507|FG003|Screening Period|Adverse Event|0|||
130769589|NCT01026818|470782504|FG000|Screening Period|Physician Decision|1|||
130769590|NCT01026818|470782505|FG001|Screening Period|Physician Decision|0|||
130769591|NCT01026818|470782506|FG002|Screening Period|Physician Decision|0|||
130769592|NCT01026818|470782507|FG003|Screening Period|Physician Decision|0|||
130769593|NCT01026818|470782504|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
130769594|NCT01026818|470782505|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
130769595|NCT01026818|470782506|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
130922618|NCT03344796|471350919|FG004|Overall Study|Lost to Follow-up|0|||
130922619|NCT03344796|471350920|FG005|Overall Study|Lost to Follow-up|2|||
130922620|NCT00289783|471350923|FG000|Primary Phase|Adverse Event|10|||
130922621|NCT00289783|471350924|FG001|Primary Phase|Adverse Event|1|||
130922622|NCT00289783|471350923|FG000|Primary Phase|Protocol Violation|27|||
130922623|NCT00289783|471350924|FG001|Primary Phase|Protocol Violation|6|||
130922624|NCT00289783|471350923|FG000|Primary Phase|Withdrawal by Subject|93|||
130922625|NCT00289783|471350924|FG001|Primary Phase|Withdrawal by Subject|40|||
130922626|NCT00289783|471350923|FG000|Primary Phase|Lost to Follow-up|60|||
130922627|NCT00289783|471350924|FG001|Primary Phase|Lost to Follow-up|14|||
130922628|NCT00289783|471350923|FG000|Primary Phase|Migration from the study area|26|||
130922629|NCT00289783|471350924|FG001|Primary Phase|Migration from the study area|10|||
130922630|NCT00289783|471350923|FG000|Primary Phase|Other|32|||
130922631|NCT00289783|471350924|FG001|Primary Phase|Other|12|||
130922632|NCT00289783|471350923|FG000|Fourth Dose Phase|Adverse Event|1|||
130922633|NCT00289783|471350924|FG001|Fourth Dose Phase|Adverse Event|0|||
130922634|NCT00289783|471350923|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
130922635|NCT00289783|471350924|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
130922636|NCT00289783|471350923|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
130922637|NCT00289783|471350924|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
130922638|NCT00289783|471350923|FG000|Fourth Dose Phase|Migration from the study area|1|||
130922639|NCT00289783|471350924|FG001|Fourth Dose Phase|Migration from the study area|1|||
130922640|NCT00289783|471350923|FG000|Fourth Dose Phase|Other|22|||
130922641|NCT00289783|471350924|FG001|Fourth Dose Phase|Other|10|||
130922642|NCT03298867|471350934|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
130922643|NCT03298867|471350935|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
130922644|NCT03298867|471350934|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
130922645|NCT03298867|471350935|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
130922646|NCT03298867|471350934|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
130922647|NCT03298867|471350935|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
130922648|NCT03298867|471350934|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
130922649|NCT03298867|471350935|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
130922650|NCT03298867|471350934|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
130922651|NCT03298867|471350935|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
130922652|NCT03298867|471350934|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
130922653|NCT03298867|471350935|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
130922654|NCT03298867|471350934|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
130922655|NCT03298867|471350935|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
130922656|NCT03298867|471350934|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
130922657|NCT03298867|471350935|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
130922658|NCT03298867|471350934|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
130922659|NCT03298867|471350935|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
130922660|NCT01453361|471350946|FG000|Overall Study|Disease Progression|6|||
130922661|NCT01453361|471350946|FG000|Overall Study|Screen-Failures|10|||
130922662|NCT01798004|471352729|FG000|Overall Study|Death|2|||
130922663|NCT01798004|471352729|FG000|Overall Study|Lack of Efficacy|8|||
130922664|NCT01798004|471352729|FG000|Overall Study|Physician Decision|25|||
130922665|NCT01798004|471352729|FG000|Overall Study|Withdrawal by Subject|4|||
130922666|NCT01798004|471352729|FG000|Overall Study|Ineligible|4|||
130922667|NCT01798004|471352729|FG000|Overall Study|Patient/parent refusal|7|||
130922668|NCT01798004|471352729|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
130922669|NCT01798004|471352729|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
130922670|NCT02323113|471352733|FG000|Overall Study|Adverse Event|3|||
130922671|NCT02323113|471352734|FG001|Overall Study|Adverse Event|3|||
130922672|NCT02323113|471352735|FG002|Overall Study|Adverse Event|2|||
130922673|NCT02323113|471352736|FG003|Overall Study|Adverse Event|5|||
130922674|NCT02323113|471352737|FG004|Overall Study|Adverse Event|8|||
130922675|NCT02323113|471352738|FG005|Overall Study|Adverse Event|3|||
130922676|NCT02323113|471352739|FG006|Overall Study|Adverse Event|6|||
130922677|NCT02323113|471352740|FG007|Overall Study|Adverse Event|0|||
130922678|NCT02323113|471352733|FG000|Overall Study|Progressive Disease|0|||
130922679|NCT02323113|471352734|FG001|Overall Study|Progressive Disease|1|||
130922680|NCT02323113|471352735|FG002|Overall Study|Progressive Disease|1|||
130922681|NCT02323113|471352736|FG003|Overall Study|Progressive Disease|0|||
130922682|NCT02323113|471352737|FG004|Overall Study|Progressive Disease|0|||
130922683|NCT02323113|471352738|FG005|Overall Study|Progressive Disease|3|||
130922684|NCT02323113|471352739|FG006|Overall Study|Progressive Disease|0|||
130922685|NCT02323113|471352740|FG007|Overall Study|Progressive Disease|0|||
130922686|NCT02323113|471352733|FG000|Overall Study|Symptomatic Deterioration|0|||
130922687|NCT02323113|471352734|FG001|Overall Study|Symptomatic Deterioration|0|||
130922688|NCT02323113|471352735|FG002|Overall Study|Symptomatic Deterioration|1|||
130922689|NCT02323113|471352736|FG003|Overall Study|Symptomatic Deterioration|0|||
130922690|NCT02323113|471352737|FG004|Overall Study|Symptomatic Deterioration|1|||
130922691|NCT02323113|471352738|FG005|Overall Study|Symptomatic Deterioration|0|||
130922692|NCT02323113|471352739|FG006|Overall Study|Symptomatic Deterioration|0|||
130922693|NCT02323113|471352740|FG007|Overall Study|Symptomatic Deterioration|0|||
130922694|NCT02323113|471352733|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
130922695|NCT02323113|471352734|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
130922696|NCT02323113|471352735|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130922697|NCT02323113|471352736|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
130922698|NCT02323113|471352737|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
130922699|NCT02323113|471352738|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
130922700|NCT02323113|471352739|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
130922701|NCT02323113|471352740|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
130922702|NCT02323113|471352733|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130922703|NCT02323113|471352734|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
130922704|NCT02323113|471352735|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
131034434|NCT04505904|471759190|FG000|Overall Study|Adverse Event|0|||
130922705|NCT02323113|471352736|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130922706|NCT02323113|471352737|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130922707|NCT02323113|471352738|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130922708|NCT02323113|471352739|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
131034435|NCT04505904|471759191|FG001|Overall Study|Adverse Event|1|||
131034436|NCT04505904|471759192|FG002|Overall Study|Adverse Event|0|||
130922709|NCT02323113|471352740|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
130922710|NCT00560105|471352747|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
130922711|NCT00560105|471352748|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
130922712|NCT01663532|471352749|FG000|Overall Study|Lost to Follow-up|9|||
130922713|NCT01663532|471352750|FG001|Overall Study|Lost to Follow-up|10|||
130922714|NCT01663532|471352749|FG000|Overall Study|Adverse Event|7|||
130922715|NCT01663532|471352750|FG001|Overall Study|Adverse Event|13|||
130922716|NCT01663532|471352749|FG000|Overall Study|Met Withdrawal Criteria|7|||
130922717|NCT01663532|471352750|FG001|Overall Study|Met Withdrawal Criteria|6|||
130922718|NCT01663532|471352749|FG000|Overall Study|Physician Decision|1|||
130922719|NCT01663532|471352750|FG001|Overall Study|Physician Decision|1|||
130922720|NCT01663532|471352749|FG000|Overall Study|Withdrawal by Subject|35|||
130922721|NCT01663532|471352750|FG001|Overall Study|Withdrawal by Subject|17|||
130922722|NCT01663532|471352749|FG000|Overall Study|Lack of Efficacy|15|||
130922723|NCT01663532|471352750|FG001|Overall Study|Lack of Efficacy|60|||
130922724|NCT01871532|471352758|FG000|Overall Study|Withdrawal by Subject|1|||
130922725|NCT01871532|471352759|FG001|Overall Study|Withdrawal by Subject|2|||
130922726|NCT01673867|471352761|FG000|Randomization|Adverse event unrelated to study drug|1|||
130922727|NCT01673867|471352762|FG001|Randomization|Adverse event unrelated to study drug|0|||
130922728|NCT01673867|471352761|FG000|Randomization|Participant request to discontinue study treatment|0|||
130922729|NCT01673867|471352762|FG001|Randomization|Participant request to discontinue study treatment|4|||
130922730|NCT01673867|471352761|FG000|Randomization|Withdrawal by participant|0|||
130922731|NCT01673867|471352762|FG001|Randomization|Withdrawal by participant|12|||
130922732|NCT01673867|471352761|FG000|Randomization|Lost to Follow-up|0|||
130922733|NCT01673867|471352762|FG001|Randomization|Lost to Follow-up|1|||
130922734|NCT01673867|471352761|FG000|Randomization|Participant no longer meets study criteria|4|||
130922735|NCT01673867|471352762|FG001|Randomization|Participant no longer meets study criteria|5|||
130922736|NCT01673867|471352761|FG000|Treatment|Disease Progression|208|||
130922737|NCT01673867|471352762|FG001|Treatment|Disease Progression|178|||
130922738|NCT01673867|471352761|FG000|Treatment|Study Drug Toxicity|23|||
130922739|NCT01673867|471352762|FG001|Treatment|Study Drug Toxicity|43|||
130922740|NCT01673867|471352761|FG000|Treatment|Death|2|||
130922741|NCT01673867|471352762|FG001|Treatment|Death|3|||
130922742|NCT01673867|471352761|FG000|Treatment|Adverse event unrelated to study drug|23|||
130922743|NCT01673867|471352762|FG001|Treatment|Adverse event unrelated to study drug|10|||
130922744|NCT01673867|471352761|FG000|Treatment|Participant request to discontinue study treatment|7|||
130922745|NCT01673867|471352762|FG001|Treatment|Participant request to discontinue study treatment|17|||
130922746|NCT01673867|471352761|FG000|Treatment|Withdrawal by participant|5|||
130922747|NCT01673867|471352762|FG001|Treatment|Withdrawal by participant|5|||
130922748|NCT01673867|471352761|FG000|Treatment|Maximum clinical benefit|1|||
130922749|NCT01673867|471352762|FG001|Treatment|Maximum clinical benefit|10|||
130922750|NCT01673867|471352761|FG000|Treatment|Participant no longer meets study criteria|2|||
130922751|NCT01673867|471352762|FG001|Treatment|Participant no longer meets study criteria|0|||
130922752|NCT01673867|471352761|FG000|Treatment|Administrative reason by sponsor|3|||
130922753|NCT01673867|471352762|FG001|Treatment|Administrative reason by sponsor|0|||
130922754|NCT01673867|471352761|FG000|Treatment|Other reason|11|||
130922755|NCT01673867|471352762|FG001|Treatment|Other reason|2|||
130922756|NCT00983437|471352763|FG000|Overall Study|Adverse Event|9|||
130922757|NCT00983437|471352763|FG000|Overall Study|Lack of Efficacy|1|||
130922758|NCT00983437|471352763|FG000|Overall Study|Withdrawal by Subject|8|||
130922759|NCT00983437|471352763|FG000|Overall Study|Noncompliance to Study Procedures|1|||
130922760|NCT00983437|471352763|FG000|Overall Study|Lost to Follow-up|2|||
130922761|NCT00983437|471352763|FG000|Overall Study|Other Reason|26|||
130922762|NCT01945281|471352764|FG000|Overall Study|Adverse Event|1|||
130922763|NCT01945281|471352765|FG001|Overall Study|Adverse Event|0|||
130922764|NCT01945281|471352764|FG000|Overall Study|Death|3|||
130700527|NCT04010227|470526435|FG000|Overall Study|Medical Reasons|4|||
130700528|NCT04010227|470526436|FG001|Overall Study|Medical Reasons|3|||
130922765|NCT01945281|471352765|FG001|Overall Study|Death|3|||
130922766|NCT01945281|471352764|FG000|Overall Study|Physician Decision|1|||
130922767|NCT01945281|471352765|FG001|Overall Study|Physician Decision|1|||
130922768|NCT01945281|471352764|FG000|Overall Study|Technical Problems|1|||
130922769|NCT01945281|471352765|FG001|Overall Study|Technical Problems|0|||
130922770|NCT02165215|471352767|FG000|Induction Phase|Adverse Event|1|||
130922771|NCT02165215|471352768|FG001|Induction Phase|Adverse Event|0|||
130700529|NCT04010227|470526435|FG000|Overall Study|Withdrawal by Subject|2|||
130922772|NCT02165215|471352769|FG002|Induction Phase|Adverse Event|0|||
130922773|NCT02165215|471352767|FG000|Induction Phase|Withdrawal by Subject|10|||
130922774|NCT02165215|471352768|FG001|Induction Phase|Withdrawal by Subject|0|||
130922775|NCT02165215|471352769|FG002|Induction Phase|Withdrawal by Subject|0|||
130700530|NCT04010227|470526436|FG001|Overall Study|Withdrawal by Subject|0|||
130720850|NCT04126213|470601547|FG002|Overall Study|Withdrawal by Subject|1|||
130922776|NCT02165215|471352767|FG000|Induction Phase|Protocol Violation|1|||
130922777|NCT02165215|471352768|FG001|Induction Phase|Protocol Violation|0|||
130922778|NCT02165215|471352769|FG002|Induction Phase|Protocol Violation|0|||
130922779|NCT02165215|471352767|FG000|Induction Phase|Physician Decision|1|||
130922780|NCT02165215|471352768|FG001|Induction Phase|Physician Decision|0|||
130922781|NCT02165215|471352769|FG002|Induction Phase|Physician Decision|0|||
130922782|NCT02165215|471352767|FG000|Induction Phase|Lack of Efficacy|2|||
130922783|NCT02165215|471352768|FG001|Induction Phase|Lack of Efficacy|0|||
130922784|NCT02165215|471352769|FG002|Induction Phase|Lack of Efficacy|0|||
130922785|NCT02165215|471352767|FG000|Induction Phase|Non-Compliance|2|||
130922786|NCT02165215|471352768|FG001|Induction Phase|Non-Compliance|0|||
130922787|NCT02165215|471352769|FG002|Induction Phase|Non-Compliance|0|||
130922788|NCT02165215|471352767|FG000|Induction Phase|Lost to Follow-up|6|||
130922789|NCT02165215|471352768|FG001|Induction Phase|Lost to Follow-up|0|||
130922790|NCT02165215|471352769|FG002|Induction Phase|Lost to Follow-up|0|||
130922791|NCT02165215|471352767|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130922792|NCT02165215|471352768|FG001|Maintenance Phase|Withdrawal by Subject|7|||
130922793|NCT02165215|471352769|FG002|Maintenance Phase|Withdrawal by Subject|3|||
130922794|NCT02165215|471352767|FG000|Maintenance Phase|Multiple reasons|0|||
131223310|NCT00363129|472445071|FG000|Overall Study|Alternate Treatment|2|||
131223311|NCT00363129|472445072|FG001|Overall Study|Alternate Treatment|4|||
131223312|NCT00363129|472445071|FG000|Overall Study|Other Medical Problems|2|||
131223313|NCT00363129|472445072|FG001|Overall Study|Other Medical Problems|4|||
131223314|NCT00363129|472445071|FG000|Overall Study|Death|0|||
131223315|NCT00363129|472445072|FG001|Overall Study|Death|1|||
131223316|NCT00363129|472445071|FG000|Overall Study|Other Reasons|6|||
131223317|NCT00363129|472445072|FG001|Overall Study|Other Reasons|3|||
131223318|NCT03125915|472445073|FG000|1 Month Follow up|Lost to Follow-up|3|||
131223319|NCT03125915|472445074|FG001|1 Month Follow up|Lost to Follow-up|3|||
131223320|NCT03125915|472445075|FG002|1 Month Follow up|Lost to Follow-up|2|||
131223321|NCT03125915|472445076|FG003|1 Month Follow up|Lost to Follow-up|3|||
131223322|NCT03125915|472445073|FG000|3 Month Follow-up|Lost to Follow-up|6|||
131223323|NCT03125915|472445074|FG001|3 Month Follow-up|Lost to Follow-up|4|||
131223324|NCT03125915|472445075|FG002|3 Month Follow-up|Lost to Follow-up|4|||
131223325|NCT03125915|472445076|FG003|3 Month Follow-up|Lost to Follow-up|2|||
131223326|NCT03125915|472445073|FG000|6 Month Follow-up|Lost to Follow-up|7|||
131223327|NCT03125915|472445074|FG001|6 Month Follow-up|Lost to Follow-up|3|||
131223328|NCT03125915|472445075|FG002|6 Month Follow-up|Lost to Follow-up|6|||
130700531|NCT04010227|470526435|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
130700532|NCT04010227|470526436|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
130700533|NCT01841073|470526437|FG000|Overall Study|Adverse Event|1|||
130700534|NCT01841073|470526438|FG001|Overall Study|Adverse Event|1|||
130700535|NCT01841073|470526437|FG000|Overall Study|Physician Decision|1|||
130700536|NCT01841073|470526438|FG001|Overall Study|Physician Decision|0|||
130700537|NCT01841073|470526437|FG000|Overall Study|Lost to Follow-up|0|||
130700538|NCT01841073|470526438|FG001|Overall Study|Lost to Follow-up|2|||
130700539|NCT00283842|470526443|FG000|Overall Study|Adverse Event|8|||
130700540|NCT00283842|470526444|FG001|Overall Study|Adverse Event|7|||
130700541|NCT00283842|470526445|FG002|Overall Study|Adverse Event|21|||
130700542|NCT00283842|470526446|FG003|Overall Study|Adverse Event|21|||
130700543|NCT00283842|470526447|FG004|Overall Study|Adverse Event|5|||
130700544|NCT00283842|470526443|FG000|Overall Study|Protocol Violation|1|||
130700545|NCT00283842|470526444|FG001|Overall Study|Protocol Violation|5|||
130700546|NCT00283842|470526445|FG002|Overall Study|Protocol Violation|4|||
130700547|NCT00283842|470526446|FG003|Overall Study|Protocol Violation|0|||
130700548|NCT00283842|470526447|FG004|Overall Study|Protocol Violation|0|||
130700549|NCT00283842|470526443|FG000|Overall Study|Protocol deviation|0|||
130700550|NCT00283842|470526444|FG001|Overall Study|Protocol deviation|0|||
130700551|NCT00283842|470526445|FG002|Overall Study|Protocol deviation|0|||
130700552|NCT00283842|470526446|FG003|Overall Study|Protocol deviation|0|||
130700553|NCT00283842|470526447|FG004|Overall Study|Protocol deviation|2|||
130700554|NCT00283842|470526443|FG000|Overall Study|Withdrawal by Subject|2|||
130700555|NCT00283842|470526444|FG001|Overall Study|Withdrawal by Subject|1|||
130700556|NCT00283842|470526445|FG002|Overall Study|Withdrawal by Subject|1|||
130700557|NCT00283842|470526446|FG003|Overall Study|Withdrawal by Subject|5|||
130700558|NCT00283842|470526447|FG004|Overall Study|Withdrawal by Subject|4|||
130922795|NCT02165215|471352768|FG001|Maintenance Phase|Multiple reasons|2|||
130922796|NCT02165215|471352769|FG002|Maintenance Phase|Multiple reasons|1|||
130922797|NCT02165215|471352767|FG000|Maintenance Phase|Lost to Follow-up|0|||
130922798|NCT02165215|471352768|FG001|Maintenance Phase|Lost to Follow-up|2|||
130922799|NCT02165215|471352769|FG002|Maintenance Phase|Lost to Follow-up|0|||
130922800|NCT02165215|471352767|FG000|Maintenance Phase|Adverse Event|0|||
130922801|NCT02165215|471352768|FG001|Maintenance Phase|Adverse Event|1|||
130922802|NCT02165215|471352769|FG002|Maintenance Phase|Adverse Event|1|||
130922803|NCT00319553|471352770|FG000|Overall Study|Protocol Violation|1|||
130922804|NCT00319553|471352771|FG001|Overall Study|Protocol Violation|2|||
131223329|NCT03125915|472445076|FG003|6 Month Follow-up|Lost to Follow-up|3|||
131223330|NCT01458119|472445082|FG000|Overall Study|Physician Decision|4|||
131223331|NCT01458119|472445082|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
131223332|NCT01458119|472445082|FG000|Overall Study|Pregnancy|1|||
131223333|NCT01458119|472445082|FG000|Overall Study|Death|2|||
130700559|NCT00283842|470526443|FG000|Overall Study|Lack of Efficacy|1|||
130700560|NCT00283842|470526444|FG001|Overall Study|Lack of Efficacy|3|||
130700561|NCT00283842|470526445|FG002|Overall Study|Lack of Efficacy|1|||
130700562|NCT00283842|470526446|FG003|Overall Study|Lack of Efficacy|0|||
130700563|NCT00283842|470526447|FG004|Overall Study|Lack of Efficacy|3|||
130700564|NCT00283842|470526443|FG000|Overall Study|Lost to Follow-up|0|||
130922805|NCT00319553|471352770|FG000|Overall Study|Lost to Follow-up|2|||
130922806|NCT00319553|471352771|FG001|Overall Study|Lost to Follow-up|1|||
130700565|NCT00283842|470526444|FG001|Overall Study|Lost to Follow-up|2|||
130700566|NCT00283842|470526445|FG002|Overall Study|Lost to Follow-up|4|||
130700567|NCT00283842|470526446|FG003|Overall Study|Lost to Follow-up|1|||
130700568|NCT00283842|470526447|FG004|Overall Study|Lost to Follow-up|1|||
130700569|NCT01824498|470526448|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
130700570|NCT01824498|470526449|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
130922807|NCT00319553|471352770|FG000|Overall Study|Withdrawal by Subject|1|||
130922808|NCT00319553|471352771|FG001|Overall Study|Withdrawal by Subject|1|||
130922809|NCT01281865|471352777|FG000|Overall Study|Adverse Event|1|||
130922810|NCT01281865|471352778|FG001|Overall Study|Adverse Event|1|||
130922811|NCT01281865|471352777|FG000|Overall Study|Withdrawal by Subject|1|||
130922812|NCT01281865|471352778|FG001|Overall Study|Withdrawal by Subject|0|||
130922813|NCT01281865|471352777|FG000|Overall Study|Lack of Efficacy|1|||
130922814|NCT01281865|471352778|FG001|Overall Study|Lack of Efficacy|0|||
130922815|NCT01849783|471352779|FG000|Overall Study|Adverse Event|5|||
130922816|NCT01849783|471352779|FG000|Overall Study|Death|2|||
130922817|NCT01849783|471352779|FG000|Overall Study|Physician Decision|1|||
130922818|NCT01849783|471352779|FG000|Overall Study|Withdrawal by Subject|1|||
130922819|NCT01849783|471352779|FG000|Overall Study|Unable to comply|2|||
130922820|NCT01849783|471352779|FG000|Overall Study|Disease progression|11|||
130922821|NCT03948581|471352780|FG000|Overall Study|Lost to Follow-up|0|||
130922822|NCT03948581|471352781|FG001|Overall Study|Lost to Follow-up|1|||
130922823|NCT04457336|471352782|FG000|Period 2: Part A|Withdrawal by Subject|0|||
130922824|NCT04457336|471352783|FG001|Period 2: Part A|Withdrawal by Subject|1|||
130922825|NCT04457336|471352784|FG002|Period 2: Part A|Withdrawal by Subject|1|||
130922826|NCT04457336|471352785|FG003|Period 2: Part A|Withdrawal by Subject|1|||
130922827|NCT04457336|471352786|FG004|Period 2: Part A|Withdrawal by Subject|0|||
130922828|NCT04457336|471352787|FG005|Period 2: Part A|Withdrawal by Subject|0|||
130922829|NCT04457336|471352788|FG006|Period 2: Part A|Withdrawal by Subject|0|||
130922830|NCT04457336|471352789|FG007|Period 2: Part A|Withdrawal by Subject|0|||
130922831|NCT04457336|471352782|FG000|Period 2: Part A|Adverse Event|0|||
130922832|NCT04457336|471352783|FG001|Period 2: Part A|Adverse Event|0|||
130922833|NCT04457336|471352784|FG002|Period 2: Part A|Adverse Event|1|||
130922834|NCT04457336|471352785|FG003|Period 2: Part A|Adverse Event|1|||
130922835|NCT04457336|471352786|FG004|Period 2: Part A|Adverse Event|0|||
130922836|NCT04457336|471352787|FG005|Period 2: Part A|Adverse Event|0|||
130922837|NCT04457336|471352788|FG006|Period 2: Part A|Adverse Event|0|||
130922838|NCT04457336|471352789|FG007|Period 2: Part A|Adverse Event|0|||
130922839|NCT04457336|471352782|FG000|Period 2: Part A|Study Terminated|0|||
130922840|NCT04457336|471352783|FG001|Period 2: Part A|Study Terminated|0|||
130922841|NCT04457336|471352784|FG002|Period 2: Part A|Study Terminated|1|||
130922842|NCT04457336|471352785|FG003|Period 2: Part A|Study Terminated|0|||
130922843|NCT04457336|471352786|FG004|Period 2: Part A|Study Terminated|0|||
130922844|NCT04457336|471352787|FG005|Period 2: Part A|Study Terminated|0|||
130922845|NCT04457336|471352788|FG006|Period 2: Part A|Study Terminated|0|||
130922846|NCT04457336|471352789|FG007|Period 2: Part A|Study Terminated|0|||
130922847|NCT04457336|471352782|FG000|Period 2: Part A|Protocol Violation|0|||
130922848|NCT04457336|471352783|FG001|Period 2: Part A|Protocol Violation|1|||
130922849|NCT04457336|471352784|FG002|Period 2: Part A|Protocol Violation|0|||
130922850|NCT04457336|471352785|FG003|Period 2: Part A|Protocol Violation|0|||
130922851|NCT04457336|471352786|FG004|Period 2: Part A|Protocol Violation|0|||
130922852|NCT04457336|471352787|FG005|Period 2: Part A|Protocol Violation|0|||
130922853|NCT04457336|471352788|FG006|Period 2: Part A|Protocol Violation|0|||
130922854|NCT04457336|471352789|FG007|Period 2: Part A|Protocol Violation|0|||
130922855|NCT04457336|471352782|FG000|Period 2: Part A|Lost to Follow-up|0|||
130922856|NCT04457336|471352783|FG001|Period 2: Part A|Lost to Follow-up|1|||
131223334|NCT01458119|472445082|FG000|Overall Study|Adverse Event|1|||
131223335|NCT01458119|472445082|FG000|Overall Study|Consent Withdrawn by Participant|8|||
130700571|NCT01824498|470526450|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
130769596|NCT01026818|470782507|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
130922857|NCT04457336|471352784|FG002|Period 2: Part A|Lost to Follow-up|0|||
130922858|NCT04457336|471352785|FG003|Period 2: Part A|Lost to Follow-up|0|||
130922859|NCT04457336|471352786|FG004|Period 2: Part A|Lost to Follow-up|0|||
130922860|NCT04457336|471352787|FG005|Period 2: Part A|Lost to Follow-up|0|||
130922861|NCT04457336|471352788|FG006|Period 2: Part A|Lost to Follow-up|0|||
130922862|NCT04457336|471352789|FG007|Period 2: Part A|Lost to Follow-up|0|||
130700572|NCT01824498|470526451|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
130922863|NCT04457336|471352782|FG000|Period 2: Part A|Other|0|||
130922864|NCT04457336|471352783|FG001|Period 2: Part A|Other|1|||
130922865|NCT04457336|471352784|FG002|Period 2: Part A|Other|0|||
130922866|NCT04457336|471352785|FG003|Period 2: Part A|Other|0|||
130922867|NCT04457336|471352786|FG004|Period 2: Part A|Other|0|||
130922868|NCT04457336|471352787|FG005|Period 2: Part A|Other|0|||
130922869|NCT04457336|471352788|FG006|Period 2: Part A|Other|0|||
130922870|NCT04457336|471352789|FG007|Period 2: Part A|Other|0|||
130922871|NCT04457336|471352782|FG000|Period 2: Part A|Physician Decision|0|||
130922872|NCT04457336|471352783|FG001|Period 2: Part A|Physician Decision|0|||
130922873|NCT04457336|471352784|FG002|Period 2: Part A|Physician Decision|0|||
130922874|NCT04457336|471352785|FG003|Period 2: Part A|Physician Decision|1|||
130922875|NCT04457336|471352786|FG004|Period 2: Part A|Physician Decision|0|||
130922876|NCT04457336|471352787|FG005|Period 2: Part A|Physician Decision|0|||
130922877|NCT04457336|471352788|FG006|Period 2: Part A|Physician Decision|0|||
130922878|NCT04457336|471352789|FG007|Period 2: Part A|Physician Decision|0|||
130922879|NCT04457336|471352782|FG000|Period 3: Part B|Study Terminated|0|||
130922880|NCT04457336|471352783|FG001|Period 3: Part B|Study Terminated|0|||
130922881|NCT04457336|471352784|FG002|Period 3: Part B|Study Terminated|0|||
130922882|NCT04457336|471352785|FG003|Period 3: Part B|Study Terminated|0|||
130922883|NCT04457336|471352786|FG004|Period 3: Part B|Study Terminated|1|||
130922884|NCT04457336|471352787|FG005|Period 3: Part B|Study Terminated|10|||
130922885|NCT04457336|471352788|FG006|Period 3: Part B|Study Terminated|13|||
130922886|NCT04457336|471352789|FG007|Period 3: Part B|Study Terminated|0|||
130922887|NCT04457336|471352782|FG000|Period 3: Part B|Withdrawal by Subject|0|||
130922888|NCT04457336|471352783|FG001|Period 3: Part B|Withdrawal by Subject|0|||
130922889|NCT04457336|471352784|FG002|Period 3: Part B|Withdrawal by Subject|0|||
130700573|NCT01824498|470526452|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
130700574|NCT01824498|470526453|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
130700575|NCT04320745|470526454|FG000|Overall Study|Adverse Event|26|||
130700576|NCT04320745|470526454|FG000|Overall Study|Withdrawal by Subject|4|||
130700577|NCT04320745|470526454|FG000|Overall Study|Lost to Follow-up|12|||
130700578|NCT04320745|470526454|FG000|Overall Study|Protocol Deviation|2|||
130700579|NCT04320745|470526454|FG000|Overall Study|Non-compliance With Study Drug|2|||
130700580|NCT04320745|470526454|FG000|Overall Study|Reason Not Specified|1|||
130700581|NCT00046839|470526455|FG000|Overall Study|Ineligible / No protocol treatment|0|||
130700582|NCT00046839|470526456|FG001|Overall Study|Ineligible / No protocol treatment|2|||
130700583|NCT00046839|470526455|FG000|Overall Study|Withdrawal of consent|1|||
130700584|NCT00046839|470526456|FG001|Overall Study|Withdrawal of consent|0|||
130922890|NCT04457336|471352785|FG003|Period 3: Part B|Withdrawal by Subject|0|||
130922891|NCT04457336|471352786|FG004|Period 3: Part B|Withdrawal by Subject|0|||
130922892|NCT04457336|471352787|FG005|Period 3: Part B|Withdrawal by Subject|1|||
130922893|NCT04457336|471352788|FG006|Period 3: Part B|Withdrawal by Subject|2|||
130922894|NCT04457336|471352789|FG007|Period 3: Part B|Withdrawal by Subject|0|||
130922895|NCT04457336|471352782|FG000|Period 4: Part C|Study Terminated|0|||
130922896|NCT04457336|471352783|FG001|Period 4: Part C|Study Terminated|0|||
130922897|NCT04457336|471352784|FG002|Period 4: Part C|Study Terminated|0|||
130922898|NCT04457336|471352785|FG003|Period 4: Part C|Study Terminated|0|||
130922899|NCT04457336|471352786|FG004|Period 4: Part C|Study Terminated|0|||
130922900|NCT04457336|471352787|FG005|Period 4: Part C|Study Terminated|0|||
130922901|NCT04457336|471352788|FG006|Period 4: Part C|Study Terminated|0|||
130922902|NCT04457336|471352789|FG007|Period 4: Part C|Study Terminated|30|||
130700585|NCT02472639|470526458|FG000|Overall Study|Physician Decision|4|||
130700586|NCT02472639|470526459|FG001|Overall Study|Physician Decision|3|||
130700587|NCT00702507|470526462|FG000|Initial Treatment Phase|Adverse Event|2|||
130700588|NCT00702507|470526462|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
130700589|NCT00702507|470526462|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
130700590|NCT00702507|470526462|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
130700591|NCT00702507|470526462|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
130700592|NCT00702507|470526462|FG000|Follow-up Phase|Protocol Violation|2|||
130700593|NCT00702507|470526462|FG000|Follow-up Phase|Lost to Follow-up|23|||
130700594|NCT00702507|470526462|FG000|Follow-up Phase|Late Enrollment|1|||
130700595|NCT02308696|470526463|FG000|Overall Study|Lost to Follow-up|28|||
130700596|NCT02308696|470526464|FG001|Overall Study|Lost to Follow-up|21|||
130700597|NCT02308696|470526463|FG000|Overall Study|Death|8|||
130700598|NCT02308696|470526464|FG001|Overall Study|Death|4|||
130922903|NCT04457336|471352782|FG000|Period 4: Part C|Adverse Event|0|||
130922904|NCT04457336|471352783|FG001|Period 4: Part C|Adverse Event|0|||
130922905|NCT04457336|471352784|FG002|Period 4: Part C|Adverse Event|0|||
130922906|NCT04457336|471352785|FG003|Period 4: Part C|Adverse Event|0|||
130922907|NCT04457336|471352786|FG004|Period 4: Part C|Adverse Event|0|||
130922908|NCT04457336|471352787|FG005|Period 4: Part C|Adverse Event|0|||
130922909|NCT04457336|471352788|FG006|Period 4: Part C|Adverse Event|0|||
130922910|NCT04457336|471352789|FG007|Period 4: Part C|Adverse Event|2|||
130922911|NCT04457336|471352782|FG000|Period 4: Part C|Site Terminated|0|||
130922912|NCT04457336|471352783|FG001|Period 4: Part C|Site Terminated|0|||
130922913|NCT04457336|471352784|FG002|Period 4: Part C|Site Terminated|0|||
130922914|NCT04457336|471352785|FG003|Period 4: Part C|Site Terminated|0|||
130922915|NCT04457336|471352786|FG004|Period 4: Part C|Site Terminated|0|||
130922916|NCT04457336|471352787|FG005|Period 4: Part C|Site Terminated|0|||
130922917|NCT04457336|471352788|FG006|Period 4: Part C|Site Terminated|0|||
130922918|NCT04457336|471352789|FG007|Period 4: Part C|Site Terminated|1|||
130922919|NCT04457336|471352782|FG000|Period 4: Part C|Other|0|||
130922920|NCT04457336|471352783|FG001|Period 4: Part C|Other|0|||
130922921|NCT04457336|471352784|FG002|Period 4: Part C|Other|0|||
130922922|NCT04457336|471352785|FG003|Period 4: Part C|Other|0|||
130922923|NCT04457336|471352786|FG004|Period 4: Part C|Other|0|||
130922924|NCT04457336|471352787|FG005|Period 4: Part C|Other|0|||
130922925|NCT04457336|471352788|FG006|Period 4: Part C|Other|0|||
130922926|NCT04457336|471352789|FG007|Period 4: Part C|Other|2|||
130922927|NCT04457336|471352782|FG000|Period 4: Part C|Withdrawal by Subject|0|||
130922928|NCT04457336|471352783|FG001|Period 4: Part C|Withdrawal by Subject|0|||
130922929|NCT04457336|471352784|FG002|Period 4: Part C|Withdrawal by Subject|0|||
130922930|NCT04457336|471352785|FG003|Period 4: Part C|Withdrawal by Subject|0|||
130922931|NCT04457336|471352786|FG004|Period 4: Part C|Withdrawal by Subject|0|||
130922932|NCT04457336|471352787|FG005|Period 4: Part C|Withdrawal by Subject|0|||
130700599|NCT02308696|470526463|FG000|Overall Study|Moved to a Higher Level of Care|17|||
130922933|NCT04457336|471352788|FG006|Period 4: Part C|Withdrawal by Subject|0|||
130922934|NCT04457336|471352789|FG007|Period 4: Part C|Withdrawal by Subject|3|||
130922935|NCT03330288|471352796|FG000|Overall Study|Other reason|1|||
130922936|NCT03330288|471352797|FG001|Overall Study|Other reason|1|||
130700600|NCT02308696|470526464|FG001|Overall Study|Moved to a Higher Level of Care|6|||
130700601|NCT01211262|470526467|FG000|Overall Study|Progressive Disease|18|||
130700602|NCT01211262|470526468|FG001|Overall Study|Progressive Disease|9|||
130700603|NCT01211262|470526467|FG000|Overall Study|Adverse Event|4|||
130700604|NCT01211262|470526468|FG001|Overall Study|Adverse Event|0|||
130700605|NCT01211262|470526467|FG000|Overall Study|Withdrawal of Consent|1|||
130700606|NCT01211262|470526468|FG001|Overall Study|Withdrawal of Consent|0|||
130700607|NCT01211262|470526467|FG000|Overall Study|Other|0|||
130700608|NCT01211262|470526468|FG001|Overall Study|Other|1|||
130700609|NCT01277510|470526471|FG000|Double-blind Phase|Non-compliance|0|||
130700610|NCT01277510|470526472|FG001|Double-blind Phase|Non-compliance|1|||
130700611|NCT01277510|470526471|FG000|Double-blind Phase|Adverse Event|1|||
130700612|NCT01277510|470526472|FG001|Double-blind Phase|Adverse Event|0|||
130700613|NCT01277510|470526471|FG000|Double-blind Phase|Withdrawal by Subject|2|||
130700614|NCT01277510|470526472|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130700615|NCT01277510|470526471|FG000|Double-blind Phase|Administrative decision|7|||
130700616|NCT01277510|470526472|FG001|Double-blind Phase|Administrative decision|9|||
130700617|NCT01277510|470526471|FG000|Double-blind Phase|Death|0|||
130700618|NCT01277510|470526472|FG001|Double-blind Phase|Death|1|||
130700619|NCT01277510|470526471|FG000|Double-blind Phase|Protocol-specified criteria|2|||
130700620|NCT01277510|470526472|FG001|Double-blind Phase|Protocol-specified criteria|6|||
130700621|NCT01277510|470526471|FG000|Double-blind Phase|Other|1|||
130700622|NCT01277510|470526472|FG001|Double-blind Phase|Other|1|||
130700623|NCT01277510|470526471|FG000|Open-label Phase|Administrative decision|4|||
130700624|NCT01277510|470526472|FG001|Open-label Phase|Administrative decision|3|||
130700625|NCT01277510|470526471|FG000|Open-label Phase|Protocol-specified criteria|1|||
130700626|NCT01277510|470526472|FG001|Open-label Phase|Protocol-specified criteria|0|||
130700627|NCT01277510|470526471|FG000|Open-label Phase|Never received investigational product|2|||
130700628|NCT01277510|470526472|FG001|Open-label Phase|Never received investigational product|0|||
130700629|NCT04768114|470526473|FG000|Overall Study|Lost to Follow-up|5|||
130700630|NCT04768114|470526474|FG001|Overall Study|Lost to Follow-up|10|||
130700631|NCT04768114|470526473|FG000|Overall Study|Withdrawal by Subject|0|||
130700632|NCT04768114|470526474|FG001|Overall Study|Withdrawal by Subject|1|||
130700633|NCT03980522|470526478|FG000|Treatment Period|Adverse Event|1|||
130700634|NCT03980522|470526479|FG001|Treatment Period|Adverse Event|0|||
130700635|NCT03980522|470526480|FG002|Treatment Period|Adverse Event|0|||
130700636|NCT03980522|470526481|FG003|Treatment Period|Adverse Event|0|||
130700637|NCT03980522|470526482|FG004|Treatment Period|Adverse Event|0|||
130700638|NCT04892147|470526483|FG000|Overall Study|Withdrawal by Subject|2|||
130700639|NCT04892147|470526484|FG001|Overall Study|Withdrawal by Subject|0|||
130700640|NCT05263505|470526485|FG000|Overall Study|Adverse Event|0|||
130700641|NCT05263505|470526486|FG001|Overall Study|Adverse Event|1|||
130700642|NCT03428945|470526488|FG000|Overall Study|Lost to Follow-up|5|||
130922937|NCT03330288|471352796|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
130922938|NCT03330288|471352797|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
130700643|NCT03428945|470526489|FG001|Overall Study|Lost to Follow-up|3|||
130700644|NCT03428945|470526488|FG000|Overall Study|Withdrawal by Subject|10|||
130700645|NCT03428945|470526489|FG001|Overall Study|Withdrawal by Subject|10|||
130700646|NCT01598896|470526491|FG000|Overall Study|Withdrawal by Subject|0|||
130700647|NCT01598896|470526492|FG001|Overall Study|Withdrawal by Subject|1|||
130700648|NCT01598896|470526491|FG000|Overall Study|Lack of Efficacy|0|||
130700649|NCT01598896|470526492|FG001|Overall Study|Lack of Efficacy|1|||
130700650|NCT01562613|470526493|FG000|Overall Study|Lost to Follow-up|2|||
130700651|NCT01562613|470526493|FG000|Overall Study|Withdrawal by Subject|2|||
130922939|NCT03330288|471352796|FG000|Overall Study|Adverse Event|1|||
130922940|NCT03330288|471352797|FG001|Overall Study|Adverse Event|0|||
130922941|NCT03330288|471352796|FG000|Overall Study|Withdrawal by Subject|1|||
130700652|NCT04640194|470526498|FG000|Overall Study|Adverse Event|3|||
130922942|NCT03330288|471352797|FG001|Overall Study|Withdrawal by Subject|0|||
130922943|NCT03330288|471352796|FG000|Overall Study|Lost to Follow-up|26|||
130922944|NCT03330288|471352797|FG001|Overall Study|Lost to Follow-up|7|||
130922945|NCT02693119|471352803|FG000|Open-Label Period|Withdrawal by Subject|0|||
130922946|NCT02693119|471352804|FG001|Open-Label Period|Withdrawal by Subject|1|||
130922947|NCT01719783|471352805|FG000|Dose 2|Physician Decision|1|||
130922948|NCT01719783|471352806|FG001|Dose 2|Physician Decision|0|||
130922949|NCT01350492|471352807|FG000|Intervention|Lost to Follow-up|2|||
130922950|NCT01350492|471352808|FG001|Intervention|Lost to Follow-up|5|||
130922951|NCT01350492|471352807|FG000|Intervention|Withdrawal by Subject|3|||
130922952|NCT01350492|471352808|FG001|Intervention|Withdrawal by Subject|1|||
130922953|NCT01350492|471352807|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
130922954|NCT01350492|471352808|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
130922955|NCT01350492|471352807|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
130922956|NCT01350492|471352808|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
130922957|NCT00939640|471352809|FG000|Overall Study|Physician Decision|1|||
130922958|NCT03988088|471352814|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
130922959|NCT03988088|471352815|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
130922960|NCT03988088|471352816|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
130922961|NCT03988088|471352817|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
130922962|NCT03988088|471352814|FG000|Open-Label Addendum|Lost to Follow-up|0|||
130922963|NCT03988088|471352815|FG001|Open-Label Addendum|Lost to Follow-up|0|||
130922964|NCT03988088|471352816|FG002|Open-Label Addendum|Lost to Follow-up|1|||
130922965|NCT03988088|471352817|FG003|Open-Label Addendum|Lost to Follow-up|0|||
130922966|NCT00181155|471352818|FG000|Overall Study|Physician Decision|1|||
130922967|NCT00181155|471352819|FG001|Overall Study|Physician Decision|0|||
130922968|NCT00181155|471352818|FG000|Overall Study|Withdrawal by Subject|1|||
130922969|NCT00181155|471352819|FG001|Overall Study|Withdrawal by Subject|0|||
130922970|NCT01548287|471352820|FG000|Screening|No reason provided|0|||
130922971|NCT01548287|471352821|FG001|Screening|No reason provided|0|||
130922972|NCT01548287|471352822|FG002|Screening|No reason provided|0|||
130922973|NCT01548287|471352823|FG003|Screening|No reason provided|0|||
130922974|NCT01548287|471352824|FG004|Screening|No reason provided|9|||
130922975|NCT01548287|471352820|FG000|Screening|Did not meet eligibility criteria|0|||
130922976|NCT01548287|471352821|FG001|Screening|Did not meet eligibility criteria|0|||
130922977|NCT01548287|471352822|FG002|Screening|Did not meet eligibility criteria|0|||
130922978|NCT01548287|471352823|FG003|Screening|Did not meet eligibility criteria|0|||
130922979|NCT01548287|471352824|FG004|Screening|Did not meet eligibility criteria|74|||
130922980|NCT01548287|471352820|FG000|Randomized Period|Did not meet inclusion criteria|0|||
130922981|NCT01548287|471352821|FG001|Randomized Period|Did not meet inclusion criteria|0|||
130922982|NCT01548287|471352822|FG002|Randomized Period|Did not meet inclusion criteria|2|||
130922983|NCT01548287|471352823|FG003|Randomized Period|Did not meet inclusion criteria|0|||
130922984|NCT01548287|471352824|FG004|Randomized Period|Did not meet inclusion criteria|0|||
130922985|NCT01548287|471352820|FG000|Randomized Period|Adverse Event|0|||
130922986|NCT01548287|471352821|FG001|Randomized Period|Adverse Event|2|||
130922987|NCT01548287|471352822|FG002|Randomized Period|Adverse Event|5|||
130922988|NCT01548287|471352823|FG003|Randomized Period|Adverse Event|0|||
130922989|NCT01548287|471352824|FG004|Randomized Period|Adverse Event|0|||
130922990|NCT02762578|471352825|FG000|Overall Study|Adverse Event|1|||
130922991|NCT02762578|471352826|FG001|Overall Study|Adverse Event|6|||
130922992|NCT02762578|471352825|FG000|Overall Study|Protocol Violation|4|||
130922993|NCT02762578|471352826|FG001|Overall Study|Protocol Violation|2|||
130922994|NCT02762578|471352825|FG000|Overall Study|Withdrawal by Subject|4|||
130922995|NCT02762578|471352826|FG001|Overall Study|Withdrawal by Subject|2|||
130922996|NCT02762578|471352825|FG000|Overall Study|Unclassified|6|||
130922997|NCT02762578|471352826|FG001|Overall Study|Unclassified|0|||
130922998|NCT02083965|471352827|FG000|Treatment Period|Other|1|||
130922999|NCT02083965|471352828|FG001|Treatment Period|Other|0|||
130923000|NCT01611155|471352829|FG000|Overall Study|Adverse Event|1|||
130923001|NCT01611155|471352830|FG001|Overall Study|Adverse Event|1|||
130923002|NCT01611155|471352829|FG000|Overall Study|Refused further treatment|6|||
130923003|NCT01611155|471352830|FG001|Overall Study|Refused further treatment|4|||
130923004|NCT01611155|471352829|FG000|Overall Study|Disease progression|1|||
130923005|NCT01611155|471352830|FG001|Overall Study|Disease progression|0|||
130923006|NCT01611155|471352829|FG000|Overall Study|Withdrawal by Subject|1|||
130923007|NCT01611155|471352830|FG001|Overall Study|Withdrawal by Subject|0|||
130923008|NCT01611155|471352829|FG000|Overall Study|Alternative treatment|0|||
130923009|NCT01611155|471352830|FG001|Overall Study|Alternative treatment|1|||
130923010|NCT01611155|471352829|FG000|Overall Study|Ineligible patient|0|||
131034437|NCT04505904|471759193|FG003|Overall Study|Adverse Event|0|||
131034438|NCT04925986|471759194|FG000|Overall Study|Death|0|||
131034439|NCT04925986|471759195|FG001|Overall Study|Death|0|||
130923011|NCT01611155|471352830|FG001|Overall Study|Ineligible patient|1|||
130923012|NCT02699593|471352833|FG000|Period 1|Unsatisfactory Visual Response|0|||
130923013|NCT02699593|471352834|FG001|Period 1|Unsatisfactory Visual Response|1|||
131034440|NCT04925986|471759196|FG002|Overall Study|Death|2|||
130923014|NCT02699593|471352833|FG000|Period 1|Torn Contact Len|4|||
130923015|NCT02699593|471352834|FG001|Period 1|Torn Contact Len|3|||
130923016|NCT02699593|471352833|FG000|Period 1|Protocol Violation|0|||
130923017|NCT02699593|471352834|FG001|Period 1|Protocol Violation|1|||
130923018|NCT02699593|471352833|FG000|Period 1|Withdrawal by Subject|0|||
130923019|NCT02699593|471352834|FG001|Period 1|Withdrawal by Subject|1|||
130923020|NCT02699593|471352833|FG000|Period 1|Adverse Event|1|||
130923021|NCT02699593|471352834|FG001|Period 1|Adverse Event|1|||
130923022|NCT02699593|471352833|FG000|Period 2|Adverse Event|1|||
130923023|NCT02699593|471352834|FG001|Period 2|Adverse Event|1|||
130923024|NCT02699593|471352833|FG000|Period 2|Lost Contact Lens|0|||
130923025|NCT02699593|471352834|FG001|Period 2|Lost Contact Lens|1|||
130923026|NCT02699593|471352833|FG000|Period 2|Torn Contact Lens|1|||
130923027|NCT02699593|471352834|FG001|Period 2|Torn Contact Lens|0|||
130923028|NCT04502433|471352835|FG000|Overall Study|Death|2|||
130923029|NCT04502433|471352836|FG001|Overall Study|Death|4|||
130923030|NCT04502433|471352835|FG000|Overall Study|Lost to Follow-up|1|||
130923031|NCT04502433|471352836|FG001|Overall Study|Lost to Follow-up|0|||
130923032|NCT04502433|471352835|FG000|Overall Study|Physician Decision|0|||
130923033|NCT04502433|471352836|FG001|Overall Study|Physician Decision|1|||
130923034|NCT00868608|471352837|FG000|Overall Study|Withdrawal by Subject|3|||
130923035|NCT00868608|471352838|FG001|Overall Study|Withdrawal by Subject|1|||
130923036|NCT00868608|471352839|FG002|Overall Study|Withdrawal by Subject|0|||
130923037|NCT00868608|471352837|FG000|Overall Study|Lost to Follow-up|3|||
130923038|NCT00868608|471352838|FG001|Overall Study|Lost to Follow-up|0|||
130923039|NCT00868608|471352839|FG002|Overall Study|Lost to Follow-up|1|||
130923040|NCT00868608|471352837|FG000|Overall Study|Death|16|||
130923041|NCT00868608|471352838|FG001|Overall Study|Death|2|||
130923042|NCT00868608|471352839|FG002|Overall Study|Death|4|||
130923043|NCT00868608|471352837|FG000|Overall Study|Other - Unspecified|1|||
130923044|NCT00868608|471352838|FG001|Overall Study|Other - Unspecified|0|||
130923045|NCT00868608|471352839|FG002|Overall Study|Other - Unspecified|0|||
130923046|NCT02935842|471352840|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
130923047|NCT02935842|471352841|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
130923048|NCT02935842|471352842|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
130923049|NCT02935842|471352843|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
130923050|NCT02935842|471352840|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
130923051|NCT02935842|471352841|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
130923052|NCT02935842|471352842|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
130923053|NCT02935842|471352843|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
130923054|NCT02935842|471352840|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
130923055|NCT02935842|471352841|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
130923056|NCT02935842|471352842|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
130923057|NCT02935842|471352843|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
130923058|NCT02935842|471352840|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
130923059|NCT02935842|471352841|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
130923060|NCT02935842|471352842|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
130923061|NCT02935842|471352843|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
130923062|NCT02935842|471352840|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
130923063|NCT02935842|471352841|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
130923064|NCT02935842|471352842|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
130923065|NCT02935842|471352843|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
130923066|NCT00911547|471352844|FG000|Overall Study|Adverse Event|8|||
130923067|NCT00911547|471352845|FG001|Overall Study|Adverse Event|27|||
130923068|NCT00911547|471352846|FG002|Overall Study|Adverse Event|11|||
130923069|NCT00911547|471352847|FG003|Overall Study|Adverse Event|6|||
130923070|NCT00911547|471352844|FG000|Overall Study|Lost to Follow-up|0|||
130923071|NCT00911547|471352845|FG001|Overall Study|Lost to Follow-up|0|||
130923072|NCT00911547|471352846|FG002|Overall Study|Lost to Follow-up|2|||
130700653|NCT04640194|470526499|FG001|Overall Study|Adverse Event|7|||
130700654|NCT04640194|470526500|FG002|Overall Study|Adverse Event|0|||
130700655|NCT04640194|470526501|FG003|Overall Study|Adverse Event|5|||
130700656|NCT04640194|470526502|FG004|Overall Study|Adverse Event|0|||
130700657|NCT04640194|470526503|FG005|Overall Study|Adverse Event|4|||
130700658|NCT04640194|470526504|FG006|Overall Study|Adverse Event|0|||
130700659|NCT04640194|470526498|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
130923073|NCT00911547|471352847|FG003|Overall Study|Lost to Follow-up|1|||
130923074|NCT00911547|471352844|FG000|Overall Study|Protocol Violation|0|||
130923075|NCT00911547|471352845|FG001|Overall Study|Protocol Violation|5|||
130923076|NCT00911547|471352846|FG002|Overall Study|Protocol Violation|5|||
130923077|NCT00911547|471352847|FG003|Overall Study|Protocol Violation|1|||
130923078|NCT00911547|471352844|FG000|Overall Study|Withdrawal by Subject|3|||
130923079|NCT00911547|471352845|FG001|Overall Study|Withdrawal by Subject|10|||
130923080|NCT00911547|471352846|FG002|Overall Study|Withdrawal by Subject|4|||
130700660|NCT04640194|470526499|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
130923081|NCT00911547|471352847|FG003|Overall Study|Withdrawal by Subject|8|||
130700661|NCT04640194|470526500|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
130923082|NCT01201785|471352848|FG000|Overall Study|Lost to Follow-up|16|||
130923083|NCT02151110|471352849|FG000|Overall Study|Withdrawal by Subject|0|||
130923084|NCT02151110|471352850|FG001|Overall Study|Withdrawal by Subject|0|||
130923085|NCT02151110|471352851|FG002|Overall Study|Withdrawal by Subject|0|||
130923086|NCT02151110|471352852|FG003|Overall Study|Withdrawal by Subject|0|||
130923087|NCT02151110|471352853|FG004|Overall Study|Withdrawal by Subject|0|||
130923088|NCT02151110|471352854|FG005|Overall Study|Withdrawal by Subject|0|||
130923089|NCT02151110|471352855|FG006|Overall Study|Withdrawal by Subject|0|||
130923090|NCT02151110|471352856|FG007|Overall Study|Withdrawal by Subject|1|||
130923091|NCT02151110|471352849|FG000|Overall Study|Lost to Follow-up|0|||
130923092|NCT02151110|471352850|FG001|Overall Study|Lost to Follow-up|0|||
130923093|NCT02151110|471352851|FG002|Overall Study|Lost to Follow-up|0|||
130923094|NCT02151110|471352852|FG003|Overall Study|Lost to Follow-up|0|||
130923095|NCT02151110|471352853|FG004|Overall Study|Lost to Follow-up|0|||
130923096|NCT02151110|471352854|FG005|Overall Study|Lost to Follow-up|0|||
130923097|NCT02151110|471352855|FG006|Overall Study|Lost to Follow-up|0|||
130923098|NCT02151110|471352856|FG007|Overall Study|Lost to Follow-up|2|||
130923099|NCT02369016|471352857|FG000|Overall Study|AE associated with clinical disease progression|2|||
130923100|NCT02369016|471352858|FG001|Overall Study|AE associated with clinical disease progression|1|||
130923101|NCT02369016|471352857|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
130923102|NCT02369016|471352858|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
130923103|NCT02369016|471352857|FG000|Overall Study|Progressive disease - clinical progression|1|||
130923104|NCT02369016|471352858|FG001|Overall Study|Progressive disease - clinical progression|4|||
130923105|NCT02369016|471352857|FG000|Overall Study|withdrawal by patient|4|||
130923106|NCT02369016|471352858|FG001|Overall Study|withdrawal by patient|0|||
130923107|NCT02369016|471352857|FG000|Overall Study|Progressive disease - radiological progression|6|||
130923108|NCT02369016|471352858|FG001|Overall Study|Progressive disease - radiological progression|2|||
130923109|NCT02229383|471352859|FG000|Overall Study|Adverse Event|7|||
130923110|NCT02229383|471352860|FG001|Overall Study|Adverse Event|4|||
130923111|NCT02229383|471352859|FG000|Overall Study|Death|0|||
130923112|NCT02229383|471352860|FG001|Overall Study|Death|1|||
130923113|NCT02229383|471352859|FG000|Overall Study|Lost to Follow-up|5|||
130923114|NCT02229383|471352860|FG001|Overall Study|Lost to Follow-up|3|||
130923115|NCT02229383|471352859|FG000|Overall Study|Withdrawal by Subject|4|||
130923116|NCT02229383|471352860|FG001|Overall Study|Withdrawal by Subject|6|||
130923117|NCT02229383|471352859|FG000|Overall Study|Did not receive treatment|1|||
130923118|NCT02229383|471352860|FG001|Overall Study|Did not receive treatment|0|||
130923119|NCT02229383|471352859|FG000|Overall Study|Other|3|||
130923120|NCT02229383|471352860|FG001|Overall Study|Other|8|||
130923121|NCT01201850|471352865|FG000|Overall Study|Tumor progression|4|||
130923122|NCT02564796|471352870|FG000|Overall Study|Physician Decision|2|||
130923123|NCT02564796|471352871|FG001|Overall Study|Physician Decision|2|||
130923124|NCT00453063|471352872|FG000|Overall Study|Adverse Event|1|||
130923125|NCT00453063|471352873|FG001|Overall Study|Adverse Event|2|||
130923126|NCT00453063|471352872|FG000|Overall Study|Withdrawal by Subject|1|||
130923127|NCT00453063|471352873|FG001|Overall Study|Withdrawal by Subject|1|||
130923128|NCT00453063|471352872|FG000|Overall Study|Protocol Violation|1|||
130923129|NCT00453063|471352873|FG001|Overall Study|Protocol Violation|0|||
130923130|NCT00566995|471352875|FG000|Overall Study|Toxicity|4|||
130923131|NCT00566995|471352875|FG000|Overall Study|Withdrew consent|3|||
130923132|NCT00404235|471352876|FG000|Overall Study|Withdrawal by Subject|1|||
130923133|NCT00404235|471352877|FG001|Overall Study|Withdrawal by Subject|2|||
130923134|NCT00594659|471352878|FG000|Overall Study|Lost to Follow-up|13|||
130923135|NCT00594659|471352879|FG001|Overall Study|Lost to Follow-up|9|||
130923136|NCT00594659|471352880|FG002|Overall Study|Lost to Follow-up|7|||
130923137|NCT00228384|471352881|FG000|Overall Study|Death|9|||
130923138|NCT00228384|471352882|FG001|Overall Study|Death|3|||
130923139|NCT00228384|471352881|FG000|Overall Study|Lost to Follow-up|6|||
131223336|NCT01458119|472445082|FG000|Overall Study|Non-compliance With Study Drug|3|||
130769597|NCT01026818|470782504|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
130769598|NCT01026818|470782505|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
130769599|NCT01026818|470782506|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
130769600|NCT01026818|470782507|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
130923140|NCT00228384|471352882|FG001|Overall Study|Lost to Follow-up|10|||
130923141|NCT00228384|471352881|FG000|Overall Study|Surgical Intervention (bypass)|5|||
130923142|NCT00228384|471352882|FG001|Overall Study|Surgical Intervention (bypass)|5|||
130923143|NCT00228384|471352881|FG000|Overall Study|Withdrawal by Subject|9|||
130923144|NCT00228384|471352882|FG001|Overall Study|Withdrawal by Subject|10|||
130923145|NCT00228384|471352881|FG000|Overall Study|Physician Decision|0|||
130923146|NCT00228384|471352882|FG001|Overall Study|Physician Decision|1|||
130923147|NCT01785069|471352887|FG000|Overall Study|Implanted with nonstudy device|1|||
130923148|NCT01785069|471352888|FG001|Overall Study|Implanted with nonstudy device|2|||
130923149|NCT01785069|471352889|FG002|Overall Study|Implanted with nonstudy device|1|||
130923150|NCT01785069|471352890|FG003|Overall Study|Implanted with nonstudy device|0|||
130923151|NCT01785069|471352887|FG000|Overall Study|Death|0|||
130923152|NCT01785069|471352888|FG001|Overall Study|Death|0|||
130923153|NCT01785069|471352889|FG002|Overall Study|Death|2|||
130923154|NCT01785069|471352890|FG003|Overall Study|Death|0|||
130923155|NCT01785069|471352887|FG000|Overall Study|Subject choice|2|||
130923156|NCT01785069|471352888|FG001|Overall Study|Subject choice|2|||
130923157|NCT01785069|471352889|FG002|Overall Study|Subject choice|0|||
130923158|NCT01785069|471352890|FG003|Overall Study|Subject choice|1|||
130923159|NCT01785069|471352887|FG000|Overall Study|Lost to Follow-up|1|||
130923160|NCT01785069|471352888|FG001|Overall Study|Lost to Follow-up|2|||
130923161|NCT01785069|471352889|FG002|Overall Study|Lost to Follow-up|4|||
130923162|NCT01785069|471352890|FG003|Overall Study|Lost to Follow-up|1|||
130923163|NCT01785069|471352887|FG000|Overall Study|Reason not Specified|1|||
130923164|NCT01785069|471352888|FG001|Overall Study|Reason not Specified|2|||
130923165|NCT01785069|471352889|FG002|Overall Study|Reason not Specified|1|||
130923166|NCT01785069|471352890|FG003|Overall Study|Reason not Specified|4|||
130923167|NCT01785069|471352887|FG000|Overall Study|Not evaluable|7|||
130923168|NCT01785069|471352888|FG001|Overall Study|Not evaluable|4|||
130923169|NCT01785069|471352889|FG002|Overall Study|Not evaluable|5|||
130923170|NCT01785069|471352890|FG003|Overall Study|Not evaluable|8|||
130923171|NCT05358444|471352892|FG000|Overall Study|Withdrawal by Subject|0|||
130923172|NCT05358444|471352893|FG001|Overall Study|Withdrawal by Subject|1|||
130923173|NCT05358444|471352892|FG000|Overall Study|Lost to Follow-up|0|||
130923174|NCT05358444|471352893|FG001|Overall Study|Lost to Follow-up|3|||
130923175|NCT04997304|471352894|FG000|Overall Study|Lost to Follow-up|11|||
130923176|NCT04997304|471352894|FG000|Overall Study|Death|1|||
130923177|NCT04997304|471352894|FG000|Overall Study|Withdrawal by Subject|14|||
130923178|NCT04560998|471352895|FG000|Overall Study|Withdrawal by Subject|18|||
130923179|NCT04560998|471352896|FG001|Overall Study|Withdrawal by Subject|12|||
130923180|NCT04560998|471352895|FG000|Overall Study|Lost to Follow-up|8|||
130923181|NCT04560998|471352896|FG001|Overall Study|Lost to Follow-up|5|||
130923182|NCT04560998|471352895|FG000|Overall Study|Physician Decision|4|||
130923183|NCT04560998|471352896|FG001|Overall Study|Physician Decision|0|||
130923184|NCT03281577|471354949|FG000|Overall Study|Adverse Event|0|||
130923185|NCT03281577|471354950|FG001|Overall Study|Adverse Event|0|||
130923186|NCT03281577|471354951|FG002|Overall Study|Adverse Event|0|||
130923187|NCT03281577|471354952|FG003|Overall Study|Adverse Event|1|||
130923188|NCT03281577|471354949|FG000|Overall Study|Withdrawal by Subject|1|||
130923189|NCT03281577|471354950|FG001|Overall Study|Withdrawal by Subject|0|||
130923190|NCT03281577|471354951|FG002|Overall Study|Withdrawal by Subject|0|||
130923191|NCT03281577|471354952|FG003|Overall Study|Withdrawal by Subject|0|||
130923192|NCT00443261|471354953|FG000|Overall Study|Death|1|||
131034441|NCT04925986|471759197|FG003|Overall Study|Death|0|||
131034442|NCT04925986|471759194|FG000|Overall Study|Lack of Efficacy|1|||
131034443|NCT04925986|471759195|FG001|Overall Study|Lack of Efficacy|2|||
131034444|NCT04925986|471759196|FG002|Overall Study|Lack of Efficacy|0|||
131034445|NCT04925986|471759197|FG003|Overall Study|Lack of Efficacy|1|||
131034446|NCT04925986|471759194|FG000|Overall Study|Withdrawal by Subject|0|||
131034447|NCT04925986|471759195|FG001|Overall Study|Withdrawal by Subject|0|||
131034448|NCT04925986|471759196|FG002|Overall Study|Withdrawal by Subject|1|||
131034449|NCT04925986|471759197|FG003|Overall Study|Withdrawal by Subject|2|||
131034450|NCT03448107|471759199|FG000|Overall Study|Lost to Follow-up|229|||
131034451|NCT03448107|471759200|FG001|Overall Study|Lost to Follow-up|258|||
131034452|NCT04025554|471759201|FG000|Overall Study|Adverse Event|3|||
131034453|NCT04948697|471759202|FG000|Overall Study|Progressive disease|27|||
131034454|NCT04948697|471759203|FG001|Overall Study|Progressive disease|18|||
131034455|NCT04948697|471759202|FG000|Overall Study|Adverse Event|14|||
131034456|NCT04948697|471759203|FG001|Overall Study|Adverse Event|4|||
131034457|NCT04948697|471759202|FG000|Overall Study|Participant moved to long term extension study|7|||
131034458|NCT04948697|471759203|FG001|Overall Study|Participant moved to long term extension study|4|||
131034459|NCT04948697|471759202|FG000|Overall Study|Withdrawal by Subject|10|||
131034460|NCT04948697|471759203|FG001|Overall Study|Withdrawal by Subject|0|||
131034461|NCT04948697|471759202|FG000|Overall Study|Closed by Sponsor|3|||
131034462|NCT04948697|471759203|FG001|Overall Study|Closed by Sponsor|2|||
131034463|NCT04948697|471759202|FG000|Overall Study|Physician Decision|0|||
131034464|NCT04948697|471759203|FG001|Overall Study|Physician Decision|2|||
131034465|NCT04948697|471759202|FG000|Overall Study|Lost to Follow-up|0|||
130923193|NCT01433991|471354957|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
130923194|NCT01433991|471354958|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
130923195|NCT01433991|471354959|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
130923196|NCT01433991|471354960|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
130923197|NCT01433991|471354957|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
130923198|NCT01433991|471354958|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
130923199|NCT01433991|471354959|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
130923200|NCT01433991|471354960|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
130923201|NCT01433991|471354957|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
131034466|NCT04948697|471759203|FG001|Overall Study|Lost to Follow-up|1|||
131034467|NCT04948697|471759202|FG000|Overall Study|Other-Miscellaneous|1|||
131034468|NCT04948697|471759203|FG001|Overall Study|Other-Miscellaneous|0|||
130700662|NCT04640194|470526501|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
130700663|NCT04640194|470526502|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
130700664|NCT04640194|470526503|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
130700665|NCT04640194|470526504|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
130700666|NCT04640194|470526498|FG000|Overall Study|fibrinogen level too low|0|||
130700667|NCT04640194|470526499|FG001|Overall Study|fibrinogen level too low|0|||
130700668|NCT04640194|470526500|FG002|Overall Study|fibrinogen level too low|0|||
130700669|NCT04640194|470526501|FG003|Overall Study|fibrinogen level too low|1|||
130700670|NCT04640194|470526502|FG004|Overall Study|fibrinogen level too low|0|||
130700671|NCT04640194|470526503|FG005|Overall Study|fibrinogen level too low|0|||
130700672|NCT04640194|470526504|FG006|Overall Study|fibrinogen level too low|0|||
130700673|NCT04640194|470526498|FG000|Overall Study|mild bleeding|0|||
130700674|NCT04640194|470526499|FG001|Overall Study|mild bleeding|0|||
130700675|NCT04640194|470526500|FG002|Overall Study|mild bleeding|0|||
130700676|NCT04640194|470526501|FG003|Overall Study|mild bleeding|1|||
130700677|NCT04640194|470526502|FG004|Overall Study|mild bleeding|0|||
130923202|NCT01433991|471354958|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
130923203|NCT01433991|471354959|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
130923204|NCT01433991|471354960|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
130923205|NCT01433991|471354957|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
130923206|NCT01433991|471354958|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
130923207|NCT01433991|471354959|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
130923208|NCT01433991|471354960|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
130923209|NCT01433991|471354957|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
130923210|NCT01433991|471354958|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
130923211|NCT01433991|471354959|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
130923212|NCT01433991|471354960|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
130923213|NCT01433991|471354957|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
130923214|NCT01433991|471354958|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
130923215|NCT01433991|471354959|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
130923216|NCT01433991|471354960|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
130923217|NCT01433991|471354957|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
130923218|NCT01433991|471354958|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
130923219|NCT01433991|471354959|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
130923220|NCT01433991|471354960|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
130923221|NCT03539081|471354962|FG000|Overall Study|Withdrawal by Subject|2|||
130923222|NCT03539081|471354963|FG001|Overall Study|Withdrawal by Subject|3|||
130923223|NCT03539081|471354964|FG002|Overall Study|Withdrawal by Subject|0|||
130923224|NCT03539081|471354962|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
130923225|NCT03539081|471354963|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
130923226|NCT03539081|471354964|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
130923227|NCT02550106|471354970|FG000|Overall Study|Adverse Event|1|||
130923228|NCT02550106|471354970|FG000|Overall Study|Lack of Efficacy|3|||
130923229|NCT02550106|471354970|FG000|Overall Study|Protocol Violation|6|||
130923230|NCT02550106|471354970|FG000|Overall Study|Withdrawal by Subject|2|||
130923231|NCT01193530|471354971|FG000|Overall Study|Withdrawal by Subject|2|||
130923232|NCT01193530|471354972|FG001|Overall Study|Withdrawal by Subject|2|||
130923233|NCT01193530|471354971|FG000|Overall Study|Began Contraindicated Therapy|1|||
130923234|NCT01193530|471354972|FG001|Overall Study|Began Contraindicated Therapy|0|||
130923235|NCT01193530|471354971|FG000|Overall Study|Lost Light Box|0|||
130923236|NCT01193530|471354972|FG001|Overall Study|Lost Light Box|1|||
130923237|NCT01193530|471354971|FG000|Overall Study|Returned home - out of state|0|||
130923238|NCT01193530|471354972|FG001|Overall Study|Returned home - out of state|1|||
130923239|NCT01193530|471354971|FG000|Overall Study|Non-Compliance|0|||
130923240|NCT01193530|471354972|FG001|Overall Study|Non-Compliance|1|||
130923241|NCT00799383|471354973|FG000|Overall Study|Protocol Violation|1|||
130923242|NCT00799383|471354974|FG001|Overall Study|Protocol Violation|1|||
130923243|NCT00799383|471354973|FG000|Overall Study|Adverse Event|0|||
130923244|NCT00799383|471354974|FG001|Overall Study|Adverse Event|1|||
130700678|NCT04640194|470526503|FG005|Overall Study|mild bleeding|0|||
130700679|NCT04640194|470526504|FG006|Overall Study|mild bleeding|0|||
130700680|NCT04640194|470526498|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700681|NCT04640194|470526499|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
130700682|NCT04640194|470526500|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700683|NCT04640194|470526501|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700684|NCT04640194|470526502|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700685|NCT04640194|470526503|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700686|NCT04640194|470526504|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130700687|NCT04773600|470526515|FG000|Overall Study|Withdrawal by Subject|15|||
130923245|NCT00799383|471354973|FG000|Overall Study|Lost to Follow-up|1|||
130923246|NCT00799383|471354974|FG001|Overall Study|Lost to Follow-up|2|||
130923247|NCT00799383|471354973|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
130923248|NCT00799383|471354974|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
130923249|NCT00799383|471354973|FG000|Overall Study|Withdrawal by Subject|0|||
130923250|NCT00799383|471354974|FG001|Overall Study|Withdrawal by Subject|1|||
130923251|NCT00064337|471354988|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
130923252|NCT00064337|471354988|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
130923253|NCT00064337|471354988|FG000|PBSCC or Induction/PBSCC|Progression|3|||
130923254|NCT00064337|471354988|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
130923255|NCT00064337|471354988|FG000|PBSCC or Induction/PBSCC|Death|2|||
130923256|NCT00064337|471354988|FG000|Transplant|Adverse Event|9|||
130923257|NCT00064337|471354988|FG000|Transplant|Not protocol-specified|5|||
130923258|NCT00064337|471354988|FG000|Transplant|Death|3|||
130923259|NCT00064337|471354988|FG000|Transplant|Patient Refusal|2|||
130923260|NCT00064337|471354988|FG000|Transplant|Progression|2|||
130923261|NCT00064337|471354988|FG000|Maintenance|Adverse Event|3|||
130923262|NCT00064337|471354988|FG000|Maintenance|Progression|2|||
130923263|NCT00064337|471354988|FG000|Maintenance|On treatment at time of analysis|2|||
130923264|NCT00064337|471354988|FG000|Maintenance|Not protocol-specified|2|||
130923265|NCT00064337|471354988|FG000|Maintenance|Death|1|||
130923266|NCT00612040|471354989|FG000|Overall Study|Adverse Event|0|||
130923267|NCT00612040|471354990|FG001|Overall Study|Adverse Event|2|||
130923268|NCT00612040|471354991|FG002|Overall Study|Adverse Event|1|||
130923269|NCT00612040|471354989|FG000|Overall Study|Protocol Violation|1|||
130923270|NCT00612040|471354990|FG001|Overall Study|Protocol Violation|2|||
130923271|NCT00612040|471354991|FG002|Overall Study|Protocol Violation|1|||
130923272|NCT00612040|471354989|FG000|Overall Study|Lack of Efficacy|2|||
130923273|NCT00612040|471354990|FG001|Overall Study|Lack of Efficacy|1|||
130923274|NCT00612040|471354991|FG002|Overall Study|Lack of Efficacy|0|||
130923275|NCT00612040|471354989|FG000|Overall Study|Unclassified|2|||
130923276|NCT00612040|471354990|FG001|Overall Study|Unclassified|2|||
130923277|NCT00612040|471354991|FG002|Overall Study|Unclassified|5|||
130923278|NCT01397890|471354992|FG000|Overall Study|Withdrawal by Subject|7|||
130923279|NCT01397890|471354993|FG001|Overall Study|Withdrawal by Subject|11|||
130923280|NCT01397890|471354992|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
130923281|NCT01397890|471354993|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
130923282|NCT01397890|471354992|FG000|Overall Study|Death|2|||
130923283|NCT01397890|471354993|FG001|Overall Study|Death|3|||
130923284|NCT01397890|471354992|FG000|Overall Study|Lost to Follow-up|1|||
130923285|NCT01397890|471354993|FG001|Overall Study|Lost to Follow-up|4|||
130923286|NCT01397890|471354992|FG000|Overall Study|Condition under Investigation Worsened|1|||
130923287|NCT01397890|471354993|FG001|Overall Study|Condition under Investigation Worsened|3|||
130923288|NCT01397890|471354992|FG000|Overall Study|Adverse Event|1|||
130923289|NCT01397890|471354993|FG001|Overall Study|Adverse Event|2|||
130923290|NCT01397890|471354992|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
130923291|NCT01397890|471354993|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
130923292|NCT01397890|471354992|FG000|Overall Study|Others|2|||
130923293|NCT01397890|471354993|FG001|Overall Study|Others|1|||
130923294|NCT00002651|471354994|FG000|Induction|Adverse Event|44|||
130923295|NCT00002651|471354995|FG001|Induction|Adverse Event|0|||
130923296|NCT00002651|471354996|FG002|Induction|Adverse Event|0|||
130923297|NCT00002651|471354994|FG000|Induction|Refusal unrelated to adverse event|50|||
130923298|NCT00002651|471354995|FG001|Induction|Refusal unrelated to adverse event|0|||
130923299|NCT00002651|471354996|FG002|Induction|Refusal unrelated to adverse event|0|||
130923300|NCT00002651|471354994|FG000|Induction|Progression/relapse|274|||
130923301|NCT00002651|471354995|FG001|Induction|Progression/relapse|0|||
130923302|NCT00002651|471354996|FG002|Induction|Progression/relapse|0|||
130923303|NCT00002651|471354994|FG000|Induction|Death|62|||
130923304|NCT00002651|471354995|FG001|Induction|Death|0|||
130923305|NCT00002651|471354996|FG002|Induction|Death|0|||
130923306|NCT00002651|471354994|FG000|Induction|Other|823|||
130923307|NCT00002651|471354995|FG001|Induction|Other|0|||
130923308|NCT00002651|471354996|FG002|Induction|Other|0|||
130923309|NCT00002651|471354994|FG000|Induction|not eligible|90|||
130923310|NCT00002651|471354995|FG001|Induction|not eligible|0|||
130923311|NCT00002651|471354996|FG002|Induction|not eligible|0|||
130923312|NCT00002651|471354994|FG000|Consolidation and Randomization|Adverse Event|0|||
130923313|NCT00002651|471354995|FG001|Consolidation and Randomization|Adverse Event|36|||
131034469|NCT04948697|471759202|FG000|Overall Study|Randomized but not treated|0|||
131034470|NCT04948697|471759203|FG001|Overall Study|Randomized but not treated|1|||
131034471|NCT04338061|471759204|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
130923314|NCT00002651|471354996|FG002|Consolidation and Randomization|Adverse Event|14|||
130923315|NCT00002651|471354994|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
130923316|NCT00002651|471354995|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
130923317|NCT00002651|471354996|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
130923318|NCT00002651|471354994|FG000|Consolidation and Randomization|Progression/relapse|0|||
130923319|NCT00002651|471354995|FG001|Consolidation and Randomization|Progression/relapse|295|||
130923320|NCT00002651|471354996|FG002|Consolidation and Randomization|Progression/relapse|298|||
130923321|NCT00002651|471354994|FG000|Consolidation and Randomization|Death|0|||
130923322|NCT00002651|471354995|FG001|Consolidation and Randomization|Death|38|||
130923323|NCT00002651|471354996|FG002|Consolidation and Randomization|Death|48|||
130923324|NCT00002651|471354994|FG000|Consolidation and Randomization|Other|0|||
130923325|NCT00002651|471354995|FG001|Consolidation and Randomization|Other|314|||
130923326|NCT00002651|471354996|FG002|Consolidation and Randomization|Other|313|||
130923327|NCT00002651|471354994|FG000|Consolidation and Randomization|not eligible|0|||
130923328|NCT00002651|471354995|FG001|Consolidation and Randomization|not eligible|102|||
130923329|NCT00002651|471354996|FG002|Consolidation and Randomization|not eligible|112|||
130923330|NCT02763462|471354997|FG000|Overall Study|Protocol Violation|6|||
130923331|NCT03417219|471354998|FG000|Overall Study|Lost to Follow-up|0|||
130923332|NCT03417219|471354999|FG001|Overall Study|Lost to Follow-up|3|||
130923333|NCT00261807|471355000|FG000|Overall Study|Lost to Follow-up|2|||
130923334|NCT00261807|471355000|FG000|Overall Study|Adverse Event|2|||
130923335|NCT00261807|471355000|FG000|Overall Study|Death|1|||
130923336|NCT00261807|471355000|FG000|Overall Study|Protocol Violation|2|||
130923337|NCT02527161|471355003|FG000|Overall Study|Failed MRI|52|||
130923338|NCT02527161|471355003|FG000|Overall Study|Withdrawal by Subject|19|||
130923339|NCT02527161|471355003|FG000|Overall Study|Delay in or unfit for surgery|16|||
130923340|NCT02527161|471355003|FG000|Overall Study|MRI contraindication|6|||
130923341|NCT02527161|471355003|FG000|Overall Study|Consent violation|4|||
130923342|NCT02527161|471355003|FG000|Overall Study|Only Recruited to Part A|27|||
130923343|NCT02527161|471355003|FG000|Overall Study|Physician Decision|1|||
130923344|NCT02527161|471355003|FG000|Overall Study|Adverse Event|1|||
130923345|NCT02527161|471355003|FG000|Overall Study|Lost to Follow-up|6|||
130923346|NCT05209360|471355004|FG000|Overall Study|Withdrawal by Subject|0|||
130923347|NCT05209360|471355005|FG001|Overall Study|Withdrawal by Subject|0|||
130923348|NCT05209360|471355006|FG002|Overall Study|Withdrawal by Subject|1|||
130923349|NCT05209360|471355007|FG003|Overall Study|Withdrawal by Subject|0|||
130923350|NCT05209360|471355008|FG004|Overall Study|Withdrawal by Subject|0|||
130923351|NCT05209360|471355009|FG005|Overall Study|Withdrawal by Subject|0|||
130923352|NCT02100514|471355010|FG000|Treatment Period|Adverse Event|0|||
130923353|NCT02100514|471355011|FG001|Treatment Period|Adverse Event|5|||
130923354|NCT02100514|471355012|FG002|Treatment Period|Adverse Event|0|||
130923355|NCT02100514|471355013|FG003|Treatment Period|Adverse Event|0|||
130923356|NCT02100514|471355014|FG004|Treatment Period|Adverse Event|0|||
130923357|NCT02100514|471355010|FG000|Treatment Period|Death|2|||
130923358|NCT02100514|471355011|FG001|Treatment Period|Death|2|||
130923359|NCT02100514|471355012|FG002|Treatment Period|Death|0|||
130923360|NCT02100514|471355013|FG003|Treatment Period|Death|0|||
130923361|NCT02100514|471355014|FG004|Treatment Period|Death|0|||
130923362|NCT02100514|471355010|FG000|Treatment Period|Lost to Follow-up|5|||
130923363|NCT02100514|471355011|FG001|Treatment Period|Lost to Follow-up|17|||
130923364|NCT02100514|471355012|FG002|Treatment Period|Lost to Follow-up|0|||
130923365|NCT02100514|471355013|FG003|Treatment Period|Lost to Follow-up|0|||
130923366|NCT02100514|471355014|FG004|Treatment Period|Lost to Follow-up|0|||
130923367|NCT02100514|471355010|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
130923368|NCT02100514|471355011|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
130923369|NCT02100514|471355012|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
130923370|NCT02100514|471355013|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
130923371|NCT02100514|471355014|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
130923372|NCT02100514|471355010|FG000|Treatment Period|Protocol Violation|1|||
130923373|NCT02100514|471355011|FG001|Treatment Period|Protocol Violation|1|||
130923374|NCT02100514|471355012|FG002|Treatment Period|Protocol Violation|0|||
130923375|NCT02100514|471355013|FG003|Treatment Period|Protocol Violation|0|||
130923376|NCT02100514|471355014|FG004|Treatment Period|Protocol Violation|0|||
130923377|NCT02100514|471355010|FG000|Treatment Period|Withdrawal by Subject|12|||
130923378|NCT02100514|471355011|FG001|Treatment Period|Withdrawal by Subject|37|||
130923379|NCT02100514|471355012|FG002|Treatment Period|Withdrawal by Subject|0|||
130923380|NCT02100514|471355013|FG003|Treatment Period|Withdrawal by Subject|0|||
130923381|NCT02100514|471355014|FG004|Treatment Period|Withdrawal by Subject|0|||
130923382|NCT02100514|471355010|FG000|Treatment Period|Other|9|||
130923383|NCT02100514|471355011|FG001|Treatment Period|Other|11|||
130923384|NCT02100514|471355012|FG002|Treatment Period|Other|0|||
130923385|NCT02100514|471355013|FG003|Treatment Period|Other|0|||
130923386|NCT02100514|471355014|FG004|Treatment Period|Other|0|||
130923387|NCT02100514|471355010|FG000|Extension Period|Withdrew consent|0|||
130923388|NCT02100514|471355011|FG001|Extension Period|Withdrew consent|0|||
130923389|NCT02100514|471355012|FG002|Extension Period|Withdrew consent|2|||
130923390|NCT02100514|471355013|FG003|Extension Period|Withdrew consent|0|||
130923391|NCT02100514|471355014|FG004|Extension Period|Withdrew consent|0|||
130923392|NCT00724932|471355015|FG000|Overall Study|Lost to Follow-up|1|||
130923393|NCT00724932|471355016|FG001|Overall Study|Lost to Follow-up|0|||
130923394|NCT00724932|471355015|FG000|Overall Study|Not treated|4|||
130923395|NCT00724932|471355016|FG001|Overall Study|Not treated|3|||
130923396|NCT02021331|471355017|FG000|Overall Study|Adverse Event|0|||
130923397|NCT02021331|471355018|FG001|Overall Study|Adverse Event|2|||
130923398|NCT00762229|471355019|FG000|Overall Study|Lost to Follow-up|1|||
130700688|NCT04773600|470526516|FG001|Overall Study|Withdrawal by Subject|9|||
130923399|NCT00762229|471355020|FG001|Overall Study|Lost to Follow-up|1|||
130923400|NCT00762229|471355019|FG000|Overall Study|did not recveive intervention|0|||
130923401|NCT00762229|471355020|FG001|Overall Study|did not recveive intervention|1|||
130923402|NCT01896102|471355023|FG000|Overall Study|Death|1|||
130923403|NCT01896102|471355023|FG000|Overall Study|Participant to receive allogenic transplant|2|||
130923404|NCT02590003|471355027|FG000|Overall Study|Death|1|||
130923405|NCT02590003|471355028|FG001|Overall Study|Death|2|||
130923406|NCT01235689|471355031|FG000|Overall Study|Adverse Event|12|||
130923407|NCT01235689|471355032|FG001|Overall Study|Adverse Event|16|||
130923408|NCT01235689|471355031|FG000|Overall Study|Lack of Efficacy|12|||
130923409|NCT01235689|471355032|FG001|Overall Study|Lack of Efficacy|5|||
130923410|NCT01235689|471355031|FG000|Overall Study|Withdrawal by Subject|3|||
130923411|NCT01235689|471355032|FG001|Overall Study|Withdrawal by Subject|4|||
130923412|NCT01235689|471355031|FG000|Overall Study|Lost to Follow-up|1|||
130923413|NCT01235689|471355032|FG001|Overall Study|Lost to Follow-up|2|||
130923414|NCT01235689|471355031|FG000|Overall Study|Miscellaneous|1|||
130923415|NCT01235689|471355032|FG001|Overall Study|Miscellaneous|5|||
130923416|NCT01443078|471355033|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
130923417|NCT01443078|471355033|FG000|Overall Study|Withdrawal by Subject|1|||
130923418|NCT01443078|471355033|FG000|Overall Study|Patient had brain mets|1|||
130923419|NCT00389597|471355034|FG000|Overall Study|Lost to Follow-up|8|||
130923420|NCT00389597|471355035|FG001|Overall Study|Lost to Follow-up|6|||
130923421|NCT00389597|471355036|FG002|Overall Study|Lost to Follow-up|4|||
130923422|NCT00389597|471355037|FG003|Overall Study|Lost to Follow-up|6|||
130923423|NCT02106975|471355038|FG000|Overall Study|Death|25|||
130923424|NCT02106975|471355039|FG001|Overall Study|Death|39|||
130923425|NCT00005044|471355042|FG000|Overall Study|Protocol Violation|37|||
130923426|NCT00005044|471355043|FG001|Overall Study|Protocol Violation|46|||
130923427|NCT00005044|471355042|FG000|Overall Study|Withdrawal by Subject|1|||
130923428|NCT00005044|471355043|FG001|Overall Study|Withdrawal by Subject|5|||
130923429|NCT00005044|471355042|FG000|Overall Study|No protocol treatment|0|||
130923430|NCT00005044|471355043|FG001|Overall Study|No protocol treatment|1|||
130923431|NCT04431453|471355044|FG000|Overall Study|Withdrew Consent|0|||
130923432|NCT04431453|471355045|FG001|Overall Study|Withdrew Consent|1|||
130923433|NCT04431453|471355046|FG002|Overall Study|Withdrew Consent|0|||
130923434|NCT04431453|471355047|FG003|Overall Study|Withdrew Consent|2|||
130923435|NCT04431453|471355048|FG004|Overall Study|Withdrew Consent|0|||
130923436|NCT04431453|471355049|FG005|Overall Study|Withdrew Consent|0|||
130923437|NCT04431453|471355050|FG006|Overall Study|Withdrew Consent|0|||
130923438|NCT04431453|471355051|FG007|Overall Study|Withdrew Consent|0|||
130923439|NCT04431453|471355044|FG000|Overall Study|Death|1|||
130923440|NCT04431453|471355045|FG001|Overall Study|Death|0|||
130923441|NCT04431453|471355046|FG002|Overall Study|Death|0|||
130923442|NCT04431453|471355047|FG003|Overall Study|Death|0|||
130923443|NCT04431453|471355048|FG004|Overall Study|Death|0|||
130923444|NCT04431453|471355049|FG005|Overall Study|Death|0|||
130923445|NCT04431453|471355050|FG006|Overall Study|Death|0|||
130923446|NCT04431453|471355051|FG007|Overall Study|Death|1|||
130923447|NCT04431453|471355044|FG000|Overall Study|Lost to Follow-up|0|||
130923448|NCT04431453|471355045|FG001|Overall Study|Lost to Follow-up|0|||
130923449|NCT04431453|471355046|FG002|Overall Study|Lost to Follow-up|1|||
130923450|NCT04431453|471355047|FG003|Overall Study|Lost to Follow-up|1|||
130923451|NCT04431453|471355048|FG004|Overall Study|Lost to Follow-up|0|||
130923452|NCT04431453|471355049|FG005|Overall Study|Lost to Follow-up|0|||
130923453|NCT04431453|471355050|FG006|Overall Study|Lost to Follow-up|0|||
130923454|NCT04431453|471355051|FG007|Overall Study|Lost to Follow-up|0|||
130923455|NCT04431453|471355044|FG000|Overall Study|Enrolled but Never Treated|0|||
130923456|NCT04431453|471355045|FG001|Overall Study|Enrolled but Never Treated|0|||
130923457|NCT04431453|471355046|FG002|Overall Study|Enrolled but Never Treated|0|||
130923458|NCT04431453|471355047|FG003|Overall Study|Enrolled but Never Treated|0|||
130923459|NCT04431453|471355048|FG004|Overall Study|Enrolled but Never Treated|1|||
130923460|NCT04431453|471355049|FG005|Overall Study|Enrolled but Never Treated|0|||
130923461|NCT04431453|471355050|FG006|Overall Study|Enrolled but Never Treated|0|||
130923462|NCT04431453|471355051|FG007|Overall Study|Enrolled but Never Treated|0|||
131223337|NCT05003167|472445083|FG000|Overall Study|Withdrawal by Subject|1|||
131223338|NCT00430638|472445084|FG000|Overall Study|Adverse Event|15|||
130700689|NCT04773600|470526515|FG000|Overall Study|Lost to Follow-up|10|||
130700690|NCT04773600|470526516|FG001|Overall Study|Lost to Follow-up|6|||
130700691|NCT04773600|470526515|FG000|Overall Study|Adverse Event|8|||
130700692|NCT04773600|470526516|FG001|Overall Study|Adverse Event|2|||
130923463|NCT01768286|471355053|FG000|Overall Study|Randomized But Not Treated|0|||
130923464|NCT01768286|471355054|FG001|Overall Study|Randomized But Not Treated|0|||
130923465|NCT01768286|471355055|FG002|Overall Study|Randomized But Not Treated|1|||
130923466|NCT01768286|471355056|FG003|Overall Study|Randomized But Not Treated|0|||
130923467|NCT01768286|471355053|FG000|Overall Study|Lack of Efficacy|7|||
130923468|NCT01768286|471355054|FG001|Overall Study|Lack of Efficacy|4|||
130923469|NCT01768286|471355055|FG002|Overall Study|Lack of Efficacy|0|||
130923470|NCT01768286|471355056|FG003|Overall Study|Lack of Efficacy|1|||
130923471|NCT01768286|471355053|FG000|Overall Study|Withdrew Consent|0|||
131223339|NCT00430638|472445085|FG001|Overall Study|Adverse Event|15|||
131223340|NCT00430638|472445084|FG000|Overall Study|Uncontrolled blood pressure|48|||
130769601|NCT01026818|470782504|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
130923472|NCT01768286|471355054|FG001|Overall Study|Withdrew Consent|0|||
130923473|NCT01768286|471355055|FG002|Overall Study|Withdrew Consent|1|||
130923474|NCT01768286|471355056|FG003|Overall Study|Withdrew Consent|0|||
130923475|NCT00087607|471355057|FG000|Overall Study|Adverse Event|14|||
130923476|NCT00087607|471355058|FG001|Overall Study|Adverse Event|24|||
130923477|NCT00087607|471355057|FG000|Overall Study|Death|0|||
130923478|NCT00087607|471355058|FG001|Overall Study|Death|1|||
130923479|NCT00087607|471355057|FG000|Overall Study|Insufficient Therapeutic Response|53|||
130923480|NCT00087607|471355058|FG001|Overall Study|Insufficient Therapeutic Response|42|||
130923481|NCT00087607|471355057|FG000|Overall Study|Failure to return|21|||
130923482|NCT00087607|471355058|FG001|Overall Study|Failure to return|17|||
130923483|NCT00087607|471355057|FG000|Overall Study|Withdrew Consent|12|||
130923484|NCT00087607|471355058|FG001|Overall Study|Withdrew Consent|16|||
130923485|NCT00087607|471355057|FG000|Overall Study|Administrative|12|||
130923486|NCT00087607|471355058|FG001|Overall Study|Administrative|12|||
130923487|NCT00087607|471355057|FG000|Overall Study|Refused Treatment|5|||
130923488|NCT00087607|471355058|FG001|Overall Study|Refused Treatment|7|||
130923489|NCT00087607|471355057|FG000|Overall Study|Other Protocol Violation|5|||
130923490|NCT00087607|471355058|FG001|Overall Study|Other Protocol Violation|2|||
130923491|NCT00087607|471355057|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
130923492|NCT00087607|471355058|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130923493|NCT04545385|471355061|FG000|Overall Study|Withdrawal by Subject|2|||
130923494|NCT04545385|471355062|FG001|Overall Study|Withdrawal by Subject|0|||
130923495|NCT04545385|471355061|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
130923496|NCT04545385|471355062|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
130923497|NCT04545385|471355061|FG000|Overall Study|Study termination|10|||
130923498|NCT04545385|471355062|FG001|Overall Study|Study termination|10|||
130923499|NCT04545385|471355061|FG000|Overall Study|Sponsor decision|2|||
130923500|NCT04545385|471355062|FG001|Overall Study|Sponsor decision|2|||
130923501|NCT04545385|471355061|FG000|Overall Study|Other than specified|1|||
130923502|NCT04545385|471355062|FG001|Overall Study|Other than specified|0|||
130923503|NCT00915278|471355063|FG000|Overall Study|Death|1|||
130923504|NCT00915278|471355064|FG001|Overall Study|Death|0|||
130923505|NCT00915278|471355065|FG002|Overall Study|Death|0|||
130923506|NCT00915278|471355066|FG003|Overall Study|Death|0|||
130923507|NCT00915278|471355067|FG004|Overall Study|Death|0|||
130923508|NCT00915278|471355068|FG005|Overall Study|Death|0|||
130923509|NCT00915278|471355063|FG000|Overall Study|Lost to Follow-up|0|||
130923510|NCT00915278|471355064|FG001|Overall Study|Lost to Follow-up|1|||
130923511|NCT00915278|471355065|FG002|Overall Study|Lost to Follow-up|0|||
130923512|NCT00915278|471355066|FG003|Overall Study|Lost to Follow-up|0|||
130923513|NCT00915278|471355067|FG004|Overall Study|Lost to Follow-up|0|||
130923514|NCT00915278|471355068|FG005|Overall Study|Lost to Follow-up|0|||
130923515|NCT00915278|471355063|FG000|Overall Study|Withdrawal by Subject|0|||
130923516|NCT00915278|471355064|FG001|Overall Study|Withdrawal by Subject|1|||
130923517|NCT00915278|471355065|FG002|Overall Study|Withdrawal by Subject|0|||
130923518|NCT00915278|471355066|FG003|Overall Study|Withdrawal by Subject|0|||
130923519|NCT00915278|471355067|FG004|Overall Study|Withdrawal by Subject|1|||
130923520|NCT00915278|471355068|FG005|Overall Study|Withdrawal by Subject|4|||
130923521|NCT00915278|471355063|FG000|Overall Study|Adverse Event|4|||
130923522|NCT00915278|471355064|FG001|Overall Study|Adverse Event|1|||
130923523|NCT00915278|471355065|FG002|Overall Study|Adverse Event|0|||
130923524|NCT00915278|471355066|FG003|Overall Study|Adverse Event|0|||
130923525|NCT00915278|471355067|FG004|Overall Study|Adverse Event|0|||
130923526|NCT00915278|471355068|FG005|Overall Study|Adverse Event|0|||
130923527|NCT00915278|471355063|FG000|Overall Study|Progressive disease/clinical progression|0|||
130923528|NCT00915278|471355064|FG001|Overall Study|Progressive disease/clinical progression|0|||
130923529|NCT00915278|471355065|FG002|Overall Study|Progressive disease/clinical progression|0|||
130923530|NCT00915278|471355066|FG003|Overall Study|Progressive disease/clinical progression|3|||
130923531|NCT00915278|471355067|FG004|Overall Study|Progressive disease/clinical progression|1|||
131223341|NCT00430638|472445085|FG001|Overall Study|Uncontrolled blood pressure|13|||
130769602|NCT01026818|470782505|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
130769603|NCT01026818|470782506|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
130923532|NCT00915278|471355068|FG005|Overall Study|Progressive disease/clinical progression|2|||
131223342|NCT00430638|472445084|FG000|Overall Study|Lost to Follow-up|1|||
130923533|NCT00915278|471355063|FG000|Overall Study|Infusion related AEs|0|||
130923534|NCT00915278|471355064|FG001|Overall Study|Infusion related AEs|0|||
130923535|NCT00915278|471355065|FG002|Overall Study|Infusion related AEs|0|||
130923536|NCT00915278|471355066|FG003|Overall Study|Infusion related AEs|0|||
130923537|NCT00915278|471355067|FG004|Overall Study|Infusion related AEs|0|||
130923538|NCT00915278|471355068|FG005|Overall Study|Infusion related AEs|2|||
130923539|NCT00915278|471355063|FG000|Overall Study|Admission to hospice|0|||
130923540|NCT00915278|471355064|FG001|Overall Study|Admission to hospice|0|||
130923541|NCT00915278|471355065|FG002|Overall Study|Admission to hospice|1|||
130923542|NCT00915278|471355066|FG003|Overall Study|Admission to hospice|0|||
130923543|NCT00915278|471355067|FG004|Overall Study|Admission to hospice|0|||
130923544|NCT00915278|471355068|FG005|Overall Study|Admission to hospice|0|||
130923545|NCT02015754|471355069|FG000|Overall Study|Disease progression|5|||
130923546|NCT02015754|471355069|FG000|Overall Study|Change in treatment modality|5|||
130923547|NCT02015754|471355069|FG000|Overall Study|Lost to Follow-up|1|||
130923548|NCT00939770|471355073|FG000|Overall Study|Adverse Event|1|||
130923549|NCT00939770|471355074|FG001|Overall Study|Adverse Event|1|||
130923550|NCT00939770|471355075|FG002|Overall Study|Adverse Event|0|||
130923551|NCT00939770|471355076|FG003|Overall Study|Adverse Event|0|||
130923552|NCT00939770|471355077|FG004|Overall Study|Adverse Event|6|||
130923553|NCT00939770|471355078|FG005|Overall Study|Adverse Event|2|||
130923554|NCT00939770|471355079|FG006|Overall Study|Adverse Event|1|||
130923555|NCT00939770|471355080|FG007|Overall Study|Adverse Event|1|||
130923556|NCT00939770|471355073|FG000|Overall Study|Lack of Efficacy|4|||
130923557|NCT00939770|471355074|FG001|Overall Study|Lack of Efficacy|6|||
130923558|NCT00939770|471355075|FG002|Overall Study|Lack of Efficacy|13|||
130923559|NCT00939770|471355076|FG003|Overall Study|Lack of Efficacy|9|||
130923560|NCT00939770|471355077|FG004|Overall Study|Lack of Efficacy|16|||
130923561|NCT00939770|471355078|FG005|Overall Study|Lack of Efficacy|8|||
130923562|NCT00939770|471355079|FG006|Overall Study|Lack of Efficacy|11|||
130923563|NCT00939770|471355080|FG007|Overall Study|Lack of Efficacy|1|||
130923564|NCT00939770|471355073|FG000|Overall Study|Lost to Follow-up|0|||
130923565|NCT00939770|471355074|FG001|Overall Study|Lost to Follow-up|0|||
130923566|NCT00939770|471355075|FG002|Overall Study|Lost to Follow-up|0|||
130923567|NCT00939770|471355076|FG003|Overall Study|Lost to Follow-up|0|||
130923568|NCT00939770|471355077|FG004|Overall Study|Lost to Follow-up|1|||
130923569|NCT00939770|471355078|FG005|Overall Study|Lost to Follow-up|0|||
130923570|NCT00939770|471355079|FG006|Overall Study|Lost to Follow-up|0|||
130923571|NCT00939770|471355080|FG007|Overall Study|Lost to Follow-up|0|||
130923572|NCT00939770|471355073|FG000|Overall Study|Physician Decision|0|||
130923573|NCT00939770|471355074|FG001|Overall Study|Physician Decision|0|||
130923574|NCT00939770|471355075|FG002|Overall Study|Physician Decision|2|||
130923575|NCT00939770|471355076|FG003|Overall Study|Physician Decision|0|||
130923576|NCT00939770|471355077|FG004|Overall Study|Physician Decision|7|||
130923577|NCT00939770|471355078|FG005|Overall Study|Physician Decision|1|||
130923578|NCT00939770|471355079|FG006|Overall Study|Physician Decision|0|||
130923579|NCT00939770|471355080|FG007|Overall Study|Physician Decision|6|||
130923580|NCT00939770|471355073|FG000|Overall Study|Protocol Violation|0|||
130923581|NCT00939770|471355074|FG001|Overall Study|Protocol Violation|0|||
130923582|NCT00939770|471355075|FG002|Overall Study|Protocol Violation|0|||
130923583|NCT00939770|471355076|FG003|Overall Study|Protocol Violation|0|||
130923584|NCT00939770|471355077|FG004|Overall Study|Protocol Violation|1|||
130923585|NCT00939770|471355078|FG005|Overall Study|Protocol Violation|0|||
130923586|NCT00939770|471355079|FG006|Overall Study|Protocol Violation|0|||
130923587|NCT00939770|471355080|FG007|Overall Study|Protocol Violation|0|||
130923588|NCT00939770|471355073|FG000|Overall Study|Withdrawal by Subject|0|||
130923589|NCT00939770|471355074|FG001|Overall Study|Withdrawal by Subject|1|||
130923590|NCT00939770|471355075|FG002|Overall Study|Withdrawal by Subject|5|||
130923591|NCT00939770|471355076|FG003|Overall Study|Withdrawal by Subject|2|||
130923592|NCT00939770|471355077|FG004|Overall Study|Withdrawal by Subject|6|||
130700693|NCT04773600|470526515|FG000|Overall Study|Lack of Efficacy|2|||
130700694|NCT04773600|470526516|FG001|Overall Study|Lack of Efficacy|3|||
130700695|NCT04773600|470526515|FG000|Overall Study|Noncompliance|2|||
130923593|NCT00939770|471355078|FG005|Overall Study|Withdrawal by Subject|0|||
130923594|NCT00939770|471355079|FG006|Overall Study|Withdrawal by Subject|2|||
130923595|NCT00939770|471355080|FG007|Overall Study|Withdrawal by Subject|2|||
130923596|NCT03338010|471355081|FG000|Overall Study|Withdrawal by Subject|14|||
130923597|NCT03338010|471355082|FG001|Overall Study|Withdrawal by Subject|8|||
130923598|NCT03338010|471355081|FG000|Overall Study|Lost to Follow-up|4|||
130923599|NCT03338010|471355082|FG001|Overall Study|Lost to Follow-up|2|||
130923600|NCT03338010|471355081|FG000|Overall Study|Adverse Event|3|||
130923601|NCT03338010|471355082|FG001|Overall Study|Adverse Event|2|||
130923602|NCT03338010|471355081|FG000|Overall Study|Physician Decision|2|||
130923603|NCT03338010|471355082|FG001|Overall Study|Physician Decision|2|||
130923604|NCT03338010|471355081|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130923605|NCT03338010|471355082|FG001|Overall Study|Non-Compliance with Study Drug|3|||
130923606|NCT03338010|471355081|FG000|Overall Study|Protocol Violation|0|||
130923607|NCT03338010|471355082|FG001|Overall Study|Protocol Violation|1|||
130923608|NCT01146665|471355083|FG000|Overall Study|Withdrawal by Subject|10|||
130923609|NCT01146665|471355084|FG001|Overall Study|Withdrawal by Subject|16|||
130923610|NCT00293033|471355085|FG000|Open-label Titration Period|Adverse Event|10|||
130923611|NCT00293033|471355085|FG000|Open-label Titration Period|Death|3|||
130700696|NCT04773600|470526516|FG001|Overall Study|Noncompliance|0|||
130923612|NCT00293033|471355085|FG000|Open-label Titration Period|Lack of Efficacy|5|||
130923613|NCT00293033|471355085|FG000|Open-label Titration Period|Protocol Violation|2|||
130923614|NCT00293033|471355085|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
130923615|NCT00293033|471355085|FG000|Open-label Titration Period|Noncompliance and other|27|||
130923616|NCT00293033|471355085|FG000|Double-blind Treatment Period|Adverse Event|3|||
130923617|NCT00293033|471355085|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
130923618|NCT00293033|471355085|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
130923619|NCT00293033|471355085|FG000|Double-blind Treatment Period|Noncompliance|4|||
130923620|NCT01817530|471355086|FG000|Overall Study|Exclusionary Medication Received|0|||
130923621|NCT01817530|471355087|FG001|Overall Study|Exclusionary Medication Received|0|||
130923622|NCT01817530|471355088|FG002|Overall Study|Exclusionary Medication Received|0|||
130923623|NCT01817530|471355089|FG003|Overall Study|Exclusionary Medication Received|0|||
130923624|NCT01817530|471355090|FG004|Overall Study|Exclusionary Medication Received|1|||
130923625|NCT01817530|471355091|FG005|Overall Study|Exclusionary Medication Received|0|||
130923626|NCT01817530|471355092|FG006|Overall Study|Exclusionary Medication Received|0|||
130923627|NCT01817530|471355093|FG007|Overall Study|Exclusionary Medication Received|0|||
130923628|NCT01817530|471355086|FG000|Overall Study|Adverse Event|6|||
130923629|NCT01817530|471355087|FG001|Overall Study|Adverse Event|3|||
130923630|NCT01817530|471355088|FG002|Overall Study|Adverse Event|2|||
130923631|NCT01817530|471355089|FG003|Overall Study|Adverse Event|5|||
130923632|NCT01817530|471355090|FG004|Overall Study|Adverse Event|0|||
130923633|NCT01817530|471355091|FG005|Overall Study|Adverse Event|10|||
130923634|NCT01817530|471355092|FG006|Overall Study|Adverse Event|5|||
130923635|NCT01817530|471355093|FG007|Overall Study|Adverse Event|8|||
130923636|NCT01817530|471355086|FG000|Overall Study|Subject Noncompliant|3|||
130923637|NCT01817530|471355087|FG001|Overall Study|Subject Noncompliant|1|||
130923638|NCT01817530|471355088|FG002|Overall Study|Subject Noncompliant|0|||
130923639|NCT01817530|471355089|FG003|Overall Study|Subject Noncompliant|4|||
130923640|NCT01817530|471355090|FG004|Overall Study|Subject Noncompliant|0|||
130923641|NCT01817530|471355091|FG005|Overall Study|Subject Noncompliant|1|||
130923642|NCT01817530|471355092|FG006|Overall Study|Subject Noncompliant|1|||
130923643|NCT01817530|471355093|FG007|Overall Study|Subject Noncompliant|1|||
130923644|NCT01817530|471355086|FG000|Overall Study|Lack of Efficacy|1|||
130923645|NCT01817530|471355087|FG001|Overall Study|Lack of Efficacy|0|||
130923646|NCT01817530|471355088|FG002|Overall Study|Lack of Efficacy|0|||
130923647|NCT01817530|471355089|FG003|Overall Study|Lack of Efficacy|0|||
130923648|NCT01817530|471355090|FG004|Overall Study|Lack of Efficacy|0|||
130923649|NCT01817530|471355091|FG005|Overall Study|Lack of Efficacy|1|||
130923650|NCT01817530|471355092|FG006|Overall Study|Lack of Efficacy|0|||
130923651|NCT01817530|471355093|FG007|Overall Study|Lack of Efficacy|1|||
130923652|NCT01817530|471355086|FG000|Overall Study|Pregnancy|0|||
130923653|NCT01817530|471355087|FG001|Overall Study|Pregnancy|0|||
130923654|NCT01817530|471355088|FG002|Overall Study|Pregnancy|0|||
130923655|NCT01817530|471355089|FG003|Overall Study|Pregnancy|0|||
130923656|NCT01817530|471355090|FG004|Overall Study|Pregnancy|0|||
130923657|NCT01817530|471355091|FG005|Overall Study|Pregnancy|1|||
130923658|NCT01817530|471355092|FG006|Overall Study|Pregnancy|0|||
130923659|NCT01817530|471355093|FG007|Overall Study|Pregnancy|0|||
130923660|NCT01817530|471355086|FG000|Overall Study|Other|0|||
130923661|NCT01817530|471355087|FG001|Overall Study|Other|1|||
130923662|NCT01817530|471355088|FG002|Overall Study|Other|0|||
130923663|NCT01817530|471355089|FG003|Overall Study|Other|0|||
130923664|NCT01817530|471355090|FG004|Overall Study|Other|1|||
130923665|NCT01817530|471355091|FG005|Overall Study|Other|0|||
130923666|NCT01817530|471355092|FG006|Overall Study|Other|5|||
130923667|NCT01817530|471355093|FG007|Overall Study|Other|0|||
130923668|NCT01817530|471355086|FG000|Overall Study|Surgery or Invasive Intervention|1|||
130923669|NCT01817530|471355087|FG001|Overall Study|Surgery or Invasive Intervention|0|||
130923670|NCT01817530|471355088|FG002|Overall Study|Surgery or Invasive Intervention|0|||
130923671|NCT01817530|471355089|FG003|Overall Study|Surgery or Invasive Intervention|0|||
130923672|NCT01817530|471355090|FG004|Overall Study|Surgery or Invasive Intervention|1|||
130923673|NCT01817530|471355091|FG005|Overall Study|Surgery or Invasive Intervention|1|||
130923674|NCT01817530|471355092|FG006|Overall Study|Surgery or Invasive Intervention|1|||
130923675|NCT01817530|471355093|FG007|Overall Study|Surgery or Invasive Intervention|0|||
130923676|NCT01817530|471355086|FG000|Overall Study|Consent Withdrawn by Subject|3|||
130700697|NCT04773600|470526515|FG000|Overall Study|Protocol Violation|2|||
130923677|NCT01817530|471355087|FG001|Overall Study|Consent Withdrawn by Subject|4|||
130923678|NCT01817530|471355088|FG002|Overall Study|Consent Withdrawn by Subject|7|||
130923679|NCT01817530|471355089|FG003|Overall Study|Consent Withdrawn by Subject|3|||
130700698|NCT04773600|470526516|FG001|Overall Study|Protocol Violation|0|||
130923680|NCT01817530|471355090|FG004|Overall Study|Consent Withdrawn by Subject|5|||
130923681|NCT01817530|471355091|FG005|Overall Study|Consent Withdrawn by Subject|3|||
130923682|NCT01817530|471355092|FG006|Overall Study|Consent Withdrawn by Subject|3|||
130700699|NCT04773600|470526515|FG000|Overall Study|Physician Decision|0|||
130923683|NCT01817530|471355093|FG007|Overall Study|Consent Withdrawn by Subject|10|||
130923684|NCT01817530|471355086|FG000|Overall Study|Lost to Follow-up|1|||
130923685|NCT01817530|471355087|FG001|Overall Study|Lost to Follow-up|4|||
130923686|NCT01817530|471355088|FG002|Overall Study|Lost to Follow-up|2|||
130923687|NCT01817530|471355089|FG003|Overall Study|Lost to Follow-up|1|||
130923688|NCT01817530|471355090|FG004|Overall Study|Lost to Follow-up|3|||
130923689|NCT01817530|471355091|FG005|Overall Study|Lost to Follow-up|2|||
130923690|NCT01817530|471355092|FG006|Overall Study|Lost to Follow-up|8|||
130923691|NCT01817530|471355093|FG007|Overall Study|Lost to Follow-up|4|||
130923692|NCT05695209|471355096|FG000|3-months|Withdrawal by Subject|2|||
130923693|NCT05695209|471355097|FG001|3-months|Withdrawal by Subject|0|||
130923694|NCT05695209|471355096|FG000|3-months|Unable to contact for 3-month data collection|0|||
130923695|NCT05695209|471355097|FG001|3-months|Unable to contact for 3-month data collection|1|||
130923696|NCT05695209|471355096|FG000|6-months|Lost to Follow-up|1|||
130923697|NCT05695209|471355097|FG001|6-months|Lost to Follow-up|1|||
130923698|NCT00354744|471356383|FG000|Overall Study|Adverse Event|2|||
130923699|NCT00354744|471356383|FG000|Overall Study|Death|2|||
130923700|NCT00354744|471356383|FG000|Overall Study|Lack of Efficacy|11|||
130923701|NCT00354744|471356383|FG000|Overall Study|Lost to Follow-up|2|||
130923702|NCT00354744|471356383|FG000|Overall Study|Physician Decision|11|||
130923703|NCT00354744|471356383|FG000|Overall Study|Withdrawal by Subject|14|||
130923704|NCT00926328|471356384|FG000|Overall Study|Lost to Follow-up|12|||
130923705|NCT00926328|471356385|FG001|Overall Study|Lost to Follow-up|14|||
130923706|NCT00289133|471356388|FG000|Overall Study|Non-study device implanted|12|||
130923707|NCT00289133|471356389|FG001|Overall Study|Non-study device implanted|0|||
130923708|NCT00289133|471356388|FG000|Overall Study|Protocol Violation|32|||
130923709|NCT00289133|471356389|FG001|Overall Study|Protocol Violation|38|||
130923710|NCT00289133|471356388|FG000|Overall Study|Withdrawal by Subject|9|||
130923711|NCT00289133|471356389|FG001|Overall Study|Withdrawal by Subject|10|||
130923712|NCT00289133|471356388|FG000|Overall Study|Death|5|||
130923713|NCT00289133|471356389|FG001|Overall Study|Death|10|||
130923714|NCT00289133|471356388|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
130923715|NCT00289133|471356389|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
130923716|NCT00289133|471356388|FG000|Overall Study|Physician Decision|41|||
130923717|NCT00289133|471356389|FG001|Overall Study|Physician Decision|45|||
130923718|NCT00289133|471356388|FG000|Overall Study|Revision|8|||
130923719|NCT00289133|471356389|FG001|Overall Study|Revision|6|||
130923720|NCT00289133|471356388|FG000|Overall Study|Lost to Follow-up|92|||
130923721|NCT00289133|471356389|FG001|Overall Study|Lost to Follow-up|115|||
130923722|NCT00726986|471356390|FG000|Induction Phase|Adverse Event|4|||
130923723|NCT00726986|471356390|FG000|Induction Phase|Withdrawal by Subject|2|||
130923724|NCT00726986|471356390|FG000|Induction Phase|Death|2|||
130923725|NCT00726986|471356390|FG000|Induction Phase|Lack of Efficacy|5|||
130923726|NCT00726986|471356390|FG000|Induction Phase|Secondary Disease|2|||
130923727|NCT00726986|471356390|FG000|Maintenance Phase|Adverse Event|1|||
130923728|NCT00726986|471356390|FG000|Maintenance Phase|Lack of Efficacy|2|||
130923729|NCT01513343|471356393|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
130923730|NCT01513343|471356394|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
130923731|NCT01513343|471356393|FG000|Post Data Collection|Dropped/withdrew from study|7|||
130923732|NCT01513343|471356394|FG001|Post Data Collection|Dropped/withdrew from study|1|||
130923733|NCT01513343|471356393|FG000|Post Data Collection|Lost to Follow-up|10|||
130923734|NCT01513343|471356394|FG001|Post Data Collection|Lost to Follow-up|23|||
130923735|NCT01513343|471356393|FG000|6-month Follow-up|Lost to Follow-up|28|||
130923736|NCT01513343|471356394|FG001|6-month Follow-up|Lost to Follow-up|17|||
130923737|NCT01513343|471356393|FG000|12-month Follow-up|Lost to Follow-up|10|||
130923738|NCT01513343|471356394|FG001|12-month Follow-up|Lost to Follow-up|3|||
130923739|NCT02279420|471356395|FG000|Overall Study|Lost to Follow-up|23|||
130923740|NCT01153347|471356398|FG000|Overall Study|Withdrawal by Subject|7|||
130923741|NCT01153347|471356399|FG001|Overall Study|Withdrawal by Subject|7|||
130923742|NCT01153347|471356400|FG002|Overall Study|Withdrawal by Subject|7|||
130923743|NCT01153347|471356401|FG003|Overall Study|Withdrawal by Subject|7|||
130923744|NCT01153347|471356398|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130923745|NCT01153347|471356399|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130923746|NCT01153347|471356400|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
130923747|NCT01153347|471356401|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130923748|NCT01153347|471356398|FG000|Overall Study|Adverse Event|3|||
130923749|NCT01153347|471356399|FG001|Overall Study|Adverse Event|9|||
130923750|NCT01153347|471356400|FG002|Overall Study|Adverse Event|21|||
130923751|NCT01153347|471356401|FG003|Overall Study|Adverse Event|7|||
130923752|NCT01153347|471356398|FG000|Overall Study|Severe non-compliance to protocol|6|||
130923753|NCT01153347|471356399|FG001|Overall Study|Severe non-compliance to protocol|7|||
130923754|NCT01153347|471356400|FG002|Overall Study|Severe non-compliance to protocol|4|||
130923755|NCT01153347|471356401|FG003|Overall Study|Severe non-compliance to protocol|3|||
130923756|NCT01153347|471356398|FG000|Overall Study|Condition under investigation worsened|1|||
130923757|NCT01153347|471356399|FG001|Overall Study|Condition under investigation worsened|1|||
130923758|NCT01153347|471356400|FG002|Overall Study|Condition under investigation worsened|0|||
130923759|NCT01153347|471356401|FG003|Overall Study|Condition under investigation worsened|0|||
130923760|NCT01153347|471356398|FG000|Overall Study|Lack of Efficacy|2|||
130923761|NCT01153347|471356399|FG001|Overall Study|Lack of Efficacy|2|||
130923762|NCT01153347|471356400|FG002|Overall Study|Lack of Efficacy|0|||
130923763|NCT01153347|471356401|FG003|Overall Study|Lack of Efficacy|4|||
130923764|NCT01153347|471356398|FG000|Overall Study|Study-specific withdrawal criteria|4|||
130923765|NCT01153347|471356399|FG001|Overall Study|Study-specific withdrawal criteria|3|||
130923766|NCT01153347|471356400|FG002|Overall Study|Study-specific withdrawal criteria|1|||
130923767|NCT01153347|471356401|FG003|Overall Study|Study-specific withdrawal criteria|2|||
130923768|NCT01153347|471356398|FG000|Overall Study|Lost to Follow-up|4|||
130923769|NCT01153347|471356399|FG001|Overall Study|Lost to Follow-up|9|||
130923770|NCT01153347|471356400|FG002|Overall Study|Lost to Follow-up|11|||
130923771|NCT01153347|471356401|FG003|Overall Study|Lost to Follow-up|8|||
130923772|NCT01153347|471356398|FG000|Overall Study|Other|5|||
130923773|NCT01153347|471356399|FG001|Overall Study|Other|5|||
130923774|NCT01153347|471356400|FG002|Overall Study|Other|4|||
130923775|NCT01153347|471356401|FG003|Overall Study|Other|0|||
130923776|NCT01153347|471356398|FG000|Overall Study|Death|1|||
130923777|NCT01153347|471356399|FG001|Overall Study|Death|0|||
130923778|NCT01153347|471356400|FG002|Overall Study|Death|0|||
130923779|NCT01153347|471356401|FG003|Overall Study|Death|0|||
130923780|NCT00297830|471356402|FG000|6 Month Visit|Death|1|||
130923781|NCT00297830|471356403|FG001|6 Month Visit|Death|0|||
130923782|NCT00297830|471356404|FG002|6 Month Visit|Death|2|||
130923783|NCT00297830|471356402|FG000|6 Month Visit|Withdrawal by Subject|2|||
130923784|NCT00297830|471356403|FG001|6 Month Visit|Withdrawal by Subject|1|||
130923785|NCT00297830|471356404|FG002|6 Month Visit|Withdrawal by Subject|1|||
130923786|NCT00297830|471356402|FG000|6 Month Visit|Adverse Event|0|||
130923787|NCT00297830|471356403|FG001|6 Month Visit|Adverse Event|1|||
130923788|NCT00297830|471356404|FG002|6 Month Visit|Adverse Event|0|||
130923789|NCT00297830|471356402|FG000|12 Month Visit|Lost to Follow-up|1|||
130923790|NCT00297830|471356403|FG001|12 Month Visit|Lost to Follow-up|0|||
130923791|NCT00297830|471356404|FG002|12 Month Visit|Lost to Follow-up|0|||
130923792|NCT00297830|471356402|FG000|12 Month Visit|Adverse Event|0|||
130923793|NCT00297830|471356403|FG001|12 Month Visit|Adverse Event|3|||
130923794|NCT00297830|471356404|FG002|12 Month Visit|Adverse Event|0|||
130923795|NCT00297830|471356402|FG000|12 Month Visit|Withdrawal by Subject|0|||
130923796|NCT00297830|471356403|FG001|12 Month Visit|Withdrawal by Subject|3|||
130923797|NCT00297830|471356404|FG002|12 Month Visit|Withdrawal by Subject|0|||
130923798|NCT05096221|471356407|FG000|Part 2|Physician Decision|0|||
130923799|NCT05096221|471356408|FG001|Part 2|Physician Decision|1|||
130923800|NCT04678661|471356410|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
130923801|NCT04678661|471356411|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
130923802|NCT04678661|471356410|FG000|Overall Study|Protocol Violation|2|||
130923803|NCT04678661|471356411|FG001|Overall Study|Protocol Violation|0|||
130923804|NCT04678661|471356410|FG000|Overall Study|Withdrawal by Subject|1|||
130923805|NCT04678661|471356411|FG001|Overall Study|Withdrawal by Subject|0|||
130923806|NCT04678661|471356410|FG000|Overall Study|Lost to Follow-up|2|||
130923807|NCT04678661|471356411|FG001|Overall Study|Lost to Follow-up|0|||
130923808|NCT04678661|471356410|FG000|Overall Study|Death|2|||
130923809|NCT04678661|471356411|FG001|Overall Study|Death|0|||
130923810|NCT03094169|471356412|FG000|Overall Study|Lack of Efficacy|0|||
130923811|NCT03094169|471356413|FG001|Overall Study|Lack of Efficacy|0|||
130923812|NCT03094169|471356414|FG002|Overall Study|Lack of Efficacy|0|||
130923813|NCT03094169|471356415|FG003|Overall Study|Lack of Efficacy|0|||
130923814|NCT03094169|471356416|FG004|Overall Study|Lack of Efficacy|0|||
130923815|NCT03094169|471356417|FG005|Overall Study|Lack of Efficacy|0|||
130923816|NCT03094169|471356418|FG006|Overall Study|Lack of Efficacy|0|||
130923817|NCT03094169|471356419|FG007|Overall Study|Lack of Efficacy|21|||
130923818|NCT03094169|471356412|FG000|Overall Study|Adverse Event|0|||
130923819|NCT03094169|471356413|FG001|Overall Study|Adverse Event|0|||
130923820|NCT03094169|471356414|FG002|Overall Study|Adverse Event|0|||
130923821|NCT03094169|471356415|FG003|Overall Study|Adverse Event|0|||
130923822|NCT03094169|471356416|FG004|Overall Study|Adverse Event|0|||
130923823|NCT03094169|471356417|FG005|Overall Study|Adverse Event|0|||
130923824|NCT03094169|471356418|FG006|Overall Study|Adverse Event|0|||
130923825|NCT03094169|471356419|FG007|Overall Study|Adverse Event|2|||
130923826|NCT03094169|471356412|FG000|Overall Study|Withdrawal by Subject|0|||
130923827|NCT03094169|471356413|FG001|Overall Study|Withdrawal by Subject|0|||
130923828|NCT03094169|471356414|FG002|Overall Study|Withdrawal by Subject|0|||
130923829|NCT03094169|471356415|FG003|Overall Study|Withdrawal by Subject|0|||
130923830|NCT03094169|471356416|FG004|Overall Study|Withdrawal by Subject|0|||
130923831|NCT03094169|471356417|FG005|Overall Study|Withdrawal by Subject|0|||
130923832|NCT03094169|471356418|FG006|Overall Study|Withdrawal by Subject|1|||
130923833|NCT03094169|471356419|FG007|Overall Study|Withdrawal by Subject|1|||
130923834|NCT03094169|471356412|FG000|Overall Study|Trial Termination|0|||
130923835|NCT03094169|471356413|FG001|Overall Study|Trial Termination|0|||
130923836|NCT03094169|471356414|FG002|Overall Study|Trial Termination|0|||
130923837|NCT03094169|471356415|FG003|Overall Study|Trial Termination|0|||
130923838|NCT03094169|471356416|FG004|Overall Study|Trial Termination|0|||
130923839|NCT03094169|471356417|FG005|Overall Study|Trial Termination|0|||
130923840|NCT03094169|471356418|FG006|Overall Study|Trial Termination|0|||
130923841|NCT03094169|471356419|FG007|Overall Study|Trial Termination|1|||
130923842|NCT04645953|471356420|FG000|Overall Study|Lost to Follow-up|2|||
130923843|NCT04645953|471356421|FG001|Overall Study|Lost to Follow-up|1|||
130923844|NCT04645953|471356422|FG002|Overall Study|Lost to Follow-up|1|||
130700700|NCT04773600|470526516|FG001|Overall Study|Physician Decision|1|||
130700701|NCT04773600|470526515|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
130700702|NCT04773600|470526516|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
130700703|NCT04773600|470526515|FG000|Overall Study|Emergency Travel Out of Country|1|||
130700704|NCT04773600|470526516|FG001|Overall Study|Emergency Travel Out of Country|0|||
130700705|NCT00500318|470528239|FG000|Overall Study|Adverse Event|3|||
130700706|NCT00500318|470528240|FG001|Overall Study|Adverse Event|8|||
130700707|NCT00500318|470528239|FG000|Overall Study|Protocol Violation|1|||
130700708|NCT00500318|470528240|FG001|Overall Study|Protocol Violation|3|||
130700709|NCT00500318|470528239|FG000|Overall Study|Withdrawal by Subject|1|||
130700710|NCT00500318|470528240|FG001|Overall Study|Withdrawal by Subject|2|||
130700711|NCT00500318|470528239|FG000|Overall Study|Lack of Efficacy|0|||
130700712|NCT00500318|470528240|FG001|Overall Study|Lack of Efficacy|3|||
130700713|NCT00500318|470528239|FG000|Overall Study|Other Reason|0|||
130700714|NCT00500318|470528240|FG001|Overall Study|Other Reason|1|||
130700715|NCT03243396|470528243|FG000|Overall Study|Lost to Follow-up|2|||
130700716|NCT03243396|470528244|FG001|Overall Study|Lost to Follow-up|3|||
130700717|NCT03243396|470528245|FG002|Overall Study|Lost to Follow-up|15|||
130700718|NCT03243396|470528246|FG003|Overall Study|Lost to Follow-up|8|||
130700719|NCT03243396|470528247|FG004|Overall Study|Lost to Follow-up|1|||
130700720|NCT03243396|470528248|FG005|Overall Study|Lost to Follow-up|4|||
130700721|NCT03243396|470528249|FG006|Overall Study|Lost to Follow-up|9|||
130700722|NCT03687242|470528250|FG000|Overall Study|Adverse Event|1|||
130700723|NCT02655224|470528251|FG000|Overall Study|Adverse Event|1|||
130700724|NCT02655224|470528252|FG001|Overall Study|Adverse Event|1|||
130700725|NCT01257581|470528253|FG000|Overall Study|Early Termination|3|||
130700726|NCT01257581|470528254|FG001|Overall Study|Early Termination|1|||
130700727|NCT01257581|470528255|FG002|Overall Study|Early Termination|2|||
130700728|NCT01257581|470528253|FG000|Overall Study|Death|2|||
130700729|NCT01257581|470528254|FG001|Overall Study|Death|2|||
130700730|NCT01257581|470528255|FG002|Overall Study|Death|4|||
130700731|NCT02104817|470528259|FG000|Overall Study|Death|363|||
130700732|NCT02104817|470528260|FG001|Overall Study|Death|330|||
130700733|NCT02104817|470528259|FG000|Overall Study|Lost to Follow-up|3|||
130700734|NCT02104817|470528260|FG001|Overall Study|Lost to Follow-up|2|||
130700735|NCT02104817|470528259|FG000|Overall Study|Protocol Violation|0|||
130700736|NCT02104817|470528260|FG001|Overall Study|Protocol Violation|1|||
130700737|NCT02104817|470528259|FG000|Overall Study|Study terminated by sponsor|5854|||
130700738|NCT02104817|470528260|FG001|Overall Study|Study terminated by sponsor|5901|||
130700739|NCT02104817|470528259|FG000|Overall Study|Withdrawal by Subject|111|||
130700740|NCT02104817|470528260|FG001|Overall Study|Withdrawal by Subject|78|||
130700741|NCT02104817|470528259|FG000|Overall Study|Other reasons|128|||
130700742|NCT02104817|470528260|FG001|Overall Study|Other reasons|135|||
130700743|NCT02575339|470528264|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
130700744|NCT02575339|470528265|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
130700745|NCT02575339|470528266|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
130700746|NCT02575339|470528264|FG000|Study Treatment|Disease Progression|5|||
130700747|NCT02575339|470528265|FG001|Study Treatment|Disease Progression|2|||
130700748|NCT02575339|470528266|FG002|Study Treatment|Disease Progression|0|||
130700749|NCT02575339|470528264|FG000|Study Treatment|Adverse Event|1|||
130700750|NCT02575339|470528265|FG001|Study Treatment|Adverse Event|2|||
130700751|NCT02575339|470528266|FG002|Study Treatment|Adverse Event|0|||
130700752|NCT02575339|470528264|FG000|Follow up|Death|6|||
130700753|NCT02575339|470528265|FG001|Follow up|Death|2|||
130700754|NCT02575339|470528266|FG002|Follow up|Death|0|||
130700755|NCT02575339|470528264|FG000|Follow up|Study Terminated|0|||
130700756|NCT02575339|470528265|FG001|Follow up|Study Terminated|2|||
130700757|NCT02575339|470528266|FG002|Follow up|Study Terminated|0|||
130700758|NCT02575339|470528264|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
130700759|NCT02575339|470528265|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
130923845|NCT04645953|471356420|FG000|Overall Study|Withdrawal by Subject|0|||
130923846|NCT04645953|471356421|FG001|Overall Study|Withdrawal by Subject|1|||
130923847|NCT04645953|471356422|FG002|Overall Study|Withdrawal by Subject|0|||
130923848|NCT04645953|471356420|FG000|Overall Study|Physician Decision|0|||
130700760|NCT02575339|470528266|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
130700761|NCT04633642|470528267|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
130700762|NCT04633642|470528268|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
130923849|NCT04645953|471356421|FG001|Overall Study|Physician Decision|1|||
130923850|NCT04645953|471356422|FG002|Overall Study|Physician Decision|0|||
130700763|NCT03223909|470528269|FG000|Overall Study|Protocol Violation|48|||
130700764|NCT03223909|470528270|FG001|Overall Study|Protocol Violation|45|||
130700765|NCT03223909|470528271|FG002|Overall Study|Protocol Violation|16|||
130700766|NCT01628549|470528272|FG000|Overall Study|Adverse Event|1|||
130700767|NCT01628549|470528273|FG001|Overall Study|Adverse Event|1|||
130700768|NCT01628549|470528274|FG002|Overall Study|Adverse Event|0|||
130700769|NCT01628549|470528275|FG003|Overall Study|Adverse Event|4|||
130769604|NCT01026818|470782507|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
130923851|NCT04645953|471356420|FG000|Overall Study|Discontinued Prior to Dosing|0|||
130923852|NCT04645953|471356421|FG001|Overall Study|Discontinued Prior to Dosing|0|||
130923853|NCT04645953|471356422|FG002|Overall Study|Discontinued Prior to Dosing|2|||
130923854|NCT04613375|471356423|FG000|Overall Study|Death|198|||
130923855|NCT04613375|471356423|FG000|Overall Study|Withdrawal by Subject|3|||
130923856|NCT03741062|471356426|FG000|Overall Study|Protocol Violation|1|||
130923857|NCT03741062|471356427|FG001|Overall Study|Protocol Violation|0|||
130923858|NCT00518284|471356430|FG000|Overall Study|Adverse Event|0|||
130700770|NCT01628549|470528272|FG000|Overall Study|Lost to Follow-up|3|||
130923859|NCT00518284|471356431|FG001|Overall Study|Adverse Event|1|||
130923860|NCT00518284|471356432|FG002|Overall Study|Adverse Event|0|||
130923861|NCT00518284|471356433|FG003|Overall Study|Adverse Event|0|||
130923862|NCT00518284|471356430|FG000|Overall Study|Study Termination|0|||
130923863|NCT00518284|471356431|FG001|Overall Study|Study Termination|2|||
130923864|NCT00518284|471356432|FG002|Overall Study|Study Termination|1|||
130923865|NCT00518284|471356433|FG003|Overall Study|Study Termination|2|||
130923866|NCT00801632|471356434|FG000|Overall Study|Re-transplant|1|||
130923867|NCT00621582|471356435|FG000|Overall Study|Adverse Event|7|||
130923868|NCT00621582|471356435|FG000|Overall Study|Protocol Violation|57|||
130923869|NCT00621582|471356435|FG000|Overall Study|Lost to Follow-up|24|||
130923870|NCT00621582|471356435|FG000|Overall Study|issues not identified by investigators|18|||
130923871|NCT01387932|471356437|FG000|Randomized and Treated|Physician Decision|3|||
130923872|NCT01387932|471356438|FG001|Randomized and Treated|Physician Decision|2|||
130923873|NCT01387932|471356437|FG000|Randomized and Treated|Withdrawal by Subject|4|||
130923874|NCT01387932|471356438|FG001|Randomized and Treated|Withdrawal by Subject|2|||
130923875|NCT01387932|471356437|FG000|Survival Follow-up|Liver Transplant|24|||
130923876|NCT01387932|471356438|FG001|Survival Follow-up|Liver Transplant|28|||
130923877|NCT01387932|471356437|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
130923878|NCT01387932|471356438|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
130923879|NCT01387932|471356437|FG000|Survival Follow-up|Withdrawal by Subject|2|||
130923880|NCT01387932|471356438|FG001|Survival Follow-up|Withdrawal by Subject|4|||
130923881|NCT01387932|471356437|FG000|Survival Follow-up|Lost to Follow-up|6|||
130923882|NCT01387932|471356438|FG001|Survival Follow-up|Lost to Follow-up|5|||
130923883|NCT00205881|471356439|FG000|Overall Study|Withdrawal by Subject|16|||
130923884|NCT04203498|471356444|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
130923885|NCT04203498|471356445|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
130923886|NCT04203498|471356444|FG000|Overall Study|Withdrawal of patient consent|7|||
130923887|NCT04203498|471356445|FG001|Overall Study|Withdrawal of patient consent|2|||
130923888|NCT04203498|471356444|FG000|Overall Study|Adverse Event|4|||
130923889|NCT04203498|471356445|FG001|Overall Study|Adverse Event|1|||
130923890|NCT04203498|471356444|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
130923891|NCT04203498|471356445|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
130923892|NCT04203498|471356444|FG000|Overall Study|Did not receive IMP|2|||
130923893|NCT04203498|471356445|FG001|Overall Study|Did not receive IMP|0|||
130923894|NCT02217878|471356448|FG000|Overall Study|required morphine due to chest pain|1|||
130923895|NCT02217878|471356449|FG001|Overall Study|required morphine due to chest pain|2|||
130923896|NCT02217878|471356448|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
130923897|NCT02217878|471356449|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
130923898|NCT00622401|471356454|FG000|Overall Study|Disease progression prior to treatment|3|||
130923899|NCT00622401|471356455|FG001|Overall Study|Disease progression prior to treatment|2|||
130923900|NCT00622401|471356456|FG002|Overall Study|Disease progression prior to treatment|0|||
130923901|NCT03546062|471356460|FG000|Overall Study|Adverse Event|6|||
130923902|NCT03546062|471356461|FG001|Overall Study|Adverse Event|5|||
130923903|NCT03546062|471356462|FG002|Overall Study|Adverse Event|8|||
130923904|NCT00190671|471356466|FG000|Overall Study|Satisfactory Response|4|||
130923905|NCT00190671|471356467|FG001|Overall Study|Satisfactory Response|7|||
130923906|NCT00190671|471356466|FG000|Overall Study|Lack of Efficacy|19|||
130923907|NCT00190671|471356467|FG001|Overall Study|Lack of Efficacy|24|||
130923908|NCT00190671|471356466|FG000|Overall Study|Death from Study Disease|1|||
130923909|NCT00190671|471356467|FG001|Overall Study|Death from Study Disease|1|||
130923910|NCT00190671|471356466|FG000|Overall Study|Adverse Event|3|||
130923911|NCT00190671|471356467|FG001|Overall Study|Adverse Event|2|||
130923912|NCT00190671|471356466|FG000|Overall Study|Clinical Relapse|0|||
130923913|NCT00190671|471356467|FG001|Overall Study|Clinical Relapse|1|||
130923914|NCT00190671|471356466|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
130700771|NCT01628549|470528273|FG001|Overall Study|Lost to Follow-up|4|||
130923915|NCT00190671|471356467|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
130923916|NCT00190671|471356466|FG000|Overall Study|Death from Other Causes|0|||
130923917|NCT00190671|471356467|FG001|Overall Study|Death from Other Causes|2|||
131120158|NCT00467779|472072314|FG003|Stage 1A|Unspecified Reason|0|||
130700772|NCT01628549|470528274|FG002|Overall Study|Lost to Follow-up|3|||
130700773|NCT01628549|470528275|FG003|Overall Study|Lost to Follow-up|3|||
130923918|NCT00190671|471356466|FG000|Overall Study|Protocol Violation|0|||
130923919|NCT00190671|471356467|FG001|Overall Study|Protocol Violation|1|||
130923920|NCT00190671|471356466|FG000|Overall Study|Withdrawal by Subject|0|||
130769605|NCT01026818|470782504|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
130769606|NCT01026818|470782505|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
130769607|NCT01026818|470782506|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
130769608|NCT01026818|470782507|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
130769609|NCT01026818|470782504|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
130769610|NCT01026818|470782505|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
130769611|NCT01026818|470782506|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
130769612|NCT01026818|470782507|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
130769613|NCT01026818|470782504|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
130769614|NCT01026818|470782505|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
130769615|NCT01026818|470782506|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
130769616|NCT01026818|470782507|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
130769617|NCT01026818|470782504|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
130769618|NCT01026818|470782505|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
130769619|NCT01026818|470782506|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
130769620|NCT01026818|470782507|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
130769621|NCT01026818|470782504|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
130769622|NCT01026818|470782505|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
130769623|NCT01026818|470782506|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
130769624|NCT01026818|470782507|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
130769625|NCT01026818|470782504|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
130769626|NCT01026818|470782505|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
130769627|NCT01026818|470782506|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
130769628|NCT01026818|470782507|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
130769629|NCT01026818|470782504|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
130769630|NCT01026818|470782505|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
130769631|NCT01026818|470782506|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
130769632|NCT01026818|470782507|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
130769633|NCT01026818|470782504|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
130769634|NCT01026818|470782505|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
130769635|NCT01026818|470782506|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
130923921|NCT00190671|471356467|FG001|Overall Study|Withdrawal by Subject|2|||
130923922|NCT03137537|471356472|FG000|Overall Study|Adverse Event|0|||
130923923|NCT03137537|471356473|FG001|Overall Study|Adverse Event|1|||
130923924|NCT00191139|471356474|FG000|Overall Study|Adverse Event|2|||
130923925|NCT00191139|471356475|FG001|Overall Study|Adverse Event|6|||
130923926|NCT00191139|471356474|FG000|Overall Study|Death|2|||
130923927|NCT00191139|471356475|FG001|Overall Study|Death|0|||
130923928|NCT00191139|471356474|FG000|Overall Study|Withdrawal by Subject|0|||
130923929|NCT00191139|471356475|FG001|Overall Study|Withdrawal by Subject|3|||
130923930|NCT00191139|471356474|FG000|Overall Study|Disease Progression|0|||
130923931|NCT00191139|471356475|FG001|Overall Study|Disease Progression|1|||
130923932|NCT00191139|471356474|FG000|Overall Study|Other|1|||
130923933|NCT00191139|471356475|FG001|Overall Study|Other|2|||
130923934|NCT02465515|471356478|FG000|Overall Study|Investigator site closed|4|||
130923935|NCT02465515|471356479|FG001|Overall Study|Investigator site closed|5|||
130923936|NCT02465515|471356478|FG000|Overall Study|Withdrawal by Subject|74|||
130923937|NCT02465515|471356479|FG001|Overall Study|Withdrawal by Subject|43|||
130923938|NCT02465515|471356478|FG000|Overall Study|Physician Decision|8|||
130923939|NCT02465515|471356479|FG001|Overall Study|Physician Decision|12|||
130923940|NCT02465515|471356478|FG000|Overall Study|Lost to Follow-up|68|||
130923941|NCT02465515|471356479|FG001|Overall Study|Lost to Follow-up|51|||
130923942|NCT00816595|471356480|FG000|Overall Study|Withdrawal by Subject|2|||
130923943|NCT00816595|471356481|FG001|Overall Study|Withdrawal by Subject|0|||
130923944|NCT00365508|471356485|FG000|Overall Study|Lost to Follow-up|139|||
130923945|NCT00365508|471356486|FG001|Overall Study|Lost to Follow-up|154|||
130923946|NCT00751933|471356487|FG000|Overall Study|Withdrawal by Subject|0|||
130923947|NCT00751933|471356488|FG001|Overall Study|Withdrawal by Subject|1|||
130923948|NCT00751933|471356489|FG002|Overall Study|Withdrawal by Subject|0|||
130923949|NCT00751933|471356490|FG003|Overall Study|Withdrawal by Subject|0|||
130923950|NCT00751933|471356487|FG000|Overall Study|Physician Decision|0|||
130923951|NCT00751933|471356488|FG001|Overall Study|Physician Decision|0|||
130923952|NCT00751933|471356489|FG002|Overall Study|Physician Decision|1|||
130923953|NCT00751933|471356490|FG003|Overall Study|Physician Decision|1|||
130923954|NCT03846804|471356492|FG000|Overall Study|Refused blood draw|1|||
130923955|NCT03846804|471356492|FG000|Overall Study|Protocol Violation|1|||
130923956|NCT05248867|471356494|FG000|Double-blind Period|Lost to Follow-up|0|||
130923957|NCT05248867|471356495|FG001|Double-blind Period|Lost to Follow-up|3|||
130923958|NCT05248867|471356496|FG002|Double-blind Period|Lost to Follow-up|0|||
130923959|NCT05248867|471356497|FG003|Double-blind Period|Lost to Follow-up|0|||
130923960|NCT05248867|471356498|FG004|Double-blind Period|Lost to Follow-up|0|||
130923961|NCT05248867|471356499|FG005|Double-blind Period|Lost to Follow-up|0|||
130700774|NCT01628549|470528272|FG000|Overall Study|Withdrawal by Subject|3|||
130700775|NCT01628549|470528273|FG001|Overall Study|Withdrawal by Subject|4|||
130700776|NCT01628549|470528274|FG002|Overall Study|Withdrawal by Subject|4|||
130700777|NCT01628549|470528275|FG003|Overall Study|Withdrawal by Subject|1|||
130700778|NCT01628549|470528272|FG000|Overall Study|Protocol Violation|2|||
130700779|NCT01628549|470528273|FG001|Overall Study|Protocol Violation|1|||
130700780|NCT01628549|470528274|FG002|Overall Study|Protocol Violation|1|||
130700781|NCT01628549|470528275|FG003|Overall Study|Protocol Violation|0|||
130700782|NCT01628549|470528272|FG000|Overall Study|withdrawn for noncompliance|0|||
130700783|NCT01628549|470528273|FG001|Overall Study|withdrawn for noncompliance|2|||
130700784|NCT01628549|470528274|FG002|Overall Study|withdrawn for noncompliance|1|||
130700785|NCT01628549|470528275|FG003|Overall Study|withdrawn for noncompliance|0|||
130700786|NCT01628549|470528272|FG000|Overall Study|abnormal laboratory test results|0|||
130700787|NCT01628549|470528273|FG001|Overall Study|abnormal laboratory test results|0|||
130700788|NCT01628549|470528274|FG002|Overall Study|abnormal laboratory test results|1|||
130700789|NCT01628549|470528275|FG003|Overall Study|abnormal laboratory test results|0|||
130700790|NCT01628549|470528272|FG000|Overall Study|positive pregnancy test|0|||
130700791|NCT01628549|470528273|FG001|Overall Study|positive pregnancy test|0|||
130700792|NCT01628549|470528274|FG002|Overall Study|positive pregnancy test|0|||
130700793|NCT01628549|470528275|FG003|Overall Study|positive pregnancy test|1|||
130700794|NCT00177164|470528279|FG000|Overall Study|Protocol Violation|0|||
130700795|NCT00177164|470528280|FG001|Overall Study|Protocol Violation|7|||
130700796|NCT00177164|470528279|FG000|Overall Study|Lost to Follow-up|4|||
130700797|NCT00177164|470528280|FG001|Overall Study|Lost to Follow-up|5|||
130700798|NCT00177164|470528279|FG000|Overall Study|increase in alcohol and drug use|1|||
130700799|NCT00177164|470528280|FG001|Overall Study|increase in alcohol and drug use|2|||
130700800|NCT00177164|470528279|FG000|Overall Study|Adverse Event|1|||
130700801|NCT00177164|470528280|FG001|Overall Study|Adverse Event|0|||
130700802|NCT00177164|470528279|FG000|Overall Study|discharge from hospital|1|||
130700803|NCT00177164|470528280|FG001|Overall Study|discharge from hospital|0|||
130700804|NCT00177164|470528279|FG000|Overall Study|Lack of Efficacy|2|||
130700805|NCT00177164|470528280|FG001|Overall Study|Lack of Efficacy|1|||
130700806|NCT00177164|470528279|FG000|Overall Study|Pregnancy|0|||
130700807|NCT00177164|470528280|FG001|Overall Study|Pregnancy|1|||
130700808|NCT00965757|470528281|FG000|Double-blind Phase|Progression of concomitant disease|1|||
130700809|NCT00965757|470528282|FG001|Double-blind Phase|Progression of concomitant disease|2|||
130700810|NCT00965757|470528283|FG002|Double-blind Phase|Progression of concomitant disease|0|||
130700811|NCT00965757|470528284|FG003|Double-blind Phase|Progression of concomitant disease|0|||
130700812|NCT00965757|470528281|FG000|Double-blind Phase|Adverse drug reaction|2|||
130700813|NCT00965757|470528282|FG001|Double-blind Phase|Adverse drug reaction|1|||
130700814|NCT00965757|470528283|FG002|Double-blind Phase|Adverse drug reaction|0|||
130700815|NCT00965757|470528284|FG003|Double-blind Phase|Adverse drug reaction|0|||
130700816|NCT00965757|470528281|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
130700817|NCT00965757|470528282|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
130769636|NCT01026818|470782507|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
130923962|NCT05248867|471356494|FG000|Double-blind Period|Withdrawal by Subject|5|||
130923963|NCT05248867|471356495|FG001|Double-blind Period|Withdrawal by Subject|14|||
130923964|NCT05248867|471356496|FG002|Double-blind Period|Withdrawal by Subject|0|||
130923965|NCT05248867|471356497|FG003|Double-blind Period|Withdrawal by Subject|0|||
130923966|NCT05248867|471356498|FG004|Double-blind Period|Withdrawal by Subject|0|||
130700818|NCT00965757|470528283|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
130700819|NCT00965757|470528284|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
130700820|NCT00965757|470528281|FG000|Double-blind Phase|Lack of Efficacy|7|||
130700821|NCT00965757|470528282|FG001|Double-blind Phase|Lack of Efficacy|11|||
130700822|NCT00965757|470528283|FG002|Double-blind Phase|Lack of Efficacy|0|||
130700823|NCT00965757|470528284|FG003|Double-blind Phase|Lack of Efficacy|0|||
130700824|NCT00965757|470528281|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
130700825|NCT00965757|470528282|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
130700826|NCT00965757|470528283|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
130700827|NCT00965757|470528284|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
130700828|NCT00965757|470528281|FG000|Double-blind Phase|Lost to Follow-up|0|||
130700829|NCT00965757|470528282|FG001|Double-blind Phase|Lost to Follow-up|1|||
130700830|NCT00965757|470528283|FG002|Double-blind Phase|Lost to Follow-up|0|||
130700831|NCT00965757|470528284|FG003|Double-blind Phase|Lost to Follow-up|0|||
130700832|NCT00965757|470528281|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
130700833|NCT00965757|470528282|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
130700834|NCT00965757|470528283|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
130700835|NCT00965757|470528284|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
130700836|NCT00965757|470528281|FG000|Double-blind Phase|Other|1|||
130700837|NCT00965757|470528282|FG001|Double-blind Phase|Other|0|||
130700838|NCT00965757|470528283|FG002|Double-blind Phase|Other|0|||
130700839|NCT00965757|470528284|FG003|Double-blind Phase|Other|0|||
130700840|NCT00965757|470528281|FG000|Extension Phase|Progression of concomitant disease|0|||
130700841|NCT00965757|470528282|FG001|Extension Phase|Progression of concomitant disease|0|||
130923967|NCT05248867|471356499|FG005|Double-blind Period|Withdrawal by Subject|0|||
130923968|NCT05248867|471356494|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
130923969|NCT05248867|471356495|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
130923970|NCT05248867|471356496|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
130923971|NCT05248867|471356497|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
130923972|NCT05248867|471356498|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
130923973|NCT05248867|471356499|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
130923974|NCT05248867|471356494|FG000|Double-blind Period|Other, not specified|3|||
130923975|NCT05248867|471356495|FG001|Double-blind Period|Other, not specified|8|||
130923976|NCT05248867|471356496|FG002|Double-blind Period|Other, not specified|0|||
130923977|NCT05248867|471356497|FG003|Double-blind Period|Other, not specified|0|||
130923978|NCT05248867|471356498|FG004|Double-blind Period|Other, not specified|0|||
130923979|NCT05248867|471356499|FG005|Double-blind Period|Other, not specified|0|||
130923980|NCT05248867|471356494|FG000|Open-label Period|Withdrawal by Subject|0|||
130923981|NCT05248867|471356495|FG001|Open-label Period|Withdrawal by Subject|0|||
130923982|NCT05248867|471356496|FG002|Open-label Period|Withdrawal by Subject|3|||
130923983|NCT05248867|471356497|FG003|Open-label Period|Withdrawal by Subject|1|||
130923984|NCT05248867|471356498|FG004|Open-label Period|Withdrawal by Subject|7|||
130923985|NCT05248867|471356499|FG005|Open-label Period|Withdrawal by Subject|9|||
130923986|NCT05248867|471356494|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
130923987|NCT05248867|471356495|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
130923988|NCT05248867|471356496|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
130923989|NCT05248867|471356497|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
130923990|NCT05248867|471356498|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
130923991|NCT05248867|471356499|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
130923992|NCT05248867|471356494|FG000|Open-label Period|Lost to Follow-up|0|||
130923993|NCT05248867|471356495|FG001|Open-label Period|Lost to Follow-up|0|||
130923994|NCT05248867|471356496|FG002|Open-label Period|Lost to Follow-up|0|||
130923995|NCT05248867|471356497|FG003|Open-label Period|Lost to Follow-up|0|||
130923996|NCT05248867|471356498|FG004|Open-label Period|Lost to Follow-up|5|||
130923997|NCT05248867|471356499|FG005|Open-label Period|Lost to Follow-up|2|||
130923998|NCT05248867|471356494|FG000|Open-label Period|COVID-19 Infection|0|||
130923999|NCT05248867|471356495|FG001|Open-label Period|COVID-19 Infection|0|||
130924000|NCT05248867|471356496|FG002|Open-label Period|COVID-19 Infection|0|||
130924001|NCT05248867|471356497|FG003|Open-label Period|COVID-19 Infection|0|||
130924002|NCT05248867|471356498|FG004|Open-label Period|COVID-19 Infection|1|||
130924003|NCT05248867|471356499|FG005|Open-label Period|COVID-19 Infection|0|||
130924004|NCT05248867|471356494|FG000|Open-label Period|Other, not specified|0|||
130924005|NCT05248867|471356495|FG001|Open-label Period|Other, not specified|0|||
130924006|NCT05248867|471356496|FG002|Open-label Period|Other, not specified|0|||
130924007|NCT05248867|471356497|FG003|Open-label Period|Other, not specified|0|||
130924008|NCT05248867|471356498|FG004|Open-label Period|Other, not specified|4|||
130924009|NCT05248867|471356499|FG005|Open-label Period|Other, not specified|0|||
130924010|NCT00345839|471356501|FG000|Overall Study|Withdrawal by Subject|91|||
130924011|NCT00345839|471356502|FG001|Overall Study|Withdrawal by Subject|98|||
130924012|NCT00345839|471356501|FG000|Overall Study|Lost to Follow-up|58|||
130924013|NCT00345839|471356502|FG001|Overall Study|Lost to Follow-up|61|||
130924014|NCT00743483|471356512|FG000|Baseline Period|Physician Decision|1|||
130924015|NCT00743483|471356512|FG000|Treatment Period|Adverse Event|1|||
130924016|NCT01084083|471356513|FG000|Overall Study|Adverse Event|5|||
130924017|NCT01084083|471356513|FG000|Overall Study|Death|1|||
130924018|NCT01084083|471356513|FG000|Overall Study|Withdrawal by Subject|2|||
130924019|NCT01084083|471356513|FG000|Overall Study|Complicating disease|1|||
130924020|NCT01084083|471356513|FG000|Overall Study|Other|2|||
130924021|NCT01084083|471356513|FG000|Overall Study|Never started assigned therapy|1|||
130924022|NCT00873912|471356515|FG000|Overall Study|Withdrawal by Subject|1|||
130924023|NCT00873912|471356516|FG001|Overall Study|Withdrawal by Subject|0|||
130924024|NCT00873912|471356515|FG000|Overall Study|Lost to Follow-up|2|||
130924025|NCT00873912|471356516|FG001|Overall Study|Lost to Follow-up|0|||
130924026|NCT01466153|471356517|FG000|Overall Study|Disease Progression|2|||
130924027|NCT01466153|471356518|FG001|Overall Study|Disease Progression|2|||
130700842|NCT00965757|470528283|FG002|Extension Phase|Progression of concomitant disease|4|||
130700843|NCT00965757|470528284|FG003|Extension Phase|Progression of concomitant disease|2|||
130924028|NCT01466153|471356519|FG002|Overall Study|Disease Progression|0|||
130924029|NCT01466153|471356517|FG000|Overall Study|Adverse Event|14|||
130924030|NCT01466153|471356518|FG001|Overall Study|Adverse Event|13|||
130924031|NCT01466153|471356519|FG002|Overall Study|Adverse Event|17|||
130924032|NCT01466153|471356517|FG000|Overall Study|Withdrawal of Consent|2|||
130924033|NCT01466153|471356518|FG001|Overall Study|Withdrawal of Consent|0|||
130924034|NCT01466153|471356519|FG002|Overall Study|Withdrawal of Consent|0|||
130924035|NCT01466153|471356517|FG000|Overall Study|Investigator Discretion|3|||
130924036|NCT01466153|471356518|FG001|Overall Study|Investigator Discretion|2|||
130924037|NCT01466153|471356519|FG002|Overall Study|Investigator Discretion|2|||
130769637|NCT01026818|470782504|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
130924038|NCT01466153|471356517|FG000|Overall Study|Randomized-Not Treated|2|||
130924039|NCT01466153|471356518|FG001|Overall Study|Randomized-Not Treated|3|||
130924040|NCT01466153|471356519|FG002|Overall Study|Randomized-Not Treated|4|||
130769638|NCT01026818|470782505|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
130769639|NCT01026818|470782506|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
130924041|NCT01466153|471356517|FG000|Overall Study|Other-Unspecified|6|||
130924042|NCT01466153|471356518|FG001|Overall Study|Other-Unspecified|4|||
130924043|NCT01466153|471356519|FG002|Overall Study|Other-Unspecified|2|||
130924044|NCT01088997|471356524|FG000|Overall Study|Physician Decision|1|||
130924045|NCT01088997|471356525|FG001|Overall Study|Physician Decision|1|||
130924046|NCT01088997|471356524|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
130924047|NCT01088997|471356525|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
130924048|NCT01088997|471356524|FG000|Overall Study|Excluded prior to receiving drug|1|||
130924049|NCT01088997|471356525|FG001|Overall Study|Excluded prior to receiving drug|1|||
130924050|NCT03749447|471358058|FG000|Overall Study|Adverse Event|11|||
130924051|NCT03749447|471358059|FG001|Overall Study|Adverse Event|3|||
130924052|NCT03749447|471358058|FG000|Overall Study|Death|1|||
130924053|NCT03749447|471358059|FG001|Overall Study|Death|1|||
130924054|NCT03749447|471358058|FG000|Overall Study|Lost to Follow-up|2|||
130924055|NCT03749447|471358059|FG001|Overall Study|Lost to Follow-up|2|||
130924056|NCT03749447|471358058|FG000|Overall Study|Reason Not Specified|0|||
130924057|NCT03749447|471358059|FG001|Overall Study|Reason Not Specified|3|||
130924058|NCT03749447|471358058|FG000|Overall Study|Physician Decision|4|||
130924059|NCT03749447|471358059|FG001|Overall Study|Physician Decision|3|||
130924060|NCT03749447|471358058|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
130924061|NCT03749447|471358059|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
130700844|NCT00965757|470528281|FG000|Extension Phase|Adverse drug reaction|0|||
130700845|NCT00965757|470528282|FG001|Extension Phase|Adverse drug reaction|0|||
130700846|NCT00965757|470528283|FG002|Extension Phase|Adverse drug reaction|6|||
130700847|NCT00965757|470528284|FG003|Extension Phase|Adverse drug reaction|3|||
130700848|NCT00965757|470528281|FG000|Extension Phase|Abnormal Laboratory Value|0|||
130700849|NCT00965757|470528282|FG001|Extension Phase|Abnormal Laboratory Value|0|||
130700850|NCT00965757|470528283|FG002|Extension Phase|Abnormal Laboratory Value|6|||
130700851|NCT00965757|470528284|FG003|Extension Phase|Abnormal Laboratory Value|1|||
130700852|NCT00965757|470528281|FG000|Extension Phase|Lack of Efficacy|0|||
130700853|NCT00965757|470528282|FG001|Extension Phase|Lack of Efficacy|0|||
130700854|NCT00965757|470528283|FG002|Extension Phase|Lack of Efficacy|8|||
130700855|NCT00965757|470528284|FG003|Extension Phase|Lack of Efficacy|12|||
130700856|NCT00965757|470528281|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
130700857|NCT00965757|470528282|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
130700858|NCT00965757|470528283|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
130700859|NCT00965757|470528284|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
130700860|NCT00965757|470528281|FG000|Extension Phase|Lost to Follow-up|0|||
130700861|NCT00965757|470528282|FG001|Extension Phase|Lost to Follow-up|0|||
130700862|NCT00965757|470528283|FG002|Extension Phase|Lost to Follow-up|0|||
130700863|NCT00965757|470528284|FG003|Extension Phase|Lost to Follow-up|1|||
130700864|NCT00965757|470528281|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
130700865|NCT00965757|470528282|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
130700866|NCT00965757|470528283|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
130700867|NCT00965757|470528284|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
130700868|NCT00965757|470528281|FG000|Extension Phase|Protocol Violation|0|||
130700869|NCT00965757|470528282|FG001|Extension Phase|Protocol Violation|0|||
130700870|NCT00965757|470528283|FG002|Extension Phase|Protocol Violation|0|||
130700871|NCT00965757|470528284|FG003|Extension Phase|Protocol Violation|1|||
130700872|NCT00965757|470528281|FG000|Extension Phase|Other|0|||
130700873|NCT00965757|470528282|FG001|Extension Phase|Other|0|||
130700874|NCT00965757|470528283|FG002|Extension Phase|Other|2|||
130700875|NCT00965757|470528284|FG003|Extension Phase|Other|1|||
130700876|NCT01344018|470528290|FG000|Overall Study|Death|22|||
130700877|NCT01344018|470528291|FG001|Overall Study|Death|25|||
130700878|NCT01344018|470528290|FG000|Overall Study|Lost to Follow-up|4|||
130700879|NCT01344018|470528291|FG001|Overall Study|Lost to Follow-up|7|||
130700880|NCT05070754|470528292|FG000|Overall Study|Withdrawal by Subject|0|||
130700881|NCT05070754|470528293|FG001|Overall Study|Withdrawal by Subject|0|||
130700882|NCT05070754|470528294|FG002|Overall Study|Withdrawal by Subject|0|||
130700883|NCT05070754|470528295|FG003|Overall Study|Withdrawal by Subject|1|||
130700884|NCT05070754|470528292|FG000|Overall Study|Protocol Violation|0|||
130700885|NCT05070754|470528293|FG001|Overall Study|Protocol Violation|0|||
130700886|NCT05070754|470528294|FG002|Overall Study|Protocol Violation|0|||
130924062|NCT03749447|471358058|FG000|Overall Study|Study Terminated By Sponsor|112|||
130924063|NCT03749447|471358059|FG001|Overall Study|Study Terminated By Sponsor|105|||
130924064|NCT03749447|471358058|FG000|Overall Study|Withdrawal by Subject|12|||
130924065|NCT03749447|471358059|FG001|Overall Study|Withdrawal by Subject|6|||
130924066|NCT03749447|471358058|FG000|Overall Study|Non-compliance With Study Drug|0|||
130769640|NCT01026818|470782507|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
130924067|NCT03749447|471358059|FG001|Overall Study|Non-compliance With Study Drug|1|||
130769641|NCT01026818|470782504|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
130769642|NCT01026818|470782505|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
130769643|NCT01026818|470782506|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
130769644|NCT01026818|470782507|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
130769645|NCT01026818|470782504|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
130769646|NCT01026818|470782505|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
130769647|NCT01026818|470782506|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
130769648|NCT01026818|470782507|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
130769649|NCT01026818|470782504|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
130769650|NCT01026818|470782505|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
130769651|NCT01026818|470782506|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
130769652|NCT01026818|470782507|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
130769653|NCT01026818|470782504|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
130769654|NCT01026818|470782505|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
130769655|NCT01026818|470782506|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
130769656|NCT01026818|470782507|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
130924068|NCT01218113|471358060|FG000|Overall Study|Withdrawal by Subject|1|||
130924069|NCT01218113|471358061|FG001|Overall Study|Withdrawal by Subject|0|||
130924070|NCT01218113|471358062|FG002|Overall Study|Withdrawal by Subject|1|||
130924071|NCT01218113|471358060|FG000|Overall Study|Lost to Follow-up|4|||
130924072|NCT01218113|471358061|FG001|Overall Study|Lost to Follow-up|1|||
130924073|NCT01218113|471358062|FG002|Overall Study|Lost to Follow-up|4|||
130924074|NCT01218113|471358060|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
130924075|NCT01218113|471358061|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
130924076|NCT01218113|471358062|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
130924077|NCT00787891|471358063|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
130924078|NCT00787891|471358064|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
130924079|NCT00787891|471358063|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
130924080|NCT00787891|471358064|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
130924081|NCT00787891|471358063|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
130924082|NCT00787891|471358064|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
130924083|NCT00787891|471358063|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
130924084|NCT00787891|471358064|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
130924085|NCT00787891|471358063|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
130924086|NCT00787891|471358064|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
130924087|NCT00787891|471358063|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
130924088|NCT00787891|471358064|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
130924089|NCT00787891|471358063|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
130924090|NCT00787891|471358064|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
130924091|NCT00787891|471358063|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
130924092|NCT00787891|471358064|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
130924093|NCT00787891|471358063|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
130924094|NCT00787891|471358064|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
130924095|NCT00787891|471358063|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
130924096|NCT00787891|471358064|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
130924097|NCT01970397|471358067|FG000|Overall Study|Adverse Event|0|||
130924098|NCT01970397|471358068|FG001|Overall Study|Adverse Event|1|||
130924099|NCT01970397|471358067|FG000|Overall Study|Lost to Follow-up|0|||
130924100|NCT01970397|471358068|FG001|Overall Study|Lost to Follow-up|1|||
130924101|NCT01970397|471358067|FG000|Overall Study|Personal Reasons|1|||
130924102|NCT01970397|471358068|FG001|Overall Study|Personal Reasons|2|||
130924103|NCT01970397|471358067|FG000|Overall Study|Protocol Violation|1|||
130924104|NCT01970397|471358068|FG001|Overall Study|Protocol Violation|1|||
130769657|NCT01026818|470782504|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
130769658|NCT01026818|470782505|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
130769659|NCT01026818|470782506|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
130769660|NCT01026818|470782507|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
130769661|NCT01026818|470782504|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
130769662|NCT01026818|470782505|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
130769663|NCT01026818|470782506|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
130769664|NCT01026818|470782507|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
130769665|NCT01026818|470782504|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
130769666|NCT01026818|470782505|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
130769667|NCT01026818|470782506|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
130769668|NCT01026818|470782507|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
130924105|NCT03305575|471358079|FG000|Overall Study|Physician Decision|1|||
130924106|NCT03305575|471358080|FG001|Overall Study|Physician Decision|0|||
130985534|NCT00394355|471572939|FG000|Overall Study|Did not meet protocol eligibility|1|||
130924107|NCT03486223|471358089|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
130924108|NCT03486223|471358090|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
130924109|NCT01819831|471358091|FG000|Overall Study|Withdrawal by Subject|1|||
130924110|NCT01434667|471358094|FG000|Overall Study|Lost to Follow-up|5|||
130924111|NCT01434667|471358095|FG001|Overall Study|Lost to Follow-up|10|||
130924112|NCT02034110|471358104|FG000|Overall Study|Physician Decision|0|||
130924113|NCT02034110|471358105|FG001|Overall Study|Physician Decision|0|||
130924114|NCT02034110|471358106|FG002|Overall Study|Physician Decision|0|||
130924115|NCT02034110|471358107|FG003|Overall Study|Physician Decision|0|||
130924116|NCT02034110|471358108|FG004|Overall Study|Physician Decision|2|||
130924117|NCT02034110|471358109|FG005|Overall Study|Physician Decision|0|||
130924118|NCT02034110|471358110|FG006|Overall Study|Physician Decision|1|||
130924119|NCT02034110|471358111|FG007|Overall Study|Physician Decision|0|||
130924120|NCT02034110|471358104|FG000|Overall Study|Lost to Follow-up|1|||
130924121|NCT02034110|471358105|FG001|Overall Study|Lost to Follow-up|0|||
130924122|NCT02034110|471358106|FG002|Overall Study|Lost to Follow-up|0|||
130924123|NCT02034110|471358107|FG003|Overall Study|Lost to Follow-up|0|||
130924124|NCT02034110|471358108|FG004|Overall Study|Lost to Follow-up|1|||
130924125|NCT02034110|471358109|FG005|Overall Study|Lost to Follow-up|0|||
130924126|NCT02034110|471358110|FG006|Overall Study|Lost to Follow-up|1|||
130924127|NCT02034110|471358111|FG007|Overall Study|Lost to Follow-up|0|||
130924128|NCT02034110|471358104|FG000|Overall Study|Withdrawal by Subject|5|||
130924129|NCT02034110|471358105|FG001|Overall Study|Withdrawal by Subject|7|||
130924130|NCT02034110|471358106|FG002|Overall Study|Withdrawal by Subject|0|||
130924131|NCT02034110|471358107|FG003|Overall Study|Withdrawal by Subject|3|||
130924132|NCT02034110|471358108|FG004|Overall Study|Withdrawal by Subject|7|||
130924133|NCT02034110|471358109|FG005|Overall Study|Withdrawal by Subject|0|||
130924134|NCT02034110|471358110|FG006|Overall Study|Withdrawal by Subject|3|||
130924135|NCT02034110|471358111|FG007|Overall Study|Withdrawal by Subject|1|||
130924136|NCT02034110|471358104|FG000|Overall Study|Study closed by sponsor|6|||
130924137|NCT02034110|471358105|FG001|Overall Study|Study closed by sponsor|2|||
130924138|NCT02034110|471358106|FG002|Overall Study|Study closed by sponsor|0|||
130924139|NCT02034110|471358107|FG003|Overall Study|Study closed by sponsor|6|||
130924140|NCT02034110|471358108|FG004|Overall Study|Study closed by sponsor|7|||
130924141|NCT02034110|471358109|FG005|Overall Study|Study closed by sponsor|0|||
130924142|NCT02034110|471358110|FG006|Overall Study|Study closed by sponsor|42|||
130924143|NCT02034110|471358111|FG007|Overall Study|Study closed by sponsor|0|||
130924144|NCT02835820|471358114|FG000|Overall Study|Baseline Screen Failure|0|||
130924145|NCT02835820|471358115|FG001|Overall Study|Baseline Screen Failure|3|||
130924146|NCT01867424|471358119|FG000|Overall Study|Patient noncompliance|2|||
130924147|NCT01867424|471358120|FG001|Overall Study|Patient noncompliance|1|||
130924148|NCT01056653|471358121|FG000|Overall Study|Lost to Follow-up|0|||
130924149|NCT01056653|471358122|FG001|Overall Study|Lost to Follow-up|0|||
130924150|NCT01056653|471358123|FG002|Overall Study|Lost to Follow-up|2|||
130924151|NCT01921387|471358124|FG000|Overall Study|Adverse Event|1|||
130924152|NCT01706146|471358127|FG000|Overall Study|Withdrawal by Subject|1|||
130924153|NCT01706146|471358127|FG000|Overall Study|Adverse Event|3|||
130924154|NCT01706146|471358127|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
130924155|NCT00675948|471358128|FG000|Overall Study|Adverse Event|23|||
130924156|NCT00675948|471358129|FG001|Overall Study|Adverse Event|1|||
130769669|NCT01031004|470782508|FG000|Overall Study|Protocol Violation|0|||
130769670|NCT01031004|470782509|FG001|Overall Study|Protocol Violation|1|||
130769671|NCT01031004|470782508|FG000|Overall Study|Lost to Follow-up|1|||
130769672|NCT01031004|470782509|FG001|Overall Study|Lost to Follow-up|0|||
130769673|NCT01641471|470782510|FG000|Overall Study|Withdrawal by Subject|19|||
130769674|NCT01641471|470782511|FG001|Overall Study|Withdrawal by Subject|19|||
130769675|NCT01641471|470782510|FG000|Overall Study|Lost to Follow-up|2|||
130769676|NCT01641471|470782511|FG001|Overall Study|Lost to Follow-up|4|||
130769677|NCT01641471|470782510|FG000|Overall Study|Protocol Violation|2|||
130769678|NCT01641471|470782511|FG001|Overall Study|Protocol Violation|4|||
130769679|NCT04575584|470782515|FG000|Overall Study|Death|6|||
130769680|NCT04575584|470782516|FG001|Overall Study|Death|4|||
130924157|NCT00675948|471358128|FG000|Overall Study|Lack of Efficacy|3|||
130924158|NCT00675948|471358129|FG001|Overall Study|Lack of Efficacy|0|||
130769681|NCT04575584|470782517|FG002|Overall Study|Death|6|||
130769682|NCT04575584|470782518|FG003|Overall Study|Death|2|||
130769683|NCT04575584|470782519|FG004|Overall Study|Death|0|||
130924159|NCT00675948|471358128|FG000|Overall Study|Withdrawal by Subject|7|||
130924160|NCT00675948|471358129|FG001|Overall Study|Withdrawal by Subject|0|||
130924161|NCT00675948|471358128|FG000|Overall Study|Lost to Follow-up|2|||
130924162|NCT00675948|471358129|FG001|Overall Study|Lost to Follow-up|0|||
130924163|NCT00675948|471358128|FG000|Overall Study|Protocol Violation|1|||
130769684|NCT04575584|470782520|FG005|Overall Study|Death|0|||
131034472|NCT04338061|471759205|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
130769685|NCT04575584|470782515|FG000|Overall Study|Lost to Follow-up|1|||
130769686|NCT04575584|470782516|FG001|Overall Study|Lost to Follow-up|1|||
130769687|NCT04575584|470782517|FG002|Overall Study|Lost to Follow-up|1|||
130924164|NCT00675948|471358129|FG001|Overall Study|Protocol Violation|0|||
130924165|NCT00675948|471358128|FG000|Overall Study|Pain under control|1|||
130924166|NCT00675948|471358129|FG001|Overall Study|Pain under control|0|||
130924167|NCT00675948|471358128|FG000|Overall Study|Sponsor decision|0|||
130924168|NCT00675948|471358129|FG001|Overall Study|Sponsor decision|1|||
130924169|NCT00675948|471358128|FG000|Overall Study|Patient died|1|||
130924170|NCT00675948|471358129|FG001|Overall Study|Patient died|0|||
130924171|NCT00675948|471358128|FG000|Overall Study|Patient unable to comply with diaries|1|||
130924172|NCT00675948|471358129|FG001|Overall Study|Patient unable to comply with diaries|0|||
130924173|NCT00675948|471358128|FG000|Overall Study|Patient feels unable to take medication|0|||
130924174|NCT00675948|471358129|FG001|Overall Study|Patient feels unable to take medication|1|||
130924175|NCT02582983|471358130|FG000|Overall Study|Death|3|||
130924176|NCT02582983|471358130|FG000|Overall Study|Withdrawal by Subject|2|||
130924177|NCT02582983|471358130|FG000|Overall Study|Adverse Event|1|||
130924178|NCT01751178|471358131|FG000|Overall Study|Adverse Event|2|||
130924179|NCT01751178|471358132|FG001|Overall Study|Adverse Event|0|||
130924180|NCT01751178|471358133|FG002|Overall Study|Adverse Event|0|||
130924181|NCT01751178|471358131|FG000|Overall Study|Other Reason (unknown)|1|||
130924182|NCT01751178|471358132|FG001|Overall Study|Other Reason (unknown)|0|||
130924183|NCT01751178|471358133|FG002|Overall Study|Other Reason (unknown)|2|||
130924184|NCT01081678|471358139|FG000|Overall Study|Ineligibility Determined|0|||
130924185|NCT01081678|471358140|FG001|Overall Study|Ineligibility Determined|0|||
130924186|NCT01081678|471358141|FG002|Overall Study|Ineligibility Determined|1|||
130924187|NCT01081678|471358142|FG003|Overall Study|Ineligibility Determined|1|||
130924188|NCT01081678|471358139|FG000|Overall Study|Noncompliance|3|||
130924189|NCT01081678|471358140|FG001|Overall Study|Noncompliance|4|||
130924190|NCT01081678|471358141|FG002|Overall Study|Noncompliance|5|||
130924191|NCT01081678|471358142|FG003|Overall Study|Noncompliance|2|||
130924192|NCT01081678|471358139|FG000|Overall Study|Adverse Event|2|||
130924193|NCT01081678|471358140|FG001|Overall Study|Adverse Event|1|||
130924194|NCT01081678|471358141|FG002|Overall Study|Adverse Event|2|||
130924195|NCT01081678|471358142|FG003|Overall Study|Adverse Event|2|||
130924196|NCT01081678|471358139|FG000|Overall Study|Withdrawal by Subject|15|||
130924197|NCT01081678|471358140|FG001|Overall Study|Withdrawal by Subject|7|||
130924198|NCT01081678|471358141|FG002|Overall Study|Withdrawal by Subject|17|||
130924199|NCT01081678|471358142|FG003|Overall Study|Withdrawal by Subject|14|||
130924200|NCT01081678|471358139|FG000|Overall Study|Administrative Decision|1|||
130924201|NCT01081678|471358140|FG001|Overall Study|Administrative Decision|0|||
130924202|NCT01081678|471358141|FG002|Overall Study|Administrative Decision|0|||
130924203|NCT01081678|471358142|FG003|Overall Study|Administrative Decision|1|||
130924204|NCT01081678|471358139|FG000|Overall Study|Lost to Follow-up|4|||
130924205|NCT01081678|471358140|FG001|Overall Study|Lost to Follow-up|1|||
130924206|NCT01081678|471358141|FG002|Overall Study|Lost to Follow-up|4|||
130700887|NCT05070754|470528295|FG003|Overall Study|Protocol Violation|1|||
130700888|NCT01398787|470528296|FG000|Overall Study|Adverse Event|1|||
130700889|NCT02351167|470528297|FG000|Overall Study|Withdrawal by Subject|19|||
130700890|NCT02351167|470528298|FG001|Overall Study|Withdrawal by Subject|18|||
130700891|NCT02351167|470528299|FG002|Overall Study|Withdrawal by Subject|21|||
130700892|NCT00668395|470528302|FG000|Overall Study|Withdrawal by Subject|4|||
130924207|NCT01081678|471358142|FG003|Overall Study|Lost to Follow-up|3|||
130924208|NCT01081678|471358139|FG000|Overall Study|Death|2|||
130924209|NCT01081678|471358140|FG001|Overall Study|Death|2|||
130924210|NCT01081678|471358141|FG002|Overall Study|Death|2|||
130924211|NCT01081678|471358142|FG003|Overall Study|Death|6|||
130924212|NCT01081678|471358139|FG000|Overall Study|Other|0|||
130924213|NCT01081678|471358140|FG001|Overall Study|Other|1|||
130924214|NCT01081678|471358141|FG002|Overall Study|Other|0|||
130924215|NCT01081678|471358142|FG003|Overall Study|Other|0|||
130924216|NCT00288054|471358143|FG000|Overall Study|Protocol Violation|2|||
130924217|NCT00288054|471358143|FG000|Overall Study|Lack of Efficacy|16|||
130924218|NCT00288054|471358143|FG000|Overall Study|Adverse Event|3|||
130924219|NCT00288054|471358143|FG000|Overall Study|Withdrawal by Subject|1|||
130924220|NCT00288054|471358143|FG000|Overall Study|Not protocol specified|2|||
130700893|NCT00668395|470528303|FG001|Overall Study|Withdrawal by Subject|4|||
130700894|NCT00668395|470528304|FG002|Overall Study|Withdrawal by Subject|1|||
130769688|NCT04575584|470782518|FG003|Overall Study|Lost to Follow-up|1|||
130769689|NCT04575584|470782519|FG004|Overall Study|Lost to Follow-up|0|||
130924221|NCT00444912|471358151|FG000|Overall Study|Death|1|||
130924222|NCT00444912|471358152|FG001|Overall Study|Death|2|||
130924223|NCT00444912|471358151|FG000|Overall Study|Lost to Follow-up|1|||
130924224|NCT00444912|471358152|FG001|Overall Study|Lost to Follow-up|0|||
130924225|NCT00444912|471358151|FG000|Overall Study|Participant Failed Mobilization|1|||
130924226|NCT00444912|471358152|FG001|Overall Study|Participant Failed Mobilization|0|||
130924227|NCT01007812|471358155|FG000|Period 1, One Week|Lost to Follow-up|0|||
130924228|NCT01007812|471358156|FG001|Period 1, One Week|Lost to Follow-up|1|||
130700895|NCT00668395|470528302|FG000|Overall Study|Adverse Event|1|||
130700896|NCT00668395|470528303|FG001|Overall Study|Adverse Event|1|||
130924229|NCT01007812|471358155|FG000|Period 1, One Week|Discomfort|1|||
130924230|NCT01007812|471358156|FG001|Period 1, One Week|Discomfort|0|||
130924231|NCT01091974|471358157|FG000|Overall Study|Did not start intervention|3|||
130924232|NCT01091974|471358158|FG001|Overall Study|Did not start intervention|1|||
130924233|NCT01091974|471358159|FG002|Overall Study|Did not start intervention|3|||
130924234|NCT01091974|471358160|FG003|Overall Study|Did not start intervention|1|||
130924235|NCT01091974|471358157|FG000|Overall Study|resumed sleep medication|0|||
130924236|NCT01091974|471358158|FG001|Overall Study|resumed sleep medication|0|||
130924237|NCT01091974|471358159|FG002|Overall Study|resumed sleep medication|1|||
130924238|NCT01091974|471358160|FG003|Overall Study|resumed sleep medication|2|||
130924239|NCT01091974|471358157|FG000|Overall Study|Withdrawal by Subject|1|||
130924240|NCT01091974|471358158|FG001|Overall Study|Withdrawal by Subject|3|||
130924241|NCT01091974|471358159|FG002|Overall Study|Withdrawal by Subject|2|||
130924242|NCT01091974|471358160|FG003|Overall Study|Withdrawal by Subject|2|||
130924243|NCT01091974|471358157|FG000|Overall Study|side-effects|1|||
130924244|NCT01091974|471358158|FG001|Overall Study|side-effects|1|||
130924245|NCT01091974|471358159|FG002|Overall Study|side-effects|0|||
130924246|NCT01091974|471358160|FG003|Overall Study|side-effects|2|||
130924247|NCT02499783|471358161|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
130924248|NCT02499783|471358162|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
130924249|NCT02499783|471358163|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
130924250|NCT02499783|471358161|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
130924251|NCT02499783|471358162|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
130924252|NCT02499783|471358163|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
130924253|NCT02499783|471358161|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
130924254|NCT02499783|471358162|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
130924255|NCT02499783|471358163|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
130924256|NCT02499783|471358161|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
131223343|NCT00430638|472445085|FG001|Overall Study|Lost to Follow-up|7|||
131223344|NCT00430638|472445084|FG000|Overall Study|Protocol Violation|6|||
130700897|NCT00668395|470528304|FG002|Overall Study|Adverse Event|0|||
130700898|NCT00668395|470528302|FG000|Overall Study|Physician Decision|1|||
130700899|NCT00668395|470528303|FG001|Overall Study|Physician Decision|1|||
130700900|NCT00668395|470528304|FG002|Overall Study|Physician Decision|0|||
130700901|NCT02858037|470528307|FG000|Overall Study|Death|1|||
130700902|NCT02858037|470528307|FG000|Overall Study|Withdrawal by Subject|18|||
130700903|NCT02858037|470528307|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
130700904|NCT02858037|470528307|FG000|Overall Study|Lost to Follow-up|3|||
130700905|NCT02858037|470528307|FG000|Overall Study|Other|4|||
130700906|NCT04049097|470528310|FG000|Overall Study|Adverse Event|18|||
130700907|NCT04049097|470528310|FG000|Overall Study|Death|2|||
130700908|NCT04049097|470528310|FG000|Overall Study|Lost to Follow-up|1|||
130700909|NCT04049097|470528310|FG000|Overall Study|Physician Decision|2|||
130700910|NCT04049097|470528310|FG000|Overall Study|Withdrawal by Subject|9|||
130700911|NCT04049097|470528310|FG000|Overall Study|Protocol Violation|2|||
130700912|NCT04049097|470528310|FG000|Overall Study|Other|1|||
130700913|NCT04049097|470528310|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
130700914|NCT01963260|470528319|FG000|Overall Study|Withdrawal by Subject|2|||
130700915|NCT01963260|470528320|FG001|Overall Study|Withdrawal by Subject|0|||
130700916|NCT01963260|470528321|FG002|Overall Study|Withdrawal by Subject|0|||
130700917|NCT01963260|470528322|FG003|Overall Study|Withdrawal by Subject|1|||
130700918|NCT01963260|470528323|FG004|Overall Study|Withdrawal by Subject|2|||
130700919|NCT01963260|470528324|FG005|Overall Study|Withdrawal by Subject|0|||
130700920|NCT01963260|470528325|FG006|Overall Study|Withdrawal by Subject|0|||
130700921|NCT01963260|470528326|FG007|Overall Study|Withdrawal by Subject|0|||
130700922|NCT01963260|470528327|FG008|Overall Study|Withdrawal by Subject|0|||
130700923|NCT01963260|470528328|FG009|Overall Study|Withdrawal by Subject|0|||
130700924|NCT01091363|470528329|FG000|Overall Study|Withdrawal by Subject|11|||
130700925|NCT01091363|470528330|FG001|Overall Study|Withdrawal by Subject|15|||
130700926|NCT01091363|470528329|FG000|Overall Study|Lost to Follow-up|2|||
130700927|NCT01091363|470528330|FG001|Overall Study|Lost to Follow-up|2|||
130700928|NCT01781234|470528331|FG000|Overall Study|Adverse Event|2|||
130700929|NCT01781234|470528332|FG001|Overall Study|Adverse Event|0|||
130924257|NCT02499783|471358162|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
130924258|NCT02499783|471358163|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
130924259|NCT02499783|471358161|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
130924260|NCT02499783|471358162|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
130700930|NCT01781234|470528331|FG000|Overall Study|Protocol Violation|3|||
130700931|NCT01781234|470528332|FG001|Overall Study|Protocol Violation|0|||
130700932|NCT01781234|470528331|FG000|Overall Study|Withdrawal by Subject|4|||
130700933|NCT01781234|470528332|FG001|Overall Study|Withdrawal by Subject|3|||
130700934|NCT05889039|470528335|FG000|Overall Study|error in completing survey|0|||
130700935|NCT05889039|470528336|FG001|Overall Study|error in completing survey|2|||
130924261|NCT02499783|471358163|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
130924262|NCT02499783|471358161|FG000|DB Period: Weeks 0-8|Other|1|||
130924263|NCT02499783|471358162|FG001|DB Period: Weeks 0-8|Other|1|||
130700936|NCT05889039|470528337|FG002|Overall Study|error in completing survey|0|||
130700937|NCT05889039|470528338|FG003|Overall Study|error in completing survey|0|||
130924264|NCT02499783|471358163|FG002|DB Period: Weeks 0-8|Other|0|||
130924265|NCT02499783|471358161|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
130924266|NCT02499783|471358162|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
130924267|NCT02499783|471358163|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
130924268|NCT02499783|471358161|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
130924269|NCT02499783|471358162|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
130924270|NCT02499783|471358163|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
130924271|NCT02499783|471358161|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
130924272|NCT02499783|471358162|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
130924273|NCT02499783|471358163|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
130924274|NCT02499783|471358161|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
130924275|NCT02499783|471358162|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
130924276|NCT02499783|471358163|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
130924277|NCT01866293|471358164|FG000|Overall Study|Adverse Event|2|||
130924278|NCT00555971|471358166|FG000|Overall Study|Adverse Event|1|||
130924279|NCT00555971|471358167|FG001|Overall Study|Adverse Event|1|||
130924280|NCT03095612|471358173|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130924281|NCT03095612|471358174|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
130924282|NCT03095612|471358175|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130924283|NCT03095612|471358176|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130924284|NCT03095612|471358177|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130924285|NCT03095612|471358178|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130924286|NCT03095612|471358179|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130924287|NCT04447794|471358182|FG000|Overall Study|Lost to Follow-up|2|||
130700938|NCT05889039|470528335|FG000|Overall Study|Lost to Follow-up|4|||
130924288|NCT04447794|471358183|FG001|Overall Study|Lost to Follow-up|3|||
130924289|NCT04447794|471358184|FG002|Overall Study|Lost to Follow-up|8|||
130924290|NCT04447794|471358182|FG000|Overall Study|Withdrawal by Subject|1|||
130924291|NCT04447794|471358183|FG001|Overall Study|Withdrawal by Subject|1|||
130924292|NCT04447794|471358184|FG002|Overall Study|Withdrawal by Subject|0|||
130924293|NCT02571075|471358185|FG000|Overall Study|Lost to Follow-up|20|||
130924294|NCT02571075|471358186|FG001|Overall Study|Lost to Follow-up|24|||
130924295|NCT00963937|471358191|FG000|Overall Study|Protocol Violation|1|||
130924296|NCT00963937|471358192|FG001|Overall Study|Protocol Violation|1|||
130924297|NCT00963937|471358193|FG002|Overall Study|Protocol Violation|0|||
130924298|NCT00963937|471358191|FG000|Overall Study|Physician Decision|18|||
130700939|NCT05889039|470528336|FG001|Overall Study|Lost to Follow-up|0|||
130700940|NCT05889039|470528337|FG002|Overall Study|Lost to Follow-up|0|||
130700941|NCT05889039|470528338|FG003|Overall Study|Lost to Follow-up|0|||
130700942|NCT02661022|470528339|FG000|Overall Study|Withdrawal by Subject|3|||
130700943|NCT02661022|470528340|FG001|Overall Study|Withdrawal by Subject|0|||
130924299|NCT00963937|471358192|FG001|Overall Study|Physician Decision|10|||
130924300|NCT00963937|471358193|FG002|Overall Study|Physician Decision|4|||
130924301|NCT02197520|471358197|FG000|Period 1|Withdrawal by Subject|1|||
130924302|NCT02197520|471358198|FG001|Period 1|Withdrawal by Subject|0|||
130924303|NCT02197520|471358197|FG000|Period 2|Adverse Event|0|||
130924304|NCT02197520|471358198|FG001|Period 2|Adverse Event|2|||
130924305|NCT02197520|471358197|FG000|Period 2|Withdrawal by Subject|1|||
130924306|NCT02197520|471358198|FG001|Period 2|Withdrawal by Subject|0|||
130700944|NCT02661022|470528339|FG000|Overall Study|Adverse Event|1|||
130700945|NCT02661022|470528340|FG001|Overall Study|Adverse Event|1|||
130700946|NCT02661022|470528339|FG000|Overall Study|Physician Decision|1|||
130700947|NCT02661022|470528340|FG001|Overall Study|Physician Decision|0|||
130700948|NCT02661022|470528339|FG000|Overall Study|Progressive Disease|2|||
130700949|NCT02661022|470528340|FG001|Overall Study|Progressive Disease|1|||
130700950|NCT01785615|470528347|FG000|Dietary Phase|Lost to Follow-up|0|||
130700951|NCT01785615|470528348|FG001|Dietary Phase|Lost to Follow-up|0|||
130700952|NCT01785615|470528349|FG002|Dietary Phase|Lost to Follow-up|0|||
130700953|NCT01785615|470528350|FG003|Dietary Phase|Lost to Follow-up|24|||
130700954|NCT01881737|470528351|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
130700955|NCT01881737|470528351|FG000|Overall Study|Withdrawal by Subject|1|||
130700956|NCT01881737|470528351|FG000|Overall Study|Worsening of baseline behavior|1|||
130700957|NCT04106817|470528356|FG000|Overall Study|Lost to Follow-up|1|||
130700958|NCT04106817|470528357|FG001|Overall Study|Lost to Follow-up|0|||
130700959|NCT04106817|470528358|FG002|Overall Study|Lost to Follow-up|0|||
130700960|NCT02260635|470528359|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
130700961|NCT02260635|470528360|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
130700962|NCT02260635|470528359|FG000|Open-Label Extension|Study Termination|25|||
130700963|NCT02260635|470528360|FG001|Open-Label Extension|Study Termination|25|||
130700964|NCT02260635|470528359|FG000|Open-Label Extension|Withdrawal by Subject|1|||
130769690|NCT04575584|470782520|FG005|Overall Study|Lost to Follow-up|0|||
130769691|NCT04575584|470782515|FG000|Overall Study|Physician Decision|0|||
130769692|NCT04575584|470782516|FG001|Overall Study|Physician Decision|1|||
130924307|NCT00369824|471358199|FG000|Overall Study|Adverse Event|0|||
130924308|NCT00369824|471358200|FG001|Overall Study|Adverse Event|2|||
130924309|NCT00369824|471358201|FG002|Overall Study|Adverse Event|0|||
130924310|NCT00369824|471358202|FG003|Overall Study|Adverse Event|0|||
130924311|NCT00369824|471358203|FG004|Overall Study|Adverse Event|1|||
130924312|NCT00369824|471358204|FG005|Overall Study|Adverse Event|0|||
130700965|NCT02260635|470528360|FG001|Open-Label Extension|Withdrawal by Subject|0|||
130924313|NCT00369824|471358199|FG000|Overall Study|Protocol Violation|0|||
130924314|NCT00369824|471358200|FG001|Overall Study|Protocol Violation|1|||
131120159|NCT00467779|472072315|FG004|Stage 1A|Unspecified Reason|0|||
130924315|NCT00369824|471358201|FG002|Overall Study|Protocol Violation|0|||
131120160|NCT00467779|472072316|FG005|Stage 1A|Unspecified Reason|0|||
131120161|NCT00467779|472072317|FG006|Stage 1A|Unspecified Reason|0|||
131120162|NCT00467779|472072318|FG007|Stage 1A|Unspecified Reason|0|||
131120163|NCT00467779|472072319|FG008|Stage 1A|Unspecified Reason|0|||
131120164|NCT00467779|472072320|FG009|Stage 1A|Unspecified Reason|0|||
131120165|NCT00467779|472072321|FG010|Stage 1A|Unspecified Reason|0|||
131120166|NCT00467779|472072322|FG011|Stage 1A|Unspecified Reason|1|||
131120167|NCT00467779|472072323|FG012|Stage 1A|Unspecified Reason|1|||
131120168|NCT00467779|472072324|FG013|Stage 1A|Unspecified Reason|0|||
131120169|NCT00467779|472072325|FG014|Stage 1A|Unspecified Reason|0|||
131120170|NCT00467779|472072311|FG000|Stage 2|Adverse Event|0|||
131120171|NCT00467779|472072312|FG001|Stage 2|Adverse Event|0|||
131120172|NCT00467779|472072313|FG002|Stage 2|Adverse Event|0|||
131120173|NCT00467779|472072314|FG003|Stage 2|Adverse Event|0|||
131120174|NCT00467779|472072315|FG004|Stage 2|Adverse Event|0|||
131120175|NCT00467779|472072316|FG005|Stage 2|Adverse Event|0|||
131120176|NCT00467779|472072317|FG006|Stage 2|Adverse Event|0|||
131120177|NCT00467779|472072318|FG007|Stage 2|Adverse Event|0|||
131120178|NCT00467779|472072319|FG008|Stage 2|Adverse Event|1|||
131120179|NCT00467779|472072320|FG009|Stage 2|Adverse Event|0|||
131120180|NCT00467779|472072321|FG010|Stage 2|Adverse Event|0|||
131120181|NCT00467779|472072322|FG011|Stage 2|Adverse Event|0|||
131120182|NCT00467779|472072323|FG012|Stage 2|Adverse Event|0|||
131120183|NCT00467779|472072324|FG013|Stage 2|Adverse Event|0|||
131120184|NCT00467779|472072325|FG014|Stage 2|Adverse Event|0|||
131120185|NCT00467779|472072311|FG000|Stage 2|Death|0|||
131120186|NCT00467779|472072312|FG001|Stage 2|Death|0|||
131120187|NCT00467779|472072313|FG002|Stage 2|Death|0|||
131120188|NCT00467779|472072314|FG003|Stage 2|Death|0|||
131120189|NCT00467779|472072315|FG004|Stage 2|Death|0|||
131120190|NCT00467779|472072316|FG005|Stage 2|Death|0|||
131120191|NCT00467779|472072317|FG006|Stage 2|Death|0|||
131120192|NCT00467779|472072318|FG007|Stage 2|Death|0|||
131120193|NCT00467779|472072319|FG008|Stage 2|Death|1|||
131120194|NCT00467779|472072320|FG009|Stage 2|Death|0|||
131120195|NCT00467779|472072321|FG010|Stage 2|Death|0|||
131120196|NCT00467779|472072322|FG011|Stage 2|Death|0|||
131120197|NCT00467779|472072323|FG012|Stage 2|Death|0|||
131120198|NCT00467779|472072324|FG013|Stage 2|Death|0|||
131120199|NCT00467779|472072325|FG014|Stage 2|Death|0|||
131120200|NCT00467779|472072311|FG000|Stage 2|Disease Progression|0|||
131120201|NCT00467779|472072312|FG001|Stage 2|Disease Progression|0|||
131120202|NCT00467779|472072313|FG002|Stage 2|Disease Progression|0|||
131120203|NCT00467779|472072314|FG003|Stage 2|Disease Progression|0|||
131120204|NCT00467779|472072315|FG004|Stage 2|Disease Progression|0|||
131120205|NCT00467779|472072316|FG005|Stage 2|Disease Progression|0|||
131120206|NCT00467779|472072317|FG006|Stage 2|Disease Progression|0|||
131120207|NCT00467779|472072318|FG007|Stage 2|Disease Progression|0|||
131120208|NCT00467779|472072319|FG008|Stage 2|Disease Progression|16|||
131120209|NCT00467779|472072320|FG009|Stage 2|Disease Progression|0|||
131120210|NCT00467779|472072321|FG010|Stage 2|Disease Progression|0|||
131120211|NCT00467779|472072322|FG011|Stage 2|Disease Progression|0|||
131120212|NCT00467779|472072323|FG012|Stage 2|Disease Progression|0|||
131120213|NCT00467779|472072324|FG013|Stage 2|Disease Progression|0|||
131120214|NCT00467779|472072325|FG014|Stage 2|Disease Progression|0|||
131120215|NCT00467779|472072311|FG000|Stage 2|Unspecified Reason|0|||
131120216|NCT00467779|472072312|FG001|Stage 2|Unspecified Reason|0|||
131120217|NCT00467779|472072313|FG002|Stage 2|Unspecified Reason|0|||
131120218|NCT00467779|472072314|FG003|Stage 2|Unspecified Reason|0|||
131120219|NCT00467779|472072315|FG004|Stage 2|Unspecified Reason|0|||
131120220|NCT00467779|472072316|FG005|Stage 2|Unspecified Reason|0|||
131120221|NCT00467779|472072317|FG006|Stage 2|Unspecified Reason|0|||
131120222|NCT00467779|472072318|FG007|Stage 2|Unspecified Reason|0|||
131120223|NCT00467779|472072319|FG008|Stage 2|Unspecified Reason|3|||
131120224|NCT00467779|472072320|FG009|Stage 2|Unspecified Reason|0|||
131120225|NCT00467779|472072321|FG010|Stage 2|Unspecified Reason|0|||
131120226|NCT00467779|472072322|FG011|Stage 2|Unspecified Reason|0|||
131120227|NCT00467779|472072323|FG012|Stage 2|Unspecified Reason|0|||
131120228|NCT00467779|472072324|FG013|Stage 2|Unspecified Reason|0|||
131120229|NCT00467779|472072325|FG014|Stage 2|Unspecified Reason|0|||
131120230|NCT00467779|472072311|FG000|Stage 2A|Adverse Event|0|||
131120231|NCT00467779|472072312|FG001|Stage 2A|Adverse Event|0|||
131120232|NCT00467779|472072313|FG002|Stage 2A|Adverse Event|0|||
130924316|NCT00369824|471358202|FG003|Overall Study|Protocol Violation|1|||
130924317|NCT00369824|471358203|FG004|Overall Study|Protocol Violation|1|||
130924318|NCT00369824|471358204|FG005|Overall Study|Protocol Violation|0|||
130924319|NCT00369824|471358199|FG000|Overall Study|Withdrawal by Subject|9|||
130924320|NCT00369824|471358200|FG001|Overall Study|Withdrawal by Subject|5|||
130924321|NCT00369824|471358201|FG002|Overall Study|Withdrawal by Subject|5|||
130924322|NCT00369824|471358202|FG003|Overall Study|Withdrawal by Subject|4|||
130924323|NCT00369824|471358203|FG004|Overall Study|Withdrawal by Subject|6|||
130924324|NCT00369824|471358204|FG005|Overall Study|Withdrawal by Subject|2|||
130924325|NCT00369824|471358199|FG000|Overall Study|Lost to Follow-up|6|||
130924326|NCT00369824|471358200|FG001|Overall Study|Lost to Follow-up|11|||
130924327|NCT00369824|471358201|FG002|Overall Study|Lost to Follow-up|7|||
130924328|NCT00369824|471358202|FG003|Overall Study|Lost to Follow-up|8|||
130924329|NCT00369824|471358203|FG004|Overall Study|Lost to Follow-up|9|||
130924330|NCT00369824|471358204|FG005|Overall Study|Lost to Follow-up|6|||
130924331|NCT00369824|471358199|FG000|Overall Study|Other|0|||
130924332|NCT00369824|471358200|FG001|Overall Study|Other|0|||
130924333|NCT00369824|471358201|FG002|Overall Study|Other|0|||
130924334|NCT00369824|471358202|FG003|Overall Study|Other|2|||
130924335|NCT00369824|471358203|FG004|Overall Study|Other|1|||
130924336|NCT00369824|471358204|FG005|Overall Study|Other|3|||
130924337|NCT00334958|471358205|FG000|Overall Study|Medication Noncompliance|0|||
130924338|NCT00334958|471358206|FG001|Overall Study|Medication Noncompliance|3|||
130924339|NCT00334958|471358205|FG000|Overall Study|Protocol Violation|2|||
130924340|NCT00334958|471358206|FG001|Overall Study|Protocol Violation|2|||
130924341|NCT00334958|471358205|FG000|Overall Study|Request of the investigator or sponsor|0|||
130924342|NCT00334958|471358206|FG001|Overall Study|Request of the investigator or sponsor|1|||
130924343|NCT00334958|471358205|FG000|Overall Study|Withdrawal by Subject|7|||
130924344|NCT00334958|471358206|FG001|Overall Study|Withdrawal by Subject|4|||
130924345|NCT00334958|471358205|FG000|Overall Study|Adverse Event|27|||
130924346|NCT00334958|471358206|FG001|Overall Study|Adverse Event|12|||
130924347|NCT00334958|471358205|FG000|Overall Study|Other|1|||
130924348|NCT00334958|471358206|FG001|Overall Study|Other|2|||
130924349|NCT00781274|471358207|FG000|Overall Study|Withdrawal by Subject|2|||
130924350|NCT02021773|471358208|FG000|Overall Study|Adverse Event|1|||
130924351|NCT02021773|471358209|FG001|Overall Study|Adverse Event|4|||
130924352|NCT02021773|471358210|FG002|Overall Study|Adverse Event|3|||
130924353|NCT02021773|471358208|FG000|Overall Study|Lack of Efficacy|2|||
130924354|NCT02021773|471358209|FG001|Overall Study|Lack of Efficacy|2|||
130924355|NCT02021773|471358210|FG002|Overall Study|Lack of Efficacy|2|||
130924356|NCT02021773|471358208|FG000|Overall Study|Protocol Violation|2|||
130924357|NCT02021773|471358209|FG001|Overall Study|Protocol Violation|3|||
130924358|NCT02021773|471358210|FG002|Overall Study|Protocol Violation|1|||
130924359|NCT02021773|471358208|FG000|Overall Study|Withdrawal by Subject|3|||
130924360|NCT02021773|471358209|FG001|Overall Study|Withdrawal by Subject|4|||
130924361|NCT02021773|471358210|FG002|Overall Study|Withdrawal by Subject|5|||
130924362|NCT02021773|471358208|FG000|Overall Study|Lost to Follow-up|1|||
130924363|NCT02021773|471358209|FG001|Overall Study|Lost to Follow-up|3|||
130924364|NCT02021773|471358210|FG002|Overall Study|Lost to Follow-up|0|||
130924365|NCT02021773|471358208|FG000|Overall Study|Reason not specified|3|||
130924366|NCT02021773|471358209|FG001|Overall Study|Reason not specified|0|||
130769693|NCT04575584|470782517|FG002|Overall Study|Physician Decision|1|||
130769694|NCT04575584|470782518|FG003|Overall Study|Physician Decision|1|||
130924367|NCT02021773|471358210|FG002|Overall Study|Reason not specified|0|||
130924368|NCT01534962|471358211|FG000|Overall Study|Randomized but did not start treatment|2|||
130924369|NCT01534962|471358212|FG001|Overall Study|Randomized but did not start treatment|0|||
130924370|NCT01534962|471358213|FG002|Overall Study|Randomized but did not start treatment|0|||
130924371|NCT01534962|471358214|FG003|Overall Study|Randomized but did not start treatment|1|||
130924372|NCT01534962|471358211|FG000|Overall Study|Discontinued at AF recurrence|35|||
130924373|NCT01534962|471358212|FG001|Overall Study|Discontinued at AF recurrence|26|||
130924374|NCT01534962|471358213|FG002|Overall Study|Discontinued at AF recurrence|24|||
130924375|NCT01534962|471358214|FG003|Overall Study|Discontinued at AF recurrence|31|||
130769695|NCT04575584|470782519|FG004|Overall Study|Physician Decision|0|||
130769696|NCT04575584|470782520|FG005|Overall Study|Physician Decision|0|||
130924376|NCT02243696|471358215|FG000|Overall Study|Death|282|||
130924377|NCT02243696|471358215|FG000|Overall Study|Withdrawal by Subject|79|||
130924378|NCT02243696|471358215|FG000|Overall Study|Lost to Follow-up|57|||
130769697|NCT04575584|470782515|FG000|Overall Study|Withdrawal by Subject|7|||
130924379|NCT02243696|471358215|FG000|Overall Study|Subject No Longer has Study System|42|||
130924380|NCT02243696|471358215|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
131223345|NCT00430638|472445085|FG001|Overall Study|Protocol Violation|4|||
130769698|NCT04575584|470782516|FG001|Overall Study|Withdrawal by Subject|9|||
130924381|NCT02243696|471358215|FG000|Overall Study|Study Terminated for EP PASSION|961|||
130924382|NCT00191269|471358216|FG000|Overall Study|Protocol Violation|0|||
130924383|NCT00191269|471358217|FG001|Overall Study|Protocol Violation|2|||
130924384|NCT00191269|471358216|FG000|Overall Study|Adverse Event|1|||
130924385|NCT00191269|471358217|FG001|Overall Study|Adverse Event|4|||
130924386|NCT00191269|471358216|FG000|Overall Study|Progression of Disease|4|||
130924387|NCT00191269|471358217|FG001|Overall Study|Progression of Disease|42|||
130924388|NCT00191269|471358216|FG000|Overall Study|Lack of Efficacy|1|||
130924389|NCT00191269|471358217|FG001|Overall Study|Lack of Efficacy|5|||
130924390|NCT00191269|471358216|FG000|Overall Study|Withdrawal by Subject|0|||
130924391|NCT00191269|471358217|FG001|Overall Study|Withdrawal by Subject|1|||
130924392|NCT00191269|471358216|FG000|Overall Study|Pathologic Aggrevation|0|||
130924393|NCT00191269|471358217|FG001|Overall Study|Pathologic Aggrevation|1|||
130924394|NCT00191269|471358216|FG000|Overall Study|Physician Decision|0|||
130924395|NCT00191269|471358217|FG001|Overall Study|Physician Decision|3|||
130924396|NCT02094677|471358227|FG000|Overall Study|Screening|3|||
130924397|NCT02094677|471358228|FG001|Overall Study|Screening|1|||
130924398|NCT01702961|471358229|FG000|Overall Study|Additional treatment|3|||
130924399|NCT01702961|471358229|FG000|Overall Study|Progressive disease|5|||
130924400|NCT01702961|471358229|FG000|Overall Study|Relapse|20|||
130924401|NCT01702961|471358229|FG000|Overall Study|Death|6|||
130924402|NCT01702961|471358229|FG000|Overall Study|Lost to Follow-up|2|||
130924403|NCT01702961|471358229|FG000|Overall Study|Ongoing|11|||
130924404|NCT00668707|471358232|FG000|Overall Study|Cancer Recurrence|58|||
130924405|NCT00668707|471358233|FG001|Overall Study|Cancer Recurrence|58|||
130924406|NCT00668707|471358232|FG000|Overall Study|Withdrawal by Subject|117|||
130924407|NCT00668707|471358233|FG001|Overall Study|Withdrawal by Subject|100|||
130924408|NCT00668707|471358232|FG000|Overall Study|Lost to Follow-up|3|||
130924409|NCT00668707|471358233|FG001|Overall Study|Lost to Follow-up|6|||
130924410|NCT00668707|471358232|FG000|Overall Study|Protocol Violation|10|||
130924411|NCT00668707|471358233|FG001|Overall Study|Protocol Violation|12|||
130924412|NCT00668707|471358232|FG000|Overall Study|Death|11|||
130924413|NCT00668707|471358233|FG001|Overall Study|Death|4|||
130924414|NCT01980940|471358236|FG000|Overall Study|Protocol Violation|0|||
130924415|NCT01980940|471358237|FG001|Overall Study|Protocol Violation|0|||
130924416|NCT01980940|471358238|FG002|Overall Study|Protocol Violation|0|||
130924417|NCT01980940|471358239|FG003|Overall Study|Protocol Violation|0|||
130924418|NCT01980940|471358240|FG004|Overall Study|Protocol Violation|0|||
130924419|NCT01980940|471358241|FG005|Overall Study|Protocol Violation|2|||
130924420|NCT01980940|471358242|FG006|Overall Study|Protocol Violation|0|||
130924421|NCT01980940|471358243|FG007|Overall Study|Protocol Violation|0|||
130924422|NCT05996718|471360201|FG000|Overall Study|Lost to Follow-up|3|||
130924423|NCT01713686|471360202|FG000|Overall Study|Lost to Follow-up|9|||
130924424|NCT01713686|471360202|FG000|Overall Study|Withdrawal by Subject|6|||
130924425|NCT04840615|471360203|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
130924426|NCT04840615|471360204|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
130924427|NCT04840615|471360205|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
130924428|NCT00967668|471360206|FG000|Overall Study|Withdrawal by Subject|13|||
130924429|NCT00967668|471360207|FG001|Overall Study|Withdrawal by Subject|8|||
130924430|NCT00967668|471360208|FG002|Overall Study|Withdrawal by Subject|8|||
130924431|NCT00967668|471360206|FG000|Overall Study|Death|0|||
130924432|NCT00967668|471360207|FG001|Overall Study|Death|2|||
130924433|NCT00967668|471360208|FG002|Overall Study|Death|4|||
130924434|NCT00967668|471360206|FG000|Overall Study|Removed due to behavior|1|||
130924435|NCT00967668|471360207|FG001|Overall Study|Removed due to behavior|1|||
130924436|NCT00967668|471360208|FG002|Overall Study|Removed due to behavior|2|||
130924437|NCT00967668|471360206|FG000|Overall Study|Refused Year 2|11|||
130924438|NCT00967668|471360207|FG001|Overall Study|Refused Year 2|6|||
130924439|NCT00967668|471360208|FG002|Overall Study|Refused Year 2|4|||
130924440|NCT00967668|471360206|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
130924441|NCT00967668|471360207|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
130924442|NCT00967668|471360208|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
130924443|NCT00967668|471360206|FG000|Overall Study|Lost to Follow-up|15|||
130924444|NCT00967668|471360207|FG001|Overall Study|Lost to Follow-up|9|||
130924445|NCT00967668|471360208|FG002|Overall Study|Lost to Follow-up|16|||
130924446|NCT00967668|471360206|FG000|Overall Study|Refused 12-mo assessment|3|||
130924447|NCT00967668|471360207|FG001|Overall Study|Refused 12-mo assessment|1|||
130700966|NCT00152516|470528361|FG000|Overall Study|Adverse Event|18|||
130924448|NCT00967668|471360208|FG002|Overall Study|Refused 12-mo assessment|9|||
130924449|NCT00967668|471360206|FG000|Overall Study|Pregnancy|1|||
130924450|NCT00967668|471360207|FG001|Overall Study|Pregnancy|0|||
130924451|NCT00967668|471360208|FG002|Overall Study|Pregnancy|0|||
130924452|NCT00115739|471360210|FG000|Overall Study|Lost to Follow-up|3|||
130924453|NCT00709761|471360213|FG000|Overall Study|Withdrawal by Subject|8|||
130924454|NCT00709761|471360213|FG000|Overall Study|study closed/terminated|17|||
130924455|NCT00709761|471360213|FG000|Overall Study|Lost to Follow-up|2|||
130924456|NCT01918774|471360214|FG000|Overall Study|Lost prior to first CBTw session|4|||
130924457|NCT01918774|471360214|FG000|Overall Study|Lost to Follow-up|1|||
130924458|NCT01606800|471360215|FG000|Overall Study|Adverse Event|3|||
130924459|NCT01606800|471360216|FG001|Overall Study|Adverse Event|1|||
130924460|NCT01606800|471360215|FG000|Overall Study|Participant withdrew consent|0|||
130924461|NCT01606800|471360216|FG001|Overall Study|Participant withdrew consent|1|||
130924462|NCT01606800|471360215|FG000|Overall Study|Missing completion status|2|||
130924463|NCT01606800|471360216|FG001|Overall Study|Missing completion status|0|||
130924464|NCT01687998|471360217|FG000|Overall Study|Withdrawal by Subject|49|||
131223346|NCT00430638|472445084|FG000|Overall Study|Withdrawal by Subject|4|||
131223347|NCT00430638|472445085|FG001|Overall Study|Withdrawal by Subject|6|||
131223348|NCT00430638|472445084|FG000|Overall Study|Non-compliant|2|||
131223349|NCT00430638|472445085|FG001|Overall Study|Non-compliant|1|||
130924465|NCT01687998|471360218|FG001|Overall Study|Withdrawal by Subject|51|||
131223350|NCT00430638|472445084|FG000|Overall Study|Other|2|||
130924466|NCT01687998|471360217|FG000|Overall Study|Known to be Alive at Study End|54|||
130924467|NCT01687998|471360218|FG001|Overall Study|Known to be Alive at Study End|62|||
130924468|NCT01687998|471360217|FG000|Overall Study|Lost to Follow-up|9|||
130924469|NCT01687998|471360218|FG001|Overall Study|Lost to Follow-up|7|||
130924470|NCT00717197|471360225|FG000|Overall Study|Unable to purchase study drug|5|||
130924471|NCT00717197|471360225|FG000|Overall Study|Tumor Progression|1|||
130924472|NCT00717197|471360225|FG000|Overall Study|Physician Decision|1|||
130924473|NCT00982137|471360226|FG000|Overall Study|Lost to Follow-up|0|||
130924474|NCT00982137|471360227|FG001|Overall Study|Lost to Follow-up|0|||
130924475|NCT00982137|471360228|FG002|Overall Study|Lost to Follow-up|0|||
131223351|NCT00430638|472445085|FG001|Overall Study|Other|2|||
131223352|NCT01123980|472445086|FG000|Overall Study|Adverse Event|1|||
131223353|NCT01123980|472445087|FG001|Overall Study|Adverse Event|1|||
131223354|NCT01123980|472445086|FG000|Overall Study|Lack of Efficacy|1|||
131223355|NCT01123980|472445087|FG001|Overall Study|Lack of Efficacy|0|||
131223356|NCT01123980|472445086|FG000|Overall Study|Physician Decision|0|||
131223357|NCT01123980|472445087|FG001|Overall Study|Physician Decision|1|||
131223358|NCT01123980|472445086|FG000|Overall Study|Lost to Follow-up|0|||
131223359|NCT01123980|472445087|FG001|Overall Study|Lost to Follow-up|6|||
131223360|NCT01123980|472445086|FG000|Overall Study|Protocol Violation|6|||
131223361|NCT01123980|472445087|FG001|Overall Study|Protocol Violation|6|||
131223362|NCT01123980|472445086|FG000|Overall Study|Withdrawal by Subject|5|||
131223363|NCT01123980|472445087|FG001|Overall Study|Withdrawal by Subject|3|||
131223364|NCT01123980|472445086|FG000|Overall Study|Unclassified|6|||
131223365|NCT01123980|472445087|FG001|Overall Study|Unclassified|7|||
131223366|NCT01225991|472445088|FG000|Overall Study|Withdrawal by Subject|6|||
131223367|NCT02094937|472445089|FG000|8 Weeks in Period 1|Adverse Event|9|||
131223368|NCT02094937|472445090|FG001|8 Weeks in Period 1|Adverse Event|0|||
131223369|NCT02094937|472445091|FG002|8 Weeks in Period 1|Adverse Event|0|||
131223370|NCT02094937|472445092|FG003|8 Weeks in Period 1|Adverse Event|0|||
131223371|NCT02094937|472445089|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
131223372|NCT02094937|472445090|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
131223373|NCT02094937|472445091|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
130700967|NCT00152516|470528361|FG000|Overall Study|Lack and Loss of Efficacy|30|||
130924476|NCT00982137|471360229|FG003|Overall Study|Lost to Follow-up|1|||
130924477|NCT00982137|471360226|FG000|Overall Study|Withdrawal by Subject|0|||
130924478|NCT00982137|471360227|FG001|Overall Study|Withdrawal by Subject|1|||
130924479|NCT00982137|471360228|FG002|Overall Study|Withdrawal by Subject|0|||
130924480|NCT00982137|471360229|FG003|Overall Study|Withdrawal by Subject|0|||
130924481|NCT03003390|471360230|FG000|Overall Study|Physician Decision|2|||
130924482|NCT03003390|471360231|FG001|Overall Study|Physician Decision|0|||
130924483|NCT03003390|471360230|FG000|Overall Study|Parent refused intervention|2|||
130924484|NCT03003390|471360231|FG001|Overall Study|Parent refused intervention|0|||
131223374|NCT02094937|472445092|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
131223375|NCT02094937|472445089|FG000|8 Weeks in Period 1|Protocol Violation|2|||
130700968|NCT00152516|470528361|FG000|Overall Study|Lost to Follow-up|5|||
130700969|NCT00152516|470528361|FG000|Overall Study|Withdrawal by Subject|8|||
130700970|NCT00152516|470528361|FG000|Overall Study|Protocol Violation|3|||
130700971|NCT00152516|470528361|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
130700972|NCT00152516|470528361|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
130924485|NCT01648101|471360232|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
130924486|NCT01648101|471360233|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
131223376|NCT02094937|472445090|FG001|8 Weeks in Period 1|Protocol Violation|0|||
131223377|NCT02094937|472445091|FG002|8 Weeks in Period 1|Protocol Violation|0|||
131223378|NCT02094937|472445092|FG003|8 Weeks in Period 1|Protocol Violation|0|||
131223379|NCT02094937|472445089|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
131223380|NCT02094937|472445090|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
130700973|NCT00152516|470528361|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
131223381|NCT02094937|472445091|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
131223382|NCT02094937|472445092|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
131223383|NCT02094937|472445089|FG000|8 Weeks in Period 1|Physician Decision|1|||
131223384|NCT02094937|472445090|FG001|8 Weeks in Period 1|Physician Decision|0|||
131223385|NCT02094937|472445091|FG002|8 Weeks in Period 1|Physician Decision|0|||
130700974|NCT00152516|470528361|FG000|Overall Study|Other: Non-Compliance|2|||
130924487|NCT01648101|471360234|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
130924488|NCT01648101|471360232|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
130924489|NCT01648101|471360233|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
130924490|NCT01648101|471360234|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
131034473|NCT04338061|471759204|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
131223386|NCT02094937|472445092|FG003|8 Weeks in Period 1|Physician Decision|0|||
130924491|NCT01648101|471360232|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
130924492|NCT01648101|471360233|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
130924493|NCT01648101|471360234|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
130924494|NCT01648101|471360232|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
130924495|NCT01648101|471360233|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
130924496|NCT01648101|471360234|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
130924497|NCT01648101|471360232|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
130924498|NCT01648101|471360233|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
130924499|NCT01648101|471360234|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
130924500|NCT01648101|471360232|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
130924501|NCT01648101|471360233|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
130924502|NCT01648101|471360234|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
130924503|NCT01648101|471360232|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
130924504|NCT01648101|471360233|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
130924505|NCT01648101|471360234|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
130924506|NCT01648101|471360232|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
130924507|NCT01648101|471360233|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
130924508|NCT01648101|471360234|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
130924509|NCT01648101|471360232|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
130924510|NCT01648101|471360233|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
130924511|NCT01648101|471360234|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
130924512|NCT01648101|471360232|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
130924513|NCT01648101|471360233|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
130924514|NCT01648101|471360234|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
130924515|NCT01648101|471360232|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
130924516|NCT01648101|471360233|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
130924517|NCT01648101|471360234|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
130924518|NCT03311724|471360235|FG000|Overall Study|Physician Decision|0|||
130924519|NCT03311724|471360236|FG001|Overall Study|Physician Decision|0|||
130924520|NCT03311724|471360237|FG002|Overall Study|Physician Decision|0|||
130924521|NCT03311724|471360238|FG003|Overall Study|Physician Decision|1|||
130924522|NCT03311724|471360235|FG000|Overall Study|Protocol Violation|1|||
130924523|NCT03311724|471360236|FG001|Overall Study|Protocol Violation|0|||
130924524|NCT03311724|471360237|FG002|Overall Study|Protocol Violation|1|||
130924525|NCT03311724|471360238|FG003|Overall Study|Protocol Violation|0|||
130924526|NCT03311724|471360235|FG000|Overall Study|Withdrawal by Subject|1|||
130924527|NCT03311724|471360236|FG001|Overall Study|Withdrawal by Subject|1|||
130924528|NCT03311724|471360237|FG002|Overall Study|Withdrawal by Subject|0|||
130924529|NCT03311724|471360238|FG003|Overall Study|Withdrawal by Subject|0|||
130924530|NCT03311724|471360235|FG000|Overall Study|Lost to Follow-up|1|||
130924531|NCT03311724|471360236|FG001|Overall Study|Lost to Follow-up|0|||
130924532|NCT03311724|471360237|FG002|Overall Study|Lost to Follow-up|0|||
130924533|NCT03311724|471360238|FG003|Overall Study|Lost to Follow-up|0|||
130924534|NCT03311724|471360235|FG000|Overall Study|Sponsor Decision|0|||
130924535|NCT03311724|471360236|FG001|Overall Study|Sponsor Decision|0|||
130924536|NCT03311724|471360237|FG002|Overall Study|Sponsor Decision|1|||
130924537|NCT03311724|471360238|FG003|Overall Study|Sponsor Decision|0|||
130924538|NCT00395304|471360247|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130924539|NCT00395304|471360248|FG001|Treatment Period 1|Withdrawal by Subject|3|||
130924540|NCT00395304|471360249|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130924541|NCT00395304|471360250|FG003|Treatment Period 1|Withdrawal by Subject|2|||
130924542|NCT00395304|471360251|FG004|Treatment Period 1|Withdrawal by Subject|1|||
130924543|NCT00395304|471360252|FG005|Treatment Period 1|Withdrawal by Subject|1|||
130924544|NCT00395304|471360247|FG000|Treatment Period 1|Lost to Follow-up|1|||
130924545|NCT00395304|471360248|FG001|Treatment Period 1|Lost to Follow-up|0|||
130924546|NCT00395304|471360249|FG002|Treatment Period 1|Lost to Follow-up|0|||
130924547|NCT00395304|471360250|FG003|Treatment Period 1|Lost to Follow-up|1|||
130924548|NCT00395304|471360251|FG004|Treatment Period 1|Lost to Follow-up|0|||
130924549|NCT00395304|471360252|FG005|Treatment Period 1|Lost to Follow-up|1|||
130924550|NCT00395304|471360247|FG000|Treatment Period 1|Physician Decision|0|||
130924551|NCT00395304|471360248|FG001|Treatment Period 1|Physician Decision|1|||
130924552|NCT00395304|471360249|FG002|Treatment Period 1|Physician Decision|0|||
130924553|NCT00395304|471360250|FG003|Treatment Period 1|Physician Decision|0|||
130924554|NCT00395304|471360251|FG004|Treatment Period 1|Physician Decision|0|||
130924555|NCT00395304|471360252|FG005|Treatment Period 1|Physician Decision|0|||
130924556|NCT00395304|471360247|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130924557|NCT00395304|471360248|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130924558|NCT00395304|471360249|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130924559|NCT00395304|471360250|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130924560|NCT00395304|471360251|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130924561|NCT00395304|471360252|FG005|Treatment Period 2|Withdrawal by Subject|2|||
130924562|NCT00395304|471360247|FG000|Treatment Period 2|Lost to Follow-up|0|||
130924563|NCT00395304|471360248|FG001|Treatment Period 2|Lost to Follow-up|3|||
130924564|NCT00395304|471360249|FG002|Treatment Period 2|Lost to Follow-up|0|||
130924565|NCT00395304|471360250|FG003|Treatment Period 2|Lost to Follow-up|0|||
130924566|NCT00395304|471360251|FG004|Treatment Period 2|Lost to Follow-up|0|||
130924567|NCT00395304|471360252|FG005|Treatment Period 2|Lost to Follow-up|0|||
130924568|NCT00395304|471360247|FG000|Treatment Period 2|Physician Decision|0|||
130924569|NCT00395304|471360248|FG001|Treatment Period 2|Physician Decision|0|||
130924570|NCT00395304|471360249|FG002|Treatment Period 2|Physician Decision|1|||
130924571|NCT00395304|471360250|FG003|Treatment Period 2|Physician Decision|0|||
130924572|NCT00395304|471360251|FG004|Treatment Period 2|Physician Decision|0|||
130924573|NCT00395304|471360252|FG005|Treatment Period 2|Physician Decision|0|||
130924574|NCT00395304|471360247|FG000|Treatment Period 2|Other|0|||
130924575|NCT00395304|471360248|FG001|Treatment Period 2|Other|1|||
130924576|NCT00395304|471360249|FG002|Treatment Period 2|Other|0|||
130924577|NCT00395304|471360250|FG003|Treatment Period 2|Other|0|||
130924578|NCT00395304|471360251|FG004|Treatment Period 2|Other|0|||
130924579|NCT00395304|471360252|FG005|Treatment Period 2|Other|0|||
130924580|NCT00395304|471360247|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130924581|NCT00395304|471360248|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130924582|NCT00395304|471360249|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130924583|NCT00395304|471360250|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130924584|NCT00395304|471360251|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130924585|NCT00395304|471360252|FG005|Treatment Period 3|Withdrawal by Subject|1|||
130924586|NCT00395304|471360247|FG000|Treatment Period 3|Lost to Follow-up|1|||
130924587|NCT00395304|471360248|FG001|Treatment Period 3|Lost to Follow-up|1|||
130924588|NCT00395304|471360249|FG002|Treatment Period 3|Lost to Follow-up|0|||
130924589|NCT00395304|471360250|FG003|Treatment Period 3|Lost to Follow-up|0|||
130924590|NCT00395304|471360251|FG004|Treatment Period 3|Lost to Follow-up|0|||
130924591|NCT00395304|471360252|FG005|Treatment Period 3|Lost to Follow-up|0|||
130924592|NCT00395304|471360247|FG000|Treatment Period 3|Physician Decision|0|||
130924593|NCT00395304|471360248|FG001|Treatment Period 3|Physician Decision|1|||
130924594|NCT00395304|471360249|FG002|Treatment Period 3|Physician Decision|0|||
130924595|NCT00395304|471360250|FG003|Treatment Period 3|Physician Decision|0|||
130924596|NCT00395304|471360251|FG004|Treatment Period 3|Physician Decision|0|||
130924597|NCT00395304|471360252|FG005|Treatment Period 3|Physician Decision|0|||
130924598|NCT00395304|471360247|FG000|Treatment Period 3|Other|0|||
130924599|NCT00395304|471360248|FG001|Treatment Period 3|Other|0|||
130924600|NCT00395304|471360249|FG002|Treatment Period 3|Other|0|||
130924601|NCT00395304|471360250|FG003|Treatment Period 3|Other|1|||
130924602|NCT00395304|471360251|FG004|Treatment Period 3|Other|0|||
130924603|NCT00395304|471360252|FG005|Treatment Period 3|Other|0|||
130924604|NCT01389817|471360253|FG000|Overall Study|Physician Decision|1|||
130924605|NCT01389817|471360254|FG001|Overall Study|Physician Decision|0|||
130924606|NCT01389817|471360253|FG000|Overall Study|Lost to Follow-up|1|||
130924607|NCT01389817|471360254|FG001|Overall Study|Lost to Follow-up|0|||
130924608|NCT01389817|471360253|FG000|Overall Study|Withdrawal by Subject|2|||
130924609|NCT01389817|471360254|FG001|Overall Study|Withdrawal by Subject|0|||
130924610|NCT01877265|471360255|FG000|Treatment Period 1|Sponsor Decision|0|||
130924611|NCT01877265|471360256|FG001|Treatment Period 1|Sponsor Decision|0|||
130924612|NCT01877265|471360257|FG002|Treatment Period 1|Sponsor Decision|1|||
130924613|NCT01877265|471360258|FG003|Treatment Period 1|Sponsor Decision|0|||
130924614|NCT01877265|471360259|FG004|Treatment Period 1|Sponsor Decision|0|||
130924615|NCT01877265|471360260|FG005|Treatment Period 1|Sponsor Decision|0|||
130924616|NCT01877265|471360255|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
130924617|NCT01877265|471360256|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
130924618|NCT01877265|471360257|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
130924619|NCT01877265|471360258|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
130924620|NCT01877265|471360259|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
130924621|NCT01877265|471360260|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
130924622|NCT01877265|471360255|FG000|Treatment Period 3|Lost to Follow-up|1|||
130924623|NCT01877265|471360256|FG001|Treatment Period 3|Lost to Follow-up|0|||
130924624|NCT01877265|471360257|FG002|Treatment Period 3|Lost to Follow-up|0|||
130924625|NCT01877265|471360258|FG003|Treatment Period 3|Lost to Follow-up|0|||
130924626|NCT01877265|471360259|FG004|Treatment Period 3|Lost to Follow-up|0|||
130924627|NCT01877265|471360260|FG005|Treatment Period 3|Lost to Follow-up|0|||
130924628|NCT03535844|471360261|FG000|Overall Study|Withdrawal by Subject|0|||
130924629|NCT03535844|471360262|FG001|Overall Study|Withdrawal by Subject|1|||
130924630|NCT03130257|471360263|FG000|Overall Study|Withdrawal by Subject|1|||
130924631|NCT03130257|471360264|FG001|Overall Study|Withdrawal by Subject|0|||
130924632|NCT03130257|471360265|FG002|Overall Study|Withdrawal by Subject|2|||
130924633|NCT01606007|471360269|FG000|Overall Study|Reason 'Other' in the protocol|0|||
130924634|NCT01606007|471360270|FG001|Overall Study|Reason 'Other' in the protocol|1|||
130924635|NCT01606007|471360271|FG002|Overall Study|Reason 'Other' in the protocol|1|||
130924636|NCT01606007|471360269|FG000|Overall Study|Pregnancy|0|||
130924637|NCT01606007|471360270|FG001|Overall Study|Pregnancy|1|||
130924638|NCT01606007|471360271|FG002|Overall Study|Pregnancy|1|||
130924639|NCT01606007|471360269|FG000|Overall Study|Withdrawal by Subject|8|||
130924640|NCT01606007|471360270|FG001|Overall Study|Withdrawal by Subject|6|||
130924641|NCT01606007|471360271|FG002|Overall Study|Withdrawal by Subject|1|||
130924642|NCT01606007|471360269|FG000|Overall Study|Adverse Event|0|||
130924643|NCT01606007|471360270|FG001|Overall Study|Adverse Event|1|||
130924644|NCT01606007|471360271|FG002|Overall Study|Adverse Event|1|||
130924645|NCT01606007|471360269|FG000|Overall Study|discontinue study treatment|0|||
130924646|NCT01606007|471360270|FG001|Overall Study|discontinue study treatment|2|||
130924647|NCT01606007|471360271|FG002|Overall Study|discontinue study treatment|1|||
130924648|NCT01606007|471360269|FG000|Overall Study|Lost to Follow-up|6|||
130924649|NCT01606007|471360270|FG001|Overall Study|Lost to Follow-up|8|||
130924650|NCT01606007|471360271|FG002|Overall Study|Lost to Follow-up|5|||
130924651|NCT01606007|471360269|FG000|Overall Study|Poor/Non-compliance|1|||
130924652|NCT01606007|471360270|FG001|Overall Study|Poor/Non-compliance|0|||
130924653|NCT01606007|471360271|FG002|Overall Study|Poor/Non-compliance|0|||
130924654|NCT03733470|471360276|FG000|Overall Study|PI Decision|1|||
130924655|NCT03733470|471360277|FG001|Overall Study|PI Decision|1|||
130924656|NCT01010061|471360278|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
130924657|NCT01010061|471360279|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
130924658|NCT01010061|471360278|FG000|Overall Study|Disease Progression|2|||
130924659|NCT01010061|471360279|FG001|Overall Study|Disease Progression|8|||
130924660|NCT01010061|471360278|FG000|Overall Study|Withdrew Consent|5|||
130924661|NCT01010061|471360279|FG001|Overall Study|Withdrew Consent|1|||
130924662|NCT01010061|471360278|FG000|Overall Study|Death|3|||
130924663|NCT01010061|471360279|FG001|Overall Study|Death|6|||
130924664|NCT01010061|471360278|FG000|Overall Study|Administrative/Other|0|||
130924665|NCT01010061|471360279|FG001|Overall Study|Administrative/Other|1|||
130924666|NCT01010061|471360278|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
130924667|NCT01010061|471360279|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
130924668|NCT01010061|471360278|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130924669|NCT01010061|471360279|FG001|Overall Study|Insufficient Therapeutic Response|5|||
130924670|NCT01010061|471360278|FG000|Overall Study|Violation of Selection Criteria|0|||
130924671|NCT01010061|471360279|FG001|Overall Study|Violation of Selection Criteria|1|||
130924672|NCT01010061|471360278|FG000|Overall Study|Did Not Receive Treatment|2|||
130924673|NCT01010061|471360279|FG001|Overall Study|Did Not Receive Treatment|2|||
130924674|NCT03470441|471360280|FG000|Overall Study|Death|0|||
130924675|NCT03470441|471360281|FG001|Overall Study|Death|1|||
130924676|NCT03470441|471360282|FG002|Overall Study|Death|1|||
130924677|NCT03470441|471360283|FG003|Overall Study|Death|0|||
130924678|NCT03470441|471360280|FG000|Overall Study|Adverse Event|0|||
130924679|NCT03470441|471360281|FG001|Overall Study|Adverse Event|0|||
130924680|NCT03470441|471360282|FG002|Overall Study|Adverse Event|0|||
130924681|NCT03470441|471360283|FG003|Overall Study|Adverse Event|1|||
130924682|NCT03470441|471360280|FG000|Overall Study|Withdrawal by Subject|1|||
130924683|NCT03470441|471360281|FG001|Overall Study|Withdrawal by Subject|4|||
130924684|NCT03470441|471360282|FG002|Overall Study|Withdrawal by Subject|1|||
130924685|NCT03470441|471360283|FG003|Overall Study|Withdrawal by Subject|3|||
130924686|NCT03768414|471360284|FG000|Overall Study|Adverse Event or side effects|72|||
130924687|NCT03768414|471360285|FG001|Overall Study|Adverse Event or side effects|28|||
130924688|NCT03768414|471360284|FG000|Overall Study|Refusal unrelated to adverse event|33|||
130924689|NCT03768414|471360285|FG001|Overall Study|Refusal unrelated to adverse event|33|||
130924690|NCT03768414|471360284|FG000|Overall Study|Progression/relapse|132|||
130924691|NCT03768414|471360285|FG001|Overall Study|Progression/relapse|60|||
130924692|NCT03768414|471360284|FG000|Overall Study|Death|9|||
130769699|NCT04575584|470782517|FG002|Overall Study|Withdrawal by Subject|5|||
130769700|NCT04575584|470782518|FG003|Overall Study|Withdrawal by Subject|3|||
130769701|NCT04575584|470782519|FG004|Overall Study|Withdrawal by Subject|0|||
130769702|NCT04575584|470782520|FG005|Overall Study|Withdrawal by Subject|0|||
130769703|NCT04575584|470782515|FG000|Overall Study|Not recorded|0|||
130769704|NCT04575584|470782516|FG001|Overall Study|Not recorded|0|||
130769705|NCT04575584|470782517|FG002|Overall Study|Not recorded|0|||
130769706|NCT04575584|470782518|FG003|Overall Study|Not recorded|1|||
130769707|NCT04575584|470782519|FG004|Overall Study|Not recorded|0|||
130769708|NCT04575584|470782520|FG005|Overall Study|Not recorded|0|||
130769709|NCT03488563|470782521|FG000|Overall Study|Lost to Follow-up|7|||
130769710|NCT03488563|470782522|FG001|Overall Study|Lost to Follow-up|6|||
130769711|NCT03488563|470782523|FG002|Overall Study|Lost to Follow-up|7|||
130769712|NCT03488563|470782521|FG000|Overall Study|Withdrawal by Subject|8|||
130769713|NCT03488563|470782522|FG001|Overall Study|Withdrawal by Subject|7|||
130769714|NCT03488563|470782523|FG002|Overall Study|Withdrawal by Subject|7|||
130769715|NCT03488563|470782521|FG000|Overall Study|Physician Decision|0|||
130769716|NCT03488563|470782522|FG001|Overall Study|Physician Decision|0|||
130924693|NCT03768414|471360285|FG001|Overall Study|Death|6|||
130924694|NCT03768414|471360284|FG000|Overall Study|Other - not protocol specified|45|||
130924695|NCT03768414|471360285|FG001|Overall Study|Other - not protocol specified|18|||
130924696|NCT03768414|471360284|FG000|Overall Study|Reason under review|3|||
130924697|NCT03768414|471360285|FG001|Overall Study|Reason under review|2|||
130924698|NCT02571777|471360286|FG000|Overall Study|Subject/guardian decision|34|||
131223387|NCT02094937|472445089|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
130769717|NCT03488563|470782523|FG002|Overall Study|Physician Decision|1|||
130769718|NCT03488563|470782521|FG000|Overall Study|Protocol Violation|3|||
130924699|NCT02571777|471360287|FG001|Overall Study|Subject/guardian decision|26|||
130924700|NCT02571777|471360288|FG002|Overall Study|Subject/guardian decision|26|||
130924701|NCT02571777|471360289|FG003|Overall Study|Subject/guardian decision|25|||
130924702|NCT02571777|471360290|FG004|Overall Study|Subject/guardian decision|27|||
130924703|NCT02571777|471360286|FG000|Overall Study|Protocol Deviation|2|||
130924704|NCT02571777|471360287|FG001|Overall Study|Protocol Deviation|3|||
130924705|NCT02571777|471360288|FG002|Overall Study|Protocol Deviation|4|||
130924706|NCT02571777|471360289|FG003|Overall Study|Protocol Deviation|8|||
130924707|NCT02571777|471360290|FG004|Overall Study|Protocol Deviation|4|||
130924708|NCT02571777|471360286|FG000|Overall Study|Death|1|||
130924709|NCT02571777|471360287|FG001|Overall Study|Death|1|||
130924710|NCT02571777|471360288|FG002|Overall Study|Death|4|||
130924711|NCT02571777|471360289|FG003|Overall Study|Death|0|||
130924712|NCT02571777|471360290|FG004|Overall Study|Death|0|||
130924713|NCT02571777|471360286|FG000|Overall Study|Lost to Follow-up|1|||
130924714|NCT02571777|471360287|FG001|Overall Study|Lost to Follow-up|1|||
130924715|NCT02571777|471360288|FG002|Overall Study|Lost to Follow-up|2|||
130924716|NCT02571777|471360289|FG003|Overall Study|Lost to Follow-up|0|||
130924717|NCT02571777|471360290|FG004|Overall Study|Lost to Follow-up|1|||
130924718|NCT02571777|471360286|FG000|Overall Study|Physician Decision|1|||
130924719|NCT02571777|471360287|FG001|Overall Study|Physician Decision|7|||
130924720|NCT02571777|471360288|FG002|Overall Study|Physician Decision|5|||
130924721|NCT02571777|471360289|FG003|Overall Study|Physician Decision|2|||
130924722|NCT02571777|471360290|FG004|Overall Study|Physician Decision|4|||
130924723|NCT02571777|471360286|FG000|Overall Study|Pregnancy|0|||
130924724|NCT02571777|471360287|FG001|Overall Study|Pregnancy|0|||
130924725|NCT02571777|471360288|FG002|Overall Study|Pregnancy|0|||
130924726|NCT02571777|471360289|FG003|Overall Study|Pregnancy|2|||
130924727|NCT02571777|471360290|FG004|Overall Study|Pregnancy|0|||
130924728|NCT03706079|471360291|FG000|Predecessor Study|Death|0|||
130924729|NCT03706079|471360292|FG001|Predecessor Study|Death|2|||
130924730|NCT03706079|471360293|FG002|Predecessor Study|Death|0|||
130769719|NCT03488563|470782522|FG001|Overall Study|Protocol Violation|2|||
130769720|NCT03488563|470782523|FG002|Overall Study|Protocol Violation|6|||
130769721|NCT03488563|470782521|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
130769722|NCT03488563|470782522|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
130769723|NCT03488563|470782523|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
130769724|NCT03488563|470782521|FG000|Overall Study|Use of prohibited medication|2|||
130769725|NCT03488563|470782522|FG001|Overall Study|Use of prohibited medication|0|||
130769726|NCT03488563|470782523|FG002|Overall Study|Use of prohibited medication|0|||
130769727|NCT03488563|470782521|FG000|Overall Study|Adverse Event|1|||
130769728|NCT03488563|470782522|FG001|Overall Study|Adverse Event|0|||
130769729|NCT03488563|470782523|FG002|Overall Study|Adverse Event|1|||
130769730|NCT03488563|470782521|FG000|Overall Study|Subject returned for ET visit|0|||
130769731|NCT03488563|470782522|FG001|Overall Study|Subject returned for ET visit|1|||
130769732|NCT03488563|470782523|FG002|Overall Study|Subject returned for ET visit|0|||
130769733|NCT03488563|470782521|FG000|Overall Study|Sponsor's decision|0|||
130769734|NCT03488563|470782522|FG001|Overall Study|Sponsor's decision|0|||
130769735|NCT03488563|470782523|FG002|Overall Study|Sponsor's decision|1|||
130769736|NCT02769312|470782536|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
130769737|NCT02769312|470782537|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
130769738|NCT02769312|470782536|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
130769739|NCT02769312|470782537|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
130769740|NCT02769312|470782536|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
130769741|NCT02769312|470782537|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
130769742|NCT02769312|470782536|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
130924731|NCT03706079|471360294|FG003|Predecessor Study|Death|1|||
130924732|NCT03706079|471360295|FG004|Predecessor Study|Death|0|||
130924733|NCT03706079|471360296|FG005|Predecessor Study|Death|0|||
130924734|NCT03706079|471360291|FG000|Predecessor Study|Lost to Follow-up|5|||
131034474|NCT04338061|471759205|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
131034475|NCT04338061|471759204|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
130769743|NCT02769312|470782537|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
130769744|NCT02769312|470782536|FG000|Follow-up|Lost to Follow-up|1|||
130769745|NCT02769312|470782537|FG001|Follow-up|Lost to Follow-up|1|||
130769746|NCT02815267|470782538|FG000|Double-Blind Phase|Adverse Event|0|||
130769747|NCT02815267|470782539|FG001|Double-Blind Phase|Adverse Event|3|||
130924735|NCT03706079|471360292|FG001|Predecessor Study|Lost to Follow-up|2|||
130924736|NCT03706079|471360293|FG002|Predecessor Study|Lost to Follow-up|0|||
130924737|NCT03706079|471360294|FG003|Predecessor Study|Lost to Follow-up|0|||
130924738|NCT03706079|471360295|FG004|Predecessor Study|Lost to Follow-up|1|||
130924739|NCT03706079|471360296|FG005|Predecessor Study|Lost to Follow-up|0|||
131034476|NCT04338061|471759205|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
130924740|NCT03706079|471360291|FG000|Predecessor Study|Withdrawal by Subject|8|||
130924741|NCT03706079|471360292|FG001|Predecessor Study|Withdrawal by Subject|15|||
130924742|NCT03706079|471360293|FG002|Predecessor Study|Withdrawal by Subject|0|||
130924743|NCT03706079|471360294|FG003|Predecessor Study|Withdrawal by Subject|5|||
130924744|NCT03706079|471360295|FG004|Predecessor Study|Withdrawal by Subject|2|||
130924745|NCT03706079|471360296|FG005|Predecessor Study|Withdrawal by Subject|0|||
130924746|NCT03706079|471360291|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
130924747|NCT03706079|471360292|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
130924748|NCT03706079|471360293|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
130924749|NCT03706079|471360294|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
130924750|NCT03706079|471360295|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
130924751|NCT03706079|471360296|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
130924752|NCT03706079|471360291|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130924753|NCT03706079|471360292|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130924754|NCT03706079|471360293|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130924755|NCT03706079|471360294|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130924756|NCT03706079|471360295|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130924757|NCT03706079|471360296|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
130924758|NCT03706079|471360291|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
130924759|NCT03706079|471360292|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
130924760|NCT03706079|471360293|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
130924761|NCT03706079|471360294|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
130924762|NCT03706079|471360295|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
130924763|NCT03706079|471360296|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
130924764|NCT03706079|471360291|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
130924765|NCT03706079|471360292|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
130924766|NCT03706079|471360293|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
130924767|NCT03706079|471360294|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
130924768|NCT03706079|471360295|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
130924769|NCT03706079|471360296|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
130924770|NCT03706079|471360291|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
130924771|NCT03706079|471360292|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
130924772|NCT03706079|471360293|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
130924773|NCT03706079|471360294|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
130924774|NCT03706079|471360295|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
130924775|NCT03706079|471360296|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
130924776|NCT03706079|471360291|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
130924777|NCT03706079|471360292|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
130924778|NCT03706079|471360293|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
130924779|NCT03706079|471360294|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
130924780|NCT03706079|471360295|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
130924781|NCT03706079|471360296|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
130924782|NCT03706079|471360291|FG000|Long Term Extension (DESTINATION)|Death|8|||
130924783|NCT03706079|471360292|FG001|Long Term Extension (DESTINATION)|Death|2|||
130924784|NCT03706079|471360293|FG002|Long Term Extension (DESTINATION)|Death|2|||
130924785|NCT03706079|471360294|FG003|Long Term Extension (DESTINATION)|Death|1|||
130924786|NCT03706079|471360295|FG004|Long Term Extension (DESTINATION)|Death|0|||
130924787|NCT03706079|471360296|FG005|Long Term Extension (DESTINATION)|Death|0|||
130924788|NCT00968513|471360297|FG000|Overall Study|Death|4|||
130924789|NCT00968513|471360298|FG001|Overall Study|Death|10|||
130924790|NCT00968513|471360299|FG002|Overall Study|Death|15|||
130924791|NCT05379231|471360300|FG000|Home Visit|Withdrawal by Subject|2|||
130924792|NCT05379231|471360300|FG000|In-lab Visit|Withdrawal by Subject|2|||
130924793|NCT01203098|471360307|FG000|Overall Study|Adverse Event|3|||
130924794|NCT01203098|471360308|FG001|Overall Study|Adverse Event|1|||
130924795|NCT01203098|471360309|FG002|Overall Study|Adverse Event|7|||
130924796|NCT01203098|471360307|FG000|Overall Study|Lost to Follow-up|0|||
130924797|NCT01203098|471360308|FG001|Overall Study|Lost to Follow-up|0|||
130924798|NCT01203098|471360309|FG002|Overall Study|Lost to Follow-up|1|||
130924799|NCT01203098|471360307|FG000|Overall Study|Physician Decision|2|||
130924800|NCT01203098|471360308|FG001|Overall Study|Physician Decision|2|||
130924801|NCT01203098|471360309|FG002|Overall Study|Physician Decision|0|||
130924802|NCT01203098|471360307|FG000|Overall Study|Withdrawal by Subject|1|||
130924803|NCT01203098|471360308|FG001|Overall Study|Withdrawal by Subject|1|||
130924804|NCT01203098|471360309|FG002|Overall Study|Withdrawal by Subject|3|||
130924805|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
130924806|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
130924807|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
130924808|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
130924809|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
130924810|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
130924811|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
130924812|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
130924813|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
130924814|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
130924815|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
130924816|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
130924817|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
130924818|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
130924819|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
130924820|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
130924821|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
130924822|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
130924823|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
130924824|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
130924825|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
130924826|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
130924827|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
130924828|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
130924829|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
130924830|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
130924831|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
130924832|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
130924833|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
130924834|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
130924835|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
130924836|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
130924837|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
130924838|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
130924839|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
130924840|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
130924841|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
130924842|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
130924843|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
130924844|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
130924845|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
130924846|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
130924847|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
130924848|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
130924849|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
130924850|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
130924851|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
130924852|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
130924853|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
130924854|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
130924855|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
130924856|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
130924857|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
130924858|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
130924859|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
130924860|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
130924861|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
130924862|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
130924863|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
130924864|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
130924865|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
130924866|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
130924867|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
130924868|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
130924869|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
130924870|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
130924871|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
130924872|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
131120233|NCT00467779|472072314|FG003|Stage 2A|Adverse Event|0|||
130924873|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
130924874|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
130924875|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Change of location|0|||
130924876|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Change of location|0|||
130924877|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Change of location|0|||
130924878|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Change of location|1|||
130924879|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Change of location|0|||
130924880|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
130924881|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
130924882|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
130924883|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
130924884|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
130924885|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
130924886|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
130924887|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
130924888|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
130924889|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
130924890|NCT00730405|471360310|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
130924891|NCT00730405|471360311|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
130924892|NCT00730405|471360312|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
130924893|NCT00730405|471360313|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
130924894|NCT00730405|471360314|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
130924895|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
130924896|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
130924897|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
130924898|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
130924899|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
130924900|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
130924901|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
130924902|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
130924903|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
130924904|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
130924905|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
130924906|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
130924907|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
130924908|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
130924909|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
130924910|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Death|0|||
130924911|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Death|1|||
130924912|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Death|0|||
130924913|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Death|1|||
130924914|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Death|0|||
130924915|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Change of location|1|||
130924916|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Change of location|1|||
130924917|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Change of location|0|||
130924918|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Change of location|1|||
130924919|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Change of location|0|||
130924920|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
130924921|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
130924922|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
130924923|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
130924924|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
130924925|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
130924926|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
130924927|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
130924928|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
130924929|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
130924930|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
130924931|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
130769748|NCT02815267|470782538|FG000|Double-Blind Phase|Lost to Follow-up|17|||
130924932|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
130924933|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
130924934|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
130924935|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
130924936|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
131223388|NCT02094937|472445090|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
130924937|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
130924938|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
130924939|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
130924940|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
130924941|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
130924942|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
130924943|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
130924944|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
130924945|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
130924946|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
130924947|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
130924948|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
130924949|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
130924950|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
130924951|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
130924952|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
130924953|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
130924954|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
130924955|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
130924956|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
130924957|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
130924958|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
130924959|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
130924960|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
130924961|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
130924962|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
130924963|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
130924964|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
130924965|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
130924966|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
130924967|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
130924968|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
130924969|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
130924970|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Missing|0|||
130924971|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Missing|0|||
130924972|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Missing|2|||
130924973|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Missing|0|||
130924974|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Missing|0|||
130924975|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
130924976|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
130924977|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
130924978|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
130924979|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
130924980|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
130924981|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
130924982|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
130924983|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
130924984|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
130924985|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
130924986|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
130924987|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
130924988|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
130924989|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
130924990|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
131034477|NCT04338061|471759204|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
131034478|NCT04338061|471759205|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
131034479|NCT04338061|471759204|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
131034480|NCT04338061|471759205|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
131034481|NCT04338061|471759204|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
131034482|NCT04338061|471759205|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
131034483|NCT04338061|471759204|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
131120234|NCT00467779|472072315|FG004|Stage 2A|Adverse Event|0|||
131120235|NCT00467779|472072316|FG005|Stage 2A|Adverse Event|0|||
131120236|NCT00467779|472072317|FG006|Stage 2A|Adverse Event|0|||
130924991|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
130924992|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
130924993|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
130924994|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
130924995|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
130924996|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
130924997|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
130924998|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
130924999|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
130925000|NCT00730405|471360310|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
130925001|NCT00730405|471360311|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
130925002|NCT00730405|471360312|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
130925003|NCT00730405|471360313|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
130925004|NCT00730405|471360314|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
130925005|NCT03851705|471360315|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
130925006|NCT03851705|471360316|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
130925007|NCT03851705|471360317|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
130925008|NCT03851705|471360318|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
130925009|NCT03851705|471360315|FG000|Part 1: Double-Blind Period|Other reason|1|||
130925010|NCT03851705|471360316|FG001|Part 1: Double-Blind Period|Other reason|0|||
130925011|NCT03851705|471360317|FG002|Part 1: Double-Blind Period|Other reason|0|||
130925012|NCT03851705|471360318|FG003|Part 1: Double-Blind Period|Other reason|0|||
130925013|NCT03851705|471360315|FG000|Part 2: Open-Label Period|Other reason|0|||
130925014|NCT03851705|471360316|FG001|Part 2: Open-Label Period|Other reason|0|||
130925015|NCT03851705|471360317|FG002|Part 2: Open-Label Period|Other reason|0|||
130925016|NCT03851705|471360318|FG003|Part 2: Open-Label Period|Other reason|1|||
130925017|NCT03851705|471360315|FG000|Part 2: Open-Label Period|Death|0|||
130925018|NCT03851705|471360316|FG001|Part 2: Open-Label Period|Death|0|||
130925019|NCT03851705|471360317|FG002|Part 2: Open-Label Period|Death|3|||
130925020|NCT03851705|471360318|FG003|Part 2: Open-Label Period|Death|0|||
130925021|NCT03851705|471360315|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
130925022|NCT03851705|471360316|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
130925023|NCT03851705|471360317|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
130925024|NCT03851705|471360318|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
130925025|NCT01496807|471360322|FG000|Overall Study|Progressive Disease|21|||
130925026|NCT01496807|471360322|FG000|Overall Study|Participant preference/toxicity|8|||
130925027|NCT01496807|471360322|FG000|Overall Study|Change in diagnosis|1|||
130925028|NCT02591290|471360329|FG000|Overall Study|Withdrawal by Subject|2|||
130925029|NCT01306942|471360330|FG000|Phase I|Adverse Event|2|||
130925030|NCT01306942|471360331|FG001|Phase I|Adverse Event|2|||
130925031|NCT01306942|471360332|FG002|Phase I|Adverse Event|0|||
130925032|NCT01306942|471360333|FG003|Phase I|Adverse Event|0|||
130925033|NCT01306942|471360330|FG000|Phase I|Physician Decision|3|||
130925034|NCT01306942|471360331|FG001|Phase I|Physician Decision|1|||
130925035|NCT01306942|471360332|FG002|Phase I|Physician Decision|0|||
130925036|NCT01306942|471360333|FG003|Phase I|Physician Decision|0|||
130925037|NCT01306942|471360330|FG000|Phase II|Adverse Event|0|||
130925038|NCT01306942|471360331|FG001|Phase II|Adverse Event|0|||
130925039|NCT01306942|471360332|FG002|Phase II|Adverse Event|0|||
130925040|NCT01306942|471360333|FG003|Phase II|Adverse Event|6|||
130925041|NCT01306942|471360330|FG000|Phase II|Physician Decision|2|||
130925042|NCT01306942|471360331|FG001|Phase II|Physician Decision|0|||
130925043|NCT01306942|471360332|FG002|Phase II|Physician Decision|0|||
130925044|NCT01306942|471360333|FG003|Phase II|Physician Decision|5|||
130925045|NCT01306942|471360330|FG000|Phase II|Withdrawal by Subject|0|||
130925046|NCT01306942|471360331|FG001|Phase II|Withdrawal by Subject|0|||
130925047|NCT01306942|471360332|FG002|Phase II|Withdrawal by Subject|0|||
130925048|NCT01306942|471360333|FG003|Phase II|Withdrawal by Subject|2|||
130925049|NCT01306942|471360330|FG000|Phase II|Death|0|||
130925050|NCT01306942|471360331|FG001|Phase II|Death|0|||
130700975|NCT00152516|470528361|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
130700976|NCT00152516|470528361|FG000|Overall Study|Other: Moved Out Of State|1|||
130700977|NCT00152516|470528361|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
130700978|NCT00152516|470528361|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
130700979|NCT00360490|470528362|FG000|Overall Study|Adverse Event|4|||
130700980|NCT00360490|470528363|FG001|Overall Study|Adverse Event|2|||
130700981|NCT00360490|470528362|FG000|Overall Study|Lost to Follow-up|2|||
130925051|NCT01306942|471360332|FG002|Phase II|Death|0|||
130925052|NCT01306942|471360333|FG003|Phase II|Death|1|||
130925053|NCT01306942|471360330|FG000|Phase II|Not finished treatment|0|||
130925054|NCT01306942|471360331|FG001|Phase II|Not finished treatment|0|||
130925055|NCT01306942|471360332|FG002|Phase II|Not finished treatment|0|||
130925056|NCT01306942|471360333|FG003|Phase II|Not finished treatment|1|||
130925057|NCT01306942|471360330|FG000|Phase II|Protocol Violation|0|||
130925058|NCT01306942|471360331|FG001|Phase II|Protocol Violation|0|||
130925059|NCT01306942|471360332|FG002|Phase II|Protocol Violation|0|||
130925060|NCT01306942|471360333|FG003|Phase II|Protocol Violation|1|||
130925061|NCT01390649|471360334|FG000|Overall Study|Physician Decision|1|||
130925062|NCT04528732|471360337|FG000|Overall Study|Death|1|||
130925063|NCT04528732|471360338|FG001|Overall Study|Death|0|||
130925064|NCT04528732|471360339|FG002|Overall Study|Death|1|||
130925065|NCT04528732|471360337|FG000|Overall Study|Lost to Follow-up|0|||
130925066|NCT04528732|471360338|FG001|Overall Study|Lost to Follow-up|1|||
130925067|NCT04528732|471360339|FG002|Overall Study|Lost to Follow-up|2|||
130925068|NCT05399641|471360340|FG000|Overall Study|Adverse Event|0|||
130925069|NCT05399641|471360341|FG001|Overall Study|Adverse Event|1|||
130925070|NCT05399641|471360342|FG002|Overall Study|Adverse Event|1|||
130925071|NCT05399641|471360340|FG000|Overall Study|Lost to Follow-up|1|||
130925072|NCT05399641|471360341|FG001|Overall Study|Lost to Follow-up|2|||
130925073|NCT05399641|471360342|FG002|Overall Study|Lost to Follow-up|2|||
130925074|NCT05399641|471360340|FG000|Overall Study|Physician Decision|1|||
130925075|NCT05399641|471360341|FG001|Overall Study|Physician Decision|3|||
130925076|NCT05399641|471360342|FG002|Overall Study|Physician Decision|3|||
130925077|NCT05399641|471360340|FG000|Overall Study|Withdrawal by Subject|4|||
130925078|NCT05399641|471360341|FG001|Overall Study|Withdrawal by Subject|11|||
130925079|NCT05399641|471360342|FG002|Overall Study|Withdrawal by Subject|7|||
130925080|NCT05399641|471360340|FG000|Overall Study|Reason not defined|3|||
130925081|NCT05399641|471360341|FG001|Overall Study|Reason not defined|5|||
130925082|NCT05399641|471360342|FG002|Overall Study|Reason not defined|6|||
130925083|NCT03408483|471360343|FG000|Overall Study|Physician Decision|3|||
130925084|NCT03408483|471360344|FG001|Overall Study|Physician Decision|3|||
130925085|NCT03408483|471360343|FG000|Overall Study|Lost to Follow-up|3|||
130925086|NCT03408483|471360344|FG001|Overall Study|Lost to Follow-up|0|||
130925087|NCT01300650|471360345|FG000|Overall Study|Adverse Event|1|||
130925088|NCT00674362|471360346|FG000|Double Blind|Adverse Event|6|||
130925089|NCT00674362|471360347|FG001|Double Blind|Adverse Event|6|||
130925090|NCT00674362|471360346|FG000|Double Blind|Lack of Efficacy|2|||
130925091|NCT00674362|471360347|FG001|Double Blind|Lack of Efficacy|6|||
130925092|NCT00674362|471360346|FG000|Double Blind|Loss of efficacy|0|||
130925093|NCT00674362|471360347|FG001|Double Blind|Loss of efficacy|1|||
130925094|NCT00674362|471360346|FG000|Double Blind|Withdrawal by Subject|4|||
130925095|NCT00674362|471360347|FG001|Double Blind|Withdrawal by Subject|3|||
130925096|NCT00674362|471360346|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
130925097|NCT00674362|471360347|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
130925098|NCT00674362|471360346|FG000|Double Blind|Other: Surgery|0|||
130925099|NCT00674362|471360347|FG001|Double Blind|Other: Surgery|1|||
130925100|NCT00674362|471360346|FG000|Open Label|Adverse Event|1|||
130925101|NCT00674362|471360347|FG001|Open Label|Adverse Event|0|||
130925102|NCT00674362|471360346|FG000|Open Label|Other: Subject moved to extension study|1|||
130925103|NCT00674362|471360347|FG001|Open Label|Other: Subject moved to extension study|0|||
130925104|NCT00923156|471360348|FG000|Overall Study|Adverse Event|0|||
130925105|NCT00923156|471360349|FG001|Overall Study|Adverse Event|2|||
130925106|NCT00923156|471360350|FG002|Overall Study|Adverse Event|1|||
130925107|NCT00923156|471360348|FG000|Overall Study|Abnormal laboratory values|0|||
130925108|NCT00923156|471360349|FG001|Overall Study|Abnormal laboratory values|0|||
130925109|NCT00923156|471360350|FG002|Overall Study|Abnormal laboratory values|1|||
130925110|NCT00923156|471360348|FG000|Overall Study|Withdrawal by Subject|0|||
130925111|NCT00923156|471360349|FG001|Overall Study|Withdrawal by Subject|1|||
130925112|NCT00923156|471360350|FG002|Overall Study|Withdrawal by Subject|0|||
130925113|NCT00923156|471360348|FG000|Overall Study|Death|0|||
130925114|NCT00923156|471360349|FG001|Overall Study|Death|1|||
130925115|NCT00923156|471360350|FG002|Overall Study|Death|0|||
130925116|NCT00923156|471360348|FG000|Overall Study|Lack of Efficacy|0|||
130925117|NCT00923156|471360349|FG001|Overall Study|Lack of Efficacy|0|||
130925118|NCT00923156|471360350|FG002|Overall Study|Lack of Efficacy|1|||
130925119|NCT04066023|471360351|FG000|Overall Study|Adverse Event|0|||
130925120|NCT04066023|471360352|FG001|Overall Study|Adverse Event|0|||
130925121|NCT04066023|471360353|FG002|Overall Study|Adverse Event|1|||
130925122|NCT04066023|471360351|FG000|Overall Study|Sponsor decision|3|||
130925123|NCT04066023|471360352|FG001|Overall Study|Sponsor decision|6|||
130925124|NCT04066023|471360353|FG002|Overall Study|Sponsor decision|2|||
130925125|NCT04066023|471360351|FG000|Overall Study|Physician Decision|0|||
130925126|NCT04066023|471360352|FG001|Overall Study|Physician Decision|0|||
130925127|NCT04066023|471360353|FG002|Overall Study|Physician Decision|1|||
130925128|NCT04066023|471360351|FG000|Overall Study|Lost to Follow-up|0|||
130925129|NCT04066023|471360352|FG001|Overall Study|Lost to Follow-up|1|||
130925130|NCT04066023|471360353|FG002|Overall Study|Lost to Follow-up|1|||
130925131|NCT04066023|471360351|FG000|Overall Study|Noncompliance|0|||
130925132|NCT04066023|471360352|FG001|Overall Study|Noncompliance|1|||
130925133|NCT04066023|471360353|FG002|Overall Study|Noncompliance|1|||
130925134|NCT03386448|471360354|FG000|Overall Study|Adverse Event|0|||
130925135|NCT03386448|471360355|FG001|Overall Study|Adverse Event|2|||
130925136|NCT03583697|471360356|FG000|Overall Study|Withdrawal by Subject|0|||
130925137|NCT03583697|471360357|FG001|Overall Study|Withdrawal by Subject|0|||
130925138|NCT03583697|471360358|FG002|Overall Study|Withdrawal by Subject|1|||
130925139|NCT03583697|471360356|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
130925140|NCT03583697|471360357|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
130925141|NCT03583697|471360358|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
130925142|NCT00114530|471360359|FG000|Overall Study|Death|3|||
130925143|NCT00114530|471360360|FG001|Overall Study|Death|11|||
130925144|NCT00114530|471360359|FG000|Overall Study|Lost to Follow-up|1|||
130925145|NCT00114530|471360360|FG001|Overall Study|Lost to Follow-up|1|||
130925146|NCT00114530|471360359|FG000|Overall Study|Physician Decision|1|||
130925147|NCT00114530|471360360|FG001|Overall Study|Physician Decision|1|||
130925148|NCT00114530|471360359|FG000|Overall Study|Withdrawal by Subject|2|||
130925149|NCT00114530|471360360|FG001|Overall Study|Withdrawal by Subject|6|||
130925150|NCT00114530|471360359|FG000|Overall Study|Breast Cancer|1|||
130925151|NCT00114530|471360360|FG001|Overall Study|Breast Cancer|0|||
130925152|NCT00114530|471360359|FG000|Overall Study|Subject decision after endpoint failure|0|||
131223389|NCT02094937|472445091|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
131223390|NCT02094937|472445092|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
131223391|NCT02094937|472445089|FG000|12 Weeks in Period 2|Adverse Event|0|||
131223392|NCT02094937|472445090|FG001|12 Weeks in Period 2|Adverse Event|2|||
130925153|NCT00114530|471360360|FG001|Overall Study|Subject decision after endpoint failure|1|||
130925154|NCT00114530|471360359|FG000|Overall Study|Ineligible|1|||
130925155|NCT00114530|471360360|FG001|Overall Study|Ineligible|0|||
130925156|NCT02538029|471360361|FG000|Overall Study|unable to complete cognitive assessments|1|||
130925157|NCT02538029|471360362|FG001|Overall Study|unable to complete cognitive assessments|0|||
130925158|NCT02538029|471360363|FG002|Overall Study|unable to complete cognitive assessments|1|||
130925159|NCT01064310|471360364|FG000|Period 1|Adverse Event|7|||
130925160|NCT01064310|471360365|FG001|Period 1|Adverse Event|10|||
130925161|NCT01064310|471360366|FG002|Period 1|Adverse Event|0|||
130925162|NCT01064310|471360364|FG000|Period 1|Physician Decision|1|||
130925163|NCT01064310|471360365|FG001|Period 1|Physician Decision|0|||
130925164|NCT01064310|471360366|FG002|Period 1|Physician Decision|0|||
130925165|NCT01064310|471360364|FG000|Period 1|Withdrawal by Subject|2|||
130925166|NCT01064310|471360365|FG001|Period 1|Withdrawal by Subject|2|||
130925167|NCT01064310|471360366|FG002|Period 1|Withdrawal by Subject|0|||
130925168|NCT01064310|471360364|FG000|Period 1|Lack of Efficacy|3|||
130925169|NCT01064310|471360365|FG001|Period 1|Lack of Efficacy|5|||
130925170|NCT01064310|471360366|FG002|Period 1|Lack of Efficacy|0|||
130925171|NCT01064310|471360364|FG000|Period 1|Entered Open-label Period|1|||
130925172|NCT01064310|471360365|FG001|Period 1|Entered Open-label Period|1|||
130925173|NCT01064310|471360366|FG002|Period 1|Entered Open-label Period|0|||
130925174|NCT01064310|471360364|FG000|Period 2|Adverse Event|2|||
130925175|NCT01064310|471360365|FG001|Period 2|Adverse Event|1|||
130925176|NCT01064310|471360366|FG002|Period 2|Adverse Event|0|||
130925177|NCT01064310|471360364|FG000|Period 2|Physician Decision|0|||
130925178|NCT01064310|471360365|FG001|Period 2|Physician Decision|1|||
130925179|NCT01064310|471360366|FG002|Period 2|Physician Decision|0|||
130925180|NCT01064310|471360364|FG000|Period 2|Entered Open-label Period|1|||
130925181|NCT01064310|471360365|FG001|Period 2|Entered Open-label Period|0|||
130925182|NCT01064310|471360366|FG002|Period 2|Entered Open-label Period|0|||
130925183|NCT01064310|471360364|FG000|Period 2|Lack of Efficacy|1|||
130925184|NCT01064310|471360365|FG001|Period 2|Lack of Efficacy|4|||
130925185|NCT01064310|471360366|FG002|Period 2|Lack of Efficacy|0|||
130925186|NCT01064310|471360364|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
130925187|NCT01064310|471360365|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
130925188|NCT01064310|471360366|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
130925189|NCT01064310|471360364|FG000|Open Label Pazopinib|Adverse Event|0|||
130925190|NCT01064310|471360365|FG001|Open Label Pazopinib|Adverse Event|0|||
130925191|NCT01064310|471360366|FG002|Open Label Pazopinib|Adverse Event|12|||
130925192|NCT01064310|471360364|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
130925193|NCT01064310|471360365|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
130925194|NCT01064310|471360366|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
131223393|NCT02094937|472445091|FG002|12 Weeks in Period 2|Adverse Event|4|||
131223394|NCT02094937|472445092|FG003|12 Weeks in Period 2|Adverse Event|1|||
131223395|NCT02094937|472445089|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
131223396|NCT02094937|472445090|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
131223397|NCT02094937|472445091|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
131223398|NCT02094937|472445092|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
131223399|NCT02094937|472445089|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
130925195|NCT01064310|471360364|FG000|Open Label Pazopinib|Physician Decision|0|||
130925196|NCT01064310|471360365|FG001|Open Label Pazopinib|Physician Decision|0|||
130925197|NCT01064310|471360366|FG002|Open Label Pazopinib|Physician Decision|20|||
130925198|NCT00679432|471360367|FG000|Overall Study|Adverse Event|5|||
130925199|NCT00679432|471360368|FG001|Overall Study|Adverse Event|6|||
130925200|NCT00679432|471360369|FG002|Overall Study|Adverse Event|10|||
130925201|NCT00679432|471360370|FG003|Overall Study|Adverse Event|7|||
130925202|NCT00679432|471360367|FG000|Overall Study|Protocol Violation|1|||
130925203|NCT00679432|471360368|FG001|Overall Study|Protocol Violation|1|||
130925204|NCT00679432|471360369|FG002|Overall Study|Protocol Violation|2|||
130925205|NCT00679432|471360370|FG003|Overall Study|Protocol Violation|1|||
130925206|NCT00679432|471360367|FG000|Overall Study|Withdrawal by Subject|8|||
130925207|NCT00679432|471360368|FG001|Overall Study|Withdrawal by Subject|11|||
130925208|NCT00679432|471360369|FG002|Overall Study|Withdrawal by Subject|10|||
130925209|NCT00679432|471360370|FG003|Overall Study|Withdrawal by Subject|9|||
130925210|NCT00679432|471360367|FG000|Overall Study|Lost to Follow-up|1|||
130925211|NCT00679432|471360368|FG001|Overall Study|Lost to Follow-up|5|||
130925212|NCT00679432|471360369|FG002|Overall Study|Lost to Follow-up|4|||
130925213|NCT00679432|471360370|FG003|Overall Study|Lost to Follow-up|2|||
130925214|NCT00679432|471360367|FG000|Overall Study|Physician Decision|3|||
130925215|NCT00679432|471360368|FG001|Overall Study|Physician Decision|2|||
130925216|NCT00679432|471360369|FG002|Overall Study|Physician Decision|2|||
130925217|NCT00679432|471360370|FG003|Overall Study|Physician Decision|2|||
130925218|NCT00679432|471360367|FG000|Overall Study|Sponsor decision|1|||
130925219|NCT00679432|471360368|FG001|Overall Study|Sponsor decision|0|||
130925220|NCT00679432|471360369|FG002|Overall Study|Sponsor decision|0|||
130925221|NCT00679432|471360370|FG003|Overall Study|Sponsor decision|0|||
130925222|NCT00679432|471360367|FG000|Overall Study|Lack of Efficacy|13|||
130925223|NCT00679432|471360368|FG001|Overall Study|Lack of Efficacy|9|||
130700982|NCT00360490|470528363|FG001|Overall Study|Lost to Follow-up|1|||
130700983|NCT00360490|470528362|FG000|Overall Study|Physician Decision|2|||
130700984|NCT00360490|470528363|FG001|Overall Study|Physician Decision|1|||
130700985|NCT00360490|470528362|FG000|Overall Study|Protocol Violation|0|||
130700986|NCT00360490|470528363|FG001|Overall Study|Protocol Violation|4|||
130925224|NCT00679432|471360369|FG002|Overall Study|Lack of Efficacy|14|||
130925225|NCT00679432|471360370|FG003|Overall Study|Lack of Efficacy|8|||
130925226|NCT00679432|471360367|FG000|Overall Study|Infectious colitis, normal histology|5|||
130700987|NCT00360490|470528362|FG000|Overall Study|Withdrawal by Subject|1|||
130700988|NCT00360490|470528363|FG001|Overall Study|Withdrawal by Subject|3|||
130700989|NCT01517867|470528364|FG000|Overall Study|never started treatment|29|||
130700990|NCT01517867|470528365|FG001|Overall Study|never started treatment|32|||
130700991|NCT01517867|470528364|FG000|Overall Study|Withdrawal by Subject|34|||
130700992|NCT01517867|470528365|FG001|Overall Study|Withdrawal by Subject|30|||
130700993|NCT01517867|470528364|FG000|Overall Study|Still in treatment at study end|0|||
130700994|NCT01517867|470528365|FG001|Overall Study|Still in treatment at study end|3|||
130700995|NCT01266603|470528367|FG000|Overall Study|Adverse Event|1|||
130700996|NCT01266603|470528367|FG000|Overall Study|Lack of Efficacy|14|||
130700997|NCT01266603|470528367|FG000|Overall Study|Withdrawal by Subject|1|||
130700998|NCT01266603|470528367|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
130700999|NCT02466386|470528368|FG000|Overall Study|Adverse Event|5|||
130701000|NCT02466386|470528368|FG000|Overall Study|Protocol Violation|2|||
130701001|NCT02466386|470528368|FG000|Overall Study|Withdrawal by Subject|14|||
130701002|NCT02466386|470528368|FG000|Overall Study|Lost to Follow-up|5|||
130701003|NCT02466386|470528368|FG000|Overall Study|Lack of Efficacy|8|||
130701004|NCT02466386|470528368|FG000|Overall Study|Other|10|||
130701005|NCT03919695|470528369|FG000|3-month Follow-up|Death|1|||
130701006|NCT03919695|470528370|FG001|3-month Follow-up|Death|1|||
130701007|NCT03919695|470528369|FG000|3-month Follow-up|unable to contact|0|||
130701008|NCT03919695|470528370|FG001|3-month Follow-up|unable to contact|3|||
130701009|NCT03919695|470528369|FG000|3-month Follow-up|in prison|0|||
130701010|NCT03919695|470528370|FG001|3-month Follow-up|in prison|1|||
130701011|NCT03919695|470528369|FG000|6-month Follow-up|Death|0|||
130701012|NCT03919695|470528370|FG001|6-month Follow-up|Death|1|||
130701013|NCT03919695|470528369|FG000|6-month Follow-up|Lost to Follow-up|1|||
130701014|NCT03919695|470528370|FG001|6-month Follow-up|Lost to Follow-up|2|||
130701015|NCT03919695|470528369|FG000|6-month Follow-up|in prison|0|||
130701016|NCT03919695|470528370|FG001|6-month Follow-up|in prison|2|||
130701017|NCT03919695|470528369|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
130701018|NCT03919695|470528370|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
130701019|NCT03919695|470528369|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
130701020|NCT03919695|470528370|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
130701021|NCT01688882|470528371|FG000|Overall Study|Adverse Event|1|||
130701022|NCT01688882|470528372|FG001|Overall Study|Adverse Event|0|||
130701023|NCT01688882|470528371|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130701024|NCT01688882|470528372|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130925227|NCT00679432|471360368|FG001|Overall Study|Infectious colitis, normal histology|4|||
130701025|NCT01688882|470528371|FG000|Overall Study|Administrative problems|1|||
130701026|NCT01688882|470528372|FG001|Overall Study|Administrative problems|0|||
130701027|NCT02387762|470528374|FG000|Overall Study|Withdrawal by Subject|1|||
130701028|NCT02387762|470528375|FG001|Overall Study|Withdrawal by Subject|0|||
130701029|NCT00642811|470528386|FG000|Overall Study|Adverse Event|2|||
130701030|NCT00642811|470528387|FG001|Overall Study|Adverse Event|3|||
130701031|NCT00642811|470528388|FG002|Overall Study|Adverse Event|0|||
130925228|NCT00679432|471360369|FG002|Overall Study|Infectious colitis, normal histology|8|||
130925229|NCT00679432|471360370|FG003|Overall Study|Infectious colitis, normal histology|3|||
130925230|NCT00679432|471360367|FG000|Overall Study|Randomization error, return to prior Rx|0|||
130925231|NCT00679432|471360368|FG001|Overall Study|Randomization error, return to prior Rx|0|||
131223400|NCT02094937|472445090|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
131223401|NCT02094937|472445091|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
131223402|NCT02094937|472445092|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
131223403|NCT02094937|472445089|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
131223404|NCT02094937|472445090|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
131223405|NCT02094937|472445091|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
131223406|NCT02094937|472445092|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
131223407|NCT02094937|472445089|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
131223408|NCT02094937|472445090|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
131223409|NCT02094937|472445091|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
131223410|NCT02094937|472445092|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
131223411|NCT01133392|472445093|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
131223412|NCT01133392|472445094|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
130769749|NCT02815267|470782539|FG001|Double-Blind Phase|Lost to Follow-up|9|||
130769750|NCT02815267|470782538|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
130769751|NCT02815267|470782539|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
130769752|NCT02815267|470782538|FG000|Double-Blind Phase|Protocol Violation|3|||
130925232|NCT00679432|471360369|FG002|Overall Study|Randomization error, return to prior Rx|3|||
130925233|NCT00679432|471360370|FG003|Overall Study|Randomization error, return to prior Rx|0|||
130925234|NCT02339584|471360371|FG000|Overall Study|Adverse Event|11|||
130925235|NCT02339584|471360372|FG001|Overall Study|Adverse Event|7|||
130925236|NCT02339584|471360371|FG000|Overall Study|Lack of Efficacy|0|||
130925237|NCT02339584|471360372|FG001|Overall Study|Lack of Efficacy|1|||
130925238|NCT02339584|471360371|FG000|Overall Study|Physician Decision|1|||
130925239|NCT02339584|471360372|FG001|Overall Study|Physician Decision|2|||
130925240|NCT02339584|471360371|FG000|Overall Study|Protocol Violation|1|||
130925241|NCT02339584|471360372|FG001|Overall Study|Protocol Violation|1|||
130925242|NCT02339584|471360371|FG000|Overall Study|Withdrawal by Subject|2|||
130925243|NCT02339584|471360372|FG001|Overall Study|Withdrawal by Subject|4|||
130925244|NCT04731363|471360373|FG000|Overall Study|Could not obtain samples|0|||
130925245|NCT04731363|471360374|FG001|Overall Study|Could not obtain samples|1|||
130925246|NCT04731363|471360375|FG002|Overall Study|Could not obtain samples|0|||
130925247|NCT04731363|471360376|FG003|Overall Study|Could not obtain samples|0|||
130925248|NCT04731363|471360373|FG000|Overall Study|Physician Decision|0|||
130925249|NCT04731363|471360374|FG001|Overall Study|Physician Decision|1|||
130925250|NCT04731363|471360375|FG002|Overall Study|Physician Decision|0|||
130925251|NCT04731363|471360376|FG003|Overall Study|Physician Decision|0|||
130925252|NCT02200211|471362069|FG000|Overall Study|Lost to Follow-up|7|||
130925253|NCT02200211|471362070|FG001|Overall Study|Lost to Follow-up|7|||
130925254|NCT02200211|471362071|FG002|Overall Study|Lost to Follow-up|1|||
130925255|NCT02200211|471362072|FG003|Overall Study|Lost to Follow-up|2|||
130925256|NCT02200211|471362069|FG000|Overall Study|Withdrawal by Subject|1|||
130925257|NCT02200211|471362070|FG001|Overall Study|Withdrawal by Subject|0|||
130925258|NCT02200211|471362071|FG002|Overall Study|Withdrawal by Subject|0|||
130925259|NCT02200211|471362072|FG003|Overall Study|Withdrawal by Subject|0|||
130925260|NCT00381485|471362073|FG000|Open-Label Run-In Period|Adverse Event|9|||
130925261|NCT00381485|471362074|FG001|Open-Label Run-In Period|Adverse Event|0|||
130925262|NCT00381485|471362075|FG002|Open-Label Run-In Period|Adverse Event|0|||
130925263|NCT00381485|471362076|FG003|Open-Label Run-In Period|Adverse Event|0|||
130925264|NCT00381485|471362073|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
130925265|NCT00381485|471362074|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
130925266|NCT00381485|471362075|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
130925267|NCT00381485|471362076|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
130925268|NCT00381485|471362073|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
130925269|NCT00381485|471362074|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
130925270|NCT00381485|471362075|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
130925271|NCT00381485|471362076|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
130925272|NCT00381485|471362073|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
130925273|NCT00381485|471362074|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
130925274|NCT00381485|471362075|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
130925275|NCT00381485|471362076|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
130925276|NCT00381485|471362073|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
130925277|NCT00381485|471362074|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
130925278|NCT00381485|471362075|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
130925279|NCT00381485|471362076|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
130925280|NCT00381485|471362073|FG000|Open-Label Run-In Period|Treatment failure|1|||
130925281|NCT00381485|471362074|FG001|Open-Label Run-In Period|Treatment failure|0|||
130925282|NCT00381485|471362075|FG002|Open-Label Run-In Period|Treatment failure|0|||
130925283|NCT00381485|471362076|FG003|Open-Label Run-In Period|Treatment failure|0|||
130925284|NCT00381485|471362073|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130925285|NCT00381485|471362074|FG001|Double-Blind Treatment Period|Adverse Event|2|||
130925286|NCT00381485|471362075|FG002|Double-Blind Treatment Period|Adverse Event|2|||
130925287|NCT00381485|471362076|FG003|Double-Blind Treatment Period|Adverse Event|5|||
130925288|NCT00381485|471362073|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130925289|NCT00381485|471362074|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
130925290|NCT00381485|471362075|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
130925291|NCT00381485|471362076|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
130925292|NCT00381485|471362073|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130769753|NCT02815267|470782539|FG001|Double-Blind Phase|Protocol Violation|2|||
130769754|NCT02815267|470782538|FG000|Double-Blind Phase|Site withdrawal|1|||
130769755|NCT02815267|470782539|FG001|Double-Blind Phase|Site withdrawal|6|||
130769756|NCT02815267|470782538|FG000|Double-Blind Phase|Received a disallowed medication|1|||
130769757|NCT02815267|470782539|FG001|Double-Blind Phase|Received a disallowed medication|1|||
130769758|NCT02815267|470782538|FG000|Open-Label Phase|Adverse Event|1|||
130769759|NCT02815267|470782539|FG001|Open-Label Phase|Adverse Event|1|||
130769760|NCT02815267|470782538|FG000|Open-Label Phase|Lost to Follow-up|23|||
130769761|NCT02815267|470782539|FG001|Open-Label Phase|Lost to Follow-up|9|||
130925293|NCT00381485|471362074|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
130925294|NCT00381485|471362075|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
130925295|NCT00381485|471362076|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
130925296|NCT00381485|471362073|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
130925297|NCT00381485|471362074|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
130925298|NCT00381485|471362075|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
130925299|NCT00381485|471362076|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
130925300|NCT00381485|471362073|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
130925301|NCT00381485|471362074|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
130925302|NCT00381485|471362075|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
130925303|NCT00381485|471362076|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
130925304|NCT00381485|471362073|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
130925305|NCT00381485|471362074|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
130925306|NCT00381485|471362075|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
130925307|NCT00381485|471362076|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
130925308|NCT00381485|471362073|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
130925309|NCT00381485|471362074|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
130925310|NCT00381485|471362075|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
130925311|NCT00381485|471362076|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
130925312|NCT00381485|471362073|FG000|Double-Blind Treatment Period|Administrative|0|||
130925313|NCT00381485|471362074|FG001|Double-Blind Treatment Period|Administrative|1|||
130925314|NCT00381485|471362075|FG002|Double-Blind Treatment Period|Administrative|0|||
130925315|NCT00381485|471362076|FG003|Double-Blind Treatment Period|Administrative|1|||
130925316|NCT01235351|471362077|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
130925317|NCT01235351|471362078|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
130925318|NCT00126191|471362081|FG000|Overall Study|Physician Decision|0|||
130925319|NCT00126191|471362082|FG001|Overall Study|Physician Decision|1|||
130925320|NCT00126191|471362081|FG000|Overall Study|Death|0|||
130925321|NCT00126191|471362082|FG001|Overall Study|Death|1|||
130925322|NCT01898806|471362083|FG000|Overall Study|Withdrawal by Subject|2|||
130925323|NCT01898806|471362083|FG000|Overall Study|Physician Decision|1|||
130925324|NCT00307294|471362096|FG000|Overall Study|Withdrawal by Subject|1|||
130925325|NCT00612690|471362097|FG000|Overall Study|Lost to Follow-up|72|||
130925326|NCT00612690|471362098|FG001|Overall Study|Lost to Follow-up|98|||
130925327|NCT00612690|471362097|FG000|Overall Study|Withdrawal by Subject|32|||
130925328|NCT00612690|471362098|FG001|Overall Study|Withdrawal by Subject|20|||
130925329|NCT00612690|471362097|FG000|Overall Study|Withdrawal by Site|11|||
130925330|NCT00612690|471362098|FG001|Overall Study|Withdrawal by Site|0|||
130925331|NCT02980601|471362100|FG000|Overall Study|Lost to Follow-up|2|||
130925332|NCT02980601|471362101|FG001|Overall Study|Lost to Follow-up|2|||
130925333|NCT02980601|471362100|FG000|Overall Study|Death|0|||
130925334|NCT02980601|471362101|FG001|Overall Study|Death|1|||
130925335|NCT02980601|471362100|FG000|Overall Study|Graft loss|1|||
130925336|NCT02980601|471362101|FG001|Overall Study|Graft loss|0|||
130925337|NCT02980601|471362100|FG000|Overall Study|Failed to sign consent|2|||
130925338|NCT02980601|471362101|FG001|Overall Study|Failed to sign consent|0|||
130925339|NCT01749137|471362102|FG000|Overall Study|Adverse Event|4|||
130925340|NCT01749137|471362103|FG001|Overall Study|Adverse Event|4|||
130925341|NCT01749137|471362102|FG000|Overall Study|Lost to Follow-up|2|||
130925342|NCT01749137|471362103|FG001|Overall Study|Lost to Follow-up|3|||
130925343|NCT01749137|471362102|FG000|Overall Study|Physician Decision|1|||
130769762|NCT02815267|470782538|FG000|Open-Label Phase|Withdrawal by Subject|24|||
130769763|NCT02815267|470782539|FG001|Open-Label Phase|Withdrawal by Subject|13|||
130925344|NCT01749137|471362103|FG001|Overall Study|Physician Decision|0|||
130925345|NCT01749137|471362102|FG000|Overall Study|Withdrawal by Subject|8|||
130925346|NCT01749137|471362103|FG001|Overall Study|Withdrawal by Subject|4|||
130925347|NCT02966028|471362111|FG000|Overall Study|Adverse Event|7|||
130925348|NCT02966028|471362112|FG001|Overall Study|Adverse Event|13|||
130925349|NCT02966028|471362113|FG002|Overall Study|Adverse Event|10|||
130925350|NCT02966028|471362111|FG000|Overall Study|Physician Decision|1|||
130925351|NCT02966028|471362112|FG001|Overall Study|Physician Decision|0|||
130925352|NCT02966028|471362113|FG002|Overall Study|Physician Decision|2|||
130925353|NCT02966028|471362111|FG000|Overall Study|Withdrawal by Subject|7|||
130925354|NCT02966028|471362112|FG001|Overall Study|Withdrawal by Subject|5|||
130925355|NCT02966028|471362113|FG002|Overall Study|Withdrawal by Subject|5|||
130925356|NCT02966028|471362111|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
130925357|NCT02966028|471362112|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
130925358|NCT02966028|471362113|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
130925359|NCT04115839|471362114|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
130925360|NCT04115839|471362115|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
130925361|NCT04115839|471362116|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
130925362|NCT04115839|471362117|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
130925363|NCT04115839|471362118|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
130925364|NCT04115839|471362119|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
130925365|NCT04115839|471362120|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
130925366|NCT04115839|471362114|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
130925367|NCT04115839|471362115|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
130925368|NCT04115839|471362116|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
130925369|NCT04115839|471362117|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
131223413|NCT01133392|472445093|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
131223414|NCT01133392|472445094|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
131223415|NCT05166421|472445105|FG000|Overall Study|Other|3|||
131223416|NCT05166421|472445106|FG001|Overall Study|Other|1|||
131223417|NCT05166421|472445107|FG002|Overall Study|Other|1|||
131223418|NCT05166421|472445105|FG000|Overall Study|Withdrawal by Subject|5|||
131223419|NCT05166421|472445106|FG001|Overall Study|Withdrawal by Subject|3|||
131223420|NCT05166421|472445107|FG002|Overall Study|Withdrawal by Subject|6|||
131223421|NCT05166421|472445105|FG000|Overall Study|Lost to Follow-up|4|||
131223422|NCT05166421|472445106|FG001|Overall Study|Lost to Follow-up|1|||
131223423|NCT05166421|472445107|FG002|Overall Study|Lost to Follow-up|7|||
131223424|NCT01246986|472446989|FG000|Overall Study|Lost to Follow-up|0|||
131223425|NCT01246986|472446990|FG001|Overall Study|Lost to Follow-up|1|||
131223426|NCT01246986|472446991|FG002|Overall Study|Lost to Follow-up|3|||
131223427|NCT01246986|472446992|FG003|Overall Study|Lost to Follow-up|0|||
131223428|NCT01246986|472446993|FG004|Overall Study|Lost to Follow-up|0|||
131223429|NCT01246986|472446994|FG005|Overall Study|Lost to Follow-up|1|||
131223430|NCT01246986|472446995|FG006|Overall Study|Lost to Follow-up|0|||
131223431|NCT01246986|472446989|FG000|Overall Study|Withdrawal by Subject|3|||
131223432|NCT01246986|472446990|FG001|Overall Study|Withdrawal by Subject|4|||
131223433|NCT01246986|472446991|FG002|Overall Study|Withdrawal by Subject|3|||
130701032|NCT00642811|470528389|FG003|Overall Study|Adverse Event|0|||
130701033|NCT00642811|470528390|FG004|Overall Study|Adverse Event|0|||
130701034|NCT00642811|470528391|FG005|Overall Study|Adverse Event|1|||
130701035|NCT00642811|470528386|FG000|Overall Study|Developement of discontinuation criteria|0|||
130701036|NCT00642811|470528387|FG001|Overall Study|Developement of discontinuation criteria|0|||
130701037|NCT00642811|470528388|FG002|Overall Study|Developement of discontinuation criteria|0|||
130701038|NCT00642811|470528389|FG003|Overall Study|Developement of discontinuation criteria|0|||
130701039|NCT00642811|470528390|FG004|Overall Study|Developement of discontinuation criteria|1|||
130701040|NCT00642811|470528391|FG005|Overall Study|Developement of discontinuation criteria|0|||
130701041|NCT00642811|470528386|FG000|Overall Study|Severe Non-compliance to protocol|1|||
130701042|NCT00642811|470528387|FG001|Overall Study|Severe Non-compliance to protocol|0|||
130701043|NCT00642811|470528388|FG002|Overall Study|Severe Non-compliance to protocol|0|||
130701044|NCT00642811|470528389|FG003|Overall Study|Severe Non-compliance to protocol|0|||
130701045|NCT00642811|470528390|FG004|Overall Study|Severe Non-compliance to protocol|0|||
130701046|NCT00642811|470528391|FG005|Overall Study|Severe Non-compliance to protocol|0|||
130701047|NCT00642811|470528386|FG000|Overall Study|Other|0|||
130701048|NCT00642811|470528387|FG001|Overall Study|Other|1|||
130701049|NCT00642811|470528388|FG002|Overall Study|Other|0|||
130701050|NCT00642811|470528389|FG003|Overall Study|Other|1|||
130701051|NCT00642811|470528390|FG004|Overall Study|Other|0|||
130701052|NCT00642811|470528391|FG005|Overall Study|Other|0|||
130701053|NCT01120691|470528392|FG000|Overall Study|Adverse Event|59|||
130701054|NCT01120691|470528393|FG001|Overall Study|Adverse Event|67|||
130925370|NCT04115839|471362118|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
131223434|NCT01246986|472446992|FG003|Overall Study|Withdrawal by Subject|0|||
131223435|NCT01246986|472446993|FG004|Overall Study|Withdrawal by Subject|4|||
131223436|NCT01246986|472446994|FG005|Overall Study|Withdrawal by Subject|0|||
131223437|NCT01246986|472446995|FG006|Overall Study|Withdrawal by Subject|0|||
131223438|NCT01335399|472446998|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
130701055|NCT01120691|470528394|FG002|Overall Study|Adverse Event|47|||
131034484|NCT04338061|471759205|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
131034485|NCT04338061|471759204|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
131034486|NCT04338061|471759205|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
131034487|NCT04338061|471759204|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
131034488|NCT04338061|471759205|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
131034489|NCT04338061|471759204|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
131034490|NCT04338061|471759205|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
131034491|NCT04338061|471759204|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
131034492|NCT04338061|471759205|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
131034493|NCT04338061|471759204|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
131034494|NCT04338061|471759205|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
131034495|NCT05030233|471759206|FG000|Overall Study|withdrawn for transfer|1|||
131034496|NCT05030233|471759207|FG001|Overall Study|withdrawn for transfer|0|||
131034497|NCT03365882|471759208|FG000|Randomization|Still Receiving Protocol Treatment|2|||
131034498|NCT03365882|471759209|FG001|Randomization|Still Receiving Protocol Treatment|0|||
131034499|NCT03365882|471759208|FG000|Randomization|Adverse Event|1|||
130701056|NCT01120691|470528392|FG000|Overall Study|Subject withdrew consent|33|||
130701057|NCT01120691|470528393|FG001|Overall Study|Subject withdrew consent|50|||
130701058|NCT01120691|470528394|FG002|Overall Study|Subject withdrew consent|44|||
130701059|NCT01120691|470528392|FG000|Overall Study|Death|21|||
130701060|NCT01120691|470528393|FG001|Overall Study|Death|22|||
130701061|NCT01120691|470528394|FG002|Overall Study|Death|24|||
130701062|NCT01120691|470528392|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
130701063|NCT01120691|470528393|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
130701064|NCT01120691|470528394|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
130701065|NCT01120691|470528392|FG000|Overall Study|Administrative problems|15|||
130701066|NCT01120691|470528393|FG001|Overall Study|Administrative problems|8|||
130701067|NCT01120691|470528394|FG002|Overall Study|Administrative problems|9|||
130701068|NCT01120691|470528392|FG000|Overall Study|Protocol deviation|13|||
130701069|NCT01120691|470528393|FG001|Overall Study|Protocol deviation|12|||
130701070|NCT01120691|470528394|FG002|Overall Study|Protocol deviation|12|||
130701071|NCT01120691|470528392|FG000|Overall Study|Lost to Follow-up|5|||
130701072|NCT01120691|470528393|FG001|Overall Study|Lost to Follow-up|6|||
130701073|NCT01120691|470528394|FG002|Overall Study|Lost to Follow-up|4|||
130701074|NCT01120691|470528392|FG000|Overall Study|Abnormal test procedure result(s)|3|||
130701075|NCT01120691|470528393|FG001|Overall Study|Abnormal test procedure result(s)|2|||
130701076|NCT01120691|470528394|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130701077|NCT01120691|470528392|FG000|Overall Study|Patient's inability to use the device|3|||
130701078|NCT01120691|470528393|FG001|Overall Study|Patient's inability to use the device|1|||
130701079|NCT01120691|470528394|FG002|Overall Study|Patient's inability to use the device|0|||
130701080|NCT01120691|470528392|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130701081|NCT01120691|470528393|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130701082|NCT01120691|470528394|FG002|Overall Study|Abnormal laboratory value(s)|4|||
130701083|NCT04553406|470528397|FG000|Overall Study|Study Discontinuation|0|||
130701084|NCT04553406|470528398|FG001|Overall Study|Study Discontinuation|1|||
130701085|NCT03370510|470528399|FG000|Overall Study|COVID-19|2|||
130701086|NCT03370510|470528400|FG001|Overall Study|COVID-19|0|||
130701087|NCT00772148|470528401|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
130701088|NCT00772148|470528402|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
130701089|NCT00772148|470528401|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
130701090|NCT00772148|470528402|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
130701091|NCT00772148|470528401|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
130701092|NCT00772148|470528402|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
130701093|NCT00772148|470528401|FG000|Maintenance Phase (Week 52)|Death|2|||
130701094|NCT00772148|470528402|FG001|Maintenance Phase (Week 52)|Death|2|||
130701095|NCT00772148|470528401|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
130701096|NCT00772148|470528402|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
130701097|NCT00772148|470528401|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
130701098|NCT00772148|470528402|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
130701099|NCT00772148|470528401|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
130701100|NCT00772148|470528402|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
130701101|NCT01525628|470528405|FG000|Overall Study|Adverse Event|1|||
130701102|NCT01525628|470528406|FG001|Overall Study|Adverse Event|1|||
130701103|NCT01525628|470528407|FG002|Overall Study|Adverse Event|2|||
131034500|NCT03365882|471759209|FG001|Randomization|Adverse Event|2|||
131034501|NCT03365882|471759208|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
130701104|NCT01525628|470528408|FG003|Overall Study|Adverse Event|0|||
130701105|NCT01525628|470528409|FG004|Overall Study|Adverse Event|1|||
130701106|NCT01525628|470528405|FG000|Overall Study|Lack of Efficacy|0|||
130701107|NCT01525628|470528406|FG001|Overall Study|Lack of Efficacy|2|||
130701108|NCT01525628|470528407|FG002|Overall Study|Lack of Efficacy|2|||
130701109|NCT01525628|470528408|FG003|Overall Study|Lack of Efficacy|1|||
130701110|NCT01525628|470528409|FG004|Overall Study|Lack of Efficacy|2|||
130925371|NCT04115839|471362119|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
130925372|NCT04115839|471362120|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
130925373|NCT04115839|471362114|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
130925374|NCT04115839|471362115|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130925375|NCT04115839|471362116|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130925376|NCT04115839|471362117|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130925377|NCT04115839|471362118|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130925378|NCT04115839|471362119|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130925379|NCT04115839|471362120|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
130925380|NCT04115839|471362114|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130701111|NCT01525628|470528405|FG000|Overall Study|Protocol Violation|0|||
130701112|NCT01525628|470528406|FG001|Overall Study|Protocol Violation|0|||
130701113|NCT01525628|470528407|FG002|Overall Study|Protocol Violation|1|||
130701114|NCT01525628|470528408|FG003|Overall Study|Protocol Violation|0|||
130701115|NCT01525628|470528409|FG004|Overall Study|Protocol Violation|0|||
130701116|NCT01525628|470528405|FG000|Overall Study|Lost to Follow-up|1|||
130701117|NCT01525628|470528406|FG001|Overall Study|Lost to Follow-up|1|||
130701118|NCT01525628|470528407|FG002|Overall Study|Lost to Follow-up|0|||
130701119|NCT01525628|470528408|FG003|Overall Study|Lost to Follow-up|0|||
130701120|NCT01525628|470528409|FG004|Overall Study|Lost to Follow-up|0|||
130701121|NCT01525628|470528405|FG000|Overall Study|Withdrawal by Subject|0|||
130701122|NCT01525628|470528406|FG001|Overall Study|Withdrawal by Subject|1|||
130701123|NCT01525628|470528407|FG002|Overall Study|Withdrawal by Subject|0|||
130701124|NCT01525628|470528408|FG003|Overall Study|Withdrawal by Subject|0|||
130701125|NCT01525628|470528409|FG004|Overall Study|Withdrawal by Subject|0|||
130701126|NCT01525628|470528405|FG000|Overall Study|Other reason not defined above|0|||
130701127|NCT01525628|470528406|FG001|Overall Study|Other reason not defined above|0|||
131223439|NCT01335399|472446999|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
131223440|NCT01335399|472446998|FG000|Pre-treatment Period|Participant request to discontinue|0|||
131223441|NCT01335399|472446999|FG001|Pre-treatment Period|Participant request to discontinue|1|||
130701128|NCT01525628|470528407|FG002|Overall Study|Other reason not defined above|0|||
130701129|NCT01525628|470528408|FG003|Overall Study|Other reason not defined above|3|||
130701130|NCT01525628|470528409|FG004|Overall Study|Other reason not defined above|0|||
130701131|NCT03573336|470528410|FG000|Overall Study|Study terminated|2|||
130701132|NCT03573336|470528411|FG001|Overall Study|Study terminated|4|||
130701133|NCT03573336|470528412|FG002|Overall Study|Study terminated|2|||
130701134|NCT00239005|470528413|FG000|Overall Study|Adverse Event|6|||
130701135|NCT00239005|470528414|FG001|Overall Study|Adverse Event|6|||
130701136|NCT00239005|470528413|FG000|Overall Study|Withdrawal by Subject|3|||
130701137|NCT00239005|470528414|FG001|Overall Study|Withdrawal by Subject|4|||
130701138|NCT00239005|470528413|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
130701139|NCT00239005|470528414|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
130701140|NCT00239005|470528413|FG000|Overall Study|Protocol Violation|1|||
130701141|NCT00239005|470528414|FG001|Overall Study|Protocol Violation|0|||
130701142|NCT00239005|470528413|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
130701143|NCT00239005|470528414|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
130701144|NCT00239005|470528413|FG000|Overall Study|Lost to Follow-up|0|||
130701145|NCT00239005|470528414|FG001|Overall Study|Lost to Follow-up|1|||
130701146|NCT02614898|470528415|FG000|Overall Study|Participated until study termination|10|||
130701147|NCT02614898|470528416|FG001|Overall Study|Participated until study termination|26|||
130701148|NCT02614898|470528415|FG000|Overall Study|Lost to Follow-up|0|||
130701149|NCT02614898|470528416|FG001|Overall Study|Lost to Follow-up|2|||
130701150|NCT02614898|470528415|FG000|Overall Study|Physician Decision|1|||
130701151|NCT02614898|470528416|FG001|Overall Study|Physician Decision|8|||
130701152|NCT02614898|470528415|FG000|Overall Study|Study Terminated by Sponsor|3|||
130701153|NCT02614898|470528416|FG001|Overall Study|Study Terminated by Sponsor|0|||
130701154|NCT02614898|470528415|FG000|Overall Study|Withdrawal by Subject|0|||
130701155|NCT02614898|470528416|FG001|Overall Study|Withdrawal by Subject|2|||
130701156|NCT02614898|470528415|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130701157|NCT02614898|470528416|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130925381|NCT04115839|471362115|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130701158|NCT02614898|470528415|FG000|Overall Study|Other-Additional Information Unavailable|0|||
130701159|NCT02614898|470528416|FG001|Overall Study|Other-Additional Information Unavailable|11|||
130701160|NCT02614898|470528415|FG000|Overall Study|Missing|0|||
130925382|NCT04115839|471362116|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
130925383|NCT04115839|471362117|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130701161|NCT02614898|470528416|FG001|Overall Study|Missing|1|||
130701162|NCT03382041|470528417|FG000|Overall Study|Consent Form Lost|2|||
130701163|NCT03382041|470528418|FG001|Overall Study|Consent Form Lost|1|||
130701164|NCT03382041|470528417|FG000|Overall Study|Withdrawal by Subject|1|||
130701165|NCT03382041|470528418|FG001|Overall Study|Withdrawal by Subject|4|||
130701166|NCT03382041|470528417|FG000|Overall Study|Lost to Follow-up|1|||
130701167|NCT03382041|470528418|FG001|Overall Study|Lost to Follow-up|4|||
130701168|NCT00787605|470528419|FG000|Overall Study|Administrative Problems|3|||
130701169|NCT00787605|470528420|FG001|Overall Study|Administrative Problems|0|||
130701170|NCT00787605|470528419|FG000|Overall Study|Adverse Event|14|||
130701171|NCT00787605|470528420|FG001|Overall Study|Adverse Event|25|||
130701172|NCT00787605|470528419|FG000|Overall Study|Lost to Follow-up|3|||
130701173|NCT00787605|470528420|FG001|Overall Study|Lost to Follow-up|6|||
130701174|NCT00787605|470528419|FG000|Overall Study|Protocol Violation|7|||
130701175|NCT00787605|470528420|FG001|Overall Study|Protocol Violation|3|||
130701176|NCT00787605|470528419|FG000|Overall Study|Withdrawal by Subject|6|||
130701177|NCT00787605|470528420|FG001|Overall Study|Withdrawal by Subject|13|||
130701178|NCT00787605|470528419|FG000|Overall Study|Lack of Efficacy|13|||
130701179|NCT00787605|470528420|FG001|Overall Study|Lack of Efficacy|9|||
130701180|NCT03493919|470528427|FG000|Overall Study|Other|2|||
130701181|NCT03493919|470528428|FG001|Overall Study|Other|0|||
130769764|NCT02815267|470782538|FG000|Open-Label Phase|Protocol Violation|0|||
130769765|NCT02815267|470782539|FG001|Open-Label Phase|Protocol Violation|1|||
130769766|NCT02815267|470782538|FG000|Open-Label Phase|Administrative|21|||
130769767|NCT02815267|470782539|FG001|Open-Label Phase|Administrative|12|||
130769768|NCT02815267|470782538|FG000|Open-Label Phase|Other|2|||
130769769|NCT02815267|470782539|FG001|Open-Label Phase|Other|5|||
130769770|NCT03594955|470782540|FG000|Overall Study|Adverse Event|1|||
130769771|NCT03594955|470782540|FG000|Overall Study|Progressive disease|5|||
130769772|NCT03594955|470782540|FG000|Overall Study|Sponsor's decision|1|||
130769773|NCT02476916|470782543|FG000|Core Period|Adverse Event|2|||
130769774|NCT02476916|470782544|FG001|Core Period|Adverse Event|2|||
130769775|NCT02476916|470782543|FG000|Core Period|Investigator decision|1|||
130769776|NCT02476916|470782544|FG001|Core Period|Investigator decision|1|||
130769777|NCT02476916|470782543|FG000|Core Period|Withdrawal by Subject|3|||
130769778|NCT02476916|470782544|FG001|Core Period|Withdrawal by Subject|0|||
130769779|NCT02476916|470782543|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
130769780|NCT02476916|470782544|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
130769781|NCT02476916|470782543|FG000|Extension Period|On Treatment|12|||
130769782|NCT02476916|470782544|FG001|Extension Period|On Treatment|17|||
130769783|NCT05600036|470782545|FG000|Overall Study|Adverse Event|0|||
130769784|NCT05600036|470782546|FG001|Overall Study|Adverse Event|2|||
130769785|NCT05600036|470782547|FG002|Overall Study|Adverse Event|1|||
130769786|NCT05600036|470782548|FG003|Overall Study|Adverse Event|0|||
130769787|NCT05600036|470782549|FG004|Overall Study|Adverse Event|1|||
130769788|NCT05600036|470782550|FG005|Overall Study|Adverse Event|0|||
130769789|NCT05600036|470782545|FG000|Overall Study|Lost to Follow-up|0|||
130769790|NCT05600036|470782546|FG001|Overall Study|Lost to Follow-up|2|||
130769791|NCT05600036|470782547|FG002|Overall Study|Lost to Follow-up|1|||
130769792|NCT05600036|470782548|FG003|Overall Study|Lost to Follow-up|1|||
130769793|NCT05600036|470782549|FG004|Overall Study|Lost to Follow-up|0|||
130769794|NCT05600036|470782550|FG005|Overall Study|Lost to Follow-up|0|||
130769795|NCT05600036|470782545|FG000|Overall Study|Protocol Violation|0|||
130769796|NCT05600036|470782546|FG001|Overall Study|Protocol Violation|0|||
130769797|NCT05600036|470782547|FG002|Overall Study|Protocol Violation|2|||
130769798|NCT05600036|470782548|FG003|Overall Study|Protocol Violation|0|||
130769799|NCT05600036|470782549|FG004|Overall Study|Protocol Violation|0|||
130769800|NCT05600036|470782550|FG005|Overall Study|Protocol Violation|0|||
130769801|NCT05600036|470782545|FG000|Overall Study|Withdrawal by Subject|0|||
130769802|NCT05600036|470782546|FG001|Overall Study|Withdrawal by Subject|1|||
130769803|NCT05600036|470782547|FG002|Overall Study|Withdrawal by Subject|2|||
130769804|NCT05600036|470782548|FG003|Overall Study|Withdrawal by Subject|0|||
130769805|NCT05600036|470782549|FG004|Overall Study|Withdrawal by Subject|3|||
130769806|NCT05600036|470782550|FG005|Overall Study|Withdrawal by Subject|5|||
130769807|NCT05600036|470782545|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130769808|NCT05600036|470782546|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130769809|NCT05600036|470782547|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130769810|NCT05600036|470782548|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
130769811|NCT05600036|470782549|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130769812|NCT05600036|470782550|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130769813|NCT05600036|470782545|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130769814|NCT05600036|470782546|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
130701182|NCT03493919|470528429|FG002|Overall Study|Other|1|||
130769815|NCT05600036|470782547|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130769816|NCT05600036|470782548|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130769817|NCT05600036|470782549|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130769818|NCT05600036|470782550|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130769819|NCT05600036|470782545|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130769820|NCT05600036|470782546|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130769821|NCT05600036|470782547|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130925384|NCT04115839|471362118|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130701183|NCT03493919|470528430|FG003|Overall Study|Other|0|||
130925385|NCT04115839|471362119|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130925386|NCT04115839|471362120|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
130925387|NCT04115839|471362114|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
130925388|NCT04115839|471362115|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
130925389|NCT04115839|471362116|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
130925390|NCT04115839|471362117|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
130925391|NCT04115839|471362118|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
131034502|NCT03365882|471759209|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
131034503|NCT03365882|471759208|FG000|Randomization|Progression/Relapse|21|||
131034504|NCT03365882|471759209|FG001|Randomization|Progression/Relapse|3|||
131034505|NCT03365882|471759208|FG000|Randomization|Death|1|||
131034506|NCT03365882|471759209|FG001|Randomization|Death|0|||
131034507|NCT03365882|471759208|FG000|Randomization|Other - Not Protocol Specified|1|||
131034508|NCT03365882|471759209|FG001|Randomization|Other - Not Protocol Specified|1|||
131034509|NCT03365882|471759208|FG000|Randomization|Major Protocol Deviation|0|||
131034510|NCT03365882|471759209|FG001|Randomization|Major Protocol Deviation|1|||
131034511|NCT03365882|471759208|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
131034512|NCT03365882|471759209|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
131034513|NCT03365882|471759208|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
131034514|NCT03365882|471759209|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
131034515|NCT03365882|471759208|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
131034516|NCT03365882|471759209|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
131034517|NCT03365882|471759208|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
131034518|NCT03365882|471759209|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
131034519|NCT04437615|471759210|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
131034520|NCT02921230|471761688|FG000|Overall Study|Withdrawal by Subject|20|||
131034521|NCT02921230|471761689|FG001|Overall Study|Withdrawal by Subject|8|||
131034522|NCT02921230|471761688|FG000|Overall Study|Death|12|||
131034523|NCT02921230|471761689|FG001|Overall Study|Death|3|||
131034524|NCT02921230|471761688|FG000|Overall Study|Protocol Violation|17|||
131034525|NCT02921230|471761689|FG001|Overall Study|Protocol Violation|6|||
131034526|NCT02921230|471761688|FG000|Overall Study|Early completion|5|||
131034527|NCT02921230|471761689|FG001|Overall Study|Early completion|1|||
131034528|NCT02921230|471761688|FG000|Overall Study|Pending data entry|1|||
131034529|NCT02921230|471761689|FG001|Overall Study|Pending data entry|0|||
131034530|NCT04971395|471761692|FG000|Overall Study|Withdrawal by Subject|0|||
131034531|NCT04971395|471761693|FG001|Overall Study|Withdrawal by Subject|1|||
131034532|NCT04971395|471761694|FG002|Overall Study|Withdrawal by Subject|0|||
131034533|NCT03953508|471761695|FG000|Baseline|Lost to Follow-up|3|||
131034534|NCT03953508|471761696|FG001|Baseline|Lost to Follow-up|2|||
131034535|NCT03953508|471761695|FG000|6-month Follow-up|Lost to Follow-up|62|||
131034536|NCT03953508|471761696|FG001|6-month Follow-up|Lost to Follow-up|70|||
131034537|NCT03771417|471761697|FG000|Overall Study|Withdrawal by Subject|1|||
131034538|NCT03771417|471761698|FG001|Overall Study|Withdrawal by Subject|0|||
131034539|NCT03771417|471761699|FG002|Overall Study|Withdrawal by Subject|0|||
131034540|NCT03771417|471761697|FG000|Overall Study|Covid-19 Shutdown|0|||
131034541|NCT03771417|471761698|FG001|Overall Study|Covid-19 Shutdown|1|||
131034542|NCT03771417|471761699|FG002|Overall Study|Covid-19 Shutdown|0|||
131034543|NCT02100813|471761700|FG000|Overall Study|Adverse Event|0|||
131034544|NCT02100813|471761701|FG001|Overall Study|Adverse Event|0|||
131034545|NCT02100813|471761702|FG002|Overall Study|Adverse Event|0|||
131034546|NCT02100813|471761703|FG003|Overall Study|Adverse Event|0|||
131034547|NCT02100813|471761704|FG004|Overall Study|Adverse Event|0|||
131034548|NCT02100813|471761705|FG005|Overall Study|Adverse Event|0|||
131034549|NCT02100813|471761706|FG006|Overall Study|Adverse Event|0|||
131034550|NCT02100813|471761707|FG007|Overall Study|Adverse Event|1|||
131034551|NCT04552223|471761708|FG000|Overall Study|Withdrawal by Subject|1|||
131034552|NCT04856163|471761709|FG000|Overall Study|Lost to Follow-up|97|||
131034553|NCT04856163|471761710|FG001|Overall Study|Lost to Follow-up|100|||
131034554|NCT00881621|471761714|FG000|Overall Study|Physician Decision|34|||
131034555|NCT03936322|471761719|FG000|Overall Study|Lost to Follow-up|1|||
131034556|NCT03936322|471761719|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
131034557|NCT02734290|471761721|FG000|Overall Study|Adverse Event|1|||
131034558|NCT02734290|471761722|FG001|Overall Study|Adverse Event|0|||
131034559|NCT02734290|471761721|FG000|Overall Study|Death|1|||
131034560|NCT02734290|471761722|FG001|Overall Study|Death|0|||
131034561|NCT03158129|471761723|FG000|Overall Study|Adverse Event|0|||
131034562|NCT03158129|471761724|FG001|Overall Study|Adverse Event|1|||
131034563|NCT03158129|471761725|FG002|Overall Study|Adverse Event|0|||
131034564|NCT03158129|471761726|FG003|Overall Study|Adverse Event|0|||
131034565|NCT03158129|471761723|FG000|Overall Study|Death|0|||
131034566|NCT03158129|471761724|FG001|Overall Study|Death|0|||
131034567|NCT03158129|471761725|FG002|Overall Study|Death|0|||
131034568|NCT03158129|471761726|FG003|Overall Study|Death|1|||
131034569|NCT03158129|471761723|FG000|Overall Study|High surgical risk|1|||
130769822|NCT05600036|470782548|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
130769823|NCT05600036|470782549|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130769824|NCT05600036|470782550|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130769825|NCT06010732|470782551|FG000|Crossover Period 1|Protocol Violation|0|||
130769826|NCT06010732|470782552|FG001|Crossover Period 1|Protocol Violation|0|||
130769827|NCT06010732|470782553|FG002|Crossover Period 1|Protocol Violation|1|||
130769828|NCT06010732|470782554|FG003|Crossover Period 1|Protocol Violation|0|||
130769829|NCT06010732|470782555|FG004|Crossover Period 1|Protocol Violation|1|||
130769830|NCT06010732|470782556|FG005|Crossover Period 1|Protocol Violation|0|||
130769831|NCT06010732|470782551|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130769832|NCT06010732|470782552|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
130769833|NCT06010732|470782553|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130769834|NCT06010732|470782554|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130769835|NCT06010732|470782555|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130769836|NCT06010732|470782556|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130769837|NCT06010732|470782551|FG000|Crossover Period 2|Adverse Event|0|||
130769838|NCT06010732|470782552|FG001|Crossover Period 2|Adverse Event|1|||
130769839|NCT06010732|470782553|FG002|Crossover Period 2|Adverse Event|0|||
130769840|NCT06010732|470782554|FG003|Crossover Period 2|Adverse Event|0|||
130769841|NCT06010732|470782555|FG004|Crossover Period 2|Adverse Event|0|||
130769842|NCT06010732|470782556|FG005|Crossover Period 2|Adverse Event|0|||
130769843|NCT06010732|470782551|FG000|Crossover Period 2|broken denture|0|||
130769844|NCT06010732|470782552|FG001|Crossover Period 2|broken denture|0|||
130769845|NCT06010732|470782553|FG002|Crossover Period 2|broken denture|1|||
130769846|NCT06010732|470782554|FG003|Crossover Period 2|broken denture|0|||
130769847|NCT06010732|470782555|FG004|Crossover Period 2|broken denture|0|||
130769848|NCT06010732|470782556|FG005|Crossover Period 2|broken denture|0|||
130769849|NCT04401202|470782557|FG000|Overall Study|Lost to Follow-up|2|||
130769850|NCT04401202|470782558|FG001|Overall Study|Lost to Follow-up|2|||
130769851|NCT04401202|470782557|FG000|Overall Study|Adverse Event|0|||
130769852|NCT04401202|470782558|FG001|Overall Study|Adverse Event|1|||
130769853|NCT04401202|470782557|FG000|Overall Study|Hospitalized|4|||
130769854|NCT04401202|470782558|FG001|Overall Study|Hospitalized|1|||
130769855|NCT02714036|470782559|FG000|Overall Study|Adverse Event|9|||
130769856|NCT02714036|470782560|FG001|Overall Study|Adverse Event|2|||
130769857|NCT02714036|470782559|FG000|Overall Study|Withdrawal by Subject|3|||
130769858|NCT02714036|470782560|FG001|Overall Study|Withdrawal by Subject|2|||
130769859|NCT01006590|470782561|FG000|Overall Study|Adverse Event|2|||
130769860|NCT01006590|470782562|FG001|Overall Study|Adverse Event|3|||
130769861|NCT01006590|470782561|FG000|Overall Study|Death|1|||
130769862|NCT01006590|470782562|FG001|Overall Study|Death|1|||
130769863|NCT01006590|470782561|FG000|Overall Study|Lost to Follow-up|1|||
130769864|NCT01006590|470782562|FG001|Overall Study|Lost to Follow-up|1|||
130769865|NCT01006590|470782561|FG000|Overall Study|Protocol Violation|1|||
130769866|NCT01006590|470782562|FG001|Overall Study|Protocol Violation|0|||
130769867|NCT01006590|470782561|FG000|Overall Study|Withdrawal by Subject|4|||
130769868|NCT01006590|470782562|FG001|Overall Study|Withdrawal by Subject|2|||
130769869|NCT01006590|470782561|FG000|Overall Study|Study specific discontinuation criteria|16|||
130769870|NCT01006590|470782562|FG001|Overall Study|Study specific discontinuation criteria|23|||
130769871|NCT01006590|470782561|FG000|Overall Study|Other|3|||
130769872|NCT01006590|470782562|FG001|Overall Study|Other|2|||
130769873|NCT03332095|470782563|FG000|Overall Study|Lost to Follow-up|1|||
130769874|NCT03332095|470782564|FG001|Overall Study|Lost to Follow-up|0|||
130769875|NCT03332095|470782563|FG000|Overall Study|Pregnancy|0|||
130769876|NCT03332095|470782564|FG001|Overall Study|Pregnancy|1|||
130925392|NCT04115839|471362119|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
130925393|NCT04115839|471362120|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
130925394|NCT04115839|471362114|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
130925395|NCT04115839|471362115|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
130925396|NCT04115839|471362116|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
130925397|NCT04115839|471362117|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
130925398|NCT04115839|471362118|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
130925399|NCT04115839|471362119|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
130769877|NCT01939223|470782565|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
130769878|NCT01939223|470782566|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
130769879|NCT01939223|470782565|FG000|Overall Study|Disease recurrence (radiological)|1|||
130925400|NCT04115839|471362120|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
130769880|NCT01939223|470782566|FG001|Overall Study|Disease recurrence (radiological)|3|||
130769881|NCT01939223|470782565|FG000|Overall Study|Study stopped by Sponsor|5|||
130769882|NCT01939223|470782566|FG001|Overall Study|Study stopped by Sponsor|7|||
130769883|NCT01939223|470782565|FG000|Overall Study|Withdrawal by Subject|6|||
130769884|NCT01939223|470782566|FG001|Overall Study|Withdrawal by Subject|0|||
130769885|NCT00703118|470782567|FG000|Overall Study|Adverse Event|1|||
130925401|NCT00621985|471362121|FG000|Dexamethasone Admission|Adverse Event|1|||
130925402|NCT02587234|471362124|FG000|Overall Study|Withdrawal by Subject|1|||
130925403|NCT02587234|471362125|FG001|Overall Study|Withdrawal by Subject|1|||
130925404|NCT02587234|471362124|FG000|Overall Study|Lost to Follow-up|0|||
130925405|NCT02587234|471362125|FG001|Overall Study|Lost to Follow-up|2|||
130925406|NCT00691015|471362126|FG000|Overall Study|Refused further treatment|1|||
130925407|NCT04160195|471362129|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
130925408|NCT04160195|471362130|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
130925409|NCT03068130|471362137|FG000|Overall Study|Adverse Event|19|||
130925410|NCT03068130|471362137|FG000|Overall Study|Death|14|||
130925411|NCT03068130|471362137|FG000|Overall Study|Lost to Follow-up|4|||
130925412|NCT03068130|471362137|FG000|Overall Study|Withdrawal by Subject|26|||
130925413|NCT03068130|471362137|FG000|Overall Study|Administrative Reasons|3|||
130925414|NCT03068130|471362137|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
130925415|NCT03068130|471362137|FG000|Overall Study|Study terminated by sponsor|194|||
130925416|NCT00590720|471362140|FG000|Overall Study|Lost to Follow-up|1|||
130925417|NCT00590720|471362141|FG001|Overall Study|Lost to Follow-up|0|||
130925418|NCT00590720|471362140|FG000|Overall Study|Withdrawal by Subject|0|||
130925419|NCT00590720|471362141|FG001|Overall Study|Withdrawal by Subject|1|||
130925420|NCT00160693|471362142|FG000|Overall Study|Adverse Event|97|||
130925421|NCT00160693|471362142|FG000|Overall Study|Lack of Efficacy|30|||
130925422|NCT00160693|471362142|FG000|Overall Study|Protocol Violation|24|||
130925423|NCT00160693|471362142|FG000|Overall Study|Lost to Follow-up|15|||
130925424|NCT00160693|471362142|FG000|Overall Study|Withdrawal by Subject|54|||
130925425|NCT00160693|471362142|FG000|Overall Study|Study terminated by sponsor|15|||
130925426|NCT03039283|471362145|FG000|Overall Study|Protocol Violation|2|||
131120237|NCT00467779|472072318|FG007|Stage 2A|Adverse Event|0|||
130925428|NCT01847274|471362147|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
130925429|NCT01847274|471362148|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
130925430|NCT01847274|471362149|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
130925431|NCT01847274|471362150|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
130925432|NCT01847274|471362151|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130925433|NCT01847274|471362152|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130925434|NCT01847274|471362153|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130925435|NCT01847274|471362154|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130925436|NCT01847274|471362155|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130925437|NCT01847274|471362156|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130925438|NCT01847274|471362157|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
130925439|NCT01847274|471362147|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
130925440|NCT01847274|471362148|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
130925441|NCT01847274|471362149|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
130701184|NCT03493919|470528427|FG000|Overall Study|Withdrawal by Subject|9|||
130701185|NCT03493919|470528428|FG001|Overall Study|Withdrawal by Subject|3|||
130925442|NCT01847274|471362150|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
130925443|NCT01847274|471362151|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130925444|NCT01847274|471362152|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130925445|NCT01847274|471362153|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130925446|NCT01847274|471362154|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130925447|NCT01847274|471362155|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130925448|NCT01847274|471362156|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130925449|NCT01847274|471362157|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
130925450|NCT01847274|471362147|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
130925451|NCT01847274|471362148|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
130925452|NCT01847274|471362149|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
130925453|NCT01847274|471362150|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
130925454|NCT01847274|471362151|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130925455|NCT01847274|471362152|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130925456|NCT01847274|471362153|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130925457|NCT01847274|471362154|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130925458|NCT01847274|471362155|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130925459|NCT01847274|471362156|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130925460|NCT01847274|471362157|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
130925461|NCT01847274|471362147|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130925462|NCT01847274|471362148|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
131034570|NCT03158129|471761724|FG001|Overall Study|High surgical risk|1|||
130701186|NCT03493919|470528429|FG002|Overall Study|Withdrawal by Subject|1|||
130701187|NCT03493919|470528430|FG003|Overall Study|Withdrawal by Subject|1|||
130925463|NCT01847274|471362149|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130925464|NCT01847274|471362150|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
130925465|NCT01847274|471362151|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130925466|NCT01847274|471362152|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130925467|NCT01847274|471362153|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130925468|NCT01847274|471362154|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130925469|NCT01847274|471362155|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130925470|NCT01847274|471362156|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130925471|NCT01847274|471362157|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130925472|NCT01847274|471362147|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
130701188|NCT03493919|470528427|FG000|Overall Study|Lost to Follow-up|5|||
130701189|NCT03493919|470528428|FG001|Overall Study|Lost to Follow-up|0|||
130701190|NCT03493919|470528429|FG002|Overall Study|Lost to Follow-up|0|||
130701191|NCT03493919|470528430|FG003|Overall Study|Lost to Follow-up|3|||
130701192|NCT03493919|470528427|FG000|Overall Study|Adverse Event|0|||
130701193|NCT03493919|470528428|FG001|Overall Study|Adverse Event|1|||
130701194|NCT03493919|470528429|FG002|Overall Study|Adverse Event|0|||
130701195|NCT03493919|470528430|FG003|Overall Study|Adverse Event|0|||
130701196|NCT00965731|470528434|FG000|Overall Study|Death|0|||
130701197|NCT00965731|470528435|FG001|Overall Study|Death|4|||
130701198|NCT00965731|470528434|FG000|Overall Study|Withdrawal by Subject|0|||
130701199|NCT00965731|470528435|FG001|Overall Study|Withdrawal by Subject|1|||
130701200|NCT00965731|470528434|FG000|Overall Study|Other|7|||
130701201|NCT00965731|470528435|FG001|Overall Study|Other|15|||
130701202|NCT00559637|470530313|FG000|Overall Study|Adverse Event|22|||
130701203|NCT00559637|470530313|FG000|Overall Study|Withdrawal by Subject|4|||
130701204|NCT00559637|470530313|FG000|Overall Study|Protocol Violation|6|||
130701205|NCT00559637|470530313|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
130701206|NCT00559637|470530313|FG000|Overall Study|Failure to return|6|||
130701207|NCT00559637|470530313|FG000|Overall Study|Insufficient response|3|||
130701208|NCT00559637|470530313|FG000|Overall Study|Started requiring dialysis after month 7|2|||
130701209|NCT00559637|470530313|FG000|Overall Study|Suspected lung cancer|1|||
130701210|NCT00559637|470530313|FG000|Overall Study|Participation in another study|1|||
130701211|NCT00559637|470530313|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
130701212|NCT00559637|470530313|FG000|Overall Study|Change of center|1|||
130701213|NCT00559637|470530313|FG000|Overall Study|Change of home|1|||
130701214|NCT00559637|470530313|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
130701215|NCT02832167|470530314|FG000|Treatment Period 1|Disease progression|90|||
130701216|NCT02832167|470530314|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
130701217|NCT02832167|470530314|FG000|Treatment Period 1|Death|2|||
130701218|NCT02832167|470530314|FG000|Treatment Period 1|Study Drug Toxicity|6|||
130701219|NCT02832167|470530314|FG000|Treatment Period 1|Participant request to discontinue|9|||
130701220|NCT02832167|470530314|FG000|Treatment Period 1|No longer meet study criteria|1|||
130701221|NCT02832167|470530314|FG000|Treatment Period 1|Participant withdrew consent|3|||
130701222|NCT02832167|470530314|FG000|Treatment Period 1|Other reasons|6|||
130701223|NCT02832167|470530314|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
130701224|NCT02832167|470530314|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
130701225|NCT02832167|470530314|FG000|Transition From Period 1 to Period 2|Death|2|||
130701226|NCT02832167|470530314|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
130701227|NCT02832167|470530314|FG000|Treatment Period 2|Disease progression|69|||
130701228|NCT02832167|470530314|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
130701229|NCT02832167|470530314|FG000|Treatment Period 2|Maximum clinical benefit|1|||
130701230|NCT02832167|470530314|FG000|Treatment Period 2|Study Drug Toxicity|5|||
130701231|NCT02832167|470530314|FG000|Treatment Period 2|Participant request to discontinue|2|||
130701232|NCT02832167|470530314|FG000|Treatment Period 2|Participant withdrew consent|3|||
130701233|NCT02832167|470530314|FG000|Treatment Period 2|Other reasons|3|||
130701234|NCT00224484|470530315|FG000|Overall Study|Serious Adverse Event|1|||
130701235|NCT00224484|470530316|FG001|Overall Study|Serious Adverse Event|1|||
130701236|NCT00224484|470530317|FG002|Overall Study|Serious Adverse Event|0|||
130701237|NCT00224484|470530315|FG000|Overall Study|Non-Serious Adverse Event|5|||
130701238|NCT00224484|470530316|FG001|Overall Study|Non-Serious Adverse Event|7|||
130701239|NCT00224484|470530317|FG002|Overall Study|Non-Serious Adverse Event|3|||
130701240|NCT00224484|470530315|FG000|Overall Study|Protocol Violation|2|||
130701241|NCT00224484|470530316|FG001|Overall Study|Protocol Violation|2|||
130701242|NCT00224484|470530317|FG002|Overall Study|Protocol Violation|0|||
130701243|NCT00224484|470530315|FG000|Overall Study|Withdrawal by Subject|49|||
130701244|NCT00224484|470530316|FG001|Overall Study|Withdrawal by Subject|18|||
130701245|NCT00224484|470530317|FG002|Overall Study|Withdrawal by Subject|16|||
130701246|NCT00224484|470530315|FG000|Overall Study|Migrated/moved from study area|18|||
130701247|NCT00224484|470530316|FG001|Overall Study|Migrated/moved from study area|5|||
130701248|NCT00224484|470530317|FG002|Overall Study|Migrated/moved from study area|5|||
130701249|NCT00224484|470530315|FG000|Overall Study|Lost to Follow-up|66|||
130769886|NCT00703118|470782568|FG001|Overall Study|Adverse Event|2|||
130701250|NCT00224484|470530316|FG001|Overall Study|Lost to Follow-up|28|||
130701251|NCT00224484|470530317|FG002|Overall Study|Lost to Follow-up|36|||
130701252|NCT00224484|470530315|FG000|Overall Study|Reason not specified|5|||
130701253|NCT00224484|470530316|FG001|Overall Study|Reason not specified|4|||
130701254|NCT00224484|470530317|FG002|Overall Study|Reason not specified|2|||
130701255|NCT02805309|470530318|FG000|Overall Study|Lost to Follow-up|2|||
130701256|NCT02805309|470530319|FG001|Overall Study|Lost to Follow-up|2|||
130701257|NCT02805309|470530320|FG002|Overall Study|Lost to Follow-up|2|||
130701258|NCT02805309|470530318|FG000|Overall Study|Post-Randomization Exclusion|0|||
130701259|NCT02805309|470530319|FG001|Overall Study|Post-Randomization Exclusion|2|||
130701260|NCT02805309|470530320|FG002|Overall Study|Post-Randomization Exclusion|1|||
130701261|NCT04675775|470530326|FG000|Overall Study|Withdrawal by Subject|7|||
130701262|NCT00348816|470530327|FG000|Overall Study|Noncompliance with radiation treatment|1|||
130701263|NCT02050321|470530334|FG000|Overall Study|Withdrawal by Subject|1|||
130701264|NCT02050321|470530334|FG000|Overall Study|Adverse Event|1|||
130701265|NCT00113919|470530335|FG000|Overall Study|Physician Decision|8|||
130701266|NCT00113919|470530335|FG000|Overall Study|Death|6|||
130701267|NCT00715676|470530336|FG000|Overall Study|Adverse Event|3|||
130701268|NCT00715676|470530337|FG001|Overall Study|Adverse Event|5|||
130701269|NCT00715676|470530338|FG002|Overall Study|Adverse Event|21|||
130701270|NCT00715676|470530336|FG000|Overall Study|Withdrawal by Subject|1|||
130701271|NCT00715676|470530337|FG001|Overall Study|Withdrawal by Subject|3|||
130701272|NCT00715676|470530338|FG002|Overall Study|Withdrawal by Subject|8|||
130701273|NCT00715676|470530336|FG000|Overall Study|Lost to Follow-up|1|||
130701274|NCT00715676|470530337|FG001|Overall Study|Lost to Follow-up|2|||
130701275|NCT00715676|470530338|FG002|Overall Study|Lost to Follow-up|1|||
130701276|NCT00715676|470530336|FG000|Overall Study|Terminated by Sponsor|1|||
130701277|NCT00715676|470530337|FG001|Overall Study|Terminated by Sponsor|0|||
130701278|NCT00715676|470530338|FG002|Overall Study|Terminated by Sponsor|0|||
130701279|NCT00715676|470530336|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
130701280|NCT00715676|470530337|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
130701281|NCT00715676|470530338|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
130701282|NCT00715676|470530336|FG000|Overall Study|Use of Exclusionary Medication|0|||
130701283|NCT00715676|470530337|FG001|Overall Study|Use of Exclusionary Medication|0|||
130701284|NCT00715676|470530338|FG002|Overall Study|Use of Exclusionary Medication|1|||
130701285|NCT00715676|470530336|FG000|Overall Study|Elevated Blood Glucose|0|||
130701286|NCT00715676|470530337|FG001|Overall Study|Elevated Blood Glucose|1|||
130701287|NCT00715676|470530338|FG002|Overall Study|Elevated Blood Glucose|0|||
130701288|NCT04994431|470530339|FG000|Overall Study|Adverse Event|1|||
130701289|NCT04994431|470530340|FG001|Overall Study|Adverse Event|0|||
130701290|NCT00372996|470530341|FG000|Overall Study|Death|11|||
130701291|NCT00372996|470530342|FG001|Overall Study|Death|4|||
130701292|NCT00372996|470530343|FG002|Overall Study|Death|8|||
130701293|NCT00372996|470530344|FG003|Overall Study|Death|7|||
130701294|NCT00372996|470530341|FG000|Overall Study|Lost to Follow-up|0|||
130701295|NCT00372996|470530342|FG001|Overall Study|Lost to Follow-up|2|||
130701296|NCT00372996|470530343|FG002|Overall Study|Lost to Follow-up|0|||
130701297|NCT00372996|470530344|FG003|Overall Study|Lost to Follow-up|1|||
130701298|NCT00372996|470530341|FG000|Overall Study|Withdrawal by Subject|12|||
130701299|NCT00372996|470530342|FG001|Overall Study|Withdrawal by Subject|6|||
130701300|NCT00372996|470530343|FG002|Overall Study|Withdrawal by Subject|9|||
130701301|NCT00372996|470530344|FG003|Overall Study|Withdrawal by Subject|5|||
130701302|NCT00372996|470530341|FG000|Overall Study|Study Terminated by Sponsor|4|||
130701303|NCT00372996|470530342|FG001|Overall Study|Study Terminated by Sponsor|0|||
130701304|NCT00372996|470530343|FG002|Overall Study|Study Terminated by Sponsor|4|||
130701305|NCT00372996|470530344|FG003|Overall Study|Study Terminated by Sponsor|0|||
130701306|NCT00372996|470530341|FG000|Overall Study|Other|10|||
130701307|NCT00372996|470530342|FG001|Overall Study|Other|2|||
131034571|NCT03158129|471761725|FG002|Overall Study|High surgical risk|0|||
131034572|NCT03158129|471761726|FG003|Overall Study|High surgical risk|0|||
131034573|NCT03158129|471761723|FG000|Overall Study|Progression|1|||
131034574|NCT03158129|471761724|FG001|Overall Study|Progression|1|||
131034575|NCT03158129|471761725|FG002|Overall Study|Progression|0|||
131034576|NCT03158129|471761726|FG003|Overall Study|Progression|0|||
131034577|NCT03158129|471761723|FG000|Overall Study|Lack of resectability|0|||
131034578|NCT03158129|471761724|FG001|Overall Study|Lack of resectability|1|||
131034579|NCT03158129|471761725|FG002|Overall Study|Lack of resectability|0|||
131034580|NCT03158129|471761726|FG003|Overall Study|Lack of resectability|0|||
131034581|NCT03158129|471761723|FG000|Overall Study|Declined surgery|0|||
131034582|NCT03158129|471761724|FG001|Overall Study|Declined surgery|1|||
131034583|NCT03158129|471761725|FG002|Overall Study|Declined surgery|0|||
131034584|NCT03158129|471761726|FG003|Overall Study|Declined surgery|0|||
131034585|NCT03158129|471761723|FG000|Overall Study|No longer surgical candidate|0|||
130701308|NCT00372996|470530343|FG002|Overall Study|Other|7|||
130701309|NCT00372996|470530344|FG003|Overall Study|Other|7|||
130701310|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
130701311|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
130769887|NCT00703118|470782569|FG002|Overall Study|Adverse Event|2|||
130925473|NCT01847274|471362148|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
130925474|NCT01847274|471362149|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
130925475|NCT01847274|471362150|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
130925476|NCT01847274|471362151|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130925477|NCT01847274|471362152|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130925478|NCT01847274|471362153|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130925479|NCT01847274|471362154|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130925480|NCT01847274|471362155|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130925481|NCT01847274|471362156|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130925482|NCT01847274|471362157|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
130925483|NCT01847274|471362147|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
130925484|NCT01847274|471362148|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
130925485|NCT01847274|471362149|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
130925486|NCT01847274|471362150|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
130925487|NCT01847274|471362151|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130925488|NCT01847274|471362152|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130925489|NCT01847274|471362153|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130925490|NCT01847274|471362154|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130925491|NCT01847274|471362155|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130925492|NCT01847274|471362156|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130925493|NCT01847274|471362157|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
130925494|NCT01847274|471362147|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
130925495|NCT01847274|471362148|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
130925496|NCT01847274|471362149|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
130925497|NCT01847274|471362150|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
130925498|NCT01847274|471362151|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130925499|NCT01847274|471362152|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130925500|NCT01847274|471362153|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130925501|NCT01847274|471362154|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130925502|NCT01847274|471362155|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130925503|NCT01847274|471362156|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130925504|NCT01847274|471362157|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130925505|NCT01847274|471362147|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130925506|NCT01847274|471362148|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130925507|NCT01847274|471362149|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130925508|NCT01847274|471362150|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130925509|NCT01847274|471362151|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130925510|NCT01847274|471362152|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
130925511|NCT01847274|471362153|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130925512|NCT01847274|471362154|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130925513|NCT01847274|471362155|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130925514|NCT01847274|471362156|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130925515|NCT01847274|471362157|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
130925516|NCT01847274|471362147|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130925517|NCT01847274|471362148|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130925518|NCT01847274|471362149|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130925519|NCT01847274|471362150|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130925520|NCT01847274|471362151|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
130925521|NCT01847274|471362152|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130925522|NCT01847274|471362153|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130925523|NCT01847274|471362154|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130925524|NCT01847274|471362155|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130925525|NCT01847274|471362156|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130925526|NCT01847274|471362157|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
130925527|NCT01847274|471362147|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130925528|NCT01847274|471362148|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130925529|NCT01847274|471362149|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130925530|NCT01847274|471362150|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130925531|NCT01847274|471362151|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130925532|NCT01847274|471362152|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130925533|NCT01847274|471362153|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
130925534|NCT01847274|471362154|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130925535|NCT01847274|471362155|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
131120238|NCT00467779|472072319|FG008|Stage 2A|Adverse Event|0|||
130701312|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
130701313|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
130701314|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
130701315|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
130701316|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
130701317|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
130701318|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
130701319|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
130701320|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
130701321|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
130701322|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
130701323|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
130701324|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
130701325|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
130701326|NCT01067521|470530348|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
130701327|NCT01067521|470530349|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
130701328|NCT01067521|470530348|FG000|Open-Label Period|Death|3|||
130701329|NCT01067521|470530349|FG001|Open-Label Period|Death|1|||
130925536|NCT01847274|471362156|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130925537|NCT01847274|471362157|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
130925538|NCT01847274|471362147|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130925539|NCT01847274|471362148|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130925540|NCT01847274|471362149|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130925541|NCT01847274|471362150|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130925542|NCT01847274|471362151|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130925543|NCT01847274|471362152|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130925544|NCT01847274|471362153|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
130925545|NCT01847274|471362154|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130925546|NCT01847274|471362155|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130925547|NCT01847274|471362156|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130925548|NCT01847274|471362157|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130925549|NCT01847274|471362147|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130925550|NCT01847274|471362148|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130925551|NCT01847274|471362149|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130925552|NCT01847274|471362150|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130925553|NCT01847274|471362151|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130925554|NCT01847274|471362152|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130925555|NCT01847274|471362153|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
130925556|NCT01847274|471362154|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130925557|NCT01847274|471362155|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130925558|NCT01847274|471362156|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130925559|NCT01847274|471362157|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130925560|NCT01847274|471362147|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130925561|NCT01847274|471362148|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130925562|NCT01847274|471362149|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130925563|NCT01847274|471362150|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130925564|NCT01847274|471362151|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130925565|NCT01847274|471362152|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130925566|NCT01847274|471362153|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
130925567|NCT01847274|471362154|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
130925568|NCT01847274|471362155|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
130925569|NCT01847274|471362156|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
130925570|NCT01847274|471362157|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
130925571|NCT01847274|471362147|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130701330|NCT01067521|470530348|FG000|Open-Label Period|Adverse Event|30|||
130701331|NCT01067521|470530349|FG001|Open-Label Period|Adverse Event|28|||
130701332|NCT01067521|470530348|FG000|Open-Label Period|Withdrawal by Subject|160|||
130701333|NCT01067521|470530349|FG001|Open-Label Period|Withdrawal by Subject|88|||
130701334|NCT01067521|470530348|FG000|Open-Label Period|Physician Decision|13|||
130701335|NCT01067521|470530349|FG001|Open-Label Period|Physician Decision|11|||
130701336|NCT01067521|470530348|FG000|Open-Label Period|Non-compliance with study drug|5|||
130701337|NCT01067521|470530349|FG001|Open-Label Period|Non-compliance with study drug|0|||
130701338|NCT01067521|470530348|FG000|Open-Label Period|Protocol Violation|3|||
130701339|NCT01067521|470530349|FG001|Open-Label Period|Protocol Violation|0|||
130701340|NCT01067521|470530348|FG000|Open-Label Period|Pregnancy|14|||
130701341|NCT01067521|470530349|FG001|Open-Label Period|Pregnancy|8|||
131223442|NCT01335399|472446998|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
131223443|NCT01335399|472446999|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
131223444|NCT01335399|472446998|FG000|Pre-treatment Period|Consent withdrawal|3|||
131223445|NCT01335399|472446999|FG001|Pre-treatment Period|Consent withdrawal|0|||
131223446|NCT01335399|472446998|FG000|Treatment Period|Disease progression|117|||
131223447|NCT01335399|472446999|FG001|Treatment Period|Disease progression|145|||
131223448|NCT01335399|472446998|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
131223449|NCT01335399|472446999|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
131223450|NCT01335399|472446998|FG000|Treatment Period|Study drug toxicity|52|||
131223451|NCT01335399|472446999|FG001|Treatment Period|Study drug toxicity|64|||
131223452|NCT01335399|472446998|FG000|Treatment Period|Participant request to discontinue|30|||
131223453|NCT01335399|472446999|FG001|Treatment Period|Participant request to discontinue|22|||
131223454|NCT01335399|472446998|FG000|Treatment Period|Other reasons|30|||
131223455|NCT01335399|472446999|FG001|Treatment Period|Other reasons|30|||
130701342|NCT01067521|470530348|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
130701343|NCT01067521|470530349|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
130701344|NCT01067521|470530348|FG000|Open-Label Period|Lost to Follow-up|21|||
130701345|NCT01067521|470530349|FG001|Open-Label Period|Lost to Follow-up|20|||
130701346|NCT02760433|470530351|FG000|Overall Study|Lost to Follow-up|1|||
130701347|NCT02760433|470530352|FG001|Overall Study|Lost to Follow-up|0|||
130701348|NCT02760433|470530353|FG002|Overall Study|Lost to Follow-up|1|||
130701349|NCT02760433|470530354|FG003|Overall Study|Lost to Follow-up|0|||
130701350|NCT02760433|470530355|FG004|Overall Study|Lost to Follow-up|0|||
130701351|NCT02760433|470530351|FG000|Overall Study|Withdrawal by Subject|23|||
130701352|NCT02760433|470530352|FG001|Overall Study|Withdrawal by Subject|9|||
130701353|NCT02760433|470530353|FG002|Overall Study|Withdrawal by Subject|0|||
130701354|NCT02760433|470530354|FG003|Overall Study|Withdrawal by Subject|2|||
130701355|NCT02760433|470530355|FG004|Overall Study|Withdrawal by Subject|9|||
130701356|NCT02760433|470530351|FG000|Overall Study|Lack of Response At Week 14|0|||
130701357|NCT02760433|470530352|FG001|Overall Study|Lack of Response At Week 14|0|||
130701358|NCT02760433|470530353|FG002|Overall Study|Lack of Response At Week 14|0|||
130701359|NCT02760433|470530354|FG003|Overall Study|Lack of Response At Week 14|0|||
130701360|NCT02760433|470530355|FG004|Overall Study|Lack of Response At Week 14|1|||
130701361|NCT02760433|470530351|FG000|Overall Study|Subject refused to continue the study|1|||
130701362|NCT02760433|470530352|FG001|Overall Study|Subject refused to continue the study|0|||
130701363|NCT02760433|470530353|FG002|Overall Study|Subject refused to continue the study|0|||
130701364|NCT02760433|470530354|FG003|Overall Study|Subject refused to continue the study|0|||
130701365|NCT02760433|470530355|FG004|Overall Study|Subject refused to continue the study|0|||
130701366|NCT02760433|470530351|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
130701367|NCT02760433|470530352|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130701368|NCT02760433|470530353|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130701369|NCT02760433|470530354|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130701370|NCT02760433|470530355|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130701371|NCT02760433|470530351|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130701372|NCT02760433|470530352|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
130701373|NCT02760433|470530353|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130769888|NCT00703118|470782567|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
130925572|NCT01847274|471362148|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130925573|NCT01847274|471362149|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130925574|NCT01847274|471362150|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130925575|NCT01847274|471362151|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130925576|NCT01847274|471362152|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130925577|NCT01847274|471362153|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130925578|NCT01847274|471362154|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
130925579|NCT01847274|471362155|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130925580|NCT01847274|471362156|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
130925581|NCT01847274|471362157|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
130925582|NCT01847274|471362147|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130925583|NCT01847274|471362148|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130925584|NCT01847274|471362149|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130925585|NCT01847274|471362150|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130925586|NCT01847274|471362151|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
131223456|NCT01335399|472446998|FG000|Treatment Period|Consent withdrawal|10|||
131223457|NCT01335399|472446999|FG001|Treatment Period|Consent withdrawal|7|||
131223458|NCT01335399|472446998|FG000|Treatment Period|Death|7|||
131223459|NCT01335399|472446999|FG001|Treatment Period|Death|6|||
130701374|NCT02760433|470530354|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130701375|NCT02760433|470530355|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130701376|NCT02151149|470530356|FG000|Treatment Period|Death|2|||
130701377|NCT02151149|470530357|FG001|Treatment Period|Death|3|||
130701378|NCT02151149|470530356|FG000|Treatment Period|Adverse Event|17|||
130701379|NCT02151149|470530357|FG001|Treatment Period|Adverse Event|14|||
130701380|NCT02151149|470530356|FG000|Treatment Period|Progressive Disease|25|||
130701381|NCT02151149|470530357|FG001|Treatment Period|Progressive Disease|24|||
130701382|NCT02151149|470530356|FG000|Treatment Period|Symptomatic Deterioration|2|||
130925587|NCT01847274|471362152|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130701383|NCT02151149|470530357|FG001|Treatment Period|Symptomatic Deterioration|10|||
130701384|NCT02151149|470530356|FG000|Treatment Period|Withdrawal by Subject|13|||
130701385|NCT02151149|470530357|FG001|Treatment Period|Withdrawal by Subject|11|||
130701386|NCT02151149|470530356|FG000|Treatment Period|Miscellaneous|8|||
130701387|NCT02151149|470530357|FG001|Treatment Period|Miscellaneous|7|||
130701388|NCT02151149|470530356|FG000|Treatment Period|Participants randomized but not treated|3|||
130701389|NCT02151149|470530357|FG001|Treatment Period|Participants randomized but not treated|2|||
130701390|NCT02151149|470530356|FG000|Follow-Up Period|Lost to Follow-up|2|||
130701391|NCT02151149|470530357|FG001|Follow-Up Period|Lost to Follow-up|3|||
130701392|NCT02151149|470530356|FG000|Follow-Up Period|Death|37|||
130701393|NCT02151149|470530357|FG001|Follow-Up Period|Death|34|||
130701394|NCT00766493|470530358|FG000|30 Days Post-Procedure|Discontinued|7|||
130701395|NCT00766493|470530358|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
130701396|NCT00766493|470530358|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
130701397|NCT03419962|470530361|FG000|Overall Study|Change to other medication|1|||
130701398|NCT03419962|470530361|FG000|Overall Study|Refusal of continuing with trial drug|1|||
130701399|NCT03419962|470530361|FG000|Overall Study|Lost to Follow-up|3|||
130701400|NCT03419962|470530361|FG000|Overall Study|Difficulty in inhaling the doses|1|||
130701401|NCT03419962|470530361|FG000|Overall Study|Missing completion data|31|||
130701402|NCT02914457|470530362|FG000|Overall Study|Withdrawal by Subject|1|||
130701403|NCT02914457|470530362|FG000|Overall Study|Physician Decision|1|||
130701404|NCT02914457|470530362|FG000|Overall Study|No veins available for lead placement|1|||
130701405|NCT02914457|470530362|FG000|Overall Study|Electrical instability of patient|1|||
130701406|NCT02914457|470530362|FG000|Overall Study|ECG acquisition error due to sweating|1|||
130701407|NCT02914457|470530362|FG000|Overall Study|Protocol Violation|1|||
130701408|NCT03439085|470530366|FG000|Overall Study|Death|2|||
130701409|NCT03439085|470530366|FG000|Overall Study|Screen Failure|20|||
130701410|NCT01863433|470530367|FG000|Overall Study|Protocol Violation|1|||
130701411|NCT01292837|470530368|FG000|Overall Study|Adverse Event|1|||
130701412|NCT01292837|470530368|FG000|Overall Study|Further treatment determined|1|||
130701413|NCT01206439|470530369|FG000|Overall Study|subject did not meet inclusion criteria|1|||
130701414|NCT04531527|470530370|FG000|Overall Study|Found to be Ineligible|3|||
130701415|NCT00982228|470530380|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
130701416|NCT00982228|470530381|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
130701417|NCT00982228|470530380|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
130701418|NCT00982228|470530381|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
130925588|NCT01847274|471362153|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130925589|NCT01847274|471362154|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
130925590|NCT01847274|471362155|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130925591|NCT01847274|471362156|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
130925592|NCT01847274|471362157|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
130925593|NCT01847274|471362147|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130925594|NCT01847274|471362148|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130925595|NCT01847274|471362149|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130925596|NCT01847274|471362150|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130925597|NCT01847274|471362151|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130701419|NCT00982228|470530380|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
130701420|NCT00982228|470530381|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
130701421|NCT00982228|470530380|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
130701422|NCT00982228|470530381|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
130701423|NCT00982228|470530380|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
130701424|NCT00982228|470530381|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
130701425|NCT00982228|470530380|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
130701426|NCT00982228|470530381|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
130701427|NCT00982228|470530380|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
130701428|NCT00982228|470530381|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
130925598|NCT01847274|471362152|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130701429|NCT00982228|470530380|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
130701430|NCT00982228|470530381|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
130701431|NCT00982228|470530380|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
130701432|NCT00982228|470530381|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
130701433|NCT00982228|470530380|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
130701434|NCT00982228|470530381|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
130701435|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
130701436|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
130701437|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
130701438|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
130701439|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
130701440|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
130701441|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
130701442|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
130701443|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
130701444|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
130701445|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
130701446|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
130701447|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
130701448|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
130701449|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
130701450|NCT02250651|470530382|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
130701451|NCT02250651|470530383|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
130701452|NCT02250651|470530384|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
130701453|NCT02250651|470530382|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
130701454|NCT02250651|470530383|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
130701455|NCT02250651|470530384|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
130701456|NCT02250651|470530382|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
130701457|NCT02250651|470530383|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
130701458|NCT02250651|470530384|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
130701459|NCT02250651|470530382|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
130769889|NCT00703118|470782568|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
130925599|NCT01847274|471362153|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130925600|NCT01847274|471362154|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130925601|NCT01847274|471362155|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130925602|NCT01847274|471362156|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
130925603|NCT01847274|471362157|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130925604|NCT03727230|471362158|FG000|Overall Study|Lost to Follow-up|12|||
130925605|NCT04377620|471362160|FG000|Overall Study|Death|42|||
130925606|NCT04377620|471362161|FG001|Overall Study|Death|48|||
130925607|NCT04377620|471362162|FG002|Overall Study|Death|36|||
130925608|NCT04377620|471362160|FG000|Overall Study|Withdrawal by Subject|0|||
130925609|NCT04377620|471362161|FG001|Overall Study|Withdrawal by Subject|2|||
130925610|NCT04377620|471362162|FG002|Overall Study|Withdrawal by Subject|0|||
130925611|NCT02849678|471362163|FG000|Overall Study|Protocol Violation|3|||
130925612|NCT02849678|471362164|FG001|Overall Study|Protocol Violation|6|||
130925613|NCT00289991|471362166|FG000|Overall Study|Death|35|||
130925614|NCT00289991|471362167|FG001|Overall Study|Death|38|||
130925615|NCT00289991|471362166|FG000|Overall Study|Adverse Event|15|||
130925616|NCT00289991|471362167|FG001|Overall Study|Adverse Event|13|||
130701460|NCT02250651|470530383|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
130701461|NCT02250651|470530384|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
130701462|NCT02250651|470530382|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
130701463|NCT02250651|470530383|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
130701464|NCT02250651|470530384|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
130701465|NCT02250651|470530382|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
130701466|NCT02250651|470530383|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
130701467|NCT02250651|470530384|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
130701468|NCT02250651|470530382|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
130701469|NCT02250651|470530383|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
130701470|NCT02250651|470530384|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
130701471|NCT02250651|470530382|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
130701472|NCT02250651|470530383|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
130701473|NCT02250651|470530384|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
130925617|NCT00289991|471362166|FG000|Overall Study|Failure of prophylaxis|1|||
130925618|NCT00289991|471362167|FG001|Overall Study|Failure of prophylaxis|1|||
130925619|NCT00289991|471362166|FG000|Overall Study|Fungal breakthrough infection|0|||
130925620|NCT00289991|471362167|FG001|Overall Study|Fungal breakthrough infection|1|||
130925621|NCT00289991|471362166|FG000|Overall Study|Lost to Follow-up|0|||
130925622|NCT00289991|471362167|FG001|Overall Study|Lost to Follow-up|1|||
130925623|NCT00289991|471362166|FG000|Overall Study|Withdrawal by Subject|2|||
130925624|NCT00289991|471362167|FG001|Overall Study|Withdrawal by Subject|12|||
130925625|NCT00289991|471362166|FG000|Overall Study|Other|5|||
130925626|NCT00289991|471362167|FG001|Overall Study|Other|14|||
130925627|NCT00913497|471362168|FG000|Overall Study|Adverse Event|1|||
130925628|NCT00913497|471362168|FG000|Overall Study|Withdrawal by Subject|2|||
130925629|NCT02002091|471362175|FG000|Screening|Lost to Follow-up|10|||
130925630|NCT02002091|471362176|FG001|Screening|Lost to Follow-up|12|||
130925631|NCT02002091|471362175|FG000|Screening|Death|3|||
130925632|NCT02002091|471362176|FG001|Screening|Death|2|||
130925633|NCT03385564|471362177|FG000|Overall Study|Adverse Event|0|||
130925634|NCT03385564|471362178|FG001|Overall Study|Adverse Event|0|||
130925635|NCT03385564|471362179|FG002|Overall Study|Adverse Event|3|||
130925636|NCT03385564|471362180|FG003|Overall Study|Adverse Event|3|||
130925637|NCT03385564|471362177|FG000|Overall Study|Other than listed|0|||
130925638|NCT03385564|471362178|FG001|Overall Study|Other than listed|0|||
130925639|NCT03385564|471362179|FG002|Overall Study|Other than listed|0|||
130925640|NCT03385564|471362180|FG003|Overall Study|Other than listed|5|||
130925641|NCT03385564|471362177|FG000|Overall Study|Withdrawal by Subject|0|||
130925642|NCT03385564|471362178|FG001|Overall Study|Withdrawal by Subject|1|||
130925643|NCT03385564|471362179|FG002|Overall Study|Withdrawal by Subject|1|||
130925644|NCT03385564|471362180|FG003|Overall Study|Withdrawal by Subject|0|||
130925645|NCT03385564|471362177|FG000|Overall Study|Lack of Efficacy|0|||
130925646|NCT03385564|471362178|FG001|Overall Study|Lack of Efficacy|0|||
130925647|NCT03385564|471362179|FG002|Overall Study|Lack of Efficacy|0|||
130925648|NCT03385564|471362180|FG003|Overall Study|Lack of Efficacy|1|||
130925649|NCT03385564|471362177|FG000|Overall Study|Death|0|||
130925650|NCT03385564|471362178|FG001|Overall Study|Death|0|||
130925651|NCT03385564|471362179|FG002|Overall Study|Death|1|||
130925652|NCT03385564|471362180|FG003|Overall Study|Death|0|||
130925653|NCT00282984|471362190|FG000|Overall Study|Death|2|||
130925654|NCT00282984|471362191|FG001|Overall Study|Death|5|||
130925655|NCT00282984|471362190|FG000|Overall Study|Adverse Event|8|||
130925656|NCT00282984|471362191|FG001|Overall Study|Adverse Event|5|||
130925657|NCT00282984|471362190|FG000|Overall Study|Lack of Efficacy|0|||
130925658|NCT00282984|471362191|FG001|Overall Study|Lack of Efficacy|2|||
130925659|NCT00282984|471362190|FG000|Overall Study|Lost to Follow-up|14|||
130925660|NCT00282984|471362191|FG001|Overall Study|Lost to Follow-up|10|||
130925661|NCT00282984|471362190|FG000|Overall Study|Withdrawal by Participant|22|||
130925662|NCT00282984|471362191|FG001|Overall Study|Withdrawal by Participant|34|||
130925663|NCT00282984|471362190|FG000|Overall Study|Participant stopped study medication|2|||
130925664|NCT00282984|471362191|FG001|Overall Study|Participant stopped study medication|2|||
130925665|NCT00282984|471362190|FG000|Overall Study|Participant only allowed phone follow-up|0|||
130925666|NCT00282984|471362191|FG001|Overall Study|Participant only allowed phone follow-up|1|||
130925667|NCT00282984|471362190|FG000|Overall Study|Participant used antipsychosis meds|0|||
130925668|NCT00282984|471362191|FG001|Overall Study|Participant used antipsychosis meds|1|||
130925669|NCT00282984|471362190|FG000|Overall Study|lack of motivation|1|||
130925670|NCT00282984|471362191|FG001|Overall Study|lack of motivation|0|||
130925671|NCT00282984|471362190|FG000|Overall Study|in prison|0|||
130925672|NCT00282984|471362191|FG001|Overall Study|in prison|1|||
130925673|NCT00282984|471362190|FG000|Overall Study|Protocol Violation|2|||
130925674|NCT00282984|471362191|FG001|Overall Study|Protocol Violation|0|||
130925675|NCT00457301|471362192|FG000|Overall Study|Withdrawal by Subject|3|||
130925676|NCT00457301|471362193|FG001|Overall Study|Withdrawal by Subject|3|||
130925677|NCT00457301|471362192|FG000|Overall Study|Censored out of the study|15|||
130925678|NCT00457301|471362193|FG001|Overall Study|Censored out of the study|14|||
130925679|NCT00457301|471362192|FG000|Overall Study|Death|5|||
130925680|NCT00457301|471362193|FG001|Overall Study|Death|7|||
130925681|NCT01128842|471362196|FG000|Overall Study|Adverse Event|1|||
130925682|NCT01128842|471362196|FG000|Overall Study|Disease Progression|6|||
130925683|NCT00478231|471362197|FG000|Overall Study|Death|7|||
130925684|NCT00478231|471362197|FG000|Overall Study|Lack of Efficacy|47|||
130925685|NCT00478231|471362197|FG000|Overall Study|Lost to Follow-up|7|||
130925686|NCT00478231|471362197|FG000|Overall Study|Withdrawal by Subject|6|||
130925687|NCT00478231|471362197|FG000|Overall Study|Other|9|||
130925688|NCT00478231|471362197|FG000|Overall Study|Adverse Event|5|||
130925689|NCT00478231|471362197|FG000|Overall Study|Randomized, not treated|3|||
130925690|NCT03035409|471362200|FG000|Overall Study|Adverse Event|5|||
130925691|NCT03035409|471362200|FG000|Overall Study|Death|2|||
130925692|NCT03035409|471362200|FG000|Overall Study|Withdrawal by Subject|2|||
130925693|NCT03035409|471362200|FG000|Overall Study|Non compliance|4|||
130925694|NCT03035409|471362200|FG000|Overall Study|Patient was jittery|1|||
130701474|NCT02250651|470530382|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
130925695|NCT03035409|471362200|FG000|Overall Study|Did not like Questionnaire|1|||
130925696|NCT03035409|471362200|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
130925697|NCT03035409|471362200|FG000|Overall Study|Did not like taking drugs|1|||
130925698|NCT01552694|471362203|FG000|Overall Study|Lost to Follow-up|0|||
130925699|NCT01552694|471362204|FG001|Overall Study|Lost to Follow-up|1|||
130925700|NCT01552694|471362203|FG000|Overall Study|Protocol Violation|0|||
130925701|NCT01552694|471362204|FG001|Overall Study|Protocol Violation|1|||
130701475|NCT02250651|470530383|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
130701476|NCT02250651|470530384|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
130701477|NCT02250651|470530382|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
130701478|NCT02250651|470530383|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
130701479|NCT02250651|470530384|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
130701480|NCT03496298|470530385|FG000|Overall Study|Adverse Event|49|||
130701481|NCT03496298|470530386|FG001|Overall Study|Adverse Event|68|||
130701482|NCT03496298|470530387|FG002|Overall Study|Adverse Event|79|||
130701483|NCT03496298|470530385|FG000|Overall Study|Study terminated by Sponsor|1050|||
130701484|NCT03496298|470530386|FG001|Overall Study|Study terminated by Sponsor|1063|||
130701485|NCT03496298|470530387|FG002|Overall Study|Study terminated by Sponsor|1071|||
130701486|NCT03496298|470530385|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
130701487|NCT03496298|470530386|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
130701488|NCT03496298|470530387|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
130701489|NCT03496298|470530385|FG000|Overall Study|Withdrawal by Subject|176|||
130701490|NCT03496298|470530386|FG001|Overall Study|Withdrawal by Subject|154|||
130701491|NCT03496298|470530387|FG002|Overall Study|Withdrawal by Subject|151|||
130701492|NCT03496298|470530385|FG000|Overall Study|Other|29|||
130701493|NCT03496298|470530386|FG001|Overall Study|Other|20|||
130925702|NCT03724032|471362206|FG000|Overall Study|Physician Decision|1|||
130925703|NCT03724032|471362207|FG001|Overall Study|Physician Decision|0|||
130925704|NCT03724032|471362208|FG002|Overall Study|Physician Decision|0|||
130925705|NCT03724032|471362206|FG000|Overall Study|Protocol Violation|2|||
130925706|NCT03724032|471362207|FG001|Overall Study|Protocol Violation|2|||
130925707|NCT03724032|471362208|FG002|Overall Study|Protocol Violation|1|||
130925708|NCT00001880|471362209|FG000|Overall Study|Death|14|||
130925709|NCT00824720|471362210|FG000|Overall Study|failed plug insertion|3|||
130925710|NCT00824720|471362211|FG001|Overall Study|failed plug insertion|1|||
130925711|NCT00824720|471362212|FG002|Overall Study|failed plug insertion|0|||
130925712|NCT00824720|471362210|FG000|Overall Study|Protocol Violation|0|||
130925713|NCT00824720|471362211|FG001|Overall Study|Protocol Violation|0|||
130925714|NCT00824720|471362212|FG002|Overall Study|Protocol Violation|1|||
130925715|NCT00873015|471362213|FG000|Overall Study|Withdrawal by Subject|0|||
130925716|NCT00873015|471362214|FG001|Overall Study|Withdrawal by Subject|1|||
130925717|NCT00873015|471362215|FG002|Overall Study|Withdrawal by Subject|0|||
130925718|NCT00873015|471362216|FG003|Overall Study|Withdrawal by Subject|0|||
130925719|NCT04094883|471362217|FG000|Overall Study|Withdrawal by Subject|1|||
130925720|NCT01382212|471362219|FG000|Overall Study|Kidney transplant|1|||
130925721|NCT01382212|471362219|FG000|Overall Study|Withdrew consent|1|||
130925722|NCT01273597|471362220|FG000|Overall Study|Adverse Event|5|||
130925723|NCT01273597|471362220|FG000|Overall Study|Underwent Kidney Transplantation|2|||
130925724|NCT01273597|471362220|FG000|Overall Study|Reason Not Reported|1|||
130925725|NCT02513394|471362233|FG000|Overall Study|Withdrawal by Subject|11|||
130925726|NCT02513394|471362234|FG001|Overall Study|Withdrawal by Subject|23|||
130925727|NCT02513394|471362233|FG000|Overall Study|Ineligible|1|||
130925728|NCT02513394|471362234|FG001|Overall Study|Ineligible|0|||
130925729|NCT00688753|471364097|FG000|Overall Study|Disease progression|55|||
130925730|NCT00688753|471364097|FG000|Overall Study|Missing|1|||
130925731|NCT00688753|471364097|FG000|Overall Study|Death|9|||
130925732|NCT00688753|471364097|FG000|Overall Study|Withdrawal by Subject|3|||
130925733|NCT00688753|471364097|FG000|Overall Study|Adverse Event|20|||
130925734|NCT00688753|471364097|FG000|Overall Study|Protocol Violation|1|||
130925735|NCT00688753|471364097|FG000|Overall Study|Lost to Follow-up|3|||
130925736|NCT03187197|471364102|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
130925737|NCT03187197|471364103|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
130925738|NCT03187197|471364104|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
130925739|NCT03187197|471364102|FG000|Overall Study|Withdrawal by Subject|8|||
130925740|NCT03187197|471364103|FG001|Overall Study|Withdrawal by Subject|63|||
130925741|NCT03187197|471364104|FG002|Overall Study|Withdrawal by Subject|4|||
130925742|NCT03187197|471364102|FG000|Overall Study|Lost to Follow-up|1|||
130925743|NCT03187197|471364103|FG001|Overall Study|Lost to Follow-up|60|||
131223460|NCT01335399|472446998|FG000|Treatment Period|Poor/Non-compliance|3|||
130701494|NCT03496298|470530387|FG002|Overall Study|Other|23|||
130701495|NCT03496298|470530385|FG000|Overall Study|Randomized and not treated|1|||
130701496|NCT03496298|470530386|FG001|Overall Study|Randomized and not treated|1|||
130701497|NCT03496298|470530387|FG002|Overall Study|Randomized and not treated|1|||
130701498|NCT01438476|470530390|FG000|Overall Study|Protocol Violation|1|||
130769890|NCT00703118|470782569|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
130925744|NCT03187197|471364104|FG002|Overall Study|Lost to Follow-up|7|||
130925745|NCT03187197|471364102|FG000|Overall Study|Adverse Event|6|||
130925746|NCT03187197|471364103|FG001|Overall Study|Adverse Event|29|||
130925747|NCT03187197|471364104|FG002|Overall Study|Adverse Event|0|||
131223461|NCT01335399|472446999|FG001|Treatment Period|Poor/Non-compliance|4|||
131223462|NCT01335399|472446998|FG000|Treatment Period|Lost to Follow-up|2|||
130925748|NCT03187197|471364102|FG000|Overall Study|Death|0|||
130925749|NCT03187197|471364103|FG001|Overall Study|Death|11|||
130925750|NCT03187197|471364104|FG002|Overall Study|Death|0|||
131223463|NCT01335399|472446999|FG001|Treatment Period|Lost to Follow-up|2|||
131223464|NCT01335399|472446998|FG000|Treatment Period|Maximum clinical benefit|1|||
131223465|NCT01335399|472446999|FG001|Treatment Period|Maximum clinical benefit|1|||
131223466|NCT01335399|472446998|FG000|Treatment Period|No longer meet study criteria|1|||
131223467|NCT01335399|472446999|FG001|Treatment Period|No longer meet study criteria|1|||
131223468|NCT01335399|472446998|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
131223469|NCT01335399|472446999|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
131223470|NCT01416142|472447000|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
131223471|NCT01416142|472447001|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
131223472|NCT01416142|472447002|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
131223473|NCT02464059|472447003|FG000|Overall Study|Lost to Follow-up|6|||
131223474|NCT01835132|472447012|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
131223475|NCT00782275|472447014|FG000|Overall Study|Adverse Event|11|||
131223476|NCT00782275|472447014|FG000|Overall Study|Withdrawal by Subject|1|||
131223477|NCT00782275|472447014|FG000|Overall Study|Progressive Disease|21|||
131223478|NCT00782275|472447014|FG000|Overall Study|Physician Decision|4|||
131223479|NCT00782275|472447014|FG000|Overall Study|Not started treatment|1|||
131223480|NCT00782275|472447014|FG000|Overall Study|Other|3|||
131223481|NCT00331773|472447017|FG000|Overall Study|Withdrawal by Subject|6|||
131223482|NCT00331773|472447018|FG001|Overall Study|Withdrawal by Subject|4|||
131223483|NCT00331773|472447017|FG000|Overall Study|Protocol Violation|10|||
131223484|NCT00331773|472447018|FG001|Overall Study|Protocol Violation|3|||
131223485|NCT00289731|472447019|FG000|Overall Study|Adverse Event|1|||
131223486|NCT00289731|472447020|FG001|Overall Study|Adverse Event|2|||
131223487|NCT00289731|472447021|FG002|Overall Study|Adverse Event|2|||
131223488|NCT00289731|472447019|FG000|Overall Study|Other|1|||
131223489|NCT00289731|472447020|FG001|Overall Study|Other|0|||
131223490|NCT00289731|472447021|FG002|Overall Study|Other|0|||
131223491|NCT02019979|472447022|FG000|Overall Study|study terminated|14|||
131223492|NCT00525031|472447030|FG000|Overall Study|Disease Progression|1|||
131223493|NCT00525031|472447031|FG001|Overall Study|Disease Progression|1|||
131223494|NCT02140164|472447032|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
131223495|NCT01872689|472447037|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
131223496|NCT01872689|472447038|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
131223497|NCT01872689|472447039|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
131223498|NCT01872689|472447040|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
131223499|NCT01872689|472447037|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
131223500|NCT01872689|472447038|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
131223501|NCT01872689|472447039|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
131223502|NCT01872689|472447040|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
131223503|NCT01872689|472447037|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
131223504|NCT01872689|472447038|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
131223505|NCT01872689|472447039|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
131223506|NCT01872689|472447040|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
131223507|NCT01872689|472447037|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
131223508|NCT01872689|472447038|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
131223509|NCT01872689|472447039|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
131223510|NCT01872689|472447040|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
131223511|NCT01872689|472447037|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
131223512|NCT01872689|472447038|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
131223513|NCT01872689|472447039|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
131223514|NCT01872689|472447040|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
131223515|NCT01872689|472447037|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
131223516|NCT01872689|472447038|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
131223517|NCT01872689|472447039|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
131223518|NCT01872689|472447040|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
131223519|NCT01872689|472447037|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
131223520|NCT01872689|472447038|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
131223521|NCT01872689|472447039|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
131223522|NCT01872689|472447040|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
131223523|NCT01872689|472447037|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
131223524|NCT01872689|472447038|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
130701499|NCT01438476|470530391|FG001|Overall Study|Protocol Violation|0|||
130701500|NCT01438476|470530390|FG000|Overall Study|Withdrawal by Subject|1|||
130701501|NCT01438476|470530391|FG001|Overall Study|Withdrawal by Subject|0|||
130701502|NCT01438476|470530390|FG000|Overall Study|No Surgery- Disease|8|||
130701503|NCT01438476|470530391|FG001|Overall Study|No Surgery- Disease|10|||
131223525|NCT01872689|472447039|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
131223526|NCT01872689|472447040|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
131223527|NCT01872689|472447037|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
130701504|NCT01438476|470530390|FG000|Overall Study|Communication barrier|0|||
130701505|NCT01438476|470530391|FG001|Overall Study|Communication barrier|1|||
130701506|NCT02522780|470530396|FG000|Overall Study|Consent withdrawn by subject|5|||
130701507|NCT02522780|470530397|FG001|Overall Study|Consent withdrawn by subject|7|||
130701508|NCT02522780|470530396|FG000|Overall Study|Protocol deviation|1|||
130701509|NCT02522780|470530397|FG001|Overall Study|Protocol deviation|3|||
130701510|NCT02522780|470530396|FG000|Overall Study|Subject refused endoscopic procedure|0|||
130701511|NCT02522780|470530397|FG001|Overall Study|Subject refused endoscopic procedure|1|||
130701512|NCT02522780|470530396|FG000|Overall Study|Adverse event, non-fatal|11|||
130701513|NCT02522780|470530397|FG001|Overall Study|Adverse event, non-fatal|16|||
130701514|NCT02058160|470530398|FG000|Overall Study|Randomized but not treated|2|||
130701515|NCT02058160|470530399|FG001|Overall Study|Randomized but not treated|4|||
130701516|NCT02058160|470530398|FG000|Overall Study|Poor compliance to protocol|4|||
130701517|NCT02058160|470530399|FG001|Overall Study|Poor compliance to protocol|1|||
130925751|NCT03187197|471364102|FG000|Overall Study|Administrative problem|1|||
130925752|NCT03187197|471364103|FG001|Overall Study|Administrative problem|1|||
130925753|NCT03187197|471364104|FG002|Overall Study|Administrative problem|0|||
130925754|NCT03187197|471364102|FG000|Overall Study|Reason not listed|2|||
130925755|NCT03187197|471364103|FG001|Overall Study|Reason not listed|54|||
130925756|NCT03187197|471364104|FG002|Overall Study|Reason not listed|1|||
130925757|NCT03187197|471364102|FG000|Overall Study|Missing|1|||
130925758|NCT03187197|471364103|FG001|Overall Study|Missing|32|||
130925759|NCT03187197|471364104|FG002|Overall Study|Missing|3|||
130925760|NCT03187197|471364102|FG000|Overall Study|Status missing|2|||
130925761|NCT03187197|471364103|FG001|Overall Study|Status missing|33|||
130925762|NCT03187197|471364104|FG002|Overall Study|Status missing|3|||
130925763|NCT03187197|471364102|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
130925764|NCT03187197|471364103|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
130925765|NCT03187197|471364104|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
130925766|NCT02385045|471364105|FG000|Overall Study|Endoscopy could not be completed|4|||
130925767|NCT00259649|471364106|FG000|Overall Study|Lost to Follow-up|7|||
130925768|NCT00259649|471364106|FG000|Overall Study|irregular menses|3|||
130925769|NCT00042289|471364108|FG000|Overall Study|Lost to Follow-up|3|||
130925770|NCT00042289|471364109|FG001|Overall Study|Lost to Follow-up|0|||
130925771|NCT00042289|471364110|FG002|Overall Study|Lost to Follow-up|0|||
131223528|NCT01872689|472447038|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
131223529|NCT01872689|472447039|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
131223530|NCT01872689|472447040|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
131223531|NCT01872689|472447037|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
131223532|NCT01872689|472447038|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
131223533|NCT01872689|472447039|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
131223534|NCT01872689|472447040|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
131223535|NCT01872689|472447037|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
130925772|NCT00042289|471364111|FG003|Overall Study|Lost to Follow-up|1|||
130925773|NCT00042289|471364112|FG004|Overall Study|Lost to Follow-up|3|||
130925774|NCT00042289|471364113|FG005|Overall Study|Lost to Follow-up|3|||
130925775|NCT00042289|471364114|FG006|Overall Study|Lost to Follow-up|6|||
130925776|NCT00042289|471364115|FG007|Overall Study|Lost to Follow-up|1|||
130925777|NCT00042289|471364116|FG008|Overall Study|Lost to Follow-up|1|||
130925778|NCT00042289|471364117|FG009|Overall Study|Lost to Follow-up|0|||
130925779|NCT00042289|471364118|FG010|Overall Study|Lost to Follow-up|0|||
130925780|NCT00042289|471364119|FG011|Overall Study|Lost to Follow-up|0|||
130925781|NCT00042289|471364120|FG012|Overall Study|Lost to Follow-up|0|||
130925782|NCT00042289|471364121|FG013|Overall Study|Lost to Follow-up|0|||
130925783|NCT00042289|471364122|FG014|Overall Study|Lost to Follow-up|0|||
130925784|NCT00042289|471364123|FG015|Overall Study|Lost to Follow-up|1|||
130925785|NCT00042289|471364124|FG016|Overall Study|Lost to Follow-up|1|||
130925786|NCT00042289|471364125|FG017|Overall Study|Lost to Follow-up|0|||
130925787|NCT00042289|471364126|FG018|Overall Study|Lost to Follow-up|3|||
130925788|NCT00042289|471364127|FG019|Overall Study|Lost to Follow-up|2|||
130925789|NCT00042289|471364128|FG020|Overall Study|Lost to Follow-up|0|||
130925790|NCT00042289|471364129|FG021|Overall Study|Lost to Follow-up|0|||
130925791|NCT00042289|471364130|FG022|Overall Study|Lost to Follow-up|0|||
130925792|NCT00042289|471364131|FG023|Overall Study|Lost to Follow-up|0|||
130925793|NCT00042289|471364132|FG024|Overall Study|Lost to Follow-up|0|||
130701518|NCT02058160|470530398|FG000|Overall Study|Adverse Event|12|||
130925794|NCT00042289|471364133|FG025|Overall Study|Lost to Follow-up|0|||
130701519|NCT02058160|470530399|FG001|Overall Study|Adverse Event|3|||
130925795|NCT00042289|471364134|FG026|Overall Study|Lost to Follow-up|2|||
130925796|NCT00042289|471364135|FG027|Overall Study|Lost to Follow-up|2|||
130701520|NCT02058160|470530398|FG000|Overall Study|Lost to Follow-up|1|||
130925797|NCT00042289|471364136|FG028|Overall Study|Lost to Follow-up|2|||
130925798|NCT00042289|471364137|FG029|Overall Study|Lost to Follow-up|0|||
130701521|NCT02058160|470530399|FG001|Overall Study|Lost to Follow-up|0|||
130701522|NCT02058160|470530398|FG000|Overall Study|Other than specified above|12|||
130925799|NCT00042289|471364138|FG030|Overall Study|Lost to Follow-up|0|||
130925800|NCT00042289|471364139|FG031|Overall Study|Lost to Follow-up|2|||
130925801|NCT00042289|471364140|FG032|Overall Study|Lost to Follow-up|1|||
130925802|NCT00042289|471364141|FG033|Overall Study|Lost to Follow-up|1|||
130925803|NCT00042289|471364142|FG034|Overall Study|Lost to Follow-up|1|||
130925804|NCT00042289|471364143|FG035|Overall Study|Lost to Follow-up|2|||
130925805|NCT00042289|471364144|FG036|Overall Study|Lost to Follow-up|1|||
130925806|NCT00042289|471364145|FG037|Overall Study|Lost to Follow-up|1|||
130925807|NCT00042289|471364146|FG038|Overall Study|Lost to Follow-up|0|||
130925808|NCT00042289|471364147|FG039|Overall Study|Lost to Follow-up|5|||
130769891|NCT00703118|470782567|FG000|Overall Study|Lost to Follow-up|6|||
130769892|NCT00703118|470782568|FG001|Overall Study|Lost to Follow-up|4|||
130769893|NCT00703118|470782569|FG002|Overall Study|Lost to Follow-up|4|||
130769894|NCT00703118|470782567|FG000|Overall Study|Withdrawal by Subject|8|||
130769895|NCT00703118|470782568|FG001|Overall Study|Withdrawal by Subject|7|||
130769896|NCT00703118|470782569|FG002|Overall Study|Withdrawal by Subject|13|||
130769897|NCT00703118|470782567|FG000|Overall Study|Other|0|||
130769898|NCT00703118|470782568|FG001|Overall Study|Other|0|||
130769899|NCT00703118|470782569|FG002|Overall Study|Other|1|||
130769900|NCT01853696|470782572|FG000|Overall Study|Withdrawal by Subject|1|||
130769901|NCT01853696|470782573|FG001|Overall Study|Withdrawal by Subject|1|||
130769902|NCT01853696|470782572|FG000|Overall Study|Lost to Follow-up|5|||
130769903|NCT01853696|470782573|FG001|Overall Study|Lost to Follow-up|4|||
130769904|NCT00431067|470782574|FG000|Overall Study|Other Adverse Event|9|||
130769905|NCT00431067|470782574|FG000|Overall Study|Progressive disease|30|||
130769906|NCT00431067|470782574|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
130769907|NCT00830518|470782584|FG000|Overall Study|Progressive Disease|18|||
130769908|NCT00830518|470782585|FG001|Overall Study|Progressive Disease|8|||
130769909|NCT00830518|470782584|FG000|Overall Study|Symptomatic Deterioration|4|||
130769910|NCT00830518|470782585|FG001|Overall Study|Symptomatic Deterioration|1|||
130769911|NCT00830518|470782584|FG000|Overall Study|Adverse Event|14|||
130769912|NCT00830518|470782585|FG001|Overall Study|Adverse Event|1|||
130769913|NCT00830518|470782584|FG000|Overall Study|Withdrawal by Patient|2|||
130769914|NCT00830518|470782585|FG001|Overall Study|Withdrawal by Patient|0|||
130769915|NCT00830518|470782584|FG000|Overall Study|Reason not Specified|8|||
130769916|NCT00830518|470782585|FG001|Overall Study|Reason not Specified|1|||
130769917|NCT02155322|470782590|FG000|Overall Study|Adverse Event|1|||
130769918|NCT02155322|470782590|FG000|Overall Study|Physician Decision|1|||
130769919|NCT02155322|470782590|FG000|Overall Study|Relapse/Recurrence|8|||
130769920|NCT02155322|470782590|FG000|Overall Study|Withdrawal by Subject|4|||
130769921|NCT03337048|470782594|FG000|Overall Study|Withdrawal by Subject|2|||
130769922|NCT03337048|470782595|FG001|Overall Study|Withdrawal by Subject|0|||
130769923|NCT03337048|470782596|FG002|Overall Study|Withdrawal by Subject|0|||
130769924|NCT02791438|470782597|FG000|Treatment Period|Adverse Event|1|||
130769925|NCT02791438|470782598|FG001|Treatment Period|Adverse Event|0|||
130769926|NCT02791438|470782597|FG000|Treatment Period|Withdrawal by Subject|0|||
130769927|NCT02791438|470782598|FG001|Treatment Period|Withdrawal by Subject|1|||
130769928|NCT02791438|470782597|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
130769929|NCT02791438|470782598|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
130769930|NCT00394771|470782599|FG000|Overall Study|Did not meet protocol requirements|1|||
130769931|NCT00394771|470782600|FG001|Overall Study|Did not meet protocol requirements|0|||
130769932|NCT00394771|470782601|FG002|Overall Study|Did not meet protocol requirements|2|||
130769933|NCT00394771|470782602|FG003|Overall Study|Did not meet protocol requirements|0|||
130769934|NCT00394771|470782599|FG000|Overall Study|Protocol Violation|2|||
130769935|NCT00394771|470782600|FG001|Overall Study|Protocol Violation|4|||
130769936|NCT00394771|470782601|FG002|Overall Study|Protocol Violation|9|||
130769937|NCT00394771|470782602|FG003|Overall Study|Protocol Violation|7|||
130769938|NCT00394771|470782599|FG000|Overall Study|Withdrawal by Subject|10|||
130769939|NCT00394771|470782600|FG001|Overall Study|Withdrawal by Subject|6|||
130769940|NCT00394771|470782601|FG002|Overall Study|Withdrawal by Subject|8|||
130925809|NCT00042289|471364148|FG040|Overall Study|Lost to Follow-up|0|||
130925810|NCT00042289|471364149|FG041|Overall Study|Lost to Follow-up|2|||
130769941|NCT00394771|470782602|FG003|Overall Study|Withdrawal by Subject|12|||
130769942|NCT00394771|470782599|FG000|Overall Study|Adverse Event|10|||
130769943|NCT00394771|470782600|FG001|Overall Study|Adverse Event|5|||
130769944|NCT00394771|470782601|FG002|Overall Study|Adverse Event|12|||
130769945|NCT00394771|470782602|FG003|Overall Study|Adverse Event|8|||
130769946|NCT00394771|470782599|FG000|Overall Study|Participant pregnant|0|||
130769947|NCT00394771|470782600|FG001|Overall Study|Participant pregnant|1|||
130769948|NCT00394771|470782601|FG002|Overall Study|Participant pregnant|2|||
130769949|NCT00394771|470782602|FG003|Overall Study|Participant pregnant|2|||
130769950|NCT00394771|470782599|FG000|Overall Study|Lost to Follow-up|15|||
130769951|NCT00394771|470782600|FG001|Overall Study|Lost to Follow-up|15|||
130769952|NCT00394771|470782601|FG002|Overall Study|Lost to Follow-up|13|||
130769953|NCT00394771|470782602|FG003|Overall Study|Lost to Follow-up|10|||
130925811|NCT00042289|471364150|FG042|Overall Study|Lost to Follow-up|2|||
131120239|NCT00467779|472072320|FG009|Stage 2A|Adverse Event|0|||
130769954|NCT00394771|470782599|FG000|Overall Study|Other|3|||
130769955|NCT00394771|470782600|FG001|Overall Study|Other|3|||
130769956|NCT00394771|470782601|FG002|Overall Study|Other|1|||
130769957|NCT00394771|470782602|FG003|Overall Study|Other|0|||
130925812|NCT00042289|471364151|FG043|Overall Study|Lost to Follow-up|0|||
130701523|NCT02058160|470530399|FG001|Overall Study|Other than specified above|6|||
130701524|NCT03310619|470530400|FG000|Pre-Treatment Period|Death|1|||
130701525|NCT03310619|470530401|FG001|Pre-Treatment Period|Death|0|||
130701526|NCT03310619|470530402|FG002|Pre-Treatment Period|Death|0|||
130701527|NCT03310619|470530403|FG003|Pre-Treatment Period|Death|0|||
130701528|NCT03310619|470530404|FG004|Pre-Treatment Period|Death|1|||
130701529|NCT03310619|470530405|FG005|Pre-Treatment Period|Death|0|||
130701530|NCT03310619|470530406|FG006|Pre-Treatment Period|Death|0|||
130701531|NCT03310619|470530407|FG007|Pre-Treatment Period|Death|0|||
130701532|NCT03310619|470530400|FG000|Pre-Treatment Period|Other reasons|2|||
130701533|NCT03310619|470530401|FG001|Pre-Treatment Period|Other reasons|1|||
130701534|NCT03310619|470530402|FG002|Pre-Treatment Period|Other reasons|2|||
130701535|NCT03310619|470530403|FG003|Pre-Treatment Period|Other reasons|0|||
130701536|NCT03310619|470530404|FG004|Pre-Treatment Period|Other reasons|0|||
130701537|NCT03310619|470530405|FG005|Pre-Treatment Period|Other reasons|0|||
130701538|NCT03310619|470530406|FG006|Pre-Treatment Period|Other reasons|2|||
130701539|NCT03310619|470530407|FG007|Pre-Treatment Period|Other reasons|0|||
130701540|NCT03310619|470530400|FG000|Treatment Period|Death|1|||
130701541|NCT03310619|470530401|FG001|Treatment Period|Death|2|||
130701542|NCT03310619|470530402|FG002|Treatment Period|Death|0|||
130701543|NCT03310619|470530403|FG003|Treatment Period|Death|0|||
130701544|NCT03310619|470530404|FG004|Treatment Period|Death|1|||
130701545|NCT03310619|470530405|FG005|Treatment Period|Death|0|||
130701546|NCT03310619|470530406|FG006|Treatment Period|Death|2|||
130701547|NCT03310619|470530407|FG007|Treatment Period|Death|0|||
130701548|NCT03310619|470530400|FG000|Treatment Period|Adverse Event|0|||
130701549|NCT03310619|470530401|FG001|Treatment Period|Adverse Event|1|||
130701550|NCT03310619|470530402|FG002|Treatment Period|Adverse Event|4|||
130701551|NCT03310619|470530403|FG003|Treatment Period|Adverse Event|1|||
130701552|NCT03310619|470530404|FG004|Treatment Period|Adverse Event|0|||
130925813|NCT00042289|471364152|FG044|Overall Study|Lost to Follow-up|0|||
130925814|NCT00042289|471364153|FG045|Overall Study|Lost to Follow-up|1|||
130925815|NCT00042289|471364154|FG046|Overall Study|Lost to Follow-up|0|||
130925816|NCT00042289|471364108|FG000|Overall Study|Other reason|0|||
130925817|NCT00042289|471364109|FG001|Overall Study|Other reason|0|||
130925818|NCT00042289|471364110|FG002|Overall Study|Other reason|0|||
130925819|NCT00042289|471364111|FG003|Overall Study|Other reason|2|||
130925820|NCT00042289|471364112|FG004|Overall Study|Other reason|0|||
130925821|NCT00042289|471364113|FG005|Overall Study|Other reason|0|||
130925822|NCT00042289|471364114|FG006|Overall Study|Other reason|0|||
130925823|NCT00042289|471364115|FG007|Overall Study|Other reason|0|||
130925824|NCT00042289|471364116|FG008|Overall Study|Other reason|0|||
130925825|NCT00042289|471364117|FG009|Overall Study|Other reason|0|||
130925826|NCT00042289|471364118|FG010|Overall Study|Other reason|0|||
130925827|NCT00042289|471364119|FG011|Overall Study|Other reason|0|||
130925828|NCT00042289|471364120|FG012|Overall Study|Other reason|0|||
130701553|NCT03310619|470530405|FG005|Treatment Period|Adverse Event|0|||
130701554|NCT03310619|470530406|FG006|Treatment Period|Adverse Event|0|||
130701555|NCT03310619|470530407|FG007|Treatment Period|Adverse Event|0|||
130925829|NCT00042289|471364121|FG013|Overall Study|Other reason|0|||
130925830|NCT00042289|471364122|FG014|Overall Study|Other reason|0|||
130925831|NCT00042289|471364123|FG015|Overall Study|Other reason|0|||
130925832|NCT00042289|471364124|FG016|Overall Study|Other reason|0|||
130701556|NCT03310619|470530400|FG000|Treatment Period|Withdrawal by participant|0|||
130701557|NCT03310619|470530401|FG001|Treatment Period|Withdrawal by participant|0|||
130701558|NCT03310619|470530402|FG002|Treatment Period|Withdrawal by participant|1|||
130701559|NCT03310619|470530403|FG003|Treatment Period|Withdrawal by participant|0|||
130701560|NCT03310619|470530404|FG004|Treatment Period|Withdrawal by participant|0|||
130701561|NCT03310619|470530405|FG005|Treatment Period|Withdrawal by participant|0|||
130701562|NCT03310619|470530406|FG006|Treatment Period|Withdrawal by participant|0|||
130701563|NCT03310619|470530407|FG007|Treatment Period|Withdrawal by participant|0|||
130925833|NCT00042289|471364125|FG017|Overall Study|Other reason|0|||
130925834|NCT00042289|471364126|FG018|Overall Study|Other reason|1|||
130925835|NCT00042289|471364127|FG019|Overall Study|Other reason|0|||
130925836|NCT00042289|471364128|FG020|Overall Study|Other reason|0|||
130701564|NCT03310619|470530400|FG000|Treatment Period|Lost to Follow-up|0|||
130701565|NCT03310619|470530401|FG001|Treatment Period|Lost to Follow-up|0|||
130701566|NCT03310619|470530402|FG002|Treatment Period|Lost to Follow-up|0|||
130701567|NCT03310619|470530403|FG003|Treatment Period|Lost to Follow-up|0|||
130701568|NCT03310619|470530404|FG004|Treatment Period|Lost to Follow-up|0|||
130701569|NCT03310619|470530405|FG005|Treatment Period|Lost to Follow-up|0|||
130701570|NCT03310619|470530406|FG006|Treatment Period|Lost to Follow-up|0|||
130701571|NCT03310619|470530407|FG007|Treatment Period|Lost to Follow-up|1|||
130769958|NCT00586898|470782607|FG000|Overall Study|Adverse Event|1|||
130701572|NCT03310619|470530400|FG000|Treatment Period|Study terminated by sponsor|0|||
130701573|NCT03310619|470530401|FG001|Treatment Period|Study terminated by sponsor|0|||
130925837|NCT00042289|471364129|FG021|Overall Study|Other reason|0|||
130925838|NCT00042289|471364130|FG022|Overall Study|Other reason|0|||
130925839|NCT00042289|471364131|FG023|Overall Study|Other reason|1|||
130925840|NCT00042289|471364132|FG024|Overall Study|Other reason|0|||
130925841|NCT00042289|471364133|FG025|Overall Study|Other reason|0|||
130925842|NCT00042289|471364134|FG026|Overall Study|Other reason|1|||
130925843|NCT00042289|471364135|FG027|Overall Study|Other reason|0|||
130925844|NCT00042289|471364136|FG028|Overall Study|Other reason|3|||
130925845|NCT00042289|471364137|FG029|Overall Study|Other reason|0|||
131034586|NCT03158129|471761724|FG001|Overall Study|No longer surgical candidate|0|||
131034587|NCT03158129|471761725|FG002|Overall Study|No longer surgical candidate|0|||
131034588|NCT03158129|471761726|FG003|Overall Study|No longer surgical candidate|1|||
131034589|NCT04292223|471761740|FG000|Overall Study|Adverse Event|1|||
130925846|NCT00042289|471364138|FG030|Overall Study|Other reason|0|||
131034590|NCT04292223|471761740|FG000|Overall Study|Lost to Follow-up|1|||
131034591|NCT04292223|471761740|FG000|Overall Study|Noncompliance with study drug|2|||
131034592|NCT04292223|471761740|FG000|Overall Study|Patient moved out of the state|1|||
130925847|NCT00042289|471364139|FG031|Overall Study|Other reason|1|||
130925848|NCT00042289|471364140|FG032|Overall Study|Other reason|0|||
130925849|NCT00042289|471364141|FG033|Overall Study|Other reason|1|||
130925850|NCT00042289|471364142|FG034|Overall Study|Other reason|0|||
130925851|NCT00042289|471364143|FG035|Overall Study|Other reason|2|||
130925852|NCT00042289|471364144|FG036|Overall Study|Other reason|0|||
130925853|NCT00042289|471364145|FG037|Overall Study|Other reason|0|||
130925854|NCT00042289|471364146|FG038|Overall Study|Other reason|0|||
130925855|NCT00042289|471364147|FG039|Overall Study|Other reason|0|||
130925856|NCT00042289|471364148|FG040|Overall Study|Other reason|0|||
130925857|NCT00042289|471364149|FG041|Overall Study|Other reason|0|||
130925858|NCT00042289|471364150|FG042|Overall Study|Other reason|0|||
130925859|NCT00042289|471364151|FG043|Overall Study|Other reason|1|||
130925860|NCT00042289|471364152|FG044|Overall Study|Other reason|0|||
130925861|NCT00042289|471364153|FG045|Overall Study|Other reason|0|||
130925862|NCT00042289|471364154|FG046|Overall Study|Other reason|0|||
130925863|NCT00042289|471364108|FG000|Overall Study|Severe debilitation, unable to continue|0|||
130701574|NCT03310619|470530402|FG002|Treatment Period|Study terminated by sponsor|0|||
130701575|NCT03310619|470530403|FG003|Treatment Period|Study terminated by sponsor|0|||
130701576|NCT03310619|470530404|FG004|Treatment Period|Study terminated by sponsor|0|||
130701577|NCT03310619|470530405|FG005|Treatment Period|Study terminated by sponsor|0|||
130701578|NCT03310619|470530406|FG006|Treatment Period|Study terminated by sponsor|0|||
130701579|NCT03310619|470530407|FG007|Treatment Period|Study terminated by sponsor|1|||
130701580|NCT03310619|470530400|FG000|Treatment Period|Physician Decision|0|||
130701581|NCT03310619|470530401|FG001|Treatment Period|Physician Decision|0|||
130701582|NCT03310619|470530402|FG002|Treatment Period|Physician Decision|0|||
130701583|NCT03310619|470530403|FG003|Treatment Period|Physician Decision|0|||
130701584|NCT03310619|470530404|FG004|Treatment Period|Physician Decision|3|||
130701585|NCT03310619|470530405|FG005|Treatment Period|Physician Decision|0|||
130701586|NCT03310619|470530406|FG006|Treatment Period|Physician Decision|0|||
130701587|NCT03310619|470530407|FG007|Treatment Period|Physician Decision|0|||
130701588|NCT03310619|470530400|FG000|Treatment Period|Other reasons|1|||
130701589|NCT03310619|470530401|FG001|Treatment Period|Other reasons|0|||
130701590|NCT03310619|470530402|FG002|Treatment Period|Other reasons|2|||
130701591|NCT03310619|470530403|FG003|Treatment Period|Other reasons|0|||
130701592|NCT03310619|470530404|FG004|Treatment Period|Other reasons|0|||
130701593|NCT03310619|470530405|FG005|Treatment Period|Other reasons|0|||
130701594|NCT03310619|470530406|FG006|Treatment Period|Other reasons|0|||
130701595|NCT03310619|470530407|FG007|Treatment Period|Other reasons|0|||
130701596|NCT02427399|470530408|FG000|Overall Study|Protocol Violation|14|||
130701597|NCT02427399|470530409|FG001|Overall Study|Protocol Violation|16|||
130701598|NCT02427399|470530410|FG002|Overall Study|Protocol Violation|12|||
130701599|NCT02427399|470530411|FG003|Overall Study|Protocol Violation|18|||
130701600|NCT02427399|470530412|FG004|Overall Study|Protocol Violation|15|||
130701601|NCT02289820|470530413|FG000|Overall Study|Withdrawal by Subject|2|||
130701602|NCT02289820|470530414|FG001|Overall Study|Withdrawal by Subject|1|||
130701603|NCT02289820|470530415|FG002|Overall Study|Withdrawal by Subject|2|||
130701604|NCT02289820|470530416|FG003|Overall Study|Withdrawal by Subject|1|||
130701605|NCT02289820|470530417|FG004|Overall Study|Withdrawal by Subject|0|||
130701606|NCT02289820|470530418|FG005|Overall Study|Withdrawal by Subject|0|||
130925864|NCT00042289|471364109|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130925865|NCT00042289|471364110|FG002|Overall Study|Severe debilitation, unable to continue|0|||
130701607|NCT02289820|470530419|FG006|Overall Study|Withdrawal by Subject|1|||
130701608|NCT02289820|470530413|FG000|Overall Study|Death|0|||
130925866|NCT00042289|471364111|FG003|Overall Study|Severe debilitation, unable to continue|0|||
130925867|NCT00042289|471364112|FG004|Overall Study|Severe debilitation, unable to continue|0|||
130925868|NCT00042289|471364113|FG005|Overall Study|Severe debilitation, unable to continue|0|||
130925869|NCT00042289|471364114|FG006|Overall Study|Severe debilitation, unable to continue|0|||
130925870|NCT00042289|471364115|FG007|Overall Study|Severe debilitation, unable to continue|0|||
131034593|NCT00753545|471761741|FG000|Overall Study|Death|98|||
131034594|NCT00753545|471761742|FG001|Overall Study|Death|112|||
131034595|NCT00753545|471761741|FG000|Overall Study|Lost to Follow-up|2|||
131034596|NCT00753545|471761742|FG001|Overall Study|Lost to Follow-up|3|||
130925871|NCT00042289|471364116|FG008|Overall Study|Severe debilitation, unable to continue|0|||
130925872|NCT00042289|471364117|FG009|Overall Study|Severe debilitation, unable to continue|0|||
130925873|NCT00042289|471364118|FG010|Overall Study|Severe debilitation, unable to continue|0|||
130925874|NCT00042289|471364119|FG011|Overall Study|Severe debilitation, unable to continue|0|||
130925875|NCT00042289|471364120|FG012|Overall Study|Severe debilitation, unable to continue|0|||
130925876|NCT00042289|471364121|FG013|Overall Study|Severe debilitation, unable to continue|0|||
130925877|NCT00042289|471364122|FG014|Overall Study|Severe debilitation, unable to continue|0|||
130925878|NCT00042289|471364123|FG015|Overall Study|Severe debilitation, unable to continue|0|||
130925879|NCT00042289|471364124|FG016|Overall Study|Severe debilitation, unable to continue|0|||
130925880|NCT00042289|471364125|FG017|Overall Study|Severe debilitation, unable to continue|0|||
130925881|NCT00042289|471364126|FG018|Overall Study|Severe debilitation, unable to continue|0|||
130925882|NCT00042289|471364127|FG019|Overall Study|Severe debilitation, unable to continue|0|||
130925883|NCT00042289|471364128|FG020|Overall Study|Severe debilitation, unable to continue|0|||
130925884|NCT00042289|471364129|FG021|Overall Study|Severe debilitation, unable to continue|1|||
130925885|NCT00042289|471364130|FG022|Overall Study|Severe debilitation, unable to continue|0|||
130925886|NCT00042289|471364131|FG023|Overall Study|Severe debilitation, unable to continue|1|||
130925887|NCT00042289|471364132|FG024|Overall Study|Severe debilitation, unable to continue|0|||
130925888|NCT00042289|471364133|FG025|Overall Study|Severe debilitation, unable to continue|0|||
130925889|NCT00042289|471364134|FG026|Overall Study|Severe debilitation, unable to continue|0|||
130925890|NCT00042289|471364135|FG027|Overall Study|Severe debilitation, unable to continue|1|||
130925891|NCT00042289|471364136|FG028|Overall Study|Severe debilitation, unable to continue|0|||
130925892|NCT00042289|471364137|FG029|Overall Study|Severe debilitation, unable to continue|0|||
130925893|NCT00042289|471364138|FG030|Overall Study|Severe debilitation, unable to continue|0|||
130925894|NCT00042289|471364139|FG031|Overall Study|Severe debilitation, unable to continue|1|||
130925895|NCT00042289|471364140|FG032|Overall Study|Severe debilitation, unable to continue|1|||
130925896|NCT00042289|471364141|FG033|Overall Study|Severe debilitation, unable to continue|0|||
130925897|NCT00042289|471364142|FG034|Overall Study|Severe debilitation, unable to continue|0|||
130925898|NCT00042289|471364143|FG035|Overall Study|Severe debilitation, unable to continue|0|||
130925899|NCT00042289|471364144|FG036|Overall Study|Severe debilitation, unable to continue|0|||
130925900|NCT00042289|471364145|FG037|Overall Study|Severe debilitation, unable to continue|0|||
130925901|NCT00042289|471364146|FG038|Overall Study|Severe debilitation, unable to continue|0|||
130925902|NCT00042289|471364147|FG039|Overall Study|Severe debilitation, unable to continue|0|||
130925903|NCT00042289|471364148|FG040|Overall Study|Severe debilitation, unable to continue|0|||
130925904|NCT00042289|471364149|FG041|Overall Study|Severe debilitation, unable to continue|0|||
130925905|NCT00042289|471364150|FG042|Overall Study|Severe debilitation, unable to continue|0|||
130925906|NCT00042289|471364151|FG043|Overall Study|Severe debilitation, unable to continue|0|||
130925907|NCT00042289|471364152|FG044|Overall Study|Severe debilitation, unable to continue|0|||
130925908|NCT00042289|471364153|FG045|Overall Study|Severe debilitation, unable to continue|0|||
130925909|NCT00042289|471364154|FG046|Overall Study|Severe debilitation, unable to continue|0|||
130925910|NCT00042289|471364108|FG000|Overall Study|Site closed|0|||
130925911|NCT00042289|471364109|FG001|Overall Study|Site closed|0|||
130925912|NCT00042289|471364110|FG002|Overall Study|Site closed|0|||
130925913|NCT00042289|471364111|FG003|Overall Study|Site closed|0|||
130925914|NCT00042289|471364112|FG004|Overall Study|Site closed|0|||
130925915|NCT00042289|471364113|FG005|Overall Study|Site closed|0|||
130925916|NCT00042289|471364114|FG006|Overall Study|Site closed|0|||
130925917|NCT00042289|471364115|FG007|Overall Study|Site closed|0|||
130925918|NCT00042289|471364116|FG008|Overall Study|Site closed|0|||
130925919|NCT00042289|471364117|FG009|Overall Study|Site closed|0|||
130925920|NCT00042289|471364118|FG010|Overall Study|Site closed|0|||
130925921|NCT00042289|471364119|FG011|Overall Study|Site closed|0|||
130925922|NCT00042289|471364120|FG012|Overall Study|Site closed|0|||
130925923|NCT00042289|471364121|FG013|Overall Study|Site closed|0|||
130925924|NCT00042289|471364122|FG014|Overall Study|Site closed|0|||
130925925|NCT00042289|471364123|FG015|Overall Study|Site closed|0|||
130925926|NCT00042289|471364124|FG016|Overall Study|Site closed|0|||
130925927|NCT00042289|471364125|FG017|Overall Study|Site closed|0|||
130925928|NCT00042289|471364126|FG018|Overall Study|Site closed|0|||
130925929|NCT00042289|471364127|FG019|Overall Study|Site closed|0|||
130925930|NCT00042289|471364128|FG020|Overall Study|Site closed|0|||
130925931|NCT00042289|471364129|FG021|Overall Study|Site closed|0|||
130925932|NCT00042289|471364130|FG022|Overall Study|Site closed|0|||
130925933|NCT00042289|471364131|FG023|Overall Study|Site closed|0|||
130925934|NCT00042289|471364132|FG024|Overall Study|Site closed|0|||
130925935|NCT00042289|471364133|FG025|Overall Study|Site closed|0|||
130925936|NCT00042289|471364134|FG026|Overall Study|Site closed|0|||
130925937|NCT00042289|471364135|FG027|Overall Study|Site closed|0|||
130925938|NCT00042289|471364136|FG028|Overall Study|Site closed|0|||
130925939|NCT00042289|471364137|FG029|Overall Study|Site closed|0|||
130925940|NCT00042289|471364138|FG030|Overall Study|Site closed|0|||
130925941|NCT00042289|471364139|FG031|Overall Study|Site closed|3|||
130925942|NCT00042289|471364140|FG032|Overall Study|Site closed|0|||
130925943|NCT00042289|471364141|FG033|Overall Study|Site closed|0|||
130925944|NCT00042289|471364142|FG034|Overall Study|Site closed|0|||
130925945|NCT00042289|471364143|FG035|Overall Study|Site closed|0|||
130925946|NCT00042289|471364144|FG036|Overall Study|Site closed|1|||
130925947|NCT00042289|471364145|FG037|Overall Study|Site closed|0|||
130925948|NCT00042289|471364146|FG038|Overall Study|Site closed|0|||
130925949|NCT00042289|471364147|FG039|Overall Study|Site closed|0|||
130925950|NCT00042289|471364148|FG040|Overall Study|Site closed|0|||
130925951|NCT00042289|471364149|FG041|Overall Study|Site closed|0|||
130925952|NCT00042289|471364150|FG042|Overall Study|Site closed|1|||
130925953|NCT00042289|471364151|FG043|Overall Study|Site closed|0|||
130925954|NCT00042289|471364152|FG044|Overall Study|Site closed|0|||
130925955|NCT00042289|471364153|FG045|Overall Study|Site closed|0|||
130925956|NCT00042289|471364154|FG046|Overall Study|Site closed|0|||
130925957|NCT00042289|471364108|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
130925958|NCT00042289|471364109|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
130925959|NCT00042289|471364110|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
130925960|NCT00042289|471364111|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
130925961|NCT00042289|471364112|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
130925962|NCT00042289|471364113|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
130925963|NCT00042289|471364114|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
130925964|NCT00042289|471364115|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
130925965|NCT00042289|471364116|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
130925966|NCT00042289|471364117|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
130925967|NCT00042289|471364118|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
130925968|NCT00042289|471364119|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
130925969|NCT00042289|471364120|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
130925970|NCT00042289|471364121|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
130925971|NCT00042289|471364122|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
130925972|NCT00042289|471364123|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
130925973|NCT00042289|471364124|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
130925974|NCT00042289|471364125|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
130925975|NCT00042289|471364126|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
130925976|NCT00042289|471364127|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
130925977|NCT00042289|471364128|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
130925978|NCT00042289|471364129|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
130925979|NCT00042289|471364130|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
130925980|NCT00042289|471364131|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
130925981|NCT00042289|471364132|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
130925982|NCT00042289|471364133|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
130925983|NCT00042289|471364134|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
130925984|NCT00042289|471364135|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
130925985|NCT00042289|471364136|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
130925986|NCT00042289|471364137|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
130925987|NCT00042289|471364138|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
130925988|NCT00042289|471364139|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
130925989|NCT00042289|471364140|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
130925990|NCT00042289|471364141|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
130925991|NCT00042289|471364142|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
130925992|NCT00042289|471364143|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
130925993|NCT00042289|471364144|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
130925994|NCT00042289|471364145|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
130925995|NCT00042289|471364146|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
130925996|NCT00042289|471364147|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
130925997|NCT00042289|471364148|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
130925998|NCT00042289|471364149|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
130925999|NCT00042289|471364150|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
130926000|NCT00042289|471364151|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
130926001|NCT00042289|471364152|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
130926002|NCT00042289|471364153|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
130926003|NCT00042289|471364154|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
130701609|NCT02289820|470530414|FG001|Overall Study|Death|0|||
130926004|NCT00042289|471364108|FG000|Overall Study|Protocol Violation|0|||
130926005|NCT00042289|471364109|FG001|Overall Study|Protocol Violation|0|||
130926006|NCT00042289|471364110|FG002|Overall Study|Protocol Violation|0|||
130926007|NCT00042289|471364111|FG003|Overall Study|Protocol Violation|0|||
130926008|NCT00042289|471364112|FG004|Overall Study|Protocol Violation|0|||
130926009|NCT00042289|471364113|FG005|Overall Study|Protocol Violation|1|||
130926010|NCT00042289|471364114|FG006|Overall Study|Protocol Violation|0|||
130926011|NCT00042289|471364115|FG007|Overall Study|Protocol Violation|1|||
130926012|NCT00042289|471364116|FG008|Overall Study|Protocol Violation|0|||
130926013|NCT00042289|471364117|FG009|Overall Study|Protocol Violation|0|||
130926014|NCT00042289|471364118|FG010|Overall Study|Protocol Violation|0|||
130926015|NCT00042289|471364119|FG011|Overall Study|Protocol Violation|0|||
130701610|NCT02289820|470530415|FG002|Overall Study|Death|1|||
130701611|NCT02289820|470530416|FG003|Overall Study|Death|0|||
130701612|NCT02289820|470530417|FG004|Overall Study|Death|0|||
130701613|NCT02289820|470530418|FG005|Overall Study|Death|0|||
130701614|NCT02289820|470530419|FG006|Overall Study|Death|0|||
130701615|NCT02289820|470530413|FG000|Overall Study|Lost to Follow-up|0|||
130701616|NCT02289820|470530414|FG001|Overall Study|Lost to Follow-up|0|||
130701617|NCT02289820|470530415|FG002|Overall Study|Lost to Follow-up|3|||
130701618|NCT02289820|470530416|FG003|Overall Study|Lost to Follow-up|1|||
130701619|NCT02289820|470530417|FG004|Overall Study|Lost to Follow-up|0|||
130701620|NCT02289820|470530418|FG005|Overall Study|Lost to Follow-up|1|||
130701621|NCT02289820|470530419|FG006|Overall Study|Lost to Follow-up|1|||
130701622|NCT02289820|470530413|FG000|Overall Study|withdrawal of consent|0|||
130701623|NCT02289820|470530414|FG001|Overall Study|withdrawal of consent|1|||
130701624|NCT02289820|470530415|FG002|Overall Study|withdrawal of consent|0|||
130701625|NCT02289820|470530416|FG003|Overall Study|withdrawal of consent|0|||
130701626|NCT02289820|470530417|FG004|Overall Study|withdrawal of consent|0|||
130701627|NCT02289820|470530418|FG005|Overall Study|withdrawal of consent|0|||
130701628|NCT02289820|470530419|FG006|Overall Study|withdrawal of consent|0|||
130701629|NCT00926367|470530422|FG000|Overall Study|Withdrawal by Subject|0|||
130701630|NCT00926367|470530423|FG001|Overall Study|Withdrawal by Subject|1|||
130701631|NCT00926367|470530422|FG000|Overall Study|Lost to Follow-up|1|||
130701632|NCT00926367|470530423|FG001|Overall Study|Lost to Follow-up|0|||
130701633|NCT00926367|470530422|FG000|Overall Study|Skin Irritation|1|||
130701634|NCT00926367|470530423|FG001|Overall Study|Skin Irritation|2|||
130701635|NCT03294317|470530424|FG000|Overall Study|Physician Decision|1|||
130701636|NCT03294317|470530424|FG000|Overall Study|Withdrawal by Subject|6|||
130701637|NCT03294317|470530424|FG000|Overall Study|Lost to Follow-up|1|||
130701638|NCT03294317|470530424|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
130701639|NCT03294317|470530424|FG000|Overall Study|Failed HB lead implant|8|||
130701640|NCT03294317|470530424|FG000|Overall Study|Received CRT instead|1|||
130701641|NCT03294317|470530424|FG000|Overall Study|Exited after lead revision|2|||
130701642|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
130701643|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
130701644|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
130926016|NCT00042289|471364120|FG012|Overall Study|Protocol Violation|0|||
130926017|NCT00042289|471364121|FG013|Overall Study|Protocol Violation|0|||
130926018|NCT00042289|471364122|FG014|Overall Study|Protocol Violation|0|||
130926019|NCT00042289|471364123|FG015|Overall Study|Protocol Violation|0|||
130769959|NCT00586898|470782607|FG000|Overall Study|Patiemt Non-compliance|1|||
130769960|NCT00586898|470782607|FG000|Overall Study|Evaluable for Toxicity Only|5|||
130769961|NCT02494401|470782609|FG000|Overall Study|Lost to Follow-up|22|||
130769962|NCT02494401|470782610|FG001|Overall Study|Lost to Follow-up|25|||
130769963|NCT02494401|470782609|FG000|Overall Study|Withdrawal by Subject|3|||
130769964|NCT02494401|470782610|FG001|Overall Study|Withdrawal by Subject|2|||
130769965|NCT00385827|470784205|FG000|Part 1|Adverse Event|1|||
130769966|NCT00385827|470784206|FG001|Part 1|Adverse Event|0|||
130769967|NCT00385827|470784207|FG002|Part 1|Adverse Event|0|||
130769968|NCT00385827|470784205|FG000|Part 1|Death|2|||
130769969|NCT00385827|470784206|FG001|Part 1|Death|0|||
130769970|NCT00385827|470784207|FG002|Part 1|Death|0|||
130926020|NCT00042289|471364124|FG016|Overall Study|Protocol Violation|0|||
130926021|NCT00042289|471364125|FG017|Overall Study|Protocol Violation|0|||
130926022|NCT00042289|471364126|FG018|Overall Study|Protocol Violation|0|||
130769971|NCT00385827|470784205|FG000|Part 1|Lack of Efficacy|5|||
130769972|NCT00385827|470784206|FG001|Part 1|Lack of Efficacy|0|||
130769973|NCT00385827|470784207|FG002|Part 1|Lack of Efficacy|0|||
130769974|NCT00385827|470784205|FG000|Part 1|Other|1|||
130769975|NCT00385827|470784206|FG001|Part 1|Other|0|||
130769976|NCT00385827|470784207|FG002|Part 1|Other|0|||
130926023|NCT00042289|471364127|FG019|Overall Study|Protocol Violation|0|||
130926024|NCT00042289|471364128|FG020|Overall Study|Protocol Violation|0|||
130926025|NCT00042289|471364129|FG021|Overall Study|Protocol Violation|0|||
130926026|NCT00042289|471364130|FG022|Overall Study|Protocol Violation|0|||
130701645|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
130701646|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
130701647|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
130701648|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
130701649|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
130701650|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
130701651|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Other|1|||
130701652|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Other|4|||
130701653|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Other|5|||
130769977|NCT00385827|470784205|FG000|Part 2|Adverse Event|0|||
130926027|NCT00042289|471364131|FG023|Overall Study|Protocol Violation|1|||
130926028|NCT00042289|471364132|FG024|Overall Study|Protocol Violation|1|||
130769978|NCT00385827|470784206|FG001|Part 2|Adverse Event|6|||
130769979|NCT00385827|470784207|FG002|Part 2|Adverse Event|10|||
130769980|NCT00385827|470784205|FG000|Part 2|Death|0|||
130769981|NCT00385827|470784206|FG001|Part 2|Death|0|||
130769982|NCT00385827|470784207|FG002|Part 2|Death|2|||
130769983|NCT00385827|470784205|FG000|Part 2|Lack of Efficacy|0|||
130769984|NCT00385827|470784206|FG001|Part 2|Lack of Efficacy|14|||
130769985|NCT00385827|470784207|FG002|Part 2|Lack of Efficacy|13|||
130769986|NCT00385827|470784205|FG000|Part 2|Randomized but not treated|0|||
130769987|NCT00385827|470784206|FG001|Part 2|Randomized but not treated|2|||
130769988|NCT00385827|470784207|FG002|Part 2|Randomized but not treated|2|||
130769989|NCT00385827|470784205|FG000|Part 2|Other|0|||
130769990|NCT00385827|470784206|FG001|Part 2|Other|11|||
130769991|NCT00385827|470784207|FG002|Part 2|Other|21|||
130769992|NCT00410072|470784208|FG000|Day 1 to Week 48|Adverse Event|1|||
130769993|NCT00410072|470784209|FG001|Day 1 to Week 48|Adverse Event|2|||
130769994|NCT00410072|470784208|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
130769995|NCT00410072|470784209|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
130769996|NCT00410072|470784208|FG000|Day 1 to Week 48|Other|0|||
130926029|NCT00042289|471364133|FG025|Overall Study|Protocol Violation|0|||
130926030|NCT00042289|471364134|FG026|Overall Study|Protocol Violation|2|||
130769997|NCT00410072|470784209|FG001|Day 1 to Week 48|Other|1|||
130769998|NCT00410072|470784208|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
130769999|NCT00410072|470784209|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
130926031|NCT00042289|471364135|FG027|Overall Study|Protocol Violation|0|||
130926032|NCT00042289|471364136|FG028|Overall Study|Protocol Violation|0|||
130926033|NCT00042289|471364137|FG029|Overall Study|Protocol Violation|0|||
130926034|NCT00042289|471364138|FG030|Overall Study|Protocol Violation|1|||
130926035|NCT00042289|471364139|FG031|Overall Study|Protocol Violation|0|||
130926036|NCT00042289|471364140|FG032|Overall Study|Protocol Violation|0|||
130926037|NCT00042289|471364141|FG033|Overall Study|Protocol Violation|0|||
130926038|NCT00042289|471364142|FG034|Overall Study|Protocol Violation|0|||
130926039|NCT00042289|471364143|FG035|Overall Study|Protocol Violation|0|||
130926040|NCT00042289|471364144|FG036|Overall Study|Protocol Violation|0|||
130926041|NCT00042289|471364145|FG037|Overall Study|Protocol Violation|0|||
130926042|NCT00042289|471364146|FG038|Overall Study|Protocol Violation|0|||
130926043|NCT00042289|471364147|FG039|Overall Study|Protocol Violation|0|||
130926044|NCT00042289|471364148|FG040|Overall Study|Protocol Violation|0|||
130926045|NCT00042289|471364149|FG041|Overall Study|Protocol Violation|1|||
130926046|NCT00042289|471364150|FG042|Overall Study|Protocol Violation|1|||
130926047|NCT00042289|471364151|FG043|Overall Study|Protocol Violation|1|||
130926048|NCT00042289|471364152|FG044|Overall Study|Protocol Violation|0|||
130926049|NCT00042289|471364153|FG045|Overall Study|Protocol Violation|0|||
130926050|NCT00042289|471364154|FG046|Overall Study|Protocol Violation|0|||
130926051|NCT00042289|471364108|FG000|Overall Study|Withdrawal by Subject|4|||
130926052|NCT00042289|471364109|FG001|Overall Study|Withdrawal by Subject|1|||
130926053|NCT00042289|471364110|FG002|Overall Study|Withdrawal by Subject|0|||
130926054|NCT00042289|471364111|FG003|Overall Study|Withdrawal by Subject|2|||
130926055|NCT00042289|471364112|FG004|Overall Study|Withdrawal by Subject|0|||
130926056|NCT00042289|471364113|FG005|Overall Study|Withdrawal by Subject|2|||
130926057|NCT00042289|471364114|FG006|Overall Study|Withdrawal by Subject|0|||
130926058|NCT00042289|471364115|FG007|Overall Study|Withdrawal by Subject|0|||
130926059|NCT00042289|471364116|FG008|Overall Study|Withdrawal by Subject|0|||
130926060|NCT00042289|471364117|FG009|Overall Study|Withdrawal by Subject|1|||
130926061|NCT00042289|471364118|FG010|Overall Study|Withdrawal by Subject|0|||
130926062|NCT00042289|471364119|FG011|Overall Study|Withdrawal by Subject|0|||
130926063|NCT00042289|471364120|FG012|Overall Study|Withdrawal by Subject|2|||
130926064|NCT00042289|471364121|FG013|Overall Study|Withdrawal by Subject|0|||
130926065|NCT00042289|471364122|FG014|Overall Study|Withdrawal by Subject|0|||
130926066|NCT00042289|471364123|FG015|Overall Study|Withdrawal by Subject|0|||
130926067|NCT00042289|471364124|FG016|Overall Study|Withdrawal by Subject|0|||
130926068|NCT00042289|471364125|FG017|Overall Study|Withdrawal by Subject|0|||
130926069|NCT00042289|471364126|FG018|Overall Study|Withdrawal by Subject|0|||
130926070|NCT00042289|471364127|FG019|Overall Study|Withdrawal by Subject|0|||
130770000|NCT00410072|470784208|FG000|Day 1 to Week 48|Pregnancy|0|||
130770001|NCT00410072|470784209|FG001|Day 1 to Week 48|Pregnancy|2|||
130926071|NCT00042289|471364128|FG020|Overall Study|Withdrawal by Subject|0|||
130926072|NCT00042289|471364129|FG021|Overall Study|Withdrawal by Subject|1|||
130926073|NCT00042289|471364130|FG022|Overall Study|Withdrawal by Subject|1|||
130926074|NCT00042289|471364131|FG023|Overall Study|Withdrawal by Subject|1|||
130926075|NCT00042289|471364132|FG024|Overall Study|Withdrawal by Subject|0|||
130926076|NCT00042289|471364133|FG025|Overall Study|Withdrawal by Subject|0|||
130926077|NCT00042289|471364134|FG026|Overall Study|Withdrawal by Subject|1|||
130926078|NCT00042289|471364135|FG027|Overall Study|Withdrawal by Subject|0|||
130926079|NCT00042289|471364136|FG028|Overall Study|Withdrawal by Subject|2|||
130770002|NCT00410072|470784208|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
130770003|NCT00410072|470784209|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
130926080|NCT00042289|471364137|FG029|Overall Study|Withdrawal by Subject|0|||
130926081|NCT00042289|471364138|FG030|Overall Study|Withdrawal by Subject|0|||
130926082|NCT00042289|471364139|FG031|Overall Study|Withdrawal by Subject|1|||
130770004|NCT00410072|470784208|FG000|After Week 48 to Week 96|Adverse Event|1|||
130770005|NCT00410072|470784209|FG001|After Week 48 to Week 96|Adverse Event|2|||
130770006|NCT00410072|470784208|FG000|After Week 48 to Week 96|Death|0|||
130770007|NCT00410072|470784209|FG001|After Week 48 to Week 96|Death|1|||
130770008|NCT00410072|470784208|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
130770009|NCT00410072|470784209|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
130770010|NCT00410072|470784208|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
130770011|NCT00410072|470784209|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
130770012|NCT00410072|470784208|FG000|After Week 48 to Week 96|Other|2|||
130770013|NCT00410072|470784209|FG001|After Week 48 to Week 96|Other|0|||
130770014|NCT00410072|470784208|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
130770015|NCT00410072|470784209|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
130770016|NCT00410072|470784208|FG000|After Week 48 to Week 96|Pregnancy|0|||
130770017|NCT00410072|470784209|FG001|After Week 48 to Week 96|Pregnancy|2|||
130770018|NCT00410072|470784208|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
130770019|NCT00410072|470784209|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
130770020|NCT03307837|470784210|FG000|Overall Study|Withdrawal by Subject|0|||
130770021|NCT03307837|470784211|FG001|Overall Study|Withdrawal by Subject|0|||
130770022|NCT03307837|470784212|FG002|Overall Study|Withdrawal by Subject|1|||
130770023|NCT03307837|470784213|FG003|Overall Study|Withdrawal by Subject|0|||
130770024|NCT03307837|470784214|FG004|Overall Study|Withdrawal by Subject|0|||
130770025|NCT03307837|470784215|FG005|Overall Study|Withdrawal by Subject|1|||
130926083|NCT00042289|471364140|FG032|Overall Study|Withdrawal by Subject|2|||
130926084|NCT00042289|471364141|FG033|Overall Study|Withdrawal by Subject|1|||
130926085|NCT00042289|471364142|FG034|Overall Study|Withdrawal by Subject|0|||
130926086|NCT00042289|471364143|FG035|Overall Study|Withdrawal by Subject|0|||
130926087|NCT00042289|471364144|FG036|Overall Study|Withdrawal by Subject|0|||
130926088|NCT00042289|471364145|FG037|Overall Study|Withdrawal by Subject|1|||
130926089|NCT00042289|471364146|FG038|Overall Study|Withdrawal by Subject|0|||
130926090|NCT00042289|471364147|FG039|Overall Study|Withdrawal by Subject|0|||
130926091|NCT00042289|471364148|FG040|Overall Study|Withdrawal by Subject|0|||
130926092|NCT00042289|471364149|FG041|Overall Study|Withdrawal by Subject|0|||
130926093|NCT00042289|471364150|FG042|Overall Study|Withdrawal by Subject|1|||
130926094|NCT00042289|471364151|FG043|Overall Study|Withdrawal by Subject|0|||
130926095|NCT00042289|471364152|FG044|Overall Study|Withdrawal by Subject|0|||
130926096|NCT00042289|471364153|FG045|Overall Study|Withdrawal by Subject|0|||
130926097|NCT00042289|471364154|FG046|Overall Study|Withdrawal by Subject|0|||
130926098|NCT00745823|471364156|FG000|Overall Study|Adverse Event|5|||
130926099|NCT00745823|471364157|FG001|Overall Study|Adverse Event|3|||
130926100|NCT00745823|471364156|FG000|Overall Study|Lack of Efficacy|20|||
130926101|NCT00745823|471364157|FG001|Overall Study|Lack of Efficacy|6|||
130926102|NCT00745823|471364156|FG000|Overall Study|Lost to Follow-up|10|||
130926103|NCT00745823|471364157|FG001|Overall Study|Lost to Follow-up|11|||
130926104|NCT00745823|471364156|FG000|Overall Study|Physician Decision|10|||
130926105|NCT00745823|471364157|FG001|Overall Study|Physician Decision|5|||
130926106|NCT00745823|471364156|FG000|Overall Study|Pregnancy|0|||
130926107|NCT00745823|471364157|FG001|Overall Study|Pregnancy|4|||
130926108|NCT00745823|471364156|FG000|Overall Study|Withdrawal by Subject|14|||
130926109|NCT00745823|471364157|FG001|Overall Study|Withdrawal by Subject|8|||
130926110|NCT00745823|471364156|FG000|Overall Study|Study Terminated by Sponsor|326|||
130926111|NCT00745823|471364157|FG001|Overall Study|Study Terminated by Sponsor|349|||
130926112|NCT02955602|471364163|FG000|Overall Study|Adverse Event|0|||
130926113|NCT02955602|471364164|FG001|Overall Study|Adverse Event|3|||
130926114|NCT02955602|471364165|FG002|Overall Study|Adverse Event|0|||
130926115|NCT02955602|471364163|FG000|Overall Study|Withdrawal of informed consent|1|||
130926116|NCT02955602|471364164|FG001|Overall Study|Withdrawal of informed consent|3|||
130926117|NCT02955602|471364165|FG002|Overall Study|Withdrawal of informed consent|2|||
130926118|NCT02955602|471364163|FG000|Overall Study|Lost to Follow-up|0|||
130926119|NCT02955602|471364164|FG001|Overall Study|Lost to Follow-up|0|||
130926120|NCT02955602|471364165|FG002|Overall Study|Lost to Follow-up|1|||
130926121|NCT02955602|471364163|FG000|Overall Study|Other|0|||
130770026|NCT03307837|470784210|FG000|Overall Study|Lost to Follow-up|1|||
130770027|NCT03307837|470784211|FG001|Overall Study|Lost to Follow-up|1|||
130770028|NCT03307837|470784212|FG002|Overall Study|Lost to Follow-up|0|||
130770029|NCT03307837|470784213|FG003|Overall Study|Lost to Follow-up|0|||
130770030|NCT03307837|470784214|FG004|Overall Study|Lost to Follow-up|0|||
130926122|NCT02955602|471364164|FG001|Overall Study|Other|1|||
130926123|NCT02955602|471364165|FG002|Overall Study|Other|3|||
130926124|NCT01575769|471364166|FG000|Overall Study|Adverse Event|1|||
130926125|NCT01575769|471364166|FG000|Overall Study|Study terminated by sponsor|40|||
130926126|NCT00844831|471364167|FG000|Overall Study|Withdrawal by Subject|4|||
130926127|NCT00844831|471364167|FG000|Overall Study|Adverse Event|1|||
130926128|NCT00844831|471364167|FG000|Overall Study|Physician Decision|1|||
130926129|NCT01581931|471364175|FG000|Washout|Adverse Event|0|||
130926130|NCT01581931|471364176|FG001|Washout|Adverse Event|1|||
130926131|NCT03156543|471364177|FG000|Overall Study|Withdrawal by Subject|1|||
130926132|NCT03156543|471364178|FG001|Overall Study|Withdrawal by Subject|0|||
130926133|NCT02954237|471364179|FG000|Overall Study|Withdrawal by Subject|25|||
130926134|NCT02954237|471364179|FG000|Overall Study|Missed visit|16|||
130926135|NCT02954237|471364179|FG000|Overall Study|Death|2|||
130926136|NCT00674700|471364180|FG000|Year 1|Adverse Event|17|||
130926137|NCT00674700|471364181|FG001|Year 1|Adverse Event|20|||
130926138|NCT00674700|471364182|FG002|Year 1|Adverse Event|5|||
130926139|NCT00674700|471364180|FG000|Year 1|Withdrawal by Subject|7|||
130701654|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
130701655|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
130701656|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
130701657|NCT02725411|470530425|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
130701658|NCT02725411|470530426|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
130701659|NCT02725411|470530427|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
130701660|NCT02725411|470530425|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
130701661|NCT02725411|470530426|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
130701662|NCT02725411|470530427|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
130701663|NCT02725411|470530425|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
130701664|NCT02725411|470530426|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
130701665|NCT02725411|470530427|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
130701666|NCT02725411|470530425|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
130701667|NCT02725411|470530426|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
130701668|NCT02725411|470530427|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
130701669|NCT02725411|470530425|FG000|Follow-up Period (24 Weeks)|Other|1|||
130701670|NCT02725411|470530426|FG001|Follow-up Period (24 Weeks)|Other|4|||
130701671|NCT02725411|470530427|FG002|Follow-up Period (24 Weeks)|Other|2|||
130701672|NCT02725411|470530425|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
130701673|NCT02725411|470530426|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
130701674|NCT02725411|470530427|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
130701675|NCT03847974|470530434|FG000|Overall Study|relocated out of region|3|||
130701676|NCT03847974|470530434|FG000|Overall Study|Withdrawal by Subject|2|||
130701677|NCT03847974|470530434|FG000|Overall Study|Adverse Event|1|||
130701678|NCT01924364|470530435|FG000|Overall Study|Physician Decision|3|||
130701679|NCT02911935|470530436|FG000|Overall Study|Lost to Follow-up|5|||
130701680|NCT02911935|470530437|FG001|Overall Study|Lost to Follow-up|7|||
130701681|NCT01685216|470530440|FG000|Overall Study|Did not receive study drug|1|||
130701682|NCT00756717|470530441|FG000|Overall Study|Withdrawal by Subject|2|||
130701683|NCT00685750|470530442|FG000|Overall Study|Tumor sampling failure|0|||
130701684|NCT00685750|470530443|FG001|Overall Study|Tumor sampling failure|0|||
130701685|NCT00685750|470530444|FG002|Overall Study|Tumor sampling failure|1|||
130701686|NCT00685750|470530445|FG003|Overall Study|Tumor sampling failure|0|||
130701687|NCT00685750|470530446|FG004|Overall Study|Tumor sampling failure|0|||
130926140|NCT00674700|471364181|FG001|Year 1|Withdrawal by Subject|7|||
130926141|NCT00674700|471364182|FG002|Year 1|Withdrawal by Subject|6|||
130926142|NCT00674700|471364180|FG000|Year 1|Any other reason not above-mentioned|7|||
130926143|NCT00674700|471364181|FG001|Year 1|Any other reason not above-mentioned|7|||
130926144|NCT00674700|471364182|FG002|Year 1|Any other reason not above-mentioned|6|||
130926145|NCT00674700|471364180|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
130926146|NCT00674700|471364181|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
130926147|NCT00674700|471364182|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
130926148|NCT00674700|471364180|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
130926149|NCT00674700|471364181|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
130926150|NCT00674700|471364182|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
130926151|NCT00674700|471364180|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
130926152|NCT00674700|471364181|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
130926153|NCT00674700|471364182|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
130926154|NCT03797014|471364184|FG000|Overall Study|Withdrawal by Subject|1|||
130926155|NCT03797014|471364184|FG000|Overall Study|Lost to Follow-up|1|||
130926156|NCT03797014|471364184|FG000|Overall Study|Protocol Violation|1|||
130926157|NCT02871297|471364185|FG000|Overall Study|Adverse Event|34|||
130926158|NCT02871297|471364185|FG000|Overall Study|Lack of Efficacy|10|||
130926159|NCT02871297|471364185|FG000|Overall Study|Non-compliance with study drug|15|||
130926160|NCT02871297|471364185|FG000|Overall Study|Protocol Violation|3|||
130926161|NCT02871297|471364185|FG000|Overall Study|Withdrawal by Subject|20|||
130926162|NCT02871297|471364185|FG000|Overall Study|Lost to Follow-up|13|||
130926163|NCT02871297|471364185|FG000|Overall Study|Rolled over to 13546A|2|||
130926164|NCT02871297|471364185|FG000|Overall Study|Other than specified|39|||
130926165|NCT00684593|471364195|FG000|Overall Study|Adverse Event|0|||
130926166|NCT00684593|471364196|FG001|Overall Study|Adverse Event|2|||
130701688|NCT00685750|470530447|FG005|Overall Study|Tumor sampling failure|0|||
130701689|NCT00685750|470530448|FG006|Overall Study|Tumor sampling failure|0|||
130701690|NCT00685750|470530442|FG000|Overall Study|Patient didn't receive the treatment|0|||
130701691|NCT00685750|470530443|FG001|Overall Study|Patient didn't receive the treatment|0|||
130701692|NCT00685750|470530444|FG002|Overall Study|Patient didn't receive the treatment|0|||
130926167|NCT01001377|471364197|FG000|Overall Study|Ineligibility determined|2|||
130926168|NCT01001377|471364198|FG001|Overall Study|Ineligibility determined|0|||
130926169|NCT01001377|471364197|FG000|Overall Study|Withdrawal by Subject|19|||
130926170|NCT01001377|471364198|FG001|Overall Study|Withdrawal by Subject|20|||
130926171|NCT01001377|471364197|FG000|Overall Study|Lost to Follow-up|14|||
130926172|NCT01001377|471364198|FG001|Overall Study|Lost to Follow-up|17|||
130926173|NCT01001377|471364197|FG000|Overall Study|Death|391|||
130926174|NCT01001377|471364198|FG001|Overall Study|Death|384|||
130926175|NCT02193867|471364202|FG000|Overall Study|Death|2|||
130926176|NCT02193867|471364202|FG000|Overall Study|Sponsor Study Termination|2|||
130926177|NCT00964860|471364203|FG000|Overall Study|Withdrawal by Subject|0|||
130926178|NCT00964860|471364204|FG001|Overall Study|Withdrawal by Subject|1|||
130926179|NCT03716024|471364205|FG000|Overall Study|Randomized, not Treated|7|||
130701693|NCT00685750|470530445|FG003|Overall Study|Patient didn't receive the treatment|0|||
130701694|NCT00685750|470530446|FG004|Overall Study|Patient didn't receive the treatment|0|||
130701695|NCT00685750|470530447|FG005|Overall Study|Patient didn't receive the treatment|0|||
130701696|NCT00685750|470530448|FG006|Overall Study|Patient didn't receive the treatment|1|||
130701697|NCT00685750|470530442|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130701698|NCT00685750|470530443|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130701699|NCT00685750|470530444|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130701700|NCT00685750|470530445|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
130701701|NCT00685750|470530446|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130701702|NCT00685750|470530447|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
130701703|NCT00685750|470530448|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
130701704|NCT04979858|470530449|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
130701705|NCT04979858|470530450|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
130701706|NCT02654015|470530451|FG000|Overall Study|Death|12|||
130701707|NCT02654015|470530451|FG000|Overall Study|Lost to Follow-up|3|||
130701708|NCT05317195|470530454|FG000|Randomization|Withdrawal by Subject|1|||
130701709|NCT05317195|470530454|FG000|Randomization|Discontinued|6|||
130701710|NCT05317195|470530454|FG000|Admission|Withdrawal by Subject|2|||
130701711|NCT03259789|470530455|FG000|Overall Study|Adverse Event|3|||
130701712|NCT03259789|470530456|FG001|Overall Study|Adverse Event|2|||
130701713|NCT03259789|470530457|FG002|Overall Study|Adverse Event|1|||
130701714|NCT03259789|470530455|FG000|Overall Study|Withdrawal by Subject|9|||
130701715|NCT03259789|470530456|FG001|Overall Study|Withdrawal by Subject|5|||
130701716|NCT03259789|470530457|FG002|Overall Study|Withdrawal by Subject|1|||
130701717|NCT03259789|470530455|FG000|Overall Study|Lost to Follow-up|5|||
130701718|NCT03259789|470530456|FG001|Overall Study|Lost to Follow-up|9|||
130701719|NCT03259789|470530457|FG002|Overall Study|Lost to Follow-up|4|||
130701720|NCT03259789|470530455|FG000|Overall Study|Physician Decision|0|||
130701721|NCT03259789|470530456|FG001|Overall Study|Physician Decision|1|||
130701722|NCT03259789|470530457|FG002|Overall Study|Physician Decision|0|||
130701723|NCT02063217|470530458|FG000|Overall Study|Withdrawal by Subject|1|||
130701724|NCT02063217|470530459|FG001|Overall Study|Withdrawal by Subject|0|||
130701725|NCT02063217|470530460|FG002|Overall Study|Withdrawal by Subject|0|||
130701726|NCT00889252|470530461|FG000|Overall Study|Adverse Event|2|||
130701727|NCT00889252|470530462|FG001|Overall Study|Adverse Event|4|||
130701728|NCT00889252|470530461|FG000|Overall Study|Withdrawal by Subject|3|||
130701729|NCT00889252|470530462|FG001|Overall Study|Withdrawal by Subject|0|||
130701730|NCT00889252|470530461|FG000|Overall Study|Protocol Violation|2|||
130701731|NCT00889252|470530462|FG001|Overall Study|Protocol Violation|0|||
130701732|NCT01160640|470530466|FG000|Overall Study|Physician Decision|3|||
130701733|NCT01160640|470530467|FG001|Overall Study|Physician Decision|3|||
130701734|NCT01160640|470530466|FG000|Overall Study|Incarceration|1|||
130701735|NCT01160640|470530467|FG001|Overall Study|Incarceration|0|||
130701736|NCT01160640|470530466|FG000|Overall Study|Withdrawal by Subject|0|||
130701737|NCT01160640|470530467|FG001|Overall Study|Withdrawal by Subject|3|||
130701738|NCT03108820|470530469|FG000|Overall Study|Lost to Follow-up|30|||
130701739|NCT03108820|470530470|FG001|Overall Study|Lost to Follow-up|28|||
130701740|NCT03108820|470530469|FG000|Overall Study|Withdrawal by Subject|32|||
130701741|NCT03108820|470530470|FG001|Overall Study|Withdrawal by Subject|24|||
130701742|NCT03108820|470530469|FG000|Overall Study|Death|6|||
130701743|NCT03108820|470530470|FG001|Overall Study|Death|11|||
130701744|NCT00089973|470530473|FG000|Overall Study|Adverse Event|3|||
130701745|NCT00089973|470530473|FG000|Overall Study|Withdrawal by Subject|1|||
130701746|NCT00089973|470530473|FG000|Overall Study|Disease progression|45|||
130701747|NCT00089973|470530473|FG000|Overall Study|Death|1|||
130701748|NCT04428645|470530474|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
130701749|NCT01074008|470532635|FG000|Overall Study|Adverse Event|0|||
130701750|NCT01074008|470532636|FG001|Overall Study|Adverse Event|1|||
130701751|NCT01074008|470532637|FG002|Overall Study|Adverse Event|0|||
130701752|NCT01074008|470532638|FG003|Overall Study|Adverse Event|0|||
130701753|NCT01074008|470532639|FG004|Overall Study|Adverse Event|0|||
130701754|NCT01074008|470532640|FG005|Overall Study|Adverse Event|0|||
130701755|NCT01074008|470532641|FG006|Overall Study|Adverse Event|0|||
130770031|NCT03307837|470784215|FG005|Overall Study|Lost to Follow-up|1|||
130770032|NCT00904917|470784217|FG000|Overall Study|Lost to Follow-up|2|||
130770033|NCT00904917|470784218|FG001|Overall Study|Lost to Follow-up|2|||
130770034|NCT00904917|470784219|FG002|Overall Study|Lost to Follow-up|2|||
130770035|NCT00904917|470784220|FG003|Overall Study|Lost to Follow-up|2|||
130770036|NCT03915626|470784221|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
130770037|NCT02190721|470784229|FG000|Overall Study|Patient was out of the city|0|||
130770038|NCT02190721|470784230|FG001|Overall Study|Patient was out of the city|1|||
130770039|NCT02190721|470784231|FG002|Overall Study|Patient was out of the city|0|||
130926180|NCT03716024|471364206|FG001|Overall Study|Randomized, not Treated|8|||
130926181|NCT03716024|471364205|FG000|Overall Study|Adverse Event|1|||
130926182|NCT03716024|471364206|FG001|Overall Study|Adverse Event|2|||
130926183|NCT03716024|471364205|FG000|Overall Study|Treatment Failure|1|||
130926184|NCT03716024|471364206|FG001|Overall Study|Treatment Failure|0|||
130926185|NCT03716024|471364205|FG000|Overall Study|Lost to Follow-up|2|||
130926186|NCT03716024|471364206|FG001|Overall Study|Lost to Follow-up|6|||
130926187|NCT03716024|471364205|FG000|Overall Study|Withdrawal by Subject|0|||
130926188|NCT03716024|471364206|FG001|Overall Study|Withdrawal by Subject|1|||
130926189|NCT03716024|471364205|FG000|Overall Study|Missing Reason|0|||
130926190|NCT03716024|471364206|FG001|Overall Study|Missing Reason|1|||
130926191|NCT00867568|471364207|FG000|Overall Study|Lack of Efficacy|10|||
130926192|NCT00867568|471364207|FG000|Overall Study|Adverse Event|4|||
130926193|NCT00867568|471364207|FG000|Overall Study|Withdrawal by Subject|1|||
130926194|NCT04930965|471364212|FG000|Overall Study|Lost to Follow-up|7|||
130926195|NCT04930965|471364213|FG001|Overall Study|Lost to Follow-up|5|||
130926196|NCT01471171|471364214|FG000|Treatment Period 1|Adverse Event|4|||
130926197|NCT01471171|471364215|FG001|Treatment Period 1|Adverse Event|1|||
130926198|NCT01471171|471364214|FG000|Treatment Period 2|Adverse Event|1|||
130926199|NCT01471171|471364215|FG001|Treatment Period 2|Adverse Event|0|||
131223536|NCT01872689|472447038|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
131223537|NCT01872689|472447039|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
131223538|NCT01872689|472447040|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
131223539|NCT01872689|472447037|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
131223540|NCT01872689|472447038|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
131223541|NCT01872689|472447039|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
131223542|NCT01872689|472447040|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
131223543|NCT01872689|472447037|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
131223544|NCT01872689|472447038|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
131223545|NCT01872689|472447039|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
131223546|NCT01872689|472447040|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
131223547|NCT01872689|472447037|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
131223548|NCT01872689|472447038|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
131223549|NCT01872689|472447039|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
131223550|NCT01872689|472447040|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
131223551|NCT00686374|472447044|FG000|Overall Study|Lack of Efficacy|10|||
131223552|NCT00686374|472447044|FG000|Overall Study|Adverse Event|8|||
130770040|NCT05025332|470784233|FG000|Screening|Screen failure|12|||
130770041|NCT05025332|470784233|FG000|Treatment & Follow Up|Protocol Violation|1|||
130770042|NCT05025332|470784233|FG000|Treatment & Follow Up|Adverse Event|4|||
130770043|NCT01928199|470784234|FG000|Overall Study|Lost to Follow-up|2|||
130770044|NCT01928199|470784235|FG001|Overall Study|Lost to Follow-up|1|||
130770045|NCT01928199|470784234|FG000|Overall Study|Withdrawal by Subject|3|||
130770046|NCT01928199|470784235|FG001|Overall Study|Withdrawal by Subject|5|||
130770047|NCT01502956|470784236|FG000|Overall Study|Death|0|||
130770048|NCT01502956|470784237|FG001|Overall Study|Death|2|||
130770049|NCT01502956|470784236|FG000|Overall Study|Lost to Follow-up|14|||
130926200|NCT04189081|471364216|FG000|Overall Study|Lost to Follow-up|1|||
130926201|NCT04189081|471364217|FG001|Overall Study|Lost to Follow-up|0|||
130926202|NCT04189081|471364218|FG002|Overall Study|Lost to Follow-up|0|||
130926203|NCT04189081|471364216|FG000|Overall Study|Withdrawal by Subject|0|||
131223553|NCT00686374|472447044|FG000|Overall Study|Withdrew consent|5|||
131223554|NCT00686374|472447044|FG000|Overall Study|Lost to Follow-up|1|||
130770050|NCT01502956|470784237|FG001|Overall Study|Lost to Follow-up|11|||
130770051|NCT01502956|470784236|FG000|Overall Study|Physician Decision|2|||
130770052|NCT01502956|470784237|FG001|Overall Study|Physician Decision|3|||
130770053|NCT01502956|470784236|FG000|Overall Study|Withdrawal by Subject|8|||
130770054|NCT01502956|470784237|FG001|Overall Study|Withdrawal by Subject|10|||
130926204|NCT04189081|471364217|FG001|Overall Study|Withdrawal by Subject|0|||
130926205|NCT04189081|471364218|FG002|Overall Study|Withdrawal by Subject|1|||
130926206|NCT00044083|471364219|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
130926207|NCT00044083|471364220|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
130926208|NCT00044083|471364219|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
131223555|NCT00686374|472447044|FG000|Overall Study|Missing reason|33|||
131223556|NCT00686374|472447044|FG000|Overall Study|Other, not specified|4|||
131223557|NCT02143947|472447046|FG000|Overall Study|Lost to Follow-up|4|||
130926209|NCT00044083|471364220|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
130926210|NCT00044083|471364219|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
130926211|NCT00044083|471364220|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
130926212|NCT00044083|471364219|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
130926213|NCT00044083|471364220|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
130926214|NCT00044083|471364219|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
130926215|NCT00044083|471364220|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
130926216|NCT00044083|471364219|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
130926217|NCT00044083|471364220|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
130926218|NCT00044083|471364219|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
130926219|NCT00044083|471364220|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
130926220|NCT00044083|471364219|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
130926221|NCT00044083|471364220|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
130926222|NCT00044083|471364219|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
130926223|NCT00044083|471364220|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
130926224|NCT00044083|471364219|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
130926225|NCT00044083|471364220|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
130926226|NCT01619423|471364225|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
130926227|NCT01619423|471364226|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
130926228|NCT01619423|471364227|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
130926229|NCT01619423|471364228|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
130926230|NCT02340975|471364232|FG000|Overall Study|Death|6|||
130926231|NCT02340975|471364233|FG001|Overall Study|Death|23|||
130926232|NCT02340975|471364234|FG002|Overall Study|Death|21|||
130926233|NCT02340975|471364235|FG003|Overall Study|Death|7|||
130926234|NCT02340975|471364236|FG004|Overall Study|Death|21|||
130926235|NCT02340975|471364237|FG005|Overall Study|Death|13|||
130926236|NCT02340975|471364232|FG000|Overall Study|Lost to Follow-up|0|||
130926237|NCT02340975|471364233|FG001|Overall Study|Lost to Follow-up|0|||
130926238|NCT02340975|471364234|FG002|Overall Study|Lost to Follow-up|0|||
130926239|NCT02340975|471364235|FG003|Overall Study|Lost to Follow-up|0|||
130926240|NCT02340975|471364236|FG004|Overall Study|Lost to Follow-up|2|||
130926241|NCT02340975|471364237|FG005|Overall Study|Lost to Follow-up|0|||
130926242|NCT02340975|471364232|FG000|Overall Study|Withdrawal by Subject|0|||
130926243|NCT02340975|471364233|FG001|Overall Study|Withdrawal by Subject|0|||
130926244|NCT02340975|471364234|FG002|Overall Study|Withdrawal by Subject|3|||
130926245|NCT02340975|471364235|FG003|Overall Study|Withdrawal by Subject|3|||
130926246|NCT02340975|471364236|FG004|Overall Study|Withdrawal by Subject|2|||
130926247|NCT02340975|471364237|FG005|Overall Study|Withdrawal by Subject|0|||
130926248|NCT02340975|471364232|FG000|Overall Study|Other|0|||
130926249|NCT02340975|471364233|FG001|Overall Study|Other|4|||
130701756|NCT01074008|470532642|FG007|Overall Study|Adverse Event|0|||
130701757|NCT01074008|470532643|FG008|Overall Study|Adverse Event|0|||
130701758|NCT01074008|470532635|FG000|Overall Study|Withdrawal by Subject|1|||
130701759|NCT01074008|470532636|FG001|Overall Study|Withdrawal by Subject|1|||
130701760|NCT01074008|470532637|FG002|Overall Study|Withdrawal by Subject|1|||
130701761|NCT01074008|470532638|FG003|Overall Study|Withdrawal by Subject|0|||
130701762|NCT01074008|470532639|FG004|Overall Study|Withdrawal by Subject|1|||
130701763|NCT01074008|470532640|FG005|Overall Study|Withdrawal by Subject|0|||
130701764|NCT01074008|470532641|FG006|Overall Study|Withdrawal by Subject|0|||
130701765|NCT01074008|470532642|FG007|Overall Study|Withdrawal by Subject|0|||
130926250|NCT02340975|471364234|FG002|Overall Study|Other|0|||
130926251|NCT02340975|471364235|FG003|Overall Study|Other|2|||
130926252|NCT02340975|471364236|FG004|Overall Study|Other|0|||
130926253|NCT02340975|471364237|FG005|Overall Study|Other|6|||
130926254|NCT02228460|471364240|FG000|Overall Study|Adverse Event|1|||
130926255|NCT02228460|471364240|FG000|Overall Study|Lost to Follow-up|1|||
130926256|NCT01243892|471364241|FG000|Overall Study|Did not meet eligibility criteria|2|||
130926257|NCT01243892|471364242|FG001|Overall Study|Did not meet eligibility criteria|0|||
130926258|NCT00119106|471364243|FG000|Overall Study|HIV infected at baseline|179|||
130926259|NCT00119106|471364244|FG001|Overall Study|HIV infected at baseline|178|||
130926260|NCT03066804|471364245|FG000|Overall Study|Physician Decision|0|||
130701766|NCT01074008|470532643|FG008|Overall Study|Withdrawal by Subject|0|||
130770055|NCT02634801|470784240|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
130926261|NCT03066804|471364246|FG001|Overall Study|Physician Decision|4|||
130926262|NCT03066804|471364245|FG000|Overall Study|Death|23|||
130926263|NCT03066804|471364246|FG001|Overall Study|Death|17|||
130701767|NCT01074008|470532635|FG000|Overall Study|Lost to Follow-up|0|||
130926264|NCT03066804|471364245|FG000|Overall Study|Withdrawal by Subject|19|||
130926265|NCT03066804|471364246|FG001|Overall Study|Withdrawal by Subject|25|||
130926266|NCT03066804|471364245|FG000|Overall Study|Lost to Follow-up|2|||
130926267|NCT03066804|471364246|FG001|Overall Study|Lost to Follow-up|0|||
130926268|NCT03066804|471364245|FG000|Overall Study|Adverse Event|2|||
130926269|NCT03066804|471364246|FG001|Overall Study|Adverse Event|3|||
130926270|NCT03066804|471364245|FG000|Overall Study|Technical problems|5|||
130926271|NCT03066804|471364246|FG001|Overall Study|Technical problems|1|||
130770056|NCT02634801|470784241|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
130701768|NCT01074008|470532636|FG001|Overall Study|Lost to Follow-up|1|||
130701769|NCT01074008|470532637|FG002|Overall Study|Lost to Follow-up|1|||
130701770|NCT01074008|470532638|FG003|Overall Study|Lost to Follow-up|1|||
130701771|NCT01074008|470532639|FG004|Overall Study|Lost to Follow-up|1|||
130701772|NCT01074008|470532640|FG005|Overall Study|Lost to Follow-up|0|||
130926272|NCT03982368|471364254|FG000|Overall Study|Adverse Event|6|||
130926273|NCT03982368|471364255|FG001|Overall Study|Adverse Event|4|||
130926274|NCT03982368|471364256|FG002|Overall Study|Adverse Event|3|||
130926275|NCT03982368|471364254|FG000|Overall Study|Lost to Follow-up|2|||
130926276|NCT03982368|471364255|FG001|Overall Study|Lost to Follow-up|1|||
130926277|NCT03982368|471364256|FG002|Overall Study|Lost to Follow-up|0|||
130926278|NCT03982368|471364254|FG000|Overall Study|Withdrawal by Subject|1|||
130926279|NCT03982368|471364255|FG001|Overall Study|Withdrawal by Subject|2|||
130926280|NCT03982368|471364256|FG002|Overall Study|Withdrawal by Subject|0|||
130926281|NCT03982368|471364254|FG000|Overall Study|unknow|4|||
130926282|NCT03982368|471364255|FG001|Overall Study|unknow|0|||
130701773|NCT01074008|470532641|FG006|Overall Study|Lost to Follow-up|1|||
130701774|NCT01074008|470532642|FG007|Overall Study|Lost to Follow-up|0|||
130701775|NCT01074008|470532643|FG008|Overall Study|Lost to Follow-up|4|||
130701776|NCT00108628|470532649|FG000|Overall Study|Withdrawal by Subject|17|||
130926283|NCT03982368|471364256|FG002|Overall Study|unknow|2|||
130926284|NCT00329238|471364257|FG000|Overall Study|Adverse Event|147|||
130926285|NCT00329238|471364258|FG001|Overall Study|Adverse Event|129|||
130926286|NCT00329238|471364257|FG000|Overall Study|Protocol Violation|23|||
130926287|NCT00329238|471364258|FG001|Overall Study|Protocol Violation|34|||
130926288|NCT00329238|471364257|FG000|Overall Study|Lost to Follow-up|2|||
130926289|NCT00329238|471364258|FG001|Overall Study|Lost to Follow-up|6|||
130701777|NCT00108628|470532650|FG001|Overall Study|Withdrawal by Subject|9|||
130926290|NCT00329238|471364257|FG000|Overall Study|Withdrawal by Subject|64|||
130926291|NCT00329238|471364258|FG001|Overall Study|Withdrawal by Subject|58|||
130926292|NCT00329238|471364257|FG000|Overall Study|Other reason (not specified)|40|||
130926293|NCT00329238|471364258|FG001|Overall Study|Other reason (not specified)|54|||
130926294|NCT02083783|471364263|FG000|Overall Study|Withdrawal by Subject|1|||
130926295|NCT02083783|471364264|FG001|Overall Study|Withdrawal by Subject|0|||
130926296|NCT02256631|471364265|FG000|Overall Study|Lost to Follow-up|1|||
130926297|NCT02256631|471364266|FG001|Overall Study|Lost to Follow-up|1|||
130926298|NCT02256631|471364267|FG002|Overall Study|Lost to Follow-up|0|||
130926299|NCT02256631|471364268|FG003|Overall Study|Lost to Follow-up|2|||
130926300|NCT02256631|471364269|FG004|Overall Study|Lost to Follow-up|0|||
130926301|NCT02256631|471364270|FG005|Overall Study|Lost to Follow-up|4|||
130926302|NCT02256631|471364271|FG006|Overall Study|Lost to Follow-up|1|||
130926303|NCT02256631|471364265|FG000|Overall Study|Withdrawal by Subject|0|||
130926304|NCT02256631|471364266|FG001|Overall Study|Withdrawal by Subject|0|||
130926305|NCT02256631|471364267|FG002|Overall Study|Withdrawal by Subject|0|||
130926306|NCT02256631|471364268|FG003|Overall Study|Withdrawal by Subject|1|||
130926307|NCT02256631|471364269|FG004|Overall Study|Withdrawal by Subject|1|||
130926308|NCT02256631|471364270|FG005|Overall Study|Withdrawal by Subject|0|||
130926309|NCT02256631|471364271|FG006|Overall Study|Withdrawal by Subject|1|||
130926310|NCT02256631|471364265|FG000|Overall Study|Unable to get to clinic|0|||
130926311|NCT02256631|471364266|FG001|Overall Study|Unable to get to clinic|2|||
130926312|NCT02256631|471364267|FG002|Overall Study|Unable to get to clinic|0|||
130701778|NCT00108628|470532649|FG000|Overall Study|Lack of Efficacy|2|||
130701779|NCT00108628|470532650|FG001|Overall Study|Lack of Efficacy|1|||
130701780|NCT00108628|470532649|FG000|Overall Study|Death|1|||
130701781|NCT00108628|470532650|FG001|Overall Study|Death|0|||
130701782|NCT01350934|470532651|FG000|Base Study|Adverse Event|6|||
130701783|NCT01350934|470532652|FG001|Base Study|Adverse Event|0|||
130770057|NCT02634801|470784242|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
130770058|NCT02634801|470784240|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
130926313|NCT02256631|471364268|FG003|Overall Study|Unable to get to clinic|1|||
131034597|NCT00753545|471761741|FG000|Overall Study|Protocol Violation|1|||
131034598|NCT00753545|471761742|FG001|Overall Study|Protocol Violation|0|||
131034599|NCT00753545|471761741|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
130701784|NCT01350934|470532651|FG000|Base Study|Lost to Follow-up|1|||
130701785|NCT01350934|470532652|FG001|Base Study|Lost to Follow-up|0|||
130926314|NCT02256631|471364269|FG004|Overall Study|Unable to get to clinic|0|||
130926315|NCT02256631|471364270|FG005|Overall Study|Unable to get to clinic|1|||
130926316|NCT02256631|471364271|FG006|Overall Study|Unable to get to clinic|2|||
130926317|NCT02639065|471364275|FG000|Study Treatment|Disease Progression|13|||
130926318|NCT02639065|471364275|FG000|Study Treatment|Adverse Event|9|||
130701786|NCT01350934|470532651|FG000|Base Study|Protocol Violation|1|||
130701787|NCT01350934|470532652|FG001|Base Study|Protocol Violation|1|||
130701788|NCT01350934|470532651|FG000|Base Study|Withdrawal by Subject|1|||
130701789|NCT01350934|470532652|FG001|Base Study|Withdrawal by Subject|2|||
130926319|NCT02639065|471364275|FG000|Study Treatment|Withdrawal by Subject|1|||
130926320|NCT02639065|471364275|FG000|Follow up|Subject refused to follow up|1|||
130926321|NCT02639065|471364275|FG000|Follow up|Symptomatic Deterioration|2|||
130926322|NCT02639065|471364275|FG000|Follow up|Death|2|||
130926323|NCT02639065|471364275|FG000|Follow up|Study Terminated|1|||
130926324|NCT02639065|471364275|FG000|Follow up|Disease Progression|3|||
130926325|NCT00481078|471364276|FG000|Overall Study|Progression of disease|11|||
130926326|NCT00481078|471364277|FG001|Overall Study|Progression of disease|11|||
130926327|NCT00481078|471364276|FG000|Overall Study|Adverse Event|15|||
130926328|NCT00481078|471364277|FG001|Overall Study|Adverse Event|3|||
130926329|NCT00481078|471364276|FG000|Overall Study|Death|5|||
130926330|NCT00481078|471364277|FG001|Overall Study|Death|3|||
130926331|NCT00481078|471364276|FG000|Overall Study|Intercurrent illness|1|||
130926332|NCT00481078|471364277|FG001|Overall Study|Intercurrent illness|0|||
130926333|NCT00481078|471364276|FG000|Overall Study|Withdrawal by Subject|7|||
130926334|NCT00481078|471364277|FG001|Overall Study|Withdrawal by Subject|1|||
130926335|NCT00481078|471364276|FG000|Overall Study|Information not available|1|||
130926336|NCT00481078|471364277|FG001|Overall Study|Information not available|0|||
130926337|NCT00481078|471364276|FG000|Overall Study|Received other treatment|2|||
130926338|NCT00481078|471364277|FG001|Overall Study|Received other treatment|1|||
130926339|NCT00481078|471364276|FG000|Overall Study|Brain metastasis|0|||
130926340|NCT00481078|471364277|FG001|Overall Study|Brain metastasis|1|||
130926341|NCT01558271|471364278|FG000|Overall Study|Adverse Event|6|||
130926342|NCT01558271|471364279|FG001|Overall Study|Adverse Event|3|||
130926343|NCT01558271|471364280|FG002|Overall Study|Adverse Event|4|||
130926344|NCT01558271|471364278|FG000|Overall Study|Lost to Follow-up|1|||
130926345|NCT01558271|471364279|FG001|Overall Study|Lost to Follow-up|0|||
130926346|NCT01558271|471364280|FG002|Overall Study|Lost to Follow-up|0|||
130926347|NCT01558271|471364278|FG000|Overall Study|Protocol Violation|1|||
130926348|NCT01558271|471364279|FG001|Overall Study|Protocol Violation|0|||
130926349|NCT01558271|471364280|FG002|Overall Study|Protocol Violation|0|||
130926350|NCT01558271|471364278|FG000|Overall Study|Withdrawal by Subject|10|||
130701790|NCT01350934|470532651|FG000|Base Study|Non-Compliance With Study Drug|2|||
130701791|NCT01350934|470532652|FG001|Base Study|Non-Compliance With Study Drug|0|||
130926351|NCT01558271|471364279|FG001|Overall Study|Withdrawal by Subject|6|||
130926352|NCT01558271|471364280|FG002|Overall Study|Withdrawal by Subject|12|||
130926353|NCT01558271|471364278|FG000|Overall Study|Physician Decision|0|||
130926354|NCT01558271|471364279|FG001|Overall Study|Physician Decision|2|||
130926355|NCT01558271|471364280|FG002|Overall Study|Physician Decision|1|||
130926356|NCT03329573|471364281|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
130926357|NCT03329573|471364282|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
130926358|NCT03329573|471364283|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
130926359|NCT03329573|471364284|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
130926360|NCT03329573|471364281|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
130926361|NCT03329573|471364282|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
130926362|NCT03329573|471364283|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130926363|NCT03329573|471364284|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
130926364|NCT03329573|471364281|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
130926365|NCT03329573|471364282|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
130926366|NCT03329573|471364283|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
130926367|NCT03329573|471364284|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
130926368|NCT03329573|471364281|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
130926369|NCT03329573|471364282|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
130926370|NCT03329573|471364283|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
130926371|NCT03329573|471364284|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
130926372|NCT02777333|471364287|FG000|Overall Study|Withdrawal by Subject|0|||
130926373|NCT02777333|471364288|FG001|Overall Study|Withdrawal by Subject|1|||
130926374|NCT02777333|471364287|FG000|Overall Study|Lost to Follow-up|0|||
130926375|NCT02777333|471364288|FG001|Overall Study|Lost to Follow-up|1|||
130926376|NCT00837811|471364289|FG000|Overall Study|Adverse Event|4|||
130926377|NCT00837811|471364290|FG001|Overall Study|Adverse Event|6|||
130926378|NCT00837811|471364291|FG002|Overall Study|Adverse Event|0|||
130926379|NCT00837811|471364289|FG000|Overall Study|Death|1|||
130926380|NCT00837811|471364290|FG001|Overall Study|Death|1|||
130926381|NCT00837811|471364291|FG002|Overall Study|Death|0|||
130926382|NCT00837811|471364289|FG000|Overall Study|Lack of Efficacy|0|||
130926383|NCT00837811|471364290|FG001|Overall Study|Lack of Efficacy|11|||
130701792|NCT01350934|470532651|FG000|Extension Study|Adverse Event|2|||
130926384|NCT00837811|471364291|FG002|Overall Study|Lack of Efficacy|0|||
130926385|NCT00837811|471364289|FG000|Overall Study|Lost to Follow-up|1|||
130926386|NCT00837811|471364290|FG001|Overall Study|Lost to Follow-up|3|||
130926387|NCT00837811|471364291|FG002|Overall Study|Lost to Follow-up|0|||
130926388|NCT00837811|471364289|FG000|Overall Study|Physician Decision|0|||
130926389|NCT00837811|471364290|FG001|Overall Study|Physician Decision|2|||
130926390|NCT00837811|471364291|FG002|Overall Study|Physician Decision|1|||
130926391|NCT00837811|471364289|FG000|Overall Study|Withdrawal by Subject|1|||
130926392|NCT00837811|471364290|FG001|Overall Study|Withdrawal by Subject|9|||
130926393|NCT00837811|471364291|FG002|Overall Study|Withdrawal by Subject|0|||
130926394|NCT00837811|471364289|FG000|Overall Study|Sponsor Decision|0|||
130926395|NCT00837811|471364290|FG001|Overall Study|Sponsor Decision|2|||
130926396|NCT00837811|471364291|FG002|Overall Study|Sponsor Decision|0|||
130926397|NCT03307967|471364292|FG000|Overall Study|Lost to Follow-up|4|||
130926398|NCT02578316|471364293|FG000|Extension Phase|Progression of disease|6|||
130926399|NCT05372419|471364294|FG000|Overall Study|Protocol Deviation|1|||
130926400|NCT05372419|471364294|FG000|Overall Study|Withdrawal by Subject|5|||
130926401|NCT05372419|471364294|FG000|Overall Study|Lost to Follow-up|7|||
130926402|NCT04362072|471364298|FG000|Treatment|Adverse Event|1|||
130926403|NCT04362072|471364298|FG000|Treatment|Death|9|||
130926404|NCT04362072|471364298|FG000|Treatment|Physician Decision|2|||
130926405|NCT04362072|471364298|FG000|Treatment|Progressive disease|27|||
130926406|NCT04362072|471364298|FG000|Treatment|Withdrawal by Subject|4|||
130926407|NCT04362072|471364298|FG000|Treatment|Global deterioration of health status|1|||
130926408|NCT04362072|471364298|FG000|Treatment|Switched to commercial Lorlatinib|13|||
130926409|NCT04362072|471364298|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
130926410|NCT04362072|471364298|FG000|Treatment|Other|3|||
130926411|NCT04362072|471364298|FG000|Follow up|Death|2|||
130926412|NCT04362072|471364298|FG000|Follow up|Other|2|||
130926413|NCT01133522|471364299|FG000|Overall Study|Withdrawal by Subject|0|||
130926414|NCT01133522|471364300|FG001|Overall Study|Withdrawal by Subject|1|||
130926415|NCT01133522|471364301|FG002|Overall Study|Withdrawal by Subject|0|||
130926416|NCT01133522|471364302|FG003|Overall Study|Withdrawal by Subject|1|||
130926417|NCT01133522|471364303|FG004|Overall Study|Withdrawal by Subject|0|||
130926418|NCT01133522|471364304|FG005|Overall Study|Withdrawal by Subject|0|||
130926419|NCT01133522|471364305|FG006|Overall Study|Withdrawal by Subject|0|||
130926420|NCT01133522|471364306|FG007|Overall Study|Withdrawal by Subject|0|||
130926421|NCT01133522|471364307|FG008|Overall Study|Withdrawal by Subject|0|||
130926422|NCT01133522|471364308|FG009|Overall Study|Withdrawal by Subject|0|||
130926423|NCT01133522|471364299|FG000|Overall Study|Physician Decision|0|||
130926424|NCT01133522|471364300|FG001|Overall Study|Physician Decision|0|||
130926425|NCT01133522|471364301|FG002|Overall Study|Physician Decision|0|||
130926426|NCT01133522|471364302|FG003|Overall Study|Physician Decision|0|||
130926427|NCT01133522|471364303|FG004|Overall Study|Physician Decision|1|||
130926428|NCT01133522|471364304|FG005|Overall Study|Physician Decision|0|||
130926429|NCT01133522|471364305|FG006|Overall Study|Physician Decision|0|||
130926430|NCT01133522|471364306|FG007|Overall Study|Physician Decision|0|||
130926431|NCT01133522|471364307|FG008|Overall Study|Physician Decision|0|||
130926432|NCT01133522|471364308|FG009|Overall Study|Physician Decision|0|||
130926433|NCT04292743|471364309|FG000|Overall Study|Physician Decision|1|||
130926434|NCT04292743|471364310|FG001|Overall Study|Physician Decision|3|||
130926435|NCT04292743|471364311|FG002|Overall Study|Physician Decision|0|||
130926436|NCT04292743|471364312|FG003|Overall Study|Physician Decision|0|||
130926437|NCT04292743|471364309|FG000|Overall Study|Withdrawal by Subject|0|||
130926438|NCT04292743|471364310|FG001|Overall Study|Withdrawal by Subject|5|||
130701793|NCT01350934|470532652|FG001|Extension Study|Adverse Event|1|||
130701794|NCT01350934|470532651|FG000|Extension Study|Lost to Follow-up|2|||
130701795|NCT01350934|470532652|FG001|Extension Study|Lost to Follow-up|0|||
130701796|NCT01350934|470532651|FG000|Extension Study|Protocol Violation|1|||
130701797|NCT01350934|470532652|FG001|Extension Study|Protocol Violation|1|||
130701798|NCT01350934|470532651|FG000|Extension Study|Lack of Efficacy|0|||
130701799|NCT01350934|470532652|FG001|Extension Study|Lack of Efficacy|1|||
130701800|NCT01350934|470532651|FG000|Extension Study|Withdrawal by Subject|0|||
130701801|NCT01350934|470532652|FG001|Extension Study|Withdrawal by Subject|1|||
130701802|NCT03547635|470532655|FG000|Overall Study|Adverse Event|5|||
130701803|NCT03547635|470532656|FG001|Overall Study|Adverse Event|2|||
130926439|NCT04292743|471364311|FG002|Overall Study|Withdrawal by Subject|0|||
130926440|NCT04292743|471364312|FG003|Overall Study|Withdrawal by Subject|0|||
130926441|NCT04292743|471364309|FG000|Overall Study|Death|0|||
130926442|NCT04292743|471364310|FG001|Overall Study|Death|1|||
130926443|NCT04292743|471364311|FG002|Overall Study|Death|0|||
130926444|NCT04292743|471364312|FG003|Overall Study|Death|0|||
130926445|NCT04292743|471364309|FG000|Overall Study|Progression of Disease|2|||
130926446|NCT04292743|471364310|FG001|Overall Study|Progression of Disease|5|||
130926447|NCT04292743|471364311|FG002|Overall Study|Progression of Disease|0|||
130926448|NCT04292743|471364312|FG003|Overall Study|Progression of Disease|0|||
130926449|NCT04292743|471364309|FG000|Overall Study|No Treatment per protocol|0|||
130926450|NCT04292743|471364310|FG001|Overall Study|No Treatment per protocol|2|||
130926451|NCT04292743|471364311|FG002|Overall Study|No Treatment per protocol|0|||
130926452|NCT04292743|471364312|FG003|Overall Study|No Treatment per protocol|0|||
130926453|NCT05766423|471364313|FG000|Overall Study|Withdrawal by Subject|1|||
130926454|NCT05766423|471364314|FG001|Overall Study|Withdrawal by Subject|0|||
130926455|NCT05766423|471364313|FG000|Overall Study|Consented, not scheduled|3|||
130926456|NCT05766423|471364314|FG001|Overall Study|Consented, not scheduled|5|||
130926457|NCT02469298|471366098|FG000|Overall Study|Protocol Violation|0|||
130926458|NCT02469298|471366099|FG001|Overall Study|Protocol Violation|1|||
130926459|NCT02469298|471366100|FG002|Overall Study|Protocol Violation|1|||
130926460|NCT02469298|471366101|FG003|Overall Study|Protocol Violation|0|||
130926461|NCT02469298|471366098|FG000|Overall Study|Lost to Follow-up|1|||
130926462|NCT02469298|471366099|FG001|Overall Study|Lost to Follow-up|0|||
130926463|NCT02469298|471366100|FG002|Overall Study|Lost to Follow-up|1|||
131223558|NCT02143947|472447047|FG001|Overall Study|Lost to Follow-up|2|||
131223559|NCT01244815|472447048|FG000|Overall Study|Not Treated|0|||
131223560|NCT01244815|472447049|FG001|Overall Study|Not Treated|1|||
131223561|NCT01244815|472447050|FG002|Overall Study|Not Treated|0|||
130926464|NCT02469298|471366101|FG003|Overall Study|Lost to Follow-up|0|||
130926465|NCT02469298|471366098|FG000|Overall Study|Physician Decision|0|||
130926466|NCT02469298|471366099|FG001|Overall Study|Physician Decision|0|||
131223562|NCT01244815|472447051|FG003|Overall Study|Not Treated|0|||
131223563|NCT01244815|472447048|FG000|Overall Study|Adverse Event|4|||
131223564|NCT01244815|472447049|FG001|Overall Study|Adverse Event|7|||
131223565|NCT01244815|472447050|FG002|Overall Study|Adverse Event|5|||
131223566|NCT01244815|472447051|FG003|Overall Study|Adverse Event|5|||
131223567|NCT01244815|472447048|FG000|Overall Study|Treatment Failure|0|||
131223568|NCT01244815|472447049|FG001|Overall Study|Treatment Failure|0|||
131223569|NCT01244815|472447050|FG002|Overall Study|Treatment Failure|0|||
131223570|NCT01244815|472447051|FG003|Overall Study|Treatment Failure|1|||
131223571|NCT01244815|472447048|FG000|Overall Study|Lost to Follow-up|3|||
131223572|NCT01244815|472447049|FG001|Overall Study|Lost to Follow-up|2|||
131223573|NCT01244815|472447050|FG002|Overall Study|Lost to Follow-up|3|||
131223574|NCT01244815|472447051|FG003|Overall Study|Lost to Follow-up|2|||
131223575|NCT01244815|472447048|FG000|Overall Study|Withdrawal by Subject|0|||
131223576|NCT01244815|472447049|FG001|Overall Study|Withdrawal by Subject|2|||
131223577|NCT01244815|472447050|FG002|Overall Study|Withdrawal by Subject|0|||
131223578|NCT01244815|472447051|FG003|Overall Study|Withdrawal by Subject|3|||
130701804|NCT03547635|470532657|FG002|Overall Study|Adverse Event|3|||
130701805|NCT03547635|470532655|FG000|Overall Study|Lost to Follow-up|1|||
130701806|NCT03547635|470532656|FG001|Overall Study|Lost to Follow-up|3|||
130701807|NCT03547635|470532657|FG002|Overall Study|Lost to Follow-up|4|||
130701808|NCT03547635|470532655|FG000|Overall Study|Withdrawal by Subject|1|||
130701809|NCT03547635|470532656|FG001|Overall Study|Withdrawal by Subject|0|||
130701810|NCT03547635|470532657|FG002|Overall Study|Withdrawal by Subject|0|||
130701811|NCT03547635|470532655|FG000|Overall Study|Withdrawal By PI|0|||
130701812|NCT03547635|470532656|FG001|Overall Study|Withdrawal By PI|1|||
130701813|NCT03547635|470532657|FG002|Overall Study|Withdrawal By PI|0|||
130701814|NCT03547635|470532655|FG000|Overall Study|Withdrawal by Sponsor|0|||
130701815|NCT03547635|470532656|FG001|Overall Study|Withdrawal by Sponsor|0|||
130701816|NCT03547635|470532657|FG002|Overall Study|Withdrawal by Sponsor|1|||
130701817|NCT03547635|470532655|FG000|Overall Study|Errant Randomization before Treatment|0|||
130701818|NCT03547635|470532656|FG001|Overall Study|Errant Randomization before Treatment|1|||
130701819|NCT03547635|470532657|FG002|Overall Study|Errant Randomization before Treatment|0|||
130701820|NCT03547635|470532655|FG000|Overall Study|Withdrawal by Subject|1|||
130701821|NCT03547635|470532656|FG001|Overall Study|Withdrawal by Subject|0|||
130701822|NCT03547635|470532657|FG002|Overall Study|Withdrawal by Subject|0|||
130701823|NCT00676650|470532660|FG000|Overall Study|Death|45|||
130701824|NCT00676650|470532661|FG001|Overall Study|Death|14|||
130701825|NCT00676650|470532660|FG000|Overall Study|Adverse Event|159|||
130701826|NCT00676650|470532661|FG001|Overall Study|Adverse Event|21|||
130701827|NCT00676650|470532660|FG000|Overall Study|Global deterioration of health status|66|||
130701828|NCT00676650|470532661|FG001|Overall Study|Global deterioration of health status|31|||
130701829|NCT00676650|470532660|FG000|Overall Study|Lost to Follow-up|0|||
130701830|NCT00676650|470532661|FG001|Overall Study|Lost to Follow-up|1|||
130701831|NCT00676650|470532660|FG000|Overall Study|Objective progression or relapse|189|||
130701832|NCT00676650|470532661|FG001|Overall Study|Objective progression or relapse|140|||
130701833|NCT00676650|470532660|FG000|Overall Study|Other|14|||
130701834|NCT00676650|470532661|FG001|Overall Study|Other|10|||
130701835|NCT00676650|470532660|FG000|Overall Study|Protocol Violation|3|||
130701836|NCT00676650|470532661|FG001|Overall Study|Protocol Violation|1|||
130701837|NCT00676650|470532660|FG000|Overall Study|Study terminated by sponsor|57|||
130701838|NCT00676650|470532661|FG001|Overall Study|Study terminated by sponsor|43|||
130770059|NCT02634801|470784241|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
130926467|NCT02469298|471366100|FG002|Overall Study|Physician Decision|0|||
130926468|NCT02469298|471366101|FG003|Overall Study|Physician Decision|1|||
131223579|NCT01244815|472447048|FG000|Overall Study|Protocol Violation|7|||
131223580|NCT01244815|472447049|FG001|Overall Study|Protocol Violation|4|||
130701839|NCT00676650|470532660|FG000|Overall Study|Withdrawal by Subject|48|||
130701840|NCT00676650|470532661|FG001|Overall Study|Withdrawal by Subject|24|||
130701841|NCT00676650|470532660|FG000|Overall Study|Randomized but not treated|3|||
130701842|NCT00676650|470532661|FG001|Overall Study|Randomized but not treated|4|||
130701843|NCT02297841|470532662|FG000|Overall Study|Withdrawal by Subject|1|||
130770060|NCT02634801|470784242|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
130926469|NCT02469298|471366098|FG000|Overall Study|Withdrawal by Subject|0|||
131223581|NCT01244815|472447050|FG002|Overall Study|Protocol Violation|3|||
130701844|NCT02297841|470532662|FG000|Overall Study|Protocol Violation|7|||
130701845|NCT00683592|470532663|FG000|Overall Study|Adverse Event|12|||
131223582|NCT01244815|472447051|FG003|Overall Study|Protocol Violation|1|||
131223583|NCT01244815|472447048|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
131223584|NCT01244815|472447049|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
131223585|NCT01244815|472447050|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
130926470|NCT02469298|471366099|FG001|Overall Study|Withdrawal by Subject|0|||
130926471|NCT02469298|471366100|FG002|Overall Study|Withdrawal by Subject|0|||
130926472|NCT02469298|471366101|FG003|Overall Study|Withdrawal by Subject|1|||
130926473|NCT01664533|471366104|FG000|Overall Study|Death|42|||
130926474|NCT01664533|471366104|FG000|Overall Study|Lost to Follow-up|3|||
130926475|NCT01664533|471366104|FG000|Overall Study|Study termination|9|||
130926476|NCT01664533|471366104|FG000|Overall Study|Protocol Violation|3|||
130926477|NCT00290888|471366105|FG000|Overall Study|Physician Decision|3|||
131034600|NCT00753545|471761742|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
131223586|NCT01244815|472447051|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
131223587|NCT00697112|472447053|FG000|Overall Study|Adverse Event|8|||
131223588|NCT00697112|472447053|FG000|Overall Study|Lost to Follow-up|1|||
131223589|NCT00697112|472447053|FG000|Overall Study|Did not meet inclusion criteria|1|||
130701846|NCT00683592|470532664|FG001|Overall Study|Adverse Event|4|||
130701847|NCT00683592|470532663|FG000|Overall Study|Withdrawal by Subject|11|||
130701848|NCT00683592|470532664|FG001|Overall Study|Withdrawal by Subject|11|||
130701849|NCT00683592|470532663|FG000|Overall Study|Lost to Follow-up|17|||
130701850|NCT00683592|470532664|FG001|Overall Study|Lost to Follow-up|17|||
130701851|NCT00683592|470532663|FG000|Overall Study|Lack of Efficacy|3|||
130701852|NCT00683592|470532664|FG001|Overall Study|Lack of Efficacy|7|||
130701853|NCT00683592|470532663|FG000|Overall Study|Physician Decision|0|||
130701854|NCT00683592|470532664|FG001|Overall Study|Physician Decision|1|||
130701855|NCT00683592|470532663|FG000|Overall Study|Non-compliance|3|||
130701856|NCT00683592|470532664|FG001|Overall Study|Non-compliance|5|||
130701857|NCT00683592|470532663|FG000|Overall Study|Other|1|||
130701858|NCT00683592|470532664|FG001|Overall Study|Other|1|||
130701859|NCT00329160|470532674|FG000|Overall Study|Adverse Event|27|||
130701860|NCT00329160|470532674|FG000|Overall Study|Withdrawal by Subject|13|||
130701861|NCT00329160|470532674|FG000|Overall Study|Protocol Violation|2|||
130701862|NCT00329160|470532674|FG000|Overall Study|Did not Receive Study Drug|1|||
130701863|NCT00329160|470532674|FG000|Overall Study|Incomplete IVUS|45|||
130701864|NCT04501094|470532675|FG000|Overall Study|Death (unrelated to research)|1|||
130701865|NCT04501094|470532676|FG001|Overall Study|Death (unrelated to research)|0|||
130701866|NCT00685035|470532678|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
130701867|NCT00685035|470532679|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
130701868|NCT00063258|470532680|FG000|Overall Study|Physician Decision|2|||
130701869|NCT00063258|470532681|FG001|Overall Study|Physician Decision|0|||
130701870|NCT00063258|470532680|FG000|Overall Study|Lack of Efficacy|2|||
130701871|NCT00063258|470532681|FG001|Overall Study|Lack of Efficacy|0|||
130701872|NCT00784979|470532684|FG000|Overall Study|incomplete data|6|||
130701873|NCT04241133|470532686|FG000|Overall Study|COVID19 Precautions|14|||
130701874|NCT04241133|470532687|FG001|Overall Study|COVID19 Precautions|34|||
130701875|NCT01235715|470532691|FG000|Overall Study|Physician Decision|0|||
130701876|NCT01235715|470532692|FG001|Overall Study|Physician Decision|2|||
130701877|NCT02994394|470532693|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
130701878|NCT02994394|470532694|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
130701879|NCT02994394|470532695|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
130701880|NCT02994394|470532696|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
130701881|NCT02994394|470532697|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
130701882|NCT02994394|470532698|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
130701883|NCT02994394|470532693|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
130701884|NCT02994394|470532694|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
130701885|NCT02994394|470532695|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
130701886|NCT02994394|470532696|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
130701887|NCT02994394|470532697|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
130701888|NCT02994394|470532698|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
130701889|NCT04982445|470532699|FG000|Overall Study|Protocol Violation|1|||
130701890|NCT04982445|470532699|FG000|Overall Study|Withdrawal by Subject|4|||
130701891|NCT04982445|470532699|FG000|Overall Study|Lost to Follow-up|1|||
130701892|NCT00396630|470532700|FG000|Overall Study|Lost to Follow-up|1|||
130701893|NCT00396630|470532701|FG001|Overall Study|Lost to Follow-up|1|||
130701894|NCT00396630|470532700|FG000|Overall Study|Withdrawal by Subject|1|||
130701895|NCT00396630|470532701|FG001|Overall Study|Withdrawal by Subject|1|||
130701896|NCT00396630|470532700|FG000|Overall Study|Not vaccinated at Visit 3|3|||
130701897|NCT00396630|470532701|FG001|Overall Study|Not vaccinated at Visit 3|3|||
130701898|NCT02327325|470532702|FG000|Overall Study|Withdrawal by Subject|1|||
130701899|NCT02327325|470532703|FG001|Overall Study|Withdrawal by Subject|4|||
130701900|NCT02327325|470532704|FG002|Overall Study|Withdrawal by Subject|4|||
130701901|NCT02327325|470532702|FG000|Overall Study|Excluded by Study Team|0|||
130701902|NCT02327325|470532703|FG001|Overall Study|Excluded by Study Team|0|||
130701903|NCT02327325|470532704|FG002|Overall Study|Excluded by Study Team|1|||
130701904|NCT01755975|470532707|FG000|Overall Study|Adverse Event|0|||
130701905|NCT01755975|470532708|FG001|Overall Study|Adverse Event|0|||
130701906|NCT01755975|470532709|FG002|Overall Study|Adverse Event|1|||
130701907|NCT01755975|470532710|FG003|Overall Study|Adverse Event|0|||
130701908|NCT01755975|470532711|FG004|Overall Study|Adverse Event|2|||
130701909|NCT03653026|470532712|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
130926478|NCT00290888|471366106|FG001|Overall Study|Physician Decision|1|||
130926479|NCT03000439|471366107|FG000|Open Label Part 1|Adverse Event|6|||
130926480|NCT03000439|471366108|FG001|Open Label Part 1|Adverse Event|0|||
130926481|NCT03000439|471366109|FG002|Open Label Part 1|Adverse Event|0|||
130926482|NCT03000439|471366110|FG003|Open Label Part 1|Adverse Event|0|||
130926483|NCT03000439|471366107|FG000|Open Label Part 1|Other|2|||
130926484|NCT03000439|471366108|FG001|Open Label Part 1|Other|0|||
130926485|NCT03000439|471366109|FG002|Open Label Part 1|Other|0|||
130926486|NCT03000439|471366110|FG003|Open Label Part 1|Other|0|||
131223590|NCT03066440|472447056|FG000|Overall Study|Physician Decision|1|||
131223591|NCT03066440|472447057|FG001|Overall Study|Physician Decision|1|||
131223592|NCT03066440|472447056|FG000|Overall Study|Protocol Violation|0|||
131223593|NCT03066440|472447057|FG001|Overall Study|Protocol Violation|2|||
130926487|NCT03000439|471366107|FG000|Open Label Part 1|Insufficient clinical response|16|||
130926488|NCT03000439|471366108|FG001|Open Label Part 1|Insufficient clinical response|0|||
130926489|NCT03000439|471366109|FG002|Open Label Part 1|Insufficient clinical response|0|||
130926490|NCT03000439|471366110|FG003|Open Label Part 1|Insufficient clinical response|0|||
130926491|NCT03000439|471366107|FG000|Open Label Part 2|Other|0|||
130926492|NCT03000439|471366108|FG001|Open Label Part 2|Other|5|||
130926493|NCT03000439|471366109|FG002|Open Label Part 2|Other|0|||
130926494|NCT03000439|471366110|FG003|Open Label Part 2|Other|0|||
131223594|NCT00736333|472447058|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
131223595|NCT00736333|472447058|FG000|Overall Study|Data Missing|2|||
131223596|NCT00736333|472447058|FG000|Overall Study|Tumor Progression|75|||
131223597|NCT00736333|472447058|FG000|Overall Study|Toxicity|6|||
130926495|NCT03000439|471366107|FG000|Open Label Part 2|Insufficient clinical response|0|||
130926496|NCT03000439|471366108|FG001|Open Label Part 2|Insufficient clinical response|12|||
130926497|NCT03000439|471366109|FG002|Open Label Part 2|Insufficient clinical response|0|||
130926498|NCT03000439|471366110|FG003|Open Label Part 2|Insufficient clinical response|0|||
130926499|NCT03000439|471366107|FG000|Double Blind Phase|Adverse Event|0|||
130926500|NCT03000439|471366108|FG001|Double Blind Phase|Adverse Event|0|||
130926501|NCT03000439|471366109|FG002|Double Blind Phase|Adverse Event|2|||
130926502|NCT03000439|471366110|FG003|Double Blind Phase|Adverse Event|1|||
130926503|NCT03000439|471366107|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
130926504|NCT03000439|471366108|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
130926505|NCT03000439|471366109|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
130926506|NCT03000439|471366110|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
130926507|NCT03000439|471366107|FG000|Double Blind Phase|Other|0|||
130926508|NCT03000439|471366108|FG001|Double Blind Phase|Other|0|||
130926509|NCT03000439|471366109|FG002|Double Blind Phase|Other|10|||
130701910|NCT03653026|470532713|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
130701911|NCT03653026|470532714|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
130701912|NCT03653026|470532715|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
130701913|NCT03653026|470532712|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
130701914|NCT03653026|470532713|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
130926510|NCT03000439|471366110|FG003|Double Blind Phase|Other|11|||
130926511|NCT03000439|471366107|FG000|Double Blind Phase|Insufficient clinical response|0|||
130926512|NCT03000439|471366108|FG001|Double Blind Phase|Insufficient clinical response|0|||
130926513|NCT03000439|471366109|FG002|Double Blind Phase|Insufficient clinical response|0|||
130926514|NCT03000439|471366110|FG003|Double Blind Phase|Insufficient clinical response|2|||
130926515|NCT02370160|471366111|FG000|Overall Study|Death|3|||
130926516|NCT02370160|471366112|FG001|Overall Study|Death|4|||
130926517|NCT02370160|471366113|FG002|Overall Study|Death|1|||
130926518|NCT00592384|471366118|FG000|Overall Study|Withdrawal by Subject|5|||
130926519|NCT00592384|471366119|FG001|Overall Study|Withdrawal by Subject|6|||
130701915|NCT03653026|470532714|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130701916|NCT03653026|470532715|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130701917|NCT03653026|470532712|FG000|Part 1: Placebo-controlled Period|Other|0|||
130701918|NCT03653026|470532713|FG001|Part 1: Placebo-controlled Period|Other|3|||
130701919|NCT03653026|470532714|FG002|Part 1: Placebo-controlled Period|Other|0|||
130701920|NCT03653026|470532715|FG003|Part 1: Placebo-controlled Period|Other|0|||
130926520|NCT02151591|471366121|FG000|Overall Study|Lost to Follow-up|6|||
130926521|NCT02151591|471366122|FG001|Overall Study|Lost to Follow-up|3|||
130701921|NCT03653026|470532712|FG000|Part 2: Open-label Extension|Adverse Event|0|||
130926522|NCT02585960|471366123|FG000|PK/Safety Assessment Period|Physician Decision|0|||
131223598|NCT00736333|472447058|FG000|Overall Study|Withdrawal by Subject|10|||
131223599|NCT00736333|472447058|FG000|Overall Study|Death|7|||
130701922|NCT03653026|470532713|FG001|Part 2: Open-label Extension|Adverse Event|0|||
130926523|NCT02585960|471366124|FG001|PK/Safety Assessment Period|Physician Decision|1|||
130926524|NCT02585960|471366125|FG002|PK/Safety Assessment Period|Physician Decision|0|||
130926525|NCT02585960|471366123|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
130926526|NCT02585960|471366124|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
130926527|NCT02585960|471366125|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
130926528|NCT02585960|471366123|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
131034601|NCT04185298|471761744|FG000|Overall Study|Lost to Follow-up|1|||
131223600|NCT00736333|472447058|FG000|Overall Study|Other|4|||
130926529|NCT02585960|471366124|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
130926530|NCT02585960|471366125|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
130926531|NCT02585960|471366123|FG000|PK/Safety Assessment Period|Other|4|||
130926532|NCT02585960|471366124|FG001|PK/Safety Assessment Period|Other|4|||
130701923|NCT03653026|470532714|FG002|Part 2: Open-label Extension|Adverse Event|1|||
130701924|NCT03653026|470532715|FG003|Part 2: Open-label Extension|Adverse Event|1|||
130701925|NCT03653026|470532712|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
130701926|NCT03653026|470532713|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
130701927|NCT03653026|470532714|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
130701928|NCT03653026|470532715|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
130701929|NCT03653026|470532712|FG000|Part 2: Open-label Extension|Other|0|||
130701930|NCT03653026|470532713|FG001|Part 2: Open-label Extension|Other|0|||
130701931|NCT03653026|470532714|FG002|Part 2: Open-label Extension|Other|1|||
130701932|NCT03653026|470532715|FG003|Part 2: Open-label Extension|Other|2|||
130701933|NCT02457819|470532718|FG000|Overall Study|reason not given|8|||
130701934|NCT02457819|470532718|FG000|Overall Study|Withdrawal by Subject|24|||
130701935|NCT02457819|470532718|FG000|Overall Study|Protocol Violation|1|||
130701936|NCT02457819|470532718|FG000|Overall Study|non compliance with study drug|4|||
130701937|NCT02457819|470532718|FG000|Overall Study|Lost to Follow-up|10|||
130701938|NCT02457819|470532718|FG000|Overall Study|Lack of Efficacy|19|||
130701939|NCT02457819|470532718|FG000|Overall Study|Adverse Event|33|||
130701940|NCT01729026|470532720|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
130701941|NCT01729026|470532721|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
130701942|NCT01729026|470532720|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
130701943|NCT01729026|470532721|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
130701944|NCT03710590|470532722|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
130701945|NCT03710590|470532723|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
130701946|NCT00852917|470532724|FG000|Overall Study|Adverse Event|13|||
130701947|NCT00852917|470532725|FG001|Overall Study|Adverse Event|20|||
130701948|NCT00852917|470532726|FG002|Overall Study|Adverse Event|35|||
130701949|NCT00852917|470532727|FG003|Overall Study|Adverse Event|17|||
130701950|NCT00852917|470532724|FG000|Overall Study|Lack of Efficacy|21|||
130701951|NCT00852917|470532725|FG001|Overall Study|Lack of Efficacy|11|||
130701952|NCT00852917|470532726|FG002|Overall Study|Lack of Efficacy|11|||
130701953|NCT00852917|470532727|FG003|Overall Study|Lack of Efficacy|47|||
130701954|NCT00852917|470532724|FG000|Overall Study|Withdrawal by Subject|4|||
130701955|NCT00852917|470532725|FG001|Overall Study|Withdrawal by Subject|8|||
130701956|NCT00852917|470532726|FG002|Overall Study|Withdrawal by Subject|10|||
130701957|NCT00852917|470532727|FG003|Overall Study|Withdrawal by Subject|9|||
130701958|NCT00852917|470532724|FG000|Overall Study|Physician Decision|6|||
130701959|NCT00852917|470532725|FG001|Overall Study|Physician Decision|7|||
130701960|NCT00852917|470532726|FG002|Overall Study|Physician Decision|2|||
130701961|NCT00852917|470532727|FG003|Overall Study|Physician Decision|19|||
130701962|NCT00852917|470532724|FG000|Overall Study|Death|0|||
130701963|NCT00852917|470532725|FG001|Overall Study|Death|0|||
130701964|NCT00852917|470532726|FG002|Overall Study|Death|0|||
130701965|NCT00852917|470532727|FG003|Overall Study|Death|1|||
130701966|NCT01045707|470532729|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
130701967|NCT01045707|470532730|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
130701968|NCT01045707|470532729|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
130701969|NCT01045707|470532730|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
130701970|NCT01045707|470532729|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
130701971|NCT01045707|470532730|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
130701972|NCT01045707|470532729|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
130701973|NCT01045707|470532730|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
130701974|NCT01045707|470532729|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
130701975|NCT01045707|470532730|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
130701976|NCT01045707|470532729|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
130701977|NCT01045707|470532730|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
130701978|NCT01045707|470532729|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
130701979|NCT01045707|470532730|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
130926533|NCT02585960|471366125|FG002|PK/Safety Assessment Period|Other|0|||
130926534|NCT02585960|471366123|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
130701980|NCT01045707|470532729|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
130701981|NCT01045707|470532730|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
130701982|NCT01045707|470532729|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
130701983|NCT01045707|470532730|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
130701984|NCT04886063|470532733|FG000|Overall Study|Adverse Event|50|||
130701985|NCT04886063|470532733|FG000|Overall Study|Lack of Efficacy|31|||
130701986|NCT04886063|470532733|FG000|Overall Study|Withdrawal by Subject|45|||
130701987|NCT04886063|470532733|FG000|Overall Study|Physician Decision|3|||
130701988|NCT04886063|470532733|FG000|Overall Study|Protocol Violation|3|||
131034602|NCT04185298|471761745|FG001|Overall Study|Lost to Follow-up|3|||
130770061|NCT02634801|470784240|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
130770062|NCT02634801|470784241|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
130770063|NCT02634801|470784242|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
130770064|NCT02634801|470784240|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
130770065|NCT02634801|470784241|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
130770066|NCT02634801|470784242|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
130770067|NCT02634801|470784240|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
130770068|NCT02634801|470784241|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
130770069|NCT02634801|470784242|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
130770070|NCT02634801|470784240|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
130770071|NCT02634801|470784241|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
130770072|NCT02634801|470784242|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
130770073|NCT02634801|470784240|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
130770074|NCT02634801|470784241|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
130770075|NCT02634801|470784242|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
130926535|NCT02585960|471366124|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
130926536|NCT02585960|471366125|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
130926537|NCT02585960|471366123|FG000|PK/Safety Assessment Period|Screen Failure|0|||
130926538|NCT02585960|471366124|FG001|PK/Safety Assessment Period|Screen Failure|0|||
130926539|NCT02585960|471366125|FG002|PK/Safety Assessment Period|Screen Failure|1|||
130926540|NCT02585960|471366123|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
130926541|NCT02585960|471366124|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
130926542|NCT02585960|471366125|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
130926543|NCT02585960|471366123|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
130926544|NCT02585960|471366124|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
130926545|NCT02585960|471366125|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
130926546|NCT03639935|471366126|FG000|Overall Study|Death|3|||
130926547|NCT03639935|471366126|FG000|Overall Study|Adverse Event|1|||
130926548|NCT06333613|471366128|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
130926549|NCT03616600|471366130|FG000|Overall Study|Withdrawal by Subject|1|||
130926550|NCT03616600|471366131|FG001|Overall Study|Withdrawal by Subject|0|||
130770076|NCT02634801|470784240|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
130770077|NCT02634801|470784241|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
130770078|NCT02634801|470784242|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
130770079|NCT02634801|470784240|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
130770080|NCT02634801|470784241|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
130770081|NCT02634801|470784242|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
130770082|NCT02634801|470784240|FG000|Follow-up Period|Lost to Follow-up|3|||
130770083|NCT02634801|470784241|FG001|Follow-up Period|Lost to Follow-up|1|||
130770084|NCT02634801|470784242|FG002|Follow-up Period|Lost to Follow-up|2|||
131034603|NCT04185298|471761744|FG000|Overall Study|Withdrawal by Subject|0|||
131034604|NCT04185298|471761745|FG001|Overall Study|Withdrawal by Subject|3|||
130770085|NCT02634801|470784240|FG000|Follow-up Period|Physician Decision|0|||
131034605|NCT04963270|471761746|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
131034606|NCT04963270|471761747|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
131034607|NCT04963270|471761748|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
131034608|NCT04963270|471761749|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
131034609|NCT04963270|471761746|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
131034610|NCT04963270|471761747|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
131034611|NCT04963270|471761748|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
131034612|NCT04963270|471761749|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
131034613|NCT04963270|471761746|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
131034614|NCT04963270|471761747|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131034615|NCT04963270|471761748|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131034616|NCT04963270|471761749|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
131034617|NCT04963270|471761746|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
131034618|NCT04963270|471761747|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
131034619|NCT04963270|471761748|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
131034620|NCT04963270|471761749|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
131034621|NCT04963270|471761746|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
131034622|NCT04963270|471761747|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
131034623|NCT04963270|471761748|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
131120240|NCT00467779|472072321|FG010|Stage 2A|Adverse Event|0|||
131120241|NCT00467779|472072322|FG011|Stage 2A|Adverse Event|0|||
131120242|NCT00467779|472072323|FG012|Stage 2A|Adverse Event|0|||
131120243|NCT00467779|472072324|FG013|Stage 2A|Adverse Event|2|||
131120244|NCT00467779|472072325|FG014|Stage 2A|Adverse Event|0|||
131120245|NCT00467779|472072311|FG000|Stage 2A|Death|0|||
131120246|NCT00467779|472072312|FG001|Stage 2A|Death|0|||
131120247|NCT00467779|472072313|FG002|Stage 2A|Death|0|||
131120248|NCT00467779|472072314|FG003|Stage 2A|Death|0|||
131120249|NCT00467779|472072315|FG004|Stage 2A|Death|0|||
131120250|NCT00467779|472072316|FG005|Stage 2A|Death|0|||
131120251|NCT00467779|472072317|FG006|Stage 2A|Death|0|||
131120252|NCT00467779|472072318|FG007|Stage 2A|Death|0|||
130926581|NCT01651039|471366141|FG000|Overall Study|Non-evaluables|5|||
130926582|NCT01651039|471366141|FG000|Overall Study|Physician Decision|2|||
130926583|NCT01651039|471366141|FG000|Overall Study|Withdrawal by Subject|1|||
130926584|NCT01651039|471366141|FG000|Overall Study|Progressive Disease|22|||
130926585|NCT03600818|471366142|FG000|Overall Study|Adverse Event|4|||
130926586|NCT03600818|471366143|FG001|Overall Study|Adverse Event|7|||
130926587|NCT03600818|471366142|FG000|Overall Study|Lack of Efficacy|9|||
130926588|NCT03600818|471366143|FG001|Overall Study|Lack of Efficacy|4|||
130926589|NCT03600818|471366142|FG000|Overall Study|Withdrawal by Subject|4|||
130926590|NCT03600818|471366143|FG001|Overall Study|Withdrawal by Subject|3|||
130926591|NCT03600818|471366142|FG000|Overall Study|Other-unspecified|5|||
130926592|NCT03600818|471366143|FG001|Overall Study|Other-unspecified|3|||
130926593|NCT03600818|471366142|FG000|Overall Study|Randomized and not treated|0|||
130926594|NCT03600818|471366143|FG001|Overall Study|Randomized and not treated|1|||
130926595|NCT02059395|471366147|FG000|Overall Study|Lost to Follow-up|2|||
130926596|NCT02059395|471366148|FG001|Overall Study|Lost to Follow-up|4|||
130926597|NCT00134082|471366149|FG000|Overall Study|Adverse Event|2|||
130926598|NCT00134082|471366149|FG000|Overall Study|Death|1|||
130926599|NCT01488370|471366152|FG000|Overall Study|Protocol Violation|0|||
130926600|NCT01488370|471366153|FG001|Overall Study|Protocol Violation|1|||
130926601|NCT01488370|471366154|FG002|Overall Study|Protocol Violation|1|||
130926602|NCT03478930|471366155|FG000|Overall Study|Adverse Event|0|||
130926603|NCT03478930|471366156|FG001|Overall Study|Adverse Event|1|||
130770086|NCT02634801|470784241|FG001|Follow-up Period|Physician Decision|0|||
130770087|NCT02634801|470784242|FG002|Follow-up Period|Physician Decision|1|||
130770088|NCT02634801|470784240|FG000|Follow-up Period|Withdrawal by Subject|1|||
130770089|NCT02634801|470784241|FG001|Follow-up Period|Withdrawal by Subject|2|||
130770090|NCT02634801|470784242|FG002|Follow-up Period|Withdrawal by Subject|5|||
130770091|NCT02634801|470784240|FG000|Follow-up Period|Adverse Event|1|||
130770092|NCT02634801|470784241|FG001|Follow-up Period|Adverse Event|5|||
130770093|NCT02634801|470784242|FG002|Follow-up Period|Adverse Event|0|||
130770094|NCT02626000|470784243|FG000|Overall Study|Decision by Sponsor|1|||
130770095|NCT02626000|470784243|FG000|Overall Study|Death|29|||
130770096|NCT03539484|470784244|FG000|Overall Study|Death|1|||
130770097|NCT03539484|470784245|FG001|Overall Study|Death|0|||
130770098|NCT03539484|470784246|FG002|Overall Study|Death|0|||
130770099|NCT03539484|470784247|FG003|Overall Study|Death|2|||
130770100|NCT03539484|470784248|FG004|Overall Study|Death|8|||
130770101|NCT03539484|470784249|FG005|Overall Study|Death|3|||
130770102|NCT03539484|470784250|FG006|Overall Study|Death|0|||
130770103|NCT03539484|470784244|FG000|Overall Study|Lost to Follow-up|0|||
130770104|NCT03539484|470784245|FG001|Overall Study|Lost to Follow-up|1|||
130926604|NCT03478930|471366155|FG000|Overall Study|Lack of Efficacy|3|||
130770105|NCT03539484|470784246|FG002|Overall Study|Lost to Follow-up|0|||
130926605|NCT03478930|471366156|FG001|Overall Study|Lack of Efficacy|3|||
130770106|NCT03539484|470784247|FG003|Overall Study|Lost to Follow-up|0|||
130770107|NCT03539484|470784248|FG004|Overall Study|Lost to Follow-up|1|||
130770108|NCT03539484|470784249|FG005|Overall Study|Lost to Follow-up|0|||
130926606|NCT03478930|471366155|FG000|Overall Study|Withdrawal by Subject|6|||
130926607|NCT03478930|471366156|FG001|Overall Study|Withdrawal by Subject|5|||
130926608|NCT00705484|471366157|FG000|Overall Study|Adverse Event|28|||
130926609|NCT00705484|471366158|FG001|Overall Study|Adverse Event|27|||
130926610|NCT00705484|471366157|FG000|Overall Study|Lost to Follow-up|169|||
130926611|NCT00705484|471366158|FG001|Overall Study|Lost to Follow-up|250|||
130926612|NCT00705484|471366157|FG000|Overall Study|Withdrawal by Subject|96|||
131120253|NCT00467779|472072319|FG008|Stage 2A|Death|0|||
131120254|NCT00467779|472072320|FG009|Stage 2A|Death|0|||
131034624|NCT04963270|471761749|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
131034625|NCT04963270|471761746|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
131034626|NCT04963270|471761747|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
131034627|NCT04963270|471761748|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
131034628|NCT04963270|471761749|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
131034629|NCT04963270|471761746|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
130701989|NCT04886063|470532733|FG000|Overall Study|Site closure|4|||
130701990|NCT04886063|470532733|FG000|Overall Study|Nursing home replacement|3|||
130701991|NCT04886063|470532733|FG000|Overall Study|Lost to Follow-up|5|||
130701992|NCT04886063|470532733|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
130701993|NCT04886063|470532733|FG000|Overall Study|>1 reason|20|||
130701994|NCT02005276|470532734|FG000|Overall Study|No longer interested|5|||
130701995|NCT02005276|470532735|FG001|Overall Study|No longer interested|2|||
130701996|NCT02005276|470532736|FG002|Overall Study|No longer interested|3|||
130701997|NCT02005276|470532737|FG003|Overall Study|No longer interested|3|||
130701998|NCT01849458|470532742|FG000|Overall Study|Lost to Follow-up|4|||
130701999|NCT01115933|470532749|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
130702000|NCT01294449|470532750|FG000|Overall Study|Death|11|||
130702001|NCT01294449|470532751|FG001|Overall Study|Death|12|||
130702002|NCT01294449|470532750|FG000|Overall Study|Withdrawal by Subject|1|||
130702003|NCT01294449|470532751|FG001|Overall Study|Withdrawal by Subject|3|||
130702004|NCT00603512|470532752|FG000|Overall Study|Adverse Event|0|||
130702005|NCT00603512|470532753|FG001|Overall Study|Adverse Event|2|||
130702006|NCT00603512|470532754|FG002|Overall Study|Adverse Event|4|||
130702007|NCT00603512|470532755|FG003|Overall Study|Adverse Event|4|||
130702008|NCT00603512|470532756|FG004|Overall Study|Adverse Event|2|||
130702009|NCT00603512|470532752|FG000|Overall Study|Lack of Efficacy|0|||
130702010|NCT00603512|470532753|FG001|Overall Study|Lack of Efficacy|1|||
130702011|NCT00603512|470532754|FG002|Overall Study|Lack of Efficacy|0|||
130702012|NCT00603512|470532755|FG003|Overall Study|Lack of Efficacy|0|||
130702013|NCT00603512|470532756|FG004|Overall Study|Lack of Efficacy|1|||
130702014|NCT00603512|470532752|FG000|Overall Study|Other|2|||
130702015|NCT00603512|470532753|FG001|Overall Study|Other|1|||
130702016|NCT00603512|470532754|FG002|Overall Study|Other|0|||
130702017|NCT00603512|470532755|FG003|Overall Study|Other|1|||
130702018|NCT00603512|470532756|FG004|Overall Study|Other|1|||
130702019|NCT00603512|470532752|FG000|Overall Study|Withdrawal by Subject|0|||
130702020|NCT00603512|470532753|FG001|Overall Study|Withdrawal by Subject|0|||
130702021|NCT00603512|470532754|FG002|Overall Study|Withdrawal by Subject|0|||
130702022|NCT00603512|470532755|FG003|Overall Study|Withdrawal by Subject|0|||
130702023|NCT00603512|470532756|FG004|Overall Study|Withdrawal by Subject|1|||
130702024|NCT00603512|470532752|FG000|Overall Study|Randomized but not treated|0|||
130702025|NCT00603512|470532753|FG001|Overall Study|Randomized but not treated|1|||
130702026|NCT00603512|470532754|FG002|Overall Study|Randomized but not treated|1|||
130702027|NCT00603512|470532755|FG003|Overall Study|Randomized but not treated|2|||
130702028|NCT00603512|470532756|FG004|Overall Study|Randomized but not treated|0|||
130702029|NCT01896505|470532757|FG000|Overall Study|Adverse Event|1|||
130702030|NCT01896505|470532758|FG001|Overall Study|Adverse Event|0|||
130702031|NCT01896505|470532759|FG002|Overall Study|Adverse Event|2|||
130702032|NCT01896505|470532760|FG003|Overall Study|Adverse Event|1|||
130702033|NCT01896505|470532761|FG004|Overall Study|Adverse Event|1|||
130702034|NCT01896505|470532762|FG005|Overall Study|Adverse Event|0|||
130702035|NCT01896505|470532757|FG000|Overall Study|Physician Decision|1|||
130702036|NCT01896505|470532758|FG001|Overall Study|Physician Decision|3|||
130702037|NCT01896505|470532759|FG002|Overall Study|Physician Decision|2|||
130702038|NCT01896505|470532760|FG003|Overall Study|Physician Decision|0|||
130702039|NCT01896505|470532761|FG004|Overall Study|Physician Decision|0|||
130702040|NCT01896505|470532762|FG005|Overall Study|Physician Decision|1|||
130702041|NCT01896505|470532757|FG000|Overall Study|Withdrawal by Subject|1|||
130702042|NCT01896505|470532758|FG001|Overall Study|Withdrawal by Subject|0|||
130702043|NCT01896505|470532759|FG002|Overall Study|Withdrawal by Subject|3|||
130702044|NCT01896505|470532760|FG003|Overall Study|Withdrawal by Subject|1|||
130702045|NCT01896505|470532761|FG004|Overall Study|Withdrawal by Subject|0|||
130702046|NCT01896505|470532762|FG005|Overall Study|Withdrawal by Subject|0|||
130702047|NCT01896505|470532757|FG000|Overall Study|Disease Progression|7|||
130702048|NCT01896505|470532758|FG001|Overall Study|Disease Progression|5|||
130702049|NCT01896505|470532759|FG002|Overall Study|Disease Progression|8|||
130702050|NCT01896505|470532760|FG003|Overall Study|Disease Progression|4|||
130702051|NCT01896505|470532761|FG004|Overall Study|Disease Progression|4|||
130702052|NCT01896505|470532762|FG005|Overall Study|Disease Progression|4|||
130702053|NCT01896505|470532757|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
130702054|NCT01896505|470532758|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
130702055|NCT01896505|470532759|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
130702056|NCT01896505|470532760|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
130702057|NCT01896505|470532761|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
130770109|NCT03539484|470784250|FG006|Overall Study|Lost to Follow-up|0|||
130770110|NCT03539484|470784244|FG000|Overall Study|Withdrawal by Subject|0|||
130926613|NCT00705484|471366158|FG001|Overall Study|Withdrawal by Subject|72|||
130926614|NCT00705484|471366157|FG000|Overall Study|Administrative|89|||
130926615|NCT00705484|471366158|FG001|Overall Study|Administrative|59|||
130926616|NCT05393895|471366167|FG000|Overall Study|Adverse Event|2|||
130926617|NCT05393895|471366168|FG001|Overall Study|Adverse Event|3|||
130926618|NCT05393895|471366167|FG000|Overall Study|Lost to Follow-up|4|||
130702058|NCT01896505|470532762|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
130702059|NCT01896505|470532757|FG000|Overall Study|Intercurrent illness|0|||
130702060|NCT01896505|470532758|FG001|Overall Study|Intercurrent illness|1|||
130702061|NCT01896505|470532759|FG002|Overall Study|Intercurrent illness|0|||
130702062|NCT01896505|470532760|FG003|Overall Study|Intercurrent illness|0|||
130702063|NCT01896505|470532761|FG004|Overall Study|Intercurrent illness|0|||
130702064|NCT01896505|470532762|FG005|Overall Study|Intercurrent illness|0|||
130702065|NCT01896505|470532757|FG000|Overall Study|Death|0|||
130702066|NCT01896505|470532758|FG001|Overall Study|Death|0|||
130702067|NCT01896505|470532759|FG002|Overall Study|Death|1|||
130702068|NCT01896505|470532760|FG003|Overall Study|Death|1|||
130702069|NCT01896505|470532761|FG004|Overall Study|Death|0|||
130702070|NCT01896505|470532762|FG005|Overall Study|Death|1|||
130702071|NCT02418754|470532763|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130702072|NCT02418754|470532764|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
130702073|NCT02418754|470532765|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130702074|NCT02418754|470532766|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130702075|NCT02418754|470532767|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130702076|NCT02418754|470532763|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
130702077|NCT02418754|470532764|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
130702078|NCT02418754|470532765|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
130702079|NCT02418754|470532766|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
130702080|NCT02418754|470532767|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
130702081|NCT02418754|470532763|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
130702082|NCT02418754|470532764|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130702083|NCT02418754|470532765|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130702084|NCT02418754|470532766|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130702085|NCT02418754|470532767|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130702086|NCT02418754|470532763|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
130702087|NCT02418754|470532764|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
130702088|NCT02418754|470532765|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
130702089|NCT02418754|470532766|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
130702090|NCT02418754|470532767|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
130702091|NCT02418754|470532763|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130702092|NCT02418754|470532764|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130702093|NCT02418754|470532765|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
130702094|NCT02418754|470532766|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130702095|NCT02418754|470532767|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130702096|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
130702097|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
130702098|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
130702099|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
130702100|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
130702101|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
130702102|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130702103|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130926619|NCT05393895|471366168|FG001|Overall Study|Lost to Follow-up|3|||
130926620|NCT05393895|471366167|FG000|Overall Study|Protocol Violation|1|||
130926621|NCT05393895|471366168|FG001|Overall Study|Protocol Violation|0|||
130926622|NCT05393895|471366167|FG000|Overall Study|Withdrawal by Subject|1|||
130926623|NCT05393895|471366168|FG001|Overall Study|Withdrawal by Subject|4|||
130702104|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130702105|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130702106|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
130702107|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
130702108|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
130702109|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
130702110|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
130926624|NCT03087643|471366179|FG000|Overall Study|Withdrawal by Subject|2|||
130702111|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
130702112|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
130702113|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
130702114|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
130702115|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
130926625|NCT03087643|471366180|FG001|Overall Study|Withdrawal by Subject|4|||
130926626|NCT03087643|471366179|FG000|Overall Study|Death|2|||
130926627|NCT03087643|471366180|FG001|Overall Study|Death|2|||
130926628|NCT01546883|471366181|FG000|Overall Study|Withdrawal by Subject|3|||
130926629|NCT01546883|471366181|FG000|Overall Study|Adverse Event|4|||
130926630|NCT01546883|471366181|FG000|Overall Study|Lost to Follow-up|2|||
130926631|NCT01546883|471366181|FG000|Overall Study|early closure of study|2|||
130926632|NCT01546883|471366181|FG000|Overall Study|other unrelated illness|1|||
130926633|NCT01427972|471366187|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130926634|NCT01427972|471366188|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130926635|NCT01427972|471366189|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130926636|NCT01427972|471366190|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130926637|NCT01427972|471366191|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130926638|NCT01427972|471366192|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130702116|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
130702117|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
130702118|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
130702119|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
130702120|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
130702121|NCT02418754|470532763|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
130702122|NCT02418754|470532764|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
130702123|NCT02418754|470532765|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
130702124|NCT02418754|470532766|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
130702125|NCT02418754|470532767|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
130702126|NCT04974580|470532768|FG000|Overall Study|Lost to Follow-up|33|||
130702127|NCT04974580|470532769|FG001|Overall Study|Lost to Follow-up|39|||
130702128|NCT04974580|470532770|FG002|Overall Study|Lost to Follow-up|30|||
130702129|NCT04974580|470532771|FG003|Overall Study|Lost to Follow-up|29|||
130702130|NCT00250705|470532774|FG000|Overall Study|Lack of Efficacy|2|||
130702131|NCT02416934|470532799|FG000|Overall Study|given steroids|1|||
130702132|NCT02416934|470532800|FG001|Overall Study|given steroids|2|||
130770111|NCT03539484|470784245|FG001|Overall Study|Withdrawal by Subject|0|||
130926639|NCT01427972|471366193|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130926640|NCT01427972|471366194|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
130926641|NCT01427972|471366195|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130926642|NCT01427972|471366196|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130926643|NCT01427972|471366197|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130926644|NCT01427972|471366198|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130926645|NCT01427972|471366187|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926646|NCT01427972|471366188|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926647|NCT01427972|471366189|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926648|NCT01427972|471366190|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926649|NCT01427972|471366191|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926650|NCT01427972|471366192|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
130926651|NCT01427972|471366193|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926652|NCT01427972|471366194|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926653|NCT01427972|471366195|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926654|NCT01427972|471366196|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926655|NCT01427972|471366197|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926656|NCT01427972|471366198|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
130926657|NCT01427972|471366187|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926658|NCT01427972|471366188|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
130926659|NCT01427972|471366189|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926660|NCT01427972|471366190|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926661|NCT01427972|471366191|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926662|NCT01427972|471366192|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926663|NCT01427972|471366193|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926664|NCT01427972|471366194|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926665|NCT01427972|471366195|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926666|NCT01427972|471366196|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926667|NCT01427972|471366197|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926668|NCT01427972|471366198|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
130926669|NCT00799422|471366202|FG000|First Week of Wear|Lost to Follow-up|0|||
130926670|NCT00799422|471366203|FG001|First Week of Wear|Lost to Follow-up|0|||
130926671|NCT00799422|471366204|FG002|First Week of Wear|Lost to Follow-up|1|||
130926672|NCT00799422|471366205|FG003|First Week of Wear|Lost to Follow-up|0|||
130926673|NCT00799422|471366206|FG004|First Week of Wear|Lost to Follow-up|0|||
130926674|NCT00799422|471366207|FG005|First Week of Wear|Lost to Follow-up|0|||
130926675|NCT00799422|471366202|FG000|First Week of Wear|Adverse Event|0|||
130926676|NCT00799422|471366203|FG001|First Week of Wear|Adverse Event|0|||
130926677|NCT00799422|471366204|FG002|First Week of Wear|Adverse Event|0|||
130926678|NCT00799422|471366205|FG003|First Week of Wear|Adverse Event|1|||
130926679|NCT00799422|471366206|FG004|First Week of Wear|Adverse Event|0|||
130926680|NCT00799422|471366207|FG005|First Week of Wear|Adverse Event|0|||
130926681|NCT00530946|471366208|FG000|Overall Study|Adverse Event|1|||
130926682|NCT00530946|471366209|FG001|Overall Study|Adverse Event|2|||
130926683|NCT00530946|471366210|FG002|Overall Study|Adverse Event|1|||
130926684|NCT00530946|471366211|FG003|Overall Study|Adverse Event|1|||
130926685|NCT00530946|471366208|FG000|Overall Study|Protocol Violation|0|||
130926686|NCT00530946|471366209|FG001|Overall Study|Protocol Violation|0|||
130926687|NCT00530946|471366210|FG002|Overall Study|Protocol Violation|0|||
130926688|NCT00530946|471366211|FG003|Overall Study|Protocol Violation|1|||
130926689|NCT00530946|471366208|FG000|Overall Study|Noncompliance|1|||
130926690|NCT00530946|471366209|FG001|Overall Study|Noncompliance|0|||
130926691|NCT00530946|471366210|FG002|Overall Study|Noncompliance|0|||
130926692|NCT00530946|471366211|FG003|Overall Study|Noncompliance|0|||
130926693|NCT00622284|471366212|FG000|Overall Study|Lack of Efficacy|45|||
130926694|NCT00622284|471366213|FG001|Overall Study|Lack of Efficacy|15|||
130926695|NCT00622284|471366212|FG000|Overall Study|Adverse Event|61|||
130926696|NCT00622284|471366213|FG001|Overall Study|Adverse Event|90|||
130926697|NCT00622284|471366212|FG000|Overall Study|Protocol Violation|12|||
130926698|NCT00622284|471366213|FG001|Overall Study|Protocol Violation|5|||
130926699|NCT00622284|471366212|FG000|Overall Study|Lost to Follow-up|11|||
130926700|NCT00622284|471366213|FG001|Overall Study|Lost to Follow-up|13|||
130926701|NCT00622284|471366212|FG000|Overall Study|Withdrawal by Subject|27|||
130926702|NCT00622284|471366213|FG001|Overall Study|Withdrawal by Subject|24|||
130926703|NCT00622284|471366212|FG000|Overall Study|Other reason (not specified)|33|||
130926704|NCT00622284|471366213|FG001|Overall Study|Other reason (not specified)|24|||
130926705|NCT00880009|471366214|FG000|Overall Study|Study terminated by sponsor|14|||
130926706|NCT00880009|471366214|FG000|Overall Study|Withdrawal by Subject|1|||
130926707|NCT00880009|471366214|FG000|Overall Study|Protocol Violation|1|||
130926708|NCT02412618|471366217|FG000|Overall Study|Withdrawal by Subject|1|||
130926709|NCT02412618|471366218|FG001|Overall Study|Withdrawal by Subject|1|||
130926710|NCT02412618|471366217|FG000|Overall Study|Expulsion|1|||
130926711|NCT02412618|471366218|FG001|Overall Study|Expulsion|1|||
130926712|NCT01253408|471366220|FG000|Overall Study|Adverse Event|0|||
130926713|NCT01253408|471366221|FG001|Overall Study|Adverse Event|1|||
130926714|NCT01253408|471366222|FG002|Overall Study|Adverse Event|0|||
130926715|NCT00629707|471366224|FG000|Overall Study|Withdrawal by Subject|0|||
130926716|NCT00629707|471366225|FG001|Overall Study|Withdrawal by Subject|1|||
130926717|NCT00629707|471366224|FG000|Overall Study|Physician Decision|0|||
130926718|NCT00629707|471366225|FG001|Overall Study|Physician Decision|1|||
130926719|NCT00361569|471366228|FG000|Overall Study|Protocol Violation|3|||
130926720|NCT00361569|471366229|FG001|Overall Study|Protocol Violation|2|||
130926721|NCT00361569|471366230|FG002|Overall Study|Protocol Violation|4|||
130926722|NCT00361569|471366231|FG003|Overall Study|Protocol Violation|2|||
130926723|NCT00361569|471366228|FG000|Overall Study|Withdrawal by Subject|2|||
130926724|NCT00361569|471366229|FG001|Overall Study|Withdrawal by Subject|1|||
130926725|NCT00361569|471366230|FG002|Overall Study|Withdrawal by Subject|9|||
130926726|NCT00361569|471366231|FG003|Overall Study|Withdrawal by Subject|14|||
130926727|NCT00361569|471366228|FG000|Overall Study|Adverse Event|3|||
130926728|NCT00361569|471366229|FG001|Overall Study|Adverse Event|5|||
130926729|NCT00361569|471366230|FG002|Overall Study|Adverse Event|2|||
130926730|NCT00361569|471366231|FG003|Overall Study|Adverse Event|2|||
130926731|NCT00361569|471366228|FG000|Overall Study|Lost to Follow-up|2|||
130926732|NCT00361569|471366229|FG001|Overall Study|Lost to Follow-up|3|||
130926733|NCT00361569|471366230|FG002|Overall Study|Lost to Follow-up|3|||
130926734|NCT00361569|471366231|FG003|Overall Study|Lost to Follow-up|2|||
130926735|NCT00361569|471366228|FG000|Overall Study|Not specified by investigator|2|||
130926736|NCT00361569|471366229|FG001|Overall Study|Not specified by investigator|0|||
130926737|NCT00361569|471366230|FG002|Overall Study|Not specified by investigator|0|||
130926738|NCT00361569|471366231|FG003|Overall Study|Not specified by investigator|1|||
130926739|NCT01845831|471366232|FG000|Inpatient Phase|Withdrawal by Subject|1|||
130926740|NCT01845831|471366233|FG001|Inpatient Phase|Withdrawal by Subject|1|||
130926741|NCT01845831|471366234|FG002|Inpatient Phase|Withdrawal by Subject|0|||
130926742|NCT01845831|471366235|FG003|Inpatient Phase|Withdrawal by Subject|0|||
130926743|NCT01845831|471366236|FG004|Inpatient Phase|Withdrawal by Subject|0|||
130926744|NCT00221403|471366237|FG000|Overall Study|Protocol Violation|1|||
130926745|NCT00221403|471366238|FG001|Overall Study|Protocol Violation|0|||
130926746|NCT00221403|471366239|FG002|Overall Study|Protocol Violation|0|||
130926747|NCT00221403|471366237|FG000|Overall Study|Physician Decision|1|||
130926748|NCT00221403|471366238|FG001|Overall Study|Physician Decision|0|||
130926749|NCT00221403|471366239|FG002|Overall Study|Physician Decision|0|||
130926750|NCT00221403|471366237|FG000|Overall Study|Withdrawal by Subject|0|||
130926751|NCT00221403|471366238|FG001|Overall Study|Withdrawal by Subject|3|||
130926752|NCT00221403|471366239|FG002|Overall Study|Withdrawal by Subject|0|||
130926753|NCT00221403|471366237|FG000|Overall Study|Lack of Efficacy|0|||
130926754|NCT00221403|471366238|FG001|Overall Study|Lack of Efficacy|1|||
130926755|NCT00221403|471366239|FG002|Overall Study|Lack of Efficacy|0|||
130926756|NCT00221403|471366237|FG000|Overall Study|Adverse Event|0|||
130926757|NCT00221403|471366238|FG001|Overall Study|Adverse Event|1|||
130926758|NCT00221403|471366239|FG002|Overall Study|Adverse Event|0|||
130702133|NCT02416934|470532799|FG000|Overall Study|Lost to Follow-up|0|||
130702134|NCT02416934|470532800|FG001|Overall Study|Lost to Follow-up|2|||
130702135|NCT02416934|470532799|FG000|Overall Study|Withdrawal by Subject|1|||
130702136|NCT02416934|470532800|FG001|Overall Study|Withdrawal by Subject|0|||
130702137|NCT02416934|470532799|FG000|Overall Study|recruited during continuing renewal proc|0|||
130702138|NCT02416934|470532800|FG001|Overall Study|recruited during continuing renewal proc|1|||
130702139|NCT02416934|470532799|FG000|Overall Study|Protocol Violation|0|||
130702140|NCT02416934|470532800|FG001|Overall Study|Protocol Violation|1|||
130702141|NCT02416934|470532799|FG000|Overall Study|surgery started late|0|||
130702142|NCT02416934|470532800|FG001|Overall Study|surgery started late|1|||
130702143|NCT02416934|470532799|FG000|Overall Study|re-operation|1|||
130702144|NCT02416934|470532800|FG001|Overall Study|re-operation|0|||
130702145|NCT01020526|470532801|FG000|Overall Study|Withdrawal by Subject|5|||
130702146|NCT01020526|470532801|FG000|Overall Study|Other reasons|3|||
130702147|NCT01020526|470532801|FG000|Overall Study|Insufficient clinical response|3|||
130702148|NCT01020526|470532801|FG000|Overall Study|Lost to Follow-up|1|||
130702149|NCT01020526|470532801|FG000|Overall Study|Adverse Event|2|||
130702150|NCT00398073|470532802|FG000|Overall Study|Withdrawal by Subject|1|||
130702151|NCT00398073|470532803|FG001|Overall Study|Withdrawal by Subject|0|||
130702152|NCT02169336|470532808|FG000|Overall Study|Lack of Efficacy|1|||
130702153|NCT02169336|470532809|FG001|Overall Study|Lack of Efficacy|1|||
130702154|NCT02169336|470532810|FG002|Overall Study|Lack of Efficacy|0|||
130702155|NCT02169336|470532808|FG000|Overall Study|Adverse Event|2|||
130702156|NCT02169336|470532809|FG001|Overall Study|Adverse Event|3|||
130702157|NCT02169336|470532810|FG002|Overall Study|Adverse Event|1|||
131223601|NCT01106352|472447061|FG000|Overall Study|Subjects untreated|0|||
131223602|NCT01106352|472447062|FG001|Overall Study|Subjects untreated|0|||
131223603|NCT01106352|472447063|FG002|Overall Study|Subjects untreated|0|||
131223604|NCT01106352|472447064|FG003|Overall Study|Subjects untreated|3|||
131223605|NCT01106352|472447065|FG004|Overall Study|Subjects untreated|4|||
130702158|NCT02169336|470532808|FG000|Overall Study|Withdrawal by Subject|1|||
130770112|NCT03539484|470784246|FG002|Overall Study|Withdrawal by Subject|0|||
130770113|NCT03539484|470784247|FG003|Overall Study|Withdrawal by Subject|0|||
130770114|NCT03539484|470784248|FG004|Overall Study|Withdrawal by Subject|2|||
130770115|NCT03539484|470784249|FG005|Overall Study|Withdrawal by Subject|0|||
130926759|NCT02610725|471366240|FG000|Overall Study|Lost to Follow-up|197|||
130926760|NCT02610725|471366240|FG000|Overall Study|self-reported contraindication|9|||
130926761|NCT00826943|471366241|FG000|Overall Study|Withdrawal by Subject|0|||
130926762|NCT00826943|471366242|FG001|Overall Study|Withdrawal by Subject|0|||
130926763|NCT00826943|471366243|FG002|Overall Study|Withdrawal by Subject|0|||
130926764|NCT00826943|471366244|FG003|Overall Study|Withdrawal by Subject|0|||
130926765|NCT00826943|471366245|FG004|Overall Study|Withdrawal by Subject|1|||
130926766|NCT00826943|471366246|FG005|Overall Study|Withdrawal by Subject|0|||
130926767|NCT01348165|471366247|FG000|Overall Study|Adverse Event|0|||
130926768|NCT01348165|471366248|FG001|Overall Study|Adverse Event|0|||
130926769|NCT01348165|471366249|FG002|Overall Study|Adverse Event|0|||
130926770|NCT01348165|471366250|FG003|Overall Study|Adverse Event|0|||
130926771|NCT01348165|471366251|FG004|Overall Study|Adverse Event|0|||
130926772|NCT01348165|471366252|FG005|Overall Study|Adverse Event|0|||
130926773|NCT01348165|471366253|FG006|Overall Study|Adverse Event|1|||
130926774|NCT00074152|471366254|FG000|Overall Study|Death|21|||
130926775|NCT00074152|471366255|FG001|Overall Study|Death|9|||
130926776|NCT00074152|471366254|FG000|Overall Study|Lack of Efficacy|34|||
130926777|NCT00074152|471366255|FG001|Overall Study|Lack of Efficacy|24|||
130926778|NCT05570500|471366258|FG000|Overall Study|Lost to Follow-up|7|||
130926779|NCT05570500|471366259|FG001|Overall Study|Lost to Follow-up|5|||
130926780|NCT04706091|471366260|FG000|Treatment 2|Withdrawal by Subject|1|||
131223606|NCT01106352|472447061|FG000|Overall Study|Sponsor Decision|1|||
130926781|NCT04706091|471366261|FG001|Treatment 2|Withdrawal by Subject|0|||
130926782|NCT02612727|471366262|FG000|Overall Study|Parent request|4|||
130926783|NCT02612727|471366263|FG001|Overall Study|Parent request|1|||
131223607|NCT01106352|472447062|FG001|Overall Study|Sponsor Decision|0|||
131223608|NCT01106352|472447063|FG002|Overall Study|Sponsor Decision|0|||
130702159|NCT02169336|470532809|FG001|Overall Study|Withdrawal by Subject|0|||
130926784|NCT02612727|471366262|FG000|Overall Study|Needed treatment incompatible with PT|1|||
130926785|NCT02612727|471366263|FG001|Overall Study|Needed treatment incompatible with PT|1|||
130926786|NCT02612727|471366262|FG000|Overall Study|Direct hyperbilirubinemia|0|||
130702160|NCT02169336|470532810|FG002|Overall Study|Withdrawal by Subject|0|||
130702161|NCT02169336|470532808|FG000|Overall Study|Physician Decision|0|||
130702162|NCT02169336|470532809|FG001|Overall Study|Physician Decision|0|||
130926787|NCT02612727|471366263|FG001|Overall Study|Direct hyperbilirubinemia|2|||
130926788|NCT01063868|471366264|FG000|Overall Study|Adverse Event|9|||
130926789|NCT01063868|471366265|FG001|Overall Study|Adverse Event|7|||
130770116|NCT03539484|470784250|FG006|Overall Study|Withdrawal by Subject|1|||
130770117|NCT03539484|470784244|FG000|Overall Study|Study Terminated by Sponsor|0|||
131223609|NCT01106352|472447064|FG003|Overall Study|Sponsor Decision|0|||
131223610|NCT01106352|472447065|FG004|Overall Study|Sponsor Decision|0|||
131223611|NCT01106352|472447061|FG000|Overall Study|Too ill to come in for the visit|0|||
130702163|NCT02169336|470532810|FG002|Overall Study|Physician Decision|1|||
130702164|NCT02169336|470532808|FG000|Overall Study|Subject declined to continue dosing|0|||
130702165|NCT02169336|470532809|FG001|Overall Study|Subject declined to continue dosing|0|||
130926790|NCT01063868|471366264|FG000|Overall Study|Withdrawal by Subject|3|||
130926791|NCT01063868|471366265|FG001|Overall Study|Withdrawal by Subject|1|||
130926792|NCT01063868|471366264|FG000|Overall Study|Study Terminated By Sponsor|23|||
130926793|NCT01063868|471366265|FG001|Overall Study|Study Terminated By Sponsor|4|||
130926794|NCT01446289|471366266|FG000|Overall Study|Withdrawal by Subject|1|||
130926795|NCT01446289|471366267|FG001|Overall Study|Withdrawal by Subject|0|||
130926796|NCT01446289|471366268|FG002|Overall Study|Withdrawal by Subject|1|||
130926797|NCT01446289|471366269|FG003|Overall Study|Withdrawal by Subject|0|||
130926798|NCT02302807|471366270|FG000|Overall Study|Withdrawal by Subject|28|||
130926799|NCT02302807|471366271|FG001|Overall Study|Withdrawal by Subject|11|||
130926800|NCT02302807|471366270|FG000|Overall Study|Lost to Follow-up|4|||
130926801|NCT02302807|471366271|FG001|Overall Study|Lost to Follow-up|6|||
130926802|NCT02302807|471366270|FG000|Overall Study|Death|397|||
130926803|NCT02302807|471366271|FG001|Overall Study|Death|385|||
130926804|NCT02302807|471366270|FG000|Overall Study|Study Terminated By Sponsor|35|||
131034630|NCT04963270|471761747|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
130926805|NCT02302807|471366271|FG001|Overall Study|Study Terminated By Sponsor|64|||
130926806|NCT02302807|471366270|FG000|Overall Study|Physician Decision|0|||
130926807|NCT02302807|471366271|FG001|Overall Study|Physician Decision|1|||
130926808|NCT03278873|471366272|FG000|Overall Study|Withdrawal by Subject|0|||
130926809|NCT03278873|471366273|FG001|Overall Study|Withdrawal by Subject|1|||
130926810|NCT03278873|471366274|FG002|Overall Study|Withdrawal by Subject|0|||
130926811|NCT03278873|471366275|FG003|Overall Study|Withdrawal by Subject|0|||
130926812|NCT03278873|471366272|FG000|Overall Study|Sponsor's decision|0|||
130926813|NCT03278873|471366273|FG001|Overall Study|Sponsor's decision|1|||
130926814|NCT03278873|471366274|FG002|Overall Study|Sponsor's decision|0|||
130926815|NCT03278873|471366275|FG003|Overall Study|Sponsor's decision|0|||
130926816|NCT03278873|471366272|FG000|Overall Study|Early Termination|2|||
130926817|NCT03278873|471366273|FG001|Overall Study|Early Termination|6|||
130926818|NCT03278873|471366274|FG002|Overall Study|Early Termination|0|||
130926819|NCT03278873|471366275|FG003|Overall Study|Early Termination|4|||
130926820|NCT03278873|471366272|FG000|Overall Study|Lost to Follow-up|0|||
130926821|NCT03278873|471366273|FG001|Overall Study|Lost to Follow-up|0|||
130926822|NCT03278873|471366274|FG002|Overall Study|Lost to Follow-up|2|||
130926823|NCT03278873|471366275|FG003|Overall Study|Lost to Follow-up|0|||
130926824|NCT03278873|471366272|FG000|Overall Study|The patient decided to withdraw via email|1|||
130926825|NCT03278873|471366273|FG001|Overall Study|The patient decided to withdraw via email|0|||
130926826|NCT03278873|471366274|FG002|Overall Study|The patient decided to withdraw via email|0|||
130926827|NCT03278873|471366275|FG003|Overall Study|The patient decided to withdraw via email|0|||
131034631|NCT04963270|471761748|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
130702166|NCT02169336|470532810|FG002|Overall Study|Subject declined to continue dosing|1|||
130702167|NCT01148225|470532811|FG000|Overall Study|Other|185|||
130702168|NCT02490800|470532812|FG000|Overall Study|Adverse Event|0|||
130702169|NCT02490800|470532813|FG001|Overall Study|Adverse Event|0|||
130702170|NCT02490800|470532814|FG002|Overall Study|Adverse Event|0|||
130702171|NCT02490800|470532815|FG003|Overall Study|Adverse Event|2|||
130702172|NCT02490800|470532816|FG004|Overall Study|Adverse Event|3|||
130702173|NCT02490800|470532817|FG005|Overall Study|Adverse Event|2|||
130702174|NCT02490800|470532818|FG006|Overall Study|Adverse Event|0|||
130702175|NCT02490800|470532819|FG007|Overall Study|Adverse Event|0|||
130702176|NCT02490800|470532820|FG008|Overall Study|Adverse Event|0|||
130702177|NCT02490800|470532821|FG009|Overall Study|Adverse Event|0|||
130702178|NCT02490800|470532822|FG010|Overall Study|Adverse Event|0|||
130702179|NCT02490800|470532823|FG011|Overall Study|Adverse Event|2|||
130702180|NCT02490800|470532824|FG012|Overall Study|Adverse Event|2|||
130702181|NCT02490800|470532812|FG000|Overall Study|Withdrawal by Subject|0|||
130702182|NCT02490800|470532813|FG001|Overall Study|Withdrawal by Subject|0|||
130702183|NCT02490800|470532814|FG002|Overall Study|Withdrawal by Subject|0|||
130702184|NCT02490800|470532815|FG003|Overall Study|Withdrawal by Subject|1|||
130702185|NCT02490800|470532816|FG004|Overall Study|Withdrawal by Subject|0|||
130702186|NCT02490800|470532817|FG005|Overall Study|Withdrawal by Subject|0|||
130926828|NCT03278873|471366272|FG000|Overall Study|The patient was unresponsive to contact|0|||
130926829|NCT03278873|471366273|FG001|Overall Study|The patient was unresponsive to contact|0|||
130926830|NCT03278873|471366274|FG002|Overall Study|The patient was unresponsive to contact|0|||
130926831|NCT03278873|471366275|FG003|Overall Study|The patient was unresponsive to contact|4|||
130926832|NCT03278873|471366272|FG000|Overall Study|The patient wished to participate no longer|0|||
130926833|NCT03278873|471366273|FG001|Overall Study|The patient wished to participate no longer|1|||
130926834|NCT03278873|471366274|FG002|Overall Study|The patient wished to participate no longer|0|||
130926835|NCT03278873|471366275|FG003|Overall Study|The patient wished to participate no longer|0|||
130926836|NCT03278873|471366272|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
130702187|NCT02490800|470532818|FG006|Overall Study|Withdrawal by Subject|0|||
130702188|NCT02490800|470532819|FG007|Overall Study|Withdrawal by Subject|0|||
130702189|NCT02490800|470532820|FG008|Overall Study|Withdrawal by Subject|1|||
130702190|NCT02490800|470532821|FG009|Overall Study|Withdrawal by Subject|0|||
130702191|NCT02490800|470532822|FG010|Overall Study|Withdrawal by Subject|0|||
130702192|NCT02490800|470532823|FG011|Overall Study|Withdrawal by Subject|0|||
130702193|NCT02490800|470532824|FG012|Overall Study|Withdrawal by Subject|0|||
130702194|NCT02490800|470532812|FG000|Overall Study|Progressive disease|3|||
130702195|NCT02490800|470532813|FG001|Overall Study|Progressive disease|3|||
130702196|NCT02490800|470532814|FG002|Overall Study|Progressive disease|3|||
130702197|NCT02490800|470532815|FG003|Overall Study|Progressive disease|4|||
130702198|NCT02490800|470532816|FG004|Overall Study|Progressive disease|4|||
130926837|NCT03278873|471366273|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
130926838|NCT03278873|471366274|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
130926839|NCT03278873|471366275|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
130926840|NCT05243641|471366276|FG000|Overall Study|Adverse Event|3|||
130926841|NCT05243641|471366277|FG001|Overall Study|Adverse Event|0|||
130926842|NCT05243641|471366278|FG002|Overall Study|Adverse Event|0|||
130926843|NCT05243641|471366279|FG003|Overall Study|Adverse Event|1|||
130926844|NCT05243641|471366280|FG004|Overall Study|Adverse Event|0|||
130926845|NCT05243641|471366281|FG005|Overall Study|Adverse Event|0|||
130926846|NCT05243641|471366276|FG000|Overall Study|Disease progression|4|||
130926847|NCT05243641|471366277|FG001|Overall Study|Disease progression|0|||
130926848|NCT05243641|471366278|FG002|Overall Study|Disease progression|0|||
130926849|NCT05243641|471366279|FG003|Overall Study|Disease progression|2|||
130926850|NCT05243641|471366280|FG004|Overall Study|Disease progression|0|||
130926851|NCT05243641|471366281|FG005|Overall Study|Disease progression|0|||
130926852|NCT00540514|471368141|FG000|Overall Study|Still on treatment|3|||
130926853|NCT00540514|471368142|FG001|Overall Study|Still on treatment|0|||
130926854|NCT00540514|471368141|FG000|Overall Study|Unacceptable Toxicity|61|||
130926855|NCT00540514|471368142|FG001|Overall Study|Unacceptable Toxicity|62|||
130926856|NCT00540514|471368141|FG000|Overall Study|Adverse Event|20|||
130926857|NCT00540514|471368142|FG001|Overall Study|Adverse Event|24|||
130926858|NCT00540514|471368141|FG000|Overall Study|Physician Decision|86|||
130926859|NCT00540514|471368142|FG001|Overall Study|Physician Decision|99|||
130926860|NCT00540514|471368141|FG000|Overall Study|Protocol Deviation|3|||
130926861|NCT00540514|471368142|FG001|Overall Study|Protocol Deviation|4|||
130926862|NCT00540514|471368141|FG000|Overall Study|Lost to Follow-up|1|||
130926863|NCT00540514|471368142|FG001|Overall Study|Lost to Follow-up|1|||
130926864|NCT00540514|471368141|FG000|Overall Study|Withdrawal by Subject|65|||
130926865|NCT00540514|471368142|FG001|Overall Study|Withdrawal by Subject|67|||
130926866|NCT00540514|471368141|FG000|Overall Study|Excluded prior to treatment|7|||
130926867|NCT00540514|471368142|FG001|Overall Study|Excluded prior to treatment|7|||
130926868|NCT00540514|471368141|FG000|Overall Study|Paclitaxel not available|0|||
130926869|NCT00540514|471368142|FG001|Overall Study|Paclitaxel not available|2|||
130926870|NCT02501473|471368143|FG000|Overall Study|Study Terminated|2|||
130926871|NCT02501473|471368144|FG001|Overall Study|Study Terminated|3|||
130702199|NCT02490800|470532817|FG005|Overall Study|Progressive disease|1|||
130702200|NCT02490800|470532818|FG006|Overall Study|Progressive disease|4|||
130702201|NCT02490800|470532819|FG007|Overall Study|Progressive disease|3|||
130702202|NCT02490800|470532820|FG008|Overall Study|Progressive disease|6|||
130702203|NCT02490800|470532821|FG009|Overall Study|Progressive disease|2|||
130926872|NCT02501473|471368145|FG002|Overall Study|Study Terminated|7|||
130926873|NCT02501473|471368146|FG003|Overall Study|Study Terminated|9|||
130926874|NCT02501473|471368147|FG004|Overall Study|Study Terminated|2|||
130926875|NCT02501473|471368148|FG005|Overall Study|Study Terminated|10|||
130926876|NCT02501473|471368149|FG006|Overall Study|Study Terminated|1|||
130702204|NCT02490800|470532822|FG010|Overall Study|Progressive disease|7|||
130770118|NCT03539484|470784245|FG001|Overall Study|Study Terminated by Sponsor|0|||
130926877|NCT02501473|471368150|FG007|Overall Study|Study Terminated|0|||
130926878|NCT02501473|471368143|FG000|Overall Study|Withdrawal by Subject|0|||
130926879|NCT02501473|471368144|FG001|Overall Study|Withdrawal by Subject|0|||
130926880|NCT02501473|471368145|FG002|Overall Study|Withdrawal by Subject|3|||
130926881|NCT02501473|471368146|FG003|Overall Study|Withdrawal by Subject|3|||
130926882|NCT02501473|471368147|FG004|Overall Study|Withdrawal by Subject|2|||
130926883|NCT02501473|471368148|FG005|Overall Study|Withdrawal by Subject|2|||
130926884|NCT02501473|471368149|FG006|Overall Study|Withdrawal by Subject|0|||
130926885|NCT02501473|471368150|FG007|Overall Study|Withdrawal by Subject|0|||
130770119|NCT03539484|470784246|FG002|Overall Study|Study Terminated by Sponsor|1|||
130926886|NCT02501473|471368143|FG000|Overall Study|Death|0|||
130926887|NCT02501473|471368144|FG001|Overall Study|Death|0|||
130926888|NCT02501473|471368145|FG002|Overall Study|Death|1|||
130926889|NCT02501473|471368146|FG003|Overall Study|Death|1|||
130702205|NCT02490800|470532823|FG011|Overall Study|Progressive disease|1|||
130702206|NCT02490800|470532824|FG012|Overall Study|Progressive disease|10|||
130926890|NCT02501473|471368147|FG004|Overall Study|Death|0|||
130926891|NCT02501473|471368148|FG005|Overall Study|Death|1|||
130926892|NCT02501473|471368149|FG006|Overall Study|Death|0|||
130926893|NCT02501473|471368150|FG007|Overall Study|Death|0|||
130926894|NCT02501473|471368143|FG000|Overall Study|Lost to Follow-up|1|||
130702207|NCT02490800|470532812|FG000|Overall Study|Patient enrolled in post-trial access|0|||
130702208|NCT02490800|470532813|FG001|Overall Study|Patient enrolled in post-trial access|0|||
130926895|NCT02501473|471368144|FG001|Overall Study|Lost to Follow-up|0|||
130926896|NCT02501473|471368145|FG002|Overall Study|Lost to Follow-up|1|||
130926897|NCT02501473|471368146|FG003|Overall Study|Lost to Follow-up|0|||
130926898|NCT02501473|471368147|FG004|Overall Study|Lost to Follow-up|0|||
130926899|NCT02501473|471368148|FG005|Overall Study|Lost to Follow-up|1|||
130926900|NCT02501473|471368149|FG006|Overall Study|Lost to Follow-up|0|||
130926901|NCT02501473|471368150|FG007|Overall Study|Lost to Follow-up|0|||
130926902|NCT02501473|471368143|FG000|Overall Study|Reason not specified|0|||
130926903|NCT02501473|471368144|FG001|Overall Study|Reason not specified|0|||
130926904|NCT02501473|471368145|FG002|Overall Study|Reason not specified|1|||
130926905|NCT02501473|471368146|FG003|Overall Study|Reason not specified|1|||
130926906|NCT02501473|471368147|FG004|Overall Study|Reason not specified|0|||
130926907|NCT02501473|471368148|FG005|Overall Study|Reason not specified|0|||
130926908|NCT02501473|471368149|FG006|Overall Study|Reason not specified|0|||
130926909|NCT02501473|471368150|FG007|Overall Study|Reason not specified|0|||
130926910|NCT04487730|471368151|FG000|Overall Study|Withdrawal by Subject|3|||
130926911|NCT04487730|471368152|FG001|Overall Study|Withdrawal by Subject|1|||
130926912|NCT04487730|471368151|FG000|Overall Study|Lost to Follow-up|0|||
130926913|NCT04487730|471368152|FG001|Overall Study|Lost to Follow-up|1|||
130926914|NCT04487730|471368151|FG000|Overall Study|Physician Decision|0|||
130926915|NCT04487730|471368152|FG001|Overall Study|Physician Decision|1|||
130926916|NCT02397278|471368155|FG000|Overall Study|Withdrawal by Subject|0|||
130926917|NCT02397278|471368156|FG001|Overall Study|Withdrawal by Subject|2|||
130926918|NCT02397278|471368155|FG000|Overall Study|Deemed ineligible following surgery|1|||
130926919|NCT02397278|471368156|FG001|Overall Study|Deemed ineligible following surgery|1|||
130926920|NCT01397084|471368161|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
130926921|NCT01397084|471368161|FG000|Overall Study|Protocol Violation|2|||
130926922|NCT01397084|471368161|FG000|Overall Study|Adverse Event|2|||
130926923|NCT01397084|471368161|FG000|Overall Study|Withdrawal by Subject|1|||
130926924|NCT01397084|471368161|FG000|Overall Study|Lost to Follow-up|1|||
130926925|NCT01397084|471368161|FG000|Overall Study|Used other proton pump inhibitor|1|||
130926926|NCT00618072|471368162|FG000|Overall Study|Lost to Follow-up|2|||
130926927|NCT00618072|471368163|FG001|Overall Study|Lost to Follow-up|0|||
130926928|NCT00618072|471368164|FG002|Overall Study|Lost to Follow-up|3|||
130926929|NCT00618072|471368162|FG000|Overall Study|Physician Decision|0|||
130926930|NCT00618072|471368163|FG001|Overall Study|Physician Decision|1|||
130926931|NCT00618072|471368164|FG002|Overall Study|Physician Decision|1|||
130926932|NCT03292588|471368165|FG000|Overall Study|Death|1|||
130926933|NCT03292588|471368166|FG001|Overall Study|Death|0|||
130926934|NCT03292588|471368165|FG000|Overall Study|Lost to Follow-up|12|||
130926935|NCT03292588|471368166|FG001|Overall Study|Lost to Follow-up|16|||
130926936|NCT03292588|471368165|FG000|Overall Study|Physician Decision|0|||
130926937|NCT03292588|471368166|FG001|Overall Study|Physician Decision|1|||
130926938|NCT03292588|471368165|FG000|Overall Study|Withdrawal by Subject|4|||
130926939|NCT03292588|471368166|FG001|Overall Study|Withdrawal by Subject|4|||
130926940|NCT03292588|471368165|FG000|Overall Study|Move out of town|1|||
130926941|NCT03292588|471368166|FG001|Overall Study|Move out of town|0|||
130926942|NCT03292588|471368165|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
130926943|NCT03292588|471368166|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
130926944|NCT00062374|471368167|FG000|Overall Study|Not treated|12|||
130926945|NCT03633695|471368170|FG000|Overall Study|Lost to Follow-up|4|||
130926946|NCT03633695|471368171|FG001|Overall Study|Lost to Follow-up|5|||
130926947|NCT03633695|471368170|FG000|Overall Study|Discontinued|8|||
130702209|NCT02490800|470532814|FG002|Overall Study|Patient enrolled in post-trial access|0|||
130702210|NCT02490800|470532815|FG003|Overall Study|Patient enrolled in post-trial access|0|||
130702211|NCT02490800|470532816|FG004|Overall Study|Patient enrolled in post-trial access|0|||
130702212|NCT02490800|470532817|FG005|Overall Study|Patient enrolled in post-trial access|0|||
130702213|NCT02490800|470532818|FG006|Overall Study|Patient enrolled in post-trial access|0|||
130926948|NCT03633695|471368171|FG001|Overall Study|Discontinued|4|||
130702214|NCT02490800|470532819|FG007|Overall Study|Patient enrolled in post-trial access|0|||
130926949|NCT00617773|471368172|FG000|Overall Study|Physician Decision|1|||
130702215|NCT02490800|470532820|FG008|Overall Study|Patient enrolled in post-trial access|0|||
130702216|NCT02490800|470532821|FG009|Overall Study|Patient enrolled in post-trial access|1|||
130926950|NCT00617773|471368172|FG000|Overall Study|Lack of compliance with the protocol|1|||
130926951|NCT00617773|471368172|FG000|Overall Study|Withdrawal by Subject|1|||
130926952|NCT00617773|471368172|FG000|Overall Study|Death|1|||
130926953|NCT00617773|471368172|FG000|Overall Study|Progressive disease|19|||
130926954|NCT00617773|471368172|FG000|Overall Study|Protocol Violation|1|||
130926955|NCT01751867|471368173|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
130926956|NCT01751867|471368174|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
130926957|NCT01751867|471368173|FG000|Overall Study|Diease Progression|4|||
130926958|NCT01751867|471368174|FG001|Overall Study|Diease Progression|18|||
130926959|NCT01751867|471368173|FG000|Overall Study|Adverse Event|8|||
130702217|NCT02490800|470532822|FG010|Overall Study|Patient enrolled in post-trial access|1|||
130702218|NCT02490800|470532823|FG011|Overall Study|Patient enrolled in post-trial access|0|||
130702219|NCT02490800|470532824|FG012|Overall Study|Patient enrolled in post-trial access|6|||
130702220|NCT01337596|470532825|FG000|Overall Study|Withdrawal by Subject|0|||
130702221|NCT01337596|470532826|FG001|Overall Study|Withdrawal by Subject|0|||
130702222|NCT01337596|470532827|FG002|Overall Study|Withdrawal by Subject|0|||
130702223|NCT01337596|470532828|FG003|Overall Study|Withdrawal by Subject|0|||
130702224|NCT01337596|470532829|FG004|Overall Study|Withdrawal by Subject|2|||
130702225|NCT01337596|470532830|FG005|Overall Study|Withdrawal by Subject|0|||
130702226|NCT01337596|470532831|FG006|Overall Study|Withdrawal by Subject|0|||
130702227|NCT01337596|470532832|FG007|Overall Study|Withdrawal by Subject|0|||
130702228|NCT01337596|470532833|FG008|Overall Study|Withdrawal by Subject|0|||
130702229|NCT01992094|470532834|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
130702230|NCT01992094|470532835|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
130702231|NCT01992094|470532836|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
130702232|NCT01992094|470532834|FG000|Overall Study|Adverse Event|1|||
130702233|NCT01992094|470532835|FG001|Overall Study|Adverse Event|0|||
130702234|NCT01992094|470532836|FG002|Overall Study|Adverse Event|0|||
130702235|NCT01992094|470532834|FG000|Overall Study|Death|5|||
130926960|NCT01751867|471368174|FG001|Overall Study|Adverse Event|15|||
130926961|NCT01751867|471368173|FG000|Overall Study|Poor Compliance|0|||
130926962|NCT01751867|471368174|FG001|Overall Study|Poor Compliance|5|||
130926963|NCT01751867|471368173|FG000|Overall Study|Withdrawal by Subject|3|||
130926964|NCT01751867|471368174|FG001|Overall Study|Withdrawal by Subject|1|||
130926965|NCT01751867|471368173|FG000|Overall Study|Physician Decision|4|||
130926966|NCT01751867|471368174|FG001|Overall Study|Physician Decision|7|||
130926967|NCT01751867|471368173|FG000|Overall Study|Protocol Violation|0|||
130926968|NCT01751867|471368174|FG001|Overall Study|Protocol Violation|2|||
130926969|NCT01751867|471368173|FG000|Overall Study|Death|0|||
130926970|NCT01751867|471368174|FG001|Overall Study|Death|5|||
130926971|NCT01751867|471368173|FG000|Overall Study|Other|11|||
130926972|NCT01751867|471368174|FG001|Overall Study|Other|37|||
130926973|NCT01751867|471368173|FG000|Overall Study|Randomized but not treated.|2|||
130926974|NCT01751867|471368174|FG001|Overall Study|Randomized but not treated.|1|||
130926975|NCT04932096|471368175|FG000|Overall Study|Withdrawal by Subject|1|||
130926976|NCT04932096|471368176|FG001|Overall Study|Withdrawal by Subject|1|||
130926977|NCT04932096|471368175|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
130926978|NCT04932096|471368176|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
130926979|NCT02170298|471368177|FG000|Overall Study|Withdrawal by Subject|0|||
130926980|NCT02170298|471368178|FG001|Overall Study|Withdrawal by Subject|1|||
130926981|NCT02170298|471368177|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
130926982|NCT02170298|471368178|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
130926983|NCT01976338|471368179|FG000|Overall Study|Physician Decision|0|||
130926984|NCT01976338|471368180|FG001|Overall Study|Physician Decision|1|||
130926985|NCT01976338|471368179|FG000|Overall Study|Lost to Follow-up|3|||
130926986|NCT01976338|471368180|FG001|Overall Study|Lost to Follow-up|0|||
130926987|NCT01976338|471368179|FG000|Overall Study|Withdrawal by Subject|5|||
130926988|NCT01976338|471368180|FG001|Overall Study|Withdrawal by Subject|2|||
130926989|NCT01976338|471368179|FG000|Overall Study|Adverse Event|5|||
130926990|NCT01976338|471368180|FG001|Overall Study|Adverse Event|1|||
130926991|NCT00777608|471368181|FG000|Overall Study|Lost to Follow-up|1|||
130702236|NCT01992094|470532835|FG001|Overall Study|Death|5|||
130702237|NCT01992094|470532836|FG002|Overall Study|Death|2|||
130702238|NCT01992094|470532834|FG000|Overall Study|Lost to Follow-up|26|||
130702239|NCT01992094|470532835|FG001|Overall Study|Lost to Follow-up|9|||
130926992|NCT00777608|471368182|FG001|Overall Study|Lost to Follow-up|1|||
130926993|NCT00777608|471368181|FG000|Overall Study|Withdrawal by Subject|1|||
130926994|NCT00777608|471368182|FG001|Overall Study|Withdrawal by Subject|3|||
130926995|NCT00777608|471368181|FG000|Overall Study|Protocol Violation|1|||
130926996|NCT00777608|471368182|FG001|Overall Study|Protocol Violation|0|||
130926997|NCT00777608|471368181|FG000|Overall Study|Investigator Decision|1|||
130702240|NCT01992094|470532836|FG002|Overall Study|Lost to Follow-up|13|||
130702241|NCT01992094|470532834|FG000|Overall Study|OTHER|4|||
130702242|NCT01992094|470532835|FG001|Overall Study|OTHER|0|||
130926998|NCT00777608|471368182|FG001|Overall Study|Investigator Decision|2|||
130926999|NCT02853604|471368183|FG000|Overall Study|Withdrawal by Subject|12|||
130702243|NCT01992094|470532836|FG002|Overall Study|OTHER|0|||
130702244|NCT01992094|470532834|FG000|Overall Study|Protocol Violation|1|||
130702245|NCT01992094|470532835|FG001|Overall Study|Protocol Violation|0|||
130702246|NCT01992094|470532836|FG002|Overall Study|Protocol Violation|1|||
130927000|NCT02853604|471368184|FG001|Overall Study|Withdrawal by Subject|35|||
130927001|NCT02853604|471368183|FG000|Overall Study|Lost to Follow-up|4|||
130702247|NCT01992094|470532834|FG000|Overall Study|Withdrawal by Subject|7|||
130702248|NCT01992094|470532835|FG001|Overall Study|Withdrawal by Subject|3|||
130927002|NCT02853604|471368184|FG001|Overall Study|Lost to Follow-up|8|||
130927003|NCT02853604|471368183|FG000|Overall Study|Death|1|||
130927004|NCT02853604|471368184|FG001|Overall Study|Death|5|||
130927005|NCT02853604|471368183|FG000|Overall Study|Miscellaneous|11|||
130927006|NCT02853604|471368184|FG001|Overall Study|Miscellaneous|2|||
130927007|NCT02853604|471368183|FG000|Overall Study|Progressive Disease|0|||
130927008|NCT02853604|471368184|FG001|Overall Study|Progressive Disease|2|||
130927009|NCT04213079|471368185|FG000|Overall Study|Lost to Follow-up|0|||
130927010|NCT04213079|471368186|FG001|Overall Study|Lost to Follow-up|2|||
130927011|NCT03766581|471368187|FG000|Randomization|Other reasons|2|||
130927012|NCT03766581|471368188|FG001|Randomization|Other reasons|1|||
130927013|NCT03766581|471368189|FG002|Randomization|Other reasons|0|||
130927014|NCT03766581|471368190|FG003|Randomization|Other reasons|1|||
130927015|NCT03766581|471368191|FG004|Randomization|Other reasons|0|||
130927016|NCT03766581|471368192|FG005|Randomization|Other reasons|0|||
130927017|NCT03766581|471368193|FG006|Randomization|Other reasons|0|||
130927018|NCT03766581|471368194|FG007|Randomization|Other reasons|0|||
130927019|NCT03766581|471368187|FG000|Randomization|Participant no longer meets study criteria|5|||
130927020|NCT03766581|471368188|FG001|Randomization|Participant no longer meets study criteria|3|||
130927021|NCT03766581|471368189|FG002|Randomization|Participant no longer meets study criteria|4|||
130927022|NCT03766581|471368190|FG003|Randomization|Participant no longer meets study criteria|0|||
130927023|NCT03766581|471368191|FG004|Randomization|Participant no longer meets study criteria|2|||
130927024|NCT03766581|471368192|FG005|Randomization|Participant no longer meets study criteria|3|||
130927025|NCT03766581|471368193|FG006|Randomization|Participant no longer meets study criteria|0|||
130927026|NCT03766581|471368194|FG007|Randomization|Participant no longer meets study criteria|1|||
130927027|NCT03766581|471368187|FG000|Randomization|Participant request to discontinue study treatment|1|||
130927028|NCT03766581|471368188|FG001|Randomization|Participant request to discontinue study treatment|0|||
130927029|NCT03766581|471368189|FG002|Randomization|Participant request to discontinue study treatment|0|||
130927030|NCT03766581|471368190|FG003|Randomization|Participant request to discontinue study treatment|0|||
130927031|NCT03766581|471368191|FG004|Randomization|Participant request to discontinue study treatment|1|||
130927032|NCT03766581|471368192|FG005|Randomization|Participant request to discontinue study treatment|2|||
130927033|NCT03766581|471368193|FG006|Randomization|Participant request to discontinue study treatment|0|||
130927034|NCT03766581|471368194|FG007|Randomization|Participant request to discontinue study treatment|0|||
130927035|NCT03766581|471368187|FG000|Randomization|Participant withdrew consent|1|||
130927036|NCT03766581|471368188|FG001|Randomization|Participant withdrew consent|0|||
130927037|NCT03766581|471368189|FG002|Randomization|Participant withdrew consent|1|||
130927038|NCT03766581|471368190|FG003|Randomization|Participant withdrew consent|2|||
130927039|NCT03766581|471368191|FG004|Randomization|Participant withdrew consent|1|||
130927040|NCT03766581|471368192|FG005|Randomization|Participant withdrew consent|1|||
130927041|NCT03766581|471368193|FG006|Randomization|Participant withdrew consent|0|||
130927042|NCT03766581|471368194|FG007|Randomization|Participant withdrew consent|0|||
130927043|NCT03766581|471368187|FG000|Treatment|Adverse Event|82|||
130927044|NCT03766581|471368188|FG001|Treatment|Adverse Event|44|||
130927045|NCT03766581|471368189|FG002|Treatment|Adverse Event|47|||
130927046|NCT03766581|471368190|FG003|Treatment|Adverse Event|46|||
130927047|NCT03766581|471368191|FG004|Treatment|Adverse Event|50|||
130927048|NCT03766581|471368192|FG005|Treatment|Adverse Event|77|||
130927049|NCT03766581|471368193|FG006|Treatment|Adverse Event|5|||
130927050|NCT03766581|471368194|FG007|Treatment|Adverse Event|2|||
130927051|NCT03766581|471368187|FG000|Treatment|Participant request to discontinue treatment|34|||
131034632|NCT04963270|471761749|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
131034633|NCT04963270|471761746|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
131034634|NCT04963270|471761747|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
131034635|NCT04963270|471761748|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
131034636|NCT04963270|471761749|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
131034637|NCT04963270|471761746|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
131034638|NCT04963270|471761747|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
131034639|NCT04963270|471761748|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
131034640|NCT04963270|471761749|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
131034641|NCT04963270|471761746|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
131034642|NCT04963270|471761747|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
131034643|NCT04963270|471761748|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
131034644|NCT04963270|471761749|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
131034645|NCT04963270|471761746|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
131034646|NCT04963270|471761747|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
131034647|NCT04963270|471761748|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
131034648|NCT04963270|471761749|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
131034649|NCT04963270|471761746|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
131034650|NCT04963270|471761747|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
131034651|NCT04963270|471761748|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
131034652|NCT04963270|471761749|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
130927052|NCT03766581|471368188|FG001|Treatment|Participant request to discontinue treatment|6|||
130927053|NCT03766581|471368189|FG002|Treatment|Participant request to discontinue treatment|10|||
130927054|NCT03766581|471368190|FG003|Treatment|Participant request to discontinue treatment|10|||
130927055|NCT03766581|471368191|FG004|Treatment|Participant request to discontinue treatment|14|||
130927056|NCT03766581|471368192|FG005|Treatment|Participant request to discontinue treatment|15|||
130927057|NCT03766581|471368193|FG006|Treatment|Participant request to discontinue treatment|0|||
130927058|NCT03766581|471368194|FG007|Treatment|Participant request to discontinue treatment|1|||
130927059|NCT03766581|471368187|FG000|Treatment|Participant withdrew consent|11|||
130927060|NCT03766581|471368188|FG001|Treatment|Participant withdrew consent|4|||
130927061|NCT03766581|471368189|FG002|Treatment|Participant withdrew consent|5|||
130927062|NCT03766581|471368190|FG003|Treatment|Participant withdrew consent|5|||
130927063|NCT03766581|471368191|FG004|Treatment|Participant withdrew consent|4|||
130927064|NCT03766581|471368192|FG005|Treatment|Participant withdrew consent|4|||
130927065|NCT03766581|471368193|FG006|Treatment|Participant withdrew consent|0|||
130927066|NCT03766581|471368194|FG007|Treatment|Participant withdrew consent|0|||
130927067|NCT03766581|471368187|FG000|Treatment|Death|1|||
130927068|NCT03766581|471368188|FG001|Treatment|Death|0|||
130927069|NCT03766581|471368189|FG002|Treatment|Death|0|||
130927070|NCT03766581|471368190|FG003|Treatment|Death|0|||
130927071|NCT03766581|471368191|FG004|Treatment|Death|0|||
130927072|NCT03766581|471368192|FG005|Treatment|Death|0|||
130927073|NCT03766581|471368193|FG006|Treatment|Death|0|||
130927074|NCT03766581|471368194|FG007|Treatment|Death|0|||
130927075|NCT03766581|471368187|FG000|Treatment|Lost to Follow-up|1|||
130927076|NCT03766581|471368188|FG001|Treatment|Lost to Follow-up|0|||
130927077|NCT03766581|471368189|FG002|Treatment|Lost to Follow-up|0|||
130927078|NCT03766581|471368190|FG003|Treatment|Lost to Follow-up|1|||
130927079|NCT03766581|471368191|FG004|Treatment|Lost to Follow-up|0|||
130927080|NCT03766581|471368192|FG005|Treatment|Lost to Follow-up|0|||
130927081|NCT03766581|471368193|FG006|Treatment|Lost to Follow-up|0|||
131034653|NCT04963270|471761746|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
130927082|NCT03766581|471368194|FG007|Treatment|Lost to Follow-up|0|||
130927083|NCT03766581|471368187|FG000|Treatment|Poor/Non compliance|2|||
131034654|NCT04963270|471761747|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
131034655|NCT04963270|471761748|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
131034656|NCT04963270|471761749|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
131034657|NCT04963270|471761746|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
131034658|NCT04963270|471761747|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
131034659|NCT04963270|471761748|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
131034660|NCT04963270|471761749|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
131034661|NCT01798498|471761750|FG000|Overall Study|Lost to Follow-up|1|||
131034662|NCT03896789|471761752|FG000|Baseline|Lost to Follow-up|1|||
131034663|NCT03896789|471761753|FG001|Baseline|Lost to Follow-up|2|||
131034664|NCT03896789|471761752|FG000|Baseline|Death|3|||
131034665|NCT03896789|471761753|FG001|Baseline|Death|6|||
131034666|NCT03896789|471761752|FG000|Post-Randomization|Lost to Follow-up|12|||
131034667|NCT03896789|471761753|FG001|Post-Randomization|Lost to Follow-up|11|||
131034668|NCT03896789|471761752|FG000|Post-Randomization|Death|12|||
131034669|NCT03896789|471761753|FG001|Post-Randomization|Death|13|||
131034670|NCT03447470|471761757|FG000|Overall Study|Death|0|||
131034671|NCT03447470|471761758|FG001|Overall Study|Death|1|||
131034672|NCT03447470|471761759|FG002|Overall Study|Death|3|||
131034673|NCT03447470|471761760|FG003|Overall Study|Death|0|||
131034674|NCT03447470|471761761|FG004|Overall Study|Death|1|||
131034675|NCT03447470|471761762|FG005|Overall Study|Death|0|||
131034676|NCT03447470|471761763|FG006|Overall Study|Death|3|||
131034677|NCT03447470|471761764|FG007|Overall Study|Death|3|||
131034678|NCT03447470|471761765|FG008|Overall Study|Death|1|||
131034679|NCT03447470|471761757|FG000|Overall Study|Withdrawal by Subject|1|||
131034680|NCT03447470|471761758|FG001|Overall Study|Withdrawal by Subject|0|||
131034681|NCT03447470|471761759|FG002|Overall Study|Withdrawal by Subject|0|||
131034682|NCT03447470|471761760|FG003|Overall Study|Withdrawal by Subject|0|||
131034683|NCT03447470|471761761|FG004|Overall Study|Withdrawal by Subject|1|||
131034684|NCT03447470|471761762|FG005|Overall Study|Withdrawal by Subject|0|||
131034685|NCT03447470|471761763|FG006|Overall Study|Withdrawal by Subject|1|||
131034686|NCT03447470|471761764|FG007|Overall Study|Withdrawal by Subject|1|||
130927084|NCT03766581|471368188|FG001|Treatment|Poor/Non compliance|2|||
130927085|NCT03766581|471368189|FG002|Treatment|Poor/Non compliance|1|||
130927086|NCT03766581|471368190|FG003|Treatment|Poor/Non compliance|1|||
130927087|NCT03766581|471368191|FG004|Treatment|Poor/Non compliance|1|||
130927088|NCT03766581|471368192|FG005|Treatment|Poor/Non compliance|1|||
130927089|NCT03766581|471368193|FG006|Treatment|Poor/Non compliance|0|||
130927090|NCT03766581|471368194|FG007|Treatment|Poor/Non compliance|0|||
131034687|NCT03447470|471761765|FG008|Overall Study|Withdrawal by Subject|3|||
131034688|NCT03447470|471761757|FG000|Overall Study|Treatment discontinued|3|||
131223612|NCT01106352|472447062|FG001|Overall Study|Too ill to come in for the visit|0|||
130702249|NCT01992094|470532836|FG002|Overall Study|Withdrawal by Subject|4|||
130927091|NCT03766581|471368187|FG000|Treatment|Participant no longer meets study criteria|9|||
131034689|NCT03447470|471761758|FG001|Overall Study|Treatment discontinued|2|||
131034690|NCT03447470|471761759|FG002|Overall Study|Treatment discontinued|4|||
130927092|NCT03766581|471368188|FG001|Treatment|Participant no longer meets study criteria|1|||
130927093|NCT03766581|471368189|FG002|Treatment|Participant no longer meets study criteria|5|||
130927094|NCT03766581|471368190|FG003|Treatment|Participant no longer meets study criteria|4|||
130927095|NCT03766581|471368191|FG004|Treatment|Participant no longer meets study criteria|4|||
130927096|NCT03766581|471368192|FG005|Treatment|Participant no longer meets study criteria|4|||
130927097|NCT03766581|471368193|FG006|Treatment|Participant no longer meets study criteria|2|||
130927098|NCT03766581|471368194|FG007|Treatment|Participant no longer meets study criteria|0|||
130927099|NCT03766581|471368187|FG000|Treatment|Other reasons|13|||
130927100|NCT03766581|471368188|FG001|Treatment|Other reasons|8|||
130927101|NCT03766581|471368189|FG002|Treatment|Other reasons|3|||
130927102|NCT03766581|471368190|FG003|Treatment|Other reasons|7|||
130927103|NCT03766581|471368191|FG004|Treatment|Other reasons|3|||
130927104|NCT03766581|471368192|FG005|Treatment|Other reasons|3|||
130927105|NCT03766581|471368193|FG006|Treatment|Other reasons|0|||
130927106|NCT03766581|471368194|FG007|Treatment|Other reasons|0|||
130927107|NCT00520936|471368195|FG000|Overall Study|Physician Decision|0|||
130927108|NCT00520936|471368196|FG001|Overall Study|Physician Decision|2|||
130927109|NCT00520936|471368197|FG002|Overall Study|Physician Decision|1|||
130927110|NCT00520936|471368198|FG003|Overall Study|Physician Decision|0|||
130927111|NCT00520936|471368199|FG004|Overall Study|Physician Decision|0|||
130927112|NCT00520936|471368200|FG005|Overall Study|Physician Decision|0|||
130927113|NCT00520936|471368201|FG006|Overall Study|Physician Decision|0|||
130927114|NCT00520936|471368202|FG007|Overall Study|Physician Decision|0|||
130927115|NCT00520936|471368195|FG000|Overall Study|Withdrawal by Subject|0|||
130927116|NCT00520936|471368196|FG001|Overall Study|Withdrawal by Subject|0|||
130927117|NCT00520936|471368197|FG002|Overall Study|Withdrawal by Subject|0|||
130927118|NCT00520936|471368198|FG003|Overall Study|Withdrawal by Subject|0|||
130927119|NCT00520936|471368199|FG004|Overall Study|Withdrawal by Subject|0|||
130927120|NCT00520936|471368200|FG005|Overall Study|Withdrawal by Subject|0|||
130927121|NCT00520936|471368201|FG006|Overall Study|Withdrawal by Subject|0|||
130927122|NCT00520936|471368202|FG007|Overall Study|Withdrawal by Subject|1|||
130927123|NCT00520936|471368195|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
130927124|NCT00520936|471368196|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
130927125|NCT00520936|471368197|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
130927126|NCT00520936|471368198|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
130927127|NCT00520936|471368199|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
130927128|NCT00520936|471368200|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
130927129|NCT00520936|471368201|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
130927130|NCT00520936|471368202|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
130927131|NCT00520936|471368195|FG000|Overall Study|Death|0|||
130927132|NCT00520936|471368196|FG001|Overall Study|Death|0|||
130927133|NCT00520936|471368197|FG002|Overall Study|Death|0|||
130927134|NCT00520936|471368198|FG003|Overall Study|Death|0|||
130927135|NCT00520936|471368199|FG004|Overall Study|Death|0|||
130927136|NCT00520936|471368200|FG005|Overall Study|Death|0|||
130927137|NCT00520936|471368201|FG006|Overall Study|Death|1|||
130927138|NCT00520936|471368202|FG007|Overall Study|Death|0|||
130927139|NCT00520936|471368195|FG000|Overall Study|Protocol Violation|0|||
130927140|NCT00520936|471368196|FG001|Overall Study|Protocol Violation|1|||
130927141|NCT00520936|471368197|FG002|Overall Study|Protocol Violation|1|||
130927142|NCT00520936|471368198|FG003|Overall Study|Protocol Violation|0|||
130927143|NCT00520936|471368199|FG004|Overall Study|Protocol Violation|1|||
130927144|NCT00520936|471368200|FG005|Overall Study|Protocol Violation|0|||
130927145|NCT00520936|471368201|FG006|Overall Study|Protocol Violation|1|||
130927146|NCT00520936|471368202|FG007|Overall Study|Protocol Violation|0|||
130927147|NCT04343261|471368203|FG000|Overall Study|Adverse Event|1|||
130927148|NCT04343261|471368203|FG000|Overall Study|received inadequate amount of antibodies|7|||
130927149|NCT05275400|471368207|FG000|Treatment Period|Adverse Event|7|||
130927150|NCT05275400|471368208|FG001|Treatment Period|Adverse Event|1|||
130927151|NCT05275400|471368207|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
130927152|NCT05275400|471368208|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
130702250|NCT01214239|470532837|FG000|Overall Study|Adverse Event|3|||
130702251|NCT01214239|470532838|FG001|Overall Study|Adverse Event|4|||
130702252|NCT01214239|470532837|FG000|Overall Study|Protocol Violation|2|||
130702253|NCT01214239|470532838|FG001|Overall Study|Protocol Violation|1|||
130702254|NCT01214239|470532837|FG000|Overall Study|Lost to Follow-up|1|||
130927153|NCT05275400|471368207|FG000|Treatment Period|Death|5|||
130927154|NCT05275400|471368208|FG001|Treatment Period|Death|2|||
130927155|NCT05275400|471368207|FG000|Treatment Period|Protocol Violation|1|||
130927156|NCT05275400|471368208|FG001|Treatment Period|Protocol Violation|0|||
130927157|NCT05275400|471368207|FG000|Treatment Period|Physician Decision|5|||
130927158|NCT05275400|471368208|FG001|Treatment Period|Physician Decision|4|||
130927159|NCT05275400|471368207|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
130702255|NCT01214239|470532838|FG001|Overall Study|Lost to Follow-up|1|||
130702256|NCT01214239|470532837|FG000|Overall Study|Withdrawal by Subject|4|||
130927160|NCT05275400|471368208|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
130927161|NCT05275400|471368207|FG000|Treatment Period|Withdrawal by Subject|30|||
130702257|NCT01214239|470532838|FG001|Overall Study|Withdrawal by Subject|9|||
130702258|NCT01214239|470532837|FG000|Overall Study|Lack of Efficacy|1|||
130702259|NCT01214239|470532838|FG001|Overall Study|Lack of Efficacy|2|||
130702260|NCT01214239|470532837|FG000|Overall Study|patient's private reason|1|||
130702261|NCT01214239|470532838|FG001|Overall Study|patient's private reason|1|||
130702262|NCT01049581|470532839|FG000|Overall Study|Lost to Follow-up|2|||
130702263|NCT01049581|470532840|FG001|Overall Study|Lost to Follow-up|1|||
130702264|NCT03203642|470532841|FG000|Overall Study|Adverse Event|3|||
130702265|NCT03203642|470532842|FG001|Overall Study|Adverse Event|1|||
130702266|NCT03203642|470532841|FG000|Overall Study|Withdrawal by Subject|6|||
130702267|NCT03203642|470532842|FG001|Overall Study|Withdrawal by Subject|6|||
130702268|NCT03203642|470532841|FG000|Overall Study|Lost to Follow-up|2|||
130702269|NCT03203642|470532842|FG001|Overall Study|Lost to Follow-up|1|||
130702270|NCT03203642|470532841|FG000|Overall Study|Termination of the study by sponsor|1|||
130702271|NCT03203642|470532842|FG001|Overall Study|Termination of the study by sponsor|1|||
130702272|NCT03203642|470532841|FG000|Overall Study|Participant moved|0|||
130702273|NCT03203642|470532842|FG001|Overall Study|Participant moved|1|||
130702274|NCT03203642|470532841|FG000|Overall Study|Investigator's decision|3|||
130702275|NCT03203642|470532842|FG001|Overall Study|Investigator's decision|0|||
130702276|NCT03203642|470532841|FG000|Overall Study|Other than above specified|0|||
130702277|NCT03203642|470532842|FG001|Overall Study|Other than above specified|1|||
130702278|NCT05068284|470532845|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
130702279|NCT05068284|470532846|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
130702280|NCT05068284|470532847|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702281|NCT05068284|470532848|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702282|NCT05068284|470532849|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702283|NCT05068284|470532850|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702284|NCT05068284|470532851|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702285|NCT05068284|470532852|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130702286|NCT05068284|470532845|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130927162|NCT05275400|471368208|FG001|Treatment Period|Withdrawal by Subject|12|||
130927163|NCT05275400|471368207|FG000|Treatment Period|Lost to Follow-up|1|||
130927164|NCT05275400|471368208|FG001|Treatment Period|Lost to Follow-up|5|||
130927165|NCT05275400|471368207|FG000|Treatment Period|Lack of Efficacy|1|||
130927166|NCT05275400|471368208|FG001|Treatment Period|Lack of Efficacy|0|||
130927167|NCT05275400|471368207|FG000|Treatment Period|Sponsor Decision|1|||
130927168|NCT05275400|471368208|FG001|Treatment Period|Sponsor Decision|0|||
130927169|NCT05275400|471368207|FG000|Follow-Up Period|Death|2|||
130927170|NCT05275400|471368208|FG001|Follow-Up Period|Death|0|||
130927171|NCT05275400|471368207|FG000|Follow-Up Period|Protocol Violation|1|||
130927172|NCT05275400|471368208|FG001|Follow-Up Period|Protocol Violation|0|||
130927173|NCT05275400|471368207|FG000|Follow-Up Period|Withdrawal by Subject|3|||
130927174|NCT05275400|471368208|FG001|Follow-Up Period|Withdrawal by Subject|0|||
130927175|NCT00587054|471368209|FG000|Overall Study|Patient not treated|9|||
130927176|NCT05537883|471368211|FG000|Overall Study|revisional surgery|4|||
130927177|NCT05537883|471368212|FG001|Overall Study|revisional surgery|2|||
130927178|NCT05537883|471368211|FG000|Overall Study|surgeries were cancelled|0|||
130927179|NCT05537883|471368212|FG001|Overall Study|surgeries were cancelled|2|||
130927180|NCT05537883|471368211|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
130927181|NCT05537883|471368212|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
130927182|NCT01328431|471368213|FG000|Baseline|Protocol Violation|0|||
130927183|NCT01328431|471368214|FG001|Baseline|Protocol Violation|2|||
130927184|NCT01328431|471368213|FG000|1 Month (1M)|Lost to Follow-up|55|||
130927185|NCT01328431|471368214|FG001|1 Month (1M)|Lost to Follow-up|58|||
130927186|NCT01328431|471368213|FG000|3 Month (3M)|Death|2|||
130927187|NCT01328431|471368214|FG001|3 Month (3M)|Death|2|||
130927188|NCT01328431|471368213|FG000|3 Month (3M)|Lost to Follow-up|75|||
130927189|NCT01328431|471368214|FG001|3 Month (3M)|Lost to Follow-up|70|||
130927190|NCT01328431|471368213|FG000|12 Month (12M)|Death|2|||
130927191|NCT01328431|471368214|FG001|12 Month (12M)|Death|6|||
130927192|NCT01328431|471368213|FG000|12 Month (12M)|Lost to Follow-up|82|||
130927193|NCT01328431|471368214|FG001|12 Month (12M)|Lost to Follow-up|91|||
130927194|NCT02296320|471368221|FG000|Overall Study|Withdrawal by Subject|4|||
130927195|NCT02296320|471368222|FG001|Overall Study|Withdrawal by Subject|0|||
130927196|NCT02296320|471368223|FG002|Overall Study|Withdrawal by Subject|2|||
130927197|NCT02296320|471368221|FG000|Overall Study|Death|24|||
130927198|NCT02296320|471368222|FG001|Overall Study|Death|3|||
130702287|NCT05068284|470532846|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130702288|NCT05068284|470532847|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
130702289|NCT05068284|470532848|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130702290|NCT05068284|470532849|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130702291|NCT05068284|470532850|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130702292|NCT05068284|470532851|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130770120|NCT03539484|470784247|FG003|Overall Study|Study Terminated by Sponsor|1|||
130927199|NCT02296320|471368223|FG002|Overall Study|Death|27|||
130927200|NCT02296320|471368221|FG000|Overall Study|Lost to Follow-up|5|||
131223613|NCT01106352|472447063|FG002|Overall Study|Too ill to come in for the visit|1|||
131223614|NCT01106352|472447064|FG003|Overall Study|Too ill to come in for the visit|0|||
131223615|NCT01106352|472447065|FG004|Overall Study|Too ill to come in for the visit|0|||
131223616|NCT01106352|472447061|FG000|Overall Study|Lost to Follow-up|0|||
131223617|NCT01106352|472447062|FG001|Overall Study|Lost to Follow-up|0|||
131223618|NCT01106352|472447063|FG002|Overall Study|Lost to Follow-up|0|||
131223619|NCT01106352|472447064|FG003|Overall Study|Lost to Follow-up|0|||
131223620|NCT01106352|472447065|FG004|Overall Study|Lost to Follow-up|1|||
131223621|NCT01106352|472447061|FG000|Overall Study|Death|0|||
131223622|NCT01106352|472447062|FG001|Overall Study|Death|0|||
131223623|NCT01106352|472447063|FG002|Overall Study|Death|1|||
131223624|NCT01106352|472447064|FG003|Overall Study|Death|3|||
131223625|NCT01106352|472447065|FG004|Overall Study|Death|1|||
131223626|NCT01106352|472447061|FG000|Overall Study|Disease progression|0|||
131223627|NCT01106352|472447062|FG001|Overall Study|Disease progression|0|||
131223628|NCT01106352|472447063|FG002|Overall Study|Disease progression|0|||
131223629|NCT01106352|472447064|FG003|Overall Study|Disease progression|1|||
131223630|NCT01106352|472447065|FG004|Overall Study|Disease progression|0|||
131223631|NCT01106352|472447061|FG000|Overall Study|Withdrawal by Subject|0|||
131223632|NCT01106352|472447062|FG001|Overall Study|Withdrawal by Subject|0|||
131223633|NCT01106352|472447063|FG002|Overall Study|Withdrawal by Subject|0|||
131223634|NCT01106352|472447064|FG003|Overall Study|Withdrawal by Subject|3|||
131223635|NCT01106352|472447065|FG004|Overall Study|Withdrawal by Subject|2|||
131223636|NCT01106352|472447061|FG000|Overall Study|Went on hospice|0|||
131223637|NCT01106352|472447062|FG001|Overall Study|Went on hospice|0|||
131223638|NCT01106352|472447063|FG002|Overall Study|Went on hospice|0|||
131223639|NCT01106352|472447064|FG003|Overall Study|Went on hospice|1|||
131223640|NCT01106352|472447065|FG004|Overall Study|Went on hospice|0|||
131223641|NCT01106352|472447061|FG000|Overall Study|Subject entered hospice|0|||
131223642|NCT01106352|472447062|FG001|Overall Study|Subject entered hospice|0|||
131223643|NCT01106352|472447063|FG002|Overall Study|Subject entered hospice|0|||
131223644|NCT01106352|472447064|FG003|Overall Study|Subject entered hospice|1|||
131223645|NCT01106352|472447065|FG004|Overall Study|Subject entered hospice|0|||
131223646|NCT01106352|472447061|FG000|Overall Study|Home hospice since July 2013|0|||
131223647|NCT01106352|472447062|FG001|Overall Study|Home hospice since July 2013|0|||
131223648|NCT01106352|472447063|FG002|Overall Study|Home hospice since July 2013|0|||
131223649|NCT01106352|472447064|FG003|Overall Study|Home hospice since July 2013|1|||
131223650|NCT01106352|472447065|FG004|Overall Study|Home hospice since July 2013|0|||
131223651|NCT03944707|472447066|FG000|Overall Study|Adverse Event|0|||
131223652|NCT03944707|472447067|FG001|Overall Study|Adverse Event|2|||
131223653|NCT03944707|472447066|FG000|Overall Study|Study terminated by sponsor|12|||
131223654|NCT03944707|472447067|FG001|Overall Study|Study terminated by sponsor|7|||
131223655|NCT03944707|472447066|FG000|Overall Study|Subject decision|0|||
131223656|NCT03944707|472447067|FG001|Overall Study|Subject decision|1|||
131223657|NCT02444182|472447075|FG000|Overall Study|non-compliance|2|||
131223658|NCT02444182|472447076|FG001|Overall Study|non-compliance|1|||
131223659|NCT02444182|472447075|FG000|Overall Study|Lost to Follow-up|0|||
131223660|NCT02444182|472447076|FG001|Overall Study|Lost to Follow-up|4|||
131223661|NCT04126733|472447079|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
131223662|NCT04126733|472447079|FG000|Treatment Period|Adverse Event|8|||
131223663|NCT04126733|472447079|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
131223664|NCT04126733|472447079|FG000|Treatment Period|Physician Decision|5|||
131223665|NCT04126733|472447079|FG000|Treatment Period|Death|1|||
131223666|NCT04126733|472447079|FG000|Treatment Period|Other Reasons|2|||
131223667|NCT04126733|472447079|FG000|Active Follow-up Period|Death|13|||
131223668|NCT04126733|472447079|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
131223669|NCT04126733|472447079|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
131223670|NCT04126733|472447079|FG000|Active Follow-up Period|Other Reasons|1|||
131223671|NCT04126733|472447079|FG000|Long-term Follow-up Period|Death|22|||
131223672|NCT04126733|472447079|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
131223673|NCT04126733|472447079|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
130702293|NCT05068284|470532852|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130702294|NCT05068284|470532845|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
131223674|NCT02598193|472447081|FG000|Overall Study|Adverse Event|13|||
130702295|NCT05068284|470532846|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
131034691|NCT03447470|471761760|FG003|Overall Study|Treatment discontinued|6|||
131034692|NCT03447470|471761761|FG004|Overall Study|Treatment discontinued|2|||
131034693|NCT03447470|471761762|FG005|Overall Study|Treatment discontinued|1|||
131034694|NCT03447470|471761763|FG006|Overall Study|Treatment discontinued|2|||
131034695|NCT03447470|471761764|FG007|Overall Study|Treatment discontinued|4|||
131034696|NCT03447470|471761765|FG008|Overall Study|Treatment discontinued|3|||
131034697|NCT04624633|471761768|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
131034698|NCT04624633|471761769|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
131034699|NCT04624633|471761768|FG000|Overall Study|Death|1|||
131034700|NCT04624633|471761769|FG001|Overall Study|Death|0|||
131223675|NCT02598193|472447081|FG000|Overall Study|Withdrawal by Subject|1|||
130927201|NCT02296320|471368222|FG001|Overall Study|Lost to Follow-up|2|||
130927202|NCT02296320|471368223|FG002|Overall Study|Lost to Follow-up|7|||
130927203|NCT02296320|471368221|FG000|Overall Study|Not treated|2|||
130927204|NCT02296320|471368222|FG001|Overall Study|Not treated|0|||
130927205|NCT02296320|471368223|FG002|Overall Study|Not treated|0|||
130927206|NCT02296320|471368221|FG000|Overall Study|Not - specified|0|||
130927207|NCT02296320|471368222|FG001|Overall Study|Not - specified|0|||
130927208|NCT02296320|471368223|FG002|Overall Study|Not - specified|1|||
130927209|NCT03310021|471368227|FG000|Overall Study|Withdrawal by Subject|0|||
130927210|NCT03310021|471368228|FG001|Overall Study|Withdrawal by Subject|0|||
130927211|NCT03310021|471368229|FG002|Overall Study|Withdrawal by Subject|0|||
130927212|NCT03310021|471368230|FG003|Overall Study|Withdrawal by Subject|0|||
130927213|NCT03310021|471368231|FG004|Overall Study|Withdrawal by Subject|0|||
130927214|NCT03310021|471368232|FG005|Overall Study|Withdrawal by Subject|0|||
130927215|NCT03310021|471368233|FG006|Overall Study|Withdrawal by Subject|1|||
130927216|NCT03310021|471368234|FG007|Overall Study|Withdrawal by Subject|0|||
130927217|NCT03310021|471368235|FG008|Overall Study|Withdrawal by Subject|0|||
130927218|NCT03310021|471368236|FG009|Overall Study|Withdrawal by Subject|0|||
130927219|NCT03310021|471368237|FG010|Overall Study|Withdrawal by Subject|0|||
130927220|NCT03310021|471368238|FG011|Overall Study|Withdrawal by Subject|0|||
130927221|NCT03310021|471368239|FG012|Overall Study|Withdrawal by Subject|0|||
130927222|NCT03310021|471368240|FG013|Overall Study|Withdrawal by Subject|0|||
130927223|NCT03310021|471368241|FG014|Overall Study|Withdrawal by Subject|0|||
130927224|NCT03310021|471368242|FG015|Overall Study|Withdrawal by Subject|0|||
130927225|NCT03310021|471368243|FG016|Overall Study|Withdrawal by Subject|0|||
130927226|NCT03310021|471368244|FG017|Overall Study|Withdrawal by Subject|0|||
130927227|NCT03310021|471368245|FG018|Overall Study|Withdrawal by Subject|0|||
130927228|NCT03310021|471368246|FG019|Overall Study|Withdrawal by Subject|0|||
130927229|NCT03310021|471368227|FG000|Overall Study|Lost to Follow-up|0|||
130927230|NCT03310021|471368228|FG001|Overall Study|Lost to Follow-up|0|||
130927231|NCT03310021|471368229|FG002|Overall Study|Lost to Follow-up|0|||
130927232|NCT03310021|471368230|FG003|Overall Study|Lost to Follow-up|0|||
130927233|NCT03310021|471368231|FG004|Overall Study|Lost to Follow-up|0|||
130927234|NCT03310021|471368232|FG005|Overall Study|Lost to Follow-up|0|||
130927235|NCT03310021|471368233|FG006|Overall Study|Lost to Follow-up|0|||
130927236|NCT03310021|471368234|FG007|Overall Study|Lost to Follow-up|0|||
130927237|NCT03310021|471368235|FG008|Overall Study|Lost to Follow-up|0|||
130927238|NCT03310021|471368236|FG009|Overall Study|Lost to Follow-up|0|||
130927239|NCT03310021|471368237|FG010|Overall Study|Lost to Follow-up|1|||
130927240|NCT03310021|471368238|FG011|Overall Study|Lost to Follow-up|0|||
130927241|NCT03310021|471368239|FG012|Overall Study|Lost to Follow-up|0|||
130927242|NCT03310021|471368240|FG013|Overall Study|Lost to Follow-up|0|||
130927243|NCT03310021|471368241|FG014|Overall Study|Lost to Follow-up|0|||
130927244|NCT03310021|471368242|FG015|Overall Study|Lost to Follow-up|0|||
130927245|NCT03310021|471368243|FG016|Overall Study|Lost to Follow-up|0|||
130927246|NCT03310021|471368244|FG017|Overall Study|Lost to Follow-up|0|||
130927247|NCT03310021|471368245|FG018|Overall Study|Lost to Follow-up|0|||
130927248|NCT03310021|471368246|FG019|Overall Study|Lost to Follow-up|0|||
130927249|NCT03322631|471368252|FG000|Overall Study|Withdrawal by Subject|0|||
130927250|NCT03322631|471368253|FG001|Overall Study|Withdrawal by Subject|1|||
130927251|NCT03322631|471368254|FG002|Overall Study|Withdrawal by Subject|0|||
130927252|NCT03322631|471368255|FG003|Overall Study|Withdrawal by Subject|0|||
130927253|NCT03322631|471368252|FG000|Overall Study|Adverse Event|0|||
130927254|NCT03322631|471368253|FG001|Overall Study|Adverse Event|0|||
130927255|NCT03322631|471368254|FG002|Overall Study|Adverse Event|1|||
130927256|NCT03322631|471368255|FG003|Overall Study|Adverse Event|0|||
130927257|NCT02378961|471368256|FG000|Overall Study|Lack of Efficacy|4|||
130927258|NCT02378961|471368257|FG001|Overall Study|Lack of Efficacy|2|||
130927259|NCT02378961|471368258|FG002|Overall Study|Lack of Efficacy|0|||
130927260|NCT02378961|471368259|FG003|Overall Study|Lack of Efficacy|1|||
130927261|NCT02378961|471368256|FG000|Overall Study|Death|0|||
130702296|NCT05068284|470532847|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
130927262|NCT02378961|471368257|FG001|Overall Study|Death|0|||
130927263|NCT02378961|471368258|FG002|Overall Study|Death|1|||
130927264|NCT02378961|471368259|FG003|Overall Study|Death|0|||
130927265|NCT01217801|471368260|FG000|Period 1|Protocol Violation|1|||
130927266|NCT01217801|471368261|FG001|Period 1|Protocol Violation|1|||
130927267|NCT01217801|471368260|FG000|Period 1|Withdrawal by Subject|0|||
130702297|NCT05068284|470532848|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
130702298|NCT05068284|470532849|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
130927268|NCT01217801|471368261|FG001|Period 1|Withdrawal by Subject|1|||
130927269|NCT04967443|471368264|FG000|Open Label Treatment|Death|1|||
130927270|NCT04967443|471368265|FG001|Open Label Treatment|Death|0|||
130702299|NCT05068284|470532850|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
130927271|NCT04967443|471368266|FG002|Open Label Treatment|Death|0|||
130927272|NCT04967443|471368267|FG003|Open Label Treatment|Death|0|||
130927273|NCT04967443|471368268|FG004|Open Label Treatment|Death|0|||
130927274|NCT04967443|471368269|FG005|Open Label Treatment|Death|0|||
130927275|NCT04967443|471368270|FG006|Open Label Treatment|Death|0|||
130702300|NCT05068284|470532851|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
130702301|NCT05068284|470532852|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
130702302|NCT05068284|470532845|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130702303|NCT05068284|470532846|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130702304|NCT05068284|470532847|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
130702305|NCT05068284|470532848|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130702306|NCT05068284|470532849|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
130702307|NCT05068284|470532850|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130702308|NCT05068284|470532851|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130702309|NCT05068284|470532852|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130927276|NCT04967443|471368271|FG007|Open Label Treatment|Death|0|||
130927277|NCT04967443|471368264|FG000|Open Label Treatment|Lost to Follow-up|0|||
130702310|NCT05068284|470532845|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130702311|NCT05068284|470532846|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130702312|NCT05068284|470532847|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130927278|NCT04967443|471368265|FG001|Open Label Treatment|Lost to Follow-up|0|||
130927279|NCT04967443|471368266|FG002|Open Label Treatment|Lost to Follow-up|1|||
130927280|NCT04967443|471368267|FG003|Open Label Treatment|Lost to Follow-up|0|||
130927281|NCT04967443|471368268|FG004|Open Label Treatment|Lost to Follow-up|0|||
130927282|NCT04967443|471368269|FG005|Open Label Treatment|Lost to Follow-up|0|||
130927283|NCT04967443|471368270|FG006|Open Label Treatment|Lost to Follow-up|0|||
130927284|NCT04967443|471368271|FG007|Open Label Treatment|Lost to Follow-up|0|||
130927285|NCT04967443|471368264|FG000|Open Label Treatment|Withdrawal by Subject|0|||
130927286|NCT04967443|471368265|FG001|Open Label Treatment|Withdrawal by Subject|1|||
131223676|NCT02598193|472447081|FG000|Overall Study|Listed in active lung transplant list|1|||
131223677|NCT02598193|472447081|FG000|Overall Study|Does not want to take Nintedanib|1|||
131223678|NCT02487979|472447084|FG000|Overall Study|Physician Decision|2|||
131223679|NCT02487979|472447084|FG000|Overall Study|Withdrawal by Subject|2|||
131223680|NCT02487979|472447084|FG000|Overall Study|Progressive Disease|17|||
131223681|NCT00447694|472447085|FG000|Overall Study|Adverse Event|2|||
131223682|NCT00447694|472447085|FG000|Overall Study|Abnormal laboratory value|1|||
131223683|NCT00447694|472447085|FG000|Overall Study|Abnormal test procedure result|1|||
131223684|NCT00447694|472447085|FG000|Overall Study|Withdrawal by Subject|2|||
131223685|NCT02354976|472447092|FG000|Overall Study|Other - reason not specified|1|||
131223686|NCT02354976|472447093|FG001|Overall Study|Other - reason not specified|0|||
131223687|NCT02354976|472447094|FG002|Overall Study|Other - reason not specified|1|||
131223688|NCT02354976|472447092|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
131223689|NCT02354976|472447093|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
131223690|NCT02354976|472447094|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
131223691|NCT02354976|472447092|FG000|Overall Study|Adverse Event|1|||
131223692|NCT02354976|472447093|FG001|Overall Study|Adverse Event|0|||
131223693|NCT02354976|472447094|FG002|Overall Study|Adverse Event|2|||
131223694|NCT00986154|472447095|FG000|Overall Study|Death|136|||
131223695|NCT00986154|472447096|FG001|Overall Study|Death|127|||
131223696|NCT00986154|472447095|FG000|Overall Study|Lost to Follow-up|7|||
131223697|NCT00986154|472447096|FG001|Overall Study|Lost to Follow-up|4|||
131223698|NCT00986154|472447095|FG000|Overall Study|Withdrawal by Subject|32|||
131223699|NCT00986154|472447096|FG001|Overall Study|Withdrawal by Subject|33|||
131223700|NCT00986154|472447095|FG000|Overall Study|investigator/subject decide not continue|6|||
131223701|NCT00986154|472447096|FG001|Overall Study|investigator/subject decide not continue|3|||
131223702|NCT00986154|472447095|FG000|Overall Study|never received study drug|25|||
131223703|NCT00986154|472447096|FG001|Overall Study|never received study drug|27|||
131223704|NCT03726437|472447097|FG000|Overall Study|Lost to Follow-up|85|||
131223705|NCT03726437|472447098|FG001|Overall Study|Lost to Follow-up|76|||
131223706|NCT00068445|472447100|FG000|Randomization|Cancel|1|||
130702313|NCT05068284|470532848|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
130702314|NCT05068284|470532849|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130702315|NCT05068284|470532850|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130702316|NCT05068284|470532851|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130927287|NCT04967443|471368266|FG002|Open Label Treatment|Withdrawal by Subject|0|||
131223707|NCT00068445|472447101|FG001|Randomization|Cancel|3|||
130927288|NCT04967443|471368267|FG003|Open Label Treatment|Withdrawal by Subject|1|||
130927289|NCT04967443|471368268|FG004|Open Label Treatment|Withdrawal by Subject|0|||
130927290|NCT04967443|471368269|FG005|Open Label Treatment|Withdrawal by Subject|1|||
131223708|NCT00068445|472447100|FG000|Randomization|Ineligible|1|||
131223709|NCT00068445|472447101|FG001|Randomization|Ineligible|1|||
131223710|NCT00068445|472447100|FG000|Treatment|Refused Further Treatment|13|||
131223711|NCT00068445|472447101|FG001|Treatment|Refused Further Treatment|10|||
130927291|NCT04967443|471368270|FG006|Open Label Treatment|Withdrawal by Subject|2|||
130927292|NCT04967443|471368271|FG007|Open Label Treatment|Withdrawal by Subject|3|||
130927293|NCT04967443|471368264|FG000|Follow-Up|Death|1|||
130927294|NCT04967443|471368265|FG001|Follow-Up|Death|0|||
131223712|NCT00068445|472447100|FG000|Treatment|Adverse Event|7|||
130927295|NCT04967443|471368266|FG002|Follow-Up|Death|0|||
130927296|NCT04967443|471368267|FG003|Follow-Up|Death|0|||
130927297|NCT04967443|471368268|FG004|Follow-Up|Death|0|||
130927298|NCT04967443|471368269|FG005|Follow-Up|Death|0|||
130927299|NCT04967443|471368270|FG006|Follow-Up|Death|0|||
130927300|NCT04967443|471368271|FG007|Follow-Up|Death|0|||
130927301|NCT04967443|471368264|FG000|Follow-Up|Lost to Follow-up|0|||
130927302|NCT04967443|471368265|FG001|Follow-Up|Lost to Follow-up|0|||
130927303|NCT04967443|471368266|FG002|Follow-Up|Lost to Follow-up|1|||
130927304|NCT04967443|471368267|FG003|Follow-Up|Lost to Follow-up|1|||
130927305|NCT04967443|471368268|FG004|Follow-Up|Lost to Follow-up|0|||
130927306|NCT04967443|471368269|FG005|Follow-Up|Lost to Follow-up|0|||
130927307|NCT04967443|471368270|FG006|Follow-Up|Lost to Follow-up|0|||
130927308|NCT04967443|471368271|FG007|Follow-Up|Lost to Follow-up|0|||
130927309|NCT04967443|471368264|FG000|Follow-Up|Withdrawal by Subject|0|||
130927310|NCT04967443|471368265|FG001|Follow-Up|Withdrawal by Subject|1|||
130927311|NCT04967443|471368266|FG002|Follow-Up|Withdrawal by Subject|0|||
130927312|NCT04967443|471368267|FG003|Follow-Up|Withdrawal by Subject|1|||
130927313|NCT04967443|471368268|FG004|Follow-Up|Withdrawal by Subject|0|||
130927314|NCT04967443|471368269|FG005|Follow-Up|Withdrawal by Subject|1|||
130927315|NCT04967443|471368270|FG006|Follow-Up|Withdrawal by Subject|2|||
130927316|NCT04967443|471368271|FG007|Follow-Up|Withdrawal by Subject|3|||
130927317|NCT02405780|471368273|FG000|Period I|Adverse Event|8|||
130927318|NCT02405780|471368274|FG001|Period I|Adverse Event|0|||
130927319|NCT02405780|471368275|FG002|Period I|Adverse Event|3|||
130927320|NCT02405780|471368276|FG003|Period I|Adverse Event|7|||
130927321|NCT02405780|471368273|FG000|Period I|Medical reasons|1|||
130927322|NCT02405780|471368274|FG001|Period I|Medical reasons|1|||
130927323|NCT02405780|471368275|FG002|Period I|Medical reasons|0|||
130927324|NCT02405780|471368276|FG003|Period I|Medical reasons|1|||
130927325|NCT02405780|471368273|FG000|Period I|Screening Failure|1|||
130927326|NCT02405780|471368274|FG001|Period I|Screening Failure|0|||
130927327|NCT02405780|471368275|FG002|Period I|Screening Failure|1|||
130927328|NCT02405780|471368276|FG003|Period I|Screening Failure|0|||
130927329|NCT02405780|471368273|FG000|Period I|Withdrawal by Subject|9|||
130927330|NCT02405780|471368274|FG001|Period I|Withdrawal by Subject|1|||
130927331|NCT02405780|471368275|FG002|Period I|Withdrawal by Subject|3|||
130927332|NCT02405780|471368276|FG003|Period I|Withdrawal by Subject|4|||
130927333|NCT02405780|471368273|FG000|Period I|Non-compliance with study procedures|8|||
130927334|NCT02405780|471368274|FG001|Period I|Non-compliance with study procedures|6|||
130927335|NCT02405780|471368275|FG002|Period I|Non-compliance with study procedures|8|||
130927336|NCT02405780|471368276|FG003|Period I|Non-compliance with study procedures|11|||
130927337|NCT02405780|471368273|FG000|Period II|Adverse Event|3|||
130927338|NCT02405780|471368274|FG001|Period II|Adverse Event|5|||
130927339|NCT02405780|471368275|FG002|Period II|Adverse Event|4|||
130927340|NCT02405780|471368276|FG003|Period II|Adverse Event|11|||
130927341|NCT02405780|471368273|FG000|Period II|Medical reason|0|||
130927342|NCT02405780|471368274|FG001|Period II|Medical reason|1|||
130927343|NCT02405780|471368275|FG002|Period II|Medical reason|0|||
130927344|NCT02405780|471368276|FG003|Period II|Medical reason|0|||
130927345|NCT02405780|471368273|FG000|Period II|Pregnancy|0|||
130927346|NCT02405780|471368274|FG001|Period II|Pregnancy|0|||
130927347|NCT02405780|471368275|FG002|Period II|Pregnancy|1|||
130927348|NCT02405780|471368276|FG003|Period II|Pregnancy|0|||
130927349|NCT02405780|471368273|FG000|Period II|Withdrawal by Subject|7|||
130927350|NCT02405780|471368274|FG001|Period II|Withdrawal by Subject|4|||
130927351|NCT02405780|471368275|FG002|Period II|Withdrawal by Subject|0|||
130927352|NCT02405780|471368276|FG003|Period II|Withdrawal by Subject|3|||
130927353|NCT02405780|471368273|FG000|Period II|Non-compliance with study procedures|5|||
130927354|NCT02405780|471368274|FG001|Period II|Non-compliance with study procedures|2|||
130927355|NCT02405780|471368275|FG002|Period II|Non-compliance with study procedures|7|||
130927356|NCT02405780|471368276|FG003|Period II|Non-compliance with study procedures|4|||
130927357|NCT01654536|471368277|FG000|Overall Study|Lost to Follow-up|5|||
130927358|NCT01654536|471368278|FG001|Overall Study|Lost to Follow-up|5|||
130927359|NCT01654536|471368277|FG000|Overall Study|Physician Decision|12|||
130927360|NCT01654536|471368278|FG001|Overall Study|Physician Decision|8|||
130927361|NCT01654536|471368277|FG000|Overall Study|Withdrawal by Subject|27|||
130927362|NCT01654536|471368278|FG001|Overall Study|Withdrawal by Subject|25|||
130927363|NCT04502693|471368281|FG000|Overall Study|Adverse Event|7|||
130927364|NCT04502693|471368282|FG001|Overall Study|Adverse Event|6|||
130927365|NCT04502693|471368283|FG002|Overall Study|Adverse Event|11|||
130927366|NCT04502693|471368284|FG003|Overall Study|Adverse Event|1|||
130927367|NCT04502693|471368281|FG000|Overall Study|Lost to Follow-up|32|||
130927368|NCT04502693|471368282|FG001|Overall Study|Lost to Follow-up|36|||
130927369|NCT04502693|471368283|FG002|Overall Study|Lost to Follow-up|69|||
130927370|NCT04502693|471368284|FG003|Overall Study|Lost to Follow-up|4|||
130927371|NCT04502693|471368281|FG000|Overall Study|Protocol Violation|8|||
130927372|NCT04502693|471368282|FG001|Overall Study|Protocol Violation|8|||
130927373|NCT04502693|471368283|FG002|Overall Study|Protocol Violation|16|||
130927374|NCT04502693|471368284|FG003|Overall Study|Protocol Violation|1|||
130927375|NCT04502693|471368281|FG000|Overall Study|Withdrawal by Subject|46|||
130927376|NCT04502693|471368282|FG001|Overall Study|Withdrawal by Subject|38|||
130702317|NCT05068284|470532852|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130702318|NCT05068284|470532845|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702319|NCT05068284|470532846|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702320|NCT05068284|470532847|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
130927377|NCT04502693|471368283|FG002|Overall Study|Withdrawal by Subject|54|||
130927378|NCT04502693|471368284|FG003|Overall Study|Withdrawal by Subject|7|||
130927379|NCT04502693|471368281|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
130927380|NCT04502693|471368282|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
130927381|NCT04502693|471368283|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
130927382|NCT04502693|471368284|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130927383|NCT04502693|471368281|FG000|Overall Study|Other|1|||
130927384|NCT04502693|471368282|FG001|Overall Study|Other|0|||
130927385|NCT04502693|471368283|FG002|Overall Study|Other|1|||
130927386|NCT04502693|471368284|FG003|Overall Study|Other|1|||
130927387|NCT00602797|471368286|FG000|Overall Study|Adverse Event|1|||
130927388|NCT03943147|471368289|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
130927389|NCT03943147|471368290|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
130927390|NCT03943147|471368289|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
130927391|NCT03943147|471368290|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
130927392|NCT03943147|471368289|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
130927393|NCT03943147|471368290|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
130927394|NCT03943147|471368289|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
130927395|NCT03943147|471368290|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
130927396|NCT03943147|471368289|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
130927397|NCT03943147|471368290|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
130927398|NCT03943147|471368289|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
130927399|NCT03943147|471368290|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
130927400|NCT03736447|471368291|FG000|Overall Study|Adverse Event|5|||
130927401|NCT03736447|471368292|FG001|Overall Study|Adverse Event|1|||
130927402|NCT03736447|471368291|FG000|Overall Study|Withdrawal by Subject|5|||
130927403|NCT03736447|471368292|FG001|Overall Study|Withdrawal by Subject|1|||
130927404|NCT03736447|471368291|FG000|Overall Study|Lost to Follow-up|1|||
130927405|NCT03736447|471368292|FG001|Overall Study|Lost to Follow-up|0|||
130927406|NCT03736447|471368291|FG000|Overall Study|Physician Decision|1|||
130927407|NCT03736447|471368292|FG001|Overall Study|Physician Decision|0|||
130927408|NCT03736447|471368291|FG000|Overall Study|Continued commitment to study treatment|3|||
130927409|NCT03736447|471368292|FG001|Overall Study|Continued commitment to study treatment|0|||
130927410|NCT03736447|471368291|FG000|Overall Study|Taste aversion to study product|0|||
130927411|NCT03736447|471368292|FG001|Overall Study|Taste aversion to study product|1|||
130927412|NCT02619175|471368293|FG000|Overall Study|Withdrawal by Subject|1|||
130927413|NCT02619175|471368294|FG001|Overall Study|Withdrawal by Subject|0|||
130927414|NCT02619175|471368293|FG000|Overall Study|foot pain|1|||
130927415|NCT02619175|471368294|FG001|Overall Study|foot pain|0|||
130927416|NCT02657369|471368295|FG000|Overall Study|Death|27|||
130927417|NCT02657369|471368295|FG000|Overall Study|Study terminated by sponsor|7|||
130927418|NCT01594762|471368296|FG000|Overall Study|Withdrawal by Subject|1|||
130927419|NCT01594762|471368297|FG001|Overall Study|Withdrawal by Subject|0|||
130927420|NCT01594762|471368296|FG000|Overall Study|Lost to Follow-up|10|||
130927421|NCT01594762|471368297|FG001|Overall Study|Lost to Follow-up|10|||
130927422|NCT03547583|471368298|FG000|Overall Study|Adverse Event|16|||
130927423|NCT03547583|471368299|FG001|Overall Study|Adverse Event|11|||
130927424|NCT03547583|471368300|FG002|Overall Study|Adverse Event|10|||
130927425|NCT03547583|471368298|FG000|Overall Study|Death|11|||
130927426|NCT03547583|471368299|FG001|Overall Study|Death|7|||
130927427|NCT03547583|471368300|FG002|Overall Study|Death|4|||
130927428|NCT03547583|471368298|FG000|Overall Study|Lost to Follow-up|1|||
130927429|NCT03547583|471368299|FG001|Overall Study|Lost to Follow-up|0|||
130927430|NCT03547583|471368300|FG002|Overall Study|Lost to Follow-up|0|||
130927431|NCT03547583|471368298|FG000|Overall Study|Non-compliance with study drug|0|||
130927432|NCT03547583|471368299|FG001|Overall Study|Non-compliance with study drug|0|||
130927433|NCT03547583|471368300|FG002|Overall Study|Non-compliance with study drug|1|||
130927434|NCT03547583|471368298|FG000|Overall Study|Physician Decision|1|||
130927435|NCT03547583|471368299|FG001|Overall Study|Physician Decision|0|||
130927436|NCT03547583|471368300|FG002|Overall Study|Physician Decision|3|||
130927437|NCT03547583|471368298|FG000|Overall Study|Protocol Violation|2|||
130927438|NCT03547583|471368299|FG001|Overall Study|Protocol Violation|1|||
130927439|NCT03547583|471368300|FG002|Overall Study|Protocol Violation|1|||
130927440|NCT03547583|471368298|FG000|Overall Study|Withdrawal by Subject|12|||
130927441|NCT03547583|471368299|FG001|Overall Study|Withdrawal by Subject|19|||
130927442|NCT03547583|471368300|FG002|Overall Study|Withdrawal by Subject|10|||
130927443|NCT03547583|471368298|FG000|Overall Study|Other|2|||
130927444|NCT03547583|471368299|FG001|Overall Study|Other|2|||
130927445|NCT03547583|471368300|FG002|Overall Study|Other|3|||
130927446|NCT00382252|471368301|FG000|Overall Study|Death|4|||
130927447|NCT00382252|471368301|FG000|Overall Study|Protocol Violation|8|||
130702321|NCT05068284|470532848|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
130702322|NCT05068284|470532849|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702323|NCT05068284|470532850|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702324|NCT05068284|470532851|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702325|NCT05068284|470532852|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130702326|NCT05068284|470532845|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702327|NCT05068284|470532846|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702328|NCT05068284|470532847|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
130702329|NCT05068284|470532848|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702330|NCT05068284|470532849|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702331|NCT05068284|470532850|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702332|NCT05068284|470532851|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702333|NCT05068284|470532852|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130702334|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
130702335|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130927448|NCT00382252|471368301|FG000|Overall Study|Not treated by RFA|1|||
130927449|NCT04518306|471368309|FG000|Double-Blind Period|Run in failure|0|||
130927450|NCT04518306|471368310|FG001|Double-Blind Period|Run in failure|0|||
130927451|NCT04518306|471368311|FG002|Double-Blind Period|Run in failure|1|||
130927452|NCT04518306|471368309|FG000|Double-Blind Period|Adverse Event|0|||
130927453|NCT04518306|471368310|FG001|Double-Blind Period|Adverse Event|2|||
130927454|NCT04518306|471368311|FG002|Double-Blind Period|Adverse Event|2|||
130927455|NCT04518306|471368309|FG000|Double-Blind Period|Lost to Follow-up|1|||
130927456|NCT04518306|471368310|FG001|Double-Blind Period|Lost to Follow-up|2|||
130927457|NCT04518306|471368311|FG002|Double-Blind Period|Lost to Follow-up|2|||
130927458|NCT04518306|471368309|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
130927459|NCT04518306|471368310|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
130927460|NCT04518306|471368311|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
130927461|NCT04518306|471368309|FG000|Double-Blind Period|Other|0|||
130927462|NCT04518306|471368310|FG001|Double-Blind Period|Other|2|||
130927463|NCT04518306|471368311|FG002|Double-Blind Period|Other|0|||
130927464|NCT04518306|471368309|FG000|Double-Blind Period|Missing|0|||
130927465|NCT04518306|471368310|FG001|Double-Blind Period|Missing|1|||
130927466|NCT04518306|471368311|FG002|Double-Blind Period|Missing|0|||
130927467|NCT02801331|471368312|FG000|Overall Study|Transferred to another hospital|8|||
130927468|NCT02801331|471368313|FG001|Overall Study|Transferred to another hospital|7|||
130927469|NCT02801331|471368312|FG000|Overall Study|Withdrawal by Subject|0|||
130927470|NCT02801331|471368313|FG001|Overall Study|Withdrawal by Subject|4|||
130927471|NCT02801331|471368312|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
130927472|NCT02801331|471368313|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
130927473|NCT04698187|471368320|FG000|Overall Study|Withdrawal by Subject|7|||
130927474|NCT04698187|471368320|FG000|Overall Study|Death|21|||
130927475|NCT04698187|471368320|FG000|Overall Study|Sponsor Decision|15|||
130927476|NCT04698187|471368320|FG000|Overall Study|In-transit Disease|1|||
130927477|NCT03904043|471368321|FG000|Overall Study|Adverse Event|1|||
130927478|NCT03904043|471368322|FG001|Overall Study|Adverse Event|1|||
130927479|NCT03904043|471368321|FG000|Overall Study|Withdrawal by Subject|1|||
130927480|NCT03904043|471368322|FG001|Overall Study|Withdrawal by Subject|0|||
130927481|NCT03904043|471368321|FG000|Overall Study|Non-compliance|1|||
130927482|NCT03904043|471368322|FG001|Overall Study|Non-compliance|0|||
130927483|NCT03904043|471368321|FG000|Overall Study|Did not start treatment|1|||
130927484|NCT03904043|471368322|FG001|Overall Study|Did not start treatment|0|||
130927485|NCT00907777|471369969|FG000|Overall Study|Withdrawal by Subject|0|||
130927486|NCT00907777|471369970|FG001|Overall Study|Withdrawal by Subject|1|||
130927487|NCT01473836|471369971|FG000|Overall Study|Adverse Event|4|||
130927488|NCT01473836|471369971|FG000|Overall Study|Lack of Efficacy|1|||
130927489|NCT01473836|471369971|FG000|Overall Study|Does not meet entrance criteria|1|||
130927490|NCT03291808|471369972|FG000|Overall Study|Lost to Follow-up|6|||
130927491|NCT03291808|471369972|FG000|Overall Study|Research burden|4|||
130927492|NCT03364023|471369973|FG000|Overall Study|Lost to Follow-up|3|||
130927493|NCT03364023|471369973|FG000|Overall Study|Death|14|||
130927494|NCT01892293|471369982|FG000|Overall Study|Apheresed but not treated|4|||
130927495|NCT03602482|471369983|FG000|Overall Study|Withdrawal by Subject|6|||
130927496|NCT03602482|471369984|FG001|Overall Study|Withdrawal by Subject|7|||
130927497|NCT03602482|471369985|FG002|Overall Study|Withdrawal by Subject|0|||
130927498|NCT03602482|471369986|FG003|Overall Study|Withdrawal by Subject|0|||
130927499|NCT00105469|471369989|FG000|Overall Study|Adverse Event|9|||
130927500|NCT00105469|471369990|FG001|Overall Study|Adverse Event|8|||
130927501|NCT00105469|471369989|FG000|Overall Study|Protocol Violation|4|||
130927502|NCT00105469|471369990|FG001|Overall Study|Protocol Violation|0|||
130927503|NCT00105469|471369989|FG000|Overall Study|Withdrawal by Subject|2|||
130927504|NCT00105469|471369990|FG001|Overall Study|Withdrawal by Subject|3|||
130927505|NCT00105469|471369989|FG000|Overall Study|Lost to Follow-up|1|||
130927506|NCT00105469|471369990|FG001|Overall Study|Lost to Follow-up|0|||
130927507|NCT00105469|471369989|FG000|Overall Study|Lack of Efficacy|2|||
130702336|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702337|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702338|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702339|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702340|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702341|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130702342|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
130927508|NCT00105469|471369990|FG001|Overall Study|Lack of Efficacy|0|||
130927509|NCT00105469|471369989|FG000|Overall Study|Other Reason|4|||
130927510|NCT00105469|471369990|FG001|Overall Study|Other Reason|0|||
130927511|NCT00599924|471369992|FG000|Overall Study|Lack of Efficacy|3|||
130927512|NCT00599924|471369993|FG001|Overall Study|Lack of Efficacy|5|||
130927513|NCT00599924|471369994|FG002|Overall Study|Lack of Efficacy|1|||
130927514|NCT00599924|471369995|FG003|Overall Study|Lack of Efficacy|2|||
130927515|NCT00599924|471369996|FG004|Overall Study|Lack of Efficacy|3|||
130927516|NCT00599924|471369997|FG005|Overall Study|Lack of Efficacy|2|||
130927517|NCT00599924|471369998|FG006|Overall Study|Lack of Efficacy|0|||
130927518|NCT00599924|471369992|FG000|Overall Study|Adverse Event|0|||
130927519|NCT00599924|471369993|FG001|Overall Study|Adverse Event|0|||
130927520|NCT00599924|471369994|FG002|Overall Study|Adverse Event|0|||
130927521|NCT00599924|471369995|FG003|Overall Study|Adverse Event|2|||
130927522|NCT00599924|471369996|FG004|Overall Study|Adverse Event|0|||
130927523|NCT00599924|471369997|FG005|Overall Study|Adverse Event|0|||
130927524|NCT00599924|471369998|FG006|Overall Study|Adverse Event|2|||
130927525|NCT00599924|471369992|FG000|Overall Study|Death|0|||
130927526|NCT00599924|471369993|FG001|Overall Study|Death|0|||
130927527|NCT00599924|471369994|FG002|Overall Study|Death|0|||
130927528|NCT00599924|471369995|FG003|Overall Study|Death|2|||
130927529|NCT00599924|471369996|FG004|Overall Study|Death|0|||
130927530|NCT00599924|471369997|FG005|Overall Study|Death|2|||
130927531|NCT00599924|471369998|FG006|Overall Study|Death|1|||
130927532|NCT00599924|471369992|FG000|Overall Study|Protocol Violation|0|||
130927533|NCT00599924|471369993|FG001|Overall Study|Protocol Violation|0|||
130927534|NCT00599924|471369994|FG002|Overall Study|Protocol Violation|0|||
130927535|NCT00599924|471369995|FG003|Overall Study|Protocol Violation|1|||
130927536|NCT00599924|471369996|FG004|Overall Study|Protocol Violation|0|||
130927537|NCT00599924|471369997|FG005|Overall Study|Protocol Violation|0|||
130927538|NCT00599924|471369998|FG006|Overall Study|Protocol Violation|0|||
130927539|NCT00599924|471369992|FG000|Overall Study|Withdrawal by Subject|0|||
130927540|NCT00599924|471369993|FG001|Overall Study|Withdrawal by Subject|0|||
130927541|NCT00599924|471369994|FG002|Overall Study|Withdrawal by Subject|1|||
130927542|NCT00599924|471369995|FG003|Overall Study|Withdrawal by Subject|0|||
130927543|NCT00599924|471369996|FG004|Overall Study|Withdrawal by Subject|1|||
131034701|NCT04316871|471761770|FG000|Overall Study|Protocol Violation|2|||
131034702|NCT04316871|471761771|FG001|Overall Study|Protocol Violation|2|||
131034703|NCT04316871|471761772|FG002|Overall Study|Protocol Violation|2|||
131034704|NCT04316871|471761773|FG003|Overall Study|Protocol Violation|2|||
131034705|NCT05087992|471761774|FG000|Overall Study|Adverse Event|0|||
131034706|NCT05087992|471761775|FG001|Overall Study|Adverse Event|1|||
131034707|NCT05087992|471761776|FG002|Overall Study|Adverse Event|0|||
131034708|NCT05087992|471761774|FG000|Overall Study|Withdrawal by Subject|2|||
131034709|NCT05087992|471761775|FG001|Overall Study|Withdrawal by Subject|0|||
131034710|NCT05087992|471761776|FG002|Overall Study|Withdrawal by Subject|0|||
131034711|NCT05087992|471761774|FG000|Overall Study|clinical disease progression|3|||
131034712|NCT05087992|471761775|FG001|Overall Study|clinical disease progression|1|||
130720851|NCT04126213|470601548|FG003|Overall Study|Withdrawal by Subject|1|||
130927544|NCT00599924|471369997|FG005|Overall Study|Withdrawal by Subject|0|||
131034713|NCT05087992|471761776|FG002|Overall Study|clinical disease progression|0|||
131034714|NCT05087992|471761774|FG000|Overall Study|objective disease progression|4|||
131034715|NCT05087992|471761775|FG001|Overall Study|objective disease progression|1|||
131034716|NCT05087992|471761776|FG002|Overall Study|objective disease progression|0|||
130927545|NCT00599924|471369998|FG006|Overall Study|Withdrawal by Subject|0|||
130927546|NCT00599924|471369992|FG000|Overall Study|Other|0|||
130927547|NCT00599924|471369993|FG001|Overall Study|Other|0|||
130927548|NCT00599924|471369994|FG002|Overall Study|Other|0|||
130927549|NCT00599924|471369995|FG003|Overall Study|Other|1|||
131034717|NCT01842542|471761777|FG000|Overall Study|Withdrawal by Subject|2|||
131034718|NCT01842542|471761777|FG000|Overall Study|Lack of Efficacy|1|||
131034719|NCT01842542|471761777|FG000|Overall Study|Protocol Non-compliance|2|||
130927550|NCT00599924|471369996|FG004|Overall Study|Other|2|||
130927551|NCT00599924|471369997|FG005|Overall Study|Other|0|||
130927552|NCT00599924|471369998|FG006|Overall Study|Other|2|||
130927553|NCT01806298|471369999|FG000|Overall Study|Adverse Event|3|||
131034720|NCT01842542|471761777|FG000|Overall Study|Lost to Follow-up|1|||
130927554|NCT01806298|471369999|FG000|Overall Study|Protocol Non-compliance|1|||
130927555|NCT01806298|471369999|FG000|Overall Study|Withdrawal by Subject|1|||
130927556|NCT01806298|471369999|FG000|Overall Study|Other|5|||
130927557|NCT02601469|471370000|FG000|Overall Study|Enrolled in Error|1|||
130927558|NCT02601469|471370001|FG001|Overall Study|Enrolled in Error|0|||
130927559|NCT03808545|471370002|FG000|Overall Study|Withdrawal by Subject|1|||
130927560|NCT03808545|471370003|FG001|Overall Study|Withdrawal by Subject|1|||
130702343|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130702344|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130702345|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130702346|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130702347|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
130702348|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
130702349|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130702350|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
130702351|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702352|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702353|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702354|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702355|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702356|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
130702357|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130702358|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
130702359|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702360|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702361|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702362|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702363|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702364|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702365|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130702366|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
130702367|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130702368|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130927561|NCT04980040|471370008|FG000|Overall Study|Violated the Inclusion Criteria|260|||
130927562|NCT04980040|471370008|FG000|Overall Study|Violated the Administration & Dosage|225|||
130927563|NCT04980040|471370008|FG000|Overall Study|Lost to Safety-Follow-up|4|||
130927564|NCT04980040|471370008|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
130927565|NCT01396148|471370021|FG000|Overall Study|Patient Decision|1|||
130927566|NCT02732119|471370024|FG000|Phase I|Adverse Event|1|||
130927567|NCT02732119|471370025|FG001|Phase I|Adverse Event|3|||
130927568|NCT02732119|471370026|FG002|Phase I|Adverse Event|1|||
130927569|NCT02732119|471370027|FG003|Phase I|Adverse Event|0|||
130927570|NCT02732119|471370028|FG004|Phase I|Adverse Event|0|||
130927571|NCT02732119|471370024|FG000|Phase I|Progressive disease|7|||
130927572|NCT02732119|471370025|FG001|Phase I|Progressive disease|3|||
130927573|NCT02732119|471370026|FG002|Phase I|Progressive disease|2|||
130927574|NCT02732119|471370027|FG003|Phase I|Progressive disease|0|||
130927575|NCT02732119|471370028|FG004|Phase I|Progressive disease|0|||
130927576|NCT02732119|471370024|FG000|Phase I|Protocol deviation|0|||
130927577|NCT02732119|471370025|FG001|Phase I|Protocol deviation|1|||
130927578|NCT02732119|471370026|FG002|Phase I|Protocol deviation|0|||
130927579|NCT02732119|471370027|FG003|Phase I|Protocol deviation|0|||
130927580|NCT02732119|471370028|FG004|Phase I|Protocol deviation|0|||
130927581|NCT02732119|471370024|FG000|Phase I|Physician Decision|0|||
130927582|NCT02732119|471370025|FG001|Phase I|Physician Decision|3|||
130927583|NCT02732119|471370026|FG002|Phase I|Physician Decision|4|||
130927584|NCT02732119|471370027|FG003|Phase I|Physician Decision|0|||
130927585|NCT02732119|471370028|FG004|Phase I|Physician Decision|0|||
130927586|NCT02732119|471370024|FG000|Phase II|Adverse Event|0|||
130927587|NCT02732119|471370025|FG001|Phase II|Adverse Event|0|||
130927588|NCT02732119|471370026|FG002|Phase II|Adverse Event|0|||
130927589|NCT02732119|471370027|FG003|Phase II|Adverse Event|3|||
130927590|NCT02732119|471370028|FG004|Phase II|Adverse Event|3|||
130927591|NCT02732119|471370024|FG000|Phase II|Death|0|||
130927592|NCT02732119|471370025|FG001|Phase II|Death|0|||
130927593|NCT02732119|471370026|FG002|Phase II|Death|0|||
130927594|NCT02732119|471370027|FG003|Phase II|Death|1|||
130927595|NCT02732119|471370028|FG004|Phase II|Death|0|||
130927596|NCT02732119|471370024|FG000|Phase II|Progressive dissease|0|||
130702369|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130702370|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130702371|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130702372|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130702373|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130927597|NCT02732119|471370025|FG001|Phase II|Progressive dissease|0|||
130927598|NCT02732119|471370026|FG002|Phase II|Progressive dissease|0|||
130927599|NCT02732119|471370027|FG003|Phase II|Progressive dissease|30|||
130927600|NCT02732119|471370028|FG004|Phase II|Progressive dissease|23|||
130927601|NCT02732119|471370024|FG000|Phase II|Study terminated by sponsor|0|||
130927602|NCT02732119|471370025|FG001|Phase II|Study terminated by sponsor|0|||
130927603|NCT02732119|471370026|FG002|Phase II|Study terminated by sponsor|0|||
130927604|NCT02732119|471370027|FG003|Phase II|Study terminated by sponsor|2|||
130927605|NCT02732119|471370028|FG004|Phase II|Study terminated by sponsor|2|||
130927606|NCT02732119|471370024|FG000|Phase II|Other|0|||
130927607|NCT02732119|471370025|FG001|Phase II|Other|0|||
130927608|NCT02732119|471370026|FG002|Phase II|Other|0|||
130927609|NCT02732119|471370027|FG003|Phase II|Other|2|||
130927610|NCT02732119|471370028|FG004|Phase II|Other|0|||
130927611|NCT02732119|471370024|FG000|Phase II|Physician Decision|0|||
130927612|NCT02732119|471370025|FG001|Phase II|Physician Decision|0|||
130927613|NCT02732119|471370026|FG002|Phase II|Physician Decision|0|||
131223713|NCT00068445|472447101|FG001|Treatment|Adverse Event|1|||
131223714|NCT00068445|472447100|FG000|Treatment|Other (Specifics not available)|9|||
131223715|NCT00068445|472447101|FG001|Treatment|Other (Specifics not available)|5|||
130927614|NCT02732119|471370027|FG003|Phase II|Physician Decision|8|||
130927615|NCT02732119|471370028|FG004|Phase II|Physician Decision|5|||
130927616|NCT00553644|471370031|FG000|Overall Study|Adverse Event|17|||
130927617|NCT00553644|471370031|FG000|Overall Study|Withdrawal by Subject|4|||
130927618|NCT00553644|471370031|FG000|Overall Study|Physician Decision|1|||
130927619|NCT00553644|471370031|FG000|Overall Study|Alternative therapy|6|||
130927620|NCT02197247|471370032|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
130927621|NCT02197247|471370032|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
130927622|NCT02197247|471370032|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
130927623|NCT02197247|471370032|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
130927624|NCT02197247|471370032|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
130927625|NCT02197247|471370032|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
130927626|NCT02197247|471370032|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
130927627|NCT02197247|471370032|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
130927628|NCT00851747|471370046|FG000|Overall Study|Physician Decision|6|||
130927629|NCT00851747|471370047|FG001|Overall Study|Physician Decision|6|||
130927630|NCT00851747|471370048|FG002|Overall Study|Physician Decision|6|||
130927631|NCT02099708|471370050|FG000|Overall Study|Data Not Available|30|||
130927632|NCT02099708|471370050|FG000|Overall Study|Lost to Follow-up|141|||
130927633|NCT02099708|471370050|FG000|Overall Study|Other|29|||
130927634|NCT05466682|471370054|FG000|Overall Study|Withdrawal by Subject|0|||
130927635|NCT05466682|471370055|FG001|Overall Study|Withdrawal by Subject|2|||
130927636|NCT05466682|471370054|FG000|Overall Study|Lost to Follow-up|2|||
130927637|NCT05466682|471370055|FG001|Overall Study|Lost to Follow-up|1|||
130927638|NCT01697566|471370056|FG000|Overall Study|Withdrawal by Subject|0|||
130927639|NCT01697566|471370057|FG001|Overall Study|Withdrawal by Subject|0|||
130927640|NCT01697566|471370058|FG002|Overall Study|Withdrawal by Subject|1|||
130927641|NCT01697566|471370059|FG003|Overall Study|Withdrawal by Subject|1|||
130927642|NCT01697566|471370056|FG000|Overall Study|Final biopsy not obtained|0|||
130927643|NCT01697566|471370057|FG001|Overall Study|Final biopsy not obtained|0|||
130927644|NCT01697566|471370058|FG002|Overall Study|Final biopsy not obtained|1|||
130927645|NCT01697566|471370059|FG003|Overall Study|Final biopsy not obtained|0|||
130927646|NCT01930123|471370060|FG000|Overall Study|Adverse Event|1|||
130927647|NCT01930123|471370061|FG001|Overall Study|Adverse Event|0|||
130927648|NCT01930123|471370060|FG000|Overall Study|Physician Decision|21|||
130927649|NCT01930123|471370061|FG001|Overall Study|Physician Decision|8|||
130927650|NCT01930123|471370060|FG000|Overall Study|Withdrawal by Subject|1|||
130927651|NCT01930123|471370061|FG001|Overall Study|Withdrawal by Subject|0|||
131223716|NCT00849524|472447103|FG000|Overall Study|Lack of Efficacy|3|||
130927652|NCT01447433|471370064|FG000|Overall Study|Lost to Follow-up|0|||
130927653|NCT01447433|471370065|FG001|Overall Study|Lost to Follow-up|2|||
130927654|NCT01447433|471370064|FG000|Overall Study|Withdrawal by Subject|3|||
130927655|NCT01447433|471370065|FG001|Overall Study|Withdrawal by Subject|3|||
130927656|NCT01447433|471370064|FG000|Overall Study|Protocol Violation|1|||
130927657|NCT01447433|471370065|FG001|Overall Study|Protocol Violation|1|||
130927658|NCT00036270|471370066|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
130927659|NCT00036270|471370067|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
130927660|NCT00036270|471370066|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
130927661|NCT00036270|471370067|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
131034721|NCT01824394|471761783|FG000|Overall Study|Early Termination|1|||
131034722|NCT01824394|471761784|FG001|Overall Study|Early Termination|1|||
130927662|NCT00036270|471370066|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
130927663|NCT00036270|471370067|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
130927664|NCT00036270|471370066|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
130927665|NCT00036270|471370067|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
130927666|NCT00036270|471370066|FG000|Study Treatment to 5 Year Report|Other|277|||
130927667|NCT00036270|471370067|FG001|Study Treatment to 5 Year Report|Other|288|||
130927668|NCT00036270|471370066|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
130927669|NCT00036270|471370067|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
130927670|NCT00036270|471370066|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
130927671|NCT00036270|471370067|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
130927672|NCT00036270|471370066|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
130927673|NCT00036270|471370067|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
130927674|NCT00036270|471370066|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
130927675|NCT00036270|471370067|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
130927676|NCT00036270|471370066|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
130927677|NCT00036270|471370067|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
130927678|NCT00036270|471370066|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
130927679|NCT00036270|471370067|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
130927680|NCT01964430|471370068|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
130927681|NCT01964430|471370069|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
130927682|NCT01964430|471370068|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
130927683|NCT01964430|471370069|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
130927684|NCT01964430|471370068|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
130927685|NCT01964430|471370069|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
130927686|NCT01964430|471370068|FG000|Treatment Period|Adverse Event|71|||
130927687|NCT01964430|471370069|FG001|Treatment Period|Adverse Event|37|||
130927688|NCT01964430|471370068|FG000|Treatment Period|Withdrawal by Subject|36|||
130927689|NCT01964430|471370069|FG001|Treatment Period|Withdrawal by Subject|27|||
130927690|NCT01964430|471370068|FG000|Treatment Period|Death|1|||
131034723|NCT01824394|471761785|FG002|Overall Study|Early Termination|3|||
131034724|NCT01824394|471761783|FG000|Overall Study|Withdrawn due to Study Termination|91|||
131034725|NCT01824394|471761784|FG001|Overall Study|Withdrawn due to Study Termination|83|||
131034726|NCT01824394|471761785|FG002|Overall Study|Withdrawn due to Study Termination|41|||
131034727|NCT01824394|471761783|FG000|Overall Study|Lost to Follow-up|0|||
131034728|NCT01824394|471761784|FG001|Overall Study|Lost to Follow-up|9|||
131034729|NCT01824394|471761785|FG002|Overall Study|Lost to Follow-up|3|||
131034730|NCT01824394|471761783|FG000|Overall Study|Death|3|||
131034731|NCT01824394|471761784|FG001|Overall Study|Death|2|||
131034732|NCT01824394|471761785|FG002|Overall Study|Death|4|||
130702374|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
130702375|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130702376|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130702377|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130702378|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130702379|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
130702380|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
130702381|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
130702382|NCT05068284|470532845|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702383|NCT05068284|470532846|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702384|NCT05068284|470532847|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702385|NCT05068284|470532848|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702386|NCT05068284|470532849|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702387|NCT05068284|470532850|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702388|NCT05068284|470532851|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
130702389|NCT05068284|470532852|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
130702390|NCT01958060|470534431|FG000|Overall Study|Not treated|2|||
130702391|NCT01958060|470534432|FG001|Overall Study|Not treated|0|||
130702392|NCT01958060|470534433|FG002|Overall Study|Not treated|0|||
130702393|NCT01958060|470534434|FG003|Overall Study|Not treated|0|||
130702394|NCT01958060|470534435|FG004|Overall Study|Not treated|1|||
130702395|NCT01958060|470534436|FG005|Overall Study|Not treated|0|||
130702396|NCT01636934|470534456|FG000|Overall Study|Withdrawal by Subject|3|||
130702397|NCT01636934|470534457|FG001|Overall Study|Withdrawal by Subject|2|||
130702398|NCT01636934|470534456|FG000|Overall Study|Chemo cancel|1|||
130927691|NCT01964430|471370069|FG001|Treatment Period|Death|3|||
131034733|NCT01824394|471761783|FG000|Overall Study|Discontinued Subjects|1|||
131034734|NCT01824394|471761784|FG001|Overall Study|Discontinued Subjects|1|||
130927692|NCT01964430|471370068|FG000|Treatment Period|Protocol Deviation|0|||
130927693|NCT01964430|471370069|FG001|Treatment Period|Protocol Deviation|1|||
130927694|NCT01964430|471370068|FG000|Treatment Period|Physician Decision|5|||
130927695|NCT01964430|471370069|FG001|Treatment Period|Physician Decision|4|||
130927696|NCT01964430|471370068|FG000|Treatment Period|Disease Relapse|28|||
130927697|NCT01964430|471370069|FG001|Treatment Period|Disease Relapse|38|||
130927698|NCT01964430|471370068|FG000|Treatment Period|Other reasons|1|||
130927699|NCT01964430|471370069|FG001|Treatment Period|Other reasons|3|||
130927700|NCT02516163|471370070|FG000|Overall Study|Withdrawal by Subject|1|||
130927701|NCT02516163|471370070|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
130927702|NCT02516163|471370070|FG000|Overall Study|Unfit/delay in surgery|3|||
130927703|NCT02516163|471370070|FG000|Overall Study|Use of incorrect measurement technique|5|||
130927704|NCT02516163|471370070|FG000|Overall Study|Data not recorded|2|||
130927705|NCT02516163|471370070|FG000|Overall Study|MRI contraindication exclusion|6|||
130927706|NCT02801396|471370071|FG000|Period 1|Withdrawal by Subject|0|||
130927707|NCT02801396|471370072|FG001|Period 1|Withdrawal by Subject|0|||
130927708|NCT02801396|471370073|FG002|Period 1|Withdrawal by Subject|0|||
130927709|NCT02801396|471370074|FG003|Period 1|Withdrawal by Subject|0|||
130927710|NCT02801396|471370075|FG004|Period 1|Withdrawal by Subject|1|||
130927711|NCT02801396|471370076|FG005|Period 1|Withdrawal by Subject|0|||
130927712|NCT01658072|471370079|FG000|Overall Study|Protocol Violation|4|||
130927713|NCT01658072|471370080|FG001|Overall Study|Protocol Violation|2|||
130927714|NCT01874054|471370082|FG000|Overall Study|Withdrawal by Subject|3|||
130927715|NCT01874054|471370082|FG000|Overall Study|Study Termination by Sponsor|42|||
130927716|NCT01874054|471370082|FG000|Overall Study|Lost to Follow-up|5|||
130927717|NCT01874054|471370082|FG000|Overall Study|Death|5|||
130927718|NCT00702923|471370083|FG000|Overall Study|Adverse Event|1|||
130927719|NCT03953820|471370085|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
130927720|NCT03953820|471370086|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
130927721|NCT03953820|471370087|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
130927722|NCT03953820|471370085|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
130927723|NCT03953820|471370086|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
130927724|NCT03953820|471370087|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
130927725|NCT01318993|471370088|FG000|Overall Study|Adverse Event|53|||
130927726|NCT01318993|471370088|FG000|Overall Study|Lack of Efficacy|121|||
130927727|NCT01318993|471370088|FG000|Overall Study|Protocol Violation|3|||
130927728|NCT01318993|471370088|FG000|Overall Study|Protocol based stopping criteria|6|||
130927729|NCT01318993|471370088|FG000|Overall Study|Study closed or terminated|174|||
130927730|NCT01318993|471370088|FG000|Overall Study|Lost to Follow-up|4|||
130927731|NCT01318993|471370088|FG000|Overall Study|Physician Decision|13|||
130927732|NCT01318993|471370088|FG000|Overall Study|Withdrawal by Subject|24|||
130927733|NCT03334539|471370089|FG000|Overall Study|Adverse Event|3|||
130927734|NCT03334539|471370090|FG001|Overall Study|Adverse Event|5|||
130927735|NCT03334539|471370091|FG002|Overall Study|Adverse Event|0|||
130927736|NCT03334539|471370089|FG000|Overall Study|Withdrawal by Subject|0|||
130927737|NCT03334539|471370090|FG001|Overall Study|Withdrawal by Subject|1|||
130927738|NCT03334539|471370091|FG002|Overall Study|Withdrawal by Subject|1|||
130927739|NCT03334539|471370089|FG000|Overall Study|Administrative Reasons|1|||
130927740|NCT03334539|471370090|FG001|Overall Study|Administrative Reasons|0|||
130927741|NCT03334539|471370091|FG002|Overall Study|Administrative Reasons|0|||
130927742|NCT03334539|471370089|FG000|Overall Study|Hypertension Not Controlled|0|||
130927743|NCT03334539|471370090|FG001|Overall Study|Hypertension Not Controlled|1|||
130927744|NCT03334539|471370091|FG002|Overall Study|Hypertension Not Controlled|0|||
130927745|NCT00968201|471370092|FG000|Base Study - (Period II)|Adverse Event|8|||
130927746|NCT00968201|471370093|FG001|Base Study - (Period II)|Adverse Event|0|||
130927747|NCT00968201|471370094|FG002|Base Study - (Period II)|Adverse Event|16|||
130927748|NCT00968201|471370092|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
130927749|NCT00968201|471370093|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
130927750|NCT00968201|471370094|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
130927751|NCT00968201|471370092|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
130927752|NCT00968201|471370093|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
130927753|NCT00968201|471370094|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
130927754|NCT00968201|471370092|FG000|Base Study - (Period II)|Protocol Violation|12|||
130927755|NCT00968201|471370093|FG001|Base Study - (Period II)|Protocol Violation|0|||
130927756|NCT00968201|471370094|FG002|Base Study - (Period II)|Protocol Violation|12|||
130927757|NCT00968201|471370092|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
130927758|NCT00968201|471370093|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
130927759|NCT00968201|471370094|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
130927760|NCT00968201|471370092|FG000|Base Study - (Period II)|Site Error|0|||
130927761|NCT00968201|471370093|FG001|Base Study - (Period II)|Site Error|0|||
130927762|NCT00968201|471370094|FG002|Base Study - (Period II)|Site Error|1|||
130927763|NCT00968201|471370092|FG000|Extension Study - (Period III)|Adverse Event|0|||
130927764|NCT00968201|471370093|FG001|Extension Study - (Period III)|Adverse Event|5|||
130927765|NCT00968201|471370094|FG002|Extension Study - (Period III)|Adverse Event|22|||
130927766|NCT00968201|471370092|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
130927767|NCT00968201|471370093|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
130927768|NCT00968201|471370094|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
130927769|NCT00968201|471370092|FG000|Extension Study - (Period III)|Protocol Violation|0|||
130927770|NCT00968201|471370093|FG001|Extension Study - (Period III)|Protocol Violation|17|||
130927771|NCT00968201|471370094|FG002|Extension Study - (Period III)|Protocol Violation|14|||
130927772|NCT00968201|471370092|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
130927773|NCT00968201|471370093|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
130927774|NCT00968201|471370094|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
131034735|NCT01824394|471761785|FG002|Overall Study|Discontinued Subjects|2|||
131223717|NCT01358708|472447106|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
130702399|NCT01636934|470534457|FG001|Overall Study|Chemo cancel|0|||
130702400|NCT01636934|470534456|FG000|Overall Study|Too ill to continue|1|||
130702401|NCT01636934|470534457|FG001|Overall Study|Too ill to continue|0|||
130702402|NCT01636934|470534456|FG000|Overall Study|Never started study medication|1|||
130702403|NCT01636934|470534457|FG001|Overall Study|Never started study medication|1|||
130702404|NCT01011335|470534458|FG000|Overall Study|Lost to Follow-up|0|||
130702405|NCT01011335|470534459|FG001|Overall Study|Lost to Follow-up|0|||
130702406|NCT01011335|470534460|FG002|Overall Study|Lost to Follow-up|1|||
130702407|NCT01011335|470534461|FG003|Overall Study|Lost to Follow-up|1|||
130702408|NCT01011335|470534462|FG004|Overall Study|Lost to Follow-up|1|||
130702409|NCT01011335|470534463|FG005|Overall Study|Lost to Follow-up|1|||
130702410|NCT01011335|470534464|FG006|Overall Study|Lost to Follow-up|2|||
130702411|NCT01011335|470534465|FG007|Overall Study|Lost to Follow-up|2|||
130702412|NCT01011335|470534466|FG008|Overall Study|Lost to Follow-up|1|||
130702413|NCT01011335|470534467|FG009|Overall Study|Lost to Follow-up|0|||
130702414|NCT01011335|470534468|FG010|Overall Study|Lost to Follow-up|0|||
130702415|NCT01011335|470534469|FG011|Overall Study|Lost to Follow-up|1|||
130702416|NCT01011335|470534470|FG012|Overall Study|Lost to Follow-up|2|||
130702417|NCT01011335|470534458|FG000|Overall Study|Protocol Violation|0|||
130702418|NCT01011335|470534459|FG001|Overall Study|Protocol Violation|1|||
130702419|NCT01011335|470534460|FG002|Overall Study|Protocol Violation|0|||
130702420|NCT01011335|470534461|FG003|Overall Study|Protocol Violation|0|||
130702421|NCT01011335|470534462|FG004|Overall Study|Protocol Violation|0|||
130702422|NCT01011335|470534463|FG005|Overall Study|Protocol Violation|0|||
130702423|NCT01011335|470534464|FG006|Overall Study|Protocol Violation|0|||
130702424|NCT01011335|470534465|FG007|Overall Study|Protocol Violation|0|||
130702425|NCT01011335|470534466|FG008|Overall Study|Protocol Violation|0|||
130702426|NCT01011335|470534467|FG009|Overall Study|Protocol Violation|0|||
130702427|NCT01011335|470534468|FG010|Overall Study|Protocol Violation|0|||
130702428|NCT01011335|470534469|FG011|Overall Study|Protocol Violation|0|||
130702429|NCT01011335|470534470|FG012|Overall Study|Protocol Violation|0|||
130702430|NCT01011335|470534458|FG000|Overall Study|Moved/deployed or no booster|1|||
130702431|NCT01011335|470534459|FG001|Overall Study|Moved/deployed or no booster|0|||
130702432|NCT01011335|470534460|FG002|Overall Study|Moved/deployed or no booster|0|||
130702433|NCT01011335|470534461|FG003|Overall Study|Moved/deployed or no booster|1|||
130702434|NCT01011335|470534462|FG004|Overall Study|Moved/deployed or no booster|0|||
130702435|NCT01011335|470534463|FG005|Overall Study|Moved/deployed or no booster|0|||
130702436|NCT01011335|470534464|FG006|Overall Study|Moved/deployed or no booster|1|||
130702437|NCT01011335|470534465|FG007|Overall Study|Moved/deployed or no booster|0|||
130702438|NCT01011335|470534466|FG008|Overall Study|Moved/deployed or no booster|1|||
130702439|NCT01011335|470534467|FG009|Overall Study|Moved/deployed or no booster|0|||
130702440|NCT01011335|470534468|FG010|Overall Study|Moved/deployed or no booster|2|||
130702441|NCT01011335|470534469|FG011|Overall Study|Moved/deployed or no booster|0|||
130702442|NCT01011335|470534470|FG012|Overall Study|Moved/deployed or no booster|0|||
130702443|NCT01011335|470534458|FG000|Overall Study|Adverse Event|0|||
130702444|NCT01011335|470534459|FG001|Overall Study|Adverse Event|0|||
130702445|NCT01011335|470534460|FG002|Overall Study|Adverse Event|0|||
130702446|NCT01011335|470534461|FG003|Overall Study|Adverse Event|0|||
130702447|NCT01011335|470534462|FG004|Overall Study|Adverse Event|0|||
130702448|NCT01011335|470534463|FG005|Overall Study|Adverse Event|0|||
130702449|NCT01011335|470534464|FG006|Overall Study|Adverse Event|0|||
130702450|NCT01011335|470534465|FG007|Overall Study|Adverse Event|0|||
130702451|NCT01011335|470534466|FG008|Overall Study|Adverse Event|0|||
130702452|NCT01011335|470534467|FG009|Overall Study|Adverse Event|0|||
130702453|NCT01011335|470534468|FG010|Overall Study|Adverse Event|4|||
130702454|NCT01011335|470534469|FG011|Overall Study|Adverse Event|0|||
130702455|NCT01011335|470534470|FG012|Overall Study|Adverse Event|1|||
130702456|NCT02459418|470534475|FG000|Overall Study|Exclusion Criteria|4|||
131223718|NCT01358708|472447107|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130927775|NCT00968201|471370092|FG000|Extension Study - (Period III)|Patient Relocated|0|||
131034736|NCT01824394|471761783|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
130702457|NCT02459418|470534476|FG001|Overall Study|Exclusion Criteria|0|||
130702458|NCT02459418|470534475|FG000|Overall Study|Protocol Violation|0|||
130702459|NCT02459418|470534476|FG001|Overall Study|Protocol Violation|2|||
130702460|NCT02459418|470534475|FG000|Overall Study|Physician Decision|0|||
130702461|NCT02459418|470534476|FG001|Overall Study|Physician Decision|2|||
130702462|NCT02459418|470534475|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
130702463|NCT02459418|470534476|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
130702464|NCT02459418|470534475|FG000|Overall Study|Adverse Event|0|||
130702465|NCT02459418|470534476|FG001|Overall Study|Adverse Event|1|||
130702466|NCT02459418|470534475|FG000|Overall Study|Withdrawal by Subject|1|||
130927776|NCT00968201|471370093|FG001|Extension Study - (Period III)|Patient Relocated|1|||
130927777|NCT00968201|471370094|FG002|Extension Study - (Period III)|Patient Relocated|1|||
130927778|NCT00968201|471370092|FG000|Extension Study - (Period III)|Noncompliance|0|||
130927779|NCT00968201|471370093|FG001|Extension Study - (Period III)|Noncompliance|0|||
130927780|NCT00968201|471370094|FG002|Extension Study - (Period III)|Noncompliance|3|||
130927781|NCT00968201|471370092|FG000|Extension Study - (Period III)|Other|0|||
130927782|NCT00968201|471370093|FG001|Extension Study - (Period III)|Other|0|||
130927783|NCT00968201|471370094|FG002|Extension Study - (Period III)|Other|2|||
130927784|NCT00968201|471370092|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
130927785|NCT00968201|471370093|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
130927786|NCT00968201|471370094|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
130927787|NCT04974697|471370096|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
130770121|NCT03539484|470784248|FG004|Overall Study|Study Terminated by Sponsor|2|||
130927788|NCT04974697|471370096|FG000|Overall Study|Lens discomfort|1|||
130927789|NCT03706456|471370097|FG000|Overall Study|Adverse Event|1|||
130927790|NCT03706456|471370097|FG000|Overall Study|Lack of Efficacy|2|||
130927791|NCT02784431|471370098|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
130927792|NCT02784431|471370098|FG000|Overall Study|Early Study Termination|19|||
130927793|NCT02605824|471370099|FG000|Overall Study|Physician Decision|1|||
130927794|NCT02605824|471370100|FG001|Overall Study|Physician Decision|0|||
130927795|NCT02010775|471370101|FG000|Overall Study|Adverse Event|0|||
130927796|NCT02010775|471370102|FG001|Overall Study|Adverse Event|0|||
130927797|NCT02010775|471370103|FG002|Overall Study|Adverse Event|0|||
130927798|NCT02010775|471370104|FG003|Overall Study|Adverse Event|0|||
130927799|NCT02010775|471370105|FG004|Overall Study|Adverse Event|1|||
130927800|NCT02010775|471370101|FG000|Overall Study|Pregnancy|0|||
130927801|NCT02010775|471370102|FG001|Overall Study|Pregnancy|0|||
130927802|NCT02010775|471370103|FG002|Overall Study|Pregnancy|2|||
130927803|NCT02010775|471370104|FG003|Overall Study|Pregnancy|0|||
130927804|NCT02010775|471370105|FG004|Overall Study|Pregnancy|0|||
130927805|NCT02010775|471370101|FG000|Overall Study|Lost to Follow-up|2|||
130927806|NCT02010775|471370102|FG001|Overall Study|Lost to Follow-up|0|||
130927807|NCT02010775|471370103|FG002|Overall Study|Lost to Follow-up|0|||
130927808|NCT02010775|471370104|FG003|Overall Study|Lost to Follow-up|1|||
130927809|NCT02010775|471370105|FG004|Overall Study|Lost to Follow-up|1|||
130927810|NCT02010775|471370101|FG000|Overall Study|Personal Reasons|3|||
130927811|NCT02010775|471370102|FG001|Overall Study|Personal Reasons|3|||
130927812|NCT02010775|471370103|FG002|Overall Study|Personal Reasons|1|||
130927813|NCT02010775|471370104|FG003|Overall Study|Personal Reasons|2|||
130927814|NCT02010775|471370105|FG004|Overall Study|Personal Reasons|4|||
130927815|NCT02030041|471370108|FG000|Overall Study|Withdrawal by Subject|2|||
130927816|NCT02030041|471370109|FG001|Overall Study|Withdrawal by Subject|2|||
130927817|NCT02030041|471370110|FG002|Overall Study|Withdrawal by Subject|1|||
130927818|NCT05201703|471370111|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
130927819|NCT05201703|471370112|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
130927820|NCT05201703|471370111|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
130927821|NCT05201703|471370112|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
131034737|NCT01824394|471761784|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
131034738|NCT01824394|471761785|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
131034739|NCT05780437|471761786|FG000|Overall Study|Withdrawal by Subject|22|||
130702467|NCT02459418|470534476|FG001|Overall Study|Withdrawal by Subject|1|||
130702468|NCT02459418|470534475|FG000|Overall Study|Elevated Creatine Kinase|1|||
130702469|NCT02459418|470534476|FG001|Overall Study|Elevated Creatine Kinase|0|||
130702470|NCT02459418|470534475|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
130702471|NCT02459418|470534476|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
130702472|NCT01872715|470534477|FG000|Overall Study|Adverse Event|1|||
130702473|NCT01872715|470534477|FG000|Overall Study|Protocol Violation|1|||
130702474|NCT01872715|470534477|FG000|Overall Study|Withdrawal by Subject|2|||
130770122|NCT03539484|470784249|FG005|Overall Study|Study Terminated by Sponsor|2|||
130927822|NCT01197560|471370113|FG000|Overall Study|Adverse Event|6|||
130927823|NCT01197560|471370114|FG001|Overall Study|Adverse Event|8|||
130927824|NCT01197560|471370113|FG000|Overall Study|Death|3|||
130927825|NCT01197560|471370114|FG001|Overall Study|Death|5|||
130927826|NCT01197560|471370113|FG000|Overall Study|Withdrawal by Subject|1|||
130702475|NCT03303417|470534478|FG000|Overall Study|Withdrawal by Subject|1|||
130702476|NCT03303417|470534479|FG001|Overall Study|Withdrawal by Subject|1|||
130927827|NCT01197560|471370114|FG001|Overall Study|Withdrawal by Subject|1|||
130702477|NCT01765270|470534482|FG000|Overall Study|Physician Decision|1|||
130702478|NCT01765270|470534483|FG001|Overall Study|Physician Decision|0|||
130702479|NCT01765270|470534482|FG000|Overall Study|Withdrawal by Subject|0|||
130702480|NCT01765270|470534483|FG001|Overall Study|Withdrawal by Subject|1|||
130702481|NCT03431337|470534484|FG000|Overall Study|Lost to Follow-up|21|||
130702482|NCT03431337|470534485|FG001|Overall Study|Lost to Follow-up|19|||
130702483|NCT03431337|470534484|FG000|Overall Study|Withdrawal by Subject|8|||
130702484|NCT03431337|470534485|FG001|Overall Study|Withdrawal by Subject|3|||
130702485|NCT03619876|470534488|FG000|Overall Study|Withdrawal by Subject|1|||
130702486|NCT03619876|470534489|FG001|Overall Study|Withdrawal by Subject|2|||
130702487|NCT03619876|470534488|FG000|Overall Study|Withdrawal due to incidental finding|0|||
130702488|NCT03619876|470534489|FG001|Overall Study|Withdrawal due to incidental finding|2|||
130702489|NCT00835796|470534493|FG000|First Intervention|Withdrawal by Subject|0|||
130702490|NCT00835796|470534494|FG001|First Intervention|Withdrawal by Subject|1|||
130702491|NCT00651183|470534499|FG000|Overall Study|Lack of Efficacy|1|||
130702492|NCT00651183|470534500|FG001|Overall Study|Lack of Efficacy|0|||
130702493|NCT00651183|470534499|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
130770123|NCT03539484|470784250|FG006|Overall Study|Study Terminated by Sponsor|1|||
130770124|NCT00329745|470784253|FG000|Overall Study|Protocol Violation|1|||
130770125|NCT00329745|470784254|FG001|Overall Study|Protocol Violation|0|||
130927828|NCT01197560|471370113|FG000|Overall Study|Disease progression|40|||
130927829|NCT01197560|471370114|FG001|Overall Study|Disease progression|35|||
130927830|NCT01197560|471370113|FG000|Overall Study|Miscellaneous|4|||
130927831|NCT01197560|471370114|FG001|Overall Study|Miscellaneous|3|||
130927832|NCT01197560|471370113|FG000|Overall Study|Missing|0|||
130927833|NCT01197560|471370114|FG001|Overall Study|Missing|1|||
130927834|NCT02006719|471370115|FG000|Overall Study|Withdrawal by Subject|10|||
130927835|NCT02006719|471370116|FG001|Overall Study|Withdrawal by Subject|2|||
130927836|NCT02006719|471370115|FG000|Overall Study|Lost to Follow-up|5|||
130927837|NCT02006719|471370116|FG001|Overall Study|Lost to Follow-up|1|||
130927838|NCT02006719|471370115|FG000|Overall Study|Protocol Violation|2|||
130927839|NCT02006719|471370116|FG001|Overall Study|Protocol Violation|0|||
130927840|NCT02006719|471370115|FG000|Overall Study|Adverse Event|1|||
130927841|NCT02006719|471370116|FG001|Overall Study|Adverse Event|1|||
130927842|NCT02006719|471370115|FG000|Overall Study|Other/Unknown|0|||
130927843|NCT02006719|471370116|FG001|Overall Study|Other/Unknown|1|||
130927844|NCT00393029|471370117|FG000|Overall Study|Not treated|0|||
130927845|NCT00393029|471370118|FG001|Overall Study|Not treated|1|||
130927846|NCT04659161|471370119|FG000|Overall Study|Adverse Event|10|||
130927847|NCT04659161|471370120|FG001|Overall Study|Adverse Event|6|||
130927848|NCT04659161|471370119|FG000|Overall Study|Withdrawal by Subject|13|||
130927849|NCT04659161|471370120|FG001|Overall Study|Withdrawal by Subject|12|||
130927850|NCT04659161|471370119|FG000|Overall Study|Other|9|||
130927851|NCT04659161|471370120|FG001|Overall Study|Other|8|||
130927852|NCT01929343|471370121|FG000|Overall Study|Physician Decision|0|||
130927853|NCT01929343|471370122|FG001|Overall Study|Physician Decision|2|||
130927854|NCT01929343|471370123|FG002|Overall Study|Physician Decision|0|||
130927855|NCT01929343|471370121|FG000|Overall Study|Withdrawal by Subject|1|||
130927856|NCT01929343|471370122|FG001|Overall Study|Withdrawal by Subject|0|||
131034740|NCT05780437|471761787|FG001|Overall Study|Withdrawal by Subject|16|||
131034741|NCT03452579|471761788|FG000|Overall Study|Death|0|||
131034742|NCT03452579|471761789|FG001|Overall Study|Death|1|||
131034743|NCT03452579|471761788|FG000|Overall Study|Withdrawal by Subject|2|||
131034744|NCT03452579|471761789|FG001|Overall Study|Withdrawal by Subject|0|||
131034745|NCT03452579|471761788|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
131034746|NCT03452579|471761789|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
131034747|NCT03452579|471761788|FG000|Overall Study|Physician Decision|1|||
131034748|NCT03452579|471761789|FG001|Overall Study|Physician Decision|1|||
131034749|NCT03452579|471761788|FG000|Overall Study|Adverse Event|1|||
131034750|NCT03452579|471761789|FG001|Overall Study|Adverse Event|4|||
131034751|NCT04810650|471761792|FG000|Overall Study|Disenrolled in error|0|||
131034752|NCT04810650|471761793|FG001|Overall Study|Disenrolled in error|0|||
131034753|NCT04810650|471761794|FG002|Overall Study|Disenrolled in error|0|||
130770126|NCT00329745|470784253|FG000|Overall Study|Withdrawal by Subject|0|||
130770127|NCT00329745|470784254|FG001|Overall Study|Withdrawal by Subject|1|||
131034754|NCT04810650|471761795|FG003|Overall Study|Disenrolled in error|0|||
130702494|NCT00651183|470534500|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
130770128|NCT00329745|470784253|FG000|Overall Study|Lost to Follow-up|86|||
130770129|NCT00329745|470784254|FG001|Overall Study|Lost to Follow-up|101|||
130927857|NCT01929343|471370123|FG002|Overall Study|Withdrawal by Subject|0|||
130927858|NCT03715530|471370126|FG000|Overall Study|Lost to Follow-up|3|||
130927859|NCT03715530|471370127|FG001|Overall Study|Lost to Follow-up|1|||
130927860|NCT03715530|471370128|FG002|Overall Study|Lost to Follow-up|2|||
130927861|NCT02197130|471370129|FG000|Overall Study|Adverse Event|13|||
130927862|NCT02197130|471370130|FG001|Overall Study|Adverse Event|4|||
130927863|NCT02197130|471370131|FG002|Overall Study|Adverse Event|23|||
130927864|NCT02197130|471370129|FG000|Overall Study|Death|0|||
131034755|NCT04810650|471761796|FG004|Overall Study|Disenrolled in error|0|||
131034756|NCT04810650|471761797|FG005|Overall Study|Disenrolled in error|0|||
130927865|NCT02197130|471370130|FG001|Overall Study|Death|1|||
130927866|NCT02197130|471370131|FG002|Overall Study|Death|0|||
130927867|NCT02197130|471370129|FG000|Overall Study|Lost to Follow-up|2|||
130927868|NCT02197130|471370130|FG001|Overall Study|Lost to Follow-up|0|||
130702495|NCT00651183|470534499|FG000|Overall Study|Tolerability insufficient|5|||
130702496|NCT00651183|470534500|FG001|Overall Study|Tolerability insufficient|2|||
130702497|NCT00651183|470534499|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
130702498|NCT00651183|470534500|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
130927869|NCT02197130|471370131|FG002|Overall Study|Lost to Follow-up|1|||
130927870|NCT02197130|471370129|FG000|Overall Study|Does not meet entrance criteria|0|||
130927871|NCT02197130|471370130|FG001|Overall Study|Does not meet entrance criteria|0|||
130927872|NCT02197130|471370131|FG002|Overall Study|Does not meet entrance criteria|1|||
130927873|NCT02197130|471370129|FG000|Overall Study|Withdrawal by Subject|0|||
130927874|NCT02197130|471370130|FG001|Overall Study|Withdrawal by Subject|3|||
130927875|NCT02197130|471370131|FG002|Overall Study|Withdrawal by Subject|4|||
130927876|NCT02197130|471370129|FG000|Overall Study|Other|1|||
130927877|NCT02197130|471370130|FG001|Overall Study|Other|0|||
130927878|NCT02197130|471370131|FG002|Overall Study|Other|3|||
130927879|NCT00558558|471370139|FG000|Overall Study|Unable to swallow|1|||
130927880|NCT00558558|471370139|FG000|Overall Study|Withdrawal by Subject|1|||
130927881|NCT00558558|471370139|FG000|Overall Study|Lack of Efficacy|4|||
130927882|NCT02166905|471370140|FG000|Overall Study|Withdrawal by Subject|1|||
130927883|NCT02166905|471370141|FG001|Overall Study|Withdrawal by Subject|0|||
130927884|NCT02166905|471370142|FG002|Overall Study|Withdrawal by Subject|0|||
130927885|NCT02166905|471370143|FG003|Overall Study|Withdrawal by Subject|0|||
130702499|NCT00651183|470534499|FG000|Overall Study|Withdrawal by Subject|6|||
130702500|NCT00651183|470534500|FG001|Overall Study|Withdrawal by Subject|3|||
130702501|NCT00651183|470534499|FG000|Overall Study|Lost to Follow-up|3|||
130927886|NCT02617628|471370144|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
130927887|NCT02617628|471370145|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
130927888|NCT05255068|471372068|FG000|Overall Study|Lost to Follow-up|0|||
130927889|NCT05255068|471372069|FG001|Overall Study|Lost to Follow-up|1|||
130927890|NCT00980057|471372074|FG000|Overall Study|Death|13|||
130927891|NCT00980057|471372075|FG001|Overall Study|Death|3|||
130927892|NCT00980057|471372074|FG000|Overall Study|Adverse Event|0|||
130927893|NCT00980057|471372075|FG001|Overall Study|Adverse Event|1|||
130927894|NCT00980057|471372074|FG000|Overall Study|Physician Decision|4|||
130927895|NCT00980057|471372075|FG001|Overall Study|Physician Decision|0|||
130927896|NCT00980057|471372074|FG000|Overall Study|Lost to Follow-up|1|||
130927897|NCT00980057|471372075|FG001|Overall Study|Lost to Follow-up|0|||
130927898|NCT00980057|471372074|FG000|Overall Study|Withdrawal by Subject|1|||
130927899|NCT00980057|471372075|FG001|Overall Study|Withdrawal by Subject|1|||
130927900|NCT01315678|471372079|FG000|Overall Study|Withdrawal by Subject|7|||
130927901|NCT01315678|471372080|FG001|Overall Study|Withdrawal by Subject|3|||
130927902|NCT01315678|471372079|FG000|Overall Study|Adverse Event|3|||
130927903|NCT01315678|471372080|FG001|Overall Study|Adverse Event|1|||
130927904|NCT01315678|471372079|FG000|Overall Study|Lost to Follow-up|1|||
130927905|NCT01315678|471372080|FG001|Overall Study|Lost to Follow-up|0|||
130927906|NCT01315678|471372079|FG000|Overall Study|similar reason to those listed above|3|||
130927907|NCT01315678|471372080|FG001|Overall Study|similar reason to those listed above|2|||
130927908|NCT00331682|471372081|FG000|Overall Study|Adverse Event|1|||
130927909|NCT00790023|471372082|FG000|Overall Study|Adverse Event|2|||
130927910|NCT00790023|471372083|FG001|Overall Study|Adverse Event|1|||
130927911|NCT00790023|471372084|FG002|Overall Study|Adverse Event|4|||
130927912|NCT00790023|471372082|FG000|Overall Study|Protocol Violation|2|||
130927913|NCT00790023|471372083|FG001|Overall Study|Protocol Violation|4|||
130927914|NCT00790023|471372084|FG002|Overall Study|Protocol Violation|2|||
130927915|NCT00790023|471372082|FG000|Overall Study|Withdrawal by Subject|2|||
130927916|NCT00790023|471372083|FG001|Overall Study|Withdrawal by Subject|0|||
130927917|NCT00790023|471372084|FG002|Overall Study|Withdrawal by Subject|6|||
130927918|NCT00790023|471372082|FG000|Overall Study|Lost to Follow-up|0|||
130927919|NCT00790023|471372083|FG001|Overall Study|Lost to Follow-up|0|||
130927920|NCT00790023|471372084|FG002|Overall Study|Lost to Follow-up|1|||
130927921|NCT00790023|471372082|FG000|Overall Study|Other|5|||
130702502|NCT00651183|470534500|FG001|Overall Study|Lost to Follow-up|1|||
130927922|NCT00790023|471372083|FG001|Overall Study|Other|5|||
130927923|NCT00790023|471372084|FG002|Overall Study|Other|8|||
131223719|NCT01358708|472447106|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
130702503|NCT00651183|470534499|FG000|Overall Study|Other reasons|4|||
130770130|NCT01597492|470784255|FG000|Overall Study|Withdrawal by Subject|1|||
130927924|NCT00573469|471372085|FG000|Overall Study|Adverse Event|1|||
130927925|NCT00573469|471372086|FG001|Overall Study|Adverse Event|1|||
130927926|NCT00573469|471372087|FG002|Overall Study|Adverse Event|1|||
130927927|NCT00573469|471372085|FG000|Overall Study|Withdrawal by Subject|0|||
130927928|NCT00573469|471372086|FG001|Overall Study|Withdrawal by Subject|2|||
130927929|NCT00573469|471372087|FG002|Overall Study|Withdrawal by Subject|0|||
130927930|NCT00573469|471372085|FG000|Overall Study|Other|5|||
130927931|NCT00573469|471372086|FG001|Overall Study|Other|1|||
130927932|NCT00573469|471372087|FG002|Overall Study|Other|3|||
130927933|NCT01338792|471372088|FG000|Overall Study|Adverse Event|2|||
130927934|NCT01338792|471372088|FG000|Overall Study|Death|1|||
130927935|NCT01338792|471372088|FG000|Overall Study|Withdrawal by Subject|1|||
130927936|NCT02468414|471372089|FG000|Overall Study|Early Study Termination by Sponsor|1|||
130927937|NCT02468414|471372090|FG001|Overall Study|Early Study Termination by Sponsor|0|||
130927938|NCT02468414|471372089|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
130927939|NCT02468414|471372090|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
130927940|NCT02468414|471372089|FG000|Overall Study|Screen Failure|1|||
130702504|NCT00651183|470534500|FG001|Overall Study|Other reasons|2|||
130927941|NCT02468414|471372090|FG001|Overall Study|Screen Failure|0|||
130927942|NCT00004978|471372091|FG000|Overall Study|Death|107|||
130927943|NCT00004978|471372092|FG001|Overall Study|Death|116|||
130927944|NCT00004978|471372091|FG000|Overall Study|Lost to Follow-up|101|||
130927945|NCT00004978|471372092|FG001|Overall Study|Lost to Follow-up|108|||
130927946|NCT00004978|471372091|FG000|Overall Study|Withdrawal by Subject|17|||
130927947|NCT00004978|471372092|FG001|Overall Study|Withdrawal by Subject|26|||
130927948|NCT00004978|471372091|FG000|Overall Study|site closure - not in analysis cohort|19|||
130927949|NCT00004978|471372092|FG001|Overall Study|site closure - not in analysis cohort|20|||
130927950|NCT01652703|471372093|FG000|Overall Study|Withdrawal by Subject|0|||
130927951|NCT01652703|471372094|FG001|Overall Study|Withdrawal by Subject|1|||
130927952|NCT01652703|471372095|FG002|Overall Study|Withdrawal by Subject|3|||
131034757|NCT04810650|471761798|FG006|Overall Study|Disenrolled in error|0|||
130702505|NCT00651183|470534499|FG000|Overall Study|missing|1|||
130702506|NCT00651183|470534500|FG001|Overall Study|missing|0|||
130770131|NCT01597492|470784256|FG001|Overall Study|Withdrawal by Subject|2|||
130770132|NCT01597492|470784255|FG000|Overall Study|Adverse Event|3|||
130770133|NCT01597492|470784256|FG001|Overall Study|Adverse Event|0|||
130770134|NCT01597492|470784255|FG000|Overall Study|Lost to Follow-up|0|||
130770135|NCT01597492|470784256|FG001|Overall Study|Lost to Follow-up|2|||
130770136|NCT01597492|470784255|FG000|Overall Study|Other Reason|2|||
130770137|NCT01597492|470784256|FG001|Overall Study|Other Reason|0|||
130770138|NCT03624569|470784260|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130770139|NCT03624569|470784261|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
130770140|NCT03624569|470784260|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
130770141|NCT03624569|470784261|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
130770142|NCT01557517|470784262|FG000|Overall Study|Death|1|||
130770143|NCT01557517|470784263|FG001|Overall Study|Death|0|||
130770144|NCT01557517|470784262|FG000|Overall Study|Refused further treatment|0|||
130770145|NCT01557517|470784263|FG001|Overall Study|Refused further treatment|2|||
130770146|NCT01557517|470784262|FG000|Overall Study|Adverse Event|0|||
130927953|NCT01652703|471372096|FG003|Overall Study|Withdrawal by Subject|1|||
130927954|NCT01652703|471372097|FG004|Overall Study|Withdrawal by Subject|0|||
130927955|NCT01652703|471372098|FG005|Overall Study|Withdrawal by Subject|1|||
131034758|NCT04810650|471761799|FG007|Overall Study|Disenrolled in error|0|||
130702507|NCT03330236|470534501|FG000|Overall Study|Death|2|||
130702508|NCT03330236|470534502|FG001|Overall Study|Death|1|||
130702509|NCT03330236|470534501|FG000|Overall Study|Withdrawal by Subject|2|||
130702510|NCT03330236|470534502|FG001|Overall Study|Withdrawal by Subject|4|||
130702511|NCT03330236|470534501|FG000|Overall Study|Lost to Follow-up|0|||
130702512|NCT03330236|470534502|FG001|Overall Study|Lost to Follow-up|2|||
130702513|NCT03330236|470534501|FG000|Overall Study|Physician Decision|2|||
130702514|NCT03330236|470534502|FG001|Overall Study|Physician Decision|0|||
130702515|NCT03330236|470534501|FG000|Overall Study|Protocol Violation|4|||
130702516|NCT03330236|470534502|FG001|Overall Study|Protocol Violation|3|||
130702517|NCT03330236|470534501|FG000|Overall Study|SedLine malfunction/blinding|19|||
130702518|NCT03330236|470534502|FG001|Overall Study|SedLine malfunction/blinding|14|||
130702519|NCT03330236|470534501|FG000|Overall Study|Volatile anesthetics used|11|||
130702520|NCT03330236|470534502|FG001|Overall Study|Volatile anesthetics used|8|||
130702521|NCT03330236|470534501|FG000|Overall Study|Surgery aborted/converted to open|60|||
130702522|NCT03330236|470534502|FG001|Overall Study|Surgery aborted/converted to open|52|||
130702523|NCT01901848|470534504|FG000|Randomized and Treated|Lost to Follow-up|3|||
130702524|NCT01901848|470534505|FG001|Randomized and Treated|Lost to Follow-up|6|||
130702525|NCT01901848|470534504|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
130702526|NCT01901848|470534505|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
130702527|NCT00763555|470534506|FG000|Overall Study|Adverse Event|2|||
130702528|NCT00763555|470534507|FG001|Overall Study|Adverse Event|1|||
130702529|NCT00763555|470534506|FG000|Overall Study|Withdrawal by Subject|2|||
130702530|NCT00763555|470534507|FG001|Overall Study|Withdrawal by Subject|6|||
130702531|NCT00763555|470534506|FG000|Overall Study|Lost to Follow-up|0|||
130702532|NCT00763555|470534507|FG001|Overall Study|Lost to Follow-up|3|||
130702533|NCT02488824|470534508|FG000|Overall Study|Adverse Event|1|||
130702534|NCT02488824|470534509|FG001|Overall Study|Adverse Event|1|||
130702535|NCT00848042|470534511|FG000|Overall Study|Death|1|||
130702536|NCT00848042|470534512|FG001|Overall Study|Death|2|||
130770147|NCT01557517|470784263|FG001|Overall Study|Adverse Event|2|||
130927956|NCT01652703|471372093|FG000|Overall Study|Other|0|||
130770148|NCT01557517|470784262|FG000|Overall Study|Pt declined before treatment started|1|||
130770149|NCT01557517|470784263|FG001|Overall Study|Pt declined before treatment started|0|||
130770150|NCT01204918|470784274|FG000|Overall Study|Withdrawal by Subject|4|||
130770151|NCT01204918|470784275|FG001|Overall Study|Withdrawal by Subject|10|||
130770152|NCT01204918|470784276|FG002|Overall Study|Withdrawal by Subject|5|||
130770153|NCT00849290|470784279|FG000|Overall Study|Adverse Event|3|||
130770154|NCT00849290|470784279|FG000|Overall Study|Death|14|||
130770155|NCT00849290|470784279|FG000|Overall Study|Withdrawal by Subject|11|||
130770156|NCT00849290|470784279|FG000|Overall Study|Lost to Follow-up|2|||
130770157|NCT00849290|470784279|FG000|Overall Study|Protocol Violation|5|||
130770158|NCT00849290|470784279|FG000|Overall Study|Disease Progression|20|||
130770159|NCT00080483|470784288|FG000|Overall Study|Lost to Follow-up|1|||
130770160|NCT00080483|470784289|FG001|Overall Study|Lost to Follow-up|1|||
130770161|NCT00080483|470784288|FG000|Overall Study|Physician Decision|1|||
130770162|NCT00080483|470784289|FG001|Overall Study|Physician Decision|1|||
130770163|NCT01119846|470784290|FG000|Overall Study|Adverse Event|1|||
130770164|NCT01119846|470784291|FG001|Overall Study|Adverse Event|0|||
130770165|NCT01119846|470784292|FG002|Overall Study|Adverse Event|6|||
130770166|NCT01119846|470784290|FG000|Overall Study|Physician Decision|1|||
130770167|NCT01119846|470784291|FG001|Overall Study|Physician Decision|0|||
130770168|NCT01119846|470784292|FG002|Overall Study|Physician Decision|0|||
130770169|NCT01119846|470784290|FG000|Overall Study|Protocol Violation|0|||
130770170|NCT01119846|470784291|FG001|Overall Study|Protocol Violation|0|||
130770171|NCT01119846|470784292|FG002|Overall Study|Protocol Violation|1|||
130770172|NCT01119846|470784290|FG000|Overall Study|Withdrawal by Subject|0|||
130770173|NCT01119846|470784291|FG001|Overall Study|Withdrawal by Subject|0|||
130770174|NCT01119846|470784292|FG002|Overall Study|Withdrawal by Subject|4|||
130770175|NCT03304184|470784297|FG000|Overall Study|Withdrawal by Subject|1|||
130770176|NCT03304184|470784298|FG001|Overall Study|Withdrawal by Subject|2|||
130770177|NCT04527978|470784299|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
130770178|NCT04527978|470784300|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
130770179|NCT01370616|470784301|FG000|Overall Study|Adverse Event|11|||
130770180|NCT01370616|470784302|FG001|Overall Study|Adverse Event|16|||
130770181|NCT01370616|470784301|FG000|Overall Study|Death|1|||
130770182|NCT01370616|470784302|FG001|Overall Study|Death|0|||
130770183|NCT01370616|470784301|FG000|Overall Study|Lack of Efficacy|6|||
130770184|NCT01370616|470784302|FG001|Overall Study|Lack of Efficacy|2|||
130770185|NCT01370616|470784301|FG000|Overall Study|Lost to Follow-up|0|||
130770186|NCT01370616|470784302|FG001|Overall Study|Lost to Follow-up|3|||
130770187|NCT01370616|470784301|FG000|Overall Study|Physician Decision|6|||
130770188|NCT01370616|470784302|FG001|Overall Study|Physician Decision|6|||
130770189|NCT01370616|470784301|FG000|Overall Study|Progressive Disease|0|||
130770190|NCT01370616|470784302|FG001|Overall Study|Progressive Disease|1|||
130770191|NCT01370616|470784301|FG000|Overall Study|Recovery|1|||
130770192|NCT01370616|470784302|FG001|Overall Study|Recovery|0|||
130770193|NCT01370616|470784301|FG000|Overall Study|Technical Problems|3|||
130770194|NCT01370616|470784302|FG001|Overall Study|Technical Problems|5|||
130770195|NCT01370616|470784301|FG000|Overall Study|Withdrawal by Subject|34|||
130770196|NCT01370616|470784302|FG001|Overall Study|Withdrawal by Subject|34|||
130770197|NCT02324699|470784303|FG000|Overall Study|study terminated|1|||
130770198|NCT01605825|470784308|FG000|Overall Study|Adverse Event|4|||
130770199|NCT01605825|470784309|FG001|Overall Study|Adverse Event|2|||
130770200|NCT01605825|470784308|FG000|Overall Study|Withdrawal by Subject|0|||
130770201|NCT01605825|470784309|FG001|Overall Study|Withdrawal by Subject|1|||
130770202|NCT01605825|470784308|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
130770203|NCT01605825|470784309|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
130770204|NCT01605825|470784308|FG000|Overall Study|Non-Compliance with Protocol|3|||
130770205|NCT01605825|470784309|FG001|Overall Study|Non-Compliance with Protocol|0|||
130770206|NCT03244618|470784314|FG000|Overall Study|Lost to Follow-up|3|||
130770207|NCT03244618|470784315|FG001|Overall Study|Lost to Follow-up|4|||
130770208|NCT03244618|470784314|FG000|Overall Study|Protocol Violation|4|||
130770209|NCT03244618|470784315|FG001|Overall Study|Protocol Violation|3|||
130770210|NCT03244618|470784314|FG000|Overall Study|Withdrawal by Subject|0|||
130770211|NCT03244618|470784315|FG001|Overall Study|Withdrawal by Subject|2|||
130770212|NCT00913770|470784317|FG000|Overall Study|Unable to contact|24|||
130770213|NCT00913770|470784318|FG001|Overall Study|Unable to contact|19|||
130770214|NCT00913770|470784319|FG002|Overall Study|Unable to contact|13|||
130770215|NCT00913770|470784317|FG000|Overall Study|Refused|11|||
130770216|NCT00913770|470784318|FG001|Overall Study|Refused|10|||
130770217|NCT00913770|470784319|FG002|Overall Study|Refused|8|||
130770218|NCT03816007|470784322|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
130770219|NCT03816007|470784323|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
130770220|NCT03816007|470784322|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
130770221|NCT03816007|470784323|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
130770222|NCT03816007|470784322|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
130770223|NCT03816007|470784323|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
130770224|NCT01926197|470784324|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
130770225|NCT01926197|470784325|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
130770226|NCT01926197|470784324|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
130770227|NCT01926197|470784325|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
130770228|NCT01428115|470784327|FG000|Overall Study|Lack of Efficacy|3|||
130770229|NCT01428115|470784327|FG000|Overall Study|Lost to Follow-up|10|||
130770230|NCT01428115|470784327|FG000|Overall Study|Pregnancy|1|||
130770231|NCT01428115|470784327|FG000|Overall Study|Protocol Violation|3|||
130770232|NCT01428115|470784327|FG000|Overall Study|Withdrawal by Subject|4|||
130770233|NCT02223364|470784328|FG000|Overall Study|Protocol Violation|3|||
130770234|NCT02223364|470784329|FG001|Overall Study|Protocol Violation|0|||
130770235|NCT02223364|470784330|FG002|Overall Study|Protocol Violation|3|||
130770236|NCT02223364|470784328|FG000|Overall Study|subject expired before surgery|1|||
130770237|NCT02223364|470784329|FG001|Overall Study|subject expired before surgery|0|||
130770238|NCT02223364|470784330|FG002|Overall Study|subject expired before surgery|0|||
130770239|NCT02223364|470784328|FG000|Overall Study|Physician Decision|1|||
130770240|NCT02223364|470784329|FG001|Overall Study|Physician Decision|0|||
130770241|NCT02223364|470784330|FG002|Overall Study|Physician Decision|0|||
130770242|NCT02620384|470784331|FG000|Overall Study|Adverse Event|2|||
130770243|NCT02620384|470784332|FG001|Overall Study|Adverse Event|1|||
130770244|NCT02620384|470784331|FG000|Overall Study|Discharged prior to 2nd dose|2|||
130770245|NCT02620384|470784332|FG001|Overall Study|Discharged prior to 2nd dose|5|||
130770246|NCT02620384|470784331|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
130770247|NCT02620384|470784332|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
130770248|NCT02101359|470784333|FG000|Overall Study|Not included|23|||
130770249|NCT02101359|470784334|FG001|Overall Study|Not included|13|||
130770250|NCT02101359|470784333|FG000|Overall Study|Withdrawal by Subject|5|||
130770251|NCT02101359|470784334|FG001|Overall Study|Withdrawal by Subject|4|||
130770252|NCT02101359|470784333|FG000|Overall Study|Lost to Follow-up|1|||
130770253|NCT02101359|470784334|FG001|Overall Study|Lost to Follow-up|0|||
130770254|NCT02101359|470784333|FG000|Overall Study|Protocol Violation|0|||
130770255|NCT02101359|470784334|FG001|Overall Study|Protocol Violation|2|||
130770256|NCT00742027|470784336|FG000|Overall Study|Disease Progression|76|||
130770257|NCT00742027|470784336|FG000|Overall Study|New Cancer Therapy|19|||
130770258|NCT00742027|470784336|FG000|Overall Study|Withdrawal by Subject|18|||
130770259|NCT00742027|470784336|FG000|Overall Study|Death|7|||
130770260|NCT00742027|470784336|FG000|Overall Study|Lost to Follow-up|4|||
130770261|NCT00742027|470784336|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
130770262|NCT00742027|470784336|FG000|Overall Study|Missing|2|||
130770263|NCT00742027|470784336|FG000|Overall Study|Administrative Problems|1|||
130770264|NCT01483599|470784338|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
130770265|NCT01483599|470784339|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130770266|NCT01483599|470784340|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130770267|NCT01483599|470784341|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
130770268|NCT01483599|470784342|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
130770269|NCT01483599|470784343|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
130770270|NCT01483599|470784344|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
130770271|NCT01483599|470784345|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130770272|NCT01483599|470784346|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130770273|NCT01483599|470784347|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130770274|NCT01483599|470784348|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130770275|NCT01483599|470784349|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130770276|NCT01483599|470784350|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130770277|NCT01483599|470784351|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130770278|NCT01483599|470784338|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770279|NCT01483599|470784339|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
130770280|NCT01483599|470784340|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770281|NCT01483599|470784341|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
130770282|NCT01483599|470784342|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770283|NCT01483599|470784343|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770284|NCT01483599|470784344|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
130770285|NCT01483599|470784345|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770286|NCT01483599|470784346|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770287|NCT01483599|470784347|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770288|NCT01483599|470784348|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770289|NCT01483599|470784349|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770290|NCT01483599|470784350|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770291|NCT01483599|470784351|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130770292|NCT01483599|470784338|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
130770293|NCT01483599|470784339|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131034759|NCT04810650|471761800|FG008|Overall Study|Disenrolled in error|1|||
130770294|NCT01483599|470784340|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
131034760|NCT04810650|471761801|FG009|Overall Study|Disenrolled in error|0|||
131034761|NCT04810650|471761802|FG010|Overall Study|Disenrolled in error|0|||
130702537|NCT00848042|470534513|FG002|Overall Study|Death|0|||
130702538|NCT00848042|470534511|FG000|Overall Study|Other Therapy|3|||
130702539|NCT00848042|470534512|FG001|Overall Study|Other Therapy|0|||
130702540|NCT00848042|470534513|FG002|Overall Study|Other Therapy|0|||
130702541|NCT00979212|470534516|FG000|Overall Study|Protocol Violation|1|||
130702542|NCT00979212|470534517|FG001|Overall Study|Protocol Violation|8|||
130702543|NCT00979212|470534516|FG000|Overall Study|No protocol therapy received|1|||
130702544|NCT00979212|470534517|FG001|Overall Study|No protocol therapy received|0|||
130702545|NCT02448563|470534524|FG000|Overall Study|Lost to Follow-up|16|||
130702546|NCT02448563|470534525|FG001|Overall Study|Lost to Follow-up|10|||
130702547|NCT02448563|470534524|FG000|Overall Study|Withdrawal by Subject|0|||
130702548|NCT02448563|470534525|FG001|Overall Study|Withdrawal by Subject|1|||
130702549|NCT02340962|470534527|FG000|Overall Study|Lost to Follow-up|1|||
130702550|NCT02340962|470534528|FG001|Overall Study|Lost to Follow-up|0|||
130702551|NCT02174276|470534529|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
130702552|NCT02174276|470534530|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
130702553|NCT02174276|470534531|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
130702554|NCT02174276|470534532|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
130702555|NCT02174276|470534529|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
130702556|NCT02174276|470534530|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
130702557|NCT02174276|470534531|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
130702558|NCT02174276|470534532|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
130702559|NCT02174276|470534529|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
130702560|NCT02174276|470534530|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
130702561|NCT02174276|470534531|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
130702562|NCT02174276|470534532|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
130702563|NCT02174276|470534529|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
130702564|NCT02174276|470534530|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
130702565|NCT02174276|470534531|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
130702566|NCT02174276|470534532|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
130702567|NCT02174276|470534529|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
130702568|NCT02174276|470534530|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
130702569|NCT02174276|470534531|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
130702570|NCT02174276|470534532|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
130702571|NCT02174276|470534529|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
130702572|NCT02174276|470534530|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
130702573|NCT02174276|470534531|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
130702574|NCT02174276|470534532|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
130702575|NCT00434837|470534540|FG000|Overall Study|Lost to Follow-up|20|||
130702576|NCT00434837|470534541|FG001|Overall Study|Lost to Follow-up|23|||
130702577|NCT00434837|470534542|FG002|Overall Study|Lost to Follow-up|30|||
130702578|NCT00515216|470534543|FG000|Overall Study|Withdrawal by Subject|1|||
130702579|NCT02786927|470534545|FG000|Overall Study|Adverse Event|1|||
130702580|NCT02786927|470534545|FG000|Overall Study|Protocol Violation|4|||
130702581|NCT01801917|470534546|FG000|Period 1 - Randomized|Adverse Event|1|||
130702582|NCT01801917|470534547|FG001|Period 1 - Randomized|Adverse Event|0|||
130702583|NCT01801917|470534548|FG002|Period 1 - Randomized|Adverse Event|1|||
130702584|NCT01801917|470534549|FG003|Period 1 - Randomized|Adverse Event|0|||
130702585|NCT04307849|470534550|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
130702586|NCT04307849|470534551|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
130702587|NCT04307849|470534552|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
130702588|NCT04307849|470534553|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
130702589|NCT04307849|470534554|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
130702590|NCT04307849|470534555|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
130702591|NCT04307849|470534550|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130702592|NCT04307849|470534551|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130702593|NCT04307849|470534552|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
130702594|NCT04307849|470534553|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130702595|NCT04307849|470534554|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130702596|NCT04307849|470534555|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130702597|NCT04307849|470534550|FG000|Overall Study|Family member did not want them to continue|0|||
130702598|NCT04307849|470534551|FG001|Overall Study|Family member did not want them to continue|0|||
130702599|NCT04307849|470534552|FG002|Overall Study|Family member did not want them to continue|1|||
130702600|NCT04307849|470534553|FG003|Overall Study|Family member did not want them to continue|0|||
130702601|NCT04307849|470534554|FG004|Overall Study|Family member did not want them to continue|0|||
130702602|NCT04307849|470534555|FG005|Overall Study|Family member did not want them to continue|0|||
130702603|NCT04307849|470534550|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
130702604|NCT04307849|470534551|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
130927957|NCT01652703|471372094|FG001|Overall Study|Other|0|||
130702605|NCT04307849|470534552|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
130927958|NCT01652703|471372095|FG002|Overall Study|Other|0|||
130927959|NCT01652703|471372096|FG003|Overall Study|Other|1|||
130927960|NCT01652703|471372097|FG004|Overall Study|Other|1|||
130927961|NCT01652703|471372098|FG005|Overall Study|Other|1|||
130927962|NCT02155608|471372102|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
130927963|NCT02155608|471372103|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
130927964|NCT02155608|471372102|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
130927965|NCT02155608|471372103|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
130927966|NCT03555591|471372104|FG000|Overall Study|Protocol Violation|77|||
130927967|NCT01532414|471372105|FG000|Overall Study|Lost to Follow-up|3|||
130927968|NCT01532414|471372106|FG001|Overall Study|Lost to Follow-up|0|||
130927969|NCT01532414|471372107|FG002|Overall Study|Lost to Follow-up|1|||
130927970|NCT01532414|471372105|FG000|Overall Study|Withdrawal by Subject|3|||
130927971|NCT01532414|471372106|FG001|Overall Study|Withdrawal by Subject|0|||
130927972|NCT01532414|471372107|FG002|Overall Study|Withdrawal by Subject|0|||
130927973|NCT01532414|471372105|FG000|Overall Study|No V6 semen sample|0|||
130927974|NCT01532414|471372106|FG001|Overall Study|No V6 semen sample|1|||
130927975|NCT01532414|471372107|FG002|Overall Study|No V6 semen sample|0|||
130927976|NCT01532414|471372105|FG000|Overall Study|Adverse Event|0|||
130927977|NCT01532414|471372106|FG001|Overall Study|Adverse Event|1|||
130927978|NCT01532414|471372107|FG002|Overall Study|Adverse Event|1|||
130927979|NCT01532414|471372105|FG000|Overall Study|Unable to complete 24 hour PK|0|||
130927980|NCT01532414|471372106|FG001|Overall Study|Unable to complete 24 hour PK|0|||
130927981|NCT01532414|471372107|FG002|Overall Study|Unable to complete 24 hour PK|1|||
130927982|NCT01532414|471372105|FG000|Overall Study|Withdrawn by sponsor|1|||
130927983|NCT01532414|471372106|FG001|Overall Study|Withdrawn by sponsor|0|||
130927984|NCT01532414|471372107|FG002|Overall Study|Withdrawn by sponsor|0|||
130927985|NCT00187486|471372108|FG000|Overall Study|Protocol Violation|1|||
130927986|NCT02380677|471372109|FG000|Overall Study|Adverse Event|0|||
130927987|NCT02380677|471372110|FG001|Overall Study|Adverse Event|0|||
130927988|NCT02380677|471372111|FG002|Overall Study|Adverse Event|0|||
130927989|NCT02380677|471372112|FG003|Overall Study|Adverse Event|1|||
130927990|NCT02380677|471372113|FG004|Overall Study|Adverse Event|1|||
130927991|NCT02380677|471372114|FG005|Overall Study|Adverse Event|4|||
130927992|NCT02380677|471372115|FG006|Overall Study|Adverse Event|2|||
130927993|NCT02380677|471372116|FG007|Overall Study|Adverse Event|2|||
130927994|NCT02380677|471372117|FG008|Overall Study|Adverse Event|2|||
130927995|NCT02380677|471372118|FG009|Overall Study|Adverse Event|1|||
130927996|NCT02380677|471372119|FG010|Overall Study|Adverse Event|2|||
130927997|NCT02380677|471372120|FG011|Overall Study|Adverse Event|1|||
130702606|NCT04307849|470534553|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
130702607|NCT04307849|470534554|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
130702608|NCT04307849|470534555|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
130702609|NCT05467982|470534558|FG000|Overall Study|Death|0|||
130702610|NCT05467982|470534559|FG001|Overall Study|Death|1|||
130702611|NCT05467982|470534558|FG000|Overall Study|Lost to Follow-up|3|||
130702612|NCT05467982|470534559|FG001|Overall Study|Lost to Follow-up|1|||
130702613|NCT01833169|470534565|FG000|Overall Study|Disease Progression|99|||
130702614|NCT01833169|470534565|FG000|Overall Study|Adverse Event|33|||
130702615|NCT01833169|470534565|FG000|Overall Study|Withdrawal by Subject|9|||
130702616|NCT01833169|470534565|FG000|Overall Study|Death|3|||
130702617|NCT01833169|470534565|FG000|Overall Study|Physician Decision|2|||
130702618|NCT00105157|470534566|FG000|Double-Blind (DB)|Never Treated|1|||
130702619|NCT00105157|470534567|FG001|Double-Blind (DB)|Never Treated|0|||
130702620|NCT00105157|470534568|FG002|Double-Blind (DB)|Never Treated|0|||
130702621|NCT00105157|470534569|FG003|Double-Blind (DB)|Never Treated|0|||
130702622|NCT00105157|470534566|FG000|Double-Blind (DB)|Adverse Event|2|||
130702623|NCT00105157|470534567|FG001|Double-Blind (DB)|Adverse Event|0|||
130702624|NCT00105157|470534568|FG002|Double-Blind (DB)|Adverse Event|1|||
130702625|NCT00105157|470534569|FG003|Double-Blind (DB)|Adverse Event|1|||
130927998|NCT02380677|471372109|FG000|Overall Study|Physician Decision|1|||
130927999|NCT02380677|471372110|FG001|Overall Study|Physician Decision|0|||
130928000|NCT02380677|471372111|FG002|Overall Study|Physician Decision|1|||
130928001|NCT02380677|471372112|FG003|Overall Study|Physician Decision|1|||
130928002|NCT02380677|471372113|FG004|Overall Study|Physician Decision|0|||
130702626|NCT00105157|470534566|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
130702627|NCT00105157|470534567|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
130702628|NCT00105157|470534568|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
130702629|NCT00105157|470534569|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
130702630|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Adverse Event|3|||
130702631|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Adverse Event|1|||
130928003|NCT02380677|471372114|FG005|Overall Study|Physician Decision|0|||
130928004|NCT02380677|471372115|FG006|Overall Study|Physician Decision|0|||
130928005|NCT02380677|471372116|FG007|Overall Study|Physician Decision|0|||
130928006|NCT02380677|471372117|FG008|Overall Study|Physician Decision|0|||
130928007|NCT02380677|471372118|FG009|Overall Study|Physician Decision|0|||
130928008|NCT02380677|471372119|FG010|Overall Study|Physician Decision|0|||
130702632|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Adverse Event|0|||
130702633|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Adverse Event|0|||
130702634|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
130702635|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
130702636|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
130702637|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
130702638|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
130702639|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
130702640|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
130702641|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
130702642|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
130702643|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
130702644|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
130702645|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
130702646|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
130702647|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
130702648|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
130702649|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
130702650|NCT00105157|470534566|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
130702651|NCT00105157|470534567|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
130702652|NCT00105157|470534568|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
130702653|NCT00105157|470534569|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
130702654|NCT00105157|470534566|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
130702655|NCT00105157|470534567|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
130702656|NCT00105157|470534568|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
130702657|NCT00105157|470534569|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
130702658|NCT00105157|470534566|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
130702659|NCT00105157|470534567|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
130702660|NCT00105157|470534568|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
130702661|NCT00105157|470534569|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
130702662|NCT00105157|470534566|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
130702663|NCT00105157|470534567|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
130928009|NCT02380677|471372120|FG011|Overall Study|Physician Decision|0|||
130928010|NCT02380677|471372109|FG000|Overall Study|Lack of Efficacy|0|||
130928011|NCT02380677|471372110|FG001|Overall Study|Lack of Efficacy|1|||
130928012|NCT02380677|471372111|FG002|Overall Study|Lack of Efficacy|2|||
130928013|NCT02380677|471372112|FG003|Overall Study|Lack of Efficacy|0|||
130928014|NCT02380677|471372113|FG004|Overall Study|Lack of Efficacy|4|||
130928015|NCT02380677|471372114|FG005|Overall Study|Lack of Efficacy|1|||
130928016|NCT02380677|471372115|FG006|Overall Study|Lack of Efficacy|1|||
130928017|NCT02380677|471372116|FG007|Overall Study|Lack of Efficacy|2|||
130928018|NCT02380677|471372117|FG008|Overall Study|Lack of Efficacy|2|||
130928019|NCT02380677|471372118|FG009|Overall Study|Lack of Efficacy|0|||
130928020|NCT02380677|471372119|FG010|Overall Study|Lack of Efficacy|2|||
130928021|NCT02380677|471372120|FG011|Overall Study|Lack of Efficacy|1|||
130928022|NCT02380677|471372109|FG000|Overall Study|Withdrawal by Subject|0|||
130928023|NCT02380677|471372110|FG001|Overall Study|Withdrawal by Subject|0|||
130928024|NCT02380677|471372111|FG002|Overall Study|Withdrawal by Subject|0|||
130702664|NCT00105157|470534568|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
130702665|NCT00105157|470534569|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
130702666|NCT00105157|470534566|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
130702667|NCT00105157|470534567|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
130702668|NCT00105157|470534568|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
130702669|NCT00105157|470534569|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
130702670|NCT00105157|470534566|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
130702671|NCT00105157|470534567|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
130702672|NCT00105157|470534568|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
130702673|NCT00105157|470534569|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
130702674|NCT02212457|470534572|FG000|Overall Study|Adverse Event|1|||
130702675|NCT02212457|470534573|FG001|Overall Study|Adverse Event|2|||
130702676|NCT02212457|470534574|FG002|Overall Study|Adverse Event|2|||
130702677|NCT02212457|470534575|FG003|Overall Study|Adverse Event|2|||
130770295|NCT01483599|470784341|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130770296|NCT01483599|470784342|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130770297|NCT01483599|470784343|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130928025|NCT02380677|471372112|FG003|Overall Study|Withdrawal by Subject|0|||
130928026|NCT02380677|471372113|FG004|Overall Study|Withdrawal by Subject|0|||
131034762|NCT04810650|471761803|FG011|Overall Study|Disenrolled in error|0|||
130928027|NCT02380677|471372114|FG005|Overall Study|Withdrawal by Subject|0|||
130928028|NCT02380677|471372115|FG006|Overall Study|Withdrawal by Subject|0|||
130928029|NCT02380677|471372116|FG007|Overall Study|Withdrawal by Subject|0|||
130928030|NCT02380677|471372117|FG008|Overall Study|Withdrawal by Subject|0|||
130928031|NCT02380677|471372118|FG009|Overall Study|Withdrawal by Subject|1|||
130928032|NCT02380677|471372119|FG010|Overall Study|Withdrawal by Subject|0|||
130928033|NCT02380677|471372120|FG011|Overall Study|Withdrawal by Subject|3|||
130928034|NCT02380677|471372109|FG000|Overall Study|Other|0|||
130928035|NCT02380677|471372110|FG001|Overall Study|Other|0|||
130928036|NCT02380677|471372111|FG002|Overall Study|Other|0|||
130928037|NCT02380677|471372112|FG003|Overall Study|Other|1|||
130928038|NCT02380677|471372113|FG004|Overall Study|Other|1|||
130928039|NCT02380677|471372114|FG005|Overall Study|Other|1|||
130928040|NCT02380677|471372115|FG006|Overall Study|Other|0|||
130928041|NCT02380677|471372116|FG007|Overall Study|Other|0|||
130928042|NCT02380677|471372117|FG008|Overall Study|Other|0|||
130928043|NCT02380677|471372118|FG009|Overall Study|Other|0|||
130928044|NCT02380677|471372119|FG010|Overall Study|Other|0|||
130928045|NCT02380677|471372120|FG011|Overall Study|Other|0|||
130928046|NCT01029795|471372128|FG000|Overall Study|Entry Criteria Not Met|2|||
130928047|NCT01029795|471372129|FG001|Overall Study|Entry Criteria Not Met|1|||
130928048|NCT01029795|471372128|FG000|Overall Study|Physician Decision|2|||
130928049|NCT01029795|471372129|FG001|Overall Study|Physician Decision|1|||
130928050|NCT01029795|471372128|FG000|Overall Study|Sponsor Decision|11|||
130928051|NCT01029795|471372129|FG001|Overall Study|Sponsor Decision|17|||
130928052|NCT01029795|471372128|FG000|Overall Study|Withdrawal by Subject|1|||
130928053|NCT01029795|471372129|FG001|Overall Study|Withdrawal by Subject|3|||
130928054|NCT03217175|471372130|FG000|Overall Study|Physician Decision|4|||
130928055|NCT03217175|471372131|FG001|Overall Study|Physician Decision|1|||
130928056|NCT05035550|471372140|FG000|Overall Study|Withdrawal by Subject|3|||
130928057|NCT05035550|471372141|FG001|Overall Study|Withdrawal by Subject|0|||
130928058|NCT00003479|471372142|FG000|Overall Study|Not evaluable|3|||
130928059|NCT02128113|471372143|FG000|Overall Study|Withdrawal by Subject|3|||
130928060|NCT02128113|471372144|FG001|Overall Study|Withdrawal by Subject|1|||
130928061|NCT02128113|471372145|FG002|Overall Study|Withdrawal by Subject|0|||
130928062|NCT02128113|471372143|FG000|Overall Study|Protocol Violation|0|||
130928063|NCT02128113|471372144|FG001|Overall Study|Protocol Violation|1|||
130928064|NCT02128113|471372145|FG002|Overall Study|Protocol Violation|0|||
130928065|NCT02128113|471372143|FG000|Overall Study|Surgery cancelled|0|||
130928066|NCT02128113|471372144|FG001|Overall Study|Surgery cancelled|1|||
130928067|NCT02128113|471372145|FG002|Overall Study|Surgery cancelled|0|||
130928068|NCT02128113|471372143|FG000|Overall Study|Adverse Event|0|||
130928069|NCT02128113|471372144|FG001|Overall Study|Adverse Event|0|||
130928070|NCT02128113|471372145|FG002|Overall Study|Adverse Event|1|||
130928071|NCT01061177|471372146|FG000|Overall Study|Adverse Event|117|||
130928072|NCT01061177|471372146|FG000|Overall Study|Withdrawal by Subject|27|||
130928073|NCT01061177|471372146|FG000|Overall Study|Disease progression|17|||
130928074|NCT01061177|471372146|FG000|Overall Study|Protocol Violation|11|||
130928075|NCT01061177|471372146|FG000|Overall Study|Lost to Follow-up|9|||
130928076|NCT01061177|471372146|FG000|Overall Study|New cancer therapy|9|||
130928077|NCT01061177|471372146|FG000|Overall Study|Abnormal laboratory values|6|||
130928078|NCT01061177|471372146|FG000|Overall Study|Abnormal test procedure results|4|||
130928079|NCT01061177|471372146|FG000|Overall Study|Administratie problems|4|||
130928080|NCT01061177|471372146|FG000|Overall Study|Death|4|||
130928081|NCT02244606|471372159|FG000|Overall Study|Adverse Event|0|||
130928082|NCT02244606|471372160|FG001|Overall Study|Adverse Event|1|||
130928083|NCT02244606|471372161|FG002|Overall Study|Adverse Event|1|||
130928084|NCT02244606|471372162|FG003|Overall Study|Adverse Event|0|||
130928085|NCT02244606|471372159|FG000|Overall Study|Lost to Follow-up|2|||
130928086|NCT02244606|471372160|FG001|Overall Study|Lost to Follow-up|2|||
130928087|NCT02244606|471372161|FG002|Overall Study|Lost to Follow-up|1|||
130928088|NCT02244606|471372162|FG003|Overall Study|Lost to Follow-up|0|||
130928089|NCT02244606|471372159|FG000|Overall Study|Protocol Violation|0|||
131223720|NCT01358708|472447107|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
130928090|NCT02244606|471372160|FG001|Overall Study|Protocol Violation|0|||
130928091|NCT02244606|471372161|FG002|Overall Study|Protocol Violation|0|||
130928092|NCT02244606|471372162|FG003|Overall Study|Protocol Violation|1|||
130928093|NCT02244606|471372159|FG000|Overall Study|Withdrawal by Subject|1|||
130928094|NCT02244606|471372160|FG001|Overall Study|Withdrawal by Subject|1|||
130928095|NCT02244606|471372161|FG002|Overall Study|Withdrawal by Subject|0|||
130928096|NCT02244606|471372162|FG003|Overall Study|Withdrawal by Subject|0|||
130928097|NCT02244606|471372159|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
130928098|NCT02244606|471372160|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
130928099|NCT02244606|471372161|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
130928100|NCT02244606|471372162|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
130928101|NCT01854710|471372163|FG000|Overall Study|Withdrawal by Subject|2|||
130928102|NCT01854710|471372164|FG001|Overall Study|Withdrawal by Subject|1|||
130928103|NCT01854710|471372165|FG002|Overall Study|Withdrawal by Subject|0|||
130928104|NCT01854710|471372166|FG003|Overall Study|Withdrawal by Subject|0|||
130928105|NCT01854710|471372167|FG004|Overall Study|Withdrawal by Subject|0|||
130928106|NCT01854710|471372168|FG005|Overall Study|Withdrawal by Subject|0|||
130928107|NCT01854710|471372163|FG000|Overall Study|CRI procedural error|2|||
130928108|NCT01854710|471372164|FG001|Overall Study|CRI procedural error|2|||
130928109|NCT01854710|471372165|FG002|Overall Study|CRI procedural error|2|||
130928110|NCT01854710|471372166|FG003|Overall Study|CRI procedural error|2|||
130928111|NCT01854710|471372167|FG004|Overall Study|CRI procedural error|2|||
130928112|NCT01854710|471372168|FG005|Overall Study|CRI procedural error|2|||
130928113|NCT01537393|471372169|FG000|Overall Study|Exclude prior to study|32|||
130928114|NCT01537393|471372170|FG001|Overall Study|Exclude prior to study|44|||
130928115|NCT01537393|471372169|FG000|Overall Study|Death|20|||
130928116|NCT01537393|471372170|FG001|Overall Study|Death|32|||
130928117|NCT01537393|471372169|FG000|Overall Study|Withdrawal by Subject|18|||
130928118|NCT01537393|471372170|FG001|Overall Study|Withdrawal by Subject|17|||
130928119|NCT01537393|471372169|FG000|Overall Study|Lost to Follow-up|53|||
130928120|NCT01537393|471372170|FG001|Overall Study|Lost to Follow-up|48|||
130928121|NCT01537393|471372169|FG000|Overall Study|Failure - Regrafted|28|||
130928122|NCT01537393|471372170|FG001|Overall Study|Failure - Regrafted|43|||
130928123|NCT01537393|471372169|FG000|Overall Study|Failure - Not regrafted|2|||
130928124|NCT01537393|471372170|FG001|Overall Study|Failure - Not regrafted|6|||
130928125|NCT01537393|471372169|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
130928126|NCT01537393|471372170|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
130928127|NCT01578187|471372171|FG000|Usability Phase|Withdrawal by Subject|1|||
130928128|NCT01709162|471372172|FG000|Overall Study|Disease progression|3|||
130928129|NCT01709162|471372173|FG001|Overall Study|Disease progression|3|||
130928130|NCT01709162|471372172|FG000|Overall Study|Study drug toxicity|2|||
130928131|NCT01709162|471372173|FG001|Overall Study|Study drug toxicity|0|||
130928132|NCT01709162|471372172|FG000|Overall Study|Administrative reason by sponsor|0|||
130928133|NCT01709162|471372173|FG001|Overall Study|Administrative reason by sponsor|1|||
130928134|NCT01709162|471372172|FG000|Overall Study|Other|1|||
130928135|NCT01709162|471372173|FG001|Overall Study|Other|0|||
130928136|NCT01709162|471372172|FG000|Overall Study|Withdrawal by Subject|0|||
130928137|NCT01709162|471372173|FG001|Overall Study|Withdrawal by Subject|1|||
130928138|NCT01844518|471372176|FG000|Overall Study|Adverse Event|7|||
130928139|NCT01844518|471372177|FG001|Overall Study|Adverse Event|1|||
130928140|NCT01844518|471372176|FG000|Overall Study|Lack of Efficacy|17|||
131034763|NCT04810650|471761804|FG012|Overall Study|Disenrolled in error|0|||
131034764|NCT04810650|471761805|FG013|Overall Study|Disenrolled in error|0|||
131034765|NCT04810650|471761792|FG000|Overall Study|Death|0|||
131034766|NCT04810650|471761793|FG001|Overall Study|Death|0|||
131034767|NCT04810650|471761794|FG002|Overall Study|Death|0|||
131034768|NCT04810650|471761795|FG003|Overall Study|Death|0|||
131034769|NCT04810650|471761796|FG004|Overall Study|Death|0|||
131034770|NCT04810650|471761797|FG005|Overall Study|Death|0|||
131034771|NCT04810650|471761798|FG006|Overall Study|Death|2|||
131034772|NCT04810650|471761799|FG007|Overall Study|Death|2|||
131034773|NCT04810650|471761800|FG008|Overall Study|Death|0|||
131034774|NCT04810650|471761801|FG009|Overall Study|Death|1|||
131034775|NCT04810650|471761802|FG010|Overall Study|Death|0|||
131034776|NCT04810650|471761803|FG011|Overall Study|Death|0|||
131034777|NCT04810650|471761804|FG012|Overall Study|Death|2|||
131034778|NCT04810650|471761805|FG013|Overall Study|Death|1|||
131034779|NCT04810650|471761792|FG000|Overall Study|Moved/transferred care|0|||
131034780|NCT04810650|471761793|FG001|Overall Study|Moved/transferred care|0|||
131034781|NCT04810650|471761794|FG002|Overall Study|Moved/transferred care|0|||
131034782|NCT04810650|471761795|FG003|Overall Study|Moved/transferred care|0|||
131034783|NCT04810650|471761796|FG004|Overall Study|Moved/transferred care|0|||
131034784|NCT04810650|471761797|FG005|Overall Study|Moved/transferred care|0|||
131034785|NCT04810650|471761798|FG006|Overall Study|Moved/transferred care|0|||
131034786|NCT04810650|471761799|FG007|Overall Study|Moved/transferred care|1|||
131034787|NCT04810650|471761800|FG008|Overall Study|Moved/transferred care|12|||
131034788|NCT04810650|471761801|FG009|Overall Study|Moved/transferred care|10|||
131034789|NCT04810650|471761802|FG010|Overall Study|Moved/transferred care|0|||
131034790|NCT04810650|471761803|FG011|Overall Study|Moved/transferred care|0|||
130928141|NCT01844518|471372177|FG001|Overall Study|Lack of Efficacy|5|||
130928142|NCT01844518|471372176|FG000|Overall Study|Participant's request to discontinue|4|||
130928143|NCT01844518|471372177|FG001|Overall Study|Participant's request to discontinue|1|||
130928144|NCT01844518|471372176|FG000|Overall Study|Poor/Non-compliance|1|||
130928145|NCT01844518|471372177|FG001|Overall Study|Poor/Non-compliance|0|||
130928146|NCT01844518|471372176|FG000|Overall Study|No Longer Met Study Criteria|2|||
130928147|NCT01844518|471372177|FG001|Overall Study|No Longer Met Study Criteria|0|||
130928148|NCT01844518|471372176|FG000|Overall Study|Withdrawal by Subject|9|||
130928149|NCT01844518|471372177|FG001|Overall Study|Withdrawal by Subject|0|||
130928150|NCT01844518|471372176|FG000|Overall Study|Pregnancy|1|||
130928151|NCT01844518|471372177|FG001|Overall Study|Pregnancy|0|||
130928152|NCT00291577|471372179|FG000|Overall Study|Adverse Event|1|||
131034791|NCT04810650|471761804|FG012|Overall Study|Moved/transferred care|0|||
131034792|NCT04810650|471761805|FG013|Overall Study|Moved/transferred care|0|||
130702678|NCT02212457|470534576|FG004|Overall Study|Adverse Event|0|||
130702679|NCT02212457|470534577|FG005|Overall Study|Adverse Event|1|||
130702680|NCT02212457|470534572|FG000|Overall Study|Withdrawal by Subject|8|||
130702681|NCT02212457|470534573|FG001|Overall Study|Withdrawal by Subject|10|||
130702682|NCT02212457|470534574|FG002|Overall Study|Withdrawal by Subject|8|||
130702683|NCT02212457|470534575|FG003|Overall Study|Withdrawal by Subject|6|||
130702684|NCT02212457|470534576|FG004|Overall Study|Withdrawal by Subject|5|||
130702685|NCT02212457|470534577|FG005|Overall Study|Withdrawal by Subject|4|||
130702686|NCT02212457|470534572|FG000|Overall Study|Lost to Follow-up|6|||
130702687|NCT02212457|470534573|FG001|Overall Study|Lost to Follow-up|7|||
130702688|NCT02212457|470534574|FG002|Overall Study|Lost to Follow-up|4|||
130702689|NCT02212457|470534575|FG003|Overall Study|Lost to Follow-up|1|||
130702690|NCT02212457|470534576|FG004|Overall Study|Lost to Follow-up|8|||
130702691|NCT02212457|470534577|FG005|Overall Study|Lost to Follow-up|4|||
130702692|NCT02212457|470534572|FG000|Overall Study|Protocol Violation|2|||
130702693|NCT02212457|470534573|FG001|Overall Study|Protocol Violation|1|||
130702694|NCT02212457|470534574|FG002|Overall Study|Protocol Violation|0|||
130702695|NCT02212457|470534575|FG003|Overall Study|Protocol Violation|1|||
130702696|NCT02212457|470534576|FG004|Overall Study|Protocol Violation|2|||
130702697|NCT02212457|470534577|FG005|Overall Study|Protocol Violation|3|||
130702698|NCT02212457|470534572|FG000|Overall Study|Other|2|||
130702699|NCT02212457|470534573|FG001|Overall Study|Other|1|||
130702700|NCT02212457|470534574|FG002|Overall Study|Other|2|||
130702701|NCT02212457|470534575|FG003|Overall Study|Other|1|||
130702702|NCT02212457|470534576|FG004|Overall Study|Other|0|||
130702703|NCT02212457|470534577|FG005|Overall Study|Other|1|||
130702704|NCT00420095|470534578|FG000|Overall Study|Adverse Event|1|||
130702705|NCT00420095|470534579|FG001|Overall Study|Adverse Event|0|||
130702706|NCT00420095|470534578|FG000|Overall Study|Protocol Violation|1|||
130702707|NCT00420095|470534579|FG001|Overall Study|Protocol Violation|1|||
130702708|NCT00420095|470534578|FG000|Overall Study|Lost to Follow-up|1|||
130702709|NCT00420095|470534579|FG001|Overall Study|Lost to Follow-up|0|||
130702710|NCT00393705|470534580|FG000|Overall Study|Adverse Event|0|||
130702711|NCT00393705|470534581|FG001|Overall Study|Adverse Event|2|||
130702712|NCT00393705|470534580|FG000|Overall Study|Death|0|||
130702713|NCT00393705|470534581|FG001|Overall Study|Death|1|||
130702714|NCT00393705|470534580|FG000|Overall Study|Lost to Follow-up|2|||
130702715|NCT00393705|470534581|FG001|Overall Study|Lost to Follow-up|2|||
130702716|NCT00393705|470534580|FG000|Overall Study|Entry Criteria Not Met|10|||
130702717|NCT00393705|470534581|FG001|Overall Study|Entry Criteria Not Met|10|||
130702718|NCT00393705|470534580|FG000|Overall Study|Protocol Violation|4|||
130702719|NCT00393705|470534581|FG001|Overall Study|Protocol Violation|3|||
130702720|NCT00393705|470534580|FG000|Overall Study|Withdrawal by Subject|5|||
131223721|NCT03056001|472447108|FG000|Overall Study|Death|24|||
131223722|NCT04380701|472447109|FG000|Overall Study|Pregnancy|0|||
130702721|NCT00393705|470534581|FG001|Overall Study|Withdrawal by Subject|3|||
130702722|NCT00393705|470534580|FG000|Overall Study|Physician Decision|2|||
130702723|NCT00393705|470534581|FG001|Overall Study|Physician Decision|2|||
130702724|NCT03185741|470534582|FG000|Baseline|Withdrawal by Subject|1|||
131034793|NCT04810650|471761792|FG000|Overall Study|Lost to Follow-up|15|||
130702725|NCT03185741|470534583|FG001|Baseline|Withdrawal by Subject|3|||
130702726|NCT03185741|470534584|FG002|Baseline|Withdrawal by Subject|2|||
130702727|NCT03185741|470534582|FG000|Baseline|Lost to Follow-up|1|||
130702728|NCT03185741|470534583|FG001|Baseline|Lost to Follow-up|2|||
130702729|NCT03185741|470534584|FG002|Baseline|Lost to Follow-up|3|||
130702730|NCT03185741|470534582|FG000|3Month|Death|1|||
130702731|NCT03185741|470534583|FG001|3Month|Death|1|||
130702732|NCT03185741|470534584|FG002|3Month|Death|2|||
130702733|NCT03185741|470534582|FG000|3Month|Withdrawal by Subject|1|||
130702734|NCT03185741|470534583|FG001|3Month|Withdrawal by Subject|5|||
130702735|NCT03185741|470534584|FG002|3Month|Withdrawal by Subject|1|||
130702736|NCT03185741|470534582|FG000|3Month|Lost to Follow-up|7|||
130702737|NCT03185741|470534583|FG001|3Month|Lost to Follow-up|9|||
130702738|NCT03185741|470534584|FG002|3Month|Lost to Follow-up|8|||
130702739|NCT03185741|470534582|FG000|3Month|Unavailable for 3Month|11|||
130702740|NCT03185741|470534583|FG001|3Month|Unavailable for 3Month|10|||
130702741|NCT03185741|470534584|FG002|3Month|Unavailable for 3Month|11|||
130702742|NCT03185741|470534582|FG000|3Month|Protocol Violation|0|||
130702743|NCT03185741|470534583|FG001|3Month|Protocol Violation|0|||
130702744|NCT03185741|470534584|FG002|3Month|Protocol Violation|3|||
130702745|NCT03185741|470534582|FG000|6Month|Death|1|||
130702746|NCT03185741|470534583|FG001|6Month|Death|1|||
130702747|NCT03185741|470534584|FG002|6Month|Death|2|||
130702748|NCT03185741|470534582|FG000|6Month|Withdrawal by Subject|2|||
130702749|NCT03185741|470534583|FG001|6Month|Withdrawal by Subject|3|||
130702750|NCT03185741|470534584|FG002|6Month|Withdrawal by Subject|1|||
130702751|NCT03185741|470534582|FG000|6Month|Lost to Follow-up|16|||
130702752|NCT03185741|470534583|FG001|6Month|Lost to Follow-up|15|||
130702753|NCT03185741|470534584|FG002|6Month|Lost to Follow-up|16|||
130702754|NCT00654641|470534586|FG000|Overall Study|Lost to Follow-up|2|||
130702755|NCT00654641|470534587|FG001|Overall Study|Lost to Follow-up|3|||
130702756|NCT03365791|470534588|FG000|Overall Study|Adverse Event|5|||
130702757|NCT03365791|470534588|FG000|Overall Study|Death|1|||
130702758|NCT03365791|470534588|FG000|Overall Study|Lost to Follow-up|1|||
130702759|NCT03365791|470534588|FG000|Overall Study|Physician Decision|9|||
130702760|NCT03365791|470534588|FG000|Overall Study|Progressive disease|51|||
130928153|NCT00291577|471372179|FG000|Overall Study|Other|4|||
130928154|NCT00291577|471372179|FG000|Overall Study|Withdrawal by Subject|2|||
130928155|NCT00291577|471372179|FG000|Overall Study|Lack of Efficacy|14|||
130928156|NCT04584645|471372180|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
130928157|NCT04584645|471372181|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
130928158|NCT00390468|471372182|FG000|Overall Study|Protocol Violation|2|||
130928159|NCT00390468|471372182|FG000|Overall Study|Lack of Efficacy|1|||
130928160|NCT03129100|471372188|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
130928161|NCT03129100|471372189|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
130928162|NCT03129100|471372190|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
130928163|NCT03129100|471372191|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
130928164|NCT03129100|471372192|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
130928165|NCT03129100|471372193|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
130928166|NCT03129100|471372194|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
130928167|NCT03129100|471372195|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
130928168|NCT03129100|471372196|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
130928169|NCT03129100|471372197|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
130928170|NCT03129100|471372198|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
130928171|NCT03129100|471372199|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
130928172|NCT03129100|471372200|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
130928173|NCT03129100|471372201|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
130928174|NCT03129100|471372202|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
130928175|NCT03129100|471372203|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
130928176|NCT03129100|471372204|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
130928177|NCT03129100|471372205|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
130928178|NCT03129100|471372206|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
130928179|NCT03129100|471372207|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
130928180|NCT03129100|471372208|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
130928181|NCT03129100|471372209|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
130928182|NCT03129100|471372210|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
130928183|NCT03129100|471372211|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
130928184|NCT03129100|471372212|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
130928185|NCT03129100|471372213|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
130928186|NCT03129100|471372188|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
130928187|NCT03129100|471372189|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928188|NCT03129100|471372190|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928189|NCT03129100|471372191|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928190|NCT03129100|471372192|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928191|NCT03129100|471372193|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928192|NCT03129100|471372194|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928193|NCT03129100|471372195|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928194|NCT03129100|471372196|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928195|NCT03129100|471372197|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928196|NCT03129100|471372198|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928197|NCT03129100|471372199|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928198|NCT03129100|471372200|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130702761|NCT03365791|470534588|FG000|Overall Study|Subject/guardian decision|5|||
130702762|NCT03693950|470534589|FG000|Overall Study|Withdrawal by Subject|1|||
130702763|NCT03693950|470534590|FG001|Overall Study|Withdrawal by Subject|0|||
130702764|NCT02129062|470535871|FG000|Overall Study|Death|1|||
130702765|NCT02129062|470535871|FG000|Overall Study|Disease Progression|2|||
130702766|NCT02722616|470535872|FG000|Overall Study|Sponsor closed study after one month|2|||
130702767|NCT02722616|470535873|FG001|Overall Study|Sponsor closed study after one month|0|||
130702768|NCT02722616|470535874|FG002|Overall Study|Sponsor closed study after one month|0|||
130702769|NCT01923311|470535875|FG000|Overall Study|Pregnancy|1|||
130702770|NCT01923311|470535876|FG001|Overall Study|Pregnancy|0|||
130702771|NCT01923311|470535875|FG000|Overall Study|Investigator's Discretion|1|||
130702772|NCT01923311|470535876|FG001|Overall Study|Investigator's Discretion|0|||
130702773|NCT01923311|470535875|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130770298|NCT01483599|470784344|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130770299|NCT01483599|470784345|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130770300|NCT01483599|470784346|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130928199|NCT03129100|471372201|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928200|NCT03129100|471372202|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928201|NCT03129100|471372203|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928202|NCT03129100|471372204|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928203|NCT03129100|471372205|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
131223723|NCT04380701|472447110|FG001|Overall Study|Pregnancy|0|||
130928204|NCT03129100|471372206|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928205|NCT03129100|471372207|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928206|NCT03129100|471372208|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928207|NCT03129100|471372209|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928208|NCT03129100|471372210|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928209|NCT03129100|471372211|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928210|NCT03129100|471372212|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928211|NCT03129100|471372213|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130928212|NCT03129100|471372188|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
130928213|NCT03129100|471372189|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
130928214|NCT03129100|471372190|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928215|NCT03129100|471372191|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928216|NCT03129100|471372192|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928217|NCT03129100|471372193|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928218|NCT03129100|471372194|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928219|NCT03129100|471372195|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928220|NCT03129100|471372196|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928221|NCT03129100|471372197|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928222|NCT03129100|471372198|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928223|NCT03129100|471372199|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928224|NCT03129100|471372200|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928225|NCT03129100|471372201|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928226|NCT03129100|471372202|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928227|NCT03129100|471372203|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928228|NCT03129100|471372204|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928229|NCT03129100|471372205|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928230|NCT03129100|471372206|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928231|NCT03129100|471372207|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928232|NCT03129100|471372208|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928233|NCT03129100|471372209|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928234|NCT03129100|471372210|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928235|NCT03129100|471372211|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928236|NCT03129100|471372212|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928237|NCT03129100|471372213|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
130928238|NCT03129100|471372188|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
130928239|NCT03129100|471372189|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
130928240|NCT03129100|471372190|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928241|NCT03129100|471372191|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928242|NCT03129100|471372192|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928243|NCT03129100|471372193|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928244|NCT03129100|471372194|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928245|NCT03129100|471372195|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928246|NCT03129100|471372196|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928247|NCT03129100|471372197|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928248|NCT03129100|471372198|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928249|NCT03129100|471372199|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928250|NCT03129100|471372200|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928251|NCT03129100|471372201|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928252|NCT03129100|471372202|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928253|NCT03129100|471372203|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928254|NCT03129100|471372204|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130702774|NCT01923311|470535876|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130928255|NCT03129100|471372205|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928256|NCT03129100|471372206|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928257|NCT03129100|471372207|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928258|NCT03129100|471372208|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928259|NCT03129100|471372209|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928260|NCT03129100|471372210|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928261|NCT03129100|471372211|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928262|NCT03129100|471372212|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928263|NCT03129100|471372213|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
130928264|NCT03129100|471372188|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928265|NCT03129100|471372189|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
130928266|NCT03129100|471372190|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928267|NCT03129100|471372191|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928268|NCT03129100|471372192|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928269|NCT03129100|471372193|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
131223724|NCT04380701|472447111|FG002|Overall Study|Pregnancy|0|||
130702775|NCT01923311|470535875|FG000|Overall Study|Withdrew Consent|1|||
130928270|NCT03129100|471372194|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928271|NCT03129100|471372195|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928272|NCT03129100|471372196|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928273|NCT03129100|471372197|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928274|NCT03129100|471372198|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928275|NCT03129100|471372199|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928276|NCT03129100|471372200|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928277|NCT03129100|471372201|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928278|NCT03129100|471372202|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928279|NCT03129100|471372203|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928280|NCT03129100|471372204|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928281|NCT03129100|471372205|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928282|NCT03129100|471372206|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928283|NCT03129100|471372207|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928284|NCT03129100|471372208|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928285|NCT03129100|471372209|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928286|NCT03129100|471372210|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928287|NCT03129100|471372211|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928288|NCT03129100|471372212|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928289|NCT03129100|471372213|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
130928290|NCT03129100|471372188|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928291|NCT03129100|471372189|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928292|NCT03129100|471372190|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
130928293|NCT03129100|471372191|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
130928294|NCT03129100|471372192|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928295|NCT03129100|471372193|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
130928296|NCT03129100|471372194|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928297|NCT03129100|471372195|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928298|NCT03129100|471372196|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928299|NCT03129100|471372197|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928300|NCT03129100|471372198|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928301|NCT03129100|471372199|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928302|NCT03129100|471372200|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928303|NCT03129100|471372201|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928304|NCT03129100|471372202|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928305|NCT03129100|471372203|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928306|NCT03129100|471372204|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928307|NCT03129100|471372205|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928308|NCT03129100|471372206|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928309|NCT03129100|471372207|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928310|NCT03129100|471372208|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928311|NCT03129100|471372209|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928312|NCT03129100|471372210|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928313|NCT03129100|471372211|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928314|NCT03129100|471372212|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928315|NCT03129100|471372213|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
130928316|NCT03129100|471372188|FG000|Period2 Extension Period (Group A and B)|Death|0|||
130928317|NCT03129100|471372189|FG001|Period2 Extension Period (Group A and B)|Death|0|||
130928318|NCT03129100|471372190|FG002|Period2 Extension Period (Group A and B)|Death|1|||
130928319|NCT03129100|471372191|FG003|Period2 Extension Period (Group A and B)|Death|0|||
130928320|NCT03129100|471372192|FG004|Period2 Extension Period (Group A and B)|Death|0|||
130928321|NCT03129100|471372193|FG005|Period2 Extension Period (Group A and B)|Death|0|||
130928322|NCT03129100|471372194|FG006|Period2 Extension Period (Group A and B)|Death|0|||
130928323|NCT03129100|471372195|FG007|Period2 Extension Period (Group A and B)|Death|0|||
130928324|NCT03129100|471372196|FG008|Period2 Extension Period (Group A and B)|Death|0|||
130928325|NCT03129100|471372197|FG009|Period2 Extension Period (Group A and B)|Death|0|||
130928326|NCT03129100|471372198|FG010|Period2 Extension Period (Group A and B)|Death|0|||
130928327|NCT03129100|471372199|FG011|Period2 Extension Period (Group A and B)|Death|0|||
130928328|NCT03129100|471372200|FG012|Period2 Extension Period (Group A and B)|Death|0|||
130928329|NCT03129100|471372201|FG013|Period2 Extension Period (Group A and B)|Death|0|||
130928330|NCT03129100|471372202|FG014|Period2 Extension Period (Group A and B)|Death|0|||
130928331|NCT03129100|471372203|FG015|Period2 Extension Period (Group A and B)|Death|0|||
130928332|NCT03129100|471372204|FG016|Period2 Extension Period (Group A and B)|Death|0|||
130928333|NCT03129100|471372205|FG017|Period2 Extension Period (Group A and B)|Death|0|||
130702776|NCT01923311|470535876|FG001|Overall Study|Withdrew Consent|0|||
130702777|NCT01923311|470535875|FG000|Overall Study|Study Terminated by Sponsor|12|||
130702778|NCT01923311|470535876|FG001|Overall Study|Study Terminated by Sponsor|0|||
130702779|NCT02031237|470535877|FG000|Overall Study|Death|1|||
130702780|NCT02031237|470535878|FG001|Overall Study|Death|5|||
130702781|NCT02031237|470535879|FG002|Overall Study|Death|0|||
130702782|NCT02031237|470535877|FG000|Overall Study|Physician Decision|0|||
130702783|NCT02031237|470535878|FG001|Overall Study|Physician Decision|1|||
130928334|NCT03129100|471372206|FG018|Period2 Extension Period (Group A and B)|Death|0|||
130928335|NCT03129100|471372207|FG019|Period2 Extension Period (Group A and B)|Death|0|||
130928336|NCT03129100|471372208|FG020|Period2 Extension Period (Group A and B)|Death|0|||
130928337|NCT03129100|471372209|FG021|Period2 Extension Period (Group A and B)|Death|0|||
130928338|NCT03129100|471372210|FG022|Period2 Extension Period (Group A and B)|Death|0|||
130928339|NCT03129100|471372211|FG023|Period2 Extension Period (Group A and B)|Death|0|||
130928340|NCT03129100|471372212|FG024|Period2 Extension Period (Group A and B)|Death|0|||
130928341|NCT03129100|471372213|FG025|Period2 Extension Period (Group A and B)|Death|0|||
130928342|NCT03129100|471372188|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928343|NCT03129100|471372189|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928344|NCT03129100|471372190|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
130928345|NCT03129100|471372191|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
130928346|NCT03129100|471372192|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
130928347|NCT03129100|471372193|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
130928348|NCT03129100|471372194|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
130928349|NCT03129100|471372195|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928350|NCT03129100|471372196|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928351|NCT03129100|471372197|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928352|NCT03129100|471372198|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928353|NCT03129100|471372199|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928354|NCT03129100|471372200|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928355|NCT03129100|471372201|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928356|NCT03129100|471372202|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928357|NCT03129100|471372203|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928358|NCT03129100|471372204|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928359|NCT03129100|471372205|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928360|NCT03129100|471372206|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928361|NCT03129100|471372207|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928362|NCT03129100|471372208|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928363|NCT03129100|471372209|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928364|NCT03129100|471372210|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928365|NCT03129100|471372211|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928366|NCT03129100|471372212|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928367|NCT03129100|471372213|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
130928368|NCT03129100|471372188|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928369|NCT03129100|471372189|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928370|NCT03129100|471372190|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
130928371|NCT03129100|471372191|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928372|NCT03129100|471372192|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928373|NCT03129100|471372193|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928374|NCT03129100|471372194|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928375|NCT03129100|471372195|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928376|NCT03129100|471372196|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928377|NCT03129100|471372197|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928378|NCT03129100|471372198|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928379|NCT03129100|471372199|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928380|NCT03129100|471372200|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928381|NCT03129100|471372201|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928382|NCT03129100|471372202|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928383|NCT03129100|471372203|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928384|NCT03129100|471372204|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928385|NCT03129100|471372205|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928386|NCT03129100|471372206|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928387|NCT03129100|471372207|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928388|NCT03129100|471372208|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928389|NCT03129100|471372209|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928390|NCT03129100|471372210|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928391|NCT03129100|471372211|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928392|NCT03129100|471372212|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130770301|NCT01483599|470784347|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130770302|NCT01483599|470784348|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130770303|NCT01483599|470784349|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130702784|NCT02031237|470535879|FG002|Overall Study|Physician Decision|0|||
130702785|NCT02031237|470535877|FG000|Overall Study|Withdrawal by Subject|2|||
130702786|NCT02031237|470535878|FG001|Overall Study|Withdrawal by Subject|2|||
130702787|NCT02031237|470535879|FG002|Overall Study|Withdrawal by Subject|0|||
130928393|NCT03129100|471372213|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
130928394|NCT03129100|471372188|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928395|NCT03129100|471372189|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928396|NCT03129100|471372190|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
130928397|NCT03129100|471372191|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928398|NCT03129100|471372192|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928399|NCT03129100|471372193|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928400|NCT03129100|471372194|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928401|NCT03129100|471372195|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130702788|NCT02031237|470535877|FG000|Overall Study|Protocol Violation|2|||
130702789|NCT02031237|470535878|FG001|Overall Study|Protocol Violation|6|||
130928402|NCT03129100|471372196|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928403|NCT03129100|471372197|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928404|NCT03129100|471372198|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928405|NCT03129100|471372199|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928406|NCT03129100|471372200|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928407|NCT03129100|471372201|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928408|NCT03129100|471372202|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928409|NCT03129100|471372203|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928410|NCT03129100|471372204|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928411|NCT03129100|471372205|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928412|NCT03129100|471372206|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928413|NCT03129100|471372207|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928414|NCT03129100|471372208|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928415|NCT03129100|471372209|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928416|NCT03129100|471372210|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928417|NCT03129100|471372211|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928418|NCT03129100|471372212|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928419|NCT03129100|471372213|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
130928420|NCT03129100|471372188|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928421|NCT03129100|471372189|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928422|NCT03129100|471372190|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
130928423|NCT03129100|471372191|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928424|NCT03129100|471372192|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928425|NCT03129100|471372193|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928426|NCT03129100|471372194|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928427|NCT03129100|471372195|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928428|NCT03129100|471372196|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928429|NCT03129100|471372197|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928430|NCT03129100|471372198|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928431|NCT03129100|471372199|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928432|NCT03129100|471372200|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928433|NCT03129100|471372201|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928434|NCT03129100|471372202|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928435|NCT03129100|471372203|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928436|NCT03129100|471372204|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928437|NCT03129100|471372205|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928438|NCT03129100|471372206|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928439|NCT03129100|471372207|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928440|NCT03129100|471372208|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928441|NCT03129100|471372209|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928442|NCT03129100|471372210|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928443|NCT03129100|471372211|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928444|NCT03129100|471372212|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
131034794|NCT04810650|471761793|FG001|Overall Study|Lost to Follow-up|12|||
130702790|NCT02031237|470535879|FG002|Overall Study|Protocol Violation|0|||
130702791|NCT02031237|470535877|FG000|Overall Study|Alternate Treatment Given|0|||
130702792|NCT02031237|470535878|FG001|Overall Study|Alternate Treatment Given|0|||
130702793|NCT02031237|470535879|FG002|Overall Study|Alternate Treatment Given|3|||
130702794|NCT02415387|470535895|FG000|Overall Study|Withdrawal by Subject|6|||
130702795|NCT02415387|470535896|FG001|Overall Study|Withdrawal by Subject|1|||
130702796|NCT02415387|470535895|FG000|Overall Study|blood draw problem|0|||
130702797|NCT02415387|470535896|FG001|Overall Study|blood draw problem|1|||
130702798|NCT02415387|470535895|FG000|Overall Study|Protocol Violation|1|||
130702799|NCT02415387|470535896|FG001|Overall Study|Protocol Violation|0|||
130928445|NCT03129100|471372213|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
130928446|NCT03129100|471372188|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928447|NCT03129100|471372189|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928448|NCT03129100|471372190|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928449|NCT03129100|471372191|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928450|NCT03129100|471372192|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
130928451|NCT03129100|471372193|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
130928452|NCT03129100|471372194|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
130928453|NCT03129100|471372195|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928454|NCT03129100|471372196|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928455|NCT03129100|471372197|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928456|NCT03129100|471372198|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928457|NCT03129100|471372199|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928458|NCT03129100|471372200|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928459|NCT03129100|471372201|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928460|NCT03129100|471372202|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928461|NCT03129100|471372203|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928462|NCT03129100|471372204|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928463|NCT03129100|471372205|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928464|NCT03129100|471372206|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928465|NCT03129100|471372207|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928466|NCT03129100|471372208|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928467|NCT03129100|471372209|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928468|NCT03129100|471372210|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928469|NCT03129100|471372211|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928470|NCT03129100|471372212|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928471|NCT03129100|471372213|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
130928472|NCT03129100|471372188|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928473|NCT03129100|471372189|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928474|NCT03129100|471372190|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928475|NCT03129100|471372191|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928476|NCT03129100|471372192|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928477|NCT03129100|471372193|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928478|NCT03129100|471372194|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928479|NCT03129100|471372195|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928480|NCT03129100|471372196|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928481|NCT03129100|471372197|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
130702800|NCT01765751|470535903|FG000|Overall Study|Lost to Follow-up|0|||
130928482|NCT03129100|471372198|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928483|NCT03129100|471372199|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928484|NCT03129100|471372200|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928485|NCT03129100|471372201|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130702801|NCT01765751|470535904|FG001|Overall Study|Lost to Follow-up|2|||
130702802|NCT01765751|470535905|FG002|Overall Study|Lost to Follow-up|1|||
130928486|NCT03129100|471372202|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928487|NCT03129100|471372203|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928488|NCT03129100|471372204|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928489|NCT03129100|471372205|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928490|NCT03129100|471372206|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928491|NCT03129100|471372207|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928492|NCT03129100|471372208|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928493|NCT03129100|471372209|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928494|NCT03129100|471372210|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928495|NCT03129100|471372211|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928496|NCT03129100|471372212|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928497|NCT03129100|471372213|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
130928498|NCT03129100|471372188|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130702803|NCT03429049|470535909|FG000|Overall Study|Adverse Event|2|||
130702804|NCT03429049|470535910|FG001|Overall Study|Adverse Event|3|||
130702805|NCT03429049|470535909|FG000|Overall Study|Death|0|||
130702806|NCT03429049|470535910|FG001|Overall Study|Death|1|||
130928499|NCT03129100|471372189|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928500|NCT03129100|471372190|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928501|NCT03129100|471372191|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928502|NCT03129100|471372192|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928503|NCT03129100|471372193|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928504|NCT03129100|471372194|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928505|NCT03129100|471372195|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928506|NCT03129100|471372196|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928507|NCT03129100|471372197|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928508|NCT03129100|471372198|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928509|NCT03129100|471372199|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
130928510|NCT03129100|471372200|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928511|NCT03129100|471372201|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928512|NCT03129100|471372202|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928513|NCT03129100|471372203|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928514|NCT03129100|471372204|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928515|NCT03129100|471372205|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928516|NCT03129100|471372206|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928517|NCT03129100|471372207|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928518|NCT03129100|471372208|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928519|NCT03129100|471372209|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928520|NCT03129100|471372210|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928521|NCT03129100|471372211|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928522|NCT03129100|471372212|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928523|NCT03129100|471372213|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
130928524|NCT03129100|471372188|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928525|NCT03129100|471372189|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928526|NCT03129100|471372190|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928527|NCT03129100|471372191|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928528|NCT03129100|471372192|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928529|NCT03129100|471372193|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928530|NCT03129100|471372194|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928531|NCT03129100|471372195|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928532|NCT03129100|471372196|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928533|NCT03129100|471372197|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928534|NCT03129100|471372198|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928535|NCT03129100|471372199|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
130928536|NCT03129100|471372200|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
130928537|NCT03129100|471372201|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
130928538|NCT03129100|471372202|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
130928539|NCT03129100|471372203|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928540|NCT03129100|471372204|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928541|NCT03129100|471372205|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928542|NCT03129100|471372206|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928543|NCT03129100|471372207|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928544|NCT03129100|471372208|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928545|NCT03129100|471372209|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928546|NCT03129100|471372210|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928547|NCT03129100|471372211|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928548|NCT03129100|471372212|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928549|NCT03129100|471372213|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130928550|NCT03129100|471372188|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928551|NCT03129100|471372189|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928552|NCT03129100|471372190|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928553|NCT03129100|471372191|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928554|NCT03129100|471372192|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928555|NCT03129100|471372193|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928556|NCT03129100|471372194|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928557|NCT03129100|471372195|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
131034795|NCT04810650|471761794|FG002|Overall Study|Lost to Follow-up|7|||
131034796|NCT04810650|471761795|FG003|Overall Study|Lost to Follow-up|9|||
131034797|NCT04810650|471761796|FG004|Overall Study|Lost to Follow-up|10|||
131034798|NCT04810650|471761797|FG005|Overall Study|Lost to Follow-up|6|||
130702807|NCT03429049|470535909|FG000|Overall Study|Lack of Efficacy|4|||
130928558|NCT03129100|471372196|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928559|NCT03129100|471372197|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928560|NCT03129100|471372198|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928561|NCT03129100|471372199|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
130928562|NCT03129100|471372200|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928563|NCT03129100|471372201|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
130928564|NCT03129100|471372202|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
130928565|NCT03129100|471372203|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928566|NCT03129100|471372204|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928567|NCT03129100|471372205|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928568|NCT03129100|471372206|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928569|NCT03129100|471372207|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928570|NCT03129100|471372208|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928571|NCT03129100|471372209|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928572|NCT03129100|471372210|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928573|NCT03129100|471372211|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928574|NCT03129100|471372212|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928575|NCT03129100|471372213|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
130928576|NCT03129100|471372188|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928577|NCT03129100|471372189|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928578|NCT03129100|471372190|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928579|NCT03129100|471372191|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928580|NCT03129100|471372192|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928581|NCT03129100|471372193|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928582|NCT03129100|471372194|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928583|NCT03129100|471372195|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928584|NCT03129100|471372196|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928585|NCT03129100|471372197|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928586|NCT03129100|471372198|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928587|NCT03129100|471372199|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928588|NCT03129100|471372200|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928589|NCT03129100|471372201|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928590|NCT03129100|471372202|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928591|NCT03129100|471372203|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
130928592|NCT03129100|471372204|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928593|NCT03129100|471372205|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928594|NCT03129100|471372206|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928595|NCT03129100|471372207|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928596|NCT03129100|471372208|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928597|NCT03129100|471372209|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928598|NCT03129100|471372210|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928599|NCT03129100|471372211|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130702808|NCT03429049|470535910|FG001|Overall Study|Lack of Efficacy|2|||
130928600|NCT03129100|471372212|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928601|NCT03129100|471372213|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
130928602|NCT03129100|471372188|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928603|NCT03129100|471372189|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928604|NCT03129100|471372190|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928605|NCT03129100|471372191|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928606|NCT03129100|471372192|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928607|NCT03129100|471372193|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928608|NCT03129100|471372194|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928609|NCT03129100|471372195|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928610|NCT03129100|471372196|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928611|NCT03129100|471372197|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928612|NCT03129100|471372198|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928613|NCT03129100|471372199|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928614|NCT03129100|471372200|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
130702809|NCT03429049|470535909|FG000|Overall Study|Lost to Follow-up|9|||
130702810|NCT03429049|470535910|FG001|Overall Study|Lost to Follow-up|8|||
130702811|NCT03429049|470535909|FG000|Overall Study|Physician Decision|1|||
130702812|NCT03429049|470535910|FG001|Overall Study|Physician Decision|0|||
130702813|NCT03429049|470535909|FG000|Overall Study|Protocol Violation|3|||
130702814|NCT03429049|470535910|FG001|Overall Study|Protocol Violation|0|||
130928615|NCT03129100|471372201|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928616|NCT03129100|471372202|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
130928617|NCT03129100|471372203|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
130928618|NCT03129100|471372204|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928619|NCT03129100|471372205|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928620|NCT03129100|471372206|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928621|NCT03129100|471372207|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928622|NCT03129100|471372208|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928623|NCT03129100|471372209|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928624|NCT03129100|471372210|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928625|NCT03129100|471372211|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928626|NCT03129100|471372212|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928627|NCT03129100|471372213|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
130928628|NCT03129100|471372188|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928629|NCT03129100|471372189|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928630|NCT03129100|471372190|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928631|NCT03129100|471372191|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928632|NCT03129100|471372192|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928633|NCT03129100|471372193|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928634|NCT03129100|471372194|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928635|NCT03129100|471372195|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928636|NCT03129100|471372196|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928637|NCT03129100|471372197|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928638|NCT03129100|471372198|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928639|NCT03129100|471372199|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928640|NCT03129100|471372200|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928641|NCT03129100|471372201|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928642|NCT03129100|471372202|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928643|NCT03129100|471372203|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928644|NCT03129100|471372204|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928645|NCT03129100|471372205|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
130928646|NCT03129100|471372206|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928647|NCT03129100|471372207|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
130928648|NCT03129100|471372208|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928649|NCT03129100|471372209|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928650|NCT03129100|471372210|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928651|NCT03129100|471372211|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928652|NCT03129100|471372212|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928653|NCT03129100|471372213|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130928654|NCT03129100|471372188|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928655|NCT03129100|471372189|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928656|NCT03129100|471372190|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928657|NCT03129100|471372191|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928658|NCT03129100|471372192|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928659|NCT03129100|471372193|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928660|NCT03129100|471372194|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928661|NCT03129100|471372195|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928662|NCT03129100|471372196|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928663|NCT03129100|471372197|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928664|NCT03129100|471372198|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928665|NCT03129100|471372199|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928666|NCT03129100|471372200|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928667|NCT03129100|471372201|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928668|NCT03129100|471372202|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928669|NCT03129100|471372203|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928670|NCT03129100|471372204|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928671|NCT03129100|471372205|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928672|NCT03129100|471372206|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928673|NCT03129100|471372207|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928674|NCT03129100|471372208|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
130928675|NCT03129100|471372209|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928676|NCT03129100|471372210|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928677|NCT03129100|471372211|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928678|NCT03129100|471372212|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928679|NCT03129100|471372213|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
130928680|NCT03129100|471372188|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
130928681|NCT03129100|471372189|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
131223725|NCT04380701|472447112|FG003|Overall Study|Pregnancy|0|||
130702815|NCT03429049|470535909|FG000|Overall Study|Sponsor Decision|2|||
130702816|NCT03429049|470535910|FG001|Overall Study|Sponsor Decision|0|||
130928682|NCT03129100|471372190|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
130928683|NCT03129100|471372191|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
130928684|NCT03129100|471372192|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
130928685|NCT03129100|471372193|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
130928686|NCT03129100|471372194|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
130928687|NCT03129100|471372195|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
130928688|NCT03129100|471372196|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
130928689|NCT03129100|471372197|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
130928690|NCT03129100|471372198|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
130928691|NCT03129100|471372199|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
130928692|NCT03129100|471372200|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
130928693|NCT03129100|471372201|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
130928694|NCT03129100|471372202|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
130928695|NCT03129100|471372203|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
130928696|NCT03129100|471372204|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
130928697|NCT03129100|471372205|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
130928698|NCT03129100|471372206|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
130928699|NCT03129100|471372207|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
130928700|NCT03129100|471372208|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
130928701|NCT03129100|471372209|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
130928702|NCT03129100|471372210|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
130928703|NCT03129100|471372211|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
130928704|NCT03129100|471372212|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
130928705|NCT03129100|471372213|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
130928706|NCT03129100|471372188|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928707|NCT03129100|471372189|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928708|NCT03129100|471372190|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928709|NCT03129100|471372191|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928710|NCT03129100|471372192|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928711|NCT03129100|471372193|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928712|NCT03129100|471372194|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928713|NCT03129100|471372195|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928714|NCT03129100|471372196|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928715|NCT03129100|471372197|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928716|NCT03129100|471372198|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928717|NCT03129100|471372199|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928718|NCT03129100|471372200|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928719|NCT03129100|471372201|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928720|NCT03129100|471372202|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928721|NCT03129100|471372203|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928722|NCT03129100|471372204|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928723|NCT03129100|471372205|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928724|NCT03129100|471372206|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928725|NCT03129100|471372207|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928726|NCT03129100|471372208|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
130928727|NCT03129100|471372209|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928728|NCT03129100|471372210|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928729|NCT03129100|471372211|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928730|NCT03129100|471372212|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928731|NCT03129100|471372213|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
130928732|NCT03129100|471372188|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
130928733|NCT03129100|471372189|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
130928734|NCT03129100|471372190|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
130928735|NCT03129100|471372191|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
130928736|NCT03129100|471372192|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
130928737|NCT03129100|471372193|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
130928738|NCT03129100|471372194|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
130928739|NCT03129100|471372195|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
130928740|NCT03129100|471372196|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
130928741|NCT03129100|471372197|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
130928742|NCT03129100|471372198|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
130928743|NCT03129100|471372199|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
130928744|NCT03129100|471372200|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
130928745|NCT03129100|471372201|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
130928746|NCT03129100|471372202|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
130928747|NCT03129100|471372203|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
130928748|NCT03129100|471372204|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
130928749|NCT03129100|471372205|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
130928750|NCT03129100|471372206|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
130928751|NCT03129100|471372207|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
130928752|NCT03129100|471372208|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
131034799|NCT04810650|471761798|FG006|Overall Study|Lost to Follow-up|0|||
130928753|NCT03129100|471372209|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
130928754|NCT03129100|471372210|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
130928755|NCT03129100|471372211|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
130928756|NCT03129100|471372212|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
130928757|NCT03129100|471372213|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
130928758|NCT03129100|471372188|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928759|NCT03129100|471372189|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928760|NCT03129100|471372190|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928761|NCT03129100|471372191|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928762|NCT03129100|471372192|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928763|NCT03129100|471372193|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928764|NCT03129100|471372194|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928765|NCT03129100|471372195|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928766|NCT03129100|471372196|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928767|NCT03129100|471372197|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928768|NCT03129100|471372198|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928769|NCT03129100|471372199|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928770|NCT03129100|471372200|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928771|NCT03129100|471372201|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928772|NCT03129100|471372202|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928773|NCT03129100|471372203|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928774|NCT03129100|471372204|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928775|NCT03129100|471372205|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928776|NCT03129100|471372206|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928777|NCT03129100|471372207|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928778|NCT03129100|471372208|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928779|NCT03129100|471372209|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928780|NCT03129100|471372210|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928781|NCT03129100|471372211|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
130928782|NCT03129100|471372212|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
130928783|NCT03129100|471372213|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
130928784|NCT03129100|471372188|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928785|NCT03129100|471372189|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928786|NCT03129100|471372190|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928787|NCT03129100|471372191|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928788|NCT03129100|471372192|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928789|NCT03129100|471372193|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928790|NCT03129100|471372194|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928791|NCT03129100|471372195|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928792|NCT03129100|471372196|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928793|NCT03129100|471372197|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928794|NCT03129100|471372198|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928795|NCT03129100|471372199|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928796|NCT03129100|471372200|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928797|NCT03129100|471372201|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928798|NCT03129100|471372202|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928799|NCT03129100|471372203|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928800|NCT03129100|471372204|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928801|NCT03129100|471372205|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928802|NCT03129100|471372206|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928803|NCT03129100|471372207|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928804|NCT03129100|471372208|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928805|NCT03129100|471372209|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928806|NCT03129100|471372210|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130928807|NCT03129100|471372211|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
130928808|NCT03129100|471372212|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
130928809|NCT03129100|471372213|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
130928810|NCT03129100|471372188|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928811|NCT03129100|471372189|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928812|NCT03129100|471372190|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928813|NCT03129100|471372191|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928814|NCT03129100|471372192|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928815|NCT03129100|471372193|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928816|NCT03129100|471372194|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928817|NCT03129100|471372195|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
131034800|NCT04810650|471761799|FG007|Overall Study|Lost to Follow-up|0|||
130928818|NCT03129100|471372196|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928819|NCT03129100|471372197|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928820|NCT03129100|471372198|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928821|NCT03129100|471372199|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928822|NCT03129100|471372200|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928823|NCT03129100|471372201|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928824|NCT03129100|471372202|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928825|NCT03129100|471372203|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928826|NCT03129100|471372204|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928827|NCT03129100|471372205|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928828|NCT03129100|471372206|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928829|NCT03129100|471372207|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928830|NCT03129100|471372208|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928831|NCT03129100|471372209|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928832|NCT03129100|471372210|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928833|NCT03129100|471372211|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928834|NCT03129100|471372212|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
130928835|NCT03129100|471372213|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
130928836|NCT03129100|471372188|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928837|NCT03129100|471372189|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928838|NCT03129100|471372190|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928839|NCT03129100|471372191|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928840|NCT03129100|471372192|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928841|NCT03129100|471372193|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928842|NCT03129100|471372194|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928843|NCT03129100|471372195|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928844|NCT03129100|471372196|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928845|NCT03129100|471372197|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928846|NCT03129100|471372198|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928847|NCT03129100|471372199|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928848|NCT03129100|471372200|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928849|NCT03129100|471372201|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928850|NCT03129100|471372202|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928851|NCT03129100|471372203|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928852|NCT03129100|471372204|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928853|NCT03129100|471372205|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928854|NCT03129100|471372206|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928855|NCT03129100|471372207|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928856|NCT03129100|471372208|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928857|NCT03129100|471372209|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928858|NCT03129100|471372210|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928859|NCT03129100|471372211|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928860|NCT03129100|471372212|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130928861|NCT03129100|471372213|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
130928862|NCT03129100|471372188|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
130928863|NCT03129100|471372189|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
130928864|NCT03129100|471372190|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
130928865|NCT03129100|471372191|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
130928866|NCT03129100|471372192|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
130928867|NCT03129100|471372193|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
130928868|NCT03129100|471372194|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
130928869|NCT03129100|471372195|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
130928870|NCT03129100|471372196|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
130928871|NCT03129100|471372197|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
130928872|NCT03129100|471372198|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
130928873|NCT03129100|471372199|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
130928874|NCT03129100|471372200|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
130928875|NCT03129100|471372201|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
130928876|NCT03129100|471372202|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
130928877|NCT03129100|471372203|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
130928878|NCT03129100|471372204|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
130928879|NCT03129100|471372205|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
130928880|NCT03129100|471372206|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
130928881|NCT03129100|471372207|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
130928882|NCT03129100|471372208|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
130928883|NCT03129100|471372209|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
130928884|NCT03129100|471372210|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
130928885|NCT03129100|471372211|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
130928886|NCT03129100|471372212|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
130928887|NCT03129100|471372213|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
130928888|NCT01587001|471372214|FG000|Overall Study|Lost to Follow-up|2|||
130928889|NCT01587001|471372215|FG001|Overall Study|Lost to Follow-up|0|||
130928890|NCT01587001|471372214|FG000|Overall Study|Insufficient samples to complete testing|4|||
130928891|NCT01587001|471372215|FG001|Overall Study|Insufficient samples to complete testing|1|||
130928892|NCT03845985|471372216|FG000|Overall Study|Lost to Follow-up|2|||
130928893|NCT03845985|471372217|FG001|Overall Study|Lost to Follow-up|1|||
130928894|NCT03845985|471372216|FG000|Overall Study|Physician Decision|1|||
130928895|NCT03845985|471372217|FG001|Overall Study|Physician Decision|0|||
130928896|NCT03845985|471372216|FG000|Overall Study|Withdrawal by Subject|4|||
130928897|NCT03845985|471372217|FG001|Overall Study|Withdrawal by Subject|1|||
130928898|NCT02756013|471372220|FG000|Overall Study|Adverse Event|1|||
130928899|NCT02756013|471372220|FG000|Overall Study|Hypersensitivity|1|||
130928900|NCT03302234|471372227|FG000|Overall Study|Death|191|||
130928901|NCT03302234|471372228|FG001|Overall Study|Death|192|||
130928902|NCT03302234|471372227|FG000|Overall Study|Withdrawal by Subject|2|||
130928903|NCT03302234|471372228|FG001|Overall Study|Withdrawal by Subject|2|||
130928904|NCT03302234|471372227|FG000|Overall Study|Sponsor Decision|90|||
130928905|NCT03302234|471372228|FG001|Overall Study|Sponsor Decision|89|||
130928906|NCT03302234|471372227|FG000|Overall Study|Laryngeal carcinoma|0|||
130928907|NCT03302234|471372228|FG001|Overall Study|Laryngeal carcinoma|1|||
130928908|NCT03302234|471372227|FG000|Overall Study|Not Reported|1|||
130928909|NCT03302234|471372228|FG001|Overall Study|Not Reported|0|||
130928910|NCT02795832|471372229|FG000|Overall Study|Adverse Event|0|||
130928911|NCT02795832|471372230|FG001|Overall Study|Adverse Event|0|||
130928912|NCT02795832|471372231|FG002|Overall Study|Adverse Event|0|||
130928913|NCT02795832|471372232|FG003|Overall Study|Adverse Event|0|||
130928914|NCT02795832|471372233|FG004|Overall Study|Adverse Event|0|||
130928915|NCT02795832|471372234|FG005|Overall Study|Adverse Event|3|||
130928916|NCT04523220|471372235|FG000|Main Treatment Period|Physician Decision|1|||
130928917|NCT04523220|471372236|FG001|Main Treatment Period|Physician Decision|1|||
130928918|NCT04523220|471372237|FG002|Main Treatment Period|Physician Decision|0|||
130928919|NCT04523220|471372235|FG000|Main Treatment Period|Other|5|||
130928920|NCT04523220|471372236|FG001|Main Treatment Period|Other|2|||
130928921|NCT04523220|471372237|FG002|Main Treatment Period|Other|4|||
130928922|NCT04523220|471372235|FG000|Main Treatment Period|Subject Decision|5|||
130928923|NCT04523220|471372236|FG001|Main Treatment Period|Subject Decision|7|||
131223726|NCT04380701|472447113|FG004|Overall Study|Pregnancy|0|||
130928924|NCT04523220|471372237|FG002|Main Treatment Period|Subject Decision|3|||
130928925|NCT04523220|471372235|FG000|Main Treatment Period|Death|5|||
130928926|NCT04523220|471372236|FG001|Main Treatment Period|Death|11|||
130928927|NCT04523220|471372237|FG002|Main Treatment Period|Death|4|||
130928928|NCT04523220|471372235|FG000|Main Treatment Period|Adverse Event|11|||
130928929|NCT04523220|471372236|FG001|Main Treatment Period|Adverse Event|9|||
130928930|NCT04523220|471372237|FG002|Main Treatment Period|Adverse Event|9|||
130928931|NCT04523220|471372235|FG000|Main Treatment Period|Withdrawal by Subject|3|||
130928932|NCT04523220|471372236|FG001|Main Treatment Period|Withdrawal by Subject|3|||
130928933|NCT04523220|471372237|FG002|Main Treatment Period|Withdrawal by Subject|4|||
130928934|NCT04523220|471372235|FG000|Main Treatment Period|Study drug never adminstered|10|||
130928935|NCT04523220|471372236|FG001|Main Treatment Period|Study drug never adminstered|3|||
130928936|NCT04523220|471372237|FG002|Main Treatment Period|Study drug never adminstered|5|||
130928937|NCT04523220|471372235|FG000|Extension Treatment Period|Physician Decision|1|||
130928938|NCT04523220|471372236|FG001|Extension Treatment Period|Physician Decision|0|||
130928939|NCT04523220|471372237|FG002|Extension Treatment Period|Physician Decision|3|||
130928940|NCT04523220|471372235|FG000|Extension Treatment Period|Other|2|||
130928941|NCT04523220|471372236|FG001|Extension Treatment Period|Other|6|||
130928942|NCT04523220|471372237|FG002|Extension Treatment Period|Other|6|||
130928943|NCT04523220|471372235|FG000|Extension Treatment Period|Subject Decision|5|||
130928944|NCT04523220|471372236|FG001|Extension Treatment Period|Subject Decision|2|||
130702817|NCT03429049|470535909|FG000|Overall Study|Withdrawal by Subject|4|||
130702818|NCT03429049|470535910|FG001|Overall Study|Withdrawal by Subject|20|||
130702819|NCT03429049|470535909|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
130702820|NCT03429049|470535910|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
130702821|NCT01841060|470535914|FG000|Overall Study|Protocol Violation|10|||
130928945|NCT04523220|471372237|FG002|Extension Treatment Period|Subject Decision|4|||
130928946|NCT04523220|471372235|FG000|Extension Treatment Period|Death|6|||
130928947|NCT04523220|471372236|FG001|Extension Treatment Period|Death|4|||
130928948|NCT04523220|471372237|FG002|Extension Treatment Period|Death|7|||
130928949|NCT04523220|471372235|FG000|Extension Treatment Period|Adverse Event|6|||
130928950|NCT04523220|471372236|FG001|Extension Treatment Period|Adverse Event|7|||
130928951|NCT04523220|471372237|FG002|Extension Treatment Period|Adverse Event|9|||
130928952|NCT04523220|471372235|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
131223727|NCT04380701|472447114|FG005|Overall Study|Pregnancy|0|||
130928953|NCT04523220|471372236|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
130928954|NCT04523220|471372237|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
130928955|NCT04523220|471372235|FG000|Extension Treatment Period|Study drug never administered|0|||
130928956|NCT04523220|471372236|FG001|Extension Treatment Period|Study drug never administered|1|||
130928957|NCT04523220|471372237|FG002|Extension Treatment Period|Study drug never administered|0|||
130928958|NCT00571948|471372238|FG000|Overall Study|Lost to Follow-up|2|||
130928959|NCT00571948|471372239|FG001|Overall Study|Lost to Follow-up|0|||
130928960|NCT00571948|471372238|FG000|Overall Study|Withdrawal by Subject|1|||
130928961|NCT00571948|471372239|FG001|Overall Study|Withdrawal by Subject|2|||
130928962|NCT00571948|471372238|FG000|Overall Study|Protocol Violation|3|||
130928963|NCT00571948|471372239|FG001|Overall Study|Protocol Violation|3|||
130928964|NCT00571948|471372238|FG000|Overall Study|infant refused study meal|3|||
130928965|NCT00571948|471372239|FG001|Overall Study|infant refused study meal|4|||
130928966|NCT00571948|471372238|FG000|Overall Study|Parent were afraid of blood colection|2|||
130928967|NCT00571948|471372239|FG001|Overall Study|Parent were afraid of blood colection|5|||
130928968|NCT04112784|471372240|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
130928969|NCT04112784|471372240|FG000|Overall Study|Screen Failures|4|||
130928970|NCT00256750|471372241|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
130928971|NCT00256750|471372242|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
130928972|NCT00256750|471372243|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
130928973|NCT00256750|471372241|FG000|Transplanted Pre-Treatment|Other|2|||
130928974|NCT00256750|471372242|FG001|Transplanted Pre-Treatment|Other|0|||
130928975|NCT00256750|471372243|FG002|Transplanted Pre-Treatment|Other|0|||
130928976|NCT00256750|471372241|FG000|Transplanted Pre-Treatment|Death|1|||
130928977|NCT00256750|471372242|FG001|Transplanted Pre-Treatment|Death|0|||
130928978|NCT00256750|471372243|FG002|Transplanted Pre-Treatment|Death|0|||
130928979|NCT00256750|471372241|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
130928980|NCT00256750|471372242|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
130928981|NCT00256750|471372243|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
130928982|NCT00256750|471372241|FG000|Post-Transplant Treated (12 Months)|Death|3|||
130928983|NCT00256750|471372242|FG001|Post-Transplant Treated (12 Months)|Death|2|||
130928984|NCT00256750|471372243|FG002|Post-Transplant Treated (12 Months)|Death|4|||
130928985|NCT00256750|471372241|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
130928986|NCT00256750|471372242|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
130928987|NCT00256750|471372243|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
130928988|NCT00256750|471372241|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
130928989|NCT00256750|471372242|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
130928990|NCT00256750|471372243|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
130928991|NCT00256750|471372241|FG000|Post-Transplant Treated (12 Months)|Other|5|||
130928992|NCT00256750|471372242|FG001|Post-Transplant Treated (12 Months)|Other|4|||
130928993|NCT00256750|471372243|FG002|Post-Transplant Treated (12 Months)|Other|2|||
130928994|NCT00256750|471372241|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
130928995|NCT00256750|471372242|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
130928996|NCT00256750|471372243|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
130928997|NCT00256750|471372241|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
130928998|NCT00256750|471372242|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
130928999|NCT00256750|471372243|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
130929000|NCT00256750|471372241|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
130929001|NCT00256750|471372242|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
130929002|NCT00256750|471372243|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
130929003|NCT00256750|471372241|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
130929004|NCT00256750|471372242|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
130929005|NCT00256750|471372243|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
130929006|NCT00256750|471372241|FG000|Post-Transplant Treated (24 Months)|Death|3|||
130929007|NCT00256750|471372242|FG001|Post-Transplant Treated (24 Months)|Death|0|||
130929008|NCT00256750|471372243|FG002|Post-Transplant Treated (24 Months)|Death|0|||
130702822|NCT00653159|470535915|FG000|Overall Study|Adverse Event|4|||
130702823|NCT00653159|470535916|FG001|Overall Study|Adverse Event|1|||
130702824|NCT00653159|470535915|FG000|Overall Study|Lost to Follow-up|1|||
130929009|NCT00256750|471372241|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
130929010|NCT00256750|471372242|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
130929011|NCT00256750|471372243|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
130929012|NCT00256750|471372241|FG000|Post-Transplant Treated (24 Months)|Other|2|||
130929013|NCT00256750|471372242|FG001|Post-Transplant Treated (24 Months)|Other|0|||
130929014|NCT00256750|471372243|FG002|Post-Transplant Treated (24 Months)|Other|1|||
130929015|NCT00256750|471372241|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
130929016|NCT00256750|471372242|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
130929017|NCT00256750|471372243|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
130929018|NCT00256750|471372241|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
130929019|NCT00256750|471372242|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
130929020|NCT00256750|471372243|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
130929021|NCT00256750|471372241|FG000|Post-Transplant Treated (36 Months)|Death|0|||
130929022|NCT00256750|471372242|FG001|Post-Transplant Treated (36 Months)|Death|2|||
130702825|NCT00653159|470535916|FG001|Overall Study|Lost to Follow-up|2|||
130702826|NCT05258630|470535917|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
130702827|NCT05258630|470535918|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
130702828|NCT05258630|470535917|FG000|Overall Study|Lost to Follow-up|0|||
130702829|NCT05258630|470535918|FG001|Overall Study|Lost to Follow-up|2|||
130702830|NCT00109837|470535919|FG000|Overall Study|Adverse Event|2|||
130702831|NCT00109837|470535919|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
130702832|NCT00109837|470535919|FG000|Overall Study|Death|1|||
130702833|NCT00109837|470535919|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
130702834|NCT00109837|470535919|FG000|Overall Study|Not treated|1|||
130702835|NCT00109837|470535919|FG000|Overall Study|Ineligible|1|||
130702836|NCT01848210|470535920|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
130702837|NCT01848210|470535921|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
130702838|NCT01848210|470535920|FG000|Overall Study|Lost to Follow-up|24|||
130702839|NCT01848210|470535921|FG001|Overall Study|Lost to Follow-up|12|||
130702840|NCT01848210|470535920|FG000|Overall Study|Protocol Violation|3|||
130702841|NCT01848210|470535921|FG001|Overall Study|Protocol Violation|5|||
130702842|NCT01848210|470535920|FG000|Overall Study|Use of Forbidden Drugs|9|||
130702843|NCT01848210|470535921|FG001|Overall Study|Use of Forbidden Drugs|10|||
130702844|NCT01848210|470535920|FG000|Overall Study|Impedition Condition|5|||
130702845|NCT01848210|470535921|FG001|Overall Study|Impedition Condition|9|||
130702846|NCT01848210|470535920|FG000|Overall Study|Adverse Event|7|||
130702847|NCT01848210|470535921|FG001|Overall Study|Adverse Event|9|||
130702848|NCT01848210|470535920|FG000|Overall Study|Discontinuation Criterion|5|||
130702849|NCT01848210|470535921|FG001|Overall Study|Discontinuation Criterion|7|||
130702850|NCT01848210|470535920|FG000|Overall Study|Hypesensitivity|1|||
130702851|NCT01848210|470535921|FG001|Overall Study|Hypesensitivity|0|||
130702852|NCT01848210|470535920|FG000|Overall Study|Hepatic Function Alteration|4|||
130702853|NCT01848210|470535921|FG001|Overall Study|Hepatic Function Alteration|0|||
130702854|NCT01848210|470535920|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
130702855|NCT01848210|470535921|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
130702856|NCT01848210|470535920|FG000|Overall Study|Administrative|1|||
130702857|NCT01848210|470535921|FG001|Overall Study|Administrative|0|||
130702858|NCT00381849|470535922|FG000|Wash Out|Withdrawal by Subject|0|||
130702859|NCT00381849|470535923|FG001|Wash Out|Withdrawal by Subject|1|||
130702860|NCT00894933|470535929|FG000|Overall Study|Lost to Follow-up|2|||
130702861|NCT00894933|470535929|FG000|Overall Study|Cancelled Procedure|1|||
130702862|NCT00894933|470535929|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
130702863|NCT00631007|470535930|FG000|Overall Study|Adverse Event|0|||
130702864|NCT00631007|470535931|FG001|Overall Study|Adverse Event|2|||
130702865|NCT00631007|470535932|FG002|Overall Study|Adverse Event|0|||
130702866|NCT00631007|470535933|FG003|Overall Study|Adverse Event|2|||
130702867|NCT00631007|470535934|FG004|Overall Study|Adverse Event|3|||
130702868|NCT00631007|470535935|FG005|Overall Study|Adverse Event|2|||
130702869|NCT00631007|470535930|FG000|Overall Study|Lost to Follow-up|2|||
130702870|NCT00631007|470535931|FG001|Overall Study|Lost to Follow-up|1|||
130702871|NCT00631007|470535932|FG002|Overall Study|Lost to Follow-up|2|||
130929023|NCT00256750|471372243|FG002|Post-Transplant Treated (36 Months)|Death|1|||
130929024|NCT00256750|471372241|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
130929025|NCT00256750|471372242|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
130929026|NCT00256750|471372243|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
130929027|NCT00256750|471372241|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
130929028|NCT00256750|471372242|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
130929029|NCT00256750|471372243|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
130929030|NCT00256750|471372241|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
130929031|NCT00256750|471372242|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
130929032|NCT00256750|471372243|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
130929033|NCT00256750|471372241|FG000|Post-Transplant Treated (36 Months)|Other|0|||
130929034|NCT00256750|471372242|FG001|Post-Transplant Treated (36 Months)|Other|1|||
130929035|NCT00256750|471372243|FG002|Post-Transplant Treated (36 Months)|Other|1|||
130929036|NCT00256750|471372241|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
130929037|NCT00256750|471372242|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
130929038|NCT00256750|471372243|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
130702872|NCT00631007|470535933|FG003|Overall Study|Lost to Follow-up|4|||
130702873|NCT00631007|470535934|FG004|Overall Study|Lost to Follow-up|5|||
130702874|NCT00631007|470535935|FG005|Overall Study|Lost to Follow-up|3|||
130702875|NCT00631007|470535930|FG000|Overall Study|Physician Decision|1|||
130702876|NCT00631007|470535931|FG001|Overall Study|Physician Decision|0|||
130702877|NCT00631007|470535932|FG002|Overall Study|Physician Decision|1|||
130702878|NCT00631007|470535933|FG003|Overall Study|Physician Decision|0|||
130702879|NCT00631007|470535934|FG004|Overall Study|Physician Decision|0|||
130702880|NCT00631007|470535935|FG005|Overall Study|Physician Decision|2|||
130702881|NCT00631007|470535930|FG000|Overall Study|Persistent Hyperglycemia|2|||
130702882|NCT00631007|470535931|FG001|Overall Study|Persistent Hyperglycemia|2|||
130702883|NCT00631007|470535932|FG002|Overall Study|Persistent Hyperglycemia|5|||
130702884|NCT00631007|470535933|FG003|Overall Study|Persistent Hyperglycemia|1|||
130929039|NCT00256750|471372241|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
130929040|NCT00256750|471372242|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
130702885|NCT00631007|470535934|FG004|Overall Study|Persistent Hyperglycemia|2|||
130929041|NCT00256750|471372243|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
130929042|NCT00256750|471372241|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
130929043|NCT00256750|471372242|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
130929044|NCT00256750|471372243|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
130929045|NCT00256750|471372241|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
130929046|NCT00256750|471372242|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
130929047|NCT00256750|471372243|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
130929048|NCT00256750|471372241|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
130929049|NCT00256750|471372242|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
130929050|NCT00256750|471372243|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
130929051|NCT00256750|471372241|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
130929052|NCT00256750|471372242|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
130929053|NCT00256750|471372243|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
130929054|NCT00256750|471372241|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
130929055|NCT00256750|471372242|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
130929056|NCT00256750|471372243|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
130929057|NCT00256750|471372241|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
130929058|NCT00256750|471372242|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
130929059|NCT00256750|471372243|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
130929060|NCT00256750|471372241|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
130929061|NCT00256750|471372242|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
130929062|NCT00256750|471372243|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
130702886|NCT00631007|470535935|FG005|Overall Study|Persistent Hyperglycemia|5|||
130702887|NCT00631007|470535930|FG000|Overall Study|Withdrawal by Subject|4|||
130702888|NCT00631007|470535931|FG001|Overall Study|Withdrawal by Subject|5|||
130929063|NCT00211510|471372244|FG000|Overall Study|Physician Decision|3|||
130929064|NCT00211510|471372245|FG001|Overall Study|Physician Decision|1|||
130929065|NCT00211510|471372244|FG000|Overall Study|Withdrawal by Subject|3|||
130929066|NCT00211510|471372245|FG001|Overall Study|Withdrawal by Subject|1|||
130929067|NCT01962896|471372246|FG000|Overall Study|Lack of Efficacy|4|||
130929068|NCT01737697|471372247|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929069|NCT01737697|471372248|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
130929070|NCT01737697|471372249|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929071|NCT01737697|471372250|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
130929072|NCT01737697|471372251|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
130929073|NCT01737697|471372252|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929074|NCT01737697|471372253|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929075|NCT01737697|471372254|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929076|NCT01737697|471372255|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929077|NCT01737697|471372256|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929078|NCT01737697|471372257|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929079|NCT01737697|471372258|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929080|NCT01737697|471372259|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929081|NCT01737697|471372260|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130702889|NCT00631007|470535932|FG002|Overall Study|Withdrawal by Subject|2|||
130702890|NCT00631007|470535933|FG003|Overall Study|Withdrawal by Subject|2|||
130702891|NCT00631007|470535934|FG004|Overall Study|Withdrawal by Subject|1|||
130702892|NCT00631007|470535935|FG005|Overall Study|Withdrawal by Subject|3|||
130702893|NCT00631007|470535930|FG000|Overall Study|Other|2|||
130702894|NCT00631007|470535931|FG001|Overall Study|Other|1|||
130702895|NCT00631007|470535932|FG002|Overall Study|Other|0|||
130702896|NCT00631007|470535933|FG003|Overall Study|Other|0|||
130702897|NCT00631007|470535934|FG004|Overall Study|Other|1|||
130702898|NCT00631007|470535935|FG005|Overall Study|Other|0|||
130702899|NCT00683787|470535936|FG000|Overall Study|Progression|3|||
130702900|NCT00683787|470535937|FG001|Overall Study|Progression|3|||
130702901|NCT00683787|470535938|FG002|Overall Study|Progression|0|||
130702902|NCT00683787|470535936|FG000|Overall Study|Adverse Event|0|||
130702903|NCT00683787|470535937|FG001|Overall Study|Adverse Event|0|||
130702904|NCT00683787|470535938|FG002|Overall Study|Adverse Event|2|||
130702905|NCT04167618|470535939|FG000|Overall Study|Trial terminated by sponsor|1|||
130929082|NCT01737697|471372261|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
130929083|NCT01737697|471372247|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
130929084|NCT01737697|471372248|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
130929085|NCT01737697|471372249|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
130702906|NCT04167618|470535940|FG001|Overall Study|Trial terminated by sponsor|1|||
130702907|NCT00996437|470535941|FG000|Overall Study|Death|1|||
130702908|NCT00996437|470535942|FG001|Overall Study|Death|0|||
130702909|NCT00996437|470535941|FG000|Overall Study|Dropped|2|||
130702910|NCT00996437|470535942|FG001|Overall Study|Dropped|2|||
130702911|NCT00996437|470535941|FG000|Overall Study|Missed|2|||
130702912|NCT00996437|470535942|FG001|Overall Study|Missed|5|||
130702913|NCT02576717|470535945|FG000|Overall Study|Other Reasons|16|||
130702914|NCT02576717|470535946|FG001|Overall Study|Other Reasons|18|||
130702915|NCT02576717|470535947|FG002|Overall Study|Other Reasons|15|||
130702916|NCT02576717|470535945|FG000|Overall Study|Covid-19 Pandemic|0|||
130702917|NCT02576717|470535946|FG001|Overall Study|Covid-19 Pandemic|1|||
130702918|NCT02576717|470535947|FG002|Overall Study|Covid-19 Pandemic|1|||
130702919|NCT02576717|470535945|FG000|Overall Study|Sponsor Decision|0|||
130702920|NCT02576717|470535946|FG001|Overall Study|Sponsor Decision|0|||
130702921|NCT02576717|470535947|FG002|Overall Study|Sponsor Decision|1|||
130702922|NCT02576717|470535945|FG000|Overall Study|Physician Decision|3|||
130702923|NCT02576717|470535946|FG001|Overall Study|Physician Decision|8|||
130702924|NCT02576717|470535947|FG002|Overall Study|Physician Decision|9|||
130702925|NCT02576717|470535945|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
130702926|NCT02576717|470535946|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
130702927|NCT02576717|470535947|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
130702928|NCT02576717|470535945|FG000|Overall Study|Death|3|||
130702929|NCT02576717|470535946|FG001|Overall Study|Death|5|||
130770304|NCT01483599|470784350|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130770305|NCT01483599|470784351|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130770306|NCT01483599|470784338|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
130770307|NCT01483599|470784339|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
130929086|NCT01737697|471372250|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929087|NCT01737697|471372251|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929088|NCT01737697|471372252|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929089|NCT01737697|471372253|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929090|NCT01737697|471372254|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929091|NCT01737697|471372255|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929092|NCT01737697|471372256|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929093|NCT01737697|471372257|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929094|NCT01737697|471372258|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929095|NCT01737697|471372259|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929096|NCT01737697|471372260|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929097|NCT01737697|471372261|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
130929098|NCT01737697|471372247|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929099|NCT01737697|471372248|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929100|NCT01737697|471372249|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929101|NCT01737697|471372250|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
130929102|NCT01737697|471372251|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929103|NCT01737697|471372252|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929104|NCT01737697|471372253|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929105|NCT01737697|471372254|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929106|NCT01737697|471372255|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929107|NCT01737697|471372256|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929108|NCT01737697|471372257|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929109|NCT01737697|471372258|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929110|NCT01737697|471372259|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929111|NCT01737697|471372260|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929112|NCT01737697|471372261|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
130929113|NCT01737697|471372247|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929114|NCT01737697|471372248|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
130929115|NCT01737697|471372249|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130770308|NCT01483599|470784340|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
130770309|NCT01483599|470784341|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
130770310|NCT01483599|470784342|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
130770311|NCT01483599|470784343|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
130770312|NCT01483599|470784344|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
130770313|NCT01483599|470784345|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
130770314|NCT01483599|470784346|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
130770315|NCT01483599|470784347|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
130770316|NCT01483599|470784348|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
130929116|NCT01737697|471372250|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929117|NCT01737697|471372251|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929118|NCT01737697|471372252|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130702930|NCT02576717|470535947|FG002|Overall Study|Death|3|||
130702931|NCT02576717|470535945|FG000|Overall Study|Lost to Follow-up|9|||
130702932|NCT02576717|470535946|FG001|Overall Study|Lost to Follow-up|10|||
130702933|NCT02576717|470535947|FG002|Overall Study|Lost to Follow-up|19|||
130702934|NCT02576717|470535945|FG000|Overall Study|Protocol Violation|4|||
130702935|NCT02576717|470535946|FG001|Overall Study|Protocol Violation|0|||
130702936|NCT02576717|470535947|FG002|Overall Study|Protocol Violation|5|||
130702937|NCT02576717|470535945|FG000|Overall Study|Lack of Efficacy|24|||
130702938|NCT02576717|470535946|FG001|Overall Study|Lack of Efficacy|28|||
130702939|NCT02576717|470535947|FG002|Overall Study|Lack of Efficacy|20|||
130702940|NCT02576717|470535945|FG000|Overall Study|Adverse Event|26|||
130702941|NCT02576717|470535946|FG001|Overall Study|Adverse Event|32|||
130702942|NCT02576717|470535947|FG002|Overall Study|Adverse Event|26|||
130702943|NCT00399893|470535948|FG000|Overall Study|Withdrawal by Subject|1|||
130702944|NCT00399893|470535949|FG001|Overall Study|Withdrawal by Subject|0|||
130702945|NCT01363011|470535950|FG000|Main Study|Adverse Event|2|||
130702946|NCT01363011|470535951|FG001|Main Study|Adverse Event|3|||
130702947|NCT01363011|470535950|FG000|Main Study|Investigator's Discretion|1|||
130702948|NCT01363011|470535951|FG001|Main Study|Investigator's Discretion|1|||
130702949|NCT01363011|470535950|FG000|Main Study|Withdrew Consent|1|||
130702950|NCT01363011|470535951|FG001|Main Study|Withdrew Consent|4|||
130702951|NCT01363011|470535950|FG000|Main Study|Protocol Violation|0|||
130702952|NCT01363011|470535951|FG001|Main Study|Protocol Violation|1|||
130702953|NCT01363011|470535950|FG000|Extension Phase|Adverse Event|1|||
130702954|NCT01363011|470535951|FG001|Extension Phase|Adverse Event|1|||
130702955|NCT01363011|470535950|FG000|Extension Phase|Lack of Efficacy|0|||
130702956|NCT01363011|470535951|FG001|Extension Phase|Lack of Efficacy|1|||
130702957|NCT01363011|470535950|FG000|Extension Phase|Investigator's Discretion|2|||
130702958|NCT01363011|470535951|FG001|Extension Phase|Investigator's Discretion|2|||
130702959|NCT01363011|470535950|FG000|Extension Phase|Withdrew Consent|0|||
130702960|NCT01363011|470535951|FG001|Extension Phase|Withdrew Consent|1|||
130702961|NCT01363011|470535950|FG000|Extension Phase|Lost to Follow-up|0|||
130702962|NCT01363011|470535951|FG001|Extension Phase|Lost to Follow-up|2|||
130702963|NCT01363011|470535950|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
130702964|NCT01363011|470535951|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
130702965|NCT00407745|470535953|FG000|Overall Study|Lack of Efficacy|1|||
130702966|NCT00407745|470535954|FG001|Overall Study|Lack of Efficacy|2|||
130702967|NCT00407745|470535953|FG000|Overall Study|Withdrawal by Subject|3|||
130702968|NCT00407745|470535954|FG001|Overall Study|Withdrawal by Subject|3|||
130702969|NCT00407745|470535953|FG000|Overall Study|Protocol Violation|5|||
130770317|NCT01483599|470784349|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
130929119|NCT01737697|471372253|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929120|NCT01737697|471372254|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929121|NCT01737697|471372255|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929122|NCT01737697|471372256|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929123|NCT01737697|471372257|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929124|NCT01737697|471372258|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929125|NCT01737697|471372259|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929126|NCT01737697|471372260|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929127|NCT01737697|471372261|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
130929128|NCT01737697|471372247|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929129|NCT01737697|471372248|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131034801|NCT04810650|471761800|FG008|Overall Study|Lost to Follow-up|0|||
131034802|NCT04810650|471761801|FG009|Overall Study|Lost to Follow-up|0|||
131034803|NCT04810650|471761802|FG010|Overall Study|Lost to Follow-up|1|||
131034804|NCT04810650|471761803|FG011|Overall Study|Lost to Follow-up|0|||
131034805|NCT04810650|471761804|FG012|Overall Study|Lost to Follow-up|3|||
131034806|NCT04810650|471761805|FG013|Overall Study|Lost to Follow-up|9|||
131034807|NCT04810650|471761792|FG000|Overall Study|Participant declined|0|||
131034808|NCT04810650|471761793|FG001|Overall Study|Participant declined|0|||
131034809|NCT04810650|471761794|FG002|Overall Study|Participant declined|0|||
131034810|NCT04810650|471761795|FG003|Overall Study|Participant declined|0|||
131034811|NCT04810650|471761796|FG004|Overall Study|Participant declined|0|||
131034812|NCT04810650|471761797|FG005|Overall Study|Participant declined|0|||
131034813|NCT04810650|471761798|FG006|Overall Study|Participant declined|0|||
131034814|NCT04810650|471761799|FG007|Overall Study|Participant declined|0|||
131034815|NCT04810650|471761800|FG008|Overall Study|Participant declined|0|||
131034816|NCT04810650|471761801|FG009|Overall Study|Participant declined|0|||
130702970|NCT00407745|470535954|FG001|Overall Study|Protocol Violation|3|||
130702971|NCT00407745|470535953|FG000|Overall Study|Adverse Event|8|||
130702972|NCT00407745|470535954|FG001|Overall Study|Adverse Event|8|||
130702973|NCT00407745|470535953|FG000|Overall Study|Other|2|||
131034817|NCT04810650|471761802|FG010|Overall Study|Participant declined|2|||
131034818|NCT04810650|471761803|FG011|Overall Study|Participant declined|0|||
131034819|NCT04810650|471761804|FG012|Overall Study|Participant declined|0|||
131034820|NCT04810650|471761805|FG013|Overall Study|Participant declined|0|||
131034821|NCT04788511|471761806|FG000|Overall Study|Withdrawal by Subject|2|||
131034822|NCT04788511|471761807|FG001|Overall Study|Withdrawal by Subject|1|||
131034823|NCT04788511|471761806|FG000|Overall Study|Lost to Follow-up|2|||
131034824|NCT04788511|471761807|FG001|Overall Study|Lost to Follow-up|7|||
130702974|NCT00407745|470535954|FG001|Overall Study|Other|0|||
130702975|NCT00407745|470535953|FG000|Overall Study|Randomized, unknown if treated|0|||
130702976|NCT00407745|470535954|FG001|Overall Study|Randomized, unknown if treated|1|||
130702977|NCT01201759|470535955|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
130929130|NCT01737697|471372249|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929131|NCT01737697|471372250|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929132|NCT01737697|471372251|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
130929133|NCT01737697|471372252|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929134|NCT01737697|471372253|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929135|NCT01737697|471372254|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929136|NCT01737697|471372255|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929137|NCT01737697|471372256|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929138|NCT01737697|471372257|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929139|NCT01737697|471372258|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929140|NCT01737697|471372259|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130702978|NCT01201759|470535956|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
130702979|NCT01201759|470535955|FG000|Visit 3 - Washout|Adverse Event|0|||
130702980|NCT01201759|470535956|FG001|Visit 3 - Washout|Adverse Event|3|||
130702981|NCT01201759|470535955|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
130702982|NCT01201759|470535956|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
130702983|NCT01201759|470535955|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
130929141|NCT01737697|471372260|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
130929142|NCT01737697|471372261|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
131034825|NCT04788511|471761806|FG000|Overall Study|Death|3|||
131034826|NCT04788511|471761807|FG001|Overall Study|Death|4|||
131034827|NCT04652700|471761810|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
131034828|NCT04652700|471761811|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
131034829|NCT04652700|471761810|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
131034830|NCT04652700|471761811|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
131034831|NCT04652700|471761810|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
131034832|NCT04652700|471761811|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
131034833|NCT04652700|471761810|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
131034834|NCT04652700|471761811|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
131034835|NCT04652700|471761810|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
131034836|NCT04652700|471761811|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
131034837|NCT04652700|471761810|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
131034838|NCT04652700|471761811|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
131034839|NCT04652700|471761810|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
131034840|NCT04652700|471761811|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
131034841|NCT04652700|471761810|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
131034842|NCT04652700|471761811|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
131034843|NCT04652700|471761810|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
131034844|NCT04652700|471761811|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
131034845|NCT04187833|471761812|FG000|Overall Study|Withdrawal by Subject|1|||
131034846|NCT05603143|471761813|FG000|Overall Study|Withdrew consent|6|||
131034847|NCT05603143|471761814|FG001|Overall Study|Withdrew consent|2|||
131034848|NCT05603143|471761813|FG000|Overall Study|Randomized but never treated|0|||
131034849|NCT05603143|471761814|FG001|Overall Study|Randomized but never treated|3|||
131034850|NCT05603143|471761813|FG000|Overall Study|Adverse Event|2|||
131034851|NCT05603143|471761814|FG001|Overall Study|Adverse Event|0|||
131034852|NCT05603143|471761813|FG000|Overall Study|Death|0|||
131034853|NCT05603143|471761814|FG001|Overall Study|Death|1|||
131034854|NCT05603143|471761813|FG000|Overall Study|Investigator's discretion|1|||
131034855|NCT05603143|471761814|FG001|Overall Study|Investigator's discretion|0|||
131034856|NCT05603143|471761813|FG000|Overall Study|Lost to Follow-up|0|||
131034857|NCT05603143|471761814|FG001|Overall Study|Lost to Follow-up|1|||
131034858|NCT05603143|471761813|FG000|Overall Study|Protocol Violation|0|||
131034859|NCT05603143|471761814|FG001|Overall Study|Protocol Violation|1|||
131034860|NCT05783102|471761815|FG000|Overall Study|Lost to Follow-up|1|||
131034861|NCT05783102|471761815|FG000|Overall Study|Withdrawal by Subject|2|||
131034862|NCT05008835|471761817|FG000|Overall Study|Adverse Event|5|||
131034863|NCT05008835|471761818|FG001|Overall Study|Adverse Event|2|||
131034864|NCT05008835|471761819|FG002|Overall Study|Adverse Event|1|||
131034865|NCT05008835|471761817|FG000|Overall Study|Lack of Efficacy|0|||
131034866|NCT05008835|471761818|FG001|Overall Study|Lack of Efficacy|0|||
131034867|NCT05008835|471761819|FG002|Overall Study|Lack of Efficacy|1|||
131034868|NCT05008835|471761817|FG000|Overall Study|Study terminated by sponsor|0|||
131034869|NCT05008835|471761818|FG001|Overall Study|Study terminated by sponsor|0|||
131034870|NCT05008835|471761819|FG002|Overall Study|Study terminated by sponsor|1|||
131034871|NCT05008835|471761817|FG000|Overall Study|Not further specified|3|||
131034872|NCT05008835|471761818|FG001|Overall Study|Not further specified|2|||
131034873|NCT05008835|471761819|FG002|Overall Study|Not further specified|1|||
130702984|NCT01201759|470535956|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
130929143|NCT01737697|471372247|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929144|NCT01737697|471372248|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
130929145|NCT01737697|471372249|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
130929146|NCT01737697|471372250|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
130929147|NCT01737697|471372251|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
130929148|NCT01737697|471372252|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929149|NCT01737697|471372253|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929150|NCT01737697|471372254|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929151|NCT01737697|471372255|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929152|NCT01737697|471372256|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929153|NCT01737697|471372257|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929154|NCT01737697|471372258|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929155|NCT01737697|471372259|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929156|NCT01737697|471372260|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929157|NCT01737697|471372261|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
130929158|NCT01737697|471372247|FG000|Subacute Phase|Adverse Event|0|||
130929159|NCT01737697|471372248|FG001|Subacute Phase|Adverse Event|0|||
130929160|NCT01737697|471372249|FG002|Subacute Phase|Adverse Event|0|||
130929161|NCT01737697|471372250|FG003|Subacute Phase|Adverse Event|0|||
130929162|NCT01737697|471372251|FG004|Subacute Phase|Adverse Event|0|||
130929163|NCT01737697|471372252|FG005|Subacute Phase|Adverse Event|1|||
130929164|NCT01737697|471372253|FG006|Subacute Phase|Adverse Event|1|||
130929165|NCT01737697|471372254|FG007|Subacute Phase|Adverse Event|1|||
130929166|NCT01737697|471372255|FG008|Subacute Phase|Adverse Event|1|||
130929167|NCT01737697|471372256|FG009|Subacute Phase|Adverse Event|1|||
130929168|NCT01737697|471372257|FG010|Subacute Phase|Adverse Event|4|||
130929169|NCT01737697|471372258|FG011|Subacute Phase|Adverse Event|1|||
130929170|NCT01737697|471372259|FG012|Subacute Phase|Adverse Event|1|||
130929171|NCT01737697|471372260|FG013|Subacute Phase|Adverse Event|0|||
130929172|NCT01737697|471372261|FG014|Subacute Phase|Adverse Event|0|||
130929173|NCT01737697|471372247|FG000|Subacute Phase|Withdrawal by Subject|0|||
130929174|NCT01737697|471372248|FG001|Subacute Phase|Withdrawal by Subject|0|||
130929175|NCT01737697|471372249|FG002|Subacute Phase|Withdrawal by Subject|0|||
130929176|NCT01737697|471372250|FG003|Subacute Phase|Withdrawal by Subject|0|||
130929177|NCT01737697|471372251|FG004|Subacute Phase|Withdrawal by Subject|0|||
130929178|NCT01737697|471372252|FG005|Subacute Phase|Withdrawal by Subject|1|||
130929179|NCT01737697|471372253|FG006|Subacute Phase|Withdrawal by Subject|0|||
130929180|NCT01737697|471372254|FG007|Subacute Phase|Withdrawal by Subject|2|||
130929181|NCT01737697|471372255|FG008|Subacute Phase|Withdrawal by Subject|0|||
130929182|NCT01737697|471372256|FG009|Subacute Phase|Withdrawal by Subject|1|||
130929183|NCT01737697|471372257|FG010|Subacute Phase|Withdrawal by Subject|0|||
130929184|NCT01737697|471372258|FG011|Subacute Phase|Withdrawal by Subject|1|||
130929185|NCT01737697|471372259|FG012|Subacute Phase|Withdrawal by Subject|1|||
130929186|NCT01737697|471372260|FG013|Subacute Phase|Withdrawal by Subject|1|||
130929187|NCT01737697|471372261|FG014|Subacute Phase|Withdrawal by Subject|0|||
130929188|NCT01737697|471372247|FG000|Subacute Phase|Lost to Follow-up|0|||
130929189|NCT01737697|471372248|FG001|Subacute Phase|Lost to Follow-up|0|||
130929190|NCT01737697|471372249|FG002|Subacute Phase|Lost to Follow-up|0|||
130929191|NCT01737697|471372250|FG003|Subacute Phase|Lost to Follow-up|0|||
130929192|NCT01737697|471372251|FG004|Subacute Phase|Lost to Follow-up|0|||
130929193|NCT01737697|471372252|FG005|Subacute Phase|Lost to Follow-up|0|||
130929194|NCT01737697|471372253|FG006|Subacute Phase|Lost to Follow-up|0|||
130929195|NCT01737697|471372254|FG007|Subacute Phase|Lost to Follow-up|0|||
130929196|NCT01737697|471372255|FG008|Subacute Phase|Lost to Follow-up|0|||
130929197|NCT01737697|471372256|FG009|Subacute Phase|Lost to Follow-up|0|||
130929198|NCT01737697|471372257|FG010|Subacute Phase|Lost to Follow-up|0|||
130929199|NCT01737697|471372258|FG011|Subacute Phase|Lost to Follow-up|0|||
130929200|NCT01737697|471372259|FG012|Subacute Phase|Lost to Follow-up|0|||
130929201|NCT01737697|471372260|FG013|Subacute Phase|Lost to Follow-up|0|||
130929202|NCT01737697|471372261|FG014|Subacute Phase|Lost to Follow-up|1|||
130929203|NCT01737697|471372247|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
130929204|NCT01737697|471372248|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
130929205|NCT01737697|471372249|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
130929206|NCT01737697|471372250|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
130929207|NCT01737697|471372251|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
130770318|NCT01483599|470784350|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
130929208|NCT01737697|471372252|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
130929209|NCT01737697|471372253|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
130929210|NCT01737697|471372254|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
130929211|NCT01737697|471372255|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
130929212|NCT01737697|471372256|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
130929213|NCT01737697|471372257|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
130929214|NCT01737697|471372258|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
130929215|NCT01737697|471372259|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
130929216|NCT01737697|471372260|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
130929217|NCT01737697|471372261|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
130929218|NCT01737697|471372247|FG000|Subacute Phase|Protocol Violation|0|||
130929219|NCT01737697|471372248|FG001|Subacute Phase|Protocol Violation|0|||
130929220|NCT01737697|471372249|FG002|Subacute Phase|Protocol Violation|0|||
130929221|NCT01737697|471372250|FG003|Subacute Phase|Protocol Violation|0|||
130929222|NCT01737697|471372251|FG004|Subacute Phase|Protocol Violation|0|||
130929223|NCT01737697|471372252|FG005|Subacute Phase|Protocol Violation|1|||
130929224|NCT01737697|471372253|FG006|Subacute Phase|Protocol Violation|0|||
130929225|NCT01737697|471372254|FG007|Subacute Phase|Protocol Violation|0|||
130929226|NCT01737697|471372255|FG008|Subacute Phase|Protocol Violation|0|||
130929227|NCT01737697|471372256|FG009|Subacute Phase|Protocol Violation|0|||
130929228|NCT01737697|471372257|FG010|Subacute Phase|Protocol Violation|1|||
130929229|NCT01737697|471372258|FG011|Subacute Phase|Protocol Violation|0|||
130929230|NCT01737697|471372259|FG012|Subacute Phase|Protocol Violation|0|||
130929231|NCT01737697|471372260|FG013|Subacute Phase|Protocol Violation|0|||
130929232|NCT01737697|471372261|FG014|Subacute Phase|Protocol Violation|0|||
130929233|NCT01737697|471372247|FG000|Subacute Phase|Physician Decision|0|||
130929234|NCT01737697|471372248|FG001|Subacute Phase|Physician Decision|0|||
130929235|NCT01737697|471372249|FG002|Subacute Phase|Physician Decision|0|||
130929236|NCT01737697|471372250|FG003|Subacute Phase|Physician Decision|0|||
130929237|NCT01737697|471372251|FG004|Subacute Phase|Physician Decision|0|||
130929238|NCT01737697|471372252|FG005|Subacute Phase|Physician Decision|0|||
130929239|NCT01737697|471372253|FG006|Subacute Phase|Physician Decision|0|||
130929240|NCT01737697|471372254|FG007|Subacute Phase|Physician Decision|0|||
130929241|NCT01737697|471372255|FG008|Subacute Phase|Physician Decision|1|||
130929242|NCT01737697|471372256|FG009|Subacute Phase|Physician Decision|0|||
130929243|NCT01737697|471372257|FG010|Subacute Phase|Physician Decision|0|||
130929244|NCT01737697|471372258|FG011|Subacute Phase|Physician Decision|0|||
130929245|NCT01737697|471372259|FG012|Subacute Phase|Physician Decision|0|||
130929246|NCT01737697|471372260|FG013|Subacute Phase|Physician Decision|0|||
130929247|NCT01737697|471372261|FG014|Subacute Phase|Physician Decision|0|||
130929248|NCT01737697|471372247|FG000|Subacute Phase|Death|0|||
130929249|NCT01737697|471372248|FG001|Subacute Phase|Death|0|||
130929250|NCT01737697|471372249|FG002|Subacute Phase|Death|0|||
130929251|NCT01737697|471372250|FG003|Subacute Phase|Death|0|||
130929252|NCT01737697|471372251|FG004|Subacute Phase|Death|0|||
130929253|NCT01737697|471372252|FG005|Subacute Phase|Death|0|||
130929254|NCT01737697|471372253|FG006|Subacute Phase|Death|0|||
130929255|NCT01737697|471372254|FG007|Subacute Phase|Death|0|||
130929256|NCT01737697|471372255|FG008|Subacute Phase|Death|0|||
130929257|NCT01737697|471372256|FG009|Subacute Phase|Death|0|||
130929258|NCT01737697|471372257|FG010|Subacute Phase|Death|1|||
130929259|NCT01737697|471372258|FG011|Subacute Phase|Death|0|||
130929260|NCT01737697|471372259|FG012|Subacute Phase|Death|0|||
130929261|NCT01737697|471372260|FG013|Subacute Phase|Death|0|||
130929262|NCT01737697|471372261|FG014|Subacute Phase|Death|0|||
130929263|NCT03338998|471372264|FG000|Treatment Period|Withdrawal by Subject|1|||
130929264|NCT03338998|471372265|FG001|Treatment Period|Withdrawal by Subject|1|||
130929265|NCT03338998|471372264|FG000|Treatment Period|Adverse Event|0|||
130929266|NCT03338998|471372265|FG001|Treatment Period|Adverse Event|2|||
130929267|NCT03338998|471372264|FG000|Treatment Period|Protocol deviation|1|||
130929268|NCT03338998|471372265|FG001|Treatment Period|Protocol deviation|0|||
130929269|NCT03338998|471372264|FG000|Treatment Period|Physician Decision|2|||
130929270|NCT03338998|471372265|FG001|Treatment Period|Physician Decision|0|||
130929271|NCT03338998|471372264|FG000|Treatment Period|Subject failed swallow test|4|||
130702985|NCT01186016|470535957|FG000|Overall Study|Withdrawal by Subject|46|||
130929272|NCT03338998|471372265|FG001|Treatment Period|Subject failed swallow test|0|||
130929273|NCT03338998|471372264|FG000|Safety Follow-Up Period|Adverse Event|0|||
130929274|NCT03338998|471372265|FG001|Safety Follow-Up Period|Adverse Event|1|||
130929275|NCT03338998|471372264|FG000|Safety Follow-Up Period|Protocol deviation|1|||
130929276|NCT03338998|471372265|FG001|Safety Follow-Up Period|Protocol deviation|0|||
130929277|NCT03338998|471372264|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
130929278|NCT03338998|471372265|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
130929279|NCT03288129|471372267|FG000|Overall Study|Adverse Event|10|||
130929280|NCT03288129|471372267|FG000|Overall Study|Lost to Follow-up|3|||
130929281|NCT03288129|471372267|FG000|Overall Study|Withdrawal by Subject|3|||
130929282|NCT03288129|471372267|FG000|Overall Study|Withdrawal of consent/assent|1|||
130929283|NCT03288129|471372267|FG000|Overall Study|Other|5|||
130929284|NCT01949506|471372272|FG000|Overall Study|Physician Decision|1|||
130929285|NCT02915016|471372273|FG000|Overall Study|Lost to Follow-up|4|||
130929286|NCT02915016|471372274|FG001|Overall Study|Lost to Follow-up|2|||
130929287|NCT02915016|471372275|FG002|Overall Study|Lost to Follow-up|5|||
130929288|NCT02915016|471372276|FG003|Overall Study|Lost to Follow-up|3|||
130929289|NCT02915016|471372277|FG004|Overall Study|Lost to Follow-up|5|||
130929290|NCT02915016|471372278|FG005|Overall Study|Lost to Follow-up|2|||
130929291|NCT02915016|471372279|FG006|Overall Study|Lost to Follow-up|8|||
130929292|NCT02915016|471372280|FG007|Overall Study|Lost to Follow-up|2|||
130929293|NCT02915016|471372273|FG000|Overall Study|Physician Decision|0|||
130929294|NCT02915016|471372274|FG001|Overall Study|Physician Decision|0|||
130929295|NCT02915016|471372275|FG002|Overall Study|Physician Decision|1|||
130929296|NCT02915016|471372276|FG003|Overall Study|Physician Decision|0|||
130929297|NCT02915016|471372277|FG004|Overall Study|Physician Decision|0|||
130929298|NCT02915016|471372278|FG005|Overall Study|Physician Decision|1|||
130929299|NCT02915016|471372279|FG006|Overall Study|Physician Decision|2|||
130929300|NCT02915016|471372280|FG007|Overall Study|Physician Decision|0|||
130929301|NCT02915016|471372273|FG000|Overall Study|Withdrawal by Subject|2|||
130929302|NCT02915016|471372274|FG001|Overall Study|Withdrawal by Subject|0|||
130929303|NCT02915016|471372275|FG002|Overall Study|Withdrawal by Subject|1|||
130929304|NCT02915016|471372276|FG003|Overall Study|Withdrawal by Subject|0|||
130929305|NCT02915016|471372277|FG004|Overall Study|Withdrawal by Subject|1|||
130929306|NCT02915016|471372278|FG005|Overall Study|Withdrawal by Subject|3|||
130929307|NCT02915016|471372279|FG006|Overall Study|Withdrawal by Subject|1|||
130929308|NCT02915016|471372280|FG007|Overall Study|Withdrawal by Subject|1|||
130929309|NCT02915016|471372273|FG000|Overall Study|Elected not to continue|0|||
130929310|NCT02915016|471372274|FG001|Overall Study|Elected not to continue|0|||
130929311|NCT02915016|471372275|FG002|Overall Study|Elected not to continue|0|||
130929312|NCT02915016|471372276|FG003|Overall Study|Elected not to continue|1|||
130929313|NCT02915016|471372277|FG004|Overall Study|Elected not to continue|0|||
130929314|NCT02915016|471372278|FG005|Overall Study|Elected not to continue|0|||
130929315|NCT02915016|471372279|FG006|Overall Study|Elected not to continue|1|||
130929316|NCT02915016|471372280|FG007|Overall Study|Elected not to continue|0|||
130929317|NCT02915016|471372273|FG000|Overall Study|HIV infection|1|||
130929318|NCT02915016|471372274|FG001|Overall Study|HIV infection|1|||
130929319|NCT02915016|471372275|FG002|Overall Study|HIV infection|1|||
130929320|NCT02915016|471372276|FG003|Overall Study|HIV infection|0|||
130929321|NCT02915016|471372277|FG004|Overall Study|HIV infection|1|||
130929322|NCT02915016|471372278|FG005|Overall Study|HIV infection|0|||
130929323|NCT02915016|471372279|FG006|Overall Study|HIV infection|0|||
130929324|NCT02915016|471372280|FG007|Overall Study|HIV infection|0|||
130929325|NCT02915016|471372273|FG000|Overall Study|Participant unable to adhere|0|||
130929326|NCT02915016|471372274|FG001|Overall Study|Participant unable to adhere|0|||
130929327|NCT02915016|471372275|FG002|Overall Study|Participant unable to adhere|0|||
130929328|NCT02915016|471372276|FG003|Overall Study|Participant unable to adhere|0|||
130929329|NCT02915016|471372277|FG004|Overall Study|Participant unable to adhere|0|||
130929330|NCT02915016|471372278|FG005|Overall Study|Participant unable to adhere|0|||
130929331|NCT02915016|471372279|FG006|Overall Study|Participant unable to adhere|0|||
130929332|NCT02915016|471372280|FG007|Overall Study|Participant unable to adhere|1|||
130929333|NCT01408485|471374279|FG000|Overall Study|Withdrawal by Subject|21|||
130929334|NCT01806545|471374283|FG000|Overall Study|Adverse Event|2|||
130929335|NCT01806545|471374284|FG001|Overall Study|Adverse Event|3|||
130929336|NCT01806545|471374283|FG000|Overall Study|Lost to Follow-up|1|||
130929337|NCT01806545|471374284|FG001|Overall Study|Lost to Follow-up|0|||
130929338|NCT01806545|471374283|FG000|Overall Study|Withdrawal by Subject|3|||
130929339|NCT01806545|471374284|FG001|Overall Study|Withdrawal by Subject|2|||
130929340|NCT01508650|471374285|FG000|Overall Study|Lost to Follow-up|0|||
130929341|NCT01508650|471374286|FG001|Overall Study|Lost to Follow-up|3|||
130929342|NCT00429273|471374287|FG000|Overall Study|Lost to Follow-up|1|||
130929343|NCT00429273|471374288|FG001|Overall Study|Lost to Follow-up|2|||
130929344|NCT00429273|471374289|FG002|Overall Study|Lost to Follow-up|2|||
130929345|NCT00429273|471374287|FG000|Overall Study|Physician Decision|6|||
130929346|NCT00429273|471374288|FG001|Overall Study|Physician Decision|5|||
130929347|NCT00429273|471374289|FG002|Overall Study|Physician Decision|5|||
130929348|NCT00429273|471374287|FG000|Overall Study|Adverse Event|1|||
130929349|NCT00429273|471374288|FG001|Overall Study|Adverse Event|1|||
130929350|NCT00429273|471374289|FG002|Overall Study|Adverse Event|2|||
130929351|NCT02064894|471374290|FG000|Overall Study|Withdrawal by Subject|43|||
130929352|NCT02064894|471374291|FG001|Overall Study|Withdrawal by Subject|102|||
130929353|NCT02064894|471374292|FG002|Overall Study|Withdrawal by Subject|115|||
130929354|NCT01438957|471374293|FG000|Overall Study|Physician Decision|1|||
130929355|NCT01438957|471374294|FG001|Overall Study|Physician Decision|1|||
130929356|NCT01438957|471374295|FG002|Overall Study|Physician Decision|0|||
130929357|NCT01438957|471374296|FG003|Overall Study|Physician Decision|1|||
130929358|NCT01438957|471374297|FG004|Overall Study|Physician Decision|0|||
130929359|NCT00884312|471374306|FG000|Overall Study|Non-fatal Progressive Disease|0|||
130929360|NCT00884312|471374307|FG001|Overall Study|Non-fatal Progressive Disease|8|||
130929361|NCT00884312|471374306|FG000|Overall Study|Fatal Progressive Disease|0|||
130929362|NCT00884312|471374307|FG001|Overall Study|Fatal Progressive Disease|1|||
130929363|NCT00884312|471374306|FG000|Overall Study|Non-fatal Adverse Event|1|||
130929364|NCT00884312|471374307|FG001|Overall Study|Non-fatal Adverse Event|0|||
130929365|NCT00884312|471374306|FG000|Overall Study|Fatal Adverse Event|1|||
130929366|NCT00884312|471374307|FG001|Overall Study|Fatal Adverse Event|4|||
130929367|NCT00884312|471374306|FG000|Overall Study|Withdrawal by Subject|0|||
130929368|NCT00884312|471374307|FG001|Overall Study|Withdrawal by Subject|6|||
130929369|NCT00884312|471374306|FG000|Overall Study|Physician Decision|0|||
131034874|NCT04171999|471761820|FG000|Overall Study|deemed ineligible after randomization|2|||
130929370|NCT00884312|471374307|FG001|Overall Study|Physician Decision|1|||
130929371|NCT00884312|471374306|FG000|Overall Study|Other|0|||
130929372|NCT00884312|471374307|FG001|Overall Study|Other|4|||
130929373|NCT00884312|471374306|FG000|Overall Study|Did Not Receive Study Drug|0|||
130929374|NCT00884312|471374307|FG001|Overall Study|Did Not Receive Study Drug|1|||
130929375|NCT00224042|471374308|FG000|Overall Study|Adverse Event|2|||
130702986|NCT01186016|470535958|FG001|Overall Study|Withdrawal by Subject|29|||
130702987|NCT01098539|470535959|FG000|Overall Study|Adverse Event|26|||
130702988|NCT01098539|470535960|FG001|Overall Study|Adverse Event|26|||
130702989|NCT01098539|470535959|FG000|Overall Study|Protocol Violation|1|||
130702990|NCT01098539|470535960|FG001|Overall Study|Protocol Violation|4|||
130702991|NCT01098539|470535959|FG000|Overall Study|Noncompliance|3|||
130702992|NCT01098539|470535960|FG001|Overall Study|Noncompliance|5|||
130702993|NCT01098539|470535959|FG000|Overall Study|Lost to Follow-up|4|||
130702994|NCT01098539|470535960|FG001|Overall Study|Lost to Follow-up|4|||
130702995|NCT01098539|470535959|FG000|Overall Study|Withdrawal by Subject|12|||
130702996|NCT01098539|470535960|FG001|Overall Study|Withdrawal by Subject|26|||
130702997|NCT01098539|470535959|FG000|Overall Study|Physician Decision|5|||
130702998|NCT01098539|470535960|FG001|Overall Study|Physician Decision|3|||
130702999|NCT00721955|470535961|FG000|Overall Study|Adverse Event|0|||
130703000|NCT00721955|470535962|FG001|Overall Study|Adverse Event|0|||
130703001|NCT00721955|470535963|FG002|Overall Study|Adverse Event|2|||
130703002|NCT01055886|470535965|FG000|Overall Study|Withdrawal by Subject|4|||
130703003|NCT01055886|470535966|FG001|Overall Study|Withdrawal by Subject|9|||
130703004|NCT01055886|470535965|FG000|Overall Study|Lost to Follow-up|1|||
130703005|NCT01055886|470535966|FG001|Overall Study|Lost to Follow-up|1|||
130703006|NCT01055886|470535965|FG000|Overall Study|Withdrawal by PI|0|||
130703007|NCT01055886|470535966|FG001|Overall Study|Withdrawal by PI|1|||
130703008|NCT01077258|470535969|FG000|Overall Study|Lost to Follow-up|1390|||
130703009|NCT01077258|470535969|FG000|Overall Study|Adverse drug reaction|218|||
130703010|NCT01077258|470535969|FG000|Overall Study|Lack of Efficacy|663|||
130703011|NCT01077258|470535969|FG000|Overall Study|Clinical remission|37|||
130703012|NCT01077258|470535969|FG000|Overall Study|Other reasons|260|||
130703013|NCT00726895|470535970|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130703014|NCT00726895|470535971|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130703015|NCT00265785|470535974|FG000|Overall Study|Adverse Event|4|||
130703016|NCT00265785|470535974|FG000|Overall Study|Withdrawal by Subject|3|||
130703017|NCT00265785|470535974|FG000|Overall Study|Progression/Relapse|15|||
130703018|NCT00265785|470535974|FG000|Overall Study|Not protocol specified|2|||
130703019|NCT00265785|470535974|FG000|Overall Study|Ineligible|1|||
130703020|NCT00265785|470535974|FG000|Overall Study|Did not receive protocol treatment|2|||
130703021|NCT00585312|470535990|FG000|Overall Study|Adverse Event|3|||
130703022|NCT00585312|470535991|FG001|Overall Study|Adverse Event|0|||
130703023|NCT00585312|470535990|FG000|Overall Study|Lack of Efficacy|6|||
130703024|NCT00585312|470535991|FG001|Overall Study|Lack of Efficacy|11|||
130703025|NCT00585312|470535990|FG000|Overall Study|Lost to Follow-up|1|||
130703026|NCT00585312|470535991|FG001|Overall Study|Lost to Follow-up|1|||
130703027|NCT00585312|470535990|FG000|Overall Study|Reason not specified|2|||
130703028|NCT00585312|470535991|FG001|Overall Study|Reason not specified|0|||
130703029|NCT00585312|470535990|FG000|Overall Study|Withdrawal by Subject|5|||
130703030|NCT00585312|470535991|FG001|Overall Study|Withdrawal by Subject|1|||
130703031|NCT00585312|470535990|FG000|Overall Study|Study terminated by the sponsor|34|||
130703032|NCT00585312|470535991|FG001|Overall Study|Study terminated by the sponsor|31|||
130703033|NCT00879684|470535995|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
130703034|NCT00879684|470535996|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
130703035|NCT00879684|470535997|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
130703036|NCT00879684|470535998|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
130703037|NCT00879684|470535999|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
130703038|NCT00879684|470536000|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
130703039|NCT00879684|470536001|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
130703040|NCT00879684|470535995|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
130703041|NCT00879684|470535996|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
130703042|NCT00879684|470535997|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
130703043|NCT00879684|470535998|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
130703044|NCT00879684|470535999|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
130703045|NCT00879684|470536000|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
130703046|NCT00879684|470536001|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
130703047|NCT00879684|470535995|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
130703048|NCT00879684|470535996|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
130703049|NCT00879684|470535997|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
130703050|NCT00879684|470535998|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
130703051|NCT00879684|470535999|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
130703052|NCT00879684|470536000|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
130703053|NCT00879684|470536001|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
130703054|NCT00879684|470535995|FG000|Stage 1: Dose Escalation|Death|0|||
130703055|NCT00879684|470535996|FG001|Stage 1: Dose Escalation|Death|0|||
130703056|NCT00879684|470535997|FG002|Stage 1: Dose Escalation|Death|1|||
130703057|NCT00879684|470535998|FG003|Stage 1: Dose Escalation|Death|0|||
130703058|NCT00879684|470535999|FG004|Stage 1: Dose Escalation|Death|0|||
130703059|NCT00879684|470536000|FG005|Stage 1: Dose Escalation|Death|0|||
130703060|NCT00879684|470536001|FG006|Stage 1: Dose Escalation|Death|0|||
130929376|NCT00224042|471374309|FG001|Overall Study|Adverse Event|1|||
130703061|NCT00879684|470535995|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703062|NCT00879684|470535996|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703063|NCT00879684|470535997|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703064|NCT00879684|470535998|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703065|NCT00879684|470535999|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703066|NCT00879684|470536000|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130703067|NCT00879684|470536001|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
130703068|NCT00879684|470535995|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703069|NCT00879684|470535996|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703070|NCT00879684|470535997|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703071|NCT00879684|470535998|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703072|NCT00879684|470535999|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703073|NCT00879684|470536000|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
130703074|NCT00879684|470536001|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
130703075|NCT00879684|470535995|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703076|NCT00879684|470535996|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703077|NCT00879684|470535997|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703078|NCT00879684|470535998|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703079|NCT00879684|470535999|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703080|NCT00879684|470536000|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130703081|NCT00879684|470536001|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
130703082|NCT01634854|470536007|FG000|Overall Study|Cesarean delivery|2|||
130703083|NCT01634854|470536008|FG001|Overall Study|Cesarean delivery|7|||
130770319|NCT01483599|470784351|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
130770320|NCT01483599|470784338|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
130770321|NCT01483599|470784339|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
130770322|NCT01483599|470784340|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
130770323|NCT01483599|470784341|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
130929377|NCT00224042|471374308|FG000|Overall Study|Protocol Violation|0|||
130929378|NCT00224042|471374309|FG001|Overall Study|Protocol Violation|1|||
130929379|NCT00224042|471374308|FG000|Overall Study|Physician Decision|0|||
130929380|NCT00224042|471374309|FG001|Overall Study|Physician Decision|1|||
130929381|NCT00224042|471374308|FG000|Overall Study|Did not meet lab incusion criteria|2|||
130929382|NCT00224042|471374309|FG001|Overall Study|Did not meet lab incusion criteria|3|||
130929383|NCT00224042|471374308|FG000|Overall Study|Other|2|||
130929384|NCT00224042|471374309|FG001|Overall Study|Other|0|||
130929385|NCT00840450|471374310|FG000|Overall Study|Adverse Event|1|||
130929386|NCT00840450|471374310|FG000|Overall Study|Lack of Efficacy|2|||
130929387|NCT00617123|471374311|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
130929388|NCT00617123|471374312|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
130929389|NCT00617123|471374311|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
130929390|NCT00617123|471374312|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
130929391|NCT00617123|471374311|FG000|Referral Screening Period|Adverse Event|0|||
130929392|NCT00617123|471374312|FG001|Referral Screening Period|Adverse Event|1|||
130929393|NCT00617123|471374311|FG000|Study Treatment Period|Withdrawal by Subject|8|||
130929394|NCT00617123|471374312|FG001|Study Treatment Period|Withdrawal by Subject|12|||
130929395|NCT00617123|471374311|FG000|Study Treatment Period|Adverse Event|7|||
130929396|NCT00617123|471374312|FG001|Study Treatment Period|Adverse Event|3|||
130929397|NCT00617123|471374311|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
130929398|NCT00617123|471374312|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
130929399|NCT00617123|471374311|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
130929400|NCT00617123|471374312|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
130929401|NCT00133952|471374314|FG000|Overall Study|Adverse Event|1|||
130929402|NCT00133952|471374315|FG001|Overall Study|Adverse Event|2|||
130929403|NCT00133952|471374314|FG000|Overall Study|Death|3|||
130929404|NCT00133952|471374315|FG001|Overall Study|Death|2|||
130703084|NCT01169038|470536009|FG000|Overall Study|Death|1|||
130703085|NCT01169038|470536009|FG000|Overall Study|Adverse Event|5|||
130770324|NCT01483599|470784342|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
130770325|NCT01483599|470784343|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
130770326|NCT01483599|470784344|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
130770327|NCT01483599|470784345|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
130929405|NCT00133952|471374314|FG000|Overall Study|Lost to Follow-up|9|||
130703086|NCT01169038|470536009|FG000|Overall Study|Required antibiotic administration|1|||
130770328|NCT01483599|470784346|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
130770329|NCT01483599|470784347|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
130929406|NCT00133952|471374315|FG001|Overall Study|Lost to Follow-up|14|||
130929407|NCT00133952|471374314|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
131223728|NCT04380701|472447115|FG006|Overall Study|Pregnancy|0|||
131223729|NCT04380701|472447116|FG007|Overall Study|Pregnancy|0|||
130929408|NCT00133952|471374315|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
130929409|NCT00133952|471374314|FG000|Overall Study|Protocol Violation|1|||
130929410|NCT00133952|471374315|FG001|Overall Study|Protocol Violation|1|||
130929411|NCT00133952|471374314|FG000|Overall Study|Withdrawal by Subject|20|||
130929412|NCT00133952|471374315|FG001|Overall Study|Withdrawal by Subject|4|||
130929413|NCT00133952|471374314|FG000|Overall Study|Physician Decision|4|||
130929414|NCT00133952|471374315|FG001|Overall Study|Physician Decision|3|||
130929415|NCT00133952|471374314|FG000|Overall Study|Sponsor Decision|0|||
130929416|NCT00133952|471374315|FG001|Overall Study|Sponsor Decision|1|||
130929417|NCT03052725|471374316|FG000|Overall Study|Adverse Event|2|||
130929418|NCT03052725|471374317|FG001|Overall Study|Adverse Event|0|||
130929419|NCT03052725|471374316|FG000|Overall Study|Withdrawal by Subject|3|||
130929420|NCT03052725|471374317|FG001|Overall Study|Withdrawal by Subject|4|||
130929421|NCT03052725|471374316|FG000|Overall Study|Pregnancy|0|||
130929422|NCT03052725|471374317|FG001|Overall Study|Pregnancy|1|||
130929423|NCT03052725|471374316|FG000|Overall Study|Site closure|0|||
130929424|NCT03052725|471374317|FG001|Overall Study|Site closure|1|||
130929425|NCT03052725|471374316|FG000|Overall Study|Study terminated by sponsor|143|||
130929426|NCT03052725|471374317|FG001|Overall Study|Study terminated by sponsor|144|||
130929427|NCT00727025|471374323|FG000|Overall Study|Physician Decision|23|||
130929428|NCT00299104|471374324|FG000|Treatment Period|Adverse Event|14|||
130929429|NCT00299104|471374325|FG001|Treatment Period|Adverse Event|9|||
130929430|NCT00299104|471374326|FG002|Treatment Period|Adverse Event|7|||
130929431|NCT00299104|471374324|FG000|Treatment Period|Death|1|||
130929432|NCT00299104|471374325|FG001|Treatment Period|Death|1|||
130929433|NCT00299104|471374326|FG002|Treatment Period|Death|1|||
130929434|NCT00299104|471374324|FG000|Treatment Period|Insufficient therapeutic response|34|||
130929435|NCT00299104|471374325|FG001|Treatment Period|Insufficient therapeutic response|13|||
130929436|NCT00299104|471374326|FG002|Treatment Period|Insufficient therapeutic response|8|||
130929437|NCT00299104|471374324|FG000|Treatment Period|Failure to return|9|||
130929438|NCT00299104|471374325|FG001|Treatment Period|Failure to return|8|||
130929439|NCT00299104|471374326|FG002|Treatment Period|Failure to return|8|||
130929440|NCT00299104|471374324|FG000|Treatment Period|Violation of selection criteria|1|||
130929441|NCT00299104|471374325|FG001|Treatment Period|Violation of selection criteria|2|||
130929442|NCT00299104|471374326|FG002|Treatment Period|Violation of selection criteria|0|||
130929443|NCT00299104|471374324|FG000|Treatment Period|Protocol Violation|1|||
130929444|NCT00299104|471374325|FG001|Treatment Period|Protocol Violation|1|||
130929445|NCT00299104|471374326|FG002|Treatment Period|Protocol Violation|0|||
130929446|NCT00299104|471374324|FG000|Treatment Period|Refused treatment|9|||
130929447|NCT00299104|471374325|FG001|Treatment Period|Refused treatment|2|||
130929448|NCT00299104|471374326|FG002|Treatment Period|Refused treatment|2|||
130929449|NCT00299104|471374324|FG000|Treatment Period|Withdrew consent|14|||
130929450|NCT00299104|471374325|FG001|Treatment Period|Withdrew consent|19|||
130929451|NCT00299104|471374326|FG002|Treatment Period|Withdrew consent|9|||
130929452|NCT00299104|471374324|FG000|Treatment Period|Administrative reasons|106|||
130929453|NCT00299104|471374325|FG001|Treatment Period|Administrative reasons|120|||
130929454|NCT00299104|471374326|FG002|Treatment Period|Administrative reasons|137|||
130929455|NCT00299104|471374324|FG000|Safety Follow-Up (SFU) Period|Death|3|||
130929456|NCT00299104|471374325|FG001|Safety Follow-Up (SFU) Period|Death|2|||
130929457|NCT00299104|471374326|FG002|Safety Follow-Up (SFU) Period|Death|1|||
130929458|NCT00299104|471374324|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
130929459|NCT00299104|471374325|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
130929460|NCT00299104|471374326|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
130929461|NCT00299104|471374324|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
130929462|NCT00299104|471374325|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
130929463|NCT00299104|471374326|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
130929464|NCT00299104|471374324|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
130929465|NCT00299104|471374325|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
130929466|NCT00299104|471374326|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
130929467|NCT00299104|471374324|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
130929468|NCT00299104|471374325|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
130929469|NCT00299104|471374326|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
130929470|NCT00299104|471374324|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
130929471|NCT00299104|471374325|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
130929472|NCT00299104|471374326|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
130929473|NCT00299104|471374324|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
130929474|NCT00299104|471374325|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
130929475|NCT00299104|471374326|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
130929476|NCT00299104|471374324|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
130929477|NCT00299104|471374325|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
130929478|NCT00299104|471374326|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
130929479|NCT00847379|471374327|FG000|Overall Study|Study terminated by Sponsor|59|||
130929480|NCT00847379|471374328|FG001|Overall Study|Study terminated by Sponsor|57|||
130929481|NCT00847379|471374329|FG002|Overall Study|Study terminated by Sponsor|57|||
130929482|NCT03978832|471374330|FG000|Overall Study|Adverse Event|1|||
130929483|NCT03978832|471374330|FG000|Overall Study|Lost to Follow-up|1|||
130929484|NCT03978832|471374330|FG000|Overall Study|Withdrawal by Subject|6|||
130929485|NCT03978832|471374330|FG000|Overall Study|Physician Decision|2|||
130929486|NCT03978832|471374330|FG000|Overall Study|did not pass screening criteria|44|||
130929487|NCT00003499|471374331|FG000|Overall Study|Not evaluable|8|||
130929488|NCT01727297|471374336|FG000|Overall Study|Death|13|||
130929489|NCT01727297|471374337|FG001|Overall Study|Death|0|||
130929490|NCT01727297|471374336|FG000|Overall Study|Protocol Violation|1|||
130929491|NCT01727297|471374337|FG001|Overall Study|Protocol Violation|10|||
130929492|NCT01727297|471374336|FG000|Overall Study|Adverse Event|3|||
130929493|NCT01727297|471374337|FG001|Overall Study|Adverse Event|1|||
130929494|NCT01727297|471374336|FG000|Overall Study|Lost to Follow-up|11|||
130929495|NCT01727297|471374337|FG001|Overall Study|Lost to Follow-up|0|||
130929496|NCT01727297|471374336|FG000|Overall Study|Withdrawal by Subject|26|||
130929497|NCT01727297|471374337|FG001|Overall Study|Withdrawal by Subject|27|||
130929498|NCT01727297|471374336|FG000|Overall Study|Physician Decision|19|||
130929499|NCT01727297|471374337|FG001|Overall Study|Physician Decision|5|||
130929500|NCT01727297|471374336|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
130929501|NCT01727297|471374337|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
130929502|NCT02042183|471374338|FG000|Overall Study|Physician Decision|7|||
130929503|NCT02042183|471374339|FG001|Overall Study|Physician Decision|2|||
130929504|NCT02042183|471374338|FG000|Overall Study|Lack of Efficacy|4|||
130929505|NCT02042183|471374339|FG001|Overall Study|Lack of Efficacy|3|||
130929506|NCT02042183|471374338|FG000|Overall Study|Non-compliance with Study Drug|2|||
130929507|NCT02042183|471374339|FG001|Overall Study|Non-compliance with Study Drug|3|||
130929508|NCT02042183|471374338|FG000|Overall Study|Adverse Event|17|||
130929509|NCT02042183|471374339|FG001|Overall Study|Adverse Event|6|||
130929510|NCT02042183|471374338|FG000|Overall Study|Other|3|||
130929511|NCT02042183|471374339|FG001|Overall Study|Other|3|||
130929512|NCT02042183|471374338|FG000|Overall Study|Withdrawal by Subject|21|||
130929513|NCT02042183|471374339|FG001|Overall Study|Withdrawal by Subject|16|||
130929514|NCT02042183|471374338|FG000|Overall Study|Site Terminated by Sponsor|2|||
130929515|NCT02042183|471374339|FG001|Overall Study|Site Terminated by Sponsor|1|||
130929516|NCT02042183|471374338|FG000|Overall Study|Lost to Follow-up|9|||
130929517|NCT02042183|471374339|FG001|Overall Study|Lost to Follow-up|2|||
130929518|NCT02864498|471374340|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
130929519|NCT02864498|471374341|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
130929520|NCT02864498|471374342|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
130929521|NCT02864498|471374340|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
130929522|NCT02864498|471374341|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
130929523|NCT02864498|471374342|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
130929524|NCT02864498|471374340|FG000|Overall Study|Investigator Discretion|0|||
130929525|NCT02864498|471374341|FG001|Overall Study|Investigator Discretion|2|||
130929526|NCT02864498|471374342|FG002|Overall Study|Investigator Discretion|1|||
130929527|NCT02864498|471374340|FG000|Overall Study|Lost to Follow-up|8|||
130929528|NCT02864498|471374341|FG001|Overall Study|Lost to Follow-up|6|||
130929529|NCT02864498|471374342|FG002|Overall Study|Lost to Follow-up|3|||
130929530|NCT02864498|471374340|FG000|Overall Study|Lack of Efficacy|5|||
130929531|NCT02864498|471374341|FG001|Overall Study|Lack of Efficacy|3|||
130929532|NCT02864498|471374342|FG002|Overall Study|Lack of Efficacy|3|||
130929533|NCT02864498|471374340|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
130929534|NCT02864498|471374341|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
130929535|NCT02864498|471374342|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
130929536|NCT02864498|471374340|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
130929537|NCT02864498|471374341|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
130929538|NCT02864498|471374342|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
130929539|NCT02864498|471374340|FG000|Overall Study|Subject moved out of the country.|0|||
130929540|NCT02864498|471374341|FG001|Overall Study|Subject moved out of the country.|0|||
130929541|NCT02864498|471374342|FG002|Overall Study|Subject moved out of the country.|1|||
130703087|NCT01488448|470536010|FG000|Overall Study|Withdrawal by Subject|3|||
130703088|NCT01488448|470536011|FG001|Overall Study|Withdrawal by Subject|1|||
130703089|NCT01488448|470536010|FG000|Overall Study|Adverse Event|9|||
130703090|NCT01488448|470536011|FG001|Overall Study|Adverse Event|4|||
130703091|NCT01488448|470536010|FG000|Overall Study|Physician Decision|4|||
130929542|NCT00378378|471374345|FG000|Overall Study|Withdrawal by Subject|0|||
130929543|NCT00378378|471374346|FG001|Overall Study|Withdrawal by Subject|1|||
130929544|NCT00378378|471374347|FG002|Overall Study|Withdrawal by Subject|0|||
130929545|NCT00378378|471374345|FG000|Overall Study|Treatment Failure|0|||
130929546|NCT00378378|471374346|FG001|Overall Study|Treatment Failure|0|||
130929547|NCT00378378|471374347|FG002|Overall Study|Treatment Failure|1|||
130929548|NCT00378378|471374345|FG000|Overall Study|Non-compliance with protocol|0|||
130929549|NCT00378378|471374346|FG001|Overall Study|Non-compliance with protocol|0|||
130929550|NCT00378378|471374347|FG002|Overall Study|Non-compliance with protocol|1|||
130703092|NCT01488448|470536011|FG001|Overall Study|Physician Decision|9|||
130929551|NCT00407797|471374348|FG000|Overall Study|Lost to Follow-up|2|||
130929552|NCT00407797|471374348|FG000|Overall Study|Adverse Event|6|||
130929553|NCT00407797|471374348|FG000|Overall Study|Other|7|||
130929554|NCT00407797|471374348|FG000|Overall Study|Withdrawal by Subject|3|||
130929555|NCT01812174|471374349|FG000|Overall Study|Death|1|||
130929556|NCT01812174|471374350|FG001|Overall Study|Death|0|||
130929557|NCT01812174|471374349|FG000|Overall Study|Protocol Violation|2|||
130929558|NCT01812174|471374350|FG001|Overall Study|Protocol Violation|0|||
131120255|NCT00467779|472072321|FG010|Stage 2A|Death|0|||
131120256|NCT00467779|472072322|FG011|Stage 2A|Death|0|||
131120257|NCT00467779|472072323|FG012|Stage 2A|Death|0|||
131120258|NCT00467779|472072324|FG013|Stage 2A|Death|1|||
130929563|NCT03132220|471374356|FG000|Overall Study|Lost to Follow-up|17|||
130929564|NCT03132220|471374357|FG001|Overall Study|Lost to Follow-up|8|||
130929565|NCT03132220|471374356|FG000|Overall Study|Withdrawal by Subject|1|||
130929566|NCT03132220|471374357|FG001|Overall Study|Withdrawal by Subject|4|||
130929567|NCT01051323|471374360|FG000|Overall Study|Discontinuation of treatment|103|||
130929568|NCT01051323|471374360|FG000|Overall Study|Transplantation|28|||
130929569|NCT01051323|471374360|FG000|Overall Study|Dialysis dependency|22|||
130929570|NCT01051323|471374360|FG000|Overall Study|Withdrawal by Subject|13|||
130929571|NCT01051323|471374360|FG000|Overall Study|Lost to Follow-up|31|||
130929572|NCT01051323|471374360|FG000|Overall Study|Death|129|||
130929573|NCT01051323|471374360|FG000|Overall Study|Hospitalization|28|||
130929574|NCT01051323|471374360|FG000|Overall Study|Other|148|||
130929575|NCT01051323|471374360|FG000|Overall Study|Missing|37|||
130929576|NCT00601458|471374361|FG000|Overall Study|Dosing Error|1|||
130929577|NCT00601458|471374362|FG001|Overall Study|Dosing Error|0|||
130929578|NCT00601458|471374363|FG002|Overall Study|Dosing Error|0|||
130929579|NCT00601458|471374361|FG000|Overall Study|Incomplete Data|0|||
130929580|NCT00601458|471374362|FG001|Overall Study|Incomplete Data|2|||
130929581|NCT00601458|471374363|FG002|Overall Study|Incomplete Data|0|||
130929582|NCT00601458|471374361|FG000|Overall Study|Protocol Violation|3|||
130929583|NCT00601458|471374362|FG001|Overall Study|Protocol Violation|2|||
130929584|NCT00601458|471374363|FG002|Overall Study|Protocol Violation|1|||
130929585|NCT00601458|471374361|FG000|Overall Study|Early Termination|0|||
130929586|NCT00601458|471374362|FG001|Overall Study|Early Termination|1|||
130929587|NCT00601458|471374363|FG002|Overall Study|Early Termination|1|||
130929588|NCT00370032|471374364|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
130929589|NCT00370032|471374365|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
130929590|NCT00370032|471374364|FG000|Washout Period|Withdrawal by Subject|0|||
130929591|NCT00370032|471374365|FG001|Washout Period|Withdrawal by Subject|1|||
130929592|NCT00370032|471374364|FG000|Washout Period|Lost to Follow-up|0|||
130929593|NCT00370032|471374365|FG001|Washout Period|Lost to Follow-up|1|||
130929594|NCT00370032|471374364|FG000|Washout Period|Adverse Event|1|||
130929595|NCT00370032|471374365|FG001|Washout Period|Adverse Event|0|||
130929596|NCT00370032|471374364|FG000|Follow-up Period|Withdrawal by Subject|1|||
130929597|NCT00370032|471374365|FG001|Follow-up Period|Withdrawal by Subject|0|||
130929598|NCT00518986|471374366|FG000|Overall Study|Adverse Event|12|||
130929599|NCT00518986|471374367|FG001|Overall Study|Adverse Event|7|||
130929600|NCT00518986|471374366|FG000|Overall Study|Lack of Efficacy|0|||
130929601|NCT00518986|471374367|FG001|Overall Study|Lack of Efficacy|2|||
130929602|NCT00518986|471374366|FG000|Overall Study|Lost to Follow-up|3|||
130929603|NCT00518986|471374367|FG001|Overall Study|Lost to Follow-up|2|||
130929604|NCT00518986|471374366|FG000|Overall Study|Physician Decision|0|||
130929605|NCT00518986|471374367|FG001|Overall Study|Physician Decision|3|||
130929606|NCT00518986|471374366|FG000|Overall Study|Protocol Violation|5|||
130929607|NCT00518986|471374367|FG001|Overall Study|Protocol Violation|7|||
130929608|NCT00518986|471374366|FG000|Overall Study|Withdrawal by Subject|4|||
130929609|NCT00518986|471374367|FG001|Overall Study|Withdrawal by Subject|4|||
130929610|NCT00518986|471374366|FG000|Overall Study|Non-Specific|2|||
130929611|NCT00518986|471374367|FG001|Overall Study|Non-Specific|1|||
130929612|NCT05683249|471374368|FG000|Overall Study|Adverse Event|3|||
130929613|NCT05683249|471374369|FG001|Overall Study|Adverse Event|1|||
130929614|NCT05683249|471374368|FG000|Overall Study|Lack of Efficacy|0|||
130929615|NCT05683249|471374369|FG001|Overall Study|Lack of Efficacy|2|||
130929616|NCT05683249|471374368|FG000|Overall Study|Lost to Follow-up|6|||
130929617|NCT05683249|471374369|FG001|Overall Study|Lost to Follow-up|5|||
130929618|NCT05683249|471374368|FG000|Overall Study|Non-compliance with Study Drug|2|||
130929619|NCT05683249|471374369|FG001|Overall Study|Non-compliance with Study Drug|0|||
130929620|NCT05683249|471374368|FG000|Overall Study|Protocol Violation|6|||
130929621|NCT05683249|471374369|FG001|Overall Study|Protocol Violation|3|||
130929622|NCT05683249|471374368|FG000|Overall Study|Withdrawal by Subject|9|||
130929623|NCT05683249|471374369|FG001|Overall Study|Withdrawal by Subject|8|||
130929624|NCT05683249|471374368|FG000|Overall Study|Other|0|||
130929625|NCT05683249|471374369|FG001|Overall Study|Other|2|||
130929626|NCT05229406|471374370|FG000|Overall Study|Withdrawal by Subject|1|||
130929627|NCT05229406|471374371|FG001|Overall Study|Withdrawal by Subject|2|||
130929628|NCT03208244|471374377|FG000|Overall Study|Death|1|||
131120259|NCT00467779|472072325|FG014|Stage 2A|Death|0|||
131120260|NCT00467779|472072311|FG000|Stage 2A|Disease Progression|0|||
130703093|NCT01488448|470536010|FG000|Overall Study|Protocol Violation|4|||
130703094|NCT01488448|470536011|FG001|Overall Study|Protocol Violation|3|||
130703095|NCT02329431|470536012|FG000|Overall Study|Lost to Follow-up|20|||
130703096|NCT02329431|470536013|FG001|Overall Study|Lost to Follow-up|13|||
130703097|NCT01475487|470536014|FG000|Overall Study|had to leave early for personal reasons|2|||
130703098|NCT01475487|470536015|FG001|Overall Study|had to leave early for personal reasons|1|||
130703099|NCT01977456|470536016|FG000|Overall Study|Death|5|||
130703100|NCT01142661|470536017|FG000|Overall Study|Adverse Event|2|||
130703101|NCT01142661|470536017|FG000|Overall Study|Withdrawal by Subject|1|||
130703102|NCT01142661|470536017|FG000|Overall Study|Physician Decision|1|||
130703103|NCT02426541|470537830|FG000|Overall Study|Protocol Violation|1|||
130703104|NCT02426541|470537831|FG001|Overall Study|Protocol Violation|0|||
130703105|NCT04412057|470537832|FG000|Overall Study|Death|3|||
130703106|NCT04412057|470537833|FG001|Overall Study|Death|7|||
130703107|NCT04412057|470537832|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
130703108|NCT04412057|470537833|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
130703109|NCT01961882|470537836|FG000|Overall Study|Adverse Event|3|||
130703110|NCT01961882|470537837|FG001|Overall Study|Adverse Event|2|||
130703111|NCT01961882|470537836|FG000|Overall Study|Physician Decision|1|||
130703112|NCT01961882|470537837|FG001|Overall Study|Physician Decision|0|||
130703113|NCT01961882|470537836|FG000|Overall Study|Withdrawal by Subject|4|||
130703114|NCT01961882|470537837|FG001|Overall Study|Withdrawal by Subject|1|||
130703115|NCT01961882|470537836|FG000|Overall Study|Relapse of AML|39|||
130703116|NCT01961882|470537837|FG001|Overall Study|Relapse of AML|37|||
130929629|NCT01637272|471374379|FG000|Overall Study|Adverse Event|6|||
130929630|NCT01637272|471374379|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130929631|NCT01637272|471374379|FG000|Overall Study|Withdrawal by Subject|3|||
130929632|NCT01637272|471374379|FG000|Overall Study|Lost to Follow-up|2|||
130929633|NCT01637272|471374379|FG000|Overall Study|completed core, did not enter ext. phase|4|||
130929634|NCT01637272|471374379|FG000|Overall Study|Administrative problems|1|||
130929635|NCT01637272|471374379|FG000|Overall Study|Protocol Violation|2|||
130929636|NCT01496612|471374380|FG000|1st Intervention|Adverse Event|1|||
130929637|NCT01496612|471374381|FG001|1st Intervention|Adverse Event|0|||
130929638|NCT01496612|471374380|FG000|1st Intervention|Withdrawal by Subject|1|||
130929639|NCT01496612|471374381|FG001|1st Intervention|Withdrawal by Subject|0|||
130929640|NCT03708328|471374389|FG000|Overall Study|Death|3|||
130929641|NCT03708328|471374390|FG001|Overall Study|Death|3|||
130929642|NCT03708328|471374391|FG002|Overall Study|Death|4|||
130929643|NCT03708328|471374392|FG003|Overall Study|Death|2|||
130929644|NCT03708328|471374393|FG004|Overall Study|Death|2|||
130929645|NCT03708328|471374394|FG005|Overall Study|Death|13|||
130929646|NCT03708328|471374395|FG006|Overall Study|Death|26|||
130929647|NCT03708328|471374396|FG007|Overall Study|Death|18|||
130929648|NCT03708328|471374397|FG008|Overall Study|Death|13|||
130929649|NCT03708328|471374398|FG009|Overall Study|Death|8|||
130929650|NCT03708328|471374389|FG000|Overall Study|Lost to Follow-up|0|||
130929651|NCT03708328|471374390|FG001|Overall Study|Lost to Follow-up|1|||
130929652|NCT03708328|471374391|FG002|Overall Study|Lost to Follow-up|0|||
130929653|NCT03708328|471374392|FG003|Overall Study|Lost to Follow-up|1|||
130929654|NCT03708328|471374393|FG004|Overall Study|Lost to Follow-up|0|||
130929655|NCT03708328|471374394|FG005|Overall Study|Lost to Follow-up|3|||
130929656|NCT03708328|471374395|FG006|Overall Study|Lost to Follow-up|3|||
130929657|NCT03708328|471374396|FG007|Overall Study|Lost to Follow-up|0|||
130929658|NCT03708328|471374397|FG008|Overall Study|Lost to Follow-up|0|||
130929659|NCT03708328|471374398|FG009|Overall Study|Lost to Follow-up|1|||
130703117|NCT01961882|470537836|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
130703118|NCT01961882|470537837|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
130703119|NCT01961882|470537836|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
130703120|NCT01961882|470537837|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
130703121|NCT00108082|470537841|FG000|Overall Study|Adverse Event|14|||
130703122|NCT00108082|470537842|FG001|Overall Study|Adverse Event|12|||
130703123|NCT00108082|470537843|FG002|Overall Study|Adverse Event|17|||
130703124|NCT00108082|470537841|FG000|Overall Study|Lost to Follow-up|6|||
130703125|NCT00108082|470537842|FG001|Overall Study|Lost to Follow-up|3|||
130703126|NCT00108082|470537843|FG002|Overall Study|Lost to Follow-up|7|||
131034875|NCT04171999|471761821|FG001|Overall Study|deemed ineligible after randomization|1|||
131034876|NCT04277442|471761824|FG000|Overall Study|Death|1|||
130703127|NCT00108082|470537841|FG000|Overall Study|Consent Withdrawn|3|||
130703128|NCT00108082|470537842|FG001|Overall Study|Consent Withdrawn|3|||
130703129|NCT00108082|470537843|FG002|Overall Study|Consent Withdrawn|5|||
130703130|NCT00108082|470537841|FG000|Overall Study|Protocol Violation|1|||
130929660|NCT03708328|471374389|FG000|Overall Study|Physician Decision|0|||
130929661|NCT03708328|471374390|FG001|Overall Study|Physician Decision|0|||
130929662|NCT03708328|471374391|FG002|Overall Study|Physician Decision|0|||
130929663|NCT03708328|471374392|FG003|Overall Study|Physician Decision|0|||
130929664|NCT03708328|471374393|FG004|Overall Study|Physician Decision|0|||
130929665|NCT03708328|471374394|FG005|Overall Study|Physician Decision|1|||
130929666|NCT03708328|471374395|FG006|Overall Study|Physician Decision|0|||
130929667|NCT03708328|471374396|FG007|Overall Study|Physician Decision|0|||
130929668|NCT03708328|471374397|FG008|Overall Study|Physician Decision|0|||
130929669|NCT03708328|471374398|FG009|Overall Study|Physician Decision|0|||
130929670|NCT03708328|471374389|FG000|Overall Study|Withdrawal by Subject|0|||
130929671|NCT03708328|471374390|FG001|Overall Study|Withdrawal by Subject|0|||
130929672|NCT03708328|471374391|FG002|Overall Study|Withdrawal by Subject|0|||
130929673|NCT03708328|471374392|FG003|Overall Study|Withdrawal by Subject|0|||
130929674|NCT03708328|471374393|FG004|Overall Study|Withdrawal by Subject|1|||
130929675|NCT03708328|471374394|FG005|Overall Study|Withdrawal by Subject|0|||
130929676|NCT03708328|471374395|FG006|Overall Study|Withdrawal by Subject|2|||
130929677|NCT03708328|471374396|FG007|Overall Study|Withdrawal by Subject|4|||
130929678|NCT03708328|471374397|FG008|Overall Study|Withdrawal by Subject|1|||
130929679|NCT03708328|471374398|FG009|Overall Study|Withdrawal by Subject|5|||
130929680|NCT03708328|471374389|FG000|Overall Study|Study Closed Locally|0|||
130929681|NCT03708328|471374390|FG001|Overall Study|Study Closed Locally|0|||
130929682|NCT03708328|471374391|FG002|Overall Study|Study Closed Locally|0|||
130929683|NCT03708328|471374392|FG003|Overall Study|Study Closed Locally|0|||
130929684|NCT03708328|471374393|FG004|Overall Study|Study Closed Locally|0|||
130929685|NCT03708328|471374394|FG005|Overall Study|Study Closed Locally|0|||
130929686|NCT03708328|471374395|FG006|Overall Study|Study Closed Locally|0|||
130929687|NCT03708328|471374396|FG007|Overall Study|Study Closed Locally|1|||
130929688|NCT03708328|471374397|FG008|Overall Study|Study Closed Locally|0|||
130929689|NCT03708328|471374398|FG009|Overall Study|Study Closed Locally|0|||
130929690|NCT03708328|471374389|FG000|Overall Study|Study Ended By Sponsor|0|||
130929691|NCT03708328|471374390|FG001|Overall Study|Study Ended By Sponsor|0|||
130929692|NCT03708328|471374391|FG002|Overall Study|Study Ended By Sponsor|0|||
130929693|NCT03708328|471374392|FG003|Overall Study|Study Ended By Sponsor|0|||
130929694|NCT03708328|471374393|FG004|Overall Study|Study Ended By Sponsor|0|||
130929695|NCT03708328|471374394|FG005|Overall Study|Study Ended By Sponsor|1|||
130929696|NCT03708328|471374395|FG006|Overall Study|Study Ended By Sponsor|0|||
130929697|NCT03708328|471374396|FG007|Overall Study|Study Ended By Sponsor|1|||
130929698|NCT03708328|471374397|FG008|Overall Study|Study Ended By Sponsor|0|||
130929699|NCT03708328|471374398|FG009|Overall Study|Study Ended By Sponsor|0|||
130929700|NCT03708328|471374389|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130929701|NCT03708328|471374390|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130929702|NCT03708328|471374391|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130929703|NCT03708328|471374392|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130929704|NCT03708328|471374393|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130929705|NCT03708328|471374394|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130929706|NCT03708328|471374395|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130929707|NCT03708328|471374396|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130929708|NCT03708328|471374397|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
130929709|NCT03708328|471374398|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
130929710|NCT02695329|471374401|FG000|Overall Study|Adverse Event|1|||
130929711|NCT02695329|471374402|FG001|Overall Study|Adverse Event|0|||
130929712|NCT02695329|471374401|FG000|Overall Study|Poor X-ray quality for measurement|4|||
130929713|NCT02695329|471374402|FG001|Overall Study|Poor X-ray quality for measurement|5|||
130929714|NCT02549937|471374407|FG000|Overall Study|Death|0|||
130929715|NCT02549937|471374408|FG001|Overall Study|Death|1|||
130703131|NCT00108082|470537842|FG001|Overall Study|Protocol Violation|2|||
130703132|NCT00108082|470537843|FG002|Overall Study|Protocol Violation|0|||
130929716|NCT02549937|471374409|FG002|Overall Study|Death|0|||
130929717|NCT02549937|471374410|FG003|Overall Study|Death|1|||
130929718|NCT02549937|471374411|FG004|Overall Study|Death|0|||
130929719|NCT02549937|471374412|FG005|Overall Study|Death|8|||
130929720|NCT02549937|471374413|FG006|Overall Study|Death|0|||
130929721|NCT02549937|471374414|FG007|Overall Study|Death|0|||
130703133|NCT00108082|470537841|FG000|Overall Study|Lack of Efficacy|3|||
130703134|NCT00108082|470537842|FG001|Overall Study|Lack of Efficacy|1|||
130703135|NCT00108082|470537843|FG002|Overall Study|Lack of Efficacy|2|||
130703136|NCT00108082|470537841|FG000|Overall Study|Amendment 4: > Month 12|5|||
130703137|NCT00108082|470537842|FG001|Overall Study|Amendment 4: > Month 12|7|||
130703138|NCT00108082|470537843|FG002|Overall Study|Amendment 4: > Month 12|5|||
130703139|NCT00108082|470537841|FG000|Overall Study|Woman of Child-bearing Potential|2|||
130703140|NCT00108082|470537842|FG001|Overall Study|Woman of Child-bearing Potential|0|||
130703141|NCT00108082|470537843|FG002|Overall Study|Woman of Child-bearing Potential|2|||
130703142|NCT00108082|470537841|FG000|Overall Study|Incorrectly Randomized|0|||
130703143|NCT00108082|470537842|FG001|Overall Study|Incorrectly Randomized|0|||
130703144|NCT00108082|470537843|FG002|Overall Study|Incorrectly Randomized|2|||
130703145|NCT00108082|470537841|FG000|Overall Study|Non-compliance|1|||
130703146|NCT00108082|470537842|FG001|Overall Study|Non-compliance|0|||
130703147|NCT00108082|470537843|FG002|Overall Study|Non-compliance|2|||
130703148|NCT00108082|470537841|FG000|Overall Study|Stopped Study Medication|0|||
130703149|NCT00108082|470537842|FG001|Overall Study|Stopped Study Medication|0|||
130703150|NCT00108082|470537843|FG002|Overall Study|Stopped Study Medication|1|||
130929722|NCT02549937|471374415|FG008|Overall Study|Death|19|||
130929723|NCT02549937|471374407|FG000|Overall Study|No follow up required|3|||
130929724|NCT02549937|471374408|FG001|Overall Study|No follow up required|6|||
130929725|NCT02549937|471374409|FG002|Overall Study|No follow up required|3|||
130929726|NCT02549937|471374410|FG003|Overall Study|No follow up required|8|||
130929727|NCT02549937|471374411|FG004|Overall Study|No follow up required|12|||
130929728|NCT02549937|471374412|FG005|Overall Study|No follow up required|21|||
130929729|NCT02549937|471374413|FG006|Overall Study|No follow up required|9|||
130929730|NCT02549937|471374414|FG007|Overall Study|No follow up required|11|||
130929731|NCT02549937|471374415|FG008|Overall Study|No follow up required|0|||
130929732|NCT02549937|471374407|FG000|Overall Study|Other|0|||
130929733|NCT02549937|471374408|FG001|Overall Study|Other|0|||
130703151|NCT00108082|470537841|FG000|Overall Study|Site Closed Study|0|||
130703152|NCT00108082|470537842|FG001|Overall Study|Site Closed Study|2|||
130703153|NCT00108082|470537843|FG002|Overall Study|Site Closed Study|0|||
130703154|NCT00108082|470537841|FG000|Overall Study|Protocol Amendment|0|||
130703155|NCT00108082|470537842|FG001|Overall Study|Protocol Amendment|1|||
130703156|NCT00108082|470537843|FG002|Overall Study|Protocol Amendment|0|||
130703157|NCT00108082|470537841|FG000|Overall Study|Study Medication Not Tapered|0|||
130703158|NCT00108082|470537842|FG001|Overall Study|Study Medication Not Tapered|1|||
130703159|NCT00108082|470537843|FG002|Overall Study|Study Medication Not Tapered|0|||
130703160|NCT00108082|470537841|FG000|Overall Study|Subject Left Site Location|1|||
130703161|NCT00108082|470537842|FG001|Overall Study|Subject Left Site Location|0|||
130703162|NCT00108082|470537843|FG002|Overall Study|Subject Left Site Location|0|||
130703163|NCT00108082|470537841|FG000|Overall Study|Investigator Not at Site|1|||
130703164|NCT00108082|470537842|FG001|Overall Study|Investigator Not at Site|0|||
130703165|NCT00108082|470537843|FG002|Overall Study|Investigator Not at Site|0|||
130703166|NCT00108082|470537841|FG000|Overall Study|Blood Pressure Not Controlled|1|||
130703167|NCT00108082|470537842|FG001|Overall Study|Blood Pressure Not Controlled|0|||
130703168|NCT00108082|470537843|FG002|Overall Study|Blood Pressure Not Controlled|0|||
130703169|NCT02940730|470537849|FG000|Intervention 2|Physician Decision|7|||
130929734|NCT02549937|471374409|FG002|Overall Study|Other|0|||
130929735|NCT02549937|471374410|FG003|Overall Study|Other|0|||
130929736|NCT02549937|471374411|FG004|Overall Study|Other|1|||
130929737|NCT02549937|471374412|FG005|Overall Study|Other|0|||
130929738|NCT02549937|471374413|FG006|Overall Study|Other|3|||
130929739|NCT02549937|471374414|FG007|Overall Study|Other|2|||
130929740|NCT02549937|471374415|FG008|Overall Study|Other|3|||
130929741|NCT02549937|471374407|FG000|Overall Study|Lost to Follow-up|0|||
130929742|NCT02549937|471374408|FG001|Overall Study|Lost to Follow-up|0|||
130929743|NCT02549937|471374409|FG002|Overall Study|Lost to Follow-up|0|||
130929744|NCT02549937|471374410|FG003|Overall Study|Lost to Follow-up|0|||
130929745|NCT02549937|471374411|FG004|Overall Study|Lost to Follow-up|0|||
130929746|NCT02549937|471374412|FG005|Overall Study|Lost to Follow-up|0|||
130929747|NCT02549937|471374413|FG006|Overall Study|Lost to Follow-up|0|||
130929748|NCT02549937|471374414|FG007|Overall Study|Lost to Follow-up|0|||
130929749|NCT02549937|471374415|FG008|Overall Study|Lost to Follow-up|3|||
130929750|NCT02549937|471374407|FG000|Overall Study|Withdrawal by Subject|0|||
130929751|NCT02549937|471374408|FG001|Overall Study|Withdrawal by Subject|0|||
130929752|NCT02549937|471374409|FG002|Overall Study|Withdrawal by Subject|0|||
130929753|NCT02549937|471374410|FG003|Overall Study|Withdrawal by Subject|0|||
130929754|NCT02549937|471374411|FG004|Overall Study|Withdrawal by Subject|0|||
130929755|NCT02549937|471374412|FG005|Overall Study|Withdrawal by Subject|1|||
130929756|NCT02549937|471374413|FG006|Overall Study|Withdrawal by Subject|4|||
130929757|NCT02549937|471374414|FG007|Overall Study|Withdrawal by Subject|3|||
130929758|NCT02549937|471374415|FG008|Overall Study|Withdrawal by Subject|2|||
130929759|NCT02549937|471374407|FG000|Overall Study|Sponsor Decision|0|||
130929760|NCT02549937|471374408|FG001|Overall Study|Sponsor Decision|0|||
130929761|NCT02549937|471374409|FG002|Overall Study|Sponsor Decision|0|||
130929762|NCT02549937|471374410|FG003|Overall Study|Sponsor Decision|0|||
130929763|NCT02549937|471374411|FG004|Overall Study|Sponsor Decision|0|||
130929764|NCT02549937|471374412|FG005|Overall Study|Sponsor Decision|0|||
130929765|NCT02549937|471374413|FG006|Overall Study|Sponsor Decision|0|||
130929766|NCT02549937|471374414|FG007|Overall Study|Sponsor Decision|0|||
130929767|NCT02549937|471374415|FG008|Overall Study|Sponsor Decision|6|||
130929768|NCT03930797|471374416|FG000|Overall Study|Lost to Follow-up|3|||
130929769|NCT03930797|471374417|FG001|Overall Study|Lost to Follow-up|10|||
130703170|NCT02940730|470537850|FG001|Intervention 2|Physician Decision|0|||
130703171|NCT03036839|470537854|FG000|Overall Study|Adverse Event|0|||
130703172|NCT03036839|470537855|FG001|Overall Study|Adverse Event|0|||
130703173|NCT03036839|470537856|FG002|Overall Study|Adverse Event|1|||
130929770|NCT05425745|471374425|FG000|Overall Study|Withdrawal of Consent|3|||
130703174|NCT03036839|470537854|FG000|Overall Study|Death|3|||
130703175|NCT03036839|470537855|FG001|Overall Study|Death|0|||
130703176|NCT03036839|470537856|FG002|Overall Study|Death|3|||
130703177|NCT03036839|470537854|FG000|Overall Study|Withdrew Consent|0|||
130703178|NCT03036839|470537855|FG001|Overall Study|Withdrew Consent|0|||
130929771|NCT05425745|471374426|FG001|Overall Study|Withdrawal of Consent|3|||
130929772|NCT05425745|471374425|FG000|Overall Study|Death|2|||
130929773|NCT05425745|471374426|FG001|Overall Study|Death|3|||
130929774|NCT05425745|471374425|FG000|Overall Study|Lost to Follow-up|1|||
130929775|NCT05425745|471374426|FG001|Overall Study|Lost to Follow-up|2|||
130929776|NCT05425745|471374425|FG000|Overall Study|Adverse Event|0|||
130929777|NCT05425745|471374426|FG001|Overall Study|Adverse Event|1|||
130929778|NCT05425745|471374425|FG000|Overall Study|Did not return for end of study visit|0|||
130703179|NCT03036839|470537856|FG002|Overall Study|Withdrew Consent|1|||
130703180|NCT00412737|470537858|FG000|Overall Study|Death|1|||
130929779|NCT05425745|471374426|FG001|Overall Study|Did not return for end of study visit|1|||
130703181|NCT00412737|470537859|FG001|Overall Study|Death|0|||
130703182|NCT00412737|470537858|FG000|Overall Study|Adverse Event|3|||
130703183|NCT00412737|470537859|FG001|Overall Study|Adverse Event|2|||
130703184|NCT00412737|470537858|FG000|Overall Study|Refused Treatment|6|||
130703185|NCT00412737|470537859|FG001|Overall Study|Refused Treatment|2|||
130703186|NCT00412737|470537858|FG000|Overall Study|Failure to Return|6|||
130703187|NCT00412737|470537859|FG001|Overall Study|Failure to Return|2|||
130703188|NCT01091103|470537866|FG000|Overall Study|Adverse Event|1|||
130703189|NCT01091103|470537866|FG000|Overall Study|Progressive Disease|3|||
130703190|NCT01270620|470537867|FG000|Overall Study|Withdrawal by Subject|1|||
130929780|NCT05425745|471374425|FG000|Overall Study|End of study visit completed by phone|1|||
130929781|NCT05425745|471374426|FG001|Overall Study|End of study visit completed by phone|0|||
130929782|NCT05425745|471374425|FG000|Overall Study|Subject decision|1|||
130929783|NCT05425745|471374426|FG001|Overall Study|Subject decision|0|||
130929784|NCT02820753|471375526|FG000|2 Month|Withdrawal by Subject|3|||
130929785|NCT02820753|471375527|FG001|2 Month|Withdrawal by Subject|3|||
130929786|NCT02820753|471375526|FG000|2 Month|Lost to Follow-up|24|||
130929787|NCT02820753|471375527|FG001|2 Month|Lost to Follow-up|26|||
130929788|NCT02820753|471375526|FG000|2 Month|Stopped per NIH Hold|51|||
130929789|NCT02820753|471375527|FG001|2 Month|Stopped per NIH Hold|13|||
130929790|NCT02820753|471375526|FG000|6 Month|Withdrawal by Subject|2|||
130929791|NCT02820753|471375527|FG001|6 Month|Withdrawal by Subject|2|||
130929792|NCT02820753|471375526|FG000|6 Month|Lost to Follow-up|20|||
130929793|NCT02820753|471375527|FG001|6 Month|Lost to Follow-up|27|||
130929794|NCT02820753|471375526|FG000|6 Month|Stopped per NIH Hold|81|||
130929795|NCT02820753|471375527|FG001|6 Month|Stopped per NIH Hold|81|||
130703191|NCT01270620|470537868|FG001|Overall Study|Withdrawal by Subject|3|||
130703192|NCT00906373|470537871|FG000|Overall Study|Withdrawal by Subject|0|||
130770330|NCT01483599|470784348|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
130770331|NCT01483599|470784349|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
130770332|NCT01483599|470784350|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
130770333|NCT01483599|470784351|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
130770334|NCT01483599|470784338|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130770335|NCT01483599|470784339|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130770336|NCT01483599|470784340|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130770337|NCT01483599|470784341|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130770338|NCT01483599|470784342|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130770339|NCT01483599|470784343|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130770340|NCT01483599|470784344|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130770341|NCT01483599|470784345|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130770342|NCT01483599|470784346|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130770343|NCT01483599|470784347|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130770344|NCT01483599|470784348|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130770345|NCT01483599|470784349|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130770346|NCT01483599|470784350|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130770347|NCT01483599|470784351|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130770348|NCT01483599|470784338|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130770349|NCT01483599|470784339|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130770350|NCT01483599|470784340|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130770351|NCT01483599|470784341|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130770352|NCT01483599|470784342|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130929796|NCT02820753|471375526|FG000|6 Month|Death|0|||
130929797|NCT02820753|471375527|FG001|6 Month|Death|1|||
130929798|NCT02161731|471375528|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
130929799|NCT02161731|471375529|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
130929800|NCT02161731|471375528|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
130703193|NCT00906373|470537872|FG001|Overall Study|Withdrawal by Subject|5|||
130703194|NCT00906373|470537871|FG000|Overall Study|Other|0|||
130770353|NCT01483599|470784343|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130929801|NCT02161731|471375529|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
130929802|NCT03761277|471375530|FG000|Enrollment to Implant|Screen Failure|17|||
130929803|NCT03761277|471375530|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
130703195|NCT00906373|470537872|FG001|Overall Study|Other|1|||
130703196|NCT00906373|470537871|FG000|Overall Study|Still on treatment at cutoff date|0|||
130929804|NCT03761277|471375530|FG000|Enrollment to Implant|Physician Decision|2|||
130929805|NCT03761277|471375530|FG000|Enrollment to Implant|Site Closure|3|||
130929806|NCT03761277|471375530|FG000|Enrollment to Implant|Sponsor Request|2|||
130929807|NCT03761277|471375530|FG000|Post-Implant to 6 Months|Adverse Event|2|||
130929808|NCT03761277|471375530|FG000|Post-Implant to 6 Months|Death|1|||
130929809|NCT03761277|471375530|FG000|Post-Implant to 6 Months|Site Closure|2|||
130929810|NCT03761277|471375530|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
130929811|NCT03761277|471375530|FG000|6 Months to 12 Months|Physician Decision|2|||
130929812|NCT03761277|471375530|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
130929813|NCT00903695|471375531|FG000|Overall Study|medical exclusion after 1st testing|1|||
130929814|NCT00903695|471375532|FG001|Overall Study|medical exclusion after 1st testing|0|||
130929815|NCT00903695|471375531|FG000|Overall Study|lung cancer|1|||
130929816|NCT00903695|471375532|FG001|Overall Study|lung cancer|0|||
130929817|NCT00543140|471375533|FG000|Overall Study|Lost to Follow-up|33|||
130929818|NCT00543140|471375533|FG000|Overall Study|Withdrawal by Subject|13|||
130929819|NCT00543140|471375533|FG000|Overall Study|Protocol Violation|10|||
130929820|NCT00543140|471375533|FG000|Overall Study|Insufficient weight loss|10|||
130770354|NCT01483599|470784344|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130770355|NCT01483599|470784345|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130770356|NCT01483599|470784346|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
130770357|NCT01483599|470784347|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130770358|NCT01483599|470784348|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130770359|NCT01483599|470784349|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
130770360|NCT01483599|470784350|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130770361|NCT01483599|470784351|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
130770362|NCT01483599|470784338|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770363|NCT01483599|470784339|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770364|NCT01483599|470784340|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770365|NCT01483599|470784341|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770366|NCT01483599|470784342|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770367|NCT01483599|470784343|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770368|NCT01483599|470784344|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770369|NCT01483599|470784345|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770370|NCT01483599|470784346|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
130770371|NCT01483599|470784347|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770372|NCT01483599|470784348|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
130770373|NCT01483599|470784349|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770374|NCT01483599|470784350|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130770375|NCT01483599|470784351|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
130770376|NCT01483599|470784338|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770377|NCT01483599|470784339|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770378|NCT01483599|470784340|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770379|NCT01483599|470784341|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770380|NCT01483599|470784342|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770381|NCT01483599|470784343|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770382|NCT01483599|470784344|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770383|NCT01483599|470784345|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770384|NCT01483599|470784346|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
130770385|NCT01483599|470784347|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770386|NCT01483599|470784348|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770387|NCT01483599|470784349|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130770388|NCT01483599|470784350|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
130770389|NCT01483599|470784351|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
130770390|NCT01483599|470784338|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
130770391|NCT01483599|470784339|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
130770392|NCT01483599|470784340|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
130770393|NCT01483599|470784341|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
130770394|NCT01483599|470784342|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
130770395|NCT01483599|470784343|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
130770396|NCT01483599|470784344|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
130770397|NCT01483599|470784345|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
130929821|NCT00543140|471375533|FG000|Overall Study|SAE leading to explant of SAGB|3|||
130929822|NCT00543140|471375533|FG000|Overall Study|Death|1|||
130929823|NCT00543140|471375533|FG000|Overall Study|Subject moved|1|||
130929824|NCT00543140|471375533|FG000|Overall Study|Conversion to different procedure|1|||
130929825|NCT00578812|471375534|FG000|Overall Study|Not treated|6|||
130929826|NCT00578812|471375535|FG001|Overall Study|Not treated|7|||
131034877|NCT03544281|471761825|FG000|Main Study Phase|Death|3|||
130770398|NCT01483599|470784346|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
130770399|NCT01483599|470784347|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
130770400|NCT01483599|470784348|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
130770401|NCT01483599|470784349|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
130770402|NCT01483599|470784350|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
130770403|NCT01483599|470784351|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
130770404|NCT00966355|470784352|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
130770405|NCT00966355|470784353|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
130770406|NCT00966355|470784354|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
130770407|NCT00966355|470784352|FG000|Overall Study|newly diagnosed advanced HCC|11|||
130770408|NCT00966355|470784353|FG001|Overall Study|newly diagnosed advanced HCC|12|||
130770409|NCT00966355|470784354|FG002|Overall Study|newly diagnosed advanced HCC|10|||
130770410|NCT00966355|470784352|FG000|Overall Study|Lost to Follow-up|5|||
130770411|NCT00966355|470784353|FG001|Overall Study|Lost to Follow-up|4|||
130770412|NCT00966355|470784354|FG002|Overall Study|Lost to Follow-up|3|||
130770413|NCT01421147|470786040|FG000|Treatment Period|Adverse Event|2|||
130770414|NCT01421147|470786041|FG001|Treatment Period|Adverse Event|3|||
130770415|NCT01421147|470786040|FG000|Treatment Period|Lost to Follow-up|2|||
130770416|NCT01421147|470786041|FG001|Treatment Period|Lost to Follow-up|1|||
130770417|NCT01421147|470786040|FG000|Treatment Period|Physician Decision|2|||
130770418|NCT01421147|470786041|FG001|Treatment Period|Physician Decision|2|||
130770419|NCT01421147|470786040|FG000|Treatment Period|Withdrawal by Subject|10|||
130770420|NCT01421147|470786041|FG001|Treatment Period|Withdrawal by Subject|5|||
130770421|NCT01421147|470786040|FG000|Extension Period|Adverse Event|0|||
130770422|NCT01421147|470786041|FG001|Extension Period|Adverse Event|2|||
130770423|NCT01421147|470786040|FG000|Extension Period|Death|0|||
130770424|NCT01421147|470786041|FG001|Extension Period|Death|1|||
130770425|NCT01421147|470786040|FG000|Extension Period|Lost to Follow-up|2|||
130770426|NCT01421147|470786041|FG001|Extension Period|Lost to Follow-up|5|||
130770427|NCT01421147|470786040|FG000|Extension Period|Physician Decision|1|||
130770428|NCT01421147|470786041|FG001|Extension Period|Physician Decision|0|||
130770429|NCT01421147|470786040|FG000|Extension Period|Withdrawal by Subject|5|||
130770430|NCT01421147|470786041|FG001|Extension Period|Withdrawal by Subject|3|||
130770431|NCT00171158|470786043|FG000|Core Study|Death|27|||
130770432|NCT00171158|470786043|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
130770433|NCT00171158|470786043|FG000|Core Study|Protocol Violation|4|||
130770434|NCT00171158|470786043|FG000|Core Study|Administrative problems|1|||
130770435|NCT00171158|470786043|FG000|Core Study|Adverse event, non-fatal|21|||
130770436|NCT00171158|470786043|FG000|Core Study|Consent withdrawn by subject|6|||
130770437|NCT00171158|470786043|FG000|Core Study|No longer required drug (BMT)|14|||
130770438|NCT00171158|470786043|FG000|Core Study|Abnormal Laboratory Values|2|||
130770439|NCT00171158|470786043|FG000|Core Study|Lost to Follow-up|1|||
130770440|NCT00171158|470786043|FG000|E2 Extension|Other|7|||
130770441|NCT03536663|470786046|FG000|Endexo|Protocol Violation|1|||
130770442|NCT02442206|470786048|FG000|Period 1|Adverse Event|1|||
130770443|NCT02442206|470786049|FG001|Period 1|Adverse Event|1|||
130929827|NCT04532164|471375536|FG000|Overall Study|Adverse Event|1|||
130929828|NCT04532164|471375536|FG000|Overall Study|Protocol Violation|5|||
130929829|NCT04532164|471375536|FG000|Overall Study|Lost to Follow-up|1|||
130929830|NCT04532164|471375536|FG000|Overall Study|Found to be Ineligible|3|||
130929831|NCT04532164|471375536|FG000|Overall Study|Withdrawal by Subject|14|||
130929832|NCT02269241|471375541|FG000|Overall Study|Lost to Follow-up|269|||
130929833|NCT02269241|471375541|FG000|Overall Study|Withdrawal by Subject|155|||
130929834|NCT02269241|471375541|FG000|Overall Study|Protocol Violation|1|||
130929835|NCT02269241|471375541|FG000|Overall Study|Physician Decision|7|||
130929836|NCT02269241|471375541|FG000|Overall Study|Pregnancy|15|||
130929837|NCT02269241|471375541|FG000|Overall Study|Wish for pregnancy|5|||
130929838|NCT02269241|471375541|FG000|Overall Study|Development of an exclusion criteria|16|||
130929839|NCT02269241|471375541|FG000|Overall Study|Adverse Event|113|||
130929840|NCT02269241|471375541|FG000|Overall Study|At the specific request of the sponsor|20|||
130929841|NCT02269241|471375541|FG000|Overall Study|Several reasons not classified|53|||
130929842|NCT02269241|471375541|FG000|Overall Study|Screening failures|546|||
130929843|NCT00489541|471375552|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
130929844|NCT00489541|471375553|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
130929845|NCT00489541|471375552|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
130770444|NCT02442206|470786048|FG000|Period 1|withdrew consent|0|||
130770445|NCT02442206|470786049|FG001|Period 1|withdrew consent|1|||
130770446|NCT02442206|470786048|FG000|Period 1|COPD exacerbation|0|||
130770447|NCT02442206|470786049|FG001|Period 1|COPD exacerbation|1|||
130770448|NCT02442206|470786048|FG000|Period 2|Adverse Event|1|||
130770449|NCT02442206|470786049|FG001|Period 2|Adverse Event|0|||
130770450|NCT00497146|470786050|FG000|Treatment Period|Adverse Event|6|||
130929846|NCT00489541|471375553|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
130770451|NCT00497146|470786051|FG001|Treatment Period|Adverse Event|2|||
130770452|NCT00497146|470786050|FG000|Treatment Period|Withdrawal by Subject|5|||
130770453|NCT00497146|470786051|FG001|Treatment Period|Withdrawal by Subject|9|||
130929847|NCT00489541|471375552|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
130929848|NCT00489541|471375553|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
130703197|NCT00906373|470537872|FG001|Overall Study|Still on treatment at cutoff date|2|||
130703198|NCT01597479|470537873|FG000|Overall Study|Protocol Violation|1|||
130703199|NCT01597479|470537874|FG001|Overall Study|Protocol Violation|0|||
130703200|NCT01597479|470537873|FG000|Overall Study|Lost to Follow-up|1|||
130703201|NCT01597479|470537874|FG001|Overall Study|Lost to Follow-up|0|||
130703202|NCT04317599|470537879|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
130703203|NCT04317599|470537879|FG000|Overall Study|treatment outside standard of care|4|||
130703204|NCT00809965|470537880|FG000|Overall Study|Death|194|||
130703205|NCT00809965|470537881|FG001|Overall Study|Death|147|||
130703206|NCT00809965|470537882|FG002|Overall Study|Death|196|||
130703207|NCT00809965|470537880|FG000|Overall Study|Lost to Follow-up|17|||
130703208|NCT00809965|470537881|FG001|Overall Study|Lost to Follow-up|10|||
130703209|NCT00809965|470537882|FG002|Overall Study|Lost to Follow-up|18|||
130703210|NCT00809965|470537880|FG000|Overall Study|Withdrawal by Subject|405|||
130703211|NCT00809965|470537881|FG001|Overall Study|Withdrawal by Subject|448|||
130703212|NCT00809965|470537882|FG002|Overall Study|Withdrawal by Subject|441|||
130703213|NCT00809965|470537880|FG000|Overall Study|Other Reason|167|||
130703214|NCT00809965|470537881|FG001|Overall Study|Other Reason|170|||
130703215|NCT00809965|470537882|FG002|Overall Study|Other Reason|189|||
130703216|NCT02780167|470537883|FG000|Overall Study|Adverse Event|9|||
130703217|NCT02780167|470537884|FG001|Overall Study|Adverse Event|8|||
130703218|NCT02780167|470537885|FG002|Overall Study|Adverse Event|8|||
130703219|NCT02780167|470537886|FG003|Overall Study|Adverse Event|12|||
130703220|NCT02780167|470537887|FG004|Overall Study|Adverse Event|8|||
130703221|NCT02780167|470537883|FG000|Overall Study|Lack of Efficacy|6|||
130703222|NCT02780167|470537884|FG001|Overall Study|Lack of Efficacy|5|||
130703223|NCT02780167|470537885|FG002|Overall Study|Lack of Efficacy|6|||
130703224|NCT02780167|470537886|FG003|Overall Study|Lack of Efficacy|1|||
130703225|NCT02780167|470537887|FG004|Overall Study|Lack of Efficacy|0|||
130703226|NCT02780167|470537883|FG000|Overall Study|Lost to Follow-up|2|||
130703227|NCT02780167|470537884|FG001|Overall Study|Lost to Follow-up|0|||
130703228|NCT02780167|470537885|FG002|Overall Study|Lost to Follow-up|1|||
130703229|NCT02780167|470537886|FG003|Overall Study|Lost to Follow-up|0|||
130770454|NCT00497146|470786050|FG000|Treatment Period|Lost to Follow-up|1|||
130770455|NCT00497146|470786051|FG001|Treatment Period|Lost to Follow-up|3|||
130770456|NCT00497146|470786050|FG000|Treatment Period|Required dialysis|4|||
130929849|NCT00489541|471375552|FG000|12-Month Clinical Follow-up|Death|3|||
130929850|NCT00489541|471375553|FG001|12-Month Clinical Follow-up|Death|2|||
130929851|NCT00489541|471375552|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
130929852|NCT00489541|471375553|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
130929853|NCT00489541|471375552|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
130929854|NCT00489541|471375553|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
130929855|NCT05131646|471375554|FG000|Overall Study|Withdrawal by Subject|1|||
130929856|NCT05131646|471375555|FG001|Overall Study|Withdrawal by Subject|0|||
130929857|NCT05131646|471375556|FG002|Overall Study|Withdrawal by Subject|0|||
130929858|NCT02548650|471375561|FG000|Triple Therapy|Adverse Event|1|||
130929859|NCT02548650|471375562|FG001|Triple Therapy|Adverse Event|0|||
130929860|NCT02548650|471375561|FG000|Triple Therapy|Withdrawal by Subject|0|||
130929861|NCT02548650|471375562|FG001|Triple Therapy|Withdrawal by Subject|4|||
130929862|NCT02548650|471375561|FG000|Double Therapy|Adverse Event|1|||
130929863|NCT02548650|471375562|FG001|Double Therapy|Adverse Event|1|||
130929864|NCT02548650|471375561|FG000|Double Therapy|Withdrawal by Subject|0|||
130929865|NCT02548650|471375562|FG001|Double Therapy|Withdrawal by Subject|1|||
130929866|NCT01909674|471375563|FG000|Overall Study|Withdrawal by Subject|5|||
130929867|NCT01909674|471375564|FG001|Overall Study|Withdrawal by Subject|2|||
130929868|NCT02969369|471375565|FG000|Study|Adverse Event|1|||
130929869|NCT02969369|471375566|FG001|Study|Adverse Event|6|||
130929870|NCT02969369|471375565|FG000|Study|Lack of Efficacy|0|||
130929871|NCT02969369|471375566|FG001|Study|Lack of Efficacy|1|||
130929872|NCT02969369|471375565|FG000|Study|Lost to Follow-up|0|||
130929873|NCT02969369|471375566|FG001|Study|Lost to Follow-up|1|||
130929874|NCT02969369|471375565|FG000|Study|Withdrawal by Subject|3|||
130929875|NCT02969369|471375566|FG001|Study|Withdrawal by Subject|5|||
131223730|NCT04380701|472447117|FG008|Overall Study|Pregnancy|0|||
130703230|NCT02780167|470537887|FG004|Overall Study|Lost to Follow-up|0|||
130703231|NCT02780167|470537883|FG000|Overall Study|Does not meet entrance criteria|0|||
130703232|NCT02780167|470537884|FG001|Overall Study|Does not meet entrance criteria|0|||
130703233|NCT02780167|470537885|FG002|Overall Study|Does not meet entrance criteria|1|||
130929876|NCT02969369|471375565|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
130929877|NCT02969369|471375566|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
131223731|NCT04380701|472447118|FG009|Overall Study|Pregnancy|0|||
130703234|NCT02780167|470537886|FG003|Overall Study|Does not meet entrance criteria|0|||
130703235|NCT02780167|470537887|FG004|Overall Study|Does not meet entrance criteria|0|||
130703236|NCT02780167|470537883|FG000|Overall Study|No longer meets eligibility criteria|0|||
130703237|NCT02780167|470537884|FG001|Overall Study|No longer meets eligibility criteria|0|||
130703238|NCT02780167|470537885|FG002|Overall Study|No longer meets eligibility criteria|0|||
130703239|NCT02780167|470537886|FG003|Overall Study|No longer meets eligibility criteria|1|||
130929878|NCT02969369|471375565|FG000|Double-blind Period|Adverse Event|1|||
130929879|NCT02969369|471375566|FG001|Double-blind Period|Adverse Event|5|||
130929880|NCT02969369|471375565|FG000|Double-blind Period|Lost to Follow-up|0|||
130929881|NCT02969369|471375566|FG001|Double-blind Period|Lost to Follow-up|1|||
130929882|NCT02969369|471375565|FG000|Double-blind Period|Withdrawal by Subject|2|||
130929883|NCT02969369|471375566|FG001|Double-blind Period|Withdrawal by Subject|3|||
130929884|NCT02969369|471375565|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
130929885|NCT02969369|471375566|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
130703240|NCT02780167|470537887|FG004|Overall Study|No longer meets eligibility criteria|1|||
130703241|NCT02780167|470537883|FG000|Overall Study|Protocol Violation|5|||
130703242|NCT02780167|470537884|FG001|Overall Study|Protocol Violation|5|||
130703243|NCT02780167|470537885|FG002|Overall Study|Protocol Violation|1|||
130703244|NCT02780167|470537886|FG003|Overall Study|Protocol Violation|1|||
130703245|NCT02780167|470537887|FG004|Overall Study|Protocol Violation|2|||
130703246|NCT02780167|470537883|FG000|Overall Study|Withdrawal by Subject|6|||
130703247|NCT02780167|470537884|FG001|Overall Study|Withdrawal by Subject|4|||
130703248|NCT02780167|470537885|FG002|Overall Study|Withdrawal by Subject|4|||
130703249|NCT02780167|470537886|FG003|Overall Study|Withdrawal by Subject|3|||
130703250|NCT02780167|470537887|FG004|Overall Study|Withdrawal by Subject|4|||
130703251|NCT02780167|470537883|FG000|Overall Study|Other|0|||
130703252|NCT02780167|470537884|FG001|Overall Study|Other|0|||
130703253|NCT02780167|470537885|FG002|Overall Study|Other|3|||
130703254|NCT02780167|470537886|FG003|Overall Study|Other|1|||
130703255|NCT02780167|470537887|FG004|Overall Study|Other|2|||
130703256|NCT02315066|470537888|FG000|Overall Study|Lost to Follow-up|0|||
130703257|NCT02315066|470537889|FG001|Overall Study|Lost to Follow-up|1|||
130703258|NCT02315066|470537890|FG002|Overall Study|Lost to Follow-up|1|||
130703259|NCT02315066|470537891|FG003|Overall Study|Lost to Follow-up|0|||
130703260|NCT02315066|470537892|FG004|Overall Study|Lost to Follow-up|1|||
130703261|NCT02315066|470537893|FG005|Overall Study|Lost to Follow-up|0|||
130703262|NCT02315066|470537894|FG006|Overall Study|Lost to Follow-up|2|||
130703263|NCT02315066|470537895|FG007|Overall Study|Lost to Follow-up|1|||
130703264|NCT02315066|470537896|FG008|Overall Study|Lost to Follow-up|0|||
130703265|NCT02315066|470537897|FG009|Overall Study|Lost to Follow-up|0|||
130703266|NCT02315066|470537898|FG010|Overall Study|Lost to Follow-up|1|||
130703267|NCT02315066|470537899|FG011|Overall Study|Lost to Follow-up|2|||
130929886|NCT02969369|471375565|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
130929887|NCT02969369|471375566|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
130929888|NCT02969369|471375565|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
130929889|NCT02969369|471375566|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
130929890|NCT02969369|471375565|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
130703268|NCT02315066|470537900|FG012|Overall Study|Lost to Follow-up|0|||
130929891|NCT02969369|471375566|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
130929892|NCT00521014|471375567|FG000|Overall Study|Inevaluable, not treated|1|||
130929893|NCT04390191|471375568|FG000|Overall Study|Withdrawal by Subject|1|||
130929894|NCT04390191|471375569|FG001|Overall Study|Withdrawal by Subject|0|||
130929895|NCT02794883|471375570|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
130929896|NCT02794883|471375571|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
130929897|NCT02794883|471375572|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
130929898|NCT02794883|471375570|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
130929899|NCT02794883|471375571|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
130929900|NCT02794883|471375572|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
130929901|NCT02794883|471375570|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
130929902|NCT02794883|471375571|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
130929903|NCT02794883|471375572|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
130929904|NCT02794883|471375570|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
130929905|NCT02794883|471375571|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
130929906|NCT02794883|471375572|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
130929907|NCT02794883|471375570|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
130929908|NCT02794883|471375571|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
130929909|NCT02794883|471375572|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
130929910|NCT02794883|471375570|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
130929911|NCT02794883|471375571|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
130703269|NCT02315066|470537901|FG013|Overall Study|Lost to Follow-up|4|||
130703270|NCT02315066|470537888|FG000|Overall Study|Death|2|||
130703271|NCT02315066|470537889|FG001|Overall Study|Death|7|||
130703272|NCT02315066|470537890|FG002|Overall Study|Death|6|||
130703273|NCT02315066|470537891|FG003|Overall Study|Death|11|||
130929912|NCT02794883|471375572|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
131034878|NCT03544281|471761826|FG001|Main Study Phase|Death|2|||
130703274|NCT02315066|470537892|FG004|Overall Study|Death|10|||
130929913|NCT02794883|471375570|FG000|Follow-up Period (up to 2 Years)|Death|12|||
130929914|NCT02794883|471375571|FG001|Follow-up Period (up to 2 Years)|Death|10|||
130703275|NCT02315066|470537893|FG005|Overall Study|Death|3|||
130703276|NCT02315066|470537894|FG006|Overall Study|Death|9|||
130929915|NCT02794883|471375572|FG002|Follow-up Period (up to 2 Years)|Death|10|||
130929916|NCT01192516|471375575|FG000|Overall Study|Lost to Follow-up|7|||
130929917|NCT01192516|471375576|FG001|Overall Study|Lost to Follow-up|10|||
130929918|NCT01192516|471375577|FG002|Overall Study|Lost to Follow-up|7|||
130929919|NCT01192516|471375575|FG000|Overall Study|Withdrawal by Subject|4|||
130929920|NCT01192516|471375576|FG001|Overall Study|Withdrawal by Subject|4|||
130929921|NCT01192516|471375577|FG002|Overall Study|Withdrawal by Subject|1|||
130929922|NCT01192516|471375575|FG000|Overall Study|started new treatment|5|||
130929923|NCT01192516|471375576|FG001|Overall Study|started new treatment|1|||
130929924|NCT01192516|471375577|FG002|Overall Study|started new treatment|0|||
130929925|NCT01192516|471375575|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
130929926|NCT01192516|471375576|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
130929927|NCT01192516|471375577|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
130929928|NCT01256008|471375578|FG000|Overall Study|Lost to Follow-up|6|||
130929929|NCT01256008|471375579|FG001|Overall Study|Lost to Follow-up|4|||
130929930|NCT01256008|471375580|FG002|Overall Study|Lost to Follow-up|11|||
130929931|NCT01256008|471375578|FG000|Overall Study|Withdrawal by Subject|2|||
130929932|NCT01256008|471375579|FG001|Overall Study|Withdrawal by Subject|3|||
130929933|NCT01256008|471375580|FG002|Overall Study|Withdrawal by Subject|10|||
130929934|NCT02321800|471375583|FG000|Overall Study|Withdrawal by Subject|3|||
130929935|NCT02321800|471375584|FG001|Overall Study|Withdrawal by Subject|3|||
130929936|NCT02321800|471375583|FG000|Overall Study|Death|1|||
130929937|NCT02321800|471375584|FG001|Overall Study|Death|0|||
130929938|NCT02321800|471375583|FG000|Overall Study|Protocol Violation|1|||
130929939|NCT02321800|471375584|FG001|Overall Study|Protocol Violation|0|||
130929940|NCT02321800|471375583|FG000|Overall Study|Lost to Follow-up|10|||
130929941|NCT02321800|471375584|FG001|Overall Study|Lost to Follow-up|4|||
130929942|NCT02321800|471375583|FG000|Overall Study|Adverse Event|2|||
130929943|NCT02321800|471375584|FG001|Overall Study|Adverse Event|3|||
130929944|NCT02321800|471375583|FG000|Overall Study|Other, Miscellaneous|3|||
130929945|NCT02321800|471375584|FG001|Overall Study|Other, Miscellaneous|1|||
130929946|NCT05228132|471375588|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
130929947|NCT05228132|471375588|FG000|Overall Study|Adverse Event|3|||
130929948|NCT05228132|471375588|FG000|Overall Study|Lost to Follow-up|1|||
130929949|NCT05228132|471375588|FG000|Overall Study|Arteriovenous-fistula mature|1|||
130929950|NCT01336764|471375589|FG000|Overall Study|Withdrawal by Subject|5|||
130929951|NCT01336764|471375590|FG001|Overall Study|Withdrawal by Subject|5|||
130929952|NCT00730132|471375591|FG000|Overall Study|Protocol Violation|154|||
130929953|NCT00730132|471375591|FG000|Overall Study|Death|1|||
130929954|NCT01626391|471375592|FG000|Overall Study|Physician Decision|1|||
130929955|NCT01626391|471375593|FG001|Overall Study|Physician Decision|0|||
130929956|NCT01626391|471375592|FG000|Overall Study|Withdrawal by Subject|1|||
130929957|NCT01626391|471375593|FG001|Overall Study|Withdrawal by Subject|0|||
130929958|NCT00420927|471375594|FG000|Period 1|Adverse Event|19|||
130929959|NCT00420927|471375595|FG001|Period 1|Adverse Event|15|||
130929960|NCT00420927|471375596|FG002|Period 1|Adverse Event|0|||
130929961|NCT00420927|471375597|FG003|Period 1|Adverse Event|0|||
130929962|NCT00420927|471375598|FG004|Period 1|Adverse Event|0|||
130929963|NCT00420927|471375599|FG005|Period 1|Adverse Event|0|||
130929964|NCT00420927|471375600|FG006|Period 1|Adverse Event|0|||
130929965|NCT00420927|471375594|FG000|Period 1|Withdrawal by Subject|7|||
130929966|NCT00420927|471375595|FG001|Period 1|Withdrawal by Subject|12|||
130929967|NCT00420927|471375596|FG002|Period 1|Withdrawal by Subject|0|||
130929968|NCT00420927|471375597|FG003|Period 1|Withdrawal by Subject|0|||
130929969|NCT00420927|471375598|FG004|Period 1|Withdrawal by Subject|0|||
130929970|NCT00420927|471375599|FG005|Period 1|Withdrawal by Subject|0|||
130929971|NCT00420927|471375600|FG006|Period 1|Withdrawal by Subject|0|||
130929972|NCT00420927|471375594|FG000|Period 1|Lost to Follow-up|8|||
130929973|NCT00420927|471375595|FG001|Period 1|Lost to Follow-up|6|||
130929974|NCT00420927|471375596|FG002|Period 1|Lost to Follow-up|0|||
130929975|NCT00420927|471375597|FG003|Period 1|Lost to Follow-up|0|||
130929976|NCT00420927|471375598|FG004|Period 1|Lost to Follow-up|0|||
130929977|NCT00420927|471375599|FG005|Period 1|Lost to Follow-up|0|||
130929978|NCT00420927|471375600|FG006|Period 1|Lost to Follow-up|0|||
130929979|NCT00420927|471375594|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
131223732|NCT04380701|472447119|FG010|Overall Study|Pregnancy|0|||
131223733|NCT04380701|472447120|FG011|Overall Study|Pregnancy|0|||
130929980|NCT00420927|471375595|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
130929981|NCT00420927|471375596|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
130929982|NCT00420927|471375597|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
130929983|NCT00420927|471375598|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
130929984|NCT00420927|471375599|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
130929985|NCT00420927|471375600|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
130929986|NCT00420927|471375594|FG000|Period 1|Death|2|||
130929987|NCT00420927|471375595|FG001|Period 1|Death|0|||
130929988|NCT00420927|471375596|FG002|Period 1|Death|0|||
130929989|NCT00420927|471375597|FG003|Period 1|Death|0|||
130929990|NCT00420927|471375598|FG004|Period 1|Death|0|||
130929991|NCT00420927|471375599|FG005|Period 1|Death|0|||
131223734|NCT04380701|472447121|FG012|Overall Study|Pregnancy|0|||
130703277|NCT02315066|470537895|FG007|Overall Study|Death|9|||
130703278|NCT02315066|470537896|FG008|Overall Study|Death|10|||
130703279|NCT02315066|470537897|FG009|Overall Study|Death|8|||
130703280|NCT02315066|470537898|FG010|Overall Study|Death|10|||
130929992|NCT00420927|471375600|FG006|Period 1|Death|0|||
130929993|NCT00420927|471375594|FG000|Period 1|Subject moved/relocated|0|||
130929994|NCT00420927|471375595|FG001|Period 1|Subject moved/relocated|2|||
130929995|NCT00420927|471375596|FG002|Period 1|Subject moved/relocated|0|||
130929996|NCT00420927|471375597|FG003|Period 1|Subject moved/relocated|0|||
130929997|NCT00420927|471375598|FG004|Period 1|Subject moved/relocated|0|||
130929998|NCT00420927|471375599|FG005|Period 1|Subject moved/relocated|0|||
130929999|NCT00420927|471375600|FG006|Period 1|Subject moved/relocated|0|||
130930000|NCT00420927|471375594|FG000|Period 1|Noncompliant with study drug|1|||
130930001|NCT00420927|471375595|FG001|Period 1|Noncompliant with study drug|1|||
130930002|NCT00420927|471375596|FG002|Period 1|Noncompliant with study drug|0|||
130930003|NCT00420927|471375597|FG003|Period 1|Noncompliant with study drug|0|||
130930004|NCT00420927|471375598|FG004|Period 1|Noncompliant with study drug|0|||
130930005|NCT00420927|471375599|FG005|Period 1|Noncompliant with study drug|0|||
130930006|NCT00420927|471375600|FG006|Period 1|Noncompliant with study drug|0|||
130930007|NCT00420927|471375594|FG000|Period 1|Randomization error|1|||
130930008|NCT00420927|471375595|FG001|Period 1|Randomization error|0|||
130930009|NCT00420927|471375596|FG002|Period 1|Randomization error|0|||
130930010|NCT00420927|471375597|FG003|Period 1|Randomization error|0|||
130930011|NCT00420927|471375598|FG004|Period 1|Randomization error|0|||
130930012|NCT00420927|471375599|FG005|Period 1|Randomization error|0|||
130930013|NCT00420927|471375600|FG006|Period 1|Randomization error|0|||
130930014|NCT00420927|471375594|FG000|Period 1|Suspected tuberculosis/positive test|1|||
130930015|NCT00420927|471375595|FG001|Period 1|Suspected tuberculosis/positive test|1|||
130703281|NCT02315066|470537899|FG011|Overall Study|Death|7|||
130703282|NCT02315066|470537900|FG012|Overall Study|Death|8|||
130930016|NCT00420927|471375596|FG002|Period 1|Suspected tuberculosis/positive test|0|||
130930017|NCT00420927|471375597|FG003|Period 1|Suspected tuberculosis/positive test|0|||
130703283|NCT02315066|470537901|FG013|Overall Study|Death|21|||
130703284|NCT02315066|470537888|FG000|Overall Study|Other|0|||
130703285|NCT02315066|470537889|FG001|Overall Study|Other|0|||
130703286|NCT02315066|470537890|FG002|Overall Study|Other|0|||
130703287|NCT02315066|470537891|FG003|Overall Study|Other|0|||
130703288|NCT02315066|470537892|FG004|Overall Study|Other|0|||
130703289|NCT02315066|470537893|FG005|Overall Study|Other|0|||
130703290|NCT02315066|470537894|FG006|Overall Study|Other|0|||
130703291|NCT02315066|470537895|FG007|Overall Study|Other|1|||
130703292|NCT02315066|470537896|FG008|Overall Study|Other|1|||
130703293|NCT02315066|470537897|FG009|Overall Study|Other|2|||
130703294|NCT02315066|470537898|FG010|Overall Study|Other|0|||
130703295|NCT02315066|470537899|FG011|Overall Study|Other|0|||
130703296|NCT02315066|470537900|FG012|Overall Study|Other|0|||
130770457|NCT00497146|470786051|FG001|Treatment Period|Required dialysis|1|||
130930018|NCT00420927|471375598|FG004|Period 1|Suspected tuberculosis/positive test|0|||
130930019|NCT00420927|471375599|FG005|Period 1|Suspected tuberculosis/positive test|0|||
130930020|NCT00420927|471375600|FG006|Period 1|Suspected tuberculosis/positive test|0|||
130930021|NCT00420927|471375594|FG000|Period 1|Study site closure|0|||
130930022|NCT00420927|471375595|FG001|Period 1|Study site closure|1|||
131120261|NCT00467779|472072312|FG001|Stage 2A|Disease Progression|0|||
131120262|NCT00467779|472072313|FG002|Stage 2A|Disease Progression|0|||
131120263|NCT00467779|472072314|FG003|Stage 2A|Disease Progression|0|||
131120264|NCT00467779|472072315|FG004|Stage 2A|Disease Progression|0|||
131120265|NCT00467779|472072316|FG005|Stage 2A|Disease Progression|0|||
131120266|NCT00467779|472072317|FG006|Stage 2A|Disease Progression|0|||
131120267|NCT00467779|472072318|FG007|Stage 2A|Disease Progression|0|||
131120268|NCT00467779|472072319|FG008|Stage 2A|Disease Progression|0|||
130703297|NCT02315066|470537901|FG013|Overall Study|Other|0|||
130703298|NCT02315066|470537888|FG000|Overall Study|Subject refused further follow-up|0|||
130930023|NCT00420927|471375596|FG002|Period 1|Study site closure|0|||
130930024|NCT00420927|471375597|FG003|Period 1|Study site closure|0|||
130930025|NCT00420927|471375598|FG004|Period 1|Study site closure|0|||
130930026|NCT00420927|471375599|FG005|Period 1|Study site closure|0|||
130930027|NCT00420927|471375600|FG006|Period 1|Study site closure|0|||
131120269|NCT00467779|472072320|FG009|Stage 2A|Disease Progression|0|||
130703299|NCT02315066|470537889|FG001|Overall Study|Subject refused further follow-up|2|||
130703300|NCT02315066|470537890|FG002|Overall Study|Subject refused further follow-up|2|||
130703301|NCT02315066|470537891|FG003|Overall Study|Subject refused further follow-up|0|||
130703302|NCT02315066|470537892|FG004|Overall Study|Subject refused further follow-up|0|||
130703303|NCT02315066|470537893|FG005|Overall Study|Subject refused further follow-up|0|||
130930028|NCT00420927|471375594|FG000|Period 1|Subject received new diagnosis|0|||
130930029|NCT00420927|471375595|FG001|Period 1|Subject received new diagnosis|2|||
130930030|NCT00420927|471375596|FG002|Period 1|Subject received new diagnosis|0|||
130930031|NCT00420927|471375597|FG003|Period 1|Subject received new diagnosis|0|||
130930032|NCT00420927|471375598|FG004|Period 1|Subject received new diagnosis|0|||
131120270|NCT00467779|472072321|FG010|Stage 2A|Disease Progression|0|||
131120271|NCT00467779|472072322|FG011|Stage 2A|Disease Progression|0|||
130930033|NCT00420927|471375599|FG005|Period 1|Subject received new diagnosis|0|||
130930034|NCT00420927|471375600|FG006|Period 1|Subject received new diagnosis|0|||
130930035|NCT00420927|471375594|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
130930036|NCT00420927|471375595|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
130930037|NCT00420927|471375596|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
130930038|NCT00420927|471375597|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
130930039|NCT00420927|471375598|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
130930040|NCT00420927|471375599|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
130770458|NCT00497146|470786050|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
130770459|NCT00497146|470786051|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
130770460|NCT00497146|470786050|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
130770461|NCT00497146|470786051|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
130770462|NCT00497146|470786050|FG000|Treatment Period|Other Reason|2|||
130770463|NCT00497146|470786051|FG001|Treatment Period|Other Reason|3|||
130770464|NCT00497146|470786050|FG000|Long-term Follow-up Period|Adverse Event|2|||
130770465|NCT00497146|470786051|FG001|Long-term Follow-up Period|Adverse Event|2|||
130770466|NCT00497146|470786050|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
130770467|NCT00497146|470786051|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
130770468|NCT00497146|470786050|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
130770469|NCT00497146|470786051|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
130770470|NCT00497146|470786050|FG000|Long-term Follow-up Period|Other|0|||
130770471|NCT00497146|470786051|FG001|Long-term Follow-up Period|Other|1|||
130770472|NCT01471444|470786052|FG000|Overall Study|Physician Decision|3|||
130770473|NCT01471444|470786053|FG001|Overall Study|Physician Decision|2|||
130770474|NCT01471444|470786052|FG000|Overall Study|Withdrawal by Subject|0|||
130770475|NCT01471444|470786053|FG001|Overall Study|Withdrawal by Subject|1|||
130770476|NCT02155309|470786056|FG000|Overall Study|Protocol Violation|0|||
130770477|NCT02155309|470786057|FG001|Overall Study|Protocol Violation|0|||
130770478|NCT02155309|470786058|FG002|Overall Study|Protocol Violation|1|||
130770479|NCT04676152|470786059|FG000|Overall Study|screen fail|9|||
130770480|NCT00662311|470786071|FG000|Overall Study|Respiratory Infection|1|||
130770481|NCT00662311|470786072|FG001|Overall Study|Respiratory Infection|0|||
130770482|NCT00662311|470786073|FG002|Overall Study|Respiratory Infection|0|||
130770483|NCT01467271|470786074|FG000|Overall Study|Death|84|||
130770484|NCT01467271|470786074|FG000|Overall Study|Lost to Follow-up|83|||
130770485|NCT01467271|470786074|FG000|Overall Study|Retraction of patient's consent|21|||
130770486|NCT01467271|470786074|FG000|Overall Study|Other reason|14|||
130770487|NCT02335346|470786093|FG000|Overall Study|Adverse Event|11|||
130770488|NCT02335346|470786093|FG000|Overall Study|Withdrawal by Subject|1|||
130770489|NCT01548768|470786094|FG000|Overall Study|Withdrawal by Subject|0|||
130770490|NCT01548768|470786095|FG001|Overall Study|Withdrawal by Subject|2|||
130770491|NCT01548768|470786096|FG002|Overall Study|Withdrawal by Subject|1|||
130770492|NCT01548768|470786097|FG003|Overall Study|Withdrawal by Subject|0|||
130770493|NCT01548768|470786094|FG000|Overall Study|Physician Decision|1|||
130770494|NCT01548768|470786095|FG001|Overall Study|Physician Decision|0|||
130770495|NCT01548768|470786096|FG002|Overall Study|Physician Decision|0|||
130770496|NCT01548768|470786097|FG003|Overall Study|Physician Decision|0|||
130770497|NCT01548768|470786094|FG000|Overall Study|Adverse Event|0|||
130770498|NCT01548768|470786095|FG001|Overall Study|Adverse Event|0|||
130770499|NCT01548768|470786096|FG002|Overall Study|Adverse Event|0|||
130770500|NCT01548768|470786097|FG003|Overall Study|Adverse Event|1|||
130770501|NCT01548768|470786094|FG000|Overall Study|Non-Compliance|0|||
130770502|NCT01548768|470786095|FG001|Overall Study|Non-Compliance|0|||
130770503|NCT01548768|470786096|FG002|Overall Study|Non-Compliance|0|||
130770504|NCT01548768|470786097|FG003|Overall Study|Non-Compliance|3|||
130770505|NCT03300050|470786098|FG000|Overall Study|Lost to Follow-up|2|||
130770506|NCT03300050|470786099|FG001|Overall Study|Lost to Follow-up|1|||
130770507|NCT03300050|470786100|FG002|Overall Study|Lost to Follow-up|0|||
130770508|NCT03300050|470786101|FG003|Overall Study|Lost to Follow-up|0|||
130770509|NCT03300050|470786102|FG004|Overall Study|Lost to Follow-up|1|||
130770510|NCT03300050|470786098|FG000|Overall Study|Withdrawal by Subject|1|||
130770511|NCT03300050|470786099|FG001|Overall Study|Withdrawal by Subject|1|||
130770512|NCT03300050|470786100|FG002|Overall Study|Withdrawal by Subject|1|||
130770513|NCT03300050|470786101|FG003|Overall Study|Withdrawal by Subject|0|||
130770514|NCT03300050|470786102|FG004|Overall Study|Withdrawal by Subject|0|||
130770515|NCT03300050|470786098|FG000|Overall Study|Death|0|||
130770516|NCT03300050|470786099|FG001|Overall Study|Death|0|||
131034879|NCT03544281|471761827|FG002|Main Study Phase|Death|6|||
130770517|NCT03300050|470786100|FG002|Overall Study|Death|1|||
130770518|NCT03300050|470786101|FG003|Overall Study|Death|0|||
130770519|NCT03300050|470786102|FG004|Overall Study|Death|0|||
130770520|NCT03300050|470786098|FG000|Overall Study|Not Eligible at Randomization|0|||
130770521|NCT03300050|470786099|FG001|Overall Study|Not Eligible at Randomization|0|||
130770522|NCT03300050|470786100|FG002|Overall Study|Not Eligible at Randomization|1|||
130770523|NCT03300050|470786101|FG003|Overall Study|Not Eligible at Randomization|1|||
130770524|NCT03300050|470786102|FG004|Overall Study|Not Eligible at Randomization|0|||
131034880|NCT03544281|471761828|FG003|Main Study Phase|Death|8|||
130930041|NCT00420927|471375600|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
130930042|NCT00420927|471375594|FG000|Period 1|Failed to meet entry criteria|8|||
130930043|NCT00420927|471375595|FG001|Period 1|Failed to meet entry criteria|7|||
130930044|NCT00420927|471375596|FG002|Period 1|Failed to meet entry criteria|0|||
130930045|NCT00420927|471375597|FG003|Period 1|Failed to meet entry criteria|0|||
130930046|NCT00420927|471375598|FG004|Period 1|Failed to meet entry criteria|0|||
130930047|NCT00420927|471375599|FG005|Period 1|Failed to meet entry criteria|0|||
130703304|NCT02315066|470537894|FG006|Overall Study|Subject refused further follow-up|2|||
130703305|NCT02315066|470537895|FG007|Overall Study|Subject refused further follow-up|3|||
130703306|NCT02315066|470537896|FG008|Overall Study|Subject refused further follow-up|0|||
130703307|NCT02315066|470537897|FG009|Overall Study|Subject refused further follow-up|1|||
130703308|NCT02315066|470537898|FG010|Overall Study|Subject refused further follow-up|1|||
130703309|NCT02315066|470537899|FG011|Overall Study|Subject refused further follow-up|2|||
130703310|NCT02315066|470537900|FG012|Overall Study|Subject refused further follow-up|2|||
130703311|NCT02315066|470537901|FG013|Overall Study|Subject refused further follow-up|4|||
130703312|NCT02315066|470537888|FG000|Overall Study|Study ongoing at date of cut-off|0|||
130703313|NCT02315066|470537889|FG001|Overall Study|Study ongoing at date of cut-off|0|||
130703314|NCT02315066|470537890|FG002|Overall Study|Study ongoing at date of cut-off|0|||
130703315|NCT02315066|470537891|FG003|Overall Study|Study ongoing at date of cut-off|0|||
130703316|NCT02315066|470537892|FG004|Overall Study|Study ongoing at date of cut-off|0|||
130703317|NCT02315066|470537893|FG005|Overall Study|Study ongoing at date of cut-off|0|||
130703318|NCT02315066|470537894|FG006|Overall Study|Study ongoing at date of cut-off|0|||
130703319|NCT02315066|470537895|FG007|Overall Study|Study ongoing at date of cut-off|0|||
130703320|NCT02315066|470537896|FG008|Overall Study|Study ongoing at date of cut-off|0|||
130703321|NCT02315066|470537897|FG009|Overall Study|Study ongoing at date of cut-off|0|||
130703322|NCT02315066|470537898|FG010|Overall Study|Study ongoing at date of cut-off|0|||
130703323|NCT02315066|470537899|FG011|Overall Study|Study ongoing at date of cut-off|0|||
130703324|NCT02315066|470537900|FG012|Overall Study|Study ongoing at date of cut-off|0|||
130703325|NCT02315066|470537901|FG013|Overall Study|Study ongoing at date of cut-off|1|||
130703326|NCT03180801|470537902|FG000|Overall Study|Physician Decision|3|||
130703327|NCT03180801|470537903|FG001|Overall Study|Physician Decision|3|||
130703328|NCT03180801|470537904|FG002|Overall Study|Physician Decision|1|||
130703329|NCT03180801|470537902|FG000|Overall Study|Non-compliance|1|||
130703330|NCT03180801|470537903|FG001|Overall Study|Non-compliance|4|||
130703331|NCT03180801|470537904|FG002|Overall Study|Non-compliance|0|||
130703332|NCT03180801|470537902|FG000|Overall Study|Inoculation Target Reached|1|||
130703333|NCT03180801|470537903|FG001|Overall Study|Inoculation Target Reached|1|||
130703334|NCT03180801|470537904|FG002|Overall Study|Inoculation Target Reached|3|||
130703335|NCT03180801|470537902|FG000|Overall Study|Adverse Event|1|||
130703336|NCT03180801|470537903|FG001|Overall Study|Adverse Event|0|||
130703337|NCT03180801|470537904|FG002|Overall Study|Adverse Event|2|||
130930048|NCT00420927|471375600|FG006|Period 1|Failed to meet entry criteria|0|||
130703338|NCT03180801|470537902|FG000|Overall Study|Withdrawal by Subject|2|||
130703339|NCT03180801|470537903|FG001|Overall Study|Withdrawal by Subject|2|||
131034881|NCT03544281|471761829|FG004|Main Study Phase|Death|4|||
131034882|NCT03544281|471761830|FG005|Main Study Phase|Death|2|||
131034883|NCT03544281|471761831|FG006|Main Study Phase|Death|4|||
131034884|NCT03544281|471761832|FG007|Main Study Phase|Death|5|||
131034885|NCT03544281|471761833|FG008|Main Study Phase|Death|5|||
131034886|NCT03544281|471761834|FG009|Main Study Phase|Death|8|||
131034887|NCT03544281|471761835|FG010|Main Study Phase|Death|6|||
131034888|NCT03544281|471761836|FG011|Main Study Phase|Death|4|||
131034889|NCT03544281|471761837|FG012|Main Study Phase|Death|0|||
131034890|NCT03544281|471761838|FG013|Main Study Phase|Death|0|||
131034891|NCT03544281|471761839|FG014|Main Study Phase|Death|0|||
131034892|NCT03544281|471761840|FG015|Main Study Phase|Death|0|||
131034893|NCT03544281|471761841|FG016|Main Study Phase|Death|0|||
131034894|NCT03544281|471761842|FG017|Main Study Phase|Death|0|||
131034895|NCT03544281|471761843|FG018|Main Study Phase|Death|0|||
131034896|NCT03544281|471761844|FG019|Main Study Phase|Death|0|||
131034897|NCT03544281|471761845|FG020|Main Study Phase|Death|0|||
131034898|NCT03544281|471761846|FG021|Main Study Phase|Death|0|||
131034899|NCT03544281|471761825|FG000|Main Study Phase|Lost to Follow-up|0|||
131034900|NCT03544281|471761826|FG001|Main Study Phase|Lost to Follow-up|0|||
131034901|NCT03544281|471761827|FG002|Main Study Phase|Lost to Follow-up|0|||
131034902|NCT03544281|471761828|FG003|Main Study Phase|Lost to Follow-up|0|||
131034903|NCT03544281|471761829|FG004|Main Study Phase|Lost to Follow-up|0|||
131034904|NCT03544281|471761830|FG005|Main Study Phase|Lost to Follow-up|0|||
131034905|NCT03544281|471761831|FG006|Main Study Phase|Lost to Follow-up|0|||
131034906|NCT03544281|471761832|FG007|Main Study Phase|Lost to Follow-up|0|||
131034907|NCT03544281|471761833|FG008|Main Study Phase|Lost to Follow-up|0|||
131034908|NCT03544281|471761834|FG009|Main Study Phase|Lost to Follow-up|0|||
131034909|NCT03544281|471761835|FG010|Main Study Phase|Lost to Follow-up|1|||
131034910|NCT03544281|471761836|FG011|Main Study Phase|Lost to Follow-up|0|||
131034911|NCT03544281|471761837|FG012|Main Study Phase|Lost to Follow-up|0|||
131034912|NCT03544281|471761838|FG013|Main Study Phase|Lost to Follow-up|0|||
130703340|NCT03180801|470537904|FG002|Overall Study|Withdrawal by Subject|1|||
130703341|NCT03180801|470537902|FG000|Overall Study|Lost to Follow-up|0|||
130703342|NCT03180801|470537903|FG001|Overall Study|Lost to Follow-up|2|||
130703343|NCT03180801|470537904|FG002|Overall Study|Lost to Follow-up|3|||
130703344|NCT00112294|470537906|FG000|Overall Study|Still on study|5|||
130703345|NCT00112294|470537907|FG001|Overall Study|Still on study|0|||
130703346|NCT01142908|470537908|FG000|Overall Study|Lost to Follow-up|19|||
130703347|NCT01142908|470537909|FG001|Overall Study|Lost to Follow-up|13|||
130703348|NCT01142908|470537908|FG000|Overall Study|Death|1|||
130703349|NCT01142908|470537909|FG001|Overall Study|Death|4|||
130703350|NCT01142908|470537908|FG000|Overall Study|Excluded - did not meet criteria|9|||
130703351|NCT01142908|470537909|FG001|Overall Study|Excluded - did not meet criteria|5|||
130930049|NCT00420927|471375594|FG000|Period 1|Took prohibited medication|1|||
130930050|NCT00420927|471375595|FG001|Period 1|Took prohibited medication|3|||
130930051|NCT00420927|471375596|FG002|Period 1|Took prohibited medication|0|||
130930052|NCT00420927|471375597|FG003|Period 1|Took prohibited medication|0|||
130930053|NCT00420927|471375598|FG004|Period 1|Took prohibited medication|0|||
130930054|NCT00420927|471375599|FG005|Period 1|Took prohibited medication|0|||
130930055|NCT00420927|471375600|FG006|Period 1|Took prohibited medication|0|||
130930056|NCT00420927|471375594|FG000|Period 2|Adverse Event|0|||
130930057|NCT00420927|471375595|FG001|Period 2|Adverse Event|0|||
130930058|NCT00420927|471375596|FG002|Period 2|Adverse Event|7|||
130930059|NCT00420927|471375597|FG003|Period 2|Adverse Event|3|||
130930060|NCT00420927|471375598|FG004|Period 2|Adverse Event|17|||
130930061|NCT00420927|471375599|FG005|Period 2|Adverse Event|6|||
130930062|NCT00420927|471375600|FG006|Period 2|Adverse Event|20|||
130930063|NCT00420927|471375594|FG000|Period 2|Withdrawal by Subject|0|||
130930064|NCT00420927|471375595|FG001|Period 2|Withdrawal by Subject|0|||
130930065|NCT00420927|471375596|FG002|Period 2|Withdrawal by Subject|1|||
130930066|NCT00420927|471375597|FG003|Period 2|Withdrawal by Subject|3|||
130930067|NCT00420927|471375598|FG004|Period 2|Withdrawal by Subject|11|||
130930068|NCT00420927|471375599|FG005|Period 2|Withdrawal by Subject|2|||
130930069|NCT00420927|471375600|FG006|Period 2|Withdrawal by Subject|12|||
130930070|NCT00420927|471375594|FG000|Period 2|Lost to Follow-up|0|||
130930071|NCT00420927|471375595|FG001|Period 2|Lost to Follow-up|0|||
130930072|NCT00420927|471375596|FG002|Period 2|Lost to Follow-up|2|||
130930073|NCT00420927|471375597|FG003|Period 2|Lost to Follow-up|2|||
130930074|NCT00420927|471375598|FG004|Period 2|Lost to Follow-up|6|||
130930075|NCT00420927|471375599|FG005|Period 2|Lost to Follow-up|3|||
130930076|NCT00420927|471375600|FG006|Period 2|Lost to Follow-up|9|||
130930077|NCT00420927|471375594|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
130930078|NCT00420927|471375595|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
130930079|NCT00420927|471375596|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
130930080|NCT00420927|471375597|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
130930081|NCT00420927|471375598|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
130930082|NCT00420927|471375599|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
130930083|NCT00420927|471375600|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
130930084|NCT00420927|471375594|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
130930085|NCT00420927|471375595|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
130930086|NCT00420927|471375596|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
130930087|NCT00420927|471375597|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
130930088|NCT00420927|471375598|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
130930089|NCT00420927|471375599|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
130703352|NCT01142908|470537908|FG000|Overall Study|Withdrawal by Subject|3|||
130703353|NCT01142908|470537909|FG001|Overall Study|Withdrawal by Subject|0|||
130703354|NCT00035555|470537910|FG000|Overall Study|Adverse Event|5|||
130703355|NCT00035555|470537911|FG001|Overall Study|Adverse Event|8|||
130770525|NCT02178358|470786116|FG000|Overall Study|Withdrawal by Subject|0|||
130703356|NCT00035555|470537912|FG002|Overall Study|Adverse Event|9|||
130703357|NCT00035555|470537910|FG000|Overall Study|Allograft loss|1|||
130703358|NCT00035555|470537911|FG001|Overall Study|Allograft loss|1|||
130703359|NCT00035555|470537912|FG002|Overall Study|Allograft loss|2|||
130703360|NCT00035555|470537910|FG000|Overall Study|Death|0|||
130703361|NCT00035555|470537911|FG001|Overall Study|Death|0|||
130770526|NCT02178358|470786117|FG001|Overall Study|Withdrawal by Subject|2|||
130770527|NCT02178358|470786118|FG002|Overall Study|Withdrawal by Subject|2|||
130770528|NCT02178358|470786116|FG000|Overall Study|Lost to Follow-up|1|||
130703362|NCT00035555|470537912|FG002|Overall Study|Death|2|||
130703363|NCT00035555|470537910|FG000|Overall Study|Lost to Follow-up|0|||
130930090|NCT00420927|471375600|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
130930091|NCT00420927|471375594|FG000|Period 2|Subject unable to find transportation|0|||
130930092|NCT00420927|471375595|FG001|Period 2|Subject unable to find transportation|0|||
130930093|NCT00420927|471375596|FG002|Period 2|Subject unable to find transportation|0|||
130930094|NCT00420927|471375597|FG003|Period 2|Subject unable to find transportation|0|||
130930095|NCT00420927|471375598|FG004|Period 2|Subject unable to find transportation|0|||
130930096|NCT00420927|471375599|FG005|Period 2|Subject unable to find transportation|0|||
130930097|NCT00420927|471375600|FG006|Period 2|Subject unable to find transportation|1|||
130930098|NCT00420927|471375594|FG000|Period 2|Physician Decision|0|||
130930099|NCT00420927|471375595|FG001|Period 2|Physician Decision|0|||
130930100|NCT00420927|471375596|FG002|Period 2|Physician Decision|0|||
130930101|NCT00420927|471375597|FG003|Period 2|Physician Decision|0|||
130930102|NCT00420927|471375598|FG004|Period 2|Physician Decision|1|||
130930103|NCT00420927|471375599|FG005|Period 2|Physician Decision|1|||
130930104|NCT00420927|471375600|FG006|Period 2|Physician Decision|0|||
130703364|NCT00035555|470537911|FG001|Overall Study|Lost to Follow-up|0|||
130930105|NCT00420927|471375594|FG000|Period 2|Sponsor decision|0|||
130930106|NCT00420927|471375595|FG001|Period 2|Sponsor decision|0|||
130930107|NCT00420927|471375596|FG002|Period 2|Sponsor decision|1|||
130930108|NCT00420927|471375597|FG003|Period 2|Sponsor decision|0|||
130930109|NCT00420927|471375598|FG004|Period 2|Sponsor decision|0|||
130930110|NCT00420927|471375599|FG005|Period 2|Sponsor decision|0|||
130930111|NCT00420927|471375600|FG006|Period 2|Sponsor decision|1|||
130930112|NCT00420927|471375594|FG000|Period 2|Randomization error|0|||
130930113|NCT00420927|471375595|FG001|Period 2|Randomization error|0|||
130930114|NCT00420927|471375596|FG002|Period 2|Randomization error|0|||
130930115|NCT00420927|471375597|FG003|Period 2|Randomization error|0|||
130930116|NCT00420927|471375598|FG004|Period 2|Randomization error|1|||
130930117|NCT00420927|471375599|FG005|Period 2|Randomization error|1|||
130703365|NCT00035555|470537912|FG002|Overall Study|Lost to Follow-up|1|||
130703366|NCT00035555|470537910|FG000|Overall Study|Noncompliance|0|||
130703367|NCT00035555|470537911|FG001|Overall Study|Noncompliance|1|||
130703368|NCT00035555|470537912|FG002|Overall Study|Noncompliance|1|||
130703369|NCT00035555|470537910|FG000|Overall Study|Prohibited medication|1|||
130703370|NCT00035555|470537911|FG001|Overall Study|Prohibited medication|1|||
130703371|NCT00035555|470537912|FG002|Overall Study|Prohibited medication|0|||
130703372|NCT00035555|470537910|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
130703373|NCT00035555|470537911|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
130703374|NCT00035555|470537912|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
130703375|NCT00035555|470537910|FG000|Overall Study|Withdrawal by Subject|2|||
130703376|NCT00035555|470537911|FG001|Overall Study|Withdrawal by Subject|0|||
130703377|NCT00035555|470537912|FG002|Overall Study|Withdrawal by Subject|2|||
130703378|NCT00035555|470537910|FG000|Overall Study|Investigator deemed not a good candidate|0|||
130703379|NCT00035555|470537911|FG001|Overall Study|Investigator deemed not a good candidate|0|||
130703380|NCT00035555|470537912|FG002|Overall Study|Investigator deemed not a good candidate|1|||
130703381|NCT00035555|470537910|FG000|Overall Study|Received cyclosporin in error|0|||
130703382|NCT00035555|470537911|FG001|Overall Study|Received cyclosporin in error|0|||
130703383|NCT00035555|470537912|FG002|Overall Study|Received cyclosporin in error|1|||
130703384|NCT02972515|470537915|FG000|Overall Study|Lost to Follow-up|78|||
130703385|NCT01450800|470537916|FG000|Overall Study|Protocol Violation|1|||
130703386|NCT01450800|470537917|FG001|Overall Study|Protocol Violation|3|||
130703387|NCT01086969|470537925|FG000|Overall Study|Withdrawal by Subject|1|||
130703388|NCT01086969|470537926|FG001|Overall Study|Withdrawal by Subject|2|||
130703389|NCT01086969|470537927|FG002|Overall Study|Withdrawal by Subject|0|||
130703390|NCT04253236|470537928|FG000|Overall Study|Adverse Event|1|||
130703391|NCT04253236|470537929|FG001|Overall Study|Adverse Event|0|||
130703392|NCT04253236|470537928|FG000|Overall Study|Safety Concerns|1|||
130703393|NCT04253236|470537929|FG001|Overall Study|Safety Concerns|0|||
130703394|NCT04253236|470537928|FG000|Overall Study|Study Terminated by Sponsor|1|||
130703395|NCT04253236|470537929|FG001|Overall Study|Study Terminated by Sponsor|0|||
130703396|NCT04291508|470537930|FG000|Overall Study|Withdrawal by Subject|1|||
130703397|NCT04291508|470537931|FG001|Overall Study|Withdrawal by Subject|0|||
130703398|NCT04291508|470537932|FG002|Overall Study|Withdrawal by Subject|1|||
130703399|NCT04291508|470537933|FG003|Overall Study|Withdrawal by Subject|0|||
130703400|NCT04291508|470537930|FG000|Overall Study|lost to follow up|4|||
130930118|NCT00420927|471375600|FG006|Period 2|Randomization error|0|||
131034913|NCT03544281|471761839|FG014|Main Study Phase|Lost to Follow-up|0|||
131034914|NCT03544281|471761840|FG015|Main Study Phase|Lost to Follow-up|0|||
131034915|NCT03544281|471761841|FG016|Main Study Phase|Lost to Follow-up|0|||
131034916|NCT03544281|471761842|FG017|Main Study Phase|Lost to Follow-up|0|||
131034917|NCT03544281|471761843|FG018|Main Study Phase|Lost to Follow-up|0|||
131034918|NCT03544281|471761844|FG019|Main Study Phase|Lost to Follow-up|0|||
131034919|NCT03544281|471761845|FG020|Main Study Phase|Lost to Follow-up|0|||
131034920|NCT03544281|471761846|FG021|Main Study Phase|Lost to Follow-up|0|||
131034921|NCT03544281|471761825|FG000|Main Study Phase|Physician Decision|0|||
131034922|NCT03544281|471761826|FG001|Main Study Phase|Physician Decision|0|||
130703401|NCT04291508|470537931|FG001|Overall Study|lost to follow up|0|||
130703402|NCT04291508|470537932|FG002|Overall Study|lost to follow up|1|||
130703403|NCT04291508|470537933|FG003|Overall Study|lost to follow up|0|||
130703404|NCT03566238|470537934|FG000|Overall Study|Adverse Event|0|||
130930119|NCT00420927|471375594|FG000|Period 2|Noncompliant with study drug|0|||
130930120|NCT00420927|471375595|FG001|Period 2|Noncompliant with study drug|0|||
130930121|NCT00420927|471375596|FG002|Period 2|Noncompliant with study drug|0|||
130930122|NCT00420927|471375597|FG003|Period 2|Noncompliant with study drug|1|||
130930123|NCT00420927|471375598|FG004|Period 2|Noncompliant with study drug|0|||
131034923|NCT03544281|471761827|FG002|Main Study Phase|Physician Decision|0|||
130930124|NCT00420927|471375599|FG005|Period 2|Noncompliant with study drug|0|||
130930125|NCT00420927|471375600|FG006|Period 2|Noncompliant with study drug|2|||
130930126|NCT00420927|471375594|FG000|Period 2|Methotrexate intolerance|0|||
130930127|NCT00420927|471375595|FG001|Period 2|Methotrexate intolerance|0|||
130930128|NCT00420927|471375596|FG002|Period 2|Methotrexate intolerance|0|||
130930129|NCT00420927|471375597|FG003|Period 2|Methotrexate intolerance|0|||
130930130|NCT00420927|471375598|FG004|Period 2|Methotrexate intolerance|0|||
130930131|NCT00420927|471375599|FG005|Period 2|Methotrexate intolerance|0|||
130930132|NCT00420927|471375600|FG006|Period 2|Methotrexate intolerance|1|||
130930133|NCT00420927|471375594|FG000|Period 2|Took prohibited medication|0|||
130930134|NCT00420927|471375595|FG001|Period 2|Took prohibited medication|0|||
130930135|NCT00420927|471375596|FG002|Period 2|Took prohibited medication|0|||
130930136|NCT00420927|471375597|FG003|Period 2|Took prohibited medication|0|||
130930137|NCT00420927|471375598|FG004|Period 2|Took prohibited medication|1|||
130930138|NCT00420927|471375599|FG005|Period 2|Took prohibited medication|0|||
130930139|NCT00420927|471375600|FG006|Period 2|Took prohibited medication|0|||
130930140|NCT00320411|471375602|FG000|Overall Study|No investigational product admin.|4|||
130930141|NCT01032837|471375603|FG000|Overall Study|Adverse event/internal illness|0|||
130930142|NCT01032837|471375604|FG001|Overall Study|Adverse event/internal illness|1|||
130930143|NCT01032837|471375605|FG002|Overall Study|Adverse event/internal illness|0|||
130930144|NCT01032837|471375606|FG003|Overall Study|Adverse event/internal illness|1|||
130930145|NCT01032837|471375603|FG000|Overall Study|Withdrew consent|0|||
130930146|NCT01032837|471375604|FG001|Overall Study|Withdrew consent|2|||
130930147|NCT01032837|471375605|FG002|Overall Study|Withdrew consent|0|||
130930148|NCT01032837|471375606|FG003|Overall Study|Withdrew consent|1|||
130930149|NCT01032837|471375603|FG000|Overall Study|Failed to return|0|||
130930150|NCT01032837|471375604|FG001|Overall Study|Failed to return|0|||
130930151|NCT01032837|471375605|FG002|Overall Study|Failed to return|1|||
130930152|NCT01032837|471375606|FG003|Overall Study|Failed to return|0|||
130930153|NCT01032837|471375603|FG000|Overall Study|Refused treatment|0|||
130703405|NCT03566238|470537935|FG001|Overall Study|Adverse Event|1|||
130703406|NCT03566238|470537936|FG002|Overall Study|Adverse Event|0|||
130703407|NCT03566238|470537934|FG000|Overall Study|Lack of Efficacy|4|||
130703408|NCT03566238|470537935|FG001|Overall Study|Lack of Efficacy|2|||
130703409|NCT03566238|470537936|FG002|Overall Study|Lack of Efficacy|5|||
130703410|NCT03566238|470537934|FG000|Overall Study|Other|1|||
130703411|NCT03566238|470537935|FG001|Overall Study|Other|0|||
130703412|NCT03566238|470537936|FG002|Overall Study|Other|0|||
130703413|NCT04203667|470537944|FG000|Overall Study|Withdrawal by Subject|1|||
130703414|NCT04203667|470537944|FG000|Overall Study|Lost to Follow-up|1|||
130703415|NCT04203667|470537944|FG000|Overall Study|Death|1|||
130703416|NCT04203667|470537944|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
130703417|NCT01183884|470537945|FG000|Overall Study|Progressive Disease|26|||
130703418|NCT01183884|470537945|FG000|Overall Study|Adverse Event|3|||
130703419|NCT01183884|470537945|FG000|Overall Study|Withdrawal by Subject|1|||
130703420|NCT01183884|470537945|FG000|Overall Study|Other Complicating Disease|3|||
130703421|NCT01183884|470537945|FG000|Overall Study|Not Treated|1|||
130703422|NCT01183884|470537945|FG000|Overall Study|Other|4|||
130703423|NCT00127166|470537946|FG000|Period I|Protocol Violation|0|||
130703424|NCT00127166|470537947|FG001|Period I|Protocol Violation|2|||
130703425|NCT00127166|470537946|FG000|Period I|Withdrawal by Subject|2|||
130703426|NCT00127166|470537947|FG001|Period I|Withdrawal by Subject|0|||
130930154|NCT01032837|471375604|FG001|Overall Study|Refused treatment|0|||
130930155|NCT01032837|471375605|FG002|Overall Study|Refused treatment|0|||
130930156|NCT01032837|471375606|FG003|Overall Study|Refused treatment|1|||
130930157|NCT03727347|471375608|FG000|Overall Study|Withdrawal by Subject|2|||
130930158|NCT03727347|471375608|FG000|Overall Study|Lost to Follow-up|1|||
130930159|NCT02837783|471375611|FG000|Overall Study|Adverse Event|1|||
130930160|NCT02837783|471375612|FG001|Overall Study|Adverse Event|0|||
130930161|NCT02837783|471375611|FG000|Overall Study|Other, Not Specified|1|||
130930162|NCT02837783|471375612|FG001|Overall Study|Other, Not Specified|2|||
130930163|NCT01487200|471375613|FG000|Overall Study|Withdrawal by Subject|0|||
131120272|NCT00467779|472072323|FG012|Stage 2A|Disease Progression|0|||
130770529|NCT02178358|470786117|FG001|Overall Study|Lost to Follow-up|0|||
131120273|NCT00467779|472072324|FG013|Stage 2A|Disease Progression|10|||
130703427|NCT00127166|470537946|FG000|Period I|Patient did not meet inclusion criteria|1|||
130703428|NCT00127166|470537947|FG001|Period I|Patient did not meet inclusion criteria|0|||
130930164|NCT01487200|471375614|FG001|Overall Study|Withdrawal by Subject|1|||
130930165|NCT01487200|471375615|FG002|Overall Study|Withdrawal by Subject|0|||
130930166|NCT01487200|471375616|FG003|Overall Study|Withdrawal by Subject|0|||
130703429|NCT00127166|470537946|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
130703430|NCT00127166|470537947|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
130703431|NCT00127166|470537946|FG000|Period II|Withdrawal by Subject|2|||
130930167|NCT02216591|471375617|FG000|Overall Study|Lost to Follow-up|0|||
130930168|NCT02216591|471375618|FG001|Overall Study|Lost to Follow-up|1|||
130930169|NCT01866930|471375619|FG000|Treatment Period|Other|1|||
130930170|NCT01866930|471375620|FG001|Treatment Period|Other|0|||
130703432|NCT00127166|470537947|FG001|Period II|Withdrawal by Subject|0|||
130930171|NCT01866930|471375619|FG000|Treatment Period|Death|0|||
130930172|NCT01866930|471375620|FG001|Treatment Period|Death|2|||
130930173|NCT01866930|471375619|FG000|Treatment Period|Poor/non compliance|0|||
130930174|NCT01866930|471375620|FG001|Treatment Period|Poor/non compliance|2|||
130930175|NCT01866930|471375619|FG000|Treatment Period|No longer meets study criteria|0|||
130930176|NCT01866930|471375620|FG001|Treatment Period|No longer meets study criteria|1|||
130930177|NCT01866930|471375619|FG000|Treatment Period|Withdrawal by Subject|2|||
130930178|NCT01866930|471375620|FG001|Treatment Period|Withdrawal by Subject|8|||
130930179|NCT01866930|471375619|FG000|Treatment Period|Lack of Efficacy|1|||
130930180|NCT01866930|471375620|FG001|Treatment Period|Lack of Efficacy|9|||
130930181|NCT01866930|471375619|FG000|Treatment Period|Adverse Event|4|||
130930182|NCT01866930|471375620|FG001|Treatment Period|Adverse Event|12|||
130930183|NCT01866930|471375619|FG000|Treatment Period|Lost to Follow-up|1|||
130930184|NCT01866930|471375620|FG001|Treatment Period|Lost to Follow-up|1|||
130930185|NCT01866930|471375619|FG000|Follow-up Period|Lost to Follow-up|1|||
130930186|NCT01866930|471375620|FG001|Follow-up Period|Lost to Follow-up|1|||
130930187|NCT01866930|471375619|FG000|Follow-up Period|Other|1|||
130930188|NCT01866930|471375620|FG001|Follow-up Period|Other|5|||
130930189|NCT01866930|471375619|FG000|Follow-up Period|No longer required per protocol|1|||
130930190|NCT01866930|471375620|FG001|Follow-up Period|No longer required per protocol|0|||
130930191|NCT01866930|471375619|FG000|Follow-up Period|Withdrawal by Subject|3|||
130930192|NCT01866930|471375620|FG001|Follow-up Period|Withdrawal by Subject|3|||
130930193|NCT03648983|471375621|FG000|Overall Study|Study was terminated due to PI departure|95|||
130930194|NCT01269463|471375622|FG000|First Intervention|Withdrawal by Subject|1|||
130930195|NCT01269463|471375623|FG001|First Intervention|Withdrawal by Subject|0|||
130930196|NCT01269463|471375622|FG000|First Intervention|Adverse Event|1|||
130930197|NCT01269463|471375623|FG001|First Intervention|Adverse Event|0|||
130930198|NCT01269463|471375622|FG000|First Intervention|Lack of Efficacy|0|||
130930199|NCT01269463|471375623|FG001|First Intervention|Lack of Efficacy|1|||
130930200|NCT01269463|471375622|FG000|First Intervention|Physician Decision|0|||
130930201|NCT01269463|471375623|FG001|First Intervention|Physician Decision|1|||
130930202|NCT00279305|471375626|FG000|Overall Study|Pregnancy|1|||
130930203|NCT00279305|471375627|FG001|Overall Study|Pregnancy|0|||
130930204|NCT00279305|471375626|FG000|Overall Study|Withdrawal by Subject|2|||
130930205|NCT00279305|471375627|FG001|Overall Study|Withdrawal by Subject|0|||
130930206|NCT00279305|471375626|FG000|Overall Study|Dificulting establishing IV|1|||
130930207|NCT00279305|471375627|FG001|Overall Study|Dificulting establishing IV|0|||
130930208|NCT00279305|471375626|FG000|Overall Study|FDA Safety Alert|4|||
130930209|NCT00279305|471375627|FG001|Overall Study|FDA Safety Alert|1|||
130930210|NCT04404361|471375629|FG000|Overall Study|Death|12|||
130930211|NCT04404361|471375630|FG001|Overall Study|Death|12|||
130930212|NCT04404361|471375629|FG000|Overall Study|Withdrawal by Subject|13|||
130930213|NCT04404361|471375630|FG001|Overall Study|Withdrawal by Subject|5|||
130930214|NCT04404361|471375629|FG000|Overall Study|Lost to Follow-up|6|||
130930215|NCT04404361|471375630|FG001|Overall Study|Lost to Follow-up|3|||
130930216|NCT04404361|471375629|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
130930217|NCT04404361|471375630|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
130930218|NCT02862171|471375631|FG000|Overall Study|Death|1|||
130930219|NCT02862171|471375631|FG000|Overall Study|Lost to Follow-up|13|||
130930220|NCT02862171|471375631|FG000|Overall Study|Withdrawal by Subject|57|||
130930221|NCT02862171|471375631|FG000|Overall Study|Non-compliance|4|||
130930222|NCT02862171|471375631|FG000|Overall Study|HIV-1 seroconversion|18|||
130930223|NCT00662012|471375632|FG000|Overall Study|Lost to Follow-up|85|||
130930224|NCT00662012|471375632|FG000|Overall Study|Death|1|||
130930225|NCT00662012|471375632|FG000|Overall Study|Withdrawal by Subject|1|||
130930226|NCT01744197|471375638|FG000|Overall Study|Received 1 patch|2|||
130930227|NCT01744197|471375639|FG001|Overall Study|Received 1 patch|1|||
130930228|NCT01744197|471375638|FG000|Overall Study|No patch received|2|||
130930229|NCT01744197|471375639|FG001|Overall Study|No patch received|2|||
130930230|NCT02144012|471375642|FG000|Overall Study|Adverse Event|1|||
130930231|NCT02144012|471375643|FG001|Overall Study|Adverse Event|0|||
130930232|NCT02144012|471375642|FG000|Overall Study|Death|1|||
130930233|NCT02144012|471375643|FG001|Overall Study|Death|0|||
130930234|NCT02144012|471375642|FG000|Overall Study|Withdrawal by Subject|11|||
130930235|NCT02144012|471375643|FG001|Overall Study|Withdrawal by Subject|3|||
130930236|NCT02144012|471375642|FG000|Overall Study|Study Terminated by Sponsor|18|||
130930237|NCT02144012|471375643|FG001|Overall Study|Study Terminated by Sponsor|12|||
130930238|NCT02144012|471375642|FG000|Overall Study|Other|3|||
130930239|NCT02144012|471375643|FG001|Overall Study|Other|0|||
130930240|NCT00317356|471375644|FG000|Overall Study|Adverse Event|0|||
130930241|NCT00317356|471375645|FG001|Overall Study|Adverse Event|0|||
130930242|NCT00317356|471375646|FG002|Overall Study|Adverse Event|1|||
130930243|NCT00317356|471375647|FG003|Overall Study|Adverse Event|0|||
130930244|NCT00317356|471375644|FG000|Overall Study|Lack of Efficacy|1|||
130703433|NCT00127166|470537946|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
130930245|NCT00317356|471375645|FG001|Overall Study|Lack of Efficacy|1|||
130930246|NCT00317356|471375646|FG002|Overall Study|Lack of Efficacy|0|||
130930247|NCT00317356|471375647|FG003|Overall Study|Lack of Efficacy|3|||
130930248|NCT00317356|471375644|FG000|Overall Study|Physician Decision|0|||
130930249|NCT00317356|471375645|FG001|Overall Study|Physician Decision|1|||
130930250|NCT00317356|471375646|FG002|Overall Study|Physician Decision|0|||
130930251|NCT00317356|471375647|FG003|Overall Study|Physician Decision|0|||
130930252|NCT04419714|471375649|FG000|Overall Study|Technical Fault|5|||
130930253|NCT04419714|471375649|FG000|Overall Study|Protocol Deviation|2|||
130930254|NCT04419714|471375649|FG000|Overall Study|Withdrawal by Subject|1|||
130930255|NCT02674529|471377526|FG000|Overall Study|Lost to Follow-up|1|||
130930256|NCT02674529|471377527|FG001|Overall Study|Lost to Follow-up|2|||
130930257|NCT02674529|471377526|FG000|Overall Study|Withdrawal by Subject|2|||
130930258|NCT02674529|471377527|FG001|Overall Study|Withdrawal by Subject|1|||
130930259|NCT02674529|471377526|FG000|Overall Study|Physician Decision|0|||
130930260|NCT02674529|471377527|FG001|Overall Study|Physician Decision|1|||
130930261|NCT02674529|471377526|FG000|Overall Study|Protocol Violation|0|||
131120274|NCT00467779|472072325|FG014|Stage 2A|Disease Progression|0|||
131120275|NCT00467779|472072311|FG000|Stage 2A|Unspecified Reason|0|||
131120276|NCT00467779|472072312|FG001|Stage 2A|Unspecified Reason|0|||
131120277|NCT00467779|472072313|FG002|Stage 2A|Unspecified Reason|0|||
131120278|NCT00467779|472072314|FG003|Stage 2A|Unspecified Reason|0|||
131120279|NCT00467779|472072315|FG004|Stage 2A|Unspecified Reason|0|||
131120280|NCT00467779|472072316|FG005|Stage 2A|Unspecified Reason|0|||
131120281|NCT00467779|472072317|FG006|Stage 2A|Unspecified Reason|0|||
131120282|NCT00467779|472072318|FG007|Stage 2A|Unspecified Reason|0|||
131120283|NCT00467779|472072319|FG008|Stage 2A|Unspecified Reason|0|||
131120284|NCT00467779|472072320|FG009|Stage 2A|Unspecified Reason|0|||
131120285|NCT00467779|472072321|FG010|Stage 2A|Unspecified Reason|0|||
130703434|NCT00127166|470537947|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
130703435|NCT00708682|470537948|FG000|Infant Series|Adverse Event|1|||
130703436|NCT00708682|470537948|FG000|Infant Series|Lost to Follow-up|4|||
130703437|NCT00708682|470537948|FG000|Infant Series|Protocol Violation|1|||
130703438|NCT00708682|470537948|FG000|Infant Series|Parent/legal guardian request|6|||
130703439|NCT00708682|470537948|FG000|Infant Series|Failed to return|2|||
130703440|NCT00708682|470537948|FG000|Infant Series|Other|19|||
130703441|NCT00708682|470537948|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
130703442|NCT00708682|470537948|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
130703443|NCT00708682|470537948|FG000|Toddler Dose|Lost to Follow-up|3|||
130703444|NCT00708682|470537948|FG000|Toddler Dose|Failed to Return|4|||
130703445|NCT04718129|470537953|FG000|Overall Study|Lost to Follow-up|6|||
130703446|NCT04718129|470537954|FG001|Overall Study|Lost to Follow-up|7|||
130703447|NCT01835548|470537958|FG000|Dose Optimization Period|Adverse Event|0|||
130703448|NCT01835548|470537959|FG001|Dose Optimization Period|Adverse Event|0|||
130703449|NCT01835548|470537960|FG002|Dose Optimization Period|Adverse Event|1|||
130703450|NCT01835548|470537958|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
130703451|NCT01835548|470537959|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
130703452|NCT01835548|470537960|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
130703453|NCT01835548|470537958|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130930262|NCT02674529|471377527|FG001|Overall Study|Protocol Violation|1|||
130930263|NCT02891850|471377528|FG000|Overall Study|Adverse Event|3|||
130930264|NCT02891850|471377529|FG001|Overall Study|Adverse Event|0|||
130930265|NCT02891850|471377528|FG000|Overall Study|Death|0|||
130930266|NCT02891850|471377529|FG001|Overall Study|Death|4|||
130930267|NCT02891850|471377528|FG000|Overall Study|Physician Decision|1|||
131120286|NCT00467779|472072322|FG011|Stage 2A|Unspecified Reason|0|||
131120287|NCT00467779|472072323|FG012|Stage 2A|Unspecified Reason|0|||
131120288|NCT00467779|472072324|FG013|Stage 2A|Unspecified Reason|7|||
131120289|NCT00467779|472072325|FG014|Stage 2A|Unspecified Reason|0|||
130703454|NCT01835548|470537959|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130703455|NCT01835548|470537960|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130703456|NCT01835548|470537958|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130703457|NCT01835548|470537959|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130930268|NCT02891850|471377529|FG001|Overall Study|Physician Decision|0|||
130930269|NCT02891850|471377528|FG000|Overall Study|Pregnancy|1|||
130930270|NCT02891850|471377529|FG001|Overall Study|Pregnancy|0|||
130930271|NCT02891850|471377528|FG000|Overall Study|Withdrawal by Subject|2|||
130930272|NCT02891850|471377529|FG001|Overall Study|Withdrawal by Subject|3|||
130703458|NCT01835548|470537960|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130703459|NCT03257254|470537961|FG000|Overall Study|Withdrawal by Subject|7|||
130703460|NCT03257254|470537961|FG000|Overall Study|Lost to Follow-up|9|||
130703461|NCT03257254|470537961|FG000|Overall Study|Study discontinued by sponsor|5|||
130703462|NCT03168906|470537962|FG000|Overall Study|Lack of Efficacy|6|||
130703463|NCT03168906|470537963|FG001|Overall Study|Lack of Efficacy|6|||
130703464|NCT01321697|470537964|FG000|Overall Study|Study Terminated|7|||
130930273|NCT00630396|471377531|FG000|Overall Study|Death|4|||
130930274|NCT00630396|471377531|FG000|Overall Study|Lost to Follow-up|3|||
130930275|NCT00056316|471377532|FG000|Overall Study|Withdrawal by Subject|2|||
130930276|NCT00056316|471377533|FG001|Overall Study|Withdrawal by Subject|2|||
131120290|NCT00467779|472072311|FG000|Stage 2A|Withdrawal by Subject|0|||
131120291|NCT00467779|472072312|FG001|Stage 2A|Withdrawal by Subject|0|||
130930277|NCT00056316|471377532|FG000|Overall Study|Death/NH placement of pt|1|||
130930278|NCT00056316|471377533|FG001|Overall Study|Death/NH placement of pt|1|||
130930279|NCT02599129|471377540|FG000|Overall Study|Lack of Efficacy|2|||
130930280|NCT02599129|471377541|FG001|Overall Study|Lack of Efficacy|2|||
131120292|NCT00467779|472072313|FG002|Stage 2A|Withdrawal by Subject|0|||
131120293|NCT00467779|472072314|FG003|Stage 2A|Withdrawal by Subject|0|||
131120294|NCT00467779|472072315|FG004|Stage 2A|Withdrawal by Subject|0|||
131120295|NCT00467779|472072316|FG005|Stage 2A|Withdrawal by Subject|0|||
130703465|NCT00857818|470537967|FG000|Overall Study|Lack of Efficacy|1|||
130703466|NCT00857818|470537968|FG001|Overall Study|Lack of Efficacy|0|||
130703467|NCT00857818|470537967|FG000|Overall Study|Adverse Event|3|||
130703468|NCT00857818|470537968|FG001|Overall Study|Adverse Event|0|||
130703469|NCT00857818|470537967|FG000|Overall Study|Withdrawal by Subject|0|||
130703470|NCT00857818|470537968|FG001|Overall Study|Withdrawal by Subject|4|||
130703471|NCT00857818|470537967|FG000|Overall Study|Sponsor terminated study|6|||
130703472|NCT00857818|470537968|FG001|Overall Study|Sponsor terminated study|4|||
130703473|NCT00857818|470537967|FG000|Overall Study|Investigator decision|1|||
130703474|NCT00857818|470537968|FG001|Overall Study|Investigator decision|0|||
130703475|NCT02625974|470537970|FG000|Part 1|Lost to Follow-up|9|||
130703476|NCT02625974|470537971|FG001|Part 1|Lost to Follow-up|3|||
130703477|NCT02625974|470537970|FG000|Part 2|Lost to Follow-up|4|||
130703478|NCT02625974|470537971|FG001|Part 2|Lost to Follow-up|6|||
130703479|NCT02625974|470537970|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
130703480|NCT02625974|470537971|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
130703481|NCT00434590|470537972|FG000|Overall Study|Administrative problems|5|||
130703482|NCT00434590|470537973|FG001|Overall Study|Administrative problems|5|||
130703483|NCT02175368|470537975|FG000|Overall Study|Lost to Follow-up|1|||
130703484|NCT02875028|470537976|FG000|Washout Period|Withdrawal by Subject|0|||
130703485|NCT02875028|470537977|FG001|Washout Period|Withdrawal by Subject|1|||
130703486|NCT03180528|470539597|FG000|Overall Study|Adverse Event|1|||
130703487|NCT03180528|470539597|FG000|Overall Study|Withdrawal by Subject|1|||
130703488|NCT03180528|470539597|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
130703489|NCT02447887|470539598|FG000|Overall Study|Study was terminated|3|||
130703490|NCT01560819|470539604|FG000|Overall Study|Physician Decision|1|||
130703491|NCT01560819|470539605|FG001|Overall Study|Physician Decision|0|||
130703492|NCT02674633|470539606|FG000|Overall Study|Lost to Follow-up|3|||
131120296|NCT00467779|472072317|FG006|Stage 2A|Withdrawal by Subject|0|||
131120297|NCT00467779|472072318|FG007|Stage 2A|Withdrawal by Subject|0|||
131120298|NCT00467779|472072319|FG008|Stage 2A|Withdrawal by Subject|0|||
131120299|NCT00467779|472072320|FG009|Stage 2A|Withdrawal by Subject|0|||
131120300|NCT00467779|472072321|FG010|Stage 2A|Withdrawal by Subject|0|||
131120301|NCT00467779|472072322|FG011|Stage 2A|Withdrawal by Subject|0|||
131120302|NCT00467779|472072323|FG012|Stage 2A|Withdrawal by Subject|0|||
131120303|NCT00467779|472072324|FG013|Stage 2A|Withdrawal by Subject|1|||
131120304|NCT00467779|472072325|FG014|Stage 2A|Withdrawal by Subject|0|||
131120305|NCT00467779|472072311|FG000|Stage 3|Adverse Event|0|||
131120306|NCT00467779|472072312|FG001|Stage 3|Adverse Event|0|||
131120307|NCT00467779|472072313|FG002|Stage 3|Adverse Event|0|||
131120308|NCT00467779|472072314|FG003|Stage 3|Adverse Event|0|||
131120309|NCT00467779|472072315|FG004|Stage 3|Adverse Event|0|||
131120310|NCT00467779|472072316|FG005|Stage 3|Adverse Event|0|||
131120311|NCT00467779|472072317|FG006|Stage 3|Adverse Event|0|||
131120312|NCT00467779|472072318|FG007|Stage 3|Adverse Event|0|||
131120313|NCT00467779|472072319|FG008|Stage 3|Adverse Event|0|||
130703493|NCT02674633|470539607|FG001|Overall Study|Lost to Follow-up|2|||
130703494|NCT02674633|470539606|FG000|Overall Study|Physician Decision|1|||
130703495|NCT02674633|470539607|FG001|Overall Study|Physician Decision|0|||
130930281|NCT02599129|471377540|FG000|Overall Study|Lost to Follow-up|1|||
130703496|NCT02674633|470539606|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131120314|NCT00467779|472072320|FG009|Stage 3|Adverse Event|0|||
131120315|NCT00467779|472072321|FG010|Stage 3|Adverse Event|0|||
131120316|NCT00467779|472072322|FG011|Stage 3|Adverse Event|0|||
131120317|NCT00467779|472072323|FG012|Stage 3|Adverse Event|0|||
130703497|NCT02674633|470539607|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130703498|NCT00460109|470539608|FG000|Overall Study|Death|1|||
130703499|NCT02344745|470539609|FG000|Overall Study|Data collection sheets were lost|2|||
130703500|NCT02344745|470539610|FG001|Overall Study|Data collection sheets were lost|0|||
130703501|NCT02788513|470539611|FG000|Overall Study|Withdrawal by Subject|3|||
130703502|NCT02788513|470539612|FG001|Overall Study|Withdrawal by Subject|0|||
130703503|NCT02788513|470539613|FG002|Overall Study|Withdrawal by Subject|2|||
130930282|NCT02599129|471377541|FG001|Overall Study|Lost to Follow-up|0|||
131120318|NCT00467779|472072324|FG013|Stage 3|Adverse Event|0|||
131120319|NCT00467779|472072325|FG014|Stage 3|Adverse Event|2|||
131120320|NCT00467779|472072311|FG000|Stage 3|Death|0|||
131120321|NCT00467779|472072312|FG001|Stage 3|Death|0|||
131120322|NCT00467779|472072313|FG002|Stage 3|Death|0|||
131120323|NCT00467779|472072314|FG003|Stage 3|Death|0|||
131120324|NCT00467779|472072315|FG004|Stage 3|Death|0|||
131120325|NCT00467779|472072316|FG005|Stage 3|Death|0|||
131120326|NCT00467779|472072317|FG006|Stage 3|Death|0|||
131120327|NCT00467779|472072318|FG007|Stage 3|Death|0|||
130930283|NCT02599129|471377540|FG000|Overall Study|Withdrawal by Subject|2|||
130930284|NCT02599129|471377541|FG001|Overall Study|Withdrawal by Subject|1|||
130930285|NCT03489720|471377544|FG000|Overall Study|Withdrawal by Subject|2|||
130930286|NCT03489720|471377545|FG001|Overall Study|Withdrawal by Subject|0|||
130930287|NCT02270957|471377546|FG000|Overall Study|Lack of Efficacy|2|||
130930288|NCT02270957|471377547|FG001|Overall Study|Lack of Efficacy|4|||
130703504|NCT02788513|470539614|FG003|Overall Study|Withdrawal by Subject|3|||
130703505|NCT02788513|470539615|FG004|Overall Study|Withdrawal by Subject|1|||
130930289|NCT02270957|471377546|FG000|Overall Study|Adverse Event|2|||
130930290|NCT02270957|471377547|FG001|Overall Study|Adverse Event|0|||
130930291|NCT00545168|471377550|FG000|Overall Study|Lost to Follow-up|5|||
130930292|NCT00545168|471377551|FG001|Overall Study|Lost to Follow-up|5|||
130930293|NCT00545168|471377552|FG002|Overall Study|Lost to Follow-up|5|||
130930294|NCT00545168|471377550|FG000|Overall Study|Withdrawal by Subject|9|||
130930295|NCT00545168|471377551|FG001|Overall Study|Withdrawal by Subject|0|||
130930296|NCT00545168|471377552|FG002|Overall Study|Withdrawal by Subject|13|||
130930297|NCT00545168|471377550|FG000|Overall Study|Protocol Violation|1|||
130930298|NCT00545168|471377551|FG001|Overall Study|Protocol Violation|0|||
130930299|NCT00545168|471377552|FG002|Overall Study|Protocol Violation|1|||
130930300|NCT00545168|471377550|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
130930301|NCT00545168|471377551|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
130930302|NCT00545168|471377552|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
130930303|NCT01218204|471377553|FG000|Part B Washout|Adverse Event|0|||
130930304|NCT01218204|471377554|FG001|Part B Washout|Adverse Event|1|||
130930305|NCT01218204|471377555|FG002|Part B Washout|Adverse Event|0|||
130930306|NCT01218204|471377556|FG003|Part B Washout|Adverse Event|0|||
130930307|NCT01218204|471377553|FG000|Part B Washout|Lost to Follow-up|0|||
130930308|NCT01218204|471377554|FG001|Part B Washout|Lost to Follow-up|2|||
130930309|NCT01218204|471377555|FG002|Part B Washout|Lost to Follow-up|0|||
130930310|NCT01218204|471377556|FG003|Part B Washout|Lost to Follow-up|0|||
130930311|NCT01218204|471377553|FG000|Part B Washout|Physician Decision|0|||
130930312|NCT01218204|471377554|FG001|Part B Washout|Physician Decision|14|||
130930313|NCT01218204|471377555|FG002|Part B Washout|Physician Decision|0|||
130930314|NCT01218204|471377556|FG003|Part B Washout|Physician Decision|0|||
130930315|NCT01218204|471377553|FG000|Part B Washout|Withdrawal by Subject|0|||
130930316|NCT01218204|471377554|FG001|Part B Washout|Withdrawal by Subject|14|||
130930317|NCT01218204|471377555|FG002|Part B Washout|Withdrawal by Subject|0|||
130930318|NCT01218204|471377556|FG003|Part B Washout|Withdrawal by Subject|0|||
130930319|NCT01218204|471377553|FG000|Part B Washout|Reached defined stopping criteria|0|||
130930320|NCT01218204|471377554|FG001|Part B Washout|Reached defined stopping criteria|2|||
130930321|NCT01218204|471377555|FG002|Part B Washout|Reached defined stopping criteria|0|||
130930322|NCT01218204|471377556|FG003|Part B Washout|Reached defined stopping criteria|0|||
130930323|NCT01218204|471377553|FG000|Part B Washout|Did not meet continuation criteria|0|||
130930324|NCT01218204|471377554|FG001|Part B Washout|Did not meet continuation criteria|112|||
130930325|NCT01218204|471377555|FG002|Part B Washout|Did not meet continuation criteria|0|||
130930326|NCT01218204|471377556|FG003|Part B Washout|Did not meet continuation criteria|0|||
130930327|NCT01218204|471377553|FG000|Part B Run-in|Adverse Event|0|||
130930328|NCT01218204|471377554|FG001|Part B Run-in|Adverse Event|0|||
130930329|NCT01218204|471377555|FG002|Part B Run-in|Adverse Event|1|||
130930330|NCT01218204|471377556|FG003|Part B Run-in|Adverse Event|0|||
130930331|NCT01218204|471377553|FG000|Part B Run-in|Protocol Violation|0|||
130930332|NCT01218204|471377554|FG001|Part B Run-in|Protocol Violation|0|||
130930333|NCT01218204|471377555|FG002|Part B Run-in|Protocol Violation|2|||
130930334|NCT01218204|471377556|FG003|Part B Run-in|Protocol Violation|0|||
130930335|NCT01218204|471377553|FG000|Part B Run-in|Withdrawal by Subject|0|||
130930336|NCT01218204|471377554|FG001|Part B Run-in|Withdrawal by Subject|0|||
130930337|NCT01218204|471377555|FG002|Part B Run-in|Withdrawal by Subject|3|||
130930338|NCT01218204|471377556|FG003|Part B Run-in|Withdrawal by Subject|0|||
130930339|NCT01218204|471377553|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
130930340|NCT01218204|471377554|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
130930341|NCT01218204|471377555|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
130703506|NCT02788513|470539611|FG000|Overall Study|Lost to Follow-up|1|||
130703507|NCT02788513|470539612|FG001|Overall Study|Lost to Follow-up|0|||
130703508|NCT02788513|470539613|FG002|Overall Study|Lost to Follow-up|0|||
130703509|NCT02788513|470539614|FG003|Overall Study|Lost to Follow-up|0|||
130703510|NCT02788513|470539615|FG004|Overall Study|Lost to Follow-up|1|||
130930342|NCT01218204|471377556|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
130930343|NCT01218204|471377553|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
130930344|NCT01218204|471377554|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
130930345|NCT01218204|471377555|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
130930346|NCT01218204|471377556|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
130703511|NCT02788513|470539611|FG000|Overall Study|Adverse Event|5|||
130703512|NCT02788513|470539612|FG001|Overall Study|Adverse Event|8|||
130930347|NCT01987505|471377557|FG000|Overall Study|Other|9|||
130930348|NCT01987505|471377557|FG000|Overall Study|Withdrawal by Subject|2|||
130930349|NCT01987505|471377557|FG000|Overall Study|Other Reason|2|||
130930350|NCT01987505|471377557|FG000|Overall Study|Lost to Follow-up|15|||
130930351|NCT01987505|471377557|FG000|Overall Study|Investigator Decision|2|||
130930352|NCT01987505|471377557|FG000|Overall Study|Death|4|||
130930353|NCT03266107|471377558|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
130930354|NCT03266107|471377558|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
130930355|NCT03266107|471377558|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
130930356|NCT03266107|471377558|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
130930357|NCT01191801|471377561|FG000|Overall Study|Death|36|||
130930358|NCT01191801|471377562|FG001|Overall Study|Death|12|||
130930359|NCT01191801|471377561|FG000|Overall Study|Lack of Efficacy|176|||
130930360|NCT01191801|471377562|FG001|Overall Study|Lack of Efficacy|258|||
130930361|NCT01191801|471377561|FG000|Overall Study|Adverse Event|9|||
130930362|NCT01191801|471377562|FG001|Overall Study|Adverse Event|8|||
130930363|NCT01191801|471377561|FG000|Overall Study|Protocol Violation|2|||
130930364|NCT01191801|471377562|FG001|Overall Study|Protocol Violation|4|||
130930365|NCT01191801|471377561|FG000|Overall Study|Physician Decision|47|||
130930366|NCT01191801|471377562|FG001|Overall Study|Physician Decision|24|||
130930367|NCT01191801|471377561|FG000|Overall Study|Withdrawal by Subject|1|||
130930368|NCT01191801|471377562|FG001|Overall Study|Withdrawal by Subject|4|||
130930369|NCT01191801|471377561|FG000|Overall Study|Not Provided|45|||
130930370|NCT01191801|471377562|FG001|Overall Study|Not Provided|27|||
130930371|NCT05147350|471377570|FG000|Overall Study|Death|2|||
130930372|NCT05147350|471377571|FG001|Overall Study|Death|3|||
130930373|NCT05147350|471377572|FG002|Overall Study|Death|3|||
130930374|NCT05147350|471377573|FG003|Overall Study|Death|2|||
130930375|NCT05147350|471377574|FG004|Overall Study|Death|2|||
130930376|NCT05147350|471377575|FG005|Overall Study|Death|1|||
130930377|NCT05147350|471377576|FG006|Overall Study|Death|1|||
130930378|NCT05147350|471377577|FG007|Overall Study|Death|3|||
130930379|NCT05147350|471377570|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
130930380|NCT05147350|471377571|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
130930381|NCT05147350|471377572|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
130930382|NCT05147350|471377573|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
130930383|NCT05147350|471377574|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
130930384|NCT05147350|471377575|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
130930385|NCT05147350|471377576|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
130930386|NCT05147350|471377577|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
130930387|NCT05147350|471377570|FG000|Overall Study|Withdrawal by Subject|0|||
130930388|NCT05147350|471377571|FG001|Overall Study|Withdrawal by Subject|0|||
130930389|NCT05147350|471377572|FG002|Overall Study|Withdrawal by Subject|3|||
130930390|NCT05147350|471377573|FG003|Overall Study|Withdrawal by Subject|1|||
130930391|NCT05147350|471377574|FG004|Overall Study|Withdrawal by Subject|1|||
130930392|NCT05147350|471377575|FG005|Overall Study|Withdrawal by Subject|0|||
130930393|NCT05147350|471377576|FG006|Overall Study|Withdrawal by Subject|1|||
130930394|NCT05147350|471377577|FG007|Overall Study|Withdrawal by Subject|0|||
130930395|NCT05147350|471377570|FG000|Overall Study|Other Reasons|0|||
130930396|NCT05147350|471377571|FG001|Overall Study|Other Reasons|0|||
130930397|NCT05147350|471377572|FG002|Overall Study|Other Reasons|2|||
130930398|NCT05147350|471377573|FG003|Overall Study|Other Reasons|0|||
130930399|NCT05147350|471377574|FG004|Overall Study|Other Reasons|0|||
130930400|NCT05147350|471377575|FG005|Overall Study|Other Reasons|2|||
130930401|NCT05147350|471377576|FG006|Overall Study|Other Reasons|1|||
130930402|NCT05147350|471377577|FG007|Overall Study|Other Reasons|1|||
130930403|NCT01539538|471377578|FG000|Overall Study|Adverse Event|13|||
130930404|NCT01539538|471377579|FG001|Overall Study|Adverse Event|18|||
130930405|NCT01539538|471377578|FG000|Overall Study|Lack of Efficacy|13|||
130930406|NCT01539538|471377579|FG001|Overall Study|Lack of Efficacy|16|||
130930407|NCT01539538|471377578|FG000|Overall Study|Withdrawal by Subject|2|||
130930408|NCT01539538|471377579|FG001|Overall Study|Withdrawal by Subject|3|||
130930409|NCT01539538|471377578|FG000|Overall Study|PCA no longer required or PCA problem|3|||
130930410|NCT01539538|471377579|FG001|Overall Study|PCA no longer required or PCA problem|7|||
130930411|NCT02088047|471377582|FG000|Overall Study|Withdrawal by Subject|1|||
130930412|NCT02088047|471377583|FG001|Overall Study|Withdrawal by Subject|0|||
130703513|NCT02788513|470539613|FG002|Overall Study|Adverse Event|4|||
131120328|NCT00467779|472072319|FG008|Stage 3|Death|0|||
131120329|NCT00467779|472072320|FG009|Stage 3|Death|0|||
130703514|NCT02788513|470539614|FG003|Overall Study|Adverse Event|2|||
130703515|NCT02788513|470539615|FG004|Overall Study|Adverse Event|2|||
130703516|NCT02788513|470539611|FG000|Overall Study|Protocol Violation|0|||
130703517|NCT02788513|470539612|FG001|Overall Study|Protocol Violation|0|||
130703518|NCT02788513|470539613|FG002|Overall Study|Protocol Violation|1|||
130703519|NCT02788513|470539614|FG003|Overall Study|Protocol Violation|1|||
130930413|NCT00459953|471377585|FG000|Overall Study|not analyzed-household member in study|1|||
130930414|NCT00459953|471377586|FG001|Overall Study|not analyzed-household member in study|1|||
130930415|NCT00040664|471377587|FG000|Overall Study|Adverse Event|12|||
130930416|NCT00040664|471377588|FG001|Overall Study|Adverse Event|3|||
130930417|NCT00040664|471377589|FG002|Overall Study|Adverse Event|2|||
130930418|NCT00040664|471377590|FG003|Overall Study|Adverse Event|7|||
130930419|NCT00040664|471377587|FG000|Overall Study|Lack of Efficacy|9|||
130703520|NCT02788513|470539615|FG004|Overall Study|Protocol Violation|0|||
130703521|NCT02788513|470539611|FG000|Overall Study|Subject decided to stop taking treatment|0|||
130703522|NCT02788513|470539612|FG001|Overall Study|Subject decided to stop taking treatment|0|||
130703523|NCT02788513|470539613|FG002|Overall Study|Subject decided to stop taking treatment|1|||
130703524|NCT02788513|470539614|FG003|Overall Study|Subject decided to stop taking treatment|0|||
130703525|NCT02788513|470539615|FG004|Overall Study|Subject decided to stop taking treatment|0|||
130703526|NCT02788513|470539611|FG000|Overall Study|Decision by the study team|0|||
130703527|NCT02788513|470539612|FG001|Overall Study|Decision by the study team|0|||
130703528|NCT02788513|470539613|FG002|Overall Study|Decision by the study team|0|||
130703529|NCT02788513|470539614|FG003|Overall Study|Decision by the study team|0|||
130703530|NCT02788513|470539615|FG004|Overall Study|Decision by the study team|1|||
130703531|NCT05996198|470539616|FG000|Overall Study|Withdrawal by Subject|1|||
130703532|NCT05996198|470539617|FG001|Overall Study|Withdrawal by Subject|0|||
130703533|NCT02014441|470539619|FG000|Overall Study|Withdrawal by Subject|12|||
130703534|NCT00114231|470539621|FG000|Overall Study|No consent|2|||
130703535|NCT00114231|470539622|FG001|Overall Study|No consent|0|||
130703536|NCT00114231|470539621|FG000|Overall Study|QARC requirement not met|1|||
130703537|NCT00114231|470539622|FG001|Overall Study|QARC requirement not met|0|||
130703538|NCT00114231|470539621|FG000|Overall Study|Suspected metastatic disease|1|||
130703539|NCT00114231|470539622|FG001|Overall Study|Suspected metastatic disease|0|||
130703540|NCT00114231|470539621|FG000|Overall Study|No adenocarcinoma|1|||
130703541|NCT00114231|470539622|FG001|Overall Study|No adenocarcinoma|0|||
130703542|NCT00114231|470539621|FG000|Overall Study|Low creatinine clearance|0|||
130703543|NCT00114231|470539622|FG001|Overall Study|Low creatinine clearance|1|||
130703544|NCT00114231|470539621|FG000|Overall Study|Tumor size > 4cm|1|||
130703545|NCT00114231|470539622|FG001|Overall Study|Tumor size > 4cm|0|||
130703546|NCT00114231|470539621|FG000|Overall Study|Tumor fixed on digital exam|0|||
130703547|NCT00114231|470539622|FG001|Overall Study|Tumor fixed on digital exam|1|||
130703548|NCT00114231|470539621|FG000|Overall Study|No Absolute Neutrophil Count|2|||
130703549|NCT00114231|470539622|FG001|Overall Study|No Absolute Neutrophil Count|0|||
130703550|NCT00114231|470539621|FG000|Overall Study|Biopsy done after registration|1|||
130703551|NCT00114231|470539622|FG001|Overall Study|Biopsy done after registration|0|||
130703552|NCT01933919|470539623|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
130703553|NCT01933919|470539624|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
130703554|NCT01933919|470539623|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
130930420|NCT00040664|471377588|FG001|Overall Study|Lack of Efficacy|2|||
130930421|NCT00040664|471377589|FG002|Overall Study|Lack of Efficacy|3|||
130930422|NCT00040664|471377590|FG003|Overall Study|Lack of Efficacy|4|||
130930423|NCT00040664|471377587|FG000|Overall Study|Insufficient CD4 response|1|||
130930424|NCT00040664|471377588|FG001|Overall Study|Insufficient CD4 response|0|||
130930425|NCT00040664|471377589|FG002|Overall Study|Insufficient CD4 response|1|||
130930426|NCT00040664|471377590|FG003|Overall Study|Insufficient CD4 response|0|||
130930427|NCT00040664|471377587|FG000|Overall Study|Lost to Follow-up|4|||
130930428|NCT00040664|471377588|FG001|Overall Study|Lost to Follow-up|2|||
130930429|NCT00040664|471377589|FG002|Overall Study|Lost to Follow-up|0|||
130930430|NCT00040664|471377590|FG003|Overall Study|Lost to Follow-up|2|||
130930431|NCT00040664|471377587|FG000|Overall Study|Protocol Violation|2|||
130930432|NCT00040664|471377588|FG001|Overall Study|Protocol Violation|1|||
130930433|NCT00040664|471377589|FG002|Overall Study|Protocol Violation|0|||
130930434|NCT00040664|471377590|FG003|Overall Study|Protocol Violation|1|||
130930435|NCT00040664|471377587|FG000|Overall Study|Withdrawal by Subject|7|||
130930436|NCT00040664|471377588|FG001|Overall Study|Withdrawal by Subject|0|||
130930437|NCT00040664|471377589|FG002|Overall Study|Withdrawal by Subject|3|||
130930438|NCT00040664|471377590|FG003|Overall Study|Withdrawal by Subject|4|||
130930439|NCT00040664|471377587|FG000|Overall Study|Pregnancy|3|||
130930440|NCT00040664|471377588|FG001|Overall Study|Pregnancy|0|||
130930441|NCT00040664|471377589|FG002|Overall Study|Pregnancy|0|||
130930442|NCT00040664|471377590|FG003|Overall Study|Pregnancy|3|||
130930443|NCT00040664|471377587|FG000|Overall Study|Medication adherence/compliance problems|8|||
130930444|NCT00040664|471377588|FG001|Overall Study|Medication adherence/compliance problems|2|||
130930445|NCT00040664|471377589|FG002|Overall Study|Medication adherence/compliance problems|1|||
130703555|NCT01933919|470539624|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
130930446|NCT00040664|471377590|FG003|Overall Study|Medication adherence/compliance problems|5|||
130930447|NCT00040664|471377587|FG000|Overall Study|Poor taste|2|||
130930448|NCT00040664|471377588|FG001|Overall Study|Poor taste|0|||
130930449|NCT00040664|471377589|FG002|Overall Study|Poor taste|2|||
130930450|NCT00040664|471377590|FG003|Overall Study|Poor taste|0|||
130930451|NCT00040664|471377587|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
130930452|NCT00040664|471377588|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
130930453|NCT00040664|471377589|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
130930454|NCT00040664|471377590|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
130930455|NCT00040664|471377587|FG000|Overall Study|Change of formulation|2|||
131120330|NCT00467779|472072321|FG010|Stage 3|Death|0|||
131120331|NCT00467779|472072322|FG011|Stage 3|Death|0|||
131120332|NCT00467779|472072323|FG012|Stage 3|Death|0|||
131120333|NCT00467779|472072324|FG013|Stage 3|Death|0|||
130930456|NCT00040664|471377588|FG001|Overall Study|Change of formulation|2|||
130930457|NCT00040664|471377589|FG002|Overall Study|Change of formulation|0|||
130930458|NCT00040664|471377590|FG003|Overall Study|Change of formulation|0|||
130930459|NCT00040664|471377587|FG000|Overall Study|Non-viability of oral suspension|1|||
130930460|NCT00040664|471377588|FG001|Overall Study|Non-viability of oral suspension|0|||
130930461|NCT00040664|471377589|FG002|Overall Study|Non-viability of oral suspension|1|||
130930462|NCT00040664|471377590|FG003|Overall Study|Non-viability of oral suspension|0|||
130930463|NCT01233258|471377592|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
130930464|NCT01233258|471377593|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
130930465|NCT01233258|471377594|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
130930466|NCT01233258|471377595|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
130930467|NCT01233258|471377596|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
130930468|NCT01233258|471377597|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
130930469|NCT01233258|471377592|FG000|First Intervention (6 Months)|Protocol Violation|0|||
130930470|NCT01233258|471377593|FG001|First Intervention (6 Months)|Protocol Violation|0|||
130930471|NCT01233258|471377594|FG002|First Intervention (6 Months)|Protocol Violation|1|||
130930472|NCT01233258|471377595|FG003|First Intervention (6 Months)|Protocol Violation|0|||
130930473|NCT01233258|471377596|FG004|First Intervention (6 Months)|Protocol Violation|0|||
130930474|NCT01233258|471377597|FG005|First Intervention (6 Months)|Protocol Violation|0|||
130930475|NCT01233258|471377592|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
130930476|NCT01233258|471377593|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
130930477|NCT01233258|471377594|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
130930478|NCT01233258|471377595|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
130930479|NCT01233258|471377596|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
130930480|NCT01233258|471377597|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
130930481|NCT01049308|471377598|FG000|Pill Counts|Withdrawal by Subject|83|||
130930482|NCT03926169|471377603|FG000|Period A|Adverse Event|2|||
130930483|NCT03926169|471377604|FG001|Period A|Adverse Event|2|||
130930484|NCT03926169|471377605|FG002|Period A|Adverse Event|1|||
130930485|NCT03926169|471377603|FG000|Period A|Withdrawal by Subject|2|||
130930486|NCT03926169|471377604|FG001|Period A|Withdrawal by Subject|2|||
130930487|NCT03926169|471377605|FG002|Period A|Withdrawal by Subject|2|||
130930488|NCT03926169|471377603|FG000|Period A|Lost to Follow-up|3|||
130930489|NCT03926169|471377604|FG001|Period A|Lost to Follow-up|1|||
131120334|NCT00467779|472072325|FG014|Stage 3|Death|1|||
131120335|NCT00467779|472072311|FG000|Stage 3|Disease Progression|0|||
131120336|NCT00467779|472072312|FG001|Stage 3|Disease Progression|0|||
131120337|NCT00467779|472072313|FG002|Stage 3|Disease Progression|0|||
131120338|NCT00467779|472072314|FG003|Stage 3|Disease Progression|0|||
131120339|NCT00467779|472072315|FG004|Stage 3|Disease Progression|0|||
131120340|NCT00467779|472072316|FG005|Stage 3|Disease Progression|0|||
131120341|NCT00467779|472072317|FG006|Stage 3|Disease Progression|0|||
130703556|NCT01933919|470539623|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
130930490|NCT03926169|471377605|FG002|Period A|Lost to Follow-up|0|||
130930491|NCT03926169|471377603|FG000|Period A|Lack of Efficacy|0|||
130930492|NCT03926169|471377604|FG001|Period A|Lack of Efficacy|2|||
130930493|NCT03926169|471377605|FG002|Period A|Lack of Efficacy|2|||
130930494|NCT03926169|471377603|FG000|Period A|COVID-19 Infection|0|||
130930495|NCT03926169|471377604|FG001|Period A|COVID-19 Infection|1|||
130930496|NCT03926169|471377605|FG002|Period A|COVID-19 Infection|0|||
130930497|NCT03926169|471377603|FG000|Period A|COVID-19 Logistical Restrictions|0|||
130930498|NCT03926169|471377604|FG001|Period A|COVID-19 Logistical Restrictions|2|||
130930499|NCT03926169|471377605|FG002|Period A|COVID-19 Logistical Restrictions|1|||
130930500|NCT03926169|471377603|FG000|Period A|Other, Not Specified|1|||
130930501|NCT03926169|471377604|FG001|Period A|Other, Not Specified|0|||
130930502|NCT03926169|471377605|FG002|Period A|Other, Not Specified|0|||
130930503|NCT03926169|471377603|FG000|Period B|Adverse Event|3|||
130930504|NCT03926169|471377604|FG001|Period B|Adverse Event|1|||
130930505|NCT03926169|471377605|FG002|Period B|Adverse Event|1|||
130930506|NCT03926169|471377603|FG000|Period B|Withdrawal by Subject|1|||
130930507|NCT03926169|471377604|FG001|Period B|Withdrawal by Subject|3|||
130930508|NCT03926169|471377605|FG002|Period B|Withdrawal by Subject|0|||
130930509|NCT03926169|471377603|FG000|Period B|Lack of Efficacy|3|||
130930510|NCT03926169|471377604|FG001|Period B|Lack of Efficacy|1|||
131034924|NCT03544281|471761828|FG003|Main Study Phase|Physician Decision|0|||
131034925|NCT03544281|471761829|FG004|Main Study Phase|Physician Decision|0|||
131034926|NCT03544281|471761830|FG005|Main Study Phase|Physician Decision|0|||
131034927|NCT03544281|471761831|FG006|Main Study Phase|Physician Decision|0|||
131034928|NCT03544281|471761832|FG007|Main Study Phase|Physician Decision|1|||
131034929|NCT03544281|471761833|FG008|Main Study Phase|Physician Decision|0|||
131034930|NCT03544281|471761834|FG009|Main Study Phase|Physician Decision|0|||
131034931|NCT03544281|471761835|FG010|Main Study Phase|Physician Decision|0|||
131034932|NCT03544281|471761836|FG011|Main Study Phase|Physician Decision|0|||
131034933|NCT03544281|471761837|FG012|Main Study Phase|Physician Decision|0|||
131120342|NCT00467779|472072318|FG007|Stage 3|Disease Progression|0|||
130930511|NCT03926169|471377605|FG002|Period B|Lack of Efficacy|1|||
130930512|NCT03926169|471377603|FG000|Period B|Lost to Follow-up|1|||
130930513|NCT03926169|471377604|FG001|Period B|Lost to Follow-up|1|||
130930514|NCT03926169|471377605|FG002|Period B|Lost to Follow-up|4|||
130930515|NCT03926169|471377603|FG000|Period B|Other, Not Specified|62|||
130930516|NCT03926169|471377604|FG001|Period B|Other, Not Specified|57|||
130930517|NCT03926169|471377605|FG002|Period B|Other, Not Specified|65|||
130930518|NCT00843024|471377606|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
130930519|NCT00843024|471377607|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
130930520|NCT00843024|471377608|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
130930521|NCT00843024|471377609|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
130930522|NCT00843024|471377610|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
130930523|NCT00843024|471377611|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
130930524|NCT00843024|471377606|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
130930525|NCT00843024|471377607|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
130930526|NCT00843024|471377608|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
130930527|NCT00843024|471377609|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
130930528|NCT00843024|471377610|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
130930529|NCT00843024|471377611|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
131120343|NCT00467779|472072319|FG008|Stage 3|Disease Progression|0|||
131120344|NCT00467779|472072320|FG009|Stage 3|Disease Progression|0|||
131120345|NCT00467779|472072321|FG010|Stage 3|Disease Progression|0|||
131120346|NCT00467779|472072322|FG011|Stage 3|Disease Progression|0|||
131120347|NCT00467779|472072323|FG012|Stage 3|Disease Progression|0|||
131120348|NCT00467779|472072324|FG013|Stage 3|Disease Progression|0|||
131120349|NCT00467779|472072325|FG014|Stage 3|Disease Progression|9|||
131120350|NCT00467779|472072311|FG000|Stage 3|Unspecified Reason|0|||
131120351|NCT00467779|472072312|FG001|Stage 3|Unspecified Reason|0|||
131120352|NCT00467779|472072313|FG002|Stage 3|Unspecified Reason|0|||
131120353|NCT00467779|472072314|FG003|Stage 3|Unspecified Reason|0|||
131120354|NCT00467779|472072315|FG004|Stage 3|Unspecified Reason|0|||
131120355|NCT00467779|472072316|FG005|Stage 3|Unspecified Reason|0|||
131120356|NCT00467779|472072317|FG006|Stage 3|Unspecified Reason|0|||
131120357|NCT00467779|472072318|FG007|Stage 3|Unspecified Reason|0|||
131120358|NCT00467779|472072319|FG008|Stage 3|Unspecified Reason|0|||
131120359|NCT00467779|472072320|FG009|Stage 3|Unspecified Reason|0|||
131120360|NCT00467779|472072321|FG010|Stage 3|Unspecified Reason|0|||
131120361|NCT00467779|472072322|FG011|Stage 3|Unspecified Reason|0|||
131120362|NCT00467779|472072323|FG012|Stage 3|Unspecified Reason|0|||
131120363|NCT00467779|472072324|FG013|Stage 3|Unspecified Reason|0|||
131120364|NCT00467779|472072325|FG014|Stage 3|Unspecified Reason|5|||
131120365|NCT01195090|472072328|FG000|Overall Study|Adverse Event|1|||
131120366|NCT01195090|472072329|FG001|Overall Study|Adverse Event|2|||
131120367|NCT01195090|472072328|FG000|Overall Study|Lost to Follow-up|2|||
131120368|NCT01195090|472072329|FG001|Overall Study|Lost to Follow-up|2|||
131120369|NCT01195090|472072328|FG000|Overall Study|Protocol Violation|3|||
131120370|NCT01195090|472072329|FG001|Overall Study|Protocol Violation|4|||
131120371|NCT05111041|472072330|FG000|Overall Study|Lost to Follow-up|6|||
131120372|NCT05111041|472072331|FG001|Overall Study|Lost to Follow-up|7|||
131120373|NCT05111041|472072330|FG000|Overall Study|Withdrawal by Subject|1|||
131120374|NCT05111041|472072331|FG001|Overall Study|Withdrawal by Subject|0|||
131120375|NCT01205230|472072332|FG000|Overall Study|Adverse Event|4|||
131120376|NCT01205230|472072333|FG001|Overall Study|Adverse Event|0|||
131120377|NCT01205230|472072332|FG000|Overall Study|Physician Decision|1|||
131120378|NCT01205230|472072333|FG001|Overall Study|Physician Decision|0|||
131120379|NCT00041080|472072334|FG000|Overall Study|Adverse Event|21|||
131120380|NCT00041080|472072335|FG001|Overall Study|Adverse Event|1|||
131120381|NCT00041080|472072334|FG000|Overall Study|Withdrawal by Subject|6|||
131120382|NCT00041080|472072335|FG001|Overall Study|Withdrawal by Subject|6|||
131120383|NCT00041080|472072334|FG000|Overall Study|Concommitant Illness/Other|1|||
131223735|NCT04380701|472447122|FG013|Overall Study|Pregnancy|0|||
130930530|NCT00843024|471377606|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
131120384|NCT00041080|472072335|FG001|Overall Study|Concommitant Illness/Other|2|||
131120385|NCT00041080|472072334|FG000|Overall Study|Did not start therapy|1|||
131120386|NCT00041080|472072335|FG001|Overall Study|Did not start therapy|1|||
131223736|NCT04380701|472447123|FG014|Overall Study|Pregnancy|0|||
131223737|NCT04380701|472447124|FG015|Overall Study|Pregnancy|0|||
131120387|NCT00041080|472072334|FG000|Overall Study|Ineligible|1|||
131120388|NCT00041080|472072335|FG001|Overall Study|Ineligible|0|||
131120389|NCT00922480|472072336|FG000|Main Study|Protocol Violation|3|||
130930531|NCT00843024|471377607|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
130930532|NCT00843024|471377608|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
131120390|NCT00922480|472072337|FG001|Main Study|Protocol Violation|6|||
131120391|NCT00922480|472072336|FG000|Main Study|Adverse Event|6|||
131120392|NCT00922480|472072337|FG001|Main Study|Adverse Event|7|||
131120393|NCT00922480|472072336|FG000|Main Study|Lack of Efficacy|3|||
131223738|NCT04380701|472447125|FG016|Overall Study|Pregnancy|0|||
130930533|NCT00843024|471377609|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
130930534|NCT00843024|471377610|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
130930535|NCT00843024|471377611|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
130930536|NCT00843024|471377606|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
130930537|NCT00843024|471377607|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
130930538|NCT00843024|471377608|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
130930539|NCT00843024|471377609|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
130930540|NCT00843024|471377610|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
130930541|NCT00843024|471377611|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
130930542|NCT00843024|471377606|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
130930543|NCT00843024|471377607|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
130930544|NCT00843024|471377608|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
130930545|NCT00843024|471377609|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
130703557|NCT01933919|470539624|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
130703558|NCT01933919|470539623|FG000|Open-label Long-term Phase|Adverse Event|2|||
130703559|NCT01933919|470539624|FG001|Open-label Long-term Phase|Adverse Event|0|||
130703560|NCT01933919|470539623|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
130930546|NCT00843024|471377610|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
130930547|NCT00843024|471377611|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
130930548|NCT00843024|471377606|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
130930549|NCT00843024|471377607|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
130930550|NCT00843024|471377608|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
130930551|NCT00843024|471377609|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
130930552|NCT00843024|471377610|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
130930553|NCT00843024|471377611|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
130930554|NCT00843024|471377606|FG000|Single-blind Placebo Run-In Phase|Other|0|||
130930555|NCT00843024|471377607|FG001|Single-blind Placebo Run-In Phase|Other|1|||
130703561|NCT01933919|470539624|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
130703562|NCT01933919|470539623|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
130703563|NCT01933919|470539624|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
130703564|NCT01933919|470539623|FG000|Open-label Long-term Phase|Other|1|||
130703565|NCT01933919|470539624|FG001|Open-label Long-term Phase|Other|2|||
130703566|NCT02510261|470539631|FG000|Overall Study|Adverse Event|5|||
130930556|NCT00843024|471377608|FG002|Single-blind Placebo Run-In Phase|Other|0|||
130930557|NCT00843024|471377609|FG003|Single-blind Placebo Run-In Phase|Other|0|||
130703567|NCT02510261|470539632|FG001|Overall Study|Adverse Event|8|||
130703568|NCT02510261|470539633|FG002|Overall Study|Adverse Event|0|||
130703569|NCT02510261|470539631|FG000|Overall Study|Physician Decision|1|||
130703570|NCT02510261|470539632|FG001|Overall Study|Physician Decision|5|||
130703571|NCT02510261|470539633|FG002|Overall Study|Physician Decision|0|||
130703572|NCT02510261|470539631|FG000|Overall Study|Death|19|||
130703573|NCT02510261|470539632|FG001|Overall Study|Death|19|||
130703574|NCT02510261|470539633|FG002|Overall Study|Death|0|||
130703575|NCT02510261|470539631|FG000|Overall Study|Withdrawal by Subject|3|||
130703576|NCT02510261|470539632|FG001|Overall Study|Withdrawal by Subject|10|||
130703577|NCT02510261|470539633|FG002|Overall Study|Withdrawal by Subject|3|||
130703578|NCT01064531|470539635|FG000|Overall Study|Lost to Follow-up|0|||
130703579|NCT01064531|470539636|FG001|Overall Study|Lost to Follow-up|2|||
130703580|NCT01064531|470539635|FG000|Overall Study|Physician Decision|0|||
130703581|NCT01064531|470539636|FG001|Overall Study|Physician Decision|1|||
130703582|NCT01064531|470539635|FG000|Overall Study|Withdrawal by Subject|2|||
130703583|NCT01064531|470539636|FG001|Overall Study|Withdrawal by Subject|2|||
130703584|NCT01064531|470539635|FG000|Overall Study|Revision due to femoral stem loosening|1|||
130703585|NCT01064531|470539636|FG001|Overall Study|Revision due to femoral stem loosening|0|||
130703586|NCT01064531|470539635|FG000|Overall Study|Revision due to dislocation|0|||
130703587|NCT01064531|470539636|FG001|Overall Study|Revision due to dislocation|1|||
130703588|NCT01064531|470539635|FG000|Overall Study|Death|0|||
130930558|NCT00843024|471377610|FG004|Single-blind Placebo Run-In Phase|Other|0|||
130930559|NCT00843024|471377611|FG005|Single-blind Placebo Run-In Phase|Other|0|||
130703589|NCT01064531|470539636|FG001|Overall Study|Death|1|||
130703590|NCT03449199|470539637|FG000|Overall Study|Lost to Follow-up|1|||
130703591|NCT03449199|470539638|FG001|Overall Study|Lost to Follow-up|1|||
130703592|NCT03449199|470539639|FG002|Overall Study|Lost to Follow-up|0|||
130703593|NCT03449199|470539637|FG000|Overall Study|Protocol Deviation|0|||
130703594|NCT03449199|470539638|FG001|Overall Study|Protocol Deviation|0|||
130703595|NCT03449199|470539639|FG002|Overall Study|Protocol Deviation|1|||
130930560|NCT00843024|471377606|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
130930561|NCT00843024|471377607|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
130930562|NCT00843024|471377608|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
130703596|NCT03449199|470539637|FG000|Overall Study|Withdrawal by Subject|0|||
130703597|NCT03449199|470539638|FG001|Overall Study|Withdrawal by Subject|0|||
130703598|NCT03449199|470539639|FG002|Overall Study|Withdrawal by Subject|1|||
130930563|NCT00843024|471377609|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
130930564|NCT00843024|471377610|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
130930565|NCT00843024|471377611|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
130930566|NCT00843024|471377606|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130930567|NCT00843024|471377607|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
130930568|NCT00843024|471377608|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
130930569|NCT00843024|471377609|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
130930570|NCT00843024|471377610|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
130930571|NCT00843024|471377611|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
130930572|NCT00843024|471377606|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130930573|NCT00843024|471377607|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130930574|NCT00843024|471377608|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130930575|NCT00843024|471377609|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
130930576|NCT00843024|471377610|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130930577|NCT00843024|471377611|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
130930578|NCT00843024|471377606|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
130930579|NCT00843024|471377607|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
130930580|NCT00843024|471377608|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
130930581|NCT00843024|471377609|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
130930582|NCT00843024|471377610|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
130930583|NCT00843024|471377611|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
130930584|NCT00843024|471377606|FG000|Double-blind Treatment Phase|Physician Decision|0|||
130930585|NCT00843024|471377607|FG001|Double-blind Treatment Phase|Physician Decision|0|||
130930586|NCT00843024|471377608|FG002|Double-blind Treatment Phase|Physician Decision|0|||
130930587|NCT00843024|471377609|FG003|Double-blind Treatment Phase|Physician Decision|3|||
130930588|NCT00843024|471377610|FG004|Double-blind Treatment Phase|Physician Decision|1|||
130930589|NCT00843024|471377611|FG005|Double-blind Treatment Phase|Physician Decision|1|||
130930590|NCT00843024|471377606|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130930591|NCT00843024|471377607|FG001|Double-blind Treatment Phase|Adverse Event|0|||
130930592|NCT00843024|471377608|FG002|Double-blind Treatment Phase|Adverse Event|0|||
130930593|NCT00843024|471377609|FG003|Double-blind Treatment Phase|Adverse Event|0|||
130930594|NCT00843024|471377610|FG004|Double-blind Treatment Phase|Adverse Event|1|||
130930595|NCT00843024|471377611|FG005|Double-blind Treatment Phase|Adverse Event|1|||
130930596|NCT00843024|471377606|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
130930597|NCT00843024|471377607|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
130930598|NCT00843024|471377608|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
130930599|NCT00843024|471377609|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
130930600|NCT00843024|471377610|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
130930601|NCT00843024|471377611|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
130930602|NCT02439138|471377613|FG000|Overall Study|Adverse Event|1|||
130930603|NCT02439138|471377613|FG000|Overall Study|PI decision to terminate the study|2|||
130930604|NCT02615145|471377618|FG000|Overall Study|Did Not Start Treatment|0|||
130930605|NCT02615145|471377619|FG001|Overall Study|Did Not Start Treatment|0|||
130930606|NCT02615145|471377620|FG002|Overall Study|Did Not Start Treatment|1|||
130930607|NCT02615145|471377621|FG003|Overall Study|Did Not Start Treatment|1|||
130930608|NCT02615145|471377618|FG000|Overall Study|Failure to Return|20|||
130930609|NCT02615145|471377619|FG001|Overall Study|Failure to Return|10|||
130930610|NCT02615145|471377620|FG002|Overall Study|Failure to Return|7|||
130930611|NCT02615145|471377621|FG003|Overall Study|Failure to Return|0|||
130930612|NCT02615145|471377618|FG000|Overall Study|Death|2|||
130930613|NCT02615145|471377619|FG001|Overall Study|Death|3|||
130930614|NCT02615145|471377620|FG002|Overall Study|Death|0|||
130930615|NCT02615145|471377621|FG003|Overall Study|Death|0|||
130930616|NCT02615145|471377618|FG000|Overall Study|Other, Not Specified|5|||
130930617|NCT02615145|471377619|FG001|Overall Study|Other, Not Specified|2|||
130930618|NCT02615145|471377620|FG002|Overall Study|Other, Not Specified|0|||
130930619|NCT02615145|471377621|FG003|Overall Study|Other, Not Specified|0|||
130930620|NCT00006237|471377622|FG000|Overall Study|Adverse Event|39|||
130930621|NCT00006237|471377623|FG001|Overall Study|Adverse Event|29|||
130930622|NCT00006237|471377622|FG000|Overall Study|Death|1|||
130930623|NCT00006237|471377623|FG001|Overall Study|Death|0|||
130930624|NCT00006237|471377622|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
130930625|NCT00006237|471377623|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
130930626|NCT00006237|471377622|FG000|Overall Study|Progression/relapse|54|||
130703599|NCT02618382|470539641|FG000|Overall Study|Physician Decision|1|||
130930627|NCT00006237|471377623|FG001|Overall Study|Progression/relapse|2|||
130930628|NCT00006237|471377622|FG000|Overall Study|Not eligible|9|||
130930629|NCT00006237|471377623|FG001|Overall Study|Not eligible|20|||
130930630|NCT00006237|471377622|FG000|Overall Study|Withdrawal by Subject|0|||
130930631|NCT00006237|471377623|FG001|Overall Study|Withdrawal by Subject|1|||
130930632|NCT00006237|471377622|FG000|Overall Study|Not protocol specified|14|||
130930633|NCT00006237|471377623|FG001|Overall Study|Not protocol specified|5|||
130930634|NCT01846416|471377628|FG000|Treatment Phase|Death|2|||
130703600|NCT02618382|470539641|FG000|Overall Study|Withdrawal by Subject|1|||
130930635|NCT01846416|471377629|FG001|Treatment Phase|Death|9|||
130930636|NCT01846416|471377630|FG002|Treatment Phase|Death|1|||
130930637|NCT01846416|471377628|FG000|Treatment Phase|Withdrawal by Subject|2|||
130930638|NCT01846416|471377629|FG001|Treatment Phase|Withdrawal by Subject|4|||
130930639|NCT01846416|471377630|FG002|Treatment Phase|Withdrawal by Subject|2|||
130930640|NCT01846416|471377628|FG000|Treatment Phase|Other|1|||
130930641|NCT01846416|471377629|FG001|Treatment Phase|Other|5|||
130930642|NCT01846416|471377630|FG002|Treatment Phase|Other|1|||
130930643|NCT01846416|471377628|FG000|Treatment Phase|Physician Decision|1|||
130930644|NCT01846416|471377629|FG001|Treatment Phase|Physician Decision|2|||
130930645|NCT01846416|471377630|FG002|Treatment Phase|Physician Decision|0|||
130930646|NCT01846416|471377628|FG000|Treatment Phase|Adverse Event|3|||
130930647|NCT01846416|471377629|FG001|Treatment Phase|Adverse Event|4|||
130930648|NCT01846416|471377630|FG002|Treatment Phase|Adverse Event|0|||
130930649|NCT01846416|471377628|FG000|Treatment Phase|Non-compliance|0|||
130930650|NCT01846416|471377629|FG001|Treatment Phase|Non-compliance|2|||
130930651|NCT01846416|471377630|FG002|Treatment Phase|Non-compliance|0|||
130930652|NCT01846416|471377628|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
130930653|NCT01846416|471377629|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
130930654|NCT01846416|471377630|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
130930655|NCT01846416|471377628|FG000|Treatment Phase|Progressive Disease|21|||
130930656|NCT01846416|471377629|FG001|Treatment Phase|Progressive Disease|63|||
130930657|NCT01846416|471377630|FG002|Treatment Phase|Progressive Disease|9|||
130930658|NCT01846416|471377628|FG000|Survival Follow-up|Death|21|||
130930659|NCT01846416|471377629|FG001|Survival Follow-up|Death|62|||
130930660|NCT01846416|471377630|FG002|Survival Follow-up|Death|9|||
130930661|NCT01846416|471377628|FG000|Survival Follow-up|Lost to Follow-up|0|||
130930662|NCT01846416|471377629|FG001|Survival Follow-up|Lost to Follow-up|2|||
130930663|NCT01846416|471377630|FG002|Survival Follow-up|Lost to Follow-up|2|||
130930664|NCT01846416|471377628|FG000|Survival Follow-up|Withdrawal by Subject|2|||
130930665|NCT01846416|471377629|FG001|Survival Follow-up|Withdrawal by Subject|7|||
130930666|NCT01846416|471377630|FG002|Survival Follow-up|Withdrawal by Subject|0|||
130930667|NCT01846416|471377628|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
130930668|NCT01846416|471377629|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
130930669|NCT01846416|471377630|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
130930670|NCT01846416|471377628|FG000|Survival Follow-up|Other|3|||
130930671|NCT01846416|471377629|FG001|Survival Follow-up|Other|1|||
130930672|NCT01846416|471377630|FG002|Survival Follow-up|Other|1|||
130930673|NCT02207244|471377631|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
130930674|NCT02207244|471377632|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
130930675|NCT02207244|471377633|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
130930676|NCT02207244|471377634|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130930677|NCT02207244|471377635|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130930678|NCT02207244|471377636|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130930679|NCT02207244|471377637|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130930680|NCT02207244|471377638|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130930681|NCT02207244|471377639|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130930682|NCT02207244|471377640|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130930683|NCT02207244|471377641|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
130930684|NCT02207244|471377631|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
130930685|NCT02207244|471377632|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130930686|NCT02207244|471377633|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
130930687|NCT02207244|471377634|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130930688|NCT02207244|471377635|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130930689|NCT02207244|471377636|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130930690|NCT02207244|471377637|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130930691|NCT02207244|471377638|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130930692|NCT02207244|471377639|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130930693|NCT02207244|471377640|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130930694|NCT02207244|471377641|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
130930695|NCT02207244|471377631|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
130930696|NCT02207244|471377632|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
130930697|NCT02207244|471377633|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
130770530|NCT02178358|470786118|FG002|Overall Study|Lost to Follow-up|0|||
130930698|NCT02207244|471377634|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130930699|NCT02207244|471377635|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
131120394|NCT00922480|472072337|FG001|Main Study|Lack of Efficacy|0|||
131120395|NCT00922480|472072336|FG000|Main Study|Withdrawal by Subject|20|||
130930700|NCT02207244|471377636|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130930701|NCT02207244|471377637|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130930702|NCT02207244|471377638|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130930703|NCT02207244|471377639|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130930704|NCT02207244|471377640|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130930705|NCT02207244|471377641|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
130930706|NCT02207244|471377631|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
130930707|NCT02207244|471377632|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
130930708|NCT02207244|471377633|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130930709|NCT02207244|471377634|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130930710|NCT02207244|471377635|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130930711|NCT02207244|471377636|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130930712|NCT02207244|471377637|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130930713|NCT02207244|471377638|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130930714|NCT02207244|471377639|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130930715|NCT02207244|471377640|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130930716|NCT02207244|471377641|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
130930717|NCT02207244|471377631|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
130930718|NCT02207244|471377632|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
130930719|NCT02207244|471377633|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
130930720|NCT02207244|471377634|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130930721|NCT02207244|471377635|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130930722|NCT02207244|471377636|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130930723|NCT02207244|471377637|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130930724|NCT02207244|471377638|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130930725|NCT02207244|471377639|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130930726|NCT02207244|471377640|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130930727|NCT02207244|471377641|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130930728|NCT02207244|471377631|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130930729|NCT02207244|471377632|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
130930730|NCT02207244|471377633|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
130930731|NCT02207244|471377634|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130930732|NCT02207244|471377635|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130930733|NCT02207244|471377636|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130930734|NCT02207244|471377637|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130930735|NCT02207244|471377638|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130930736|NCT02207244|471377639|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130930737|NCT02207244|471377640|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130930738|NCT02207244|471377641|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
130930739|NCT02207244|471377631|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
130930740|NCT02207244|471377632|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
130930741|NCT02207244|471377633|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
130930742|NCT02207244|471377634|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
130930743|NCT02207244|471377635|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
130930744|NCT02207244|471377636|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
130930745|NCT02207244|471377637|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
130930746|NCT02207244|471377638|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
130930747|NCT02207244|471377639|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
130930748|NCT02207244|471377640|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
130930749|NCT02207244|471377641|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
130930750|NCT02207244|471377631|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130930751|NCT02207244|471377632|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130930752|NCT02207244|471377633|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130930753|NCT02207244|471377634|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130930754|NCT02207244|471377635|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
130930755|NCT02207244|471377636|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
130930756|NCT02207244|471377637|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130930757|NCT02207244|471377638|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130930758|NCT02207244|471377639|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130930759|NCT02207244|471377640|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130930760|NCT02207244|471377641|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
130930761|NCT02207244|471377631|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130930762|NCT02207244|471377632|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130930763|NCT02207244|471377633|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131223739|NCT04380701|472447126|FG017|Overall Study|Pregnancy|0|||
130930764|NCT02207244|471377634|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130930765|NCT02207244|471377635|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130930766|NCT02207244|471377636|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
130930767|NCT02207244|471377637|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
131223740|NCT04380701|472447127|FG018|Overall Study|Pregnancy|0|||
130930768|NCT02207244|471377638|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130930769|NCT02207244|471377639|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130930770|NCT02207244|471377640|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130930771|NCT02207244|471377641|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
130930772|NCT02207244|471377631|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130930773|NCT02207244|471377632|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130930774|NCT02207244|471377633|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130930775|NCT02207244|471377634|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
130930776|NCT02207244|471377635|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
130930777|NCT02207244|471377636|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
130930778|NCT02207244|471377637|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130930779|NCT02207244|471377638|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130930780|NCT02207244|471377639|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130930781|NCT02207244|471377640|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130930782|NCT02207244|471377641|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
130930783|NCT02207244|471377631|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130930784|NCT02207244|471377632|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130930785|NCT02207244|471377633|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130930786|NCT02207244|471377634|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
130930787|NCT02207244|471377635|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
130930788|NCT02207244|471377636|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
130930789|NCT02207244|471377637|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130930790|NCT02207244|471377638|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130930791|NCT02207244|471377639|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130930792|NCT02207244|471377640|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130930793|NCT02207244|471377641|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
130930794|NCT02207244|471377631|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130930795|NCT02207244|471377632|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130930796|NCT02207244|471377633|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130930797|NCT02207244|471377634|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
130930798|NCT02207244|471377635|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130930799|NCT02207244|471377636|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
130930800|NCT02207244|471377637|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130930801|NCT02207244|471377638|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130930802|NCT02207244|471377639|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130930803|NCT02207244|471377640|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130930804|NCT02207244|471377641|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
130930805|NCT02207244|471377631|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
130930806|NCT02207244|471377632|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
130930807|NCT02207244|471377633|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
130930808|NCT02207244|471377634|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
130703601|NCT02618382|470539641|FG000|Overall Study|Protocol Violation|1|||
130703602|NCT03235479|470539644|FG000|Overall Study|Lost to Follow-up|8|||
130703603|NCT03235479|470539645|FG001|Overall Study|Lost to Follow-up|11|||
130703604|NCT03235479|470539644|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
130703605|NCT03235479|470539645|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
130703606|NCT03235479|470539644|FG000|Overall Study|Pregnancy|1|||
130703607|NCT03235479|470539645|FG001|Overall Study|Pregnancy|0|||
130703608|NCT03235479|470539644|FG000|Overall Study|Protocol Deviation|1|||
130703609|NCT03235479|470539645|FG001|Overall Study|Protocol Deviation|3|||
130703610|NCT03235479|470539644|FG000|Overall Study|Technical Problems|3|||
130703611|NCT03235479|470539645|FG001|Overall Study|Technical Problems|2|||
130703612|NCT03235479|470539644|FG000|Overall Study|Withdrawal by Subject|2|||
130703613|NCT03235479|470539645|FG001|Overall Study|Withdrawal by Subject|2|||
130703614|NCT03235479|470539644|FG000|Overall Study|Other Reasons|3|||
130703615|NCT03235479|470539645|FG001|Overall Study|Other Reasons|5|||
130703616|NCT00309985|470539648|FG000|Overall Study|Disease progression|12|||
130703617|NCT00309985|470539649|FG001|Overall Study|Disease progression|0|||
130703618|NCT00309985|470539648|FG000|Overall Study|Adverse Event|30|||
130703619|NCT00309985|470539649|FG001|Overall Study|Adverse Event|0|||
130703620|NCT00309985|470539648|FG000|Overall Study|Death|2|||
130703621|NCT00309985|470539649|FG001|Overall Study|Death|0|||
130703622|NCT00309985|470539648|FG000|Overall Study|Withdrawal by Subject|5|||
130703623|NCT00309985|470539649|FG001|Overall Study|Withdrawal by Subject|1|||
130703624|NCT00309985|470539648|FG000|Overall Study|Physician Decision|3|||
130703625|NCT00309985|470539649|FG001|Overall Study|Physician Decision|0|||
130703626|NCT00309985|470539648|FG000|Overall Study|Never started treatment|7|||
130703627|NCT00309985|470539649|FG001|Overall Study|Never started treatment|0|||
130703628|NCT00309985|470539648|FG000|Overall Study|Complicating disease|1|||
130770531|NCT01066663|470786119|FG000|Overall Study|Adverse Event|0|||
130770532|NCT01066663|470786120|FG001|Overall Study|Adverse Event|0|||
130770533|NCT01066663|470786121|FG002|Overall Study|Adverse Event|1|||
130770534|NCT02985021|470786122|FG000|Overall Study|Inability to comply with study procedures|1|||
130770535|NCT01090050|470786123|FG000|Overall Study|Lost to Follow-up|0|||
130770536|NCT01090050|470786124|FG001|Overall Study|Lost to Follow-up|1|||
130770537|NCT01090050|470786123|FG000|Overall Study|Lack of Efficacy|1|||
130770538|NCT01090050|470786124|FG001|Overall Study|Lack of Efficacy|5|||
130770539|NCT01090050|470786123|FG000|Overall Study|Physician Decision|0|||
130770540|NCT01090050|470786124|FG001|Overall Study|Physician Decision|1|||
130770541|NCT02232061|470786125|FG000|Overall Study|Administrative problems|1|||
130770542|NCT02232061|470786125|FG000|Overall Study|Withdrawal by Subject|1|||
130770543|NCT00560703|470786127|FG000|Overall Study|Adverse Event|0|||
130770544|NCT00560703|470786128|FG001|Overall Study|Adverse Event|2|||
130770545|NCT00560703|470786127|FG000|Overall Study|Protocol Violation|0|||
130770546|NCT00560703|470786128|FG001|Overall Study|Protocol Violation|2|||
130770547|NCT00560703|470786127|FG000|Overall Study|Withdrawal by Subject|0|||
130770548|NCT00560703|470786128|FG001|Overall Study|Withdrawal by Subject|1|||
130770549|NCT00560703|470786127|FG000|Overall Study|non-compliance|0|||
130770550|NCT00560703|470786128|FG001|Overall Study|non-compliance|1|||
130770551|NCT00790556|470786130|FG000|Treatment Period 1|Physician Decision|1|||
130770552|NCT00790556|470786131|FG001|Treatment Period 1|Physician Decision|0|||
130770553|NCT00790556|470786130|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130770554|NCT00790556|470786131|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130770555|NCT00339833|470786134|FG000|Overall Study|Withdrawal by Subject|1|||
130770556|NCT00339833|470786135|FG001|Overall Study|Withdrawal by Subject|2|||
130770557|NCT00339833|470786134|FG000|Overall Study|toothache|0|||
130770558|NCT00339833|470786135|FG001|Overall Study|toothache|1|||
130770559|NCT00339833|470786134|FG000|Overall Study|indigestion|0|||
130770560|NCT00339833|470786135|FG001|Overall Study|indigestion|1|||
130770561|NCT00339833|470786134|FG000|Overall Study|Chest pain|0|||
130770562|NCT00339833|470786135|FG001|Overall Study|Chest pain|1|||
130770563|NCT00339833|470786134|FG000|Overall Study|minor infection|0|||
130770564|NCT00339833|470786135|FG001|Overall Study|minor infection|1|||
130703629|NCT00309985|470539649|FG001|Overall Study|Complicating disease|0|||
130930809|NCT02207244|471377635|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
130930810|NCT02207244|471377636|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
130930811|NCT02207244|471377637|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
130930812|NCT02207244|471377638|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
130930813|NCT02207244|471377639|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
130930814|NCT02207244|471377640|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
130930815|NCT02207244|471377641|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
130930816|NCT02207244|471377631|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130930817|NCT02207244|471377632|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130930818|NCT02207244|471377633|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130930819|NCT02207244|471377634|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130930820|NCT02207244|471377635|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130703630|NCT00309985|470539648|FG000|Overall Study|Non-compliance|1|||
130703631|NCT00309985|470539649|FG001|Overall Study|Non-compliance|0|||
130703632|NCT00309985|470539648|FG000|Overall Study|Chemotherapy discontinued only|1|||
130703633|NCT00309985|470539649|FG001|Overall Study|Chemotherapy discontinued only|0|||
130703634|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
130703635|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
130703636|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
130703637|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
130703638|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
130703639|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
130703640|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130703641|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130703642|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
130703643|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
130770565|NCT00339833|470786134|FG000|Overall Study|Poor venous access|2|||
130770566|NCT00339833|470786135|FG001|Overall Study|Poor venous access|2|||
130770567|NCT00339833|470786134|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
130770568|NCT00339833|470786135|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
130770569|NCT00339833|470786134|FG000|Overall Study|Error in data records|1|||
130770570|NCT00339833|470786135|FG001|Overall Study|Error in data records|0|||
130930821|NCT02207244|471377636|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130703644|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
130703645|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130770571|NCT00482170|470786138|FG000|Overall Study|Adverse Event|5|||
130770572|NCT00482170|470786139|FG001|Overall Study|Adverse Event|14|||
130770573|NCT00482170|470786138|FG000|Overall Study|Withdrawal by Subject|6|||
130770574|NCT00482170|470786139|FG001|Overall Study|Withdrawal by Subject|1|||
130770575|NCT00482170|470786138|FG000|Overall Study|Protocol Violation|2|||
130770576|NCT00482170|470786139|FG001|Overall Study|Protocol Violation|3|||
130703646|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
130703647|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
130703648|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130703649|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130703650|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Death|2|||
130703651|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Death|1|||
130703652|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Death|0|||
130703653|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Death|0|||
130703654|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
130703655|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
130703656|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
130703657|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
130703658|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
130703659|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
130703660|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
130703661|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
130703662|NCT03110380|470539659|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
130703663|NCT03110380|470539660|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
130703664|NCT03110380|470539661|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
130703665|NCT03110380|470539662|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
130703666|NCT03110380|470539659|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
130703667|NCT03110380|470539660|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
130703668|NCT03110380|470539661|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
130703669|NCT03110380|470539662|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
130703670|NCT03110380|470539659|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
130703671|NCT03110380|470539660|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
130703672|NCT03110380|470539661|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
130703673|NCT03110380|470539662|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
130703674|NCT03110380|470539659|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
130703675|NCT03110380|470539660|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
130703676|NCT03110380|470539661|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
130703677|NCT03110380|470539662|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
130703678|NCT01355302|470539665|FG000|Phase 1b|Death|4|||
130703679|NCT01355302|470539666|FG001|Phase 1b|Death|0|||
130703680|NCT01355302|470539667|FG002|Phase 1b|Death|0|||
130703681|NCT01355302|470539665|FG000|Phase 1b|Study terminated by sponsor|2|||
130703682|NCT01355302|470539666|FG001|Phase 1b|Study terminated by sponsor|0|||
130703683|NCT01355302|470539667|FG002|Phase 1b|Study terminated by sponsor|0|||
130703684|NCT00693225|470539668|FG000|Overall Study|Lost to Follow-up|1|||
130703685|NCT00693225|470539669|FG001|Overall Study|Lost to Follow-up|2|||
130703686|NCT00693225|470539668|FG000|Overall Study|Adverse Event|1|||
130703687|NCT00693225|470539669|FG001|Overall Study|Adverse Event|3|||
130703688|NCT02531594|470539670|FG000|Overall Study|Withdrawal by Subject|7|||
130703689|NCT02531594|470539671|FG001|Overall Study|Withdrawal by Subject|8|||
130703690|NCT03750695|470539674|FG000|Overall Study|Lost to Follow-up|0|||
130703691|NCT03750695|470539675|FG001|Overall Study|Lost to Follow-up|1|||
130703692|NCT03843125|470539676|FG000|Overall Study|Adverse Event|17|||
130703693|NCT03843125|470539677|FG001|Overall Study|Adverse Event|13|||
130703694|NCT03843125|470539678|FG002|Overall Study|Adverse Event|5|||
130703695|NCT03843125|470539679|FG003|Overall Study|Adverse Event|9|||
130703696|NCT03843125|470539676|FG000|Overall Study|Death|0|||
130703697|NCT03843125|470539677|FG001|Overall Study|Death|6|||
130703698|NCT03843125|470539678|FG002|Overall Study|Death|2|||
130703699|NCT03843125|470539679|FG003|Overall Study|Death|0|||
130703700|NCT03843125|470539676|FG000|Overall Study|Lack of Efficacy|14|||
130703701|NCT03843125|470539677|FG001|Overall Study|Lack of Efficacy|11|||
130703702|NCT03843125|470539678|FG002|Overall Study|Lack of Efficacy|9|||
130703703|NCT03843125|470539679|FG003|Overall Study|Lack of Efficacy|4|||
130703704|NCT03843125|470539676|FG000|Overall Study|Lost to Follow-up|3|||
130703705|NCT03843125|470539677|FG001|Overall Study|Lost to Follow-up|4|||
130703706|NCT03843125|470539678|FG002|Overall Study|Lost to Follow-up|0|||
130703707|NCT03843125|470539679|FG003|Overall Study|Lost to Follow-up|2|||
130930822|NCT02207244|471377637|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
130930823|NCT02207244|471377638|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
130930824|NCT02207244|471377639|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
130930825|NCT02207244|471377640|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
130930826|NCT02207244|471377641|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
130930827|NCT02207244|471377631|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
131034934|NCT03544281|471761838|FG013|Main Study Phase|Physician Decision|0|||
131034935|NCT03544281|471761839|FG014|Main Study Phase|Physician Decision|0|||
130703708|NCT03843125|470539676|FG000|Overall Study|Other|12|||
130703709|NCT03843125|470539677|FG001|Overall Study|Other|14|||
130703710|NCT03843125|470539678|FG002|Overall Study|Other|3|||
130703711|NCT03843125|470539679|FG003|Overall Study|Other|4|||
130930828|NCT02207244|471377632|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130930829|NCT02207244|471377633|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130930830|NCT02207244|471377634|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130930831|NCT02207244|471377635|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130930832|NCT02207244|471377636|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130930833|NCT02207244|471377637|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130930834|NCT02207244|471377638|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
130930835|NCT02207244|471377639|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130930836|NCT02207244|471377640|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130930837|NCT02207244|471377641|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
130930838|NCT02207244|471377631|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130703712|NCT03843125|470539676|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
130703713|NCT03843125|470539677|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
130703714|NCT03843125|470539678|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
130703715|NCT03843125|470539679|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
130930839|NCT02207244|471377632|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130930840|NCT02207244|471377633|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130930841|NCT02207244|471377634|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130930842|NCT02207244|471377635|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130930843|NCT02207244|471377636|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130930844|NCT02207244|471377637|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
130930845|NCT02207244|471377638|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
130930846|NCT02207244|471377639|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
130930847|NCT02207244|471377640|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
130930848|NCT02207244|471377641|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
130930849|NCT02207244|471377631|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130930850|NCT02207244|471377632|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130930851|NCT02207244|471377633|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130930852|NCT02207244|471377634|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130930853|NCT02207244|471377635|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130930854|NCT02207244|471377636|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130930855|NCT02207244|471377637|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
130930856|NCT02207244|471377638|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
130930857|NCT02207244|471377639|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130930858|NCT02207244|471377640|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
130930859|NCT02207244|471377641|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
130930860|NCT02207244|471377631|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130930861|NCT02207244|471377632|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130930862|NCT02207244|471377633|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130930863|NCT02207244|471377634|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130930864|NCT02207244|471377635|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130930865|NCT02207244|471377636|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130930866|NCT02207244|471377637|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
130930867|NCT02207244|471377638|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
130930868|NCT02207244|471377639|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
130930869|NCT02207244|471377640|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
130703716|NCT03843125|470539676|FG000|Overall Study|Study Terminated by Sponsor|318|||
130703717|NCT03843125|470539677|FG001|Overall Study|Study Terminated by Sponsor|318|||
130930870|NCT02207244|471377641|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130930871|NCT02207244|471377631|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130930872|NCT02207244|471377632|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130930873|NCT02207244|471377633|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130930874|NCT02207244|471377634|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130930875|NCT02207244|471377635|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130930876|NCT02207244|471377636|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130930877|NCT02207244|471377637|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130930878|NCT02207244|471377638|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
130930879|NCT02207244|471377639|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
130930880|NCT02207244|471377640|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130930881|NCT02207244|471377641|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130930882|NCT02207244|471377631|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130930883|NCT02207244|471377632|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130930884|NCT02207244|471377633|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130703718|NCT03843125|470539678|FG002|Overall Study|Study Terminated by Sponsor|163|||
130703719|NCT03843125|470539679|FG003|Overall Study|Study Terminated by Sponsor|163|||
130930885|NCT02207244|471377634|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130930886|NCT02207244|471377635|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130930887|NCT02207244|471377636|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130930888|NCT02207244|471377637|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130930889|NCT02207244|471377638|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130930890|NCT02207244|471377639|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
130930891|NCT02207244|471377640|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130930892|NCT02207244|471377641|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
130930893|NCT02207244|471377631|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130930894|NCT02207244|471377632|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130930895|NCT02207244|471377633|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130930896|NCT02207244|471377634|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130770577|NCT00482170|470786138|FG000|Overall Study|Lost to Follow-up|2|||
130770578|NCT00482170|470786139|FG001|Overall Study|Lost to Follow-up|0|||
130770579|NCT00482170|470786138|FG000|Overall Study|Unspecified reason|0|||
130770580|NCT00482170|470786139|FG001|Overall Study|Unspecified reason|2|||
130770581|NCT00162097|470786140|FG000|Overall Study|Participant no longer met study criteria|0|||
130770582|NCT00162097|470786141|FG001|Overall Study|Participant no longer met study criteria|0|||
130770583|NCT00162097|470786142|FG002|Overall Study|Participant no longer met study criteria|0|||
130770584|NCT00162097|470786143|FG003|Overall Study|Participant no longer met study criteria|1|||
130770585|NCT03585712|470786146|FG000|Treatment Period 1|Protocol Violation|1|||
130770586|NCT03585712|470786147|FG001|Treatment Period 1|Protocol Violation|0|||
130770587|NCT03585712|470786148|FG002|Treatment Period 1|Protocol Violation|0|||
130770588|NCT03585712|470786146|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
130770589|NCT03585712|470786147|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
130770590|NCT03585712|470786148|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
130770591|NCT03585712|470786146|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
130770592|NCT03585712|470786147|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
130770593|NCT03585712|470786148|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
130770594|NCT03585712|470786146|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
130770595|NCT03585712|470786147|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
130770596|NCT03585712|470786148|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
130770597|NCT03004924|470786155|FG000|Overall Study|Adverse Event|6|||
130770598|NCT03004924|470786156|FG001|Overall Study|Adverse Event|5|||
130770599|NCT03004924|470786157|FG002|Overall Study|Adverse Event|10|||
130930897|NCT02207244|471377635|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130770600|NCT03004924|470786155|FG000|Overall Study|Protocol Violation|4|||
130930898|NCT02207244|471377636|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130930899|NCT02207244|471377637|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130930900|NCT02207244|471377638|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
130930901|NCT02207244|471377639|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130930902|NCT02207244|471377640|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130930903|NCT02207244|471377641|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
130930904|NCT02207244|471377631|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130930905|NCT02207244|471377632|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130930906|NCT02207244|471377633|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130930907|NCT02207244|471377634|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130930908|NCT02207244|471377635|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130930909|NCT02207244|471377636|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130930910|NCT02207244|471377637|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
130930911|NCT02207244|471377638|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130930912|NCT02207244|471377639|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130930913|NCT02207244|471377640|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130930914|NCT02207244|471377641|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
130930915|NCT02207244|471377631|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130930916|NCT02207244|471377632|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130930917|NCT02207244|471377633|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130930918|NCT02207244|471377634|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130930919|NCT02207244|471377635|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130930920|NCT02207244|471377636|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130930921|NCT02207244|471377637|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130930922|NCT02207244|471377638|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130930923|NCT02207244|471377639|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
130930924|NCT02207244|471377640|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
130770601|NCT03004924|470786156|FG001|Overall Study|Protocol Violation|0|||
130770602|NCT03004924|470786157|FG002|Overall Study|Protocol Violation|1|||
130703720|NCT03843125|470539676|FG000|Overall Study|Withdrawal by Subject|23|||
130703721|NCT03843125|470539677|FG001|Overall Study|Withdrawal by Subject|12|||
130703722|NCT03843125|470539678|FG002|Overall Study|Withdrawal by Subject|6|||
130703723|NCT03843125|470539679|FG003|Overall Study|Withdrawal by Subject|9|||
130703724|NCT03843125|470539676|FG000|Overall Study|Missing data|0|||
130703725|NCT03843125|470539677|FG001|Overall Study|Missing data|1|||
130703726|NCT03843125|470539678|FG002|Overall Study|Missing data|1|||
130703727|NCT03843125|470539679|FG003|Overall Study|Missing data|0|||
130703728|NCT03173560|470539680|FG000|Overall Study|Death|70|||
130703729|NCT03173560|470539681|FG001|Overall Study|Death|60|||
130703730|NCT03173560|470539680|FG000|Overall Study|Lost to Follow-up|1|||
130703731|NCT03173560|470539681|FG001|Overall Study|Lost to Follow-up|4|||
130703732|NCT03173560|470539680|FG000|Overall Study|Withdrawal by Subject|10|||
130703733|NCT03173560|470539681|FG001|Overall Study|Withdrawal by Subject|5|||
130703734|NCT03173560|470539680|FG000|Overall Study|Other|0|||
130703735|NCT03173560|470539681|FG001|Overall Study|Other|1|||
130703736|NCT04254809|470539683|FG000|Overall Study|Lost to Follow-up|5|||
130703737|NCT04254809|470539684|FG001|Overall Study|Lost to Follow-up|10|||
130703738|NCT04480307|470539685|FG000|Overall Study|Withdrawal by Subject|0|||
130703739|NCT04480307|470539686|FG001|Overall Study|Withdrawal by Subject|1|||
130703740|NCT04480307|470539687|FG002|Overall Study|Withdrawal by Subject|0|||
130703741|NCT04480307|470539688|FG003|Overall Study|Withdrawal by Subject|0|||
130703742|NCT04480307|470539685|FG000|Overall Study|Adverse Event|0|||
130703743|NCT04480307|470539686|FG001|Overall Study|Adverse Event|0|||
130703744|NCT04480307|470539687|FG002|Overall Study|Adverse Event|0|||
130930925|NCT02207244|471377641|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
130930926|NCT02207244|471377631|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130930927|NCT02207244|471377632|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130930928|NCT02207244|471377633|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130930929|NCT02207244|471377634|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130930930|NCT02207244|471377635|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130930931|NCT02207244|471377636|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130930932|NCT02207244|471377637|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130930933|NCT02207244|471377638|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130930934|NCT02207244|471377639|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
131034936|NCT03544281|471761840|FG015|Main Study Phase|Physician Decision|0|||
130930935|NCT02207244|471377640|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130930936|NCT02207244|471377641|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
130930937|NCT02207244|471377631|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130930938|NCT02207244|471377632|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130930939|NCT02207244|471377633|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130930940|NCT02207244|471377634|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130930941|NCT02207244|471377635|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130930942|NCT02207244|471377636|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130930943|NCT02207244|471377637|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130930944|NCT02207244|471377638|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130930945|NCT02207244|471377639|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
130930946|NCT02207244|471377640|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
130930947|NCT02207244|471377641|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
130930948|NCT02207244|471377631|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130930949|NCT02207244|471377632|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130930950|NCT02207244|471377633|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130930951|NCT02207244|471377634|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130930952|NCT02207244|471377635|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
131034937|NCT03544281|471761841|FG016|Main Study Phase|Physician Decision|0|||
131034938|NCT03544281|471761842|FG017|Main Study Phase|Physician Decision|0|||
131034939|NCT03544281|471761843|FG018|Main Study Phase|Physician Decision|0|||
130703745|NCT04480307|470539688|FG003|Overall Study|Adverse Event|1|||
130703746|NCT02608476|470539689|FG000|Overall Study|Withdrawal by Subject|30|||
130703747|NCT02608476|470539690|FG001|Overall Study|Withdrawal by Subject|37|||
130703748|NCT02608476|470539689|FG000|Overall Study|Lost to Follow-up|24|||
130703749|NCT02608476|470539690|FG001|Overall Study|Lost to Follow-up|24|||
130703750|NCT02608476|470539689|FG000|Overall Study|Adverse Event|2|||
130703751|NCT02608476|470539690|FG001|Overall Study|Adverse Event|8|||
130703752|NCT02608476|470539689|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
130703753|NCT02608476|470539690|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
130703754|NCT02608476|470539689|FG000|Overall Study|Noncompliance with treatment|1|||
130703755|NCT02608476|470539690|FG001|Overall Study|Noncompliance with treatment|5|||
130703756|NCT02608476|470539689|FG000|Overall Study|Lack of Efficacy|3|||
130703757|NCT02608476|470539690|FG001|Overall Study|Lack of Efficacy|1|||
130703758|NCT02608476|470539689|FG000|Overall Study|Other|0|||
130703759|NCT02608476|470539690|FG001|Overall Study|Other|1|||
130703760|NCT02608476|470539689|FG000|Overall Study|Physician Decision|1|||
130770603|NCT03004924|470786155|FG000|Overall Study|Withdrawal by Subject|5|||
130770604|NCT03004924|470786156|FG001|Overall Study|Withdrawal by Subject|3|||
130770605|NCT03004924|470786157|FG002|Overall Study|Withdrawal by Subject|5|||
131120396|NCT00922480|472072337|FG001|Main Study|Withdrawal by Subject|15|||
131120397|NCT00922480|472072336|FG000|Main Study|Lost to Follow-up|5|||
131120398|NCT00922480|472072337|FG001|Main Study|Lost to Follow-up|0|||
130770606|NCT03004924|470786155|FG000|Overall Study|Lost to Follow-up|6|||
130770607|NCT03004924|470786156|FG001|Overall Study|Lost to Follow-up|1|||
130770608|NCT03004924|470786157|FG002|Overall Study|Lost to Follow-up|4|||
130770609|NCT03004924|470786155|FG000|Overall Study|Lack of Efficacy|2|||
130770610|NCT03004924|470786156|FG001|Overall Study|Lack of Efficacy|4|||
130770611|NCT03004924|470786157|FG002|Overall Study|Lack of Efficacy|2|||
130770612|NCT03004924|470786155|FG000|Overall Study|Physician Decision|1|||
131120399|NCT00922480|472072336|FG000|Main Study|Physician Decision|0|||
131120400|NCT00922480|472072337|FG001|Main Study|Physician Decision|1|||
131120401|NCT00922480|472072336|FG000|Extension Study|Protocol Violation|3|||
131120402|NCT00922480|472072337|FG001|Extension Study|Protocol Violation|0|||
131120403|NCT00922480|472072336|FG000|Extension Study|Adverse Event|1|||
130770613|NCT03004924|470786156|FG001|Overall Study|Physician Decision|0|||
131120404|NCT00922480|472072337|FG001|Extension Study|Adverse Event|1|||
130703761|NCT02608476|470539690|FG001|Overall Study|Physician Decision|0|||
130703762|NCT02608476|470539689|FG000|Overall Study|Pregnancy|0|||
130703763|NCT02608476|470539690|FG001|Overall Study|Pregnancy|1|||
130703764|NCT02608476|470539689|FG000|Overall Study|Progressive disease|1|||
130703765|NCT02608476|470539690|FG001|Overall Study|Progressive disease|0|||
130703766|NCT02795676|470539691|FG000|Overall Study|Adverse Event|2|||
130703767|NCT02795676|470539692|FG001|Overall Study|Adverse Event|0|||
130703768|NCT02795676|470539691|FG000|Overall Study|Withdrawal by Subject|3|||
130703769|NCT02795676|470539692|FG001|Overall Study|Withdrawal by Subject|1|||
130703770|NCT01609582|470539703|FG000|Overall Study|Adverse Event|20|||
130703771|NCT01609582|470539704|FG001|Overall Study|Adverse Event|18|||
130703772|NCT01609582|470539703|FG000|Overall Study|Lost to Follow-up|10|||
130703773|NCT01609582|470539704|FG001|Overall Study|Lost to Follow-up|10|||
130703774|NCT01609582|470539703|FG000|Overall Study|Withdrawal by Subject|21|||
130770614|NCT03004924|470786157|FG002|Overall Study|Physician Decision|1|||
130930953|NCT02207244|471377636|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130930954|NCT02207244|471377637|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130930955|NCT02207244|471377638|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130930956|NCT02207244|471377639|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
130930957|NCT02207244|471377640|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
130930958|NCT02207244|471377641|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
130930959|NCT02207244|471377631|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
130930960|NCT02207244|471377632|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
130930961|NCT02207244|471377633|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
130930962|NCT02207244|471377634|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
130930963|NCT02207244|471377635|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
130930964|NCT02207244|471377636|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
130930965|NCT02207244|471377637|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
130930966|NCT02207244|471377638|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
130930967|NCT02207244|471377639|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
130930968|NCT02207244|471377640|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
130930969|NCT02207244|471377641|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
130930970|NCT02207244|471377631|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
130930971|NCT02207244|471377632|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
130930972|NCT02207244|471377633|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
130930973|NCT02207244|471377634|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
130930974|NCT02207244|471377635|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
130930975|NCT02207244|471377636|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
130930976|NCT02207244|471377637|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
130930977|NCT02207244|471377638|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
130930978|NCT02207244|471377639|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
130930979|NCT02207244|471377640|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
130930980|NCT02207244|471377641|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
130930981|NCT02207244|471377631|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130930982|NCT02207244|471377632|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130930983|NCT02207244|471377633|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130930984|NCT02207244|471377634|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130930985|NCT02207244|471377635|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130930986|NCT02207244|471377636|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130930987|NCT02207244|471377637|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130930988|NCT02207244|471377638|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130930989|NCT02207244|471377639|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130930990|NCT02207244|471377640|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
130703775|NCT01609582|470539704|FG001|Overall Study|Withdrawal by Subject|15|||
130703776|NCT01609582|470539703|FG000|Overall Study|Study Terminated by Sponsor|1543|||
130770615|NCT03004924|470786155|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130770616|NCT03004924|470786156|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131034940|NCT03544281|471761844|FG019|Main Study Phase|Physician Decision|0|||
131034941|NCT03544281|471761845|FG020|Main Study Phase|Physician Decision|0|||
131034942|NCT03544281|471761846|FG021|Main Study Phase|Physician Decision|0|||
131034943|NCT03544281|471761825|FG000|Main Study Phase|Withdrawal by Subject|2|||
131034944|NCT03544281|471761826|FG001|Main Study Phase|Withdrawal by Subject|0|||
131034945|NCT03544281|471761827|FG002|Main Study Phase|Withdrawal by Subject|1|||
131034946|NCT03544281|471761828|FG003|Main Study Phase|Withdrawal by Subject|2|||
131034947|NCT03544281|471761829|FG004|Main Study Phase|Withdrawal by Subject|0|||
131034948|NCT03544281|471761830|FG005|Main Study Phase|Withdrawal by Subject|0|||
131034949|NCT03544281|471761831|FG006|Main Study Phase|Withdrawal by Subject|0|||
131034950|NCT03544281|471761832|FG007|Main Study Phase|Withdrawal by Subject|0|||
131034951|NCT03544281|471761833|FG008|Main Study Phase|Withdrawal by Subject|2|||
131034952|NCT03544281|471761834|FG009|Main Study Phase|Withdrawal by Subject|3|||
131034953|NCT03544281|471761835|FG010|Main Study Phase|Withdrawal by Subject|0|||
131034954|NCT03544281|471761836|FG011|Main Study Phase|Withdrawal by Subject|4|||
130703777|NCT01609582|470539704|FG001|Overall Study|Study Terminated by Sponsor|1548|||
130703778|NCT01609582|470539703|FG000|Overall Study|Other|9|||
130703779|NCT01609582|470539704|FG001|Overall Study|Other|10|||
130703780|NCT01609582|470539703|FG000|Overall Study|Randomized, but not treated|0|||
130703781|NCT01609582|470539704|FG001|Overall Study|Randomized, but not treated|3|||
130703782|NCT00819767|470539705|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130703783|NCT00819767|470539706|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130703784|NCT00587431|470539709|FG000|Overall Study|Adverse Event|1|||
130703785|NCT00587431|470539710|FG001|Overall Study|Adverse Event|0|||
130703786|NCT00587431|470539709|FG000|Overall Study|Withdrawal by Subject|0|||
130703787|NCT00587431|470539710|FG001|Overall Study|Withdrawal by Subject|1|||
130703788|NCT02762994|470539711|FG000|Overall Study|Withdrawal by Subject|0|||
130703789|NCT02762994|470539712|FG001|Overall Study|Withdrawal by Subject|1|||
130703790|NCT02762994|470539713|FG002|Overall Study|Withdrawal by Subject|2|||
130703791|NCT02762994|470539714|FG003|Overall Study|Withdrawal by Subject|0|||
130703792|NCT02762994|470539711|FG000|Overall Study|Protocol Violation|1|||
130703793|NCT02762994|470539712|FG001|Overall Study|Protocol Violation|0|||
130703794|NCT02762994|470539713|FG002|Overall Study|Protocol Violation|0|||
130703795|NCT02762994|470539714|FG003|Overall Study|Protocol Violation|2|||
130703796|NCT01701973|470539718|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703797|NCT01701973|470539719|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
130703798|NCT01701973|470539720|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703799|NCT01701973|470539721|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703800|NCT01701973|470539722|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703801|NCT01701973|470539723|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703802|NCT01701973|470539724|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703803|NCT01701973|470539725|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130703804|NCT04330157|470539728|FG000|Overall Study|Protocol Violation|4|||
130703805|NCT04330157|470539728|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
130703806|NCT01263561|470539729|FG000|Overall Study|Death|1|||
130703807|NCT01263561|470539730|FG001|Overall Study|Death|2|||
130703808|NCT01396421|470539731|FG000|Overall Study|Lost to Follow-up|0|||
130703809|NCT01396421|470539732|FG001|Overall Study|Lost to Follow-up|0|||
130703810|NCT01396421|470539733|FG002|Overall Study|Lost to Follow-up|0|||
130703811|NCT01396421|470539734|FG003|Overall Study|Lost to Follow-up|1|||
130703812|NCT01396421|470539731|FG000|Overall Study|Adverse Event|17|||
130703813|NCT01396421|470539732|FG001|Overall Study|Adverse Event|15|||
130703814|NCT01396421|470539733|FG002|Overall Study|Adverse Event|12|||
130703815|NCT01396421|470539734|FG003|Overall Study|Adverse Event|32|||
130703816|NCT01396421|470539731|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
130703817|NCT01396421|470539732|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
130703818|NCT01396421|470539733|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
130703819|NCT01396421|470539734|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
130703820|NCT01396421|470539731|FG000|Overall Study|Physician Decision|1|||
130703821|NCT01396421|470539732|FG001|Overall Study|Physician Decision|1|||
130703822|NCT01396421|470539733|FG002|Overall Study|Physician Decision|0|||
130703823|NCT01396421|470539734|FG003|Overall Study|Physician Decision|3|||
130703824|NCT01396421|470539731|FG000|Overall Study|Withdrawal by Subject|31|||
130703825|NCT01396421|470539732|FG001|Overall Study|Withdrawal by Subject|24|||
130703826|NCT01396421|470539733|FG002|Overall Study|Withdrawal by Subject|13|||
130703827|NCT01396421|470539734|FG003|Overall Study|Withdrawal by Subject|21|||
131034955|NCT03544281|471761837|FG012|Main Study Phase|Withdrawal by Subject|0|||
130703828|NCT01396421|470539731|FG000|Overall Study|Protocol Deviation|2|||
130703829|NCT01396421|470539732|FG001|Overall Study|Protocol Deviation|1|||
130703830|NCT01396421|470539733|FG002|Overall Study|Protocol Deviation|1|||
130703831|NCT01396421|470539734|FG003|Overall Study|Protocol Deviation|0|||
130703832|NCT01396421|470539731|FG000|Overall Study|Lack of Efficacy|7|||
130703833|NCT01396421|470539732|FG001|Overall Study|Lack of Efficacy|17|||
130703834|NCT01396421|470539733|FG002|Overall Study|Lack of Efficacy|7|||
131034956|NCT03544281|471761838|FG013|Main Study Phase|Withdrawal by Subject|0|||
130703835|NCT01396421|470539734|FG003|Overall Study|Lack of Efficacy|18|||
130703836|NCT03689894|470539739|FG000|Overall Study|Adverse Event|1|||
130703837|NCT00569777|470539740|FG000|Overall Study|Withdrawal by Subject|4|||
130703838|NCT00569777|470539741|FG001|Overall Study|Withdrawal by Subject|0|||
130703839|NCT00569777|470539740|FG000|Overall Study|Adverse Event|3|||
130703840|NCT00569777|470539741|FG001|Overall Study|Adverse Event|0|||
130703841|NCT00569777|470539740|FG000|Overall Study|Lost to Follow-up|1|||
130703842|NCT00569777|470539741|FG001|Overall Study|Lost to Follow-up|0|||
130703843|NCT00569777|470539740|FG000|Overall Study|scheduled eye surgery|0|||
130703844|NCT00569777|470539741|FG001|Overall Study|scheduled eye surgery|1|||
130703845|NCT00569777|470539740|FG000|Overall Study|did not meet exclusion criteria|1|||
130703846|NCT00569777|470539741|FG001|Overall Study|did not meet exclusion criteria|2|||
130703847|NCT00569777|470539740|FG000|Overall Study|pregnant|1|||
130703848|NCT00569777|470539741|FG001|Overall Study|pregnant|0|||
130703849|NCT02030535|470539746|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
130703850|NCT01588548|470539747|FG000|Overall Study|Withdrawal by Subject|0|||
130703851|NCT01588548|470539748|FG001|Overall Study|Withdrawal by Subject|1|||
130703852|NCT01588548|470539749|FG002|Overall Study|Withdrawal by Subject|1|||
130703853|NCT01588548|470539750|FG003|Overall Study|Withdrawal by Subject|1|||
130703854|NCT01588548|470539751|FG004|Overall Study|Withdrawal by Subject|2|||
130703855|NCT01588548|470539752|FG005|Overall Study|Withdrawal by Subject|3|||
130703856|NCT01588548|470539747|FG000|Overall Study|Adverse Event|0|||
130930991|NCT02207244|471377641|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
130930992|NCT00039130|471377642|FG000|Overall Study|Adverse Event|11|||
130930993|NCT00039130|471377642|FG000|Overall Study|Death|9|||
130930994|NCT00039130|471377642|FG000|Overall Study|Withdrawal by Subject|3|||
130930995|NCT00039130|471377642|FG000|Overall Study|Progression|2|||
130930996|NCT00039130|471377642|FG000|Overall Study|Subsequent treatment|2|||
130930997|NCT00039130|471377642|FG000|Overall Study|Physician Decision|3|||
130930998|NCT01950741|471377643|FG000|Overall Study|Lost to Follow-up|1|||
130930999|NCT01950741|471377643|FG000|Overall Study|Death|1|||
130931000|NCT01950741|471377643|FG000|Overall Study|Withdrawal by Subject|1|||
130931001|NCT02521870|471377644|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931002|NCT02521870|471377645|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
130931003|NCT02521870|471377646|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931004|NCT02521870|471377647|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931005|NCT02521870|471377648|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931006|NCT02521870|471377649|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931007|NCT02521870|471377650|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931008|NCT02521870|471377651|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931009|NCT02521870|471377652|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931010|NCT02521870|471377653|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931011|NCT02521870|471377654|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931012|NCT02521870|471377655|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130931013|NCT02521870|471377644|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
130931014|NCT02521870|471377645|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
130931015|NCT02521870|471377646|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
130931016|NCT02521870|471377647|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
130931017|NCT02521870|471377648|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
130931018|NCT02521870|471377649|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
130931019|NCT02521870|471377650|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
130931020|NCT02521870|471377651|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
130931021|NCT02521870|471377652|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
130931022|NCT02521870|471377653|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
130931023|NCT02521870|471377654|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
130931024|NCT02521870|471377655|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
130931025|NCT02521870|471377644|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
130931026|NCT02521870|471377645|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
130931027|NCT02521870|471377646|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
130931028|NCT02521870|471377647|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
130931029|NCT02521870|471377648|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
130931030|NCT02521870|471377649|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
130931031|NCT02521870|471377650|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
130931032|NCT02521870|471377651|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
130931033|NCT02521870|471377652|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
130931034|NCT02521870|471377653|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
130931035|NCT02521870|471377654|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
130931036|NCT02521870|471377655|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
130931037|NCT02521870|471377644|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130931038|NCT02521870|471377645|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130931039|NCT02521870|471377646|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130931040|NCT02521870|471377647|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130703857|NCT01588548|470539748|FG001|Overall Study|Adverse Event|0|||
130703858|NCT01588548|470539749|FG002|Overall Study|Adverse Event|1|||
130703859|NCT01588548|470539750|FG003|Overall Study|Adverse Event|2|||
130931041|NCT02521870|471377648|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
130931042|NCT02521870|471377649|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
130931043|NCT02521870|471377650|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
130931044|NCT02521870|471377651|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130931045|NCT02521870|471377652|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
130931046|NCT02521870|471377653|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
130931047|NCT02521870|471377654|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
130931048|NCT02521870|471377655|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130931049|NCT02521870|471377644|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
130931050|NCT02521870|471377645|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
130931051|NCT02521870|471377646|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
130931052|NCT02521870|471377647|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
130931053|NCT02521870|471377648|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
130931054|NCT02521870|471377649|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
130931055|NCT02521870|471377650|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
130931056|NCT02521870|471377651|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
130931057|NCT02521870|471377652|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
130931058|NCT02521870|471377653|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
130931059|NCT02521870|471377654|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
130931060|NCT02521870|471377655|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
130931061|NCT02521870|471377644|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
130931062|NCT02521870|471377645|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
130931063|NCT02521870|471377646|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
130931064|NCT02521870|471377647|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
130931065|NCT02521870|471377648|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
130931066|NCT02521870|471377649|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
130931067|NCT02521870|471377650|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
130931068|NCT02521870|471377651|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
130931069|NCT02521870|471377652|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
130931070|NCT02521870|471377653|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
130931071|NCT02521870|471377654|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
130931072|NCT02521870|471377655|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
130931073|NCT02521870|471377644|FG000|Phase 2: Dose Expansion|Death|0|||
130931074|NCT02521870|471377645|FG001|Phase 2: Dose Expansion|Death|0|||
130931075|NCT02521870|471377646|FG002|Phase 2: Dose Expansion|Death|0|||
130931076|NCT02521870|471377647|FG003|Phase 2: Dose Expansion|Death|0|||
130931077|NCT02521870|471377648|FG004|Phase 2: Dose Expansion|Death|1|||
130931078|NCT02521870|471377649|FG005|Phase 2: Dose Expansion|Death|1|||
130931079|NCT02521870|471377650|FG006|Phase 2: Dose Expansion|Death|3|||
130931080|NCT02521870|471377651|FG007|Phase 2: Dose Expansion|Death|1|||
130931081|NCT02521870|471377652|FG008|Phase 2: Dose Expansion|Death|1|||
130931082|NCT02521870|471377653|FG009|Phase 2: Dose Expansion|Death|5|||
130931083|NCT02521870|471377654|FG010|Phase 2: Dose Expansion|Death|2|||
130931084|NCT02521870|471377655|FG011|Phase 2: Dose Expansion|Death|2|||
130931085|NCT02521870|471377644|FG000|Phase 2: Dose Expansion|Other|0|||
130931086|NCT02521870|471377645|FG001|Phase 2: Dose Expansion|Other|0|||
130931087|NCT02521870|471377646|FG002|Phase 2: Dose Expansion|Other|0|||
130931088|NCT02521870|471377647|FG003|Phase 2: Dose Expansion|Other|0|||
130931089|NCT02521870|471377648|FG004|Phase 2: Dose Expansion|Other|10|||
130931090|NCT02521870|471377649|FG005|Phase 2: Dose Expansion|Other|3|||
130931091|NCT02521870|471377650|FG006|Phase 2: Dose Expansion|Other|2|||
130931092|NCT02521870|471377651|FG007|Phase 2: Dose Expansion|Other|0|||
131034957|NCT03544281|471761839|FG014|Main Study Phase|Withdrawal by Subject|0|||
130770617|NCT03004924|470786157|FG002|Overall Study|Withdrawal by parent/guardian|2|||
130770618|NCT03004924|470786155|FG000|Overall Study|Screen Failure|1|||
130770619|NCT03004924|470786156|FG001|Overall Study|Screen Failure|0|||
130770620|NCT03004924|470786157|FG002|Overall Study|Screen Failure|0|||
130770621|NCT03004924|470786155|FG000|Overall Study|Pregnancy|0|||
130770622|NCT03004924|470786156|FG001|Overall Study|Pregnancy|1|||
130770623|NCT03004924|470786157|FG002|Overall Study|Pregnancy|0|||
130770624|NCT03004924|470786155|FG000|Overall Study|Terminated by Sponsor|0|||
130931093|NCT02521870|471377652|FG008|Phase 2: Dose Expansion|Other|10|||
130931094|NCT02521870|471377653|FG009|Phase 2: Dose Expansion|Other|5|||
130931095|NCT02521870|471377654|FG010|Phase 2: Dose Expansion|Other|1|||
131034958|NCT03544281|471761840|FG015|Main Study Phase|Withdrawal by Subject|0|||
131034959|NCT03544281|471761841|FG016|Main Study Phase|Withdrawal by Subject|0|||
130931096|NCT02521870|471377655|FG011|Phase 2: Dose Expansion|Other|7|||
130931097|NCT02521870|471377644|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130931098|NCT02521870|471377645|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130931099|NCT02521870|471377646|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130931100|NCT02521870|471377647|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130931101|NCT02521870|471377648|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
130931102|NCT02521870|471377649|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
131034960|NCT03544281|471761842|FG017|Main Study Phase|Withdrawal by Subject|0|||
130770625|NCT03004924|470786156|FG001|Overall Study|Terminated by Sponsor|0|||
130770626|NCT03004924|470786157|FG002|Overall Study|Terminated by Sponsor|1|||
131120405|NCT00922480|472072336|FG000|Extension Study|Withdrawal by Subject|1|||
131120406|NCT00922480|472072337|FG001|Extension Study|Withdrawal by Subject|1|||
131120407|NCT00922480|472072336|FG000|Extension Study|Others|0|||
131120408|NCT00922480|472072337|FG001|Extension Study|Others|1|||
131120409|NCT04784897|472072338|FG000|Overall Study|Death|4|||
131120410|NCT04784897|472072339|FG001|Overall Study|Death|2|||
131120411|NCT04784897|472072340|FG002|Overall Study|Death|1|||
131120412|NCT04784897|472072338|FG000|Overall Study|Withdrawal by Subject|0|||
131120413|NCT04784897|472072339|FG001|Overall Study|Withdrawal by Subject|0|||
131120414|NCT04784897|472072340|FG002|Overall Study|Withdrawal by Subject|1|||
131120415|NCT01994382|472072341|FG000|Overall Study|Informed consent withdrawn|0|||
131120416|NCT01994382|472072342|FG001|Overall Study|Informed consent withdrawn|0|||
130931103|NCT02521870|471377650|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130931104|NCT02521870|471377651|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130931105|NCT02521870|471377652|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130931106|NCT02521870|471377653|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130931107|NCT02521870|471377654|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130931108|NCT02521870|471377655|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130931109|NCT02521870|471377644|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931110|NCT02521870|471377645|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931111|NCT02521870|471377646|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931112|NCT02521870|471377647|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931113|NCT02521870|471377648|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
130931114|NCT02521870|471377649|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931115|NCT02521870|471377650|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931116|NCT02521870|471377651|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931117|NCT02521870|471377652|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931118|NCT02521870|471377653|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931119|NCT02521870|471377654|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931120|NCT02521870|471377655|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
130931121|NCT00519831|471377656|FG000|Overall Study|Adverse Event|3|||
130931122|NCT00621153|471377663|FG000|Overall Study|Safety Reason|8|||
130931123|NCT00621153|471377664|FG001|Overall Study|Safety Reason|7|||
130931124|NCT00621153|471377663|FG000|Overall Study|Adverse Event|3|||
130931125|NCT00621153|471377664|FG001|Overall Study|Adverse Event|2|||
130931126|NCT00621153|471377663|FG000|Overall Study|Lost to Follow-up|5|||
130931127|NCT00621153|471377664|FG001|Overall Study|Lost to Follow-up|1|||
130931128|NCT00621153|471377663|FG000|Overall Study|Withdrawal by Subject|4|||
130931129|NCT00621153|471377664|FG001|Overall Study|Withdrawal by Subject|5|||
130931130|NCT00753415|471377665|FG000|Part A|Disease progression|1|||
130931131|NCT00753415|471377666|FG001|Part A|Disease progression|0|||
130931132|NCT00753415|471377667|FG002|Part A|Disease progression|1|||
130931133|NCT00753415|471377668|FG003|Part A|Disease progression|2|||
130931134|NCT00753415|471377669|FG004|Part A|Disease progression|0|||
130931135|NCT00753415|471377670|FG005|Part A|Disease progression|0|||
130931136|NCT00753415|471377671|FG006|Part A|Disease progression|0|||
130931137|NCT00753415|471377672|FG007|Part A|Disease progression|0|||
130931138|NCT00753415|471377673|FG008|Part A|Disease progression|0|||
130931139|NCT00753415|471377674|FG009|Part A|Disease progression|0|||
130931140|NCT00753415|471377665|FG000|Part A|Withdrawal by Subject|0|||
130931141|NCT00753415|471377666|FG001|Part A|Withdrawal by Subject|0|||
130931142|NCT00753415|471377667|FG002|Part A|Withdrawal by Subject|1|||
130931143|NCT00753415|471377668|FG003|Part A|Withdrawal by Subject|0|||
130931144|NCT00753415|471377669|FG004|Part A|Withdrawal by Subject|0|||
130931145|NCT00753415|471377670|FG005|Part A|Withdrawal by Subject|0|||
130931146|NCT00753415|471377671|FG006|Part A|Withdrawal by Subject|0|||
130931147|NCT00753415|471377672|FG007|Part A|Withdrawal by Subject|0|||
130931148|NCT00753415|471377673|FG008|Part A|Withdrawal by Subject|0|||
130931149|NCT00753415|471377674|FG009|Part A|Withdrawal by Subject|0|||
130931150|NCT00753415|471377665|FG000|Part B|Lost to Follow-up|0|||
130931151|NCT00753415|471377666|FG001|Part B|Lost to Follow-up|0|||
131120417|NCT01994382|472072343|FG002|Overall Study|Informed consent withdrawn|0|||
131120418|NCT01994382|472072344|FG003|Overall Study|Informed consent withdrawn|0|||
131120419|NCT01994382|472072345|FG004|Overall Study|Informed consent withdrawn|0|||
131120420|NCT01994382|472072346|FG005|Overall Study|Informed consent withdrawn|0|||
130703860|NCT01588548|470539751|FG004|Overall Study|Adverse Event|1|||
130703861|NCT01588548|470539752|FG005|Overall Study|Adverse Event|0|||
130931152|NCT00753415|471377667|FG002|Part B|Lost to Follow-up|0|||
130931153|NCT00753415|471377668|FG003|Part B|Lost to Follow-up|0|||
130931154|NCT00753415|471377669|FG004|Part B|Lost to Follow-up|0|||
130931155|NCT00753415|471377670|FG005|Part B|Lost to Follow-up|0|||
130931156|NCT00753415|471377671|FG006|Part B|Lost to Follow-up|0|||
130931157|NCT00753415|471377672|FG007|Part B|Lost to Follow-up|1|||
130931158|NCT00753415|471377673|FG008|Part B|Lost to Follow-up|1|||
130931159|NCT00753415|471377674|FG009|Part B|Lost to Follow-up|0|||
130931160|NCT00753415|471377665|FG000|Part B|Disease progression|0|||
131120421|NCT01994382|472072347|FG006|Overall Study|Informed consent withdrawn|1|||
130770627|NCT03004924|470786155|FG000|Overall Study|Missed Study Visit|0|||
130770628|NCT03004924|470786156|FG001|Overall Study|Missed Study Visit|0|||
130770629|NCT03004924|470786157|FG002|Overall Study|Missed Study Visit|2|||
130770630|NCT03004924|470786155|FG000|Overall Study|HSV1 Positive|1|||
130770631|NCT03004924|470786156|FG001|Overall Study|HSV1 Positive|0|||
130770632|NCT03004924|470786157|FG002|Overall Study|HSV1 Positive|0|||
130770633|NCT01280682|470786158|FG000|Overall Study|Lost to Follow-up|0|||
130770634|NCT01280682|470786159|FG001|Overall Study|Lost to Follow-up|6|||
130770635|NCT01280682|470786158|FG000|Overall Study|Withdrawal by Subject|0|||
130770636|NCT01280682|470786159|FG001|Overall Study|Withdrawal by Subject|7|||
130770637|NCT00269477|470786162|FG000|Overall Study|Protocol Violation|5|||
130770638|NCT00269477|470786163|FG001|Overall Study|Protocol Violation|5|||
130770639|NCT00269477|470786164|FG002|Overall Study|Protocol Violation|1|||
130770640|NCT00269477|470786165|FG003|Overall Study|Protocol Violation|0|||
130770641|NCT00269477|470786162|FG000|Overall Study|Missed post-vaccination blood draw|0|||
130770642|NCT00269477|470786163|FG001|Overall Study|Missed post-vaccination blood draw|1|||
130770643|NCT00269477|470786164|FG002|Overall Study|Missed post-vaccination blood draw|0|||
130770644|NCT00269477|470786165|FG003|Overall Study|Missed post-vaccination blood draw|0|||
130770645|NCT01964716|470786172|FG000|Overall Study|Withdrawal by Subject|2|||
130770646|NCT01964716|470786173|FG001|Overall Study|Withdrawal by Subject|3|||
130770647|NCT01964716|470786172|FG000|Overall Study|Lost to Follow-up|1|||
130770648|NCT01964716|470786173|FG001|Overall Study|Lost to Follow-up|2|||
130770649|NCT01964716|470786172|FG000|Overall Study|No longer met eligibility criteria|1|||
130770650|NCT01964716|470786173|FG001|Overall Study|No longer met eligibility criteria|1|||
130770651|NCT01964716|470786172|FG000|Overall Study|Death|1|||
131034961|NCT03544281|471761843|FG018|Main Study Phase|Withdrawal by Subject|0|||
131034962|NCT03544281|471761844|FG019|Main Study Phase|Withdrawal by Subject|0|||
131034963|NCT03544281|471761845|FG020|Main Study Phase|Withdrawal by Subject|0|||
130770652|NCT01964716|470786173|FG001|Overall Study|Death|0|||
130770653|NCT01464619|470786174|FG000|Overall Study|Lost to Follow-up|3|||
130770654|NCT01464619|470786175|FG001|Overall Study|Lost to Follow-up|4|||
130770655|NCT01578499|470786178|FG000|Overall Study|Reason not Specified|0|||
130770656|NCT01578499|470786179|FG001|Overall Study|Reason not Specified|1|||
130770657|NCT01578499|470786178|FG000|Overall Study|Lost to Follow-up|2|||
130770658|NCT01578499|470786179|FG001|Overall Study|Lost to Follow-up|1|||
130770659|NCT01578499|470786178|FG000|Overall Study|Withdrawal by Subject|10|||
130770660|NCT01578499|470786179|FG001|Overall Study|Withdrawal by Subject|16|||
130770661|NCT01578499|470786178|FG000|Overall Study|Death|20|||
130770662|NCT01578499|470786179|FG001|Overall Study|Death|25|||
131034964|NCT03544281|471761846|FG021|Main Study Phase|Withdrawal by Subject|0|||
131034965|NCT03544281|471761825|FG000|Main Study Phase|Ongoing|3|||
131034966|NCT03544281|471761826|FG001|Main Study Phase|Ongoing|1|||
131034967|NCT03544281|471761827|FG002|Main Study Phase|Ongoing|2|||
131034968|NCT03544281|471761828|FG003|Main Study Phase|Ongoing|4|||
131034969|NCT03544281|471761829|FG004|Main Study Phase|Ongoing|2|||
131034970|NCT03544281|471761830|FG005|Main Study Phase|Ongoing|4|||
131034971|NCT03544281|471761831|FG006|Main Study Phase|Ongoing|4|||
131034972|NCT03544281|471761832|FG007|Main Study Phase|Ongoing|0|||
131034973|NCT03544281|471761833|FG008|Main Study Phase|Ongoing|2|||
131034974|NCT03544281|471761834|FG009|Main Study Phase|Ongoing|2|||
131034975|NCT03544281|471761835|FG010|Main Study Phase|Ongoing|1|||
131034976|NCT03544281|471761836|FG011|Main Study Phase|Ongoing|0|||
131034977|NCT03544281|471761837|FG012|Main Study Phase|Ongoing|0|||
131034978|NCT03544281|471761838|FG013|Main Study Phase|Ongoing|0|||
131034979|NCT03544281|471761839|FG014|Main Study Phase|Ongoing|0|||
131034980|NCT03544281|471761840|FG015|Main Study Phase|Ongoing|0|||
131034981|NCT03544281|471761841|FG016|Main Study Phase|Ongoing|0|||
131034982|NCT03544281|471761842|FG017|Main Study Phase|Ongoing|0|||
131034983|NCT03544281|471761843|FG018|Main Study Phase|Ongoing|0|||
131034984|NCT03544281|471761844|FG019|Main Study Phase|Ongoing|0|||
131034985|NCT03544281|471761845|FG020|Main Study Phase|Ongoing|0|||
131034986|NCT03544281|471761846|FG021|Main Study Phase|Ongoing|0|||
131120422|NCT01994382|472072348|FG007|Overall Study|Informed consent withdrawn|0|||
131120423|NCT01994382|472072349|FG008|Overall Study|Informed consent withdrawn|0|||
130770663|NCT01578499|470786178|FG000|Overall Study|Died and End of Study Page not Completed|2|||
130770664|NCT01578499|470786179|FG001|Overall Study|Died and End of Study Page not Completed|0|||
130770665|NCT02670382|470786180|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
130770666|NCT02670382|470786181|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
130770667|NCT03469999|470786184|FG000|Overall Study|Lost to Follow-up|2|||
130770668|NCT01863732|470786185|FG000|Overall Study|Adverse Event|2|||
130770669|NCT01863732|470786186|FG001|Overall Study|Adverse Event|0|||
130770670|NCT01863732|470786187|FG002|Overall Study|Adverse Event|3|||
130770671|NCT01863732|470786188|FG003|Overall Study|Adverse Event|3|||
131120424|NCT01994382|472072350|FG009|Overall Study|Informed consent withdrawn|0|||
130770672|NCT01863732|470786185|FG000|Overall Study|Lack of Efficacy|1|||
131034987|NCT03544281|471761825|FG000|Main Study Phase|Investigator Site Closed|0|||
131034988|NCT03544281|471761826|FG001|Main Study Phase|Investigator Site Closed|0|||
131034989|NCT03544281|471761827|FG002|Main Study Phase|Investigator Site Closed|0|||
131034990|NCT03544281|471761828|FG003|Main Study Phase|Investigator Site Closed|0|||
131034991|NCT03544281|471761829|FG004|Main Study Phase|Investigator Site Closed|0|||
131034992|NCT03544281|471761830|FG005|Main Study Phase|Investigator Site Closed|0|||
130703862|NCT01588548|470539747|FG000|Overall Study|Condition Under Investigation Worsened|3|||
130703863|NCT01588548|470539748|FG001|Overall Study|Condition Under Investigation Worsened|6|||
130703864|NCT01588548|470539749|FG002|Overall Study|Condition Under Investigation Worsened|4|||
130703865|NCT01588548|470539750|FG003|Overall Study|Condition Under Investigation Worsened|4|||
130703866|NCT01588548|470539751|FG004|Overall Study|Condition Under Investigation Worsened|3|||
130703867|NCT01588548|470539752|FG005|Overall Study|Condition Under Investigation Worsened|3|||
130770673|NCT01863732|470786186|FG001|Overall Study|Lack of Efficacy|0|||
130770674|NCT01863732|470786187|FG002|Overall Study|Lack of Efficacy|2|||
130770675|NCT01863732|470786188|FG003|Overall Study|Lack of Efficacy|1|||
130770676|NCT01863732|470786185|FG000|Overall Study|Lost to Follow-up|2|||
130770677|NCT01863732|470786186|FG001|Overall Study|Lost to Follow-up|2|||
130770678|NCT01863732|470786187|FG002|Overall Study|Lost to Follow-up|1|||
130770679|NCT01863732|470786188|FG003|Overall Study|Lost to Follow-up|1|||
130770680|NCT01863732|470786185|FG000|Overall Study|Physician Decision|1|||
130770681|NCT01863732|470786186|FG001|Overall Study|Physician Decision|0|||
130770682|NCT01863732|470786187|FG002|Overall Study|Physician Decision|1|||
130770683|NCT01863732|470786188|FG003|Overall Study|Physician Decision|0|||
130770684|NCT01863732|470786185|FG000|Overall Study|Pregnancy|0|||
130770685|NCT01863732|470786186|FG001|Overall Study|Pregnancy|0|||
130770686|NCT01863732|470786187|FG002|Overall Study|Pregnancy|0|||
130770687|NCT01863732|470786188|FG003|Overall Study|Pregnancy|1|||
130770688|NCT01863732|470786185|FG000|Overall Study|Technical problems|0|||
130770689|NCT01863732|470786186|FG001|Overall Study|Technical problems|1|||
130770690|NCT01863732|470786187|FG002|Overall Study|Technical problems|1|||
130770691|NCT01863732|470786188|FG003|Overall Study|Technical problems|0|||
130770692|NCT01863732|470786185|FG000|Overall Study|Subject/guardian decision|6|||
130770693|NCT01863732|470786186|FG001|Overall Study|Subject/guardian decision|9|||
130703868|NCT00537017|470539753|FG000|Treatment Phase|Adverse Event|19|||
130703869|NCT00537017|470539753|FG000|Treatment Phase|Withdrawal by Subject|13|||
130703870|NCT00537017|470539753|FG000|Treatment Phase|Protocol Violation|2|||
130703871|NCT00537017|470539753|FG000|Follow-up Phase|Withdrawal by Subject|9|||
130703872|NCT01362296|470539754|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
130703873|NCT01362296|470539755|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
130703874|NCT01362296|470539756|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
130703875|NCT01362296|470539757|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
130703876|NCT01362296|470539754|FG000|Randomized Phase (RP)|Physician Decision|1|||
130703877|NCT01362296|470539755|FG001|Randomized Phase (RP)|Physician Decision|9|||
130703878|NCT01362296|470539756|FG002|Randomized Phase (RP)|Physician Decision|0|||
130703879|NCT01362296|470539757|FG003|Randomized Phase (RP)|Physician Decision|0|||
130703880|NCT01362296|470539754|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
130703881|NCT01362296|470539755|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
130703882|NCT01362296|470539756|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
130703883|NCT01362296|470539757|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
130703884|NCT01362296|470539754|FG000|Randomized Phase (RP)|Adverse Event|20|||
130703885|NCT01362296|470539755|FG001|Randomized Phase (RP)|Adverse Event|4|||
130703886|NCT01362296|470539756|FG002|Randomized Phase (RP)|Adverse Event|0|||
130703887|NCT01362296|470539757|FG003|Randomized Phase (RP)|Adverse Event|0|||
130703888|NCT01362296|470539754|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
130703889|NCT01362296|470539755|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
130703890|NCT01362296|470539756|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
130703891|NCT01362296|470539757|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
130770694|NCT01863732|470786187|FG002|Overall Study|Subject/guardian decision|3|||
130770695|NCT01863732|470786188|FG003|Overall Study|Subject/guardian decision|1|||
130770696|NCT01863732|470786185|FG000|Overall Study|Death|1|||
130770697|NCT01863732|470786186|FG001|Overall Study|Death|0|||
130770698|NCT01863732|470786187|FG002|Overall Study|Death|0|||
130770699|NCT01863732|470786188|FG003|Overall Study|Death|1|||
130703892|NCT01362296|470539754|FG000|Crossover Phase|PD including Death due to PD|0|||
130703893|NCT01362296|470539755|FG001|Crossover Phase|PD including Death due to PD|0|||
130703894|NCT01362296|470539756|FG002|Crossover Phase|PD including Death due to PD|16|||
130703895|NCT01362296|470539757|FG003|Crossover Phase|PD including Death due to PD|1|||
130703896|NCT01362296|470539754|FG000|Crossover Phase|Withdrawal by Subject|0|||
130703897|NCT01362296|470539755|FG001|Crossover Phase|Withdrawal by Subject|0|||
130703898|NCT01362296|470539756|FG002|Crossover Phase|Withdrawal by Subject|2|||
130770700|NCT00460746|470786189|FG000|Overall Study|Adverse Event|1|||
130770701|NCT00460746|470786189|FG000|Overall Study|Lost to Follow-up|1|||
130703899|NCT01362296|470539757|FG003|Crossover Phase|Withdrawal by Subject|1|||
130770702|NCT00636961|470786195|FG000|Period 1|Administrative problems|1|||
130770703|NCT00636961|470786196|FG001|Period 1|Administrative problems|1|||
130770704|NCT00636961|470786195|FG000|Period 2|Adverse Event|1|||
130770705|NCT00636961|470786196|FG001|Period 2|Adverse Event|0|||
130770706|NCT02756364|470786198|FG000|Overall Study|Site Terminated by Sponsor|24|||
130703900|NCT01362296|470539754|FG000|Crossover Phase|Adverse Event|0|||
130703901|NCT01362296|470539755|FG001|Crossover Phase|Adverse Event|0|||
130703902|NCT01362296|470539756|FG002|Crossover Phase|Adverse Event|4|||
130770707|NCT02756364|470786199|FG001|Overall Study|Site Terminated by Sponsor|30|||
130770708|NCT02756364|470786200|FG002|Overall Study|Site Terminated by Sponsor|21|||
130770709|NCT02756364|470786198|FG000|Overall Study|Death|20|||
130770710|NCT02756364|470786199|FG001|Overall Study|Death|15|||
130770711|NCT02756364|470786200|FG002|Overall Study|Death|18|||
130770712|NCT02756364|470786198|FG000|Overall Study|Withdrawal by Patient|2|||
130770713|NCT02756364|470786199|FG001|Overall Study|Withdrawal by Patient|1|||
130770714|NCT02756364|470786200|FG002|Overall Study|Withdrawal by Patient|8|||
130770715|NCT02756364|470786198|FG000|Overall Study|Lost to Follow-up|0|||
130770716|NCT02756364|470786199|FG001|Overall Study|Lost to Follow-up|1|||
130770717|NCT02756364|470786200|FG002|Overall Study|Lost to Follow-up|1|||
130770718|NCT00793546|470786201|FG000|Overall Study|Death|3|||
130770719|NCT00793546|470786202|FG001|Overall Study|Death|0|||
130770720|NCT00793546|470786201|FG000|Overall Study|Lost to Follow-up|1|||
130770721|NCT00793546|470786202|FG001|Overall Study|Lost to Follow-up|0|||
130770722|NCT00793546|470786201|FG000|Overall Study|Withdrawal by Subject|1|||
130770723|NCT00793546|470786202|FG001|Overall Study|Withdrawal by Subject|1|||
130770724|NCT00793546|470786201|FG000|Overall Study|Study Terminated by Sponsor|8|||
130770725|NCT00793546|470786202|FG001|Overall Study|Study Terminated by Sponsor|27|||
130770726|NCT00793546|470786201|FG000|Overall Study|Other|1|||
130770727|NCT00793546|470786202|FG001|Overall Study|Other|0|||
130770728|NCT01841567|470786203|FG000|Overall Study|Adverse Event|3|||
130770729|NCT01416155|470786204|FG000|Overall Study|Adverse Event|8|||
130770730|NCT01416155|470786204|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
130770731|NCT01416155|470786204|FG000|Overall Study|Withdrawal by Subject|33|||
130770732|NCT01416155|470786204|FG000|Overall Study|Investigator decision|8|||
130770733|NCT01416155|470786204|FG000|Overall Study|Other|7|||
130770734|NCT00762034|470787666|FG000|Induction Period|Protocol Violation|1|||
130770735|NCT00762034|470787667|FG001|Induction Period|Protocol Violation|2|||
130770736|NCT00762034|470787666|FG000|Induction Period|Entry Criterion Not Met|12|||
130770737|NCT00762034|470787667|FG001|Induction Period|Entry Criterion Not Met|11|||
130770738|NCT00762034|470787666|FG000|Induction Period|Adverse Event|27|||
130931161|NCT00753415|471377666|FG001|Part B|Disease progression|0|||
130931162|NCT00753415|471377667|FG002|Part B|Disease progression|0|||
130931163|NCT00753415|471377668|FG003|Part B|Disease progression|0|||
130931164|NCT00753415|471377669|FG004|Part B|Disease progression|0|||
130931165|NCT00753415|471377670|FG005|Part B|Disease progression|0|||
130931166|NCT00753415|471377671|FG006|Part B|Disease progression|0|||
130931167|NCT00753415|471377672|FG007|Part B|Disease progression|0|||
130931168|NCT00753415|471377673|FG008|Part B|Disease progression|2|||
130931169|NCT00753415|471377674|FG009|Part B|Disease progression|1|||
130931170|NCT04212650|471377675|FG000|Overall Study|Withdrawal by Subject|1|||
130931171|NCT04212650|471377676|FG001|Overall Study|Withdrawal by Subject|0|||
130931172|NCT02634320|471377677|FG000|Overall Study|Adverse Event|2|||
130931173|NCT02634320|471377677|FG000|Overall Study|Lost to Follow-up|3|||
130931174|NCT02634320|471377677|FG000|Overall Study|Moved out of area|2|||
130931175|NCT02634320|471377677|FG000|Overall Study|Out of window for study visits|1|||
130931176|NCT02634320|471377677|FG000|Overall Study|Protocol Violation|1|||
130931177|NCT02634320|471377677|FG000|Overall Study|Withdrawal by Subject|5|||
130931178|NCT02634320|471377677|FG000|Overall Study|Lack of Efficacy|2|||
130931179|NCT03919799|471377681|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
130931180|NCT03919799|471377682|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
130931181|NCT03919799|471377683|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
130931182|NCT03919799|471377684|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
130931183|NCT03919799|471377685|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
130931184|NCT03919799|471377681|FG000|DB Period (28 Weeks)|Adverse Event|1|||
130931185|NCT03919799|471377682|FG001|DB Period (28 Weeks)|Adverse Event|1|||
130931186|NCT03919799|471377683|FG002|DB Period (28 Weeks)|Adverse Event|1|||
130931187|NCT03919799|471377684|FG003|DB Period (28 Weeks)|Adverse Event|0|||
130931188|NCT03919799|471377685|FG004|DB Period (28 Weeks)|Adverse Event|0|||
130931189|NCT03919799|471377681|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
130931190|NCT03919799|471377682|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
130770739|NCT00762034|470787667|FG001|Induction Period|Adverse Event|38|||
130770740|NCT00762034|470787666|FG000|Induction Period|Lost to Follow-up|1|||
130770741|NCT00762034|470787667|FG001|Induction Period|Lost to Follow-up|1|||
130770742|NCT00762034|470787666|FG000|Induction Period|Progressive Disease|73|||
130770743|NCT00762034|470787667|FG001|Induction Period|Progressive Disease|55|||
130931191|NCT03919799|471377683|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
130931192|NCT03919799|471377684|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
130931193|NCT03919799|471377685|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
130931194|NCT03919799|471377681|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
130931195|NCT03919799|471377682|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
130770744|NCT00762034|470787666|FG000|Induction Period|Physician Decision|21|||
130770745|NCT00762034|470787667|FG001|Induction Period|Physician Decision|20|||
130770746|NCT00762034|470787666|FG000|Induction Period|Withdrawal by Subject|15|||
130770747|NCT00762034|470787667|FG001|Induction Period|Withdrawal by Subject|19|||
130770748|NCT00762034|470787666|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
130770749|NCT00762034|470787667|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
130770750|NCT00762034|470787666|FG000|Induction Period|Deaths Due to Study Disease|9|||
130770751|NCT00762034|470787667|FG001|Induction Period|Deaths Due to Study Disease|9|||
130770752|NCT00762034|470787666|FG000|Maintenance Period|Protocol Violation|1|||
130770753|NCT00762034|470787667|FG001|Maintenance Period|Protocol Violation|3|||
130770754|NCT00762034|470787666|FG000|Maintenance Period|Entry Criterion Not Met|0|||
130770755|NCT00762034|470787667|FG001|Maintenance Period|Entry Criterion Not Met|2|||
130770756|NCT00762034|470787666|FG000|Maintenance Period|Adverse Event|42|||
130770757|NCT00762034|470787667|FG001|Maintenance Period|Adverse Event|26|||
130770758|NCT00762034|470787666|FG000|Maintenance Period|Progressive Disease|186|||
130931196|NCT03919799|471377683|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
130931197|NCT03919799|471377684|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
130931198|NCT03919799|471377685|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
130931199|NCT03919799|471377681|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
130931200|NCT03919799|471377682|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
130931201|NCT03919799|471377683|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
130770759|NCT00762034|470787667|FG001|Maintenance Period|Progressive Disease|224|||
130770760|NCT00762034|470787666|FG000|Maintenance Period|Physician Decision|25|||
130770761|NCT00762034|470787667|FG001|Maintenance Period|Physician Decision|20|||
130931202|NCT03919799|471377684|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
130931203|NCT03919799|471377685|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
130931204|NCT04656691|471377690|FG000|Overall Study|Adverse Event|1|||
130931205|NCT03199274|471377691|FG000|Overall Study|Withdrawal by Subject|4|||
130931206|NCT03199274|471377692|FG001|Overall Study|Withdrawal by Subject|0|||
130931207|NCT03199274|471377691|FG000|Overall Study|Lost to Follow-up|0|||
130931208|NCT03199274|471377692|FG001|Overall Study|Lost to Follow-up|1|||
130931209|NCT03199274|471377691|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
130931210|NCT03199274|471377692|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
130931211|NCT05980182|471377698|FG000|Overall Study|Lost to Follow-up|10|||
130931212|NCT04023526|471379014|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
130931213|NCT04023526|471379015|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
130931214|NCT04023526|471379014|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
130931215|NCT04023526|471379015|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
130931216|NCT00638378|471379020|FG000|Overall Study|Death|2|||
130931217|NCT00638378|471379020|FG000|Overall Study|Adverse Event|1|||
130931218|NCT00638378|471379020|FG000|Overall Study|Disease progression|15|||
130931219|NCT00638378|471379020|FG000|Overall Study|Physician Decision|4|||
130931220|NCT03902574|471379035|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
130931221|NCT03902574|471379036|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
130931222|NCT03902574|471379037|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
130931223|NCT04492618|471379039|FG000|Overall Study|Withdrawal by Subject|1|||
130931224|NCT02101060|471379044|FG000|Overall Study|Adverse Event|1|||
130931225|NCT02101060|471379045|FG001|Overall Study|Adverse Event|0|||
130931226|NCT02101060|471379044|FG000|Overall Study|Withdrawal by Subject|1|||
130931227|NCT02101060|471379045|FG001|Overall Study|Withdrawal by Subject|1|||
130931228|NCT02101060|471379044|FG000|Overall Study|Lost to Follow-up|3|||
130931229|NCT02101060|471379045|FG001|Overall Study|Lost to Follow-up|3|||
130931230|NCT00166114|471379049|FG000|Overall Study|Protocol Violation|2|||
130931231|NCT00166114|471379050|FG001|Overall Study|Protocol Violation|1|||
130931232|NCT00166114|471379049|FG000|Overall Study|Withdrawal by Subject|10|||
130931233|NCT00166114|471379050|FG001|Overall Study|Withdrawal by Subject|4|||
130931234|NCT00166114|471379049|FG000|Overall Study|Adverse Event|2|||
130770762|NCT00762034|470787666|FG000|Maintenance Period|Withdrawal by Subject|34|||
130770763|NCT00762034|470787667|FG001|Maintenance Period|Withdrawal by Subject|14|||
130770764|NCT00762034|470787666|FG000|Maintenance Period|Death not due to study disease|2|||
130770765|NCT00762034|470787667|FG001|Maintenance Period|Death not due to study disease|5|||
130770766|NCT00762034|470787666|FG000|Maintenance Period|Death due to study disease|3|||
130770767|NCT00762034|470787667|FG001|Maintenance Period|Death due to study disease|3|||
130770768|NCT00762034|470787666|FG000|Maintenance Period|Other|1|||
130770769|NCT00762034|470787667|FG001|Maintenance Period|Other|1|||
130931235|NCT00166114|471379050|FG001|Overall Study|Adverse Event|1|||
131034993|NCT03544281|471761831|FG006|Main Study Phase|Investigator Site Closed|0|||
130770770|NCT01299896|470787668|FG000|Overall Study|Withdrawal by Subject|1|||
130770771|NCT01299896|470787669|FG001|Overall Study|Withdrawal by Subject|7|||
130931236|NCT00127660|471379054|FG000|Overall Study|Protocol Violation|3|||
130931237|NCT00127660|471379055|FG001|Overall Study|Protocol Violation|3|||
130931238|NCT00127660|471379056|FG002|Overall Study|Protocol Violation|5|||
130931239|NCT00127660|471379057|FG003|Overall Study|Protocol Violation|0|||
130931240|NCT01402492|471379059|FG000|Overall Study|Withdrawal by Subject|17|||
130931241|NCT01402492|471379060|FG001|Overall Study|Withdrawal by Subject|11|||
130931242|NCT01402492|471379061|FG002|Overall Study|Withdrawal by Subject|11|||
130931243|NCT01402492|471379059|FG000|Overall Study|Adverse Event|2|||
130770772|NCT01299896|470787668|FG000|Overall Study|Lost to Follow-up|0|||
130770773|NCT01299896|470787669|FG001|Overall Study|Lost to Follow-up|11|||
130770774|NCT02107313|470787670|FG000|Overall Study|One participant did not do the FED cohor|0|||
130703903|NCT01362296|470539757|FG003|Crossover Phase|Adverse Event|0|||
130703904|NCT01362296|470539754|FG000|Crossover Phase|Study Closed/Terminated|0|||
130703905|NCT01362296|470539755|FG001|Crossover Phase|Study Closed/Terminated|0|||
130703906|NCT01362296|470539756|FG002|Crossover Phase|Study Closed/Terminated|1|||
130703907|NCT01362296|470539757|FG003|Crossover Phase|Study Closed/Terminated|0|||
130703908|NCT04149535|470539762|FG000|Overall Study|Death|11|||
130703909|NCT04149535|470539763|FG001|Overall Study|Death|7|||
130703910|NCT04149535|470539762|FG000|Overall Study|Physician Decision|10|||
130703911|NCT04149535|470539763|FG001|Overall Study|Physician Decision|4|||
130703912|NCT04149535|470539762|FG000|Overall Study|Withdrawal by Subject|6|||
130703913|NCT04149535|470539763|FG001|Overall Study|Withdrawal by Subject|7|||
130931244|NCT01402492|471379060|FG001|Overall Study|Adverse Event|3|||
130931245|NCT01402492|471379061|FG002|Overall Study|Adverse Event|4|||
130931246|NCT01402492|471379059|FG000|Overall Study|Physician Decision|0|||
130931247|NCT01402492|471379060|FG001|Overall Study|Physician Decision|3|||
130931248|NCT01402492|471379061|FG002|Overall Study|Physician Decision|0|||
130931249|NCT01402492|471379059|FG000|Overall Study|Incarcerated (N=3)|2|||
130931250|NCT01402492|471379060|FG001|Overall Study|Incarcerated (N=3)|0|||
130931251|NCT01402492|471379061|FG002|Overall Study|Incarcerated (N=3)|1|||
130931252|NCT00171730|471379064|FG000|Overall Study|Adverse Event|3|||
130931253|NCT00171730|471379064|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
130931254|NCT00171730|471379064|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
130931255|NCT00171730|471379064|FG000|Overall Study|Withdrawal by Subject|3|||
130931256|NCT02220205|471379065|FG000|Overall Study|Withdrawal by Subject|1|||
130703914|NCT04149535|470539762|FG000|Overall Study|Not described|2|||
130703915|NCT04149535|470539763|FG001|Overall Study|Not described|0|||
130703916|NCT02839798|470541141|FG000|Overall Study|Withdrawal by Subject|2|||
130703917|NCT04703855|470541142|FG000|Overall Study|Heart Transplant|1|||
130931257|NCT02220205|471379066|FG001|Overall Study|Withdrawal by Subject|0|||
130931258|NCT02266225|471379067|FG000|Overall Study|Lost to Follow-up|2|||
130931259|NCT02266225|471379067|FG000|Overall Study|Death|1|||
130931260|NCT02266225|471379067|FG000|Overall Study|Withdrawal by Subject|13|||
130931261|NCT01465997|471379068|FG000|Overall Study|Adverse Event|12|||
130931262|NCT01465997|471379069|FG001|Overall Study|Adverse Event|22|||
130931263|NCT01465997|471379068|FG000|Overall Study|Lack of Efficacy|13|||
130931264|NCT01465997|471379069|FG001|Overall Study|Lack of Efficacy|1|||
130931265|NCT01465997|471379068|FG000|Overall Study|Protocol Violation|1|||
130931266|NCT01465997|471379069|FG001|Overall Study|Protocol Violation|4|||
130931267|NCT01465997|471379068|FG000|Overall Study|Lost to Follow-up|6|||
130931268|NCT01465997|471379069|FG001|Overall Study|Lost to Follow-up|9|||
130931269|NCT01465997|471379068|FG000|Overall Study|Withdrawal by Subject|32|||
130931270|NCT01465997|471379069|FG001|Overall Study|Withdrawal by Subject|35|||
130931271|NCT01465997|471379068|FG000|Overall Study|investigator's decision|1|||
130931272|NCT01465997|471379069|FG001|Overall Study|investigator's decision|1|||
130931273|NCT01465997|471379068|FG000|Overall Study|Death|0|||
130931274|NCT01465997|471379069|FG001|Overall Study|Death|1|||
130931275|NCT01465997|471379068|FG000|Overall Study|sponsor's decision|1|||
130931276|NCT01465997|471379069|FG001|Overall Study|sponsor's decision|1|||
130931277|NCT01465997|471379068|FG000|Overall Study|subject withdrew consent|1|||
130931278|NCT01465997|471379069|FG001|Overall Study|subject withdrew consent|0|||
130931279|NCT01465997|471379068|FG000|Overall Study|local lab unblinded site|1|||
130931280|NCT01465997|471379069|FG001|Overall Study|local lab unblinded site|0|||
130931281|NCT01465997|471379068|FG000|Overall Study|withdrew before follow-up|0|||
130931282|NCT01465997|471379069|FG001|Overall Study|withdrew before follow-up|13|||
130931283|NCT01465997|471379068|FG000|Overall Study|decision by site staff|0|||
130931284|NCT01465997|471379069|FG001|Overall Study|decision by site staff|1|||
130931285|NCT01465997|471379068|FG000|Overall Study|subject left participation SP0993|0|||
130931286|NCT01465997|471379069|FG001|Overall Study|subject left participation SP0993|1|||
130931287|NCT02246660|471379070|FG000|Overall Study|Withdrawal by Subject|0|||
130931288|NCT02246660|471379071|FG001|Overall Study|Withdrawal by Subject|1|||
130931289|NCT02246660|471379072|FG002|Overall Study|Withdrawal by Subject|0|||
130931290|NCT02246660|471379070|FG000|Overall Study|Death|0|||
130931291|NCT02246660|471379071|FG001|Overall Study|Death|0|||
130931292|NCT02246660|471379072|FG002|Overall Study|Death|1|||
130931293|NCT03018704|471379073|FG000|Overall Study|Lost to Follow-up|1|||
130931294|NCT03018704|471379074|FG001|Overall Study|Lost to Follow-up|1|||
130931295|NCT00642460|471379077|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
130931296|NCT00642460|471379078|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
130931297|NCT00642460|471379079|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
130931298|NCT00642460|471379080|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
130931299|NCT00642460|471379081|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
131034994|NCT03544281|471761832|FG007|Main Study Phase|Investigator Site Closed|0|||
130703918|NCT00401245|470541143|FG000|Double Blind Titration Phase|Adverse Event|3|||
130703919|NCT00401245|470541144|FG001|Double Blind Titration Phase|Adverse Event|2|||
130703920|NCT00401245|470541145|FG002|Double Blind Titration Phase|Adverse Event|5|||
130703921|NCT00401245|470541146|FG003|Double Blind Titration Phase|Adverse Event|12|||
130931300|NCT00642460|471379082|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
130931301|NCT00642460|471379077|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
130931302|NCT00642460|471379078|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
130931303|NCT00642460|471379079|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
130931304|NCT00642460|471379080|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
130931305|NCT00642460|471379081|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
130931306|NCT00642460|471379082|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
130931307|NCT00642460|471379077|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
130931308|NCT00642460|471379078|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
130931309|NCT00642460|471379079|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
130931310|NCT00642460|471379080|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
130931311|NCT00642460|471379081|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
130931312|NCT00642460|471379082|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
130931313|NCT00642460|471379077|FG000|Part II: Open-Label Up to Week 92|Death|0|||
130931314|NCT00642460|471379078|FG001|Part II: Open-Label Up to Week 92|Death|1|||
130931315|NCT00642460|471379079|FG002|Part II: Open-Label Up to Week 92|Death|0|||
130931316|NCT00642460|471379080|FG003|Part II: Open-Label Up to Week 92|Death|2|||
130931317|NCT00642460|471379081|FG004|Part II: Open-Label Up to Week 92|Death|0|||
130931318|NCT00642460|471379082|FG005|Part II: Open-Label Up to Week 92|Death|0|||
130931319|NCT00642460|471379077|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
130931320|NCT00642460|471379078|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
130931321|NCT00642460|471379079|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
130931322|NCT00642460|471379080|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
130931323|NCT00642460|471379081|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
130931324|NCT00642460|471379082|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
130931325|NCT00642460|471379077|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
130931326|NCT00642460|471379078|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
130931327|NCT00642460|471379079|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
130931328|NCT00642460|471379080|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
130931329|NCT00642460|471379081|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
130931330|NCT00642460|471379082|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
130931331|NCT00642460|471379077|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
130931332|NCT00642460|471379078|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
130931333|NCT00642460|471379079|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
130931334|NCT00642460|471379080|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
130931335|NCT00642460|471379081|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
130931336|NCT00642460|471379082|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
130931337|NCT00642460|471379077|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
130931338|NCT00642460|471379078|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
130931339|NCT00642460|471379079|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
130931340|NCT00642460|471379080|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
130931341|NCT00642460|471379081|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
130931342|NCT00642460|471379082|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
130931343|NCT00642460|471379077|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
130931344|NCT00642460|471379078|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
130931345|NCT00642460|471379079|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
130931346|NCT00642460|471379080|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
130931347|NCT00642460|471379081|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
130931348|NCT00642460|471379082|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
130931349|NCT00642460|471379077|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
130931350|NCT00642460|471379078|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
130931351|NCT00642460|471379079|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
130931352|NCT00642460|471379080|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
130931353|NCT00642460|471379081|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
131034995|NCT03544281|471761833|FG008|Main Study Phase|Investigator Site Closed|0|||
130703922|NCT00401245|470541147|FG004|Double Blind Titration Phase|Adverse Event|0|||
130703923|NCT00401245|470541148|FG005|Double Blind Titration Phase|Adverse Event|0|||
130703924|NCT00401245|470541149|FG006|Double Blind Titration Phase|Adverse Event|0|||
130703925|NCT00401245|470541150|FG007|Double Blind Titration Phase|Adverse Event|0|||
130703926|NCT00401245|470541143|FG000|Double Blind Titration Phase|Other|0|||
130703927|NCT00401245|470541144|FG001|Double Blind Titration Phase|Other|0|||
130703928|NCT00401245|470541145|FG002|Double Blind Titration Phase|Other|1|||
130703929|NCT00401245|470541146|FG003|Double Blind Titration Phase|Other|0|||
130703930|NCT00401245|470541147|FG004|Double Blind Titration Phase|Other|0|||
131034996|NCT03544281|471761834|FG009|Main Study Phase|Investigator Site Closed|1|||
130931354|NCT00642460|471379082|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
131034997|NCT03544281|471761835|FG010|Main Study Phase|Investigator Site Closed|0|||
130703931|NCT00401245|470541148|FG005|Double Blind Titration Phase|Other|0|||
130703932|NCT00401245|470541149|FG006|Double Blind Titration Phase|Other|0|||
130703933|NCT00401245|470541150|FG007|Double Blind Titration Phase|Other|0|||
130703934|NCT00401245|470541143|FG000|Double Blind Titration Phase|Protocol Violation|0|||
130703935|NCT00401245|470541144|FG001|Double Blind Titration Phase|Protocol Violation|0|||
130703936|NCT00401245|470541145|FG002|Double Blind Titration Phase|Protocol Violation|0|||
130703937|NCT00401245|470541146|FG003|Double Blind Titration Phase|Protocol Violation|1|||
130703938|NCT00401245|470541147|FG004|Double Blind Titration Phase|Protocol Violation|0|||
130703939|NCT00401245|470541148|FG005|Double Blind Titration Phase|Protocol Violation|0|||
130703940|NCT00401245|470541149|FG006|Double Blind Titration Phase|Protocol Violation|0|||
130703941|NCT00401245|470541150|FG007|Double Blind Titration Phase|Protocol Violation|0|||
130703942|NCT00401245|470541143|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
130703943|NCT00401245|470541144|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
130703944|NCT00401245|470541145|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
130703945|NCT00401245|470541146|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
130703946|NCT00401245|470541147|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
130703947|NCT00401245|470541148|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
130703948|NCT00401245|470541149|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
130703949|NCT00401245|470541150|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
130703950|NCT00401245|470541143|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703951|NCT00401245|470541144|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
130703952|NCT00401245|470541145|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703953|NCT00401245|470541146|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
130703954|NCT00401245|470541147|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703955|NCT00401245|470541148|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703956|NCT00401245|470541149|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703957|NCT00401245|470541150|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130703958|NCT00401245|470541143|FG000|Open Label Phase|Adverse Event|5|||
130703959|NCT00401245|470541144|FG001|Open Label Phase|Adverse Event|14|||
130703960|NCT00401245|470541145|FG002|Open Label Phase|Adverse Event|6|||
130703961|NCT00401245|470541146|FG003|Open Label Phase|Adverse Event|7|||
130703962|NCT00401245|470541147|FG004|Open Label Phase|Adverse Event|0|||
130703963|NCT00401245|470541148|FG005|Open Label Phase|Adverse Event|0|||
130703964|NCT00401245|470541149|FG006|Open Label Phase|Adverse Event|0|||
130703965|NCT00401245|470541150|FG007|Open Label Phase|Adverse Event|0|||
130703966|NCT00401245|470541143|FG000|Open Label Phase|Lost to Follow-up|5|||
130703967|NCT00401245|470541144|FG001|Open Label Phase|Lost to Follow-up|7|||
130703968|NCT00401245|470541145|FG002|Open Label Phase|Lost to Follow-up|5|||
130703969|NCT00401245|470541146|FG003|Open Label Phase|Lost to Follow-up|4|||
130703970|NCT00401245|470541147|FG004|Open Label Phase|Lost to Follow-up|0|||
130703971|NCT00401245|470541148|FG005|Open Label Phase|Lost to Follow-up|0|||
130703972|NCT00401245|470541149|FG006|Open Label Phase|Lost to Follow-up|0|||
130703973|NCT00401245|470541150|FG007|Open Label Phase|Lost to Follow-up|0|||
130703974|NCT00401245|470541143|FG000|Open Label Phase|Other|4|||
130703975|NCT00401245|470541144|FG001|Open Label Phase|Other|8|||
130703976|NCT00401245|470541145|FG002|Open Label Phase|Other|7|||
130770775|NCT02107313|470787671|FG001|Overall Study|One participant did not do the FED cohor|1|||
130770776|NCT00582426|470787682|FG000|Overall Study|Lost to Follow-up|0|||
130931355|NCT00642460|471379077|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
130931356|NCT00642460|471379078|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
130931357|NCT00642460|471379079|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
130931358|NCT00642460|471379080|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
130931359|NCT00642460|471379081|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
130931360|NCT00642460|471379082|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
130931361|NCT00642460|471379077|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
130931362|NCT00642460|471379078|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
130931363|NCT00642460|471379079|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
130931364|NCT00642460|471379080|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
130931365|NCT00642460|471379081|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
130931366|NCT00642460|471379082|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
130931367|NCT00642460|471379077|FG000|Part III: Open-Label Up to Week 260|Other|0|||
130931368|NCT00642460|471379078|FG001|Part III: Open-Label Up to Week 260|Other|0|||
130931369|NCT00642460|471379079|FG002|Part III: Open-Label Up to Week 260|Other|0|||
130931370|NCT00642460|471379080|FG003|Part III: Open-Label Up to Week 260|Other|0|||
130931371|NCT00642460|471379081|FG004|Part III: Open-Label Up to Week 260|Other|2|||
130931372|NCT00642460|471379082|FG005|Part III: Open-Label Up to Week 260|Other|2|||
130703977|NCT00401245|470541146|FG003|Open Label Phase|Other|8|||
130931373|NCT00642460|471379077|FG000|Part III: Open-Label Up to Week 260|Death|0|||
130931374|NCT00642460|471379078|FG001|Part III: Open-Label Up to Week 260|Death|0|||
131034998|NCT03544281|471761836|FG011|Main Study Phase|Investigator Site Closed|0|||
130703978|NCT00401245|470541147|FG004|Open Label Phase|Other|0|||
130931375|NCT00642460|471379079|FG002|Part III: Open-Label Up to Week 260|Death|0|||
130931376|NCT00642460|471379080|FG003|Part III: Open-Label Up to Week 260|Death|0|||
130931377|NCT00642460|471379081|FG004|Part III: Open-Label Up to Week 260|Death|0|||
130931378|NCT00642460|471379082|FG005|Part III: Open-Label Up to Week 260|Death|3|||
130931379|NCT00642460|471379077|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
130931380|NCT00642460|471379078|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
130931381|NCT00642460|471379079|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
130931382|NCT00642460|471379080|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
130931383|NCT00642460|471379081|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
130931384|NCT00642460|471379082|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
130931385|NCT00642460|471379077|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
130931386|NCT00642460|471379078|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
130931387|NCT00642460|471379079|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
130931388|NCT00642460|471379080|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
130931389|NCT00642460|471379081|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
130931390|NCT00642460|471379082|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
130931391|NCT02557646|471379085|FG000|Overall Study|Adverse Event|40|||
130931392|NCT02557646|471379085|FG000|Overall Study|Death|1|||
130931393|NCT02557646|471379085|FG000|Overall Study|Lack of Efficacy|186|||
130931394|NCT02557646|471379085|FG000|Overall Study|Withdrawal by Subject|18|||
130931395|NCT02557646|471379085|FG000|Overall Study|Lost to Follow-up|17|||
130931396|NCT02557646|471379085|FG000|Overall Study|Other|14|||
130931397|NCT04448171|471379086|FG000|Overall Study|Procedure Cancelled|1|||
130931398|NCT04448171|471379087|FG001|Overall Study|Procedure Cancelled|0|||
130931399|NCT04448171|471379086|FG000|Overall Study|Protocol Violation|1|||
130931400|NCT04448171|471379087|FG001|Overall Study|Protocol Violation|0|||
130931401|NCT04605484|471379090|FG000|Overall Study|Lost to Follow-up|0|||
130931402|NCT04605484|471379091|FG001|Overall Study|Lost to Follow-up|1|||
130931403|NCT04605484|471379092|FG002|Overall Study|Lost to Follow-up|1|||
130931404|NCT04605484|471379090|FG000|Overall Study|Other|0|||
130931405|NCT04605484|471379091|FG001|Overall Study|Other|1|||
130931406|NCT04605484|471379092|FG002|Overall Study|Other|0|||
130931407|NCT00660309|471379095|FG000|Overall Study|Adverse Event|2|||
130931408|NCT00660309|471379096|FG001|Overall Study|Adverse Event|0|||
130931409|NCT00660309|471379095|FG000|Overall Study|Withdrawal by Subject|0|||
130931410|NCT00660309|471379096|FG001|Overall Study|Withdrawal by Subject|3|||
130931411|NCT02573311|471379099|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
130931412|NCT02573311|471379100|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
130931413|NCT02573311|471379099|FG000|Disposition for Part 2|Physician Decision|25|||
130931414|NCT02573311|471379100|FG001|Disposition for Part 2|Physician Decision|7|||
130931415|NCT02573311|471379099|FG000|Disposition for Part 2|Adverse Event|36|||
130931416|NCT02573311|471379100|FG001|Disposition for Part 2|Adverse Event|5|||
130931417|NCT02573311|471379099|FG000|Disposition for Part 2|Lost to Follow-up|76|||
130931418|NCT02573311|471379100|FG001|Disposition for Part 2|Lost to Follow-up|7|||
130931419|NCT02573311|471379099|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
130931420|NCT02573311|471379100|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
130931421|NCT02573311|471379099|FG000|Disposition for Part 2|Investigator decision|0|||
130931422|NCT02573311|471379100|FG001|Disposition for Part 2|Investigator decision|1|||
130931423|NCT02573311|471379099|FG000|Disposition for Part 2|Other than specified above|13|||
130931424|NCT02573311|471379100|FG001|Disposition for Part 2|Other than specified above|3|||
130931425|NCT04171531|471379102|FG000|Overall Study|Lost to Follow-up|4|||
130931426|NCT04171531|471379103|FG001|Overall Study|Lost to Follow-up|5|||
130931427|NCT04171531|471379102|FG000|Overall Study|Consent only through 6 months|1|||
130931428|NCT04171531|471379103|FG001|Overall Study|Consent only through 6 months|1|||
130931429|NCT04171531|471379102|FG000|Overall Study|Insurance did not cover procedure|0|||
130931430|NCT04171531|471379103|FG001|Overall Study|Insurance did not cover procedure|1|||
130931431|NCT04171531|471379102|FG000|Overall Study|Physician Decision|0|||
130931432|NCT04171531|471379103|FG001|Overall Study|Physician Decision|3|||
130931433|NCT04171531|471379102|FG000|Overall Study|Withdrawal by Subject|1|||
130931434|NCT04171531|471379103|FG001|Overall Study|Withdrawal by Subject|5|||
130931435|NCT04862585|471379106|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
130931436|NCT04862585|471379107|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
130931437|NCT04862585|471379106|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
130931438|NCT04862585|471379107|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
130931439|NCT04862585|471379106|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
130931440|NCT04862585|471379107|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
130931441|NCT04862585|471379106|FG000|Overall Study|one withdrew without providing a reason|0|||
131223741|NCT04380701|472447128|FG019|Overall Study|Pregnancy|0|||
130931442|NCT04862585|471379107|FG001|Overall Study|one withdrew without providing a reason|1|||
131223742|NCT04380701|472447129|FG020|Overall Study|Pregnancy|0|||
131223743|NCT04380701|472447130|FG021|Overall Study|Pregnancy|0|||
131223744|NCT04380701|472447131|FG022|Overall Study|Pregnancy|0|||
130931443|NCT03366337|471379108|FG000|Overall Study|Lost to Follow-up|1|||
130931444|NCT03366337|471379109|FG001|Overall Study|Lost to Follow-up|0|||
130931445|NCT03366337|471379110|FG002|Overall Study|Lost to Follow-up|1|||
130931446|NCT03366337|471379111|FG003|Overall Study|Lost to Follow-up|0|||
130931447|NCT03366337|471379108|FG000|Overall Study|Withdrawal by Subject|2|||
130931448|NCT03366337|471379109|FG001|Overall Study|Withdrawal by Subject|0|||
130931449|NCT03366337|471379110|FG002|Overall Study|Withdrawal by Subject|1|||
130931450|NCT03366337|471379111|FG003|Overall Study|Withdrawal by Subject|1|||
130931451|NCT05288062|471379113|FG000|Overall Study|Ineligible|0|||
130931452|NCT05288062|471379114|FG001|Overall Study|Ineligible|0|||
130931453|NCT05288062|471379115|FG002|Overall Study|Ineligible|1|||
130931454|NCT05288062|471379116|FG003|Overall Study|Ineligible|0|||
130931455|NCT05288062|471379113|FG000|Overall Study|Withdrawal by Subject|0|||
130931456|NCT05288062|471379114|FG001|Overall Study|Withdrawal by Subject|0|||
130931457|NCT05288062|471379115|FG002|Overall Study|Withdrawal by Subject|1|||
130931458|NCT05288062|471379116|FG003|Overall Study|Withdrawal by Subject|0|||
130931459|NCT00211809|471379117|FG000|Overall Study|Lack of Efficacy|1|||
130931460|NCT00211809|471379117|FG000|Overall Study|Lost to Follow-up|2|||
130931461|NCT00211809|471379117|FG000|Overall Study|Pregnancy|1|||
130931462|NCT00211809|471379117|FG000|Overall Study|side effects|2|||
130931463|NCT00496470|471379118|FG000|Overall Study|Adverse Event|8|||
130931464|NCT00496470|471379119|FG001|Overall Study|Adverse Event|10|||
130931465|NCT00496470|471379118|FG000|Overall Study|Withdrawal by Subject|5|||
130931466|NCT00496470|471379119|FG001|Overall Study|Withdrawal by Subject|12|||
130931467|NCT00496470|471379118|FG000|Overall Study|Incorrectly enrolled|13|||
130931468|NCT00496470|471379119|FG001|Overall Study|Incorrectly enrolled|5|||
130931469|NCT00496470|471379118|FG000|Overall Study|Other reason|0|||
130931470|NCT00496470|471379119|FG001|Overall Study|Other reason|2|||
130931471|NCT01370356|471379120|FG000|Overall Study|Death|1|||
130931472|NCT01370356|471379121|FG001|Overall Study|Death|0|||
130931473|NCT01370356|471379120|FG000|Overall Study|Lack of Efficacy|6|||
130931474|NCT01370356|471379121|FG001|Overall Study|Lack of Efficacy|28|||
130931475|NCT01370356|471379120|FG000|Overall Study|Lost to Follow-up|76|||
130931476|NCT01370356|471379121|FG001|Overall Study|Lost to Follow-up|81|||
130931477|NCT01370356|471379120|FG000|Overall Study|Withdrawal by Subject|54|||
130931478|NCT01370356|471379121|FG001|Overall Study|Withdrawal by Subject|59|||
130931479|NCT01370356|471379120|FG000|Overall Study|Reason not specified|39|||
130931480|NCT01370356|471379121|FG001|Overall Study|Reason not specified|43|||
130931481|NCT01370356|471379120|FG000|Overall Study|Protocol Violation|3|||
130931482|NCT01370356|471379121|FG001|Overall Study|Protocol Violation|3|||
130931483|NCT01370356|471379120|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
130931484|NCT01370356|471379121|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
130931485|NCT01370356|471379120|FG000|Overall Study|AE Not Related to Study Drug|1|||
130931486|NCT01370356|471379121|FG001|Overall Study|AE Not Related to Study Drug|4|||
130931487|NCT00729651|471379122|FG000|Overall Study|Withdrawal by Subject|5|||
130931488|NCT00729651|471379123|FG001|Overall Study|Withdrawal by Subject|6|||
130931489|NCT00729651|471379122|FG000|Overall Study|Lost to Follow-up|5|||
130931490|NCT00729651|471379123|FG001|Overall Study|Lost to Follow-up|4|||
130703979|NCT00401245|470541148|FG005|Open Label Phase|Other|0|||
130703980|NCT00401245|470541149|FG006|Open Label Phase|Other|0|||
130931491|NCT00729651|471379122|FG000|Overall Study|Protocol Violation|0|||
130931492|NCT00729651|471379123|FG001|Overall Study|Protocol Violation|1|||
130931493|NCT00729651|471379122|FG000|Overall Study|Adverse Event|7|||
130931494|NCT00729651|471379123|FG001|Overall Study|Adverse Event|3|||
130931495|NCT00729651|471379122|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
130931496|NCT00729651|471379123|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
130931497|NCT00729651|471379122|FG000|Overall Study|Subject's private reason|2|||
130931498|NCT00729651|471379123|FG001|Overall Study|Subject's private reason|0|||
130931499|NCT01218243|471379124|FG000|Overall Study|Lack of Efficacy|1|||
130931500|NCT01218243|471379125|FG001|Overall Study|Lack of Efficacy|1|||
130931501|NCT01218243|471379124|FG000|Overall Study|Lost to Follow-up|3|||
130931502|NCT01218243|471379125|FG001|Overall Study|Lost to Follow-up|3|||
130931503|NCT01218243|471379124|FG000|Overall Study|Protocol Violation|5|||
130931504|NCT01218243|471379125|FG001|Overall Study|Protocol Violation|10|||
130931505|NCT02854631|471379126|FG000|Overall Study|Adverse Event|1|||
130931506|NCT02854631|471379127|FG001|Overall Study|Adverse Event|2|||
130931507|NCT02854631|471379126|FG000|Overall Study|Withdrew Consent|3|||
130931508|NCT02854631|471379127|FG001|Overall Study|Withdrew Consent|2|||
130931509|NCT02854631|471379126|FG000|Overall Study|Investigator's Discretion|2|||
130931510|NCT02854631|471379127|FG001|Overall Study|Investigator's Discretion|0|||
130931511|NCT02854631|471379126|FG000|Overall Study|Death|12|||
130931512|NCT02854631|471379127|FG001|Overall Study|Death|8|||
130931513|NCT02854631|471379126|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
130931514|NCT02854631|471379127|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
130931515|NCT02854631|471379126|FG000|Overall Study|Protocol Violation|0|||
131223745|NCT04380701|472447132|FG023|Overall Study|Pregnancy|0|||
130931516|NCT02854631|471379127|FG001|Overall Study|Protocol Violation|1|||
130931517|NCT02854631|471379126|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
131223746|NCT04380701|472447133|FG024|Overall Study|Pregnancy|0|||
130931518|NCT02854631|471379127|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
130931519|NCT02854631|471379126|FG000|Overall Study|Lost to Follow-up|4|||
130931520|NCT02854631|471379127|FG001|Overall Study|Lost to Follow-up|2|||
130931521|NCT03200860|471379128|FG000|Overall Study|Withdrawal by Subject|1|||
130931522|NCT03200860|471379129|FG001|Overall Study|Withdrawal by Subject|0|||
130931523|NCT00844896|471379130|FG000|Overall Study|Lost to Follow-up|12|||
130931524|NCT00844896|471379131|FG001|Overall Study|Lost to Follow-up|16|||
130931525|NCT00844896|471379130|FG000|Overall Study|Parents did not have time to complete|0|||
130931526|NCT00844896|471379131|FG001|Overall Study|Parents did not have time to complete|1|||
130931527|NCT02233647|471379135|FG000|Overall Study|Adverse Event|1|||
130931528|NCT04342897|471379136|FG000|Overall Study|Death|7|||
130931529|NCT04342897|471379137|FG001|Overall Study|Death|4|||
130931530|NCT04342897|471379136|FG000|Overall Study|Lost to Follow-up|6|||
130931531|NCT04342897|471379137|FG001|Overall Study|Lost to Follow-up|6|||
130931532|NCT04342897|471379136|FG000|Overall Study|Withdrawal by Subject|1|||
130931533|NCT04342897|471379137|FG001|Overall Study|Withdrawal by Subject|2|||
130931534|NCT02846779|471379139|FG000|Overall Study|Lost Enrollment|83|||
130931535|NCT02846779|471379140|FG001|Overall Study|Lost Enrollment|82|||
130931536|NCT02846779|471379141|FG002|Overall Study|Lost Enrollment|86|||
130931537|NCT02846779|471379139|FG000|Overall Study|Less than 31 days of follow-up|56|||
130931538|NCT02846779|471379140|FG001|Overall Study|Less than 31 days of follow-up|45|||
130931539|NCT02846779|471379141|FG002|Overall Study|Less than 31 days of follow-up|52|||
130931540|NCT05475236|471379144|FG000|Overall Study|Withdrawal by Subject|0|||
130931541|NCT05475236|471379145|FG001|Overall Study|Withdrawal by Subject|1|||
130931542|NCT02324569|471380762|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
130931543|NCT02324569|471380763|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
130931544|NCT02324569|471380762|FG000|Overall Study|Voluntary Withdrawal|3|||
130931545|NCT02324569|471380763|FG001|Overall Study|Voluntary Withdrawal|6|||
130931546|NCT02324569|471380762|FG000|Overall Study|Lack of Efficacy|2|||
130931547|NCT02324569|471380763|FG001|Overall Study|Lack of Efficacy|3|||
130931548|NCT02324569|471380762|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
130931549|NCT02324569|471380763|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
130931550|NCT02324569|471380762|FG000|Overall Study|Inconvenient Schedule|2|||
130931551|NCT02324569|471380763|FG001|Overall Study|Inconvenient Schedule|0|||
130931552|NCT01411774|471380784|FG000|Overall Study|Withdrawal by Subject|0|||
130931553|NCT01411774|471380785|FG001|Overall Study|Withdrawal by Subject|3|||
130931554|NCT02990910|471380787|FG000|Overall Study|Lack of Efficacy|6|||
130770777|NCT00582426|470787683|FG001|Overall Study|Lost to Follow-up|2|||
130770778|NCT00582426|470787682|FG000|Overall Study|Adverse Event|4|||
130770779|NCT00582426|470787683|FG001|Overall Study|Adverse Event|2|||
130770780|NCT00582426|470787682|FG000|Overall Study|Protocol Violation|6|||
130931555|NCT02990910|471380788|FG001|Overall Study|Lack of Efficacy|10|||
130931556|NCT00684307|471380793|FG000|Overall Study|Adverse Event|11|||
130931557|NCT00684307|471380794|FG001|Overall Study|Adverse Event|6|||
130931558|NCT00684307|471380795|FG002|Overall Study|Adverse Event|15|||
130931559|NCT00684307|471380796|FG003|Overall Study|Adverse Event|16|||
130931560|NCT00684307|471380797|FG004|Overall Study|Adverse Event|8|||
130931561|NCT00684307|471380793|FG000|Overall Study|Development of increasing Liver Function|0|||
130931562|NCT00684307|471380794|FG001|Overall Study|Development of increasing Liver Function|2|||
130931563|NCT00684307|471380795|FG002|Overall Study|Development of increasing Liver Function|0|||
130931564|NCT00684307|471380796|FG003|Overall Study|Development of increasing Liver Function|1|||
130931565|NCT00684307|471380797|FG004|Overall Study|Development of increasing Liver Function|0|||
130931566|NCT00684307|471380793|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
130931567|NCT00684307|471380794|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
130931568|NCT00684307|471380795|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
130931569|NCT00684307|471380796|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
130931570|NCT00684307|471380797|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
130931571|NCT00684307|471380793|FG000|Overall Study|Incorrect enrolment or randomization|4|||
130931572|NCT00684307|471380794|FG001|Overall Study|Incorrect enrolment or randomization|0|||
130931573|NCT00684307|471380795|FG002|Overall Study|Incorrect enrolment or randomization|0|||
130931574|NCT00684307|471380796|FG003|Overall Study|Incorrect enrolment or randomization|0|||
130931575|NCT00684307|471380797|FG004|Overall Study|Incorrect enrolment or randomization|0|||
130931576|NCT00684307|471380793|FG000|Overall Study|Interupted IP for more than 7 days|0|||
130931577|NCT00684307|471380794|FG001|Overall Study|Interupted IP for more than 7 days|4|||
130931578|NCT00684307|471380795|FG002|Overall Study|Interupted IP for more than 7 days|1|||
130931579|NCT00684307|471380796|FG003|Overall Study|Interupted IP for more than 7 days|3|||
130931580|NCT00684307|471380797|FG004|Overall Study|Interupted IP for more than 7 days|3|||
130770781|NCT00582426|470787683|FG001|Overall Study|Protocol Violation|2|||
130770782|NCT00582426|470787682|FG000|Overall Study|Death|4|||
130770783|NCT00582426|470787683|FG001|Overall Study|Death|3|||
130931581|NCT00684307|471380793|FG000|Overall Study|Severe non compliance to protocol|1|||
130931582|NCT00684307|471380794|FG001|Overall Study|Severe non compliance to protocol|0|||
130931583|NCT00684307|471380795|FG002|Overall Study|Severe non compliance to protocol|0|||
130931584|NCT00684307|471380796|FG003|Overall Study|Severe non compliance to protocol|1|||
130931585|NCT00684307|471380797|FG004|Overall Study|Severe non compliance to protocol|2|||
130931586|NCT00684307|471380793|FG000|Overall Study|Participant not willing to continue|7|||
130931587|NCT00684307|471380794|FG001|Overall Study|Participant not willing to continue|10|||
130931588|NCT00684307|471380795|FG002|Overall Study|Participant not willing to continue|11|||
130931589|NCT00684307|471380796|FG003|Overall Study|Participant not willing to continue|5|||
130931590|NCT00684307|471380797|FG004|Overall Study|Participant not willing to continue|8|||
130931591|NCT00684307|471380793|FG000|Overall Study|Criteria from the CSR|0|||
130931592|NCT00684307|471380794|FG001|Overall Study|Criteria from the CSR|0|||
130931593|NCT00684307|471380795|FG002|Overall Study|Criteria from the CSR|1|||
130931594|NCT00684307|471380796|FG003|Overall Study|Criteria from the CSR|3|||
130931595|NCT00684307|471380797|FG004|Overall Study|Criteria from the CSR|3|||
130931596|NCT02430311|471380798|FG000|Part A|Adverse Event|0|||
130931597|NCT02430311|471380799|FG001|Part A|Adverse Event|1|||
130931598|NCT02430311|471380798|FG000|Part A|Withdrawal by Subject|1|||
130931599|NCT02430311|471380799|FG001|Part A|Withdrawal by Subject|0|||
130931600|NCT02430311|471380798|FG000|Part B|Meet study-specific withdrawal criteria|6|||
130931601|NCT02430311|471380799|FG001|Part B|Meet study-specific withdrawal criteria|6|||
130931602|NCT02430311|471380798|FG000|Part B|Withdrawal by Subject|2|||
130931603|NCT02430311|471380799|FG001|Part B|Withdrawal by Subject|2|||
130931604|NCT02430311|471380798|FG000|Part B|Adverse Event|1|||
130931605|NCT02430311|471380799|FG001|Part B|Adverse Event|0|||
130931606|NCT02430311|471380798|FG000|Part B|Death|1|||
130931607|NCT02430311|471380799|FG001|Part B|Death|0|||
130931608|NCT04160091|471380800|FG000|Overall Study|Terminated by Sponsor|7|||
130931609|NCT04160091|471380801|FG001|Overall Study|Terminated by Sponsor|3|||
130931610|NCT04160091|471380802|FG002|Overall Study|Terminated by Sponsor|5|||
130931611|NCT04160091|471380803|FG003|Overall Study|Terminated by Sponsor|2|||
130931612|NCT04160091|471380800|FG000|Overall Study|Noncompliance|0|||
130931613|NCT04160091|471380801|FG001|Overall Study|Noncompliance|0|||
130931614|NCT04160091|471380802|FG002|Overall Study|Noncompliance|0|||
130931615|NCT04160091|471380803|FG003|Overall Study|Noncompliance|1|||
130931616|NCT04160091|471380800|FG000|Overall Study|Withdrawal by Subject|0|||
130931617|NCT04160091|471380801|FG001|Overall Study|Withdrawal by Subject|0|||
130931618|NCT04160091|471380802|FG002|Overall Study|Withdrawal by Subject|0|||
130931619|NCT04160091|471380803|FG003|Overall Study|Withdrawal by Subject|1|||
130931620|NCT00309387|471380808|FG000|Overall Study|Death|72|||
130931621|NCT00309387|471380809|FG001|Overall Study|Death|73|||
130931622|NCT00309387|471380808|FG000|Overall Study|Lost to Follow-up|70|||
130931623|NCT00309387|471380809|FG001|Overall Study|Lost to Follow-up|86|||
130931624|NCT02483520|471380810|FG000|Overall Study|Lost to Follow-up|3|||
130931625|NCT02483520|471380811|FG001|Overall Study|Lost to Follow-up|4|||
130931626|NCT02483520|471380810|FG000|Overall Study|Withdrawal by Subject|4|||
130931627|NCT02483520|471380811|FG001|Overall Study|Withdrawal by Subject|14|||
130931628|NCT02483520|471380810|FG000|Overall Study|Hospitalized|2|||
130931629|NCT02483520|471380811|FG001|Overall Study|Hospitalized|3|||
130931630|NCT02483520|471380810|FG000|Overall Study|Moved to LTC|2|||
130931631|NCT02483520|471380811|FG001|Overall Study|Moved to LTC|3|||
130931632|NCT01104493|471380812|FG000|Overall Study|Lost to Follow-up|0|||
130931633|NCT01104493|471380813|FG001|Overall Study|Lost to Follow-up|2|||
130931634|NCT01342796|471380815|FG000|Overall Study|Withdrawal by Subject|2|||
130931635|NCT01342796|471380816|FG001|Overall Study|Withdrawal by Subject|0|||
130931636|NCT01342796|471380815|FG000|Overall Study|Lost to Follow-up|0|||
130931637|NCT01342796|471380816|FG001|Overall Study|Lost to Follow-up|3|||
130931638|NCT01342796|471380815|FG000|Overall Study|Inappropriate enrollment|1|||
130931639|NCT01342796|471380816|FG001|Overall Study|Inappropriate enrollment|0|||
130931640|NCT01599234|471380820|FG000|Overall Study|Adverse Event|9|||
130931641|NCT01599234|471380821|FG001|Overall Study|Adverse Event|5|||
130931642|NCT01599234|471380820|FG000|Overall Study|Withdrawal by Subject|2|||
130931643|NCT01599234|471380821|FG001|Overall Study|Withdrawal by Subject|1|||
130931644|NCT01599234|471380820|FG000|Overall Study|Lost to Follow-up|1|||
130931645|NCT01599234|471380821|FG001|Overall Study|Lost to Follow-up|2|||
130931646|NCT01599234|471380820|FG000|Overall Study|Lack of Efficacy|2|||
130931647|NCT01599234|471380821|FG001|Overall Study|Lack of Efficacy|4|||
131034999|NCT03544281|471761837|FG012|Main Study Phase|Investigator Site Closed|0|||
131035000|NCT03544281|471761838|FG013|Main Study Phase|Investigator Site Closed|0|||
131035001|NCT03544281|471761839|FG014|Main Study Phase|Investigator Site Closed|0|||
131035002|NCT03544281|471761840|FG015|Main Study Phase|Investigator Site Closed|0|||
131223747|NCT04380701|472447134|FG025|Overall Study|Pregnancy|0|||
130931648|NCT01599234|471380820|FG000|Overall Study|Unable to operate spray|1|||
130931649|NCT01599234|471380821|FG001|Overall Study|Unable to operate spray|0|||
130931650|NCT01599234|471380820|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
130931651|NCT01599234|471380821|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
130931652|NCT01599234|471380820|FG000|Overall Study|Death|1|||
130931653|NCT01599234|471380821|FG001|Overall Study|Death|0|||
130931654|NCT01599234|471380820|FG000|Overall Study|Patient would not stop driving|1|||
130931655|NCT01599234|471380821|FG001|Overall Study|Patient would not stop driving|0|||
130931656|NCT01599234|471380820|FG000|Overall Study|Contra-indication discovered|0|||
130931657|NCT01599234|471380821|FG001|Overall Study|Contra-indication discovered|1|||
130931658|NCT01599234|471380820|FG000|Overall Study|Pregnancy|0|||
130931659|NCT01599234|471380821|FG001|Overall Study|Pregnancy|1|||
130931660|NCT02485301|471380828|FG000|Overall Study|Serious Adverse Events|2|||
130931661|NCT02485301|471380829|FG001|Overall Study|Serious Adverse Events|1|||
130931662|NCT02485301|471380828|FG000|Overall Study|Protocol Violation|0|||
130931663|NCT02485301|471380829|FG001|Overall Study|Protocol Violation|1|||
130703981|NCT00401245|470541150|FG007|Open Label Phase|Other|0|||
130703982|NCT00401245|470541143|FG000|Open Label Phase|Protocol Violation|0|||
130931664|NCT02485301|471380828|FG000|Overall Study|Withdrawal by Subject|6|||
130931665|NCT02485301|471380829|FG001|Overall Study|Withdrawal by Subject|7|||
130931666|NCT02485301|471380828|FG000|Overall Study|Migrated/moved from study area|10|||
130931667|NCT02485301|471380829|FG001|Overall Study|Migrated/moved from study area|19|||
130931668|NCT02485301|471380828|FG000|Overall Study|Lost to Follow-up|17|||
130931669|NCT02485301|471380829|FG001|Overall Study|Lost to Follow-up|17|||
130931670|NCT02485301|471380828|FG000|Overall Study|Other|3|||
130931671|NCT02485301|471380829|FG001|Overall Study|Other|4|||
131223748|NCT04380701|472447135|FG026|Overall Study|Pregnancy|0|||
130703983|NCT00401245|470541144|FG001|Open Label Phase|Protocol Violation|1|||
130703984|NCT00401245|470541145|FG002|Open Label Phase|Protocol Violation|0|||
130703985|NCT00401245|470541146|FG003|Open Label Phase|Protocol Violation|1|||
130931672|NCT01059825|471380833|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130931673|NCT01059825|471380834|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130931674|NCT01059825|471380835|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130931675|NCT01059825|471380836|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130931676|NCT01059825|471380837|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130931677|NCT01059825|471380838|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
130931678|NCT01059825|471380839|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
130931679|NCT01059825|471380833|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130931680|NCT01059825|471380834|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130931681|NCT01059825|471380835|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130931682|NCT01059825|471380836|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130931683|NCT01059825|471380837|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130931684|NCT01059825|471380838|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
130931685|NCT01059825|471380839|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
130931686|NCT01059825|471380833|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
130931687|NCT01059825|471380834|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
130931688|NCT01059825|471380835|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
130931689|NCT01059825|471380836|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
130931690|NCT01059825|471380837|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
130931691|NCT01059825|471380838|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
130931692|NCT01059825|471380839|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
130931693|NCT01059825|471380833|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130931694|NCT01059825|471380834|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130931695|NCT01059825|471380835|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130931696|NCT01059825|471380836|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130931697|NCT01059825|471380837|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130931698|NCT01059825|471380838|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
130703986|NCT00401245|470541147|FG004|Open Label Phase|Protocol Violation|0|||
130703987|NCT00401245|470541148|FG005|Open Label Phase|Protocol Violation|0|||
130703988|NCT00401245|470541149|FG006|Open Label Phase|Protocol Violation|0|||
130931699|NCT01059825|471380839|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
130931700|NCT01059825|471380833|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
130931701|NCT01059825|471380834|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
130931702|NCT01059825|471380835|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
130931703|NCT01059825|471380836|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
130931704|NCT01059825|471380837|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
130931705|NCT01059825|471380838|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
130703989|NCT00401245|470541150|FG007|Open Label Phase|Protocol Violation|0|||
130703990|NCT00401245|470541143|FG000|Open Label Phase|Withdrawal by Subject|3|||
130703991|NCT00401245|470541144|FG001|Open Label Phase|Withdrawal by Subject|3|||
130703992|NCT00401245|470541145|FG002|Open Label Phase|Withdrawal by Subject|2|||
130703993|NCT00401245|470541146|FG003|Open Label Phase|Withdrawal by Subject|1|||
130703994|NCT00401245|470541147|FG004|Open Label Phase|Withdrawal by Subject|0|||
130703995|NCT00401245|470541148|FG005|Open Label Phase|Withdrawal by Subject|0|||
130770784|NCT00582426|470787682|FG000|Overall Study|Withdrawal by Subject|3|||
130931706|NCT01059825|471380839|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
130931707|NCT01059825|471380833|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
130931708|NCT01059825|471380834|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
130931709|NCT01059825|471380835|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
130931710|NCT01059825|471380836|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
131223749|NCT04380701|472447136|FG027|Overall Study|Pregnancy|0|||
130703996|NCT00401245|470541149|FG006|Open Label Phase|Withdrawal by Subject|0|||
130931711|NCT01059825|471380837|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
130931712|NCT01059825|471380838|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
130931713|NCT01059825|471380839|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
130931714|NCT01059825|471380833|FG000|Treatment Period|Lost to Follow-up|2|||
130931715|NCT01059825|471380834|FG001|Treatment Period|Lost to Follow-up|1|||
130931716|NCT01059825|471380835|FG002|Treatment Period|Lost to Follow-up|0|||
130931717|NCT01059825|471380836|FG003|Treatment Period|Lost to Follow-up|1|||
130931718|NCT01059825|471380837|FG004|Treatment Period|Lost to Follow-up|2|||
130931719|NCT01059825|471380838|FG005|Treatment Period|Lost to Follow-up|0|||
130931720|NCT01059825|471380839|FG006|Treatment Period|Lost to Follow-up|0|||
130931721|NCT01059825|471380833|FG000|Treatment Period|Withdrawal by Subject|3|||
130931722|NCT01059825|471380834|FG001|Treatment Period|Withdrawal by Subject|0|||
130931723|NCT01059825|471380835|FG002|Treatment Period|Withdrawal by Subject|1|||
130931724|NCT01059825|471380836|FG003|Treatment Period|Withdrawal by Subject|5|||
130931725|NCT01059825|471380837|FG004|Treatment Period|Withdrawal by Subject|4|||
130931726|NCT01059825|471380838|FG005|Treatment Period|Withdrawal by Subject|1|||
130931727|NCT01059825|471380839|FG006|Treatment Period|Withdrawal by Subject|0|||
130931728|NCT01059825|471380833|FG000|Treatment Period|Other reason not specified|1|||
130931729|NCT01059825|471380834|FG001|Treatment Period|Other reason not specified|2|||
130931730|NCT01059825|471380835|FG002|Treatment Period|Other reason not specified|1|||
130931731|NCT01059825|471380836|FG003|Treatment Period|Other reason not specified|2|||
130931732|NCT01059825|471380837|FG004|Treatment Period|Other reason not specified|0|||
130931733|NCT01059825|471380838|FG005|Treatment Period|Other reason not specified|0|||
130931734|NCT01059825|471380839|FG006|Treatment Period|Other reason not specified|0|||
130931735|NCT01059825|471380833|FG000|Treatment Period|Protocol Violation|0|||
130931736|NCT01059825|471380834|FG001|Treatment Period|Protocol Violation|0|||
130931737|NCT01059825|471380835|FG002|Treatment Period|Protocol Violation|1|||
130931738|NCT01059825|471380836|FG003|Treatment Period|Protocol Violation|1|||
130931739|NCT01059825|471380837|FG004|Treatment Period|Protocol Violation|1|||
130931740|NCT01059825|471380838|FG005|Treatment Period|Protocol Violation|1|||
130931741|NCT01059825|471380839|FG006|Treatment Period|Protocol Violation|0|||
130931742|NCT01059825|471380833|FG000|Treatment Period|Adverse event related to study drug|1|||
130931743|NCT01059825|471380834|FG001|Treatment Period|Adverse event related to study drug|0|||
130931744|NCT01059825|471380835|FG002|Treatment Period|Adverse event related to study drug|1|||
130931745|NCT01059825|471380836|FG003|Treatment Period|Adverse event related to study drug|1|||
130931746|NCT01059825|471380837|FG004|Treatment Period|Adverse event related to study drug|0|||
130931747|NCT01059825|471380838|FG005|Treatment Period|Adverse event related to study drug|0|||
130931748|NCT01059825|471380839|FG006|Treatment Period|Adverse event related to study drug|0|||
130931749|NCT01059825|471380833|FG000|Treatment Period|Insufficient clinical response|3|||
130931750|NCT01059825|471380834|FG001|Treatment Period|Insufficient clinical response|0|||
130931751|NCT01059825|471380835|FG002|Treatment Period|Insufficient clinical response|0|||
130931752|NCT01059825|471380836|FG003|Treatment Period|Insufficient clinical response|0|||
130931753|NCT01059825|471380837|FG004|Treatment Period|Insufficient clinical response|0|||
130931754|NCT01059825|471380838|FG005|Treatment Period|Insufficient clinical response|0|||
130931755|NCT01059825|471380839|FG006|Treatment Period|Insufficient clinical response|0|||
130931756|NCT01059825|471380833|FG000|Treatment Period|Adverse event not related to study drug|0|||
130931757|NCT01059825|471380834|FG001|Treatment Period|Adverse event not related to study drug|1|||
130931758|NCT01059825|471380835|FG002|Treatment Period|Adverse event not related to study drug|2|||
130931759|NCT01059825|471380836|FG003|Treatment Period|Adverse event not related to study drug|1|||
130931760|NCT01059825|471380837|FG004|Treatment Period|Adverse event not related to study drug|1|||
130931761|NCT01059825|471380838|FG005|Treatment Period|Adverse event not related to study drug|1|||
130931762|NCT01059825|471380839|FG006|Treatment Period|Adverse event not related to study drug|0|||
130931763|NCT03020160|471380840|FG000|Overall Study|Withdrawal by Subject|1|||
130931764|NCT03020160|471380841|FG001|Overall Study|Withdrawal by Subject|0|||
130931765|NCT01513473|471380842|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
130931766|NCT01513473|471380843|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
130931767|NCT01513473|471380842|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
130703997|NCT00401245|470541150|FG007|Open Label Phase|Withdrawal by Subject|0|||
130931768|NCT01513473|471380843|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
130703998|NCT00401245|470541143|FG000|Open Label Phase|Lack of Efficacy|4|||
130703999|NCT00401245|470541144|FG001|Open Label Phase|Lack of Efficacy|2|||
130704000|NCT00401245|470541145|FG002|Open Label Phase|Lack of Efficacy|3|||
130704001|NCT00401245|470541146|FG003|Open Label Phase|Lack of Efficacy|0|||
130931769|NCT01513473|471380842|FG000|Main Trial (26 Weeks)|Unclassified|0|||
130931770|NCT01513473|471380843|FG001|Main Trial (26 Weeks)|Unclassified|2|||
130931771|NCT01513473|471380842|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
130931772|NCT01513473|471380843|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
130931773|NCT01513473|471380842|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
130704002|NCT00401245|470541147|FG004|Open Label Phase|Lack of Efficacy|0|||
130931774|NCT01513473|471380843|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
131223750|NCT04380701|472447137|FG028|Overall Study|Pregnancy|0|||
130704003|NCT00401245|470541148|FG005|Open Label Phase|Lack of Efficacy|0|||
130931775|NCT03462082|471380844|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130931776|NCT03462082|471380845|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130931777|NCT03462082|471380846|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130931778|NCT03462082|471380847|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130931779|NCT03462082|471380848|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130931780|NCT03462082|471380849|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
130931781|NCT03462082|471380850|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
130931782|NCT03462082|471380851|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
130931783|NCT00743340|471380854|FG000|Overall Study|Study medication non-compliance|1|||
130931784|NCT00743340|471380854|FG000|Overall Study|Lost to Follow-up|1|||
130931785|NCT00743340|471380854|FG000|Overall Study|Withdrawal from the Study|5|||
130931786|NCT00743340|471380854|FG000|Overall Study|Protocol Violation|1|||
130931787|NCT00743340|471380854|FG000|Overall Study|Virologic failure|8|||
130931788|NCT00743340|471380854|FG000|Overall Study|Pregnancy|1|||
130931789|NCT00743340|471380854|FG000|Overall Study|Rolled over to other Gilead Study|23|||
130931790|NCT00743340|471380854|FG000|Overall Study|Participant Relocated|1|||
130931791|NCT01425281|471380857|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
130931792|NCT01425281|471380858|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
130931793|NCT01425281|471380857|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
130931794|NCT01425281|471380858|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
130931795|NCT01425281|471380857|FG000|At 180-day Clinical Follow-up|Death|0|||
130931796|NCT01425281|471380858|FG001|At 180-day Clinical Follow-up|Death|1|||
130931797|NCT01425281|471380857|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
130931798|NCT01425281|471380858|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
130931799|NCT01425281|471380857|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
130931800|NCT01425281|471380858|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
130931801|NCT01425281|471380857|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
130931802|NCT01425281|471380858|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
130931803|NCT01425281|471380857|FG000|At 2-year Clinical Follow-up|Death|2|||
130931804|NCT01425281|471380858|FG001|At 2-year Clinical Follow-up|Death|0|||
130931805|NCT01425281|471380857|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
130931806|NCT01425281|471380858|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
130931807|NCT01425281|471380857|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
130931808|NCT01425281|471380858|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
130931809|NCT01425281|471380857|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
130931810|NCT01425281|471380858|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
130931811|NCT01425281|471380857|FG000|At 3-year Clinical Follow-up|Death|2|||
130931812|NCT01425281|471380858|FG001|At 3-year Clinical Follow-up|Death|3|||
130931813|NCT01425281|471380857|FG000|At 4-year Clinical Follow-up|Death|7|||
130931814|NCT01425281|471380858|FG001|At 4-year Clinical Follow-up|Death|3|||
130931815|NCT01425281|471380857|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
130931816|NCT01425281|471380858|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
130931817|NCT01425281|471380857|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
130931818|NCT01425281|471380858|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
130931819|NCT01425281|471380857|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
130931820|NCT01425281|471380858|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
130931821|NCT01425281|471380857|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
130931822|NCT01425281|471380858|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
130931823|NCT01425281|471380857|FG000|At 5-year Clinical Follow-up|Death|2|||
130931824|NCT01425281|471380858|FG001|At 5-year Clinical Follow-up|Death|0|||
130931825|NCT01425281|471380857|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
130931826|NCT01425281|471380858|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
130931827|NCT01425281|471380857|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
130931828|NCT01425281|471380858|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
130931829|NCT01425281|471380857|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
130931830|NCT01425281|471380858|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
130931831|NCT03454997|471380859|FG000|Overall Study|Staff Coach - Left Oranization|1|||
130931832|NCT03454997|471380860|FG001|Overall Study|Staff Coach - Left Oranization|1|||
130931833|NCT03454997|471380859|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
130931834|NCT03454997|471380860|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
130931835|NCT03454997|471380859|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
130931836|NCT03454997|471380860|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
130931837|NCT03454997|471380859|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
130931838|NCT03454997|471380860|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
130931839|NCT03454997|471380859|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
130931840|NCT03454997|471380860|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
130931841|NCT03454997|471380859|FG000|Overall Study|Client with SMI - Left organization|0|||
131035003|NCT03544281|471761841|FG016|Main Study Phase|Investigator Site Closed|0|||
130931842|NCT03454997|471380860|FG001|Overall Study|Client with SMI - Left organization|1|||
130931843|NCT03454997|471380859|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
130931844|NCT03454997|471380860|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
130931845|NCT00814164|471380865|FG000|Overall Study|Progression|7|||
130931846|NCT00814164|471380865|FG000|Overall Study|not stated|7|||
130931847|NCT00814164|471380865|FG000|Overall Study|Death|5|||
130931848|NCT01169493|471380871|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
130931849|NCT01169493|471380872|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
130931850|NCT01169493|471380873|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
130931851|NCT01169493|471380874|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
130931852|NCT01169493|471380875|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
130931853|NCT01169493|471380876|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
130931854|NCT01169493|471380871|FG000|Period 3 (6 Months)|Adverse Event|0|||
130931855|NCT01169493|471380872|FG001|Period 3 (6 Months)|Adverse Event|1|||
130931856|NCT01169493|471380873|FG002|Period 3 (6 Months)|Adverse Event|0|||
130931857|NCT01169493|471380874|FG003|Period 3 (6 Months)|Adverse Event|0|||
130931858|NCT01169493|471380875|FG004|Period 3 (6 Months)|Adverse Event|0|||
130931859|NCT01169493|471380876|FG005|Period 3 (6 Months)|Adverse Event|0|||
130931860|NCT01169493|471380871|FG000|Period 3 (6 Months)|Physician Decision|0|||
130931861|NCT01169493|471380872|FG001|Period 3 (6 Months)|Physician Decision|1|||
130931862|NCT01169493|471380873|FG002|Period 3 (6 Months)|Physician Decision|1|||
130931863|NCT01169493|471380874|FG003|Period 3 (6 Months)|Physician Decision|0|||
130931864|NCT01169493|471380875|FG004|Period 3 (6 Months)|Physician Decision|0|||
130931865|NCT01169493|471380876|FG005|Period 3 (6 Months)|Physician Decision|0|||
130931866|NCT01906008|471380880|FG000|Overall Study|Lost to Follow-up|2|||
130931867|NCT01906008|471380881|FG001|Overall Study|Lost to Follow-up|0|||
130931868|NCT01906008|471380880|FG000|Overall Study|Oxaliplatin toxicity|2|||
130931869|NCT01906008|471380881|FG001|Overall Study|Oxaliplatin toxicity|0|||
130931870|NCT01906008|471380880|FG000|Overall Study|Protocol Violation|0|||
130931871|NCT01906008|471380881|FG001|Overall Study|Protocol Violation|1|||
130931872|NCT01906008|471380880|FG000|Overall Study|Withdrawal by Subject|1|||
130931873|NCT01906008|471380881|FG001|Overall Study|Withdrawal by Subject|5|||
130931874|NCT01906008|471380880|FG000|Overall Study|Did not start study med|3|||
130931875|NCT01906008|471380881|FG001|Overall Study|Did not start study med|4|||
130931876|NCT01906008|471380880|FG000|Overall Study|Oxaliplatin stops|10|||
130931877|NCT01906008|471380881|FG001|Overall Study|Oxaliplatin stops|8|||
130931878|NCT01906008|471380880|FG000|Overall Study|Hospice|1|||
130931879|NCT01906008|471380881|FG001|Overall Study|Hospice|0|||
130931880|NCT01906008|471380880|FG000|Overall Study|Physician Decision|3|||
130931881|NCT01906008|471380881|FG001|Overall Study|Physician Decision|3|||
130931882|NCT01906008|471380880|FG000|Overall Study|Lack of compliance of study med|5|||
130931883|NCT01906008|471380881|FG001|Overall Study|Lack of compliance of study med|3|||
130931884|NCT01906008|471380880|FG000|Overall Study|Adverse Event|0|||
130931885|NCT01906008|471380881|FG001|Overall Study|Adverse Event|3|||
130931886|NCT02651922|471380883|FG000|Overall Study|due to exclusion criteria|2|||
130931887|NCT01217814|471380885|FG000|Overall Study|Adverse Event|1|||
130931888|NCT01217814|471380886|FG001|Overall Study|Adverse Event|1|||
130931889|NCT01217814|471380887|FG002|Overall Study|Adverse Event|0|||
130931890|NCT01217814|471380885|FG000|Overall Study|Lack of Efficacy|0|||
130931891|NCT01217814|471380886|FG001|Overall Study|Lack of Efficacy|0|||
130931892|NCT01217814|471380887|FG002|Overall Study|Lack of Efficacy|1|||
130931893|NCT00496054|471380890|FG000|Overall Study|Adverse Event|1|||
130931894|NCT00496054|471380890|FG000|Overall Study|Lost to Follow-up|7|||
130931895|NCT00471328|471380897|FG000|Core Phase|Adverse Event|18|||
130931896|NCT00471328|471380898|FG001|Core Phase|Adverse Event|6|||
130931897|NCT00471328|471380897|FG000|Core Phase|Death|8|||
130931898|NCT00471328|471380898|FG001|Core Phase|Death|4|||
130931899|NCT00471328|471380897|FG000|Core Phase|Withdrawal by Subject|2|||
130931900|NCT00471328|471380898|FG001|Core Phase|Withdrawal by Subject|2|||
130931901|NCT00471328|471380897|FG000|Core Phase|Abnormal laboratory value|1|||
130931902|NCT00471328|471380898|FG001|Core Phase|Abnormal laboratory value|0|||
130931903|NCT00471328|471380897|FG000|Core Phase|Disease Progression|78|||
130931904|NCT00471328|471380898|FG001|Core Phase|Disease Progression|53|||
130931905|NCT00471328|471380897|FG000|Core Phase|Administrative Problem|0|||
130931906|NCT00471328|471380898|FG001|Core Phase|Administrative Problem|1|||
130931907|NCT00471328|471380897|FG000|Core Phase|Protocol Deviation|0|||
130931908|NCT00471328|471380898|FG001|Core Phase|Protocol Deviation|1|||
130931909|NCT00471328|471380897|FG000|Extension Phase|Adverse Event|3|||
130931910|NCT00471328|471380898|FG001|Extension Phase|Adverse Event|12|||
130931911|NCT00471328|471380897|FG000|Extension Phase|Withdrawal by Subject|0|||
130931912|NCT00471328|471380898|FG001|Extension Phase|Withdrawal by Subject|2|||
130931913|NCT00471328|471380897|FG000|Extension Phase|Death|1|||
130931914|NCT00471328|471380898|FG001|Extension Phase|Death|7|||
130931915|NCT00471328|471380897|FG000|Extension Phase|Protocol Deviation|3|||
130931916|NCT00471328|471380898|FG001|Extension Phase|Protocol Deviation|1|||
130931917|NCT00471328|471380897|FG000|Extension Phase|Treatment duration as per protocol|0|||
130931918|NCT00471328|471380898|FG001|Extension Phase|Treatment duration as per protocol|1|||
130931919|NCT00471328|471380897|FG000|Extension Phase|Disease Progression|32|||
130931920|NCT00471328|471380898|FG001|Extension Phase|Disease Progression|44|||
130931921|NCT00471328|471380897|FG000|Extension Phase|New cancer Therapy|1|||
130931922|NCT00471328|471380898|FG001|Extension Phase|New cancer Therapy|0|||
130931923|NCT00471328|471380897|FG000|Extension Phase|Administrative Problem|1|||
130931924|NCT00471328|471380898|FG001|Extension Phase|Administrative Problem|0|||
130931925|NCT00357968|471380899|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
130931926|NCT00357968|471380900|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
130931927|NCT00357968|471380899|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
130931928|NCT00357968|471380900|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
130704004|NCT00401245|470541149|FG006|Open Label Phase|Lack of Efficacy|0|||
130931929|NCT00439244|471380901|FG000|Overall Study|Adverse Event|5|||
130931930|NCT00439244|471380902|FG001|Overall Study|Adverse Event|2|||
130931931|NCT00439244|471380903|FG002|Overall Study|Adverse Event|3|||
130931932|NCT00439244|471380901|FG000|Overall Study|Withdrawal by Subject|3|||
130931933|NCT00439244|471380902|FG001|Overall Study|Withdrawal by Subject|1|||
130704005|NCT00401245|470541150|FG007|Open Label Phase|Lack of Efficacy|0|||
130704006|NCT00401245|470541143|FG000|Double Blind Tapering Phase|Adverse Event|0|||
130704007|NCT00401245|470541144|FG001|Double Blind Tapering Phase|Adverse Event|0|||
130704008|NCT00401245|470541145|FG002|Double Blind Tapering Phase|Adverse Event|0|||
130704009|NCT00401245|470541146|FG003|Double Blind Tapering Phase|Adverse Event|0|||
130704010|NCT00401245|470541147|FG004|Double Blind Tapering Phase|Adverse Event|1|||
130704011|NCT00401245|470541148|FG005|Double Blind Tapering Phase|Adverse Event|1|||
130704012|NCT00401245|470541149|FG006|Double Blind Tapering Phase|Adverse Event|2|||
130704013|NCT00401245|470541150|FG007|Double Blind Tapering Phase|Adverse Event|4|||
130704014|NCT00401245|470541143|FG000|Double Blind Tapering Phase|Investigator request|0|||
130704015|NCT00401245|470541144|FG001|Double Blind Tapering Phase|Investigator request|0|||
130704016|NCT00401245|470541145|FG002|Double Blind Tapering Phase|Investigator request|0|||
130704017|NCT00401245|470541146|FG003|Double Blind Tapering Phase|Investigator request|0|||
130704018|NCT00401245|470541147|FG004|Double Blind Tapering Phase|Investigator request|0|||
130704019|NCT00401245|470541148|FG005|Double Blind Tapering Phase|Investigator request|0|||
130704020|NCT00401245|470541149|FG006|Double Blind Tapering Phase|Investigator request|0|||
130704021|NCT00401245|470541150|FG007|Double Blind Tapering Phase|Investigator request|1|||
130704022|NCT00401245|470541143|FG000|Double Blind Tapering Phase|Other|0|||
130704023|NCT00401245|470541144|FG001|Double Blind Tapering Phase|Other|0|||
130704024|NCT00401245|470541145|FG002|Double Blind Tapering Phase|Other|0|||
130704025|NCT00401245|470541146|FG003|Double Blind Tapering Phase|Other|0|||
130704026|NCT00401245|470541147|FG004|Double Blind Tapering Phase|Other|1|||
130704027|NCT00401245|470541148|FG005|Double Blind Tapering Phase|Other|0|||
130704028|NCT00401245|470541149|FG006|Double Blind Tapering Phase|Other|2|||
130931934|NCT00439244|471380903|FG002|Overall Study|Withdrawal by Subject|2|||
130931935|NCT00439244|471380901|FG000|Overall Study|Lost to Follow-up|2|||
130931936|NCT00439244|471380902|FG001|Overall Study|Lost to Follow-up|1|||
130931937|NCT00439244|471380903|FG002|Overall Study|Lost to Follow-up|2|||
130931938|NCT00439244|471380901|FG000|Overall Study|Death|0|||
130931939|NCT00439244|471380902|FG001|Overall Study|Death|1|||
130931940|NCT00439244|471380903|FG002|Overall Study|Death|0|||
130931941|NCT00439244|471380901|FG000|Overall Study|Protocol Violation|0|||
130931942|NCT00439244|471380902|FG001|Overall Study|Protocol Violation|1|||
130931943|NCT00439244|471380903|FG002|Overall Study|Protocol Violation|0|||
130931944|NCT00439244|471380901|FG000|Overall Study|Administrative problems|1|||
130931945|NCT00439244|471380902|FG001|Overall Study|Administrative problems|0|||
130931946|NCT00439244|471380903|FG002|Overall Study|Administrative problems|0|||
130931947|NCT04102020|471380904|FG000|Overall Study|Adverse Event|1|||
130931948|NCT04102020|471380905|FG001|Overall Study|Adverse Event|0|||
130931949|NCT04102020|471380906|FG002|Overall Study|Adverse Event|0|||
130931950|NCT04102020|471380907|FG003|Overall Study|Adverse Event|1|||
130931951|NCT04102020|471380908|FG004|Overall Study|Adverse Event|0|||
130931952|NCT04102020|471380904|FG000|Overall Study|Withdrawal by Subject|0|||
130931953|NCT04102020|471380905|FG001|Overall Study|Withdrawal by Subject|1|||
130931954|NCT04102020|471380906|FG002|Overall Study|Withdrawal by Subject|1|||
130931955|NCT04102020|471380907|FG003|Overall Study|Withdrawal by Subject|1|||
130931956|NCT04102020|471380908|FG004|Overall Study|Withdrawal by Subject|1|||
130704029|NCT00401245|470541150|FG007|Double Blind Tapering Phase|Other|2|||
130704030|NCT00401245|470541143|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130704031|NCT00401245|470541144|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130931957|NCT04102020|471380904|FG000|Overall Study|Death|1|||
130931958|NCT04102020|471380905|FG001|Overall Study|Death|4|||
130931959|NCT04102020|471380906|FG002|Overall Study|Death|1|||
130931960|NCT04102020|471380907|FG003|Overall Study|Death|1|||
130931961|NCT04102020|471380908|FG004|Overall Study|Death|0|||
130704032|NCT00401245|470541145|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130704033|NCT00401245|470541146|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130931962|NCT04102020|471380904|FG000|Overall Study|Physician Decision|1|||
130931963|NCT04102020|471380905|FG001|Overall Study|Physician Decision|2|||
130931964|NCT04102020|471380906|FG002|Overall Study|Physician Decision|2|||
130931965|NCT04102020|471380907|FG003|Overall Study|Physician Decision|0|||
130931966|NCT04102020|471380908|FG004|Overall Study|Physician Decision|1|||
130931967|NCT04102020|471380904|FG000|Overall Study|COVID-19 Infection|1|||
130770785|NCT00582426|470787683|FG001|Overall Study|Withdrawal by Subject|2|||
130770786|NCT00582426|470787682|FG000|Overall Study|Disease Progression|2|||
130770787|NCT00582426|470787683|FG001|Overall Study|Disease Progression|2|||
130770788|NCT00582426|470787682|FG000|Overall Study|Use of illicit drugs|1|||
130770789|NCT00582426|470787683|FG001|Overall Study|Use of illicit drugs|0|||
130770790|NCT02164318|470787684|FG000|Overall Study|Withdrawal by Subject|0|||
130770791|NCT02164318|470787685|FG001|Overall Study|Withdrawal by Subject|1|||
130770792|NCT02164318|470787686|FG002|Overall Study|Withdrawal by Subject|0|||
130770793|NCT02164318|470787687|FG003|Overall Study|Withdrawal by Subject|1|||
130770794|NCT04126317|470787691|FG000|Overall Study|Adverse Event|0|||
130770795|NCT04126317|470787692|FG001|Overall Study|Adverse Event|1|||
130770796|NCT04126317|470787691|FG000|Overall Study|Withdrawal by Subject|4|||
130770797|NCT04126317|470787692|FG001|Overall Study|Withdrawal by Subject|1|||
130770798|NCT03297021|470787694|FG000|Overall Study|Incomplete/illegible data sheet|4|||
130770799|NCT03297021|470787695|FG001|Overall Study|Incomplete/illegible data sheet|2|||
130770800|NCT03297021|470787696|FG002|Overall Study|Incomplete/illegible data sheet|3|||
130770801|NCT03297021|470787694|FG000|Overall Study|Missing Post-Op Data|1|||
130770802|NCT03297021|470787695|FG001|Overall Study|Missing Post-Op Data|2|||
130770803|NCT03297021|470787696|FG002|Overall Study|Missing Post-Op Data|1|||
130770804|NCT00948922|470787698|FG000|Overall Study|Did not start study treatment|2|||
130770805|NCT00948922|470787699|FG001|Overall Study|Did not start study treatment|5|||
130704034|NCT00401245|470541147|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
130704035|NCT00401245|470541148|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
130704036|NCT00401245|470541149|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
130704037|NCT00401245|470541150|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130704038|NCT00401245|470541143|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704039|NCT00401245|470541144|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704040|NCT00401245|470541145|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704041|NCT00401245|470541146|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704042|NCT00401245|470541147|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704043|NCT00401245|470541148|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
130704044|NCT00401245|470541149|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704045|NCT00401245|470541150|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
130704046|NCT01989676|470541151|FG000|Overall Study|Death|52|||
130704047|NCT01989676|470541152|FG001|Overall Study|Death|60|||
130704048|NCT01989676|470541151|FG000|Overall Study|Protocol Violation|2|||
130704049|NCT01989676|470541152|FG001|Overall Study|Protocol Violation|1|||
130704050|NCT01989676|470541151|FG000|Overall Study|Lost to Follow-up|8|||
130704051|NCT01989676|470541152|FG001|Overall Study|Lost to Follow-up|18|||
130704052|NCT01989676|470541151|FG000|Overall Study|No longer willing to participate in study|26|||
130704053|NCT01989676|470541152|FG001|Overall Study|No longer willing to participate in study|26|||
130704054|NCT01989676|470541151|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
130704055|NCT01989676|470541152|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
130704056|NCT01989676|470541151|FG000|Overall Study|Other|4|||
130704057|NCT01989676|470541152|FG001|Overall Study|Other|3|||
130704058|NCT03941834|470541153|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
130704059|NCT03941834|470541154|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
130704060|NCT03941834|470541155|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
130704061|NCT03941834|470541153|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
130704062|NCT03941834|470541154|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
130704063|NCT03941834|470541155|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
130704064|NCT03941834|470541153|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
130704065|NCT03941834|470541154|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
130704066|NCT03941834|470541155|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
130704067|NCT03941834|470541153|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
130704068|NCT03941834|470541154|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
130704069|NCT03941834|470541155|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
130770806|NCT00948922|470787700|FG002|Overall Study|Did not start study treatment|0|||
130770807|NCT00948922|470787698|FG000|Overall Study|Withdrawal by Subject|0|||
130704070|NCT03941834|470541153|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
130704071|NCT03941834|470541154|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
130704072|NCT03941834|470541155|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
130704073|NCT03941834|470541153|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
130704074|NCT03941834|470541154|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
130704075|NCT03941834|470541155|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
130704076|NCT00991510|470541158|FG000|Period I (Days 1-14)|Adverse Event|1|||
130704077|NCT00991510|470541159|FG001|Period I (Days 1-14)|Adverse Event|0|||
130931968|NCT04102020|471380905|FG001|Overall Study|COVID-19 Infection|0|||
130704078|NCT00991510|470541158|FG000|Period III (Days 29-112)|Adverse Event|1|||
130770808|NCT00948922|470787699|FG001|Overall Study|Withdrawal by Subject|2|||
130770809|NCT00948922|470787700|FG002|Overall Study|Withdrawal by Subject|1|||
130770810|NCT00948922|470787698|FG000|Overall Study|Death|3|||
130931969|NCT04102020|471380906|FG002|Overall Study|COVID-19 Infection|0|||
130931970|NCT04102020|471380907|FG003|Overall Study|COVID-19 Infection|0|||
130931971|NCT04102020|471380908|FG004|Overall Study|COVID-19 Infection|0|||
130931972|NCT04102020|471380904|FG000|Overall Study|Not disclosed|5|||
130931973|NCT04102020|471380905|FG001|Overall Study|Not disclosed|3|||
130931974|NCT04102020|471380906|FG002|Overall Study|Not disclosed|8|||
130931975|NCT04102020|471380907|FG003|Overall Study|Not disclosed|0|||
130931976|NCT04102020|471380908|FG004|Overall Study|Not disclosed|1|||
130931977|NCT04102020|471380904|FG000|Overall Study|MIssing|1|||
130931978|NCT04102020|471380905|FG001|Overall Study|MIssing|0|||
130931979|NCT04102020|471380906|FG002|Overall Study|MIssing|1|||
130931980|NCT04102020|471380907|FG003|Overall Study|MIssing|1|||
130931981|NCT04102020|471380908|FG004|Overall Study|MIssing|1|||
130931982|NCT04102020|471380904|FG000|Overall Study|Continuing in ongoing study|13|||
130931983|NCT04102020|471380905|FG001|Overall Study|Continuing in ongoing study|13|||
130931984|NCT04102020|471380906|FG002|Overall Study|Continuing in ongoing study|7|||
130931985|NCT04102020|471380907|FG003|Overall Study|Continuing in ongoing study|26|||
130931986|NCT04102020|471380908|FG004|Overall Study|Continuing in ongoing study|12|||
130931987|NCT04600921|471380911|FG000|Overall Study|Withdrawal by Subject|3|||
130931988|NCT04600921|471380912|FG001|Overall Study|Withdrawal by Subject|5|||
130931989|NCT04600921|471380911|FG000|Overall Study|Death|0|||
130704079|NCT00991510|470541159|FG001|Period III (Days 29-112)|Adverse Event|1|||
130704080|NCT01124695|470541160|FG000|Overall Study|Disease progression|77|||
130704081|NCT01124695|470541160|FG000|Overall Study|Adverse Event|11|||
130704082|NCT01124695|470541160|FG000|Overall Study|Death|1|||
130704083|NCT01124695|470541160|FG000|Overall Study|Withdrawal by Subject|7|||
130931990|NCT04600921|471380912|FG001|Overall Study|Death|1|||
130704084|NCT01124695|470541160|FG000|Overall Study|Physician Decision|3|||
130704085|NCT01124695|470541160|FG000|Overall Study|Alternative therapy|9|||
130704086|NCT01124695|470541160|FG000|Overall Study|No documentation that patient went off treatment|4|||
130704087|NCT01124695|470541160|FG000|Overall Study|Ineligible|9|||
130704088|NCT01124695|470541160|FG000|Overall Study|Ineligible and never start treatment|2|||
130704089|NCT02443324|470541164|FG000|Overall Study|Death|4|||
130704090|NCT02443324|470541165|FG001|Overall Study|Death|1|||
130704091|NCT02443324|470541166|FG002|Overall Study|Death|0|||
130704092|NCT02443324|470541167|FG003|Overall Study|Death|3|||
130704093|NCT02443324|470541168|FG004|Overall Study|Death|1|||
130704094|NCT02443324|470541169|FG005|Overall Study|Death|3|||
130704095|NCT02443324|470541170|FG006|Overall Study|Death|2|||
130704096|NCT02443324|470541164|FG000|Overall Study|Lost to Follow-up|0|||
130704097|NCT02443324|470541165|FG001|Overall Study|Lost to Follow-up|0|||
130704098|NCT02443324|470541166|FG002|Overall Study|Lost to Follow-up|0|||
130704099|NCT02443324|470541167|FG003|Overall Study|Lost to Follow-up|1|||
130704100|NCT02443324|470541168|FG004|Overall Study|Lost to Follow-up|0|||
130704101|NCT02443324|470541169|FG005|Overall Study|Lost to Follow-up|1|||
130704102|NCT02443324|470541170|FG006|Overall Study|Lost to Follow-up|0|||
130704103|NCT02443324|470541164|FG000|Overall Study|Physician Decision|0|||
130704104|NCT02443324|470541165|FG001|Overall Study|Physician Decision|3|||
130704105|NCT02443324|470541166|FG002|Overall Study|Physician Decision|5|||
130704106|NCT02443324|470541167|FG003|Overall Study|Physician Decision|1|||
130704107|NCT02443324|470541168|FG004|Overall Study|Physician Decision|1|||
130704108|NCT02443324|470541169|FG005|Overall Study|Physician Decision|0|||
130704109|NCT02443324|470541170|FG006|Overall Study|Physician Decision|2|||
130704110|NCT02443324|470541164|FG000|Overall Study|Progressive Disease|20|||
130704111|NCT02443324|470541165|FG001|Overall Study|Progressive Disease|20|||
130704112|NCT02443324|470541166|FG002|Overall Study|Progressive Disease|13|||
130704113|NCT02443324|470541167|FG003|Overall Study|Progressive Disease|10|||
130931991|NCT02239978|471382604|FG000|Overall Study|Withdrawal by Subject|2|||
130931992|NCT02239978|471382605|FG001|Overall Study|Withdrawal by Subject|0|||
130931993|NCT01943292|471382609|FG000|Overall Study|Withdrawal by Subject|1|||
131223751|NCT04380701|472447138|FG029|Overall Study|Pregnancy|0|||
130704114|NCT02443324|470541168|FG004|Overall Study|Progressive Disease|13|||
130704115|NCT02443324|470541169|FG005|Overall Study|Progressive Disease|17|||
130704116|NCT02443324|470541170|FG006|Overall Study|Progressive Disease|10|||
130704117|NCT02443324|470541164|FG000|Overall Study|Withdrawal by Subject|0|||
130704118|NCT02443324|470541165|FG001|Overall Study|Withdrawal by Subject|0|||
130704119|NCT02443324|470541166|FG002|Overall Study|Withdrawal by Subject|3|||
130704120|NCT02443324|470541167|FG003|Overall Study|Withdrawal by Subject|1|||
130704121|NCT02443324|470541168|FG004|Overall Study|Withdrawal by Subject|1|||
130704122|NCT02443324|470541169|FG005|Overall Study|Withdrawal by Subject|0|||
130704123|NCT02443324|470541170|FG006|Overall Study|Withdrawal by Subject|1|||
130704124|NCT02443324|470541164|FG000|Overall Study|Adverse Event|0|||
130931994|NCT01943292|471382610|FG001|Overall Study|Withdrawal by Subject|0|||
130931995|NCT01943292|471382611|FG002|Overall Study|Withdrawal by Subject|0|||
130931996|NCT00911820|471382612|FG000|Overall Study|RECIST progression|12|||
130704125|NCT02443324|470541165|FG001|Overall Study|Adverse Event|1|||
130704126|NCT02443324|470541166|FG002|Overall Study|Adverse Event|3|||
130704127|NCT02443324|470541167|FG003|Overall Study|Adverse Event|0|||
130704128|NCT02443324|470541168|FG004|Overall Study|Adverse Event|4|||
130931997|NCT00911820|471382613|FG001|Overall Study|RECIST progression|8|||
130931998|NCT00911820|471382612|FG000|Overall Study|Adverse Event|8|||
130704129|NCT02443324|470541169|FG005|Overall Study|Adverse Event|3|||
130704130|NCT02443324|470541170|FG006|Overall Study|Adverse Event|3|||
130931999|NCT00911820|471382613|FG001|Overall Study|Adverse Event|8|||
130932000|NCT00911820|471382612|FG000|Overall Study|Clinical Progression|7|||
130932001|NCT00911820|471382613|FG001|Overall Study|Clinical Progression|5|||
130932002|NCT00911820|471382612|FG000|Overall Study|Physician Decision|5|||
130932003|NCT00911820|471382613|FG001|Overall Study|Physician Decision|9|||
130932004|NCT00911820|471382612|FG000|Overall Study|Decline in Performance Status|4|||
130932005|NCT00911820|471382613|FG001|Overall Study|Decline in Performance Status|2|||
130932006|NCT00911820|471382612|FG000|Overall Study|Withdrawal by Subject|3|||
130932007|NCT00911820|471382613|FG001|Overall Study|Withdrawal by Subject|4|||
130932008|NCT00911820|471382612|FG000|Overall Study|Death|1|||
130932009|NCT00911820|471382613|FG001|Overall Study|Death|2|||
130932010|NCT00911820|471382612|FG000|Overall Study|Pursue surgery|1|||
130932011|NCT00911820|471382613|FG001|Overall Study|Pursue surgery|1|||
130932012|NCT00911820|471382612|FG000|Overall Study|Pursue Radiation|1|||
130932013|NCT00911820|471382613|FG001|Overall Study|Pursue Radiation|0|||
130932014|NCT00911820|471382612|FG000|Overall Study|Still on Therapy|2|||
130932015|NCT00911820|471382613|FG001|Overall Study|Still on Therapy|2|||
130932016|NCT00911820|471382612|FG000|Overall Study|Pathology Not Confirmed|1|||
130932017|NCT00911820|471382613|FG001|Overall Study|Pathology Not Confirmed|0|||
130932018|NCT00911820|471382612|FG000|Overall Study|Withdraw before Receive Treatment|0|||
130932019|NCT00911820|471382613|FG001|Overall Study|Withdraw before Receive Treatment|2|||
130932020|NCT01852110|471382614|FG000|Overall Study|Adverse Event|12|||
130932021|NCT01852110|471382615|FG001|Overall Study|Adverse Event|5|||
130932022|NCT01852110|471382616|FG002|Overall Study|Adverse Event|0|||
130932023|NCT01852110|471382617|FG003|Overall Study|Adverse Event|0|||
130932024|NCT01852110|471382618|FG004|Overall Study|Adverse Event|0|||
130932025|NCT01852110|471382619|FG005|Overall Study|Adverse Event|0|||
130932026|NCT01852110|471382614|FG000|Overall Study|Lost to Follow-up|1|||
130932027|NCT01852110|471382615|FG001|Overall Study|Lost to Follow-up|3|||
130932028|NCT01852110|471382616|FG002|Overall Study|Lost to Follow-up|0|||
130932029|NCT01852110|471382617|FG003|Overall Study|Lost to Follow-up|0|||
130932030|NCT01852110|471382618|FG004|Overall Study|Lost to Follow-up|0|||
130932031|NCT01852110|471382619|FG005|Overall Study|Lost to Follow-up|0|||
130932032|NCT01852110|471382614|FG000|Overall Study|Non-compliance with Study Drug|2|||
130932033|NCT01852110|471382615|FG001|Overall Study|Non-compliance with Study Drug|1|||
130932034|NCT01852110|471382616|FG002|Overall Study|Non-compliance with Study Drug|0|||
130932035|NCT01852110|471382617|FG003|Overall Study|Non-compliance with Study Drug|0|||
130932036|NCT01852110|471382618|FG004|Overall Study|Non-compliance with Study Drug|0|||
130932037|NCT01852110|471382619|FG005|Overall Study|Non-compliance with Study Drug|0|||
130932038|NCT01852110|471382614|FG000|Overall Study|Physician Decision|1|||
130932039|NCT01852110|471382615|FG001|Overall Study|Physician Decision|0|||
130932040|NCT01852110|471382616|FG002|Overall Study|Physician Decision|0|||
130932041|NCT01852110|471382617|FG003|Overall Study|Physician Decision|0|||
130932042|NCT01852110|471382618|FG004|Overall Study|Physician Decision|0|||
130932043|NCT01852110|471382619|FG005|Overall Study|Physician Decision|0|||
130932044|NCT01852110|471382614|FG000|Overall Study|Protocol Violation|0|||
130932045|NCT01852110|471382615|FG001|Overall Study|Protocol Violation|1|||
130932046|NCT01852110|471382616|FG002|Overall Study|Protocol Violation|0|||
130932047|NCT01852110|471382617|FG003|Overall Study|Protocol Violation|0|||
130932048|NCT01852110|471382618|FG004|Overall Study|Protocol Violation|0|||
130932049|NCT01852110|471382619|FG005|Overall Study|Protocol Violation|0|||
130932050|NCT01852110|471382614|FG000|Overall Study|Study Terminated by Sponsor|30|||
130932051|NCT01852110|471382615|FG001|Overall Study|Study Terminated by Sponsor|32|||
130932052|NCT01852110|471382616|FG002|Overall Study|Study Terminated by Sponsor|0|||
130932053|NCT01852110|471382617|FG003|Overall Study|Study Terminated by Sponsor|0|||
130932054|NCT01852110|471382618|FG004|Overall Study|Study Terminated by Sponsor|0|||
130932055|NCT01852110|471382619|FG005|Overall Study|Study Terminated by Sponsor|0|||
130932056|NCT01852110|471382614|FG000|Overall Study|Withdrawal by Subject|4|||
130932057|NCT01852110|471382615|FG001|Overall Study|Withdrawal by Subject|4|||
130932058|NCT01852110|471382616|FG002|Overall Study|Withdrawal by Subject|0|||
130704131|NCT02443324|470541164|FG000|Overall Study|Enrolled but Never Treated|0|||
130704132|NCT02443324|470541165|FG001|Overall Study|Enrolled but Never Treated|0|||
130704133|NCT02443324|470541166|FG002|Overall Study|Enrolled but Never Treated|1|||
130704134|NCT02443324|470541167|FG003|Overall Study|Enrolled but Never Treated|0|||
130704135|NCT02443324|470541168|FG004|Overall Study|Enrolled but Never Treated|1|||
130704136|NCT02443324|470541169|FG005|Overall Study|Enrolled but Never Treated|0|||
130932059|NCT01852110|471382617|FG003|Overall Study|Withdrawal by Subject|0|||
130932060|NCT01852110|471382618|FG004|Overall Study|Withdrawal by Subject|0|||
130932061|NCT01852110|471382619|FG005|Overall Study|Withdrawal by Subject|0|||
130932062|NCT00410046|471382622|FG000|Overall Study|Adverse Event|3|||
130932063|NCT00410046|471382622|FG000|Overall Study|Withdrawal by Subject|1|||
130932064|NCT00410046|471382622|FG000|Overall Study|Lost to Follow-up|1|||
130932065|NCT03098550|471382623|FG000|Overall Study|Disease Progression|30|||
130932066|NCT03098550|471382624|FG001|Overall Study|Disease Progression|19|||
130932067|NCT03098550|471382625|FG002|Overall Study|Disease Progression|41|||
130932068|NCT03098550|471382623|FG000|Overall Study|Study Drug Toxicity|2|||
130932069|NCT03098550|471382624|FG001|Overall Study|Study Drug Toxicity|1|||
130932070|NCT03098550|471382625|FG002|Overall Study|Study Drug Toxicity|0|||
130932071|NCT03098550|471382623|FG000|Overall Study|Death|1|||
130932072|NCT03098550|471382624|FG001|Overall Study|Death|0|||
130932073|NCT03098550|471382625|FG002|Overall Study|Death|0|||
130932074|NCT03098550|471382623|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
130932075|NCT03098550|471382624|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
130932076|NCT03098550|471382625|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
130932077|NCT03098550|471382623|FG000|Overall Study|Administrative reason by sponsor|0|||
130932078|NCT03098550|471382624|FG001|Overall Study|Administrative reason by sponsor|0|||
130932079|NCT03098550|471382625|FG002|Overall Study|Administrative reason by sponsor|1|||
130932080|NCT03098550|471382623|FG000|Overall Study|Other reasons|2|||
130932081|NCT03098550|471382624|FG001|Overall Study|Other reasons|0|||
130932082|NCT03098550|471382625|FG002|Overall Study|Other reasons|0|||
130932083|NCT00381095|471382632|FG000|Overall Study|Death|3|||
130932084|NCT00381095|471382633|FG001|Overall Study|Death|4|||
130932085|NCT00381095|471382632|FG000|Overall Study|Lack of Efficacy|2|||
130932086|NCT00381095|471382633|FG001|Overall Study|Lack of Efficacy|4|||
130932087|NCT00381095|471382632|FG000|Overall Study|Other|2|||
130932088|NCT00381095|471382633|FG001|Overall Study|Other|2|||
130932089|NCT00381095|471382632|FG000|Overall Study|Protocol Violation|1|||
130932090|NCT00381095|471382633|FG001|Overall Study|Protocol Violation|1|||
130932091|NCT00381095|471382632|FG000|Overall Study|Withdrawal by Subject|3|||
130932092|NCT00381095|471382633|FG001|Overall Study|Withdrawal by Subject|3|||
130932093|NCT00381095|471382632|FG000|Overall Study|Adverse Event|2|||
130932094|NCT00381095|471382633|FG001|Overall Study|Adverse Event|7|||
130932095|NCT00411645|471382637|FG000|Overall Study|Consent Withdrawn|13|||
130932096|NCT00411645|471382638|FG001|Overall Study|Consent Withdrawn|22|||
130932097|NCT00411645|471382637|FG000|Overall Study|Death|56|||
130932098|NCT00411645|471382638|FG001|Overall Study|Death|135|||
130932099|NCT00411645|471382637|FG000|Overall Study|Investigator/Sponsor Decision|10|||
130932100|NCT00411645|471382638|FG001|Overall Study|Investigator/Sponsor Decision|7|||
130932101|NCT00411645|471382637|FG000|Overall Study|Lost to Follow-up|2|||
130932102|NCT00411645|471382638|FG001|Overall Study|Lost to Follow-up|0|||
130932103|NCT02495168|471382639|FG000|Overall Study|Other than Specified|18|||
130932104|NCT02495168|471382640|FG001|Overall Study|Other than Specified|22|||
130932105|NCT02495168|471382641|FG002|Overall Study|Other than Specified|5|||
130932106|NCT02495168|471382639|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
130932107|NCT02495168|471382640|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
130932108|NCT02495168|471382641|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
130932109|NCT02495168|471382639|FG000|Overall Study|Physician Decision|1|||
130932110|NCT02495168|471382640|FG001|Overall Study|Physician Decision|1|||
130932111|NCT02495168|471382641|FG002|Overall Study|Physician Decision|0|||
130932112|NCT02495168|471382639|FG000|Overall Study|Lost to Follow-up|10|||
130932113|NCT02495168|471382640|FG001|Overall Study|Lost to Follow-up|6|||
130932114|NCT02495168|471382641|FG002|Overall Study|Lost to Follow-up|1|||
130932115|NCT02495168|471382639|FG000|Overall Study|Withdrawal by Subject|1|||
130932116|NCT02495168|471382640|FG001|Overall Study|Withdrawal by Subject|4|||
130932117|NCT02495168|471382641|FG002|Overall Study|Withdrawal by Subject|2|||
130932118|NCT02495168|471382639|FG000|Overall Study|Protocol Violation|0|||
130932119|NCT02495168|471382640|FG001|Overall Study|Protocol Violation|10|||
130704137|NCT02443324|470541170|FG006|Overall Study|Enrolled but Never Treated|1|||
130704138|NCT00298740|470541171|FG000|Overall Study|Lack of Efficacy|6|||
130704139|NCT00298740|470541171|FG000|Overall Study|Withdrawal by Subject|3|||
130704140|NCT00684567|470541172|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
130704141|NCT00684567|470541172|FG000|Monotherapy Period|Adverse Event|2|||
130704142|NCT00684567|470541172|FG000|Monotherapy Period|Death|1|||
130704143|NCT00684567|470541172|FG000|Monotherapy Period|Progression of primary disease|11|||
130704144|NCT03136406|470541175|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
130704145|NCT00988208|470541178|FG000|Overall Study|Adverse Event|71|||
130704146|NCT00988208|470541179|FG001|Overall Study|Adverse Event|122|||
130704147|NCT00988208|470541178|FG000|Overall Study|Disease Progression|103|||
130704148|NCT00988208|470541179|FG001|Overall Study|Disease Progression|89|||
130704149|NCT00988208|470541178|FG000|Overall Study|Withdrawal by Subject|50|||
130704150|NCT00988208|470541179|FG001|Overall Study|Withdrawal by Subject|57|||
130704151|NCT00988208|470541178|FG000|Overall Study|Death|9|||
130704152|NCT00988208|470541179|FG001|Overall Study|Death|15|||
130704153|NCT00988208|470541178|FG000|Overall Study|Lost to Follow-up|2|||
130704154|NCT00988208|470541179|FG001|Overall Study|Lost to Follow-up|3|||
130704155|NCT00988208|470541178|FG000|Overall Study|Protocol Violation|9|||
130932120|NCT02495168|471382641|FG002|Overall Study|Protocol Violation|1|||
130932121|NCT02495168|471382639|FG000|Overall Study|Adverse Event|4|||
130932122|NCT02495168|471382640|FG001|Overall Study|Adverse Event|8|||
130932123|NCT02495168|471382641|FG002|Overall Study|Adverse Event|3|||
130932124|NCT02495168|471382639|FG000|Overall Study|Lack of Efficacy|0|||
131035004|NCT03544281|471761842|FG017|Main Study Phase|Investigator Site Closed|0|||
130932125|NCT02495168|471382640|FG001|Overall Study|Lack of Efficacy|0|||
130932126|NCT02495168|471382641|FG002|Overall Study|Lack of Efficacy|3|||
130932127|NCT04626297|471382644|FG000|Overall Study|Adverse Event|5|||
130932128|NCT04626297|471382645|FG001|Overall Study|Adverse Event|3|||
130932129|NCT04626297|471382644|FG000|Overall Study|Lost to Follow-up|7|||
130932130|NCT04626297|471382645|FG001|Overall Study|Lost to Follow-up|3|||
130932131|NCT04626297|471382644|FG000|Overall Study|Protocol Violation|5|||
130932132|NCT04626297|471382645|FG001|Overall Study|Protocol Violation|1|||
130932133|NCT04626297|471382644|FG000|Overall Study|Withdrawal by Subject|20|||
130932134|NCT04626297|471382645|FG001|Overall Study|Withdrawal by Subject|6|||
130932135|NCT04626297|471382644|FG000|Overall Study|Sponsor decision|2|||
130932136|NCT04626297|471382645|FG001|Overall Study|Sponsor decision|1|||
130932137|NCT05048784|471382652|FG000|Period 1|Adverse Event|3|||
130932138|NCT05048784|471382653|FG001|Period 1|Adverse Event|1|||
130932139|NCT05048784|471382654|FG002|Period 1|Adverse Event|0|||
130932140|NCT05048784|471382655|FG003|Period 1|Adverse Event|0|||
130932141|NCT05048784|471382652|FG000|Period 2|Lost to Follow-up|0|||
130932142|NCT05048784|471382653|FG001|Period 2|Lost to Follow-up|1|||
130932143|NCT05048784|471382654|FG002|Period 2|Lost to Follow-up|0|||
130932144|NCT05048784|471382655|FG003|Period 2|Lost to Follow-up|0|||
130932145|NCT03521934|471382656|FG000|Overall Study|Death|65|||
130932146|NCT03521934|471382657|FG001|Overall Study|Death|73|||
130932147|NCT03521934|471382656|FG000|Overall Study|Withdrawal by Subject|18|||
130932148|NCT03521934|471382657|FG001|Overall Study|Withdrawal by Subject|23|||
130932149|NCT03521934|471382656|FG000|Overall Study|Site Terminated by Sponsor|39|||
130932150|NCT03521934|471382657|FG001|Overall Study|Site Terminated by Sponsor|35|||
130932151|NCT03521934|471382656|FG000|Overall Study|Study Terminated by Sponsor|483|||
130932152|NCT03521934|471382657|FG001|Overall Study|Study Terminated by Sponsor|477|||
130932153|NCT03521934|471382656|FG000|Overall Study|Reason not Specified|3|||
130932154|NCT03521934|471382657|FG001|Overall Study|Reason not Specified|6|||
130932155|NCT04016285|471382658|FG000|Overall Study|Did not progress to surgery|2|||
130932156|NCT04016285|471382659|FG001|Overall Study|Did not progress to surgery|5|||
130932157|NCT04016285|471382658|FG000|Overall Study|Failed to collect outcome data|5|||
130932158|NCT04016285|471382659|FG001|Overall Study|Failed to collect outcome data|3|||
130932159|NCT01750242|471382664|FG000|Overall Study|Unreadable Images|3|||
130932160|NCT00299975|471382672|FG000|Overall Study|Adverse Event|1|||
130932161|NCT00299975|471382673|FG001|Overall Study|Adverse Event|0|||
130932162|NCT00299975|471382674|FG002|Overall Study|Adverse Event|2|||
130932163|NCT00299975|471382672|FG000|Overall Study|Pregnancy|0|||
130932164|NCT00299975|471382673|FG001|Overall Study|Pregnancy|0|||
130932165|NCT00299975|471382674|FG002|Overall Study|Pregnancy|1|||
130932166|NCT00299975|471382672|FG000|Overall Study|Lack of Efficacy|1|||
130932167|NCT00299975|471382673|FG001|Overall Study|Lack of Efficacy|0|||
130932168|NCT00299975|471382674|FG002|Overall Study|Lack of Efficacy|1|||
130932169|NCT00299975|471382672|FG000|Overall Study|Lost to Follow-up|1|||
130932170|NCT00299975|471382673|FG001|Overall Study|Lost to Follow-up|0|||
130932171|NCT00299975|471382674|FG002|Overall Study|Lost to Follow-up|0|||
130932172|NCT00299975|471382672|FG000|Overall Study|Withdrawal by Subject|0|||
130932173|NCT00299975|471382673|FG001|Overall Study|Withdrawal by Subject|1|||
130932174|NCT00299975|471382674|FG002|Overall Study|Withdrawal by Subject|3|||
130932175|NCT00299975|471382672|FG000|Overall Study|Physician Decision|0|||
130932176|NCT00299975|471382673|FG001|Overall Study|Physician Decision|0|||
130932177|NCT00299975|471382674|FG002|Overall Study|Physician Decision|1|||
130932178|NCT00982878|471382675|FG000|Overall Study|Physician Decision|1|||
130932179|NCT03167411|471382678|FG000|Overall Study|Adverse Event|0|||
130932180|NCT03167411|471382679|FG001|Overall Study|Adverse Event|1|||
130932181|NCT02627144|471382682|FG000|Overall Study|Serious adverse event|32|||
130932182|NCT02627144|471382682|FG000|Overall Study|Cancer progression|171|||
130932183|NCT02627144|471382682|FG000|Overall Study|Death from cancer|20|||
130932184|NCT02627144|471382682|FG000|Overall Study|Death from other cause|8|||
130932185|NCT02627144|471382682|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
130932186|NCT02627144|471382682|FG000|Overall Study|Administrative reasons|65|||
130932187|NCT02627144|471382682|FG000|Overall Study|Lost to Follow-up|8|||
130932188|NCT02627144|471382682|FG000|Overall Study|Enrolled, not treated|6|||
130932189|NCT02627144|471382682|FG000|Overall Study|Other|17|||
130932190|NCT01025752|471382689|FG000|Overall Study|Lost to Follow-up|7|||
130932191|NCT01025752|471382690|FG001|Overall Study|Lost to Follow-up|10|||
130932192|NCT01025752|471382689|FG000|Overall Study|Physician Decision|1|||
130932193|NCT01025752|471382690|FG001|Overall Study|Physician Decision|3|||
130932194|NCT01417234|471382693|FG000|Overall Study|Subject non-compliant|3|||
130932195|NCT00023764|471382694|FG000|Overall Study|Other|1|||
130932196|NCT00023764|471382694|FG000|Overall Study|Adverse Event|4|||
130932197|NCT00023764|471382694|FG000|Overall Study|Withdrawal by Subject|1|||
130932198|NCT00023764|471382694|FG000|Overall Study|Progression of disease|6|||
130932199|NCT00023764|471382694|FG000|Overall Study|patient received other treatment|1|||
130932200|NCT00023764|471382694|FG000|Overall Study|delay in obtaining staging images|1|||
130932201|NCT04294472|471382695|FG000|Overall Study|Adverse Event|0|||
130932202|NCT04294472|471382696|FG001|Overall Study|Adverse Event|1|||
130932203|NCT04294472|471382697|FG002|Overall Study|Adverse Event|1|||
130932204|NCT04294472|471382695|FG000|Overall Study|Randomized but not treated|0|||
130932205|NCT04294472|471382696|FG001|Overall Study|Randomized but not treated|1|||
130932206|NCT04294472|471382697|FG002|Overall Study|Randomized but not treated|1|||
130932207|NCT02925494|471382704|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
130932208|NCT02925494|471382705|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
130932209|NCT02925494|471382706|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
130932210|NCT02925494|471382707|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
130932211|NCT02925494|471382704|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130932212|NCT02925494|471382705|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130932213|NCT02925494|471382706|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
130932214|NCT02925494|471382707|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
130932215|NCT02925494|471382704|FG000|Post-Treatment Follow-Up Period|Other|1|||
130932216|NCT02925494|471382705|FG001|Post-Treatment Follow-Up Period|Other|4|||
130932217|NCT02925494|471382706|FG002|Post-Treatment Follow-Up Period|Other|3|||
130932218|NCT02925494|471382707|FG003|Post-Treatment Follow-Up Period|Other|6|||
130932219|NCT02925494|471382704|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
130932220|NCT02925494|471382705|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
130932221|NCT02925494|471382706|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
130932222|NCT02925494|471382707|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
130932223|NCT02925494|471382704|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
130932224|NCT02925494|471382705|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
130932225|NCT02925494|471382706|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
130932226|NCT02925494|471382707|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
130932227|NCT02925494|471382704|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130932228|NCT02925494|471382705|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130932229|NCT02925494|471382706|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
130932230|NCT02925494|471382707|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
130932231|NCT02925494|471382704|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
130932232|NCT02925494|471382705|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
130932233|NCT02925494|471382706|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
130932234|NCT02925494|471382707|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
130932235|NCT01782222|471382708|FG000|Overall Study|Adverse Event|4|||
130932236|NCT01782222|471382709|FG001|Overall Study|Adverse Event|5|||
130932237|NCT01782222|471382710|FG002|Overall Study|Adverse Event|3|||
130932238|NCT01782222|471382708|FG000|Overall Study|Lack of Efficacy|2|||
130932239|NCT01782222|471382709|FG001|Overall Study|Lack of Efficacy|1|||
130932240|NCT01782222|471382710|FG002|Overall Study|Lack of Efficacy|0|||
130932241|NCT01782222|471382708|FG000|Overall Study|Protocol Violation|1|||
130932242|NCT01782222|471382709|FG001|Overall Study|Protocol Violation|0|||
130932243|NCT01782222|471382710|FG002|Overall Study|Protocol Violation|0|||
130932244|NCT01782222|471382708|FG000|Overall Study|Withdrawal by Subject|1|||
130932245|NCT01782222|471382709|FG001|Overall Study|Withdrawal by Subject|4|||
130932246|NCT01782222|471382710|FG002|Overall Study|Withdrawal by Subject|1|||
130932247|NCT01782222|471382708|FG000|Overall Study|Moved to other state|0|||
130932248|NCT01782222|471382709|FG001|Overall Study|Moved to other state|1|||
130932249|NCT01782222|471382710|FG002|Overall Study|Moved to other state|0|||
130932250|NCT01756898|471382711|FG000|Overall Study|Adverse Event|7|||
130932251|NCT01756898|471382712|FG001|Overall Study|Adverse Event|1|||
130932252|NCT01756898|471382713|FG002|Overall Study|Adverse Event|0|||
130932253|NCT01756898|471382714|FG003|Overall Study|Adverse Event|0|||
130932254|NCT01756898|471382711|FG000|Overall Study|Lack of Efficacy|4|||
130932255|NCT01756898|471382712|FG001|Overall Study|Lack of Efficacy|7|||
130932256|NCT01756898|471382713|FG002|Overall Study|Lack of Efficacy|6|||
130932257|NCT01756898|471382714|FG003|Overall Study|Lack of Efficacy|6|||
130932258|NCT01756898|471382711|FG000|Overall Study|Lost to Follow-up|2|||
130932259|NCT01756898|471382712|FG001|Overall Study|Lost to Follow-up|4|||
130932260|NCT01756898|471382713|FG002|Overall Study|Lost to Follow-up|2|||
130932261|NCT01756898|471382714|FG003|Overall Study|Lost to Follow-up|3|||
130932262|NCT01756898|471382711|FG000|Overall Study|Protocol Violation|1|||
130932263|NCT01756898|471382712|FG001|Overall Study|Protocol Violation|2|||
130932264|NCT01756898|471382713|FG002|Overall Study|Protocol Violation|2|||
130932265|NCT01756898|471382714|FG003|Overall Study|Protocol Violation|1|||
130932266|NCT01756898|471382711|FG000|Overall Study|Withdrew Consent|5|||
130932267|NCT01756898|471382712|FG001|Overall Study|Withdrew Consent|3|||
130932268|NCT01756898|471382713|FG002|Overall Study|Withdrew Consent|5|||
131035005|NCT03544281|471761843|FG018|Main Study Phase|Investigator Site Closed|0|||
131223752|NCT04380701|472447139|FG030|Overall Study|Pregnancy|0|||
130932269|NCT01756898|471382714|FG003|Overall Study|Withdrew Consent|6|||
130932270|NCT01756898|471382711|FG000|Overall Study|Other|0|||
130932271|NCT01756898|471382712|FG001|Overall Study|Other|2|||
130932272|NCT01756898|471382713|FG002|Overall Study|Other|2|||
130932273|NCT01756898|471382714|FG003|Overall Study|Other|0|||
130932274|NCT00833794|471382715|FG000|Open-label Phase|Adverse Event|225|||
130932275|NCT00833794|471382716|FG001|Open-label Phase|Adverse Event|0|||
130932276|NCT00833794|471382715|FG000|Open-label Phase|Lack of Efficacy|28|||
130932277|NCT00833794|471382716|FG001|Open-label Phase|Lack of Efficacy|0|||
130932278|NCT00833794|471382715|FG000|Open-label Phase|Withdrawal by Subject|48|||
131223753|NCT04380701|472447140|FG031|Overall Study|Pregnancy|0|||
130932279|NCT00833794|471382716|FG001|Open-label Phase|Withdrawal by Subject|0|||
130932280|NCT00833794|471382715|FG000|Open-label Phase|Physician Decision|20|||
130932281|NCT00833794|471382716|FG001|Open-label Phase|Physician Decision|0|||
130932282|NCT00833794|471382715|FG000|Open-label Phase|Administrative reason|1|||
130932283|NCT00833794|471382716|FG001|Open-label Phase|Administrative reason|0|||
130932284|NCT00833794|471382715|FG000|Open-label Phase|Protocol Violation|47|||
130932285|NCT00833794|471382716|FG001|Open-label Phase|Protocol Violation|0|||
130932286|NCT00833794|471382715|FG000|Open-label Phase|Did not complete wash-out period|12|||
130932287|NCT00833794|471382716|FG001|Open-label Phase|Did not complete wash-out period|0|||
130932288|NCT00833794|471382715|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
130932289|NCT00833794|471382716|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
130932290|NCT00833794|471382715|FG000|Double-blind Phase|Adverse Event|44|||
130932291|NCT00833794|471382716|FG001|Double-blind Phase|Adverse Event|11|||
130932292|NCT00833794|471382715|FG000|Double-blind Phase|Lack of Efficacy|34|||
130932293|NCT00833794|471382716|FG001|Double-blind Phase|Lack of Efficacy|22|||
130932294|NCT00833794|471382715|FG000|Double-blind Phase|Withdrawal by Subject|23|||
130932295|NCT00833794|471382716|FG001|Double-blind Phase|Withdrawal by Subject|6|||
130932296|NCT00833794|471382715|FG000|Double-blind Phase|Physician Decision|4|||
130932297|NCT00833794|471382716|FG001|Double-blind Phase|Physician Decision|7|||
130932298|NCT00833794|471382715|FG000|Double-blind Phase|Administrative reason|1|||
130932299|NCT00833794|471382716|FG001|Double-blind Phase|Administrative reason|3|||
130932300|NCT04051008|471382721|FG000|Overall Study|Withdrawal by Subject|2|||
130932301|NCT04051008|471382722|FG001|Overall Study|Withdrawal by Subject|0|||
130932302|NCT04051008|471382723|FG002|Overall Study|Withdrawal by Subject|1|||
130932303|NCT01835587|471382724|FG000|Overall Study|Disease Recurrence or Relapse|0|||
130932304|NCT01835587|471382725|FG001|Overall Study|Disease Recurrence or Relapse|3|||
130932305|NCT01835587|471382726|FG002|Overall Study|Disease Recurrence or Relapse|0|||
130932306|NCT01835587|471382727|FG003|Overall Study|Disease Recurrence or Relapse|3|||
130932307|NCT01835587|471382724|FG000|Overall Study|Withdrawal by Subject|2|||
130932308|NCT01835587|471382725|FG001|Overall Study|Withdrawal by Subject|0|||
130932309|NCT01835587|471382726|FG002|Overall Study|Withdrawal by Subject|0|||
130932310|NCT01835587|471382727|FG003|Overall Study|Withdrawal by Subject|3|||
130932311|NCT01835587|471382724|FG000|Overall Study|Adverse Event|0|||
130932312|NCT01835587|471382725|FG001|Overall Study|Adverse Event|0|||
130932313|NCT01835587|471382726|FG002|Overall Study|Adverse Event|2|||
130932314|NCT01835587|471382727|FG003|Overall Study|Adverse Event|2|||
130932315|NCT01835587|471382724|FG000|Overall Study|Death|0|||
130932316|NCT01835587|471382725|FG001|Overall Study|Death|0|||
130932317|NCT01835587|471382726|FG002|Overall Study|Death|0|||
130932318|NCT01835587|471382727|FG003|Overall Study|Death|1|||
130932319|NCT01835587|471382724|FG000|Overall Study|Miscellaneous|0|||
130932320|NCT01835587|471382725|FG001|Overall Study|Miscellaneous|1|||
130932321|NCT01835587|471382726|FG002|Overall Study|Miscellaneous|0|||
130932322|NCT01835587|471382727|FG003|Overall Study|Miscellaneous|0|||
130932323|NCT02132130|471382728|FG000|Overall Study|Lost to Follow-up|0|||
130932324|NCT02132130|471382729|FG001|Overall Study|Lost to Follow-up|2|||
130704156|NCT00988208|470541179|FG001|Overall Study|Protocol Violation|2|||
130704157|NCT00988208|470541178|FG000|Overall Study|Sponsor Decision|102|||
130704158|NCT00988208|470541179|FG001|Overall Study|Sponsor Decision|78|||
130704159|NCT00988208|470541178|FG000|Overall Study|Clinical Progression|17|||
130704160|NCT00988208|470541179|FG001|Overall Study|Clinical Progression|16|||
130704161|NCT00988208|470541178|FG000|Overall Study|Biochemical Progression|21|||
130704162|NCT00988208|470541179|FG001|Overall Study|Biochemical Progression|7|||
130704163|NCT00988208|470541178|FG000|Overall Study|Clinical Deterioration|7|||
130704164|NCT00988208|470541179|FG001|Overall Study|Clinical Deterioration|14|||
130704165|NCT00988208|470541178|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
130704166|NCT00988208|470541179|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
130704167|NCT00988208|470541178|FG000|Overall Study|Other|8|||
130704168|NCT00988208|470541179|FG001|Overall Study|Other|3|||
130704169|NCT01315028|470541183|FG000|Overall Study|Lost to Follow-up|1|||
130704170|NCT01315028|470541184|FG001|Overall Study|Lost to Follow-up|0|||
130704171|NCT01315028|470541183|FG000|Overall Study|Death|0|||
130704172|NCT01315028|470541184|FG001|Overall Study|Death|1|||
130704173|NCT00725764|470541187|FG000|Overall Study|Withdrawal by Subject|2|||
130932325|NCT02132130|471382730|FG002|Overall Study|Lost to Follow-up|0|||
130932326|NCT02132130|471382731|FG003|Overall Study|Lost to Follow-up|0|||
130932327|NCT02132130|471382728|FG000|Overall Study|Withdrawal by Subject|0|||
130932328|NCT02132130|471382729|FG001|Overall Study|Withdrawal by Subject|0|||
131223754|NCT04380701|472447141|FG032|Overall Study|Pregnancy|1|||
130704174|NCT00725764|470541187|FG000|Overall Study|Physician Decision|1|||
130704175|NCT00725764|470541187|FG000|Overall Study|Progressive Disease|7|||
130932329|NCT02132130|471382730|FG002|Overall Study|Withdrawal by Subject|0|||
130932330|NCT02132130|471382731|FG003|Overall Study|Withdrawal by Subject|1|||
130932331|NCT00838578|471382732|FG000|Overall Study|Protocol Violation|2|||
130932332|NCT00600483|471382733|FG000|Overall Study|Lost to Follow-up|26|||
130932333|NCT00600483|471382734|FG001|Overall Study|Lost to Follow-up|47|||
130932334|NCT00600483|471382733|FG000|Overall Study|Randomized but not treated|10|||
130932335|NCT00600483|471382734|FG001|Overall Study|Randomized but not treated|0|||
130932336|NCT01482884|471382742|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
130932337|NCT01482884|471382743|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
130932338|NCT01482884|471382742|FG000|Overall Study|Protocol Violation|1|||
130932339|NCT01482884|471382743|FG001|Overall Study|Protocol Violation|0|||
130932340|NCT01482884|471382742|FG000|Overall Study|Lost to Follow-up|2|||
130932341|NCT01482884|471382743|FG001|Overall Study|Lost to Follow-up|2|||
130932342|NCT01482884|471382742|FG000|Overall Study|Lack of Efficacy|0|||
130932343|NCT01482884|471382743|FG001|Overall Study|Lack of Efficacy|1|||
130932344|NCT01482884|471382742|FG000|Overall Study|Adverse Event|2|||
130932345|NCT01482884|471382743|FG001|Overall Study|Adverse Event|1|||
130932346|NCT01482884|471382742|FG000|Overall Study|Withdrawal by Subject|8|||
130932347|NCT01482884|471382743|FG001|Overall Study|Withdrawal by Subject|13|||
130932348|NCT00580606|471382753|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
130932349|NCT00580606|471382754|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
130932350|NCT00580606|471382753|FG000|Open Label (OL)|Withdrawal by Subject|4|||
130932351|NCT00580606|471382754|FG001|Open Label (OL)|Withdrawal by Subject|6|||
130932352|NCT00580606|471382753|FG000|Open Label (OL)|Dosing Symptoms|0|||
130932353|NCT00580606|471382754|FG001|Open Label (OL)|Dosing Symptoms|1|||
130932354|NCT00580606|471382753|FG000|Open Label (OL)|Lost to Follow-up|0|||
130932355|NCT00580606|471382754|FG001|Open Label (OL)|Lost to Follow-up|1|||
130932356|NCT00580606|471382753|FG000|Open Label (OL)|Pregnancy|0|||
130932357|NCT00580606|471382754|FG001|Open Label (OL)|Pregnancy|1|||
130932358|NCT00580606|471382753|FG000|Open Label (OL)|Non-compliance|2|||
130932359|NCT00580606|471382754|FG001|Open Label (OL)|Non-compliance|0|||
130932360|NCT00580606|471382753|FG000|Open Label (OL)|Physician Decision|1|||
130932361|NCT00580606|471382754|FG001|Open Label (OL)|Physician Decision|1|||
130932362|NCT00580606|471382753|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
130932363|NCT00580606|471382754|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
130932364|NCT03655691|471382757|FG000|Overall Study|Adverse Event|0|||
130932365|NCT03655691|471382758|FG001|Overall Study|Adverse Event|0|||
130932366|NCT03655691|471382759|FG002|Overall Study|Adverse Event|1|||
130932367|NCT03655691|471382757|FG000|Overall Study|Lost to Follow-up|1|||
130932368|NCT03655691|471382758|FG001|Overall Study|Lost to Follow-up|1|||
130932369|NCT03655691|471382759|FG002|Overall Study|Lost to Follow-up|2|||
130932370|NCT03655691|471382757|FG000|Overall Study|Protocol Violation|0|||
130932371|NCT03655691|471382758|FG001|Overall Study|Protocol Violation|1|||
130932372|NCT03655691|471382759|FG002|Overall Study|Protocol Violation|0|||
130932373|NCT03655691|471382757|FG000|Overall Study|Withdrawal by Subject|1|||
130932374|NCT03655691|471382758|FG001|Overall Study|Withdrawal by Subject|1|||
130932375|NCT03655691|471382759|FG002|Overall Study|Withdrawal by Subject|0|||
130932376|NCT01325584|471382762|FG000|Overall Study|Death|1|||
130932377|NCT00887978|471382763|FG000|Overall Study|Adverse Event|18|||
130932378|NCT00887978|471382764|FG001|Overall Study|Adverse Event|5|||
130932379|NCT00887978|471382763|FG000|Overall Study|Clinical Worsening|4|||
130932380|NCT00887978|471382764|FG001|Overall Study|Clinical Worsening|4|||
130932381|NCT00887978|471382763|FG000|Overall Study|Death|2|||
130932382|NCT00887978|471382764|FG001|Overall Study|Death|3|||
130932383|NCT00887978|471382763|FG000|Overall Study|Withdrawal by Subject|1|||
130932384|NCT00887978|471382764|FG001|Overall Study|Withdrawal by Subject|2|||
130932385|NCT00887978|471382763|FG000|Overall Study|Lost to Follow-up|0|||
130932386|NCT00887978|471382764|FG001|Overall Study|Lost to Follow-up|1|||
130985535|NCT00394355|471572940|FG001|Overall Study|Did not meet protocol eligibility|5|||
130985536|NCT00394355|471572941|FG002|Overall Study|Did not meet protocol eligibility|4|||
130985537|NCT00394355|471572942|FG003|Overall Study|Did not meet protocol eligibility|2|||
130985538|NCT00394355|471572939|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
130985539|NCT00394355|471572940|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
130985540|NCT00394355|471572941|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
130985541|NCT00394355|471572942|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
130985542|NCT00394355|471572939|FG000|Overall Study|Subject withdrawal - related to drug|1|||
130985543|NCT00394355|471572940|FG001|Overall Study|Subject withdrawal - related to drug|0|||
130985544|NCT00394355|471572941|FG002|Overall Study|Subject withdrawal - related to drug|0|||
130985545|NCT00394355|471572942|FG003|Overall Study|Subject withdrawal - related to drug|0|||
130985546|NCT00394355|471572939|FG000|Overall Study|Lost to Follow-up|7|||
130985547|NCT00394355|471572940|FG001|Overall Study|Lost to Follow-up|5|||
131120425|NCT01994382|472072351|FG010|Overall Study|Informed consent withdrawn|0|||
131120426|NCT01994382|472072352|FG011|Overall Study|Informed consent withdrawn|0|||
130985548|NCT00394355|471572941|FG002|Overall Study|Lost to Follow-up|4|||
130985549|NCT00394355|471572942|FG003|Overall Study|Lost to Follow-up|3|||
131120427|NCT01994382|472072353|FG012|Overall Study|Informed consent withdrawn|0|||
130985550|NCT00394355|471572939|FG000|Overall Study|Noncompliance with protocol|4|||
130985551|NCT00394355|471572940|FG001|Overall Study|Noncompliance with protocol|3|||
130985552|NCT00394355|471572941|FG002|Overall Study|Noncompliance with protocol|10|||
130985553|NCT00394355|471572942|FG003|Overall Study|Noncompliance with protocol|8|||
130985554|NCT00394355|471572939|FG000|Overall Study|Administrative|0|||
130985555|NCT00394355|471572940|FG001|Overall Study|Administrative|1|||
131223755|NCT04380701|472447142|FG033|Overall Study|Pregnancy|0|||
130932387|NCT02700815|471384531|FG000|Overall Study|Adverse Event|0|||
130932388|NCT02700815|471384532|FG001|Overall Study|Adverse Event|6|||
130932389|NCT02700815|471384533|FG002|Overall Study|Adverse Event|2|||
130932390|NCT02700815|471384534|FG003|Overall Study|Adverse Event|3|||
130932391|NCT02700815|471384531|FG000|Overall Study|Lack of Efficacy|0|||
130932392|NCT02700815|471384532|FG001|Overall Study|Lack of Efficacy|0|||
130932393|NCT02700815|471384533|FG002|Overall Study|Lack of Efficacy|1|||
130932394|NCT02700815|471384534|FG003|Overall Study|Lack of Efficacy|2|||
130932395|NCT02700815|471384531|FG000|Overall Study|Lost to Follow-up|1|||
130932396|NCT02700815|471384532|FG001|Overall Study|Lost to Follow-up|0|||
130932397|NCT02700815|471384533|FG002|Overall Study|Lost to Follow-up|0|||
130932398|NCT02700815|471384534|FG003|Overall Study|Lost to Follow-up|1|||
130932399|NCT02700815|471384531|FG000|Overall Study|Refusal to continue medication|0|||
130932400|NCT02700815|471384532|FG001|Overall Study|Refusal to continue medication|1|||
130932401|NCT02700815|471384533|FG002|Overall Study|Refusal to continue medication|0|||
130932402|NCT02700815|471384534|FG003|Overall Study|Refusal to continue medication|1|||
130932403|NCT02700815|471384531|FG000|Overall Study|Withdrawal by Subject|0|||
130932404|NCT02700815|471384532|FG001|Overall Study|Withdrawal by Subject|0|||
130932405|NCT02700815|471384533|FG002|Overall Study|Withdrawal by Subject|1|||
130932406|NCT02700815|471384534|FG003|Overall Study|Withdrawal by Subject|0|||
130932407|NCT00996216|471384540|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
130932408|NCT00996216|471384540|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
130932409|NCT00996216|471384540|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
130932410|NCT00793403|471384543|FG000|Overall Study|Other|73|||
130932411|NCT00842712|471384544|FG000|Safety Run-in Part|Adverse Event|0|||
130932412|NCT00842712|471384545|FG001|Safety Run-in Part|Adverse Event|1|||
130932413|NCT00842712|471384546|FG002|Safety Run-in Part|Adverse Event|0|||
130932414|NCT00842712|471384547|FG003|Safety Run-in Part|Adverse Event|0|||
130932415|NCT00842712|471384548|FG004|Safety Run-in Part|Adverse Event|0|||
130932416|NCT00842712|471384549|FG005|Safety Run-in Part|Adverse Event|0|||
130932417|NCT00842712|471384550|FG006|Safety Run-in Part|Adverse Event|0|||
130932418|NCT00842712|471384544|FG000|Safety Run-in Part|Progressive disease|3|||
130932419|NCT00842712|471384545|FG001|Safety Run-in Part|Progressive disease|1|||
130932420|NCT00842712|471384546|FG002|Safety Run-in Part|Progressive disease|0|||
130932421|NCT00842712|471384547|FG003|Safety Run-in Part|Progressive disease|1|||
130932422|NCT00842712|471384548|FG004|Safety Run-in Part|Progressive disease|0|||
130932423|NCT00842712|471384549|FG005|Safety Run-in Part|Progressive disease|0|||
130932424|NCT00842712|471384550|FG006|Safety Run-in Part|Progressive disease|0|||
130932425|NCT00842712|471384544|FG000|Randomized Part|Randomized but not treated|0|||
130932426|NCT00842712|471384545|FG001|Randomized Part|Randomized but not treated|0|||
130932427|NCT00842712|471384546|FG002|Randomized Part|Randomized but not treated|0|||
130932428|NCT00842712|471384547|FG003|Randomized Part|Randomized but not treated|0|||
130932429|NCT00842712|471384548|FG004|Randomized Part|Randomized but not treated|0|||
130932430|NCT00842712|471384549|FG005|Randomized Part|Randomized but not treated|1|||
130932431|NCT00842712|471384550|FG006|Randomized Part|Randomized but not treated|4|||
130932432|NCT00842712|471384544|FG000|Randomized Part|Ongoing at cut-off date|0|||
130932433|NCT00842712|471384545|FG001|Randomized Part|Ongoing at cut-off date|0|||
130932434|NCT00842712|471384546|FG002|Randomized Part|Ongoing at cut-off date|0|||
130932435|NCT00842712|471384547|FG003|Randomized Part|Ongoing at cut-off date|0|||
130932436|NCT00842712|471384548|FG004|Randomized Part|Ongoing at cut-off date|0|||
130932437|NCT00842712|471384549|FG005|Randomized Part|Ongoing at cut-off date|0|||
130932438|NCT00842712|471384550|FG006|Randomized Part|Ongoing at cut-off date|2|||
130932439|NCT00963547|471384552|FG000|Overall Study|Adverse Event|0|||
130932440|NCT00963547|471384553|FG001|Overall Study|Adverse Event|1|||
130932441|NCT00963547|471384554|FG002|Overall Study|Adverse Event|0|||
130932442|NCT00963547|471384555|FG003|Overall Study|Adverse Event|1|||
130932443|NCT00963547|471384556|FG004|Overall Study|Adverse Event|0|||
130932444|NCT00963547|471384557|FG005|Overall Study|Adverse Event|0|||
130704176|NCT00725764|470541187|FG000|Overall Study|Lost to Follow-up|1|||
130932445|NCT00963547|471384558|FG006|Overall Study|Adverse Event|0|||
130932446|NCT00963547|471384552|FG000|Overall Study|Physician Decision|1|||
130704177|NCT00725764|470541187|FG000|Overall Study|Death|1|||
130770811|NCT00948922|470787699|FG001|Overall Study|Death|0|||
130932447|NCT00963547|471384553|FG001|Overall Study|Physician Decision|1|||
130932448|NCT00963547|471384554|FG002|Overall Study|Physician Decision|0|||
130932449|NCT00963547|471384555|FG003|Overall Study|Physician Decision|0|||
130932450|NCT00963547|471384556|FG004|Overall Study|Physician Decision|0|||
130932451|NCT00963547|471384557|FG005|Overall Study|Physician Decision|0|||
130932452|NCT00963547|471384558|FG006|Overall Study|Physician Decision|0|||
130932453|NCT00963547|471384552|FG000|Overall Study|Progressive Disease|3|||
131120428|NCT01994382|472072354|FG013|Overall Study|Informed consent withdrawn|0|||
131120429|NCT01994382|472072355|FG014|Overall Study|Informed consent withdrawn|0|||
130932454|NCT00963547|471384553|FG001|Overall Study|Progressive Disease|8|||
131120430|NCT01994382|472072356|FG015|Overall Study|Informed consent withdrawn|0|||
130932455|NCT00963547|471384554|FG002|Overall Study|Progressive Disease|9|||
131120431|NCT01994382|472072357|FG016|Overall Study|Informed consent withdrawn|0|||
131120432|NCT01994382|472072341|FG000|Overall Study|Progressive disease|3|||
130932456|NCT00963547|471384555|FG003|Overall Study|Progressive Disease|5|||
130932457|NCT00963547|471384556|FG004|Overall Study|Progressive Disease|0|||
130932458|NCT00963547|471384557|FG005|Overall Study|Progressive Disease|0|||
130932459|NCT00963547|471384558|FG006|Overall Study|Progressive Disease|0|||
130932460|NCT00963547|471384552|FG000|Overall Study|Withdrawal by Subject|0|||
130932461|NCT00963547|471384553|FG001|Overall Study|Withdrawal by Subject|0|||
130932462|NCT00963547|471384554|FG002|Overall Study|Withdrawal by Subject|3|||
130932463|NCT00963547|471384555|FG003|Overall Study|Withdrawal by Subject|0|||
130932464|NCT00963547|471384556|FG004|Overall Study|Withdrawal by Subject|0|||
130932465|NCT00963547|471384557|FG005|Overall Study|Withdrawal by Subject|0|||
130932466|NCT00963547|471384558|FG006|Overall Study|Withdrawal by Subject|0|||
130932467|NCT00963547|471384552|FG000|Overall Study|Reason Unknown|0|||
130932468|NCT00963547|471384553|FG001|Overall Study|Reason Unknown|1|||
130932469|NCT00963547|471384554|FG002|Overall Study|Reason Unknown|0|||
130932470|NCT00963547|471384555|FG003|Overall Study|Reason Unknown|0|||
130932471|NCT00963547|471384556|FG004|Overall Study|Reason Unknown|0|||
130932472|NCT00963547|471384557|FG005|Overall Study|Reason Unknown|0|||
130932473|NCT00963547|471384558|FG006|Overall Study|Reason Unknown|0|||
130932474|NCT00482612|471384565|FG000|In-treatment Period|No study medication administered|0|||
130932475|NCT00482612|471384566|FG001|In-treatment Period|No study medication administered|0|||
130932476|NCT00482612|471384567|FG002|In-treatment Period|No study medication administered|1|||
130932477|NCT00482612|471384568|FG003|In-treatment Period|No study medication administered|0|||
130704178|NCT00725764|470541187|FG000|Overall Study|Participant non compliant with protocol|1|||
130704179|NCT00725764|470541187|FG000|Overall Study|Decline in performance status|1|||
130704180|NCT01928615|470541189|FG000|Overall Study|Study Terminated by Sponsor|2|||
130704181|NCT03023137|470541190|FG000|Overall Study|Multiple pregnancy|2|||
130704182|NCT03023137|470541191|FG001|Overall Study|Multiple pregnancy|4|||
130704183|NCT03023137|470541190|FG000|Overall Study|Lost to Follow-up|1|||
130704184|NCT03023137|470541191|FG001|Overall Study|Lost to Follow-up|1|||
130704185|NCT03023137|470541190|FG000|Overall Study|Protocol Violation|0|||
130704186|NCT03023137|470541191|FG001|Overall Study|Protocol Violation|4|||
130704187|NCT03023137|470541190|FG000|Overall Study|Lost the baby in a car accident|1|||
130704188|NCT03023137|470541191|FG001|Overall Study|Lost the baby in a car accident|0|||
130704189|NCT01203917|470541193|FG000|Overall Study|Death|29|||
130704190|NCT01203917|470541193|FG000|Overall Study|Lost to Follow-up|2|||
130704191|NCT01203917|470541193|FG000|Overall Study|Withdrawal by Subject|3|||
130704192|NCT01203917|470541193|FG000|Overall Study|Due to objective disease progression|1|||
130704193|NCT01203917|470541193|FG000|Overall Study|Due to EGFR M+I patient|1|||
130704194|NCT04660032|470541204|FG000|Overall Study|Protocol Violation|1|||
130704195|NCT04660032|470541205|FG001|Overall Study|Protocol Violation|1|||
130704196|NCT00090753|470541206|FG000|First Treatment Period|Adverse Event|20|||
130704197|NCT00090753|470541207|FG001|First Treatment Period|Adverse Event|8|||
130704198|NCT00090753|470541206|FG000|First Treatment Period|Death|88|||
130704199|NCT00090753|470541207|FG001|First Treatment Period|Death|62|||
130704200|NCT00090753|470541206|FG000|First Treatment Period|Lack of Efficacy|2|||
130704201|NCT00090753|470541207|FG001|First Treatment Period|Lack of Efficacy|1|||
130704202|NCT00090753|470541206|FG000|First Treatment Period|Refused Treatment|32|||
130704203|NCT00090753|470541207|FG001|First Treatment Period|Refused Treatment|25|||
130704204|NCT00090753|470541206|FG000|First Treatment Period|Lost to Follow-up|4|||
130704205|NCT00090753|470541207|FG001|First Treatment Period|Lost to Follow-up|4|||
130704206|NCT00090753|470541206|FG000|First Treatment Period|Renal Transplant|70|||
130704207|NCT00090753|470541207|FG001|First Treatment Period|Renal Transplant|50|||
130704208|NCT00090753|470541206|FG000|First Treatment Period|Mircera Commercialization|1|||
130704209|NCT00090753|470541207|FG001|First Treatment Period|Mircera Commercialization|0|||
130704210|NCT00090753|470541206|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
130704211|NCT00090753|470541207|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
130704212|NCT00090753|470541206|FG000|Extended Treatment Period|Adverse Event|11|||
130704213|NCT00090753|470541207|FG001|Extended Treatment Period|Adverse Event|0|||
130704214|NCT00090753|470541206|FG000|Extended Treatment Period|Death|58|||
130704215|NCT00090753|470541207|FG001|Extended Treatment Period|Death|30|||
130704216|NCT00090753|470541206|FG000|Extended Treatment Period|Lack of Efficacy|1|||
130704217|NCT00090753|470541207|FG001|Extended Treatment Period|Lack of Efficacy|0|||
130704218|NCT00090753|470541206|FG000|Extended Treatment Period|Refused Treatment|18|||
130704219|NCT00090753|470541207|FG001|Extended Treatment Period|Refused Treatment|12|||
130932478|NCT00482612|471384565|FG000|Follow-up Period|Other|4|||
130932479|NCT00482612|471384566|FG001|Follow-up Period|Other|2|||
130932480|NCT00482612|471384567|FG002|Follow-up Period|Other|1|||
130932481|NCT00482612|471384568|FG003|Follow-up Period|Other|2|||
130704220|NCT00090753|470541206|FG000|Extended Treatment Period|Lost to Follow-up|3|||
130704221|NCT00090753|470541207|FG001|Extended Treatment Period|Lost to Follow-up|1|||
130932482|NCT00482612|471384565|FG000|Follow-up Period|Lack of compliance|0|||
130932483|NCT00482612|471384566|FG001|Follow-up Period|Lack of compliance|0|||
130932484|NCT00482612|471384567|FG002|Follow-up Period|Lack of compliance|1|||
130932485|NCT00482612|471384568|FG003|Follow-up Period|Lack of compliance|0|||
130932486|NCT00482612|471384565|FG000|Follow-up Period|Lost to Follow-up|0|||
130932487|NCT00482612|471384566|FG001|Follow-up Period|Lost to Follow-up|4|||
130932488|NCT00482612|471384567|FG002|Follow-up Period|Lost to Follow-up|2|||
130932489|NCT00482612|471384568|FG003|Follow-up Period|Lost to Follow-up|1|||
130932490|NCT00482612|471384565|FG000|Follow-up Period|Adverse Event|4|||
130932491|NCT00482612|471384566|FG001|Follow-up Period|Adverse Event|7|||
130932492|NCT00482612|471384567|FG002|Follow-up Period|Adverse Event|9|||
130932493|NCT00482612|471384568|FG003|Follow-up Period|Adverse Event|0|||
130932494|NCT00482612|471384565|FG000|Follow-up Period|Lack of Efficacy|2|||
130932495|NCT00482612|471384566|FG001|Follow-up Period|Lack of Efficacy|0|||
130932496|NCT00482612|471384567|FG002|Follow-up Period|Lack of Efficacy|1|||
130932497|NCT00482612|471384568|FG003|Follow-up Period|Lack of Efficacy|0|||
130932498|NCT00482612|471384565|FG000|Follow-up Period|Withdrawal by Subject|3|||
130932499|NCT00482612|471384566|FG001|Follow-up Period|Withdrawal by Subject|5|||
131035006|NCT03544281|471761844|FG019|Main Study Phase|Investigator Site Closed|0|||
131035007|NCT03544281|471761845|FG020|Main Study Phase|Investigator Site Closed|0|||
131035008|NCT03544281|471761846|FG021|Main Study Phase|Investigator Site Closed|0|||
130932500|NCT00482612|471384567|FG002|Follow-up Period|Withdrawal by Subject|7|||
130932501|NCT00482612|471384568|FG003|Follow-up Period|Withdrawal by Subject|2|||
130932502|NCT00482612|471384565|FG000|Follow-up Period|Reasons not related to trial|1|||
130932503|NCT00482612|471384566|FG001|Follow-up Period|Reasons not related to trial|0|||
130932504|NCT00482612|471384567|FG002|Follow-up Period|Reasons not related to trial|1|||
130932505|NCT00482612|471384568|FG003|Follow-up Period|Reasons not related to trial|3|||
130932506|NCT01366521|471384569|FG000|Overall Study|Adverse Event|1|||
130932507|NCT01366521|471384570|FG001|Overall Study|Adverse Event|0|||
130932508|NCT01366521|471384571|FG002|Overall Study|Adverse Event|0|||
130932509|NCT01366521|471384572|FG003|Overall Study|Adverse Event|0|||
130932510|NCT01366521|471384569|FG000|Overall Study|Protocol Violation|0|||
130932511|NCT01366521|471384570|FG001|Overall Study|Protocol Violation|0|||
130932512|NCT01366521|471384571|FG002|Overall Study|Protocol Violation|1|||
130932513|NCT01366521|471384572|FG003|Overall Study|Protocol Violation|0|||
130932514|NCT01366521|471384569|FG000|Overall Study|Physician Decision|0|||
130932515|NCT01366521|471384570|FG001|Overall Study|Physician Decision|0|||
130932516|NCT01366521|471384571|FG002|Overall Study|Physician Decision|1|||
130932517|NCT01366521|471384572|FG003|Overall Study|Physician Decision|0|||
130704222|NCT00090753|470541206|FG000|Extended Treatment Period|Renal Transplant|15|||
130704223|NCT00090753|470541207|FG001|Extended Treatment Period|Renal Transplant|12|||
130704224|NCT00090753|470541206|FG000|Extended Treatment Period|Mircera Commercialization|188|||
130704225|NCT00090753|470541207|FG001|Extended Treatment Period|Mircera Commercialization|93|||
130704226|NCT00090753|470541206|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
130704227|NCT00090753|470541207|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
130704228|NCT00605176|470541210|FG000|Overall Study|Adverse Event|2|||
130704229|NCT00605176|470541211|FG001|Overall Study|Adverse Event|1|||
130704230|NCT00605176|470541212|FG002|Overall Study|Adverse Event|3|||
130704231|NCT00605176|470541210|FG000|Overall Study|Withdrawal by Subject|4|||
130704232|NCT00605176|470541211|FG001|Overall Study|Withdrawal by Subject|2|||
130704233|NCT00605176|470541212|FG002|Overall Study|Withdrawal by Subject|4|||
130704234|NCT00605176|470541210|FG000|Overall Study|Lost to Follow-up|2|||
130704235|NCT00605176|470541211|FG001|Overall Study|Lost to Follow-up|2|||
130704236|NCT00605176|470541212|FG002|Overall Study|Lost to Follow-up|1|||
130932518|NCT01366521|471384569|FG000|Overall Study|Withdrawal by Subject|0|||
130932519|NCT01366521|471384570|FG001|Overall Study|Withdrawal by Subject|1|||
130932520|NCT01366521|471384571|FG002|Overall Study|Withdrawal by Subject|0|||
130932521|NCT01366521|471384572|FG003|Overall Study|Withdrawal by Subject|0|||
130932522|NCT00660023|471384573|FG000|Overall Study|Adverse Event|2|||
130932523|NCT00660023|471384573|FG000|Overall Study|Death|8|||
130932524|NCT00660023|471384573|FG000|Overall Study|Blood Transfusion|5|||
130932525|NCT00660023|471384573|FG000|Overall Study|Renal Transplantation|3|||
131120433|NCT01994382|472072342|FG001|Overall Study|Progressive disease|4|||
131120434|NCT01994382|472072343|FG002|Overall Study|Progressive disease|4|||
131120435|NCT01994382|472072344|FG003|Overall Study|Progressive disease|3|||
131120436|NCT01994382|472072345|FG004|Overall Study|Progressive disease|2|||
131120437|NCT01994382|472072346|FG005|Overall Study|Progressive disease|3|||
131120438|NCT01994382|472072347|FG006|Overall Study|Progressive disease|3|||
131120439|NCT01994382|472072348|FG007|Overall Study|Progressive disease|6|||
131120440|NCT01994382|472072349|FG008|Overall Study|Progressive disease|2|||
131120441|NCT01994382|472072350|FG009|Overall Study|Progressive disease|2|||
131120442|NCT01994382|472072351|FG010|Overall Study|Progressive disease|13|||
131120443|NCT01994382|472072352|FG011|Overall Study|Progressive disease|8|||
131120444|NCT01994382|472072353|FG012|Overall Study|Progressive disease|7|||
131120445|NCT01994382|472072354|FG013|Overall Study|Progressive disease|3|||
131120446|NCT01994382|472072355|FG014|Overall Study|Progressive disease|6|||
131120447|NCT01994382|472072356|FG015|Overall Study|Progressive disease|44|||
131120448|NCT01994382|472072357|FG016|Overall Study|Progressive disease|28|||
131120449|NCT01994382|472072341|FG000|Overall Study|Physician Decision|0|||
131120450|NCT01994382|472072342|FG001|Overall Study|Physician Decision|1|||
131120451|NCT01994382|472072343|FG002|Overall Study|Physician Decision|0|||
131120452|NCT01994382|472072344|FG003|Overall Study|Physician Decision|0|||
131120453|NCT01994382|472072345|FG004|Overall Study|Physician Decision|0|||
130932526|NCT00660023|471384573|FG000|Overall Study|Withdrawal by Subject|1|||
130932527|NCT00660023|471384573|FG000|Overall Study|Missed Pregnancy Test|1|||
130932528|NCT00660023|471384573|FG000|Overall Study|Other Screening Failure|9|||
130932529|NCT00759031|471384574|FG000|First Intervention (1 Day)|Physician Decision|1|||
130932530|NCT00759031|471384575|FG001|First Intervention (1 Day)|Physician Decision|0|||
130932531|NCT00759031|471384574|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
130932532|NCT00759031|471384575|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
130932533|NCT00759031|471384574|FG000|First Intervention (1 Day)|Screening failure|1|||
130932534|NCT00759031|471384575|FG001|First Intervention (1 Day)|Screening failure|0|||
130932535|NCT04180488|471384576|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
130932536|NCT04180488|471384577|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
130932537|NCT04180488|471384578|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
130932538|NCT04180488|471384579|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
130932539|NCT04180488|471384580|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
130932540|NCT04180488|471384581|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
130932541|NCT04180488|471384576|FG000|Overall Study|Withdrawal by Subject|8|||
130932542|NCT04180488|471384577|FG001|Overall Study|Withdrawal by Subject|4|||
130932543|NCT04180488|471384578|FG002|Overall Study|Withdrawal by Subject|5|||
130932544|NCT04180488|471384579|FG003|Overall Study|Withdrawal by Subject|2|||
130932545|NCT04180488|471384580|FG004|Overall Study|Withdrawal by Subject|8|||
130932546|NCT04180488|471384581|FG005|Overall Study|Withdrawal by Subject|6|||
130932547|NCT04180488|471384576|FG000|Overall Study|Adverse Event|3|||
130932548|NCT04180488|471384577|FG001|Overall Study|Adverse Event|2|||
130932549|NCT04180488|471384578|FG002|Overall Study|Adverse Event|0|||
130932550|NCT04180488|471384579|FG003|Overall Study|Adverse Event|0|||
130932551|NCT04180488|471384580|FG004|Overall Study|Adverse Event|0|||
130932552|NCT04180488|471384581|FG005|Overall Study|Adverse Event|0|||
130932553|NCT04180488|471384576|FG000|Overall Study|Poor compliance to protocol|0|||
130932554|NCT04180488|471384577|FG001|Overall Study|Poor compliance to protocol|0|||
130932555|NCT04180488|471384578|FG002|Overall Study|Poor compliance to protocol|1|||
130932556|NCT04180488|471384579|FG003|Overall Study|Poor compliance to protocol|0|||
130932557|NCT04180488|471384580|FG004|Overall Study|Poor compliance to protocol|0|||
130932558|NCT04180488|471384581|FG005|Overall Study|Poor compliance to protocol|0|||
130932559|NCT03506815|471384582|FG000|Overall Study|Adverse Event|8|||
130932560|NCT03506815|471384583|FG001|Overall Study|Adverse Event|0|||
130932561|NCT03506815|471384582|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
130932562|NCT03506815|471384583|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
130932563|NCT03506815|471384582|FG000|Overall Study|Protocol Violation|1|||
130932564|NCT03506815|471384583|FG001|Overall Study|Protocol Violation|0|||
130932565|NCT03506815|471384582|FG000|Overall Study|Elective Surgery|1|||
130932566|NCT03506815|471384583|FG001|Overall Study|Elective Surgery|0|||
130932567|NCT02899988|471384587|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
130932568|NCT02899988|471384588|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
130932569|NCT02899988|471384589|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130932570|NCT02899988|471384590|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130932571|NCT02899988|471384591|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130932572|NCT02899988|471384592|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130932573|NCT02899988|471384593|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130932574|NCT02899988|471384594|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130932575|NCT02899988|471384595|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130932576|NCT02899988|471384596|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130932577|NCT02899988|471384597|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130932578|NCT02899988|471384587|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
130932579|NCT02899988|471384588|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
130932580|NCT02899988|471384589|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
130932581|NCT02899988|471384590|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
130932582|NCT02899988|471384591|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
130932583|NCT02899988|471384592|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
130932584|NCT02899988|471384593|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
130932585|NCT02899988|471384594|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
131035009|NCT03544281|471761825|FG000|Main Study Phase|Did not receive study treatment|0|||
130932586|NCT02899988|471384595|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
130932587|NCT02899988|471384596|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
130932588|NCT02899988|471384597|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
130932589|NCT02899988|471384587|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
130932590|NCT02899988|471384588|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
130932591|NCT02899988|471384589|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
130932592|NCT02899988|471384590|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
130932593|NCT02899988|471384591|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
130932594|NCT02899988|471384592|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
130932595|NCT02899988|471384593|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
130932596|NCT02899988|471384594|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
130932597|NCT02899988|471384595|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
130932598|NCT02899988|471384596|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
130932599|NCT02899988|471384597|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
130932600|NCT02899988|471384587|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
130932601|NCT02899988|471384588|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
130932602|NCT02899988|471384589|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
130932603|NCT02899988|471384590|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
130932604|NCT02899988|471384591|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
130932605|NCT02899988|471384592|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
130932606|NCT02899988|471384593|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
130932607|NCT02899988|471384594|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
130932608|NCT02899988|471384595|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
130932609|NCT02899988|471384596|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
130932610|NCT02899988|471384597|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
130932611|NCT02899988|471384587|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130932612|NCT02899988|471384588|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130932613|NCT02899988|471384589|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130932614|NCT02899988|471384590|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130932615|NCT02899988|471384591|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130932616|NCT02899988|471384592|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
130932617|NCT02899988|471384593|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130932618|NCT02899988|471384594|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
130932619|NCT02899988|471384595|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130932620|NCT02899988|471384596|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130932621|NCT02899988|471384597|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
130932622|NCT02899988|471384587|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130932623|NCT02899988|471384588|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130932624|NCT02899988|471384589|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
131035010|NCT03544281|471761826|FG001|Main Study Phase|Did not receive study treatment|0|||
130704237|NCT00605176|470541210|FG000|Overall Study|Non-complicance with study procedures|1|||
130704238|NCT00605176|470541211|FG001|Overall Study|Non-complicance with study procedures|0|||
130704239|NCT00605176|470541212|FG002|Overall Study|Non-complicance with study procedures|0|||
130704240|NCT00605176|470541210|FG000|Overall Study|Use of concomitant therapy|1|||
130704241|NCT00605176|470541211|FG001|Overall Study|Use of concomitant therapy|0|||
130704242|NCT00605176|470541212|FG002|Overall Study|Use of concomitant therapy|1|||
131035011|NCT03544281|471761827|FG002|Main Study Phase|Did not receive study treatment|0|||
131035012|NCT03544281|471761828|FG003|Main Study Phase|Did not receive study treatment|0|||
130704243|NCT00605176|470541210|FG000|Overall Study|Other (not due to AE)|1|||
130704244|NCT00605176|470541211|FG001|Overall Study|Other (not due to AE)|1|||
130704245|NCT00605176|470541212|FG002|Overall Study|Other (not due to AE)|0|||
130704246|NCT01256060|470541213|FG000|Overall Study|Lost to Follow-up|0|||
130704247|NCT01256060|470541214|FG001|Overall Study|Lost to Follow-up|1|||
130704248|NCT01256060|470541215|FG002|Overall Study|Lost to Follow-up|0|||
130704249|NCT01256060|470541216|FG003|Overall Study|Lost to Follow-up|0|||
130704250|NCT01466036|470541219|FG000|Overall Study|Death|1|||
130704251|NCT01466036|470541220|FG001|Overall Study|Death|1|||
130704252|NCT01466036|470541219|FG000|Overall Study|Physician Decision|0|||
130704253|NCT01466036|470541220|FG001|Overall Study|Physician Decision|4|||
130704254|NCT01466036|470541219|FG000|Overall Study|Adverse Event|2|||
130704255|NCT01466036|470541220|FG001|Overall Study|Adverse Event|6|||
130704256|NCT01466036|470541219|FG000|Overall Study|Withdrawal by Subject|2|||
130704257|NCT01466036|470541220|FG001|Overall Study|Withdrawal by Subject|8|||
130704258|NCT01466036|470541219|FG000|Overall Study|progression/relapse|14|||
130704259|NCT01466036|470541220|FG001|Overall Study|progression/relapse|21|||
130704260|NCT01466036|470541219|FG000|Overall Study|prolonged treatment delay|1|||
130704261|NCT01466036|470541220|FG001|Overall Study|prolonged treatment delay|1|||
130704262|NCT00985231|470541227|FG000|Overall Study|ineligible|1|||
130704263|NCT00985231|470541228|FG001|Overall Study|ineligible|0|||
130704264|NCT00985231|470541227|FG000|Overall Study|Protocol Violation|1|||
130704265|NCT00985231|470541228|FG001|Overall Study|Protocol Violation|0|||
130704266|NCT00985231|470541227|FG000|Overall Study|Withdrawal by Subject|1|||
130704267|NCT00985231|470541228|FG001|Overall Study|Withdrawal by Subject|0|||
130704268|NCT00985231|470541227|FG000|Overall Study|Lost to Follow-up|0|||
130704269|NCT00985231|470541228|FG001|Overall Study|Lost to Follow-up|1|||
130704270|NCT00985231|470541227|FG000|Overall Study|Study related symptoms & complaints|0|||
130704271|NCT00985231|470541228|FG001|Overall Study|Study related symptoms & complaints|2|||
130704272|NCT00808509|470541236|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
130704273|NCT00808509|470541237|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
130932625|NCT02899988|471384590|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130932626|NCT02899988|471384591|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
130932627|NCT02899988|471384592|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130932628|NCT02899988|471384593|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
130932629|NCT02899988|471384594|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
130932630|NCT02899988|471384595|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
130932631|NCT02899988|471384596|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
130932632|NCT02899988|471384597|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
130932633|NCT01401283|471384599|FG000|Overall Study|surgery cancelled|5|||
130932634|NCT01401283|471384600|FG001|Overall Study|surgery cancelled|8|||
130932635|NCT01401283|471384599|FG000|Overall Study|preoperative arrhythmia|5|||
130932636|NCT01401283|471384600|FG001|Overall Study|preoperative arrhythmia|0|||
130932637|NCT01401283|471384599|FG000|Overall Study|no central venous access|0|||
130932638|NCT01401283|471384600|FG001|Overall Study|no central venous access|1|||
130932639|NCT01401283|471384599|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
130932640|NCT01401283|471384600|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
130932641|NCT02433483|471384601|FG000|Overall Study|Unacceptable toxicity|1|||
130932642|NCT02433483|471384601|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
130932643|NCT01327885|471384606|FG000|Overall Study|Disease progression-according to RECIST|173|||
130932644|NCT01327885|471384607|FG001|Overall Study|Disease progression-according to RECIST|165|||
130932645|NCT01327885|471384606|FG000|Overall Study|Clinical progression|24|||
130932646|NCT01327885|471384607|FG001|Overall Study|Clinical progression|27|||
130932647|NCT01327885|471384606|FG000|Overall Study|Adverse Event|14|||
130932648|NCT01327885|471384607|FG001|Overall Study|Adverse Event|10|||
130932649|NCT01327885|471384606|FG000|Overall Study|Subject choice|5|||
130932650|NCT01327885|471384607|FG001|Overall Study|Subject choice|10|||
130932651|NCT01327885|471384606|FG000|Overall Study|Other|8|||
130932652|NCT01327885|471384607|FG001|Overall Study|Other|6|||
130932653|NCT01327885|471384606|FG000|Overall Study|Withdrawal of consent from study|3|||
130932654|NCT01327885|471384607|FG001|Overall Study|Withdrawal of consent from study|4|||
130932655|NCT01327885|471384606|FG000|Overall Study|Not treated|1|||
130932656|NCT01327885|471384607|FG001|Overall Study|Not treated|1|||
130932657|NCT01327885|471384606|FG000|Overall Study|Administrative decision|0|||
130932658|NCT01327885|471384607|FG001|Overall Study|Administrative decision|1|||
130932659|NCT03824912|471384610|FG000|Overall Study|Lost to Follow-up|18|||
130932660|NCT03824912|471384611|FG001|Overall Study|Lost to Follow-up|15|||
130932661|NCT03824912|471384612|FG002|Overall Study|Lost to Follow-up|8|||
130932662|NCT03824912|471384610|FG000|Overall Study|Negative Baseline Culture Result|118|||
130932663|NCT03824912|471384611|FG001|Overall Study|Negative Baseline Culture Result|112|||
130932664|NCT03824912|471384612|FG002|Overall Study|Negative Baseline Culture Result|57|||
130932665|NCT03824912|471384610|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130932666|NCT03824912|471384611|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130932667|NCT03824912|471384612|FG002|Overall Study|Non-Compliance with Study Drug|1|||
130932668|NCT03824912|471384610|FG000|Overall Study|Protocol Violation|1|||
130932669|NCT03824912|471384611|FG001|Overall Study|Protocol Violation|4|||
130932670|NCT03824912|471384612|FG002|Overall Study|Protocol Violation|1|||
130932671|NCT03824912|471384610|FG000|Overall Study|Withdrawal by Subject|3|||
130932672|NCT03824912|471384611|FG001|Overall Study|Withdrawal by Subject|2|||
130932673|NCT03824912|471384612|FG002|Overall Study|Withdrawal by Subject|1|||
130932674|NCT03824912|471384610|FG000|Overall Study|Participation in another study|0|||
130932675|NCT03824912|471384611|FG001|Overall Study|Participation in another study|1|||
130932676|NCT03824912|471384612|FG002|Overall Study|Participation in another study|0|||
130932677|NCT02511184|471384613|FG000|Overall Study|Death|1|||
130932678|NCT02511184|471384614|FG001|Overall Study|Death|0|||
130932679|NCT02511184|471384613|FG000|Overall Study|Lost to Follow-up|0|||
130932680|NCT02511184|471384614|FG001|Overall Study|Lost to Follow-up|1|||
130932681|NCT02511184|471384613|FG000|Overall Study|Study terminated by sponsor|1|||
130932682|NCT02511184|471384614|FG001|Overall Study|Study terminated by sponsor|5|||
130932683|NCT02511184|471384613|FG000|Overall Study|Withdrawal by Subject|0|||
130932684|NCT02511184|471384614|FG001|Overall Study|Withdrawal by Subject|1|||
130932685|NCT04271605|471384615|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
130932686|NCT03342690|471384616|FG000|Overall Study|Missing Information|9|||
130932687|NCT03342690|471384616|FG000|Overall Study|Protocol Violation|16|||
130932688|NCT00085631|471384617|FG000|Overall Study|Missing Data|4|||
130932689|NCT00085631|471384618|FG001|Overall Study|Missing Data|11|||
130932690|NCT00085631|471384619|FG002|Overall Study|Missing Data|7|||
130932691|NCT00284050|471384622|FG000|Overall Study|Adverse Event|1|||
130932692|NCT00284050|471384623|FG001|Overall Study|Adverse Event|1|||
130932693|NCT00284050|471384624|FG002|Overall Study|Adverse Event|1|||
130932694|NCT00284050|471384622|FG000|Overall Study|Lack of Efficacy|0|||
130932695|NCT00284050|471384623|FG001|Overall Study|Lack of Efficacy|1|||
130932696|NCT00284050|471384624|FG002|Overall Study|Lack of Efficacy|3|||
130932697|NCT00284050|471384622|FG000|Overall Study|Protocol Violation|0|||
130932698|NCT00284050|471384623|FG001|Overall Study|Protocol Violation|1|||
130932699|NCT00284050|471384624|FG002|Overall Study|Protocol Violation|2|||
130932700|NCT00284050|471384622|FG000|Overall Study|Withdrawal by Subject|2|||
130932701|NCT00284050|471384623|FG001|Overall Study|Withdrawal by Subject|2|||
130932702|NCT00284050|471384624|FG002|Overall Study|Withdrawal by Subject|2|||
130932703|NCT00284050|471384622|FG000|Overall Study|Lost to Follow-up|1|||
130932704|NCT00284050|471384623|FG001|Overall Study|Lost to Follow-up|0|||
130932705|NCT00284050|471384624|FG002|Overall Study|Lost to Follow-up|1|||
130932706|NCT00284050|471384622|FG000|Overall Study|Death|1|||
130932707|NCT00284050|471384623|FG001|Overall Study|Death|0|||
130932708|NCT00284050|471384624|FG002|Overall Study|Death|0|||
130932709|NCT02573350|471384626|FG000|Overall Study|Lost to Follow-up|2|||
130932710|NCT02573350|471384627|FG001|Overall Study|Lost to Follow-up|1|||
130932711|NCT02573350|471384626|FG000|Overall Study|Adverse Event|3|||
130932712|NCT02573350|471384627|FG001|Overall Study|Adverse Event|4|||
130932713|NCT02573350|471384626|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
130932714|NCT02573350|471384627|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
130932715|NCT02573350|471384626|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
130932716|NCT02573350|471384627|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
130932717|NCT02573350|471384626|FG000|Overall Study|Subject withdrew consent to participate|6|||
130932718|NCT02573350|471384627|FG001|Overall Study|Subject withdrew consent to participate|1|||
130932719|NCT02573350|471384626|FG000|Overall Study|Protocol Deviation|1|||
130932720|NCT02573350|471384627|FG001|Overall Study|Protocol Deviation|1|||
130932721|NCT01833520|471384628|FG000|Overall Study|Lack of Efficacy|3|||
130932722|NCT01833520|471384629|FG001|Overall Study|Lack of Efficacy|3|||
130932723|NCT01833520|471384630|FG002|Overall Study|Lack of Efficacy|8|||
130932724|NCT01833520|471384631|FG003|Overall Study|Lack of Efficacy|3|||
130932725|NCT02547649|471384632|FG000|Overall Study|Lost to Follow-up|3|||
130932726|NCT02547649|471384633|FG001|Overall Study|Lost to Follow-up|1|||
130932727|NCT02547649|471384634|FG002|Overall Study|Lost to Follow-up|1|||
130932728|NCT02547649|471384632|FG000|Overall Study|Not vaccinated|0|||
130932729|NCT02547649|471384633|FG001|Overall Study|Not vaccinated|0|||
130932730|NCT02547649|471384634|FG002|Overall Study|Not vaccinated|1|||
130932731|NCT02547649|471384632|FG000|Overall Study|Withdrawal by Subject|0|||
130932732|NCT02547649|471384633|FG001|Overall Study|Withdrawal by Subject|4|||
130932733|NCT02547649|471384634|FG002|Overall Study|Withdrawal by Subject|2|||
130932734|NCT03765918|471384637|FG000|Overall Study|Death|109|||
130932735|NCT03765918|471384638|FG001|Overall Study|Death|127|||
130932736|NCT03765918|471384637|FG000|Overall Study|Lost to Follow-up|2|||
130932737|NCT03765918|471384638|FG001|Overall Study|Lost to Follow-up|3|||
130932738|NCT03765918|471384637|FG000|Overall Study|Withdrawal by Subject|12|||
130932739|NCT03765918|471384638|FG001|Overall Study|Withdrawal by Subject|16|||
130932740|NCT03765918|471384637|FG000|Overall Study|Participants Ongoing|240|||
130932741|NCT03765918|471384638|FG001|Overall Study|Participants Ongoing|205|||
130932742|NCT00006903|471384639|FG000|Overall Study|Still receiving treatment|0|||
130932743|NCT00006903|471384640|FG001|Overall Study|Still receiving treatment|0|||
130932744|NCT00006903|471384641|FG002|Overall Study|Still receiving treatment|1|||
130932745|NCT00006903|471384639|FG000|Overall Study|Refused further treatment|0|||
130932746|NCT00006903|471384640|FG001|Overall Study|Refused further treatment|2|||
130932747|NCT00006903|471384641|FG002|Overall Study|Refused further treatment|1|||
130932748|NCT00006903|471384639|FG000|Overall Study|Adverse Event|0|||
130932749|NCT00006903|471384640|FG001|Overall Study|Adverse Event|0|||
130932750|NCT00006903|471384641|FG002|Overall Study|Adverse Event|1|||
130932751|NCT00006903|471384639|FG000|Overall Study|Death|0|||
130932752|NCT00006903|471384640|FG001|Overall Study|Death|1|||
130932753|NCT00006903|471384641|FG002|Overall Study|Death|0|||
130932754|NCT00006903|471384639|FG000|Overall Study|Patient never treated|0|||
130932755|NCT00006903|471384640|FG001|Overall Study|Patient never treated|0|||
130932756|NCT00006903|471384641|FG002|Overall Study|Patient never treated|1|||
130932757|NCT00006903|471384639|FG000|Overall Study|Ineligible|10|||
130932758|NCT00006903|471384640|FG001|Overall Study|Ineligible|1|||
130932759|NCT00006903|471384641|FG002|Overall Study|Ineligible|2|||
130932760|NCT01484197|471384644|FG000|Treatment Period 1|Adverse Event|1|||
130932761|NCT01484197|471384645|FG001|Treatment Period 1|Adverse Event|0|||
130932762|NCT01484197|471384646|FG002|Treatment Period 1|Adverse Event|0|||
130932763|NCT01484197|471384647|FG003|Treatment Period 1|Adverse Event|0|||
130932764|NCT01484197|471384644|FG000|Treatment Period 2|Subject withdrew consent|0|||
130932765|NCT01484197|471384645|FG001|Treatment Period 2|Subject withdrew consent|0|||
130932766|NCT01484197|471384646|FG002|Treatment Period 2|Subject withdrew consent|0|||
130932767|NCT01484197|471384647|FG003|Treatment Period 2|Subject withdrew consent|1|||
130932768|NCT06149247|471384655|FG000|Overall Study|Adverse Event|0|||
130932769|NCT06149247|471384656|FG001|Overall Study|Adverse Event|1|||
130932770|NCT02289417|471384657|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
130932771|NCT02289417|471384658|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130932772|NCT02289417|471384659|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
130932773|NCT02289417|471384660|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130704274|NCT00808509|470541236|FG000|Randomized Phase|Reduced methotrexate dose|1|||
130932774|NCT02289417|471384661|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130932775|NCT02289417|471384662|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130932776|NCT02289417|471384663|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130770812|NCT00948922|470787700|FG002|Overall Study|Death|0|||
130932777|NCT02289417|471384664|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130932778|NCT02289417|471384665|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130932779|NCT02289417|471384657|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
130985556|NCT00394355|471572941|FG002|Overall Study|Administrative|1|||
130932780|NCT02289417|471384658|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
130932781|NCT02289417|471384659|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
130932782|NCT02289417|471384660|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130932783|NCT02289417|471384661|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130932784|NCT02289417|471384662|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130932785|NCT02289417|471384663|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130932786|NCT02289417|471384664|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130932787|NCT02289417|471384665|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
130932788|NCT02289417|471384657|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130932789|NCT02289417|471384658|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
130932790|NCT02289417|471384659|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130932791|NCT02289417|471384660|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130932792|NCT02289417|471384661|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130932793|NCT02289417|471384662|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130932794|NCT02289417|471384663|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130932795|NCT02289417|471384664|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130932796|NCT02289417|471384665|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
130932797|NCT02289417|471384657|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
130932798|NCT02289417|471384658|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130932799|NCT02289417|471384659|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130932800|NCT02289417|471384660|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130932801|NCT02289417|471384661|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130932802|NCT02289417|471384662|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130932803|NCT02289417|471384663|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130932804|NCT02289417|471384664|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130932805|NCT02289417|471384665|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
130932806|NCT02289417|471384657|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
130932807|NCT02289417|471384658|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
130932808|NCT02289417|471384659|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
130932809|NCT02289417|471384660|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
130932810|NCT02289417|471384661|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
130932811|NCT02289417|471384662|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
130932812|NCT02289417|471384663|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
130932813|NCT02289417|471384664|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
130932814|NCT02289417|471384665|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
130932815|NCT02289417|471384657|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130932816|NCT02289417|471384658|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130932817|NCT02289417|471384659|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
130932818|NCT02289417|471384660|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130932819|NCT02289417|471384661|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130932820|NCT02289417|471384662|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130932821|NCT02289417|471384663|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130932822|NCT02289417|471384664|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130932823|NCT02289417|471384665|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
130932824|NCT02289417|471384657|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
130932825|NCT02289417|471384658|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
130932826|NCT02289417|471384659|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
130932827|NCT02289417|471384660|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
130932828|NCT02289417|471384661|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
130932829|NCT02289417|471384662|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
130932830|NCT02289417|471384663|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
130932831|NCT02289417|471384664|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
131120454|NCT01994382|472072346|FG005|Overall Study|Physician Decision|0|||
131120455|NCT01994382|472072347|FG006|Overall Study|Physician Decision|0|||
131120456|NCT01994382|472072348|FG007|Overall Study|Physician Decision|0|||
131120457|NCT01994382|472072349|FG008|Overall Study|Physician Decision|0|||
131120458|NCT01994382|472072350|FG009|Overall Study|Physician Decision|0|||
131120459|NCT01994382|472072351|FG010|Overall Study|Physician Decision|3|||
131120460|NCT01994382|472072352|FG011|Overall Study|Physician Decision|1|||
131120461|NCT01994382|472072353|FG012|Overall Study|Physician Decision|1|||
130932832|NCT02289417|471384665|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
131120462|NCT01994382|472072354|FG013|Overall Study|Physician Decision|0|||
131120463|NCT01994382|472072355|FG014|Overall Study|Physician Decision|1|||
130932833|NCT02289417|471384657|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130932834|NCT02289417|471384658|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130932835|NCT02289417|471384659|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
130932836|NCT02289417|471384660|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
131120464|NCT01994382|472072356|FG015|Overall Study|Physician Decision|4|||
131120465|NCT01994382|472072357|FG016|Overall Study|Physician Decision|2|||
130932837|NCT02289417|471384661|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
130932838|NCT02289417|471384662|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
130932839|NCT02289417|471384663|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130932840|NCT02289417|471384664|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130932841|NCT02289417|471384665|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
130932842|NCT02289417|471384657|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130932843|NCT02289417|471384658|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130932844|NCT02289417|471384659|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130932845|NCT02289417|471384660|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130932846|NCT02289417|471384661|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
131035013|NCT03544281|471761829|FG004|Main Study Phase|Did not receive study treatment|0|||
131035014|NCT03544281|471761830|FG005|Main Study Phase|Did not receive study treatment|0|||
131035015|NCT03544281|471761831|FG006|Main Study Phase|Did not receive study treatment|1|||
131035016|NCT03544281|471761832|FG007|Main Study Phase|Did not receive study treatment|0|||
130932847|NCT02289417|471384662|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130932848|NCT02289417|471384663|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
130932849|NCT02289417|471384664|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130932850|NCT02289417|471384665|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
130932851|NCT02289417|471384657|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130932852|NCT02289417|471384658|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130932853|NCT02289417|471384659|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130932854|NCT02289417|471384660|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
130932855|NCT02289417|471384661|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130932856|NCT02289417|471384662|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130932857|NCT02289417|471384663|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
130932858|NCT02289417|471384664|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130932859|NCT02289417|471384665|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
130932860|NCT02289417|471384657|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
130932861|NCT02289417|471384658|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
130932862|NCT02289417|471384659|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
130932863|NCT02289417|471384660|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
130932864|NCT02289417|471384661|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
130932865|NCT02289417|471384662|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
130932866|NCT02289417|471384663|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
130932867|NCT02289417|471384664|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
130932868|NCT02289417|471384665|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
130932869|NCT02289417|471384657|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130932870|NCT02289417|471384658|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130932871|NCT02289417|471384659|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130932872|NCT02289417|471384660|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130932873|NCT02289417|471384661|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130932874|NCT02289417|471384662|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130932875|NCT02289417|471384663|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
130932876|NCT02289417|471384664|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
130932877|NCT02289417|471384665|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
130932878|NCT02289417|471384657|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130932879|NCT02289417|471384658|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130932880|NCT02289417|471384659|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130932881|NCT02289417|471384660|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130932882|NCT02289417|471384661|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130932883|NCT02289417|471384662|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
130932884|NCT02289417|471384663|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
131035017|NCT03544281|471761833|FG008|Main Study Phase|Did not receive study treatment|0|||
131035018|NCT03544281|471761834|FG009|Main Study Phase|Did not receive study treatment|0|||
131035019|NCT03544281|471761835|FG010|Main Study Phase|Did not receive study treatment|0|||
131035020|NCT03544281|471761836|FG011|Main Study Phase|Did not receive study treatment|0|||
131035021|NCT03544281|471761837|FG012|Main Study Phase|Did not receive study treatment|0|||
130932885|NCT02289417|471384664|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
130932886|NCT02289417|471384665|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
131035022|NCT03544281|471761838|FG013|Main Study Phase|Did not receive study treatment|0|||
131035023|NCT03544281|471761839|FG014|Main Study Phase|Did not receive study treatment|0|||
131035024|NCT03544281|471761840|FG015|Main Study Phase|Did not receive study treatment|0|||
131035025|NCT03544281|471761841|FG016|Main Study Phase|Did not receive study treatment|0|||
131035026|NCT03544281|471761842|FG017|Main Study Phase|Did not receive study treatment|0|||
130932887|NCT02289417|471384657|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
130932888|NCT02289417|471384658|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
130932889|NCT02289417|471384659|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
130932890|NCT02289417|471384660|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
130932891|NCT02289417|471384661|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
130932892|NCT02289417|471384662|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
130932893|NCT02289417|471384663|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
130932894|NCT02289417|471384664|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
130704275|NCT00808509|470541237|FG001|Randomized Phase|Reduced methotrexate dose|2|||
130704276|NCT00808509|470541236|FG000|Randomized Phase|Patient refused rescue therapy|0|||
130704277|NCT00808509|470541237|FG001|Randomized Phase|Patient refused rescue therapy|3|||
130704278|NCT00436917|470541238|FG000|Overall Study|Withdrawal by Subject|13|||
130704279|NCT00436917|470541238|FG000|Overall Study|Adverse Event|2|||
130704280|NCT00436917|470541238|FG000|Overall Study|Physician Decision|1|||
130932895|NCT02289417|471384665|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
130932896|NCT04786990|471384666|FG000|Overall Study|Withdrawal by Subject|1|||
130932897|NCT04786990|471384666|FG000|Overall Study|Adverse Event|1|||
130932898|NCT04786990|471384666|FG000|Overall Study|Lost to Follow-up|1|||
130932899|NCT04786990|471384666|FG000|Overall Study|Noncompliance|1|||
130932900|NCT04786990|471384666|FG000|Overall Study|Unable to complete site visits|1|||
130932901|NCT04786990|471384666|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
130932902|NCT01500694|471384672|FG000|Overall Study|Adverse Event|4|||
130932903|NCT01500694|471384673|FG001|Overall Study|Adverse Event|3|||
130932904|NCT01500694|471384672|FG000|Overall Study|Protocol Violation|0|||
130932905|NCT01500694|471384673|FG001|Overall Study|Protocol Violation|1|||
130932906|NCT01500694|471384672|FG000|Overall Study|Withdrawal by Subject|23|||
130932907|NCT01500694|471384673|FG001|Overall Study|Withdrawal by Subject|14|||
130932908|NCT01500694|471384672|FG000|Overall Study|Lost to Follow-up|2|||
130932909|NCT01500694|471384673|FG001|Overall Study|Lost to Follow-up|3|||
130932910|NCT01500694|471384672|FG000|Overall Study|Lack of Efficacy|14|||
130932911|NCT01500694|471384673|FG001|Overall Study|Lack of Efficacy|5|||
130932912|NCT01500694|471384672|FG000|Overall Study|Other|9|||
130932913|NCT01500694|471384673|FG001|Overall Study|Other|3|||
130932914|NCT02007109|471384674|FG000|Overall Study|Diary not returned or excluded|102|||
130932915|NCT02007109|471384674|FG000|Overall Study|Excluded - Age<7yo|9|||
130932916|NCT01858389|471384676|FG000|Overall Study|Death|1|||
130932917|NCT01858389|471384677|FG001|Overall Study|Death|3|||
130932918|NCT01858389|471384676|FG000|Overall Study|Study terminated by sponsor|0|||
130932919|NCT01858389|471384677|FG001|Overall Study|Study terminated by sponsor|2|||
130932920|NCT01858389|471384676|FG000|Overall Study|Withdrawal by Subject|0|||
130932921|NCT01858389|471384677|FG001|Overall Study|Withdrawal by Subject|1|||
130932922|NCT01858389|471384676|FG000|Overall Study|Progressive disease|10|||
130932923|NCT01858389|471384677|FG001|Overall Study|Progressive disease|11|||
130932924|NCT01858389|471384676|FG000|Overall Study|Other|2|||
130932925|NCT01858389|471384677|FG001|Overall Study|Other|4|||
130932926|NCT01858389|471384676|FG000|Overall Study|Adverse Event|3|||
130932927|NCT01858389|471384677|FG001|Overall Study|Adverse Event|1|||
130932928|NCT01858389|471384676|FG000|Overall Study|Did not receive treatment|0|||
130932929|NCT01858389|471384677|FG001|Overall Study|Did not receive treatment|3|||
130932930|NCT00458211|471384678|FG000|Overall Study|Lack of Efficacy|12|||
130932931|NCT00458211|471384678|FG000|Overall Study|Withdrawal by Subject|2|||
130932932|NCT00458211|471384678|FG000|Overall Study|Protocol Violation|2|||
130932933|NCT03310775|471384690|FG000|Overall Study|Lost to Follow-up|2|||
130932934|NCT03310775|471384691|FG001|Overall Study|Lost to Follow-up|3|||
130932935|NCT03310775|471384690|FG000|Overall Study|aggravation of depression|0|||
130932936|NCT03310775|471384691|FG001|Overall Study|aggravation of depression|1|||
130932937|NCT00646776|471384692|FG000|Overall Study|Adverse Event|1|||
130932938|NCT00646776|471384693|FG001|Overall Study|Adverse Event|9|||
130932939|NCT00646776|471384692|FG000|Overall Study|Investigator discretion|0|||
130932940|NCT00646776|471384693|FG001|Overall Study|Investigator discretion|4|||
130932941|NCT00126568|471384694|FG000|Overall Study|Death|2|||
130932942|NCT03031678|471384695|FG000|Overall Study|Study closed prior to completion|1|||
130932943|NCT01753856|471384696|FG000|Overall Study|Adverse Event|1|||
131035027|NCT03544281|471761843|FG018|Main Study Phase|Did not receive study treatment|0|||
130932944|NCT01753856|471384697|FG001|Overall Study|Adverse Event|0|||
130932945|NCT01753856|471384696|FG000|Overall Study|Withdrawal by Subject|0|||
131035028|NCT03544281|471761844|FG019|Main Study Phase|Did not receive study treatment|0|||
130932946|NCT01753856|471384697|FG001|Overall Study|Withdrawal by Subject|2|||
130932947|NCT01753856|471384696|FG000|Overall Study|Sponsor Decision|2|||
131035029|NCT03544281|471761845|FG020|Main Study Phase|Did not receive study treatment|0|||
130932948|NCT01753856|471384697|FG001|Overall Study|Sponsor Decision|0|||
130932949|NCT05353985|471384698|FG000|Overall Study|Adverse Event|5|||
130932950|NCT05353985|471384699|FG001|Overall Study|Adverse Event|7|||
130932951|NCT05353985|471384698|FG000|Overall Study|Lost to Follow-up|1|||
130932952|NCT05353985|471384699|FG001|Overall Study|Lost to Follow-up|1|||
130932953|NCT05353985|471384698|FG000|Overall Study|Protocol Violation|1|||
130932954|NCT05353985|471384699|FG001|Overall Study|Protocol Violation|0|||
130932955|NCT05353985|471384698|FG000|Overall Study|Withdrawal by Subject|13|||
130932956|NCT05353985|471384699|FG001|Overall Study|Withdrawal by Subject|17|||
130932957|NCT05353985|471384698|FG000|Overall Study|Reason Not Specified|1|||
130704281|NCT00436917|470541238|FG000|Overall Study|Death|1|||
130704282|NCT00436917|470541238|FG000|Overall Study|Lost to Follow-up|1|||
130932958|NCT05353985|471384699|FG001|Overall Study|Reason Not Specified|0|||
130932959|NCT05353985|471384698|FG000|Overall Study|Randomized in Error & Not Treated|0|||
130932960|NCT05353985|471384699|FG001|Overall Study|Randomized in Error & Not Treated|1|||
130932961|NCT01937559|471384700|FG000|Overall Study|Physician Decision|3|||
130932962|NCT01937559|471384701|FG001|Overall Study|Physician Decision|3|||
130932963|NCT01937559|471384702|FG002|Overall Study|Physician Decision|0|||
130932964|NCT01937559|471384700|FG000|Overall Study|Withdrawal by Subject|6|||
130932965|NCT01937559|471384701|FG001|Overall Study|Withdrawal by Subject|4|||
130932966|NCT01937559|471384702|FG002|Overall Study|Withdrawal by Subject|0|||
130932967|NCT01937559|471384700|FG000|Overall Study|screen fail|2|||
130932968|NCT01937559|471384701|FG001|Overall Study|screen fail|4|||
130932969|NCT01937559|471384702|FG002|Overall Study|screen fail|0|||
130932970|NCT04847557|471384703|FG000|Overall Study|Adverse Event|1|||
130932971|NCT04847557|471384704|FG001|Overall Study|Adverse Event|0|||
130932972|NCT04847557|471384703|FG000|Overall Study|Death|19|||
130932973|NCT04847557|471384704|FG001|Overall Study|Death|15|||
130932974|NCT04847557|471384703|FG000|Overall Study|Lost to Follow-up|3|||
130932975|NCT04847557|471384704|FG001|Overall Study|Lost to Follow-up|6|||
130932976|NCT04847557|471384703|FG000|Overall Study|Physician Decision|1|||
130932977|NCT04847557|471384704|FG001|Overall Study|Physician Decision|0|||
130932978|NCT04847557|471384703|FG000|Overall Study|Protocol Violation|0|||
130932979|NCT04847557|471384704|FG001|Overall Study|Protocol Violation|1|||
130932980|NCT04847557|471384703|FG000|Overall Study|Withdrawal by Subject|8|||
130932981|NCT04847557|471384704|FG001|Overall Study|Withdrawal by Subject|14|||
130932982|NCT02310568|471386648|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
130932983|NCT02310568|471386649|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
130932984|NCT02310568|471386650|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
130932985|NCT02310568|471386651|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
130932986|NCT02310568|471386652|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
130932987|NCT02310568|471386648|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
130932988|NCT02310568|471386649|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
130932989|NCT02310568|471386650|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
130932990|NCT02310568|471386651|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
130932991|NCT02310568|471386652|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
130932992|NCT02310568|471386648|FG000|Stage 1 ( 4 Weeks)|Other|1|||
130704283|NCT00436917|470541238|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
130704284|NCT00436917|470541238|FG000|Overall Study|Increased creatinine|1|||
130704285|NCT00436917|470541238|FG000|Overall Study|Personal conflicts of patient|1|||
130704286|NCT02169791|470541239|FG000|Overall Study|Death|6|||
130704287|NCT02169791|470541239|FG000|Overall Study|patient withdrew consent|1|||
130704288|NCT00220727|470541244|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
130704289|NCT00220727|470541245|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
130704290|NCT00761176|470541246|FG000|Overall Study|Death|1|||
130704291|NCT00761176|470541247|FG001|Overall Study|Death|0|||
130704292|NCT00761176|470541246|FG000|Overall Study|Withdrawal by Subject|1|||
130704293|NCT00761176|470541247|FG001|Overall Study|Withdrawal by Subject|1|||
130704294|NCT05103657|470541250|FG000|Overall Study|Other reasons than listed|9|||
130704295|NCT05103657|470541251|FG001|Overall Study|Other reasons than listed|8|||
130704296|NCT05103657|470541250|FG000|Overall Study|Protocol deviation|2|||
130704297|NCT05103657|470541251|FG001|Overall Study|Protocol deviation|2|||
130704298|NCT05103657|470541250|FG000|Overall Study|No reason available|5|||
130932993|NCT02310568|471386649|FG001|Stage 1 ( 4 Weeks)|Other|1|||
130932994|NCT02310568|471386650|FG002|Stage 1 ( 4 Weeks)|Other|0|||
130932995|NCT02310568|471386651|FG003|Stage 1 ( 4 Weeks)|Other|0|||
130932996|NCT02310568|471386652|FG004|Stage 1 ( 4 Weeks)|Other|0|||
130704299|NCT05103657|470541251|FG001|Overall Study|No reason available|4|||
130704300|NCT05103657|470541250|FG000|Overall Study|Burden of study procedures|3|||
130704301|NCT05103657|470541251|FG001|Overall Study|Burden of study procedures|1|||
130704302|NCT05103657|470541250|FG000|Overall Study|Perceived lack of efficacy|1|||
130704303|NCT05103657|470541251|FG001|Overall Study|Perceived lack of efficacy|1|||
130704304|NCT05103657|470541250|FG000|Overall Study|Adverse Event|6|||
130704305|NCT05103657|470541251|FG001|Overall Study|Adverse Event|14|||
130704306|NCT05103657|470541250|FG000|Overall Study|Not Treated|1|||
130932997|NCT02310568|471386648|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
130932998|NCT02310568|471386649|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
130932999|NCT02310568|471386650|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
130933000|NCT02310568|471386651|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
130933001|NCT02310568|471386652|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
130933002|NCT02310568|471386648|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
130933003|NCT02310568|471386649|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
130933004|NCT02310568|471386650|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
130985557|NCT00394355|471572942|FG003|Overall Study|Administrative|1|||
130704307|NCT05103657|470541251|FG001|Overall Study|Not Treated|1|||
130720852|NCT04126213|470601549|FG004|Overall Study|Withdrawal by Subject|1|||
130985558|NCT00394355|471572939|FG000|Overall Study|Lack of Efficacy|0|||
130985559|NCT00394355|471572940|FG001|Overall Study|Lack of Efficacy|0|||
130985560|NCT00394355|471572941|FG002|Overall Study|Lack of Efficacy|2|||
130985561|NCT00394355|471572942|FG003|Overall Study|Lack of Efficacy|3|||
130704308|NCT04234464|470541255|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
130704309|NCT04234464|470541256|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
130704310|NCT03635983|470541257|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
130704311|NCT03635983|470541258|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
130704312|NCT03635983|470541257|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130933005|NCT02310568|471386651|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
130933006|NCT02310568|471386652|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
130704313|NCT03635983|470541258|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130704314|NCT03635983|470541257|FG000|Pre-Treatment Period|Other reasons|0|||
130704315|NCT03635983|470541258|FG001|Pre-Treatment Period|Other reasons|1|||
130704316|NCT03635983|470541257|FG000|Pre-Treatment Period|Disease Progression|0|||
130704317|NCT03635983|470541258|FG001|Pre-Treatment Period|Disease Progression|1|||
130704318|NCT03635983|470541257|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
130704319|NCT03635983|470541258|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
130704320|NCT03635983|470541257|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
130704321|NCT03635983|470541258|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
130704322|NCT03635983|470541257|FG000|Treatment Period|Withdrawal by Subject|3|||
130933007|NCT02310568|471386648|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
130933008|NCT02310568|471386649|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
130933009|NCT02310568|471386650|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
130933010|NCT02310568|471386651|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
130933011|NCT02310568|471386652|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
130933012|NCT02310568|471386648|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
130933013|NCT02310568|471386649|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
130933014|NCT02310568|471386650|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
130933015|NCT02310568|471386651|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
130933016|NCT02310568|471386652|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
130933017|NCT02310568|471386648|FG000|Stage 2 (4 Weeks)|Other|0|||
130933018|NCT02310568|471386649|FG001|Stage 2 (4 Weeks)|Other|1|||
130933019|NCT02310568|471386650|FG002|Stage 2 (4 Weeks)|Other|1|||
130933020|NCT02310568|471386651|FG003|Stage 2 (4 Weeks)|Other|0|||
130933021|NCT02310568|471386652|FG004|Stage 2 (4 Weeks)|Other|0|||
130933022|NCT02310568|471386648|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
130933023|NCT02310568|471386649|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
130933024|NCT02310568|471386650|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
130933025|NCT02310568|471386651|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
130933026|NCT02310568|471386652|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
130933027|NCT02310568|471386648|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
130933028|NCT02310568|471386649|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
130933029|NCT02310568|471386650|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
130933030|NCT02310568|471386651|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
130933031|NCT02310568|471386652|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
130770813|NCT00948922|470787698|FG000|Overall Study|Disease progression|0|||
130770814|NCT00948922|470787699|FG001|Overall Study|Disease progression|1|||
130770815|NCT00948922|470787700|FG002|Overall Study|Disease progression|0|||
130933032|NCT02310568|471386648|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
130933033|NCT02310568|471386649|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
130933034|NCT02310568|471386650|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
130704323|NCT03635983|470541258|FG001|Treatment Period|Withdrawal by Subject|5|||
130704324|NCT03635983|470541257|FG000|Treatment Period|Death|3|||
130704325|NCT03635983|470541258|FG001|Treatment Period|Death|5|||
130770816|NCT00948922|470787698|FG000|Overall Study|Insurance issues|1|||
130770817|NCT00948922|470787699|FG001|Overall Study|Insurance issues|0|||
130770818|NCT00948922|470787700|FG002|Overall Study|Insurance issues|0|||
130933035|NCT02310568|471386651|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
130933036|NCT02310568|471386652|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
130933037|NCT01384760|471386653|FG000|Overall Study|Lost to Follow-up|0|||
130933038|NCT01384760|471386654|FG001|Overall Study|Lost to Follow-up|6|||
130933039|NCT01384760|471386653|FG000|Overall Study|Protocol Violation|16|||
130933040|NCT01384760|471386654|FG001|Overall Study|Protocol Violation|0|||
130933041|NCT02989194|471386664|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
130933042|NCT02989194|471386665|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
130933043|NCT02989194|471386666|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
130933044|NCT02989194|471386664|FG000|Overall Study|Lost to Follow-up|0|||
130933045|NCT02989194|471386665|FG001|Overall Study|Lost to Follow-up|1|||
130933046|NCT02989194|471386666|FG002|Overall Study|Lost to Follow-up|0|||
130933047|NCT02989194|471386664|FG000|Overall Study|Withdrawal by Subject|0|||
130933048|NCT02989194|471386665|FG001|Overall Study|Withdrawal by Subject|1|||
130933049|NCT02989194|471386666|FG002|Overall Study|Withdrawal by Subject|0|||
130933050|NCT01549860|471386667|FG000|Overall Study|Withdrawal by Subject|1|||
130933051|NCT01549860|471386668|FG001|Overall Study|Withdrawal by Subject|0|||
130933052|NCT01549860|471386667|FG000|Overall Study|Physician Decision|1|||
130933053|NCT01549860|471386668|FG001|Overall Study|Physician Decision|1|||
130933054|NCT02041286|471386672|FG000|Overall Study|Adverse Event|1|||
130704326|NCT03635983|470541257|FG000|Treatment Period|Poor/Non-compliance|2|||
130933055|NCT01963403|471386685|FG000|Overall Study|Lost to Follow-up|2|||
130933056|NCT01963403|471386686|FG001|Overall Study|Lost to Follow-up|3|||
130933057|NCT01963403|471386685|FG000|Overall Study|Implant removal|0|||
130933058|NCT01963403|471386686|FG001|Overall Study|Implant removal|1|||
130933059|NCT00549302|471386689|FG000|Double-Blind|Death|2|||
130933060|NCT00549302|471386690|FG001|Double-Blind|Death|9|||
130933061|NCT00549302|471386691|FG002|Double-Blind|Death|0|||
130933062|NCT00549302|471386689|FG000|Double-Blind|Adverse Event|3|||
130933063|NCT00549302|471386690|FG001|Double-Blind|Adverse Event|16|||
130933064|NCT00549302|471386691|FG002|Double-Blind|Adverse Event|0|||
130933065|NCT00549302|471386689|FG000|Double-Blind|Withdrawal by Subject|3|||
130933066|NCT00549302|471386690|FG001|Double-Blind|Withdrawal by Subject|8|||
130933067|NCT00549302|471386691|FG002|Double-Blind|Withdrawal by Subject|0|||
130933068|NCT00549302|471386689|FG000|Double-Blind|Investigator Decision|1|||
130933069|NCT00549302|471386690|FG001|Double-Blind|Investigator Decision|5|||
130933070|NCT00549302|471386691|FG002|Double-Blind|Investigator Decision|0|||
130933071|NCT00549302|471386689|FG000|Double-Blind|Sponsor Decision|0|||
130933072|NCT00549302|471386690|FG001|Double-Blind|Sponsor Decision|1|||
130933073|NCT00549302|471386691|FG002|Double-Blind|Sponsor Decision|0|||
130933074|NCT00549302|471386689|FG000|Double-Blind|Lost to Follow-up|1|||
130933075|NCT00549302|471386690|FG001|Double-Blind|Lost to Follow-up|2|||
130933076|NCT00549302|471386691|FG002|Double-Blind|Lost to Follow-up|0|||
130933077|NCT00549302|471386689|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
130933078|NCT00549302|471386690|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
130704327|NCT03635983|470541258|FG001|Treatment Period|Poor/Non-compliance|1|||
130704328|NCT03635983|470541257|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
130704329|NCT03635983|470541258|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
130704330|NCT03635983|470541257|FG000|Treatment Period|Other reasons|7|||
130933079|NCT00549302|471386691|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
130933080|NCT00549302|471386689|FG000|Double-Blind|New condition or starts new therapy|0|||
130933081|NCT00549302|471386690|FG001|Double-Blind|New condition or starts new therapy|2|||
130933082|NCT00549302|471386691|FG002|Double-Blind|New condition or starts new therapy|0|||
130933083|NCT00549302|471386689|FG000|Open-Label|Adverse Event|0|||
130933084|NCT00549302|471386690|FG001|Open-Label|Adverse Event|0|||
130933085|NCT00549302|471386691|FG002|Open-Label|Adverse Event|11|||
130933086|NCT00549302|471386689|FG000|Open-Label|Death|0|||
130933087|NCT00549302|471386690|FG001|Open-Label|Death|0|||
130933088|NCT00549302|471386691|FG002|Open-Label|Death|40|||
130933089|NCT00549302|471386689|FG000|Open-Label|Investigator Decision|0|||
130933090|NCT00549302|471386690|FG001|Open-Label|Investigator Decision|0|||
130933091|NCT00549302|471386691|FG002|Open-Label|Investigator Decision|5|||
130933092|NCT00549302|471386689|FG000|Open-Label|Lost to Follow-up|0|||
130933093|NCT00549302|471386690|FG001|Open-Label|Lost to Follow-up|0|||
130933094|NCT00549302|471386691|FG002|Open-Label|Lost to Follow-up|2|||
130933095|NCT00549302|471386689|FG000|Open-Label|Other|0|||
130933096|NCT00549302|471386690|FG001|Open-Label|Other|0|||
130933097|NCT00549302|471386691|FG002|Open-Label|Other|3|||
130933098|NCT00549302|471386689|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
130933099|NCT00549302|471386690|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
130933100|NCT00549302|471386691|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
130933101|NCT00549302|471386689|FG000|Open-Label|Withdrawal by Subject|0|||
130933102|NCT00549302|471386690|FG001|Open-Label|Withdrawal by Subject|0|||
130933103|NCT00549302|471386691|FG002|Open-Label|Withdrawal by Subject|6|||
130933104|NCT03585504|471386692|FG000|Overall Study|Lost to Follow-up|26|||
130933105|NCT03585504|471386693|FG001|Overall Study|Lost to Follow-up|29|||
130933106|NCT01414114|471386694|FG000|Overall Study|Adverse Event|2|||
130933107|NCT01414114|471386694|FG000|Overall Study|Withdrawal by Subject|1|||
130933108|NCT01414114|471386694|FG000|Overall Study|Other|2|||
130933109|NCT00105482|471386695|FG000|Overall Study|Adverse Event|1|||
130933110|NCT00105482|471386696|FG001|Overall Study|Adverse Event|1|||
130933111|NCT00105482|471386695|FG000|Overall Study|Lost to Follow-up|26|||
130933112|NCT00105482|471386696|FG001|Overall Study|Lost to Follow-up|17|||
130933113|NCT00105482|471386695|FG000|Overall Study|Withdrawal by Subject|0|||
130933114|NCT00105482|471386696|FG001|Overall Study|Withdrawal by Subject|1|||
130933115|NCT00105482|471386695|FG000|Overall Study|Lost Interest|29|||
130704331|NCT03635983|470541258|FG001|Treatment Period|Other reasons|4|||
130933116|NCT00105482|471386696|FG001|Overall Study|Lost Interest|32|||
130933117|NCT00105482|471386695|FG000|Overall Study|Scheduling Conflict|2|||
130933118|NCT00105482|471386696|FG001|Overall Study|Scheduling Conflict|3|||
130933119|NCT00105482|471386695|FG000|Overall Study|Withdrawn by PI|1|||
130933120|NCT00105482|471386696|FG001|Overall Study|Withdrawn by PI|1|||
130933121|NCT05620563|471386697|FG000|Overall Study|Adverse Event|3|||
130933122|NCT05620563|471386698|FG001|Overall Study|Adverse Event|1|||
130933123|NCT05620563|471386697|FG000|Overall Study|Lost to Follow-up|0|||
130933124|NCT05620563|471386698|FG001|Overall Study|Lost to Follow-up|2|||
130933125|NCT05620563|471386697|FG000|Overall Study|Protocol Deviation|1|||
130933126|NCT05620563|471386698|FG001|Overall Study|Protocol Deviation|2|||
131120466|NCT01994382|472072341|FG000|Overall Study|Death|0|||
130933127|NCT05620563|471386697|FG000|Overall Study|Withdrawal by Subject|3|||
130933128|NCT05620563|471386698|FG001|Overall Study|Withdrawal by Subject|3|||
130933129|NCT05620563|471386697|FG000|Overall Study|Physician Decision|0|||
130933130|NCT05620563|471386698|FG001|Overall Study|Physician Decision|1|||
130933131|NCT02085785|471386703|FG000|Overall Study|Withdrawal by Subject|2|||
130933132|NCT02085785|471386704|FG001|Overall Study|Withdrawal by Subject|1|||
130933133|NCT02085785|471386703|FG000|Overall Study|Lost to Follow-up|0|||
130933134|NCT02085785|471386704|FG001|Overall Study|Lost to Follow-up|1|||
130933135|NCT00779467|471386705|FG000|Overall Study|Lack of Efficacy|11|||
130933136|NCT00779467|471386706|FG001|Overall Study|Lack of Efficacy|2|||
130933137|NCT00779467|471386707|FG002|Overall Study|Lack of Efficacy|6|||
130933138|NCT00779467|471386708|FG003|Overall Study|Lack of Efficacy|11|||
130933139|NCT00779467|471386705|FG000|Overall Study|failed inclusion criteria|3|||
130933140|NCT00779467|471386706|FG001|Overall Study|failed inclusion criteria|3|||
130933141|NCT00779467|471386707|FG002|Overall Study|failed inclusion criteria|1|||
130933142|NCT00779467|471386708|FG003|Overall Study|failed inclusion criteria|2|||
130933143|NCT00779467|471386705|FG000|Overall Study|missing data|1|||
130933144|NCT00779467|471386706|FG001|Overall Study|missing data|0|||
130933145|NCT00779467|471386707|FG002|Overall Study|missing data|1|||
130933146|NCT00779467|471386708|FG003|Overall Study|missing data|4|||
130933147|NCT00779467|471386705|FG000|Overall Study|technical issue|0|||
130933148|NCT00779467|471386706|FG001|Overall Study|technical issue|0|||
130933149|NCT00779467|471386707|FG002|Overall Study|technical issue|2|||
130933150|NCT00779467|471386708|FG003|Overall Study|technical issue|1|||
130933151|NCT00779467|471386705|FG000|Overall Study|unavailable research staff|0|||
130933152|NCT00779467|471386706|FG001|Overall Study|unavailable research staff|0|||
130933153|NCT00779467|471386707|FG002|Overall Study|unavailable research staff|0|||
130933154|NCT00779467|471386708|FG003|Overall Study|unavailable research staff|1|||
130933155|NCT02692703|471386709|FG000|Overall Study|Lost to Follow-up|1|||
130933156|NCT02692703|471386709|FG000|Overall Study|Other|1|||
130933157|NCT04118166|471386710|FG000|Overall Study|Adverse Event|1|||
130933158|NCT02708121|471386712|FG000|Overall Study|Withdrawn by Study Team|1|||
130933159|NCT02708121|471386713|FG001|Overall Study|Withdrawn by Study Team|1|||
130933160|NCT02708121|471386712|FG000|Overall Study|Withdrawal by Subject|0|||
130933161|NCT02708121|471386713|FG001|Overall Study|Withdrawal by Subject|4|||
130933162|NCT04202965|471386716|FG000|Overall Study|Adverse Event|3|||
130933163|NCT04202965|471386716|FG000|Overall Study|Did not meet inclusion criteria|1|||
130933164|NCT02706691|471386718|FG000|Overall Study|Adverse Event|1|||
130933165|NCT01980992|471386719|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
130933166|NCT01980992|471386720|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
130933167|NCT01980992|471386719|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
130933168|NCT01980992|471386720|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
130933169|NCT01980992|471386719|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
130933170|NCT01980992|471386720|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
130933171|NCT01980992|471386719|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
130933172|NCT01980992|471386720|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
130933173|NCT01980992|471386719|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
130933174|NCT01980992|471386720|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
130933175|NCT01980992|471386719|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
130933176|NCT01980992|471386720|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
130933177|NCT05025241|471386726|FG000|Screening|Failed Screening|5|||
130933178|NCT05025241|471386726|FG000|Treatment and Follow Up|Adverse Event|3|||
130933179|NCT01366209|471386727|FG000|Overall Study|Adverse Event|6|||
130933180|NCT01366209|471386728|FG001|Overall Study|Adverse Event|7|||
130933181|NCT01366209|471386727|FG000|Overall Study|Withdrawal by Subject|4|||
130933182|NCT01366209|471386728|FG001|Overall Study|Withdrawal by Subject|4|||
130933183|NCT01366209|471386727|FG000|Overall Study|Death|12|||
130933184|NCT01366209|471386728|FG001|Overall Study|Death|19|||
130933185|NCT01366209|471386727|FG000|Overall Study|Lung transplantation|6|||
130933186|NCT01366209|471386728|FG001|Overall Study|Lung transplantation|1|||
130933187|NCT01366209|471386727|FG000|Overall Study|Lost to Follow-up|2|||
130933188|NCT01366209|471386728|FG001|Overall Study|Lost to Follow-up|1|||
130933189|NCT01366209|471386727|FG000|Overall Study|Physician Decision|1|||
130933190|NCT01366209|471386728|FG001|Overall Study|Physician Decision|0|||
130933191|NCT01366209|471386727|FG000|Overall Study|Sponsors decision|0|||
130933192|NCT01366209|471386728|FG001|Overall Study|Sponsors decision|1|||
130933193|NCT01366209|471386727|FG000|Overall Study|Withdrew consent|4|||
130933194|NCT01366209|471386728|FG001|Overall Study|Withdrew consent|3|||
130770819|NCT00948922|470787698|FG000|Overall Study|Transplant eligibility issues|2|||
130933195|NCT02670837|471386729|FG000|Overall Study|Death|2|||
130933196|NCT02670837|471386730|FG001|Overall Study|Death|0|||
130770820|NCT00948922|470787699|FG001|Overall Study|Transplant eligibility issues|3|||
130933197|NCT02670837|471386731|FG002|Overall Study|Death|0|||
130933198|NCT01053221|471386732|FG000|Overall Study|The study was closed prematurely|5|||
130770821|NCT00948922|470787700|FG002|Overall Study|Transplant eligibility issues|0|||
130770822|NCT00948922|470787698|FG000|Overall Study|Not evaluable at time of analysis|0|||
130770823|NCT00948922|470787699|FG001|Overall Study|Not evaluable at time of analysis|3|||
130933199|NCT01053221|471386733|FG001|Overall Study|The study was closed prematurely|9|||
130933200|NCT01919723|471386734|FG000|Overall Study|Blood Samples Hemolyzed|2|||
130933201|NCT01919723|471386735|FG001|Overall Study|Blood Samples Hemolyzed|2|||
130933202|NCT00555321|471386736|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
130933203|NCT00555321|471386737|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
130933204|NCT00555321|471386738|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
130933205|NCT00555321|471386739|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
130933206|NCT00555321|471386740|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
130933207|NCT00555321|471386736|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
130933208|NCT00555321|471386737|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
130933209|NCT00555321|471386738|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
130933210|NCT00555321|471386739|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
130933211|NCT00555321|471386740|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
130933212|NCT00555321|471386736|FG000|Treatment Phase up to 12-months|Death|2|||
130933213|NCT00555321|471386737|FG001|Treatment Phase up to 12-months|Death|1|||
130933214|NCT00555321|471386738|FG002|Treatment Phase up to 12-months|Death|4|||
130933215|NCT00555321|471386739|FG003|Treatment Phase up to 12-months|Death|0|||
130933216|NCT00555321|471386740|FG004|Treatment Phase up to 12-months|Death|0|||
130933217|NCT00555321|471386736|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
130933218|NCT00555321|471386737|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
130933219|NCT00555321|471386738|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
130933220|NCT00555321|471386739|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
130933221|NCT00555321|471386740|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
130933222|NCT00555321|471386736|FG000|Treatment Phase up to 12-months|Other Reason|1|||
130933223|NCT00555321|471386737|FG001|Treatment Phase up to 12-months|Other Reason|3|||
130933224|NCT00555321|471386738|FG002|Treatment Phase up to 12-months|Other Reason|2|||
130933225|NCT00555321|471386739|FG003|Treatment Phase up to 12-months|Other Reason|0|||
130933226|NCT00555321|471386740|FG004|Treatment Phase up to 12-months|Other Reason|0|||
130933227|NCT00555321|471386736|FG000|Treatment Phase up to 12-months|Never treated|2|||
130933228|NCT00555321|471386737|FG001|Treatment Phase up to 12-months|Never treated|3|||
130933229|NCT00555321|471386738|FG002|Treatment Phase up to 12-months|Never treated|1|||
130933230|NCT00555321|471386739|FG003|Treatment Phase up to 12-months|Never treated|0|||
130933231|NCT00555321|471386740|FG004|Treatment Phase up to 12-months|Never treated|4|||
130933232|NCT00555321|471386736|FG000|Long-term Extension Phase|Adverse Event|2|||
130933233|NCT00555321|471386737|FG001|Long-term Extension Phase|Adverse Event|5|||
130933234|NCT00555321|471386738|FG002|Long-term Extension Phase|Adverse Event|2|||
130933235|NCT00555321|471386739|FG003|Long-term Extension Phase|Adverse Event|1|||
130933236|NCT00555321|471386740|FG004|Long-term Extension Phase|Adverse Event|0|||
130933237|NCT00555321|471386736|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
130933238|NCT00555321|471386737|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
130933239|NCT00555321|471386738|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
130933240|NCT00555321|471386739|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
130933241|NCT00555321|471386740|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
130933242|NCT00555321|471386736|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
130933243|NCT00555321|471386737|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
130933244|NCT00555321|471386738|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
130933245|NCT00555321|471386739|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
130933246|NCT00555321|471386740|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
130933247|NCT00555321|471386736|FG000|Long-term Extension Phase|Death|2|||
130933248|NCT00555321|471386737|FG001|Long-term Extension Phase|Death|0|||
130933249|NCT00555321|471386738|FG002|Long-term Extension Phase|Death|0|||
130933250|NCT00555321|471386739|FG003|Long-term Extension Phase|Death|3|||
130933251|NCT00555321|471386740|FG004|Long-term Extension Phase|Death|0|||
130933252|NCT00555321|471386736|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
130933253|NCT00555321|471386737|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
130933254|NCT00555321|471386738|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
130933255|NCT00555321|471386739|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
130933256|NCT00555321|471386740|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
130933257|NCT00555321|471386736|FG000|Long-term Extension Phase|Other Reason|1|||
130933258|NCT00555321|471386737|FG001|Long-term Extension Phase|Other Reason|0|||
130933259|NCT00555321|471386738|FG002|Long-term Extension Phase|Other Reason|2|||
130933260|NCT00555321|471386739|FG003|Long-term Extension Phase|Other Reason|0|||
130933261|NCT00555321|471386740|FG004|Long-term Extension Phase|Other Reason|0|||
130933262|NCT00582166|471386743|FG000|Overall Study|Death|1|||
130933263|NCT00582166|471386743|FG000|Overall Study|Ineligible pathology|1|||
131223756|NCT04380701|472447109|FG000|Overall Study|Lost to Follow-up|0|||
131223757|NCT04380701|472447110|FG001|Overall Study|Lost to Follow-up|0|||
131223758|NCT04380701|472447111|FG002|Overall Study|Lost to Follow-up|0|||
130770824|NCT00948922|470787700|FG002|Overall Study|Not evaluable at time of analysis|0|||
130770825|NCT02095197|470787701|FG000|Overall Study|Lost to Follow-up|0|||
130933264|NCT02532972|471386744|FG000|Overall Study|Withdrawal by Subject|1|||
130933265|NCT03944954|471386745|FG000|Overall Study|Withdrawal by Subject|22|||
130933266|NCT03944954|471386746|FG001|Overall Study|Withdrawal by Subject|4|||
130933267|NCT03944954|471386745|FG000|Overall Study|Lost to Follow-up|18|||
130933268|NCT03944954|471386746|FG001|Overall Study|Lost to Follow-up|0|||
130933269|NCT03944954|471386745|FG000|Overall Study|Failed Medical Screening|7|||
130933270|NCT03944954|471386746|FG001|Overall Study|Failed Medical Screening|0|||
130933271|NCT02268084|471386749|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
130933272|NCT02268084|471386750|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
130933273|NCT02268084|471386749|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
130933274|NCT02268084|471386750|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
130933275|NCT05227027|471386751|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
130933276|NCT05227027|471386752|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
130933277|NCT02603419|471386753|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
130933278|NCT02603419|471386754|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
130933279|NCT02603419|471386755|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
130933280|NCT02603419|471386756|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
130933281|NCT02603419|471386757|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
130933282|NCT02603419|471386758|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
130933283|NCT02603419|471386753|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
130933284|NCT02603419|471386754|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
130933285|NCT02603419|471386755|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
130933286|NCT02603419|471386756|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
130933287|NCT02603419|471386757|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
130933288|NCT02603419|471386758|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
130933289|NCT02603419|471386753|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
130933290|NCT02603419|471386754|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
130933291|NCT02603419|471386755|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
130933292|NCT02603419|471386756|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
130933293|NCT02603419|471386757|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
130933294|NCT02603419|471386758|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
130933295|NCT02603419|471386753|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
130933296|NCT02603419|471386754|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
130933297|NCT02603419|471386755|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
130933298|NCT02603419|471386756|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
130933299|NCT02603419|471386757|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
130933300|NCT02603419|471386758|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
130933301|NCT02603419|471386753|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
130933302|NCT02603419|471386754|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
130933303|NCT02603419|471386755|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
130933304|NCT02603419|471386756|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
130933305|NCT02603419|471386757|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
130933306|NCT02603419|471386758|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
130933307|NCT02603419|471386753|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
130933308|NCT02603419|471386754|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
130933309|NCT02603419|471386755|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
130933310|NCT02603419|471386756|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
130933311|NCT02603419|471386757|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
130704332|NCT03635983|470541257|FG000|Treatment Period|Disease progression|230|||
130704333|NCT03635983|470541258|FG001|Treatment Period|Disease progression|201|||
130933312|NCT02603419|471386758|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
130933313|NCT02603419|471386753|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
130933314|NCT02603419|471386754|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
130933315|NCT02603419|471386755|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
130933316|NCT02603419|471386756|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
130933317|NCT02603419|471386757|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
130933318|NCT02603419|471386758|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
130933319|NCT02603419|471386753|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
130933320|NCT02603419|471386754|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
130704334|NCT03635983|470541257|FG000|Treatment Period|Study drug toxicity|35|||
130933321|NCT02603419|471386755|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
130704335|NCT03635983|470541258|FG001|Treatment Period|Study drug toxicity|36|||
130770826|NCT02095197|470787702|FG001|Overall Study|Lost to Follow-up|3|||
130704336|NCT03635983|470541257|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
130704337|NCT03635983|470541258|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
130704338|NCT03635983|470541257|FG000|Treatment Period|Maximum clinical benefit|3|||
130704339|NCT03635983|470541258|FG001|Treatment Period|Maximum clinical benefit|5|||
130704340|NCT03635983|470541257|FG000|Treatment Period|Administrative reason by the sponsor|1|||
130704341|NCT03635983|470541258|FG001|Treatment Period|Administrative reason by the sponsor|2|||
130704342|NCT03635983|470541257|FG000|Treatment Period|Lost to Follow-up|0|||
130704343|NCT03635983|470541258|FG001|Treatment Period|Lost to Follow-up|1|||
130704344|NCT03430011|470541260|FG000|Pre-Treatment|Death|1|||
130704345|NCT03430011|470541261|FG001|Pre-Treatment|Death|0|||
130704346|NCT03430011|470541262|FG002|Pre-Treatment|Death|0|||
130704347|NCT03430011|470541263|FG003|Pre-Treatment|Death|0|||
130704348|NCT03430011|470541264|FG004|Pre-Treatment|Death|1|||
130704349|NCT03430011|470541265|FG005|Pre-Treatment|Death|0|||
130704350|NCT03430011|470541266|FG006|Pre-Treatment|Death|1|||
130704351|NCT03430011|470541267|FG007|Pre-Treatment|Death|0|||
130704352|NCT03430011|470541260|FG000|Pre-Treatment|Screen Fail|0|||
130933322|NCT02603419|471386756|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
130933323|NCT02603419|471386757|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
130933324|NCT02603419|471386758|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
130933325|NCT02603419|471386753|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
130933326|NCT02603419|471386754|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
130933327|NCT02603419|471386755|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
130704353|NCT03430011|470541261|FG001|Pre-Treatment|Screen Fail|0|||
130704354|NCT03430011|470541262|FG002|Pre-Treatment|Screen Fail|0|||
130704355|NCT03430011|470541263|FG003|Pre-Treatment|Screen Fail|0|||
130704356|NCT03430011|470541264|FG004|Pre-Treatment|Screen Fail|1|||
130704357|NCT03430011|470541265|FG005|Pre-Treatment|Screen Fail|0|||
130704358|NCT03430011|470541266|FG006|Pre-Treatment|Screen Fail|0|||
130704359|NCT03430011|470541267|FG007|Pre-Treatment|Screen Fail|0|||
130704360|NCT03430011|470541260|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
130770827|NCT02829047|470787706|FG000|Overall Study|Withdrawal by Subject|1|||
130770828|NCT03077607|470787708|FG000|Period 1 (15 Days)|Adverse Event|1|||
130770829|NCT03077607|470787709|FG001|Period 1 (15 Days)|Adverse Event|0|||
130770830|NCT03077607|470787708|FG000|Period 1 (15 Days)|Death|1|||
130933328|NCT02603419|471386756|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
130933329|NCT02603419|471386757|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
130933330|NCT02603419|471386758|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
130933331|NCT02603419|471386753|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
130933332|NCT02603419|471386754|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
130933333|NCT02603419|471386755|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
130933334|NCT02603419|471386756|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
130933335|NCT02603419|471386757|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
130933336|NCT02603419|471386758|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
130933337|NCT03334448|471386762|FG000|Washout|Personal Reason|0|||
130933338|NCT03334448|471386763|FG001|Washout|Personal Reason|1|||
130933339|NCT03334448|471386764|FG002|Washout|Personal Reason|0|||
130933340|NCT03334448|471386765|FG003|Washout|Personal Reason|0|||
130933341|NCT03334448|471386762|FG000|Washout|Protocol Violation|0|||
130933342|NCT03334448|471386763|FG001|Washout|Protocol Violation|0|||
130933343|NCT03334448|471386764|FG002|Washout|Protocol Violation|0|||
130933344|NCT03334448|471386765|FG003|Washout|Protocol Violation|1|||
130933345|NCT00855920|471386767|FG000|Overall Study|Protocol Violation|0|||
130933346|NCT00855920|471386768|FG001|Overall Study|Protocol Violation|0|||
130933347|NCT00855920|471386769|FG002|Overall Study|Protocol Violation|2|||
130933348|NCT00855920|471386767|FG000|Overall Study|Adverse Event|2|||
130933349|NCT00855920|471386768|FG001|Overall Study|Adverse Event|1|||
130933350|NCT00855920|471386769|FG002|Overall Study|Adverse Event|1|||
130933351|NCT00855920|471386767|FG000|Overall Study|Lack of Efficacy|2|||
130933352|NCT00855920|471386768|FG001|Overall Study|Lack of Efficacy|2|||
130933353|NCT00855920|471386769|FG002|Overall Study|Lack of Efficacy|2|||
130933354|NCT00855920|471386767|FG000|Overall Study|Withdrawal by Subject|2|||
130933355|NCT00855920|471386768|FG001|Overall Study|Withdrawal by Subject|3|||
130933356|NCT00855920|471386769|FG002|Overall Study|Withdrawal by Subject|2|||
130933357|NCT00855920|471386767|FG000|Overall Study|Lost to Follow-up|1|||
130933358|NCT00855920|471386768|FG001|Overall Study|Lost to Follow-up|0|||
130933359|NCT00855920|471386769|FG002|Overall Study|Lost to Follow-up|2|||
130933360|NCT00855920|471386767|FG000|Overall Study|Death|0|||
130933361|NCT00855920|471386768|FG001|Overall Study|Death|1|||
130933362|NCT00855920|471386769|FG002|Overall Study|Death|0|||
130933363|NCT00855920|471386767|FG000|Overall Study|Decision by the sponsor|0|||
130933364|NCT00855920|471386768|FG001|Overall Study|Decision by the sponsor|1|||
130933365|NCT00855920|471386769|FG002|Overall Study|Decision by the sponsor|1|||
130933366|NCT00855920|471386767|FG000|Overall Study|Other than specified above|1|||
130933367|NCT00855920|471386768|FG001|Overall Study|Other than specified above|1|||
130933368|NCT00855920|471386769|FG002|Overall Study|Other than specified above|1|||
130933369|NCT02496611|471386772|FG000|Overall Study|Lost to Follow-up|2|||
130933370|NCT02496611|471386773|FG001|Overall Study|Lost to Follow-up|1|||
130933371|NCT02496611|471386772|FG000|Overall Study|Withdrawal by Subject|5|||
130933372|NCT02496611|471386773|FG001|Overall Study|Withdrawal by Subject|2|||
130933373|NCT02850965|471386774|FG000|Overall Study|Other than listed|3|||
130933374|NCT02850965|471386775|FG001|Overall Study|Other than listed|4|||
130933375|NCT02850965|471386774|FG000|Overall Study|Protocol Violation|0|||
130933376|NCT02850965|471386775|FG001|Overall Study|Protocol Violation|2|||
130933377|NCT02850965|471386774|FG000|Overall Study|Lost to Follow-up|5|||
130933378|NCT02850965|471386775|FG001|Overall Study|Lost to Follow-up|3|||
130933379|NCT02850965|471386774|FG000|Overall Study|Lack of Efficacy|4|||
130933380|NCT02850965|471386775|FG001|Overall Study|Lack of Efficacy|8|||
130933381|NCT02850965|471386774|FG000|Overall Study|Adverse Event|3|||
130933382|NCT02850965|471386775|FG001|Overall Study|Adverse Event|2|||
130933383|NCT02850965|471386774|FG000|Overall Study|Withdrawal by Subject|3|||
130933384|NCT02850965|471386775|FG001|Overall Study|Withdrawal by Subject|4|||
130933385|NCT02850965|471386774|FG000|Overall Study|Physician Decision|0|||
130933386|NCT02850965|471386775|FG001|Overall Study|Physician Decision|1|||
130933387|NCT02850965|471386774|FG000|Overall Study|Randomized but not treated|0|||
130933388|NCT02850965|471386775|FG001|Overall Study|Randomized but not treated|1|||
130933389|NCT02788357|471386779|FG000|Overall Study|Lost to Follow-up|3|||
130933390|NCT02788357|471386780|FG001|Overall Study|Lost to Follow-up|0|||
130933391|NCT01365910|471386781|FG000|Overall Study|Withdrawal by Subject|7|||
130933392|NCT01365910|471386781|FG000|Overall Study|disease progression|18|||
130933393|NCT01365910|471386781|FG000|Overall Study|Adverse Event|3|||
130933394|NCT01365910|471386781|FG000|Overall Study|other complicating disease|1|||
130933395|NCT01365910|471386781|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
130933396|NCT00371137|471386782|FG000|Overall Study|Adverse Event|20|||
130933397|NCT00371137|471386783|FG001|Overall Study|Adverse Event|35|||
130933398|NCT00371137|471386784|FG002|Overall Study|Adverse Event|42|||
130933399|NCT00371137|471386782|FG000|Overall Study|Withdrawal by Subject|11|||
130933400|NCT00371137|471386783|FG001|Overall Study|Withdrawal by Subject|10|||
130933401|NCT00371137|471386784|FG002|Overall Study|Withdrawal by Subject|15|||
130933402|NCT00371137|471386782|FG000|Overall Study|Lost to Follow-up|6|||
130933403|NCT00371137|471386783|FG001|Overall Study|Lost to Follow-up|3|||
130933404|NCT00371137|471386784|FG002|Overall Study|Lost to Follow-up|5|||
130933405|NCT00371137|471386782|FG000|Overall Study|Lack of Efficacy|30|||
130933406|NCT00371137|471386783|FG001|Overall Study|Lack of Efficacy|12|||
130933407|NCT00371137|471386784|FG002|Overall Study|Lack of Efficacy|13|||
130933408|NCT00371137|471386782|FG000|Overall Study|Sponsor Decision|2|||
130933409|NCT00371137|471386783|FG001|Overall Study|Sponsor Decision|1|||
130933410|NCT00371137|471386784|FG002|Overall Study|Sponsor Decision|2|||
130933411|NCT00371137|471386782|FG000|Overall Study|Physician Decision|1|||
130933412|NCT00371137|471386783|FG001|Overall Study|Physician Decision|1|||
130933413|NCT00371137|471386784|FG002|Overall Study|Physician Decision|1|||
130933414|NCT00371137|471386782|FG000|Overall Study|Protocol Violation|2|||
130933415|NCT00371137|471386783|FG001|Overall Study|Protocol Violation|1|||
130933416|NCT00371137|471386784|FG002|Overall Study|Protocol Violation|1|||
130933417|NCT00536198|471386785|FG000|Overall Study|Lost to Follow-up|15|||
130933418|NCT00536198|471386786|FG001|Overall Study|Lost to Follow-up|14|||
130933419|NCT00536198|471386785|FG000|Overall Study|Withdrawal by Subject|16|||
130933420|NCT00536198|471386786|FG001|Overall Study|Withdrawal by Subject|12|||
130933421|NCT00536198|471386785|FG000|Overall Study|Adverse Event|2|||
130933422|NCT00536198|471386786|FG001|Overall Study|Adverse Event|2|||
130933423|NCT00536198|471386785|FG000|Overall Study|Rescue|3|||
130933424|NCT00536198|471386786|FG001|Overall Study|Rescue|9|||
130933425|NCT00536198|471386785|FG000|Overall Study|Pregnancy|1|||
130933426|NCT00536198|471386786|FG001|Overall Study|Pregnancy|1|||
130933427|NCT00536198|471386785|FG000|Overall Study|Protocol Violation|0|||
130933428|NCT00536198|471386786|FG001|Overall Study|Protocol Violation|1|||
130933429|NCT01666782|471386787|FG000|Overall Study|Received 2 doses of vaccine|0|||
130933430|NCT01666782|471386788|FG001|Overall Study|Received 2 doses of vaccine|1|||
130704361|NCT03430011|470541261|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
130704362|NCT03430011|470541262|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
130704363|NCT03430011|470541263|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
130704364|NCT03430011|470541264|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
130933431|NCT01666782|471386787|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
130933432|NCT01666782|471386788|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
130933433|NCT03572062|471386800|FG000|Overall Study|Adverse Event|0|||
130933434|NCT03572062|471386801|FG001|Overall Study|Adverse Event|0|||
130933435|NCT03572062|471386802|FG002|Overall Study|Adverse Event|0|||
130933436|NCT03572062|471386803|FG003|Overall Study|Adverse Event|0|||
131120467|NCT01994382|472072342|FG001|Overall Study|Death|0|||
131120468|NCT01994382|472072343|FG002|Overall Study|Death|0|||
130933437|NCT03572062|471386804|FG004|Overall Study|Adverse Event|0|||
130933438|NCT03572062|471386805|FG005|Overall Study|Adverse Event|0|||
130933439|NCT03572062|471386806|FG006|Overall Study|Adverse Event|0|||
130933440|NCT03572062|471386807|FG007|Overall Study|Adverse Event|0|||
130933441|NCT03572062|471386808|FG008|Overall Study|Adverse Event|1|||
131120469|NCT01994382|472072344|FG003|Overall Study|Death|0|||
130933442|NCT03572062|471386809|FG009|Overall Study|Adverse Event|3|||
130933443|NCT03572062|471386800|FG000|Overall Study|Death|0|||
130933444|NCT03572062|471386801|FG001|Overall Study|Death|0|||
130933445|NCT03572062|471386802|FG002|Overall Study|Death|0|||
130933446|NCT03572062|471386803|FG003|Overall Study|Death|0|||
130933447|NCT03572062|471386804|FG004|Overall Study|Death|0|||
130933448|NCT03572062|471386805|FG005|Overall Study|Death|1|||
130933449|NCT03572062|471386806|FG006|Overall Study|Death|0|||
130933450|NCT03572062|471386807|FG007|Overall Study|Death|0|||
130933451|NCT03572062|471386808|FG008|Overall Study|Death|0|||
130933452|NCT03572062|471386809|FG009|Overall Study|Death|0|||
130933453|NCT03572062|471386800|FG000|Overall Study|Lost to Follow-up|0|||
130933454|NCT03572062|471386801|FG001|Overall Study|Lost to Follow-up|0|||
130933455|NCT03572062|471386802|FG002|Overall Study|Lost to Follow-up|0|||
130933456|NCT03572062|471386803|FG003|Overall Study|Lost to Follow-up|0|||
130933457|NCT03572062|471386804|FG004|Overall Study|Lost to Follow-up|0|||
130933458|NCT03572062|471386805|FG005|Overall Study|Lost to Follow-up|1|||
130933459|NCT03572062|471386806|FG006|Overall Study|Lost to Follow-up|1|||
130933460|NCT03572062|471386807|FG007|Overall Study|Lost to Follow-up|0|||
130933461|NCT03572062|471386808|FG008|Overall Study|Lost to Follow-up|0|||
130933462|NCT03572062|471386809|FG009|Overall Study|Lost to Follow-up|0|||
130933463|NCT03572062|471386800|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130933464|NCT03572062|471386801|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130933465|NCT03572062|471386802|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130933466|NCT03572062|471386803|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130933467|NCT03572062|471386804|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
130933468|NCT03572062|471386805|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130933469|NCT03572062|471386806|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
130933470|NCT03572062|471386807|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130933471|NCT03572062|471386808|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
130933472|NCT03572062|471386809|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
130933473|NCT03572062|471386800|FG000|Overall Study|Study Terminated By Sponsor|0|||
130933474|NCT03572062|471386801|FG001|Overall Study|Study Terminated By Sponsor|0|||
130933475|NCT03572062|471386802|FG002|Overall Study|Study Terminated By Sponsor|0|||
130933476|NCT03572062|471386803|FG003|Overall Study|Study Terminated By Sponsor|0|||
130933477|NCT03572062|471386804|FG004|Overall Study|Study Terminated By Sponsor|0|||
130933478|NCT03572062|471386805|FG005|Overall Study|Study Terminated By Sponsor|0|||
130933479|NCT03572062|471386806|FG006|Overall Study|Study Terminated By Sponsor|0|||
130933480|NCT03572062|471386807|FG007|Overall Study|Study Terminated By Sponsor|0|||
130933481|NCT03572062|471386808|FG008|Overall Study|Study Terminated By Sponsor|29|||
130933482|NCT03572062|471386809|FG009|Overall Study|Study Terminated By Sponsor|27|||
130933483|NCT03572062|471386800|FG000|Overall Study|Physician Decision|0|||
130933484|NCT03572062|471386801|FG001|Overall Study|Physician Decision|0|||
130933485|NCT03572062|471386802|FG002|Overall Study|Physician Decision|0|||
130933486|NCT03572062|471386803|FG003|Overall Study|Physician Decision|0|||
130933487|NCT03572062|471386804|FG004|Overall Study|Physician Decision|0|||
130933488|NCT03572062|471386805|FG005|Overall Study|Physician Decision|0|||
130933489|NCT03572062|471386806|FG006|Overall Study|Physician Decision|0|||
130933490|NCT03572062|471386807|FG007|Overall Study|Physician Decision|0|||
130933491|NCT03572062|471386808|FG008|Overall Study|Physician Decision|1|||
130933492|NCT03572062|471386809|FG009|Overall Study|Physician Decision|0|||
130933493|NCT03572062|471386800|FG000|Overall Study|Withdrawal by Subject|0|||
130933494|NCT03572062|471386801|FG001|Overall Study|Withdrawal by Subject|0|||
130933495|NCT03572062|471386802|FG002|Overall Study|Withdrawal by Subject|0|||
131035030|NCT03544281|471761846|FG021|Main Study Phase|Did not receive study treatment|0|||
131035031|NCT03544281|471761825|FG000|PACT Phase|Adverse Event|0|||
131035032|NCT03544281|471761826|FG001|PACT Phase|Adverse Event|0|||
130704365|NCT03430011|470541265|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
130704366|NCT03430011|470541266|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
130704367|NCT03430011|470541267|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
130704368|NCT03430011|470541260|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
130933496|NCT03572062|471386803|FG003|Overall Study|Withdrawal by Subject|0|||
130933497|NCT03572062|471386804|FG004|Overall Study|Withdrawal by Subject|0|||
130933498|NCT03572062|471386805|FG005|Overall Study|Withdrawal by Subject|0|||
130933499|NCT03572062|471386806|FG006|Overall Study|Withdrawal by Subject|0|||
130933500|NCT03572062|471386807|FG007|Overall Study|Withdrawal by Subject|0|||
131035033|NCT03544281|471761827|FG002|PACT Phase|Adverse Event|0|||
130933501|NCT03572062|471386808|FG008|Overall Study|Withdrawal by Subject|0|||
130933502|NCT03572062|471386809|FG009|Overall Study|Withdrawal by Subject|1|||
130933503|NCT03572062|471386800|FG000|Overall Study|Randomized But Not Treated|0|||
130933504|NCT03572062|471386801|FG001|Overall Study|Randomized But Not Treated|0|||
130933505|NCT03572062|471386802|FG002|Overall Study|Randomized But Not Treated|0|||
131035034|NCT03544281|471761828|FG003|PACT Phase|Adverse Event|0|||
130933506|NCT03572062|471386803|FG003|Overall Study|Randomized But Not Treated|0|||
130933507|NCT03572062|471386804|FG004|Overall Study|Randomized But Not Treated|1|||
131035035|NCT03544281|471761829|FG004|PACT Phase|Adverse Event|0|||
131035036|NCT03544281|471761830|FG005|PACT Phase|Adverse Event|0|||
130770831|NCT03077607|470787709|FG001|Period 1 (15 Days)|Death|0|||
130770832|NCT03077607|470787708|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
130770833|NCT03077607|470787709|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
131035037|NCT03544281|471761831|FG006|PACT Phase|Adverse Event|0|||
131035038|NCT03544281|471761832|FG007|PACT Phase|Adverse Event|0|||
131035039|NCT03544281|471761833|FG008|PACT Phase|Adverse Event|0|||
131035040|NCT03544281|471761834|FG009|PACT Phase|Adverse Event|0|||
130770834|NCT03077607|470787708|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
130770835|NCT03077607|470787709|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
130770836|NCT01005901|470787711|FG000|Overall Study|Withdrawal by Subject|38|||
130770837|NCT01005901|470787712|FG001|Overall Study|Withdrawal by Subject|14|||
130770838|NCT01005901|470787711|FG000|Overall Study|Adverse Event|30|||
130770839|NCT01005901|470787712|FG001|Overall Study|Adverse Event|16|||
130770840|NCT01005901|470787711|FG000|Overall Study|Administrative problems|21|||
130770841|NCT01005901|470787712|FG001|Overall Study|Administrative problems|13|||
130770842|NCT01005901|470787711|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130933508|NCT03572062|471386805|FG005|Overall Study|Randomized But Not Treated|2|||
130933509|NCT03572062|471386806|FG006|Overall Study|Randomized But Not Treated|0|||
130933510|NCT03572062|471386807|FG007|Overall Study|Randomized But Not Treated|1|||
130933511|NCT03572062|471386808|FG008|Overall Study|Randomized But Not Treated|0|||
130933512|NCT03572062|471386809|FG009|Overall Study|Randomized But Not Treated|0|||
130933513|NCT01691781|471386810|FG000|Overall Study|Withdrawal by Subject|4|||
130933514|NCT01691781|471386811|FG001|Overall Study|Withdrawal by Subject|3|||
130933515|NCT01691781|471386810|FG000|Overall Study|Physician Decision|1|||
130933516|NCT01691781|471386811|FG001|Overall Study|Physician Decision|1|||
130933517|NCT01691781|471386810|FG000|Overall Study|Protocol Violation|2|||
130933518|NCT01691781|471386811|FG001|Overall Study|Protocol Violation|2|||
130933519|NCT01691781|471386810|FG000|Overall Study|Adverse Event|0|||
130933520|NCT01691781|471386811|FG001|Overall Study|Adverse Event|1|||
130933521|NCT01605877|471386812|FG000|Overall Study|Withdrawal by Subject|1|||
131035041|NCT03544281|471761835|FG010|PACT Phase|Adverse Event|0|||
131035042|NCT03544281|471761836|FG011|PACT Phase|Adverse Event|0|||
131035043|NCT03544281|471761837|FG012|PACT Phase|Adverse Event|1|||
130933522|NCT01918085|471386815|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
130933523|NCT01918085|471386816|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
130933524|NCT00687323|471386821|FG000|Overall Study|Death|25|||
130933525|NCT00687323|471386821|FG000|Overall Study|Withdrawal by Subject|1|||
130933526|NCT00687323|471386821|FG000|Overall Study|Excluded from efficacy evaluations|6|||
130933527|NCT00687323|471386821|FG000|Overall Study|Screen failure|148|||
130933528|NCT00679302|471386824|FG000|Overall Study|Lost to Follow-up|8|||
130933529|NCT00679302|471386825|FG001|Overall Study|Lost to Follow-up|4|||
130933530|NCT00434330|471386831|FG000|Overall Study|Adverse Event|0|||
130933531|NCT00434330|471386832|FG001|Overall Study|Adverse Event|0|||
130933532|NCT00434330|471386833|FG002|Overall Study|Adverse Event|1|||
131035044|NCT03544281|471761838|FG013|PACT Phase|Adverse Event|0|||
131035045|NCT03544281|471761839|FG014|PACT Phase|Adverse Event|0|||
130933533|NCT00434330|471386834|FG003|Overall Study|Adverse Event|0|||
130933534|NCT00434330|471386835|FG004|Overall Study|Adverse Event|0|||
130933535|NCT00434330|471386836|FG005|Overall Study|Adverse Event|0|||
130933536|NCT00434330|471386831|FG000|Overall Study|Death|1|||
130933537|NCT00434330|471386832|FG001|Overall Study|Death|0|||
130933538|NCT00434330|471386833|FG002|Overall Study|Death|0|||
130933539|NCT00434330|471386834|FG003|Overall Study|Death|0|||
130933540|NCT00434330|471386835|FG004|Overall Study|Death|1|||
130933541|NCT00434330|471386836|FG005|Overall Study|Death|1|||
130933542|NCT00434330|471386831|FG000|Overall Study|Withdrawal by Subject|0|||
130933543|NCT00434330|471386832|FG001|Overall Study|Withdrawal by Subject|0|||
130933544|NCT00434330|471386833|FG002|Overall Study|Withdrawal by Subject|1|||
130933545|NCT00434330|471386834|FG003|Overall Study|Withdrawal by Subject|1|||
130933546|NCT00434330|471386835|FG004|Overall Study|Withdrawal by Subject|0|||
130933547|NCT00434330|471386836|FG005|Overall Study|Withdrawal by Subject|0|||
130933548|NCT00434330|471386831|FG000|Overall Study|Renal transplant|0|||
130933549|NCT00434330|471386832|FG001|Overall Study|Renal transplant|0|||
130933550|NCT00434330|471386833|FG002|Overall Study|Renal transplant|0|||
130933551|NCT00434330|471386834|FG003|Overall Study|Renal transplant|1|||
131035046|NCT03544281|471761840|FG015|PACT Phase|Adverse Event|0|||
130933552|NCT00434330|471386835|FG004|Overall Study|Renal transplant|0|||
131035047|NCT03544281|471761841|FG016|PACT Phase|Adverse Event|0|||
131223759|NCT04380701|472447112|FG003|Overall Study|Lost to Follow-up|0|||
130933553|NCT00434330|471386836|FG005|Overall Study|Renal transplant|0|||
130933554|NCT00434330|471386831|FG000|Overall Study|Subject Not Compliant With Study|0|||
130933555|NCT00434330|471386832|FG001|Overall Study|Subject Not Compliant With Study|0|||
130933556|NCT00434330|471386833|FG002|Overall Study|Subject Not Compliant With Study|1|||
130933557|NCT00434330|471386834|FG003|Overall Study|Subject Not Compliant With Study|0|||
130933558|NCT00434330|471386835|FG004|Overall Study|Subject Not Compliant With Study|0|||
130770843|NCT01005901|470787712|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
130770844|NCT01005901|470787711|FG000|Overall Study|Protocol Violation|4|||
130933559|NCT00434330|471386836|FG005|Overall Study|Subject Not Compliant With Study|0|||
131035048|NCT03544281|471761842|FG017|PACT Phase|Adverse Event|1|||
130933560|NCT03278613|471386839|FG000|Overall Study|Lost to Follow-up|3|||
130933561|NCT03278613|471386840|FG001|Overall Study|Lost to Follow-up|1|||
130933562|NCT02154490|471389064|FG000|Overall Study|No tissue submitted|23|||
130933563|NCT02154490|471389064|FG000|Overall Study|No biomarker results|167|||
130933564|NCT02154490|471389064|FG000|Overall Study|Not assigned to a sub-study|270|||
130933565|NCT02154490|471389064|FG000|Overall Study|Did not register to a sub-study|749|||
130933566|NCT02961751|471389065|FG000|Overall Study|Lost to Follow-up|11|||
130933567|NCT02961751|471389065|FG000|Overall Study|Physician Decision|2|||
130933568|NCT02961751|471389065|FG000|Overall Study|Not Eligible at Enrollment|1|||
130933569|NCT02961751|471389065|FG000|Overall Study|Protocol Violation|1|||
130933570|NCT00720434|471389068|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
130933571|NCT00720434|471389069|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
130933572|NCT00720434|471389070|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
130933573|NCT00720434|471389071|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
130933574|NCT00720434|471389068|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
130933575|NCT00720434|471389069|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
130933576|NCT00720434|471389070|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
130933577|NCT00720434|471389071|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
130933578|NCT00720434|471389068|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
130933579|NCT00720434|471389069|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
130933580|NCT00720434|471389070|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
130933581|NCT00720434|471389071|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
130933582|NCT00720434|471389068|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
130933583|NCT00720434|471389069|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
130933584|NCT00720434|471389070|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
130933585|NCT00720434|471389071|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
130933586|NCT00720434|471389068|FG000|Open-Label Period (Week 5-72)|Other|4|||
130933587|NCT00720434|471389069|FG001|Open-Label Period (Week 5-72)|Other|3|||
130933588|NCT00720434|471389070|FG002|Open-Label Period (Week 5-72)|Other|3|||
130933589|NCT00720434|471389071|FG003|Open-Label Period (Week 5-72)|Other|2|||
130933590|NCT01224431|471389072|FG000|Overall Study|not randomized|0|||
130933591|NCT01224431|471389073|FG001|Overall Study|not randomized|4|||
130933592|NCT01224431|471389072|FG000|Overall Study|no video record|0|||
130933593|NCT01224431|471389073|FG001|Overall Study|no video record|1|||
130933594|NCT03138889|471389080|FG000|Overall Study|Withdrawal by Subject|5|||
130933595|NCT03138889|471389081|FG001|Overall Study|Withdrawal by Subject|5|||
130933596|NCT03138889|471389082|FG002|Overall Study|Withdrawal by Subject|0|||
130933597|NCT03138889|471389083|FG003|Overall Study|Withdrawal by Subject|2|||
130933598|NCT03138889|471389084|FG004|Overall Study|Withdrawal by Subject|1|||
130933599|NCT03138889|471389085|FG005|Overall Study|Withdrawal by Subject|3|||
130933600|NCT03138889|471389086|FG006|Overall Study|Withdrawal by Subject|0|||
130933601|NCT03138889|471389087|FG007|Overall Study|Withdrawal by Subject|1|||
130933602|NCT01349790|471389095|FG000|Overall Study|Investigator Judgement|3|||
130933603|NCT01349790|471389095|FG000|Overall Study|Death|2|||
130933604|NCT01349790|471389095|FG000|Overall Study|Withdrawal by Patient|2|||
130933605|NCT01349790|471389095|FG000|Overall Study|Adverse Event|1|||
130933606|NCT01349790|471389095|FG000|Overall Study|Lost to Follow-up|1|||
130933607|NCT02289690|471389096|FG000|Overall Study|Adverse Event Related to Progression|0|||
130933608|NCT02289690|471389097|FG001|Overall Study|Adverse Event Related to Progression|1|||
130933609|NCT02289690|471389098|FG002|Overall Study|Adverse Event Related to Progression|1|||
130933610|NCT02289690|471389099|FG003|Overall Study|Adverse Event Related to Progression|0|||
130933611|NCT02289690|471389100|FG004|Overall Study|Adverse Event Related to Progression|1|||
130933612|NCT02289690|471389101|FG005|Overall Study|Adverse Event Related to Progression|0|||
130933613|NCT02289690|471389102|FG006|Overall Study|Adverse Event Related to Progression|1|||
130933614|NCT02289690|471389103|FG007|Overall Study|Adverse Event Related to Progression|0|||
130933615|NCT02289690|471389104|FG008|Overall Study|Adverse Event Related to Progression|0|||
130933616|NCT02289690|471389105|FG009|Overall Study|Adverse Event Related to Progression|0|||
130933617|NCT02289690|471389096|FG000|Overall Study|Withdrawal by Subject|1|||
130933618|NCT02289690|471389097|FG001|Overall Study|Withdrawal by Subject|0|||
130933619|NCT02289690|471389098|FG002|Overall Study|Withdrawal by Subject|0|||
130933620|NCT02289690|471389099|FG003|Overall Study|Withdrawal by Subject|0|||
130933621|NCT02289690|471389100|FG004|Overall Study|Withdrawal by Subject|1|||
130933622|NCT02289690|471389101|FG005|Overall Study|Withdrawal by Subject|1|||
130933623|NCT02289690|471389102|FG006|Overall Study|Withdrawal by Subject|0|||
130933624|NCT02289690|471389103|FG007|Overall Study|Withdrawal by Subject|0|||
130933625|NCT02289690|471389104|FG008|Overall Study|Withdrawal by Subject|4|||
131035049|NCT03544281|471761843|FG018|PACT Phase|Adverse Event|1|||
131035050|NCT03544281|471761844|FG019|PACT Phase|Adverse Event|0|||
130933626|NCT02289690|471389105|FG009|Overall Study|Withdrawal by Subject|2|||
130933627|NCT02289690|471389096|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
130933628|NCT02289690|471389097|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
131035051|NCT03544281|471761845|FG020|PACT Phase|Adverse Event|0|||
130933629|NCT02289690|471389098|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
130933630|NCT02289690|471389099|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
130933631|NCT02289690|471389100|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
130933632|NCT02289690|471389101|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
130933633|NCT02289690|471389102|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
130933634|NCT02289690|471389103|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
130933635|NCT02289690|471389104|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
130933636|NCT02289690|471389105|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
130933637|NCT02289690|471389096|FG000|Overall Study|Lost to Follow-up|0|||
130933638|NCT02289690|471389097|FG001|Overall Study|Lost to Follow-up|0|||
130933639|NCT02289690|471389098|FG002|Overall Study|Lost to Follow-up|0|||
130933640|NCT02289690|471389099|FG003|Overall Study|Lost to Follow-up|0|||
130933641|NCT02289690|471389100|FG004|Overall Study|Lost to Follow-up|0|||
130933642|NCT02289690|471389101|FG005|Overall Study|Lost to Follow-up|0|||
130933643|NCT02289690|471389102|FG006|Overall Study|Lost to Follow-up|0|||
130933644|NCT02289690|471389103|FG007|Overall Study|Lost to Follow-up|1|||
130933645|NCT02289690|471389104|FG008|Overall Study|Lost to Follow-up|0|||
130933646|NCT02289690|471389105|FG009|Overall Study|Lost to Follow-up|2|||
130933647|NCT02289690|471389096|FG000|Overall Study|Death|0|||
130933648|NCT02289690|471389097|FG001|Overall Study|Death|0|||
130933649|NCT02289690|471389098|FG002|Overall Study|Death|0|||
130933650|NCT02289690|471389099|FG003|Overall Study|Death|0|||
130933651|NCT02289690|471389100|FG004|Overall Study|Death|0|||
130933652|NCT02289690|471389101|FG005|Overall Study|Death|0|||
130933653|NCT02289690|471389102|FG006|Overall Study|Death|0|||
130933654|NCT02289690|471389103|FG007|Overall Study|Death|49|||
130933655|NCT02289690|471389104|FG008|Overall Study|Death|45|||
130933656|NCT02289690|471389105|FG009|Overall Study|Death|41|||
130933657|NCT02289690|471389096|FG000|Overall Study|Sponsor Discontinued Study|0|||
130933658|NCT02289690|471389097|FG001|Overall Study|Sponsor Discontinued Study|0|||
130933659|NCT02289690|471389098|FG002|Overall Study|Sponsor Discontinued Study|0|||
130933660|NCT02289690|471389099|FG003|Overall Study|Sponsor Discontinued Study|0|||
130933661|NCT02289690|471389100|FG004|Overall Study|Sponsor Discontinued Study|0|||
130933662|NCT02289690|471389101|FG005|Overall Study|Sponsor Discontinued Study|0|||
130933663|NCT02289690|471389102|FG006|Overall Study|Sponsor Discontinued Study|0|||
130933664|NCT02289690|471389103|FG007|Overall Study|Sponsor Discontinued Study|9|||
130933665|NCT02289690|471389104|FG008|Overall Study|Sponsor Discontinued Study|7|||
130933666|NCT02289690|471389105|FG009|Overall Study|Sponsor Discontinued Study|15|||
130933667|NCT02289690|471389096|FG000|Overall Study|Other|0|||
130933668|NCT02289690|471389097|FG001|Overall Study|Other|0|||
130933669|NCT02289690|471389098|FG002|Overall Study|Other|0|||
130933670|NCT02289690|471389099|FG003|Overall Study|Other|1|||
130933671|NCT02289690|471389100|FG004|Overall Study|Other|1|||
130933672|NCT02289690|471389101|FG005|Overall Study|Other|0|||
130933673|NCT02289690|471389102|FG006|Overall Study|Other|1|||
130933674|NCT02289690|471389103|FG007|Overall Study|Other|2|||
130933675|NCT02289690|471389104|FG008|Overall Study|Other|3|||
130933676|NCT02289690|471389105|FG009|Overall Study|Other|1|||
130933677|NCT00885105|471389106|FG000|Overall Study|Withdrawal by Subject|0|||
130933678|NCT00885105|471389107|FG001|Overall Study|Withdrawal by Subject|8|||
130933679|NCT00885105|471389106|FG000|Overall Study|Adverse Event|1|||
130933680|NCT00885105|471389107|FG001|Overall Study|Adverse Event|0|||
130933681|NCT00885105|471389106|FG000|Overall Study|Protocol Violation|0|||
130933682|NCT00885105|471389107|FG001|Overall Study|Protocol Violation|2|||
130933683|NCT03519932|471389108|FG000|First Intervention|Adverse Event|1|||
130933684|NCT03519932|471389109|FG001|First Intervention|Adverse Event|3|||
130933685|NCT02254486|471389110|FG000|Overall Study|Adverse Event|1|||
130933686|NCT02254486|471389111|FG001|Overall Study|Adverse Event|1|||
130933687|NCT02254486|471389110|FG000|Overall Study|Lack of Efficacy|1|||
130933688|NCT02254486|471389111|FG001|Overall Study|Lack of Efficacy|0|||
130933689|NCT02254486|471389110|FG000|Overall Study|Lost to Follow-up|2|||
130933690|NCT02254486|471389111|FG001|Overall Study|Lost to Follow-up|4|||
130933691|NCT02254486|471389110|FG000|Overall Study|Protocol Violation|1|||
130933692|NCT02254486|471389111|FG001|Overall Study|Protocol Violation|2|||
130933693|NCT02254486|471389110|FG000|Overall Study|Withdrawal by Subject|17|||
130933694|NCT02254486|471389111|FG001|Overall Study|Withdrawal by Subject|15|||
130933695|NCT02254486|471389110|FG000|Overall Study|GFR<60mL/min|16|||
130933696|NCT02254486|471389111|FG001|Overall Study|GFR<60mL/min|21|||
130933697|NCT02254486|471389110|FG000|Overall Study|Various|12|||
130933698|NCT02254486|471389111|FG001|Overall Study|Various|12|||
130933699|NCT01350414|471389118|FG000|Overall Study|Lost to Follow-up|13|||
130933700|NCT01350414|471389118|FG000|Overall Study|Withdrawal by Subject|4|||
130933701|NCT01350414|471389118|FG000|Overall Study|Physician Decision|2|||
131120470|NCT01994382|472072345|FG004|Overall Study|Death|1|||
130933702|NCT04166435|471389119|FG000|Overall Study|2 patients ineligible for response|2|||
130933703|NCT02743520|471389122|FG000|Overall Study|Withdrawal by Subject|1|||
130933704|NCT01749514|471389123|FG000|Overall Study|Lost to Follow-up|0|||
130933705|NCT01749514|471389124|FG001|Overall Study|Lost to Follow-up|0|||
130933706|NCT01749514|471389125|FG002|Overall Study|Lost to Follow-up|0|||
130933707|NCT01749514|471389126|FG003|Overall Study|Lost to Follow-up|0|||
130933708|NCT01749514|471389127|FG004|Overall Study|Lost to Follow-up|0|||
131120471|NCT01994382|472072346|FG005|Overall Study|Death|0|||
130933709|NCT01749514|471389128|FG005|Overall Study|Lost to Follow-up|0|||
130933710|NCT01749514|471389129|FG006|Overall Study|Lost to Follow-up|0|||
130933711|NCT01749514|471389130|FG007|Overall Study|Lost to Follow-up|1|||
130933712|NCT01749514|471389123|FG000|Overall Study|Withdrawal by Subject|0|||
130933713|NCT01749514|471389124|FG001|Overall Study|Withdrawal by Subject|0|||
130933714|NCT01749514|471389125|FG002|Overall Study|Withdrawal by Subject|0|||
130933715|NCT01749514|471389126|FG003|Overall Study|Withdrawal by Subject|0|||
130933716|NCT01749514|471389127|FG004|Overall Study|Withdrawal by Subject|0|||
130933717|NCT01749514|471389128|FG005|Overall Study|Withdrawal by Subject|1|||
130933718|NCT01749514|471389129|FG006|Overall Study|Withdrawal by Subject|0|||
130933719|NCT01749514|471389130|FG007|Overall Study|Withdrawal by Subject|1|||
130933720|NCT01749514|471389123|FG000|Overall Study|Not Reported|0|||
130933721|NCT01749514|471389124|FG001|Overall Study|Not Reported|0|||
130933722|NCT01749514|471389125|FG002|Overall Study|Not Reported|0|||
130933723|NCT01749514|471389126|FG003|Overall Study|Not Reported|0|||
130933724|NCT01749514|471389127|FG004|Overall Study|Not Reported|0|||
130933725|NCT01749514|471389128|FG005|Overall Study|Not Reported|0|||
130933726|NCT01749514|471389129|FG006|Overall Study|Not Reported|0|||
130933727|NCT01749514|471389130|FG007|Overall Study|Not Reported|5|||
130933728|NCT01979016|471389132|FG000|Overall Study|Withdrawal by Subject|2|||
130933729|NCT01979016|471389133|FG001|Overall Study|Withdrawal by Subject|0|||
130933730|NCT01979016|471389132|FG000|Overall Study|Adverse Event|0|||
130933731|NCT01979016|471389133|FG001|Overall Study|Adverse Event|1|||
130933732|NCT00938639|471389134|FG000|Overall Study|Moved away from study area|0|||
130933733|NCT00938639|471389135|FG001|Overall Study|Moved away from study area|1|||
130933734|NCT00938639|471389134|FG000|Overall Study|Lost to Follow-up|1|||
130933735|NCT00938639|471389135|FG001|Overall Study|Lost to Follow-up|2|||
130933736|NCT00938639|471389134|FG000|Overall Study|Family issues|1|||
130933737|NCT00938639|471389135|FG001|Overall Study|Family issues|1|||
130933738|NCT00938639|471389134|FG000|Overall Study|Participant noncompliance|1|||
130933739|NCT00938639|471389135|FG001|Overall Study|Participant noncompliance|0|||
130933740|NCT02509156|471389136|FG000|Randomized Phase|Death|1|||
130933741|NCT02509156|471389137|FG001|Randomized Phase|Death|0|||
130933742|NCT02509156|471389136|FG000|Randomized Phase|Withdrawal by Subject|1|||
130933743|NCT02509156|471389137|FG001|Randomized Phase|Withdrawal by Subject|1|||
130933744|NCT03042533|471389140|FG000|Overall Study|MD left program|1|||
130933745|NCT03042533|471389141|FG001|Overall Study|MD left program|4|||
130933746|NCT03042533|471389142|FG002|Overall Study|MD left program|1|||
130933747|NCT04326231|471389143|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
130933748|NCT01111149|471389148|FG000|Overall Study|Protocol Violation|1|||
130933749|NCT01111149|471389149|FG001|Overall Study|Protocol Violation|1|||
130933750|NCT01111149|471389150|FG002|Overall Study|Protocol Violation|2|||
130933751|NCT01111149|471389148|FG000|Overall Study|Withdrawal by Subject|1|||
130933752|NCT01111149|471389149|FG001|Overall Study|Withdrawal by Subject|0|||
130933753|NCT01111149|471389150|FG002|Overall Study|Withdrawal by Subject|2|||
130933754|NCT02551731|471389153|FG000|Overall Study|Withdrawal by Subject|2|||
130933755|NCT01678911|471389154|FG000|Second Intervention|Lost to Follow-up|2|||
130933756|NCT01678911|471389155|FG001|Second Intervention|Lost to Follow-up|0|||
130933757|NCT00356369|471389156|FG000|Active Phase|Withdrawal by Subject|2|||
130933758|NCT00356369|471389157|FG001|Active Phase|Withdrawal by Subject|1|||
130933759|NCT02117648|471389161|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
130933760|NCT02117648|471389161|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
130933761|NCT02117648|471389161|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
130933762|NCT02117648|471389161|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
130933763|NCT02117648|471389161|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
130933764|NCT02117648|471389161|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
130933765|NCT02117648|471389161|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
130933766|NCT02117648|471389161|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
130933767|NCT02117648|471389161|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
131120472|NCT01994382|472072347|FG006|Overall Study|Death|0|||
130933768|NCT02117648|471389161|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
130933769|NCT02117648|471389161|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
130933770|NCT01985867|471389162|FG000|Overall Study|Lost to Follow-up|3|||
130933771|NCT01985867|471389163|FG001|Overall Study|Lost to Follow-up|4|||
130933772|NCT01985867|471389162|FG000|Overall Study|Adverse Event|3|||
131120473|NCT01994382|472072348|FG007|Overall Study|Death|0|||
131120474|NCT01994382|472072349|FG008|Overall Study|Death|1|||
130933773|NCT01985867|471389163|FG001|Overall Study|Adverse Event|2|||
130933774|NCT01985867|471389162|FG000|Overall Study|Lack of Efficacy|1|||
130933775|NCT01985867|471389163|FG001|Overall Study|Lack of Efficacy|0|||
130933776|NCT00553514|471389166|FG000|Overall Study|Protocol deviation|0|||
130933777|NCT00553514|471389167|FG001|Overall Study|Protocol deviation|0|||
130933778|NCT00553514|471389168|FG002|Overall Study|Protocol deviation|0|||
131120475|NCT01994382|472072350|FG009|Overall Study|Death|1|||
130933779|NCT00553514|471389169|FG003|Overall Study|Protocol deviation|1|||
130933780|NCT00553514|471389170|FG004|Overall Study|Protocol deviation|0|||
130933781|NCT00553514|471389166|FG000|Overall Study|Lack of ovarian response|4|||
130933782|NCT00553514|471389167|FG001|Overall Study|Lack of ovarian response|5|||
130933783|NCT00553514|471389168|FG002|Overall Study|Lack of ovarian response|5|||
130933784|NCT00553514|471389169|FG003|Overall Study|Lack of ovarian response|5|||
130933785|NCT00553514|471389170|FG004|Overall Study|Lack of ovarian response|6|||
130933786|NCT00553514|471389166|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
130933787|NCT00553514|471389167|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
130933788|NCT00553514|471389168|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
130933789|NCT00553514|471389169|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
130933790|NCT00553514|471389170|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
130933791|NCT00553514|471389166|FG000|Overall Study|Risk of multiple pregnancy|0|||
130933792|NCT00553514|471389167|FG001|Overall Study|Risk of multiple pregnancy|2|||
130933793|NCT00553514|471389168|FG002|Overall Study|Risk of multiple pregnancy|0|||
130933794|NCT00553514|471389169|FG003|Overall Study|Risk of multiple pregnancy|1|||
130933795|NCT00553514|471389170|FG004|Overall Study|Risk of multiple pregnancy|0|||
130933796|NCT00553514|471389166|FG000|Overall Study|Other|1|||
130933797|NCT00553514|471389167|FG001|Overall Study|Other|1|||
130933798|NCT00553514|471389168|FG002|Overall Study|Other|0|||
130933799|NCT00553514|471389169|FG003|Overall Study|Other|0|||
130933800|NCT00553514|471389170|FG004|Overall Study|Other|1|||
130933801|NCT00752232|471389171|FG000|Overall Study|Protocol Violation|0|||
130933802|NCT00752232|471389172|FG001|Overall Study|Protocol Violation|0|||
130933803|NCT00752232|471389173|FG002|Overall Study|Protocol Violation|0|||
130933804|NCT00752232|471389174|FG003|Overall Study|Protocol Violation|0|||
130933805|NCT00752232|471389175|FG004|Overall Study|Protocol Violation|0|||
130933806|NCT00752232|471389176|FG005|Overall Study|Protocol Violation|1|||
130933807|NCT00752232|471389177|FG006|Overall Study|Protocol Violation|0|||
130933808|NCT00752232|471389171|FG000|Overall Study|Caregiver request|2|||
130933809|NCT00752232|471389172|FG001|Overall Study|Caregiver request|0|||
130933810|NCT00752232|471389173|FG002|Overall Study|Caregiver request|0|||
130933811|NCT00752232|471389174|FG003|Overall Study|Caregiver request|0|||
130933812|NCT00752232|471389175|FG004|Overall Study|Caregiver request|1|||
130933813|NCT00752232|471389176|FG005|Overall Study|Caregiver request|0|||
130933814|NCT00752232|471389177|FG006|Overall Study|Caregiver request|0|||
130933815|NCT00752232|471389171|FG000|Overall Study|Investigator request|0|||
130933816|NCT00752232|471389172|FG001|Overall Study|Investigator request|0|||
130933817|NCT00752232|471389173|FG002|Overall Study|Investigator request|0|||
130933818|NCT00752232|471389174|FG003|Overall Study|Investigator request|0|||
130933819|NCT00752232|471389175|FG004|Overall Study|Investigator request|1|||
130933820|NCT00752232|471389176|FG005|Overall Study|Investigator request|0|||
130933821|NCT00752232|471389177|FG006|Overall Study|Investigator request|0|||
130933822|NCT00752232|471389171|FG000|Overall Study|Subject request|0|||
130933823|NCT00752232|471389172|FG001|Overall Study|Subject request|0|||
130933824|NCT00752232|471389173|FG002|Overall Study|Subject request|1|||
130933825|NCT00752232|471389174|FG003|Overall Study|Subject request|0|||
130933826|NCT00752232|471389175|FG004|Overall Study|Subject request|0|||
130933827|NCT00752232|471389176|FG005|Overall Study|Subject request|0|||
130933828|NCT00752232|471389177|FG006|Overall Study|Subject request|0|||
130933829|NCT00752232|471389171|FG000|Overall Study|Group home admission|0|||
130933830|NCT00752232|471389172|FG001|Overall Study|Group home admission|0|||
130933831|NCT00752232|471389173|FG002|Overall Study|Group home admission|0|||
130933832|NCT00752232|471389174|FG003|Overall Study|Group home admission|1|||
130933833|NCT00752232|471389175|FG004|Overall Study|Group home admission|0|||
130933834|NCT00752232|471389176|FG005|Overall Study|Group home admission|0|||
130933835|NCT00752232|471389177|FG006|Overall Study|Group home admission|0|||
130933836|NCT00752232|471389171|FG000|Overall Study|Caregiver could not attend the subject|0|||
130933837|NCT00752232|471389172|FG001|Overall Study|Caregiver could not attend the subject|0|||
130933838|NCT00752232|471389173|FG002|Overall Study|Caregiver could not attend the subject|0|||
130933839|NCT00752232|471389174|FG003|Overall Study|Caregiver could not attend the subject|0|||
130933840|NCT00752232|471389175|FG004|Overall Study|Caregiver could not attend the subject|1|||
130933841|NCT00752232|471389176|FG005|Overall Study|Caregiver could not attend the subject|0|||
130933842|NCT00752232|471389177|FG006|Overall Study|Caregiver could not attend the subject|0|||
130933843|NCT04502589|471389178|FG000|Overall Study|Physician Decision|1|||
130933844|NCT04502589|471389179|FG001|Overall Study|Physician Decision|0|||
130933845|NCT01606436|471389180|FG000|Overall Study|Withdrawal by Subject|0|||
130933846|NCT01606436|471389181|FG001|Overall Study|Withdrawal by Subject|0|||
130933847|NCT01606436|471389182|FG002|Overall Study|Withdrawal by Subject|1|||
130933848|NCT01606436|471389183|FG003|Overall Study|Withdrawal by Subject|1|||
130933849|NCT01606436|471389184|FG004|Overall Study|Withdrawal by Subject|1|||
130933850|NCT01606436|471389185|FG005|Overall Study|Withdrawal by Subject|0|||
130933851|NCT01606436|471389180|FG000|Overall Study|Adverse Event|0|||
130933852|NCT01606436|471389181|FG001|Overall Study|Adverse Event|0|||
130933853|NCT01606436|471389182|FG002|Overall Study|Adverse Event|1|||
130933854|NCT01606436|471389183|FG003|Overall Study|Adverse Event|0|||
130933855|NCT01606436|471389184|FG004|Overall Study|Adverse Event|0|||
130933856|NCT01606436|471389185|FG005|Overall Study|Adverse Event|0|||
131223760|NCT04380701|472447113|FG004|Overall Study|Lost to Follow-up|0|||
130933857|NCT01606436|471389180|FG000|Overall Study|Sponsor Decision|0|||
131035052|NCT03544281|471761846|FG021|PACT Phase|Adverse Event|0|||
130933858|NCT01606436|471389181|FG001|Overall Study|Sponsor Decision|0|||
130933859|NCT01606436|471389182|FG002|Overall Study|Sponsor Decision|0|||
130933860|NCT01606436|471389183|FG003|Overall Study|Sponsor Decision|1|||
130933861|NCT01606436|471389184|FG004|Overall Study|Sponsor Decision|0|||
130933862|NCT01606436|471389185|FG005|Overall Study|Sponsor Decision|0|||
130933863|NCT02859454|471389186|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
130933864|NCT01683383|471389187|FG000|Overall Study|Infant was not transported|1|||
130933865|NCT01683383|471389188|FG001|Overall Study|Infant was not transported|0|||
130933866|NCT00996307|471389189|FG000|Overall Study|Adverse Event|0|||
130933867|NCT00996307|471389190|FG001|Overall Study|Adverse Event|1|||
130933868|NCT00996307|471389191|FG002|Overall Study|Adverse Event|0|||
130933869|NCT00996307|471389192|FG003|Overall Study|Adverse Event|0|||
130933870|NCT00996307|471389189|FG000|Overall Study|Withdrawal by Subject|3|||
130933871|NCT00996307|471389190|FG001|Overall Study|Withdrawal by Subject|2|||
130933872|NCT00996307|471389191|FG002|Overall Study|Withdrawal by Subject|5|||
130933873|NCT00996307|471389192|FG003|Overall Study|Withdrawal by Subject|5|||
130933874|NCT00996307|471389189|FG000|Overall Study|Lost to Follow-up|13|||
130933875|NCT00996307|471389190|FG001|Overall Study|Lost to Follow-up|13|||
130933876|NCT00996307|471389191|FG002|Overall Study|Lost to Follow-up|7|||
130933877|NCT00996307|471389192|FG003|Overall Study|Lost to Follow-up|15|||
130933878|NCT00996307|471389189|FG000|Overall Study|Administrative reason|0|||
130933879|NCT00996307|471389190|FG001|Overall Study|Administrative reason|1|||
130933880|NCT00996307|471389191|FG002|Overall Study|Administrative reason|0|||
130933881|NCT00996307|471389192|FG003|Overall Study|Administrative reason|0|||
130933882|NCT00996307|471389189|FG000|Overall Study|Unable to classify|4|||
130933883|NCT00996307|471389190|FG001|Overall Study|Unable to classify|0|||
130933884|NCT00996307|471389191|FG002|Overall Study|Unable to classify|2|||
130933885|NCT00996307|471389192|FG003|Overall Study|Unable to classify|1|||
130933886|NCT02013791|471389193|FG000|Period 1|Lost to Follow-up|0|||
130933887|NCT02013791|471389194|FG001|Period 1|Lost to Follow-up|0|||
130933888|NCT02013791|471389195|FG002|Period 1|Lost to Follow-up|0|||
130933889|NCT02013791|471389196|FG003|Period 1|Lost to Follow-up|1|||
130933890|NCT02013791|471389197|FG004|Period 1|Lost to Follow-up|0|||
130933891|NCT02013791|471389198|FG005|Period 1|Lost to Follow-up|0|||
130933892|NCT02013791|471389199|FG006|Period 1|Lost to Follow-up|1|||
130933893|NCT02013791|471389200|FG007|Period 1|Lost to Follow-up|1|||
130933894|NCT02013791|471389201|FG008|Period 1|Lost to Follow-up|0|||
130933895|NCT02013791|471389193|FG000|Period 1|Other Miscellaneous Reasons|0|||
130933896|NCT02013791|471389194|FG001|Period 1|Other Miscellaneous Reasons|2|||
130933897|NCT02013791|471389195|FG002|Period 1|Other Miscellaneous Reasons|0|||
130933898|NCT02013791|471389196|FG003|Period 1|Other Miscellaneous Reasons|0|||
130933899|NCT02013791|471389197|FG004|Period 1|Other Miscellaneous Reasons|0|||
131035053|NCT02547987|471761847|FG000|Overall Study|Withdrawal by Subject|1|||
130933900|NCT02013791|471389198|FG005|Period 1|Other Miscellaneous Reasons|0|||
130933901|NCT02013791|471389199|FG006|Period 1|Other Miscellaneous Reasons|0|||
130933902|NCT02013791|471389200|FG007|Period 1|Other Miscellaneous Reasons|0|||
130933903|NCT02013791|471389201|FG008|Period 1|Other Miscellaneous Reasons|0|||
130933904|NCT03798483|471389202|FG000|Overall Study|Lost to Follow-up|2|||
130933905|NCT02725710|471389203|FG000|Overall Study|Lost to Follow-up|1|||
130933906|NCT02725710|471389204|FG001|Overall Study|Lost to Follow-up|0|||
130933907|NCT01927367|471389205|FG000|Overall Study|Withdrawal by Subject|7|||
130933908|NCT01927367|471389206|FG001|Overall Study|Withdrawal by Subject|4|||
130770845|NCT01005901|470787712|FG001|Overall Study|Protocol Violation|3|||
130933909|NCT01927367|471389205|FG000|Overall Study|No baseline data|0|||
130933910|NCT01927367|471389206|FG001|Overall Study|No baseline data|1|||
130933911|NCT02142959|471389211|FG000|Overall Study|Adverse Event|1|||
130933912|NCT02142959|471389212|FG001|Overall Study|Adverse Event|0|||
130933913|NCT02142959|471389213|FG002|Overall Study|Adverse Event|0|||
130933914|NCT02142959|471389211|FG000|Overall Study|Death|0|||
130933915|NCT02142959|471389212|FG001|Overall Study|Death|1|||
131035054|NCT02547987|471761847|FG000|Overall Study|Adverse Event|2|||
131035055|NCT04282148|471761848|FG000|Overall Study|Death|7|||
130933916|NCT02142959|471389213|FG002|Overall Study|Death|0|||
130933917|NCT02142959|471389211|FG000|Overall Study|Withdrawal by Subject|3|||
131223761|NCT04380701|472447114|FG005|Overall Study|Lost to Follow-up|0|||
131035056|NCT04282148|471761848|FG000|Overall Study|Withdrawal by Subject|1|||
131223762|NCT04380701|472447115|FG006|Overall Study|Lost to Follow-up|0|||
130933918|NCT02142959|471389212|FG001|Overall Study|Withdrawal by Subject|1|||
130933919|NCT02142959|471389213|FG002|Overall Study|Withdrawal by Subject|3|||
130933920|NCT02142959|471389211|FG000|Overall Study|Administrative Reasons|1|||
130933921|NCT02142959|471389212|FG001|Overall Study|Administrative Reasons|0|||
130770846|NCT01005901|470787711|FG000|Overall Study|Death|2|||
131035057|NCT04282148|471761848|FG000|Overall Study|Physician Decision|1|||
130933922|NCT02142959|471389213|FG002|Overall Study|Administrative Reasons|1|||
130933923|NCT02142959|471389211|FG000|Overall Study|Missing|0|||
130933924|NCT02142959|471389212|FG001|Overall Study|Missing|1|||
130933925|NCT02142959|471389213|FG002|Overall Study|Missing|0|||
130933926|NCT02142959|471389211|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
130933927|NCT02142959|471389212|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
130933928|NCT02142959|471389213|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
130933929|NCT02142959|471389211|FG000|Overall Study|Patient didn't complete end of study visit|0|||
130933930|NCT02142959|471389212|FG001|Overall Study|Patient didn't complete end of study visit|0|||
130933931|NCT02142959|471389213|FG002|Overall Study|Patient didn't complete end of study visit|1|||
130933932|NCT03547687|471389214|FG000|Overall Study|Withdrawal by Subject|1|||
130933933|NCT03547687|471389214|FG000|Overall Study|Death|1|||
130933934|NCT02547454|471389218|FG000|Overall Study|Due to hemodialysis|53|||
130933935|NCT02547454|471389218|FG000|Overall Study|Due to transplantation|1|||
130933936|NCT02547454|471389218|FG000|Overall Study|Due to no further need to treat|4|||
130933937|NCT02547454|471389218|FG000|Overall Study|Death|38|||
130933938|NCT02547454|471389218|FG000|Overall Study|Lost to Follow-up|26|||
130770847|NCT01005901|470787712|FG001|Overall Study|Death|3|||
130770848|NCT01005901|470787711|FG000|Overall Study|Lost to Follow-up|1|||
130770849|NCT01005901|470787712|FG001|Overall Study|Lost to Follow-up|2|||
130770850|NCT01005901|470787711|FG000|Overall Study|Patient's inability to use the device|1|||
130933939|NCT02547454|471389218|FG000|Overall Study|Other|39|||
130933940|NCT02547454|471389218|FG000|Overall Study|No data|11|||
130933941|NCT03064451|471389220|FG000|Overall Study|Lost to Follow-up|1|||
130933942|NCT03064451|471389220|FG000|Overall Study|Mapping Failure|4|||
130933943|NCT03064451|471389220|FG000|Overall Study|Exited prior to procedure|8|||
130933944|NCT03064451|471389220|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
130933945|NCT05109442|471389221|FG000|Overall Study|Withdrawal by Subject|0|||
130933946|NCT05109442|471389222|FG001|Overall Study|Withdrawal by Subject|0|||
130933947|NCT05109442|471389223|FG002|Overall Study|Withdrawal by Subject|1|||
130933948|NCT05109442|471389224|FG003|Overall Study|Withdrawal by Subject|0|||
130933949|NCT05109442|471389225|FG004|Overall Study|Withdrawal by Subject|0|||
130933950|NCT05109442|471389226|FG005|Overall Study|Withdrawal by Subject|0|||
130933951|NCT05109442|471389221|FG000|Overall Study|Adverse Event|0|||
130933952|NCT05109442|471389222|FG001|Overall Study|Adverse Event|1|||
130933953|NCT05109442|471389223|FG002|Overall Study|Adverse Event|5|||
130933954|NCT05109442|471389224|FG003|Overall Study|Adverse Event|0|||
130933955|NCT05109442|471389225|FG004|Overall Study|Adverse Event|0|||
130933956|NCT05109442|471389226|FG005|Overall Study|Adverse Event|2|||
130933957|NCT05109442|471389221|FG000|Overall Study|Death|0|||
130933958|NCT05109442|471389222|FG001|Overall Study|Death|0|||
130933959|NCT05109442|471389223|FG002|Overall Study|Death|4|||
130933960|NCT05109442|471389224|FG003|Overall Study|Death|0|||
130933961|NCT05109442|471389225|FG004|Overall Study|Death|0|||
130933962|NCT05109442|471389226|FG005|Overall Study|Death|1|||
130933963|NCT05109442|471389221|FG000|Overall Study|Physician Decision|1|||
130933964|NCT05109442|471389222|FG001|Overall Study|Physician Decision|0|||
130933965|NCT05109442|471389223|FG002|Overall Study|Physician Decision|1|||
130933966|NCT05109442|471389224|FG003|Overall Study|Physician Decision|0|||
130933967|NCT05109442|471389225|FG004|Overall Study|Physician Decision|0|||
130933968|NCT05109442|471389226|FG005|Overall Study|Physician Decision|2|||
130933969|NCT05109442|471389221|FG000|Overall Study|Other than listed|0|||
130933970|NCT05109442|471389222|FG001|Overall Study|Other than listed|0|||
130933971|NCT05109442|471389223|FG002|Overall Study|Other than listed|9|||
130933972|NCT05109442|471389224|FG003|Overall Study|Other than listed|2|||
130933973|NCT05109442|471389225|FG004|Overall Study|Other than listed|0|||
130933974|NCT05109442|471389226|FG005|Overall Study|Other than listed|8|||
130933975|NCT05109442|471389221|FG000|Overall Study|Lack of Efficacy|3|||
130933976|NCT05109442|471389222|FG001|Overall Study|Lack of Efficacy|5|||
130933977|NCT05109442|471389223|FG002|Overall Study|Lack of Efficacy|29|||
130933978|NCT05109442|471389224|FG003|Overall Study|Lack of Efficacy|10|||
131035058|NCT02146378|471761849|FG000|Overall Study|No information of administration|2|||
131035059|NCT06181760|471761850|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
131035060|NCT06181760|471761851|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
130933979|NCT05109442|471389225|FG004|Overall Study|Lack of Efficacy|11|||
131035061|NCT06181760|471761852|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
131035062|NCT06181760|471761853|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
130933980|NCT05109442|471389226|FG005|Overall Study|Lack of Efficacy|17|||
130933981|NCT04853225|471389227|FG000|Overall Study|Withdrawal by Subject|81|||
130933982|NCT04853225|471389228|FG001|Overall Study|Withdrawal by Subject|4|||
130933983|NCT04853225|471389229|FG002|Overall Study|Withdrawal by Subject|1|||
130933984|NCT04853225|471389227|FG000|Overall Study|Physician Decision|12|||
131035063|NCT03524612|471761854|FG000|Overall Study|Lack of Efficacy|10|||
130933985|NCT04853225|471389228|FG001|Overall Study|Physician Decision|4|||
131035064|NCT03524612|471761854|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
130933986|NCT04853225|471389229|FG002|Overall Study|Physician Decision|1|||
130933987|NCT04853225|471389227|FG000|Overall Study|Lost to Follow-up|50|||
130933988|NCT04853225|471389228|FG001|Overall Study|Lost to Follow-up|0|||
130933989|NCT04853225|471389229|FG002|Overall Study|Lost to Follow-up|0|||
130933990|NCT04853225|471389227|FG000|Overall Study|Other|102|||
130933991|NCT04853225|471389228|FG001|Overall Study|Other|11|||
130933992|NCT04853225|471389229|FG002|Overall Study|Other|5|||
130770851|NCT01005901|470787712|FG001|Overall Study|Patient's inability to use the device|1|||
130770852|NCT01005901|470787711|FG000|Overall Study|No longer requires study drug|0|||
130770853|NCT01005901|470787712|FG001|Overall Study|No longer requires study drug|1|||
130770854|NCT00760487|470787713|FG000|Overall Study|Unilateral implantation|3|||
130770855|NCT01658904|470787716|FG000|Overall Study|Principal Investigator discretion|2|||
130770856|NCT01658904|470787717|FG001|Overall Study|Principal Investigator discretion|0|||
130770857|NCT01658904|470787718|FG002|Overall Study|Principal Investigator discretion|0|||
130770858|NCT01603394|470787728|FG000|Overall Study|Adverse Event|1|||
130770859|NCT04399538|470787730|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
130770860|NCT04399538|470787731|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
130770861|NCT04399538|470787732|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
130770862|NCT04399538|470787733|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
130770863|NCT04399538|470787734|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
130770864|NCT04399538|470787730|FG000|Double-Blind Treatment|Adverse Event|0|||
130770865|NCT04399538|470787731|FG001|Double-Blind Treatment|Adverse Event|0|||
130770866|NCT04399538|470787732|FG002|Double-Blind Treatment|Adverse Event|0|||
130770867|NCT04399538|470787733|FG003|Double-Blind Treatment|Adverse Event|0|||
130770868|NCT04399538|470787734|FG004|Double-Blind Treatment|Adverse Event|1|||
130770869|NCT04399538|470787730|FG000|Follow-Up|Adverse Event|0|||
130770870|NCT04399538|470787731|FG001|Follow-Up|Adverse Event|0|||
130770871|NCT04399538|470787732|FG002|Follow-Up|Adverse Event|0|||
130770872|NCT04399538|470787733|FG003|Follow-Up|Adverse Event|0|||
130770873|NCT04399538|470787734|FG004|Follow-Up|Adverse Event|1|||
130770874|NCT04399538|470787730|FG000|Follow-Up|Withdrawal by Subject|0|||
130770875|NCT04399538|470787731|FG001|Follow-Up|Withdrawal by Subject|0|||
130770876|NCT04399538|470787732|FG002|Follow-Up|Withdrawal by Subject|0|||
130770877|NCT04399538|470787733|FG003|Follow-Up|Withdrawal by Subject|2|||
130770878|NCT04399538|470787734|FG004|Follow-Up|Withdrawal by Subject|0|||
130770879|NCT01215435|470787735|FG000|Overall Study|Adverse Event|1|||
130770880|NCT01215435|470787736|FG001|Overall Study|Adverse Event|0|||
130770881|NCT01215435|470787735|FG000|Overall Study|Protocol Violation|2|||
130770882|NCT01215435|470787736|FG001|Overall Study|Protocol Violation|0|||
130770883|NCT01215435|470787735|FG000|Overall Study|Withdrawal Criteria|8|||
130770884|NCT01215435|470787736|FG001|Overall Study|Withdrawal Criteria|11|||
130770885|NCT01215435|470787735|FG000|Overall Study|Lost to Follow-up|3|||
130770886|NCT01215435|470787736|FG001|Overall Study|Lost to Follow-up|0|||
130770887|NCT01215435|470787735|FG000|Overall Study|Unclassified|5|||
130770888|NCT01215435|470787736|FG001|Overall Study|Unclassified|5|||
130770889|NCT00840034|470787737|FG000|Acute Treatment Phase|Adverse Event|6|||
130770890|NCT00840034|470787738|FG001|Acute Treatment Phase|Adverse Event|8|||
130770891|NCT00840034|470787737|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
130770892|NCT00840034|470787738|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
130770893|NCT00840034|470787737|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
130770894|NCT00840034|470787738|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
130770895|NCT00840034|470787737|FG000|Acute Treatment Phase|Physician Decision|0|||
130770896|NCT00840034|470787738|FG001|Acute Treatment Phase|Physician Decision|1|||
130770897|NCT00840034|470787737|FG000|Acute Treatment Phase|Protocol Violation|2|||
130933993|NCT04853225|471389227|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
130933994|NCT04853225|471389228|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
130933995|NCT04853225|471389229|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
130933996|NCT04853225|471389227|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
130933997|NCT04853225|471389228|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
130933998|NCT04853225|471389229|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
130933999|NCT03918447|471389230|FG000|Overall Study|Death|1|||
130934000|NCT03918447|471389231|FG001|Overall Study|Death|0|||
130934001|NCT03918447|471389230|FG000|Overall Study|Lost to Follow-up|13|||
130934002|NCT03918447|471389231|FG001|Overall Study|Lost to Follow-up|6|||
130934003|NCT03918447|471389230|FG000|Overall Study|Withdrawal by Subject|19|||
130934004|NCT03918447|471389231|FG001|Overall Study|Withdrawal by Subject|17|||
131035065|NCT03524612|471761854|FG000|Overall Study|Adverse Event|10|||
131035066|NCT03524612|471761854|FG000|Overall Study|Withdrawal by Subject|7|||
131035067|NCT03524612|471761854|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
130770898|NCT00840034|470787738|FG001|Acute Treatment Phase|Protocol Violation|4|||
130770899|NCT00840034|470787737|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
130770900|NCT00840034|470787738|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
130770901|NCT00840034|470787737|FG000|Taper Phase|Adverse Event|1|||
130770902|NCT00840034|470787738|FG001|Taper Phase|Adverse Event|0|||
130770903|NCT00840034|470787737|FG000|Taper Phase|Lost to Follow-up|1|||
130770904|NCT00840034|470787738|FG001|Taper Phase|Lost to Follow-up|1|||
130770905|NCT00840034|470787737|FG000|Taper Phase|Withdrawal by Subject|1|||
130770906|NCT00840034|470787738|FG001|Taper Phase|Withdrawal by Subject|1|||
130934005|NCT03918447|471389230|FG000|Overall Study|Study Terminated by Sponsor|195|||
130934006|NCT03918447|471389231|FG001|Overall Study|Study Terminated by Sponsor|197|||
130770907|NCT02179749|470787750|FG000|Overall Study|Adverse Event|0|||
130770908|NCT02179749|470787751|FG001|Overall Study|Adverse Event|0|||
130934007|NCT03918447|471389230|FG000|Overall Study|Reason not Specified|0|||
130934008|NCT03918447|471389231|FG001|Overall Study|Reason not Specified|1|||
130934009|NCT01405456|471389232|FG000|Overall Study|Lost to Follow-up|2|||
130934010|NCT01405456|471389233|FG001|Overall Study|Lost to Follow-up|1|||
130934011|NCT01405456|471389232|FG000|Overall Study|Physician Decision|1|||
130934012|NCT01405456|471389233|FG001|Overall Study|Physician Decision|0|||
130934013|NCT01774968|471389234|FG000|Overall Study|Adverse Event|4|||
130934014|NCT01774968|471389235|FG001|Overall Study|Adverse Event|4|||
130934015|NCT01774968|471389234|FG000|Overall Study|Death|0|||
130934016|NCT01774968|471389235|FG001|Overall Study|Death|1|||
131035068|NCT03524612|471761854|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
131035069|NCT03524612|471761854|FG000|Overall Study|New therapy for study indication|6|||
131035070|NCT03524612|471761854|FG000|Overall Study|Death|3|||
131035071|NCT03524612|471761854|FG000|Overall Study|Lost to Follow-up|2|||
131035072|NCT03524612|471761854|FG000|Overall Study|Protocol Violation|1|||
131035073|NCT04770532|471761855|FG000|Overall Study|Withdrawal by Subject|0|||
131035074|NCT04770532|471761856|FG001|Overall Study|Withdrawal by Subject|3|||
131035075|NCT04770532|471761855|FG000|Overall Study|Physician Decision|1|||
131035076|NCT04770532|471761856|FG001|Overall Study|Physician Decision|0|||
131035077|NCT04770532|471761855|FG000|Overall Study|Death|2|||
131035078|NCT04770532|471761856|FG001|Overall Study|Death|2|||
131035079|NCT05457647|471761857|FG000|Overall Study|Lost to Follow-up|3|||
131035080|NCT04938492|471761858|FG000|Overall Study|Lost to Follow-up|17|||
131035081|NCT04938492|471761859|FG001|Overall Study|Lost to Follow-up|18|||
131035082|NCT02683447|471761860|FG000|Overall Study|Lost to Follow-up|2|||
131035083|NCT03115476|471761861|FG000|LP0084-1369|Death|1|||
131035084|NCT03115476|471761862|FG001|LP0084-1369|Death|0|||
131035085|NCT03115476|471761863|FG002|LP0084-1369|Death|2|||
131035086|NCT03115476|471761861|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
131035087|NCT03115476|471761862|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
131035088|NCT03115476|471761863|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
131035089|NCT05257486|471761867|FG000|Overall Study|Protocol Violation|3|||
131120476|NCT01994382|472072351|FG010|Overall Study|Death|0|||
131120477|NCT01994382|472072352|FG011|Overall Study|Death|0|||
131120478|NCT01994382|472072353|FG012|Overall Study|Death|0|||
131120479|NCT01994382|472072354|FG013|Overall Study|Death|0|||
131120480|NCT01994382|472072355|FG014|Overall Study|Death|0|||
131120481|NCT01994382|472072356|FG015|Overall Study|Death|1|||
131120482|NCT01994382|472072357|FG016|Overall Study|Death|0|||
131120483|NCT01994382|472072341|FG000|Overall Study|Adverse Event|0|||
130934017|NCT01774968|471389234|FG000|Overall Study|Lost to Follow-up|1|||
130934018|NCT01774968|471389235|FG001|Overall Study|Lost to Follow-up|3|||
130934019|NCT01774968|471389234|FG000|Overall Study|Physician Decision|5|||
130934020|NCT01774968|471389235|FG001|Overall Study|Physician Decision|1|||
130934021|NCT01774968|471389234|FG000|Overall Study|Protocol Violation|14|||
130934022|NCT01774968|471389235|FG001|Overall Study|Protocol Violation|13|||
130934023|NCT01774968|471389234|FG000|Overall Study|Sponsor Decision|0|||
130934024|NCT01774968|471389235|FG001|Overall Study|Sponsor Decision|2|||
130934025|NCT01774968|471389234|FG000|Overall Study|Withdrawal by Subject|6|||
130934026|NCT01774968|471389235|FG001|Overall Study|Withdrawal by Subject|11|||
130934027|NCT05355805|471389238|FG000|Overall Study|Lost to Follow-up|6|||
130934028|NCT05355805|471389239|FG001|Overall Study|Lost to Follow-up|11|||
130934029|NCT05355805|471389240|FG002|Overall Study|Lost to Follow-up|10|||
130934030|NCT05355805|471389241|FG003|Overall Study|Lost to Follow-up|6|||
130934031|NCT05355805|471389238|FG000|Overall Study|Decision by Sponsor|0|||
130934032|NCT05355805|471389239|FG001|Overall Study|Decision by Sponsor|0|||
130934033|NCT05355805|471389240|FG002|Overall Study|Decision by Sponsor|1|||
130934034|NCT05355805|471389241|FG003|Overall Study|Decision by Sponsor|0|||
130934035|NCT05355805|471389238|FG000|Overall Study|Withdrawal by Subject|7|||
130934036|NCT05355805|471389239|FG001|Overall Study|Withdrawal by Subject|14|||
130934037|NCT05355805|471389240|FG002|Overall Study|Withdrawal by Subject|15|||
130934038|NCT05355805|471389241|FG003|Overall Study|Withdrawal by Subject|13|||
130934039|NCT02167893|471389242|FG000|Overall Study|Investigator transferred|85|||
130934040|NCT02167893|471389242|FG000|Overall Study|Investigator health reasons|10|||
130934041|NCT02167893|471389242|FG000|Overall Study|Case report forms not collected|68|||
130934042|NCT04818840|471389243|FG000|Overall Study|Lost to Follow-up|0|||
131120484|NCT01994382|472072342|FG001|Overall Study|Adverse Event|1|||
131120485|NCT01994382|472072343|FG002|Overall Study|Adverse Event|2|||
130934043|NCT04818840|471389244|FG001|Overall Study|Lost to Follow-up|5|||
131120486|NCT01994382|472072344|FG003|Overall Study|Adverse Event|0|||
131120487|NCT01994382|472072345|FG004|Overall Study|Adverse Event|0|||
131120488|NCT01994382|472072346|FG005|Overall Study|Adverse Event|0|||
130934044|NCT04818840|471389243|FG000|Overall Study|Physician Decision|1|||
130934045|NCT04818840|471389244|FG001|Overall Study|Physician Decision|0|||
130934046|NCT04818840|471389243|FG000|Overall Study|Site Terminated by Sponsor|0|||
130934047|NCT04818840|471389244|FG001|Overall Study|Site Terminated by Sponsor|3|||
130934048|NCT04818840|471389243|FG000|Overall Study|Study Terminated by Sponsor|43|||
131120489|NCT01994382|472072347|FG006|Overall Study|Adverse Event|0|||
130934049|NCT04818840|471389244|FG001|Overall Study|Study Terminated by Sponsor|7|||
131120490|NCT01994382|472072348|FG007|Overall Study|Adverse Event|0|||
131120491|NCT01994382|472072349|FG008|Overall Study|Adverse Event|0|||
130934050|NCT04818840|471389243|FG000|Overall Study|Withdrawal by Subject|0|||
130934051|NCT04818840|471389244|FG001|Overall Study|Withdrawal by Subject|1|||
130934052|NCT02373202|471390870|FG000|Overall Study|Adverse Event|2|||
130934053|NCT02373202|471390871|FG001|Overall Study|Adverse Event|5|||
130934054|NCT02373202|471390872|FG002|Overall Study|Adverse Event|2|||
130934055|NCT02373202|471390873|FG003|Overall Study|Adverse Event|1|||
131120492|NCT01994382|472072350|FG009|Overall Study|Adverse Event|0|||
131120493|NCT01994382|472072351|FG010|Overall Study|Adverse Event|15|||
131120494|NCT01994382|472072352|FG011|Overall Study|Adverse Event|2|||
131120495|NCT01994382|472072353|FG012|Overall Study|Adverse Event|7|||
130934056|NCT02373202|471390870|FG000|Overall Study|Lack of Efficacy|0|||
130934057|NCT02373202|471390871|FG001|Overall Study|Lack of Efficacy|0|||
130934058|NCT02373202|471390872|FG002|Overall Study|Lack of Efficacy|1|||
130934059|NCT02373202|471390873|FG003|Overall Study|Lack of Efficacy|0|||
130934060|NCT02373202|471390870|FG000|Overall Study|Other|0|||
130934061|NCT02373202|471390871|FG001|Overall Study|Other|1|||
130934062|NCT02373202|471390872|FG002|Overall Study|Other|0|||
130934063|NCT02373202|471390873|FG003|Overall Study|Other|0|||
130934064|NCT01411228|471390875|FG000|Overall Study|Lost to Follow-up|0|||
130934065|NCT01411228|471390876|FG001|Overall Study|Lost to Follow-up|0|||
130934066|NCT01411228|471390877|FG002|Overall Study|Lost to Follow-up|1|||
130934067|NCT01411228|471390875|FG000|Overall Study|Withdrawal by Subject|1|||
130934068|NCT01411228|471390876|FG001|Overall Study|Withdrawal by Subject|0|||
130934069|NCT01411228|471390877|FG002|Overall Study|Withdrawal by Subject|0|||
130934070|NCT03909295|471390878|FG000|Overall Study|Adverse Event|2|||
130934071|NCT03909295|471390878|FG000|Overall Study|Study terminated by sponsor|50|||
130934072|NCT02670083|471390881|FG000|Overall Study|Adverse Event|16|||
130934073|NCT02670083|471390882|FG001|Overall Study|Adverse Event|13|||
130934074|NCT02670083|471390881|FG000|Overall Study|Death|4|||
130934075|NCT02670083|471390882|FG001|Overall Study|Death|6|||
130934076|NCT02670083|471390881|FG000|Overall Study|Lost to Follow-up|2|||
130934077|NCT02670083|471390882|FG001|Overall Study|Lost to Follow-up|2|||
130934078|NCT02670083|471390881|FG000|Overall Study|Multiple Reasons|9|||
130934079|NCT02670083|471390882|FG001|Overall Study|Multiple Reasons|9|||
130934080|NCT02670083|471390881|FG000|Overall Study|Physician Decision|0|||
130934081|NCT02670083|471390882|FG001|Overall Study|Physician Decision|2|||
130934082|NCT02670083|471390881|FG000|Overall Study|Study Terminated By Sponsor|257|||
130934083|NCT02670083|471390882|FG001|Overall Study|Study Terminated By Sponsor|254|||
130934084|NCT02670083|471390881|FG000|Overall Study|Symptomatic Deterioration|0|||
130934085|NCT02670083|471390882|FG001|Overall Study|Symptomatic Deterioration|2|||
130934086|NCT02670083|471390881|FG000|Overall Study|Withdrawal by Subject|32|||
130934087|NCT02670083|471390882|FG001|Overall Study|Withdrawal by Subject|31|||
130934088|NCT02670083|471390881|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130934089|NCT02670083|471390882|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130934090|NCT02057406|471390884|FG000|Overall Study|Physician Decision|0|||
130934091|NCT02057406|471390885|FG001|Overall Study|Physician Decision|0|||
130934092|NCT02057406|471390886|FG002|Overall Study|Physician Decision|2|||
130934093|NCT02057406|471390884|FG000|Overall Study|Withdrawal by Subject|0|||
130934094|NCT02057406|471390885|FG001|Overall Study|Withdrawal by Subject|2|||
130934095|NCT02057406|471390886|FG002|Overall Study|Withdrawal by Subject|0|||
130934096|NCT02057406|471390884|FG000|Overall Study|Lost to Follow-up|0|||
130934097|NCT02057406|471390885|FG001|Overall Study|Lost to Follow-up|0|||
130934098|NCT02057406|471390886|FG002|Overall Study|Lost to Follow-up|1|||
130934099|NCT02057406|471390884|FG000|Overall Study|Death|1|||
130934100|NCT02057406|471390885|FG001|Overall Study|Death|0|||
130934101|NCT02057406|471390886|FG002|Overall Study|Death|0|||
130934102|NCT02057406|471390884|FG000|Overall Study|Protocol Violation|0|||
130934103|NCT02057406|471390885|FG001|Overall Study|Protocol Violation|1|||
130934104|NCT02057406|471390886|FG002|Overall Study|Protocol Violation|0|||
130934105|NCT02057406|471390884|FG000|Overall Study|Patient transportation issues|0|||
130934106|NCT02057406|471390885|FG001|Overall Study|Patient transportation issues|0|||
131120496|NCT01994382|472072354|FG013|Overall Study|Adverse Event|3|||
131035108|NCT00613106|471761871|FG000|Overall Study|Adverse Event|3|||
131035109|NCT00613106|471761872|FG001|Overall Study|Adverse Event|1|||
131035110|NCT00613106|471761871|FG000|Overall Study|Withdrawal by Subject|6|||
131035111|NCT00613106|471761872|FG001|Overall Study|Withdrawal by Subject|3|||
130934107|NCT02057406|471390886|FG002|Overall Study|Patient transportation issues|1|||
130934108|NCT02425046|471390887|FG000|Overall Study|Lost to Follow-up|52|||
130934109|NCT02425046|471390888|FG001|Overall Study|Lost to Follow-up|50|||
130934110|NCT02425046|471390889|FG002|Overall Study|Lost to Follow-up|56|||
131035112|NCT00613106|471761871|FG000|Overall Study|Lost to Follow-up|7|||
131035113|NCT00613106|471761872|FG001|Overall Study|Lost to Follow-up|2|||
130934111|NCT02425046|471390887|FG000|Overall Study|Withdrawal by Subject|16|||
130934112|NCT02425046|471390888|FG001|Overall Study|Withdrawal by Subject|12|||
130934113|NCT02425046|471390889|FG002|Overall Study|Withdrawal by Subject|0|||
130934114|NCT03654651|471390890|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
131035114|NCT00613106|471761871|FG000|Overall Study|misc|4|||
130934115|NCT03654651|471390891|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
130934116|NCT00856284|471390896|FG000|Overall Study|Hyperglycemic rescue|231|||
130934117|NCT00856284|471390897|FG001|Overall Study|Hyperglycemic rescue|201|||
130934118|NCT00856284|471390898|FG002|Overall Study|Hyperglycemic rescue|235|||
130934119|NCT00856284|471390896|FG000|Overall Study|Adverse Event|60|||
130934120|NCT00856284|471390897|FG001|Overall Study|Adverse Event|74|||
130934121|NCT00856284|471390898|FG002|Overall Study|Adverse Event|82|||
130934122|NCT00856284|471390896|FG000|Overall Study|Major protocol deviation|24|||
130934123|NCT00856284|471390897|FG001|Overall Study|Major protocol deviation|16|||
130934124|NCT00856284|471390898|FG002|Overall Study|Major protocol deviation|15|||
130934125|NCT00856284|471390896|FG000|Overall Study|Lost to Follow-up|20|||
130934126|NCT00856284|471390897|FG001|Overall Study|Lost to Follow-up|22|||
130934127|NCT00856284|471390898|FG002|Overall Study|Lost to Follow-up|28|||
130934128|NCT00856284|471390896|FG000|Overall Study|Voluntary withdrawal|48|||
130934129|NCT00856284|471390897|FG001|Overall Study|Voluntary withdrawal|52|||
130934130|NCT00856284|471390898|FG002|Overall Study|Voluntary withdrawal|62|||
130934131|NCT00856284|471390896|FG000|Overall Study|Pregnancy|1|||
130934132|NCT00856284|471390897|FG001|Overall Study|Pregnancy|2|||
130934133|NCT00856284|471390898|FG002|Overall Study|Pregnancy|0|||
130934134|NCT00856284|471390896|FG000|Overall Study|Investigator discretion|9|||
130934135|NCT00856284|471390897|FG001|Overall Study|Investigator discretion|8|||
130934136|NCT00856284|471390898|FG002|Overall Study|Investigator discretion|10|||
130934137|NCT00856284|471390896|FG000|Overall Study|Other|15|||
130934138|NCT00856284|471390897|FG001|Overall Study|Other|17|||
130934139|NCT00856284|471390898|FG002|Overall Study|Other|14|||
130934140|NCT00856284|471390896|FG000|Overall Study|Randomized in error|0|||
130934141|NCT00856284|471390897|FG001|Overall Study|Randomized in error|0|||
130934142|NCT00856284|471390898|FG002|Overall Study|Randomized in error|1|||
130934143|NCT00267046|471390906|FG000|Overall Study|Disease progression|4|||
130934144|NCT00267046|471390907|FG001|Overall Study|Disease progression|2|||
130934145|NCT00267046|471390906|FG000|Overall Study|Chemotoxicity|2|||
130934146|NCT00267046|471390907|FG001|Overall Study|Chemotoxicity|0|||
130934147|NCT00267046|471390906|FG000|Overall Study|Open-label palifermin|2|||
130934148|NCT00267046|471390907|FG001|Overall Study|Open-label palifermin|7|||
130934149|NCT00267046|471390906|FG000|Overall Study|Surgery|3|||
130934150|NCT00267046|471390907|FG001|Overall Study|Surgery|1|||
130934151|NCT00267046|471390906|FG000|Overall Study|Withdrawal by Subject|1|||
130934152|NCT00267046|471390907|FG001|Overall Study|Withdrawal by Subject|0|||
130934153|NCT00267046|471390906|FG000|Overall Study|Radiation|0|||
130934154|NCT00267046|471390907|FG001|Overall Study|Radiation|1|||
130934155|NCT00865124|471390908|FG000|Overall Study|Physician Decision|2|||
130934156|NCT00865124|471390909|FG001|Overall Study|Physician Decision|1|||
130934157|NCT00865124|471390910|FG002|Overall Study|Physician Decision|0|||
130934158|NCT00865124|471390908|FG000|Overall Study|Withdrawn consent|2|||
130934159|NCT00865124|471390909|FG001|Overall Study|Withdrawn consent|0|||
130934160|NCT00865124|471390910|FG002|Overall Study|Withdrawn consent|0|||
130934161|NCT04983264|471390911|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
130934162|NCT04983264|471390912|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
130934163|NCT04983264|471390913|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
130934164|NCT04983264|471390911|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
130934165|NCT04983264|471390912|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
130934166|NCT04983264|471390913|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
130934167|NCT00372112|471390925|FG000|Overall Study|Adverse Event|0|||
130934168|NCT00372112|471390926|FG001|Overall Study|Adverse Event|1|||
130934169|NCT00372112|471390927|FG002|Overall Study|Adverse Event|1|||
130934170|NCT00372112|471390928|FG003|Overall Study|Adverse Event|1|||
130934171|NCT00372112|471390925|FG000|Overall Study|Withdrawal by Subject|0|||
130934172|NCT00372112|471390926|FG001|Overall Study|Withdrawal by Subject|0|||
130934173|NCT00372112|471390927|FG002|Overall Study|Withdrawal by Subject|2|||
130934174|NCT00372112|471390928|FG003|Overall Study|Withdrawal by Subject|1|||
130934175|NCT00372112|471390925|FG000|Overall Study|Exacerbation|0|||
131223763|NCT04380701|472447116|FG007|Overall Study|Lost to Follow-up|0|||
131223764|NCT04380701|472447117|FG008|Overall Study|Lost to Follow-up|0|||
131223765|NCT04380701|472447118|FG009|Overall Study|Lost to Follow-up|0|||
130934176|NCT00372112|471390926|FG001|Overall Study|Exacerbation|0|||
130934177|NCT00372112|471390927|FG002|Overall Study|Exacerbation|0|||
130934178|NCT00372112|471390928|FG003|Overall Study|Exacerbation|1|||
130934179|NCT00372112|471390925|FG000|Overall Study|PR >240 at Visit 3|0|||
130934180|NCT00372112|471390926|FG001|Overall Study|PR >240 at Visit 3|0|||
130934181|NCT00372112|471390927|FG002|Overall Study|PR >240 at Visit 3|0|||
130934182|NCT00372112|471390928|FG003|Overall Study|PR >240 at Visit 3|1|||
131223766|NCT04380701|472447119|FG010|Overall Study|Lost to Follow-up|0|||
130934183|NCT00372112|471390925|FG000|Overall Study|Hepatitis B|1|||
130934184|NCT00372112|471390926|FG001|Overall Study|Hepatitis B|0|||
130934185|NCT00372112|471390927|FG002|Overall Study|Hepatitis B|0|||
130934186|NCT00372112|471390928|FG003|Overall Study|Hepatitis B|0|||
130934187|NCT00372112|471390925|FG000|Overall Study|Other-protocol violation|0|||
130934188|NCT00372112|471390926|FG001|Overall Study|Other-protocol violation|0|||
130934189|NCT00372112|471390927|FG002|Overall Study|Other-protocol violation|1|||
130934190|NCT00372112|471390928|FG003|Overall Study|Other-protocol violation|0|||
131035115|NCT00613106|471761872|FG001|Overall Study|misc|3|||
130934191|NCT04649060|471390943|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
130934192|NCT04649060|471390944|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
130934193|NCT04649060|471390943|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
130934194|NCT04649060|471390944|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
130934195|NCT04649060|471390943|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
130934196|NCT04649060|471390944|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
130934197|NCT04649060|471390943|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
130934198|NCT04649060|471390944|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
130934199|NCT04649060|471390943|FG000|Arm A/Arm B Treatment|Patient Request|1|||
130934200|NCT04649060|471390944|FG001|Arm A/Arm B Treatment|Patient Request|0|||
130934201|NCT04649060|471390943|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
130934202|NCT04649060|471390944|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
130934203|NCT04649060|471390943|FG000|Arm A/Arm B Treatment|Other|1|||
130934204|NCT04649060|471390944|FG001|Arm A/Arm B Treatment|Other|0|||
130934205|NCT04649060|471390943|FG000|Crossover (Arm B)|Adverse Event|0|||
130934206|NCT04649060|471390944|FG001|Crossover (Arm B)|Adverse Event|1|||
130934207|NCT04649060|471390943|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
130934208|NCT04649060|471390944|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
130934209|NCT01442675|471390951|FG000|Overall Study|Protocol Violation|6|||
130934210|NCT01442675|471390951|FG000|Overall Study|Lost to Follow-up|2|||
130934211|NCT01442675|471390951|FG000|Overall Study|Withdrawal by Subject|4|||
130934212|NCT00137046|471390959|FG000|Overall Study|Death|2|||
130934213|NCT00137046|471390960|FG001|Overall Study|Death|1|||
130934214|NCT00137046|471390959|FG000|Overall Study|Adverse Event|16|||
130934215|NCT00137046|471390960|FG001|Overall Study|Adverse Event|5|||
130934216|NCT00137046|471390959|FG000|Overall Study|Laboratory Abnormality|2|||
130934217|NCT00137046|471390960|FG001|Overall Study|Laboratory Abnormality|0|||
130934218|NCT00137046|471390959|FG000|Overall Study|Lack of Efficacy|13|||
130934219|NCT00137046|471390960|FG001|Overall Study|Lack of Efficacy|1|||
130934220|NCT00137046|471390959|FG000|Overall Study|Lost to Follow-up|8|||
130934221|NCT00137046|471390960|FG001|Overall Study|Lost to Follow-up|24|||
130934222|NCT00137046|471390959|FG000|Overall Study|Other|23|||
130934223|NCT00137046|471390960|FG001|Overall Study|Other|19|||
130934224|NCT00137046|471390959|FG000|Overall Study|Withdrawal by Subject|33|||
130934225|NCT00137046|471390960|FG001|Overall Study|Withdrawal by Subject|42|||
130934226|NCT00137046|471390959|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
130934227|NCT00137046|471390960|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
130934228|NCT00137046|471390959|FG000|Overall Study|Withdrew prior to study treatment|1|||
130934229|NCT00137046|471390960|FG001|Overall Study|Withdrew prior to study treatment|1|||
130934230|NCT00160251|471390961|FG000|Prior to Amendment 2|Adverse Event|2|||
130934231|NCT00160251|471390962|FG001|Prior to Amendment 2|Adverse Event|1|||
130934232|NCT00160251|471390963|FG002|Prior to Amendment 2|Adverse Event|3|||
130934233|NCT00160251|471390964|FG003|Prior to Amendment 2|Adverse Event|1|||
130934234|NCT00160251|471390965|FG004|Prior to Amendment 2|Adverse Event|1|||
130934235|NCT00160251|471390966|FG005|Prior to Amendment 2|Adverse Event|1|||
130934236|NCT00160251|471390967|FG006|Prior to Amendment 2|Adverse Event|1|||
130934237|NCT00160251|471390968|FG007|Prior to Amendment 2|Adverse Event|0|||
130934238|NCT00160251|471390961|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
130934239|NCT00160251|471390962|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
130934240|NCT00160251|471390963|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
130934241|NCT00160251|471390964|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
130934242|NCT00160251|471390965|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
130934243|NCT00160251|471390966|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
130934244|NCT00160251|471390967|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
130934245|NCT00160251|471390968|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
130934246|NCT00160251|471390961|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
130934247|NCT00160251|471390962|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
130934248|NCT00160251|471390963|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
130934249|NCT00160251|471390964|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
130934250|NCT00160251|471390965|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
130934251|NCT00160251|471390966|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
130934252|NCT00160251|471390967|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
130934253|NCT00160251|471390968|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
130934254|NCT00160251|471390961|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
130934255|NCT00160251|471390962|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
130934256|NCT00160251|471390963|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
130934257|NCT00160251|471390964|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
130934258|NCT00160251|471390965|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
130934259|NCT00160251|471390966|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
130934260|NCT00160251|471390967|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
130934261|NCT00160251|471390968|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
130934262|NCT00160251|471390961|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
130934263|NCT00160251|471390962|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
130934264|NCT00160251|471390963|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
130934265|NCT00160251|471390964|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
130934266|NCT00160251|471390965|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
130934267|NCT00160251|471390966|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
130934268|NCT00160251|471390967|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
130934269|NCT00160251|471390968|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
130934270|NCT00160251|471390961|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
130934271|NCT00160251|471390962|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
130934272|NCT00160251|471390963|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
130934273|NCT00160251|471390964|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
130934274|NCT00160251|471390965|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
130934275|NCT00160251|471390966|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
130934276|NCT00160251|471390967|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
130934277|NCT00160251|471390968|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
130934278|NCT00160251|471390961|FG000|Post-amendment 2|Adverse Event|0|||
130934279|NCT00160251|471390962|FG001|Post-amendment 2|Adverse Event|0|||
130934280|NCT00160251|471390963|FG002|Post-amendment 2|Adverse Event|0|||
130934281|NCT00160251|471390964|FG003|Post-amendment 2|Adverse Event|0|||
130934282|NCT00160251|471390965|FG004|Post-amendment 2|Adverse Event|0|||
130934283|NCT00160251|471390966|FG005|Post-amendment 2|Adverse Event|0|||
130934284|NCT00160251|471390967|FG006|Post-amendment 2|Adverse Event|0|||
130770909|NCT02179749|470787752|FG002|Overall Study|Adverse Event|1|||
130934285|NCT00160251|471390968|FG007|Post-amendment 2|Adverse Event|20|||
130934286|NCT00160251|471390961|FG000|Post-amendment 2|Lack of Efficacy|0|||
130934287|NCT00160251|471390962|FG001|Post-amendment 2|Lack of Efficacy|0|||
130934288|NCT00160251|471390963|FG002|Post-amendment 2|Lack of Efficacy|0|||
130934289|NCT00160251|471390964|FG003|Post-amendment 2|Lack of Efficacy|0|||
130934290|NCT00160251|471390965|FG004|Post-amendment 2|Lack of Efficacy|0|||
130934291|NCT00160251|471390966|FG005|Post-amendment 2|Lack of Efficacy|0|||
130934292|NCT00160251|471390967|FG006|Post-amendment 2|Lack of Efficacy|0|||
130934293|NCT00160251|471390968|FG007|Post-amendment 2|Lack of Efficacy|24|||
130934294|NCT00160251|471390961|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130934295|NCT00160251|471390962|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130934296|NCT00160251|471390963|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130934297|NCT00160251|471390964|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130934298|NCT00160251|471390965|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130934299|NCT00160251|471390966|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130934300|NCT00160251|471390967|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
130934301|NCT00160251|471390968|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
130934302|NCT02730455|471390970|FG000|Overall Study|Death|5|||
130934303|NCT02730455|471390971|FG001|Overall Study|Death|6|||
130934304|NCT02730455|471390972|FG002|Overall Study|Death|4|||
130934305|NCT02730455|471390970|FG000|Overall Study|Consent withdrawn|2|||
130770910|NCT02179749|470787750|FG000|Overall Study|Withdrawal by Subject|0|||
130770911|NCT02179749|470787751|FG001|Overall Study|Withdrawal by Subject|0|||
130770912|NCT02179749|470787752|FG002|Overall Study|Withdrawal by Subject|1|||
130934306|NCT02730455|471390971|FG001|Overall Study|Consent withdrawn|4|||
130934307|NCT02730455|471390972|FG002|Overall Study|Consent withdrawn|1|||
130934308|NCT02730455|471390970|FG000|Overall Study|Lost to Follow-up|3|||
130934309|NCT02730455|471390971|FG001|Overall Study|Lost to Follow-up|1|||
130934310|NCT02730455|471390972|FG002|Overall Study|Lost to Follow-up|4|||
130934311|NCT02730455|471390970|FG000|Overall Study|Other|1|||
130934312|NCT02730455|471390971|FG001|Overall Study|Other|1|||
130934313|NCT02730455|471390972|FG002|Overall Study|Other|2|||
130934314|NCT02730455|471390970|FG000|Overall Study|Other|2|||
130934315|NCT02730455|471390971|FG001|Overall Study|Other|2|||
130934316|NCT02730455|471390972|FG002|Overall Study|Other|0|||
130934317|NCT01018186|471390976|FG000|2-week Run-in Period|Protocol Violation|1|||
131120497|NCT01994382|472072355|FG014|Overall Study|Adverse Event|17|||
131120498|NCT01994382|472072356|FG015|Overall Study|Adverse Event|6|||
131120499|NCT01994382|472072357|FG016|Overall Study|Adverse Event|3|||
131120500|NCT01994382|472072341|FG000|Overall Study|Other than specified|0|||
131120501|NCT01994382|472072342|FG001|Overall Study|Other than specified|0|||
131120502|NCT01994382|472072343|FG002|Overall Study|Other than specified|0|||
131120503|NCT01994382|472072344|FG003|Overall Study|Other than specified|0|||
131120504|NCT01994382|472072345|FG004|Overall Study|Other than specified|0|||
131120505|NCT01994382|472072346|FG005|Overall Study|Other than specified|0|||
131120506|NCT01994382|472072347|FG006|Overall Study|Other than specified|0|||
131120507|NCT01994382|472072348|FG007|Overall Study|Other than specified|0|||
131120508|NCT01994382|472072349|FG008|Overall Study|Other than specified|0|||
131120509|NCT01994382|472072350|FG009|Overall Study|Other than specified|0|||
130934318|NCT01018186|471390977|FG001|2-week Run-in Period|Protocol Violation|0|||
131120510|NCT01994382|472072351|FG010|Overall Study|Other than specified|2|||
131120511|NCT01994382|472072352|FG011|Overall Study|Other than specified|0|||
130934319|NCT01018186|471390978|FG002|2-week Run-in Period|Protocol Violation|0|||
130934320|NCT01018186|471390979|FG003|2-week Run-in Period|Protocol Violation|0|||
130934321|NCT01018186|471390976|FG000|2-week Run-in Period|Lost to Follow-up|2|||
130934322|NCT01018186|471390977|FG001|2-week Run-in Period|Lost to Follow-up|0|||
130934323|NCT01018186|471390978|FG002|2-week Run-in Period|Lost to Follow-up|0|||
130934324|NCT01018186|471390979|FG003|2-week Run-in Period|Lost to Follow-up|0|||
130934325|NCT01018186|471390976|FG000|2-week Run-in Period|Physician Decision|3|||
130934326|NCT01018186|471390977|FG001|2-week Run-in Period|Physician Decision|0|||
130934327|NCT01018186|471390978|FG002|2-week Run-in Period|Physician Decision|0|||
130934328|NCT01018186|471390979|FG003|2-week Run-in Period|Physician Decision|0|||
130934329|NCT01018186|471390976|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
130934330|NCT01018186|471390977|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130934331|NCT01018186|471390978|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130934332|NCT01018186|471390979|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
130934333|NCT01018186|471390976|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
130934334|NCT01018186|471390977|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130934335|NCT01018186|471390978|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130934336|NCT01018186|471390979|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130934337|NCT01018186|471390976|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
130934338|NCT01018186|471390977|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
130934339|NCT01018186|471390978|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
130934340|NCT01018186|471390979|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
130934341|NCT01018186|471390976|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
130934342|NCT01018186|471390977|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
130934343|NCT01018186|471390978|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
130934344|NCT01018186|471390979|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
130934345|NCT01018186|471390976|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
130934346|NCT01018186|471390977|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
130934347|NCT01018186|471390978|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
130934348|NCT01018186|471390979|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
130934349|NCT01018186|471390976|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
130934350|NCT01018186|471390977|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
130934351|NCT01018186|471390978|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
130934352|NCT01018186|471390979|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
130934353|NCT01018186|471390976|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
130934354|NCT01018186|471390977|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
130934355|NCT01018186|471390978|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
130934356|NCT01018186|471390979|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
130934357|NCT01018186|471390976|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
130934358|NCT01018186|471390977|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
130934359|NCT01018186|471390978|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
130934360|NCT01018186|471390979|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
130934361|NCT01018186|471390976|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130934362|NCT01018186|471390977|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
130934363|NCT01018186|471390978|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
130934364|NCT01018186|471390979|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
130934365|NCT03552198|471390980|FG000|Overall Study|Lost to Follow-up|42|||
130934366|NCT03552198|471390981|FG001|Overall Study|Lost to Follow-up|48|||
130934367|NCT03552198|471390982|FG002|Overall Study|Lost to Follow-up|15|||
130934368|NCT03552198|471390983|FG003|Overall Study|Lost to Follow-up|19|||
130934369|NCT03552198|471390980|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
130934370|NCT03552198|471390981|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
130934371|NCT03552198|471390982|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
130934372|NCT03552198|471390983|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
130934373|NCT03552198|471390980|FG000|Overall Study|Did not receive air alerts|1|||
130934374|NCT03552198|471390981|FG001|Overall Study|Did not receive air alerts|0|||
130934375|NCT03552198|471390982|FG002|Overall Study|Did not receive air alerts|0|||
130934376|NCT03552198|471390983|FG003|Overall Study|Did not receive air alerts|1|||
130934377|NCT03235154|471390984|FG000|Overall Study|Withdrawal by Subject|1|||
130934378|NCT03235154|471390984|FG000|Overall Study|Adverse Event|1|||
130934379|NCT03235154|471390984|FG000|Overall Study|Lost to Follow-up|2|||
130934380|NCT00276744|471390985|FG000|PART A|Reason unknown|98|||
130934381|NCT00640601|471390990|FG000|Overall Study|Adverse Event|43|||
130934382|NCT00640601|471390990|FG000|Overall Study|Withdrawal by Subject|20|||
130934383|NCT00640601|471390990|FG000|Overall Study|Protocol Violation|6|||
130934384|NCT00640601|471390990|FG000|Overall Study|Lack of Efficacy|16|||
130934385|NCT00640601|471390990|FG000|Overall Study|Lost to Follow-up|9|||
130934386|NCT00640601|471390990|FG000|Overall Study|Physician Decision|8|||
130934387|NCT00640601|471390990|FG000|Overall Study|treatment naive, combination therapy|10|||
130770913|NCT01573754|470787757|FG000|Overall Study|Noncompliance or remission not achieved|3|||
130934388|NCT00598832|471390995|FG000|Overall Study|Lack of Efficacy|3|||
130934389|NCT00598832|471390996|FG001|Overall Study|Lack of Efficacy|7|||
130934390|NCT00598832|471390995|FG000|Overall Study|Adverse Event|6|||
130934391|NCT00598832|471390996|FG001|Overall Study|Adverse Event|2|||
130934392|NCT00598832|471390995|FG000|Overall Study|Withdrawal by Subject|25|||
130934393|NCT00598832|471390996|FG001|Overall Study|Withdrawal by Subject|36|||
130934394|NCT00598832|471390995|FG000|Overall Study|Protocol Violation|0|||
130934395|NCT00598832|471390996|FG001|Overall Study|Protocol Violation|2|||
130934396|NCT00598832|471390995|FG000|Overall Study|Lost to Follow-up|24|||
130934397|NCT00598832|471390996|FG001|Overall Study|Lost to Follow-up|29|||
130934398|NCT00598832|471390995|FG000|Overall Study|Pregnancy|2|||
130934399|NCT00598832|471390996|FG001|Overall Study|Pregnancy|2|||
130934400|NCT00598832|471390995|FG000|Overall Study|Physician Decision|1|||
130934401|NCT00598832|471390996|FG001|Overall Study|Physician Decision|4|||
130934402|NCT00598832|471390995|FG000|Overall Study|Non compliance|1|||
130934403|NCT00598832|471390996|FG001|Overall Study|Non compliance|0|||
130934404|NCT02760069|471390997|FG000|Overall Study|Withdrawal by Subject|0|||
130934405|NCT02760069|471390998|FG001|Overall Study|Withdrawal by Subject|1|||
130934406|NCT02760069|471390999|FG002|Overall Study|Withdrawal by Subject|1|||
130934407|NCT01648205|471391005|FG000|Placebo|Pregnancy|1|||
130934408|NCT01648205|471391005|FG000|Placebo|Withdrawal by Subject|1|||
130934409|NCT01648205|471391005|FG000|Placebo|Protocol Violation|2|||
130934410|NCT01648205|471391005|FG000|Ranolazine|Death|1|||
130934411|NCT01648205|471391005|FG000|Ranolazine|Withdrawal by Subject|1|||
130934412|NCT01648205|471391005|FG000|Ranolazine|Protocol Violation|3|||
130934413|NCT03667924|471391008|FG000|Baseline Completed|Lost to Follow-up|0|||
130934414|NCT03667924|471391009|FG001|Baseline Completed|Lost to Follow-up|2|||
130934415|NCT03667924|471391010|FG002|Baseline Completed|Lost to Follow-up|0|||
130934416|NCT03667924|471391008|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
130934417|NCT03667924|471391009|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
130934418|NCT03667924|471391010|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
130934419|NCT03667924|471391008|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
130934420|NCT03667924|471391009|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
130934421|NCT03667924|471391010|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
130934422|NCT03667924|471391008|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
130934423|NCT03667924|471391009|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
130934424|NCT03667924|471391010|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
130934425|NCT03667924|471391008|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
130934426|NCT03667924|471391009|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
130934427|NCT03667924|471391010|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
130934428|NCT03667924|471391008|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
130934429|NCT03667924|471391009|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
130934430|NCT03667924|471391010|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
130934431|NCT03667924|471391008|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
130934432|NCT03667924|471391009|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
130934433|NCT03667924|471391010|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
130934434|NCT04557371|471391016|FG000|Overall Study|Covid-19-related|0|||
130934435|NCT04557371|471391017|FG001|Overall Study|Covid-19-related|1|||
130934436|NCT04557371|471391018|FG002|Overall Study|Covid-19-related|0|||
130934437|NCT04557371|471391016|FG000|Overall Study|Withdrawal by Subject|0|||
130934438|NCT04557371|471391017|FG001|Overall Study|Withdrawal by Subject|1|||
130934439|NCT04557371|471391018|FG002|Overall Study|Withdrawal by Subject|0|||
130934440|NCT04557371|471391016|FG000|Overall Study|Adverse Event|1|||
130934441|NCT04557371|471391017|FG001|Overall Study|Adverse Event|0|||
130934442|NCT04557371|471391018|FG002|Overall Study|Adverse Event|0|||
130934443|NCT03694821|471391019|FG000|Overall Study|Study terminated|4|||
130934444|NCT03694821|471391020|FG001|Overall Study|Study terminated|8|||
130934445|NCT03694821|471391021|FG002|Overall Study|Study terminated|4|||
130934446|NCT00203996|471391022|FG000|Overall Study|Lost to Follow-up|0|||
130934447|NCT00203996|471391023|FG001|Overall Study|Lost to Follow-up|0|||
130934448|NCT00203996|471391024|FG002|Overall Study|Lost to Follow-up|0|||
130934449|NCT00203996|471391025|FG003|Overall Study|Lost to Follow-up|1|||
130934450|NCT00203996|471391026|FG004|Overall Study|Lost to Follow-up|0|||
130934451|NCT00203996|471391027|FG005|Overall Study|Lost to Follow-up|0|||
130934452|NCT00203996|471391028|FG006|Overall Study|Lost to Follow-up|0|||
130934453|NCT00203996|471391029|FG007|Overall Study|Lost to Follow-up|0|||
130934454|NCT00203996|471391030|FG008|Overall Study|Lost to Follow-up|0|||
130934455|NCT00203996|471391031|FG009|Overall Study|Lost to Follow-up|0|||
130934456|NCT00203996|471391022|FG000|Overall Study|Protocol Violation|0|||
130934457|NCT00203996|471391023|FG001|Overall Study|Protocol Violation|0|||
130934458|NCT00203996|471391024|FG002|Overall Study|Protocol Violation|0|||
130934459|NCT00203996|471391025|FG003|Overall Study|Protocol Violation|6|||
131035116|NCT05296525|471761881|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
131223767|NCT04380701|472447120|FG011|Overall Study|Lost to Follow-up|0|||
131035117|NCT05296525|471761882|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
131035118|NCT05296525|471761883|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
131223768|NCT04380701|472447121|FG012|Overall Study|Lost to Follow-up|0|||
130934460|NCT00203996|471391026|FG004|Overall Study|Protocol Violation|1|||
130934461|NCT00203996|471391027|FG005|Overall Study|Protocol Violation|0|||
130934462|NCT00203996|471391028|FG006|Overall Study|Protocol Violation|0|||
130934463|NCT00203996|471391029|FG007|Overall Study|Protocol Violation|0|||
130934464|NCT00203996|471391030|FG008|Overall Study|Protocol Violation|0|||
130934465|NCT00203996|471391031|FG009|Overall Study|Protocol Violation|0|||
130934466|NCT00203996|471391022|FG000|Overall Study|Physician Decision|0|||
130934467|NCT00203996|471391023|FG001|Overall Study|Physician Decision|0|||
130934468|NCT00203996|471391024|FG002|Overall Study|Physician Decision|0|||
130934469|NCT00203996|471391025|FG003|Overall Study|Physician Decision|2|||
130934470|NCT00203996|471391026|FG004|Overall Study|Physician Decision|0|||
130934471|NCT00203996|471391027|FG005|Overall Study|Physician Decision|0|||
130934472|NCT00203996|471391028|FG006|Overall Study|Physician Decision|0|||
130934473|NCT00203996|471391029|FG007|Overall Study|Physician Decision|0|||
130934474|NCT00203996|471391030|FG008|Overall Study|Physician Decision|0|||
130934475|NCT00203996|471391031|FG009|Overall Study|Physician Decision|1|||
130934476|NCT00203996|471391022|FG000|Overall Study|CPAP machine malfunction|0|||
130934477|NCT00203996|471391023|FG001|Overall Study|CPAP machine malfunction|0|||
130934478|NCT00203996|471391024|FG002|Overall Study|CPAP machine malfunction|0|||
130934479|NCT00203996|471391025|FG003|Overall Study|CPAP machine malfunction|1|||
130934480|NCT00203996|471391026|FG004|Overall Study|CPAP machine malfunction|0|||
130934481|NCT00203996|471391027|FG005|Overall Study|CPAP machine malfunction|0|||
130934482|NCT00203996|471391028|FG006|Overall Study|CPAP machine malfunction|0|||
130934483|NCT00203996|471391029|FG007|Overall Study|CPAP machine malfunction|0|||
130934484|NCT00203996|471391030|FG008|Overall Study|CPAP machine malfunction|0|||
130934485|NCT00203996|471391031|FG009|Overall Study|CPAP machine malfunction|0|||
130934486|NCT00203996|471391022|FG000|Overall Study|Scheduling issue|0|||
130934487|NCT00203996|471391023|FG001|Overall Study|Scheduling issue|0|||
130934488|NCT00203996|471391024|FG002|Overall Study|Scheduling issue|0|||
130934489|NCT00203996|471391025|FG003|Overall Study|Scheduling issue|0|||
130934490|NCT00203996|471391026|FG004|Overall Study|Scheduling issue|0|||
130934491|NCT00203996|471391027|FG005|Overall Study|Scheduling issue|0|||
130934492|NCT00203996|471391028|FG006|Overall Study|Scheduling issue|0|||
130934493|NCT00203996|471391029|FG007|Overall Study|Scheduling issue|2|||
130934494|NCT00203996|471391030|FG008|Overall Study|Scheduling issue|0|||
130934495|NCT00203996|471391031|FG009|Overall Study|Scheduling issue|0|||
130934496|NCT00897104|471391034|FG000|Overall Study|Lost to Follow-up|12|||
130934497|NCT00897104|471391035|FG001|Overall Study|Lost to Follow-up|17|||
130934498|NCT00897104|471391036|FG002|Overall Study|Lost to Follow-up|2|||
130934499|NCT00897104|471391034|FG000|Overall Study|Pregnancy|0|||
130934500|NCT00897104|471391035|FG001|Overall Study|Pregnancy|1|||
130934501|NCT00897104|471391036|FG002|Overall Study|Pregnancy|0|||
130934502|NCT00897104|471391034|FG000|Overall Study|Protocol Violation|0|||
130934503|NCT00897104|471391035|FG001|Overall Study|Protocol Violation|1|||
130934504|NCT00897104|471391036|FG002|Overall Study|Protocol Violation|0|||
130934505|NCT00897104|471391034|FG000|Overall Study|Withdrawal by Subject|23|||
130934506|NCT00897104|471391035|FG001|Overall Study|Withdrawal by Subject|27|||
130934507|NCT00897104|471391036|FG002|Overall Study|Withdrawal by Subject|3|||
130934508|NCT00897104|471391034|FG000|Overall Study|Abnormal Prestudy Labs|2|||
130934509|NCT00897104|471391035|FG001|Overall Study|Abnormal Prestudy Labs|0|||
130934510|NCT00897104|471391036|FG002|Overall Study|Abnormal Prestudy Labs|0|||
130934511|NCT00897104|471391034|FG000|Overall Study|Abnormal Baseline ECG|2|||
130934512|NCT00897104|471391035|FG001|Overall Study|Abnormal Baseline ECG|2|||
130934513|NCT00897104|471391036|FG002|Overall Study|Abnormal Baseline ECG|0|||
130934514|NCT00897104|471391034|FG000|Overall Study|Need for Concom. Med.|0|||
130934515|NCT00897104|471391035|FG001|Overall Study|Need for Concom. Med.|1|||
130934516|NCT00897104|471391036|FG002|Overall Study|Need for Concom. Med.|1|||
130934517|NCT00897104|471391034|FG000|Overall Study|Lack of Migraine Attack|20|||
130770914|NCT01573754|470787758|FG001|Overall Study|Noncompliance or remission not achieved|15|||
130770915|NCT00829829|470787760|FG000|Overall Study|Protocol Violation|0|||
130770916|NCT00829829|470787761|FG001|Overall Study|Protocol Violation|3|||
130934518|NCT00897104|471391035|FG001|Overall Study|Lack of Migraine Attack|22|||
130934519|NCT00897104|471391036|FG002|Overall Study|Lack of Migraine Attack|1|||
130934520|NCT00897104|471391034|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
130934521|NCT00897104|471391035|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
130934522|NCT00897104|471391036|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
130934523|NCT00897104|471391034|FG000|Overall Study|Other|3|||
130934524|NCT00897104|471391035|FG001|Overall Study|Other|0|||
130934525|NCT00897104|471391036|FG002|Overall Study|Other|0|||
130934526|NCT00897104|471391034|FG000|Overall Study|Protocol Violation|1|||
130934527|NCT00897104|471391035|FG001|Overall Study|Protocol Violation|0|||
130934528|NCT00897104|471391036|FG002|Overall Study|Protocol Violation|0|||
131035119|NCT05296525|471761884|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
130934529|NCT00897104|471391034|FG000|Overall Study|Withdrawal by Subject|0|||
130934530|NCT00897104|471391035|FG001|Overall Study|Withdrawal by Subject|0|||
130934531|NCT00897104|471391036|FG002|Overall Study|Withdrawal by Subject|1|||
130934532|NCT00750204|471391037|FG000|Overall Study|study halted prematurely|1|||
130934533|NCT00750204|471391038|FG001|Overall Study|study halted prematurely|1|||
130770917|NCT00829829|470787762|FG002|Overall Study|Protocol Violation|0|||
130770918|NCT00829829|470787760|FG000|Overall Study|Adverse Event|4|||
130770919|NCT00829829|470787761|FG001|Overall Study|Adverse Event|4|||
130770920|NCT00829829|470787762|FG002|Overall Study|Adverse Event|3|||
130770921|NCT00829829|470787760|FG000|Overall Study|Withdrawal by Subject|8|||
130770922|NCT00829829|470787761|FG001|Overall Study|Withdrawal by Subject|4|||
130770923|NCT00829829|470787762|FG002|Overall Study|Withdrawal by Subject|2|||
130770924|NCT00829829|470787760|FG000|Overall Study|Decision by the Sponsor|1|||
130770925|NCT00829829|470787761|FG001|Overall Study|Decision by the Sponsor|0|||
130770926|NCT00829829|470787762|FG002|Overall Study|Decision by the Sponsor|2|||
130934534|NCT00850564|471391039|FG000|Overall Study|Withdrawal by Subject|2|||
130934535|NCT00477971|471391040|FG000|Overall Study|Disease progression|6|||
130934536|NCT00477971|471391041|FG001|Overall Study|Disease progression|0|||
130934537|NCT00477971|471391040|FG000|Overall Study|Withdrawal by Subject|3|||
130934538|NCT00477971|471391041|FG001|Overall Study|Withdrawal by Subject|1|||
130934539|NCT00477971|471391040|FG000|Overall Study|Adverse Event|3|||
130934540|NCT00477971|471391041|FG001|Overall Study|Adverse Event|0|||
130934541|NCT00477971|471391040|FG000|Overall Study|Death|2|||
130934542|NCT00477971|471391041|FG001|Overall Study|Death|4|||
130934543|NCT00477971|471391040|FG000|Overall Study|Alternative treatment|3|||
130770927|NCT00829829|470787760|FG000|Overall Study|Lost to Follow-up|7|||
130770928|NCT00829829|470787761|FG001|Overall Study|Lost to Follow-up|3|||
130770929|NCT00829829|470787762|FG002|Overall Study|Lost to Follow-up|3|||
130770930|NCT00829829|470787760|FG000|Overall Study|Other than specified above|2|||
130770931|NCT00829829|470787761|FG001|Overall Study|Other than specified above|2|||
130770932|NCT00829829|470787762|FG002|Overall Study|Other than specified above|1|||
130770933|NCT02984267|470787763|FG000|Overall Study|Protocol Violation|1|||
130770934|NCT02984267|470787764|FG001|Overall Study|Protocol Violation|0|||
130770935|NCT02984267|470787763|FG000|Overall Study|Withdrawal by Subject|0|||
130770936|NCT02984267|470787764|FG001|Overall Study|Withdrawal by Subject|1|||
130770937|NCT00520767|470787765|FG000|Overall Study|Death|2|||
130770938|NCT03597139|470787766|FG000|Overall Study|Adverse Event|3|||
130770939|NCT03597139|470787767|FG001|Overall Study|Adverse Event|0|||
130770940|NCT03597139|470787766|FG000|Overall Study|Protocol Non-compliance|1|||
130770941|NCT03597139|470787767|FG001|Overall Study|Protocol Non-compliance|0|||
130770942|NCT00382109|470787770|FG000|Overall Study|Adverse Event|3|||
130770943|NCT00382109|470787771|FG001|Overall Study|Adverse Event|0|||
131035120|NCT04065841|471761889|FG000|Overall Study|Adverse Event|4|||
131035121|NCT04065841|471761890|FG001|Overall Study|Adverse Event|2|||
131035122|NCT04065841|471761891|FG002|Overall Study|Adverse Event|10|||
130934544|NCT00477971|471391041|FG001|Overall Study|Alternative treatment|1|||
130934545|NCT00524368|471392798|FG000|Overall Study|Adverse Event|10|||
130934546|NCT00524368|471392799|FG001|Overall Study|Adverse Event|12|||
130934547|NCT00524368|471392798|FG000|Overall Study|Lost to Follow-up|9|||
130934548|NCT00524368|471392799|FG001|Overall Study|Lost to Follow-up|13|||
131035123|NCT04065841|471761892|FG003|Overall Study|Adverse Event|1|||
131035124|NCT04065841|471761889|FG000|Overall Study|Lost to Follow-up|1|||
131035125|NCT04065841|471761890|FG001|Overall Study|Lost to Follow-up|2|||
131035126|NCT04065841|471761891|FG002|Overall Study|Lost to Follow-up|2|||
131035127|NCT04065841|471761892|FG003|Overall Study|Lost to Follow-up|2|||
130770944|NCT00382109|470787770|FG000|Overall Study|Physician Decision|6|||
130770945|NCT00382109|470787771|FG001|Overall Study|Physician Decision|1|||
130770946|NCT00382109|470787770|FG000|Overall Study|Withdrawal by Subject|1|||
130934549|NCT00524368|471392798|FG000|Overall Study|Withdrawal by Subject|4|||
131035128|NCT04065841|471761889|FG000|Overall Study|Physician Decision|1|||
131035129|NCT04065841|471761890|FG001|Overall Study|Physician Decision|0|||
131223769|NCT04380701|472447122|FG013|Overall Study|Lost to Follow-up|0|||
130934550|NCT00524368|471392799|FG001|Overall Study|Withdrawal by Subject|5|||
130934551|NCT00524368|471392798|FG000|Overall Study|Non-compliant|8|||
130934552|NCT00524368|471392799|FG001|Overall Study|Non-compliant|9|||
130934553|NCT00524368|471392798|FG000|Overall Study|Reached a Virologic Endpoint|3|||
130934554|NCT00524368|471392799|FG001|Overall Study|Reached a Virologic Endpoint|2|||
130934555|NCT00524368|471392798|FG000|Overall Study|Sponsor's Decision|2|||
130934556|NCT00524368|471392799|FG001|Overall Study|Sponsor's Decision|0|||
130934557|NCT00524368|471392798|FG000|Overall Study|Ineligible to Continue the study|2|||
130934558|NCT00524368|471392799|FG001|Overall Study|Ineligible to Continue the study|5|||
131035130|NCT04065841|471761891|FG002|Overall Study|Physician Decision|0|||
131035131|NCT04065841|471761892|FG003|Overall Study|Physician Decision|0|||
130770947|NCT00382109|470787771|FG001|Overall Study|Withdrawal by Subject|0|||
130770948|NCT00382109|470787770|FG000|Overall Study|ineligible|2|||
130770949|NCT00382109|470787771|FG001|Overall Study|ineligible|0|||
130770950|NCT00382109|470787770|FG000|Overall Study|Other|0|||
130934559|NCT00524368|471392798|FG000|Overall Study|Other|3|||
130934560|NCT00524368|471392799|FG001|Overall Study|Other|2|||
130934561|NCT00793598|471392800|FG000|Overall Study|Patient Request|0|||
131035132|NCT04065841|471761889|FG000|Overall Study|Protocol Violation|0|||
131035133|NCT04065841|471761890|FG001|Overall Study|Protocol Violation|1|||
130770951|NCT00382109|470787771|FG001|Overall Study|Other|2|||
130770952|NCT00382109|470787770|FG000|Overall Study|consent withdrawal|0|||
130934562|NCT00793598|471392801|FG001|Overall Study|Patient Request|1|||
130934563|NCT00793598|471392802|FG002|Overall Study|Patient Request|0|||
130934564|NCT00793598|471392803|FG003|Overall Study|Patient Request|0|||
130934565|NCT00793598|471392804|FG004|Overall Study|Patient Request|0|||
130934566|NCT00793598|471392805|FG005|Overall Study|Patient Request|0|||
130934567|NCT00793598|471392806|FG006|Overall Study|Patient Request|0|||
130934568|NCT00793598|471392807|FG007|Overall Study|Patient Request|0|||
130934569|NCT00793598|471392800|FG000|Overall Study|Protocol Violation|0|||
130934570|NCT00793598|471392801|FG001|Overall Study|Protocol Violation|0|||
130934571|NCT00793598|471392802|FG002|Overall Study|Protocol Violation|0|||
130934572|NCT00793598|471392803|FG003|Overall Study|Protocol Violation|0|||
130934573|NCT00793598|471392804|FG004|Overall Study|Protocol Violation|0|||
130934574|NCT00793598|471392805|FG005|Overall Study|Protocol Violation|0|||
130934575|NCT00793598|471392806|FG006|Overall Study|Protocol Violation|0|||
130934576|NCT00793598|471392807|FG007|Overall Study|Protocol Violation|1|||
130934577|NCT00793598|471392800|FG000|Overall Study|Subject not dosed|0|||
130934578|NCT00793598|471392801|FG001|Overall Study|Subject not dosed|0|||
130934579|NCT00793598|471392802|FG002|Overall Study|Subject not dosed|0|||
130934580|NCT00793598|471392803|FG003|Overall Study|Subject not dosed|0|||
130934581|NCT00793598|471392804|FG004|Overall Study|Subject not dosed|0|||
130934582|NCT00793598|471392805|FG005|Overall Study|Subject not dosed|1|||
130934583|NCT00793598|471392806|FG006|Overall Study|Subject not dosed|0|||
130934584|NCT00793598|471392807|FG007|Overall Study|Subject not dosed|0|||
130934585|NCT02141282|471392818|FG000|Overall Study|Adverse event, not related to progression|8|||
130934586|NCT02141282|471392819|FG001|Overall Study|Adverse event, not related to progression|1|||
130934587|NCT02141282|471392820|FG002|Overall Study|Adverse event, not related to progression|3|||
130934588|NCT02141282|471392821|FG003|Overall Study|Adverse event, not related to progression|1|||
130934589|NCT02141282|471392818|FG000|Overall Study|Adverse event, related to progression|1|||
130934590|NCT02141282|471392819|FG001|Overall Study|Adverse event, related to progression|0|||
130934591|NCT02141282|471392820|FG002|Overall Study|Adverse event, related to progression|2|||
130934592|NCT02141282|471392821|FG003|Overall Study|Adverse event, related to progression|0|||
130934593|NCT02141282|471392818|FG000|Overall Study|COVID-19 infection|1|||
130934594|NCT02141282|471392819|FG001|Overall Study|COVID-19 infection|0|||
130934595|NCT02141282|471392820|FG002|Overall Study|COVID-19 infection|0|||
130934596|NCT02141282|471392821|FG003|Overall Study|COVID-19 infection|0|||
130934597|NCT02141282|471392818|FG000|Overall Study|Lost to Follow-up|0|||
130934598|NCT02141282|471392819|FG001|Overall Study|Lost to Follow-up|0|||
130934599|NCT02141282|471392820|FG002|Overall Study|Lost to Follow-up|4|||
130934600|NCT02141282|471392821|FG003|Overall Study|Lost to Follow-up|2|||
130934601|NCT02141282|471392818|FG000|Overall Study|Other, not specified|14|||
130934602|NCT02141282|471392819|FG001|Overall Study|Other, not specified|11|||
130934603|NCT02141282|471392820|FG002|Overall Study|Other, not specified|23|||
130934604|NCT02141282|471392821|FG003|Overall Study|Other, not specified|9|||
130934605|NCT02141282|471392818|FG000|Overall Study|Progressive disease, Richter's|4|||
130934606|NCT02141282|471392819|FG001|Overall Study|Progressive disease, Richter's|1|||
130934607|NCT02141282|471392820|FG002|Overall Study|Progressive disease, Richter's|1|||
130934608|NCT02141282|471392821|FG003|Overall Study|Progressive disease, Richter's|1|||
130934609|NCT02141282|471392818|FG000|Overall Study|Progressive disease per protocol|12|||
130934610|NCT02141282|471392819|FG001|Overall Study|Progressive disease per protocol|7|||
130934611|NCT02141282|471392820|FG002|Overall Study|Progressive disease per protocol|9|||
130934612|NCT02141282|471392821|FG003|Overall Study|Progressive disease per protocol|2|||
130934613|NCT02141282|471392818|FG000|Overall Study|Stem cell transplant|1|||
130934614|NCT02141282|471392819|FG001|Overall Study|Stem cell transplant|0|||
130934615|NCT02141282|471392820|FG002|Overall Study|Stem cell transplant|1|||
130934616|NCT02141282|471392821|FG003|Overall Study|Stem cell transplant|0|||
130934617|NCT02141282|471392818|FG000|Overall Study|Study terminated by Sponsor|0|||
130934618|NCT02141282|471392819|FG001|Overall Study|Study terminated by Sponsor|1|||
130934619|NCT02141282|471392820|FG002|Overall Study|Study terminated by Sponsor|0|||
130934620|NCT02141282|471392821|FG003|Overall Study|Study terminated by Sponsor|0|||
130934621|NCT02141282|471392818|FG000|Overall Study|Subject non-compliance|0|||
130934622|NCT02141282|471392819|FG001|Overall Study|Subject non-compliance|0|||
130934623|NCT02141282|471392820|FG002|Overall Study|Subject non-compliance|1|||
130934624|NCT02141282|471392821|FG003|Overall Study|Subject non-compliance|0|||
130934625|NCT02141282|471392818|FG000|Overall Study|Withdrew consent|2|||
130934626|NCT02141282|471392819|FG001|Overall Study|Withdrew consent|0|||
130934627|NCT02141282|471392820|FG002|Overall Study|Withdrew consent|4|||
130934628|NCT02141282|471392821|FG003|Overall Study|Withdrew consent|0|||
130934629|NCT01752907|471392824|FG000|Overall Study|Withdrawal by Subject|4|||
130934630|NCT01752907|471392825|FG001|Overall Study|Withdrawal by Subject|10|||
130934631|NCT01752907|471392824|FG000|Overall Study|Lost to Follow-up|2|||
130934632|NCT01752907|471392825|FG001|Overall Study|Lost to Follow-up|1|||
130934633|NCT01752907|471392824|FG000|Overall Study|Decision by Sponsor|6|||
130934634|NCT01752907|471392825|FG001|Overall Study|Decision by Sponsor|9|||
130934635|NCT02782780|471392830|FG000|Overall Study|dropped out after randomization.|7|||
130934636|NCT02782780|471392831|FG001|Overall Study|dropped out after randomization.|5|||
130934637|NCT02782780|471392830|FG000|Overall Study|Protocol Violation|0|||
130934638|NCT02782780|471392831|FG001|Overall Study|Protocol Violation|2|||
130934639|NCT03562481|471392832|FG000|First Intervention|Lost to Follow-up|1|||
130934640|NCT03562481|471392833|FG001|First Intervention|Lost to Follow-up|0|||
130934641|NCT02904512|471392834|FG000|Overall Study|Withdrawal by Subject|1|||
130934642|NCT02904512|471392835|FG001|Overall Study|Withdrawal by Subject|0|||
130934643|NCT02904512|471392834|FG000|Overall Study|Transferred to ICU|1|||
130934644|NCT02904512|471392835|FG001|Overall Study|Transferred to ICU|0|||
130934645|NCT02904512|471392834|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
130934646|NCT02904512|471392835|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
130934647|NCT00460408|471392836|FG000|Overall Study|Adverse Event|1|||
130934648|NCT00460408|471392837|FG001|Overall Study|Adverse Event|0|||
130934649|NCT00460408|471392838|FG002|Overall Study|Adverse Event|0|||
130934650|NCT00460408|471392839|FG003|Overall Study|Adverse Event|0|||
130934651|NCT00460408|471392836|FG000|Overall Study|Death|7|||
130934652|NCT00460408|471392837|FG001|Overall Study|Death|0|||
130934653|NCT00460408|471392838|FG002|Overall Study|Death|0|||
130934654|NCT00460408|471392839|FG003|Overall Study|Death|0|||
130934655|NCT00460408|471392836|FG000|Overall Study|Lost to Follow-up|11|||
130934656|NCT00460408|471392837|FG001|Overall Study|Lost to Follow-up|0|||
130934657|NCT00460408|471392838|FG002|Overall Study|Lost to Follow-up|1|||
130934658|NCT00460408|471392839|FG003|Overall Study|Lost to Follow-up|0|||
130934659|NCT00460408|471392836|FG000|Overall Study|Withdrawal by Subject|31|||
130934660|NCT00460408|471392837|FG001|Overall Study|Withdrawal by Subject|0|||
130934661|NCT00460408|471392838|FG002|Overall Study|Withdrawal by Subject|0|||
130934662|NCT00460408|471392839|FG003|Overall Study|Withdrawal by Subject|0|||
130934663|NCT00460408|471392836|FG000|Overall Study|Insufficient clinical response|5|||
130934664|NCT00460408|471392837|FG001|Overall Study|Insufficient clinical response|1|||
130934665|NCT00460408|471392838|FG002|Overall Study|Insufficient clinical response|5|||
130934666|NCT00460408|471392839|FG003|Overall Study|Insufficient clinical response|0|||
130934667|NCT00460408|471392836|FG000|Overall Study|Other|12|||
130934668|NCT00460408|471392837|FG001|Overall Study|Other|2|||
130934669|NCT00460408|471392838|FG002|Overall Study|Other|0|||
130934670|NCT00460408|471392839|FG003|Overall Study|Other|0|||
130934671|NCT03247530|471392845|FG000|Overall Study|Withdrawal by caregiver|19|||
130770953|NCT00382109|470787771|FG001|Overall Study|consent withdrawal|1|||
130770954|NCT01249833|470787772|FG000|Overall Study|Lost to Follow-up|0|||
130770955|NCT01249833|470787773|FG001|Overall Study|Lost to Follow-up|1|||
130770956|NCT03796676|470787774|FG000|Overall Study|Adverse Event|2|||
130934672|NCT03247530|471392846|FG001|Overall Study|Withdrawal by caregiver|8|||
130934673|NCT03247530|471392847|FG002|Overall Study|Withdrawal by caregiver|10|||
130934674|NCT03247530|471392845|FG000|Overall Study|Lost to Follow-up|3|||
130934675|NCT03247530|471392846|FG001|Overall Study|Lost to Follow-up|9|||
130934676|NCT03247530|471392847|FG002|Overall Study|Lost to Follow-up|6|||
130934677|NCT03247530|471392845|FG000|Overall Study|Adverse Event|2|||
130934678|NCT03247530|471392846|FG001|Overall Study|Adverse Event|5|||
130934679|NCT03247530|471392847|FG002|Overall Study|Adverse Event|2|||
130934680|NCT03247530|471392845|FG000|Overall Study|Failure to follow procedure|1|||
130934681|NCT03247530|471392846|FG001|Overall Study|Failure to follow procedure|1|||
130934682|NCT03247530|471392847|FG002|Overall Study|Failure to follow procedure|1|||
130934683|NCT03247530|471392845|FG000|Overall Study|Withdrawal by Subject|1|||
130934684|NCT03247530|471392846|FG001|Overall Study|Withdrawal by Subject|1|||
130934685|NCT03247530|471392847|FG002|Overall Study|Withdrawal by Subject|0|||
130934686|NCT03247530|471392845|FG000|Overall Study|Study medication misuse|0|||
130934687|NCT03247530|471392846|FG001|Overall Study|Study medication misuse|1|||
130934688|NCT03247530|471392847|FG002|Overall Study|Study medication misuse|0|||
130934689|NCT03247530|471392845|FG000|Overall Study|Other, multiple categories|1|||
130770957|NCT03796676|470787775|FG001|Overall Study|Adverse Event|1|||
130934690|NCT03247530|471392846|FG001|Overall Study|Other, multiple categories|3|||
130934691|NCT03247530|471392847|FG002|Overall Study|Other, multiple categories|1|||
130934692|NCT01442493|471392849|FG000|Overall Study|withdrawn from study|3|||
130934693|NCT01442493|471392850|FG001|Overall Study|withdrawn from study|2|||
130934694|NCT01986985|471392851|FG000|Overall Study|Withdrawal by Subject|4|||
130934695|NCT01986985|471392851|FG000|Overall Study|Scan not completed due to malfunction|3|||
130934696|NCT02288559|471392852|FG000|Overall Study|Adverse Event|1|||
130934697|NCT02288559|471392853|FG001|Overall Study|Adverse Event|1|||
130934698|NCT02288559|471392854|FG002|Overall Study|Adverse Event|5|||
130934699|NCT02288559|471392855|FG003|Overall Study|Adverse Event|0|||
130934700|NCT02288559|471392852|FG000|Overall Study|Death|0|||
130934701|NCT02288559|471392853|FG001|Overall Study|Death|0|||
130934702|NCT02288559|471392854|FG002|Overall Study|Death|1|||
130934703|NCT02288559|471392855|FG003|Overall Study|Death|0|||
130934704|NCT02288559|471392852|FG000|Overall Study|Lost to Follow-up|0|||
130934705|NCT02288559|471392853|FG001|Overall Study|Lost to Follow-up|0|||
130770958|NCT03796676|470787776|FG002|Overall Study|Adverse Event|2|||
130934706|NCT02288559|471392854|FG002|Overall Study|Lost to Follow-up|0|||
130934707|NCT02288559|471392855|FG003|Overall Study|Lost to Follow-up|1|||
130934708|NCT02288559|471392852|FG000|Overall Study|Withdrawal by Subject|0|||
130934709|NCT02288559|471392853|FG001|Overall Study|Withdrawal by Subject|0|||
131035134|NCT04065841|471761891|FG002|Overall Study|Protocol Violation|0|||
130770959|NCT03796676|470787774|FG000|Overall Study|Lost to Follow-up|2|||
130770960|NCT03796676|470787775|FG001|Overall Study|Lost to Follow-up|1|||
130770961|NCT03796676|470787776|FG002|Overall Study|Lost to Follow-up|0|||
130770962|NCT03796676|470787774|FG000|Overall Study|Protocol Violation|0|||
130770963|NCT03796676|470787775|FG001|Overall Study|Protocol Violation|0|||
130770964|NCT03796676|470787776|FG002|Overall Study|Protocol Violation|1|||
130770965|NCT03796676|470787774|FG000|Overall Study|Withdrawal by Subject|1|||
131035135|NCT04065841|471761892|FG003|Overall Study|Protocol Violation|0|||
131035136|NCT04065841|471761889|FG000|Overall Study|Study terminated by Sponsor|22|||
131035137|NCT04065841|471761890|FG001|Overall Study|Study terminated by Sponsor|16|||
130770966|NCT03796676|470787775|FG001|Overall Study|Withdrawal by Subject|1|||
130770967|NCT03796676|470787776|FG002|Overall Study|Withdrawal by Subject|0|||
130770968|NCT03796676|470787774|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
130770969|NCT03796676|470787775|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
130770970|NCT03796676|470787776|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
130770971|NCT01900899|470787780|FG000|Overall Study|Withdrawal by Subject|7|||
130770972|NCT01900899|470787781|FG001|Overall Study|Withdrawal by Subject|1|||
130770973|NCT01900899|470787780|FG000|Overall Study|Migrated from study area|2|||
130934710|NCT02288559|471392854|FG002|Overall Study|Withdrawal by Subject|2|||
130934711|NCT02288559|471392855|FG003|Overall Study|Withdrawal by Subject|1|||
130934712|NCT02288559|471392852|FG000|Overall Study|Reason Not Specified|0|||
130934713|NCT02288559|471392853|FG001|Overall Study|Reason Not Specified|0|||
130934714|NCT02288559|471392854|FG002|Overall Study|Reason Not Specified|3|||
130934715|NCT02288559|471392855|FG003|Overall Study|Reason Not Specified|0|||
130934716|NCT03303079|471392856|FG000|Overall Study|Adverse Event|0|||
130934717|NCT03303079|471392857|FG001|Overall Study|Adverse Event|1|||
130934718|NCT03303079|471392858|FG002|Overall Study|Adverse Event|3|||
130934719|NCT03303079|471392856|FG000|Overall Study|Protocol Violation|5|||
130934720|NCT03303079|471392857|FG001|Overall Study|Protocol Violation|4|||
130934721|NCT03303079|471392858|FG002|Overall Study|Protocol Violation|7|||
130934722|NCT03303079|471392856|FG000|Overall Study|Withdrawal by Subject|2|||
130934723|NCT03303079|471392857|FG001|Overall Study|Withdrawal by Subject|4|||
130934724|NCT03303079|471392858|FG002|Overall Study|Withdrawal by Subject|2|||
130934725|NCT03303079|471392856|FG000|Overall Study|Other than specified|0|||
130934726|NCT03303079|471392857|FG001|Overall Study|Other than specified|2|||
130934727|NCT03303079|471392858|FG002|Overall Study|Other than specified|0|||
130934728|NCT02005445|471392859|FG000|Overall Study|Dual study enrollment|0|||
130934729|NCT02005445|471392860|FG001|Overall Study|Dual study enrollment|1|||
130934730|NCT00759954|471392861|FG000|Overall Study|Personal reason|1|||
130934731|NCT00759954|471392862|FG001|Overall Study|Personal reason|0|||
130934732|NCT00759954|471392861|FG000|Overall Study|Adverse Event|1|||
130934733|NCT00759954|471392862|FG001|Overall Study|Adverse Event|2|||
130934734|NCT03315208|471392864|FG000|Overall Study|Lost to Follow-up|11|||
130934735|NCT03315208|471392865|FG001|Overall Study|Lost to Follow-up|6|||
130934736|NCT03315208|471392864|FG000|Overall Study|Withdrawal by Subject|2|||
130770974|NCT01900899|470787781|FG001|Overall Study|Migrated from study area|0|||
130770975|NCT00248833|470787782|FG000|Overall Study|Adverse Event|2|||
130770976|NCT00248833|470787783|FG001|Overall Study|Adverse Event|0|||
130770977|NCT00248833|470787784|FG002|Overall Study|Adverse Event|0|||
130934737|NCT03315208|471392865|FG001|Overall Study|Withdrawal by Subject|0|||
130934738|NCT02875860|471392866|FG000|Overall Study|Withdrawal by Subject|0|||
130934739|NCT02875860|471392867|FG001|Overall Study|Withdrawal by Subject|1|||
130934740|NCT02320149|471392868|FG000|Overall Study|Adverse Event|3|||
130934741|NCT02320149|471392869|FG001|Overall Study|Adverse Event|7|||
130934742|NCT02320149|471392868|FG000|Overall Study|Withdrawal of Consent|28|||
130934743|NCT02320149|471392869|FG001|Overall Study|Withdrawal of Consent|32|||
130934744|NCT02320149|471392868|FG000|Overall Study|Lost to Follow-up|21|||
130934745|NCT02320149|471392869|FG001|Overall Study|Lost to Follow-up|34|||
130934746|NCT02320149|471392868|FG000|Overall Study|Protocol Violation|2|||
130934747|NCT02320149|471392869|FG001|Overall Study|Protocol Violation|1|||
130934748|NCT02320149|471392868|FG000|Overall Study|Noncompliance with Study Treatment|7|||
130934749|NCT02320149|471392869|FG001|Overall Study|Noncompliance with Study Treatment|2|||
130934750|NCT02320149|471392868|FG000|Overall Study|Lack of Efficacy|0|||
130934751|NCT02320149|471392869|FG001|Overall Study|Lack of Efficacy|1|||
130934752|NCT02320149|471392868|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130934753|NCT02320149|471392869|FG001|Overall Study|Other Miscellaneous Reasons|3|||
130934754|NCT01156311|471392873|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
130934755|NCT01156311|471392874|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
131035138|NCT04065841|471761891|FG002|Overall Study|Study terminated by Sponsor|28|||
131035139|NCT04065841|471761892|FG003|Overall Study|Study terminated by Sponsor|17|||
130770978|NCT00248833|470787782|FG000|Overall Study|Withdrawal by Subject|0|||
130770979|NCT00248833|470787783|FG001|Overall Study|Withdrawal by Subject|1|||
130770980|NCT00248833|470787784|FG002|Overall Study|Withdrawal by Subject|1|||
130934756|NCT01156311|471392875|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
130934757|NCT01156311|471392876|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
130934758|NCT01156311|471392873|FG000|2-Month Monotherapy Period|Physician Decision|0|||
130770981|NCT00248833|470787782|FG000|Overall Study|Lost to Follow-up|1|||
130770982|NCT00248833|470787783|FG001|Overall Study|Lost to Follow-up|1|||
130770983|NCT00248833|470787784|FG002|Overall Study|Lost to Follow-up|1|||
130770984|NCT00248833|470787782|FG000|Overall Study|Other|0|||
130770985|NCT00248833|470787783|FG001|Overall Study|Other|1|||
130770986|NCT00248833|470787784|FG002|Overall Study|Other|0|||
130770987|NCT00723697|470787787|FG000|Overall Study|Physician questionnaires not received|2|||
130770988|NCT00723697|470787787|FG000|Overall Study|Missing Informed Consent Form|10|||
130770989|NCT00723697|470787787|FG000|Overall Study|Other exclusion criteria applied|6|||
130770990|NCT00448812|470787790|FG000|Year 2|Missed visit but remained in study|4|||
130770991|NCT00448812|470787791|FG001|Year 2|Missed visit but remained in study|1|||
130770992|NCT00448812|470787790|FG000|Year 3|Withdrawal by Subject|1|||
130770993|NCT00448812|470787791|FG001|Year 3|Withdrawal by Subject|3|||
130770994|NCT00448812|470787790|FG000|Year 3|Lost to Follow-up|1|||
130770995|NCT00448812|470787791|FG001|Year 3|Lost to Follow-up|0|||
130770996|NCT00448812|470787790|FG000|Year 3|Missed visit but remained in study|2|||
130770997|NCT00448812|470787791|FG001|Year 3|Missed visit but remained in study|0|||
130770998|NCT00448812|470787790|FG000|Year 5|Missed visit but remained in study|1|||
130770999|NCT00448812|470787791|FG001|Year 5|Missed visit but remained in study|0|||
130771000|NCT03885999|470787792|FG000|Overall Study|Adverse Event|1|||
130771001|NCT02452554|470787793|FG000|Overall Study|Death|2|||
130771002|NCT02452554|470787794|FG001|Overall Study|Death|1|||
130771003|NCT02452554|470787795|FG002|Overall Study|Death|0|||
130771004|NCT02452554|470787796|FG003|Overall Study|Death|0|||
130771005|NCT02452554|470787797|FG004|Overall Study|Death|0|||
130771006|NCT02452554|470787798|FG005|Overall Study|Death|0|||
130771007|NCT02452554|470787793|FG000|Overall Study|Lack of Efficacy|13|||
130771008|NCT02452554|470787794|FG001|Overall Study|Lack of Efficacy|14|||
130771009|NCT02452554|470787795|FG002|Overall Study|Lack of Efficacy|9|||
130934759|NCT01156311|471392874|FG001|2-Month Monotherapy Period|Physician Decision|1|||
130934760|NCT01156311|471392875|FG002|2-Month Monotherapy Period|Physician Decision|0|||
130934761|NCT01156311|471392876|FG003|2-Month Monotherapy Period|Physician Decision|0|||
130934762|NCT01156311|471392873|FG000|2-Month Monotherapy Period|Other|1|||
130934763|NCT01156311|471392874|FG001|2-Month Monotherapy Period|Other|0|||
130934764|NCT01156311|471392875|FG002|2-Month Monotherapy Period|Other|0|||
130934765|NCT01156311|471392876|FG003|2-Month Monotherapy Period|Other|0|||
130934766|NCT01156311|471392873|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
130934767|NCT01156311|471392874|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
130934768|NCT01156311|471392875|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
130934769|NCT01156311|471392876|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
130934770|NCT01156311|471392873|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
130934771|NCT01156311|471392874|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
130934772|NCT01156311|471392875|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
130934773|NCT01156311|471392876|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
130934774|NCT01156311|471392873|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
130934775|NCT01156311|471392874|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
130934776|NCT01156311|471392875|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
130934777|NCT01156311|471392876|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
130934778|NCT01156311|471392873|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
130934779|NCT01156311|471392874|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
130934780|NCT01156311|471392875|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
130934781|NCT01156311|471392876|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
130934782|NCT01156311|471392873|FG000|6-month Add-on Therapy Period|Other|0|||
130934783|NCT01156311|471392874|FG001|6-month Add-on Therapy Period|Other|0|||
130934784|NCT01156311|471392875|FG002|6-month Add-on Therapy Period|Other|1|||
130934785|NCT01156311|471392876|FG003|6-month Add-on Therapy Period|Other|2|||
130934786|NCT01359449|471392877|FG000|Overall Study|Lost to Follow-up|1|||
130934787|NCT01359449|471392878|FG001|Overall Study|Lost to Follow-up|0|||
130934788|NCT01359449|471392877|FG000|Overall Study|Protocol Violation|0|||
130934789|NCT01359449|471392878|FG001|Overall Study|Protocol Violation|2|||
130934790|NCT01359449|471392877|FG000|Overall Study|Withdrawal by Subject|3|||
131223770|NCT04380701|472447123|FG014|Overall Study|Lost to Follow-up|0|||
130771010|NCT02452554|470787796|FG003|Overall Study|Lack of Efficacy|1|||
130771011|NCT02452554|470787797|FG004|Overall Study|Lack of Efficacy|5|||
130771012|NCT02452554|470787798|FG005|Overall Study|Lack of Efficacy|8|||
130771013|NCT02452554|470787793|FG000|Overall Study|Physician Decision|0|||
130771014|NCT02452554|470787794|FG001|Overall Study|Physician Decision|1|||
130771015|NCT02452554|470787795|FG002|Overall Study|Physician Decision|0|||
130771016|NCT02452554|470787796|FG003|Overall Study|Physician Decision|0|||
130771017|NCT02452554|470787797|FG004|Overall Study|Physician Decision|0|||
130771018|NCT02452554|470787798|FG005|Overall Study|Physician Decision|0|||
130771019|NCT02452554|470787793|FG000|Overall Study|Withdrawal by Subject|1|||
130771020|NCT02452554|470787794|FG001|Overall Study|Withdrawal by Subject|0|||
130934791|NCT01359449|471392878|FG001|Overall Study|Withdrawal by Subject|2|||
130934792|NCT01830972|471392879|FG000|Part II|Withdrawal by Subject|2|||
130934793|NCT01830972|471392880|FG001|Part II|Withdrawal by Subject|2|||
131223771|NCT04380701|472447124|FG015|Overall Study|Lost to Follow-up|0|||
130771021|NCT02452554|470787795|FG002|Overall Study|Withdrawal by Subject|2|||
130771022|NCT02452554|470787796|FG003|Overall Study|Withdrawal by Subject|0|||
130771023|NCT02452554|470787797|FG004|Overall Study|Withdrawal by Subject|0|||
130771024|NCT02452554|470787798|FG005|Overall Study|Withdrawal by Subject|1|||
130771025|NCT02452554|470787793|FG000|Overall Study|Ineligible|0|||
130771026|NCT02452554|470787794|FG001|Overall Study|Ineligible|1|||
130771027|NCT02452554|470787795|FG002|Overall Study|Ineligible|0|||
130771028|NCT02452554|470787796|FG003|Overall Study|Ineligible|0|||
130771029|NCT02452554|470787797|FG004|Overall Study|Ineligible|0|||
130771030|NCT02452554|470787798|FG005|Overall Study|Ineligible|0|||
130771031|NCT02452554|470787793|FG000|Overall Study|Never Received Treatment|1|||
130771032|NCT02452554|470787794|FG001|Overall Study|Never Received Treatment|0|||
130771033|NCT02452554|470787795|FG002|Overall Study|Never Received Treatment|0|||
130771034|NCT02452554|470787796|FG003|Overall Study|Never Received Treatment|0|||
130771035|NCT02452554|470787797|FG004|Overall Study|Never Received Treatment|0|||
130771036|NCT02452554|470787798|FG005|Overall Study|Never Received Treatment|0|||
130771037|NCT00467558|470787799|FG000|Overall Study|Lost to Follow-up|2|||
130771038|NCT00467558|470787800|FG001|Overall Study|Lost to Follow-up|0|||
130771039|NCT02636439|470787801|FG000|Overall Study|Adverse Event|2|||
130771040|NCT02636439|470787802|FG001|Overall Study|Adverse Event|2|||
130771041|NCT02636439|470787801|FG000|Overall Study|Lost to Follow-up|1|||
130771042|NCT02636439|470787802|FG001|Overall Study|Lost to Follow-up|0|||
130771043|NCT02636439|470787801|FG000|Overall Study|Non-compliance|1|||
130771044|NCT02636439|470787802|FG001|Overall Study|Non-compliance|1|||
130771045|NCT02636439|470787801|FG000|Overall Study|Personal reasons|2|||
130771046|NCT02636439|470787802|FG001|Overall Study|Personal reasons|0|||
130771047|NCT05188729|470787804|FG000|Overall Study|Withdrawal by Subject|0|||
130771048|NCT05188729|470787805|FG001|Overall Study|Withdrawal by Subject|0|||
130771049|NCT05188729|470787806|FG002|Overall Study|Withdrawal by Subject|0|||
130771050|NCT05188729|470787807|FG003|Overall Study|Withdrawal by Subject|0|||
130771051|NCT05188729|470787808|FG004|Overall Study|Withdrawal by Subject|0|||
130771052|NCT05188729|470787809|FG005|Overall Study|Withdrawal by Subject|0|||
130771053|NCT05188729|470787810|FG006|Overall Study|Withdrawal by Subject|0|||
130771054|NCT05188729|470787811|FG007|Overall Study|Withdrawal by Subject|0|||
130771055|NCT05188729|470787812|FG008|Overall Study|Withdrawal by Subject|0|||
130771056|NCT05188729|470787813|FG009|Overall Study|Withdrawal by Subject|1|||
130771057|NCT05188729|470787814|FG010|Overall Study|Withdrawal by Subject|0|||
130771058|NCT05188729|470787815|FG011|Overall Study|Withdrawal by Subject|0|||
130771059|NCT05188729|470787816|FG012|Overall Study|Withdrawal by Subject|0|||
130771060|NCT05188729|470787804|FG000|Overall Study|Lost to Follow-up|0|||
130771061|NCT05188729|470787805|FG001|Overall Study|Lost to Follow-up|0|||
130771062|NCT05188729|470787806|FG002|Overall Study|Lost to Follow-up|0|||
130771063|NCT05188729|470787807|FG003|Overall Study|Lost to Follow-up|0|||
130771064|NCT05188729|470787808|FG004|Overall Study|Lost to Follow-up|0|||
130771065|NCT05188729|470787809|FG005|Overall Study|Lost to Follow-up|0|||
130771066|NCT05188729|470787810|FG006|Overall Study|Lost to Follow-up|0|||
130771067|NCT05188729|470787811|FG007|Overall Study|Lost to Follow-up|0|||
130771068|NCT05188729|470787812|FG008|Overall Study|Lost to Follow-up|0|||
130771069|NCT05188729|470787813|FG009|Overall Study|Lost to Follow-up|0|||
130771070|NCT05188729|470787814|FG010|Overall Study|Lost to Follow-up|1|||
130771071|NCT05188729|470787815|FG011|Overall Study|Lost to Follow-up|1|||
130771072|NCT05188729|470787816|FG012|Overall Study|Lost to Follow-up|0|||
130771073|NCT03084302|470789813|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
130771074|NCT03084302|470789813|FG000|Overall Study|No valid objective monitor data|6|||
130771075|NCT00929994|470789814|FG000|Overall Study|Withdrawal by Subject|1|||
130771076|NCT00929994|470789814|FG000|Overall Study|medical issue unrelated to intervention|4|||
130771077|NCT00929994|470789814|FG000|Overall Study|employment|1|||
130771078|NCT01214668|470789815|FG000|Overall Study|Adverse Event|0|||
130771079|NCT01214668|470789816|FG001|Overall Study|Adverse Event|1|||
130771080|NCT01214668|470789817|FG002|Overall Study|Adverse Event|0|||
130771081|NCT01214668|470789818|FG003|Overall Study|Adverse Event|2|||
130771082|NCT01214668|470789819|FG004|Overall Study|Adverse Event|1|||
130771083|NCT01214668|470789820|FG005|Overall Study|Adverse Event|1|||
131223772|NCT04380701|472447125|FG016|Overall Study|Lost to Follow-up|0|||
130771084|NCT01214668|470789815|FG000|Overall Study|Death|0|||
130771085|NCT01214668|470789816|FG001|Overall Study|Death|0|||
130771086|NCT01214668|470789817|FG002|Overall Study|Death|1|||
130771087|NCT01214668|470789818|FG003|Overall Study|Death|0|||
130771088|NCT01214668|470789819|FG004|Overall Study|Death|0|||
130771089|NCT01214668|470789820|FG005|Overall Study|Death|0|||
130771090|NCT01214668|470789815|FG000|Overall Study|Progressive Disease|4|||
130771091|NCT01214668|470789816|FG001|Overall Study|Progressive Disease|2|||
130771092|NCT01214668|470789817|FG002|Overall Study|Progressive Disease|5|||
130771093|NCT01214668|470789818|FG003|Overall Study|Progressive Disease|4|||
130771094|NCT01214668|470789819|FG004|Overall Study|Progressive Disease|4|||
130771095|NCT01214668|470789820|FG005|Overall Study|Progressive Disease|5|||
130771096|NCT01214668|470789815|FG000|Overall Study|Withdrawal by Subject|0|||
130771097|NCT01214668|470789816|FG001|Overall Study|Withdrawal by Subject|0|||
130771098|NCT01214668|470789817|FG002|Overall Study|Withdrawal by Subject|0|||
130934794|NCT01830972|471392879|FG000|Part III|Withdrawal by Subject|1|||
130934795|NCT01830972|471392880|FG001|Part III|Withdrawal by Subject|0|||
130934796|NCT01830972|471392879|FG000|Part III|Noncompliance|1|||
130934797|NCT01830972|471392880|FG001|Part III|Noncompliance|0|||
130934798|NCT01830972|471392879|FG000|Part IV|Withdrawal by Subject|2|||
130934799|NCT01830972|471392880|FG001|Part IV|Withdrawal by Subject|1|||
130934800|NCT01830972|471392879|FG000|Part IV|Non-Compliance|1|||
130934801|NCT01830972|471392880|FG001|Part IV|Non-Compliance|0|||
130934802|NCT01426373|471392884|FG000|Overall Study|Adverse Event|6|||
130934803|NCT01426373|471392884|FG000|Overall Study|Lost to Follow-up|14|||
130934804|NCT01426373|471392884|FG000|Overall Study|Participant Convenience|10|||
130934805|NCT01426373|471392884|FG000|Overall Study|Miscellaneous Reasons|4|||
130934806|NCT00726661|471392885|FG000|Overall Study|Lost to Follow-up|36|||
130934807|NCT00726661|471392886|FG001|Overall Study|Lost to Follow-up|11|||
130934808|NCT00726661|471392885|FG000|Overall Study|Withdrawal by Subject|17|||
130934809|NCT00726661|471392886|FG001|Overall Study|Withdrawal by Subject|13|||
130934810|NCT00726661|471392885|FG000|Overall Study|Trial terminated by sponsor|214|||
130934811|NCT00726661|471392886|FG001|Overall Study|Trial terminated by sponsor|187|||
130934812|NCT00726661|471392885|FG000|Overall Study|Death|475|||
130934813|NCT00726661|471392886|FG001|Overall Study|Death|159|||
130934814|NCT00726661|471392885|FG000|Overall Study|Physician Decision|25|||
130934815|NCT00726661|471392886|FG001|Overall Study|Physician Decision|13|||
130934816|NCT00726661|471392885|FG000|Overall Study|Other|47|||
130934817|NCT00726661|471392886|FG001|Overall Study|Other|35|||
130934818|NCT01285310|471392887|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
130934819|NCT01285310|471392888|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
130934820|NCT01285310|471392889|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
130934821|NCT01285310|471392890|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
130934822|NCT01285310|471392891|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
130934823|NCT01285310|471392887|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
130934824|NCT01285310|471392888|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
130934825|NCT01285310|471392889|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
130934826|NCT01285310|471392890|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
130934827|NCT01285310|471392891|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
130934828|NCT01285310|471392887|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
130934829|NCT01285310|471392888|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
130934830|NCT01285310|471392889|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
130934831|NCT01285310|471392890|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
130934832|NCT01285310|471392891|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
130934833|NCT01285310|471392887|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
130934834|NCT01285310|471392888|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
130934835|NCT01285310|471392889|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
130934836|NCT01285310|471392890|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
130934837|NCT01285310|471392891|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
130934838|NCT01285310|471392887|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
130934839|NCT01285310|471392888|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
130934840|NCT01285310|471392889|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
130934841|NCT01285310|471392890|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
130934842|NCT01285310|471392891|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
130934843|NCT01285310|471392887|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
130934844|NCT01285310|471392888|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
130934845|NCT01285310|471392889|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
130934846|NCT01285310|471392890|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
131120512|NCT01994382|472072353|FG012|Overall Study|Other than specified|2|||
131120513|NCT01994382|472072354|FG013|Overall Study|Other than specified|0|||
131120514|NCT01994382|472072355|FG014|Overall Study|Other than specified|0|||
131120515|NCT01994382|472072356|FG015|Overall Study|Other than specified|4|||
131120516|NCT01994382|472072357|FG016|Overall Study|Other than specified|4|||
131120517|NCT01994382|472072341|FG000|Overall Study|Withdrawal by Subject|0|||
131120518|NCT01994382|472072342|FG001|Overall Study|Withdrawal by Subject|0|||
131120519|NCT01994382|472072343|FG002|Overall Study|Withdrawal by Subject|0|||
131120520|NCT01994382|472072344|FG003|Overall Study|Withdrawal by Subject|0|||
131120521|NCT01994382|472072345|FG004|Overall Study|Withdrawal by Subject|0|||
131120522|NCT01994382|472072346|FG005|Overall Study|Withdrawal by Subject|0|||
131120523|NCT01994382|472072347|FG006|Overall Study|Withdrawal by Subject|0|||
130934847|NCT01285310|471392891|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
130934848|NCT01285310|471392887|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
130934849|NCT01285310|471392888|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
130934850|NCT01285310|471392889|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
130934851|NCT01285310|471392890|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
130934852|NCT01285310|471392891|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
130771099|NCT01214668|470789818|FG003|Overall Study|Withdrawal by Subject|0|||
130704369|NCT03430011|470541261|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
130704370|NCT03430011|470541262|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
130704371|NCT03430011|470541263|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
130704372|NCT03430011|470541264|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
130704373|NCT03430011|470541265|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
130934853|NCT01285310|471392887|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
130934854|NCT01285310|471392888|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
130934855|NCT01285310|471392889|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
130934856|NCT01285310|471392890|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
130934857|NCT01285310|471392891|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
130934858|NCT01285310|471392887|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
130934859|NCT01285310|471392888|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
130934860|NCT01285310|471392889|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
130934861|NCT01285310|471392890|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
130934862|NCT01285310|471392891|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
130934863|NCT01285310|471392887|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
130934864|NCT01285310|471392888|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
130934865|NCT01285310|471392889|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
130934866|NCT01285310|471392890|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
130934867|NCT01285310|471392891|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
130934868|NCT01285310|471392887|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
130934869|NCT01285310|471392888|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
130934870|NCT01285310|471392889|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
130934871|NCT01285310|471392890|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
130934872|NCT01285310|471392891|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
130934873|NCT01285310|471392887|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
130934874|NCT01285310|471392888|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
130934875|NCT01285310|471392889|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
130934876|NCT01285310|471392890|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
130934877|NCT01285310|471392891|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
130934878|NCT01574326|471392892|FG000|Overall Study|Randomized but not treated|0|||
130934879|NCT01574326|471392893|FG001|Overall Study|Randomized but not treated|1|||
130934880|NCT01574326|471392892|FG000|Overall Study|Withdrawal by Participant|2|||
130934881|NCT01574326|471392893|FG001|Overall Study|Withdrawal by Participant|4|||
130934882|NCT01574326|471392892|FG000|Overall Study|Physician Decision|5|||
130934883|NCT01574326|471392893|FG001|Overall Study|Physician Decision|3|||
130934884|NCT01574326|471392892|FG000|Overall Study|Adverse Event|1|||
130934885|NCT01574326|471392893|FG001|Overall Study|Adverse Event|3|||
130934886|NCT01574326|471392892|FG000|Overall Study|Other: Mainly kidney transplant|8|||
130934887|NCT01574326|471392893|FG001|Overall Study|Other: Mainly kidney transplant|8|||
130934888|NCT04997161|471392916|FG000|Overall Study|Study terminated by sponsor|3|||
130934889|NCT00005937|471392917|FG000|Overall Study|Lack of Efficacy|5|||
130934890|NCT01574612|471392918|FG000|Overall Study|Adverse Event|3|||
130934891|NCT01574612|471392918|FG000|Overall Study|non compliant with drug|2|||
130934892|NCT01574612|471392918|FG000|Overall Study|Withdrawal by Subject|1|||
130934893|NCT01574612|471392918|FG000|Overall Study|Lost to Follow-up|2|||
130934894|NCT03049280|471392922|FG000|Overall Study|Physician Decision|1|||
130934895|NCT03681405|471392924|FG000|Overall Study|Found to be ineligible after randomized|1|||
130934896|NCT03681405|471392925|FG001|Overall Study|Found to be ineligible after randomized|0|||
130934897|NCT03978520|471392926|FG000|Overall Study|Adverse Event|2|||
130934898|NCT03978520|471392927|FG001|Overall Study|Adverse Event|5|||
130934899|NCT03978520|471392928|FG002|Overall Study|Adverse Event|3|||
130934900|NCT03978520|471392929|FG003|Overall Study|Adverse Event|5|||
130934901|NCT03978520|471392930|FG004|Overall Study|Adverse Event|6|||
130934902|NCT03978520|471392926|FG000|Overall Study|Withdrawal by Subject|10|||
130934903|NCT03978520|471392927|FG001|Overall Study|Withdrawal by Subject|4|||
130934904|NCT03978520|471392928|FG002|Overall Study|Withdrawal by Subject|5|||
130934905|NCT03978520|471392929|FG003|Overall Study|Withdrawal by Subject|6|||
130934906|NCT03978520|471392930|FG004|Overall Study|Withdrawal by Subject|5|||
130934907|NCT03978520|471392926|FG000|Overall Study|Lost to Follow-up|2|||
130934908|NCT03978520|471392927|FG001|Overall Study|Lost to Follow-up|2|||
130934909|NCT03978520|471392928|FG002|Overall Study|Lost to Follow-up|2|||
130704374|NCT03430011|470541266|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
130934910|NCT03978520|471392929|FG003|Overall Study|Lost to Follow-up|0|||
130934911|NCT03978520|471392930|FG004|Overall Study|Lost to Follow-up|1|||
130934912|NCT03978520|471392926|FG000|Overall Study|COVID-19 infection|0|||
130934913|NCT03978520|471392927|FG001|Overall Study|COVID-19 infection|1|||
130934914|NCT03978520|471392928|FG002|Overall Study|COVID-19 infection|0|||
130934915|NCT03978520|471392929|FG003|Overall Study|COVID-19 infection|0|||
130934916|NCT03978520|471392930|FG004|Overall Study|COVID-19 infection|0|||
130934917|NCT03978520|471392926|FG000|Overall Study|Other, not specified|9|||
131120524|NCT01994382|472072348|FG007|Overall Study|Withdrawal by Subject|0|||
130934918|NCT03978520|471392927|FG001|Overall Study|Other, not specified|4|||
130934919|NCT03978520|471392928|FG002|Overall Study|Other, not specified|1|||
130934920|NCT03978520|471392929|FG003|Overall Study|Other, not specified|1|||
130934921|NCT03978520|471392930|FG004|Overall Study|Other, not specified|2|||
130934922|NCT03978520|471392926|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
130934923|NCT03978520|471392927|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
130934924|NCT03978520|471392928|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
130934925|NCT03978520|471392929|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
130934926|NCT03978520|471392930|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
130934927|NCT00230607|471392931|FG000|Overall Study|Other|3|||
130934928|NCT02860169|471392932|FG000|Part A|Withdrawal by Subject|1|||
130934929|NCT02860169|471392932|FG000|Part A|Other (Screening failure)|6|||
130934930|NCT02860169|471392932|FG000|Part A|Other (Survey not completed)|3|||
130934931|NCT02860169|471392932|FG000|Part A|Other (did not completed consent)|1|||
130934932|NCT02860169|471392932|FG000|Part B|Other (Screening failure)|10|||
130934933|NCT02860169|471392932|FG000|Part B|Withdrawal by Subject|1|||
130934934|NCT02860169|471392932|FG000|Part C|Other (Screening failure)|1|||
130934935|NCT00071513|471392935|FG000|Intervention Component|Withdrawal by Subject|2|||
130934936|NCT00071513|471392936|FG001|Intervention Component|Withdrawal by Subject|3|||
130934937|NCT00071513|471392935|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
130934938|NCT00071513|471392936|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
130934939|NCT01244425|471392938|FG000|Overall Study|Withdrawal by Subject|2|||
130934940|NCT01244425|471392939|FG001|Overall Study|Withdrawal by Subject|2|||
130934941|NCT01244425|471392938|FG000|Overall Study|Adverse Event|1|||
130934942|NCT01244425|471392939|FG001|Overall Study|Adverse Event|1|||
130934943|NCT01059799|471392940|FG000|Overall Study|Adverse Event|2|||
130934944|NCT01059799|471392941|FG001|Overall Study|Adverse Event|3|||
130934945|NCT01059799|471392940|FG000|Overall Study|Lack of Efficacy|1|||
130934946|NCT01059799|471392941|FG001|Overall Study|Lack of Efficacy|0|||
130934947|NCT01059799|471392940|FG000|Overall Study|Protocol Violation|3|||
130934948|NCT01059799|471392941|FG001|Overall Study|Protocol Violation|2|||
130934949|NCT01059799|471392940|FG000|Overall Study|Withdrawal criteria|13|||
130934950|NCT01059799|471392941|FG001|Overall Study|Withdrawal criteria|2|||
130934951|NCT01059799|471392940|FG000|Overall Study|Other|12|||
130934952|NCT01059799|471392941|FG001|Overall Study|Other|3|||
130934953|NCT03700671|471392942|FG000|Overall Study|Lack of Efficacy|1|||
130934954|NCT03700671|471392943|FG001|Overall Study|Lack of Efficacy|2|||
130934955|NCT01317160|471392944|FG000|Overall Study|Incorrect inclusion|1|||
130934956|NCT01317160|471392945|FG001|Overall Study|Incorrect inclusion|1|||
130934957|NCT01317160|471392944|FG000|Overall Study|Lost to Follow-up|3|||
130934958|NCT01317160|471392945|FG001|Overall Study|Lost to Follow-up|3|||
130934959|NCT01317160|471392944|FG000|Overall Study|Withdrawal by Subject|0|||
130934960|NCT01317160|471392945|FG001|Overall Study|Withdrawal by Subject|2|||
130934961|NCT00531232|471394616|FG000|Overall Study|Investigator decision|0|||
130934962|NCT00531232|471394617|FG001|Overall Study|Investigator decision|0|||
130934963|NCT00531232|471394618|FG002|Overall Study|Investigator decision|4|||
130934964|NCT00531232|471394616|FG000|Overall Study|Participants refused further treatment|0|||
130934965|NCT00531232|471394617|FG001|Overall Study|Participants refused further treatment|1|||
130934966|NCT00531232|471394618|FG002|Overall Study|Participants refused further treatment|2|||
130934967|NCT00531232|471394616|FG000|Overall Study|Adverse events (AEs)|1|||
130934968|NCT00531232|471394617|FG001|Overall Study|Adverse events (AEs)|2|||
130934969|NCT00531232|471394618|FG002|Overall Study|Adverse events (AEs)|2|||
130934970|NCT00531232|471394616|FG000|Overall Study|Treatment failure|1|||
130934971|NCT00531232|471394617|FG001|Overall Study|Treatment failure|3|||
130934972|NCT00531232|471394618|FG002|Overall Study|Treatment failure|7|||
130934973|NCT00531232|471394616|FG000|Overall Study|Disease recurrence|0|||
130934974|NCT00531232|471394617|FG001|Overall Study|Disease recurrence|0|||
130934975|NCT00531232|471394618|FG002|Overall Study|Disease recurrence|1|||
130934976|NCT00531232|471394616|FG000|Overall Study|Deceased|2|||
130934977|NCT00531232|471394617|FG001|Overall Study|Deceased|2|||
130934978|NCT00531232|471394618|FG002|Overall Study|Deceased|2|||
130934979|NCT00531232|471394616|FG000|Overall Study|Withdrawal by Subject|0|||
130771100|NCT01214668|470789819|FG004|Overall Study|Withdrawal by Subject|1|||
130934980|NCT00531232|471394617|FG001|Overall Study|Withdrawal by Subject|1|||
131120525|NCT01994382|472072349|FG008|Overall Study|Withdrawal by Subject|0|||
130934981|NCT00531232|471394618|FG002|Overall Study|Withdrawal by Subject|2|||
130934982|NCT00531232|471394616|FG000|Overall Study|Other|0|||
130934983|NCT00531232|471394617|FG001|Overall Study|Other|0|||
130934984|NCT00531232|471394618|FG002|Overall Study|Other|5|||
131120526|NCT01994382|472072350|FG009|Overall Study|Withdrawal by Subject|0|||
130934985|NCT02345850|471394624|FG000|Overall Study|Not transplanted|10|||
130934986|NCT02345850|471394625|FG001|Overall Study|Not transplanted|5|||
130934987|NCT02345850|471394626|FG002|Overall Study|Not transplanted|4|||
131120527|NCT01994382|472072351|FG010|Overall Study|Withdrawal by Subject|6|||
130934988|NCT02345850|471394624|FG000|Overall Study|Lost to Follow-up|2|||
130934989|NCT02345850|471394625|FG001|Overall Study|Lost to Follow-up|3|||
130934990|NCT02345850|471394626|FG002|Overall Study|Lost to Follow-up|2|||
130934991|NCT02345850|471394624|FG000|Overall Study|Withdrawal by Subject|1|||
130934992|NCT02345850|471394625|FG001|Overall Study|Withdrawal by Subject|0|||
130934993|NCT02345850|471394626|FG002|Overall Study|Withdrawal by Subject|0|||
130934994|NCT01991067|471394635|FG000|Overall Study|Lost to Follow-up|6|||
130934995|NCT01991067|471394636|FG001|Overall Study|Lost to Follow-up|5|||
130934996|NCT02064868|471394641|FG000|Overall Study|Lost to Follow-up|14|||
130934997|NCT02064868|471394642|FG001|Overall Study|Lost to Follow-up|8|||
130934998|NCT02064868|471394641|FG000|Overall Study|Physician Decision|1|||
130934999|NCT02064868|471394642|FG001|Overall Study|Physician Decision|0|||
130935000|NCT02064868|471394641|FG000|Overall Study|Withdrawal by Subject|14|||
130935001|NCT02064868|471394642|FG001|Overall Study|Withdrawal by Subject|3|||
130935002|NCT02064868|471394641|FG000|Overall Study|Technical Problems or Missing|5|||
130935003|NCT02064868|471394642|FG001|Overall Study|Technical Problems or Missing|2|||
130935004|NCT00464087|471394646|FG000|Overall Study|No PCI per inclusion criteria|0|||
130935005|NCT00464087|471394647|FG001|Overall Study|No PCI per inclusion criteria|0|||
130935006|NCT00464087|471394648|FG002|Overall Study|No PCI per inclusion criteria|29|||
130935007|NCT00609492|471394649|FG000|Overall Study|Withdrawal by Subject|0|||
130935008|NCT00609492|471394650|FG001|Overall Study|Withdrawal by Subject|2|||
130935009|NCT00609492|471394651|FG002|Overall Study|Withdrawal by Subject|3|||
130935010|NCT00609492|471394649|FG000|Overall Study|Lost to Follow-up|1|||
130935011|NCT00609492|471394650|FG001|Overall Study|Lost to Follow-up|1|||
130935012|NCT00609492|471394651|FG002|Overall Study|Lost to Follow-up|4|||
130935013|NCT00418314|471394652|FG000|Overall Study|Withdrawal by Subject|1|||
130935014|NCT00418314|471394653|FG001|Overall Study|Withdrawal by Subject|2|||
130935015|NCT02692716|471394654|FG000|Overall Study|Lost to Follow-up|2|||
130935016|NCT02692716|471394655|FG001|Overall Study|Lost to Follow-up|5|||
130935017|NCT02692716|471394654|FG000|Overall Study|Withdrawal by Subject|3|||
130935018|NCT02692716|471394655|FG001|Overall Study|Withdrawal by Subject|1|||
130935019|NCT01529346|471394660|FG000|Overall Study|Lost to Follow-up|2|||
130935020|NCT01529346|471394661|FG001|Overall Study|Lost to Follow-up|0|||
130935021|NCT01529346|471394662|FG002|Overall Study|Lost to Follow-up|1|||
130935022|NCT01529346|471394663|FG003|Overall Study|Lost to Follow-up|0|||
130935023|NCT01529346|471394664|FG004|Overall Study|Lost to Follow-up|0|||
130935024|NCT01529346|471394660|FG000|Overall Study|Other|0|||
130935025|NCT01529346|471394661|FG001|Overall Study|Other|1|||
130935026|NCT01529346|471394662|FG002|Overall Study|Other|1|||
130935027|NCT01529346|471394663|FG003|Overall Study|Other|0|||
130935028|NCT01529346|471394664|FG004|Overall Study|Other|0|||
130935029|NCT00589914|471394670|FG000|Overall Study|Adverse Event|19|||
130935030|NCT00589914|471394671|FG001|Overall Study|Adverse Event|10|||
130935031|NCT00589914|471394670|FG000|Overall Study|Death|2|||
130935032|NCT00589914|471394671|FG001|Overall Study|Death|0|||
130935033|NCT00589914|471394670|FG000|Overall Study|Lack of Efficacy|40|||
130935034|NCT00589914|471394671|FG001|Overall Study|Lack of Efficacy|43|||
130935035|NCT00589914|471394670|FG000|Overall Study|Lost to Follow-up|11|||
130935036|NCT00589914|471394671|FG001|Overall Study|Lost to Follow-up|18|||
130935037|NCT00589914|471394670|FG000|Overall Study|Pregnancy|1|||
130935038|NCT00589914|471394671|FG001|Overall Study|Pregnancy|0|||
130935039|NCT00589914|471394670|FG000|Overall Study|Withdrawal by Subject|55|||
130935040|NCT00589914|471394671|FG001|Overall Study|Withdrawal by Subject|49|||
130935041|NCT00589914|471394670|FG000|Overall Study|Other|22|||
130935042|NCT00589914|471394671|FG001|Overall Study|Other|17|||
130935043|NCT03590041|471394672|FG000|Overall Study|Protocol Violation|4|||
130935044|NCT03590041|471394673|FG001|Overall Study|Protocol Violation|3|||
130935045|NCT03590041|471394672|FG000|Overall Study|No session data recorded|14|||
130935046|NCT03590041|471394673|FG001|Overall Study|No session data recorded|2|||
130704375|NCT03430011|470541267|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
130935047|NCT01124422|471394675|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
130935048|NCT01124422|471394676|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
130935049|NCT01124422|471394677|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
130935050|NCT01124422|471394675|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
130935051|NCT01124422|471394676|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
130704376|NCT03430011|470541260|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
130704377|NCT03430011|470541261|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
130704378|NCT03430011|470541262|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
130935052|NCT01124422|471394677|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
130935053|NCT01124422|471394675|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
130935054|NCT01124422|471394676|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
130935055|NCT01124422|471394677|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
130935056|NCT01124422|471394675|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
130935057|NCT01124422|471394676|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
131035140|NCT04065841|471761889|FG000|Overall Study|Withdrawal by Subject|1|||
131035141|NCT04065841|471761890|FG001|Overall Study|Withdrawal by Subject|1|||
130935058|NCT01124422|471394677|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
130935059|NCT01124422|471394675|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
131223773|NCT04380701|472447126|FG017|Overall Study|Lost to Follow-up|0|||
130935060|NCT01124422|471394676|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
130935061|NCT01124422|471394677|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
130935062|NCT01124422|471394675|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
130935063|NCT01124422|471394676|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
130935064|NCT01124422|471394677|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
130935065|NCT01124422|471394675|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
130935066|NCT01124422|471394676|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
130935067|NCT01124422|471394677|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
130935068|NCT01124422|471394675|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
130935069|NCT01124422|471394676|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
130935070|NCT01124422|471394677|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
130935071|NCT01124422|471394675|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
130935072|NCT01124422|471394676|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
130935073|NCT01124422|471394677|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
130935074|NCT01124422|471394675|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
130935075|NCT01124422|471394676|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
130935076|NCT01124422|471394677|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
130935077|NCT00449540|471394683|FG000|Pretreatment Phase|No migraine experienced|66|||
130935078|NCT00449540|471394684|FG001|Pretreatment Phase|No migraine experienced|0|||
130935079|NCT00449540|471394685|FG002|Pretreatment Phase|No migraine experienced|0|||
130935080|NCT00449540|471394683|FG000|Treatment Phase|did not experience or treat migraine|0|||
130935081|NCT00449540|471394684|FG001|Treatment Phase|did not experience or treat migraine|20|||
130935082|NCT00449540|471394685|FG002|Treatment Phase|did not experience or treat migraine|17|||
130935083|NCT00010374|471394688|FG000|Overall Study|False positive phrenic nerve test|1|||
130935084|NCT01961323|471394689|FG000|Overall Study|Withdrawal by Subject|7|||
130935085|NCT01961323|471394689|FG000|Overall Study|Lost to Follow-up|8|||
130935086|NCT01961323|471394689|FG000|Overall Study|screen failure|34|||
130935087|NCT01881776|471394693|FG000|Overall Study|Lost to Follow-up|1|||
130935088|NCT01881776|471394694|FG001|Overall Study|Lost to Follow-up|2|||
130935089|NCT01881776|471394695|FG002|Overall Study|Lost to Follow-up|1|||
130935090|NCT01881776|471394693|FG000|Overall Study|Protocol Violation|0|||
130935091|NCT01881776|471394694|FG001|Overall Study|Protocol Violation|2|||
130935092|NCT01881776|471394695|FG002|Overall Study|Protocol Violation|1|||
130935093|NCT01741701|471394696|FG000|Overall Study|Adverse Event|5|||
130935094|NCT01741701|471394697|FG001|Overall Study|Adverse Event|1|||
130935095|NCT01741701|471394696|FG000|Overall Study|Withdrawal by Subject|0|||
130935096|NCT01741701|471394697|FG001|Overall Study|Withdrawal by Subject|1|||
130935097|NCT03033394|471394702|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
130935098|NCT03033394|471394702|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
130935099|NCT03033394|471394702|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
130935100|NCT03033394|471394702|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
130935101|NCT03033394|471394702|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
130935102|NCT02036294|471394703|FG000|Overall Study|Death|7|||
130935103|NCT02036294|471394704|FG001|Overall Study|Death|8|||
130935104|NCT02036294|471394703|FG000|Overall Study|Withdrawal by Subject|2|||
130704379|NCT03430011|470541263|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
130704380|NCT03430011|470541264|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
130704381|NCT03430011|470541265|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
130704382|NCT03430011|470541266|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
130704383|NCT03430011|470541267|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
130704384|NCT03430011|470541260|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
130704385|NCT03430011|470541261|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
130704386|NCT03430011|470541262|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
130704387|NCT03430011|470541263|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
130704388|NCT03430011|470541264|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
130935105|NCT02036294|471394704|FG001|Overall Study|Withdrawal by Subject|3|||
130935106|NCT04952402|471394705|FG000|Overall Study|Lost to Follow-up|1|||
130935107|NCT04952402|471394706|FG001|Overall Study|Lost to Follow-up|3|||
130935108|NCT04952402|471394705|FG000|Overall Study|Lack Of Venous Access|0|||
130935109|NCT04952402|471394706|FG001|Overall Study|Lack Of Venous Access|1|||
130935110|NCT02407704|471394709|FG000|Overall Study|Lost to Follow-up|0|||
130935111|NCT02407704|471394710|FG001|Overall Study|Lost to Follow-up|0|||
130935112|NCT02407704|471394711|FG002|Overall Study|Lost to Follow-up|0|||
130935113|NCT02407704|471394712|FG003|Overall Study|Lost to Follow-up|2|||
130935114|NCT02407704|471394709|FG000|Overall Study|Protocol Violation|0|||
130935115|NCT02407704|471394710|FG001|Overall Study|Protocol Violation|0|||
130704389|NCT03430011|470541265|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
130704390|NCT03430011|470541266|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
130704391|NCT03430011|470541267|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
130935116|NCT02407704|471394711|FG002|Overall Study|Protocol Violation|0|||
130935117|NCT02407704|471394712|FG003|Overall Study|Protocol Violation|1|||
130704392|NCT03430011|470541260|FG000|JCARH125 Treatment|Death|4|||
130935118|NCT02407704|471394709|FG000|Overall Study|Withdrawal by Subject|0|||
130704393|NCT03430011|470541261|FG001|JCARH125 Treatment|Death|19|||
130704394|NCT03430011|470541262|FG002|JCARH125 Treatment|Death|10|||
130704395|NCT03430011|470541263|FG003|JCARH125 Treatment|Death|8|||
130704396|NCT03430011|470541264|FG004|JCARH125 Treatment|Death|5|||
130704397|NCT03430011|470541265|FG005|JCARH125 Treatment|Death|3|||
130704398|NCT03430011|470541266|FG006|JCARH125 Treatment|Death|4|||
130704399|NCT03430011|470541267|FG007|JCARH125 Treatment|Death|2|||
130704400|NCT03430011|470541260|FG000|JCARH125 Treatment|Other reasons|1|||
130704401|NCT03430011|470541261|FG001|JCARH125 Treatment|Other reasons|0|||
130704402|NCT03430011|470541262|FG002|JCARH125 Treatment|Other reasons|4|||
130704403|NCT03430011|470541263|FG003|JCARH125 Treatment|Other reasons|2|||
130704404|NCT03430011|470541264|FG004|JCARH125 Treatment|Other reasons|2|||
130704405|NCT03430011|470541265|FG005|JCARH125 Treatment|Other reasons|1|||
130704406|NCT03430011|470541266|FG006|JCARH125 Treatment|Other reasons|3|||
130704407|NCT03430011|470541267|FG007|JCARH125 Treatment|Other reasons|2|||
130704408|NCT04126343|470541268|FG000|Overall Study|Adverse Event|0|||
130704409|NCT04126343|470541269|FG001|Overall Study|Adverse Event|0|||
130704410|NCT04126343|470541270|FG002|Overall Study|Adverse Event|0|||
130704411|NCT04126343|470541271|FG003|Overall Study|Adverse Event|0|||
130704412|NCT04126343|470541272|FG004|Overall Study|Adverse Event|0|||
130704413|NCT04126343|470541273|FG005|Overall Study|Adverse Event|1|||
130704414|NCT04126343|470541268|FG000|Overall Study|Withdrawal by Subject|0|||
130704415|NCT04126343|470541269|FG001|Overall Study|Withdrawal by Subject|0|||
130704416|NCT04126343|470541270|FG002|Overall Study|Withdrawal by Subject|0|||
130704417|NCT04126343|470541271|FG003|Overall Study|Withdrawal by Subject|1|||
130935119|NCT02407704|471394710|FG001|Overall Study|Withdrawal by Subject|0|||
130935120|NCT02407704|471394711|FG002|Overall Study|Withdrawal by Subject|1|||
130935121|NCT02407704|471394712|FG003|Overall Study|Withdrawal by Subject|0|||
130935122|NCT01957644|471394715|FG000|Overall Study|Adverse Event|4|||
130935123|NCT01957644|471394716|FG001|Overall Study|Adverse Event|2|||
130935124|NCT01957644|471394717|FG002|Overall Study|Adverse Event|0|||
130935125|NCT01957644|471394718|FG003|Overall Study|Adverse Event|0|||
130935126|NCT01957644|471394719|FG004|Overall Study|Adverse Event|1|||
130935127|NCT01957644|471394715|FG000|Overall Study|Progressive disease / relapse|0|||
130935128|NCT01957644|471394716|FG001|Overall Study|Progressive disease / relapse|1|||
130935129|NCT01957644|471394717|FG002|Overall Study|Progressive disease / relapse|0|||
130935130|NCT01957644|471394718|FG003|Overall Study|Progressive disease / relapse|1|||
130935131|NCT01957644|471394719|FG004|Overall Study|Progressive disease / relapse|0|||
130935132|NCT01957644|471394715|FG000|Overall Study|Other reason|1|||
130935133|NCT01957644|471394716|FG001|Overall Study|Other reason|2|||
130935134|NCT01957644|471394717|FG002|Overall Study|Other reason|1|||
130935135|NCT01957644|471394718|FG003|Overall Study|Other reason|1|||
130935136|NCT01957644|471394719|FG004|Overall Study|Other reason|0|||
130935137|NCT01957644|471394715|FG000|Overall Study|Withdrawal by Subject|1|||
130935138|NCT01957644|471394716|FG001|Overall Study|Withdrawal by Subject|0|||
130935139|NCT01957644|471394717|FG002|Overall Study|Withdrawal by Subject|0|||
130935140|NCT01957644|471394718|FG003|Overall Study|Withdrawal by Subject|0|||
130935141|NCT01957644|471394719|FG004|Overall Study|Withdrawal by Subject|0|||
130935142|NCT01957644|471394715|FG000|Overall Study|Protocol Violation|0|||
130935143|NCT01957644|471394716|FG001|Overall Study|Protocol Violation|1|||
130935144|NCT01957644|471394717|FG002|Overall Study|Protocol Violation|0|||
130935145|NCT01957644|471394718|FG003|Overall Study|Protocol Violation|0|||
130935146|NCT01957644|471394719|FG004|Overall Study|Protocol Violation|0|||
130935147|NCT04044716|471394720|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
130935148|NCT04044716|471394721|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
130935149|NCT04044716|471394722|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
130935150|NCT04044716|471394720|FG000|Overall Study|Lost to Follow-up|2|||
131120528|NCT01994382|472072352|FG011|Overall Study|Withdrawal by Subject|0|||
131120529|NCT01994382|472072353|FG012|Overall Study|Withdrawal by Subject|2|||
131120530|NCT01994382|472072354|FG013|Overall Study|Withdrawal by Subject|0|||
131120531|NCT01994382|472072355|FG014|Overall Study|Withdrawal by Subject|4|||
131120532|NCT01994382|472072356|FG015|Overall Study|Withdrawal by Subject|3|||
130704418|NCT04126343|470541272|FG004|Overall Study|Withdrawal by Subject|0|||
130935151|NCT04044716|471394721|FG001|Overall Study|Lost to Follow-up|3|||
130935152|NCT04044716|471394722|FG002|Overall Study|Lost to Follow-up|0|||
130771101|NCT01214668|470789820|FG005|Overall Study|Withdrawal by Subject|0|||
130771102|NCT01964989|470789821|FG000|Overall Study|Protocol Violation|3|||
130935153|NCT01324999|471394725|FG000|Overall Study|Adverse Event|3|||
130935154|NCT01324999|471394725|FG000|Overall Study|Withdrawal by Subject|2|||
130935155|NCT01714635|471394729|FG000|Overall Study|Discontinued|1|||
130935156|NCT01714635|471394730|FG001|Overall Study|Discontinued|0|||
130935157|NCT01714635|471394731|FG002|Overall Study|Discontinued|2|||
130935158|NCT01714635|471394729|FG000|Overall Study|Missed 6-month exam|1|||
130935159|NCT01714635|471394730|FG001|Overall Study|Missed 6-month exam|0|||
130704419|NCT04126343|470541273|FG005|Overall Study|Withdrawal by Subject|0|||
130704420|NCT04126343|470541268|FG000|Overall Study|Related to COVID-19 pandemic|3|||
130704421|NCT04126343|470541269|FG001|Overall Study|Related to COVID-19 pandemic|4|||
130704422|NCT04126343|470541270|FG002|Overall Study|Related to COVID-19 pandemic|3|||
130771103|NCT01964989|470789822|FG001|Overall Study|Protocol Violation|4|||
130935160|NCT01714635|471394731|FG002|Overall Study|Missed 6-month exam|0|||
130935161|NCT02743871|471394732|FG000|Overall Study|Lost to Follow-up|0|||
130935162|NCT02743871|471394733|FG001|Overall Study|Lost to Follow-up|0|||
130935163|NCT02743871|471394734|FG002|Overall Study|Lost to Follow-up|0|||
130935164|NCT02743871|471394735|FG003|Overall Study|Lost to Follow-up|1|||
130935165|NCT02743871|471394736|FG004|Overall Study|Lost to Follow-up|0|||
130935166|NCT02743871|471394737|FG005|Overall Study|Lost to Follow-up|0|||
130935167|NCT02743871|471394738|FG006|Overall Study|Lost to Follow-up|1|||
130935168|NCT02743871|471394739|FG007|Overall Study|Lost to Follow-up|0|||
130935169|NCT02743871|471394740|FG008|Overall Study|Lost to Follow-up|0|||
130935170|NCT02743871|471394741|FG009|Overall Study|Lost to Follow-up|0|||
130935171|NCT02743871|471394742|FG010|Overall Study|Lost to Follow-up|0|||
130935172|NCT02743871|471394743|FG011|Overall Study|Lost to Follow-up|2|||
130935173|NCT02743871|471394744|FG012|Overall Study|Lost to Follow-up|0|||
130935174|NCT02743871|471394745|FG013|Overall Study|Lost to Follow-up|0|||
130935175|NCT02743871|471394732|FG000|Overall Study|Withdrawal by Subject|0|||
130935176|NCT02743871|471394733|FG001|Overall Study|Withdrawal by Subject|0|||
130935177|NCT02743871|471394734|FG002|Overall Study|Withdrawal by Subject|0|||
130935178|NCT02743871|471394735|FG003|Overall Study|Withdrawal by Subject|0|||
130935179|NCT02743871|471394736|FG004|Overall Study|Withdrawal by Subject|0|||
130935180|NCT02743871|471394737|FG005|Overall Study|Withdrawal by Subject|0|||
130935181|NCT02743871|471394738|FG006|Overall Study|Withdrawal by Subject|0|||
130935182|NCT02743871|471394739|FG007|Overall Study|Withdrawal by Subject|0|||
130935183|NCT02743871|471394740|FG008|Overall Study|Withdrawal by Subject|0|||
130935184|NCT02743871|471394741|FG009|Overall Study|Withdrawal by Subject|0|||
130935185|NCT02743871|471394742|FG010|Overall Study|Withdrawal by Subject|1|||
130935186|NCT02743871|471394743|FG011|Overall Study|Withdrawal by Subject|0|||
130935187|NCT02743871|471394744|FG012|Overall Study|Withdrawal by Subject|12|||
130935188|NCT02743871|471394745|FG013|Overall Study|Withdrawal by Subject|6|||
130935189|NCT02743871|471394732|FG000|Overall Study|Adverse Event|1|||
130935190|NCT02743871|471394733|FG001|Overall Study|Adverse Event|0|||
130935191|NCT02743871|471394734|FG002|Overall Study|Adverse Event|0|||
130935192|NCT02743871|471394735|FG003|Overall Study|Adverse Event|0|||
130935193|NCT02743871|471394736|FG004|Overall Study|Adverse Event|0|||
130935194|NCT02743871|471394737|FG005|Overall Study|Adverse Event|0|||
130935195|NCT02743871|471394738|FG006|Overall Study|Adverse Event|0|||
130935196|NCT02743871|471394739|FG007|Overall Study|Adverse Event|0|||
130935197|NCT02743871|471394740|FG008|Overall Study|Adverse Event|0|||
130935198|NCT02743871|471394741|FG009|Overall Study|Adverse Event|0|||
130935199|NCT02743871|471394742|FG010|Overall Study|Adverse Event|0|||
130935200|NCT02743871|471394743|FG011|Overall Study|Adverse Event|0|||
130935201|NCT02743871|471394744|FG012|Overall Study|Adverse Event|0|||
130935202|NCT02743871|471394745|FG013|Overall Study|Adverse Event|0|||
130935203|NCT02743871|471394732|FG000|Overall Study|Other|0|||
130935204|NCT02743871|471394733|FG001|Overall Study|Other|0|||
130935205|NCT02743871|471394734|FG002|Overall Study|Other|0|||
130935206|NCT02743871|471394735|FG003|Overall Study|Other|0|||
130935207|NCT02743871|471394736|FG004|Overall Study|Other|0|||
130935208|NCT02743871|471394737|FG005|Overall Study|Other|0|||
130935209|NCT02743871|471394738|FG006|Overall Study|Other|0|||
130935210|NCT02743871|471394739|FG007|Overall Study|Other|0|||
130935211|NCT02743871|471394740|FG008|Overall Study|Other|0|||
130935212|NCT02743871|471394741|FG009|Overall Study|Other|0|||
130935213|NCT02743871|471394742|FG010|Overall Study|Other|0|||
130935214|NCT02743871|471394743|FG011|Overall Study|Other|1|||
130935215|NCT02743871|471394744|FG012|Overall Study|Other|1|||
131120533|NCT01994382|472072357|FG016|Overall Study|Withdrawal by Subject|0|||
130771104|NCT01964989|470789821|FG000|Overall Study|Administrative Reason|103|||
130771105|NCT01964989|470789822|FG001|Overall Study|Administrative Reason|95|||
130935216|NCT02743871|471394745|FG013|Overall Study|Other|1|||
130935217|NCT02743871|471394732|FG000|Overall Study|Protocol Violation|0|||
130935218|NCT02743871|471394733|FG001|Overall Study|Protocol Violation|0|||
130935219|NCT02743871|471394734|FG002|Overall Study|Protocol Violation|0|||
130935220|NCT02743871|471394735|FG003|Overall Study|Protocol Violation|0|||
130935221|NCT02743871|471394736|FG004|Overall Study|Protocol Violation|0|||
130935222|NCT02743871|471394737|FG005|Overall Study|Protocol Violation|0|||
131120534|NCT01994382|472072341|FG000|Overall Study|Lost to Follow-up|0|||
131120535|NCT01994382|472072342|FG001|Overall Study|Lost to Follow-up|0|||
130935223|NCT02743871|471394738|FG006|Overall Study|Protocol Violation|0|||
131120536|NCT01994382|472072343|FG002|Overall Study|Lost to Follow-up|0|||
131120537|NCT01994382|472072344|FG003|Overall Study|Lost to Follow-up|0|||
130935224|NCT02743871|471394739|FG007|Overall Study|Protocol Violation|0|||
130935225|NCT02743871|471394740|FG008|Overall Study|Protocol Violation|0|||
130935226|NCT02743871|471394741|FG009|Overall Study|Protocol Violation|0|||
130935227|NCT02743871|471394742|FG010|Overall Study|Protocol Violation|0|||
130935228|NCT02743871|471394743|FG011|Overall Study|Protocol Violation|0|||
130935229|NCT02743871|471394744|FG012|Overall Study|Protocol Violation|2|||
130935230|NCT02743871|471394745|FG013|Overall Study|Protocol Violation|0|||
130935231|NCT02848651|471394750|FG000|Overall Study|Death|85|||
130935232|NCT02848651|471394750|FG000|Overall Study|Lost to Follow-up|1|||
130935233|NCT02848651|471394750|FG000|Overall Study|Non-Compliance|1|||
130935234|NCT02848651|471394750|FG000|Overall Study|Symptomatic Deterioration|1|||
130935235|NCT02848651|471394750|FG000|Overall Study|Physician Decision|4|||
130935236|NCT02848651|471394750|FG000|Overall Study|Withdrawal by Subject|14|||
130935237|NCT02744391|471394753|FG000|Overall Study|Lost to Follow-up|9|||
130935238|NCT02744391|471394753|FG000|Overall Study|Physician Decision|2|||
130935239|NCT02744391|471394753|FG000|Overall Study|Withdrawal by Subject|3|||
130935240|NCT01428453|471394754|FG000|Overall Study|Adverse Event|2|||
130935241|NCT01428453|471394755|FG001|Overall Study|Adverse Event|7|||
130935242|NCT01428453|471394754|FG000|Overall Study|Protocol Violation|1|||
130935243|NCT01428453|471394755|FG001|Overall Study|Protocol Violation|0|||
130935244|NCT01428453|471394754|FG000|Overall Study|Lost to Follow-up|0|||
130935245|NCT01428453|471394755|FG001|Overall Study|Lost to Follow-up|1|||
130935246|NCT01428453|471394754|FG000|Overall Study|Withdrawal by Subject|3|||
130935247|NCT01428453|471394755|FG001|Overall Study|Withdrawal by Subject|1|||
130935248|NCT01996709|471394756|FG000|Overall Study|Withdrawal by Subject|1|||
130935249|NCT01996709|471394757|FG001|Overall Study|Withdrawal by Subject|0|||
130935250|NCT01996709|471394756|FG000|Overall Study|Lost to Follow-up|3|||
130935251|NCT01996709|471394757|FG001|Overall Study|Lost to Follow-up|0|||
130935252|NCT01996709|471394756|FG000|Overall Study|Subject Non-Compliant|1|||
130935253|NCT01996709|471394757|FG001|Overall Study|Subject Non-Compliant|0|||
130935254|NCT01996709|471394756|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130935255|NCT01996709|471394757|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
130935256|NCT03789318|471394766|FG000|Overall Study|Adverse Event|0|||
130935257|NCT03789318|471394767|FG001|Overall Study|Adverse Event|0|||
130935258|NCT03789318|471394768|FG002|Overall Study|Adverse Event|1|||
130935259|NCT03789318|471394769|FG003|Overall Study|Adverse Event|1|||
130935260|NCT03789318|471394770|FG004|Overall Study|Adverse Event|0|||
130935261|NCT03789318|471394766|FG000|Overall Study|Lost to Follow-up|0|||
130935262|NCT03789318|471394767|FG001|Overall Study|Lost to Follow-up|0|||
130935263|NCT03789318|471394768|FG002|Overall Study|Lost to Follow-up|1|||
130935264|NCT03789318|471394769|FG003|Overall Study|Lost to Follow-up|0|||
130935265|NCT03789318|471394770|FG004|Overall Study|Lost to Follow-up|0|||
130935266|NCT03789318|471394766|FG000|Overall Study|Withdrawal by Subject|0|||
130935267|NCT03789318|471394767|FG001|Overall Study|Withdrawal by Subject|0|||
130935268|NCT03789318|471394768|FG002|Overall Study|Withdrawal by Subject|1|||
130935269|NCT03789318|471394769|FG003|Overall Study|Withdrawal by Subject|0|||
130935270|NCT03789318|471394770|FG004|Overall Study|Withdrawal by Subject|0|||
130935271|NCT02480114|471394771|FG000|Overall Study|Not completing surveys|3|||
130935272|NCT02480114|471394772|FG001|Overall Study|Not completing surveys|2|||
130935273|NCT02480114|471394771|FG000|Overall Study|Withdrawal by Subject|2|||
130935274|NCT02480114|471394772|FG001|Overall Study|Withdrawal by Subject|4|||
130935275|NCT02480114|471394771|FG000|Overall Study|Disease progression|3|||
130935276|NCT02480114|471394772|FG001|Overall Study|Disease progression|0|||
130935277|NCT02480114|471394771|FG000|Overall Study|Improper completion of survey|1|||
130935278|NCT02480114|471394772|FG001|Overall Study|Improper completion of survey|1|||
130935279|NCT02480114|471394771|FG000|Overall Study|Not eligible|0|||
130935280|NCT02480114|471394772|FG001|Overall Study|Not eligible|1|||
130935281|NCT01535053|471394773|FG000|Overall Study|Ineligible|1|||
130935282|NCT01535053|471394774|FG001|Overall Study|Ineligible|2|||
130935283|NCT00512707|471394775|FG000|Overall Study|Lost to Follow-up|5|||
130935284|NCT00512707|471394776|FG001|Overall Study|Lost to Follow-up|11|||
130935285|NCT00512707|471394775|FG000|Overall Study|Developed skin irritation|2|||
130935286|NCT00512707|471394776|FG001|Overall Study|Developed skin irritation|1|||
130935287|NCT00512707|471394775|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
130935288|NCT00512707|471394776|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
130935289|NCT00512707|471394775|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
130935290|NCT00512707|471394776|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
131120538|NCT01994382|472072345|FG004|Overall Study|Lost to Follow-up|0|||
131120539|NCT01994382|472072346|FG005|Overall Study|Lost to Follow-up|0|||
131120540|NCT01994382|472072347|FG006|Overall Study|Lost to Follow-up|0|||
131120541|NCT01994382|472072348|FG007|Overall Study|Lost to Follow-up|0|||
131120542|NCT01994382|472072349|FG008|Overall Study|Lost to Follow-up|0|||
131120543|NCT01994382|472072350|FG009|Overall Study|Lost to Follow-up|0|||
131120544|NCT01994382|472072351|FG010|Overall Study|Lost to Follow-up|1|||
131223774|NCT04380701|472447127|FG018|Overall Study|Lost to Follow-up|0|||
130935291|NCT04405037|471394779|FG000|Overall Study|Withdrawal by Subject|1|||
130935292|NCT04405037|471394780|FG001|Overall Study|Withdrawal by Subject|0|||
130935293|NCT04405037|471394779|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
130935294|NCT04405037|471394780|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
130935295|NCT04203238|471396565|FG000|Overall Study|Withdrawal by Subject|1|||
130935296|NCT04203238|471396566|FG001|Overall Study|Withdrawal by Subject|1|||
130935297|NCT04203238|471396565|FG000|Overall Study|Covid-19|3|||
130935298|NCT04203238|471396566|FG001|Overall Study|Covid-19|0|||
131120545|NCT01994382|472072352|FG011|Overall Study|Lost to Follow-up|0|||
131120546|NCT01994382|472072353|FG012|Overall Study|Lost to Follow-up|0|||
131120547|NCT01994382|472072354|FG013|Overall Study|Lost to Follow-up|0|||
130935299|NCT01955733|471396567|FG000|Period 1|Lost to Follow-up|1|||
130935300|NCT01955733|471396568|FG001|Period 1|Lost to Follow-up|0|||
130935301|NCT01955733|471396569|FG002|Period 1|Lost to Follow-up|0|||
130935302|NCT01955733|471396567|FG000|Period 2|Adverse Event|1|||
130935303|NCT01955733|471396568|FG001|Period 2|Adverse Event|0|||
130935304|NCT01955733|471396569|FG002|Period 2|Adverse Event|0|||
130935305|NCT01955733|471396567|FG000|Period 2|Physician Decision|0|||
130935306|NCT01955733|471396568|FG001|Period 2|Physician Decision|0|||
130935307|NCT01955733|471396569|FG002|Period 2|Physician Decision|1|||
130935308|NCT01955733|471396567|FG000|Period 2|Withdrawal by Subject|1|||
130935309|NCT01955733|471396568|FG001|Period 2|Withdrawal by Subject|3|||
130935310|NCT01955733|471396569|FG002|Period 2|Withdrawal by Subject|2|||
130935311|NCT01955733|471396567|FG000|Period 2|Study terminated by sponsor|8|||
130935312|NCT01955733|471396568|FG001|Period 2|Study terminated by sponsor|14|||
130935313|NCT01955733|471396569|FG002|Period 2|Study terminated by sponsor|16|||
130935314|NCT01955733|471396567|FG000|Period 2|Lost to Follow-up|2|||
130935315|NCT01955733|471396568|FG001|Period 2|Lost to Follow-up|0|||
130935316|NCT01955733|471396569|FG002|Period 2|Lost to Follow-up|0|||
130935317|NCT01955733|471396567|FG000|Period 2|Other not defined above|0|||
130935318|NCT01955733|471396568|FG001|Period 2|Other not defined above|2|||
130935319|NCT01955733|471396569|FG002|Period 2|Other not defined above|2|||
130935320|NCT00733408|471396570|FG000|Overall Study|Adverse Event|4|||
130935321|NCT04221009|471396571|FG000|Overall Study|Withdrawal by Subject|4|||
130935322|NCT02762266|471396572|FG000|Overall Study|Physician Decision|2|||
130935323|NCT02762266|471396573|FG001|Overall Study|Physician Decision|0|||
130935324|NCT01438424|471396574|FG000|Overall Study|Continuing treatment|29|||
130935325|NCT01438424|471396574|FG000|Overall Study|Minimal virologic response|95|||
130935326|NCT01438424|471396574|FG000|Overall Study|Not identified|55|||
130935327|NCT01438424|471396574|FG000|Overall Study|Withdrawal by Subject|104|||
130935328|NCT01438424|471396574|FG000|Overall Study|Progression of chronic hepatitis B|22|||
130935329|NCT01438424|471396574|FG000|Overall Study|Death|22|||
130935330|NCT01438424|471396574|FG000|Overall Study|Adverse Event|17|||
130935331|NCT01438424|471396574|FG000|Overall Study|Lost to Follow-up|17|||
130935332|NCT01438424|471396574|FG000|Overall Study|Abnormal laboratory test result|14|||
130935333|NCT01438424|471396574|FG000|Overall Study|Need for drug prohibited by protocol|14|||
130935334|NCT01438424|471396574|FG000|Overall Study|Pregnancy|7|||
130935335|NCT01438424|471396574|FG000|Overall Study|No longer met inclusion criteria|1|||
130935336|NCT01438424|471396574|FG000|Overall Study|Participant noncompliance|20|||
130935337|NCT04232124|471396575|FG000|Overall Study|Lost to Follow-up|3|||
130935338|NCT01404325|471396576|FG000|Overall Study|Lost to Follow-up|1|||
130935339|NCT01404325|471396577|FG001|Overall Study|Lost to Follow-up|0|||
130935340|NCT01404325|471396576|FG000|Overall Study|Death|2|||
130935341|NCT01404325|471396577|FG001|Overall Study|Death|0|||
130935342|NCT01404325|471396576|FG000|Overall Study|Graft loss/Retransplantation|1|||
130935343|NCT01404325|471396577|FG001|Overall Study|Graft loss/Retransplantation|0|||
130935344|NCT01404325|471396576|FG000|Overall Study|non-specified reason|0|||
130935345|NCT01404325|471396577|FG001|Overall Study|non-specified reason|2|||
130935346|NCT03312933|471396583|FG000|Overall Study|Protocol Violation|15|||
130935347|NCT03312933|471396583|FG000|Overall Study|Lost to Follow-up|36|||
130935348|NCT03312933|471396583|FG000|Overall Study|Withdrawal by Subject|3|||
130935349|NCT00224055|471396589|FG000|Overall Study|Adverse Event|9|||
130935350|NCT00224055|471396590|FG001|Overall Study|Adverse Event|3|||
130935351|NCT00224055|471396589|FG000|Overall Study|Lost to Follow-up|1|||
130935352|NCT00224055|471396590|FG001|Overall Study|Lost to Follow-up|2|||
130935353|NCT00224055|471396589|FG000|Overall Study|Protocol Violation|1|||
130935354|NCT00224055|471396590|FG001|Overall Study|Protocol Violation|1|||
130935355|NCT00224055|471396589|FG000|Overall Study|Inclusion Violation|3|||
130935356|NCT00224055|471396590|FG001|Overall Study|Inclusion Violation|6|||
130935357|NCT00224055|471396589|FG000|Overall Study|Withdrawal by Subject|0|||
130935358|NCT00224055|471396590|FG001|Overall Study|Withdrawal by Subject|2|||
130935359|NCT00224055|471396589|FG000|Overall Study|Other|1|||
130935360|NCT00224055|471396590|FG001|Overall Study|Other|0|||
130935361|NCT02068443|471396591|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130935362|NCT02068443|471396592|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
130935363|NCT02068443|471396593|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
130935364|NCT02068443|471396591|FG000|Overall Study|Voluntary Withdrawal|4|||
130935365|NCT02068443|471396592|FG001|Overall Study|Voluntary Withdrawal|0|||
130935366|NCT02068443|471396593|FG002|Overall Study|Voluntary Withdrawal|1|||
130935367|NCT02068443|471396591|FG000|Overall Study|Lack of Efficacy|2|||
130935368|NCT02068443|471396592|FG001|Overall Study|Lack of Efficacy|1|||
130935369|NCT02068443|471396593|FG002|Overall Study|Lack of Efficacy|0|||
130935370|NCT02068443|471396591|FG000|Overall Study|Other Reason Not Specified|1|||
130935371|NCT02068443|471396592|FG001|Overall Study|Other Reason Not Specified|0|||
130935372|NCT02068443|471396593|FG002|Overall Study|Other Reason Not Specified|0|||
130935373|NCT01986855|471396594|FG000|Overall Study|Adverse Event|1|||
130935374|NCT01986855|471396595|FG001|Overall Study|Adverse Event|0|||
130935375|NCT01986855|471396596|FG002|Overall Study|Adverse Event|0|||
130935376|NCT01986855|471396594|FG000|Overall Study|Death|3|||
130935377|NCT01986855|471396595|FG001|Overall Study|Death|4|||
130771106|NCT01964989|470789821|FG000|Overall Study|Adverse Event|0|||
130771107|NCT01964989|470789822|FG001|Overall Study|Adverse Event|1|||
130771108|NCT01964989|470789821|FG000|Overall Study|Death|1|||
130771109|NCT01964989|470789822|FG001|Overall Study|Death|3|||
130771110|NCT01964989|470789821|FG000|Overall Study|Withdrawal by Subject|156|||
130771111|NCT01964989|470789822|FG001|Overall Study|Withdrawal by Subject|160|||
130771112|NCT01964989|470789821|FG000|Overall Study|Lost to Follow-up|254|||
130935378|NCT01986855|471396596|FG002|Overall Study|Death|4|||
130935379|NCT01986855|471396594|FG000|Overall Study|Lost to Follow-up|2|||
130935380|NCT01986855|471396595|FG001|Overall Study|Lost to Follow-up|1|||
130771113|NCT01964989|470789822|FG001|Overall Study|Lost to Follow-up|232|||
130771114|NCT01964989|470789821|FG000|Overall Study|Other|267|||
130771115|NCT01964989|470789822|FG001|Overall Study|Other|252|||
130771116|NCT00424593|470789823|FG000|Acute Double-Blind Period|Adverse Event|16|||
130935381|NCT01986855|471396596|FG002|Overall Study|Lost to Follow-up|0|||
130935382|NCT01986855|471396594|FG000|Overall Study|Screen Failure|0|||
130935383|NCT01986855|471396595|FG001|Overall Study|Screen Failure|1|||
130935384|NCT01986855|471396596|FG002|Overall Study|Screen Failure|0|||
130935385|NCT01986855|471396594|FG000|Overall Study|Participant Moved|0|||
130935386|NCT01986855|471396595|FG001|Overall Study|Participant Moved|0|||
130935387|NCT01986855|471396596|FG002|Overall Study|Participant Moved|2|||
130935388|NCT01986855|471396594|FG000|Overall Study|Withdrawal by Subject|7|||
130935389|NCT01986855|471396595|FG001|Overall Study|Withdrawal by Subject|8|||
130935390|NCT01986855|471396596|FG002|Overall Study|Withdrawal by Subject|5|||
130935391|NCT00931762|471396598|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
130935392|NCT00931762|471396598|FG000|Overall Study|Administrative Problems|5|||
130935393|NCT00931762|471396598|FG000|Overall Study|Death|1|||
130935394|NCT00931762|471396598|FG000|Overall Study|Disease Progression|3|||
130935395|NCT00931762|471396598|FG000|Overall Study|Adverse Event (s)|11|||
130935396|NCT00931762|471396598|FG000|Overall Study|Subject withdrew consent|13|||
130935397|NCT02664441|471396599|FG000|Randomization|Withdrawal by Subject|0|||
130935398|NCT02664441|471396600|FG001|Randomization|Withdrawal by Subject|1|||
130935399|NCT02664441|471396599|FG000|36-week Randomized Trial|Adverse Event|2|||
130935400|NCT02664441|471396600|FG001|36-week Randomized Trial|Adverse Event|0|||
130935401|NCT02664441|471396599|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
130935402|NCT02664441|471396600|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
130935403|NCT02664441|471396599|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
130935404|NCT02664441|471396600|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
130935405|NCT02664441|471396599|FG000|18-week Open Label Extension|Adverse Event|1|||
130935406|NCT02664441|471396600|FG001|18-week Open Label Extension|Adverse Event|0|||
130935407|NCT02664441|471396599|FG000|18-week Open Label Extension|Physician Decision|1|||
130935408|NCT02664441|471396600|FG001|18-week Open Label Extension|Physician Decision|0|||
130935409|NCT02664441|471396599|FG000|18-week Open Label Extension|Death|1|||
130935410|NCT02664441|471396600|FG001|18-week Open Label Extension|Death|0|||
130935411|NCT02664441|471396599|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
130935412|NCT02664441|471396600|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
130935413|NCT01413191|471396601|FG000|Overall Study|Lost to Follow-up|5|||
130935414|NCT01413191|471396601|FG000|Overall Study|Disease Progression|5|||
130935415|NCT01413191|471396601|FG000|Overall Study|Death|1|||
130935416|NCT01702454|471396602|FG000|Overall Study|Consent withdrawal|0|||
130935417|NCT01702454|471396603|FG001|Overall Study|Consent withdrawal|1|||
130935418|NCT01702454|471396602|FG000|Overall Study|Migrated/moved from study area|0|||
130935419|NCT01702454|471396603|FG001|Overall Study|Migrated/moved from study area|1|||
130935420|NCT01702454|471396602|FG000|Overall Study|Lost to Follow-up|3|||
130935421|NCT01702454|471396603|FG001|Overall Study|Lost to Follow-up|6|||
130935422|NCT00710710|471396604|FG000|Overall Study|Consent withdrawn|2|||
130935423|NCT00710710|471396605|FG001|Overall Study|Consent withdrawn|2|||
130935424|NCT00710710|471396604|FG000|Overall Study|Protocol Violation|0|||
130935425|NCT00710710|471396605|FG001|Overall Study|Protocol Violation|1|||
130935426|NCT00710710|471396604|FG000|Overall Study|Adverse Event|3|||
130935427|NCT00710710|471396605|FG001|Overall Study|Adverse Event|3|||
130935428|NCT00710710|471396604|FG000|Overall Study|Progressive disease|40|||
130935429|NCT00710710|471396605|FG001|Overall Study|Progressive disease|38|||
130935430|NCT03510884|471396606|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
130935431|NCT03510884|471396607|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
130935432|NCT03510884|471396608|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
130935433|NCT03510884|471396609|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
130935434|NCT03510884|471396606|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
130935435|NCT03510884|471396607|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
130935436|NCT03510884|471396608|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
130935437|NCT03510884|471396609|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
130935438|NCT03510884|471396606|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
130935439|NCT03510884|471396607|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
130935440|NCT03510884|471396608|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
131120548|NCT01994382|472072355|FG014|Overall Study|Lost to Follow-up|0|||
131035142|NCT04065841|471761891|FG002|Overall Study|Withdrawal by Subject|2|||
131035143|NCT04065841|471761892|FG003|Overall Study|Withdrawal by Subject|0|||
131035144|NCT01420237|471761893|FG000|Overall Study|Death|13|||
131035145|NCT01420237|471761893|FG000|Overall Study|Withdrawal by Subject|41|||
131035146|NCT01420237|471761893|FG000|Overall Study|Lost to Follow-up|32|||
131035147|NCT01420237|471761893|FG000|Overall Study|Adverse Event|10|||
131035148|NCT01420237|471761893|FG000|Overall Study|Investigative Site Termination|43|||
131035149|NCT01420237|471761893|FG000|Overall Study|Censored because study device not implanted|21|||
131035150|NCT01420237|471761893|FG000|Overall Study|Censored because surgery not performed|2|||
131035151|NCT01420237|471761893|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
131035152|NCT01420237|471761893|FG000|Overall Study|Sponsor terminated study early|127|||
131035153|NCT04492722|471761894|FG000|Overall Study|Adverse Event|7|||
131035154|NCT04492722|471761895|FG001|Overall Study|Adverse Event|2|||
131035155|NCT04492722|471761896|FG002|Overall Study|Adverse Event|3|||
131035156|NCT04492722|471761897|FG003|Overall Study|Adverse Event|0|||
131035157|NCT04492722|471761894|FG000|Overall Study|Death|0|||
131035158|NCT04492722|471761895|FG001|Overall Study|Death|0|||
131035159|NCT04492722|471761896|FG002|Overall Study|Death|0|||
131035160|NCT04492722|471761897|FG003|Overall Study|Death|1|||
131035161|NCT04492722|471761894|FG000|Overall Study|Lost to Follow-up|0|||
131035162|NCT04492722|471761895|FG001|Overall Study|Lost to Follow-up|1|||
131035163|NCT04492722|471761896|FG002|Overall Study|Lost to Follow-up|0|||
131035164|NCT04492722|471761897|FG003|Overall Study|Lost to Follow-up|1|||
131035165|NCT04492722|471761894|FG000|Overall Study|Physician Decision|0|||
131035166|NCT04492722|471761895|FG001|Overall Study|Physician Decision|3|||
131035167|NCT04492722|471761896|FG002|Overall Study|Physician Decision|1|||
131035168|NCT04492722|471761897|FG003|Overall Study|Physician Decision|1|||
131035169|NCT04492722|471761894|FG000|Overall Study|Withdrawal by Subject|6|||
131035170|NCT04492722|471761895|FG001|Overall Study|Withdrawal by Subject|6|||
131035171|NCT04492722|471761896|FG002|Overall Study|Withdrawal by Subject|0|||
131035172|NCT04492722|471761897|FG003|Overall Study|Withdrawal by Subject|3|||
131035173|NCT04492722|471761894|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
131035174|NCT04492722|471761895|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
131035175|NCT04492722|471761896|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
131035176|NCT04492722|471761897|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
131035177|NCT04492722|471761894|FG000|Overall Study|Due to Covid-19 pandemic|7|||
131035178|NCT04492722|471761895|FG001|Overall Study|Due to Covid-19 pandemic|3|||
131035179|NCT04492722|471761896|FG002|Overall Study|Due to Covid-19 pandemic|7|||
131035180|NCT04492722|471761897|FG003|Overall Study|Due to Covid-19 pandemic|6|||
131035181|NCT04492722|471761894|FG000|Overall Study|Failure to meet randomisation criteria|2|||
131035182|NCT04492722|471761895|FG001|Overall Study|Failure to meet randomisation criteria|3|||
131035183|NCT04492722|471761896|FG002|Overall Study|Failure to meet randomisation criteria|4|||
131035184|NCT04492722|471761897|FG003|Overall Study|Failure to meet randomisation criteria|2|||
131035185|NCT04492722|471761894|FG000|Overall Study|Early termination from the study|54|||
131035186|NCT04492722|471761895|FG001|Overall Study|Early termination from the study|51|||
131035187|NCT04492722|471761896|FG002|Overall Study|Early termination from the study|50|||
131035188|NCT04492722|471761897|FG003|Overall Study|Early termination from the study|50|||
131035189|NCT04492722|471761894|FG000|Overall Study|Missing|3|||
131035190|NCT04492722|471761895|FG001|Overall Study|Missing|0|||
131035191|NCT04492722|471761896|FG002|Overall Study|Missing|0|||
131035192|NCT04492722|471761897|FG003|Overall Study|Missing|5|||
131035193|NCT04492722|471761894|FG000|Overall Study|Participants who did not receive treatment|0|||
131035194|NCT04492722|471761895|FG001|Overall Study|Participants who did not receive treatment|1|||
131035195|NCT04492722|471761896|FG002|Overall Study|Participants who did not receive treatment|4|||
131035196|NCT04492722|471761897|FG003|Overall Study|Participants who did not receive treatment|0|||
131035197|NCT03631784|471761899|FG000|Overall Study|Participants Ongoing|1|||
131035198|NCT03631784|471761900|FG001|Overall Study|Participants Ongoing|0|||
131035199|NCT03631784|471761899|FG000|Overall Study|Withdrawal by Subject|3|||
131035200|NCT03631784|471761900|FG001|Overall Study|Withdrawal by Subject|3|||
131035201|NCT03631784|471761899|FG000|Overall Study|Sponsor's Decision|36|||
131035202|NCT03631784|471761900|FG001|Overall Study|Sponsor's Decision|52|||
131035203|NCT03631784|471761899|FG000|Overall Study|Lost to Follow-up|1|||
130704423|NCT04126343|470541271|FG003|Overall Study|Related to COVID-19 pandemic|3|||
130704424|NCT04126343|470541272|FG004|Overall Study|Related to COVID-19 pandemic|3|||
130704425|NCT04126343|470541273|FG005|Overall Study|Related to COVID-19 pandemic|3|||
131035204|NCT03631784|471761900|FG001|Overall Study|Lost to Follow-up|0|||
131035205|NCT03631784|471761899|FG000|Overall Study|Death|71|||
131035206|NCT03631784|471761900|FG001|Overall Study|Death|49|||
131035207|NCT01396278|471763908|FG000|Overall Study|Adverse Event|0|||
131035208|NCT01396278|471763909|FG001|Overall Study|Adverse Event|0|||
131035209|NCT01396278|471763910|FG002|Overall Study|Adverse Event|0|||
131035210|NCT01396278|471763911|FG003|Overall Study|Adverse Event|2|||
131035211|NCT01396278|471763912|FG004|Overall Study|Adverse Event|0|||
131035212|NCT01396278|471763908|FG000|Overall Study|Withdraw due to trial termination|2|||
131223775|NCT04380701|472447128|FG019|Overall Study|Lost to Follow-up|0|||
130935441|NCT03510884|471396609|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
130935442|NCT03510884|471396606|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
130935443|NCT03510884|471396607|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
130935444|NCT03510884|471396608|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
130935445|NCT03510884|471396609|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
130935446|NCT03510884|471396606|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
130935447|NCT03510884|471396607|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
130935448|NCT03510884|471396608|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
130935449|NCT03510884|471396609|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
130935450|NCT03510884|471396606|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
130935451|NCT03510884|471396607|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
130935452|NCT03510884|471396608|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
130935453|NCT03510884|471396609|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
130935454|NCT03510884|471396606|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
130935455|NCT03510884|471396607|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
130935456|NCT03510884|471396608|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
130935457|NCT03510884|471396609|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
130935458|NCT03510884|471396606|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
130935459|NCT03510884|471396607|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
130935460|NCT03510884|471396608|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
130935461|NCT03510884|471396609|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
130935462|NCT03510884|471396606|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
130935463|NCT03510884|471396607|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
130935464|NCT03510884|471396608|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
130935465|NCT03510884|471396609|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
130935466|NCT03510884|471396606|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
130935467|NCT03510884|471396607|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
130935468|NCT03510884|471396608|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
130935469|NCT03510884|471396609|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
130935470|NCT01594125|471396615|FG000|Overall Study|Withdrawal by Subject|1|||
130935471|NCT01594125|471396616|FG001|Overall Study|Withdrawal by Subject|0|||
130935472|NCT01594125|471396617|FG002|Overall Study|Withdrawal by Subject|0|||
130935473|NCT01594125|471396618|FG003|Overall Study|Withdrawal by Subject|1|||
130935474|NCT01594125|471396619|FG004|Overall Study|Withdrawal by Subject|0|||
130935475|NCT01594125|471396615|FG000|Overall Study|Progressive Disease|3|||
130935476|NCT01594125|471396616|FG001|Overall Study|Progressive Disease|12|||
130935477|NCT01594125|471396617|FG002|Overall Study|Progressive Disease|3|||
130935478|NCT01594125|471396618|FG003|Overall Study|Progressive Disease|3|||
130935479|NCT01594125|471396619|FG004|Overall Study|Progressive Disease|7|||
130935480|NCT03454893|471396621|FG000|Overall Study|Study Terminated by the Sponsor|5|||
130935481|NCT03454893|471396621|FG000|Overall Study|Did not pass screening|4|||
130935482|NCT02051608|471396622|FG000|Part 1: Double Blind Treatment|Death|3|||
130935483|NCT02051608|471396623|FG001|Part 1: Double Blind Treatment|Death|3|||
130935484|NCT02051608|471396624|FG002|Part 1: Double Blind Treatment|Death|0|||
130935485|NCT02051608|471396625|FG003|Part 1: Double Blind Treatment|Death|0|||
130935486|NCT02051608|471396622|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
130935487|NCT02051608|471396623|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
130935488|NCT02051608|471396624|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
130935489|NCT02051608|471396625|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
130935490|NCT02051608|471396622|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
130935491|NCT02051608|471396623|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
130935492|NCT02051608|471396624|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
130935493|NCT02051608|471396625|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
130935494|NCT02051608|471396622|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
130935495|NCT02051608|471396623|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
130935496|NCT02051608|471396624|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
130935497|NCT02051608|471396625|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
130935498|NCT02051608|471396622|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
130935499|NCT02051608|471396623|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
130935500|NCT02051608|471396624|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
130935501|NCT02051608|471396625|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
130935502|NCT02051608|471396622|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
130704426|NCT00084799|470541274|FG000|Overall Study|Disease Progression|1|||
131223776|NCT04380701|472447129|FG020|Overall Study|Lost to Follow-up|1|||
130704427|NCT00084799|470541275|FG001|Overall Study|Disease Progression|0|||
130704428|NCT01235442|470541276|FG000|Overall Study|Lost to Follow-up|12|||
130935503|NCT02051608|471396623|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
130935504|NCT02051608|471396624|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
130935505|NCT02051608|471396625|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
130935506|NCT02051608|471396622|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
130935507|NCT02051608|471396623|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
130935508|NCT02051608|471396624|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
130935509|NCT02051608|471396625|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
130935510|NCT02051608|471396622|FG000|Part 1: Double Blind Treatment|Other|6|||
130935511|NCT02051608|471396623|FG001|Part 1: Double Blind Treatment|Other|3|||
130935512|NCT02051608|471396624|FG002|Part 1: Double Blind Treatment|Other|0|||
130935513|NCT02051608|471396625|FG003|Part 1: Double Blind Treatment|Other|0|||
130935514|NCT02051608|471396622|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
130935515|NCT02051608|471396623|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
130935516|NCT02051608|471396624|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
130935517|NCT02051608|471396625|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
130935518|NCT02051608|471396622|FG000|Part 2: Open-label Extension|Adverse Event|0|||
130935519|NCT02051608|471396623|FG001|Part 2: Open-label Extension|Adverse Event|0|||
130935520|NCT02051608|471396624|FG002|Part 2: Open-label Extension|Adverse Event|6|||
130935521|NCT02051608|471396625|FG003|Part 2: Open-label Extension|Adverse Event|8|||
130935522|NCT02051608|471396622|FG000|Part 2: Open-label Extension|Death|0|||
130935523|NCT02051608|471396623|FG001|Part 2: Open-label Extension|Death|0|||
130935524|NCT02051608|471396624|FG002|Part 2: Open-label Extension|Death|7|||
130935525|NCT02051608|471396625|FG003|Part 2: Open-label Extension|Death|4|||
130935526|NCT02051608|471396622|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
130935527|NCT02051608|471396623|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
130935528|NCT02051608|471396624|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
130935529|NCT02051608|471396625|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
130935530|NCT02051608|471396622|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
130935531|NCT02051608|471396623|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
130935532|NCT02051608|471396624|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
130935533|NCT02051608|471396625|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
130935534|NCT02051608|471396622|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
130935535|NCT02051608|471396623|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
130935536|NCT02051608|471396624|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
130935537|NCT02051608|471396625|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
130935538|NCT02051608|471396622|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
130935539|NCT02051608|471396623|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
130935540|NCT02051608|471396624|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
130935541|NCT02051608|471396625|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
130935542|NCT02051608|471396622|FG000|Part 2: Open-label Extension|Physician Decision|0|||
130935543|NCT02051608|471396623|FG001|Part 2: Open-label Extension|Physician Decision|0|||
130935544|NCT02051608|471396624|FG002|Part 2: Open-label Extension|Physician Decision|8|||
130935545|NCT02051608|471396625|FG003|Part 2: Open-label Extension|Physician Decision|5|||
130935546|NCT02051608|471396622|FG000|Part 2: Open-label Extension|Other|0|||
130935547|NCT02051608|471396623|FG001|Part 2: Open-label Extension|Other|0|||
130935548|NCT02051608|471396624|FG002|Part 2: Open-label Extension|Other|9|||
130935549|NCT02051608|471396625|FG003|Part 2: Open-label Extension|Other|9|||
130935550|NCT04876274|471396626|FG000|Overall Study|Lost to Follow-up|9|||
130935551|NCT04876274|471396627|FG001|Overall Study|Lost to Follow-up|12|||
130935552|NCT00142584|471396628|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
130935553|NCT00142584|471396629|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
130935554|NCT00142584|471396628|FG000|Overall Study|Withdrawal by Subject|30|||
130935555|NCT00142584|471396629|FG001|Overall Study|Withdrawal by Subject|16|||
130935556|NCT00142584|471396628|FG000|Overall Study|Lost to Follow-up|22|||
130935557|NCT00142584|471396629|FG001|Overall Study|Lost to Follow-up|12|||
130935558|NCT00142584|471396628|FG000|Overall Study|Adverse Event|14|||
130935559|NCT00142584|471396629|FG001|Overall Study|Adverse Event|5|||
130935560|NCT00142584|471396628|FG000|Overall Study|Protocol Violation|4|||
130935561|NCT00142584|471396629|FG001|Overall Study|Protocol Violation|7|||
130935562|NCT00142584|471396628|FG000|Overall Study|Treatment Failure|2|||
130935563|NCT00142584|471396629|FG001|Overall Study|Treatment Failure|0|||
130935564|NCT01948050|471396633|FG000|Overall Study|Withdrawal by Subject|0|||
130935565|NCT01948050|471396634|FG001|Overall Study|Withdrawal by Subject|1|||
130935566|NCT00558025|471396635|FG000|Overall Study|Adverse Event|1|||
130935567|NCT00558025|471396636|FG001|Overall Study|Adverse Event|1|||
131223777|NCT04380701|472447130|FG021|Overall Study|Lost to Follow-up|0|||
130935568|NCT00558025|471396635|FG000|Overall Study|Withdrawal by Subject|2|||
130935569|NCT00558025|471396636|FG001|Overall Study|Withdrawal by Subject|2|||
130935570|NCT00558025|471396635|FG000|Overall Study|Protocol Violation|1|||
130935571|NCT00558025|471396636|FG001|Overall Study|Protocol Violation|0|||
130935572|NCT01314443|471396637|FG000|Overall Study|Withdrawal by Subject|2|||
130704429|NCT01235442|470541277|FG001|Overall Study|Lost to Follow-up|10|||
130935573|NCT01314443|471396638|FG001|Overall Study|Withdrawal by Subject|1|||
130935574|NCT01314443|471396639|FG002|Overall Study|Withdrawal by Subject|1|||
130935575|NCT01314443|471396640|FG003|Overall Study|Withdrawal by Subject|1|||
130935576|NCT01314443|471396637|FG000|Overall Study|Protocol Violation|2|||
130935577|NCT01314443|471396638|FG001|Overall Study|Protocol Violation|2|||
130935578|NCT01314443|471396639|FG002|Overall Study|Protocol Violation|1|||
130935579|NCT01314443|471396640|FG003|Overall Study|Protocol Violation|1|||
130935580|NCT02709785|471396641|FG000|Overall Study|Withdrawal by Subject|1|||
130935581|NCT02709785|471396642|FG001|Overall Study|Withdrawal by Subject|2|||
130935582|NCT02709785|471396643|FG002|Overall Study|Withdrawal by Subject|1|||
130935583|NCT00276159|471396646|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
130935584|NCT02393547|471396649|FG000|Overall Study|Adverse Event|2|||
130935585|NCT02393547|471396649|FG000|Overall Study|Withdrawal by Subject|3|||
130935586|NCT02393547|471396649|FG000|Overall Study|Lost to Follow-up|1|||
130935587|NCT02927431|471396650|FG000|Overall Study|Withdrawal by Subject|0|||
130935588|NCT02927431|471396651|FG001|Overall Study|Withdrawal by Subject|0|||
130935589|NCT02927431|471396652|FG002|Overall Study|Withdrawal by Subject|1|||
130704430|NCT01235442|470541276|FG000|Overall Study|Death|0|||
130704431|NCT01235442|470541277|FG001|Overall Study|Death|2|||
130935590|NCT00673465|471396653|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
130935591|NCT00673465|471396654|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
130935592|NCT00673465|471396655|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
130935593|NCT00673465|471396656|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
130935594|NCT00673465|471396657|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
130935595|NCT00673465|471396658|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
130935596|NCT00673465|471396659|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
130935597|NCT00673465|471396660|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
130935598|NCT00673465|471396661|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
130935599|NCT00673465|471396662|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
130935600|NCT00673465|471396663|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
130935601|NCT00673465|471396664|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
130935602|NCT00673465|471396653|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935603|NCT00673465|471396654|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935604|NCT00673465|471396655|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935605|NCT00673465|471396656|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935606|NCT00673465|471396657|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
130935607|NCT00673465|471396658|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935608|NCT00673465|471396659|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935609|NCT00673465|471396660|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935610|NCT00673465|471396661|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935611|NCT00673465|471396662|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935612|NCT00673465|471396663|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935613|NCT00673465|471396664|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
130935614|NCT00429104|471396665|FG000|Overall Study|Protocol Violation|1|||
130935615|NCT01829191|471396666|FG000|Overall Study|Relocation|0|||
130935616|NCT01829191|471396667|FG001|Overall Study|Relocation|1|||
130935617|NCT01829191|471396666|FG000|Overall Study|Lens discomfort|0|||
130935618|NCT01829191|471396667|FG001|Overall Study|Lens discomfort|3|||
130935619|NCT01829191|471396666|FG000|Overall Study|Lens handling difficulty|1|||
130935620|NCT01829191|471396667|FG001|Overall Study|Lens handling difficulty|4|||
130935621|NCT01829191|471396666|FG000|Overall Study|Protocol Violation|4|||
130935622|NCT01829191|471396667|FG001|Overall Study|Protocol Violation|1|||
130935623|NCT01829191|471396666|FG000|Overall Study|Withdrawal by Subject|2|||
130935624|NCT01829191|471396667|FG001|Overall Study|Withdrawal by Subject|3|||
130935625|NCT01829191|471396666|FG000|Overall Study|Lost to Follow-up|0|||
130935626|NCT01829191|471396667|FG001|Overall Study|Lost to Follow-up|1|||
130935627|NCT01829191|471396666|FG000|Overall Study|Subject was fit for ortho - k|0|||
130935628|NCT01829191|471396667|FG001|Overall Study|Subject was fit for ortho - k|1|||
130935629|NCT01907815|471396668|FG000|Overall Study|Withdrawal by Subject|1|||
130935630|NCT01907815|471396669|FG001|Overall Study|Withdrawal by Subject|0|||
130935631|NCT01276353|471396670|FG000|Double-blind|Adverse Event|2|||
130935632|NCT01276353|471396671|FG001|Double-blind|Adverse Event|0|||
130935633|NCT01276353|471396670|FG000|Double-blind|Withdrawal by Subject|1|||
130935634|NCT01276353|471396671|FG001|Double-blind|Withdrawal by Subject|0|||
130935635|NCT01276353|471396670|FG000|Extension|Adverse Event|2|||
130935636|NCT01276353|471396671|FG001|Extension|Adverse Event|5|||
130935637|NCT01276353|471396670|FG000|Extension|Withdrawal by Subject|1|||
130935638|NCT01276353|471396671|FG001|Extension|Withdrawal by Subject|2|||
130935639|NCT01276353|471396670|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
130935640|NCT01276353|471396671|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
130935641|NCT01276353|471396670|FG000|Extension|Physician Decision|1|||
130935642|NCT01276353|471396671|FG001|Extension|Physician Decision|0|||
130704432|NCT01235442|470541276|FG000|Overall Study|Pregnancy|1|||
130935643|NCT01276353|471396670|FG000|Extension|Prohibited concomitant medications|0|||
130935644|NCT01276353|471396671|FG001|Extension|Prohibited concomitant medications|1|||
130935645|NCT02205814|471396672|FG000|Overall Study|Lost to Follow-up|0|||
130935646|NCT02205814|471396673|FG001|Overall Study|Lost to Follow-up|0|||
130935647|NCT02205814|471396674|FG002|Overall Study|Lost to Follow-up|0|||
130935648|NCT02205814|471396675|FG003|Overall Study|Lost to Follow-up|1|||
130935649|NCT02205814|471396672|FG000|Overall Study|Lack of Efficacy|1|||
130935650|NCT02205814|471396673|FG001|Overall Study|Lack of Efficacy|0|||
130935651|NCT02205814|471396674|FG002|Overall Study|Lack of Efficacy|1|||
130935652|NCT02205814|471396675|FG003|Overall Study|Lack of Efficacy|1|||
130935653|NCT02205814|471396672|FG000|Overall Study|Physician Decision|0|||
130935654|NCT02205814|471396673|FG001|Overall Study|Physician Decision|0|||
130935655|NCT02205814|471396674|FG002|Overall Study|Physician Decision|1|||
130935656|NCT02205814|471396675|FG003|Overall Study|Physician Decision|0|||
130935657|NCT02205814|471396672|FG000|Overall Study|Protocol Violation|1|||
130935658|NCT02205814|471396673|FG001|Overall Study|Protocol Violation|0|||
130935659|NCT02205814|471396674|FG002|Overall Study|Protocol Violation|0|||
130935660|NCT02205814|471396675|FG003|Overall Study|Protocol Violation|1|||
130935661|NCT02205814|471396672|FG000|Overall Study|Withdrawal by Subject|0|||
130935662|NCT02205814|471396673|FG001|Overall Study|Withdrawal by Subject|1|||
130935663|NCT02205814|471396674|FG002|Overall Study|Withdrawal by Subject|2|||
130935664|NCT02205814|471396675|FG003|Overall Study|Withdrawal by Subject|1|||
130935665|NCT02205814|471396672|FG000|Overall Study|not compliant with study procedures|0|||
130935666|NCT02205814|471396673|FG001|Overall Study|not compliant with study procedures|0|||
130935667|NCT02205814|471396674|FG002|Overall Study|not compliant with study procedures|1|||
130935668|NCT02205814|471396675|FG003|Overall Study|not compliant with study procedures|0|||
130935669|NCT00143403|471396676|FG000|Overall Study|Adverse Event|3|||
130935670|NCT00143403|471396677|FG001|Overall Study|Adverse Event|8|||
130935671|NCT00143403|471396676|FG000|Overall Study|Death|1|||
130935672|NCT00143403|471396677|FG001|Overall Study|Death|0|||
130935673|NCT00143403|471396676|FG000|Overall Study|Withdrawal by Subject|3|||
130935674|NCT00143403|471396677|FG001|Overall Study|Withdrawal by Subject|12|||
130935675|NCT00143403|471396676|FG000|Overall Study|Relapse|15|||
130935676|NCT00143403|471396677|FG001|Overall Study|Relapse|7|||
130935677|NCT00143403|471396676|FG000|Overall Study|Protocol Violation|2|||
130935678|NCT00143403|471396677|FG001|Overall Study|Protocol Violation|2|||
130935679|NCT00143403|471396676|FG000|Overall Study|specified by site|4|||
130935680|NCT00143403|471396677|FG001|Overall Study|specified by site|9|||
130935681|NCT00143403|471396676|FG000|Overall Study|Randomized Not Treated|7|||
130935682|NCT00143403|471396677|FG001|Overall Study|Randomized Not Treated|8|||
130935683|NCT00514540|471396678|FG000|First-Line Chemo|Withdrawal by Subject|1|||
130935684|NCT00514540|471396678|FG000|First-Line Chemo|Protocol Violation|7|||
130935685|NCT00514540|471396678|FG000|Second-Line|Physician/Patient Decision|31|||
130935686|NCT00587639|471396679|FG000|Overall Study|Withdrawal by Subject|1|||
130935687|NCT01996982|471396680|FG000|Overall Study|PI/team left institution|7|||
130935688|NCT01195415|471396681|FG000|Overall Study|No repeat biopsy due to progression|2|||
130935689|NCT00533845|471396682|FG000|Overall Study|Physician Decision|1|||
130935690|NCT00533845|471396683|FG001|Overall Study|Physician Decision|0|||
130935691|NCT01288469|471396689|FG000|Overall Study|Adverse Event|4|||
130935692|NCT01288469|471396690|FG001|Overall Study|Adverse Event|1|||
130935693|NCT01288469|471396691|FG002|Overall Study|Adverse Event|1|||
130935694|NCT01288469|471396689|FG000|Overall Study|Poor compliance to protocol|0|||
130935695|NCT01288469|471396690|FG001|Overall Study|Poor compliance to protocol|1|||
130935696|NCT01288469|471396691|FG002|Overall Study|Poor compliance to protocol|0|||
130935697|NCT01288469|471396689|FG000|Overall Study|Participant Moved|1|||
130935698|NCT01288469|471396690|FG001|Overall Study|Participant Moved|0|||
130935699|NCT01288469|471396691|FG002|Overall Study|Participant Moved|0|||
130935700|NCT01288469|471396689|FG000|Overall Study|Consent withdrawn by subject|1|||
130935701|NCT01288469|471396690|FG001|Overall Study|Consent withdrawn by subject|1|||
130935702|NCT01288469|471396691|FG002|Overall Study|Consent withdrawn by subject|1|||
130935703|NCT01288469|471396689|FG000|Overall Study|Exclusion criteria finally met|1|||
130935704|NCT01288469|471396690|FG001|Overall Study|Exclusion criteria finally met|0|||
130935705|NCT01288469|471396691|FG002|Overall Study|Exclusion criteria finally met|0|||
130935706|NCT00110149|471396692|FG000|Overall Study|Physician Decision|3|||
130935707|NCT00563381|471396693|FG000|Overall Study|Adverse Event|264|||
130935708|NCT00563381|471396694|FG001|Overall Study|Adverse Event|292|||
130935709|NCT00563381|471396693|FG000|Overall Study|Protocol Violation|66|||
130935710|NCT00563381|471396694|FG001|Overall Study|Protocol Violation|74|||
130935711|NCT00563381|471396693|FG000|Overall Study|Lost to Follow-up|7|||
130935712|NCT00563381|471396694|FG001|Overall Study|Lost to Follow-up|15|||
130935713|NCT00563381|471396693|FG000|Overall Study|Withdrawal by Subject|192|||
130935714|NCT00563381|471396694|FG001|Overall Study|Withdrawal by Subject|209|||
130935715|NCT00563381|471396693|FG000|Overall Study|Lack of Efficacy|32|||
130935716|NCT00563381|471396694|FG001|Overall Study|Lack of Efficacy|24|||
130935717|NCT00563381|471396693|FG000|Overall Study|Individual different reasons|24|||
130935718|NCT00563381|471396694|FG001|Overall Study|Individual different reasons|34|||
130935719|NCT02452398|471396697|FG000|Overall Study|Adverse Event|1|||
130935720|NCT02452398|471396697|FG000|Overall Study|Lost to Follow-up|28|||
131223778|NCT04380701|472447131|FG022|Overall Study|Lost to Follow-up|0|||
130704433|NCT01235442|470541277|FG001|Overall Study|Pregnancy|1|||
130935721|NCT02452398|471396697|FG000|Overall Study|Physician Decision|2|||
130935722|NCT02452398|471396697|FG000|Overall Study|Withdrawal by Subject|6|||
130935723|NCT02452398|471396697|FG000|Overall Study|Moved away|4|||
130935724|NCT02326025|471396701|FG000|Overall Study|Adverse Event|3|||
130935725|NCT02326025|471396702|FG001|Overall Study|Adverse Event|0|||
130935726|NCT02326025|471396701|FG000|Overall Study|Physician Decision|1|||
130935727|NCT02326025|471396702|FG001|Overall Study|Physician Decision|2|||
130935728|NCT02326025|471396701|FG000|Overall Study|Physician and Participant Decision|1|||
130935729|NCT02326025|471396702|FG001|Overall Study|Physician and Participant Decision|0|||
130935730|NCT02326025|471396701|FG000|Overall Study|Withdrawal by Subject|0|||
130935731|NCT02326025|471396702|FG001|Overall Study|Withdrawal by Subject|2|||
130935732|NCT02326025|471396701|FG000|Overall Study|Protocol Violation|0|||
130935733|NCT02326025|471396702|FG001|Overall Study|Protocol Violation|1|||
130935734|NCT00001723|471396703|FG000|Overall Study|Lack of Efficacy|6|||
130935735|NCT00001723|471396704|FG001|Overall Study|Lack of Efficacy|7|||
130935736|NCT00001723|471396703|FG000|Overall Study|Lack of family interest|4|||
130935737|NCT00001723|471396704|FG001|Overall Study|Lack of family interest|5|||
130935738|NCT00001723|471396703|FG000|Overall Study|Lost to Follow-up|2|||
130935739|NCT00001723|471396704|FG001|Overall Study|Lost to Follow-up|2|||
130935740|NCT00001723|471396703|FG000|Overall Study|medication intolerance|1|||
130935741|NCT00001723|471396704|FG001|Overall Study|medication intolerance|2|||
130935742|NCT00927784|471396705|FG000|Overall Study|Death|1|||
130935743|NCT00927784|471396706|FG001|Overall Study|Death|0|||
130935744|NCT00927784|471396705|FG000|Overall Study|Withdrawal by Subject|1|||
130935745|NCT00927784|471396706|FG001|Overall Study|Withdrawal by Subject|0|||
130935746|NCT02170051|471396707|FG000|Overall Study|Withdrawal by Subject|10|||
130935747|NCT02170051|471396708|FG001|Overall Study|Withdrawal by Subject|10|||
130935748|NCT02170051|471396707|FG000|Overall Study|Lost to Follow-up|1|||
130935749|NCT02170051|471396708|FG001|Overall Study|Lost to Follow-up|3|||
130935750|NCT02643082|471396709|FG000|Period 1|Adverse Event|1|||
130935751|NCT02643082|471396710|FG001|Period 1|Adverse Event|0|||
130935752|NCT01867021|471396711|FG000|Overall Study|Adverse Event|0|||
130935753|NCT01867021|471396712|FG001|Overall Study|Adverse Event|1|||
130935754|NCT01867021|471396711|FG000|Overall Study|Not Eligible|0|||
130935755|NCT01867021|471396712|FG001|Overall Study|Not Eligible|1|||
130935756|NCT01867021|471396711|FG000|Overall Study|Death|1|||
130935757|NCT01867021|471396712|FG001|Overall Study|Death|0|||
130935758|NCT01867021|471396711|FG000|Overall Study|Lost to Follow-up|0|||
130935759|NCT01867021|471396712|FG001|Overall Study|Lost to Follow-up|2|||
130935760|NCT01867021|471396711|FG000|Overall Study|Withdrawal by Subject|1|||
130935761|NCT01867021|471396712|FG001|Overall Study|Withdrawal by Subject|6|||
130935762|NCT00881712|471396713|FG000|Overall Study|Death|1|||
130935763|NCT00881712|471396714|FG001|Overall Study|Death|0|||
130935764|NCT00881712|471396715|FG002|Overall Study|Death|0|||
130935765|NCT00881712|471396713|FG000|Overall Study|Withdrawal by Subject|1|||
130935766|NCT00881712|471396714|FG001|Overall Study|Withdrawal by Subject|0|||
130935767|NCT00881712|471396715|FG002|Overall Study|Withdrawal by Subject|0|||
130935768|NCT02505867|471396720|FG000|Overall Study|Lack of Efficacy|6|||
130935769|NCT02505867|471396721|FG001|Overall Study|Lack of Efficacy|6|||
130935770|NCT01862874|471396722|FG000|Overall Study|Randomized not treated|1|||
130935771|NCT01862874|471396723|FG001|Overall Study|Randomized not treated|0|||
130935772|NCT01862874|471396722|FG000|Overall Study|Adverse Event|0|||
130935773|NCT01862874|471396723|FG001|Overall Study|Adverse Event|3|||
130935774|NCT01862874|471396722|FG000|Overall Study|Lost to Follow-up|26|||
130935775|NCT01862874|471396723|FG001|Overall Study|Lost to Follow-up|29|||
130935776|NCT01862874|471396722|FG000|Overall Study|Physician Decision|5|||
130935777|NCT01862874|471396723|FG001|Overall Study|Physician Decision|3|||
130935778|NCT01862874|471396722|FG000|Overall Study|Withdrawn by parent/guardian|1|||
130935779|NCT01862874|471396723|FG001|Overall Study|Withdrawn by parent/guardian|1|||
130935780|NCT01862874|471396722|FG000|Overall Study|Withdrawal by Subject|46|||
130935781|NCT01862874|471396723|FG001|Overall Study|Withdrawal by Subject|40|||
130935782|NCT01862874|471396722|FG000|Overall Study|Death|0|||
130935783|NCT01862874|471396723|FG001|Overall Study|Death|1|||
130935784|NCT03241342|471396731|FG000|Overall Study|Adverse Event|5|||
130935785|NCT03241342|471396732|FG001|Overall Study|Adverse Event|8|||
130935786|NCT03241342|471396733|FG002|Overall Study|Adverse Event|4|||
130935787|NCT03241342|471396731|FG000|Overall Study|Lack of Efficacy|0|||
130935788|NCT03241342|471396732|FG001|Overall Study|Lack of Efficacy|0|||
130935789|NCT03241342|471396733|FG002|Overall Study|Lack of Efficacy|1|||
130935790|NCT03241342|471396731|FG000|Overall Study|noncompliance with study drug|2|||
130935791|NCT03241342|471396732|FG001|Overall Study|noncompliance with study drug|1|||
130935792|NCT03241342|471396733|FG002|Overall Study|noncompliance with study drug|1|||
130704434|NCT01235442|470541276|FG000|Overall Study|Ineligibility determined|5|||
130935793|NCT03241342|471396731|FG000|Overall Study|sponsor decision|0|||
130935794|NCT03241342|471396732|FG001|Overall Study|sponsor decision|1|||
130935795|NCT03241342|471396733|FG002|Overall Study|sponsor decision|2|||
130935796|NCT03241342|471396731|FG000|Overall Study|not reported|15|||
130935797|NCT03241342|471396732|FG001|Overall Study|not reported|21|||
130935798|NCT03241342|471396733|FG002|Overall Study|not reported|19|||
130935799|NCT01846611|471396735|FG000|Overall Study|Lost to Follow-up|4|||
130935800|NCT01846611|471396736|FG001|Overall Study|Lost to Follow-up|6|||
130935801|NCT01846611|471396735|FG000|Overall Study|Withdrawal by Subject|15|||
130935802|NCT01846611|471396736|FG001|Overall Study|Withdrawal by Subject|19|||
130935803|NCT01846611|471396735|FG000|Overall Study|Other|19|||
130935804|NCT01846611|471396736|FG001|Overall Study|Other|18|||
130935805|NCT00662363|471396737|FG000|Overall Study|Withdrawal by Subject|6|||
130935806|NCT00662363|471396738|FG001|Overall Study|Withdrawal by Subject|5|||
130935807|NCT00662363|471396737|FG000|Overall Study|Adverse Event|0|||
130935808|NCT00662363|471396738|FG001|Overall Study|Adverse Event|3|||
130935809|NCT00662363|471396737|FG000|Overall Study|Discharged early from rehab|4|||
130935810|NCT00662363|471396738|FG001|Overall Study|Discharged early from rehab|1|||
130935811|NCT00662363|471396737|FG000|Overall Study|Protocol Violation|1|||
130935812|NCT00662363|471396738|FG001|Overall Study|Protocol Violation|1|||
130935813|NCT01134783|471397932|FG000|Overall Study|Pregnancy|16|||
130935814|NCT01134783|471397933|FG001|Overall Study|Pregnancy|8|||
130935815|NCT01134783|471397932|FG000|Overall Study|Withdrawal by Subject|15|||
130935816|NCT01134783|471397933|FG001|Overall Study|Withdrawal by Subject|9|||
130935817|NCT01134783|471397932|FG000|Overall Study|Lost to Follow-up|5|||
130935818|NCT01134783|471397933|FG001|Overall Study|Lost to Follow-up|20|||
130935819|NCT02329730|471397935|FG000|Overall Study|Protocol Violation|0|||
130935820|NCT02329730|471397936|FG001|Overall Study|Protocol Violation|0|||
130935821|NCT02329730|471397937|FG002|Overall Study|Protocol Violation|0|||
130935822|NCT02329730|471397938|FG003|Overall Study|Protocol Violation|0|||
130935823|NCT02329730|471397939|FG004|Overall Study|Protocol Violation|2|||
130935824|NCT02329730|471397940|FG005|Overall Study|Protocol Violation|2|||
130935825|NCT02329730|471397941|FG006|Overall Study|Protocol Violation|0|||
130935826|NCT02329730|471397942|FG007|Overall Study|Protocol Violation|0|||
130935827|NCT02329730|471397943|FG008|Overall Study|Protocol Violation|0|||
130935828|NCT02329730|471397944|FG009|Overall Study|Protocol Violation|0|||
130935829|NCT02329730|471397945|FG010|Overall Study|Protocol Violation|0|||
130935830|NCT02329730|471397946|FG011|Overall Study|Protocol Violation|0|||
130935831|NCT02329730|471397935|FG000|Overall Study|Withdrawal by Subject|0|||
130935832|NCT02329730|471397936|FG001|Overall Study|Withdrawal by Subject|0|||
130935833|NCT02329730|471397937|FG002|Overall Study|Withdrawal by Subject|0|||
130935834|NCT02329730|471397938|FG003|Overall Study|Withdrawal by Subject|0|||
130935835|NCT02329730|471397939|FG004|Overall Study|Withdrawal by Subject|1|||
130935836|NCT02329730|471397940|FG005|Overall Study|Withdrawal by Subject|0|||
130935837|NCT02329730|471397941|FG006|Overall Study|Withdrawal by Subject|1|||
130935838|NCT02329730|471397942|FG007|Overall Study|Withdrawal by Subject|1|||
130935839|NCT02329730|471397943|FG008|Overall Study|Withdrawal by Subject|1|||
130935840|NCT02329730|471397944|FG009|Overall Study|Withdrawal by Subject|1|||
130935841|NCT02329730|471397945|FG010|Overall Study|Withdrawal by Subject|0|||
130935842|NCT02329730|471397946|FG011|Overall Study|Withdrawal by Subject|0|||
130935843|NCT02392247|471397951|FG000|Overall Study|Withdrawal by Subject|1|||
130935844|NCT02392247|471397951|FG000|Overall Study|Surgery cancelled; no data|1|||
130935845|NCT03010254|471397952|FG000|Overall Study|Adverse Event|0|||
130935846|NCT03010254|471397953|FG001|Overall Study|Adverse Event|1|||
130935847|NCT03010254|471397952|FG000|Overall Study|Lost to Follow-up|4|||
130935848|NCT03010254|471397953|FG001|Overall Study|Lost to Follow-up|0|||
130935849|NCT03010254|471397952|FG000|Overall Study|Withdrawal by Subject|1|||
130935850|NCT03010254|471397953|FG001|Overall Study|Withdrawal by Subject|1|||
130935851|NCT03010254|471397952|FG000|Overall Study|Other|2|||
130935852|NCT03010254|471397953|FG001|Overall Study|Other|3|||
130935853|NCT00664742|471397954|FG000|Overall Study|Withdrawn due to adverse events|3|||
130935854|NCT00664742|471397954|FG000|Overall Study|Withdrawal by Subject|31|||
130935855|NCT00664742|471397954|FG000|Overall Study|Lost to Follow-up|92|||
130935856|NCT04317066|471397955|FG000|Overall Study|Sponsor decision|5|||
130935857|NCT04317066|471397955|FG000|Overall Study|Death|2|||
130935858|NCT00848081|471397958|FG000|Overall Study|Adverse Event|6|||
130935859|NCT00848081|471397959|FG001|Overall Study|Adverse Event|7|||
130935860|NCT00848081|471397958|FG000|Overall Study|Protocol Violation|8|||
130935861|NCT00848081|471397959|FG001|Overall Study|Protocol Violation|5|||
130935862|NCT00848081|471397958|FG000|Overall Study|Lost to Follow-up|1|||
130935863|NCT00848081|471397959|FG001|Overall Study|Lost to Follow-up|0|||
130935864|NCT00848081|471397958|FG000|Overall Study|Physician Decision|0|||
130935865|NCT00848081|471397959|FG001|Overall Study|Physician Decision|3|||
130935866|NCT00848081|471397958|FG000|Overall Study|Withdrawal by Subject|5|||
130935867|NCT00848081|471397959|FG001|Overall Study|Withdrawal by Subject|3|||
130935868|NCT02014597|471397960|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
130935869|NCT02014597|471397961|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
130935870|NCT02825992|471397962|FG000|Overall Study|Withdrawal by Subject|4|||
130935871|NCT02825992|471397962|FG000|Overall Study|Lost to Follow-up|2|||
130935872|NCT02825992|471397962|FG000|Overall Study|Procedure terminated|2|||
130935873|NCT02279173|471397963|FG000|Overall Study|Protocol-specified Criteria|67|||
130935874|NCT02279173|471397963|FG000|Overall Study|Withdrawal by Subject|20|||
130935875|NCT02279173|471397963|FG000|Overall Study|Decision by Sponsor|4|||
130935876|NCT02279173|471397963|FG000|Overall Study|Lost to Follow-up|3|||
130935877|NCT00754624|471397964|FG000|Overall Study|Adverse Event|16|||
130935878|NCT00754624|471397964|FG000|Overall Study|Death|1|||
130935879|NCT00754624|471397964|FG000|Overall Study|Physician Decision|8|||
130935880|NCT00754624|471397964|FG000|Overall Study|Protocol Violation|1|||
130935881|NCT00754624|471397964|FG000|Overall Study|Withdrawal by Subject|28|||
130935882|NCT00754624|471397964|FG000|Overall Study|Various|12|||
130935883|NCT00754624|471397964|FG000|Overall Study|Lost to Follow-up|3|||
130935884|NCT00715078|471397967|FG000|Overall Study|Death|29|||
130935885|NCT00715078|471397968|FG001|Overall Study|Death|36|||
130935886|NCT00715078|471397969|FG002|Overall Study|Death|36|||
130935887|NCT00715078|471397967|FG000|Overall Study|Withdrawal by Subject|1|||
130935888|NCT00715078|471397968|FG001|Overall Study|Withdrawal by Subject|0|||
130935889|NCT00715078|471397969|FG002|Overall Study|Withdrawal by Subject|1|||
130935890|NCT00715078|471397967|FG000|Overall Study|Unable to start due to disease prog.|0|||
130935891|NCT00715078|471397968|FG001|Overall Study|Unable to start due to disease prog.|0|||
130935892|NCT00715078|471397969|FG002|Overall Study|Unable to start due to disease prog.|1|||
130935893|NCT00503308|471397970|FG000|Overall Study|Protocol Violation|2|||
130935894|NCT00503308|471397971|FG001|Overall Study|Protocol Violation|1|||
130935895|NCT02233309|471397974|FG000|Overall Study|Physician Decision|5|||
130935896|NCT00232817|471397975|FG000|Overall Study|Protocol Violation|2|||
130935897|NCT00232817|471397976|FG001|Overall Study|Protocol Violation|1|||
130935898|NCT00799487|471397977|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
130935899|NCT00799487|471397978|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
130935900|NCT00799487|471397979|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
130935901|NCT00799487|471397977|FG000|Dose Adjustment Period|Adverse Event|2|||
130935902|NCT00799487|471397978|FG001|Dose Adjustment Period|Adverse Event|0|||
130935903|NCT00799487|471397979|FG002|Dose Adjustment Period|Adverse Event|0|||
130935904|NCT00799487|471397977|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
130935905|NCT00799487|471397978|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
130935906|NCT00799487|471397979|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
130935907|NCT00799487|471397977|FG000|Dose Adjustment Period|Investigator Discretion|2|||
130935908|NCT00799487|471397978|FG001|Dose Adjustment Period|Investigator Discretion|0|||
130935909|NCT00799487|471397979|FG002|Dose Adjustment Period|Investigator Discretion|0|||
130935910|NCT00799487|471397977|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
130935911|NCT00799487|471397978|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
130935912|NCT00799487|471397979|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
130935913|NCT00799487|471397977|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
130935914|NCT00799487|471397978|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
130935915|NCT00799487|471397979|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
130935916|NCT00799487|471397977|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
130935917|NCT00799487|471397978|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
130935918|NCT00799487|471397979|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
130935919|NCT00799487|471397977|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
130935920|NCT00799487|471397978|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
130935921|NCT00799487|471397979|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
130935922|NCT00799487|471397977|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
130935923|NCT00799487|471397978|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
130935924|NCT00799487|471397979|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
130935925|NCT00799487|471397977|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
130935926|NCT00799487|471397978|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
130935927|NCT00799487|471397979|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
130935928|NCT00799487|471397977|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
130935929|NCT00799487|471397978|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
130935930|NCT00799487|471397979|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
130935931|NCT00799487|471397977|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
130935932|NCT00799487|471397978|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
130935933|NCT00799487|471397979|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
130935934|NCT01463878|471397980|FG000|Overall Study|no longer met criteria for tube feed|2|||
130935935|NCT01463878|471397981|FG001|Overall Study|no longer met criteria for tube feed|2|||
130935936|NCT02436889|471397982|FG000|Overall Study|No improvement in symptoms|1|||
130771117|NCT00424593|470789824|FG001|Acute Double-Blind Period|Adverse Event|7|||
130935937|NCT02436889|471397983|FG001|Overall Study|No improvement in symptoms|0|||
130935938|NCT02436889|471397982|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
130935939|NCT02436889|471397983|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
130935940|NCT01084174|471397984|FG000|Overall Study|gastrointestinal symptoms|1|||
131035213|NCT01396278|471763909|FG001|Overall Study|Withdraw due to trial termination|1|||
130935941|NCT01084174|471397985|FG001|Overall Study|gastrointestinal symptoms|1|||
130935942|NCT01084174|471397984|FG000|Overall Study|Eosinophilic esophagitis|0|||
130935943|NCT01084174|471397985|FG001|Overall Study|Eosinophilic esophagitis|1|||
130935944|NCT01084174|471397984|FG000|Overall Study|Anaphylaxis|0|||
131120549|NCT01994382|472072356|FG015|Overall Study|Lost to Follow-up|0|||
131120550|NCT01994382|472072357|FG016|Overall Study|Lost to Follow-up|0|||
131120551|NCT01994382|472072341|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120552|NCT01994382|472072342|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120553|NCT01994382|472072343|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120554|NCT01994382|472072344|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120555|NCT01994382|472072345|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120556|NCT01994382|472072346|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120557|NCT01994382|472072347|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120558|NCT01994382|472072348|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120559|NCT01994382|472072349|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120560|NCT01994382|472072350|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120561|NCT01994382|472072351|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
131120562|NCT01994382|472072352|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120563|NCT01994382|472072353|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
131120564|NCT01994382|472072354|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130704435|NCT01235442|470541277|FG001|Overall Study|Ineligibility determined|4|||
130704436|NCT01235442|470541276|FG000|Overall Study|Protocol Violation|3|||
130935945|NCT01084174|471397985|FG001|Overall Study|Anaphylaxis|1|||
130935946|NCT01084174|471397984|FG000|Overall Study|Participant noncompliance|0|||
130935947|NCT01084174|471397985|FG001|Overall Study|Participant noncompliance|1|||
130935948|NCT00849381|471397986|FG000|Overall Study|Adverse Event|1|||
130935949|NCT00849381|471397986|FG000|Overall Study|Lost to Follow-up|129|||
130935950|NCT00849381|471397986|FG000|Overall Study|Protocol Violation|5|||
130935951|NCT00849381|471397986|FG000|Overall Study|Withdrawal by Subject|6|||
130935952|NCT00849381|471397986|FG000|Overall Study|Other|4|||
130935953|NCT02618434|471397987|FG000|Overall Study|Withdrawal by Subject|0|||
130935954|NCT02618434|471397988|FG001|Overall Study|Withdrawal by Subject|2|||
130935955|NCT02618434|471397989|FG002|Overall Study|Withdrawal by Subject|3|||
130935956|NCT02618434|471397987|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
130935957|NCT02618434|471397988|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
130935958|NCT02618434|471397989|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
130935959|NCT02618434|471397987|FG000|Overall Study|Lost to Follow-up|3|||
130935960|NCT02618434|471397988|FG001|Overall Study|Lost to Follow-up|1|||
130935961|NCT02618434|471397989|FG002|Overall Study|Lost to Follow-up|3|||
130935962|NCT02618434|471397987|FG000|Overall Study|Adverse Event|1|||
130935963|NCT02618434|471397988|FG001|Overall Study|Adverse Event|0|||
130935964|NCT02618434|471397989|FG002|Overall Study|Adverse Event|12|||
130935965|NCT02618434|471397987|FG000|Overall Study|Physician Decision|0|||
130935966|NCT02618434|471397988|FG001|Overall Study|Physician Decision|1|||
130935967|NCT02618434|471397989|FG002|Overall Study|Physician Decision|0|||
130935968|NCT02618434|471397987|FG000|Overall Study|Protocol Violation|0|||
130935969|NCT02618434|471397988|FG001|Overall Study|Protocol Violation|0|||
130935970|NCT02618434|471397989|FG002|Overall Study|Protocol Violation|1|||
130935971|NCT02618434|471397987|FG000|Overall Study|Other, Multiple categories|1|||
130935972|NCT02618434|471397988|FG001|Overall Study|Other, Multiple categories|1|||
130935973|NCT02618434|471397989|FG002|Overall Study|Other, Multiple categories|1|||
130935974|NCT02289898|471397994|FG000|Overall Study|Death|5|||
130935975|NCT02289898|471397995|FG001|Overall Study|Death|4|||
130935976|NCT02289898|471397996|FG002|Overall Study|Death|3|||
130935977|NCT02289898|471397994|FG000|Overall Study|Physician Decision|2|||
130935978|NCT02289898|471397995|FG001|Overall Study|Physician Decision|5|||
130935979|NCT02289898|471397996|FG002|Overall Study|Physician Decision|2|||
130935980|NCT02289898|471397994|FG000|Overall Study|Withdrawal by Subject|0|||
130935981|NCT02289898|471397995|FG001|Overall Study|Withdrawal by Subject|4|||
130935982|NCT02289898|471397996|FG002|Overall Study|Withdrawal by Subject|1|||
130935983|NCT02289898|471397994|FG000|Overall Study|Adverse Event|3|||
130935984|NCT02289898|471397995|FG001|Overall Study|Adverse Event|5|||
130935985|NCT02289898|471397996|FG002|Overall Study|Adverse Event|5|||
130704437|NCT01235442|470541277|FG001|Overall Study|Protocol Violation|3|||
130704438|NCT01235442|470541276|FG000|Overall Study|Adverse Event|4|||
130704439|NCT01235442|470541277|FG001|Overall Study|Adverse Event|6|||
130935986|NCT02289898|471397994|FG000|Overall Study|Disease progression|34|||
130935987|NCT02289898|471397995|FG001|Overall Study|Disease progression|28|||
130935988|NCT02289898|471397996|FG002|Overall Study|Disease progression|34|||
130935989|NCT02289898|471397994|FG000|Overall Study|Use of another anticancer therapy|0|||
130935990|NCT02289898|471397995|FG001|Overall Study|Use of another anticancer therapy|0|||
130935991|NCT02289898|471397996|FG002|Overall Study|Use of another anticancer therapy|1|||
130935992|NCT02289898|471397994|FG000|Overall Study|Other|8|||
130704440|NCT01235442|470541276|FG000|Overall Study|Withdrawal by Subject|15|||
130935993|NCT02289898|471397995|FG001|Overall Study|Other|7|||
130935994|NCT02289898|471397996|FG002|Overall Study|Other|10|||
130935995|NCT01402544|471397997|FG000|Overall Study|Withdrawal by Subject|6|||
130935996|NCT01828281|471397998|FG000|Overall Study|Withdrawal by Subject|1|||
130935997|NCT01828281|471397999|FG001|Overall Study|Withdrawal by Subject|0|||
130935998|NCT03070782|471398000|FG000|Overall Study|Adverse Event|3|||
130935999|NCT03070782|471398001|FG001|Overall Study|Adverse Event|0|||
130936000|NCT03070782|471398002|FG002|Overall Study|Adverse Event|3|||
130936001|NCT03070782|471398003|FG003|Overall Study|Adverse Event|1|||
130936002|NCT03070782|471398004|FG004|Overall Study|Adverse Event|6|||
130936003|NCT03070782|471398005|FG005|Overall Study|Adverse Event|2|||
130936004|NCT03070782|471398000|FG000|Overall Study|Withdrawal by Subject|2|||
130936005|NCT03070782|471398001|FG001|Overall Study|Withdrawal by Subject|1|||
130936006|NCT03070782|471398002|FG002|Overall Study|Withdrawal by Subject|1|||
130936007|NCT03070782|471398003|FG003|Overall Study|Withdrawal by Subject|0|||
130936008|NCT03070782|471398004|FG004|Overall Study|Withdrawal by Subject|4|||
130936009|NCT03070782|471398005|FG005|Overall Study|Withdrawal by Subject|3|||
130936010|NCT03070782|471398000|FG000|Overall Study|Reason Not Specified|2|||
130936011|NCT03070782|471398001|FG001|Overall Study|Reason Not Specified|0|||
130936012|NCT03070782|471398002|FG002|Overall Study|Reason Not Specified|0|||
130936013|NCT03070782|471398003|FG003|Overall Study|Reason Not Specified|1|||
130936014|NCT03070782|471398004|FG004|Overall Study|Reason Not Specified|2|||
130936015|NCT03070782|471398005|FG005|Overall Study|Reason Not Specified|1|||
130936016|NCT03070782|471398000|FG000|Overall Study|Ineligibility|0|||
130936017|NCT03070782|471398001|FG001|Overall Study|Ineligibility|0|||
130936018|NCT03070782|471398002|FG002|Overall Study|Ineligibility|0|||
130936019|NCT03070782|471398003|FG003|Overall Study|Ineligibility|1|||
130936020|NCT03070782|471398004|FG004|Overall Study|Ineligibility|0|||
130936021|NCT03070782|471398005|FG005|Overall Study|Ineligibility|1|||
130936022|NCT03070782|471398000|FG000|Overall Study|Pregnancy|0|||
130936023|NCT03070782|471398001|FG001|Overall Study|Pregnancy|0|||
131120565|NCT01994382|472072355|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
131120566|NCT01994382|472072356|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
131120567|NCT01994382|472072357|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
131120568|NCT01994382|472072341|FG000|Overall Study|Protocol violation/noncompliance|0|||
131120569|NCT01994382|472072342|FG001|Overall Study|Protocol violation/noncompliance|0|||
130936024|NCT03070782|471398002|FG002|Overall Study|Pregnancy|0|||
130936025|NCT03070782|471398003|FG003|Overall Study|Pregnancy|1|||
130936026|NCT03070782|471398004|FG004|Overall Study|Pregnancy|0|||
130936027|NCT03070782|471398005|FG005|Overall Study|Pregnancy|0|||
130936028|NCT03070782|471398000|FG000|Overall Study|Investigator Judgement|0|||
130936029|NCT03070782|471398001|FG001|Overall Study|Investigator Judgement|0|||
130936030|NCT03070782|471398002|FG002|Overall Study|Investigator Judgement|0|||
130936031|NCT03070782|471398003|FG003|Overall Study|Investigator Judgement|1|||
130936032|NCT03070782|471398004|FG004|Overall Study|Investigator Judgement|0|||
130936033|NCT03070782|471398005|FG005|Overall Study|Investigator Judgement|0|||
130936034|NCT01083576|471398006|FG000|Overall Study|Treatment Failure|6|||
130936035|NCT01083576|471398007|FG001|Overall Study|Treatment Failure|1|||
130936036|NCT03527966|471398008|FG000|Overall Study|Lost to Follow-up|3|||
130936037|NCT03527966|471398009|FG001|Overall Study|Lost to Follow-up|0|||
130936038|NCT00487747|471398010|FG000|Overall Study|Adverse Event|1|||
130936039|NCT00487747|471398010|FG000|Overall Study|Lost to Follow-up|9|||
130936040|NCT00487747|471398010|FG000|Overall Study|Lack of Efficacy|1|||
130936041|NCT00333866|471398011|FG000|Overall Study|Adverse Event|23|||
130936042|NCT00333866|471398012|FG001|Overall Study|Adverse Event|37|||
130936043|NCT00333866|471398013|FG002|Overall Study|Adverse Event|38|||
130936044|NCT00333866|471398014|FG003|Overall Study|Adverse Event|47|||
130936045|NCT00333866|471398011|FG000|Overall Study|Other|3|||
130936046|NCT00333866|471398012|FG001|Overall Study|Other|2|||
130936047|NCT00333866|471398013|FG002|Overall Study|Other|2|||
130936048|NCT00333866|471398014|FG003|Overall Study|Other|2|||
130936049|NCT00333866|471398011|FG000|Overall Study|Lack of Efficacy|8|||
130936050|NCT00333866|471398012|FG001|Overall Study|Lack of Efficacy|6|||
130936051|NCT00333866|471398013|FG002|Overall Study|Lack of Efficacy|3|||
130936052|NCT00333866|471398014|FG003|Overall Study|Lack of Efficacy|5|||
130936053|NCT00333866|471398011|FG000|Overall Study|Lost to Follow-up|1|||
130936054|NCT00333866|471398012|FG001|Overall Study|Lost to Follow-up|2|||
130936055|NCT00333866|471398013|FG002|Overall Study|Lost to Follow-up|2|||
130936056|NCT00333866|471398014|FG003|Overall Study|Lost to Follow-up|2|||
130936057|NCT00333866|471398011|FG000|Overall Study|Withdrawal by Subject|8|||
130936058|NCT00333866|471398012|FG001|Overall Study|Withdrawal by Subject|14|||
130936059|NCT00333866|471398013|FG002|Overall Study|Withdrawal by Subject|4|||
130936060|NCT00333866|471398014|FG003|Overall Study|Withdrawal by Subject|9|||
130936061|NCT00333866|471398011|FG000|Overall Study|Randomized but not Treated|5|||
130936062|NCT00333866|471398012|FG001|Overall Study|Randomized but not Treated|3|||
130936063|NCT00333866|471398013|FG002|Overall Study|Randomized but not Treated|2|||
130936064|NCT00333866|471398014|FG003|Overall Study|Randomized but not Treated|1|||
130936065|NCT01957553|471398031|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
130936066|NCT01957553|471398032|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
130936067|NCT01957553|471398031|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
130936068|NCT01957553|471398032|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
131120570|NCT01994382|472072343|FG002|Overall Study|Protocol violation/noncompliance|0|||
131120571|NCT01994382|472072344|FG003|Overall Study|Protocol violation/noncompliance|0|||
131120572|NCT01994382|472072345|FG004|Overall Study|Protocol violation/noncompliance|0|||
131120573|NCT01994382|472072346|FG005|Overall Study|Protocol violation/noncompliance|0|||
131120574|NCT01994382|472072347|FG006|Overall Study|Protocol violation/noncompliance|0|||
131120575|NCT01994382|472072348|FG007|Overall Study|Protocol violation/noncompliance|0|||
130936069|NCT01957553|471398031|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
130936070|NCT01957553|471398032|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
130936071|NCT01957553|471398031|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
130936072|NCT01957553|471398032|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
130936073|NCT01957553|471398031|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
130936074|NCT01957553|471398032|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
130936075|NCT01957553|471398031|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
130936076|NCT01957553|471398032|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
130936077|NCT01957553|471398031|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
130936078|NCT01957553|471398032|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
130936079|NCT01957553|471398031|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
130936080|NCT01957553|471398032|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
130936081|NCT01957553|471398031|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
130936082|NCT01957553|471398032|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
130936083|NCT02733367|471398033|FG000|Overall Study|Withdrawal by Subject|6|||
130936084|NCT01348347|471398034|FG000|Overall Study|Withdrawal by Subject|1|||
130936085|NCT01348347|471398035|FG001|Overall Study|Withdrawal by Subject|1|||
130936086|NCT01348347|471398036|FG002|Overall Study|Withdrawal by Subject|1|||
130936087|NCT01348347|471398034|FG000|Overall Study|Progressive disease|2|||
130936088|NCT01348347|471398035|FG001|Overall Study|Progressive disease|5|||
130936089|NCT01348347|471398036|FG002|Overall Study|Progressive disease|5|||
130936090|NCT00748033|471398037|FG000|Overall Study|Adverse Event|0|||
130936091|NCT00748033|471398038|FG001|Overall Study|Adverse Event|1|||
130936092|NCT03060629|471398044|FG000|Overall Study|Death|4|||
130936093|NCT03060629|471398045|FG001|Overall Study|Death|5|||
130936094|NCT03060629|471398044|FG000|Overall Study|Withdrawal by Subject|50|||
130936095|NCT03060629|471398045|FG001|Overall Study|Withdrawal by Subject|35|||
130936096|NCT03060629|471398044|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
130936097|NCT03060629|471398045|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
130936098|NCT03060629|471398044|FG000|Overall Study|Participant Relocate|15|||
130936099|NCT03060629|471398045|FG001|Overall Study|Participant Relocate|15|||
130936100|NCT03060629|471398044|FG000|Overall Study|Unable to Contact Participant|34|||
130936101|NCT03060629|471398045|FG001|Overall Study|Unable to Contact Participant|23|||
130936102|NCT03060629|471398044|FG000|Overall Study|Investigator Decision|7|||
130936103|NCT03060629|471398045|FG001|Overall Study|Investigator Decision|7|||
130936104|NCT03060629|471398044|FG000|Overall Study|Study Terminated by Sponsor|1100|||
130936105|NCT03060629|471398045|FG001|Overall Study|Study Terminated by Sponsor|1123|||
130936106|NCT03060629|471398044|FG000|Overall Study|Other|4|||
130936107|NCT03060629|471398045|FG001|Overall Study|Other|4|||
130936108|NCT01405742|471398046|FG000|Overall Study|Lost to Follow-up|1|||
130936109|NCT01405742|471398047|FG001|Overall Study|Lost to Follow-up|0|||
130936110|NCT03672747|471398049|FG000|Overall Study|Lost to Follow-up|1|||
130936111|NCT03672747|471398050|FG001|Overall Study|Lost to Follow-up|1|||
130936112|NCT03672747|471398051|FG002|Overall Study|Lost to Follow-up|2|||
130936113|NCT03672747|471398052|FG003|Overall Study|Lost to Follow-up|2|||
130936114|NCT03672747|471398053|FG004|Overall Study|Lost to Follow-up|2|||
130936115|NCT03672747|471398054|FG005|Overall Study|Lost to Follow-up|1|||
130936116|NCT01782495|471398058|FG000|Overall Study|Adverse Event|0|||
130936117|NCT01782495|471398059|FG001|Overall Study|Adverse Event|0|||
130936118|NCT01782495|471398060|FG002|Overall Study|Adverse Event|0|||
130936119|NCT01782495|471398061|FG003|Overall Study|Adverse Event|0|||
130936120|NCT01782495|471398062|FG004|Overall Study|Adverse Event|0|||
130936121|NCT01782495|471398063|FG005|Overall Study|Adverse Event|0|||
130936122|NCT01782495|471398064|FG006|Overall Study|Adverse Event|0|||
130936123|NCT01782495|471398065|FG007|Overall Study|Adverse Event|2|||
130936124|NCT01782495|471398066|FG008|Overall Study|Adverse Event|0|||
130936125|NCT01782495|471398067|FG009|Overall Study|Adverse Event|0|||
130936126|NCT01782495|471398068|FG010|Overall Study|Adverse Event|0|||
130936127|NCT01782495|471398058|FG000|Overall Study|Withdrew Consent|0|||
130936128|NCT01782495|471398059|FG001|Overall Study|Withdrew Consent|1|||
130936129|NCT01782495|471398060|FG002|Overall Study|Withdrew Consent|0|||
130936130|NCT01782495|471398061|FG003|Overall Study|Withdrew Consent|0|||
130936131|NCT01782495|471398062|FG004|Overall Study|Withdrew Consent|0|||
130936132|NCT01782495|471398063|FG005|Overall Study|Withdrew Consent|0|||
130936133|NCT01782495|471398064|FG006|Overall Study|Withdrew Consent|0|||
130936134|NCT01782495|471398065|FG007|Overall Study|Withdrew Consent|1|||
130936135|NCT01782495|471398066|FG008|Overall Study|Withdrew Consent|0|||
130936136|NCT01782495|471398067|FG009|Overall Study|Withdrew Consent|0|||
130936137|NCT01782495|471398068|FG010|Overall Study|Withdrew Consent|0|||
130936138|NCT03428360|471398069|FG000|Overall Study|Informed consent withdrawn|5|||
130936139|NCT03428360|471398069|FG000|Overall Study|Withdrawal by Subject|4|||
130936140|NCT03428360|471398069|FG000|Overall Study|Lost to Follow-up|5|||
130936141|NCT03428360|471398069|FG000|Overall Study|Physician Decision|2|||
130936142|NCT03428360|471398069|FG000|Overall Study|Informed consent withdrawn|5|||
130936143|NCT03428360|471398069|FG000|Overall Study|Study terminated by sponsor|10|||
130936144|NCT03428360|471398069|FG000|Overall Study|Non-compliant with study|1|||
130936145|NCT03428360|471398069|FG000|Overall Study|Non-compliant with study drug|3|||
130936146|NCT03428360|471398069|FG000|Overall Study|Death|3|||
130936147|NCT03428360|471398069|FG000|Overall Study|Adverse Event|1|||
130936148|NCT03428360|471398069|FG000|Overall Study|Not on antiepileptic drug|1|||
130936149|NCT02260921|471398070|FG000|Overall Study|Adverse Event|1|||
130936150|NCT02260921|471398071|FG001|Overall Study|Adverse Event|0|||
130936151|NCT02260921|471398070|FG000|Overall Study|Lost to Follow-up|4|||
130936152|NCT02260921|471398071|FG001|Overall Study|Lost to Follow-up|3|||
130936153|NCT02260921|471398070|FG000|Overall Study|Withdraw Consent|4|||
130936154|NCT02260921|471398071|FG001|Overall Study|Withdraw Consent|1|||
130936155|NCT02260921|471398070|FG000|Overall Study|Death|1|||
130936156|NCT02260921|471398071|FG001|Overall Study|Death|0|||
130936157|NCT02260921|471398070|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
130936158|NCT02260921|471398071|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
130936159|NCT02927080|471400147|FG000|Overall Study|Withdrawal by Subject|0|||
130936160|NCT02927080|471400148|FG001|Overall Study|Withdrawal by Subject|0|||
130936161|NCT02927080|471400149|FG002|Overall Study|Withdrawal by Subject|0|||
130936162|NCT02927080|471400150|FG003|Overall Study|Withdrawal by Subject|0|||
130936163|NCT02927080|471400151|FG004|Overall Study|Withdrawal by Subject|1|||
130936164|NCT02927080|471400152|FG005|Overall Study|Withdrawal by Subject|0|||
130936165|NCT02927080|471400153|FG006|Overall Study|Withdrawal by Subject|1|||
130936166|NCT02927080|471400154|FG007|Overall Study|Withdrawal by Subject|1|||
130936167|NCT02927080|471400155|FG008|Overall Study|Withdrawal by Subject|0|||
130936168|NCT02927080|471400156|FG009|Overall Study|Withdrawal by Subject|2|||
130936169|NCT02927080|471400147|FG000|Overall Study|Willingness to comply with protocol|0|||
130936170|NCT02927080|471400148|FG001|Overall Study|Willingness to comply with protocol|0|||
130936171|NCT02927080|471400149|FG002|Overall Study|Willingness to comply with protocol|0|||
130936172|NCT02927080|471400150|FG003|Overall Study|Willingness to comply with protocol|0|||
130936173|NCT02927080|471400151|FG004|Overall Study|Willingness to comply with protocol|0|||
130936174|NCT02927080|471400152|FG005|Overall Study|Willingness to comply with protocol|0|||
130936175|NCT02927080|471400153|FG006|Overall Study|Willingness to comply with protocol|0|||
130936176|NCT02927080|471400154|FG007|Overall Study|Willingness to comply with protocol|0|||
130936177|NCT02927080|471400155|FG008|Overall Study|Willingness to comply with protocol|0|||
130936178|NCT02927080|471400156|FG009|Overall Study|Willingness to comply with protocol|1|||
130936179|NCT02927080|471400147|FG000|Overall Study|Study terminated by Sponsor|0|||
130936180|NCT02927080|471400148|FG001|Overall Study|Study terminated by Sponsor|0|||
130936181|NCT02927080|471400149|FG002|Overall Study|Study terminated by Sponsor|0|||
130936182|NCT02927080|471400150|FG003|Overall Study|Study terminated by Sponsor|0|||
130936183|NCT02927080|471400151|FG004|Overall Study|Study terminated by Sponsor|0|||
130936184|NCT02927080|471400152|FG005|Overall Study|Study terminated by Sponsor|0|||
130936185|NCT02927080|471400153|FG006|Overall Study|Study terminated by Sponsor|6|||
130936186|NCT02927080|471400154|FG007|Overall Study|Study terminated by Sponsor|7|||
130936187|NCT02927080|471400155|FG008|Overall Study|Study terminated by Sponsor|2|||
131120576|NCT01994382|472072349|FG008|Overall Study|Protocol violation/noncompliance|0|||
131120577|NCT01994382|472072350|FG009|Overall Study|Protocol violation/noncompliance|0|||
131120578|NCT01994382|472072351|FG010|Overall Study|Protocol violation/noncompliance|0|||
131120579|NCT01994382|472072352|FG011|Overall Study|Protocol violation/noncompliance|1|||
131120580|NCT01994382|472072353|FG012|Overall Study|Protocol violation/noncompliance|0|||
131120581|NCT01994382|472072354|FG013|Overall Study|Protocol violation/noncompliance|0|||
131120582|NCT01994382|472072355|FG014|Overall Study|Protocol violation/noncompliance|0|||
131120583|NCT01994382|472072356|FG015|Overall Study|Protocol violation/noncompliance|0|||
131120584|NCT01994382|472072357|FG016|Overall Study|Protocol violation/noncompliance|2|||
131120585|NCT01994382|472072341|FG000|Overall Study|Rolled over to Phase 2a|0|||
131120586|NCT01994382|472072342|FG001|Overall Study|Rolled over to Phase 2a|0|||
131120587|NCT01994382|472072343|FG002|Overall Study|Rolled over to Phase 2a|1|||
131120588|NCT01994382|472072344|FG003|Overall Study|Rolled over to Phase 2a|0|||
131120589|NCT01994382|472072345|FG004|Overall Study|Rolled over to Phase 2a|0|||
131120590|NCT01994382|472072346|FG005|Overall Study|Rolled over to Phase 2a|0|||
131120591|NCT01994382|472072347|FG006|Overall Study|Rolled over to Phase 2a|0|||
131120592|NCT01994382|472072348|FG007|Overall Study|Rolled over to Phase 2a|0|||
130936188|NCT02927080|471400156|FG009|Overall Study|Study terminated by Sponsor|3|||
130936189|NCT02927080|471400147|FG000|Overall Study|Adverse Event|0|||
130936190|NCT02927080|471400148|FG001|Overall Study|Adverse Event|1|||
130936191|NCT02927080|471400149|FG002|Overall Study|Adverse Event|0|||
130936192|NCT02927080|471400150|FG003|Overall Study|Adverse Event|0|||
130936193|NCT02927080|471400151|FG004|Overall Study|Adverse Event|0|||
130936194|NCT02927080|471400152|FG005|Overall Study|Adverse Event|0|||
131120593|NCT01994382|472072349|FG008|Overall Study|Rolled over to Phase 2a|0|||
130936195|NCT02927080|471400153|FG006|Overall Study|Adverse Event|0|||
130704441|NCT01235442|470541277|FG001|Overall Study|Withdrawal by Subject|9|||
130704442|NCT01235442|470541276|FG000|Overall Study|Lack of Efficacy|1|||
130704443|NCT01235442|470541277|FG001|Overall Study|Lack of Efficacy|3|||
130704444|NCT01235442|470541276|FG000|Overall Study|Noncompliance|1|||
130936196|NCT02927080|471400154|FG007|Overall Study|Adverse Event|1|||
130936197|NCT02927080|471400155|FG008|Overall Study|Adverse Event|0|||
130936198|NCT02927080|471400156|FG009|Overall Study|Adverse Event|1|||
130936199|NCT02927080|471400147|FG000|Overall Study|Other|0|||
130936200|NCT02927080|471400148|FG001|Overall Study|Other|0|||
130936201|NCT02927080|471400149|FG002|Overall Study|Other|0|||
130936202|NCT02927080|471400150|FG003|Overall Study|Other|0|||
130936203|NCT02927080|471400151|FG004|Overall Study|Other|0|||
130936204|NCT02927080|471400152|FG005|Overall Study|Other|0|||
130936205|NCT02927080|471400153|FG006|Overall Study|Other|1|||
130936206|NCT02927080|471400154|FG007|Overall Study|Other|0|||
130936207|NCT02927080|471400155|FG008|Overall Study|Other|1|||
130936208|NCT02927080|471400156|FG009|Overall Study|Other|0|||
130936209|NCT00157950|471400157|FG000|Overall Study|Death|1|||
130936210|NCT00157950|471400158|FG001|Overall Study|Death|0|||
130936211|NCT02892760|471400159|FG000|Overall Study|Withdrawal by Subject|3|||
130936212|NCT00386776|471400164|FG000|Overall Study|Withdrawal by Subject|8|||
130936213|NCT01500629|471400165|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
130936214|NCT01500629|471400166|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
130936215|NCT00588848|471400167|FG000|Overall Study|Physician Decision|0|||
130936216|NCT00588848|471400168|FG001|Overall Study|Physician Decision|3|||
130936217|NCT01499667|471400169|FG000|Overall Study|administrative problems|4|||
130936218|NCT01499667|471400170|FG001|Overall Study|administrative problems|5|||
130936219|NCT01499667|471400171|FG002|Overall Study|administrative problems|5|||
130936220|NCT01499667|471400169|FG000|Overall Study|Protocol Violation|1|||
130936221|NCT01499667|471400170|FG001|Overall Study|Protocol Violation|3|||
130936222|NCT01499667|471400171|FG002|Overall Study|Protocol Violation|2|||
130936223|NCT01499667|471400169|FG000|Overall Study|Adverse Event|0|||
130936224|NCT01499667|471400170|FG001|Overall Study|Adverse Event|2|||
130936225|NCT01499667|471400171|FG002|Overall Study|Adverse Event|2|||
130936226|NCT01499667|471400169|FG000|Overall Study|Withdrawal by Subject|2|||
130936227|NCT01499667|471400170|FG001|Overall Study|Withdrawal by Subject|1|||
130936228|NCT01499667|471400171|FG002|Overall Study|Withdrawal by Subject|1|||
130936229|NCT01499667|471400169|FG000|Overall Study|Lack of Efficacy|2|||
130936230|NCT01499667|471400170|FG001|Overall Study|Lack of Efficacy|0|||
130936231|NCT01499667|471400171|FG002|Overall Study|Lack of Efficacy|0|||
130936232|NCT02902965|471400172|FG000|Overall Study|Withdrawal by Subject|10|||
130936233|NCT02673489|471400173|FG000|Treatment Period|Lost to Follow-up|3|||
130936234|NCT02673489|471400174|FG001|Treatment Period|Lost to Follow-up|0|||
130936235|NCT02673489|471400173|FG000|Treatment Period|Participant request to discontinue|1|||
130936236|NCT02673489|471400174|FG001|Treatment Period|Participant request to discontinue|1|||
130936237|NCT02673489|471400173|FG000|Treatment Period|Participant moved to another province|1|||
130936238|NCT02673489|471400174|FG001|Treatment Period|Participant moved to another province|0|||
130936239|NCT02673489|471400173|FG000|Treatment Period|Participant was incarcerated|0|||
130936240|NCT02673489|471400174|FG001|Treatment Period|Participant was incarcerated|1|||
130936241|NCT02673489|471400173|FG000|Treatment Period|Adverse Event|0|||
130936242|NCT02673489|471400174|FG001|Treatment Period|Adverse Event|1|||
130936243|NCT02673489|471400173|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
130936244|NCT02673489|471400174|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
130936245|NCT02673489|471400173|FG000|Follow Up Period|Unable to return for follow-up|0|||
130936246|NCT02673489|471400174|FG001|Follow Up Period|Unable to return for follow-up|1|||
130936247|NCT00293254|471400175|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
130936248|NCT00293254|471400176|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
130936249|NCT00293254|471400175|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
130936250|NCT00293254|471400176|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
130704445|NCT01235442|470541277|FG001|Overall Study|Noncompliance|2|||
130704446|NCT01235442|470541276|FG000|Overall Study|Administrative decision|1|||
130704447|NCT01235442|470541277|FG001|Overall Study|Administrative decision|2|||
130936251|NCT00293254|471400175|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
130936252|NCT00293254|471400176|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
130936253|NCT00293254|471400175|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
130936254|NCT00293254|471400176|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
130936255|NCT00293254|471400175|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
131035214|NCT01396278|471763910|FG002|Overall Study|Withdraw due to trial termination|1|||
131035215|NCT01396278|471763911|FG003|Overall Study|Withdraw due to trial termination|0|||
130936256|NCT00293254|471400176|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
131035216|NCT01396278|471763912|FG004|Overall Study|Withdraw due to trial termination|2|||
130936257|NCT00293254|471400175|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
131035217|NCT04515576|471763915|FG000|Overall Study|Withdrawal by Subject|0|||
130704448|NCT01235442|470541276|FG000|Overall Study|Other unspecified|1|||
130704449|NCT01235442|470541277|FG001|Overall Study|Other unspecified|2|||
130704450|NCT03712124|470541278|FG000|Overall Study|Protocol Violation|1|||
130936258|NCT00293254|471400176|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
130936259|NCT00293254|471400175|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
130936260|NCT00293254|471400176|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
130936261|NCT00293254|471400175|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
130936262|NCT00293254|471400176|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
130936263|NCT00293254|471400175|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
130936264|NCT00293254|471400176|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
130936265|NCT00293254|471400175|FG000|Extension - Double-Blind Week 49-156|Death|4|||
130936266|NCT00293254|471400176|FG001|Extension - Double-Blind Week 49-156|Death|1|||
130936267|NCT00293254|471400175|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
130936268|NCT00293254|471400176|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
130936269|NCT00293254|471400175|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
130936270|NCT00293254|471400176|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
130936271|NCT00293254|471400175|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
130936272|NCT00293254|471400176|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
130936273|NCT00293254|471400175|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
130936274|NCT00293254|471400176|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
130936275|NCT00293254|471400175|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
130936276|NCT00293254|471400176|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
130936277|NCT00293254|471400175|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
130936278|NCT00293254|471400176|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
130936279|NCT00293254|471400175|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
130936280|NCT00293254|471400176|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
130936281|NCT00293254|471400175|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
130936282|NCT00293254|471400176|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
130936283|NCT00293254|471400175|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
130936284|NCT00293254|471400176|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
130936285|NCT00293254|471400175|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
130936286|NCT00293254|471400176|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
130936287|NCT00293254|471400175|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
130936288|NCT00293254|471400176|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
130936289|NCT00293254|471400175|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
130936290|NCT00293254|471400176|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
130936291|NCT00293254|471400175|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
130936292|NCT00293254|471400176|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
130936293|NCT00293254|471400175|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
130936294|NCT00293254|471400176|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
130936295|NCT00293254|471400175|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
130936296|NCT00293254|471400176|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
130936297|NCT00293254|471400175|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
130936298|NCT00293254|471400176|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
130936299|NCT00293254|471400175|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
130936300|NCT00293254|471400176|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
130936301|NCT02335489|471400177|FG000|Overall Study|Sponsor terminated study|4|||
130936302|NCT02335489|471400177|FG000|Overall Study|Lost to Follow-up|1|||
130936303|NCT02335489|471400177|FG000|Overall Study|Withdrawal by Subject|2|||
130936304|NCT02335489|471400177|FG000|Overall Study|Physician Decision|2|||
130936305|NCT02335489|471400177|FG000|Overall Study|Lack of Efficacy|1|||
130936306|NCT00531050|471400178|FG000|Part 1: Period 1|Adverse Event|0|||
130936307|NCT00531050|471400179|FG001|Part 1: Period 1|Adverse Event|1|||
130936308|NCT00531050|471400180|FG002|Part 1: Period 1|Adverse Event|0|||
130936309|NCT00531050|471400181|FG003|Part 1: Period 1|Adverse Event|0|||
130936310|NCT00531050|471400182|FG004|Part 1: Period 1|Adverse Event|0|||
130936311|NCT00531050|471400183|FG005|Part 1: Period 1|Adverse Event|0|||
130936312|NCT00531050|471400178|FG000|Part 1: Period 1|Protocol Deviation|0|||
130936313|NCT00531050|471400179|FG001|Part 1: Period 1|Protocol Deviation|0|||
130936314|NCT00531050|471400180|FG002|Part 1: Period 1|Protocol Deviation|0|||
131120594|NCT01994382|472072350|FG009|Overall Study|Rolled over to Phase 2a|2|||
131120595|NCT01994382|472072351|FG010|Overall Study|Rolled over to Phase 2a|0|||
131120596|NCT01994382|472072352|FG011|Overall Study|Rolled over to Phase 2a|0|||
131120597|NCT01994382|472072353|FG012|Overall Study|Rolled over to Phase 2a|0|||
131120598|NCT01994382|472072354|FG013|Overall Study|Rolled over to Phase 2a|0|||
130771118|NCT00424593|470789823|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
130936315|NCT00531050|471400181|FG003|Part 1: Period 1|Protocol Deviation|1|||
130936316|NCT00531050|471400182|FG004|Part 1: Period 1|Protocol Deviation|0|||
130936317|NCT00531050|471400183|FG005|Part 1: Period 1|Protocol Deviation|0|||
131120599|NCT01994382|472072355|FG014|Overall Study|Rolled over to Phase 2a|0|||
131120600|NCT01994382|472072356|FG015|Overall Study|Rolled over to Phase 2a|0|||
130704451|NCT03712124|470541279|FG001|Overall Study|Protocol Violation|0|||
130704452|NCT02941523|470541281|FG000|Monotherapy|Withdrawal by Subject|0|||
130704453|NCT02941523|470541282|FG001|Monotherapy|Withdrawal by Subject|1|||
130704454|NCT02941523|470541281|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
130704455|NCT02941523|470541282|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
130704456|NCT02941523|470541281|FG000|Carboplatin Combination Therapy|Death|1|||
130936318|NCT00531050|471400178|FG000|Part 1: Period 3|Adverse Event|1|||
130936319|NCT00531050|471400179|FG001|Part 1: Period 3|Adverse Event|0|||
130936320|NCT00531050|471400180|FG002|Part 1: Period 3|Adverse Event|0|||
130936321|NCT00531050|471400181|FG003|Part 1: Period 3|Adverse Event|0|||
130936322|NCT00531050|471400182|FG004|Part 1: Period 3|Adverse Event|0|||
130936323|NCT00531050|471400183|FG005|Part 1: Period 3|Adverse Event|0|||
130936324|NCT00531050|471400178|FG000|Part 2: Period 1|Adverse Event|0|||
130936325|NCT00531050|471400179|FG001|Part 2: Period 1|Adverse Event|0|||
130936326|NCT00531050|471400180|FG002|Part 2: Period 1|Adverse Event|0|||
130936327|NCT00531050|471400181|FG003|Part 2: Period 1|Adverse Event|0|||
130936328|NCT00531050|471400182|FG004|Part 2: Period 1|Adverse Event|0|||
130936329|NCT00531050|471400183|FG005|Part 2: Period 1|Adverse Event|1|||
130936330|NCT00531050|471400178|FG000|Part 2: Period 3|Abnormal test procedure|1|||
130936331|NCT00531050|471400179|FG001|Part 2: Period 3|Abnormal test procedure|0|||
130936332|NCT00531050|471400180|FG002|Part 2: Period 3|Abnormal test procedure|0|||
130936333|NCT00531050|471400181|FG003|Part 2: Period 3|Abnormal test procedure|0|||
130936334|NCT00531050|471400182|FG004|Part 2: Period 3|Abnormal test procedure|0|||
130936335|NCT00531050|471400183|FG005|Part 2: Period 3|Abnormal test procedure|1|||
130936336|NCT04481750|471400184|FG000|Period 1 (Fasted)|Adverse Event|0|||
130936337|NCT04481750|471400185|FG001|Period 1 (Fasted)|Adverse Event|0|||
130936338|NCT04481750|471400186|FG002|Period 1 (Fasted)|Adverse Event|1|||
130936339|NCT04481750|471400187|FG003|Period 1 (Fasted)|Adverse Event|0|||
130936340|NCT04481750|471400188|FG004|Period 1 (Fasted)|Adverse Event|0|||
130936341|NCT04481750|471400189|FG005|Period 1 (Fasted)|Adverse Event|0|||
130936342|NCT04481750|471400190|FG006|Period 1 (Fasted)|Adverse Event|0|||
130936343|NCT04481750|471400191|FG007|Period 1 (Fasted)|Adverse Event|0|||
130936344|NCT04481750|471400192|FG008|Period 1 (Fasted)|Adverse Event|0|||
130936345|NCT04481750|471400193|FG009|Period 1 (Fasted)|Adverse Event|0|||
130936346|NCT04481750|471400194|FG010|Period 1 (Fasted)|Adverse Event|0|||
130936347|NCT03263442|471400195|FG000|Inpatient Phase|Death|1|||
130936348|NCT03263442|471400196|FG001|Inpatient Phase|Death|0|||
130936349|NCT03263442|471400195|FG000|Inpatient Phase|Withdrawal by Subject|1|||
130936350|NCT03263442|471400196|FG001|Inpatient Phase|Withdrawal by Subject|0|||
130936351|NCT03263442|471400195|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
130936352|NCT03263442|471400196|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
130936353|NCT03263442|471400195|FG000|1-month Follow-Up|Lost to Follow-up|1|||
130936354|NCT03263442|471400196|FG001|1-month Follow-Up|Lost to Follow-up|0|||
130936355|NCT03263442|471400195|FG000|3-month Follow-Up|Lost to Follow-up|1|||
130936356|NCT03263442|471400196|FG001|3-month Follow-Up|Lost to Follow-up|3|||
130936357|NCT03263442|471400195|FG000|6-month Follow-Up|Lost to Follow-up|2|||
130936358|NCT03263442|471400196|FG001|6-month Follow-Up|Lost to Follow-up|2|||
130936359|NCT03804879|471400197|FG000|Overall Study|Adverse Event|3|||
130936360|NCT03804879|471400198|FG001|Overall Study|Adverse Event|0|||
130936361|NCT03804879|471400197|FG000|Overall Study|Study Terminated By Sponsor|10|||
130936362|NCT03804879|471400198|FG001|Overall Study|Study Terminated By Sponsor|12|||
130936363|NCT03804879|471400197|FG000|Overall Study|Withdrawal by Subject|3|||
130936364|NCT03804879|471400198|FG001|Overall Study|Withdrawal by Subject|1|||
130936365|NCT01034462|471400199|FG000|Overall Study|Adverse Event|7|||
130936366|NCT01034462|471400200|FG001|Overall Study|Adverse Event|17|||
130936367|NCT01034462|471400199|FG000|Overall Study|Lack of Efficacy|4|||
130936368|NCT01034462|471400200|FG001|Overall Study|Lack of Efficacy|4|||
130936369|NCT01034462|471400199|FG000|Overall Study|Protocol Violation|10|||
130936370|NCT01034462|471400200|FG001|Overall Study|Protocol Violation|7|||
130936371|NCT01034462|471400199|FG000|Overall Study|Withdrawal by Subject|9|||
130936372|NCT01034462|471400200|FG001|Overall Study|Withdrawal by Subject|8|||
130936373|NCT01034462|471400199|FG000|Overall Study|Lost to Follow-up|14|||
130936374|NCT01034462|471400200|FG001|Overall Study|Lost to Follow-up|16|||
130936375|NCT01034462|471400199|FG000|Overall Study|Other reasons|1|||
130936376|NCT01034462|471400200|FG001|Overall Study|Other reasons|2|||
130936377|NCT01484873|471400201|FG000|Overall Study|Withdrawal by Subject|2|||
130936378|NCT02564042|471400202|FG000|Overall Study|Adverse Event|4|||
130936379|NCT02564042|471400203|FG001|Overall Study|Adverse Event|4|||
130936380|NCT02564042|471400204|FG002|Overall Study|Adverse Event|3|||
130936381|NCT02564042|471400205|FG003|Overall Study|Adverse Event|0|||
130936382|NCT02564042|471400206|FG004|Overall Study|Adverse Event|0|||
130704457|NCT02941523|470541282|FG001|Carboplatin Combination Therapy|Death|2|||
130704458|NCT02941523|470541281|FG000|Carboplatin Combination Therapy|Disease progression|2|||
130704459|NCT02941523|470541282|FG001|Carboplatin Combination Therapy|Disease progression|0|||
130936383|NCT02564042|471400207|FG005|Overall Study|Adverse Event|1|||
130936384|NCT02564042|471400202|FG000|Overall Study|Lost to Follow-up|1|||
130936385|NCT02564042|471400203|FG001|Overall Study|Lost to Follow-up|1|||
130936386|NCT02564042|471400204|FG002|Overall Study|Lost to Follow-up|1|||
130936387|NCT02564042|471400205|FG003|Overall Study|Lost to Follow-up|0|||
130936388|NCT02564042|471400206|FG004|Overall Study|Lost to Follow-up|1|||
130936389|NCT02564042|471400207|FG005|Overall Study|Lost to Follow-up|1|||
130936390|NCT02564042|471400202|FG000|Overall Study|Physician Decision|1|||
130936391|NCT02564042|471400203|FG001|Overall Study|Physician Decision|0|||
130936392|NCT02564042|471400204|FG002|Overall Study|Physician Decision|0|||
130936393|NCT02564042|471400205|FG003|Overall Study|Physician Decision|1|||
130936394|NCT02564042|471400206|FG004|Overall Study|Physician Decision|0|||
130936395|NCT02564042|471400207|FG005|Overall Study|Physician Decision|0|||
130936396|NCT02564042|471400202|FG000|Overall Study|Withdrawal by Subject|5|||
130936397|NCT02564042|471400203|FG001|Overall Study|Withdrawal by Subject|3|||
130936398|NCT02564042|471400204|FG002|Overall Study|Withdrawal by Subject|2|||
130936399|NCT02564042|471400205|FG003|Overall Study|Withdrawal by Subject|2|||
130936400|NCT02564042|471400206|FG004|Overall Study|Withdrawal by Subject|10|||
130936401|NCT02564042|471400207|FG005|Overall Study|Withdrawal by Subject|12|||
130936402|NCT01356966|471400208|FG000|Overall Study|Withdrawal by Subject|1|||
130936403|NCT01356966|471400209|FG001|Overall Study|Withdrawal by Subject|2|||
130936404|NCT01356966|471400208|FG000|Overall Study|Physician Decision|1|||
130936405|NCT01356966|471400209|FG001|Overall Study|Physician Decision|0|||
130936406|NCT01549392|471400210|FG000|Overall Study|Withdrawal by Subject|1|||
130936407|NCT01549392|471400211|FG001|Overall Study|Withdrawal by Subject|0|||
130936408|NCT02743806|471400212|FG000|Overall Study|Adverse Event|9|||
130936409|NCT02743806|471400212|FG000|Overall Study|Lost to Follow-up|8|||
130936410|NCT02743806|471400212|FG000|Overall Study|Voluntary Withdrawal|54|||
130936411|NCT02743806|471400212|FG000|Overall Study|Study Termination|65|||
130936412|NCT02743806|471400212|FG000|Overall Study|Pregnancy|6|||
130936413|NCT02743806|471400212|FG000|Overall Study|No Longer Clinically Benefiting|27|||
130936414|NCT02743806|471400212|FG000|Overall Study|Reason Not Specified|12|||
130936415|NCT04273217|471400216|FG000|Overall Study|Lost to Follow-up|0|||
130936416|NCT04273217|471400217|FG001|Overall Study|Lost to Follow-up|0|||
130936417|NCT04273217|471400218|FG002|Overall Study|Lost to Follow-up|0|||
130936418|NCT04273217|471400219|FG003|Overall Study|Lost to Follow-up|0|||
130936419|NCT04273217|471400220|FG004|Overall Study|Lost to Follow-up|0|||
130936420|NCT04273217|471400221|FG005|Overall Study|Lost to Follow-up|1|||
130936421|NCT04273217|471400216|FG000|Overall Study|Participant non-compliance|0|||
130936422|NCT04273217|471400217|FG001|Overall Study|Participant non-compliance|0|||
130936423|NCT04273217|471400218|FG002|Overall Study|Participant non-compliance|0|||
130936424|NCT04273217|471400219|FG003|Overall Study|Participant non-compliance|0|||
130936425|NCT04273217|471400220|FG004|Overall Study|Participant non-compliance|1|||
130936426|NCT04273217|471400221|FG005|Overall Study|Participant non-compliance|0|||
130936427|NCT04273217|471400216|FG000|Overall Study|Positive urine drug screen|1|||
130936428|NCT04273217|471400217|FG001|Overall Study|Positive urine drug screen|0|||
130936429|NCT04273217|471400218|FG002|Overall Study|Positive urine drug screen|1|||
130936430|NCT04273217|471400219|FG003|Overall Study|Positive urine drug screen|0|||
130936431|NCT04273217|471400220|FG004|Overall Study|Positive urine drug screen|0|||
130936432|NCT04273217|471400221|FG005|Overall Study|Positive urine drug screen|1|||
130936433|NCT01988103|471400222|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
130936434|NCT01988103|471400223|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
130936435|NCT01988103|471400224|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
130936436|NCT01988103|471400225|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
130936437|NCT01988103|471400226|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
130936438|NCT01988103|471400222|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
130936439|NCT01988103|471400223|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
130936440|NCT01988103|471400224|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
130936441|NCT01988103|471400225|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
130936442|NCT01988103|471400226|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
130936443|NCT01988103|471400222|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
130936444|NCT01988103|471400223|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
130936445|NCT01988103|471400224|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
130936446|NCT01988103|471400225|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
130936447|NCT01988103|471400226|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
131223779|NCT04380701|472447132|FG023|Overall Study|Lost to Follow-up|1|||
130936448|NCT01988103|471400222|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
130936449|NCT01988103|471400223|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
130936450|NCT01988103|471400224|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
130936451|NCT01988103|471400225|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
130936452|NCT01988103|471400226|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
130936453|NCT01988103|471400222|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
130936454|NCT01988103|471400223|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
130936455|NCT01988103|471400224|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
130936456|NCT01988103|471400225|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
130936457|NCT01988103|471400226|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
130936458|NCT01988103|471400222|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
130936459|NCT01988103|471400223|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
130936460|NCT01988103|471400224|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
130936461|NCT01988103|471400225|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
130936462|NCT01988103|471400226|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
130936463|NCT01988103|471400222|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
130936464|NCT01988103|471400223|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
130936465|NCT01988103|471400224|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
130936466|NCT01988103|471400225|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
130936467|NCT01988103|471400226|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
130936468|NCT00311623|471400233|FG000|Overall Study|Physician Decision|0|||
130936469|NCT00311623|471400234|FG001|Overall Study|Physician Decision|0|||
130936470|NCT00311623|471400235|FG002|Overall Study|Physician Decision|2|||
130936471|NCT03998189|471400236|FG000|Overall Study|Lack of Efficacy|0|||
130936472|NCT03998189|471400237|FG001|Overall Study|Lack of Efficacy|1|||
130936473|NCT03414424|471400238|FG000|Overall Study|Screened out after consent|0|||
130936474|NCT03414424|471400239|FG001|Overall Study|Screened out after consent|2|||
130936475|NCT03414424|471400238|FG000|Overall Study|Lost to Follow-up|0|||
130936476|NCT03414424|471400239|FG001|Overall Study|Lost to Follow-up|1|||
130936477|NCT02746874|471400243|FG000|Overall Study|Withdrawal by Subject|0|||
130936478|NCT02746874|471400244|FG001|Overall Study|Withdrawal by Subject|1|||
130936479|NCT02746874|471400243|FG000|Overall Study|Surgery Date Changed|0|||
130936480|NCT02746874|471400244|FG001|Overall Study|Surgery Date Changed|2|||
130936481|NCT00022633|471400247|FG000|Overall Study|Adverse Event|11|||
130936482|NCT00022633|471400248|FG001|Overall Study|Adverse Event|1|||
130936483|NCT00022633|471400247|FG000|Overall Study|Refusal unrelated to adverse event|1|||
130936484|NCT00022633|471400248|FG001|Overall Study|Refusal unrelated to adverse event|0|||
130936485|NCT00022633|471400247|FG000|Overall Study|Progression/relapse|9|||
130936486|NCT00022633|471400248|FG001|Overall Study|Progression/relapse|2|||
130936487|NCT00022633|471400247|FG000|Overall Study|Death|4|||
130936488|NCT00022633|471400248|FG001|Overall Study|Death|0|||
130936489|NCT00022633|471400247|FG000|Overall Study|Other - not protocol specified|3|||
130936490|NCT00022633|471400248|FG001|Overall Study|Other - not protocol specified|2|||
130936491|NCT00022633|471400247|FG000|Overall Study|Ineligible|4|||
130936492|NCT00022633|471400248|FG001|Overall Study|Ineligible|0|||
130936493|NCT03402386|471400251|FG000|Overall Study|Adverse Event|3|||
130936494|NCT03402386|471400251|FG000|Overall Study|Physician Decision|1|||
130936495|NCT03402386|471400251|FG000|Overall Study|Difficult to control Hb|2|||
130936496|NCT02956486|471400260|FG000|Core Phase|Adverse Event|51|||
130936497|NCT02956486|471400261|FG001|Core Phase|Adverse Event|88|||
130936498|NCT02956486|471400262|FG002|Core Phase|Adverse Event|0|||
130936499|NCT02956486|471400260|FG000|Core Phase|Lost to Follow-up|8|||
130936500|NCT02956486|471400261|FG001|Core Phase|Lost to Follow-up|6|||
130936501|NCT02956486|471400262|FG002|Core Phase|Lost to Follow-up|0|||
130936502|NCT02956486|471400260|FG000|Core Phase|Inadequate therapeutic effect|4|||
130936503|NCT02956486|471400261|FG001|Core Phase|Inadequate therapeutic effect|5|||
130936504|NCT02956486|471400262|FG002|Core Phase|Inadequate therapeutic effect|0|||
130936505|NCT02956486|471400260|FG000|Core Phase|Withdrawal by Subject|101|||
130936506|NCT02956486|471400261|FG001|Core Phase|Withdrawal by Subject|104|||
130936507|NCT02956486|471400262|FG002|Core Phase|Withdrawal by Subject|0|||
130936508|NCT02956486|471400260|FG000|Core Phase|Study terminated by sponsor|888|||
130936509|NCT02956486|471400261|FG001|Core Phase|Study terminated by sponsor|848|||
130936510|NCT02956486|471400262|FG002|Core Phase|Study terminated by sponsor|0|||
130936511|NCT02956486|471400260|FG000|Core Phase|Other|27|||
130936512|NCT02956486|471400261|FG001|Core Phase|Other|18|||
130936513|NCT02956486|471400262|FG002|Core Phase|Other|0|||
130936514|NCT02956486|471400260|FG000|Core Phase|Not treated|0|||
130936515|NCT02956486|471400261|FG001|Core Phase|Not treated|3|||
130936516|NCT02956486|471400262|FG002|Core Phase|Not treated|0|||
130936517|NCT02956486|471400260|FG000|Extension Phase|Adverse Event|0|||
130936518|NCT02956486|471400261|FG001|Extension Phase|Adverse Event|0|||
130936519|NCT02956486|471400262|FG002|Extension Phase|Adverse Event|2|||
130936520|NCT02956486|471400260|FG000|Extension Phase|Study terminated by sponsor|0|||
130936521|NCT02956486|471400261|FG001|Extension Phase|Study terminated by sponsor|0|||
130936522|NCT02956486|471400262|FG002|Extension Phase|Study terminated by sponsor|16|||
130936523|NCT02956486|471400260|FG000|Extension Phase|Not Treated|0|||
130936524|NCT02956486|471400261|FG001|Extension Phase|Not Treated|0|||
130936525|NCT02956486|471400262|FG002|Extension Phase|Not Treated|1|||
130936526|NCT03325075|471400265|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
130936527|NCT03325075|471400266|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
130936528|NCT03325075|471400267|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
130936529|NCT03325075|471400268|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
130936530|NCT03325075|471400265|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
130936531|NCT03325075|471400266|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
130936532|NCT03325075|471400267|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
130936533|NCT03325075|471400268|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
130936534|NCT03325075|471400265|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
130936535|NCT03325075|471400266|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
130936536|NCT03325075|471400267|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
130936537|NCT03325075|471400268|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
130936538|NCT00422591|471400269|FG000|Overall Study|Physician Decision|4|||
130936539|NCT00422591|471400269|FG000|Overall Study|Withdrawal by Subject|2|||
130936540|NCT02485574|471400275|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
130936541|NCT00255047|471400276|FG000|Overall Study|Serious Adverse Events|2|||
130936542|NCT00255047|471400277|FG001|Overall Study|Serious Adverse Events|1|||
130936543|NCT00255047|471400278|FG002|Overall Study|Serious Adverse Events|2|||
130936544|NCT00255047|471400279|FG003|Overall Study|Serious Adverse Events|1|||
130936545|NCT00255047|471400276|FG000|Overall Study|Adverse Event|0|||
130936546|NCT00255047|471400277|FG001|Overall Study|Adverse Event|3|||
130936547|NCT00255047|471400278|FG002|Overall Study|Adverse Event|2|||
130936548|NCT00255047|471400279|FG003|Overall Study|Adverse Event|1|||
130704460|NCT02941523|470541281|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
130704461|NCT02941523|470541282|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
130704462|NCT04499482|470541283|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
130936549|NCT00255047|471400276|FG000|Overall Study|Protocol Violation|13|||
130936550|NCT00255047|471400277|FG001|Overall Study|Protocol Violation|13|||
131035218|NCT04515576|471763916|FG001|Overall Study|Withdrawal by Subject|0|||
131035219|NCT04515576|471763917|FG002|Overall Study|Withdrawal by Subject|0|||
131035220|NCT04515576|471763918|FG003|Overall Study|Withdrawal by Subject|0|||
131035221|NCT04515576|471763919|FG004|Overall Study|Withdrawal by Subject|0|||
131035222|NCT04515576|471763920|FG005|Overall Study|Withdrawal by Subject|1|||
131035223|NCT02908477|471763922|FG000|Overall Study|Withdrawal by Subject|8|||
131035224|NCT02908477|471763923|FG001|Overall Study|Withdrawal by Subject|28|||
131035225|NCT02140554|471763924|FG000|Overall Study|Withdrawal of consent|1|||
131035226|NCT02140554|471763925|FG001|Overall Study|Withdrawal of consent|0|||
131035227|NCT02140554|471763926|FG002|Overall Study|Withdrawal of consent|4|||
131035228|NCT02140554|471763924|FG000|Overall Study|Physician Decision|1|||
131035229|NCT02140554|471763925|FG001|Overall Study|Physician Decision|0|||
131035230|NCT02140554|471763926|FG002|Overall Study|Physician Decision|2|||
131035231|NCT02140554|471763924|FG000|Overall Study|Death|0|||
131035232|NCT02140554|471763925|FG001|Overall Study|Death|0|||
131035233|NCT02140554|471763926|FG002|Overall Study|Death|1|||
131035234|NCT02140554|471763924|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
131035235|NCT02140554|471763925|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
131035236|NCT02140554|471763926|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
131035237|NCT05590403|471763927|FG000|Overall Study|Lost to Follow-up|13|||
131035238|NCT05590403|471763928|FG001|Overall Study|Lost to Follow-up|1|||
131035239|NCT05590403|471763929|FG002|Overall Study|Lost to Follow-up|7|||
131035240|NCT05590403|471763930|FG003|Overall Study|Lost to Follow-up|3|||
131035241|NCT05590403|471763931|FG004|Overall Study|Lost to Follow-up|4|||
131035242|NCT05590403|471763927|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
131035243|NCT05590403|471763928|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
131035244|NCT05590403|471763929|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
131035245|NCT05590403|471763930|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
131035246|NCT05590403|471763931|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
131035247|NCT05590403|471763927|FG000|Overall Study|Other|2|||
131035248|NCT05590403|471763928|FG001|Overall Study|Other|0|||
131035249|NCT05590403|471763929|FG002|Overall Study|Other|2|||
131035250|NCT05590403|471763930|FG003|Overall Study|Other|2|||
131035251|NCT05590403|471763931|FG004|Overall Study|Other|0|||
131035252|NCT05590403|471763927|FG000|Overall Study|Migrated / moved from the study area|1|||
131035253|NCT05590403|471763928|FG001|Overall Study|Migrated / moved from the study area|1|||
131035254|NCT05590403|471763929|FG002|Overall Study|Migrated / moved from the study area|0|||
131035255|NCT05590403|471763930|FG003|Overall Study|Migrated / moved from the study area|3|||
131035256|NCT05590403|471763931|FG004|Overall Study|Migrated / moved from the study area|1|||
131035257|NCT05590403|471763927|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
131035258|NCT05590403|471763928|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
131035259|NCT05590403|471763929|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
131035260|NCT05590403|471763930|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
131035261|NCT05590403|471763931|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
131035262|NCT05659537|471763932|FG000|Overall Study|Adverse Event|5|||
131035263|NCT05659537|471763932|FG000|Overall Study|Lost to Follow-up|4|||
131035264|NCT05659537|471763932|FG000|Overall Study|Withdrawal by Subject|13|||
131035265|NCT05659537|471763932|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
131035266|NCT05659537|471763932|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
131035267|NCT05659537|471763932|FG000|Overall Study|Participant was suffering from anaemia|1|||
131035268|NCT01160211|471763935|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
131035269|NCT01160211|471763936|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
130936551|NCT00255047|471400278|FG002|Overall Study|Protocol Violation|16|||
130936552|NCT00255047|471400279|FG003|Overall Study|Protocol Violation|20|||
130936553|NCT00255047|471400276|FG000|Overall Study|Lost to Follow-up|9|||
130936554|NCT00255047|471400277|FG001|Overall Study|Lost to Follow-up|8|||
130936555|NCT00255047|471400278|FG002|Overall Study|Lost to Follow-up|5|||
130936556|NCT00255047|471400279|FG003|Overall Study|Lost to Follow-up|6|||
130936557|NCT00255047|471400276|FG000|Overall Study|Withdrawal by Subject|24|||
130936558|NCT00255047|471400277|FG001|Overall Study|Withdrawal by Subject|23|||
130936559|NCT00255047|471400278|FG002|Overall Study|Withdrawal by Subject|25|||
130936560|NCT00255047|471400279|FG003|Overall Study|Withdrawal by Subject|18|||
130936561|NCT00811473|471400280|FG000|Overall Study|Adverse Event|3|||
130936562|NCT00811473|471400281|FG001|Overall Study|Adverse Event|12|||
130936563|NCT00811473|471400280|FG000|Overall Study|Lost to Follow-up|5|||
130936564|NCT00811473|471400281|FG001|Overall Study|Lost to Follow-up|1|||
130936565|NCT00811473|471400280|FG000|Overall Study|Withdrawal by Subject|2|||
130936566|NCT00811473|471400281|FG001|Overall Study|Withdrawal by Subject|4|||
130936567|NCT00811473|471400280|FG000|Overall Study|Severe non-compliance to protocol|2|||
130936568|NCT00811473|471400281|FG001|Overall Study|Severe non-compliance to protocol|4|||
130936569|NCT00811473|471400280|FG000|Overall Study|Lack of therapeutic response|4|||
130936570|NCT00811473|471400281|FG001|Overall Study|Lack of therapeutic response|1|||
130936571|NCT00811473|471400280|FG000|Overall Study|Condition under investigation worsened|1|||
130936572|NCT00811473|471400281|FG001|Overall Study|Condition under investigation worsened|3|||
130936573|NCT00811473|471400280|FG000|Overall Study|Other 2|4|||
130936574|NCT00811473|471400281|FG001|Overall Study|Other 2|1|||
130936575|NCT00811473|471400280|FG000|Overall Study|Incorrect Enrollment|1|||
130936576|NCT00811473|471400281|FG001|Overall Study|Incorrect Enrollment|0|||
130936577|NCT00811473|471400280|FG000|Overall Study|Safety Reasons|1|||
131035270|NCT01160211|471763937|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
131035271|NCT01160211|471763935|FG000|Overall Study|Lost to Follow-up|4|||
131035272|NCT01160211|471763936|FG001|Overall Study|Lost to Follow-up|8|||
131035273|NCT01160211|471763937|FG002|Overall Study|Lost to Follow-up|4|||
131035274|NCT01160211|471763935|FG000|Overall Study|Physician Decision|1|||
131035275|NCT01160211|471763936|FG001|Overall Study|Physician Decision|0|||
131035276|NCT01160211|471763937|FG002|Overall Study|Physician Decision|0|||
131035277|NCT01160211|471763935|FG000|Overall Study|Withdrawal by Subject|4|||
131035278|NCT01160211|471763936|FG001|Overall Study|Withdrawal by Subject|2|||
131035279|NCT01160211|471763937|FG002|Overall Study|Withdrawal by Subject|2|||
131035280|NCT01160211|471763935|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
131035281|NCT01160211|471763936|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
131035282|NCT01160211|471763937|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
131035283|NCT04806451|471763944|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
131035284|NCT04806451|471763945|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
131035285|NCT04806451|471763944|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
131035286|NCT04806451|471763945|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
131035287|NCT04806451|471763944|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
131035288|NCT04806451|471763945|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
131035289|NCT03134196|471763951|FG000|Overall Study|Death|2|||
131035290|NCT03134196|471763952|FG001|Overall Study|Death|1|||
131035291|NCT03134196|471763951|FG000|Overall Study|Lost to Follow-up|13|||
131035292|NCT03134196|471763952|FG001|Overall Study|Lost to Follow-up|15|||
131035293|NCT03134196|471763951|FG000|Overall Study|Physician Decision|0|||
131035294|NCT03134196|471763952|FG001|Overall Study|Physician Decision|1|||
131035295|NCT03134196|471763951|FG000|Overall Study|Withdrawal by Subject|19|||
131035296|NCT03134196|471763952|FG001|Overall Study|Withdrawal by Subject|12|||
131035297|NCT03134196|471763951|FG000|Overall Study|Site Unable to Contact Participant|2|||
131035298|NCT03134196|471763952|FG001|Overall Study|Site Unable to Contact Participant|0|||
131035299|NCT03134196|471763951|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
131035300|NCT03134196|471763952|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
131035301|NCT03134196|471763951|FG000|Overall Study|Scheduling Conflict|1|||
131035302|NCT03134196|471763952|FG001|Overall Study|Scheduling Conflict|0|||
131035303|NCT06516705|471763953|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
131035304|NCT06516705|471763954|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
131035305|NCT06516705|471763953|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
131035306|NCT06516705|471763954|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
131035307|NCT06516705|471763953|FG000|T3 ( 3 Month After Education)|covid-19|1|||
131035308|NCT06516705|471763954|FG001|T3 ( 3 Month After Education)|covid-19|2|||
130936578|NCT00811473|471400281|FG001|Overall Study|Safety Reasons|0|||
130936579|NCT00667368|471400289|FG000|Overall Study|Lost to Follow-up|176|||
130936580|NCT00667368|471400290|FG001|Overall Study|Lost to Follow-up|155|||
130936581|NCT00667368|471400289|FG000|Overall Study|Discontinued early|24|||
130936582|NCT00667368|471400290|FG001|Overall Study|Discontinued early|17|||
130936583|NCT01585194|471400293|FG000|Overall Study|Withdrawal by Subject|1|||
130936584|NCT01585194|471400293|FG000|Overall Study|Physician Decision|2|||
131035309|NCT06516705|471763953|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
131035310|NCT06516705|471763954|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
131035311|NCT06516705|471763953|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
130704463|NCT01899326|470541284|FG000|Overall Study|Withdrawal by Subject|1|||
130704464|NCT01899326|470541284|FG000|Overall Study|Adverse Event|2|||
130704465|NCT01899326|470541284|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
130704466|NCT00373425|470541285|FG000|Overall Study|Relapse of NSCLC|116|||
130704467|NCT00373425|470541286|FG001|Overall Study|Relapse of NSCLC|104|||
130704468|NCT00373425|470541287|FG002|Overall Study|Relapse of NSCLC|19|||
130936585|NCT01585194|471400293|FG000|Overall Study|Lack of insurance|1|||
130936586|NCT00732615|471400294|FG000|Overall Study|Withdrawal by Subject|3|||
130936587|NCT00732615|471400295|FG001|Overall Study|Withdrawal by Subject|1|||
130936588|NCT00732615|471400294|FG000|Overall Study|Lost to Follow-up|0|||
130936589|NCT00732615|471400295|FG001|Overall Study|Lost to Follow-up|1|||
130936590|NCT00732615|471400294|FG000|Overall Study|Adverse Event|0|||
130936591|NCT00732615|471400295|FG001|Overall Study|Adverse Event|2|||
130936592|NCT00732615|471400294|FG000|Overall Study|Physician Decision|3|||
130936593|NCT00732615|471400295|FG001|Overall Study|Physician Decision|0|||
130936594|NCT00732615|471400294|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
130936595|NCT00732615|471400295|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
130936596|NCT01333059|471400296|FG000|Overall Study|Physician Decision|3|||
131035312|NCT06516705|471763954|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
131035313|NCT06516705|471763953|FG000|T4 ( 6 Month After Education)|covid-19|3|||
131035314|NCT06516705|471763954|FG001|T4 ( 6 Month After Education)|covid-19|2|||
131035315|NCT06516705|471763953|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
131035316|NCT06516705|471763954|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
131035317|NCT04719390|471763955|FG000|Overall Study|Withdrawal by Subject|1|||
131035318|NCT05746455|471763956|FG000|Overall Study|Discharged from Clinical Service|1|||
131035319|NCT05746455|471763956|FG000|Overall Study|Lost to Follow-up|1|||
131035320|NCT05453773|471763957|FG000|Overall Study|Withdrawal by Subject|3|||
131035321|NCT05453773|471763957|FG000|Overall Study|Lost to Follow-up|3|||
131035322|NCT05453773|471763957|FG000|Overall Study|Difficult Blood Draw|3|||
131035323|NCT02023866|471763961|FG000|Overall Study|Non-compliance|2|||
131035324|NCT02023866|471763961|FG000|Overall Study|Adverse Event|3|||
131035325|NCT02023866|471763961|FG000|Overall Study|Withdrawal by Subject|1|||
131035326|NCT03023410|471763962|FG000|Overall Study|study termination|0|||
131035327|NCT03023410|471763963|FG001|Overall Study|study termination|1|||
131035328|NCT04799899|471763964|FG000|Overall Study|Lost to Follow-up|2|||
131035329|NCT04799899|471763965|FG001|Overall Study|Lost to Follow-up|4|||
131035330|NCT04683744|471763972|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
131035331|NCT04683744|471763973|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
131035332|NCT04683744|471763974|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
131035333|NCT04295798|471763984|FG000|Overall Study|Lost to Follow-up|1|||
131035334|NCT04927364|471763985|FG000|Overall Study|Withdrawal by Subject|3|||
131035335|NCT04927364|471763985|FG000|Overall Study|Unable to complete preassessment MRI|1|||
131035336|NCT04650269|471763991|FG000|Overall Study|Death|3|||
131035337|NCT04650269|471763991|FG000|Overall Study|Lost to Follow-up|6|||
131035338|NCT01437709|471763992|FG000|Overall Study|Adverse Event|0|||
131035339|NCT01437709|471763993|FG001|Overall Study|Adverse Event|1|||
131035340|NCT01437709|471763994|FG002|Overall Study|Adverse Event|0|||
131035341|NCT01437709|471763992|FG000|Overall Study|Pt trasnferred care|0|||
131035342|NCT01437709|471763993|FG001|Overall Study|Pt trasnferred care|1|||
131035343|NCT01437709|471763994|FG002|Overall Study|Pt trasnferred care|0|||
131035344|NCT04091750|471763995|FG000|Overall Study|Adverse Event|4|||
131035345|NCT04091750|471763995|FG000|Overall Study|Withdrawal by Subject|1|||
131035346|NCT03560609|471763996|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
131035347|NCT03560609|471763997|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
131035348|NCT04293055|471763998|FG000|Overall Study|Lost to Follow-up|1|||
131035349|NCT04293055|471763999|FG001|Overall Study|Lost to Follow-up|1|||
131035350|NCT04293055|471763998|FG000|Overall Study|Did not trigger randomization|6|||
131035351|NCT04293055|471763999|FG001|Overall Study|Did not trigger randomization|5|||
131035352|NCT01369355|471764009|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
131035353|NCT01369355|471764010|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
131035354|NCT01369355|471764011|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
131035355|NCT01369355|471764012|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
131035356|NCT01369355|471764013|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
131035357|NCT01369355|471764014|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
131035358|NCT01369355|471764015|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
131035359|NCT01369355|471764016|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
131035360|NCT01369355|471764017|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
131035361|NCT01369355|471764009|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
131035362|NCT01369355|471764010|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
131035363|NCT01369355|471764011|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
131035364|NCT01369355|471764012|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
131035365|NCT01369355|471764013|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
131035366|NCT01369355|471764014|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
131120601|NCT01994382|472072357|FG016|Overall Study|Rolled over to Phase 2a|0|||
131120602|NCT04667377|472072358|FG000|Dose Escalation Period|Other not specified below|3|||
131120603|NCT04667377|472072359|FG001|Dose Escalation Period|Other not specified below|3|||
131120604|NCT04667377|472072360|FG002|Dose Escalation Period|Other not specified below|2|||
131120605|NCT04667377|472072361|FG003|Dose Escalation Period|Other not specified below|1|||
131120606|NCT04667377|472072362|FG004|Dose Escalation Period|Other not specified below|3|||
131120607|NCT04667377|472072358|FG000|Dose Escalation Period|Protocol Violation|2|||
131120608|NCT04667377|472072359|FG001|Dose Escalation Period|Protocol Violation|2|||
130704469|NCT00373425|470541288|FG003|Overall Study|Relapse of NSCLC|2|||
130704470|NCT00373425|470541289|FG004|Overall Study|Relapse of NSCLC|26|||
130704471|NCT00373425|470541285|FG000|Overall Study|Adverse Event|191|||
130704472|NCT00373425|470541286|FG001|Overall Study|Adverse Event|22|||
130704473|NCT00373425|470541287|FG002|Overall Study|Adverse Event|59|||
130704474|NCT00373425|470541288|FG003|Overall Study|Adverse Event|0|||
130704475|NCT00373425|470541289|FG004|Overall Study|Adverse Event|34|||
130704476|NCT00373425|470541285|FG000|Overall Study|Patient request|35|||
130704477|NCT00373425|470541286|FG001|Overall Study|Patient request|18|||
130936597|NCT01333059|471400297|FG001|Overall Study|Physician Decision|3|||
130936598|NCT01333059|471400296|FG000|Overall Study|Protocol Violation|3|||
130936599|NCT01333059|471400297|FG001|Overall Study|Protocol Violation|0|||
130936600|NCT03566823|471400298|FG000|Overall Study|Lack of Efficacy|0|||
130936601|NCT03566823|471400299|FG001|Overall Study|Lack of Efficacy|1|||
130936602|NCT03566823|471400300|FG002|Overall Study|Lack of Efficacy|0|||
130936603|NCT03566823|471400298|FG000|Overall Study|Withdrawal by Subject|1|||
130936604|NCT03566823|471400299|FG001|Overall Study|Withdrawal by Subject|2|||
130936605|NCT03566823|471400300|FG002|Overall Study|Withdrawal by Subject|0|||
130936606|NCT03566823|471400298|FG000|Overall Study|Adverse Event|1|||
130704478|NCT00373425|470541287|FG002|Overall Study|Patient request|43|||
130704479|NCT00373425|470541288|FG003|Overall Study|Patient request|6|||
130704480|NCT00373425|470541289|FG004|Overall Study|Patient request|7|||
130704481|NCT00373425|470541285|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
130936607|NCT03566823|471400299|FG001|Overall Study|Adverse Event|0|||
130936608|NCT03566823|471400300|FG002|Overall Study|Adverse Event|2|||
130936609|NCT00191789|471400301|FG000|Overall Study|Adverse Event|5|||
130936610|NCT00191789|471400301|FG000|Overall Study|Patient: Satisfactory Response|5|||
130936611|NCT00191789|471400301|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
130936612|NCT00191789|471400301|FG000|Overall Study|Withdrawal by Subject|4|||
130936613|NCT00191789|471400301|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
130936614|NCT00191789|471400301|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
130936615|NCT00191789|471400301|FG000|Overall Study|Death - Not Study-Drug Related|1|||
130936616|NCT01922089|471400304|FG000|Overall Study|Adverse Event|18|||
130936617|NCT01922089|471400305|FG001|Overall Study|Adverse Event|13|||
130936618|NCT01922089|471400304|FG000|Overall Study|Protocol Deviation|10|||
130936619|NCT01922089|471400305|FG001|Overall Study|Protocol Deviation|7|||
130936620|NCT01922089|471400304|FG000|Overall Study|Withdrawal by Subject|3|||
130936621|NCT01922089|471400305|FG001|Overall Study|Withdrawal by Subject|4|||
130936622|NCT01922089|471400304|FG000|Overall Study|administrative problems|4|||
130936623|NCT01922089|471400305|FG001|Overall Study|administrative problems|1|||
130936624|NCT01922089|471400304|FG000|Overall Study|Physician Decision|2|||
130936625|NCT01922089|471400305|FG001|Overall Study|Physician Decision|3|||
130936626|NCT01922089|471400304|FG000|Overall Study|Death|2|||
130936627|NCT01922089|471400305|FG001|Overall Study|Death|1|||
130936628|NCT01922089|471400304|FG000|Overall Study|Lost to Follow-up|0|||
130936629|NCT01922089|471400305|FG001|Overall Study|Lost to Follow-up|1|||
130936630|NCT04903626|471400306|FG000|Overall Study|Lost to Follow-up|6|||
130704482|NCT00373425|470541286|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
130704483|NCT00373425|470541287|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
130704484|NCT00373425|470541288|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
130704485|NCT00373425|470541289|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
130704486|NCT00373425|470541285|FG000|Overall Study|Death|7|||
130704487|NCT00373425|470541286|FG001|Overall Study|Death|0|||
130704488|NCT00373425|470541287|FG002|Overall Study|Death|3|||
130704489|NCT00373425|470541288|FG003|Overall Study|Death|1|||
130704490|NCT00373425|470541289|FG004|Overall Study|Death|0|||
130704491|NCT00551616|470541292|FG000|Overall Study|Lost to Follow-up|48|||
130704492|NCT00551616|470541293|FG001|Overall Study|Lost to Follow-up|40|||
130936631|NCT04903626|471400306|FG000|Overall Study|Withdrawal by Subject|1|||
130936632|NCT04903626|471400306|FG000|Overall Study|Other, Not Specified|1|||
131120609|NCT04667377|472072360|FG002|Dose Escalation Period|Protocol Violation|0|||
131223780|NCT04380701|472447133|FG024|Overall Study|Lost to Follow-up|0|||
130704493|NCT01083680|470541294|FG000|Overall Study|Lost to Follow-up|2758|||
130704494|NCT01083680|470541294|FG000|Overall Study|Withdrawal by Subject|1086|||
130704495|NCT03942211|470541295|FG000|Overall Study|Death|1|||
130704496|NCT03942211|470541296|FG001|Overall Study|Death|0|||
130704497|NCT03942211|470541295|FG000|Overall Study|Study terminated by sponsor|5|||
130704498|NCT03942211|470541296|FG001|Overall Study|Study terminated by sponsor|3|||
130704499|NCT03942211|470541295|FG000|Overall Study|Adverse Event|0|||
130704500|NCT03942211|470541296|FG001|Overall Study|Adverse Event|1|||
130936633|NCT00165776|471400310|FG000|Overall Study|Lack of Efficacy|0|||
130936634|NCT00165776|471400311|FG001|Overall Study|Lack of Efficacy|0|||
130936635|NCT00165776|471400312|FG002|Overall Study|Lack of Efficacy|0|||
130936636|NCT00165776|471400313|FG003|Overall Study|Lack of Efficacy|1|||
130936637|NCT00165776|471400310|FG000|Overall Study|Withdrawal by Subject|4|||
130936638|NCT00165776|471400311|FG001|Overall Study|Withdrawal by Subject|1|||
130936639|NCT00165776|471400312|FG002|Overall Study|Withdrawal by Subject|2|||
130936640|NCT00165776|471400313|FG003|Overall Study|Withdrawal by Subject|0|||
130936641|NCT00165776|471400310|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
130936642|NCT00165776|471400311|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
130936643|NCT00165776|471400312|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
130936644|NCT00165776|471400313|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
130936645|NCT02622321|471400316|FG000|Overall Study|Withdrawal by Subject|2|||
130936646|NCT02622321|471400317|FG001|Overall Study|Withdrawal by Subject|0|||
130936647|NCT02622321|471400318|FG002|Overall Study|Withdrawal by Subject|0|||
130936648|NCT02622321|471400319|FG003|Overall Study|Withdrawal by Subject|0|||
130936649|NCT02622321|471400316|FG000|Overall Study|Death|0|||
130936650|NCT02622321|471400317|FG001|Overall Study|Death|0|||
130936651|NCT02622321|471400318|FG002|Overall Study|Death|1|||
130936652|NCT02622321|471400319|FG003|Overall Study|Death|0|||
130936653|NCT02622321|471400316|FG000|Overall Study|Physician Decision|1|||
130936654|NCT02622321|471400317|FG001|Overall Study|Physician Decision|0|||
130936655|NCT02622321|471400318|FG002|Overall Study|Physician Decision|0|||
130704501|NCT02219308|470541297|FG000|Overall Study|Withdrawal by Subject|1|||
130704502|NCT02219308|470541298|FG001|Overall Study|Withdrawal by Subject|2|||
130704503|NCT01976728|470542690|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
130704504|NCT01976728|470542691|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
130704505|NCT01976728|470542692|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
130704506|NCT01976728|470542693|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
130704507|NCT02356211|470542694|FG000|Overall Study|Withdrawal by Subject|2|||
130704508|NCT02356211|470542695|FG001|Overall Study|Withdrawal by Subject|2|||
130704509|NCT02356211|470542694|FG000|Overall Study|ineligible|1|||
130704510|NCT02356211|470542695|FG001|Overall Study|ineligible|8|||
130704511|NCT01563237|470542699|FG000|Overall Study|Lost to Follow-up|6|||
130936656|NCT02622321|471400319|FG003|Overall Study|Physician Decision|0|||
130704512|NCT01563237|470542700|FG001|Overall Study|Lost to Follow-up|0|||
130704513|NCT01563237|470542699|FG000|Overall Study|Withdrawal by Subject|1|||
130704514|NCT01563237|470542700|FG001|Overall Study|Withdrawal by Subject|0|||
130704515|NCT01563237|470542699|FG000|Overall Study|Adverse Event|1|||
130704516|NCT01563237|470542700|FG001|Overall Study|Adverse Event|0|||
130704517|NCT01563237|470542699|FG000|Overall Study|Medical Reasons|1|||
130704518|NCT01563237|470542700|FG001|Overall Study|Medical Reasons|0|||
130704519|NCT01563237|470542699|FG000|Overall Study|Death|1|||
130704520|NCT01563237|470542700|FG001|Overall Study|Death|0|||
130704521|NCT00966381|470542701|FG000|Overall Study|Withdrawal by Subject|2|||
130704522|NCT00966381|470542702|FG001|Overall Study|Withdrawal by Subject|2|||
130704523|NCT00097786|470542706|FG000|Overall Study|lost to follow-up for all-cause death|296|||
130704524|NCT00097786|470542707|FG001|Overall Study|lost to follow-up for all-cause death|292|||
130704525|NCT00097786|470542708|FG002|Overall Study|lost to follow-up for all-cause death|313|||
130704526|NCT00097786|470542709|FG003|Overall Study|lost to follow-up for all-cause death|310|||
130704527|NCT02668822|470542710|FG000|Overall Study|Protocol Violation|2|||
130704528|NCT02668822|470542711|FG001|Overall Study|Protocol Violation|0|||
130704529|NCT02668822|470542710|FG000|Overall Study|Study Terminated by Sponsor|7|||
130704530|NCT02668822|470542711|FG001|Overall Study|Study Terminated by Sponsor|9|||
130704531|NCT01522950|470542712|FG000|Overall Study|Withdrawal by Subject|3|||
130704532|NCT01522950|470542713|FG001|Overall Study|Withdrawal by Subject|2|||
130704533|NCT01522950|470542714|FG002|Overall Study|Withdrawal by Subject|1|||
130704534|NCT01522950|470542712|FG000|Overall Study|Adverse Event|3|||
130704535|NCT01522950|470542713|FG001|Overall Study|Adverse Event|1|||
131120610|NCT04667377|472072361|FG003|Dose Escalation Period|Protocol Violation|2|||
131120611|NCT04667377|472072362|FG004|Dose Escalation Period|Protocol Violation|1|||
131120612|NCT04667377|472072358|FG000|Dose Escalation Period|Burden of study procedures|2|||
131120613|NCT04667377|472072359|FG001|Dose Escalation Period|Burden of study procedures|1|||
131120614|NCT04667377|472072360|FG002|Dose Escalation Period|Burden of study procedures|1|||
131120615|NCT04667377|472072361|FG003|Dose Escalation Period|Burden of study procedures|1|||
131120616|NCT04667377|472072362|FG004|Dose Escalation Period|Burden of study procedures|5|||
131120617|NCT04667377|472072358|FG000|Dose Escalation Period|Change of residence|0|||
130936657|NCT00241280|471400321|FG000|Overall Study|Adverse Event|2|||
130936658|NCT00241280|471400322|FG001|Overall Study|Adverse Event|6|||
130936659|NCT00241280|471400321|FG000|Overall Study|Discomfort|11|||
130936660|NCT00241280|471400322|FG001|Overall Study|Discomfort|16|||
130936661|NCT00241280|471400321|FG000|Overall Study|Pregnancy|1|||
130936662|NCT00241280|471400322|FG001|Overall Study|Pregnancy|5|||
131120618|NCT04667377|472072359|FG001|Dose Escalation Period|Change of residence|0|||
131223781|NCT04380701|472447134|FG025|Overall Study|Lost to Follow-up|0|||
130704536|NCT01522950|470542714|FG002|Overall Study|Adverse Event|1|||
130936663|NCT00241280|471400321|FG000|Overall Study|Lost to Follow-up|5|||
130704537|NCT01522950|470542712|FG000|Overall Study|Protocol Violation|0|||
130936664|NCT00241280|471400322|FG001|Overall Study|Lost to Follow-up|8|||
130936665|NCT00241280|471400321|FG000|Overall Study|Withdrawal by Subject|7|||
130936666|NCT00241280|471400322|FG001|Overall Study|Withdrawal by Subject|4|||
130936667|NCT00241280|471400321|FG000|Overall Study|Protocol Violation|4|||
130936668|NCT00241280|471400322|FG001|Overall Study|Protocol Violation|10|||
130936669|NCT00241280|471400321|FG000|Overall Study|Relocation|4|||
130936670|NCT00241280|471400322|FG001|Overall Study|Relocation|4|||
130936671|NCT00241280|471400321|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
130936672|NCT00241280|471400322|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
130936673|NCT00241280|471400321|FG000|Overall Study|Unsatisfactory Visual Response|1|||
130936674|NCT00241280|471400322|FG001|Overall Study|Unsatisfactory Visual Response|1|||
130936675|NCT00241280|471400321|FG000|Overall Study|Diabetic|1|||
130936676|NCT00241280|471400322|FG001|Overall Study|Diabetic|0|||
130936677|NCT00241280|471400321|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
130936678|NCT00241280|471400322|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
130936679|NCT00241280|471400321|FG000|Overall Study|Dispensed incorrect test article|1|||
130936680|NCT00241280|471400322|FG001|Overall Study|Dispensed incorrect test article|2|||
130936681|NCT00241280|471400321|FG000|Overall Study|Unacceptable Fit|0|||
130936682|NCT00241280|471400322|FG001|Overall Study|Unacceptable Fit|1|||
130936683|NCT00241280|471400321|FG000|Overall Study|Scheduling Conflict|0|||
130936684|NCT00241280|471400322|FG001|Overall Study|Scheduling Conflict|2|||
130936685|NCT00241280|471400321|FG000|Overall Study|History of Ocular Surgery|0|||
130936686|NCT00241280|471400322|FG001|Overall Study|History of Ocular Surgery|1|||
130936687|NCT00241280|471400321|FG000|Overall Study|Coating on Lens|1|||
130936688|NCT00241280|471400322|FG001|Overall Study|Coating on Lens|0|||
130936689|NCT00241280|471400321|FG000|Overall Study|Excessive Dryness|0|||
130936690|NCT00241280|471400322|FG001|Overall Study|Excessive Dryness|1|||
130936691|NCT00965718|471400323|FG000|Overall Study|Withdrawal by Subject|4|||
130936692|NCT00368355|471400325|FG000|Overall Study|Adverse Event|1|||
130936693|NCT00368355|471400326|FG001|Overall Study|Adverse Event|0|||
130936694|NCT00368355|471400325|FG000|Overall Study|Death|2|||
130936695|NCT00368355|471400326|FG001|Overall Study|Death|4|||
130936696|NCT00368355|471400325|FG000|Overall Study|Relapse|6|||
130936697|NCT00368355|471400326|FG001|Overall Study|Relapse|10|||
130936698|NCT00368355|471400325|FG000|Overall Study|Subsequent transplant|0|||
131120619|NCT04667377|472072360|FG002|Dose Escalation Period|Change of residence|1|||
131120620|NCT04667377|472072361|FG003|Dose Escalation Period|Change of residence|0|||
131120621|NCT04667377|472072362|FG004|Dose Escalation Period|Change of residence|0|||
131120622|NCT04667377|472072358|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
131120623|NCT04667377|472072359|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
131120624|NCT04667377|472072360|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
131120625|NCT04667377|472072361|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
131120626|NCT04667377|472072362|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
131120627|NCT04667377|472072358|FG000|Dose Escalation Period|Adverse Event|9|||
131120628|NCT04667377|472072359|FG001|Dose Escalation Period|Adverse Event|10|||
131120629|NCT04667377|472072360|FG002|Dose Escalation Period|Adverse Event|12|||
131120630|NCT04667377|472072361|FG003|Dose Escalation Period|Adverse Event|17|||
131120631|NCT04667377|472072362|FG004|Dose Escalation Period|Adverse Event|3|||
131120632|NCT04667377|472072358|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
131120633|NCT04667377|472072359|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
131120634|NCT04667377|472072360|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
131120635|NCT04667377|472072361|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
131120636|NCT04667377|472072362|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
131120637|NCT04667377|472072358|FG000|Dose Escalation Period|Not treated|1|||
131120638|NCT04667377|472072359|FG001|Dose Escalation Period|Not treated|0|||
131120639|NCT04667377|472072360|FG002|Dose Escalation Period|Not treated|0|||
131120640|NCT04667377|472072361|FG003|Dose Escalation Period|Not treated|0|||
131120641|NCT04667377|472072362|FG004|Dose Escalation Period|Not treated|0|||
131120642|NCT04667377|472072358|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
130936699|NCT00368355|471400326|FG001|Overall Study|Subsequent transplant|3|||
130936700|NCT00368355|471400325|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
130936701|NCT00368355|471400326|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
130936702|NCT03334903|471400334|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
130936703|NCT03334903|471400335|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
130936704|NCT03334903|471400334|FG000|Overall Study|Protocol Violation|1|||
130936705|NCT03334903|471400335|FG001|Overall Study|Protocol Violation|3|||
130936706|NCT03334903|471400334|FG000|Overall Study|Surgery postponed|1|||
130936707|NCT03334903|471400335|FG001|Overall Study|Surgery postponed|0|||
131120643|NCT04667377|472072359|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
131120644|NCT04667377|472072360|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
130704538|NCT01522950|470542713|FG001|Overall Study|Protocol Violation|0|||
131120645|NCT04667377|472072361|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
131120646|NCT04667377|472072362|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
130936708|NCT03334903|471400334|FG000|Overall Study|Adverse Event|1|||
130936709|NCT03334903|471400335|FG001|Overall Study|Adverse Event|1|||
130936710|NCT03334903|471400334|FG000|Overall Study|Withdrawal by Subject|0|||
130936711|NCT03334903|471400335|FG001|Overall Study|Withdrawal by Subject|1|||
130936712|NCT03032705|471400336|FG000|Overall Study|Lost to Follow-up|16|||
130936713|NCT03032705|471400337|FG001|Overall Study|Lost to Follow-up|17|||
130936714|NCT03032705|471400336|FG000|Overall Study|did not quality|6|||
130936715|NCT03032705|471400337|FG001|Overall Study|did not quality|6|||
130936716|NCT02759471|471400338|FG000|Overall Study|discomfort|2|||
130936717|NCT00001596|471402043|FG000|Overall Study|Death|1|||
130936718|NCT00001596|471402044|FG001|Overall Study|Death|0|||
130936719|NCT00001596|471402043|FG000|Overall Study|Withdrawal by Subject|3|||
130936720|NCT00001596|471402044|FG001|Overall Study|Withdrawal by Subject|1|||
130936721|NCT00001596|471402043|FG000|Overall Study|Study Termination|12|||
130936722|NCT00001596|471402044|FG001|Overall Study|Study Termination|9|||
130936723|NCT00001596|471402043|FG000|Overall Study|Adverse Event|1|||
130936724|NCT00001596|471402044|FG001|Overall Study|Adverse Event|0|||
130936725|NCT04067544|471402045|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
130936726|NCT02282020|471402048|FG000|Overall Study|Objective Disease Progression|128|||
130936727|NCT02282020|471402049|FG001|Overall Study|Objective Disease Progression|30|||
130936728|NCT02282020|471402048|FG000|Overall Study|Adverse Event|18|||
130936729|NCT02282020|471402049|FG001|Overall Study|Adverse Event|15|||
130936730|NCT02282020|471402048|FG000|Overall Study|Withdrawal by Subject|7|||
130936731|NCT02282020|471402049|FG001|Overall Study|Withdrawal by Subject|10|||
130936732|NCT02282020|471402048|FG000|Overall Study|Miscellaneous|5|||
130936733|NCT02282020|471402049|FG001|Overall Study|Miscellaneous|19|||
130936734|NCT02282020|471402048|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
130936735|NCT02282020|471402049|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
130936736|NCT02282020|471402048|FG000|Overall Study|Developed Discontinuation Criteria|0|||
130936737|NCT02282020|471402049|FG001|Overall Study|Developed Discontinuation Criteria|2|||
130936738|NCT02282020|471402048|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
130936739|NCT02282020|471402049|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
130936740|NCT00082355|471402050|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
130936741|NCT00082355|471402050|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
131120647|NCT04667377|472072358|FG000|Dose Escalation Period|Lost to Follow-up|0|||
131120648|NCT04667377|472072359|FG001|Dose Escalation Period|Lost to Follow-up|1|||
131120649|NCT04667377|472072360|FG002|Dose Escalation Period|Lost to Follow-up|0|||
131120650|NCT04667377|472072361|FG003|Dose Escalation Period|Lost to Follow-up|0|||
131120651|NCT04667377|472072362|FG004|Dose Escalation Period|Lost to Follow-up|0|||
131120652|NCT04667377|472072358|FG000|Maintenance Period|Perceived lack of efficacy|0|||
131120653|NCT04667377|472072359|FG001|Maintenance Period|Perceived lack of efficacy|2|||
131120654|NCT04667377|472072360|FG002|Maintenance Period|Perceived lack of efficacy|1|||
131120655|NCT04667377|472072361|FG003|Maintenance Period|Perceived lack of efficacy|0|||
131120656|NCT04667377|472072362|FG004|Maintenance Period|Perceived lack of efficacy|1|||
131120657|NCT04667377|472072358|FG000|Maintenance Period|Adverse Event|2|||
131120658|NCT04667377|472072359|FG001|Maintenance Period|Adverse Event|8|||
131120659|NCT04667377|472072360|FG002|Maintenance Period|Adverse Event|5|||
131120660|NCT04667377|472072361|FG003|Maintenance Period|Adverse Event|4|||
131120661|NCT04667377|472072362|FG004|Maintenance Period|Adverse Event|1|||
131120662|NCT04667377|472072358|FG000|Maintenance Period|Adverse event: COVID infection|0|||
131120663|NCT04667377|472072359|FG001|Maintenance Period|Adverse event: COVID infection|1|||
131120664|NCT04667377|472072360|FG002|Maintenance Period|Adverse event: COVID infection|0|||
131120665|NCT04667377|472072361|FG003|Maintenance Period|Adverse event: COVID infection|0|||
131120666|NCT04667377|472072362|FG004|Maintenance Period|Adverse event: COVID infection|0|||
131120667|NCT04667377|472072358|FG000|Maintenance Period|COVID-related|0|||
131120668|NCT04667377|472072359|FG001|Maintenance Period|COVID-related|0|||
131120669|NCT04667377|472072360|FG002|Maintenance Period|COVID-related|1|||
131120670|NCT04667377|472072361|FG003|Maintenance Period|COVID-related|1|||
131120671|NCT04667377|472072362|FG004|Maintenance Period|COVID-related|0|||
130936742|NCT00082355|471402050|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
130936743|NCT02259582|471402051|FG000|Overall Study|Physician Decision|0|||
130936744|NCT02259582|471402052|FG001|Overall Study|Physician Decision|1|||
130936745|NCT02259582|471402053|FG002|Overall Study|Physician Decision|0|||
130936746|NCT02259582|471402051|FG000|Overall Study|Death|0|||
130936747|NCT02259582|471402052|FG001|Overall Study|Death|0|||
131120672|NCT04667377|472072358|FG000|Maintenance Period|Protocol Violation|1|||
131120673|NCT04667377|472072359|FG001|Maintenance Period|Protocol Violation|0|||
130936748|NCT02259582|471402053|FG002|Overall Study|Death|1|||
130936749|NCT02259582|471402051|FG000|Overall Study|Adverse Event|1|||
130936750|NCT02259582|471402052|FG001|Overall Study|Adverse Event|0|||
130936751|NCT02259582|471402053|FG002|Overall Study|Adverse Event|1|||
130936752|NCT02259582|471402051|FG000|Overall Study|Withdrawal by Subject|0|||
131120674|NCT04667377|472072360|FG002|Maintenance Period|Protocol Violation|0|||
131120675|NCT04667377|472072361|FG003|Maintenance Period|Protocol Violation|0|||
131120676|NCT04667377|472072362|FG004|Maintenance Period|Protocol Violation|1|||
131120677|NCT04667377|472072358|FG000|Maintenance Period|Burden of study procedures|1|||
130936753|NCT02259582|471402052|FG001|Overall Study|Withdrawal by Subject|0|||
130936754|NCT02259582|471402053|FG002|Overall Study|Withdrawal by Subject|1|||
130936755|NCT02259582|471402051|FG000|Overall Study|Disease progression|14|||
130936756|NCT02259582|471402052|FG001|Overall Study|Disease progression|15|||
130936757|NCT02259582|471402053|FG002|Overall Study|Disease progression|17|||
130936758|NCT02259582|471402051|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
130936759|NCT02259582|471402052|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
130936760|NCT02259582|471402053|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
130936761|NCT00759863|471402055|FG000|Overall Study|Death, moved, or lost contact|20|||
130936762|NCT00759863|471402056|FG001|Overall Study|Death, moved, or lost contact|18|||
130936763|NCT00475176|471402062|FG000|Overall Study|Adverse Event|2|||
130936764|NCT00475176|471402062|FG000|Overall Study|Withdrawal by Subject|1|||
130936765|NCT00475176|471402062|FG000|Overall Study|Protocol Violation|1|||
130936766|NCT01585428|471402063|FG000|Overall Study|Death during treatment|1|||
130936767|NCT01585428|471402064|FG001|Overall Study|Death during treatment|0|||
130704539|NCT01522950|470542714|FG002|Overall Study|Protocol Violation|2|||
130936768|NCT00303498|471402067|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
130936769|NCT00303498|471402068|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
130936770|NCT00303498|471402067|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
130936771|NCT00303498|471402068|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
130936772|NCT00303498|471402067|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
130936773|NCT00303498|471402068|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
130936774|NCT00303498|471402067|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
130936775|NCT00303498|471402068|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
130936776|NCT00303498|471402067|FG000|Run-In-Phase (10 Weeks)|Other|4|||
130936777|NCT00303498|471402068|FG001|Run-In-Phase (10 Weeks)|Other|1|||
130936778|NCT00303498|471402067|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
130936779|NCT00303498|471402068|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
130936780|NCT00303498|471402067|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
130936781|NCT00303498|471402068|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
130936782|NCT00303498|471402067|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
130936783|NCT00303498|471402068|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
130936784|NCT00303498|471402067|FG000|Maintenance Phase (24 Weeks)|Death|1|||
130936785|NCT00303498|471402068|FG001|Maintenance Phase (24 Weeks)|Death|0|||
130936786|NCT00303498|471402067|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
130936787|NCT00303498|471402068|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
130936788|NCT00303498|471402067|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
130936789|NCT00303498|471402068|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
130936790|NCT00303498|471402067|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
130936791|NCT00303498|471402068|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
130936792|NCT00303498|471402067|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
130936793|NCT00303498|471402068|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
130936794|NCT00303498|471402067|FG000|Maintenance Phase (24 Weeks)|Other|1|||
130936795|NCT00303498|471402068|FG001|Maintenance Phase (24 Weeks)|Other|0|||
130936796|NCT00303498|471402067|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
130936797|NCT00303498|471402068|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
130936798|NCT00303498|471402067|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
130936799|NCT00303498|471402068|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
130936800|NCT00460031|471402069|FG000|Overall Study|Adverse Event|5|||
130936801|NCT00460031|471402069|FG000|Overall Study|Withdrawal by Subject|5|||
130936802|NCT00460031|471402069|FG000|Overall Study|Death|1|||
130936803|NCT04532099|471402070|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
130936804|NCT04532099|471402071|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
130936805|NCT04532099|471402072|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
130936806|NCT00644995|471402082|FG000|Overall Study|Lost to Follow-up|1|||
130936807|NCT00644995|471402083|FG001|Overall Study|Lost to Follow-up|4|||
130936808|NCT00644995|471402082|FG000|Overall Study|Refused|1|||
130936809|NCT00644995|471402083|FG001|Overall Study|Refused|0|||
130936810|NCT02066233|471402089|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
130704540|NCT01522950|470542712|FG000|Overall Study|Death|0|||
130704541|NCT01522950|470542713|FG001|Overall Study|Death|1|||
130704542|NCT01522950|470542714|FG002|Overall Study|Death|1|||
130936811|NCT02066233|471402090|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
130936812|NCT00103142|471402091|FG000|Overall Study|Adverse Event|1|||
130936813|NCT00103142|471402092|FG001|Overall Study|Adverse Event|0|||
130936814|NCT00103142|471402091|FG000|Overall Study|Progression of disease|2|||
130936815|NCT00103142|471402092|FG001|Overall Study|Progression of disease|1|||
130936816|NCT02772081|471402093|FG000|Overall Study|Physician Decision|1|||
130936817|NCT02772081|471402094|FG001|Overall Study|Physician Decision|1|||
130936818|NCT02772081|471402093|FG000|Overall Study|Death|1|||
130936819|NCT02772081|471402094|FG001|Overall Study|Death|1|||
130936820|NCT02598076|471402095|FG000|Overall Study|Lost to Follow-up|2|||
130704543|NCT01522950|470542712|FG000|Overall Study|Study Medication Sensitivity|0|||
130936821|NCT02598076|471402096|FG001|Overall Study|Lost to Follow-up|3|||
130936822|NCT03227029|471402097|FG000|Overall Study|Child Wheezed (no treatment)|0|||
130936823|NCT03227029|471402098|FG001|Overall Study|Child Wheezed (no treatment)|1|||
130936824|NCT03227029|471402099|FG002|Overall Study|Child Wheezed (no treatment)|0|||
130936825|NCT03227029|471402097|FG000|Overall Study|No post RSV season visit due to COVID|3|||
130936826|NCT03227029|471402098|FG001|Overall Study|No post RSV season visit due to COVID|3|||
130936827|NCT03227029|471402099|FG002|Overall Study|No post RSV season visit due to COVID|2|||
130936828|NCT03227029|471402097|FG000|Overall Study|Not able to get to clinic|0|||
130936829|NCT03227029|471402098|FG001|Overall Study|Not able to get to clinic|0|||
130936830|NCT03227029|471402099|FG002|Overall Study|Not able to get to clinic|1|||
130936831|NCT03227029|471402097|FG000|Overall Study|Withdrawal by Subject|1|||
130936832|NCT03227029|471402098|FG001|Overall Study|Withdrawal by Subject|0|||
130936833|NCT03227029|471402099|FG002|Overall Study|Withdrawal by Subject|0|||
130936834|NCT03227029|471402097|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
130936835|NCT03227029|471402098|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
130936836|NCT03227029|471402099|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
130936837|NCT00390858|471402100|FG000|Overall Study|Adverse Event|6|||
130936838|NCT00390858|471402101|FG001|Overall Study|Adverse Event|2|||
130936839|NCT00390858|471402100|FG000|Overall Study|Lack of Efficacy|0|||
130936840|NCT00390858|471402101|FG001|Overall Study|Lack of Efficacy|1|||
130936841|NCT00390858|471402100|FG000|Overall Study|Withdrawal by Subject|3|||
130936842|NCT00390858|471402101|FG001|Overall Study|Withdrawal by Subject|4|||
130936843|NCT01949051|471402104|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
130936844|NCT01949051|471402105|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
130936845|NCT01949051|471402106|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
130936846|NCT01949051|471402107|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
130936847|NCT01949051|471402108|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
130936848|NCT01949051|471402109|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
130936849|NCT01949051|471402104|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
130936850|NCT01949051|471402105|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130936851|NCT01949051|471402106|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130936852|NCT01949051|471402107|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130936853|NCT01949051|471402108|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130936854|NCT01949051|471402109|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
130936855|NCT01949051|471402104|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
130936856|NCT01949051|471402105|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
130936857|NCT01949051|471402106|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
130936858|NCT01949051|471402107|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
130936859|NCT01949051|471402108|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
130936860|NCT01949051|471402109|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
130936861|NCT01949051|471402104|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
130936862|NCT01949051|471402105|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
130936863|NCT01949051|471402106|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
130936864|NCT01949051|471402107|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
130936865|NCT01949051|471402108|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
130936866|NCT01949051|471402109|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
130936867|NCT01949051|471402104|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
130936868|NCT01949051|471402105|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
130936869|NCT01949051|471402106|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
130936870|NCT01949051|471402107|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
130936871|NCT01949051|471402108|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
130936872|NCT01949051|471402109|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
130936873|NCT02611778|471402111|FG000|Overall Study|Withdrawal by Subject|2|||
130936874|NCT02611778|471402112|FG001|Overall Study|Withdrawal by Subject|8|||
130936875|NCT02611778|471402111|FG000|Overall Study|Adverse Event|1|||
130936876|NCT02611778|471402112|FG001|Overall Study|Adverse Event|2|||
130936877|NCT02611778|471402111|FG000|Overall Study|Death|2|||
130936878|NCT02611778|471402112|FG001|Overall Study|Death|1|||
130936879|NCT02611778|471402111|FG000|Overall Study|Protocol Violation|1|||
130936880|NCT02611778|471402112|FG001|Overall Study|Protocol Violation|0|||
130936881|NCT02611778|471402111|FG000|Overall Study|Lost to Follow-up|3|||
130936882|NCT02611778|471402112|FG001|Overall Study|Lost to Follow-up|1|||
131035367|NCT01369355|471764015|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
131035368|NCT01369355|471764016|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
131035369|NCT01369355|471764017|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
130936883|NCT02611778|471402111|FG000|Overall Study|Need for alternative treatment|1|||
130936884|NCT02611778|471402112|FG001|Overall Study|Need for alternative treatment|0|||
130936885|NCT02611778|471402111|FG000|Overall Study|Other Reason|2|||
130936886|NCT02611778|471402112|FG001|Overall Study|Other Reason|1|||
130936887|NCT01408914|471402121|FG000|Overall Study|Could not complete tx in protocol period|5|||
130936888|NCT01408914|471402122|FG001|Overall Study|Could not complete tx in protocol period|5|||
131035370|NCT01369355|471764009|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131035371|NCT01369355|471764010|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
131035372|NCT01369355|471764011|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
131035373|NCT01369355|471764012|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131035374|NCT01369355|471764013|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131035375|NCT01369355|471764014|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
131035376|NCT01369355|471764015|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131035377|NCT01369355|471764016|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131035378|NCT01369355|471764017|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
131035379|NCT01369355|471764009|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
131035380|NCT01369355|471764010|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
131035381|NCT01369355|471764011|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
131035382|NCT01369355|471764012|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
131035383|NCT01369355|471764013|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
131035384|NCT01369355|471764014|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
131035385|NCT01369355|471764015|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
131035386|NCT01369355|471764016|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
131035387|NCT01369355|471764017|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
131035388|NCT01369355|471764009|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
131120678|NCT04667377|472072359|FG001|Maintenance Period|Burden of study procedures|2|||
131120679|NCT04667377|472072360|FG002|Maintenance Period|Burden of study procedures|0|||
131120680|NCT04667377|472072361|FG003|Maintenance Period|Burden of study procedures|1|||
131120681|NCT04667377|472072362|FG004|Maintenance Period|Burden of study procedures|0|||
131120682|NCT04667377|472072358|FG000|Maintenance Period|Change of residence|0|||
131120683|NCT04667377|472072359|FG001|Maintenance Period|Change of residence|1|||
131120684|NCT04667377|472072360|FG002|Maintenance Period|Change of residence|0|||
131120685|NCT04667377|472072361|FG003|Maintenance Period|Change of residence|0|||
131120686|NCT04667377|472072362|FG004|Maintenance Period|Change of residence|1|||
131120687|NCT04667377|472072358|FG000|Maintenance Period|Missing|1|||
131120688|NCT04667377|472072359|FG001|Maintenance Period|Missing|0|||
131120689|NCT04667377|472072360|FG002|Maintenance Period|Missing|0|||
131120690|NCT04667377|472072361|FG003|Maintenance Period|Missing|0|||
131120691|NCT04667377|472072362|FG004|Maintenance Period|Missing|0|||
131120692|NCT04667377|472072358|FG000|Maintenance Period|Other than listed above|2|||
131120693|NCT04667377|472072359|FG001|Maintenance Period|Other than listed above|0|||
131120694|NCT04667377|472072360|FG002|Maintenance Period|Other than listed above|3|||
131120695|NCT04667377|472072361|FG003|Maintenance Period|Other than listed above|2|||
131120696|NCT04667377|472072362|FG004|Maintenance Period|Other than listed above|6|||
131120697|NCT04667377|472072358|FG000|Maintenance Period|Withdrawal by Subject|0|||
131120698|NCT04667377|472072359|FG001|Maintenance Period|Withdrawal by Subject|1|||
131120699|NCT04667377|472072360|FG002|Maintenance Period|Withdrawal by Subject|0|||
131120700|NCT04667377|472072361|FG003|Maintenance Period|Withdrawal by Subject|0|||
130936889|NCT01408914|471402123|FG002|Overall Study|Could not complete tx in protocol period|6|||
130936890|NCT01408914|471402121|FG000|Overall Study|Lost to Follow-up|4|||
130936891|NCT01408914|471402122|FG001|Overall Study|Lost to Follow-up|1|||
130936892|NCT01408914|471402123|FG002|Overall Study|Lost to Follow-up|2|||
130936893|NCT01408914|471402121|FG000|Overall Study|Physician Decision|1|||
130936894|NCT01408914|471402122|FG001|Overall Study|Physician Decision|1|||
130936895|NCT01408914|471402123|FG002|Overall Study|Physician Decision|0|||
130936896|NCT01408914|471402121|FG000|Overall Study|Withdrawal by Subject|1|||
130936897|NCT01408914|471402122|FG001|Overall Study|Withdrawal by Subject|0|||
130936898|NCT01408914|471402123|FG002|Overall Study|Withdrawal by Subject|1|||
130936899|NCT01408914|471402121|FG000|Overall Study|Moved out of study jurisdiction|1|||
130936900|NCT01408914|471402122|FG001|Overall Study|Moved out of study jurisdiction|1|||
130936901|NCT01408914|471402123|FG002|Overall Study|Moved out of study jurisdiction|0|||
130936902|NCT01408914|471402121|FG000|Overall Study|Late exclusion|0|||
130936903|NCT01408914|471402122|FG001|Overall Study|Late exclusion|3|||
130936904|NCT01408914|471402123|FG002|Overall Study|Late exclusion|3|||
130936905|NCT01408914|471402121|FG000|Overall Study|Change in local TB/HIV norms|0|||
130936906|NCT01408914|471402122|FG001|Overall Study|Change in local TB/HIV norms|1|||
130936907|NCT01408914|471402123|FG002|Overall Study|Change in local TB/HIV norms|1|||
130936908|NCT00330616|471402126|FG000|Overall Study|Adverse Event|13|||
130936909|NCT00330616|471402126|FG000|Overall Study|Lack of Efficacy|1|||
130936910|NCT00330616|471402126|FG000|Overall Study|Lost to Follow-up|2|||
130936911|NCT00330616|471402126|FG000|Overall Study|Withdrawal by Subject|4|||
130936912|NCT00330616|471402126|FG000|Overall Study|Other|1|||
130936913|NCT02049957|471402127|FG000|Overall Study|Progressive Disease|5|||
131035389|NCT01369355|471764010|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
131035390|NCT01369355|471764011|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
131120701|NCT04667377|472072362|FG004|Maintenance Period|Withdrawal by Subject|0|||
131120702|NCT04667377|472072358|FG000|Maintenance Period|Lost to Follow-up|1|||
131120703|NCT04667377|472072359|FG001|Maintenance Period|Lost to Follow-up|0|||
130936914|NCT02049957|471402128|FG001|Overall Study|Progressive Disease|4|||
131120704|NCT04667377|472072360|FG002|Maintenance Period|Lost to Follow-up|1|||
131120705|NCT04667377|472072361|FG003|Maintenance Period|Lost to Follow-up|0|||
130936915|NCT02049957|471402129|FG002|Overall Study|Progressive Disease|2|||
130936916|NCT02049957|471402130|FG003|Overall Study|Progressive Disease|2|||
130936917|NCT02049957|471402131|FG004|Overall Study|Progressive Disease|6|||
130936918|NCT02049957|471402132|FG005|Overall Study|Progressive Disease|35|||
130936919|NCT02049957|471402133|FG006|Overall Study|Progressive Disease|7|||
130936920|NCT02049957|471402134|FG007|Overall Study|Progressive Disease|26|||
130936921|NCT02049957|471402135|FG008|Overall Study|Progressive Disease|6|||
130936922|NCT02049957|471402127|FG000|Overall Study|Adverse Event|1|||
130936923|NCT02049957|471402128|FG001|Overall Study|Adverse Event|1|||
130936924|NCT02049957|471402129|FG002|Overall Study|Adverse Event|1|||
130936925|NCT02049957|471402130|FG003|Overall Study|Adverse Event|0|||
130936926|NCT02049957|471402131|FG004|Overall Study|Adverse Event|0|||
130936927|NCT02049957|471402132|FG005|Overall Study|Adverse Event|5|||
130936928|NCT02049957|471402133|FG006|Overall Study|Adverse Event|0|||
130936929|NCT02049957|471402134|FG007|Overall Study|Adverse Event|6|||
130936930|NCT02049957|471402135|FG008|Overall Study|Adverse Event|1|||
130936931|NCT02049957|471402127|FG000|Overall Study|Study Terminated by Sponsor|0|||
130936932|NCT02049957|471402128|FG001|Overall Study|Study Terminated by Sponsor|1|||
130936933|NCT02049957|471402129|FG002|Overall Study|Study Terminated by Sponsor|0|||
130936934|NCT02049957|471402130|FG003|Overall Study|Study Terminated by Sponsor|0|||
130936935|NCT02049957|471402131|FG004|Overall Study|Study Terminated by Sponsor|0|||
130936936|NCT02049957|471402132|FG005|Overall Study|Study Terminated by Sponsor|0|||
130936937|NCT02049957|471402133|FG006|Overall Study|Study Terminated by Sponsor|1|||
130936938|NCT02049957|471402134|FG007|Overall Study|Study Terminated by Sponsor|0|||
130936939|NCT02049957|471402135|FG008|Overall Study|Study Terminated by Sponsor|0|||
130936940|NCT02049957|471402127|FG000|Overall Study|Withdrawal by Subject|0|||
130936941|NCT02049957|471402128|FG001|Overall Study|Withdrawal by Subject|0|||
130936942|NCT02049957|471402129|FG002|Overall Study|Withdrawal by Subject|0|||
130936943|NCT02049957|471402130|FG003|Overall Study|Withdrawal by Subject|1|||
130936944|NCT02049957|471402131|FG004|Overall Study|Withdrawal by Subject|0|||
130936945|NCT02049957|471402132|FG005|Overall Study|Withdrawal by Subject|2|||
130936946|NCT02049957|471402133|FG006|Overall Study|Withdrawal by Subject|0|||
130936947|NCT02049957|471402134|FG007|Overall Study|Withdrawal by Subject|3|||
130936948|NCT02049957|471402135|FG008|Overall Study|Withdrawal by Subject|1|||
130936949|NCT02049957|471402127|FG000|Overall Study|Physician Decision|0|||
130936950|NCT02049957|471402128|FG001|Overall Study|Physician Decision|0|||
130936951|NCT02049957|471402129|FG002|Overall Study|Physician Decision|0|||
130936952|NCT02049957|471402130|FG003|Overall Study|Physician Decision|0|||
130936953|NCT02049957|471402131|FG004|Overall Study|Physician Decision|0|||
130936954|NCT02049957|471402132|FG005|Overall Study|Physician Decision|1|||
130936955|NCT02049957|471402133|FG006|Overall Study|Physician Decision|0|||
130936956|NCT02049957|471402134|FG007|Overall Study|Physician Decision|0|||
130936957|NCT02049957|471402135|FG008|Overall Study|Physician Decision|0|||
130936958|NCT01958008|471402136|FG000|Overall Study|Worsening of disease under study|0|||
130936959|NCT01958008|471402137|FG001|Overall Study|Worsening of disease under study|0|||
130936960|NCT01958008|471402138|FG002|Overall Study|Worsening of disease under study|1|||
130936961|NCT01958008|471402139|FG003|Overall Study|Worsening of disease under study|0|||
130936962|NCT01958008|471402136|FG000|Overall Study|Other adverse event|1|||
130936963|NCT01958008|471402137|FG001|Overall Study|Other adverse event|0|||
130936964|NCT01958008|471402138|FG002|Overall Study|Other adverse event|0|||
130936965|NCT01958008|471402139|FG003|Overall Study|Other adverse event|0|||
131035391|NCT01369355|471764012|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
131035392|NCT01369355|471764013|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
131035393|NCT01369355|471764014|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
131035394|NCT01369355|471764015|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
131035395|NCT01369355|471764016|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
131035396|NCT01369355|471764017|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
131035397|NCT01369355|471764009|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
131035398|NCT01369355|471764010|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
131035399|NCT01369355|471764011|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
131035400|NCT01369355|471764012|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
131035401|NCT01369355|471764013|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
131035402|NCT01369355|471764014|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
131035403|NCT01369355|471764015|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
131035404|NCT01369355|471764016|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
131035405|NCT01369355|471764017|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
131035406|NCT01369355|471764009|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
131035407|NCT01369355|471764010|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
131035408|NCT01369355|471764011|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
131035409|NCT01369355|471764012|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
131035410|NCT01369355|471764013|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
131035411|NCT01369355|471764014|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
131035412|NCT01369355|471764015|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
131035413|NCT01369355|471764016|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
131223782|NCT04380701|472447135|FG026|Overall Study|Lost to Follow-up|0|||
130936966|NCT01634360|471402140|FG000|Overall Study|Adverse Event|10|||
131035414|NCT01369355|471764017|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
131035415|NCT01369355|471764009|FG000|Long-term Extension (Week 44-272)|Death|0|||
131035416|NCT01369355|471764010|FG001|Long-term Extension (Week 44-272)|Death|0|||
131035417|NCT01369355|471764011|FG002|Long-term Extension (Week 44-272)|Death|0|||
131035418|NCT01369355|471764012|FG003|Long-term Extension (Week 44-272)|Death|0|||
131035419|NCT01369355|471764013|FG004|Long-term Extension (Week 44-272)|Death|0|||
131035420|NCT01369355|471764014|FG005|Long-term Extension (Week 44-272)|Death|0|||
131035421|NCT01369355|471764015|FG006|Long-term Extension (Week 44-272)|Death|0|||
131035422|NCT01369355|471764016|FG007|Long-term Extension (Week 44-272)|Death|1|||
131035423|NCT01369355|471764017|FG008|Long-term Extension (Week 44-272)|Death|3|||
131035424|NCT01369355|471764009|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131035425|NCT01369355|471764010|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131035426|NCT01369355|471764011|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131035427|NCT01369355|471764012|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131035428|NCT01369355|471764013|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131035429|NCT01369355|471764014|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
131035430|NCT01369355|471764015|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
131035431|NCT01369355|471764016|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
131035432|NCT01369355|471764017|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
131035433|NCT01369355|471764009|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131035434|NCT01369355|471764010|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131035435|NCT01369355|471764011|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131035436|NCT01369355|471764012|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131035437|NCT01369355|471764013|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131035438|NCT01369355|471764014|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131035439|NCT01369355|471764015|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
131035440|NCT01369355|471764016|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
131035441|NCT01369355|471764017|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
131035442|NCT01369355|471764009|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
131035443|NCT01369355|471764010|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
131035444|NCT01369355|471764011|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
131035445|NCT01369355|471764012|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
131035446|NCT01369355|471764013|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
131120706|NCT04667377|472072362|FG004|Maintenance Period|Lost to Follow-up|1|||
131120707|NCT01011439|472072363|FG000|Overall Study|Death|37|||
131120708|NCT01011439|472072363|FG000|Overall Study|Lost to Follow-up|4|||
131120709|NCT01011439|472072363|FG000|Overall Study|Withdrawal by Subject|1|||
131120710|NCT01011439|472072363|FG000|Overall Study|Sponsor's decision|15|||
131120711|NCT02428855|472072364|FG000|Overall Study|Withdrawal by Subject|2|||
131120712|NCT02066311|472072365|FG000|Overall Study|Adverse Event|4|||
131120713|NCT02066311|472072365|FG000|Overall Study|Withdrawal by Subject|1|||
131120714|NCT03198520|472072372|FG000|Overall Study|Physician Decision|2|||
131120715|NCT03198520|472072372|FG000|Overall Study|Protocol Violation|2|||
131120716|NCT03198520|472072372|FG000|Overall Study|Withdrawal by Subject|1|||
131120717|NCT03198520|472072372|FG000|Overall Study|Study Ended|1|||
131120718|NCT01670539|472072373|FG000|Overall Study|Death|3|||
131120719|NCT01670539|472072374|FG001|Overall Study|Death|5|||
131120720|NCT01670539|472072373|FG000|Overall Study|Withdrawal by Subject|3|||
131120721|NCT01670539|472072374|FG001|Overall Study|Withdrawal by Subject|0|||
131120722|NCT04353596|472072375|FG000|Overall Study|Protocol Violation|4|||
131120723|NCT04353596|472072376|FG001|Overall Study|Protocol Violation|4|||
131120724|NCT04353596|472072375|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
131120725|NCT04353596|472072376|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
131120726|NCT05418673|472072377|FG000|Overall Study|Study Terminated by Sponsor|2|||
131120727|NCT05418673|472072378|FG001|Overall Study|Study Terminated by Sponsor|4|||
131120728|NCT05418673|472072377|FG000|Overall Study|Lost to Follow-up|1|||
131120729|NCT05418673|472072378|FG001|Overall Study|Lost to Follow-up|0|||
131120730|NCT02665052|472072381|FG000|Overall Study|Lost to Follow-up|1|||
131120731|NCT02665052|472072382|FG001|Overall Study|Lost to Follow-up|0|||
131035447|NCT01369355|471764014|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
131035448|NCT01369355|471764015|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
131035449|NCT01369355|471764016|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
131120732|NCT02665052|472072383|FG002|Overall Study|Lost to Follow-up|0|||
131035450|NCT01369355|471764017|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
131035451|NCT01369355|471764009|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131120733|NCT02665052|472072384|FG003|Overall Study|Lost to Follow-up|0|||
131120734|NCT02665052|472072381|FG000|Overall Study|Withdrawal by Subject|1|||
131120735|NCT02665052|472072382|FG001|Overall Study|Withdrawal by Subject|1|||
131120736|NCT02665052|472072383|FG002|Overall Study|Withdrawal by Subject|0|||
131120737|NCT02665052|472072384|FG003|Overall Study|Withdrawal by Subject|5|||
131120738|NCT02665052|472072381|FG000|Overall Study|Adverse Event|1|||
131120739|NCT02665052|472072382|FG001|Overall Study|Adverse Event|1|||
131120740|NCT02665052|472072383|FG002|Overall Study|Adverse Event|0|||
130704544|NCT01522950|470542713|FG001|Overall Study|Study Medication Sensitivity|1|||
130704545|NCT01522950|470542714|FG002|Overall Study|Study Medication Sensitivity|0|||
130704546|NCT01844531|470542718|FG000|Overall Study|Withdrawal by Subject|0|||
130704547|NCT01844531|470542719|FG001|Overall Study|Withdrawal by Subject|1|||
130704548|NCT01844531|470542720|FG002|Overall Study|Withdrawal by Subject|0|||
130704549|NCT01844531|470542721|FG003|Overall Study|Withdrawal by Subject|0|||
130704550|NCT02000531|470542723|FG000|Overall Study|Lost to Follow-up|1|||
130704551|NCT02000531|470542724|FG001|Overall Study|Lost to Follow-up|0|||
130704552|NCT02000531|470542723|FG000|Overall Study|Discontinued due to data cut-off|3|||
130704553|NCT02000531|470542724|FG001|Overall Study|Discontinued due to data cut-off|8|||
130704554|NCT01345318|470542727|FG000|Overall Study|Adverse Event|16|||
130704555|NCT01345318|470542727|FG000|Overall Study|Lack of Efficacy|17|||
130704556|NCT01345318|470542727|FG000|Overall Study|Lost to Follow-up|2|||
130704557|NCT01345318|470542727|FG000|Overall Study|Protocol Violation|1|||
130704558|NCT01345318|470542727|FG000|Overall Study|Withdrawal by Subject|41|||
130704559|NCT01345318|470542727|FG000|Overall Study|Other|3|||
130704560|NCT00317642|470542728|FG000|Overall Study|Not Received Either Study Drug|1|||
130704561|NCT00317642|470542729|FG001|Overall Study|Not Received Either Study Drug|3|||
130704562|NCT00317642|470542728|FG000|Overall Study|Physician Decision|15|||
130704563|NCT00317642|470542729|FG001|Overall Study|Physician Decision|7|||
130704564|NCT00317642|470542728|FG000|Overall Study|Participant declined treatment|14|||
130704565|NCT00317642|470542729|FG001|Overall Study|Participant declined treatment|3|||
130704566|NCT00317642|470542728|FG000|Overall Study|Adverse Event|17|||
130704567|NCT00317642|470542729|FG001|Overall Study|Adverse Event|5|||
130704568|NCT00317642|470542728|FG000|Overall Study|Treatment Failure|56|||
130704569|NCT00317642|470542729|FG001|Overall Study|Treatment Failure|102|||
130704570|NCT00317642|470542728|FG000|Overall Study|Disease Recurrence|1|||
130704571|NCT00317642|470542729|FG001|Overall Study|Disease Recurrence|2|||
130704572|NCT00317642|470542728|FG000|Overall Study|Death|14|||
130704573|NCT00317642|470542729|FG001|Overall Study|Death|7|||
130704574|NCT00317642|470542728|FG000|Overall Study|Not Continue to Consolidation|2|||
130704575|NCT00317642|470542729|FG001|Overall Study|Not Continue to Consolidation|0|||
130704576|NCT00317642|470542728|FG000|Overall Study|Withdrawal by Subject|0|||
130704577|NCT00317642|470542729|FG001|Overall Study|Withdrawal by Subject|1|||
130704578|NCT00317642|470542728|FG000|Overall Study|Referred For Transplantation|1|||
130704579|NCT00317642|470542729|FG001|Overall Study|Referred For Transplantation|0|||
130704580|NCT00317642|470542728|FG000|Overall Study|AML Not Centrally Confirmed|1|||
130704581|NCT00317642|470542729|FG001|Overall Study|AML Not Centrally Confirmed|5|||
130704582|NCT01239472|470542734|FG000|Overall Study|Withdrawal by Subject|5|||
130704583|NCT01239472|470542735|FG001|Overall Study|Withdrawal by Subject|1|||
130704584|NCT01239472|470542734|FG000|Overall Study|Adverse Event|0|||
130704585|NCT01239472|470542735|FG001|Overall Study|Adverse Event|1|||
130704586|NCT01239472|470542734|FG000|Overall Study|Lack of Efficacy|0|||
130704587|NCT01239472|470542735|FG001|Overall Study|Lack of Efficacy|1|||
130704588|NCT01049412|470542739|FG000|Period I|Withdrawal by Subject|4|||
130704589|NCT01049412|470542740|FG001|Period I|Withdrawal by Subject|6|||
130704590|NCT01049412|470542739|FG000|Period I|Lost to Follow-up|2|||
130936967|NCT01634360|471402141|FG001|Overall Study|Adverse Event|34|||
130936968|NCT01634360|471402140|FG000|Overall Study|subject withdrew consent|13|||
130936969|NCT01634360|471402141|FG001|Overall Study|subject withdrew consent|23|||
130936970|NCT01634360|471402140|FG000|Overall Study|Protocol Violation|1|||
130936971|NCT01634360|471402141|FG001|Overall Study|Protocol Violation|1|||
130936972|NCT01634360|471402140|FG000|Overall Study|Lack of Efficacy|4|||
130936973|NCT01634360|471402141|FG001|Overall Study|Lack of Efficacy|14|||
130936974|NCT01634360|471402140|FG000|Overall Study|Other|3|||
130704591|NCT01049412|470542740|FG001|Period I|Lost to Follow-up|2|||
130704592|NCT01049412|470542739|FG000|Period I|Physician Decision|0|||
130704593|NCT01049412|470542740|FG001|Period I|Physician Decision|3|||
130704594|NCT01049412|470542739|FG000|Period I|Protocol Violation|1|||
130704595|NCT01049412|470542740|FG001|Period I|Protocol Violation|2|||
130704596|NCT01049412|470542739|FG000|Period I|Adverse Event|1|||
130704597|NCT01049412|470542740|FG001|Period I|Adverse Event|0|||
130704598|NCT01049412|470542739|FG000|Period II|Withdrawal by Subject|2|||
130704599|NCT01049412|470542740|FG001|Period II|Withdrawal by Subject|3|||
130704600|NCT01049412|470542739|FG000|Period II|Adverse Event|1|||
130704601|NCT01049412|470542740|FG001|Period II|Adverse Event|0|||
130704602|NCT01049412|470542739|FG000|Period II|Lost to Follow-up|1|||
130704603|NCT01049412|470542740|FG001|Period II|Lost to Follow-up|0|||
130704604|NCT01280617|470542741|FG000|Overall Study|Adverse Event|0|||
130704605|NCT01280617|470542742|FG001|Overall Study|Adverse Event|1|||
130704606|NCT05966090|470542743|FG000|Overall Study|Lost to Follow-up|6|||
130704607|NCT05966090|470542744|FG001|Overall Study|Lost to Follow-up|6|||
130704608|NCT05966090|470542743|FG000|Overall Study|Adverse Event|1|||
130936975|NCT01634360|471402141|FG001|Overall Study|Other|20|||
130936976|NCT01634360|471402140|FG000|Overall Study|Study termination by sponsor|18|||
130704609|NCT05966090|470542744|FG001|Overall Study|Adverse Event|1|||
130704610|NCT05966090|470542743|FG000|Overall Study|Withdrawal by Subject|1|||
130704611|NCT05966090|470542744|FG001|Overall Study|Withdrawal by Subject|1|||
131120741|NCT02665052|472072384|FG003|Overall Study|Adverse Event|0|||
130704612|NCT05966090|470542743|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131120742|NCT00823823|472072385|FG000|Overall Study|Lost to Follow-up|3|||
131120743|NCT00823823|472072386|FG001|Overall Study|Lost to Follow-up|1|||
131120744|NCT00823823|472072385|FG000|Overall Study|Protocol Violation|5|||
131120745|NCT00823823|472072386|FG001|Overall Study|Protocol Violation|5|||
131120746|NCT02234284|472072387|FG000|Overall Study|Death|4|||
131120747|NCT02234284|472072388|FG001|Overall Study|Death|2|||
131120748|NCT02234284|472072387|FG000|Overall Study|Withdrawal by Subject|1|||
131120749|NCT02234284|472072388|FG001|Overall Study|Withdrawal by Subject|0|||
131120750|NCT02234284|472072387|FG000|Overall Study|Lost to Follow-up|20|||
131120751|NCT02234284|472072388|FG001|Overall Study|Lost to Follow-up|7|||
131120752|NCT01835015|472072389|FG000|Overall Study|Adverse Event|0|||
131120753|NCT01835015|472072390|FG001|Overall Study|Adverse Event|0|||
131120754|NCT01835015|472072391|FG002|Overall Study|Adverse Event|1|||
131120755|NCT01835015|472072392|FG003|Overall Study|Adverse Event|0|||
131120756|NCT01835015|472072393|FG004|Overall Study|Adverse Event|0|||
131120757|NCT00536809|472072396|FG000|Phase II|Adverse Event|1|||
131120758|NCT00536809|472072396|FG000|Phase II|Referred for surgical resection|1|||
131120759|NCT01576172|472072397|FG000|Overall Study|Ineligible|2|||
131120760|NCT01576172|472072398|FG001|Overall Study|Ineligible|1|||
131120761|NCT01576172|472072397|FG000|Overall Study|Withdrawal by Subject|2|||
131120762|NCT01576172|472072398|FG001|Overall Study|Withdrawal by Subject|0|||
131120763|NCT01576172|472072397|FG000|Overall Study|Insurance issue|1|||
131120764|NCT01576172|472072398|FG001|Overall Study|Insurance issue|0|||
131120765|NCT01303965|472072400|FG000|Overall Study|Adverse Event|1|||
131120766|NCT01303965|472072401|FG001|Overall Study|Adverse Event|1|||
131120767|NCT01303965|472072400|FG000|Overall Study|Death|0|||
131120768|NCT01303965|472072401|FG001|Overall Study|Death|3|||
131120769|NCT01303965|472072400|FG000|Overall Study|Withdrawal by Subject|1|||
131120770|NCT01303965|472072401|FG001|Overall Study|Withdrawal by Subject|0|||
131120771|NCT01303965|472072400|FG000|Overall Study|Disease Progression|1|||
131120772|NCT01303965|472072401|FG001|Overall Study|Disease Progression|6|||
131120773|NCT01490814|472072406|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
131120774|NCT01490814|472072407|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
131120775|NCT01490814|472072406|FG000|Overall Study|Physician Decision|1|||
131120776|NCT01490814|472072407|FG001|Overall Study|Physician Decision|0|||
131120777|NCT01490814|472072406|FG000|Overall Study|Withdrawal by Subject|0|||
131120778|NCT01490814|472072407|FG001|Overall Study|Withdrawal by Subject|5|||
131120779|NCT03024970|472072411|FG000|First Intervention|Adverse Event|1|||
131120780|NCT03024970|472072412|FG001|First Intervention|Adverse Event|0|||
131120781|NCT03024970|472072411|FG000|Second Intervention|Lost to Follow-up|1|||
131120782|NCT03024970|472072412|FG001|Second Intervention|Lost to Follow-up|0|||
131120783|NCT02790138|472072415|FG000|Overall Study|Adverse Event|5|||
131120784|NCT02790138|472072416|FG001|Overall Study|Adverse Event|2|||
131120785|NCT02790138|472072415|FG000|Overall Study|Significant Protocol Deviation|0|||
131120786|NCT02790138|472072416|FG001|Overall Study|Significant Protocol Deviation|1|||
131120787|NCT02790138|472072415|FG000|Overall Study|Lost to Follow-up|1|||
131120788|NCT02790138|472072416|FG001|Overall Study|Lost to Follow-up|0|||
131120789|NCT02790138|472072415|FG000|Overall Study|Voluntary Withdrawal|8|||
131120790|NCT02790138|472072416|FG001|Overall Study|Voluntary Withdrawal|9|||
131120791|NCT02790138|472072415|FG000|Overall Study|Lack of Efficacy|6|||
131120792|NCT02790138|472072416|FG001|Overall Study|Lack of Efficacy|7|||
131120793|NCT02790138|472072415|FG000|Overall Study|Reason not Specified|1|||
130936977|NCT01634360|471402141|FG001|Overall Study|Study termination by sponsor|44|||
130936978|NCT02028065|471402144|FG000|Randomization Through Start Treatment|Not treated|1|||
130936979|NCT02028065|471402145|FG001|Randomization Through Start Treatment|Not treated|3|||
130936980|NCT02028065|471402146|FG002|Randomization Through Start Treatment|Not treated|3|||
130936981|NCT02028065|471402144|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
130936982|NCT02028065|471402145|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
130936983|NCT02028065|471402146|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
130936984|NCT02028065|471402144|FG000|Treatment Through Study Completion|Physician Decision|1|||
131120794|NCT02790138|472072416|FG001|Overall Study|Reason not Specified|0|||
130936985|NCT02028065|471402145|FG001|Treatment Through Study Completion|Physician Decision|0|||
130936986|NCT02028065|471402146|FG002|Treatment Through Study Completion|Physician Decision|0|||
130936987|NCT02028065|471402144|FG000|Treatment Through Study Completion|Protocol Violation|1|||
131120795|NCT01786603|472072417|FG000|Overall Study|Death|5|||
131120796|NCT01786603|472072418|FG001|Overall Study|Death|1|||
131120797|NCT01786603|472072417|FG000|Overall Study|Adverse Event|6|||
131120798|NCT01786603|472072418|FG001|Overall Study|Adverse Event|2|||
130704613|NCT05966090|470542744|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
131120799|NCT01786603|472072417|FG000|Overall Study|Physician decision to withdraw|6|||
131120800|NCT01786603|472072418|FG001|Overall Study|Physician decision to withdraw|7|||
131120801|NCT01786603|472072417|FG000|Overall Study|Lost to Follow-up|1|||
131120802|NCT01786603|472072418|FG001|Overall Study|Lost to Follow-up|2|||
131120803|NCT01226459|472072419|FG000|Overall Study|Adverse Event|2|||
131120804|NCT01226459|472072420|FG001|Overall Study|Adverse Event|8|||
131120805|NCT01226459|472072419|FG000|Overall Study|Protocol Violation|4|||
130704614|NCT05966090|470542743|FG000|Overall Study|Other|1|||
130704615|NCT05966090|470542744|FG001|Overall Study|Other|1|||
130936988|NCT02028065|471402145|FG001|Treatment Through Study Completion|Protocol Violation|4|||
130936989|NCT02028065|471402146|FG002|Treatment Through Study Completion|Protocol Violation|0|||
130936990|NCT02028065|471402144|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
130936991|NCT02028065|471402145|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
130936992|NCT02028065|471402146|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
130936993|NCT02028065|471402144|FG000|Treatment Through Study Completion|Adverse Event|3|||
130936994|NCT02028065|471402145|FG001|Treatment Through Study Completion|Adverse Event|3|||
130936995|NCT02028065|471402146|FG002|Treatment Through Study Completion|Adverse Event|5|||
130936996|NCT01414855|471402147|FG000|Overall Study|Death|17|||
130936997|NCT01414855|471402147|FG000|Overall Study|Lost to Follow-up|5|||
130936998|NCT01414855|471402147|FG000|Overall Study|Withdrawal by Subject|7|||
130936999|NCT04851314|471402148|FG000|Overall Study|Unable to complete research set-up procedures|0|||
130937000|NCT04851314|471402149|FG001|Overall Study|Unable to complete research set-up procedures|2|||
130937001|NCT04851314|471402148|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
130937002|NCT04851314|471402149|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
130937003|NCT00867009|471402150|FG000|Induction Period|Nonserious Adverse Event|5|||
130937004|NCT00867009|471402150|FG000|Induction Period|Serious Adverse Event|10|||
130937005|NCT00867009|471402150|FG000|Induction Period|Death due to serious adverse event|6|||
130937006|NCT00867009|471402150|FG000|Induction Period|Death due to Study Disease|4|||
130937007|NCT00867009|471402150|FG000|Induction Period|Protocol Violation|1|||
130937008|NCT00867009|471402150|FG000|Induction Period|Withdrawal by Subject|8|||
130937009|NCT00867009|471402150|FG000|Induction Period|Physician Decision|3|||
130937010|NCT00867009|471402150|FG000|Induction Period|Progressive Disease (PD)|25|||
130937011|NCT00867009|471402150|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
130704616|NCT00337428|470542745|FG000|Overall Study|Withdrawal by Subject|1|||
130704617|NCT00337428|470542746|FG001|Overall Study|Withdrawal by Subject|2|||
130704618|NCT00337428|470542745|FG000|Overall Study|Lack of Time|1|||
130937012|NCT01850524|471402157|FG000|Overall Study|Lost to Follow-up|5|||
130937013|NCT01850524|471402158|FG001|Overall Study|Lost to Follow-up|10|||
130937014|NCT01850524|471402157|FG000|Overall Study|Withdrawal by Subject|24|||
130937015|NCT01850524|471402158|FG001|Overall Study|Withdrawal by Subject|22|||
130937016|NCT01850524|471402157|FG000|Overall Study|Reason not Specified|142|||
130704619|NCT00337428|470542746|FG001|Overall Study|Lack of Time|1|||
130937017|NCT01850524|471402158|FG001|Overall Study|Reason not Specified|141|||
130937018|NCT00459667|471402161|FG000|Overall Study|Adverse Event|9|||
130937019|NCT00459667|471402162|FG001|Overall Study|Adverse Event|12|||
130937020|NCT00459667|471402163|FG002|Overall Study|Adverse Event|8|||
130937021|NCT00459667|471402161|FG000|Overall Study|Lost to Follow-up|5|||
130937022|NCT00459667|471402162|FG001|Overall Study|Lost to Follow-up|9|||
130937023|NCT00459667|471402163|FG002|Overall Study|Lost to Follow-up|3|||
130937024|NCT00459667|471402161|FG000|Overall Study|Pregnancy|1|||
130937025|NCT00459667|471402162|FG001|Overall Study|Pregnancy|1|||
130937026|NCT00459667|471402163|FG002|Overall Study|Pregnancy|1|||
130937027|NCT00459667|471402161|FG000|Overall Study|Protocol Violation|1|||
130937028|NCT00459667|471402162|FG001|Overall Study|Protocol Violation|0|||
130937029|NCT00459667|471402163|FG002|Overall Study|Protocol Violation|0|||
130937030|NCT00459667|471402161|FG000|Overall Study|Withdrawal by Subject|3|||
130937031|NCT00459667|471402162|FG001|Overall Study|Withdrawal by Subject|5|||
130937032|NCT00459667|471402163|FG002|Overall Study|Withdrawal by Subject|5|||
130937033|NCT00459667|471402161|FG000|Overall Study|Other disease modifying treatment|1|||
130937034|NCT00459667|471402162|FG001|Overall Study|Other disease modifying treatment|2|||
130937035|NCT00459667|471402163|FG002|Overall Study|Other disease modifying treatment|1|||
130937036|NCT00459667|471402161|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
130937037|NCT00459667|471402162|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
130937038|NCT00459667|471402163|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
130937039|NCT00459667|471402161|FG000|Overall Study|No treatment administered|6|||
130937040|NCT00459667|471402162|FG001|Overall Study|No treatment administered|3|||
130937041|NCT00459667|471402163|FG002|Overall Study|No treatment administered|1|||
130937042|NCT00396591|471402164|FG000|Overall Study|Disease Progression|13|||
130937043|NCT00396591|471402164|FG000|Overall Study|Adverse Event|2|||
130937044|NCT00396591|471402164|FG000|Overall Study|Participant request|1|||
130937045|NCT01013701|471402165|FG000|Overall Study|study prematurely terminated|7|||
130937046|NCT00847704|471402166|FG000|Overall Study|Withdrawal by Subject|1|||
130937047|NCT02671422|471402167|FG000|Overall Study|Lost to Follow-up|1|||
130937048|NCT02671422|471402167|FG000|Overall Study|Adverse Event|68|||
130937049|NCT02671422|471402167|FG000|Overall Study|Lack of Efficacy|1|||
130937050|NCT02671422|471402167|FG000|Overall Study|Lost to Follow-up|4|||
130704620|NCT00337428|470542745|FG000|Overall Study|Unwilling to Continue|1|||
130937051|NCT02671422|471402167|FG000|Overall Study|Withdrawal by Subject|7|||
130937052|NCT02671422|471402167|FG000|Overall Study|Progressive Disease|156|||
130937053|NCT02671422|471402167|FG000|Overall Study|Worsening of Disease|4|||
130704621|NCT00337428|470542746|FG001|Overall Study|Unwilling to Continue|0|||
130704622|NCT00337428|470542745|FG000|Overall Study|Anorexia|1|||
130704623|NCT00337428|470542746|FG001|Overall Study|Anorexia|0|||
130937054|NCT02671422|471402167|FG000|Overall Study|Sponsor decision|5|||
131120806|NCT01226459|472072420|FG001|Overall Study|Protocol Violation|3|||
131120807|NCT01226459|472072419|FG000|Overall Study|Withdrawal by Subject|10|||
131120808|NCT01226459|472072420|FG001|Overall Study|Withdrawal by Subject|13|||
131120809|NCT01226459|472072419|FG000|Overall Study|Lost to Follow-up|4|||
131120810|NCT01226459|472072420|FG001|Overall Study|Lost to Follow-up|8|||
131120811|NCT01226459|472072419|FG000|Overall Study|Pregnancy|1|||
131120812|NCT01226459|472072420|FG001|Overall Study|Pregnancy|0|||
131120813|NCT00474708|472072421|FG000|Overall Study|Lack of Efficacy|11|||
131120814|NCT00474708|472072422|FG001|Overall Study|Lack of Efficacy|5|||
131120815|NCT00474708|472072421|FG000|Overall Study|Suicide ideation/behavior|0|||
131120816|NCT00474708|472072422|FG001|Overall Study|Suicide ideation/behavior|1|||
131120817|NCT00474708|472072421|FG000|Overall Study|Withdrawal by Subject|7|||
131120818|NCT00474708|472072422|FG001|Overall Study|Withdrawal by Subject|0|||
131120819|NCT00474708|472072421|FG000|Overall Study|Lack of compliance|12|||
131120820|NCT00474708|472072422|FG001|Overall Study|Lack of compliance|4|||
131120821|NCT00474708|472072421|FG000|Overall Study|Lost to Follow-up|18|||
131120822|NCT00474708|472072422|FG001|Overall Study|Lost to Follow-up|9|||
131120823|NCT00474708|472072421|FG000|Overall Study|Physician Decision|9|||
131120824|NCT00474708|472072422|FG001|Overall Study|Physician Decision|6|||
131120825|NCT03700320|472072423|FG000|Overall Study|Adverse Event|5|||
131120826|NCT03700320|472072424|FG001|Overall Study|Adverse Event|31|||
131120827|NCT03700320|472072423|FG000|Overall Study|Lack of Efficacy|2|||
131120828|NCT03700320|472072424|FG001|Overall Study|Lack of Efficacy|5|||
131120829|NCT03700320|472072423|FG000|Overall Study|Withdrawal by Subject|29|||
131120830|NCT03700320|472072424|FG001|Overall Study|Withdrawal by Subject|75|||
131120831|NCT03700320|472072423|FG000|Overall Study|Lost to Follow-up|16|||
131120832|NCT03700320|472072424|FG001|Overall Study|Lost to Follow-up|23|||
131120833|NCT03700320|472072423|FG000|Overall Study|Pregnancy|2|||
131120834|NCT03700320|472072424|FG001|Overall Study|Pregnancy|4|||
131120835|NCT03700320|472072423|FG000|Overall Study|Protocol Deviation|7|||
131120836|NCT03700320|472072424|FG001|Overall Study|Protocol Deviation|31|||
131120837|NCT03700320|472072423|FG000|Overall Study|Non-compliance with Study Drug|1|||
131120838|NCT03700320|472072424|FG001|Overall Study|Non-compliance with Study Drug|3|||
131120839|NCT03700320|472072423|FG000|Overall Study|Reason not Specified|0|||
131120840|NCT03700320|472072424|FG001|Overall Study|Reason not Specified|1|||
131120841|NCT00175877|472072428|FG000|Overall Study|Adverse Event|136|||
131120842|NCT00175877|472072428|FG000|Overall Study|Withdrawal by Subject|141|||
131120843|NCT00175877|472072428|FG000|Overall Study|Lost to Follow-up|9|||
131120844|NCT00175877|472072428|FG000|Overall Study|Lack of Efficacy|26|||
131120845|NCT00175877|472072428|FG000|Overall Study|Protocol Violation|15|||
131120846|NCT00175877|472072428|FG000|Overall Study|Other Reason|20|||
131120847|NCT00175877|472072428|FG000|Overall Study|AE & Other|1|||
131120848|NCT00175877|472072428|FG000|Overall Study|Withdrawal by subject & Other|1|||
131120849|NCT01092143|472072431|FG000|Overall Study|Adverse Event|10|||
131120850|NCT01092143|472072432|FG001|Overall Study|Adverse Event|5|||
131120851|NCT01092143|472072433|FG002|Overall Study|Adverse Event|1|||
131120852|NCT01092143|472072434|FG003|Overall Study|Adverse Event|4|||
131120853|NCT01092143|472072435|FG004|Overall Study|Adverse Event|3|||
131120854|NCT01092143|472072431|FG000|Overall Study|Lost to Follow-up|1|||
130937055|NCT02671422|471402167|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
130937056|NCT02671422|471402167|FG000|Overall Study|Not treated with Vargatef®|3|||
130937057|NCT02671422|471402167|FG000|Overall Study|Other not defined above|3|||
130937058|NCT04772755|471402168|FG000|Overall Study|Withdrawal by Subject|1|||
130937059|NCT04772755|471402169|FG001|Overall Study|Withdrawal by Subject|0|||
130937060|NCT04772755|471402168|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
130937061|NCT04772755|471402169|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
130937062|NCT01905657|471402170|FG000|Overall Study|Adverse Event|23|||
130937063|NCT01905657|471402171|FG001|Overall Study|Adverse Event|17|||
130937064|NCT01905657|471402172|FG002|Overall Study|Adverse Event|18|||
130937065|NCT01905657|471402170|FG000|Overall Study|Clinical Progression|103|||
130937066|NCT01905657|471402171|FG001|Overall Study|Clinical Progression|78|||
130937067|NCT01905657|471402172|FG002|Overall Study|Clinical Progression|59|||
130937068|NCT01905657|471402170|FG000|Overall Study|Death|40|||
131120855|NCT01092143|472072432|FG001|Overall Study|Lost to Follow-up|0|||
130937069|NCT01905657|471402171|FG001|Overall Study|Death|43|||
130937070|NCT01905657|471402172|FG002|Overall Study|Death|47|||
131120856|NCT01092143|472072433|FG002|Overall Study|Lost to Follow-up|1|||
130704624|NCT03756883|470542747|FG000|Overall Study|Adverse Event|2|||
130937071|NCT01905657|471402170|FG000|Overall Study|Excluded Medication|13|||
131120857|NCT01092143|472072434|FG003|Overall Study|Lost to Follow-up|0|||
131120858|NCT01092143|472072435|FG004|Overall Study|Lost to Follow-up|0|||
131120859|NCT01092143|472072431|FG000|Overall Study|Consent withdrawn|2|||
131120860|NCT01092143|472072432|FG001|Overall Study|Consent withdrawn|1|||
131120861|NCT01092143|472072433|FG002|Overall Study|Consent withdrawn|0|||
131120862|NCT01092143|472072434|FG003|Overall Study|Consent withdrawn|1|||
131120863|NCT01092143|472072435|FG004|Overall Study|Consent withdrawn|3|||
131035452|NCT01369355|471764010|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131035453|NCT01369355|471764011|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131035454|NCT01369355|471764012|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131035455|NCT01369355|471764013|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131035456|NCT01369355|471764014|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
131035457|NCT01369355|471764015|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
131035458|NCT01369355|471764016|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
131035459|NCT01369355|471764017|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
131035460|NCT01369355|471764009|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131035461|NCT01369355|471764010|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131035462|NCT01369355|471764011|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131035463|NCT01369355|471764012|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131035464|NCT01369355|471764013|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131035465|NCT01369355|471764014|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
131035466|NCT01369355|471764015|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
131035467|NCT01369355|471764016|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
131035468|NCT01369355|471764017|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
131035469|NCT01369355|471764009|FG000|Long-term Extension (Week 44-272)|Other|0|||
131035470|NCT01369355|471764010|FG001|Long-term Extension (Week 44-272)|Other|0|||
131035471|NCT01369355|471764011|FG002|Long-term Extension (Week 44-272)|Other|0|||
131035472|NCT01369355|471764012|FG003|Long-term Extension (Week 44-272)|Other|0|||
131035473|NCT01369355|471764013|FG004|Long-term Extension (Week 44-272)|Other|0|||
131035474|NCT01369355|471764014|FG005|Long-term Extension (Week 44-272)|Other|0|||
131035475|NCT01369355|471764015|FG006|Long-term Extension (Week 44-272)|Other|110|||
131035476|NCT01369355|471764016|FG007|Long-term Extension (Week 44-272)|Other|9|||
131035477|NCT01369355|471764017|FG008|Long-term Extension (Week 44-272)|Other|17|||
131035478|NCT01902173|471764018|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
131035479|NCT01902173|471764019|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
131035480|NCT01902173|471764020|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
131035481|NCT01902173|471764021|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
131035482|NCT01902173|471764022|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
131035483|NCT01902173|471764023|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
131035484|NCT01902173|471764018|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
131035485|NCT01902173|471764019|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
131035486|NCT01902173|471764020|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
131035487|NCT01902173|471764021|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
131035488|NCT01902173|471764022|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
131035489|NCT01902173|471764023|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
131035490|NCT01902173|471764018|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
131035491|NCT01902173|471764019|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
131035492|NCT01902173|471764020|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
131035493|NCT01902173|471764021|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
131035494|NCT01902173|471764022|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
131035495|NCT01902173|471764023|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
131120864|NCT01092143|472072431|FG000|Overall Study|Not treated|0|||
131120865|NCT01092143|472072432|FG001|Overall Study|Not treated|0|||
131120866|NCT01092143|472072433|FG002|Overall Study|Not treated|1|||
131120867|NCT01092143|472072434|FG003|Overall Study|Not treated|0|||
131120868|NCT01092143|472072435|FG004|Overall Study|Not treated|0|||
131120869|NCT01092143|472072431|FG000|Overall Study|did not reversibility criteria|0|||
131120870|NCT01092143|472072432|FG001|Overall Study|did not reversibility criteria|0|||
131120871|NCT01092143|472072433|FG002|Overall Study|did not reversibility criteria|1|||
131120872|NCT01092143|472072434|FG003|Overall Study|did not reversibility criteria|0|||
131120873|NCT01092143|472072435|FG004|Overall Study|did not reversibility criteria|0|||
131120874|NCT01092143|472072431|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
131120875|NCT01092143|472072432|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
131120876|NCT01092143|472072433|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
131120877|NCT01092143|472072434|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
130704625|NCT03756883|470542748|FG001|Overall Study|Adverse Event|2|||
130704626|NCT03756883|470542749|FG002|Overall Study|Adverse Event|2|||
130704627|NCT03756883|470542747|FG000|Overall Study|Lack of Efficacy|0|||
131120878|NCT01092143|472072435|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
131120879|NCT01092143|472072431|FG000|Overall Study|Ineligible patient|1|||
131120880|NCT01092143|472072432|FG001|Overall Study|Ineligible patient|0|||
131120881|NCT01092143|472072433|FG002|Overall Study|Ineligible patient|0|||
131120882|NCT01092143|472072434|FG003|Overall Study|Ineligible patient|0|||
131035496|NCT01902173|471764018|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
131120883|NCT01092143|472072435|FG004|Overall Study|Ineligible patient|0|||
131120884|NCT01092143|472072431|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
130704628|NCT03756883|470542748|FG001|Overall Study|Lack of Efficacy|1|||
130704629|NCT03756883|470542749|FG002|Overall Study|Lack of Efficacy|2|||
130771119|NCT00424593|470789824|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
130937072|NCT01905657|471402171|FG001|Overall Study|Excluded Medication|16|||
130937073|NCT01905657|471402172|FG002|Overall Study|Excluded Medication|9|||
130937074|NCT01905657|471402170|FG000|Overall Study|Lost to Follow-up|1|||
130937075|NCT01905657|471402171|FG001|Overall Study|Lost to Follow-up|2|||
130937076|NCT01905657|471402172|FG002|Overall Study|Lost to Follow-up|1|||
130937077|NCT01905657|471402170|FG000|Overall Study|Physician Decision|5|||
130937078|NCT01905657|471402171|FG001|Overall Study|Physician Decision|8|||
130937079|NCT01905657|471402172|FG002|Overall Study|Physician Decision|12|||
131120885|NCT01092143|472072432|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
131120886|NCT01092143|472072433|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
131120887|NCT01092143|472072434|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
131120888|NCT01092143|472072435|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
131120889|NCT01092143|472072431|FG000|Overall Study|Patient travel|0|||
131120890|NCT01092143|472072432|FG001|Overall Study|Patient travel|0|||
131120891|NCT01092143|472072433|FG002|Overall Study|Patient travel|0|||
131120892|NCT01092143|472072434|FG003|Overall Study|Patient travel|0|||
131120893|NCT01092143|472072435|FG004|Overall Study|Patient travel|1|||
131120894|NCT01092143|472072431|FG000|Overall Study|Non compliance with study medication|0|||
131120895|NCT01092143|472072432|FG001|Overall Study|Non compliance with study medication|0|||
131120896|NCT01092143|472072433|FG002|Overall Study|Non compliance with study medication|0|||
131120897|NCT01092143|472072434|FG003|Overall Study|Non compliance with study medication|0|||
131120898|NCT01092143|472072435|FG004|Overall Study|Non compliance with study medication|1|||
131120899|NCT01092143|472072431|FG000|Overall Study|Randomized by mistake|0|||
131120900|NCT01092143|472072432|FG001|Overall Study|Randomized by mistake|0|||
131120901|NCT01092143|472072433|FG002|Overall Study|Randomized by mistake|0|||
131120902|NCT01092143|472072434|FG003|Overall Study|Randomized by mistake|1|||
131120903|NCT01092143|472072435|FG004|Overall Study|Randomized by mistake|0|||
131120904|NCT01092143|472072431|FG000|Overall Study|Pregnancy|0|||
131120905|NCT01092143|472072432|FG001|Overall Study|Pregnancy|0|||
131120906|NCT01092143|472072433|FG002|Overall Study|Pregnancy|0|||
131120907|NCT01092143|472072434|FG003|Overall Study|Pregnancy|1|||
131120908|NCT01092143|472072435|FG004|Overall Study|Pregnancy|0|||
131120909|NCT03986866|472072436|FG000|Overall Study|Withdrawal by Subject|0|||
131120910|NCT03986866|472072437|FG001|Overall Study|Withdrawal by Subject|3|||
131120911|NCT03986866|472072436|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
131120912|NCT03986866|472072437|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
131120913|NCT05093322|472072440|FG000|Overall Study|Death|6|||
131120914|NCT05093322|472072441|FG001|Overall Study|Death|2|||
131120915|NCT05093322|472072440|FG000|Overall Study|Other|4|||
131120916|NCT05093322|472072441|FG001|Overall Study|Other|1|||
131120917|NCT00545402|472072444|FG000|Overall Study|Discontinuation of treatment|17|||
131120918|NCT00545402|472072445|FG001|Overall Study|Discontinuation of treatment|9|||
131120919|NCT00545402|472072444|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
131120920|NCT00545402|472072445|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
131120921|NCT00545402|472072444|FG000|Overall Study|Death|5|||
131120922|NCT00545402|472072445|FG001|Overall Study|Death|7|||
131120923|NCT00545402|472072444|FG000|Overall Study|Graft loss|2|||
131120924|NCT00545402|472072445|FG001|Overall Study|Graft loss|4|||
131120925|NCT00545402|472072444|FG000|Overall Study|Withdrawal by Subject|0|||
131120926|NCT00545402|472072445|FG001|Overall Study|Withdrawal by Subject|1|||
131120927|NCT00545402|472072444|FG000|Overall Study|Protocol Violation|1|||
131120928|NCT00545402|472072445|FG001|Overall Study|Protocol Violation|0|||
131120929|NCT00545402|472072444|FG000|Overall Study|Reason not specified|1|||
131120930|NCT00545402|472072445|FG001|Overall Study|Reason not specified|1|||
131120931|NCT00555477|472072446|FG000|Overall Study|Adverse Event|0|||
131120932|NCT00555477|472072447|FG001|Overall Study|Adverse Event|9|||
131120933|NCT00555477|472072446|FG000|Overall Study|Withdrawal by Subject|1|||
131120934|NCT00555477|472072447|FG001|Overall Study|Withdrawal by Subject|2|||
131120935|NCT00555477|472072446|FG000|Overall Study|Physician Decision|1|||
131120936|NCT00555477|472072447|FG001|Overall Study|Physician Decision|2|||
131120937|NCT01721876|472072448|FG000|Overall Study|Not treated|1|||
130771120|NCT00424593|470789823|FG000|Acute Double-Blind Period|Protocol Violation|2|||
131120938|NCT01721876|472072449|FG001|Overall Study|Not treated|4|||
131120939|NCT01721876|472072448|FG000|Overall Study|Disease progression / relapse|123|||
131120940|NCT01721876|472072449|FG001|Overall Study|Disease progression / relapse|156|||
131120941|NCT01721876|472072448|FG000|Overall Study|Death|6|||
130937080|NCT01905657|471402170|FG000|Overall Study|Protocol Violation|2|||
130937081|NCT01905657|471402171|FG001|Overall Study|Protocol Violation|1|||
130937082|NCT01905657|471402172|FG002|Overall Study|Protocol Violation|1|||
130937083|NCT01905657|471402170|FG000|Overall Study|Screen Failure|0|||
131120942|NCT01721876|472072449|FG001|Overall Study|Death|13|||
131120943|NCT01721876|472072448|FG000|Overall Study|Adverse Event|41|||
131120944|NCT01721876|472072449|FG001|Overall Study|Adverse Event|165|||
131120945|NCT01721876|472072448|FG000|Overall Study|Protocol Violation|2|||
131120946|NCT01721876|472072449|FG001|Overall Study|Protocol Violation|1|||
131120947|NCT01721876|472072448|FG000|Overall Study|Withdrawal by Subject|15|||
131223783|NCT04380701|472447136|FG027|Overall Study|Lost to Follow-up|0|||
131223784|NCT04380701|472447137|FG028|Overall Study|Lost to Follow-up|0|||
131223785|NCT04380701|472447138|FG029|Overall Study|Lost to Follow-up|1|||
131223786|NCT04380701|472447139|FG030|Overall Study|Lost to Follow-up|0|||
131223787|NCT04380701|472447140|FG031|Overall Study|Lost to Follow-up|0|||
131223788|NCT04380701|472447141|FG032|Overall Study|Lost to Follow-up|0|||
131223789|NCT04380701|472447142|FG033|Overall Study|Lost to Follow-up|1|||
131223790|NCT04380701|472447109|FG000|Overall Study|Private reason(s)|0|||
131223791|NCT04380701|472447110|FG001|Overall Study|Private reason(s)|0|||
131223792|NCT04380701|472447111|FG002|Overall Study|Private reason(s)|0|||
131223793|NCT04380701|472447112|FG003|Overall Study|Private reason(s)|0|||
131223794|NCT04380701|472447113|FG004|Overall Study|Private reason(s)|0|||
131223795|NCT04380701|472447114|FG005|Overall Study|Private reason(s)|0|||
131223796|NCT04380701|472447115|FG006|Overall Study|Private reason(s)|1|||
131223797|NCT04380701|472447116|FG007|Overall Study|Private reason(s)|0|||
131223798|NCT04380701|472447117|FG008|Overall Study|Private reason(s)|1|||
131223799|NCT04380701|472447118|FG009|Overall Study|Private reason(s)|1|||
131223800|NCT04380701|472447119|FG010|Overall Study|Private reason(s)|0|||
131223801|NCT04380701|472447120|FG011|Overall Study|Private reason(s)|0|||
131223802|NCT04380701|472447121|FG012|Overall Study|Private reason(s)|0|||
131223803|NCT04380701|472447122|FG013|Overall Study|Private reason(s)|0|||
131223804|NCT04380701|472447123|FG014|Overall Study|Private reason(s)|0|||
131223805|NCT04380701|472447124|FG015|Overall Study|Private reason(s)|0|||
131223806|NCT04380701|472447125|FG016|Overall Study|Private reason(s)|0|||
131223807|NCT04380701|472447126|FG017|Overall Study|Private reason(s)|0|||
131223808|NCT04380701|472447127|FG018|Overall Study|Private reason(s)|0|||
131223809|NCT04380701|472447128|FG019|Overall Study|Private reason(s)|0|||
131223810|NCT04380701|472447129|FG020|Overall Study|Private reason(s)|0|||
131223811|NCT04380701|472447130|FG021|Overall Study|Private reason(s)|0|||
131223812|NCT04380701|472447131|FG022|Overall Study|Private reason(s)|0|||
131223813|NCT04380701|472447132|FG023|Overall Study|Private reason(s)|1|||
131223814|NCT04380701|472447133|FG024|Overall Study|Private reason(s)|0|||
131223815|NCT04380701|472447134|FG025|Overall Study|Private reason(s)|0|||
131223816|NCT04380701|472447135|FG026|Overall Study|Private reason(s)|0|||
131223817|NCT04380701|472447136|FG027|Overall Study|Private reason(s)|0|||
131223818|NCT04380701|472447137|FG028|Overall Study|Private reason(s)|0|||
131223819|NCT04380701|472447138|FG029|Overall Study|Private reason(s)|1|||
131223820|NCT04380701|472447139|FG030|Overall Study|Private reason(s)|0|||
131223821|NCT04380701|472447140|FG031|Overall Study|Private reason(s)|0|||
131223822|NCT04380701|472447141|FG032|Overall Study|Private reason(s)|0|||
131223823|NCT04380701|472447142|FG033|Overall Study|Private reason(s)|0|||
131223824|NCT04380701|472447109|FG000|Overall Study|Withdrawal by Subject|0|||
131223825|NCT04380701|472447110|FG001|Overall Study|Withdrawal by Subject|0|||
131223826|NCT04380701|472447111|FG002|Overall Study|Withdrawal by Subject|0|||
130937084|NCT01905657|471402171|FG001|Overall Study|Screen Failure|1|||
130937085|NCT01905657|471402172|FG002|Overall Study|Screen Failure|0|||
130937086|NCT01905657|471402170|FG000|Overall Study|Withdrawal by Subject|15|||
130937087|NCT01905657|471402171|FG001|Overall Study|Withdrawal by Subject|21|||
130937088|NCT01905657|471402172|FG002|Overall Study|Withdrawal by Subject|53|||
130937089|NCT01905657|471402170|FG000|Overall Study|Sponsor Decision|1|||
130937090|NCT01905657|471402171|FG001|Overall Study|Sponsor Decision|0|||
130937091|NCT01905657|471402172|FG002|Overall Study|Sponsor Decision|0|||
130937092|NCT04080297|471402174|FG000|Overall Study|Adverse Event|1|||
130937093|NCT04080297|471402175|FG001|Overall Study|Adverse Event|3|||
130937094|NCT04080297|471402174|FG000|Overall Study|concurrent illness|1|||
130937095|NCT04080297|471402175|FG001|Overall Study|concurrent illness|0|||
130937096|NCT04702997|471402176|FG000|Overall Study|Withdrawal by Subject|1|||
130937097|NCT04702997|471402177|FG001|Overall Study|Withdrawal by Subject|1|||
130937098|NCT02200445|471402180|FG000|Overall Study|Lack of Efficacy|1|||
130937099|NCT02200445|471402181|FG001|Overall Study|Lack of Efficacy|2|||
130937100|NCT02200445|471402182|FG002|Overall Study|Lack of Efficacy|2|||
130937101|NCT02200445|471402180|FG000|Overall Study|Adverse Event|0|||
131223827|NCT04380701|472447112|FG003|Overall Study|Withdrawal by Subject|0|||
131223828|NCT04380701|472447113|FG004|Overall Study|Withdrawal by Subject|0|||
130937102|NCT02200445|471402181|FG001|Overall Study|Adverse Event|2|||
130937103|NCT02200445|471402182|FG002|Overall Study|Adverse Event|0|||
131223829|NCT04380701|472447114|FG005|Overall Study|Withdrawal by Subject|0|||
131223830|NCT04380701|472447115|FG006|Overall Study|Withdrawal by Subject|1|||
130937104|NCT01031069|471402183|FG000|Overall Study|Serious Adverse Event|0|||
130937105|NCT01031069|471402184|FG001|Overall Study|Serious Adverse Event|1|||
131223831|NCT04380701|472447116|FG007|Overall Study|Withdrawal by Subject|1|||
131223832|NCT04380701|472447117|FG008|Overall Study|Withdrawal by Subject|0|||
131223833|NCT04380701|472447118|FG009|Overall Study|Withdrawal by Subject|0|||
130937106|NCT01031069|471402185|FG002|Overall Study|Serious Adverse Event|0|||
131223834|NCT04380701|472447119|FG010|Overall Study|Withdrawal by Subject|0|||
131223835|NCT04380701|472447120|FG011|Overall Study|Withdrawal by Subject|1|||
131223836|NCT04380701|472447121|FG012|Overall Study|Withdrawal by Subject|0|||
131223837|NCT04380701|472447122|FG013|Overall Study|Withdrawal by Subject|1|||
131223838|NCT04380701|472447123|FG014|Overall Study|Withdrawal by Subject|0|||
131035497|NCT01902173|471764019|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
131035498|NCT01902173|471764020|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
131035499|NCT01902173|471764021|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
131035500|NCT01902173|471764022|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
131035501|NCT01902173|471764023|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
131035502|NCT01902173|471764018|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
131035503|NCT01902173|471764019|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
131035504|NCT01902173|471764020|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
131035505|NCT01902173|471764021|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
131035506|NCT01902173|471764022|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
131035507|NCT01902173|471764023|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
131035508|NCT01902173|471764018|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
131035509|NCT01902173|471764019|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
131035510|NCT01902173|471764020|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
131035511|NCT01902173|471764021|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
131035512|NCT01902173|471764022|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
131035513|NCT01902173|471764023|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
131035514|NCT01902173|471764018|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
131035515|NCT01902173|471764019|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
131035516|NCT01902173|471764020|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
131035517|NCT01902173|471764021|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
131035518|NCT01902173|471764022|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
131035519|NCT01902173|471764023|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
131035520|NCT01902173|471764018|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
131035521|NCT01902173|471764019|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
131035522|NCT01902173|471764020|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
131035523|NCT01902173|471764021|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
130704630|NCT03756883|470542747|FG000|Overall Study|Lost to Follow-up|3|||
130704631|NCT03756883|470542748|FG001|Overall Study|Lost to Follow-up|3|||
131035524|NCT01902173|471764022|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
131035525|NCT01902173|471764023|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
131035526|NCT01902173|471764018|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
131035527|NCT01902173|471764019|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
131035528|NCT01902173|471764020|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
131035529|NCT01902173|471764021|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
131035530|NCT01902173|471764022|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
131035531|NCT01902173|471764023|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
131035532|NCT01902173|471764018|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
131035533|NCT01902173|471764019|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
131035534|NCT01902173|471764020|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
131035535|NCT01902173|471764021|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
131120948|NCT01721876|472072449|FG001|Overall Study|Withdrawal by Subject|38|||
131120949|NCT01721876|472072448|FG000|Overall Study|Reason not listed|34|||
131120950|NCT01721876|472072449|FG001|Overall Study|Reason not listed|63|||
131120951|NCT01721876|472072448|FG000|Overall Study|Sponsor terminated trial|0|||
131120952|NCT01721876|472072449|FG001|Overall Study|Sponsor terminated trial|4|||
131120953|NCT01721057|472072452|FG000|Treatment Period|Withdrawal by Subject|11|||
131120954|NCT01721057|472072453|FG001|Treatment Period|Withdrawal by Subject|5|||
131120955|NCT01721057|472072454|FG002|Treatment Period|Withdrawal by Subject|8|||
131120956|NCT01721057|472072455|FG003|Treatment Period|Withdrawal by Subject|0|||
131120957|NCT01721057|472072456|FG004|Treatment Period|Withdrawal by Subject|0|||
131120958|NCT01721057|472072457|FG005|Treatment Period|Withdrawal by Subject|0|||
131120959|NCT01721057|472072458|FG006|Treatment Period|Withdrawal by Subject|0|||
131120960|NCT01721057|472072452|FG000|Treatment Period|Adverse Event|7|||
131120961|NCT01721057|472072453|FG001|Treatment Period|Adverse Event|10|||
131120962|NCT01721057|472072454|FG002|Treatment Period|Adverse Event|12|||
130704632|NCT03756883|470542749|FG002|Overall Study|Lost to Follow-up|0|||
130704633|NCT03756883|470542747|FG000|Overall Study|Protocol Violation|2|||
130704634|NCT03756883|470542748|FG001|Overall Study|Protocol Violation|0|||
131035536|NCT01902173|471764022|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
131035537|NCT01902173|471764023|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
131035538|NCT01902173|471764018|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
131035539|NCT01902173|471764019|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
131035540|NCT01902173|471764020|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
131035541|NCT01902173|471764021|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
131035542|NCT01902173|471764022|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
130704635|NCT03756883|470542749|FG002|Overall Study|Protocol Violation|1|||
131035543|NCT01902173|471764023|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
131120963|NCT01721057|472072455|FG003|Treatment Period|Adverse Event|0|||
131120964|NCT01721057|472072456|FG004|Treatment Period|Adverse Event|0|||
130704636|NCT03756883|470542747|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
130937107|NCT01031069|471402186|FG003|Overall Study|Serious Adverse Event|0|||
130937108|NCT01031069|471402183|FG000|Overall Study|Withdrawal by Subject|2|||
130937109|NCT01031069|471402184|FG001|Overall Study|Withdrawal by Subject|3|||
130937110|NCT01031069|471402185|FG002|Overall Study|Withdrawal by Subject|18|||
130937111|NCT01031069|471402186|FG003|Overall Study|Withdrawal by Subject|18|||
130937112|NCT01031069|471402183|FG000|Overall Study|Migrated/moved from study area|1|||
130937113|NCT01031069|471402184|FG001|Overall Study|Migrated/moved from study area|2|||
130937114|NCT01031069|471402185|FG002|Overall Study|Migrated/moved from study area|1|||
130937115|NCT01031069|471402186|FG003|Overall Study|Migrated/moved from study area|1|||
130937116|NCT01031069|471402183|FG000|Overall Study|Lost to Follow-up|9|||
130937117|NCT01031069|471402184|FG001|Overall Study|Lost to Follow-up|5|||
130937118|NCT01031069|471402185|FG002|Overall Study|Lost to Follow-up|21|||
130937119|NCT01031069|471402186|FG003|Overall Study|Lost to Follow-up|15|||
130937120|NCT01031069|471402183|FG000|Overall Study|Other|0|||
130937121|NCT01031069|471402184|FG001|Overall Study|Other|0|||
130937122|NCT01031069|471402185|FG002|Overall Study|Other|1|||
130937123|NCT01031069|471402186|FG003|Overall Study|Other|0|||
130937124|NCT01386554|471402192|FG000|Overall Study|Lost to Follow-up|0|||
130937125|NCT01386554|471402193|FG001|Overall Study|Lost to Follow-up|0|||
130937126|NCT01386554|471402194|FG002|Overall Study|Lost to Follow-up|1|||
131120965|NCT01721057|472072457|FG005|Treatment Period|Adverse Event|0|||
131120966|NCT01721057|472072458|FG006|Treatment Period|Adverse Event|0|||
131120967|NCT01721057|472072452|FG000|Treatment Period|Lack of Efficacy|7|||
131120968|NCT01721057|472072453|FG001|Treatment Period|Lack of Efficacy|3|||
131120969|NCT01721057|472072454|FG002|Treatment Period|Lack of Efficacy|0|||
131120970|NCT01721057|472072455|FG003|Treatment Period|Lack of Efficacy|0|||
131120971|NCT01721057|472072456|FG004|Treatment Period|Lack of Efficacy|0|||
131120972|NCT01721057|472072457|FG005|Treatment Period|Lack of Efficacy|0|||
131120973|NCT01721057|472072458|FG006|Treatment Period|Lack of Efficacy|0|||
131120974|NCT01721057|472072452|FG000|Treatment Period|Lost to Follow-up|1|||
131120975|NCT01721057|472072453|FG001|Treatment Period|Lost to Follow-up|0|||
131120976|NCT01721057|472072454|FG002|Treatment Period|Lost to Follow-up|0|||
131120977|NCT01721057|472072455|FG003|Treatment Period|Lost to Follow-up|0|||
131120978|NCT01721057|472072456|FG004|Treatment Period|Lost to Follow-up|0|||
131120979|NCT01721057|472072457|FG005|Treatment Period|Lost to Follow-up|0|||
131120980|NCT01721057|472072458|FG006|Treatment Period|Lost to Follow-up|0|||
131120981|NCT01721057|472072452|FG000|Treatment Period|Physician Decision|0|||
131120982|NCT01721057|472072453|FG001|Treatment Period|Physician Decision|1|||
131120983|NCT01721057|472072454|FG002|Treatment Period|Physician Decision|3|||
131120984|NCT01721057|472072455|FG003|Treatment Period|Physician Decision|0|||
131120985|NCT01721057|472072456|FG004|Treatment Period|Physician Decision|0|||
131120986|NCT01721057|472072457|FG005|Treatment Period|Physician Decision|0|||
131120987|NCT01721057|472072458|FG006|Treatment Period|Physician Decision|0|||
131120988|NCT01721057|472072452|FG000|Treatment Period|Death|2|||
131120989|NCT01721057|472072453|FG001|Treatment Period|Death|0|||
131120990|NCT01721057|472072454|FG002|Treatment Period|Death|0|||
131120991|NCT01721057|472072455|FG003|Treatment Period|Death|0|||
131120992|NCT01721057|472072456|FG004|Treatment Period|Death|0|||
131120993|NCT01721057|472072457|FG005|Treatment Period|Death|0|||
131120994|NCT01721057|472072458|FG006|Treatment Period|Death|0|||
131120995|NCT01721057|472072452|FG000|Rescue Period|Adverse Event|0|||
131120996|NCT01721057|472072453|FG001|Rescue Period|Adverse Event|0|||
131120997|NCT01721057|472072454|FG002|Rescue Period|Adverse Event|0|||
131120998|NCT01721057|472072455|FG003|Rescue Period|Adverse Event|1|||
131120999|NCT01721057|472072456|FG004|Rescue Period|Adverse Event|0|||
131121000|NCT01721057|472072457|FG005|Rescue Period|Adverse Event|0|||
131121001|NCT01721057|472072458|FG006|Rescue Period|Adverse Event|0|||
130937127|NCT01386554|471402192|FG000|Overall Study|Adverse Event|2|||
130937128|NCT01386554|471402193|FG001|Overall Study|Adverse Event|5|||
130937129|NCT01386554|471402194|FG002|Overall Study|Adverse Event|2|||
130937130|NCT01386554|471402192|FG000|Overall Study|Progressive disease|1|||
130937131|NCT01386554|471402193|FG001|Overall Study|Progressive disease|2|||
130937132|NCT01386554|471402194|FG002|Overall Study|Progressive disease|2|||
130937133|NCT01386554|471402192|FG000|Overall Study|Administration of live vaccines|0|||
130937134|NCT01386554|471402193|FG001|Overall Study|Administration of live vaccines|1|||
131121002|NCT01721057|472072452|FG000|Rescue Period|Lack of Efficacy|0|||
131121003|NCT01721057|472072453|FG001|Rescue Period|Lack of Efficacy|0|||
131121004|NCT01721057|472072454|FG002|Rescue Period|Lack of Efficacy|0|||
131121005|NCT01721057|472072455|FG003|Rescue Period|Lack of Efficacy|2|||
131121006|NCT01721057|472072456|FG004|Rescue Period|Lack of Efficacy|0|||
130937135|NCT01386554|471402194|FG002|Overall Study|Administration of live vaccines|0|||
130937136|NCT01386554|471402192|FG000|Overall Study|Investigator discretion|0|||
130937137|NCT01386554|471402193|FG001|Overall Study|Investigator discretion|0|||
130937138|NCT01386554|471402194|FG002|Overall Study|Investigator discretion|1|||
131121007|NCT01721057|472072457|FG005|Rescue Period|Lack of Efficacy|0|||
131121008|NCT01721057|472072458|FG006|Rescue Period|Lack of Efficacy|0|||
130937139|NCT01386554|471402192|FG000|Overall Study|Reason not collected|0|||
131121009|NCT01202279|472072459|FG000|Overall Study|Adverse Event|8|||
131121010|NCT01202279|472072460|FG001|Overall Study|Adverse Event|6|||
130937140|NCT01386554|471402193|FG001|Overall Study|Reason not collected|1|||
130937141|NCT01386554|471402194|FG002|Overall Study|Reason not collected|0|||
130937142|NCT02879305|471402196|FG000|Overall Study|Investigator Site Closed|55|||
130937143|NCT02879305|471402197|FG001|Overall Study|Investigator Site Closed|57|||
130937144|NCT02879305|471402196|FG000|Overall Study|Withdrawal by Subject|44|||
130937145|NCT02879305|471402197|FG001|Overall Study|Withdrawal by Subject|42|||
130937146|NCT02879305|471402196|FG000|Overall Study|Lost to Follow-up|17|||
130937147|NCT02879305|471402197|FG001|Overall Study|Lost to Follow-up|12|||
130937148|NCT02879305|471402196|FG000|Overall Study|Other|1|||
130937149|NCT02879305|471402197|FG001|Overall Study|Other|0|||
130937150|NCT01853826|471404476|FG000|Overall Study|Patients who switched to commercial drug|11|||
130937151|NCT01853826|471404476|FG000|Overall Study|Patient refused to continue medication|21|||
130937152|NCT01853826|471404476|FG000|Overall Study|Lost to Follow-up|2|||
130937153|NCT01853826|471404476|FG000|Overall Study|Non-compliant with protocol|4|||
130937154|NCT01853826|471404476|FG000|Overall Study|Other adverse events (AE)|62|||
130937155|NCT01853826|471404476|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
130937156|NCT01853826|471404476|FG000|Overall Study|Progressive disease|342|||
130937157|NCT01853826|471404476|FG000|Overall Study|Other than listed|13|||
130937158|NCT01853826|471404476|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
130937159|NCT00982488|471404480|FG000|Overall Study|Administrative reason by sponsor|81|||
130937160|NCT00982488|471404481|FG001|Overall Study|Administrative reason by sponsor|3|||
130937161|NCT00982488|471404482|FG002|Overall Study|Administrative reason by sponsor|11|||
130937162|NCT00982488|471404483|FG003|Overall Study|Administrative reason by sponsor|0|||
130937163|NCT00982488|471404484|FG004|Overall Study|Administrative reason by sponsor|0|||
130937164|NCT00982488|471404480|FG000|Overall Study|Adverse event unrelated to study drug|5|||
130937165|NCT00982488|471404481|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130937166|NCT00982488|471404482|FG002|Overall Study|Adverse event unrelated to study drug|0|||
130937167|NCT00982488|471404483|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130937168|NCT00982488|471404484|FG004|Overall Study|Adverse event unrelated to study drug|0|||
130937169|NCT00982488|471404480|FG000|Overall Study|Death|11|||
130937170|NCT00982488|471404481|FG001|Overall Study|Death|0|||
130937171|NCT00982488|471404482|FG002|Overall Study|Death|2|||
130937172|NCT00982488|471404483|FG003|Overall Study|Death|0|||
130937173|NCT00982488|471404484|FG004|Overall Study|Death|0|||
130937174|NCT00982488|471404480|FG000|Overall Study|Disease progression|30|||
130937175|NCT00982488|471404481|FG001|Overall Study|Disease progression|5|||
130937176|NCT00982488|471404482|FG002|Overall Study|Disease progression|10|||
130937177|NCT00982488|471404483|FG003|Overall Study|Disease progression|1|||
130937178|NCT00982488|471404484|FG004|Overall Study|Disease progression|1|||
130937179|NCT00982488|471404480|FG000|Overall Study|Lost to Follow-up|1|||
130937180|NCT00982488|471404481|FG001|Overall Study|Lost to Follow-up|0|||
131121011|NCT01202279|472072459|FG000|Overall Study|Withdrawal by Subject|13|||
131121012|NCT01202279|472072460|FG001|Overall Study|Withdrawal by Subject|10|||
131121013|NCT01202279|472072459|FG000|Overall Study|Physician Decision|0|||
131121014|NCT01202279|472072460|FG001|Overall Study|Physician Decision|1|||
131121015|NCT01202279|472072459|FG000|Overall Study|Lost to Follow-up|10|||
131121016|NCT01202279|472072460|FG001|Overall Study|Lost to Follow-up|7|||
131121017|NCT01202279|472072459|FG000|Overall Study|Protocol Violation|1|||
131121018|NCT01202279|472072460|FG001|Overall Study|Protocol Violation|1|||
131121019|NCT01202279|472072459|FG000|Overall Study|study compliance|5|||
131121020|NCT01202279|472072460|FG001|Overall Study|study compliance|2|||
131121021|NCT01177683|472072461|FG000|Study Treatment|Disease Progressions during treatment|2|||
131121022|NCT01177683|472072462|FG001|Study Treatment|Disease Progressions during treatment|0|||
131121023|NCT01177683|472072463|FG002|Study Treatment|Disease Progressions during treatment|3|||
131121024|NCT01177683|472072461|FG000|Study Treatment|Adverse Event|0|||
131121025|NCT01177683|472072462|FG001|Study Treatment|Adverse Event|1|||
131121026|NCT01177683|472072463|FG002|Study Treatment|Adverse Event|12|||
131121027|NCT01177683|472072461|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
131121028|NCT01177683|472072462|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
131121029|NCT01177683|472072463|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
131121030|NCT01177683|472072461|FG000|Study Treatment|Alternative therapy|0|||
131121031|NCT01177683|472072462|FG001|Study Treatment|Alternative therapy|0|||
131121032|NCT01177683|472072463|FG002|Study Treatment|Alternative therapy|4|||
131121033|NCT01177683|472072461|FG000|Study Treatment|Physician Decision|1|||
131121034|NCT01177683|472072462|FG001|Study Treatment|Physician Decision|0|||
131121035|NCT01177683|472072463|FG002|Study Treatment|Physician Decision|1|||
130937181|NCT00982488|471404482|FG002|Overall Study|Lost to Follow-up|0|||
130937182|NCT00982488|471404483|FG003|Overall Study|Lost to Follow-up|0|||
130937183|NCT00982488|471404484|FG004|Overall Study|Lost to Follow-up|0|||
130937184|NCT00982488|471404480|FG000|Overall Study|Maximum clinical benefit|1|||
130937185|NCT00982488|471404481|FG001|Overall Study|Maximum clinical benefit|1|||
131121036|NCT01177683|472072461|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
130937186|NCT00982488|471404482|FG002|Overall Study|Maximum clinical benefit|1|||
130937187|NCT00982488|471404483|FG003|Overall Study|Maximum clinical benefit|0|||
131121037|NCT01177683|472072462|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
131035544|NCT01902173|471764018|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
131035545|NCT01902173|471764019|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
131035546|NCT01902173|471764020|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
131035547|NCT01902173|471764021|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
131035548|NCT01902173|471764022|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
131035549|NCT01902173|471764023|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
131035550|NCT01902173|471764018|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
131035551|NCT01902173|471764019|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
131035552|NCT01902173|471764020|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
131035553|NCT01902173|471764021|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
131035554|NCT01902173|471764022|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
131035555|NCT01902173|471764023|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
131035556|NCT01902173|471764018|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
131035557|NCT01902173|471764019|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
131035558|NCT01902173|471764020|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
131035559|NCT01902173|471764021|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
131035560|NCT01902173|471764022|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
131035561|NCT01902173|471764023|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
131035562|NCT02262728|471764024|FG000|Follow-up Phase (3 Years)|Death|0|||
131035563|NCT02262728|471764025|FG001|Follow-up Phase (3 Years)|Death|1|||
131035564|NCT02262728|471764024|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
131035565|NCT02262728|471764025|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
131035566|NCT02262728|471764024|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
131035567|NCT02262728|471764025|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
131035568|NCT00227344|471764026|FG000|Overall Study|study terminated early|12|||
131035569|NCT00227344|471764027|FG001|Overall Study|study terminated early|5|||
131035570|NCT01987895|471764028|FG000|Overall Study|Withdrawal by Subject|12|||
131121038|NCT01177683|472072463|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
131121039|NCT01177683|472072461|FG000|Study Treatment|Symptomatic Deterioration|0|||
131121040|NCT01177683|472072462|FG001|Study Treatment|Symptomatic Deterioration|0|||
131121041|NCT01177683|472072463|FG002|Study Treatment|Symptomatic Deterioration|1|||
131121042|NCT01177683|472072461|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
131121043|NCT01177683|472072462|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
131121044|NCT01177683|472072463|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
131121045|NCT01177683|472072461|FG000|Follow up|Patient lost to follow up|0|||
131121046|NCT01177683|472072462|FG001|Follow up|Patient lost to follow up|0|||
131121047|NCT01177683|472072463|FG002|Follow up|Patient lost to follow up|2|||
131121048|NCT01177683|472072461|FG000|Follow up|Death|2|||
131121049|NCT01177683|472072462|FG001|Follow up|Death|1|||
131121050|NCT01177683|472072463|FG002|Follow up|Death|7|||
131121051|NCT01177683|472072461|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
131121052|NCT01177683|472072462|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
131121053|NCT01177683|472072463|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
131121054|NCT02064920|472072464|FG000|Overall Study|Adverse Event|0|||
131121055|NCT02064920|472072465|FG001|Overall Study|Adverse Event|4|||
131121056|NCT02064920|472072464|FG000|Overall Study|Physician Decision|0|||
131121057|NCT02064920|472072465|FG001|Overall Study|Physician Decision|1|||
131121058|NCT02064920|472072464|FG000|Overall Study|Technical Problems|0|||
131121059|NCT02064920|472072465|FG001|Overall Study|Technical Problems|1|||
131121060|NCT02064920|472072464|FG000|Overall Study|Withdrawal by Subject|1|||
131121061|NCT02064920|472072465|FG001|Overall Study|Withdrawal by Subject|3|||
131121062|NCT02109562|472072466|FG000|Overall Study|Insufficient clinical response|2|||
131121063|NCT02109562|472072467|FG001|Overall Study|Insufficient clinical response|0|||
131121064|NCT02109562|472072468|FG002|Overall Study|Insufficient clinical response|4|||
131121065|NCT02109562|472072466|FG000|Overall Study|Adverse Event|0|||
131121066|NCT02109562|472072467|FG001|Overall Study|Adverse Event|2|||
131121067|NCT02109562|472072468|FG002|Overall Study|Adverse Event|3|||
131121068|NCT02109562|472072466|FG000|Overall Study|Lost to Follow-up|1|||
131121069|NCT02109562|472072467|FG001|Overall Study|Lost to Follow-up|0|||
131121070|NCT02109562|472072468|FG002|Overall Study|Lost to Follow-up|1|||
131121071|NCT02109562|472072466|FG000|Overall Study|Protocol Violation|0|||
131121072|NCT02109562|472072467|FG001|Overall Study|Protocol Violation|3|||
131121073|NCT02109562|472072468|FG002|Overall Study|Protocol Violation|1|||
131121074|NCT02109562|472072466|FG000|Overall Study|Withdrawal by Subject|20|||
131121075|NCT02109562|472072467|FG001|Overall Study|Withdrawal by Subject|25|||
131121076|NCT02109562|472072468|FG002|Overall Study|Withdrawal by Subject|21|||
131035571|NCT01987895|471764029|FG001|Overall Study|Withdrawal by Subject|7|||
131035572|NCT01987895|471764028|FG000|Overall Study|Physician Decision|8|||
131035573|NCT01987895|471764029|FG001|Overall Study|Physician Decision|10|||
131121077|NCT02109562|472072466|FG000|Overall Study|Physician Decision|3|||
131121078|NCT02109562|472072467|FG001|Overall Study|Physician Decision|4|||
131121079|NCT02109562|472072468|FG002|Overall Study|Physician Decision|5|||
131121080|NCT00682448|472073805|FG000|Overall Study|Adverse Event|1|||
131121081|NCT00682448|472073806|FG001|Overall Study|Adverse Event|2|||
131121082|NCT00682448|472073805|FG000|Overall Study|Lack of Efficacy|1|||
131121083|NCT00682448|472073806|FG001|Overall Study|Lack of Efficacy|0|||
131121084|NCT00682448|472073805|FG000|Overall Study|Lost to Follow-up|1|||
131121085|NCT00682448|472073806|FG001|Overall Study|Lost to Follow-up|3|||
131121086|NCT00682448|472073805|FG000|Overall Study|Pregnancy|0|||
131223839|NCT04380701|472447124|FG015|Overall Study|Withdrawal by Subject|0|||
131223840|NCT04380701|472447125|FG016|Overall Study|Withdrawal by Subject|1|||
131223841|NCT04380701|472447126|FG017|Overall Study|Withdrawal by Subject|0|||
131223842|NCT04380701|472447127|FG018|Overall Study|Withdrawal by Subject|0|||
131223843|NCT04380701|472447128|FG019|Overall Study|Withdrawal by Subject|0|||
131223844|NCT04380701|472447129|FG020|Overall Study|Withdrawal by Subject|0|||
131223845|NCT04380701|472447130|FG021|Overall Study|Withdrawal by Subject|0|||
131223846|NCT04380701|472447131|FG022|Overall Study|Withdrawal by Subject|2|||
131223847|NCT04380701|472447132|FG023|Overall Study|Withdrawal by Subject|2|||
131223848|NCT04380701|472447133|FG024|Overall Study|Withdrawal by Subject|1|||
131223849|NCT04380701|472447134|FG025|Overall Study|Withdrawal by Subject|1|||
131223850|NCT04380701|472447135|FG026|Overall Study|Withdrawal by Subject|0|||
131223851|NCT04380701|472447136|FG027|Overall Study|Withdrawal by Subject|0|||
131223852|NCT04380701|472447137|FG028|Overall Study|Withdrawal by Subject|0|||
131223853|NCT04380701|472447138|FG029|Overall Study|Withdrawal by Subject|0|||
131223854|NCT04380701|472447139|FG030|Overall Study|Withdrawal by Subject|0|||
131223855|NCT04380701|472447140|FG031|Overall Study|Withdrawal by Subject|0|||
131223856|NCT04380701|472447141|FG032|Overall Study|Withdrawal by Subject|0|||
131223857|NCT04380701|472447142|FG033|Overall Study|Withdrawal by Subject|0|||
131223858|NCT04380701|472447109|FG000|Overall Study|Adverse Event|0|||
131223859|NCT04380701|472447110|FG001|Overall Study|Adverse Event|0|||
131223860|NCT04380701|472447111|FG002|Overall Study|Adverse Event|0|||
131223861|NCT04380701|472447112|FG003|Overall Study|Adverse Event|0|||
131223862|NCT04380701|472447113|FG004|Overall Study|Adverse Event|0|||
131223863|NCT04380701|472447114|FG005|Overall Study|Adverse Event|1|||
131223864|NCT04380701|472447115|FG006|Overall Study|Adverse Event|0|||
131223865|NCT04380701|472447116|FG007|Overall Study|Adverse Event|0|||
131223866|NCT04380701|472447117|FG008|Overall Study|Adverse Event|0|||
131223867|NCT04380701|472447118|FG009|Overall Study|Adverse Event|0|||
131223868|NCT04380701|472447119|FG010|Overall Study|Adverse Event|0|||
131223869|NCT04380701|472447120|FG011|Overall Study|Adverse Event|0|||
131223870|NCT04380701|472447121|FG012|Overall Study|Adverse Event|0|||
131223871|NCT04380701|472447122|FG013|Overall Study|Adverse Event|0|||
131223872|NCT04380701|472447123|FG014|Overall Study|Adverse Event|0|||
131223873|NCT04380701|472447124|FG015|Overall Study|Adverse Event|1|||
130937188|NCT00982488|471404484|FG004|Overall Study|Maximum clinical benefit|0|||
130937189|NCT00982488|471404480|FG000|Overall Study|Other|15|||
130937190|NCT00982488|471404481|FG001|Overall Study|Other|1|||
131121087|NCT00682448|472073806|FG001|Overall Study|Pregnancy|1|||
131121088|NCT00682448|472073805|FG000|Overall Study|Withdrawal by Subject|2|||
131121089|NCT00682448|472073806|FG001|Overall Study|Withdrawal by Subject|0|||
131121090|NCT00257166|472073810|FG000|Overall Study|Adverse Event|18|||
131121091|NCT00257166|472073811|FG001|Overall Study|Adverse Event|13|||
131121092|NCT00257166|472073810|FG000|Overall Study|Laboratory abnormality|1|||
131121093|NCT00257166|472073811|FG001|Overall Study|Laboratory abnormality|0|||
131121094|NCT00257166|472073810|FG000|Overall Study|Lost to Follow-up|8|||
131121095|NCT00257166|472073811|FG001|Overall Study|Lost to Follow-up|1|||
131121096|NCT00257166|472073810|FG000|Overall Study|Withdrawal by Subject|9|||
131121097|NCT00257166|472073811|FG001|Overall Study|Withdrawal by Subject|2|||
131121098|NCT00257166|472073810|FG000|Overall Study|Other|16|||
131121099|NCT00257166|472073811|FG001|Overall Study|Other|21|||
131121100|NCT00257166|472073810|FG000|Overall Study|Randomized, but not treated|1|||
131121101|NCT00257166|472073811|FG001|Overall Study|Randomized, but not treated|0|||
130937191|NCT00982488|471404482|FG002|Overall Study|Other|3|||
130937192|NCT00982488|471404483|FG003|Overall Study|Other|1|||
130937193|NCT00982488|471404484|FG004|Overall Study|Other|0|||
130937194|NCT00982488|471404480|FG000|Overall Study|Poor compliance/noncompliance|0|||
130937195|NCT00982488|471404481|FG001|Overall Study|Poor compliance/noncompliance|1|||
131121102|NCT02737852|472073814|FG000|Overall Study|Withdrawal by Subject|2|||
131121103|NCT00525044|472073815|FG000|Overall Study|Lost to Follow-up|0|||
131121104|NCT00525044|472073816|FG001|Overall Study|Lost to Follow-up|1|||
131223874|NCT04380701|472447125|FG016|Overall Study|Adverse Event|0|||
131223875|NCT04380701|472447126|FG017|Overall Study|Adverse Event|0|||
131223876|NCT04380701|472447127|FG018|Overall Study|Adverse Event|0|||
131223877|NCT04380701|472447128|FG019|Overall Study|Adverse Event|1|||
131223878|NCT04380701|472447129|FG020|Overall Study|Adverse Event|0|||
131223879|NCT04380701|472447130|FG021|Overall Study|Adverse Event|0|||
131223880|NCT04380701|472447131|FG022|Overall Study|Adverse Event|0|||
130937196|NCT00982488|471404482|FG002|Overall Study|Poor compliance/noncompliance|0|||
130937197|NCT00982488|471404483|FG003|Overall Study|Poor compliance/noncompliance|0|||
131223881|NCT04380701|472447132|FG023|Overall Study|Adverse Event|0|||
130937198|NCT00982488|471404484|FG004|Overall Study|Poor compliance/noncompliance|0|||
131223882|NCT04380701|472447133|FG024|Overall Study|Adverse Event|0|||
131121105|NCT04042740|472073818|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
131223883|NCT04380701|472447134|FG025|Overall Study|Adverse Event|0|||
131223884|NCT04380701|472447135|FG026|Overall Study|Adverse Event|0|||
131223885|NCT04380701|472447136|FG027|Overall Study|Adverse Event|0|||
131223886|NCT04380701|472447137|FG028|Overall Study|Adverse Event|0|||
131223887|NCT04380701|472447138|FG029|Overall Study|Adverse Event|0|||
131223888|NCT04380701|472447139|FG030|Overall Study|Adverse Event|0|||
131223889|NCT04380701|472447140|FG031|Overall Study|Adverse Event|0|||
131223890|NCT04380701|472447141|FG032|Overall Study|Adverse Event|0|||
131223891|NCT04380701|472447142|FG033|Overall Study|Adverse Event|0|||
131223892|NCT04380701|472447109|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
130937199|NCT00982488|471404480|FG000|Overall Study|Stem cell transplant|2|||
130937200|NCT00982488|471404481|FG001|Overall Study|Stem cell transplant|0|||
130937201|NCT00982488|471404482|FG002|Overall Study|Stem cell transplant|0|||
130937202|NCT00982488|471404483|FG003|Overall Study|Stem cell transplant|1|||
131121106|NCT04042740|472073818|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
131121107|NCT02713542|472073822|FG000|Overall Study|Use of prohibited medication|14|||
131121108|NCT02713542|472073823|FG001|Overall Study|Use of prohibited medication|5|||
131121109|NCT02713542|472073822|FG000|Overall Study|Withdrawal by Subject|4|||
131121110|NCT02713542|472073823|FG001|Overall Study|Withdrawal by Subject|1|||
131121111|NCT00066742|472073824|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
131121112|NCT00066742|472073824|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
131121113|NCT00066742|472073824|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
131121114|NCT00066742|472073824|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
131121115|NCT00066742|472073824|FG000|Induction Chemoradiotherapy|Ineligible|3|||
131121116|NCT00066742|472073824|FG000|Consolidation Chemotherapy|not protocol specified|1|||
131121117|NCT00066742|472073824|FG000|Consolidation Chemotherapy|Ineligible|2|||
131121118|NCT01134614|472073828|FG000|Overall Study|Still on treatment as of March 2013|21|||
131121119|NCT01134614|472073829|FG001|Overall Study|Still on treatment as of March 2013|13|||
131121120|NCT01134614|472073828|FG000|Overall Study|Progressive disease|60|||
131121121|NCT01134614|472073829|FG001|Overall Study|Progressive disease|54|||
131121122|NCT01134614|472073828|FG000|Overall Study|Adverse Event|26|||
131121123|NCT01134614|472073829|FG001|Overall Study|Adverse Event|39|||
131223893|NCT04380701|472447110|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
131223894|NCT04380701|472447111|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
131223895|NCT04380701|472447112|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
131223896|NCT04380701|472447113|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
131223897|NCT04380701|472447114|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
131223898|NCT04380701|472447115|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
131223899|NCT04380701|472447116|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
131223900|NCT04380701|472447117|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
131223901|NCT04380701|472447118|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
131223902|NCT04380701|472447119|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
131223903|NCT04380701|472447120|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
131223904|NCT04380701|472447121|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
131223905|NCT04380701|472447122|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
130704637|NCT03756883|470542748|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
130704638|NCT03756883|470542749|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
130704639|NCT03756883|470542747|FG000|Overall Study|Withdrawal by Subject|4|||
130704640|NCT03756883|470542748|FG001|Overall Study|Withdrawal by Subject|1|||
130704641|NCT03756883|470542749|FG002|Overall Study|Withdrawal by Subject|0|||
130704642|NCT03756883|470542747|FG000|Overall Study|Other Reasons|2|||
131223906|NCT04380701|472447123|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
130704643|NCT03756883|470542748|FG001|Overall Study|Other Reasons|4|||
130704644|NCT03756883|470542749|FG002|Overall Study|Other Reasons|0|||
131121124|NCT01134614|472073828|FG000|Overall Study|Death|5|||
131121125|NCT01134614|472073829|FG001|Overall Study|Death|8|||
131121126|NCT01134614|472073828|FG000|Overall Study|Withdrawal by Subject|3|||
131121127|NCT01134614|472073829|FG001|Overall Study|Withdrawal by Subject|2|||
131121128|NCT01134614|472073828|FG000|Overall Study|Alternative therapy|2|||
131121129|NCT01134614|472073829|FG001|Overall Study|Alternative therapy|0|||
131121130|NCT01134614|472073828|FG000|Overall Study|Complicating disease|2|||
131121131|NCT01134614|472073829|FG001|Overall Study|Complicating disease|1|||
131121132|NCT01134614|472073828|FG000|Overall Study|Physician's decision|0|||
131121133|NCT01134614|472073829|FG001|Overall Study|Physician's decision|1|||
131121134|NCT01134614|472073828|FG000|Overall Study|Never started treatment|4|||
131223907|NCT04380701|472447124|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
130771121|NCT00424593|470789824|FG001|Acute Double-Blind Period|Protocol Violation|2|||
131223908|NCT04380701|472447125|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
130704645|NCT00529217|470542751|FG000|Overall Study|Lack of Efficacy|2|||
130771122|NCT00424593|470789823|FG000|Acute Double-Blind Period|Physician Decision|1|||
131223909|NCT04380701|472447126|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
130704646|NCT00529217|470542751|FG000|Overall Study|Unable to adhere to study schedule|2|||
130771123|NCT00424593|470789824|FG001|Acute Double-Blind Period|Physician Decision|2|||
131035574|NCT01987895|471764028|FG000|Overall Study|Death|7|||
131035575|NCT01987895|471764029|FG001|Overall Study|Death|7|||
131035576|NCT01987895|471764028|FG000|Overall Study|Lost to Follow-up|3|||
131035577|NCT01987895|471764029|FG001|Overall Study|Lost to Follow-up|5|||
131035578|NCT01987895|471764028|FG000|Overall Study|randomized before giving IC|0|||
131035579|NCT01987895|471764029|FG001|Overall Study|randomized before giving IC|1|||
131035580|NCT05364671|471764030|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
131035581|NCT05364671|471764031|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
131035582|NCT05364671|471764030|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
131035583|NCT05364671|471764031|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
131035584|NCT05364671|471764030|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
131035585|NCT05364671|471764031|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
131035586|NCT05364671|471764030|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
131035587|NCT05364671|471764031|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
131035588|NCT05364671|471764030|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
131035589|NCT05364671|471764031|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
131035590|NCT02359890|471764032|FG000|Overall Study|Not meeting eligibility|4|||
131035591|NCT02359890|471764032|FG000|Overall Study|Never treated with study catheter|6|||
131035592|NCT05256017|471764033|FG000|Treatment Period|Withdrawal by Subject|1|||
131035593|NCT05256017|471764034|FG001|Treatment Period|Withdrawal by Subject|1|||
131035594|NCT05256017|471764033|FG000|Follow-up|Lost to Follow-up|7|||
131035595|NCT05256017|471764034|FG001|Follow-up|Lost to Follow-up|1|||
131035596|NCT05256017|471764033|FG000|Follow-up|Withdrawal by Subject|1|||
131035597|NCT05256017|471764034|FG001|Follow-up|Withdrawal by Subject|0|||
131035598|NCT05256017|471764033|FG000|Follow-up|Death|0|||
131035599|NCT05256017|471764034|FG001|Follow-up|Death|1|||
131035600|NCT03536754|471764039|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
131035601|NCT03536754|471764040|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
131035602|NCT03536754|471764041|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
131035603|NCT03536754|471764042|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
131035604|NCT03536754|471764043|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
131035605|NCT03536754|471764039|FG000|Open Label Extension|Other|0|||
131035606|NCT03536754|471764040|FG001|Open Label Extension|Other|0|||
131035607|NCT03536754|471764041|FG002|Open Label Extension|Other|0|||
131035608|NCT03536754|471764042|FG003|Open Label Extension|Other|0|||
131035609|NCT03536754|471764043|FG004|Open Label Extension|Other|1|||
131035610|NCT04858321|471764044|FG000|Overall Study|Withdrawal by Subject|3|||
131035611|NCT05057247|471764045|FG000|Overall Study|Death|4|||
131035612|NCT05057247|471764045|FG000|Overall Study|Physician Decision|3|||
131035613|NCT05057247|471764045|FG000|Overall Study|Progressive Disease|7|||
131035614|NCT05057247|471764045|FG000|Overall Study|Withdrawal by Subject|3|||
131035615|NCT05057247|471764045|FG000|Overall Study|Adverse Event|6|||
131035616|NCT05057247|471764045|FG000|Overall Study|Subject Non-Compliance|1|||
131035617|NCT05057247|471764045|FG000|Overall Study|On treatment|2|||
131035618|NCT04632992|471764047|FG000|Overall Study|Adverse Event|0|||
131035619|NCT04632992|471764048|FG001|Overall Study|Adverse Event|0|||
131035620|NCT04632992|471764049|FG002|Overall Study|Adverse Event|0|||
130771124|NCT00424593|470789823|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
130771125|NCT00424593|470789824|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
130771126|NCT00424593|470789823|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
130771127|NCT00424593|470789824|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
130771128|NCT00424593|470789823|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
130771129|NCT00424593|470789824|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
130771130|NCT00424593|470789823|FG000|Dose-Blind Extension Period|Adverse Event|18|||
130771131|NCT00424593|470789824|FG001|Dose-Blind Extension Period|Adverse Event|0|||
130771132|NCT00424593|470789823|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
130771133|NCT00424593|470789824|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
130771134|NCT00424593|470789823|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
130771135|NCT00424593|470789824|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
130771136|NCT00424593|470789823|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
130771137|NCT00424593|470789824|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
130771138|NCT00424593|470789823|FG000|Dose-Blind Extension Period|Physician Decision|3|||
130771139|NCT00424593|470789824|FG001|Dose-Blind Extension Period|Physician Decision|0|||
130771140|NCT01796301|470789825|FG000|Overall Study|Withdrawal by Subject|15|||
131035621|NCT04632992|471764050|FG003|Overall Study|Adverse Event|0|||
131035622|NCT04632992|471764051|FG004|Overall Study|Adverse Event|0|||
131035623|NCT04632992|471764052|FG005|Overall Study|Adverse Event|0|||
131035624|NCT04632992|471764053|FG006|Overall Study|Adverse Event|0|||
131035625|NCT04632992|471764054|FG007|Overall Study|Adverse Event|0|||
131035626|NCT04632992|471764055|FG008|Overall Study|Adverse Event|0|||
131035627|NCT04632992|471764056|FG009|Overall Study|Adverse Event|0|||
131035628|NCT04632992|471764057|FG010|Overall Study|Adverse Event|0|||
131035629|NCT04632992|471764058|FG011|Overall Study|Adverse Event|0|||
130937203|NCT00982488|471404484|FG004|Overall Study|Stem cell transplant|0|||
130937204|NCT00982488|471404480|FG000|Overall Study|Study drug toxicity|34|||
130937205|NCT00982488|471404481|FG001|Overall Study|Study drug toxicity|1|||
130937206|NCT00982488|471404482|FG002|Overall Study|Study drug toxicity|6|||
130937207|NCT00982488|471404483|FG003|Overall Study|Study drug toxicity|0|||
130937208|NCT00982488|471404484|FG004|Overall Study|Study drug toxicity|0|||
130937209|NCT00982488|471404480|FG000|Overall Study|Withdrawal by Subject|5|||
130937210|NCT00982488|471404481|FG001|Overall Study|Withdrawal by Subject|1|||
130937211|NCT00982488|471404482|FG002|Overall Study|Withdrawal by Subject|1|||
130937212|NCT00982488|471404483|FG003|Overall Study|Withdrawal by Subject|0|||
130937213|NCT00982488|471404484|FG004|Overall Study|Withdrawal by Subject|0|||
130937214|NCT00180414|471404493|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
130937215|NCT00180414|471404494|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
130937216|NCT00463346|471404495|FG000|Overall Study|Withdrawal by Subject|3|||
130937217|NCT00463346|471404496|FG001|Overall Study|Withdrawal by Subject|3|||
130937218|NCT01199289|471404498|FG000|Overall Study|Ineligibility determined|2|||
130937219|NCT01199289|471404499|FG001|Overall Study|Ineligibility determined|1|||
130937220|NCT01199289|471404500|FG002|Overall Study|Ineligibility determined|0|||
130937221|NCT01199289|471404501|FG003|Overall Study|Ineligibility determined|0|||
130937222|NCT01199289|471404498|FG000|Overall Study|Protocol Violation|1|||
130937223|NCT01199289|471404499|FG001|Overall Study|Protocol Violation|0|||
130937224|NCT01199289|471404500|FG002|Overall Study|Protocol Violation|0|||
130937225|NCT01199289|471404501|FG003|Overall Study|Protocol Violation|1|||
130937226|NCT01199289|471404498|FG000|Overall Study|Noncompliance|1|||
130937227|NCT01199289|471404499|FG001|Overall Study|Noncompliance|0|||
130937228|NCT01199289|471404500|FG002|Overall Study|Noncompliance|2|||
130937229|NCT01199289|471404501|FG003|Overall Study|Noncompliance|0|||
130937230|NCT01199289|471404498|FG000|Overall Study|Adverse Event|0|||
130704647|NCT01999894|470542752|FG000|Overall Study|Adverse Event|9|||
130937231|NCT01199289|471404499|FG001|Overall Study|Adverse Event|3|||
130937232|NCT01199289|471404500|FG002|Overall Study|Adverse Event|1|||
130937233|NCT01199289|471404501|FG003|Overall Study|Adverse Event|4|||
130937234|NCT01199289|471404498|FG000|Overall Study|Full consent withdrawn|2|||
130937235|NCT01199289|471404499|FG001|Overall Study|Full consent withdrawn|2|||
130937236|NCT01199289|471404500|FG002|Overall Study|Full consent withdrawn|2|||
130937237|NCT01199289|471404501|FG003|Overall Study|Full consent withdrawn|3|||
130937238|NCT01199289|471404498|FG000|Overall Study|Administrative decision|0|||
130937239|NCT01199289|471404499|FG001|Overall Study|Administrative decision|0|||
130937240|NCT01199289|471404500|FG002|Overall Study|Administrative decision|0|||
130937241|NCT01199289|471404501|FG003|Overall Study|Administrative decision|1|||
130937242|NCT01199289|471404498|FG000|Overall Study|Lost to Follow-up|0|||
130937243|NCT01199289|471404499|FG001|Overall Study|Lost to Follow-up|0|||
130937244|NCT01199289|471404500|FG002|Overall Study|Lost to Follow-up|0|||
130937245|NCT01199289|471404501|FG003|Overall Study|Lost to Follow-up|1|||
130937246|NCT01199289|471404498|FG000|Overall Study|Protocol-specified criteria|3|||
130937247|NCT01199289|471404499|FG001|Overall Study|Protocol-specified criteria|0|||
130937248|NCT01199289|471404500|FG002|Overall Study|Protocol-specified criteria|0|||
130937249|NCT01199289|471404501|FG003|Overall Study|Protocol-specified criteria|1|||
130937250|NCT01199289|471404498|FG000|Overall Study|Pregnancy|0|||
130937251|NCT01199289|471404499|FG001|Overall Study|Pregnancy|1|||
130937252|NCT01199289|471404500|FG002|Overall Study|Pregnancy|0|||
130937253|NCT01199289|471404501|FG003|Overall Study|Pregnancy|1|||
130937254|NCT02723084|471404503|FG000|Overall Study|Withdrawal by Subject|1|||
130937255|NCT02723084|471404504|FG001|Overall Study|Withdrawal by Subject|1|||
130937256|NCT02723084|471404503|FG000|Overall Study|Lost to Follow-up|3|||
130937257|NCT02723084|471404504|FG001|Overall Study|Lost to Follow-up|0|||
130937258|NCT02450903|471404505|FG000|Overall Study|Adverse Event|3|||
130937259|NCT02450903|471404505|FG000|Overall Study|Progressive disease|15|||
130937260|NCT02450903|471404505|FG000|Overall Study|Switched to commercial drug|1|||
130937261|NCT02450903|471404505|FG000|Overall Study|Subject/guardian decision|1|||
130937262|NCT01320085|471404506|FG000|Overall Study|Disease Progression|26|||
130937263|NCT01320085|471404507|FG001|Overall Study|Disease Progression|93|||
130937264|NCT01320085|471404508|FG002|Overall Study|Disease Progression|17|||
131035630|NCT04632992|471764059|FG012|Overall Study|Adverse Event|1|||
130937265|NCT01320085|471404506|FG000|Overall Study|Adverse Event|12|||
130937266|NCT01320085|471404507|FG001|Overall Study|Adverse Event|20|||
130937267|NCT01320085|471404508|FG002|Overall Study|Adverse Event|5|||
130937268|NCT01320085|471404506|FG000|Overall Study|Withdrawal by Subject|2|||
130937269|NCT01320085|471404507|FG001|Overall Study|Withdrawal by Subject|4|||
130937270|NCT01320085|471404508|FG002|Overall Study|Withdrawal by Subject|1|||
130937271|NCT01320085|471404506|FG000|Overall Study|Protocol Deviation|1|||
130937272|NCT01320085|471404507|FG001|Overall Study|Protocol Deviation|0|||
130937273|NCT01320085|471404508|FG002|Overall Study|Protocol Deviation|1|||
130937274|NCT01320085|471404506|FG000|Overall Study|Administrative problems|0|||
130937275|NCT01320085|471404507|FG001|Overall Study|Administrative problems|0|||
130937276|NCT01320085|471404508|FG002|Overall Study|Administrative problems|1|||
130937277|NCT03020407|471404515|FG000|Overall Study|Withdrawal by Subject|2|||
130937278|NCT03020407|471404516|FG001|Overall Study|Withdrawal by Subject|1|||
130704648|NCT01999894|470542752|FG000|Overall Study|Lack of Efficacy|5|||
130704649|NCT01999894|470542752|FG000|Overall Study|Protocol Violation|1|||
131121135|NCT01134614|472073829|FG001|Overall Study|Never started treatment|1|||
131121136|NCT01134614|472073828|FG000|Overall Study|Pt received tx not allowed on study|0|||
131121137|NCT01134614|472073829|FG001|Overall Study|Pt received tx not allowed on study|1|||
131121138|NCT01134614|472073828|FG000|Overall Study|Symptomatic deterioration|0|||
131121139|NCT01134614|472073829|FG001|Overall Study|Symptomatic deterioration|1|||
131121140|NCT01134614|472073828|FG000|Overall Study|Patient in hospice care|0|||
131121141|NCT01134614|472073829|FG001|Overall Study|Patient in hospice care|1|||
131121142|NCT01519934|472073830|FG000|Overall Study|Lost to Follow-up|3|||
131121143|NCT00359021|472073831|FG000|Overall Study|Adverse Event|26|||
131121144|NCT00359021|472073832|FG001|Overall Study|Adverse Event|8|||
131121145|NCT00359021|472073831|FG000|Overall Study|Subject Non-Compliant|1|||
131121146|NCT00359021|472073832|FG001|Overall Study|Subject Non-Compliant|2|||
131121147|NCT00359021|472073831|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
131121148|NCT00359021|472073832|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
131121149|NCT00359021|472073831|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
131121150|NCT00359021|472073832|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
131121151|NCT00359021|472073831|FG000|Overall Study|Withdrawal by Subject|2|||
131121152|NCT00359021|472073832|FG001|Overall Study|Withdrawal by Subject|9|||
131121153|NCT00359021|472073831|FG000|Overall Study|Lost to Follow-up|1|||
131121154|NCT00359021|472073832|FG001|Overall Study|Lost to Follow-up|0|||
131121155|NCT00359021|472073831|FG000|Overall Study|Other|4|||
131121156|NCT00359021|472073832|FG001|Overall Study|Other|1|||
131121157|NCT00359021|472073831|FG000|Overall Study|Pregnancy|1|||
131121158|NCT00359021|472073832|FG001|Overall Study|Pregnancy|0|||
131121159|NCT02161575|472073833|FG000|Overall Study|Protocol Violation|8|||
131121160|NCT02161575|472073833|FG000|Overall Study|Lack of Efficacy|1|||
131121161|NCT02161575|472073833|FG000|Overall Study|Adverse Event|2|||
131121162|NCT00702325|472073837|FG000|Overall Study|Adverse Event|1|||
131121163|NCT00702325|472073838|FG001|Overall Study|Adverse Event|0|||
131121164|NCT00702325|472073837|FG000|Overall Study|Withdrawal by Subject|7|||
131121165|NCT00702325|472073838|FG001|Overall Study|Withdrawal by Subject|7|||
131121166|NCT00702325|472073837|FG000|Overall Study|Lost to Follow-up|3|||
131121167|NCT00702325|472073838|FG001|Overall Study|Lost to Follow-up|4|||
131121168|NCT00702325|472073837|FG000|Overall Study|Incorrect enrollment|5|||
131121169|NCT00702325|472073838|FG001|Overall Study|Incorrect enrollment|7|||
131121170|NCT00702325|472073837|FG000|Overall Study|Developed study discontinuation criteria|18|||
131121171|NCT00702325|472073838|FG001|Overall Study|Developed study discontinuation criteria|28|||
131121172|NCT00702325|472073837|FG000|Overall Study|Severe noncompliance to protocol|3|||
131121173|NCT00702325|472073838|FG001|Overall Study|Severe noncompliance to protocol|3|||
131121174|NCT00702325|472073837|FG000|Overall Study|Termination due to lab results|1|||
131121175|NCT00702325|472073838|FG001|Overall Study|Termination due to lab results|0|||
131121176|NCT00702325|472073837|FG000|Overall Study|Didn't follow study medication dosage|0|||
131121177|NCT00702325|472073838|FG001|Overall Study|Didn't follow study medication dosage|2|||
131121178|NCT00702325|472073837|FG000|Overall Study|Withdrew consent|0|||
131121179|NCT00702325|472073838|FG001|Overall Study|Withdrew consent|1|||
131121180|NCT00702325|472073837|FG000|Overall Study|Incorrectly Discontinued|0|||
131121181|NCT00702325|472073838|FG001|Overall Study|Incorrectly Discontinued|1|||
131121182|NCT01022502|472073842|FG000|Overall Study|Adverse Event|1|||
131121183|NCT01022502|472073842|FG000|Overall Study|employment related reasons|1|||
131121184|NCT01022502|472073842|FG000|Overall Study|Withdrawal by Subject|1|||
131121185|NCT03716050|472073843|FG000|Overall Study|Lost to Follow-up|0|||
131121186|NCT03716050|472073844|FG001|Overall Study|Lost to Follow-up|0|||
131121187|NCT03716050|472073845|FG002|Overall Study|Lost to Follow-up|1|||
131121188|NCT03716050|472073846|FG003|Overall Study|Lost to Follow-up|0|||
131121189|NCT03716050|472073847|FG004|Overall Study|Lost to Follow-up|0|||
131121190|NCT03716050|472073848|FG005|Overall Study|Lost to Follow-up|0|||
131121191|NCT03716050|472073849|FG006|Overall Study|Lost to Follow-up|0|||
131121192|NCT03716050|472073850|FG007|Overall Study|Lost to Follow-up|0|||
131121193|NCT03716050|472073843|FG000|Overall Study|Physician Decision|0|||
131121194|NCT03716050|472073844|FG001|Overall Study|Physician Decision|0|||
131121195|NCT03716050|472073845|FG002|Overall Study|Physician Decision|0|||
131121196|NCT03716050|472073846|FG003|Overall Study|Physician Decision|1|||
131121197|NCT03716050|472073847|FG004|Overall Study|Physician Decision|0|||
131121198|NCT03716050|472073848|FG005|Overall Study|Physician Decision|0|||
130704650|NCT01999894|470542752|FG000|Overall Study|Withdrawal by Subject|7|||
131121199|NCT03716050|472073849|FG006|Overall Study|Physician Decision|0|||
131121200|NCT03716050|472073850|FG007|Overall Study|Physician Decision|0|||
130704651|NCT01999894|470542752|FG000|Overall Study|Lost to Follow-up|10|||
130704652|NCT01999894|470542752|FG000|Overall Study|Other Reason|3|||
130937279|NCT03020407|471404515|FG000|Overall Study|Lost to Follow-up|2|||
131121201|NCT03716050|472073843|FG000|Overall Study|Protocol Violation|0|||
131121202|NCT03716050|472073844|FG001|Overall Study|Protocol Violation|0|||
131121203|NCT03716050|472073845|FG002|Overall Study|Protocol Violation|0|||
131121204|NCT03716050|472073846|FG003|Overall Study|Protocol Violation|1|||
131121205|NCT03716050|472073847|FG004|Overall Study|Protocol Violation|0|||
130704653|NCT01999894|470542752|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
130704654|NCT01546519|470542753|FG000|Overall Study|Adverse Event|0|||
130704655|NCT01546519|470542754|FG001|Overall Study|Adverse Event|0|||
131035631|NCT04632992|471764060|FG013|Overall Study|Adverse Event|0|||
131035632|NCT04632992|471764047|FG000|Overall Study|Death|17|||
131035633|NCT04632992|471764048|FG001|Overall Study|Death|1|||
131035634|NCT04632992|471764049|FG002|Overall Study|Death|14|||
131035635|NCT04632992|471764050|FG003|Overall Study|Death|14|||
131035636|NCT04632992|471764051|FG004|Overall Study|Death|13|||
131035637|NCT04632992|471764052|FG005|Overall Study|Death|6|||
131035638|NCT04632992|471764053|FG006|Overall Study|Death|7|||
131035639|NCT04632992|471764054|FG007|Overall Study|Death|12|||
131035640|NCT04632992|471764055|FG008|Overall Study|Death|15|||
131035641|NCT04632992|471764056|FG009|Overall Study|Death|20|||
131035642|NCT04632992|471764057|FG010|Overall Study|Death|8|||
131035643|NCT04632992|471764058|FG011|Overall Study|Death|2|||
131035644|NCT04632992|471764059|FG012|Overall Study|Death|10|||
131035645|NCT04632992|471764060|FG013|Overall Study|Death|1|||
130704656|NCT01546519|470542755|FG002|Overall Study|Adverse Event|1|||
130704657|NCT01546519|470542756|FG003|Overall Study|Adverse Event|1|||
130704658|NCT01546519|470542753|FG000|Overall Study|Death|0|||
130704659|NCT01546519|470542754|FG001|Overall Study|Death|1|||
130704660|NCT01546519|470542755|FG002|Overall Study|Death|3|||
130704661|NCT01546519|470542756|FG003|Overall Study|Death|1|||
130704662|NCT01546519|470542753|FG000|Overall Study|related to disease progression|2|||
130704663|NCT01546519|470542754|FG001|Overall Study|related to disease progression|2|||
130704664|NCT01546519|470542755|FG002|Overall Study|related to disease progression|2|||
130704665|NCT01546519|470542756|FG003|Overall Study|related to disease progression|1|||
130704666|NCT01546519|470542753|FG000|Overall Study|Physician Decision|6|||
130704667|NCT01546519|470542754|FG001|Overall Study|Physician Decision|5|||
130704668|NCT01546519|470542755|FG002|Overall Study|Physician Decision|2|||
130704669|NCT01546519|470542756|FG003|Overall Study|Physician Decision|3|||
130704670|NCT01546519|470542753|FG000|Overall Study|Withdrawal by Subject|1|||
130704671|NCT01546519|470542754|FG001|Overall Study|Withdrawal by Subject|0|||
130704672|NCT01546519|470542755|FG002|Overall Study|Withdrawal by Subject|0|||
130704673|NCT01546519|470542756|FG003|Overall Study|Withdrawal by Subject|0|||
130704674|NCT00779402|470542759|FG000|Treatment Phase 1|Disease Progression|1|||
130704675|NCT00779402|470542760|FG001|Treatment Phase 1|Disease Progression|0|||
130704676|NCT00779402|470542759|FG000|Treatment Phase 1|Adverse Event|2|||
130704677|NCT00779402|470542760|FG001|Treatment Phase 1|Adverse Event|0|||
130704678|NCT00779402|470542759|FG000|Treatment Phase 1|Protocol Violation|1|||
130704679|NCT00779402|470542760|FG001|Treatment Phase 1|Protocol Violation|0|||
130704680|NCT00779402|470542759|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
130704681|NCT00779402|470542760|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
130704682|NCT00779402|470542759|FG000|Treatment Phase 1|Lost to Follow-up|0|||
130704683|NCT00779402|470542760|FG001|Treatment Phase 1|Lost to Follow-up|1|||
130704684|NCT00779402|470542759|FG000|Treatment Phase 1|Death|0|||
130704685|NCT00779402|470542760|FG001|Treatment Phase 1|Death|1|||
130704686|NCT00779402|470542759|FG000|Treatment Phase 1|Intercurrent Illness|1|||
130704687|NCT00779402|470542760|FG001|Treatment Phase 1|Intercurrent Illness|1|||
130704688|NCT00779402|470542759|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
130704689|NCT00779402|470542760|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
130704690|NCT00779402|470542759|FG000|Treatment Phase 1|Other|4|||
130704691|NCT00779402|470542760|FG001|Treatment Phase 1|Other|2|||
130704692|NCT00779402|470542759|FG000|Treatment Phase 1|Closure of Study|3|||
130704693|NCT00779402|470542760|FG001|Treatment Phase 1|Closure of Study|2|||
130704694|NCT00779402|470542759|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
130704695|NCT00779402|470542760|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
130704696|NCT00779402|470542759|FG000|Surveillance Phase|Protocol Violation|0|||
130704697|NCT00779402|470542760|FG001|Surveillance Phase|Protocol Violation|1|||
130704698|NCT00779402|470542759|FG000|Surveillance Phase|Patient refused to continue|22|||
130704699|NCT00779402|470542760|FG001|Surveillance Phase|Patient refused to continue|14|||
130704700|NCT00779402|470542759|FG000|Surveillance Phase|Lost to Follow-up|2|||
130704701|NCT00779402|470542760|FG001|Surveillance Phase|Lost to Follow-up|1|||
130704702|NCT00779402|470542759|FG000|Surveillance Phase|Death|0|||
131035646|NCT04632992|471764047|FG000|Overall Study|Lost to Follow-up|1|||
131223910|NCT04380701|472447127|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
130704703|NCT00779402|470542760|FG001|Surveillance Phase|Death|1|||
130704704|NCT00779402|470542759|FG000|Surveillance Phase|Intercurrent Illness|2|||
130704705|NCT00779402|470542760|FG001|Surveillance Phase|Intercurrent Illness|0|||
130704706|NCT00779402|470542759|FG000|Surveillance Phase|Other|5|||
130704707|NCT00779402|470542760|FG001|Surveillance Phase|Other|5|||
130704708|NCT00779402|470542759|FG000|Surveillance Phase|Withdrawal by Subject|4|||
131035647|NCT04632992|471764048|FG001|Overall Study|Lost to Follow-up|0|||
131035648|NCT04632992|471764049|FG002|Overall Study|Lost to Follow-up|1|||
131035649|NCT04632992|471764050|FG003|Overall Study|Lost to Follow-up|0|||
131035650|NCT04632992|471764051|FG004|Overall Study|Lost to Follow-up|2|||
131035651|NCT04632992|471764052|FG005|Overall Study|Lost to Follow-up|0|||
131035652|NCT04632992|471764053|FG006|Overall Study|Lost to Follow-up|1|||
130704709|NCT00779402|470542760|FG001|Surveillance Phase|Withdrawal by Subject|1|||
130704710|NCT00779402|470542759|FG000|Surveillance Phase|Closure of study|5|||
130704711|NCT00779402|470542760|FG001|Surveillance Phase|Closure of study|6|||
130704712|NCT00779402|470542759|FG000|Surveillance Phase|Completed Protocol Visits|3|||
130704713|NCT00779402|470542760|FG001|Surveillance Phase|Completed Protocol Visits|2|||
130704714|NCT00779402|470542759|FG000|Long-term Follow-up|Patient refused to continue|2|||
130704715|NCT00779402|470542760|FG001|Long-term Follow-up|Patient refused to continue|0|||
130704716|NCT00779402|470542759|FG000|Long-term Follow-up|Other|5|||
130704717|NCT00779402|470542760|FG001|Long-term Follow-up|Other|0|||
130704718|NCT00779402|470542759|FG000|Long-term Follow-up|Closure of Study|8|||
130704719|NCT00779402|470542760|FG001|Long-term Follow-up|Closure of Study|4|||
130704720|NCT00779402|470542759|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
130704721|NCT00779402|470542760|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
130704722|NCT02274948|470542763|FG000|Overall Study|Lost to Follow-up|28|||
130704723|NCT02274948|470542764|FG001|Overall Study|Lost to Follow-up|25|||
130704724|NCT02274948|470542763|FG000|Overall Study|Withdrawal by Subject|64|||
130704725|NCT02274948|470542764|FG001|Overall Study|Withdrawal by Subject|58|||
130704726|NCT02274948|470542763|FG000|Overall Study|Stopped on family Practitioner advice|2|||
130704727|NCT02274948|470542764|FG001|Overall Study|Stopped on family Practitioner advice|5|||
130704728|NCT02274948|470542763|FG000|Overall Study|Left the area|4|||
130704729|NCT02274948|470542764|FG001|Overall Study|Left the area|3|||
130704730|NCT00707434|470542765|FG000|Overall Study|Adverse Event|1|||
130704731|NCT01386125|470542766|FG000|Overall Study|Lost to Follow-up|3|||
130704732|NCT01386125|470542767|FG001|Overall Study|Lost to Follow-up|9|||
130704733|NCT01386125|470542766|FG000|Overall Study|Physician Decision|0|||
130704734|NCT01386125|470542767|FG001|Overall Study|Physician Decision|1|||
130704735|NCT01386125|470542766|FG000|Overall Study|Protocol Violation|5|||
130704736|NCT01386125|470542767|FG001|Overall Study|Protocol Violation|7|||
130704737|NCT01386125|470542766|FG000|Overall Study|Disease Progress|1|||
130704738|NCT01386125|470542767|FG001|Overall Study|Disease Progress|2|||
130704739|NCT01386125|470542766|FG000|Overall Study|Withdrawal by Subject|13|||
130704740|NCT01386125|470542767|FG001|Overall Study|Withdrawal by Subject|12|||
130704741|NCT01386125|470542766|FG000|Overall Study|Adverse Event|2|||
130704742|NCT01386125|470542767|FG001|Overall Study|Adverse Event|5|||
130704743|NCT01386125|470542766|FG000|Overall Study|Lack of Efficacy|0|||
130704744|NCT01386125|470542767|FG001|Overall Study|Lack of Efficacy|1|||
130704745|NCT01386125|470542766|FG000|Overall Study|Participant Leaving Country|1|||
130704746|NCT01386125|470542767|FG001|Overall Study|Participant Leaving Country|0|||
130704747|NCT00732160|470542771|FG000|Overall Study|Adverse Event|1|||
130704748|NCT00732160|470542772|FG001|Overall Study|Adverse Event|0|||
130704749|NCT00732160|470542773|FG002|Overall Study|Adverse Event|1|||
130704750|NCT00732160|470542774|FG003|Overall Study|Adverse Event|1|||
130704751|NCT00732160|470542771|FG000|Overall Study|scheduling|4|||
130704752|NCT00732160|470542772|FG001|Overall Study|scheduling|4|||
130704753|NCT00732160|470542773|FG002|Overall Study|scheduling|2|||
130704754|NCT00732160|470542774|FG003|Overall Study|scheduling|1|||
130704755|NCT00676494|470542775|FG000|Overall Study|Missed Visit|8|||
130704756|NCT00676494|470542775|FG000|Overall Study|Withdrawal by Subject|6|||
130704757|NCT01264835|470542776|FG000|Overall Study|Lost to Follow-up|1|||
130704758|NCT01808248|470542779|FG000|Overall Study|Lack of Efficacy|3|||
130704759|NCT01808248|470542779|FG000|Overall Study|Withdrawal by Subject|1|||
130704760|NCT01808248|470542779|FG000|Overall Study|Lost to Follow-up|1|||
130704761|NCT03507686|470542783|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
130704762|NCT03507686|470542784|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
130704763|NCT03507686|470542783|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
130704764|NCT03507686|470542784|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
130704765|NCT03507686|470542783|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
130704766|NCT03507686|470542784|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
130704767|NCT03507686|470542783|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
130704768|NCT03507686|470542784|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
130704769|NCT03507686|470542783|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
130704770|NCT03507686|470542784|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
130704771|NCT03507686|470542783|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
130704772|NCT03507686|470542784|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
130704773|NCT02508116|470542785|FG000|Overall Study|Lost to Follow-up|2|||
130704774|NCT02508116|470542786|FG001|Overall Study|Lost to Follow-up|3|||
130704775|NCT02508116|470542785|FG000|Overall Study|Withdrawal by Subject|3|||
130704776|NCT02508116|470542786|FG001|Overall Study|Withdrawal by Subject|2|||
130704777|NCT02508116|470542785|FG000|Overall Study|Protocol Violation|1|||
130704778|NCT02508116|470542786|FG001|Overall Study|Protocol Violation|2|||
130704779|NCT02508116|470542785|FG000|Overall Study|Physician Decision|2|||
130704780|NCT02508116|470542786|FG001|Overall Study|Physician Decision|0|||
130704781|NCT00109850|470542789|FG000|Overall Study|Adverse Event|1|||
130704782|NCT00109850|470542789|FG000|Overall Study|Death|2|||
130704783|NCT00109850|470542789|FG000|Overall Study|Ineligible|1|||
130704784|NCT00983528|470542790|FG000|Overall Study|Death|4|||
131121206|NCT03716050|472073848|FG005|Overall Study|Protocol Violation|0|||
131121207|NCT03716050|472073849|FG006|Overall Study|Protocol Violation|0|||
131121208|NCT03716050|472073850|FG007|Overall Study|Protocol Violation|2|||
131121209|NCT03123250|472073851|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
131121210|NCT01390272|472073852|FG000|Overall Study|Death|3|||
131121211|NCT01390272|472073853|FG001|Overall Study|Death|2|||
131121212|NCT01390272|472073852|FG000|Overall Study|Withdrawal by Subject|9|||
131121213|NCT01390272|472073853|FG001|Overall Study|Withdrawal by Subject|5|||
131121214|NCT01390272|472073852|FG000|Overall Study|Patient moved, no longer eligible|5|||
131121215|NCT01390272|472073853|FG001|Overall Study|Patient moved, no longer eligible|8|||
131121216|NCT03199040|472073854|FG000|Overall Study|Lack of Efficacy|2|||
131121217|NCT03199040|472073855|FG001|Overall Study|Lack of Efficacy|0|||
131121218|NCT03199040|472073854|FG000|Overall Study|Withdrawal by Subject|2|||
131121219|NCT03199040|472073855|FG001|Overall Study|Withdrawal by Subject|0|||
131121220|NCT03199040|472073854|FG000|Overall Study|Adverse Event|0|||
131121221|NCT03199040|472073855|FG001|Overall Study|Adverse Event|1|||
131121222|NCT03199040|472073854|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
131121223|NCT03199040|472073855|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
131121224|NCT00199836|472073856|FG000|Overall Study|Progressive Disease|5|||
131121225|NCT00199836|472073856|FG000|Overall Study|Death|1|||
131121226|NCT01854645|472073862|FG000|Overall Study|Protocol-Specified Criteria|13|||
131121227|NCT01854645|472073863|FG001|Overall Study|Protocol-Specified Criteria|10|||
131121228|NCT01854645|472073864|FG002|Overall Study|Protocol-Specified Criteria|8|||
131121229|NCT01854645|472073865|FG003|Overall Study|Protocol-Specified Criteria|5|||
131121230|NCT01854645|472073866|FG004|Overall Study|Protocol-Specified Criteria|7|||
131121231|NCT01854645|472073862|FG000|Overall Study|Administrative Reasons / Missing|0|||
131121232|NCT01854645|472073863|FG001|Overall Study|Administrative Reasons / Missing|0|||
131121233|NCT01854645|472073864|FG002|Overall Study|Administrative Reasons / Missing|0|||
131121234|NCT01854645|472073865|FG003|Overall Study|Administrative Reasons / Missing|1|||
131121235|NCT01854645|472073866|FG004|Overall Study|Administrative Reasons / Missing|1|||
131121236|NCT01854645|472073862|FG000|Overall Study|Protocol Violation|3|||
131121237|NCT01854645|472073863|FG001|Overall Study|Protocol Violation|0|||
131121238|NCT01854645|472073864|FG002|Overall Study|Protocol Violation|5|||
131121239|NCT01854645|472073865|FG003|Overall Study|Protocol Violation|4|||
131121240|NCT01854645|472073866|FG004|Overall Study|Protocol Violation|1|||
131121241|NCT01854645|472073862|FG000|Overall Study|Lost to Follow-up|10|||
131121242|NCT01854645|472073863|FG001|Overall Study|Lost to Follow-up|7|||
131121243|NCT01854645|472073864|FG002|Overall Study|Lost to Follow-up|8|||
131121244|NCT01854645|472073865|FG003|Overall Study|Lost to Follow-up|5|||
131121245|NCT01854645|472073866|FG004|Overall Study|Lost to Follow-up|0|||
131121246|NCT01854645|472073862|FG000|Overall Study|Physician Decision|1|||
131121247|NCT01854645|472073863|FG001|Overall Study|Physician Decision|5|||
131121248|NCT01854645|472073864|FG002|Overall Study|Physician Decision|3|||
131121249|NCT01854645|472073865|FG003|Overall Study|Physician Decision|3|||
131121250|NCT01854645|472073866|FG004|Overall Study|Physician Decision|7|||
131121251|NCT01854645|472073862|FG000|Overall Study|Withdrawal by Subject|31|||
131121252|NCT01854645|472073863|FG001|Overall Study|Withdrawal by Subject|41|||
131121253|NCT01854645|472073864|FG002|Overall Study|Withdrawal by Subject|30|||
131121254|NCT01854645|472073865|FG003|Overall Study|Withdrawal by Subject|21|||
131121255|NCT01854645|472073866|FG004|Overall Study|Withdrawal by Subject|24|||
131121256|NCT01854645|472073862|FG000|Overall Study|Lack of Efficacy|7|||
131121257|NCT01854645|472073863|FG001|Overall Study|Lack of Efficacy|12|||
131121258|NCT01854645|472073864|FG002|Overall Study|Lack of Efficacy|9|||
131121259|NCT01854645|472073865|FG003|Overall Study|Lack of Efficacy|3|||
131121260|NCT01854645|472073866|FG004|Overall Study|Lack of Efficacy|9|||
131121261|NCT01854645|472073862|FG000|Overall Study|Adverse Event|33|||
131121262|NCT01854645|472073863|FG001|Overall Study|Adverse Event|31|||
131121263|NCT01854645|472073864|FG002|Overall Study|Adverse Event|19|||
131121264|NCT01854645|472073865|FG003|Overall Study|Adverse Event|20|||
131121265|NCT01854645|472073866|FG004|Overall Study|Adverse Event|11|||
131121266|NCT00430482|472073867|FG000|Completed Treatment|Insufficient Treatment|7|||
131121267|NCT00430482|472073868|FG001|Completed Treatment|Insufficient Treatment|11|||
131121268|NCT02546765|472073872|FG000|Overall Study|Withdrawal by Subject|0|||
131121269|NCT02546765|472073873|FG001|Overall Study|Withdrawal by Subject|1|||
131121270|NCT02546765|472073874|FG002|Overall Study|Withdrawal by Subject|0|||
131121271|NCT02546765|472073875|FG003|Overall Study|Withdrawal by Subject|0|||
131121272|NCT00475722|472073876|FG000|Overall Study|Withdrawal by Subject|12|||
131121273|NCT00475722|472073877|FG001|Overall Study|Withdrawal by Subject|12|||
131121274|NCT00475722|472073876|FG000|Overall Study|Protocol Violation|3|||
131121275|NCT00475722|472073877|FG001|Overall Study|Protocol Violation|0|||
131121276|NCT00916279|472073878|FG000|Overall Study|Death|2|||
131121277|NCT00916279|472073878|FG000|Overall Study|Lost to Follow-up|2|||
131121278|NCT00310804|472073879|FG000|Overall Study|Lost to Follow-up|2|||
131121279|NCT00310804|472073880|FG001|Overall Study|Lost to Follow-up|0|||
131121280|NCT00310804|472073879|FG000|Overall Study|Withdrawal by Subject|3|||
131121281|NCT00310804|472073880|FG001|Overall Study|Withdrawal by Subject|0|||
131121282|NCT00688155|472073881|FG000|Overall Study|Withdrawal by Subject|2|||
130937280|NCT03020407|471404516|FG001|Overall Study|Lost to Follow-up|3|||
130937281|NCT03020407|471404515|FG000|Overall Study|Protocol Violation|0|||
130937282|NCT03020407|471404516|FG001|Overall Study|Protocol Violation|1|||
130937283|NCT00708162|471404517|FG000|Randomized Phase|Randomized but Not Treated|7|||
130937284|NCT00708162|471404518|FG001|Randomized Phase|Randomized but Not Treated|5|||
130937285|NCT00708162|471404517|FG000|Randomized Phase|Participant Noncompliance|40|||
131121283|NCT00688155|472073882|FG001|Overall Study|Withdrawal by Subject|2|||
131121284|NCT00688155|472073883|FG002|Overall Study|Withdrawal by Subject|1|||
131121285|NCT00688155|472073884|FG003|Overall Study|Withdrawal by Subject|1|||
130937286|NCT00708162|471404518|FG001|Randomized Phase|Participant Noncompliance|32|||
130937287|NCT00708162|471404517|FG000|Randomized Phase|Lost to Follow-up|34|||
130937288|NCT00708162|471404518|FG001|Randomized Phase|Lost to Follow-up|34|||
130937289|NCT00708162|471404517|FG000|Randomized Phase|Withdrew Consent|31|||
130937290|NCT00708162|471404518|FG001|Randomized Phase|Withdrew Consent|22|||
130937291|NCT00708162|471404517|FG000|Randomized Phase|Lack of Efficacy|14|||
130937292|NCT00708162|471404518|FG001|Randomized Phase|Lack of Efficacy|19|||
130937293|NCT00708162|471404517|FG000|Randomized Phase|Protocol Violation|10|||
130937294|NCT00708162|471404518|FG001|Randomized Phase|Protocol Violation|11|||
130937295|NCT00708162|471404517|FG000|Randomized Phase|Adverse Event|8|||
130937296|NCT00708162|471404518|FG001|Randomized Phase|Adverse Event|12|||
130937297|NCT00708162|471404517|FG000|Randomized Phase|Investigator's Discretion|7|||
130937298|NCT00708162|471404518|FG001|Randomized Phase|Investigator's Discretion|10|||
130937299|NCT00708162|471404517|FG000|Randomized Phase|Death|2|||
130937300|NCT00708162|471404518|FG001|Randomized Phase|Death|9|||
130937301|NCT00708162|471404517|FG000|Randomized Phase|Pregnancy|3|||
130937302|NCT00708162|471404518|FG001|Randomized Phase|Pregnancy|0|||
131121286|NCT01889238|472073888|FG000|Overall Study|Death|1|||
131121287|NCT01889238|472073888|FG000|Overall Study|Withdrawal by Subject|1|||
131121288|NCT01889238|472073888|FG000|Overall Study|Adverse Event|6|||
131121289|NCT01889238|472073888|FG000|Overall Study|Disease Progression|104|||
131121290|NCT01889238|472073888|FG000|Overall Study|Other|6|||
131121291|NCT04136184|472073889|FG000|Overall Study|Lost to Follow-up|0|||
131121292|NCT04136184|472073890|FG001|Overall Study|Lost to Follow-up|3|||
131121293|NCT04136184|472073889|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
131121294|NCT04136184|472073890|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
131121295|NCT03318978|472073891|FG000|Overall Study|Withdrawal by Subject|1|||
131121296|NCT02844816|472073892|FG000|Overall Study|No protocol treatment received|5|||
131121297|NCT02844816|472073893|FG001|Overall Study|No protocol treatment received|1|||
131121298|NCT02844816|472073892|FG000|Overall Study|Ineligible|22|||
131121299|NCT02844816|472073893|FG001|Overall Study|Ineligible|15|||
131121300|NCT02844816|472073892|FG000|Overall Study|Participant refusal|5|||
131121301|NCT02844816|472073893|FG001|Overall Study|Participant refusal|5|||
131121302|NCT02844816|472073892|FG000|Overall Study|Adverse Event|5|||
131121303|NCT02844816|472073893|FG001|Overall Study|Adverse Event|4|||
131121304|NCT02844816|472073892|FG000|Overall Study|Death|0|||
131121305|NCT02844816|472073893|FG001|Overall Study|Death|1|||
131121306|NCT02844816|472073892|FG000|Overall Study|Disease progression/recurrence|50|||
131121307|NCT02844816|472073893|FG001|Overall Study|Disease progression/recurrence|24|||
131121308|NCT02844816|472073892|FG000|Overall Study|Physician Decision|1|||
131121309|NCT02844816|472073893|FG001|Overall Study|Physician Decision|1|||
131121310|NCT01200238|472073895|FG000|Overall Study|Adverse Event|2|||
131121311|NCT01200238|472073896|FG001|Overall Study|Adverse Event|1|||
131121312|NCT01200238|472073895|FG000|Overall Study|Progressive Disease|5|||
131121313|NCT01200238|472073896|FG001|Overall Study|Progressive Disease|8|||
131121314|NCT01200238|472073895|FG000|Overall Study|Withdrawal by Subject|0|||
131121315|NCT01200238|472073896|FG001|Overall Study|Withdrawal by Subject|1|||
131121316|NCT02717754|472073897|FG000|Overall Study|Incorrect Infusion Duration|0|||
130704785|NCT00983528|470542790|FG000|Overall Study|Lost to Follow-up|1|||
130704786|NCT00983528|470542790|FG000|Overall Study|Study Terminated|1|||
130704787|NCT00476593|470542791|FG000|Overall Study|Lost to Follow-up|10|||
130704788|NCT00476593|470542792|FG001|Overall Study|Lost to Follow-up|2|||
130704789|NCT00476593|470542793|FG002|Overall Study|Lost to Follow-up|8|||
131121317|NCT02717754|472073898|FG001|Overall Study|Incorrect Infusion Duration|0|||
131121318|NCT02717754|472073899|FG002|Overall Study|Incorrect Infusion Duration|0|||
131121319|NCT02717754|472073900|FG003|Overall Study|Incorrect Infusion Duration|10|||
130937303|NCT00708162|471404517|FG000|Open-Label Phase|Lost to Follow-up|10|||
131121320|NCT02717754|472073901|FG004|Overall Study|Incorrect Infusion Duration|20|||
131121321|NCT02717754|472073902|FG005|Overall Study|Incorrect Infusion Duration|20|||
130937304|NCT00708162|471404518|FG001|Open-Label Phase|Lost to Follow-up|8|||
130937305|NCT00708162|471404517|FG000|Open-Label Phase|Withdrew Consent|12|||
130937306|NCT00708162|471404518|FG001|Open-Label Phase|Withdrew Consent|6|||
130937307|NCT00708162|471404517|FG000|Open-Label Phase|Participant Noncompliance|7|||
130937308|NCT00708162|471404518|FG001|Open-Label Phase|Participant Noncompliance|7|||
131121322|NCT03734016|472073906|FG000|Overall Study|Sponsor Ended Study|225|||
131121323|NCT03734016|472073907|FG001|Overall Study|Sponsor Ended Study|200|||
131121324|NCT03734016|472073906|FG000|Overall Study|Death|69|||
131121325|NCT03734016|472073907|FG001|Overall Study|Death|83|||
131121326|NCT03734016|472073906|FG000|Overall Study|Withdrawal by Subject|21|||
131121327|NCT03734016|472073907|FG001|Overall Study|Withdrawal by Subject|27|||
131121328|NCT03734016|472073906|FG000|Overall Study|Physician Decision|1|||
131121329|NCT03734016|472073907|FG001|Overall Study|Physician Decision|12|||
131121330|NCT03734016|472073906|FG000|Overall Study|Lost to Follow-up|6|||
131121331|NCT03734016|472073907|FG001|Overall Study|Lost to Follow-up|2|||
131121332|NCT03734016|472073906|FG000|Overall Study|Miscellaneous|5|||
131121333|NCT03734016|472073907|FG001|Overall Study|Miscellaneous|1|||
131121334|NCT01979835|472073908|FG000|Primary Outcome SA Measurment|failed insertion|18|||
131121335|NCT01979835|472073908|FG000|Follow-up|Lost to Follow-up|32|||
130704790|NCT00476593|470542794|FG003|Overall Study|Lost to Follow-up|22|||
130704791|NCT00575380|470542795|FG000|Overall Study|Withdrawal by Subject|1|||
130704792|NCT00575380|470542796|FG001|Overall Study|Withdrawal by Subject|0|||
130704793|NCT00575380|470542795|FG000|Overall Study|Adverse Event|0|||
130704794|NCT00575380|470542796|FG001|Overall Study|Adverse Event|1|||
130704795|NCT00575380|470542795|FG000|Overall Study|Various|0|||
130704796|NCT00575380|470542796|FG001|Overall Study|Various|2|||
130704797|NCT00559364|470542797|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
130704798|NCT00559364|470542798|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
130704799|NCT00330460|470542801|FG000|Overall Study|Physician Decision|1|||
130704800|NCT00330460|470542802|FG001|Overall Study|Physician Decision|0|||
130704801|NCT00330460|470542801|FG000|Overall Study|Adverse Event|10|||
130704802|NCT00330460|470542802|FG001|Overall Study|Adverse Event|8|||
130704803|NCT00330460|470542801|FG000|Overall Study|Withdrawal by Subject|18|||
130704804|NCT00330460|470542802|FG001|Overall Study|Withdrawal by Subject|17|||
130704805|NCT00330460|470542801|FG000|Overall Study|Death|1|||
130704806|NCT00330460|470542802|FG001|Overall Study|Death|1|||
130704807|NCT00330460|470542801|FG000|Overall Study|Ineligibility determined|1|||
130704808|NCT00330460|470542802|FG001|Overall Study|Ineligibility determined|3|||
130704809|NCT00330460|470542801|FG000|Overall Study|Lost to Follow-up|8|||
130704810|NCT00330460|470542802|FG001|Overall Study|Lost to Follow-up|3|||
130704811|NCT00330460|470542801|FG000|Overall Study|Noncompliance|2|||
130704812|NCT00330460|470542802|FG001|Overall Study|Noncompliance|1|||
130704813|NCT00330460|470542801|FG000|Overall Study|Other|1|||
130704814|NCT00330460|470542802|FG001|Overall Study|Other|0|||
130704815|NCT02412722|470542803|FG000|Overall Study|Adverse Event|0|||
130704816|NCT02412722|470542804|FG001|Overall Study|Adverse Event|2|||
130704817|NCT02412722|470542805|FG002|Overall Study|Adverse Event|0|||
130704818|NCT02412722|470542806|FG003|Overall Study|Adverse Event|3|||
130704819|NCT02412722|470542807|FG004|Overall Study|Adverse Event|0|||
130704820|NCT02412722|470542808|FG005|Overall Study|Adverse Event|3|||
130704821|NCT02412722|470542803|FG000|Overall Study|Progressive Disease|6|||
130704822|NCT02412722|470542804|FG001|Overall Study|Progressive Disease|4|||
130704823|NCT02412722|470542805|FG002|Overall Study|Progressive Disease|4|||
130704824|NCT02412722|470542806|FG003|Overall Study|Progressive Disease|9|||
130704825|NCT02412722|470542807|FG004|Overall Study|Progressive Disease|3|||
130704826|NCT02412722|470542808|FG005|Overall Study|Progressive Disease|3|||
130704827|NCT02412722|470542803|FG000|Overall Study|Withdrawal by Subject|2|||
130704828|NCT02412722|470542804|FG001|Overall Study|Withdrawal by Subject|0|||
130704829|NCT02412722|470542805|FG002|Overall Study|Withdrawal by Subject|1|||
130704830|NCT02412722|470542806|FG003|Overall Study|Withdrawal by Subject|2|||
130704831|NCT02412722|470542807|FG004|Overall Study|Withdrawal by Subject|1|||
130704832|NCT02412722|470542808|FG005|Overall Study|Withdrawal by Subject|1|||
130704833|NCT02412722|470542803|FG000|Overall Study|Lost to Follow-up|0|||
130704834|NCT02412722|470542804|FG001|Overall Study|Lost to Follow-up|0|||
130704835|NCT02412722|470542805|FG002|Overall Study|Lost to Follow-up|0|||
130704836|NCT02412722|470542806|FG003|Overall Study|Lost to Follow-up|0|||
130704837|NCT02412722|470542807|FG004|Overall Study|Lost to Follow-up|1|||
130704838|NCT02412722|470542808|FG005|Overall Study|Lost to Follow-up|0|||
130704839|NCT02412722|470542803|FG000|Overall Study|Received drug in run-in and discontinued|0|||
130704840|NCT02412722|470542804|FG001|Overall Study|Received drug in run-in and discontinued|2|||
130704841|NCT02412722|470542805|FG002|Overall Study|Received drug in run-in and discontinued|0|||
130704842|NCT02412722|470542806|FG003|Overall Study|Received drug in run-in and discontinued|0|||
130704843|NCT02412722|470542807|FG004|Overall Study|Received drug in run-in and discontinued|0|||
130704844|NCT02412722|470542808|FG005|Overall Study|Received drug in run-in and discontinued|0|||
131121336|NCT02592018|472073911|FG000|Overall Study|Adverse Event|1|||
130704845|NCT02412722|470542803|FG000|Overall Study|Reason not Specified|3|||
131121337|NCT02592018|472073911|FG000|Overall Study|Lost to Follow-up|1|||
131223911|NCT04380701|472447128|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
130704846|NCT02412722|470542804|FG001|Overall Study|Reason not Specified|0|||
130704847|NCT02412722|470542805|FG002|Overall Study|Reason not Specified|2|||
130704848|NCT02412722|470542806|FG003|Overall Study|Reason not Specified|1|||
130704849|NCT02412722|470542807|FG004|Overall Study|Reason not Specified|2|||
130937309|NCT00708162|471404517|FG000|Open-Label Phase|Lack of Efficacy|7|||
130937310|NCT00708162|471404518|FG001|Open-Label Phase|Lack of Efficacy|4|||
130937311|NCT00708162|471404517|FG000|Open-Label Phase|Investigator's Discretion|3|||
130937312|NCT00708162|471404518|FG001|Open-Label Phase|Investigator's Discretion|2|||
131121338|NCT02710136|472073914|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
131223912|NCT04380701|472447129|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
131223913|NCT04380701|472447130|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
131223914|NCT04380701|472447131|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
131223915|NCT04380701|472447132|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
131223916|NCT04380701|472447133|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
131223917|NCT04380701|472447134|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
131223918|NCT04380701|472447135|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
131223919|NCT04380701|472447136|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
131223920|NCT04380701|472447137|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
131223921|NCT04380701|472447138|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
131223922|NCT04380701|472447139|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
131223923|NCT04380701|472447140|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
131223924|NCT04380701|472447141|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
131223925|NCT04380701|472447142|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
130704850|NCT02412722|470542808|FG005|Overall Study|Reason not Specified|6|||
130704851|NCT04449341|470542809|FG000|Overall Study|Protocol Violation|1|||
130937313|NCT00708162|471404517|FG000|Open-Label Phase|Death|3|||
130937314|NCT00708162|471404518|FG001|Open-Label Phase|Death|1|||
130937315|NCT00708162|471404517|FG000|Open-Label Phase|Adverse Event|1|||
130937316|NCT00708162|471404518|FG001|Open-Label Phase|Adverse Event|2|||
130937317|NCT00708162|471404517|FG000|Open-Label Phase|Other|1|||
130937318|NCT00708162|471404518|FG001|Open-Label Phase|Other|0|||
130937319|NCT00708643|471404519|FG000|Overall Study|Adverse Event|0|||
130937320|NCT00708643|471404520|FG001|Overall Study|Adverse Event|1|||
130937321|NCT02699554|471404521|FG000|Overall Study|Lost to Follow-up|9|||
130937322|NCT00788151|471404522|FG000|Overall Study|Other adverse event|0|||
130937323|NCT00788151|471404523|FG001|Overall Study|Other adverse event|2|||
130937324|NCT00788151|471404522|FG000|Overall Study|Protocol Violation|0|||
130937325|NCT00788151|471404523|FG001|Overall Study|Protocol Violation|1|||
130937326|NCT00788151|471404522|FG000|Overall Study|Withdrawal by Subject|13|||
130937327|NCT00788151|471404523|FG001|Overall Study|Withdrawal by Subject|6|||
130937328|NCT00788151|471404522|FG000|Overall Study|Enrolled but not treated|1|||
130937329|NCT00788151|471404523|FG001|Overall Study|Enrolled but not treated|1|||
130937330|NCT00503009|471404524|FG000|Overall Study|Protocol Violation|1|||
130937331|NCT00503009|471404525|FG001|Overall Study|Protocol Violation|0|||
130937332|NCT00503009|471404526|FG002|Overall Study|Protocol Violation|1|||
130937333|NCT00503009|471404524|FG000|Overall Study|Withdrawal by Subject|0|||
130937334|NCT00503009|471404525|FG001|Overall Study|Withdrawal by Subject|1|||
130937335|NCT00503009|471404526|FG002|Overall Study|Withdrawal by Subject|1|||
130937336|NCT00503009|471404524|FG000|Overall Study|Physician Decision|0|||
130937337|NCT00503009|471404525|FG001|Overall Study|Physician Decision|1|||
130937338|NCT00503009|471404526|FG002|Overall Study|Physician Decision|1|||
130937339|NCT01244906|471404527|FG000|Overall Study|Death|2|||
130937340|NCT01244906|471404527|FG000|Overall Study|Progression of disease post treatment|6|||
130937341|NCT03720470|471404528|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
130937342|NCT03720470|471404529|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
130937343|NCT03720470|471404530|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
131223926|NCT04380701|472447109|FG000|Overall Study|Physician Decision|0|||
131223927|NCT04380701|472447110|FG001|Overall Study|Physician Decision|0|||
131223928|NCT04380701|472447111|FG002|Overall Study|Physician Decision|0|||
131223929|NCT04380701|472447112|FG003|Overall Study|Physician Decision|0|||
131223930|NCT04380701|472447113|FG004|Overall Study|Physician Decision|0|||
130704852|NCT04449341|470542810|FG001|Overall Study|Protocol Violation|0|||
130704853|NCT04314843|470542811|FG000|Overall Study|Death|2|||
130704854|NCT04314843|470542812|FG001|Overall Study|Death|2|||
130704855|NCT04314843|470542811|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
130704856|NCT04314843|470542812|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
130704857|NCT01644149|470542813|FG000|Overall Study|Withdrawal by Subject|1|||
130704858|NCT01644149|470542814|FG001|Overall Study|Withdrawal by Subject|0|||
130704859|NCT01644149|470542813|FG000|Overall Study|Lost to Follow-up|3|||
130704860|NCT01644149|470542814|FG001|Overall Study|Lost to Follow-up|1|||
130704861|NCT05766787|470542815|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
130704862|NCT05766787|470542816|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
130704863|NCT05766787|470542815|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
130771141|NCT01796301|470789826|FG001|Overall Study|Withdrawal by Subject|15|||
130771142|NCT01796301|470789825|FG000|Overall Study|Lost to Follow-up|3|||
130771143|NCT01796301|470789826|FG001|Overall Study|Lost to Follow-up|3|||
130771144|NCT01796301|470789825|FG000|Overall Study|Death|0|||
130937344|NCT03720470|471404531|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
130937345|NCT03720470|471404532|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
130937346|NCT03720470|471404533|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
130937347|NCT03720470|471404528|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
130937348|NCT03720470|471404529|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
130937349|NCT03720470|471404530|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
131223931|NCT04380701|472447114|FG005|Overall Study|Physician Decision|0|||
130937350|NCT03720470|471404531|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
130937351|NCT03720470|471404532|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
130937352|NCT03720470|471404533|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
130937353|NCT03720470|471404528|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
130937354|NCT03720470|471404529|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
130937355|NCT03720470|471404530|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
130937356|NCT03720470|471404531|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
130937357|NCT03720470|471404532|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
130937358|NCT03720470|471404533|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
130937359|NCT03720470|471404528|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
130937360|NCT03720470|471404529|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
130937361|NCT03720470|471404530|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
130937362|NCT03720470|471404531|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
130937363|NCT03720470|471404532|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
130937364|NCT03720470|471404533|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
130937365|NCT03720470|471404528|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
130937366|NCT03720470|471404529|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
130937367|NCT03720470|471404530|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
130937368|NCT03720470|471404531|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
130937369|NCT03720470|471404532|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
130937370|NCT03720470|471404533|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
130937371|NCT03720470|471404528|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
130937372|NCT03720470|471404529|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
130937373|NCT03720470|471404530|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
130937374|NCT03720470|471404531|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
130937375|NCT03720470|471404532|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
130937376|NCT03720470|471404533|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
130937377|NCT03720470|471404528|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
130937378|NCT03720470|471404529|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
130937379|NCT03720470|471404530|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
130937380|NCT03720470|471404531|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
130937381|NCT03720470|471404532|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
130937382|NCT03720470|471404533|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
130937383|NCT03720470|471404528|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
130937384|NCT03720470|471404529|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
130937385|NCT03720470|471404530|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
130704864|NCT05766787|470542816|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
131035653|NCT04632992|471764054|FG007|Overall Study|Lost to Follow-up|1|||
131035654|NCT04632992|471764055|FG008|Overall Study|Lost to Follow-up|1|||
131035655|NCT04632992|471764056|FG009|Overall Study|Lost to Follow-up|1|||
131035656|NCT04632992|471764057|FG010|Overall Study|Lost to Follow-up|2|||
131035657|NCT04632992|471764058|FG011|Overall Study|Lost to Follow-up|0|||
131035658|NCT04632992|471764059|FG012|Overall Study|Lost to Follow-up|0|||
131035659|NCT04632992|471764060|FG013|Overall Study|Lost to Follow-up|0|||
131035660|NCT04632992|471764047|FG000|Overall Study|Reason not Specified|2|||
131035661|NCT04632992|471764048|FG001|Overall Study|Reason not Specified|0|||
131035662|NCT04632992|471764049|FG002|Overall Study|Reason not Specified|1|||
131035663|NCT04632992|471764050|FG003|Overall Study|Reason not Specified|1|||
131035664|NCT04632992|471764051|FG004|Overall Study|Reason not Specified|0|||
131035665|NCT04632992|471764052|FG005|Overall Study|Reason not Specified|0|||
131035666|NCT04632992|471764053|FG006|Overall Study|Reason not Specified|0|||
131035667|NCT04632992|471764054|FG007|Overall Study|Reason not Specified|0|||
131035668|NCT04632992|471764055|FG008|Overall Study|Reason not Specified|0|||
131035669|NCT04632992|471764056|FG009|Overall Study|Reason not Specified|0|||
131035670|NCT04632992|471764057|FG010|Overall Study|Reason not Specified|1|||
131035671|NCT04632992|471764058|FG011|Overall Study|Reason not Specified|0|||
131035672|NCT04632992|471764059|FG012|Overall Study|Reason not Specified|0|||
131035673|NCT04632992|471764060|FG013|Overall Study|Reason not Specified|0|||
131035674|NCT04632992|471764047|FG000|Overall Study|Physician Decision|0|||
131035675|NCT04632992|471764048|FG001|Overall Study|Physician Decision|0|||
131035676|NCT04632992|471764049|FG002|Overall Study|Physician Decision|0|||
131035677|NCT04632992|471764050|FG003|Overall Study|Physician Decision|2|||
131035678|NCT04632992|471764051|FG004|Overall Study|Physician Decision|1|||
131035679|NCT04632992|471764052|FG005|Overall Study|Physician Decision|0|||
131035680|NCT04632992|471764053|FG006|Overall Study|Physician Decision|0|||
131035681|NCT04632992|471764054|FG007|Overall Study|Physician Decision|0|||
131035682|NCT04632992|471764055|FG008|Overall Study|Physician Decision|0|||
131035683|NCT04632992|471764056|FG009|Overall Study|Physician Decision|0|||
131223932|NCT04380701|472447115|FG006|Overall Study|Physician Decision|0|||
131223933|NCT04380701|472447116|FG007|Overall Study|Physician Decision|0|||
131223934|NCT04380701|472447117|FG008|Overall Study|Physician Decision|0|||
131223935|NCT04380701|472447118|FG009|Overall Study|Physician Decision|0|||
131223936|NCT04380701|472447119|FG010|Overall Study|Physician Decision|0|||
131223937|NCT04380701|472447120|FG011|Overall Study|Physician Decision|0|||
131223938|NCT04380701|472447121|FG012|Overall Study|Physician Decision|0|||
131223939|NCT04380701|472447122|FG013|Overall Study|Physician Decision|0|||
131223940|NCT04380701|472447123|FG014|Overall Study|Physician Decision|0|||
131223941|NCT04380701|472447124|FG015|Overall Study|Physician Decision|0|||
131223942|NCT04380701|472447125|FG016|Overall Study|Physician Decision|0|||
131223943|NCT04380701|472447126|FG017|Overall Study|Physician Decision|0|||
131223944|NCT04380701|472447127|FG018|Overall Study|Physician Decision|0|||
131223945|NCT04380701|472447128|FG019|Overall Study|Physician Decision|0|||
131223946|NCT04380701|472447129|FG020|Overall Study|Physician Decision|0|||
131223947|NCT04380701|472447130|FG021|Overall Study|Physician Decision|0|||
131223948|NCT04380701|472447131|FG022|Overall Study|Physician Decision|0|||
131223949|NCT04380701|472447132|FG023|Overall Study|Physician Decision|0|||
131223950|NCT04380701|472447133|FG024|Overall Study|Physician Decision|2|||
131223951|NCT04380701|472447134|FG025|Overall Study|Physician Decision|0|||
131223952|NCT04380701|472447135|FG026|Overall Study|Physician Decision|0|||
131223953|NCT04380701|472447136|FG027|Overall Study|Physician Decision|0|||
131223954|NCT04380701|472447137|FG028|Overall Study|Physician Decision|0|||
131223955|NCT04380701|472447138|FG029|Overall Study|Physician Decision|0|||
131223956|NCT04380701|472447139|FG030|Overall Study|Physician Decision|0|||
130704865|NCT05766787|470542815|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
130704866|NCT05766787|470542816|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
130937386|NCT03720470|471404531|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
130937387|NCT03720470|471404532|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
130937388|NCT03720470|471404533|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
130937389|NCT03720470|471404528|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
130937390|NCT03720470|471404529|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
130937391|NCT03720470|471404530|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
130937392|NCT03720470|471404531|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
130937393|NCT03720470|471404532|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
131035684|NCT04632992|471764057|FG010|Overall Study|Physician Decision|0|||
131035685|NCT04632992|471764058|FG011|Overall Study|Physician Decision|0|||
131035686|NCT04632992|471764059|FG012|Overall Study|Physician Decision|3|||
131035687|NCT04632992|471764060|FG013|Overall Study|Physician Decision|0|||
131035688|NCT04632992|471764047|FG000|Overall Study|Progressive Disease|0|||
131035689|NCT04632992|471764048|FG001|Overall Study|Progressive Disease|0|||
131035690|NCT04632992|471764049|FG002|Overall Study|Progressive Disease|0|||
131035691|NCT04632992|471764050|FG003|Overall Study|Progressive Disease|0|||
131035692|NCT04632992|471764051|FG004|Overall Study|Progressive Disease|1|||
131035693|NCT04632992|471764052|FG005|Overall Study|Progressive Disease|0|||
131035694|NCT04632992|471764053|FG006|Overall Study|Progressive Disease|0|||
131035695|NCT04632992|471764054|FG007|Overall Study|Progressive Disease|0|||
131035696|NCT04632992|471764055|FG008|Overall Study|Progressive Disease|0|||
131035697|NCT04632992|471764056|FG009|Overall Study|Progressive Disease|1|||
131035698|NCT04632992|471764057|FG010|Overall Study|Progressive Disease|1|||
131035699|NCT04632992|471764058|FG011|Overall Study|Progressive Disease|0|||
131035700|NCT04632992|471764059|FG012|Overall Study|Progressive Disease|2|||
131035701|NCT04632992|471764060|FG013|Overall Study|Progressive Disease|0|||
131035702|NCT04632992|471764047|FG000|Overall Study|Withdrawal by Subject|4|||
131035703|NCT04632992|471764048|FG001|Overall Study|Withdrawal by Subject|1|||
131035704|NCT04632992|471764049|FG002|Overall Study|Withdrawal by Subject|5|||
131035705|NCT04632992|471764050|FG003|Overall Study|Withdrawal by Subject|4|||
131035706|NCT04632992|471764051|FG004|Overall Study|Withdrawal by Subject|3|||
131035707|NCT04632992|471764052|FG005|Overall Study|Withdrawal by Subject|3|||
131035708|NCT04632992|471764053|FG006|Overall Study|Withdrawal by Subject|0|||
131035709|NCT04632992|471764054|FG007|Overall Study|Withdrawal by Subject|5|||
131035710|NCT04632992|471764055|FG008|Overall Study|Withdrawal by Subject|0|||
131223957|NCT04380701|472447140|FG031|Overall Study|Physician Decision|0|||
130937394|NCT03720470|471404533|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
130937395|NCT03720470|471404528|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
131035711|NCT04632992|471764056|FG009|Overall Study|Withdrawal by Subject|2|||
131035712|NCT04632992|471764057|FG010|Overall Study|Withdrawal by Subject|8|||
131223958|NCT04380701|472447141|FG032|Overall Study|Physician Decision|0|||
131035713|NCT04632992|471764058|FG011|Overall Study|Withdrawal by Subject|0|||
131035714|NCT04632992|471764059|FG012|Overall Study|Withdrawal by Subject|1|||
131035715|NCT04632992|471764060|FG013|Overall Study|Withdrawal by Subject|1|||
131035716|NCT05647304|471764061|FG000|Overall Study|Withdrawal by Subject|1|||
131223959|NCT04380701|472447142|FG033|Overall Study|Physician Decision|0|||
131223960|NCT04380701|472447109|FG000|Overall Study|Death|0|||
131223961|NCT04380701|472447110|FG001|Overall Study|Death|0|||
131223962|NCT04380701|472447111|FG002|Overall Study|Death|0|||
131035717|NCT05647304|471764062|FG001|Overall Study|Withdrawal by Subject|0|||
131035718|NCT03092518|471764064|FG000|Overall Study|Ineligible|2|||
131035719|NCT03603600|471764067|FG000|Overall Study|Withdrawal by Subject|5|||
131035720|NCT03603600|471764068|FG001|Overall Study|Withdrawal by Subject|7|||
131035721|NCT03603600|471764067|FG000|Overall Study|Lost to Follow-up|2|||
131035722|NCT03603600|471764068|FG001|Overall Study|Lost to Follow-up|3|||
131035723|NCT03603600|471764067|FG000|Overall Study|Death|3|||
131035724|NCT03603600|471764068|FG001|Overall Study|Death|1|||
131035725|NCT03603600|471764067|FG000|Overall Study|Physician Decision|2|||
131035726|NCT03603600|471764068|FG001|Overall Study|Physician Decision|1|||
131035727|NCT03603600|471764067|FG000|Overall Study|Other reason|1|||
131035728|NCT03603600|471764068|FG001|Overall Study|Other reason|0|||
131035729|NCT05084508|471764069|FG000|Overall Study|Lost to Follow-up|6|||
131035730|NCT05084508|471764070|FG001|Overall Study|Lost to Follow-up|3|||
131035731|NCT05084508|471764071|FG002|Overall Study|Lost to Follow-up|7|||
131035732|NCT05084508|471764072|FG003|Overall Study|Lost to Follow-up|3|||
131035733|NCT05084508|471764069|FG000|Overall Study|Withdrawal by Subject|0|||
131035734|NCT05084508|471764070|FG001|Overall Study|Withdrawal by Subject|2|||
131035735|NCT05084508|471764071|FG002|Overall Study|Withdrawal by Subject|3|||
131035736|NCT05084508|471764072|FG003|Overall Study|Withdrawal by Subject|1|||
131035737|NCT05084508|471764069|FG000|Overall Study|Other|0|||
131035738|NCT05084508|471764070|FG001|Overall Study|Other|0|||
131035739|NCT05084508|471764071|FG002|Overall Study|Other|0|||
131035740|NCT05084508|471764072|FG003|Overall Study|Other|1|||
131035741|NCT03812679|471766137|FG000|Overall Study|Adverse Event|2|||
131035742|NCT03812679|471766137|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
131035743|NCT03812679|471766137|FG000|Overall Study|Renal transplant|1|||
131035744|NCT03812679|471766137|FG000|Overall Study|Withdrawal by Subject|1|||
131035745|NCT03812679|471766137|FG000|Overall Study|Termination of study|2|||
131035746|NCT03812679|471766137|FG000|Overall Study|Water device replacement|1|||
131035747|NCT05653427|471766138|FG000|Overall Study|Study Terminated by Sponsor|13|||
131035748|NCT05486078|471766146|FG000|Overall Study|4 drop out and one withdrawn|5|||
131035749|NCT04256941|471766147|FG000|Overall Study|Withdrawal by Subject|0|||
131035750|NCT04256941|471766148|FG001|Overall Study|Withdrawal by Subject|1|||
131035751|NCT04256941|471766147|FG000|Overall Study|Death|1|||
131035752|NCT04256941|471766148|FG001|Overall Study|Death|0|||
131035753|NCT04256941|471766147|FG000|Overall Study|Disease Progession|0|||
131035754|NCT04256941|471766148|FG001|Overall Study|Disease Progession|2|||
131035755|NCT04728347|471766155|FG000|Overall Study|Sponsor decision|0|||
131035756|NCT04728347|471766156|FG001|Overall Study|Sponsor decision|0|||
131035757|NCT04728347|471766157|FG002|Overall Study|Sponsor decision|1|||
131035758|NCT04728347|471766158|FG003|Overall Study|Sponsor decision|0|||
131035759|NCT03766009|471766160|FG000|Usual Care|Death|0|||
131035760|NCT03766009|471766161|FG001|Usual Care|Death|0|||
131035761|NCT03766009|471766162|FG002|Usual Care|Death|0|||
131035762|NCT03766009|471766163|FG003|Usual Care|Death|1|||
131035763|NCT03766009|471766164|FG004|Usual Care|Death|0|||
131035764|NCT03766009|471766165|FG005|Usual Care|Death|0|||
131035765|NCT03766009|471766160|FG000|Usual Care|Lost to Follow-up|0|||
131035766|NCT03766009|471766161|FG001|Usual Care|Lost to Follow-up|0|||
131035767|NCT03766009|471766162|FG002|Usual Care|Lost to Follow-up|0|||
131035768|NCT03766009|471766163|FG003|Usual Care|Lost to Follow-up|1|||
131035769|NCT03766009|471766164|FG004|Usual Care|Lost to Follow-up|0|||
131035770|NCT03766009|471766165|FG005|Usual Care|Lost to Follow-up|0|||
131035771|NCT03766009|471766160|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
131035772|NCT03766009|471766161|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
131035773|NCT03766009|471766162|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
131121339|NCT02710136|472073915|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
131121340|NCT00418665|472073916|FG000|Treatment Period|Ineligibility determined|1|||
131121341|NCT00418665|472073917|FG001|Treatment Period|Ineligibility determined|1|||
131121342|NCT00418665|472073918|FG002|Treatment Period|Ineligibility determined|0|||
131121343|NCT00418665|472073916|FG000|Treatment Period|Adverse Event|2|||
131121344|NCT00418665|472073917|FG001|Treatment Period|Adverse Event|2|||
131121345|NCT00418665|472073918|FG002|Treatment Period|Adverse Event|0|||
131035774|NCT03766009|471766163|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
131035775|NCT03766009|471766164|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
131035776|NCT03766009|471766165|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
131035777|NCT03766009|471766160|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
131035778|NCT03766009|471766161|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
131035779|NCT03766009|471766162|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
131035780|NCT03766009|471766163|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
131035781|NCT03766009|471766164|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
131035782|NCT03766009|471766165|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
131035783|NCT03766009|471766160|FG000|Usual Care|No treatment or declined surgery|0|||
131035784|NCT03766009|471766161|FG001|Usual Care|No treatment or declined surgery|0|||
131035785|NCT03766009|471766162|FG002|Usual Care|No treatment or declined surgery|0|||
131035786|NCT03766009|471766163|FG003|Usual Care|No treatment or declined surgery|2|||
131035787|NCT03766009|471766164|FG004|Usual Care|No treatment or declined surgery|0|||
131035788|NCT03766009|471766165|FG005|Usual Care|No treatment or declined surgery|0|||
131035789|NCT03766009|471766160|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
131035790|NCT03766009|471766161|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
131035791|NCT03766009|471766162|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
131035792|NCT03766009|471766163|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
131035793|NCT03766009|471766164|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
131035794|NCT03766009|471766165|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
131035795|NCT03766009|471766160|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
131035796|NCT03766009|471766161|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
131035797|NCT03766009|471766162|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
131035798|NCT03766009|471766163|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
131035799|NCT03766009|471766164|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
131035800|NCT03766009|471766165|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
131035801|NCT03766009|471766160|FG000|Usual Care|Ineligible|0|||
131035802|NCT03766009|471766161|FG001|Usual Care|Ineligible|1|||
131035803|NCT03766009|471766162|FG002|Usual Care|Ineligible|0|||
131035804|NCT03766009|471766163|FG003|Usual Care|Ineligible|0|||
131035805|NCT03766009|471766164|FG004|Usual Care|Ineligible|0|||
131035806|NCT03766009|471766165|FG005|Usual Care|Ineligible|0|||
131035807|NCT03766009|471766160|FG000|Usual Care|Other: Staff turnover|0|||
131035808|NCT03766009|471766161|FG001|Usual Care|Other: Staff turnover|0|||
131035809|NCT03766009|471766162|FG002|Usual Care|Other: Staff turnover|0|||
131035810|NCT03766009|471766163|FG003|Usual Care|Other: Staff turnover|0|||
131035811|NCT03766009|471766164|FG004|Usual Care|Other: Staff turnover|0|||
131035812|NCT03766009|471766165|FG005|Usual Care|Other: Staff turnover|2|||
131035813|NCT04526704|471766170|FG000|Overall Study|Adverse Event|1|||
131035814|NCT04526704|471766171|FG001|Overall Study|Adverse Event|0|||
131121346|NCT00418665|472073916|FG000|Treatment Period|Withdrawal by Subject|0|||
131121347|NCT00418665|472073917|FG001|Treatment Period|Withdrawal by Subject|3|||
131121348|NCT00418665|472073918|FG002|Treatment Period|Withdrawal by Subject|1|||
130771145|NCT01796301|470789826|FG001|Overall Study|Death|1|||
130771146|NCT01796301|470789825|FG000|Overall Study|Decision by Sponsor|0|||
130771147|NCT01796301|470789826|FG001|Overall Study|Decision by Sponsor|1|||
130771148|NCT00667563|470789827|FG000|Overall Study|Protocol Violation|24|||
130771149|NCT02187029|470789829|FG000|Overall Study|Adverse Event|0|||
130771150|NCT02187029|470789830|FG001|Overall Study|Adverse Event|1|||
130771151|NCT02187029|470789831|FG002|Overall Study|Adverse Event|1|||
130771152|NCT02187029|470789832|FG003|Overall Study|Adverse Event|0|||
130771153|NCT02187029|470789829|FG000|Overall Study|Study Terminated by Sponsor|0|||
130771154|NCT02187029|470789830|FG001|Overall Study|Study Terminated by Sponsor|0|||
130771155|NCT02187029|470789831|FG002|Overall Study|Study Terminated by Sponsor|10|||
130771156|NCT02187029|470789832|FG003|Overall Study|Study Terminated by Sponsor|3|||
130771157|NCT02187029|470789829|FG000|Overall Study|Withdrawal by Subject|1|||
130771158|NCT02187029|470789830|FG001|Overall Study|Withdrawal by Subject|0|||
130771159|NCT02187029|470789831|FG002|Overall Study|Withdrawal by Subject|0|||
130771160|NCT02187029|470789832|FG003|Overall Study|Withdrawal by Subject|0|||
130771161|NCT03042910|470789833|FG000|Overall Study|Adverse Event|1|||
130771162|NCT03042910|470789833|FG000|Overall Study|Disease Progression|2|||
130771163|NCT03042910|470789833|FG000|Overall Study|Withdrawal by Subject|3|||
130771164|NCT03042910|470789833|FG000|Overall Study|Enrolled but not treated|1|||
130771165|NCT02756819|470789837|FG000|Overall Study|Lost for observation|23|||
130771166|NCT02756819|470789837|FG000|Overall Study|Patient's unwillingness|16|||
130771167|NCT02756819|470789837|FG000|Overall Study|Insufficient efficacy|2|||
130771168|NCT02756819|470789837|FG000|Overall Study|Adverse Event|2|||
130771169|NCT02756819|470789837|FG000|Overall Study|Reason not Specified|9|||
130771170|NCT01491841|470789839|FG000|Overall Study|Screen Failure|10|||
130771171|NCT01491841|470789839|FG000|Overall Study|Withdrawal by Subject|1|||
130771172|NCT02933528|470789840|FG000|Overall Study|Lost to Follow-up|2|||
130771173|NCT01301079|470789841|FG000|Overall Study|Lost to Follow-up|2|||
130771174|NCT01301079|470789842|FG001|Overall Study|Lost to Follow-up|2|||
130771175|NCT00264290|470789846|FG000|Intervention (8 Weeks)|Adverse Event|1|||
130771176|NCT00264290|470789847|FG001|Intervention (8 Weeks)|Adverse Event|0|||
131035815|NCT04526704|471766170|FG000|Overall Study|Physician Decision|1|||
130771177|NCT02496039|470789848|FG000|Overall Study|Adverse Event|3|||
130771178|NCT02496039|470789848|FG000|Overall Study|Protocol Violation|1|||
130771179|NCT04472494|470789849|FG000|Pre-treatment|Other reasons|2|||
130771180|NCT04472494|470789850|FG001|Pre-treatment|Other reasons|0|||
131035816|NCT04526704|471766171|FG001|Overall Study|Physician Decision|0|||
130771181|NCT04472494|470789849|FG000|Treatment|Death|5|||
131035817|NCT04526704|471766170|FG000|Overall Study|Withdrawal by Subject|2|||
131035818|NCT04526704|471766171|FG001|Overall Study|Withdrawal by Subject|0|||
130771182|NCT04472494|470789850|FG001|Treatment|Death|2|||
130771183|NCT04472494|470789849|FG000|Treatment|Hospital discharge|1|||
130704867|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
130704868|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
130704869|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
130704870|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
130937396|NCT03720470|471404529|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
130937397|NCT03720470|471404530|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
130937398|NCT03720470|471404531|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
130937399|NCT03720470|471404532|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
130937400|NCT03720470|471404533|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
130937401|NCT03720470|471404528|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130937402|NCT03720470|471404529|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130937403|NCT03720470|471404530|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
130937404|NCT03720470|471404531|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130937405|NCT03720470|471404532|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130937406|NCT03720470|471404533|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130937407|NCT03720470|471404528|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
130937408|NCT03720470|471404529|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
130937409|NCT03720470|471404530|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
130937410|NCT03720470|471404531|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
130937411|NCT03720470|471404532|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
130937412|NCT03720470|471404533|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
130937413|NCT03720470|471404528|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
130937414|NCT03720470|471404529|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
130937415|NCT03720470|471404530|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
130937416|NCT03720470|471404531|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
130937417|NCT03720470|471404532|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
130937418|NCT03720470|471404533|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
130937419|NCT03720470|471404528|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
130937420|NCT03720470|471404529|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
130937421|NCT03720470|471404530|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
130937422|NCT03720470|471404531|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
130937423|NCT03720470|471404532|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
130937424|NCT03720470|471404533|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
130937425|NCT03720470|471404528|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
130937426|NCT03720470|471404529|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
130937427|NCT03720470|471404530|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
130937428|NCT03720470|471404531|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
130937429|NCT03720470|471404532|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
130937430|NCT03720470|471404533|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
130937431|NCT03720470|471404528|FG000|Treatment Period: Final 4 Weeks|Other|0|||
130937432|NCT03720470|471404529|FG001|Treatment Period: Final 4 Weeks|Other|1|||
131121349|NCT00418665|472073916|FG000|Treatment Period|Requirement for alternative therapy|1|||
131121350|NCT00418665|472073917|FG001|Treatment Period|Requirement for alternative therapy|0|||
131121351|NCT00418665|472073918|FG002|Treatment Period|Requirement for alternative therapy|0|||
131121352|NCT00418665|472073916|FG000|Treatment Period|Physician Decision|1|||
131121353|NCT00418665|472073917|FG001|Treatment Period|Physician Decision|0|||
131121354|NCT00418665|472073918|FG002|Treatment Period|Physician Decision|3|||
131121355|NCT00418665|472073916|FG000|Treatment Extension|Adverse Event|1|||
131121356|NCT00418665|472073917|FG001|Treatment Extension|Adverse Event|0|||
130937433|NCT03720470|471404530|FG002|Treatment Period: Final 4 Weeks|Other|0|||
130937434|NCT03720470|471404531|FG003|Treatment Period: Final 4 Weeks|Other|2|||
130704871|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
130704872|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
130704873|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
130937435|NCT03720470|471404532|FG004|Treatment Period: Final 4 Weeks|Other|1|||
130937436|NCT03720470|471404533|FG005|Treatment Period: Final 4 Weeks|Other|0|||
130937437|NCT01946425|471404534|FG000|Overall Study|Protocol Violation|1|||
130937438|NCT01946425|471404535|FG001|Overall Study|Protocol Violation|0|||
130937439|NCT01946425|471404534|FG000|Overall Study|Withdrawal by Subject|1|||
130937440|NCT01946425|471404535|FG001|Overall Study|Withdrawal by Subject|0|||
130937441|NCT01113801|471404536|FG000|Overall Study|Adverse Event|4|||
130937442|NCT01113801|471404537|FG001|Overall Study|Adverse Event|0|||
131121357|NCT00418665|472073918|FG002|Treatment Extension|Adverse Event|0|||
131121358|NCT00418665|472073916|FG000|Treatment Extension|Withdrawal by Subject|1|||
130704874|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
130771184|NCT04472494|470789850|FG001|Treatment|Hospital discharge|1|||
130937443|NCT01113801|471404538|FG002|Overall Study|Adverse Event|2|||
130937444|NCT01113801|471404539|FG003|Overall Study|Adverse Event|6|||
130937445|NCT01113801|471404536|FG000|Overall Study|Death|4|||
131121359|NCT00418665|472073917|FG001|Treatment Extension|Withdrawal by Subject|0|||
131121360|NCT00418665|472073918|FG002|Treatment Extension|Withdrawal by Subject|0|||
131121361|NCT00418665|472073916|FG000|Treatment Extension|Requirement for alternative therapy|2|||
130937446|NCT01113801|471404537|FG001|Overall Study|Death|5|||
130937447|NCT01113801|471404538|FG002|Overall Study|Death|3|||
130937448|NCT01113801|471404539|FG003|Overall Study|Death|4|||
130937449|NCT01113801|471404536|FG000|Overall Study|Protocol Violation|0|||
130937450|NCT01113801|471404537|FG001|Overall Study|Protocol Violation|1|||
130937451|NCT01113801|471404538|FG002|Overall Study|Protocol Violation|0|||
130937452|NCT01113801|471404539|FG003|Overall Study|Protocol Violation|0|||
130937453|NCT01113801|471404536|FG000|Overall Study|Withdrawal by Subject|9|||
130937454|NCT01113801|471404537|FG001|Overall Study|Withdrawal by Subject|7|||
130937455|NCT01113801|471404538|FG002|Overall Study|Withdrawal by Subject|7|||
130771185|NCT00571103|470789851|FG000|Overall Study|Withdrawal by Subject|1|||
130937456|NCT01113801|471404539|FG003|Overall Study|Withdrawal by Subject|8|||
130937457|NCT01113801|471404536|FG000|Overall Study|Physician Decision|2|||
130937458|NCT01113801|471404537|FG001|Overall Study|Physician Decision|2|||
130937459|NCT01113801|471404538|FG002|Overall Study|Physician Decision|3|||
130937460|NCT01113801|471404539|FG003|Overall Study|Physician Decision|3|||
130937461|NCT01113801|471404536|FG000|Overall Study|Sponsor Decision|15|||
130937462|NCT01113801|471404537|FG001|Overall Study|Sponsor Decision|21|||
130937463|NCT01113801|471404538|FG002|Overall Study|Sponsor Decision|20|||
130937464|NCT01113801|471404539|FG003|Overall Study|Sponsor Decision|15|||
130937465|NCT01113801|471404536|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
130937466|NCT01113801|471404537|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
130937467|NCT01113801|471404538|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
130937468|NCT01113801|471404539|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
130937469|NCT01506479|471404540|FG000|Overall Study|Lost to Follow-up|1|||
130937470|NCT01506479|471404541|FG001|Overall Study|Lost to Follow-up|2|||
130937471|NCT01506479|471404542|FG002|Overall Study|Lost to Follow-up|2|||
130937472|NCT01506479|471404540|FG000|Overall Study|Withdrawal by Subject|1|||
130937473|NCT01506479|471404541|FG001|Overall Study|Withdrawal by Subject|2|||
130937474|NCT01506479|471404542|FG002|Overall Study|Withdrawal by Subject|1|||
130937475|NCT01506479|471404540|FG000|Overall Study|Missing assessment|1|||
130937476|NCT01506479|471404541|FG001|Overall Study|Missing assessment|0|||
130937477|NCT01506479|471404542|FG002|Overall Study|Missing assessment|0|||
130937478|NCT01506479|471404540|FG000|Overall Study|Adverse Event|0|||
130937479|NCT01506479|471404541|FG001|Overall Study|Adverse Event|1|||
130771186|NCT00571103|470789851|FG000|Overall Study|Lost to Follow-up|1|||
130937480|NCT01506479|471404542|FG002|Overall Study|Adverse Event|0|||
130937481|NCT01782859|471404543|FG000|Overall Study|Protocol Violation|6|||
130937482|NCT01782859|471404544|FG001|Overall Study|Protocol Violation|6|||
130937483|NCT01782859|471404543|FG000|Overall Study|Withdrawal by Subject|0|||
130937484|NCT01782859|471404544|FG001|Overall Study|Withdrawal by Subject|1|||
130937485|NCT03318315|471404547|FG000|Overall Study|Lost to Follow-up|3|||
130937486|NCT03318315|471404548|FG001|Overall Study|Lost to Follow-up|2|||
130937487|NCT03318315|471404549|FG002|Overall Study|Lost to Follow-up|1|||
130937488|NCT03318315|471404547|FG000|Overall Study|Protocol Violation|1|||
130937489|NCT03318315|471404548|FG001|Overall Study|Protocol Violation|1|||
130937490|NCT03318315|471404549|FG002|Overall Study|Protocol Violation|1|||
130937491|NCT03318315|471404547|FG000|Overall Study|Withdrawal by Subject|0|||
130937492|NCT03318315|471404548|FG001|Overall Study|Withdrawal by Subject|0|||
130937493|NCT03318315|471404549|FG002|Overall Study|Withdrawal by Subject|2|||
130937494|NCT01896531|471404550|FG000|Overall Study|Death|57|||
130937495|NCT01896531|471404551|FG001|Overall Study|Death|59|||
130937496|NCT01896531|471404550|FG000|Overall Study|Lost to Follow-up|3|||
130937497|NCT01896531|471404551|FG001|Overall Study|Lost to Follow-up|0|||
130937498|NCT01896531|471404550|FG000|Overall Study|Non-compliance|0|||
130937499|NCT01896531|471404551|FG001|Overall Study|Non-compliance|1|||
130937500|NCT01896531|471404550|FG000|Overall Study|Study Ended by Sponsor|7|||
130937501|NCT01896531|471404551|FG001|Overall Study|Study Ended by Sponsor|20|||
130937502|NCT01896531|471404550|FG000|Overall Study|Withdrawal by Subject|3|||
130937503|NCT01896531|471404551|FG001|Overall Study|Withdrawal by Subject|2|||
130937504|NCT01896531|471404550|FG000|Overall Study|Death Prior to Treatment|1|||
130937505|NCT01896531|471404551|FG001|Overall Study|Death Prior to Treatment|0|||
130937506|NCT00770289|471404554|FG000|Overall Study|Other|6|||
130937507|NCT02659631|471404555|FG000|Overall Study|Lost to Follow-up|0|||
130937508|NCT02659631|471404556|FG001|Overall Study|Lost to Follow-up|0|||
130937509|NCT02659631|471404557|FG002|Overall Study|Lost to Follow-up|2|||
130771187|NCT01308463|470789852|FG000|Overall Study|Study Discontinued|23|||
130937510|NCT02659631|471404558|FG003|Overall Study|Lost to Follow-up|0|||
130937511|NCT02659631|471404559|FG004|Overall Study|Lost to Follow-up|0|||
130937512|NCT02659631|471404560|FG005|Overall Study|Lost to Follow-up|1|||
130937513|NCT02659631|471404561|FG006|Overall Study|Lost to Follow-up|0|||
130937514|NCT02659631|471404562|FG007|Overall Study|Lost to Follow-up|0|||
130937515|NCT02659631|471404563|FG008|Overall Study|Lost to Follow-up|0|||
130937516|NCT02659631|471404564|FG009|Overall Study|Lost to Follow-up|0|||
130937517|NCT02659631|471404555|FG000|Overall Study|Withdrawal prior to treatment|0|||
131121362|NCT00418665|472073917|FG001|Treatment Extension|Requirement for alternative therapy|2|||
130937518|NCT02659631|471404556|FG001|Overall Study|Withdrawal prior to treatment|0|||
130937519|NCT02659631|471404557|FG002|Overall Study|Withdrawal prior to treatment|0|||
130937520|NCT02659631|471404558|FG003|Overall Study|Withdrawal prior to treatment|0|||
130937521|NCT02659631|471404559|FG004|Overall Study|Withdrawal prior to treatment|1|||
130937522|NCT02659631|471404560|FG005|Overall Study|Withdrawal prior to treatment|0|||
130937523|NCT02659631|471404561|FG006|Overall Study|Withdrawal prior to treatment|0|||
130937524|NCT02659631|471404562|FG007|Overall Study|Withdrawal prior to treatment|0|||
130937525|NCT02659631|471404563|FG008|Overall Study|Withdrawal prior to treatment|0|||
130937526|NCT02659631|471404564|FG009|Overall Study|Withdrawal prior to treatment|0|||
130937527|NCT02659631|471404555|FG000|Overall Study|Participant refused further follow-up|0|||
130937528|NCT02659631|471404556|FG001|Overall Study|Participant refused further follow-up|0|||
130937529|NCT02659631|471404557|FG002|Overall Study|Participant refused further follow-up|0|||
130937530|NCT02659631|471404558|FG003|Overall Study|Participant refused further follow-up|1|||
131035819|NCT02737436|471766172|FG000|Washout Period|Lost to Follow-up|5|||
131035820|NCT02737436|471766173|FG001|Washout Period|Lost to Follow-up|11|||
131121363|NCT00418665|472073918|FG002|Treatment Extension|Requirement for alternative therapy|0|||
131121364|NCT00418665|472073916|FG000|Treatment Extension|Physician Decision|2|||
131121365|NCT00418665|472073917|FG001|Treatment Extension|Physician Decision|2|||
131121366|NCT00418665|472073918|FG002|Treatment Extension|Physician Decision|1|||
131121367|NCT00418665|472073916|FG000|Treatment Extension|Death|0|||
131121368|NCT00418665|472073917|FG001|Treatment Extension|Death|0|||
131121369|NCT00418665|472073918|FG002|Treatment Extension|Death|1|||
131121370|NCT01133379|472073921|FG000|Overall Study|Withdrawal by Subject|0|||
131121371|NCT01133379|472073922|FG001|Overall Study|Withdrawal by Subject|1|||
131121372|NCT01133379|472073923|FG002|Overall Study|Withdrawal by Subject|1|||
131121373|NCT01133379|472073921|FG000|Overall Study|Lost to Follow-up|1|||
131121374|NCT01133379|472073922|FG001|Overall Study|Lost to Follow-up|1|||
131121375|NCT01133379|472073923|FG002|Overall Study|Lost to Follow-up|1|||
131121376|NCT03861936|472074874|FG000|Overall Study|Withdrawal by Subject|4|||
131121377|NCT03861936|472074875|FG001|Overall Study|Withdrawal by Subject|1|||
131121378|NCT03861936|472074876|FG002|Overall Study|Withdrawal by Subject|3|||
131121379|NCT03861936|472074874|FG000|Overall Study|Lost to Follow-up|5|||
131121380|NCT03861936|472074875|FG001|Overall Study|Lost to Follow-up|3|||
131121381|NCT03861936|472074876|FG002|Overall Study|Lost to Follow-up|3|||
131121382|NCT03861936|472074874|FG000|Overall Study|Physician Decision|0|||
131121383|NCT03861936|472074875|FG001|Overall Study|Physician Decision|1|||
131121384|NCT03861936|472074876|FG002|Overall Study|Physician Decision|0|||
131121385|NCT03861936|472074874|FG000|Overall Study|Protocol Deviation|0|||
131121386|NCT03861936|472074875|FG001|Overall Study|Protocol Deviation|0|||
131121387|NCT03861936|472074876|FG002|Overall Study|Protocol Deviation|1|||
131121388|NCT03861936|472074874|FG000|Overall Study|Reason not Specified|5|||
131121389|NCT03861936|472074875|FG001|Overall Study|Reason not Specified|5|||
131121390|NCT03861936|472074876|FG002|Overall Study|Reason not Specified|3|||
131121391|NCT01236573|472074877|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131121392|NCT01236573|472074878|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131121393|NCT01236573|472074879|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131121394|NCT01236573|472074880|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131121395|NCT01236573|472074881|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131035821|NCT02737436|471766172|FG000|Data Analysis|Scanning data problems|5|||
131035822|NCT02737436|471766173|FG001|Data Analysis|Scanning data problems|8|||
131035823|NCT02105766|471766174|FG000|Overall Study|Physician Decision|1|||
131035824|NCT02105766|471766175|FG001|Overall Study|Physician Decision|1|||
131035825|NCT02105766|471766176|FG002|Overall Study|Physician Decision|0|||
131035826|NCT02105766|471766174|FG000|Overall Study|Lost to Follow-up|2|||
131035827|NCT02105766|471766175|FG001|Overall Study|Lost to Follow-up|0|||
131035828|NCT02105766|471766176|FG002|Overall Study|Lost to Follow-up|0|||
131035829|NCT02105766|471766174|FG000|Overall Study|Death|1|||
131035830|NCT02105766|471766175|FG001|Overall Study|Death|1|||
131035831|NCT02105766|471766176|FG002|Overall Study|Death|0|||
131035832|NCT03701399|471766177|FG000|Overall Study|Adverse Event|3|||
131035833|NCT03701399|471766178|FG001|Overall Study|Adverse Event|5|||
131035834|NCT03701399|471766177|FG000|Overall Study|Withdrawal by Subject|6|||
131035835|NCT03701399|471766178|FG001|Overall Study|Withdrawal by Subject|3|||
131035836|NCT03701399|471766177|FG000|Overall Study|Investigators decision|1|||
131035837|NCT03701399|471766178|FG001|Overall Study|Investigators decision|2|||
131035838|NCT03701399|471766177|FG000|Overall Study|Lost to Follow-up|1|||
131035839|NCT03701399|471766178|FG001|Overall Study|Lost to Follow-up|2|||
131121396|NCT01236573|472074882|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131121397|NCT01236573|472074883|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
131121398|NCT01236573|472074884|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131121399|NCT01236573|472074885|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
131121400|NCT01236573|472074886|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
131035840|NCT03701399|471766177|FG000|Overall Study|Death|1|||
131035841|NCT03701399|471766178|FG001|Overall Study|Death|1|||
131035842|NCT03701399|471766177|FG000|Overall Study|Randomized but not treated|1|||
131035843|NCT03701399|471766178|FG001|Overall Study|Randomized but not treated|0|||
131035844|NCT00554788|471766179|FG000|Overall Study|Adverse Event|0|||
131035845|NCT00554788|471766180|FG001|Overall Study|Adverse Event|1|||
130937531|NCT02659631|471404559|FG004|Overall Study|Participant refused further follow-up|0|||
131121401|NCT01236573|472074887|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
131121402|NCT01236573|472074877|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131121403|NCT01236573|472074878|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131121404|NCT01236573|472074879|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131121405|NCT01236573|472074880|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131121406|NCT01236573|472074881|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131121407|NCT01236573|472074882|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131121408|NCT01236573|472074883|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131121409|NCT01236573|472074884|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131121410|NCT01236573|472074885|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
131121411|NCT01236573|472074886|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131121412|NCT01236573|472074887|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
131121413|NCT01236573|472074877|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131121414|NCT01236573|472074878|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131121415|NCT01236573|472074879|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131121416|NCT01236573|472074880|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131121417|NCT01236573|472074881|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131121418|NCT01236573|472074882|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131121419|NCT01236573|472074883|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131121420|NCT01236573|472074884|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131121421|NCT01236573|472074885|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131121422|NCT01236573|472074886|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
131121423|NCT01236573|472074887|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
131121424|NCT04109222|472074898|FG000|Overall Study|Adverse Event|1|||
131121425|NCT04109222|472074899|FG001|Overall Study|Adverse Event|0|||
131121426|NCT04109222|472074900|FG002|Overall Study|Adverse Event|0|||
131121427|NCT03023059|472074901|FG000|Overall Study|Withdrawal by Subject|5|||
131121428|NCT04569032|472074902|FG000|Overall Study|Death|10|||
131121429|NCT04569032|472074903|FG001|Overall Study|Death|13|||
131121430|NCT04569032|472074902|FG000|Overall Study|Withdrawal by Subject|2|||
131121431|NCT04569032|472074903|FG001|Overall Study|Withdrawal by Subject|0|||
130937532|NCT02659631|471404560|FG005|Overall Study|Participant refused further follow-up|0|||
131121432|NCT04569032|472074902|FG000|Overall Study|Lost to Follow-up|0|||
131121433|NCT04569032|472074903|FG001|Overall Study|Lost to Follow-up|1|||
131121434|NCT04569032|472074902|FG000|Overall Study|In long term follow up|22|||
131121435|NCT04569032|472074903|FG001|Overall Study|In long term follow up|34|||
131121436|NCT00701090|472074905|FG000|Overall Study|Adverse Event|11|||
131121437|NCT00701090|472074906|FG001|Overall Study|Adverse Event|2|||
131121438|NCT00701090|472074905|FG000|Overall Study|Death|0|||
131121439|NCT00701090|472074906|FG001|Overall Study|Death|1|||
131121440|NCT00701090|472074905|FG000|Overall Study|Lack of Efficacy|5|||
131121441|NCT00701090|472074906|FG001|Overall Study|Lack of Efficacy|4|||
131121442|NCT00701090|472074905|FG000|Overall Study|Lost to Follow-up|9|||
131121443|NCT00701090|472074906|FG001|Overall Study|Lost to Follow-up|9|||
131121444|NCT00701090|472074905|FG000|Overall Study|Physician Decision|3|||
131121445|NCT00701090|472074906|FG001|Overall Study|Physician Decision|4|||
131121446|NCT00701090|472074905|FG000|Overall Study|Protocol Violation|2|||
131121447|NCT00701090|472074906|FG001|Overall Study|Protocol Violation|3|||
131121448|NCT00701090|472074905|FG000|Overall Study|Withdrawal by Subject|11|||
130704875|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
130704876|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
130704877|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
130704878|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
130704879|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
130704880|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
130937533|NCT02659631|471404561|FG006|Overall Study|Participant refused further follow-up|0|||
130937534|NCT02659631|471404562|FG007|Overall Study|Participant refused further follow-up|0|||
130937535|NCT02659631|471404563|FG008|Overall Study|Participant refused further follow-up|1|||
130937536|NCT02659631|471404564|FG009|Overall Study|Participant refused further follow-up|0|||
130937537|NCT02659631|471404555|FG000|Overall Study|Death (follow-up phase)|1|||
130937538|NCT02659631|471404556|FG001|Overall Study|Death (follow-up phase)|2|||
130937539|NCT02659631|471404557|FG002|Overall Study|Death (follow-up phase)|1|||
130704881|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
130937540|NCT02659631|471404558|FG003|Overall Study|Death (follow-up phase)|1|||
130937541|NCT02659631|471404559|FG004|Overall Study|Death (follow-up phase)|3|||
130937542|NCT02659631|471404560|FG005|Overall Study|Death (follow-up phase)|2|||
131121449|NCT00701090|472074906|FG001|Overall Study|Withdrawal by Subject|16|||
131121450|NCT00701090|472074905|FG000|Overall Study|Other|7|||
131121451|NCT00701090|472074906|FG001|Overall Study|Other|12|||
130704882|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
130937543|NCT02659631|471404561|FG006|Overall Study|Death (follow-up phase)|0|||
130937544|NCT02659631|471404562|FG007|Overall Study|Death (follow-up phase)|3|||
130937545|NCT02659631|471404563|FG008|Overall Study|Death (follow-up phase)|1|||
130937546|NCT02659631|471404564|FG009|Overall Study|Death (follow-up phase)|0|||
130937547|NCT02659631|471404555|FG000|Overall Study|Death (treatment phase)|0|||
130937548|NCT02659631|471404556|FG001|Overall Study|Death (treatment phase)|0|||
130937549|NCT02659631|471404557|FG002|Overall Study|Death (treatment phase)|0|||
130937550|NCT02659631|471404558|FG003|Overall Study|Death (treatment phase)|0|||
131121452|NCT00873366|472074907|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
130771188|NCT01308463|470789852|FG000|Overall Study|Death|4|||
130771189|NCT01308463|470789852|FG000|Overall Study|Revision|2|||
130771190|NCT02784288|470789853|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
131121453|NCT00873366|472074907|FG000|Overall Study|Off tamoxifen due to side effects|2|||
131121454|NCT00873366|472074907|FG000|Overall Study|Refused to continue DM-BT testing|3|||
131121455|NCT01537198|472074919|FG000|Overall Study|RSV infection|2|||
131121456|NCT01537198|472074919|FG000|Overall Study|Adverse Event|4|||
131121457|NCT01537198|472074919|FG000|Overall Study|No Further Visits to the Clinic|37|||
131121458|NCT01537198|472074919|FG000|Overall Study|Other|111|||
131121459|NCT01231659|472074920|FG000|Overall Study|Adverse Event|9|||
131121460|NCT01231659|472074920|FG000|Overall Study|Disease Progression|48|||
131121461|NCT01231659|472074920|FG000|Overall Study|Death|2|||
131121462|NCT01231659|472074920|FG000|Overall Study|Patient refused to complete study visit|1|||
131121463|NCT01231659|472074920|FG000|Overall Study|Other protocol defined criteria|12|||
131121464|NCT04534491|472074921|FG000|Overall Study|Not completed end-of-study interview|24|||
131121465|NCT04534491|472074921|FG000|Overall Study|Non-users|70|||
131121466|NCT04534491|472074921|FG000|Overall Study|Non-verifiable users|58|||
131121467|NCT00131469|472074923|FG000|Overall Study|Withdrawal by Subject|3|||
131121468|NCT00131469|472074924|FG001|Overall Study|Withdrawal by Subject|4|||
131121469|NCT00131469|472074923|FG000|Overall Study|Protocol Violation|3|||
131121470|NCT00131469|472074924|FG001|Overall Study|Protocol Violation|1|||
131121471|NCT00131469|472074923|FG000|Overall Study|Death|0|||
131121472|NCT00131469|472074924|FG001|Overall Study|Death|1|||
131121473|NCT00131469|472074923|FG000|Overall Study|Lost to Follow-up|0|||
131121474|NCT00131469|472074924|FG001|Overall Study|Lost to Follow-up|1|||
131121475|NCT00131469|472074923|FG000|Overall Study|scan not analyzable|3|||
131121476|NCT00131469|472074924|FG001|Overall Study|scan not analyzable|6|||
131121477|NCT00356889|472074926|FG000|Overall Study|Protocol Violation|2|||
131121478|NCT00356889|472074926|FG000|Overall Study|Adverse Event|1|||
131121479|NCT02247960|472074927|FG000|Patient Consent and Randomization|Physician Decision|2|||
131121480|NCT02247960|472074928|FG001|Patient Consent and Randomization|Physician Decision|2|||
131121481|NCT02247960|472074927|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
131121482|NCT02247960|472074928|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
131121483|NCT02247960|472074927|FG000|Catheter Removed|Lost to Follow-up|7|||
131121484|NCT02247960|472074928|FG001|Catheter Removed|Lost to Follow-up|10|||
131121485|NCT00736034|472074929|FG000|Overall Study|Adverse Event|2|||
131121486|NCT02566577|472074931|FG000|Overall Study|Withdrawal by Subject|1|||
131121487|NCT02566577|472074932|FG001|Overall Study|Withdrawal by Subject|1|||
131121488|NCT02566577|472074931|FG000|Overall Study|Equipment failure|1|||
131121489|NCT02566577|472074932|FG001|Overall Study|Equipment failure|1|||
131121490|NCT02566577|472074931|FG000|Overall Study|Physical limitation|1|||
131121491|NCT02566577|472074932|FG001|Overall Study|Physical limitation|0|||
131121492|NCT00073528|472074938|FG000|Overall Study|Death|488|||
131121493|NCT00073528|472074939|FG001|Overall Study|Death|473|||
131121494|NCT00073528|472074938|FG000|Overall Study|Lost to Follow-up|52|||
131121495|NCT00073528|472074939|FG001|Overall Study|Lost to Follow-up|45|||
131121496|NCT00073528|472074938|FG000|Overall Study|Withdrawal by Subject|50|||
131121497|NCT00073528|472074939|FG001|Overall Study|Withdrawal by Subject|45|||
131121498|NCT00073528|472074938|FG000|Overall Study|Study terminated by Sponsor|10|||
131121499|NCT00073528|472074939|FG001|Overall Study|Study terminated by Sponsor|29|||
131121500|NCT00073528|472074938|FG000|Overall Study|Other|18|||
130771191|NCT02734862|470789854|FG000|Part A|Death|3|||
130771192|NCT02734862|470789855|FG001|Part A|Death|4|||
131121501|NCT00073528|472074939|FG001|Overall Study|Other|19|||
131121502|NCT00073528|472074938|FG000|Overall Study|Other|9|||
131121503|NCT00073528|472074939|FG001|Overall Study|Other|12|||
131121504|NCT00073528|472074938|FG000|Overall Study|Protocol Violation|3|||
130771193|NCT02734862|470789856|FG002|Part A|Death|6|||
131121505|NCT00073528|472074939|FG001|Overall Study|Protocol Violation|5|||
131121506|NCT03086057|472074940|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
130771194|NCT02734862|470789854|FG000|Part A|Lost to Follow-up|2|||
130771195|NCT02734862|470789855|FG001|Part A|Lost to Follow-up|1|||
130771196|NCT02734862|470789856|FG002|Part A|Lost to Follow-up|1|||
130937551|NCT02659631|471404559|FG004|Overall Study|Death (treatment phase)|1|||
131121507|NCT03086057|472074941|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
131121508|NCT03086057|472074942|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
131121509|NCT03086057|472074943|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
131121510|NCT03086057|472074940|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
131121511|NCT03086057|472074941|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
131121512|NCT03086057|472074942|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
130771197|NCT02734862|470789854|FG000|Part A|Withdrawal by Subject|1|||
130771198|NCT02734862|470789855|FG001|Part A|Withdrawal by Subject|1|||
130771199|NCT02734862|470789856|FG002|Part A|Withdrawal by Subject|2|||
130771200|NCT02734862|470789854|FG000|Part A|Physician Decision|2|||
130771201|NCT02734862|470789855|FG001|Part A|Physician Decision|0|||
130771202|NCT02734862|470789856|FG002|Part A|Physician Decision|1|||
130771203|NCT02734862|470789854|FG000|Part A|Adverse Event|2|||
130771204|NCT02734862|470789855|FG001|Part A|Adverse Event|0|||
131121513|NCT03086057|472074943|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
131121514|NCT03086057|472074940|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
131121515|NCT03086057|472074941|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
131121516|NCT03086057|472074942|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
131121517|NCT03086057|472074943|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
131121518|NCT03086057|472074940|FG000|Stage 1: PrEP Uptake|Death|1|||
131121519|NCT03086057|472074941|FG001|Stage 1: PrEP Uptake|Death|0|||
131121520|NCT03086057|472074942|FG002|Stage 1: PrEP Uptake|Death|0|||
131121521|NCT03086057|472074943|FG003|Stage 1: PrEP Uptake|Death|0|||
131121522|NCT03086057|472074940|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
131121523|NCT03086057|472074941|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
131121524|NCT03086057|472074942|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
131121525|NCT03086057|472074943|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
131121526|NCT03086057|472074940|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
131121527|NCT03086057|472074941|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
131121528|NCT03086057|472074942|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
131121529|NCT03086057|472074943|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
131121530|NCT03086057|472074940|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
131121531|NCT03086057|472074941|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
131121532|NCT03086057|472074942|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
131121533|NCT03086057|472074943|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
131121534|NCT04305275|472074944|FG000|Overall Study|Adverse Event|4|||
131121535|NCT04305275|472074945|FG001|Overall Study|Adverse Event|0|||
131121536|NCT04305275|472074944|FG000|Overall Study|Lost to Follow-up|1|||
131121537|NCT04305275|472074945|FG001|Overall Study|Lost to Follow-up|1|||
131121538|NCT04305275|472074944|FG000|Overall Study|Withdrawal by Participant|8|||
131121539|NCT04305275|472074945|FG001|Overall Study|Withdrawal by Participant|1|||
131121540|NCT01708291|472074956|FG000|Overall Study|fighting|2|||
131121541|NCT01708291|472074957|FG001|Overall Study|fighting|1|||
131121542|NCT01536951|472074958|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131121543|NCT01536951|472074959|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131121544|NCT01536951|472074960|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
131121545|NCT01536951|472074961|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131121546|NCT01536951|472074962|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131121547|NCT01536951|472074963|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131121548|NCT01536951|472074964|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131121549|NCT01536951|472074965|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131121550|NCT01536951|472074966|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
131121551|NCT01536951|472074958|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
130704883|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
130704884|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
130704885|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
130704886|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
130704887|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
130704888|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
130704889|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
130704890|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
130704891|NCT01435928|470542817|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
130704892|NCT01435928|470542818|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
130704893|NCT01435928|470542819|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
130704894|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
130704895|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
130704896|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
130704897|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
130704898|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
130704899|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
130704900|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
130704901|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
130704902|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
130771205|NCT02734862|470789856|FG002|Part A|Adverse Event|1|||
130771206|NCT02734862|470789854|FG000|Part A|Noncompliance|1|||
130771207|NCT02734862|470789855|FG001|Part A|Noncompliance|1|||
131121552|NCT01536951|472074959|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
131121553|NCT01536951|472074960|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
130771208|NCT02734862|470789856|FG002|Part A|Noncompliance|0|||
130771209|NCT02734862|470789854|FG000|Part A|Other|1|||
130771210|NCT02734862|470789855|FG001|Part A|Other|1|||
130771211|NCT02734862|470789856|FG002|Part A|Other|3|||
130771212|NCT02734862|470789854|FG000|Part B|Death|8|||
130771213|NCT02734862|470789855|FG001|Part B|Death|3|||
130771214|NCT02734862|470789856|FG002|Part B|Death|5|||
130771215|NCT02734862|470789854|FG000|Part B|Lost to Follow-up|2|||
130771216|NCT02734862|470789855|FG001|Part B|Lost to Follow-up|2|||
130771217|NCT02734862|470789856|FG002|Part B|Lost to Follow-up|0|||
130771218|NCT02734862|470789854|FG000|Part B|Withdrawal by Subject|3|||
130771219|NCT02734862|470789855|FG001|Part B|Withdrawal by Subject|1|||
130771220|NCT02734862|470789856|FG002|Part B|Withdrawal by Subject|0|||
130771221|NCT02734862|470789854|FG000|Part B|Other|0|||
130937552|NCT02659631|471404560|FG005|Overall Study|Death (treatment phase)|0|||
130937553|NCT02659631|471404561|FG006|Overall Study|Death (treatment phase)|1|||
130937554|NCT02659631|471404562|FG007|Overall Study|Death (treatment phase)|0|||
130937555|NCT02659631|471404563|FG008|Overall Study|Death (treatment phase)|0|||
130937556|NCT02659631|471404564|FG009|Overall Study|Death (treatment phase)|0|||
130937557|NCT02377466|471404565|FG000|Overall Study|Other: Randomized and not treated|0|||
130937558|NCT02377466|471404566|FG001|Overall Study|Other: Randomized and not treated|2|||
130937559|NCT00495170|471404567|FG000|Overall Study|Lost to Follow-up|9|||
130771222|NCT02734862|470789855|FG001|Part B|Other|1|||
130771223|NCT02734862|470789856|FG002|Part B|Other|0|||
130771224|NCT02131233|470789857|FG000|Overall Study|Not Treated|2|||
130771225|NCT02131233|470789858|FG001|Overall Study|Not Treated|3|||
130771226|NCT02131233|470789857|FG000|Overall Study|Adverse Event|7|||
130771227|NCT02131233|470789858|FG001|Overall Study|Adverse Event|6|||
130771228|NCT02131233|470789857|FG000|Overall Study|Death|0|||
130771229|NCT02131233|470789858|FG001|Overall Study|Death|1|||
130771230|NCT02131233|470789857|FG000|Overall Study|Lack of Efficacy|6|||
130771231|NCT02131233|470789858|FG001|Overall Study|Lack of Efficacy|3|||
130771232|NCT02131233|470789857|FG000|Overall Study|Lost to Follow-up|14|||
130771233|NCT02131233|470789858|FG001|Overall Study|Lost to Follow-up|13|||
130771234|NCT02131233|470789857|FG000|Overall Study|Non-Compliance With Study Drug|8|||
130771235|NCT02131233|470789858|FG001|Overall Study|Non-Compliance With Study Drug|5|||
130771236|NCT02131233|470789857|FG000|Overall Study|Physician Decision|7|||
130771237|NCT02131233|470789858|FG001|Overall Study|Physician Decision|0|||
130771238|NCT02131233|470789857|FG000|Overall Study|Pregnancy|4|||
130771239|NCT02131233|470789858|FG001|Overall Study|Pregnancy|0|||
130771240|NCT02131233|470789857|FG000|Overall Study|Withdrawal by Subject|18|||
130771241|NCT02131233|470789858|FG001|Overall Study|Withdrawal by Subject|11|||
130771242|NCT00217581|470789867|FG000|Overall Study|Withdrawal by Subject|1|||
130771243|NCT04399889|470789868|FG000|Overall Study|Death|5|||
130771244|NCT04399889|470789869|FG001|Overall Study|Death|1|||
130771245|NCT04399889|470789870|FG002|Overall Study|Death|1|||
130771246|NCT06360588|470789871|FG000|Overall Study|Adverse Event|3|||
130771247|NCT06360588|470789871|FG000|Overall Study|Death|2|||
130771248|NCT06360588|470789871|FG000|Overall Study|Disease Progression|14|||
130771249|NCT06360588|470789871|FG000|Overall Study|Withdrawal by Subject|1|||
130771250|NCT06360588|470789871|FG000|Overall Study|Lack of Efficacy|1|||
130771251|NCT06360588|470789871|FG000|Overall Study|Ineligible|1|||
130771252|NCT02087943|470789873|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
130771253|NCT02087943|470789874|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
130771254|NCT02087943|470789875|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
130771255|NCT02087943|470789876|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
130771256|NCT02087943|470789877|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
130771257|NCT02087943|470789873|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
130771258|NCT02087943|470789874|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
130771259|NCT02087943|470789875|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
130771260|NCT02087943|470789876|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
130771261|NCT02087943|470789877|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
130771262|NCT02087943|470789873|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
130771263|NCT02087943|470789874|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
130771264|NCT02087943|470789875|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
130771265|NCT02087943|470789876|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
130771266|NCT02087943|470789877|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
130771267|NCT02087943|470789873|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
130771268|NCT02087943|470789874|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
130771269|NCT02087943|470789875|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
130771270|NCT02087943|470789876|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
130771271|NCT02087943|470789877|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
130771272|NCT02087943|470789873|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130771273|NCT02087943|470789874|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
130771274|NCT02087943|470789875|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130771275|NCT02087943|470789876|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130937560|NCT00495170|471404567|FG000|Overall Study|Withdrawal by Subject|3|||
131035846|NCT00554788|471766181|FG002|Overall Study|Adverse Event|2|||
131035847|NCT00554788|471766179|FG000|Overall Study|Lost to Follow-up|4|||
131035848|NCT00554788|471766180|FG001|Overall Study|Lost to Follow-up|3|||
131035849|NCT00554788|471766181|FG002|Overall Study|Lost to Follow-up|3|||
131035850|NCT00554788|471766179|FG000|Overall Study|Physician Decision|1|||
131035851|NCT00554788|471766180|FG001|Overall Study|Physician Decision|1|||
131035852|NCT00554788|471766181|FG002|Overall Study|Physician Decision|3|||
131035853|NCT00554788|471766179|FG000|Overall Study|Withdrawal by Subject|0|||
131035854|NCT00554788|471766180|FG001|Overall Study|Withdrawal by Subject|0|||
131035855|NCT00554788|471766181|FG002|Overall Study|Withdrawal by Subject|1|||
131035856|NCT00554788|471766179|FG000|Overall Study|Refusal of further protocol therapy|0|||
131121554|NCT01536951|472074961|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
131223963|NCT04380701|472447112|FG003|Overall Study|Death|0|||
130704903|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
130704904|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
130704905|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
130704906|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
130704907|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
130704908|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
130704909|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
130704910|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
130704911|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
130704912|NCT01435928|470542817|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
130704913|NCT01435928|470542818|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
130704914|NCT01435928|470542819|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
130704915|NCT00442546|470542822|FG000|Overall Study|Adverse Event|11|||
130704916|NCT00442546|470542823|FG001|Overall Study|Adverse Event|17|||
130704917|NCT00442546|470542824|FG002|Overall Study|Adverse Event|13|||
130704918|NCT00442546|470542822|FG000|Overall Study|Lost to Follow-up|1|||
130704919|NCT00442546|470542823|FG001|Overall Study|Lost to Follow-up|2|||
130704920|NCT00442546|470542824|FG002|Overall Study|Lost to Follow-up|1|||
130704921|NCT00442546|470542822|FG000|Overall Study|Other|4|||
130704922|NCT00442546|470542823|FG001|Overall Study|Other|9|||
130704923|NCT00442546|470542824|FG002|Overall Study|Other|6|||
130704924|NCT00442546|470542822|FG000|Overall Study|Withdrawal by Subject|5|||
130704925|NCT00442546|470542823|FG001|Overall Study|Withdrawal by Subject|5|||
130704926|NCT00442546|470542824|FG002|Overall Study|Withdrawal by Subject|7|||
130704927|NCT00442546|470542822|FG000|Overall Study|Randomized But Not Treated|5|||
130704928|NCT00442546|470542823|FG001|Overall Study|Randomized But Not Treated|4|||
130704929|NCT00442546|470542824|FG002|Overall Study|Randomized But Not Treated|6|||
130704930|NCT01557582|470542825|FG000|Overall Study|Protocol Violation|4|||
130704931|NCT01557582|470542825|FG000|Overall Study|Operator error|2|||
130704932|NCT03840382|470542826|FG000|Overall Study|Lost to Follow-up|11|||
130704933|NCT02843659|470542827|FG000|Overall Study|Subject Withdrew Consent|0|||
130704934|NCT02843659|470542828|FG001|Overall Study|Subject Withdrew Consent|0|||
130704935|NCT02843659|470542829|FG002|Overall Study|Subject Withdrew Consent|1|||
130704936|NCT02843659|470542827|FG000|Overall Study|Administrative Reason by Sponsor|4|||
130704937|NCT02843659|470542828|FG001|Overall Study|Administrative Reason by Sponsor|5|||
130704938|NCT02843659|470542829|FG002|Overall Study|Administrative Reason by Sponsor|4|||
130704939|NCT02843659|470542827|FG000|Overall Study|Adverse Event|0|||
130704940|NCT02843659|470542828|FG001|Overall Study|Adverse Event|1|||
130704941|NCT02843659|470542829|FG002|Overall Study|Adverse Event|0|||
130704942|NCT02413294|470542830|FG000|Overall Study|Withdrawal by Subject|1|||
130704943|NCT00831233|470544944|FG000|Overall Study|Adverse Event|0|||
130704944|NCT00831233|470544945|FG001|Overall Study|Adverse Event|1|||
130704945|NCT00831233|470544944|FG000|Overall Study|Protocol Violation|1|||
130704946|NCT00831233|470544945|FG001|Overall Study|Protocol Violation|0|||
130704947|NCT00831233|470544944|FG000|Overall Study|Selection Criteria Not Met|2|||
130704948|NCT00831233|470544945|FG001|Overall Study|Selection Criteria Not Met|0|||
130704949|NCT02211014|470544946|FG000|Overall Study|Adverse Event|0|||
130704950|NCT02211014|470544947|FG001|Overall Study|Adverse Event|2|||
130704951|NCT02211014|470544946|FG000|Overall Study|Physician Decision|1|||
130704952|NCT02211014|470544947|FG001|Overall Study|Physician Decision|2|||
130704953|NCT02211014|470544946|FG000|Overall Study|Started another cancer therapy|1|||
130704954|NCT02211014|470544947|FG001|Overall Study|Started another cancer therapy|0|||
130704955|NCT02211014|470544946|FG000|Overall Study|Withdrawal by Subject|0|||
130704956|NCT02211014|470544947|FG001|Overall Study|Withdrawal by Subject|1|||
130704957|NCT02211014|470544946|FG000|Overall Study|In agreement with patient, no benefit|0|||
130704958|NCT02211014|470544947|FG001|Overall Study|In agreement with patient, no benefit|1|||
130704959|NCT01796964|470544954|FG000|Overall Study|Adverse Event|1|||
130704960|NCT01796964|470544955|FG001|Overall Study|Adverse Event|1|||
130704961|NCT01796964|470544954|FG000|Overall Study|Death|1|||
130704962|NCT01796964|470544955|FG001|Overall Study|Death|0|||
130704963|NCT01796964|470544954|FG000|Overall Study|Protocol Violation|0|||
130704964|NCT01796964|470544955|FG001|Overall Study|Protocol Violation|1|||
130704965|NCT01796964|470544954|FG000|Overall Study|Withdrawal by Subject|1|||
130771276|NCT02087943|470789877|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130771277|NCT02087943|470789873|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
130771278|NCT02087943|470789874|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
130771279|NCT02087943|470789875|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
130771280|NCT02087943|470789876|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
130771281|NCT02087943|470789877|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
130771282|NCT02087943|470789873|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
130771283|NCT02087943|470789874|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
130771284|NCT02087943|470789875|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
130771285|NCT02087943|470789876|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
130937561|NCT00495170|471404567|FG000|Overall Study|Inappropriate staging|8|||
130937562|NCT04210310|471404568|FG000|Overall Study|Lost to Follow-up|32|||
130937563|NCT04210310|471404569|FG001|Overall Study|Lost to Follow-up|1|||
130937564|NCT04285879|471404584|FG000|Overall Study|Lost to Follow-up|1|||
130937565|NCT04285879|471404585|FG001|Overall Study|Lost to Follow-up|8|||
130937566|NCT04285879|471404584|FG000|Overall Study|medical/surgical exclusion|16|||
130937567|NCT04285879|471404585|FG001|Overall Study|medical/surgical exclusion|0|||
131121555|NCT01536951|472074962|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
131121556|NCT01536951|472074963|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
131121557|NCT01536951|472074964|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
131121558|NCT01536951|472074965|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
131121559|NCT01536951|472074966|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
131121560|NCT01843972|472074967|FG000|Overall Study|Withdrawal by Subject|0|||
131121561|NCT01843972|472074968|FG001|Overall Study|Withdrawal by Subject|0|||
131121562|NCT01843972|472074969|FG002|Overall Study|Withdrawal by Subject|0|||
131121563|NCT01843972|472074970|FG003|Overall Study|Withdrawal by Subject|0|||
131121564|NCT01843972|472074971|FG004|Overall Study|Withdrawal by Subject|1|||
131121565|NCT01843972|472074972|FG005|Overall Study|Withdrawal by Subject|0|||
131121566|NCT01843972|472074973|FG006|Overall Study|Withdrawal by Subject|0|||
131121567|NCT01843972|472074974|FG007|Overall Study|Withdrawal by Subject|0|||
131121568|NCT01843972|472074975|FG008|Overall Study|Withdrawal by Subject|0|||
131121569|NCT01843972|472074976|FG009|Overall Study|Withdrawal by Subject|0|||
131121570|NCT00932425|472074977|FG000|Overall Study|Lost to Follow-up|0|||
130771286|NCT02087943|470789877|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
130771287|NCT02087943|470789873|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130771288|NCT02087943|470789874|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130771289|NCT02087943|470789875|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
130937568|NCT02056340|471404586|FG000|Overall Study|Lost to Follow-up|5|||
130771290|NCT02087943|470789876|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130771291|NCT02087943|470789877|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130771292|NCT02087943|470789873|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130771293|NCT02087943|470789874|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130771294|NCT02087943|470789875|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130771295|NCT02087943|470789876|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130771296|NCT02087943|470789877|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
130771297|NCT02087943|470789873|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
130937569|NCT02056340|471404587|FG001|Overall Study|Lost to Follow-up|5|||
130937570|NCT02056340|471404586|FG000|Overall Study|Withdrawal by Subject|2|||
130937571|NCT02056340|471404587|FG001|Overall Study|Withdrawal by Subject|6|||
130937572|NCT04900220|471404589|FG000|Overall Study|Lost to Follow-up|1|||
130937573|NCT04900220|471404590|FG001|Overall Study|Lost to Follow-up|1|||
130937574|NCT00877383|471404594|FG000|Overall Study|Adverse Event|13|||
130937575|NCT00877383|471404595|FG001|Overall Study|Adverse Event|14|||
130937576|NCT00877383|471404594|FG000|Overall Study|Lost to Follow-up|5|||
130771298|NCT02087943|470789874|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
130771299|NCT02087943|470789875|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
130771300|NCT02087943|470789876|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
130771301|NCT02087943|470789877|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
130771302|NCT01690299|470789878|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
130771303|NCT01690299|470789879|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
130771304|NCT01690299|470789880|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
130771305|NCT01690299|470789881|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
130771306|NCT01690299|470789882|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
130771307|NCT01690299|470789883|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
130771308|NCT01690299|470789878|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
130771309|NCT01690299|470789879|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130771310|NCT01690299|470789880|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130771311|NCT01690299|470789881|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130771312|NCT01690299|470789882|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130937577|NCT00877383|471404595|FG001|Overall Study|Lost to Follow-up|3|||
130704966|NCT01796964|470544955|FG001|Overall Study|Withdrawal by Subject|1|||
130704967|NCT04025684|470544956|FG000|Overall Study|Withdrawal by Subject|1|||
130771313|NCT01690299|470789883|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130771314|NCT01690299|470789878|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
130771315|NCT01690299|470789879|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
130771316|NCT01690299|470789880|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130771317|NCT01690299|470789881|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130771318|NCT01690299|470789882|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130771319|NCT01690299|470789883|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130771320|NCT01690299|470789878|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
130771321|NCT01690299|470789879|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
130771322|NCT01690299|470789880|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
130771323|NCT01690299|470789881|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
130771324|NCT01690299|470789882|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
130771325|NCT01690299|470789883|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
130771326|NCT01690299|470789878|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
130771327|NCT01690299|470789879|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
130771328|NCT01690299|470789880|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
130771329|NCT01690299|470789881|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
130771330|NCT01690299|470789882|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
130771331|NCT01690299|470789883|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
130771332|NCT01690299|470789878|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
130771333|NCT01690299|470789879|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
130771334|NCT01690299|470789880|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
130771335|NCT01690299|470789881|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
130771336|NCT01690299|470789882|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
130771337|NCT01690299|470789883|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
130771338|NCT01690299|470789878|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130771339|NCT01690299|470789879|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130771340|NCT01690299|470789880|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130771341|NCT01690299|470789881|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130771342|NCT01690299|470789882|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
130771343|NCT01690299|470789883|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
130937578|NCT00877383|471404594|FG000|Overall Study|Subject withdrew consent|3|||
130937579|NCT00877383|471404595|FG001|Overall Study|Subject withdrew consent|12|||
130937580|NCT00877383|471404594|FG000|Overall Study|Subject no longer requires study drug|2|||
130937581|NCT00877383|471404595|FG001|Overall Study|Subject no longer requires study drug|0|||
130937582|NCT00877383|471404594|FG000|Overall Study|Administrative problems|2|||
130937583|NCT00877383|471404595|FG001|Overall Study|Administrative problems|0|||
130937584|NCT00877383|471404594|FG000|Overall Study|Protocol deviation|2|||
130937585|NCT00877383|471404595|FG001|Overall Study|Protocol deviation|6|||
130937586|NCT00877383|471404594|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130937587|NCT00877383|471404595|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130937588|NCT00877383|471404594|FG000|Overall Study|Death|1|||
130937589|NCT00877383|471404595|FG001|Overall Study|Death|2|||
130937590|NCT02107482|471404602|FG000|Overall Study|inconveinence|2|||
130937591|NCT02107482|471404602|FG000|Overall Study|Lost to Follow-up|1|||
130937592|NCT02107482|471404602|FG000|Overall Study|Lack of Efficacy|1|||
130937593|NCT04868890|471404603|FG000|Overall Study|Death|2|||
130937594|NCT04868890|471404604|FG001|Overall Study|Death|1|||
130937595|NCT04868890|471404603|FG000|Overall Study|Withdrawal by Subject|1|||
130937596|NCT04868890|471404604|FG001|Overall Study|Withdrawal by Subject|5|||
130937597|NCT03358290|471404606|FG000|Overall Study|Study discontinued by Sponsor|0|||
130937598|NCT03358290|471404607|FG001|Overall Study|Study discontinued by Sponsor|1|||
130937599|NCT03358290|471404608|FG002|Overall Study|Study discontinued by Sponsor|1|||
130937600|NCT03358290|471404609|FG003|Overall Study|Study discontinued by Sponsor|0|||
130937601|NCT03358290|471404610|FG004|Overall Study|Study discontinued by Sponsor|0|||
130937602|NCT03358290|471404606|FG000|Overall Study|Adverse Event|0|||
130937603|NCT03358290|471404607|FG001|Overall Study|Adverse Event|0|||
130937604|NCT03358290|471404608|FG002|Overall Study|Adverse Event|1|||
131035857|NCT00554788|471766180|FG001|Overall Study|Refusal of further protocol therapy|1|||
131035858|NCT00554788|471766181|FG002|Overall Study|Refusal of further protocol therapy|1|||
130704968|NCT04025684|470544957|FG001|Overall Study|Withdrawal by Subject|1|||
130704969|NCT04025684|470544958|FG002|Overall Study|Withdrawal by Subject|0|||
130704970|NCT04025684|470544959|FG003|Overall Study|Withdrawal by Subject|0|||
130704971|NCT04025684|470544956|FG000|Overall Study|Multiple reasons|1|||
130704972|NCT04025684|470544957|FG001|Overall Study|Multiple reasons|3|||
130704973|NCT04025684|470544958|FG002|Overall Study|Multiple reasons|0|||
130704974|NCT04025684|470544959|FG003|Overall Study|Multiple reasons|1|||
130704975|NCT02070757|470544960|FG000|Overall Study|Adverse Event|107|||
130704976|NCT02070757|470544961|FG001|Overall Study|Adverse Event|99|||
130704977|NCT02070757|470544960|FG000|Overall Study|Lost to Follow-up|7|||
130704978|NCT02070757|470544961|FG001|Overall Study|Lost to Follow-up|4|||
130704979|NCT02070757|470544960|FG000|Overall Study|Protocol Violation|0|||
130704980|NCT02070757|470544961|FG001|Overall Study|Protocol Violation|4|||
130704981|NCT02070757|470544960|FG000|Overall Study|Withdrawal by Subject|1|||
130704982|NCT02070757|470544961|FG001|Overall Study|Withdrawal by Subject|3|||
130704983|NCT02070757|470544960|FG000|Overall Study|Investigator Decision|0|||
130704984|NCT02070757|470544961|FG001|Overall Study|Investigator Decision|2|||
130704985|NCT02070757|470544960|FG000|Overall Study|Discharged from Study Hospital|2|||
130704986|NCT02070757|470544961|FG001|Overall Study|Discharged from Study Hospital|2|||
130704987|NCT01546922|470544962|FG000|First Period of 10 Weeks|Protocol Violation|3|||
130704988|NCT01546922|470544963|FG001|First Period of 10 Weeks|Protocol Violation|1|||
130771344|NCT01690299|470789878|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
130771345|NCT01690299|470789879|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
130771346|NCT01690299|470789880|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
130771347|NCT01690299|470789881|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
130771348|NCT01690299|470789882|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
130771349|NCT01690299|470789883|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
130771350|NCT01690299|470789878|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
130771351|NCT01690299|470789879|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
130771352|NCT01690299|470789880|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
130704989|NCT01546922|470544962|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
130704990|NCT01546922|470544963|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
130704991|NCT01546922|470544962|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
130704992|NCT01546922|470544963|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
130704993|NCT01546922|470544962|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
130704994|NCT01546922|470544963|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
130704995|NCT01546922|470544962|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
130704996|NCT01546922|470544963|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
130704997|NCT00792623|470544976|FG000|Overall Study|Adverse Event|2|||
130704998|NCT00792623|470544976|FG000|Overall Study|Withdrawal by Subject|5|||
130704999|NCT02916693|470544977|FG000|Overall Study|Lost to Follow-up|7|||
130705000|NCT02001051|470544982|FG000|Overall Study|Deemed not eligible following enrollment|0|||
130705001|NCT02001051|470544983|FG001|Overall Study|Deemed not eligible following enrollment|1|||
130705002|NCT04205162|470544989|FG000|Overall Study|Lost to Follow-up|1|||
130705003|NCT04205162|470544990|FG001|Overall Study|Lost to Follow-up|0|||
130771353|NCT01690299|470789881|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
130771354|NCT01690299|470789882|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
130771355|NCT01690299|470789883|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
130771356|NCT01690299|470789878|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130771357|NCT01690299|470789879|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
131121571|NCT00932425|472074978|FG001|Overall Study|Lost to Follow-up|1|||
131121572|NCT00932425|472074977|FG000|Overall Study|Withdrawal by Subject|0|||
131121573|NCT00932425|472074978|FG001|Overall Study|Withdrawal by Subject|1|||
131121574|NCT00382018|472074979|FG000|Overall Study|Progression|0|||
131121575|NCT00382018|472074980|FG001|Overall Study|Progression|136|||
131121576|NCT00382018|472074981|FG002|Overall Study|Progression|51|||
131121577|NCT00382018|472074982|FG003|Overall Study|Progression|43|||
131121578|NCT00382018|472074979|FG000|Overall Study|Death|0|||
131121579|NCT00382018|472074980|FG001|Overall Study|Death|9|||
131121580|NCT00382018|472074981|FG002|Overall Study|Death|7|||
131121581|NCT00382018|472074982|FG003|Overall Study|Death|11|||
131121582|NCT00382018|472074979|FG000|Overall Study|Withdrawal by Subject|0|||
131121583|NCT00382018|472074980|FG001|Overall Study|Withdrawal by Subject|4|||
131121584|NCT00382018|472074981|FG002|Overall Study|Withdrawal by Subject|3|||
131121585|NCT00382018|472074982|FG003|Overall Study|Withdrawal by Subject|4|||
131121586|NCT00382018|472074979|FG000|Overall Study|Other, not protocol specified|0|||
131121587|NCT00382018|472074980|FG001|Overall Study|Other, not protocol specified|16|||
131121588|NCT00382018|472074981|FG002|Overall Study|Other, not protocol specified|3|||
131121589|NCT00382018|472074982|FG003|Overall Study|Other, not protocol specified|1|||
131121590|NCT03805750|472074983|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
130705004|NCT04205162|470544989|FG000|Overall Study|Withdrawal by Subject|2|||
130705005|NCT04205162|470544990|FG001|Overall Study|Withdrawal by Subject|0|||
131121591|NCT03805750|472074984|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
131121592|NCT02811549|472074985|FG000|Overall Study|Lost to Follow-up|1|||
131121593|NCT02811549|472074985|FG000|Overall Study|Withdrawal by Subject|3|||
131121594|NCT02811549|472074985|FG000|Overall Study|Subject screen failed|4|||
130705006|NCT04205162|470544989|FG000|Overall Study|University closure due to COVID-19|1|||
130705007|NCT04205162|470544990|FG001|Overall Study|University closure due to COVID-19|0|||
130705008|NCT01098110|470544994|FG000|Overall Study|Withdrawal by Subject|14|||
130705009|NCT01098110|470544995|FG001|Overall Study|Withdrawal by Subject|24|||
130937605|NCT03358290|471404609|FG003|Overall Study|Adverse Event|2|||
130937606|NCT03358290|471404610|FG004|Overall Study|Adverse Event|0|||
130771358|NCT01690299|470789880|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130771359|NCT01690299|470789881|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130937607|NCT03358290|471404606|FG000|Overall Study|Withdrawal by Subject|0|||
130937608|NCT03358290|471404607|FG001|Overall Study|Withdrawal by Subject|0|||
130937609|NCT03358290|471404608|FG002|Overall Study|Withdrawal by Subject|0|||
130937610|NCT03358290|471404609|FG003|Overall Study|Withdrawal by Subject|0|||
130937611|NCT03358290|471404610|FG004|Overall Study|Withdrawal by Subject|1|||
130937612|NCT02999854|471404616|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
130937613|NCT02999854|471404617|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
130771360|NCT01690299|470789882|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130771361|NCT01690299|470789883|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
130771362|NCT03836209|470789884|FG000|Overall Study|Adverse Event|5|||
130771363|NCT03836209|470789885|FG001|Overall Study|Adverse Event|2|||
130937614|NCT02999854|471404616|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
130937615|NCT02999854|471404617|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
130937616|NCT02999854|471404616|FG000|Active Study Phase (up to 18 Months)|Death|7|||
130937617|NCT02999854|471404617|FG001|Active Study Phase (up to 18 Months)|Death|5|||
130937618|NCT02999854|471404616|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
130937619|NCT02999854|471404617|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
130705010|NCT01098110|470544996|FG002|Overall Study|Withdrawal by Subject|19|||
130705011|NCT01098110|470544994|FG000|Overall Study|Adverse Event|30|||
130705012|NCT01098110|470544995|FG001|Overall Study|Adverse Event|32|||
130705013|NCT01098110|470544996|FG002|Overall Study|Adverse Event|43|||
130705014|NCT01098110|470544994|FG000|Overall Study|Lack of Efficacy|13|||
130705015|NCT01098110|470544995|FG001|Overall Study|Lack of Efficacy|9|||
130705016|NCT01098110|470544996|FG002|Overall Study|Lack of Efficacy|27|||
130705017|NCT01098110|470544994|FG000|Overall Study|Other|4|||
130705018|NCT01098110|470544995|FG001|Overall Study|Other|7|||
130705019|NCT01098110|470544996|FG002|Overall Study|Other|5|||
130705020|NCT01098110|470544994|FG000|Overall Study|Untreated|1|||
130705021|NCT01098110|470544995|FG001|Overall Study|Untreated|1|||
130705022|NCT01098110|470544996|FG002|Overall Study|Untreated|0|||
130705023|NCT02147587|470544997|FG000|Overall Study|Adverse Event|9|||
130705024|NCT02147587|470544998|FG001|Overall Study|Adverse Event|4|||
130705025|NCT02147587|470544997|FG000|Overall Study|Lack of Efficacy|2|||
130705026|NCT02147587|470544998|FG001|Overall Study|Lack of Efficacy|1|||
130705027|NCT00263887|470544999|FG000|Overall Study|Withdrawal by Subject|1|||
130705028|NCT00263887|470545000|FG001|Overall Study|Withdrawal by Subject|1|||
130705029|NCT00263887|470544999|FG000|Overall Study|Lung transplantation|1|||
130705030|NCT00263887|470545000|FG001|Overall Study|Lung transplantation|2|||
130705031|NCT00263887|470544999|FG000|Overall Study|Too ill to attend visit|1|||
130705032|NCT00263887|470545000|FG001|Overall Study|Too ill to attend visit|0|||
130705033|NCT00263887|470544999|FG000|Overall Study|Adverse Event|0|||
130705034|NCT00263887|470545000|FG001|Overall Study|Adverse Event|2|||
130705035|NCT00263887|470544999|FG000|Overall Study|Disease progression|0|||
130705036|NCT00263887|470545000|FG001|Overall Study|Disease progression|1|||
130705037|NCT00263887|470544999|FG000|Overall Study|Lack of Efficacy|0|||
130705038|NCT00263887|470545000|FG001|Overall Study|Lack of Efficacy|1|||
130705039|NCT01519947|470545005|FG000|Overall Study|Death|0|||
130705040|NCT01519947|470545006|FG001|Overall Study|Death|0|||
130705041|NCT01519947|470545007|FG002|Overall Study|Death|0|||
130705042|NCT01519947|470545008|FG003|Overall Study|Death|1|||
130705043|NCT01519947|470545005|FG000|Overall Study|Protocol Violation|0|||
130705044|NCT01519947|470545006|FG001|Overall Study|Protocol Violation|0|||
130705045|NCT01519947|470545007|FG002|Overall Study|Protocol Violation|2|||
130705046|NCT01519947|470545008|FG003|Overall Study|Protocol Violation|1|||
130705047|NCT01519947|470545005|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
130705048|NCT01519947|470545006|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
130705049|NCT01519947|470545007|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
130705050|NCT01519947|470545008|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
130705051|NCT01519947|470545005|FG000|Overall Study|Development of Anemia|0|||
130705052|NCT01519947|470545006|FG001|Overall Study|Development of Anemia|1|||
130705053|NCT01519947|470545007|FG002|Overall Study|Development of Anemia|0|||
130705054|NCT01519947|470545008|FG003|Overall Study|Development of Anemia|1|||
130705055|NCT01519947|470545005|FG000|Overall Study|Blood Transfusion|0|||
130771364|NCT03836209|470789884|FG000|Overall Study|Death|4|||
130771365|NCT03836209|470789885|FG001|Overall Study|Death|1|||
130771366|NCT03836209|470789884|FG000|Overall Study|Lack of Efficacy|7|||
130985562|NCT04225988|471572944|FG000|Overall Study|Withdrawal by Subject|2|||
130705056|NCT01519947|470545006|FG001|Overall Study|Blood Transfusion|1|||
130705057|NCT01519947|470545007|FG002|Overall Study|Blood Transfusion|1|||
130705058|NCT01519947|470545008|FG003|Overall Study|Blood Transfusion|0|||
130705059|NCT01519947|470545005|FG000|Overall Study|Withdrawal by Subject|0|||
130705060|NCT01519947|470545006|FG001|Overall Study|Withdrawal by Subject|1|||
130771367|NCT03836209|470789885|FG001|Overall Study|Lack of Efficacy|10|||
130705061|NCT01519947|470545007|FG002|Overall Study|Withdrawal by Subject|0|||
130705062|NCT01519947|470545008|FG003|Overall Study|Withdrawal by Subject|1|||
130705063|NCT01519947|470545005|FG000|Overall Study|Lost to Follow-up|0|||
130705064|NCT01519947|470545006|FG001|Overall Study|Lost to Follow-up|0|||
130705065|NCT01519947|470545007|FG002|Overall Study|Lost to Follow-up|3|||
130705066|NCT01519947|470545008|FG003|Overall Study|Lost to Follow-up|2|||
130705067|NCT01519947|470545005|FG000|Overall Study|Poor Response|1|||
130705068|NCT01519947|470545006|FG001|Overall Study|Poor Response|0|||
130705069|NCT01519947|470545007|FG002|Overall Study|Poor Response|0|||
130705070|NCT01519947|470545008|FG003|Overall Study|Poor Response|1|||
130705071|NCT01519947|470545005|FG000|Overall Study|Adverse Event|1|||
130705072|NCT01519947|470545006|FG001|Overall Study|Adverse Event|0|||
130705073|NCT01519947|470545007|FG002|Overall Study|Adverse Event|1|||
130705074|NCT01519947|470545008|FG003|Overall Study|Adverse Event|1|||
130705075|NCT00530348|470545013|FG000|Overall Study|Adverse Event|5|||
130705076|NCT00530348|470545014|FG001|Overall Study|Adverse Event|1|||
130705077|NCT00530348|470545013|FG000|Overall Study|Death|0|||
130705078|NCT00530348|470545014|FG001|Overall Study|Death|1|||
130705079|NCT00530348|470545013|FG000|Overall Study|Lack of Efficacy|2|||
130705080|NCT00530348|470545014|FG001|Overall Study|Lack of Efficacy|0|||
130705081|NCT00530348|470545013|FG000|Overall Study|Lost to Follow-up|0|||
130705082|NCT00530348|470545014|FG001|Overall Study|Lost to Follow-up|2|||
130705083|NCT00530348|470545013|FG000|Overall Study|Physician Decision|1|||
130705084|NCT00530348|470545014|FG001|Overall Study|Physician Decision|2|||
130705085|NCT00530348|470545013|FG000|Overall Study|Pregnancy|1|||
130705086|NCT00530348|470545014|FG001|Overall Study|Pregnancy|0|||
130705087|NCT00530348|470545013|FG000|Overall Study|Withdrawal by Subject|12|||
130705088|NCT00530348|470545014|FG001|Overall Study|Withdrawal by Subject|12|||
130705089|NCT00530348|470545013|FG000|Overall Study|Randomised in error|1|||
130705090|NCT00530348|470545014|FG001|Overall Study|Randomised in error|0|||
130705091|NCT00530348|470545013|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
130705092|NCT00530348|470545014|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
130705093|NCT04364763|470545015|FG000|Overall Study|Death|1|||
130705094|NCT04364763|470545016|FG001|Overall Study|Death|2|||
130705095|NCT04364763|470545015|FG000|Overall Study|Lost to Follow-up|1|||
130705096|NCT04364763|470545016|FG001|Overall Study|Lost to Follow-up|0|||
130705097|NCT02359864|470545017|FG000|Overall Study|Withdrawal by Subject|1|||
130705098|NCT02359864|470545018|FG001|Overall Study|Withdrawal by Subject|0|||
130705099|NCT02020967|470545019|FG000|Overall Study|Withdrawal by Subject|51|||
130705100|NCT02663882|470545026|FG000|Overall Study|Lost to Follow-up|4|||
130705101|NCT02663882|470545027|FG001|Overall Study|Lost to Follow-up|2|||
130705102|NCT00388037|470545032|FG000|Overall Study|Protocol Violation|1|||
130705103|NCT00602537|470545033|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
130705104|NCT00602537|470545034|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
130705105|NCT00602537|470545033|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
130705106|NCT00602537|470545034|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
130705107|NCT00602537|470545033|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
130705108|NCT00602537|470545034|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
130705109|NCT00602537|470545033|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
130705110|NCT00602537|470545034|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
130705111|NCT00602537|470545033|FG000|Follow Up Study Comparison|Adverse Event|1|||
130705112|NCT00602537|470545034|FG001|Follow Up Study Comparison|Adverse Event|0|||
130705113|NCT00602537|470545033|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
130771368|NCT03836209|470789884|FG000|Overall Study|Physician Decision|7|||
130937620|NCT02999854|471404616|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
130937621|NCT02999854|471404617|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
130705114|NCT00602537|470545034|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
130705115|NCT00602537|470545033|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
130705116|NCT00602537|470545034|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
130705117|NCT02539368|470545041|FG000|Overall Study|Death|4|||
130705118|NCT02539368|470545042|FG001|Overall Study|Death|2|||
130705119|NCT02539368|470545043|FG002|Overall Study|Death|1|||
130705120|NCT02539368|470545044|FG003|Overall Study|Death|0|||
130705121|NCT02539368|470545045|FG004|Overall Study|Death|0|||
130705122|NCT02539368|470545041|FG000|Overall Study|Withdrawal by Subject|44|||
130705123|NCT02539368|470545042|FG001|Overall Study|Withdrawal by Subject|35|||
130705124|NCT02539368|470545043|FG002|Overall Study|Withdrawal by Subject|9|||
130705125|NCT02539368|470545044|FG003|Overall Study|Withdrawal by Subject|1|||
130705126|NCT02539368|470545045|FG004|Overall Study|Withdrawal by Subject|3|||
130705127|NCT02539368|470545041|FG000|Overall Study|Physician Decision|49|||
130705128|NCT02539368|470545042|FG001|Overall Study|Physician Decision|15|||
130705129|NCT02539368|470545043|FG002|Overall Study|Physician Decision|7|||
130705130|NCT02539368|470545044|FG003|Overall Study|Physician Decision|0|||
130705131|NCT02539368|470545045|FG004|Overall Study|Physician Decision|2|||
130705132|NCT02539368|470545041|FG000|Overall Study|Lost to Follow-up|96|||
130705133|NCT02539368|470545042|FG001|Overall Study|Lost to Follow-up|21|||
130705134|NCT02539368|470545043|FG002|Overall Study|Lost to Follow-up|16|||
131121595|NCT02811549|472074985|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
131121596|NCT00789880|472074986|FG000|Overall Study|Adverse Event|0|||
131121597|NCT00789880|472074987|FG001|Overall Study|Adverse Event|0|||
131121598|NCT00789880|472074988|FG002|Overall Study|Adverse Event|0|||
131121599|NCT00789880|472074989|FG003|Overall Study|Adverse Event|0|||
131121600|NCT00789880|472074990|FG004|Overall Study|Adverse Event|1|||
131121601|NCT00789880|472074991|FG005|Overall Study|Adverse Event|0|||
131121602|NCT00789880|472074986|FG000|Overall Study|Protocol Violation|0|||
131121603|NCT00789880|472074987|FG001|Overall Study|Protocol Violation|1|||
131121604|NCT00789880|472074988|FG002|Overall Study|Protocol Violation|0|||
131121605|NCT00789880|472074989|FG003|Overall Study|Protocol Violation|1|||
131121606|NCT00789880|472074990|FG004|Overall Study|Protocol Violation|0|||
131121607|NCT00789880|472074991|FG005|Overall Study|Protocol Violation|0|||
131121608|NCT00789880|472074986|FG000|Overall Study|Withdrawal by Subject|1|||
131121609|NCT00789880|472074987|FG001|Overall Study|Withdrawal by Subject|0|||
131121610|NCT00789880|472074988|FG002|Overall Study|Withdrawal by Subject|0|||
131121611|NCT00789880|472074989|FG003|Overall Study|Withdrawal by Subject|0|||
131121612|NCT00789880|472074990|FG004|Overall Study|Withdrawal by Subject|2|||
131121613|NCT00789880|472074991|FG005|Overall Study|Withdrawal by Subject|0|||
131121614|NCT01977820|472074996|FG000|Overall Study|Sponsor terminated the study|1|||
131121615|NCT01977820|472074997|FG001|Overall Study|Sponsor terminated the study|1|||
131121616|NCT00493220|472074998|FG000|Third Intervention|Withdrawal by Subject|1|||
131121617|NCT00493220|472074999|FG001|Third Intervention|Withdrawal by Subject|0|||
131121618|NCT00493220|472075000|FG002|Third Intervention|Withdrawal by Subject|0|||
131121619|NCT00493220|472075001|FG003|Third Intervention|Withdrawal by Subject|0|||
131121620|NCT00493220|472075002|FG004|Third Intervention|Withdrawal by Subject|0|||
131121621|NCT00493220|472075003|FG005|Third Intervention|Withdrawal by Subject|0|||
131121622|NCT02568475|472075004|FG000|Overall Study|Lost to Follow-up|40|||
131121623|NCT02568475|472075005|FG001|Overall Study|Lost to Follow-up|39|||
131121624|NCT02568475|472075004|FG000|Overall Study|Withdrawal by Subject|2|||
131121625|NCT02568475|472075005|FG001|Overall Study|Withdrawal by Subject|0|||
131121626|NCT02568475|472075004|FG000|Overall Study|Discharged home|4|||
131121627|NCT02568475|472075005|FG001|Overall Study|Discharged home|4|||
131121628|NCT02568475|472075004|FG000|Overall Study|Short-term: Discharge location unknown|4|||
131121629|NCT02568475|472075005|FG001|Overall Study|Short-term: Discharge location unknown|0|||
130705135|NCT02539368|470545044|FG003|Overall Study|Lost to Follow-up|4|||
130705136|NCT02539368|470545045|FG004|Overall Study|Lost to Follow-up|3|||
130705137|NCT02539368|470545041|FG000|Overall Study|Adverse Event|44|||
130705138|NCT02539368|470545042|FG001|Overall Study|Adverse Event|5|||
130705139|NCT02539368|470545043|FG002|Overall Study|Adverse Event|9|||
131035859|NCT00554788|471766179|FG000|Overall Study|Progressive disease|0|||
131035860|NCT00554788|471766180|FG001|Overall Study|Progressive disease|0|||
131035861|NCT00554788|471766181|FG002|Overall Study|Progressive disease|3|||
131035862|NCT00554788|471766179|FG000|Overall Study|Ineligible|2|||
131035863|NCT00554788|471766180|FG001|Overall Study|Ineligible|0|||
131035864|NCT00554788|471766181|FG002|Overall Study|Ineligible|1|||
131035865|NCT03897465|471766182|FG000|Overall Study|Lost to Follow-up|2|||
131035866|NCT03897465|471766183|FG001|Overall Study|Lost to Follow-up|1|||
131035867|NCT03897465|471766182|FG000|Overall Study|Adverse Event|2|||
131035868|NCT03897465|471766183|FG001|Overall Study|Adverse Event|0|||
131035869|NCT03897465|471766182|FG000|Overall Study|complete healing by V2|1|||
131035870|NCT03897465|471766183|FG001|Overall Study|complete healing by V2|0|||
131035871|NCT03897465|471766182|FG000|Overall Study|occurence of exclusion criterion|1|||
131035872|NCT03897465|471766183|FG001|Overall Study|occurence of exclusion criterion|1|||
131035873|NCT03897465|471766182|FG000|Overall Study|Other|1|||
131035874|NCT03897465|471766183|FG001|Overall Study|Other|0|||
131035875|NCT02985957|471766185|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131035876|NCT02985957|471766186|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131035877|NCT02985957|471766187|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131035878|NCT02985957|471766188|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131035879|NCT02985957|471766189|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
131035880|NCT02985957|471766190|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131035881|NCT02985957|471766191|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131035882|NCT02985957|471766185|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
131121630|NCT02568475|472075004|FG000|Overall Study|Transferred to another facility|1|||
131121631|NCT02568475|472075005|FG001|Overall Study|Transferred to another facility|0|||
130705140|NCT02539368|470545044|FG003|Overall Study|Adverse Event|0|||
131035883|NCT02985957|471766186|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
131121632|NCT02625233|472075006|FG000|Overall Study|Adverse Event|2|||
131121633|NCT02625233|472075007|FG001|Overall Study|Adverse Event|0|||
131121634|NCT00445224|472075015|FG000|Specific Exercises|Withdrawal by Subject|3|||
130705141|NCT02539368|470545045|FG004|Overall Study|Adverse Event|3|||
130705142|NCT02539368|470545041|FG000|Overall Study|Participant Non-compliant|13|||
131035884|NCT02985957|471766187|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
131035885|NCT02985957|471766188|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
130705143|NCT02539368|470545042|FG001|Overall Study|Participant Non-compliant|2|||
130705144|NCT02539368|470545043|FG002|Overall Study|Participant Non-compliant|1|||
130705145|NCT02539368|470545044|FG003|Overall Study|Participant Non-compliant|1|||
130705146|NCT02539368|470545045|FG004|Overall Study|Participant Non-compliant|0|||
130771369|NCT03836209|470789885|FG001|Overall Study|Physician Decision|11|||
130771370|NCT03836209|470789884|FG000|Overall Study|Protocol Violation|0|||
131121635|NCT00445224|472075016|FG001|Specific Exercises|Withdrawal by Subject|3|||
131121636|NCT00445224|472075015|FG000|Specific Exercises|Withdrawal by Subject|1|||
131121637|NCT00445224|472075016|FG001|Specific Exercises|Withdrawal by Subject|0|||
131121638|NCT00591214|472075019|FG000|Overall Study|Physician Decision|7|||
131121639|NCT00591214|472075019|FG000|Overall Study|Withdrawal by Subject|1|||
131121640|NCT01129921|472075020|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
131121641|NCT01129921|472075021|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
131121642|NCT01129921|472075020|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
131121643|NCT01129921|472075021|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
131121644|NCT01129921|472075020|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
131121645|NCT01129921|472075021|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
131121646|NCT01129921|472075020|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
131121647|NCT01129921|472075021|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
131121648|NCT05050318|472076330|FG000|Overall Study|Protocol Deviation|1|||
131121649|NCT05050318|472076331|FG001|Overall Study|Protocol Deviation|0|||
131121650|NCT05050318|472076332|FG002|Overall Study|Protocol Deviation|0|||
131121651|NCT00574145|472076340|FG000|Overall Study|Withdrawal by Subject|2|||
131121652|NCT00574145|472076341|FG001|Overall Study|Withdrawal by Subject|1|||
131121653|NCT03227471|472076345|FG000|Overall Study|Withdrawal by Subject|0|||
131121654|NCT03227471|472076346|FG001|Overall Study|Withdrawal by Subject|0|||
131121655|NCT03227471|472076347|FG002|Overall Study|Withdrawal by Subject|0|||
131121656|NCT03227471|472076348|FG003|Overall Study|Withdrawal by Subject|0|||
131121657|NCT03227471|472076349|FG004|Overall Study|Withdrawal by Subject|1|||
131121658|NCT03227471|472076350|FG005|Overall Study|Withdrawal by Subject|0|||
131121659|NCT03227471|472076351|FG006|Overall Study|Withdrawal by Subject|0|||
131121660|NCT03227471|472076352|FG007|Overall Study|Withdrawal by Subject|0|||
131121661|NCT03227471|472076353|FG008|Overall Study|Withdrawal by Subject|0|||
131121662|NCT03227471|472076354|FG009|Overall Study|Withdrawal by Subject|0|||
131121663|NCT03227471|472076355|FG010|Overall Study|Withdrawal by Subject|0|||
131121664|NCT03227471|472076356|FG011|Overall Study|Withdrawal by Subject|0|||
131121665|NCT03227471|472076357|FG012|Overall Study|Withdrawal by Subject|1|||
131121666|NCT03227471|472076358|FG013|Overall Study|Withdrawal by Subject|0|||
131121667|NCT03227471|472076359|FG014|Overall Study|Withdrawal by Subject|0|||
131121668|NCT03227471|472076345|FG000|Overall Study|Randomized, Never Dosed|0|||
131121669|NCT03227471|472076346|FG001|Overall Study|Randomized, Never Dosed|0|||
131121670|NCT03227471|472076347|FG002|Overall Study|Randomized, Never Dosed|0|||
131121671|NCT03227471|472076348|FG003|Overall Study|Randomized, Never Dosed|0|||
131121672|NCT03227471|472076349|FG004|Overall Study|Randomized, Never Dosed|0|||
131121673|NCT03227471|472076350|FG005|Overall Study|Randomized, Never Dosed|0|||
131121674|NCT03227471|472076351|FG006|Overall Study|Randomized, Never Dosed|0|||
131121675|NCT03227471|472076352|FG007|Overall Study|Randomized, Never Dosed|0|||
131121676|NCT03227471|472076353|FG008|Overall Study|Randomized, Never Dosed|0|||
131121677|NCT03227471|472076354|FG009|Overall Study|Randomized, Never Dosed|0|||
131121678|NCT03227471|472076355|FG010|Overall Study|Randomized, Never Dosed|0|||
131121679|NCT03227471|472076356|FG011|Overall Study|Randomized, Never Dosed|0|||
131121680|NCT03227471|472076357|FG012|Overall Study|Randomized, Never Dosed|0|||
131121681|NCT03227471|472076358|FG013|Overall Study|Randomized, Never Dosed|0|||
131121682|NCT03227471|472076359|FG014|Overall Study|Randomized, Never Dosed|1|||
131121683|NCT00382720|472076360|FG000|Overall Study|Adverse Event|21|||
131121684|NCT00382720|472076361|FG001|Overall Study|Adverse Event|23|||
131121685|NCT00382720|472076362|FG002|Overall Study|Adverse Event|15|||
130705147|NCT02539368|470545041|FG000|Overall Study|Other|145|||
130705148|NCT02539368|470545042|FG001|Overall Study|Other|18|||
130705149|NCT02539368|470545043|FG002|Overall Study|Other|24|||
130705150|NCT02539368|470545044|FG003|Overall Study|Other|1|||
130937622|NCT02999854|471404616|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
131121686|NCT00382720|472076360|FG000|Overall Study|Protocol Violation|2|||
131121687|NCT00382720|472076361|FG001|Overall Study|Protocol Violation|5|||
131121688|NCT00382720|472076362|FG002|Overall Study|Protocol Violation|1|||
131121689|NCT00382720|472076360|FG000|Overall Study|Death|0|||
131121690|NCT00382720|472076361|FG001|Overall Study|Death|1|||
131121691|NCT00382720|472076362|FG002|Overall Study|Death|2|||
131121692|NCT00382720|472076360|FG000|Overall Study|Progressive disease|37|||
131121693|NCT00382720|472076361|FG001|Overall Study|Progressive disease|28|||
131121694|NCT00382720|472076362|FG002|Overall Study|Progressive disease|38|||
131121695|NCT00382720|472076360|FG000|Overall Study|Withdrew consent|1|||
131121696|NCT00382720|472076361|FG001|Overall Study|Withdrew consent|1|||
130705151|NCT02539368|470545045|FG004|Overall Study|Other|3|||
130705152|NCT02539368|470545041|FG000|Overall Study|Missing|10|||
130771371|NCT03836209|470789885|FG001|Overall Study|Protocol Violation|3|||
130771372|NCT03836209|470789884|FG000|Overall Study|Withdrawal by Subject|2|||
130771373|NCT03836209|470789885|FG001|Overall Study|Withdrawal by Subject|10|||
130771374|NCT03836209|470789884|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
130771375|NCT03836209|470789885|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
130771376|NCT03739710|470789886|FG000|Overall Study|Screen Failed|81|||
130771377|NCT01753115|470789887|FG000|Overall Study|Lost to Follow-up|3|||
130771378|NCT01753115|470789888|FG001|Overall Study|Lost to Follow-up|6|||
130771379|NCT01753115|470789889|FG002|Overall Study|Lost to Follow-up|8|||
130771380|NCT01753115|470789887|FG000|Overall Study|Withdrawal by Subject|6|||
130771381|NCT01753115|470789888|FG001|Overall Study|Withdrawal by Subject|5|||
130771382|NCT01753115|470789889|FG002|Overall Study|Withdrawal by Subject|6|||
130771383|NCT01753115|470789887|FG000|Overall Study|Subject non-compliant|3|||
130771384|NCT01753115|470789888|FG001|Overall Study|Subject non-compliant|3|||
130771385|NCT01753115|470789889|FG002|Overall Study|Subject non-compliant|0|||
130771386|NCT01753115|470789887|FG000|Overall Study|Used excluded drug|0|||
130771387|NCT01753115|470789888|FG001|Overall Study|Used excluded drug|1|||
130771388|NCT01753115|470789889|FG002|Overall Study|Used excluded drug|0|||
130771389|NCT01424241|470789892|FG000|Overall Study|Withdrawal by Subject|1|||
130771390|NCT01424241|470789892|FG000|Overall Study|Time constraints|2|||
130771391|NCT00496587|470789893|FG000|Overall Study|Adverse Event|2|||
130771392|NCT00496587|470789893|FG000|Overall Study|Progressive Disease|24|||
130771393|NCT00496587|470789893|FG000|Overall Study|Withdrawal by Subject|2|||
130771394|NCT00496587|470789893|FG000|Overall Study|Death|1|||
130771395|NCT00496587|470789893|FG000|Overall Study|Complications unrelated|2|||
130771396|NCT05259917|470789899|FG000|Overall Study|Protocol Violation|0|||
130771397|NCT05259917|470789900|FG001|Overall Study|Protocol Violation|0|||
130771398|NCT05259917|470789901|FG002|Overall Study|Protocol Violation|1|||
130771399|NCT05259917|470789902|FG003|Overall Study|Protocol Violation|0|||
130771400|NCT05259917|470789903|FG004|Overall Study|Protocol Violation|0|||
130771401|NCT05259917|470789904|FG005|Overall Study|Protocol Violation|0|||
130771402|NCT05259917|470789899|FG000|Overall Study|Lost to Follow-up|0|||
130771403|NCT05259917|470789900|FG001|Overall Study|Lost to Follow-up|0|||
130771404|NCT05259917|470789901|FG002|Overall Study|Lost to Follow-up|1|||
130771405|NCT05259917|470789902|FG003|Overall Study|Lost to Follow-up|0|||
130771406|NCT05259917|470789903|FG004|Overall Study|Lost to Follow-up|0|||
130771407|NCT05259917|470789904|FG005|Overall Study|Lost to Follow-up|1|||
130771408|NCT05259917|470789899|FG000|Overall Study|Physician Decision|0|||
131121697|NCT00382720|472076362|FG002|Overall Study|Withdrew consent|2|||
131121698|NCT00382720|472076360|FG000|Overall Study|Withdrawal by Subject|11|||
131223964|NCT04380701|472447113|FG004|Overall Study|Death|0|||
131223965|NCT04380701|472447114|FG005|Overall Study|Death|0|||
131223966|NCT04380701|472447115|FG006|Overall Study|Death|0|||
131223967|NCT04380701|472447116|FG007|Overall Study|Death|0|||
131223968|NCT04380701|472447117|FG008|Overall Study|Death|0|||
131223969|NCT04380701|472447118|FG009|Overall Study|Death|0|||
131223970|NCT04380701|472447119|FG010|Overall Study|Death|0|||
131223971|NCT04380701|472447120|FG011|Overall Study|Death|0|||
131223972|NCT04380701|472447121|FG012|Overall Study|Death|0|||
131223973|NCT04380701|472447122|FG013|Overall Study|Death|0|||
131223974|NCT04380701|472447123|FG014|Overall Study|Death|0|||
131223975|NCT04380701|472447124|FG015|Overall Study|Death|0|||
131223976|NCT04380701|472447125|FG016|Overall Study|Death|0|||
131223977|NCT04380701|472447126|FG017|Overall Study|Death|0|||
131223978|NCT04380701|472447127|FG018|Overall Study|Death|0|||
131223979|NCT04380701|472447128|FG019|Overall Study|Death|0|||
130771409|NCT05259917|470789900|FG001|Overall Study|Physician Decision|1|||
131121699|NCT00382720|472076361|FG001|Overall Study|Withdrawal by Subject|20|||
131121700|NCT00382720|472076362|FG002|Overall Study|Withdrawal by Subject|12|||
131121701|NCT00382720|472076360|FG000|Overall Study|Surgery|1|||
131121702|NCT00382720|472076361|FG001|Overall Study|Surgery|1|||
131121703|NCT00382720|472076362|FG002|Overall Study|Surgery|4|||
131121704|NCT00382720|472076360|FG000|Overall Study|Patient did not receive study medication|1|||
131121705|NCT00382720|472076361|FG001|Overall Study|Patient did not receive study medication|1|||
130771410|NCT05259917|470789901|FG002|Overall Study|Physician Decision|0|||
130771411|NCT05259917|470789902|FG003|Overall Study|Physician Decision|0|||
130771412|NCT05259917|470789903|FG004|Overall Study|Physician Decision|0|||
130771413|NCT05259917|470789904|FG005|Overall Study|Physician Decision|0|||
130771414|NCT05259917|470789899|FG000|Overall Study|Withdrawal by Subject|0|||
130771415|NCT05259917|470789900|FG001|Overall Study|Withdrawal by Subject|1|||
131121706|NCT00382720|472076362|FG002|Overall Study|Patient did not receive study medication|4|||
131121707|NCT00382720|472076360|FG000|Overall Study|Clinically progressive disease|0|||
131223980|NCT04380701|472447129|FG020|Overall Study|Death|0|||
131223981|NCT04380701|472447130|FG021|Overall Study|Death|0|||
131223982|NCT04380701|472447131|FG022|Overall Study|Death|0|||
130771416|NCT05259917|470789901|FG002|Overall Study|Withdrawal by Subject|0|||
131223983|NCT04380701|472447132|FG023|Overall Study|Death|0|||
131223984|NCT04380701|472447133|FG024|Overall Study|Death|1|||
131223985|NCT04380701|472447134|FG025|Overall Study|Death|0|||
131223986|NCT04380701|472447135|FG026|Overall Study|Death|0|||
131121708|NCT00382720|472076361|FG001|Overall Study|Clinically progressive disease|1|||
131121709|NCT00382720|472076362|FG002|Overall Study|Clinically progressive disease|0|||
131121710|NCT00382720|472076360|FG000|Overall Study|Good prognosis|0|||
131121711|NCT00382720|472076361|FG001|Overall Study|Good prognosis|1|||
130705153|NCT02539368|470545042|FG001|Overall Study|Missing|3|||
130705154|NCT02539368|470545043|FG002|Overall Study|Missing|0|||
130705155|NCT02539368|470545044|FG003|Overall Study|Missing|0|||
130705156|NCT02539368|470545045|FG004|Overall Study|Missing|0|||
130705157|NCT03573817|470545047|FG000|Overall Study|Adverse Event|0|||
130705158|NCT03573817|470545048|FG001|Overall Study|Adverse Event|2|||
130705159|NCT03573817|470545047|FG000|Overall Study|Protocol Violation|0|||
130705160|NCT03573817|470545048|FG001|Overall Study|Protocol Violation|1|||
130705161|NCT03573817|470545047|FG000|Overall Study|Withdrawal by Subject|1|||
130705162|NCT03573817|470545048|FG001|Overall Study|Withdrawal by Subject|1|||
130705163|NCT02692482|470545055|FG000|Overall Study|Death|2|||
130705164|NCT02692482|470545056|FG001|Overall Study|Death|2|||
130771417|NCT05259917|470789902|FG003|Overall Study|Withdrawal by Subject|0|||
131121712|NCT00382720|472076362|FG002|Overall Study|Good prognosis|0|||
131121713|NCT00382720|472076360|FG000|Overall Study|Investigator/Clinical decision|5|||
131121714|NCT00382720|472076361|FG001|Overall Study|Investigator/Clinical decision|6|||
131121715|NCT00382720|472076362|FG002|Overall Study|Investigator/Clinical decision|6|||
131121716|NCT00382720|472076360|FG000|Overall Study|Discontinued at end of study|0|||
131121717|NCT00382720|472076361|FG001|Overall Study|Discontinued at end of study|1|||
131121718|NCT00382720|472076362|FG002|Overall Study|Discontinued at end of study|2|||
131223987|NCT04380701|472447136|FG027|Overall Study|Death|0|||
130771418|NCT05259917|470789903|FG004|Overall Study|Withdrawal by Subject|1|||
130771419|NCT05259917|470789904|FG005|Overall Study|Withdrawal by Subject|1|||
130771420|NCT05259917|470789899|FG000|Overall Study|Trial Termination by Sponsor|7|||
130771421|NCT05259917|470789900|FG001|Overall Study|Trial Termination by Sponsor|2|||
130771422|NCT05259917|470789901|FG002|Overall Study|Trial Termination by Sponsor|3|||
130771423|NCT05259917|470789902|FG003|Overall Study|Trial Termination by Sponsor|5|||
130771424|NCT05259917|470789903|FG004|Overall Study|Trial Termination by Sponsor|11|||
130771425|NCT05259917|470789904|FG005|Overall Study|Trial Termination by Sponsor|4|||
130771426|NCT05259917|470789899|FG000|Overall Study|Other|1|||
130771427|NCT05259917|470789900|FG001|Overall Study|Other|0|||
130771428|NCT05259917|470789901|FG002|Overall Study|Other|2|||
130771429|NCT05259917|470789902|FG003|Overall Study|Other|0|||
130771430|NCT05259917|470789903|FG004|Overall Study|Other|0|||
130771431|NCT05259917|470789904|FG005|Overall Study|Other|0|||
130771432|NCT01808222|470789905|FG000|Overall Study|mpMR scan was not performed|1|||
130771433|NCT02383355|470789906|FG000|Overall Study|Adverse Event|2|||
130771434|NCT02383355|470789907|FG001|Overall Study|Adverse Event|0|||
130771435|NCT01146561|470789909|FG000|Overall Study|Withdrawal by Subject|1|||
130771436|NCT01146561|470789909|FG000|Overall Study|Lost to Follow-up|1|||
130771437|NCT01778751|470789910|FG000|Overall Study|Lost to Follow-up|1|||
130771438|NCT01778751|470789911|FG001|Overall Study|Lost to Follow-up|0|||
130771439|NCT01778751|470789910|FG000|Overall Study|Withdrawal by Subject|0|||
130771440|NCT01778751|470789911|FG001|Overall Study|Withdrawal by Subject|2|||
130771441|NCT01778751|470789910|FG000|Overall Study|Transfered care|1|||
130771442|NCT01778751|470789911|FG001|Overall Study|Transfered care|0|||
130771443|NCT03628716|470789913|FG000|Overall Study|Adverse Event|1|||
130771444|NCT03628716|470789914|FG001|Overall Study|Adverse Event|1|||
130771445|NCT03628716|470789913|FG000|Overall Study|Death|1|||
130771446|NCT03628716|470789914|FG001|Overall Study|Death|0|||
130771447|NCT03628716|470789913|FG000|Overall Study|Lack of Efficacy|15|||
131223988|NCT04380701|472447137|FG028|Overall Study|Death|0|||
131223989|NCT04380701|472447138|FG029|Overall Study|Death|0|||
131223990|NCT04380701|472447139|FG030|Overall Study|Death|0|||
130771448|NCT03628716|470789914|FG001|Overall Study|Lack of Efficacy|20|||
130771449|NCT03628716|470789913|FG000|Overall Study|Withdrawal by Subject|1|||
130771450|NCT03628716|470789914|FG001|Overall Study|Withdrawal by Subject|2|||
131121719|NCT02142738|472076365|FG000|Overall Study|Adverse Event|13|||
131121720|NCT02142738|472076366|FG001|Overall Study|Adverse Event|9|||
131223991|NCT04380701|472447140|FG031|Overall Study|Death|0|||
131223992|NCT04380701|472447141|FG032|Overall Study|Death|0|||
130705165|NCT02692482|470545055|FG000|Overall Study|Withdrawal by Subject|1|||
130771451|NCT03628716|470789913|FG000|Overall Study|Study Terminated by Sponsor|1|||
130771452|NCT03628716|470789914|FG001|Overall Study|Study Terminated by Sponsor|0|||
130771453|NCT00856843|470789915|FG000|Overall Study|Withdrawal by Subject|1|||
130771454|NCT00856843|470789916|FG001|Overall Study|Withdrawal by Subject|5|||
130771455|NCT00856843|470789915|FG000|Overall Study|Lack of Efficacy|1|||
130771456|NCT00856843|470789916|FG001|Overall Study|Lack of Efficacy|0|||
130771457|NCT01994902|470789917|FG000|Test Period 1|Withdrawal by Subject|3|||
131121721|NCT02142738|472076365|FG000|Overall Study|Death|92|||
131121722|NCT02142738|472076366|FG001|Overall Study|Death|112|||
130705166|NCT02692482|470545056|FG001|Overall Study|Withdrawal by Subject|2|||
130705167|NCT00613730|470545057|FG000|Overall Study|Disease progression|2|||
130771458|NCT01994902|470789918|FG001|Test Period 1|Withdrawal by Subject|0|||
131223993|NCT04380701|472447142|FG033|Overall Study|Death|0|||
130771459|NCT01994902|470789917|FG000|Test Period 1|device deficiency with adverse event|0|||
130771460|NCT01994902|470789918|FG001|Test Period 1|device deficiency with adverse event|1|||
130771461|NCT01994902|470789917|FG000|Test Period 1|Adverse Event|2|||
130771462|NCT01994902|470789918|FG001|Test Period 1|Adverse Event|1|||
130771463|NCT01994902|470789917|FG000|Test Period 1|Lack of Efficacy|0|||
131121723|NCT02142738|472076365|FG000|Overall Study|Lost to Follow-up|0|||
131121724|NCT02142738|472076366|FG001|Overall Study|Lost to Follow-up|3|||
131121725|NCT02142738|472076365|FG000|Overall Study|Withdrawal by Subject|6|||
131121726|NCT02142738|472076366|FG001|Overall Study|Withdrawal by Subject|7|||
131121727|NCT02142738|472076365|FG000|Overall Study|Follow up ended by sponsor|43|||
131121728|NCT02142738|472076366|FG001|Overall Study|Follow up ended by sponsor|20|||
131121729|NCT03688880|472076367|FG000|Overall Study|Withdrawal by Subject|0|||
131121730|NCT03688880|472076368|FG001|Overall Study|Withdrawal by Subject|2|||
131121731|NCT03688880|472076367|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
131121732|NCT03688880|472076368|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
131121733|NCT03688880|472076367|FG000|Overall Study|Lost to Follow-up|4|||
131121734|NCT03688880|472076368|FG001|Overall Study|Lost to Follow-up|7|||
131121735|NCT03688880|472076367|FG000|Overall Study|Adverse Event|0|||
131121736|NCT03688880|472076368|FG001|Overall Study|Adverse Event|2|||
131121737|NCT03688880|472076367|FG000|Overall Study|Device deficiencies|0|||
131121738|NCT03688880|472076368|FG001|Overall Study|Device deficiencies|2|||
131121739|NCT03688880|472076367|FG000|Overall Study|Other|10|||
131121740|NCT03688880|472076368|FG001|Overall Study|Other|16|||
131121741|NCT01704287|472076370|FG000|Initial Treatment Period|Death|139|||
131121742|NCT01704287|472076371|FG001|Initial Treatment Period|Death|129|||
131121743|NCT01704287|472076372|FG002|Initial Treatment Period|Death|71|||
131121744|NCT01704287|472076373|FG003|Initial Treatment Period|Death|0|||
131121745|NCT01704287|472076374|FG004|Initial Treatment Period|Death|0|||
131121746|NCT01704287|472076370|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
131121747|NCT01704287|472076371|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
131121748|NCT01704287|472076372|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
131121749|NCT01704287|472076373|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
131121750|NCT01704287|472076374|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
131121751|NCT01704287|472076370|FG000|Initial Treatment Period|Lost to Follow-up|5|||
131121752|NCT01704287|472076371|FG001|Initial Treatment Period|Lost to Follow-up|3|||
131121753|NCT01704287|472076372|FG002|Initial Treatment Period|Lost to Follow-up|0|||
131121754|NCT01704287|472076373|FG003|Initial Treatment Period|Lost to Follow-up|0|||
131121755|NCT01704287|472076374|FG004|Initial Treatment Period|Lost to Follow-up|0|||
131121756|NCT01704287|472076370|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
131121757|NCT01704287|472076371|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
131121758|NCT01704287|472076372|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
131121759|NCT01704287|472076373|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
131121760|NCT01704287|472076374|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
131121761|NCT01704287|472076370|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
131121762|NCT01704287|472076371|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
131121763|NCT01704287|472076372|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
131121764|NCT01704287|472076373|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
131121765|NCT01704287|472076374|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
131121766|NCT01704287|472076370|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
131121767|NCT01704287|472076371|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
131121768|NCT01704287|472076372|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
131121769|NCT01704287|472076373|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
131121770|NCT01704287|472076374|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
131121771|NCT01704287|472076370|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
131121772|NCT01704287|472076371|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
131121773|NCT01704287|472076372|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
131121774|NCT01704287|472076373|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
131121775|NCT01704287|472076374|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
131121776|NCT04024228|472076375|FG000|Overall Study|Adverse Event|1|||
131121777|NCT04024228|472076376|FG001|Overall Study|Adverse Event|0|||
131121778|NCT04024228|472076375|FG000|Overall Study|Protocol Deviation|0|||
131121779|NCT04024228|472076376|FG001|Overall Study|Protocol Deviation|2|||
131121780|NCT04024228|472076375|FG000|Overall Study|Withdrawal by Subject|3|||
130771464|NCT01994902|470789918|FG001|Test Period 1|Lack of Efficacy|1|||
131121781|NCT04024228|472076376|FG001|Overall Study|Withdrawal by Subject|4|||
131121782|NCT04490395|472076377|FG000|Overall Study|Lost to Follow-up|0|||
131121783|NCT04490395|472076378|FG001|Overall Study|Lost to Follow-up|1|||
131121784|NCT00938717|472076379|FG000|Overall Study|Adverse Event|10|||
131121785|NCT00938717|472076380|FG001|Overall Study|Adverse Event|41|||
130771465|NCT01994902|470789917|FG000|Test Period 1|bag too small|1|||
131121786|NCT00938717|472076379|FG000|Overall Study|Protocol Violation|11|||
131121787|NCT00938717|472076380|FG001|Overall Study|Protocol Violation|8|||
130771466|NCT01994902|470789918|FG001|Test Period 1|bag too small|0|||
130705168|NCT00613730|470545057|FG000|Overall Study|Administrative decision|1|||
130705169|NCT00479388|470545058|FG000|Overall Study|Adverse Event|90|||
130771467|NCT01994902|470789917|FG000|Test Period 2|Withdrawal by Subject|0|||
130771468|NCT01994902|470789918|FG001|Test Period 2|Withdrawal by Subject|2|||
130771469|NCT01994902|470789917|FG000|Test Period 2|Lack of Efficacy|0|||
130705170|NCT00479388|470545059|FG001|Overall Study|Adverse Event|45|||
130705171|NCT00479388|470545058|FG000|Overall Study|Lost to Follow-up|0|||
130705172|NCT00479388|470545059|FG001|Overall Study|Lost to Follow-up|2|||
130705173|NCT00479388|470545058|FG000|Overall Study|Protocol Violation|10|||
130705174|NCT00479388|470545059|FG001|Overall Study|Protocol Violation|9|||
130705175|NCT00479388|470545058|FG000|Overall Study|Withdrawal by Subject|32|||
130705176|NCT00479388|470545059|FG001|Overall Study|Withdrawal by Subject|17|||
130705177|NCT01955044|470545062|FG000|Overall Study|Death|1|||
130705178|NCT01955044|470545063|FG001|Overall Study|Death|1|||
130705179|NCT01955044|470545064|FG002|Overall Study|Death|0|||
130705180|NCT01876368|470545065|FG000|Overall Study|Adverse Event|2|||
130705181|NCT01876368|470545066|FG001|Overall Study|Adverse Event|5|||
130705182|NCT01876368|470545065|FG000|Overall Study|Lack of Efficacy|1|||
130705183|NCT01876368|470545066|FG001|Overall Study|Lack of Efficacy|0|||
130705184|NCT01876368|470545065|FG000|Overall Study|Lost to Follow-up|0|||
130705185|NCT01876368|470545066|FG001|Overall Study|Lost to Follow-up|1|||
130705186|NCT01876368|470545065|FG000|Overall Study|Non-compliance with study treatment|0|||
130705187|NCT01876368|470545066|FG001|Overall Study|Non-compliance with study treatment|1|||
130705188|NCT01876368|470545065|FG000|Overall Study|Physician Decision|0|||
130705189|NCT01876368|470545066|FG001|Overall Study|Physician Decision|2|||
130705190|NCT01876368|470545065|FG000|Overall Study|Protocol deviation|3|||
130705191|NCT01876368|470545066|FG001|Overall Study|Protocol deviation|3|||
130705192|NCT01876368|470545065|FG000|Overall Study|Subject/guardian decision|3|||
130705193|NCT01876368|470545066|FG001|Overall Study|Subject/guardian decision|1|||
130705194|NCT01867606|470545067|FG000|Overall Study|Withdrawal by Subject|10|||
130771470|NCT01994902|470789918|FG001|Test Period 2|Lack of Efficacy|1|||
130771471|NCT01994902|470789917|FG000|Test Period 2|Other|0|||
130771472|NCT01994902|470789918|FG001|Test Period 2|Other|3|||
130771473|NCT02717442|470789920|FG000|Overall Study|Study Terminated by Sponsor|31|||
131035886|NCT02985957|471766189|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
131035887|NCT02985957|471766190|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
131035888|NCT02985957|471766191|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
131035889|NCT02985957|471766185|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131035890|NCT02985957|471766186|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131035891|NCT02985957|471766187|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131035892|NCT02985957|471766188|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131035893|NCT02985957|471766189|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131035894|NCT02985957|471766190|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131035895|NCT02985957|471766191|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
131035896|NCT02985957|471766185|FG000|Treatment Period|Death|0|||
131035897|NCT02985957|471766186|FG001|Treatment Period|Death|0|||
131035898|NCT02985957|471766187|FG002|Treatment Period|Death|0|||
131035899|NCT02985957|471766188|FG003|Treatment Period|Death|0|||
131035900|NCT02985957|471766189|FG004|Treatment Period|Death|1|||
131035901|NCT02985957|471766190|FG005|Treatment Period|Death|0|||
131035902|NCT02985957|471766191|FG006|Treatment Period|Death|0|||
131035903|NCT02985957|471766185|FG000|Treatment Period|Participant withdrew consent|0|||
131035904|NCT02985957|471766186|FG001|Treatment Period|Participant withdrew consent|0|||
131035905|NCT02985957|471766187|FG002|Treatment Period|Participant withdrew consent|0|||
131035906|NCT02985957|471766188|FG003|Treatment Period|Participant withdrew consent|1|||
131035907|NCT02985957|471766189|FG004|Treatment Period|Participant withdrew consent|3|||
131035908|NCT02985957|471766190|FG005|Treatment Period|Participant withdrew consent|0|||
131035909|NCT02985957|471766191|FG006|Treatment Period|Participant withdrew consent|1|||
131035910|NCT02985957|471766185|FG000|Treatment Period|Lost to Follow-up|0|||
131035911|NCT02985957|471766186|FG001|Treatment Period|Lost to Follow-up|0|||
131035912|NCT02985957|471766187|FG002|Treatment Period|Lost to Follow-up|0|||
131035913|NCT02985957|471766188|FG003|Treatment Period|Lost to Follow-up|0|||
130705195|NCT01867606|470545068|FG001|Overall Study|Withdrawal by Subject|14|||
130705196|NCT01867606|470545067|FG000|Overall Study|Protocol Violation|0|||
130771474|NCT02717442|470789921|FG001|Overall Study|Study Terminated by Sponsor|29|||
131035914|NCT02985957|471766189|FG004|Treatment Period|Lost to Follow-up|1|||
131035915|NCT02985957|471766190|FG005|Treatment Period|Lost to Follow-up|0|||
130771475|NCT02717442|470789920|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
130771476|NCT02717442|470789921|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
130705197|NCT01867606|470545068|FG001|Overall Study|Protocol Violation|1|||
130705198|NCT01378962|470545069|FG000|Overall Study|Death|14|||
130705199|NCT01378962|470545069|FG000|Overall Study|Lost to Follow-up|1|||
130705200|NCT01378962|470545069|FG000|Overall Study|Other|2|||
130705201|NCT00292227|470545072|FG000|Patch Period|Adverse Event|1|||
130705202|NCT00292227|470545073|FG001|Patch Period|Adverse Event|0|||
130705203|NCT00292227|470545074|FG002|Patch Period|Adverse Event|2|||
131121788|NCT00938717|472076379|FG000|Overall Study|Withdrawal by Subject|26|||
130771477|NCT02717442|470789920|FG000|Overall Study|Other - Not Specified|2|||
130771478|NCT02717442|470789921|FG001|Overall Study|Other - Not Specified|0|||
130771479|NCT00528372|470789925|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
130771480|NCT00528372|470789926|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130771481|NCT00528372|470789927|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130771482|NCT00528372|470789928|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130771483|NCT00528372|470789929|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130771484|NCT00528372|470789930|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130771485|NCT00528372|470789931|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130771486|NCT00528372|470789932|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130771487|NCT00528372|470789933|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130771488|NCT00528372|470789925|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130771489|NCT00528372|470789926|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
130771490|NCT00528372|470789927|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
130771491|NCT00528372|470789928|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
130771492|NCT00528372|470789929|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130771493|NCT00528372|470789930|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
130771494|NCT00528372|470789931|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
130771495|NCT00528372|470789932|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130771496|NCT00528372|470789933|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130771497|NCT00528372|470789925|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
130771498|NCT00528372|470789926|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
130771499|NCT00528372|470789927|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
130771500|NCT00528372|470789928|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
130771501|NCT00528372|470789929|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
130771502|NCT00528372|470789930|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
130771503|NCT00528372|470789931|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
130771504|NCT00528372|470789932|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
130771505|NCT00528372|470789933|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
130771506|NCT00528372|470789925|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
130771507|NCT00528372|470789926|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
130771508|NCT00528372|470789927|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
130771509|NCT00528372|470789928|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
130771510|NCT00528372|470789929|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
130771511|NCT00528372|470789930|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
130771512|NCT00528372|470789931|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
130771513|NCT00528372|470789932|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
130771514|NCT00528372|470789933|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
130771515|NCT00528372|470789925|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130771516|NCT00528372|470789926|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130771517|NCT00528372|470789927|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130771518|NCT00528372|470789928|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
130771519|NCT00528372|470789929|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130771520|NCT00528372|470789930|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
130771521|NCT00528372|470789931|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130771522|NCT00528372|470789932|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130771523|NCT00528372|470789933|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130771524|NCT00528372|470789925|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
130771525|NCT00528372|470789926|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130771526|NCT00528372|470789927|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
131121789|NCT00938717|472076380|FG001|Overall Study|Withdrawal by Subject|24|||
130771527|NCT00528372|470789928|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130771528|NCT00528372|470789929|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130771529|NCT00528372|470789930|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
131121790|NCT00938717|472076379|FG000|Overall Study|Lost to Follow-up|13|||
131121791|NCT00938717|472076380|FG001|Overall Study|Lost to Follow-up|18|||
130771530|NCT00528372|470789931|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130771531|NCT00528372|470789932|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130771532|NCT00528372|470789933|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130771533|NCT00528372|470789925|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
130771534|NCT00528372|470789926|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
131121792|NCT00938717|472076379|FG000|Overall Study|Lack of Efficacy|33|||
131121793|NCT00938717|472076380|FG001|Overall Study|Lack of Efficacy|15|||
131121794|NCT00938717|472076379|FG000|Overall Study|Other reason|5|||
131223994|NCT04380701|472447109|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131223995|NCT04380701|472447110|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131223996|NCT04380701|472447111|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131223997|NCT04380701|472447112|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130771535|NCT00528372|470789927|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130705204|NCT00292227|470545072|FG000|Patch Period|Withdrawal by Subject|0|||
130771536|NCT00528372|470789928|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
130771537|NCT00528372|470789929|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130771538|NCT00528372|470789930|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130771539|NCT00528372|470789931|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130771540|NCT00528372|470789932|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
130771541|NCT00528372|470789933|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130771542|NCT00528372|470789925|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
130771543|NCT00528372|470789926|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
130771544|NCT00528372|470789927|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
130771545|NCT00528372|470789928|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
130771546|NCT00528372|470789929|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
130771547|NCT00528372|470789930|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
130771548|NCT00528372|470789931|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
130771549|NCT00528372|470789932|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
130771550|NCT00528372|470789933|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
130771551|NCT00528372|470789925|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
130771552|NCT00528372|470789926|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
130771553|NCT00528372|470789927|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
130937623|NCT02999854|471404617|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
130937624|NCT02999854|471404616|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
130937625|NCT02999854|471404617|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
130937626|NCT02999854|471404616|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
130937627|NCT02999854|471404617|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
130937628|NCT01339429|471404618|FG000|Overall Study|Withdrawal by Subject|1|||
130937629|NCT01339429|471404618|FG000|Overall Study|Physician Decision|3|||
130937630|NCT01085591|471404619|FG000|Overall Study|Adverse Event|0|||
130937631|NCT01085591|471404620|FG001|Overall Study|Adverse Event|1|||
130937632|NCT01085591|471404621|FG002|Overall Study|Adverse Event|3|||
130937633|NCT01085591|471404619|FG000|Overall Study|Physician Decision|1|||
130937634|NCT01085591|471404620|FG001|Overall Study|Physician Decision|0|||
130937635|NCT01085591|471404621|FG002|Overall Study|Physician Decision|1|||
130937636|NCT01085591|471404619|FG000|Overall Study|Withdrawal by Subject|0|||
130937637|NCT01085591|471404620|FG001|Overall Study|Withdrawal by Subject|2|||
130937638|NCT01085591|471404621|FG002|Overall Study|Withdrawal by Subject|1|||
130937639|NCT01085591|471404619|FG000|Overall Study|Lost to Follow-up|0|||
130937640|NCT01085591|471404620|FG001|Overall Study|Lost to Follow-up|1|||
130937641|NCT01085591|471404621|FG002|Overall Study|Lost to Follow-up|1|||
130937642|NCT01085591|471404619|FG000|Overall Study|Protocol Violation|1|||
130937643|NCT01085591|471404620|FG001|Overall Study|Protocol Violation|1|||
130937644|NCT01085591|471404621|FG002|Overall Study|Protocol Violation|1|||
131223998|NCT04380701|472447113|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130705205|NCT00292227|470545073|FG001|Patch Period|Withdrawal by Subject|0|||
130705206|NCT00292227|470545074|FG002|Patch Period|Withdrawal by Subject|1|||
130705207|NCT02093923|470545075|FG000|Overall Study|Lost to Follow-up|0|||
130705208|NCT02093923|470545076|FG001|Overall Study|Lost to Follow-up|0|||
130705209|NCT02093923|470545077|FG002|Overall Study|Lost to Follow-up|0|||
130705210|NCT02093923|470545078|FG003|Overall Study|Lost to Follow-up|1|||
130705211|NCT02093923|470545079|FG004|Overall Study|Lost to Follow-up|0|||
130705212|NCT02093923|470545075|FG000|Overall Study|Screen failure after randomization|0|||
130705213|NCT02093923|470545076|FG001|Overall Study|Screen failure after randomization|0|||
130705214|NCT02093923|470545077|FG002|Overall Study|Screen failure after randomization|0|||
130705215|NCT02093923|470545078|FG003|Overall Study|Screen failure after randomization|1|||
130705216|NCT02093923|470545079|FG004|Overall Study|Screen failure after randomization|0|||
130705217|NCT00248170|470545080|FG000|Overall Study|Withdrawal by Subject|71|||
130705218|NCT00248170|470545081|FG001|Overall Study|Withdrawal by Subject|79|||
130937645|NCT01085591|471404619|FG000|Overall Study|Other|0|||
130705219|NCT00248170|470545080|FG000|Overall Study|Protocol Violation|35|||
130705220|NCT00248170|470545081|FG001|Overall Study|Protocol Violation|30|||
130937646|NCT01085591|471404620|FG001|Overall Study|Other|1|||
130937647|NCT01085591|471404621|FG002|Overall Study|Other|0|||
130937648|NCT01085591|471404619|FG000|Overall Study|Not Properly Consented|1|||
130937649|NCT01085591|471404620|FG001|Overall Study|Not Properly Consented|0|||
130705221|NCT00248170|470545080|FG000|Overall Study|Lost to Follow-up|28|||
130705222|NCT00248170|470545081|FG001|Overall Study|Lost to Follow-up|35|||
130705223|NCT00248170|470545080|FG000|Overall Study|Disease progression|196|||
130771554|NCT00528372|470789928|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
130937650|NCT01085591|471404621|FG002|Overall Study|Not Properly Consented|0|||
130705224|NCT00248170|470545081|FG001|Overall Study|Disease progression|216|||
130705225|NCT00248170|470545080|FG000|Overall Study|Death|28|||
130705226|NCT00248170|470545081|FG001|Overall Study|Death|47|||
130705227|NCT00248170|470545080|FG000|Overall Study|Adverse Event|311|||
130937651|NCT04140292|471404622|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
130937652|NCT04140292|471404623|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
130937653|NCT00556712|471404624|FG000|Overall Study|Adverse Event|7|||
130937654|NCT00556712|471404625|FG001|Overall Study|Adverse Event|19|||
130937655|NCT00556712|471404624|FG000|Overall Study|Death|5|||
130937656|NCT00556712|471404625|FG001|Overall Study|Death|10|||
130937657|NCT00556712|471404624|FG000|Overall Study|Progressive Disease|383|||
130937658|NCT00556712|471404625|FG001|Overall Study|Progressive Disease|320|||
131035916|NCT02985957|471766191|FG006|Treatment Period|Lost to Follow-up|0|||
130705228|NCT00248170|470545081|FG001|Overall Study|Adverse Event|296|||
130705229|NCT00248170|470545080|FG000|Overall Study|Administrative problems|22|||
130705230|NCT00248170|470545081|FG001|Overall Study|Administrative problems|25|||
130705231|NCT00248170|470545080|FG000|Overall Study|Abnormal test procedure(s) result|49|||
130705232|NCT00248170|470545081|FG001|Overall Study|Abnormal test procedure(s) result|61|||
130705233|NCT00248170|470545080|FG000|Overall Study|Abnormal laboratory values|4|||
130705234|NCT00248170|470545081|FG001|Overall Study|Abnormal laboratory values|0|||
130705235|NCT00248170|470545080|FG000|Overall Study|Protocol deviation|17|||
130705236|NCT00248170|470545081|FG001|Overall Study|Protocol deviation|19|||
130705237|NCT01253317|470545093|FG000|Overall Study|Adverse Event|2|||
130705238|NCT00802178|470547186|FG000|Overall Study|Lack of Efficacy|36|||
130705239|NCT00802178|470547186|FG000|Overall Study|Insufficient tolerability (IT)|17|||
130705240|NCT00802178|470547186|FG000|Overall Study|Withdrawal by Subject|18|||
130705241|NCT00802178|470547186|FG000|Overall Study|Other|32|||
130705242|NCT00802178|470547186|FG000|Overall Study|Lack of efficacy and patient wish|1|||
130705243|NCT00802178|470547186|FG000|Overall Study|IT and patient wish|8|||
130705244|NCT00802178|470547186|FG000|Overall Study|Patients wish and other reason|1|||
130705245|NCT04100096|470547187|FG000|Overall Study|Adverse Event|19|||
130705246|NCT04100096|470547188|FG001|Overall Study|Adverse Event|7|||
130705247|NCT04100096|470547187|FG000|Overall Study|Lack of Efficacy|0|||
130705248|NCT04100096|470547188|FG001|Overall Study|Lack of Efficacy|1|||
130705249|NCT04100096|470547187|FG000|Overall Study|Lost to Follow-up|13|||
130705250|NCT04100096|470547188|FG001|Overall Study|Lost to Follow-up|11|||
130705251|NCT04100096|470547187|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130705252|NCT04100096|470547188|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130705253|NCT04100096|470547187|FG000|Overall Study|Protocol Deviation|1|||
130705254|NCT04100096|470547188|FG001|Overall Study|Protocol Deviation|1|||
130705255|NCT04100096|470547187|FG000|Overall Study|Withdrawal by Participant|13|||
130705256|NCT04100096|470547188|FG001|Overall Study|Withdrawal by Participant|15|||
130705257|NCT01613378|470547192|FG000|Overall Study|Lack of Efficacy|13|||
130705258|NCT01613378|470547192|FG000|Overall Study|Adverse Event|11|||
130705259|NCT01613378|470547192|FG000|Overall Study|Withdrawal by Subject|8|||
130705260|NCT01613378|470547192|FG000|Overall Study|Death|2|||
130705261|NCT01613378|470547192|FG000|Overall Study|Lost to Follow-up|1|||
130705262|NCT01613378|470547192|FG000|Overall Study|Other Reason|4|||
130705263|NCT02744755|470547193|FG000|Study Period 1|Protocol Violation|2|||
130705264|NCT02744755|470547194|FG001|Study Period 1|Protocol Violation|1|||
130705265|NCT02744755|470547193|FG000|Study Period 1|not defined|0|||
130705266|NCT02744755|470547194|FG001|Study Period 1|not defined|1|||
130705267|NCT02744755|470547193|FG000|Study Period 1|Pregnancy|1|||
130705268|NCT02744755|470547194|FG001|Study Period 1|Pregnancy|0|||
130705269|NCT02744755|470547193|FG000|Study Period 1|Adverse Event|1|||
130705270|NCT02744755|470547194|FG001|Study Period 1|Adverse Event|1|||
130705271|NCT02744755|470547193|FG000|Study Period 1|Lost to Follow-up|1|||
130705272|NCT02744755|470547194|FG001|Study Period 1|Lost to Follow-up|1|||
130705273|NCT02744755|470547193|FG000|Study Period 1|Lack of Efficacy|1|||
130705274|NCT02744755|470547194|FG001|Study Period 1|Lack of Efficacy|0|||
130705275|NCT02744755|470547193|FG000|Study Period 1|Withdrawal by Subject|8|||
130705276|NCT02744755|470547194|FG001|Study Period 1|Withdrawal by Subject|4|||
130705277|NCT02744755|470547193|FG000|Study Period 2|Adverse Event|5|||
130705278|NCT02744755|470547194|FG001|Study Period 2|Adverse Event|0|||
130705279|NCT02744755|470547193|FG000|Study Period 2|Protocol Violation|1|||
130705280|NCT02744755|470547194|FG001|Study Period 2|Protocol Violation|0|||
130705281|NCT02744755|470547193|FG000|Study Period 2|not defined|3|||
130705282|NCT02744755|470547194|FG001|Study Period 2|not defined|2|||
130705283|NCT02744755|470547193|FG000|Study Period 2|Lost to Follow-up|0|||
130705284|NCT02744755|470547194|FG001|Study Period 2|Lost to Follow-up|2|||
130705285|NCT02744755|470547193|FG000|Study Period 2|Withdrawal by Subject|2|||
130705286|NCT02744755|470547194|FG001|Study Period 2|Withdrawal by Subject|2|||
130705287|NCT02744755|470547193|FG000|Study Period 2|Lack of Efficacy|3|||
130705288|NCT02744755|470547194|FG001|Study Period 2|Lack of Efficacy|2|||
130705289|NCT00880087|470547195|FG000|Overall Study|Lost to Follow-up|0|||
130705290|NCT00880087|470547196|FG001|Overall Study|Lost to Follow-up|2|||
130705291|NCT01011556|470547197|FG000|Overall Study|Adverse Event|1|||
130937659|NCT00556712|471404624|FG000|Overall Study|Protocol Violation|3|||
131121795|NCT00938717|472076380|FG001|Overall Study|Other reason|2|||
131121796|NCT01462435|472076383|FG000|Overall Study|Lack of Efficacy|1|||
131121797|NCT01462435|472076384|FG001|Overall Study|Lack of Efficacy|0|||
131121798|NCT01462435|472076385|FG002|Overall Study|Lack of Efficacy|0|||
130705292|NCT01011556|470547198|FG001|Overall Study|Adverse Event|3|||
130705293|NCT01011556|470547199|FG002|Overall Study|Adverse Event|2|||
130705294|NCT01011556|470547200|FG003|Overall Study|Adverse Event|1|||
130705295|NCT01011556|470547197|FG000|Overall Study|Lost to Follow-up|1|||
130705296|NCT01011556|470547198|FG001|Overall Study|Lost to Follow-up|0|||
130705297|NCT01011556|470547199|FG002|Overall Study|Lost to Follow-up|0|||
130705298|NCT01011556|470547200|FG003|Overall Study|Lost to Follow-up|0|||
130705299|NCT01011556|470547197|FG000|Overall Study|Physician Decision|1|||
130705300|NCT01011556|470547198|FG001|Overall Study|Physician Decision|0|||
130705301|NCT01011556|470547199|FG002|Overall Study|Physician Decision|0|||
130705302|NCT01011556|470547200|FG003|Overall Study|Physician Decision|1|||
130705303|NCT01011556|470547197|FG000|Overall Study|Protocol Violation|0|||
130705304|NCT01011556|470547198|FG001|Overall Study|Protocol Violation|1|||
130705305|NCT01011556|470547199|FG002|Overall Study|Protocol Violation|0|||
130705306|NCT01011556|470547200|FG003|Overall Study|Protocol Violation|0|||
130705307|NCT01011556|470547197|FG000|Overall Study|Withdrawal by Subject|1|||
130705308|NCT01011556|470547198|FG001|Overall Study|Withdrawal by Subject|2|||
130705309|NCT01011556|470547199|FG002|Overall Study|Withdrawal by Subject|4|||
130705310|NCT01011556|470547200|FG003|Overall Study|Withdrawal by Subject|4|||
130705311|NCT01011556|470547197|FG000|Overall Study|Sponsor decision|0|||
130705312|NCT01011556|470547198|FG001|Overall Study|Sponsor decision|1|||
130705313|NCT01011556|470547199|FG002|Overall Study|Sponsor decision|1|||
131121799|NCT01462435|472076386|FG003|Overall Study|Lack of Efficacy|3|||
131121800|NCT01462435|472076383|FG000|Overall Study|Physician Decision|0|||
131121801|NCT01462435|472076384|FG001|Overall Study|Physician Decision|0|||
131121802|NCT01462435|472076385|FG002|Overall Study|Physician Decision|1|||
131121803|NCT01462435|472076386|FG003|Overall Study|Physician Decision|0|||
131121804|NCT01462435|472076383|FG000|Overall Study|Withdrawal by Subject|0|||
131121805|NCT01462435|472076384|FG001|Overall Study|Withdrawal by Subject|0|||
131121806|NCT01462435|472076385|FG002|Overall Study|Withdrawal by Subject|0|||
131121807|NCT01462435|472076386|FG003|Overall Study|Withdrawal by Subject|1|||
131121808|NCT01462435|472076383|FG000|Overall Study|Lost to Follow-up|0|||
131121809|NCT01462435|472076384|FG001|Overall Study|Lost to Follow-up|0|||
131121810|NCT01462435|472076385|FG002|Overall Study|Lost to Follow-up|0|||
131121811|NCT01462435|472076386|FG003|Overall Study|Lost to Follow-up|1|||
131121812|NCT05092919|472076387|FG000|Overall Study|Lost to Follow-up|7|||
131121813|NCT05092919|472076387|FG000|Overall Study|Withdrawal by Subject|2|||
131121814|NCT01942148|472076389|FG000|Overall Study|Adverse Event|4|||
131121815|NCT01942148|472076389|FG000|Overall Study|Lack of Efficacy|2|||
131121816|NCT01942148|472076389|FG000|Overall Study|Physician Decision|11|||
131121817|NCT01942148|472076389|FG000|Overall Study|Protocol Violation|1|||
131121818|NCT01942148|472076389|FG000|Overall Study|Withdrawal by Subject|8|||
130705314|NCT01011556|470547200|FG003|Overall Study|Sponsor decision|2|||
131121819|NCT01942148|472076389|FG000|Overall Study|Use of the prohibition medicine|1|||
131121820|NCT02163187|472076390|FG000|Overall Study|Device removed|1|||
131121821|NCT02163187|472076391|FG001|Overall Study|Device removed|0|||
131121822|NCT02163187|472076390|FG000|Overall Study|Progressive disease|1|||
131121823|NCT02163187|472076391|FG001|Overall Study|Progressive disease|0|||
131121824|NCT00257725|472076393|FG000|Overall Study|Adverse Event|3|||
131121825|NCT01858532|472076394|FG000|Overall Study|Adverse Event|58|||
131121826|NCT01858532|472076395|FG001|Overall Study|Adverse Event|50|||
131121827|NCT01858532|472076396|FG002|Overall Study|Adverse Event|23|||
131121828|NCT01858532|472076397|FG003|Overall Study|Adverse Event|28|||
131121829|NCT01858532|472076394|FG000|Overall Study|Withdrew consent|71|||
131121830|NCT01858532|472076395|FG001|Overall Study|Withdrew consent|93|||
131121831|NCT01858532|472076396|FG002|Overall Study|Withdrew consent|46|||
131121832|NCT01858532|472076397|FG003|Overall Study|Withdrew consent|27|||
131121833|NCT01858532|472076394|FG000|Overall Study|Lost to Follow-up|17|||
131121834|NCT01858532|472076395|FG001|Overall Study|Lost to Follow-up|26|||
131121835|NCT01858532|472076396|FG002|Overall Study|Lost to Follow-up|11|||
131121836|NCT01858532|472076397|FG003|Overall Study|Lost to Follow-up|14|||
131121837|NCT01858532|472076394|FG000|Overall Study|Deterioration of medical status|3|||
131121838|NCT01858532|472076395|FG001|Overall Study|Deterioration of medical status|4|||
131121839|NCT01858532|472076396|FG002|Overall Study|Deterioration of medical status|3|||
131121840|NCT01858532|472076397|FG003|Overall Study|Deterioration of medical status|7|||
130705315|NCT01011556|470547197|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
130937660|NCT00556712|471404625|FG001|Overall Study|Protocol Violation|2|||
131121841|NCT01858532|472076394|FG000|Overall Study|Investigator request|3|||
131121842|NCT01858532|472076395|FG001|Overall Study|Investigator request|4|||
131121843|NCT01858532|472076396|FG002|Overall Study|Investigator request|2|||
131121844|NCT01858532|472076397|FG003|Overall Study|Investigator request|6|||
131121845|NCT01858532|472076394|FG000|Overall Study|Other, not specified|29|||
131121846|NCT01858532|472076395|FG001|Overall Study|Other, not specified|15|||
131121847|NCT01858532|472076396|FG002|Overall Study|Other, not specified|13|||
131121848|NCT01858532|472076397|FG003|Overall Study|Other, not specified|11|||
130771555|NCT00528372|470789929|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
130771556|NCT00528372|470789930|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
130771557|NCT00528372|470789931|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
130771558|NCT00528372|470789932|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
130771559|NCT00528372|470789933|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
130771560|NCT00528372|470789925|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
130771561|NCT00528372|470789926|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
130771562|NCT00528372|470789927|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
130771563|NCT00528372|470789928|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
130771564|NCT00528372|470789929|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
130771565|NCT00528372|470789930|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
130771566|NCT00528372|470789931|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
130771567|NCT00528372|470789932|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
130771568|NCT00528372|470789933|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
130771569|NCT00528372|470789925|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
130771570|NCT00528372|470789926|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
130771571|NCT00528372|470789927|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
130771572|NCT00528372|470789928|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
130771573|NCT00528372|470789929|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
130771574|NCT00528372|470789930|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
130771575|NCT00528372|470789931|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
130771576|NCT00528372|470789932|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
130771577|NCT00528372|470789933|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
130771578|NCT00528372|470789925|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
131121849|NCT00514514|472076398|FG000|Pre-phase|Death|10|||
131121850|NCT00514514|472076399|FG001|Pre-phase|Death|0|||
131121851|NCT00514514|472076400|FG002|Pre-phase|Death|0|||
131121852|NCT00514514|472076398|FG000|Pre-phase|administrative problems|2|||
131121853|NCT00514514|472076399|FG001|Pre-phase|administrative problems|0|||
131121854|NCT00514514|472076400|FG002|Pre-phase|administrative problems|0|||
131121855|NCT00514514|472076398|FG000|Pre-phase|Protocol Violation|6|||
131121856|NCT00514514|472076399|FG001|Pre-phase|Protocol Violation|0|||
131121857|NCT00514514|472076400|FG002|Pre-phase|Protocol Violation|0|||
131121858|NCT00514514|472076398|FG000|Pre-phase|condition no longer requires study drug|7|||
131121859|NCT00514514|472076399|FG001|Pre-phase|condition no longer requires study drug|0|||
131121860|NCT00514514|472076400|FG002|Pre-phase|condition no longer requires study drug|0|||
131121861|NCT00514514|472076398|FG000|Pre-phase|abnormal test procedure results|15|||
131121862|NCT00514514|472076399|FG001|Pre-phase|abnormal test procedure results|0|||
131121863|NCT00514514|472076400|FG002|Pre-phase|abnormal test procedure results|0|||
131121864|NCT00514514|472076398|FG000|Pre-phase|Lost to Follow-up|2|||
131121865|NCT00514514|472076399|FG001|Pre-phase|Lost to Follow-up|0|||
131121866|NCT00514514|472076400|FG002|Pre-phase|Lost to Follow-up|0|||
131121867|NCT00514514|472076398|FG000|Pre-phase|abnormal lab values|23|||
131121868|NCT00514514|472076399|FG001|Pre-phase|abnormal lab values|0|||
131121869|NCT00514514|472076400|FG002|Pre-phase|abnormal lab values|0|||
131121870|NCT00514514|472076398|FG000|Pre-phase|Lack of Efficacy|35|||
131121871|NCT00514514|472076399|FG001|Pre-phase|Lack of Efficacy|0|||
131121872|NCT00514514|472076400|FG002|Pre-phase|Lack of Efficacy|0|||
131121873|NCT00514514|472076398|FG000|Pre-phase|Adverse Event|137|||
131121874|NCT00514514|472076399|FG001|Pre-phase|Adverse Event|0|||
131121875|NCT00514514|472076400|FG002|Pre-phase|Adverse Event|0|||
131121876|NCT00514514|472076398|FG000|Pre-phase|Withdrawal by Subject|66|||
131121877|NCT00514514|472076399|FG001|Pre-phase|Withdrawal by Subject|0|||
131121878|NCT00514514|472076400|FG002|Pre-phase|Withdrawal by Subject|0|||
131121879|NCT00514514|472076398|FG000|Randomized - 9 Month|Death|3|||
131121880|NCT00514514|472076399|FG001|Randomized - 9 Month|Death|2|||
131121881|NCT00514514|472076400|FG002|Randomized - 9 Month|Death|2|||
131121882|NCT00514514|472076398|FG000|Randomized - 9 Month|Administrative problems|1|||
130771579|NCT00528372|470789926|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130771580|NCT00528372|470789927|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130771581|NCT00528372|470789928|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
131121883|NCT00514514|472076399|FG001|Randomized - 9 Month|Administrative problems|1|||
131121884|NCT00514514|472076400|FG002|Randomized - 9 Month|Administrative problems|2|||
131121885|NCT00514514|472076398|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
131121886|NCT00514514|472076399|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
131121887|NCT00514514|472076400|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
130771582|NCT00528372|470789929|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
131121888|NCT00514514|472076398|FG000|Randomized - 9 Month|Protocol Violation|1|||
131121889|NCT00514514|472076399|FG001|Randomized - 9 Month|Protocol Violation|1|||
131121890|NCT00514514|472076400|FG002|Randomized - 9 Month|Protocol Violation|0|||
131121891|NCT00514514|472076398|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
131121892|NCT00514514|472076399|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
130771583|NCT00528372|470789930|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130771584|NCT00528372|470789931|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130771585|NCT00528372|470789932|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130771586|NCT00528372|470789933|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130771587|NCT00528372|470789925|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130771588|NCT00528372|470789926|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130771589|NCT00528372|470789927|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130771590|NCT00528372|470789928|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130771591|NCT00528372|470789929|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
130771592|NCT00528372|470789930|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
130771593|NCT00528372|470789931|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130771594|NCT00528372|470789932|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130771595|NCT00528372|470789933|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130771596|NCT00528372|470789925|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130771597|NCT00528372|470789926|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
130771598|NCT00528372|470789927|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130771599|NCT00528372|470789928|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130771600|NCT00528372|470789929|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130771601|NCT00528372|470789930|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130771602|NCT00528372|470789931|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
130771603|NCT00528372|470789932|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130771604|NCT00528372|470789933|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
130771605|NCT00528372|470789925|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
130771606|NCT00528372|470789926|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
130771607|NCT00528372|470789927|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
130771608|NCT00528372|470789928|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
130771609|NCT00528372|470789929|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
130771610|NCT00528372|470789930|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
130771611|NCT00528372|470789931|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
130771612|NCT00528372|470789932|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
130771613|NCT00528372|470789933|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
130771614|NCT02772809|470789936|FG000|Overall Study|not completed some tasks|6|||
130771615|NCT00534105|470789937|FG000|Overall Study|Lost to Follow-up|23|||
130771616|NCT00534105|470789938|FG001|Overall Study|Lost to Follow-up|39|||
130771617|NCT02774005|470789939|FG000|Overall Study|Adverse Event|8|||
130771618|NCT02774005|470789939|FG000|Overall Study|Withdrawal by Subject|23|||
130771619|NCT02774005|470789939|FG000|Overall Study|Lost to Follow-up|7|||
130771620|NCT02774005|470789939|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
130771621|NCT02774005|470789939|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
130771622|NCT02774005|470789939|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
130771623|NCT02774005|470789939|FG000|Overall Study|Death|1|||
130771624|NCT02774005|470789939|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
130771625|NCT02774005|470789939|FG000|Overall Study|Lack of compliance with study medication|4|||
130771626|NCT02774005|470789939|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
130771627|NCT02774005|470789939|FG000|Overall Study|another study|1|||
130771628|NCT02774005|470789939|FG000|Overall Study|cardiologist imposed travel restriction|1|||
130771629|NCT03275389|470789940|FG000|Overall Study|Lost to Follow-up|10|||
130771630|NCT03275389|470789941|FG001|Overall Study|Lost to Follow-up|10|||
130771631|NCT03275389|470789942|FG002|Overall Study|Lost to Follow-up|19|||
130771632|NCT03275389|470789943|FG003|Overall Study|Lost to Follow-up|12|||
130771633|NCT03275389|470789944|FG004|Overall Study|Lost to Follow-up|11|||
130771634|NCT03275389|470789945|FG005|Overall Study|Lost to Follow-up|12|||
130771635|NCT03275389|470789946|FG006|Overall Study|Lost to Follow-up|21|||
130771636|NCT03275389|470789947|FG007|Overall Study|Lost to Follow-up|15|||
130771637|NCT03275389|470789948|FG008|Overall Study|Lost to Follow-up|12|||
130771638|NCT03275389|470789949|FG009|Overall Study|Lost to Follow-up|14|||
130771639|NCT03275389|470789940|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130771640|NCT03275389|470789941|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130771641|NCT03275389|470789942|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130771642|NCT03275389|470789943|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130771643|NCT03275389|470789944|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130771644|NCT03275389|470789945|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
130771645|NCT03275389|470789946|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130771646|NCT03275389|470789947|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130771647|NCT03275389|470789948|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130771648|NCT03275389|470789949|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
130937661|NCT00556712|471404624|FG000|Overall Study|Refused Treatment|17|||
130771649|NCT03275389|470789940|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
130771650|NCT03275389|470789941|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130771651|NCT03275389|470789942|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130771652|NCT03275389|470789943|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
130771653|NCT03275389|470789944|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130771654|NCT03275389|470789945|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130771655|NCT03275389|470789946|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130771656|NCT03275389|470789947|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130771657|NCT03275389|470789948|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
130771658|NCT03275389|470789949|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
130771659|NCT03275389|470789940|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130771660|NCT03275389|470789941|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130771661|NCT03275389|470789942|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130771662|NCT03275389|470789943|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
130771663|NCT03275389|470789944|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130771664|NCT03275389|470789945|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130771665|NCT03275389|470789946|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130771666|NCT03275389|470789947|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130771667|NCT03275389|470789948|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130771668|NCT03275389|470789949|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130771669|NCT03275389|470789940|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130771670|NCT03275389|470789941|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130771671|NCT03275389|470789942|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
130771672|NCT03275389|470789943|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130937662|NCT00556712|471404625|FG001|Overall Study|Refused Treatment|16|||
130937663|NCT00556712|471404624|FG000|Overall Study|Failure to Return|2|||
131035917|NCT02985957|471766185|FG000|Treatment Period|Other reasons|0|||
131035918|NCT02985957|471766186|FG001|Treatment Period|Other reasons|0|||
131035919|NCT02985957|471766187|FG002|Treatment Period|Other reasons|1|||
131035920|NCT02985957|471766188|FG003|Treatment Period|Other reasons|3|||
131035921|NCT02985957|471766189|FG004|Treatment Period|Other reasons|6|||
131035922|NCT02985957|471766190|FG005|Treatment Period|Other reasons|0|||
131035923|NCT02985957|471766191|FG006|Treatment Period|Other reasons|1|||
131035924|NCT02985957|471766185|FG000|Treatment Period|Not reported|0|||
131035925|NCT02985957|471766186|FG001|Treatment Period|Not reported|1|||
131121893|NCT00514514|472076400|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
131121894|NCT00514514|472076398|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
131121895|NCT00514514|472076399|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
131121896|NCT00514514|472076400|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
130771673|NCT03275389|470789944|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130771674|NCT03275389|470789945|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130771675|NCT03275389|470789946|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130771676|NCT03275389|470789947|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130771677|NCT03275389|470789948|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130771678|NCT03275389|470789949|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
130937664|NCT00556712|471404625|FG001|Overall Study|Failure to Return|3|||
130937665|NCT00556712|471404624|FG000|Overall Study|Other|2|||
130937666|NCT00556712|471404625|FG001|Overall Study|Other|2|||
130937667|NCT00556712|471404624|FG000|Overall Study|Ongoing at Data Cutoff|32|||
130937668|NCT00556712|471404625|FG001|Overall Study|Ongoing at Data Cutoff|66|||
130937669|NCT01962207|471404626|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
130937670|NCT01962207|471404627|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
130937671|NCT01962207|471404628|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
130937672|NCT01962207|471404629|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
130937673|NCT01962207|471404626|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
130937674|NCT01962207|471404627|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
130937675|NCT01962207|471404628|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
130937676|NCT01962207|471404629|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
130937677|NCT01962207|471404626|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
130937678|NCT01962207|471404627|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
130937679|NCT01962207|471404628|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
130937680|NCT01962207|471404629|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
130937681|NCT01962207|471404626|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
130937682|NCT01962207|471404627|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
130937683|NCT01962207|471404628|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
130937684|NCT01962207|471404629|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
131035926|NCT02985957|471766187|FG002|Treatment Period|Not reported|2|||
131035927|NCT02985957|471766188|FG003|Treatment Period|Not reported|5|||
131121897|NCT00514514|472076398|FG000|Randomized - 9 Month|Adverse Event|25|||
131121898|NCT00514514|472076399|FG001|Randomized - 9 Month|Adverse Event|44|||
130705316|NCT01011556|470547198|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
130705317|NCT01011556|470547199|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
130705318|NCT01011556|470547200|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
130705319|NCT00194792|470547202|FG000|Overall Study|Withdrawal by Subject|1|||
130705320|NCT01714739|470547203|FG000|Overall Study|Disease progression|3|||
130705321|NCT01714739|470547204|FG001|Overall Study|Disease progression|5|||
130705322|NCT01714739|470547205|FG002|Overall Study|Disease progression|5|||
130705323|NCT01714739|470547206|FG003|Overall Study|Disease progression|204|||
130705324|NCT01714739|470547207|FG004|Overall Study|Disease progression|1|||
130705325|NCT01714739|470547208|FG005|Overall Study|Disease progression|3|||
130705326|NCT01714739|470547209|FG006|Overall Study|Disease progression|5|||
130705327|NCT01714739|470547203|FG000|Overall Study|Study drug toxicity|1|||
130705328|NCT01714739|470547204|FG001|Overall Study|Study drug toxicity|1|||
130705329|NCT01714739|470547205|FG002|Overall Study|Study drug toxicity|1|||
130705330|NCT01714739|470547206|FG003|Overall Study|Study drug toxicity|15|||
130705331|NCT01714739|470547207|FG004|Overall Study|Study drug toxicity|0|||
130705332|NCT01714739|470547208|FG005|Overall Study|Study drug toxicity|0|||
130705333|NCT01714739|470547209|FG006|Overall Study|Study drug toxicity|5|||
130705334|NCT01714739|470547203|FG000|Overall Study|Death|0|||
130705335|NCT01714739|470547204|FG001|Overall Study|Death|0|||
130705336|NCT01714739|470547205|FG002|Overall Study|Death|0|||
130705337|NCT01714739|470547206|FG003|Overall Study|Death|1|||
130705338|NCT01714739|470547207|FG004|Overall Study|Death|0|||
130705339|NCT01714739|470547208|FG005|Overall Study|Death|0|||
130705340|NCT01714739|470547209|FG006|Overall Study|Death|0|||
130705341|NCT01714739|470547203|FG000|Overall Study|Adverse Event unrelated to drug|0|||
130705342|NCT01714739|470547204|FG001|Overall Study|Adverse Event unrelated to drug|0|||
130705343|NCT01714739|470547205|FG002|Overall Study|Adverse Event unrelated to drug|3|||
130705344|NCT01714739|470547206|FG003|Overall Study|Adverse Event unrelated to drug|21|||
130705345|NCT01714739|470547207|FG004|Overall Study|Adverse Event unrelated to drug|0|||
130705346|NCT01714739|470547208|FG005|Overall Study|Adverse Event unrelated to drug|0|||
130705347|NCT01714739|470547209|FG006|Overall Study|Adverse Event unrelated to drug|0|||
130705348|NCT01714739|470547203|FG000|Overall Study|Participant request to stop therapy|0|||
130705349|NCT01714739|470547204|FG001|Overall Study|Participant request to stop therapy|1|||
130705350|NCT01714739|470547205|FG002|Overall Study|Participant request to stop therapy|0|||
130705351|NCT01714739|470547206|FG003|Overall Study|Participant request to stop therapy|6|||
130705352|NCT01714739|470547207|FG004|Overall Study|Participant request to stop therapy|0|||
130705353|NCT01714739|470547208|FG005|Overall Study|Participant request to stop therapy|0|||
130705354|NCT01714739|470547209|FG006|Overall Study|Participant request to stop therapy|0|||
130705355|NCT01714739|470547203|FG000|Overall Study|Participant withdrew consent|0|||
130705356|NCT01714739|470547204|FG001|Overall Study|Participant withdrew consent|1|||
130705357|NCT01714739|470547205|FG002|Overall Study|Participant withdrew consent|0|||
130705358|NCT01714739|470547206|FG003|Overall Study|Participant withdrew consent|8|||
130705359|NCT01714739|470547207|FG004|Overall Study|Participant withdrew consent|0|||
130705360|NCT01714739|470547208|FG005|Overall Study|Participant withdrew consent|0|||
130705361|NCT01714739|470547209|FG006|Overall Study|Participant withdrew consent|0|||
130705362|NCT01714739|470547203|FG000|Overall Study|Lost to Follow-up|0|||
130705363|NCT01714739|470547204|FG001|Overall Study|Lost to Follow-up|0|||
130705364|NCT01714739|470547205|FG002|Overall Study|Lost to Follow-up|0|||
130705365|NCT01714739|470547206|FG003|Overall Study|Lost to Follow-up|1|||
130705366|NCT01714739|470547207|FG004|Overall Study|Lost to Follow-up|0|||
130705367|NCT01714739|470547208|FG005|Overall Study|Lost to Follow-up|0|||
130705368|NCT01714739|470547209|FG006|Overall Study|Lost to Follow-up|0|||
130705369|NCT01714739|470547203|FG000|Overall Study|Maximum clinical benefit|0|||
130705370|NCT01714739|470547204|FG001|Overall Study|Maximum clinical benefit|1|||
130705371|NCT01714739|470547205|FG002|Overall Study|Maximum clinical benefit|1|||
130705372|NCT01714739|470547206|FG003|Overall Study|Maximum clinical benefit|3|||
130705373|NCT01714739|470547207|FG004|Overall Study|Maximum clinical benefit|0|||
130705374|NCT01714739|470547208|FG005|Overall Study|Maximum clinical benefit|0|||
130705375|NCT01714739|470547209|FG006|Overall Study|Maximum clinical benefit|0|||
130705376|NCT01714739|470547203|FG000|Overall Study|Poor/non-comliance|0|||
130705377|NCT01714739|470547204|FG001|Overall Study|Poor/non-comliance|1|||
130771679|NCT03275389|470789940|FG000|Overall Study|Other|0|||
131121899|NCT00514514|472076400|FG002|Randomized - 9 Month|Adverse Event|27|||
131121900|NCT00514514|472076398|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
130705378|NCT01714739|470547205|FG002|Overall Study|Poor/non-comliance|0|||
130705379|NCT01714739|470547206|FG003|Overall Study|Poor/non-comliance|1|||
130705380|NCT01714739|470547207|FG004|Overall Study|Poor/non-comliance|0|||
130705381|NCT01714739|470547208|FG005|Overall Study|Poor/non-comliance|0|||
130705382|NCT01714739|470547209|FG006|Overall Study|Poor/non-comliance|0|||
130705383|NCT01714739|470547203|FG000|Overall Study|No longer meets study criteria|0|||
130705384|NCT01714739|470547204|FG001|Overall Study|No longer meets study criteria|0|||
130705385|NCT01714739|470547205|FG002|Overall Study|No longer meets study criteria|0|||
130771680|NCT03275389|470789941|FG001|Overall Study|Other|4|||
130705386|NCT01714739|470547206|FG003|Overall Study|No longer meets study criteria|1|||
130771681|NCT03275389|470789942|FG002|Overall Study|Other|3|||
130771682|NCT03275389|470789943|FG003|Overall Study|Other|2|||
130771683|NCT03275389|470789944|FG004|Overall Study|Other|2|||
130771684|NCT03275389|470789945|FG005|Overall Study|Other|2|||
130771685|NCT03275389|470789946|FG006|Overall Study|Other|0|||
130771686|NCT03275389|470789947|FG007|Overall Study|Other|0|||
130771687|NCT03275389|470789948|FG008|Overall Study|Other|1|||
130771688|NCT03275389|470789949|FG009|Overall Study|Other|0|||
130771689|NCT00978341|470789953|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
130771690|NCT00978341|470789954|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
130771691|NCT03035916|470789955|FG000|Overall Study|Puncture failed|0|||
130771692|NCT03035916|470789956|FG001|Overall Study|Puncture failed|2|||
130771693|NCT03035916|470789957|FG002|Overall Study|Puncture failed|0|||
130771694|NCT02749799|470789958|FG000|Overall Study|Adverse Event|2|||
130771695|NCT02749799|470789958|FG000|Overall Study|Lost to Follow-up|4|||
130771696|NCT02749799|470789958|FG000|Overall Study|Protocol Violation|1|||
130771697|NCT02749799|470789958|FG000|Overall Study|Withdrawal by Subject|1|||
131035928|NCT02985957|471766189|FG004|Treatment Period|Not reported|0|||
131035929|NCT02985957|471766190|FG005|Treatment Period|Not reported|0|||
130771698|NCT03749109|470789959|FG000|Overall Study|Adverse Event|2|||
130771699|NCT03749109|470789960|FG001|Overall Study|Adverse Event|0|||
131035930|NCT02985957|471766191|FG006|Treatment Period|Not reported|0|||
131035931|NCT02985957|471766185|FG000|Treatment Period|Maximum clinical benefit|0|||
131035932|NCT02985957|471766186|FG001|Treatment Period|Maximum clinical benefit|0|||
131035933|NCT02985957|471766187|FG002|Treatment Period|Maximum clinical benefit|1|||
131035934|NCT02985957|471766188|FG003|Treatment Period|Maximum clinical benefit|1|||
131035935|NCT02985957|471766189|FG004|Treatment Period|Maximum clinical benefit|0|||
131035936|NCT02985957|471766190|FG005|Treatment Period|Maximum clinical benefit|0|||
131035937|NCT02985957|471766191|FG006|Treatment Period|Maximum clinical benefit|2|||
130705387|NCT01714739|470547207|FG004|Overall Study|No longer meets study criteria|0|||
130705388|NCT01714739|470547208|FG005|Overall Study|No longer meets study criteria|0|||
130705389|NCT01714739|470547209|FG006|Overall Study|No longer meets study criteria|0|||
130771700|NCT02075008|470792679|FG000|Overall Study|Technical problems|1|||
130771701|NCT02075008|470792679|FG000|Overall Study|Pregnancy|1|||
130771702|NCT02075008|470792679|FG000|Overall Study|Physician Decision|1|||
130705390|NCT01714739|470547203|FG000|Overall Study|Other reason|0|||
130705391|NCT01714739|470547204|FG001|Overall Study|Other reason|0|||
130705392|NCT01714739|470547205|FG002|Overall Study|Other reason|0|||
130705393|NCT01714739|470547206|FG003|Overall Study|Other reason|3|||
130705394|NCT01714739|470547207|FG004|Overall Study|Other reason|1|||
130705395|NCT01714739|470547208|FG005|Overall Study|Other reason|0|||
130705396|NCT01714739|470547209|FG006|Overall Study|Other reason|0|||
130705397|NCT03585959|470547210|FG000|Overall Study|Physician Decision|1|||
130705398|NCT03585959|470547210|FG000|Overall Study|Unsuccessful Procedure|2|||
130705399|NCT01740791|470547211|FG000|Overall Study|Randomized but never treated|5|||
130705400|NCT01740791|470547212|FG001|Overall Study|Randomized but never treated|3|||
130705401|NCT01740791|470547213|FG002|Overall Study|Randomized but never treated|2|||
130705402|NCT01740791|470547214|FG003|Overall Study|Randomized but never treated|2|||
130705403|NCT01740791|470547215|FG004|Overall Study|Randomized but never treated|1|||
130705404|NCT01740791|470547216|FG005|Overall Study|Randomized but never treated|3|||
130705405|NCT01740791|470547211|FG000|Overall Study|Lost to Follow-up|2|||
130705406|NCT01740791|470547212|FG001|Overall Study|Lost to Follow-up|0|||
130705407|NCT01740791|470547213|FG002|Overall Study|Lost to Follow-up|2|||
130705408|NCT01740791|470547214|FG003|Overall Study|Lost to Follow-up|3|||
130705409|NCT01740791|470547215|FG004|Overall Study|Lost to Follow-up|2|||
130705410|NCT01740791|470547216|FG005|Overall Study|Lost to Follow-up|3|||
130705411|NCT01740791|470547211|FG000|Overall Study|Withdrew Consent|4|||
130705412|NCT01740791|470547212|FG001|Overall Study|Withdrew Consent|0|||
130705413|NCT01740791|470547213|FG002|Overall Study|Withdrew Consent|1|||
130705414|NCT01740791|470547214|FG003|Overall Study|Withdrew Consent|2|||
130705415|NCT01740791|470547215|FG004|Overall Study|Withdrew Consent|0|||
130705416|NCT01740791|470547216|FG005|Overall Study|Withdrew Consent|3|||
130705417|NCT01740791|470547211|FG000|Overall Study|Investigator's discretion|1|||
130705418|NCT01740791|470547212|FG001|Overall Study|Investigator's discretion|0|||
130705419|NCT01740791|470547213|FG002|Overall Study|Investigator's discretion|1|||
130771703|NCT02075008|470792679|FG000|Overall Study|Lost to Follow-up|1|||
130771704|NCT02075008|470792679|FG000|Overall Study|Lack of Efficacy|1|||
130771705|NCT02075008|470792679|FG000|Overall Study|Death|1|||
130771706|NCT02075008|470792679|FG000|Overall Study|Adverse Event|5|||
131035938|NCT02985957|471766185|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
131035939|NCT02985957|471766186|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
130705420|NCT01740791|470547214|FG003|Overall Study|Investigator's discretion|0|||
130705421|NCT01740791|470547215|FG004|Overall Study|Investigator's discretion|0|||
130705422|NCT01740791|470547216|FG005|Overall Study|Investigator's discretion|1|||
130705423|NCT01740791|470547211|FG000|Overall Study|Adverse Event|0|||
130771707|NCT02075008|470792679|FG000|Overall Study|Withdrawal by Subject|6|||
130771708|NCT02075008|470792679|FG000|Overall Study|Study terminated by Sponsor|159|||
130771709|NCT00660595|470792680|FG000|Overall Study|Lost to Follow-up|0|||
130937685|NCT01962207|471404626|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
130937686|NCT01962207|471404627|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
130937687|NCT01962207|471404628|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
130937688|NCT01962207|471404629|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
130937689|NCT01962207|471404626|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
130937690|NCT01962207|471404627|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
130937691|NCT01962207|471404628|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
130937692|NCT01962207|471404629|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
130937693|NCT03036072|471404632|FG000|Overall Study|Death|0|||
130937694|NCT03036072|471404633|FG001|Overall Study|Death|1|||
130937695|NCT03036072|471404632|FG000|Overall Study|Withdrawal by Subject|0|||
130937696|NCT03036072|471404633|FG001|Overall Study|Withdrawal by Subject|1|||
130937697|NCT03036072|471404632|FG000|Overall Study|Physician Decision|0|||
130937698|NCT03036072|471404633|FG001|Overall Study|Physician Decision|1|||
130937699|NCT02484729|471404634|FG000|Overall Study|Failure of IntelliCap Error|0|||
130937700|NCT02484729|471404635|FG001|Overall Study|Failure of IntelliCap Error|0|||
130937701|NCT02484729|471404636|FG002|Overall Study|Failure of IntelliCap Error|0|||
130771710|NCT00660595|470792681|FG001|Overall Study|Lost to Follow-up|1|||
130771711|NCT00660595|470792680|FG000|Overall Study|Did not consent to participate in study|12|||
130937702|NCT02484729|471404637|FG003|Overall Study|Failure of IntelliCap Error|0|||
130937703|NCT02484729|471404638|FG004|Overall Study|Failure of IntelliCap Error|0|||
131121901|NCT00514514|472076399|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
131121902|NCT00514514|472076400|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
131121903|NCT00514514|472076398|FG000|Extension - 4 Years|Lost to Follow-up|12|||
131121904|NCT00514514|472076399|FG001|Extension - 4 Years|Lost to Follow-up|10|||
130771712|NCT00660595|470792681|FG001|Overall Study|Did not consent to participate in study|8|||
130771713|NCT00660595|470792680|FG000|Overall Study|Participant left hospital|1|||
130771714|NCT00660595|470792681|FG001|Overall Study|Participant left hospital|0|||
130771715|NCT00660595|470792680|FG000|Overall Study|Non Specified reasons|5|||
130771716|NCT00660595|470792681|FG001|Overall Study|Non Specified reasons|0|||
130771717|NCT05205005|470792682|FG000|Overall Study|Withdrawal by Subject|1|||
130771718|NCT05205005|470792683|FG001|Overall Study|Withdrawal by Subject|0|||
130771719|NCT05205005|470792682|FG000|Overall Study|Adverse Event|1|||
130771720|NCT05205005|470792683|FG001|Overall Study|Adverse Event|0|||
130771721|NCT01763203|470792690|FG000|Overall Study|Death|4|||
130771722|NCT01763203|470792691|FG001|Overall Study|Death|7|||
130771723|NCT01763203|470792690|FG000|Overall Study|Lost to Follow-up|12|||
130771724|NCT01763203|470792691|FG001|Overall Study|Lost to Follow-up|12|||
130771725|NCT01763203|470792690|FG000|Overall Study|Withdrawal by Subject|8|||
130771726|NCT01763203|470792691|FG001|Overall Study|Withdrawal by Subject|12|||
130771727|NCT01763203|470792690|FG000|Overall Study|Moved out of study region|7|||
130771728|NCT01763203|470792691|FG001|Overall Study|Moved out of study region|10|||
130771729|NCT01763203|470792690|FG000|Overall Study|Physician Decision|2|||
130771730|NCT01763203|470792691|FG001|Overall Study|Physician Decision|1|||
130771731|NCT02187861|470792692|FG000|Overall Study|Adverse Event|2|||
130771732|NCT02187861|470792693|FG001|Overall Study|Adverse Event|1|||
130771733|NCT02187861|470792694|FG002|Overall Study|Adverse Event|2|||
130771734|NCT02187861|470792695|FG003|Overall Study|Adverse Event|1|||
130771735|NCT02187861|470792692|FG000|Overall Study|Death|0|||
130771736|NCT02187861|470792693|FG001|Overall Study|Death|3|||
130771737|NCT02187861|470792694|FG002|Overall Study|Death|1|||
130771738|NCT02187861|470792695|FG003|Overall Study|Death|2|||
130771739|NCT02187861|470792692|FG000|Overall Study|Physician Decision|0|||
130771740|NCT02187861|470792693|FG001|Overall Study|Physician Decision|1|||
130771741|NCT02187861|470792694|FG002|Overall Study|Physician Decision|0|||
131121905|NCT00514514|472076400|FG002|Extension - 4 Years|Lost to Follow-up|9|||
130771742|NCT02187861|470792695|FG003|Overall Study|Physician Decision|3|||
130771743|NCT02187861|470792692|FG000|Overall Study|Progressive Disease|4|||
130771744|NCT02187861|470792693|FG001|Overall Study|Progressive Disease|42|||
130771745|NCT02187861|470792694|FG002|Overall Study|Progressive Disease|19|||
130771746|NCT02187861|470792695|FG003|Overall Study|Progressive Disease|22|||
130771747|NCT02187861|470792692|FG000|Overall Study|Withdrawal by Subject|0|||
130771748|NCT02187861|470792693|FG001|Overall Study|Withdrawal by Subject|0|||
130771749|NCT02187861|470792694|FG002|Overall Study|Withdrawal by Subject|3|||
130771750|NCT02187861|470792695|FG003|Overall Study|Withdrawal by Subject|3|||
130771751|NCT02187861|470792692|FG000|Overall Study|Other|0|||
130771752|NCT02187861|470792693|FG001|Overall Study|Other|1|||
130771753|NCT02187861|470792694|FG002|Overall Study|Other|7|||
130771754|NCT02187861|470792695|FG003|Overall Study|Other|1|||
130771755|NCT02757625|470792697|FG000|Overall Study|Investigator's discretion|0|||
130771756|NCT02757625|470792698|FG001|Overall Study|Investigator's discretion|0|||
130771757|NCT02757625|470792699|FG002|Overall Study|Investigator's discretion|1|||
130771758|NCT02757625|470792700|FG003|Overall Study|Investigator's discretion|0|||
130771759|NCT02757625|470792697|FG000|Overall Study|Adverse Event|0|||
130771760|NCT02757625|470792698|FG001|Overall Study|Adverse Event|0|||
130937704|NCT02484729|471404639|FG005|Overall Study|Failure of IntelliCap Error|0|||
130937705|NCT02484729|471404640|FG006|Overall Study|Failure of IntelliCap Error|0|||
130937706|NCT02484729|471404641|FG007|Overall Study|Failure of IntelliCap Error|0|||
130937707|NCT02484729|471404642|FG008|Overall Study|Failure of IntelliCap Error|0|||
130937708|NCT02484729|471404643|FG009|Overall Study|Failure of IntelliCap Error|1|||
130937709|NCT02111850|471404646|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130937710|NCT02111850|471404647|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130937711|NCT02111850|471404648|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130937712|NCT02111850|471404649|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130937713|NCT02111850|471404650|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
130937714|NCT02111850|471404651|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130937715|NCT02111850|471404652|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130937716|NCT02111850|471404653|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130937717|NCT02111850|471404654|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130937718|NCT02111850|471404655|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130937719|NCT02111850|471404656|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
130705424|NCT01740791|470547212|FG001|Overall Study|Adverse Event|0|||
130705425|NCT01740791|470547213|FG002|Overall Study|Adverse Event|0|||
130705426|NCT01740791|470547214|FG003|Overall Study|Adverse Event|0|||
130705427|NCT01740791|470547215|FG004|Overall Study|Adverse Event|0|||
130705428|NCT01740791|470547216|FG005|Overall Study|Adverse Event|1|||
130705429|NCT01463982|470547217|FG000|Overall Study|Withdrawal by Subject|0|||
130705430|NCT01463982|470547218|FG001|Overall Study|Withdrawal by Subject|1|||
130705431|NCT01463982|470547219|FG002|Overall Study|Withdrawal by Subject|1|||
130705432|NCT01463982|470547220|FG003|Overall Study|Withdrawal by Subject|0|||
130705433|NCT01463982|470547217|FG000|Overall Study|Treatment delay over 5 week|0|||
130705434|NCT01463982|470547218|FG001|Overall Study|Treatment delay over 5 week|0|||
130705435|NCT01463982|470547219|FG002|Overall Study|Treatment delay over 5 week|1|||
130705436|NCT01463982|470547220|FG003|Overall Study|Treatment delay over 5 week|0|||
130705437|NCT04220775|470547223|FG000|Overall Study|Adverse Event|1|||
130705438|NCT04220775|470547224|FG001|Overall Study|Adverse Event|0|||
130705439|NCT04220775|470547223|FG000|Overall Study|Disease Progression|1|||
130705440|NCT04220775|470547224|FG001|Overall Study|Disease Progression|0|||
130705441|NCT00089076|470547225|FG000|Overall Study|Alternate Therapy|1|||
130705442|NCT00089076|470547225|FG000|Overall Study|Withdrawal by Subject|2|||
130705443|NCT00089076|470547225|FG000|Overall Study|Progression|7|||
130705444|NCT00931463|470547226|FG000|Overall Study|Death|8|||
130705445|NCT00931463|470547227|FG001|Overall Study|Death|4|||
130705446|NCT00931463|470547226|FG000|Overall Study|Withdrawal by Subject|5|||
130705447|NCT00931463|470547227|FG001|Overall Study|Withdrawal by Subject|0|||
130705448|NCT00931463|470547226|FG000|Overall Study|Lost to Follow-up|4|||
130705449|NCT00931463|470547227|FG001|Overall Study|Lost to Follow-up|1|||
130705450|NCT03170869|470547228|FG000|Overall Study|Protocol Violation|5|||
130705451|NCT03170869|470547228|FG000|Overall Study|Early study termination|3|||
130705452|NCT01009515|470547229|FG000|Overall Study|Withdrawal by Subject|3|||
130705453|NCT00983476|470547235|FG000|Overall Study|Did not receive intervention|17|||
130705454|NCT00983476|470547236|FG001|Overall Study|Did not receive intervention|22|||
130705455|NCT00983476|470547237|FG002|Overall Study|Did not receive intervention|0|||
130705456|NCT01175473|470547239|FG000|Overall Study|Adverse Event|2|||
130705457|NCT01175473|470547240|FG001|Overall Study|Adverse Event|2|||
130705458|NCT01857206|470547241|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
130705459|NCT01857206|470547242|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
130705460|NCT01857206|470547241|FG000|Overall Study|Lost to Follow-up|9|||
130705461|NCT01857206|470547242|FG001|Overall Study|Lost to Follow-up|6|||
130705462|NCT01857206|470547241|FG000|Overall Study|Unclassified|3|||
130705463|NCT01857206|470547242|FG001|Overall Study|Unclassified|3|||
130705464|NCT01857206|470547241|FG000|Overall Study|Withdrawal by Subject|1|||
130705465|NCT01857206|470547242|FG001|Overall Study|Withdrawal by Subject|0|||
130705466|NCT01857973|470547243|FG000|Overall Study|Subject did not meet required BG range|3|||
130705467|NCT01857973|470547243|FG000|Overall Study|drop out after 3 failed attempts|1|||
130705468|NCT01857973|470547243|FG000|Overall Study|Physician Decision|1|||
130705469|NCT00129116|470547246|FG000|Primary Phase|Lost to Follow-up|1|||
130705470|NCT00129116|470547247|FG001|Primary Phase|Lost to Follow-up|1|||
130705471|NCT00129116|470547248|FG002|Primary Phase|Lost to Follow-up|0|||
130705472|NCT00129116|470547249|FG003|Primary Phase|Lost to Follow-up|1|||
130705473|NCT00129116|470547250|FG004|Primary Phase|Lost to Follow-up|1|||
130705474|NCT00129116|470547246|FG000|Primary Phase|Protocol Violation|0|||
130705475|NCT00129116|470547247|FG001|Primary Phase|Protocol Violation|1|||
130705476|NCT00129116|470547248|FG002|Primary Phase|Protocol Violation|0|||
130705477|NCT00129116|470547249|FG003|Primary Phase|Protocol Violation|0|||
130705478|NCT00129116|470547250|FG004|Primary Phase|Protocol Violation|0|||
130705479|NCT00129116|470547246|FG000|Primary Phase|Adverse Event|1|||
130705480|NCT00129116|470547247|FG001|Primary Phase|Adverse Event|1|||
130705481|NCT00129116|470547248|FG002|Primary Phase|Adverse Event|0|||
130705482|NCT00129116|470547249|FG003|Primary Phase|Adverse Event|0|||
130705483|NCT00129116|470547250|FG004|Primary Phase|Adverse Event|0|||
130937720|NCT00665847|471404657|FG000|Overall Study|Adverse Event|8|||
130937721|NCT00665847|471404657|FG000|Overall Study|Withdrawal by Subject|2|||
130937722|NCT00665847|471404657|FG000|Overall Study|Subject non-compliant|8|||
130937723|NCT00665847|471404657|FG000|Overall Study|Subject reached a virologic endpoint|4|||
130937724|NCT00665847|471404657|FG000|Overall Study|Resistance to TMC125|1|||
130937725|NCT00665847|471404657|FG000|Overall Study|Subject ineligible to continue the trial|1|||
130937726|NCT00665847|471404657|FG000|Overall Study|Switch to Commercial Medication|1|||
130937727|NCT03605303|471404658|FG000|Period 1|Study Terminated|2|||
130937728|NCT03605303|471404659|FG001|Period 1|Study Terminated|1|||
130937729|NCT00353262|471404660|FG000|Overall Study|Adverse Event|8|||
131035940|NCT02985957|471766187|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
130771761|NCT02757625|470792699|FG002|Overall Study|Adverse Event|1|||
130771762|NCT02757625|470792700|FG003|Overall Study|Adverse Event|0|||
130771763|NCT04854057|470792701|FG000|Overall Study|Adverse Event|0|||
130771764|NCT04854057|470792702|FG001|Overall Study|Adverse Event|1|||
130771765|NCT03519919|470792703|FG000|Overall Study|Withdrawal by Subject|1|||
130771766|NCT03519919|470792703|FG000|Overall Study|Lack of Efficacy|1|||
130771767|NCT03519919|470792703|FG000|Overall Study|Screen Failure|1|||
130771768|NCT00645671|470792704|FG000|Overall Study|Protocol Violation|1|||
130771769|NCT00645671|470792705|FG001|Overall Study|Protocol Violation|0|||
130771770|NCT00645671|470792704|FG000|Overall Study|Withdrawal by Subject|0|||
130771771|NCT00645671|470792705|FG001|Overall Study|Withdrawal by Subject|4|||
130771772|NCT00645671|470792704|FG000|Overall Study|Adverse Event|0|||
130771773|NCT00645671|470792705|FG001|Overall Study|Adverse Event|1|||
130771774|NCT00645671|470792704|FG000|Overall Study|Physician Decision|0|||
130771775|NCT00645671|470792705|FG001|Overall Study|Physician Decision|1|||
130771776|NCT05114564|470792706|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
130771777|NCT05114564|470792707|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
130771778|NCT05114564|470792706|FG000|First Intervention|Adverse Event|0|||
130771779|NCT05114564|470792707|FG001|First Intervention|Adverse Event|1|||
130771780|NCT00493311|470792708|FG000|Overall Study|Need for rescue medication|2|||
130771781|NCT00493311|470792709|FG001|Overall Study|Need for rescue medication|2|||
130771782|NCT02779075|470792710|FG000|Overall Study|Withdrawal by Subject|1|||
130771783|NCT02779075|470792711|FG001|Overall Study|Withdrawal by Subject|3|||
130771784|NCT02779075|470792710|FG000|Overall Study|IV lost during 2nd study|1|||
130771785|NCT02779075|470792711|FG001|Overall Study|IV lost during 2nd study|0|||
130771786|NCT01951573|470792712|FG000|Washout Period|Adverse Event|0|||
130771787|NCT01951573|470792713|FG001|Washout Period|Adverse Event|1|||
130771788|NCT00707980|470792714|FG000|Overall Study|Adverse Event|49|||
130771789|NCT00707980|470792714|FG000|Overall Study|Lack of Efficacy|35|||
130771790|NCT00707980|470792714|FG000|Overall Study|Non-Compliance with Study Drug|28|||
130771791|NCT00707980|470792714|FG000|Overall Study|Protocol Deviations|19|||
130771792|NCT00707980|470792714|FG000|Overall Study|Withdrawal of Consent|81|||
130771793|NCT00707980|470792714|FG000|Overall Study|Lost to Follow-up|59|||
130771794|NCT00707980|470792714|FG000|Overall Study|Other|39|||
130771795|NCT01909973|470792715|FG000|Overall Study|Lost to Follow-up|1|||
130771796|NCT01909973|470792716|FG001|Overall Study|Lost to Follow-up|0|||
130771797|NCT01152996|470792717|FG000|Overall Study|Withdrawal by Subject|142|||
130771798|NCT01152996|470792717|FG000|Overall Study|Adverse Event|115|||
130771799|NCT01152996|470792717|FG000|Overall Study|Lost to Follow-up|112|||
130771800|NCT01152996|470792717|FG000|Overall Study|Lack of Efficacy|68|||
130771801|NCT01152996|470792717|FG000|Overall Study|Noncompliance|41|||
130771802|NCT01152996|470792717|FG000|Overall Study|Other|36|||
130771803|NCT01152996|470792717|FG000|Overall Study|Protocol Violation|22|||
130771804|NCT01152996|470792717|FG000|Overall Study|Elevated liver enzymes|1|||
130771805|NCT02072941|470792718|FG000|Overall Study|Withdrawal by Subject|29|||
130771806|NCT02072941|470792719|FG001|Overall Study|Withdrawal by Subject|21|||
130771807|NCT02072941|470792718|FG000|Overall Study|Lost to Follow-up|4|||
130771808|NCT02072941|470792719|FG001|Overall Study|Lost to Follow-up|4|||
130771809|NCT02072941|470792718|FG000|Overall Study|Death|3|||
130771810|NCT02072941|470792719|FG001|Overall Study|Death|2|||
130771811|NCT02072941|470792718|FG000|Overall Study|Removed by Study Staff|2|||
130771812|NCT02072941|470792719|FG001|Overall Study|Removed by Study Staff|2|||
130771813|NCT00460239|470792720|FG000|Overall Study|Physician Decision|0|||
130771814|NCT00460239|470792721|FG001|Overall Study|Physician Decision|1|||
130771815|NCT00460239|470792722|FG002|Overall Study|Physician Decision|0|||
130771816|NCT00460239|470792723|FG003|Overall Study|Physician Decision|0|||
130771817|NCT00460239|470792724|FG004|Overall Study|Physician Decision|0|||
130771818|NCT00460239|470792725|FG005|Overall Study|Physician Decision|2|||
130771819|NCT00460239|470792726|FG006|Overall Study|Physician Decision|0|||
130771820|NCT00460239|470792727|FG007|Overall Study|Physician Decision|0|||
130771821|NCT00460239|470792728|FG008|Overall Study|Physician Decision|0|||
130771822|NCT00460239|470792720|FG000|Overall Study|Withdrawal by Subject|0|||
130771823|NCT00460239|470792721|FG001|Overall Study|Withdrawal by Subject|0|||
130771824|NCT00460239|470792722|FG002|Overall Study|Withdrawal by Subject|0|||
130937730|NCT00353262|471404660|FG000|Overall Study|Withdrawal by Subject|2|||
130937731|NCT00353262|471404660|FG000|Overall Study|Insufficient Therapeutic Response|13|||
130771825|NCT00460239|470792723|FG003|Overall Study|Withdrawal by Subject|0|||
130771826|NCT00460239|470792724|FG004|Overall Study|Withdrawal by Subject|0|||
130771827|NCT00460239|470792725|FG005|Overall Study|Withdrawal by Subject|1|||
130771828|NCT00460239|470792726|FG006|Overall Study|Withdrawal by Subject|0|||
130771829|NCT00460239|470792727|FG007|Overall Study|Withdrawal by Subject|0|||
130771830|NCT00460239|470792728|FG008|Overall Study|Withdrawal by Subject|0|||
130771831|NCT04217317|470792757|FG000|Overall Study|Lack of Efficacy|4|||
130771832|NCT04217317|470792757|FG000|Overall Study|Physician Decision|1|||
130771833|NCT04313400|470792763|FG000|Overall Study|Withdrawal by Subject|0|||
131121906|NCT00514514|472076398|FG000|Extension - 4 Years|Administrative problems|3|||
131121907|NCT00514514|472076399|FG001|Extension - 4 Years|Administrative problems|1|||
131121908|NCT00514514|472076400|FG002|Extension - 4 Years|Administrative problems|1|||
131121909|NCT00514514|472076398|FG000|Extension - 4 Years|Death|8|||
131121910|NCT00514514|472076399|FG001|Extension - 4 Years|Death|3|||
131121911|NCT00514514|472076400|FG002|Extension - 4 Years|Death|6|||
131121912|NCT00514514|472076398|FG000|Extension - 4 Years|Adverse Event|9|||
131121913|NCT00514514|472076399|FG001|Extension - 4 Years|Adverse Event|6|||
131121914|NCT00514514|472076400|FG002|Extension - 4 Years|Adverse Event|3|||
131121915|NCT03785925|472076402|FG000|Overall Study|Withdrawal by Subject|15|||
131121916|NCT03785925|472076402|FG000|Overall Study|Lost to Follow-up|1|||
131121917|NCT01848288|472076407|FG000|Overall Study|Death|1|||
131121918|NCT01848288|472076407|FG000|Overall Study|Protocol Violation|1|||
131121919|NCT01848288|472076407|FG000|Overall Study|Withdrawal by Subject|1|||
131121920|NCT01007032|472076409|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
131121921|NCT01007032|472076410|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
131121922|NCT01007032|472076411|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
131121923|NCT01007032|472076412|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
131121924|NCT01007032|472076409|FG000|Overall Study|Withdrawal by Subject|0|||
131121925|NCT01007032|472076410|FG001|Overall Study|Withdrawal by Subject|0|||
131121926|NCT01007032|472076411|FG002|Overall Study|Withdrawal by Subject|0|||
131121927|NCT01007032|472076412|FG003|Overall Study|Withdrawal by Subject|1|||
131121928|NCT01841749|472076413|FG000|Overall Study|Protocol Violation|1|||
131121929|NCT00677820|472076414|FG000|Overall Study|Lost to Follow-up|1|||
131121930|NCT00677820|472076415|FG001|Overall Study|Lost to Follow-up|0|||
131121931|NCT00290290|472076416|FG000|Overall Study|Death|3|||
131121932|NCT00290290|472076417|FG001|Overall Study|Death|4|||
131121933|NCT00290290|472076416|FG000|Overall Study|Withdrawal by Subject|2|||
131121934|NCT00290290|472076417|FG001|Overall Study|Withdrawal by Subject|2|||
131121935|NCT00290290|472076416|FG000|Overall Study|Underwent clean surgical procedure|13|||
131121936|NCT00290290|472076417|FG001|Overall Study|Underwent clean surgical procedure|12|||
131121937|NCT03794583|472076423|FG000|Overall Study|Death|8|||
131121938|NCT03794583|472076423|FG000|Overall Study|Study Terminated by Sponsor|24|||
131121939|NCT03794583|472076423|FG000|Overall Study|Withdrawal by Subject|9|||
131121940|NCT00003895|472076424|FG000|Overall Study|Adverse Event|4|||
131121941|NCT00003895|472076425|FG001|Overall Study|Adverse Event|0|||
131121942|NCT00003895|472076424|FG000|Overall Study|Lack of Efficacy|1|||
131121943|NCT00003895|472076425|FG001|Overall Study|Lack of Efficacy|1|||
131121944|NCT00003895|472076424|FG000|Overall Study|Patient Vacation|2|||
131121945|NCT00003895|472076425|FG001|Overall Study|Patient Vacation|0|||
131121946|NCT00003895|472076424|FG000|Overall Study|Withdrawal by Subject|0|||
131121947|NCT00003895|472076425|FG001|Overall Study|Withdrawal by Subject|3|||
131121948|NCT00806195|472076428|FG000|Overall Study|Death|6|||
131121949|NCT00806195|472076429|FG001|Overall Study|Death|0|||
131121950|NCT00806195|472076430|FG002|Overall Study|Death|1|||
131121951|NCT00806195|472076431|FG003|Overall Study|Death|0|||
131121952|NCT00806195|472076428|FG000|Overall Study|Adverse Event|25|||
131121953|NCT00806195|472076429|FG001|Overall Study|Adverse Event|5|||
131121954|NCT00806195|472076430|FG002|Overall Study|Adverse Event|11|||
131121955|NCT00806195|472076431|FG003|Overall Study|Adverse Event|2|||
131121956|NCT00806195|472076428|FG000|Overall Study|Withdrawal by Subject|119|||
131121957|NCT00806195|472076429|FG001|Overall Study|Withdrawal by Subject|31|||
131121958|NCT00806195|472076430|FG002|Overall Study|Withdrawal by Subject|76|||
131121959|NCT00806195|472076431|FG003|Overall Study|Withdrawal by Subject|35|||
131121960|NCT00806195|472076428|FG000|Overall Study|Lost to Follow-up|217|||
131121961|NCT00806195|472076429|FG001|Overall Study|Lost to Follow-up|66|||
131121962|NCT00806195|472076430|FG002|Overall Study|Lost to Follow-up|90|||
131121963|NCT00806195|472076431|FG003|Overall Study|Lost to Follow-up|34|||
131121964|NCT00806195|472076428|FG000|Overall Study|Inappropriate Enrollment|0|||
131121965|NCT00806195|472076429|FG001|Overall Study|Inappropriate Enrollment|1|||
131121966|NCT00806195|472076430|FG002|Overall Study|Inappropriate Enrollment|0|||
131121967|NCT00806195|472076431|FG003|Overall Study|Inappropriate Enrollment|0|||
131121968|NCT00806195|472076428|FG000|Overall Study|Administrative Reason|113|||
131121969|NCT00806195|472076429|FG001|Overall Study|Administrative Reason|35|||
131121970|NCT00806195|472076430|FG002|Overall Study|Administrative Reason|66|||
131121971|NCT00806195|472076431|FG003|Overall Study|Administrative Reason|26|||
131121972|NCT00806195|472076428|FG000|Overall Study|Protocol Violation|34|||
131121973|NCT00806195|472076429|FG001|Overall Study|Protocol Violation|24|||
131121974|NCT00806195|472076430|FG002|Overall Study|Protocol Violation|26|||
130705484|NCT00129116|470547246|FG000|Primary Phase|Withdrawal by Subject|0|||
130705485|NCT00129116|470547247|FG001|Primary Phase|Withdrawal by Subject|1|||
130705486|NCT00129116|470547248|FG002|Primary Phase|Withdrawal by Subject|0|||
130705487|NCT00129116|470547249|FG003|Primary Phase|Withdrawal by Subject|0|||
130705488|NCT00129116|470547250|FG004|Primary Phase|Withdrawal by Subject|0|||
130705489|NCT00129116|470547246|FG000|Primary Phase|Other|0|||
130705490|NCT00129116|470547247|FG001|Primary Phase|Other|0|||
130705491|NCT00129116|470547248|FG002|Primary Phase|Other|1|||
130705492|NCT00129116|470547249|FG003|Primary Phase|Other|0|||
130705493|NCT00129116|470547250|FG004|Primary Phase|Other|0|||
130705494|NCT00129116|470547246|FG000|Booster Phase|Lost to Follow-up|2|||
130705495|NCT00129116|470547247|FG001|Booster Phase|Lost to Follow-up|0|||
130705496|NCT00129116|470547248|FG002|Booster Phase|Lost to Follow-up|0|||
130705497|NCT00129116|470547249|FG003|Booster Phase|Lost to Follow-up|0|||
130705498|NCT00129116|470547250|FG004|Booster Phase|Lost to Follow-up|1|||
130705499|NCT00869440|470547251|FG000|Overall Study|Withdrawal by Subject|1|||
130705500|NCT00869440|470547252|FG001|Overall Study|Withdrawal by Subject|0|||
130705501|NCT00869440|470547253|FG002|Overall Study|Withdrawal by Subject|0|||
130705502|NCT00869440|470547254|FG003|Overall Study|Withdrawal by Subject|0|||
130705503|NCT00869440|470547251|FG000|Overall Study|Physician Decision|1|||
130705504|NCT00869440|470547252|FG001|Overall Study|Physician Decision|1|||
130705505|NCT00869440|470547253|FG002|Overall Study|Physician Decision|0|||
130705506|NCT00869440|470547254|FG003|Overall Study|Physician Decision|0|||
130705507|NCT03558139|470547255|FG000|Overall Study|Consent Withdrawn|1|||
130705508|NCT03558139|470547256|FG001|Overall Study|Consent Withdrawn|1|||
130705509|NCT03558139|470547257|FG002|Overall Study|Consent Withdrawn|4|||
130705510|NCT03558139|470547255|FG000|Overall Study|Death|5|||
130705511|NCT03558139|470547256|FG001|Overall Study|Death|3|||
130705512|NCT03558139|470547257|FG002|Overall Study|Death|8|||
130705513|NCT03558139|470547255|FG000|Overall Study|Lost to Follow-up|0|||
130705514|NCT03558139|470547256|FG001|Overall Study|Lost to Follow-up|0|||
130705515|NCT03558139|470547257|FG002|Overall Study|Lost to Follow-up|3|||
130705516|NCT03558139|470547255|FG000|Overall Study|Study Ended Per Protocol|0|||
130705517|NCT03558139|470547256|FG001|Overall Study|Study Ended Per Protocol|3|||
130705518|NCT03558139|470547257|FG002|Overall Study|Study Ended Per Protocol|6|||
130705519|NCT02752802|470547258|FG000|Overall Study|Contrast Volume Not Collected|1|||
130705520|NCT02752802|470547259|FG001|Overall Study|Contrast Volume Not Collected|0|||
130705521|NCT02808819|470547260|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
130705522|NCT02808819|470547261|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
130705523|NCT02808819|470547260|FG000|Overall Study|Withdrawal by Subject|10|||
130705524|NCT02808819|470547261|FG001|Overall Study|Withdrawal by Subject|13|||
130705525|NCT02808819|470547260|FG000|Overall Study|Site terminated by sponsor|2|||
130705526|NCT02808819|470547261|FG001|Overall Study|Site terminated by sponsor|0|||
130705527|NCT02808819|470547260|FG000|Overall Study|Pregnancy|1|||
130705528|NCT02808819|470547261|FG001|Overall Study|Pregnancy|0|||
130705529|NCT02808819|470547260|FG000|Overall Study|Lost to Follow-up|1|||
130705530|NCT02808819|470547261|FG001|Overall Study|Lost to Follow-up|6|||
130705531|NCT02808819|470547260|FG000|Overall Study|Protocol Violation|0|||
130705532|NCT02808819|470547261|FG001|Overall Study|Protocol Violation|1|||
130705533|NCT02808819|470547260|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
130705534|NCT02808819|470547261|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
130705535|NCT02808819|470547260|FG000|Overall Study|Death|1|||
130705536|NCT02808819|470547261|FG001|Overall Study|Death|0|||
130705537|NCT02808819|470547260|FG000|Overall Study|Adverse Event|3|||
130705538|NCT02808819|470547261|FG001|Overall Study|Adverse Event|4|||
130705539|NCT02013531|470547262|FG000|Overall Study|Lost to Follow-up|3|||
130705540|NCT02013531|470547262|FG000|Overall Study|Met Withdrawal Criteria|1|||
130705541|NCT02013531|470547262|FG000|Overall Study|Withdrawal by Subject|1|||
130705542|NCT03546647|470547263|FG000|Overall Study|Adverse Event|1|||
130705543|NCT03546647|470547264|FG001|Overall Study|Adverse Event|0|||
130771834|NCT04313400|470792764|FG001|Overall Study|Withdrawal by Subject|0|||
130771835|NCT04313400|470792765|FG002|Overall Study|Withdrawal by Subject|0|||
130705544|NCT02400476|470547265|FG000|Overall Study|Adverse Event|57|||
130705545|NCT02400476|470547266|FG001|Overall Study|Adverse Event|10|||
130705546|NCT02400476|470547267|FG002|Overall Study|Adverse Event|22|||
130705547|NCT02400476|470547268|FG003|Overall Study|Adverse Event|19|||
130771836|NCT04313400|470792766|FG003|Overall Study|Withdrawal by Subject|0|||
130771837|NCT04313400|470792767|FG004|Overall Study|Withdrawal by Subject|0|||
131121975|NCT00806195|472076431|FG003|Overall Study|Protocol Violation|9|||
130705548|NCT02400476|470547269|FG004|Overall Study|Adverse Event|5|||
130705549|NCT02400476|470547270|FG005|Overall Study|Adverse Event|8|||
130705550|NCT02400476|470547265|FG000|Overall Study|Withdrawal by Subject|4|||
130705551|NCT02400476|470547266|FG001|Overall Study|Withdrawal by Subject|1|||
130705552|NCT02400476|470547267|FG002|Overall Study|Withdrawal by Subject|12|||
130705553|NCT02400476|470547268|FG003|Overall Study|Withdrawal by Subject|7|||
130705554|NCT02400476|470547269|FG004|Overall Study|Withdrawal by Subject|5|||
130705555|NCT02400476|470547270|FG005|Overall Study|Withdrawal by Subject|5|||
130705556|NCT02400476|470547265|FG000|Overall Study|Lost to Follow-up|0|||
130705557|NCT02400476|470547266|FG001|Overall Study|Lost to Follow-up|0|||
130771838|NCT04313400|470792768|FG005|Overall Study|Withdrawal by Subject|4|||
130771839|NCT04313400|470792769|FG006|Overall Study|Withdrawal by Subject|1|||
130771840|NCT04313400|470792763|FG000|Overall Study|Adverse Event|0|||
130771841|NCT04313400|470792764|FG001|Overall Study|Adverse Event|0|||
130937732|NCT00353262|471404660|FG000|Overall Study|Progression|1|||
131223999|NCT04380701|472447114|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130771842|NCT04313400|470792765|FG002|Overall Study|Adverse Event|0|||
130771843|NCT04313400|470792766|FG003|Overall Study|Adverse Event|0|||
130771844|NCT04313400|470792767|FG004|Overall Study|Adverse Event|0|||
130771845|NCT04313400|470792768|FG005|Overall Study|Adverse Event|1|||
131224000|NCT04380701|472447115|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224001|NCT04380701|472447116|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224002|NCT04380701|472447117|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224003|NCT04380701|472447118|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224004|NCT04380701|472447119|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224005|NCT04380701|472447120|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224006|NCT04380701|472447121|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224007|NCT04380701|472447122|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224008|NCT04380701|472447123|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224009|NCT04380701|472447124|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224010|NCT04380701|472447125|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224011|NCT04380701|472447126|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224012|NCT04380701|472447127|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224013|NCT04380701|472447128|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224014|NCT04380701|472447129|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224015|NCT04380701|472447130|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
131224016|NCT04380701|472447131|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
131224017|NCT04380701|472447132|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
131224018|NCT04380701|472447133|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
131224019|NCT04380701|472447134|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224020|NCT04380701|472447135|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224021|NCT04380701|472447136|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224022|NCT04380701|472447137|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224023|NCT04380701|472447138|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130705558|NCT02400476|470547267|FG002|Overall Study|Lost to Follow-up|0|||
130705559|NCT02400476|470547268|FG003|Overall Study|Lost to Follow-up|1|||
130705560|NCT02400476|470547269|FG004|Overall Study|Lost to Follow-up|3|||
130705561|NCT02400476|470547270|FG005|Overall Study|Lost to Follow-up|1|||
130705562|NCT02400476|470547265|FG000|Overall Study|Physician Decision|0|||
130705563|NCT02400476|470547266|FG001|Overall Study|Physician Decision|0|||
130705564|NCT02400476|470547267|FG002|Overall Study|Physician Decision|1|||
130705565|NCT02400476|470547268|FG003|Overall Study|Physician Decision|1|||
130705566|NCT02400476|470547269|FG004|Overall Study|Physician Decision|0|||
130705567|NCT02400476|470547270|FG005|Overall Study|Physician Decision|1|||
130705568|NCT02400476|470547265|FG000|Overall Study|Other, Disease Progression|0|||
130705569|NCT02400476|470547266|FG001|Overall Study|Other, Disease Progression|1|||
130705570|NCT02400476|470547267|FG002|Overall Study|Other, Disease Progression|2|||
130705571|NCT02400476|470547268|FG003|Overall Study|Other, Disease Progression|1|||
130705572|NCT02400476|470547269|FG004|Overall Study|Other, Disease Progression|2|||
130705573|NCT02400476|470547270|FG005|Overall Study|Other, Disease Progression|1|||
130705574|NCT02400476|470547265|FG000|Overall Study|Other, Decreased Quality of Life|0|||
130705575|NCT02400476|470547266|FG001|Overall Study|Other, Decreased Quality of Life|0|||
130705576|NCT02400476|470547267|FG002|Overall Study|Other, Decreased Quality of Life|2|||
130705577|NCT02400476|470547268|FG003|Overall Study|Other, Decreased Quality of Life|0|||
130705578|NCT02400476|470547269|FG004|Overall Study|Other, Decreased Quality of Life|0|||
130705579|NCT02400476|470547270|FG005|Overall Study|Other, Decreased Quality of Life|0|||
130705580|NCT02400476|470547265|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130705581|NCT02400476|470547266|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130705582|NCT02400476|470547267|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
130705583|NCT02400476|470547268|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
130705584|NCT02400476|470547269|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130705585|NCT02400476|470547270|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130771846|NCT04313400|470792769|FG006|Overall Study|Adverse Event|0|||
130771847|NCT04313400|470792763|FG000|Overall Study|Lost to Follow-up|0|||
130771848|NCT04313400|470792764|FG001|Overall Study|Lost to Follow-up|0|||
130771849|NCT04313400|470792765|FG002|Overall Study|Lost to Follow-up|0|||
130771850|NCT04313400|470792766|FG003|Overall Study|Lost to Follow-up|0|||
130771851|NCT04313400|470792767|FG004|Overall Study|Lost to Follow-up|0|||
130771852|NCT04313400|470792768|FG005|Overall Study|Lost to Follow-up|1|||
130705586|NCT00003531|470547273|FG000|Overall Study|Not evaluable|10|||
130705587|NCT00588731|470547274|FG000|Overall Study|Withdrawal by Subject|3|||
130705588|NCT00588731|470547275|FG001|Overall Study|Withdrawal by Subject|2|||
130705589|NCT00251316|470547276|FG000|Overall Study|Physician Decision|2|||
130705590|NCT00251316|470547277|FG001|Overall Study|Physician Decision|3|||
130705591|NCT00346164|470547278|FG000|Overall Study|Adverse Event|0|||
130705592|NCT00346164|470547279|FG001|Overall Study|Adverse Event|0|||
130705593|NCT00346164|470547280|FG002|Overall Study|Adverse Event|0|||
130705594|NCT00346164|470547281|FG003|Overall Study|Adverse Event|1|||
130705595|NCT00346164|470547278|FG000|Overall Study|Lack of Efficacy|0|||
130705596|NCT00346164|470547279|FG001|Overall Study|Lack of Efficacy|1|||
130705597|NCT00346164|470547280|FG002|Overall Study|Lack of Efficacy|7|||
130705598|NCT00346164|470547281|FG003|Overall Study|Lack of Efficacy|25|||
130705599|NCT00346164|470547278|FG000|Overall Study|Physician Decision|0|||
130705600|NCT00346164|470547279|FG001|Overall Study|Physician Decision|1|||
130705601|NCT00346164|470547280|FG002|Overall Study|Physician Decision|2|||
130705602|NCT00346164|470547281|FG003|Overall Study|Physician Decision|27|||
130705603|NCT00346164|470547278|FG000|Overall Study|Protocol Violation|6|||
130705604|NCT00346164|470547279|FG001|Overall Study|Protocol Violation|2|||
130705605|NCT00346164|470547280|FG002|Overall Study|Protocol Violation|10|||
130705606|NCT00346164|470547281|FG003|Overall Study|Protocol Violation|4|||
130771853|NCT04313400|470792769|FG006|Overall Study|Lost to Follow-up|0|||
130771854|NCT00770913|470792772|FG000|Overall Study|Adverse Event|1|||
130771855|NCT00770913|470792773|FG001|Overall Study|Adverse Event|3|||
130771856|NCT00770913|470792774|FG002|Overall Study|Adverse Event|6|||
130771857|NCT00770913|470792772|FG000|Overall Study|Refusal to continue participation|6|||
130771858|NCT00770913|470792773|FG001|Overall Study|Refusal to continue participation|4|||
130771859|NCT00770913|470792774|FG002|Overall Study|Refusal to continue participation|5|||
130771860|NCT00770913|470792772|FG000|Overall Study|Physician Decision|0|||
130771861|NCT00770913|470792773|FG001|Overall Study|Physician Decision|1|||
130771862|NCT00770913|470792774|FG002|Overall Study|Physician Decision|1|||
130771863|NCT00770913|470792772|FG000|Overall Study|Protocol Violation|3|||
130771864|NCT00770913|470792773|FG001|Overall Study|Protocol Violation|0|||
130771865|NCT00770913|470792774|FG002|Overall Study|Protocol Violation|1|||
130771866|NCT00770913|470792772|FG000|Overall Study|Incorrect drug was allocated|1|||
130937733|NCT00353262|471404660|FG000|Overall Study|Surgery|4|||
130937734|NCT00353262|471404660|FG000|Overall Study|Break from Chemotherapy|1|||
130937735|NCT05286307|471404661|FG000|Overall Study|Incomplete outcome assessments|2|||
130937736|NCT05286307|471404662|FG001|Overall Study|Incomplete outcome assessments|1|||
130937737|NCT05286307|471404661|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
130937738|NCT05286307|471404662|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
130771867|NCT00770913|470792773|FG001|Overall Study|Incorrect drug was allocated|0|||
130771868|NCT00770913|470792774|FG002|Overall Study|Incorrect drug was allocated|0|||
130771869|NCT00359294|470792775|FG000|Overall Study|Progressive disease|1|||
130771870|NCT00359294|470792776|FG001|Overall Study|Progressive disease|1|||
130771871|NCT00359294|470792777|FG002|Overall Study|Progressive disease|2|||
130771872|NCT00359294|470792778|FG003|Overall Study|Progressive disease|3|||
130771873|NCT00359294|470792779|FG004|Overall Study|Progressive disease|2|||
130771874|NCT00359294|470792775|FG000|Overall Study|Withdrawal by Subject|0|||
130771875|NCT00359294|470792776|FG001|Overall Study|Withdrawal by Subject|0|||
130771876|NCT00359294|470792777|FG002|Overall Study|Withdrawal by Subject|0|||
130771877|NCT00359294|470792778|FG003|Overall Study|Withdrawal by Subject|0|||
130771878|NCT00359294|470792779|FG004|Overall Study|Withdrawal by Subject|1|||
130771879|NCT00359294|470792775|FG000|Overall Study|Not treated|0|||
130771880|NCT00359294|470792776|FG001|Overall Study|Not treated|0|||
130771881|NCT00359294|470792777|FG002|Overall Study|Not treated|0|||
130771882|NCT00359294|470792778|FG003|Overall Study|Not treated|1|||
130771883|NCT00359294|470792779|FG004|Overall Study|Not treated|0|||
130771884|NCT00359294|470792775|FG000|Overall Study|Physician Decision|0|||
130771885|NCT00359294|470792776|FG001|Overall Study|Physician Decision|0|||
130771886|NCT00359294|470792777|FG002|Overall Study|Physician Decision|1|||
130771887|NCT00359294|470792778|FG003|Overall Study|Physician Decision|0|||
130771888|NCT00359294|470792779|FG004|Overall Study|Physician Decision|0|||
130771889|NCT00524680|470792782|FG000|Overall Study|progression|0|||
131035941|NCT02985957|471766188|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
131035942|NCT02985957|471766189|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
130705607|NCT00346164|470547278|FG000|Overall Study|Withdrawal by Subject|0|||
130705608|NCT00346164|470547279|FG001|Overall Study|Withdrawal by Subject|0|||
130705609|NCT00346164|470547280|FG002|Overall Study|Withdrawal by Subject|2|||
130705610|NCT00346164|470547281|FG003|Overall Study|Withdrawal by Subject|0|||
130705611|NCT00346164|470547278|FG000|Overall Study|Ineligible|11|||
130771890|NCT00524680|470792783|FG001|Overall Study|progression|0|||
130937739|NCT05286307|471404661|FG000|Overall Study|Lost to follow up at 6 months|25|||
130937740|NCT05286307|471404662|FG001|Overall Study|Lost to follow up at 6 months|35|||
130937741|NCT05286307|471404661|FG000|Overall Study|Study medication not available|1|||
130937742|NCT05286307|471404662|FG001|Overall Study|Study medication not available|1|||
131035943|NCT02985957|471766190|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
130705612|NCT00346164|470547279|FG001|Overall Study|Ineligible|2|||
130705613|NCT00346164|470547280|FG002|Overall Study|Ineligible|2|||
130705614|NCT00346164|470547281|FG003|Overall Study|Ineligible|23|||
130705615|NCT00346164|470547278|FG000|Overall Study|Refusal of further protocol therapy|0|||
130705616|NCT00346164|470547279|FG001|Overall Study|Refusal of further protocol therapy|1|||
130705617|NCT00346164|470547280|FG002|Overall Study|Refusal of further protocol therapy|3|||
130705618|NCT00346164|470547281|FG003|Overall Study|Refusal of further protocol therapy|15|||
130705619|NCT00346164|470547278|FG000|Overall Study|Inability to start week 16 tx on time|0|||
130705620|NCT00346164|470547279|FG001|Overall Study|Inability to start week 16 tx on time|0|||
130705621|NCT00346164|470547280|FG002|Overall Study|Inability to start week 16 tx on time|0|||
130705622|NCT00346164|470547281|FG003|Overall Study|Inability to start week 16 tx on time|11|||
130705623|NCT00612677|470547284|FG000|Overall Study|study closed before treatment started|1|||
130705624|NCT03417830|470547285|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
130705625|NCT03417830|470547286|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
130705626|NCT00823199|470547287|FG000|Overall Study|Withdrawal by Subject|2|||
130705627|NCT01998243|470547288|FG000|Overall Study|Pregnancy|0|||
130705628|NCT01998243|470547289|FG001|Overall Study|Pregnancy|1|||
130705629|NCT01998243|470547288|FG000|Overall Study|Protocol Violation|5|||
130705630|NCT01998243|470547289|FG001|Overall Study|Protocol Violation|2|||
130705631|NCT01998243|470547288|FG000|Overall Study|Withdrawal by Subject|3|||
130705632|NCT01998243|470547289|FG001|Overall Study|Withdrawal by Subject|4|||
130705633|NCT04569786|470547292|FG000|Overall Study|Lost to Follow-up|1|||
130705634|NCT04569786|470547293|FG001|Overall Study|Lost to Follow-up|0|||
130705635|NCT04569786|470547294|FG002|Overall Study|Lost to Follow-up|4|||
130705636|NCT04569786|470547295|FG003|Overall Study|Lost to Follow-up|1|||
130705637|NCT04569786|470547296|FG004|Overall Study|Lost to Follow-up|0|||
130705638|NCT04569786|470547292|FG000|Overall Study|Withdrawal by Subject|0|||
130705639|NCT04569786|470547293|FG001|Overall Study|Withdrawal by Subject|0|||
130705640|NCT04569786|470547294|FG002|Overall Study|Withdrawal by Subject|0|||
130705641|NCT04569786|470547295|FG003|Overall Study|Withdrawal by Subject|5|||
130705642|NCT04569786|470547296|FG004|Overall Study|Withdrawal by Subject|1|||
130937743|NCT01103284|471404663|FG000|Overall Study|Death|2|||
130937744|NCT01103284|471404664|FG001|Overall Study|Death|0|||
130937745|NCT01103284|471404663|FG000|Overall Study|Lost to Follow-up|9|||
130937746|NCT01103284|471404664|FG001|Overall Study|Lost to Follow-up|10|||
130937747|NCT01103284|471404663|FG000|Overall Study|Pregnancy|3|||
130937748|NCT01103284|471404664|FG001|Overall Study|Pregnancy|1|||
130705643|NCT04569786|470547292|FG000|Overall Study|Physician Decision|0|||
130705644|NCT04569786|470547293|FG001|Overall Study|Physician Decision|0|||
130705645|NCT04569786|470547294|FG002|Overall Study|Physician Decision|0|||
130705646|NCT04569786|470547295|FG003|Overall Study|Physician Decision|1|||
130705647|NCT04569786|470547296|FG004|Overall Study|Physician Decision|0|||
130705648|NCT01640184|470547297|FG000|Overall Study|Death|1|||
130705649|NCT01640184|470547298|FG001|Overall Study|Death|0|||
130705650|NCT01640184|470547299|FG002|Overall Study|Death|0|||
130705651|NCT01640184|470547297|FG000|Overall Study|Lost to Follow-up|4|||
130705652|NCT01640184|470547298|FG001|Overall Study|Lost to Follow-up|1|||
130705653|NCT01640184|470547299|FG002|Overall Study|Lost to Follow-up|0|||
130705654|NCT01640184|470547297|FG000|Overall Study|Physician Decision|3|||
130705655|NCT01640184|470547298|FG001|Overall Study|Physician Decision|0|||
130705656|NCT01640184|470547299|FG002|Overall Study|Physician Decision|0|||
130705657|NCT01640184|470547297|FG000|Overall Study|Withdrawal by Subject|0|||
130705658|NCT01640184|470547298|FG001|Overall Study|Withdrawal by Subject|1|||
130937749|NCT01103284|471404663|FG000|Overall Study|Protocol Violation|12|||
130705659|NCT01640184|470547299|FG002|Overall Study|Withdrawal by Subject|1|||
130705660|NCT01640184|470547297|FG000|Overall Study|Protocol Violation|0|||
130705661|NCT01640184|470547298|FG001|Overall Study|Protocol Violation|0|||
130705662|NCT01640184|470547299|FG002|Overall Study|Protocol Violation|1|||
130705663|NCT01684878|470547300|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
130937750|NCT01103284|471404664|FG001|Overall Study|Protocol Violation|5|||
131121976|NCT02490475|472076432|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
131121977|NCT02490475|472076433|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
131121978|NCT02490475|472076434|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
131121979|NCT02490475|472076435|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
130705664|NCT01684878|470547301|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
130705665|NCT01684878|470547302|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
130705666|NCT01684878|470547303|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
130705667|NCT01684878|470547300|FG000|Part 1: Safety Run in Phase|Death|15|||
130705668|NCT01684878|470547301|FG001|Part 1: Safety Run in Phase|Death|20|||
130937751|NCT01103284|471404663|FG000|Overall Study|Adverse Event|0|||
130705669|NCT01684878|470547302|FG002|Part 1: Safety Run in Phase|Death|0|||
130705670|NCT01684878|470547303|FG003|Part 1: Safety Run in Phase|Death|0|||
130937752|NCT01103284|471404664|FG001|Overall Study|Adverse Event|5|||
130937753|NCT01103284|471404663|FG000|Overall Study|Withdrawal by Subject|14|||
131121980|NCT02490475|472076432|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
130705671|NCT01684878|470547300|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
130705672|NCT01684878|470547301|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
130937754|NCT01103284|471404664|FG001|Overall Study|Withdrawal by Subject|18|||
131121981|NCT02490475|472076433|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
131121982|NCT02490475|472076434|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
131121983|NCT02490475|472076435|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
131121984|NCT02490475|472076432|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
131121985|NCT02490475|472076433|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
131121986|NCT02490475|472076434|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
131121987|NCT02490475|472076435|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
131121988|NCT02490475|472076432|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
131121989|NCT02490475|472076433|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
131121990|NCT02490475|472076434|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
131121991|NCT02490475|472076435|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
131121992|NCT02490475|472076432|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
131121993|NCT02490475|472076433|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
131121994|NCT02490475|472076434|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
131121995|NCT02490475|472076435|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
131121996|NCT02490475|472076432|FG000|Period 2: Extension Phase|Refused Treatment|0|||
131121997|NCT02490475|472076433|FG001|Period 2: Extension Phase|Refused Treatment|0|||
131121998|NCT02490475|472076434|FG002|Period 2: Extension Phase|Refused Treatment|0|||
131121999|NCT02490475|472076435|FG003|Period 2: Extension Phase|Refused Treatment|1|||
131122000|NCT02490475|472076432|FG000|Period 2: Extension Phase|Adverse Event|0|||
131122001|NCT02490475|472076433|FG001|Period 2: Extension Phase|Adverse Event|0|||
131122002|NCT02490475|472076434|FG002|Period 2: Extension Phase|Adverse Event|1|||
131122003|NCT02490475|472076435|FG003|Period 2: Extension Phase|Adverse Event|0|||
131122004|NCT00139776|472076436|FG000|Period I|Did not enter Period II|575|||
131122005|NCT00139776|472076437|FG001|Period I|Did not enter Period II|0|||
131122006|NCT00139776|472076438|FG002|Period I|Did not enter Period II|0|||
131122007|NCT00139776|472076439|FG003|Period I|Did not enter Period II|0|||
131122008|NCT00139776|472076436|FG000|Period II|Not Randomized into Period III|0|||
131122009|NCT00139776|472076437|FG001|Period II|Not Randomized into Period III|322|||
131122010|NCT00139776|472076438|FG002|Period II|Not Randomized into Period III|0|||
131122011|NCT00139776|472076439|FG003|Period II|Not Randomized into Period III|0|||
131122012|NCT00139776|472076436|FG000|Period III|Adverse Event|0|||
131122013|NCT00139776|472076437|FG001|Period III|Adverse Event|0|||
131122014|NCT00139776|472076438|FG002|Period III|Adverse Event|22|||
131122015|NCT00139776|472076439|FG003|Period III|Adverse Event|23|||
131122016|NCT00139776|472076436|FG000|Period III|Other|0|||
131122017|NCT00139776|472076437|FG001|Period III|Other|0|||
131122018|NCT00139776|472076438|FG002|Period III|Other|23|||
131122019|NCT00139776|472076439|FG003|Period III|Other|34|||
131122020|NCT00139776|472076436|FG000|Period III|Lack of Efficacy|0|||
131122021|NCT00139776|472076437|FG001|Period III|Lack of Efficacy|0|||
131122022|NCT00139776|472076438|FG002|Period III|Lack of Efficacy|10|||
131122023|NCT00139776|472076439|FG003|Period III|Lack of Efficacy|24|||
131122024|NCT00139776|472076436|FG000|Period III|Lost to Follow-up|0|||
131122025|NCT00139776|472076437|FG001|Period III|Lost to Follow-up|0|||
131122026|NCT00139776|472076438|FG002|Period III|Lost to Follow-up|5|||
131122027|NCT00139776|472076439|FG003|Period III|Lost to Follow-up|4|||
131122028|NCT00139776|472076436|FG000|Period III|Withdrawal by Subject|0|||
131122029|NCT00139776|472076437|FG001|Period III|Withdrawal by Subject|0|||
131122030|NCT00139776|472076438|FG002|Period III|Withdrawal by Subject|16|||
131122031|NCT00139776|472076439|FG003|Period III|Withdrawal by Subject|21|||
131122032|NCT04912245|472076442|FG000|Overall Study|Withdrawal by Subject|21|||
131122033|NCT04912245|472076443|FG001|Overall Study|Withdrawal by Subject|4|||
131122034|NCT04912245|472076442|FG000|Overall Study|Lost to Follow-up|5|||
131122035|NCT04912245|472076443|FG001|Overall Study|Lost to Follow-up|11|||
131122036|NCT02752035|472076444|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
131122037|NCT02752035|472076445|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
131122038|NCT02752035|472076446|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
131122039|NCT02752035|472076447|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
131122040|NCT02752035|472076444|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
131122041|NCT02752035|472076445|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
131122042|NCT02752035|472076446|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
131122043|NCT02752035|472076447|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
131122044|NCT02752035|472076444|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
131122045|NCT02752035|472076445|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
131122046|NCT02752035|472076446|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
131122047|NCT02752035|472076447|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
131122048|NCT02752035|472076444|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
131122049|NCT02752035|472076445|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
131122050|NCT02752035|472076446|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
131122051|NCT02752035|472076447|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
131122052|NCT02752035|472076444|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
130937755|NCT01103284|471404663|FG000|Overall Study|Dermal Hypersensitivity|0|||
130937756|NCT01103284|471404664|FG001|Overall Study|Dermal Hypersensitivity|1|||
130937757|NCT01103284|471404663|FG000|Overall Study|Termination by the Sponsor|0|||
130937758|NCT01103284|471404664|FG001|Overall Study|Termination by the Sponsor|1|||
130937759|NCT01103284|471404663|FG000|Overall Study|Not described|2|||
130937760|NCT01103284|471404664|FG001|Overall Study|Not described|1|||
130771891|NCT00524680|470792784|FG002|Overall Study|progression|0|||
130771892|NCT00524680|470792785|FG003|Overall Study|progression|1|||
130771893|NCT00524680|470792782|FG000|Overall Study|Adverse Event|2|||
130771894|NCT00524680|470792783|FG001|Overall Study|Adverse Event|0|||
130771895|NCT00524680|470792784|FG002|Overall Study|Adverse Event|0|||
130771896|NCT00524680|470792785|FG003|Overall Study|Adverse Event|1|||
130771897|NCT00524680|470792782|FG000|Overall Study|Other|0|||
130771898|NCT00524680|470792783|FG001|Overall Study|Other|1|||
130771899|NCT00524680|470792784|FG002|Overall Study|Other|2|||
130771900|NCT00524680|470792785|FG003|Overall Study|Other|3|||
130771901|NCT00524680|470792782|FG000|Overall Study|Withdrawal by Subject|1|||
130771902|NCT00524680|470792783|FG001|Overall Study|Withdrawal by Subject|0|||
130771903|NCT00524680|470792784|FG002|Overall Study|Withdrawal by Subject|1|||
130771904|NCT00524680|470792785|FG003|Overall Study|Withdrawal by Subject|1|||
130771905|NCT03124537|470792786|FG000|Overall Study|Lost to Follow-up|3|||
130771906|NCT03124537|470792787|FG001|Overall Study|Lost to Follow-up|5|||
130771907|NCT03124537|470792786|FG000|Overall Study|App Crash, Incomplete Data|7|||
130771908|NCT03124537|470792787|FG001|Overall Study|App Crash, Incomplete Data|8|||
130771909|NCT03681184|470792788|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
131122053|NCT02752035|472076445|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
131122054|NCT02752035|472076446|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
131122055|NCT02752035|472076447|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
131122056|NCT02752035|472076444|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
131122057|NCT02752035|472076445|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
131122058|NCT02752035|472076446|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
131122059|NCT02752035|472076447|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
131122060|NCT02752035|472076444|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
131122061|NCT02752035|472076445|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
131122062|NCT02752035|472076446|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
131122063|NCT02752035|472076447|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
131122064|NCT02752035|472076444|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
131122065|NCT02752035|472076445|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
131122066|NCT02752035|472076446|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
131122067|NCT02752035|472076447|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
131122068|NCT02752035|472076444|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
131122069|NCT02752035|472076445|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
131122070|NCT02752035|472076446|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
131122071|NCT02752035|472076447|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
131122072|NCT02752035|472076444|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
131122073|NCT02752035|472076445|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
131122074|NCT02752035|472076446|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
131122075|NCT02752035|472076447|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
131122076|NCT02752035|472076444|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
131122077|NCT02752035|472076445|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
131122078|NCT02752035|472076446|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
131122079|NCT02752035|472076447|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
131122080|NCT02752035|472076444|FG000|Randomization: Approximately 3 Years|Death|0|||
131122081|NCT02752035|472076445|FG001|Randomization: Approximately 3 Years|Death|25|||
131122082|NCT02752035|472076446|FG002|Randomization: Approximately 3 Years|Death|13|||
131122083|NCT02752035|472076447|FG003|Randomization: Approximately 3 Years|Death|4|||
130771910|NCT03681184|470792789|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
130771911|NCT01607346|470792792|FG000|Overall Study|Adverse Event|3|||
130771912|NCT01098162|470792793|FG000|Overall Study|Adverse Event|37|||
130771913|NCT01098162|470792793|FG000|Overall Study|Lack of Efficacy|4|||
130771914|NCT01098162|470792793|FG000|Overall Study|Wish of Patient|7|||
130771915|NCT01098162|470792793|FG000|Overall Study|Lost to Follow-up|9|||
130771916|NCT01098162|470792793|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
130771917|NCT01098162|470792793|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
131122084|NCT02752035|472076444|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
131122085|NCT02752035|472076445|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
131122086|NCT02752035|472076446|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
131122087|NCT02752035|472076447|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
130771918|NCT01098162|470792793|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
130771919|NCT01098162|470792793|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
130771920|NCT01098162|470792793|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
130771921|NCT01098162|470792793|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
130771922|NCT01098162|470792793|FG000|Overall Study|Other Reason|1|||
130771923|NCT01098162|470792793|FG000|Overall Study|Reason Unknown|26|||
130771924|NCT00625183|470792794|FG000|Overall Study|Disease Progression|1|||
130771925|NCT04318132|470792795|FG000|Overall Study|Protocol Violation|0|||
130771926|NCT04318132|470792796|FG001|Overall Study|Protocol Violation|0|||
130771927|NCT04318132|470792797|FG002|Overall Study|Protocol Violation|3|||
131035944|NCT02985957|471766191|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
131035945|NCT02985957|471766185|FG000|Treatment Period|Study drug toxicity|1|||
131224024|NCT04380701|472447139|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224025|NCT04380701|472447140|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224026|NCT04380701|472447141|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224027|NCT04380701|472447142|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
131224028|NCT03707522|472447143|FG000|Overall Study|Lost to Follow-up|24|||
131224029|NCT03707522|472447144|FG001|Overall Study|Lost to Follow-up|27|||
131224030|NCT03707522|472447145|FG002|Overall Study|Lost to Follow-up|41|||
131224031|NCT03707522|472447146|FG003|Overall Study|Lost to Follow-up|36|||
131224032|NCT04363736|472447147|FG000|Overall Study|Withdrawal by Subject|1|||
131224033|NCT04363736|472447148|FG001|Overall Study|Withdrawal by Subject|0|||
130771928|NCT04318132|470792798|FG003|Overall Study|Protocol Violation|0|||
131035946|NCT02985957|471766186|FG001|Treatment Period|Study drug toxicity|23|||
131035947|NCT02985957|471766187|FG002|Treatment Period|Study drug toxicity|20|||
131035948|NCT02985957|471766188|FG003|Treatment Period|Study drug toxicity|11|||
131035949|NCT02985957|471766189|FG004|Treatment Period|Study drug toxicity|19|||
131035950|NCT02985957|471766190|FG005|Treatment Period|Study drug toxicity|3|||
131035951|NCT02985957|471766191|FG006|Treatment Period|Study drug toxicity|5|||
131035952|NCT02985957|471766185|FG000|Treatment Period|Disease progression|0|||
131035953|NCT02985957|471766186|FG001|Treatment Period|Disease progression|16|||
131035954|NCT02985957|471766187|FG002|Treatment Period|Disease progression|20|||
131035955|NCT02985957|471766188|FG003|Treatment Period|Disease progression|39|||
131035956|NCT02985957|471766189|FG004|Treatment Period|Disease progression|29|||
131224034|NCT04363736|472447147|FG000|Overall Study|Lost to Follow-up|10|||
130705673|NCT01684878|470547302|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
130705674|NCT01684878|470547303|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
130705675|NCT01684878|470547300|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
130771929|NCT04424914|470792799|FG000|Overall Study|Other|0|||
130771930|NCT04424914|470792800|FG001|Overall Study|Other|0|||
130937761|NCT01103284|471404663|FG000|Overall Study|Missing CRF entries for study completion|0|||
130937762|NCT01103284|471404664|FG001|Overall Study|Missing CRF entries for study completion|2|||
130937763|NCT01572909|471406286|FG000|Overall Study|Adverse Event|7|||
130937764|NCT01572909|471406287|FG001|Overall Study|Adverse Event|2|||
130937765|NCT01572909|471406286|FG000|Overall Study|Death|3|||
130937766|NCT01572909|471406287|FG001|Overall Study|Death|1|||
130937767|NCT01572909|471406286|FG000|Overall Study|Lost to Follow-up|8|||
130937768|NCT01572909|471406287|FG001|Overall Study|Lost to Follow-up|7|||
130937769|NCT01572909|471406286|FG000|Overall Study|Physician Decision|1|||
130937770|NCT01572909|471406287|FG001|Overall Study|Physician Decision|1|||
130771931|NCT04424914|470792801|FG002|Overall Study|Other|28|||
130771932|NCT04424914|470792799|FG000|Overall Study|Withdrawal by Subject|3|||
130771933|NCT04424914|470792800|FG001|Overall Study|Withdrawal by Subject|0|||
130771934|NCT04424914|470792801|FG002|Overall Study|Withdrawal by Subject|0|||
130771935|NCT04424914|470792799|FG000|Overall Study|Study terminated by sponsor|23|||
130771936|NCT04424914|470792800|FG001|Overall Study|Study terminated by sponsor|7|||
130771937|NCT04424914|470792801|FG002|Overall Study|Study terminated by sponsor|0|||
130771938|NCT04424914|470792799|FG000|Overall Study|Lost to Follow-up|0|||
130771939|NCT04424914|470792800|FG001|Overall Study|Lost to Follow-up|0|||
130771940|NCT04424914|470792801|FG002|Overall Study|Lost to Follow-up|1|||
130771941|NCT04424914|470792799|FG000|Overall Study|Death|3|||
130771942|NCT04424914|470792800|FG001|Overall Study|Death|1|||
130771943|NCT04424914|470792801|FG002|Overall Study|Death|0|||
130771944|NCT02685072|470792812|FG000|Treatment Period|Lost to Follow-up|12|||
130937771|NCT01572909|471406286|FG000|Overall Study|Technical Issues|1|||
130937772|NCT01572909|471406287|FG001|Overall Study|Technical Issues|0|||
131035957|NCT02985957|471766190|FG005|Treatment Period|Disease progression|11|||
130705676|NCT01684878|470547301|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
130705677|NCT01684878|470547302|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
130705678|NCT01684878|470547303|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
130705679|NCT01684878|470547300|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
130705680|NCT01684878|470547301|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
130705681|NCT01684878|470547302|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
130705682|NCT01684878|470547303|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
130705683|NCT01684878|470547300|FG000|Part 2: Randomized Phase|Death|0|||
130705684|NCT01684878|470547301|FG001|Part 2: Randomized Phase|Death|0|||
131035958|NCT02985957|471766191|FG006|Treatment Period|Disease progression|28|||
131035959|NCT02985957|471766185|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
131122088|NCT02752035|472076444|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
131122089|NCT02752035|472076445|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
131122090|NCT02752035|472076446|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
131122091|NCT02752035|472076447|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
131122092|NCT02752035|472076444|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
131122093|NCT02752035|472076445|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
131122094|NCT02752035|472076446|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
131122095|NCT02752035|472076447|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
131122096|NCT02752035|472076444|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
131122097|NCT02752035|472076445|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
131122098|NCT02752035|472076446|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
131122099|NCT02752035|472076447|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
131122100|NCT02752035|472076444|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
131122101|NCT02752035|472076445|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
131122102|NCT02752035|472076446|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
131122103|NCT02752035|472076447|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
131122104|NCT04754802|472076454|FG000|Overall Study|Lost to Follow-up|0|||
131122105|NCT04754802|472076455|FG001|Overall Study|Lost to Follow-up|2|||
131122106|NCT04754802|472076454|FG000|Overall Study|Withdrawal by Subject|2|||
131122107|NCT04754802|472076455|FG001|Overall Study|Withdrawal by Subject|0|||
131122108|NCT04451161|472076456|FG000|Overall Study|Lost to Follow-up|28|||
131122109|NCT04451161|472076457|FG001|Overall Study|Lost to Follow-up|37|||
131122110|NCT04451161|472076458|FG002|Overall Study|Lost to Follow-up|22|||
131122111|NCT04451161|472076459|FG003|Overall Study|Lost to Follow-up|13|||
131122112|NCT04451161|472076460|FG004|Overall Study|Lost to Follow-up|11|||
131122113|NCT04451161|472076461|FG005|Overall Study|Lost to Follow-up|14|||
131122114|NCT04451161|472076456|FG000|Overall Study|Withdrawal by Subject|3|||
131122115|NCT04451161|472076457|FG001|Overall Study|Withdrawal by Subject|0|||
131122116|NCT04451161|472076458|FG002|Overall Study|Withdrawal by Subject|0|||
131122117|NCT04451161|472076459|FG003|Overall Study|Withdrawal by Subject|0|||
131122118|NCT04451161|472076460|FG004|Overall Study|Withdrawal by Subject|2|||
131122119|NCT04451161|472076461|FG005|Overall Study|Withdrawal by Subject|4|||
131122120|NCT00117598|472076467|FG000|Prior to Treatment Cross Over|Death|40|||
131122121|NCT00117598|472076468|FG001|Prior to Treatment Cross Over|Death|41|||
131122122|NCT00117598|472076469|FG002|Prior to Treatment Cross Over|Death|37|||
131122123|NCT00117598|472076470|FG003|Prior to Treatment Cross Over|Death|0|||
131122124|NCT00117598|472076471|FG004|Prior to Treatment Cross Over|Death|0|||
131122125|NCT00117598|472076467|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
131122126|NCT00117598|472076468|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
131122127|NCT00117598|472076469|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
131122128|NCT00117598|472076470|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
131122129|NCT00117598|472076471|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
131122130|NCT00117598|472076467|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
131122131|NCT00117598|472076468|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
131122132|NCT00117598|472076469|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
131122133|NCT00117598|472076470|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
131122134|NCT00117598|472076471|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
131122135|NCT00117598|472076467|FG000|Prior to Treatment Cross Over|Other|15|||
131122136|NCT00117598|472076468|FG001|Prior to Treatment Cross Over|Other|9|||
131122137|NCT00117598|472076469|FG002|Prior to Treatment Cross Over|Other|9|||
131122138|NCT00117598|472076470|FG003|Prior to Treatment Cross Over|Other|0|||
131122139|NCT00117598|472076471|FG004|Prior to Treatment Cross Over|Other|0|||
131122140|NCT00117598|472076467|FG000|After Treament Cross Over|Death|0|||
130937773|NCT01572909|471406286|FG000|Overall Study|Withdrawal by Subject|12|||
130937774|NCT01572909|471406287|FG001|Overall Study|Withdrawal by Subject|11|||
130937775|NCT01572909|471406286|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
130937776|NCT01572909|471406287|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
130937777|NCT03641651|471406288|FG000|Overall Study|organizational issues at one study site|1|||
130937778|NCT04779489|471406289|FG000|Overall Study|Physician Decision|1|||
130937779|NCT00623727|471406290|FG000|Double Blind (DB)|Adverse Event|1|||
130937780|NCT00623727|471406291|FG001|Double Blind (DB)|Adverse Event|3|||
130937781|NCT00623727|471406290|FG000|Double Blind (DB)|Physician Decision|0|||
130937782|NCT00623727|471406291|FG001|Double Blind (DB)|Physician Decision|1|||
130937783|NCT00623727|471406290|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
131122141|NCT00117598|472076468|FG001|After Treament Cross Over|Death|0|||
131122142|NCT00117598|472076469|FG002|After Treament Cross Over|Death|0|||
131122143|NCT00117598|472076470|FG003|After Treament Cross Over|Death|1|||
131122144|NCT00117598|472076471|FG004|After Treament Cross Over|Death|2|||
131122145|NCT00117598|472076467|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
131122146|NCT00117598|472076468|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
131122147|NCT00117598|472076469|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
131122148|NCT00117598|472076470|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
130771945|NCT02685072|470792813|FG001|Treatment Period|Lost to Follow-up|6|||
131122149|NCT00117598|472076471|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
131122150|NCT00117598|472076467|FG000|After Treament Cross Over|Other|0|||
131122151|NCT00117598|472076468|FG001|After Treament Cross Over|Other|0|||
131122152|NCT00117598|472076469|FG002|After Treament Cross Over|Other|0|||
131122153|NCT00117598|472076470|FG003|After Treament Cross Over|Other|1|||
131122154|NCT00117598|472076471|FG004|After Treament Cross Over|Other|2|||
131122155|NCT04688775|472076474|FG000|Placebo-controlled Period|Randomized, not treated|1|||
131122156|NCT04688775|472076475|FG001|Placebo-controlled Period|Randomized, not treated|1|||
131122157|NCT04688775|472076476|FG002|Placebo-controlled Period|Randomized, not treated|0|||
131122158|NCT04688775|472076477|FG003|Placebo-controlled Period|Randomized, not treated|0|||
131122159|NCT04688775|472076474|FG000|Placebo-controlled Period|Adverse Event|2|||
131122160|NCT04688775|472076475|FG001|Placebo-controlled Period|Adverse Event|0|||
131122161|NCT04688775|472076476|FG002|Placebo-controlled Period|Adverse Event|0|||
131122162|NCT04688775|472076477|FG003|Placebo-controlled Period|Adverse Event|0|||
131122163|NCT04688775|472076474|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
131122164|NCT04688775|472076475|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
131122165|NCT04688775|472076476|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
131122166|NCT04688775|472076477|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
131122167|NCT04688775|472076474|FG000|Placebo-controlled Period|Protocol Violation|0|||
130771946|NCT02685072|470792812|FG000|Treatment Period|Withdrawal by Subject|1|||
130771947|NCT02685072|470792813|FG001|Treatment Period|Withdrawal by Subject|3|||
130771948|NCT02685072|470792812|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
130771949|NCT02685072|470792813|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
130771950|NCT02634710|470792814|FG000|Overall Study|Death|4|||
130771951|NCT02483572|470792815|FG000|Overall Study|Withdrawal by Subject|1|||
130771952|NCT02483572|470792816|FG001|Overall Study|Withdrawal by Subject|0|||
130771953|NCT02483572|470792815|FG000|Overall Study|Lost to Follow-up|1|||
130771954|NCT02483572|470792816|FG001|Overall Study|Lost to Follow-up|0|||
130771955|NCT02483572|470792815|FG000|Overall Study|Physician Decision|0|||
130771956|NCT02483572|470792816|FG001|Overall Study|Physician Decision|1|||
130771957|NCT04811664|470792817|FG000|Overall Study|Lost to Follow-up|78|||
130771958|NCT04811664|470792818|FG001|Overall Study|Lost to Follow-up|125|||
130771959|NCT04811664|470792819|FG002|Overall Study|Lost to Follow-up|46|||
130771960|NCT04811664|470792817|FG000|Overall Study|Withdrawal by Subject|39|||
130771961|NCT04811664|470792818|FG001|Overall Study|Withdrawal by Subject|76|||
130771962|NCT04811664|470792819|FG002|Overall Study|Withdrawal by Subject|12|||
130937784|NCT00623727|471406291|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
130937785|NCT00623727|471406290|FG000|Double Blind (DB)|Lack of Efficacy|2|||
130937786|NCT00623727|471406291|FG001|Double Blind (DB)|Lack of Efficacy|2|||
130937787|NCT00623727|471406290|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
130937788|NCT00623727|471406291|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
130937789|NCT00623727|471406290|FG000|Double Blind (DB)|Lost to Follow-up|1|||
130937790|NCT00623727|471406291|FG001|Double Blind (DB)|Lost to Follow-up|1|||
130937791|NCT00623727|471406290|FG000|Double Blind (DB)|Protocol Violation|2|||
130937792|NCT00623727|471406291|FG001|Double Blind (DB)|Protocol Violation|2|||
130937793|NCT00623727|471406290|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
130937794|NCT00623727|471406291|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
130937795|NCT00623727|471406290|FG000|Open Label Follow-up|Study termination|0|||
130937796|NCT00623727|471406291|FG001|Open Label Follow-up|Study termination|6|||
130937797|NCT00623727|471406290|FG000|Open Label Follow-up|Participant convenience|0|||
130937798|NCT00623727|471406291|FG001|Open Label Follow-up|Participant convenience|1|||
130937799|NCT00951665|471406292|FG000|Phase 1b|Adverse Event|2|||
130937800|NCT00951665|471406293|FG001|Phase 1b|Adverse Event|1|||
130937801|NCT00951665|471406294|FG002|Phase 1b|Adverse Event|0|||
130937802|NCT00951665|471406295|FG003|Phase 1b|Adverse Event|1|||
130937803|NCT00951665|471406296|FG004|Phase 1b|Adverse Event|0|||
130937804|NCT00951665|471406297|FG005|Phase 1b|Adverse Event|0|||
130937805|NCT00951665|471406292|FG000|Phase 1b|Death|1|||
130937806|NCT00951665|471406293|FG001|Phase 1b|Death|0|||
131122168|NCT04688775|472076475|FG001|Placebo-controlled Period|Protocol Violation|1|||
130937807|NCT00951665|471406294|FG002|Phase 1b|Death|2|||
130937808|NCT00951665|471406295|FG003|Phase 1b|Death|0|||
130937809|NCT00951665|471406296|FG004|Phase 1b|Death|0|||
130937810|NCT00951665|471406297|FG005|Phase 1b|Death|0|||
130937811|NCT00951665|471406292|FG000|Phase 1b|Physician Decision|4|||
131122169|NCT04688775|472076476|FG002|Placebo-controlled Period|Protocol Violation|0|||
131122170|NCT04688775|472076477|FG003|Placebo-controlled Period|Protocol Violation|0|||
131224035|NCT04363736|472447148|FG001|Overall Study|Lost to Follow-up|7|||
130937812|NCT00951665|471406293|FG001|Phase 1b|Physician Decision|0|||
130937813|NCT00951665|471406294|FG002|Phase 1b|Physician Decision|1|||
130937814|NCT00951665|471406295|FG003|Phase 1b|Physician Decision|0|||
130937815|NCT00951665|471406296|FG004|Phase 1b|Physician Decision|0|||
130937816|NCT00951665|471406297|FG005|Phase 1b|Physician Decision|0|||
130937817|NCT00951665|471406292|FG000|Phase 1b|Withdrawal by Subject|0|||
130937818|NCT00951665|471406293|FG001|Phase 1b|Withdrawal by Subject|1|||
130937819|NCT00951665|471406294|FG002|Phase 1b|Withdrawal by Subject|0|||
130937820|NCT00951665|471406295|FG003|Phase 1b|Withdrawal by Subject|0|||
130937821|NCT00951665|471406296|FG004|Phase 1b|Withdrawal by Subject|0|||
131035960|NCT02985957|471766186|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
131035961|NCT02985957|471766187|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
131035962|NCT02985957|471766188|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
131035963|NCT02985957|471766189|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
131035964|NCT02985957|471766190|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
131035965|NCT02985957|471766191|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
131035966|NCT02985957|471766185|FG000|Treatment Period|Poor/Non-Compliance|0|||
131035967|NCT02985957|471766186|FG001|Treatment Period|Poor/Non-Compliance|0|||
131035968|NCT02985957|471766187|FG002|Treatment Period|Poor/Non-Compliance|0|||
131035969|NCT02985957|471766188|FG003|Treatment Period|Poor/Non-Compliance|0|||
131035970|NCT02985957|471766189|FG004|Treatment Period|Poor/Non-Compliance|1|||
131035971|NCT02985957|471766190|FG005|Treatment Period|Poor/Non-Compliance|1|||
131035972|NCT02985957|471766191|FG006|Treatment Period|Poor/Non-Compliance|0|||
131035973|NCT02985957|471766185|FG000|Treatment Period|Continuing in Treatment Period|0|||
131035974|NCT02985957|471766186|FG001|Treatment Period|Continuing in Treatment Period|1|||
131035975|NCT02985957|471766187|FG002|Treatment Period|Continuing in Treatment Period|0|||
131035976|NCT02985957|471766188|FG003|Treatment Period|Continuing in Treatment Period|4|||
131035977|NCT02985957|471766189|FG004|Treatment Period|Continuing in Treatment Period|4|||
131035978|NCT02985957|471766190|FG005|Treatment Period|Continuing in Treatment Period|0|||
131035979|NCT02985957|471766191|FG006|Treatment Period|Continuing in Treatment Period|0|||
131035980|NCT04342494|471766192|FG000|Overall Study|Questionnaire partially completed|1|||
131035981|NCT04342494|471766193|FG001|Overall Study|Questionnaire partially completed|0|||
131035982|NCT04342494|471766194|FG002|Overall Study|Questionnaire partially completed|2|||
131035983|NCT04342494|471766195|FG003|Overall Study|Questionnaire partially completed|0|||
131035984|NCT04342494|471766196|FG004|Overall Study|Questionnaire partially completed|1|||
131035985|NCT04342494|471766192|FG000|Overall Study|Lost to Follow-up|49|||
131035986|NCT04342494|471766193|FG001|Overall Study|Lost to Follow-up|38|||
131035987|NCT04342494|471766194|FG002|Overall Study|Lost to Follow-up|34|||
131035988|NCT04342494|471766195|FG003|Overall Study|Lost to Follow-up|34|||
131035989|NCT04342494|471766196|FG004|Overall Study|Lost to Follow-up|35|||
131035990|NCT05119023|471766197|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
131035991|NCT05119023|471766197|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
131035992|NCT05119023|471766197|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
131122171|NCT04688775|472076474|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
131122172|NCT04688775|472076475|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
131122173|NCT04688775|472076476|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
131122174|NCT04688775|472076477|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
131122175|NCT04688775|472076474|FG000|Placebo-controlled Period|Other reasons|0|||
131122176|NCT04688775|472076475|FG001|Placebo-controlled Period|Other reasons|1|||
131122177|NCT04688775|472076476|FG002|Placebo-controlled Period|Other reasons|0|||
131122178|NCT04688775|472076477|FG003|Placebo-controlled Period|Other reasons|0|||
131122179|NCT04688775|472076474|FG000|Delayed Start Period|Adverse Event|0|||
131122180|NCT04688775|472076475|FG001|Delayed Start Period|Adverse Event|0|||
131122181|NCT04688775|472076476|FG002|Delayed Start Period|Adverse Event|1|||
131122182|NCT04688775|472076477|FG003|Delayed Start Period|Adverse Event|0|||
131122183|NCT04688775|472076474|FG000|Delayed Start Period|Lack of Efficacy|0|||
131122184|NCT04688775|472076475|FG001|Delayed Start Period|Lack of Efficacy|0|||
131122185|NCT04688775|472076476|FG002|Delayed Start Period|Lack of Efficacy|0|||
131122186|NCT04688775|472076477|FG003|Delayed Start Period|Lack of Efficacy|3|||
131122187|NCT04688775|472076474|FG000|Delayed Start Period|Withdrawal by Subject|0|||
131122188|NCT04688775|472076475|FG001|Delayed Start Period|Withdrawal by Subject|0|||
131122189|NCT04688775|472076476|FG002|Delayed Start Period|Withdrawal by Subject|2|||
131122190|NCT04688775|472076477|FG003|Delayed Start Period|Withdrawal by Subject|4|||
131122191|NCT04688775|472076474|FG000|Delayed Start Period|Lost to Follow-up|0|||
131122192|NCT04688775|472076475|FG001|Delayed Start Period|Lost to Follow-up|0|||
131122193|NCT04688775|472076476|FG002|Delayed Start Period|Lost to Follow-up|2|||
131122194|NCT04688775|472076477|FG003|Delayed Start Period|Lost to Follow-up|1|||
131122195|NCT04688775|472076474|FG000|Delayed Start Period|other reasons|0|||
131122196|NCT04688775|472076475|FG001|Delayed Start Period|other reasons|0|||
130705685|NCT01684878|470547302|FG002|Part 2: Randomized Phase|Death|62|||
131122197|NCT04688775|472076476|FG002|Delayed Start Period|other reasons|1|||
131122198|NCT04688775|472076477|FG003|Delayed Start Period|other reasons|0|||
131122199|NCT00898443|472076478|FG000|Overall Study|Withdrawal by Subject|1|||
131122200|NCT00898443|472076479|FG001|Overall Study|Withdrawal by Subject|0|||
130705686|NCT01684878|470547303|FG003|Part 2: Randomized Phase|Death|68|||
131035993|NCT05835336|471766199|FG000|Overall Study|Withdrawal by Subject|5|||
131122201|NCT04695392|472076480|FG000|Overall Study|Withdrawn by parent/guardian|0|||
130705687|NCT01684878|470547300|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
131122202|NCT04695392|472076481|FG001|Overall Study|Withdrawn by parent/guardian|1|||
131122203|NCT04695392|472076480|FG000|Overall Study|Withdrawn by physician|0|||
131122204|NCT04695392|472076481|FG001|Overall Study|Withdrawn by physician|1|||
131122205|NCT04085523|472076490|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
131122206|NCT04085523|472076491|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
131122207|NCT04085523|472076492|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
131122208|NCT04085523|472076493|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
131122209|NCT04085523|472076494|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
131122210|NCT04085523|472076495|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
131122211|NCT03697720|472077957|FG000|Overall Study|Lost to Follow-up|7|||
131122212|NCT02573870|472077962|FG000|Overall Study|Adverse Event|0|||
131122213|NCT02573870|472077963|FG001|Overall Study|Adverse Event|2|||
131122214|NCT02573870|472077962|FG000|Overall Study|Lack of Efficacy|0|||
131122215|NCT02573870|472077963|FG001|Overall Study|Lack of Efficacy|1|||
131122216|NCT02573870|472077962|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
131122217|NCT02573870|472077963|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
131122218|NCT02573870|472077962|FG000|Overall Study|Lost to Follow-up|0|||
131122219|NCT02573870|472077963|FG001|Overall Study|Lost to Follow-up|1|||
131122220|NCT02573870|472077962|FG000|Overall Study|Other: Fail to Meet Visit|0|||
131122221|NCT02573870|472077963|FG001|Overall Study|Other: Fail to Meet Visit|2|||
131122222|NCT00762892|472077971|FG000|Overall Study|Lost to Follow-up|2|||
131122223|NCT00762892|472077972|FG001|Overall Study|Lost to Follow-up|5|||
131122224|NCT00762892|472077971|FG000|Overall Study|Withdrawal by Subject|0|||
131122225|NCT00762892|472077972|FG001|Overall Study|Withdrawal by Subject|1|||
131122226|NCT00762892|472077971|FG000|Overall Study|Death|1|||
131122227|NCT00762892|472077972|FG001|Overall Study|Death|0|||
131122228|NCT00762892|472077971|FG000|Overall Study|Pregnancy|1|||
131122229|NCT00762892|472077972|FG001|Overall Study|Pregnancy|0|||
131122230|NCT00762892|472077971|FG000|Overall Study|Incarceration|1|||
131122231|NCT00762892|472077972|FG001|Overall Study|Incarceration|0|||
131122232|NCT01101438|472077976|FG000|Overall Study|Withdrawal by Subject|8|||
131122233|NCT01101438|472077977|FG001|Overall Study|Withdrawal by Subject|9|||
131122234|NCT00549939|472077997|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
131122235|NCT00549939|472077998|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
131122236|NCT00549939|472077999|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
131122237|NCT00549939|472077997|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
131122238|NCT00549939|472077998|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
131122239|NCT00549939|472077999|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
131122240|NCT00549939|472077997|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
131122241|NCT00549939|472077998|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
131122242|NCT00549939|472077999|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
131122243|NCT00549939|472077997|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
131122244|NCT00549939|472077998|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
131122245|NCT00549939|472077999|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
131122246|NCT00549939|472077997|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
131122247|NCT00549939|472077998|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
131122248|NCT00549939|472077999|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
131122249|NCT00549939|472077997|FG000|40-week Open Label Treatment Period|Other|0|||
131122250|NCT00549939|472077998|FG001|40-week Open Label Treatment Period|Other|1|||
131122251|NCT00549939|472077999|FG002|40-week Open Label Treatment Period|Other|4|||
131122252|NCT03677596|472078000|FG000|Overall Study|Adverse Event|0|||
131122253|NCT03677596|472078001|FG001|Overall Study|Adverse Event|1|||
131122254|NCT03677596|472078000|FG000|Overall Study|Death|10|||
131122255|NCT03677596|472078001|FG001|Overall Study|Death|6|||
131122256|NCT03677596|472078000|FG000|Overall Study|Lost to Follow-up|0|||
131122257|NCT03677596|472078001|FG001|Overall Study|Lost to Follow-up|1|||
131122258|NCT03677596|472078000|FG000|Overall Study|Progressive Disease|8|||
131122259|NCT03677596|472078001|FG001|Overall Study|Progressive Disease|8|||
131122260|NCT03677596|472078000|FG000|Overall Study|Withdrawal by Subject|3|||
131122261|NCT03677596|472078001|FG001|Overall Study|Withdrawal by Subject|0|||
131122262|NCT03677596|472078000|FG000|Overall Study|Disease Relapse|2|||
131122263|NCT03677596|472078001|FG001|Overall Study|Disease Relapse|2|||
131122264|NCT03677596|472078000|FG000|Overall Study|Other|0|||
131122265|NCT03677596|472078001|FG001|Overall Study|Other|1|||
131122266|NCT05197049|472078004|FG000|Overall Study|Death|0|||
131122267|NCT05197049|472078005|FG001|Overall Study|Death|1|||
131122268|NCT05197049|472078006|FG002|Overall Study|Death|0|||
131122269|NCT05197049|472078004|FG000|Overall Study|Lost to Follow-up|3|||
131122270|NCT05197049|472078005|FG001|Overall Study|Lost to Follow-up|1|||
131122271|NCT05197049|472078006|FG002|Overall Study|Lost to Follow-up|0|||
130771963|NCT04811664|470792817|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
130937822|NCT00951665|471406297|FG005|Phase 1b|Withdrawal by Subject|0|||
131122272|NCT05197049|472078004|FG000|Overall Study|Withdrawal by Subject|15|||
131122273|NCT05197049|472078005|FG001|Overall Study|Withdrawal by Subject|3|||
131122274|NCT05197049|472078006|FG002|Overall Study|Withdrawal by Subject|1|||
131122275|NCT05197049|472078004|FG000|Overall Study|GCP non-compliance|1|||
131122276|NCT05197049|472078005|FG001|Overall Study|GCP non-compliance|2|||
131122277|NCT05197049|472078006|FG002|Overall Study|GCP non-compliance|0|||
130937823|NCT00951665|471406292|FG000|Phase 1b|Disease Progression|13|||
130937824|NCT00951665|471406293|FG001|Phase 1b|Disease Progression|2|||
130937825|NCT00951665|471406294|FG002|Phase 1b|Disease Progression|14|||
130937826|NCT00951665|471406295|FG003|Phase 1b|Disease Progression|0|||
130937827|NCT00951665|471406296|FG004|Phase 1b|Disease Progression|0|||
130937828|NCT00951665|471406297|FG005|Phase 1b|Disease Progression|0|||
130937829|NCT00951665|471406292|FG000|Phase 1b|Protocol Violation|2|||
130937830|NCT00951665|471406293|FG001|Phase 1b|Protocol Violation|0|||
130937831|NCT00951665|471406294|FG002|Phase 1b|Protocol Violation|0|||
130937832|NCT00951665|471406295|FG003|Phase 1b|Protocol Violation|0|||
130937833|NCT00951665|471406296|FG004|Phase 1b|Protocol Violation|0|||
130937834|NCT00951665|471406297|FG005|Phase 1b|Protocol Violation|0|||
130937835|NCT00951665|471406292|FG000|Phase 2a|Adverse Event|0|||
130937836|NCT00951665|471406293|FG001|Phase 2a|Adverse Event|0|||
130937837|NCT00951665|471406294|FG002|Phase 2a|Adverse Event|0|||
130937838|NCT00951665|471406295|FG003|Phase 2a|Adverse Event|0|||
130937839|NCT00951665|471406296|FG004|Phase 2a|Adverse Event|2|||
130937840|NCT00951665|471406297|FG005|Phase 2a|Adverse Event|0|||
130937841|NCT00951665|471406292|FG000|Phase 2a|Death|0|||
130937842|NCT00951665|471406293|FG001|Phase 2a|Death|0|||
130937843|NCT00951665|471406294|FG002|Phase 2a|Death|0|||
130937844|NCT00951665|471406295|FG003|Phase 2a|Death|0|||
130937845|NCT00951665|471406296|FG004|Phase 2a|Death|1|||
130937846|NCT00951665|471406297|FG005|Phase 2a|Death|1|||
130937847|NCT00951665|471406292|FG000|Phase 2a|Lost to Follow-up|0|||
130937848|NCT00951665|471406293|FG001|Phase 2a|Lost to Follow-up|0|||
130937849|NCT00951665|471406294|FG002|Phase 2a|Lost to Follow-up|0|||
130937850|NCT00951665|471406295|FG003|Phase 2a|Lost to Follow-up|0|||
130937851|NCT00951665|471406296|FG004|Phase 2a|Lost to Follow-up|1|||
130937852|NCT00951665|471406297|FG005|Phase 2a|Lost to Follow-up|0|||
130937853|NCT00951665|471406292|FG000|Phase 2a|Physician Decision|0|||
130937854|NCT00951665|471406293|FG001|Phase 2a|Physician Decision|0|||
130937855|NCT00951665|471406294|FG002|Phase 2a|Physician Decision|0|||
130937856|NCT00951665|471406295|FG003|Phase 2a|Physician Decision|0|||
130937857|NCT00951665|471406296|FG004|Phase 2a|Physician Decision|0|||
130937858|NCT00951665|471406297|FG005|Phase 2a|Physician Decision|1|||
130937859|NCT00951665|471406292|FG000|Phase 2a|Withdrawal by Subject|0|||
130937860|NCT00951665|471406293|FG001|Phase 2a|Withdrawal by Subject|0|||
130937861|NCT00951665|471406294|FG002|Phase 2a|Withdrawal by Subject|0|||
130937862|NCT00951665|471406295|FG003|Phase 2a|Withdrawal by Subject|0|||
130937863|NCT00951665|471406296|FG004|Phase 2a|Withdrawal by Subject|2|||
130937864|NCT00951665|471406297|FG005|Phase 2a|Withdrawal by Subject|0|||
130937865|NCT00951665|471406292|FG000|Phase 2a|Disease Progression|0|||
130937866|NCT00951665|471406293|FG001|Phase 2a|Disease Progression|0|||
130937867|NCT00951665|471406294|FG002|Phase 2a|Disease Progression|0|||
130937868|NCT00951665|471406295|FG003|Phase 2a|Disease Progression|0|||
130937869|NCT00951665|471406296|FG004|Phase 2a|Disease Progression|6|||
130937870|NCT00951665|471406297|FG005|Phase 2a|Disease Progression|5|||
130937871|NCT00127712|471406303|FG000|Overall Study|Adverse Event|3|||
130937872|NCT00127712|471406304|FG001|Overall Study|Adverse Event|0|||
130937873|NCT00127712|471406303|FG000|Overall Study|Lack of GI access to continue|2|||
130937874|NCT00127712|471406304|FG001|Overall Study|Lack of GI access to continue|0|||
130937875|NCT02642614|471406305|FG000|Overall Study|Adverse Event|1|||
130937876|NCT02642614|471406306|FG001|Overall Study|Adverse Event|1|||
130937877|NCT02642614|471406307|FG002|Overall Study|Adverse Event|2|||
130937878|NCT02642614|471406308|FG003|Overall Study|Adverse Event|2|||
130937879|NCT02642614|471406305|FG000|Overall Study|Lost to Follow-up|1|||
130937880|NCT02642614|471406306|FG001|Overall Study|Lost to Follow-up|0|||
130937881|NCT02642614|471406307|FG002|Overall Study|Lost to Follow-up|0|||
130937882|NCT02642614|471406308|FG003|Overall Study|Lost to Follow-up|0|||
130937883|NCT02642614|471406305|FG000|Overall Study|Withdrawal by Subject|1|||
130937884|NCT02642614|471406306|FG001|Overall Study|Withdrawal by Subject|1|||
130937885|NCT02642614|471406307|FG002|Overall Study|Withdrawal by Subject|0|||
130937886|NCT02642614|471406308|FG003|Overall Study|Withdrawal by Subject|0|||
130937887|NCT01164956|471406309|FG000|Overall Study|Side Effects|1|||
130937888|NCT01164956|471406310|FG001|Overall Study|Side Effects|0|||
130937889|NCT01164956|471406311|FG002|Overall Study|Side Effects|1|||
130937890|NCT01349803|471406314|FG000|Overall Study|Adverse Event|0|||
130937891|NCT01349803|471406315|FG001|Overall Study|Adverse Event|0|||
130937892|NCT01349803|471406316|FG002|Overall Study|Adverse Event|0|||
130937893|NCT01349803|471406317|FG003|Overall Study|Adverse Event|2|||
130937894|NCT01349803|471406314|FG000|Overall Study|Withdrawal by Subject|1|||
130937895|NCT01349803|471406315|FG001|Overall Study|Withdrawal by Subject|0|||
130937896|NCT01349803|471406316|FG002|Overall Study|Withdrawal by Subject|0|||
130771964|NCT04811664|470792818|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
130937897|NCT01349803|471406317|FG003|Overall Study|Withdrawal by Subject|0|||
130937898|NCT01349803|471406314|FG000|Overall Study|Protocol-specified criteria|0|||
130937899|NCT01349803|471406315|FG001|Overall Study|Protocol-specified criteria|1|||
130937900|NCT01349803|471406316|FG002|Overall Study|Protocol-specified criteria|3|||
130937901|NCT01349803|471406317|FG003|Overall Study|Protocol-specified criteria|0|||
130937902|NCT01710033|471406318|FG000|Stage 2|Adverse Event|0|||
131122278|NCT01368536|472078007|FG000|Overall Study|Adverse Event|5|||
131122279|NCT01368536|472078008|FG001|Overall Study|Adverse Event|6|||
130771965|NCT04811664|470792819|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
130771966|NCT04811664|470792817|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
130937903|NCT01710033|471406319|FG001|Stage 2|Adverse Event|0|||
131122280|NCT01368536|472078009|FG002|Overall Study|Adverse Event|8|||
131122281|NCT01368536|472078007|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131122282|NCT01368536|472078008|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131122283|NCT01368536|472078009|FG002|Overall Study|Abnormal laboratory value(s)|2|||
131122284|NCT01368536|472078007|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131122285|NCT01368536|472078008|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131122286|NCT01368536|472078009|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131122287|NCT01368536|472078007|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
131122288|NCT01368536|472078008|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131122289|NCT01368536|472078009|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
131122290|NCT01368536|472078007|FG000|Overall Study|No longer required study medication|0|||
131122291|NCT01368536|472078008|FG001|Overall Study|No longer required study medication|0|||
131122292|NCT01368536|472078009|FG002|Overall Study|No longer required study medication|1|||
131122293|NCT01368536|472078007|FG000|Overall Study|Withdrawal by Subject|2|||
131122294|NCT01368536|472078008|FG001|Overall Study|Withdrawal by Subject|5|||
131122295|NCT01368536|472078009|FG002|Overall Study|Withdrawal by Subject|4|||
131122296|NCT01368536|472078007|FG000|Overall Study|Lost to Follow-up|3|||
131122297|NCT01368536|472078008|FG001|Overall Study|Lost to Follow-up|3|||
131122298|NCT01368536|472078009|FG002|Overall Study|Lost to Follow-up|5|||
131122299|NCT01368536|472078007|FG000|Overall Study|Administrative problems|34|||
131122300|NCT01368536|472078008|FG001|Overall Study|Administrative problems|39|||
131122301|NCT01368536|472078009|FG002|Overall Study|Administrative problems|35|||
131122302|NCT01368536|472078007|FG000|Overall Study|Protocol deviation|0|||
131122303|NCT01368536|472078008|FG001|Overall Study|Protocol deviation|3|||
131122304|NCT01368536|472078009|FG002|Overall Study|Protocol deviation|1|||
131122305|NCT01161043|472078012|FG000|Overall Study|Withdrawal by Subject|3|||
131122306|NCT02164929|472078019|FG000|Overall Study|Converted to open procedure|1|||
131122307|NCT02164929|472078020|FG001|Overall Study|Converted to open procedure|0|||
131122308|NCT02164929|472078021|FG002|Overall Study|Converted to open procedure|0|||
131122309|NCT02164929|472078022|FG003|Overall Study|Converted to open procedure|2|||
131122310|NCT02164929|472078019|FG000|Overall Study|Failed regional block|0|||
131122311|NCT02164929|472078020|FG001|Overall Study|Failed regional block|0|||
131122312|NCT02164929|472078021|FG002|Overall Study|Failed regional block|1|||
131122313|NCT02164929|472078022|FG003|Overall Study|Failed regional block|0|||
131122314|NCT00971178|472078023|FG000|Overall Study|Lost to Follow-up|2|||
131122315|NCT00971178|472078024|FG001|Overall Study|Lost to Follow-up|2|||
131122316|NCT00971178|472078025|FG002|Overall Study|Lost to Follow-up|2|||
131122317|NCT00424749|472078027|FG000|Overall Study|Withdrawal by Subject|1|||
131122318|NCT02577406|472078028|FG000|Randomized Period|Death|1|||
131122319|NCT02577406|472078029|FG001|Randomized Period|Death|0|||
131122320|NCT02577406|472078028|FG000|Randomized Period|Other reasons|0|||
131122321|NCT02577406|472078029|FG001|Randomized Period|Other reasons|20|||
131122322|NCT02577406|472078028|FG000|Treatment Period|Death|38|||
131122323|NCT02577406|472078029|FG001|Treatment Period|Death|23|||
130937904|NCT01710033|471406320|FG002|Stage 2|Adverse Event|0|||
130937905|NCT01710033|471406321|FG003|Stage 2|Adverse Event|0|||
130937906|NCT01710033|471406322|FG004|Stage 2|Adverse Event|1|||
130937907|NCT00100815|471406323|FG000|Overall Study|Progression|24|||
130937908|NCT00100815|471406323|FG000|Overall Study|Adverse Event|18|||
130937909|NCT00100815|471406323|FG000|Overall Study|Death|4|||
130937910|NCT00100815|471406323|FG000|Overall Study|Other|3|||
130937911|NCT01647282|471406325|FG000|Overall Study|Physician Decision|7|||
130937912|NCT01647282|471406326|FG001|Overall Study|Physician Decision|5|||
130937913|NCT00723892|471406332|FG000|Overall Study|Participant not tracked|33|||
130937914|NCT00723892|471406333|FG001|Overall Study|Participant not tracked|35|||
130937915|NCT00723892|471406332|FG000|Overall Study|Virological criterion|24|||
130937916|NCT00723892|471406333|FG001|Overall Study|Virological criterion|9|||
130937917|NCT00723892|471406332|FG000|Overall Study|Withdrawal by Subject|6|||
130937918|NCT00723892|471406333|FG001|Overall Study|Withdrawal by Subject|9|||
130937919|NCT00723892|471406332|FG000|Overall Study|End planned|11|||
130937920|NCT00723892|471406333|FG001|Overall Study|End planned|7|||
130937921|NCT00723892|471406332|FG000|Overall Study|Bad tolerance|5|||
130937922|NCT00723892|471406333|FG001|Overall Study|Bad tolerance|5|||
130937923|NCT00723892|471406332|FG000|Overall Study|Multiple reasons|17|||
130937924|NCT00723892|471406333|FG001|Overall Study|Multiple reasons|12|||
130937925|NCT00723892|471406332|FG000|Overall Study|Other|6|||
130937926|NCT00723892|471406333|FG001|Overall Study|Other|3|||
130937927|NCT00723892|471406332|FG000|Overall Study|Study end|1|||
130937928|NCT00723892|471406333|FG001|Overall Study|Study end|3|||
130937929|NCT00723892|471406332|FG000|Overall Study|Weight loss|1|||
130937930|NCT00723892|471406333|FG001|Overall Study|Weight loss|3|||
130937931|NCT00723892|471406332|FG000|Overall Study|Alcohol abuse|0|||
131035994|NCT05835336|471766199|FG000|Overall Study|Did not complete the personalization process|3|||
131035995|NCT03016754|471766202|FG000|Overall Study|Death|5|||
131035996|NCT03016754|471766203|FG001|Overall Study|Death|4|||
131035997|NCT03016754|471766204|FG002|Overall Study|Death|5|||
131035998|NCT03016754|471766205|FG003|Overall Study|Death|1|||
131035999|NCT03016754|471766202|FG000|Overall Study|Lost to Follow-up|23|||
131036000|NCT03016754|471766203|FG001|Overall Study|Lost to Follow-up|17|||
131036001|NCT03016754|471766204|FG002|Overall Study|Lost to Follow-up|4|||
131036002|NCT03016754|471766205|FG003|Overall Study|Lost to Follow-up|2|||
131036003|NCT03016754|471766202|FG000|Overall Study|Withdrawal by Subject|6|||
131036004|NCT03016754|471766203|FG001|Overall Study|Withdrawal by Subject|6|||
131036005|NCT03016754|471766204|FG002|Overall Study|Withdrawal by Subject|2|||
131036006|NCT03016754|471766205|FG003|Overall Study|Withdrawal by Subject|2|||
131036007|NCT03016754|471766202|FG000|Overall Study|Other/Unknown|2|||
131036008|NCT03016754|471766203|FG001|Overall Study|Other/Unknown|4|||
131122324|NCT02577406|472078028|FG000|Treatment Period|Adverse Event|17|||
131122325|NCT02577406|472078029|FG001|Treatment Period|Adverse Event|12|||
131122326|NCT02577406|472078028|FG000|Treatment Period|Progressive Disease|53|||
131122327|NCT02577406|472078029|FG001|Treatment Period|Progressive Disease|37|||
131122328|NCT02577406|472078028|FG000|Treatment Period|Withdrawal by Subject|10|||
131122329|NCT02577406|472078029|FG001|Treatment Period|Withdrawal by Subject|24|||
131122330|NCT02577406|472078028|FG000|Treatment Period|Lost to Follow-up|0|||
131122331|NCT02577406|472078029|FG001|Treatment Period|Lost to Follow-up|1|||
131122332|NCT02577406|472078028|FG000|Treatment Period|Transition to commercially available treatment|1|||
131122333|NCT02577406|472078029|FG001|Treatment Period|Transition to commercially available treatment|1|||
131122334|NCT02577406|472078028|FG000|Treatment Period|Physician Decision|1|||
131122335|NCT02577406|472078029|FG001|Treatment Period|Physician Decision|0|||
131122336|NCT02577406|472078028|FG000|Treatment Period|Disease Relapse|28|||
131122337|NCT02577406|472078029|FG001|Treatment Period|Disease Relapse|1|||
131122338|NCT02577406|472078028|FG000|Treatment Period|Protocol Violation|0|||
131122339|NCT02577406|472078029|FG001|Treatment Period|Protocol Violation|1|||
131122340|NCT02577406|472078028|FG000|Treatment Period|Other Reasons|3|||
131122341|NCT02577406|472078029|FG001|Treatment Period|Other Reasons|39|||
131122342|NCT02577406|472078028|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
131122343|NCT02577406|472078029|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
131122344|NCT02138617|472078030|FG000|Overall Study|Death|1|||
131122345|NCT02138617|472078031|FG001|Overall Study|Death|2|||
131122346|NCT02138617|472078032|FG002|Overall Study|Death|2|||
131122347|NCT02138617|472078030|FG000|Overall Study|Adverse Event|8|||
131122348|NCT02138617|472078031|FG001|Overall Study|Adverse Event|5|||
131122349|NCT02138617|472078032|FG002|Overall Study|Adverse Event|2|||
131122350|NCT02138617|472078030|FG000|Overall Study|Disease Progression|20|||
131122351|NCT02138617|472078031|FG001|Overall Study|Disease Progression|13|||
131122352|NCT02138617|472078032|FG002|Overall Study|Disease Progression|4|||
131122353|NCT02138617|472078030|FG000|Overall Study|Withdrawal by Subject|7|||
131122354|NCT02138617|472078031|FG001|Overall Study|Withdrawal by Subject|10|||
131122355|NCT02138617|472078032|FG002|Overall Study|Withdrawal by Subject|2|||
131122356|NCT02138617|472078030|FG000|Overall Study|other complicating disease|0|||
131122357|NCT02138617|472078031|FG001|Overall Study|other complicating disease|2|||
131122358|NCT02138617|472078032|FG002|Overall Study|other complicating disease|0|||
131122359|NCT02138617|472078030|FG000|Overall Study|Protocol Violation|1|||
131122360|NCT02138617|472078031|FG001|Overall Study|Protocol Violation|0|||
131122361|NCT02138617|472078032|FG002|Overall Study|Protocol Violation|0|||
131122362|NCT02138617|472078030|FG000|Overall Study|Physician Decision|7|||
131122363|NCT02138617|472078031|FG001|Overall Study|Physician Decision|6|||
131122364|NCT02138617|472078032|FG002|Overall Study|Physician Decision|0|||
131036009|NCT03016754|471766204|FG002|Overall Study|Other/Unknown|2|||
131122365|NCT02138617|472078030|FG000|Overall Study|financial reason|0|||
131122366|NCT02138617|472078031|FG001|Overall Study|financial reason|1|||
131122367|NCT02138617|472078032|FG002|Overall Study|financial reason|0|||
131122368|NCT02138617|472078030|FG000|Overall Study|other therapy|3|||
131122369|NCT02138617|472078031|FG001|Overall Study|other therapy|4|||
131122370|NCT02138617|472078032|FG002|Overall Study|other therapy|0|||
130771967|NCT04811664|470792818|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
131036010|NCT03016754|471766205|FG003|Overall Study|Other/Unknown|1|||
131036011|NCT03016754|471766202|FG000|Overall Study|Protocol Violation|0|||
131036012|NCT03016754|471766203|FG001|Overall Study|Protocol Violation|0|||
131036013|NCT03016754|471766204|FG002|Overall Study|Protocol Violation|0|||
130937932|NCT00723892|471406333|FG001|Overall Study|Alcohol abuse|1|||
130937933|NCT00723892|471406332|FG000|Overall Study|Intercurrent infection|2|||
130937934|NCT00723892|471406333|FG001|Overall Study|Intercurrent infection|0|||
130937935|NCT00723892|471406332|FG000|Overall Study|Drug addiction|1|||
130937936|NCT00723892|471406333|FG001|Overall Study|Drug addiction|0|||
130937937|NCT02411292|471406337|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
130937938|NCT02411292|471406337|FG000|Overall Study|Death|2|||
130937939|NCT02411292|471406337|FG000|Overall Study|Lost to Follow-up|3|||
130937940|NCT00453921|471406338|FG000|Overall Study|Withdrawal by Subject|1|||
130937941|NCT00453921|471406339|FG001|Overall Study|Withdrawal by Subject|1|||
130937942|NCT00453921|471406340|FG002|Overall Study|Withdrawal by Subject|1|||
130937943|NCT00453921|471406341|FG003|Overall Study|Withdrawal by Subject|1|||
130937944|NCT00453921|471406338|FG000|Overall Study|Lost to Follow-up|0|||
130937945|NCT00453921|471406339|FG001|Overall Study|Lost to Follow-up|0|||
130937946|NCT00453921|471406340|FG002|Overall Study|Lost to Follow-up|1|||
130937947|NCT00453921|471406341|FG003|Overall Study|Lost to Follow-up|0|||
130937948|NCT02232425|471406342|FG000|Overall Study|Lost to Follow-up|6|||
130937949|NCT02232425|471406343|FG001|Overall Study|Lost to Follow-up|2|||
130937950|NCT02232425|471406342|FG000|Overall Study|Adverse Event|2|||
130937951|NCT02232425|471406343|FG001|Overall Study|Adverse Event|0|||
130937952|NCT02232425|471406342|FG000|Overall Study|Withdrawal by Subject|5|||
130937953|NCT02232425|471406343|FG001|Overall Study|Withdrawal by Subject|6|||
130937954|NCT02232425|471406342|FG000|Overall Study|Lack of Efficacy|1|||
130937955|NCT02232425|471406343|FG001|Overall Study|Lack of Efficacy|0|||
130937956|NCT00665353|471406344|FG000|Study Step 1|Adverse Event|1|||
130937957|NCT00665353|471406344|FG000|Study Step 1|Withdrawal by Subject|2|||
130937958|NCT00665353|471406344|FG000|Study Step 2|Lost to Follow-up|2|||
130937959|NCT00665353|471406344|FG000|Study Step 2|Lack of Efficacy|12|||
130937960|NCT00498602|471406345|FG000|Overall Study|Death|0|||
130937961|NCT00498602|471406346|FG001|Overall Study|Death|0|||
130937962|NCT00498602|471406347|FG002|Overall Study|Death|0|||
130937963|NCT00498602|471406348|FG003|Overall Study|Death|0|||
130937964|NCT00498602|471406349|FG004|Overall Study|Death|0|||
130937965|NCT00498602|471406350|FG005|Overall Study|Death|1|||
130937966|NCT00498602|471406351|FG006|Overall Study|Death|0|||
130937967|NCT00498602|471406345|FG000|Overall Study|Lack of Efficacy|1|||
130937968|NCT00498602|471406346|FG001|Overall Study|Lack of Efficacy|0|||
130937969|NCT00498602|471406347|FG002|Overall Study|Lack of Efficacy|0|||
130937970|NCT00498602|471406348|FG003|Overall Study|Lack of Efficacy|0|||
130937971|NCT00498602|471406349|FG004|Overall Study|Lack of Efficacy|0|||
130937972|NCT00498602|471406350|FG005|Overall Study|Lack of Efficacy|0|||
130937973|NCT00498602|471406351|FG006|Overall Study|Lack of Efficacy|0|||
130937974|NCT00498602|471406345|FG000|Overall Study|Lost to Follow-up|0|||
130937975|NCT00498602|471406346|FG001|Overall Study|Lost to Follow-up|2|||
130937976|NCT00498602|471406347|FG002|Overall Study|Lost to Follow-up|0|||
130937977|NCT00498602|471406348|FG003|Overall Study|Lost to Follow-up|2|||
130937978|NCT00498602|471406349|FG004|Overall Study|Lost to Follow-up|0|||
130937979|NCT00498602|471406350|FG005|Overall Study|Lost to Follow-up|0|||
130937980|NCT00498602|471406351|FG006|Overall Study|Lost to Follow-up|0|||
130937981|NCT00498602|471406345|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
130937982|NCT00498602|471406346|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130937983|NCT00498602|471406347|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
130937984|NCT00498602|471406348|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
130937985|NCT00498602|471406349|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130937986|NCT00498602|471406350|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
130937987|NCT00498602|471406351|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130937988|NCT00498602|471406345|FG000|Overall Study|AE not related to Study Drug|1|||
130937989|NCT00498602|471406346|FG001|Overall Study|AE not related to Study Drug|3|||
130937990|NCT00498602|471406347|FG002|Overall Study|AE not related to Study Drug|0|||
130937991|NCT00498602|471406348|FG003|Overall Study|AE not related to Study Drug|0|||
130937992|NCT00498602|471406349|FG004|Overall Study|AE not related to Study Drug|2|||
130937993|NCT00498602|471406350|FG005|Overall Study|AE not related to Study Drug|2|||
131224036|NCT04363736|472447147|FG000|Overall Study|Death|8|||
131224037|NCT04363736|472447148|FG001|Overall Study|Death|6|||
131224038|NCT00383019|472447149|FG000|Overall Study|Adverse Event|5|||
131224039|NCT00383019|472447150|FG001|Overall Study|Adverse Event|1|||
130937994|NCT00498602|471406351|FG006|Overall Study|AE not related to Study Drug|1|||
130937995|NCT00498602|471406345|FG000|Overall Study|Caregiver Request|2|||
130937996|NCT00498602|471406346|FG001|Overall Study|Caregiver Request|2|||
130937997|NCT00498602|471406347|FG002|Overall Study|Caregiver Request|2|||
130937998|NCT00498602|471406348|FG003|Overall Study|Caregiver Request|0|||
130937999|NCT00498602|471406349|FG004|Overall Study|Caregiver Request|1|||
130938000|NCT00498602|471406350|FG005|Overall Study|Caregiver Request|2|||
130938001|NCT00498602|471406351|FG006|Overall Study|Caregiver Request|0|||
130938002|NCT00498602|471406345|FG000|Overall Study|Investigator Request|0|||
130938003|NCT00498602|471406346|FG001|Overall Study|Investigator Request|0|||
130938004|NCT00498602|471406347|FG002|Overall Study|Investigator Request|1|||
131224040|NCT00383019|472447149|FG000|Overall Study|Withdrawal by Subject|0|||
130938005|NCT00498602|471406348|FG003|Overall Study|Investigator Request|0|||
130938006|NCT00498602|471406349|FG004|Overall Study|Investigator Request|0|||
130938007|NCT00498602|471406350|FG005|Overall Study|Investigator Request|0|||
130938008|NCT00498602|471406351|FG006|Overall Study|Investigator Request|0|||
130938009|NCT00498602|471406345|FG000|Overall Study|Subject Request|3|||
130938010|NCT00498602|471406346|FG001|Overall Study|Subject Request|0|||
130938011|NCT00498602|471406347|FG002|Overall Study|Subject Request|1|||
130938012|NCT00498602|471406348|FG003|Overall Study|Subject Request|1|||
130771968|NCT04811664|470792819|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
130938013|NCT00498602|471406349|FG004|Overall Study|Subject Request|1|||
130938014|NCT00498602|471406350|FG005|Overall Study|Subject Request|4|||
130938015|NCT00498602|471406351|FG006|Overall Study|Subject Request|1|||
130938016|NCT00498602|471406345|FG000|Overall Study|Other|2|||
130938017|NCT00498602|471406346|FG001|Overall Study|Other|3|||
130938018|NCT00498602|471406347|FG002|Overall Study|Other|1|||
130938019|NCT00498602|471406348|FG003|Overall Study|Other|0|||
131036014|NCT03016754|471766205|FG003|Overall Study|Protocol Violation|4|||
131036015|NCT03839940|471766206|FG000|Overall Study|Withdrawal by Subject|3|||
131036016|NCT03839940|471766207|FG001|Overall Study|Withdrawal by Subject|0|||
131036017|NCT03839940|471766206|FG000|Overall Study|Protocol Violation|0|||
131036018|NCT03839940|471766207|FG001|Overall Study|Protocol Violation|1|||
131036019|NCT03839940|471766206|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
131036020|NCT03839940|471766207|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
131036021|NCT03241745|471766208|FG000|Overall Study|Adverse Event|7|||
131036022|NCT03241745|471766208|FG000|Overall Study|Death|1|||
131036023|NCT03241745|471766208|FG000|Overall Study|Withdrawal by Subject|5|||
131036024|NCT03241745|471766208|FG000|Overall Study|Treatment delay >28 days|2|||
131036025|NCT03241745|471766208|FG000|Overall Study|Lack of Efficacy|14|||
131036026|NCT00470704|471766210|FG000|Overall Study|Withdrawal by Subject|4|||
131036027|NCT00470704|471766211|FG001|Overall Study|Withdrawal by Subject|3|||
131036028|NCT00470704|471766210|FG000|Overall Study|Relapse/Progression|37|||
131036029|NCT00470704|471766211|FG001|Overall Study|Relapse/Progression|42|||
131036030|NCT00470704|471766210|FG000|Overall Study|toxicity|0|||
131036031|NCT00470704|471766211|FG001|Overall Study|toxicity|1|||
131036032|NCT04019873|471766212|FG000|Overall Study|Discontinued from the treatment|1|||
131036033|NCT04019873|471766213|FG001|Overall Study|Discontinued from the treatment|39|||
131036034|NCT04019873|471766214|FG002|Overall Study|Discontinued from the treatment|2|||
131036035|NCT00085735|471766215|FG000|Overall Study|Adverse Event|1|||
131036036|NCT00085735|471766216|FG001|Overall Study|Adverse Event|0|||
131036037|NCT00085735|471766217|FG002|Overall Study|Adverse Event|0|||
131036038|NCT00085735|471766218|FG003|Overall Study|Adverse Event|0|||
131036039|NCT00085735|471766219|FG004|Overall Study|Adverse Event|0|||
131036040|NCT00085735|471766220|FG005|Overall Study|Adverse Event|0|||
131036041|NCT00085735|471766215|FG000|Overall Study|Lack of Efficacy|2|||
131036042|NCT00085735|471766216|FG001|Overall Study|Lack of Efficacy|4|||
131036043|NCT00085735|471766217|FG002|Overall Study|Lack of Efficacy|6|||
131036044|NCT00085735|471766218|FG003|Overall Study|Lack of Efficacy|3|||
131036045|NCT00085735|471766219|FG004|Overall Study|Lack of Efficacy|4|||
131036046|NCT00085735|471766220|FG005|Overall Study|Lack of Efficacy|3|||
131036047|NCT00085735|471766215|FG000|Overall Study|Lost to Follow-up|0|||
131036048|NCT00085735|471766216|FG001|Overall Study|Lost to Follow-up|1|||
131036049|NCT00085735|471766217|FG002|Overall Study|Lost to Follow-up|0|||
131036050|NCT00085735|471766218|FG003|Overall Study|Lost to Follow-up|0|||
131036051|NCT00085735|471766219|FG004|Overall Study|Lost to Follow-up|1|||
131036052|NCT00085735|471766220|FG005|Overall Study|Lost to Follow-up|0|||
131036053|NCT00085735|471766215|FG000|Overall Study|Physician Decision|2|||
131036054|NCT00085735|471766216|FG001|Overall Study|Physician Decision|3|||
131036055|NCT00085735|471766217|FG002|Overall Study|Physician Decision|2|||
131036056|NCT00085735|471766218|FG003|Overall Study|Physician Decision|3|||
131036057|NCT00085735|471766219|FG004|Overall Study|Physician Decision|11|||
131036058|NCT00085735|471766220|FG005|Overall Study|Physician Decision|8|||
131036059|NCT00085735|471766215|FG000|Overall Study|Protocol Violation|1|||
131036060|NCT00085735|471766216|FG001|Overall Study|Protocol Violation|0|||
131036061|NCT00085735|471766217|FG002|Overall Study|Protocol Violation|0|||
131036062|NCT00085735|471766218|FG003|Overall Study|Protocol Violation|0|||
131036063|NCT00085735|471766219|FG004|Overall Study|Protocol Violation|0|||
131036064|NCT00085735|471766220|FG005|Overall Study|Protocol Violation|0|||
131036065|NCT00085735|471766215|FG000|Overall Study|Withdrawal by Subject|1|||
131036066|NCT00085735|471766216|FG001|Overall Study|Withdrawal by Subject|0|||
131036067|NCT00085735|471766217|FG002|Overall Study|Withdrawal by Subject|4|||
131036068|NCT00085735|471766218|FG003|Overall Study|Withdrawal by Subject|5|||
131036069|NCT00085735|471766219|FG004|Overall Study|Withdrawal by Subject|7|||
131036070|NCT00085735|471766220|FG005|Overall Study|Withdrawal by Subject|8|||
131036071|NCT00085735|471766215|FG000|Overall Study|Patient ineligible|1|||
131036072|NCT00085735|471766216|FG001|Overall Study|Patient ineligible|0|||
131036073|NCT00085735|471766217|FG002|Overall Study|Patient ineligible|3|||
130938020|NCT00498602|471406349|FG004|Overall Study|Other|0|||
130938021|NCT00498602|471406350|FG005|Overall Study|Other|3|||
130938022|NCT00498602|471406351|FG006|Overall Study|Other|0|||
130938023|NCT03103919|471406355|FG000|Overall Study|Adverse Event|2|||
130938024|NCT03103919|471406356|FG001|Overall Study|Adverse Event|2|||
130938025|NCT01291173|471406357|FG000|Overall Study|Adverse Event|0|||
130938026|NCT01291173|471406358|FG001|Overall Study|Adverse Event|3|||
130938027|NCT01291173|471406359|FG002|Overall Study|Adverse Event|1|||
130938028|NCT01291173|471406360|FG003|Overall Study|Adverse Event|3|||
130938029|NCT01291173|471406357|FG000|Overall Study|Protocol Violation|7|||
130938030|NCT01291173|471406358|FG001|Overall Study|Protocol Violation|2|||
130938031|NCT01291173|471406359|FG002|Overall Study|Protocol Violation|2|||
130938032|NCT01291173|471406360|FG003|Overall Study|Protocol Violation|5|||
130938033|NCT01291173|471406357|FG000|Overall Study|Withdrawal by Subject|6|||
130938034|NCT01291173|471406358|FG001|Overall Study|Withdrawal by Subject|4|||
130938035|NCT01291173|471406359|FG002|Overall Study|Withdrawal by Subject|4|||
130938036|NCT01291173|471406360|FG003|Overall Study|Withdrawal by Subject|2|||
130938037|NCT01291173|471406357|FG000|Overall Study|Lost to Follow-up|4|||
130938038|NCT01291173|471406358|FG001|Overall Study|Lost to Follow-up|6|||
130938039|NCT01291173|471406359|FG002|Overall Study|Lost to Follow-up|3|||
130938040|NCT01291173|471406360|FG003|Overall Study|Lost to Follow-up|2|||
130938041|NCT01291173|471406357|FG000|Overall Study|Unable to meet visit schedule|0|||
130938042|NCT01291173|471406358|FG001|Overall Study|Unable to meet visit schedule|0|||
130938043|NCT01291173|471406359|FG002|Overall Study|Unable to meet visit schedule|1|||
130938044|NCT01291173|471406360|FG003|Overall Study|Unable to meet visit schedule|0|||
130938045|NCT01291173|471406357|FG000|Overall Study|Lack of compliance|0|||
130938046|NCT01291173|471406358|FG001|Overall Study|Lack of compliance|0|||
130938047|NCT01291173|471406359|FG002|Overall Study|Lack of compliance|0|||
130938048|NCT01291173|471406360|FG003|Overall Study|Lack of compliance|1|||
130938049|NCT01291173|471406357|FG000|Overall Study|Subject was unblinded|0|||
130938050|NCT01291173|471406358|FG001|Overall Study|Subject was unblinded|0|||
130938051|NCT01291173|471406359|FG002|Overall Study|Subject was unblinded|1|||
130938052|NCT01291173|471406360|FG003|Overall Study|Subject was unblinded|0|||
130938053|NCT01291173|471406357|FG000|Overall Study|Excluded therapy|0|||
130938054|NCT01291173|471406358|FG001|Overall Study|Excluded therapy|0|||
130938055|NCT01291173|471406359|FG002|Overall Study|Excluded therapy|1|||
130938056|NCT01291173|471406360|FG003|Overall Study|Excluded therapy|0|||
130938057|NCT01846507|471406361|FG000|Overall Study|Lost to Follow-up|4|||
130938058|NCT01846507|471406361|FG000|Overall Study|Protocol Violation|1|||
130938059|NCT01846507|471406361|FG000|Overall Study|Missing data|2|||
130938060|NCT00993291|471406365|FG000|Overall Study|Withdrawal by Subject|1|||
130938061|NCT02763189|471406366|FG000|Overall Study|Device failure|0|||
130938062|NCT02763189|471406367|FG001|Overall Study|Device failure|2|||
130938063|NCT00573534|471406368|FG000|Overall Study|oppositional behavior|3|||
130938064|NCT00467259|471406374|FG000|Overall Study|Adverse Event|24|||
130938065|NCT00467259|471406375|FG001|Overall Study|Adverse Event|90|||
130938066|NCT00467259|471406374|FG000|Overall Study|Protocol Violation|1|||
130938067|NCT00467259|471406375|FG001|Overall Study|Protocol Violation|7|||
130938068|NCT00467259|471406374|FG000|Overall Study|Withdrawal by Subject|34|||
130938069|NCT00467259|471406375|FG001|Overall Study|Withdrawal by Subject|108|||
130938070|NCT00467259|471406374|FG000|Overall Study|Physician Decision|0|||
130938071|NCT00467259|471406375|FG001|Overall Study|Physician Decision|2|||
130938072|NCT00467259|471406374|FG000|Overall Study|Lost to Follow-up|14|||
130938073|NCT00467259|471406375|FG001|Overall Study|Lost to Follow-up|34|||
130938074|NCT00467259|471406374|FG000|Overall Study|Site Closed|2|||
130938075|NCT00467259|471406375|FG001|Overall Study|Site Closed|1|||
130938076|NCT01129960|471406383|FG000|Overall Study|Withdrawal by Subject|3|||
130938077|NCT01129960|471406384|FG001|Overall Study|Withdrawal by Subject|0|||
130938078|NCT01129960|471406385|FG002|Overall Study|Withdrawal by Subject|3|||
130938079|NCT01129960|471406386|FG003|Overall Study|Withdrawal by Subject|2|||
130938080|NCT01129960|471406383|FG000|Overall Study|Lack of Efficacy|1|||
130938081|NCT01129960|471406384|FG001|Overall Study|Lack of Efficacy|1|||
130938082|NCT01129960|471406385|FG002|Overall Study|Lack of Efficacy|1|||
130938083|NCT01129960|471406386|FG003|Overall Study|Lack of Efficacy|1|||
130938084|NCT01129960|471406383|FG000|Overall Study|Adverse Event|23|||
130938085|NCT01129960|471406384|FG001|Overall Study|Adverse Event|16|||
130938086|NCT01129960|471406385|FG002|Overall Study|Adverse Event|16|||
130938087|NCT01129960|471406386|FG003|Overall Study|Adverse Event|7|||
130938088|NCT01129960|471406383|FG000|Overall Study|Protocol Violation|1|||
130938089|NCT01129960|471406384|FG001|Overall Study|Protocol Violation|2|||
130938090|NCT01129960|471406385|FG002|Overall Study|Protocol Violation|3|||
130938091|NCT01129960|471406386|FG003|Overall Study|Protocol Violation|0|||
130938092|NCT01129960|471406383|FG000|Overall Study|Lost to Follow-up|0|||
130938093|NCT01129960|471406384|FG001|Overall Study|Lost to Follow-up|2|||
130938094|NCT01129960|471406385|FG002|Overall Study|Lost to Follow-up|3|||
130938095|NCT01129960|471406386|FG003|Overall Study|Lost to Follow-up|3|||
130938096|NCT01129960|471406383|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
130938097|NCT01129960|471406384|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
130938098|NCT01129960|471406385|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
130938099|NCT01129960|471406386|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
130938100|NCT01129960|471406383|FG000|Overall Study|Physician Decision|1|||
130938101|NCT01129960|471406384|FG001|Overall Study|Physician Decision|0|||
130938102|NCT01129960|471406385|FG002|Overall Study|Physician Decision|0|||
130938103|NCT01129960|471406386|FG003|Overall Study|Physician Decision|0|||
130938104|NCT01129960|471406383|FG000|Overall Study|Pregnancy|1|||
130938105|NCT01129960|471406384|FG001|Overall Study|Pregnancy|0|||
130938106|NCT01129960|471406385|FG002|Overall Study|Pregnancy|0|||
130938107|NCT01129960|471406386|FG003|Overall Study|Pregnancy|0|||
130938108|NCT02669433|471406389|FG000|Overall Study|Protocol Violation|0|||
130938109|NCT02669433|471406390|FG001|Overall Study|Protocol Violation|4|||
130938110|NCT02669433|471406391|FG002|Overall Study|Protocol Violation|1|||
130938111|NCT02669433|471406389|FG000|Overall Study|Disease Progression|1|||
130938112|NCT02669433|471406390|FG001|Overall Study|Disease Progression|0|||
130938113|NCT02669433|471406391|FG002|Overall Study|Disease Progression|0|||
130938114|NCT02669433|471406389|FG000|Overall Study|Physician Decision|1|||
130938115|NCT02669433|471406390|FG001|Overall Study|Physician Decision|1|||
130938116|NCT02669433|471406391|FG002|Overall Study|Physician Decision|0|||
130938117|NCT02669433|471406389|FG000|Overall Study|Adverse Event|6|||
130938118|NCT02669433|471406390|FG001|Overall Study|Adverse Event|7|||
130938119|NCT02669433|471406391|FG002|Overall Study|Adverse Event|10|||
130938120|NCT02669433|471406389|FG000|Overall Study|Sponsor Termination|1|||
130938121|NCT02669433|471406390|FG001|Overall Study|Sponsor Termination|0|||
130938122|NCT02669433|471406391|FG002|Overall Study|Sponsor Termination|1|||
130938123|NCT02669433|471406389|FG000|Overall Study|Withdrawal by Subject|5|||
130938124|NCT02669433|471406390|FG001|Overall Study|Withdrawal by Subject|1|||
130938125|NCT02669433|471406391|FG002|Overall Study|Withdrawal by Subject|0|||
130938126|NCT02669433|471406389|FG000|Overall Study|Withdrawal by Caregiver|1|||
130938127|NCT02669433|471406390|FG001|Overall Study|Withdrawal by Caregiver|0|||
130938128|NCT02669433|471406391|FG002|Overall Study|Withdrawal by Caregiver|2|||
130938129|NCT02669433|471406389|FG000|Overall Study|Death|0|||
130938130|NCT02669433|471406390|FG001|Overall Study|Death|1|||
130938131|NCT02669433|471406391|FG002|Overall Study|Death|1|||
130938132|NCT00576927|471406392|FG000|Clinical Assessment|Lack of Efficacy|24|||
130938133|NCT00576927|471406392|FG000|Clinical Assessment|Death|1|||
130938134|NCT00576927|471406392|FG000|Clinical Assessment|Withdrawal by Subject|10|||
130938135|NCT00576927|471406392|FG000|Clinical Assessment|Physician Decision|1|||
130938136|NCT00576927|471406392|FG000|Baseline|Physician Decision|9|||
130938137|NCT00576927|471406392|FG000|Baseline|Medication Change by PCP of subject|1|||
130938138|NCT00576927|471406392|FG000|Baseline|Withdrawal by Subject|3|||
130938139|NCT00576927|471406392|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
130938140|NCT00576927|471406392|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
130938141|NCT00576927|471406392|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
130938142|NCT00576927|471406392|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
130938143|NCT00576927|471406392|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
130938144|NCT03266094|471406393|FG000|Overall Study|Lost to Follow-up|1|||
130938145|NCT03266094|471406393|FG000|Overall Study|Withdrawal by Subject|1|||
130938146|NCT03128892|471406394|FG000|Overall Study|Withdrawal by Subject|2|||
130938147|NCT03128892|471406394|FG000|Overall Study|Physician Decision|1|||
130938148|NCT00459108|471406396|FG000|Overall Study|Withdrawal by Subject|5|||
130938149|NCT00459108|471406396|FG000|Overall Study|Adverse Event|3|||
130938150|NCT00459108|471406396|FG000|Overall Study|Death|2|||
130938151|NCT00459108|471406396|FG000|Overall Study|Progression|1|||
130938152|NCT03473808|471406401|FG000|Overall Study|Withdrawal by Subject|1|||
130938153|NCT02157298|471406402|FG000|Overall Study|Adverse Event|1|||
130938154|NCT02157298|471406403|FG001|Overall Study|Adverse Event|0|||
130938155|NCT02157298|471406402|FG000|Overall Study|Subject no longer meets study criteria|1|||
130938156|NCT02157298|471406403|FG001|Overall Study|Subject no longer meets study criteria|2|||
130938157|NCT02157298|471406402|FG000|Overall Study|Poor/Non-compliance|1|||
130938158|NCT02157298|471406403|FG001|Overall Study|Poor/Non-compliance|0|||
130938159|NCT02157298|471406402|FG000|Overall Study|Withdrawal by Subject|1|||
130938160|NCT02157298|471406403|FG001|Overall Study|Withdrawal by Subject|0|||
130938161|NCT03171415|471406404|FG000|Overall Study|Lost to Follow-up|0|||
130938162|NCT03171415|471406405|FG001|Overall Study|Lost to Follow-up|0|||
130938163|NCT03171415|471406406|FG002|Overall Study|Lost to Follow-up|0|||
130938164|NCT03171415|471406407|FG003|Overall Study|Lost to Follow-up|0|||
130938165|NCT03171415|471406408|FG004|Overall Study|Lost to Follow-up|2|||
130938166|NCT04059094|471406409|FG000|Overall Study|Adverse Event|0|||
130938167|NCT04059094|471406410|FG001|Overall Study|Adverse Event|0|||
130938168|NCT04059094|471406411|FG002|Overall Study|Adverse Event|0|||
130938169|NCT04059094|471406412|FG003|Overall Study|Adverse Event|0|||
130938170|NCT04059094|471406413|FG004|Overall Study|Adverse Event|1|||
130938171|NCT04059094|471406409|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
130938172|NCT04059094|471406410|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
130938173|NCT04059094|471406411|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
130938174|NCT04059094|471406412|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
131224041|NCT00383019|472447150|FG001|Overall Study|Withdrawal by Subject|1|||
131224042|NCT01374906|472447155|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130938175|NCT04059094|471406413|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
130938176|NCT00883116|471406418|FG000|Overall Study|Adverse event unrelated to study drug|5|||
130938177|NCT00883116|471406419|FG001|Overall Study|Adverse event unrelated to study drug|10|||
130938178|NCT00883116|471406418|FG000|Overall Study|Death|6|||
130938179|NCT00883116|471406419|FG001|Overall Study|Death|2|||
130938180|NCT00883116|471406418|FG000|Overall Study|Disease progression|130|||
130938181|NCT00883116|471406419|FG001|Overall Study|Disease progression|128|||
130938182|NCT00883116|471406418|FG000|Overall Study|Lost to Follow-up|0|||
130938183|NCT00883116|471406419|FG001|Overall Study|Lost to Follow-up|1|||
130938184|NCT00883116|471406418|FG000|Overall Study|Maximum clinical benefit|13|||
130938185|NCT00883116|471406419|FG001|Overall Study|Maximum clinical benefit|46|||
130938186|NCT00883116|471406418|FG000|Overall Study|Not identified|3|||
130938187|NCT00883116|471406419|FG001|Overall Study|Not identified|6|||
130938188|NCT00883116|471406418|FG000|Overall Study|Study drug toxicity|36|||
130938189|NCT00883116|471406419|FG001|Overall Study|Study drug toxicity|16|||
130938190|NCT00883116|471406418|FG000|Overall Study|Withdrawal by Subject|14|||
130938191|NCT00883116|471406419|FG001|Overall Study|Withdrawal by Subject|8|||
130938192|NCT00883116|471406418|FG000|Overall Study|No longer meets study criteria|2|||
130938193|NCT00883116|471406419|FG001|Overall Study|No longer meets study criteria|2|||
130938194|NCT03715764|471406420|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
130938195|NCT03715764|471406421|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
130938196|NCT03715764|471406420|FG000|3 Month Follow-up|Lost to Follow-up|2|||
130938197|NCT03715764|471406421|FG001|3 Month Follow-up|Lost to Follow-up|2|||
130938198|NCT03715764|471406420|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
130938199|NCT03715764|471406421|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
130938200|NCT03715764|471406420|FG000|6 Month Follow-up|Lost to Follow-up|3|||
130938201|NCT03715764|471406421|FG001|6 Month Follow-up|Lost to Follow-up|0|||
130938202|NCT03715764|471406420|FG000|12 Month Follow-up|Lost to Follow-up|2|||
130938203|NCT03715764|471406421|FG001|12 Month Follow-up|Lost to Follow-up|3|||
130938204|NCT03715764|471406420|FG000|12 Month Follow-up|Pregnancy|0|||
130938205|NCT03715764|471406421|FG001|12 Month Follow-up|Pregnancy|1|||
130938206|NCT03715764|471406420|FG000|12 Month Follow-up|Surgery|2|||
130938207|NCT03715764|471406421|FG001|12 Month Follow-up|Surgery|0|||
130938208|NCT03715764|471406420|FG000|12 Month Follow-up|Wrong address|1|||
130938209|NCT03715764|471406421|FG001|12 Month Follow-up|Wrong address|0|||
130938210|NCT03715764|471406420|FG000|12 Month Follow-up|No symptoms|1|||
130938211|NCT03715764|471406421|FG001|12 Month Follow-up|No symptoms|0|||
130938212|NCT03715764|471406420|FG000|12 Month Follow-up|Changed primary care centre|0|||
130938213|NCT03715764|471406421|FG001|12 Month Follow-up|Changed primary care centre|1|||
130938214|NCT00818662|471406427|FG000|Overall Study|Adverse Event|5|||
130938215|NCT00818662|471406428|FG001|Overall Study|Adverse Event|14|||
130938216|NCT00818662|471406429|FG002|Overall Study|Adverse Event|4|||
130938217|NCT00818662|471406430|FG003|Overall Study|Adverse Event|3|||
130938218|NCT00818662|471406427|FG000|Overall Study|Withdrawal by Subject|5|||
130938219|NCT00818662|471406428|FG001|Overall Study|Withdrawal by Subject|4|||
130938220|NCT00818662|471406429|FG002|Overall Study|Withdrawal by Subject|2|||
130938221|NCT00818662|471406430|FG003|Overall Study|Withdrawal by Subject|2|||
130938222|NCT00818662|471406427|FG000|Overall Study|Death|1|||
130938223|NCT00818662|471406428|FG001|Overall Study|Death|3|||
130771969|NCT04811664|470792817|FG000|Overall Study|Protocol Violation|0|||
130938224|NCT00818662|471406429|FG002|Overall Study|Death|0|||
130938225|NCT00818662|471406430|FG003|Overall Study|Death|0|||
130938226|NCT00818662|471406427|FG000|Overall Study|Physician Decision|1|||
130938227|NCT00818662|471406428|FG001|Overall Study|Physician Decision|0|||
130938228|NCT00818662|471406429|FG002|Overall Study|Physician Decision|0|||
130938229|NCT00818662|471406430|FG003|Overall Study|Physician Decision|0|||
130938230|NCT00818662|471406427|FG000|Overall Study|Lost to Follow-up|0|||
130938231|NCT00818662|471406428|FG001|Overall Study|Lost to Follow-up|0|||
130938232|NCT00818662|471406429|FG002|Overall Study|Lost to Follow-up|0|||
131224043|NCT01374906|472447156|FG001|Overall Study|Abnormal laboratory value(s)|3|||
131224044|NCT01374906|472447155|FG000|Overall Study|Administrative problems|2|||
131224045|NCT01374906|472447156|FG001|Overall Study|Administrative problems|2|||
130705688|NCT01684878|470547301|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
130705689|NCT01684878|470547302|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
130705690|NCT01684878|470547303|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
130938233|NCT00818662|471406430|FG003|Overall Study|Lost to Follow-up|1|||
130938234|NCT00818662|471406427|FG000|Overall Study|Unwilling or Unable to Participate|4|||
130938235|NCT00818662|471406428|FG001|Overall Study|Unwilling or Unable to Participate|6|||
130938236|NCT00818662|471406429|FG002|Overall Study|Unwilling or Unable to Participate|2|||
130938237|NCT00818662|471406430|FG003|Overall Study|Unwilling or Unable to Participate|4|||
130938238|NCT00818662|471406427|FG000|Overall Study|Protocol Violation|1|||
130938239|NCT00818662|471406428|FG001|Overall Study|Protocol Violation|1|||
130938240|NCT00818662|471406429|FG002|Overall Study|Protocol Violation|0|||
130938241|NCT00818662|471406430|FG003|Overall Study|Protocol Violation|0|||
130938242|NCT00818662|471406427|FG000|Overall Study|Requires a Prohibited Medication|1|||
130938243|NCT00818662|471406428|FG001|Overall Study|Requires a Prohibited Medication|0|||
130938244|NCT00818662|471406429|FG002|Overall Study|Requires a Prohibited Medication|0|||
130938245|NCT00818662|471406430|FG003|Overall Study|Requires a Prohibited Medication|0|||
130705691|NCT01684878|470547300|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
130705692|NCT01684878|470547301|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
130705693|NCT01684878|470547302|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
130705694|NCT01684878|470547303|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
130938246|NCT00818662|471406427|FG000|Overall Study|Safety Risk|1|||
130938247|NCT00818662|471406428|FG001|Overall Study|Safety Risk|1|||
130938248|NCT00818662|471406429|FG002|Overall Study|Safety Risk|0|||
130938249|NCT00818662|471406430|FG003|Overall Study|Safety Risk|1|||
130938250|NCT00818662|471406427|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
130938251|NCT00818662|471406428|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
130938252|NCT00818662|471406429|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
130938253|NCT00818662|471406430|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
130938254|NCT00818662|471406427|FG000|Overall Study|Participant's health declined|0|||
130938255|NCT00818662|471406428|FG001|Overall Study|Participant's health declined|0|||
130938256|NCT00818662|471406429|FG002|Overall Study|Participant's health declined|0|||
130938257|NCT00818662|471406430|FG003|Overall Study|Participant's health declined|1|||
130938258|NCT00818662|471406427|FG000|Overall Study|Caregiver to pursue other treatment|0|||
130938259|NCT00818662|471406428|FG001|Overall Study|Caregiver to pursue other treatment|1|||
130938260|NCT00818662|471406429|FG002|Overall Study|Caregiver to pursue other treatment|0|||
130938261|NCT00818662|471406430|FG003|Overall Study|Caregiver to pursue other treatment|0|||
130938262|NCT00818662|471406427|FG000|Overall Study|Moving out of state|0|||
130938263|NCT00818662|471406428|FG001|Overall Study|Moving out of state|0|||
130938264|NCT00818662|471406429|FG002|Overall Study|Moving out of state|0|||
130938265|NCT00818662|471406430|FG003|Overall Study|Moving out of state|1|||
130938266|NCT00818662|471406427|FG000|Overall Study|Declined move to another study site|1|||
130938267|NCT00818662|471406428|FG001|Overall Study|Declined move to another study site|0|||
130938268|NCT00818662|471406429|FG002|Overall Study|Declined move to another study site|0|||
130938269|NCT00818662|471406430|FG003|Overall Study|Declined move to another study site|0|||
130938270|NCT00818662|471406427|FG000|Overall Study|Change in living situation|0|||
130771970|NCT04811664|470792818|FG001|Overall Study|Protocol Violation|5|||
130938271|NCT00818662|471406428|FG001|Overall Study|Change in living situation|0|||
131224046|NCT01374906|472447155|FG000|Overall Study|Adverse Event|10|||
131224047|NCT01374906|472447156|FG001|Overall Study|Adverse Event|11|||
131224048|NCT01374906|472447155|FG000|Overall Study|Death|0|||
130938272|NCT00818662|471406429|FG002|Overall Study|Change in living situation|0|||
130938273|NCT00818662|471406430|FG003|Overall Study|Change in living situation|1|||
130938274|NCT00818662|471406427|FG000|Overall Study|Study partner decision|0|||
130938275|NCT00818662|471406428|FG001|Overall Study|Study partner decision|0|||
130938276|NCT00818662|471406429|FG002|Overall Study|Study partner decision|0|||
130938277|NCT00818662|471406430|FG003|Overall Study|Study partner decision|1|||
130938278|NCT00818662|471406427|FG000|Overall Study|Admitted to long term nursing care|0|||
130938279|NCT00818662|471406428|FG001|Overall Study|Admitted to long term nursing care|1|||
130771971|NCT04811664|470792819|FG002|Overall Study|Protocol Violation|11|||
130938280|NCT00818662|471406429|FG002|Overall Study|Admitted to long term nursing care|0|||
130938281|NCT00818662|471406430|FG003|Overall Study|Admitted to long term nursing care|0|||
130938282|NCT01472081|471406431|FG000|Overall Study|Continuing treatment at time of analysis|1|||
130938283|NCT01472081|471406432|FG001|Overall Study|Continuing treatment at time of analysis|4|||
130938284|NCT01472081|471406433|FG002|Overall Study|Continuing treatment at time of analysis|1|||
130938285|NCT01472081|471406434|FG003|Overall Study|Continuing treatment at time of analysis|8|||
131224049|NCT01374906|472447156|FG001|Overall Study|Death|2|||
130938286|NCT01472081|471406435|FG004|Overall Study|Continuing treatment at time of analysis|9|||
131224050|NCT01374906|472447155|FG000|Overall Study|Protocol Violation|2|||
131224051|NCT01374906|472447156|FG001|Overall Study|Protocol Violation|2|||
131224052|NCT01374906|472447155|FG000|Overall Study|Withdrawal by Subject|15|||
131224053|NCT01374906|472447156|FG001|Overall Study|Withdrawal by Subject|9|||
131036074|NCT00085735|471766218|FG003|Overall Study|Patient ineligible|7|||
131036075|NCT00085735|471766219|FG004|Overall Study|Patient ineligible|17|||
131036076|NCT00085735|471766220|FG005|Overall Study|Patient ineligible|8|||
131036077|NCT00085735|471766215|FG000|Overall Study|Excess residual disease|2|||
131036078|NCT00085735|471766216|FG001|Overall Study|Excess residual disease|2|||
131036079|NCT00085735|471766217|FG002|Overall Study|Excess residual disease|1|||
131036080|NCT00085735|471766218|FG003|Overall Study|Excess residual disease|1|||
131036081|NCT00085735|471766219|FG004|Overall Study|Excess residual disease|1|||
131036082|NCT00085735|471766220|FG005|Overall Study|Excess residual disease|4|||
131036083|NCT00085735|471766215|FG000|Overall Study|Reason not documented|1|||
131036084|NCT00085735|471766216|FG001|Overall Study|Reason not documented|0|||
131036085|NCT00085735|471766217|FG002|Overall Study|Reason not documented|1|||
131036086|NCT00085735|471766218|FG003|Overall Study|Reason not documented|0|||
131036087|NCT00085735|471766219|FG004|Overall Study|Reason not documented|1|||
131036088|NCT00085735|471766220|FG005|Overall Study|Reason not documented|0|||
131036089|NCT00085735|471766215|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
131036090|NCT00085735|471766216|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
131036091|NCT00085735|471766217|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
131036092|NCT00085735|471766218|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
131036093|NCT00085735|471766219|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
131036094|NCT00085735|471766220|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
131036095|NCT04473222|471766221|FG000|Overall Study|Lost to Follow-up|13|||
131036096|NCT04473222|471766222|FG001|Overall Study|Lost to Follow-up|13|||
131036097|NCT04473222|471766221|FG000|Overall Study|Withdrawal by Subject|0|||
131036098|NCT04473222|471766222|FG001|Overall Study|Withdrawal by Subject|1|||
131036099|NCT04473222|471766221|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
131036100|NCT04473222|471766222|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
131036101|NCT02919306|471766223|FG000|Overall Study|Withdrawal by Subject|1|||
131036102|NCT02919306|471766224|FG001|Overall Study|Withdrawal by Subject|0|||
130938287|NCT01472081|471406436|FG005|Overall Study|Continuing treatment at time of analysis|0|||
130938288|NCT01472081|471406431|FG000|Overall Study|Disease Progression|4|||
130938289|NCT01472081|471406432|FG001|Overall Study|Disease Progression|10|||
130938290|NCT01472081|471406433|FG002|Overall Study|Disease Progression|12|||
130938291|NCT01472081|471406434|FG003|Overall Study|Disease Progression|31|||
130938292|NCT01472081|471406435|FG004|Overall Study|Disease Progression|22|||
130938293|NCT01472081|471406436|FG005|Overall Study|Disease Progression|3|||
130938294|NCT01472081|471406431|FG000|Overall Study|Study drug toxicity|2|||
130938295|NCT01472081|471406432|FG001|Overall Study|Study drug toxicity|9|||
130938296|NCT01472081|471406433|FG002|Overall Study|Study drug toxicity|4|||
130938297|NCT01472081|471406434|FG003|Overall Study|Study drug toxicity|6|||
130938298|NCT01472081|471406435|FG004|Overall Study|Study drug toxicity|13|||
130938299|NCT01472081|471406436|FG005|Overall Study|Study drug toxicity|2|||
131224054|NCT01374906|472447155|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
131224055|NCT01374906|472447156|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
131224056|NCT02475980|472447157|FG000|Overall Study|Lost to Follow-up|4|||
130938300|NCT01472081|471406431|FG000|Overall Study|Death|0|||
130938301|NCT01472081|471406432|FG001|Overall Study|Death|0|||
130938302|NCT01472081|471406433|FG002|Overall Study|Death|0|||
130938303|NCT01472081|471406434|FG003|Overall Study|Death|0|||
130938304|NCT01472081|471406435|FG004|Overall Study|Death|1|||
130938305|NCT01472081|471406436|FG005|Overall Study|Death|0|||
130938306|NCT01472081|471406431|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
130938307|NCT01472081|471406432|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
131036103|NCT02919306|471766223|FG000|Overall Study|Protocol Violation|1|||
131036104|NCT02919306|471766224|FG001|Overall Study|Protocol Violation|0|||
131036105|NCT04195698|471766227|FG000|Overall Study|Adverse Event|4|||
131036106|NCT04195698|471766228|FG001|Overall Study|Adverse Event|11|||
131036107|NCT04195698|471766227|FG000|Overall Study|Withdrawal by Subject|9|||
131036108|NCT04195698|471766228|FG001|Overall Study|Withdrawal by Subject|10|||
131036109|NCT04195698|471766227|FG000|Overall Study|Lost to Follow-up|5|||
131036110|NCT04195698|471766228|FG001|Overall Study|Lost to Follow-up|4|||
131036111|NCT04195698|471766227|FG000|Overall Study|Lack of Efficacy|2|||
131036112|NCT04195698|471766228|FG001|Overall Study|Lack of Efficacy|10|||
131036113|NCT04195698|471766227|FG000|Overall Study|Other|5|||
131036114|NCT04195698|471766228|FG001|Overall Study|Other|4|||
131036115|NCT05459688|471766229|FG000|Overall Study|Lost to Follow-up|6|||
131036116|NCT05459688|471766229|FG000|Overall Study|Physician Decision|1|||
131036117|NCT05459688|471766229|FG000|Overall Study|Withdrawal by Subject|19|||
131036118|NCT05459688|471766229|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
131036119|NCT03339713|471766231|FG000|Overall Study|Lost to Follow-up|2|||
131036120|NCT03339713|471766232|FG001|Overall Study|Lost to Follow-up|1|||
131036121|NCT03339713|471766231|FG000|Overall Study|Protocol Violation|1|||
131036122|NCT03339713|471766232|FG001|Overall Study|Protocol Violation|0|||
131036123|NCT03339713|471766231|FG000|Overall Study|Withdrawal by Subject|1|||
131036124|NCT03339713|471766232|FG001|Overall Study|Withdrawal by Subject|1|||
131036125|NCT01959425|471766233|FG000|Overall Study|Withdrawal by Subject|5|||
131036126|NCT01959425|471766234|FG001|Overall Study|Withdrawal by Subject|4|||
131036127|NCT01959425|471766233|FG000|Overall Study|Lost to Follow-up|1|||
131036128|NCT01959425|471766234|FG001|Overall Study|Lost to Follow-up|0|||
131036129|NCT01959425|471766233|FG000|Overall Study|Discontinued Subjects|6|||
131036130|NCT01959425|471766234|FG001|Overall Study|Discontinued Subjects|4|||
131036131|NCT05540665|471766236|FG000|Overall Study|Study terminated by sponsor|6|||
131036132|NCT05540665|471766237|FG001|Overall Study|Study terminated by sponsor|6|||
131036133|NCT05540665|471766238|FG002|Overall Study|Study terminated by sponsor|7|||
131036134|NCT02619838|471766241|FG000|Overall Study|Lost to Follow-up|9|||
131036135|NCT02619838|471766241|FG000|Overall Study|Withdrawal by Subject|15|||
131036136|NCT01715285|471766242|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
131036137|NCT01715285|471766243|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
131036138|NCT01715285|471766244|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
131036139|NCT01715285|471766242|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
131036140|NCT01715285|471766243|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
131036141|NCT01715285|471766244|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
131036142|NCT01715285|471766242|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
131036143|NCT01715285|471766243|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
131036144|NCT01715285|471766244|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
131036145|NCT01715285|471766242|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
131036146|NCT01715285|471766243|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
131036147|NCT01715285|471766244|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
131036148|NCT01715285|471766242|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
131036149|NCT01715285|471766243|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
131036150|NCT01715285|471766244|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
131036151|NCT01715285|471766242|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
131036152|NCT01715285|471766243|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
131036153|NCT01715285|471766244|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
131036154|NCT01715285|471766242|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
131036155|NCT01715285|471766243|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
131036156|NCT01715285|471766244|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
131036157|NCT01715285|471766242|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
131036158|NCT01715285|471766243|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
131036159|NCT01715285|471766244|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
131036160|NCT01715285|471766242|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
131036161|NCT01715285|471766243|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
130705695|NCT01435031|470547307|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
130705696|NCT01435031|470547307|FG000|ITT at 1 Month|Death|1|||
130705697|NCT01435031|470547307|FG000|ITT at 1 Month|Lost to Follow-up|4|||
130705698|NCT01435031|470547307|FG000|ITT at 6 Months|Death|2|||
130938308|NCT01472081|471406433|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
130938309|NCT01472081|471406434|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
130938310|NCT01472081|471406435|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
130938311|NCT01472081|471406436|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
131224057|NCT02475980|472447157|FG000|Overall Study|Withdrawal by Subject|1|||
131224058|NCT00990093|472447158|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
131224059|NCT00990093|472447159|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
131224060|NCT00990093|472447158|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
131224061|NCT00990093|472447159|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
130938312|NCT01472081|471406431|FG000|Overall Study|Withdrawal by Subject|0|||
130938313|NCT01472081|471406432|FG001|Overall Study|Withdrawal by Subject|0|||
130938314|NCT01472081|471406433|FG002|Overall Study|Withdrawal by Subject|0|||
130938315|NCT01472081|471406434|FG003|Overall Study|Withdrawal by Subject|0|||
130938316|NCT01472081|471406435|FG004|Overall Study|Withdrawal by Subject|0|||
131224062|NCT00990093|472447158|FG000|Test Period 1 (1-14 Days)|Other|1|||
131224063|NCT00990093|472447159|FG001|Test Period 1 (1-14 Days)|Other|0|||
131224064|NCT00990093|472447158|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
131224065|NCT00990093|472447159|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
130705699|NCT01435031|470547307|FG000|ITT at 6 Months|Lost to Follow-up|3|||
130938317|NCT01472081|471406436|FG005|Overall Study|Withdrawal by Subject|1|||
131224066|NCT00990093|472447158|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
130705700|NCT01435031|470547307|FG000|ITT at 1 Year|Death|1|||
130705701|NCT01435031|470547307|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
130705702|NCT01435031|470547307|FG000|ITT at 1 Year|Lost to Follow-up|6|||
130938318|NCT01472081|471406431|FG000|Overall Study|Poor/non-compliance|0|||
130938319|NCT01472081|471406432|FG001|Overall Study|Poor/non-compliance|0|||
130938320|NCT01472081|471406433|FG002|Overall Study|Poor/non-compliance|1|||
130938321|NCT01472081|471406434|FG003|Overall Study|Poor/non-compliance|0|||
130938322|NCT01472081|471406435|FG004|Overall Study|Poor/non-compliance|1|||
130938323|NCT01472081|471406436|FG005|Overall Study|Poor/non-compliance|0|||
130938324|NCT01472081|471406431|FG000|Overall Study|No longer meets study criteria|0|||
130938325|NCT01472081|471406432|FG001|Overall Study|No longer meets study criteria|0|||
130938326|NCT01472081|471406433|FG002|Overall Study|No longer meets study criteria|1|||
130938327|NCT01472081|471406434|FG003|Overall Study|No longer meets study criteria|0|||
130938328|NCT01472081|471406435|FG004|Overall Study|No longer meets study criteria|0|||
130938329|NCT01472081|471406436|FG005|Overall Study|No longer meets study criteria|0|||
130938330|NCT01472081|471406431|FG000|Overall Study|Subject request to discontinue treatment|0|||
130938331|NCT01472081|471406432|FG001|Overall Study|Subject request to discontinue treatment|3|||
130938332|NCT01472081|471406433|FG002|Overall Study|Subject request to discontinue treatment|1|||
130938333|NCT01472081|471406434|FG003|Overall Study|Subject request to discontinue treatment|1|||
130938334|NCT01472081|471406435|FG004|Overall Study|Subject request to discontinue treatment|0|||
130938335|NCT01472081|471406436|FG005|Overall Study|Subject request to discontinue treatment|0|||
130938336|NCT01705652|471406438|FG000|Overall Study|Adverse Event|1|||
131036162|NCT01715285|471766244|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
131036163|NCT01715285|471766242|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
131036164|NCT01715285|471766243|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
131036165|NCT01715285|471766244|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
131036166|NCT01715285|471766242|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
131036167|NCT01715285|471766243|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
131036168|NCT01715285|471766244|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
131036169|NCT01715285|471766242|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
131036170|NCT01715285|471766243|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
131036171|NCT01715285|471766244|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
131036172|NCT01715285|471766242|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
131036173|NCT01715285|471766243|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
131036174|NCT01715285|471766244|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
131036175|NCT01715285|471766242|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
131036176|NCT01715285|471766243|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
131036177|NCT01715285|471766244|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
131036178|NCT02677805|471766265|FG000|Double Blind Phase|Lost to Follow-up|8|||
131036179|NCT02677805|471766266|FG001|Double Blind Phase|Lost to Follow-up|3|||
131036180|NCT02677805|471766267|FG002|Double Blind Phase|Lost to Follow-up|0|||
131036181|NCT02677805|471766265|FG000|Double Blind Phase|Withdrawal by Subject|5|||
131036182|NCT02677805|471766266|FG001|Double Blind Phase|Withdrawal by Subject|2|||
131036183|NCT02677805|471766267|FG002|Double Blind Phase|Withdrawal by Subject|0|||
131036184|NCT02677805|471766265|FG000|Open Label Phase|Lost to Follow-up|0|||
131036185|NCT02677805|471766266|FG001|Open Label Phase|Lost to Follow-up|0|||
131036186|NCT02677805|471766267|FG002|Open Label Phase|Lost to Follow-up|10|||
131036187|NCT02677805|471766265|FG000|Open Label Phase|Withdrawal by Subject|0|||
131036188|NCT02677805|471766266|FG001|Open Label Phase|Withdrawal by Subject|0|||
131036189|NCT02677805|471766267|FG002|Open Label Phase|Withdrawal by Subject|6|||
131036190|NCT04350463|471766272|FG000|Overall Study|Other reason|0|||
131036191|NCT04350463|471766273|FG001|Overall Study|Other reason|0|||
131036192|NCT04350463|471766274|FG002|Overall Study|Other reason|0|||
131036193|NCT04350463|471766275|FG003|Overall Study|Other reason|1|||
131036194|NCT04350463|471766272|FG000|Overall Study|Lost to Follow-up|0|||
131036195|NCT04350463|471766273|FG001|Overall Study|Lost to Follow-up|0|||
131036196|NCT04350463|471766274|FG002|Overall Study|Lost to Follow-up|0|||
131036197|NCT04350463|471766275|FG003|Overall Study|Lost to Follow-up|2|||
131036198|NCT04350463|471766272|FG000|Overall Study|Withdrawal by Subject|4|||
131036199|NCT04350463|471766273|FG001|Overall Study|Withdrawal by Subject|0|||
131036200|NCT04350463|471766274|FG002|Overall Study|Withdrawal by Subject|1|||
131036201|NCT04350463|471766275|FG003|Overall Study|Withdrawal by Subject|4|||
131036202|NCT04350463|471766272|FG000|Overall Study|Adverse Event|0|||
131036203|NCT04350463|471766273|FG001|Overall Study|Adverse Event|0|||
131036204|NCT04350463|471766274|FG002|Overall Study|Adverse Event|0|||
131036205|NCT04350463|471766275|FG003|Overall Study|Adverse Event|2|||
131036206|NCT04350463|471766272|FG000|Overall Study|Death|27|||
131036207|NCT04350463|471766273|FG001|Overall Study|Death|2|||
131036208|NCT04350463|471766274|FG002|Overall Study|Death|13|||
131036209|NCT04350463|471766275|FG003|Overall Study|Death|26|||
130938337|NCT01705652|471406439|FG001|Overall Study|Adverse Event|0|||
130938338|NCT01705652|471406438|FG000|Overall Study|Withdrawal by Subject|1|||
130705703|NCT01435031|470547307|FG000|ITT at 2 Years|Death|7|||
130938339|NCT01705652|471406439|FG001|Overall Study|Withdrawal by Subject|2|||
130705704|NCT01435031|470547307|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
130705705|NCT01435031|470547307|FG000|ITT at 2 Years|Lost to Follow-up|4|||
130705706|NCT01435031|470547307|FG000|ITT at 3 Years|Death|5|||
130705707|NCT01435031|470547307|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
130705708|NCT01435031|470547307|FG000|ITT at 3 Years|Lost to Follow-up|4|||
130705709|NCT01435031|470547307|FG000|ITT at 4 Years|Death|4|||
130705710|NCT01435031|470547307|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
130705711|NCT01435031|470547307|FG000|ITT at 4 Years|Lost to Follow-up|1|||
130705712|NCT02927834|470547308|FG000|Overall Study|Lost to Follow-up|1|||
130705713|NCT02927834|470547309|FG001|Overall Study|Lost to Follow-up|2|||
130705714|NCT02927834|470547310|FG002|Overall Study|Lost to Follow-up|2|||
130705715|NCT03234608|470547323|FG000|Overall Study|Lost to Follow-up|23|||
130705716|NCT03234608|470547324|FG001|Overall Study|Lost to Follow-up|21|||
130705717|NCT01662362|470547330|FG000|Overall Study|Lost to Follow-up|38|||
130705718|NCT01181531|470547335|FG000|Overall Study|Other|17|||
130705719|NCT01181531|470547336|FG001|Overall Study|Other|12|||
130705720|NCT01181531|470547335|FG000|Overall Study|Partial consent by subject withdrawn|0|||
130705721|NCT01181531|470547336|FG001|Overall Study|Partial consent by subject withdrawn|1|||
130705722|NCT01181531|470547335|FG000|Overall Study|Physician Decision|3|||
130705723|NCT01181531|470547336|FG001|Overall Study|Physician Decision|1|||
130705724|NCT01181531|470547335|FG000|Overall Study|Noncompliance|2|||
130705725|NCT01181531|470547336|FG001|Overall Study|Noncompliance|2|||
130705726|NCT01181531|470547335|FG000|Overall Study|Ineligibility determined|1|||
130705727|NCT01181531|470547336|FG001|Overall Study|Ineligibility determined|2|||
130705728|NCT01181531|470547335|FG000|Overall Study|Protocol Specified Criteria|15|||
130705729|NCT01181531|470547336|FG001|Overall Study|Protocol Specified Criteria|8|||
130705730|NCT01181531|470547335|FG000|Overall Study|Pregnancy|0|||
130705731|NCT01181531|470547336|FG001|Overall Study|Pregnancy|1|||
130705732|NCT01181531|470547335|FG000|Overall Study|Withdrawal by Subject|8|||
130705733|NCT01181531|470547336|FG001|Overall Study|Withdrawal by Subject|7|||
130705734|NCT01181531|470547335|FG000|Overall Study|Protocol Violation|6|||
130705735|NCT01181531|470547336|FG001|Overall Study|Protocol Violation|6|||
130705736|NCT01181531|470547335|FG000|Overall Study|Death|9|||
130705737|NCT01181531|470547336|FG001|Overall Study|Death|12|||
130705738|NCT01181531|470547335|FG000|Overall Study|Adverse Event|0|||
130705739|NCT01181531|470547336|FG001|Overall Study|Adverse Event|1|||
130705740|NCT00987831|470547337|FG000|Overall Study|Never flared in 12 months|1|||
130705741|NCT00987831|470547338|FG001|Overall Study|Never flared in 12 months|0|||
130705742|NCT00987831|470547339|FG002|Overall Study|Never flared in 12 months|0|||
130705743|NCT00987831|470547337|FG000|Overall Study|Lost to Follow-up|0|||
130705744|NCT00987831|470547338|FG001|Overall Study|Lost to Follow-up|3|||
130705745|NCT00987831|470547339|FG002|Overall Study|Lost to Follow-up|0|||
130705746|NCT02792218|470547341|FG000|Overall Study|Patient/guardian decision|15|||
130705747|NCT02792218|470547342|FG001|Overall Study|Patient/guardian decision|42|||
130705748|NCT02792218|470547341|FG000|Overall Study|Adverse Event|15|||
130705749|NCT02792218|470547342|FG001|Overall Study|Adverse Event|14|||
130938340|NCT01705652|471406438|FG000|Overall Study|non-compliance|1|||
130938341|NCT01705652|471406439|FG001|Overall Study|non-compliance|1|||
130938342|NCT01686633|471406440|FG000|Overall Study|Lack of Efficacy|33|||
130938343|NCT01686633|471406441|FG001|Overall Study|Lack of Efficacy|13|||
130705750|NCT02792218|470547341|FG000|Overall Study|Lost to Follow-up|10|||
130705751|NCT02792218|470547342|FG001|Overall Study|Lost to Follow-up|5|||
130705752|NCT02792218|470547341|FG000|Overall Study|Lack of Efficacy|1|||
130705753|NCT02792218|470547342|FG001|Overall Study|Lack of Efficacy|12|||
130705754|NCT02792218|470547341|FG000|Overall Study|Physician Decision|4|||
130705755|NCT02792218|470547342|FG001|Overall Study|Physician Decision|4|||
130705756|NCT02792218|470547341|FG000|Overall Study|Protocol deviation|3|||
130705757|NCT02792218|470547342|FG001|Overall Study|Protocol deviation|2|||
130705758|NCT02792218|470547341|FG000|Overall Study|New therapy for study indication|0|||
130938344|NCT01686633|471406442|FG002|Overall Study|Lack of Efficacy|11|||
130705759|NCT02792218|470547342|FG001|Overall Study|New therapy for study indication|1|||
130705760|NCT02792218|470547341|FG000|Overall Study|Non-compliance with study treatment|0|||
130705761|NCT02792218|470547342|FG001|Overall Study|Non-compliance with study treatment|1|||
130705762|NCT02792218|470547341|FG000|Overall Study|Pregnancy|1|||
130705763|NCT02792218|470547342|FG001|Overall Study|Pregnancy|0|||
130705764|NCT00810602|470547343|FG000|Overall Study|Withdrawal by Subject|8|||
130938345|NCT01686633|471406440|FG000|Overall Study|Withdrawal by Subject|8|||
130938346|NCT01686633|471406441|FG001|Overall Study|Withdrawal by Subject|8|||
130938347|NCT01686633|471406442|FG002|Overall Study|Withdrawal by Subject|5|||
130938348|NCT01686633|471406440|FG000|Overall Study|Physician Decision|3|||
130938349|NCT01686633|471406441|FG001|Overall Study|Physician Decision|4|||
130938350|NCT01686633|471406442|FG002|Overall Study|Physician Decision|4|||
130938351|NCT01686633|471406440|FG000|Overall Study|Adverse Event|4|||
130938352|NCT01686633|471406441|FG001|Overall Study|Adverse Event|3|||
130938353|NCT01686633|471406442|FG002|Overall Study|Adverse Event|3|||
130938354|NCT01686633|471406440|FG000|Overall Study|Protocol Violation|2|||
130938355|NCT01686633|471406441|FG001|Overall Study|Protocol Violation|3|||
130938356|NCT01686633|471406442|FG002|Overall Study|Protocol Violation|0|||
130938357|NCT01686633|471406440|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
130938358|NCT01686633|471406441|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
130938359|NCT01686633|471406442|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
130938360|NCT01686633|471406440|FG000|Overall Study|Lost to Follow-up|0|||
130938361|NCT01686633|471406441|FG001|Overall Study|Lost to Follow-up|1|||
130938362|NCT01686633|471406442|FG002|Overall Study|Lost to Follow-up|1|||
130938363|NCT02626520|471406447|FG000|Overall Study|Physician Decision|1|||
130938364|NCT02626520|471406448|FG001|Overall Study|Physician Decision|1|||
130938365|NCT02626520|471406447|FG000|Overall Study|Adverse Event|0|||
130938366|NCT02626520|471406448|FG001|Overall Study|Adverse Event|4|||
130938367|NCT02626520|471406447|FG000|Overall Study|Lack of Efficacy|0|||
130938368|NCT02626520|471406448|FG001|Overall Study|Lack of Efficacy|2|||
130938369|NCT02626520|471406447|FG000|Overall Study|Did not start protocol therapy|0|||
130938370|NCT02626520|471406448|FG001|Overall Study|Did not start protocol therapy|2|||
130938371|NCT02626520|471406447|FG000|Overall Study|Study terminated|0|||
130938372|NCT02626520|471406448|FG001|Overall Study|Study terminated|1|||
130938373|NCT00492115|471406449|FG000|Overall Study|Withdrawal by Subject|3|||
130938374|NCT00492115|471406450|FG001|Overall Study|Withdrawal by Subject|4|||
130938375|NCT03564145|471406453|FG000|Overall Study|Adverse Event|4|||
130938376|NCT03564145|471406453|FG000|Overall Study|Lost to Follow-up|21|||
130938377|NCT03564145|471406453|FG000|Overall Study|Protocol Violation|2|||
130938378|NCT03564145|471406453|FG000|Overall Study|Withdrawal by Subject|48|||
130938379|NCT03564145|471406453|FG000|Overall Study|Study Terminated by Sponsor|146|||
130938380|NCT03564145|471406453|FG000|Overall Study|Physician Decision|1|||
130938381|NCT03564145|471406453|FG000|Overall Study|Other Than Specified|1|||
130938382|NCT03564145|471406453|FG000|Overall Study|Pregnancy|1|||
130938383|NCT03915496|471406454|FG000|Overall Study|Adverse Event|2|||
130938384|NCT03915496|471406455|FG001|Overall Study|Adverse Event|1|||
130938385|NCT03915496|471406456|FG002|Overall Study|Adverse Event|2|||
130938386|NCT00397982|471408348|FG000|Overall Study|Withdrawal by Subject|1|||
130938387|NCT00397982|471408348|FG000|Overall Study|Adverse Event|1|||
130938388|NCT00397982|471408348|FG000|Overall Study|noncompliance|1|||
130938389|NCT00397982|471408348|FG000|Overall Study|Unrelated health issues|1|||
130938390|NCT02636868|471408349|FG000|Overall Study|Death|0|||
130938391|NCT02636868|471408350|FG001|Overall Study|Death|1|||
130938392|NCT02636868|471408351|FG002|Overall Study|Death|2|||
130938393|NCT03025542|471408352|FG000|Overall Study|Adverse Event|0|||
130938394|NCT03025542|471408353|FG001|Overall Study|Adverse Event|2|||
130938395|NCT03025542|471408352|FG000|Overall Study|Lost to Follow-up|1|||
130938396|NCT03025542|471408353|FG001|Overall Study|Lost to Follow-up|0|||
130938397|NCT03025542|471408352|FG000|Overall Study|Withdrawal by Subject|1|||
130938398|NCT03025542|471408353|FG001|Overall Study|Withdrawal by Subject|0|||
130938399|NCT05024058|471408354|FG000|Treatment|Study terminated by sponsor|5|||
130938400|NCT05024058|471408355|FG001|Treatment|Study terminated by sponsor|6|||
130938401|NCT05024058|471408356|FG002|Treatment|Study terminated by sponsor|4|||
130938402|NCT05024058|471408357|FG003|Treatment|Study terminated by sponsor|2|||
130938403|NCT05024058|471408358|FG004|Treatment|Study terminated by sponsor|3|||
130938404|NCT05024058|471408359|FG005|Treatment|Study terminated by sponsor|3|||
130938405|NCT05024058|471408360|FG006|Treatment|Study terminated by sponsor|1|||
130938406|NCT05024058|471408361|FG007|Treatment|Study terminated by sponsor|3|||
130938407|NCT05024058|471408362|FG008|Treatment|Study terminated by sponsor|6|||
130938408|NCT05024058|471408363|FG009|Treatment|Study terminated by sponsor|6|||
130938409|NCT05024058|471408354|FG000|Follow-up|Withdrawal by Subject|1|||
130938410|NCT05024058|471408355|FG001|Follow-up|Withdrawal by Subject|0|||
130938411|NCT05024058|471408356|FG002|Follow-up|Withdrawal by Subject|1|||
131036210|NCT04111536|471766276|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
131036211|NCT04111536|471766277|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130938412|NCT05024058|471408357|FG003|Follow-up|Withdrawal by Subject|0|||
130938413|NCT05024058|471408358|FG004|Follow-up|Withdrawal by Subject|0|||
130938414|NCT05024058|471408359|FG005|Follow-up|Withdrawal by Subject|0|||
131036212|NCT04111536|471766276|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
130938415|NCT05024058|471408360|FG006|Follow-up|Withdrawal by Subject|0|||
130938416|NCT05024058|471408361|FG007|Follow-up|Withdrawal by Subject|1|||
130938417|NCT05024058|471408362|FG008|Follow-up|Withdrawal by Subject|0|||
130938418|NCT05024058|471408363|FG009|Follow-up|Withdrawal by Subject|1|||
130938419|NCT00501293|471408364|FG000|Optimization Period|Enrolled in error|1|||
130938420|NCT00501293|471408365|FG001|Optimization Period|Enrolled in error|0|||
130938421|NCT00501293|471408364|FG000|Maintenance Period|Withdrawal by Subject|14|||
130938422|NCT00501293|471408365|FG001|Maintenance Period|Withdrawal by Subject|13|||
130938423|NCT00501293|471408364|FG000|Maintenance Period|Lost to Follow-up|12|||
130938424|NCT00501293|471408365|FG001|Maintenance Period|Lost to Follow-up|7|||
130938425|NCT00501293|471408364|FG000|Maintenance Period|Adverse Event|6|||
130938426|NCT00501293|471408365|FG001|Maintenance Period|Adverse Event|6|||
130938427|NCT00501293|471408364|FG000|Maintenance Period|Protocol Violation|2|||
130938428|NCT00501293|471408365|FG001|Maintenance Period|Protocol Violation|1|||
130938429|NCT00501293|471408364|FG000|Maintenance Period|Lack of Efficacy|4|||
130938430|NCT00501293|471408365|FG001|Maintenance Period|Lack of Efficacy|1|||
130938431|NCT00501293|471408364|FG000|Maintenance Period|Noncompliant with study medication|5|||
130938432|NCT00501293|471408365|FG001|Maintenance Period|Noncompliant with study medication|0|||
130938433|NCT00501293|471408364|FG000|Maintenance Period|Went into rehabilitation|1|||
130938434|NCT00501293|471408365|FG001|Maintenance Period|Went into rehabilitation|0|||
130938435|NCT00501293|471408364|FG000|Maintenance Period|Would not wear patch|1|||
130938436|NCT00501293|471408365|FG001|Maintenance Period|Would not wear patch|0|||
130938437|NCT00501293|471408364|FG000|Maintenance Period|Application site reaction|1|||
130938438|NCT00501293|471408365|FG001|Maintenance Period|Application site reaction|0|||
130938439|NCT00696696|471408371|FG000|Overall Study|Adverse Event|5|||
130938440|NCT00696696|471408371|FG000|Overall Study|Withdrawal by Subject|8|||
130938441|NCT00696696|471408371|FG000|Overall Study|Physician Decision|2|||
130938442|NCT00696696|471408371|FG000|Overall Study|Death|3|||
130938443|NCT02507505|471408372|FG000|Overall Study|Withdrawal by Subject|13|||
130938444|NCT02507505|471408373|FG001|Overall Study|Withdrawal by Subject|11|||
130938445|NCT02507505|471408372|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
130938446|NCT02507505|471408373|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
130938447|NCT02507505|471408372|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
130938448|NCT02507505|471408373|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
130938449|NCT02507505|471408372|FG000|Overall Study|Death before receipt of anesthesia|0|||
130938450|NCT02507505|471408373|FG001|Overall Study|Death before receipt of anesthesia|1|||
130938451|NCT00967798|471408374|FG000|Overall Study|Withdrawal by Subject|5|||
131122693|NCT05807464|472078052|FG000|Overall Study|Adverse Event|1|||
131122694|NCT05525689|472078054|FG000|Overall Study|Lost to Follow-up|1|||
131122695|NCT05525689|472078055|FG001|Overall Study|Lost to Follow-up|0|||
131122696|NCT01671111|472078058|FG000|Overall Study|Adverse Event|2|||
131122697|NCT01671111|472078058|FG000|Overall Study|Lack of Efficacy|1|||
131122698|NCT01671111|472078058|FG000|Overall Study|Withdrawal by Subject|2|||
131122699|NCT01671111|472078058|FG000|Overall Study|Physician Decision|1|||
130938452|NCT00967798|471408375|FG001|Overall Study|Withdrawal by Subject|2|||
130938453|NCT00967798|471408374|FG000|Overall Study|Lost to Follow-up|4|||
130938454|NCT00967798|471408375|FG001|Overall Study|Lost to Follow-up|1|||
130938455|NCT03182829|471408376|FG000|Overall Study|Protocol Violation|12|||
130938456|NCT03182829|471408377|FG001|Overall Study|Protocol Violation|12|||
130938457|NCT03182829|471408376|FG000|Overall Study|Other|4|||
130938458|NCT03182829|471408377|FG001|Overall Study|Other|3|||
130938459|NCT03316131|471408378|FG000|Treatment Period 2|Protocol deviation|1|||
131224067|NCT00990093|472447159|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
131224068|NCT00990093|472447158|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
131224069|NCT00990093|472447159|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
131224070|NCT00990093|472447158|FG000|Test Period 2 (15-28 Days)|Other|0|||
131224071|NCT00990093|472447159|FG001|Test Period 2 (15-28 Days)|Other|1|||
131224072|NCT00995930|472447160|FG000|Overall Study|Protocol deviation|2|||
131224073|NCT00995930|472447161|FG001|Overall Study|Protocol deviation|5|||
131224074|NCT00995930|472447160|FG000|Overall Study|Death|0|||
131224075|NCT00995930|472447161|FG001|Overall Study|Death|1|||
131224076|NCT00995930|472447160|FG000|Overall Study|Administrative problems|4|||
131224077|NCT00995930|472447161|FG001|Overall Study|Administrative problems|2|||
131224078|NCT00995930|472447160|FG000|Overall Study|Lost to Follow-up|1|||
131224079|NCT00995930|472447161|FG001|Overall Study|Lost to Follow-up|2|||
131224080|NCT00995930|472447160|FG000|Overall Study|Withdrawal by Subject|3|||
131224081|NCT00995930|472447161|FG001|Overall Study|Withdrawal by Subject|4|||
131224082|NCT00995930|472447160|FG000|Overall Study|Adverse Event|11|||
131224083|NCT00995930|472447161|FG001|Overall Study|Adverse Event|14|||
131224084|NCT02367781|472447164|FG000|Overall Study|Withdrawal by Subject|20|||
131224085|NCT02367781|472447165|FG001|Overall Study|Withdrawal by Subject|13|||
131224086|NCT02367781|472447164|FG000|Overall Study|Protocol Violation|0|||
131224087|NCT02367781|472447165|FG001|Overall Study|Protocol Violation|1|||
131224088|NCT02367781|472447164|FG000|Overall Study|Physician Decision|7|||
131224089|NCT02367781|472447165|FG001|Overall Study|Physician Decision|0|||
131224090|NCT02367781|472447164|FG000|Overall Study|Randomized in Error|5|||
131224091|NCT02367781|472447165|FG001|Overall Study|Randomized in Error|4|||
131224092|NCT02367781|472447164|FG000|Overall Study|Non-Compliance|1|||
131224093|NCT02367781|472447165|FG001|Overall Study|Non-Compliance|0|||
131224094|NCT02367781|472447164|FG000|Overall Study|Lost to Follow-up|1|||
131224095|NCT02367781|472447165|FG001|Overall Study|Lost to Follow-up|2|||
131224096|NCT02367781|472447164|FG000|Overall Study|Death|330|||
131224097|NCT02367781|472447165|FG001|Overall Study|Death|176|||
131224098|NCT02367781|472447164|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
131224099|NCT02367781|472447165|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
131224100|NCT02367781|472447164|FG000|Overall Study|Prolonged Hospitalization|1|||
131224101|NCT02367781|472447165|FG001|Overall Study|Prolonged Hospitalization|0|||
131224102|NCT02367781|472447164|FG000|Overall Study|Death Prior First Dose|1|||
130705765|NCT00810602|470547344|FG001|Overall Study|Withdrawal by Subject|3|||
130705766|NCT00824369|470547348|FG000|Overall Study|Nolonger willing to participate in study|1|||
130705767|NCT00824369|470547349|FG001|Overall Study|Nolonger willing to participate in study|0|||
130705768|NCT00824369|470547350|FG002|Overall Study|Nolonger willing to participate in study|1|||
130705769|NCT00824369|470547351|FG003|Overall Study|Nolonger willing to participate in study|2|||
130705770|NCT00824369|470547352|FG004|Overall Study|Nolonger willing to participate in study|0|||
130705771|NCT00824369|470547353|FG005|Overall Study|Nolonger willing to participate in study|1|||
130705772|NCT00824369|470547348|FG000|Overall Study|Lost to Follow-up|0|||
130705773|NCT00824369|470547349|FG001|Overall Study|Lost to Follow-up|0|||
130705774|NCT00824369|470547350|FG002|Overall Study|Lost to Follow-up|0|||
130705775|NCT00824369|470547351|FG003|Overall Study|Lost to Follow-up|0|||
130705776|NCT00824369|470547352|FG004|Overall Study|Lost to Follow-up|1|||
130705777|NCT00824369|470547353|FG005|Overall Study|Lost to Follow-up|0|||
130705778|NCT01619579|470549549|FG000|Overall Study|Withdrawal by Subject|0|||
130705779|NCT01619579|470549550|FG001|Overall Study|Withdrawal by Subject|3|||
130705780|NCT02012452|470549554|FG000|Overall Study|Lost to Follow-up|2|||
130705781|NCT02012452|470549555|FG001|Overall Study|Lost to Follow-up|1|||
130705782|NCT02012452|470549554|FG000|Overall Study|Withdrawal by Subject|4|||
130705783|NCT02012452|470549555|FG001|Overall Study|Withdrawal by Subject|0|||
130705784|NCT02688387|470549556|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705785|NCT02688387|470549557|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705786|NCT02688387|470549558|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
130705787|NCT02688387|470549559|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705788|NCT02688387|470549560|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705789|NCT02688387|470549561|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705790|NCT02688387|470549562|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705791|NCT02688387|470549563|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705792|NCT02688387|470549564|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705793|NCT02688387|470549565|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705794|NCT02688387|470549566|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705795|NCT02688387|470549567|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705796|NCT02688387|470549568|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705797|NCT02688387|470549569|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705798|NCT02688387|470549570|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705799|NCT02688387|470549571|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
131224103|NCT02367781|472447165|FG001|Overall Study|Death Prior First Dose|0|||
131224104|NCT02367781|472447164|FG000|Overall Study|Administrative-Change Facility|1|||
131224105|NCT02367781|472447165|FG001|Overall Study|Administrative-Change Facility|0|||
131224106|NCT02367781|472447164|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
130771972|NCT04811664|470792817|FG000|Overall Study|Study Terminated by Sponsor|4|||
130771973|NCT04811664|470792818|FG001|Overall Study|Study Terminated by Sponsor|3|||
130771974|NCT04811664|470792819|FG002|Overall Study|Study Terminated by Sponsor|34|||
130771975|NCT04811664|470792817|FG000|Overall Study|Early Study Closure|3|||
130771976|NCT04811664|470792818|FG001|Overall Study|Early Study Closure|7|||
130771977|NCT04811664|470792819|FG002|Overall Study|Early Study Closure|79|||
131122700|NCT01671111|472078058|FG000|Overall Study|Other|24|||
131122701|NCT00596947|472078059|FG000|Overall Study|study halted due to low enrollment|5|||
130938460|NCT03316131|471408379|FG001|Treatment Period 2|Protocol deviation|0|||
130938461|NCT01409564|471408380|FG000|Overall Study|low medication compliance|4|||
130938462|NCT01409564|471408381|FG001|Overall Study|low medication compliance|3|||
130938463|NCT01409564|471408380|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
130938464|NCT01409564|471408381|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
130938465|NCT00254540|471408382|FG000|Overall Study|Adverse Event|6|||
130938466|NCT00254540|471408383|FG001|Overall Study|Adverse Event|7|||
130938467|NCT00254540|471408382|FG000|Overall Study|Lack of Efficacy|13|||
130938468|NCT00254540|471408383|FG001|Overall Study|Lack of Efficacy|13|||
130938469|NCT00254540|471408382|FG000|Overall Study|Death|0|||
130938470|NCT00254540|471408383|FG001|Overall Study|Death|1|||
130938471|NCT00254540|471408382|FG000|Overall Study|Laboratory Test Abnormality|0|||
130938472|NCT00254540|471408383|FG001|Overall Study|Laboratory Test Abnormality|1|||
130938473|NCT00225251|471408384|FG000|Overall Study|Withdrawal by Subject|1|||
130938474|NCT00225251|471408385|FG001|Overall Study|Withdrawal by Subject|1|||
130938475|NCT01313767|471408389|FG000|Overall Study|Adverse Event|1|||
130938476|NCT01313767|471408390|FG001|Overall Study|Adverse Event|0|||
130938477|NCT01313767|471408389|FG000|Overall Study|Lost to Follow-up|1|||
130938478|NCT01313767|471408390|FG001|Overall Study|Lost to Follow-up|0|||
130938479|NCT01313767|471408389|FG000|Overall Study|Withdrawal by Subject|2|||
130938480|NCT01313767|471408390|FG001|Overall Study|Withdrawal by Subject|1|||
130938481|NCT01313767|471408389|FG000|Overall Study|Protocol Violation|3|||
130938482|NCT01313767|471408390|FG001|Overall Study|Protocol Violation|1|||
130938483|NCT01287897|471408391|FG000|Overall Study|Adverse Event|5|||
130938484|NCT01287897|471408392|FG001|Overall Study|Adverse Event|3|||
130938485|NCT01287897|471408393|FG002|Overall Study|Adverse Event|6|||
130938486|NCT01287897|471408394|FG003|Overall Study|Adverse Event|4|||
130938487|NCT01287897|471408391|FG000|Overall Study|Lack of Efficacy|2|||
130938488|NCT01287897|471408392|FG001|Overall Study|Lack of Efficacy|0|||
130938489|NCT01287897|471408393|FG002|Overall Study|Lack of Efficacy|0|||
130938490|NCT01287897|471408394|FG003|Overall Study|Lack of Efficacy|0|||
130938491|NCT01287897|471408391|FG000|Overall Study|Protocol Violation|1|||
130938492|NCT01287897|471408392|FG001|Overall Study|Protocol Violation|1|||
130938493|NCT01287897|471408393|FG002|Overall Study|Protocol Violation|0|||
130938494|NCT01287897|471408394|FG003|Overall Study|Protocol Violation|1|||
130938495|NCT01287897|471408391|FG000|Overall Study|Lost to Follow-up|0|||
131122702|NCT00596947|472078060|FG001|Overall Study|study halted due to low enrollment|3|||
131122703|NCT00596947|472078059|FG000|Overall Study|Lost to Follow-up|1|||
131122704|NCT00596947|472078060|FG001|Overall Study|Lost to Follow-up|0|||
131122705|NCT00496730|472078061|FG000|Overall Study|Lost to Follow-up|4|||
131122706|NCT00496730|472078062|FG001|Overall Study|Lost to Follow-up|3|||
131122707|NCT00496730|472078061|FG000|Overall Study|Withdrawal by Subject|2|||
131122708|NCT00496730|472078062|FG001|Overall Study|Withdrawal by Subject|2|||
131122709|NCT00113074|472078063|FG000|Overall Study|Lost to Follow-up|10|||
131122710|NCT00113074|472078064|FG001|Overall Study|Lost to Follow-up|10|||
131122711|NCT00113074|472078065|FG002|Overall Study|Lost to Follow-up|14|||
131224107|NCT02367781|472447165|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
130771978|NCT04811664|470792817|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
130771979|NCT04811664|470792818|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
130771980|NCT04811664|470792819|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
130771981|NCT05052697|470792820|FG000|Substudy A|Lost to Follow-up|0|||
130771982|NCT05052697|470792821|FG001|Substudy A|Lost to Follow-up|0|||
130938496|NCT01287897|471408392|FG001|Overall Study|Lost to Follow-up|0|||
130938497|NCT01287897|471408393|FG002|Overall Study|Lost to Follow-up|2|||
130938498|NCT01287897|471408394|FG003|Overall Study|Lost to Follow-up|0|||
130938499|NCT01287897|471408391|FG000|Overall Study|Withdrawal by Subject|1|||
130938500|NCT01287897|471408392|FG001|Overall Study|Withdrawal by Subject|5|||
130938501|NCT01287897|471408393|FG002|Overall Study|Withdrawal by Subject|3|||
130938502|NCT01287897|471408394|FG003|Overall Study|Withdrawal by Subject|2|||
131122712|NCT03680911|472078066|FG000|At Home Treatment|Study Termination|3|||
130771983|NCT05052697|470792822|FG002|Substudy A|Lost to Follow-up|0|||
130938503|NCT01287897|471408391|FG000|Overall Study|Not consented properly|0|||
130938504|NCT01287897|471408392|FG001|Overall Study|Not consented properly|1|||
130938505|NCT01287897|471408393|FG002|Overall Study|Not consented properly|0|||
130938506|NCT01287897|471408394|FG003|Overall Study|Not consented properly|0|||
130938507|NCT01287897|471408391|FG000|Overall Study|Not meeting entrance criteria|1|||
130938508|NCT01287897|471408392|FG001|Overall Study|Not meeting entrance criteria|1|||
130938509|NCT01287897|471408393|FG002|Overall Study|Not meeting entrance criteria|0|||
130938510|NCT01287897|471408394|FG003|Overall Study|Not meeting entrance criteria|0|||
130938511|NCT01287897|471408391|FG000|Overall Study|Other|1|||
130938512|NCT01287897|471408392|FG001|Overall Study|Other|0|||
130938513|NCT01287897|471408393|FG002|Overall Study|Other|1|||
130771984|NCT05052697|470792823|FG003|Substudy A|Lost to Follow-up|0|||
130771985|NCT05052697|470792824|FG004|Substudy A|Lost to Follow-up|0|||
130938514|NCT01287897|471408394|FG003|Overall Study|Other|0|||
130938515|NCT00350636|471408395|FG000|Overall Study|Adverse Event|19|||
130938516|NCT00350636|471408396|FG001|Overall Study|Adverse Event|13|||
130938517|NCT00350636|471408395|FG000|Overall Study|Protocol Violation|1|||
130938518|NCT00350636|471408396|FG001|Overall Study|Protocol Violation|3|||
130938519|NCT00350636|471408395|FG000|Overall Study|Withdrawal by Subject|13|||
130938520|NCT00350636|471408396|FG001|Overall Study|Withdrawal by Subject|17|||
130938521|NCT00350636|471408395|FG000|Overall Study|Lost to Follow-up|9|||
130938522|NCT00350636|471408396|FG001|Overall Study|Lost to Follow-up|8|||
130938523|NCT00350636|471408395|FG000|Overall Study|Physician Decision|0|||
130938524|NCT00350636|471408396|FG001|Overall Study|Physician Decision|2|||
130938525|NCT00350636|471408395|FG000|Overall Study|Other|1|||
130938526|NCT00350636|471408396|FG001|Overall Study|Other|2|||
130938527|NCT01042236|471408401|FG000|Treatment Period 1|Adverse Event|0|||
130938528|NCT01042236|471408402|FG001|Treatment Period 1|Adverse Event|1|||
130938529|NCT01042236|471408403|FG002|Treatment Period 1|Adverse Event|0|||
130938530|NCT01042236|471408404|FG003|Treatment Period 1|Adverse Event|0|||
130938531|NCT01042236|471408405|FG004|Treatment Period 1|Adverse Event|1|||
130771986|NCT05052697|470792825|FG005|Substudy A|Lost to Follow-up|1|||
130771987|NCT05052697|470792826|FG006|Substudy A|Lost to Follow-up|0|||
130771988|NCT05052697|470792827|FG007|Substudy A|Lost to Follow-up|0|||
130771989|NCT05052697|470792828|FG008|Substudy A|Lost to Follow-up|0|||
130771990|NCT05052697|470792829|FG009|Substudy A|Lost to Follow-up|0|||
130771991|NCT05052697|470792830|FG010|Substudy A|Lost to Follow-up|0|||
130771992|NCT05052697|470792831|FG011|Substudy A|Lost to Follow-up|0|||
130771993|NCT05052697|470792832|FG012|Substudy A|Lost to Follow-up|0|||
130771994|NCT05052697|470792833|FG013|Substudy A|Lost to Follow-up|0|||
130771995|NCT05052697|470792834|FG014|Substudy A|Lost to Follow-up|0|||
130771996|NCT05052697|470792835|FG015|Substudy A|Lost to Follow-up|2|||
130771997|NCT05052697|470792836|FG016|Substudy A|Lost to Follow-up|0|||
130771998|NCT05052697|470792837|FG017|Substudy A|Lost to Follow-up|0|||
130771999|NCT05052697|470792838|FG018|Substudy A|Lost to Follow-up|0|||
130772000|NCT05052697|470792839|FG019|Substudy A|Lost to Follow-up|0|||
130772001|NCT05052697|470792840|FG020|Substudy A|Lost to Follow-up|0|||
130772002|NCT05052697|470792841|FG021|Substudy A|Lost to Follow-up|0|||
130772003|NCT05052697|470792842|FG022|Substudy A|Lost to Follow-up|0|||
130772004|NCT05052697|470792843|FG023|Substudy A|Lost to Follow-up|0|||
130772005|NCT05052697|470792844|FG024|Substudy A|Lost to Follow-up|0|||
130772006|NCT05052697|470792845|FG025|Substudy A|Lost to Follow-up|0|||
130772007|NCT05052697|470792846|FG026|Substudy A|Lost to Follow-up|0|||
130772008|NCT05052697|470792847|FG027|Substudy A|Lost to Follow-up|0|||
130772009|NCT05052697|470792848|FG028|Substudy A|Lost to Follow-up|0|||
130772010|NCT05052697|470792849|FG029|Substudy A|Lost to Follow-up|0|||
130772011|NCT05052697|470792850|FG030|Substudy A|Lost to Follow-up|0|||
130772012|NCT05052697|470792851|FG031|Substudy A|Lost to Follow-up|0|||
130772013|NCT05052697|470792852|FG032|Substudy A|Lost to Follow-up|0|||
130772014|NCT05052697|470792853|FG033|Substudy A|Lost to Follow-up|0|||
130772015|NCT05052697|470792820|FG000|Substudy A|No longer met eligibility criteria|0|||
130772016|NCT05052697|470792821|FG001|Substudy A|No longer met eligibility criteria|0|||
130772017|NCT05052697|470792822|FG002|Substudy A|No longer met eligibility criteria|0|||
130772018|NCT05052697|470792823|FG003|Substudy A|No longer met eligibility criteria|0|||
130772019|NCT05052697|470792824|FG004|Substudy A|No longer met eligibility criteria|0|||
130772020|NCT05052697|470792825|FG005|Substudy A|No longer met eligibility criteria|0|||
130772021|NCT05052697|470792826|FG006|Substudy A|No longer met eligibility criteria|0|||
130772022|NCT05052697|470792827|FG007|Substudy A|No longer met eligibility criteria|0|||
130772023|NCT05052697|470792828|FG008|Substudy A|No longer met eligibility criteria|0|||
130772024|NCT05052697|470792829|FG009|Substudy A|No longer met eligibility criteria|0|||
130772025|NCT05052697|470792830|FG010|Substudy A|No longer met eligibility criteria|0|||
130772026|NCT05052697|470792831|FG011|Substudy A|No longer met eligibility criteria|0|||
130772027|NCT05052697|470792832|FG012|Substudy A|No longer met eligibility criteria|0|||
130772028|NCT05052697|470792833|FG013|Substudy A|No longer met eligibility criteria|1|||
130772029|NCT05052697|470792834|FG014|Substudy A|No longer met eligibility criteria|0|||
130772030|NCT05052697|470792835|FG015|Substudy A|No longer met eligibility criteria|0|||
130938532|NCT01042236|471408406|FG005|Treatment Period 1|Adverse Event|0|||
130938533|NCT01042236|471408401|FG000|Treatment Period 3|Adverse Event|0|||
130938534|NCT01042236|471408402|FG001|Treatment Period 3|Adverse Event|0|||
130938535|NCT01042236|471408403|FG002|Treatment Period 3|Adverse Event|0|||
130938536|NCT01042236|471408404|FG003|Treatment Period 3|Adverse Event|1|||
130772031|NCT05052697|470792836|FG016|Substudy A|No longer met eligibility criteria|0|||
130938537|NCT01042236|471408405|FG004|Treatment Period 3|Adverse Event|0|||
130938538|NCT01042236|471408406|FG005|Treatment Period 3|Adverse Event|0|||
130938539|NCT01042236|471408401|FG000|Treatment Period 3|Protocol Violation|0|||
130938540|NCT01042236|471408402|FG001|Treatment Period 3|Protocol Violation|0|||
131122713|NCT03680911|472078067|FG001|At Home Treatment|Study Termination|0|||
131122714|NCT03680911|472078066|FG000|At Home Treatment|Lost to Follow-up|0|||
131122715|NCT03680911|472078067|FG001|At Home Treatment|Lost to Follow-up|1|||
131122716|NCT03680911|472078066|FG000|At Home Treatment|Withdrawal by Subject|0|||
131122717|NCT03680911|472078067|FG001|At Home Treatment|Withdrawal by Subject|2|||
131122718|NCT03680911|472078066|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
131122719|NCT03680911|472078067|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
131122720|NCT02114268|472078068|FG000|Overall Study|Lost to Follow-up|4|||
131122721|NCT02114268|472078069|FG001|Overall Study|Lost to Follow-up|1|||
131122722|NCT02114268|472078070|FG002|Overall Study|Lost to Follow-up|1|||
131122723|NCT02114268|472078071|FG003|Overall Study|Lost to Follow-up|0|||
131122724|NCT02114268|472078072|FG004|Overall Study|Lost to Follow-up|0|||
131122725|NCT02114268|472078073|FG005|Overall Study|Lost to Follow-up|2|||
131122726|NCT02114268|472078068|FG000|Overall Study|Withdrawal by Subject|1|||
131122727|NCT02114268|472078069|FG001|Overall Study|Withdrawal by Subject|0|||
131122728|NCT02114268|472078070|FG002|Overall Study|Withdrawal by Subject|0|||
131122729|NCT02114268|472078071|FG003|Overall Study|Withdrawal by Subject|0|||
131122730|NCT02114268|472078072|FG004|Overall Study|Withdrawal by Subject|0|||
131122731|NCT02114268|472078073|FG005|Overall Study|Withdrawal by Subject|1|||
130938541|NCT01042236|471408403|FG002|Treatment Period 3|Protocol Violation|0|||
130938542|NCT01042236|471408404|FG003|Treatment Period 3|Protocol Violation|1|||
130938543|NCT01042236|471408405|FG004|Treatment Period 3|Protocol Violation|0|||
130938544|NCT01042236|471408406|FG005|Treatment Period 3|Protocol Violation|0|||
130938545|NCT00227903|471408407|FG000|Overall Study|Withdrawal by Subject|2|||
130938546|NCT00227903|471408408|FG001|Overall Study|Withdrawal by Subject|5|||
130938547|NCT00227903|471408407|FG000|Overall Study|Subject moved out of area|1|||
130938548|NCT00227903|471408408|FG001|Overall Study|Subject moved out of area|2|||
130938549|NCT00227903|471408407|FG000|Overall Study|Lost to Follow-up|1|||
130938550|NCT00227903|471408408|FG001|Overall Study|Lost to Follow-up|3|||
130938551|NCT00227903|471408407|FG000|Overall Study|Miscarriage|1|||
130938552|NCT00227903|471408408|FG001|Overall Study|Miscarriage|0|||
130938553|NCT01475331|471408409|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
130938554|NCT01475331|471408410|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
130938555|NCT01475331|471408409|FG000|Overall Study|excessive main duct communication|1|||
130938556|NCT01475331|471408410|FG001|Overall Study|excessive main duct communication|1|||
130938557|NCT01475331|471408409|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
130938558|NCT01475331|471408410|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
130938559|NCT01475331|471408409|FG000|Overall Study|Sign of malignancy during the procedure|2|||
130938560|NCT01475331|471408410|FG001|Overall Study|Sign of malignancy during the procedure|0|||
130938561|NCT01475331|471408409|FG000|Overall Study|cyst found to be prohibitively small|0|||
130938562|NCT01475331|471408410|FG001|Overall Study|cyst found to be prohibitively small|1|||
130938563|NCT01525550|471408411|FG000|Overall Study|Lost to Follow-up|8|||
130938564|NCT01525550|471408412|FG001|Overall Study|Lost to Follow-up|2|||
130938565|NCT01525550|471408411|FG000|Overall Study|Death|19|||
130938566|NCT01525550|471408412|FG001|Overall Study|Death|28|||
130938567|NCT01525550|471408411|FG000|Overall Study|Other|0|||
130938568|NCT01525550|471408412|FG001|Overall Study|Other|4|||
130938569|NCT01525550|471408411|FG000|Overall Study|Sponsor's Decision|30|||
130938570|NCT01525550|471408412|FG001|Overall Study|Sponsor's Decision|11|||
130938571|NCT01525550|471408411|FG000|Overall Study|Withdrawal by Subject|4|||
130938572|NCT01525550|471408412|FG001|Overall Study|Withdrawal by Subject|0|||
130938573|NCT03683758|471408415|FG000|Overall Study|Non-study commitment conflict|1|||
130938574|NCT03683758|471408416|FG001|Overall Study|Non-study commitment conflict|3|||
130938575|NCT03683758|471408415|FG000|Overall Study|Illness preventing participation|1|||
130938576|NCT03683758|471408416|FG001|Overall Study|Illness preventing participation|0|||
130938577|NCT03683758|471408415|FG000|Overall Study|Adverse Event|1|||
130938578|NCT03683758|471408416|FG001|Overall Study|Adverse Event|0|||
130938579|NCT01172847|471408417|FG000|Overall Study|Withdrawal by Subject|3|||
130938580|NCT01163279|471408418|FG000|Overall Study|Withdrawal by Subject|2|||
131122732|NCT02114268|472078068|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
130938581|NCT01163279|471408419|FG001|Overall Study|Withdrawal by Subject|0|||
131122733|NCT02114268|472078069|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
131122734|NCT02114268|472078070|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
130938582|NCT01601626|471408420|FG000|Overall Study|Death|1|||
130938583|NCT01601626|471408421|FG001|Overall Study|Death|1|||
130938584|NCT01601626|471408422|FG002|Overall Study|Death|1|||
131122735|NCT02114268|472078071|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
131122736|NCT02114268|472078072|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
131122737|NCT02114268|472078073|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
130938585|NCT01601626|471408420|FG000|Overall Study|Lost to Follow-up|1|||
130938586|NCT01601626|471408421|FG001|Overall Study|Lost to Follow-up|2|||
130938587|NCT01601626|471408422|FG002|Overall Study|Lost to Follow-up|0|||
130938588|NCT01601626|471408420|FG000|Overall Study|Unable to Get to Clinic|0|||
131122738|NCT03962738|472078076|FG000|Overall Study|Protocol Deviation|3|||
131122739|NCT03962738|472078077|FG001|Overall Study|Protocol Deviation|0|||
131122740|NCT03962738|472078078|FG002|Overall Study|Protocol Deviation|1|||
131122741|NCT03962738|472078079|FG003|Overall Study|Protocol Deviation|1|||
131122742|NCT03962738|472078076|FG000|Overall Study|Withdrawal by Subject|4|||
131122743|NCT03962738|472078077|FG001|Overall Study|Withdrawal by Subject|0|||
131122744|NCT03962738|472078078|FG002|Overall Study|Withdrawal by Subject|0|||
131122745|NCT03962738|472078079|FG003|Overall Study|Withdrawal by Subject|0|||
131122746|NCT03962738|472078076|FG000|Overall Study|Lost to Follow-up|0|||
131122747|NCT03962738|472078077|FG001|Overall Study|Lost to Follow-up|0|||
131122748|NCT03962738|472078078|FG002|Overall Study|Lost to Follow-up|1|||
131122749|NCT03962738|472078079|FG003|Overall Study|Lost to Follow-up|0|||
131122750|NCT00509067|472078080|FG000|Overall Study|Lost to Follow-up|1|||
131122751|NCT00509067|472078081|FG001|Overall Study|Lost to Follow-up|1|||
131122752|NCT00509067|472078080|FG000|Overall Study|Adverse Event|3|||
131122753|NCT00509067|472078081|FG001|Overall Study|Adverse Event|1|||
131122754|NCT00509067|472078080|FG000|Overall Study|Protocol Violation|0|||
131122755|NCT00509067|472078081|FG001|Overall Study|Protocol Violation|3|||
131122756|NCT00574288|472078082|FG000|Overall Study|Adverse Event|2|||
131122757|NCT00574288|472078083|FG001|Overall Study|Adverse Event|0|||
131122758|NCT00574288|472078084|FG002|Overall Study|Adverse Event|0|||
131224108|NCT02367781|472447164|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
131224109|NCT02367781|472447165|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
131224110|NCT02367781|472447164|FG000|Overall Study|Study Terminated by Sponsor|3|||
131224111|NCT02367781|472447165|FG001|Overall Study|Study Terminated by Sponsor|1|||
131224112|NCT02367781|472447164|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
131224113|NCT02367781|472447165|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
131224114|NCT02367781|472447164|FG000|Overall Study|Sponsor Decision|2|||
131224115|NCT02367781|472447165|FG001|Overall Study|Sponsor Decision|0|||
131224116|NCT02367781|472447164|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
131122759|NCT00574288|472078085|FG003|Overall Study|Adverse Event|0|||
131122760|NCT00574288|472078086|FG004|Overall Study|Adverse Event|1|||
131122761|NCT00574288|472078087|FG005|Overall Study|Adverse Event|0|||
131122762|NCT00574288|472078088|FG006|Overall Study|Adverse Event|0|||
131122763|NCT00574288|472078082|FG000|Overall Study|Death|0|||
131122764|NCT00574288|472078083|FG001|Overall Study|Death|0|||
131122765|NCT00574288|472078084|FG002|Overall Study|Death|0|||
131122766|NCT00574288|472078085|FG003|Overall Study|Death|0|||
131122767|NCT00574288|472078086|FG004|Overall Study|Death|0|||
131122768|NCT00574288|472078087|FG005|Overall Study|Death|25|||
131122769|NCT00574288|472078088|FG006|Overall Study|Death|21|||
131122770|NCT00574288|472078082|FG000|Overall Study|Lost to Follow-up|0|||
131122771|NCT00574288|472078083|FG001|Overall Study|Lost to Follow-up|0|||
131122772|NCT00574288|472078084|FG002|Overall Study|Lost to Follow-up|0|||
131122773|NCT00574288|472078085|FG003|Overall Study|Lost to Follow-up|0|||
131122774|NCT00574288|472078086|FG004|Overall Study|Lost to Follow-up|0|||
131122775|NCT00574288|472078087|FG005|Overall Study|Lost to Follow-up|1|||
131122776|NCT00574288|472078088|FG006|Overall Study|Lost to Follow-up|2|||
131122777|NCT00574288|472078082|FG000|Overall Study|Study Terminated By Sponsor|0|||
131122778|NCT00574288|472078083|FG001|Overall Study|Study Terminated By Sponsor|0|||
131122779|NCT00574288|472078084|FG002|Overall Study|Study Terminated By Sponsor|0|||
131122780|NCT00574288|472078085|FG003|Overall Study|Study Terminated By Sponsor|0|||
131036213|NCT04111536|471766277|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
131036214|NCT04111536|471766276|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
131036215|NCT04111536|471766277|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
131036216|NCT04111536|471766276|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
131036217|NCT04111536|471766277|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
131036218|NCT02547233|471766279|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
131036219|NCT02547233|471766280|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
131036220|NCT02547233|471766279|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
131036221|NCT02547233|471766280|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
131036222|NCT02547233|471766279|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
131036223|NCT02547233|471766280|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
131036224|NCT02547233|471766279|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
131036225|NCT02547233|471766280|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
131036226|NCT02547233|471766279|FG000|12-month Follow-up|Withdrawal by Subject|10|||
131036227|NCT02547233|471766280|FG001|12-month Follow-up|Withdrawal by Subject|10|||
131036228|NCT02547233|471766279|FG000|12-month Follow-up|Lost to Follow-up|3|||
131036229|NCT02547233|471766280|FG001|12-month Follow-up|Lost to Follow-up|3|||
131036230|NCT02547233|471766279|FG000|12-month Follow-up|Lack of Efficacy|1|||
131036231|NCT02547233|471766280|FG001|12-month Follow-up|Lack of Efficacy|2|||
131036232|NCT02547233|471766279|FG000|12-month Follow-up|Protocol Violation|0|||
131036233|NCT02547233|471766280|FG001|12-month Follow-up|Protocol Violation|1|||
131036234|NCT02547233|471766279|FG000|12-month Follow-up|Other|0|||
131122781|NCT00574288|472078086|FG004|Overall Study|Study Terminated By Sponsor|0|||
131122782|NCT00574288|472078087|FG005|Overall Study|Study Terminated By Sponsor|0|||
131122783|NCT00574288|472078088|FG006|Overall Study|Study Terminated By Sponsor|5|||
131122784|NCT00574288|472078082|FG000|Overall Study|Progressive Disease|17|||
131122785|NCT00574288|472078083|FG001|Overall Study|Progressive Disease|2|||
131122786|NCT00574288|472078084|FG002|Overall Study|Progressive Disease|3|||
131122787|NCT00574288|472078085|FG003|Overall Study|Progressive Disease|2|||
131122788|NCT00574288|472078086|FG004|Overall Study|Progressive Disease|1|||
131122789|NCT00574288|472078087|FG005|Overall Study|Progressive Disease|0|||
131122790|NCT00574288|472078088|FG006|Overall Study|Progressive Disease|0|||
131122791|NCT00574288|472078082|FG000|Overall Study|Other|1|||
131122792|NCT00574288|472078083|FG001|Overall Study|Other|1|||
131122793|NCT00574288|472078084|FG002|Overall Study|Other|0|||
131122794|NCT00574288|472078085|FG003|Overall Study|Other|0|||
131122795|NCT00574288|472078086|FG004|Overall Study|Other|0|||
131122796|NCT00574288|472078087|FG005|Overall Study|Other|0|||
131122797|NCT00574288|472078088|FG006|Overall Study|Other|0|||
131122798|NCT02361944|472078091|FG000|Overall Study|surgery cancellation|0|||
131122799|NCT02361944|472078092|FG001|Overall Study|surgery cancellation|1|||
131122800|NCT03654976|472078095|FG000|Overall Study|Withdrawal by Subject|12|||
131122801|NCT03654976|472078096|FG001|Overall Study|Withdrawal by Subject|11|||
131122802|NCT03654976|472078095|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
131122803|NCT03654976|472078096|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
131122804|NCT03654976|472078095|FG000|Overall Study|Adverse Event|5|||
131122805|NCT03654976|472078096|FG001|Overall Study|Adverse Event|0|||
131122806|NCT03654976|472078095|FG000|Overall Study|Lost to Follow-up|2|||
131122807|NCT03654976|472078096|FG001|Overall Study|Lost to Follow-up|0|||
131122808|NCT03654976|472078095|FG000|Overall Study|Lack of Efficacy|0|||
131122809|NCT03654976|472078096|FG001|Overall Study|Lack of Efficacy|1|||
131122810|NCT03098836|472078097|FG000|Overall Study|Adverse Event|1|||
131122811|NCT03098836|472078098|FG001|Overall Study|Adverse Event|3|||
131122812|NCT03098836|472078097|FG000|Overall Study|Lack of Efficacy|30|||
131122813|NCT03098836|472078098|FG001|Overall Study|Lack of Efficacy|15|||
131122814|NCT03098836|472078097|FG000|Overall Study|Physician Decision|2|||
131122815|NCT03098836|472078098|FG001|Overall Study|Physician Decision|1|||
131122816|NCT03098836|472078097|FG000|Overall Study|Withdrawal by Subject|3|||
131122817|NCT03098836|472078098|FG001|Overall Study|Withdrawal by Subject|2|||
131122818|NCT01770912|472078099|FG000|Overall Study|Lost to Follow-up|2|||
131122819|NCT01770912|472078100|FG001|Overall Study|Lost to Follow-up|0|||
131122820|NCT01817751|472078103|FG000|Overall Study|Physician Decision|1|||
131122821|NCT01846624|472078106|FG000|Overall Study|Died during induction, no midostaurin|1|||
131122822|NCT03472924|472078110|FG000|Overall Study|Adverse Event|1|||
131122823|NCT03472924|472078111|FG001|Overall Study|Adverse Event|0|||
131122824|NCT00427349|472078112|FG000|Overall Study|Lack of Efficacy|23|||
131122825|NCT00427349|472078112|FG000|Overall Study|Adverse Event|14|||
131122826|NCT00427349|472078112|FG000|Overall Study|Death|1|||
131122827|NCT00427349|472078112|FG000|Overall Study|Withdrawal by Subject|3|||
131122828|NCT00427349|472078112|FG000|Overall Study|Alternative therapy|1|||
131122829|NCT00427349|472078112|FG000|Overall Study|Other|2|||
131122830|NCT00427349|472078112|FG000|Overall Study|Ineligible|1|||
131122831|NCT00427349|472078112|FG000|Overall Study|Never started therapy|1|||
131122832|NCT00698997|472078114|FG000|Overall Study|Lost to Follow-up|3|||
131122833|NCT00698997|472078115|FG001|Overall Study|Lost to Follow-up|0|||
130938589|NCT01601626|471408421|FG001|Overall Study|Unable to Get to Clinic|1|||
130938590|NCT01601626|471408422|FG002|Overall Study|Unable to Get to Clinic|0|||
130938591|NCT01601626|471408420|FG000|Overall Study|Withdrawal by Subject|0|||
130938592|NCT01601626|471408421|FG001|Overall Study|Withdrawal by Subject|1|||
130938593|NCT01601626|471408422|FG002|Overall Study|Withdrawal by Subject|1|||
130938594|NCT01601626|471408420|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
130938595|NCT01601626|471408421|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
130938596|NCT01601626|471408422|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
130938597|NCT02632552|471408426|FG000|Overall Study|Lost to Follow-up|14|||
130938598|NCT02632552|471408427|FG001|Overall Study|Lost to Follow-up|8|||
130938599|NCT02632552|471408426|FG000|Overall Study|Withdrawal by Subject|2|||
130938600|NCT02632552|471408427|FG001|Overall Study|Withdrawal by Subject|0|||
131122834|NCT00698997|472078114|FG000|Overall Study|Withdrawal by Subject|7|||
131122835|NCT00698997|472078115|FG001|Overall Study|Withdrawal by Subject|27|||
131122836|NCT05082376|472078118|FG000|Overall Study|Lost to Follow-up|2|||
131122837|NCT04425720|472078119|FG000|Overall Study|Withdrawal by Subject|0|||
131122838|NCT04425720|472078120|FG001|Overall Study|Withdrawal by Subject|20|||
131122839|NCT00290186|472078121|FG000|Overall Study|Adverse Event|1|||
131122840|NCT00290186|472078122|FG001|Overall Study|Adverse Event|1|||
131122841|NCT00290186|472078121|FG000|Overall Study|Lost to Follow-up|3|||
131122842|NCT00290186|472078122|FG001|Overall Study|Lost to Follow-up|2|||
131122843|NCT00290186|472078121|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
131122844|NCT00290186|472078122|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
131122845|NCT00290186|472078121|FG000|Overall Study|Withdrawal by Subject|0|||
131122846|NCT00290186|472078122|FG001|Overall Study|Withdrawal by Subject|1|||
131122847|NCT03496012|472079645|FG000|Overall Study|Withdrawal by Subject|2|||
131122848|NCT03496012|472079646|FG001|Overall Study|Withdrawal by Subject|0|||
130938601|NCT02632552|471408426|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
130938602|NCT02632552|471408427|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
130938603|NCT02728895|471408428|FG000|Overall Study|Other|1|||
130938604|NCT02728895|471408429|FG001|Overall Study|Other|2|||
130938605|NCT02728895|471408428|FG000|Overall Study|Withdrawal by Subject|0|||
130938606|NCT02728895|471408429|FG001|Overall Study|Withdrawal by Subject|3|||
130938607|NCT02436356|471408432|FG000|Overall Study|Excluded by MRI Screening|0|||
130938608|NCT02436356|471408433|FG001|Overall Study|Excluded by MRI Screening|0|||
130938609|NCT02436356|471408434|FG002|Overall Study|Excluded by MRI Screening|2|||
130938610|NCT02436356|471408432|FG000|Overall Study|Lost to Follow-up|0|||
130938611|NCT02436356|471408433|FG001|Overall Study|Lost to Follow-up|1|||
130938612|NCT02436356|471408434|FG002|Overall Study|Lost to Follow-up|0|||
130938613|NCT02436356|471408432|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
130938614|NCT02436356|471408433|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
130938615|NCT02436356|471408434|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
130938616|NCT02436356|471408432|FG000|Overall Study|Excluded due to other medical conditions|3|||
130938617|NCT02436356|471408433|FG001|Overall Study|Excluded due to other medical conditions|0|||
130938618|NCT02436356|471408434|FG002|Overall Study|Excluded due to other medical conditions|0|||
130938619|NCT02436356|471408432|FG000|Overall Study|Withdrawal by Subject|1|||
130938620|NCT02436356|471408433|FG001|Overall Study|Withdrawal by Subject|0|||
130938621|NCT02436356|471408434|FG002|Overall Study|Withdrawal by Subject|0|||
130938622|NCT04577118|471408439|FG000|Overall Study|Withdrawal by Subject|4|||
130938623|NCT00810407|471408440|FG000|Overall Study|Protocol Violation|3|||
130938624|NCT00810407|471408440|FG000|Overall Study|No Visit After First Day of Treatment|3|||
130938625|NCT02968563|471408441|FG000|Overall Study|Adverse Event|0|||
130938626|NCT02968563|471408442|FG001|Overall Study|Adverse Event|6|||
130938627|NCT02968563|471408441|FG000|Overall Study|Death|1|||
130938628|NCT02968563|471408442|FG001|Overall Study|Death|1|||
130938629|NCT02968563|471408441|FG000|Overall Study|Lost to Follow-up|0|||
130938630|NCT02968563|471408442|FG001|Overall Study|Lost to Follow-up|1|||
130938631|NCT00674661|471408443|FG000|Overall Study|Other|5|||
130938632|NCT00674661|471408444|FG001|Overall Study|Other|7|||
130938633|NCT00674661|471408443|FG000|Overall Study|Lost to Follow-up|6|||
130938634|NCT00674661|471408444|FG001|Overall Study|Lost to Follow-up|3|||
130938635|NCT00674661|471408443|FG000|Overall Study|Withdrawal by Subject|0|||
130938636|NCT00674661|471408444|FG001|Overall Study|Withdrawal by Subject|5|||
130938637|NCT03108027|471408446|FG000|Period 1|Subject/Guardian Decision|0|||
130938638|NCT03108027|471408447|FG001|Period 1|Subject/Guardian Decision|0|||
130938639|NCT03108027|471408448|FG002|Period 1|Subject/Guardian Decision|0|||
130938640|NCT03108027|471408449|FG003|Period 1|Subject/Guardian Decision|2|||
130938641|NCT03108027|471408450|FG004|Period 1|Subject/Guardian Decision|0|||
130938642|NCT03108027|471408451|FG005|Period 1|Subject/Guardian Decision|0|||
130938643|NCT03108027|471408446|FG000|Period 3|Adverse Event|0|||
130938644|NCT03108027|471408447|FG001|Period 3|Adverse Event|1|||
130938645|NCT03108027|471408448|FG002|Period 3|Adverse Event|0|||
130938646|NCT03108027|471408449|FG003|Period 3|Adverse Event|0|||
130938647|NCT03108027|471408450|FG004|Period 3|Adverse Event|0|||
130938648|NCT03108027|471408451|FG005|Period 3|Adverse Event|0|||
130938649|NCT02426892|471408452|FG000|Overall Study|Adverse Event|2|||
130938650|NCT02426892|471408452|FG000|Overall Study|Lack of Efficacy|17|||
130938651|NCT02426892|471408452|FG000|Overall Study|Withdrawal by Subject|1|||
130938652|NCT02574247|471408453|FG000|Overall Study|Withdrawal by Subject|1|||
130938653|NCT02574247|471408454|FG001|Overall Study|Withdrawal by Subject|0|||
130705800|NCT02688387|470549572|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705801|NCT02688387|470549573|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705802|NCT02688387|470549574|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130938654|NCT02574247|471408455|FG002|Overall Study|Withdrawal by Subject|0|||
130938655|NCT02574247|471408453|FG000|Overall Study|Did not meet inclusion criteria|4|||
130938656|NCT02574247|471408454|FG001|Overall Study|Did not meet inclusion criteria|3|||
130938657|NCT02574247|471408455|FG002|Overall Study|Did not meet inclusion criteria|5|||
130938658|NCT03178773|471408456|FG000|Overall Study|Death|0|||
130938659|NCT03178773|471408457|FG001|Overall Study|Death|1|||
130938660|NCT03178773|471408456|FG000|Overall Study|Lost to Follow-up|29|||
130938661|NCT03178773|471408457|FG001|Overall Study|Lost to Follow-up|25|||
130938662|NCT03178773|471408456|FG000|Overall Study|Withdrawal by Subject|10|||
130938663|NCT03178773|471408457|FG001|Overall Study|Withdrawal by Subject|14|||
130705803|NCT02688387|470549575|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705804|NCT02688387|470549576|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130938664|NCT01382446|471408458|FG000|Overall Study|Withdrawal by Subject|0|||
130938665|NCT01382446|471408459|FG001|Overall Study|Withdrawal by Subject|1|||
130938666|NCT01382446|471408458|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
130938667|NCT01382446|471408459|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
130938668|NCT00268996|471408460|FG000|Overall Study|Adverse Event|11|||
130938669|NCT00268996|471408461|FG001|Overall Study|Adverse Event|7|||
130938670|NCT00268996|471408460|FG000|Overall Study|Lost to Follow-up|3|||
130938671|NCT00268996|471408461|FG001|Overall Study|Lost to Follow-up|1|||
130705805|NCT02688387|470549577|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130705806|NCT02688387|470549556|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705807|NCT02688387|470549557|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705808|NCT02688387|470549558|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130938672|NCT00268996|471408460|FG000|Overall Study|Withdrawal by Subject|5|||
130938673|NCT00268996|471408461|FG001|Overall Study|Withdrawal by Subject|11|||
130938674|NCT00268996|471408460|FG000|Overall Study|Non-compliance|1|||
130938675|NCT00268996|471408461|FG001|Overall Study|Non-compliance|0|||
130938676|NCT00268996|471408460|FG000|Overall Study|Other|1|||
130938677|NCT00268996|471408461|FG001|Overall Study|Other|1|||
130938678|NCT00451321|471408470|FG000|Overall Study|Lost to Follow-up|3|||
130938679|NCT00451321|471408471|FG001|Overall Study|Lost to Follow-up|3|||
130938680|NCT00451321|471408472|FG002|Overall Study|Lost to Follow-up|1|||
130938681|NCT00451321|471408473|FG003|Overall Study|Lost to Follow-up|3|||
130938682|NCT00451321|471408474|FG004|Overall Study|Lost to Follow-up|0|||
130938683|NCT00451321|471408475|FG005|Overall Study|Lost to Follow-up|1|||
130938684|NCT00451321|471408476|FG006|Overall Study|Lost to Follow-up|0|||
130938685|NCT00451321|471408477|FG007|Overall Study|Lost to Follow-up|0|||
130938686|NCT00451321|471408470|FG000|Overall Study|Withdrawal by Subject|3|||
130938687|NCT00451321|471408471|FG001|Overall Study|Withdrawal by Subject|1|||
130938688|NCT00451321|471408472|FG002|Overall Study|Withdrawal by Subject|0|||
130938689|NCT00451321|471408473|FG003|Overall Study|Withdrawal by Subject|4|||
130938690|NCT00451321|471408474|FG004|Overall Study|Withdrawal by Subject|0|||
130938691|NCT00451321|471408475|FG005|Overall Study|Withdrawal by Subject|0|||
130938692|NCT00451321|471408476|FG006|Overall Study|Withdrawal by Subject|0|||
130938693|NCT00451321|471408477|FG007|Overall Study|Withdrawal by Subject|0|||
130938694|NCT00451321|471408470|FG000|Overall Study|Study closed/terminated|1|||
130938695|NCT00451321|471408471|FG001|Overall Study|Study closed/terminated|1|||
130938696|NCT00451321|471408472|FG002|Overall Study|Study closed/terminated|17|||
130938697|NCT00451321|471408473|FG003|Overall Study|Study closed/terminated|5|||
130938698|NCT00451321|471408474|FG004|Overall Study|Study closed/terminated|7|||
130938699|NCT00451321|471408475|FG005|Overall Study|Study closed/terminated|7|||
130938700|NCT00451321|471408476|FG006|Overall Study|Study closed/terminated|5|||
130938701|NCT00451321|471408477|FG007|Overall Study|Study closed/terminated|3|||
130938702|NCT00451321|471408470|FG000|Overall Study|Sponsor decision to amend protocol|0|||
130938703|NCT00451321|471408471|FG001|Overall Study|Sponsor decision to amend protocol|0|||
130938704|NCT00451321|471408472|FG002|Overall Study|Sponsor decision to amend protocol|0|||
130938705|NCT00451321|471408473|FG003|Overall Study|Sponsor decision to amend protocol|0|||
130938706|NCT00451321|471408474|FG004|Overall Study|Sponsor decision to amend protocol|0|||
130938707|NCT00451321|471408475|FG005|Overall Study|Sponsor decision to amend protocol|1|||
130938708|NCT00451321|471408476|FG006|Overall Study|Sponsor decision to amend protocol|1|||
130938709|NCT00451321|471408477|FG007|Overall Study|Sponsor decision to amend protocol|3|||
130938710|NCT01119131|471408480|FG000|Overall Study|Adverse Event|1|||
130938711|NCT01119131|471408481|FG001|Overall Study|Adverse Event|1|||
130938712|NCT01119131|471408482|FG002|Overall Study|Adverse Event|1|||
131224117|NCT02367781|472447165|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
131224118|NCT00789828|472447166|FG000|Core Period (48 Weeks)|Administrative problems|0|||
131224119|NCT00789828|472447167|FG001|Core Period (48 Weeks)|Administrative problems|1|||
131224120|NCT00789828|472447166|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
131224121|NCT00789828|472447167|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
131224122|NCT00789828|472447166|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
131224123|NCT00789828|472447167|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
131224124|NCT00789828|472447166|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
131224125|NCT00789828|472447167|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
130705809|NCT02688387|470549559|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
130938713|NCT01119131|471408480|FG000|Overall Study|Non-Compliance|1|||
130938714|NCT01119131|471408481|FG001|Overall Study|Non-Compliance|0|||
130938715|NCT01119131|471408482|FG002|Overall Study|Non-Compliance|4|||
130938716|NCT01119131|471408480|FG000|Overall Study|Physician Decision|0|||
130938717|NCT01119131|471408481|FG001|Overall Study|Physician Decision|0|||
130938718|NCT01119131|471408482|FG002|Overall Study|Physician Decision|1|||
130705810|NCT02688387|470549560|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705811|NCT02688387|470549561|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130938719|NCT01528254|471408483|FG000|Overall Study|Administrative problems|96|||
130938720|NCT01528254|471408484|FG001|Overall Study|Administrative problems|94|||
130938721|NCT01528254|471408483|FG000|Overall Study|Adverse Event|28|||
130938722|NCT01528254|471408484|FG001|Overall Study|Adverse Event|44|||
130938723|NCT01528254|471408483|FG000|Overall Study|Lost to Follow-up|17|||
130938724|NCT01528254|471408484|FG001|Overall Study|Lost to Follow-up|24|||
130938725|NCT01528254|471408483|FG000|Overall Study|Death|13|||
130938726|NCT01528254|471408484|FG001|Overall Study|Death|9|||
130938727|NCT01528254|471408483|FG000|Overall Study|Protocol deviation|9|||
130938728|NCT01528254|471408484|FG001|Overall Study|Protocol deviation|19|||
130938729|NCT01528254|471408483|FG000|Overall Study|New therapy for study indication|8|||
130938730|NCT01528254|471408484|FG001|Overall Study|New therapy for study indication|6|||
130705812|NCT02688387|470549562|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705813|NCT02688387|470549563|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130938731|NCT01528254|471408483|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130938732|NCT01528254|471408484|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
130938733|NCT01528254|471408483|FG000|Overall Study|Withdrawal by Subject|5|||
130938734|NCT01528254|471408484|FG001|Overall Study|Withdrawal by Subject|4|||
130938735|NCT01528254|471408483|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130938736|NCT01528254|471408484|FG001|Overall Study|Abnormal laboratory value(s)|7|||
130938737|NCT01528254|471408483|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130938738|NCT01528254|471408484|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130938739|NCT01528254|471408483|FG000|Overall Study|No longer requires study drug|1|||
130938740|NCT01528254|471408484|FG001|Overall Study|No longer requires study drug|1|||
130938741|NCT01909479|471408485|FG000|From Baseline to Week 26|Adverse Event|3|||
130938742|NCT01909479|471408486|FG001|From Baseline to Week 26|Adverse Event|2|||
130938743|NCT01909479|471408485|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
130938744|NCT01909479|471408486|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
130938745|NCT01909479|471408485|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
130938746|NCT01909479|471408486|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
130938747|NCT01909479|471408485|FG000|26 - 52 Weeks|Adverse Event|0|||
130938748|NCT01909479|471408486|FG001|26 - 52 Weeks|Adverse Event|1|||
130938749|NCT01909479|471408485|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
130938750|NCT01909479|471408486|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
130938751|NCT01909479|471408485|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
130938752|NCT01909479|471408486|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
130938753|NCT01909479|471408485|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
130938754|NCT01909479|471408486|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
130938755|NCT01909479|471408485|FG000|52 Weeks to End of Study|Adverse Event|2|||
130938756|NCT01909479|471408486|FG001|52 Weeks to End of Study|Adverse Event|1|||
130938757|NCT01909479|471408485|FG000|52 Weeks to End of Study|Death|0|||
130938758|NCT01909479|471408486|FG001|52 Weeks to End of Study|Death|1|||
130938759|NCT01909479|471408485|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
130938760|NCT01909479|471408486|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
130938761|NCT01909479|471408485|FG000|52 Weeks to End of Study|Protocol Violation|1|||
130938762|NCT01909479|471408486|FG001|52 Weeks to End of Study|Protocol Violation|0|||
130938763|NCT01909479|471408485|FG000|52 Weeks to End of Study|Progressive disease|1|||
130938764|NCT01909479|471408486|FG001|52 Weeks to End of Study|Progressive disease|1|||
130938765|NCT01909479|471408485|FG000|52 Weeks to End of Study|Personal reasons|2|||
130938766|NCT01909479|471408486|FG001|52 Weeks to End of Study|Personal reasons|1|||
130938767|NCT01909479|471408485|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
130938768|NCT01909479|471408486|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
130938769|NCT01909479|471408485|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
130938770|NCT01909479|471408486|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
130938771|NCT01909479|471408485|FG000|52 Weeks to End of Study|Lack of contact|1|||
130938772|NCT01909479|471408486|FG001|52 Weeks to End of Study|Lack of contact|0|||
130938773|NCT01909479|471408485|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
130938774|NCT01909479|471408486|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
130938775|NCT01909479|471408485|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
130938776|NCT01909479|471408486|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
130938777|NCT04446377|471408487|FG000|Overall Study|Withdrawal by Subject|6|||
130938778|NCT04446377|471408488|FG001|Overall Study|Withdrawal by Subject|1|||
130938779|NCT04446377|471408487|FG000|Overall Study|Physician Decision|1|||
130938780|NCT04446377|471408488|FG001|Overall Study|Physician Decision|1|||
130938781|NCT04446377|471408487|FG000|Overall Study|Lost to Follow-up|0|||
130938782|NCT04446377|471408488|FG001|Overall Study|Lost to Follow-up|2|||
130938783|NCT04446377|471408487|FG000|Overall Study|Not eligible|0|||
130938784|NCT04446377|471408488|FG001|Overall Study|Not eligible|1|||
130938785|NCT03198234|471408492|FG000|Overall Study|Relapse of primary disease|0|||
130938786|NCT03198234|471408493|FG001|Overall Study|Relapse of primary disease|1|||
130938787|NCT03198234|471408494|FG002|Overall Study|Relapse of primary disease|0|||
130938788|NCT02196558|471408495|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
130938789|NCT02196558|471408496|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
130938790|NCT02196558|471408497|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
130938791|NCT02196558|471408495|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
130938792|NCT02196558|471408496|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
130938793|NCT02196558|471408497|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
131224126|NCT00789828|472447166|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
130938794|NCT02196558|471408495|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
130938795|NCT02196558|471408496|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
130938796|NCT02196558|471408497|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
131224127|NCT00789828|472447167|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
131224128|NCT00789828|472447166|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
130938797|NCT02196558|471408495|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
130705814|NCT02688387|470549564|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705815|NCT02688387|470549565|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705816|NCT02688387|470549566|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705817|NCT02688387|470549567|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705818|NCT02688387|470549568|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705819|NCT02688387|470549569|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705820|NCT02688387|470549570|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705821|NCT02688387|470549571|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705822|NCT02688387|470549572|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705823|NCT02688387|470549573|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705824|NCT02688387|470549574|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705825|NCT02688387|470549575|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705826|NCT02688387|470549576|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705827|NCT02688387|470549577|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705828|NCT02688387|470549556|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705829|NCT02688387|470549557|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
130705830|NCT02688387|470549558|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705831|NCT02688387|470549559|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705832|NCT02688387|470549560|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705833|NCT02688387|470549561|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705834|NCT02688387|470549562|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705835|NCT02688387|470549563|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705836|NCT02688387|470549564|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705837|NCT02688387|470549565|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705838|NCT02688387|470549566|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705839|NCT02688387|470549567|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705840|NCT02688387|470549568|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705841|NCT02688387|470549569|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705842|NCT02688387|470549570|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705843|NCT02688387|470549571|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705844|NCT02688387|470549572|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130938798|NCT02196558|471408496|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
130938799|NCT02196558|471408497|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
130938800|NCT02196558|471408495|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
130938801|NCT02196558|471408496|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
130938802|NCT02196558|471408497|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
130938803|NCT01361464|471408499|FG000|Overall Study|Death|1|||
130938804|NCT01361464|471408499|FG000|Overall Study|Withdrawal by Subject|2|||
130938805|NCT01106898|471408503|FG000|Overall Study|Adverse Event|6|||
130938806|NCT00541034|471408504|FG000|Overall Study|Non-Compliance|3|||
130938807|NCT01505868|471408505|FG000|Overall Study|Withdrawal by Subject|1|||
130938808|NCT01505868|471408506|FG001|Overall Study|Withdrawal by Subject|0|||
130938809|NCT01505868|471408507|FG002|Overall Study|Withdrawal by Subject|0|||
130938810|NCT01505868|471408508|FG003|Overall Study|Withdrawal by Subject|0|||
130938811|NCT01505868|471408509|FG004|Overall Study|Withdrawal by Subject|0|||
130938812|NCT02289079|471408510|FG000|Overall Study|Physician Decision|2|||
130938813|NCT02289079|471408511|FG001|Overall Study|Physician Decision|0|||
130938814|NCT02289079|471408510|FG000|Overall Study|Lost to Follow-up|0|||
130938815|NCT02289079|471408511|FG001|Overall Study|Lost to Follow-up|1|||
130938816|NCT03061331|471408512|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
130938817|NCT03061331|471408513|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
130938818|NCT01980875|471408514|FG000|Overall Study|Withdrew Consent|1|||
130938819|NCT01980875|471408515|FG001|Overall Study|Withdrew Consent|1|||
130938820|NCT01980875|471408516|FG002|Overall Study|Withdrew Consent|1|||
130938821|NCT01980875|471408514|FG000|Overall Study|Study Terminated by Sponsor|7|||
130938822|NCT01980875|471408515|FG001|Overall Study|Study Terminated by Sponsor|24|||
130938823|NCT01980875|471408516|FG002|Overall Study|Study Terminated by Sponsor|22|||
130938824|NCT01980875|471408514|FG000|Overall Study|Lost to Follow-up|0|||
130938825|NCT01980875|471408515|FG001|Overall Study|Lost to Follow-up|0|||
130705845|NCT02688387|470549573|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705846|NCT02688387|470549574|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705847|NCT02688387|470549575|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705848|NCT02688387|470549576|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130938826|NCT01980875|471408516|FG002|Overall Study|Lost to Follow-up|1|||
130938827|NCT02625259|471408517|FG000|First Intervention (Day 1)|Other|0|||
130938828|NCT02625259|471408518|FG001|First Intervention (Day 1)|Other|0|||
130938829|NCT02625259|471408519|FG002|First Intervention (Day 1)|Other|1|||
130938830|NCT02625259|471408520|FG003|First Intervention (Day 1)|Other|0|||
130938831|NCT02625259|471408521|FG004|First Intervention (Day 1)|Other|0|||
130938832|NCT02625259|471408517|FG000|First Intervention (Day 1)|Adverse Event|2|||
130938833|NCT02625259|471408518|FG001|First Intervention (Day 1)|Adverse Event|1|||
131122849|NCT03496012|472079647|FG002|Overall Study|Withdrawal by Subject|2|||
131122850|NCT03496012|472079645|FG000|Overall Study|Adverse Event|0|||
131122851|NCT03496012|472079646|FG001|Overall Study|Adverse Event|0|||
130938834|NCT02625259|471408519|FG002|First Intervention (Day 1)|Adverse Event|0|||
130938835|NCT02625259|471408520|FG003|First Intervention (Day 1)|Adverse Event|0|||
130938836|NCT02625259|471408521|FG004|First Intervention (Day 1)|Adverse Event|0|||
130938837|NCT02625259|471408517|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
130938838|NCT02625259|471408518|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
130938839|NCT02625259|471408519|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
130938840|NCT02625259|471408520|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
130938841|NCT02625259|471408521|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
130938842|NCT02998840|471408522|FG000|Overall Study|Lost to Follow-up|1|||
130938843|NCT02998840|471408523|FG001|Overall Study|Lost to Follow-up|1|||
130938844|NCT02998840|471408524|FG002|Overall Study|Lost to Follow-up|2|||
130938845|NCT02998840|471408525|FG003|Overall Study|Lost to Follow-up|3|||
130938846|NCT02998840|471408522|FG000|Overall Study|Withdrawal by Subject|1|||
130938847|NCT02998840|471408523|FG001|Overall Study|Withdrawal by Subject|1|||
130938848|NCT02998840|471408524|FG002|Overall Study|Withdrawal by Subject|0|||
130938849|NCT02998840|471408525|FG003|Overall Study|Withdrawal by Subject|1|||
130938850|NCT02998840|471408522|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
130938851|NCT02998840|471408523|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
130938852|NCT02998840|471408524|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
131122852|NCT03496012|472079647|FG002|Overall Study|Adverse Event|1|||
131122853|NCT03496012|472079645|FG000|Overall Study|Reason Not Specified|2|||
131122854|NCT03496012|472079646|FG001|Overall Study|Reason Not Specified|0|||
131122855|NCT03496012|472079647|FG002|Overall Study|Reason Not Specified|1|||
131122856|NCT02322125|472079648|FG000|Overall Study|Withdrawal by Subject|2|||
131122857|NCT00449670|472079650|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
131122858|NCT00449670|472079651|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
131122859|NCT00449670|472079650|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
131122860|NCT00449670|472079651|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
131122861|NCT00449670|472079650|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
131122862|NCT00449670|472079651|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
131122863|NCT00449670|472079650|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
131122864|NCT00449670|472079651|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
130938853|NCT02998840|471408525|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
130938854|NCT02081690|471410840|FG000|Overall Study|Death|3|||
130938855|NCT02081690|471410840|FG000|Overall Study|Physician Decision|3|||
130938856|NCT02081690|471410840|FG000|Overall Study|Withdrawal by Subject|1|||
130938857|NCT03204981|471410842|FG000|Overall Study|Physician Decision|2|||
130938858|NCT03204981|471410842|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
130938859|NCT04244786|471410846|FG000|Overall Study|Adverse Event|0|||
130938860|NCT04244786|471410847|FG001|Overall Study|Adverse Event|0|||
130938861|NCT04244786|471410848|FG002|Overall Study|Adverse Event|2|||
130938862|NCT04244786|471410846|FG000|Overall Study|Withdrawal by Subject|0|||
130938863|NCT04244786|471410847|FG001|Overall Study|Withdrawal by Subject|0|||
130938864|NCT04244786|471410848|FG002|Overall Study|Withdrawal by Subject|5|||
130938865|NCT00613938|471410855|FG000|Overall Study|Withdrawal by Subject|2|||
130938866|NCT00613938|471410856|FG001|Overall Study|Withdrawal by Subject|4|||
130938867|NCT00613938|471410857|FG002|Overall Study|Withdrawal by Subject|9|||
130938868|NCT00613938|471410858|FG003|Overall Study|Withdrawal by Subject|9|||
130938869|NCT00613938|471410855|FG000|Overall Study|Adverse Event|1|||
130938870|NCT00613938|471410856|FG001|Overall Study|Adverse Event|4|||
130938871|NCT00613938|471410857|FG002|Overall Study|Adverse Event|8|||
130938872|NCT00613938|471410858|FG003|Overall Study|Adverse Event|5|||
130938873|NCT00613938|471410855|FG000|Overall Study|Lack of Efficacy|16|||
130938874|NCT00613938|471410856|FG001|Overall Study|Lack of Efficacy|18|||
130938875|NCT00613938|471410857|FG002|Overall Study|Lack of Efficacy|5|||
130938876|NCT00613938|471410858|FG003|Overall Study|Lack of Efficacy|9|||
131122865|NCT00449670|472079650|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
131122866|NCT00449670|472079651|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
131122867|NCT00449670|472079650|FG000|Booster Phase (Study no.109873)|Other|0|||
130938877|NCT00613938|471410855|FG000|Overall Study|Other|1|||
130938878|NCT00613938|471410856|FG001|Overall Study|Other|2|||
130938879|NCT00613938|471410857|FG002|Overall Study|Other|1|||
130938880|NCT00613938|471410858|FG003|Overall Study|Other|3|||
130938881|NCT03220217|471410859|FG000|Overall Study|Withdrawal by Subject|0|||
130938882|NCT03220217|471410860|FG001|Overall Study|Withdrawal by Subject|1|||
130938883|NCT03220217|471410861|FG002|Overall Study|Withdrawal by Subject|0|||
130938884|NCT03220217|471410859|FG000|Overall Study|Subject Missed Procedure|0|||
130938885|NCT03220217|471410860|FG001|Overall Study|Subject Missed Procedure|0|||
131122868|NCT00449670|472079651|FG001|Booster Phase (Study no.109873)|Other|2|||
131122869|NCT04183790|472079652|FG000|Overall Study|Participants did not rollover to Part B|12|||
130938886|NCT03220217|471410861|FG002|Overall Study|Subject Missed Procedure|1|||
130938887|NCT03745937|471410863|FG000|Overall Study|Withdrawal by Subject|0|||
130938888|NCT03745937|471410864|FG001|Overall Study|Withdrawal by Subject|0|||
130938889|NCT03745937|471410865|FG002|Overall Study|Withdrawal by Subject|0|||
130938890|NCT03745937|471410866|FG003|Overall Study|Withdrawal by Subject|1|||
130938891|NCT03745937|471410863|FG000|Overall Study|Not-specifed|0|||
130938892|NCT03745937|471410864|FG001|Overall Study|Not-specifed|1|||
130938893|NCT03745937|471410865|FG002|Overall Study|Not-specifed|0|||
130938894|NCT03745937|471410866|FG003|Overall Study|Not-specifed|1|||
130938895|NCT00312494|471410867|FG000|Overall Study|Randomized; not treated with study drug|9|||
131122870|NCT04183790|472079653|FG001|Overall Study|Participants did not rollover to Part B|0|||
131122871|NCT04183790|472079652|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
131122872|NCT04183790|472079653|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
131122873|NCT04183790|472079652|FG000|Overall Study|Commercial drug is available for participant|6|||
131122874|NCT04183790|472079653|FG001|Overall Study|Commercial drug is available for participant|0|||
131122875|NCT04183790|472079652|FG000|Overall Study|Adverse Event|1|||
131122876|NCT04183790|472079653|FG001|Overall Study|Adverse Event|0|||
131122877|NCT04183790|472079652|FG000|Overall Study|Not enrolled in 107 study|0|||
131122878|NCT04183790|472079653|FG001|Overall Study|Not enrolled in 107 study|2|||
131122879|NCT00937937|472079654|FG000|Overall Study|Adverse Event|6|||
130938896|NCT00312494|471410868|FG001|Overall Study|Randomized; not treated with study drug|10|||
130938897|NCT00312494|471410869|FG002|Overall Study|Randomized; not treated with study drug|5|||
130938898|NCT00312494|471410867|FG000|Overall Study|Adverse Event|33|||
130938899|NCT00312494|471410868|FG001|Overall Study|Adverse Event|15|||
130938900|NCT00312494|471410869|FG002|Overall Study|Adverse Event|11|||
130938901|NCT00312494|471410867|FG000|Overall Study|Lack of Efficacy|4|||
130938902|NCT00312494|471410868|FG001|Overall Study|Lack of Efficacy|6|||
130938903|NCT00312494|471410869|FG002|Overall Study|Lack of Efficacy|8|||
130938904|NCT00312494|471410867|FG000|Overall Study|Laboratory abnormality|1|||
130938905|NCT00312494|471410868|FG001|Overall Study|Laboratory abnormality|0|||
130938906|NCT00312494|471410869|FG002|Overall Study|Laboratory abnormality|0|||
130938907|NCT00312494|471410867|FG000|Overall Study|Lost to Follow-up|8|||
130938908|NCT00312494|471410868|FG001|Overall Study|Lost to Follow-up|8|||
130938909|NCT00312494|471410869|FG002|Overall Study|Lost to Follow-up|8|||
130938910|NCT00312494|471410867|FG000|Overall Study|Withdrawal by Subject|6|||
130938911|NCT00312494|471410868|FG001|Overall Study|Withdrawal by Subject|9|||
130938912|NCT00312494|471410869|FG002|Overall Study|Withdrawal by Subject|10|||
130938913|NCT00312494|471410867|FG000|Overall Study|Other|10|||
130938914|NCT00312494|471410868|FG001|Overall Study|Other|10|||
130938915|NCT00312494|471410869|FG002|Overall Study|Other|1|||
130938916|NCT02734810|471410871|FG000|Overall Study|Adverse Event|1|||
130938917|NCT02734810|471410872|FG001|Overall Study|Adverse Event|0|||
130938918|NCT02734810|471410871|FG000|Overall Study|Lack of Efficacy|1|||
131122880|NCT00937937|472079654|FG000|Overall Study|Withdrawal by Subject|2|||
131122881|NCT00937937|472079654|FG000|Overall Study|Progression/relapse|61|||
131122882|NCT00937937|472079654|FG000|Overall Study|Death|1|||
131122883|NCT00937937|472079654|FG000|Overall Study|Other|2|||
131122884|NCT03197493|472079655|FG000|Overall Study|Withdrawal by Subject|5|||
131122885|NCT02248259|472079656|FG000|Treatment Period 1|Adverse Event|0|||
131122886|NCT02248259|472079657|FG001|Treatment Period 1|Adverse Event|0|||
131122887|NCT02248259|472079658|FG002|Treatment Period 1|Adverse Event|1|||
131122888|NCT02248259|472079659|FG003|Treatment Period 1|Adverse Event|0|||
131122889|NCT02807480|472079660|FG000|Overall Study|Withdrawal by Subject|14|||
131122890|NCT02807480|472079661|FG001|Overall Study|Withdrawal by Subject|10|||
131122891|NCT02369848|472079662|FG000|Overall Study|Death|1|||
131122892|NCT02369848|472079662|FG000|Overall Study|Withdrawal by Subject|2|||
131122893|NCT02369848|472079662|FG000|Overall Study|Lost to Follow-up|1|||
131122894|NCT03281668|472079664|FG000|Overall Study|Physician Decision|1|||
131122895|NCT03281668|472079664|FG000|Overall Study|scheduling conflict, family circumstance|2|||
131122896|NCT03281668|472079664|FG000|Overall Study|Withdrawal by Subject|4|||
131122897|NCT03281668|472079664|FG000|Overall Study|Lost to Follow-up|1|||
131122898|NCT01543152|472079665|FG000|Overall Study|Withdrawal by Subject|0|||
131122899|NCT01543152|472079666|FG001|Overall Study|Withdrawal by Subject|2|||
131122900|NCT01543152|472079667|FG002|Overall Study|Withdrawal by Subject|0|||
130772032|NCT05052697|470792837|FG017|Substudy A|No longer met eligibility criteria|0|||
130938919|NCT02734810|471410872|FG001|Overall Study|Lack of Efficacy|0|||
130938920|NCT00488345|471410874|FG000|Overall Study|Adverse Event|0|||
130938921|NCT00488345|471410875|FG001|Overall Study|Adverse Event|1|||
130938922|NCT00488345|471410876|FG002|Overall Study|Adverse Event|1|||
130938923|NCT00488345|471410874|FG000|Overall Study|Unable to administer antibiotics at home|0|||
130938924|NCT00488345|471410875|FG001|Overall Study|Unable to administer antibiotics at home|1|||
130938925|NCT00488345|471410876|FG002|Overall Study|Unable to administer antibiotics at home|0|||
130938926|NCT00488345|471410874|FG000|Overall Study|Institutional Review Board review|0|||
130938927|NCT00488345|471410875|FG001|Overall Study|Institutional Review Board review|0|||
130938928|NCT00488345|471410876|FG002|Overall Study|Institutional Review Board review|1|||
130938929|NCT00488345|471410874|FG000|Overall Study|Surgical team recommendation|0|||
130938930|NCT00488345|471410875|FG001|Overall Study|Surgical team recommendation|1|||
130938931|NCT00488345|471410876|FG002|Overall Study|Surgical team recommendation|0|||
130938932|NCT00488345|471410874|FG000|Overall Study|Parent/legal guardian request|0|||
130938933|NCT00488345|471410875|FG001|Overall Study|Parent/legal guardian request|1|||
130938934|NCT00488345|471410876|FG002|Overall Study|Parent/legal guardian request|1|||
130938935|NCT00903617|471410882|FG000|Overall Study|Adverse Event|0|||
130938936|NCT00903617|471410883|FG001|Overall Study|Adverse Event|1|||
130938937|NCT00903617|471410884|FG002|Overall Study|Adverse Event|1|||
130938938|NCT00903617|471410885|FG003|Overall Study|Adverse Event|0|||
130938939|NCT00903617|471410882|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130938940|NCT00903617|471410883|FG001|Overall Study|Protocol-defined stopping criteria|2|||
130938941|NCT00903617|471410884|FG002|Overall Study|Protocol-defined stopping criteria|0|||
130938942|NCT00903617|471410885|FG003|Overall Study|Protocol-defined stopping criteria|0|||
130938943|NCT00903617|471410882|FG000|Overall Study|Lost to Follow-up|2|||
130938944|NCT00903617|471410883|FG001|Overall Study|Lost to Follow-up|0|||
130938945|NCT00903617|471410884|FG002|Overall Study|Lost to Follow-up|1|||
130938946|NCT00903617|471410885|FG003|Overall Study|Lost to Follow-up|1|||
130938947|NCT00903617|471410882|FG000|Overall Study|Withdrawal by Subject|1|||
130938948|NCT00903617|471410883|FG001|Overall Study|Withdrawal by Subject|2|||
130938949|NCT00903617|471410884|FG002|Overall Study|Withdrawal by Subject|3|||
130938950|NCT00903617|471410885|FG003|Overall Study|Withdrawal by Subject|0|||
130938951|NCT01104636|471410886|FG000|Overall Study|Lack of Efficacy|43|||
130938952|NCT01104636|471410886|FG000|Overall Study|Lost to Follow-up|24|||
130938953|NCT01104636|471410886|FG000|Overall Study|Withdrawal by Subject|4|||
130938954|NCT01104636|471410886|FG000|Overall Study|Other|43|||
130938955|NCT01104636|471410886|FG000|Overall Study|Study terminated by sponsor|1|||
130938956|NCT01104636|471410886|FG000|Overall Study|Pregnancy|2|||
130938957|NCT01104636|471410886|FG000|Overall Study|Adverse Event|40|||
130938958|NCT01104636|471410886|FG000|Overall Study|Ongoing|21|||
130938959|NCT01706003|471410887|FG000|Overall Study|Withdrawal by Subject|2|||
130938960|NCT01706003|471410888|FG001|Overall Study|Withdrawal by Subject|0|||
130938961|NCT01706003|471410887|FG000|Overall Study|Not scheduled|3|||
130938962|NCT01706003|471410888|FG001|Overall Study|Not scheduled|0|||
130938963|NCT01706003|471410887|FG000|Overall Study|Lost to Follow-up|6|||
130938964|NCT01706003|471410888|FG001|Overall Study|Lost to Follow-up|4|||
130938965|NCT00407563|471410889|FG000|Overall Study|Patient continues on treatment|1|||
130938966|NCT03055260|471410890|FG000|Overall Study|Withdrawal by Subject|1|||
130938967|NCT03055260|471410891|FG001|Overall Study|Withdrawal by Subject|0|||
130938968|NCT03045328|471410897|FG000|Overall Study|Withdrawal by Subject|2|||
130938969|NCT00592839|471410898|FG000|Overall Study|Withdrawal by Subject|1|||
130938970|NCT00592839|471410899|FG001|Overall Study|Withdrawal by Subject|1|||
130938971|NCT00592839|471410900|FG002|Overall Study|Withdrawal by Subject|3|||
130938972|NCT00592839|471410898|FG000|Overall Study|Protocol Violation|1|||
130938973|NCT00592839|471410899|FG001|Overall Study|Protocol Violation|1|||
130938974|NCT00592839|471410900|FG002|Overall Study|Protocol Violation|2|||
130938975|NCT00592839|471410898|FG000|Overall Study|Adverse Event|0|||
130938976|NCT00592839|471410899|FG001|Overall Study|Adverse Event|1|||
130938977|NCT00592839|471410900|FG002|Overall Study|Adverse Event|0|||
130938978|NCT00592839|471410898|FG000|Overall Study|Lost to Follow-up|0|||
130938979|NCT00592839|471410899|FG001|Overall Study|Lost to Follow-up|1|||
130938980|NCT00592839|471410900|FG002|Overall Study|Lost to Follow-up|1|||
130938981|NCT00249444|471410906|FG000|Overall Study|Lost to Follow-up|2|||
130938982|NCT00249444|471410907|FG001|Overall Study|Lost to Follow-up|2|||
130938983|NCT00249444|471410906|FG000|Overall Study|non-compliant|9|||
130938984|NCT00249444|471410907|FG001|Overall Study|non-compliant|11|||
130938985|NCT00249444|471410906|FG000|Overall Study|Adverse Event|1|||
130938986|NCT00249444|471410907|FG001|Overall Study|Adverse Event|1|||
130938987|NCT00249444|471410906|FG000|Overall Study|life event|0|||
130938988|NCT00249444|471410907|FG001|Overall Study|life event|1|||
130938989|NCT00936910|471410910|FG000|Overall Study|Lack of Efficacy|3|||
130938990|NCT00412854|471410911|FG000|Overall Study|Withdrawn due to adverse events|1|||
130938991|NCT00412854|471410912|FG001|Overall Study|Withdrawn due to adverse events|5|||
130938992|NCT00412854|471410911|FG000|Overall Study|Withdrawn for other reasons|13|||
130938993|NCT00412854|471410912|FG001|Overall Study|Withdrawn for other reasons|11|||
130938994|NCT04483011|471410916|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
130938995|NCT04483011|471410917|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
130705849|NCT02688387|470549577|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130705850|NCT02688387|470549556|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130938996|NCT03518073|471410918|FG000|Overall Study|Adverse Event|2|||
130938997|NCT03518073|471410919|FG001|Overall Study|Adverse Event|4|||
130938998|NCT03518073|471410920|FG002|Overall Study|Adverse Event|2|||
130938999|NCT03518073|471410918|FG000|Overall Study|Death|2|||
130939000|NCT03518073|471410919|FG001|Overall Study|Death|1|||
130939001|NCT03518073|471410920|FG002|Overall Study|Death|3|||
130939002|NCT03518073|471410918|FG000|Overall Study|Lost to Follow-up|1|||
130705851|NCT02688387|470549557|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705852|NCT02688387|470549558|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
130772033|NCT05052697|470792838|FG018|Substudy A|No longer met eligibility criteria|0|||
130772034|NCT05052697|470792839|FG019|Substudy A|No longer met eligibility criteria|0|||
130772035|NCT05052697|470792840|FG020|Substudy A|No longer met eligibility criteria|0|||
130772036|NCT05052697|470792841|FG021|Substudy A|No longer met eligibility criteria|0|||
130772037|NCT05052697|470792842|FG022|Substudy A|No longer met eligibility criteria|0|||
130772038|NCT05052697|470792843|FG023|Substudy A|No longer met eligibility criteria|0|||
130772039|NCT05052697|470792844|FG024|Substudy A|No longer met eligibility criteria|0|||
130772040|NCT05052697|470792845|FG025|Substudy A|No longer met eligibility criteria|0|||
130772041|NCT05052697|470792846|FG026|Substudy A|No longer met eligibility criteria|0|||
130772042|NCT05052697|470792847|FG027|Substudy A|No longer met eligibility criteria|0|||
130772043|NCT05052697|470792848|FG028|Substudy A|No longer met eligibility criteria|0|||
130772044|NCT05052697|470792849|FG029|Substudy A|No longer met eligibility criteria|0|||
130705853|NCT02688387|470549559|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705854|NCT02688387|470549560|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
130705855|NCT02688387|470549561|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130772045|NCT05052697|470792850|FG030|Substudy A|No longer met eligibility criteria|0|||
130772046|NCT05052697|470792851|FG031|Substudy A|No longer met eligibility criteria|0|||
130772047|NCT05052697|470792852|FG032|Substudy A|No longer met eligibility criteria|0|||
130772048|NCT05052697|470792853|FG033|Substudy A|No longer met eligibility criteria|0|||
130772049|NCT05052697|470792820|FG000|Substudy A|Not vaccinated|0|||
130772050|NCT05052697|470792821|FG001|Substudy A|Not vaccinated|0|||
130772051|NCT05052697|470792822|FG002|Substudy A|Not vaccinated|0|||
130772052|NCT05052697|470792823|FG003|Substudy A|Not vaccinated|1|||
130705856|NCT02688387|470549562|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705857|NCT02688387|470549563|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705858|NCT02688387|470549564|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705859|NCT02688387|470549565|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705860|NCT02688387|470549566|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705861|NCT02688387|470549567|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705862|NCT02688387|470549568|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705863|NCT02688387|470549569|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705864|NCT02688387|470549570|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705865|NCT02688387|470549571|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705866|NCT02688387|470549572|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705867|NCT02688387|470549573|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705868|NCT02688387|470549574|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705869|NCT02688387|470549575|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705870|NCT02688387|470549576|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705871|NCT02688387|470549577|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130705872|NCT02688387|470549556|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
130705873|NCT02688387|470549557|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705874|NCT02688387|470549558|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705875|NCT02688387|470549559|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705876|NCT02688387|470549560|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705877|NCT02688387|470549561|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705878|NCT02688387|470549562|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705879|NCT02688387|470549563|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705880|NCT02688387|470549564|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705881|NCT02688387|470549565|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705882|NCT02688387|470549566|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705883|NCT02688387|470549567|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705884|NCT02688387|470549568|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705885|NCT02688387|470549569|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130772053|NCT05052697|470792824|FG004|Substudy A|Not vaccinated|0|||
130772054|NCT05052697|470792825|FG005|Substudy A|Not vaccinated|0|||
130772055|NCT05052697|470792826|FG006|Substudy A|Not vaccinated|0|||
130772056|NCT05052697|470792827|FG007|Substudy A|Not vaccinated|0|||
130939003|NCT03518073|471410919|FG001|Overall Study|Lost to Follow-up|0|||
130939004|NCT03518073|471410920|FG002|Overall Study|Lost to Follow-up|1|||
130939005|NCT03518073|471410918|FG000|Overall Study|Physician Decision|5|||
130939006|NCT03518073|471410919|FG001|Overall Study|Physician Decision|0|||
130939007|NCT03518073|471410920|FG002|Overall Study|Physician Decision|2|||
130939008|NCT03518073|471410918|FG000|Overall Study|Progressive disease|1|||
130939009|NCT03518073|471410919|FG001|Overall Study|Progressive disease|1|||
130939010|NCT03518073|471410920|FG002|Overall Study|Progressive disease|1|||
130939011|NCT03518073|471410918|FG000|Overall Study|Protocol Violation|1|||
130939012|NCT03518073|471410919|FG001|Overall Study|Protocol Violation|0|||
130939013|NCT03518073|471410920|FG002|Overall Study|Protocol Violation|0|||
130939014|NCT03518073|471410918|FG000|Overall Study|Withdrawal by Subject|30|||
130939015|NCT03518073|471410919|FG001|Overall Study|Withdrawal by Subject|34|||
130939016|NCT03518073|471410920|FG002|Overall Study|Withdrawal by Subject|29|||
130939017|NCT03518073|471410918|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
130939018|NCT03518073|471410919|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
130939019|NCT03518073|471410920|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
130939020|NCT03518073|471410918|FG000|Overall Study|Covid-19|1|||
130939021|NCT03518073|471410919|FG001|Overall Study|Covid-19|2|||
130939022|NCT03518073|471410920|FG002|Overall Study|Covid-19|1|||
130939023|NCT03045081|471410921|FG000|Overall Study|Withdrawal by Subject|6|||
130939024|NCT03045081|471410922|FG001|Overall Study|Withdrawal by Subject|11|||
130939025|NCT01853046|471410923|FG000|Overall Study|Withdrawal by Subject|1|||
130939026|NCT01853046|471410924|FG001|Overall Study|Withdrawal by Subject|1|||
130939027|NCT01853046|471410923|FG000|Overall Study|Adverse Event|4|||
130939028|NCT01853046|471410924|FG001|Overall Study|Adverse Event|2|||
130939029|NCT01853046|471410923|FG000|Overall Study|Disease progression|13|||
130939030|NCT01853046|471410924|FG001|Overall Study|Disease progression|3|||
130939031|NCT02057198|471410929|FG000|Overall Study|Death|0|||
130939032|NCT02057198|471410930|FG001|Overall Study|Death|0|||
130939033|NCT02057198|471410931|FG002|Overall Study|Death|1|||
130939034|NCT02057198|471410929|FG000|Overall Study|Discharged early; lost to followup|0|||
130939035|NCT02057198|471410930|FG001|Overall Study|Discharged early; lost to followup|1|||
130939036|NCT02057198|471410931|FG002|Overall Study|Discharged early; lost to followup|0|||
130939037|NCT00065507|471410932|FG000|Overall Study|Death|16|||
130939038|NCT00065507|471410933|FG001|Overall Study|Death|17|||
130939039|NCT00065507|471410932|FG000|Overall Study|Adverse Event|4|||
130939040|NCT00065507|471410933|FG001|Overall Study|Adverse Event|3|||
130939041|NCT00065507|471410932|FG000|Overall Study|Lack of Efficacy|0|||
130939042|NCT00065507|471410933|FG001|Overall Study|Lack of Efficacy|6|||
130939043|NCT00065507|471410932|FG000|Overall Study|Poor/Non-compliance|3|||
130939044|NCT00065507|471410933|FG001|Overall Study|Poor/Non-compliance|2|||
130939045|NCT00065507|471410932|FG000|Overall Study|Lost to Follow-up|3|||
130939046|NCT00065507|471410933|FG001|Overall Study|Lost to Follow-up|0|||
130939047|NCT00065507|471410932|FG000|Overall Study|Subject Withdrew Consent|2|||
130939048|NCT00065507|471410933|FG001|Overall Study|Subject Withdrew Consent|1|||
130939049|NCT00065507|471410932|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
130939050|NCT00065507|471410933|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
130939051|NCT02169739|471410934|FG000|Overall Study|Lost to Follow-up|0|||
130939052|NCT02169739|471410935|FG001|Overall Study|Lost to Follow-up|4|||
130939053|NCT03635957|471410936|FG000|Run-In Period|Lost to Follow-up|1|||
130939054|NCT03635957|471410936|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
130939055|NCT02489344|471410937|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
130939056|NCT02489344|471410937|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
130939057|NCT02489344|471410937|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
130939058|NCT02489344|471410937|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
130939059|NCT00546637|471410940|FG000|Overall Study|Adverse Event|46|||
130939060|NCT00546637|471410941|FG001|Overall Study|Adverse Event|20|||
130939061|NCT00546637|471410940|FG000|Overall Study|Lack of Efficacy|5|||
130939062|NCT00546637|471410941|FG001|Overall Study|Lack of Efficacy|5|||
130939063|NCT00546637|471410940|FG000|Overall Study|Lost to Follow-up|2|||
130939064|NCT00546637|471410941|FG001|Overall Study|Lost to Follow-up|2|||
130939065|NCT00546637|471410940|FG000|Overall Study|Other|10|||
130939066|NCT00546637|471410941|FG001|Overall Study|Other|12|||
130939067|NCT00546637|471410940|FG000|Overall Study|Withdrawal by Subject|7|||
131122901|NCT01543152|472079668|FG003|Overall Study|Withdrawal by Subject|0|||
131122902|NCT01543152|472079669|FG004|Overall Study|Withdrawal by Subject|0|||
130772057|NCT05052697|470792828|FG008|Substudy A|Not vaccinated|1|||
130939068|NCT00546637|471410941|FG001|Overall Study|Withdrawal by Subject|9|||
130939069|NCT00546637|471410940|FG000|Overall Study|Randomized, but not treated|3|||
130939070|NCT00546637|471410941|FG001|Overall Study|Randomized, but not treated|1|||
130939071|NCT01074450|471410942|FG000|First Intervention|Emesis in Dosing Interval|0|||
130939072|NCT01074450|471410943|FG001|First Intervention|Emesis in Dosing Interval|2|||
130939073|NCT01074450|471410942|FG000|Second Intervention|Protocol Violation|1|||
130939074|NCT01074450|471410943|FG001|Second Intervention|Protocol Violation|0|||
130939075|NCT01074450|471410942|FG000|Second Intervention|Physician Decision|0|||
130939076|NCT01074450|471410943|FG001|Second Intervention|Physician Decision|1|||
130939077|NCT01928329|471410944|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
130939078|NCT01928329|471410945|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
130939079|NCT01928329|471410944|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
130939080|NCT01928329|471410945|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
130939081|NCT01928329|471410944|FG000|Overall Study|Adverse Event|5|||
130939082|NCT01928329|471410945|FG001|Overall Study|Adverse Event|3|||
130939083|NCT01928329|471410944|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
130939084|NCT01928329|471410945|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
130939085|NCT01928329|471410944|FG000|Overall Study|Withdrawal by Subject|1|||
130939086|NCT01928329|471410945|FG001|Overall Study|Withdrawal by Subject|5|||
130939087|NCT01928329|471410944|FG000|Overall Study|Physician Decision|1|||
130939088|NCT01928329|471410945|FG001|Overall Study|Physician Decision|1|||
130705886|NCT02688387|470549570|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705887|NCT02688387|470549571|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705888|NCT02688387|470549572|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705889|NCT02688387|470549573|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130939089|NCT02617511|471410946|FG000|Overall Study|Withdrawal by Subject|1|||
130939090|NCT02617511|471410947|FG001|Overall Study|Withdrawal by Subject|0|||
130939091|NCT02604212|471410950|FG000|Overall Study|Study Terminated by Sponsor|2|||
130939092|NCT02604212|471410951|FG001|Overall Study|Study Terminated by Sponsor|1|||
130939093|NCT02604212|471410952|FG002|Overall Study|Study Terminated by Sponsor|3|||
130939094|NCT02604212|471410953|FG003|Overall Study|Study Terminated by Sponsor|3|||
130939095|NCT02604212|471410950|FG000|Overall Study|Withdrawal by Subject|0|||
130939096|NCT02604212|471410951|FG001|Overall Study|Withdrawal by Subject|0|||
130939097|NCT02604212|471410952|FG002|Overall Study|Withdrawal by Subject|1|||
130939098|NCT02604212|471410953|FG003|Overall Study|Withdrawal by Subject|0|||
130939099|NCT00597766|471410956|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
130939100|NCT00597766|471410957|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
130939101|NCT00597766|471410958|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
130939102|NCT00597766|471410956|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
130939103|NCT00597766|471410957|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
130939104|NCT00597766|471410958|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
130939105|NCT01166763|471410960|FG000|Overall Study|Withdrawal by Subject|3|||
130939106|NCT04339296|471410961|FG000|Overall Study|Refuse to participate after allocation|1|||
130939107|NCT04339296|471410962|FG001|Overall Study|Refuse to participate after allocation|1|||
130939108|NCT04339296|471410961|FG000|Overall Study|Withdrew after completion of baseline|2|||
130939109|NCT04339296|471410962|FG001|Overall Study|Withdrew after completion of baseline|1|||
130939110|NCT04339296|471410961|FG000|Overall Study|Lost to Follow-up|0|||
130939111|NCT04339296|471410962|FG001|Overall Study|Lost to Follow-up|4|||
130939112|NCT04339296|471410961|FG000|Overall Study|Discontinued intervention|5|||
131122919|NCT00383084|472079683|FG000|Overall Study|Withdrawal by Subject|12|||
131122920|NCT00383084|472079684|FG001|Overall Study|Withdrawal by Subject|10|||
130705890|NCT02688387|470549574|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705891|NCT02688387|470549575|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705892|NCT02688387|470549576|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705893|NCT02688387|470549577|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130705894|NCT02688387|470549556|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705895|NCT02688387|470549557|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705896|NCT02688387|470549558|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705897|NCT02688387|470549559|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705898|NCT02688387|470549560|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705899|NCT02688387|470549561|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705900|NCT02688387|470549562|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705901|NCT02688387|470549563|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705902|NCT02688387|470549564|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705903|NCT02688387|470549565|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130772058|NCT05052697|470792829|FG009|Substudy A|Not vaccinated|0|||
130939113|NCT04339296|471410962|FG001|Overall Study|Discontinued intervention|3|||
130939114|NCT03557151|471410966|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
130939115|NCT03557151|471410967|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
130939116|NCT03557151|471410966|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
131122921|NCT00326209|472079685|FG000|Overall Study|Adverse Event|28|||
131122922|NCT00326209|472079685|FG000|Overall Study|Withdrawal by Subject|22|||
130939117|NCT03557151|471410967|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
130939118|NCT03557151|471410966|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
131122923|NCT00326209|472079685|FG000|Overall Study|Lack of Efficacy|31|||
131122924|NCT00326209|472079685|FG000|Overall Study|Lost to Follow-up|18|||
131122925|NCT00326209|472079685|FG000|Overall Study|Participant non-compliant|6|||
130939119|NCT03557151|471410967|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
130939120|NCT01414075|471410968|FG000|Overall Study|Adverse Event|1|||
130939121|NCT01414075|471410969|FG001|Overall Study|Adverse Event|0|||
130939122|NCT01414075|471410970|FG002|Overall Study|Adverse Event|1|||
130939123|NCT01414075|471410971|FG003|Overall Study|Adverse Event|0|||
130939124|NCT01414075|471410968|FG000|Overall Study|Death|1|||
130939125|NCT01414075|471410969|FG001|Overall Study|Death|0|||
130939126|NCT01414075|471410970|FG002|Overall Study|Death|0|||
130939127|NCT01414075|471410971|FG003|Overall Study|Death|1|||
130939128|NCT01414075|471410968|FG000|Overall Study|Withdrawal by Subject|0|||
130939129|NCT01414075|471410969|FG001|Overall Study|Withdrawal by Subject|0|||
130939130|NCT01414075|471410970|FG002|Overall Study|Withdrawal by Subject|0|||
130939131|NCT01414075|471410971|FG003|Overall Study|Withdrawal by Subject|1|||
130939132|NCT01414075|471410968|FG000|Overall Study|Other than specified|1|||
130939133|NCT01414075|471410969|FG001|Overall Study|Other than specified|0|||
130939134|NCT01414075|471410970|FG002|Overall Study|Other than specified|1|||
130939135|NCT01414075|471410971|FG003|Overall Study|Other than specified|0|||
130939136|NCT02810392|471410972|FG000|Overall Study|Subject too ill to continue|1|||
130939137|NCT02810392|471410973|FG001|Overall Study|Subject too ill to continue|0|||
130939138|NCT02810392|471410972|FG000|Overall Study|COVID 19 research restrictions|0|||
130939139|NCT02810392|471410973|FG001|Overall Study|COVID 19 research restrictions|1|||
130939140|NCT01187043|471410974|FG000|Overall Study|Adverse Event|0|||
130939141|NCT01187043|471410975|FG001|Overall Study|Adverse Event|0|||
130939142|NCT01187043|471410976|FG002|Overall Study|Adverse Event|0|||
130939143|NCT01187043|471410977|FG003|Overall Study|Adverse Event|0|||
130939144|NCT01187043|471410978|FG004|Overall Study|Adverse Event|1|||
130939145|NCT01187043|471410974|FG000|Overall Study|Unable to make scheduled visits|1|||
130939146|NCT01187043|471410975|FG001|Overall Study|Unable to make scheduled visits|0|||
130939147|NCT01187043|471410976|FG002|Overall Study|Unable to make scheduled visits|4|||
130939148|NCT01187043|471410977|FG003|Overall Study|Unable to make scheduled visits|0|||
130939149|NCT01187043|471410978|FG004|Overall Study|Unable to make scheduled visits|1|||
130939150|NCT02457910|471410980|FG000|Overall Study|Withdrawal by Subject|0|||
130939151|NCT02457910|471410981|FG001|Overall Study|Withdrawal by Subject|0|||
130939152|NCT02457910|471410982|FG002|Overall Study|Withdrawal by Subject|0|||
130939153|NCT02457910|471410983|FG003|Overall Study|Withdrawal by Subject|0|||
130939154|NCT02457910|471410984|FG004|Overall Study|Withdrawal by Subject|0|||
130939155|NCT02457910|471410985|FG005|Overall Study|Withdrawal by Subject|1|||
130939156|NCT02457910|471410980|FG000|Overall Study|Adverse Event|0|||
130939157|NCT02457910|471410981|FG001|Overall Study|Adverse Event|2|||
130939158|NCT02457910|471410982|FG002|Overall Study|Adverse Event|1|||
130939159|NCT02457910|471410983|FG003|Overall Study|Adverse Event|1|||
130939160|NCT02457910|471410984|FG004|Overall Study|Adverse Event|1|||
131122926|NCT00326209|472079685|FG000|Overall Study|Sponsor closed study|173|||
131122927|NCT00326209|472079685|FG000|Overall Study|Prohibited medication use|1|||
131122928|NCT00326209|472079685|FG000|Overall Study|Violation of entry criteria|1|||
131122929|NCT00326209|472079685|FG000|Overall Study|Withdrawn in error|1|||
131122930|NCT00326209|472079685|FG000|Overall Study|Pregnancy|1|||
131122931|NCT01299376|472079690|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
131122932|NCT01299376|472079691|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
131122933|NCT01299376|472079690|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
131122934|NCT01299376|472079691|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
131122935|NCT01299376|472079690|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
131122936|NCT01299376|472079691|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
131122937|NCT01299376|472079690|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
131122938|NCT01299376|472079691|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
131122939|NCT01299376|472079690|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
131122940|NCT01299376|472079691|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
130772059|NCT05052697|470792830|FG010|Substudy A|Not vaccinated|0|||
130772060|NCT05052697|470792831|FG011|Substudy A|Not vaccinated|0|||
130772061|NCT05052697|470792832|FG012|Substudy A|Not vaccinated|0|||
130939161|NCT02457910|471410985|FG005|Overall Study|Adverse Event|3|||
130939162|NCT02457910|471410980|FG000|Overall Study|Disease progression|3|||
130939163|NCT02457910|471410981|FG001|Overall Study|Disease progression|3|||
130939164|NCT02457910|471410982|FG002|Overall Study|Disease progression|1|||
130939165|NCT02457910|471410983|FG003|Overall Study|Disease progression|1|||
130939166|NCT02457910|471410984|FG004|Overall Study|Disease progression|4|||
130939167|NCT02457910|471410985|FG005|Overall Study|Disease progression|6|||
130939168|NCT02457910|471410980|FG000|Overall Study|Other complicating illness|0|||
130939169|NCT02457910|471410981|FG001|Overall Study|Other complicating illness|0|||
131122941|NCT01299376|472079690|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
131122942|NCT01299376|472079691|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
131122943|NCT01299376|472079690|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
130939170|NCT02457910|471410982|FG002|Overall Study|Other complicating illness|0|||
130939171|NCT02457910|471410983|FG003|Overall Study|Other complicating illness|0|||
131122944|NCT01299376|472079691|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
131122945|NCT01299376|472079690|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
131122946|NCT01299376|472079691|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
131122947|NCT01299376|472079690|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
131122948|NCT01299376|472079691|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
131122949|NCT01299376|472079690|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
131122950|NCT01299376|472079691|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
131122951|NCT01299376|472079690|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
131122952|NCT01299376|472079691|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
131122953|NCT02343159|472079692|FG000|Overall Study|Early Study Termination|16|||
131122954|NCT02343159|472079693|FG001|Overall Study|Early Study Termination|19|||
131122955|NCT02343159|472079694|FG002|Overall Study|Early Study Termination|23|||
131122956|NCT02343159|472079692|FG000|Overall Study|Physician Decision|2|||
131122957|NCT02343159|472079693|FG001|Overall Study|Physician Decision|0|||
131122958|NCT02343159|472079694|FG002|Overall Study|Physician Decision|1|||
131122959|NCT02343159|472079692|FG000|Overall Study|Withdrawal by Subject|3|||
131122960|NCT02343159|472079693|FG001|Overall Study|Withdrawal by Subject|0|||
131122961|NCT02343159|472079694|FG002|Overall Study|Withdrawal by Subject|2|||
131122962|NCT02343159|472079692|FG000|Overall Study|Lost to Follow-up|0|||
131122963|NCT02343159|472079693|FG001|Overall Study|Lost to Follow-up|2|||
131122964|NCT02343159|472079694|FG002|Overall Study|Lost to Follow-up|2|||
131122965|NCT02343159|472079692|FG000|Overall Study|Adverse Event|4|||
131122966|NCT02343159|472079693|FG001|Overall Study|Adverse Event|4|||
131122967|NCT02343159|472079694|FG002|Overall Study|Adverse Event|2|||
131122968|NCT02343159|472079692|FG000|Overall Study|Sponsor Decision|0|||
131122969|NCT02343159|472079693|FG001|Overall Study|Sponsor Decision|1|||
131122970|NCT02343159|472079694|FG002|Overall Study|Sponsor Decision|0|||
131122971|NCT02343159|472079692|FG000|Overall Study|Enrollment Error|1|||
130705904|NCT02688387|470549566|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
130939172|NCT02457910|471410984|FG004|Overall Study|Other complicating illness|0|||
130939173|NCT02457910|471410985|FG005|Overall Study|Other complicating illness|1|||
130939174|NCT02457910|471410980|FG000|Overall Study|Death|0|||
130939175|NCT02457910|471410981|FG001|Overall Study|Death|0|||
130939176|NCT02457910|471410982|FG002|Overall Study|Death|1|||
130939177|NCT02457910|471410983|FG003|Overall Study|Death|0|||
130939178|NCT02457910|471410984|FG004|Overall Study|Death|0|||
130939179|NCT02457910|471410985|FG005|Overall Study|Death|0|||
130939180|NCT00619801|471410986|FG000|Overall Study|Lack of Efficacy|0|||
130939181|NCT00619801|471410987|FG001|Overall Study|Lack of Efficacy|1|||
130939182|NCT00619801|471410986|FG000|Overall Study|Withdrawal by Subject|1|||
130939183|NCT00619801|471410987|FG001|Overall Study|Withdrawal by Subject|1|||
130939184|NCT00619801|471410986|FG000|Overall Study|Loss of efficacy|0|||
130939185|NCT00619801|471410987|FG001|Overall Study|Loss of efficacy|1|||
130939186|NCT01722071|471410989|FG000|Overall Study|Protocol Violation|1|||
130939187|NCT01722071|471410990|FG001|Overall Study|Protocol Violation|0|||
130939188|NCT02062879|471410991|FG000|Overall Study|Withdrawal by Subject|4|||
130939189|NCT02062879|471410992|FG001|Overall Study|Withdrawal by Subject|1|||
130939190|NCT00680043|471410993|FG000|Overall Study|Withdrawal by Subject|1|||
130939191|NCT00680043|471410994|FG001|Overall Study|Withdrawal by Subject|0|||
130939192|NCT00680043|471410995|FG002|Overall Study|Withdrawal by Subject|0|||
130939193|NCT00680043|471410993|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
130939194|NCT00680043|471410994|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
130939195|NCT00680043|471410995|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
130939196|NCT00680043|471410993|FG000|Overall Study|Renal Transplant|1|||
130939197|NCT00680043|471410994|FG001|Overall Study|Renal Transplant|0|||
130939198|NCT00680043|471410995|FG002|Overall Study|Renal Transplant|4|||
130939199|NCT00553150|471410996|FG000|Overall Study|Withdrawal by Subject|0|||
130705905|NCT02688387|470549567|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705906|NCT02688387|470549568|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705907|NCT02688387|470549569|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130939200|NCT00553150|471410997|FG001|Overall Study|Withdrawal by Subject|0|||
130939201|NCT00553150|471410998|FG002|Overall Study|Withdrawal by Subject|0|||
130939202|NCT00553150|471410999|FG003|Overall Study|Withdrawal by Subject|2|||
130939203|NCT00553150|471410996|FG000|Overall Study|Protocol Violation|0|||
130939204|NCT00553150|471410997|FG001|Overall Study|Protocol Violation|0|||
130939205|NCT00553150|471410998|FG002|Overall Study|Protocol Violation|0|||
130939206|NCT00553150|471410999|FG003|Overall Study|Protocol Violation|1|||
130939207|NCT00553150|471410996|FG000|Overall Study|Ineligible|0|||
130939208|NCT00553150|471410997|FG001|Overall Study|Ineligible|0|||
130939209|NCT00553150|471410998|FG002|Overall Study|Ineligible|0|||
130939210|NCT00553150|471410999|FG003|Overall Study|Ineligible|1|||
130939211|NCT00513474|471411003|FG000|Overall Study|Death|6|||
131122972|NCT02343159|472079693|FG001|Overall Study|Enrollment Error|0|||
131122973|NCT02343159|472079694|FG002|Overall Study|Enrollment Error|0|||
131122974|NCT04702737|472079697|FG000|Overall Study|Decision by Sponsor|1|||
130772062|NCT05052697|470792833|FG013|Substudy A|Not vaccinated|0|||
130772063|NCT05052697|470792834|FG014|Substudy A|Not vaccinated|0|||
130772064|NCT05052697|470792835|FG015|Substudy A|Not vaccinated|0|||
130772065|NCT05052697|470792836|FG016|Substudy A|Not vaccinated|0|||
130772066|NCT05052697|470792837|FG017|Substudy A|Not vaccinated|0|||
130772067|NCT05052697|470792838|FG018|Substudy A|Not vaccinated|0|||
130772068|NCT05052697|470792839|FG019|Substudy A|Not vaccinated|0|||
130772069|NCT05052697|470792840|FG020|Substudy A|Not vaccinated|0|||
130772070|NCT05052697|470792841|FG021|Substudy A|Not vaccinated|0|||
130772071|NCT05052697|470792842|FG022|Substudy A|Not vaccinated|0|||
130772072|NCT05052697|470792843|FG023|Substudy A|Not vaccinated|0|||
130772073|NCT05052697|470792844|FG024|Substudy A|Not vaccinated|0|||
130772074|NCT05052697|470792845|FG025|Substudy A|Not vaccinated|0|||
130772075|NCT05052697|470792846|FG026|Substudy A|Not vaccinated|0|||
130772076|NCT05052697|470792847|FG027|Substudy A|Not vaccinated|0|||
130772077|NCT05052697|470792848|FG028|Substudy A|Not vaccinated|0|||
130772078|NCT05052697|470792849|FG029|Substudy A|Not vaccinated|0|||
131036235|NCT02547233|471766280|FG001|12-month Follow-up|Other|1|||
131036236|NCT02489903|471766284|FG000|Screening|Screen Failure|24|||
130705908|NCT02688387|470549570|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705909|NCT02688387|470549571|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705910|NCT02688387|470549572|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705911|NCT02688387|470549573|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705912|NCT02688387|470549574|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705913|NCT02688387|470549575|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705914|NCT02688387|470549576|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705915|NCT02688387|470549577|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130705916|NCT02688387|470549556|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705917|NCT02688387|470549557|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705918|NCT02688387|470549558|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705919|NCT02688387|470549559|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705920|NCT02688387|470549560|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705921|NCT02688387|470549561|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705922|NCT02688387|470549562|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705923|NCT02688387|470549563|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130772079|NCT05052697|470792850|FG030|Substudy A|Not vaccinated|0|||
130772080|NCT05052697|470792851|FG031|Substudy A|Not vaccinated|0|||
130772081|NCT05052697|470792852|FG032|Substudy A|Not vaccinated|0|||
130772082|NCT05052697|470792853|FG033|Substudy A|Not vaccinated|0|||
130772083|NCT05052697|470792820|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130939212|NCT00513474|471411004|FG001|Overall Study|Death|9|||
130939213|NCT00513474|471411003|FG000|Overall Study|Participant Withdrew Consent|1|||
130939214|NCT00513474|471411004|FG001|Overall Study|Participant Withdrew Consent|0|||
130939215|NCT00195676|471411009|FG000|Period O - Open-label Treatment|Adverse Event|82|||
130939216|NCT00195676|471411009|FG000|Period O - Open-label Treatment|Death|6|||
130939217|NCT00195676|471411009|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
130939218|NCT00195676|471411009|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
130939219|NCT00195676|471411009|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
130939220|NCT00195676|471411009|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
130939221|NCT00195676|471411009|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
130939222|NCT00195676|471411009|FG000|Period O - Open-label Treatment|Other reasons|68|||
130939223|NCT00195676|471411009|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
130939224|NCT00195676|471411009|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
130939225|NCT00195676|471411009|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
130939226|NCT00195676|471411009|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
130939227|NCT00195676|471411009|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
130939228|NCT00195676|471411009|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
130939229|NCT00195676|471411009|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
130939230|NCT00195676|471411009|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
130939231|NCT00195676|471411009|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
130939232|NCT00195676|471411009|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
130939233|NCT00195676|471411009|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
130939234|NCT00195676|471411009|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
130939235|NCT00195676|471411009|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
130939236|NCT01189812|471411010|FG000|Overall Study|Withdrawal by Subject|2|||
130939237|NCT01189812|471411011|FG001|Overall Study|Withdrawal by Subject|3|||
130939238|NCT01189812|471411010|FG000|Overall Study|Adverse Event|1|||
130939239|NCT01189812|471411011|FG001|Overall Study|Adverse Event|0|||
130939240|NCT01189812|471411010|FG000|Overall Study|Out of Window|4|||
130939241|NCT01189812|471411011|FG001|Overall Study|Out of Window|3|||
130939242|NCT01189812|471411010|FG000|Overall Study|Moved out of State|1|||
130939243|NCT01189812|471411011|FG001|Overall Study|Moved out of State|2|||
130939244|NCT02953314|471411013|FG000|Overall Study|Adverse Event|0|||
131036237|NCT02489903|471766285|FG001|Screening|Screen Failure|0|||
131036238|NCT02489903|471766286|FG002|Screening|Screen Failure|0|||
131036239|NCT02489903|471766287|FG003|Screening|Screen Failure|8|||
131036240|NCT02489903|471766284|FG000|Randomized and Received Treatment|Protocol Violation|0|||
131036241|NCT02489903|471766285|FG001|Randomized and Received Treatment|Protocol Violation|1|||
131036242|NCT02489903|471766286|FG002|Randomized and Received Treatment|Protocol Violation|0|||
131036243|NCT02489903|471766287|FG003|Randomized and Received Treatment|Protocol Violation|0|||
131036244|NCT02489903|471766284|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
131036245|NCT02489903|471766285|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
131036246|NCT02489903|471766286|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
131036247|NCT02489903|471766287|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
131036248|NCT02489903|471766284|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
131036249|NCT02489903|471766285|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
131036250|NCT02489903|471766286|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
131036251|NCT02489903|471766287|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
131036252|NCT02489903|471766284|FG000|Randomized and Received Treatment|Death|10|||
131036253|NCT02489903|471766285|FG001|Randomized and Received Treatment|Death|1|||
131036254|NCT02489903|471766286|FG002|Randomized and Received Treatment|Death|0|||
131036255|NCT02489903|471766287|FG003|Randomized and Received Treatment|Death|0|||
131036256|NCT05126433|471766288|FG000|Overall Study|Withdrawal by Subject|3|||
131036257|NCT05126433|471766289|FG001|Overall Study|Withdrawal by Subject|0|||
131036258|NCT05126433|471766290|FG002|Overall Study|Withdrawal by Subject|4|||
131122975|NCT04702737|472079697|FG000|Overall Study|Withdrawal of Consent from Study|3|||
131122976|NCT04702737|472079697|FG000|Overall Study|Lost to Follow-up|1|||
131036259|NCT05126433|471766288|FG000|Overall Study|Death|9|||
131036260|NCT05126433|471766289|FG001|Overall Study|Death|3|||
131036261|NCT05126433|471766290|FG002|Overall Study|Death|5|||
131036262|NCT05126433|471766288|FG000|Overall Study|Study Terminated by sponsor|0|||
131036263|NCT05126433|471766289|FG001|Overall Study|Study Terminated by sponsor|1|||
131036264|NCT05126433|471766290|FG002|Overall Study|Study Terminated by sponsor|2|||
131036265|NCT05126433|471766288|FG000|Overall Study|Progressive Disease|1|||
131036266|NCT05126433|471766289|FG001|Overall Study|Progressive Disease|4|||
131036267|NCT05126433|471766290|FG002|Overall Study|Progressive Disease|3|||
131122977|NCT04702737|472079697|FG000|Overall Study|Death|35|||
131122978|NCT03184077|472079698|FG000|Overall Study|Lost to Follow-up|21|||
131122979|NCT03184077|472079699|FG001|Overall Study|Lost to Follow-up|21|||
131122980|NCT00262522|472079702|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
131122981|NCT00262522|472079703|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
131122982|NCT00262522|472079704|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
131122983|NCT00262522|472079705|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
131122984|NCT00262522|472079702|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
131122985|NCT00262522|472079703|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
131122986|NCT00262522|472079704|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
131122987|NCT00262522|472079705|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
131122988|NCT00262522|472079702|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
131122989|NCT00262522|472079703|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
131122990|NCT00262522|472079704|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
131122991|NCT00262522|472079705|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
131122992|NCT00262522|472079702|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
131122993|NCT00262522|472079703|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
131122994|NCT00262522|472079704|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
131122995|NCT00262522|472079705|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
131122996|NCT00262522|472079702|FG000|Study Start Through 8 Weeks|Death|1|||
131122997|NCT00262522|472079703|FG001|Study Start Through 8 Weeks|Death|0|||
131122998|NCT00262522|472079704|FG002|Study Start Through 8 Weeks|Death|0|||
131122999|NCT00262522|472079705|FG003|Study Start Through 8 Weeks|Death|0|||
131036268|NCT05126433|471766288|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
131036269|NCT05126433|471766289|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
131036270|NCT05126433|471766290|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
131036271|NCT04137289|471766291|FG000|Overall Study|Death|0|||
131036272|NCT04137289|471766292|FG001|Overall Study|Death|0|||
130772084|NCT05052697|470792821|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131123000|NCT00262522|472079702|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
131123001|NCT00262522|472079703|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
131123002|NCT00262522|472079704|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
131123003|NCT00262522|472079705|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
131123004|NCT00262522|472079702|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
131036273|NCT04137289|471766293|FG002|Overall Study|Death|0|||
131036274|NCT04137289|471766294|FG003|Overall Study|Death|0|||
131036275|NCT04137289|471766295|FG004|Overall Study|Death|0|||
131036276|NCT04137289|471766296|FG005|Overall Study|Death|0|||
131036277|NCT04137289|471766297|FG006|Overall Study|Death|1|||
131036278|NCT04137289|471766298|FG007|Overall Study|Death|0|||
131036279|NCT04137289|471766299|FG008|Overall Study|Death|0|||
130939245|NCT02953314|471411014|FG001|Overall Study|Adverse Event|1|||
130939246|NCT02953314|471411013|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
130939247|NCT02953314|471411014|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
130939248|NCT00535223|471411015|FG000|Overall Study|Withdrawal by Subject|4|||
130939249|NCT00535223|471411016|FG001|Overall Study|Withdrawal by Subject|1|||
130939250|NCT01765153|471411017|FG000|Training Phase 1|Format of intervention differed|1|||
130939251|NCT01765153|471411018|FG001|Training Phase 1|Format of intervention differed|0|||
131224129|NCT00789828|472447167|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
131224130|NCT00789828|472447166|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
130939252|NCT01765153|471411017|FG000|Training Phase 1|Poor participation in intervention|0|||
130939253|NCT01765153|471411018|FG001|Training Phase 1|Poor participation in intervention|1|||
130939254|NCT01765153|471411017|FG000|Rest Phase 1|Withdrawal by Subject|0|||
130939255|NCT01765153|471411018|FG001|Rest Phase 1|Withdrawal by Subject|1|||
130939256|NCT01765153|471411017|FG000|Training Phase 2|Withdrawal by Subject|0|||
130939257|NCT01765153|471411018|FG001|Training Phase 2|Withdrawal by Subject|1|||
130939258|NCT01765153|471411017|FG000|Rest Phase 2|Lost to Follow-up|2|||
130939259|NCT01765153|471411018|FG001|Rest Phase 2|Lost to Follow-up|1|||
130939260|NCT02554812|471411019|FG000|Overall Study|Adverse Event|2|||
130939261|NCT02554812|471411020|FG001|Overall Study|Adverse Event|5|||
130939262|NCT02554812|471411021|FG002|Overall Study|Adverse Event|3|||
130939263|NCT02554812|471411022|FG003|Overall Study|Adverse Event|0|||
130939264|NCT02554812|471411023|FG004|Overall Study|Adverse Event|5|||
130939265|NCT02554812|471411024|FG005|Overall Study|Adverse Event|0|||
130939266|NCT02554812|471411025|FG006|Overall Study|Adverse Event|1|||
130939267|NCT02554812|471411026|FG007|Overall Study|Adverse Event|6|||
130939268|NCT02554812|471411027|FG008|Overall Study|Adverse Event|2|||
130939269|NCT02554812|471411028|FG009|Overall Study|Adverse Event|2|||
130939270|NCT02554812|471411029|FG010|Overall Study|Adverse Event|1|||
130939271|NCT02554812|471411030|FG011|Overall Study|Adverse Event|2|||
130939272|NCT02554812|471411031|FG012|Overall Study|Adverse Event|0|||
130939273|NCT02554812|471411032|FG013|Overall Study|Adverse Event|3|||
130939274|NCT02554812|471411033|FG014|Overall Study|Adverse Event|2|||
130939275|NCT02554812|471411034|FG015|Overall Study|Adverse Event|1|||
130939276|NCT02554812|471411035|FG016|Overall Study|Adverse Event|0|||
130939277|NCT02554812|471411036|FG017|Overall Study|Adverse Event|1|||
130939278|NCT02554812|471411037|FG018|Overall Study|Adverse Event|0|||
130939279|NCT02554812|471411038|FG019|Overall Study|Adverse Event|0|||
130939280|NCT02554812|471411039|FG020|Overall Study|Adverse Event|0|||
130939281|NCT02554812|471411040|FG021|Overall Study|Adverse Event|2|||
130939282|NCT02554812|471411041|FG022|Overall Study|Adverse Event|1|||
130939283|NCT02554812|471411042|FG023|Overall Study|Adverse Event|1|||
130939284|NCT02554812|471411043|FG024|Overall Study|Adverse Event|1|||
130939285|NCT02554812|471411044|FG025|Overall Study|Adverse Event|2|||
130939286|NCT02554812|471411045|FG026|Overall Study|Adverse Event|1|||
130939287|NCT02554812|471411019|FG000|Overall Study|Death|1|||
130939288|NCT02554812|471411020|FG001|Overall Study|Death|2|||
130939289|NCT02554812|471411021|FG002|Overall Study|Death|2|||
130939290|NCT02554812|471411022|FG003|Overall Study|Death|2|||
130939291|NCT02554812|471411023|FG004|Overall Study|Death|0|||
130939292|NCT02554812|471411024|FG005|Overall Study|Death|1|||
130939293|NCT02554812|471411025|FG006|Overall Study|Death|1|||
130939294|NCT02554812|471411026|FG007|Overall Study|Death|1|||
130939295|NCT02554812|471411027|FG008|Overall Study|Death|0|||
130939296|NCT02554812|471411028|FG009|Overall Study|Death|0|||
130939297|NCT02554812|471411029|FG010|Overall Study|Death|0|||
130939298|NCT02554812|471411030|FG011|Overall Study|Death|0|||
130939299|NCT02554812|471411031|FG012|Overall Study|Death|0|||
130939300|NCT02554812|471411032|FG013|Overall Study|Death|0|||
130939301|NCT02554812|471411033|FG014|Overall Study|Death|1|||
130939302|NCT02554812|471411034|FG015|Overall Study|Death|1|||
130939303|NCT02554812|471411035|FG016|Overall Study|Death|1|||
130939304|NCT02554812|471411036|FG017|Overall Study|Death|0|||
130939305|NCT02554812|471411037|FG018|Overall Study|Death|1|||
130939306|NCT02554812|471411038|FG019|Overall Study|Death|2|||
130939307|NCT02554812|471411039|FG020|Overall Study|Death|0|||
130939308|NCT02554812|471411040|FG021|Overall Study|Death|1|||
131224131|NCT00789828|472447167|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
130939309|NCT02554812|471411041|FG022|Overall Study|Death|1|||
130939310|NCT02554812|471411042|FG023|Overall Study|Death|0|||
130939311|NCT02554812|471411043|FG024|Overall Study|Death|0|||
130939312|NCT02554812|471411044|FG025|Overall Study|Death|0|||
130939313|NCT02554812|471411045|FG026|Overall Study|Death|0|||
130939314|NCT02554812|471411019|FG000|Overall Study|Lost to Follow-up|0|||
130939315|NCT02554812|471411020|FG001|Overall Study|Lost to Follow-up|1|||
130939316|NCT02554812|471411021|FG002|Overall Study|Lost to Follow-up|0|||
130939317|NCT02554812|471411022|FG003|Overall Study|Lost to Follow-up|0|||
130939318|NCT02554812|471411023|FG004|Overall Study|Lost to Follow-up|0|||
130939319|NCT02554812|471411024|FG005|Overall Study|Lost to Follow-up|0|||
130939320|NCT02554812|471411025|FG006|Overall Study|Lost to Follow-up|0|||
130939321|NCT02554812|471411026|FG007|Overall Study|Lost to Follow-up|0|||
130939322|NCT02554812|471411027|FG008|Overall Study|Lost to Follow-up|0|||
130939323|NCT02554812|471411028|FG009|Overall Study|Lost to Follow-up|0|||
130939324|NCT02554812|471411029|FG010|Overall Study|Lost to Follow-up|0|||
130939325|NCT02554812|471411030|FG011|Overall Study|Lost to Follow-up|0|||
130939326|NCT02554812|471411031|FG012|Overall Study|Lost to Follow-up|0|||
130939327|NCT02554812|471411032|FG013|Overall Study|Lost to Follow-up|0|||
130939328|NCT02554812|471411033|FG014|Overall Study|Lost to Follow-up|0|||
130939329|NCT02554812|471411034|FG015|Overall Study|Lost to Follow-up|0|||
130939330|NCT02554812|471411035|FG016|Overall Study|Lost to Follow-up|0|||
130939331|NCT02554812|471411036|FG017|Overall Study|Lost to Follow-up|0|||
130939332|NCT02554812|471411037|FG018|Overall Study|Lost to Follow-up|0|||
130939333|NCT02554812|471411038|FG019|Overall Study|Lost to Follow-up|0|||
130939334|NCT02554812|471411039|FG020|Overall Study|Lost to Follow-up|0|||
130939335|NCT02554812|471411040|FG021|Overall Study|Lost to Follow-up|0|||
130939336|NCT02554812|471411041|FG022|Overall Study|Lost to Follow-up|0|||
130939337|NCT02554812|471411042|FG023|Overall Study|Lost to Follow-up|0|||
130939338|NCT02554812|471411043|FG024|Overall Study|Lost to Follow-up|0|||
130939339|NCT02554812|471411044|FG025|Overall Study|Lost to Follow-up|0|||
130939340|NCT02554812|471411045|FG026|Overall Study|Lost to Follow-up|0|||
130939341|NCT02554812|471411019|FG000|Overall Study|Global deterioration of health status|4|||
130939342|NCT02554812|471411020|FG001|Overall Study|Global deterioration of health status|3|||
130939343|NCT02554812|471411021|FG002|Overall Study|Global deterioration of health status|3|||
130939344|NCT02554812|471411022|FG003|Overall Study|Global deterioration of health status|2|||
130939345|NCT02554812|471411023|FG004|Overall Study|Global deterioration of health status|5|||
130939346|NCT02554812|471411024|FG005|Overall Study|Global deterioration of health status|0|||
130939347|NCT02554812|471411025|FG006|Overall Study|Global deterioration of health status|2|||
130939348|NCT02554812|471411026|FG007|Overall Study|Global deterioration of health status|1|||
130939349|NCT02554812|471411027|FG008|Overall Study|Global deterioration of health status|1|||
130939350|NCT02554812|471411028|FG009|Overall Study|Global deterioration of health status|1|||
130939351|NCT02554812|471411029|FG010|Overall Study|Global deterioration of health status|2|||
130939352|NCT02554812|471411030|FG011|Overall Study|Global deterioration of health status|1|||
130939353|NCT02554812|471411031|FG012|Overall Study|Global deterioration of health status|0|||
130939354|NCT02554812|471411032|FG013|Overall Study|Global deterioration of health status|0|||
130939355|NCT02554812|471411033|FG014|Overall Study|Global deterioration of health status|0|||
130939356|NCT02554812|471411034|FG015|Overall Study|Global deterioration of health status|1|||
130939357|NCT02554812|471411035|FG016|Overall Study|Global deterioration of health status|0|||
130939358|NCT02554812|471411036|FG017|Overall Study|Global deterioration of health status|0|||
130939359|NCT02554812|471411037|FG018|Overall Study|Global deterioration of health status|0|||
130939360|NCT02554812|471411038|FG019|Overall Study|Global deterioration of health status|0|||
130939361|NCT02554812|471411039|FG020|Overall Study|Global deterioration of health status|0|||
130939362|NCT02554812|471411040|FG021|Overall Study|Global deterioration of health status|0|||
130939363|NCT02554812|471411041|FG022|Overall Study|Global deterioration of health status|0|||
130939364|NCT02554812|471411042|FG023|Overall Study|Global deterioration of health status|0|||
130939365|NCT02554812|471411043|FG024|Overall Study|Global deterioration of health status|0|||
130939366|NCT02554812|471411044|FG025|Overall Study|Global deterioration of health status|0|||
130939367|NCT02554812|471411045|FG026|Overall Study|Global deterioration of health status|0|||
130939368|NCT02554812|471411019|FG000|Overall Study|Progressive disease|20|||
130939369|NCT02554812|471411020|FG001|Overall Study|Progressive disease|16|||
130939370|NCT02554812|471411021|FG002|Overall Study|Progressive disease|19|||
130939371|NCT02554812|471411022|FG003|Overall Study|Progressive disease|18|||
130939372|NCT02554812|471411023|FG004|Overall Study|Progressive disease|21|||
130939373|NCT02554812|471411024|FG005|Overall Study|Progressive disease|15|||
130939374|NCT02554812|471411025|FG006|Overall Study|Progressive disease|6|||
130939375|NCT02554812|471411026|FG007|Overall Study|Progressive disease|13|||
130939376|NCT02554812|471411027|FG008|Overall Study|Progressive disease|6|||
130939377|NCT02554812|471411028|FG009|Overall Study|Progressive disease|6|||
130939378|NCT02554812|471411029|FG010|Overall Study|Progressive disease|8|||
130939379|NCT02554812|471411030|FG011|Overall Study|Progressive disease|8|||
130939380|NCT02554812|471411031|FG012|Overall Study|Progressive disease|6|||
130939381|NCT02554812|471411032|FG013|Overall Study|Progressive disease|10|||
130939382|NCT02554812|471411033|FG014|Overall Study|Progressive disease|20|||
130939383|NCT02554812|471411034|FG015|Overall Study|Progressive disease|6|||
130939384|NCT02554812|471411035|FG016|Overall Study|Progressive disease|3|||
130939385|NCT02554812|471411036|FG017|Overall Study|Progressive disease|3|||
130939386|NCT02554812|471411037|FG018|Overall Study|Progressive disease|11|||
130939387|NCT02554812|471411038|FG019|Overall Study|Progressive disease|7|||
130939388|NCT02554812|471411039|FG020|Overall Study|Progressive disease|11|||
130939389|NCT02554812|471411040|FG021|Overall Study|Progressive disease|6|||
130939390|NCT02554812|471411041|FG022|Overall Study|Progressive disease|9|||
130939391|NCT02554812|471411042|FG023|Overall Study|Progressive disease|9|||
130939392|NCT02554812|471411043|FG024|Overall Study|Progressive disease|4|||
130939393|NCT02554812|471411044|FG025|Overall Study|Progressive disease|5|||
130939394|NCT02554812|471411045|FG026|Overall Study|Progressive disease|5|||
130939395|NCT02554812|471411019|FG000|Overall Study|Other|0|||
130939396|NCT02554812|471411020|FG001|Overall Study|Other|0|||
130939397|NCT02554812|471411021|FG002|Overall Study|Other|2|||
131123005|NCT00262522|472079703|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
131123006|NCT00262522|472079704|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
131123007|NCT00262522|472079705|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
131123008|NCT00262522|472079702|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
131123009|NCT00262522|472079703|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
131123010|NCT00262522|472079704|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
131123011|NCT00262522|472079705|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
131123012|NCT00262522|472079702|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
131123013|NCT00262522|472079703|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
131123014|NCT00262522|472079704|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
130705924|NCT02688387|470549564|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705925|NCT02688387|470549565|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705926|NCT02688387|470549566|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705927|NCT02688387|470549567|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705928|NCT02688387|470549568|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130939398|NCT02554812|471411022|FG003|Overall Study|Other|3|||
130939399|NCT02554812|471411023|FG004|Overall Study|Other|2|||
130939400|NCT02554812|471411024|FG005|Overall Study|Other|1|||
130939401|NCT02554812|471411025|FG006|Overall Study|Other|0|||
130939402|NCT02554812|471411026|FG007|Overall Study|Other|0|||
130939403|NCT02554812|471411027|FG008|Overall Study|Other|1|||
131123015|NCT00262522|472079705|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
131123016|NCT00262522|472079702|FG000|Study Start Through 48 Weeks|Death|2|||
131123017|NCT00262522|472079703|FG001|Study Start Through 48 Weeks|Death|0|||
131123018|NCT00262522|472079704|FG002|Study Start Through 48 Weeks|Death|1|||
131123019|NCT00262522|472079705|FG003|Study Start Through 48 Weeks|Death|0|||
131123020|NCT00262522|472079702|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
131123021|NCT00262522|472079703|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
131123022|NCT00262522|472079704|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
131123023|NCT00262522|472079705|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
131123024|NCT00262522|472079702|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
131123025|NCT00262522|472079703|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
131123026|NCT00262522|472079704|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
131123027|NCT00262522|472079705|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
131123028|NCT00262522|472079702|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
131123029|NCT00262522|472079703|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
131123030|NCT00262522|472079704|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
131123031|NCT00262522|472079705|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
131123032|NCT00262522|472079702|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
131123033|NCT00262522|472079703|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
131123034|NCT00262522|472079704|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
131123035|NCT00262522|472079705|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
131123036|NCT00262522|472079702|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
131123037|NCT00262522|472079703|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
131123038|NCT00262522|472079704|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
131123039|NCT00262522|472079705|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
131123040|NCT00262522|472079702|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
131123041|NCT00262522|472079703|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
131123042|NCT00262522|472079704|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
131123043|NCT00262522|472079705|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
131123044|NCT00262522|472079702|FG000|Study Start Through 96 Weeks|Death|2|||
131224132|NCT00789828|472447166|FG000|Open-label Extension Period (4 Years)|Death|1|||
130705929|NCT02688387|470549569|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705930|NCT02688387|470549570|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
130705931|NCT02688387|470549571|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705932|NCT02688387|470549572|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705933|NCT02688387|470549573|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705934|NCT02688387|470549574|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705935|NCT02688387|470549575|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705936|NCT02688387|470549576|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705937|NCT02688387|470549577|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130705938|NCT02688387|470549556|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705939|NCT02688387|470549557|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705940|NCT02688387|470549558|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705941|NCT02688387|470549559|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705942|NCT02688387|470549560|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705943|NCT02688387|470549561|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130939404|NCT02554812|471411028|FG009|Overall Study|Other|1|||
130939405|NCT02554812|471411029|FG010|Overall Study|Other|0|||
130939406|NCT02554812|471411030|FG011|Overall Study|Other|0|||
130939407|NCT02554812|471411031|FG012|Overall Study|Other|1|||
130939408|NCT02554812|471411032|FG013|Overall Study|Other|0|||
130939409|NCT02554812|471411033|FG014|Overall Study|Other|1|||
130939410|NCT02554812|471411034|FG015|Overall Study|Other|0|||
130939411|NCT02554812|471411035|FG016|Overall Study|Other|0|||
130939412|NCT02554812|471411036|FG017|Overall Study|Other|0|||
130939413|NCT02554812|471411037|FG018|Overall Study|Other|0|||
130939414|NCT02554812|471411038|FG019|Overall Study|Other|0|||
130939415|NCT02554812|471411039|FG020|Overall Study|Other|0|||
130939416|NCT02554812|471411040|FG021|Overall Study|Other|2|||
130939417|NCT02554812|471411041|FG022|Overall Study|Other|0|||
130939418|NCT02554812|471411042|FG023|Overall Study|Other|0|||
130939419|NCT02554812|471411043|FG024|Overall Study|Other|0|||
130939420|NCT02554812|471411044|FG025|Overall Study|Other|0|||
130939421|NCT02554812|471411045|FG026|Overall Study|Other|0|||
130939422|NCT02554812|471411019|FG000|Overall Study|Withdrawal by Subject|1|||
130939423|NCT02554812|471411020|FG001|Overall Study|Withdrawal by Subject|0|||
130939424|NCT02554812|471411021|FG002|Overall Study|Withdrawal by Subject|0|||
130939425|NCT02554812|471411022|FG003|Overall Study|Withdrawal by Subject|2|||
130939426|NCT02554812|471411023|FG004|Overall Study|Withdrawal by Subject|2|||
130939427|NCT02554812|471411024|FG005|Overall Study|Withdrawal by Subject|3|||
130939428|NCT02554812|471411025|FG006|Overall Study|Withdrawal by Subject|0|||
130939429|NCT02554812|471411026|FG007|Overall Study|Withdrawal by Subject|0|||
130939430|NCT02554812|471411027|FG008|Overall Study|Withdrawal by Subject|1|||
130939431|NCT02554812|471411028|FG009|Overall Study|Withdrawal by Subject|1|||
130939432|NCT02554812|471411029|FG010|Overall Study|Withdrawal by Subject|0|||
130939433|NCT02554812|471411030|FG011|Overall Study|Withdrawal by Subject|1|||
130939434|NCT02554812|471411031|FG012|Overall Study|Withdrawal by Subject|1|||
130939435|NCT02554812|471411032|FG013|Overall Study|Withdrawal by Subject|1|||
130939436|NCT02554812|471411033|FG014|Overall Study|Withdrawal by Subject|1|||
130939437|NCT02554812|471411034|FG015|Overall Study|Withdrawal by Subject|1|||
130939438|NCT02554812|471411035|FG016|Overall Study|Withdrawal by Subject|3|||
130939439|NCT02554812|471411036|FG017|Overall Study|Withdrawal by Subject|1|||
130939440|NCT02554812|471411037|FG018|Overall Study|Withdrawal by Subject|0|||
130939441|NCT02554812|471411038|FG019|Overall Study|Withdrawal by Subject|2|||
130939442|NCT02554812|471411039|FG020|Overall Study|Withdrawal by Subject|0|||
130939443|NCT02554812|471411040|FG021|Overall Study|Withdrawal by Subject|1|||
130939444|NCT02554812|471411041|FG022|Overall Study|Withdrawal by Subject|0|||
130939445|NCT02554812|471411042|FG023|Overall Study|Withdrawal by Subject|1|||
130939446|NCT02554812|471411043|FG024|Overall Study|Withdrawal by Subject|0|||
130939447|NCT02554812|471411044|FG025|Overall Study|Withdrawal by Subject|0|||
130939448|NCT02554812|471411045|FG026|Overall Study|Withdrawal by Subject|1|||
130939449|NCT02554812|471411019|FG000|Overall Study|Physician Decision|1|||
130939450|NCT02554812|471411020|FG001|Overall Study|Physician Decision|0|||
130939451|NCT02554812|471411021|FG002|Overall Study|Physician Decision|0|||
131123045|NCT00262522|472079703|FG001|Study Start Through 96 Weeks|Death|0|||
130705944|NCT02688387|470549562|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705945|NCT02688387|470549563|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705946|NCT02688387|470549564|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705947|NCT02688387|470549565|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705948|NCT02688387|470549566|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705949|NCT02688387|470549567|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705950|NCT02688387|470549568|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705951|NCT02688387|470549569|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705952|NCT02688387|470549570|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705953|NCT02688387|470549571|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705954|NCT02688387|470549572|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705955|NCT02688387|470549573|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705956|NCT02688387|470549574|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705957|NCT02688387|470549575|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130939452|NCT02554812|471411022|FG003|Overall Study|Physician Decision|1|||
130939453|NCT02554812|471411023|FG004|Overall Study|Physician Decision|0|||
130939454|NCT02554812|471411024|FG005|Overall Study|Physician Decision|1|||
130939455|NCT02554812|471411025|FG006|Overall Study|Physician Decision|0|||
130939456|NCT02554812|471411026|FG007|Overall Study|Physician Decision|0|||
131123046|NCT00262522|472079704|FG002|Study Start Through 96 Weeks|Death|2|||
130939457|NCT02554812|471411027|FG008|Overall Study|Physician Decision|0|||
130939458|NCT02554812|471411028|FG009|Overall Study|Physician Decision|0|||
130939459|NCT02554812|471411029|FG010|Overall Study|Physician Decision|1|||
130939460|NCT02554812|471411030|FG011|Overall Study|Physician Decision|0|||
130939461|NCT02554812|471411031|FG012|Overall Study|Physician Decision|0|||
130939462|NCT02554812|471411032|FG013|Overall Study|Physician Decision|0|||
130939463|NCT02554812|471411033|FG014|Overall Study|Physician Decision|0|||
130939464|NCT02554812|471411034|FG015|Overall Study|Physician Decision|0|||
130939465|NCT02554812|471411035|FG016|Overall Study|Physician Decision|1|||
130939466|NCT02554812|471411036|FG017|Overall Study|Physician Decision|1|||
130705958|NCT02688387|470549576|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
130705959|NCT02688387|470549577|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130705960|NCT02688387|470549556|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705961|NCT02688387|470549557|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705962|NCT02688387|470549558|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705963|NCT02688387|470549559|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705964|NCT02688387|470549560|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705965|NCT02688387|470549561|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705966|NCT02688387|470549562|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705967|NCT02688387|470549563|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705968|NCT02688387|470549564|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705969|NCT02688387|470549565|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705970|NCT02688387|470549566|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705971|NCT02688387|470549567|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705972|NCT02688387|470549568|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705973|NCT02688387|470549569|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705974|NCT02688387|470549570|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705975|NCT02688387|470549571|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705976|NCT02688387|470549572|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705977|NCT02688387|470549573|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705978|NCT02688387|470549574|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
130705979|NCT02688387|470549575|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705980|NCT02688387|470549576|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
130705981|NCT02688387|470549577|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130705982|NCT02688387|470549556|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705983|NCT02688387|470549557|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705984|NCT02688387|470549558|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705985|NCT02688387|470549559|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705986|NCT02688387|470549560|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705987|NCT02688387|470549561|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705988|NCT02688387|470549562|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705989|NCT02688387|470549563|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705990|NCT02688387|470549564|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705991|NCT02688387|470549565|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705992|NCT02688387|470549566|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705993|NCT02688387|470549567|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705994|NCT02688387|470549568|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705995|NCT02688387|470549569|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705996|NCT02688387|470549570|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705997|NCT02688387|470549571|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705998|NCT02688387|470549572|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130705999|NCT02688387|470549573|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130706000|NCT02688387|470549574|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130706001|NCT02688387|470549575|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
130706002|NCT02688387|470549576|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130706003|NCT02688387|470549577|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130706004|NCT01115855|470549580|FG000|Overall Study|Adverse Event|16|||
130706005|NCT01115855|470549581|FG001|Overall Study|Adverse Event|18|||
130706006|NCT01115855|470549580|FG000|Overall Study|Death|6|||
130706007|NCT01115855|470549581|FG001|Overall Study|Death|5|||
130706008|NCT01115855|470549580|FG000|Overall Study|Lab Abnormality|1|||
130939467|NCT02554812|471411037|FG018|Overall Study|Physician Decision|0|||
130939468|NCT02554812|471411038|FG019|Overall Study|Physician Decision|1|||
130939469|NCT02554812|471411039|FG020|Overall Study|Physician Decision|1|||
130939470|NCT02554812|471411040|FG021|Overall Study|Physician Decision|0|||
130706009|NCT01115855|470549581|FG001|Overall Study|Lab Abnormality|1|||
130706010|NCT01115855|470549580|FG000|Overall Study|Protocol Violation|0|||
130706011|NCT01115855|470549581|FG001|Overall Study|Protocol Violation|1|||
130939471|NCT02554812|471411041|FG022|Overall Study|Physician Decision|1|||
130939472|NCT02554812|471411042|FG023|Overall Study|Physician Decision|0|||
130939473|NCT02554812|471411043|FG024|Overall Study|Physician Decision|0|||
130706012|NCT01115855|470549580|FG000|Overall Study|Withdrawal by Subject|5|||
130706013|NCT01115855|470549581|FG001|Overall Study|Withdrawal by Subject|5|||
130706014|NCT01115855|470549580|FG000|Overall Study|Other|8|||
130706015|NCT01115855|470549581|FG001|Overall Study|Other|6|||
130706016|NCT02284347|470549582|FG000|Overall Study|Lost to Follow-up|2|||
130706017|NCT02284347|470549582|FG000|Overall Study|Withdrawn prior to treatment|1|||
130706018|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
130706019|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
130939474|NCT02554812|471411044|FG025|Overall Study|Physician Decision|0|||
130939475|NCT02554812|471411045|FG026|Overall Study|Physician Decision|0|||
130939476|NCT02554812|471411019|FG000|Overall Study|Study terminated by sponsor|0|||
130939477|NCT02554812|471411020|FG001|Overall Study|Study terminated by sponsor|0|||
130939478|NCT02554812|471411021|FG002|Overall Study|Study terminated by sponsor|0|||
130939479|NCT02554812|471411022|FG003|Overall Study|Study terminated by sponsor|0|||
130939480|NCT02554812|471411023|FG004|Overall Study|Study terminated by sponsor|0|||
130939481|NCT02554812|471411024|FG005|Overall Study|Study terminated by sponsor|0|||
130939482|NCT02554812|471411025|FG006|Overall Study|Study terminated by sponsor|0|||
130939483|NCT02554812|471411026|FG007|Overall Study|Study terminated by sponsor|0|||
130939484|NCT02554812|471411027|FG008|Overall Study|Study terminated by sponsor|0|||
130939485|NCT02554812|471411028|FG009|Overall Study|Study terminated by sponsor|0|||
130939486|NCT02554812|471411029|FG010|Overall Study|Study terminated by sponsor|0|||
130939487|NCT02554812|471411030|FG011|Overall Study|Study terminated by sponsor|0|||
130939488|NCT02554812|471411031|FG012|Overall Study|Study terminated by sponsor|0|||
130939489|NCT02554812|471411032|FG013|Overall Study|Study terminated by sponsor|0|||
130939490|NCT02554812|471411033|FG014|Overall Study|Study terminated by sponsor|0|||
130939491|NCT02554812|471411034|FG015|Overall Study|Study terminated by sponsor|0|||
130939492|NCT02554812|471411035|FG016|Overall Study|Study terminated by sponsor|0|||
130939493|NCT02554812|471411036|FG017|Overall Study|Study terminated by sponsor|0|||
130939494|NCT02554812|471411037|FG018|Overall Study|Study terminated by sponsor|0|||
130939495|NCT02554812|471411038|FG019|Overall Study|Study terminated by sponsor|0|||
130939496|NCT02554812|471411039|FG020|Overall Study|Study terminated by sponsor|0|||
130939497|NCT02554812|471411040|FG021|Overall Study|Study terminated by sponsor|0|||
130939498|NCT02554812|471411041|FG022|Overall Study|Study terminated by sponsor|0|||
130939499|NCT02554812|471411042|FG023|Overall Study|Study terminated by sponsor|0|||
130939500|NCT02554812|471411043|FG024|Overall Study|Study terminated by sponsor|1|||
130939501|NCT02554812|471411044|FG025|Overall Study|Study terminated by sponsor|0|||
130939502|NCT02554812|471411045|FG026|Overall Study|Study terminated by sponsor|0|||
130939503|NCT02554812|471411019|FG000|Overall Study|No longer meets eligibility criteria|0|||
130939504|NCT02554812|471411020|FG001|Overall Study|No longer meets eligibility criteria|1|||
130939505|NCT02554812|471411021|FG002|Overall Study|No longer meets eligibility criteria|0|||
130939506|NCT02554812|471411022|FG003|Overall Study|No longer meets eligibility criteria|0|||
130939507|NCT02554812|471411023|FG004|Overall Study|No longer meets eligibility criteria|0|||
130939508|NCT02554812|471411024|FG005|Overall Study|No longer meets eligibility criteria|0|||
130939509|NCT02554812|471411025|FG006|Overall Study|No longer meets eligibility criteria|0|||
130939510|NCT02554812|471411026|FG007|Overall Study|No longer meets eligibility criteria|0|||
130939511|NCT02554812|471411027|FG008|Overall Study|No longer meets eligibility criteria|0|||
130939512|NCT02554812|471411028|FG009|Overall Study|No longer meets eligibility criteria|0|||
130939513|NCT02554812|471411029|FG010|Overall Study|No longer meets eligibility criteria|0|||
130939514|NCT02554812|471411030|FG011|Overall Study|No longer meets eligibility criteria|0|||
130939515|NCT02554812|471411031|FG012|Overall Study|No longer meets eligibility criteria|0|||
130939516|NCT02554812|471411032|FG013|Overall Study|No longer meets eligibility criteria|0|||
130939517|NCT02554812|471411033|FG014|Overall Study|No longer meets eligibility criteria|0|||
130939518|NCT02554812|471411034|FG015|Overall Study|No longer meets eligibility criteria|0|||
130939519|NCT02554812|471411035|FG016|Overall Study|No longer meets eligibility criteria|0|||
130939520|NCT02554812|471411036|FG017|Overall Study|No longer meets eligibility criteria|0|||
130939521|NCT02554812|471411037|FG018|Overall Study|No longer meets eligibility criteria|0|||
130706020|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
130706021|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
130706022|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
130706023|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
130706024|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
130939522|NCT02554812|471411038|FG019|Overall Study|No longer meets eligibility criteria|0|||
130939523|NCT02554812|471411039|FG020|Overall Study|No longer meets eligibility criteria|0|||
130939524|NCT02554812|471411040|FG021|Overall Study|No longer meets eligibility criteria|0|||
130939525|NCT02554812|471411041|FG022|Overall Study|No longer meets eligibility criteria|0|||
130939526|NCT02554812|471411042|FG023|Overall Study|No longer meets eligibility criteria|0|||
130939527|NCT02554812|471411043|FG024|Overall Study|No longer meets eligibility criteria|0|||
130939528|NCT02554812|471411044|FG025|Overall Study|No longer meets eligibility criteria|0|||
130939529|NCT02554812|471411045|FG026|Overall Study|No longer meets eligibility criteria|0|||
130939530|NCT01485640|471412814|FG000|Overall Study|Adverse Event|10|||
130939531|NCT01485640|471412814|FG000|Overall Study|Lack of Efficacy|2|||
130939532|NCT01485640|471412814|FG000|Overall Study|Protocol Violation|1|||
130939533|NCT01485640|471412814|FG000|Overall Study|Withdrawal by Subject|14|||
130939534|NCT01485640|471412814|FG000|Overall Study|Terminated by Sponsor|95|||
130706025|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
130706026|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
130706027|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
130939535|NCT02355691|471412819|FG000|Overall Study|Loss of Research Personnel|7|||
130939536|NCT02355691|471412820|FG001|Overall Study|Loss of Research Personnel|9|||
130939537|NCT00462761|471412824|FG000|Overall Study|Adverse Event|6|||
130939538|NCT00462761|471412824|FG000|Overall Study|Withdrawal by Subject|9|||
130939539|NCT00462761|471412824|FG000|Overall Study|Physician Decision|5|||
130939540|NCT00462761|471412824|FG000|Overall Study|Disease progression|43|||
130939541|NCT00462761|471412824|FG000|Overall Study|Death|12|||
130939542|NCT00462761|471412824|FG000|Overall Study|Other|1|||
130939543|NCT02345811|471412825|FG000|First Intervention|Withdrawal by Subject|1|||
130939544|NCT02345811|471412826|FG001|First Intervention|Withdrawal by Subject|1|||
130939545|NCT02877082|471412827|FG000|Overall Study|Trial was closed early|5|||
130939546|NCT02522286|471412828|FG000|Overall Study|Withdrawal by Subject|3|||
130939547|NCT02522286|471412829|FG001|Overall Study|Withdrawal by Subject|0|||
130939548|NCT02522286|471412830|FG002|Overall Study|Withdrawal by Subject|0|||
130939549|NCT02522286|471412831|FG003|Overall Study|Withdrawal by Subject|3|||
130939550|NCT03480750|471412832|FG000|Overall Study|Withdrawal by Subject|0|||
130939551|NCT03480750|471412833|FG001|Overall Study|Withdrawal by Subject|1|||
130939552|NCT03480750|471412834|FG002|Overall Study|Withdrawal by Subject|0|||
130939553|NCT03480750|471412835|FG003|Overall Study|Withdrawal by Subject|0|||
130939554|NCT03480750|471412836|FG004|Overall Study|Withdrawal by Subject|0|||
130939555|NCT03480750|471412837|FG005|Overall Study|Withdrawal by Subject|0|||
130939556|NCT03480750|471412832|FG000|Overall Study|The interruption in Trientine shippment|0|||
130939557|NCT03480750|471412833|FG001|Overall Study|The interruption in Trientine shippment|0|||
130939558|NCT03480750|471412834|FG002|Overall Study|The interruption in Trientine shippment|0|||
130939559|NCT03480750|471412835|FG003|Overall Study|The interruption in Trientine shippment|0|||
130939560|NCT03480750|471412836|FG004|Overall Study|The interruption in Trientine shippment|0|||
130939561|NCT03480750|471412837|FG005|Overall Study|The interruption in Trientine shippment|1|||
130939562|NCT00605813|471412838|FG000|Overall Study|Protocol Violation|25|||
130939563|NCT01132482|471412839|FG000|Overall Study|Adverse Event|1|||
130939564|NCT01132482|471412840|FG001|Overall Study|Adverse Event|0|||
130939565|NCT00174915|471412845|FG000|Overall Study|Lost to Follow-up|19|||
130939566|NCT00174915|471412846|FG001|Overall Study|Lost to Follow-up|17|||
130939567|NCT00174915|471412847|FG002|Overall Study|Lost to Follow-up|9|||
130939568|NCT00174915|471412848|FG003|Overall Study|Lost to Follow-up|17|||
130939569|NCT00174915|471412849|FG004|Overall Study|Lost to Follow-up|10|||
130939570|NCT00174915|471412845|FG000|Overall Study|Adverse Event|18|||
130939571|NCT00174915|471412846|FG001|Overall Study|Adverse Event|16|||
130939572|NCT00174915|471412847|FG002|Overall Study|Adverse Event|11|||
130939573|NCT00174915|471412848|FG003|Overall Study|Adverse Event|18|||
130939574|NCT00174915|471412849|FG004|Overall Study|Adverse Event|5|||
130939575|NCT00174915|471412845|FG000|Overall Study|Personal Reason(s)|16|||
130939576|NCT00174915|471412846|FG001|Overall Study|Personal Reason(s)|16|||
130939577|NCT00174915|471412847|FG002|Overall Study|Personal Reason(s)|9|||
130939578|NCT00174915|471412848|FG003|Overall Study|Personal Reason(s)|9|||
130939579|NCT00174915|471412849|FG004|Overall Study|Personal Reason(s)|9|||
130939580|NCT00174915|471412845|FG000|Overall Study|Other|15|||
131123047|NCT00262522|472079705|FG003|Study Start Through 96 Weeks|Death|0|||
131123048|NCT00262522|472079702|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
131123049|NCT00262522|472079703|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
131123050|NCT00262522|472079704|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
131123051|NCT00262522|472079705|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
131123052|NCT00262522|472079702|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
131123053|NCT00262522|472079703|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
131123054|NCT00262522|472079704|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
131123055|NCT00262522|472079705|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
131123056|NCT03159091|472079706|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
131123057|NCT03159091|472079707|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
131123058|NCT03159091|472079706|FG000|Overall Study|Patient has taken no dose of study drug|0|||
131123059|NCT03159091|472079707|FG001|Overall Study|Patient has taken no dose of study drug|1|||
131123060|NCT04814823|472079708|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
130939581|NCT00174915|471412846|FG001|Overall Study|Other|8|||
130939582|NCT00174915|471412847|FG002|Overall Study|Other|6|||
130939583|NCT00174915|471412848|FG003|Overall Study|Other|5|||
130939584|NCT00174915|471412849|FG004|Overall Study|Other|3|||
130939585|NCT00174915|471412845|FG000|Overall Study|Gout Flare|13|||
130939586|NCT00174915|471412846|FG001|Overall Study|Gout Flare|6|||
130706028|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
130939587|NCT00174915|471412847|FG002|Overall Study|Gout Flare|8|||
130939588|NCT00174915|471412848|FG003|Overall Study|Gout Flare|1|||
130939589|NCT00174915|471412849|FG004|Overall Study|Gout Flare|0|||
130939590|NCT00174915|471412845|FG000|Overall Study|Protocol Violation|6|||
130939591|NCT00174915|471412846|FG001|Overall Study|Protocol Violation|3|||
130939592|NCT00174915|471412847|FG002|Overall Study|Protocol Violation|3|||
130939593|NCT00174915|471412848|FG003|Overall Study|Protocol Violation|6|||
130939594|NCT00174915|471412849|FG004|Overall Study|Protocol Violation|3|||
130772085|NCT05052697|470792822|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772086|NCT05052697|470792823|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772087|NCT05052697|470792824|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772088|NCT05052697|470792825|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772089|NCT05052697|470792826|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772090|NCT05052697|470792827|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772091|NCT05052697|470792828|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772092|NCT05052697|470792829|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772093|NCT05052697|470792830|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772094|NCT05052697|470792831|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772095|NCT05052697|470792832|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772096|NCT05052697|470792833|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772097|NCT05052697|470792834|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772098|NCT05052697|470792835|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772099|NCT05052697|470792836|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772100|NCT05052697|470792837|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772101|NCT05052697|470792838|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
130772102|NCT05052697|470792839|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
130772103|NCT05052697|470792840|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772104|NCT05052697|470792841|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
130772105|NCT05052697|470792842|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
130772106|NCT05052697|470792843|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130939595|NCT00174915|471412845|FG000|Overall Study|Therapeutic Failure|6|||
130939596|NCT00174915|471412846|FG001|Overall Study|Therapeutic Failure|3|||
130939597|NCT00174915|471412847|FG002|Overall Study|Therapeutic Failure|2|||
130939598|NCT00174915|471412848|FG003|Overall Study|Therapeutic Failure|1|||
130939599|NCT00174915|471412849|FG004|Overall Study|Therapeutic Failure|3|||
130939600|NCT03060447|471412854|FG000|Overall Study|Withdrawal by Subject|2|||
130939601|NCT03060447|471412855|FG001|Overall Study|Withdrawal by Subject|0|||
130939602|NCT00573755|471412856|FG000|Overall Study|Still receiving treatment|1|||
130939603|NCT00573755|471412857|FG001|Overall Study|Still receiving treatment|0|||
130939604|NCT03274440|471412861|FG000|Overall Study|Time commitment too great|1|||
130939605|NCT03274440|471412862|FG001|Overall Study|Time commitment too great|0|||
130939606|NCT03274440|471412863|FG002|Overall Study|Time commitment too great|0|||
130939607|NCT03274440|471412864|FG003|Overall Study|Time commitment too great|1|||
130939608|NCT03274440|471412865|FG004|Overall Study|Time commitment too great|0|||
130939609|NCT03274440|471412866|FG005|Overall Study|Time commitment too great|0|||
130939610|NCT00450450|471412867|FG000|Overall Study|Death|1|||
130939611|NCT00450450|471412868|FG001|Overall Study|Death|3|||
130939612|NCT00450450|471412867|FG000|Overall Study|Relapse|2|||
130939613|NCT00450450|471412868|FG001|Overall Study|Relapse|0|||
130939614|NCT00450450|471412867|FG000|Overall Study|Missing Data|2|||
130939615|NCT00450450|471412868|FG001|Overall Study|Missing Data|0|||
130939616|NCT04984993|471412869|FG000|Overall Study|Withdrawal by Subject|8|||
130939617|NCT04984993|471412870|FG001|Overall Study|Withdrawal by Subject|2|||
130939618|NCT04984993|471412869|FG000|Overall Study|Lost to Follow-up|2|||
130939619|NCT04984993|471412870|FG001|Overall Study|Lost to Follow-up|2|||
130939620|NCT04984993|471412869|FG000|Overall Study|Both patients moved to another country|4|||
130939621|NCT04984993|471412870|FG001|Overall Study|Both patients moved to another country|0|||
130939622|NCT02865187|471412871|FG000|Overall Study|Lost to Follow-up|12|||
130939623|NCT02865187|471412872|FG001|Overall Study|Lost to Follow-up|7|||
130939624|NCT02865187|471412871|FG000|Overall Study|Adverse Event|1|||
130939625|NCT02865187|471412872|FG001|Overall Study|Adverse Event|0|||
130939626|NCT01110707|471412873|FG000|Overall Study|Protocol Violation|0|||
130939627|NCT01110707|471412874|FG001|Overall Study|Protocol Violation|3|||
130939628|NCT02710045|471412879|FG000|Overall Study|Death|1|||
131123065|NCT03740165|472079711|FG000|Overall Study|Death|232|||
131123066|NCT03740165|472079712|FG001|Overall Study|Death|242|||
131123067|NCT03740165|472079713|FG002|Overall Study|Death|229|||
131123068|NCT03740165|472079711|FG000|Overall Study|Lost to Follow-up|0|||
131123069|NCT03740165|472079712|FG001|Overall Study|Lost to Follow-up|0|||
131123070|NCT03740165|472079713|FG002|Overall Study|Lost to Follow-up|1|||
131123071|NCT03740165|472079711|FG000|Overall Study|Withdrawal by Subject|7|||
130772107|NCT05052697|470792844|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
131123072|NCT03740165|472079712|FG001|Overall Study|Withdrawal by Subject|4|||
130939629|NCT02710045|471412880|FG001|Overall Study|Death|2|||
130939630|NCT02710045|471412881|FG002|Overall Study|Death|0|||
130939631|NCT02710045|471412879|FG000|Overall Study|Withdrawal by Subject|6|||
130939632|NCT02710045|471412880|FG001|Overall Study|Withdrawal by Subject|6|||
130939633|NCT02710045|471412881|FG002|Overall Study|Withdrawal by Subject|2|||
130939634|NCT02710045|471412879|FG000|Overall Study|Protocol Violation|1|||
130939635|NCT02710045|471412880|FG001|Overall Study|Protocol Violation|2|||
130939636|NCT02710045|471412881|FG002|Overall Study|Protocol Violation|3|||
130939637|NCT02710045|471412879|FG000|Overall Study|Lost to Follow-up|3|||
130939638|NCT02710045|471412880|FG001|Overall Study|Lost to Follow-up|6|||
130706029|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
130706030|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
130706031|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
130706032|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
130706033|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
130706034|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
130706035|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
130706036|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
130706037|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
130706038|NCT02960438|470549584|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
130706039|NCT02960438|470549585|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
130706040|NCT02960438|470549586|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
130706041|NCT02960438|470549587|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
130706042|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
130706043|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
130706044|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
130706045|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
130706046|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
130706047|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
130706048|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
130706049|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
130706050|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
130706051|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
130706052|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
130706053|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
130706054|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
130706055|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
130706056|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
130706057|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
130706058|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
130706059|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
130706060|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
130706061|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
130706062|NCT02960438|470549584|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
130706063|NCT02960438|470549585|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
130706064|NCT02960438|470549586|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
130706065|NCT02960438|470549587|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
130706066|NCT01647711|470549588|FG000|Overall Study|Progressive disease|6|||
130706067|NCT01647711|470549589|FG001|Overall Study|Progressive disease|2|||
130706068|NCT01647711|470549590|FG002|Overall Study|Progressive disease|6|||
130706069|NCT01647711|470549591|FG003|Overall Study|Progressive disease|8|||
130706070|NCT01647711|470549592|FG004|Overall Study|Progressive disease|2|||
130706071|NCT01647711|470549588|FG000|Overall Study|Other adverse event|0|||
130706072|NCT01647711|470549589|FG001|Overall Study|Other adverse event|0|||
130706073|NCT01647711|470549590|FG002|Overall Study|Other adverse event|2|||
130706074|NCT01647711|470549591|FG003|Overall Study|Other adverse event|0|||
130706075|NCT01647711|470549592|FG004|Overall Study|Other adverse event|2|||
130706076|NCT01647711|470549588|FG000|Overall Study|Protocol Violation|0|||
130706077|NCT01647711|470549589|FG001|Overall Study|Protocol Violation|0|||
130706078|NCT01647711|470549590|FG002|Overall Study|Protocol Violation|0|||
130706079|NCT01647711|470549591|FG003|Overall Study|Protocol Violation|0|||
130706080|NCT01647711|470549592|FG004|Overall Study|Protocol Violation|1|||
130706081|NCT01647711|470549588|FG000|Overall Study|Refused to continue taking medication|0|||
130706082|NCT01647711|470549589|FG001|Overall Study|Refused to continue taking medication|0|||
130706083|NCT01647711|470549590|FG002|Overall Study|Refused to continue taking medication|0|||
130706084|NCT01647711|470549591|FG003|Overall Study|Refused to continue taking medication|2|||
130706085|NCT01647711|470549592|FG004|Overall Study|Refused to continue taking medication|1|||
130706086|NCT01647711|470549588|FG000|Overall Study|Other reason not defined|0|||
130706087|NCT01647711|470549589|FG001|Overall Study|Other reason not defined|1|||
130706088|NCT01647711|470549590|FG002|Overall Study|Other reason not defined|1|||
130706089|NCT01647711|470549591|FG003|Overall Study|Other reason not defined|1|||
130706090|NCT01647711|470549592|FG004|Overall Study|Other reason not defined|0|||
131036280|NCT04137289|471766291|FG000|Overall Study|Clinical disease progression|0|||
130706091|NCT00754013|470549597|FG000|Overall Study|Lost to Follow-up|1|||
130772108|NCT05052697|470792845|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130706092|NCT00754013|470549598|FG001|Overall Study|Lost to Follow-up|1|||
130706093|NCT00754013|470549597|FG000|Overall Study|didn't return after study termed|3|||
131036281|NCT04137289|471766292|FG001|Overall Study|Clinical disease progression|0|||
131036282|NCT04137289|471766293|FG002|Overall Study|Clinical disease progression|0|||
130706094|NCT00754013|470549598|FG001|Overall Study|didn't return after study termed|4|||
130706095|NCT04039919|470549599|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130706096|NCT04039919|470549600|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130706097|NCT04039919|470549601|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130706098|NCT04039919|470549602|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130706099|NCT04039919|470549603|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130706100|NCT04039919|470549599|FG000|Treatment Period 1|Sponsor's decision|0|||
130706101|NCT04039919|470549600|FG001|Treatment Period 1|Sponsor's decision|0|||
130706102|NCT04039919|470549601|FG002|Treatment Period 1|Sponsor's decision|0|||
130706103|NCT04039919|470549602|FG003|Treatment Period 1|Sponsor's decision|0|||
130706104|NCT04039919|470549603|FG004|Treatment Period 1|Sponsor's decision|16|||
130706105|NCT04039919|470549599|FG000|Treatment Period 5|Withdrawal by Subject|1|||
130706106|NCT04039919|470549600|FG001|Treatment Period 5|Withdrawal by Subject|0|||
130706107|NCT04039919|470549601|FG002|Treatment Period 5|Withdrawal by Subject|0|||
130706108|NCT04039919|470549602|FG003|Treatment Period 5|Withdrawal by Subject|0|||
130706109|NCT04039919|470549603|FG004|Treatment Period 5|Withdrawal by Subject|0|||
130706110|NCT00983918|470549604|FG000|Overall Study|conversion to open cholecystectomy|0|||
130706111|NCT00983918|470549605|FG001|Overall Study|conversion to open cholecystectomy|2|||
130706112|NCT00983918|470549606|FG002|Overall Study|conversion to open cholecystectomy|2|||
130706113|NCT00983918|470549607|FG003|Overall Study|conversion to open cholecystectomy|2|||
130706114|NCT00794417|470549617|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
130706115|NCT00794417|470549618|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
130706116|NCT00794417|470549619|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
130706117|NCT00794417|470549620|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
130706118|NCT00794417|470549617|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
130706119|NCT00794417|470549618|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
130706120|NCT00794417|470549619|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
130706121|NCT00794417|470549620|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
130706122|NCT00794417|470549617|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
130706123|NCT00794417|470549618|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
130706124|NCT00794417|470549619|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
130706125|NCT00794417|470549620|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
130706126|NCT00794417|470549617|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
130706127|NCT00794417|470549618|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
130706128|NCT00794417|470549619|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
130706129|NCT00794417|470549620|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
130706130|NCT00794417|470549617|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
130706131|NCT00794417|470549618|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
130706132|NCT00794417|470549619|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
130706133|NCT00794417|470549620|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
130706134|NCT00794417|470549617|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
130706135|NCT00794417|470549618|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
130706136|NCT00794417|470549619|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
130706137|NCT00794417|470549620|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
130706138|NCT00804141|470549623|FG000|Overall Study|Adverse Event|157|||
130706139|NCT00804141|470549623|FG000|Overall Study|Death|4|||
130706140|NCT00804141|470549623|FG000|Overall Study|Failed to return|96|||
130706141|NCT00804141|470549623|FG000|Overall Study|Investigator request|8|||
130706142|NCT00804141|470549623|FG000|Overall Study|Protocol Violation|85|||
130706143|NCT00804141|470549623|FG000|Overall Study|Withdrawal by Subject|131|||
130706144|NCT00804141|470549623|FG000|Overall Study|Lack of Efficacy|46|||
130706145|NCT00804141|470549623|FG000|Overall Study|Other than specified|30|||
130706146|NCT00804141|470549623|FG000|Overall Study|Enrolled but not treated|6|||
130706147|NCT00572039|470549624|FG000|Overall Study|Withdrawal by Subject|9|||
130706148|NCT00572039|470549625|FG001|Overall Study|Withdrawal by Subject|6|||
130706149|NCT00572039|470549624|FG000|Overall Study|Death|2|||
130706150|NCT00572039|470549625|FG001|Overall Study|Death|3|||
130706151|NCT00572039|470549624|FG000|Overall Study|Ill|5|||
130706152|NCT00572039|470549625|FG001|Overall Study|Ill|1|||
130706153|NCT02973321|470549628|FG000|Overall Study|Other than specified|0|||
130706154|NCT02973321|470549629|FG001|Overall Study|Other than specified|5|||
130706155|NCT02973321|470549630|FG002|Overall Study|Other than specified|3|||
130706156|NCT02973321|470549631|FG003|Overall Study|Other than specified|3|||
130706157|NCT02973321|470549632|FG004|Overall Study|Other than specified|1|||
130706158|NCT02973321|470549628|FG000|Overall Study|Lack of Efficacy|0|||
130706159|NCT02973321|470549629|FG001|Overall Study|Lack of Efficacy|0|||
130706160|NCT02973321|470549630|FG002|Overall Study|Lack of Efficacy|0|||
130706161|NCT02973321|470549631|FG003|Overall Study|Lack of Efficacy|0|||
130706162|NCT02973321|470549632|FG004|Overall Study|Lack of Efficacy|1|||
130706163|NCT02973321|470549628|FG000|Overall Study|Adverse Event|1|||
130706164|NCT02973321|470549629|FG001|Overall Study|Adverse Event|10|||
130706165|NCT02973321|470549630|FG002|Overall Study|Adverse Event|11|||
131036283|NCT04137289|471766294|FG003|Overall Study|Clinical disease progression|4|||
131224133|NCT00789828|472447167|FG001|Open-label Extension Period (4 Years)|Death|0|||
130939639|NCT02710045|471412881|FG002|Overall Study|Lost to Follow-up|7|||
130939640|NCT02710045|471412879|FG000|Overall Study|Physician Decision|0|||
130939641|NCT02710045|471412880|FG001|Overall Study|Physician Decision|0|||
130939642|NCT02710045|471412881|FG002|Overall Study|Physician Decision|1|||
130939643|NCT02710045|471412879|FG000|Overall Study|Poor Attendance|0|||
130939644|NCT02710045|471412880|FG001|Overall Study|Poor Attendance|1|||
130939645|NCT02710045|471412881|FG002|Overall Study|Poor Attendance|0|||
130939646|NCT01275833|471412882|FG000|Overall Study|Study terminated|1|||
131036284|NCT04137289|471766295|FG004|Overall Study|Clinical disease progression|4|||
130939647|NCT01275833|471412883|FG001|Overall Study|Study terminated|1|||
130939648|NCT02733991|471412884|FG000|Overall Study|Adverse Event|1|||
130939649|NCT02733991|471412885|FG001|Overall Study|Adverse Event|0|||
130939650|NCT02733991|471412884|FG000|Overall Study|Withdrawal by Subject|0|||
130939651|NCT02733991|471412885|FG001|Overall Study|Withdrawal by Subject|5|||
130939652|NCT04191499|471412886|FG000|Overall Study|Adverse Event|1|||
130939653|NCT04191499|471412887|FG001|Overall Study|Adverse Event|0|||
130939654|NCT04191499|471412886|FG000|Overall Study|Death|42|||
130939655|NCT04191499|471412887|FG001|Overall Study|Death|55|||
130939656|NCT04191499|471412886|FG000|Overall Study|Lost to Follow-up|4|||
130939657|NCT04191499|471412887|FG001|Overall Study|Lost to Follow-up|1|||
130939658|NCT04191499|471412886|FG000|Overall Study|Physician Decision|1|||
130939659|NCT04191499|471412887|FG001|Overall Study|Physician Decision|0|||
130939660|NCT04191499|471412886|FG000|Overall Study|Progressive Disease|1|||
130939661|NCT04191499|471412887|FG001|Overall Study|Progressive Disease|0|||
130939662|NCT04191499|471412886|FG000|Overall Study|Symptomatic Deterioration|1|||
130939663|NCT04191499|471412887|FG001|Overall Study|Symptomatic Deterioration|0|||
130939664|NCT04191499|471412886|FG000|Overall Study|Withdrawal by Subject|7|||
130939665|NCT04191499|471412887|FG001|Overall Study|Withdrawal by Subject|11|||
130939666|NCT04191499|471412886|FG000|Overall Study|Ongoing in the study|104|||
130939667|NCT04191499|471412887|FG001|Overall Study|Ongoing in the study|97|||
130939668|NCT00680745|471412888|FG000|Overall Study|Withdrawal by Subject|8|||
130939669|NCT00680745|471412889|FG001|Overall Study|Withdrawal by Subject|3|||
130939670|NCT00680745|471412890|FG002|Overall Study|Withdrawal by Subject|2|||
130939671|NCT00680745|471412891|FG003|Overall Study|Withdrawal by Subject|8|||
130939672|NCT00680745|471412888|FG000|Overall Study|Lost to Follow-up|0|||
130939673|NCT00680745|471412889|FG001|Overall Study|Lost to Follow-up|1|||
130939674|NCT00680745|471412890|FG002|Overall Study|Lost to Follow-up|1|||
130939675|NCT00680745|471412891|FG003|Overall Study|Lost to Follow-up|0|||
130939676|NCT00680745|471412888|FG000|Overall Study|Death|1|||
130939677|NCT00680745|471412889|FG001|Overall Study|Death|0|||
130939678|NCT00680745|471412890|FG002|Overall Study|Death|1|||
130939679|NCT00680745|471412891|FG003|Overall Study|Death|0|||
130939680|NCT00680745|471412888|FG000|Overall Study|Adverse Event|5|||
130939681|NCT00680745|471412889|FG001|Overall Study|Adverse Event|3|||
130939682|NCT00680745|471412890|FG002|Overall Study|Adverse Event|3|||
130939683|NCT00680745|471412891|FG003|Overall Study|Adverse Event|3|||
130939684|NCT00680745|471412888|FG000|Overall Study|Poor/Non-compliance|0|||
130939685|NCT00680745|471412889|FG001|Overall Study|Poor/Non-compliance|3|||
130939686|NCT00680745|471412890|FG002|Overall Study|Poor/Non-compliance|0|||
130939687|NCT00680745|471412891|FG003|Overall Study|Poor/Non-compliance|0|||
130939688|NCT00680745|471412888|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
130939689|NCT00680745|471412889|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
130939690|NCT00680745|471412890|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
130939691|NCT00680745|471412891|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
130939692|NCT00680745|471412888|FG000|Overall Study|False Treatment|0|||
131036285|NCT04137289|471766296|FG005|Overall Study|Clinical disease progression|2|||
131036286|NCT04137289|471766297|FG006|Overall Study|Clinical disease progression|5|||
131036287|NCT04137289|471766298|FG007|Overall Study|Clinical disease progression|1|||
131036288|NCT04137289|471766299|FG008|Overall Study|Clinical disease progression|0|||
131036289|NCT04137289|471766291|FG000|Overall Study|Lost to Follow-up|0|||
131036290|NCT04137289|471766292|FG001|Overall Study|Lost to Follow-up|0|||
131036291|NCT04137289|471766293|FG002|Overall Study|Lost to Follow-up|0|||
131036292|NCT04137289|471766294|FG003|Overall Study|Lost to Follow-up|1|||
131036293|NCT04137289|471766295|FG004|Overall Study|Lost to Follow-up|0|||
131036294|NCT04137289|471766296|FG005|Overall Study|Lost to Follow-up|0|||
131036295|NCT04137289|471766297|FG006|Overall Study|Lost to Follow-up|0|||
131036296|NCT04137289|471766298|FG007|Overall Study|Lost to Follow-up|0|||
131036297|NCT04137289|471766299|FG008|Overall Study|Lost to Follow-up|0|||
130939693|NCT00680745|471412889|FG001|Overall Study|False Treatment|1|||
130939694|NCT00680745|471412890|FG002|Overall Study|False Treatment|3|||
130939695|NCT00680745|471412891|FG003|Overall Study|False Treatment|0|||
130939696|NCT02612428|471412892|FG000|VTL-308|Death|14|||
130939697|NCT02612428|471412893|FG001|VTL-308|Death|16|||
130939698|NCT02612428|471412892|FG000|VTL-308|Withdrawal by Subject|0|||
130939699|NCT02612428|471412893|FG001|VTL-308|Withdrawal by Subject|1|||
130939700|NCT02612428|471412892|FG000|VTL-308E|Death|9|||
130939701|NCT02612428|471412893|FG001|VTL-308E|Death|7|||
130939702|NCT02612428|471412892|FG000|VTL-308E|Lost to Follow-up|2|||
130939703|NCT02612428|471412893|FG001|VTL-308E|Lost to Follow-up|0|||
130939704|NCT00742001|471412894|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
130939705|NCT00742001|471412895|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
130939706|NCT00742001|471412896|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
130939707|NCT00137423|471412897|FG000|Overall Study|Adverse Event|7|||
130939708|NCT00137423|471412898|FG001|Overall Study|Adverse Event|9|||
130939709|NCT00137423|471412897|FG000|Overall Study|consent withdrawn|1|||
130939710|NCT00137423|471412898|FG001|Overall Study|consent withdrawn|1|||
130939711|NCT00137423|471412897|FG000|Overall Study|Lack of Efficacy|31|||
130939712|NCT00137423|471412898|FG001|Overall Study|Lack of Efficacy|33|||
130939713|NCT00137423|471412897|FG000|Overall Study|Death|0|||
130939714|NCT00137423|471412898|FG001|Overall Study|Death|1|||
130939715|NCT03187262|471412899|FG000|Induction|Lack of Efficacy|2|||
130939716|NCT03187262|471412899|FG000|Induction|Progressive Disease|4|||
130939717|NCT03187262|471412899|FG000|Consolidation|Progressive Disease|5|||
130939718|NCT02141997|471412901|FG000|Overall Study|Adverse Event|0|||
130939719|NCT02141997|471412902|FG001|Overall Study|Adverse Event|2|||
130939720|NCT02141997|471412903|FG002|Overall Study|Adverse Event|0|||
130939721|NCT02141997|471412904|FG003|Overall Study|Adverse Event|1|||
130939722|NCT02141997|471412901|FG000|Overall Study|Participant noncompliance|1|||
130939723|NCT02141997|471412902|FG001|Overall Study|Participant noncompliance|0|||
130939724|NCT02141997|471412903|FG002|Overall Study|Participant noncompliance|0|||
130939725|NCT02141997|471412904|FG003|Overall Study|Participant noncompliance|0|||
130939726|NCT02141997|471412901|FG000|Overall Study|Withdrew consent|1|||
130939727|NCT02141997|471412902|FG001|Overall Study|Withdrew consent|0|||
130939728|NCT02141997|471412903|FG002|Overall Study|Withdrew consent|3|||
130939729|NCT02141997|471412904|FG003|Overall Study|Withdrew consent|0|||
130939730|NCT02141997|471412901|FG000|Overall Study|Other|1|||
130939731|NCT02141997|471412902|FG001|Overall Study|Other|4|||
130939732|NCT02141997|471412903|FG002|Overall Study|Other|0|||
130939733|NCT02141997|471412904|FG003|Overall Study|Other|0|||
130939734|NCT00909389|471412905|FG000|Overall Study|Adverse Event|6|||
130939735|NCT00909389|471412905|FG000|Overall Study|Death|4|||
130939736|NCT00909389|471412905|FG000|Overall Study|Poor Compliance|16|||
130939737|NCT00909389|471412905|FG000|Overall Study|Lost to Follow-up|4|||
130939738|NCT00909389|471412905|FG000|Overall Study|No Information|103|||
130939739|NCT00003492|471412906|FG000|Overall Study|Not evaluable|6|||
130939740|NCT00737282|471412909|FG000|Overall Study|Study prematurely terminated|175|||
130939741|NCT00840294|471412910|FG000|Overall Study|Withdrawal by Subject|2|||
130939742|NCT00840294|471412911|FG001|Overall Study|Withdrawal by Subject|1|||
130939743|NCT00840294|471412910|FG000|Overall Study|Protocol Violation|1|||
130939744|NCT00840294|471412911|FG001|Overall Study|Protocol Violation|3|||
130939745|NCT00840294|471412910|FG000|Overall Study|Illness|0|||
130939746|NCT00840294|471412911|FG001|Overall Study|Illness|1|||
130939747|NCT00453544|471412914|FG000|Overall Study|Withdrawal by Subject|1|||
130939748|NCT00453544|471412915|FG001|Overall Study|Withdrawal by Subject|0|||
130939749|NCT00453544|471412916|FG002|Overall Study|Withdrawal by Subject|0|||
130939750|NCT00453544|471412917|FG003|Overall Study|Withdrawal by Subject|0|||
130939751|NCT00453544|471412914|FG000|Overall Study|Primary outcome measure not completed|1|||
130939752|NCT00453544|471412915|FG001|Overall Study|Primary outcome measure not completed|1|||
130939753|NCT00453544|471412916|FG002|Overall Study|Primary outcome measure not completed|0|||
130939754|NCT00453544|471412917|FG003|Overall Study|Primary outcome measure not completed|1|||
130939755|NCT03721276|471412920|FG000|Overall Study|Lost to Follow-up|5|||
130939756|NCT03721276|471412921|FG001|Overall Study|Lost to Follow-up|3|||
130939757|NCT03721276|471412920|FG000|Overall Study|Adverse Event|0|||
130939758|NCT03721276|471412921|FG001|Overall Study|Adverse Event|1|||
130939759|NCT01340898|471412922|FG000|Primary Phase|Serious Adverse Events|0|||
130939760|NCT01340898|471412923|FG001|Primary Phase|Serious Adverse Events|0|||
130939761|NCT01340898|471412924|FG002|Primary Phase|Serious Adverse Events|1|||
131036298|NCT04137289|471766291|FG000|Overall Study|Adverse Event|0|||
130939762|NCT01340898|471412922|FG000|Primary Phase|Withdrawal by Subject|8|||
130939763|NCT01340898|471412923|FG001|Primary Phase|Withdrawal by Subject|7|||
130939764|NCT01340898|471412924|FG002|Primary Phase|Withdrawal by Subject|5|||
130939765|NCT01340898|471412922|FG000|Primary Phase|Migrated/moved from study area|4|||
130939766|NCT01340898|471412923|FG001|Primary Phase|Migrated/moved from study area|1|||
130939767|NCT01340898|471412924|FG002|Primary Phase|Migrated/moved from study area|0|||
130939768|NCT01340898|471412922|FG000|Primary Phase|Lost to Follow-up|4|||
130939769|NCT01340898|471412923|FG001|Primary Phase|Lost to Follow-up|1|||
130939770|NCT01340898|471412924|FG002|Primary Phase|Lost to Follow-up|0|||
130939771|NCT01340898|471412922|FG000|Booster Phase|Withdrawal by Subject|3|||
130939772|NCT01340898|471412923|FG001|Booster Phase|Withdrawal by Subject|0|||
130939773|NCT01340898|471412924|FG002|Booster Phase|Withdrawal by Subject|4|||
130939774|NCT01340898|471412922|FG000|Booster Phase|Migrated/moved from study area|3|||
130939775|NCT01340898|471412923|FG001|Booster Phase|Migrated/moved from study area|0|||
130939776|NCT01340898|471412924|FG002|Booster Phase|Migrated/moved from study area|0|||
130939777|NCT01340898|471412922|FG000|Booster Phase|Lost to Follow-up|4|||
130939778|NCT01340898|471412923|FG001|Booster Phase|Lost to Follow-up|2|||
130939779|NCT01340898|471412924|FG002|Booster Phase|Lost to Follow-up|3|||
130939780|NCT01214629|471412925|FG000|Overall Study|Progressive Disease|1|||
130939781|NCT01214629|471412926|FG001|Overall Study|Progressive Disease|1|||
130939782|NCT01214629|471412927|FG002|Overall Study|Progressive Disease|0|||
130939783|NCT01214629|471412928|FG003|Overall Study|Progressive Disease|1|||
130939784|NCT01214629|471412929|FG004|Overall Study|Progressive Disease|2|||
130939785|NCT01214629|471412930|FG005|Overall Study|Progressive Disease|3|||
130939786|NCT01214629|471412931|FG006|Overall Study|Progressive Disease|1|||
130939787|NCT01214629|471412932|FG007|Overall Study|Progressive Disease|1|||
130939788|NCT01214629|471412933|FG008|Overall Study|Progressive Disease|1|||
130939789|NCT01214629|471412934|FG009|Overall Study|Progressive Disease|5|||
130939790|NCT01214629|471412935|FG010|Overall Study|Progressive Disease|1|||
130939791|NCT01214629|471412925|FG000|Overall Study|Adverse Event|0|||
130939792|NCT01214629|471412926|FG001|Overall Study|Adverse Event|0|||
130939793|NCT01214629|471412927|FG002|Overall Study|Adverse Event|0|||
130939794|NCT01214629|471412928|FG003|Overall Study|Adverse Event|1|||
130939795|NCT01214629|471412929|FG004|Overall Study|Adverse Event|0|||
130939796|NCT01214629|471412930|FG005|Overall Study|Adverse Event|1|||
130939797|NCT01214629|471412931|FG006|Overall Study|Adverse Event|0|||
130939798|NCT01214629|471412932|FG007|Overall Study|Adverse Event|0|||
130939799|NCT01214629|471412933|FG008|Overall Study|Adverse Event|0|||
130939800|NCT01214629|471412934|FG009|Overall Study|Adverse Event|1|||
130939801|NCT01214629|471412935|FG010|Overall Study|Adverse Event|0|||
130939802|NCT01214629|471412925|FG000|Overall Study|Physician Decision|0|||
130939803|NCT01214629|471412926|FG001|Overall Study|Physician Decision|0|||
130939804|NCT01214629|471412927|FG002|Overall Study|Physician Decision|0|||
130939805|NCT01214629|471412928|FG003|Overall Study|Physician Decision|0|||
130939806|NCT01214629|471412929|FG004|Overall Study|Physician Decision|0|||
130939807|NCT01214629|471412930|FG005|Overall Study|Physician Decision|0|||
130939808|NCT01214629|471412931|FG006|Overall Study|Physician Decision|0|||
130939809|NCT01214629|471412932|FG007|Overall Study|Physician Decision|0|||
130939810|NCT01214629|471412933|FG008|Overall Study|Physician Decision|0|||
130939811|NCT01214629|471412934|FG009|Overall Study|Physician Decision|0|||
130939812|NCT01214629|471412935|FG010|Overall Study|Physician Decision|1|||
130939813|NCT01214629|471412925|FG000|Overall Study|Withdrawal by Subject|0|||
130939814|NCT01214629|471412926|FG001|Overall Study|Withdrawal by Subject|0|||
130939815|NCT01214629|471412927|FG002|Overall Study|Withdrawal by Subject|0|||
130939816|NCT01214629|471412928|FG003|Overall Study|Withdrawal by Subject|0|||
130939817|NCT01214629|471412929|FG004|Overall Study|Withdrawal by Subject|0|||
130939818|NCT01214629|471412930|FG005|Overall Study|Withdrawal by Subject|0|||
130939819|NCT01214629|471412931|FG006|Overall Study|Withdrawal by Subject|0|||
130939820|NCT01214629|471412932|FG007|Overall Study|Withdrawal by Subject|0|||
130939821|NCT01214629|471412933|FG008|Overall Study|Withdrawal by Subject|0|||
130939822|NCT01214629|471412934|FG009|Overall Study|Withdrawal by Subject|1|||
130939823|NCT01214629|471412935|FG010|Overall Study|Withdrawal by Subject|0|||
130939824|NCT01829230|471412936|FG000|Overall Study|Protocol Violation|0|||
130939825|NCT01829230|471412937|FG001|Overall Study|Protocol Violation|2|||
130939826|NCT01829230|471412936|FG000|Overall Study|Withdrawal by Subject|0|||
130939827|NCT01829230|471412937|FG001|Overall Study|Withdrawal by Subject|1|||
130939828|NCT01829230|471412936|FG000|Overall Study|Lost to Follow-up|1|||
130939829|NCT01829230|471412937|FG001|Overall Study|Lost to Follow-up|1|||
130939830|NCT04501666|471412938|FG000|Overall Study|Physician Decision|0|||
130939831|NCT04501666|471412939|FG001|Overall Study|Physician Decision|1|||
130772109|NCT05052697|470792846|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772110|NCT05052697|470792847|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130939832|NCT04501666|471412938|FG000|Overall Study|Adverse Event|12|||
130939833|NCT04501666|471412939|FG001|Overall Study|Adverse Event|4|||
130939834|NCT04501666|471412938|FG000|Overall Study|Subject's request|10|||
130939835|NCT04501666|471412939|FG001|Overall Study|Subject's request|6|||
130939836|NCT04501666|471412938|FG000|Overall Study|Protocol Deviation|2|||
130939837|NCT04501666|471412939|FG001|Overall Study|Protocol Deviation|1|||
130939838|NCT04501666|471412938|FG000|Overall Study|Other-- site permanently closing|0|||
131036299|NCT04137289|471766292|FG001|Overall Study|Adverse Event|0|||
130939839|NCT04501666|471412939|FG001|Overall Study|Other-- site permanently closing|1|||
130939840|NCT03021265|471412940|FG000|Overall Study|Adverse Event|29|||
130939841|NCT03021265|471412940|FG000|Overall Study|Lack of Efficacy|3|||
130939842|NCT03021265|471412940|FG000|Overall Study|Improved|17|||
130939843|NCT03021265|471412940|FG000|Overall Study|Lost to Follow-up|67|||
130939844|NCT03021265|471412940|FG000|Overall Study|No reason given|2|||
130939845|NCT03021265|471412940|FG000|Overall Study|No visit since the first visit|4|||
130939846|NCT00642941|471412941|FG000|Overall Study|Physician Decision|3|||
130939847|NCT00642941|471412942|FG001|Overall Study|Physician Decision|1|||
131036300|NCT04137289|471766293|FG002|Overall Study|Adverse Event|1|||
131036301|NCT04137289|471766294|FG003|Overall Study|Adverse Event|0|||
130939848|NCT00642941|471412943|FG002|Overall Study|Physician Decision|0|||
130939849|NCT00642941|471412944|FG003|Overall Study|Physician Decision|0|||
130939850|NCT00642941|471412945|FG004|Overall Study|Physician Decision|0|||
130939851|NCT00642941|471412946|FG005|Overall Study|Physician Decision|0|||
130939852|NCT00642941|471412947|FG006|Overall Study|Physician Decision|1|||
130939853|NCT00642941|471412948|FG007|Overall Study|Physician Decision|0|||
130939854|NCT00642941|471412949|FG008|Overall Study|Physician Decision|0|||
130939855|NCT00642941|471412950|FG009|Overall Study|Physician Decision|1|||
130939856|NCT00642941|471412951|FG010|Overall Study|Physician Decision|0|||
130939857|NCT00642941|471412952|FG011|Overall Study|Physician Decision|1|||
130939858|NCT00642941|471412941|FG000|Overall Study|Death|4|||
130939859|NCT00642941|471412942|FG001|Overall Study|Death|0|||
130939860|NCT00642941|471412943|FG002|Overall Study|Death|1|||
130939861|NCT00642941|471412944|FG003|Overall Study|Death|1|||
130939862|NCT00642941|471412945|FG004|Overall Study|Death|2|||
130939863|NCT00642941|471412946|FG005|Overall Study|Death|1|||
130939864|NCT00642941|471412947|FG006|Overall Study|Death|0|||
130939865|NCT00642941|471412948|FG007|Overall Study|Death|0|||
130939866|NCT00642941|471412949|FG008|Overall Study|Death|0|||
130939867|NCT00642941|471412950|FG009|Overall Study|Death|0|||
130939868|NCT00642941|471412951|FG010|Overall Study|Death|0|||
130939869|NCT00642941|471412952|FG011|Overall Study|Death|1|||
130939870|NCT00642941|471412941|FG000|Overall Study|Study closed by Sponsor|0|||
130939871|NCT00642941|471412942|FG001|Overall Study|Study closed by Sponsor|1|||
130939872|NCT00642941|471412943|FG002|Overall Study|Study closed by Sponsor|0|||
130939873|NCT00642941|471412944|FG003|Overall Study|Study closed by Sponsor|0|||
130939874|NCT00642941|471412945|FG004|Overall Study|Study closed by Sponsor|0|||
130939875|NCT00642941|471412946|FG005|Overall Study|Study closed by Sponsor|0|||
130939876|NCT00642941|471412947|FG006|Overall Study|Study closed by Sponsor|0|||
130939877|NCT00642941|471412948|FG007|Overall Study|Study closed by Sponsor|0|||
130939878|NCT00642941|471412949|FG008|Overall Study|Study closed by Sponsor|0|||
130939879|NCT00642941|471412950|FG009|Overall Study|Study closed by Sponsor|0|||
130939880|NCT00642941|471412951|FG010|Overall Study|Study closed by Sponsor|0|||
130939881|NCT00642941|471412952|FG011|Overall Study|Study closed by Sponsor|0|||
130939882|NCT00642941|471412941|FG000|Overall Study|Withdrawal by Subject|1|||
130939883|NCT00642941|471412942|FG001|Overall Study|Withdrawal by Subject|0|||
130939884|NCT00642941|471412943|FG002|Overall Study|Withdrawal by Subject|0|||
130939885|NCT00642941|471412944|FG003|Overall Study|Withdrawal by Subject|2|||
130939886|NCT00642941|471412945|FG004|Overall Study|Withdrawal by Subject|0|||
130939887|NCT00642941|471412946|FG005|Overall Study|Withdrawal by Subject|0|||
130939888|NCT00642941|471412947|FG006|Overall Study|Withdrawal by Subject|2|||
130939889|NCT00642941|471412948|FG007|Overall Study|Withdrawal by Subject|0|||
130939890|NCT00642941|471412949|FG008|Overall Study|Withdrawal by Subject|1|||
130939891|NCT00642941|471412950|FG009|Overall Study|Withdrawal by Subject|0|||
130939892|NCT00642941|471412951|FG010|Overall Study|Withdrawal by Subject|0|||
130939893|NCT00642941|471412952|FG011|Overall Study|Withdrawal by Subject|1|||
130939894|NCT00642941|471412941|FG000|Overall Study|Protocol Violation|0|||
130939895|NCT00642941|471412942|FG001|Overall Study|Protocol Violation|0|||
130939896|NCT00642941|471412943|FG002|Overall Study|Protocol Violation|0|||
130939897|NCT00642941|471412944|FG003|Overall Study|Protocol Violation|0|||
130939898|NCT00642941|471412945|FG004|Overall Study|Protocol Violation|0|||
130939899|NCT00642941|471412946|FG005|Overall Study|Protocol Violation|0|||
130939900|NCT00642941|471412947|FG006|Overall Study|Protocol Violation|1|||
130939901|NCT00642941|471412948|FG007|Overall Study|Protocol Violation|0|||
130939902|NCT00642941|471412949|FG008|Overall Study|Protocol Violation|0|||
130939903|NCT00642941|471412950|FG009|Overall Study|Protocol Violation|0|||
130939904|NCT00642941|471412951|FG010|Overall Study|Protocol Violation|0|||
130939905|NCT00642941|471412952|FG011|Overall Study|Protocol Violation|0|||
130939906|NCT00642941|471412941|FG000|Overall Study|Adverse Event|1|||
130939907|NCT00642941|471412942|FG001|Overall Study|Adverse Event|1|||
130939908|NCT00642941|471412943|FG002|Overall Study|Adverse Event|0|||
131123073|NCT03740165|472079713|FG002|Overall Study|Withdrawal by Subject|3|||
130939909|NCT00642941|471412944|FG003|Overall Study|Adverse Event|0|||
130939910|NCT00642941|471412945|FG004|Overall Study|Adverse Event|0|||
130939911|NCT00642941|471412946|FG005|Overall Study|Adverse Event|0|||
130939912|NCT00642941|471412947|FG006|Overall Study|Adverse Event|1|||
130939913|NCT00642941|471412948|FG007|Overall Study|Adverse Event|1|||
130939914|NCT00642941|471412949|FG008|Overall Study|Adverse Event|0|||
130939915|NCT00642941|471412950|FG009|Overall Study|Adverse Event|1|||
130939916|NCT00642941|471412951|FG010|Overall Study|Adverse Event|0|||
130939917|NCT00642941|471412952|FG011|Overall Study|Adverse Event|0|||
130939918|NCT00642941|471412941|FG000|Overall Study|Other|1|||
131123074|NCT03740165|472079711|FG000|Overall Study|Ongoing in Study|216|||
131123075|NCT03740165|472079712|FG001|Overall Study|Ongoing in Study|212|||
130706166|NCT02973321|470549631|FG003|Overall Study|Adverse Event|13|||
130939919|NCT00642941|471412942|FG001|Overall Study|Other|1|||
130939920|NCT00642941|471412943|FG002|Overall Study|Other|1|||
130939921|NCT00642941|471412944|FG003|Overall Study|Other|1|||
130939922|NCT00642941|471412945|FG004|Overall Study|Other|0|||
130939923|NCT00642941|471412946|FG005|Overall Study|Other|1|||
130939924|NCT00642941|471412947|FG006|Overall Study|Other|0|||
130939925|NCT00642941|471412948|FG007|Overall Study|Other|1|||
130939926|NCT00642941|471412949|FG008|Overall Study|Other|0|||
130939927|NCT00642941|471412950|FG009|Overall Study|Other|0|||
130939928|NCT00642941|471412951|FG010|Overall Study|Other|0|||
130939929|NCT00642941|471412952|FG011|Overall Study|Other|1|||
130939930|NCT00642941|471412941|FG000|Overall Study|Disease progression|60|||
130939931|NCT00642941|471412942|FG001|Overall Study|Disease progression|50|||
130939932|NCT00642941|471412943|FG002|Overall Study|Disease progression|5|||
130706167|NCT02973321|470549632|FG004|Overall Study|Adverse Event|3|||
130706168|NCT01790113|470549639|FG000|Overall Study|Adverse Event|2|||
130706169|NCT01790113|470549640|FG001|Overall Study|Adverse Event|7|||
130706170|NCT01790113|470549639|FG000|Overall Study|Study ended due to FDA clearance|1|||
130706171|NCT01790113|470549640|FG001|Overall Study|Study ended due to FDA clearance|68|||
130706172|NCT00865514|470549641|FG000|Overall Study|Infusion cost exceeded funding|2|||
130706173|NCT03920280|470549642|FG000|Overall Study|Adverse Event|2|||
130706174|NCT03920280|470549643|FG001|Overall Study|Adverse Event|3|||
130706175|NCT03920280|470549642|FG000|Overall Study|Lost to Follow-up|0|||
130706176|NCT03920280|470549643|FG001|Overall Study|Lost to Follow-up|1|||
130706177|NCT03920280|470549642|FG000|Overall Study|Withdrawal by Subject|1|||
130706178|NCT03920280|470549643|FG001|Overall Study|Withdrawal by Subject|1|||
130706179|NCT03920280|470549642|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
130706180|NCT03920280|470549643|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
130706181|NCT02487082|470549644|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
130706182|NCT02487082|470549645|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
130706183|NCT02487082|470549644|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
130706184|NCT02487082|470549645|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
130706185|NCT03297294|470549646|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
130706186|NCT03297294|470549647|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
130706187|NCT03297294|470549648|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130706188|NCT03297294|470549649|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130706189|NCT03297294|470549650|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130706190|NCT03297294|470549646|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
130706191|NCT03297294|470549647|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
130706192|NCT03297294|470549648|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130706193|NCT03297294|470549649|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130706194|NCT03297294|470549650|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130706195|NCT03297294|470549646|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
130706196|NCT03297294|470549647|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
130706197|NCT03297294|470549648|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130706198|NCT03297294|470549649|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130706199|NCT03297294|470549650|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130706200|NCT03297294|470549646|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
130706201|NCT03297294|470549647|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
130706202|NCT03297294|470549648|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130706203|NCT03297294|470549649|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130706204|NCT03297294|470549650|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130706205|NCT03297294|470549646|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130706206|NCT03297294|470549647|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130706207|NCT03297294|470549648|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130706208|NCT03297294|470549649|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
130706209|NCT03297294|470549650|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130706210|NCT01198873|470549651|FG000|Overall Study|Adverse Event|4|||
130706211|NCT01198873|470549652|FG001|Overall Study|Adverse Event|7|||
130706212|NCT01198873|470549651|FG000|Overall Study|Study closure|29|||
130706213|NCT01198873|470549652|FG001|Overall Study|Study closure|23|||
130706214|NCT01198873|470549651|FG000|Overall Study|Other than above|4|||
130706215|NCT01198873|470549652|FG001|Overall Study|Other than above|2|||
130706216|NCT03139240|470549653|FG000|Overall Study|Lost to Follow-up|0|||
130706217|NCT03139240|470549654|FG001|Overall Study|Lost to Follow-up|1|||
130706218|NCT03139240|470549655|FG002|Overall Study|Lost to Follow-up|1|||
130706219|NCT03139240|470549656|FG003|Overall Study|Lost to Follow-up|0|||
130706220|NCT00268892|470549657|FG000|Overall Study|Adverse Event|14|||
130706221|NCT00268892|470549658|FG001|Overall Study|Adverse Event|17|||
130706222|NCT00268892|470549659|FG002|Overall Study|Adverse Event|20|||
130706223|NCT00268892|470549657|FG000|Overall Study|Lack of Efficacy|1|||
130706224|NCT00268892|470549658|FG001|Overall Study|Lack of Efficacy|3|||
130706225|NCT00268892|470549659|FG002|Overall Study|Lack of Efficacy|0|||
130706226|NCT00268892|470549657|FG000|Overall Study|Withdrawal by Subject|14|||
130706227|NCT00268892|470549658|FG001|Overall Study|Withdrawal by Subject|15|||
130706228|NCT00268892|470549659|FG002|Overall Study|Withdrawal by Subject|13|||
130706229|NCT00268892|470549657|FG000|Overall Study|Physician Decision|0|||
130706230|NCT00268892|470549658|FG001|Overall Study|Physician Decision|1|||
130706231|NCT00268892|470549659|FG002|Overall Study|Physician Decision|0|||
130706232|NCT00268892|470549657|FG000|Overall Study|Lost to Follow-up|5|||
130706233|NCT00268892|470549658|FG001|Overall Study|Lost to Follow-up|2|||
130706234|NCT00268892|470549659|FG002|Overall Study|Lost to Follow-up|4|||
130706235|NCT00268892|470549657|FG000|Overall Study|Protocol Violation|0|||
130706236|NCT00268892|470549658|FG001|Overall Study|Protocol Violation|1|||
130706237|NCT00268892|470549659|FG002|Overall Study|Protocol Violation|0|||
130772111|NCT05052697|470792848|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772112|NCT05052697|470792849|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772113|NCT05052697|470792850|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772114|NCT05052697|470792851|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772115|NCT05052697|470792852|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772116|NCT05052697|470792853|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130772117|NCT05052697|470792820|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772118|NCT05052697|470792821|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772119|NCT05052697|470792822|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772120|NCT05052697|470792823|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772121|NCT05052697|470792824|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772122|NCT05052697|470792825|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
130939933|NCT00642941|471412944|FG003|Overall Study|Disease progression|36|||
130939934|NCT00642941|471412945|FG004|Overall Study|Disease progression|23|||
130939935|NCT00642941|471412946|FG005|Overall Study|Disease progression|39|||
130939936|NCT00642941|471412947|FG006|Overall Study|Disease progression|18|||
130939937|NCT00642941|471412948|FG007|Overall Study|Disease progression|12|||
130939938|NCT00642941|471412949|FG008|Overall Study|Disease progression|10|||
130939939|NCT00642941|471412950|FG009|Overall Study|Disease progression|7|||
130939940|NCT00642941|471412951|FG010|Overall Study|Disease progression|12|||
130939941|NCT00642941|471412952|FG011|Overall Study|Disease progression|7|||
130939942|NCT01338493|471412953|FG000|Enrolled|Withdrawal by Subject|1|||
130939943|NCT01338493|471412953|FG000|Enrolled|Patient not implanted|4|||
130939944|NCT01338493|471412953|FG000|Discharge|Death|1|||
130939945|NCT01338493|471412953|FG000|Discharge|Missed visit|1|||
130939946|NCT01338493|471412953|FG000|6 Months Follow up|Lost to Follow-up|11|||
130939947|NCT01338493|471412953|FG000|6 Months Follow up|Missed visit|8|||
130939948|NCT01338493|471412953|FG000|12 Months Follow up|Lost to Follow-up|9|||
130939949|NCT01698801|471412954|FG000|Treatment Phase|Adverse Event|4|||
130939950|NCT01698801|471412954|FG000|Treatment Phase|Protocol Violation|1|||
130939951|NCT01698801|471412954|FG000|Treatment Phase|Other|4|||
131036302|NCT04137289|471766295|FG004|Overall Study|Adverse Event|0|||
131036303|NCT04137289|471766296|FG005|Overall Study|Adverse Event|1|||
131036304|NCT04137289|471766297|FG006|Overall Study|Adverse Event|0|||
131036305|NCT04137289|471766298|FG007|Overall Study|Adverse Event|0|||
130706238|NCT00268892|470549657|FG000|Overall Study|Disease Progression|1|||
130706239|NCT00268892|470549658|FG001|Overall Study|Disease Progression|1|||
130706240|NCT00268892|470549659|FG002|Overall Study|Disease Progression|0|||
130706241|NCT00268892|470549657|FG000|Overall Study|Trial Site Closed|4|||
130706242|NCT00268892|470549658|FG001|Overall Study|Trial Site Closed|2|||
131036306|NCT04137289|471766299|FG008|Overall Study|Adverse Event|0|||
131036307|NCT04137289|471766291|FG000|Overall Study|Lack of clinical benefit|0|||
131036308|NCT04137289|471766292|FG001|Overall Study|Lack of clinical benefit|0|||
130706243|NCT00268892|470549659|FG002|Overall Study|Trial Site Closed|2|||
130706244|NCT02492841|470549660|FG000|Overall Study|Lost to Follow-up|34|||
130706245|NCT02492841|470549661|FG001|Overall Study|Lost to Follow-up|31|||
130706246|NCT02492841|470549662|FG002|Overall Study|Lost to Follow-up|35|||
130706247|NCT02563769|470549667|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
130706248|NCT02563769|470549668|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
130706249|NCT02563769|470549669|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
130706250|NCT00690482|470549670|FG000|Overall Study|Adverse Event|2|||
130706251|NCT00690482|470549671|FG001|Overall Study|Adverse Event|1|||
130706252|NCT00690482|470549670|FG000|Overall Study|Incorrect enrolment|0|||
130706253|NCT00690482|470549671|FG001|Overall Study|Incorrect enrolment|1|||
130939952|NCT01698801|471412954|FG000|Treatment Phase|Withdrawal by Subject|1|||
130939953|NCT01698801|471412954|FG000|Treatment Phase|Disease progression|1|||
131036309|NCT04137289|471766293|FG002|Overall Study|Lack of clinical benefit|0|||
131036310|NCT04137289|471766294|FG003|Overall Study|Lack of clinical benefit|0|||
131036311|NCT04137289|471766295|FG004|Overall Study|Lack of clinical benefit|0|||
131036312|NCT04137289|471766296|FG005|Overall Study|Lack of clinical benefit|0|||
131036313|NCT04137289|471766297|FG006|Overall Study|Lack of clinical benefit|0|||
131036314|NCT04137289|471766298|FG007|Overall Study|Lack of clinical benefit|0|||
131036315|NCT04137289|471766299|FG008|Overall Study|Lack of clinical benefit|1|||
130939954|NCT01698801|471412954|FG000|Follow Up Phase|Withdrawal by Subject|1|||
130939955|NCT01698801|471412954|FG000|Follow Up Phase|Death|4|||
130939956|NCT00656474|471412955|FG000|Overall Study|Other Reason|1|||
131036316|NCT04137289|471766291|FG000|Overall Study|Objective disease progression|1|||
131036317|NCT04137289|471766292|FG001|Overall Study|Objective disease progression|1|||
131036318|NCT04137289|471766293|FG002|Overall Study|Objective disease progression|6|||
131123076|NCT03740165|472079713|FG002|Overall Study|Ongoing in Study|221|||
131123077|NCT05318937|472079718|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130706254|NCT00690482|470549670|FG000|Overall Study|Study-specific discontinuation criteria|1|||
130772123|NCT05052697|470792826|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
130939957|NCT01614067|471412957|FG000|Overall Study|Pregnancy|1|||
131036319|NCT04137289|471766294|FG003|Overall Study|Objective disease progression|18|||
130706255|NCT00690482|470549671|FG001|Overall Study|Study-specific discontinuation criteria|0|||
130772124|NCT05052697|470792827|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772125|NCT05052697|470792828|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772126|NCT05052697|470792829|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772127|NCT05052697|470792830|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772128|NCT05052697|470792831|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
130939958|NCT01614067|471412958|FG001|Overall Study|Pregnancy|0|||
130939959|NCT01614067|471412957|FG000|Overall Study|Physician Decision|6|||
130939960|NCT01614067|471412958|FG001|Overall Study|Physician Decision|5|||
130939961|NCT01614067|471412957|FG000|Overall Study|Withdrawal by Subject|0|||
130939962|NCT01614067|471412958|FG001|Overall Study|Withdrawal by Subject|1|||
130939963|NCT01614067|471412957|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
130939964|NCT01614067|471412958|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
130939965|NCT00056407|471412959|FG000|Overall Study|Adverse Event|282|||
130939966|NCT00056407|471412960|FG001|Overall Study|Adverse Event|364|||
130939967|NCT00056407|471412959|FG000|Overall Study|Withdrawal by Subject|377|||
130939968|NCT00056407|471412960|FG001|Overall Study|Withdrawal by Subject|361|||
130939969|NCT00056407|471412959|FG000|Overall Study|Lost to Follow-up|123|||
130939970|NCT00056407|471412960|FG001|Overall Study|Lost to Follow-up|113|||
130939971|NCT00056407|471412959|FG000|Overall Study|Protocol Violation|104|||
130939972|NCT00056407|471412960|FG001|Overall Study|Protocol Violation|95|||
130939973|NCT00056407|471412959|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
130939974|NCT00056407|471412960|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
130939975|NCT00056407|471412959|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
130772129|NCT05052697|470792832|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772130|NCT05052697|470792833|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772131|NCT05052697|470792834|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
130939976|NCT00056407|471412960|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
130939977|NCT00056407|471412959|FG000|Overall Study|Missing|25|||
130939978|NCT00056407|471412960|FG001|Overall Study|Missing|34|||
130939979|NCT00616655|471412961|FG000|Overall Study|Adverse Event|10|||
130939980|NCT00616655|471412962|FG001|Overall Study|Adverse Event|7|||
130939981|NCT00616655|471412963|FG002|Overall Study|Adverse Event|12|||
130939982|NCT00616655|471412961|FG000|Overall Study|Lack of Efficacy|5|||
130939983|NCT00616655|471412962|FG001|Overall Study|Lack of Efficacy|5|||
130939984|NCT00616655|471412963|FG002|Overall Study|Lack of Efficacy|5|||
130939985|NCT00616655|471412961|FG000|Overall Study|Lost to Follow-up|3|||
130939986|NCT00616655|471412962|FG001|Overall Study|Lost to Follow-up|12|||
130939987|NCT00616655|471412963|FG002|Overall Study|Lost to Follow-up|10|||
130939988|NCT00616655|471412961|FG000|Overall Study|Protocol Violation|2|||
130772132|NCT05052697|470792835|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772133|NCT05052697|470792836|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772134|NCT05052697|470792837|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
130772135|NCT05052697|470792838|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772136|NCT05052697|470792839|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772137|NCT05052697|470792840|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772138|NCT05052697|470792841|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772139|NCT05052697|470792842|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772140|NCT05052697|470792843|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772141|NCT05052697|470792844|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772142|NCT05052697|470792845|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772143|NCT05052697|470792846|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772144|NCT05052697|470792847|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772145|NCT05052697|470792848|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772146|NCT05052697|470792849|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772147|NCT05052697|470792850|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772148|NCT05052697|470792851|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772149|NCT05052697|470792852|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772150|NCT05052697|470792853|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
130772151|NCT05052697|470792820|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772152|NCT05052697|470792821|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130939989|NCT00616655|471412962|FG001|Overall Study|Protocol Violation|4|||
130939990|NCT00616655|471412963|FG002|Overall Study|Protocol Violation|3|||
130939991|NCT00616655|471412961|FG000|Overall Study|Withdrawal by Subject|9|||
131036320|NCT04137289|471766295|FG004|Overall Study|Objective disease progression|12|||
130772153|NCT05052697|470792822|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130939992|NCT00616655|471412962|FG001|Overall Study|Withdrawal by Subject|7|||
130939993|NCT00616655|471412963|FG002|Overall Study|Withdrawal by Subject|11|||
130939994|NCT00616655|471412961|FG000|Overall Study|Does not meet in/ex criteria|0|||
130939995|NCT00616655|471412962|FG001|Overall Study|Does not meet in/ex criteria|0|||
130939996|NCT00616655|471412963|FG002|Overall Study|Does not meet in/ex criteria|2|||
130939997|NCT00616655|471412961|FG000|Overall Study|Other|6|||
131036321|NCT04137289|471766296|FG005|Overall Study|Objective disease progression|20|||
130939998|NCT00616655|471412962|FG001|Overall Study|Other|6|||
130939999|NCT00616655|471412963|FG002|Overall Study|Other|5|||
130940000|NCT03761147|471412964|FG000|Overall Study|Withdrawal by Subject|6|||
130940001|NCT03761147|471412965|FG001|Overall Study|Withdrawal by Subject|1|||
130940002|NCT03761147|471412964|FG000|Overall Study|Adverse Event|1|||
130940003|NCT03761147|471412965|FG001|Overall Study|Adverse Event|3|||
130940004|NCT02663674|471412969|FG000|Overall Study|Lost to Follow-up|5|||
130940005|NCT02663674|471412970|FG001|Overall Study|Lost to Follow-up|4|||
130940006|NCT02663674|471412969|FG000|Overall Study|Withdrawal by Subject|1|||
130940007|NCT02663674|471412970|FG001|Overall Study|Withdrawal by Subject|4|||
130940008|NCT02663674|471412969|FG000|Overall Study|Physician Decision|1|||
130940009|NCT02663674|471412970|FG001|Overall Study|Physician Decision|1|||
130940010|NCT02663674|471412969|FG000|Overall Study|Other Event (Health Related)|0|||
130940011|NCT02663674|471412970|FG001|Overall Study|Other Event (Health Related)|1|||
130940012|NCT00415909|471414067|FG000|Overall Study|Withdrawal by Subject|2|||
130940013|NCT00415909|471414067|FG000|Overall Study|Death|1|||
130940014|NCT02369341|471414072|FG000|Overall Study|Migrated/moved from study area|1|||
130940015|NCT02369341|471414073|FG001|Overall Study|Migrated/moved from study area|0|||
130940016|NCT03287804|471414074|FG000|Overall Study|Death|1|||
130940017|NCT03287804|471414074|FG000|Overall Study|Physician Decision|2|||
130940018|NCT03287804|471414074|FG000|Overall Study|Progressive disease|8|||
130706256|NCT00690482|470549670|FG000|Overall Study|Intake of prohibited medicine|1|||
130940019|NCT02707991|471414077|FG000|Overall Study|Protocol Violation|1|||
130940020|NCT02707991|471414078|FG001|Overall Study|Protocol Violation|0|||
130940021|NCT02707991|471414077|FG000|Overall Study|Became ineligible|0|||
130940022|NCT02707991|471414078|FG001|Overall Study|Became ineligible|1|||
130940023|NCT01496313|471414081|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
130940024|NCT01496313|471414082|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
130940025|NCT01496313|471414083|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
130940026|NCT01496313|471414084|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
130940027|NCT01496313|471414085|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
130940028|NCT01496313|471414086|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
130940029|NCT01496313|471414081|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
130940030|NCT01496313|471414082|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
130940031|NCT01496313|471414083|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
130940032|NCT01496313|471414084|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
130940033|NCT01496313|471414085|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
130940034|NCT01496313|471414086|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
130940035|NCT01496313|471414081|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
130940036|NCT01496313|471414082|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
130940037|NCT01496313|471414083|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
130940038|NCT01496313|471414084|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
130940039|NCT01496313|471414085|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
130940040|NCT01496313|471414086|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
130940041|NCT01496313|471414081|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
130940042|NCT01496313|471414082|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
130940043|NCT01496313|471414083|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
130940044|NCT01496313|471414084|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
130940045|NCT01496313|471414085|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
130940046|NCT01496313|471414086|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
130940047|NCT01496313|471414081|FG000|Randomized Period (up to 14 Months)|Other|1|||
130940048|NCT01496313|471414082|FG001|Randomized Period (up to 14 Months)|Other|2|||
130940049|NCT01496313|471414083|FG002|Randomized Period (up to 14 Months)|Other|0|||
130940050|NCT01496313|471414084|FG003|Randomized Period (up to 14 Months)|Other|0|||
130940051|NCT01496313|471414085|FG004|Randomized Period (up to 14 Months)|Other|0|||
130940052|NCT01496313|471414086|FG005|Randomized Period (up to 14 Months)|Other|0|||
130940053|NCT01496313|471414081|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
130940054|NCT01496313|471414082|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
130940055|NCT01496313|471414083|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
130940056|NCT01496313|471414084|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
130940057|NCT01496313|471414085|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
130940058|NCT01496313|471414086|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
130940059|NCT01496313|471414081|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
130940060|NCT01496313|471414082|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
130940061|NCT01496313|471414083|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
130940062|NCT01496313|471414084|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
130940063|NCT01496313|471414085|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
130940064|NCT01496313|471414086|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
130940065|NCT01496313|471414081|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
130940066|NCT01496313|471414082|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
130940067|NCT01496313|471414083|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
130940068|NCT01496313|471414084|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
130940069|NCT01496313|471414085|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
130940070|NCT01496313|471414086|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
130940071|NCT04105998|471414089|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
130940072|NCT04105998|471414090|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
130940073|NCT01050257|471414091|FG000|Overall Study|Adverse Event|4|||
130940074|NCT01050257|471414092|FG001|Overall Study|Adverse Event|4|||
130940075|NCT01050257|471414093|FG002|Overall Study|Adverse Event|2|||
130940076|NCT01050257|471414091|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
130940077|NCT01050257|471414092|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
130940078|NCT01050257|471414093|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
130940079|NCT01050257|471414091|FG000|Overall Study|Withdrawal by Subject|0|||
130940080|NCT01050257|471414092|FG001|Overall Study|Withdrawal by Subject|3|||
130940081|NCT01050257|471414093|FG002|Overall Study|Withdrawal by Subject|0|||
130940082|NCT01050257|471414091|FG000|Overall Study|No reason specified|0|||
130940083|NCT01050257|471414092|FG001|Overall Study|No reason specified|0|||
130940084|NCT01050257|471414093|FG002|Overall Study|No reason specified|2|||
130940085|NCT01050257|471414091|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
130940086|NCT01050257|471414092|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
130940087|NCT01050257|471414093|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
130940088|NCT01050257|471414091|FG000|Overall Study|Violation criteria|0|||
130940089|NCT01050257|471414092|FG001|Overall Study|Violation criteria|1|||
130940090|NCT01050257|471414093|FG002|Overall Study|Violation criteria|0|||
130940091|NCT01050257|471414091|FG000|Overall Study|Failure to return|0|||
130940092|NCT01050257|471414092|FG001|Overall Study|Failure to return|2|||
130940093|NCT01050257|471414093|FG002|Overall Study|Failure to return|0|||
130940094|NCT01050257|471414091|FG000|Overall Study|Death|0|||
130940095|NCT01050257|471414092|FG001|Overall Study|Death|0|||
130940096|NCT01050257|471414093|FG002|Overall Study|Death|1|||
130940097|NCT00278109|471414095|FG000|Overall Study|Adverse Event|3|||
130940098|NCT00278109|471414095|FG000|Overall Study|social circumstances|1|||
130940099|NCT02580357|471414096|FG000|Overall Study|Lost to Follow-up|2|||
130940100|NCT02580357|471414097|FG001|Overall Study|Lost to Follow-up|0|||
130940101|NCT02580357|471414098|FG002|Overall Study|Lost to Follow-up|0|||
130940102|NCT02580357|471414096|FG000|Overall Study|Protocol Violation|1|||
130940103|NCT02580357|471414097|FG001|Overall Study|Protocol Violation|0|||
130940104|NCT02580357|471414098|FG002|Overall Study|Protocol Violation|0|||
130940105|NCT02064166|471414099|FG000|Overall Study|Adverse Event|1|||
130940106|NCT02064166|471414100|FG001|Overall Study|Adverse Event|0|||
130940107|NCT04519645|471414103|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
130940108|NCT04519645|471414104|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
130940109|NCT04519645|471414105|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
130940110|NCT04519645|471414103|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
130940111|NCT04519645|471414104|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
130940112|NCT04519645|471414105|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
130940113|NCT04519645|471414103|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
130940114|NCT04519645|471414104|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
130940115|NCT04519645|471414105|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
130940116|NCT04519645|471414103|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
130940117|NCT04519645|471414104|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
130940118|NCT04519645|471414105|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
130940119|NCT03742037|471414107|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130940120|NCT03742037|471414108|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
130940121|NCT03742037|471414109|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130940122|NCT03742037|471414110|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130940123|NCT03742037|471414111|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
131123078|NCT05318937|472079719|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131123079|NCT05318937|472079718|FG000|Overall Study|Lost to Follow-up|0|||
131123080|NCT05318937|472079719|FG001|Overall Study|Lost to Follow-up|1|||
131123081|NCT05318937|472079718|FG000|Overall Study|Withdrawal by Subject|0|||
131123082|NCT05318937|472079719|FG001|Overall Study|Withdrawal by Subject|2|||
131123083|NCT05318937|472079718|FG000|Overall Study|Protocol Violation|0|||
130940124|NCT03742037|471414112|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130940125|NCT03742037|471414113|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
130940126|NCT03742037|471414107|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
131123084|NCT05318937|472079719|FG001|Overall Study|Protocol Violation|1|||
130940127|NCT03742037|471414108|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
131123085|NCT01877915|472079727|FG000|Overall Study|Lost to Follow-up|10|||
131123086|NCT01877915|472079728|FG001|Overall Study|Lost to Follow-up|9|||
131224134|NCT00789828|472447166|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
130772154|NCT05052697|470792823|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772155|NCT05052697|470792824|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772156|NCT05052697|470792825|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772157|NCT05052697|470792826|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772158|NCT05052697|470792827|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772159|NCT05052697|470792828|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772160|NCT05052697|470792829|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772161|NCT05052697|470792830|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772162|NCT05052697|470792831|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772163|NCT05052697|470792832|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772164|NCT05052697|470792833|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772165|NCT05052697|470792834|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772166|NCT05052697|470792835|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772167|NCT05052697|470792836|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772168|NCT05052697|470792837|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772169|NCT05052697|470792838|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772170|NCT05052697|470792839|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
130772171|NCT05052697|470792840|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772172|NCT05052697|470792841|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772173|NCT05052697|470792842|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772174|NCT05052697|470792843|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772175|NCT05052697|470792844|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772176|NCT05052697|470792845|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772177|NCT05052697|470792846|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772178|NCT05052697|470792847|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772179|NCT05052697|470792848|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772180|NCT05052697|470792849|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772181|NCT05052697|470792850|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772182|NCT05052697|470792851|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772183|NCT05052697|470792852|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772184|NCT05052697|470792853|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130772185|NCT05052697|470792820|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772186|NCT05052697|470792821|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772187|NCT05052697|470792822|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772188|NCT05052697|470792823|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772189|NCT05052697|470792824|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772190|NCT05052697|470792825|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772191|NCT05052697|470792826|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772192|NCT05052697|470792827|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772193|NCT05052697|470792828|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772194|NCT05052697|470792829|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772195|NCT05052697|470792830|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772196|NCT05052697|470792831|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130940128|NCT03742037|471414109|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
130940129|NCT03742037|471414110|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
130940130|NCT03742037|471414111|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
130940131|NCT03742037|471414112|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
130940132|NCT03742037|471414113|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
130940133|NCT03742037|471414107|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
130940134|NCT03742037|471414108|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
130772197|NCT05052697|470792832|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130940135|NCT03742037|471414109|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
130940136|NCT03742037|471414110|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
130940137|NCT03742037|471414111|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
130940138|NCT03742037|471414112|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
130940139|NCT03742037|471414113|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
130940140|NCT03742037|471414107|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
130940141|NCT03742037|471414108|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
130940142|NCT03742037|471414109|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
130940143|NCT03742037|471414110|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
130940144|NCT03742037|471414111|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
130940145|NCT03742037|471414112|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
130940146|NCT03742037|471414113|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
130940147|NCT03742037|471414107|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
130940148|NCT03742037|471414108|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
130940149|NCT03742037|471414109|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
130940150|NCT03742037|471414110|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
131224135|NCT00789828|472447167|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
130940151|NCT03742037|471414111|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
130940152|NCT03742037|471414112|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
130940153|NCT03742037|471414113|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
130940154|NCT03742037|471414107|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130940155|NCT03742037|471414108|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130940156|NCT03742037|471414109|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130940157|NCT03742037|471414110|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130940158|NCT03742037|471414111|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130940159|NCT03742037|471414112|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
130940160|NCT03742037|471414113|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
130940161|NCT03742037|471414107|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
130940162|NCT03742037|471414108|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
130940163|NCT03742037|471414109|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
130940164|NCT03742037|471414110|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
130940165|NCT03742037|471414111|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
130940166|NCT03742037|471414112|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
130940167|NCT03742037|471414113|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
130940168|NCT03742037|471414107|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130940169|NCT03742037|471414108|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130940170|NCT03742037|471414109|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130940171|NCT03742037|471414110|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130940172|NCT03742037|471414111|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130940173|NCT03742037|471414112|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
130940174|NCT03742037|471414113|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
130940175|NCT03742037|471414107|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
130940176|NCT03742037|471414108|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
130940177|NCT03742037|471414109|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
130940178|NCT03742037|471414110|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
130940179|NCT03742037|471414111|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
130940180|NCT03742037|471414112|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
130940181|NCT03742037|471414113|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
130940182|NCT03742037|471414107|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
130940183|NCT03742037|471414108|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
130940184|NCT03742037|471414109|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
130940185|NCT03742037|471414110|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
130940186|NCT03742037|471414111|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
130940187|NCT03742037|471414112|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
130940188|NCT03742037|471414113|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
130940189|NCT03742037|471414107|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
130940190|NCT03742037|471414108|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
130940191|NCT03742037|471414109|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
130940192|NCT03742037|471414110|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
130940193|NCT03742037|471414111|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
130940194|NCT03742037|471414112|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
130940195|NCT03742037|471414113|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
130940196|NCT03742037|471414107|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
130940197|NCT03742037|471414108|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
130940198|NCT03742037|471414109|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
130940199|NCT03742037|471414110|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
130940200|NCT03742037|471414111|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
130940201|NCT03742037|471414112|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
130940202|NCT03742037|471414113|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
130706257|NCT00690482|470549671|FG001|Overall Study|Intake of prohibited medicine|0|||
130940203|NCT03742037|471414107|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
130706258|NCT00690482|470549670|FG000|Overall Study|withdrew consent at rand.day|0|||
130940204|NCT03742037|471414108|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
130940205|NCT03742037|471414109|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
130940206|NCT03742037|471414110|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
130940207|NCT03742037|471414111|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
130940208|NCT03742037|471414112|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
130940209|NCT03742037|471414113|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
130940210|NCT03742037|471414107|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
131036322|NCT04137289|471766297|FG006|Overall Study|Objective disease progression|18|||
130706259|NCT00690482|470549671|FG001|Overall Study|withdrew consent at rand.day|1|||
130706260|NCT01610063|470549672|FG000|Overall Study|Lost to Follow-up|42|||
130706261|NCT01610063|470549673|FG001|Overall Study|Lost to Follow-up|20|||
130706262|NCT04405739|470549674|FG000|Overall Study|Adverse Event|0|||
130706263|NCT04405739|470549675|FG001|Overall Study|Adverse Event|1|||
130706264|NCT04405739|470549676|FG002|Overall Study|Adverse Event|0|||
130706265|NCT04405739|470549677|FG003|Overall Study|Adverse Event|0|||
130706266|NCT04405739|470549674|FG000|Overall Study|Lost to Follow-up|0|||
130706267|NCT04405739|470549675|FG001|Overall Study|Lost to Follow-up|2|||
130706268|NCT04405739|470549676|FG002|Overall Study|Lost to Follow-up|1|||
130706269|NCT04405739|470549677|FG003|Overall Study|Lost to Follow-up|3|||
130706270|NCT04405739|470549674|FG000|Overall Study|Withdrawal by Subject|0|||
130706271|NCT04405739|470549675|FG001|Overall Study|Withdrawal by Subject|2|||
130706272|NCT04405739|470549676|FG002|Overall Study|Withdrawal by Subject|1|||
130706273|NCT04405739|470549677|FG003|Overall Study|Withdrawal by Subject|1|||
130706274|NCT04405739|470549674|FG000|Overall Study|Death|0|||
130706275|NCT04405739|470549675|FG001|Overall Study|Death|0|||
130706276|NCT04405739|470549676|FG002|Overall Study|Death|1|||
130706277|NCT04405739|470549677|FG003|Overall Study|Death|0|||
130706278|NCT04405739|470549674|FG000|Overall Study|Transferred to rehab|0|||
130706279|NCT04405739|470549675|FG001|Overall Study|Transferred to rehab|0|||
130706280|NCT04405739|470549676|FG002|Overall Study|Transferred to rehab|0|||
130706281|NCT04405739|470549677|FG003|Overall Study|Transferred to rehab|1|||
130706282|NCT04405739|470549674|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
130706283|NCT04405739|470549675|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
130706284|NCT04405739|470549676|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
130706285|NCT04405739|470549677|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
130706286|NCT01436643|470549678|FG000|2-week Pre-treatment|Abnormal test result|0|||
130706287|NCT01436643|470549679|FG001|2-week Pre-treatment|Abnormal test result|0|||
130706288|NCT01436643|470549680|FG002|2-week Pre-treatment|Abnormal test result|0|||
130706289|NCT01436643|470549681|FG003|2-week Pre-treatment|Abnormal test result|1|||
130706290|NCT01436643|470549678|FG000|2-week Pre-treatment|Adverse Event|0|||
130706291|NCT01436643|470549679|FG001|2-week Pre-treatment|Adverse Event|0|||
130706292|NCT01436643|470549680|FG002|2-week Pre-treatment|Adverse Event|0|||
130706293|NCT01436643|470549681|FG003|2-week Pre-treatment|Adverse Event|5|||
130706294|NCT01436643|470549678|FG000|2-week Pre-treatment|Protocol Violation|0|||
130706295|NCT01436643|470549679|FG001|2-week Pre-treatment|Protocol Violation|0|||
130706296|NCT01436643|470549680|FG002|2-week Pre-treatment|Protocol Violation|0|||
130706297|NCT01436643|470549681|FG003|2-week Pre-treatment|Protocol Violation|4|||
130706298|NCT01436643|470549678|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
130706299|NCT01436643|470549679|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
130706300|NCT01436643|470549680|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
130706301|NCT01436643|470549681|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
130706302|NCT01436643|470549678|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
130706303|NCT01436643|470549679|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
130706304|NCT01436643|470549680|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
130706305|NCT01436643|470549681|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
130706306|NCT01436643|470549678|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
130706307|NCT01436643|470549679|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
130706308|NCT01436643|470549680|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
130706309|NCT01436643|470549681|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
130706310|NCT03718117|470549682|FG000|Overall Study|Death|12|||
130706311|NCT03718117|470549683|FG001|Overall Study|Death|11|||
130706312|NCT03718117|470549684|FG002|Overall Study|Death|0|||
130706313|NCT03718117|470549682|FG000|Overall Study|Other|0|||
130706314|NCT03718117|470549683|FG001|Overall Study|Other|1|||
130706315|NCT03718117|470549684|FG002|Overall Study|Other|0|||
130706316|NCT03718117|470549682|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
130706317|NCT03718117|470549683|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
131036323|NCT04137289|471766298|FG007|Overall Study|Objective disease progression|7|||
131036324|NCT04137289|471766299|FG008|Overall Study|Objective disease progression|6|||
131036325|NCT03931174|471766304|FG000|Providers|Staff left organization|26|||
131036326|NCT03931174|471766305|FG001|Providers|Staff left organization|25|||
130706318|NCT03718117|470549684|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
130706319|NCT03718117|470549682|FG000|Overall Study|Participant not met eligibility criteria|0|||
130706320|NCT03718117|470549683|FG001|Overall Study|Participant not met eligibility criteria|0|||
130706321|NCT03718117|470549684|FG002|Overall Study|Participant not met eligibility criteria|2|||
130706322|NCT02056652|470549687|FG000|Overall Study|Withdrawal by Subject|1|||
130706323|NCT02056652|470549688|FG001|Overall Study|Withdrawal by Subject|0|||
130706324|NCT02056652|470549687|FG000|Overall Study|Lost to Follow-up|0|||
130706325|NCT02056652|470549688|FG001|Overall Study|Lost to Follow-up|3|||
130706326|NCT04232540|470549689|FG000|Overall Study|Lost to Follow-up|1|||
130706327|NCT04232540|470549690|FG001|Overall Study|Lost to Follow-up|0|||
130706328|NCT02105701|470549691|FG000|Overall Study|Lost to Follow-up|1|||
130706329|NCT02105701|470549692|FG001|Overall Study|Lost to Follow-up|0|||
131036327|NCT03931174|471766304|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
131036328|NCT03931174|471766305|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
131036329|NCT03931174|471766304|FG000|Providers|Lost to Follow-up|4|||
131036330|NCT03931174|471766305|FG001|Providers|Lost to Follow-up|4|||
131036331|NCT03931174|471766304|FG000|Patients|Post-consent screening failure|1|||
131036332|NCT03931174|471766305|FG001|Patients|Post-consent screening failure|1|||
131036333|NCT03931174|471766304|FG000|Patients|Death|1|||
131036334|NCT03931174|471766305|FG001|Patients|Death|1|||
131036335|NCT03931174|471766304|FG000|Patients|Lost to Follow-up|60|||
131036336|NCT03931174|471766305|FG001|Patients|Lost to Follow-up|89|||
130940211|NCT03742037|471414108|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
130940212|NCT03742037|471414109|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
130940213|NCT03742037|471414110|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
130940214|NCT03742037|471414111|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
130940215|NCT03742037|471414112|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
130940216|NCT03742037|471414113|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
130940217|NCT03742037|471414107|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130940218|NCT03742037|471414108|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130940219|NCT03742037|471414109|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
130940220|NCT03742037|471414110|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130940221|NCT03742037|471414111|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130940222|NCT03742037|471414112|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130940223|NCT03742037|471414113|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
130940224|NCT00383149|471414122|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
130940225|NCT00383149|471414122|FG000|Overall Study|Death|2|||
130940226|NCT00383149|471414122|FG000|Overall Study|Disease Progression|38|||
130940227|NCT00383149|471414122|FG000|Overall Study|Lost to Follow-up|1|||
130940228|NCT00383149|471414122|FG000|Overall Study|Other|1|||
130940229|NCT00383149|471414122|FG000|Overall Study|Study Drug Toxicity|4|||
130940230|NCT00383149|471414122|FG000|Overall Study|Request to Discontinue Treatment|4|||
130940231|NCT00383149|471414122|FG000|Overall Study|Participant Withdrew Consent|1|||
130940232|NCT00450333|471414123|FG000|Overall Study|Study terminated|47|||
130940233|NCT00450333|471414124|FG001|Overall Study|Study terminated|54|||
130940234|NCT00450333|471414125|FG002|Overall Study|Study terminated|16|||
130940235|NCT00450333|471414126|FG003|Overall Study|Study terminated|21|||
130940236|NCT00450333|471414123|FG000|Overall Study|Adverse Event|1|||
130940237|NCT00450333|471414124|FG001|Overall Study|Adverse Event|7|||
130940238|NCT00450333|471414125|FG002|Overall Study|Adverse Event|2|||
130940239|NCT00450333|471414126|FG003|Overall Study|Adverse Event|2|||
130940240|NCT00450333|471414123|FG000|Overall Study|Protocol Violation|1|||
130940241|NCT00450333|471414124|FG001|Overall Study|Protocol Violation|0|||
130940242|NCT00450333|471414125|FG002|Overall Study|Protocol Violation|1|||
130940243|NCT00450333|471414126|FG003|Overall Study|Protocol Violation|0|||
130940244|NCT00450333|471414123|FG000|Overall Study|Withdrawal by Subject|1|||
130940245|NCT00450333|471414124|FG001|Overall Study|Withdrawal by Subject|0|||
130940246|NCT00450333|471414125|FG002|Overall Study|Withdrawal by Subject|3|||
130940247|NCT00450333|471414126|FG003|Overall Study|Withdrawal by Subject|0|||
130940248|NCT00450333|471414123|FG000|Overall Study|Kidney transplant|1|||
130940249|NCT00450333|471414124|FG001|Overall Study|Kidney transplant|0|||
130940250|NCT00450333|471414125|FG002|Overall Study|Kidney transplant|1|||
130940251|NCT00450333|471414126|FG003|Overall Study|Kidney transplant|3|||
130940252|NCT00450333|471414123|FG000|Overall Study|Death|3|||
130940253|NCT00450333|471414124|FG001|Overall Study|Death|2|||
130940254|NCT00450333|471414125|FG002|Overall Study|Death|2|||
130940255|NCT00450333|471414126|FG003|Overall Study|Death|2|||
130940256|NCT00416078|471414139|FG000|Overall Study|Death|3|||
130706330|NCT02105701|470549693|FG002|Overall Study|Lost to Follow-up|2|||
130940257|NCT00416078|471414140|FG001|Overall Study|Death|4|||
130940258|NCT00416078|471414139|FG000|Overall Study|Withdrawal by Subject|3|||
130940259|NCT00416078|471414140|FG001|Overall Study|Withdrawal by Subject|2|||
130940260|NCT00416078|471414139|FG000|Overall Study|Physician Decision|1|||
130940261|NCT00416078|471414140|FG001|Overall Study|Physician Decision|0|||
130940262|NCT00416078|471414139|FG000|Overall Study|Lost to Follow-up|4|||
130940263|NCT00416078|471414140|FG001|Overall Study|Lost to Follow-up|2|||
131224136|NCT00789828|472447166|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
130940264|NCT00969150|471414149|FG000|Overall Study|Adverse Event|4|||
130940265|NCT00969150|471414150|FG001|Overall Study|Adverse Event|14|||
130940266|NCT00969150|471414149|FG000|Overall Study|Lack of Efficacy|1|||
130940267|NCT00969150|471414150|FG001|Overall Study|Lack of Efficacy|1|||
130940268|NCT00969150|471414149|FG000|Overall Study|Protocol Violation|9|||
130940269|NCT00969150|471414150|FG001|Overall Study|Protocol Violation|12|||
131123087|NCT01877915|472079727|FG000|Overall Study|Withdrawal by Subject|42|||
131123088|NCT01877915|472079728|FG001|Overall Study|Withdrawal by Subject|55|||
131123089|NCT01877915|472079727|FG000|Overall Study|Other|2|||
131123090|NCT01877915|472079728|FG001|Overall Study|Other|4|||
131123091|NCT05678257|472079729|FG000|Overall Study|Withdrawal by Subject|2|||
131123092|NCT05678257|472079730|FG001|Overall Study|Withdrawal by Subject|0|||
131123093|NCT05678257|472079731|FG002|Overall Study|Withdrawal by Subject|5|||
131123094|NCT05678257|472079729|FG000|Overall Study|Physician Decision|1|||
131123095|NCT05678257|472079730|FG001|Overall Study|Physician Decision|0|||
130940270|NCT00969150|471414149|FG000|Overall Study|Withdrawal by Subject|13|||
130940271|NCT00969150|471414150|FG001|Overall Study|Withdrawal by Subject|9|||
130940272|NCT00969150|471414149|FG000|Overall Study|Lost to Follow-up|5|||
130940273|NCT00969150|471414150|FG001|Overall Study|Lost to Follow-up|4|||
130940274|NCT00969150|471414149|FG000|Overall Study|Other reasons|1|||
130940275|NCT00969150|471414150|FG001|Overall Study|Other reasons|0|||
130940276|NCT00461682|471414154|FG000|Overall Study|Protocol Violation|1|||
130940277|NCT04128267|471414163|FG000|Overall Study|Withdrawal by Subject|6|||
130940278|NCT04128267|471414163|FG000|Overall Study|Death|2|||
130940279|NCT04128267|471414163|FG000|Overall Study|Disease progression|1|||
130940280|NCT04128267|471414163|FG000|Overall Study|Participant had other medical issues|4|||
130940281|NCT04128267|471414163|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
130940282|NCT01026792|471414164|FG000|Overall Study|Protocol Violation|1|||
130940283|NCT00309842|471414165|FG000|Overall Study|Lost to Follow-up|1|||
130940284|NCT00423150|471414166|FG000|Overall Study|Adverse Event|11|||
130940285|NCT00423150|471414166|FG000|Overall Study|Progression of disease being studied|69|||
131036349|NCT03492216|471766308|FG000|Overall Study|Death|1|||
131036350|NCT03492216|471766309|FG001|Overall Study|Death|0|||
131036351|NCT03492216|471766310|FG002|Overall Study|Death|4|||
131036352|NCT03492216|471766311|FG003|Overall Study|Death|0|||
131036353|NCT03492216|471766308|FG000|Overall Study|Withdrawal by Subject|5|||
131036354|NCT03492216|471766309|FG001|Overall Study|Withdrawal by Subject|3|||
131036355|NCT03492216|471766310|FG002|Overall Study|Withdrawal by Subject|1|||
131036356|NCT03492216|471766311|FG003|Overall Study|Withdrawal by Subject|1|||
131036357|NCT03492216|471766308|FG000|Overall Study|Lost to Follow-up|9|||
131036358|NCT03492216|471766309|FG001|Overall Study|Lost to Follow-up|2|||
131036359|NCT03492216|471766310|FG002|Overall Study|Lost to Follow-up|7|||
131036360|NCT03492216|471766311|FG003|Overall Study|Lost to Follow-up|8|||
131036361|NCT03492216|471766308|FG000|Overall Study|Moved|5|||
131036362|NCT03492216|471766309|FG001|Overall Study|Moved|3|||
131036363|NCT03492216|471766310|FG002|Overall Study|Moved|3|||
131036364|NCT03492216|471766311|FG003|Overall Study|Moved|5|||
131036365|NCT03492216|471766308|FG000|Overall Study|Too ill|0|||
131036366|NCT03492216|471766309|FG001|Overall Study|Too ill|1|||
131036367|NCT03492216|471766310|FG002|Overall Study|Too ill|0|||
131036368|NCT03492216|471766311|FG003|Overall Study|Too ill|0|||
131036369|NCT03492216|471766308|FG000|Overall Study|Incarcerated|0|||
131036370|NCT03492216|471766309|FG001|Overall Study|Incarcerated|0|||
131036371|NCT03492216|471766310|FG002|Overall Study|Incarcerated|2|||
131036372|NCT03492216|471766311|FG003|Overall Study|Incarcerated|0|||
131123096|NCT05678257|472079731|FG002|Overall Study|Physician Decision|1|||
131123097|NCT05678257|472079729|FG000|Overall Study|Adverse Event|1|||
130940286|NCT00423150|471414166|FG000|Overall Study|Withdrawal by Subject|1|||
130940287|NCT00423150|471414166|FG000|Overall Study|Non-compliance with protocol|1|||
131036373|NCT05028634|471768115|FG000|Overall Study|Withdrawal by Subject|0|||
131036374|NCT05028634|471768116|FG001|Overall Study|Withdrawal by Subject|1|||
131036375|NCT03869866|471768117|FG000|Overall Study|Protocol Violation|1|||
131036376|NCT03869866|471768117|FG000|Overall Study|Withdrawal by Subject|3|||
131036377|NCT06190691|471768127|FG000|Overall Study|Adverse Event|2|||
131036378|NCT06190691|471768128|FG001|Overall Study|Adverse Event|0|||
131036379|NCT06190691|471768129|FG002|Overall Study|Adverse Event|0|||
131036380|NCT06190691|471768130|FG003|Overall Study|Adverse Event|0|||
131123098|NCT05678257|472079730|FG001|Overall Study|Adverse Event|3|||
131123099|NCT05678257|472079731|FG002|Overall Study|Adverse Event|1|||
130940288|NCT00423150|471414166|FG000|Overall Study|Administrative|4|||
130940289|NCT03204305|471414167|FG000|Overall Study|Lost to Follow-up|6|||
130940290|NCT03204305|471414168|FG001|Overall Study|Lost to Follow-up|4|||
130706331|NCT02105701|470549694|FG003|Overall Study|Lost to Follow-up|1|||
130706332|NCT02105701|470549691|FG000|Overall Study|Protocol Violation|0|||
130706333|NCT02105701|470549692|FG001|Overall Study|Protocol Violation|0|||
130706334|NCT02105701|470549693|FG002|Overall Study|Protocol Violation|1|||
130706335|NCT02105701|470549694|FG003|Overall Study|Protocol Violation|0|||
130706336|NCT02105701|470549691|FG000|Overall Study|Withdrawal by Subject|2|||
130706337|NCT02105701|470549692|FG001|Overall Study|Withdrawal by Subject|1|||
130940291|NCT03204305|471414169|FG002|Overall Study|Lost to Follow-up|0|||
130940292|NCT03204305|471414170|FG003|Overall Study|Lost to Follow-up|0|||
130940293|NCT03204305|471414167|FG000|Overall Study|Physician Decision|1|||
130940294|NCT03204305|471414168|FG001|Overall Study|Physician Decision|0|||
130940295|NCT03204305|471414169|FG002|Overall Study|Physician Decision|0|||
130940296|NCT03204305|471414170|FG003|Overall Study|Physician Decision|0|||
130940297|NCT03204305|471414167|FG000|Overall Study|failure to place arterial line|2|||
130940298|NCT03204305|471414168|FG001|Overall Study|failure to place arterial line|1|||
130940299|NCT03204305|471414169|FG002|Overall Study|failure to place arterial line|0|||
130940300|NCT03204305|471414170|FG003|Overall Study|failure to place arterial line|0|||
130940301|NCT03204305|471414167|FG000|Overall Study|Withdrawal by Subject|2|||
130940302|NCT03204305|471414168|FG001|Overall Study|Withdrawal by Subject|0|||
130940303|NCT03204305|471414169|FG002|Overall Study|Withdrawal by Subject|0|||
130940304|NCT03204305|471414170|FG003|Overall Study|Withdrawal by Subject|0|||
130940305|NCT02045797|471414171|FG000|Overall Study|Adverse Event|3|||
130940306|NCT02045797|471414172|FG001|Overall Study|Adverse Event|1|||
130940307|NCT02045797|471414173|FG002|Overall Study|Adverse Event|0|||
130940308|NCT02045797|471414171|FG000|Overall Study|Lack of Efficacy|1|||
130940309|NCT02045797|471414172|FG001|Overall Study|Lack of Efficacy|0|||
130940310|NCT02045797|471414173|FG002|Overall Study|Lack of Efficacy|0|||
130940311|NCT02045797|471414171|FG000|Overall Study|Lost to Follow-up|2|||
130940312|NCT02045797|471414172|FG001|Overall Study|Lost to Follow-up|3|||
130940313|NCT02045797|471414173|FG002|Overall Study|Lost to Follow-up|1|||
130940314|NCT02045797|471414171|FG000|Overall Study|Physician Decision|0|||
130940315|NCT02045797|471414172|FG001|Overall Study|Physician Decision|1|||
130940316|NCT02045797|471414173|FG002|Overall Study|Physician Decision|0|||
130940317|NCT02045797|471414171|FG000|Overall Study|Withdrawal by Subject|1|||
130940318|NCT02045797|471414172|FG001|Overall Study|Withdrawal by Subject|2|||
130940319|NCT02045797|471414173|FG002|Overall Study|Withdrawal by Subject|0|||
130940320|NCT00101907|471414177|FG000|Overall Study|Adverse Event|1|||
130940321|NCT00101907|471414178|FG001|Overall Study|Adverse Event|0|||
130940322|NCT00101907|471414179|FG002|Overall Study|Adverse Event|0|||
130940323|NCT00101907|471414180|FG003|Overall Study|Adverse Event|0|||
130940324|NCT00101907|471414181|FG004|Overall Study|Adverse Event|0|||
130940325|NCT00101907|471414182|FG005|Overall Study|Adverse Event|0|||
130706338|NCT02105701|470549693|FG002|Overall Study|Withdrawal by Subject|0|||
130706339|NCT02105701|470549694|FG003|Overall Study|Withdrawal by Subject|1|||
130706340|NCT02105701|470549691|FG000|Overall Study|Death|1|||
130706341|NCT02105701|470549692|FG001|Overall Study|Death|0|||
130706342|NCT02105701|470549693|FG002|Overall Study|Death|0|||
130706343|NCT02105701|470549694|FG003|Overall Study|Death|0|||
130706344|NCT02148445|470549695|FG000|Overall Study|Death|1|||
130706345|NCT02148445|470549696|FG001|Overall Study|Death|3|||
130706346|NCT03450629|470549697|FG000|Overall Study|Adverse Event|15|||
130706347|NCT03450629|470549698|FG001|Overall Study|Adverse Event|14|||
130706348|NCT03450629|470549697|FG000|Overall Study|Physician Decision|2|||
130706349|NCT03450629|470549698|FG001|Overall Study|Physician Decision|2|||
130706350|NCT03450629|470549697|FG000|Overall Study|Lack of Efficacy|2|||
130706351|NCT03450629|470549698|FG001|Overall Study|Lack of Efficacy|0|||
130706352|NCT03450629|470549697|FG000|Overall Study|Lost to Follow-up|4|||
130706353|NCT03450629|470549698|FG001|Overall Study|Lost to Follow-up|2|||
130706354|NCT03450629|470549697|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130706355|NCT03450629|470549698|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
130706356|NCT03450629|470549697|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130706357|NCT03450629|470549698|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130940326|NCT00101907|471414177|FG000|Overall Study|Death|0|||
130940327|NCT00101907|471414178|FG001|Overall Study|Death|1|||
130940328|NCT00101907|471414179|FG002|Overall Study|Death|0|||
130940329|NCT00101907|471414180|FG003|Overall Study|Death|0|||
130940330|NCT00101907|471414181|FG004|Overall Study|Death|3|||
130940331|NCT00101907|471414182|FG005|Overall Study|Death|0|||
130940332|NCT00101907|471414177|FG000|Overall Study|Physician Decision|0|||
130706358|NCT03450629|470549697|FG000|Overall Study|Protocol Violation|11|||
130706359|NCT03450629|470549698|FG001|Overall Study|Protocol Violation|8|||
130706360|NCT03450629|470549697|FG000|Overall Study|Withdrawal by Subject|12|||
130706361|NCT03450629|470549698|FG001|Overall Study|Withdrawal by Subject|6|||
130706362|NCT04230876|470549699|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
130940333|NCT00101907|471414178|FG001|Overall Study|Physician Decision|0|||
130940334|NCT00101907|471414179|FG002|Overall Study|Physician Decision|0|||
130940335|NCT00101907|471414180|FG003|Overall Study|Physician Decision|1|||
130940336|NCT00101907|471414181|FG004|Overall Study|Physician Decision|1|||
130940337|NCT00101907|471414182|FG005|Overall Study|Physician Decision|0|||
130940338|NCT00101907|471414177|FG000|Overall Study|Withdrawal by Subject|1|||
131123100|NCT05678257|472079729|FG000|Overall Study|Progressive disease|11|||
131123101|NCT05678257|472079730|FG001|Overall Study|Progressive disease|18|||
131123102|NCT05678257|472079731|FG002|Overall Study|Progressive disease|7|||
131123103|NCT05678257|472079729|FG000|Overall Study|No longer clinically benefitting|2|||
131123104|NCT05678257|472079730|FG001|Overall Study|No longer clinically benefitting|1|||
131123105|NCT05678257|472079731|FG002|Overall Study|No longer clinically benefitting|0|||
131123106|NCT05678257|472079729|FG000|Overall Study|Sponsor decision|5|||
131123107|NCT05678257|472079730|FG001|Overall Study|Sponsor decision|9|||
131123108|NCT05678257|472079731|FG002|Overall Study|Sponsor decision|8|||
131123109|NCT05678257|472079729|FG000|Overall Study|Protocol Violation|0|||
131123110|NCT05678257|472079730|FG001|Overall Study|Protocol Violation|0|||
130940339|NCT00101907|471414178|FG001|Overall Study|Withdrawal by Subject|0|||
130940340|NCT00101907|471414179|FG002|Overall Study|Withdrawal by Subject|1|||
130940341|NCT00101907|471414180|FG003|Overall Study|Withdrawal by Subject|0|||
130940342|NCT00101907|471414181|FG004|Overall Study|Withdrawal by Subject|1|||
130940343|NCT00101907|471414182|FG005|Overall Study|Withdrawal by Subject|0|||
130940344|NCT03279692|471414185|FG000|Overall Study|Withdrawal by Subject|1|||
130940345|NCT04958785|471415002|FG000|Overall Study|Study Terminated by Sponsor|4|||
130940346|NCT04958785|471415003|FG001|Overall Study|Study Terminated by Sponsor|10|||
130940347|NCT04958785|471415004|FG002|Overall Study|Study Terminated by Sponsor|7|||
130940348|NCT04958785|471415005|FG003|Overall Study|Study Terminated by Sponsor|6|||
130940349|NCT04958785|471415006|FG004|Overall Study|Study Terminated by Sponsor|34|||
130940350|NCT04958785|471415002|FG000|Overall Study|Death|2|||
130940351|NCT04958785|471415003|FG001|Overall Study|Death|3|||
130940352|NCT04958785|471415004|FG002|Overall Study|Death|4|||
130940353|NCT04958785|471415005|FG003|Overall Study|Death|5|||
130940354|NCT04958785|471415006|FG004|Overall Study|Death|5|||
130940355|NCT04958785|471415002|FG000|Overall Study|Withdrew consent|2|||
130940356|NCT04958785|471415003|FG001|Overall Study|Withdrew consent|0|||
130940357|NCT04958785|471415004|FG002|Overall Study|Withdrew consent|3|||
130940358|NCT04958785|471415005|FG003|Overall Study|Withdrew consent|1|||
130940359|NCT04958785|471415006|FG004|Overall Study|Withdrew consent|0|||
130940360|NCT04958785|471415002|FG000|Overall Study|Investigator's discretion|0|||
130940361|NCT04958785|471415003|FG001|Overall Study|Investigator's discretion|1|||
130940362|NCT04958785|471415004|FG002|Overall Study|Investigator's discretion|0|||
130940363|NCT04958785|471415005|FG003|Overall Study|Investigator's discretion|1|||
130940364|NCT04958785|471415006|FG004|Overall Study|Investigator's discretion|2|||
130940365|NCT04958785|471415002|FG000|Overall Study|Adverse Event|0|||
130940366|NCT04958785|471415003|FG001|Overall Study|Adverse Event|0|||
130940367|NCT04958785|471415004|FG002|Overall Study|Adverse Event|0|||
130940368|NCT04958785|471415005|FG003|Overall Study|Adverse Event|0|||
130940369|NCT04958785|471415006|FG004|Overall Study|Adverse Event|1|||
130940370|NCT04958785|471415002|FG000|Overall Study|Lost to Follow-up|0|||
130940371|NCT04958785|471415003|FG001|Overall Study|Lost to Follow-up|0|||
130940372|NCT04958785|471415004|FG002|Overall Study|Lost to Follow-up|0|||
130940373|NCT04958785|471415005|FG003|Overall Study|Lost to Follow-up|0|||
130940374|NCT04958785|471415006|FG004|Overall Study|Lost to Follow-up|1|||
130940375|NCT03274687|471415015|FG000|Overall Study|Protocol Violation|1|||
130940376|NCT03274687|471415016|FG001|Overall Study|Protocol Violation|1|||
130940377|NCT04734652|471415021|FG000|Overall Study|Withdrawal by Subject|2|||
130940378|NCT04734652|471415022|FG001|Overall Study|Withdrawal by Subject|0|||
130940379|NCT04734652|471415021|FG000|Overall Study|Death|0|||
130940380|NCT04734652|471415022|FG001|Overall Study|Death|1|||
130940381|NCT03232281|471415023|FG000|Overall Study|Adverse Event|1|||
130940382|NCT03232281|471415024|FG001|Overall Study|Adverse Event|1|||
130940383|NCT03232281|471415023|FG000|Overall Study|Withdrawal by Subject|5|||
130940384|NCT03232281|471415024|FG001|Overall Study|Withdrawal by Subject|4|||
130940385|NCT03232281|471415023|FG000|Overall Study|Protocol Deviation|1|||
130940386|NCT03232281|471415024|FG001|Overall Study|Protocol Deviation|1|||
130940387|NCT02132767|471415028|FG000|Overall Study|Death|3|||
130940388|NCT02132767|471415029|FG001|Overall Study|Death|2|||
130940389|NCT02132767|471415028|FG000|Overall Study|Withdrawal by Subject|10|||
130940390|NCT02132767|471415029|FG001|Overall Study|Withdrawal by Subject|9|||
130940391|NCT02132767|471415028|FG000|Overall Study|Lost to Follow-up|4|||
131123111|NCT05678257|472079731|FG002|Overall Study|Protocol Violation|1|||
130940392|NCT02132767|471415029|FG001|Overall Study|Lost to Follow-up|4|||
131123112|NCT05678257|472079729|FG000|Overall Study|Patient non-compliance|0|||
131123113|NCT05678257|472079730|FG001|Overall Study|Patient non-compliance|0|||
131123114|NCT05678257|472079731|FG002|Overall Study|Patient non-compliance|3|||
130940393|NCT00778700|471415032|FG000|Overall Study|Adverse Event|6|||
130940394|NCT00778700|471415033|FG001|Overall Study|Adverse Event|1|||
130940395|NCT00778700|471415034|FG002|Overall Study|Adverse Event|3|||
130940396|NCT00778700|471415035|FG003|Overall Study|Adverse Event|5|||
130940397|NCT00778700|471415032|FG000|Overall Study|Protocol Violation|1|||
130940398|NCT00778700|471415033|FG001|Overall Study|Protocol Violation|1|||
130940399|NCT00778700|471415034|FG002|Overall Study|Protocol Violation|0|||
130940400|NCT00778700|471415035|FG003|Overall Study|Protocol Violation|0|||
130940401|NCT00778700|471415032|FG000|Overall Study|Subject Withdrew Consent|6|||
130706363|NCT04230876|470549700|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
130706364|NCT03438006|470549704|FG000|Overall Study|Adverse Event|1|||
130706365|NCT03438006|470549704|FG000|Overall Study|Lost to Follow-up|67|||
130706366|NCT03438006|470549704|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
130706367|NCT03438006|470549704|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
130706368|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
130706369|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706370|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706371|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706372|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706373|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706374|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706375|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706376|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130706377|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
130706378|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706379|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706380|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706381|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706382|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706383|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706384|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706385|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130706386|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
130706387|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706388|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706389|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706390|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706391|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706392|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706393|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706394|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130706395|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
130706396|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706397|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706398|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706399|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706400|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706401|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706402|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706403|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130706404|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
130706405|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706406|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706407|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706408|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706409|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706410|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706411|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706412|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130706413|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
130706414|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706415|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706416|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706417|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706418|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706419|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706420|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
131036381|NCT02485938|471768131|FG000|Overall Study|Withdrawal of consent|2|||
131036382|NCT02485938|471768132|FG001|Overall Study|Withdrawal of consent|0|||
131036383|NCT04908722|471768135|FG000|Overall Study|Protocol deviation|1|||
131036384|NCT04908722|471768136|FG001|Overall Study|Protocol deviation|0|||
131036385|NCT04908722|471768137|FG002|Overall Study|Protocol deviation|0|||
131036386|NCT04908722|471768138|FG003|Overall Study|Protocol deviation|0|||
131224137|NCT00789828|472447167|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
131224138|NCT05788237|472447168|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
131224139|NCT05788237|472447169|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
131224140|NCT05788237|472447170|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
131224141|NCT05788237|472447171|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
131224142|NCT05788237|472447168|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
131224143|NCT05788237|472447169|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
131224144|NCT05788237|472447170|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
131224145|NCT05788237|472447171|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
131224146|NCT05788237|472447168|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
131224147|NCT05788237|472447169|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
131224148|NCT05788237|472447170|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
131224149|NCT05788237|472447171|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
131224150|NCT05788237|472447168|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
131224151|NCT05788237|472447169|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
131224152|NCT05788237|472447170|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
131123115|NCT02046096|472079732|FG000|Overall Study|Death|28|||
131123116|NCT02046096|472079733|FG001|Overall Study|Death|45|||
131123117|NCT02046096|472079732|FG000|Overall Study|Lost to Follow-up|9|||
131123118|NCT02046096|472079733|FG001|Overall Study|Lost to Follow-up|20|||
131123119|NCT02046096|472079732|FG000|Overall Study|Withdrawal by Subject|5|||
131123120|NCT02046096|472079733|FG001|Overall Study|Withdrawal by Subject|17|||
131224153|NCT05788237|472447171|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
130940402|NCT00778700|471415033|FG001|Overall Study|Subject Withdrew Consent|4|||
130940403|NCT00778700|471415034|FG002|Overall Study|Subject Withdrew Consent|1|||
130940404|NCT00778700|471415035|FG003|Overall Study|Subject Withdrew Consent|4|||
130940405|NCT00778700|471415032|FG000|Overall Study|Lost to Follow-up|3|||
130940406|NCT00778700|471415033|FG001|Overall Study|Lost to Follow-up|1|||
130940407|NCT00778700|471415034|FG002|Overall Study|Lost to Follow-up|0|||
130940408|NCT00778700|471415035|FG003|Overall Study|Lost to Follow-up|1|||
130940409|NCT00778700|471415032|FG000|Overall Study|Reason not Specified|2|||
130940410|NCT00778700|471415033|FG001|Overall Study|Reason not Specified|0|||
130940411|NCT00778700|471415034|FG002|Overall Study|Reason not Specified|1|||
130940412|NCT00778700|471415035|FG003|Overall Study|Reason not Specified|3|||
130940413|NCT00778700|471415032|FG000|Overall Study|Other|0|||
130940414|NCT00778700|471415033|FG001|Overall Study|Other|0|||
130940415|NCT00778700|471415034|FG002|Overall Study|Other|1|||
130940416|NCT00778700|471415035|FG003|Overall Study|Other|0|||
130940417|NCT04267133|471415043|FG000|Overall Study|Withdrawal by Subject|1|||
130940418|NCT04267133|471415043|FG000|Overall Study|Adverse Event|4|||
130940419|NCT05104476|471415045|FG000|Overall Study|Randomized But Not Treated|1|||
130940420|NCT05104476|471415046|FG001|Overall Study|Randomized But Not Treated|2|||
130940421|NCT05104476|471415045|FG000|Overall Study|Adverse Event|2|||
130940422|NCT05104476|471415046|FG001|Overall Study|Adverse Event|2|||
130940423|NCT05104476|471415045|FG000|Overall Study|Withdrawal by Subject|3|||
130940424|NCT05104476|471415046|FG001|Overall Study|Withdrawal by Subject|3|||
130940425|NCT05104476|471415045|FG000|Overall Study|Other Than Specified|0|||
130940426|NCT05104476|471415046|FG001|Overall Study|Other Than Specified|3|||
130940427|NCT04008030|471415047|FG000|Pre-Treatment|Withdrawal by Subject|0|||
130940428|NCT04008030|471415048|FG001|Pre-Treatment|Withdrawal by Subject|0|||
130940429|NCT04008030|471415049|FG002|Pre-Treatment|Withdrawal by Subject|9|||
130940430|NCT04008030|471415047|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
130940431|NCT04008030|471415048|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
130940432|NCT04008030|471415049|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
130940433|NCT04008030|471415047|FG000|Pre-Treatment|Other reasons|0|||
130940434|NCT04008030|471415048|FG001|Pre-Treatment|Other reasons|1|||
130940435|NCT04008030|471415049|FG002|Pre-Treatment|Other reasons|6|||
130940436|NCT04008030|471415047|FG000|Treatment|Withdrawal by Subject|1|||
130940437|NCT04008030|471415048|FG001|Treatment|Withdrawal by Subject|1|||
130940438|NCT04008030|471415049|FG002|Treatment|Withdrawal by Subject|1|||
130940439|NCT04008030|471415047|FG000|Treatment|Death|2|||
130940440|NCT04008030|471415048|FG001|Treatment|Death|4|||
130940441|NCT04008030|471415049|FG002|Treatment|Death|0|||
130940442|NCT04008030|471415047|FG000|Treatment|Pregnancy|0|||
130940443|NCT04008030|471415048|FG001|Treatment|Pregnancy|1|||
130940444|NCT04008030|471415049|FG002|Treatment|Pregnancy|0|||
131224154|NCT05788237|472447168|FG000|SSA (Approximately 2 Months)|Death|0|||
130940445|NCT04008030|471415047|FG000|Treatment|Participant no longer meets study criteria|0|||
130940446|NCT04008030|471415048|FG001|Treatment|Participant no longer meets study criteria|1|||
130940447|NCT04008030|471415049|FG002|Treatment|Participant no longer meets study criteria|0|||
131123121|NCT02046096|472079732|FG000|Overall Study|Other endpoint|2|||
131123122|NCT02046096|472079733|FG001|Overall Study|Other endpoint|19|||
131123123|NCT03520959|472079734|FG000|Overall Study|Study terminated by Sponsor|0|||
131123124|NCT03520959|472079735|FG001|Overall Study|Study terminated by Sponsor|1|||
130940448|NCT04008030|471415047|FG000|Treatment|Other reasons|5|||
130940449|NCT04008030|471415048|FG001|Treatment|Other reasons|13|||
130940450|NCT04008030|471415049|FG002|Treatment|Other reasons|6|||
130940451|NCT04008030|471415047|FG000|Treatment|Disease Progression|137|||
130940452|NCT04008030|471415048|FG001|Treatment|Disease Progression|82|||
130940453|NCT04008030|471415049|FG002|Treatment|Disease Progression|85|||
130940454|NCT04008030|471415047|FG000|Treatment|Study drug toxicity|28|||
130940455|NCT04008030|471415048|FG001|Treatment|Study drug toxicity|48|||
130940456|NCT04008030|471415049|FG002|Treatment|Study drug toxicity|8|||
130940457|NCT04008030|471415047|FG000|Treatment|Adverse Event unrelated to study drug|28|||
130940458|NCT04008030|471415048|FG001|Treatment|Adverse Event unrelated to study drug|22|||
130940459|NCT04008030|471415049|FG002|Treatment|Adverse Event unrelated to study drug|6|||
130940460|NCT04008030|471415047|FG000|Treatment|Maximum Clinical Benefit|0|||
130940461|NCT04008030|471415048|FG001|Treatment|Maximum Clinical Benefit|1|||
130940462|NCT04008030|471415049|FG002|Treatment|Maximum Clinical Benefit|9|||
130940463|NCT04008030|471415047|FG000|Treatment|On-going treatment|13|||
130940464|NCT04008030|471415048|FG001|Treatment|On-going treatment|20|||
130940465|NCT04008030|471415049|FG002|Treatment|On-going treatment|0|||
130940466|NCT00003901|471415053|FG000|Overall Study|Adverse Event|1|||
130940467|NCT00003901|471415053|FG000|Overall Study|Withdrawal by Subject|1|||
130940468|NCT00003901|471415053|FG000|Overall Study|Ineligible|6|||
130940469|NCT00003901|471415053|FG000|Overall Study|CT Scan not within protocol requirement|2|||
130940470|NCT00003901|471415053|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
130940471|NCT00003901|471415053|FG000|Overall Study|Medical problems|6|||
130940472|NCT04447755|471415058|FG000|Overall Study|Death|9|||
130940473|NCT04447755|471415059|FG001|Overall Study|Death|16|||
130940474|NCT04447755|471415060|FG002|Overall Study|Death|8|||
130940475|NCT04447755|471415061|FG003|Overall Study|Death|9|||
130940476|NCT04447755|471415062|FG004|Overall Study|Death|8|||
130940477|NCT04447755|471415063|FG005|Overall Study|Death|9|||
130940478|NCT04447755|471415064|FG006|Overall Study|Death|55|||
130940479|NCT04447755|471415058|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130940480|NCT04447755|471415059|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130940481|NCT04447755|471415060|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130940482|NCT04447755|471415061|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130940483|NCT04447755|471415062|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130940484|NCT04447755|471415063|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130940485|NCT04447755|471415064|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
130940486|NCT04447755|471415058|FG000|Overall Study|Sponsor Decision|0|||
130940487|NCT04447755|471415059|FG001|Overall Study|Sponsor Decision|0|||
130940488|NCT04447755|471415060|FG002|Overall Study|Sponsor Decision|0|||
130940489|NCT04447755|471415061|FG003|Overall Study|Sponsor Decision|0|||
130940490|NCT04447755|471415062|FG004|Overall Study|Sponsor Decision|1|||
130940491|NCT04447755|471415063|FG005|Overall Study|Sponsor Decision|0|||
130940492|NCT04447755|471415064|FG006|Overall Study|Sponsor Decision|10|||
130940493|NCT04447755|471415058|FG000|Overall Study|Lost to Follow-up|0|||
130940494|NCT04447755|471415059|FG001|Overall Study|Lost to Follow-up|0|||
130940495|NCT04447755|471415060|FG002|Overall Study|Lost to Follow-up|0|||
130940496|NCT04447755|471415061|FG003|Overall Study|Lost to Follow-up|0|||
130940497|NCT04447755|471415062|FG004|Overall Study|Lost to Follow-up|0|||
130940498|NCT04447755|471415063|FG005|Overall Study|Lost to Follow-up|0|||
130940499|NCT04447755|471415064|FG006|Overall Study|Lost to Follow-up|1|||
130940500|NCT04219891|471415067|FG000|Overall Study|Lost to Follow-up|3|||
130940501|NCT04219891|471415067|FG000|Overall Study|Withdrawal by Subject|2|||
130940502|NCT00597012|471415068|FG000|Overall Study|Death|1|||
130940503|NCT00597012|471415069|FG001|Overall Study|Death|1|||
130940504|NCT00597012|471415068|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
130940505|NCT00597012|471415069|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
130940506|NCT00597012|471415068|FG000|Overall Study|Withdrawal by Subject|7|||
131224155|NCT05788237|472447169|FG001|SSA (Approximately 2 Months)|Death|1|||
131224156|NCT05788237|472447170|FG002|SSA (Approximately 2 Months)|Death|0|||
131224157|NCT05788237|472447171|FG003|SSA (Approximately 2 Months)|Death|0|||
130940507|NCT00597012|471415069|FG001|Overall Study|Withdrawal by Subject|4|||
130940508|NCT00597012|471415068|FG000|Overall Study|Ineligible|2|||
130940509|NCT00597012|471415069|FG001|Overall Study|Ineligible|0|||
130940510|NCT00597012|471415068|FG000|Overall Study|Lost to Follow-up|0|||
130940511|NCT00597012|471415069|FG001|Overall Study|Lost to Follow-up|2|||
130940512|NCT00587561|471415931|FG000|Overall Study|Lost to Follow-up|6|||
130940513|NCT00587561|471415932|FG001|Overall Study|Lost to Follow-up|4|||
130940514|NCT00202644|471415933|FG000|Overall Study|Adverse Event|12|||
130940515|NCT00202644|471415934|FG001|Overall Study|Adverse Event|13|||
130940516|NCT00202644|471415933|FG000|Overall Study|Withdrawal by Subject|8|||
130940517|NCT00202644|471415934|FG001|Overall Study|Withdrawal by Subject|6|||
130940518|NCT00202644|471415933|FG000|Overall Study|Lack of Efficacy|6|||
130940519|NCT00202644|471415934|FG001|Overall Study|Lack of Efficacy|6|||
130940520|NCT00202644|471415933|FG000|Overall Study|Lost to Follow-up|0|||
130940521|NCT00202644|471415934|FG001|Overall Study|Lost to Follow-up|1|||
130940522|NCT00202644|471415933|FG000|Overall Study|Other|9|||
130940523|NCT00202644|471415934|FG001|Overall Study|Other|1|||
130940524|NCT02268864|471415937|FG000|Overall Study|Withdrawal by Subject|2|||
130940525|NCT02268864|471415938|FG001|Overall Study|Withdrawal by Subject|0|||
130940526|NCT02268864|471415939|FG002|Overall Study|Withdrawal by Subject|0|||
130940527|NCT02268864|471415937|FG000|Overall Study|Death|0|||
130940528|NCT02268864|471415938|FG001|Overall Study|Death|1|||
130940529|NCT02268864|471415939|FG002|Overall Study|Death|0|||
130940530|NCT05407675|471415940|FG000|Overall Study|Withdrawal by Subject|0|||
130940531|NCT05407675|471415941|FG001|Overall Study|Withdrawal by Subject|2|||
130940532|NCT05407675|471415942|FG002|Overall Study|Withdrawal by Subject|3|||
130940533|NCT05407675|471415943|FG003|Overall Study|Withdrawal by Subject|5|||
130940534|NCT05407675|471415944|FG004|Overall Study|Withdrawal by Subject|0|||
130940535|NCT05407675|471415945|FG005|Overall Study|Withdrawal by Subject|2|||
130940536|NCT05407675|471415946|FG006|Overall Study|Withdrawal by Subject|0|||
130940537|NCT05407675|471415947|FG007|Overall Study|Withdrawal by Subject|0|||
130940538|NCT05407675|471415948|FG008|Overall Study|Withdrawal by Subject|2|||
130940539|NCT05407675|471415949|FG009|Overall Study|Withdrawal by Subject|0|||
130940540|NCT05407675|471415950|FG010|Overall Study|Withdrawal by Subject|1|||
130940541|NCT05407675|471415951|FG011|Overall Study|Withdrawal by Subject|0|||
130940542|NCT05407675|471415952|FG012|Overall Study|Withdrawal by Subject|0|||
130940543|NCT05407675|471415940|FG000|Overall Study|Site terminated by sponsor|0|||
130940544|NCT05407675|471415941|FG001|Overall Study|Site terminated by sponsor|0|||
130940545|NCT05407675|471415942|FG002|Overall Study|Site terminated by sponsor|1|||
130940546|NCT05407675|471415943|FG003|Overall Study|Site terminated by sponsor|0|||
130940547|NCT05407675|471415944|FG004|Overall Study|Site terminated by sponsor|2|||
130940548|NCT05407675|471415945|FG005|Overall Study|Site terminated by sponsor|0|||
130940549|NCT05407675|471415946|FG006|Overall Study|Site terminated by sponsor|1|||
131123125|NCT01449461|472079736|FG000|Overall Study|Adverse Event|0|||
131123126|NCT01449461|472079737|FG001|Overall Study|Adverse Event|3|||
131123127|NCT01449461|472079738|FG002|Overall Study|Adverse Event|2|||
131123128|NCT01449461|472079739|FG003|Overall Study|Adverse Event|3|||
131123129|NCT01449461|472079740|FG004|Overall Study|Adverse Event|4|||
131123130|NCT01449461|472079741|FG005|Overall Study|Adverse Event|4|||
130940550|NCT05407675|471415947|FG007|Overall Study|Site terminated by sponsor|0|||
130940551|NCT05407675|471415948|FG008|Overall Study|Site terminated by sponsor|0|||
130940552|NCT05407675|471415949|FG009|Overall Study|Site terminated by sponsor|2|||
130940553|NCT05407675|471415950|FG010|Overall Study|Site terminated by sponsor|2|||
130940554|NCT05407675|471415951|FG011|Overall Study|Site terminated by sponsor|2|||
130940555|NCT05407675|471415952|FG012|Overall Study|Site terminated by sponsor|1|||
130940556|NCT05407675|471415940|FG000|Overall Study|Disease Progression|0|||
130940557|NCT05407675|471415941|FG001|Overall Study|Disease Progression|0|||
130940558|NCT05407675|471415942|FG002|Overall Study|Disease Progression|0|||
130940559|NCT05407675|471415943|FG003|Overall Study|Disease Progression|0|||
130940560|NCT05407675|471415944|FG004|Overall Study|Disease Progression|0|||
130940561|NCT05407675|471415945|FG005|Overall Study|Disease Progression|0|||
130940562|NCT05407675|471415946|FG006|Overall Study|Disease Progression|0|||
130940563|NCT05407675|471415947|FG007|Overall Study|Disease Progression|0|||
130940564|NCT05407675|471415948|FG008|Overall Study|Disease Progression|0|||
130940565|NCT05407675|471415949|FG009|Overall Study|Disease Progression|0|||
130940566|NCT05407675|471415950|FG010|Overall Study|Disease Progression|1|||
130940567|NCT05407675|471415951|FG011|Overall Study|Disease Progression|0|||
130940568|NCT05407675|471415952|FG012|Overall Study|Disease Progression|0|||
130940569|NCT05407675|471415940|FG000|Overall Study|Physician Decision|0|||
130940570|NCT05407675|471415941|FG001|Overall Study|Physician Decision|0|||
130940571|NCT05407675|471415942|FG002|Overall Study|Physician Decision|0|||
130940572|NCT05407675|471415943|FG003|Overall Study|Physician Decision|0|||
130940573|NCT05407675|471415944|FG004|Overall Study|Physician Decision|0|||
130940574|NCT05407675|471415945|FG005|Overall Study|Physician Decision|0|||
130940575|NCT05407675|471415946|FG006|Overall Study|Physician Decision|0|||
130940576|NCT05407675|471415947|FG007|Overall Study|Physician Decision|0|||
130940577|NCT05407675|471415948|FG008|Overall Study|Physician Decision|0|||
130940578|NCT05407675|471415949|FG009|Overall Study|Physician Decision|0|||
130940579|NCT05407675|471415950|FG010|Overall Study|Physician Decision|1|||
130940580|NCT05407675|471415951|FG011|Overall Study|Physician Decision|0|||
130940581|NCT05407675|471415952|FG012|Overall Study|Physician Decision|0|||
130940582|NCT05407675|471415940|FG000|Overall Study|Other reasons|0|||
130940583|NCT05407675|471415941|FG001|Overall Study|Other reasons|0|||
130940584|NCT05407675|471415942|FG002|Overall Study|Other reasons|0|||
131123131|NCT01449461|472079736|FG000|Overall Study|Death|0|||
131123132|NCT01449461|472079737|FG001|Overall Study|Death|2|||
130940585|NCT05407675|471415943|FG003|Overall Study|Other reasons|0|||
130940586|NCT05407675|471415944|FG004|Overall Study|Other reasons|0|||
130940587|NCT05407675|471415945|FG005|Overall Study|Other reasons|0|||
130940588|NCT05407675|471415946|FG006|Overall Study|Other reasons|0|||
130940589|NCT05407675|471415947|FG007|Overall Study|Other reasons|0|||
131123133|NCT01449461|472079738|FG002|Overall Study|Death|0|||
131123134|NCT01449461|472079739|FG003|Overall Study|Death|0|||
131123135|NCT01449461|472079740|FG004|Overall Study|Death|7|||
130940590|NCT05407675|471415948|FG008|Overall Study|Other reasons|1|||
130940591|NCT05407675|471415949|FG009|Overall Study|Other reasons|1|||
130940592|NCT05407675|471415950|FG010|Overall Study|Other reasons|1|||
131123136|NCT01449461|472079741|FG005|Overall Study|Death|1|||
130940593|NCT05407675|471415951|FG011|Overall Study|Other reasons|1|||
130940594|NCT05407675|471415952|FG012|Overall Study|Other reasons|0|||
130940595|NCT05407675|471415940|FG000|Overall Study|Death|3|||
130940596|NCT05407675|471415941|FG001|Overall Study|Death|4|||
130940597|NCT05407675|471415942|FG002|Overall Study|Death|3|||
130940598|NCT05407675|471415943|FG003|Overall Study|Death|6|||
130940599|NCT05407675|471415944|FG004|Overall Study|Death|0|||
130940600|NCT05407675|471415945|FG005|Overall Study|Death|2|||
130940601|NCT05407675|471415946|FG006|Overall Study|Death|4|||
130940602|NCT05407675|471415947|FG007|Overall Study|Death|2|||
130940603|NCT05407675|471415948|FG008|Overall Study|Death|2|||
130940604|NCT05407675|471415949|FG009|Overall Study|Death|4|||
130940605|NCT05407675|471415950|FG010|Overall Study|Death|2|||
130940606|NCT05407675|471415951|FG011|Overall Study|Death|1|||
130940607|NCT05407675|471415952|FG012|Overall Study|Death|0|||
130940608|NCT05407675|471415940|FG000|Overall Study|Adverse Event|0|||
130940609|NCT05407675|471415941|FG001|Overall Study|Adverse Event|0|||
130940610|NCT05407675|471415942|FG002|Overall Study|Adverse Event|0|||
130940611|NCT05407675|471415943|FG003|Overall Study|Adverse Event|0|||
130940612|NCT05407675|471415944|FG004|Overall Study|Adverse Event|1|||
130940613|NCT05407675|471415945|FG005|Overall Study|Adverse Event|0|||
130940614|NCT05407675|471415946|FG006|Overall Study|Adverse Event|0|||
130940615|NCT05407675|471415947|FG007|Overall Study|Adverse Event|0|||
130940616|NCT05407675|471415948|FG008|Overall Study|Adverse Event|0|||
130940617|NCT05407675|471415949|FG009|Overall Study|Adverse Event|0|||
130940618|NCT05407675|471415950|FG010|Overall Study|Adverse Event|0|||
130940619|NCT05407675|471415951|FG011|Overall Study|Adverse Event|1|||
130940620|NCT05407675|471415952|FG012|Overall Study|Adverse Event|0|||
130940621|NCT05407675|471415940|FG000|Overall Study|Ongoing Treatment|0|||
130940622|NCT05407675|471415941|FG001|Overall Study|Ongoing Treatment|0|||
130940623|NCT05407675|471415942|FG002|Overall Study|Ongoing Treatment|0|||
130940624|NCT05407675|471415943|FG003|Overall Study|Ongoing Treatment|0|||
130940625|NCT05407675|471415944|FG004|Overall Study|Ongoing Treatment|0|||
130940626|NCT05407675|471415945|FG005|Overall Study|Ongoing Treatment|0|||
130940627|NCT05407675|471415946|FG006|Overall Study|Ongoing Treatment|0|||
130940628|NCT05407675|471415947|FG007|Overall Study|Ongoing Treatment|0|||
130940629|NCT05407675|471415948|FG008|Overall Study|Ongoing Treatment|1|||
130940630|NCT05407675|471415949|FG009|Overall Study|Ongoing Treatment|0|||
130940631|NCT05407675|471415950|FG010|Overall Study|Ongoing Treatment|0|||
130940632|NCT05407675|471415951|FG011|Overall Study|Ongoing Treatment|0|||
130940633|NCT05407675|471415952|FG012|Overall Study|Ongoing Treatment|0|||
130940634|NCT00857220|471415953|FG000|Overall Study|Adverse Event|35|||
130940635|NCT00857220|471415953|FG000|Overall Study|Death|1|||
130940636|NCT00857220|471415953|FG000|Overall Study|Lack of Efficacy|11|||
130940637|NCT00857220|471415953|FG000|Overall Study|Lost to Follow-up|30|||
130940638|NCT00857220|471415953|FG000|Overall Study|Physician Decision|4|||
130940639|NCT00857220|471415953|FG000|Overall Study|Protocol Violation|16|||
130940640|NCT00857220|471415953|FG000|Overall Study|Withdrawal by Subject|67|||
130940641|NCT00857220|471415953|FG000|Overall Study|Clinical Hold|6|||
130940642|NCT00857220|471415953|FG000|Overall Study|Site Closed|5|||
130940643|NCT00857220|471415953|FG000|Overall Study|Miscellaneous|8|||
130940644|NCT03698994|471415954|FG000|Overall Study|Adverse Event|2|||
130940645|NCT03698994|471415954|FG000|Overall Study|Death|1|||
130940646|NCT03698994|471415954|FG000|Overall Study|Physician Decision|1|||
130940647|NCT03698994|471415954|FG000|Overall Study|Withdrawal by Subject|3|||
130940648|NCT03698994|471415954|FG000|Overall Study|Progressive Disease|12|||
130940649|NCT02375113|471415957|FG000|Overall Study|Undisclosed Reason(s).|1|||
130940650|NCT02375113|471415958|FG001|Overall Study|Undisclosed Reason(s).|1|||
130940651|NCT02375113|471415957|FG000|Overall Study|Poor adherence (<70%).|1|||
130940652|NCT02375113|471415958|FG001|Overall Study|Poor adherence (<70%).|0|||
130940653|NCT02375113|471415957|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
130940654|NCT02375113|471415958|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
130940655|NCT04387435|471415964|FG000|Overall Study|Physician Decision|1|||
130940656|NCT03855280|471415965|FG000|Treatment Phase|Adverse Event|1|||
130940657|NCT03855280|471415965|FG000|Treatment Phase|Withdrawal by Subject|1|||
130772198|NCT05052697|470792833|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772199|NCT05052697|470792834|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130940658|NCT03855280|471415965|FG000|Continuation Phase|Protocol Violation|1|||
130940659|NCT03855280|471415965|FG000|Continuation Phase|Adverse Event|1|||
130940660|NCT03855280|471415965|FG000|Continuation Phase|Sponsor Concluded Study|1|||
130940661|NCT03338855|471415968|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
130940662|NCT03338855|471415969|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
130940663|NCT00511667|471415970|FG000|Overall Study|Adverse Event|1|||
130940664|NCT00511667|471415971|FG001|Overall Study|Adverse Event|0|||
130940665|NCT00511667|471415970|FG000|Overall Study|Protocol Violation|1|||
130940666|NCT00511667|471415971|FG001|Overall Study|Protocol Violation|1|||
130940667|NCT00511667|471415970|FG000|Overall Study|Withdrawal by Subject|2|||
130940668|NCT00511667|471415971|FG001|Overall Study|Withdrawal by Subject|0|||
130940669|NCT00511667|471415970|FG000|Overall Study|Site terminated|6|||
130940670|NCT00511667|471415971|FG001|Overall Study|Site terminated|1|||
131224158|NCT05788237|472447168|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
131224159|NCT05788237|472447169|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
130772200|NCT05052697|470792835|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772201|NCT05052697|470792836|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772202|NCT05052697|470792837|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
130772203|NCT05052697|470792838|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772204|NCT05052697|470792839|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772205|NCT05052697|470792840|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772206|NCT05052697|470792841|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772207|NCT05052697|470792842|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772208|NCT05052697|470792843|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772209|NCT05052697|470792844|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772210|NCT05052697|470792845|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
130772211|NCT05052697|470792846|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772212|NCT05052697|470792847|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
130772213|NCT05052697|470792848|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772214|NCT05052697|470792849|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772215|NCT05052697|470792850|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772216|NCT05052697|470792851|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772217|NCT05052697|470792852|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772218|NCT05052697|470792853|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130772219|NCT05052697|470792820|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772220|NCT05052697|470792821|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772221|NCT05052697|470792822|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772222|NCT05052697|470792823|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772223|NCT05052697|470792824|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772224|NCT05052697|470792825|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772225|NCT05052697|470792826|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131036387|NCT04908722|471768139|FG004|Overall Study|Protocol deviation|0|||
131036388|NCT04908722|471768140|FG005|Overall Study|Protocol deviation|1|||
130772226|NCT05052697|470792827|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772227|NCT05052697|470792828|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772228|NCT05052697|470792829|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131036389|NCT04908722|471768135|FG000|Overall Study|Lost to Follow-up|33|||
131036390|NCT04908722|471768136|FG001|Overall Study|Lost to Follow-up|33|||
131036391|NCT04908722|471768137|FG002|Overall Study|Lost to Follow-up|36|||
131036392|NCT04908722|471768138|FG003|Overall Study|Lost to Follow-up|30|||
131036393|NCT04908722|471768139|FG004|Overall Study|Lost to Follow-up|32|||
131036394|NCT04908722|471768140|FG005|Overall Study|Lost to Follow-up|34|||
131036395|NCT04908722|471768135|FG000|Overall Study|Physician Decision|1|||
131036396|NCT04908722|471768136|FG001|Overall Study|Physician Decision|1|||
131036397|NCT04908722|471768137|FG002|Overall Study|Physician Decision|1|||
131036398|NCT04908722|471768138|FG003|Overall Study|Physician Decision|2|||
131036399|NCT04908722|471768139|FG004|Overall Study|Physician Decision|0|||
131036400|NCT04908722|471768140|FG005|Overall Study|Physician Decision|0|||
131036401|NCT04908722|471768135|FG000|Overall Study|Death|1|||
131036402|NCT04908722|471768136|FG001|Overall Study|Death|0|||
131123137|NCT01449461|472079736|FG000|Overall Study|Physician Decision|0|||
131123138|NCT01449461|472079737|FG001|Overall Study|Physician Decision|1|||
131123139|NCT01449461|472079738|FG002|Overall Study|Physician Decision|0|||
131123140|NCT01449461|472079739|FG003|Overall Study|Physician Decision|4|||
130772229|NCT05052697|470792830|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772230|NCT05052697|470792831|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772231|NCT05052697|470792832|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772232|NCT05052697|470792833|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772233|NCT05052697|470792834|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772234|NCT05052697|470792835|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131036403|NCT04908722|471768137|FG002|Overall Study|Death|0|||
131123141|NCT01449461|472079740|FG004|Overall Study|Physician Decision|1|||
131123142|NCT01449461|472079741|FG005|Overall Study|Physician Decision|0|||
131123143|NCT01449461|472079736|FG000|Overall Study|Documented Progressive Disease|4|||
131123144|NCT01449461|472079737|FG001|Overall Study|Documented Progressive Disease|7|||
131123145|NCT01449461|472079738|FG002|Overall Study|Documented Progressive Disease|14|||
131123146|NCT01449461|472079739|FG003|Overall Study|Documented Progressive Disease|15|||
131224160|NCT05788237|472447170|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
131224161|NCT05788237|472447171|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
131123147|NCT01449461|472079740|FG004|Overall Study|Documented Progressive Disease|24|||
131123148|NCT01449461|472079741|FG005|Overall Study|Documented Progressive Disease|5|||
131123149|NCT01449461|472079736|FG000|Overall Study|Clinical Progressive Disease|2|||
130772235|NCT05052697|470792836|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
131036404|NCT04908722|471768138|FG003|Overall Study|Death|0|||
131036405|NCT04908722|471768139|FG004|Overall Study|Death|0|||
131036406|NCT04908722|471768140|FG005|Overall Study|Death|1|||
130940671|NCT00511667|471415970|FG000|Overall Study|Other|2|||
130940672|NCT00511667|471415971|FG001|Overall Study|Other|1|||
130940673|NCT03251079|471415972|FG000|Overall Study|Withdrawal by Subject|1|||
130940674|NCT02335099|471415973|FG000|Treatment|Withdrawal by Subject|1|||
130940675|NCT02335099|471415974|FG001|Treatment|Withdrawal by Subject|3|||
130940676|NCT02335099|471415973|FG000|Treatment|Lost to Follow-up|2|||
130940677|NCT02335099|471415974|FG001|Treatment|Lost to Follow-up|0|||
130940678|NCT02335099|471415973|FG000|Treatment|Death|1|||
130940679|NCT02335099|471415974|FG001|Treatment|Death|0|||
130940680|NCT02335099|471415973|FG000|Treatment|Adverse Event|1|||
130940681|NCT02335099|471415974|FG001|Treatment|Adverse Event|2|||
130940682|NCT02335099|471415973|FG000|Follow-up|Death|0|||
130940683|NCT02335099|471415974|FG001|Follow-up|Death|1|||
130940684|NCT00484939|471415977|FG000|Overall Study|Death|9|||
130940685|NCT00484939|471415978|FG001|Overall Study|Death|13|||
130940686|NCT00484939|471415977|FG000|Overall Study|Adverse Event|22|||
130940687|NCT00484939|471415978|FG001|Overall Study|Adverse Event|12|||
130940688|NCT00484939|471415977|FG000|Overall Study|Patient Withdrew Consent|19|||
130940689|NCT00484939|471415978|FG001|Overall Study|Patient Withdrew Consent|10|||
130940690|NCT00484939|471415977|FG000|Overall Study|Protocol Violation|3|||
130940691|NCT00484939|471415978|FG001|Overall Study|Protocol Violation|3|||
130940692|NCT00484939|471415977|FG000|Overall Study|Lost to Follow-up|0|||
130940693|NCT00484939|471415978|FG001|Overall Study|Lost to Follow-up|3|||
130940694|NCT00484939|471415977|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
130940695|NCT00484939|471415978|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
130940696|NCT00484939|471415977|FG000|Overall Study|Disease progression|67|||
130940697|NCT00484939|471415978|FG001|Overall Study|Disease progression|88|||
130940698|NCT00484939|471415977|FG000|Overall Study|Screen Failure|2|||
130940699|NCT00484939|471415978|FG001|Overall Study|Screen Failure|2|||
130940700|NCT00484939|471415977|FG000|Overall Study|Reason Not Specified|11|||
130940701|NCT00484939|471415978|FG001|Overall Study|Reason Not Specified|6|||
130940702|NCT01474876|471415981|FG000|Overall Study|Adverse Event|11|||
130940703|NCT01474876|471415982|FG001|Overall Study|Adverse Event|5|||
130940704|NCT01474876|471415983|FG002|Overall Study|Adverse Event|0|||
130940705|NCT01474876|471415981|FG000|Overall Study|Serious Adverse Event|2|||
130940706|NCT01474876|471415982|FG001|Overall Study|Serious Adverse Event|3|||
130940707|NCT01474876|471415983|FG002|Overall Study|Serious Adverse Event|0|||
130940708|NCT01474876|471415981|FG000|Overall Study|Lost to Follow-up|5|||
130940709|NCT01474876|471415982|FG001|Overall Study|Lost to Follow-up|4|||
130940710|NCT01474876|471415983|FG002|Overall Study|Lost to Follow-up|0|||
130940711|NCT01474876|471415981|FG000|Overall Study|Investigator's decision|28|||
130940712|NCT01474876|471415982|FG001|Overall Study|Investigator's decision|6|||
130940713|NCT01474876|471415983|FG002|Overall Study|Investigator's decision|0|||
130940714|NCT01474876|471415981|FG000|Overall Study|Patient's request|19|||
130940715|NCT01474876|471415982|FG001|Overall Study|Patient's request|5|||
130706421|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130706422|NCT00739973|470549715|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
130706423|NCT00739973|470549716|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706424|NCT00739973|470549717|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706425|NCT00739973|470549718|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706426|NCT00739973|470549719|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130940716|NCT01474876|471415983|FG002|Overall Study|Patient's request|0|||
130940717|NCT01474876|471415981|FG000|Overall Study|Investigator's decision and pt request|1|||
131036407|NCT04908722|471768135|FG000|Overall Study|Withdrawal by Subject|12|||
131036408|NCT04908722|471768136|FG001|Overall Study|Withdrawal by Subject|8|||
131036409|NCT04908722|471768137|FG002|Overall Study|Withdrawal by Subject|7|||
131036410|NCT04908722|471768138|FG003|Overall Study|Withdrawal by Subject|6|||
131036411|NCT04908722|471768139|FG004|Overall Study|Withdrawal by Subject|12|||
131036412|NCT04908722|471768140|FG005|Overall Study|Withdrawal by Subject|14|||
131224162|NCT05788237|472447168|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
130706427|NCT00739973|470549720|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706428|NCT00739973|470549721|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706429|NCT00739973|470549722|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130706430|NCT00739973|470549723|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130940718|NCT01474876|471415982|FG001|Overall Study|Investigator's decision and pt request|0|||
130940719|NCT01474876|471415983|FG002|Overall Study|Investigator's decision and pt request|0|||
130940720|NCT01523886|471415984|FG000|Overall Study|surgery cancelled|0|||
130940721|NCT01523886|471415985|FG001|Overall Study|surgery cancelled|1|||
130940722|NCT01173718|471415995|FG000|Overall Study|Death|17|||
130940723|NCT01173718|471415995|FG000|Overall Study|Abandonment of study graft|27|||
130940724|NCT01367158|471415996|FG000|Overall Study|Withdrew consent|0|||
130940725|NCT01367158|471415997|FG001|Overall Study|Withdrew consent|2|||
130940726|NCT01367158|471415998|FG002|Overall Study|Withdrew consent|1|||
130940727|NCT01367158|471415999|FG003|Overall Study|Withdrew consent|0|||
130940728|NCT01367158|471416000|FG004|Overall Study|Withdrew consent|2|||
130940729|NCT01367158|471416001|FG005|Overall Study|Withdrew consent|0|||
131036413|NCT04908722|471768135|FG000|Overall Study|Other|3|||
130706431|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
130706432|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
130940730|NCT01367158|471416002|FG006|Overall Study|Withdrew consent|0|||
130940731|NCT01367158|471416003|FG007|Overall Study|Withdrew consent|1|||
130940732|NCT01367158|471416004|FG008|Overall Study|Withdrew consent|0|||
130940733|NCT01367158|471416005|FG009|Overall Study|Withdrew consent|0|||
130940734|NCT01367158|471416006|FG010|Overall Study|Withdrew consent|0|||
130940735|NCT01367158|471415996|FG000|Overall Study|Lost to Follow-up|0|||
130940736|NCT01367158|471415997|FG001|Overall Study|Lost to Follow-up|0|||
130940737|NCT01367158|471415998|FG002|Overall Study|Lost to Follow-up|0|||
130940738|NCT01367158|471415999|FG003|Overall Study|Lost to Follow-up|1|||
130940739|NCT01367158|471416000|FG004|Overall Study|Lost to Follow-up|0|||
130940740|NCT01367158|471416001|FG005|Overall Study|Lost to Follow-up|2|||
130940741|NCT01367158|471416002|FG006|Overall Study|Lost to Follow-up|0|||
130706433|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
130706434|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
130706435|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
130706436|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
130706437|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
130706438|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
130706439|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
130706440|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706441|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706442|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706443|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706444|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
130706445|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706446|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130940742|NCT01367158|471416003|FG007|Overall Study|Lost to Follow-up|1|||
130940743|NCT01367158|471416004|FG008|Overall Study|Lost to Follow-up|0|||
130940744|NCT01367158|471416005|FG009|Overall Study|Lost to Follow-up|0|||
130940745|NCT01367158|471416006|FG010|Overall Study|Lost to Follow-up|1|||
130940746|NCT01367158|471415996|FG000|Overall Study|Protocol Violation|0|||
130940747|NCT01367158|471415997|FG001|Overall Study|Protocol Violation|1|||
130940748|NCT01367158|471415998|FG002|Overall Study|Protocol Violation|0|||
130940749|NCT01367158|471415999|FG003|Overall Study|Protocol Violation|0|||
130940750|NCT01367158|471416000|FG004|Overall Study|Protocol Violation|0|||
130940751|NCT01367158|471416001|FG005|Overall Study|Protocol Violation|0|||
130706447|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
130706448|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130706449|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
130706450|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
130706451|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706452|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706453|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706454|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706455|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706456|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706457|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130706458|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
130706459|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
130706460|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
130706461|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
130706462|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
130720853|NCT04126213|470601550|FG005|Overall Study|Withdrawal by Subject|1|||
130720854|NCT04126213|470601545|FG000|Overall Study|Other|0|||
130720855|NCT04126213|470601546|FG001|Overall Study|Other|0|||
130720856|NCT04126213|470601547|FG002|Overall Study|Other|2|||
130720857|NCT04126213|470601548|FG003|Overall Study|Other|2|||
130720858|NCT04126213|470601549|FG004|Overall Study|Other|0|||
130720859|NCT04126213|470601550|FG005|Overall Study|Other|1|||
130720860|NCT04126213|470601545|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130720861|NCT04126213|470601546|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130720862|NCT04126213|470601547|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130720863|NCT04126213|470601548|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130720864|NCT04126213|470601549|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130720865|NCT04126213|470601550|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130720866|NCT02853370|470601551|FG000|Overall Study|Physician Decision|1|||
130772236|NCT05052697|470792837|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772237|NCT05052697|470792838|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130940752|NCT01367158|471416002|FG006|Overall Study|Protocol Violation|0|||
130940753|NCT01367158|471416003|FG007|Overall Study|Protocol Violation|0|||
130940754|NCT01367158|471416004|FG008|Overall Study|Protocol Violation|0|||
130940755|NCT01367158|471416005|FG009|Overall Study|Protocol Violation|0|||
130940756|NCT01367158|471416006|FG010|Overall Study|Protocol Violation|0|||
130940757|NCT02226003|471416007|FG000|Overall Study|Lost to Follow-up|2|||
130940758|NCT02226003|471416008|FG001|Overall Study|Lost to Follow-up|1|||
130940759|NCT02226003|471416009|FG002|Overall Study|Lost to Follow-up|3|||
130940760|NCT02226003|471416007|FG000|Overall Study|Withdrawal by Subject|0|||
130940761|NCT02226003|471416008|FG001|Overall Study|Withdrawal by Subject|0|||
130940762|NCT02226003|471416009|FG002|Overall Study|Withdrawal by Subject|3|||
130940763|NCT01499563|471416012|FG000|Overall Study|Withdrawal by Subject|10|||
130940764|NCT01499563|471416013|FG001|Overall Study|Withdrawal by Subject|11|||
130940765|NCT01499563|471416014|FG002|Overall Study|Withdrawal by Subject|7|||
130940766|NCT01499563|471416015|FG003|Overall Study|Withdrawal by Subject|8|||
130940767|NCT01499563|471416012|FG000|Overall Study|Physician Decision|2|||
130940768|NCT01499563|471416013|FG001|Overall Study|Physician Decision|1|||
130940769|NCT01499563|471416014|FG002|Overall Study|Physician Decision|3|||
130940770|NCT01499563|471416015|FG003|Overall Study|Physician Decision|0|||
130940771|NCT01499563|471416012|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
130940772|NCT01499563|471416013|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
130940773|NCT01499563|471416014|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
130940774|NCT01499563|471416015|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
130940775|NCT01499563|471416012|FG000|Overall Study|Adverse Event|2|||
130940776|NCT01499563|471416013|FG001|Overall Study|Adverse Event|0|||
130940777|NCT01499563|471416014|FG002|Overall Study|Adverse Event|1|||
130940778|NCT01499563|471416015|FG003|Overall Study|Adverse Event|3|||
130940779|NCT01499563|471416012|FG000|Overall Study|Lack of Efficacy|0|||
130940780|NCT01499563|471416013|FG001|Overall Study|Lack of Efficacy|1|||
130940781|NCT01499563|471416014|FG002|Overall Study|Lack of Efficacy|6|||
130940782|NCT01499563|471416015|FG003|Overall Study|Lack of Efficacy|3|||
130940783|NCT01499563|471416012|FG000|Overall Study|Other|8|||
130940784|NCT01499563|471416013|FG001|Overall Study|Other|6|||
130940785|NCT01499563|471416014|FG002|Overall Study|Other|6|||
130940786|NCT01499563|471416015|FG003|Overall Study|Other|4|||
130940787|NCT02472795|471416019|FG000|Overall Study|Adverse Event|0|||
130940788|NCT02472795|471416020|FG001|Overall Study|Adverse Event|1|||
130940789|NCT02472795|471416021|FG002|Overall Study|Adverse Event|0|||
130940790|NCT02472795|471416022|FG003|Overall Study|Adverse Event|0|||
130940791|NCT02472795|471416023|FG004|Overall Study|Adverse Event|2|||
130940792|NCT02472795|471416019|FG000|Overall Study|Withdrawal by Subject|0|||
130772238|NCT05052697|470792839|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772239|NCT05052697|470792840|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772240|NCT05052697|470792841|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772241|NCT05052697|470792842|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130940793|NCT02472795|471416020|FG001|Overall Study|Withdrawal by Subject|0|||
130940794|NCT02472795|471416021|FG002|Overall Study|Withdrawal by Subject|0|||
130940795|NCT02472795|471416022|FG003|Overall Study|Withdrawal by Subject|0|||
130940796|NCT02472795|471416023|FG004|Overall Study|Withdrawal by Subject|1|||
130940797|NCT00410761|471417337|FG000|Randomized Treatment Period|Adverse Event|34|||
130940798|NCT00410761|471417338|FG001|Randomized Treatment Period|Adverse Event|3|||
130940799|NCT00410761|471417337|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
130940800|NCT00410761|471417338|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
130940801|NCT00410761|471417337|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
130940802|NCT00410761|471417338|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
130940803|NCT00410761|471417337|FG000|Randomized Treatment Period|Other|69|||
130940804|NCT00410761|471417338|FG001|Randomized Treatment Period|Other|21|||
130940805|NCT00410761|471417337|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
130940806|NCT00410761|471417338|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
130940807|NCT00410761|471417337|FG000|Open-Label Treatment Period|Adverse Event|13|||
130940808|NCT00410761|471417338|FG001|Open-Label Treatment Period|Adverse Event|15|||
130940809|NCT00410761|471417337|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
130940810|NCT00410761|471417338|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
130940811|NCT00410761|471417337|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
130940812|NCT00410761|471417338|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
130940813|NCT00410761|471417337|FG000|Open-Label Treatment Period|Other|18|||
130940814|NCT00410761|471417338|FG001|Open-Label Treatment Period|Other|9|||
130940815|NCT02926924|471417340|FG000|Overall Study|withdrawal - reason unknown|0|||
130940816|NCT02926924|471417341|FG001|Overall Study|withdrawal - reason unknown|1|||
130940817|NCT04568590|471417344|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
130940818|NCT03724812|471417349|FG000|Overall Study|Missed Visit|1|||
130940819|NCT03724812|471417349|FG000|Overall Study|Death|2|||
130940820|NCT03724812|471417349|FG000|Overall Study|Withdrawal by Subject|1|||
131123150|NCT01449461|472079737|FG001|Overall Study|Clinical Progressive Disease|2|||
131123151|NCT01449461|472079738|FG002|Overall Study|Clinical Progressive Disease|0|||
131123152|NCT01449461|472079739|FG003|Overall Study|Clinical Progressive Disease|3|||
131123153|NCT01449461|472079740|FG004|Overall Study|Clinical Progressive Disease|4|||
131123154|NCT01449461|472079741|FG005|Overall Study|Clinical Progressive Disease|2|||
131123155|NCT01449461|472079736|FG000|Overall Study|Protocol Violation|0|||
131123156|NCT01449461|472079737|FG001|Overall Study|Protocol Violation|0|||
131123157|NCT01449461|472079738|FG002|Overall Study|Protocol Violation|0|||
131123158|NCT01449461|472079739|FG003|Overall Study|Protocol Violation|1|||
131123159|NCT01449461|472079740|FG004|Overall Study|Protocol Violation|0|||
131123160|NCT01449461|472079741|FG005|Overall Study|Protocol Violation|0|||
131123161|NCT01449461|472079736|FG000|Overall Study|Site Terminated by Sponsor|0|||
131123162|NCT01449461|472079737|FG001|Overall Study|Site Terminated by Sponsor|1|||
131123163|NCT01449461|472079738|FG002|Overall Study|Site Terminated by Sponsor|2|||
131123164|NCT01449461|472079739|FG003|Overall Study|Site Terminated by Sponsor|3|||
131123165|NCT01449461|472079740|FG004|Overall Study|Site Terminated by Sponsor|4|||
131123166|NCT01449461|472079741|FG005|Overall Study|Site Terminated by Sponsor|1|||
131123167|NCT01449461|472079736|FG000|Overall Study|Withdrawal by Subject|0|||
131123168|NCT01449461|472079737|FG001|Overall Study|Withdrawal by Subject|1|||
131123169|NCT01449461|472079738|FG002|Overall Study|Withdrawal by Subject|0|||
131123170|NCT01449461|472079739|FG003|Overall Study|Withdrawal by Subject|0|||
131123171|NCT01449461|472079740|FG004|Overall Study|Withdrawal by Subject|2|||
131123172|NCT01449461|472079741|FG005|Overall Study|Withdrawal by Subject|1|||
131123173|NCT01449461|472079736|FG000|Overall Study|Reason not Specified|0|||
131123174|NCT01449461|472079737|FG001|Overall Study|Reason not Specified|1|||
131123175|NCT01449461|472079738|FG002|Overall Study|Reason not Specified|0|||
131123176|NCT01449461|472079739|FG003|Overall Study|Reason not Specified|3|||
131123177|NCT01449461|472079740|FG004|Overall Study|Reason not Specified|2|||
131123178|NCT01449461|472079741|FG005|Overall Study|Reason not Specified|1|||
131123179|NCT05314517|472079742|FG000|Double-blind Period|Adverse Event|4|||
131123180|NCT05314517|472079743|FG001|Double-blind Period|Adverse Event|0|||
130706463|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
130706464|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
130706465|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
130706466|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
130706467|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706468|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706469|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
130706470|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706471|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706472|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706473|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706474|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706475|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130706476|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130706477|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
130706478|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130706479|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
130706480|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130706481|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130706482|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
130706483|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
130706484|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130706485|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
130706486|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
130706487|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
130706488|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
130706489|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
130706490|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
130706491|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
130706492|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
130706493|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
130720867|NCT02853370|470601551|FG000|Overall Study|Lack of Efficacy|2|||
131123181|NCT05314517|472079744|FG002|Double-blind Period|Adverse Event|0|||
131123182|NCT05314517|472079745|FG003|Double-blind Period|Adverse Event|0|||
131123183|NCT05314517|472079742|FG000|Double-blind Period|Noncompliance|0|||
131123184|NCT05314517|472079743|FG001|Double-blind Period|Noncompliance|1|||
131224163|NCT05788237|472447169|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
131224164|NCT05788237|472447170|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
131224165|NCT05788237|472447171|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
131224166|NCT05788237|472447168|FG000|SSB (Approximately 1 Month)|Other|0|||
131224167|NCT05788237|472447169|FG001|SSB (Approximately 1 Month)|Other|0|||
131224168|NCT05788237|472447170|FG002|SSB (Approximately 1 Month)|Other|0|||
131224169|NCT05788237|472447171|FG003|SSB (Approximately 1 Month)|Other|1|||
131224170|NCT02842086|472447172|FG000|Overall Study|Randomized but Never Treated|6|||
131224171|NCT02842086|472447173|FG001|Overall Study|Randomized but Never Treated|6|||
131224172|NCT02842086|472447172|FG000|Overall Study|Still in Double-Blind Phase|7|||
131224173|NCT02842086|472447173|FG001|Overall Study|Still in Double-Blind Phase|3|||
131224174|NCT02842086|472447172|FG000|Overall Study|Adverse Event|18|||
131224175|NCT02842086|472447173|FG001|Overall Study|Adverse Event|20|||
131224176|NCT02842086|472447172|FG000|Overall Study|Death|3|||
131224177|NCT02842086|472447173|FG001|Overall Study|Death|3|||
131224178|NCT02842086|472447172|FG000|Overall Study|Investigator's Discretion|9|||
131224179|NCT02842086|472447173|FG001|Overall Study|Investigator's Discretion|13|||
131224180|NCT02842086|472447172|FG000|Overall Study|Non-Compliance with Study Drug|9|||
131224181|NCT02842086|472447173|FG001|Overall Study|Non-Compliance with Study Drug|8|||
131224182|NCT02842086|472447172|FG000|Overall Study|Protocol Violation|8|||
131224183|NCT02842086|472447173|FG001|Overall Study|Protocol Violation|4|||
131224184|NCT02842086|472447172|FG000|Overall Study|Withdrew Consent|205|||
131224185|NCT02842086|472447173|FG001|Overall Study|Withdrew Consent|194|||
131224186|NCT02842086|472447172|FG000|Overall Study|Lost to Follow-up|274|||
131224187|NCT02842086|472447173|FG001|Overall Study|Lost to Follow-up|236|||
131224188|NCT02842086|472447172|FG000|Overall Study|HIV-1 Infection|5|||
131224189|NCT02842086|472447173|FG001|Overall Study|HIV-1 Infection|6|||
131224190|NCT03751124|472447174|FG000|Overall Study|Adverse Event|4|||
131224191|NCT03751124|472447175|FG001|Overall Study|Adverse Event|3|||
131224192|NCT03751124|472447174|FG000|Overall Study|Protocol Deviation|0|||
131224193|NCT03751124|472447175|FG001|Overall Study|Protocol Deviation|1|||
131224194|NCT03751124|472447174|FG000|Overall Study|Lost to Follow-up|6|||
131224195|NCT03751124|472447175|FG001|Overall Study|Lost to Follow-up|4|||
131224196|NCT03751124|472447174|FG000|Overall Study|Withdrawal by Subject|6|||
131224197|NCT03751124|472447175|FG001|Overall Study|Withdrawal by Subject|8|||
131224198|NCT03751124|472447174|FG000|Overall Study|Lack of Efficacy|1|||
131224199|NCT03751124|472447175|FG001|Overall Study|Lack of Efficacy|1|||
130940821|NCT01770379|471417350|FG000|Overall Study|Technical issues|1|||
130940822|NCT01770379|471417351|FG001|Overall Study|Technical issues|0|||
130940823|NCT01770379|471417352|FG002|Overall Study|Technical issues|0|||
130940824|NCT01770379|471417350|FG000|Overall Study|Withdrawal by Subject|7|||
130940825|NCT01770379|471417351|FG001|Overall Study|Withdrawal by Subject|10|||
130940826|NCT01770379|471417352|FG002|Overall Study|Withdrawal by Subject|7|||
130940827|NCT01770379|471417350|FG000|Overall Study|study terminated by sponsor|22|||
130940828|NCT01770379|471417351|FG001|Overall Study|study terminated by sponsor|23|||
130940829|NCT01770379|471417352|FG002|Overall Study|study terminated by sponsor|22|||
130940830|NCT01770379|471417350|FG000|Overall Study|Protocol Violation|0|||
130940831|NCT01770379|471417351|FG001|Overall Study|Protocol Violation|1|||
130940832|NCT01770379|471417352|FG002|Overall Study|Protocol Violation|1|||
130940833|NCT01770379|471417350|FG000|Overall Study|Physician Decision|0|||
130940834|NCT01770379|471417351|FG001|Overall Study|Physician Decision|1|||
130940835|NCT01770379|471417352|FG002|Overall Study|Physician Decision|2|||
130940836|NCT01770379|471417350|FG000|Overall Study|Lost to Follow-up|0|||
130940837|NCT01770379|471417351|FG001|Overall Study|Lost to Follow-up|0|||
130940838|NCT01770379|471417352|FG002|Overall Study|Lost to Follow-up|2|||
130940839|NCT01770379|471417350|FG000|Overall Study|Lack of Efficacy|8|||
130940840|NCT01770379|471417351|FG001|Overall Study|Lack of Efficacy|6|||
130940841|NCT01770379|471417352|FG002|Overall Study|Lack of Efficacy|6|||
130940842|NCT01770379|471417350|FG000|Overall Study|Adverse Event|1|||
130940843|NCT01770379|471417351|FG001|Overall Study|Adverse Event|3|||
130940844|NCT01770379|471417352|FG002|Overall Study|Adverse Event|2|||
130940845|NCT03045887|471417353|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
131224200|NCT03751124|472447174|FG000|Overall Study|Pregnancy|0|||
131224201|NCT03751124|472447175|FG001|Overall Study|Pregnancy|1|||
131224202|NCT03751124|472447174|FG000|Overall Study|Other|9|||
131224203|NCT03751124|472447175|FG001|Overall Study|Other|9|||
131224204|NCT03751124|472447174|FG000|Overall Study|Participants who did not receive any study drug|0|||
130720868|NCT02853370|470601551|FG000|Overall Study|Death|1|||
130720869|NCT02853370|470601551|FG000|Overall Study|Adverse Event|4|||
130720870|NCT02853370|470601551|FG000|Overall Study|Withdrawal by Subject|3|||
130720871|NCT03275064|470601552|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130720872|NCT03275064|470601553|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130720873|NCT03275064|470601554|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130720874|NCT03275064|470601555|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
130720875|NCT03275064|470601556|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130706494|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130940846|NCT03045887|471417354|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130940847|NCT03045887|471417355|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130940848|NCT03045887|471417356|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130940849|NCT03045887|471417357|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130940850|NCT03045887|471417358|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130940851|NCT03045887|471417359|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130940852|NCT03045887|471417360|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130940853|NCT03045887|471417361|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130940854|NCT03045887|471417362|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
130940855|NCT03045887|471417353|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130940856|NCT03045887|471417354|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130940857|NCT03045887|471417355|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130940858|NCT03045887|471417356|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
130940859|NCT03045887|471417357|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130940860|NCT03045887|471417358|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130940861|NCT03045887|471417359|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130940862|NCT03045887|471417360|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130940863|NCT03045887|471417361|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130940864|NCT03045887|471417362|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
130940865|NCT03045887|471417353|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
130940866|NCT03045887|471417354|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
130940867|NCT03045887|471417355|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
130940868|NCT03045887|471417356|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
130940869|NCT03045887|471417357|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
130940870|NCT03045887|471417358|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
130940871|NCT03045887|471417359|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
130940872|NCT03045887|471417360|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
130940873|NCT03045887|471417361|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
130940874|NCT03045887|471417362|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
130940875|NCT03045887|471417353|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130940876|NCT03045887|471417354|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130940877|NCT03045887|471417355|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
130940878|NCT03045887|471417356|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
130940879|NCT03045887|471417357|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130940880|NCT03045887|471417358|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130940881|NCT03045887|471417359|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130940882|NCT03045887|471417360|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130940883|NCT03045887|471417361|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130940884|NCT03045887|471417362|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
130940885|NCT03045887|471417353|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130940886|NCT03045887|471417354|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130940887|NCT03045887|471417355|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130940888|NCT03045887|471417356|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
130940889|NCT03045887|471417357|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130940890|NCT03045887|471417358|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130940891|NCT03045887|471417359|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130940892|NCT03045887|471417360|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130940893|NCT03045887|471417361|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130940894|NCT03045887|471417362|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130940895|NCT01912287|471417363|FG000|Overall Study|Ineligible|1|||
130940896|NCT01912287|471417364|FG001|Overall Study|Ineligible|0|||
130940897|NCT01912287|471417365|FG002|Overall Study|Ineligible|1|||
130940898|NCT01912287|471417363|FG000|Overall Study|No-show|0|||
130940899|NCT01912287|471417364|FG001|Overall Study|No-show|0|||
130940900|NCT01912287|471417365|FG002|Overall Study|No-show|1|||
130940901|NCT01912287|471417363|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
130940902|NCT01912287|471417364|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
130940903|NCT01912287|471417365|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
130940904|NCT01912287|471417363|FG000|Overall Study|Felt treatment no longer needed|0|||
130706495|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706496|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706497|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706498|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130940905|NCT01912287|471417364|FG001|Overall Study|Felt treatment no longer needed|1|||
130940906|NCT01912287|471417365|FG002|Overall Study|Felt treatment no longer needed|0|||
130940907|NCT01912287|471417363|FG000|Overall Study|Life circumstances|4|||
130940908|NCT01912287|471417364|FG001|Overall Study|Life circumstances|2|||
130940909|NCT01912287|471417365|FG002|Overall Study|Life circumstances|0|||
130772242|NCT05052697|470792843|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772243|NCT05052697|470792844|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772244|NCT05052697|470792845|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772245|NCT05052697|470792846|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772246|NCT05052697|470792847|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130940910|NCT01912287|471417363|FG000|Overall Study|Lost Interest|1|||
130940911|NCT01912287|471417364|FG001|Overall Study|Lost Interest|0|||
131224205|NCT03751124|472447175|FG001|Overall Study|Participants who did not receive any study drug|1|||
131224206|NCT00555399|472447178|FG000|Overall Study|Withdrawal by Subject|0|||
131224207|NCT00555399|472447179|FG001|Overall Study|Withdrawal by Subject|0|||
131224208|NCT00555399|472447180|FG002|Overall Study|Withdrawal by Subject|1|||
131224209|NCT00555399|472447181|FG003|Overall Study|Withdrawal by Subject|0|||
131224210|NCT00555399|472447182|FG004|Overall Study|Withdrawal by Subject|0|||
131224211|NCT00555399|472447183|FG005|Overall Study|Withdrawal by Subject|0|||
131224212|NCT00555399|472447184|FG006|Overall Study|Withdrawal by Subject|0|||
130706499|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706500|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
130706501|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706502|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130706503|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
130706504|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
130706505|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
130706506|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
130706507|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
130706508|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
130706509|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
130706510|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
130706511|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
130706512|NCT00739973|470549715|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706513|NCT00739973|470549716|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
130706514|NCT00739973|470549717|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706515|NCT00739973|470549718|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706516|NCT00739973|470549719|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706517|NCT00739973|470549720|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706518|NCT00739973|470549721|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
130706519|NCT00739973|470549722|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706520|NCT00739973|470549723|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130706521|NCT03078478|470549724|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
130706522|NCT03078478|470549725|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
130706523|NCT03078478|470549724|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
130706524|NCT03078478|470549725|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
130706525|NCT03078478|470549724|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
130706526|NCT03078478|470549725|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
130706527|NCT03078478|470549724|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
130706528|NCT03078478|470549725|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
130706529|NCT03078478|470549724|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
130706530|NCT03078478|470549725|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
130706531|NCT03078478|470549724|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
130706532|NCT03078478|470549725|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
130706533|NCT03078478|470549724|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
130940912|NCT01912287|471417365|FG002|Overall Study|Lost Interest|0|||
130940913|NCT01912287|471417363|FG000|Overall Study|Uknown reason - subject drop out|5|||
130940914|NCT01912287|471417364|FG001|Overall Study|Uknown reason - subject drop out|7|||
130940915|NCT01912287|471417365|FG002|Overall Study|Uknown reason - subject drop out|3|||
130940916|NCT01912287|471417363|FG000|Overall Study|Missed Assesment|1|||
130940917|NCT01912287|471417364|FG001|Overall Study|Missed Assesment|1|||
130940918|NCT01912287|471417365|FG002|Overall Study|Missed Assesment|1|||
130940919|NCT01912287|471417363|FG000|Overall Study|Scheduling/change in availability|17|||
130940920|NCT01912287|471417364|FG001|Overall Study|Scheduling/change in availability|10|||
130940921|NCT01912287|471417365|FG002|Overall Study|Scheduling/change in availability|8|||
130940922|NCT03914326|471417368|FG000|Overall Study|Withdrawal by Subject|27|||
130940923|NCT03914326|471417369|FG001|Overall Study|Withdrawal by Subject|34|||
130940924|NCT03914326|471417368|FG000|Overall Study|Lost to Follow-up|43|||
130940925|NCT03914326|471417369|FG001|Overall Study|Lost to Follow-up|51|||
130940926|NCT03914326|471417368|FG000|Overall Study|Randomised more than once|0|||
130940927|NCT03914326|471417369|FG001|Overall Study|Randomised more than once|1|||
130706534|NCT03078478|470549725|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
130706535|NCT03078478|470549724|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
130706536|NCT03078478|470549725|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
130706537|NCT03253094|470549727|FG000|Overall Study|Adverse Event|2|||
130706538|NCT03253094|470549728|FG001|Overall Study|Adverse Event|0|||
130940928|NCT02024867|471417371|FG000|Overall Study|Protocol Violation|3|||
130940929|NCT02024867|471417372|FG001|Overall Study|Protocol Violation|3|||
130940930|NCT02024867|471417371|FG000|Overall Study|Lost to Follow-up|6|||
130940931|NCT02024867|471417372|FG001|Overall Study|Lost to Follow-up|4|||
130940932|NCT02150954|471417373|FG000|Overall Study|Protocol Violation|1|||
130940933|NCT02150954|471417374|FG001|Overall Study|Protocol Violation|0|||
130940934|NCT02278263|471417378|FG000|Overall Study|Protocol Violation|7|||
130940935|NCT02278263|471417379|FG001|Overall Study|Protocol Violation|0|||
130940936|NCT02278263|471417380|FG002|Overall Study|Protocol Violation|9|||
130940937|NCT03164928|471417381|FG000|Overall Study|Lost to Follow-up|1|||
130940938|NCT03164928|471417382|FG001|Overall Study|Lost to Follow-up|0|||
130940939|NCT01998737|471417383|FG000|Overall Study|Corrupted database|23|||
130940940|NCT01998737|471417384|FG001|Overall Study|Corrupted database|0|||
130940941|NCT03997383|471417385|FG000|Double-blind Treatment Period|Adverse Event|4|||
130940942|NCT03997383|471417386|FG001|Double-blind Treatment Period|Adverse Event|3|||
130940943|NCT03997383|471417385|FG000|Double-blind Treatment Period|Death|4|||
130940944|NCT03997383|471417386|FG001|Double-blind Treatment Period|Death|4|||
130940945|NCT03997383|471417385|FG000|Double-blind Treatment Period|Physician Decision|2|||
130940946|NCT03997383|471417386|FG001|Double-blind Treatment Period|Physician Decision|0|||
130940947|NCT03997383|471417385|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
130940948|NCT03997383|471417386|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
130940949|NCT03997383|471417385|FG000|Open-label Extension Period|Ongoing|148|||
130940950|NCT03997383|471417386|FG001|Open-label Extension Period|Ongoing|151|||
130940951|NCT03997383|471417385|FG000|Open-label Extension Period|Adverse Event|4|||
130940952|NCT03997383|471417386|FG001|Open-label Extension Period|Adverse Event|1|||
130940953|NCT03997383|471417385|FG000|Open-label Extension Period|Death|8|||
130940954|NCT03997383|471417386|FG001|Open-label Extension Period|Death|9|||
130940955|NCT03997383|471417385|FG000|Open-label Extension Period|Physician Decision|1|||
130940956|NCT03997383|471417386|FG001|Open-label Extension Period|Physician Decision|1|||
130940957|NCT03997383|471417385|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
130940958|NCT03997383|471417386|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
130940959|NCT03997383|471417385|FG000|Open-label Extension Period|Reason Not Specified|2|||
130940960|NCT03997383|471417386|FG001|Open-label Extension Period|Reason Not Specified|0|||
130940961|NCT02118012|471417387|FG000|Overall Study|Adverse Event|0|||
130940962|NCT02118012|471417388|FG001|Overall Study|Adverse Event|1|||
130940963|NCT02118012|471417387|FG000|Overall Study|Physician Decision|0|||
130940964|NCT02118012|471417388|FG001|Overall Study|Physician Decision|1|||
130940965|NCT00171223|471417389|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
130940966|NCT00171223|471417390|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
130940967|NCT00171223|471417391|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
130940968|NCT00171223|471417389|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
130940969|NCT00171223|471417390|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
130940970|NCT00171223|471417391|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
130940971|NCT00171223|471417389|FG000|Overall Study|Abnormal Procedure|1|||
130940972|NCT00171223|471417390|FG001|Overall Study|Abnormal Procedure|0|||
130940973|NCT00171223|471417391|FG002|Overall Study|Abnormal Procedure|0|||
130940974|NCT00171223|471417389|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
130940975|NCT00171223|471417390|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
130940976|NCT00171223|471417391|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
130940977|NCT00171223|471417389|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
130940978|NCT00171223|471417390|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
130940979|NCT00171223|471417391|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
130940980|NCT00171223|471417389|FG000|Overall Study|Protocol Violation|2|||
130940981|NCT00171223|471417390|FG001|Overall Study|Protocol Violation|2|||
130706539|NCT03253094|470549729|FG002|Overall Study|Adverse Event|0|||
130706540|NCT03253094|470549730|FG003|Overall Study|Adverse Event|0|||
130772247|NCT05052697|470792848|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
130772248|NCT05052697|470792849|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130706541|NCT03253094|470549731|FG004|Overall Study|Adverse Event|0|||
130940982|NCT00171223|471417391|FG002|Overall Study|Protocol Violation|3|||
130940983|NCT00171223|471417389|FG000|Overall Study|Participant Withdrew Consent|12|||
130706542|NCT03253094|470549732|FG005|Overall Study|Adverse Event|0|||
130940984|NCT00171223|471417390|FG001|Overall Study|Participant Withdrew Consent|21|||
130940985|NCT00171223|471417391|FG002|Overall Study|Participant Withdrew Consent|15|||
130940986|NCT00171223|471417389|FG000|Overall Study|Lost to Follow-up|5|||
130940987|NCT00171223|471417390|FG001|Overall Study|Lost to Follow-up|2|||
130940988|NCT00171223|471417391|FG002|Overall Study|Lost to Follow-up|3|||
130940989|NCT00171223|471417389|FG000|Overall Study|Administrative Problems|4|||
130706543|NCT03253094|470549727|FG000|Overall Study|Lack of Efficacy|0|||
130706544|NCT03253094|470549728|FG001|Overall Study|Lack of Efficacy|0|||
130706545|NCT03253094|470549729|FG002|Overall Study|Lack of Efficacy|2|||
130706546|NCT03253094|470549730|FG003|Overall Study|Lack of Efficacy|1|||
131123185|NCT05314517|472079744|FG002|Double-blind Period|Noncompliance|0|||
131123186|NCT05314517|472079745|FG003|Double-blind Period|Noncompliance|0|||
131123187|NCT05314517|472079742|FG000|Double-blind Period|Randomized, not treated|1|||
131123188|NCT05314517|472079743|FG001|Double-blind Period|Randomized, not treated|0|||
131123189|NCT05314517|472079744|FG002|Double-blind Period|Randomized, not treated|0|||
131123190|NCT05314517|472079745|FG003|Double-blind Period|Randomized, not treated|0|||
131123191|NCT05314517|472079742|FG000|Open-label Extension|Adverse Event|0|||
131123192|NCT05314517|472079743|FG001|Open-label Extension|Adverse Event|0|||
131123193|NCT05314517|472079744|FG002|Open-label Extension|Adverse Event|1|||
131123194|NCT05314517|472079745|FG003|Open-label Extension|Adverse Event|2|||
131123195|NCT05314517|472079742|FG000|Open-label Extension|Investigator decision|0|||
131123196|NCT05314517|472079743|FG001|Open-label Extension|Investigator decision|0|||
131123197|NCT05314517|472079744|FG002|Open-label Extension|Investigator decision|1|||
131123198|NCT05314517|472079745|FG003|Open-label Extension|Investigator decision|0|||
131123199|NCT05314517|472079742|FG000|Open-label Extension|Lost to Follow-up|0|||
131123200|NCT05314517|472079743|FG001|Open-label Extension|Lost to Follow-up|0|||
131123201|NCT05314517|472079744|FG002|Open-label Extension|Lost to Follow-up|0|||
130706547|NCT03253094|470549731|FG004|Overall Study|Lack of Efficacy|2|||
130706548|NCT03253094|470549732|FG005|Overall Study|Lack of Efficacy|1|||
130706549|NCT03253094|470549727|FG000|Overall Study|Lost to Follow-up|0|||
130706550|NCT03253094|470549728|FG001|Overall Study|Lost to Follow-up|0|||
130706551|NCT03253094|470549729|FG002|Overall Study|Lost to Follow-up|1|||
130706552|NCT03253094|470549730|FG003|Overall Study|Lost to Follow-up|1|||
130706553|NCT03253094|470549731|FG004|Overall Study|Lost to Follow-up|0|||
130706554|NCT03253094|470549732|FG005|Overall Study|Lost to Follow-up|1|||
130706555|NCT03253094|470549727|FG000|Overall Study|Physician Decision|1|||
130706556|NCT03253094|470549728|FG001|Overall Study|Physician Decision|0|||
130706557|NCT03253094|470549729|FG002|Overall Study|Physician Decision|0|||
130772249|NCT05052697|470792850|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
130772250|NCT05052697|470792851|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
130940990|NCT00171223|471417390|FG001|Overall Study|Administrative Problems|7|||
130940991|NCT00171223|471417391|FG002|Overall Study|Administrative Problems|6|||
130940992|NCT00171223|471417389|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
130940993|NCT00171223|471417390|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
130940994|NCT00171223|471417391|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
130940995|NCT00171223|471417389|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
130940996|NCT00171223|471417390|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
130940997|NCT00171223|471417391|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
130940998|NCT00455429|471417408|FG000|Overall Study|Study Terminated by Sponsor|0|||
130940999|NCT00455429|471417409|FG001|Overall Study|Study Terminated by Sponsor|0|||
130941000|NCT00455429|471417410|FG002|Overall Study|Study Terminated by Sponsor|0|||
130941001|NCT00455429|471417411|FG003|Overall Study|Study Terminated by Sponsor|3|||
130941002|NCT00455429|471417408|FG000|Overall Study|Lost to Follow-up|1|||
130941003|NCT00455429|471417409|FG001|Overall Study|Lost to Follow-up|0|||
130941004|NCT00455429|471417410|FG002|Overall Study|Lost to Follow-up|0|||
130941005|NCT00455429|471417411|FG003|Overall Study|Lost to Follow-up|3|||
130941006|NCT00455429|471417408|FG000|Overall Study|Withdrawal by Subject|0|||
130941007|NCT00455429|471417409|FG001|Overall Study|Withdrawal by Subject|1|||
130941008|NCT00455429|471417410|FG002|Overall Study|Withdrawal by Subject|1|||
130941009|NCT00455429|471417411|FG003|Overall Study|Withdrawal by Subject|0|||
130941010|NCT00455429|471417408|FG000|Overall Study|Lack of Efficacy|0|||
130941011|NCT00455429|471417409|FG001|Overall Study|Lack of Efficacy|1|||
130941012|NCT00455429|471417410|FG002|Overall Study|Lack of Efficacy|0|||
130941013|NCT00455429|471417411|FG003|Overall Study|Lack of Efficacy|1|||
130941014|NCT00455429|471417408|FG000|Overall Study|Adverse Event|0|||
130941015|NCT00455429|471417409|FG001|Overall Study|Adverse Event|1|||
130941016|NCT00455429|471417410|FG002|Overall Study|Adverse Event|0|||
131123202|NCT05314517|472079745|FG003|Open-label Extension|Lost to Follow-up|1|||
130941017|NCT00455429|471417411|FG003|Overall Study|Adverse Event|3|||
130941018|NCT00455429|471417408|FG000|Overall Study|Randomly assigned but not treated|0|||
131123203|NCT05314517|472079742|FG000|Open-label Extension|Withdrawal by Subject|0|||
131123204|NCT05314517|472079743|FG001|Open-label Extension|Withdrawal by Subject|0|||
130706558|NCT03253094|470549730|FG003|Overall Study|Physician Decision|1|||
130941019|NCT00455429|471417409|FG001|Overall Study|Randomly assigned but not treated|0|||
130941020|NCT00455429|471417410|FG002|Overall Study|Randomly assigned but not treated|0|||
130706559|NCT03253094|470549731|FG004|Overall Study|Physician Decision|0|||
130706560|NCT03253094|470549732|FG005|Overall Study|Physician Decision|2|||
130706561|NCT03253094|470549727|FG000|Overall Study|Withdrawal by Subject|1|||
130941021|NCT00455429|471417411|FG003|Overall Study|Randomly assigned but not treated|2|||
130941022|NCT00455429|471417408|FG000|Overall Study|Personal Reason|1|||
130706562|NCT03253094|470549728|FG001|Overall Study|Withdrawal by Subject|2|||
130941023|NCT00455429|471417409|FG001|Overall Study|Personal Reason|0|||
130941024|NCT00455429|471417410|FG002|Overall Study|Personal Reason|0|||
130941025|NCT00455429|471417411|FG003|Overall Study|Personal Reason|0|||
130941026|NCT00455429|471417408|FG000|Overall Study|Non-compliance|0|||
130941027|NCT00455429|471417409|FG001|Overall Study|Non-compliance|0|||
130941028|NCT00455429|471417410|FG002|Overall Study|Non-compliance|0|||
130941029|NCT00455429|471417411|FG003|Overall Study|Non-compliance|1|||
130941030|NCT00455429|471417408|FG000|Overall Study|Other|0|||
130941031|NCT00455429|471417409|FG001|Overall Study|Other|2|||
130941032|NCT00455429|471417410|FG002|Overall Study|Other|0|||
130941033|NCT00455429|471417411|FG003|Overall Study|Other|1|||
130941034|NCT01165554|471417418|FG000|Overall Study|Withdrawal by Subject|23|||
130941035|NCT02951156|471417419|FG000|Overall Study|Death|3|||
130941036|NCT02951156|471417420|FG001|Overall Study|Death|8|||
130941037|NCT02951156|471417421|FG002|Overall Study|Death|5|||
130941038|NCT02951156|471417419|FG000|Overall Study|Progressive disease|1|||
130941039|NCT02951156|471417420|FG001|Overall Study|Progressive disease|0|||
130941040|NCT02951156|471417421|FG002|Overall Study|Progressive disease|1|||
130941041|NCT02951156|471417419|FG000|Overall Study|Withdrawal by Subject|0|||
130941042|NCT02951156|471417420|FG001|Overall Study|Withdrawal by Subject|0|||
130941043|NCT02951156|471417421|FG002|Overall Study|Withdrawal by Subject|1|||
130941044|NCT02951156|471417419|FG000|Overall Study|Study terminated by sponsor|0|||
130941045|NCT02951156|471417420|FG001|Overall Study|Study terminated by sponsor|0|||
130941046|NCT02951156|471417421|FG002|Overall Study|Study terminated by sponsor|1|||
130941047|NCT02951156|471417419|FG000|Overall Study|Other|5|||
130941048|NCT02951156|471417420|FG001|Overall Study|Other|1|||
130941049|NCT02951156|471417421|FG002|Overall Study|Other|2|||
130941050|NCT04351087|471417422|FG000|Overall Study|Lost to Follow-up|7|||
130941051|NCT04351087|471417423|FG001|Overall Study|Lost to Follow-up|3|||
130941052|NCT04351087|471417422|FG000|Overall Study|Withdrawal by Subject|3|||
130941053|NCT04351087|471417423|FG001|Overall Study|Withdrawal by Subject|4|||
130941054|NCT04351087|471417422|FG000|Overall Study|Lack of Efficacy|3|||
130941055|NCT04351087|471417423|FG001|Overall Study|Lack of Efficacy|2|||
130941056|NCT01603459|471417426|FG000|Overall Study|Adverse Event|5|||
130941057|NCT01603459|471417426|FG000|Overall Study|Withdrawal by Subject|5|||
130941058|NCT01603459|471417426|FG000|Overall Study|Lost to Follow-up|3|||
130941059|NCT01603459|471417426|FG000|Overall Study|Predefined discontinuation criteria|3|||
130941060|NCT01603459|471417426|FG000|Overall Study|Non-compliance|1|||
130941061|NCT01603459|471417426|FG000|Overall Study|Administrative reason|1|||
130941062|NCT03519347|471417429|FG000|Interventional Crossover Period 1|Death|0|||
130941063|NCT03519347|471417430|FG001|Interventional Crossover Period 1|Death|0|||
130941064|NCT03519347|471417431|FG002|Interventional Crossover Period 1|Death|0|||
130941065|NCT03519347|471417432|FG003|Interventional Crossover Period 1|Death|1|||
130941066|NCT05517382|471417433|FG000|Overall Study|Lost to Follow-up|0|||
130941067|NCT05517382|471417434|FG001|Overall Study|Lost to Follow-up|1|||
130941068|NCT01641692|471417435|FG000|Treatment Period 1|Adverse Event|1|||
130941069|NCT01641692|471417436|FG001|Treatment Period 1|Adverse Event|0|||
130941070|NCT01641692|471417437|FG002|Treatment Period 1|Adverse Event|0|||
130941071|NCT01641692|471417438|FG003|Treatment Period 1|Adverse Event|0|||
130941072|NCT01641692|471417439|FG004|Treatment Period 1|Adverse Event|0|||
130941073|NCT01641692|471417440|FG005|Treatment Period 1|Adverse Event|0|||
130941074|NCT01641692|471417441|FG006|Treatment Period 1|Adverse Event|0|||
130941075|NCT01641692|471417442|FG007|Treatment Period 1|Adverse Event|0|||
130941076|NCT01641692|471417435|FG000|Treatment Period 1|Lack of Efficacy|0|||
130941077|NCT01641692|471417436|FG001|Treatment Period 1|Lack of Efficacy|0|||
130941078|NCT01641692|471417437|FG002|Treatment Period 1|Lack of Efficacy|0|||
130941079|NCT01641692|471417438|FG003|Treatment Period 1|Lack of Efficacy|0|||
130941080|NCT01641692|471417439|FG004|Treatment Period 1|Lack of Efficacy|0|||
130941081|NCT01641692|471417440|FG005|Treatment Period 1|Lack of Efficacy|0|||
130941082|NCT01641692|471417441|FG006|Treatment Period 1|Lack of Efficacy|0|||
130941083|NCT01641692|471417442|FG007|Treatment Period 1|Lack of Efficacy|1|||
130941084|NCT01641692|471417435|FG000|Treatment Period 1|Protocol Violation|1|||
130941085|NCT01641692|471417436|FG001|Treatment Period 1|Protocol Violation|0|||
130941086|NCT01641692|471417437|FG002|Treatment Period 1|Protocol Violation|0|||
131036414|NCT04908722|471768136|FG001|Overall Study|Other|1|||
131036415|NCT04908722|471768137|FG002|Overall Study|Other|3|||
131036416|NCT04908722|471768138|FG003|Overall Study|Other|2|||
131036417|NCT04908722|471768139|FG004|Overall Study|Other|4|||
131036418|NCT04908722|471768140|FG005|Overall Study|Other|1|||
131036419|NCT04908722|471768135|FG000|Overall Study|Initiated prohibited medication|0|||
131036420|NCT04908722|471768136|FG001|Overall Study|Initiated prohibited medication|0|||
131036421|NCT04908722|471768137|FG002|Overall Study|Initiated prohibited medication|0|||
130772251|NCT05052697|470792852|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
130941087|NCT01641692|471417438|FG003|Treatment Period 1|Protocol Violation|0|||
130941088|NCT01641692|471417439|FG004|Treatment Period 1|Protocol Violation|2|||
130941089|NCT01641692|471417440|FG005|Treatment Period 1|Protocol Violation|0|||
130941090|NCT01641692|471417441|FG006|Treatment Period 1|Protocol Violation|0|||
130941091|NCT01641692|471417442|FG007|Treatment Period 1|Protocol Violation|0|||
131036422|NCT04908722|471768138|FG003|Overall Study|Initiated prohibited medication|1|||
131036423|NCT04908722|471768139|FG004|Overall Study|Initiated prohibited medication|0|||
130772252|NCT05052697|470792853|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130772253|NCT05052697|470792820|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772254|NCT05052697|470792821|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772255|NCT05052697|470792822|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772256|NCT05052697|470792823|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772257|NCT05052697|470792824|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772258|NCT05052697|470792825|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772259|NCT05052697|470792826|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130706563|NCT03253094|470549729|FG002|Overall Study|Withdrawal by Subject|1|||
130706564|NCT03253094|470549730|FG003|Overall Study|Withdrawal by Subject|0|||
130706565|NCT03253094|470549731|FG004|Overall Study|Withdrawal by Subject|3|||
130706566|NCT03253094|470549732|FG005|Overall Study|Withdrawal by Subject|0|||
130706567|NCT03253094|470549727|FG000|Overall Study|Other|0|||
130706568|NCT03253094|470549728|FG001|Overall Study|Other|1|||
130772260|NCT05052697|470792827|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772261|NCT05052697|470792828|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772262|NCT05052697|470792829|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772263|NCT05052697|470792830|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772264|NCT05052697|470792831|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772265|NCT05052697|470792832|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772266|NCT05052697|470792833|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772267|NCT05052697|470792834|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772268|NCT05052697|470792835|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772269|NCT05052697|470792836|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772270|NCT05052697|470792837|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772271|NCT05052697|470792838|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772272|NCT05052697|470792839|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772273|NCT05052697|470792840|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772274|NCT05052697|470792841|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772275|NCT05052697|470792842|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772276|NCT05052697|470792843|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772277|NCT05052697|470792844|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772278|NCT05052697|470792845|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772279|NCT05052697|470792846|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772280|NCT05052697|470792847|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
131123205|NCT05314517|472079744|FG002|Open-label Extension|Withdrawal by Subject|1|||
131123206|NCT05314517|472079745|FG003|Open-label Extension|Withdrawal by Subject|2|||
131123207|NCT05314517|472079742|FG000|Open-label Extension|Use of prohibited medication|0|||
130706569|NCT03253094|470549729|FG002|Overall Study|Other|2|||
130706570|NCT03253094|470549730|FG003|Overall Study|Other|1|||
130706571|NCT03253094|470549731|FG004|Overall Study|Other|0|||
130706572|NCT03253094|470549732|FG005|Overall Study|Other|0|||
130706573|NCT02339090|470549733|FG000|Overall Study|Adverse Event|1|||
130706574|NCT02339090|470549734|FG001|Overall Study|Adverse Event|0|||
130706575|NCT02339090|470549733|FG000|Overall Study|Lost to Follow-up|0|||
130706576|NCT02339090|470549734|FG001|Overall Study|Lost to Follow-up|1|||
130706577|NCT02339090|470549733|FG000|Overall Study|Non-compliance With Study Drug|0|||
130706578|NCT02339090|470549734|FG001|Overall Study|Non-compliance With Study Drug|1|||
130706579|NCT02339090|470549733|FG000|Overall Study|Withdrawal by Subject|2|||
130706580|NCT02339090|470549734|FG001|Overall Study|Withdrawal by Subject|1|||
130706581|NCT02339090|470549733|FG000|Overall Study|Poor Growth|3|||
130706582|NCT02339090|470549734|FG001|Overall Study|Poor Growth|0|||
130706583|NCT02339090|470549733|FG000|Overall Study|Randomized but not treated|0|||
130706584|NCT02339090|470549734|FG001|Overall Study|Randomized but not treated|2|||
130706585|NCT02737592|470549737|FG000|Overall Study|Withdrawal by Subject|1|||
131123208|NCT05314517|472079743|FG001|Open-label Extension|Use of prohibited medication|0|||
131123209|NCT05314517|472079744|FG002|Open-label Extension|Use of prohibited medication|1|||
131123210|NCT05314517|472079745|FG003|Open-label Extension|Use of prohibited medication|0|||
131123211|NCT05314517|472079742|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
131123212|NCT05314517|472079743|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
131123213|NCT05314517|472079744|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
131123214|NCT05314517|472079745|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
131123215|NCT04969276|472079746|FG000|Overall Study|Protocol Deviation|0|||
131123216|NCT04969276|472079747|FG001|Overall Study|Protocol Deviation|1|||
130706586|NCT00576303|470549738|FG000|Dose Titration Period|Early withdrawal|17|||
130706587|NCT00576303|470549738|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
130706588|NCT00576303|470549738|FG000|Long Term Safety Period|Early withdrawal|16|||
130706589|NCT00955721|470549739|FG000|Overall Study|Physician Decision|1|||
130706590|NCT00955721|470549740|FG001|Overall Study|Physician Decision|0|||
130706591|NCT00955721|470549739|FG000|Overall Study|Death|1|||
130706592|NCT00955721|470549740|FG001|Overall Study|Death|0|||
130706593|NCT00955721|470549739|FG000|Overall Study|Withdrawal by Subject|1|||
130772281|NCT05052697|470792848|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
130772282|NCT05052697|470792849|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
130941092|NCT01641692|471417435|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130941093|NCT01641692|471417436|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130941094|NCT01641692|471417437|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130941095|NCT01641692|471417438|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130941096|NCT01641692|471417439|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
130941097|NCT01641692|471417440|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130941098|NCT01641692|471417441|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
130941099|NCT01641692|471417442|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
130941100|NCT01641692|471417435|FG000|Treatment Period 1|Lost to Follow-up|0|||
130941101|NCT01641692|471417436|FG001|Treatment Period 1|Lost to Follow-up|0|||
130941102|NCT01641692|471417437|FG002|Treatment Period 1|Lost to Follow-up|1|||
130941103|NCT01641692|471417438|FG003|Treatment Period 1|Lost to Follow-up|0|||
130941104|NCT01641692|471417439|FG004|Treatment Period 1|Lost to Follow-up|0|||
130941105|NCT01641692|471417440|FG005|Treatment Period 1|Lost to Follow-up|0|||
130941106|NCT01641692|471417441|FG006|Treatment Period 1|Lost to Follow-up|0|||
130941107|NCT01641692|471417442|FG007|Treatment Period 1|Lost to Follow-up|0|||
130941108|NCT01641692|471417435|FG000|Treatment Period 1|Physician Decision|0|||
130941109|NCT01641692|471417436|FG001|Treatment Period 1|Physician Decision|0|||
130941110|NCT01641692|471417437|FG002|Treatment Period 1|Physician Decision|0|||
130941111|NCT01641692|471417438|FG003|Treatment Period 1|Physician Decision|0|||
130941112|NCT01641692|471417439|FG004|Treatment Period 1|Physician Decision|1|||
130941113|NCT01641692|471417440|FG005|Treatment Period 1|Physician Decision|0|||
130941114|NCT01641692|471417441|FG006|Treatment Period 1|Physician Decision|0|||
130941115|NCT01641692|471417442|FG007|Treatment Period 1|Physician Decision|0|||
130941116|NCT01641692|471417435|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130941117|NCT01641692|471417436|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130941118|NCT01641692|471417437|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130941119|NCT01641692|471417438|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130941120|NCT01641692|471417439|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130941121|NCT01641692|471417440|FG005|Treatment Period 1|Withdrawal by Subject|2|||
130941122|NCT01641692|471417441|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130941123|NCT01641692|471417442|FG007|Treatment Period 1|Withdrawal by Subject|1|||
130941124|NCT01641692|471417435|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
130941125|NCT01641692|471417436|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130941126|NCT01641692|471417437|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130941127|NCT01641692|471417438|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130941128|NCT01641692|471417439|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130941129|NCT01641692|471417440|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130941130|NCT01641692|471417441|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130941131|NCT01641692|471417442|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
130941132|NCT01641692|471417435|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130941133|NCT01641692|471417436|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130941134|NCT01641692|471417437|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130941135|NCT01641692|471417438|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130941136|NCT01641692|471417439|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130941137|NCT01641692|471417440|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130941138|NCT01641692|471417441|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
130941139|NCT01641692|471417442|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130941140|NCT01641692|471417435|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
130941141|NCT01641692|471417436|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130941142|NCT01641692|471417437|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
130941143|NCT01641692|471417438|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
130941144|NCT01641692|471417439|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
130941145|NCT01641692|471417440|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130941146|NCT01641692|471417441|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130941147|NCT01641692|471417442|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
130941148|NCT01641692|471417435|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
131036424|NCT04908722|471768140|FG005|Overall Study|Initiated prohibited medication|1|||
130941149|NCT01641692|471417436|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
131036425|NCT04908722|471768135|FG000|Overall Study|Randomized but not vaccinated|3|||
131036426|NCT04908722|471768136|FG001|Overall Study|Randomized but not vaccinated|1|||
131036427|NCT04908722|471768137|FG002|Overall Study|Randomized but not vaccinated|2|||
131036428|NCT04908722|471768138|FG003|Overall Study|Randomized but not vaccinated|2|||
130941150|NCT01641692|471417437|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130941151|NCT01641692|471417438|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
130941152|NCT01641692|471417439|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
130941153|NCT01641692|471417440|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
131036429|NCT04908722|471768139|FG004|Overall Study|Randomized but not vaccinated|3|||
130941154|NCT01641692|471417441|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
131123217|NCT04969276|472079748|FG002|Overall Study|Protocol Deviation|0|||
130772283|NCT05052697|470792850|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
130772284|NCT05052697|470792851|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
130772285|NCT05052697|470792852|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
130772286|NCT05052697|470792853|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130772287|NCT05052697|470792820|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772288|NCT05052697|470792821|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772289|NCT05052697|470792822|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772290|NCT05052697|470792823|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772291|NCT05052697|470792824|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772292|NCT05052697|470792825|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772293|NCT05052697|470792826|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131036430|NCT04908722|471768140|FG005|Overall Study|Randomized but not vaccinated|4|||
131036431|NCT02319759|471768141|FG000|Week 0 - 16|Lack of Efficacy|1|||
131036432|NCT02319759|471768142|FG001|Week 0 - 16|Lack of Efficacy|0|||
131036433|NCT02319759|471768143|FG002|Week 0 - 16|Lack of Efficacy|0|||
131036434|NCT02319759|471768144|FG003|Week 0 - 16|Lack of Efficacy|0|||
131036435|NCT02319759|471768145|FG004|Week 0 - 16|Lack of Efficacy|0|||
131036436|NCT02319759|471768141|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
131036437|NCT02319759|471768142|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
131036438|NCT02319759|471768143|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
131123218|NCT04969276|472079746|FG000|Overall Study|Withdrawal by Subject|1|||
131123219|NCT04969276|472079747|FG001|Overall Study|Withdrawal by Subject|10|||
131123220|NCT04969276|472079748|FG002|Overall Study|Withdrawal by Subject|0|||
131123221|NCT04969276|472079746|FG000|Overall Study|Lost to Follow-up|0|||
131123222|NCT04969276|472079747|FG001|Overall Study|Lost to Follow-up|1|||
131123223|NCT04969276|472079748|FG002|Overall Study|Lost to Follow-up|0|||
131123224|NCT04655144|472079752|FG000|Overall Study|Consumed THC|1|||
131123225|NCT04655144|472079753|FG001|Overall Study|Consumed THC|0|||
131123226|NCT04655144|472079752|FG000|Overall Study|Unilateral embolization|0|||
131123227|NCT04655144|472079753|FG001|Overall Study|Unilateral embolization|1|||
131123228|NCT04490018|472079757|FG000|Overall Study|Protocol Violation|0|||
131123229|NCT04490018|472079758|FG001|Overall Study|Protocol Violation|2|||
131123230|NCT04490018|472079759|FG002|Overall Study|Protocol Violation|1|||
131123231|NCT04490018|472079757|FG000|Overall Study|Lost to Follow-up|2|||
131123232|NCT04490018|472079758|FG001|Overall Study|Lost to Follow-up|2|||
131123233|NCT04490018|472079759|FG002|Overall Study|Lost to Follow-up|0|||
131123234|NCT04490018|472079757|FG000|Overall Study|Withdrawal by Subject|2|||
131123235|NCT04490018|472079758|FG001|Overall Study|Withdrawal by Subject|1|||
131123236|NCT04490018|472079759|FG002|Overall Study|Withdrawal by Subject|0|||
131123237|NCT04490018|472079757|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131123238|NCT04490018|472079758|FG001|Overall Study|Withdrawal by parent/guardian|3|||
131123239|NCT04490018|472079759|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131123240|NCT00943579|472079761|FG000|Overall Study|Adverse Event|4|||
131123241|NCT00943579|472079762|FG001|Overall Study|Adverse Event|3|||
130706594|NCT00955721|470549740|FG001|Overall Study|Withdrawal by Subject|0|||
130706595|NCT00749411|470549744|FG000|Overall Study|Adverse Event|0|||
130706596|NCT00749411|470549745|FG001|Overall Study|Adverse Event|2|||
130706597|NCT00749411|470549744|FG000|Overall Study|Lack of Efficacy|0|||
130706598|NCT00749411|470549745|FG001|Overall Study|Lack of Efficacy|1|||
130706599|NCT00749411|470549744|FG000|Overall Study|Protocol Violation|1|||
130706600|NCT00749411|470549745|FG001|Overall Study|Protocol Violation|1|||
130706601|NCT00749411|470549744|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130706602|NCT00749411|470549745|FG001|Overall Study|Protocol-defined stopping criteria|1|||
130706603|NCT03183141|470549747|FG000|Overall Study|Withdrawal by Subject|2|||
130706604|NCT03183141|470549748|FG001|Overall Study|Withdrawal by Subject|4|||
130706605|NCT03183141|470549747|FG000|Overall Study|Death|0|||
130706606|NCT03183141|470549748|FG001|Overall Study|Death|8|||
130706607|NCT02756637|470549750|FG000|Overall Study|Not eligible for initial SWOG study|10|||
130706608|NCT02756637|470549751|FG001|Overall Study|Not eligible for initial SWOG study|10|||
131036439|NCT02319759|471768144|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
131123242|NCT00943579|472079761|FG000|Overall Study|Lack of Efficacy|2|||
131123243|NCT00943579|472079762|FG001|Overall Study|Lack of Efficacy|2|||
131123244|NCT01401842|472079763|FG000|Overall Study|Withdrawal by Subject|3|||
131123245|NCT01401842|472079764|FG001|Overall Study|Withdrawal by Subject|2|||
131123246|NCT01401842|472079763|FG000|Overall Study|academic reason|4|||
131123247|NCT01401842|472079764|FG001|Overall Study|academic reason|1|||
131123248|NCT01401842|472079763|FG000|Overall Study|changed companies|20|||
130706609|NCT02756637|470549750|FG000|Overall Study|No available NLR value|44|||
130706610|NCT02756637|470549751|FG001|Overall Study|No available NLR value|44|||
130706611|NCT02756637|470549750|FG000|Overall Study|Did not complete curative therapy|33|||
130706612|NCT02756637|470549751|FG001|Overall Study|Did not complete curative therapy|0|||
130706613|NCT04034355|470549752|FG000|Overall Study|Study terminated by Sponsor|10|||
130706614|NCT04034355|470549753|FG001|Overall Study|Study terminated by Sponsor|17|||
130772294|NCT05052697|470792827|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772295|NCT05052697|470792828|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772296|NCT05052697|470792829|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772297|NCT05052697|470792830|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772298|NCT05052697|470792831|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772299|NCT05052697|470792832|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772300|NCT05052697|470792833|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772301|NCT05052697|470792834|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772302|NCT05052697|470792835|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772303|NCT05052697|470792836|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772304|NCT05052697|470792837|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772305|NCT05052697|470792838|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772306|NCT05052697|470792839|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772307|NCT05052697|470792840|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772308|NCT05052697|470792841|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772309|NCT05052697|470792842|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772310|NCT05052697|470792843|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772311|NCT05052697|470792844|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130941155|NCT01641692|471417442|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130941156|NCT01641692|471417435|FG000|Treatment Period 2|Lack of Efficacy|1|||
130941157|NCT01641692|471417436|FG001|Treatment Period 2|Lack of Efficacy|0|||
130941158|NCT01641692|471417437|FG002|Treatment Period 2|Lack of Efficacy|0|||
130941159|NCT01641692|471417438|FG003|Treatment Period 2|Lack of Efficacy|0|||
130941160|NCT01641692|471417439|FG004|Treatment Period 2|Lack of Efficacy|0|||
130941161|NCT01641692|471417440|FG005|Treatment Period 2|Lack of Efficacy|0|||
130941162|NCT01641692|471417441|FG006|Treatment Period 2|Lack of Efficacy|0|||
130941163|NCT01641692|471417442|FG007|Treatment Period 2|Lack of Efficacy|0|||
130941164|NCT01641692|471417435|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
130941165|NCT01641692|471417436|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130941166|NCT01641692|471417437|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130941167|NCT01641692|471417438|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130941168|NCT01641692|471417439|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130941169|NCT01641692|471417440|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130941170|NCT01641692|471417441|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130941171|NCT01641692|471417442|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131123249|NCT01401842|472079764|FG001|Overall Study|changed companies|34|||
131123250|NCT01401842|472079763|FG000|Overall Study|discharged from US Army|3|||
131123251|NCT01401842|472079764|FG001|Overall Study|discharged from US Army|4|||
131123252|NCT01401842|472079763|FG000|Overall Study|invalid follow-up strength data|1|||
131123253|NCT01401842|472079764|FG001|Overall Study|invalid follow-up strength data|4|||
131123254|NCT01401842|472079763|FG000|Overall Study|on profile|9|||
131123255|NCT01401842|472079764|FG001|Overall Study|on profile|5|||
131123256|NCT01401842|472079763|FG000|Overall Study|other/unknown|28|||
131123257|NCT01401842|472079764|FG001|Overall Study|other/unknown|17|||
131123258|NCT00282295|472079765|FG000|Overall Study|Adverse Event|0|||
131123259|NCT00282295|472079766|FG001|Overall Study|Adverse Event|1|||
131123260|NCT00282295|472079767|FG002|Overall Study|Adverse Event|0|||
131123261|NCT00282295|472079765|FG000|Overall Study|Serious Adverse Events|0|||
131123262|NCT00282295|472079766|FG001|Overall Study|Serious Adverse Events|0|||
131123263|NCT00282295|472079767|FG002|Overall Study|Serious Adverse Events|1|||
131123264|NCT00282295|472079765|FG000|Overall Study|Protocol Violation|0|||
131123265|NCT00282295|472079766|FG001|Overall Study|Protocol Violation|2|||
131123266|NCT00282295|472079767|FG002|Overall Study|Protocol Violation|1|||
131123267|NCT00282295|472079765|FG000|Overall Study|Withdrawal by Subject|2|||
131123268|NCT00282295|472079766|FG001|Overall Study|Withdrawal by Subject|6|||
131123269|NCT00282295|472079767|FG002|Overall Study|Withdrawal by Subject|4|||
131123270|NCT00282295|472079765|FG000|Overall Study|Lost to Follow-up|1|||
131123271|NCT00282295|472079766|FG001|Overall Study|Lost to Follow-up|7|||
131123272|NCT00282295|472079767|FG002|Overall Study|Lost to Follow-up|2|||
131123273|NCT00282295|472079765|FG000|Overall Study|Other|0|||
131123274|NCT00282295|472079766|FG001|Overall Study|Other|1|||
131123275|NCT00282295|472079767|FG002|Overall Study|Other|0|||
131123276|NCT03337542|472079768|FG000|Overall Study|Withdrew Consent|17|||
131123277|NCT03337542|472079768|FG000|Overall Study|Allergic Adverse Event|1|||
131123278|NCT03337542|472079768|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
131123279|NCT03337542|472079768|FG000|Overall Study|Lost to Follow-up|1|||
131123280|NCT03337542|472079768|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
131123281|NCT00121108|472079769|FG000|Overall Study|Lost to Follow-up|10|||
131123282|NCT00121108|472079770|FG001|Overall Study|Lost to Follow-up|22|||
131123283|NCT00121108|472079769|FG000|Overall Study|Withdrawal by Subject|106|||
131123284|NCT00121108|472079770|FG001|Overall Study|Withdrawal by Subject|195|||
131123285|NCT00121108|472079769|FG000|Overall Study|Death|5|||
131123286|NCT00121108|472079770|FG001|Overall Study|Death|8|||
130772312|NCT05052697|470792845|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772313|NCT05052697|470792846|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772314|NCT05052697|470792847|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772315|NCT05052697|470792848|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772316|NCT05052697|470792849|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130772317|NCT05052697|470792850|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130941172|NCT01641692|471417435|FG000|Treatment Period 2|Lost to Follow-up|0|||
130941173|NCT01641692|471417436|FG001|Treatment Period 2|Lost to Follow-up|0|||
130941174|NCT01641692|471417437|FG002|Treatment Period 2|Lost to Follow-up|0|||
130941175|NCT01641692|471417438|FG003|Treatment Period 2|Lost to Follow-up|0|||
130941176|NCT01641692|471417439|FG004|Treatment Period 2|Lost to Follow-up|0|||
130941177|NCT01641692|471417440|FG005|Treatment Period 2|Lost to Follow-up|1|||
130941178|NCT01641692|471417441|FG006|Treatment Period 2|Lost to Follow-up|0|||
130941179|NCT01641692|471417442|FG007|Treatment Period 2|Lost to Follow-up|0|||
130941180|NCT01641692|471417435|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130941181|NCT01641692|471417436|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130941182|NCT01641692|471417437|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130941183|NCT01641692|471417438|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130941184|NCT01641692|471417439|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130941185|NCT01641692|471417440|FG005|Treatment Period 2|Withdrawal by Subject|1|||
130941186|NCT01641692|471417441|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130941187|NCT01641692|471417442|FG007|Treatment Period 2|Withdrawal by Subject|1|||
130941188|NCT01641692|471417435|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130941189|NCT01641692|471417436|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130941190|NCT01641692|471417437|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130941191|NCT01641692|471417438|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130941192|NCT01641692|471417439|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
130941193|NCT01641692|471417440|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
130941194|NCT01641692|471417441|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
130941195|NCT01641692|471417442|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
131036440|NCT02319759|471768145|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
131036441|NCT02319759|471768141|FG000|Week 16 - 24|Lack of Efficacy|1|||
131036442|NCT02319759|471768142|FG001|Week 16 - 24|Lack of Efficacy|0|||
131036443|NCT02319759|471768143|FG002|Week 16 - 24|Lack of Efficacy|1|||
131036444|NCT02319759|471768144|FG003|Week 16 - 24|Lack of Efficacy|0|||
131036445|NCT02319759|471768145|FG004|Week 16 - 24|Lack of Efficacy|0|||
131036446|NCT02319759|471768141|FG000|Week 16 - 24|Lost to Follow-up|1|||
131036447|NCT02319759|471768142|FG001|Week 16 - 24|Lost to Follow-up|0|||
131036448|NCT02319759|471768143|FG002|Week 16 - 24|Lost to Follow-up|0|||
131036449|NCT02319759|471768144|FG003|Week 16 - 24|Lost to Follow-up|0|||
131036450|NCT02319759|471768145|FG004|Week 16 - 24|Lost to Follow-up|0|||
131036451|NCT02319759|471768141|FG000|Week 16 - 24|Withdrawal by Subject|0|||
131036452|NCT02319759|471768142|FG001|Week 16 - 24|Withdrawal by Subject|0|||
131036453|NCT02319759|471768143|FG002|Week 16 - 24|Withdrawal by Subject|2|||
131036454|NCT02319759|471768144|FG003|Week 16 - 24|Withdrawal by Subject|0|||
131036455|NCT02319759|471768145|FG004|Week 16 - 24|Withdrawal by Subject|0|||
131036456|NCT02319759|471768141|FG000|Week 24 - 56|Adverse Event|0|||
131036457|NCT02319759|471768142|FG001|Week 24 - 56|Adverse Event|0|||
131036458|NCT02319759|471768143|FG002|Week 24 - 56|Adverse Event|2|||
131036459|NCT02319759|471768144|FG003|Week 24 - 56|Adverse Event|0|||
131036460|NCT02319759|471768145|FG004|Week 24 - 56|Adverse Event|0|||
131036461|NCT02319759|471768141|FG000|Week 24 - 56|Lack of Efficacy|0|||
131036462|NCT02319759|471768142|FG001|Week 24 - 56|Lack of Efficacy|0|||
131036463|NCT02319759|471768143|FG002|Week 24 - 56|Lack of Efficacy|0|||
131036464|NCT02319759|471768144|FG003|Week 24 - 56|Lack of Efficacy|2|||
131036465|NCT02319759|471768145|FG004|Week 24 - 56|Lack of Efficacy|1|||
131036466|NCT02319759|471768141|FG000|Week 24 - 56|Withdrawal by Subject|0|||
131036467|NCT02319759|471768142|FG001|Week 24 - 56|Withdrawal by Subject|1|||
131036468|NCT02319759|471768143|FG002|Week 24 - 56|Withdrawal by Subject|0|||
131036469|NCT02319759|471768144|FG003|Week 24 - 56|Withdrawal by Subject|0|||
131036470|NCT02319759|471768145|FG004|Week 24 - 56|Withdrawal by Subject|0|||
131036471|NCT02319759|471768141|FG000|Week 24 - 56|Lost to Follow-up|0|||
131036472|NCT02319759|471768142|FG001|Week 24 - 56|Lost to Follow-up|0|||
131036473|NCT02319759|471768143|FG002|Week 24 - 56|Lost to Follow-up|0|||
131036474|NCT02319759|471768144|FG003|Week 24 - 56|Lost to Follow-up|0|||
131123287|NCT01380379|472079771|FG000|Overall Study|Pregnancy|1|||
131123288|NCT01357577|472079774|FG000|Overall Study|Lost to Follow-up|20|||
131123289|NCT01357577|472079775|FG001|Overall Study|Lost to Follow-up|16|||
131123290|NCT01357577|472079774|FG000|Overall Study|Withdrawal by Subject|16|||
131123291|NCT01357577|472079775|FG001|Overall Study|Withdrawal by Subject|8|||
131036475|NCT02319759|471768145|FG004|Week 24 - 56|Lost to Follow-up|1|||
131036476|NCT06424236|471768148|FG000|Overall Study|Adverse Event|0|||
131036477|NCT06424236|471768149|FG001|Overall Study|Adverse Event|1|||
131036478|NCT06424236|471768150|FG002|Overall Study|Adverse Event|0|||
131036479|NCT06424236|471768148|FG000|Overall Study|Withdrawal by Subject|3|||
131123292|NCT01357577|472079774|FG000|Overall Study|look at data in database?|1|||
130772318|NCT05052697|470792851|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
131224213|NCT00555399|472447185|FG007|Overall Study|Withdrawal by Subject|0|||
130941196|NCT01641692|471417435|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130941197|NCT01641692|471417436|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130941198|NCT01641692|471417437|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
130941199|NCT01641692|471417438|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130941200|NCT01641692|471417439|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130941201|NCT01641692|471417440|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
130706615|NCT04034355|470549752|FG000|Overall Study|Withdrawal by Subject|12|||
130706616|NCT04034355|470549753|FG001|Overall Study|Withdrawal by Subject|11|||
130706617|NCT04034355|470549752|FG000|Overall Study|Site terminated by Sponsor|4|||
130706618|NCT04034355|470549753|FG001|Overall Study|Site terminated by Sponsor|5|||
130706619|NCT04034355|470549752|FG000|Overall Study|Adverse Event|2|||
130706620|NCT04034355|470549753|FG001|Overall Study|Adverse Event|0|||
130706621|NCT04034355|470549752|FG000|Overall Study|Death|1|||
130706622|NCT04034355|470549753|FG001|Overall Study|Death|1|||
130941202|NCT01641692|471417441|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130941203|NCT01641692|471417442|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
130941204|NCT01641692|471417435|FG000|Treatment Period 3|Adverse Event|0|||
130941205|NCT01641692|471417436|FG001|Treatment Period 3|Adverse Event|0|||
130941206|NCT01641692|471417437|FG002|Treatment Period 3|Adverse Event|0|||
130941207|NCT01641692|471417438|FG003|Treatment Period 3|Adverse Event|0|||
130941208|NCT01641692|471417439|FG004|Treatment Period 3|Adverse Event|0|||
130941209|NCT01641692|471417440|FG005|Treatment Period 3|Adverse Event|0|||
130941210|NCT01641692|471417441|FG006|Treatment Period 3|Adverse Event|1|||
130941211|NCT01641692|471417442|FG007|Treatment Period 3|Adverse Event|0|||
130941212|NCT01641692|471417435|FG000|Treatment Period 3|Protocol Violation|0|||
130941213|NCT01641692|471417436|FG001|Treatment Period 3|Protocol Violation|0|||
130941214|NCT01641692|471417437|FG002|Treatment Period 3|Protocol Violation|1|||
130941215|NCT01641692|471417438|FG003|Treatment Period 3|Protocol Violation|0|||
130941216|NCT01641692|471417439|FG004|Treatment Period 3|Protocol Violation|0|||
130941217|NCT01641692|471417440|FG005|Treatment Period 3|Protocol Violation|0|||
130941218|NCT01641692|471417441|FG006|Treatment Period 3|Protocol Violation|0|||
130941219|NCT01641692|471417442|FG007|Treatment Period 3|Protocol Violation|0|||
130941220|NCT01641692|471417435|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130941221|NCT01641692|471417436|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130941222|NCT01641692|471417437|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130941223|NCT01641692|471417438|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130941224|NCT01641692|471417439|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130941225|NCT01641692|471417440|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130941226|NCT01641692|471417441|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
130941227|NCT01641692|471417442|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130941228|NCT01641692|471417435|FG000|Treatment Period 3|Lost to Follow-up|0|||
130941229|NCT01641692|471417436|FG001|Treatment Period 3|Lost to Follow-up|1|||
130941230|NCT01641692|471417437|FG002|Treatment Period 3|Lost to Follow-up|0|||
130941231|NCT01641692|471417438|FG003|Treatment Period 3|Lost to Follow-up|0|||
130941232|NCT01641692|471417439|FG004|Treatment Period 3|Lost to Follow-up|0|||
130941233|NCT01641692|471417440|FG005|Treatment Period 3|Lost to Follow-up|0|||
130941234|NCT01641692|471417441|FG006|Treatment Period 3|Lost to Follow-up|0|||
130941235|NCT01641692|471417442|FG007|Treatment Period 3|Lost to Follow-up|0|||
130941236|NCT01641692|471417435|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
130941237|NCT01641692|471417436|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
130941238|NCT01641692|471417437|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
131036480|NCT06424236|471768149|FG001|Overall Study|Withdrawal by Subject|1|||
131036481|NCT06424236|471768150|FG002|Overall Study|Withdrawal by Subject|2|||
131036482|NCT06424236|471768148|FG000|Overall Study|Physician Decision|0|||
131036483|NCT06424236|471768149|FG001|Overall Study|Physician Decision|1|||
131036484|NCT06424236|471768150|FG002|Overall Study|Physician Decision|0|||
131036485|NCT06424236|471768148|FG000|Overall Study|Study Terminated by Sponsor|11|||
131036486|NCT06424236|471768149|FG001|Overall Study|Study Terminated by Sponsor|20|||
131036487|NCT06424236|471768150|FG002|Overall Study|Study Terminated by Sponsor|16|||
131036488|NCT06424236|471768148|FG000|Overall Study|Lost to Follow-up|0|||
131036489|NCT06424236|471768149|FG001|Overall Study|Lost to Follow-up|1|||
131036490|NCT06424236|471768150|FG002|Overall Study|Lost to Follow-up|0|||
131036491|NCT06424236|471768148|FG000|Overall Study|Disease Progression|0|||
131036492|NCT06424236|471768149|FG001|Overall Study|Disease Progression|1|||
131224214|NCT00555399|472447186|FG008|Overall Study|Withdrawal by Subject|0|||
130706623|NCT04034355|470549752|FG000|Overall Study|Not reported|2|||
130706624|NCT04034355|470549753|FG001|Overall Study|Not reported|0|||
130706625|NCT04034355|470549752|FG000|Overall Study|Lost to Follow-up|1|||
130941239|NCT01641692|471417438|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
130941240|NCT01641692|471417439|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
131036493|NCT06424236|471768150|FG002|Overall Study|Disease Progression|2|||
130706626|NCT04034355|470549753|FG001|Overall Study|Lost to Follow-up|0|||
130706627|NCT04034355|470549752|FG000|Overall Study|Physician Decision|1|||
130941241|NCT01641692|471417440|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
130941242|NCT01641692|471417441|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
130941243|NCT01641692|471417442|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
130941244|NCT01641692|471417435|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
130941245|NCT01641692|471417436|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
130941246|NCT01641692|471417437|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
130941247|NCT01641692|471417438|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
130941248|NCT01641692|471417439|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
130941249|NCT01641692|471417440|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
130941250|NCT01641692|471417441|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
130941251|NCT01641692|471417442|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
130941252|NCT04948450|471417447|FG000|Overall Study|Return home|1|||
130941253|NCT04948450|471417448|FG001|Overall Study|Return home|3|||
130941254|NCT05198843|471417451|FG000|Overall Study|Lack of Efficacy|1|||
130941255|NCT04166513|471417452|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
130941256|NCT04166513|471417453|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
130941257|NCT04166513|471417454|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
130941258|NCT04166513|471417455|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
130941259|NCT04166513|471417452|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
130941260|NCT04166513|471417453|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
130941261|NCT04166513|471417454|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
130941262|NCT04166513|471417455|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
130941263|NCT04166513|471417452|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
130941264|NCT04166513|471417453|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
130941265|NCT04166513|471417454|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
130941266|NCT04166513|471417455|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
130941267|NCT04166513|471417452|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
130941268|NCT04166513|471417453|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
130941269|NCT04166513|471417454|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
130941270|NCT04166513|471417455|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
130941271|NCT04166513|471417452|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
130941272|NCT04166513|471417453|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
130941273|NCT04166513|471417454|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
130941274|NCT04166513|471417455|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
130941275|NCT02750592|471418913|FG000|Overall Study|Adverse Event|3|||
130941276|NCT02750592|471418913|FG000|Overall Study|Lack of Efficacy|2|||
130941277|NCT02981342|471418916|FG000|Overall Study|Adverse Event|0|||
130941278|NCT02981342|471418917|FG001|Overall Study|Adverse Event|0|||
130941279|NCT02981342|471418918|FG002|Overall Study|Adverse Event|0|||
130941280|NCT02981342|471418919|FG003|Overall Study|Adverse Event|1|||
130941281|NCT02981342|471418916|FG000|Overall Study|Death|0|||
130941282|NCT02981342|471418917|FG001|Overall Study|Death|9|||
130941283|NCT02981342|471418918|FG002|Overall Study|Death|9|||
130941284|NCT02981342|471418919|FG003|Overall Study|Death|4|||
130941285|NCT02981342|471418916|FG000|Overall Study|Withdrawal by Subject|0|||
130941286|NCT02981342|471418917|FG001|Overall Study|Withdrawal by Subject|0|||
130941287|NCT02981342|471418918|FG002|Overall Study|Withdrawal by Subject|3|||
130941288|NCT02981342|471418919|FG003|Overall Study|Withdrawal by Subject|1|||
130941289|NCT02981342|471418916|FG000|Overall Study|Study closed by sponsor|0|||
130941290|NCT02981342|471418917|FG001|Overall Study|Study closed by sponsor|0|||
130941291|NCT02981342|471418918|FG002|Overall Study|Study closed by sponsor|1|||
130941292|NCT02981342|471418919|FG003|Overall Study|Study closed by sponsor|1|||
130941293|NCT02981342|471418916|FG000|Overall Study|Randomized, Never Treated|0|||
130941294|NCT02981342|471418917|FG001|Overall Study|Randomized, Never Treated|1|||
130941295|NCT02981342|471418918|FG002|Overall Study|Randomized, Never Treated|0|||
130941296|NCT02981342|471418919|FG003|Overall Study|Randomized, Never Treated|7|||
130941297|NCT02981342|471418916|FG000|Overall Study|Lost to Follow-up|0|||
130941298|NCT02981342|471418917|FG001|Overall Study|Lost to Follow-up|1|||
130941299|NCT02981342|471418918|FG002|Overall Study|Lost to Follow-up|0|||
130941300|NCT02981342|471418919|FG003|Overall Study|Lost to Follow-up|0|||
130941301|NCT05333900|471418920|FG000|Overall Study|Protocol Violation|0|||
130941302|NCT05333900|471418921|FG001|Overall Study|Protocol Violation|1|||
130941303|NCT05333900|471418920|FG000|Overall Study|Withdrawal by Subject|0|||
130941304|NCT05333900|471418921|FG001|Overall Study|Withdrawal by Subject|1|||
130941305|NCT05333900|471418920|FG000|Overall Study|COVID-19 Pandemic|1|||
130941306|NCT05333900|471418921|FG001|Overall Study|COVID-19 Pandemic|1|||
130941307|NCT01851720|471418922|FG000|Overall Study|Lost to Follow-up|0|||
130941308|NCT01851720|471418923|FG001|Overall Study|Lost to Follow-up|1|||
130941309|NCT01870583|471418926|FG000|Overall Study|Protocol Violation|0|||
130941310|NCT01870583|471418927|FG001|Overall Study|Protocol Violation|5|||
130941311|NCT01870583|471418928|FG002|Overall Study|Protocol Violation|3|||
130941312|NCT01870583|471418926|FG000|Overall Study|Lost to Follow-up|11|||
130941313|NCT01870583|471418927|FG001|Overall Study|Lost to Follow-up|13|||
130941314|NCT01870583|471418928|FG002|Overall Study|Lost to Follow-up|5|||
130941315|NCT01394523|471418931|FG000|Overall Study|Unable to place block|1|||
130941316|NCT01394523|471418932|FG001|Overall Study|Unable to place block|0|||
130941317|NCT01394523|471418933|FG002|Overall Study|Unable to place block|0|||
130941318|NCT02389998|471418934|FG000|Overall Study|car accident|1|||
130941319|NCT02389998|471418935|FG001|Overall Study|car accident|0|||
130941320|NCT03525574|471418936|FG000|Overall Study|Adverse Event|15|||
130941321|NCT03525574|471418937|FG001|Overall Study|Adverse Event|0|||
130941322|NCT03525574|471418936|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
130941323|NCT03525574|471418937|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
130941324|NCT03525574|471418936|FG000|Overall Study|Lost to Follow-up|4|||
130941325|NCT03525574|471418937|FG001|Overall Study|Lost to Follow-up|0|||
130941326|NCT03525574|471418936|FG000|Overall Study|Commercial drug is Available for participant|48|||
130941327|NCT03525574|471418937|FG001|Overall Study|Commercial drug is Available for participant|0|||
130941328|NCT03525574|471418936|FG000|Overall Study|Death|1|||
130941329|NCT03525574|471418937|FG001|Overall Study|Death|0|||
130941330|NCT03525574|471418936|FG000|Overall Study|Other non-compliance|2|||
130941331|NCT03525574|471418937|FG001|Overall Study|Other non-compliance|0|||
130941332|NCT03525574|471418936|FG000|Overall Study|Physician Decision|6|||
130706628|NCT04034355|470549753|FG001|Overall Study|Physician Decision|0|||
130941333|NCT03525574|471418937|FG001|Overall Study|Physician Decision|0|||
130941334|NCT03525574|471418936|FG000|Overall Study|Other|58|||
130941335|NCT03525574|471418937|FG001|Overall Study|Other|0|||
130941336|NCT03525574|471418936|FG000|Overall Study|Enrolled but never dosed|1|||
130941337|NCT03525574|471418937|FG001|Overall Study|Enrolled but never dosed|0|||
130941338|NCT03525574|471418936|FG000|Overall Study|Not enrolled in 105 study|0|||
130941339|NCT03525574|471418937|FG001|Overall Study|Not enrolled in 105 study|3|||
130941340|NCT04741074|471418940|FG000|Overall Study|Withdrawal by Subject|1|||
130941341|NCT04741074|471418941|FG001|Overall Study|Withdrawal by Subject|1|||
130941342|NCT04741074|471418940|FG000|Overall Study|Study terminated prematurely|1|||
130941343|NCT04741074|471418941|FG001|Overall Study|Study terminated prematurely|0|||
130941344|NCT02432846|471418942|FG000|Overall Study (4 Arms/Strata)|Death|3|||
130941345|NCT02432846|471418943|FG001|Overall Study (4 Arms/Strata)|Death|2|||
130941346|NCT02432846|471418944|FG002|Overall Study (4 Arms/Strata)|Death|4|||
130941347|NCT02432846|471418945|FG003|Overall Study (4 Arms/Strata)|Death|3|||
130941348|NCT02432846|471418946|FG004|Overall Study (4 Arms/Strata)|Death|0|||
130941349|NCT02432846|471418947|FG005|Overall Study (4 Arms/Strata)|Death|0|||
130941350|NCT02432846|471418942|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
130941351|NCT02432846|471418943|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
130941352|NCT02432846|471418944|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
130941353|NCT02432846|471418945|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
130941354|NCT02432846|471418946|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
130941355|NCT02432846|471418947|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
130941356|NCT02432846|471418942|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
130941357|NCT02432846|471418943|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
130941358|NCT02432846|471418944|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
130941359|NCT02432846|471418945|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
130941360|NCT02432846|471418946|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
130941361|NCT02432846|471418947|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
130941362|NCT02432846|471418942|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
130941363|NCT02432846|471418943|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
130941364|NCT02432846|471418944|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
130941365|NCT02432846|471418945|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
130941366|NCT02432846|471418946|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
130941367|NCT02432846|471418947|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
130941368|NCT02432846|471418942|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
130941369|NCT02432846|471418943|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
130941370|NCT02432846|471418944|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
130941371|NCT02432846|471418945|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
130941372|NCT02432846|471418946|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
130941373|NCT02432846|471418947|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
130941374|NCT02432846|471418942|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
130941375|NCT02432846|471418943|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
130941376|NCT02432846|471418944|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
131123293|NCT01357577|472079775|FG001|Overall Study|look at data in database?|2|||
131123294|NCT06156215|472079778|FG000|Overall Study|Withdrawal by Subject|2|||
131123295|NCT06156215|472079779|FG001|Overall Study|Withdrawal by Subject|4|||
131123296|NCT06156215|472079780|FG002|Overall Study|Withdrawal by Subject|4|||
130706629|NCT04034355|470549752|FG000|Overall Study|Protocol Violation|0|||
130941377|NCT02432846|471418945|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
130941378|NCT02432846|471418946|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
130941379|NCT02432846|471418947|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
130941380|NCT02432846|471418942|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
131123297|NCT06156215|472079781|FG003|Overall Study|Withdrawal by Subject|0|||
130941381|NCT02432846|471418943|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
130941382|NCT02432846|471418944|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
130941383|NCT02432846|471418945|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
130941384|NCT02432846|471418946|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
130941385|NCT02432846|471418947|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
130941386|NCT02432846|471418942|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
130941387|NCT02432846|471418943|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
130941388|NCT02432846|471418944|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
130941389|NCT02432846|471418945|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
130941390|NCT02432846|471418946|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
130941391|NCT02432846|471418947|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
130941392|NCT02432846|471418942|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
130941393|NCT02432846|471418943|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
130941394|NCT02432846|471418944|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
130941395|NCT02432846|471418945|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
130941396|NCT02432846|471418946|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
130941397|NCT02432846|471418947|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
130941398|NCT02432846|471418942|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
130941399|NCT02432846|471418943|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
130941400|NCT02432846|471418944|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
130941401|NCT02432846|471418945|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
130941402|NCT02432846|471418946|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
130941403|NCT02432846|471418947|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
130941404|NCT02432846|471418942|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
130941405|NCT02432846|471418943|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
130941406|NCT02432846|471418944|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
130941407|NCT02432846|471418945|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
130941408|NCT02432846|471418946|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
130941409|NCT02432846|471418947|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
130941410|NCT02432846|471418942|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
130941411|NCT02432846|471418943|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
130941412|NCT02432846|471418944|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
130941413|NCT02432846|471418945|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
130941414|NCT02432846|471418946|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
130941415|NCT02432846|471418947|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
130941416|NCT02432846|471418942|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
130941417|NCT02432846|471418943|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
130941418|NCT02432846|471418944|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
130941419|NCT02432846|471418945|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
130941420|NCT02432846|471418946|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
130941421|NCT02432846|471418947|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
130941422|NCT02432846|471418942|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
130941423|NCT02432846|471418943|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
130941424|NCT02432846|471418944|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
130941425|NCT02432846|471418945|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
130941426|NCT02432846|471418946|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
130941427|NCT02432846|471418947|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
130941428|NCT03226392|471418952|FG000|Overall Study|Protocol Deviation|1|||
130941429|NCT03226392|471418953|FG001|Overall Study|Protocol Deviation|0|||
130941430|NCT03226392|471418952|FG000|Overall Study|Physician Decision|1|||
130941431|NCT03226392|471418953|FG001|Overall Study|Physician Decision|0|||
130941432|NCT03226392|471418952|FG000|Overall Study|Lost to Follow-up|1|||
130941433|NCT03226392|471418953|FG001|Overall Study|Lost to Follow-up|0|||
130941434|NCT03226392|471418952|FG000|Overall Study|Adverse Event|1|||
130941435|NCT03226392|471418953|FG001|Overall Study|Adverse Event|0|||
130941436|NCT03226392|471418952|FG000|Overall Study|Technical Problems|0|||
130941437|NCT03226392|471418953|FG001|Overall Study|Technical Problems|2|||
131123298|NCT06156215|472079782|FG004|Overall Study|Withdrawal by Subject|2|||
131123299|NCT06156215|472079783|FG005|Overall Study|Withdrawal by Subject|2|||
131123300|NCT06156215|472079778|FG000|Overall Study|Left ED without completing study|9|||
131123301|NCT06156215|472079779|FG001|Overall Study|Left ED without completing study|3|||
130772319|NCT05052697|470792852|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
130941438|NCT03226392|471418952|FG000|Overall Study|Subject/Guardian Decision|7|||
130941439|NCT03226392|471418953|FG001|Overall Study|Subject/Guardian Decision|6|||
130941440|NCT04788953|471418954|FG000|Overall Study|Adverse Event|1|||
130941441|NCT04788953|471418955|FG001|Overall Study|Adverse Event|1|||
131123302|NCT06156215|472079780|FG002|Overall Study|Left ED without completing study|9|||
131123303|NCT06156215|472079781|FG003|Overall Study|Left ED without completing study|0|||
131123304|NCT06156215|472079782|FG004|Overall Study|Left ED without completing study|8|||
130941442|NCT04788953|471418954|FG000|Overall Study|Withdrawal by Subject|1|||
130941443|NCT04788953|471418955|FG001|Overall Study|Withdrawal by Subject|0|||
130941444|NCT04788953|471418954|FG000|Overall Study|Protocol Violation|0|||
130941445|NCT04788953|471418955|FG001|Overall Study|Protocol Violation|1|||
130941446|NCT00937157|471418956|FG000|Overall Study|Pregnancy|1|||
130941447|NCT00937157|471418956|FG000|Overall Study|Lost to Follow-up|3|||
130941448|NCT00469092|471418957|FG000|Overall Study|Adverse Event|5|||
130941449|NCT00469092|471418958|FG001|Overall Study|Adverse Event|4|||
130941450|NCT00469092|471418957|FG000|Overall Study|Lack of Efficacy|1|||
130941451|NCT00469092|471418958|FG001|Overall Study|Lack of Efficacy|0|||
130941452|NCT00469092|471418957|FG000|Overall Study|Lost to Follow-up|1|||
130941453|NCT00469092|471418958|FG001|Overall Study|Lost to Follow-up|2|||
130941454|NCT00469092|471418957|FG000|Overall Study|Protocol Violation|3|||
130941455|NCT00469092|471418958|FG001|Overall Study|Protocol Violation|3|||
130941456|NCT00469092|471418957|FG000|Overall Study|Withdrawal by Subject|4|||
130941457|NCT00469092|471418958|FG001|Overall Study|Withdrawal by Subject|4|||
130941458|NCT00469092|471418957|FG000|Overall Study|Withdrawal Criteria|3|||
130941459|NCT00469092|471418958|FG001|Overall Study|Withdrawal Criteria|4|||
130941460|NCT00469092|471418957|FG000|Overall Study|Incorrectly Randomised|4|||
130941461|NCT00469092|471418958|FG001|Overall Study|Incorrectly Randomised|3|||
130941462|NCT00469092|471418957|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
130941463|NCT00469092|471418958|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
130941464|NCT00469092|471418957|FG000|Overall Study|Use of lipid lowering drug|1|||
130941465|NCT00469092|471418958|FG001|Overall Study|Use of lipid lowering drug|0|||
130941466|NCT00469092|471418957|FG000|Overall Study|Hypoglycaemic Episodes|1|||
130941467|NCT00469092|471418958|FG001|Overall Study|Hypoglycaemic Episodes|1|||
130941468|NCT00469092|471418957|FG000|Overall Study|Abnormal lab value|1|||
130941469|NCT00469092|471418958|FG001|Overall Study|Abnormal lab value|0|||
130941470|NCT00469092|471418957|FG000|Overall Study|Use of Corticosteroid|1|||
130941471|NCT00469092|471418958|FG001|Overall Study|Use of Corticosteroid|0|||
130941472|NCT01998633|471418959|FG000|Overall Study|Death|1|||
130941473|NCT00413192|471418960|FG000|Overall Study|Disease progression|26|||
130941474|NCT00413192|471418961|FG001|Overall Study|Disease progression|31|||
130941475|NCT00413192|471418962|FG002|Overall Study|Disease progression|16|||
130941476|NCT00413192|471418963|FG003|Overall Study|Disease progression|25|||
130941477|NCT00413192|471418960|FG000|Overall Study|Toxicity|3|||
130941478|NCT00413192|471418961|FG001|Overall Study|Toxicity|2|||
130941479|NCT00413192|471418962|FG002|Overall Study|Toxicity|2|||
130941480|NCT00413192|471418963|FG003|Overall Study|Toxicity|2|||
130941481|NCT00413192|471418960|FG000|Overall Study|Withdrawal by Subject|3|||
130941482|NCT00413192|471418961|FG001|Overall Study|Withdrawal by Subject|5|||
130941483|NCT00413192|471418962|FG002|Overall Study|Withdrawal by Subject|0|||
130941484|NCT00413192|471418963|FG003|Overall Study|Withdrawal by Subject|1|||
130941485|NCT00413192|471418960|FG000|Overall Study|Intercurrent illness|0|||
130941486|NCT00413192|471418961|FG001|Overall Study|Intercurrent illness|0|||
130941487|NCT00413192|471418962|FG002|Overall Study|Intercurrent illness|0|||
130941488|NCT00413192|471418963|FG003|Overall Study|Intercurrent illness|1|||
130941489|NCT00413192|471418960|FG000|Overall Study|Intercurrent death|0|||
130941490|NCT00413192|471418961|FG001|Overall Study|Intercurrent death|1|||
130941491|NCT00413192|471418962|FG002|Overall Study|Intercurrent death|0|||
130941492|NCT00413192|471418963|FG003|Overall Study|Intercurrent death|0|||
130941493|NCT00413192|471418960|FG000|Overall Study|Other|5|||
130941494|NCT00413192|471418961|FG001|Overall Study|Other|1|||
130941495|NCT00413192|471418962|FG002|Overall Study|Other|1|||
130941496|NCT00413192|471418963|FG003|Overall Study|Other|2|||
130941497|NCT00413192|471418960|FG000|Overall Study|Not treated|0|||
130941498|NCT00413192|471418961|FG001|Overall Study|Not treated|0|||
130941499|NCT00413192|471418962|FG002|Overall Study|Not treated|0|||
131123305|NCT06156215|472079783|FG005|Overall Study|Left ED without completing study|16|||
131123306|NCT06156215|472079778|FG000|Overall Study|Physician Decision|1|||
130941500|NCT00413192|471418963|FG003|Overall Study|Not treated|1|||
130941501|NCT03814746|471418964|FG000|Overall Study|Participant decision|9|||
130941502|NCT03814746|471418965|FG001|Overall Study|Participant decision|6|||
130941503|NCT03814746|471418966|FG002|Overall Study|Participant decision|15|||
130941504|NCT03814746|471418964|FG000|Overall Study|Physician Decision|2|||
130941505|NCT03814746|471418965|FG001|Overall Study|Physician Decision|2|||
130706630|NCT04034355|470549753|FG001|Overall Study|Protocol Violation|1|||
130941506|NCT03814746|471418966|FG002|Overall Study|Physician Decision|4|||
130706631|NCT04034355|470549752|FG000|Overall Study|Progressive disease|1|||
130706632|NCT04034355|470549753|FG001|Overall Study|Progressive disease|0|||
130941507|NCT03814746|471418964|FG000|Overall Study|Death|2|||
130941508|NCT03814746|471418965|FG001|Overall Study|Death|2|||
130941509|NCT03814746|471418966|FG002|Overall Study|Death|2|||
130941510|NCT03814746|471418964|FG000|Overall Study|Adverse Event|2|||
130941511|NCT03814746|471418965|FG001|Overall Study|Adverse Event|2|||
130941512|NCT03814746|471418966|FG002|Overall Study|Adverse Event|1|||
130941513|NCT03814746|471418964|FG000|Overall Study|Lost to Follow-up|2|||
130941514|NCT03814746|471418965|FG001|Overall Study|Lost to Follow-up|1|||
130941515|NCT03814746|471418966|FG002|Overall Study|Lost to Follow-up|2|||
130941516|NCT03814746|471418964|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130941517|NCT03814746|471418965|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130941518|NCT03814746|471418966|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130941519|NCT03814746|471418964|FG000|Overall Study|Pregnancy|0|||
130941520|NCT03814746|471418965|FG001|Overall Study|Pregnancy|1|||
130941521|NCT03814746|471418966|FG002|Overall Study|Pregnancy|1|||
130941522|NCT03814746|471418964|FG000|Overall Study|Protocol Violation|1|||
130941523|NCT03814746|471418965|FG001|Overall Study|Protocol Violation|0|||
130941524|NCT03814746|471418966|FG002|Overall Study|Protocol Violation|0|||
130941525|NCT02631850|471418967|FG000|Treatment Period|Lost to Follow-up|0|||
130941526|NCT02631850|471418968|FG001|Treatment Period|Lost to Follow-up|1|||
130941527|NCT02631850|471418969|FG002|Treatment Period|Lost to Follow-up|0|||
130941528|NCT02631850|471418970|FG003|Treatment Period|Lost to Follow-up|0|||
130941529|NCT02631850|471418967|FG000|Treatment Period|Protocol Violation|1|||
130941530|NCT02631850|471418968|FG001|Treatment Period|Protocol Violation|0|||
130941531|NCT02631850|471418969|FG002|Treatment Period|Protocol Violation|0|||
130941532|NCT02631850|471418970|FG003|Treatment Period|Protocol Violation|0|||
130941533|NCT02631850|471418967|FG000|Treatment Period|Withdrawal by Subject|0|||
130941534|NCT02631850|471418968|FG001|Treatment Period|Withdrawal by Subject|5|||
130941535|NCT02631850|471418969|FG002|Treatment Period|Withdrawal by Subject|2|||
130941536|NCT02631850|471418970|FG003|Treatment Period|Withdrawal by Subject|2|||
130941537|NCT02631850|471418967|FG000|Treatment Period|Adverse Event|1|||
130941538|NCT02631850|471418968|FG001|Treatment Period|Adverse Event|0|||
130941539|NCT02631850|471418969|FG002|Treatment Period|Adverse Event|2|||
130941540|NCT02631850|471418970|FG003|Treatment Period|Adverse Event|3|||
130941541|NCT02631850|471418967|FG000|Treatment Period|Family medical issue|1|||
130941542|NCT02631850|471418968|FG001|Treatment Period|Family medical issue|0|||
130941543|NCT02631850|471418969|FG002|Treatment Period|Family medical issue|0|||
130941544|NCT02631850|471418970|FG003|Treatment Period|Family medical issue|0|||
130941545|NCT02631850|471418967|FG000|6 Month Follow up|Lost to Follow-up|5|||
130941546|NCT02631850|471418968|FG001|6 Month Follow up|Lost to Follow-up|8|||
130941547|NCT02631850|471418969|FG002|6 Month Follow up|Lost to Follow-up|3|||
130941548|NCT02631850|471418970|FG003|6 Month Follow up|Lost to Follow-up|5|||
130941549|NCT02631850|471418967|FG000|6 Month Follow up|Withdrawal by Subject|1|||
130941550|NCT02631850|471418968|FG001|6 Month Follow up|Withdrawal by Subject|0|||
130941551|NCT02631850|471418969|FG002|6 Month Follow up|Withdrawal by Subject|0|||
130941552|NCT02631850|471418970|FG003|6 Month Follow up|Withdrawal by Subject|2|||
130941553|NCT02631850|471418967|FG000|6 Month Follow up|Adverse Event|1|||
130941554|NCT02631850|471418968|FG001|6 Month Follow up|Adverse Event|4|||
130941555|NCT02631850|471418969|FG002|6 Month Follow up|Adverse Event|1|||
130941556|NCT02631850|471418970|FG003|6 Month Follow up|Adverse Event|3|||
130941557|NCT02631850|471418967|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
130941558|NCT02631850|471418968|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
130941559|NCT02631850|471418969|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
130941560|NCT02631850|471418970|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
130941561|NCT03992781|471418979|FG000|Overall Study|Lost to Follow-up|5|||
130941562|NCT03992781|471418979|FG000|Overall Study|Adverse Event|1|||
130941563|NCT03992781|471418979|FG000|Overall Study|Lack of Efficacy|5|||
130941564|NCT01086540|471418980|FG000|Overall Study|Death|3|||
130941565|NCT01086540|471418981|FG001|Overall Study|Death|1|||
130941566|NCT01086540|471418980|FG000|Overall Study|Physician Decision|2|||
130941567|NCT01086540|471418981|FG001|Overall Study|Physician Decision|1|||
130941568|NCT01086540|471418980|FG000|Overall Study|Addition of new therapy for PAH|1|||
130941569|NCT01086540|471418981|FG001|Overall Study|Addition of new therapy for PAH|0|||
130941570|NCT00518323|471418982|FG000|Overall Study|Lack of Efficacy|14|||
130941571|NCT00518323|471418983|FG001|Overall Study|Lack of Efficacy|2|||
130941572|NCT00518323|471418984|FG002|Overall Study|Lack of Efficacy|4|||
130941573|NCT00518323|471418985|FG003|Overall Study|Lack of Efficacy|20|||
130941574|NCT00518323|471418982|FG000|Overall Study|Withdrawal by Subject|1|||
130941575|NCT00518323|471418983|FG001|Overall Study|Withdrawal by Subject|2|||
130941576|NCT00518323|471418984|FG002|Overall Study|Withdrawal by Subject|4|||
130941577|NCT00518323|471418985|FG003|Overall Study|Withdrawal by Subject|2|||
130941578|NCT00518323|471418982|FG000|Overall Study|Lost to Follow-up|0|||
130941579|NCT00518323|471418983|FG001|Overall Study|Lost to Follow-up|2|||
130941580|NCT00518323|471418984|FG002|Overall Study|Lost to Follow-up|1|||
130941581|NCT00518323|471418985|FG003|Overall Study|Lost to Follow-up|3|||
130941582|NCT00518323|471418982|FG000|Overall Study|Adverse Event|1|||
130941583|NCT00518323|471418983|FG001|Overall Study|Adverse Event|1|||
130941584|NCT00518323|471418984|FG002|Overall Study|Adverse Event|1|||
130941585|NCT00518323|471418985|FG003|Overall Study|Adverse Event|0|||
130941586|NCT00518323|471418982|FG000|Overall Study|Prohibited medication and others|3|||
130941587|NCT00518323|471418983|FG001|Overall Study|Prohibited medication and others|1|||
130941588|NCT00518323|471418984|FG002|Overall Study|Prohibited medication and others|1|||
130941589|NCT00518323|471418985|FG003|Overall Study|Prohibited medication and others|0|||
130941590|NCT03880019|471418988|FG000|Overall Study|Competing disease|1|||
130941591|NCT00326950|471418989|FG000|Overall Study|Progressive Disease|1|||
130941592|NCT03424265|471418995|FG000|Overall Study|screening failure|1|||
130941593|NCT03424265|471418996|FG001|Overall Study|screening failure|0|||
130941594|NCT03424265|471418995|FG000|Overall Study|Withdrawal by Subject|0|||
130941595|NCT03424265|471418996|FG001|Overall Study|Withdrawal by Subject|2|||
130941596|NCT00894322|471419002|FG000|Overall Study|Withdrawal by Subject|1|||
130941597|NCT00894322|471419003|FG001|Overall Study|Withdrawal by Subject|0|||
130941598|NCT00894322|471419004|FG002|Overall Study|Withdrawal by Subject|0|||
130941599|NCT03447990|471419012|FG000|Overall Study|Withdrawal by Subject|0|||
130941600|NCT03447990|471419013|FG001|Overall Study|Withdrawal by Subject|0|||
130941601|NCT03447990|471419014|FG002|Overall Study|Withdrawal by Subject|0|||
130941602|NCT03447990|471419015|FG003|Overall Study|Withdrawal by Subject|0|||
130941603|NCT03447990|471419016|FG004|Overall Study|Withdrawal by Subject|0|||
130941604|NCT03447990|471419017|FG005|Overall Study|Withdrawal by Subject|0|||
130941605|NCT03447990|471419018|FG006|Overall Study|Withdrawal by Subject|1|||
130941606|NCT02738450|471419019|FG000|Overall Study|Withdrawal by Subject|0|||
130941607|NCT02738450|471419020|FG001|Overall Study|Withdrawal by Subject|2|||
130941608|NCT02738450|471419021|FG002|Overall Study|Withdrawal by Subject|0|||
130941609|NCT00399360|471419024|FG000|Overall Study|Lost to Follow-up|2|||
130941610|NCT00399360|471419025|FG001|Overall Study|Lost to Follow-up|1|||
130941611|NCT00399360|471419026|FG002|Overall Study|Lost to Follow-up|2|||
130941612|NCT00399360|471419027|FG003|Overall Study|Lost to Follow-up|4|||
130941613|NCT00399360|471419024|FG000|Overall Study|Adverse Event|0|||
130941614|NCT00399360|471419025|FG001|Overall Study|Adverse Event|0|||
130941615|NCT00399360|471419026|FG002|Overall Study|Adverse Event|1|||
130941616|NCT00399360|471419027|FG003|Overall Study|Adverse Event|0|||
130941617|NCT00399360|471419024|FG000|Overall Study|Withdrawal by Subject|0|||
130941618|NCT00399360|471419025|FG001|Overall Study|Withdrawal by Subject|2|||
130941619|NCT00399360|471419026|FG002|Overall Study|Withdrawal by Subject|0|||
130941620|NCT00399360|471419027|FG003|Overall Study|Withdrawal by Subject|2|||
130941621|NCT01412021|471419028|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
130941622|NCT01412021|471419028|FG000|Overall Study|Treatment Prior to Approval|3|||
130941623|NCT01412021|471419028|FG000|Overall Study|Transferred to Other Hospital|9|||
130941624|NCT01166178|471419029|FG000|Overall Study|Withdrawal by Subject|1|||
130941625|NCT01166178|471419030|FG001|Overall Study|Withdrawal by Subject|0|||
130941626|NCT01166178|471419029|FG000|Overall Study|Study was terminated|20|||
130941627|NCT01166178|471419030|FG001|Overall Study|Study was terminated|8|||
130941628|NCT04537234|471419034|FG000|Overall Study|Withdrawal by Subject|2|||
130941629|NCT04537234|471419035|FG001|Overall Study|Withdrawal by Subject|0|||
130941630|NCT00296374|471419036|FG000|Overall Study|Adverse Event|14|||
130941631|NCT00296374|471419037|FG001|Overall Study|Adverse Event|10|||
130941632|NCT00296374|471419038|FG002|Overall Study|Adverse Event|7|||
130941633|NCT00296374|471419036|FG000|Overall Study|Withdrawal by Subject|3|||
130941634|NCT00296374|471419037|FG001|Overall Study|Withdrawal by Subject|5|||
130941635|NCT00296374|471419038|FG002|Overall Study|Withdrawal by Subject|11|||
130941636|NCT00296374|471419036|FG000|Overall Study|Incorrect enrollment|3|||
130941637|NCT00296374|471419037|FG001|Overall Study|Incorrect enrollment|3|||
130941638|NCT00296374|471419038|FG002|Overall Study|Incorrect enrollment|4|||
130941639|NCT00296374|471419036|FG000|Overall Study|Protocol Violation|1|||
130941640|NCT00296374|471419037|FG001|Overall Study|Protocol Violation|2|||
130941641|NCT00296374|471419038|FG002|Overall Study|Protocol Violation|3|||
130941642|NCT00296374|471419036|FG000|Overall Study|Lost to Follow-up|3|||
130941643|NCT00296374|471419037|FG001|Overall Study|Lost to Follow-up|1|||
130941644|NCT00296374|471419038|FG002|Overall Study|Lost to Follow-up|1|||
130941645|NCT00296374|471419036|FG000|Overall Study|Relocated to another state|1|||
130941646|NCT00296374|471419037|FG001|Overall Study|Relocated to another state|0|||
130941647|NCT00296374|471419038|FG002|Overall Study|Relocated to another state|0|||
130941648|NCT00296374|471419036|FG000|Overall Study|Stopped drug before end of study visit|0|||
130941649|NCT00296374|471419037|FG001|Overall Study|Stopped drug before end of study visit|1|||
130941650|NCT00296374|471419038|FG002|Overall Study|Stopped drug before end of study visit|0|||
130941651|NCT00296374|471419036|FG000|Overall Study|Nephrologist introduced ACE|0|||
130941652|NCT00296374|471419037|FG001|Overall Study|Nephrologist introduced ACE|1|||
130941653|NCT00296374|471419038|FG002|Overall Study|Nephrologist introduced ACE|0|||
130941654|NCT00296374|471419036|FG000|Overall Study|Pregnancy|0|||
130941655|NCT00296374|471419037|FG001|Overall Study|Pregnancy|0|||
131036494|NCT06424236|471768148|FG000|Overall Study|Other|0|||
131036495|NCT06424236|471768149|FG001|Overall Study|Other|0|||
131036496|NCT06424236|471768150|FG002|Overall Study|Other|1|||
131036497|NCT04625283|471768151|FG000|Overall Study|post randomization exclusion|28|||
131036498|NCT04625283|471768152|FG001|Overall Study|post randomization exclusion|20|||
131036499|NCT03462030|471768155|FG000|Overall Study|Withdrawal by Subject|1|||
131036500|NCT03462030|471768156|FG001|Overall Study|Withdrawal by Subject|1|||
130941656|NCT00296374|471419038|FG002|Overall Study|Pregnancy|2|||
131036501|NCT05020249|471768157|FG000|Overall Study|Protocol Violation|1|||
130941657|NCT00296374|471419036|FG000|Overall Study|Other|0|||
130941658|NCT00296374|471419037|FG001|Overall Study|Other|0|||
130941659|NCT00296374|471419038|FG002|Overall Study|Other|1|||
130941660|NCT01721330|471419039|FG000|Overall Study|Withdrawal by Subject|0|||
130941661|NCT01721330|471419040|FG001|Overall Study|Withdrawal by Subject|1|||
130941662|NCT01786629|471420769|FG000|Overall Study|Lack of Efficacy|0|||
130941663|NCT01786629|471420770|FG001|Overall Study|Lack of Efficacy|4|||
130941664|NCT01786629|471420769|FG000|Overall Study|Adverse Event|0|||
130941665|NCT01786629|471420770|FG001|Overall Study|Adverse Event|1|||
130941666|NCT03712904|471420771|FG000|Overall Study|Death|0|||
130941667|NCT03712904|471420772|FG001|Overall Study|Death|1|||
130941668|NCT03712904|471420771|FG000|Overall Study|Withdrawal by Subject|0|||
130941669|NCT03712904|471420772|FG001|Overall Study|Withdrawal by Subject|1|||
130941670|NCT03712904|471420771|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
130941671|NCT03712904|471420772|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
130941672|NCT01921179|471420774|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
130941673|NCT01921179|471420775|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
130941674|NCT01921179|471420774|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
130941675|NCT01921179|471420775|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
130941676|NCT05608005|471420779|FG000|Overall Study|Adverse Event|2|||
130941677|NCT05608005|471420780|FG001|Overall Study|Adverse Event|1|||
130941678|NCT05608005|471420781|FG002|Overall Study|Adverse Event|3|||
130941679|NCT05608005|471420779|FG000|Overall Study|Protocol Violation|2|||
130941680|NCT05608005|471420780|FG001|Overall Study|Protocol Violation|3|||
130941681|NCT05608005|471420781|FG002|Overall Study|Protocol Violation|0|||
130941682|NCT05608005|471420779|FG000|Overall Study|Withdrawal by Subject|10|||
130941683|NCT05608005|471420780|FG001|Overall Study|Withdrawal by Subject|12|||
130941684|NCT05608005|471420781|FG002|Overall Study|Withdrawal by Subject|4|||
130941685|NCT05608005|471420779|FG000|Overall Study|Lost to Follow-up|25|||
130941686|NCT05608005|471420780|FG001|Overall Study|Lost to Follow-up|27|||
130941687|NCT05608005|471420781|FG002|Overall Study|Lost to Follow-up|15|||
130941688|NCT05608005|471420779|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
130941689|NCT05608005|471420780|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
130941690|NCT05608005|471420781|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
130941691|NCT04708886|471420782|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
130941692|NCT04708886|471420782|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
130941693|NCT01372501|471420783|FG000|Overall Study|Adverse Event|4|||
130941694|NCT01372501|471420783|FG000|Overall Study|Device migration|1|||
130941695|NCT01466348|471420784|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
130941696|NCT01466348|471420785|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
130941697|NCT03989440|471420786|FG000|Overall Study|COVID-19 travel restrictions|0|||
130941698|NCT03989440|471420787|FG001|Overall Study|COVID-19 travel restrictions|0|||
130941699|NCT03989440|471420788|FG002|Overall Study|COVID-19 travel restrictions|1|||
130941700|NCT03989440|471420789|FG003|Overall Study|COVID-19 travel restrictions|0|||
130941701|NCT03989440|471420790|FG004|Overall Study|COVID-19 travel restrictions|0|||
130941702|NCT03989440|471420791|FG005|Overall Study|COVID-19 travel restrictions|0|||
130941703|NCT03989440|471420786|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
130941704|NCT03989440|471420787|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
130941705|NCT03989440|471420788|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
130941706|NCT03989440|471420789|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
130941707|NCT03989440|471420790|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
130941708|NCT03989440|471420791|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
130941709|NCT02784821|471420796|FG000|Overall Study|Death|0|||
130941710|NCT02784821|471420797|FG001|Overall Study|Death|5|||
130941711|NCT02784821|471420798|FG002|Overall Study|Death|4|||
130941712|NCT02784821|471420799|FG003|Overall Study|Death|5|||
130941713|NCT02357901|471420800|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
130941714|NCT02357901|471420801|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
130941715|NCT02357901|471420802|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
130941716|NCT02357901|471420803|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
130941717|NCT02357901|471420800|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
130941718|NCT02357901|471420801|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
130941719|NCT02357901|471420802|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
130941720|NCT02357901|471420803|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
130941721|NCT02357901|471420800|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
130941722|NCT02357901|471420801|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
130941723|NCT02357901|471420802|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
130941724|NCT02357901|471420803|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
130941725|NCT02357901|471420800|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
130941726|NCT02357901|471420801|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
130941727|NCT02357901|471420802|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
130941728|NCT02357901|471420803|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
131036502|NCT05020249|471768158|FG001|Overall Study|Protocol Violation|0|||
130941729|NCT02357901|471420800|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
130941730|NCT02357901|471420801|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
130941731|NCT02357901|471420802|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
130941732|NCT02357901|471420803|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
130941733|NCT02357901|471420800|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
130941734|NCT02357901|471420801|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
130941735|NCT02357901|471420802|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
130941736|NCT02357901|471420803|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
130941737|NCT02357901|471420800|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
130941738|NCT02357901|471420801|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
130941739|NCT02357901|471420802|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
130941740|NCT02357901|471420803|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
130941741|NCT02357901|471420800|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
130941742|NCT02357901|471420801|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
130941743|NCT02357901|471420802|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
130941744|NCT02357901|471420803|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
130941745|NCT02357901|471420800|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
130941746|NCT02357901|471420801|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
130941747|NCT02357901|471420802|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
130941748|NCT02357901|471420803|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
130941749|NCT02357901|471420800|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
130941750|NCT02357901|471420801|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
130941751|NCT02357901|471420802|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
130941752|NCT02357901|471420803|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
130941753|NCT02357901|471420800|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
130941754|NCT02357901|471420801|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
130941755|NCT02357901|471420802|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
130941756|NCT02357901|471420803|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
130941757|NCT00491387|471420809|FG000|Overall Study|study terminated|20|||
130941758|NCT01266460|471420819|FG000|Overall Study|Adverse Event|3|||
130941759|NCT01266460|471420819|FG000|Overall Study|Withdrawal by Subject|5|||
130941760|NCT01266460|471420819|FG000|Overall Study|Disease Progression|18|||
130941761|NCT01266460|471420819|FG000|Overall Study|Not otherwise specified|8|||
130941762|NCT01132547|471420820|FG000|Overall Study|Withdrawal by Subject|3|||
130941763|NCT01132547|471420821|FG001|Overall Study|Withdrawal by Subject|1|||
130941764|NCT01132547|471420820|FG000|Overall Study|Death|1|||
130941765|NCT01132547|471420821|FG001|Overall Study|Death|0|||
130941766|NCT05811234|471420822|FG000|Overall Study|Loss of Effectiveness|2|||
130941767|NCT05811234|471420822|FG000|Overall Study|Adverse Event|4|||
130941768|NCT05811234|471420822|FG000|Overall Study|Pregnancy|1|||
130941769|NCT05811234|471420822|FG000|Overall Study|Disease progression|1|||
130941770|NCT05811234|471420822|FG000|Overall Study|Withdrawal by Subject|4|||
130941771|NCT05811234|471420822|FG000|Overall Study|Lost to Follow-up|13|||
130941772|NCT05811234|471420822|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
130941773|NCT04499781|471420823|FG000|Overall Study|Lost to Follow-up|2|||
130941774|NCT04499781|471420824|FG001|Overall Study|Lost to Follow-up|3|||
130941775|NCT04499781|471420823|FG000|Overall Study|Withdrawal by Subject|2|||
130941776|NCT04499781|471420824|FG001|Overall Study|Withdrawal by Subject|0|||
130941777|NCT00227305|471420829|FG000|Overall Study|Adverse Event|40|||
130941778|NCT00227305|471420829|FG000|Overall Study|Withdrawal by Subject|42|||
130941779|NCT00227305|471420829|FG000|Overall Study|Lost to Follow-up|33|||
130941780|NCT00227305|471420829|FG000|Overall Study|Study specific discontinuation|13|||
130941781|NCT00227305|471420829|FG000|Overall Study|MOVED OUT OF AREA|3|||
130941782|NCT00227305|471420829|FG000|Overall Study|Lack of Efficacy|7|||
130941783|NCT00227305|471420829|FG000|Overall Study|Physician Decision|3|||
130941784|NCT00227305|471420829|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
130941785|NCT00227305|471420829|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
130941786|NCT00227305|471420829|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
130941787|NCT00483379|471420830|FG000|Treatment Period|Adverse Event|1|||
130941788|NCT00483379|471420831|FG001|Treatment Period|Adverse Event|0|||
130941789|NCT00483379|471420830|FG000|Treatment Period|Withdrawal by Subject|1|||
130941790|NCT00483379|471420831|FG001|Treatment Period|Withdrawal by Subject|0|||
130941791|NCT00730912|471420843|FG000|Overall Study|Discontinued|0|||
130941792|NCT00730912|471420844|FG001|Overall Study|Discontinued|0|||
130941793|NCT00730912|471420845|FG002|Overall Study|Discontinued|1|||
130941794|NCT03311659|471420846|FG000|Overall Study|Protocol Violation|1|||
130941795|NCT04053023|471420847|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
130772320|NCT05052697|470792853|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130941796|NCT04053023|471420848|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
130941797|NCT00071760|471420849|FG000|Overall Study|Adverse Event|2|||
130941798|NCT00071760|471420850|FG001|Overall Study|Adverse Event|1|||
131123307|NCT06156215|472079779|FG001|Overall Study|Physician Decision|0|||
131123308|NCT06156215|472079780|FG002|Overall Study|Physician Decision|0|||
131123309|NCT06156215|472079781|FG003|Overall Study|Physician Decision|0|||
131123310|NCT06156215|472079782|FG004|Overall Study|Physician Decision|0|||
131123311|NCT06156215|472079783|FG005|Overall Study|Physician Decision|0|||
131123312|NCT06156215|472079778|FG000|Overall Study|Became or found ineligible|2|||
131123313|NCT06156215|472079779|FG001|Overall Study|Became or found ineligible|0|||
131123314|NCT06156215|472079780|FG002|Overall Study|Became or found ineligible|2|||
131123315|NCT06156215|472079781|FG003|Overall Study|Became or found ineligible|0|||
131123316|NCT06156215|472079782|FG004|Overall Study|Became or found ineligible|1|||
131123317|NCT06156215|472079783|FG005|Overall Study|Became or found ineligible|2|||
131123318|NCT03977974|472079788|FG000|Period 2|Adverse Event|0|||
131123319|NCT03977974|472079789|FG001|Period 2|Adverse Event|0|||
131123320|NCT03977974|472079790|FG002|Period 2|Adverse Event|0|||
131123321|NCT03977974|472079791|FG003|Period 2|Adverse Event|0|||
131123322|NCT03977974|472079792|FG004|Period 2|Adverse Event|1|||
131123323|NCT03977974|472079793|FG005|Period 2|Adverse Event|0|||
131123324|NCT03977974|472079794|FG006|Period 2|Adverse Event|0|||
131123325|NCT03977974|472079795|FG007|Period 2|Adverse Event|0|||
131123326|NCT03977974|472079796|FG008|Period 2|Adverse Event|0|||
131123327|NCT03977974|472079797|FG009|Period 2|Adverse Event|0|||
131123328|NCT03977974|472079798|FG010|Period 2|Adverse Event|0|||
131123329|NCT03977974|472079799|FG011|Period 2|Adverse Event|0|||
131123330|NCT03977974|472079800|FG012|Period 2|Adverse Event|0|||
131036527|NCT01073566|471768165|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
131036528|NCT01073566|471768166|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
131036529|NCT05006872|471768180|FG000|Overall Study|Lost to Follow-up|37|||
131036530|NCT05006872|471768181|FG001|Overall Study|Lost to Follow-up|31|||
131036531|NCT05499377|471768187|FG000|Overall Study|Withdrawal by Subject|2|||
131036532|NCT05499377|471768188|FG001|Overall Study|Withdrawal by Subject|0|||
131036533|NCT05499377|471768187|FG000|Overall Study|Physician Decision|1|||
131036534|NCT05499377|471768188|FG001|Overall Study|Physician Decision|0|||
131036535|NCT04971681|471768190|FG000|Followup|Lost to Follow-up|1|||
131036536|NCT04971681|471768191|FG001|Followup|Lost to Follow-up|0|||
131036537|NCT00686335|471768192|FG000|Run-in Period|Adverse Event|1|||
131036538|NCT00686335|471768192|FG000|Run-in Period|asthma exacerbation|1|||
131036539|NCT00686335|471768192|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
131036540|NCT02268253|471768193|FG000|Stage 1|Withdrawal by Subject|1|||
131036541|NCT02268253|471768194|FG001|Stage 1|Withdrawal by Subject|0|||
131036542|NCT02268253|471768195|FG002|Stage 1|Withdrawal by Subject|0|||
131036543|NCT02268253|471768196|FG003|Stage 1|Withdrawal by Subject|0|||
131036544|NCT02268253|471768197|FG004|Stage 1|Withdrawal by Subject|0|||
131036545|NCT02268253|471768198|FG005|Stage 1|Withdrawal by Subject|0|||
131036546|NCT02268253|471768199|FG006|Stage 1|Withdrawal by Subject|0|||
131036547|NCT02268253|471768193|FG000|Stage 1|Death|0|||
131036548|NCT02268253|471768194|FG001|Stage 1|Death|2|||
131036549|NCT02268253|471768195|FG002|Stage 1|Death|2|||
131036550|NCT02268253|471768196|FG003|Stage 1|Death|2|||
131036551|NCT02268253|471768197|FG004|Stage 1|Death|1|||
131036552|NCT02268253|471768198|FG005|Stage 1|Death|1|||
131036553|NCT02268253|471768199|FG006|Stage 1|Death|0|||
131036554|NCT02268253|471768193|FG000|Stage 2|Disease Recurrence/ Progression|0|||
131036555|NCT02268253|471768194|FG001|Stage 2|Disease Recurrence/ Progression|0|||
131036556|NCT02268253|471768195|FG002|Stage 2|Disease Recurrence/ Progression|1|||
131036557|NCT02268253|471768196|FG003|Stage 2|Disease Recurrence/ Progression|0|||
131036558|NCT02268253|471768197|FG004|Stage 2|Disease Recurrence/ Progression|0|||
131036559|NCT02268253|471768198|FG005|Stage 2|Disease Recurrence/ Progression|0|||
131036560|NCT02268253|471768199|FG006|Stage 2|Disease Recurrence/ Progression|0|||
130706633|NCT03581188|470551508|FG000|Overall Study|Inclusion criteria not met|3|||
130706634|NCT03581188|470551509|FG001|Overall Study|Inclusion criteria not met|2|||
130706635|NCT03581188|470551508|FG000|Overall Study|Lost to Follow-up|5|||
130706636|NCT03581188|470551509|FG001|Overall Study|Lost to Follow-up|5|||
131036561|NCT02268253|471768193|FG000|Stage 2|Withdrawal by Subject|0|||
131036562|NCT02268253|471768194|FG001|Stage 2|Withdrawal by Subject|0|||
131036563|NCT02268253|471768195|FG002|Stage 2|Withdrawal by Subject|2|||
131123331|NCT04419610|472081259|FG000|Overall Study|Withdrawal by Subject|3|||
131123332|NCT04419610|472081260|FG001|Overall Study|Withdrawal by Subject|1|||
131123333|NCT04419610|472081259|FG000|Overall Study|Adverse Event|1|||
131123334|NCT04419610|472081260|FG001|Overall Study|Adverse Event|0|||
131036564|NCT02268253|471768196|FG003|Stage 2|Withdrawal by Subject|0|||
131036565|NCT02268253|471768197|FG004|Stage 2|Withdrawal by Subject|0|||
131036566|NCT02268253|471768198|FG005|Stage 2|Withdrawal by Subject|2|||
131036567|NCT02268253|471768199|FG006|Stage 2|Withdrawal by Subject|0|||
130706637|NCT03581188|470551508|FG000|Overall Study|Discontinued intervention|11|||
130706638|NCT03581188|470551509|FG001|Overall Study|Discontinued intervention|8|||
131036568|NCT02268253|471768193|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
131036569|NCT02268253|471768194|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
131036570|NCT02268253|471768195|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
131036571|NCT02268253|471768196|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
131123335|NCT04419610|472081259|FG000|Overall Study|discharged early|1|||
131123336|NCT04419610|472081260|FG001|Overall Study|discharged early|1|||
131123337|NCT01524198|472081261|FG000|Overall Study|Protocol Violation|8|||
131123338|NCT01524198|472081262|FG001|Overall Study|Protocol Violation|6|||
131123339|NCT01524198|472081261|FG000|Overall Study|Withdrawal by Subject|15|||
131123340|NCT01524198|472081262|FG001|Overall Study|Withdrawal by Subject|10|||
131123341|NCT01439282|472081263|FG000|Overall Study|Adverse Event|5|||
131123342|NCT01439282|472081264|FG001|Overall Study|Adverse Event|0|||
130941799|NCT00071760|471420849|FG000|Overall Study|Lost to Follow-up|0|||
130941800|NCT00071760|471420850|FG001|Overall Study|Lost to Follow-up|3|||
130941801|NCT00071760|471420849|FG000|Overall Study|Protocol Violation|1|||
130941802|NCT00071760|471420850|FG001|Overall Study|Protocol Violation|0|||
130941803|NCT00071760|471420849|FG000|Overall Study|Withdrawal by Subject|0|||
130941804|NCT00071760|471420850|FG001|Overall Study|Withdrawal by Subject|1|||
130941805|NCT00071760|471420849|FG000|Overall Study|Insufficient Viral Load Response|1|||
130941806|NCT00071760|471420850|FG001|Overall Study|Insufficient Viral Load Response|1|||
130941807|NCT00071760|471420849|FG000|Overall Study|Lack of availability of RTV|1|||
130941808|NCT00071760|471420850|FG001|Overall Study|Lack of availability of RTV|0|||
130941809|NCT00071760|471420849|FG000|Overall Study|Physician Decision|2|||
130941810|NCT00071760|471420850|FG001|Overall Study|Physician Decision|1|||
130941811|NCT00071760|471420849|FG000|Overall Study|Relocation|0|||
130941812|NCT00071760|471420850|FG001|Overall Study|Relocation|1|||
130941813|NCT01994629|471420851|FG000|Overall Study|Withdrawal by Subject|1|||
130941814|NCT01994629|471420852|FG001|Overall Study|Withdrawal by Subject|0|||
130941815|NCT01994629|471420851|FG000|Overall Study|Lost to Follow-up|0|||
130941816|NCT01994629|471420852|FG001|Overall Study|Lost to Follow-up|3|||
130941817|NCT01170091|471420855|FG000|Overall Study|Missing efficacy evaluation|3|||
130941818|NCT01170091|471420855|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
130941819|NCT00391274|471420863|FG000|Overall Study|Death Due to Study Disease|55|||
130941820|NCT00391274|471420864|FG001|Overall Study|Death Due to Study Disease|45|||
130941821|NCT00391274|471420863|FG000|Overall Study|Lost to Follow-up|0|||
130941822|NCT00391274|471420864|FG001|Overall Study|Lost to Follow-up|3|||
130941823|NCT00391274|471420863|FG000|Overall Study|Physician Decision|4|||
130941824|NCT00391274|471420864|FG001|Overall Study|Physician Decision|2|||
130941825|NCT00391274|471420863|FG000|Overall Study|Withdrawal by Subject|0|||
130941826|NCT00391274|471420864|FG001|Overall Study|Withdrawal by Subject|3|||
130941827|NCT00391274|471420863|FG000|Overall Study|Death Due to Adverse Event|1|||
130941828|NCT00391274|471420864|FG001|Overall Study|Death Due to Adverse Event|3|||
130941829|NCT00391274|471420863|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
130941830|NCT00391274|471420864|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
130941831|NCT00391274|471420863|FG000|Overall Study|Death Not Study Related|0|||
130941832|NCT00391274|471420864|FG001|Overall Study|Death Not Study Related|1|||
130941833|NCT03051607|471420865|FG000|Overall Study|Adverse Event|66|||
130941834|NCT05104567|471420869|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130941835|NCT05104567|471420870|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
130941836|NCT05104567|471420871|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130941837|NCT05104567|471420872|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130941838|NCT05104567|471420873|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130941839|NCT05104567|471420874|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130941840|NCT05104567|471420875|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
130941841|NCT05104567|471420869|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
130941842|NCT05104567|471420870|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
130941843|NCT05104567|471420871|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
130941844|NCT05104567|471420872|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
130941845|NCT05104567|471420873|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
130941846|NCT05104567|471420874|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
130941847|NCT05104567|471420875|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
130941848|NCT05104567|471420869|FG000|Overall Study|Progressive disease|3|||
130941849|NCT05104567|471420870|FG001|Overall Study|Progressive disease|13|||
130941850|NCT05104567|471420871|FG002|Overall Study|Progressive disease|13|||
130941851|NCT05104567|471420872|FG003|Overall Study|Progressive disease|17|||
130941852|NCT05104567|471420873|FG004|Overall Study|Progressive disease|17|||
130941853|NCT05104567|471420874|FG005|Overall Study|Progressive disease|28|||
130941854|NCT05104567|471420875|FG006|Overall Study|Progressive disease|24|||
130941855|NCT05104567|471420869|FG000|Overall Study|Withdrawal by Subject|1|||
130941856|NCT05104567|471420870|FG001|Overall Study|Withdrawal by Subject|1|||
130941857|NCT05104567|471420871|FG002|Overall Study|Withdrawal by Subject|2|||
130941858|NCT05104567|471420872|FG003|Overall Study|Withdrawal by Subject|0|||
130941859|NCT05104567|471420873|FG004|Overall Study|Withdrawal by Subject|0|||
130941860|NCT05104567|471420874|FG005|Overall Study|Withdrawal by Subject|0|||
130941861|NCT05104567|471420875|FG006|Overall Study|Withdrawal by Subject|0|||
131123343|NCT01439282|472081263|FG000|Overall Study|Withdrawal by Subject|2|||
130941862|NCT05104567|471420869|FG000|Overall Study|Other|1|||
131123344|NCT01439282|472081264|FG001|Overall Study|Withdrawal by Subject|0|||
131123345|NCT01439282|472081263|FG000|Overall Study|Other|1|||
131036572|NCT02268253|471768197|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
131036573|NCT02268253|471768198|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
131036574|NCT02268253|471768199|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
131036575|NCT02268253|471768193|FG000|Stage 2|Death|0|||
131036576|NCT02268253|471768194|FG001|Stage 2|Death|0|||
131036577|NCT02268253|471768195|FG002|Stage 2|Death|19|||
131036578|NCT02268253|471768196|FG003|Stage 2|Death|0|||
131036579|NCT02268253|471768197|FG004|Stage 2|Death|0|||
131036580|NCT02268253|471768198|FG005|Stage 2|Death|20|||
131036581|NCT02268253|471768199|FG006|Stage 2|Death|1|||
131036582|NCT02268253|471768193|FG000|Stage 2|Lost to Follow-up|0|||
131036583|NCT02268253|471768194|FG001|Stage 2|Lost to Follow-up|0|||
131036584|NCT02268253|471768195|FG002|Stage 2|Lost to Follow-up|0|||
131036585|NCT02268253|471768196|FG003|Stage 2|Lost to Follow-up|0|||
130941863|NCT05104567|471420870|FG001|Overall Study|Other|1|||
130941864|NCT05104567|471420871|FG002|Overall Study|Other|1|||
130941865|NCT05104567|471420872|FG003|Overall Study|Other|0|||
130941866|NCT05104567|471420873|FG004|Overall Study|Other|0|||
130941867|NCT05104567|471420874|FG005|Overall Study|Other|0|||
130941868|NCT05104567|471420875|FG006|Overall Study|Other|0|||
130941869|NCT00733746|471420880|FG000|Overall Study|Ineligible|5|||
130941870|NCT05778786|471420881|FG000|Period 1|COVID-19 Related|3|||
130941871|NCT05778786|471420882|FG001|Period 1|COVID-19 Related|3|||
130941872|NCT05778786|471420881|FG000|Period 1|Withdrew Consent during Study|1|||
130941873|NCT05778786|471420882|FG001|Period 1|Withdrew Consent during Study|0|||
130941874|NCT05778786|471420881|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
130941875|NCT05778786|471420882|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
130941876|NCT05778786|471420881|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
130941877|NCT05778786|471420882|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
130941878|NCT03658538|471420884|FG000|Overall Study|Death|2|||
130941879|NCT03658538|471420885|FG001|Overall Study|Death|1|||
130941880|NCT03658538|471420884|FG000|Overall Study|Cancer diagnosis|1|||
130941881|NCT03658538|471420885|FG001|Overall Study|Cancer diagnosis|0|||
130941882|NCT03658538|471420884|FG000|Overall Study|Change residence|1|||
130941883|NCT03658538|471420885|FG001|Overall Study|Change residence|2|||
130941884|NCT03658538|471420884|FG000|Overall Study|Lost to Follow-up|3|||
130941885|NCT03658538|471420885|FG001|Overall Study|Lost to Follow-up|3|||
130941886|NCT03658538|471420884|FG000|Overall Study|Unblinded|2|||
130941887|NCT03658538|471420885|FG001|Overall Study|Unblinded|3|||
130941888|NCT03658538|471420884|FG000|Overall Study|Physician Decision|0|||
130941889|NCT03658538|471420885|FG001|Overall Study|Physician Decision|1|||
130941890|NCT03658538|471420884|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
130941891|NCT03658538|471420885|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
130941892|NCT03658538|471420884|FG000|Overall Study|Evicted from home|1|||
130941893|NCT03658538|471420885|FG001|Overall Study|Evicted from home|0|||
130941894|NCT05478252|471420888|FG000|Overall Study|Withdrawal by Subject|2|||
130941895|NCT05478252|471420889|FG001|Overall Study|Withdrawal by Subject|3|||
130941896|NCT05478252|471420888|FG000|Overall Study|Lost to Follow-up|4|||
130941897|NCT05478252|471420889|FG001|Overall Study|Lost to Follow-up|2|||
130941898|NCT05478252|471420888|FG000|Overall Study|Physician Decision|1|||
131036586|NCT02268253|471768197|FG004|Stage 2|Lost to Follow-up|0|||
131036587|NCT02268253|471768198|FG005|Stage 2|Lost to Follow-up|4|||
131036588|NCT02268253|471768199|FG006|Stage 2|Lost to Follow-up|0|||
131123346|NCT01439282|472081264|FG001|Overall Study|Other|1|||
131123347|NCT02232802|472081265|FG000|Period 1|Sponsor request|1|||
131123348|NCT02232802|472081266|FG001|Period 1|Sponsor request|0|||
131123349|NCT02232802|472081265|FG000|Period 1|Adverse Event|1|||
130941899|NCT05478252|471420889|FG001|Overall Study|Physician Decision|1|||
130941900|NCT05478252|471420888|FG000|Overall Study|Death|1|||
130941901|NCT05478252|471420889|FG001|Overall Study|Death|0|||
130941902|NCT07114198|471420890|FG000|Overall Study|Protocol Violation|1|||
130941903|NCT07114198|471420891|FG001|Overall Study|Protocol Violation|1|||
130941904|NCT00670800|471423072|FG000|Overall Study|2 controls were insulin resistant|0|||
130941905|NCT00670800|471423073|FG001|Overall Study|2 controls were insulin resistant|2|||
130941906|NCT04736199|471423074|FG000|Overall Study|Adverse Event|28|||
130941907|NCT04736199|471423075|FG001|Overall Study|Adverse Event|22|||
130941908|NCT04736199|471423074|FG000|Overall Study|Death|9|||
130941909|NCT04736199|471423075|FG001|Overall Study|Death|3|||
130941910|NCT04736199|471423074|FG000|Overall Study|Lost to Follow-up|4|||
130941911|NCT04736199|471423075|FG001|Overall Study|Lost to Follow-up|1|||
130941912|NCT04736199|471423074|FG000|Overall Study|Physician Decision|5|||
130941913|NCT04736199|471423075|FG001|Overall Study|Physician Decision|9|||
130941914|NCT04736199|471423074|FG000|Overall Study|Withdrawal by Subject|21|||
131036589|NCT02268253|471768193|FG000|Stage 2|Transferred to Hospice|0|||
131036590|NCT02268253|471768194|FG001|Stage 2|Transferred to Hospice|0|||
131036591|NCT02268253|471768195|FG002|Stage 2|Transferred to Hospice|0|||
131036592|NCT02268253|471768196|FG003|Stage 2|Transferred to Hospice|0|||
130941915|NCT04736199|471423075|FG001|Overall Study|Withdrawal by Subject|9|||
131036593|NCT02268253|471768197|FG004|Stage 2|Transferred to Hospice|0|||
131123350|NCT02232802|472081266|FG001|Period 1|Adverse Event|1|||
130941916|NCT04736199|471423074|FG000|Overall Study|Progressive disease|120|||
131123351|NCT00885703|472081273|FG000|Overall Study|Death|9|||
131036594|NCT02268253|471768198|FG005|Stage 2|Transferred to Hospice|2|||
131036595|NCT02268253|471768199|FG006|Stage 2|Transferred to Hospice|0|||
131036596|NCT02268253|471768193|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
131036597|NCT02268253|471768194|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
131036598|NCT02268253|471768195|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
131036599|NCT02268253|471768196|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
131036600|NCT02268253|471768197|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
131036601|NCT02268253|471768198|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
131036602|NCT02268253|471768199|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
131036603|NCT02268253|471768193|FG000|Stage 3A|Withdrawal by Subject|0|||
131036604|NCT02268253|471768194|FG001|Stage 3A|Withdrawal by Subject|0|||
131036605|NCT02268253|471768195|FG002|Stage 3A|Withdrawal by Subject|2|||
131036606|NCT02268253|471768196|FG003|Stage 3A|Withdrawal by Subject|0|||
131036607|NCT02268253|471768197|FG004|Stage 3A|Withdrawal by Subject|0|||
131036608|NCT02268253|471768198|FG005|Stage 3A|Withdrawal by Subject|0|||
131036609|NCT02268253|471768199|FG006|Stage 3A|Withdrawal by Subject|0|||
131036610|NCT02268253|471768193|FG000|Stage 3A|Physician Decision|0|||
131036611|NCT02268253|471768194|FG001|Stage 3A|Physician Decision|0|||
131036612|NCT02268253|471768195|FG002|Stage 3A|Physician Decision|2|||
131036613|NCT02268253|471768196|FG003|Stage 3A|Physician Decision|0|||
131036614|NCT02268253|471768197|FG004|Stage 3A|Physician Decision|0|||
131036615|NCT02268253|471768198|FG005|Stage 3A|Physician Decision|0|||
131036616|NCT02268253|471768199|FG006|Stage 3A|Physician Decision|0|||
130941917|NCT04736199|471423075|FG001|Overall Study|Progressive disease|101|||
130941918|NCT04736199|471423074|FG000|Overall Study|Subject decision|13|||
130941919|NCT04736199|471423075|FG001|Overall Study|Subject decision|13|||
130941920|NCT04736199|471423074|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
130941921|NCT04736199|471423075|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
130941922|NCT04736199|471423074|FG000|Overall Study|Additional primary malignancy|1|||
130941923|NCT04736199|471423075|FG001|Overall Study|Additional primary malignancy|0|||
130941924|NCT04736199|471423074|FG000|Overall Study|Non-compliance with study drug|0|||
130941925|NCT04736199|471423075|FG001|Overall Study|Non-compliance with study drug|1|||
130941926|NCT04736199|471423074|FG000|Overall Study|Other reason|0|||
130941927|NCT04736199|471423075|FG001|Overall Study|Other reason|1|||
130941928|NCT04736199|471423074|FG000|Overall Study|Ongoing with study drug|240|||
130941929|NCT04736199|471423075|FG001|Overall Study|Ongoing with study drug|63|||
130941930|NCT04736199|471423074|FG000|Overall Study|Study drug never administered|3|||
130941931|NCT04736199|471423075|FG001|Overall Study|Study drug never administered|0|||
130941932|NCT04318080|471423076|FG000|Overall Study|Study closed by sponsor|10|||
130941933|NCT04318080|471423077|FG001|Overall Study|Study closed by sponsor|22|||
130941934|NCT04318080|471423076|FG000|Overall Study|Death|3|||
130941935|NCT04318080|471423077|FG001|Overall Study|Death|9|||
130941936|NCT04318080|471423076|FG000|Overall Study|Withdrawal by Subject|1|||
130941937|NCT04318080|471423077|FG001|Overall Study|Withdrawal by Subject|0|||
130941938|NCT04318080|471423076|FG000|Overall Study|Protocol Deviation|1|||
130941939|NCT04318080|471423077|FG001|Overall Study|Protocol Deviation|0|||
130941940|NCT06308822|471423078|FG000|Overall Study|Mutation Status Not Confirmed|17|||
130941941|NCT06308822|471423078|FG000|Overall Study|Adverse Event|1|||
130941942|NCT06308822|471423078|FG000|Overall Study|Death|5|||
130941943|NCT06308822|471423078|FG000|Overall Study|Disease progression|8|||
130941944|NCT06308822|471423078|FG000|Overall Study|Withdrawal by Subject|1|||
130941945|NCT06308822|471423078|FG000|Overall Study|Physician Decision|3|||
130941946|NCT01852942|471423086|FG000|Overall Study|Physician Decision|1|||
130941947|NCT01852942|471423087|FG001|Overall Study|Physician Decision|0|||
130941948|NCT01852942|471423086|FG000|Overall Study|Death|1|||
130941949|NCT01852942|471423087|FG001|Overall Study|Death|1|||
130941950|NCT01852942|471423086|FG000|Overall Study|Withdrawal by Subject|2|||
130941951|NCT01852942|471423087|FG001|Overall Study|Withdrawal by Subject|3|||
130941952|NCT01852942|471423086|FG000|Overall Study|Lost to Follow-up|1|||
131123352|NCT00885703|472081274|FG001|Overall Study|Death|7|||
131123353|NCT00885703|472081275|FG002|Overall Study|Death|8|||
131123354|NCT00885703|472081276|FG003|Overall Study|Death|7|||
131123355|NCT00885703|472081277|FG004|Overall Study|Death|7|||
131123356|NCT00885703|472081278|FG005|Overall Study|Death|8|||
131123357|NCT00885703|472081279|FG006|Overall Study|Death|4|||
131123358|NCT00885703|472081273|FG000|Overall Study|Lost to Follow-up|0|||
130941953|NCT01852942|471423087|FG001|Overall Study|Lost to Follow-up|2|||
130941954|NCT00858442|471423089|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
130941955|NCT00858442|471423090|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
130941956|NCT03970733|471423093|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
130941957|NCT03970733|471423094|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
131036617|NCT02268253|471768193|FG000|Stage 3A|Study Terminated by Sponsor|0|||
131036618|NCT02268253|471768194|FG001|Stage 3A|Study Terminated by Sponsor|0|||
131036619|NCT02268253|471768195|FG002|Stage 3A|Study Terminated by Sponsor|2|||
131036620|NCT02268253|471768196|FG003|Stage 3A|Study Terminated by Sponsor|0|||
131036621|NCT02268253|471768197|FG004|Stage 3A|Study Terminated by Sponsor|0|||
131123359|NCT00885703|472081274|FG001|Overall Study|Lost to Follow-up|0|||
131123360|NCT00885703|472081275|FG002|Overall Study|Lost to Follow-up|1|||
130941958|NCT03970733|471423095|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
130941959|NCT03970733|471423096|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
130941960|NCT03970733|471423097|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
130941961|NCT03970733|471423093|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
130941962|NCT03970733|471423094|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
130941963|NCT03970733|471423095|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
130941964|NCT03970733|471423096|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
130941965|NCT03970733|471423097|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
130941966|NCT03970733|471423093|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
130941967|NCT03970733|471423094|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
130941968|NCT03970733|471423095|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
130941969|NCT03970733|471423096|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
130941970|NCT03970733|471423097|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
130941971|NCT03970733|471423093|FG000|Main Study Phase (18 Months)|Other|1|||
130941972|NCT03970733|471423094|FG001|Main Study Phase (18 Months)|Other|1|||
130941973|NCT03970733|471423095|FG002|Main Study Phase (18 Months)|Other|0|||
130941974|NCT03970733|471423096|FG003|Main Study Phase (18 Months)|Other|0|||
130941975|NCT03970733|471423097|FG004|Main Study Phase (18 Months)|Other|0|||
130941976|NCT03970733|471423093|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
130941977|NCT03970733|471423094|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
130941978|NCT03970733|471423095|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
130941979|NCT03970733|471423096|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
130941980|NCT03970733|471423097|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
130941981|NCT02189473|471423101|FG000|Overall Study|Death|22|||
130941982|NCT02189473|471423102|FG001|Overall Study|Death|23|||
130941983|NCT02189473|471423101|FG000|Overall Study|Lost to Follow-up|1|||
130941984|NCT02189473|471423102|FG001|Overall Study|Lost to Follow-up|2|||
130941985|NCT01955161|471423103|FG000|Overall Study|Withdrawal before treatment|2|||
130941986|NCT01955161|471423104|FG001|Overall Study|Withdrawal before treatment|0|||
130941987|NCT01955161|471423105|FG002|Overall Study|Withdrawal before treatment|1|||
130941988|NCT01955161|471423103|FG000|Overall Study|Adverse Event|10|||
130941989|NCT01955161|471423104|FG001|Overall Study|Adverse Event|14|||
130941990|NCT01955161|471423105|FG002|Overall Study|Adverse Event|15|||
130941991|NCT01955161|471423103|FG000|Overall Study|Death|1|||
130941992|NCT01955161|471423104|FG001|Overall Study|Death|1|||
130941993|NCT01955161|471423105|FG002|Overall Study|Death|3|||
130941994|NCT01955161|471423103|FG000|Overall Study|Withdrawal by Subject|9|||
130941995|NCT01955161|471423104|FG001|Overall Study|Withdrawal by Subject|8|||
130941996|NCT01955161|471423105|FG002|Overall Study|Withdrawal by Subject|12|||
130941997|NCT01955161|471423103|FG000|Overall Study|Protocol Violation|2|||
130941998|NCT01955161|471423104|FG001|Overall Study|Protocol Violation|0|||
130941999|NCT01955161|471423105|FG002|Overall Study|Protocol Violation|0|||
130942000|NCT01955161|471423103|FG000|Overall Study|Other reason: physician decision|0|||
130942001|NCT01955161|471423104|FG001|Overall Study|Other reason: physician decision|1|||
130942002|NCT01955161|471423105|FG002|Overall Study|Other reason: physician decision|1|||
130942003|NCT01955161|471423103|FG000|Overall Study|Other reason: disallowed medication|1|||
130942004|NCT01955161|471423104|FG001|Overall Study|Other reason: disallowed medication|0|||
130942005|NCT01955161|471423105|FG002|Overall Study|Other reason: disallowed medication|1|||
130942006|NCT01955161|471423103|FG000|Overall Study|Other reason: caregiver unavailable|1|||
130942007|NCT01955161|471423104|FG001|Overall Study|Other reason: caregiver unavailable|0|||
130942008|NCT01955161|471423105|FG002|Overall Study|Other reason: caregiver unavailable|0|||
130942009|NCT01955161|471423103|FG000|Overall Study|Other reason: moved to nursing home|0|||
131123361|NCT00885703|472081276|FG003|Overall Study|Lost to Follow-up|0|||
131123362|NCT00885703|472081277|FG004|Overall Study|Lost to Follow-up|0|||
131123363|NCT00885703|472081278|FG005|Overall Study|Lost to Follow-up|1|||
131123364|NCT00885703|472081279|FG006|Overall Study|Lost to Follow-up|0|||
131123365|NCT00885703|472081273|FG000|Overall Study|Withdrawal by Subject|0|||
131123366|NCT00885703|472081274|FG001|Overall Study|Withdrawal by Subject|0|||
131123367|NCT00885703|472081275|FG002|Overall Study|Withdrawal by Subject|0|||
130706639|NCT02124902|470551512|FG000|Overall Study|Adverse Event|7|||
130706640|NCT02124902|470551513|FG001|Overall Study|Adverse Event|2|||
130706641|NCT02124902|470551512|FG000|Overall Study|Went to alternative treatment|4|||
130942010|NCT01955161|471423104|FG001|Overall Study|Other reason: moved to nursing home|1|||
130942011|NCT01955161|471423105|FG002|Overall Study|Other reason: moved to nursing home|0|||
131123368|NCT00885703|472081276|FG003|Overall Study|Withdrawal by Subject|1|||
130942012|NCT01955161|471423103|FG000|Overall Study|Other reason: insufficient compliance|0|||
130942013|NCT01955161|471423104|FG001|Overall Study|Other reason: insufficient compliance|0|||
130942014|NCT01955161|471423105|FG002|Overall Study|Other reason: insufficient compliance|1|||
130942015|NCT01955161|471423103|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
130942016|NCT01955161|471423104|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
130942017|NCT01955161|471423105|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
130942018|NCT01955161|471423103|FG000|Overall Study|Other reason: patient's will|0|||
131123369|NCT00885703|472081277|FG004|Overall Study|Withdrawal by Subject|3|||
130942019|NCT01955161|471423104|FG001|Overall Study|Other reason: patient's will|0|||
130942020|NCT01955161|471423105|FG002|Overall Study|Other reason: patient's will|1|||
130942021|NCT01277523|471423106|FG000|Overall Study|Adverse Event|1|||
130942022|NCT01277523|471423107|FG001|Overall Study|Adverse Event|0|||
130942023|NCT01277523|471423108|FG002|Overall Study|Adverse Event|0|||
130942024|NCT01277523|471423106|FG000|Overall Study|Protocol Violation|2|||
130942025|NCT01277523|471423107|FG001|Overall Study|Protocol Violation|0|||
130942026|NCT01277523|471423108|FG002|Overall Study|Protocol Violation|0|||
130942027|NCT01277523|471423106|FG000|Overall Study|Other Reason not Defined|0|||
130942028|NCT01277523|471423107|FG001|Overall Study|Other Reason not Defined|1|||
130942029|NCT01277523|471423108|FG002|Overall Study|Other Reason not Defined|0|||
130942030|NCT01881230|471423114|FG000|Overall Study|Death|2|||
130942031|NCT01881230|471423115|FG001|Overall Study|Death|0|||
130942032|NCT01881230|471423116|FG002|Overall Study|Death|1|||
130942033|NCT01881230|471423114|FG000|Overall Study|Adverse Event|9|||
130942034|NCT01881230|471423115|FG001|Overall Study|Adverse Event|13|||
130942035|NCT01881230|471423116|FG002|Overall Study|Adverse Event|12|||
130942036|NCT01881230|471423114|FG000|Overall Study|Progressive Disease|31|||
130942037|NCT01881230|471423115|FG001|Overall Study|Progressive Disease|35|||
130942038|NCT01881230|471423116|FG002|Overall Study|Progressive Disease|36|||
130942039|NCT01881230|471423114|FG000|Overall Study|Symptomatic Deterioration|3|||
130942040|NCT01881230|471423115|FG001|Overall Study|Symptomatic Deterioration|3|||
130942041|NCT01881230|471423116|FG002|Overall Study|Symptomatic Deterioration|1|||
130942042|NCT01881230|471423114|FG000|Overall Study|Withdrawal by Subject|6|||
130942043|NCT01881230|471423115|FG001|Overall Study|Withdrawal by Subject|4|||
130942044|NCT01881230|471423116|FG002|Overall Study|Withdrawal by Subject|6|||
130942045|NCT01881230|471423114|FG000|Overall Study|Physician Decision|4|||
130942046|NCT01881230|471423115|FG001|Overall Study|Physician Decision|3|||
130942047|NCT01881230|471423116|FG002|Overall Study|Physician Decision|6|||
130942048|NCT01881230|471423114|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130942049|NCT01881230|471423115|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130942050|NCT01881230|471423116|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130942051|NCT01881230|471423114|FG000|Overall Study|Given Commercially Available Drug|0|||
130942052|NCT01881230|471423115|FG001|Overall Study|Given Commercially Available Drug|0|||
130942053|NCT01881230|471423116|FG002|Overall Study|Given Commercially Available Drug|2|||
130942054|NCT01881230|471423114|FG000|Overall Study|Protocol Violation|1|||
130942055|NCT01881230|471423115|FG001|Overall Study|Protocol Violation|1|||
130942056|NCT01881230|471423116|FG002|Overall Study|Protocol Violation|0|||
130942057|NCT01881230|471423114|FG000|Overall Study|Miscellaneous|3|||
130942058|NCT01881230|471423115|FG001|Overall Study|Miscellaneous|3|||
130942059|NCT01881230|471423116|FG002|Overall Study|Miscellaneous|0|||
130942060|NCT01881230|471423114|FG000|Overall Study|Untreated: Other|0|||
130942061|NCT01881230|471423115|FG001|Overall Study|Untreated: Other|0|||
130942062|NCT01881230|471423116|FG002|Overall Study|Untreated: Other|1|||
130942063|NCT01881230|471423114|FG000|Overall Study|Untreated: Death|0|||
130942064|NCT01881230|471423115|FG001|Overall Study|Untreated: Death|0|||
130942065|NCT01881230|471423116|FG002|Overall Study|Untreated: Death|1|||
130942066|NCT01881230|471423114|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
130942067|NCT01881230|471423115|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
130942068|NCT01881230|471423116|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
130942069|NCT02385266|471423117|FG000|Overall Study|Withdrawal by Subject|1|||
130942070|NCT02385266|471423118|FG001|Overall Study|Withdrawal by Subject|3|||
130942071|NCT00112502|471423119|FG000|Overall Study|Withdrawal by Subject|0|||
130942072|NCT00112502|471423120|FG001|Overall Study|Withdrawal by Subject|1|||
130942073|NCT00112502|471423121|FG002|Overall Study|Withdrawal by Subject|1|||
130942074|NCT00112502|471423122|FG003|Overall Study|Withdrawal by Subject|4|||
130942075|NCT00112502|471423123|FG004|Overall Study|Withdrawal by Subject|2|||
130942076|NCT00112502|471423124|FG005|Overall Study|Withdrawal by Subject|5|||
130942077|NCT00112502|471423125|FG006|Overall Study|Withdrawal by Subject|3|||
130942078|NCT00112502|471423126|FG007|Overall Study|Withdrawal by Subject|7|||
130942079|NCT01030523|471423127|FG000|Initial Study (5 Years)|Death|1|||
130942080|NCT01030523|471423128|FG001|Initial Study (5 Years)|Death|0|||
130942081|NCT01030523|471423127|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
130942082|NCT01030523|471423128|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
130942083|NCT01030523|471423127|FG000|Initial Study (5 Years)|Implant failure|1|||
130942084|NCT01030523|471423128|FG001|Initial Study (5 Years)|Implant failure|0|||
130942085|NCT01030523|471423127|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
130942086|NCT01030523|471423128|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
131123370|NCT00885703|472081278|FG005|Overall Study|Withdrawal by Subject|1|||
131123371|NCT00885703|472081279|FG006|Overall Study|Withdrawal by Subject|1|||
130942087|NCT01030523|471423127|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
130942088|NCT01030523|471423128|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
130942089|NCT01030523|471423127|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
130942090|NCT01030523|471423128|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
130942091|NCT03329690|471423138|FG000|Overall Study|Progressive disease per RECIST|85|||
130942092|NCT03329690|471423139|FG001|Overall Study|Progressive disease per RECIST|44|||
130942093|NCT03329690|471423140|FG002|Overall Study|Progressive disease per RECIST|6|||
130942094|NCT03329690|471423141|FG003|Overall Study|Progressive disease per RECIST|16|||
130942095|NCT03329690|471423142|FG004|Overall Study|Progressive disease per RECIST|20|||
130942096|NCT03329690|471423138|FG000|Overall Study|Clinical progression|7|||
130942097|NCT03329690|471423139|FG001|Overall Study|Clinical progression|4|||
130942098|NCT03329690|471423140|FG002|Overall Study|Clinical progression|1|||
130942099|NCT03329690|471423141|FG003|Overall Study|Clinical progression|1|||
130942100|NCT03329690|471423142|FG004|Overall Study|Clinical progression|1|||
130942101|NCT03329690|471423138|FG000|Overall Study|Adverse Event|22|||
130942102|NCT03329690|471423139|FG001|Overall Study|Adverse Event|4|||
130942103|NCT03329690|471423140|FG002|Overall Study|Adverse Event|0|||
130942104|NCT03329690|471423141|FG003|Overall Study|Adverse Event|1|||
130942105|NCT03329690|471423142|FG004|Overall Study|Adverse Event|2|||
130942106|NCT03329690|471423138|FG000|Overall Study|Death|2|||
130942107|NCT03329690|471423139|FG001|Overall Study|Death|0|||
130942108|NCT03329690|471423140|FG002|Overall Study|Death|0|||
130942109|NCT03329690|471423141|FG003|Overall Study|Death|1|||
130942110|NCT03329690|471423142|FG004|Overall Study|Death|0|||
130942111|NCT03329690|471423138|FG000|Overall Study|Withdrawal by Subject|2|||
130942112|NCT03329690|471423139|FG001|Overall Study|Withdrawal by Subject|3|||
130942113|NCT03329690|471423140|FG002|Overall Study|Withdrawal by Subject|0|||
130942114|NCT03329690|471423141|FG003|Overall Study|Withdrawal by Subject|1|||
130942115|NCT03329690|471423142|FG004|Overall Study|Withdrawal by Subject|0|||
130942116|NCT03329690|471423138|FG000|Overall Study|Physician Decision|1|||
130942117|NCT03329690|471423139|FG001|Overall Study|Physician Decision|0|||
130942118|NCT03329690|471423140|FG002|Overall Study|Physician Decision|0|||
130942119|NCT03329690|471423141|FG003|Overall Study|Physician Decision|0|||
130942120|NCT03329690|471423142|FG004|Overall Study|Physician Decision|1|||
130942121|NCT03329690|471423138|FG000|Overall Study|Miscellaneous|6|||
130942122|NCT03329690|471423139|FG001|Overall Study|Miscellaneous|0|||
130942123|NCT03329690|471423140|FG002|Overall Study|Miscellaneous|0|||
130942124|NCT03329690|471423141|FG003|Overall Study|Miscellaneous|0|||
130942125|NCT03329690|471423142|FG004|Overall Study|Miscellaneous|0|||
130942126|NCT03329690|471423138|FG000|Overall Study|Did not receive treatment|1|||
130942127|NCT03329690|471423139|FG001|Overall Study|Did not receive treatment|0|||
130942128|NCT03329690|471423140|FG002|Overall Study|Did not receive treatment|0|||
130942129|NCT03329690|471423141|FG003|Overall Study|Did not receive treatment|1|||
130942130|NCT03329690|471423142|FG004|Overall Study|Did not receive treatment|0|||
130942131|NCT02337907|471423144|FG000|Overall Study|Other than listed|1|||
130942132|NCT02337907|471423145|FG001|Overall Study|Other than listed|0|||
130942133|NCT02337907|471423146|FG002|Overall Study|Other than listed|0|||
130942134|NCT02337907|471423147|FG003|Overall Study|Other than listed|1|||
130942135|NCT02337907|471423148|FG004|Overall Study|Other than listed|1|||
130942136|NCT02337907|471423149|FG005|Overall Study|Other than listed|0|||
130942137|NCT02337907|471423144|FG000|Overall Study|Withdrawal by Subject|2|||
130942138|NCT02337907|471423145|FG001|Overall Study|Withdrawal by Subject|3|||
130942139|NCT02337907|471423146|FG002|Overall Study|Withdrawal by Subject|0|||
130942140|NCT02337907|471423147|FG003|Overall Study|Withdrawal by Subject|2|||
130942141|NCT02337907|471423148|FG004|Overall Study|Withdrawal by Subject|5|||
130942142|NCT02337907|471423149|FG005|Overall Study|Withdrawal by Subject|0|||
130942143|NCT02337907|471423144|FG000|Overall Study|Lost to Follow-up|0|||
130942144|NCT02337907|471423145|FG001|Overall Study|Lost to Follow-up|0|||
130942145|NCT02337907|471423146|FG002|Overall Study|Lost to Follow-up|0|||
130942146|NCT02337907|471423147|FG003|Overall Study|Lost to Follow-up|0|||
130942147|NCT02337907|471423148|FG004|Overall Study|Lost to Follow-up|0|||
130942148|NCT02337907|471423149|FG005|Overall Study|Lost to Follow-up|1|||
130942149|NCT02337907|471423144|FG000|Overall Study|Adverse Event|1|||
130942150|NCT02337907|471423145|FG001|Overall Study|Adverse Event|1|||
130942151|NCT02337907|471423146|FG002|Overall Study|Adverse Event|1|||
130942152|NCT02337907|471423147|FG003|Overall Study|Adverse Event|1|||
130942153|NCT02337907|471423148|FG004|Overall Study|Adverse Event|4|||
130942154|NCT02337907|471423149|FG005|Overall Study|Adverse Event|0|||
131036622|NCT02268253|471768198|FG005|Stage 3A|Study Terminated by Sponsor|0|||
131036623|NCT02268253|471768199|FG006|Stage 3A|Study Terminated by Sponsor|0|||
131036624|NCT02268253|471768193|FG000|Stage 3A|Lost to Follow-up|0|||
131036625|NCT02268253|471768194|FG001|Stage 3A|Lost to Follow-up|0|||
131036626|NCT02268253|471768195|FG002|Stage 3A|Lost to Follow-up|1|||
131036627|NCT02268253|471768196|FG003|Stage 3A|Lost to Follow-up|0|||
131036628|NCT02268253|471768197|FG004|Stage 3A|Lost to Follow-up|0|||
131036629|NCT02268253|471768198|FG005|Stage 3A|Lost to Follow-up|0|||
131036630|NCT02268253|471768199|FG006|Stage 3A|Lost to Follow-up|0|||
130942155|NCT02488681|471423156|FG000|Overall Study|Implant unsuccessful|7|||
130942156|NCT02809677|471423157|FG000|Overall Study|Withdrawal by Subject|8|||
130942157|NCT03165110|471423158|FG000|Overall Study|Anroid phone software incompatibility|1|||
130942158|NCT05533632|471423159|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
130942159|NCT05533632|471423159|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
130942160|NCT05533632|471423159|FG000|Overall Study|Lost to Follow-up|1|||
130942161|NCT05533632|471423159|FG000|Overall Study|Withdrawal by Subject|4|||
130942162|NCT05533632|471423159|FG000|Overall Study|Adverse Event|4|||
130942163|NCT04327388|471423162|FG000|Overall Study|Adverse Event|17|||
130942164|NCT04327388|471423163|FG001|Overall Study|Adverse Event|18|||
130942165|NCT04327388|471423164|FG002|Overall Study|Adverse Event|9|||
130942166|NCT04327388|471423162|FG000|Overall Study|Other|1|||
130942167|NCT04327388|471423163|FG001|Overall Study|Other|2|||
130942168|NCT04327388|471423164|FG002|Overall Study|Other|0|||
130942169|NCT04327388|471423162|FG000|Overall Study|Randomized and not treated|2|||
130942170|NCT04327388|471423163|FG001|Overall Study|Randomized and not treated|0|||
130942171|NCT04327388|471423164|FG002|Overall Study|Randomized and not treated|2|||
130942172|NCT04120974|471423165|FG000|Overall Study|Death|1|||
130942173|NCT04120974|471423165|FG000|Overall Study|Physician Decision|1|||
130942174|NCT04120974|471423165|FG000|Overall Study|Lost to Follow-up|6|||
130942175|NCT03338062|471423166|FG000|Overall Study|Alternative Therapy|1|||
130942176|NCT03338062|471423167|FG001|Overall Study|Alternative Therapy|0|||
130942177|NCT01558752|471423168|FG000|Overall Study|Physician Decision|2|||
130942178|NCT01558752|471423169|FG001|Overall Study|Physician Decision|0|||
130942179|NCT04340362|471423173|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
130942180|NCT03341533|471423174|FG000|Overall Study|Withdrawal by Subject|1|||
130942181|NCT03341533|471423175|FG001|Overall Study|Withdrawal by Subject|1|||
130942182|NCT03341533|471423174|FG000|Overall Study|Not eligible after randomization|2|||
130942183|NCT03341533|471423175|FG001|Overall Study|Not eligible after randomization|1|||
130942184|NCT03559257|471423176|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
130942185|NCT03559257|471423177|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
130942186|NCT03559257|471423176|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130942187|NCT03559257|471423177|FG001|Double Blind Treatment Period|Protocol Violation|4|||
130942188|NCT03559257|471423176|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
130942189|NCT03559257|471423177|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
130942190|NCT03559257|471423176|FG000|Double Blind Treatment Period|Adverse Event|0|||
130942191|NCT03559257|471423177|FG001|Double Blind Treatment Period|Adverse Event|1|||
130942192|NCT03559257|471423176|FG000|Double Blind Treatment Period|Screen Failure|0|||
130942193|NCT03559257|471423177|FG001|Double Blind Treatment Period|Screen Failure|1|||
130942194|NCT03559257|471423176|FG000|Open-label Treatment Period|Adverse Event|1|||
130942195|NCT03559257|471423177|FG001|Open-label Treatment Period|Adverse Event|4|||
130942196|NCT03559257|471423176|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
130942197|NCT03559257|471423177|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
130942198|NCT03559257|471423176|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
130942199|NCT03559257|471423177|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130942200|NCT03559257|471423176|FG000|Open-label Treatment Period|Protocol Violation|2|||
130942201|NCT03559257|471423177|FG001|Open-label Treatment Period|Protocol Violation|0|||
130942202|NCT03559257|471423176|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
130942203|NCT03559257|471423177|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
130942204|NCT03559257|471423176|FG000|Open-label Treatment Period|Physician Decision|0|||
130942205|NCT03559257|471423177|FG001|Open-label Treatment Period|Physician Decision|1|||
130942206|NCT01519960|471423178|FG000|Overall Study|Withdrawal from the study|26|||
130942207|NCT01519960|471423179|FG001|Overall Study|Withdrawal from the study|22|||
130942208|NCT01519960|471423180|FG002|Overall Study|Withdrawal from the study|5|||
130942209|NCT01387347|471423181|FG000|Overall Study|Lost to Follow-up|2|||
130942210|NCT01387347|471423182|FG001|Overall Study|Lost to Follow-up|1|||
130942211|NCT00561080|471423185|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
130942212|NCT00561080|471423186|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
130942213|NCT00561080|471423187|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
130942214|NCT00561080|471423185|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
130942215|NCT00561080|471423186|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
130706642|NCT02124902|470551513|FG001|Overall Study|Went to alternative treatment|0|||
130942216|NCT00561080|471423187|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
130942217|NCT00561080|471423185|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
130942218|NCT00561080|471423186|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
130942219|NCT00561080|471423187|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
130942220|NCT00561080|471423185|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
130942221|NCT00561080|471423186|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
130942222|NCT00561080|471423187|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
130942223|NCT00561080|471423185|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
130942224|NCT00561080|471423186|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
130942225|NCT00561080|471423187|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
130942226|NCT00561080|471423185|FG000|Vaccination Period (up to Month 4)|Other|0|||
130942227|NCT00561080|471423186|FG001|Vaccination Period (up to Month 4)|Other|2|||
130942228|NCT00561080|471423187|FG002|Vaccination Period (up to Month 4)|Other|1|||
130942229|NCT00561080|471423185|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
130942230|NCT00561080|471423186|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
130942231|NCT00561080|471423187|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
130706643|NCT02124902|470551512|FG000|Overall Study|Withdrawal by Subject|2|||
130942232|NCT00561080|471423185|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
130942233|NCT00561080|471423186|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
130942234|NCT00561080|471423187|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
130942235|NCT00561080|471423185|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
130942236|NCT00561080|471423186|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
130942237|NCT00561080|471423187|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
130942238|NCT00561080|471423185|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
130942239|NCT00561080|471423186|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
130942240|NCT00561080|471423187|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
130942241|NCT01288287|471423188|FG000|Overall Study|Lost to Follow-up|8|||
130942242|NCT01288287|471423188|FG000|Overall Study|Withdrawal by Subject|4|||
130942243|NCT01288287|471423188|FG000|Overall Study|Lack of Efficacy|13|||
130942244|NCT01288287|471423188|FG000|Overall Study|Other Reason|13|||
130942245|NCT01288287|471423188|FG000|Overall Study|Unknown Reason|1|||
130942246|NCT01288287|471423188|FG000|Overall Study|Unknown Status|7|||
130942247|NCT01092182|471423189|FG000|Overall Study|Death|0|||
130942248|NCT01092182|471423190|FG001|Overall Study|Death|5|||
130942249|NCT01092182|471423191|FG002|Overall Study|Death|3|||
130942250|NCT01092182|471423189|FG000|Overall Study|participant safety|1|||
130942251|NCT01092182|471423190|FG001|Overall Study|participant safety|2|||
130942252|NCT01092182|471423191|FG002|Overall Study|participant safety|0|||
130942253|NCT01092182|471423189|FG000|Overall Study|Physician Decision|0|||
130942254|NCT01092182|471423190|FG001|Overall Study|Physician Decision|6|||
130942255|NCT01092182|471423191|FG002|Overall Study|Physician Decision|0|||
130942256|NCT01092182|471423189|FG000|Overall Study|Did not meet criteria|0|||
130942257|NCT01092182|471423190|FG001|Overall Study|Did not meet criteria|0|||
130942258|NCT01092182|471423191|FG002|Overall Study|Did not meet criteria|25|||
130942259|NCT01092182|471423189|FG000|Overall Study|Non-compliance|0|||
130942260|NCT01092182|471423190|FG001|Overall Study|Non-compliance|3|||
130942261|NCT01092182|471423191|FG002|Overall Study|Non-compliance|0|||
130942262|NCT01092182|471423189|FG000|Overall Study|Participant refused follow-up|0|||
130942263|NCT01092182|471423190|FG001|Overall Study|Participant refused follow-up|2|||
130942264|NCT01092182|471423191|FG002|Overall Study|Participant refused follow-up|0|||
130942265|NCT02515045|471423198|FG000|Overall Study|Adverse Event|0|||
130942266|NCT02515045|471423199|FG001|Overall Study|Adverse Event|3|||
130942267|NCT02515045|471423200|FG002|Overall Study|Adverse Event|3|||
130942268|NCT02515045|471423198|FG000|Overall Study|Lost to Follow-up|0|||
130942269|NCT02515045|471423199|FG001|Overall Study|Lost to Follow-up|1|||
130942270|NCT02515045|471423200|FG002|Overall Study|Lost to Follow-up|1|||
130942271|NCT00238121|471423201|FG000|Overall Study|Withdrawal by Subject|1|||
130942272|NCT00238121|471423202|FG001|Overall Study|Withdrawal by Subject|1|||
130942273|NCT00238121|471423201|FG000|Overall Study|Adverse Event|2|||
130942274|NCT00238121|471423202|FG001|Overall Study|Adverse Event|1|||
130942275|NCT03255382|471423205|FG000|Overall Study|Adverse Event|3|||
130942276|NCT03255382|471423206|FG001|Overall Study|Adverse Event|0|||
130942277|NCT03255382|471423205|FG000|Overall Study|Lost to Follow-up|2|||
130942278|NCT03255382|471423206|FG001|Overall Study|Lost to Follow-up|0|||
130942279|NCT03255382|471423205|FG000|Overall Study|Withdrawal by Subject|2|||
130942280|NCT03255382|471423206|FG001|Overall Study|Withdrawal by Subject|0|||
130942281|NCT03255382|471423205|FG000|Overall Study|Other|6|||
130942282|NCT03255382|471423206|FG001|Overall Study|Other|0|||
130942283|NCT02221284|471423209|FG000|Overall Study|Case Report Forms Uncollected|56|||
130942284|NCT02221284|471423209|FG000|Overall Study|Protocol Deviation|5|||
130942285|NCT02587065|471423211|FG000|Overall Study|Adverse Event|14|||
130942286|NCT02587065|471423211|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
130942287|NCT02587065|471423211|FG000|Overall Study|Non-adherence to the Protocol|3|||
130942288|NCT02587065|471423211|FG000|Overall Study|Discontinuation of Study Medication|2|||
130942289|NCT02587065|471423211|FG000|Overall Study|Reason not Specified|3|||
130942290|NCT02446990|471423215|FG000|Overall Study|Death|485|||
130942291|NCT02446990|471423216|FG001|Overall Study|Death|458|||
130942292|NCT02446990|471423215|FG000|Overall Study|Lost to Follow-up|3|||
130942293|NCT02446990|471423216|FG001|Overall Study|Lost to Follow-up|1|||
130942294|NCT02446990|471423215|FG000|Overall Study|Physician Decision|1|||
130706644|NCT02124902|470551513|FG001|Overall Study|Withdrawal by Subject|1|||
130706645|NCT02124902|470551512|FG000|Overall Study|Physician Decision|2|||
130942295|NCT02446990|471423216|FG001|Overall Study|Physician Decision|0|||
130942296|NCT02446990|471423215|FG000|Overall Study|Withdrawal by Subject|231|||
130942297|NCT02446990|471423216|FG001|Overall Study|Withdrawal by Subject|199|||
130942298|NCT01064401|471423217|FG000|Overall Study|Adverse Event|47|||
130942299|NCT01064401|471423218|FG001|Overall Study|Adverse Event|56|||
130942300|NCT01064401|471423217|FG000|Overall Study|Lack of Efficacy|46|||
130942301|NCT01064401|471423218|FG001|Overall Study|Lack of Efficacy|23|||
130942302|NCT01064401|471423217|FG000|Overall Study|Lost to Follow-up|12|||
130706646|NCT02124902|470551513|FG001|Overall Study|Physician Decision|0|||
130942303|NCT01064401|471423218|FG001|Overall Study|Lost to Follow-up|9|||
130942304|NCT01064401|471423217|FG000|Overall Study|Consent Withdrawn|98|||
130942305|NCT01064401|471423218|FG001|Overall Study|Consent Withdrawn|80|||
131036631|NCT02268253|471768193|FG000|Stage 3A|Death|0|||
130942306|NCT01064401|471423217|FG000|Overall Study|Investigator Decision|4|||
130942307|NCT01064401|471423218|FG001|Overall Study|Investigator Decision|6|||
130942308|NCT01064401|471423217|FG000|Overall Study|Death|4|||
130942309|NCT01064401|471423218|FG001|Overall Study|Death|0|||
130942310|NCT01064401|471423217|FG000|Overall Study|Pregnancy|4|||
130942311|NCT01064401|471423218|FG001|Overall Study|Pregnancy|7|||
130942312|NCT01064401|471423217|FG000|Overall Study|Noncompliance|7|||
130942313|NCT01064401|471423218|FG001|Overall Study|Noncompliance|8|||
130942314|NCT01064401|471423217|FG000|Overall Study|Site Closure|4|||
130942315|NCT01064401|471423218|FG001|Overall Study|Site Closure|5|||
130942316|NCT01064401|471423217|FG000|Overall Study|Other|2|||
130942317|NCT01064401|471423218|FG001|Overall Study|Other|1|||
130942318|NCT03158051|471423219|FG000|Overall Study|Lost to Follow-up|41|||
130942319|NCT03158051|471423220|FG001|Overall Study|Lost to Follow-up|47|||
130942320|NCT03158051|471423219|FG000|Overall Study|Physician Decision|6|||
130942321|NCT03158051|471423220|FG001|Overall Study|Physician Decision|7|||
130942322|NCT03158051|471423219|FG000|Overall Study|Withdrawal by Subject|24|||
130942323|NCT03158051|471423220|FG001|Overall Study|Withdrawal by Subject|15|||
130942324|NCT03158051|471423219|FG000|Overall Study|Death|0|||
130942325|NCT03158051|471423220|FG001|Overall Study|Death|1|||
130942326|NCT02738151|471423221|FG000|Overall Study|Randomized but not treated|4|||
130942327|NCT02738151|471423222|FG001|Overall Study|Randomized but not treated|1|||
130942328|NCT02738151|471423221|FG000|Overall Study|Adverse Event|4|||
130942329|NCT02738151|471423222|FG001|Overall Study|Adverse Event|5|||
130942330|NCT02738151|471423221|FG000|Overall Study|Hypoglycemia|0|||
130942331|NCT02738151|471423222|FG001|Overall Study|Hypoglycemia|1|||
130942332|NCT02738151|471423221|FG000|Overall Study|Poor Compliance to Protocol|4|||
130942333|NCT02738151|471423222|FG001|Overall Study|Poor Compliance to Protocol|3|||
130942334|NCT02738151|471423221|FG000|Overall Study|Other than specified above|11|||
130942335|NCT02738151|471423222|FG001|Overall Study|Other than specified above|21|||
130942336|NCT02588833|471423223|FG000|Part 1|Withdrawal by Subject|1|||
130942337|NCT02588833|471423224|FG001|Part 1|Withdrawal by Subject|0|||
130942338|NCT02588833|471423223|FG000|Part 2A|Physician Decision|0|||
130942339|NCT02588833|471423224|FG001|Part 2A|Physician Decision|1|||
130942340|NCT02588833|471423223|FG000|Part 2A|Withdrawal by Subject|0|||
130942341|NCT02588833|471423224|FG001|Part 2A|Withdrawal by Subject|1|||
130942342|NCT02588833|471423223|FG000|Part 2B|Adverse Event|0|||
130942343|NCT02588833|471423224|FG001|Part 2B|Adverse Event|1|||
130942344|NCT02588833|471423223|FG000|Part 2C|Adverse Event|0|||
130942345|NCT02588833|471423224|FG001|Part 2C|Adverse Event|1|||
130942346|NCT02588833|471423223|FG000|Part 2C|Withdrawal by Subject|0|||
130942347|NCT02588833|471423224|FG001|Part 2C|Withdrawal by Subject|1|||
130942348|NCT02588833|471423223|FG000|Part 3 (Safety Follow-up)|Other|0|||
130942349|NCT02588833|471423224|FG001|Part 3 (Safety Follow-up)|Other|2|||
130942350|NCT03333044|471423228|FG000|Overall Study|Pregnancy|1|||
130942351|NCT03333044|471423229|FG001|Overall Study|Pregnancy|0|||
130942352|NCT03333044|471423230|FG002|Overall Study|Pregnancy|0|||
130942353|NCT03333044|471423228|FG000|Overall Study|Lost to Follow-up|0|||
130942354|NCT03333044|471423229|FG001|Overall Study|Lost to Follow-up|14|||
130942355|NCT03333044|471423230|FG002|Overall Study|Lost to Follow-up|6|||
130942356|NCT03649711|471423231|FG000|Overall Study|Adverse Event|0|||
130942357|NCT03649711|471423232|FG001|Overall Study|Adverse Event|1|||
130942358|NCT03649711|471423233|FG002|Overall Study|Adverse Event|0|||
130942359|NCT03649711|471423231|FG000|Overall Study|Kidney Transplant|1|||
130942360|NCT03649711|471423232|FG001|Overall Study|Kidney Transplant|0|||
130942361|NCT03649711|471423233|FG002|Overall Study|Kidney Transplant|0|||
130942362|NCT03188094|471423238|FG000|Overall Study|Screen failure|1|||
130942363|NCT03188094|471423239|FG001|Overall Study|Screen failure|0|||
130942364|NCT03188094|471423240|FG002|Overall Study|Screen failure|0|||
130942365|NCT03188094|471423238|FG000|Overall Study|Pregnancy|3|||
130942366|NCT03188094|471423239|FG001|Overall Study|Pregnancy|0|||
130942367|NCT03188094|471423240|FG002|Overall Study|Pregnancy|0|||
130942368|NCT03188094|471423238|FG000|Overall Study|Ineligible|1|||
130942369|NCT03188094|471423239|FG001|Overall Study|Ineligible|0|||
130942370|NCT03188094|471423240|FG002|Overall Study|Ineligible|0|||
130942371|NCT03188094|471423238|FG000|Overall Study|Lost to Follow-up|0|||
130942372|NCT03188094|471423239|FG001|Overall Study|Lost to Follow-up|0|||
130942373|NCT03188094|471423240|FG002|Overall Study|Lost to Follow-up|17|||
130942374|NCT02921776|471423241|FG000|Overall Study|patient deterioration, fatigue|2|||
130942375|NCT02921776|471423242|FG001|Overall Study|patient deterioration, fatigue|6|||
130942376|NCT02921776|471423243|FG002|Overall Study|patient deterioration, fatigue|0|||
130942377|NCT02921776|471423244|FG003|Overall Study|patient deterioration, fatigue|0|||
130942378|NCT02921776|471423245|FG004|Overall Study|patient deterioration, fatigue|0|||
130942379|NCT02921776|471423246|FG005|Overall Study|patient deterioration, fatigue|0|||
130942380|NCT02921776|471423247|FG006|Overall Study|patient deterioration, fatigue|0|||
130942381|NCT02921776|471423248|FG007|Overall Study|patient deterioration, fatigue|0|||
130942382|NCT02921776|471423241|FG000|Overall Study|Withdrawal by Subject|0|||
130942383|NCT02921776|471423242|FG001|Overall Study|Withdrawal by Subject|2|||
130942384|NCT02921776|471423243|FG002|Overall Study|Withdrawal by Subject|0|||
130942385|NCT02921776|471423244|FG003|Overall Study|Withdrawal by Subject|1|||
130942386|NCT02921776|471423245|FG004|Overall Study|Withdrawal by Subject|1|||
130942387|NCT02921776|471423246|FG005|Overall Study|Withdrawal by Subject|0|||
130942388|NCT02921776|471423247|FG006|Overall Study|Withdrawal by Subject|8|||
130942389|NCT02921776|471423248|FG007|Overall Study|Withdrawal by Subject|1|||
130942390|NCT02921776|471423241|FG000|Overall Study|Death|0|||
130942391|NCT02921776|471423242|FG001|Overall Study|Death|0|||
130942392|NCT02921776|471423243|FG002|Overall Study|Death|0|||
130942393|NCT02921776|471423244|FG003|Overall Study|Death|2|||
130942394|NCT02921776|471423245|FG004|Overall Study|Death|0|||
130942395|NCT02921776|471423246|FG005|Overall Study|Death|0|||
130942396|NCT02921776|471423247|FG006|Overall Study|Death|0|||
130942397|NCT02921776|471423248|FG007|Overall Study|Death|0|||
130942398|NCT02921776|471423241|FG000|Overall Study|extubation or early discharge|0|||
130942399|NCT02921776|471423242|FG001|Overall Study|extubation or early discharge|0|||
130942400|NCT02921776|471423243|FG002|Overall Study|extubation or early discharge|0|||
130942401|NCT02921776|471423244|FG003|Overall Study|extubation or early discharge|5|||
130942402|NCT02921776|471423245|FG004|Overall Study|extubation or early discharge|5|||
130942403|NCT02921776|471423246|FG005|Overall Study|extubation or early discharge|0|||
130942404|NCT02921776|471423247|FG006|Overall Study|extubation or early discharge|0|||
130942405|NCT02921776|471423248|FG007|Overall Study|extubation or early discharge|0|||
130942406|NCT02921776|471423241|FG000|Overall Study|Lost to Follow-up|0|||
130942407|NCT02921776|471423242|FG001|Overall Study|Lost to Follow-up|0|||
130942408|NCT02921776|471423243|FG002|Overall Study|Lost to Follow-up|0|||
130942409|NCT02921776|471423244|FG003|Overall Study|Lost to Follow-up|0|||
130942410|NCT02921776|471423245|FG004|Overall Study|Lost to Follow-up|0|||
130942411|NCT02921776|471423246|FG005|Overall Study|Lost to Follow-up|2|||
130942412|NCT02921776|471423247|FG006|Overall Study|Lost to Follow-up|3|||
130942413|NCT02921776|471423248|FG007|Overall Study|Lost to Follow-up|6|||
130942414|NCT02070744|471423254|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
130942415|NCT02070744|471423255|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
130942416|NCT02070744|471423256|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
130942417|NCT02070744|471423257|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
130942418|NCT02070744|471423258|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
130942419|NCT02070744|471423254|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
130942420|NCT02070744|471423255|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
130942421|NCT02070744|471423256|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
130942422|NCT02070744|471423257|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
130942423|NCT02070744|471423258|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
130942424|NCT02070744|471423254|FG000|OLE Phase (48 Weeks)|Other|0|||
130942425|NCT02070744|471423255|FG001|OLE Phase (48 Weeks)|Other|0|||
130942426|NCT02070744|471423256|FG002|OLE Phase (48 Weeks)|Other|0|||
130942427|NCT02070744|471423257|FG003|OLE Phase (48 Weeks)|Other|0|||
130942428|NCT02070744|471423258|FG004|OLE Phase (48 Weeks)|Other|1|||
130942429|NCT04199117|471423259|FG000|Overall Study|Withdrawal by Subject|3|||
130942430|NCT04199117|471423260|FG001|Overall Study|Withdrawal by Subject|0|||
130942431|NCT04199117|471423261|FG002|Overall Study|Withdrawal by Subject|0|||
130942432|NCT04199117|471423262|FG003|Overall Study|Withdrawal by Subject|1|||
130942433|NCT04199117|471423263|FG004|Overall Study|Withdrawal by Subject|1|||
130942434|NCT04199117|471423264|FG005|Overall Study|Withdrawal by Subject|0|||
130942435|NCT04199117|471423265|FG006|Overall Study|Withdrawal by Subject|0|||
130942436|NCT04199117|471423266|FG007|Overall Study|Withdrawal by Subject|2|||
130942437|NCT04199117|471423267|FG008|Overall Study|Withdrawal by Subject|0|||
130942438|NCT04199117|471423268|FG009|Overall Study|Withdrawal by Subject|0|||
130942439|NCT04199117|471423269|FG010|Overall Study|Withdrawal by Subject|1|||
130942440|NCT04199117|471423270|FG011|Overall Study|Withdrawal by Subject|1|||
130942441|NCT04199117|471423271|FG012|Overall Study|Withdrawal by Subject|2|||
130942442|NCT04199117|471423272|FG013|Overall Study|Withdrawal by Subject|1|||
130942443|NCT04199117|471423273|FG014|Overall Study|Withdrawal by Subject|1|||
130942444|NCT04199117|471423274|FG015|Overall Study|Withdrawal by Subject|1|||
130942445|NCT04199117|471423259|FG000|Overall Study|Death|1|||
130942446|NCT04199117|471423260|FG001|Overall Study|Death|1|||
130942447|NCT04199117|471423261|FG002|Overall Study|Death|0|||
130942448|NCT04199117|471423262|FG003|Overall Study|Death|0|||
130942449|NCT04199117|471423263|FG004|Overall Study|Death|0|||
131123372|NCT00885703|472081273|FG000|Overall Study|Ineligible (no CM)|1|||
131123373|NCT00885703|472081274|FG001|Overall Study|Ineligible (no CM)|3|||
131123374|NCT00885703|472081275|FG002|Overall Study|Ineligible (no CM)|2|||
131123375|NCT00885703|472081276|FG003|Overall Study|Ineligible (no CM)|1|||
130942450|NCT04199117|471423264|FG005|Overall Study|Death|0|||
130942451|NCT04199117|471423265|FG006|Overall Study|Death|0|||
130942452|NCT04199117|471423266|FG007|Overall Study|Death|0|||
130942453|NCT04199117|471423267|FG008|Overall Study|Death|0|||
130942454|NCT04199117|471423268|FG009|Overall Study|Death|0|||
130942455|NCT04199117|471423269|FG010|Overall Study|Death|0|||
130942456|NCT04199117|471423270|FG011|Overall Study|Death|1|||
130942457|NCT04199117|471423271|FG012|Overall Study|Death|0|||
130942458|NCT04199117|471423272|FG013|Overall Study|Death|1|||
130942459|NCT04199117|471423273|FG014|Overall Study|Death|0|||
131123376|NCT00885703|472081277|FG004|Overall Study|Ineligible (no CM)|2|||
130772321|NCT05052697|470792820|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772322|NCT05052697|470792821|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130942460|NCT04199117|471423274|FG015|Overall Study|Death|0|||
130942461|NCT04199117|471423259|FG000|Overall Study|Withdrawal by PI|0|||
130942462|NCT04199117|471423260|FG001|Overall Study|Withdrawal by PI|0|||
130942463|NCT04199117|471423261|FG002|Overall Study|Withdrawal by PI|0|||
130942464|NCT04199117|471423262|FG003|Overall Study|Withdrawal by PI|0|||
130942465|NCT04199117|471423263|FG004|Overall Study|Withdrawal by PI|0|||
130942466|NCT04199117|471423264|FG005|Overall Study|Withdrawal by PI|0|||
130942467|NCT04199117|471423265|FG006|Overall Study|Withdrawal by PI|0|||
130942468|NCT04199117|471423266|FG007|Overall Study|Withdrawal by PI|0|||
130942469|NCT04199117|471423267|FG008|Overall Study|Withdrawal by PI|0|||
130942470|NCT04199117|471423268|FG009|Overall Study|Withdrawal by PI|0|||
130942471|NCT04199117|471423269|FG010|Overall Study|Withdrawal by PI|0|||
130942472|NCT04199117|471423270|FG011|Overall Study|Withdrawal by PI|0|||
130942473|NCT04199117|471423271|FG012|Overall Study|Withdrawal by PI|1|||
130942474|NCT04199117|471423272|FG013|Overall Study|Withdrawal by PI|0|||
130942475|NCT04199117|471423273|FG014|Overall Study|Withdrawal by PI|0|||
130942476|NCT04199117|471423274|FG015|Overall Study|Withdrawal by PI|0|||
130942477|NCT04439253|471424734|FG000|Overall Study|Adverse Event|1|||
130942478|NCT04439253|471424734|FG000|Overall Study|Disease progression|2|||
130942479|NCT04439253|471424734|FG000|Overall Study|Complicating disease|1|||
130942480|NCT00702403|471424735|FG000|From Consent to Engraftment|Progressive leukemia|6|||
130942481|NCT00702403|471424735|FG000|From Consent to Engraftment|Critically ill|2|||
130942482|NCT00702403|471424735|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
130942483|NCT00702403|471424735|FG000|From Consent to Engraftment|Myocardial infarction|1|||
130942484|NCT00702403|471424735|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
130942485|NCT00702403|471424735|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
130942486|NCT00702403|471424735|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
130942487|NCT00702403|471424735|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
130942488|NCT00702403|471424735|FG000|From Engraftment to Study Completion|Non-compliance|2|||
130942489|NCT00702403|471424735|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
130942490|NCT00702403|471424735|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
130942491|NCT00702403|471424735|FG000|From Engraftment to Study Completion|Suicide|1|||
130942492|NCT00702403|471424735|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
130942493|NCT00702403|471424735|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
130942494|NCT00702403|471424735|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
130942495|NCT00380978|471424737|FG000|Overall Study|Refused allocated intervention|0|||
130942496|NCT00380978|471424738|FG001|Overall Study|Refused allocated intervention|6|||
130942497|NCT00380978|471424737|FG000|Overall Study|Wrong study envelope|0|||
130942498|NCT00380978|471424738|FG001|Overall Study|Wrong study envelope|2|||
130942499|NCT00380978|471424737|FG000|Overall Study|Allocation prior to analgesia request|1|||
130942500|NCT00380978|471424738|FG001|Overall Study|Allocation prior to analgesia request|2|||
130942501|NCT00380978|471424737|FG000|Overall Study|Parous patient|1|||
130942502|NCT00380978|471424738|FG001|Overall Study|Parous patient|0|||
130942503|NCT04146545|471424739|FG000|Overall Study|deemed ineligible after randomization|1|||
130942504|NCT04146545|471424740|FG001|Overall Study|deemed ineligible after randomization|0|||
130942505|NCT01729754|471424741|FG000|Part 1|Adverse Event|2|||
130942506|NCT01729754|471424742|FG001|Part 1|Adverse Event|0|||
130942507|NCT01729754|471424743|FG002|Part 1|Adverse Event|0|||
130942508|NCT01729754|471424744|FG003|Part 1|Adverse Event|1|||
130942509|NCT01729754|471424745|FG004|Part 1|Adverse Event|0|||
130942510|NCT01729754|471424746|FG005|Part 1|Adverse Event|0|||
130942511|NCT01729754|471424747|FG006|Part 1|Adverse Event|2|||
130942512|NCT01729754|471424748|FG007|Part 1|Adverse Event|0|||
130942513|NCT01729754|471424749|FG008|Part 1|Adverse Event|0|||
130942514|NCT01729754|471424750|FG009|Part 1|Adverse Event|5|||
130942515|NCT01729754|471424741|FG000|Part 1|Lack of Efficacy|1|||
130942516|NCT01729754|471424742|FG001|Part 1|Lack of Efficacy|0|||
130942517|NCT01729754|471424743|FG002|Part 1|Lack of Efficacy|0|||
130942518|NCT01729754|471424744|FG003|Part 1|Lack of Efficacy|0|||
130942519|NCT01729754|471424745|FG004|Part 1|Lack of Efficacy|0|||
130942520|NCT01729754|471424746|FG005|Part 1|Lack of Efficacy|0|||
130942521|NCT01729754|471424747|FG006|Part 1|Lack of Efficacy|2|||
130942522|NCT01729754|471424748|FG007|Part 1|Lack of Efficacy|0|||
130942523|NCT01729754|471424749|FG008|Part 1|Lack of Efficacy|0|||
130942524|NCT01729754|471424750|FG009|Part 1|Lack of Efficacy|0|||
130942525|NCT01729754|471424741|FG000|Part 1|Lost to Follow-up|1|||
130942526|NCT01729754|471424742|FG001|Part 1|Lost to Follow-up|0|||
130942527|NCT01729754|471424743|FG002|Part 1|Lost to Follow-up|0|||
130772323|NCT05052697|470792822|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130942528|NCT01729754|471424744|FG003|Part 1|Lost to Follow-up|2|||
130942529|NCT01729754|471424745|FG004|Part 1|Lost to Follow-up|0|||
130942530|NCT01729754|471424746|FG005|Part 1|Lost to Follow-up|0|||
130942531|NCT01729754|471424747|FG006|Part 1|Lost to Follow-up|3|||
130942532|NCT01729754|471424748|FG007|Part 1|Lost to Follow-up|0|||
130772324|NCT05052697|470792823|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130942533|NCT01729754|471424749|FG008|Part 1|Lost to Follow-up|0|||
130942534|NCT01729754|471424750|FG009|Part 1|Lost to Follow-up|3|||
130942535|NCT01729754|471424741|FG000|Part 1|Non-compliance with Study Drug|1|||
130942536|NCT01729754|471424742|FG001|Part 1|Non-compliance with Study Drug|0|||
130942537|NCT01729754|471424743|FG002|Part 1|Non-compliance with Study Drug|0|||
130942538|NCT01729754|471424744|FG003|Part 1|Non-compliance with Study Drug|0|||
130942539|NCT01729754|471424745|FG004|Part 1|Non-compliance with Study Drug|0|||
130942540|NCT01729754|471424746|FG005|Part 1|Non-compliance with Study Drug|0|||
130942541|NCT01729754|471424747|FG006|Part 1|Non-compliance with Study Drug|0|||
130942542|NCT01729754|471424748|FG007|Part 1|Non-compliance with Study Drug|0|||
130942543|NCT01729754|471424749|FG008|Part 1|Non-compliance with Study Drug|0|||
130942544|NCT01729754|471424750|FG009|Part 1|Non-compliance with Study Drug|0|||
130942545|NCT01729754|471424741|FG000|Part 1|Physician Decision|0|||
130942546|NCT01729754|471424742|FG001|Part 1|Physician Decision|0|||
130942547|NCT01729754|471424743|FG002|Part 1|Physician Decision|0|||
130942548|NCT01729754|471424744|FG003|Part 1|Physician Decision|0|||
130942549|NCT01729754|471424745|FG004|Part 1|Physician Decision|0|||
130942550|NCT01729754|471424746|FG005|Part 1|Physician Decision|0|||
130942551|NCT01729754|471424747|FG006|Part 1|Physician Decision|0|||
130942552|NCT01729754|471424748|FG007|Part 1|Physician Decision|0|||
130942553|NCT01729754|471424749|FG008|Part 1|Physician Decision|0|||
130942554|NCT01729754|471424750|FG009|Part 1|Physician Decision|4|||
130942555|NCT01729754|471424741|FG000|Part 1|Pregnancy|0|||
130942556|NCT01729754|471424742|FG001|Part 1|Pregnancy|0|||
130942557|NCT01729754|471424743|FG002|Part 1|Pregnancy|0|||
131036632|NCT02268253|471768194|FG001|Stage 3A|Death|0|||
131036633|NCT02268253|471768195|FG002|Stage 3A|Death|5|||
131036634|NCT02268253|471768196|FG003|Stage 3A|Death|0|||
131036635|NCT02268253|471768197|FG004|Stage 3A|Death|0|||
130706647|NCT02124902|470551512|FG000|Overall Study|Not eligible|1|||
130706648|NCT02124902|470551513|FG001|Overall Study|Not eligible|0|||
130706649|NCT02124902|470551512|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
130706650|NCT02124902|470551513|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
130772325|NCT05052697|470792824|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772326|NCT05052697|470792825|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772327|NCT05052697|470792826|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772328|NCT05052697|470792827|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772329|NCT05052697|470792828|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772330|NCT05052697|470792829|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772331|NCT05052697|470792830|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130706651|NCT02190279|470551514|FG000|Overall Study|Withdrawal consent|1|||
130706652|NCT02190279|470551515|FG001|Overall Study|Withdrawal consent|0|||
130942558|NCT01729754|471424744|FG003|Part 1|Pregnancy|1|||
130942559|NCT01729754|471424745|FG004|Part 1|Pregnancy|0|||
131036636|NCT02268253|471768198|FG005|Stage 3A|Death|0|||
130706653|NCT02190279|470551516|FG002|Overall Study|Withdrawal consent|1|||
130706654|NCT02190279|470551514|FG000|Overall Study|Lost to Follow-up|2|||
130706655|NCT02190279|470551515|FG001|Overall Study|Lost to Follow-up|0|||
130706656|NCT02190279|470551516|FG002|Overall Study|Lost to Follow-up|0|||
130706657|NCT02190279|470551514|FG000|Overall Study|Refused further treatment|0|||
130706658|NCT02190279|470551515|FG001|Overall Study|Refused further treatment|0|||
130706659|NCT02190279|470551516|FG002|Overall Study|Refused further treatment|1|||
130706660|NCT02190279|470551514|FG000|Overall Study|Screening failure|0|||
130706661|NCT02190279|470551515|FG001|Overall Study|Screening failure|0|||
130706662|NCT02190279|470551516|FG002|Overall Study|Screening failure|1|||
130706663|NCT02938442|470551517|FG000|Overall Study|Death|0|||
130706664|NCT02938442|470551518|FG001|Overall Study|Death|1|||
130706665|NCT02938442|470551517|FG000|Overall Study|Lost to Follow-up|0|||
130706666|NCT02938442|470551518|FG001|Overall Study|Lost to Follow-up|1|||
130706667|NCT02938442|470551517|FG000|Overall Study|Physician Decision|0|||
130706668|NCT02938442|470551518|FG001|Overall Study|Physician Decision|1|||
130706669|NCT02938442|470551517|FG000|Overall Study|Withdrawal by Subject|2|||
130706670|NCT02938442|470551518|FG001|Overall Study|Withdrawal by Subject|0|||
130706671|NCT04403399|470551519|FG000|Period 2|Physician Decision|0|||
130706672|NCT04403399|470551520|FG001|Period 2|Physician Decision|1|||
130706673|NCT01606228|470551522|FG000|Overall Study|Lost to Follow-up|20|||
130706674|NCT01606228|470551522|FG000|Overall Study|Withdrawal by Subject|3|||
130706675|NCT01606228|470551522|FG000|Overall Study|Non-compliant|3|||
130706676|NCT01606228|470551522|FG000|Overall Study|Lack of Efficacy|2|||
130706677|NCT01606228|470551522|FG000|Overall Study|Adverse Event|1|||
130706678|NCT00546910|470551523|FG000|Overall Study|Adverse Event|2|||
130706679|NCT00546910|470551524|FG001|Overall Study|Adverse Event|3|||
130706680|NCT00546910|470551523|FG000|Overall Study|Lack of Efficacy|5|||
130772332|NCT05052697|470792831|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130942560|NCT01729754|471424746|FG005|Part 1|Pregnancy|0|||
130942561|NCT01729754|471424747|FG006|Part 1|Pregnancy|0|||
130942562|NCT01729754|471424748|FG007|Part 1|Pregnancy|0|||
130942563|NCT01729754|471424749|FG008|Part 1|Pregnancy|0|||
130942564|NCT01729754|471424750|FG009|Part 1|Pregnancy|1|||
130942565|NCT01729754|471424741|FG000|Part 1|Progressive Disease|0|||
131036637|NCT02268253|471768199|FG006|Stage 3A|Death|0|||
131036638|NCT05714761|471768200|FG000|Overall Study|Lost to Follow-up|3|||
130706681|NCT00546910|470551524|FG001|Overall Study|Lack of Efficacy|7|||
130706682|NCT00546910|470551523|FG000|Overall Study|Physician Decision|0|||
130706683|NCT00546910|470551524|FG001|Overall Study|Physician Decision|1|||
130706684|NCT00546910|470551523|FG000|Overall Study|Withdrawal by Subject|2|||
130706685|NCT00546910|470551524|FG001|Overall Study|Withdrawal by Subject|0|||
130706686|NCT01316419|470551530|FG000|Overall Study|Not treated|103|||
130706687|NCT01316419|470551530|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
130706688|NCT01316419|470551530|FG000|Overall Study|Lost to Follow-up|19|||
130706689|NCT02310789|470551533|FG000|Overall Study|Adverse Event|1|||
130706690|NCT01197417|470551534|FG000|Overall Study|Physician Decision|3|||
130706691|NCT01197417|470551535|FG001|Overall Study|Physician Decision|2|||
130706692|NCT01197417|470551534|FG000|Overall Study|Withdrawal by Subject|2|||
130706693|NCT01197417|470551535|FG001|Overall Study|Withdrawal by Subject|4|||
130706694|NCT01197417|470551534|FG000|Overall Study|Site miscommunication|0|||
130706695|NCT01197417|470551535|FG001|Overall Study|Site miscommunication|1|||
130706696|NCT01197417|470551534|FG000|Overall Study|Subject transferred to intensive care|0|||
130706697|NCT01197417|470551535|FG001|Overall Study|Subject transferred to intensive care|1|||
130706698|NCT01197417|470551534|FG000|Overall Study|Not consented in time to receive drug|0|||
130706699|NCT01197417|470551535|FG001|Overall Study|Not consented in time to receive drug|1|||
130706700|NCT01197417|470551534|FG000|Overall Study|Hypotension|1|||
130706701|NCT01197417|470551535|FG001|Overall Study|Hypotension|2|||
130706702|NCT01197417|470551534|FG000|Overall Study|Found to be ineligible|2|||
130706703|NCT01197417|470551535|FG001|Overall Study|Found to be ineligible|5|||
130706704|NCT01197417|470551534|FG000|Overall Study|No 25-hour magnesium level|0|||
130706705|NCT01197417|470551535|FG001|Overall Study|No 25-hour magnesium level|2|||
130706706|NCT03919448|470551536|FG000|Overall Study|Withdrawal by Subject|1|||
130706707|NCT03919448|470551537|FG001|Overall Study|Withdrawal by Subject|0|||
130706708|NCT03919448|470551538|FG002|Overall Study|Withdrawal by Subject|0|||
130706709|NCT01652729|470551539|FG000|Overall Study|Withdrawal by Subject|14|||
130706710|NCT01652729|470551540|FG001|Overall Study|Withdrawal by Subject|7|||
130706711|NCT01652729|470551541|FG002|Overall Study|Withdrawal by Subject|7|||
130706712|NCT01652729|470551539|FG000|Overall Study|Adverse Event|4|||
130706713|NCT01652729|470551540|FG001|Overall Study|Adverse Event|0|||
130706714|NCT01652729|470551541|FG002|Overall Study|Adverse Event|3|||
130706715|NCT01652729|470551539|FG000|Overall Study|Physician Decision|1|||
130706716|NCT01652729|470551540|FG001|Overall Study|Physician Decision|0|||
130706717|NCT01652729|470551541|FG002|Overall Study|Physician Decision|1|||
130706718|NCT01652729|470551539|FG000|Overall Study|Protocol Violation|1|||
130706719|NCT01652729|470551540|FG001|Overall Study|Protocol Violation|0|||
130706720|NCT01652729|470551541|FG002|Overall Study|Protocol Violation|0|||
130706721|NCT01652729|470551539|FG000|Overall Study|Lost to Follow-up|6|||
130706722|NCT01652729|470551540|FG001|Overall Study|Lost to Follow-up|6|||
130706723|NCT01652729|470551541|FG002|Overall Study|Lost to Follow-up|3|||
130706724|NCT01652729|470551539|FG000|Overall Study|Administrative|1|||
130706725|NCT01652729|470551540|FG001|Overall Study|Administrative|0|||
130706726|NCT01652729|470551541|FG002|Overall Study|Administrative|0|||
130706727|NCT04364737|470551542|FG000|Overall Study|Withdrawal by Subject|4|||
130706728|NCT04364737|470551543|FG001|Overall Study|Withdrawal by Subject|9|||
130706729|NCT04364737|470551542|FG000|Overall Study|Lost to Follow-up|1|||
130706730|NCT04364737|470551543|FG001|Overall Study|Lost to Follow-up|1|||
130706731|NCT01220609|470551544|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
130706732|NCT01220609|470551544|FG000|Overall Study|Ineligible- Wrong cell type|1|||
130706733|NCT01220609|470551544|FG000|Overall Study|Ineligible-Never treated|1|||
130706734|NCT02225665|470551545|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
130706735|NCT02225665|470551546|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
130706736|NCT02225665|470551545|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
130706737|NCT02225665|470551546|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
130706738|NCT01311557|470551547|FG000|Overall Study|Serious adverse event|0|||
130706739|NCT01311557|470551548|FG001|Overall Study|Serious adverse event|1|||
130706740|NCT01311557|470551547|FG000|Overall Study|Protocol Violation|4|||
130706741|NCT01311557|470551548|FG001|Overall Study|Protocol Violation|2|||
130706742|NCT01311557|470551547|FG000|Overall Study|Lost to Follow-up|0|||
130706743|NCT01311557|470551548|FG001|Overall Study|Lost to Follow-up|1|||
130706744|NCT01311557|470551547|FG000|Overall Study|Withdrawal by Subject|1|||
130706745|NCT01311557|470551548|FG001|Overall Study|Withdrawal by Subject|2|||
130706746|NCT01470417|470551551|FG000|Overall Study|Disease progression|0|||
131036639|NCT05714761|471768200|FG000|Overall Study|Withdrawal by Subject|3|||
130706747|NCT01470417|470551552|FG001|Overall Study|Disease progression|2|||
130706748|NCT02418455|470551553|FG000|48-Week Treatment Period|Other- Not Specified|1|||
130706749|NCT02418455|470551553|FG000|Continuation Period|Sponsor Decision|7|||
130706750|NCT00614822|470551557|FG000|Overall Study|Adverse Event|3|||
130706751|NCT01557920|470551558|FG000|Overall Study|Withdrawal by Subject|2|||
130706752|NCT01557920|470551559|FG001|Overall Study|Withdrawal by Subject|3|||
130706753|NCT01557920|470551558|FG000|Overall Study|Lack of Efficacy|1|||
130706754|NCT01557920|470551559|FG001|Overall Study|Lack of Efficacy|0|||
130706755|NCT02075606|470551562|FG000|Overall Study|Adverse Event|5|||
130706756|NCT02075606|470551562|FG000|Overall Study|Withdrawal by Subject|1|||
130706757|NCT02075606|470551562|FG000|Overall Study|Death|1|||
130706758|NCT02075606|470551562|FG000|Overall Study|Investigator's decision|1|||
130706759|NCT02075606|470551562|FG000|Overall Study|Symptom management|1|||
130706760|NCT02075606|470551562|FG000|Overall Study|Increasing Symptoms|1|||
130706761|NCT02310763|470551567|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
130706762|NCT02310763|470551568|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
130706763|NCT02310763|470551569|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
130706764|NCT02310763|470551567|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
130706765|NCT02310763|470551568|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
130706766|NCT02310763|470551569|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
130706767|NCT02310763|470551567|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
130706768|NCT02310763|470551568|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
130706769|NCT02310763|470551569|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
130706770|NCT02310763|470551567|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
130706771|NCT02310763|470551568|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
130706772|NCT02310763|470551569|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
130706773|NCT02310763|470551567|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
130706774|NCT02310763|470551568|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
130706775|NCT02310763|470551569|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
130706776|NCT00271024|470551575|FG000|Overall Study|Lost Interest|3|||
130706777|NCT00271024|470551576|FG001|Overall Study|Lost Interest|4|||
130706778|NCT00271024|470551577|FG002|Overall Study|Lost Interest|2|||
130706779|NCT00271024|470551578|FG003|Overall Study|Lost Interest|3|||
130706780|NCT00271024|470551575|FG000|Overall Study|Unknown/Unspecified|11|||
130706781|NCT00271024|470551576|FG001|Overall Study|Unknown/Unspecified|11|||
130706782|NCT00271024|470551577|FG002|Overall Study|Unknown/Unspecified|8|||
130706783|NCT00271024|470551578|FG003|Overall Study|Unknown/Unspecified|4|||
130706784|NCT00271024|470551575|FG000|Overall Study|Protocol Violation|1|||
130706785|NCT00271024|470551576|FG001|Overall Study|Protocol Violation|6|||
130706786|NCT00271024|470551577|FG002|Overall Study|Protocol Violation|5|||
130706787|NCT00271024|470551578|FG003|Overall Study|Protocol Violation|11|||
130706788|NCT00271024|470551575|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
130706789|NCT00271024|470551576|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
130706790|NCT00271024|470551577|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
130706791|NCT00271024|470551578|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
130706792|NCT00271024|470551575|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
130706793|NCT00271024|470551576|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
130706794|NCT00271024|470551577|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
130706795|NCT00271024|470551578|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
130706796|NCT01040793|470551582|FG000|Overall Study|Adverse Event|5|||
130706797|NCT01040793|470551583|FG001|Overall Study|Adverse Event|3|||
130706798|NCT01040793|470551584|FG002|Overall Study|Adverse Event|0|||
130706799|NCT01040793|470551585|FG003|Overall Study|Adverse Event|2|||
130706800|NCT01040793|470551586|FG004|Overall Study|Adverse Event|2|||
130706801|NCT01040793|470551587|FG005|Overall Study|Adverse Event|1|||
130706802|NCT01040793|470551582|FG000|Overall Study|Protocol Violation|1|||
130706803|NCT01040793|470551583|FG001|Overall Study|Protocol Violation|1|||
130706804|NCT01040793|470551584|FG002|Overall Study|Protocol Violation|1|||
130706805|NCT01040793|470551585|FG003|Overall Study|Protocol Violation|0|||
130706806|NCT01040793|470551586|FG004|Overall Study|Protocol Violation|1|||
130706807|NCT01040793|470551587|FG005|Overall Study|Protocol Violation|0|||
130706808|NCT01040793|470551582|FG000|Overall Study|Lost to Follow-up|0|||
130706809|NCT01040793|470551583|FG001|Overall Study|Lost to Follow-up|1|||
130706810|NCT01040793|470551584|FG002|Overall Study|Lost to Follow-up|1|||
130706811|NCT01040793|470551585|FG003|Overall Study|Lost to Follow-up|0|||
130706812|NCT01040793|470551586|FG004|Overall Study|Lost to Follow-up|0|||
130706813|NCT01040793|470551587|FG005|Overall Study|Lost to Follow-up|0|||
130706814|NCT01040793|470551582|FG000|Overall Study|Withdrawal by Subject|0|||
130706815|NCT01040793|470551583|FG001|Overall Study|Withdrawal by Subject|0|||
130706816|NCT01040793|470551584|FG002|Overall Study|Withdrawal by Subject|0|||
130706817|NCT01040793|470551585|FG003|Overall Study|Withdrawal by Subject|2|||
130706818|NCT01040793|470551586|FG004|Overall Study|Withdrawal by Subject|0|||
130706819|NCT01040793|470551587|FG005|Overall Study|Withdrawal by Subject|0|||
130706820|NCT01040793|470551582|FG000|Overall Study|Other reasons not listed above|0|||
130942566|NCT01729754|471424742|FG001|Part 1|Progressive Disease|0|||
130942567|NCT01729754|471424743|FG002|Part 1|Progressive Disease|0|||
130942568|NCT01729754|471424744|FG003|Part 1|Progressive Disease|0|||
130706821|NCT01040793|470551583|FG001|Overall Study|Other reasons not listed above|0|||
130706822|NCT01040793|470551584|FG002|Overall Study|Other reasons not listed above|1|||
130706823|NCT01040793|470551585|FG003|Overall Study|Other reasons not listed above|0|||
130706824|NCT01040793|470551586|FG004|Overall Study|Other reasons not listed above|1|||
130942569|NCT01729754|471424745|FG004|Part 1|Progressive Disease|0|||
130942570|NCT01729754|471424746|FG005|Part 1|Progressive Disease|0|||
130706825|NCT01040793|470551587|FG005|Overall Study|Other reasons not listed above|0|||
130706826|NCT00939627|470551590|FG000|Overall Study|Disease Progression|16|||
130706827|NCT00939627|470551591|FG001|Overall Study|Disease Progression|12|||
130706828|NCT00939627|470551592|FG002|Overall Study|Disease Progression|0|||
130706829|NCT00939627|470551590|FG000|Overall Study|Adverse Event|6|||
130706830|NCT00939627|470551591|FG001|Overall Study|Adverse Event|7|||
130706831|NCT00939627|470551592|FG002|Overall Study|Adverse Event|0|||
130706832|NCT00939627|470551590|FG000|Overall Study|Death|0|||
130706833|NCT00939627|470551591|FG001|Overall Study|Death|2|||
130706834|NCT00939627|470551592|FG002|Overall Study|Death|0|||
130706835|NCT00939627|470551590|FG000|Overall Study|Withdrawal by Subject|2|||
130706836|NCT00939627|470551591|FG001|Overall Study|Withdrawal by Subject|4|||
130706837|NCT00939627|470551592|FG002|Overall Study|Withdrawal by Subject|0|||
130706838|NCT00939627|470551590|FG000|Overall Study|Other complicating disease|1|||
130706839|NCT00939627|470551591|FG001|Overall Study|Other complicating disease|1|||
130706840|NCT00939627|470551592|FG002|Overall Study|Other complicating disease|0|||
130706841|NCT00939627|470551590|FG000|Overall Study|Not compliant|2|||
130706842|NCT00939627|470551591|FG001|Overall Study|Not compliant|0|||
130706843|NCT00939627|470551592|FG002|Overall Study|Not compliant|0|||
130706844|NCT00939627|470551590|FG000|Overall Study|No off-tx reason given|0|||
130706845|NCT00939627|470551591|FG001|Overall Study|No off-tx reason given|2|||
130706846|NCT00939627|470551592|FG002|Overall Study|No off-tx reason given|0|||
130706847|NCT00124462|470551593|FG000|Overall Study|Lost to Follow-up|3|||
130706848|NCT00124462|470551594|FG001|Overall Study|Lost to Follow-up|3|||
130706849|NCT00124462|470551593|FG000|Overall Study|Physician Decision|3|||
130706850|NCT00124462|470551594|FG001|Overall Study|Physician Decision|4|||
130706851|NCT00124462|470551593|FG000|Overall Study|Withdrawal by Subject|4|||
130706852|NCT00124462|470551594|FG001|Overall Study|Withdrawal by Subject|5|||
130706853|NCT00124462|470551593|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
130706854|NCT00124462|470551594|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
130706855|NCT02039063|470551596|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
130706856|NCT02039063|470551597|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
130706857|NCT02039063|470551598|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
130706858|NCT02039063|470551599|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
130706859|NCT02039063|470551596|FG000|Treatment Phase|Progression of disease|0|||
130706860|NCT02039063|470551597|FG001|Treatment Phase|Progression of disease|0|||
130706861|NCT02039063|470551598|FG002|Treatment Phase|Progression of disease|1|||
130706862|NCT02039063|470551599|FG003|Treatment Phase|Progression of disease|1|||
130706863|NCT02039063|470551596|FG000|Extension Phase|Inadequate therapeutic effect|0|||
131224215|NCT00555399|472447187|FG009|Overall Study|Withdrawal by Subject|0|||
131224216|NCT00555399|472447188|FG010|Overall Study|Withdrawal by Subject|0|||
131224217|NCT00555399|472447189|FG011|Overall Study|Withdrawal by Subject|1|||
131224218|NCT00555399|472447178|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
131224219|NCT00555399|472447179|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
131224220|NCT00555399|472447180|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
131224221|NCT00555399|472447181|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
131224222|NCT00555399|472447182|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
131224223|NCT00555399|472447183|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
131224224|NCT00555399|472447184|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
131224225|NCT00555399|472447185|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
131224226|NCT00555399|472447186|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
131224227|NCT00555399|472447187|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
131224228|NCT00555399|472447188|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
131224229|NCT00555399|472447189|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
131224230|NCT00343642|472448785|FG000|Overall Study|Lost to Follow-up|0|||
131224231|NCT00343642|472448786|FG001|Overall Study|Lost to Follow-up|1|||
131224232|NCT00343642|472448787|FG002|Overall Study|Lost to Follow-up|0|||
130706864|NCT02039063|470551597|FG001|Extension Phase|Inadequate therapeutic effect|1|||
130706865|NCT02039063|470551598|FG002|Extension Phase|Inadequate therapeutic effect|2|||
130706866|NCT02039063|470551599|FG003|Extension Phase|Inadequate therapeutic effect|0|||
130706867|NCT02039063|470551596|FG000|Extension Phase|Progression of disease|0|||
130706868|NCT02039063|470551597|FG001|Extension Phase|Progression of disease|0|||
130706869|NCT02039063|470551598|FG002|Extension Phase|Progression of disease|0|||
130706870|NCT02039063|470551599|FG003|Extension Phase|Progression of disease|1|||
130942571|NCT01729754|471424747|FG006|Part 1|Progressive Disease|0|||
130942572|NCT01729754|471424748|FG007|Part 1|Progressive Disease|0|||
130942573|NCT01729754|471424749|FG008|Part 1|Progressive Disease|0|||
130942574|NCT01729754|471424750|FG009|Part 1|Progressive Disease|1|||
130706871|NCT02039063|470551596|FG000|Extension Phase|Adverse Event|0|||
130706872|NCT02039063|470551597|FG001|Extension Phase|Adverse Event|0|||
130706873|NCT02039063|470551598|FG002|Extension Phase|Adverse Event|1|||
130706874|NCT02039063|470551599|FG003|Extension Phase|Adverse Event|0|||
130942575|NCT01729754|471424741|FG000|Part 1|Protocol Violation|2|||
130942576|NCT01729754|471424742|FG001|Part 1|Protocol Violation|0|||
131224233|NCT00343642|472448785|FG000|Overall Study|Pregnancy|1|||
130706875|NCT02260258|470551605|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
130706876|NCT02260258|470551606|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
130706877|NCT03314662|470551614|FG000|Overall Study|Withdrawal by Subject|1|||
131224234|NCT00343642|472448786|FG001|Overall Study|Pregnancy|0|||
131123377|NCT00885703|472081278|FG005|Overall Study|Ineligible (no CM)|3|||
131123378|NCT00885703|472081279|FG006|Overall Study|Ineligible (no CM)|1|||
131123379|NCT01183143|472081281|FG000|Overall Study|Protocol Violation|115|||
131123380|NCT01183143|472081281|FG000|Overall Study|Withdrawal by Subject|19|||
131123381|NCT01183143|472081281|FG000|Overall Study|Subject Questionnaires not returned|5|||
131123382|NCT01183143|472081281|FG000|Overall Study|Subjects enrolled, but not treated|11|||
131123383|NCT01502709|472081283|FG000|Overall Study|Lost to Follow-up|4|||
131123384|NCT01502709|472081284|FG001|Overall Study|Lost to Follow-up|0|||
131123385|NCT04096274|472081285|FG000|Phase I|Lost to Follow-up|5|||
131123386|NCT04096274|472081286|FG001|Phase I|Lost to Follow-up|5|||
131123387|NCT04096274|472081285|FG000|Phase II|Lost to Follow-up|11|||
131123388|NCT04096274|472081286|FG001|Phase II|Lost to Follow-up|11|||
131123389|NCT01490450|472081288|FG000|Period 1|Lack of Efficacy|2|||
131123390|NCT01490450|472081289|FG001|Period 1|Lack of Efficacy|0|||
131123391|NCT01490450|472081290|FG002|Period 1|Lack of Efficacy|3|||
131123392|NCT01490450|472081291|FG003|Period 1|Lack of Efficacy|0|||
131123393|NCT01490450|472081288|FG000|Period 1|Adverse Event|0|||
131123394|NCT01490450|472081289|FG001|Period 1|Adverse Event|0|||
131123395|NCT01490450|472081290|FG002|Period 1|Adverse Event|0|||
131123396|NCT01490450|472081291|FG003|Period 1|Adverse Event|5|||
131123397|NCT01490450|472081288|FG000|Period 1|Request to discontinue treatment|1|||
131123398|NCT01490450|472081289|FG001|Period 1|Request to discontinue treatment|0|||
131123399|NCT01490450|472081290|FG002|Period 1|Request to discontinue treatment|0|||
131123400|NCT01490450|472081291|FG003|Period 1|Request to discontinue treatment|0|||
131123401|NCT01490450|472081288|FG000|Period 1|Withdrawal by Subject|0|||
131123402|NCT01490450|472081289|FG001|Period 1|Withdrawal by Subject|0|||
131123403|NCT01490450|472081290|FG002|Period 1|Withdrawal by Subject|0|||
131123404|NCT01490450|472081291|FG003|Period 1|Withdrawal by Subject|3|||
131123405|NCT01490450|472081288|FG000|Period 1|No longer met study criteria|0|||
131123406|NCT01490450|472081289|FG001|Period 1|No longer met study criteria|1|||
131123407|NCT01490450|472081290|FG002|Period 1|No longer met study criteria|1|||
131123408|NCT01490450|472081291|FG003|Period 1|No longer met study criteria|0|||
131123409|NCT01490450|472081288|FG000|Period 2|Lack of Efficacy|0|||
131123410|NCT01490450|472081289|FG001|Period 2|Lack of Efficacy|0|||
131123411|NCT01490450|472081290|FG002|Period 2|Lack of Efficacy|0|||
131123412|NCT01490450|472081291|FG003|Period 2|Lack of Efficacy|1|||
131123413|NCT01490450|472081288|FG000|Period 2|Adverse Event|1|||
131123414|NCT01490450|472081289|FG001|Period 2|Adverse Event|1|||
131123415|NCT01490450|472081290|FG002|Period 2|Adverse Event|0|||
131123416|NCT01490450|472081291|FG003|Period 2|Adverse Event|1|||
131123417|NCT01490450|472081288|FG000|Period 2|Withdrawal by Subject|1|||
131123418|NCT01490450|472081289|FG001|Period 2|Withdrawal by Subject|0|||
131123419|NCT01490450|472081290|FG002|Period 2|Withdrawal by Subject|0|||
131123420|NCT01490450|472081291|FG003|Period 2|Withdrawal by Subject|0|||
131123421|NCT01490450|472081288|FG000|Period 2|Lost to Follow-up|0|||
131123422|NCT01490450|472081289|FG001|Period 2|Lost to Follow-up|0|||
131123423|NCT01490450|472081290|FG002|Period 2|Lost to Follow-up|0|||
131123424|NCT01490450|472081291|FG003|Period 2|Lost to Follow-up|2|||
131123425|NCT00636675|472081292|FG000|Overall Study|Lost to Follow-up|121|||
131224235|NCT00343642|472448787|FG002|Overall Study|Pregnancy|2|||
131224236|NCT00343642|472448785|FG000|Overall Study|Withdrawal by Subject|2|||
131224237|NCT00343642|472448786|FG001|Overall Study|Withdrawal by Subject|3|||
130706878|NCT03314662|470551615|FG001|Overall Study|Withdrawal by Subject|1|||
130706879|NCT03314662|470551616|FG002|Overall Study|Withdrawal by Subject|1|||
130706880|NCT03314662|470551614|FG000|Overall Study|Lost to Follow-up|5|||
130706881|NCT03314662|470551615|FG001|Overall Study|Lost to Follow-up|4|||
130706882|NCT03314662|470551616|FG002|Overall Study|Lost to Follow-up|4|||
130942577|NCT01729754|471424743|FG002|Part 1|Protocol Violation|0|||
130942578|NCT01729754|471424744|FG003|Part 1|Protocol Violation|1|||
130942579|NCT01729754|471424745|FG004|Part 1|Protocol Violation|0|||
131123426|NCT00636675|472081293|FG001|Overall Study|Lost to Follow-up|31|||
131123427|NCT00636675|472081292|FG000|Overall Study|Withdrawal by Subject|19|||
131123428|NCT00636675|472081293|FG001|Overall Study|Withdrawal by Subject|10|||
131123429|NCT00096785|472081296|FG000|Overall Study|Lost to Follow-up|1|||
131123430|NCT00096785|472081297|FG001|Overall Study|Lost to Follow-up|0|||
131123431|NCT00096785|472081296|FG000|Overall Study|Withdrawal by Subject|0|||
131123432|NCT00096785|472081297|FG001|Overall Study|Withdrawal by Subject|1|||
131123433|NCT00096785|472081296|FG000|Overall Study|Relocated|1|||
131123434|NCT00096785|472081297|FG001|Overall Study|Relocated|0|||
131123435|NCT02081534|472081302|FG000|Overall Study|Adverse Event|5|||
130706883|NCT03314662|470551614|FG000|Overall Study|Death|2|||
130942580|NCT01729754|471424746|FG005|Part 1|Protocol Violation|0|||
131123436|NCT02081534|472081303|FG001|Overall Study|Adverse Event|4|||
131123437|NCT02081534|472081304|FG002|Overall Study|Adverse Event|3|||
131123438|NCT02081534|472081305|FG003|Overall Study|Adverse Event|10|||
131123439|NCT02081534|472081306|FG004|Overall Study|Adverse Event|2|||
130706884|NCT03314662|470551615|FG001|Overall Study|Death|0|||
130706885|NCT03314662|470551616|FG002|Overall Study|Death|0|||
130706886|NCT00925301|470551619|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
130706887|NCT00925301|470551620|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
130706888|NCT00925301|470551621|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
130706889|NCT00925301|470551622|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
130706890|NCT00925301|470551619|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
130706891|NCT00925301|470551620|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
130706892|NCT00925301|470551621|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
130706893|NCT00925301|470551622|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
130706894|NCT00925301|470551619|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
130706895|NCT00925301|470551620|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
130706896|NCT00925301|470551621|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
130706897|NCT00925301|470551622|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
130706898|NCT00925301|470551619|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
130706899|NCT00925301|470551620|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
130706900|NCT00925301|470551621|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
130706901|NCT00925301|470551622|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
130706902|NCT00925301|470551619|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
130706903|NCT00925301|470551620|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
130706904|NCT00925301|470551621|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
130706905|NCT00925301|470551622|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
130706906|NCT00925301|470551619|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
130706907|NCT00925301|470551620|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
130706908|NCT00925301|470551621|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
130706909|NCT00925301|470551622|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
130706910|NCT00925301|470551619|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
130706911|NCT00925301|470551620|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
130706912|NCT00925301|470551621|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
130706913|NCT00925301|470551622|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
130706914|NCT01117766|470551623|FG000|First Intervention|Adverse Event|0|||
130706915|NCT01117766|470551624|FG001|First Intervention|Adverse Event|1|||
130706916|NCT01117766|470551623|FG000|First Intervention|Protocol Violation|1|||
130706917|NCT01117766|470551624|FG001|First Intervention|Protocol Violation|0|||
130706918|NCT01117766|470551623|FG000|Washout Period|Protocol Violation|0|||
130706919|NCT01117766|470551624|FG001|Washout Period|Protocol Violation|2|||
130706920|NCT01117766|470551623|FG000|Second Intervention|Lost to Follow-up|1|||
130706921|NCT01117766|470551624|FG001|Second Intervention|Lost to Follow-up|0|||
130706922|NCT01117766|470551623|FG000|Second Intervention|Other|1|||
130706923|NCT01117766|470551624|FG001|Second Intervention|Other|2|||
130706924|NCT01117766|470551623|FG000|Second Intervention|Adverse Event|0|||
130706925|NCT01117766|470551624|FG001|Second Intervention|Adverse Event|2|||
130706926|NCT01117766|470551623|FG000|Second Intervention|Withdrawal by Subject|0|||
130706927|NCT01117766|470551624|FG001|Second Intervention|Withdrawal by Subject|1|||
130706928|NCT00438659|470551625|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
130706929|NCT00438659|470551626|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
130706930|NCT00438659|470551625|FG000|Overall Study|Cancel|5|||
130706931|NCT00438659|470551626|FG001|Overall Study|Cancel|2|||
130706932|NCT01117987|470551627|FG000|Overall Study|Protocol deviation|0|||
130706933|NCT01117987|470551628|FG001|Overall Study|Protocol deviation|1|||
130706934|NCT01117987|470551627|FG000|Overall Study|Subject no longer requires study drug|1|||
130706935|NCT01117987|470551628|FG001|Overall Study|Subject no longer requires study drug|0|||
130706936|NCT01117987|470551627|FG000|Overall Study|Lost to Follow-up|1|||
130706937|NCT01117987|470551628|FG001|Overall Study|Lost to Follow-up|1|||
130706938|NCT01117987|470551627|FG000|Overall Study|Abnormal test procedure result|2|||
130706939|NCT01117987|470551628|FG001|Overall Study|Abnormal test procedure result|0|||
130706940|NCT01117987|470551627|FG000|Overall Study|Lack of Efficacy|3|||
130706941|NCT01117987|470551628|FG001|Overall Study|Lack of Efficacy|4|||
130706942|NCT01117987|470551627|FG000|Overall Study|Death|5|||
130706943|NCT01117987|470551628|FG001|Overall Study|Death|10|||
130706944|NCT01117987|470551627|FG000|Overall Study|Withdrawal by Subject|5|||
130706945|NCT01117987|470551628|FG001|Overall Study|Withdrawal by Subject|10|||
130706946|NCT01117987|470551627|FG000|Overall Study|Adverse Event|19|||
130706947|NCT01117987|470551628|FG001|Overall Study|Adverse Event|26|||
130706948|NCT01117987|470551627|FG000|Overall Study|Administrative problems|25|||
130706949|NCT01117987|470551628|FG001|Overall Study|Administrative problems|22|||
130706950|NCT00440115|470551629|FG000|Overall Study|Death|7|||
130706951|NCT00440115|470551630|FG001|Overall Study|Death|9|||
130706952|NCT00440115|470551631|FG002|Overall Study|Death|5|||
130706953|NCT00440115|470551629|FG000|Overall Study|Incarceration|0|||
130706954|NCT00440115|470551630|FG001|Overall Study|Incarceration|2|||
130706955|NCT00440115|470551631|FG002|Overall Study|Incarceration|1|||
130706956|NCT03069417|470551633|FG000|Overall Study|Lost to Follow-up|2|||
130706957|NCT03069417|470551634|FG001|Overall Study|Lost to Follow-up|0|||
130706958|NCT03069417|470551633|FG000|Overall Study|Reason Unknown|4|||
130706959|NCT03069417|470551634|FG001|Overall Study|Reason Unknown|7|||
130706960|NCT02244424|470551635|FG000|Overall Study|Lost to Follow-up|20|||
130706961|NCT02244424|470551636|FG001|Overall Study|Lost to Follow-up|10|||
130706962|NCT00206102|470551637|FG000|Overall Study|Adverse Event|119|||
130706963|NCT00206102|470551638|FG001|Overall Study|Adverse Event|82|||
130706964|NCT00206102|470551637|FG000|Overall Study|Protocol Violation|0|||
130706965|NCT00206102|470551638|FG001|Overall Study|Protocol Violation|2|||
130706966|NCT00206102|470551637|FG000|Overall Study|Lack of therapeutic response|16|||
130706967|NCT00206102|470551638|FG001|Overall Study|Lack of therapeutic response|11|||
130706968|NCT00206102|470551637|FG000|Overall Study|Lost to Follow-up|95|||
130706969|NCT00206102|470551638|FG001|Overall Study|Lost to Follow-up|66|||
130706970|NCT00206102|470551637|FG000|Overall Study|Withdrawal by Subject|118|||
130706971|NCT00206102|470551638|FG001|Overall Study|Withdrawal by Subject|101|||
130706972|NCT00206102|470551637|FG000|Overall Study|Study-specific discontinuation criteria|18|||
130706973|NCT00206102|470551638|FG001|Overall Study|Study-specific discontinuation criteria|17|||
130706974|NCT00206102|470551637|FG000|Overall Study|None of those categories|42|||
130706975|NCT00206102|470551638|FG001|Overall Study|None of those categories|36|||
130706976|NCT04117945|470551639|FG000|Overall Study|Death|1|||
130706977|NCT04117945|470551640|FG001|Overall Study|Death|0|||
130706978|NCT04117945|470551639|FG000|Overall Study|Withdrawal by Subject|3|||
130706979|NCT04117945|470551640|FG001|Overall Study|Withdrawal by Subject|1|||
130706980|NCT04117945|470551639|FG000|Overall Study|Disease Progression|0|||
130706981|NCT04117945|470551640|FG001|Overall Study|Disease Progression|2|||
130706982|NCT04117945|470551639|FG000|Overall Study|Ineligible|8|||
130706983|NCT04117945|470551640|FG001|Overall Study|Ineligible|7|||
130706984|NCT00402025|470551642|FG000|Overall Study|Adverse Event|0|||
130772333|NCT05052697|470792832|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772334|NCT05052697|470792833|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772335|NCT05052697|470792834|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772336|NCT05052697|470792835|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772337|NCT05052697|470792836|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772338|NCT05052697|470792837|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772339|NCT05052697|470792838|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772340|NCT05052697|470792839|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772341|NCT05052697|470792840|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772342|NCT05052697|470792841|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772343|NCT05052697|470792842|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772344|NCT05052697|470792843|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772345|NCT05052697|470792844|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130942581|NCT01729754|471424747|FG006|Part 1|Protocol Violation|1|||
130942582|NCT01729754|471424748|FG007|Part 1|Protocol Violation|0|||
130942583|NCT01729754|471424749|FG008|Part 1|Protocol Violation|0|||
130942584|NCT01729754|471424750|FG009|Part 1|Protocol Violation|0|||
130942585|NCT01729754|471424741|FG000|Part 1|Withdrawal by Subject|5|||
130942586|NCT01729754|471424742|FG001|Part 1|Withdrawal by Subject|0|||
130942587|NCT01729754|471424743|FG002|Part 1|Withdrawal by Subject|0|||
130942588|NCT01729754|471424744|FG003|Part 1|Withdrawal by Subject|7|||
130942589|NCT01729754|471424745|FG004|Part 1|Withdrawal by Subject|0|||
130942590|NCT01729754|471424746|FG005|Part 1|Withdrawal by Subject|0|||
130942591|NCT01729754|471424747|FG006|Part 1|Withdrawal by Subject|5|||
130942592|NCT01729754|471424748|FG007|Part 1|Withdrawal by Subject|0|||
130942593|NCT01729754|471424749|FG008|Part 1|Withdrawal by Subject|0|||
130942594|NCT01729754|471424750|FG009|Part 1|Withdrawal by Subject|6|||
130942595|NCT01729754|471424741|FG000|Part 1|Other Protocol Specified Criteria|2|||
130942596|NCT01729754|471424742|FG001|Part 1|Other Protocol Specified Criteria|0|||
130942597|NCT01729754|471424743|FG002|Part 1|Other Protocol Specified Criteria|0|||
130942598|NCT01729754|471424744|FG003|Part 1|Other Protocol Specified Criteria|0|||
130942599|NCT01729754|471424745|FG004|Part 1|Other Protocol Specified Criteria|0|||
130942600|NCT01729754|471424746|FG005|Part 1|Other Protocol Specified Criteria|0|||
130942601|NCT01729754|471424747|FG006|Part 1|Other Protocol Specified Criteria|1|||
130942602|NCT01729754|471424748|FG007|Part 1|Other Protocol Specified Criteria|0|||
130942603|NCT01729754|471424749|FG008|Part 1|Other Protocol Specified Criteria|0|||
130942604|NCT01729754|471424750|FG009|Part 1|Other Protocol Specified Criteria|4|||
130942605|NCT01729754|471424741|FG000|Part 2|Adverse Event|2|||
130942606|NCT01729754|471424742|FG001|Part 2|Adverse Event|0|||
130942607|NCT01729754|471424743|FG002|Part 2|Adverse Event|0|||
130942608|NCT01729754|471424744|FG003|Part 2|Adverse Event|0|||
130942609|NCT01729754|471424745|FG004|Part 2|Adverse Event|0|||
130942610|NCT01729754|471424746|FG005|Part 2|Adverse Event|0|||
130942611|NCT01729754|471424747|FG006|Part 2|Adverse Event|0|||
130942612|NCT01729754|471424748|FG007|Part 2|Adverse Event|0|||
130942613|NCT01729754|471424749|FG008|Part 2|Adverse Event|1|||
130942614|NCT01729754|471424750|FG009|Part 2|Adverse Event|2|||
130942615|NCT01729754|471424741|FG000|Part 2|Lack of Efficacy|0|||
130942616|NCT01729754|471424742|FG001|Part 2|Lack of Efficacy|0|||
130942617|NCT01729754|471424743|FG002|Part 2|Lack of Efficacy|0|||
130942618|NCT01729754|471424744|FG003|Part 2|Lack of Efficacy|0|||
130942619|NCT01729754|471424745|FG004|Part 2|Lack of Efficacy|0|||
131123440|NCT02081534|472081307|FG005|Overall Study|Adverse Event|8|||
131123441|NCT02081534|472081308|FG006|Overall Study|Adverse Event|2|||
131123442|NCT02081534|472081302|FG000|Overall Study|Withdrawal by Subject|0|||
131123443|NCT02081534|472081303|FG001|Overall Study|Withdrawal by Subject|1|||
131123444|NCT02081534|472081304|FG002|Overall Study|Withdrawal by Subject|1|||
131123445|NCT02081534|472081305|FG003|Overall Study|Withdrawal by Subject|1|||
131123446|NCT02081534|472081306|FG004|Overall Study|Withdrawal by Subject|1|||
131123447|NCT02081534|472081307|FG005|Overall Study|Withdrawal by Subject|0|||
131123448|NCT02081534|472081308|FG006|Overall Study|Withdrawal by Subject|1|||
131123449|NCT02081534|472081302|FG000|Overall Study|Protocol Violation|0|||
131123450|NCT02081534|472081303|FG001|Overall Study|Protocol Violation|3|||
130706985|NCT00402025|470551643|FG001|Overall Study|Adverse Event|0|||
130706986|NCT00402025|470551644|FG002|Overall Study|Adverse Event|2|||
130706987|NCT00402025|470551642|FG000|Overall Study|Death|0|||
130706988|NCT00402025|470551643|FG001|Overall Study|Death|1|||
130706989|NCT00402025|470551644|FG002|Overall Study|Death|5|||
130706990|NCT00402025|470551642|FG000|Overall Study|Disease Progression|1|||
130706991|NCT00402025|470551643|FG001|Overall Study|Disease Progression|1|||
130706992|NCT00402025|470551644|FG002|Overall Study|Disease Progression|2|||
130706993|NCT00402025|470551642|FG000|Overall Study|Physician Decision|1|||
130706994|NCT00402025|470551643|FG001|Overall Study|Physician Decision|1|||
130706995|NCT00402025|470551644|FG002|Overall Study|Physician Decision|0|||
130706996|NCT00402025|470551642|FG000|Overall Study|Participant Decision|0|||
130706997|NCT00402025|470551643|FG001|Overall Study|Participant Decision|0|||
130706998|NCT00402025|470551644|FG002|Overall Study|Participant Decision|1|||
130706999|NCT01917968|470551645|FG000|Overall Study|Death|3|||
130707000|NCT01917968|470551646|FG001|Overall Study|Death|2|||
130707001|NCT01917968|470551645|FG000|Overall Study|Lost to Follow-up|21|||
130707002|NCT01917968|470551646|FG001|Overall Study|Lost to Follow-up|39|||
130707003|NCT01917968|470551645|FG000|Overall Study|Physician Decision|1|||
130707004|NCT01917968|470551646|FG001|Overall Study|Physician Decision|2|||
130707005|NCT01917968|470551645|FG000|Overall Study|Withdrawal by Subject|20|||
130707006|NCT01917968|470551646|FG001|Overall Study|Withdrawal by Subject|35|||
130707007|NCT01917968|470551645|FG000|Overall Study|Subject Relocation|5|||
130707008|NCT01917968|470551646|FG001|Overall Study|Subject Relocation|1|||
130707009|NCT01917968|470551645|FG000|Overall Study|36M Missed Visit|3|||
130707010|NCT01917968|470551646|FG001|Overall Study|36M Missed Visit|2|||
130707011|NCT01917968|470551645|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
130707012|NCT01917968|470551646|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
130707013|NCT01917968|470551645|FG000|Overall Study|Change in Family Circumstances|0|||
130707014|NCT01917968|470551646|FG001|Overall Study|Change in Family Circumstances|1|||
130707015|NCT01917968|470551645|FG000|Overall Study|No Data Available|0|||
130707016|NCT01917968|470551646|FG001|Overall Study|No Data Available|2|||
130707017|NCT01507090|470551649|FG000|Overall Study|incomplete dataset|18|||
130707018|NCT04678817|470553223|FG000|Overall Study|Lost to Follow-up|28|||
130707019|NCT04678817|470553224|FG001|Overall Study|Lost to Follow-up|0|||
130707020|NCT04678817|470553225|FG002|Overall Study|Lost to Follow-up|0|||
130707021|NCT03064438|470553228|FG000|Overall Study|Lost to Follow-up|1|||
130707022|NCT03064438|470553229|FG001|Overall Study|Lost to Follow-up|0|||
130707023|NCT03064438|470553228|FG000|Overall Study|Withdrawal by Subject|0|||
130707024|NCT03064438|470553229|FG001|Overall Study|Withdrawal by Subject|1|||
130707025|NCT01937351|470553230|FG000|Overall Study|Withdrawal by Subject|4|||
130707026|NCT01937351|470553231|FG001|Overall Study|Withdrawal by Subject|2|||
130707027|NCT01937351|470553230|FG000|Overall Study|Death|1|||
130707028|NCT01937351|470553231|FG001|Overall Study|Death|0|||
130707029|NCT01937351|470553230|FG000|Overall Study|Not treated w device, per protocol fail|4|||
130707030|NCT01937351|470553231|FG001|Overall Study|Not treated w device, per protocol fail|0|||
130707031|NCT01961687|470553232|FG000|Overall Study|Lost to Follow-up|19|||
130707032|NCT01961687|470553232|FG000|Overall Study|Re-operation|17|||
130707033|NCT01961687|470553232|FG000|Overall Study|Death|7|||
130707034|NCT01961687|470553232|FG000|Overall Study|Withdrawal by Subject|6|||
130707035|NCT01961687|470553232|FG000|Overall Study|Adverse Event|6|||
130707036|NCT01961687|470553232|FG000|Overall Study|Moved to area without study site|2|||
130707037|NCT01961687|470553232|FG000|Overall Study|Sponsor decision|2|||
130707038|NCT01961687|470553232|FG000|Overall Study|Physician Decision|1|||
131123451|NCT02081534|472081304|FG002|Overall Study|Protocol Violation|0|||
131123452|NCT02081534|472081305|FG003|Overall Study|Protocol Violation|0|||
131123453|NCT02081534|472081306|FG004|Overall Study|Protocol Violation|0|||
131123454|NCT02081534|472081307|FG005|Overall Study|Protocol Violation|0|||
130707039|NCT01961687|470553232|FG000|Overall Study|Unable to meet follow-up requirements|1|||
130707040|NCT01467479|470553233|FG000|Overall Study|No Study Medication|1|||
130707041|NCT01467479|470553234|FG001|Overall Study|No Study Medication|0|||
130707042|NCT01467479|470553235|FG002|Overall Study|No Study Medication|2|||
130707043|NCT01467479|470553233|FG000|Overall Study|Adverse Event|1|||
130707044|NCT01467479|470553234|FG001|Overall Study|Adverse Event|2|||
130707045|NCT01467479|470553235|FG002|Overall Study|Adverse Event|0|||
130707046|NCT01467479|470553233|FG000|Overall Study|Death|0|||
131123455|NCT02081534|472081308|FG006|Overall Study|Protocol Violation|1|||
131123456|NCT02081534|472081302|FG000|Overall Study|Lost to Follow-up|0|||
130707047|NCT01467479|470553234|FG001|Overall Study|Death|0|||
130707048|NCT01467479|470553235|FG002|Overall Study|Death|1|||
130707049|NCT01467479|470553233|FG000|Overall Study|Lost to Follow-up|2|||
130707050|NCT01467479|470553234|FG001|Overall Study|Lost to Follow-up|5|||
130707051|NCT01467479|470553235|FG002|Overall Study|Lost to Follow-up|3|||
130707052|NCT01467479|470553233|FG000|Overall Study|Withdrawal of Consent|3|||
130707053|NCT01467479|470553234|FG001|Overall Study|Withdrawal of Consent|7|||
130707054|NCT01467479|470553235|FG002|Overall Study|Withdrawal of Consent|7|||
130707055|NCT01467479|470553233|FG000|Overall Study|Study Terminated by Sponsor|1|||
130707056|NCT01467479|470553234|FG001|Overall Study|Study Terminated by Sponsor|3|||
130707057|NCT01467479|470553235|FG002|Overall Study|Study Terminated by Sponsor|3|||
130707058|NCT01467479|470553233|FG000|Overall Study|Other|1|||
130707059|NCT01467479|470553234|FG001|Overall Study|Other|0|||
130707060|NCT01467479|470553235|FG002|Overall Study|Other|0|||
130707061|NCT01915940|470553247|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
130707062|NCT01915940|470553248|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
130707063|NCT01915940|470553249|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
130707064|NCT01915940|470553247|FG000|Treatment Period|Decision of Participant|0|||
130707065|NCT01915940|470553248|FG001|Treatment Period|Decision of Participant|1|||
130707066|NCT01915940|470553249|FG002|Treatment Period|Decision of Participant|3|||
130707067|NCT01915940|470553247|FG000|Treatment Period|Adverse Event|0|||
130707068|NCT01915940|470553248|FG001|Treatment Period|Adverse Event|9|||
130707069|NCT01915940|470553249|FG002|Treatment Period|Adverse Event|1|||
130707070|NCT01915940|470553247|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
130707071|NCT01915940|470553248|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
130707072|NCT01915940|470553249|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
130707073|NCT02999984|470553250|FG000|Overall Study|Treatment Failure|1|||
130707074|NCT04086641|470553251|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
130707075|NCT04086641|470553252|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
130707076|NCT01042535|470553253|FG000|Overall Study|disease progression prior to treatment|3|||
130707077|NCT01042535|470553253|FG000|Overall Study|disease progression during treatment|3|||
130707078|NCT01042535|470553253|FG000|Overall Study|complications from other disease|2|||
130707079|NCT03438539|470553262|FG000|Overall Study|Lost to Follow-up|8|||
130707080|NCT03438539|470553263|FG001|Overall Study|Lost to Follow-up|4|||
130707081|NCT03438539|470553264|FG002|Overall Study|Lost to Follow-up|10|||
130707082|NCT03438539|470553265|FG003|Overall Study|Lost to Follow-up|9|||
130707083|NCT03438539|470553266|FG004|Overall Study|Lost to Follow-up|3|||
130707084|NCT03438539|470553267|FG005|Overall Study|Lost to Follow-up|8|||
130707085|NCT04213209|470553268|FG000|Overall Study|Protocol Violation|1|||
130707086|NCT04213209|470553269|FG001|Overall Study|Protocol Violation|0|||
130707087|NCT04213209|470553270|FG002|Overall Study|Protocol Violation|0|||
130707088|NCT04213209|470553271|FG003|Overall Study|Protocol Violation|0|||
130707089|NCT04213209|470553272|FG004|Overall Study|Protocol Violation|0|||
130707090|NCT04213209|470553273|FG005|Overall Study|Protocol Violation|0|||
130707091|NCT00743509|470553274|FG000|Overall Study|Withdrawal by Subject|2|||
130707092|NCT02065713|470553280|FG000|Overall Study|Adverse Event|0|||
130707093|NCT02065713|470553281|FG001|Overall Study|Adverse Event|1|||
130707094|NCT02065713|470553280|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130707095|NCT02065713|470553281|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130707096|NCT00418522|470553284|FG000|Overall Study|Adverse Event|7|||
130707097|NCT00418522|470553285|FG001|Overall Study|Adverse Event|1|||
130707098|NCT00418522|470553284|FG000|Overall Study|Lack of Efficacy|1|||
130707099|NCT00418522|470553285|FG001|Overall Study|Lack of Efficacy|3|||
130707100|NCT00418522|470553284|FG000|Overall Study|Lost to Follow-up|10|||
130707101|NCT00418522|470553285|FG001|Overall Study|Lost to Follow-up|4|||
130707102|NCT00418522|470553284|FG000|Overall Study|Withdrawal by Subject|31|||
130707103|NCT00418522|470553285|FG001|Overall Study|Withdrawal by Subject|7|||
130707104|NCT00418522|470553284|FG000|Overall Study|Other|27|||
130707105|NCT00418522|470553285|FG001|Overall Study|Other|23|||
130707106|NCT00418522|470553284|FG000|Overall Study|Randomized but did not receive treatment|7|||
131123457|NCT02081534|472081303|FG001|Overall Study|Lost to Follow-up|0|||
131123458|NCT02081534|472081304|FG002|Overall Study|Lost to Follow-up|0|||
131123459|NCT02081534|472081305|FG003|Overall Study|Lost to Follow-up|2|||
130707107|NCT00418522|470553285|FG001|Overall Study|Randomized but did not receive treatment|4|||
131123460|NCT02081534|472081306|FG004|Overall Study|Lost to Follow-up|1|||
131123461|NCT02081534|472081307|FG005|Overall Study|Lost to Follow-up|1|||
130707108|NCT02695719|470553286|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
130707109|NCT02695719|470553287|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
130707110|NCT02695719|470553286|FG000|Overall Study|Significant Protocol Deviation|0|||
130707111|NCT02695719|470553287|FG001|Overall Study|Significant Protocol Deviation|1|||
130707112|NCT02695719|470553286|FG000|Overall Study|Voluntary Withdrawal|1|||
130707113|NCT02695719|470553287|FG001|Overall Study|Voluntary Withdrawal|0|||
130707114|NCT00483548|470553288|FG000|Overall Study|Randomized; not treated with study drug|1|||
130707115|NCT00483548|470553289|FG001|Overall Study|Randomized; not treated with study drug|3|||
130707116|NCT00483548|470553288|FG000|Overall Study|Adverse Event|25|||
131123462|NCT02081534|472081308|FG006|Overall Study|Lost to Follow-up|0|||
130707117|NCT00483548|470553289|FG001|Overall Study|Adverse Event|14|||
130707118|NCT00483548|470553288|FG000|Overall Study|Laboratory abnormality|1|||
130707119|NCT00483548|470553289|FG001|Overall Study|Laboratory abnormality|2|||
130707120|NCT00483548|470553288|FG000|Overall Study|Lack of Efficacy|4|||
130707121|NCT00483548|470553289|FG001|Overall Study|Lack of Efficacy|8|||
130707122|NCT00483548|470553288|FG000|Overall Study|Protocol Violation|11|||
130707123|NCT00483548|470553289|FG001|Overall Study|Protocol Violation|7|||
130707124|NCT00483548|470553288|FG000|Overall Study|Pregnancy|1|||
130707125|NCT00483548|470553289|FG001|Overall Study|Pregnancy|0|||
130707126|NCT00483548|470553288|FG000|Overall Study|Protocol required discontinuation|6|||
130707127|NCT00483548|470553289|FG001|Overall Study|Protocol required discontinuation|6|||
130707128|NCT00483548|470553288|FG000|Overall Study|Unable to comply with protocol schedule|1|||
130707129|NCT00483548|470553289|FG001|Overall Study|Unable to comply with protocol schedule|0|||
130707130|NCT00483548|470553288|FG000|Overall Study|Non-compliance with medication|2|||
130707131|NCT00483548|470553289|FG001|Overall Study|Non-compliance with medication|0|||
130707132|NCT00483548|470553288|FG000|Overall Study|Lost to Follow-up|3|||
130707133|NCT00483548|470553289|FG001|Overall Study|Lost to Follow-up|4|||
130707134|NCT00483548|470553288|FG000|Overall Study|Withdrawal by Subject|5|||
130707135|NCT00483548|470553289|FG001|Overall Study|Withdrawal by Subject|2|||
130707136|NCT00126126|470553290|FG000|Overall Study|Lost to Follow-up|0|||
130707137|NCT00126126|470553291|FG001|Overall Study|Lost to Follow-up|2|||
130707138|NCT02694549|470553292|FG000|Overall Study|screen failures|2|||
130707139|NCT01534078|470553293|FG000|Overall Study|Death|1|||
130707140|NCT01534078|470553293|FG000|Overall Study|Withdrawal by Subject|1|||
130707141|NCT02459665|470553294|FG000|Overall Study|Withdrawal by Subject|0|||
130707142|NCT02459665|470553295|FG001|Overall Study|Withdrawal by Subject|1|||
130707143|NCT02459665|470553296|FG002|Overall Study|Withdrawal by Subject|1|||
130707144|NCT02459665|470553297|FG003|Overall Study|Withdrawal by Subject|2|||
130707145|NCT01223235|470553298|FG000|Overall Study|Withdrawal by Subject|1|||
130707146|NCT00868296|470553303|FG000|Overall Study|Adverse Event|0|||
130707147|NCT00868296|470553304|FG001|Overall Study|Adverse Event|2|||
130707148|NCT00868296|470553303|FG000|Overall Study|Withdrawal by Subject|0|||
130707149|NCT00868296|470553304|FG001|Overall Study|Withdrawal by Subject|1|||
130707150|NCT00573170|470553309|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
130707151|NCT00573170|470553310|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
130707152|NCT00573170|470553311|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
130707153|NCT00573170|470553312|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
130707154|NCT00573170|470553313|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
130707155|NCT00573170|470553314|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
130707156|NCT00573170|470553309|FG000|First Washout Period|Adverse Event|1|||
130707157|NCT00573170|470553310|FG001|First Washout Period|Adverse Event|1|||
130707158|NCT00573170|470553311|FG002|First Washout Period|Adverse Event|0|||
130707159|NCT00573170|470553312|FG003|First Washout Period|Adverse Event|0|||
130707160|NCT00573170|470553313|FG004|First Washout Period|Adverse Event|0|||
130707161|NCT00573170|470553314|FG005|First Washout Period|Adverse Event|1|||
130707162|NCT00573170|470553309|FG000|First Washout Period|Lack of Efficacy|0|||
130707163|NCT00573170|470553310|FG001|First Washout Period|Lack of Efficacy|0|||
131123463|NCT02234479|472081309|FG000|Overall Study|Withdrawal by Subject|1|||
130707164|NCT00573170|470553311|FG002|First Washout Period|Lack of Efficacy|0|||
130707165|NCT00573170|470553312|FG003|First Washout Period|Lack of Efficacy|0|||
130707166|NCT00573170|470553313|FG004|First Washout Period|Lack of Efficacy|0|||
130707167|NCT00573170|470553314|FG005|First Washout Period|Lack of Efficacy|1|||
130707168|NCT00573170|470553309|FG000|First Washout Period|Lost to Follow-up|1|||
130707169|NCT00573170|470553310|FG001|First Washout Period|Lost to Follow-up|1|||
130707170|NCT00573170|470553311|FG002|First Washout Period|Lost to Follow-up|0|||
130707171|NCT00573170|470553312|FG003|First Washout Period|Lost to Follow-up|2|||
130707172|NCT00573170|470553313|FG004|First Washout Period|Lost to Follow-up|0|||
130707173|NCT00573170|470553314|FG005|First Washout Period|Lost to Follow-up|2|||
130707174|NCT00573170|470553309|FG000|First Washout Period|Withdrawal by Subject|2|||
130707175|NCT00573170|470553310|FG001|First Washout Period|Withdrawal by Subject|0|||
130707176|NCT00573170|470553311|FG002|First Washout Period|Withdrawal by Subject|0|||
131123464|NCT02234479|472081310|FG001|Overall Study|Withdrawal by Subject|3|||
131123465|NCT02318667|472081311|FG000|Overall Study|Adverse Event|1|||
130707177|NCT00573170|470553312|FG003|First Washout Period|Withdrawal by Subject|2|||
130707178|NCT00573170|470553313|FG004|First Washout Period|Withdrawal by Subject|3|||
130707179|NCT00573170|470553314|FG005|First Washout Period|Withdrawal by Subject|3|||
130707180|NCT00573170|470553309|FG000|First Washout Period|Other|4|||
130707181|NCT00573170|470553310|FG001|First Washout Period|Other|0|||
130707182|NCT00573170|470553311|FG002|First Washout Period|Other|1|||
130707183|NCT00573170|470553312|FG003|First Washout Period|Other|1|||
130707184|NCT00573170|470553313|FG004|First Washout Period|Other|0|||
130707185|NCT00573170|470553314|FG005|First Washout Period|Other|0|||
130707186|NCT00573170|470553309|FG000|Second Washout Period|Adverse Event|1|||
130707187|NCT00573170|470553310|FG001|Second Washout Period|Adverse Event|0|||
130707188|NCT00573170|470553311|FG002|Second Washout Period|Adverse Event|0|||
131123466|NCT02318667|472081311|FG000|Overall Study|Lack of Efficacy|6|||
130707189|NCT00573170|470553312|FG003|Second Washout Period|Adverse Event|0|||
130707190|NCT00573170|470553313|FG004|Second Washout Period|Adverse Event|1|||
130707191|NCT00573170|470553314|FG005|Second Washout Period|Adverse Event|0|||
130707192|NCT00573170|470553309|FG000|Second Washout Period|Protocol Violation|2|||
130707193|NCT00573170|470553310|FG001|Second Washout Period|Protocol Violation|1|||
130707194|NCT00573170|470553311|FG002|Second Washout Period|Protocol Violation|1|||
130707195|NCT00573170|470553312|FG003|Second Washout Period|Protocol Violation|0|||
130707196|NCT00573170|470553313|FG004|Second Washout Period|Protocol Violation|0|||
130707197|NCT00573170|470553314|FG005|Second Washout Period|Protocol Violation|0|||
130707198|NCT00573170|470553309|FG000|Second Washout Period|Withdrawal by Subject|1|||
130707199|NCT00573170|470553310|FG001|Second Washout Period|Withdrawal by Subject|1|||
130707200|NCT00573170|470553311|FG002|Second Washout Period|Withdrawal by Subject|2|||
130707201|NCT00573170|470553312|FG003|Second Washout Period|Withdrawal by Subject|0|||
130707202|NCT00573170|470553313|FG004|Second Washout Period|Withdrawal by Subject|1|||
130707203|NCT00573170|470553314|FG005|Second Washout Period|Withdrawal by Subject|0|||
130707204|NCT00573170|470553309|FG000|Second Washout Period|Lost to Follow-up|0|||
130707205|NCT00573170|470553310|FG001|Second Washout Period|Lost to Follow-up|0|||
130707206|NCT00573170|470553311|FG002|Second Washout Period|Lost to Follow-up|0|||
130707207|NCT00573170|470553312|FG003|Second Washout Period|Lost to Follow-up|1|||
130707208|NCT00573170|470553313|FG004|Second Washout Period|Lost to Follow-up|0|||
130707209|NCT00573170|470553314|FG005|Second Washout Period|Lost to Follow-up|0|||
130707210|NCT00573170|470553309|FG000|Second Washout Period|Other|1|||
130707211|NCT00573170|470553310|FG001|Second Washout Period|Other|2|||
130707212|NCT00573170|470553311|FG002|Second Washout Period|Other|1|||
130707213|NCT00573170|470553312|FG003|Second Washout Period|Other|4|||
130707214|NCT00573170|470553313|FG004|Second Washout Period|Other|6|||
130707215|NCT00573170|470553314|FG005|Second Washout Period|Other|2|||
130707216|NCT00573170|470553309|FG000|Third Treatment Period|Withdrawal by Subject|1|||
130707217|NCT00573170|470553310|FG001|Third Treatment Period|Withdrawal by Subject|0|||
130707218|NCT00573170|470553311|FG002|Third Treatment Period|Withdrawal by Subject|0|||
130707219|NCT00573170|470553312|FG003|Third Treatment Period|Withdrawal by Subject|0|||
130707220|NCT00573170|470553313|FG004|Third Treatment Period|Withdrawal by Subject|0|||
130707221|NCT00573170|470553314|FG005|Third Treatment Period|Withdrawal by Subject|0|||
130707222|NCT00573170|470553309|FG000|Third Treatment Period|Lost to Follow-up|0|||
130707223|NCT00573170|470553310|FG001|Third Treatment Period|Lost to Follow-up|0|||
130707224|NCT00573170|470553311|FG002|Third Treatment Period|Lost to Follow-up|0|||
130707225|NCT00573170|470553312|FG003|Third Treatment Period|Lost to Follow-up|0|||
130707226|NCT00573170|470553313|FG004|Third Treatment Period|Lost to Follow-up|0|||
130707227|NCT00573170|470553314|FG005|Third Treatment Period|Lost to Follow-up|2|||
130707228|NCT00986570|470553315|FG000|Overall Study|Lost to Follow-up|6|||
130707229|NCT00986570|470553315|FG000|Overall Study|Potential bias for objective assessment|1|||
130707230|NCT00493454|470553317|FG000|Overall Study|Withdrawal by Subject|1|||
130707231|NCT00103038|470553318|FG000|Overall Study|Withdrawal by Subject|8|||
130707232|NCT00103038|470553318|FG000|Overall Study|Screen failure|3|||
130707233|NCT00103038|470553318|FG000|Overall Study|Death|1|||
130707234|NCT00103038|470553318|FG000|Overall Study|Physician Decision|1|||
130707235|NCT03649412|470553325|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
130707236|NCT03649412|470553326|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
130707237|NCT03649412|470553325|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
130707238|NCT03649412|470553326|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
130707239|NCT03649412|470553325|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
130707240|NCT03649412|470553326|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130707241|NCT03649412|470553325|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
130707242|NCT03649412|470553326|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
131123467|NCT02318667|472081311|FG000|Overall Study|Protocol Violation|2|||
131123468|NCT01033734|472081312|FG000|Overall Study|Withdrawal by Subject|1|||
131123469|NCT00003535|472081313|FG000|Overall Study|Not evaluable|5|||
130707243|NCT03649412|470553325|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
130707244|NCT03649412|470553326|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
131123470|NCT02113436|472081315|FG000|Period 1: 8 Weeks|Adverse Event|1|||
131123471|NCT02113436|472081316|FG001|Period 1: 8 Weeks|Adverse Event|0|||
131123472|NCT02113436|472081317|FG002|Period 1: 8 Weeks|Adverse Event|0|||
131123473|NCT02113436|472081318|FG003|Period 1: 8 Weeks|Adverse Event|0|||
130707245|NCT03649412|470553325|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
130707246|NCT03649412|470553326|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
130707247|NCT02865395|470553327|FG000|Overall Study|Physician Decision|6|||
130707248|NCT02865395|470553328|FG001|Overall Study|Physician Decision|10|||
130707249|NCT02865395|470553329|FG002|Overall Study|Physician Decision|7|||
130707250|NCT01439724|470553330|FG000|Overall Study|missing consultation|9|||
130707251|NCT01439724|470553331|FG001|Overall Study|missing consultation|8|||
130707252|NCT04019054|470553333|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
130707253|NCT04019054|470553334|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
131123474|NCT02113436|472081315|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
130707254|NCT04019054|470553333|FG000|Overall Study|Withdrawal by Subject|3|||
130707255|NCT04019054|470553334|FG001|Overall Study|Withdrawal by Subject|1|||
130707256|NCT01731886|470553335|FG000|Overall Study|Death|1|||
130707257|NCT01731886|470553336|FG001|Overall Study|Death|0|||
130707258|NCT01731886|470553335|FG000|Overall Study|Never started treatment|0|||
130707259|NCT01731886|470553336|FG001|Overall Study|Never started treatment|1|||
130707260|NCT01731886|470553335|FG000|Overall Study|Non-compliant|1|||
130707261|NCT01731886|470553336|FG001|Overall Study|Non-compliant|0|||
130707262|NCT03877926|470553342|FG000|Overall Study|Adverse Event|1|||
130707263|NCT03877926|470553343|FG001|Overall Study|Adverse Event|0|||
130707264|NCT03877926|470553344|FG002|Overall Study|Adverse Event|0|||
131036640|NCT05714761|471768200|FG000|Overall Study|unblinding of sensor data|1|||
131036641|NCT05714761|471768200|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
131036642|NCT05714761|471768200|FG000|Overall Study|did not return second CGM sensor|4|||
131036643|NCT05672069|471768201|FG000|Overall Study|Implant removal|1|||
131036644|NCT05672069|471768201|FG000|Overall Study|Lost to Follow-up|2|||
131036645|NCT05949788|471768202|FG000|Overall Study|severe birth deformity|2|||
131036646|NCT05949788|471768203|FG001|Overall Study|severe birth deformity|7|||
130707265|NCT03877926|470553345|FG003|Overall Study|Adverse Event|0|||
130707266|NCT03877926|470553342|FG000|Overall Study|Death|2|||
130707267|NCT03877926|470553343|FG001|Overall Study|Death|2|||
130707268|NCT03877926|470553344|FG002|Overall Study|Death|2|||
130707269|NCT03877926|470553345|FG003|Overall Study|Death|0|||
130707270|NCT03877926|470553342|FG000|Overall Study|Lost to Follow-up|41|||
130707271|NCT03877926|470553343|FG001|Overall Study|Lost to Follow-up|52|||
130707272|NCT03877926|470553344|FG002|Overall Study|Lost to Follow-up|45|||
130707273|NCT03877926|470553345|FG003|Overall Study|Lost to Follow-up|17|||
130707274|NCT03877926|470553342|FG000|Overall Study|Physician Decision|2|||
130707275|NCT03877926|470553343|FG001|Overall Study|Physician Decision|0|||
130707276|NCT03877926|470553344|FG002|Overall Study|Physician Decision|2|||
130707277|NCT03877926|470553345|FG003|Overall Study|Physician Decision|0|||
130707278|NCT03877926|470553342|FG000|Overall Study|Withdrawal by Subject|18|||
130707279|NCT03877926|470553343|FG001|Overall Study|Withdrawal by Subject|21|||
130707280|NCT03877926|470553344|FG002|Overall Study|Withdrawal by Subject|12|||
130707281|NCT03877926|470553345|FG003|Overall Study|Withdrawal by Subject|4|||
130707282|NCT03877926|470553342|FG000|Overall Study|Other - Various|4|||
130707283|NCT03877926|470553343|FG001|Overall Study|Other - Various|1|||
130707284|NCT03877926|470553344|FG002|Overall Study|Other - Various|1|||
130707285|NCT03877926|470553345|FG003|Overall Study|Other - Various|0|||
130707286|NCT03877926|470553342|FG000|Overall Study|Not Treated|3|||
130707287|NCT03877926|470553343|FG001|Overall Study|Not Treated|1|||
130707288|NCT03877926|470553344|FG002|Overall Study|Not Treated|1|||
130707289|NCT03877926|470553345|FG003|Overall Study|Not Treated|0|||
130707290|NCT00467831|470553349|FG000|Overall Study|Death|2|||
130707291|NCT00467831|470553349|FG000|Overall Study|Withdrawal by Subject|1|||
130707292|NCT00860743|470553352|FG000|Overall Study|Withdrawal by Subject|3|||
130707293|NCT00860743|470553353|FG001|Overall Study|Withdrawal by Subject|0|||
130707294|NCT02776553|470553357|FG000|Overall Study|Lost to Follow-up|1|||
130707295|NCT02776553|470553358|FG001|Overall Study|Lost to Follow-up|0|||
130707296|NCT02776553|470553357|FG000|Overall Study|got liver transplant|1|||
130707297|NCT02776553|470553358|FG001|Overall Study|got liver transplant|2|||
130707298|NCT02776553|470553357|FG000|Overall Study|had other surgery|1|||
130707299|NCT02776553|470553358|FG001|Overall Study|had other surgery|0|||
130707300|NCT02776553|470553357|FG000|Overall Study|Protocol Violation|0|||
130707301|NCT02776553|470553358|FG001|Overall Study|Protocol Violation|1|||
130707302|NCT00171340|470553360|FG000|Overall Study|Adverse Event|46|||
130707303|NCT00171340|470553361|FG001|Overall Study|Adverse Event|42|||
130707304|NCT00171340|470553360|FG000|Overall Study|Lack of Efficacy|29|||
130707305|NCT00171340|470553361|FG001|Overall Study|Lack of Efficacy|41|||
130707306|NCT00171340|470553360|FG000|Overall Study|Protocol Violation|7|||
130707307|NCT00171340|470553361|FG001|Overall Study|Protocol Violation|8|||
130707308|NCT00171340|470553360|FG000|Overall Study|Withdrawal by Subject|22|||
130772346|NCT05052697|470792845|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130707309|NCT00171340|470553361|FG001|Overall Study|Withdrawal by Subject|19|||
130707310|NCT00171340|470553360|FG000|Overall Study|Lost to Follow-up|0|||
130707311|NCT00171340|470553361|FG001|Overall Study|Lost to Follow-up|5|||
130707312|NCT00171340|470553360|FG000|Overall Study|Abnormal Laboratory Results|2|||
130707313|NCT00171340|470553361|FG001|Overall Study|Abnormal Laboratory Results|0|||
130707314|NCT00171340|470553360|FG000|Overall Study|Abnormal Test Procedure Results|6|||
130707315|NCT00171340|470553361|FG001|Overall Study|Abnormal Test Procedure Results|11|||
130707316|NCT00171340|470553360|FG000|Overall Study|No Longer Required Study Drug|1|||
130707317|NCT00171340|470553361|FG001|Overall Study|No Longer Required Study Drug|1|||
130707318|NCT00171340|470553360|FG000|Overall Study|Administrative Problems|5|||
130707319|NCT00171340|470553361|FG001|Overall Study|Administrative Problems|2|||
130707320|NCT00171340|470553360|FG000|Overall Study|Death|6|||
130707321|NCT00171340|470553361|FG001|Overall Study|Death|6|||
130707322|NCT01056640|470553362|FG000|Overall Study|Withdrawal by Subject|11|||
130707323|NCT01056640|470553363|FG001|Overall Study|Withdrawal by Subject|8|||
131036647|NCT05949788|471768202|FG000|Overall Study|twin-twin transfusion syndrome|2|||
130707324|NCT01056640|470553362|FG000|Overall Study|Death|15|||
130707325|NCT01056640|470553363|FG001|Overall Study|Death|4|||
130707326|NCT03648879|470553364|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
130707327|NCT03812991|470553365|FG000|Overall Study|Lost to Follow-up|3|||
130707328|NCT03812991|470553366|FG001|Overall Study|Lost to Follow-up|1|||
130707329|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
130707330|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
130707331|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
130707332|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
130707333|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
130707334|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
130707335|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
130707336|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
130707337|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
130707338|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
130707339|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
130707340|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
130707341|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
130707342|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
130707343|NCT04740931|470553367|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
130707344|NCT04740931|470553368|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
130707345|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
130707346|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
130707347|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
130707348|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
130707349|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
130707350|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
130707351|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
130707352|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
130707353|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
130707354|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
130707355|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
130707356|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
130707357|NCT04740931|470553367|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
130707358|NCT04740931|470553368|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
130707359|NCT00895037|470553371|FG000|Overall Study|Death|0|||
130707360|NCT00895037|470553372|FG001|Overall Study|Death|2|||
130707361|NCT00895037|470553373|FG002|Overall Study|Death|1|||
130707362|NCT00104247|470553389|FG000|Overall Study|Withdrawal by Subject|1|||
130707363|NCT00104247|470553390|FG001|Overall Study|Withdrawal by Subject|0|||
130707364|NCT00104247|470553389|FG000|Overall Study|Noncompliant with dosing|0|||
130707365|NCT00104247|470553390|FG001|Overall Study|Noncompliant with dosing|1|||
130707366|NCT04798482|470553393|FG000|Overall Study|Physician Decision|1|||
130707367|NCT04798482|470553393|FG000|Overall Study|Lost eligibility|1|||
130707368|NCT01192399|470553396|FG000|Overall Study|Lack of Efficacy|2|||
130707369|NCT01930175|470553397|FG000|Core Study|Lost to Follow-up|0|||
130707370|NCT01930175|470553398|FG001|Core Study|Lost to Follow-up|1|||
130707371|NCT01930175|470553399|FG002|Core Study|Lost to Follow-up|0|||
130707372|NCT01930175|470553397|FG000|Core Study|Adverse Event|0|||
130707373|NCT01930175|470553398|FG001|Core Study|Adverse Event|0|||
130707374|NCT01930175|470553399|FG002|Core Study|Adverse Event|1|||
130707375|NCT02820740|470553400|FG000|Overall Study|Did not have procedure|2|||
130707376|NCT01684215|470554905|FG000|Phase 1, Part 1|Adverse Event|1|||
130707377|NCT01684215|470554906|FG001|Phase 1, Part 1|Adverse Event|0|||
130707378|NCT01684215|470554907|FG002|Phase 1, Part 1|Adverse Event|0|||
130707379|NCT01684215|470554908|FG003|Phase 1, Part 1|Adverse Event|0|||
130707380|NCT01684215|470554905|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
130707381|NCT01684215|470554906|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
130707382|NCT01684215|470554907|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
130707383|NCT01684215|470554908|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
130707384|NCT01684215|470554905|FG000|Phase 1, Part 2|Adverse Event|0|||
130707385|NCT01684215|470554906|FG001|Phase 1, Part 2|Adverse Event|0|||
130707386|NCT01684215|470554907|FG002|Phase 1, Part 2|Adverse Event|1|||
130707387|NCT01684215|470554908|FG003|Phase 1, Part 2|Adverse Event|0|||
130707388|NCT01684215|470554905|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
130707389|NCT01684215|470554906|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
130707390|NCT01684215|470554907|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
130707391|NCT01684215|470554908|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
130707392|NCT01684215|470554905|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
130707393|NCT01684215|470554906|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
130707394|NCT01684215|470554907|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
130707395|NCT01684215|470554908|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
130707396|NCT01684215|470554905|FG000|Phase 2|Death|0|||
130707397|NCT01684215|470554906|FG001|Phase 2|Death|0|||
130707398|NCT01684215|470554907|FG002|Phase 2|Death|0|||
130707399|NCT01684215|470554908|FG003|Phase 2|Death|8|||
130707400|NCT01684215|470554905|FG000|Phase 2|Study terminated by sponsor|0|||
130707401|NCT01684215|470554906|FG001|Phase 2|Study terminated by sponsor|0|||
130707402|NCT01684215|470554907|FG002|Phase 2|Study terminated by sponsor|0|||
130707403|NCT01684215|470554908|FG003|Phase 2|Study terminated by sponsor|30|||
130707404|NCT01684215|470554905|FG000|Phase 2|Enrolled but not treated|0|||
130707405|NCT01684215|470554906|FG001|Phase 2|Enrolled but not treated|0|||
130707406|NCT01684215|470554907|FG002|Phase 2|Enrolled but not treated|0|||
130707407|NCT01684215|470554908|FG003|Phase 2|Enrolled but not treated|1|||
130707408|NCT01684215|470554905|FG000|Phase 2|Lost to Follow-up|0|||
130707409|NCT01684215|470554906|FG001|Phase 2|Lost to Follow-up|0|||
130707410|NCT01684215|470554907|FG002|Phase 2|Lost to Follow-up|0|||
130707411|NCT01684215|470554908|FG003|Phase 2|Lost to Follow-up|4|||
130707412|NCT01301482|470554909|FG000|Overall Study|Withdrawal by Subject|1|||
130707413|NCT00480324|470554910|FG000|Overall Study|Adverse Event|1|||
130707414|NCT00480324|470554911|FG001|Overall Study|Adverse Event|1|||
130707415|NCT00480324|470554910|FG000|Overall Study|Protocol Violation|0|||
130707416|NCT00480324|470554911|FG001|Overall Study|Protocol Violation|1|||
130707417|NCT00480324|470554910|FG000|Overall Study|Withdrawal by Subject|14|||
130707418|NCT00480324|470554911|FG001|Overall Study|Withdrawal by Subject|5|||
130707419|NCT00480324|470554910|FG000|Overall Study|Lost to Follow-up|17|||
130707420|NCT00480324|470554911|FG001|Overall Study|Lost to Follow-up|8|||
130707421|NCT00480324|470554910|FG000|Overall Study|Subject's mother pregnant|0|||
130707422|NCT00480324|470554911|FG001|Overall Study|Subject's mother pregnant|1|||
130707423|NCT00784134|470554912|FG000|Overall Study|Lost to Follow-up|3|||
130707424|NCT00784134|470554913|FG001|Overall Study|Lost to Follow-up|6|||
130707425|NCT03785145|470554914|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
130707426|NCT03785145|470554915|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
130707427|NCT03785145|470554914|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
130707428|NCT03785145|470554915|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
130707429|NCT03785145|470554914|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
130707430|NCT03785145|470554915|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
130707431|NCT03785145|470554914|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
130707432|NCT03785145|470554915|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
130707433|NCT03785145|470554914|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
130707434|NCT03785145|470554915|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
130707435|NCT03785145|470554914|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
130707436|NCT03785145|470554915|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
130707437|NCT03785145|470554914|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
130707438|NCT03785145|470554915|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
130707439|NCT03785145|470554914|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
130707440|NCT03785145|470554915|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
130707441|NCT03785145|470554914|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
130707442|NCT03785145|470554915|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
130707443|NCT03785145|470554914|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
130707444|NCT03785145|470554915|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
130707445|NCT03785145|470554914|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
130707446|NCT03785145|470554915|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
130707447|NCT03250299|470554917|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
130707448|NCT03250299|470554918|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
130707449|NCT03250299|470554919|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
130707450|NCT03250299|470554920|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
130707451|NCT03250299|470554921|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
130707452|NCT03250299|470554917|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
130707453|NCT03250299|470554918|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
130707454|NCT03250299|470554919|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
130707455|NCT03250299|470554920|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
130707456|NCT03250299|470554921|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
130707457|NCT03250299|470554917|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130707458|NCT03250299|470554918|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130707459|NCT03250299|470554919|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
130707460|NCT03250299|470554920|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130707461|NCT03250299|470554921|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130707462|NCT03250299|470554917|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
130707463|NCT03250299|470554918|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
130707464|NCT03250299|470554919|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
130707465|NCT03250299|470554920|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
130707466|NCT03250299|470554921|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
130707467|NCT03346070|470554926|FG000|Overall Study|Death|0|||
130707468|NCT03346070|470554927|FG001|Overall Study|Death|0|||
130942620|NCT01729754|471424746|FG005|Part 2|Lack of Efficacy|0|||
130707469|NCT03346070|470554928|FG002|Overall Study|Death|0|||
130707470|NCT03346070|470554929|FG003|Overall Study|Death|0|||
130707471|NCT03346070|470554930|FG004|Overall Study|Death|1|||
130707472|NCT03346070|470554926|FG000|Overall Study|Lost to Follow-up|0|||
130707473|NCT03346070|470554927|FG001|Overall Study|Lost to Follow-up|1|||
130707474|NCT03346070|470554928|FG002|Overall Study|Lost to Follow-up|2|||
130707475|NCT03346070|470554929|FG003|Overall Study|Lost to Follow-up|0|||
130707476|NCT03346070|470554930|FG004|Overall Study|Lost to Follow-up|0|||
130707477|NCT03346070|470554926|FG000|Overall Study|Physician Decision|0|||
130707478|NCT03346070|470554927|FG001|Overall Study|Physician Decision|0|||
131224238|NCT00343642|472448787|FG002|Overall Study|Withdrawal by Subject|4|||
130707479|NCT03346070|470554928|FG002|Overall Study|Physician Decision|0|||
130707480|NCT03346070|470554929|FG003|Overall Study|Physician Decision|1|||
130707481|NCT03346070|470554930|FG004|Overall Study|Physician Decision|1|||
130707482|NCT03346070|470554926|FG000|Overall Study|Withdrawal by Subject|1|||
130707483|NCT03346070|470554927|FG001|Overall Study|Withdrawal by Subject|0|||
130707484|NCT03346070|470554928|FG002|Overall Study|Withdrawal by Subject|0|||
130707485|NCT03346070|470554929|FG003|Overall Study|Withdrawal by Subject|1|||
130707486|NCT03346070|470554930|FG004|Overall Study|Withdrawal by Subject|0|||
130707487|NCT03346070|470554926|FG000|Overall Study|Study medication not received as planned|2|||
130707488|NCT03346070|470554927|FG001|Overall Study|Study medication not received as planned|3|||
130707489|NCT03346070|470554928|FG002|Overall Study|Study medication not received as planned|2|||
130707490|NCT03346070|470554929|FG003|Overall Study|Study medication not received as planned|3|||
130707491|NCT03346070|470554930|FG004|Overall Study|Study medication not received as planned|2|||
130707492|NCT03346070|470554926|FG000|Overall Study|Screen Failure|0|||
130707493|NCT03346070|470554927|FG001|Overall Study|Screen Failure|0|||
130707494|NCT03346070|470554928|FG002|Overall Study|Screen Failure|0|||
130707495|NCT03346070|470554929|FG003|Overall Study|Screen Failure|1|||
130707496|NCT03346070|470554930|FG004|Overall Study|Screen Failure|1|||
130707497|NCT00977548|470554931|FG000|Overall Study|Ineligible|4|||
130707498|NCT00977548|470554931|FG000|Overall Study|Adverse Event|8|||
130707499|NCT00977548|470554931|FG000|Overall Study|Withdrawal by Subject|1|||
130707500|NCT01546142|470554935|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
130707501|NCT01546142|470554936|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
130707502|NCT01546142|470554935|FG000|Overall Study|Subject Noncompliance|1|||
130707503|NCT01546142|470554936|FG001|Overall Study|Subject Noncompliance|1|||
130707504|NCT01546142|470554935|FG000|Overall Study|Adverse Event|6|||
130707505|NCT01546142|470554936|FG001|Overall Study|Adverse Event|3|||
130707506|NCT01546142|470554935|FG000|Overall Study|Lost to Follow-up|20|||
130707507|NCT01546142|470554936|FG001|Overall Study|Lost to Follow-up|15|||
130707508|NCT01546142|470554935|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
130707509|NCT01546142|470554936|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
130707510|NCT01546142|470554935|FG000|Overall Study|Subject Randomized but Not Treated|1|||
130707511|NCT01546142|470554936|FG001|Overall Study|Subject Randomized but Not Treated|0|||
130707512|NCT00440466|470554939|FG000|Overall Study|Death|3|||
130707513|NCT00440466|470554940|FG001|Overall Study|Death|2|||
130707514|NCT00440466|470554941|FG002|Overall Study|Death|9|||
130707515|NCT00440466|470554939|FG000|Overall Study|Adverse Event|3|||
130707516|NCT00440466|470554940|FG001|Overall Study|Adverse Event|4|||
130707517|NCT00440466|470554941|FG002|Overall Study|Adverse Event|11|||
130707518|NCT00440466|470554939|FG000|Overall Study|Lost to Follow-up|1|||
130707519|NCT00440466|470554940|FG001|Overall Study|Lost to Follow-up|0|||
130707520|NCT00440466|470554941|FG002|Overall Study|Lost to Follow-up|2|||
130707521|NCT00440466|470554939|FG000|Overall Study|Physician Decision|2|||
130707522|NCT00440466|470554940|FG001|Overall Study|Physician Decision|0|||
130707523|NCT00440466|470554941|FG002|Overall Study|Physician Decision|1|||
130707524|NCT00440466|470554939|FG000|Overall Study|Protocol Violation|2|||
130707525|NCT00440466|470554940|FG001|Overall Study|Protocol Violation|0|||
130707526|NCT00440466|470554941|FG002|Overall Study|Protocol Violation|4|||
130707527|NCT00440466|470554939|FG000|Overall Study|Withdrawal by Subject|2|||
130707528|NCT00440466|470554940|FG001|Overall Study|Withdrawal by Subject|5|||
130707529|NCT00440466|470554941|FG002|Overall Study|Withdrawal by Subject|9|||
130707530|NCT00440466|470554939|FG000|Overall Study|Began Dialysis|0|||
130707531|NCT00440466|470554940|FG001|Overall Study|Began Dialysis|0|||
130707532|NCT00440466|470554941|FG002|Overall Study|Began Dialysis|1|||
130707533|NCT00440466|470554939|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
130707534|NCT00440466|470554940|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
130707535|NCT00440466|470554941|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
130707536|NCT01005329|470554944|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
130707537|NCT00608517|470554945|FG000|Overall Study|Death|1|||
130707538|NCT00608517|470554946|FG001|Overall Study|Death|0|||
130707539|NCT00608517|470554947|FG002|Overall Study|Death|0|||
130707540|NCT01501110|470554948|FG000|Overall Study|Death|0|||
130707541|NCT01501110|470554949|FG001|Overall Study|Death|1|||
130707542|NCT02674386|470554952|FG000|Overall Study|Lost to Follow-up|0|||
130707543|NCT02674386|470554953|FG001|Overall Study|Lost to Follow-up|1|||
130707544|NCT02674386|470554954|FG002|Overall Study|Lost to Follow-up|1|||
130707545|NCT02674386|470554952|FG000|Overall Study|Withdrawal by Subject|0|||
130707546|NCT02674386|470554953|FG001|Overall Study|Withdrawal by Subject|4|||
130707547|NCT02674386|470554954|FG002|Overall Study|Withdrawal by Subject|0|||
130707548|NCT02674386|470554952|FG000|Overall Study|Other|0|||
130707549|NCT02674386|470554953|FG001|Overall Study|Other|1|||
130707550|NCT02674386|470554954|FG002|Overall Study|Other|0|||
130707551|NCT02674386|470554952|FG000|Overall Study|Enrolled but not evaluated|0|||
130707552|NCT02674386|470554953|FG001|Overall Study|Enrolled but not evaluated|4|||
130707553|NCT02674386|470554954|FG002|Overall Study|Enrolled but not evaluated|0|||
130707554|NCT02462486|470554959|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
130707555|NCT02462486|470554960|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
130707556|NCT02462486|470554961|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
130707557|NCT02462486|470554959|FG000|Overall Study|Adverse Event|53|||
130707558|NCT02462486|470554960|FG001|Overall Study|Adverse Event|48|||
130707559|NCT02462486|470554961|FG002|Overall Study|Adverse Event|21|||
130707560|NCT02462486|470554959|FG000|Overall Study|Lack of Efficacy|6|||
130707561|NCT02462486|470554960|FG001|Overall Study|Lack of Efficacy|12|||
130707562|NCT02462486|470554961|FG002|Overall Study|Lack of Efficacy|3|||
130707563|NCT02462486|470554959|FG000|Overall Study|Lost to Follow-up|3|||
130707564|NCT02462486|470554960|FG001|Overall Study|Lost to Follow-up|4|||
130707565|NCT02462486|470554961|FG002|Overall Study|Lost to Follow-up|2|||
130707566|NCT02462486|470554959|FG000|Overall Study|Withdrawal by Subject|25|||
130707567|NCT02462486|470554960|FG001|Overall Study|Withdrawal by Subject|22|||
130707568|NCT02462486|470554961|FG002|Overall Study|Withdrawal by Subject|19|||
130707569|NCT02462486|470554959|FG000|Overall Study|Protocol Violation|3|||
130707570|NCT02462486|470554960|FG001|Overall Study|Protocol Violation|1|||
130707571|NCT02462486|470554961|FG002|Overall Study|Protocol Violation|1|||
130707572|NCT02462486|470554959|FG000|Overall Study|Reason not Specified|3|||
130707573|NCT02462486|470554960|FG001|Overall Study|Reason not Specified|4|||
130707574|NCT02462486|470554961|FG002|Overall Study|Reason not Specified|3|||
130707575|NCT01261624|470554962|FG000|Week 0 to Week 12|Disease Progression|1|||
130707576|NCT01261624|470554963|FG001|Week 0 to Week 12|Disease Progression|1|||
130707577|NCT01261624|470554962|FG000|Week 0 to Week 12|Insufficient Response|0|||
130707578|NCT01261624|470554963|FG001|Week 0 to Week 12|Insufficient Response|2|||
130707579|NCT01261624|470554962|FG000|Week 13 to Week 24|Insufficient Response|0|||
130707580|NCT01261624|470554963|FG001|Week 13 to Week 24|Insufficient Response|1|||
130707581|NCT02094261|470554966|FG000|Overall Study|Death|24|||
130707582|NCT02094261|470554966|FG000|Overall Study|Lost to Follow-up|1|||
130707583|NCT02094261|470554966|FG000|Overall Study|Withdrawal by Subject|4|||
130707584|NCT02094261|470554966|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
130707585|NCT02363439|470554969|FG000|Overall Study|Lack of Efficacy|4|||
130707586|NCT01719562|470554970|FG000|Overall Study|Lost to Follow-up|1|||
130707587|NCT01719562|470554971|FG001|Overall Study|Lost to Follow-up|0|||
130707588|NCT01719562|470554970|FG000|Overall Study|Death|1|||
130707589|NCT01719562|470554971|FG001|Overall Study|Death|0|||
130707590|NCT01719562|470554970|FG000|Overall Study|New cancer diagnosis|1|||
130707591|NCT01719562|470554971|FG001|Overall Study|New cancer diagnosis|0|||
130707592|NCT00508027|470554972|FG000|Dose Level 1|Lost to Follow-up|4|||
130707593|NCT00508027|470554972|FG000|Dose Level 1|Withdrawal by Subject|2|||
130707594|NCT00508027|470554972|FG000|Dose Level 1|Physician Decision|2|||
130707595|NCT00508027|470554972|FG000|Dose Level 2|Lost to Follow-up|2|||
130707596|NCT00508027|470554972|FG000|Dose Level 2|Withdrawal by Subject|2|||
130707597|NCT03554317|470554973|FG000|Overall Study|Withdrawal by Subject|1|||
130707598|NCT03554317|470554973|FG000|Overall Study|PSA Progression|3|||
130707599|NCT03554317|470554973|FG000|Overall Study|Radiographic Progression|4|||
130707600|NCT00537199|470554974|FG000|Overall Study|Study Terminated|1|||
130707601|NCT03827018|470554981|FG000|Overall Study|Adverse Event|1|||
130707602|NCT03827018|470554982|FG001|Overall Study|Adverse Event|0|||
130707603|NCT03827018|470554981|FG000|Overall Study|Withdrawal by Subject|2|||
130707604|NCT03827018|470554982|FG001|Overall Study|Withdrawal by Subject|2|||
130707605|NCT03827018|470554981|FG000|Overall Study|Lack of Efficacy|0|||
130707606|NCT03827018|470554982|FG001|Overall Study|Lack of Efficacy|1|||
130707607|NCT00775528|470554984|FG000|Overall Study|Protocol Violation|1|||
130707608|NCT02087176|470554985|FG000|Overall Study|Withdrawal by Subject|1|||
130707609|NCT02087176|470554985|FG000|Overall Study|Death|10|||
130707610|NCT02087176|470554985|FG000|Overall Study|Censored|19|||
130707611|NCT02087176|470554985|FG000|Overall Study|Study Terminated by Sponsor|2|||
130707612|NCT04099641|470554988|FG000|Overall Study|Death|46|||
130707613|NCT04099641|470554989|FG001|Overall Study|Death|12|||
130707614|NCT04099641|470554988|FG000|Overall Study|Lost to Follow-up|1|||
130707615|NCT04099641|470554989|FG001|Overall Study|Lost to Follow-up|0|||
130707616|NCT04099641|470554988|FG000|Overall Study|Withdrawal by Subject|2|||
130707617|NCT04099641|470554989|FG001|Overall Study|Withdrawal by Subject|0|||
130707618|NCT00834899|470554990|FG000|Overall Study|Withdrawal by Subject|1|||
130707619|NCT00834899|470554991|FG001|Overall Study|Withdrawal by Subject|1|||
130707620|NCT01534637|470554992|FG000|Overall Study|Physician Decision|3|||
130707621|NCT01534637|470554992|FG000|Overall Study|Lack of Efficacy|3|||
130707622|NCT01534637|470554992|FG000|Overall Study|Withdrawal by Subject|1|||
130707623|NCT01534637|470554992|FG000|Overall Study|Adverse Event|1|||
130707624|NCT01534637|470554992|FG000|Overall Study|Liver Mets before treatment|1|||
130707625|NCT00605917|470554993|FG000|Overall Study|Protocol Violation|79|||
130707626|NCT00890552|470554994|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
130707627|NCT00890552|470554994|FG000|On-treatment|Early prog disease/ death|10|||
130707628|NCT04965389|470554996|FG000|Overall Study|Other reasons|1|||
130707629|NCT04965389|470554997|FG001|Overall Study|Other reasons|0|||
130707630|NCT04965389|470554998|FG002|Overall Study|Other reasons|0|||
130707631|NCT04965389|470554999|FG003|Overall Study|Other reasons|0|||
130707632|NCT04965389|470554996|FG000|Overall Study|Participant withdrew consent|0|||
130707633|NCT04965389|470554997|FG001|Overall Study|Participant withdrew consent|1|||
130707634|NCT04965389|470554998|FG002|Overall Study|Participant withdrew consent|0|||
130707635|NCT04965389|470554999|FG003|Overall Study|Participant withdrew consent|0|||
130707636|NCT04965389|470554996|FG000|Overall Study|Poor/Non-compliance|0|||
130707637|NCT04965389|470554997|FG001|Overall Study|Poor/Non-compliance|1|||
130707638|NCT04965389|470554998|FG002|Overall Study|Poor/Non-compliance|0|||
130707639|NCT04965389|470554999|FG003|Overall Study|Poor/Non-compliance|0|||
130707640|NCT03903159|470555002|FG000|Overall Study|Discharged with Staff Approval|2|||
130707641|NCT03903159|470555002|FG000|Overall Study|Discharged at Staff Request|2|||
130707642|NCT03903159|470555002|FG000|Overall Study|Discharged Against Staff Advice|1|||
130707643|NCT02443545|470555003|FG000|Overall Study|Adverse Event|1|||
130707644|NCT02443545|470555004|FG001|Overall Study|Adverse Event|1|||
130707645|NCT02443545|470555003|FG000|Overall Study|Lost to Follow-up|0|||
130707646|NCT02443545|470555004|FG001|Overall Study|Lost to Follow-up|2|||
130707647|NCT02443545|470555003|FG000|Overall Study|Physician Decision|3|||
130707648|NCT02443545|470555004|FG001|Overall Study|Physician Decision|0|||
130707649|NCT02443545|470555003|FG000|Overall Study|Protocol Violation|8|||
130707650|NCT02443545|470555004|FG001|Overall Study|Protocol Violation|1|||
130707651|NCT02443545|470555003|FG000|Overall Study|Pregnancy|1|||
130707652|NCT02443545|470555004|FG001|Overall Study|Pregnancy|1|||
130707653|NCT02443545|470555003|FG000|Overall Study|Withdrawal by Subject|6|||
130707654|NCT02443545|470555004|FG001|Overall Study|Withdrawal by Subject|3|||
130707655|NCT02443545|470555003|FG000|Overall Study|Termination of study|20|||
130707656|NCT02443545|470555004|FG001|Overall Study|Termination of study|11|||
130707657|NCT00724373|470555005|FG000|Overall Study|Adverse Event|41|||
130707658|NCT00724373|470555005|FG000|Overall Study|Lack of Efficacy|82|||
130707659|NCT00724373|470555005|FG000|Overall Study|Lost to Follow-up|7|||
130707660|NCT00724373|470555005|FG000|Overall Study|Non-compliance|2|||
130707661|NCT00724373|470555005|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
130707662|NCT00724373|470555005|FG000|Overall Study|Participant moved away|1|||
130707663|NCT00724373|470555005|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
130707664|NCT00724373|470555005|FG000|Overall Study|Only to have 24 week regimen|1|||
130707665|NCT00724373|470555005|FG000|Overall Study|Viral Relapse|1|||
130707666|NCT00724373|470555005|FG000|Overall Study|Acute HCV infection|1|||
130707667|NCT00724373|470555005|FG000|Overall Study|Drug Relapse|1|||
130707668|NCT00724373|470555005|FG000|Overall Study|Tolerability|23|||
130707669|NCT00536484|470555006|FG000|Overall Study|Adverse Event|21|||
130707670|NCT00536484|470555007|FG001|Overall Study|Adverse Event|34|||
130707671|NCT00536484|470555006|FG000|Overall Study|Withdrawal by Subject|11|||
130707672|NCT00536484|470555007|FG001|Overall Study|Withdrawal by Subject|11|||
130707673|NCT00536484|470555006|FG000|Overall Study|Lost to Follow-up|8|||
130707674|NCT00536484|470555007|FG001|Overall Study|Lost to Follow-up|6|||
130707675|NCT00536484|470555006|FG000|Overall Study|Lack of Efficacy|16|||
130707676|NCT00536484|470555007|FG001|Overall Study|Lack of Efficacy|5|||
130707677|NCT00536484|470555006|FG000|Overall Study|Other|4|||
130707678|NCT00536484|470555007|FG001|Overall Study|Other|0|||
131123475|NCT02113436|472081316|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
131123476|NCT02113436|472081317|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
130707679|NCT01506908|470555008|FG000|Overall Study|Adverse Event|1|||
130707680|NCT01506908|470555009|FG001|Overall Study|Adverse Event|0|||
130707681|NCT03043560|470555013|FG000|Overall Study|Discontinued Intervention|1|||
130707682|NCT03043560|470555014|FG001|Overall Study|Discontinued Intervention|2|||
130707683|NCT03043560|470555013|FG000|Overall Study|Lost to Follow-up|0|||
130707684|NCT03043560|470555014|FG001|Overall Study|Lost to Follow-up|1|||
130707685|NCT01382251|470555015|FG000|Overall Study|Surgeries cancelled or delayed|16|||
130707686|NCT01382251|470555016|FG001|Overall Study|Surgeries cancelled or delayed|16|||
131123477|NCT02113436|472081318|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
130707687|NCT01382251|470555015|FG000|Overall Study|Lost to Follow-up|4|||
130707688|NCT01382251|470555016|FG001|Overall Study|Lost to Follow-up|4|||
130707689|NCT01382251|470555015|FG000|Overall Study|Contacted after study closed|1|||
130707690|NCT01382251|470555016|FG001|Overall Study|Contacted after study closed|1|||
130707691|NCT00562120|470555017|FG000|First Intervention Period|Adverse Event|1|||
130707692|NCT00562120|470555018|FG001|First Intervention Period|Adverse Event|0|||
130707693|NCT00562120|470555019|FG002|First Intervention Period|Adverse Event|0|||
130707694|NCT00562120|470555020|FG003|First Intervention Period|Adverse Event|0|||
130707695|NCT00562120|470555017|FG000|First Intervention Period|Randomized but not Treated|1|||
130707696|NCT00562120|470555018|FG001|First Intervention Period|Randomized but not Treated|0|||
130707697|NCT00562120|470555019|FG002|First Intervention Period|Randomized but not Treated|0|||
130772347|NCT05052697|470792846|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772348|NCT05052697|470792847|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772349|NCT05052697|470792848|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
130772350|NCT05052697|470792849|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
130772351|NCT05052697|470792850|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
130772352|NCT05052697|470792851|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772353|NCT05052697|470792852|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772354|NCT05052697|470792853|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130772355|NCT01289574|470792857|FG000|Overall Study|Lack of Efficacy|4|||
130772356|NCT01289574|470792858|FG001|Overall Study|Lack of Efficacy|0|||
130772357|NCT01289574|470792859|FG002|Overall Study|Lack of Efficacy|1|||
130772358|NCT01289574|470792857|FG000|Overall Study|Lost to Follow-up|2|||
130772359|NCT01289574|470792858|FG001|Overall Study|Lost to Follow-up|0|||
130772360|NCT01289574|470792859|FG002|Overall Study|Lost to Follow-up|1|||
130772361|NCT01289574|470792857|FG000|Overall Study|Withdrawal by Subject|1|||
130772362|NCT01289574|470792858|FG001|Overall Study|Withdrawal by Subject|1|||
130772363|NCT01289574|470792859|FG002|Overall Study|Withdrawal by Subject|1|||
130772364|NCT01289574|470792857|FG000|Overall Study|Adverse Event|0|||
130772365|NCT01289574|470792858|FG001|Overall Study|Adverse Event|1|||
130772366|NCT01289574|470792859|FG002|Overall Study|Adverse Event|0|||
130772367|NCT01289574|470792857|FG000|Overall Study|Subject wanted alternate treatment|0|||
130772368|NCT01289574|470792858|FG001|Overall Study|Subject wanted alternate treatment|1|||
130772369|NCT01289574|470792859|FG002|Overall Study|Subject wanted alternate treatment|0|||
130772370|NCT02432144|470792860|FG000|Overall Study|Participant Non-Compliance|1|||
130772371|NCT00262002|470792861|FG000|Overall Study|Adverse Event|2|||
130772372|NCT00262002|470792862|FG001|Overall Study|Adverse Event|1|||
130772373|NCT00262002|470792863|FG002|Overall Study|Adverse Event|0|||
130772374|NCT00262002|470792864|FG003|Overall Study|Adverse Event|0|||
130772375|NCT00262002|470792865|FG004|Overall Study|Adverse Event|0|||
130772376|NCT00262002|470792866|FG005|Overall Study|Adverse Event|1|||
130772377|NCT00262002|470792867|FG006|Overall Study|Adverse Event|0|||
130772378|NCT00262002|470792861|FG000|Overall Study|Withdrawal by Subject|4|||
130772379|NCT00262002|470792862|FG001|Overall Study|Withdrawal by Subject|2|||
130772380|NCT00262002|470792863|FG002|Overall Study|Withdrawal by Subject|0|||
130772381|NCT00262002|470792864|FG003|Overall Study|Withdrawal by Subject|1|||
130772382|NCT00262002|470792865|FG004|Overall Study|Withdrawal by Subject|2|||
130772383|NCT00262002|470792866|FG005|Overall Study|Withdrawal by Subject|2|||
130772384|NCT00262002|470792867|FG006|Overall Study|Withdrawal by Subject|2|||
130772385|NCT00262002|470792861|FG000|Overall Study|Lost to Follow-up|2|||
130772386|NCT00262002|470792862|FG001|Overall Study|Lost to Follow-up|0|||
130772387|NCT00262002|470792863|FG002|Overall Study|Lost to Follow-up|0|||
130772388|NCT00262002|470792864|FG003|Overall Study|Lost to Follow-up|2|||
130772389|NCT00262002|470792865|FG004|Overall Study|Lost to Follow-up|0|||
130772390|NCT00262002|470792866|FG005|Overall Study|Lost to Follow-up|1|||
130772391|NCT00262002|470792867|FG006|Overall Study|Lost to Follow-up|0|||
130772392|NCT00262002|470792861|FG000|Overall Study|Inapropriate enrollment|0|||
130772393|NCT00262002|470792862|FG001|Overall Study|Inapropriate enrollment|1|||
130772394|NCT00262002|470792863|FG002|Overall Study|Inapropriate enrollment|0|||
130772395|NCT00262002|470792864|FG003|Overall Study|Inapropriate enrollment|0|||
130772396|NCT00262002|470792865|FG004|Overall Study|Inapropriate enrollment|0|||
130772397|NCT00262002|470792866|FG005|Overall Study|Inapropriate enrollment|0|||
130772398|NCT00262002|470792867|FG006|Overall Study|Inapropriate enrollment|0|||
130772399|NCT00262002|470792861|FG000|Overall Study|Protocol Violation|3|||
130772400|NCT00262002|470792862|FG001|Overall Study|Protocol Violation|2|||
130772401|NCT00262002|470792863|FG002|Overall Study|Protocol Violation|0|||
130772402|NCT00262002|470792864|FG003|Overall Study|Protocol Violation|2|||
130772403|NCT00262002|470792865|FG004|Overall Study|Protocol Violation|5|||
130772404|NCT00262002|470792866|FG005|Overall Study|Protocol Violation|3|||
130772405|NCT00262002|470792867|FG006|Overall Study|Protocol Violation|2|||
130772406|NCT00262002|470792861|FG000|Overall Study|Unable to classify|0|||
130772407|NCT00262002|470792862|FG001|Overall Study|Unable to classify|0|||
130772408|NCT00262002|470792863|FG002|Overall Study|Unable to classify|0|||
130772409|NCT00262002|470792864|FG003|Overall Study|Unable to classify|0|||
130772410|NCT00262002|470792865|FG004|Overall Study|Unable to classify|0|||
130772411|NCT00262002|470792866|FG005|Overall Study|Unable to classify|0|||
130772412|NCT00262002|470792867|FG006|Overall Study|Unable to classify|2|||
130772413|NCT01451554|470792868|FG000|Overall Study|Withdrawal by Subject|14|||
130772414|NCT01451554|470792869|FG001|Overall Study|Withdrawal by Subject|9|||
130772415|NCT01402986|470792870|FG000|Overall Study|Withdrawal by Subject|7|||
130772416|NCT01402986|470792871|FG001|Overall Study|Withdrawal by Subject|10|||
130772417|NCT01402986|470792872|FG002|Overall Study|Withdrawal by Subject|7|||
130772418|NCT01402986|470792873|FG003|Overall Study|Withdrawal by Subject|13|||
130772419|NCT01402986|470792870|FG000|Overall Study|Death|0|||
130772420|NCT01402986|470792871|FG001|Overall Study|Death|0|||
130772421|NCT01402986|470792872|FG002|Overall Study|Death|0|||
130772422|NCT01402986|470792873|FG003|Overall Study|Death|2|||
130772423|NCT01402986|470792870|FG000|Overall Study|Lost to Follow-up|0|||
130772424|NCT01402986|470792871|FG001|Overall Study|Lost to Follow-up|0|||
130707698|NCT00562120|470555020|FG003|First Intervention Period|Randomized but not Treated|0|||
130707699|NCT03366194|470555024|FG000|Overall Study|Lost to Follow-up|2|||
130707700|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
130707701|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
130707702|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
130707703|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
130707704|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
130707705|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
130707706|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
130707707|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
130707708|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
130707709|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
130707710|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
130707711|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
130707712|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Death|0|||
130707713|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Death|1|||
130707714|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Death|0|||
130707715|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Death|0|||
130707716|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
130707717|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
130707718|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
130707719|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
131123478|NCT02113436|472081315|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
131123479|NCT02113436|472081316|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
131123480|NCT02113436|472081317|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
131123481|NCT02113436|472081318|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
131123482|NCT02113436|472081315|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
131123483|NCT02113436|472081316|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
131123484|NCT02113436|472081317|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
131123485|NCT02113436|472081318|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
131123486|NCT02113436|472081315|FG000|Period 2: 16 Weeks|Adverse Event|0|||
131123487|NCT02113436|472081316|FG001|Period 2: 16 Weeks|Adverse Event|0|||
131123488|NCT02113436|472081317|FG002|Period 2: 16 Weeks|Adverse Event|4|||
131123489|NCT02113436|472081318|FG003|Period 2: 16 Weeks|Adverse Event|5|||
131123490|NCT02113436|472081315|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
131123491|NCT02113436|472081316|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
131123492|NCT02113436|472081317|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
131123493|NCT02113436|472081318|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
131123494|NCT02113436|472081315|FG000|Period 2: 16 Weeks|Physician Decision|0|||
131123495|NCT02113436|472081316|FG001|Period 2: 16 Weeks|Physician Decision|0|||
131123496|NCT02113436|472081317|FG002|Period 2: 16 Weeks|Physician Decision|2|||
131123497|NCT02113436|472081318|FG003|Period 2: 16 Weeks|Physician Decision|0|||
131123498|NCT02113436|472081315|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
131123499|NCT02113436|472081316|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
131123500|NCT02113436|472081317|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
131123501|NCT02113436|472081318|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
131123502|NCT01263483|472081319|FG000|Overall Study|Adverse Event|4|||
131123503|NCT01263483|472081320|FG001|Overall Study|Adverse Event|0|||
131123504|NCT01263483|472081321|FG002|Overall Study|Adverse Event|3|||
131123505|NCT01263483|472081319|FG000|Overall Study|Withdrawal by Subject|1|||
131123506|NCT01263483|472081320|FG001|Overall Study|Withdrawal by Subject|0|||
131123507|NCT01263483|472081321|FG002|Overall Study|Withdrawal by Subject|0|||
131123508|NCT01263483|472081319|FG000|Overall Study|Lack of Efficacy|2|||
131123509|NCT01263483|472081320|FG001|Overall Study|Lack of Efficacy|0|||
131123510|NCT01263483|472081321|FG002|Overall Study|Lack of Efficacy|0|||
131123511|NCT01263483|472081319|FG000|Overall Study|Protocol Violation|0|||
131123512|NCT01263483|472081320|FG001|Overall Study|Protocol Violation|1|||
130707720|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
130707721|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
130707722|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
130707723|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
130772425|NCT01402986|470792872|FG002|Overall Study|Lost to Follow-up|0|||
131123513|NCT01263483|472081321|FG002|Overall Study|Protocol Violation|1|||
131123514|NCT01263483|472081319|FG000|Overall Study|Participant Unavailability|0|||
131123515|NCT01263483|472081320|FG001|Overall Study|Participant Unavailability|1|||
131123516|NCT01263483|472081321|FG002|Overall Study|Participant Unavailability|1|||
131123517|NCT00714285|472081322|FG000|Overall Study|Lost to Follow-up|0|||
131123518|NCT00714285|472081323|FG001|Overall Study|Lost to Follow-up|2|||
131123519|NCT00714285|472081324|FG002|Overall Study|Lost to Follow-up|0|||
131123520|NCT00714285|472081325|FG003|Overall Study|Lost to Follow-up|1|||
131123521|NCT00714285|472081322|FG000|Overall Study|Migrated/moved from study area|0|||
131123522|NCT00714285|472081323|FG001|Overall Study|Migrated/moved from study area|1|||
131123523|NCT00714285|472081324|FG002|Overall Study|Migrated/moved from study area|0|||
131123524|NCT00714285|472081325|FG003|Overall Study|Migrated/moved from study area|0|||
130707724|NCT00545688|470555027|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
130707725|NCT00545688|470555028|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
130707726|NCT00545688|470555029|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
130707727|NCT00545688|470555030|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
130707728|NCT00545688|470555027|FG000|Adjuvant Treatment Period|Disease Progression|3|||
130707729|NCT00545688|470555028|FG001|Adjuvant Treatment Period|Disease Progression|3|||
130707730|NCT00545688|470555029|FG002|Adjuvant Treatment Period|Disease Progression|0|||
130707731|NCT00545688|470555030|FG003|Adjuvant Treatment Period|Disease Progression|7|||
130707732|NCT00545688|470555027|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
130707733|NCT00545688|470555028|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
130707734|NCT00545688|470555029|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
130707735|NCT00545688|470555030|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
130707736|NCT00545688|470555027|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
130707737|NCT00545688|470555028|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
130707738|NCT00545688|470555029|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
130707739|NCT00545688|470555030|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
130707740|NCT00545688|470555027|FG000|Adjuvant Treatment Period|Adverse Event|0|||
130707741|NCT00545688|470555028|FG001|Adjuvant Treatment Period|Adverse Event|3|||
130707742|NCT00545688|470555029|FG002|Adjuvant Treatment Period|Adverse Event|2|||
130707743|NCT00545688|470555030|FG003|Adjuvant Treatment Period|Adverse Event|2|||
130707744|NCT00545688|470555027|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
130707745|NCT00545688|470555028|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
130707746|NCT00545688|470555029|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
130707747|NCT00545688|470555030|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
130707748|NCT00545688|470555027|FG000|Follow-Up Period|Death|4|||
130707749|NCT00545688|470555028|FG001|Follow-Up Period|Death|2|||
130707750|NCT00545688|470555029|FG002|Follow-Up Period|Death|2|||
130707751|NCT00545688|470555030|FG003|Follow-Up Period|Death|6|||
130707752|NCT00545688|470555027|FG000|Follow-Up Period|Disease Progression|6|||
130707753|NCT00545688|470555028|FG001|Follow-Up Period|Disease Progression|5|||
130707754|NCT00545688|470555029|FG002|Follow-Up Period|Disease Progression|9|||
130707755|NCT00545688|470555030|FG003|Follow-Up Period|Disease Progression|9|||
130707756|NCT00545688|470555027|FG000|Follow-Up Period|Refused Treatment|6|||
130707757|NCT00545688|470555028|FG001|Follow-Up Period|Refused Treatment|2|||
130707758|NCT00545688|470555029|FG002|Follow-Up Period|Refused Treatment|0|||
130707759|NCT00545688|470555030|FG003|Follow-Up Period|Refused Treatment|2|||
130707760|NCT00545688|470555027|FG000|Follow-Up Period|Lost to Follow-up|3|||
130707761|NCT00545688|470555028|FG001|Follow-Up Period|Lost to Follow-up|3|||
130707762|NCT00545688|470555029|FG002|Follow-Up Period|Lost to Follow-up|3|||
130707763|NCT00545688|470555030|FG003|Follow-Up Period|Lost to Follow-up|1|||
130707764|NCT00545688|470555027|FG000|Follow-Up Period|Unspecified Reason|2|||
130707765|NCT00545688|470555028|FG001|Follow-Up Period|Unspecified Reason|5|||
130707766|NCT00545688|470555029|FG002|Follow-Up Period|Unspecified Reason|6|||
130707767|NCT00545688|470555030|FG003|Follow-Up Period|Unspecified Reason|8|||
130707768|NCT00545688|470555027|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
130707769|NCT00545688|470555028|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
130707770|NCT00545688|470555029|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
130707771|NCT00545688|470555030|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
130707772|NCT03123783|470555031|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707773|NCT03123783|470555032|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
130707774|NCT03123783|470555033|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707775|NCT03123783|470555034|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707776|NCT03123783|470555035|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707777|NCT03123783|470555036|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707778|NCT03123783|470555037|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130707779|NCT03123783|470555031|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
130707780|NCT03123783|470555032|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
130707781|NCT03123783|470555033|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
130707782|NCT03123783|470555034|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
130707783|NCT03123783|470555035|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
130707784|NCT03123783|470555036|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
130707785|NCT03123783|470555037|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
130707786|NCT03123783|470555031|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
130707787|NCT03123783|470555032|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
130707788|NCT03123783|470555033|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
130707789|NCT03123783|470555034|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
130707790|NCT03123783|470555035|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
130707791|NCT03123783|470555036|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
130707792|NCT03123783|470555037|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
130707793|NCT03123783|470555031|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707794|NCT03123783|470555032|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707795|NCT03123783|470555033|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707796|NCT03123783|470555034|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707797|NCT03123783|470555035|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
130707798|NCT03123783|470555036|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707799|NCT03123783|470555037|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130707800|NCT02953678|470555043|FG000|Overall Study|Adverse Event|20|||
130707801|NCT02953678|470555043|FG000|Overall Study|Death|7|||
130707802|NCT02953678|470555043|FG000|Overall Study|Physician Decision|23|||
130707803|NCT02953678|470555043|FG000|Overall Study|Progressive Disease of GVHD|7|||
130707804|NCT02953678|470555043|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
130707805|NCT02953678|470555043|FG000|Overall Study|Withdrawal by participant|3|||
130707806|NCT02953678|470555043|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
130707807|NCT02953678|470555043|FG000|Overall Study|Participants were transferred to commercial product.|3|||
130707808|NCT00952276|470555044|FG000|Overall Study|Withdrawal by Subject|1|||
130707809|NCT00952276|470555045|FG001|Overall Study|Withdrawal by Subject|0|||
130707810|NCT00952276|470555046|FG002|Overall Study|Withdrawal by Subject|0|||
130707811|NCT00952276|470555047|FG003|Overall Study|Withdrawal by Subject|1|||
130707812|NCT00952276|470555048|FG004|Overall Study|Withdrawal by Subject|0|||
130707813|NCT01730040|470556562|FG000|Overall Study|Randomized but not treated|0|||
130707814|NCT01730040|470556563|FG001|Overall Study|Randomized but not treated|0|||
130707815|NCT01730040|470556564|FG002|Overall Study|Randomized but not treated|0|||
130707816|NCT01730040|470556565|FG003|Overall Study|Randomized but not treated|0|||
130707817|NCT01730040|470556566|FG004|Overall Study|Randomized but not treated|0|||
130707818|NCT01730040|470556567|FG005|Overall Study|Randomized but not treated|1|||
130707819|NCT01730040|470556568|FG006|Overall Study|Randomized but not treated|0|||
130707820|NCT01730040|470556562|FG000|Overall Study|Subject moved|0|||
130707821|NCT01730040|470556563|FG001|Overall Study|Subject moved|0|||
130707822|NCT01730040|470556564|FG002|Overall Study|Subject moved|1|||
130707823|NCT01730040|470556565|FG003|Overall Study|Subject moved|0|||
130707824|NCT01730040|470556566|FG004|Overall Study|Subject moved|0|||
130707825|NCT01730040|470556567|FG005|Overall Study|Subject moved|0|||
130707826|NCT01730040|470556568|FG006|Overall Study|Subject moved|1|||
130707827|NCT01730040|470556562|FG000|Overall Study|Physician Decision|0|||
130707828|NCT01730040|470556563|FG001|Overall Study|Physician Decision|0|||
130707829|NCT01730040|470556564|FG002|Overall Study|Physician Decision|0|||
130707830|NCT01730040|470556565|FG003|Overall Study|Physician Decision|0|||
130707831|NCT01730040|470556566|FG004|Overall Study|Physician Decision|0|||
130707832|NCT01730040|470556567|FG005|Overall Study|Physician Decision|1|||
130707833|NCT01730040|470556568|FG006|Overall Study|Physician Decision|1|||
130707834|NCT01730040|470556562|FG000|Overall Study|Other than specified|7|||
130707835|NCT01730040|470556563|FG001|Overall Study|Other than specified|8|||
130707836|NCT01730040|470556564|FG002|Overall Study|Other than specified|5|||
130707837|NCT01730040|470556565|FG003|Overall Study|Other than specified|5|||
130707838|NCT01730040|470556566|FG004|Overall Study|Other than specified|5|||
130707839|NCT01730040|470556567|FG005|Overall Study|Other than specified|4|||
130707840|NCT01730040|470556568|FG006|Overall Study|Other than specified|4|||
130707841|NCT01730040|470556562|FG000|Overall Study|Adverse Event|4|||
130707842|NCT01730040|470556563|FG001|Overall Study|Adverse Event|3|||
130707843|NCT01730040|470556564|FG002|Overall Study|Adverse Event|5|||
130707844|NCT01730040|470556565|FG003|Overall Study|Adverse Event|3|||
130707845|NCT01730040|470556566|FG004|Overall Study|Adverse Event|1|||
130707846|NCT01730040|470556567|FG005|Overall Study|Adverse Event|1|||
130707847|NCT01730040|470556568|FG006|Overall Study|Adverse Event|2|||
130707848|NCT01730040|470556562|FG000|Overall Study|Poor compliance to protocol|2|||
130707849|NCT01730040|470556563|FG001|Overall Study|Poor compliance to protocol|4|||
130707850|NCT01730040|470556564|FG002|Overall Study|Poor compliance to protocol|0|||
130707851|NCT01730040|470556565|FG003|Overall Study|Poor compliance to protocol|0|||
130707852|NCT01730040|470556566|FG004|Overall Study|Poor compliance to protocol|0|||
130707853|NCT01730040|470556567|FG005|Overall Study|Poor compliance to protocol|0|||
130707854|NCT01730040|470556568|FG006|Overall Study|Poor compliance to protocol|1|||
130707855|NCT01552369|470556569|FG000|Overall Study|Did not consent to extended follow up|8|||
130707856|NCT01552369|470556570|FG001|Overall Study|Did not consent to extended follow up|9|||
130707857|NCT04776746|470556576|FG000|Overall Study|Study terminated by sponsor|61|||
130707858|NCT04776746|470556576|FG000|Overall Study|Adverse Event|5|||
130707859|NCT04776746|470556576|FG000|Overall Study|Death|4|||
130707860|NCT04776746|470556576|FG000|Overall Study|Lack of Efficacy|3|||
130707861|NCT04776746|470556576|FG000|Overall Study|Noncompliance with study drug|2|||
130707862|NCT04776746|470556576|FG000|Overall Study|Not related to COVID-19|2|||
130707863|NCT04109313|470556585|FG000|Overall Study|Pregnancy|1|||
130707864|NCT04109313|470556585|FG000|Overall Study|Adverse Event|11|||
131036648|NCT05949788|471768203|FG001|Overall Study|twin-twin transfusion syndrome|7|||
131224239|NCT00343642|472448785|FG000|Overall Study|Adverse Event|0|||
130707865|NCT04109313|470556585|FG000|Overall Study|Lack of Efficacy|11|||
130707866|NCT04109313|470556585|FG000|Overall Study|Lost to Follow-up|1|||
130707867|NCT04109313|470556585|FG000|Overall Study|Physician Decision|2|||
130707868|NCT04109313|470556585|FG000|Overall Study|Subject Decision|13|||
130707869|NCT04109313|470556585|FG000|Overall Study|Covid-19 situation|2|||
130707870|NCT01132664|470556586|FG000|Phase lb|Adverse Event|0|||
130707871|NCT01132664|470556587|FG001|Phase lb|Adverse Event|1|||
130707872|NCT01132664|470556588|FG002|Phase lb|Adverse Event|0|||
130707873|NCT01132664|470556589|FG003|Phase lb|Adverse Event|0|||
130707874|NCT01132664|470556590|FG004|Phase lb|Adverse Event|0|||
130707875|NCT01132664|470556586|FG000|Phase lb|Withdrawal by Subject|1|||
130707876|NCT01132664|470556587|FG001|Phase lb|Withdrawal by Subject|2|||
130707877|NCT01132664|470556588|FG002|Phase lb|Withdrawal by Subject|0|||
130707878|NCT01132664|470556589|FG003|Phase lb|Withdrawal by Subject|0|||
130707879|NCT01132664|470556590|FG004|Phase lb|Withdrawal by Subject|0|||
130707880|NCT01132664|470556586|FG000|Phase lb|Disease Progression|4|||
130707881|NCT01132664|470556587|FG001|Phase lb|Disease Progression|9|||
130707882|NCT01132664|470556588|FG002|Phase lb|Disease Progression|0|||
130707883|NCT01132664|470556589|FG003|Phase lb|Disease Progression|0|||
130707884|NCT01132664|470556590|FG004|Phase lb|Disease Progression|0|||
130707885|NCT01132664|470556586|FG000|Phase ll|Death|0|||
130707886|NCT01132664|470556587|FG001|Phase ll|Death|0|||
130707887|NCT01132664|470556588|FG002|Phase ll|Death|2|||
130707888|NCT01132664|470556589|FG003|Phase ll|Death|0|||
130707889|NCT01132664|470556590|FG004|Phase ll|Death|0|||
130707890|NCT01132664|470556586|FG000|Phase ll|Adverse Event|0|||
130707891|NCT01132664|470556587|FG001|Phase ll|Adverse Event|0|||
130707892|NCT01132664|470556588|FG002|Phase ll|Adverse Event|10|||
130707893|NCT01132664|470556589|FG003|Phase ll|Adverse Event|0|||
130707894|NCT01132664|470556590|FG004|Phase ll|Adverse Event|0|||
130707895|NCT01132664|470556586|FG000|Phase ll|Withdrawal by Subject|0|||
130707896|NCT01132664|470556587|FG001|Phase ll|Withdrawal by Subject|0|||
130707897|NCT01132664|470556588|FG002|Phase ll|Withdrawal by Subject|3|||
130707898|NCT01132664|470556589|FG003|Phase ll|Withdrawal by Subject|0|||
130707899|NCT01132664|470556590|FG004|Phase ll|Withdrawal by Subject|0|||
130707900|NCT01132664|470556586|FG000|Phase ll|Disease progression|0|||
130707901|NCT01132664|470556587|FG001|Phase ll|Disease progression|0|||
130707902|NCT01132664|470556588|FG002|Phase ll|Disease progression|35|||
130707903|NCT01132664|470556589|FG003|Phase ll|Disease progression|0|||
130707904|NCT01132664|470556590|FG004|Phase ll|Disease progression|0|||
130707905|NCT01132664|470556586|FG000|BM Cohort|Disease progression|0|||
130707906|NCT01132664|470556587|FG001|BM Cohort|Disease progression|0|||
130707907|NCT01132664|470556588|FG002|BM Cohort|Disease progression|0|||
130707908|NCT01132664|470556589|FG003|BM Cohort|Disease progression|3|||
130707909|NCT01132664|470556590|FG004|BM Cohort|Disease progression|4|||
130707910|NCT01132664|470556586|FG000|BM Cohort|Adverse Event|0|||
130707911|NCT01132664|470556587|FG001|BM Cohort|Adverse Event|0|||
130707912|NCT01132664|470556588|FG002|BM Cohort|Adverse Event|0|||
130707913|NCT01132664|470556589|FG003|BM Cohort|Adverse Event|0|||
130707914|NCT01132664|470556590|FG004|BM Cohort|Adverse Event|1|||
130707915|NCT01132664|470556586|FG000|BM Cohort|Withdrawal by Subject|0|||
130707916|NCT01132664|470556587|FG001|BM Cohort|Withdrawal by Subject|0|||
130707917|NCT01132664|470556588|FG002|BM Cohort|Withdrawal by Subject|0|||
130707918|NCT01132664|470556589|FG003|BM Cohort|Withdrawal by Subject|0|||
130707919|NCT01132664|470556590|FG004|BM Cohort|Withdrawal by Subject|1|||
130707920|NCT00655850|470556593|FG000|Overall Study|Death|2|||
130707921|NCT00655850|470556593|FG000|Overall Study|Withdrawal by Subject|1|||
130707922|NCT01567826|470556596|FG000|Overall Study|Lost to Follow-up|3|||
130707923|NCT01567826|470556597|FG001|Overall Study|Lost to Follow-up|2|||
130707924|NCT01360866|470556611|FG000|Overall Study|Lost to Follow-up|11|||
130707925|NCT01360866|470556612|FG001|Overall Study|Lost to Follow-up|28|||
130707926|NCT01360866|470556613|FG002|Overall Study|Lost to Follow-up|41|||
130707927|NCT01360866|470556614|FG003|Overall Study|Lost to Follow-up|0|||
130707928|NCT01360866|470556611|FG000|Overall Study|Adverse Event|56|||
130772426|NCT01402986|470792873|FG003|Overall Study|Lost to Follow-up|1|||
130707929|NCT01360866|470556612|FG001|Overall Study|Adverse Event|61|||
130707930|NCT01360866|470556613|FG002|Overall Study|Adverse Event|134|||
130707931|NCT01360866|470556614|FG003|Overall Study|Adverse Event|6|||
130707932|NCT01360866|470556611|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
130707933|NCT01360866|470556612|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
130707934|NCT01360866|470556613|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
130707935|NCT01360866|470556614|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
130707936|NCT01360866|470556611|FG000|Overall Study|Withdrawn by Investigator|9|||
130707937|NCT01360866|470556612|FG001|Overall Study|Withdrawn by Investigator|8|||
130707938|NCT01360866|470556613|FG002|Overall Study|Withdrawn by Investigator|31|||
130707939|NCT01360866|470556614|FG003|Overall Study|Withdrawn by Investigator|2|||
130707940|NCT01360866|470556611|FG000|Overall Study|Withdrawal by participant|79|||
130707941|NCT01360866|470556612|FG001|Overall Study|Withdrawal by participant|89|||
130707942|NCT01360866|470556613|FG002|Overall Study|Withdrawal by participant|168|||
130707943|NCT01360866|470556614|FG003|Overall Study|Withdrawal by participant|8|||
130707944|NCT01360866|470556611|FG000|Overall Study|Protocol Deviation|25|||
130707945|NCT01360866|470556612|FG001|Overall Study|Protocol Deviation|33|||
130707946|NCT01360866|470556613|FG002|Overall Study|Protocol Deviation|61|||
130707947|NCT01360866|470556614|FG003|Overall Study|Protocol Deviation|2|||
130707948|NCT01360866|470556611|FG000|Overall Study|Lack of Efficacy|30|||
130707949|NCT01360866|470556612|FG001|Overall Study|Lack of Efficacy|40|||
130707950|NCT01360866|470556613|FG002|Overall Study|Lack of Efficacy|30|||
130707951|NCT01360866|470556614|FG003|Overall Study|Lack of Efficacy|4|||
130707952|NCT03702049|470556618|FG000|Overall Study|Lost to Follow-up|4|||
130707953|NCT03702049|470556618|FG000|Overall Study|Physician Decision|1|||
130707954|NCT01715896|470556619|FG000|Overall Study|Lost to Follow-up|0|||
130707955|NCT01715896|470556620|FG001|Overall Study|Lost to Follow-up|2|||
130707956|NCT01715896|470556619|FG000|Overall Study|Withdrawal by Subject|1|||
130707957|NCT01715896|470556620|FG001|Overall Study|Withdrawal by Subject|4|||
130707958|NCT01715896|470556619|FG000|Overall Study|Other|2|||
130707959|NCT01715896|470556620|FG001|Overall Study|Other|5|||
130707960|NCT01048502|470556622|FG000|Overall Study|Lost to Follow-up|2|||
130707961|NCT01048502|470556623|FG001|Overall Study|Lost to Follow-up|0|||
130707962|NCT01048502|470556624|FG002|Overall Study|Lost to Follow-up|0|||
130707963|NCT01048502|470556625|FG003|Overall Study|Lost to Follow-up|0|||
130707964|NCT01048502|470556622|FG000|Overall Study|Adverse Event|1|||
130707965|NCT01048502|470556623|FG001|Overall Study|Adverse Event|0|||
130707966|NCT01048502|470556624|FG002|Overall Study|Adverse Event|0|||
130707967|NCT01048502|470556625|FG003|Overall Study|Adverse Event|0|||
130707968|NCT01048502|470556622|FG000|Overall Study|Withdrawal by Subject|1|||
130707969|NCT01048502|470556623|FG001|Overall Study|Withdrawal by Subject|4|||
130707970|NCT01048502|470556624|FG002|Overall Study|Withdrawal by Subject|5|||
130707971|NCT01048502|470556625|FG003|Overall Study|Withdrawal by Subject|3|||
130707972|NCT01048502|470556622|FG000|Overall Study|Physician Decision|0|||
130707973|NCT01048502|470556623|FG001|Overall Study|Physician Decision|3|||
130707974|NCT01048502|470556624|FG002|Overall Study|Physician Decision|0|||
130707975|NCT01048502|470556625|FG003|Overall Study|Physician Decision|1|||
130707976|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
130707977|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
130707978|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
130707979|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
130707980|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
130707981|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
130707982|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
130707983|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
130707984|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
130707985|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
130707986|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
130707987|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
130707988|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
130707989|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
130707990|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
130707991|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
130707992|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
130707993|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
130707994|NCT00384293|470556626|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
130707995|NCT00384293|470556627|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
130707996|NCT00384293|470556628|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
130707997|NCT00384293|470556626|FG000|Post-randomization Period|Adverse Event|0|||
131224240|NCT00343642|472448786|FG001|Overall Study|Adverse Event|0|||
130707998|NCT00384293|470556627|FG001|Post-randomization Period|Adverse Event|23|||
130707999|NCT00384293|470556628|FG002|Post-randomization Period|Adverse Event|7|||
130708000|NCT00384293|470556626|FG000|Post-randomization Period|Lost to Follow-up|0|||
130708001|NCT00384293|470556627|FG001|Post-randomization Period|Lost to Follow-up|2|||
130708002|NCT00384293|470556628|FG002|Post-randomization Period|Lost to Follow-up|1|||
130708003|NCT00384293|470556626|FG000|Post-randomization Period|Protocol Violation|0|||
130708004|NCT00384293|470556627|FG001|Post-randomization Period|Protocol Violation|1|||
130708005|NCT00384293|470556628|FG002|Post-randomization Period|Protocol Violation|0|||
130708006|NCT00384293|470556626|FG000|Post-randomization Period|Withdrawal by Subject|0|||
130708007|NCT00384293|470556627|FG001|Post-randomization Period|Withdrawal by Subject|8|||
130708008|NCT00384293|470556628|FG002|Post-randomization Period|Withdrawal by Subject|6|||
130708009|NCT00384293|470556626|FG000|Post-randomization Period|Trial Termination|0|||
130708010|NCT00384293|470556627|FG001|Post-randomization Period|Trial Termination|180|||
130708011|NCT00384293|470556628|FG002|Post-randomization Period|Trial Termination|204|||
130708012|NCT00384293|470556626|FG000|Post-randomization Period|Patient Randomized in Error|0|||
130708013|NCT00384293|470556627|FG001|Post-randomization Period|Patient Randomized in Error|0|||
131224241|NCT00343642|472448787|FG002|Overall Study|Adverse Event|1|||
131224242|NCT00343642|472448785|FG000|Overall Study|Flare up|6|||
130708014|NCT00384293|470556628|FG002|Post-randomization Period|Patient Randomized in Error|1|||
130708015|NCT05212883|470556629|FG000|Overall Study|Invalid test result|125|||
130708016|NCT02502734|470556630|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
130708017|NCT02502734|470556631|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
130708018|NCT02502734|470556630|FG000|Washout Period|Adverse Event|1|||
130708019|NCT02502734|470556631|FG001|Washout Period|Adverse Event|0|||
130708020|NCT01483625|470556634|FG000|Overall Study|Adverse Event|1|||
130708021|NCT01483625|470556635|FG001|Overall Study|Adverse Event|1|||
130708022|NCT01483625|470556634|FG000|Overall Study|Refused to continue medication|2|||
130708023|NCT01483625|470556635|FG001|Overall Study|Refused to continue medication|1|||
130708024|NCT01483625|470556634|FG000|Overall Study|Due to other reason|1|||
130708025|NCT01483625|470556635|FG001|Overall Study|Due to other reason|0|||
130708026|NCT05444543|470556639|FG000|Overall Study|Withdrawal by Subject|1|||
130708027|NCT05444543|470556640|FG001|Overall Study|Withdrawal by Subject|0|||
130708028|NCT05444543|470556639|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
130708029|NCT05444543|470556640|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
130708030|NCT05444543|470556639|FG000|Overall Study|Adverse Event|0|||
130708031|NCT05444543|470556640|FG001|Overall Study|Adverse Event|1|||
130708032|NCT05444543|470556639|FG000|Overall Study|Family relocating at a distance from study site|0|||
130708033|NCT05444543|470556640|FG001|Overall Study|Family relocating at a distance from study site|1|||
130708034|NCT02280187|470556641|FG000|Overall Study|Lost to Follow-up|218|||
130708035|NCT04668274|470556642|FG000|Part 1 Study Period 1|Adverse Event|3|||
130708036|NCT04668274|470556643|FG001|Part 1 Study Period 1|Adverse Event|0|||
130708037|NCT04668274|470556644|FG002|Part 1 Study Period 1|Adverse Event|0|||
130708038|NCT04668274|470556645|FG003|Part 1 Study Period 1|Adverse Event|0|||
130708039|NCT04668274|470556642|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
130708040|NCT04668274|470556643|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
130708041|NCT04668274|470556644|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
130708042|NCT04668274|470556645|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
130708043|NCT04668274|470556642|FG000|Part 1 Study Period 2|Other|0|||
130708044|NCT04668274|470556643|FG001|Part 1 Study Period 2|Other|1|||
130708045|NCT04668274|470556644|FG002|Part 1 Study Period 2|Other|0|||
130708046|NCT04668274|470556645|FG003|Part 1 Study Period 2|Other|0|||
130708047|NCT04668274|470556642|FG000|Part 1 Study Period 3|Adverse Event|0|||
130708048|NCT04668274|470556643|FG001|Part 1 Study Period 3|Adverse Event|0|||
130708049|NCT04668274|470556644|FG002|Part 1 Study Period 3|Adverse Event|1|||
130708050|NCT04668274|470556645|FG003|Part 1 Study Period 3|Adverse Event|0|||
130708051|NCT04668274|470556642|FG000|Part 1 Study Period 3|Other|0|||
130708052|NCT04668274|470556643|FG001|Part 1 Study Period 3|Other|0|||
130708053|NCT04668274|470556644|FG002|Part 1 Study Period 3|Other|2|||
130708054|NCT04668274|470556645|FG003|Part 1 Study Period 3|Other|0|||
130708055|NCT04668274|470556642|FG000|Part 2 Study Period 4|Other|0|||
130708056|NCT04668274|470556643|FG001|Part 2 Study Period 4|Other|0|||
130708057|NCT04668274|470556644|FG002|Part 2 Study Period 4|Other|0|||
130708058|NCT04668274|470556645|FG003|Part 2 Study Period 4|Other|1|||
130708059|NCT01832402|470556648|FG000|Overall Study|Lost to Follow-up|2|||
130708060|NCT01832402|470556649|FG001|Overall Study|Lost to Follow-up|0|||
130708061|NCT01832402|470556648|FG000|Overall Study|Withdrawal by Subject|3|||
130708062|NCT01832402|470556649|FG001|Overall Study|Withdrawal by Subject|3|||
130708063|NCT01832402|470556648|FG000|Overall Study|Declining Performance status|2|||
130942621|NCT01729754|471424747|FG006|Part 2|Lack of Efficacy|0|||
130708064|NCT01832402|470556649|FG001|Overall Study|Declining Performance status|1|||
130708065|NCT00941720|470556650|FG000|Overall Study|Withdrawal by Subject|1|||
130708066|NCT00941720|470556650|FG000|Overall Study|Insurance denied participation|11|||
130708067|NCT00941720|470556650|FG000|Overall Study|ineligible|2|||
130708068|NCT01682148|470556651|FG000|Overall Study|Withdrawal by Subject|2|||
130708069|NCT01682148|470556652|FG001|Overall Study|Withdrawal by Subject|0|||
130942622|NCT01729754|471424748|FG007|Part 2|Lack of Efficacy|0|||
130942623|NCT01729754|471424749|FG008|Part 2|Lack of Efficacy|2|||
130942624|NCT01729754|471424750|FG009|Part 2|Lack of Efficacy|2|||
130942625|NCT01729754|471424741|FG000|Part 2|Lost to Follow-up|0|||
130942626|NCT01729754|471424742|FG001|Part 2|Lost to Follow-up|0|||
130942627|NCT01729754|471424743|FG002|Part 2|Lost to Follow-up|0|||
130942628|NCT01729754|471424744|FG003|Part 2|Lost to Follow-up|2|||
130942629|NCT01729754|471424745|FG004|Part 2|Lost to Follow-up|0|||
130942630|NCT01729754|471424746|FG005|Part 2|Lost to Follow-up|0|||
130942631|NCT01729754|471424747|FG006|Part 2|Lost to Follow-up|0|||
130942632|NCT01729754|471424748|FG007|Part 2|Lost to Follow-up|1|||
130942633|NCT01729754|471424749|FG008|Part 2|Lost to Follow-up|0|||
130942634|NCT01729754|471424750|FG009|Part 2|Lost to Follow-up|2|||
130708070|NCT01682148|470556651|FG000|Overall Study|Lost to Follow-up|1|||
130708071|NCT01682148|470556652|FG001|Overall Study|Lost to Follow-up|2|||
130708072|NCT01682148|470556651|FG000|Overall Study|Protocol Violation|1|||
130708073|NCT01682148|470556652|FG001|Overall Study|Protocol Violation|1|||
130942635|NCT01729754|471424741|FG000|Part 2|Non-Compliance with Study Drug|0|||
130772427|NCT01402986|470792870|FG000|Overall Study|Other|2|||
130942636|NCT01729754|471424742|FG001|Part 2|Non-Compliance with Study Drug|0|||
130942637|NCT01729754|471424743|FG002|Part 2|Non-Compliance with Study Drug|0|||
131123525|NCT01372384|472081326|FG000|Overall Study|Progression of disease|3|||
131123526|NCT00829179|472081328|FG000|Overall Study|Withdrawal by Subject|1|||
130708074|NCT01803269|470556655|FG000|Overall Study|Withdrawal by Subject|3|||
130708075|NCT01803269|470556656|FG001|Overall Study|Withdrawal by Subject|0|||
130708076|NCT01803269|470556657|FG002|Overall Study|Withdrawal by Subject|0|||
130708077|NCT01202877|470556658|FG000|Overall Study|Disease Progression|0|||
130708078|NCT01202877|470556659|FG001|Overall Study|Disease Progression|1|||
130708079|NCT01202877|470556660|FG002|Overall Study|Disease Progression|2|||
130708080|NCT01202877|470556658|FG000|Overall Study|Adverse Event|0|||
130708081|NCT01202877|470556659|FG001|Overall Study|Adverse Event|0|||
130708082|NCT01202877|470556660|FG002|Overall Study|Adverse Event|2|||
130708083|NCT01202877|470556658|FG000|Overall Study|Withdrawal by Subject|0|||
130708084|NCT01202877|470556659|FG001|Overall Study|Withdrawal by Subject|0|||
130708085|NCT01202877|470556660|FG002|Overall Study|Withdrawal by Subject|1|||
130708086|NCT01202877|470556658|FG000|Overall Study|Death|0|||
130708087|NCT01202877|470556659|FG001|Overall Study|Death|0|||
130708088|NCT01202877|470556660|FG002|Overall Study|Death|1|||
130708089|NCT00396331|470556661|FG000|Overall Study|Failed to mobilize - no transplant|8|||
130708090|NCT00396331|470556661|FG000|Overall Study|Did not go on to transplant|5|||
130708091|NCT00396331|470556661|FG000|Overall Study|Lost to Follow-up|3|||
130708092|NCT00396331|470556661|FG000|Overall Study|Death|16|||
130708093|NCT00350402|470556662|FG000|Overall Study|Lost to Follow-up|1|||
130708094|NCT00350402|470556663|FG001|Overall Study|Lost to Follow-up|1|||
130708095|NCT01884688|470556664|FG000|Overall Study|Screen Failure|2|||
130708096|NCT01029392|470556674|FG000|Overall Study|Withdrawal by Subject|18|||
130708097|NCT01029392|470556675|FG001|Overall Study|Withdrawal by Subject|11|||
130708098|NCT01029392|470556674|FG000|Overall Study|Physician Decision|2|||
130708099|NCT01029392|470556675|FG001|Overall Study|Physician Decision|0|||
130708100|NCT00063882|470556676|FG000|Overall Study|Protocol Violation|3|||
130708101|NCT00063882|470556677|FG001|Overall Study|Protocol Violation|3|||
130708102|NCT00063882|470556676|FG000|Overall Study|Withdrawal by Subject|2|||
130708103|NCT00063882|470556677|FG001|Overall Study|Withdrawal by Subject|1|||
130708104|NCT01103479|470556678|FG000|Overall Study|Up to date with CRC screening|1|||
130708105|NCT01103479|470556679|FG001|Overall Study|Up to date with CRC screening|9|||
130708106|NCT01103479|470556680|FG002|Overall Study|Up to date with CRC screening|12|||
130708107|NCT01103479|470556678|FG000|Overall Study|Family history of CRC|1|||
130708108|NCT01103479|470556679|FG001|Overall Study|Family history of CRC|0|||
130708109|NCT01103479|470556680|FG002|Overall Study|Family history of CRC|2|||
130708110|NCT01103479|470556678|FG000|Overall Study|Active cancer|1|||
130708111|NCT01103479|470556679|FG001|Overall Study|Active cancer|0|||
130708112|NCT01103479|470556680|FG002|Overall Study|Active cancer|0|||
130708113|NCT01103479|470556678|FG000|Overall Study|Saw non-study physician|2|||
130708114|NCT01103479|470556679|FG001|Overall Study|Saw non-study physician|0|||
130708115|NCT01103479|470556680|FG002|Overall Study|Saw non-study physician|0|||
130708116|NCT02709486|470556681|FG000|Overall Study|Adverse Event|2|||
130708117|NCT02709486|470556682|FG001|Overall Study|Adverse Event|5|||
130708118|NCT02709486|470556683|FG002|Overall Study|Adverse Event|3|||
130708119|NCT02709486|470556681|FG000|Overall Study|Death|0|||
130708120|NCT02709486|470556682|FG001|Overall Study|Death|0|||
130708121|NCT02709486|470556683|FG002|Overall Study|Death|2|||
130708122|NCT02709486|470556681|FG000|Overall Study|Insufficient clinical response|7|||
130708123|NCT02709486|470556682|FG001|Overall Study|Insufficient clinical response|3|||
130708124|NCT02709486|470556683|FG002|Overall Study|Insufficient clinical response|3|||
130708125|NCT02709486|470556681|FG000|Overall Study|Lost to Follow-up|3|||
131123527|NCT03000179|472081329|FG000|Overall Study|Lost to Follow-up|2|||
131123528|NCT01075412|472081333|FG000|Overall Study|Withdrawal by Subject|0|||
131123529|NCT01075412|472081334|FG001|Overall Study|Withdrawal by Subject|1|||
131123530|NCT00865904|472081339|FG000|Overall Study|Randomized but not Treated|2|||
131123531|NCT00865904|472081340|FG001|Overall Study|Randomized but not Treated|0|||
131123532|NCT00865904|472081341|FG002|Overall Study|Randomized but not Treated|0|||
131123533|NCT00865904|472081342|FG003|Overall Study|Randomized but not Treated|1|||
131123534|NCT00865904|472081343|FG004|Overall Study|Randomized but not Treated|1|||
131123535|NCT03625687|472081344|FG000|Overall Study|Death|1|||
131123536|NCT00711425|472081349|FG000|Overall Study|Protocol Violation|1|||
131123537|NCT00711425|472081349|FG000|Overall Study|Death|2|||
130708126|NCT02709486|470556682|FG001|Overall Study|Lost to Follow-up|2|||
130708127|NCT02709486|470556683|FG002|Overall Study|Lost to Follow-up|2|||
130708128|NCT02709486|470556681|FG000|Overall Study|Other|0|||
131123538|NCT00711425|472081349|FG000|Overall Study|Lost to Follow-up|1|||
131123540|NCT05879107|472081353|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
130708129|NCT02709486|470556682|FG001|Overall Study|Other|2|||
130708130|NCT02709486|470556683|FG002|Overall Study|Other|3|||
130708131|NCT02709486|470556681|FG000|Overall Study|Withdrawal by Subject|32|||
130708132|NCT02709486|470556682|FG001|Overall Study|Withdrawal by Subject|22|||
130708133|NCT02709486|470556683|FG002|Overall Study|Withdrawal by Subject|32|||
130708134|NCT02377921|470556687|FG000|Overall Study|Subject non-compliance|1|||
130708135|NCT02377921|470556688|FG001|Overall Study|Subject non-compliance|1|||
131224243|NCT00343642|472448786|FG001|Overall Study|Flare up|4|||
131224244|NCT00343642|472448787|FG002|Overall Study|Flare up|0|||
131224245|NCT00860574|472448788|FG000|Overall Study|Death|2|||
131224246|NCT00860574|472448788|FG000|Overall Study|Relapse|1|||
131224247|NCT01011907|472448790|FG000|Overall Study|Withdrawal by Subject|13|||
131224248|NCT01011907|472448791|FG001|Overall Study|Withdrawal by Subject|11|||
131224249|NCT01011907|472448790|FG000|Overall Study|Adverse Event|1|||
131224250|NCT01011907|472448791|FG001|Overall Study|Adverse Event|4|||
131224251|NCT00304954|472448792|FG000|Overall Study|Withdrawal by Subject|0|||
131224252|NCT00304954|472448793|FG001|Overall Study|Withdrawal by Subject|0|||
131224253|NCT00304954|472448794|FG002|Overall Study|Withdrawal by Subject|1|||
131224254|NCT00304954|472448795|FG003|Overall Study|Withdrawal by Subject|0|||
131224255|NCT00304954|472448792|FG000|Overall Study|Adverse Event|1|||
131224256|NCT00304954|472448793|FG001|Overall Study|Adverse Event|0|||
131224257|NCT00304954|472448794|FG002|Overall Study|Adverse Event|0|||
131224258|NCT00304954|472448795|FG003|Overall Study|Adverse Event|0|||
131224259|NCT01406873|472448800|FG000|Overall Study|Withdrawal by Subject|1|||
131224260|NCT01406873|472448801|FG001|Overall Study|Withdrawal by Subject|1|||
131224261|NCT03990389|472448802|FG000|Overall Study|Lost to Follow-up|3|||
131224262|NCT03990389|472448803|FG001|Overall Study|Lost to Follow-up|0|||
131224263|NCT00207714|472448804|FG000|Overall Study|Adverse Event|6|||
131224264|NCT00207714|472448805|FG001|Overall Study|Adverse Event|2|||
131224265|NCT00207714|472448806|FG002|Overall Study|Adverse Event|4|||
131224266|NCT00207714|472448807|FG003|Overall Study|Adverse Event|3|||
131224267|NCT00207714|472448808|FG004|Overall Study|Adverse Event|1|||
131224268|NCT00207714|472448804|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
131224269|NCT00207714|472448805|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131224270|NCT00207714|472448806|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
131224271|NCT00207714|472448807|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
131224272|NCT00207714|472448808|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
131224273|NCT00207714|472448804|FG000|Overall Study|Other|3|||
131224274|NCT00207714|472448805|FG001|Overall Study|Other|2|||
131224275|NCT00207714|472448806|FG002|Overall Study|Other|5|||
131224276|NCT00207714|472448807|FG003|Overall Study|Other|1|||
131224277|NCT00207714|472448808|FG004|Overall Study|Other|0|||
131224278|NCT00736099|472448810|FG000|Overall Study|Adverse Event|61|||
131224279|NCT00736099|472448811|FG001|Overall Study|Adverse Event|18|||
131224280|NCT00736099|472448810|FG000|Overall Study|Protocol Violation|10|||
131224281|NCT00736099|472448811|FG001|Overall Study|Protocol Violation|4|||
131224282|NCT00736099|472448810|FG000|Overall Study|Lost to Follow-up|12|||
131224283|NCT00736099|472448811|FG001|Overall Study|Lost to Follow-up|5|||
131224284|NCT00736099|472448810|FG000|Overall Study|Withdrawal by Subject|42|||
131224285|NCT00736099|472448811|FG001|Overall Study|Withdrawal by Subject|13|||
131224286|NCT00736099|472448810|FG000|Overall Study|Lack of Efficacy|15|||
131224287|NCT00736099|472448811|FG001|Overall Study|Lack of Efficacy|8|||
131224288|NCT00736099|472448810|FG000|Overall Study|Other reason|43|||
131224289|NCT00736099|472448811|FG001|Overall Study|Other reason|10|||
131224290|NCT02290028|472448814|FG000|Overall Study|Death|217|||
131224291|NCT02290028|472448814|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
131224292|NCT02290028|472448814|FG000|Overall Study|No longer under care of study physician|76|||
131224293|NCT02290028|472448814|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
131224294|NCT02290028|472448814|FG000|Overall Study|Withdrawal by Subject|52|||
131224295|NCT02290028|472448814|FG000|Overall Study|Study site closure|44|||
131224296|NCT02290028|472448814|FG000|Overall Study|Lost to Follow-up|34|||
131224297|NCT02290028|472448814|FG000|Overall Study|Miscellaneous|10|||
130772428|NCT01402986|470792871|FG001|Overall Study|Other|5|||
130772429|NCT01402986|470792872|FG002|Overall Study|Other|1|||
131224298|NCT02290028|472448814|FG000|Overall Study|Transition to EP PASSION|1295|||
131224299|NCT02290028|472448814|FG000|Overall Study|Planned study completion at 12 months|257|||
131224300|NCT03202511|472448815|FG000|Overall Study|Withdrawal by Subject|1|||
131224301|NCT03202511|472448816|FG001|Overall Study|Withdrawal by Subject|0|||
131224302|NCT00833547|472448817|FG000|Overall Study|Withdrawal by Subject|2|||
131224303|NCT00833547|472448818|FG001|Overall Study|Withdrawal by Subject|2|||
131224304|NCT00686790|472448819|FG000|Overall Study|Adverse Event|2|||
131224305|NCT00686790|472448819|FG000|Overall Study|Withdrawal by Subject|1|||
131224306|NCT00686790|472448819|FG000|Overall Study|Death|1|||
131224307|NCT00686790|472448819|FG000|Overall Study|Lost to Follow-up|12|||
131224308|NCT00265083|472448820|FG000|Overall Study|Adverse Event|5|||
131224309|NCT00265083|472448821|FG001|Overall Study|Adverse Event|13|||
131224310|NCT00265083|472448822|FG002|Overall Study|Adverse Event|15|||
131224311|NCT00265083|472448820|FG000|Overall Study|Lost to Follow-up|3|||
131224312|NCT00265083|472448821|FG001|Overall Study|Lost to Follow-up|4|||
131224313|NCT00265083|472448822|FG002|Overall Study|Lost to Follow-up|4|||
131224314|NCT00265083|472448820|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
131224315|NCT00265083|472448821|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
131224316|NCT00265083|472448822|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
131224317|NCT00265083|472448820|FG000|Overall Study|Other|1|||
131224318|NCT00265083|472448821|FG001|Overall Study|Other|12|||
131224319|NCT00265083|472448822|FG002|Overall Study|Other|9|||
130708136|NCT02549573|470556693|FG000|Overall Study|Withdrawal by Subject|0|||
130708137|NCT02549573|470556694|FG001|Overall Study|Withdrawal by Subject|2|||
130708138|NCT02549573|470556693|FG000|Overall Study|Protocol Violation|0|||
130708139|NCT02549573|470556694|FG001|Overall Study|Protocol Violation|1|||
130708140|NCT01010126|470558279|FG000|Overall Study|Withdrawal by Subject|1|||
130708141|NCT01010126|470558280|FG001|Overall Study|Withdrawal by Subject|0|||
130708142|NCT01010126|470558281|FG002|Overall Study|Withdrawal by Subject|1|||
130708143|NCT01010126|470558282|FG003|Overall Study|Withdrawal by Subject|0|||
130708144|NCT01010126|470558283|FG004|Overall Study|Withdrawal by Subject|3|||
130708145|NCT01010126|470558284|FG005|Overall Study|Withdrawal by Subject|0|||
130708146|NCT00595335|470558287|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
130708147|NCT00595335|470558288|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
130708148|NCT00595335|470558287|FG000|Baseline to Six Months|Disease Progression|1|||
130708149|NCT00595335|470558288|FG001|Baseline to Six Months|Disease Progression|1|||
130708150|NCT00595335|470558287|FG000|Baseline to Six Months|Adverse Event|1|||
130708151|NCT00595335|470558288|FG001|Baseline to Six Months|Adverse Event|0|||
130708152|NCT00595335|470558287|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
130708153|NCT00595335|470558288|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
130708154|NCT00595335|470558287|FG000|Six Months to Twelve Months|Disease Progression|1|||
130708155|NCT00595335|470558288|FG001|Six Months to Twelve Months|Disease Progression|0|||
130708156|NCT02658487|470558294|FG000|Overall Study|Death|2|||
130708157|NCT02658487|470558294|FG000|Overall Study|Disease progression|10|||
130708158|NCT02658487|470558294|FG000|Overall Study|Alternative therapy|1|||
130708159|NCT02658487|470558294|FG000|Overall Study|Adverse Event|1|||
130708160|NCT02658487|470558294|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
130708161|NCT02658487|470558294|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
130708162|NCT01647958|470558295|FG000|Initial Study|Lost to Follow-up|2|||
130708163|NCT01647958|470558296|FG001|Initial Study|Lost to Follow-up|3|||
130708164|NCT01647958|470558295|FG000|Continuation Phase|treatment received during Overall Study|39|||
130708165|NCT01647958|470558296|FG001|Continuation Phase|treatment received during Overall Study|0|||
130708166|NCT01647958|470558295|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
130708167|NCT01647958|470558296|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
130708168|NCT00544817|470558297|FG000|Combined Modality|Lack of Efficacy|2|||
130708169|NCT00544817|470558297|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
130708170|NCT00544817|470558297|FG000|Combined Modality|Adverse Event|2|||
130708171|NCT00544817|470558297|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
130708172|NCT00544817|470558297|FG000|No Treatment Interval|Lack of Efficacy|8|||
130708173|NCT00544817|470558297|FG000|No Treatment Interval|Physician Decision|3|||
130708174|NCT00544817|470558297|FG000|No Treatment Interval|Adverse Event|1|||
130708175|NCT00544817|470558297|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
130708176|NCT00544817|470558297|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
130708177|NCT00544817|470558297|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
130708178|NCT01131299|470558298|FG000|Overall Study|Withdrawal by Subject|4|||
130708179|NCT01131299|470558299|FG001|Overall Study|Withdrawal by Subject|7|||
130708180|NCT03686150|470558306|FG000|Overall Study|Withdrawal by Subject|1|||
130708181|NCT03686150|470558307|FG001|Overall Study|Withdrawal by Subject|1|||
130708182|NCT03686150|470558308|FG002|Overall Study|Withdrawal by Subject|1|||
130708183|NCT03686150|470558309|FG003|Overall Study|Withdrawal by Subject|0|||
130708184|NCT03686150|470558310|FG004|Overall Study|Withdrawal by Subject|1|||
130708185|NCT03686150|470558311|FG005|Overall Study|Withdrawal by Subject|2|||
130708186|NCT03686150|470558306|FG000|Overall Study|Physician Decision|1|||
130942638|NCT01729754|471424744|FG003|Part 2|Non-Compliance with Study Drug|0|||
131123541|NCT05879107|472081354|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
131123542|NCT05879107|472081353|FG000|Overall Study|Migrated / moved from the study area|1|||
131123543|NCT05879107|472081354|FG001|Overall Study|Migrated / moved from the study area|1|||
131123544|NCT05879107|472081353|FG000|Overall Study|Lost to Follow-up|8|||
131123545|NCT05879107|472081354|FG001|Overall Study|Lost to Follow-up|13|||
131123546|NCT05879107|472081353|FG000|Overall Study|Death|0|||
131123547|NCT05879107|472081354|FG001|Overall Study|Death|2|||
131123548|NCT05879107|472081353|FG000|Overall Study|Other|0|||
131123549|NCT05879107|472081354|FG001|Overall Study|Other|3|||
131123550|NCT04607148|472081357|FG000|Overall Study|Withdrawal by Subject|0|||
131123551|NCT04607148|472081358|FG001|Overall Study|Withdrawal by Subject|4|||
130708187|NCT03686150|470558307|FG001|Overall Study|Physician Decision|0|||
130708188|NCT03686150|470558308|FG002|Overall Study|Physician Decision|0|||
130708189|NCT03686150|470558309|FG003|Overall Study|Physician Decision|0|||
130708190|NCT03686150|470558310|FG004|Overall Study|Physician Decision|0|||
130708191|NCT03686150|470558311|FG005|Overall Study|Physician Decision|1|||
130708192|NCT03686150|470558306|FG000|Overall Study|Lost to Follow-up|0|||
130708193|NCT03686150|470558307|FG001|Overall Study|Lost to Follow-up|1|||
130708194|NCT03686150|470558308|FG002|Overall Study|Lost to Follow-up|0|||
131123552|NCT04607148|472081359|FG002|Overall Study|Withdrawal by Subject|2|||
131123553|NCT04607148|472081360|FG003|Overall Study|Withdrawal by Subject|8|||
131123554|NCT04607148|472081357|FG000|Overall Study|Study Terminated by Sponsor|14|||
131123555|NCT04607148|472081358|FG001|Overall Study|Study Terminated by Sponsor|59|||
130708195|NCT03686150|470558309|FG003|Overall Study|Lost to Follow-up|0|||
130708196|NCT03686150|470558310|FG004|Overall Study|Lost to Follow-up|0|||
130708197|NCT03686150|470558311|FG005|Overall Study|Lost to Follow-up|0|||
130708198|NCT00614926|470558312|FG000|Overall Study|Burden of travel|1|||
130708199|NCT00614926|470558313|FG001|Overall Study|Burden of travel|0|||
130708200|NCT00614926|470558312|FG000|Overall Study|Adverse Event|3|||
130708201|NCT00614926|470558313|FG001|Overall Study|Adverse Event|0|||
130708202|NCT03341000|470558316|FG000|Overall Study|Adverse Event|1|||
130708203|NCT02813421|470558319|FG000|Overall Study|Withdrawal by Subject|1|||
130708204|NCT02813421|470558320|FG001|Overall Study|Withdrawal by Subject|2|||
130708205|NCT02813421|470558319|FG000|Overall Study|Lost to Follow-up|1|||
130708206|NCT02813421|470558320|FG001|Overall Study|Lost to Follow-up|1|||
130708207|NCT01213836|470558335|FG000|Period 1, First Intervention|Adverse Event|2|||
130708208|NCT01213836|470558336|FG001|Period 1, First Intervention|Adverse Event|1|||
130708209|NCT01213836|470558335|FG000|Period 1, First Intervention|Protocol Violation|0|||
130708210|NCT01213836|470558336|FG001|Period 1, First Intervention|Protocol Violation|1|||
130708211|NCT01213836|470558335|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
130708212|NCT01213836|470558336|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
130708213|NCT00255151|470558337|FG000|Overall Study|Adverse Event|10|||
130708214|NCT00255151|470558338|FG001|Overall Study|Adverse Event|6|||
130708215|NCT00255151|470558339|FG002|Overall Study|Adverse Event|9|||
130708216|NCT00255151|470558337|FG000|Overall Study|Lost to Follow-up|4|||
130708217|NCT00255151|470558338|FG001|Overall Study|Lost to Follow-up|3|||
130708218|NCT00255151|470558339|FG002|Overall Study|Lost to Follow-up|4|||
130708219|NCT00255151|470558337|FG000|Overall Study|Withdrawal by Subject|18|||
130708220|NCT00255151|470558338|FG001|Overall Study|Withdrawal by Subject|17|||
130708221|NCT00255151|470558339|FG002|Overall Study|Withdrawal by Subject|8|||
130708222|NCT00255151|470558337|FG000|Overall Study|Noncompliance|0|||
130708223|NCT00255151|470558338|FG001|Overall Study|Noncompliance|1|||
130708224|NCT00255151|470558339|FG002|Overall Study|Noncompliance|2|||
130708225|NCT00255151|470558337|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
130708226|NCT00255151|470558338|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
130708227|NCT00255151|470558339|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
130708228|NCT00255151|470558337|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
130708229|NCT00255151|470558338|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
130708230|NCT00255151|470558339|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
130708231|NCT00255151|470558337|FG000|Overall Study|Possible Barrett's Esophagus|1|||
130708232|NCT00255151|470558338|FG001|Overall Study|Possible Barrett's Esophagus|3|||
130708233|NCT00255151|470558339|FG002|Overall Study|Possible Barrett's Esophagus|8|||
130708234|NCT00255151|470558337|FG000|Overall Study|Esophageal Stricture|0|||
130708235|NCT00255151|470558338|FG001|Overall Study|Esophageal Stricture|0|||
130708236|NCT00255151|470558339|FG002|Overall Study|Esophageal Stricture|1|||
130708237|NCT00255151|470558337|FG000|Overall Study|Therapeutic Failure|11|||
130708238|NCT00255151|470558338|FG001|Overall Study|Therapeutic Failure|2|||
130708239|NCT00255151|470558339|FG002|Overall Study|Therapeutic Failure|3|||
130708240|NCT00706095|470558340|FG000|Overall Study|Progressive Disease|4|||
130708241|NCT00706095|470558341|FG001|Overall Study|Progressive Disease|5|||
130708242|NCT00706095|470558342|FG002|Overall Study|Progressive Disease|3|||
130708243|NCT00706095|470558340|FG000|Overall Study|Clinical Progression|1|||
130708244|NCT00706095|470558341|FG001|Overall Study|Clinical Progression|2|||
130708245|NCT00706095|470558342|FG002|Overall Study|Clinical Progression|2|||
130708246|NCT00706095|470558340|FG000|Overall Study|Withdrawal by Subject|1|||
130708247|NCT00706095|470558341|FG001|Overall Study|Withdrawal by Subject|0|||
130708248|NCT00706095|470558342|FG002|Overall Study|Withdrawal by Subject|0|||
130708249|NCT02676284|470558343|FG000|Overall Study|Withdrawal by Subject|1|||
130708250|NCT01685073|470558344|FG000|Overall Study|Lost to Follow-up|6|||
130708251|NCT01685073|470558345|FG001|Overall Study|Lost to Follow-up|8|||
130708252|NCT01685073|470558344|FG000|Overall Study|Withdrawal by Subject|24|||
130708253|NCT01685073|470558345|FG001|Overall Study|Withdrawal by Subject|24|||
130708254|NCT00107042|470558350|FG000|Overall Study|Lost to Follow-up|9|||
130708255|NCT00107042|470558351|FG001|Overall Study|Lost to Follow-up|7|||
130708256|NCT00107042|470558350|FG000|Overall Study|Withdrawal by Subject|6|||
130708257|NCT00107042|470558351|FG001|Overall Study|Withdrawal by Subject|1|||
130708258|NCT00107042|470558350|FG000|Overall Study|Moved out of area|5|||
130708259|NCT00107042|470558351|FG001|Overall Study|Moved out of area|3|||
130708260|NCT00107042|470558350|FG000|Overall Study|Pregnancy|1|||
130708261|NCT00107042|470558351|FG001|Overall Study|Pregnancy|1|||
130708262|NCT00107042|470558350|FG000|Overall Study|Inadvertent enrollment|0|||
130708263|NCT00107042|470558351|FG001|Overall Study|Inadvertent enrollment|1|||
130708264|NCT00107042|470558350|FG000|Overall Study|vaccinated outside window|1|||
130708265|NCT00107042|470558351|FG001|Overall Study|vaccinated outside window|1|||
130708266|NCT00107042|470558350|FG000|Overall Study|Disallowed medications|0|||
130708267|NCT00107042|470558351|FG001|Overall Study|Disallowed medications|2|||
130772430|NCT01402986|470792873|FG003|Overall Study|Other|6|||
131224320|NCT03208933|472448823|FG000|Overall Study|Death|3|||
130708268|NCT01221090|470558352|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
130772431|NCT02427802|470792874|FG000|Overall Study|Adverse Event|11|||
130708269|NCT01221090|470558353|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
130708270|NCT01221090|470558354|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
130708271|NCT01221090|470558355|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
130708272|NCT01221090|470558352|FG000|Overall Study|Withdrawal by Subject|0|||
130708273|NCT01221090|470558353|FG001|Overall Study|Withdrawal by Subject|22|||
130708274|NCT01221090|470558354|FG002|Overall Study|Withdrawal by Subject|27|||
130708275|NCT01221090|470558355|FG003|Overall Study|Withdrawal by Subject|2|||
130708276|NCT00708708|470558356|FG000|Overall Study|Another therapy instead of Enbrel|141|||
130708277|NCT00708708|470558356|FG000|Overall Study|Lost to Follow-up|52|||
130708278|NCT00708708|470558356|FG000|Overall Study|Withdrawal by Subject|51|||
130708279|NCT00708708|470558356|FG000|Overall Study|Intolerance|42|||
130708280|NCT00708708|470558356|FG000|Overall Study|Another therapy along with Enbrel|15|||
130708281|NCT00708708|470558356|FG000|Overall Study|Other unspecified|11|||
130708282|NCT00708708|470558356|FG000|Overall Study|Good effectiveness|9|||
130708283|NCT00708708|470558356|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
130708284|NCT00708708|470558356|FG000|Overall Study|Administrative reasons|7|||
130708285|NCT00708708|470558356|FG000|Overall Study|Lack of effectiveness|4|||
130708286|NCT00708708|470558356|FG000|Overall Study|Lack of compliance|3|||
130708287|NCT00708708|470558356|FG000|Overall Study|Pregnancy|3|||
130708288|NCT00708708|470558356|FG000|Overall Study|Adverse Event|3|||
130708289|NCT00708708|470558356|FG000|Overall Study|Missing values|392|||
130708290|NCT03768726|470558360|FG000|Treatment Phase|Adverse Event|2|||
130708291|NCT03768726|470558361|FG001|Treatment Phase|Adverse Event|2|||
130708292|NCT03768726|470558360|FG000|Treatment Phase|Lost to Follow-up|1|||
130708293|NCT03768726|470558361|FG001|Treatment Phase|Lost to Follow-up|0|||
130708294|NCT03768726|470558360|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
130708295|NCT03768726|470558361|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
130708296|NCT03768726|470558360|FG000|Treatment Phase|Withdrawal by Subject|3|||
130708297|NCT03768726|470558361|FG001|Treatment Phase|Withdrawal by Subject|1|||
130708298|NCT03768726|470558360|FG000|Follow-Up|Adverse Event|2|||
130708299|NCT03768726|470558361|FG001|Follow-Up|Adverse Event|2|||
130708300|NCT03768726|470558360|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
130708301|NCT03768726|470558361|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
130708302|NCT03768726|470558360|FG000|Follow-Up|Withdrawal by Subject|2|||
130708303|NCT03768726|470558361|FG001|Follow-Up|Withdrawal by Subject|0|||
130708304|NCT03768726|470558360|FG000|Follow-Up|Other|1|||
130708305|NCT03768726|470558361|FG001|Follow-Up|Other|0|||
130708306|NCT01286558|470558362|FG000|Overall Study|Adverse Event|1|||
130708307|NCT01286558|470558363|FG001|Overall Study|Adverse Event|1|||
130708308|NCT01286558|470558362|FG000|Overall Study|Withdrawal by Subject|0|||
130708309|NCT01286558|470558363|FG001|Overall Study|Withdrawal by Subject|1|||
130708310|NCT01787279|470558365|FG000|Overall Study|Lost to Follow-up|2|||
130708311|NCT01787279|470558365|FG000|Overall Study|Lack of Efficacy|1|||
130708312|NCT01272921|470558367|FG000|Overall Study|Protocol Violation|2|||
130708313|NCT01272921|470558368|FG001|Overall Study|Protocol Violation|1|||
130708314|NCT00892281|470558370|FG000|Overall Study|Adverse Event|65|||
130708315|NCT00892281|470558371|FG001|Overall Study|Adverse Event|8|||
130708316|NCT00892281|470558370|FG000|Overall Study|Lost to Follow-up|81|||
130708317|NCT00892281|470558371|FG001|Overall Study|Lost to Follow-up|8|||
130708318|NCT00892281|470558370|FG000|Overall Study|Pregnancy|1|||
130708319|NCT00892281|470558371|FG001|Overall Study|Pregnancy|0|||
130708320|NCT00892281|470558370|FG000|Overall Study|Protocol Violation|7|||
130708321|NCT00892281|470558371|FG001|Overall Study|Protocol Violation|2|||
130708322|NCT00892281|470558370|FG000|Overall Study|Withdrawal by Subject|86|||
130708323|NCT00892281|470558371|FG001|Overall Study|Withdrawal by Subject|14|||
130708324|NCT00892281|470558370|FG000|Overall Study|Subject failed to return for final visit|2|||
130708325|NCT00892281|470558371|FG001|Overall Study|Subject failed to return for final visit|0|||
130708326|NCT00892281|470558370|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
130708327|NCT00892281|470558371|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
130708328|NCT00892281|470558370|FG000|Overall Study|Final visit completed 4 weeks late|0|||
130708329|NCT00892281|470558371|FG001|Overall Study|Final visit completed 4 weeks late|1|||
131123556|NCT04607148|472081359|FG002|Overall Study|Study Terminated by Sponsor|9|||
131123557|NCT04607148|472081360|FG003|Overall Study|Study Terminated by Sponsor|39|||
131123558|NCT04607148|472081357|FG000|Overall Study|Sponsor Decision|0|||
131123559|NCT04607148|472081358|FG001|Overall Study|Sponsor Decision|0|||
130708330|NCT00892281|470558370|FG000|Overall Study|Subject completed day after study closed|1|||
130708331|NCT00892281|470558371|FG001|Overall Study|Subject completed day after study closed|0|||
130708332|NCT00892281|470558370|FG000|Overall Study|Family emergency|1|||
130708333|NCT00892281|470558371|FG001|Overall Study|Family emergency|0|||
130708334|NCT00892281|470558370|FG000|Overall Study|Last visit not done - death in family|1|||
130708335|NCT00892281|470558371|FG001|Overall Study|Last visit not done - death in family|0|||
130708336|NCT00892281|470558370|FG000|Overall Study|Did not meet incl/excl criteria|1|||
130708337|NCT00892281|470558371|FG001|Overall Study|Did not meet incl/excl criteria|0|||
130708338|NCT00892281|470558370|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
130708339|NCT00892281|470558371|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
130772432|NCT02427802|470792875|FG001|Overall Study|Adverse Event|3|||
130708340|NCT00892281|470558370|FG000|Overall Study|Unable to redeem the drug voucher|1|||
130708341|NCT00892281|470558371|FG001|Overall Study|Unable to redeem the drug voucher|0|||
130708342|NCT00892281|470558370|FG000|Overall Study|Subject not good candidate for study|1|||
130708343|NCT00892281|470558371|FG001|Overall Study|Subject not good candidate for study|0|||
130708344|NCT00892281|470558370|FG000|Overall Study|Subject did not return for any visits|1|||
130708345|NCT00892281|470558371|FG001|Overall Study|Subject did not return for any visits|0|||
130708346|NCT00892281|470558370|FG000|Overall Study|Subject missed several visits/lost meds|1|||
130708347|NCT00892281|470558371|FG001|Overall Study|Subject missed several visits/lost meds|0|||
130708348|NCT00892281|470558370|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
130708349|NCT00892281|470558371|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
130708350|NCT00892281|470558370|FG000|Overall Study|Scheduled for knee replacement|0|||
130708351|NCT00892281|470558371|FG001|Overall Study|Scheduled for knee replacement|1|||
130708352|NCT00892281|470558370|FG000|Overall Study|PI complained of inadequate compensation|3|||
130708353|NCT00892281|470558371|FG001|Overall Study|PI complained of inadequate compensation|0|||
130708354|NCT00892281|470558370|FG000|Overall Study|Subject lost interest in program|0|||
130708355|NCT00892281|470558371|FG001|Overall Study|Subject lost interest in program|1|||
130708356|NCT00892281|470558370|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
130708357|NCT00892281|470558371|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
130708358|NCT00892281|470558370|FG000|Overall Study|Death in family|1|||
130708359|NCT00892281|470558371|FG001|Overall Study|Death in family|0|||
130708360|NCT00892281|470558370|FG000|Overall Study|Lack of efficacy of study product|2|||
130708361|NCT00892281|470558371|FG001|Overall Study|Lack of efficacy of study product|0|||
130708362|NCT00892281|470558370|FG000|Overall Study|Subject not seen by PI at final visit|1|||
130708363|NCT00892281|470558371|FG001|Overall Study|Subject not seen by PI at final visit|0|||
130708364|NCT00892281|470558370|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
130708365|NCT00892281|470558371|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
130708366|NCT00892281|470558370|FG000|Overall Study|Missed multiple visits|1|||
130708367|NCT00892281|470558371|FG001|Overall Study|Missed multiple visits|0|||
130708368|NCT00892281|470558370|FG000|Overall Study|Missed visits rescheduled out of window|1|||
130708369|NCT00892281|470558371|FG001|Overall Study|Missed visits rescheduled out of window|0|||
130708370|NCT00892281|470558370|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
130708371|NCT00892281|470558371|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
130708372|NCT00892281|470558370|FG000|Overall Study|Subject had history of drug abuse|1|||
130708373|NCT00892281|470558371|FG001|Overall Study|Subject had history of drug abuse|0|||
130708374|NCT00892281|470558370|FG000|Overall Study|Rash on hand|1|||
130708375|NCT00892281|470558371|FG001|Overall Study|Rash on hand|0|||
130708376|NCT00892281|470558370|FG000|Overall Study|Visit 4 date out of window|1|||
130708377|NCT00892281|470558371|FG001|Overall Study|Visit 4 date out of window|0|||
130708378|NCT00140413|470558372|FG000|Overall Study|Lost to Follow-up|1|||
130708379|NCT00140413|470558373|FG001|Overall Study|Lost to Follow-up|0|||
130708380|NCT00140413|470558372|FG000|Overall Study|Withdrawal by Subject|2|||
130708381|NCT00140413|470558373|FG001|Overall Study|Withdrawal by Subject|0|||
130708382|NCT00865098|470558374|FG000|Overall Study|Progressive disease|1|||
130708383|NCT01304693|470558375|FG000|Overall Study|Adverse Event|0|||
130708384|NCT01304693|470558376|FG001|Overall Study|Adverse Event|0|||
130708385|NCT01304693|470558377|FG002|Overall Study|Adverse Event|0|||
130708386|NCT01304693|470558378|FG003|Overall Study|Adverse Event|0|||
130708387|NCT01304693|470558379|FG004|Overall Study|Adverse Event|1|||
130708388|NCT01304693|470558375|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
130708389|NCT01304693|470558376|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
130708390|NCT01304693|470558377|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
130708391|NCT01304693|470558378|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
130708392|NCT01304693|470558379|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
130708393|NCT02129647|470558380|FG000|Overall Study|Adverse Event|2|||
130708394|NCT02129647|470558380|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
130708395|NCT01833533|470558388|FG000|Overall Study|Adverse Event|0|||
130708396|NCT01833533|470558389|FG001|Overall Study|Adverse Event|1|||
130708397|NCT01833533|470558388|FG000|Overall Study|Lost to Follow-up|4|||
130708398|NCT01833533|470558389|FG001|Overall Study|Lost to Follow-up|9|||
130708399|NCT01833533|470558388|FG000|Overall Study|To Enter an Extension Study|0|||
130708400|NCT01833533|470558389|FG001|Overall Study|To Enter an Extension Study|4|||
130708401|NCT01833533|470558388|FG000|Overall Study|Other|2|||
130708402|NCT01833533|470558389|FG001|Overall Study|Other|7|||
130772433|NCT02427802|470792876|FG002|Overall Study|Adverse Event|7|||
130772434|NCT02427802|470792874|FG000|Overall Study|Death|0|||
130772435|NCT02427802|470792875|FG001|Overall Study|Death|4|||
130708403|NCT01138826|470558393|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
130708404|NCT01138826|470558394|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
130708405|NCT01138826|470558395|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
130708406|NCT01138826|470558396|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
130708407|NCT01138826|470558397|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
130772436|NCT02427802|470792876|FG002|Overall Study|Death|1|||
130708408|NCT01138826|470558398|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
130708409|NCT01333072|470558402|FG000|Overall Study|Lost to Follow-up|3|||
130708410|NCT01333072|470558403|FG001|Overall Study|Lost to Follow-up|0|||
130708411|NCT01333072|470558402|FG000|Overall Study|Adverse Event|2|||
130708412|NCT01333072|470558403|FG001|Overall Study|Adverse Event|4|||
130708413|NCT01333072|470558402|FG000|Overall Study|Physician Decision|1|||
130708414|NCT01333072|470558403|FG001|Overall Study|Physician Decision|0|||
130708415|NCT01557842|470558404|FG000|Overall Study|Lost to Follow-up|0|||
130708416|NCT01557842|470558405|FG001|Overall Study|Lost to Follow-up|1|||
130708417|NCT01557842|470558404|FG000|Overall Study|Death|1|||
130708418|NCT01557842|470558405|FG001|Overall Study|Death|0|||
130708419|NCT01557842|470558404|FG000|Overall Study|Lack of Efficacy|0|||
130708420|NCT01557842|470558405|FG001|Overall Study|Lack of Efficacy|1|||
130708421|NCT01557842|470558404|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
130708422|NCT01557842|470558405|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
130708423|NCT01557842|470558404|FG000|Overall Study|Study Terminated by Sponsor|3|||
130708424|NCT01557842|470558405|FG001|Overall Study|Study Terminated by Sponsor|4|||
130708425|NCT01557842|470558404|FG000|Overall Study|Not Ablated|2|||
130708426|NCT01557842|470558405|FG001|Overall Study|Not Ablated|0|||
130708427|NCT02457611|470558409|FG000|Overall Study|Lost to Follow-up|3|||
130708428|NCT03005067|470558410|FG000|Overall Study|Withdrawal by Subject|3|||
130708429|NCT03005067|470558411|FG001|Overall Study|Withdrawal by Subject|2|||
130708430|NCT03005067|470558410|FG000|Overall Study|Adverse Event|4|||
130708431|NCT03005067|470558411|FG001|Overall Study|Adverse Event|3|||
130708432|NCT03005067|470558410|FG000|Overall Study|Other (reason not specified)|3|||
130708433|NCT03005067|470558411|FG001|Overall Study|Other (reason not specified)|1|||
130708434|NCT03005067|470558410|FG000|Overall Study|Protocol Violation|0|||
130708435|NCT03005067|470558411|FG001|Overall Study|Protocol Violation|1|||
130708436|NCT00619359|470558414|FG000|Overall Study|Adverse Event|32|||
130708437|NCT00619359|470558415|FG001|Overall Study|Adverse Event|36|||
130708438|NCT00619359|470558414|FG000|Overall Study|Lost to Follow-up|12|||
130708439|NCT00619359|470558415|FG001|Overall Study|Lost to Follow-up|16|||
130708440|NCT00619359|470558414|FG000|Overall Study|Physician Decision|0|||
130708441|NCT00619359|470558415|FG001|Overall Study|Physician Decision|7|||
130708442|NCT00619359|470558414|FG000|Overall Study|Protocol Violation|1|||
130708443|NCT00619359|470558415|FG001|Overall Study|Protocol Violation|1|||
130708444|NCT00619359|470558414|FG000|Overall Study|Withdrawal by Subject|19|||
130708445|NCT00619359|470558415|FG001|Overall Study|Withdrawal by Subject|20|||
130708446|NCT00619359|470558414|FG000|Overall Study|Progressive Disease|3|||
130708447|NCT00619359|470558415|FG001|Overall Study|Progressive Disease|1|||
130708448|NCT03891329|470558431|FG000|Overall Study|Death|5|||
130708449|NCT03891329|470558431|FG000|Overall Study|Lost to Follow-up|4|||
130708450|NCT03891329|470558431|FG000|Overall Study|Physician Decision|4|||
130708451|NCT03891329|470558431|FG000|Overall Study|Device explanted|3|||
130708452|NCT03891329|470558431|FG000|Overall Study|No study device implanted|3|||
131123560|NCT04607148|472081359|FG002|Overall Study|Sponsor Decision|1|||
131123561|NCT04607148|472081360|FG003|Overall Study|Sponsor Decision|0|||
131123562|NCT04607148|472081357|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131123563|NCT04607148|472081358|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131123564|NCT04607148|472081359|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131123565|NCT04607148|472081360|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131123566|NCT04607148|472081357|FG000|Overall Study|Lost to Follow-up|0|||
131123567|NCT04607148|472081358|FG001|Overall Study|Lost to Follow-up|2|||
131123568|NCT04607148|472081359|FG002|Overall Study|Lost to Follow-up|0|||
131123569|NCT04607148|472081360|FG003|Overall Study|Lost to Follow-up|0|||
131123570|NCT04607148|472081357|FG000|Overall Study|Death|0|||
131123571|NCT04607148|472081358|FG001|Overall Study|Death|3|||
131123572|NCT04607148|472081359|FG002|Overall Study|Death|0|||
131123573|NCT04607148|472081360|FG003|Overall Study|Death|1|||
131123574|NCT04607148|472081357|FG000|Overall Study|Adverse Event|0|||
131123575|NCT04607148|472081358|FG001|Overall Study|Adverse Event|1|||
131123576|NCT04607148|472081359|FG002|Overall Study|Adverse Event|0|||
131123577|NCT04607148|472081360|FG003|Overall Study|Adverse Event|0|||
130708453|NCT03176784|470558432|FG000|Overall Study|Lost to Follow-up|77|||
130708454|NCT03176784|470558433|FG001|Overall Study|Lost to Follow-up|79|||
130942639|NCT01729754|471424745|FG004|Part 2|Non-Compliance with Study Drug|0|||
130708455|NCT03176784|470558434|FG002|Overall Study|Lost to Follow-up|79|||
130708456|NCT03176784|470558435|FG003|Overall Study|Lost to Follow-up|49|||
130708457|NCT03176784|470558432|FG000|Overall Study|Withdrawal by Subject|28|||
130708458|NCT03176784|470558433|FG001|Overall Study|Withdrawal by Subject|34|||
130708459|NCT03176784|470558434|FG002|Overall Study|Withdrawal by Subject|34|||
130708460|NCT03176784|470558435|FG003|Overall Study|Withdrawal by Subject|21|||
130708461|NCT01351350|470558436|FG000|Overall Study|Disease Progression|5|||
130708462|NCT01351350|470558437|FG001|Overall Study|Disease Progression|13|||
130708463|NCT01351350|470558438|FG002|Overall Study|Disease Progression|6|||
131123578|NCT00916149|472081363|FG000|Overall Study|Lost to Follow-up|3|||
131123579|NCT00916149|472081364|FG001|Overall Study|Lost to Follow-up|2|||
131123580|NCT00916149|472081365|FG002|Overall Study|Lost to Follow-up|0|||
131123581|NCT00916149|472081363|FG000|Overall Study|Unable to place scalp EEG leads|1|||
131224321|NCT03208933|472448823|FG000|Overall Study|Withdrawal by Subject|3|||
131224322|NCT03208933|472448823|FG000|Overall Study|Adverse Event|1|||
131224323|NCT03208933|472448823|FG000|Overall Study|Lost to Follow-up|2|||
131224324|NCT03208933|472448823|FG000|Overall Study|Physician Decision|3|||
131224325|NCT03208933|472448823|FG000|Overall Study|Protocol Violation|1|||
131224326|NCT04242186|472448824|FG000|Overall Study|Death|5|||
131224327|NCT00379587|472448825|FG000|Overall Study|Lost to Follow-up|2|||
131224328|NCT01070966|472448836|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
131224329|NCT01070966|472448836|FG000|Participants for Safety Evaluation|Off-label use|9|||
131224330|NCT01070966|472448836|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
130708464|NCT01351350|470558439|FG003|Overall Study|Disease Progression|8|||
130708465|NCT01351350|470558440|FG004|Overall Study|Disease Progression|5|||
130708466|NCT01351350|470558436|FG000|Overall Study|Adverse Event|1|||
130708467|NCT01351350|470558437|FG001|Overall Study|Adverse Event|10|||
130708468|NCT01351350|470558438|FG002|Overall Study|Adverse Event|1|||
130708469|NCT01351350|470558439|FG003|Overall Study|Adverse Event|2|||
130708470|NCT01351350|470558440|FG004|Overall Study|Adverse Event|0|||
130708471|NCT01351350|470558436|FG000|Overall Study|Participant Decision|2|||
130708472|NCT01351350|470558437|FG001|Overall Study|Participant Decision|6|||
130708473|NCT01351350|470558438|FG002|Overall Study|Participant Decision|3|||
130708474|NCT01351350|470558439|FG003|Overall Study|Participant Decision|3|||
130708475|NCT01351350|470558440|FG004|Overall Study|Participant Decision|2|||
130708476|NCT01351350|470558436|FG000|Overall Study|Enrolled but not Treated|0|||
130708477|NCT01351350|470558437|FG001|Overall Study|Enrolled but not Treated|0|||
130708478|NCT01351350|470558438|FG002|Overall Study|Enrolled but not Treated|1|||
130708479|NCT01351350|470558439|FG003|Overall Study|Enrolled but not Treated|0|||
130708480|NCT01351350|470558440|FG004|Overall Study|Enrolled but not Treated|0|||
130708481|NCT01258101|470558441|FG000|Overall Study|Adverse Event|5|||
130708482|NCT01258101|470558442|FG001|Overall Study|Adverse Event|6|||
130708483|NCT01258101|470558443|FG002|Overall Study|Adverse Event|0|||
130708484|NCT01258101|470558444|FG003|Overall Study|Adverse Event|0|||
130708485|NCT01258101|470558441|FG000|Overall Study|Extra exclusion criterion amended|2|||
130708486|NCT01258101|470558442|FG001|Overall Study|Extra exclusion criterion amended|1|||
130708487|NCT01258101|470558443|FG002|Overall Study|Extra exclusion criterion amended|1|||
130708488|NCT01258101|470558444|FG003|Overall Study|Extra exclusion criterion amended|1|||
130708489|NCT01258101|470558441|FG000|Overall Study|Informed consent has been withdrawn|2|||
130708490|NCT01258101|470558442|FG001|Overall Study|Informed consent has been withdrawn|2|||
130708491|NCT01258101|470558443|FG002|Overall Study|Informed consent has been withdrawn|1|||
130708492|NCT01258101|470558444|FG003|Overall Study|Informed consent has been withdrawn|1|||
130708493|NCT01258101|470558441|FG000|Overall Study|Patient is not able to attend visits|8|||
130708494|NCT01258101|470558442|FG001|Overall Study|Patient is not able to attend visits|9|||
130708495|NCT01258101|470558443|FG002|Overall Study|Patient is not able to attend visits|7|||
130708496|NCT01258101|470558444|FG003|Overall Study|Patient is not able to attend visits|6|||
130708497|NCT01258101|470558441|FG000|Overall Study|Patient´s compliance|4|||
130708498|NCT01258101|470558442|FG001|Overall Study|Patient´s compliance|3|||
130708499|NCT01258101|470558443|FG002|Overall Study|Patient´s compliance|1|||
130708500|NCT01258101|470558444|FG003|Overall Study|Patient´s compliance|2|||
130708501|NCT01258101|470558441|FG000|Overall Study|Lost to Follow-up|5|||
130708502|NCT01258101|470558442|FG001|Overall Study|Lost to Follow-up|5|||
130708503|NCT01258101|470558443|FG002|Overall Study|Lost to Follow-up|0|||
130708504|NCT01258101|470558444|FG003|Overall Study|Lost to Follow-up|6|||
130708505|NCT01258101|470558441|FG000|Overall Study|PCR positive at week 24|0|||
130708506|NCT01258101|470558442|FG001|Overall Study|PCR positive at week 24|0|||
130708507|NCT01258101|470558443|FG002|Overall Study|PCR positive at week 24|0|||
130708508|NCT01258101|470558444|FG003|Overall Study|PCR positive at week 24|1|||
130708509|NCT01258101|470558441|FG000|Overall Study|Other reason|7|||
130708510|NCT01258101|470558442|FG001|Overall Study|Other reason|8|||
130708511|NCT01258101|470558443|FG002|Overall Study|Other reason|1|||
130708512|NCT01258101|470558444|FG003|Overall Study|Other reason|8|||
131123582|NCT00916149|472081364|FG001|Overall Study|Unable to place scalp EEG leads|0|||
131123583|NCT00916149|472081365|FG002|Overall Study|Unable to place scalp EEG leads|0|||
131123584|NCT00589420|472081366|FG000|Overall Study|screen failure|1|||
131123585|NCT00912028|472081367|FG000|Overall Study|Lost to Follow-up|2|||
131123586|NCT00912028|472081368|FG001|Overall Study|Lost to Follow-up|3|||
131123587|NCT00912028|472081369|FG002|Overall Study|Lost to Follow-up|0|||
131123588|NCT00912028|472081370|FG003|Overall Study|Lost to Follow-up|1|||
131123589|NCT00912028|472081371|FG004|Overall Study|Lost to Follow-up|3|||
131123590|NCT00912028|472081367|FG000|Overall Study|Withdrawal by Subject|3|||
131123591|NCT00912028|472081368|FG001|Overall Study|Withdrawal by Subject|0|||
131123592|NCT00912028|472081369|FG002|Overall Study|Withdrawal by Subject|0|||
130708513|NCT00303667|470558446|FG000|Overall Study|Death|0|||
130772437|NCT02427802|470792874|FG000|Overall Study|Lost to Follow-up|13|||
130772438|NCT02427802|470792875|FG001|Overall Study|Lost to Follow-up|8|||
131224331|NCT01070966|472448836|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
130772439|NCT02427802|470792876|FG002|Overall Study|Lost to Follow-up|8|||
131123593|NCT00912028|472081370|FG003|Overall Study|Withdrawal by Subject|0|||
130708514|NCT00303667|470558447|FG001|Overall Study|Death|4|||
130708515|NCT01807117|470558448|FG000|Overall Study|Physician Decision|2|||
130708516|NCT01807117|470558448|FG000|Overall Study|Disease diagnosis not a study disease|1|||
130708517|NCT00706355|470558449|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
130708518|NCT00706355|470558450|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
130708519|NCT00706355|470558451|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
130708520|NCT00706355|470558452|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
130708521|NCT00706355|470558449|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
130708522|NCT00706355|470558450|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
130708523|NCT00706355|470558451|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
130708524|NCT00706355|470558452|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
130708525|NCT00706355|470558449|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
130708526|NCT00706355|470558450|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
130708527|NCT00706355|470558451|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
130708528|NCT00706355|470558452|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
130708529|NCT00706355|470558449|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
130708530|NCT00706355|470558450|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
130708531|NCT00706355|470558451|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
130708532|NCT00706355|470558452|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
130708533|NCT00706355|470558449|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
130708534|NCT00706355|470558450|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
130708535|NCT00706355|470558451|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
130708536|NCT00706355|470558452|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
130708537|NCT00706355|470558449|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
130708538|NCT00706355|470558450|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
130708539|NCT00706355|470558451|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
130708540|NCT00706355|470558452|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
130708541|NCT00706355|470558449|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
130708542|NCT00706355|470558450|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
130708543|NCT00706355|470558451|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
130708544|NCT00706355|470558452|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
130708545|NCT00706355|470558449|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
130708546|NCT00706355|470558450|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
130708547|NCT00706355|470558451|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
130708548|NCT00706355|470558452|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
130708549|NCT00706355|470558449|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
130708550|NCT00706355|470558450|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
130708551|NCT00706355|470558451|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
130708552|NCT00706355|470558452|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
130708553|NCT04179019|470558453|FG000|Overall Study|Lost to Follow-up|2|||
130708554|NCT04179019|470558453|FG000|Overall Study|Physician Decision|2|||
130708555|NCT04179019|470558453|FG000|Overall Study|Withdrawal by Subject|5|||
130708556|NCT04179019|470558453|FG000|Overall Study|Adverse Event|4|||
130708557|NCT03465436|470558454|FG000|Period 1|Protocol Violation|0|||
130708558|NCT03465436|470558455|FG001|Period 1|Protocol Violation|0|||
130708559|NCT03465436|470558456|FG002|Period 1|Protocol Violation|1|||
130708560|NCT03465436|470558457|FG003|Period 1|Protocol Violation|0|||
130708561|NCT03465436|470558454|FG000|Period 2|Protocol Violation|0|||
130708562|NCT03465436|470558455|FG001|Period 2|Protocol Violation|1|||
130708563|NCT03465436|470558456|FG002|Period 2|Protocol Violation|0|||
130708564|NCT03465436|470558457|FG003|Period 2|Protocol Violation|0|||
130708565|NCT03465436|470558454|FG000|Period 3|Protocol Violation|1|||
130708566|NCT03465436|470558455|FG001|Period 3|Protocol Violation|1|||
130708567|NCT03465436|470558456|FG002|Period 3|Protocol Violation|0|||
130708568|NCT03465436|470558457|FG003|Period 3|Protocol Violation|0|||
130708569|NCT03465436|470558454|FG000|Period 4|Protocol Violation|0|||
130708570|NCT03465436|470558455|FG001|Period 4|Protocol Violation|0|||
130708571|NCT03465436|470558456|FG002|Period 4|Protocol Violation|1|||
130708572|NCT03465436|470558457|FG003|Period 4|Protocol Violation|0|||
130708573|NCT02243293|470558458|FG000|Overall Study|Adverse Event|1|||
130708574|NCT02243293|470558459|FG001|Overall Study|Adverse Event|0|||
130708575|NCT02243293|470558460|FG002|Overall Study|Adverse Event|0|||
130708576|NCT02243293|470558461|FG003|Overall Study|Adverse Event|0|||
131123594|NCT00912028|472081371|FG004|Overall Study|Withdrawal by Subject|0|||
131123595|NCT00942175|472081372|FG000|Overall Study|Adverse Event|2|||
131123596|NCT00942175|472081373|FG001|Overall Study|Adverse Event|1|||
130708577|NCT02243293|470558462|FG004|Overall Study|Adverse Event|0|||
130708578|NCT02243293|470558463|FG005|Overall Study|Adverse Event|0|||
130708579|NCT02243293|470558464|FG006|Overall Study|Adverse Event|0|||
130708580|NCT02243293|470558465|FG007|Overall Study|Adverse Event|0|||
130708581|NCT02243293|470558466|FG008|Overall Study|Adverse Event|0|||
131123597|NCT00942175|472081374|FG002|Overall Study|Adverse Event|0|||
131224332|NCT01070966|472448836|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
131224333|NCT01070966|472448836|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
131224334|NCT01070966|472448836|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
131224335|NCT01070966|472448836|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
131224336|NCT02770716|472448837|FG000|Overall Study|Death|101|||
131224337|NCT02770716|472448838|FG001|Overall Study|Death|45|||
131224338|NCT02770716|472448837|FG000|Overall Study|Withdrawal by Subject|4|||
131224339|NCT02770716|472448838|FG001|Overall Study|Withdrawal by Subject|2|||
131224340|NCT02770716|472448837|FG000|Overall Study|Lost to Follow-up|1|||
131224341|NCT02770716|472448838|FG001|Overall Study|Lost to Follow-up|0|||
131224342|NCT02770716|472448837|FG000|Overall Study|Various reasons|6|||
131224343|NCT02770716|472448838|FG001|Overall Study|Various reasons|2|||
131224344|NCT01725113|472448839|FG000|Overall Study|Kidney Transplant|1|||
131224345|NCT01725113|472448840|FG001|Overall Study|Kidney Transplant|1|||
131224346|NCT01725113|472448839|FG000|Overall Study|Withdrawal by Subject|0|||
131224347|NCT01725113|472448840|FG001|Overall Study|Withdrawal by Subject|1|||
131224348|NCT03989115|472448841|FG000|Overall Study|Withdrawal by Subject|2|||
131224349|NCT03989115|472448842|FG001|Overall Study|Withdrawal by Subject|1|||
131224350|NCT03989115|472448843|FG002|Overall Study|Withdrawal by Subject|3|||
131224351|NCT03989115|472448844|FG003|Overall Study|Withdrawal by Subject|0|||
131224352|NCT03989115|472448845|FG004|Overall Study|Withdrawal by Subject|17|||
131224353|NCT03989115|472448846|FG005|Overall Study|Withdrawal by Subject|1|||
131224354|NCT03989115|472448847|FG006|Overall Study|Withdrawal by Subject|0|||
131224355|NCT03989115|472448848|FG007|Overall Study|Withdrawal by Subject|0|||
131224356|NCT03989115|472448841|FG000|Overall Study|Sponsor decision to terminate the study|1|||
131224357|NCT03989115|472448842|FG001|Overall Study|Sponsor decision to terminate the study|1|||
131224358|NCT03989115|472448843|FG002|Overall Study|Sponsor decision to terminate the study|0|||
131224359|NCT03989115|472448844|FG003|Overall Study|Sponsor decision to terminate the study|1|||
131224360|NCT03989115|472448845|FG004|Overall Study|Sponsor decision to terminate the study|11|||
131224361|NCT03989115|472448846|FG005|Overall Study|Sponsor decision to terminate the study|0|||
131224362|NCT03989115|472448847|FG006|Overall Study|Sponsor decision to terminate the study|2|||
131224363|NCT03989115|472448848|FG007|Overall Study|Sponsor decision to terminate the study|1|||
131224364|NCT03989115|472448841|FG000|Overall Study|Lost to Follow-up|2|||
131224365|NCT03989115|472448842|FG001|Overall Study|Lost to Follow-up|0|||
131224366|NCT03989115|472448843|FG002|Overall Study|Lost to Follow-up|0|||
131224367|NCT03989115|472448844|FG003|Overall Study|Lost to Follow-up|0|||
131123598|NCT00942175|472081375|FG003|Overall Study|Adverse Event|0|||
131123599|NCT00942175|472081372|FG000|Overall Study|Protocol Violation|0|||
131123600|NCT00942175|472081373|FG001|Overall Study|Protocol Violation|1|||
131123601|NCT00942175|472081374|FG002|Overall Study|Protocol Violation|2|||
131123602|NCT00942175|472081375|FG003|Overall Study|Protocol Violation|0|||
131123603|NCT00942175|472081372|FG000|Overall Study|Pregnancy|0|||
131123604|NCT00942175|472081373|FG001|Overall Study|Pregnancy|0|||
131123605|NCT00942175|472081374|FG002|Overall Study|Pregnancy|0|||
131123606|NCT00942175|472081375|FG003|Overall Study|Pregnancy|1|||
131123607|NCT00942175|472081372|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
131123608|NCT00942175|472081373|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
131123609|NCT00942175|472081374|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
131123610|NCT00942175|472081375|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
131123611|NCT00942175|472081372|FG000|Overall Study|Low Platelet Count|0|||
131123612|NCT00942175|472081373|FG001|Overall Study|Low Platelet Count|2|||
131123613|NCT00942175|472081374|FG002|Overall Study|Low Platelet Count|0|||
131123614|NCT00942175|472081375|FG003|Overall Study|Low Platelet Count|0|||
131123615|NCT02664272|472081376|FG000|Overall Study|Fluoroscopic images not made available|2|||
131123616|NCT03073980|472081377|FG000|Overall Study|Lost to Follow-up|10|||
131224368|NCT03989115|472448845|FG004|Overall Study|Lost to Follow-up|1|||
131224369|NCT03989115|472448846|FG005|Overall Study|Lost to Follow-up|0|||
130708582|NCT02243293|470558467|FG009|Overall Study|Adverse Event|0|||
130708583|NCT02243293|470558468|FG010|Overall Study|Adverse Event|0|||
130708584|NCT02243293|470558469|FG011|Overall Study|Adverse Event|0|||
130708585|NCT02243293|470558470|FG012|Overall Study|Adverse Event|0|||
130708586|NCT02243293|470558471|FG013|Overall Study|Adverse Event|0|||
130708587|NCT02243293|470558472|FG014|Overall Study|Adverse Event|0|||
131123617|NCT03073980|472081378|FG001|Overall Study|Lost to Follow-up|2|||
131123618|NCT03073980|472081379|FG002|Overall Study|Lost to Follow-up|9|||
130708588|NCT02243293|470558473|FG015|Overall Study|Adverse Event|1|||
131123619|NCT03073980|472081377|FG000|Overall Study|No post-procedure data|0|||
131123620|NCT03073980|472081378|FG001|Overall Study|No post-procedure data|0|||
131224370|NCT03989115|472448847|FG006|Overall Study|Lost to Follow-up|0|||
131224371|NCT03989115|472448848|FG007|Overall Study|Lost to Follow-up|0|||
131224372|NCT03989115|472448841|FG000|Overall Study|Death|2|||
130708589|NCT02243293|470558474|FG016|Overall Study|Adverse Event|0|||
130708590|NCT02243293|470558475|FG017|Overall Study|Adverse Event|0|||
131123621|NCT03073980|472081379|FG002|Overall Study|No post-procedure data|2|||
130708591|NCT02243293|470558476|FG018|Overall Study|Adverse Event|0|||
131123622|NCT00545064|472081380|FG000|Overall Study|Lost to Follow-up|3|||
130708592|NCT02243293|470558477|FG019|Overall Study|Adverse Event|0|||
130708593|NCT02243293|470558478|FG020|Overall Study|Adverse Event|1|||
130708594|NCT02243293|470558479|FG021|Overall Study|Adverse Event|0|||
130708595|NCT02243293|470558458|FG000|Overall Study|Withdrawal by Subject|1|||
130708596|NCT02243293|470558459|FG001|Overall Study|Withdrawal by Subject|0|||
130708597|NCT02243293|470558460|FG002|Overall Study|Withdrawal by Subject|0|||
130708598|NCT02243293|470558461|FG003|Overall Study|Withdrawal by Subject|0|||
130708599|NCT02243293|470558462|FG004|Overall Study|Withdrawal by Subject|0|||
130708600|NCT02243293|470558463|FG005|Overall Study|Withdrawal by Subject|0|||
130708601|NCT02243293|470558464|FG006|Overall Study|Withdrawal by Subject|0|||
130708602|NCT02243293|470558465|FG007|Overall Study|Withdrawal by Subject|0|||
130708603|NCT02243293|470558466|FG008|Overall Study|Withdrawal by Subject|0|||
130708604|NCT02243293|470558467|FG009|Overall Study|Withdrawal by Subject|1|||
130708605|NCT02243293|470558468|FG010|Overall Study|Withdrawal by Subject|0|||
130708606|NCT02243293|470558469|FG011|Overall Study|Withdrawal by Subject|1|||
130708607|NCT02243293|470558470|FG012|Overall Study|Withdrawal by Subject|0|||
130708608|NCT02243293|470558471|FG013|Overall Study|Withdrawal by Subject|0|||
130708609|NCT02243293|470558472|FG014|Overall Study|Withdrawal by Subject|0|||
130708610|NCT02243293|470558473|FG015|Overall Study|Withdrawal by Subject|0|||
130708611|NCT02243293|470558474|FG016|Overall Study|Withdrawal by Subject|0|||
130708612|NCT02243293|470558475|FG017|Overall Study|Withdrawal by Subject|0|||
130708613|NCT02243293|470558476|FG018|Overall Study|Withdrawal by Subject|0|||
130708614|NCT02243293|470558477|FG019|Overall Study|Withdrawal by Subject|0|||
130708615|NCT02243293|470558478|FG020|Overall Study|Withdrawal by Subject|0|||
130708616|NCT02243293|470558479|FG021|Overall Study|Withdrawal by Subject|1|||
130708617|NCT02243293|470558458|FG000|Overall Study|Lost to Follow-up|0|||
130708618|NCT02243293|470558459|FG001|Overall Study|Lost to Follow-up|1|||
130708619|NCT02243293|470558460|FG002|Overall Study|Lost to Follow-up|1|||
130708620|NCT02243293|470558461|FG003|Overall Study|Lost to Follow-up|1|||
130708621|NCT02243293|470558462|FG004|Overall Study|Lost to Follow-up|0|||
130708622|NCT02243293|470558463|FG005|Overall Study|Lost to Follow-up|0|||
130708623|NCT02243293|470558464|FG006|Overall Study|Lost to Follow-up|3|||
130708624|NCT02243293|470558465|FG007|Overall Study|Lost to Follow-up|0|||
130708625|NCT02243293|470558466|FG008|Overall Study|Lost to Follow-up|0|||
130708626|NCT02243293|470558467|FG009|Overall Study|Lost to Follow-up|0|||
130708627|NCT02243293|470558468|FG010|Overall Study|Lost to Follow-up|0|||
130708628|NCT02243293|470558469|FG011|Overall Study|Lost to Follow-up|2|||
130708629|NCT02243293|470558470|FG012|Overall Study|Lost to Follow-up|0|||
130708630|NCT02243293|470558471|FG013|Overall Study|Lost to Follow-up|0|||
130708631|NCT02243293|470558472|FG014|Overall Study|Lost to Follow-up|0|||
131123623|NCT00545064|472081380|FG000|Overall Study|Withdrawal by Subject|2|||
131123624|NCT00545064|472081380|FG000|Overall Study|did not complete course of treatment|1|||
131123625|NCT00545064|472081380|FG000|Overall Study|cancel all appointments, no rebooking|1|||
131123626|NCT00545064|472081380|FG000|Overall Study|inclement weather|1|||
131123627|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
131123628|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
131123629|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
131123630|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
131123631|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
131123632|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
131123633|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
131123634|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
131123635|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
131123636|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
131123637|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
131123638|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
131123639|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
131123640|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
131123641|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
130708632|NCT02243293|470558473|FG015|Overall Study|Lost to Follow-up|0|||
131123642|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
130708633|NCT02243293|470558474|FG016|Overall Study|Lost to Follow-up|3|||
131123643|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
131123644|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
131123645|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
130708634|NCT02243293|470558475|FG017|Overall Study|Lost to Follow-up|1|||
130708635|NCT02243293|470558476|FG018|Overall Study|Lost to Follow-up|0|||
130708636|NCT02243293|470558477|FG019|Overall Study|Lost to Follow-up|0|||
130708637|NCT02243293|470558478|FG020|Overall Study|Lost to Follow-up|1|||
130708638|NCT02243293|470558479|FG021|Overall Study|Lost to Follow-up|2|||
130708639|NCT02243293|470558458|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
130708640|NCT02243293|470558459|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
131123646|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
130708641|NCT02243293|470558460|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
131123647|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
131123648|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
131123649|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
131123650|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
131123651|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Death|2|||
131123652|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Death|1|||
131123653|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Death|0|||
131123654|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Death|0|||
131123655|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
131123656|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
131123657|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
131123658|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
131123659|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
131123660|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
131123661|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
131123662|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
131123663|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
131123664|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
131123665|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
131123666|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
131123667|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
131123668|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
131123669|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
131123670|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
131123671|NCT01940471|472081383|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
131123672|NCT01940471|472081384|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
131123673|NCT01940471|472081385|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
131123674|NCT01940471|472081386|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
131123675|NCT01940471|472081383|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
131123676|NCT01940471|472081384|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
131123677|NCT01940471|472081385|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
131123678|NCT01940471|472081386|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
131123679|NCT01940471|472081383|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
131123680|NCT01940471|472081384|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
131123681|NCT01940471|472081385|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
131123682|NCT01940471|472081386|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
131123683|NCT01940471|472081383|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
131123684|NCT01940471|472081384|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
131123685|NCT01940471|472081385|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
131123686|NCT01940471|472081386|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
131123687|NCT01940471|472081383|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
131123688|NCT01940471|472081384|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
131123689|NCT01940471|472081385|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
131123690|NCT01940471|472081386|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
131123691|NCT01940471|472081383|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
131123692|NCT01940471|472081384|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
131123693|NCT01940471|472081385|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
131123694|NCT01940471|472081386|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
131123695|NCT01940471|472081383|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
131123696|NCT01940471|472081384|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
131123697|NCT01940471|472081385|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
131123698|NCT01940471|472081386|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
131123699|NCT01940471|472081383|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
131123700|NCT01940471|472081384|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
131123701|NCT01940471|472081385|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
131123702|NCT01940471|472081386|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
131123703|NCT01940471|472081383|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
131123704|NCT01940471|472081384|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
131123705|NCT01940471|472081385|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
131123706|NCT01940471|472081386|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
131123707|NCT01940471|472081383|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
131123708|NCT01940471|472081384|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
131123709|NCT01940471|472081385|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
130772440|NCT02427802|470792874|FG000|Overall Study|Physician Decision|4|||
130708642|NCT02243293|470558461|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
131123710|NCT01940471|472081386|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
131123711|NCT00258674|472081387|FG000|Overall Study|Death|32|||
131123712|NCT00258674|472081388|FG001|Overall Study|Death|53|||
131123713|NCT00258674|472081389|FG002|Overall Study|Death|34|||
131123714|NCT03715153|472081390|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
131123715|NCT03715153|472081391|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
131123716|NCT03715153|472081390|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
131123717|NCT03715153|472081391|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
131123718|NCT03715153|472081390|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
131123719|NCT03715153|472081391|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
131123720|NCT03715153|472081390|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
131123721|NCT03715153|472081391|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
131123722|NCT03715153|472081390|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
131123723|NCT03715153|472081391|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
131123724|NCT03715153|472081390|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
131123725|NCT03715153|472081391|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
131123726|NCT01358760|472081396|FG000|Overall Study|Adverse Event|3|||
131123727|NCT01358760|472081397|FG001|Overall Study|Adverse Event|4|||
131123728|NCT01358760|472081398|FG002|Overall Study|Adverse Event|3|||
131123729|NCT01358760|472081396|FG000|Overall Study|Lost to Follow-up|1|||
131123730|NCT01358760|472081397|FG001|Overall Study|Lost to Follow-up|1|||
130708643|NCT02243293|470558462|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
130708644|NCT02243293|470558463|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
131123731|NCT01358760|472081398|FG002|Overall Study|Lost to Follow-up|3|||
131123732|NCT01358760|472081396|FG000|Overall Study|Withdrawal by Subject|5|||
131123733|NCT01358760|472081397|FG001|Overall Study|Withdrawal by Subject|3|||
131123734|NCT01358760|472081398|FG002|Overall Study|Withdrawal by Subject|2|||
131123735|NCT01358760|472081396|FG000|Overall Study|Physician Decision|1|||
131123736|NCT01358760|472081397|FG001|Overall Study|Physician Decision|0|||
131123737|NCT01358760|472081398|FG002|Overall Study|Physician Decision|1|||
131123738|NCT01358760|472081396|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
131123739|NCT01358760|472081397|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
131123740|NCT01358760|472081398|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
131123741|NCT01506960|472081401|FG000|Overall Study|Did not meet angiographic criteria|47|||
131123742|NCT00450723|472081403|FG000|Overall Study|Physician Decision|5|||
131123743|NCT03574753|472081406|FG000|Overall Study|Adverse Event|3|||
131123744|NCT03574753|472081406|FG000|Overall Study|Progression/relapse|19|||
131123745|NCT03574753|472081406|FG000|Overall Study|Death|1|||
131123746|NCT01436084|472081409|FG000|Overall Study|Disease Progression|2|||
131123747|NCT01436084|472081409|FG000|Overall Study|Withdrawal by Subject|1|||
131123748|NCT01436084|472081409|FG000|Overall Study|Early Closure of Study|1|||
131123749|NCT01744665|472081410|FG000|Monitoring Phase|Adverse Event|4|||
131123750|NCT01744665|472081410|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
131123751|NCT01744665|472081410|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
131123752|NCT01744665|472081410|FG000|Monitoring Phase|Withdrawal by Subject|5|||
131123753|NCT01744665|472081410|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
131123754|NCT01744665|472081410|FG000|Consolidation Phase|Adverse Event|2|||
131123755|NCT01744665|472081410|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
131123756|NCT01744665|472081410|FG000|Consolidation Phase|Withdrawal by Subject|4|||
131123757|NCT01744665|472081410|FG000|Consolidation Phase|Administrative problems|9|||
131123758|NCT01744665|472081410|FG000|Re-initiation Phase|Administrative problems|10|||
131123759|NCT01744665|472081410|FG000|Re-initiation Phase|Adverse Event|1|||
131123760|NCT01744665|472081410|FG000|Re-initiation Phase|No longer required treatment|1|||
131123761|NCT01744665|472081410|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
131123762|NCT02044133|472081412|FG000|Overall Study|Lost to Follow-up|1|||
131123763|NCT02044133|472081413|FG001|Overall Study|Lost to Follow-up|1|||
131123764|NCT02044133|472081412|FG000|Overall Study|Death|1|||
131123765|NCT02044133|472081413|FG001|Overall Study|Death|0|||
131123766|NCT02044133|472081412|FG000|Overall Study|Release|3|||
131123767|NCT02044133|472081413|FG001|Overall Study|Release|4|||
131123768|NCT02044133|472081412|FG000|Overall Study|Transfer|1|||
131224373|NCT03989115|472448842|FG001|Overall Study|Death|2|||
130708645|NCT02243293|470558464|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
131123769|NCT02044133|472081413|FG001|Overall Study|Transfer|0|||
131123770|NCT02044133|472081412|FG000|Overall Study|refusal of blood sampling|0|||
131123771|NCT02044133|472081413|FG001|Overall Study|refusal of blood sampling|1|||
131123772|NCT00736255|472082830|FG000|Overall Study|Adverse Event|1|||
131123773|NCT00736255|472082831|FG001|Overall Study|Adverse Event|0|||
131123774|NCT00736255|472082830|FG000|Overall Study|Physician Decision|1|||
131123775|NCT00736255|472082831|FG001|Overall Study|Physician Decision|0|||
131123776|NCT00736255|472082830|FG000|Overall Study|Non-compliance|1|||
131123777|NCT00736255|472082831|FG001|Overall Study|Non-compliance|1|||
131123778|NCT00766038|472082836|FG000|Overall Study|Lost to Follow-up|15|||
131123779|NCT00766038|472082837|FG001|Overall Study|Lost to Follow-up|14|||
131224374|NCT03989115|472448843|FG002|Overall Study|Death|9|||
130708646|NCT02243293|470558465|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
130708647|NCT02243293|470558466|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
130708648|NCT02243293|470558467|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
130708649|NCT02243293|470558468|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
130708650|NCT02243293|470558469|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
130708651|NCT02243293|470558470|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
130708652|NCT02243293|470558471|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
130708653|NCT02243293|470558472|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
130708654|NCT02243293|470558473|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
130708655|NCT02243293|470558474|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
130708656|NCT02243293|470558475|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
130708657|NCT02243293|470558476|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
130708658|NCT02243293|470558477|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
130708659|NCT02243293|470558478|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
130708660|NCT02243293|470558479|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
130708661|NCT02243293|470558458|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
130708662|NCT02243293|470558459|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
130708663|NCT02243293|470558460|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
130708664|NCT02243293|470558461|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
130708665|NCT02243293|470558462|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
130708666|NCT02243293|470558463|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
130708667|NCT02243293|470558464|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
130708668|NCT02243293|470558465|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
130708669|NCT02243293|470558466|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
130708670|NCT02243293|470558467|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
130708671|NCT02243293|470558468|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
130708672|NCT02243293|470558469|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
130708673|NCT02243293|470558470|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
130708674|NCT02243293|470558471|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
130708675|NCT02243293|470558472|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
130708676|NCT02243293|470558473|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
130708677|NCT02243293|470558474|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
130708678|NCT02243293|470558475|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
130708679|NCT02243293|470558476|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
130708680|NCT02243293|470558477|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
130708681|NCT02243293|470558478|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
130708682|NCT02243293|470558479|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
130720876|NCT03275064|470601552|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
130720877|NCT03275064|470601553|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130720878|NCT03275064|470601554|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130720879|NCT03275064|470601555|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130720880|NCT03275064|470601556|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130720881|NCT03275064|470601552|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
130720882|NCT03275064|470601553|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
130720883|NCT03275064|470601554|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
130720884|NCT03275064|470601555|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
130720885|NCT03275064|470601556|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
130720886|NCT03275064|470601552|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130720887|NCT03275064|470601553|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130720888|NCT03275064|470601554|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130720889|NCT03275064|470601555|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
130720890|NCT03275064|470601556|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130720891|NCT03275064|470601552|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
130720892|NCT03275064|470601553|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
130720893|NCT03275064|470601554|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
130720894|NCT03275064|470601555|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
130720895|NCT03275064|470601556|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
130772441|NCT02427802|470792875|FG001|Overall Study|Physician Decision|2|||
130772442|NCT02427802|470792876|FG002|Overall Study|Physician Decision|4|||
131036649|NCT05949788|471768202|FG000|Overall Study|neonatal hemolytic disease|3|||
130720896|NCT01341782|470601557|FG000|Overall Study|Adverse Event|1|||
130720897|NCT01341782|470601558|FG001|Overall Study|Adverse Event|1|||
130720898|NCT01341782|470601557|FG000|Overall Study|Withdrawal by Subject|6|||
130772443|NCT02427802|470792874|FG000|Overall Study|Withdrawal by Subject|10|||
131036650|NCT05949788|471768203|FG001|Overall Study|neonatal hemolytic disease|8|||
131123780|NCT01251653|472082842|FG000|Overall Study|Progressive Disease|1|||
130772444|NCT02427802|470792875|FG001|Overall Study|Withdrawal by Subject|5|||
130772445|NCT02427802|470792876|FG002|Overall Study|Withdrawal by Subject|11|||
130772446|NCT02427802|470792874|FG000|Overall Study|Protocol Violation|3|||
130772447|NCT02427802|470792875|FG001|Overall Study|Protocol Violation|1|||
130772448|NCT02427802|470792876|FG002|Overall Study|Protocol Violation|1|||
130772449|NCT02427802|470792874|FG000|Overall Study|protocol specific treatment unrelated|18|||
130772450|NCT02427802|470792875|FG001|Overall Study|protocol specific treatment unrelated|11|||
130772451|NCT02427802|470792876|FG002|Overall Study|protocol specific treatment unrelated|11|||
130772452|NCT01085084|470792877|FG000|Overall Study|Withdrawal by Subject|1|||
130772453|NCT01085084|470792878|FG001|Overall Study|Withdrawal by Subject|0|||
130772454|NCT01085084|470792879|FG002|Overall Study|Withdrawal by Subject|0|||
130772455|NCT01085084|470792877|FG000|Overall Study|Lost to Follow-up|2|||
130772456|NCT01085084|470792878|FG001|Overall Study|Lost to Follow-up|1|||
130772457|NCT01085084|470792879|FG002|Overall Study|Lost to Follow-up|1|||
130772458|NCT01085084|470792877|FG000|Overall Study|Adverse Event|4|||
130772459|NCT01085084|470792878|FG001|Overall Study|Adverse Event|3|||
130772460|NCT01085084|470792879|FG002|Overall Study|Adverse Event|6|||
130772461|NCT01085084|470792877|FG000|Overall Study|Treatment Failure|0|||
130772462|NCT01085084|470792878|FG001|Overall Study|Treatment Failure|1|||
130772463|NCT01085084|470792879|FG002|Overall Study|Treatment Failure|2|||
130772464|NCT02070978|470792880|FG000|Overall Study|Adverse Event|6|||
130772465|NCT02070978|470792881|FG001|Overall Study|Adverse Event|2|||
130772466|NCT02070978|470792882|FG002|Overall Study|Adverse Event|0|||
130772467|NCT02070978|470792880|FG000|Overall Study|Lost to Follow-up|1|||
130772468|NCT02070978|470792881|FG001|Overall Study|Lost to Follow-up|3|||
130772469|NCT02070978|470792882|FG002|Overall Study|Lost to Follow-up|4|||
130772470|NCT02070978|470792880|FG000|Overall Study|Withdrawal by Subject|3|||
130772471|NCT02070978|470792881|FG001|Overall Study|Withdrawal by Subject|5|||
130772472|NCT02070978|470792882|FG002|Overall Study|Withdrawal by Subject|3|||
130772473|NCT02070978|470792880|FG000|Overall Study|Protocol Violation|1|||
130772474|NCT02070978|470792881|FG001|Overall Study|Protocol Violation|0|||
130772475|NCT02070978|470792882|FG002|Overall Study|Protocol Violation|3|||
130772476|NCT02070978|470792880|FG000|Overall Study|Lack of Efficacy|0|||
130772477|NCT02070978|470792881|FG001|Overall Study|Lack of Efficacy|1|||
130772478|NCT02070978|470792882|FG002|Overall Study|Lack of Efficacy|0|||
130772479|NCT02070978|470792880|FG000|Overall Study|Death|0|||
130772480|NCT02070978|470792881|FG001|Overall Study|Death|0|||
130772481|NCT02070978|470792882|FG002|Overall Study|Death|2|||
130772482|NCT02070978|470792880|FG000|Overall Study|Un-specified|3|||
130772483|NCT02070978|470792881|FG001|Overall Study|Un-specified|2|||
130772484|NCT02070978|470792882|FG002|Overall Study|Un-specified|2|||
130772485|NCT02070978|470792880|FG000|Overall Study|Terminated by Sponsor|33|||
130772486|NCT02070978|470792881|FG001|Overall Study|Terminated by Sponsor|40|||
130772487|NCT02070978|470792882|FG002|Overall Study|Terminated by Sponsor|39|||
130772488|NCT02634983|470792883|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
130772489|NCT02634983|470792884|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
130772490|NCT03178851|470792885|FG000|Overall Study|Death|48|||
130772491|NCT03178851|470792886|FG001|Overall Study|Death|2|||
130772492|NCT03178851|470792887|FG002|Overall Study|Death|25|||
130772493|NCT03178851|470792885|FG000|Overall Study|Withdrawal by Subject|8|||
130772494|NCT03178851|470792886|FG001|Overall Study|Withdrawal by Subject|0|||
130772495|NCT03178851|470792887|FG002|Overall Study|Withdrawal by Subject|0|||
130772496|NCT03178851|470792885|FG000|Overall Study|Lost to Follow-up|5|||
130772497|NCT03178851|470792886|FG001|Overall Study|Lost to Follow-up|2|||
130772498|NCT03178851|470792887|FG002|Overall Study|Lost to Follow-up|0|||
130772499|NCT03178851|470792885|FG000|Overall Study|Adverse Event|0|||
130772500|NCT03178851|470792886|FG001|Overall Study|Adverse Event|0|||
130772501|NCT03178851|470792887|FG002|Overall Study|Adverse Event|1|||
130772502|NCT03178851|470792885|FG000|Overall Study|Study Termination by Sponsor|31|||
130772503|NCT03178851|470792886|FG001|Overall Study|Study Termination by Sponsor|7|||
130942640|NCT01729754|471424746|FG005|Part 2|Non-Compliance with Study Drug|0|||
130942641|NCT01729754|471424747|FG006|Part 2|Non-Compliance with Study Drug|0|||
130942642|NCT01729754|471424748|FG007|Part 2|Non-Compliance with Study Drug|0|||
130942643|NCT01729754|471424749|FG008|Part 2|Non-Compliance with Study Drug|0|||
130772504|NCT03178851|470792887|FG002|Overall Study|Study Termination by Sponsor|26|||
130772505|NCT03951753|470792888|FG000|Overall Study|Adverse Event|1|||
130772506|NCT03951753|470792889|FG001|Overall Study|Adverse Event|0|||
130772507|NCT03951753|470792890|FG002|Overall Study|Adverse Event|3|||
130772508|NCT03951753|470792888|FG000|Overall Study|Withdrawal by Subject|3|||
130772509|NCT03951753|470792889|FG001|Overall Study|Withdrawal by Subject|1|||
130772510|NCT03951753|470792890|FG002|Overall Study|Withdrawal by Subject|0|||
130772511|NCT03951753|470792888|FG000|Overall Study|Lost to Follow-up|0|||
130772512|NCT03951753|470792889|FG001|Overall Study|Lost to Follow-up|0|||
130772513|NCT03951753|470792890|FG002|Overall Study|Lost to Follow-up|1|||
130772514|NCT02669043|470792895|FG000|Overall Study|Didn't meet I/E criteria|4|||
130772515|NCT02552888|470792898|FG000|Overall Study|Lost to Follow-up|1|||
130772516|NCT02552888|470792899|FG001|Overall Study|Lost to Follow-up|1|||
130772517|NCT00401193|470794716|FG000|Overall Study|Adverse Event|1|||
131224375|NCT03989115|472448844|FG003|Overall Study|Death|6|||
131224376|NCT03989115|472448845|FG004|Overall Study|Death|31|||
131224377|NCT03989115|472448846|FG005|Overall Study|Death|6|||
131224378|NCT03989115|472448847|FG006|Overall Study|Death|2|||
131224379|NCT03989115|472448848|FG007|Overall Study|Death|3|||
131224380|NCT03989115|472448841|FG000|Overall Study|Other|1|||
131224381|NCT03989115|472448842|FG001|Overall Study|Other|2|||
131224382|NCT03989115|472448843|FG002|Overall Study|Other|0|||
130708683|NCT01475253|470560446|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
130708684|NCT01475253|470560447|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
130708685|NCT01475253|470560448|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
130708686|NCT01475253|470560449|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
130708687|NCT01475253|470560446|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
130708688|NCT01475253|470560447|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
130708689|NCT01475253|470560448|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
130708690|NCT01475253|470560449|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
130708691|NCT03135899|470560450|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708692|NCT03135899|470560451|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708693|NCT03135899|470560452|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708694|NCT03135899|470560453|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708695|NCT03135899|470560454|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708696|NCT03135899|470560455|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708697|NCT03135899|470560456|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
130708698|NCT03135899|470560457|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
130708699|NCT03135899|470560450|FG000|Overall Study|Withdrawal by Subject|0|||
130708700|NCT03135899|470560451|FG001|Overall Study|Withdrawal by Subject|0|||
130708701|NCT03135899|470560452|FG002|Overall Study|Withdrawal by Subject|0|||
130708702|NCT03135899|470560453|FG003|Overall Study|Withdrawal by Subject|0|||
130708703|NCT03135899|470560454|FG004|Overall Study|Withdrawal by Subject|0|||
130708704|NCT03135899|470560455|FG005|Overall Study|Withdrawal by Subject|2|||
130708705|NCT03135899|470560456|FG006|Overall Study|Withdrawal by Subject|0|||
130708706|NCT03135899|470560457|FG007|Overall Study|Withdrawal by Subject|0|||
130708707|NCT00856830|470560462|FG000|Irinotecan & Bendamustine|Death|0|||
130708708|NCT00856830|470560463|FG001|Irinotecan & Bendamustine|Death|0|||
130708709|NCT00856830|470560464|FG002|Irinotecan & Bendamustine|Death|0|||
130708710|NCT00856830|470560465|FG003|Irinotecan & Bendamustine|Death|2|||
130708711|NCT00856830|470560462|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
130708712|NCT00856830|470560463|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
130708713|NCT00856830|470560464|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
130708714|NCT00856830|470560465|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
130708715|NCT01744093|470560466|FG000|Overall Study|Withdrawal by Subject|6|||
130708716|NCT01744093|470560467|FG001|Overall Study|Withdrawal by Subject|1|||
130708717|NCT01570283|470560468|FG000|Cohort 1: Dose Level 1|Death|0|||
130708718|NCT01570283|470560469|FG001|Cohort 1: Dose Level 1|Death|1|||
130708719|NCT01570283|470560470|FG002|Cohort 1: Dose Level 1|Death|0|||
130708720|NCT01570283|470560471|FG003|Cohort 1: Dose Level 1|Death|0|||
130708721|NCT01570283|470560472|FG004|Cohort 1: Dose Level 1|Death|0|||
130708722|NCT01570283|470560473|FG005|Cohort 1: Dose Level 1|Death|0|||
130708723|NCT01570283|470560468|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130708724|NCT01570283|470560469|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
130708725|NCT01570283|470560470|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130708726|NCT01570283|470560471|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130708727|NCT01570283|470560472|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130708728|NCT01570283|470560473|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
131224383|NCT03989115|472448844|FG003|Overall Study|Other|0|||
130708729|NCT01570283|470560468|FG000|Cohort 2: Dose Level 2|Death|0|||
130708730|NCT01570283|470560469|FG001|Cohort 2: Dose Level 2|Death|0|||
130708731|NCT01570283|470560470|FG002|Cohort 2: Dose Level 2|Death|1|||
130708732|NCT01570283|470560471|FG003|Cohort 2: Dose Level 2|Death|0|||
130708733|NCT01570283|470560472|FG004|Cohort 2: Dose Level 2|Death|0|||
130708734|NCT01570283|470560473|FG005|Cohort 2: Dose Level 2|Death|0|||
130708735|NCT01570283|470560468|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130708736|NCT01570283|470560469|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130708737|NCT01570283|470560470|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130708738|NCT01570283|470560471|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
130942644|NCT01729754|471424750|FG009|Part 2|Non-Compliance with Study Drug|1|||
130708739|NCT01570283|470560472|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130708740|NCT01570283|470560473|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130708741|NCT01570283|470560468|FG000|Cohort 3: Dose Level 3|Death|0|||
130942645|NCT01729754|471424741|FG000|Part 2|Pregnancy|0|||
130942646|NCT01729754|471424742|FG001|Part 2|Pregnancy|0|||
130942647|NCT01729754|471424743|FG002|Part 2|Pregnancy|0|||
131224384|NCT03989115|472448845|FG004|Overall Study|Other|5|||
131224385|NCT03989115|472448846|FG005|Overall Study|Other|0|||
131224386|NCT03989115|472448847|FG006|Overall Study|Other|0|||
131224387|NCT03989115|472448848|FG007|Overall Study|Other|0|||
131224388|NCT01808209|472448849|FG000|Overall Study|Lost to Follow-up|0|||
131224389|NCT01808209|472448850|FG001|Overall Study|Lost to Follow-up|1|||
131224390|NCT01427920|472448851|FG000|Overall Study|Adverse Event|1|||
131224391|NCT01427920|472448852|FG001|Overall Study|Adverse Event|2|||
131224392|NCT01427920|472448851|FG000|Overall Study|Lack of Efficacy|1|||
131224393|NCT01427920|472448852|FG001|Overall Study|Lack of Efficacy|0|||
131224394|NCT01427920|472448851|FG000|Overall Study|Protocol Violation|1|||
131224395|NCT01427920|472448852|FG001|Overall Study|Protocol Violation|3|||
131224396|NCT01427920|472448851|FG000|Overall Study|Withdrawal Criteria|4|||
131224397|NCT01427920|472448852|FG001|Overall Study|Withdrawal Criteria|4|||
131224398|NCT01427920|472448851|FG000|Overall Study|Unclassified|2|||
131224399|NCT01427920|472448852|FG001|Overall Study|Unclassified|8|||
131224400|NCT04228302|472448853|FG000|Overall Study|Adverse Event|0|||
131224401|NCT04228302|472448854|FG001|Overall Study|Adverse Event|0|||
131224402|NCT04228302|472448855|FG002|Overall Study|Adverse Event|0|||
131224403|NCT04228302|472448856|FG003|Overall Study|Adverse Event|0|||
131224404|NCT04228302|472448857|FG004|Overall Study|Adverse Event|1|||
131224405|NCT04228302|472448858|FG005|Overall Study|Adverse Event|0|||
131224406|NCT00751998|472448877|FG000|Overall Study|Lost to Follow-up|7|||
130708742|NCT01570283|470560469|FG001|Cohort 3: Dose Level 3|Death|0|||
130708743|NCT01570283|470560470|FG002|Cohort 3: Dose Level 3|Death|0|||
130708744|NCT01570283|470560471|FG003|Cohort 3: Dose Level 3|Death|0|||
130708745|NCT01570283|470560472|FG004|Cohort 3: Dose Level 3|Death|0|||
130708746|NCT01570283|470560473|FG005|Cohort 3: Dose Level 3|Death|1|||
130708747|NCT01570283|470560468|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130708748|NCT01570283|470560469|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130708749|NCT01570283|470560470|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130708750|NCT01570283|470560471|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130708751|NCT01570283|470560472|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130708752|NCT01570283|470560473|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
130708753|NCT03028740|470560476|FG000|Overall Study|Did not Receive Study Drug|4|||
130708754|NCT03028740|470560477|FG001|Overall Study|Did not Receive Study Drug|5|||
130708755|NCT03028740|470560476|FG000|Overall Study|Adverse Event|8|||
130708756|NCT03028740|470560477|FG001|Overall Study|Adverse Event|26|||
130708757|NCT03028740|470560476|FG000|Overall Study|Lack of Efficacy|0|||
130708758|NCT03028740|470560477|FG001|Overall Study|Lack of Efficacy|1|||
130708759|NCT03028740|470560476|FG000|Overall Study|Withdrawal by Subject|48|||
130708760|NCT03028740|470560477|FG001|Overall Study|Withdrawal by Subject|101|||
130708761|NCT03028740|470560476|FG000|Overall Study|Lost to Follow-up|30|||
130708762|NCT03028740|470560477|FG001|Overall Study|Lost to Follow-up|54|||
130708763|NCT03028740|470560476|FG000|Overall Study|Physician Decision|4|||
130708764|NCT03028740|470560477|FG001|Overall Study|Physician Decision|11|||
130708765|NCT03028740|470560476|FG000|Overall Study|Protocol Violation|4|||
130708766|NCT03028740|470560477|FG001|Overall Study|Protocol Violation|8|||
130708767|NCT03028740|470560476|FG000|Overall Study|Non-compliance with Study Drug|0|||
130708768|NCT03028740|470560477|FG001|Overall Study|Non-compliance with Study Drug|2|||
130708769|NCT03028740|470560476|FG000|Overall Study|Study Terminated by Sponsor|467|||
130708770|NCT03028740|470560477|FG001|Overall Study|Study Terminated by Sponsor|917|||
130708771|NCT03028740|470560476|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
130708772|NCT03028740|470560477|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
130708773|NCT03028740|470560476|FG000|Overall Study|Reason not Specified|1|||
130708774|NCT03028740|470560477|FG001|Overall Study|Reason not Specified|5|||
130708775|NCT00685802|470560483|FG000|Washout Period of 7 Days|Protocol Violation|2|||
130708776|NCT00685802|470560484|FG001|Washout Period of 7 Days|Protocol Violation|0|||
130708777|NCT00685802|470560483|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130708778|NCT00685802|470560484|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130708779|NCT03336242|470560488|FG000|Overall Study|Adverse Event|0|||
130708780|NCT03336242|470560489|FG001|Overall Study|Adverse Event|1|||
130708781|NCT02224573|470560492|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
131224407|NCT00751998|472448877|FG000|Overall Study|Death|11|||
130708782|NCT02224573|470560493|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
130708783|NCT02224573|470560492|FG000|Treatment Phase|Started on Other IMP|1|||
130708784|NCT02224573|470560493|FG001|Treatment Phase|Started on Other IMP|0|||
130708785|NCT02224573|470560492|FG000|Treatment Phase|Participant Discontinued IMP|0|||
130708786|NCT02224573|470560493|FG001|Treatment Phase|Participant Discontinued IMP|1|||
130772518|NCT00401193|470794717|FG001|Overall Study|Adverse Event|3|||
130708787|NCT02224573|470560492|FG000|Treatment Phase|Lack of Efficacy|15|||
130708788|NCT02224573|470560493|FG001|Treatment Phase|Lack of Efficacy|8|||
130708789|NCT02224573|470560492|FG000|Treatment Phase|Began Commercial Product|1|||
130772519|NCT00401193|470794718|FG002|Overall Study|Adverse Event|1|||
130942648|NCT01729754|471424744|FG003|Part 2|Pregnancy|1|||
131224408|NCT00751998|472448877|FG000|Overall Study|Withdrawal by Subject|2|||
131224409|NCT02629133|472448878|FG000|Overall Study|Lost to Follow-up|3|||
131224410|NCT02629133|472448879|FG001|Overall Study|Lost to Follow-up|1|||
131224411|NCT02629133|472448878|FG000|Overall Study|Withdrawal by Subject|1|||
130708790|NCT02224573|470560493|FG001|Treatment Phase|Began Commercial Product|0|||
130708791|NCT02224573|470560492|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
130708792|NCT02224573|470560493|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
130708793|NCT02224573|470560492|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
130708794|NCT02224573|470560493|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
130708795|NCT02224573|470560492|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
130708796|NCT02224573|470560493|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
130708797|NCT02224573|470560492|FG000|Treatment Phase|Continued Compassionate Use|1|||
130708798|NCT02224573|470560493|FG001|Treatment Phase|Continued Compassionate Use|0|||
130708799|NCT02224573|470560492|FG000|Treatment Phase|Lack of Efficiency|2|||
130708800|NCT02224573|470560493|FG001|Treatment Phase|Lack of Efficiency|1|||
130708801|NCT02224573|470560492|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
130708802|NCT02224573|470560493|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
130708803|NCT02224573|470560492|FG000|Treatment Phase|Participant Moved|2|||
130708804|NCT02224573|470560493|FG001|Treatment Phase|Participant Moved|0|||
130708805|NCT02224573|470560492|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
130708806|NCT02224573|470560493|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
130708807|NCT02224573|470560492|FG000|Treatment Phase|Refused Medication|1|||
130708808|NCT02224573|470560493|FG001|Treatment Phase|Refused Medication|1|||
130708809|NCT02224573|470560492|FG000|Treatment Phase|Adverse Event|26|||
130708810|NCT02224573|470560493|FG001|Treatment Phase|Adverse Event|38|||
130708811|NCT02224573|470560492|FG000|Treatment Phase|Placed in Group Home|0|||
130708812|NCT02224573|470560493|FG001|Treatment Phase|Placed in Group Home|1|||
130708813|NCT02224573|470560492|FG000|Treatment Phase|Pursued Other Trials|1|||
130708814|NCT02224573|470560493|FG001|Treatment Phase|Pursued Other Trials|0|||
130708815|NCT02224573|470560492|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
130708816|NCT02224573|470560493|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
130708817|NCT02224573|470560492|FG000|Treatment Phase|Lost to Follow-up|2|||
130772520|NCT00401193|470794716|FG000|Overall Study|Protocol Violation|3|||
130942649|NCT01729754|471424745|FG004|Part 2|Pregnancy|0|||
130942650|NCT01729754|471424746|FG005|Part 2|Pregnancy|0|||
130942651|NCT01729754|471424747|FG006|Part 2|Pregnancy|0|||
130942652|NCT01729754|471424748|FG007|Part 2|Pregnancy|0|||
130942653|NCT01729754|471424749|FG008|Part 2|Pregnancy|0|||
130942654|NCT01729754|471424750|FG009|Part 2|Pregnancy|1|||
130942655|NCT01729754|471424741|FG000|Part 2|Withdrawal by Subject|3|||
130942656|NCT01729754|471424742|FG001|Part 2|Withdrawal by Subject|0|||
130942657|NCT01729754|471424743|FG002|Part 2|Withdrawal by Subject|0|||
130942658|NCT01729754|471424744|FG003|Part 2|Withdrawal by Subject|2|||
130942659|NCT01729754|471424745|FG004|Part 2|Withdrawal by Subject|0|||
130942660|NCT01729754|471424746|FG005|Part 2|Withdrawal by Subject|0|||
130942661|NCT01729754|471424747|FG006|Part 2|Withdrawal by Subject|0|||
130942662|NCT01729754|471424748|FG007|Part 2|Withdrawal by Subject|1|||
130942663|NCT01729754|471424749|FG008|Part 2|Withdrawal by Subject|1|||
130942664|NCT01729754|471424750|FG009|Part 2|Withdrawal by Subject|4|||
130942665|NCT01729754|471424741|FG000|Part 2|Other Protocol Specified Criteria|1|||
130942666|NCT01729754|471424742|FG001|Part 2|Other Protocol Specified Criteria|0|||
130942667|NCT01729754|471424743|FG002|Part 2|Other Protocol Specified Criteria|0|||
130942668|NCT01729754|471424744|FG003|Part 2|Other Protocol Specified Criteria|0|||
130942669|NCT01729754|471424745|FG004|Part 2|Other Protocol Specified Criteria|0|||
130942670|NCT01729754|471424746|FG005|Part 2|Other Protocol Specified Criteria|0|||
130942671|NCT01729754|471424747|FG006|Part 2|Other Protocol Specified Criteria|0|||
130942672|NCT01729754|471424748|FG007|Part 2|Other Protocol Specified Criteria|1|||
130942673|NCT01729754|471424749|FG008|Part 2|Other Protocol Specified Criteria|0|||
130942674|NCT01729754|471424750|FG009|Part 2|Other Protocol Specified Criteria|0|||
130942675|NCT01729754|471424741|FG000|Part 3|Adverse Event|0|||
130942676|NCT01729754|471424742|FG001|Part 3|Adverse Event|0|||
130942677|NCT01729754|471424743|FG002|Part 3|Adverse Event|1|||
130942678|NCT01729754|471424744|FG003|Part 3|Adverse Event|0|||
131036651|NCT05949788|471768202|FG000|Overall Study|death within 14 days after birth|2|||
131036652|NCT05949788|471768203|FG001|Overall Study|death within 14 days after birth|6|||
131036653|NCT05949788|471768202|FG000|Overall Study|transfer to another hospital|2|||
131036654|NCT05949788|471768203|FG001|Overall Study|transfer to another hospital|6|||
131036655|NCT01824537|471768204|FG000|Overall Study|Lost to Follow-up|78|||
131036656|NCT01824537|471768205|FG001|Overall Study|Lost to Follow-up|87|||
131036657|NCT04096040|471768206|FG000|Overall Study|Protocol Violation|12|||
130708818|NCT02224573|470560493|FG001|Treatment Phase|Lost to Follow-up|1|||
130708819|NCT02224573|470560492|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
130708820|NCT02224573|470560493|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
130708821|NCT02224573|470560492|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
130708822|NCT02224573|470560493|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
130708823|NCT02224573|470560492|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
130708824|NCT02224573|470560493|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
130708825|NCT02224573|470560492|FG000|Taper Phase|Adverse Event|1|||
130942679|NCT01729754|471424745|FG004|Part 3|Adverse Event|0|||
131036658|NCT04096040|471768206|FG000|Overall Study|Non-compliant site|4|||
130772521|NCT00401193|470794717|FG001|Overall Study|Protocol Violation|1|||
130772522|NCT00401193|470794718|FG002|Overall Study|Protocol Violation|1|||
130772523|NCT00401193|470794716|FG000|Overall Study|Lost to Follow-up|6|||
130772524|NCT00401193|470794717|FG001|Overall Study|Lost to Follow-up|5|||
130772525|NCT00401193|470794718|FG002|Overall Study|Lost to Follow-up|1|||
130772526|NCT00401193|470794716|FG000|Overall Study|Withdrawal by Subject|2|||
130772527|NCT00401193|470794717|FG001|Overall Study|Withdrawal by Subject|0|||
130772528|NCT00401193|470794718|FG002|Overall Study|Withdrawal by Subject|1|||
130772529|NCT00401193|470794716|FG000|Overall Study|Other Event|3|||
130772530|NCT00401193|470794717|FG001|Overall Study|Other Event|2|||
130772531|NCT00401193|470794718|FG002|Overall Study|Other Event|2|||
130772532|NCT00398216|470794719|FG000|Overall Study|Adverse Event|4|||
130772533|NCT00398216|470794720|FG001|Overall Study|Adverse Event|2|||
130772534|NCT00398216|470794721|FG002|Overall Study|Adverse Event|5|||
130772535|NCT00398216|470794722|FG003|Overall Study|Adverse Event|7|||
130772536|NCT00398216|470794723|FG004|Overall Study|Adverse Event|2|||
130772537|NCT00398216|470794719|FG000|Overall Study|Protocol Violation|2|||
130772538|NCT00398216|470794720|FG001|Overall Study|Protocol Violation|4|||
130772539|NCT00398216|470794721|FG002|Overall Study|Protocol Violation|5|||
130772540|NCT00398216|470794722|FG003|Overall Study|Protocol Violation|7|||
130772541|NCT00398216|470794723|FG004|Overall Study|Protocol Violation|5|||
130772542|NCT00398216|470794719|FG000|Overall Study|Lost to Follow-up|1|||
130772543|NCT00398216|470794720|FG001|Overall Study|Lost to Follow-up|6|||
130772544|NCT00398216|470794721|FG002|Overall Study|Lost to Follow-up|4|||
130772545|NCT00398216|470794722|FG003|Overall Study|Lost to Follow-up|4|||
130772546|NCT00398216|470794723|FG004|Overall Study|Lost to Follow-up|1|||
130772547|NCT00398216|470794719|FG000|Overall Study|Death|0|||
130772548|NCT00398216|470794720|FG001|Overall Study|Death|3|||
130772549|NCT00398216|470794721|FG002|Overall Study|Death|0|||
130772550|NCT00398216|470794722|FG003|Overall Study|Death|0|||
130772551|NCT00398216|470794723|FG004|Overall Study|Death|0|||
130772552|NCT00398216|470794719|FG000|Overall Study|Withdrawal by Subject|1|||
130772553|NCT00398216|470794720|FG001|Overall Study|Withdrawal by Subject|0|||
130772554|NCT00398216|470794721|FG002|Overall Study|Withdrawal by Subject|3|||
130772555|NCT00398216|470794722|FG003|Overall Study|Withdrawal by Subject|1|||
130772556|NCT00398216|470794723|FG004|Overall Study|Withdrawal by Subject|2|||
130772557|NCT00398216|470794719|FG000|Overall Study|administrative reasons|3|||
130772558|NCT00398216|470794720|FG001|Overall Study|administrative reasons|4|||
130772559|NCT00398216|470794721|FG002|Overall Study|administrative reasons|4|||
130772560|NCT00398216|470794722|FG003|Overall Study|administrative reasons|3|||
130772561|NCT00398216|470794723|FG004|Overall Study|administrative reasons|3|||
130772562|NCT00398216|470794719|FG000|Overall Study|entrance criteria|0|||
130772563|NCT00398216|470794720|FG001|Overall Study|entrance criteria|0|||
130772564|NCT00398216|470794721|FG002|Overall Study|entrance criteria|0|||
130772565|NCT00398216|470794722|FG003|Overall Study|entrance criteria|0|||
130772566|NCT00398216|470794723|FG004|Overall Study|entrance criteria|2|||
130772567|NCT00376532|470794724|FG000|Overall Study|Lack sufficient blood sample|6|||
130772568|NCT00376532|470794725|FG001|Overall Study|Lack sufficient blood sample|6|||
130772569|NCT04227405|470794726|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
130772570|NCT04227405|470794727|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
130772571|NCT04227405|470794726|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
130772572|NCT04227405|470794727|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
130772573|NCT04227405|470794726|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
130772574|NCT04227405|470794727|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
130772575|NCT02207400|470794728|FG000|Overall Study|Adverse Event|1|||
130772576|NCT02207400|470794729|FG001|Overall Study|Adverse Event|1|||
130772577|NCT02207400|470794728|FG000|Overall Study|Lost to Follow-up|6|||
130772578|NCT02207400|470794729|FG001|Overall Study|Lost to Follow-up|7|||
130772579|NCT02207400|470794728|FG000|Overall Study|Protocol Violation|1|||
130772580|NCT02207400|470794729|FG001|Overall Study|Protocol Violation|1|||
130772581|NCT02207400|470794728|FG000|Overall Study|Withdrawal by Subject|8|||
130772582|NCT02207400|470794729|FG001|Overall Study|Withdrawal by Subject|4|||
130772583|NCT02207400|470794728|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
131123781|NCT01251653|472082843|FG001|Overall Study|Progressive Disease|7|||
131123782|NCT01251653|472082844|FG002|Overall Study|Progressive Disease|16|||
131123783|NCT01251653|472082845|FG003|Overall Study|Progressive Disease|4|||
131123784|NCT01251653|472082846|FG004|Overall Study|Progressive Disease|0|||
131123785|NCT01251653|472082847|FG005|Overall Study|Progressive Disease|17|||
131123786|NCT01251653|472082848|FG006|Overall Study|Progressive Disease|14|||
130772584|NCT02207400|470794729|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
130772585|NCT02849704|470794732|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
130772586|NCT02849704|470794733|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
131123787|NCT01251653|472082849|FG007|Overall Study|Progressive Disease|7|||
131123788|NCT01251653|472082850|FG008|Overall Study|Progressive Disease|5|||
130772587|NCT02849704|470794732|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
130772588|NCT02849704|470794733|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
130942680|NCT01729754|471424746|FG005|Part 3|Adverse Event|5|||
130772589|NCT02849704|470794732|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
130772590|NCT02849704|470794733|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
130772591|NCT02757352|470794734|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
130772592|NCT02757352|470794735|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130772593|NCT02757352|470794736|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
130772594|NCT02757352|470794737|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130772595|NCT02757352|470794738|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130772596|NCT02757352|470794739|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130772597|NCT02757352|470794740|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130772598|NCT02757352|470794741|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130772599|NCT02757352|470794742|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130772600|NCT02757352|470794743|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130772601|NCT02757352|470794734|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130942681|NCT01729754|471424747|FG006|Part 3|Adverse Event|0|||
130942682|NCT01729754|471424748|FG007|Part 3|Adverse Event|0|||
130942683|NCT01729754|471424749|FG008|Part 3|Adverse Event|0|||
130942684|NCT01729754|471424750|FG009|Part 3|Adverse Event|3|||
130942685|NCT01729754|471424741|FG000|Part 3|Death|0|||
130942686|NCT01729754|471424742|FG001|Part 3|Death|0|||
130942687|NCT01729754|471424743|FG002|Part 3|Death|0|||
130942688|NCT01729754|471424744|FG003|Part 3|Death|0|||
130942689|NCT01729754|471424745|FG004|Part 3|Death|0|||
130942690|NCT01729754|471424746|FG005|Part 3|Death|2|||
130942691|NCT01729754|471424747|FG006|Part 3|Death|0|||
130942692|NCT01729754|471424748|FG007|Part 3|Death|0|||
130942693|NCT01729754|471424749|FG008|Part 3|Death|0|||
130942694|NCT01729754|471424750|FG009|Part 3|Death|0|||
130942695|NCT01729754|471424741|FG000|Part 3|Lack of Efficacy|0|||
130942696|NCT01729754|471424742|FG001|Part 3|Lack of Efficacy|0|||
130942697|NCT01729754|471424743|FG002|Part 3|Lack of Efficacy|0|||
130942698|NCT01729754|471424744|FG003|Part 3|Lack of Efficacy|0|||
130942699|NCT01729754|471424745|FG004|Part 3|Lack of Efficacy|2|||
130942700|NCT01729754|471424746|FG005|Part 3|Lack of Efficacy|0|||
130942701|NCT01729754|471424747|FG006|Part 3|Lack of Efficacy|0|||
130942702|NCT01729754|471424748|FG007|Part 3|Lack of Efficacy|0|||
130942703|NCT01729754|471424749|FG008|Part 3|Lack of Efficacy|0|||
130942704|NCT01729754|471424750|FG009|Part 3|Lack of Efficacy|4|||
130942705|NCT01729754|471424741|FG000|Part 3|Lost to Follow-up|0|||
130942706|NCT01729754|471424742|FG001|Part 3|Lost to Follow-up|1|||
130942707|NCT01729754|471424743|FG002|Part 3|Lost to Follow-up|2|||
130942708|NCT01729754|471424744|FG003|Part 3|Lost to Follow-up|0|||
130942709|NCT01729754|471424745|FG004|Part 3|Lost to Follow-up|0|||
130942710|NCT01729754|471424746|FG005|Part 3|Lost to Follow-up|3|||
130942711|NCT01729754|471424747|FG006|Part 3|Lost to Follow-up|0|||
130942712|NCT01729754|471424748|FG007|Part 3|Lost to Follow-up|0|||
130942713|NCT01729754|471424749|FG008|Part 3|Lost to Follow-up|1|||
130942714|NCT01729754|471424750|FG009|Part 3|Lost to Follow-up|0|||
130942715|NCT01729754|471424741|FG000|Part 3|Physician Decision|0|||
130942716|NCT01729754|471424742|FG001|Part 3|Physician Decision|0|||
130942717|NCT01729754|471424743|FG002|Part 3|Physician Decision|1|||
130942718|NCT01729754|471424744|FG003|Part 3|Physician Decision|0|||
130942719|NCT01729754|471424745|FG004|Part 3|Physician Decision|0|||
130942720|NCT01729754|471424746|FG005|Part 3|Physician Decision|0|||
130942721|NCT01729754|471424747|FG006|Part 3|Physician Decision|0|||
130942722|NCT01729754|471424748|FG007|Part 3|Physician Decision|0|||
130942723|NCT01729754|471424749|FG008|Part 3|Physician Decision|0|||
130942724|NCT01729754|471424750|FG009|Part 3|Physician Decision|0|||
130942725|NCT01729754|471424741|FG000|Part 3|Withdrawal by Subject|0|||
130942726|NCT01729754|471424742|FG001|Part 3|Withdrawal by Subject|4|||
130942727|NCT01729754|471424743|FG002|Part 3|Withdrawal by Subject|1|||
130942728|NCT01729754|471424744|FG003|Part 3|Withdrawal by Subject|0|||
130942729|NCT01729754|471424745|FG004|Part 3|Withdrawal by Subject|2|||
130942730|NCT01729754|471424746|FG005|Part 3|Withdrawal by Subject|1|||
130942731|NCT01729754|471424747|FG006|Part 3|Withdrawal by Subject|0|||
130942732|NCT01729754|471424748|FG007|Part 3|Withdrawal by Subject|2|||
130942733|NCT01729754|471424749|FG008|Part 3|Withdrawal by Subject|0|||
130942734|NCT01729754|471424750|FG009|Part 3|Withdrawal by Subject|0|||
130942735|NCT01729754|471424741|FG000|Part 3|Other Protocol Specified Criteria|0|||
130942736|NCT01729754|471424742|FG001|Part 3|Other Protocol Specified Criteria|0|||
130942737|NCT01729754|471424743|FG002|Part 3|Other Protocol Specified Criteria|0|||
130942738|NCT01729754|471424744|FG003|Part 3|Other Protocol Specified Criteria|0|||
130942739|NCT01729754|471424745|FG004|Part 3|Other Protocol Specified Criteria|0|||
131123789|NCT01251653|472082842|FG000|Overall Study|Dose-limiting toxicity|0|||
130942740|NCT01729754|471424746|FG005|Part 3|Other Protocol Specified Criteria|2|||
130942741|NCT01729754|471424747|FG006|Part 3|Other Protocol Specified Criteria|0|||
130942742|NCT01729754|471424748|FG007|Part 3|Other Protocol Specified Criteria|1|||
131123790|NCT01251653|472082843|FG001|Overall Study|Dose-limiting toxicity|1|||
130942743|NCT01729754|471424749|FG008|Part 3|Other Protocol Specified Criteria|0|||
130942744|NCT01729754|471424750|FG009|Part 3|Other Protocol Specified Criteria|0|||
130942745|NCT00773292|471424751|FG000|Treatment 48 Weeks|Adverse Event|1|||
130942746|NCT00773292|471424751|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
130942747|NCT02794103|471424752|FG000|Overall Study|Loss to follow up due to high sedation|3|||
130942748|NCT04608500|471424753|FG000|Overall Study|Adverse Event|2|||
130942749|NCT04608500|471424754|FG001|Overall Study|Adverse Event|0|||
130942750|NCT04608500|471424753|FG000|Overall Study|Lost to Follow-up|15|||
130942751|NCT04608500|471424754|FG001|Overall Study|Lost to Follow-up|9|||
130942752|NCT04608500|471424753|FG000|Overall Study|Participant request|11|||
130942753|NCT04608500|471424754|FG001|Overall Study|Participant request|7|||
130942754|NCT04608500|471424753|FG000|Overall Study|Protocol Violation|1|||
130942755|NCT04608500|471424754|FG001|Overall Study|Protocol Violation|0|||
130942756|NCT04608500|471424753|FG000|Overall Study|Other|6|||
130942757|NCT04608500|471424754|FG001|Overall Study|Other|2|||
130942758|NCT00542919|471424755|FG000|Overall Study|Adverse Event|1|||
130942759|NCT00542919|471424756|FG001|Overall Study|Adverse Event|5|||
130942760|NCT00542919|471424757|FG002|Overall Study|Adverse Event|1|||
130942761|NCT00542919|471424755|FG000|Overall Study|Withdrawal by Subject|1|||
130942762|NCT00542919|471424756|FG001|Overall Study|Withdrawal by Subject|0|||
130942763|NCT00542919|471424757|FG002|Overall Study|Withdrawal by Subject|3|||
130942764|NCT00542919|471424755|FG000|Overall Study|Physician Decision|2|||
130942765|NCT00542919|471424756|FG001|Overall Study|Physician Decision|2|||
130942766|NCT00542919|471424757|FG002|Overall Study|Physician Decision|1|||
130942767|NCT00542919|471424755|FG000|Overall Study|Sponsor Decision|1|||
130942768|NCT00542919|471424756|FG001|Overall Study|Sponsor Decision|0|||
130942769|NCT00542919|471424757|FG002|Overall Study|Sponsor Decision|0|||
130942770|NCT00542919|471424755|FG000|Overall Study|Lost to Follow-up|2|||
130942771|NCT00542919|471424756|FG001|Overall Study|Lost to Follow-up|0|||
130942772|NCT00542919|471424757|FG002|Overall Study|Lost to Follow-up|1|||
130942773|NCT02747420|471424758|FG000|Overall Study|Lost to Follow-up|4|||
130942774|NCT02747420|471424759|FG001|Overall Study|Lost to Follow-up|2|||
130942775|NCT02747420|471424758|FG000|Overall Study|Withdrawal by Subject|3|||
130942776|NCT02747420|471424759|FG001|Overall Study|Withdrawal by Subject|2|||
130942777|NCT03662542|471424760|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
130942778|NCT03662542|471424761|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130942779|NCT03662542|471424762|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130942780|NCT03662542|471424763|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130942781|NCT03662542|471424764|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130942782|NCT03662542|471424765|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130942783|NCT03662542|471424766|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130942784|NCT03662542|471424767|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130942785|NCT03662542|471424768|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
130942786|NCT03662542|471424760|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130942787|NCT03662542|471424761|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
130942788|NCT03662542|471424762|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130942789|NCT03662542|471424763|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130942790|NCT03662542|471424764|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130942791|NCT03662542|471424765|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130942792|NCT03662542|471424766|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130942793|NCT03662542|471424767|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130942794|NCT03662542|471424768|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
130942795|NCT03662542|471424760|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
130942796|NCT03662542|471424761|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
130942797|NCT03662542|471424762|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
130942798|NCT03662542|471424763|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
130942799|NCT03662542|471424764|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
130942800|NCT03662542|471424765|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
130942801|NCT03662542|471424766|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
131123791|NCT01251653|472082844|FG002|Overall Study|Dose-limiting toxicity|1|||
131123792|NCT01251653|472082845|FG003|Overall Study|Dose-limiting toxicity|1|||
131123793|NCT01251653|472082846|FG004|Overall Study|Dose-limiting toxicity|0|||
131123794|NCT01251653|472082847|FG005|Overall Study|Dose-limiting toxicity|0|||
131123795|NCT01251653|472082848|FG006|Overall Study|Dose-limiting toxicity|2|||
131123796|NCT01251653|472082849|FG007|Overall Study|Dose-limiting toxicity|0|||
130942802|NCT03662542|471424767|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
130942803|NCT03662542|471424768|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
130942804|NCT03662542|471424760|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
130942805|NCT03662542|471424761|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130942806|NCT03662542|471424762|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130942807|NCT03662542|471424763|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130942808|NCT03662542|471424764|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
131123797|NCT01251653|472082850|FG008|Overall Study|Dose-limiting toxicity|0|||
130942809|NCT03662542|471424765|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130942810|NCT03662542|471424766|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
131123798|NCT01251653|472082842|FG000|Overall Study|Adverse Event|1|||
131123799|NCT01251653|472082843|FG001|Overall Study|Adverse Event|0|||
130942811|NCT03662542|471424767|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130942812|NCT03662542|471424768|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
130942813|NCT03662542|471424760|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130942814|NCT03662542|471424761|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130942815|NCT03662542|471424762|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130942816|NCT03662542|471424763|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130942817|NCT03662542|471424764|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130942818|NCT03662542|471424765|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
130942819|NCT03662542|471424766|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130942820|NCT03662542|471424767|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130942821|NCT03662542|471424768|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
130942822|NCT03662542|471424760|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130942823|NCT03662542|471424761|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130942824|NCT03662542|471424762|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130942825|NCT03662542|471424763|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
130942826|NCT03662542|471424764|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
130942827|NCT03662542|471424765|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130942828|NCT03662542|471424766|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130942829|NCT03662542|471424767|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130942830|NCT03662542|471424768|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
130942831|NCT03662542|471424760|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130942832|NCT03662542|471424761|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130942833|NCT03662542|471424762|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130942834|NCT03662542|471424763|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
130942835|NCT03662542|471424764|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
130942836|NCT03662542|471424765|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
130942837|NCT03662542|471424766|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130942838|NCT03662542|471424767|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130942839|NCT03662542|471424768|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
130942840|NCT03662542|471424760|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130942841|NCT03662542|471424761|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130942842|NCT03662542|471424762|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130942843|NCT03662542|471424763|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130942844|NCT03662542|471424764|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
130942845|NCT03662542|471424765|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
130942846|NCT03662542|471424766|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130942847|NCT03662542|471424767|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130942848|NCT03662542|471424768|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
130942849|NCT03662542|471424760|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130942850|NCT03662542|471424761|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130942851|NCT03662542|471424762|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130942852|NCT03662542|471424763|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130942853|NCT03662542|471424764|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130942854|NCT03662542|471424765|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
130942855|NCT03662542|471424766|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130942856|NCT03662542|471424767|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130942857|NCT03662542|471424768|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
130942858|NCT03662542|471424760|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
130942859|NCT03662542|471424761|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
130942860|NCT03662542|471424762|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
130942861|NCT03662542|471424763|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
130942862|NCT03662542|471424764|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
130942863|NCT03662542|471424765|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
130942864|NCT03662542|471424766|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
130942865|NCT03662542|471424767|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
130942866|NCT03662542|471424768|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
130942867|NCT03662542|471424760|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130942868|NCT03662542|471424761|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130942869|NCT03662542|471424762|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130942870|NCT03662542|471424763|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130942871|NCT03662542|471424764|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130942872|NCT03662542|471424765|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130942873|NCT03662542|471424766|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
130942874|NCT03662542|471424767|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
130942875|NCT03662542|471424768|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
130942876|NCT03662542|471424760|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130942877|NCT03662542|471424761|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130942878|NCT03662542|471424762|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
131036659|NCT04973254|471768209|FG000|Overall Study|Not adherent|0|||
131224412|NCT02629133|472448879|FG001|Overall Study|Withdrawal by Subject|1|||
130942879|NCT03662542|471424763|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130942880|NCT03662542|471424764|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130942881|NCT03662542|471424765|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130942882|NCT03662542|471424766|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
130942883|NCT03662542|471424767|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
130942884|NCT03662542|471424768|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
130942885|NCT03662542|471424760|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
130942886|NCT03662542|471424761|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
130942887|NCT03662542|471424762|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
130942888|NCT03662542|471424763|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
130942889|NCT03662542|471424764|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
130942890|NCT03662542|471424765|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
130942891|NCT03662542|471424766|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
130942892|NCT03662542|471424767|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
130942893|NCT03662542|471424768|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
130942894|NCT01217060|471424770|FG000|Overall Study|Withdrawal by Subject|1|||
130942895|NCT03388138|471424774|FG000|Overall Study|Protocol Violation|1|||
130772602|NCT02757352|470794735|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130772603|NCT02757352|470794736|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
130772604|NCT02757352|470794737|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130772605|NCT02757352|470794738|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130772606|NCT02757352|470794739|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130772607|NCT02757352|470794740|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130772608|NCT02757352|470794741|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130772609|NCT02757352|470794742|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130772610|NCT02757352|470794743|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130772611|NCT02757352|470794734|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
130772612|NCT02757352|470794735|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
130772613|NCT02757352|470794736|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
130772614|NCT02757352|470794737|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130772615|NCT02757352|470794738|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130772616|NCT02757352|470794739|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130772617|NCT02757352|470794740|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130772618|NCT02757352|470794741|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130772619|NCT02757352|470794742|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130772620|NCT02757352|470794743|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130772621|NCT02757352|470794734|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130772622|NCT02757352|470794735|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
130772623|NCT02757352|470794736|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130772624|NCT02757352|470794737|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130772625|NCT02757352|470794738|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130772626|NCT02757352|470794739|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130772627|NCT02757352|470794740|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130772628|NCT02757352|470794741|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130772629|NCT02757352|470794742|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130772630|NCT02757352|470794743|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130772631|NCT02757352|470794734|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772632|NCT02757352|470794735|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130772633|NCT02757352|470794736|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130942896|NCT03388138|471424775|FG001|Overall Study|Protocol Violation|0|||
130942897|NCT01528072|471424778|FG000|Overall Study|Withdrawal by Subject|5|||
130942898|NCT01528072|471424778|FG000|Overall Study|Physician Decision|1|||
130942899|NCT01528072|471424778|FG000|Overall Study|Determined not eligible by AEAC|1|||
130942900|NCT01528072|471424778|FG000|Overall Study|Missed Visit|2|||
130942901|NCT01528072|471424778|FG000|Overall Study|Lost to Follow-up|5|||
130942902|NCT01528072|471424778|FG000|Overall Study|Explanted|2|||
130942903|NCT01528072|471424778|FG000|Overall Study|Site Closure|4|||
130942904|NCT01528072|471424778|FG000|Overall Study|Death|2|||
130942905|NCT01528072|471424778|FG000|Overall Study|Early Termination of Study|52|||
130942906|NCT01859494|471424781|FG000|Overall Study|Adverse Event|1|||
130942907|NCT02769247|471424790|FG000|Overall Study|Withdrawal by Subject|1|||
131036660|NCT04973254|471768210|FG001|Overall Study|Not adherent|1|||
131036661|NCT04973254|471768211|FG002|Overall Study|Not adherent|0|||
131036662|NCT05170009|471768212|FG000|Overall Study|Physician Decision|0|||
131036663|NCT05170009|471768213|FG001|Overall Study|Physician Decision|1|||
131036664|NCT03808818|471768218|FG000|Overall Study|Death|6|||
131036665|NCT03808818|471768219|FG001|Overall Study|Death|6|||
131036666|NCT03808818|471768218|FG000|Overall Study|Withdrawal by Subject|7|||
131036667|NCT03808818|471768219|FG001|Overall Study|Withdrawal by Subject|18|||
131036668|NCT03808818|471768218|FG000|Overall Study|Lost to Follow-up|31|||
130942908|NCT02769247|471424791|FG001|Overall Study|Withdrawal by Subject|0|||
130942909|NCT02769247|471424792|FG002|Overall Study|Withdrawal by Subject|0|||
130942910|NCT02769247|471424793|FG003|Overall Study|Withdrawal by Subject|1|||
130942911|NCT02769247|471424790|FG000|Overall Study|Protocol Violation|0|||
130942912|NCT02769247|471424791|FG001|Overall Study|Protocol Violation|0|||
130942913|NCT02769247|471424792|FG002|Overall Study|Protocol Violation|1|||
130942914|NCT02769247|471424793|FG003|Overall Study|Protocol Violation|0|||
130942915|NCT02769247|471424790|FG000|Overall Study|Physician Decision|1|||
130942916|NCT02769247|471424791|FG001|Overall Study|Physician Decision|0|||
130942917|NCT02769247|471424792|FG002|Overall Study|Physician Decision|0|||
130942918|NCT02769247|471424793|FG003|Overall Study|Physician Decision|0|||
130942919|NCT01462084|471424799|FG000|Overall Study|Withdrawal by Subject|1|||
130942920|NCT01462084|471424800|FG001|Overall Study|Withdrawal by Subject|0|||
130942921|NCT01462084|471424799|FG000|Overall Study|Protocol Violation|1|||
130942922|NCT01462084|471424800|FG001|Overall Study|Protocol Violation|1|||
130942923|NCT01996826|471424801|FG000|Overall Study|Lost to Follow-up|6|||
130942924|NCT01996826|471424802|FG001|Overall Study|Lost to Follow-up|2|||
130942925|NCT01996826|471424801|FG000|Overall Study|Physician Decision|1|||
130942926|NCT01996826|471424802|FG001|Overall Study|Physician Decision|1|||
130942927|NCT01514760|471424804|FG000|Overall Study|Lost to Follow-up|2|||
130942928|NCT02092662|471424805|FG000|Overall Study|Lost to Follow-up|13|||
130942929|NCT02092662|471424806|FG001|Overall Study|Lost to Follow-up|0|||
130942930|NCT01592344|471424807|FG000|Overall Study|Adverse Event|1|||
130942931|NCT01592344|471424808|FG001|Overall Study|Adverse Event|1|||
130942932|NCT01592344|471424807|FG000|Overall Study|Lack of Efficacy|1|||
130942933|NCT01592344|471424808|FG001|Overall Study|Lack of Efficacy|0|||
130708826|NCT02224573|470560493|FG001|Taper Phase|Adverse Event|1|||
130708827|NCT02546362|470560494|FG000|4-week Treatment Period|Lost to Follow-up|1|||
130708828|NCT02546362|470560494|FG000|4-week Treatment Period|Change in medication|2|||
130942934|NCT01592344|471424807|FG000|Overall Study|not available at primary outcome visit|2|||
130942935|NCT01592344|471424808|FG001|Overall Study|not available at primary outcome visit|4|||
130942936|NCT04969224|471424809|FG000|Overall Study|Adverse Event|1|||
130942937|NCT04969224|471424809|FG000|Overall Study|Enrolled but never dosed|1|||
130942938|NCT00613015|471424810|FG000|Overall Study|Lost to Follow-up|0|||
130942939|NCT00613015|471424811|FG001|Overall Study|Lost to Follow-up|1|||
130942940|NCT00613015|471424812|FG002|Overall Study|Lost to Follow-up|3|||
130942941|NCT00613015|471424813|FG003|Overall Study|Lost to Follow-up|3|||
130942942|NCT00613015|471424814|FG004|Overall Study|Lost to Follow-up|2|||
130942943|NCT00613015|471424815|FG005|Overall Study|Lost to Follow-up|3|||
130942944|NCT04256785|471424816|FG000|Overall Study|Adverse Event|8|||
130942945|NCT04256785|471424817|FG001|Overall Study|Adverse Event|6|||
130942946|NCT04256785|471424816|FG000|Overall Study|Lack of Efficacy|3|||
130942947|NCT04256785|471424817|FG001|Overall Study|Lack of Efficacy|4|||
130942948|NCT04256785|471424816|FG000|Overall Study|Lost to Follow-up|7|||
130942949|NCT04256785|471424817|FG001|Overall Study|Lost to Follow-up|7|||
130942950|NCT04256785|471424816|FG000|Overall Study|Protocol Violation|1|||
130942951|NCT04256785|471424817|FG001|Overall Study|Protocol Violation|0|||
130942952|NCT04256785|471424816|FG000|Overall Study|Withdrawal by Subject|4|||
130942953|NCT04256785|471424817|FG001|Overall Study|Withdrawal by Subject|1|||
130942954|NCT04256785|471424816|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
131123800|NCT01251653|472082844|FG002|Overall Study|Adverse Event|2|||
131123801|NCT01251653|472082845|FG003|Overall Study|Adverse Event|1|||
131123802|NCT01251653|472082846|FG004|Overall Study|Adverse Event|1|||
131123803|NCT01251653|472082847|FG005|Overall Study|Adverse Event|0|||
131123804|NCT01251653|472082848|FG006|Overall Study|Adverse Event|2|||
131123805|NCT01251653|472082849|FG007|Overall Study|Adverse Event|2|||
131123806|NCT01251653|472082850|FG008|Overall Study|Adverse Event|1|||
131123807|NCT01251653|472082842|FG000|Overall Study|Withdrawal by Subject|1|||
131123808|NCT01251653|472082843|FG001|Overall Study|Withdrawal by Subject|0|||
131123809|NCT01251653|472082844|FG002|Overall Study|Withdrawal by Subject|1|||
131123810|NCT01251653|472082845|FG003|Overall Study|Withdrawal by Subject|0|||
131123811|NCT01251653|472082846|FG004|Overall Study|Withdrawal by Subject|1|||
131123812|NCT01251653|472082847|FG005|Overall Study|Withdrawal by Subject|1|||
131123813|NCT01251653|472082848|FG006|Overall Study|Withdrawal by Subject|0|||
131123814|NCT01251653|472082849|FG007|Overall Study|Withdrawal by Subject|1|||
131123815|NCT01251653|472082850|FG008|Overall Study|Withdrawal by Subject|0|||
131123816|NCT01251653|472082842|FG000|Overall Study|Other reason not mentioned above|0|||
131123817|NCT01251653|472082843|FG001|Overall Study|Other reason not mentioned above|0|||
131123818|NCT01251653|472082844|FG002|Overall Study|Other reason not mentioned above|0|||
131123819|NCT01251653|472082845|FG003|Overall Study|Other reason not mentioned above|0|||
131123820|NCT01251653|472082846|FG004|Overall Study|Other reason not mentioned above|0|||
131123821|NCT01251653|472082847|FG005|Overall Study|Other reason not mentioned above|0|||
130942955|NCT04256785|471424817|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
130942956|NCT02153112|471424821|FG000|Overall Study|Adverse Event|0|||
130942957|NCT02153112|471424822|FG001|Overall Study|Adverse Event|0|||
131123822|NCT01251653|472082848|FG006|Overall Study|Other reason not mentioned above|0|||
131123823|NCT01251653|472082849|FG007|Overall Study|Other reason not mentioned above|2|||
130942958|NCT02153112|471424823|FG002|Overall Study|Adverse Event|1|||
130942959|NCT02153112|471424824|FG003|Overall Study|Adverse Event|0|||
130942960|NCT02153112|471424825|FG004|Overall Study|Adverse Event|0|||
130942961|NCT02153112|471424826|FG005|Overall Study|Adverse Event|0|||
130942962|NCT02153112|471424827|FG006|Overall Study|Adverse Event|0|||
130942963|NCT02153112|471424828|FG007|Overall Study|Adverse Event|0|||
130942964|NCT02153112|471424829|FG008|Overall Study|Adverse Event|0|||
130942965|NCT02153112|471424830|FG009|Overall Study|Adverse Event|0|||
130942966|NCT02153112|471424821|FG000|Overall Study|Lost to Follow-up|1|||
130942967|NCT02153112|471424822|FG001|Overall Study|Lost to Follow-up|1|||
130942968|NCT02153112|471424823|FG002|Overall Study|Lost to Follow-up|0|||
130942969|NCT02153112|471424824|FG003|Overall Study|Lost to Follow-up|0|||
130942970|NCT02153112|471424825|FG004|Overall Study|Lost to Follow-up|2|||
130942971|NCT02153112|471424826|FG005|Overall Study|Lost to Follow-up|1|||
130942972|NCT02153112|471424827|FG006|Overall Study|Lost to Follow-up|1|||
130942973|NCT02153112|471424828|FG007|Overall Study|Lost to Follow-up|0|||
130942974|NCT02153112|471424829|FG008|Overall Study|Lost to Follow-up|1|||
130942975|NCT02153112|471424830|FG009|Overall Study|Lost to Follow-up|1|||
130942976|NCT02153112|471424821|FG000|Overall Study|Withdrawal by Subject|3|||
130942977|NCT02153112|471424822|FG001|Overall Study|Withdrawal by Subject|1|||
130942978|NCT02153112|471424823|FG002|Overall Study|Withdrawal by Subject|2|||
130942979|NCT02153112|471424824|FG003|Overall Study|Withdrawal by Subject|2|||
130942980|NCT02153112|471424825|FG004|Overall Study|Withdrawal by Subject|1|||
130942981|NCT02153112|471424826|FG005|Overall Study|Withdrawal by Subject|1|||
130942982|NCT02153112|471424827|FG006|Overall Study|Withdrawal by Subject|7|||
130942983|NCT02153112|471424828|FG007|Overall Study|Withdrawal by Subject|2|||
130942984|NCT02153112|471424829|FG008|Overall Study|Withdrawal by Subject|13|||
130942985|NCT02153112|471424830|FG009|Overall Study|Withdrawal by Subject|12|||
130942986|NCT02153112|471424821|FG000|Overall Study|Reason not Specified|0|||
130942987|NCT02153112|471424822|FG001|Overall Study|Reason not Specified|0|||
130942988|NCT02153112|471424823|FG002|Overall Study|Reason not Specified|0|||
131123824|NCT01251653|472082850|FG008|Overall Study|Other reason not mentioned above|0|||
131123825|NCT00847145|472082851|FG000|Overall Study|AE or Death|0|||
131123826|NCT00847145|472082852|FG001|Overall Study|AE or Death|1|||
131123827|NCT00847145|472082853|FG002|Overall Study|AE or Death|1|||
131123828|NCT00847145|472082854|FG003|Overall Study|AE or Death|0|||
131123829|NCT00847145|472082855|FG004|Overall Study|AE or Death|0|||
131123830|NCT00847145|472082856|FG005|Overall Study|AE or Death|0|||
131123831|NCT00847145|472082857|FG006|Overall Study|AE or Death|0|||
131123832|NCT00847145|472082858|FG007|Overall Study|AE or Death|0|||
131123833|NCT00847145|472082851|FG000|Overall Study|Withdrawal by Subject|3|||
131123834|NCT00847145|472082852|FG001|Overall Study|Withdrawal by Subject|4|||
131123835|NCT00847145|472082853|FG002|Overall Study|Withdrawal by Subject|6|||
131123836|NCT00847145|472082854|FG003|Overall Study|Withdrawal by Subject|1|||
131123837|NCT00847145|472082855|FG004|Overall Study|Withdrawal by Subject|0|||
131123838|NCT00847145|472082856|FG005|Overall Study|Withdrawal by Subject|0|||
131123839|NCT00847145|472082857|FG006|Overall Study|Withdrawal by Subject|1|||
131123840|NCT00847145|472082858|FG007|Overall Study|Withdrawal by Subject|1|||
131123841|NCT00847145|472082851|FG000|Overall Study|Lost to Follow-up|3|||
131123842|NCT00847145|472082852|FG001|Overall Study|Lost to Follow-up|1|||
131123843|NCT00847145|472082853|FG002|Overall Study|Lost to Follow-up|1|||
131123844|NCT00847145|472082854|FG003|Overall Study|Lost to Follow-up|0|||
131123845|NCT00847145|472082855|FG004|Overall Study|Lost to Follow-up|4|||
131123846|NCT00847145|472082856|FG005|Overall Study|Lost to Follow-up|4|||
131123847|NCT00847145|472082857|FG006|Overall Study|Lost to Follow-up|8|||
131123848|NCT00847145|472082858|FG007|Overall Study|Lost to Follow-up|2|||
131123849|NCT00847145|472082851|FG000|Overall Study|Inappropriate enrollment|0|||
131123850|NCT00847145|472082852|FG001|Overall Study|Inappropriate enrollment|0|||
131123851|NCT00847145|472082853|FG002|Overall Study|Inappropriate enrollment|0|||
131123852|NCT00847145|472082854|FG003|Overall Study|Inappropriate enrollment|0|||
131123853|NCT00847145|472082855|FG004|Overall Study|Inappropriate enrollment|1|||
131123854|NCT00847145|472082856|FG005|Overall Study|Inappropriate enrollment|0|||
131123855|NCT00847145|472082857|FG006|Overall Study|Inappropriate enrollment|0|||
131123856|NCT00847145|472082858|FG007|Overall Study|Inappropriate enrollment|0|||
131123857|NCT00847145|472082851|FG000|Overall Study|Protocol Violation|0|||
131123858|NCT00847145|472082852|FG001|Overall Study|Protocol Violation|0|||
131123859|NCT00847145|472082853|FG002|Overall Study|Protocol Violation|3|||
131123860|NCT00847145|472082854|FG003|Overall Study|Protocol Violation|0|||
131123861|NCT00847145|472082855|FG004|Overall Study|Protocol Violation|1|||
131123862|NCT00847145|472082856|FG005|Overall Study|Protocol Violation|0|||
131123863|NCT00847145|472082857|FG006|Overall Study|Protocol Violation|0|||
130942989|NCT02153112|471424824|FG003|Overall Study|Reason not Specified|0|||
130942990|NCT02153112|471424825|FG004|Overall Study|Reason not Specified|0|||
130942991|NCT02153112|471424826|FG005|Overall Study|Reason not Specified|0|||
131123864|NCT00847145|472082858|FG007|Overall Study|Protocol Violation|1|||
131123865|NCT02833974|472082860|FG000|Overall Study|Lost to Follow-up|1|||
131123866|NCT02833974|472082861|FG001|Overall Study|Lost to Follow-up|0|||
130942992|NCT02153112|471424827|FG006|Overall Study|Reason not Specified|0|||
131123867|NCT02833974|472082860|FG000|Overall Study|Adverse Event|0|||
130708829|NCT02546362|470560494|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
130708830|NCT02546362|470560494|FG000|12-week Treatment Period|Lost to Follow-up|2|||
130708831|NCT02546362|470560494|FG000|12-week Treatment Period|Change in medication|1|||
130708832|NCT05206448|470560495|FG000|Overall Study|Lost to Follow-up|2|||
130708833|NCT05206448|470560496|FG001|Overall Study|Lost to Follow-up|2|||
130708834|NCT05206448|470560495|FG000|Overall Study|Withdrawal by Subject|2|||
130708835|NCT05206448|470560496|FG001|Overall Study|Withdrawal by Subject|0|||
130942993|NCT02153112|471424828|FG007|Overall Study|Reason not Specified|0|||
130942994|NCT02153112|471424829|FG008|Overall Study|Reason not Specified|1|||
130942995|NCT02153112|471424830|FG009|Overall Study|Reason not Specified|1|||
130942996|NCT01675128|471424838|FG000|Overall Study|Disease progression on study|1|||
130942997|NCT01675128|471424839|FG001|Overall Study|Disease progression on study|1|||
130942998|NCT01675128|471424840|FG002|Overall Study|Disease progression on study|1|||
130942999|NCT01675128|471424838|FG000|Overall Study|Refused further treatment|1|||
130943000|NCT01675128|471424839|FG001|Overall Study|Refused further treatment|0|||
130943001|NCT01675128|471424840|FG002|Overall Study|Refused further treatment|0|||
131036669|NCT03808818|471768219|FG001|Overall Study|Lost to Follow-up|33|||
131036670|NCT04629716|471768223|FG000|Overall Study|Lost to Follow-up|7|||
131036671|NCT04629716|471768224|FG001|Overall Study|Lost to Follow-up|3|||
131036672|NCT04537715|471768231|FG000|Overall Study|Death|3|||
131036673|NCT04537715|471768232|FG001|Overall Study|Death|1|||
131036674|NCT04537715|471768231|FG000|Overall Study|Withdrawal by Subject|3|||
131036675|NCT04537715|471768232|FG001|Overall Study|Withdrawal by Subject|1|||
131036676|NCT04537715|471768231|FG000|Overall Study|Other|4|||
131036677|NCT04537715|471768232|FG001|Overall Study|Other|3|||
131036678|NCT04537715|471768231|FG000|Overall Study|Progressive disease|1|||
131036679|NCT04537715|471768232|FG001|Overall Study|Progressive disease|0|||
131036680|NCT02191618|471768233|FG000|Overall Study|Withdrawal by Subject|3|||
131036681|NCT02191618|471768233|FG000|Overall Study|Missed Visit|4|||
131036682|NCT03031470|471768236|FG000|Overall Study|Adverse Event|3|||
131036683|NCT03031470|471768237|FG001|Overall Study|Adverse Event|0|||
131036684|NCT03031470|471768236|FG000|Overall Study|Death|3|||
131036685|NCT03031470|471768237|FG001|Overall Study|Death|1|||
131036686|NCT03031470|471768236|FG000|Overall Study|Lost to Follow-up|1|||
131036687|NCT03031470|471768237|FG001|Overall Study|Lost to Follow-up|1|||
131036688|NCT03031470|471768236|FG000|Overall Study|Withdrawal by Subject|1|||
131036689|NCT03031470|471768237|FG001|Overall Study|Withdrawal by Subject|0|||
131036690|NCT03031470|471768236|FG000|Overall Study|Protocol entry criteria not met|0|||
131036691|NCT03031470|471768237|FG001|Overall Study|Protocol entry criteria not met|1|||
131036692|NCT03031470|471768236|FG000|Overall Study|Cancel the operation|0|||
131036693|NCT03031470|471768237|FG001|Overall Study|Cancel the operation|1|||
131036694|NCT03461276|471768238|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
131036695|NCT03461276|471768239|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
131036696|NCT03461276|471768238|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
131036697|NCT03461276|471768239|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
131036698|NCT03461276|471768238|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
131036699|NCT03461276|471768239|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
131036700|NCT03461276|471768238|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
131036701|NCT03461276|471768239|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
131036702|NCT03461276|471768238|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
131036703|NCT03461276|471768239|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
131036704|NCT03461276|471768238|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
131036705|NCT03461276|471768239|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
131036706|NCT03461276|471768238|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
131036707|NCT03461276|471768239|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
131036708|NCT03461276|471768238|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
131036709|NCT03461276|471768239|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
131036710|NCT03461276|471768238|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
131036711|NCT03461276|471768239|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
131036712|NCT03461276|471768238|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
131036713|NCT03461276|471768239|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
131036714|NCT04623671|471768240|FG000|Overall Study|Adverse Event|0|||
131036715|NCT04623671|471768241|FG001|Overall Study|Adverse Event|1|||
131036716|NCT04623671|471768240|FG000|Overall Study|Lost to Follow-up|2|||
131036717|NCT04623671|471768241|FG001|Overall Study|Lost to Follow-up|1|||
131036718|NCT04623671|471768240|FG000|Overall Study|Death|5|||
131123868|NCT02833974|472082861|FG001|Overall Study|Adverse Event|3|||
131123869|NCT00307151|472082863|FG000|Overall Study|Death|4|||
131123870|NCT00307151|472082864|FG001|Overall Study|Death|3|||
131123871|NCT00307151|472082865|FG002|Overall Study|Death|10|||
131123872|NCT00307151|472082866|FG003|Overall Study|Death|3|||
131123873|NCT00307151|472082863|FG000|Overall Study|Severe debilitation, unable to continue|1|||
131123874|NCT00307151|472082864|FG001|Overall Study|Severe debilitation, unable to continue|0|||
131036719|NCT04623671|471768241|FG001|Overall Study|Death|5|||
131224413|NCT03216954|472448880|FG000|Overall Study|Adverse Event|0|||
130943002|NCT01675128|471424838|FG000|Overall Study|Pulmonary complication; off study|0|||
130943003|NCT01675128|471424839|FG001|Overall Study|Pulmonary complication; off study|1|||
130943004|NCT01675128|471424840|FG002|Overall Study|Pulmonary complication; off study|0|||
130943005|NCT00832585|471424849|FG000|Overall Study|Withdrawal by Subject|1|||
130943006|NCT00832585|471424849|FG000|Overall Study|Lost to Follow-up|1|||
130943007|NCT03526458|471424855|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
130943008|NCT03526458|471424856|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
130943009|NCT03526458|471424855|FG000|Overall Study|Stone passed, surgery cancelled|2|||
130943010|NCT03526458|471424856|FG001|Overall Study|Stone passed, surgery cancelled|1|||
130943011|NCT03526458|471424855|FG000|Overall Study|Withdrawal by Subject|1|||
130943012|NCT03526458|471424856|FG001|Overall Study|Withdrawal by Subject|0|||
130943013|NCT03526458|471424855|FG000|Overall Study|Physician Decision|2|||
130943014|NCT03526458|471424856|FG001|Overall Study|Physician Decision|1|||
130943015|NCT03526458|471424855|FG000|Overall Study|Lack of equipment|1|||
130943016|NCT03526458|471424856|FG001|Overall Study|Lack of equipment|1|||
130943017|NCT00271947|471424857|FG000|Overall Study|Lost to Follow-up|1|||
130943018|NCT01522365|471424860|FG000|Overall Study|Withdrawal by Subject|1|||
130943019|NCT01522365|471424861|FG001|Overall Study|Withdrawal by Subject|1|||
130943020|NCT01522365|471424860|FG000|Overall Study|Lost to Follow-up|1|||
130943021|NCT01522365|471424861|FG001|Overall Study|Lost to Follow-up|1|||
130943022|NCT00673179|471424862|FG000|Overall Study|Toxicity/Complications|3|||
130943023|NCT00673179|471424863|FG001|Overall Study|Toxicity/Complications|0|||
130943024|NCT02466555|471424864|FG000|Overall Study|Lost to Follow-up|2|||
130943025|NCT04170348|471424865|FG000|Overall Study|Lost to Follow-up|2|||
130943026|NCT04170348|471424866|FG001|Overall Study|Lost to Follow-up|2|||
130943027|NCT04170348|471424865|FG000|Overall Study|Withdrawal by Subject|1|||
130943028|NCT04170348|471424866|FG001|Overall Study|Withdrawal by Subject|5|||
130943029|NCT04170348|471424865|FG000|Overall Study|Non-adherence|1|||
130943030|NCT04170348|471424866|FG001|Overall Study|Non-adherence|1|||
130943031|NCT04170348|471424865|FG000|Overall Study|Adverse Event|1|||
130943032|NCT04170348|471424866|FG001|Overall Study|Adverse Event|0|||
130943033|NCT00529542|471424868|FG000|Overall Study|Withdrawal by Subject|1|||
130943034|NCT00529542|471424869|FG001|Overall Study|Withdrawal by Subject|0|||
130943035|NCT00529542|471424868|FG000|Overall Study|Lost to Follow-up|0|||
130943036|NCT00529542|471424869|FG001|Overall Study|Lost to Follow-up|1|||
130943037|NCT02113956|471424874|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
130943038|NCT02113956|471424875|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
130943039|NCT02113956|471424874|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
130943040|NCT02113956|471424875|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
130943041|NCT02113956|471424874|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
130943042|NCT02113956|471424875|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
130943043|NCT01602380|471424876|FG000|Overall Study|Death|147|||
130943044|NCT01602380|471424877|FG001|Overall Study|Death|145|||
131123875|NCT00307151|472082865|FG002|Overall Study|Severe debilitation, unable to continue|0|||
131123876|NCT00307151|472082866|FG003|Overall Study|Severe debilitation, unable to continue|0|||
131123877|NCT00307151|472082863|FG000|Overall Study|Subject unable to get to clinic|1|||
131123878|NCT00307151|472082864|FG001|Overall Study|Subject unable to get to clinic|0|||
131123879|NCT00307151|472082865|FG002|Overall Study|Subject unable to get to clinic|6|||
131123880|NCT00307151|472082866|FG003|Overall Study|Subject unable to get to clinic|2|||
131123881|NCT00307151|472082863|FG000|Overall Study|Withdrew consent|0|||
131123882|NCT00307151|472082864|FG001|Overall Study|Withdrew consent|1|||
131123883|NCT00307151|472082865|FG002|Overall Study|Withdrew consent|1|||
131123884|NCT00307151|472082866|FG003|Overall Study|Withdrew consent|3|||
131123885|NCT00307151|472082863|FG000|Overall Study|Not willing to adhere to study reqs|2|||
131123886|NCT00307151|472082864|FG001|Overall Study|Not willing to adhere to study reqs|0|||
131123887|NCT00307151|472082865|FG002|Overall Study|Not willing to adhere to study reqs|2|||
131123888|NCT00307151|472082866|FG003|Overall Study|Not willing to adhere to study reqs|2|||
131123889|NCT00307151|472082863|FG000|Overall Study|Clinic unable to contact subject|3|||
130708836|NCT05206448|470560495|FG000|Overall Study|found ineligible after randomization|1|||
130708837|NCT05206448|470560496|FG001|Overall Study|found ineligible after randomization|1|||
130708838|NCT05206448|470560495|FG000|Overall Study|unable to complete study due to personal constraints|1|||
130943045|NCT01602380|471424876|FG000|Overall Study|Withdrawal by Subject|39|||
130943046|NCT01602380|471424877|FG001|Overall Study|Withdrawal by Subject|41|||
130943047|NCT01602380|471424876|FG000|Overall Study|Lost to Follow-up|15|||
130943048|NCT01602380|471424877|FG001|Overall Study|Lost to Follow-up|12|||
130943049|NCT01602380|471424876|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130943050|NCT01602380|471424877|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
130943051|NCT01602380|471424876|FG000|Overall Study|Other|2|||
130943052|NCT01602380|471424877|FG001|Overall Study|Other|0|||
131123890|NCT00307151|472082864|FG001|Overall Study|Clinic unable to contact subject|3|||
131123891|NCT00307151|472082865|FG002|Overall Study|Clinic unable to contact subject|1|||
130943053|NCT02005250|471424879|FG000|Overall Study|Lost to Follow-up|15|||
131123892|NCT00307151|472082866|FG003|Overall Study|Clinic unable to contact subject|1|||
131123893|NCT02966509|472082870|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
130943054|NCT02005250|471424880|FG001|Overall Study|Lost to Follow-up|5|||
130943055|NCT04007094|471424881|FG000|Overall Study|Lost to Follow-up|1|||
130943056|NCT04007094|471424882|FG001|Overall Study|Lost to Follow-up|1|||
130943057|NCT04350788|471424883|FG000|Overall Study|Lost to Follow-up|6|||
130943058|NCT04350788|471424884|FG001|Overall Study|Lost to Follow-up|2|||
130943059|NCT04350788|471424883|FG000|Overall Study|Withdrawal by Subject|2|||
130943060|NCT04350788|471424884|FG001|Overall Study|Withdrawal by Subject|4|||
130943061|NCT04350788|471424883|FG000|Overall Study|Protocol Violation|4|||
130943062|NCT04350788|471424884|FG001|Overall Study|Protocol Violation|0|||
130943063|NCT05089682|471426137|FG000|Overall Study|Withdrawal by Subject|2|||
130943064|NCT00695396|471426138|FG000|Overall Study|Study Closed Prematurely|5|||
130943065|NCT00695396|471426139|FG001|Overall Study|Study Closed Prematurely|6|||
130943066|NCT00695396|471426140|FG002|Overall Study|Study Closed Prematurely|8|||
130943067|NCT00695396|471426138|FG000|Overall Study|Withdrawal by Subject|2|||
130943068|NCT00695396|471426139|FG001|Overall Study|Withdrawal by Subject|2|||
130943069|NCT00695396|471426140|FG002|Overall Study|Withdrawal by Subject|0|||
130943070|NCT00371254|471426141|FG000|Overall Study|Disease progression|13|||
130943071|NCT00371254|471426142|FG001|Overall Study|Disease progression|13|||
130943072|NCT00371254|471426141|FG000|Overall Study|Study drug toxicity|3|||
130943073|NCT00371254|471426142|FG001|Overall Study|Study drug toxicity|5|||
130943074|NCT00371254|471426141|FG000|Overall Study|Subject request|5|||
130943075|NCT00371254|471426142|FG001|Overall Study|Subject request|0|||
130943076|NCT00371254|471426141|FG000|Overall Study|Investigator Decision|2|||
130943077|NCT00371254|471426142|FG001|Overall Study|Investigator Decision|0|||
130943078|NCT00371254|471426141|FG000|Overall Study|Adverse event unrelated to study drug|0|||
130943079|NCT00371254|471426142|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130943080|NCT00371254|471426141|FG000|Overall Study|Lost to Follow-up|0|||
130943081|NCT00371254|471426142|FG001|Overall Study|Lost to Follow-up|1|||
130943082|NCT00371254|471426141|FG000|Overall Study|Withdrawal by Subject|0|||
130943083|NCT00371254|471426142|FG001|Overall Study|Withdrawal by Subject|1|||
130943084|NCT02418468|471426146|FG000|Overall Study|Adverse Event|1|||
130943085|NCT02418468|471426147|FG001|Overall Study|Adverse Event|0|||
130943086|NCT02418468|471426146|FG000|Overall Study|Withdrawal of informed consent|1|||
130943087|NCT02418468|471426147|FG001|Overall Study|Withdrawal of informed consent|1|||
130943088|NCT02914769|471426148|FG000|Overall Study|Protocol Violation|3|||
130943089|NCT02914769|471426149|FG001|Overall Study|Protocol Violation|2|||
130943090|NCT02914769|471426148|FG000|Overall Study|Withdrawal by Subject|0|||
130943091|NCT02914769|471426149|FG001|Overall Study|Withdrawal by Subject|1|||
130943092|NCT00099437|471426152|FG000|Overall Study|Lost to Follow-up|30|||
130943093|NCT00099437|471426153|FG001|Overall Study|Lost to Follow-up|33|||
130943094|NCT00099437|471426152|FG000|Overall Study|Death|293|||
130943095|NCT00099437|471426153|FG001|Overall Study|Death|261|||
130943096|NCT00099437|471426152|FG000|Overall Study|Withdrawal by Subject|6|||
130943097|NCT00099437|471426153|FG001|Overall Study|Withdrawal by Subject|10|||
130943098|NCT00099437|471426152|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
130943099|NCT00099437|471426153|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
130943100|NCT05413369|471426154|FG000|Overall Study|Adverse Event|1|||
130943101|NCT05413369|471426155|FG001|Overall Study|Adverse Event|1|||
130943102|NCT05413369|471426154|FG000|Overall Study|Withdrawal by Subject|13|||
130943103|NCT05413369|471426155|FG001|Overall Study|Withdrawal by Subject|4|||
130943104|NCT05413369|471426154|FG000|Overall Study|Non-compliance with study schedule|2|||
130943105|NCT05413369|471426155|FG001|Overall Study|Non-compliance with study schedule|1|||
130943106|NCT05413369|471426154|FG000|Overall Study|Other|1|||
130943107|NCT05413369|471426155|FG001|Overall Study|Other|1|||
130943108|NCT00720057|471426156|FG000|Overall Study|Lost to Follow-up|0|||
130943109|NCT00720057|471426157|FG001|Overall Study|Lost to Follow-up|2|||
130943110|NCT00720057|471426156|FG000|Overall Study|Protocol Violation|1|||
131123894|NCT02966509|472082871|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
130772634|NCT02757352|470794737|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772635|NCT02757352|470794738|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772636|NCT02757352|470794739|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130943111|NCT00720057|471426157|FG001|Overall Study|Protocol Violation|0|||
130943112|NCT00720057|471426156|FG000|Overall Study|Withdrawal by Subject|0|||
130943113|NCT00720057|471426157|FG001|Overall Study|Withdrawal by Subject|1|||
130943114|NCT02726074|471426158|FG000|Overall Study|Withdrawal by Subject|4|||
130943115|NCT02726074|471426158|FG000|Overall Study|Adverse Event|14|||
130943116|NCT02726074|471426158|FG000|Overall Study|Protocol Violation|3|||
130943117|NCT02726074|471426158|FG000|Overall Study|Lost to Follow-up|2|||
130943118|NCT02726074|471426158|FG000|Overall Study|Others|3|||
131123895|NCT02966509|472082870|FG000|Baseline Satisfaction Survey|Death|0|||
130943119|NCT01179477|471426162|FG000|Overall Study|Death|542|||
130943120|NCT01179477|471426162|FG000|Overall Study|Unsuccessful implant|80|||
130943121|NCT01179477|471426162|FG000|Overall Study|Non-death withdrawal|438|||
130943122|NCT01179477|471426162|FG000|Overall Study|Did not complete final visit|27|||
130943123|NCT00975481|471426171|FG000|Second Intervention Period|Adverse Event|2|||
130943124|NCT00975481|471426172|FG001|Second Intervention Period|Adverse Event|1|||
130943125|NCT00975481|471426173|FG002|Second Intervention Period|Adverse Event|0|||
130943126|NCT00975481|471426174|FG003|Second Intervention Period|Adverse Event|0|||
130943127|NCT00975481|471426175|FG004|Second Intervention Period|Adverse Event|0|||
130943128|NCT00975481|471426176|FG005|Second Intervention Period|Adverse Event|0|||
130943129|NCT00975481|471426171|FG000|Second Intervention Period|Withdrawal by Subject|0|||
130943130|NCT00975481|471426172|FG001|Second Intervention Period|Withdrawal by Subject|0|||
130943131|NCT00975481|471426173|FG002|Second Intervention Period|Withdrawal by Subject|1|||
130943132|NCT00975481|471426174|FG003|Second Intervention Period|Withdrawal by Subject|0|||
130943133|NCT00975481|471426175|FG004|Second Intervention Period|Withdrawal by Subject|0|||
130943134|NCT00975481|471426176|FG005|Second Intervention Period|Withdrawal by Subject|0|||
130943135|NCT00975481|471426171|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
130943136|NCT00975481|471426172|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
130943137|NCT00975481|471426173|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
130943138|NCT00975481|471426174|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
130943139|NCT00975481|471426175|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
130943140|NCT00975481|471426176|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
130943141|NCT00975481|471426171|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
130943142|NCT00975481|471426172|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
130772637|NCT02757352|470794740|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772638|NCT02757352|470794741|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772639|NCT02757352|470794742|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772640|NCT02757352|470794743|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772641|NCT02757352|470794734|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130772642|NCT02757352|470794735|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130943143|NCT00975481|471426173|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
130943144|NCT00975481|471426174|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
130943145|NCT00975481|471426175|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
130943146|NCT00975481|471426176|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
130943147|NCT00643682|471426177|FG000|Overall Study|did not keep appointment|522|||
130943148|NCT00643682|471426178|FG001|Overall Study|did not keep appointment|509|||
130943149|NCT01374087|471426182|FG000|Overall Study|Adverse Event|1|||
130943150|NCT01374087|471426183|FG001|Overall Study|Adverse Event|0|||
130943151|NCT01374087|471426182|FG000|Overall Study|Disease progression|2|||
130943152|NCT01374087|471426183|FG001|Overall Study|Disease progression|2|||
130943153|NCT01374087|471426182|FG000|Overall Study|Study discontinued|13|||
130943154|NCT01374087|471426183|FG001|Overall Study|Study discontinued|13|||
130943155|NCT03011307|471426184|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
130943156|NCT03011307|471426185|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
130943157|NCT03011307|471426184|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
130943158|NCT03011307|471426185|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
130943159|NCT03011307|471426184|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
130943160|NCT03011307|471426185|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
130943161|NCT02677987|471426186|FG000|Overall Study|Withdrawal by Subject|3|||
130943162|NCT02677987|471426187|FG001|Overall Study|Withdrawal by Subject|0|||
130943163|NCT02677987|471426186|FG000|Overall Study|Lost to Follow-up|1|||
130943164|NCT02677987|471426187|FG001|Overall Study|Lost to Follow-up|0|||
130943165|NCT01120756|471426188|FG000|Overall Study|Withdrawal by Subject|1|||
130943166|NCT01120756|471426189|FG001|Overall Study|Withdrawal by Subject|1|||
130943167|NCT03760146|471426194|FG000|Overall Study|Adverse Event|11|||
130943168|NCT03760146|471426195|FG001|Overall Study|Adverse Event|8|||
130943169|NCT03760146|471426196|FG002|Overall Study|Adverse Event|0|||
130943170|NCT03760146|471426197|FG003|Overall Study|Adverse Event|0|||
130943171|NCT03760146|471426198|FG004|Overall Study|Adverse Event|0|||
130943172|NCT03760146|471426199|FG005|Overall Study|Adverse Event|0|||
130943173|NCT03760146|471426194|FG000|Overall Study|Death|1|||
130943174|NCT03760146|471426195|FG001|Overall Study|Death|0|||
130943175|NCT03760146|471426196|FG002|Overall Study|Death|0|||
130943176|NCT03760146|471426197|FG003|Overall Study|Death|0|||
130943177|NCT03760146|471426198|FG004|Overall Study|Death|0|||
130943178|NCT03760146|471426199|FG005|Overall Study|Death|0|||
130943179|NCT03760146|471426194|FG000|Overall Study|Lost to Follow-up|41|||
130943180|NCT03760146|471426195|FG001|Overall Study|Lost to Follow-up|28|||
130943181|NCT03760146|471426196|FG002|Overall Study|Lost to Follow-up|9|||
130943182|NCT03760146|471426197|FG003|Overall Study|Lost to Follow-up|2|||
130943183|NCT03760146|471426198|FG004|Overall Study|Lost to Follow-up|14|||
130943184|NCT03760146|471426199|FG005|Overall Study|Lost to Follow-up|8|||
130943185|NCT03760146|471426194|FG000|Overall Study|No longer met eligibility criteria|3|||
130943186|NCT03760146|471426195|FG001|Overall Study|No longer met eligibility criteria|9|||
130943187|NCT03760146|471426196|FG002|Overall Study|No longer met eligibility criteria|0|||
130943188|NCT03760146|471426197|FG003|Overall Study|No longer met eligibility criteria|0|||
130943189|NCT03760146|471426198|FG004|Overall Study|No longer met eligibility criteria|1|||
130943190|NCT03760146|471426199|FG005|Overall Study|No longer met eligibility criteria|0|||
130943191|NCT03760146|471426194|FG000|Overall Study|Protocol Violation|21|||
130943192|NCT03760146|471426195|FG001|Overall Study|Protocol Violation|13|||
130943193|NCT03760146|471426196|FG002|Overall Study|Protocol Violation|1|||
130943194|NCT03760146|471426197|FG003|Overall Study|Protocol Violation|0|||
130943195|NCT03760146|471426198|FG004|Overall Study|Protocol Violation|1|||
130943196|NCT03760146|471426199|FG005|Overall Study|Protocol Violation|0|||
130943197|NCT03760146|471426194|FG000|Overall Study|Withdrawal by Subject|19|||
130943198|NCT03760146|471426195|FG001|Overall Study|Withdrawal by Subject|20|||
130943199|NCT03760146|471426196|FG002|Overall Study|Withdrawal by Subject|1|||
130943200|NCT03760146|471426197|FG003|Overall Study|Withdrawal by Subject|0|||
130943201|NCT03760146|471426198|FG004|Overall Study|Withdrawal by Subject|1|||
130943202|NCT03760146|471426199|FG005|Overall Study|Withdrawal by Subject|0|||
130943203|NCT00449644|471426200|FG000|Overall Study|Adverse Event|0|||
130943204|NCT00449644|471426201|FG001|Overall Study|Adverse Event|0|||
130943205|NCT00449644|471426202|FG002|Overall Study|Adverse Event|3|||
130943206|NCT00449644|471426203|FG003|Overall Study|Adverse Event|5|||
130943207|NCT00449644|471426200|FG000|Overall Study|Death|1|||
130943208|NCT00449644|471426201|FG001|Overall Study|Death|0|||
130943209|NCT00449644|471426202|FG002|Overall Study|Death|6|||
130943210|NCT00449644|471426203|FG003|Overall Study|Death|1|||
130943211|NCT00449644|471426200|FG000|Overall Study|Lost to Follow-up|1|||
130943212|NCT00449644|471426201|FG001|Overall Study|Lost to Follow-up|1|||
130943213|NCT00449644|471426202|FG002|Overall Study|Lost to Follow-up|5|||
130943214|NCT00449644|471426203|FG003|Overall Study|Lost to Follow-up|3|||
130943215|NCT00449644|471426200|FG000|Overall Study|Pregnancy|0|||
130943216|NCT00449644|471426201|FG001|Overall Study|Pregnancy|0|||
130943217|NCT00449644|471426202|FG002|Overall Study|Pregnancy|3|||
130943218|NCT00449644|471426203|FG003|Overall Study|Pregnancy|2|||
130943219|NCT00449644|471426200|FG000|Overall Study|Protocol Violation|4|||
130943220|NCT00449644|471426201|FG001|Overall Study|Protocol Violation|4|||
130943221|NCT00449644|471426202|FG002|Overall Study|Protocol Violation|3|||
130943222|NCT00449644|471426203|FG003|Overall Study|Protocol Violation|7|||
130943223|NCT00449644|471426200|FG000|Overall Study|Withdrawal by Subject|3|||
130943224|NCT00449644|471426201|FG001|Overall Study|Withdrawal by Subject|4|||
130943225|NCT00449644|471426202|FG002|Overall Study|Withdrawal by Subject|6|||
130943226|NCT00449644|471426203|FG003|Overall Study|Withdrawal by Subject|7|||
130943227|NCT00449644|471426200|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
130943228|NCT00449644|471426201|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
130943229|NCT00449644|471426202|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
130943230|NCT00449644|471426203|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
130943231|NCT00449644|471426200|FG000|Overall Study|Other|1|||
130943232|NCT00449644|471426201|FG001|Overall Study|Other|4|||
130943233|NCT00449644|471426202|FG002|Overall Study|Other|1|||
130943234|NCT00449644|471426203|FG003|Overall Study|Other|0|||
130943235|NCT00449644|471426200|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
130943236|NCT00449644|471426201|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
130943237|NCT00449644|471426202|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
130943238|NCT00449644|471426203|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
130943239|NCT01082965|471426204|FG000|Overall Study|Protocol Violation|0|||
130943240|NCT01082965|471426205|FG001|Overall Study|Protocol Violation|1|||
130943241|NCT01082965|471426204|FG000|Overall Study|Other|1|||
130943242|NCT01082965|471426205|FG001|Overall Study|Other|1|||
130943243|NCT01559012|471426208|FG000|Overall Study|Withdrawal by Subject|0|||
130943244|NCT01559012|471426209|FG001|Overall Study|Withdrawal by Subject|1|||
130943245|NCT00946712|471426210|FG000|Overall Study|Adverse Event|118|||
130943246|NCT00946712|471426211|FG001|Overall Study|Adverse Event|124|||
130943247|NCT00946712|471426210|FG000|Overall Study|Disease progression|308|||
130943248|NCT00946712|471426211|FG001|Overall Study|Disease progression|404|||
130943249|NCT00946712|471426210|FG000|Overall Study|Death|21|||
130708839|NCT05206448|470560496|FG001|Overall Study|unable to complete study due to personal constraints|0|||
130708840|NCT05206448|470560495|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
130708841|NCT05206448|470560496|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
130708842|NCT02025010|470560497|FG000|Overall Study|Symptomatic or radiographic progression|36|||
130708843|NCT02025010|470560497|FG000|Overall Study|Adverse Event|6|||
130708844|NCT02025010|470560497|FG000|Overall Study|Physician Decision|7|||
130708845|NCT02025010|470560497|FG000|Overall Study|Withdrawal by Subject|3|||
130708846|NCT02025010|470560497|FG000|Overall Study|Intercurrent illness|3|||
130943250|NCT00946712|471426211|FG001|Overall Study|Death|22|||
130943251|NCT00946712|471426210|FG000|Overall Study|No treatment given|25|||
130708847|NCT02025010|470560497|FG000|Overall Study|Patients still on treatment|3|||
130943252|NCT00946712|471426211|FG001|Overall Study|No treatment given|29|||
130943253|NCT00946712|471426210|FG000|Overall Study|Other reasons|61|||
130943254|NCT00946712|471426211|FG001|Overall Study|Other reasons|73|||
130943255|NCT00946712|471426210|FG000|Overall Study|On Treatment|0|||
130943256|NCT00946712|471426211|FG001|Overall Study|On Treatment|4|||
130943257|NCT00946712|471426210|FG000|Overall Study|Ineligible|14|||
130943258|NCT00946712|471426211|FG001|Overall Study|Ineligible|6|||
130943259|NCT02291055|471426214|FG000|Overall Study|Death|2|||
130943260|NCT02291055|471426215|FG001|Overall Study|Death|2|||
130943261|NCT02291055|471426216|FG002|Overall Study|Death|5|||
130943262|NCT02291055|471426217|FG003|Overall Study|Death|8|||
130943263|NCT02291055|471426218|FG004|Overall Study|Death|12|||
130943264|NCT02291055|471426214|FG000|Overall Study|Lost to Follow-up|0|||
130943265|NCT02291055|471426215|FG001|Overall Study|Lost to Follow-up|0|||
130943266|NCT02291055|471426216|FG002|Overall Study|Lost to Follow-up|0|||
130943267|NCT02291055|471426217|FG003|Overall Study|Lost to Follow-up|1|||
130943268|NCT02291055|471426218|FG004|Overall Study|Lost to Follow-up|2|||
130943269|NCT02291055|471426214|FG000|Overall Study|Withdrawal by Subject|3|||
130943270|NCT02291055|471426215|FG001|Overall Study|Withdrawal by Subject|1|||
130943271|NCT02291055|471426216|FG002|Overall Study|Withdrawal by Subject|1|||
130943272|NCT02291055|471426217|FG003|Overall Study|Withdrawal by Subject|5|||
130943273|NCT02291055|471426218|FG004|Overall Study|Withdrawal by Subject|10|||
130943274|NCT02291055|471426214|FG000|Overall Study|Progressive Disease|0|||
130943275|NCT02291055|471426215|FG001|Overall Study|Progressive Disease|0|||
130943276|NCT02291055|471426216|FG002|Overall Study|Progressive Disease|1|||
130943277|NCT02291055|471426217|FG003|Overall Study|Progressive Disease|4|||
130943278|NCT02291055|471426218|FG004|Overall Study|Progressive Disease|2|||
130943279|NCT02291055|471426214|FG000|Overall Study|Study Terminated by Sponsor|0|||
130943280|NCT02291055|471426215|FG001|Overall Study|Study Terminated by Sponsor|0|||
130943281|NCT02291055|471426216|FG002|Overall Study|Study Terminated by Sponsor|0|||
130943282|NCT02291055|471426217|FG003|Overall Study|Study Terminated by Sponsor|5|||
130943283|NCT02291055|471426218|FG004|Overall Study|Study Terminated by Sponsor|1|||
130943284|NCT02291055|471426214|FG000|Overall Study|Other|0|||
130943285|NCT02291055|471426215|FG001|Overall Study|Other|2|||
130943286|NCT02291055|471426216|FG002|Overall Study|Other|1|||
130943287|NCT02291055|471426217|FG003|Overall Study|Other|4|||
130943288|NCT02291055|471426218|FG004|Overall Study|Other|0|||
130943289|NCT00853723|471426220|FG000|Overall Study|Adverse Event|3|||
130943290|NCT00853723|471426221|FG001|Overall Study|Adverse Event|4|||
130943291|NCT00853723|471426222|FG002|Overall Study|Adverse Event|1|||
130943292|NCT00853723|471426220|FG000|Overall Study|Withdrawal by Subject|2|||
130943293|NCT00853723|471426221|FG001|Overall Study|Withdrawal by Subject|1|||
130943294|NCT00853723|471426222|FG002|Overall Study|Withdrawal by Subject|0|||
130943295|NCT00853723|471426220|FG000|Overall Study|Protocol Violation|1|||
130943296|NCT00853723|471426221|FG001|Overall Study|Protocol Violation|2|||
130943297|NCT00853723|471426222|FG002|Overall Study|Protocol Violation|1|||
130943298|NCT03839212|471426225|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
130943299|NCT00445965|471426226|FG000|Overall Study|Adverse Event|2|||
130943300|NCT00445965|471426226|FG000|Overall Study|Physician Decision|1|||
130943301|NCT00445965|471426226|FG000|Overall Study|Enrolled but not treated|1|||
130943302|NCT00445965|471426226|FG000|Overall Study|Removed due to progressive disease|29|||
130943303|NCT00679263|471426227|FG000|Visit 2/Dose 1|Adverse Event|1|||
130943304|NCT00679263|471426228|FG001|Visit 2/Dose 1|Adverse Event|0|||
130943305|NCT00679263|471426229|FG002|Visit 2/Dose 1|Adverse Event|0|||
130943306|NCT00679263|471426227|FG000|Visit 2/Dose 1|subject not compliance|1|||
130943307|NCT00679263|471426228|FG001|Visit 2/Dose 1|subject not compliance|1|||
130943308|NCT00679263|471426229|FG002|Visit 2/Dose 1|subject not compliance|0|||
130943309|NCT01464346|471426233|FG000|Overall Study|Withdrawal by Subject|0|||
130943310|NCT01464346|471426234|FG001|Overall Study|Withdrawal by Subject|0|||
130943311|NCT01464346|471426235|FG002|Overall Study|Withdrawal by Subject|1|||
130943312|NCT03999892|471426236|FG000|Overall Study|Lost to Follow-up|1|||
130943313|NCT02295995|471426237|FG000|Overall Study|Lost to Follow-up|5|||
130943314|NCT02295995|471426238|FG001|Overall Study|Lost to Follow-up|1|||
130943315|NCT02447081|471426239|FG000|Overall Study|Death|161|||
130943316|NCT02447081|471426239|FG000|Overall Study|Lost to Follow-up|36|||
130943317|NCT02447081|471426239|FG000|Overall Study|Visit not completed|17|||
130943318|NCT02447081|471426239|FG000|Overall Study|unsuccessful implant procedure|10|||
130943319|NCT01848756|471426242|FG000|Overall Study|Adverse Event|1|||
130943320|NCT01848756|471426242|FG000|Overall Study|Withdrawal by Subject|1|||
131036720|NCT04542317|471768242|FG000|Overall Study|Care recipients passed away|18|||
131036721|NCT04542317|471768243|FG001|Overall Study|Care recipients passed away|13|||
130943321|NCT01848756|471426242|FG000|Overall Study|Enrolled in Error|1|||
130943322|NCT02075658|471426243|FG000|Overall Study|Physician Decision|2|||
130943323|NCT02075658|471426244|FG001|Overall Study|Physician Decision|2|||
130943324|NCT01498458|471426245|FG000|Overall Study|Adverse Event|4|||
130943325|NCT01498458|471426245|FG000|Overall Study|Physician Decision|3|||
130943326|NCT02406651|471426246|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
130943327|NCT00718328|471426247|FG000|Overall Study|Lost to Follow-up|1|||
130943328|NCT00718328|471426248|FG001|Overall Study|Lost to Follow-up|0|||
131036722|NCT04542317|471768242|FG000|Overall Study|No longer a primary caregiver|5|||
131036723|NCT04542317|471768243|FG001|Overall Study|No longer a primary caregiver|1|||
130943329|NCT02865915|471426249|FG000|Overall Study|Pregnancy|1|||
130943330|NCT02865915|471426250|FG001|Overall Study|Pregnancy|0|||
130943331|NCT02865915|471426249|FG000|Overall Study|Withdrawal by Subject|1|||
130943332|NCT02865915|471426250|FG001|Overall Study|Withdrawal by Subject|1|||
130943333|NCT02865915|471426249|FG000|Overall Study|Adverse Event|0|||
130943334|NCT02865915|471426250|FG001|Overall Study|Adverse Event|4|||
130772643|NCT02757352|470794736|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
130772644|NCT02757352|470794737|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772645|NCT02757352|470794738|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772646|NCT02757352|470794739|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772647|NCT02757352|470794740|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772648|NCT02757352|470794741|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772649|NCT02757352|470794742|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772650|NCT02757352|470794743|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772651|NCT02757352|470794734|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
130772652|NCT02757352|470794735|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
130772653|NCT02757352|470794736|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
130772654|NCT02757352|470794737|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130772655|NCT02757352|470794738|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130772656|NCT02757352|470794739|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130772657|NCT02757352|470794740|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130772658|NCT02757352|470794741|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130772659|NCT02757352|470794742|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130772660|NCT02757352|470794743|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130772661|NCT02757352|470794734|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130772662|NCT02757352|470794735|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130772663|NCT02757352|470794736|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130772664|NCT02757352|470794737|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
130772665|NCT02757352|470794738|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130772666|NCT02757352|470794739|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
130772667|NCT02757352|470794740|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130772668|NCT02757352|470794741|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130772669|NCT02757352|470794742|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130772670|NCT02757352|470794743|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130772671|NCT02757352|470794734|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772672|NCT02757352|470794735|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772673|NCT02757352|470794736|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772674|NCT02757352|470794737|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
130772675|NCT02757352|470794738|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130772676|NCT02757352|470794739|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
130772677|NCT02757352|470794740|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772678|NCT02757352|470794741|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
131123896|NCT02966509|472082871|FG001|Baseline Satisfaction Survey|Death|1|||
131123897|NCT02966509|472082870|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
131123898|NCT02966509|472082871|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
131123899|NCT02966509|472082870|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
131123900|NCT02966509|472082871|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
131123901|NCT02966509|472082870|FG000|6 Month Satisfaction Decision Survey|Death|22|||
130772679|NCT02757352|470794742|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772680|NCT02757352|470794743|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130772681|NCT02757352|470794734|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130772682|NCT02757352|470794735|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130772683|NCT02757352|470794736|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130772684|NCT02757352|470794737|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130943335|NCT02865915|471426249|FG000|Overall Study|Lost to Follow-up|0|||
130943336|NCT02865915|471426250|FG001|Overall Study|Lost to Follow-up|1|||
130943337|NCT02865915|471426249|FG000|Overall Study|Protocol Violation|0|||
130943338|NCT02865915|471426250|FG001|Overall Study|Protocol Violation|1|||
130943339|NCT02865915|471426249|FG000|Overall Study|Study terminated by sponsor|23|||
131123902|NCT02966509|472082871|FG001|6 Month Satisfaction Decision Survey|Death|25|||
130943340|NCT02865915|471426250|FG001|Overall Study|Study terminated by sponsor|18|||
130943341|NCT02865915|471426249|FG000|Overall Study|Dosing group discontinued|0|||
130943342|NCT02865915|471426250|FG001|Overall Study|Dosing group discontinued|5|||
130943343|NCT02946047|471426262|FG000|Overall Study|Adverse Event|1|||
130943344|NCT02946047|471426263|FG001|Overall Study|Adverse Event|0|||
130943345|NCT02946047|471426264|FG002|Overall Study|Adverse Event|0|||
130943346|NCT02946047|471426265|FG003|Overall Study|Adverse Event|0|||
130943347|NCT01581307|471426274|FG000|Overall Study|Withdrawal by Subject|1|||
130943348|NCT00378209|471426277|FG000|Overall Study|Progressive disease|11|||
130943349|NCT00378209|471426277|FG000|Overall Study|Adverse Event|3|||
130943350|NCT00378209|471426277|FG000|Overall Study|Initiation of non-protocol therapy|3|||
130943351|NCT00378209|471426277|FG000|Overall Study|Physician Decision|3|||
131036724|NCT04542317|471768242|FG000|Overall Study|Withdrawal by Subject|4|||
131036725|NCT04542317|471768243|FG001|Overall Study|Withdrawal by Subject|2|||
131036726|NCT04542317|471768242|FG000|Overall Study|Caregivers passed away|0|||
131036727|NCT04542317|471768243|FG001|Overall Study|Caregivers passed away|2|||
131036728|NCT03496168|471768246|FG000|Overall Study|Other Reasons|1|||
131036729|NCT03496168|471768246|FG000|Overall Study|Adverse Event|1|||
131036730|NCT04599062|471768251|FG000|Overall Study|Physician Decision|1|||
131036731|NCT04599062|471768252|FG001|Overall Study|Physician Decision|0|||
131036732|NCT05329220|471768253|FG000|Active Trial Period|Adverse Event|0|||
131036733|NCT05329220|471768254|FG001|Active Trial Period|Adverse Event|0|||
131036734|NCT05329220|471768255|FG002|Active Trial Period|Adverse Event|0|||
131036735|NCT05329220|471768256|FG003|Active Trial Period|Adverse Event|0|||
131036736|NCT05329220|471768257|FG004|Active Trial Period|Adverse Event|1|||
131036737|NCT05329220|471768258|FG005|Active Trial Period|Adverse Event|0|||
131036738|NCT05329220|471768253|FG000|Active Trial Period|Lost to Follow-up|0|||
131036739|NCT05329220|471768254|FG001|Active Trial Period|Lost to Follow-up|0|||
131036740|NCT05329220|471768255|FG002|Active Trial Period|Lost to Follow-up|0|||
131036741|NCT05329220|471768256|FG003|Active Trial Period|Lost to Follow-up|0|||
131036742|NCT05329220|471768257|FG004|Active Trial Period|Lost to Follow-up|32|||
131036743|NCT05329220|471768258|FG005|Active Trial Period|Lost to Follow-up|28|||
131036744|NCT05329220|471768253|FG000|Active Trial Period|Physician Decision|0|||
131036745|NCT05329220|471768254|FG001|Active Trial Period|Physician Decision|0|||
131036746|NCT05329220|471768255|FG002|Active Trial Period|Physician Decision|0|||
131036747|NCT05329220|471768256|FG003|Active Trial Period|Physician Decision|0|||
131036748|NCT05329220|471768257|FG004|Active Trial Period|Physician Decision|2|||
131036749|NCT05329220|471768258|FG005|Active Trial Period|Physician Decision|0|||
131036750|NCT05329220|471768253|FG000|Active Trial Period|Protocol Violation|0|||
131036751|NCT05329220|471768254|FG001|Active Trial Period|Protocol Violation|0|||
131036752|NCT05329220|471768255|FG002|Active Trial Period|Protocol Violation|0|||
131036753|NCT05329220|471768256|FG003|Active Trial Period|Protocol Violation|0|||
131036754|NCT05329220|471768257|FG004|Active Trial Period|Protocol Violation|1|||
131036755|NCT05329220|471768258|FG005|Active Trial Period|Protocol Violation|3|||
131036756|NCT05329220|471768253|FG000|Active Trial Period|Withdrawal by Subject|0|||
131036757|NCT05329220|471768254|FG001|Active Trial Period|Withdrawal by Subject|0|||
131036758|NCT05329220|471768255|FG002|Active Trial Period|Withdrawal by Subject|0|||
131036759|NCT05329220|471768256|FG003|Active Trial Period|Withdrawal by Subject|1|||
130708848|NCT02025010|470560497|FG000|Overall Study|Never initiate the treatment|2|||
130708849|NCT01661881|470560499|FG000|Overall Study|Disease Progression|1|||
130708850|NCT00949988|470560504|FG000|Overall Study|Withdrawal by Subject|3|||
130708851|NCT00484419|470560511|FG000|Overall Study|Adverse Event|3|||
130708852|NCT00484419|470560512|FG001|Overall Study|Adverse Event|0|||
130708853|NCT00484419|470560513|FG002|Overall Study|Adverse Event|0|||
130708854|NCT00484419|470560511|FG000|Overall Study|Lost to Follow-up|1|||
130708855|NCT00484419|470560512|FG001|Overall Study|Lost to Follow-up|0|||
130708856|NCT00484419|470560513|FG002|Overall Study|Lost to Follow-up|2|||
130708857|NCT00484419|470560511|FG000|Overall Study|Withdrawal by Subject|3|||
130708858|NCT00484419|470560512|FG001|Overall Study|Withdrawal by Subject|1|||
130708859|NCT00484419|470560513|FG002|Overall Study|Withdrawal by Subject|1|||
130708860|NCT00484419|470560511|FG000|Overall Study|subject met discontinuation criteria|2|||
130708861|NCT00484419|470560512|FG001|Overall Study|subject met discontinuation criteria|2|||
130708862|NCT00484419|470560513|FG002|Overall Study|subject met discontinuation criteria|4|||
130708863|NCT00484419|470560511|FG000|Overall Study|required restricted medication|1|||
130708864|NCT00484419|470560512|FG001|Overall Study|required restricted medication|0|||
130708865|NCT00484419|470560513|FG002|Overall Study|required restricted medication|1|||
130708866|NCT00484419|470560511|FG000|Overall Study|Physician Decision|1|||
130708867|NCT00484419|470560512|FG001|Overall Study|Physician Decision|1|||
130708868|NCT00484419|470560513|FG002|Overall Study|Physician Decision|1|||
130708869|NCT00484419|470560511|FG000|Overall Study|subject unable to receive medication|1|||
130708870|NCT00484419|470560512|FG001|Overall Study|subject unable to receive medication|0|||
130708871|NCT00484419|470560513|FG002|Overall Study|subject unable to receive medication|0|||
130708872|NCT00484419|470560511|FG000|Overall Study|subject relocated|0|||
130708873|NCT00484419|470560512|FG001|Overall Study|subject relocated|1|||
130708874|NCT00484419|470560513|FG002|Overall Study|subject relocated|0|||
130708875|NCT00484419|470560511|FG000|Overall Study|sponsor decision, randomized in error|0|||
130708876|NCT00484419|470560512|FG001|Overall Study|sponsor decision, randomized in error|0|||
130708877|NCT00484419|470560513|FG002|Overall Study|sponsor decision, randomized in error|2|||
130708878|NCT00355472|470560516|FG000|Overall Study|Physician Decision|1|||
130708879|NCT03095118|470560517|FG000|Overall Study|Adverse Event|1|||
130708880|NCT03095118|470560517|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
131036760|NCT05329220|471768257|FG004|Active Trial Period|Withdrawal by Subject|12|||
131036761|NCT05329220|471768258|FG005|Active Trial Period|Withdrawal by Subject|13|||
131036762|NCT05329220|471768253|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
131036763|NCT05329220|471768254|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
131045840|NCT03582033|471802287|FG009|Part C|Study terminated by sponsor|0|||
131224414|NCT03216954|472448881|FG001|Overall Study|Adverse Event|0|||
131224415|NCT03216954|472448882|FG002|Overall Study|Adverse Event|1|||
130772685|NCT02757352|470794738|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
130772686|NCT02757352|470794739|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130772687|NCT02757352|470794740|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130943352|NCT00378209|471426277|FG000|Overall Study|Death|1|||
130943353|NCT00378209|471426277|FG000|Overall Study|Treatment delay|1|||
130943354|NCT01894581|471426280|FG000|Overall Study|Withdrawal by Subject|2|||
130943355|NCT01894581|471426281|FG001|Overall Study|Withdrawal by Subject|3|||
130943356|NCT01894581|471426280|FG000|Overall Study|Screen Failure|3|||
130943357|NCT01894581|471426281|FG001|Overall Study|Screen Failure|4|||
130943358|NCT03313804|471426285|FG000|Treatment|Death|5|||
130943359|NCT03313804|471426285|FG000|Treatment|still on treatment|2|||
130943360|NCT03313804|471426285|FG000|Follow Up|still on follow up|3|||
130943361|NCT03795298|471426286|FG000|Overall Study|Death|34|||
130943362|NCT03795298|471426287|FG001|Overall Study|Death|29|||
130943363|NCT03795298|471426286|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
130943364|NCT03795298|471426287|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
130943365|NCT03795298|471426286|FG000|Overall Study|Lost to Follow-up|28|||
130943366|NCT03795298|471426287|FG001|Overall Study|Lost to Follow-up|17|||
130943367|NCT03795298|471426286|FG000|Overall Study|Physician Decision|5|||
130943368|NCT03795298|471426287|FG001|Overall Study|Physician Decision|4|||
130943369|NCT03795298|471426286|FG000|Overall Study|Withdrawal by Subject|43|||
130943370|NCT03795298|471426287|FG001|Overall Study|Withdrawal by Subject|28|||
130943371|NCT03795298|471426286|FG000|Overall Study|Reason not reported|7|||
130943372|NCT03795298|471426287|FG001|Overall Study|Reason not reported|9|||
130943373|NCT04814433|471426288|FG000|Overall Study|Survey not returned|4|||
130943374|NCT04814433|471426289|FG001|Overall Study|Survey not returned|8|||
130943375|NCT04814433|471426290|FG002|Overall Study|Survey not returned|4|||
130943376|NCT04814433|471426291|FG003|Overall Study|Survey not returned|5|||
130943377|NCT01816893|471426292|FG000|Washout Period|Withdrawal by Subject|2|||
130943378|NCT01816893|471426293|FG001|Washout Period|Withdrawal by Subject|0|||
130943379|NCT02016625|471428136|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
130943380|NCT02016625|471428137|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
130943381|NCT02016625|471428136|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
130943382|NCT02016625|471428137|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
130943383|NCT02016625|471428136|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
130943384|NCT02016625|471428137|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
130943385|NCT01190254|471428138|FG000|Overall Study|Adverse Event|3|||
130943386|NCT01190254|471428139|FG001|Overall Study|Adverse Event|6|||
130943387|NCT01190254|471428140|FG002|Overall Study|Adverse Event|8|||
130943388|NCT01190254|471428138|FG000|Overall Study|Lack of Efficacy|7|||
130943389|NCT01190254|471428139|FG001|Overall Study|Lack of Efficacy|4|||
130943390|NCT01190254|471428140|FG002|Overall Study|Lack of Efficacy|5|||
130943391|NCT01190254|471428138|FG000|Overall Study|Lost to Follow-up|4|||
130943392|NCT01190254|471428139|FG001|Overall Study|Lost to Follow-up|2|||
130943393|NCT01190254|471428140|FG002|Overall Study|Lost to Follow-up|0|||
130943394|NCT01190254|471428138|FG000|Overall Study|Withdrawal by Subject|4|||
130943395|NCT01190254|471428139|FG001|Overall Study|Withdrawal by Subject|5|||
130943396|NCT01190254|471428140|FG002|Overall Study|Withdrawal by Subject|7|||
130943397|NCT01190254|471428138|FG000|Overall Study|Protocol Violation|2|||
130943398|NCT01190254|471428139|FG001|Overall Study|Protocol Violation|0|||
131036764|NCT05329220|471768255|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
130772688|NCT02757352|470794741|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130772689|NCT02757352|470794742|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130772690|NCT02757352|470794743|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130943399|NCT01190254|471428140|FG002|Overall Study|Protocol Violation|2|||
130943400|NCT01190254|471428138|FG000|Overall Study|Did not meet protocol eligibility|1|||
130943401|NCT01190254|471428139|FG001|Overall Study|Did not meet protocol eligibility|0|||
130943402|NCT01190254|471428140|FG002|Overall Study|Did not meet protocol eligibility|0|||
130943403|NCT02603809|471428141|FG000|Overall Study|Withdrawal by Subject|4|||
130943404|NCT02603809|471428142|FG001|Overall Study|Withdrawal by Subject|1|||
131036765|NCT05329220|471768256|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
131224416|NCT03216954|472448883|FG003|Overall Study|Adverse Event|0|||
130943405|NCT02603809|471428143|FG002|Overall Study|Withdrawal by Subject|2|||
130943406|NCT02603809|471428144|FG003|Overall Study|Withdrawal by Subject|3|||
131224417|NCT03216954|472448884|FG004|Overall Study|Adverse Event|1|||
130943407|NCT02603809|471428145|FG004|Overall Study|Withdrawal by Subject|3|||
130943408|NCT02603809|471428146|FG005|Overall Study|Withdrawal by Subject|4|||
130943409|NCT02603809|471428141|FG000|Overall Study|Lost to Follow-up|2|||
130943410|NCT02603809|471428142|FG001|Overall Study|Lost to Follow-up|3|||
130943411|NCT02603809|471428143|FG002|Overall Study|Lost to Follow-up|1|||
130943412|NCT02603809|471428144|FG003|Overall Study|Lost to Follow-up|4|||
130943413|NCT02603809|471428145|FG004|Overall Study|Lost to Follow-up|2|||
130943414|NCT02603809|471428146|FG005|Overall Study|Lost to Follow-up|2|||
130708881|NCT03847194|470560520|FG000|Overall Study|Lost to Follow-up|2|||
130708882|NCT03847194|470560521|FG001|Overall Study|Lost to Follow-up|5|||
130708883|NCT03847194|470560520|FG000|Overall Study|Withdrawal by Subject|1|||
130708884|NCT03847194|470560521|FG001|Overall Study|Withdrawal by Subject|2|||
130708885|NCT03847194|470560520|FG000|Overall Study|Death|0|||
130708886|NCT03847194|470560521|FG001|Overall Study|Death|1|||
130708887|NCT02408120|470560522|FG000|Overall Study|Withdrawal by Subject|0|||
130708888|NCT02408120|470560523|FG001|Overall Study|Withdrawal by Subject|1|||
130708889|NCT02408120|470560522|FG000|Overall Study|Treatment Refusal|1|||
130708890|NCT02408120|470560523|FG001|Overall Study|Treatment Refusal|0|||
130708891|NCT02408120|470560522|FG000|Overall Study|Received Steroids|1|||
130708892|NCT02408120|470560523|FG001|Overall Study|Received Steroids|1|||
130708893|NCT02408120|470560522|FG000|Overall Study|Discharged same day|1|||
130708894|NCT02408120|470560523|FG001|Overall Study|Discharged same day|1|||
130708895|NCT02408120|470560522|FG000|Overall Study|Did not receive insulin|1|||
130708896|NCT02408120|470560523|FG001|Overall Study|Did not receive insulin|2|||
130708897|NCT01144403|470560524|FG000|Overall Study|Lost to Follow-up|3|||
130708898|NCT01144403|470560524|FG000|Overall Study|Death|1|||
130708899|NCT01144403|470560524|FG000|Overall Study|Adverse Event|1|||
130708900|NCT00680186|470560529|FG000|Overall Study|Adverse Event|47|||
130708901|NCT00680186|470560530|FG001|Overall Study|Adverse Event|44|||
130708902|NCT00680186|470560529|FG000|Overall Study|Protocol Violation|31|||
130708903|NCT00680186|470560530|FG001|Overall Study|Protocol Violation|26|||
130708904|NCT00680186|470560529|FG000|Overall Study|Lost to Follow-up|11|||
130708905|NCT00680186|470560530|FG001|Overall Study|Lost to Follow-up|6|||
130708906|NCT00680186|470560529|FG000|Overall Study|Withdrawal by Subject|32|||
130708907|NCT00680186|470560530|FG001|Overall Study|Withdrawal by Subject|39|||
130708908|NCT00680186|470560529|FG000|Overall Study|Other|4|||
130708909|NCT00680186|470560530|FG001|Overall Study|Other|1|||
130943415|NCT02603809|471428141|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
130943416|NCT02603809|471428142|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
130943417|NCT02603809|471428143|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
130943418|NCT02603809|471428144|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
130943419|NCT02603809|471428145|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
130943420|NCT02603809|471428146|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
130943421|NCT02603809|471428141|FG000|Overall Study|Physician Decision|0|||
130943422|NCT02603809|471428142|FG001|Overall Study|Physician Decision|0|||
130943423|NCT02603809|471428143|FG002|Overall Study|Physician Decision|0|||
130943424|NCT02603809|471428144|FG003|Overall Study|Physician Decision|1|||
130943425|NCT02603809|471428145|FG004|Overall Study|Physician Decision|2|||
130943426|NCT02603809|471428146|FG005|Overall Study|Physician Decision|1|||
130943427|NCT02603809|471428141|FG000|Overall Study|Adverse Event|3|||
130943428|NCT02603809|471428142|FG001|Overall Study|Adverse Event|0|||
130943429|NCT02603809|471428143|FG002|Overall Study|Adverse Event|2|||
130943430|NCT02603809|471428144|FG003|Overall Study|Adverse Event|2|||
130943431|NCT02603809|471428145|FG004|Overall Study|Adverse Event|1|||
130943432|NCT02603809|471428146|FG005|Overall Study|Adverse Event|1|||
130943433|NCT02603809|471428141|FG000|Overall Study|Lack of Efficacy|0|||
130943434|NCT02603809|471428142|FG001|Overall Study|Lack of Efficacy|1|||
130943435|NCT02603809|471428143|FG002|Overall Study|Lack of Efficacy|0|||
130943436|NCT02603809|471428144|FG003|Overall Study|Lack of Efficacy|0|||
130943437|NCT02603809|471428145|FG004|Overall Study|Lack of Efficacy|0|||
130943438|NCT02603809|471428146|FG005|Overall Study|Lack of Efficacy|1|||
130943439|NCT04729127|471428147|FG000|Overall Study|Suspended/Terminated EI Services|4|||
130943440|NCT04729127|471428148|FG001|Overall Study|Suspended/Terminated EI Services|0|||
130943441|NCT04729127|471428149|FG002|Overall Study|Suspended/Terminated EI Services|4|||
130943442|NCT04729127|471428150|FG003|Overall Study|Suspended/Terminated EI Services|6|||
131045841|NCT03582033|471802278|FG000|Part C|Withdrawal by Subject|0|||
131224418|NCT03216954|472448880|FG000|Overall Study|Withdrawal by Subject|2|||
130708910|NCT04647383|470560535|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
130708911|NCT04647383|470560536|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
130772691|NCT02757352|470794734|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131224419|NCT03216954|472448881|FG001|Overall Study|Withdrawal by Subject|0|||
130708912|NCT04647383|470560537|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
130772692|NCT02757352|470794735|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130772693|NCT02757352|470794736|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130943443|NCT04729127|471428151|FG004|Overall Study|Suspended/Terminated EI Services|0|||
130943444|NCT04729127|471428152|FG005|Overall Study|Suspended/Terminated EI Services|6|||
130943445|NCT04729127|471428153|FG006|Overall Study|Suspended/Terminated EI Services|2|||
130708913|NCT04647383|470560538|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
130708914|NCT00873119|470560546|FG000|Overall Study|Patient request|4|||
130708915|NCT00873119|470560547|FG001|Overall Study|Patient request|2|||
130708916|NCT00873119|470560546|FG000|Overall Study|Adverse Event|8|||
130943446|NCT04729127|471428154|FG007|Overall Study|Suspended/Terminated EI Services|0|||
130943447|NCT04729127|471428155|FG008|Overall Study|Suspended/Terminated EI Services|2|||
130708917|NCT00873119|470560547|FG001|Overall Study|Adverse Event|0|||
130708918|NCT00873119|470560546|FG000|Overall Study|Progressive disease|26|||
130943448|NCT04729127|471428147|FG000|Overall Study|Withdrawal by Subject|1|||
130943449|NCT04729127|471428148|FG001|Overall Study|Withdrawal by Subject|0|||
130943450|NCT04729127|471428149|FG002|Overall Study|Withdrawal by Subject|1|||
130943451|NCT04729127|471428150|FG003|Overall Study|Withdrawal by Subject|0|||
130943452|NCT04729127|471428151|FG004|Overall Study|Withdrawal by Subject|0|||
130943453|NCT04729127|471428152|FG005|Overall Study|Withdrawal by Subject|0|||
130943454|NCT04729127|471428153|FG006|Overall Study|Withdrawal by Subject|0|||
130943455|NCT04729127|471428154|FG007|Overall Study|Withdrawal by Subject|0|||
130943456|NCT04729127|471428155|FG008|Overall Study|Withdrawal by Subject|0|||
130943457|NCT04729127|471428147|FG000|Overall Study|Switched Agency/Setting|1|||
130943458|NCT04729127|471428148|FG001|Overall Study|Switched Agency/Setting|0|||
130943459|NCT04729127|471428149|FG002|Overall Study|Switched Agency/Setting|1|||
130943460|NCT04729127|471428150|FG003|Overall Study|Switched Agency/Setting|1|||
130943461|NCT04729127|471428151|FG004|Overall Study|Switched Agency/Setting|0|||
130943462|NCT04729127|471428152|FG005|Overall Study|Switched Agency/Setting|1|||
130943463|NCT04729127|471428153|FG006|Overall Study|Switched Agency/Setting|1|||
130943464|NCT04729127|471428154|FG007|Overall Study|Switched Agency/Setting|0|||
130943465|NCT04729127|471428155|FG008|Overall Study|Switched Agency/Setting|1|||
130943466|NCT00887354|471428156|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
130943467|NCT00887354|471428157|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
130943468|NCT00887354|471428156|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
130943469|NCT00887354|471428157|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
130943470|NCT00887354|471428156|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
130943471|NCT00887354|471428157|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
130943472|NCT00887354|471428156|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
130943473|NCT00887354|471428157|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
130943474|NCT00887354|471428156|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
130943475|NCT00887354|471428157|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
130943476|NCT00887354|471428156|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
130708919|NCT00873119|470560547|FG001|Overall Study|Progressive disease|18|||
130708920|NCT00873119|470560546|FG000|Overall Study|Death|2|||
130708921|NCT00873119|470560547|FG001|Overall Study|Death|1|||
130708922|NCT00873119|470560546|FG000|Overall Study|Other|2|||
130708923|NCT00873119|470560547|FG001|Overall Study|Other|5|||
130708924|NCT00873119|470560546|FG000|Overall Study|Not treated|2|||
130708925|NCT00873119|470560547|FG001|Overall Study|Not treated|0|||
130708926|NCT00285584|470560548|FG000|Month 3|Lost to Follow-up|3|||
130708927|NCT00285584|470560549|FG001|Month 3|Lost to Follow-up|3|||
130708928|NCT00285584|470560548|FG000|Month 3|Withdrawal by Subject|1|||
130708929|NCT00285584|470560549|FG001|Month 3|Withdrawal by Subject|0|||
130708930|NCT00285584|470560548|FG000|Month 6|Lost to Follow-up|0|||
130708931|NCT00285584|470560549|FG001|Month 6|Lost to Follow-up|1|||
130772694|NCT02757352|470794737|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130772695|NCT02757352|470794738|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130943477|NCT00887354|471428157|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
130943478|NCT00887354|471428156|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
130943479|NCT00887354|471428157|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
130943480|NCT00887354|471428156|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
130943481|NCT00887354|471428157|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
130943482|NCT00887354|471428156|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
130943483|NCT00887354|471428157|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
130943484|NCT00887354|471428156|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
130943485|NCT00887354|471428157|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
130943486|NCT00887354|471428156|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
130943487|NCT00887354|471428157|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
130943488|NCT00887354|471428156|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
130943489|NCT00887354|471428157|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
130943490|NCT00887354|471428156|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
130943491|NCT00887354|471428157|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
130943492|NCT00887354|471428156|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
130943493|NCT00887354|471428157|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
130943494|NCT00887354|471428156|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
130943495|NCT00887354|471428157|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
130943496|NCT03257631|471428173|FG000|Overall Study|Death|1|||
130943497|NCT03257631|471428174|FG001|Overall Study|Death|0|||
130943498|NCT03257631|471428175|FG002|Overall Study|Death|1|||
130708932|NCT00645944|470560550|FG000|Randomized|Withdrawal by Subject|1|||
130708933|NCT00645944|470560551|FG001|Randomized|Withdrawal by Subject|2|||
130943499|NCT03257631|471428176|FG003|Overall Study|Death|1|||
130943500|NCT03257631|471428173|FG000|Overall Study|Progressive Disease|10|||
130943501|NCT03257631|471428174|FG001|Overall Study|Progressive Disease|9|||
130943502|NCT03257631|471428175|FG002|Overall Study|Progressive Disease|17|||
130943503|NCT03257631|471428176|FG003|Overall Study|Progressive Disease|8|||
130708934|NCT00645944|470560550|FG000|Received Medication|Adverse Event|2|||
130708935|NCT00645944|470560551|FG001|Received Medication|Adverse Event|1|||
130708936|NCT00645944|470560550|FG000|Received Medication|Withdrawal by Subject|1|||
130708937|NCT00645944|470560551|FG001|Received Medication|Withdrawal by Subject|1|||
130708938|NCT00645944|470560550|FG000|Received Medication|Lost to Follow-up|1|||
130708939|NCT00645944|470560551|FG001|Received Medication|Lost to Follow-up|0|||
130708940|NCT00645944|470560550|FG000|Received Medication|Protocol Violation|2|||
130708941|NCT00645944|470560551|FG001|Received Medication|Protocol Violation|1|||
130708942|NCT02096588|470560552|FG000|Overall Study|Lack of Efficacy|2|||
130708943|NCT02096588|470560553|FG001|Overall Study|Lack of Efficacy|0|||
130708944|NCT02096588|470560552|FG000|Overall Study|Withdrawal by Subject|0|||
130708945|NCT02096588|470560553|FG001|Overall Study|Withdrawal by Subject|1|||
130708946|NCT02470091|470560554|FG000|Overall Study|Withdrawal by Subject|1|||
130708947|NCT02470091|470560555|FG001|Overall Study|Withdrawal by Subject|0|||
130708948|NCT02470091|470560554|FG000|Overall Study|Ineligible|0|||
130708949|NCT02470091|470560555|FG001|Overall Study|Ineligible|2|||
130708950|NCT01523587|470560557|FG000|Overall Study|Other than listed|5|||
130708951|NCT01523587|470560558|FG001|Overall Study|Other than listed|5|||
130708952|NCT01523587|470560557|FG000|Overall Study|Worsening of underlying cancer disease|19|||
130708953|NCT01523587|470560558|FG001|Overall Study|Worsening of underlying cancer disease|34|||
130708954|NCT01523587|470560557|FG000|Overall Study|Adverse Event|68|||
130708955|NCT01523587|470560558|FG001|Overall Study|Adverse Event|52|||
130708956|NCT01523587|470560557|FG000|Overall Study|Protocol Violation|5|||
130708957|NCT01523587|470560558|FG001|Overall Study|Protocol Violation|3|||
130708958|NCT01523587|470560557|FG000|Overall Study|Lost to Follow-up|2|||
130943504|NCT03257631|471428173|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130943505|NCT03257631|471428174|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130708959|NCT01523587|470560558|FG001|Overall Study|Lost to Follow-up|2|||
130708960|NCT01523587|470560557|FG000|Overall Study|Withdrawal by Subject|28|||
130708961|NCT01523587|470560558|FG001|Overall Study|Withdrawal by Subject|20|||
130708962|NCT01523587|470560557|FG000|Overall Study|Withdrew due to Progressive disease|265|||
130708963|NCT01523587|470560558|FG001|Overall Study|Withdrew due to Progressive disease|279|||
130708964|NCT01523587|470560557|FG000|Overall Study|Randomised but bot treated|6|||
130708965|NCT01523587|470560558|FG001|Overall Study|Randomised but bot treated|2|||
130943506|NCT03257631|471428175|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130943507|NCT03257631|471428176|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
130943508|NCT03257631|471428173|FG000|Overall Study|Adverse Event|0|||
130943509|NCT03257631|471428174|FG001|Overall Study|Adverse Event|0|||
130943510|NCT03257631|471428175|FG002|Overall Study|Adverse Event|2|||
130943511|NCT03257631|471428176|FG003|Overall Study|Adverse Event|0|||
130943512|NCT02529137|471428177|FG000|Overall Study|Discontinuation for different reasons|8|||
130943513|NCT01290666|471428181|FG000|Overall Study|Lost to Follow-up|11|||
130943514|NCT01290666|471428181|FG000|Overall Study|Withdrawal by Subject|23|||
130708966|NCT01298778|470560559|FG000|Overall Study|Lost to Follow-up|2|||
130708967|NCT01298778|470560560|FG001|Overall Study|Lost to Follow-up|3|||
130708968|NCT01298778|470560559|FG000|Overall Study|Incorrect use of VAS|1|||
130708969|NCT01298778|470560560|FG001|Overall Study|Incorrect use of VAS|0|||
130708970|NCT01298778|470560559|FG000|Overall Study|Withdrawal by Subject|0|||
130708971|NCT01298778|470560560|FG001|Overall Study|Withdrawal by Subject|1|||
130708972|NCT01298778|470560559|FG000|Overall Study|Protocol Violation|0|||
130708973|NCT01298778|470560560|FG001|Overall Study|Protocol Violation|1|||
130708974|NCT01298778|470560559|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
130708975|NCT01298778|470560560|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
130708976|NCT01020799|470560579|FG000|Overall Study|Adverse Event|4|||
130708977|NCT01020799|470560580|FG001|Overall Study|Adverse Event|3|||
130708978|NCT01020799|470560581|FG002|Overall Study|Adverse Event|2|||
130708979|NCT01020799|470560579|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
130708980|NCT01020799|470560580|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
130708981|NCT01020799|470560581|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
130708982|NCT01020799|470560579|FG000|Overall Study|Protocol Violation|3|||
130708983|NCT01020799|470560580|FG001|Overall Study|Protocol Violation|2|||
130708984|NCT01020799|470560581|FG002|Overall Study|Protocol Violation|0|||
130708985|NCT01020799|470560579|FG000|Overall Study|Withdrawal by Subject|2|||
130708986|NCT01020799|470560580|FG001|Overall Study|Withdrawal by Subject|2|||
130708987|NCT01020799|470560581|FG002|Overall Study|Withdrawal by Subject|3|||
130708988|NCT01020799|470560579|FG000|Overall Study|Lost to Follow-up|6|||
130708989|NCT01020799|470560580|FG001|Overall Study|Lost to Follow-up|4|||
130708990|NCT01020799|470560581|FG002|Overall Study|Lost to Follow-up|2|||
130708991|NCT02610816|470560582|FG000|Phase 1|Withdrawal by Subject|2|||
130708992|NCT02610816|470560583|FG001|Phase 1|Withdrawal by Subject|6|||
130708993|NCT02610816|470560584|FG002|Phase 1|Withdrawal by Subject|0|||
130943515|NCT01290666|471428181|FG000|Overall Study|Early Termination of Study|4|||
130943516|NCT03036098|471428182|FG000|Pre-Treatment|Other Reasons|1|||
130943517|NCT03036098|471428183|FG001|Pre-Treatment|Other Reasons|2|||
130943518|NCT03036098|471428184|FG002|Pre-Treatment|Other Reasons|0|||
130708994|NCT02610816|470560585|FG003|Phase 1|Withdrawal by Subject|0|||
130708995|NCT02610816|470560582|FG000|Phase 1|Lost to Follow-up|2|||
130772696|NCT02757352|470794739|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
130772697|NCT02757352|470794740|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130772698|NCT02757352|470794741|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
131036766|NCT05329220|471768257|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
131224420|NCT03216954|472448882|FG002|Overall Study|Withdrawal by Subject|0|||
131224421|NCT03216954|472448883|FG003|Overall Study|Withdrawal by Subject|0|||
131224422|NCT03216954|472448884|FG004|Overall Study|Withdrawal by Subject|0|||
131224423|NCT03216954|472448880|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
131224424|NCT03216954|472448881|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
131224425|NCT03216954|472448882|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
131224426|NCT03216954|472448883|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
131224427|NCT03216954|472448884|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
131224428|NCT01965535|472448885|FG000|Overall Study|Lack of Efficacy|2|||
131224429|NCT01965535|472448886|FG001|Overall Study|Lack of Efficacy|1|||
131224430|NCT02983227|472448887|FG000|Overall Study|Adverse Event|21|||
131224431|NCT02983227|472448888|FG001|Overall Study|Adverse Event|3|||
131224432|NCT02983227|472448887|FG000|Overall Study|Death|3|||
131224433|NCT02983227|472448888|FG001|Overall Study|Death|0|||
131224434|NCT02983227|472448887|FG000|Overall Study|Lack of Efficacy|8|||
131224435|NCT02983227|472448888|FG001|Overall Study|Lack of Efficacy|1|||
131224436|NCT02983227|472448887|FG000|Overall Study|Lost to Follow-up|3|||
131224437|NCT02983227|472448888|FG001|Overall Study|Lost to Follow-up|0|||
131224438|NCT02983227|472448887|FG000|Overall Study|Multiple Reasons|2|||
131224439|NCT02983227|472448888|FG001|Overall Study|Multiple Reasons|1|||
131224440|NCT02983227|472448887|FG000|Overall Study|Physician Decision|3|||
131224441|NCT02983227|472448888|FG001|Overall Study|Physician Decision|1|||
131224442|NCT02983227|472448887|FG000|Overall Study|Withdrawal by Subject|19|||
131224443|NCT02983227|472448888|FG001|Overall Study|Withdrawal by Subject|8|||
131224444|NCT01946282|472448893|FG000|Year 1|Did not return FIT kit|4186|||
131224445|NCT01946282|472448894|FG001|Year 1|Did not return FIT kit|608|||
131224446|NCT01946282|472448895|FG002|Year 1|Did not return FIT kit|654|||
131224447|NCT01946282|472448893|FG000|Year 2|Did not return FIT kit|803|||
131224448|NCT01946282|472448894|FG001|Year 2|Did not return FIT kit|131|||
130772699|NCT02757352|470794742|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130772700|NCT02757352|470794743|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130772701|NCT02757352|470794734|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772702|NCT02757352|470794735|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130943519|NCT03036098|471428185|FG003|Pre-Treatment|Other Reasons|5|||
130943520|NCT03036098|471428182|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
130943521|NCT03036098|471428183|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
130943522|NCT03036098|471428184|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
130943523|NCT03036098|471428185|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
130943524|NCT03036098|471428182|FG000|Pre-Treatment|Withdrawal by Subject|1|||
130943525|NCT03036098|471428183|FG001|Pre-Treatment|Withdrawal by Subject|14|||
130943526|NCT03036098|471428184|FG002|Pre-Treatment|Withdrawal by Subject|0|||
130943527|NCT03036098|471428185|FG003|Pre-Treatment|Withdrawal by Subject|5|||
130943528|NCT03036098|471428182|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
130943529|NCT03036098|471428183|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
130943530|NCT03036098|471428184|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
130943531|NCT03036098|471428185|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
130943532|NCT03036098|471428182|FG000|Treatment|Disease Progression|130|||
130943533|NCT03036098|471428183|FG001|Treatment|Disease Progression|77|||
130943534|NCT03036098|471428184|FG002|Treatment|Disease Progression|168|||
130943535|NCT03036098|471428185|FG003|Treatment|Disease Progression|50|||
130943536|NCT03036098|471428182|FG000|Treatment|Study Drug Toxicity|95|||
130943537|NCT03036098|471428183|FG001|Treatment|Study Drug Toxicity|45|||
130943538|NCT03036098|471428184|FG002|Treatment|Study Drug Toxicity|26|||
130943539|NCT03036098|471428185|FG003|Treatment|Study Drug Toxicity|22|||
130943540|NCT03036098|471428182|FG000|Treatment|Death|9|||
130943541|NCT03036098|471428183|FG001|Treatment|Death|3|||
130943542|NCT03036098|471428184|FG002|Treatment|Death|1|||
130943543|NCT03036098|471428185|FG003|Treatment|Death|2|||
130943544|NCT03036098|471428182|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
130943545|NCT03036098|471428183|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
130943546|NCT03036098|471428184|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
130943547|NCT03036098|471428185|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
130943548|NCT03036098|471428182|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
130943549|NCT03036098|471428183|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
130943550|NCT03036098|471428184|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
130943551|NCT03036098|471428185|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
130708996|NCT02610816|470560583|FG001|Phase 1|Lost to Follow-up|1|||
130708997|NCT02610816|470560584|FG002|Phase 1|Lost to Follow-up|0|||
130708998|NCT02610816|470560585|FG003|Phase 1|Lost to Follow-up|0|||
130708999|NCT02610816|470560582|FG000|Phase 1|Physician Decision|0|||
130709000|NCT02610816|470560583|FG001|Phase 1|Physician Decision|1|||
130709001|NCT02610816|470560584|FG002|Phase 1|Physician Decision|0|||
130709002|NCT02610816|470560585|FG003|Phase 1|Physician Decision|0|||
130709003|NCT02610816|470560582|FG000|Phase 2|Withdrawal by Subject|0|||
130709004|NCT02610816|470560583|FG001|Phase 2|Withdrawal by Subject|0|||
130709005|NCT02610816|470560584|FG002|Phase 2|Withdrawal by Subject|9|||
130709006|NCT02610816|470560585|FG003|Phase 2|Withdrawal by Subject|3|||
130709007|NCT02610816|470560582|FG000|Phase 2|Lost to Follow-up|0|||
130709008|NCT02610816|470560583|FG001|Phase 2|Lost to Follow-up|0|||
130709009|NCT02610816|470560584|FG002|Phase 2|Lost to Follow-up|2|||
130709010|NCT02610816|470560585|FG003|Phase 2|Lost to Follow-up|0|||
130709011|NCT02610816|470560582|FG000|Phase 2|Physician Decision|0|||
130709012|NCT02610816|470560583|FG001|Phase 2|Physician Decision|0|||
130709013|NCT02610816|470560584|FG002|Phase 2|Physician Decision|0|||
130709014|NCT02610816|470560585|FG003|Phase 2|Physician Decision|2|||
130709015|NCT02610816|470560582|FG000|Phase 2|Pregnancy|0|||
130709016|NCT02610816|470560583|FG001|Phase 2|Pregnancy|0|||
130709017|NCT02610816|470560584|FG002|Phase 2|Pregnancy|0|||
130709018|NCT02610816|470560585|FG003|Phase 2|Pregnancy|1|||
130709019|NCT03438227|470560588|FG000|Overall Study|Withdrawal by Subject|10|||
130709020|NCT03438227|470560589|FG001|Overall Study|Withdrawal by Subject|5|||
130709021|NCT01855048|470560590|FG000|Overall Study|Withdrawal by Subject|0|||
130709022|NCT01855048|470560591|FG001|Overall Study|Withdrawal by Subject|1|||
130709023|NCT01855048|470560592|FG002|Overall Study|Withdrawal by Subject|0|||
130709024|NCT01855048|470560593|FG003|Overall Study|Withdrawal by Subject|0|||
130709025|NCT01855048|470560594|FG004|Overall Study|Withdrawal by Subject|1|||
130709026|NCT01855048|470560595|FG005|Overall Study|Withdrawal by Subject|0|||
130709027|NCT02691741|470560596|FG000|Overall Study|Adverse Event|0|||
130709028|NCT02691741|470560597|FG001|Overall Study|Adverse Event|2|||
130709029|NCT02691741|470560596|FG000|Overall Study|Lost to Follow-up|1|||
130709030|NCT02691741|470560597|FG001|Overall Study|Lost to Follow-up|0|||
130943552|NCT03036098|471428182|FG000|Treatment|Withdrawal by Subject|2|||
130943553|NCT03036098|471428183|FG001|Treatment|Withdrawal by Subject|9|||
130943554|NCT03036098|471428184|FG002|Treatment|Withdrawal by Subject|2|||
130943555|NCT03036098|471428185|FG003|Treatment|Withdrawal by Subject|4|||
130943556|NCT03036098|471428182|FG000|Treatment|Maximum Clinical Benefit|6|||
130943557|NCT03036098|471428183|FG001|Treatment|Maximum Clinical Benefit|1|||
130943558|NCT03036098|471428184|FG002|Treatment|Maximum Clinical Benefit|6|||
130709031|NCT02691741|470560596|FG000|Overall Study|Physician Decision|0|||
130709032|NCT02691741|470560597|FG001|Overall Study|Physician Decision|1|||
131123903|NCT02966509|472082870|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
131123904|NCT02966509|472082871|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
130709033|NCT02691741|470560596|FG000|Overall Study|Withdrawal by Subject|0|||
130709034|NCT02691741|470560597|FG001|Overall Study|Withdrawal by Subject|4|||
130943559|NCT03036098|471428185|FG003|Treatment|Maximum Clinical Benefit|10|||
130943560|NCT03036098|471428182|FG000|Treatment|Poor/Non Compliance|1|||
130943561|NCT03036098|471428183|FG001|Treatment|Poor/Non Compliance|2|||
130943562|NCT03036098|471428184|FG002|Treatment|Poor/Non Compliance|0|||
131123905|NCT02966509|472082870|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
131123906|NCT02966509|472082871|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
131123907|NCT02966509|472082870|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
130709035|NCT02139124|470560598|FG000|Overall Study|Adverse Event|2|||
130709036|NCT02139124|470560599|FG001|Overall Study|Adverse Event|0|||
130943563|NCT03036098|471428185|FG003|Treatment|Poor/Non Compliance|1|||
130943564|NCT03036098|471428182|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
130943565|NCT03036098|471428183|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
130943566|NCT03036098|471428184|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
130943567|NCT03036098|471428185|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
130943568|NCT03036098|471428182|FG000|Treatment|Administrative Reason by Sponsor|1|||
130943569|NCT03036098|471428183|FG001|Treatment|Administrative Reason by Sponsor|0|||
130943570|NCT03036098|471428184|FG002|Treatment|Administrative Reason by Sponsor|2|||
130943571|NCT03036098|471428185|FG003|Treatment|Administrative Reason by Sponsor|1|||
130943572|NCT03036098|471428182|FG000|Treatment|Other Reasons|31|||
130943573|NCT03036098|471428183|FG001|Treatment|Other Reasons|5|||
130943574|NCT03036098|471428184|FG002|Treatment|Other Reasons|21|||
130943575|NCT03036098|471428185|FG003|Treatment|Other Reasons|8|||
130943576|NCT03036098|471428182|FG000|Treatment|Ongoing Treatment|0|||
130943577|NCT03036098|471428183|FG001|Treatment|Ongoing Treatment|0|||
130943578|NCT03036098|471428184|FG002|Treatment|Ongoing Treatment|23|||
130943579|NCT03036098|471428185|FG003|Treatment|Ongoing Treatment|0|||
130943580|NCT02063854|471428187|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
130709037|NCT02139124|470560600|FG002|Overall Study|Adverse Event|1|||
130943581|NCT02063854|471428188|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
130943582|NCT02063854|471428189|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
130709038|NCT02139124|470560601|FG003|Overall Study|Adverse Event|2|||
130709039|NCT02139124|470560602|FG004|Overall Study|Adverse Event|5|||
130709040|NCT02139124|470560598|FG000|Overall Study|Withdrawal by Subject|2|||
130709041|NCT02139124|470560599|FG001|Overall Study|Withdrawal by Subject|2|||
130709042|NCT02139124|470560600|FG002|Overall Study|Withdrawal by Subject|2|||
130709043|NCT02139124|470560601|FG003|Overall Study|Withdrawal by Subject|2|||
130709044|NCT02139124|470560602|FG004|Overall Study|Withdrawal by Subject|3|||
130709045|NCT02139124|470560598|FG000|Overall Study|Protocol Violation|0|||
130709046|NCT02139124|470560599|FG001|Overall Study|Protocol Violation|0|||
130709047|NCT02139124|470560600|FG002|Overall Study|Protocol Violation|0|||
130709048|NCT02139124|470560601|FG003|Overall Study|Protocol Violation|1|||
130709049|NCT02139124|470560602|FG004|Overall Study|Protocol Violation|1|||
130709050|NCT02139124|470560598|FG000|Overall Study|non-compliant|1|||
130709051|NCT02139124|470560599|FG001|Overall Study|non-compliant|0|||
130709052|NCT02139124|470560600|FG002|Overall Study|non-compliant|0|||
130709053|NCT02139124|470560601|FG003|Overall Study|non-compliant|2|||
130709054|NCT02139124|470560602|FG004|Overall Study|non-compliant|0|||
130709055|NCT02139124|470560598|FG000|Overall Study|incarceration|0|||
130709056|NCT02139124|470560599|FG001|Overall Study|incarceration|0|||
130709057|NCT02139124|470560600|FG002|Overall Study|incarceration|1|||
130709058|NCT02139124|470560601|FG003|Overall Study|incarceration|0|||
130709059|NCT02139124|470560602|FG004|Overall Study|incarceration|0|||
130709060|NCT02139124|470560598|FG000|Overall Study|subject moved|1|||
130709061|NCT02139124|470560599|FG001|Overall Study|subject moved|0|||
130709062|NCT02139124|470560600|FG002|Overall Study|subject moved|0|||
130709063|NCT02139124|470560601|FG003|Overall Study|subject moved|0|||
130709064|NCT02139124|470560602|FG004|Overall Study|subject moved|0|||
130709065|NCT02139124|470560598|FG000|Overall Study|Lost to Follow-up|3|||
130709066|NCT02139124|470560599|FG001|Overall Study|Lost to Follow-up|2|||
130709067|NCT02139124|470560600|FG002|Overall Study|Lost to Follow-up|0|||
130709068|NCT02139124|470560601|FG003|Overall Study|Lost to Follow-up|5|||
130709069|NCT02139124|470560602|FG004|Overall Study|Lost to Follow-up|4|||
130709070|NCT01813071|470560603|FG000|Overall Study|Protocol Violation|0|||
130709071|NCT01813071|470560604|FG001|Overall Study|Protocol Violation|0|||
130709072|NCT01813071|470560605|FG002|Overall Study|Protocol Violation|0|||
130709073|NCT01813071|470560606|FG003|Overall Study|Protocol Violation|0|||
130709074|NCT01813071|470560607|FG004|Overall Study|Protocol Violation|1|||
130709075|NCT01813071|470560608|FG005|Overall Study|Protocol Violation|4|||
130709076|NCT01813071|470560609|FG006|Overall Study|Protocol Violation|2|||
130709077|NCT01813071|470560610|FG007|Overall Study|Protocol Violation|4|||
130709078|NCT01813071|470560611|FG008|Overall Study|Protocol Violation|2|||
130709079|NCT01813071|470560603|FG000|Overall Study|Withdrawal by Subject|0|||
130709080|NCT01813071|470560604|FG001|Overall Study|Withdrawal by Subject|0|||
130709081|NCT01813071|470560605|FG002|Overall Study|Withdrawal by Subject|0|||
130709082|NCT01813071|470560606|FG003|Overall Study|Withdrawal by Subject|0|||
130709083|NCT01813071|470560607|FG004|Overall Study|Withdrawal by Subject|0|||
130709084|NCT01813071|470560608|FG005|Overall Study|Withdrawal by Subject|1|||
130709085|NCT01813071|470560609|FG006|Overall Study|Withdrawal by Subject|0|||
130709086|NCT01813071|470560610|FG007|Overall Study|Withdrawal by Subject|0|||
130709087|NCT01813071|470560611|FG008|Overall Study|Withdrawal by Subject|0|||
130709088|NCT01813071|470560603|FG000|Overall Study|Adverse Event|0|||
130709089|NCT01813071|470560604|FG001|Overall Study|Adverse Event|0|||
130709090|NCT01813071|470560605|FG002|Overall Study|Adverse Event|0|||
130709091|NCT01813071|470560606|FG003|Overall Study|Adverse Event|0|||
130709092|NCT01813071|470560607|FG004|Overall Study|Adverse Event|0|||
130709093|NCT01813071|470560608|FG005|Overall Study|Adverse Event|1|||
130709094|NCT01813071|470560609|FG006|Overall Study|Adverse Event|0|||
130709095|NCT01813071|470560610|FG007|Overall Study|Adverse Event|0|||
130943583|NCT02063854|471428190|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
131123908|NCT02966509|472082871|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
131123909|NCT02966509|472082870|FG000|6 Month Satisfaction Survey|Death|36|||
131123910|NCT02966509|472082871|FG001|6 Month Satisfaction Survey|Death|33|||
130943584|NCT02063854|471428191|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
130943585|NCT02063854|471428192|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
130709096|NCT01813071|470560611|FG008|Overall Study|Adverse Event|0|||
130709097|NCT01813071|470560603|FG000|Overall Study|Physician Decision|0|||
130709098|NCT01813071|470560604|FG001|Overall Study|Physician Decision|0|||
130709099|NCT01813071|470560605|FG002|Overall Study|Physician Decision|0|||
130709100|NCT01813071|470560606|FG003|Overall Study|Physician Decision|0|||
130709101|NCT01813071|470560607|FG004|Overall Study|Physician Decision|0|||
130709102|NCT01813071|470560608|FG005|Overall Study|Physician Decision|0|||
130709103|NCT01813071|470560609|FG006|Overall Study|Physician Decision|1|||
130709104|NCT01813071|470560610|FG007|Overall Study|Physician Decision|0|||
130709105|NCT01813071|470560611|FG008|Overall Study|Physician Decision|0|||
130709106|NCT01813071|470560603|FG000|Overall Study|Met inc/exc criteria|0|||
130709107|NCT01813071|470560604|FG001|Overall Study|Met inc/exc criteria|0|||
130943586|NCT02063854|471428193|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
130709108|NCT01813071|470560605|FG002|Overall Study|Met inc/exc criteria|0|||
130709109|NCT01813071|470560606|FG003|Overall Study|Met inc/exc criteria|0|||
131224449|NCT01946282|472448895|FG002|Year 2|Did not return FIT kit|115|||
131224450|NCT01946282|472448893|FG000|Year 3|Did not return FIT kit|288|||
131224451|NCT01946282|472448894|FG001|Year 3|Did not return FIT kit|43|||
131224452|NCT01946282|472448895|FG002|Year 3|Did not return FIT kit|30|||
131224453|NCT01493531|472448896|FG000|Overall Study|Adverse Event|4|||
131224454|NCT01493531|472448897|FG001|Overall Study|Adverse Event|12|||
131224455|NCT01493531|472448898|FG002|Overall Study|Adverse Event|9|||
131224456|NCT01493531|472448896|FG000|Overall Study|Gout flare|3|||
131224457|NCT01493531|472448897|FG001|Overall Study|Gout flare|0|||
131224458|NCT01493531|472448898|FG002|Overall Study|Gout flare|2|||
131224459|NCT01493531|472448896|FG000|Overall Study|Protocol Violation|8|||
130943587|NCT02063854|471428187|FG000|Overall Study|Major Protocol Deviation|0|||
130943588|NCT02063854|471428188|FG001|Overall Study|Major Protocol Deviation|0|||
130943589|NCT02063854|471428189|FG002|Overall Study|Major Protocol Deviation|3|||
130943590|NCT02063854|471428190|FG003|Overall Study|Major Protocol Deviation|0|||
130943591|NCT02063854|471428191|FG004|Overall Study|Major Protocol Deviation|0|||
130943592|NCT02063854|471428192|FG005|Overall Study|Major Protocol Deviation|0|||
130943593|NCT02063854|471428193|FG006|Overall Study|Major Protocol Deviation|0|||
130943594|NCT02063854|471428187|FG000|Overall Study|Voluntary Withdrawal|2|||
130943595|NCT02063854|471428188|FG001|Overall Study|Voluntary Withdrawal|0|||
130943596|NCT02063854|471428189|FG002|Overall Study|Voluntary Withdrawal|8|||
130943597|NCT02063854|471428190|FG003|Overall Study|Voluntary Withdrawal|1|||
130943598|NCT02063854|471428191|FG004|Overall Study|Voluntary Withdrawal|3|||
130943599|NCT02063854|471428192|FG005|Overall Study|Voluntary Withdrawal|6|||
131036767|NCT05329220|471768258|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
131224460|NCT01493531|472448897|FG001|Overall Study|Protocol Violation|15|||
131224461|NCT01493531|472448898|FG002|Overall Study|Protocol Violation|12|||
131224462|NCT01493531|472448896|FG000|Overall Study|Sponsor terminated study|5|||
131036768|NCT05329220|471768253|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
131036769|NCT05329220|471768254|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
131036770|NCT05329220|471768255|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
131224463|NCT01493531|472448897|FG001|Overall Study|Sponsor terminated study|2|||
131224464|NCT01493531|472448898|FG002|Overall Study|Sponsor terminated study|3|||
131224465|NCT01493531|472448896|FG000|Overall Study|Lost to Follow-up|5|||
131224466|NCT01493531|472448897|FG001|Overall Study|Lost to Follow-up|7|||
131224467|NCT01493531|472448898|FG002|Overall Study|Lost to Follow-up|11|||
131224468|NCT01493531|472448896|FG000|Overall Study|Withdrawal by Subject|16|||
131224469|NCT01493531|472448897|FG001|Overall Study|Withdrawal by Subject|13|||
131224470|NCT01493531|472448898|FG002|Overall Study|Withdrawal by Subject|11|||
131224471|NCT01493531|472448896|FG000|Overall Study|Death|0|||
131224472|NCT01493531|472448897|FG001|Overall Study|Death|1|||
131224473|NCT01493531|472448898|FG002|Overall Study|Death|0|||
131224474|NCT01027884|472448905|FG000|Overall Study|Adverse Event|2|||
130709110|NCT01813071|470560607|FG004|Overall Study|Met inc/exc criteria|0|||
130709111|NCT01813071|470560608|FG005|Overall Study|Met inc/exc criteria|1|||
130709112|NCT01813071|470560609|FG006|Overall Study|Met inc/exc criteria|0|||
130709113|NCT01813071|470560610|FG007|Overall Study|Met inc/exc criteria|1|||
130709114|NCT01813071|470560611|FG008|Overall Study|Met inc/exc criteria|1|||
130709115|NCT01425528|470560612|FG000|Overall Study|Withdrawal by Subject|1|||
130709116|NCT01425528|470560613|FG001|Overall Study|Withdrawal by Subject|1|||
130709117|NCT00842530|470560614|FG000|Overall Study|Serious adverse event|0|||
130709118|NCT00842530|470560615|FG001|Overall Study|Serious adverse event|6|||
130709119|NCT00842530|470560614|FG000|Overall Study|Other adverse event|6|||
130709120|NCT00842530|470560615|FG001|Overall Study|Other adverse event|1|||
130709121|NCT00842530|470560614|FG000|Overall Study|Protocol Violation|32|||
130709122|NCT00842530|470560615|FG001|Overall Study|Protocol Violation|14|||
130709123|NCT00842530|470560614|FG000|Overall Study|Lost to Follow-up|6|||
130709124|NCT00842530|470560615|FG001|Overall Study|Lost to Follow-up|8|||
130709125|NCT00842530|470560614|FG000|Overall Study|Withdrawal by Subject|73|||
130709126|NCT00842530|470560615|FG001|Overall Study|Withdrawal by Subject|28|||
130709127|NCT02939950|470560616|FG000|Overall Study|Lost to Follow-up|13|||
130709128|NCT02939950|470560617|FG001|Overall Study|Lost to Follow-up|16|||
130709129|NCT02939950|470560616|FG000|Overall Study|Positive slit lamp findings|0|||
130709130|NCT02939950|470560617|FG001|Overall Study|Positive slit lamp findings|1|||
131224475|NCT01027884|472448906|FG001|Overall Study|Adverse Event|1|||
130709131|NCT02939950|470560616|FG000|Overall Study|Chalazion upper lid|0|||
130709132|NCT02939950|470560617|FG001|Overall Study|Chalazion upper lid|1|||
130709133|NCT02939950|470560616|FG000|Overall Study|Lack of motivation|0|||
130709134|NCT02939950|470560617|FG001|Overall Study|Lack of motivation|2|||
130709135|NCT02939950|470560616|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
130943600|NCT02063854|471428193|FG006|Overall Study|Voluntary Withdrawal|1|||
130943601|NCT02063854|471428187|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
130943602|NCT02063854|471428188|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
130943603|NCT02063854|471428189|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
130709136|NCT02939950|470560617|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
130943604|NCT02063854|471428190|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
130943605|NCT02063854|471428191|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
130943606|NCT02063854|471428192|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
130943607|NCT02063854|471428193|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
130943608|NCT02063854|471428187|FG000|Overall Study|Reason Not Specified|1|||
130943609|NCT02063854|471428188|FG001|Overall Study|Reason Not Specified|0|||
130943610|NCT02063854|471428189|FG002|Overall Study|Reason Not Specified|0|||
130943611|NCT02063854|471428190|FG003|Overall Study|Reason Not Specified|0|||
130943612|NCT02063854|471428191|FG004|Overall Study|Reason Not Specified|0|||
130943613|NCT02063854|471428192|FG005|Overall Study|Reason Not Specified|0|||
130943614|NCT02063854|471428193|FG006|Overall Study|Reason Not Specified|0|||
130943615|NCT02063854|471428187|FG000|Overall Study|Did Not Receive Study Drug|0|||
130943616|NCT02063854|471428188|FG001|Overall Study|Did Not Receive Study Drug|0|||
130943617|NCT02063854|471428189|FG002|Overall Study|Did Not Receive Study Drug|0|||
130943618|NCT02063854|471428190|FG003|Overall Study|Did Not Receive Study Drug|0|||
130943619|NCT02063854|471428191|FG004|Overall Study|Did Not Receive Study Drug|0|||
130943620|NCT02063854|471428192|FG005|Overall Study|Did Not Receive Study Drug|1|||
130943621|NCT02063854|471428193|FG006|Overall Study|Did Not Receive Study Drug|0|||
130943622|NCT03538158|471428194|FG000|Overall Study|Lost to Follow-up|13|||
130943623|NCT03538158|471428195|FG001|Overall Study|Lost to Follow-up|7|||
130943624|NCT03538158|471428194|FG000|Overall Study|Withdrawal by Subject|2|||
130943625|NCT03538158|471428195|FG001|Overall Study|Withdrawal by Subject|1|||
130943626|NCT02255981|471428197|FG000|Overall Study|Lost to Follow-up|3|||
130943627|NCT02255981|471428197|FG000|Overall Study|Withdrawal by Subject|1|||
130943628|NCT01046682|471428200|FG000|Overall Study|Adverse Event|2|||
130943629|NCT01046682|471428201|FG001|Overall Study|Adverse Event|0|||
130943630|NCT00772707|471428202|FG000|Overall Study|Withdrawn|3|||
130943631|NCT01454570|471428203|FG000|Overall Study|Withdrawal by Subject|2|||
130943632|NCT01454570|471428203|FG000|Overall Study|Screen Failure|7|||
130943633|NCT02246673|471428204|FG000|Overall Study|Sponsor Decision|1|||
130943634|NCT02246673|471428205|FG001|Overall Study|Sponsor Decision|0|||
130943635|NCT02246673|471428206|FG002|Overall Study|Sponsor Decision|0|||
130943636|NCT02246673|471428207|FG003|Overall Study|Sponsor Decision|0|||
130943637|NCT02246673|471428208|FG004|Overall Study|Sponsor Decision|0|||
130943638|NCT02246673|471428204|FG000|Overall Study|Withdrawal by Subject|0|||
130943639|NCT02246673|471428205|FG001|Overall Study|Withdrawal by Subject|0|||
130943640|NCT02246673|471428206|FG002|Overall Study|Withdrawal by Subject|0|||
130943641|NCT02246673|471428207|FG003|Overall Study|Withdrawal by Subject|0|||
130943642|NCT02246673|471428208|FG004|Overall Study|Withdrawal by Subject|1|||
130943643|NCT02246673|471428204|FG000|Overall Study|Lost to Follow-up|0|||
130943644|NCT02246673|471428205|FG001|Overall Study|Lost to Follow-up|0|||
131123911|NCT02966509|472082870|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
131123912|NCT02966509|472082871|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
131123913|NCT02966509|472082870|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
131123914|NCT02966509|472082871|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
131123915|NCT02966509|472082870|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
131123916|NCT02966509|472082871|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
130709137|NCT02939950|470560616|FG000|Overall Study|Military orders|1|||
130709138|NCT02939950|470560617|FG001|Overall Study|Military orders|0|||
130709139|NCT02939950|470560616|FG000|Overall Study|Participant Relocated|5|||
130709140|NCT02939950|470560617|FG001|Overall Study|Participant Relocated|3|||
130709141|NCT02939950|470560616|FG000|Overall Study|Study related symptoms|8|||
130709142|NCT02939950|470560617|FG001|Overall Study|Study related symptoms|8|||
130709143|NCT02939950|470560616|FG000|Overall Study|Unacceptable lens movement|2|||
130709144|NCT02939950|470560617|FG001|Overall Study|Unacceptable lens movement|0|||
130709145|NCT02939950|470560616|FG000|Overall Study|Protocol Violation|6|||
130709146|NCT02939950|470560617|FG001|Overall Study|Protocol Violation|3|||
130709147|NCT02939950|470560616|FG000|Overall Study|Physician Decision|2|||
130709148|NCT02939950|470560617|FG001|Overall Study|Physician Decision|0|||
130709149|NCT02939950|470560616|FG000|Overall Study|Pregnancy|6|||
130709150|NCT02939950|470560617|FG001|Overall Study|Pregnancy|7|||
130709151|NCT02939950|470560616|FG000|Overall Study|Withdrawal by Subject|12|||
131123917|NCT02966509|472082870|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
131224476|NCT01027884|472448905|FG000|Overall Study|Protocol Violation|1|||
130943645|NCT02246673|471428206|FG002|Overall Study|Lost to Follow-up|0|||
130709152|NCT02939950|470560617|FG001|Overall Study|Withdrawal by Subject|28|||
130709153|NCT02939950|470560616|FG000|Overall Study|Adverse Event|7|||
130943646|NCT02246673|471428207|FG003|Overall Study|Lost to Follow-up|1|||
130943647|NCT02246673|471428208|FG004|Overall Study|Lost to Follow-up|0|||
130943648|NCT02246673|471428204|FG000|Overall Study|Protocol Violation|0|||
130943649|NCT02246673|471428205|FG001|Overall Study|Protocol Violation|0|||
130943650|NCT02246673|471428206|FG002|Overall Study|Protocol Violation|0|||
130943651|NCT02246673|471428207|FG003|Overall Study|Protocol Violation|1|||
130943652|NCT02246673|471428208|FG004|Overall Study|Protocol Violation|0|||
130943653|NCT01679002|471428213|FG000|Overall Study|Adverse Event|1|||
130709154|NCT02939950|470560617|FG001|Overall Study|Adverse Event|3|||
130709155|NCT02939950|470560616|FG000|Overall Study|Randomized, not dispensed|1|||
131036771|NCT05329220|471768256|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
131036772|NCT05329220|471768257|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
131036773|NCT05329220|471768258|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
131036774|NCT05329220|471768253|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
131036775|NCT05329220|471768254|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
131036776|NCT05329220|471768255|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
131036777|NCT05329220|471768256|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
131036778|NCT05329220|471768257|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
131036779|NCT05329220|471768258|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
131123918|NCT02966509|472082871|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
131123919|NCT02966509|472082870|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
131123920|NCT02966509|472082871|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
130772703|NCT02757352|470794736|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772704|NCT02757352|470794737|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
130772705|NCT02757352|470794738|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130772706|NCT02757352|470794739|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130772707|NCT02757352|470794740|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772708|NCT02757352|470794741|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772709|NCT02757352|470794742|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772710|NCT02757352|470794743|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130772711|NCT02757352|470794734|FG000|Follow-Up Period|Adverse Event|0|||
130772712|NCT02757352|470794735|FG001|Follow-Up Period|Adverse Event|0|||
130772713|NCT02757352|470794736|FG002|Follow-Up Period|Adverse Event|0|||
130772714|NCT02757352|470794737|FG003|Follow-Up Period|Adverse Event|0|||
130772715|NCT02757352|470794738|FG004|Follow-Up Period|Adverse Event|0|||
130772716|NCT02757352|470794739|FG005|Follow-Up Period|Adverse Event|0|||
130772717|NCT02757352|470794740|FG006|Follow-Up Period|Adverse Event|1|||
130772718|NCT02757352|470794741|FG007|Follow-Up Period|Adverse Event|0|||
130772719|NCT02757352|470794742|FG008|Follow-Up Period|Adverse Event|2|||
130772720|NCT02757352|470794743|FG009|Follow-Up Period|Adverse Event|0|||
130772721|NCT02757352|470794734|FG000|Follow-Up Period|Lost to Follow-up|0|||
130772722|NCT02757352|470794735|FG001|Follow-Up Period|Lost to Follow-up|0|||
130772723|NCT02757352|470794736|FG002|Follow-Up Period|Lost to Follow-up|0|||
130772724|NCT02757352|470794737|FG003|Follow-Up Period|Lost to Follow-up|0|||
130772725|NCT02757352|470794738|FG004|Follow-Up Period|Lost to Follow-up|0|||
130772726|NCT02757352|470794739|FG005|Follow-Up Period|Lost to Follow-up|0|||
130772727|NCT02757352|470794740|FG006|Follow-Up Period|Lost to Follow-up|0|||
130772728|NCT02757352|470794741|FG007|Follow-Up Period|Lost to Follow-up|0|||
130772729|NCT02757352|470794742|FG008|Follow-Up Period|Lost to Follow-up|1|||
130772730|NCT02757352|470794743|FG009|Follow-Up Period|Lost to Follow-up|0|||
130772731|NCT02757352|470794734|FG000|Follow-Up Period|Lack of Efficacy|0|||
130772732|NCT02757352|470794735|FG001|Follow-Up Period|Lack of Efficacy|0|||
130772733|NCT02757352|470794736|FG002|Follow-Up Period|Lack of Efficacy|0|||
130772734|NCT02757352|470794737|FG003|Follow-Up Period|Lack of Efficacy|0|||
130772735|NCT02757352|470794738|FG004|Follow-Up Period|Lack of Efficacy|0|||
130772736|NCT02757352|470794739|FG005|Follow-Up Period|Lack of Efficacy|0|||
130772737|NCT02757352|470794740|FG006|Follow-Up Period|Lack of Efficacy|0|||
130772738|NCT02757352|470794741|FG007|Follow-Up Period|Lack of Efficacy|0|||
130772739|NCT02757352|470794742|FG008|Follow-Up Period|Lack of Efficacy|1|||
130772740|NCT02757352|470794743|FG009|Follow-Up Period|Lack of Efficacy|1|||
130772741|NCT02757352|470794734|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130772742|NCT02757352|470794735|FG001|Follow-Up Period|Withdrawal by Subject|0|||
130772743|NCT02757352|470794736|FG002|Follow-Up Period|Withdrawal by Subject|0|||
130772744|NCT02757352|470794737|FG003|Follow-Up Period|Withdrawal by Subject|0|||
130772745|NCT02757352|470794738|FG004|Follow-Up Period|Withdrawal by Subject|0|||
131123921|NCT01717287|472082874|FG000|Overall Study|Lost to Follow-up|0|||
131123922|NCT01717287|472082875|FG001|Overall Study|Lost to Follow-up|2|||
131123923|NCT01717287|472082874|FG000|Overall Study|Protocol Violation|0|||
131123924|NCT01717287|472082875|FG001|Overall Study|Protocol Violation|1|||
131123925|NCT00404820|472082876|FG000|Overall Study|Adverse Event|4|||
131123926|NCT00404820|472082877|FG001|Overall Study|Adverse Event|16|||
130772746|NCT02757352|470794739|FG005|Follow-Up Period|Withdrawal by Subject|0|||
130772747|NCT02757352|470794740|FG006|Follow-Up Period|Withdrawal by Subject|0|||
130772748|NCT02757352|470794741|FG007|Follow-Up Period|Withdrawal by Subject|1|||
131036780|NCT05329220|471768253|FG000|Follow-up Period|Adverse Event|0|||
131036781|NCT05329220|471768254|FG001|Follow-up Period|Adverse Event|0|||
131036782|NCT05329220|471768255|FG002|Follow-up Period|Adverse Event|0|||
131123927|NCT00404820|472082876|FG000|Overall Study|Withdrawal by Subject|5|||
130772749|NCT02757352|470794742|FG008|Follow-Up Period|Withdrawal by Subject|6|||
130772750|NCT02757352|470794743|FG009|Follow-Up Period|Withdrawal by Subject|2|||
130772751|NCT03638466|470794744|FG000|Overall Study|Early Termination|0|||
130772752|NCT03638466|470794745|FG001|Overall Study|Early Termination|1|||
131224477|NCT01027884|472448906|FG001|Overall Study|Protocol Violation|0|||
130943654|NCT01679002|471428214|FG001|Overall Study|Adverse Event|1|||
130943655|NCT01679002|471428215|FG002|Overall Study|Adverse Event|0|||
130943656|NCT03630120|471428216|FG000|Overall Study|Disease progression|0|||
130943657|NCT03630120|471428217|FG001|Overall Study|Disease progression|1|||
130943658|NCT03630120|471428218|FG002|Overall Study|Disease progression|1|||
130943659|NCT03630120|471428219|FG003|Overall Study|Disease progression|1|||
130943660|NCT03755414|471428221|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
130943661|NCT03755414|471428222|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
130943662|NCT03755414|471428223|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
130943663|NCT03755414|471428221|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
130943664|NCT03755414|471428222|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
130943665|NCT03755414|471428223|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
130943666|NCT03755414|471428221|FG000|Overall Study|Non-compliance|0|||
130943667|NCT03755414|471428222|FG001|Overall Study|Non-compliance|1|||
130943668|NCT03755414|471428223|FG002|Overall Study|Non-compliance|0|||
130943669|NCT00741039|471428226|FG000|Overall Study|Patient non-compliance|2|||
130943670|NCT00741039|471428227|FG001|Overall Study|Patient non-compliance|0|||
130943671|NCT00322842|471428232|FG000|Overall Study|Withdrawal by Subject|0|||
130943672|NCT00322842|471428233|FG001|Overall Study|Withdrawal by Subject|1|||
130943673|NCT00322842|471428232|FG000|Overall Study|Lost to Follow-up|0|||
130943674|NCT00322842|471428233|FG001|Overall Study|Lost to Follow-up|1|||
130943675|NCT00322842|471428232|FG000|Overall Study|Refused transplant|1|||
130943676|NCT00322842|471428233|FG001|Overall Study|Refused transplant|0|||
130943677|NCT00322842|471428232|FG000|Overall Study|Death|1|||
130943678|NCT00322842|471428233|FG001|Overall Study|Death|0|||
130943679|NCT02068222|471428236|FG000|Overall Study|Lost to Follow-up|1|||
130943680|NCT01782664|471428237|FG000|Overall Study|Adverse Event|2|||
130943681|NCT01782664|471428238|FG001|Overall Study|Adverse Event|2|||
130943682|NCT01782664|471428239|FG002|Overall Study|Adverse Event|2|||
130943683|NCT01782664|471428240|FG003|Overall Study|Adverse Event|2|||
130943684|NCT01782664|471428241|FG004|Overall Study|Adverse Event|0|||
130943685|NCT01782664|471428242|FG005|Overall Study|Adverse Event|0|||
130943686|NCT01782664|471428237|FG000|Overall Study|Lack of Efficacy|2|||
130943687|NCT01782664|471428238|FG001|Overall Study|Lack of Efficacy|0|||
130943688|NCT01782664|471428239|FG002|Overall Study|Lack of Efficacy|2|||
130943689|NCT01782664|471428240|FG003|Overall Study|Lack of Efficacy|2|||
130943690|NCT01782664|471428241|FG004|Overall Study|Lack of Efficacy|0|||
130943691|NCT01782664|471428242|FG005|Overall Study|Lack of Efficacy|0|||
130943692|NCT01782664|471428237|FG000|Overall Study|Protocol Violation|0|||
130943693|NCT01782664|471428238|FG001|Overall Study|Protocol Violation|1|||
130943694|NCT01782664|471428239|FG002|Overall Study|Protocol Violation|0|||
130943695|NCT01782664|471428240|FG003|Overall Study|Protocol Violation|1|||
130943696|NCT01782664|471428241|FG004|Overall Study|Protocol Violation|0|||
130943697|NCT01782664|471428242|FG005|Overall Study|Protocol Violation|0|||
130943698|NCT01782664|471428237|FG000|Overall Study|Withdrawal by Subject|2|||
131036783|NCT05329220|471768256|FG003|Follow-up Period|Adverse Event|0|||
131036784|NCT05329220|471768257|FG004|Follow-up Period|Adverse Event|2|||
131036785|NCT05329220|471768258|FG005|Follow-up Period|Adverse Event|1|||
131036786|NCT05329220|471768253|FG000|Follow-up Period|Death|0|||
131036787|NCT05329220|471768254|FG001|Follow-up Period|Death|0|||
131036788|NCT05329220|471768255|FG002|Follow-up Period|Death|1|||
131036789|NCT05329220|471768256|FG003|Follow-up Period|Death|1|||
131036790|NCT05329220|471768257|FG004|Follow-up Period|Death|0|||
131036791|NCT05329220|471768258|FG005|Follow-up Period|Death|1|||
131036792|NCT05329220|471768253|FG000|Follow-up Period|Lost to Follow-up|0|||
131036793|NCT05329220|471768254|FG001|Follow-up Period|Lost to Follow-up|1|||
131036794|NCT05329220|471768255|FG002|Follow-up Period|Lost to Follow-up|2|||
131036795|NCT05329220|471768256|FG003|Follow-up Period|Lost to Follow-up|2|||
131036796|NCT05329220|471768257|FG004|Follow-up Period|Lost to Follow-up|113|||
131036797|NCT05329220|471768258|FG005|Follow-up Period|Lost to Follow-up|89|||
131036798|NCT05329220|471768253|FG000|Follow-up Period|Physician Decision|0|||
131036799|NCT05329220|471768254|FG001|Follow-up Period|Physician Decision|0|||
131036800|NCT05329220|471768255|FG002|Follow-up Period|Physician Decision|0|||
131036801|NCT05329220|471768256|FG003|Follow-up Period|Physician Decision|0|||
131036802|NCT05329220|471768257|FG004|Follow-up Period|Physician Decision|2|||
131036803|NCT05329220|471768258|FG005|Follow-up Period|Physician Decision|2|||
131036804|NCT05329220|471768253|FG000|Follow-up Period|Protocol Violation|0|||
131036805|NCT05329220|471768254|FG001|Follow-up Period|Protocol Violation|0|||
131036806|NCT05329220|471768255|FG002|Follow-up Period|Protocol Violation|0|||
131036807|NCT05329220|471768256|FG003|Follow-up Period|Protocol Violation|0|||
131036808|NCT05329220|471768257|FG004|Follow-up Period|Protocol Violation|0|||
131036809|NCT05329220|471768258|FG005|Follow-up Period|Protocol Violation|1|||
131036810|NCT05329220|471768253|FG000|Follow-up Period|Withdrawal by Subject|0|||
130943699|NCT01782664|471428238|FG001|Overall Study|Withdrawal by Subject|2|||
130943700|NCT01782664|471428239|FG002|Overall Study|Withdrawal by Subject|0|||
130943701|NCT01782664|471428240|FG003|Overall Study|Withdrawal by Subject|0|||
130943702|NCT01782664|471428241|FG004|Overall Study|Withdrawal by Subject|0|||
130943703|NCT01782664|471428242|FG005|Overall Study|Withdrawal by Subject|0|||
130943704|NCT00651755|471428244|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
130943705|NCT00651755|471428245|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
130943706|NCT00651755|471428244|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
130943707|NCT00651755|471428245|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
130943708|NCT00624052|471428248|FG000|Overall Study|Adverse Event|7|||
130943709|NCT00624052|471428249|FG001|Overall Study|Adverse Event|6|||
130943710|NCT00624052|471428250|FG002|Overall Study|Adverse Event|0|||
130943711|NCT00624052|471428251|FG003|Overall Study|Adverse Event|3|||
130943712|NCT00624052|471428248|FG000|Overall Study|Lack of Efficacy|1|||
130943713|NCT00624052|471428249|FG001|Overall Study|Lack of Efficacy|1|||
130943714|NCT00624052|471428250|FG002|Overall Study|Lack of Efficacy|0|||
130943715|NCT00624052|471428251|FG003|Overall Study|Lack of Efficacy|0|||
130943716|NCT00624052|471428248|FG000|Overall Study|Lost to Follow-up|2|||
130943717|NCT00624052|471428249|FG001|Overall Study|Lost to Follow-up|3|||
130943718|NCT00624052|471428250|FG002|Overall Study|Lost to Follow-up|1|||
130943719|NCT00624052|471428251|FG003|Overall Study|Lost to Follow-up|0|||
130943720|NCT00624052|471428248|FG000|Overall Study|Non compliant with the protocol|2|||
130943721|NCT00624052|471428249|FG001|Overall Study|Non compliant with the protocol|1|||
130943722|NCT00624052|471428250|FG002|Overall Study|Non compliant with the protocol|1|||
130943723|NCT00624052|471428251|FG003|Overall Study|Non compliant with the protocol|1|||
131123928|NCT00404820|472082877|FG001|Overall Study|Withdrawal by Subject|3|||
131123929|NCT00404820|472082876|FG000|Overall Study|Lost to Follow-up|7|||
131123930|NCT00404820|472082877|FG001|Overall Study|Lost to Follow-up|3|||
131123931|NCT00404820|472082876|FG000|Overall Study|Administrative problems|2|||
130709156|NCT02939950|470560617|FG001|Overall Study|Randomized, not dispensed|0|||
130709157|NCT02939950|470560616|FG000|Overall Study|Ineligible at Baseline|2|||
130709158|NCT02939950|470560617|FG001|Overall Study|Ineligible at Baseline|8|||
130709159|NCT02985879|470560625|FG000|Overall Study|Adverse Event|7|||
130709160|NCT02985879|470560626|FG001|Overall Study|Adverse Event|9|||
130709161|NCT02985879|470560627|FG002|Overall Study|Adverse Event|7|||
130709162|NCT02985879|470560625|FG000|Overall Study|Withdrew consent|6|||
130709163|NCT02985879|470560626|FG001|Overall Study|Withdrew consent|8|||
130709164|NCT02985879|470560627|FG002|Overall Study|Withdrew consent|10|||
130709165|NCT02985879|470560625|FG000|Overall Study|Lost to Follow-up|1|||
130709166|NCT02985879|470560626|FG001|Overall Study|Lost to Follow-up|0|||
130709167|NCT02985879|470560627|FG002|Overall Study|Lost to Follow-up|2|||
130709168|NCT02985879|470560625|FG000|Overall Study|Other, not specified|62|||
130709169|NCT02985879|470560626|FG001|Overall Study|Other, not specified|58|||
130709170|NCT02985879|470560627|FG002|Overall Study|Other, not specified|58|||
130709171|NCT04974619|470562277|FG000|Overall Study|Lost to Follow-up|0|||
130709172|NCT04974619|470562278|FG001|Overall Study|Lost to Follow-up|0|||
130709173|NCT04974619|470562279|FG002|Overall Study|Lost to Follow-up|1|||
130709174|NCT04974619|470562277|FG000|Overall Study|Withdrawal by Subject|0|||
130709175|NCT04974619|470562278|FG001|Overall Study|Withdrawal by Subject|0|||
130709176|NCT04974619|470562279|FG002|Overall Study|Withdrawal by Subject|1|||
130709177|NCT04974619|470562277|FG000|Overall Study|Protocol Violation|0|||
130709178|NCT04974619|470562278|FG001|Overall Study|Protocol Violation|1|||
130709179|NCT04974619|470562279|FG002|Overall Study|Protocol Violation|0|||
130709180|NCT00493779|470562286|FG000|Overall Study|Logistical issue at site|1|||
130709181|NCT01885182|470562288|FG000|Overall Study|Adverse Event|11|||
130709182|NCT01885182|470562289|FG001|Overall Study|Adverse Event|13|||
130709183|NCT01885182|470562288|FG000|Overall Study|Withdrawal by Subject|13|||
130709184|NCT01885182|470562289|FG001|Overall Study|Withdrawal by Subject|6|||
130709185|NCT01885182|470562288|FG000|Overall Study|Lost to Follow-up|2|||
130709186|NCT01885182|470562289|FG001|Overall Study|Lost to Follow-up|2|||
130709187|NCT01885182|470562288|FG000|Overall Study|Lack of Efficacy|8|||
130709188|NCT01885182|470562289|FG001|Overall Study|Lack of Efficacy|1|||
130709189|NCT01207440|470562296|FG000|Overall Study|Adverse Event|46|||
130709190|NCT01207440|470562297|FG001|Overall Study|Adverse Event|11|||
130709191|NCT01207440|470562298|FG002|Overall Study|Adverse Event|7|||
130709192|NCT01207440|470562299|FG003|Overall Study|Adverse Event|2|||
130709193|NCT01207440|470562300|FG004|Overall Study|Adverse Event|6|||
130709194|NCT01207440|470562301|FG005|Overall Study|Adverse Event|6|||
130709195|NCT01207440|470562302|FG006|Overall Study|Adverse Event|2|||
130709196|NCT01207440|470562296|FG000|Overall Study|Death|6|||
131123932|NCT00404820|472082877|FG001|Overall Study|Administrative problems|0|||
130709197|NCT01207440|470562297|FG001|Overall Study|Death|3|||
130709198|NCT01207440|470562298|FG002|Overall Study|Death|2|||
130709199|NCT01207440|470562299|FG003|Overall Study|Death|2|||
130709200|NCT01207440|470562300|FG004|Overall Study|Death|7|||
130709201|NCT01207440|470562301|FG005|Overall Study|Death|5|||
130709202|NCT01207440|470562302|FG006|Overall Study|Death|1|||
130709203|NCT01207440|470562296|FG000|Overall Study|Lack of Efficacy|13|||
130709204|NCT01207440|470562297|FG001|Overall Study|Lack of Efficacy|2|||
130943724|NCT00624052|471428248|FG000|Overall Study|Consent withdrawn|3|||
130943725|NCT00624052|471428249|FG001|Overall Study|Consent withdrawn|1|||
130943726|NCT00624052|471428250|FG002|Overall Study|Consent withdrawn|1|||
130943727|NCT00624052|471428251|FG003|Overall Study|Consent withdrawn|0|||
130709205|NCT01207440|470562298|FG002|Overall Study|Lack of Efficacy|5|||
130709206|NCT01207440|470562299|FG003|Overall Study|Lack of Efficacy|1|||
130709207|NCT01207440|470562300|FG004|Overall Study|Lack of Efficacy|2|||
130709208|NCT01207440|470562301|FG005|Overall Study|Lack of Efficacy|3|||
130709209|NCT01207440|470562302|FG006|Overall Study|Lack of Efficacy|0|||
130709210|NCT01207440|470562296|FG000|Overall Study|Lost to Follow-up|0|||
130709211|NCT01207440|470562297|FG001|Overall Study|Lost to Follow-up|0|||
130709212|NCT01207440|470562298|FG002|Overall Study|Lost to Follow-up|2|||
130709213|NCT01207440|470562299|FG003|Overall Study|Lost to Follow-up|1|||
130709214|NCT01207440|470562300|FG004|Overall Study|Lost to Follow-up|0|||
130709215|NCT01207440|470562301|FG005|Overall Study|Lost to Follow-up|0|||
130709216|NCT01207440|470562302|FG006|Overall Study|Lost to Follow-up|0|||
130709217|NCT01207440|470562296|FG000|Overall Study|Non-compliance with Study Drug|3|||
130709218|NCT01207440|470562297|FG001|Overall Study|Non-compliance with Study Drug|0|||
130709219|NCT01207440|470562298|FG002|Overall Study|Non-compliance with Study Drug|1|||
130709220|NCT01207440|470562299|FG003|Overall Study|Non-compliance with Study Drug|0|||
130709221|NCT01207440|470562300|FG004|Overall Study|Non-compliance with Study Drug|0|||
130709222|NCT01207440|470562301|FG005|Overall Study|Non-compliance with Study Drug|0|||
130709223|NCT01207440|470562302|FG006|Overall Study|Non-compliance with Study Drug|0|||
130709224|NCT01207440|470562296|FG000|Overall Study|Physician Decision|6|||
130709225|NCT01207440|470562297|FG001|Overall Study|Physician Decision|5|||
130709226|NCT01207440|470562298|FG002|Overall Study|Physician Decision|5|||
130709227|NCT01207440|470562299|FG003|Overall Study|Physician Decision|0|||
130709228|NCT01207440|470562300|FG004|Overall Study|Physician Decision|1|||
130709229|NCT01207440|470562301|FG005|Overall Study|Physician Decision|0|||
130709230|NCT01207440|470562302|FG006|Overall Study|Physician Decision|0|||
130709231|NCT01207440|470562296|FG000|Overall Study|Progressive Disease|19|||
130709232|NCT01207440|470562297|FG001|Overall Study|Progressive Disease|10|||
130709233|NCT01207440|470562298|FG002|Overall Study|Progressive Disease|19|||
130709234|NCT01207440|470562299|FG003|Overall Study|Progressive Disease|7|||
130709235|NCT01207440|470562300|FG004|Overall Study|Progressive Disease|23|||
130709236|NCT01207440|470562301|FG005|Overall Study|Progressive Disease|27|||
130709237|NCT01207440|470562302|FG006|Overall Study|Progressive Disease|0|||
130709238|NCT01207440|470562296|FG000|Overall Study|Protocol Violation|2|||
130709239|NCT01207440|470562297|FG001|Overall Study|Protocol Violation|0|||
130709240|NCT01207440|470562298|FG002|Overall Study|Protocol Violation|0|||
130709241|NCT01207440|470562299|FG003|Overall Study|Protocol Violation|0|||
130709242|NCT01207440|470562300|FG004|Overall Study|Protocol Violation|0|||
130709243|NCT01207440|470562301|FG005|Overall Study|Protocol Violation|0|||
130709244|NCT01207440|470562302|FG006|Overall Study|Protocol Violation|0|||
130709245|NCT01207440|470562296|FG000|Overall Study|Site Terminated by Sponsor|69|||
130709246|NCT01207440|470562297|FG001|Overall Study|Site Terminated by Sponsor|19|||
130709247|NCT01207440|470562298|FG002|Overall Study|Site Terminated by Sponsor|12|||
130709248|NCT01207440|470562299|FG003|Overall Study|Site Terminated by Sponsor|2|||
130709249|NCT01207440|470562300|FG004|Overall Study|Site Terminated by Sponsor|3|||
130709250|NCT01207440|470562301|FG005|Overall Study|Site Terminated by Sponsor|0|||
130709251|NCT01207440|470562302|FG006|Overall Study|Site Terminated by Sponsor|2|||
130709252|NCT01207440|470562296|FG000|Overall Study|Withdrawal by Subject|29|||
130709253|NCT01207440|470562297|FG001|Overall Study|Withdrawal by Subject|4|||
130709254|NCT01207440|470562298|FG002|Overall Study|Withdrawal by Subject|5|||
130709255|NCT01207440|470562299|FG003|Overall Study|Withdrawal by Subject|3|||
130709256|NCT01207440|470562300|FG004|Overall Study|Withdrawal by Subject|2|||
130709257|NCT01207440|470562301|FG005|Overall Study|Withdrawal by Subject|2|||
130709258|NCT01207440|470562302|FG006|Overall Study|Withdrawal by Subject|0|||
131036811|NCT05329220|471768254|FG001|Follow-up Period|Withdrawal by Subject|0|||
131036812|NCT05329220|471768255|FG002|Follow-up Period|Withdrawal by Subject|1|||
131036813|NCT05329220|471768256|FG003|Follow-up Period|Withdrawal by Subject|1|||
131036814|NCT05329220|471768257|FG004|Follow-up Period|Withdrawal by Subject|34|||
131036815|NCT05329220|471768258|FG005|Follow-up Period|Withdrawal by Subject|35|||
131036816|NCT05329220|471768253|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
131036817|NCT05329220|471768254|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
131036818|NCT05329220|471768255|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
131036819|NCT05329220|471768256|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
131123933|NCT00404820|472082876|FG000|Overall Study|Death|1|||
131123934|NCT00404820|472082877|FG001|Overall Study|Death|0|||
131123935|NCT00404820|472082876|FG000|Overall Study|Other|0|||
131036820|NCT05329220|471768257|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
131036821|NCT05329220|471768258|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
130709259|NCT01207440|470562296|FG000|Overall Study|Reason Not Specified|10|||
130709260|NCT01207440|470562297|FG001|Overall Study|Reason Not Specified|10|||
130709261|NCT01207440|470562298|FG002|Overall Study|Reason Not Specified|7|||
130709262|NCT01207440|470562299|FG003|Overall Study|Reason Not Specified|0|||
130709263|NCT01207440|470562300|FG004|Overall Study|Reason Not Specified|4|||
130709264|NCT01207440|470562301|FG005|Overall Study|Reason Not Specified|3|||
130709265|NCT01207440|470562302|FG006|Overall Study|Reason Not Specified|0|||
130709266|NCT01592721|470562303|FG000|Long-term Follow-up|Death|1|||
130772753|NCT01128400|470794746|FG000|Overall Study|Lost to Follow-up|1|||
130772754|NCT01128400|470794747|FG001|Overall Study|Lost to Follow-up|0|||
130772755|NCT01128400|470794748|FG002|Overall Study|Lost to Follow-up|1|||
130772756|NCT01128400|470794746|FG000|Overall Study|Screening failure|1|||
130772757|NCT01128400|470794747|FG001|Overall Study|Screening failure|0|||
130772758|NCT01128400|470794748|FG002|Overall Study|Screening failure|0|||
130772759|NCT01128400|470794746|FG000|Overall Study|were not invited to participate on taste|0|||
130772760|NCT01128400|470794747|FG001|Overall Study|were not invited to participate on taste|0|||
130772761|NCT01128400|470794748|FG002|Overall Study|were not invited to participate on taste|15|||
130772762|NCT01128400|470794746|FG000|Overall Study|Excluded due to sinus problems|0|||
130772763|NCT01128400|470794747|FG001|Overall Study|Excluded due to sinus problems|1|||
130772764|NCT01128400|470794748|FG002|Overall Study|Excluded due to sinus problems|0|||
130772765|NCT02362425|470794749|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
130772766|NCT02362425|470794750|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
130772767|NCT02362425|470794751|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
130772768|NCT02362425|470794752|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
130772769|NCT02362425|470794749|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
130772770|NCT02362425|470794750|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
130772771|NCT02362425|470794751|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
130772772|NCT02362425|470794752|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
130772773|NCT02362425|470794749|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
130772774|NCT02362425|470794750|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
130772775|NCT02362425|470794751|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
130772776|NCT02362425|470794752|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
130772777|NCT02362425|470794749|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
130772778|NCT02362425|470794750|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
130772779|NCT02362425|470794751|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
130772780|NCT02362425|470794752|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
130772781|NCT02362425|470794749|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
130772782|NCT02362425|470794750|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
130772783|NCT02362425|470794751|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
130772784|NCT02362425|470794752|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
130772785|NCT02362425|470794749|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
130772786|NCT02362425|470794750|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
130772787|NCT02362425|470794751|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
130772788|NCT02362425|470794752|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
130772789|NCT02362425|470794749|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
130772790|NCT02362425|470794750|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
130772791|NCT02362425|470794751|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
130772792|NCT02362425|470794752|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
130772793|NCT02362425|470794749|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
130772794|NCT02362425|470794750|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
130772795|NCT02362425|470794751|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
130772796|NCT02362425|470794752|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
130772797|NCT00802672|470794759|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
130772798|NCT00802672|470794760|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
130772799|NCT00802672|470794761|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
130772800|NCT00802672|470794759|FG000|Overall Study|Adverse Event|1|||
130772801|NCT00802672|470794760|FG001|Overall Study|Adverse Event|1|||
130772802|NCT00802672|470794761|FG002|Overall Study|Adverse Event|1|||
130772803|NCT00802672|470794759|FG000|Overall Study|Protocol Violation|2|||
130772804|NCT00802672|470794760|FG001|Overall Study|Protocol Violation|1|||
130772805|NCT00802672|470794761|FG002|Overall Study|Protocol Violation|1|||
130772806|NCT00802672|470794759|FG000|Overall Study|Lost to Follow-up|5|||
130772807|NCT00802672|470794760|FG001|Overall Study|Lost to Follow-up|5|||
130772808|NCT00802672|470794761|FG002|Overall Study|Lost to Follow-up|3|||
130772809|NCT00802672|470794759|FG000|Overall Study|Withdrawal by Subject|1|||
130772810|NCT00802672|470794760|FG001|Overall Study|Withdrawal by Subject|1|||
130772811|NCT00802672|470794761|FG002|Overall Study|Withdrawal by Subject|2|||
130772812|NCT00802672|470794759|FG000|Overall Study|other|3|||
130772813|NCT00802672|470794760|FG001|Overall Study|other|1|||
130772814|NCT00802672|470794761|FG002|Overall Study|other|2|||
130772815|NCT01616758|470794763|FG000|Overall Study|Adverse Event|1|||
130772816|NCT01616758|470794763|FG000|Overall Study|Withdrawal by Subject|2|||
130772817|NCT01616758|470794763|FG000|Overall Study|Disease progression|18|||
131224478|NCT01027884|472448905|FG000|Overall Study|Non-compliance|1|||
130772818|NCT01616758|470794763|FG000|Overall Study|Study termination by Sponsor|1|||
130772819|NCT03026283|470794764|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
130772820|NCT03026283|470794765|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
131045842|NCT03582033|471802279|FG001|Part C|Withdrawal by Subject|0|||
131224479|NCT01027884|472448906|FG001|Overall Study|Non-compliance|1|||
130772821|NCT03026283|470794766|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
130772822|NCT03026283|470794767|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
130772823|NCT03026283|470794768|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
130772824|NCT03026283|470794769|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
130772825|NCT03026283|470794770|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
130943728|NCT00624052|471428248|FG000|Overall Study|Changed job/ran out if meds|0|||
130943729|NCT00624052|471428249|FG001|Overall Study|Changed job/ran out if meds|2|||
130943730|NCT00624052|471428250|FG002|Overall Study|Changed job/ran out if meds|0|||
130943731|NCT00624052|471428251|FG003|Overall Study|Changed job/ran out if meds|0|||
130943732|NCT00281684|471428252|FG000|Overall Study|Lost to Follow-up|0|||
130943733|NCT00281684|471428253|FG001|Overall Study|Lost to Follow-up|0|||
130943734|NCT00281684|471428254|FG002|Overall Study|Lost to Follow-up|1|||
130943735|NCT00281684|471428255|FG003|Overall Study|Lost to Follow-up|0|||
130943736|NCT00281684|471428252|FG000|Overall Study|Withdrawal by Subject|1|||
130943737|NCT00281684|471428253|FG001|Overall Study|Withdrawal by Subject|0|||
130943738|NCT00281684|471428254|FG002|Overall Study|Withdrawal by Subject|0|||
130943739|NCT00281684|471428255|FG003|Overall Study|Withdrawal by Subject|0|||
130943740|NCT00698581|471428258|FG000|Overall Study|Lack of Efficacy|23|||
130943741|NCT00698581|471428259|FG001|Overall Study|Lack of Efficacy|11|||
130943742|NCT00698581|471428258|FG000|Overall Study|Withdrawal by Subject|6|||
130943743|NCT00698581|471428259|FG001|Overall Study|Withdrawal by Subject|0|||
130943744|NCT00698581|471428258|FG000|Overall Study|Other reason|9|||
130943745|NCT00698581|471428259|FG001|Overall Study|Other reason|1|||
130943746|NCT00698581|471428258|FG000|Overall Study|SAE, non-fatal|1|||
130943747|NCT00698581|471428259|FG001|Overall Study|SAE, non-fatal|0|||
130943748|NCT00698581|471428258|FG000|Overall Study|AE, non-serious non-fatal|4|||
130943749|NCT00698581|471428259|FG001|Overall Study|AE, non-serious non-fatal|0|||
130943750|NCT00698581|471428258|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130943751|NCT00698581|471428259|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130943752|NCT00698581|471428258|FG000|Overall Study|AE of unknown type|1|||
130943753|NCT00698581|471428259|FG001|Overall Study|AE of unknown type|0|||
130943754|NCT03642717|471428260|FG000|Overall Study|Lost to Follow-up|2|||
130943755|NCT03642717|471428260|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
130943756|NCT03642717|471428260|FG000|Overall Study|Taken study drug prior to contract date|3|||
130943757|NCT00302458|471428261|FG000|Overall Study|Lost to Follow-up|1|||
130943758|NCT00302458|471428261|FG000|Overall Study|Ineligible after screening|1|||
130943759|NCT00302458|471428261|FG000|Overall Study|Withdrawal by Subject|1|||
130943760|NCT01531387|471428262|FG000|Overall Study|Early termination of study|11|||
130943761|NCT01531387|471428263|FG001|Overall Study|Early termination of study|11|||
130943762|NCT02642432|471428264|FG000|Overall Study|Adverse Event|2|||
130943763|NCT02642432|471428264|FG000|Overall Study|Withdrew Consent|1|||
130943764|NCT02642432|471428264|FG000|Overall Study|Lost to Follow-up|2|||
130943765|NCT02642432|471428264|FG000|Overall Study|Other|3|||
130943766|NCT03245008|471428265|FG000|Overall Study|Adverse Event|15|||
130943767|NCT03245008|471428266|FG001|Overall Study|Adverse Event|18|||
130943768|NCT03245008|471428267|FG002|Overall Study|Adverse Event|15|||
130943769|NCT03245008|471428268|FG003|Overall Study|Adverse Event|0|||
130943770|NCT03245008|471428269|FG004|Overall Study|Adverse Event|1|||
130943771|NCT03245008|471428265|FG000|Overall Study|Lack of Efficacy|0|||
130943772|NCT03245008|471428266|FG001|Overall Study|Lack of Efficacy|1|||
130943773|NCT03245008|471428267|FG002|Overall Study|Lack of Efficacy|0|||
130943774|NCT03245008|471428268|FG003|Overall Study|Lack of Efficacy|0|||
130943775|NCT03245008|471428269|FG004|Overall Study|Lack of Efficacy|0|||
130943776|NCT03245008|471428265|FG000|Overall Study|Lost to Follow-up|4|||
130943777|NCT03245008|471428266|FG001|Overall Study|Lost to Follow-up|1|||
130943778|NCT03245008|471428267|FG002|Overall Study|Lost to Follow-up|0|||
130943779|NCT03245008|471428268|FG003|Overall Study|Lost to Follow-up|0|||
130943780|NCT03245008|471428269|FG004|Overall Study|Lost to Follow-up|1|||
130943781|NCT03245008|471428265|FG000|Overall Study|Physician Decision|1|||
130943782|NCT03245008|471428266|FG001|Overall Study|Physician Decision|3|||
130943783|NCT03245008|471428267|FG002|Overall Study|Physician Decision|4|||
130943784|NCT03245008|471428268|FG003|Overall Study|Physician Decision|0|||
130943785|NCT03245008|471428269|FG004|Overall Study|Physician Decision|0|||
130943786|NCT03245008|471428265|FG000|Overall Study|Protocol Violation|0|||
130943787|NCT03245008|471428266|FG001|Overall Study|Protocol Violation|1|||
130943788|NCT03245008|471428267|FG002|Overall Study|Protocol Violation|0|||
130943789|NCT03245008|471428268|FG003|Overall Study|Protocol Violation|0|||
130943790|NCT03245008|471428269|FG004|Overall Study|Protocol Violation|0|||
130943791|NCT03245008|471428265|FG000|Overall Study|Withdrawal by Subject|20|||
130943792|NCT03245008|471428266|FG001|Overall Study|Withdrawal by Subject|19|||
131123936|NCT00404820|472082877|FG001|Overall Study|Other|2|||
131123937|NCT00516048|472082882|FG000|Overall Study|Death|0|||
130943793|NCT03245008|471428267|FG002|Overall Study|Withdrawal by Subject|11|||
130943794|NCT03245008|471428268|FG003|Overall Study|Withdrawal by Subject|0|||
130943795|NCT03245008|471428269|FG004|Overall Study|Withdrawal by Subject|0|||
130943796|NCT03245008|471428265|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
130943797|NCT03245008|471428266|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
130709267|NCT02516410|470562304|FG000|Overall Study|Adverse Event|0|||
130709268|NCT02516410|470562305|FG001|Overall Study|Adverse Event|1|||
130709269|NCT02516410|470562304|FG000|Overall Study|Withdrawal by Subject|0|||
130709270|NCT02516410|470562305|FG001|Overall Study|Withdrawal by Subject|1|||
130709271|NCT01432574|470562306|FG000|Overall Study|Moved|2|||
130709272|NCT01432574|470562306|FG000|Overall Study|Not interested|1|||
130709273|NCT04146363|470562312|FG000|Induction Period|Adverse Event|1|||
130709274|NCT04146363|470562313|FG001|Induction Period|Adverse Event|2|||
131036822|NCT05329220|471768253|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
130709275|NCT04146363|470562314|FG002|Induction Period|Adverse Event|0|||
130709276|NCT04146363|470562315|FG003|Induction Period|Adverse Event|0|||
130709277|NCT04146363|470562316|FG004|Induction Period|Adverse Event|0|||
130709278|NCT04146363|470562317|FG005|Induction Period|Adverse Event|0|||
130709279|NCT04146363|470562318|FG006|Induction Period|Adverse Event|0|||
130709280|NCT04146363|470562319|FG007|Induction Period|Adverse Event|0|||
130709281|NCT04146363|470562320|FG008|Induction Period|Adverse Event|0|||
130709282|NCT04146363|470562321|FG009|Induction Period|Adverse Event|0|||
130709283|NCT04146363|470562322|FG010|Induction Period|Adverse Event|0|||
130709284|NCT04146363|470562312|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
130709285|NCT04146363|470562313|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
130709286|NCT04146363|470562314|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
130709287|NCT04146363|470562315|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
130709288|NCT04146363|470562316|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
130709289|NCT04146363|470562317|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
130709290|NCT04146363|470562318|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
130709291|NCT04146363|470562319|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
130709292|NCT04146363|470562320|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
130709293|NCT04146363|470562321|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
130709294|NCT04146363|470562322|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
131036823|NCT05329220|471768254|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
131036824|NCT05329220|471768255|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
131036825|NCT05329220|471768256|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
131036826|NCT05329220|471768257|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
131036827|NCT05329220|471768258|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
131036828|NCT05329220|471768253|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
131036829|NCT05329220|471768254|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
131036830|NCT05329220|471768255|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
131036831|NCT05329220|471768256|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
131036832|NCT05329220|471768257|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
131036833|NCT05329220|471768258|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
131036834|NCT05329220|471768253|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
131036835|NCT05329220|471768254|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
131036836|NCT05329220|471768255|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
131036837|NCT05329220|471768256|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
131036838|NCT05329220|471768257|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
131036839|NCT05329220|471768258|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
131036840|NCT05329220|471768253|FG000|Follow-up Period|EARLY TERMINATION|0|||
131036841|NCT05329220|471768254|FG001|Follow-up Period|EARLY TERMINATION|0|||
131036842|NCT05329220|471768255|FG002|Follow-up Period|EARLY TERMINATION|0|||
131036843|NCT05329220|471768256|FG003|Follow-up Period|EARLY TERMINATION|0|||
131036844|NCT05329220|471768257|FG004|Follow-up Period|EARLY TERMINATION|0|||
131036845|NCT05329220|471768258|FG005|Follow-up Period|EARLY TERMINATION|1|||
131036846|NCT05329220|471768253|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
131036847|NCT05329220|471768254|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
131036848|NCT05329220|471768255|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
131036849|NCT05329220|471768256|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
131036850|NCT05329220|471768257|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
131036851|NCT05329220|471768258|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
131036852|NCT05329220|471768253|FG000|Follow-up Period|DROPPED|0|||
131036853|NCT05329220|471768254|FG001|Follow-up Period|DROPPED|0|||
131036854|NCT05329220|471768255|FG002|Follow-up Period|DROPPED|0|||
131036855|NCT05329220|471768256|FG003|Follow-up Period|DROPPED|0|||
131036856|NCT05329220|471768257|FG004|Follow-up Period|DROPPED|0|||
131036857|NCT05329220|471768258|FG005|Follow-up Period|DROPPED|1|||
131123938|NCT00516048|472082883|FG001|Overall Study|Death|0|||
130709295|NCT04146363|470562312|FG000|Induction Period|Lack of Efficacy|7|||
130709296|NCT04146363|470562313|FG001|Induction Period|Lack of Efficacy|2|||
130709297|NCT04146363|470562314|FG002|Induction Period|Lack of Efficacy|0|||
130709298|NCT04146363|470562315|FG003|Induction Period|Lack of Efficacy|0|||
130709299|NCT04146363|470562316|FG004|Induction Period|Lack of Efficacy|0|||
130709300|NCT04146363|470562317|FG005|Induction Period|Lack of Efficacy|0|||
130772826|NCT03026283|470794771|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
130772827|NCT03026283|470794764|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
130772828|NCT03026283|470794765|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
130772829|NCT03026283|470794766|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
130772830|NCT03026283|470794767|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
130772831|NCT03026283|470794768|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
130772832|NCT03026283|470794769|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
130772833|NCT03026283|470794770|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
130772834|NCT03026283|470794771|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
130772835|NCT03026283|470794764|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130772836|NCT03026283|470794765|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
130772837|NCT03026283|470794766|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130772838|NCT03026283|470794767|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130772839|NCT03026283|470794768|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130772840|NCT03026283|470794769|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130772841|NCT03026283|470794770|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130772842|NCT03026283|470794771|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130772843|NCT03026283|470794764|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130772844|NCT03026283|470794765|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130772845|NCT03026283|470794766|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
130772846|NCT03026283|470794767|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130772847|NCT03026283|470794768|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130772848|NCT03026283|470794769|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130772849|NCT03026283|470794770|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130772850|NCT03026283|470794771|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130772851|NCT03026283|470794764|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130772852|NCT03026283|470794765|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130772853|NCT03026283|470794766|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130772854|NCT03026283|470794767|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
130772855|NCT03026283|470794768|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
130772856|NCT03026283|470794769|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130772857|NCT03026283|470794770|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130772858|NCT03026283|470794771|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130772859|NCT03026283|470794764|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130772860|NCT03026283|470794765|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130772861|NCT03026283|470794766|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130772862|NCT03026283|470794767|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
130772863|NCT03026283|470794768|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
130772864|NCT03026283|470794769|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
130772865|NCT03026283|470794770|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130772866|NCT03026283|470794771|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130772867|NCT03026283|470794764|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130772868|NCT03026283|470794765|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130772869|NCT03026283|470794766|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130772870|NCT03026283|470794767|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
130772871|NCT03026283|470794768|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130772872|NCT03026283|470794769|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
130772873|NCT03026283|470794770|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130772874|NCT03026283|470794771|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130772875|NCT03026283|470794764|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130772876|NCT03026283|470794765|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130772877|NCT03026283|470794766|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130772878|NCT03026283|470794767|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
130943798|NCT03245008|471428267|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
130943799|NCT03245008|471428268|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
130943800|NCT03245008|471428269|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
130943801|NCT03245008|471428265|FG000|Overall Study|Failure to meet randomization criteria|0|||
130943802|NCT03245008|471428266|FG001|Overall Study|Failure to meet randomization criteria|1|||
130943803|NCT03245008|471428267|FG002|Overall Study|Failure to meet randomization criteria|0|||
130943804|NCT03245008|471428268|FG003|Overall Study|Failure to meet randomization criteria|1|||
130943805|NCT03245008|471428269|FG004|Overall Study|Failure to meet randomization criteria|0|||
130943806|NCT01286012|471428270|FG000|Overall Study|Adverse Event|3|||
130943807|NCT01286012|471428271|FG001|Overall Study|Adverse Event|3|||
131123939|NCT00516048|472082884|FG002|Overall Study|Death|1|||
131123940|NCT00516048|472082882|FG000|Overall Study|Subject Decision|0|||
131123941|NCT00516048|472082883|FG001|Overall Study|Subject Decision|2|||
131123942|NCT00516048|472082884|FG002|Overall Study|Subject Decision|0|||
130709301|NCT04146363|470562318|FG006|Induction Period|Lack of Efficacy|0|||
130709302|NCT04146363|470562319|FG007|Induction Period|Lack of Efficacy|0|||
130709303|NCT04146363|470562320|FG008|Induction Period|Lack of Efficacy|0|||
130709304|NCT04146363|470562321|FG009|Induction Period|Lack of Efficacy|0|||
130709305|NCT04146363|470562322|FG010|Induction Period|Lack of Efficacy|0|||
130709306|NCT04146363|470562312|FG000|Induction Period|Lost to Follow-up|1|||
130709307|NCT04146363|470562313|FG001|Induction Period|Lost to Follow-up|4|||
130709308|NCT04146363|470562314|FG002|Induction Period|Lost to Follow-up|0|||
130709309|NCT04146363|470562315|FG003|Induction Period|Lost to Follow-up|0|||
130709310|NCT04146363|470562316|FG004|Induction Period|Lost to Follow-up|0|||
130709311|NCT04146363|470562317|FG005|Induction Period|Lost to Follow-up|0|||
130709312|NCT04146363|470562318|FG006|Induction Period|Lost to Follow-up|0|||
130709313|NCT04146363|470562319|FG007|Induction Period|Lost to Follow-up|0|||
130709314|NCT04146363|470562320|FG008|Induction Period|Lost to Follow-up|0|||
130709315|NCT04146363|470562321|FG009|Induction Period|Lost to Follow-up|0|||
130709316|NCT04146363|470562322|FG010|Induction Period|Lost to Follow-up|0|||
130709317|NCT04146363|470562312|FG000|Induction Period|Positive quantiferon test|0|||
130709318|NCT04146363|470562313|FG001|Induction Period|Positive quantiferon test|1|||
130709319|NCT04146363|470562314|FG002|Induction Period|Positive quantiferon test|0|||
130709320|NCT04146363|470562315|FG003|Induction Period|Positive quantiferon test|0|||
130709321|NCT04146363|470562316|FG004|Induction Period|Positive quantiferon test|0|||
130709322|NCT04146363|470562317|FG005|Induction Period|Positive quantiferon test|0|||
130709323|NCT04146363|470562318|FG006|Induction Period|Positive quantiferon test|0|||
130709324|NCT04146363|470562319|FG007|Induction Period|Positive quantiferon test|0|||
130709325|NCT04146363|470562320|FG008|Induction Period|Positive quantiferon test|0|||
130709326|NCT04146363|470562321|FG009|Induction Period|Positive quantiferon test|0|||
130709327|NCT04146363|470562322|FG010|Induction Period|Positive quantiferon test|0|||
130709328|NCT04146363|470562312|FG000|Induction Period|Protocol Deviation|5|||
130709329|NCT04146363|470562313|FG001|Induction Period|Protocol Deviation|6|||
130709330|NCT04146363|470562314|FG002|Induction Period|Protocol Deviation|0|||
130709331|NCT04146363|470562315|FG003|Induction Period|Protocol Deviation|0|||
130709332|NCT04146363|470562316|FG004|Induction Period|Protocol Deviation|0|||
130709333|NCT04146363|470562317|FG005|Induction Period|Protocol Deviation|0|||
130709334|NCT04146363|470562318|FG006|Induction Period|Protocol Deviation|0|||
130709335|NCT04146363|470562319|FG007|Induction Period|Protocol Deviation|0|||
130709336|NCT04146363|470562320|FG008|Induction Period|Protocol Deviation|0|||
130709337|NCT04146363|470562321|FG009|Induction Period|Protocol Deviation|0|||
130709338|NCT04146363|470562322|FG010|Induction Period|Protocol Deviation|0|||
130709339|NCT04146363|470562312|FG000|Induction Period|Withdrawal by Subject|6|||
130709340|NCT04146363|470562313|FG001|Induction Period|Withdrawal by Subject|3|||
130709341|NCT04146363|470562314|FG002|Induction Period|Withdrawal by Subject|0|||
130709342|NCT04146363|470562315|FG003|Induction Period|Withdrawal by Subject|0|||
130709343|NCT04146363|470562316|FG004|Induction Period|Withdrawal by Subject|0|||
130709344|NCT04146363|470562317|FG005|Induction Period|Withdrawal by Subject|0|||
130709345|NCT04146363|470562318|FG006|Induction Period|Withdrawal by Subject|0|||
130709346|NCT04146363|470562319|FG007|Induction Period|Withdrawal by Subject|0|||
130709347|NCT04146363|470562320|FG008|Induction Period|Withdrawal by Subject|0|||
130709348|NCT04146363|470562321|FG009|Induction Period|Withdrawal by Subject|0|||
130709349|NCT04146363|470562322|FG010|Induction Period|Withdrawal by Subject|0|||
130709350|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709351|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709352|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709353|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709354|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709355|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709356|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
130709357|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
130709358|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709359|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709360|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
130709361|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709362|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709363|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709364|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709365|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709366|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709367|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709368|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
130709369|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709370|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130943808|NCT01286012|471428270|FG000|Overall Study|Death|2|||
130709371|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130709372|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709373|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709374|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709375|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709376|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709377|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709378|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
130709379|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
130709380|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709381|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130709382|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130772879|NCT03026283|470794768|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130772880|NCT03026283|470794769|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130772881|NCT03026283|470794770|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130772882|NCT03026283|470794771|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130772883|NCT03026283|470794764|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130772884|NCT03026283|470794765|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130772885|NCT03026283|470794766|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130772886|NCT03026283|470794767|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130772887|NCT03026283|470794768|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
130772888|NCT03026283|470794769|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
130772889|NCT03026283|470794770|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130772890|NCT03026283|470794771|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130772891|NCT04076319|470794776|FG000|Overall Study|Withdrawal by Subject|2|||
130772892|NCT04076319|470794777|FG001|Overall Study|Withdrawal by Subject|0|||
130772893|NCT04076319|470794776|FG000|Overall Study|Death|1|||
130772894|NCT04076319|470794777|FG001|Overall Study|Death|0|||
130772895|NCT01054222|470794778|FG000|Overall Study|Lack of Efficacy|1|||
130772896|NCT01054222|470794778|FG000|Overall Study|Lost to Follow-up|4|||
130772897|NCT01054222|470794778|FG000|Overall Study|Withdrawal by Subject|6|||
130772898|NCT03782571|470794779|FG000|Period 1|Withdrawal by Subject|1|||
130772899|NCT03782571|470794780|FG001|Period 1|Withdrawal by Subject|0|||
130772900|NCT03782571|470794781|FG002|Period 1|Withdrawal by Subject|0|||
130772901|NCT03782571|470794782|FG003|Period 1|Withdrawal by Subject|0|||
130772902|NCT03782571|470794779|FG000|Period 3|Subject Unable to Attend V5|1|||
130772903|NCT03782571|470794780|FG001|Period 3|Subject Unable to Attend V5|0|||
130772904|NCT03782571|470794781|FG002|Period 3|Subject Unable to Attend V5|0|||
130772905|NCT03782571|470794782|FG003|Period 3|Subject Unable to Attend V5|0|||
130772906|NCT03782571|470794779|FG000|Period 3|Adverse Event|1|||
130772907|NCT03782571|470794780|FG001|Period 3|Adverse Event|0|||
130772908|NCT03782571|470794781|FG002|Period 3|Adverse Event|0|||
130772909|NCT03782571|470794782|FG003|Period 3|Adverse Event|0|||
130772910|NCT03091738|470794783|FG000|Overall Study|Adverse Event|1|||
130772911|NCT03091738|470794783|FG000|Overall Study|Lost to Follow-up|1|||
130772912|NCT02090283|470794793|FG000|Overall Study|Withdrawal by Subject|6|||
130772913|NCT02090283|470794794|FG001|Overall Study|Withdrawal by Subject|6|||
130772914|NCT02090283|470794795|FG002|Overall Study|Withdrawal by Subject|6|||
130772915|NCT02090283|470794793|FG000|Overall Study|Sponsor Terminated Study|6|||
130772916|NCT02090283|470794794|FG001|Overall Study|Sponsor Terminated Study|6|||
130772917|NCT02090283|470794795|FG002|Overall Study|Sponsor Terminated Study|1|||
130772918|NCT02090283|470794793|FG000|Overall Study|Lost to Follow-up|2|||
130772919|NCT02090283|470794794|FG001|Overall Study|Lost to Follow-up|2|||
130772920|NCT02090283|470794795|FG002|Overall Study|Lost to Follow-up|3|||
131036858|NCT05329220|471768253|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
131036859|NCT05329220|471768254|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
131036860|NCT05329220|471768255|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
131036861|NCT05329220|471768256|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
131036862|NCT05329220|471768257|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
131036863|NCT05329220|471768258|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
131036864|NCT03322267|471768259|FG000|Overall Study|Lack of Efficacy|11|||
131036865|NCT03322267|471768259|FG000|Overall Study|Adverse Event|1|||
131036866|NCT03322267|471768259|FG000|Overall Study|Withdrawal by Subject|2|||
131036867|NCT03852472|471768263|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
131036868|NCT03852472|471768264|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
131036869|NCT03852472|471768265|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
131036870|NCT03852472|471768266|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
130772921|NCT02090283|470794793|FG000|Overall Study|Adverse Event|1|||
131036871|NCT03852472|471768267|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
131036872|NCT03852472|471768263|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
130943809|NCT01286012|471428271|FG001|Overall Study|Death|3|||
130709383|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709384|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709385|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
130709386|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709387|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709388|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
130709389|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
130943810|NCT01286012|471428270|FG000|Overall Study|Protocol Violation|1|||
131123943|NCT00054704|472082887|FG000|Overall Study|Lack of Efficacy|2|||
131123944|NCT00054704|472082888|FG001|Overall Study|Lack of Efficacy|3|||
131123945|NCT00054704|472082887|FG000|Overall Study|Adverse Event|3|||
131123946|NCT00054704|472082888|FG001|Overall Study|Adverse Event|1|||
131123947|NCT00054704|472082887|FG000|Overall Study|Lost to Follow-up|0|||
131123948|NCT00054704|472082888|FG001|Overall Study|Lost to Follow-up|1|||
131123949|NCT00362414|472082889|FG000|Overall Study|Death|2|||
131123950|NCT00362414|472082889|FG000|Overall Study|Adverse Event|1|||
131123951|NCT01469182|472082892|FG000|Overall Study|Adverse Event|21|||
131123952|NCT01469182|472082893|FG001|Overall Study|Adverse Event|3|||
131123953|NCT01469182|472082892|FG000|Overall Study|Lost to Follow-up|3|||
131123954|NCT01469182|472082893|FG001|Overall Study|Lost to Follow-up|0|||
131123955|NCT01469182|472082892|FG000|Overall Study|Withdrawal by Subject|4|||
131123956|NCT01469182|472082893|FG001|Overall Study|Withdrawal by Subject|1|||
131123957|NCT01469182|472082892|FG000|Overall Study|Protocol Violation|4|||
130709390|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709391|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709392|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709393|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
130709394|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709395|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709396|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709397|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709398|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
130709399|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
130709400|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
130709401|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
130709402|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709403|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709404|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130709405|NCT04146363|470562312|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709406|NCT04146363|470562313|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709407|NCT04146363|470562314|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
130709408|NCT04146363|470562315|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709409|NCT04146363|470562316|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709410|NCT04146363|470562317|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
130709411|NCT04146363|470562318|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
130709412|NCT04146363|470562319|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
130709413|NCT04146363|470562320|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709414|NCT04146363|470562321|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709415|NCT04146363|470562322|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130709416|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709417|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709418|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709419|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709420|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709421|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709422|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709423|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709424|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
130709425|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
130709426|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
130709427|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709428|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130943811|NCT01286012|471428271|FG001|Overall Study|Protocol Violation|1|||
131123958|NCT01469182|472082893|FG001|Overall Study|Protocol Violation|2|||
131123959|NCT01469182|472082892|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
131123960|NCT01469182|472082893|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
131123961|NCT02053168|472082894|FG000|Overall Study|Withdrawal by Subject|1|||
131123962|NCT02053168|472082894|FG000|Overall Study|Physician Decision|1|||
131123963|NCT02053168|472082894|FG000|Overall Study|Lost to Follow-up|1|||
131123964|NCT02687542|472082895|FG000|Overall Study|Medication error without associated AEs|0|||
131123965|NCT02687542|472082896|FG001|Overall Study|Medication error without associated AEs|0|||
131123966|NCT02687542|472082897|FG002|Overall Study|Medication error without associated AEs|0|||
131123967|NCT02687542|472082898|FG003|Overall Study|Medication error without associated AEs|0|||
131123968|NCT02687542|472082899|FG004|Overall Study|Medication error without associated AEs|1|||
131123969|NCT02687542|472082895|FG000|Overall Study|Lost to Follow-up|0|||
131123970|NCT02687542|472082896|FG001|Overall Study|Lost to Follow-up|0|||
131123971|NCT02687542|472082897|FG002|Overall Study|Lost to Follow-up|0|||
131123972|NCT02687542|472082898|FG003|Overall Study|Lost to Follow-up|0|||
131123973|NCT02687542|472082899|FG004|Overall Study|Lost to Follow-up|1|||
131123974|NCT02687542|472082895|FG000|Overall Study|Protocol Violation|0|||
131123975|NCT02687542|472082896|FG001|Overall Study|Protocol Violation|1|||
131123976|NCT02687542|472082897|FG002|Overall Study|Protocol Violation|0|||
131123977|NCT02687542|472082898|FG003|Overall Study|Protocol Violation|0|||
131123978|NCT02687542|472082899|FG004|Overall Study|Protocol Violation|0|||
131123979|NCT02687542|472082895|FG000|Overall Study|Other|5|||
131123980|NCT02687542|472082896|FG001|Overall Study|Other|9|||
131123981|NCT02687542|472082897|FG002|Overall Study|Other|10|||
131123982|NCT02687542|472082898|FG003|Overall Study|Other|6|||
131123983|NCT02687542|472082899|FG004|Overall Study|Other|5|||
131123984|NCT02687542|472082895|FG000|Overall Study|Adverse Event|3|||
131123985|NCT02687542|472082896|FG001|Overall Study|Adverse Event|1|||
131123986|NCT02687542|472082897|FG002|Overall Study|Adverse Event|3|||
131123987|NCT02687542|472082898|FG003|Overall Study|Adverse Event|2|||
131123988|NCT02687542|472082899|FG004|Overall Study|Adverse Event|9|||
131123989|NCT02687542|472082895|FG000|Overall Study|Withdrawal by Subject|0|||
131123990|NCT02687542|472082896|FG001|Overall Study|Withdrawal by Subject|1|||
131123991|NCT02687542|472082897|FG002|Overall Study|Withdrawal by Subject|1|||
130709429|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709430|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709431|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709432|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709433|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709434|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130709435|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
130709436|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
130709437|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
130709438|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709439|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709440|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709441|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709442|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709443|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709444|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709445|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709446|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
130709447|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
130709448|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130709449|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709450|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709451|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709452|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709453|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709454|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709455|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709456|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709457|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
130709458|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
130709459|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
130709460|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709461|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709462|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709463|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709464|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709465|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709466|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130709467|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131123992|NCT02687542|472082898|FG003|Overall Study|Withdrawal by Subject|2|||
131123993|NCT02687542|472082899|FG004|Overall Study|Withdrawal by Subject|4|||
131123994|NCT01838616|472082900|FG000|Titration Period|Adverse Event|18|||
131123995|NCT01838616|472082901|FG001|Titration Period|Adverse Event|48|||
130709468|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
130709469|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
130709470|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
130709471|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709472|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709473|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709474|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709475|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709476|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709477|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709478|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709479|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709480|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
130709481|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
130709482|NCT04146363|470562312|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709483|NCT04146363|470562313|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709484|NCT04146363|470562314|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709485|NCT04146363|470562315|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709486|NCT04146363|470562316|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709487|NCT04146363|470562317|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709488|NCT04146363|470562318|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709489|NCT04146363|470562319|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709490|NCT04146363|470562320|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709491|NCT04146363|470562321|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
130709492|NCT04146363|470562322|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130709493|NCT02914236|470562324|FG000|Overall Study|Lost to Follow-up|1|||
130709494|NCT02148913|470562329|FG000|Overall Study|Death|0|||
130709495|NCT02148913|470562330|FG001|Overall Study|Death|1|||
130709496|NCT02148913|470562331|FG002|Overall Study|Death|0|||
130709497|NCT02148913|470562332|FG003|Overall Study|Death|0|||
130709498|NCT00918463|470562336|FG000|Overall Study|Death|1|||
130709499|NCT00918463|470562336|FG000|Overall Study|Lack of Efficacy|1|||
130709500|NCT01014624|470562341|FG000|Overall Study|Adverse Event|0|||
130709501|NCT01014624|470562342|FG001|Overall Study|Adverse Event|1|||
130709502|NCT01014624|470562341|FG000|Overall Study|Protocol Violation|1|||
130709503|NCT01014624|470562342|FG001|Overall Study|Protocol Violation|0|||
130709504|NCT01014624|470562341|FG000|Overall Study|Withdrawal by Subject|1|||
130709505|NCT01014624|470562342|FG001|Overall Study|Withdrawal by Subject|0|||
130709506|NCT02954159|470562344|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
130709507|NCT02954159|470562345|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
130709508|NCT02954159|470562344|FG000|Overall Study|Withdrawal by Subject|0|||
130709509|NCT02954159|470562345|FG001|Overall Study|Withdrawal by Subject|1|||
130709510|NCT01117337|470562350|FG000|Overall Study|Lost to Follow-up|4|||
130709511|NCT01117337|470562351|FG001|Overall Study|Lost to Follow-up|0|||
130709512|NCT03575871|470562352|FG000|Overall Study|Adverse Event|5|||
130709513|NCT03575871|470562353|FG001|Overall Study|Adverse Event|5|||
130709514|NCT03575871|470562354|FG002|Overall Study|Adverse Event|8|||
131036873|NCT03852472|471768264|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
131036874|NCT03852472|471768265|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
131036875|NCT03852472|471768266|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
131036876|NCT03852472|471768267|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
131036877|NCT03852472|471768263|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
131036878|NCT03852472|471768264|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
131036879|NCT03852472|471768265|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
131036880|NCT03852472|471768266|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
131036881|NCT03852472|471768267|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
131036882|NCT03852472|471768263|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
131036883|NCT03852472|471768264|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
131036884|NCT03852472|471768265|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
131036885|NCT03852472|471768266|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
131036886|NCT03852472|471768267|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
131036887|NCT03852472|471768263|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
131036888|NCT03852472|471768264|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
131036889|NCT03852472|471768265|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
131036890|NCT03852472|471768266|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
131036891|NCT03852472|471768267|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
131036892|NCT03852472|471768263|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
131036893|NCT03852472|471768264|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
131036894|NCT03852472|471768265|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
130709515|NCT03575871|470562352|FG000|Overall Study|Death|1|||
131224480|NCT01027884|472448905|FG000|Overall Study|Withdrawal by Subject|0|||
130772922|NCT02090283|470794794|FG001|Overall Study|Adverse Event|1|||
130772923|NCT02090283|470794795|FG002|Overall Study|Adverse Event|0|||
130772924|NCT02090283|470794793|FG000|Overall Study|Protocol Violation|2|||
130772925|NCT02090283|470794794|FG001|Overall Study|Protocol Violation|0|||
130772926|NCT02090283|470794795|FG002|Overall Study|Protocol Violation|0|||
130772927|NCT01411319|470794803|FG000|Overall Study|Lost to Follow-up|1|||
130772928|NCT02499263|470794804|FG000|Overall Study|Lost to Follow-up|9|||
130772929|NCT02499263|470794804|FG000|Overall Study|Participant's withdrawal of consent|4|||
130772930|NCT02499263|470794804|FG000|Overall Study|Lack of Efficacy|22|||
130772931|NCT02499263|470794804|FG000|Overall Study|investigator's judgment|12|||
130772932|NCT02499263|470794804|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
130772933|NCT02499263|470794804|FG000|Overall Study|Participant's decision|3|||
130772934|NCT02499263|470794804|FG000|Overall Study|Pregnancy|1|||
130772935|NCT01148459|470794823|FG000|Overall Study|Serious Adverse Event|5|||
130772936|NCT01148459|470794824|FG001|Overall Study|Serious Adverse Event|4|||
130772937|NCT01148459|470794823|FG000|Overall Study|Withdrawal by Subject|1|||
130772938|NCT01148459|470794824|FG001|Overall Study|Withdrawal by Subject|0|||
130772939|NCT01148459|470794823|FG000|Overall Study|Migrated/moved from study area|3|||
130772940|NCT01148459|470794824|FG001|Overall Study|Migrated/moved from study area|6|||
130772941|NCT01148459|470794823|FG000|Overall Study|Lost to Follow-up|2|||
130772942|NCT01148459|470794824|FG001|Overall Study|Lost to Follow-up|0|||
130772943|NCT01148459|470794823|FG000|Overall Study|Refusal|1|||
130772944|NCT01148459|470794824|FG001|Overall Study|Refusal|0|||
130772945|NCT01148459|470794823|FG000|Overall Study|Failure to comply with study procedures|0|||
130772946|NCT01148459|470794824|FG001|Overall Study|Failure to comply with study procedures|1|||
130772947|NCT00694356|470794825|FG000|Overall Study|Adverse Event|1|||
130772948|NCT00694356|470794826|FG001|Overall Study|Adverse Event|0|||
130772949|NCT00694356|470794827|FG002|Overall Study|Adverse Event|0|||
130772950|NCT00694356|470794825|FG000|Overall Study|Progressive Disease|2|||
130772951|NCT00694356|470794826|FG001|Overall Study|Progressive Disease|6|||
130772952|NCT00694356|470794827|FG002|Overall Study|Progressive Disease|6|||
130772953|NCT03224624|470794834|FG000|Overall Study|Lost to Follow-up|9|||
130772954|NCT03224624|470794835|FG001|Overall Study|Lost to Follow-up|4|||
130772955|NCT03224624|470794834|FG000|Overall Study|Death|1|||
130772956|NCT03224624|470794835|FG001|Overall Study|Death|0|||
130772957|NCT01884545|470794836|FG000|Overall Study|Lost to Follow-up|6|||
130772958|NCT01884545|470794837|FG001|Overall Study|Lost to Follow-up|4|||
130772959|NCT01884545|470794838|FG002|Overall Study|Lost to Follow-up|9|||
130772960|NCT01884545|470794839|FG003|Overall Study|Lost to Follow-up|4|||
130772961|NCT01884545|470794836|FG000|Overall Study|Patient withdrawn|7|||
130772962|NCT01884545|470794837|FG001|Overall Study|Patient withdrawn|12|||
130772963|NCT01884545|470794838|FG002|Overall Study|Patient withdrawn|5|||
130772964|NCT01884545|470794839|FG003|Overall Study|Patient withdrawn|5|||
130772965|NCT01884545|470794836|FG000|Overall Study|Non-adherence|0|||
130772966|NCT01884545|470794837|FG001|Overall Study|Non-adherence|2|||
130772967|NCT01884545|470794838|FG002|Overall Study|Non-adherence|0|||
130772968|NCT01884545|470794839|FG003|Overall Study|Non-adherence|0|||
130772969|NCT02782377|470794840|FG000|Overall Study|Physician Decision|5|||
130772970|NCT02521792|470794841|FG000|Overall Study|Study Terminated|6|||
130772971|NCT01188668|470794842|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
131224481|NCT01027884|472448906|FG001|Overall Study|Withdrawal by Subject|1|||
130772972|NCT01188668|470794842|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
130772973|NCT01188668|470794842|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
131036895|NCT03852472|471768266|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
131036896|NCT03852472|471768267|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
131036897|NCT03852472|471768263|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
131036898|NCT03852472|471768264|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
131036899|NCT03852472|471768265|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
131036900|NCT03852472|471768266|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
131036901|NCT03852472|471768267|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
131036902|NCT03852472|471768263|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
131036903|NCT03852472|471768264|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
131036904|NCT03852472|471768265|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
131036905|NCT03852472|471768266|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
131036906|NCT03852472|471768267|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
131224482|NCT01027884|472448905|FG000|Overall Study|Lost to Follow-up|0|||
131224483|NCT01027884|472448906|FG001|Overall Study|Lost to Follow-up|1|||
130772974|NCT00303472|470794843|FG000|Treatment Period|Adverse Event|0|||
130772975|NCT00303472|470794844|FG001|Treatment Period|Adverse Event|0|||
130772976|NCT00303472|470794845|FG002|Treatment Period|Adverse Event|0|||
130772977|NCT00303472|470794846|FG003|Treatment Period|Adverse Event|0|||
130772978|NCT00303472|470794847|FG004|Treatment Period|Adverse Event|1|||
130772979|NCT00303472|470794848|FG005|Treatment Period|Adverse Event|0|||
130772980|NCT00303472|470794849|FG006|Treatment Period|Adverse Event|0|||
130772981|NCT00303472|470794843|FG000|Treatment Period|Death|0|||
130772982|NCT00303472|470794844|FG001|Treatment Period|Death|0|||
130772983|NCT00303472|470794845|FG002|Treatment Period|Death|0|||
130772984|NCT00303472|470794846|FG003|Treatment Period|Death|1|||
130709516|NCT03575871|470562353|FG001|Overall Study|Death|0|||
130709517|NCT03575871|470562354|FG002|Overall Study|Death|0|||
130709518|NCT03575871|470562352|FG000|Overall Study|Lack of Efficacy|5|||
130709519|NCT03575871|470562353|FG001|Overall Study|Lack of Efficacy|4|||
130709520|NCT03575871|470562354|FG002|Overall Study|Lack of Efficacy|7|||
130709521|NCT03575871|470562352|FG000|Overall Study|Lost to Follow-up|1|||
130709522|NCT03575871|470562353|FG001|Overall Study|Lost to Follow-up|1|||
130709523|NCT03575871|470562354|FG002|Overall Study|Lost to Follow-up|1|||
130709524|NCT03575871|470562352|FG000|Overall Study|Protocol Deviation|1|||
130709525|NCT03575871|470562353|FG001|Overall Study|Protocol Deviation|1|||
130709526|NCT03575871|470562354|FG002|Overall Study|Protocol Deviation|1|||
130709527|NCT03575871|470562352|FG000|Overall Study|Withdrawal by Subject|6|||
130709528|NCT03575871|470562353|FG001|Overall Study|Withdrawal by Subject|1|||
130709529|NCT03575871|470562354|FG002|Overall Study|Withdrawal by Subject|9|||
130709530|NCT03575871|470562352|FG000|Overall Study|Other than specified|2|||
130709531|NCT03575871|470562353|FG001|Overall Study|Other than specified|2|||
130709532|NCT03575871|470562354|FG002|Overall Study|Other than specified|0|||
130709533|NCT01045993|470562355|FG000|Overall Study|Treated-later found eligibility not met|0|||
130709534|NCT01045993|470562356|FG001|Overall Study|Treated-later found eligibility not met|1|||
130709535|NCT01045993|470562357|FG002|Overall Study|Treated-later found eligibility not met|0|||
130709536|NCT01045993|470562358|FG003|Overall Study|Treated-later found eligibility not met|0|||
130709537|NCT05506358|470562359|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
130709538|NCT05506358|470562360|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130943812|NCT01286012|471428270|FG000|Overall Study|Withdrawal by Subject|4|||
130943813|NCT01286012|471428271|FG001|Overall Study|Withdrawal by Subject|4|||
130709539|NCT05506358|470562361|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130709540|NCT05506358|470562362|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130709541|NCT05506358|470562363|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130709542|NCT05506358|470562359|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
130709543|NCT05506358|470562360|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130709544|NCT05506358|470562361|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130709545|NCT05506358|470562362|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130709546|NCT05506358|470562363|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130709547|NCT05506358|470562359|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130709548|NCT05506358|470562360|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130709549|NCT05506358|470562361|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130709550|NCT05506358|470562362|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
130709551|NCT05506358|470562363|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130709552|NCT05506358|470562359|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
130709553|NCT05506358|470562360|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
130709554|NCT05506358|470562361|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
130709555|NCT05506358|470562362|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
130709556|NCT05506358|470562363|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
130709557|NCT05506358|470562359|FG000|Overall Study|HbE trait|0|||
130709558|NCT05506358|470562360|FG001|Overall Study|HbE trait|0|||
130709559|NCT05506358|470562361|FG002|Overall Study|HbE trait|0|||
130709560|NCT05506358|470562362|FG003|Overall Study|HbE trait|1|||
130709561|NCT05506358|470562363|FG004|Overall Study|HbE trait|0|||
130709562|NCT01659736|470562364|FG000|Treatment Period|Adverse Event|1|||
130709563|NCT01659736|470562365|FG001|Treatment Period|Adverse Event|1|||
130709564|NCT01659736|470562364|FG000|Treatment Period|Protocol Violation|3|||
130709565|NCT01659736|470562365|FG001|Treatment Period|Protocol Violation|1|||
130709566|NCT01659736|470562364|FG000|Treatment Period|Withdrawal by Subject|1|||
130709567|NCT01659736|470562365|FG001|Treatment Period|Withdrawal by Subject|0|||
130709568|NCT01659736|470562364|FG000|3-month Follow-up|Lost to Follow-up|0|||
130709569|NCT01659736|470562365|FG001|3-month Follow-up|Lost to Follow-up|1|||
130709570|NCT01173471|470562374|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130709571|NCT01173471|470562375|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130709572|NCT01173471|470562376|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130709573|NCT01173471|470562377|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130943814|NCT01286012|471428270|FG000|Overall Study|Physician Decision|2|||
130943815|NCT01286012|471428271|FG001|Overall Study|Physician Decision|0|||
130943816|NCT01286012|471428270|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
130943817|NCT01286012|471428271|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
130943818|NCT00663052|471428275|FG000|Overall Study|Adverse Event|6|||
130943819|NCT00663052|471428276|FG001|Overall Study|Adverse Event|3|||
130943820|NCT00663052|471428275|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
130709574|NCT01173471|470562374|FG000|Overall Study|Condition under investigation worsened|2|||
130709575|NCT01173471|470562375|FG001|Overall Study|Condition under investigation worsened|0|||
131045843|NCT03582033|471802280|FG002|Part C|Withdrawal by Subject|0|||
131123996|NCT01838616|472082900|FG000|Titration Period|Lack of Efficacy|5|||
131123997|NCT01838616|472082901|FG001|Titration Period|Lack of Efficacy|12|||
131123998|NCT01838616|472082900|FG000|Titration Period|Withdrawal by Subject|5|||
131123999|NCT01838616|472082901|FG001|Titration Period|Withdrawal by Subject|5|||
131124000|NCT01838616|472082900|FG000|Titration Period|Technical problems|1|||
131124001|NCT01838616|472082901|FG001|Titration Period|Technical problems|0|||
131124002|NCT01838616|472082900|FG000|Titration Period|Other|1|||
131124003|NCT01838616|472082901|FG001|Titration Period|Other|0|||
131124004|NCT01838616|472082900|FG000|Titration Period|Protocol Violation|0|||
131124005|NCT01838616|472082901|FG001|Titration Period|Protocol Violation|1|||
131124006|NCT01838616|472082900|FG000|Continuation Period|Lack of Efficacy|3|||
131124007|NCT01838616|472082901|FG001|Continuation Period|Lack of Efficacy|5|||
131224484|NCT01027884|472448905|FG000|Overall Study|Spinal fixation surgery|0|||
130709576|NCT01173471|470562376|FG002|Overall Study|Condition under investigation worsened|0|||
130709577|NCT01173471|470562377|FG003|Overall Study|Condition under investigation worsened|0|||
130709578|NCT01173471|470562374|FG000|Overall Study|Lost to Follow-up|0|||
130709579|NCT01173471|470562375|FG001|Overall Study|Lost to Follow-up|0|||
130709580|NCT01173471|470562376|FG002|Overall Study|Lost to Follow-up|1|||
130709581|NCT01173471|470562377|FG003|Overall Study|Lost to Follow-up|0|||
130709582|NCT01173471|470562374|FG000|Overall Study|Reason given as Other|0|||
130709583|NCT01173471|470562375|FG001|Overall Study|Reason given as Other|0|||
130709584|NCT01173471|470562376|FG002|Overall Study|Reason given as Other|1|||
130709585|NCT01173471|470562377|FG003|Overall Study|Reason given as Other|0|||
130709586|NCT00252174|470562378|FG000|Overall Study|Withdrawal by Subject|0|||
130709587|NCT00252174|470562379|FG001|Overall Study|Withdrawal by Subject|1|||
130709588|NCT00252174|470562380|FG002|Overall Study|Withdrawal by Subject|0|||
130709589|NCT00102687|470562382|FG000|Initial Period|Withdrawal by Subject|6|||
130709590|NCT00102687|470562383|FG001|Initial Period|Withdrawal by Subject|3|||
130709591|NCT00102687|470562384|FG002|Initial Period|Withdrawal by Subject|5|||
130709592|NCT00102687|470562385|FG003|Initial Period|Withdrawal by Subject|0|||
130709593|NCT00102687|470562386|FG004|Initial Period|Withdrawal by Subject|0|||
130709594|NCT00102687|470562382|FG000|Initial Period|Adverse Event|4|||
130709595|NCT00102687|470562383|FG001|Initial Period|Adverse Event|7|||
130709596|NCT00102687|470562384|FG002|Initial Period|Adverse Event|9|||
130709597|NCT00102687|470562385|FG003|Initial Period|Adverse Event|0|||
130709598|NCT00102687|470562386|FG004|Initial Period|Adverse Event|0|||
130709599|NCT00102687|470562382|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
130709600|NCT00102687|470562383|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
130709601|NCT00102687|470562384|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
130709602|NCT00102687|470562385|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
130709603|NCT00102687|470562386|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
130709604|NCT00102687|470562382|FG000|Initial Period|Protocol Violation|0|||
130709605|NCT00102687|470562383|FG001|Initial Period|Protocol Violation|0|||
130709606|NCT00102687|470562384|FG002|Initial Period|Protocol Violation|2|||
130709607|NCT00102687|470562385|FG003|Initial Period|Protocol Violation|0|||
130709608|NCT00102687|470562386|FG004|Initial Period|Protocol Violation|0|||
130709609|NCT00102687|470562382|FG000|Initial Period|Physician Decision|2|||
130709610|NCT00102687|470562383|FG001|Initial Period|Physician Decision|9|||
130709611|NCT00102687|470562384|FG002|Initial Period|Physician Decision|6|||
130709612|NCT00102687|470562385|FG003|Initial Period|Physician Decision|0|||
130709613|NCT00102687|470562386|FG004|Initial Period|Physician Decision|0|||
130709614|NCT00102687|470562382|FG000|Initial Period|Sponsor's decision|0|||
130709615|NCT00102687|470562383|FG001|Initial Period|Sponsor's decision|1|||
130709616|NCT00102687|470562384|FG002|Initial Period|Sponsor's decision|1|||
130709617|NCT00102687|470562385|FG003|Initial Period|Sponsor's decision|0|||
130709618|NCT00102687|470562386|FG004|Initial Period|Sponsor's decision|0|||
130709619|NCT00102687|470562382|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
130709620|NCT00102687|470562383|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
130709621|NCT00102687|470562384|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
130709622|NCT00102687|470562385|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
130709623|NCT00102687|470562386|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
130709624|NCT00102687|470562382|FG000|Initial Period|Death|1|||
130709625|NCT00102687|470562383|FG001|Initial Period|Death|1|||
130709626|NCT00102687|470562384|FG002|Initial Period|Death|1|||
131224485|NCT01027884|472448906|FG001|Overall Study|Spinal fixation surgery|3|||
130709627|NCT00102687|470562385|FG003|Initial Period|Death|0|||
130709628|NCT00102687|470562386|FG004|Initial Period|Death|0|||
130709629|NCT00102687|470562382|FG000|Maintenance Period|Withdrawal by Subject|4|||
130709630|NCT00102687|470562383|FG001|Maintenance Period|Withdrawal by Subject|0|||
130709631|NCT00102687|470562384|FG002|Maintenance Period|Withdrawal by Subject|2|||
131124008|NCT01838616|472082900|FG000|Continuation Period|Adverse Event|8|||
130772985|NCT00303472|470794847|FG004|Treatment Period|Death|0|||
130709632|NCT00102687|470562385|FG003|Maintenance Period|Withdrawal by Subject|3|||
130709633|NCT00102687|470562386|FG004|Maintenance Period|Withdrawal by Subject|1|||
130709634|NCT00102687|470562382|FG000|Maintenance Period|Adverse Event|1|||
130709635|NCT00102687|470562383|FG001|Maintenance Period|Adverse Event|0|||
131124009|NCT01838616|472082901|FG001|Continuation Period|Adverse Event|4|||
130709636|NCT00102687|470562384|FG002|Maintenance Period|Adverse Event|0|||
130709637|NCT00102687|470562385|FG003|Maintenance Period|Adverse Event|1|||
130709638|NCT00102687|470562386|FG004|Maintenance Period|Adverse Event|3|||
130709639|NCT00102687|470562382|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
130709640|NCT00102687|470562383|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
130709641|NCT00102687|470562384|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
130709642|NCT00102687|470562385|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
130709643|NCT00102687|470562386|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
130709644|NCT00102687|470562382|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
130709645|NCT00102687|470562383|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
130709646|NCT00102687|470562384|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
130709647|NCT00102687|470562385|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
130709648|NCT00102687|470562386|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
130709649|NCT00102687|470562382|FG000|Maintenance Period|Death|0|||
130709650|NCT00102687|470562383|FG001|Maintenance Period|Death|0|||
130772986|NCT00303472|470794848|FG005|Treatment Period|Death|0|||
130772987|NCT00303472|470794849|FG006|Treatment Period|Death|1|||
130772988|NCT00303472|470794843|FG000|Treatment Period|Withdrawal by Subject|0|||
130772989|NCT00303472|470794844|FG001|Treatment Period|Withdrawal by Subject|0|||
130772990|NCT00303472|470794845|FG002|Treatment Period|Withdrawal by Subject|0|||
130772991|NCT00303472|470794846|FG003|Treatment Period|Withdrawal by Subject|1|||
130772992|NCT00303472|470794847|FG004|Treatment Period|Withdrawal by Subject|0|||
130943821|NCT00663052|471428276|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130943822|NCT00663052|471428275|FG000|Overall Study|Protocol Violation|1|||
130943823|NCT00663052|471428276|FG001|Overall Study|Protocol Violation|0|||
130943824|NCT00663052|471428275|FG000|Overall Study|Withdrawal by Subject|2|||
130943825|NCT00663052|471428276|FG001|Overall Study|Withdrawal by Subject|5|||
130943826|NCT00663052|471428275|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
130943827|NCT00663052|471428276|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
130943828|NCT00663052|471428275|FG000|Overall Study|Other|0|||
130943829|NCT00663052|471428276|FG001|Overall Study|Other|1|||
130943830|NCT05760300|471428279|FG000|Overall Study|Adverse Event|0|||
130943831|NCT05760300|471428280|FG001|Overall Study|Adverse Event|0|||
130943832|NCT05760300|471428281|FG002|Overall Study|Adverse Event|1|||
130943833|NCT05760300|471428282|FG003|Overall Study|Adverse Event|0|||
130943834|NCT05760300|471428279|FG000|Overall Study|Participant Decision|1|||
130943835|NCT05760300|471428280|FG001|Overall Study|Participant Decision|0|||
130943836|NCT05760300|471428281|FG002|Overall Study|Participant Decision|0|||
130943837|NCT05760300|471428282|FG003|Overall Study|Participant Decision|0|||
130943838|NCT01252940|471428286|FG000|Main Study Phase|Randomized but not treated|4|||
130943839|NCT01252940|471428287|FG001|Main Study Phase|Randomized but not treated|2|||
130943840|NCT01252940|471428286|FG000|Main Study Phase|Adverse Event|3|||
130943841|NCT01252940|471428287|FG001|Main Study Phase|Adverse Event|1|||
130943842|NCT01252940|471428286|FG000|Main Study Phase|Lack of Efficacy|1|||
130943843|NCT01252940|471428287|FG001|Main Study Phase|Lack of Efficacy|0|||
130943844|NCT01252940|471428286|FG000|Main Study Phase|Lost to Follow-up|6|||
130943845|NCT01252940|471428287|FG001|Main Study Phase|Lost to Follow-up|1|||
130943846|NCT01252940|471428286|FG000|Main Study Phase|Physician Decision|1|||
130943847|NCT01252940|471428287|FG001|Main Study Phase|Physician Decision|0|||
131036907|NCT03852472|471768263|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
131036908|NCT03852472|471768264|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
131036909|NCT03852472|471768265|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
131036910|NCT03852472|471768266|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
131036911|NCT03852472|471768267|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
131036912|NCT03852472|471768263|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
131036913|NCT03852472|471768264|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
131036914|NCT03852472|471768265|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
131036915|NCT03852472|471768266|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
131036916|NCT03852472|471768267|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
131036917|NCT03852472|471768263|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
131036918|NCT03852472|471768264|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
131036919|NCT03852472|471768265|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
131036920|NCT03852472|471768266|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
131036921|NCT03852472|471768267|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
131036922|NCT03852472|471768263|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
131036923|NCT03852472|471768264|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
131045844|NCT03582033|471802281|FG003|Part C|Withdrawal by Subject|0|||
130772993|NCT00303472|470794848|FG005|Treatment Period|Withdrawal by Subject|1|||
130709651|NCT00102687|470562384|FG002|Maintenance Period|Death|0|||
130943848|NCT01252940|471428286|FG000|Main Study Phase|Protocol Violation|4|||
130943849|NCT01252940|471428287|FG001|Main Study Phase|Protocol Violation|2|||
130943850|NCT01252940|471428286|FG000|Main Study Phase|Withdrawal by Subject|6|||
130772994|NCT00303472|470794849|FG006|Treatment Period|Withdrawal by Subject|0|||
130772995|NCT00303472|470794843|FG000|Treatment Period|Other|0|||
130772996|NCT00303472|470794844|FG001|Treatment Period|Other|0|||
130772997|NCT00303472|470794845|FG002|Treatment Period|Other|0|||
130772998|NCT00303472|470794846|FG003|Treatment Period|Other|0|||
130772999|NCT00303472|470794847|FG004|Treatment Period|Other|1|||
130773000|NCT00303472|470794848|FG005|Treatment Period|Other|0|||
130773001|NCT00303472|470794849|FG006|Treatment Period|Other|1|||
130773002|NCT00303472|470794843|FG000|Treatment Period|Disease Progression (to AML)|0|||
130773003|NCT00303472|470794844|FG001|Treatment Period|Disease Progression (to AML)|0|||
130773004|NCT00303472|470794845|FG002|Treatment Period|Disease Progression (to AML)|0|||
130773005|NCT00303472|470794846|FG003|Treatment Period|Disease Progression (to AML)|0|||
130773006|NCT00303472|470794847|FG004|Treatment Period|Disease Progression (to AML)|1|||
130773007|NCT00303472|470794848|FG005|Treatment Period|Disease Progression (to AML)|0|||
130773008|NCT00303472|470794849|FG006|Treatment Period|Disease Progression (to AML)|0|||
130773009|NCT00303472|470794843|FG000|Treatment Extension (Optional)|Adverse Event|1|||
130773010|NCT00303472|470794844|FG001|Treatment Extension (Optional)|Adverse Event|0|||
130773011|NCT00303472|470794845|FG002|Treatment Extension (Optional)|Adverse Event|1|||
130773012|NCT00303472|470794846|FG003|Treatment Extension (Optional)|Adverse Event|0|||
130773013|NCT00303472|470794847|FG004|Treatment Extension (Optional)|Adverse Event|0|||
130773014|NCT00303472|470794848|FG005|Treatment Extension (Optional)|Adverse Event|0|||
130773015|NCT00303472|470794849|FG006|Treatment Extension (Optional)|Adverse Event|0|||
130773016|NCT00303472|470794843|FG000|Treatment Extension (Optional)|Death|2|||
130773017|NCT00303472|470794844|FG001|Treatment Extension (Optional)|Death|0|||
130773018|NCT00303472|470794845|FG002|Treatment Extension (Optional)|Death|1|||
130773019|NCT00303472|470794846|FG003|Treatment Extension (Optional)|Death|0|||
130773020|NCT00303472|470794847|FG004|Treatment Extension (Optional)|Death|0|||
130773021|NCT00303472|470794848|FG005|Treatment Extension (Optional)|Death|0|||
130773022|NCT00303472|470794849|FG006|Treatment Extension (Optional)|Death|0|||
130773023|NCT00303472|470794843|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
130773024|NCT00303472|470794844|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
130773025|NCT00303472|470794845|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
130773026|NCT00303472|470794846|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
130773027|NCT00303472|470794847|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
130773028|NCT00303472|470794848|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
130773029|NCT00303472|470794849|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
130773030|NCT00303472|470794843|FG000|Treatment Extension (Optional)|Physician Decision|0|||
130773031|NCT00303472|470794844|FG001|Treatment Extension (Optional)|Physician Decision|4|||
131124010|NCT01838616|472082900|FG000|Continuation Period|Protocol Violation|2|||
130773032|NCT00303472|470794845|FG002|Treatment Extension (Optional)|Physician Decision|2|||
131124011|NCT01838616|472082901|FG001|Continuation Period|Protocol Violation|0|||
131124012|NCT01838616|472082900|FG000|Continuation Period|Lost to Follow-up|1|||
131124013|NCT01838616|472082901|FG001|Continuation Period|Lost to Follow-up|0|||
131124014|NCT01838616|472082900|FG000|Continuation Period|Withdrawal by Subject|0|||
131124015|NCT01838616|472082901|FG001|Continuation Period|Withdrawal by Subject|4|||
131124016|NCT01838616|472082900|FG000|Continuation Period|Technical problems|0|||
131124017|NCT01838616|472082901|FG001|Continuation Period|Technical problems|1|||
131124018|NCT01838616|472082900|FG000|Pick-up Arm|Lack of Efficacy|4|||
131124019|NCT01838616|472082901|FG001|Pick-up Arm|Lack of Efficacy|0|||
131124020|NCT01838616|472082900|FG000|Pick-up Arm|Adverse Event|9|||
131124021|NCT01838616|472082901|FG001|Pick-up Arm|Adverse Event|0|||
131224486|NCT03670537|472448907|FG000|Overall Study|Protocol Violation|1|||
131224487|NCT02059187|472448908|FG000|Overall Study|Adverse Event|0|||
131224488|NCT02059187|472448909|FG001|Overall Study|Adverse Event|3|||
130773033|NCT00303472|470794846|FG003|Treatment Extension (Optional)|Physician Decision|3|||
130773034|NCT00303472|470794847|FG004|Treatment Extension (Optional)|Physician Decision|2|||
130773035|NCT00303472|470794848|FG005|Treatment Extension (Optional)|Physician Decision|0|||
130773036|NCT00303472|470794849|FG006|Treatment Extension (Optional)|Physician Decision|0|||
130773037|NCT00303472|470794843|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
130773038|NCT00303472|470794844|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
130773039|NCT00303472|470794845|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
130773040|NCT00303472|470794846|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
130773041|NCT00303472|470794847|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
130773042|NCT00303472|470794848|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
130773043|NCT00303472|470794849|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
131224489|NCT02059187|472448908|FG000|Overall Study|Death|1|||
131224490|NCT02059187|472448909|FG001|Overall Study|Death|1|||
130773044|NCT00303472|470794843|FG000|Treatment Extension (Optional)|Other|0|||
130773045|NCT00303472|470794844|FG001|Treatment Extension (Optional)|Other|2|||
131124022|NCT01838616|472082900|FG000|Pick-up Arm|Withdrawal by Subject|1|||
130773046|NCT00303472|470794845|FG002|Treatment Extension (Optional)|Other|4|||
130773047|NCT00303472|470794846|FG003|Treatment Extension (Optional)|Other|2|||
131124023|NCT01838616|472082901|FG001|Pick-up Arm|Withdrawal by Subject|0|||
131124024|NCT01838616|472082900|FG000|Pick-up Arm|Technical problems|1|||
130709652|NCT00102687|470562385|FG003|Maintenance Period|Death|1|||
130709653|NCT00102687|470562386|FG004|Maintenance Period|Death|1|||
130709654|NCT00102687|470562382|FG000|Maintenance Period|Physician Decision|1|||
130709655|NCT00102687|470562383|FG001|Maintenance Period|Physician Decision|2|||
130709656|NCT00102687|470562384|FG002|Maintenance Period|Physician Decision|3|||
130709657|NCT00102687|470562385|FG003|Maintenance Period|Physician Decision|0|||
130709658|NCT00102687|470562386|FG004|Maintenance Period|Physician Decision|4|||
130709659|NCT00351351|470562387|FG000|Overall Study|surgical access pbs; device issues|9|||
130709660|NCT00351351|470562388|FG001|Overall Study|surgical access pbs; device issues|4|||
130709661|NCT00466726|470562389|FG000|Overall Study|Not evaluable for response|14|||
130709662|NCT04403763|470562390|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
130709663|NCT04403763|470562391|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
130709664|NCT04403763|470562392|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
130709665|NCT04403763|470562393|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
130709666|NCT04403763|470562394|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
130709667|NCT04403763|470562395|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
130709668|NCT04403763|470562396|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
130709669|NCT04403763|470562390|FG000|Stage 1|Early termination due to PK tube failure|0|||
130709670|NCT04403763|470562391|FG001|Stage 1|Early termination due to PK tube failure|0|||
130709671|NCT04403763|470562392|FG002|Stage 1|Early termination due to PK tube failure|1|||
130709672|NCT04403763|470562393|FG003|Stage 1|Early termination due to PK tube failure|0|||
130709673|NCT04403763|470562394|FG004|Stage 1|Early termination due to PK tube failure|0|||
130709674|NCT04403763|470562395|FG005|Stage 1|Early termination due to PK tube failure|0|||
130709675|NCT04403763|470562396|FG006|Stage 1|Early termination due to PK tube failure|0|||
130709676|NCT04403763|470562390|FG000|Stage 2A|Adverse Event|0|||
130709677|NCT04403763|470562391|FG001|Stage 2A|Adverse Event|0|||
130709678|NCT04403763|470562392|FG002|Stage 2A|Adverse Event|0|||
130709679|NCT04403763|470562393|FG003|Stage 2A|Adverse Event|0|||
130709680|NCT04403763|470562394|FG004|Stage 2A|Adverse Event|0|||
130709681|NCT04403763|470562395|FG005|Stage 2A|Adverse Event|0|||
130709682|NCT04403763|470562396|FG006|Stage 2A|Adverse Event|1|||
130709683|NCT01376310|470562397|FG000|Overall Study|Study closed/terminated|1|||
130709684|NCT01376310|470562398|FG001|Overall Study|Study closed/terminated|2|||
130709685|NCT01376310|470562397|FG000|Overall Study|Withdrawal by Subject|8|||
130709686|NCT01376310|470562398|FG001|Overall Study|Withdrawal by Subject|2|||
130709687|NCT01376310|470562397|FG000|Overall Study|Physician Decision|26|||
130709688|NCT01376310|470562398|FG001|Overall Study|Physician Decision|7|||
130709689|NCT01376310|470562397|FG000|Overall Study|Lost to Follow-up|1|||
130709690|NCT01376310|470562398|FG001|Overall Study|Lost to Follow-up|0|||
130709691|NCT02339740|470562401|FG000|Overall Study|Death|1|||
130709692|NCT02339740|470562402|FG001|Overall Study|Death|0|||
130709693|NCT02339740|470562401|FG000|Overall Study|Physician Decision|0|||
130709694|NCT02339740|470562402|FG001|Overall Study|Physician Decision|2|||
130709695|NCT02339740|470562401|FG000|Overall Study|Withdrawal by Subject|5|||
130943851|NCT01252940|471428287|FG001|Main Study Phase|Withdrawal by Subject|5|||
130943852|NCT01252940|471428286|FG000|Main Study Phase|Subject Non-compliance|1|||
130943853|NCT01252940|471428287|FG001|Main Study Phase|Subject Non-compliance|1|||
130943854|NCT01252940|471428286|FG000|Extension Phase|Adverse Event|2|||
131124025|NCT01838616|472082901|FG001|Pick-up Arm|Technical problems|0|||
130709696|NCT02339740|470562402|FG001|Overall Study|Withdrawal by Subject|1|||
130709697|NCT02339740|470562401|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
130709698|NCT02339740|470562402|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
130709699|NCT00606502|470562403|FG000|Randomization|Randomized but not treated|3|||
130709700|NCT00606502|470562404|FG001|Randomization|Randomized but not treated|0|||
130709701|NCT00606502|470562403|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
130709702|NCT00606502|470562404|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
130709703|NCT02083926|470562407|FG000|Overall Study|Withdrawal by Subject|1|||
130709704|NCT02083926|470562408|FG001|Overall Study|Withdrawal by Subject|0|||
130709705|NCT00384176|470562409|FG000|Overall Study|Death|239|||
130709706|NCT00384176|470562410|FG001|Overall Study|Death|247|||
130709707|NCT00384176|470562411|FG002|Overall Study|Death|105|||
130709708|NCT00384176|470562409|FG000|Overall Study|Withdrawal by Subject|52|||
130709709|NCT00384176|470562410|FG001|Overall Study|Withdrawal by Subject|48|||
130709710|NCT00384176|470562411|FG002|Overall Study|Withdrawal by Subject|22|||
130709711|NCT00384176|470562409|FG000|Overall Study|Lost to Follow-up|16|||
130709712|NCT00384176|470562410|FG001|Overall Study|Lost to Follow-up|18|||
130709713|NCT00384176|470562411|FG002|Overall Study|Lost to Follow-up|4|||
130709714|NCT00384176|470562409|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
130709715|NCT00384176|470562410|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
130709716|NCT00384176|470562411|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
130709717|NCT00384176|470562409|FG000|Overall Study|Longer QTC as Visit 1|1|||
130709718|NCT00384176|470562410|FG001|Overall Study|Longer QTC as Visit 1|0|||
130709719|NCT00384176|470562411|FG002|Overall Study|Longer QTC as Visit 1|0|||
130709720|NCT00384176|470562409|FG000|Overall Study|Toxicity of treatment|1|||
130709721|NCT00384176|470562410|FG001|Overall Study|Toxicity of treatment|0|||
130943855|NCT01252940|471428287|FG001|Extension Phase|Adverse Event|1|||
130943856|NCT01252940|471428286|FG000|Extension Phase|Lack of Efficacy|1|||
130943857|NCT01252940|471428287|FG001|Extension Phase|Lack of Efficacy|0|||
130943858|NCT01252940|471428286|FG000|Extension Phase|Lost to Follow-up|5|||
130943859|NCT01252940|471428287|FG001|Extension Phase|Lost to Follow-up|0|||
130943860|NCT01252940|471428286|FG000|Extension Phase|Physician Decision|0|||
130943861|NCT01252940|471428287|FG001|Extension Phase|Physician Decision|1|||
130943862|NCT01252940|471428286|FG000|Extension Phase|Subject Non-compliance|1|||
130943863|NCT01252940|471428287|FG001|Extension Phase|Subject Non-compliance|0|||
130943864|NCT01252940|471428286|FG000|Extension Phase|Withdrawal by Subject|1|||
130943865|NCT01252940|471428287|FG001|Extension Phase|Withdrawal by Subject|1|||
130943866|NCT02496533|471428292|FG000|Overall Study|Lack of data on outcome|3|||
130943867|NCT02496533|471428293|FG001|Overall Study|Lack of data on outcome|0|||
130943868|NCT02496533|471428292|FG000|Overall Study|Patient did not complete all measures|0|||
130943869|NCT02496533|471428293|FG001|Overall Study|Patient did not complete all measures|4|||
130943870|NCT02496533|471428292|FG000|Overall Study|Late for radiologic testing|0|||
130943871|NCT02496533|471428293|FG001|Overall Study|Late for radiologic testing|2|||
130943872|NCT04364620|471428296|FG000|Overall Study|Disease Progression|20|||
130943873|NCT04364620|471428296|FG000|Overall Study|Adverse Event|5|||
130943874|NCT04364620|471428296|FG000|Overall Study|Physician Decision|4|||
130943875|NCT04364620|471428296|FG000|Overall Study|Death|3|||
130943876|NCT04364620|471428296|FG000|Overall Study|Other|2|||
130943877|NCT04364620|471428296|FG000|Overall Study|Withdrawal by Subject|1|||
130943878|NCT03971695|471429297|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130943879|NCT03971695|471429298|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130709722|NCT00384176|470562411|FG002|Overall Study|Toxicity of treatment|0|||
130709723|NCT00384176|470562409|FG000|Overall Study|Did not receive study treatment|0|||
130709724|NCT00384176|470562410|FG001|Overall Study|Did not receive study treatment|1|||
130709725|NCT00384176|470562411|FG002|Overall Study|Did not receive study treatment|1|||
130709726|NCT00384176|470562409|FG000|Overall Study|Physician Decision|0|||
130709727|NCT00384176|470562410|FG001|Overall Study|Physician Decision|2|||
130709728|NCT00384176|470562411|FG002|Overall Study|Physician Decision|0|||
130709729|NCT00384176|470562409|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
130709730|NCT00384176|470562410|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
130709731|NCT00384176|470562411|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
130709732|NCT02697773|470562412|FG000|Overall Study|Adverse Event|2|||
130709733|NCT02697773|470562413|FG001|Overall Study|Adverse Event|1|||
130709734|NCT02697773|470562414|FG002|Overall Study|Adverse Event|2|||
130709735|NCT02697773|470562412|FG000|Overall Study|Death|0|||
130709736|NCT02697773|470562413|FG001|Overall Study|Death|0|||
130709737|NCT02697773|470562414|FG002|Overall Study|Death|2|||
130709738|NCT02697773|470562412|FG000|Overall Study|Lack of Efficacy|4|||
130709739|NCT02697773|470562413|FG001|Overall Study|Lack of Efficacy|6|||
130709740|NCT02697773|470562414|FG002|Overall Study|Lack of Efficacy|6|||
130709741|NCT02697773|470562412|FG000|Overall Study|Lost to Follow-up|5|||
130709742|NCT02697773|470562413|FG001|Overall Study|Lost to Follow-up|5|||
130709743|NCT02697773|470562414|FG002|Overall Study|Lost to Follow-up|7|||
130709744|NCT02697773|470562412|FG000|Overall Study|Other|15|||
130709745|NCT02697773|470562413|FG001|Overall Study|Other|11|||
130943880|NCT03971695|471429299|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130943881|NCT03971695|471429300|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
130943882|NCT03971695|471429301|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
130943883|NCT03971695|471429302|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130943884|NCT03971695|471429303|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130943885|NCT03971695|471429304|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130943886|NCT03971695|471429305|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
130943887|NCT03971695|471429306|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
130943888|NCT03971695|471429307|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
130943889|NCT03971695|471429308|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
130709746|NCT02697773|470562414|FG002|Overall Study|Other|10|||
130709747|NCT02697773|470562412|FG000|Overall Study|Protocol Violation|1|||
130709748|NCT02697773|470562413|FG001|Overall Study|Protocol Violation|1|||
130709749|NCT02697773|470562414|FG002|Overall Study|Protocol Violation|0|||
130709750|NCT02697773|470562412|FG000|Overall Study|Withdrawal by Subject|10|||
130709751|NCT02697773|470562413|FG001|Overall Study|Withdrawal by Subject|13|||
130943890|NCT03971695|471429309|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
130943891|NCT02155738|471429317|FG000|Overall Study|Missing critical information|1|||
130943892|NCT02155738|471429318|FG001|Overall Study|Missing critical information|0|||
130943893|NCT02155738|471429319|FG002|Overall Study|Missing critical information|0|||
130943894|NCT02155738|471429320|FG003|Overall Study|Missing critical information|1|||
130943895|NCT02356783|471429321|FG000|Overall Study|Lost to Follow-up|1|||
130943896|NCT02356783|471429322|FG001|Overall Study|Lost to Follow-up|3|||
130709752|NCT02697773|470562414|FG002|Overall Study|Withdrawal by Subject|13|||
130709753|NCT02697773|470562412|FG000|Overall Study|Randomized but not treated|1|||
130709754|NCT02697773|470562413|FG001|Overall Study|Randomized but not treated|1|||
130709755|NCT02697773|470562414|FG002|Overall Study|Randomized but not treated|0|||
130709756|NCT00613834|470562415|FG000|Overall Study|Withdrawal by Subject|0|||
130709757|NCT00613834|470562416|FG001|Overall Study|Withdrawal by Subject|3|||
130709758|NCT01660022|470562417|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
130709759|NCT01660022|470562418|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
130709760|NCT01660022|470562419|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
130709761|NCT01660022|470562420|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
130709762|NCT01660022|470562421|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
130709763|NCT01660022|470562422|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
130709764|NCT01660022|470562417|FG000|First Sequence (7 Days)|Adverse Event|0|||
130709765|NCT01660022|470562418|FG001|First Sequence (7 Days)|Adverse Event|0|||
130709766|NCT01660022|470562419|FG002|First Sequence (7 Days)|Adverse Event|0|||
130709767|NCT01660022|470562420|FG003|First Sequence (7 Days)|Adverse Event|0|||
130709768|NCT01660022|470562421|FG004|First Sequence (7 Days)|Adverse Event|1|||
130709769|NCT01660022|470562422|FG005|First Sequence (7 Days)|Adverse Event|3|||
130709770|NCT01660022|470562417|FG000|First Sequence (7 Days)|Protocol Violation|0|||
130709771|NCT01660022|470562418|FG001|First Sequence (7 Days)|Protocol Violation|0|||
130709772|NCT01660022|470562419|FG002|First Sequence (7 Days)|Protocol Violation|0|||
130943897|NCT01365507|471429323|FG000|Overall Study|Withdrawal Criteria|8|||
130943898|NCT01365507|471429324|FG001|Overall Study|Withdrawal Criteria|5|||
130943899|NCT01365507|471429323|FG000|Overall Study|Unclassified|1|||
130943900|NCT01365507|471429324|FG001|Overall Study|Unclassified|4|||
130943901|NCT00192504|471429327|FG000|Overall Study|Lost to Follow-up|1|||
130943902|NCT00192504|471429328|FG001|Overall Study|Lost to Follow-up|0|||
130943903|NCT00192504|471429329|FG002|Overall Study|Lost to Follow-up|0|||
130943904|NCT00192504|471429330|FG003|Overall Study|Lost to Follow-up|0|||
130943905|NCT00192504|471429327|FG000|Overall Study|Dosing window missed|0|||
130943906|NCT00192504|471429328|FG001|Overall Study|Dosing window missed|0|||
130943907|NCT00192504|471429329|FG002|Overall Study|Dosing window missed|1|||
130943908|NCT00192504|471429330|FG003|Overall Study|Dosing window missed|0|||
130943909|NCT01139450|471429331|FG000|Overall Study|Withdrawal by Subject|7|||
130943910|NCT01139450|471429332|FG001|Overall Study|Withdrawal by Subject|10|||
130943911|NCT01139450|471429333|FG002|Overall Study|Withdrawal by Subject|13|||
130943912|NCT01139450|471429331|FG000|Overall Study|Lack of Efficacy|3|||
130943913|NCT01139450|471429332|FG001|Overall Study|Lack of Efficacy|1|||
130943914|NCT01139450|471429333|FG002|Overall Study|Lack of Efficacy|8|||
130943915|NCT01139450|471429331|FG000|Overall Study|Protocol Violation|6|||
130943916|NCT01139450|471429332|FG001|Overall Study|Protocol Violation|5|||
130943917|NCT01139450|471429333|FG002|Overall Study|Protocol Violation|2|||
130943918|NCT01139450|471429331|FG000|Overall Study|Lost to Follow-up|9|||
130943919|NCT01139450|471429332|FG001|Overall Study|Lost to Follow-up|7|||
130943920|NCT01139450|471429333|FG002|Overall Study|Lost to Follow-up|11|||
130709773|NCT01660022|470562420|FG003|First Sequence (7 Days)|Protocol Violation|0|||
130709774|NCT01660022|470562421|FG004|First Sequence (7 Days)|Protocol Violation|0|||
130709775|NCT01660022|470562422|FG005|First Sequence (7 Days)|Protocol Violation|1|||
130709776|NCT02149121|470562428|FG000|Main Study Period|Lack of Efficacy|2|||
130709777|NCT02149121|470562429|FG001|Main Study Period|Lack of Efficacy|2|||
130709778|NCT02149121|470562430|FG002|Main Study Period|Lack of Efficacy|1|||
130709779|NCT02149121|470562431|FG003|Main Study Period|Lack of Efficacy|0|||
130709780|NCT02149121|470562432|FG004|Main Study Period|Lack of Efficacy|0|||
130709781|NCT02149121|470562433|FG005|Main Study Period|Lack of Efficacy|0|||
130943921|NCT01139450|471429331|FG000|Overall Study|Administrative|0|||
130943922|NCT01139450|471429332|FG001|Overall Study|Administrative|0|||
130943923|NCT01139450|471429333|FG002|Overall Study|Administrative|1|||
130943924|NCT01139450|471429331|FG000|Overall Study|Adverse Event|2|||
130773048|NCT00303472|470794847|FG004|Treatment Extension (Optional)|Other|1|||
130943925|NCT01139450|471429332|FG001|Overall Study|Adverse Event|2|||
130943926|NCT01139450|471429333|FG002|Overall Study|Adverse Event|3|||
130943927|NCT00914810|471429340|FG000|Overall Study|Withdrawal by Subject|1|||
130943928|NCT00914810|471429341|FG001|Overall Study|Withdrawal by Subject|0|||
130709782|NCT02149121|470562434|FG006|Main Study Period|Lack of Efficacy|0|||
130709783|NCT02149121|470562428|FG000|Main Study Period|Withdrawal by Subject|9|||
130709784|NCT02149121|470562429|FG001|Main Study Period|Withdrawal by Subject|5|||
130709785|NCT02149121|470562430|FG002|Main Study Period|Withdrawal by Subject|1|||
130709786|NCT02149121|470562431|FG003|Main Study Period|Withdrawal by Subject|0|||
130773049|NCT00303472|470794848|FG005|Treatment Extension (Optional)|Other|0|||
130943929|NCT00914810|471429340|FG000|Overall Study|Relocated out of state|1|||
130943930|NCT00914810|471429341|FG001|Overall Study|Relocated out of state|0|||
130943931|NCT00914810|471429340|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
130943932|NCT00914810|471429341|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
130943933|NCT05129488|471429344|FG000|Overall Study|Protocol Violation|3|||
130943934|NCT04782856|471429345|FG000|Overall Study|Withdrawal by Subject|0|||
130943935|NCT04782856|471429346|FG001|Overall Study|Withdrawal by Subject|1|||
130709787|NCT02149121|470562432|FG004|Main Study Period|Withdrawal by Subject|0|||
130709788|NCT02149121|470562433|FG005|Main Study Period|Withdrawal by Subject|0|||
130709789|NCT02149121|470562434|FG006|Main Study Period|Withdrawal by Subject|0|||
130709790|NCT02149121|470562428|FG000|Main Study Period|Adverse Event|2|||
130709791|NCT02149121|470562429|FG001|Main Study Period|Adverse Event|5|||
130709792|NCT02149121|470562430|FG002|Main Study Period|Adverse Event|1|||
130709793|NCT02149121|470562431|FG003|Main Study Period|Adverse Event|0|||
130773050|NCT00303472|470794849|FG006|Treatment Extension (Optional)|Other|0|||
130773051|NCT00303472|470794843|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
130773052|NCT00303472|470794844|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130773053|NCT00303472|470794845|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130773054|NCT00303472|470794846|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130773055|NCT00303472|470794847|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130773056|NCT00303472|470794848|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
130773057|NCT00303472|470794849|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130773058|NCT02937636|470794850|FG000|Overall Study|Other (Not specified)|3|||
130773059|NCT02937636|470794851|FG001|Overall Study|Other (Not specified)|2|||
130773060|NCT03383692|470794864|FG000|Overall Study|Progressive disease as per RECIST|3|||
130773061|NCT03383692|470794865|FG001|Overall Study|Progressive disease as per RECIST|3|||
130773062|NCT03383692|470794864|FG000|Overall Study|Clinical progression|0|||
130773063|NCT03383692|470794865|FG001|Overall Study|Clinical progression|1|||
130773064|NCT03383692|470794864|FG000|Overall Study|Adverse Event|3|||
130773065|NCT03383692|470794865|FG001|Overall Study|Adverse Event|0|||
130773066|NCT00893971|470794866|FG000|Overall Study|Physician Decision|3|||
130773067|NCT02453256|470794867|FG000|Double Blind Period|Death|1|||
130773068|NCT02453256|470794868|FG001|Double Blind Period|Death|1|||
130773069|NCT02453256|470794867|FG000|Double Blind Period|Adverse Event|3|||
130943936|NCT01465022|471429347|FG000|Overall Study|Lost to Follow-up|15|||
130943937|NCT01465022|471429348|FG001|Overall Study|Lost to Follow-up|14|||
130773070|NCT02453256|470794868|FG001|Double Blind Period|Adverse Event|2|||
130773071|NCT02453256|470794867|FG000|Double Blind Period|Withdrawal by Subject|9|||
130773072|NCT02453256|470794868|FG001|Double Blind Period|Withdrawal by Subject|5|||
130773073|NCT02453256|470794867|FG000|Double Blind Period|Other|0|||
130773074|NCT02453256|470794868|FG001|Double Blind Period|Other|1|||
130773075|NCT02453256|470794867|FG000|Open Label Period|Adverse Event|1|||
130773076|NCT02453256|470794868|FG001|Open Label Period|Adverse Event|3|||
130773077|NCT02453256|470794867|FG000|Open Label Period|Death|0|||
130773078|NCT02453256|470794868|FG001|Open Label Period|Death|1|||
130773079|NCT02453256|470794867|FG000|Open Label Period|Lost to Follow-up|1|||
130773080|NCT02453256|470794868|FG001|Open Label Period|Lost to Follow-up|0|||
130773081|NCT02453256|470794867|FG000|Open Label Period|Other|0|||
130773082|NCT02453256|470794868|FG001|Open Label Period|Other|2|||
130773083|NCT02453256|470794867|FG000|Open Label Period|Withdrawal by Subject|5|||
130773084|NCT02453256|470794868|FG001|Open Label Period|Withdrawal by Subject|1|||
130943938|NCT01465022|471429349|FG002|Overall Study|Lost to Follow-up|0|||
130943939|NCT01465022|471429347|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
130943940|NCT01465022|471429348|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
130943941|NCT01465022|471429349|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
130943942|NCT01465022|471429347|FG000|Overall Study|Not Randomized|0|||
130943943|NCT01465022|471429348|FG001|Overall Study|Not Randomized|0|||
130943944|NCT01465022|471429349|FG002|Overall Study|Not Randomized|70|||
130943945|NCT01327300|471429350|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
131036924|NCT03852472|471768265|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
131036925|NCT03852472|471768266|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
131036926|NCT03852472|471768267|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
131036927|NCT03852472|471768263|FG000|Period 2 - Week 44|Adverse Event|0|||
131036928|NCT03852472|471768264|FG001|Period 2 - Week 44|Adverse Event|3|||
131036929|NCT03852472|471768265|FG002|Period 2 - Week 44|Adverse Event|1|||
131036930|NCT03852472|471768266|FG003|Period 2 - Week 44|Adverse Event|2|||
131036931|NCT03852472|471768267|FG004|Period 2 - Week 44|Adverse Event|2|||
131036932|NCT03852472|471768263|FG000|Period 2 - Week 44|COVID-19 Related|0|||
131036933|NCT03852472|471768264|FG001|Period 2 - Week 44|COVID-19 Related|0|||
131036934|NCT03852472|471768265|FG002|Period 2 - Week 44|COVID-19 Related|0|||
131036935|NCT03852472|471768266|FG003|Period 2 - Week 44|COVID-19 Related|1|||
131036936|NCT03852472|471768267|FG004|Period 2 - Week 44|COVID-19 Related|0|||
131036937|NCT03852472|471768263|FG000|Period 2 - Week 44|Reason not stated|0|||
130709794|NCT02149121|470562432|FG004|Main Study Period|Adverse Event|0|||
130709795|NCT02149121|470562433|FG005|Main Study Period|Adverse Event|0|||
130773085|NCT01366638|470794869|FG000|Overall Study|Withdrawal by Subject|0|||
130773086|NCT01366638|470794870|FG001|Overall Study|Withdrawal by Subject|0|||
130773087|NCT01366638|470794871|FG002|Overall Study|Withdrawal by Subject|6|||
130773088|NCT01366638|470794869|FG000|Overall Study|Other|1|||
130773089|NCT01366638|470794870|FG001|Overall Study|Other|0|||
130773090|NCT01366638|470794871|FG002|Overall Study|Other|0|||
130773091|NCT01237327|470794872|FG000|Overall Study|Protocol Violation: Core Study|1|||
130943946|NCT01327300|471429351|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
130943947|NCT03020823|471429352|FG000|Overall Study|Physician Decision|4|||
130943948|NCT03020823|471429352|FG000|Overall Study|Lack of Efficacy|4|||
130943949|NCT03020823|471429352|FG000|Overall Study|Adverse Event|2|||
130943950|NCT03739112|471429353|FG000|Overall Study|Adverse Event|2|||
130943951|NCT03739112|471429354|FG001|Overall Study|Adverse Event|2|||
130943952|NCT03739112|471429353|FG000|Overall Study|Withdrawal by Subject|38|||
130943953|NCT03739112|471429354|FG001|Overall Study|Withdrawal by Subject|19|||
130943954|NCT03739112|471429353|FG000|Overall Study|Lost to Follow-up|31|||
130943955|NCT03739112|471429354|FG001|Overall Study|Lost to Follow-up|33|||
130943956|NCT03739112|471429353|FG000|Overall Study|Protocol Deviation|12|||
130943957|NCT03739112|471429354|FG001|Overall Study|Protocol Deviation|9|||
130943958|NCT03739112|471429353|FG000|Overall Study|Physician Decision|1|||
130943959|NCT03739112|471429354|FG001|Overall Study|Physician Decision|0|||
130943960|NCT03739112|471429353|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
130943961|NCT03739112|471429354|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
130943962|NCT03739112|471429353|FG000|Overall Study|Site went on hold|65|||
130709796|NCT02149121|470562434|FG006|Main Study Period|Adverse Event|0|||
130709797|NCT02149121|470562428|FG000|Main Study Period|Protocol Violation|2|||
130709798|NCT02149121|470562429|FG001|Main Study Period|Protocol Violation|0|||
130709799|NCT02149121|470562430|FG002|Main Study Period|Protocol Violation|0|||
130709800|NCT02149121|470562431|FG003|Main Study Period|Protocol Violation|0|||
130709801|NCT02149121|470562432|FG004|Main Study Period|Protocol Violation|0|||
130709802|NCT02149121|470562433|FG005|Main Study Period|Protocol Violation|0|||
130709803|NCT02149121|470562434|FG006|Main Study Period|Protocol Violation|0|||
130709804|NCT02149121|470562428|FG000|Main Study Period|Lost to Follow-up|2|||
130709805|NCT02149121|470562429|FG001|Main Study Period|Lost to Follow-up|1|||
130709806|NCT02149121|470562430|FG002|Main Study Period|Lost to Follow-up|0|||
130709807|NCT02149121|470562431|FG003|Main Study Period|Lost to Follow-up|0|||
130709808|NCT02149121|470562432|FG004|Main Study Period|Lost to Follow-up|0|||
130709809|NCT02149121|470562433|FG005|Main Study Period|Lost to Follow-up|0|||
130709810|NCT02149121|470562434|FG006|Main Study Period|Lost to Follow-up|0|||
130709811|NCT02149121|470562428|FG000|Main Study Period|Death|1|||
130709812|NCT02149121|470562429|FG001|Main Study Period|Death|0|||
130709813|NCT02149121|470562430|FG002|Main Study Period|Death|0|||
130709814|NCT02149121|470562431|FG003|Main Study Period|Death|0|||
130709815|NCT02149121|470562432|FG004|Main Study Period|Death|0|||
130709816|NCT02149121|470562433|FG005|Main Study Period|Death|0|||
130709817|NCT02149121|470562434|FG006|Main Study Period|Death|0|||
130709818|NCT02149121|470562428|FG000|Main Study Period|Physician Decision|1|||
130709819|NCT02149121|470562429|FG001|Main Study Period|Physician Decision|0|||
130709820|NCT02149121|470562430|FG002|Main Study Period|Physician Decision|0|||
130709821|NCT02149121|470562431|FG003|Main Study Period|Physician Decision|0|||
130709822|NCT02149121|470562432|FG004|Main Study Period|Physician Decision|0|||
130709823|NCT02149121|470562433|FG005|Main Study Period|Physician Decision|0|||
130709824|NCT02149121|470562434|FG006|Main Study Period|Physician Decision|0|||
130709825|NCT02149121|470562428|FG000|Main Study Period|Developed any malignancy|0|||
130709826|NCT02149121|470562429|FG001|Main Study Period|Developed any malignancy|1|||
130709827|NCT02149121|470562430|FG002|Main Study Period|Developed any malignancy|1|||
130709828|NCT02149121|470562431|FG003|Main Study Period|Developed any malignancy|0|||
130709829|NCT02149121|470562432|FG004|Main Study Period|Developed any malignancy|0|||
130709830|NCT02149121|470562433|FG005|Main Study Period|Developed any malignancy|0|||
130709831|NCT02149121|470562434|FG006|Main Study Period|Developed any malignancy|0|||
130709832|NCT02149121|470562428|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
130709833|NCT02149121|470562429|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
130709834|NCT02149121|470562430|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
130709835|NCT02149121|470562431|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
130709836|NCT02149121|470562432|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
130943963|NCT03739112|471429354|FG001|Overall Study|Site went on hold|67|||
130943964|NCT03739112|471429353|FG000|Overall Study|Other than specified|8|||
130943965|NCT03739112|471429354|FG001|Overall Study|Other than specified|5|||
131224491|NCT02059187|472448908|FG000|Overall Study|Lost to Follow-up|9|||
130709837|NCT02149121|470562433|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
130709838|NCT02149121|470562434|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
130709839|NCT02149121|470562428|FG000|Main Study Period|Disease progression|0|||
130709840|NCT02149121|470562429|FG001|Main Study Period|Disease progression|1|||
130709841|NCT02149121|470562430|FG002|Main Study Period|Disease progression|0|||
130943966|NCT03739112|471429353|FG000|Overall Study|Randomized but not vaccinated|31|||
130943967|NCT03739112|471429354|FG001|Overall Study|Randomized but not vaccinated|25|||
130709842|NCT02149121|470562431|FG003|Main Study Period|Disease progression|0|||
130709843|NCT02149121|470562432|FG004|Main Study Period|Disease progression|0|||
130709844|NCT02149121|470562433|FG005|Main Study Period|Disease progression|0|||
130709845|NCT02149121|470562434|FG006|Main Study Period|Disease progression|0|||
130709846|NCT02149121|470562428|FG000|Extension Study Period|Withdrawal by Subject|0|||
130709847|NCT02149121|470562429|FG001|Extension Study Period|Withdrawal by Subject|0|||
130709848|NCT02149121|470562430|FG002|Extension Study Period|Withdrawal by Subject|0|||
130709849|NCT02149121|470562431|FG003|Extension Study Period|Withdrawal by Subject|1|||
130773092|NCT01237327|470794873|FG001|Overall Study|Protocol Violation: Core Study|0|||
130773093|NCT01237327|470794872|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
130773094|NCT01237327|470794873|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
130773095|NCT01237327|470794872|FG000|Overall Study|Progression of Disease: Core Study|18|||
130773096|NCT01237327|470794873|FG001|Overall Study|Progression of Disease: Core Study|22|||
130773097|NCT01237327|470794872|FG000|Overall Study|Progression of Disease: Extension Study|15|||
130773098|NCT01237327|470794873|FG001|Overall Study|Progression of Disease: Extension Study|13|||
130773099|NCT01237327|470794872|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
130773100|NCT01237327|470794873|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
130773101|NCT01237327|470794872|FG000|Overall Study|Withdrawal by Subject|1|||
130773102|NCT01237327|470794873|FG001|Overall Study|Withdrawal by Subject|3|||
130773103|NCT01237327|470794872|FG000|Overall Study|Lost to Follow-up|3|||
130773104|NCT01237327|470794873|FG001|Overall Study|Lost to Follow-up|0|||
130773105|NCT01790516|470794876|FG000|Overall Study|Physician Decision|1|||
130773106|NCT01790516|470794877|FG001|Overall Study|Physician Decision|0|||
130773107|NCT01554163|470794878|FG000|Overall Study|Adverse Event|3|||
130773108|NCT01554163|470794879|FG001|Overall Study|Adverse Event|0|||
130773109|NCT01554163|470794878|FG000|Overall Study|Lack of Efficacy|1|||
130773110|NCT01554163|470794879|FG001|Overall Study|Lack of Efficacy|0|||
130773111|NCT01554163|470794878|FG000|Overall Study|Lost to Follow-up|1|||
130773112|NCT01554163|470794879|FG001|Overall Study|Lost to Follow-up|0|||
130773113|NCT01554163|470794878|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130773114|NCT01554163|470794879|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130773115|NCT01554163|470794878|FG000|Overall Study|Protocol Violation|0|||
130773116|NCT01554163|470794879|FG001|Overall Study|Protocol Violation|4|||
130773117|NCT01554163|470794878|FG000|Overall Study|Withdrawal by Subject|1|||
130773118|NCT01554163|470794879|FG001|Overall Study|Withdrawal by Subject|5|||
130773119|NCT01554163|470794878|FG000|Overall Study|Not Treated|1|||
130773120|NCT01554163|470794879|FG001|Overall Study|Not Treated|0|||
130773121|NCT02226120|470794880|FG000|Overall Study|Adverse Event|60|||
130773122|NCT02226120|470794880|FG000|Overall Study|Death|172|||
130773123|NCT02226120|470794880|FG000|Overall Study|Study terminated by sponsor|1|||
130773124|NCT02226120|470794880|FG000|Overall Study|Technical problems|4|||
130773125|NCT02226120|470794880|FG000|Overall Study|Lost to Follow-up|13|||
130773126|NCT02226120|470794880|FG000|Overall Study|Physician Decision|21|||
130773127|NCT02226120|470794880|FG000|Overall Study|Withdrawal by parent/guardian|36|||
130773128|NCT02226120|470794880|FG000|Overall Study|Non-compliance with study drug|10|||
130773129|NCT02226120|470794880|FG000|Overall Study|Protocol deviation|1|||
130773130|NCT02226120|470794880|FG000|Overall Study|missing treatment disposition pages|2|||
130773131|NCT03034135|470794881|FG000|Overall Study|Withdrawal by Subject|2|||
130773132|NCT01972464|470794885|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
130773133|NCT01972464|470794886|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
130773134|NCT01972464|470794885|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
130773135|NCT01972464|470794886|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
130773136|NCT01972464|470794885|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
130773137|NCT01972464|470794886|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
130773138|NCT01972464|470794885|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
130773139|NCT01972464|470794886|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
130709850|NCT02149121|470562432|FG004|Extension Study Period|Withdrawal by Subject|0|||
130709851|NCT02149121|470562433|FG005|Extension Study Period|Withdrawal by Subject|2|||
130709852|NCT02149121|470562434|FG006|Extension Study Period|Withdrawal by Subject|0|||
130709853|NCT03166124|470562435|FG000|Treatment Period 1|Adverse Event|0|||
130709854|NCT03166124|470562436|FG001|Treatment Period 1|Adverse Event|0|||
130709855|NCT03166124|470562437|FG002|Treatment Period 1|Adverse Event|1|||
130709856|NCT03166124|470562438|FG003|Treatment Period 1|Adverse Event|0|||
130709857|NCT03166124|470562435|FG000|Wash-out Period|Withdrawal by Subject|0|||
130709858|NCT03166124|470562436|FG001|Wash-out Period|Withdrawal by Subject|1|||
130773140|NCT02526160|470796919|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
130773141|NCT02526160|470796920|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
130773142|NCT02526160|470796919|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
130773143|NCT02526160|470796920|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
131124026|NCT01566773|472082904|FG000|Overall Study|Protocol specified criteria|4|||
131124027|NCT01566773|472082904|FG000|Overall Study|Protocol Violation|4|||
130773144|NCT02526160|470796919|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
130773145|NCT02526160|470796920|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
130709859|NCT03166124|470562437|FG002|Wash-out Period|Withdrawal by Subject|0|||
130709860|NCT03166124|470562438|FG003|Wash-out Period|Withdrawal by Subject|1|||
130773146|NCT02526160|470796919|FG000|Open-Label Treatment Extension Period I|Death|0|||
130709861|NCT03166124|470562435|FG000|Wash-out Period|Adverse Event|0|||
130709862|NCT03166124|470562436|FG001|Wash-out Period|Adverse Event|1|||
131124028|NCT01566773|472082904|FG000|Overall Study|Withdrawal by Subject|9|||
131124029|NCT01566773|472082904|FG000|Overall Study|Administrative reason|1|||
131124030|NCT01566773|472082904|FG000|Overall Study|Adverse Event|10|||
131124031|NCT01566773|472082904|FG000|Overall Study|Physician Decision|2|||
131124032|NCT00833053|472082906|FG000|Overall Study|Adverse Event|4|||
131124033|NCT00833053|472082907|FG001|Overall Study|Adverse Event|0|||
131124034|NCT00833053|472082906|FG000|Overall Study|Treatment Failure|3|||
131124035|NCT00833053|472082907|FG001|Overall Study|Treatment Failure|1|||
130709863|NCT03166124|470562437|FG002|Wash-out Period|Adverse Event|1|||
130709864|NCT03166124|470562438|FG003|Wash-out Period|Adverse Event|0|||
130709865|NCT00766831|470562439|FG000|Overall Study|Withdrawal by Subject|4|||
130709866|NCT00766831|470562439|FG000|Overall Study|Lost to Follow-up|3|||
130709867|NCT00766831|470562439|FG000|Overall Study|Adverse Event|20|||
130709868|NCT00766831|470562439|FG000|Overall Study|Protocol Violation|15|||
130709869|NCT00766831|470562439|FG000|Overall Study|Physician Decision|5|||
130709870|NCT00766831|470562439|FG000|Overall Study|Withdrawal of consent|26|||
130709871|NCT00766831|470562439|FG000|Overall Study|Non cooperation by participants|14|||
130709872|NCT00766831|470562439|FG000|Overall Study|Other|28|||
130709873|NCT01172821|470562442|FG000|Overall Study|Adverse Event|5|||
130709874|NCT01172821|470562443|FG001|Overall Study|Adverse Event|2|||
130709875|NCT01172821|470562444|FG002|Overall Study|Adverse Event|2|||
130709876|NCT01172821|470562445|FG003|Overall Study|Adverse Event|7|||
130709877|NCT01172821|470562442|FG000|Overall Study|Protocol Violation|0|||
130709878|NCT01172821|470562443|FG001|Overall Study|Protocol Violation|2|||
130709879|NCT01172821|470562444|FG002|Overall Study|Protocol Violation|1|||
130709880|NCT01172821|470562445|FG003|Overall Study|Protocol Violation|2|||
130709881|NCT01172821|470562442|FG000|Overall Study|Lost to Follow-up|4|||
130709882|NCT01172821|470562443|FG001|Overall Study|Lost to Follow-up|1|||
130709883|NCT01172821|470562444|FG002|Overall Study|Lost to Follow-up|2|||
130709884|NCT01172821|470562445|FG003|Overall Study|Lost to Follow-up|2|||
130709885|NCT01172821|470562442|FG000|Overall Study|Withdrawal by Subject|2|||
130709886|NCT01172821|470562443|FG001|Overall Study|Withdrawal by Subject|3|||
130709887|NCT01172821|470562444|FG002|Overall Study|Withdrawal by Subject|3|||
130709888|NCT01172821|470562445|FG003|Overall Study|Withdrawal by Subject|3|||
130709889|NCT01172821|470562442|FG000|Overall Study|Other|3|||
130709890|NCT01172821|470562443|FG001|Overall Study|Other|4|||
130709891|NCT01172821|470562444|FG002|Overall Study|Other|5|||
130709892|NCT01172821|470562445|FG003|Overall Study|Other|3|||
130709893|NCT00094094|470562446|FG000|Overall Study|Death|2|||
130709894|NCT00094094|470562446|FG000|Overall Study|Lack of Efficacy|23|||
130709895|NCT00094094|470562446|FG000|Overall Study|Adverse Event|7|||
130709896|NCT00710749|470562447|FG000|First Intervention|Withdrawal by Subject|1|||
130709897|NCT00710749|470562448|FG001|First Intervention|Withdrawal by Subject|0|||
130709898|NCT05626803|470564733|FG000|Overall Study|Lost to Follow-up|0|||
130709899|NCT05626803|470564734|FG001|Overall Study|Lost to Follow-up|1|||
130709900|NCT05626803|470564735|FG002|Overall Study|Lost to Follow-up|0|||
130709901|NCT05626803|470564736|FG003|Overall Study|Lost to Follow-up|0|||
130709902|NCT01000610|470564741|FG000|Overall Study|Adverse Event|1|||
130709903|NCT01000610|470564741|FG000|Overall Study|Lost to Follow-up|4|||
130709904|NCT01000610|470564741|FG000|Overall Study|Treatment failure|1|||
130709905|NCT00493246|470564742|FG000|Overall Study|Withdrawal by Subject|0|||
130709906|NCT00493246|470564743|FG001|Overall Study|Withdrawal by Subject|0|||
130709907|NCT00493246|470564744|FG002|Overall Study|Withdrawal by Subject|0|||
130709908|NCT00493246|470564745|FG003|Overall Study|Withdrawal by Subject|0|||
130709909|NCT00493246|470564746|FG004|Overall Study|Withdrawal by Subject|1|||
130709910|NCT00493246|470564747|FG005|Overall Study|Withdrawal by Subject|0|||
130709911|NCT00493246|470564748|FG006|Overall Study|Withdrawal by Subject|0|||
130709912|NCT00493246|470564749|FG007|Overall Study|Withdrawal by Subject|0|||
130709913|NCT00493246|470564742|FG000|Overall Study|No access to draw blood|0|||
130709914|NCT00493246|470564743|FG001|Overall Study|No access to draw blood|0|||
130709915|NCT00493246|470564744|FG002|Overall Study|No access to draw blood|0|||
130709916|NCT00493246|470564745|FG003|Overall Study|No access to draw blood|0|||
130709917|NCT00493246|470564746|FG004|Overall Study|No access to draw blood|0|||
131124036|NCT00833053|472082906|FG000|Overall Study|Withdrawal by Subject|0|||
131124037|NCT00833053|472082907|FG001|Overall Study|Withdrawal by Subject|1|||
131124038|NCT00833053|472082906|FG000|Overall Study|Protocol Violation|2|||
131124039|NCT00833053|472082907|FG001|Overall Study|Protocol Violation|1|||
131124040|NCT02187471|472082909|FG000|Overall Study|Protocol Violation|4|||
130709918|NCT00493246|470564747|FG005|Overall Study|No access to draw blood|1|||
130709919|NCT00493246|470564748|FG006|Overall Study|No access to draw blood|0|||
130709920|NCT00493246|470564749|FG007|Overall Study|No access to draw blood|0|||
130709921|NCT00493246|470564742|FG000|Overall Study|Lost to Follow-up|0|||
130709922|NCT00493246|470564743|FG001|Overall Study|Lost to Follow-up|0|||
130709923|NCT00493246|470564744|FG002|Overall Study|Lost to Follow-up|0|||
130709924|NCT00493246|470564745|FG003|Overall Study|Lost to Follow-up|0|||
130709925|NCT00493246|470564746|FG004|Overall Study|Lost to Follow-up|0|||
130709926|NCT00493246|470564747|FG005|Overall Study|Lost to Follow-up|0|||
130709927|NCT00493246|470564748|FG006|Overall Study|Lost to Follow-up|1|||
130709928|NCT00493246|470564749|FG007|Overall Study|Lost to Follow-up|0|||
130943968|NCT04307446|471429355|FG000|Overall Study|Lost to Follow-up|2|||
131124041|NCT02187471|472082910|FG001|Overall Study|Protocol Violation|5|||
131124042|NCT02187471|472082911|FG002|Overall Study|Protocol Violation|4|||
131124043|NCT02187471|472082912|FG003|Overall Study|Protocol Violation|4|||
131124044|NCT02187471|472082909|FG000|Overall Study|Missing|0|||
131124045|NCT02187471|472082910|FG001|Overall Study|Missing|0|||
131124046|NCT02187471|472082911|FG002|Overall Study|Missing|0|||
131124047|NCT02187471|472082912|FG003|Overall Study|Missing|1|||
131124048|NCT02187471|472082909|FG000|Overall Study|Lack of Efficacy|18|||
131124049|NCT02187471|472082910|FG001|Overall Study|Lack of Efficacy|9|||
131124050|NCT02187471|472082911|FG002|Overall Study|Lack of Efficacy|13|||
131124051|NCT02187471|472082912|FG003|Overall Study|Lack of Efficacy|11|||
131124052|NCT02187471|472082909|FG000|Overall Study|Adverse Event|24|||
131124053|NCT02187471|472082910|FG001|Overall Study|Adverse Event|34|||
131124054|NCT02187471|472082911|FG002|Overall Study|Adverse Event|44|||
131124055|NCT02187471|472082912|FG003|Overall Study|Adverse Event|36|||
131124056|NCT02187471|472082909|FG000|Overall Study|Withdrawal by Subject|23|||
131124057|NCT02187471|472082910|FG001|Overall Study|Withdrawal by Subject|29|||
131124058|NCT02187471|472082911|FG002|Overall Study|Withdrawal by Subject|22|||
131124059|NCT02187471|472082912|FG003|Overall Study|Withdrawal by Subject|24|||
131124060|NCT02187471|472082909|FG000|Overall Study|Other|7|||
131124061|NCT02187471|472082910|FG001|Overall Study|Other|5|||
131124062|NCT02187471|472082911|FG002|Overall Study|Other|3|||
131124063|NCT02187471|472082912|FG003|Overall Study|Other|4|||
131124064|NCT02236520|472082913|FG000|Overall Study|Physician Decision|0|||
131124065|NCT02236520|472082914|FG001|Overall Study|Physician Decision|5|||
131124066|NCT02236520|472082915|FG002|Overall Study|Physician Decision|0|||
131124067|NCT02236520|472082916|FG003|Overall Study|Physician Decision|0|||
130709929|NCT02698865|470564751|FG000|Overall Study|Other|11|||
130709930|NCT02698865|470564752|FG001|Overall Study|Other|11|||
130709931|NCT02698865|470564751|FG000|Overall Study|Withdrawal by Subject|20|||
130709932|NCT02698865|470564752|FG001|Overall Study|Withdrawal by Subject|16|||
130709933|NCT02698865|470564751|FG000|Overall Study|Physician Decision|0|||
130709934|NCT02698865|470564752|FG001|Overall Study|Physician Decision|4|||
130709935|NCT02698865|470564751|FG000|Overall Study|Lost to Follow-up|4|||
130709936|NCT02698865|470564752|FG001|Overall Study|Lost to Follow-up|2|||
130709937|NCT03861481|470564753|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
130709938|NCT03861481|470564754|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
130709939|NCT03861481|470564753|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
130709940|NCT03861481|470564754|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
130709941|NCT03861481|470564753|FG000|Overall Study|Relapse|1|||
130709942|NCT03861481|470564754|FG001|Overall Study|Relapse|0|||
130709943|NCT03861481|470564753|FG000|Overall Study|Withdrawal by Subject|0|||
130709944|NCT03861481|470564754|FG001|Overall Study|Withdrawal by Subject|1|||
130709945|NCT03861481|470564753|FG000|Overall Study|Lack of Efficacy|4|||
130709946|NCT03861481|470564754|FG001|Overall Study|Lack of Efficacy|5|||
130709947|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
130773147|NCT02526160|470796920|FG001|Open-Label Treatment Extension Period I|Death|1|||
130943969|NCT04307446|471429356|FG001|Overall Study|Lost to Follow-up|0|||
130943970|NCT02672423|471429359|FG000|Period 1|Adverse Event|0|||
130943971|NCT02672423|471429360|FG001|Period 1|Adverse Event|0|||
130943972|NCT02672423|471429361|FG002|Period 1|Adverse Event|0|||
130943973|NCT02672423|471429362|FG003|Period 1|Adverse Event|0|||
130943974|NCT02672423|471429363|FG004|Period 1|Adverse Event|1|||
130943975|NCT02672423|471429364|FG005|Period 1|Adverse Event|0|||
130943976|NCT02672423|471429365|FG006|Period 1|Adverse Event|0|||
130943977|NCT02672423|471429366|FG007|Period 1|Adverse Event|0|||
130943978|NCT02672423|471429367|FG008|Period 1|Adverse Event|0|||
130943979|NCT02672423|471429368|FG009|Period 1|Adverse Event|0|||
130943980|NCT02672423|471429359|FG000|Period 2|Withdrawal by Subject|0|||
131036938|NCT03852472|471768264|FG001|Period 2 - Week 44|Reason not stated|0|||
131036939|NCT03852472|471768265|FG002|Period 2 - Week 44|Reason not stated|0|||
131036940|NCT03852472|471768266|FG003|Period 2 - Week 44|Reason not stated|0|||
131036941|NCT03852472|471768267|FG004|Period 2 - Week 44|Reason not stated|1|||
131036942|NCT06457802|471768268|FG000|Overall Study|Early termination of study prior to participant completion|2|||
131036943|NCT06457802|471768269|FG001|Overall Study|Early termination of study prior to participant completion|2|||
131036944|NCT03161028|471768270|FG000|Overall Study|Withdrawal by Subject|6|||
131036945|NCT03161028|471768271|FG001|Overall Study|Withdrawal by Subject|4|||
131124068|NCT02236520|472082913|FG000|Overall Study|Withdrawal by Subject|1|||
131124069|NCT02236520|472082914|FG001|Overall Study|Withdrawal by Subject|0|||
131124070|NCT02236520|472082915|FG002|Overall Study|Withdrawal by Subject|0|||
131124071|NCT02236520|472082916|FG003|Overall Study|Withdrawal by Subject|1|||
130709948|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
130709949|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
130709950|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
130709951|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
130943981|NCT02672423|471429360|FG001|Period 2|Withdrawal by Subject|0|||
130943982|NCT02672423|471429361|FG002|Period 2|Withdrawal by Subject|1|||
130773148|NCT02526160|470796919|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
130773149|NCT02526160|470796920|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
130773150|NCT02526160|470796919|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
130773151|NCT02526160|470796920|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
130773152|NCT02526160|470796919|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
130773153|NCT02526160|470796920|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
130773154|NCT02526160|470796919|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
130773155|NCT02526160|470796920|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
130773156|NCT01048944|470796923|FG000|Overall Study|Protocol Violation|8|||
130773157|NCT01048944|470796924|FG001|Overall Study|Protocol Violation|10|||
130773158|NCT01048944|470796925|FG002|Overall Study|Protocol Violation|10|||
130773159|NCT01048944|470796926|FG003|Overall Study|Protocol Violation|2|||
130773160|NCT01844817|470796927|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
130773161|NCT01844817|470796928|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
130773162|NCT01844817|470796927|FG000|Treatment|Progressive Disease|27|||
130773163|NCT01844817|470796928|FG001|Treatment|Progressive Disease|36|||
130773164|NCT01844817|470796927|FG000|Treatment|Adverse Event|17|||
130773165|NCT01844817|470796928|FG001|Treatment|Adverse Event|9|||
130773166|NCT01844817|470796927|FG000|Treatment|Withdrawal by Subject|10|||
131036946|NCT03161028|471768270|FG000|Overall Study|Adverse Event|5|||
131036947|NCT03161028|471768271|FG001|Overall Study|Adverse Event|1|||
131036948|NCT03161028|471768270|FG000|Overall Study|Study drug side effects|2|||
131036949|NCT03161028|471768271|FG001|Overall Study|Study drug side effects|2|||
131124072|NCT02236520|472082913|FG000|Overall Study|Pregnancy|1|||
131124073|NCT02236520|472082914|FG001|Overall Study|Pregnancy|0|||
131124074|NCT02236520|472082915|FG002|Overall Study|Pregnancy|0|||
131124075|NCT02236520|472082916|FG003|Overall Study|Pregnancy|0|||
131124076|NCT01785160|472082917|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
130709952|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
130709953|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
130709954|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
131124077|NCT01785160|472082917|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
131124078|NCT00957528|472082918|FG000|Overall Study|Protocol Violation|0|||
131124079|NCT00957528|472082919|FG001|Overall Study|Protocol Violation|1|||
131124080|NCT00957528|472082920|FG002|Overall Study|Protocol Violation|0|||
131124081|NCT00957528|472082918|FG000|Overall Study|Withdrawal by Subject|0|||
130709955|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
130709956|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
130709957|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
130709958|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
130709959|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
130709960|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
130709961|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
130709962|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
130709963|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
130773167|NCT01844817|470796928|FG001|Treatment|Withdrawal by Subject|6|||
130773168|NCT01844817|470796927|FG000|Treatment|Death|10|||
131036950|NCT03161028|471768270|FG000|Overall Study|Administrative PD/UP|4|||
131036951|NCT03161028|471768271|FG001|Overall Study|Administrative PD/UP|2|||
131036952|NCT03161028|471768270|FG000|Overall Study|Lost to Follow-up|2|||
131036953|NCT03161028|471768271|FG001|Overall Study|Lost to Follow-up|0|||
131036954|NCT03161028|471768270|FG000|Overall Study|Unable to comply with procedures|1|||
131036955|NCT03161028|471768271|FG001|Overall Study|Unable to comply with procedures|1|||
131036956|NCT00736723|471768272|FG000|Overall Study|Withdrawal by Subject|4|||
131036957|NCT00736723|471768273|FG001|Overall Study|Withdrawal by Subject|3|||
131036958|NCT04797897|471768274|FG000|Overall Study|Study Termination by Sponsor|1|||
131036959|NCT04797897|471768275|FG001|Overall Study|Study Termination by Sponsor|1|||
131036960|NCT03024437|471768281|FG000|Overall Study|Adverse Event|0|||
131036961|NCT03024437|471768282|FG001|Overall Study|Adverse Event|1|||
131036962|NCT03024437|471768283|FG002|Overall Study|Adverse Event|3|||
131036963|NCT03024437|471768284|FG003|Overall Study|Adverse Event|5|||
131036964|NCT03024437|471768285|FG004|Overall Study|Adverse Event|0|||
131036965|NCT03024437|471768281|FG000|Overall Study|Physician Decision|1|||
131036966|NCT03024437|471768282|FG001|Overall Study|Physician Decision|0|||
131036967|NCT03024437|471768283|FG002|Overall Study|Physician Decision|0|||
131124082|NCT00957528|472082919|FG001|Overall Study|Withdrawal by Subject|0|||
131124083|NCT00957528|472082920|FG002|Overall Study|Withdrawal by Subject|1|||
130773169|NCT01844817|470796928|FG001|Treatment|Death|8|||
131124084|NCT02289742|472082921|FG000|First Wear Period|Adverse event prior to treatment|0|||
130773170|NCT01844817|470796927|FG000|Treatment|Lost to Follow-up|0|||
130773171|NCT01844817|470796928|FG001|Treatment|Lost to Follow-up|1|||
131036968|NCT03024437|471768284|FG003|Overall Study|Physician Decision|1|||
131036969|NCT03024437|471768285|FG004|Overall Study|Physician Decision|0|||
131036970|NCT03024437|471768281|FG000|Overall Study|Disease progression, relapse|1|||
130709964|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
131124085|NCT02289742|472082922|FG001|First Wear Period|Adverse event prior to treatment|1|||
130709965|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
130709966|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130709967|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130709968|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130709969|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130709970|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130709971|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
130709972|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130709973|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130709974|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
130709975|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130709976|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130709977|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
130709978|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
130709979|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
130709980|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
130709981|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
130709982|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
130709983|NCT00773734|470564755|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130709984|NCT00773734|470564756|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130709985|NCT00773734|470564757|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130709986|NCT00773734|470564758|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130709987|NCT00773734|470564759|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
130709988|NCT00773734|470564760|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
130709989|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
130709990|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
130709991|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
130709992|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
130709993|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
130709994|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
130709995|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
130709996|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
130709997|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
130709998|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
130709999|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
130710000|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
130710001|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
130710002|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
130710003|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
130710004|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
130710005|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
130710006|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
130710007|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130710008|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
130710009|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
130710010|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130710011|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130710012|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130710013|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
130710014|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130943983|NCT02672423|471429362|FG003|Period 2|Withdrawal by Subject|0|||
130943984|NCT02672423|471429363|FG004|Period 2|Withdrawal by Subject|0|||
130943985|NCT02672423|471429364|FG005|Period 2|Withdrawal by Subject|0|||
130943986|NCT02672423|471429365|FG006|Period 2|Withdrawal by Subject|0|||
130943987|NCT02672423|471429366|FG007|Period 2|Withdrawal by Subject|0|||
130943988|NCT02672423|471429367|FG008|Period 2|Withdrawal by Subject|0|||
130943989|NCT02672423|471429368|FG009|Period 2|Withdrawal by Subject|0|||
130943990|NCT02672423|471429359|FG000|Period 3|Withdrawal by Subject|0|||
130943991|NCT02672423|471429360|FG001|Period 3|Withdrawal by Subject|0|||
130943992|NCT02672423|471429361|FG002|Period 3|Withdrawal by Subject|0|||
130943993|NCT02672423|471429362|FG003|Period 3|Withdrawal by Subject|0|||
130943994|NCT02672423|471429363|FG004|Period 3|Withdrawal by Subject|0|||
131124086|NCT02289742|472082923|FG002|First Wear Period|Adverse event prior to treatment|0|||
130943995|NCT02672423|471429364|FG005|Period 3|Withdrawal by Subject|0|||
130943996|NCT02672423|471429365|FG006|Period 3|Withdrawal by Subject|0|||
131124087|NCT02289742|472082924|FG003|First Wear Period|Adverse event prior to treatment|0|||
130710015|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130710016|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130710017|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
130710018|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130710019|NCT00773734|470564755|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
130710020|NCT00773734|470564756|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
130710021|NCT00773734|470564757|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
130710022|NCT00773734|470564758|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
130710023|NCT00773734|470564759|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
130710024|NCT00773734|470564760|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
130710025|NCT00773734|470564755|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130710026|NCT00773734|470564756|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130710027|NCT00773734|470564757|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130710028|NCT00773734|470564758|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130710029|NCT00773734|470564759|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
130710030|NCT00773734|470564760|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
130710031|NCT00773734|470564755|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
130710032|NCT00773734|470564756|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
130710033|NCT00773734|470564757|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
130710034|NCT00773734|470564758|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
130710035|NCT00773734|470564759|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
130710036|NCT00773734|470564760|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
130710037|NCT00773734|470564755|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
130710038|NCT00773734|470564756|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
130710039|NCT00773734|470564757|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
130710040|NCT00773734|470564758|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
130710041|NCT00773734|470564759|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
130710042|NCT00773734|470564760|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
130710043|NCT00773734|470564755|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
130710044|NCT00773734|470564756|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
130710045|NCT00773734|470564757|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
130710046|NCT00773734|470564758|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
130710047|NCT00773734|470564759|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
130710048|NCT00773734|470564760|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
130710049|NCT00773734|470564755|FG000|Extension: Active Treatment Week 24-52|Other|0|||
130710050|NCT00773734|470564756|FG001|Extension: Active Treatment Week 24-52|Other|0|||
130710051|NCT00773734|470564757|FG002|Extension: Active Treatment Week 24-52|Other|1|||
130710052|NCT00773734|470564758|FG003|Extension: Active Treatment Week 24-52|Other|2|||
130710053|NCT00773734|470564759|FG004|Extension: Active Treatment Week 24-52|Other|0|||
130710054|NCT00773734|470564760|FG005|Extension: Active Treatment Week 24-52|Other|1|||
130710055|NCT00773734|470564755|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130710056|NCT00773734|470564756|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130710057|NCT00773734|470564757|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130710058|NCT00773734|470564758|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
130710059|NCT00773734|470564759|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130710060|NCT00773734|470564760|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130710061|NCT00773734|470564755|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130710062|NCT00773734|470564756|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130710063|NCT00773734|470564757|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
130710064|NCT00773734|470564758|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
130710065|NCT00773734|470564759|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130710066|NCT00773734|470564760|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130710067|NCT00773734|470564755|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130710068|NCT00773734|470564756|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130710069|NCT00773734|470564757|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
130710070|NCT00773734|470564758|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
130710071|NCT00773734|470564759|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130710072|NCT00773734|470564760|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130710073|NCT00773734|470564755|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130710074|NCT00773734|470564756|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130710075|NCT00773734|470564757|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
130710076|NCT00773734|470564758|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
130710077|NCT00773734|470564759|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130710078|NCT00773734|470564760|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130710079|NCT01220297|470564763|FG000|Overall Study|Death|2|||
130710080|NCT01220297|470564763|FG000|Overall Study|Lost to Follow-up|1|||
130710081|NCT01287039|470564764|FG000|Overall Study|Noncompliance with study procedures|0|||
130710082|NCT01287039|470564765|FG001|Overall Study|Noncompliance with study procedures|1|||
130710083|NCT01287039|470564764|FG000|Overall Study|Change of location/residence|0|||
130710084|NCT01287039|470564765|FG001|Overall Study|Change of location/residence|3|||
130710085|NCT01287039|470564764|FG000|Overall Study|Elective surgery|0|||
130710086|NCT01287039|470564765|FG001|Overall Study|Elective surgery|1|||
130710087|NCT01287039|470564764|FG000|Overall Study|Protocol Violation|2|||
130710088|NCT01287039|470564765|FG001|Overall Study|Protocol Violation|3|||
130710089|NCT01287039|470564764|FG000|Overall Study|Excluded medication taken|1|||
130710090|NCT01287039|470564765|FG001|Overall Study|Excluded medication taken|0|||
130710091|NCT01287039|470564764|FG000|Overall Study|Noncompliance with study medication|0|||
130710092|NCT01287039|470564765|FG001|Overall Study|Noncompliance with study medication|1|||
131036971|NCT03024437|471768282|FG001|Overall Study|Disease progression, relapse|0|||
130710093|NCT01287039|470564764|FG000|Overall Study|Problem with travel|0|||
130710094|NCT01287039|470564765|FG001|Overall Study|Problem with travel|1|||
130710095|NCT01287039|470564764|FG000|Overall Study|Death|1|||
130710096|NCT01287039|470564765|FG001|Overall Study|Death|0|||
130710097|NCT01287039|470564764|FG000|Overall Study|Change of residence|1|||
130710098|NCT01287039|470564765|FG001|Overall Study|Change of residence|0|||
130710099|NCT01287039|470564764|FG000|Overall Study|Adverse Event|7|||
130710100|NCT01287039|470564765|FG001|Overall Study|Adverse Event|4|||
130710101|NCT01287039|470564764|FG000|Overall Study|Withdrawal by Subject|14|||
130710102|NCT01287039|470564765|FG001|Overall Study|Withdrawal by Subject|11|||
130710103|NCT01287039|470564764|FG000|Overall Study|Lost to Follow-up|3|||
130710104|NCT01287039|470564765|FG001|Overall Study|Lost to Follow-up|2|||
130710105|NCT05016622|470564766|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
130710106|NCT05016622|470564766|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
130710107|NCT02581163|470564769|FG000|Overall Study|Failure to return|15|||
130710108|NCT02581163|470564769|FG000|Overall Study|Insufficient virological response|3|||
130710109|NCT02581163|470564769|FG000|Overall Study|Withdrew consent|1|||
130710110|NCT02581163|470564769|FG000|Overall Study|Death|1|||
130710111|NCT02581163|470564769|FG000|Overall Study|Other, not specified|9|||
130710112|NCT02791893|470564770|FG000|Blinded Phase|Lost to Follow-up|2|||
130710113|NCT02791893|470564771|FG001|Blinded Phase|Lost to Follow-up|2|||
130710114|NCT02791893|470564770|FG000|Blinded Phase|Withdrawal by Subject|1|||
131036972|NCT03024437|471768283|FG002|Overall Study|Disease progression, relapse|0|||
131224492|NCT02059187|472448909|FG001|Overall Study|Lost to Follow-up|8|||
131224493|NCT02059187|472448908|FG000|Overall Study|Non-compliance with study drug|1|||
131224494|NCT02059187|472448909|FG001|Overall Study|Non-compliance with study drug|0|||
131224495|NCT02059187|472448908|FG000|Overall Study|Physician Decision|1|||
131224496|NCT02059187|472448909|FG001|Overall Study|Physician Decision|2|||
131224497|NCT02059187|472448908|FG000|Overall Study|Protocol Violation|1|||
131224498|NCT02059187|472448909|FG001|Overall Study|Protocol Violation|0|||
131224499|NCT02059187|472448908|FG000|Overall Study|Withdrawal by Subject|12|||
131224500|NCT02059187|472448909|FG001|Overall Study|Withdrawal by Subject|8|||
131224501|NCT03070431|472448910|FG000|Overall Study|Withdrawal by Subject|2|||
131224502|NCT03070431|472448910|FG000|Overall Study|Lost to Follow-up|2|||
131224503|NCT01889862|472448911|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
131224504|NCT01889862|472448912|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
131224505|NCT01889862|472448913|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
131224506|NCT01889862|472448914|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
131224507|NCT01889862|472448915|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
131224508|NCT01889862|472448911|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
131224509|NCT01889862|472448912|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
131224510|NCT01889862|472448913|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
131224511|NCT01889862|472448914|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
131224512|NCT01889862|472448915|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
131224513|NCT01889862|472448911|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
131224514|NCT01889862|472448912|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
131224515|NCT01889862|472448913|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
131224516|NCT01889862|472448914|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
131224517|NCT01889862|472448915|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
131224518|NCT01889862|472448911|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
131224519|NCT01889862|472448912|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
131224520|NCT01889862|472448913|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
131224521|NCT01889862|472448914|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
131224522|NCT01889862|472448915|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
131224523|NCT01889862|472448911|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
131224524|NCT01889862|472448912|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
131224525|NCT01889862|472448913|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
131224526|NCT01889862|472448914|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
131224527|NCT01889862|472448915|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
131224528|NCT01889862|472448911|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
131224529|NCT01889862|472448912|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
131224530|NCT01889862|472448913|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
131224531|NCT01889862|472448914|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
130773172|NCT01844817|470796927|FG000|Treatment|Other|0|||
130773173|NCT01844817|470796928|FG001|Treatment|Other|3|||
130773174|NCT01133704|470796929|FG000|Overall Study|Death|44|||
130773175|NCT01133704|470796930|FG001|Overall Study|Death|26|||
130773176|NCT01133704|470796929|FG000|Overall Study|Patient refused to continue|4|||
130773177|NCT01133704|470796930|FG001|Overall Study|Patient refused to continue|0|||
130773178|NCT01133704|470796929|FG000|Overall Study|Study Closure|1|||
130773179|NCT01133704|470796930|FG001|Overall Study|Study Closure|0|||
130773180|NCT03396822|470796933|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
130773181|NCT03396822|470796933|FG000|Overall Study|Physician Decision|1|||
130773182|NCT04985942|470796934|FG000|Overall Study|Adverse Event|14|||
130773183|NCT04985942|470796935|FG001|Overall Study|Adverse Event|2|||
130773184|NCT04985942|470796934|FG000|Overall Study|Lack of Efficacy|0|||
130773185|NCT04985942|470796935|FG001|Overall Study|Lack of Efficacy|3|||
130773186|NCT04985942|470796934|FG000|Overall Study|Lost to Follow-up|1|||
130773187|NCT04985942|470796935|FG001|Overall Study|Lost to Follow-up|1|||
130773188|NCT04985942|470796934|FG000|Overall Study|Protocol Violation|1|||
130773189|NCT04985942|470796935|FG001|Overall Study|Protocol Violation|1|||
130773190|NCT04985942|470796934|FG000|Overall Study|Withdrawal by Subject|5|||
130773191|NCT04985942|470796935|FG001|Overall Study|Withdrawal by Subject|4|||
130773192|NCT03630705|470796936|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
130773193|NCT03630705|470796937|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
130773194|NCT03630705|470796938|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130773195|NCT03630705|470796939|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130773196|NCT03630705|470796936|FG000|Overall Study|Lost to Follow-up|1|||
130773197|NCT03630705|470796937|FG001|Overall Study|Lost to Follow-up|2|||
130773198|NCT03630705|470796938|FG002|Overall Study|Lost to Follow-up|0|||
130773199|NCT03630705|470796939|FG003|Overall Study|Lost to Follow-up|0|||
130773200|NCT02576977|470796943|FG000|Overall Study|Adverse Event|13|||
130773201|NCT02576977|470796944|FG001|Overall Study|Adverse Event|2|||
130773202|NCT02576977|470796943|FG000|Overall Study|Death|73|||
130773203|NCT02576977|470796944|FG001|Overall Study|Death|60|||
130773204|NCT02576977|470796943|FG000|Overall Study|Screen failure|1|||
130773205|NCT02576977|470796944|FG001|Overall Study|Screen failure|0|||
130773206|NCT02576977|470796943|FG000|Overall Study|Study Terminated at Selected Sites|27|||
130773207|NCT02576977|470796944|FG001|Overall Study|Study Terminated at Selected Sites|50|||
130773208|NCT02576977|470796943|FG000|Overall Study|Withdrawal by Subject|11|||
130773209|NCT02576977|470796944|FG001|Overall Study|Withdrawal by Subject|11|||
130773210|NCT02576977|470796943|FG000|Overall Study|Final Disposition Unknown|0|||
130773211|NCT02576977|470796944|FG001|Overall Study|Final Disposition Unknown|1|||
130773212|NCT02576977|470796943|FG000|Overall Study|Lost to Follow-up|1|||
130773213|NCT02576977|470796944|FG001|Overall Study|Lost to Follow-up|0|||
130773214|NCT02576977|470796943|FG000|Overall Study|Progressive Disease|0|||
130773215|NCT02576977|470796944|FG001|Overall Study|Progressive Disease|1|||
130773216|NCT03251482|470796945|FG000|Overall Study|Withdrawal by Subject|0|||
130773217|NCT03251482|470796946|FG001|Overall Study|Withdrawal by Subject|1|||
130773218|NCT03251482|470796947|FG002|Overall Study|Withdrawal by Subject|0|||
130773219|NCT03251482|470796948|FG003|Overall Study|Withdrawal by Subject|0|||
130773220|NCT03251482|470796949|FG004|Overall Study|Withdrawal by Subject|0|||
130773221|NCT02447328|470796952|FG000|Overall Study|Withdrawal by Subject|1|||
130943997|NCT02672423|471429366|FG007|Period 3|Withdrawal by Subject|1|||
130943998|NCT02672423|471429367|FG008|Period 3|Withdrawal by Subject|0|||
130943999|NCT02672423|471429368|FG009|Period 3|Withdrawal by Subject|0|||
130944000|NCT02672423|471429359|FG000|Period 3|Physician Decision|0|||
130944001|NCT02672423|471429360|FG001|Period 3|Physician Decision|0|||
130944002|NCT02672423|471429361|FG002|Period 3|Physician Decision|0|||
130944003|NCT02672423|471429362|FG003|Period 3|Physician Decision|0|||
130944004|NCT02672423|471429363|FG004|Period 3|Physician Decision|0|||
130944005|NCT02672423|471429364|FG005|Period 3|Physician Decision|1|||
130773222|NCT00314808|470796958|FG000|Overall Study|Disease Progression without AE|4|||
130944006|NCT02672423|471429365|FG006|Period 3|Physician Decision|0|||
130773223|NCT00314808|470796958|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
130773224|NCT04304508|470796959|FG000|Overall Study|Subject Decision|29|||
130773225|NCT04304508|470796960|FG001|Overall Study|Subject Decision|39|||
130773226|NCT04304508|470796961|FG002|Overall Study|Subject Decision|37|||
130773227|NCT04304508|470796962|FG003|Overall Study|Subject Decision|48|||
130944007|NCT02672423|471429366|FG007|Period 3|Physician Decision|0|||
130944008|NCT02672423|471429367|FG008|Period 3|Physician Decision|0|||
130944009|NCT02672423|471429368|FG009|Period 3|Physician Decision|0|||
130944010|NCT00536107|471429372|FG000|Overall Study|Death|5|||
130944011|NCT00536107|471429373|FG001|Overall Study|Death|1|||
130944012|NCT00536107|471429372|FG000|Overall Study|Incorrect enrolment|1|||
130944013|NCT00536107|471429373|FG001|Overall Study|Incorrect enrolment|0|||
130944014|NCT00536107|471429372|FG000|Overall Study|Withdrawal by Subject|0|||
130773228|NCT04304508|470796959|FG000|Overall Study|Death|6|||
130773229|NCT04304508|470796960|FG001|Overall Study|Death|1|||
130773230|NCT04304508|470796961|FG002|Overall Study|Death|8|||
130773231|NCT04304508|470796962|FG003|Overall Study|Death|5|||
130944015|NCT00536107|471429373|FG001|Overall Study|Withdrawal by Subject|1|||
130944016|NCT00536107|471429372|FG000|Overall Study|Study Termination|2|||
130944017|NCT00536107|471429373|FG001|Overall Study|Study Termination|4|||
130944018|NCT04356963|471429375|FG000|First Session|Withdrawal by Subject|1|||
130944019|NCT04356963|471429375|FG000|Second Session|Withdrawal by Subject|3|||
130944020|NCT04356963|471429375|FG000|Second Session|Lost to Follow-up|1|||
130944021|NCT04356963|471429375|FG000|Third Session|Lost to Follow-up|6|||
130944022|NCT04356963|471429375|FG000|Third Session|Withdrawal by Subject|1|||
130944023|NCT05172544|471429380|FG000|Overall Study|Withdrawal by Subject|1|||
130944024|NCT05172544|471429381|FG001|Overall Study|Withdrawal by Subject|0|||
130944025|NCT05172544|471429382|FG002|Overall Study|Withdrawal by Subject|0|||
130944026|NCT05172544|471429380|FG000|Overall Study|Physician Decision|0|||
130944027|NCT05172544|471429381|FG001|Overall Study|Physician Decision|0|||
130944028|NCT05172544|471429382|FG002|Overall Study|Physician Decision|1|||
130944029|NCT01176266|471429385|FG000|Overall Study|Death|6|||
130944030|NCT01176266|471429385|FG000|Overall Study|Withdrawal by Subject|3|||
130944031|NCT04829318|471429386|FG000|Overall Study|Adverse Event|6|||
130944032|NCT04829318|471429386|FG000|Overall Study|Death|1|||
130944033|NCT04829318|471429386|FG000|Overall Study|Lost to Follow-up|1|||
130944034|NCT04829318|471429386|FG000|Overall Study|Physician Decision|1|||
130944035|NCT04829318|471429386|FG000|Overall Study|Withdrawal by Subject|19|||
130944036|NCT04829318|471429386|FG000|Overall Study|Site terminated by sponsor|1|||
130944037|NCT04829318|471429386|FG000|Overall Study|Sponsor decision|5|||
131224532|NCT01889862|472448915|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
131224533|NCT01889862|472448911|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
131224534|NCT01889862|472448912|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
131224535|NCT01889862|472448913|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
131224536|NCT01889862|472448914|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
131224537|NCT01889862|472448915|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
131224538|NCT01889862|472448911|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
131224539|NCT01889862|472448912|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
131224540|NCT01889862|472448913|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
131224541|NCT01889862|472448914|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
131224542|NCT01889862|472448915|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
131224543|NCT01889862|472448911|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
131224544|NCT01889862|472448912|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
131224545|NCT01889862|472448913|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
131224546|NCT01889862|472448914|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
131224547|NCT01889862|472448915|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
131224548|NCT01889862|472448911|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
131224549|NCT01889862|472448912|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
131224550|NCT01889862|472448913|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
131224551|NCT01889862|472448914|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
131224552|NCT01889862|472448915|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
131224553|NCT00845026|472448916|FG000|Study Period III|Adverse Event|23|||
131224554|NCT00845026|472448917|FG001|Study Period III|Adverse Event|19|||
131224555|NCT00845026|472448916|FG000|Study Period III|Perceived lack of efficacy|27|||
131224556|NCT00845026|472448917|FG001|Study Period III|Perceived lack of efficacy|15|||
131224557|NCT00845026|472448916|FG000|Study Period III|Withdrawal by Subject|19|||
131224558|NCT00845026|472448917|FG001|Study Period III|Withdrawal by Subject|15|||
131224559|NCT00845026|472448916|FG000|Study Period III|Entry Criteria not met|8|||
131224560|NCT00845026|472448917|FG001|Study Period III|Entry Criteria not met|11|||
131224561|NCT00845026|472448916|FG000|Study Period III|Lost to Follow-up|4|||
131224562|NCT00845026|472448917|FG001|Study Period III|Lost to Follow-up|5|||
131224563|NCT00845026|472448916|FG000|Study Period III|Protocol Violation|8|||
131224564|NCT00845026|472448917|FG001|Study Period III|Protocol Violation|1|||
131224565|NCT00845026|472448916|FG000|Study Period III|Scheduled conflict|3|||
131224566|NCT00845026|472448917|FG001|Study Period III|Scheduled conflict|1|||
131224567|NCT00845026|472448916|FG000|Study Period III|Subject is moving or has moved|2|||
131224568|NCT00845026|472448917|FG001|Study Period III|Subject is moving or has moved|4|||
131224569|NCT00845026|472448916|FG000|Study Period III|Transportation issues|1|||
131224570|NCT00845026|472448917|FG001|Study Period III|Transportation issues|1|||
131224571|NCT00845026|472448916|FG000|Study Period IV|Adverse Event|4|||
131224572|NCT00845026|472448917|FG001|Study Period IV|Adverse Event|0|||
131224573|NCT00845026|472448916|FG000|Study Period IV|Perceived lack of efficacy|2|||
131224574|NCT00845026|472448917|FG001|Study Period IV|Perceived lack of efficacy|1|||
130944038|NCT04829318|471429386|FG000|Overall Study|Other|1|||
130944039|NCT00728130|471429387|FG000|Overall Study|Withdrawal by Subject|1|||
130944040|NCT00728130|471429387|FG000|Overall Study|Paperwork not completed in time|1|||
130944041|NCT00728130|471429387|FG000|Overall Study|Physician Decision|1|||
130944042|NCT02073279|471429390|FG000|Double-blind Period|Adverse Event|1|||
130944043|NCT02073279|471429391|FG001|Double-blind Period|Adverse Event|1|||
130944044|NCT02073279|471429390|FG000|Double-blind Period|Switched to another treatment|1|||
131224575|NCT00845026|472448916|FG000|Study Period IV|Protocol Violation|3|||
131224576|NCT00845026|472448917|FG001|Study Period IV|Protocol Violation|1|||
131224577|NCT00845026|472448916|FG000|Study Period IV|Lost to Follow-up|1|||
131124088|NCT02289742|472082921|FG000|First Wear Period|Adverse Event|0|||
131124089|NCT02289742|472082922|FG001|First Wear Period|Adverse Event|0|||
131124090|NCT02289742|472082923|FG002|First Wear Period|Adverse Event|1|||
131124091|NCT02289742|472082924|FG003|First Wear Period|Adverse Event|0|||
131124092|NCT02289742|472082921|FG000|First Wear Period|Other prior to treatment|0|||
131124093|NCT02289742|472082922|FG001|First Wear Period|Other prior to treatment|0|||
131124094|NCT02289742|472082923|FG002|First Wear Period|Other prior to treatment|0|||
131124095|NCT02289742|472082924|FG003|First Wear Period|Other prior to treatment|1|||
131124096|NCT02289742|472082921|FG000|Third Wear Period|Adverse Event|0|||
131124097|NCT02289742|472082922|FG001|Third Wear Period|Adverse Event|1|||
131124098|NCT02289742|472082923|FG002|Third Wear Period|Adverse Event|0|||
131124099|NCT02289742|472082924|FG003|Third Wear Period|Adverse Event|0|||
131224578|NCT00845026|472448917|FG001|Study Period IV|Lost to Follow-up|0|||
130773232|NCT04304508|470796959|FG000|Overall Study|Non-compliance With Study Drug|3|||
130773233|NCT04304508|470796960|FG001|Overall Study|Non-compliance With Study Drug|1|||
130944045|NCT02073279|471429391|FG001|Double-blind Period|Switched to another treatment|2|||
130944046|NCT02073279|471429390|FG000|Double-blind Period|Protocol Violation|0|||
130944047|NCT02073279|471429391|FG001|Double-blind Period|Protocol Violation|1|||
130944048|NCT02073279|471429390|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
130944049|NCT02073279|471429391|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
130944050|NCT02073279|471429390|FG000|Double-blind Period|Withdrawal by Subject|2|||
130944051|NCT02073279|471429391|FG001|Double-blind Period|Withdrawal by Subject|2|||
130944052|NCT02073279|471429390|FG000|Open-label Extension Period|Adverse Event|1|||
130944053|NCT02073279|471429391|FG001|Open-label Extension Period|Adverse Event|0|||
130944054|NCT02073279|471429390|FG000|Open-label Extension Period|Lack of Efficacy|1|||
130944055|NCT02073279|471429391|FG001|Open-label Extension Period|Lack of Efficacy|0|||
130944056|NCT02073279|471429390|FG000|Open-label Extension Period|Lost to Follow-up|0|||
130944057|NCT02073279|471429391|FG001|Open-label Extension Period|Lost to Follow-up|4|||
130944058|NCT02073279|471429390|FG000|Open-label Extension Period|Switched to another treatment|1|||
130944059|NCT02073279|471429391|FG001|Open-label Extension Period|Switched to another treatment|4|||
130944060|NCT02073279|471429390|FG000|Open-label Extension Period|Protocol Violation|0|||
130944061|NCT02073279|471429391|FG001|Open-label Extension Period|Protocol Violation|1|||
130944062|NCT02073279|471429390|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
130944063|NCT02073279|471429391|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
130944064|NCT02073279|471429390|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
130944065|NCT02073279|471429391|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
130944066|NCT05075850|471429397|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
130944067|NCT01265849|471429398|FG000|Overall Study|Randomized//Treatment not initiated|1|||
130944068|NCT01265849|471429399|FG001|Overall Study|Randomized//Treatment not initiated|4|||
130944069|NCT01265849|471429400|FG002|Overall Study|Randomized//Treatment not initiated|0|||
130944070|NCT01265849|471429398|FG000|Overall Study|Physician Decision|1|||
130944071|NCT01265849|471429399|FG001|Overall Study|Physician Decision|2|||
130944072|NCT01265849|471429400|FG002|Overall Study|Physician Decision|0|||
130944073|NCT01265849|471429398|FG000|Overall Study|Lost to Follow-up|18|||
130944074|NCT01265849|471429399|FG001|Overall Study|Lost to Follow-up|15|||
130944075|NCT01265849|471429400|FG002|Overall Study|Lost to Follow-up|5|||
131224579|NCT00845026|472448916|FG000|Study Period IV|Withdrawal by Subject|4|||
131224580|NCT00845026|472448917|FG001|Study Period IV|Withdrawal by Subject|1|||
131224581|NCT00845026|472448916|FG000|Study Period IV|Entry Criteria Not Met|1|||
131224582|NCT00845026|472448917|FG001|Study Period IV|Entry Criteria Not Met|0|||
131224583|NCT00845026|472448916|FG000|Study Period IV|Subject is moving or has moved|0|||
131224584|NCT00845026|472448917|FG001|Study Period IV|Subject is moving or has moved|1|||
131224585|NCT00845026|472448916|FG000|Study Period IV|Scheduling conflict|1|||
131224586|NCT00845026|472448917|FG001|Study Period IV|Scheduling conflict|0|||
131224587|NCT01325532|472448918|FG000|Overall Study|Withdrawal by Subject|2|||
131224588|NCT01325532|472448919|FG001|Overall Study|Withdrawal by Subject|0|||
131224589|NCT03012815|472448920|FG000|Overall Study|Lost to Follow-up|1|||
131224590|NCT03012815|472448921|FG001|Overall Study|Lost to Follow-up|0|||
131224591|NCT03012815|472448920|FG000|Overall Study|Physician Decision|3|||
131224592|NCT03012815|472448921|FG001|Overall Study|Physician Decision|2|||
131224593|NCT03012815|472448920|FG000|Overall Study|Adverse Event|1|||
130773234|NCT04304508|470796961|FG002|Overall Study|Non-compliance With Study Drug|2|||
130944076|NCT01265849|471429398|FG000|Overall Study|Not otherwise specified|1|||
130944077|NCT01265849|471429399|FG001|Overall Study|Not otherwise specified|6|||
130944078|NCT01265849|471429400|FG002|Overall Study|Not otherwise specified|1|||
130944079|NCT01265849|471429398|FG000|Overall Study|Withdrawal by Subject|25|||
130944080|NCT01265849|471429399|FG001|Overall Study|Withdrawal by Subject|34|||
131124100|NCT02289742|472082921|FG000|Third Wear Period|Reason not given|0|||
131124101|NCT02289742|472082922|FG001|Third Wear Period|Reason not given|0|||
131124102|NCT02289742|472082923|FG002|Third Wear Period|Reason not given|0|||
131124103|NCT02289742|472082924|FG003|Third Wear Period|Reason not given|1|||
131224594|NCT03012815|472448921|FG001|Overall Study|Adverse Event|0|||
131224595|NCT02065791|472448922|FG000|Overall Study|Closed Site|1|||
131224596|NCT02065791|472448923|FG001|Overall Study|Closed Site|1|||
131224597|NCT02065791|472448922|FG000|Overall Study|Withdrawal by Subject|11|||
131224598|NCT02065791|472448923|FG001|Overall Study|Withdrawal by Subject|5|||
131224599|NCT02065791|472448922|FG000|Overall Study|Lost to Follow-up|13|||
131224600|NCT02065791|472448923|FG001|Overall Study|Lost to Follow-up|9|||
131224601|NCT00272961|472448924|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
131224602|NCT00272961|472448925|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
131224603|NCT00272961|472448926|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
131224604|NCT00272961|472448927|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
131224605|NCT00272961|472448928|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
131224606|NCT00272961|472448924|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
131224607|NCT00272961|472448925|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
131224608|NCT00272961|472448926|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
131224609|NCT00272961|472448927|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
131224610|NCT00272961|472448928|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
131224611|NCT00272961|472448924|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
131224612|NCT00272961|472448925|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
131224613|NCT00272961|472448926|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
131224614|NCT00272961|472448927|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
131224615|NCT00272961|472448928|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
131224616|NCT00272961|472448924|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
131224617|NCT00272961|472448925|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
131224618|NCT00272961|472448926|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
131224619|NCT00272961|472448927|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
131224620|NCT00272961|472448928|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
131224621|NCT00272961|472448924|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
131224622|NCT00272961|472448925|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
131224623|NCT00272961|472448926|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
131224624|NCT00272961|472448927|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
131224625|NCT00272961|472448928|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
131224626|NCT00272961|472448924|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
131224627|NCT00272961|472448925|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
131224628|NCT00272961|472448926|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
131224629|NCT00272961|472448927|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
131224630|NCT00272961|472448928|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
131224631|NCT00272961|472448924|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
131224632|NCT00272961|472448925|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
131224633|NCT00272961|472448926|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
131224634|NCT00272961|472448927|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
131224635|NCT00272961|472448928|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
131224636|NCT00272961|472448924|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
131224637|NCT00272961|472448925|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
131224638|NCT00272961|472448926|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
131224639|NCT00272961|472448927|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
131224640|NCT00272961|472448928|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
131224641|NCT01507831|472448929|FG000|Overall Study|Randomized but not treated|0|||
131224642|NCT01507831|472448930|FG001|Overall Study|Randomized but not treated|3|||
131224643|NCT01507831|472448929|FG000|Overall Study|Adverse Event|48|||
131224644|NCT01507831|472448930|FG001|Overall Study|Adverse Event|113|||
131224645|NCT01507831|472448929|FG000|Overall Study|Death|6|||
131224646|NCT01507831|472448930|FG001|Overall Study|Death|2|||
131224647|NCT01507831|472448929|FG000|Overall Study|Poor compliance to protocol|38|||
131224648|NCT01507831|472448930|FG001|Overall Study|Poor compliance to protocol|60|||
130944081|NCT01265849|471429400|FG002|Overall Study|Withdrawal by Subject|13|||
130944082|NCT03194321|471429402|FG000|Overall Study|Withdrawal by Subject|1|||
130944083|NCT03194321|471429402|FG000|Overall Study|Lost to Follow-up|1|||
130944084|NCT03194321|471429402|FG000|Overall Study|Travel for Follow-up|1|||
130944085|NCT03803774|471429403|FG000|Dose Escalation|Withdrawal by Subject|0|||
130944086|NCT03803774|471429404|FG001|Dose Escalation|Withdrawal by Subject|0|||
130944087|NCT03803774|471429405|FG002|Dose Escalation|Withdrawal by Subject|0|||
130944088|NCT03803774|471429406|FG003|Dose Escalation|Withdrawal by Subject|1|||
130944089|NCT03803774|471429407|FG004|Dose Escalation|Withdrawal by Subject|0|||
130944090|NCT00271609|471429408|FG000|Overall Study|Adverse Event|11|||
131224649|NCT01507831|472448929|FG000|Overall Study|Physician Decision|0|||
131224650|NCT01507831|472448930|FG001|Overall Study|Physician Decision|4|||
131224651|NCT01507831|472448929|FG000|Overall Study|Participant moved|5|||
131224652|NCT01507831|472448930|FG001|Overall Study|Participant moved|19|||
130944091|NCT00271609|471429409|FG001|Overall Study|Adverse Event|3|||
130944092|NCT00271609|471429408|FG000|Overall Study|Withdrawal by Subject|2|||
130944093|NCT00271609|471429409|FG001|Overall Study|Withdrawal by Subject|0|||
130944094|NCT02188589|471429410|FG000|Overall Study|Withdrawal by Subject|5|||
131224653|NCT01507831|472448929|FG000|Overall Study|Consent withdrawn by participant|34|||
130944095|NCT00878709|471429414|FG000|Overall Study|Withdrawal by Subject|197|||
131224654|NCT01507831|472448930|FG001|Overall Study|Consent withdrawn by participant|72|||
130944096|NCT00878709|471429415|FG001|Overall Study|Withdrawal by Subject|120|||
130944097|NCT00878709|471429414|FG000|Overall Study|Lost to Follow-up|35|||
130944098|NCT00878709|471429415|FG001|Overall Study|Lost to Follow-up|33|||
130944099|NCT00878709|471429414|FG000|Overall Study|Other Reasons|93|||
130944100|NCT00878709|471429415|FG001|Overall Study|Other Reasons|84|||
130944101|NCT01712854|471429416|FG000|Overall Study|Physician Decision|1|||
130944102|NCT00768300|471429419|FG000|Overall Study|Randomized but not treated|1|||
130944103|NCT00768300|471429420|FG001|Overall Study|Randomized but not treated|1|||
130944104|NCT00768300|471429419|FG000|Overall Study|Adverse Event|10|||
130944105|NCT00768300|471429420|FG001|Overall Study|Adverse Event|2|||
130944106|NCT00768300|471429419|FG000|Overall Study|Protocol Violation|6|||
130944107|NCT00768300|471429420|FG001|Overall Study|Protocol Violation|1|||
130944108|NCT00768300|471429419|FG000|Overall Study|Withdrawal by Subject|13|||
130944109|NCT00768300|471429420|FG001|Overall Study|Withdrawal by Subject|7|||
130944110|NCT00768300|471429419|FG000|Overall Study|Physician Decision|2|||
130944111|NCT00768300|471429420|FG001|Overall Study|Physician Decision|3|||
130944112|NCT00768300|471429419|FG000|Overall Study|Study discontinued by Sponsor|271|||
130944113|NCT00768300|471429420|FG001|Overall Study|Study discontinued by Sponsor|140|||
130944114|NCT00768300|471429419|FG000|Overall Study|Death|21|||
130944115|NCT00768300|471429420|FG001|Overall Study|Death|5|||
130944116|NCT00768300|471429419|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
130944117|NCT00768300|471429420|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
130944118|NCT00768300|471429419|FG000|Overall Study|Screen failure following randomization|1|||
130944119|NCT00768300|471429420|FG001|Overall Study|Screen failure following randomization|0|||
130944120|NCT00768300|471429419|FG000|Overall Study|Received lung transplant|1|||
130944121|NCT00768300|471429420|FG001|Overall Study|Received lung transplant|1|||
130944122|NCT00768300|471429419|FG000|Overall Study|Lost to Follow-up|0|||
130944123|NCT00768300|471429420|FG001|Overall Study|Lost to Follow-up|1|||
130944124|NCT00768300|471429419|FG000|Overall Study|Began prohibited concomitant medication|0|||
130944125|NCT00768300|471429420|FG001|Overall Study|Began prohibited concomitant medication|1|||
130944126|NCT00768300|471429419|FG000|Overall Study|Treated but never dosed with Study drug|1|||
130944127|NCT00768300|471429420|FG001|Overall Study|Treated but never dosed with Study drug|0|||
130944128|NCT00768300|471429419|FG000|Overall Study|Missing data|1|||
130944129|NCT00768300|471429420|FG001|Overall Study|Missing data|0|||
130944130|NCT04690751|471429422|FG000|Overall Study|Protocol Violation|0|||
130944131|NCT04690751|471429423|FG001|Overall Study|Protocol Violation|1|||
130944132|NCT04690751|471429424|FG002|Overall Study|Protocol Violation|0|||
130944133|NCT04690751|471429425|FG003|Overall Study|Protocol Violation|1|||
130944134|NCT04690751|471429426|FG004|Overall Study|Protocol Violation|2|||
130944135|NCT04690751|471429427|FG005|Overall Study|Protocol Violation|0|||
130944136|NCT04690751|471429422|FG000|Overall Study|Adverse Event|0|||
130944137|NCT04690751|471429423|FG001|Overall Study|Adverse Event|0|||
130944138|NCT04690751|471429424|FG002|Overall Study|Adverse Event|1|||
130944139|NCT04690751|471429425|FG003|Overall Study|Adverse Event|0|||
130944140|NCT04690751|471429426|FG004|Overall Study|Adverse Event|0|||
130944141|NCT04690751|471429427|FG005|Overall Study|Adverse Event|0|||
130944142|NCT04690751|471429422|FG000|Overall Study|Positive urine drug screen test|0|||
130944143|NCT04690751|471429423|FG001|Overall Study|Positive urine drug screen test|0|||
130944144|NCT04690751|471429424|FG002|Overall Study|Positive urine drug screen test|0|||
130944145|NCT04690751|471429425|FG003|Overall Study|Positive urine drug screen test|0|||
130944146|NCT04690751|471429426|FG004|Overall Study|Positive urine drug screen test|1|||
130944147|NCT04690751|471429427|FG005|Overall Study|Positive urine drug screen test|0|||
130944148|NCT01344161|471429428|FG000|Overall Study|Lost to Follow-up|4|||
131224655|NCT01507831|472448929|FG000|Overall Study|Related to study drug administration|5|||
131224656|NCT01507831|472448930|FG001|Overall Study|Related to study drug administration|14|||
131224657|NCT01507831|472448929|FG000|Overall Study|Last visit outside protocol visit window|51|||
131224658|NCT01507831|472448930|FG001|Overall Study|Last visit outside protocol visit window|143|||
131224659|NCT01507831|472448929|FG000|Overall Study|Selection criteria finally not met|0|||
131224660|NCT01507831|472448930|FG001|Overall Study|Selection criteria finally not met|1|||
131224661|NCT01507831|472448929|FG000|Overall Study|Site closure|0|||
130944149|NCT01344161|471429429|FG001|Overall Study|Lost to Follow-up|1|||
130944150|NCT01344161|471429428|FG000|Overall Study|Pregnancy|0|||
130944151|NCT01344161|471429429|FG001|Overall Study|Pregnancy|1|||
130944152|NCT01344161|471429428|FG000|Overall Study|Protocol Violation|1|||
131224662|NCT01507831|472448930|FG001|Overall Study|Site closure|3|||
130944153|NCT01344161|471429429|FG001|Overall Study|Protocol Violation|1|||
130944154|NCT03759379|471431257|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
130944155|NCT03759379|471431258|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
130944156|NCT03759379|471431257|FG000|Treatment Period|Death|2|||
130944157|NCT03759379|471431258|FG001|Treatment Period|Death|3|||
130944158|NCT03759379|471431257|FG000|Treatment Period|Lost to Follow-up|1|||
130944159|NCT03759379|471431258|FG001|Treatment Period|Lost to Follow-up|0|||
131036973|NCT03024437|471768284|FG003|Overall Study|Disease progression, relapse|3|||
131036974|NCT03024437|471768285|FG004|Overall Study|Disease progression, relapse|0|||
131036975|NCT03024437|471768281|FG000|Overall Study|Disease progression, refractory disease|4|||
131224663|NCT01507831|472448929|FG000|Overall Study|Potential lost to follow-up|3|||
130773235|NCT04304508|470796962|FG003|Overall Study|Non-compliance With Study Drug|0|||
130773236|NCT04304508|470796959|FG000|Overall Study|Switching To Other Therapy|1|||
130773237|NCT04304508|470796960|FG001|Overall Study|Switching To Other Therapy|1|||
130773238|NCT04304508|470796961|FG002|Overall Study|Switching To Other Therapy|1|||
130773239|NCT04304508|470796962|FG003|Overall Study|Switching To Other Therapy|2|||
130773240|NCT04304508|470796959|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
130773241|NCT04304508|470796960|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
130773242|NCT04304508|470796961|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
130773243|NCT04304508|470796962|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
130773244|NCT04304508|470796959|FG000|Overall Study|Withdrawal by Subject|7|||
130773245|NCT04304508|470796960|FG001|Overall Study|Withdrawal by Subject|5|||
130773246|NCT04304508|470796961|FG002|Overall Study|Withdrawal by Subject|11|||
130773247|NCT04304508|470796962|FG003|Overall Study|Withdrawal by Subject|6|||
130773248|NCT04304508|470796959|FG000|Overall Study|Logistical Difficulties|2|||
130773249|NCT04304508|470796960|FG001|Overall Study|Logistical Difficulties|2|||
130773250|NCT04304508|470796961|FG002|Overall Study|Logistical Difficulties|3|||
130773251|NCT04304508|470796962|FG003|Overall Study|Logistical Difficulties|2|||
130773252|NCT04304508|470796959|FG000|Overall Study|Missing Information|1|||
130773253|NCT04304508|470796960|FG001|Overall Study|Missing Information|2|||
130773254|NCT04304508|470796961|FG002|Overall Study|Missing Information|1|||
130773255|NCT04304508|470796962|FG003|Overall Study|Missing Information|3|||
130773256|NCT04304508|470796959|FG000|Overall Study|Other|7|||
130773257|NCT04304508|470796960|FG001|Overall Study|Other|6|||
130773258|NCT04304508|470796961|FG002|Overall Study|Other|5|||
130773259|NCT04304508|470796962|FG003|Overall Study|Other|4|||
130773260|NCT04304508|470796959|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
130773261|NCT04304508|470796960|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
130773262|NCT04304508|470796961|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
130773263|NCT04304508|470796962|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
130773264|NCT04304508|470796959|FG000|Overall Study|Physician Decision|3|||
130773265|NCT04304508|470796960|FG001|Overall Study|Physician Decision|4|||
130773266|NCT04304508|470796961|FG002|Overall Study|Physician Decision|9|||
130773267|NCT04304508|470796962|FG003|Overall Study|Physician Decision|7|||
130773268|NCT04304508|470796959|FG000|Overall Study|Study drug never administered|10|||
130773269|NCT04304508|470796960|FG001|Overall Study|Study drug never administered|4|||
130773270|NCT04304508|470796961|FG002|Overall Study|Study drug never administered|4|||
130773271|NCT04304508|470796962|FG003|Overall Study|Study drug never administered|4|||
130773272|NCT04304508|470796959|FG000|Overall Study|Adverse Event|49|||
130773273|NCT04304508|470796960|FG001|Overall Study|Adverse Event|50|||
130773274|NCT04304508|470796961|FG002|Overall Study|Adverse Event|51|||
130773275|NCT04304508|470796962|FG003|Overall Study|Adverse Event|56|||
130773276|NCT04304508|470796959|FG000|Overall Study|Lost to Follow-up|1|||
130773277|NCT04304508|470796960|FG001|Overall Study|Lost to Follow-up|5|||
130773278|NCT04304508|470796961|FG002|Overall Study|Lost to Follow-up|2|||
131036976|NCT03024437|471768282|FG001|Overall Study|Disease progression, refractory disease|4|||
131036977|NCT03024437|471768283|FG002|Overall Study|Disease progression, refractory disease|2|||
131036978|NCT03024437|471768284|FG003|Overall Study|Disease progression, refractory disease|2|||
131036979|NCT03024437|471768285|FG004|Overall Study|Disease progression, refractory disease|1|||
131036980|NCT03024437|471768281|FG000|Overall Study|Newly diagnosed cancer|0|||
131036981|NCT03024437|471768282|FG001|Overall Study|Newly diagnosed cancer|0|||
131036982|NCT03024437|471768283|FG002|Overall Study|Newly diagnosed cancer|0|||
131036983|NCT03024437|471768284|FG003|Overall Study|Newly diagnosed cancer|1|||
131036984|NCT03024437|471768285|FG004|Overall Study|Newly diagnosed cancer|0|||
131224664|NCT01507831|472448930|FG001|Overall Study|Potential lost to follow-up|0|||
131224665|NCT01507831|472448929|FG000|Overall Study|Other|3|||
131224666|NCT01507831|472448930|FG001|Overall Study|Other|6|||
131224667|NCT03296553|472448932|FG000|Overall Study|Withdrawal by Subject|1|||
131224668|NCT03296553|472448933|FG001|Overall Study|Withdrawal by Subject|1|||
131224669|NCT03296553|472448932|FG000|Overall Study|Death|1|||
131224670|NCT03296553|472448933|FG001|Overall Study|Death|0|||
131224671|NCT02295280|472448934|FG000|Overall Study|Adverse Event|0|||
131224672|NCT02295280|472448935|FG001|Overall Study|Adverse Event|1|||
130773279|NCT04304508|470796962|FG003|Overall Study|Lost to Follow-up|3|||
130773280|NCT02688764|470796963|FG000|Overall Study|Adverse Event|3|||
131224673|NCT00124449|472448936|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
130773281|NCT02688764|470796964|FG001|Overall Study|Adverse Event|3|||
130773282|NCT02688764|470796963|FG000|Overall Study|AE/Kidney transplant|1|||
130773283|NCT02688764|470796964|FG001|Overall Study|AE/Kidney transplant|0|||
130773284|NCT02688764|470796963|FG000|Overall Study|AE/Lack of efficacy|1|||
130773285|NCT02688764|470796964|FG001|Overall Study|AE/Lack of efficacy|0|||
130773286|NCT02688764|470796963|FG000|Overall Study|AE/Non-compl.|1|||
130944160|NCT03759379|471431257|FG000|Treatment Period|Physician Decision|0|||
130944161|NCT03759379|471431258|FG001|Treatment Period|Physician Decision|1|||
131224674|NCT00124449|472448937|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
131224675|NCT00124449|472448936|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
131224676|NCT00124449|472448937|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
131224677|NCT00124449|472448936|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
131224678|NCT00124449|472448937|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
131224679|NCT00124449|472448936|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
131224680|NCT00124449|472448937|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
131224681|NCT00124449|472448936|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
131224682|NCT00124449|472448937|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
131224683|NCT00124449|472448936|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
131224684|NCT00124449|472448937|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
131224685|NCT00124449|472448936|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
131224686|NCT00124449|472448937|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
131224687|NCT00124449|472448936|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
131224688|NCT00124449|472448937|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
131224689|NCT00124449|472448936|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
131224690|NCT00124449|472448937|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
131224691|NCT00124449|472448936|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
131224692|NCT00124449|472448937|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
131224693|NCT00124449|472448936|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
131224694|NCT00124449|472448937|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
131224695|NCT00124449|472448936|FG000|18-Month Untreated Observation Period|Relocated|1|||
131224696|NCT00124449|472448937|FG001|18-Month Untreated Observation Period|Relocated|0|||
131224697|NCT02971605|472448938|FG000|Overall Study|Withdrawal by Subject|1|||
131224698|NCT01021137|472448939|FG000|Overall Study|Lost to Follow-up|9|||
131224699|NCT01021137|472448940|FG001|Overall Study|Lost to Follow-up|4|||
131224700|NCT01021137|472448941|FG002|Overall Study|Lost to Follow-up|2|||
131224701|NCT01021137|472448942|FG003|Overall Study|Lost to Follow-up|6|||
131224702|NCT01021137|472448939|FG000|Overall Study|Withdrawal by Subject|1|||
131224703|NCT01021137|472448940|FG001|Overall Study|Withdrawal by Subject|0|||
131224704|NCT01021137|472448941|FG002|Overall Study|Withdrawal by Subject|0|||
131224705|NCT01021137|472448942|FG003|Overall Study|Withdrawal by Subject|3|||
131224706|NCT03439293|472448943|FG000|Overall Study|Death|22|||
131224707|NCT03439293|472448943|FG000|Overall Study|Withdrawal by Subject|8|||
131224708|NCT03439293|472448943|FG000|Overall Study|Lost to Follow-up|2|||
131224709|NCT03439293|472448943|FG000|Overall Study|Reason Not Specified|28|||
131224710|NCT03439293|472448943|FG000|Overall Study|Missing|1|||
131224711|NCT02766400|472448948|FG000|Overall Study|Death|1|||
131224712|NCT02766400|472448949|FG001|Overall Study|Death|2|||
131224713|NCT02766400|472448948|FG000|Overall Study|Withdrawal by Subject|1|||
131224714|NCT02766400|472448949|FG001|Overall Study|Withdrawal by Subject|0|||
131224715|NCT03499249|472448954|FG000|Overall Study|Physician Decision|1|||
131224716|NCT00534092|472450506|FG000|Overall Study|Lost to Follow-up|1|||
131224717|NCT00534092|472450507|FG001|Overall Study|Lost to Follow-up|0|||
131224718|NCT00534092|472450506|FG000|Overall Study|personal reasons/family concerns|1|||
131224719|NCT00534092|472450507|FG001|Overall Study|personal reasons/family concerns|0|||
131224720|NCT02919475|472450508|FG000|Overall Study|Adverse Event|3|||
131224721|NCT02919475|472450509|FG001|Overall Study|Adverse Event|3|||
131224722|NCT02919475|472450510|FG002|Overall Study|Adverse Event|3|||
131224723|NCT02919475|472450511|FG003|Overall Study|Adverse Event|9|||
131224724|NCT02919475|472450512|FG004|Overall Study|Adverse Event|2|||
130773287|NCT02688764|470796964|FG001|Overall Study|AE/Non-compl.|0|||
130773288|NCT02688764|470796963|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
130773289|NCT02688764|470796964|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
130773290|NCT02688764|470796963|FG000|Overall Study|AE/Other|0|||
130773291|NCT02688764|470796964|FG001|Overall Study|AE/Other|1|||
130773292|NCT02688764|470796963|FG000|Overall Study|AE/Physician decision|1|||
130773293|NCT02688764|470796964|FG001|Overall Study|AE/Physician decision|0|||
130773294|NCT02688764|470796963|FG000|Overall Study|AE/Withd. parent|3|||
130773295|NCT02688764|470796964|FG001|Overall Study|AE/Withd. parent|0|||
130773296|NCT02688764|470796963|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
130773297|NCT02688764|470796964|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
130773298|NCT02688764|470796963|FG000|Overall Study|AE/Withd. subject|1|||
130773299|NCT02688764|470796964|FG001|Overall Study|AE/Withd. subject|0|||
130773300|NCT02688764|470796963|FG000|Overall Study|Kidney transplant|10|||
130773301|NCT02688764|470796964|FG001|Overall Study|Kidney transplant|4|||
130773302|NCT02688764|470796963|FG000|Overall Study|Lack of Efficacy|3|||
130773303|NCT02688764|470796964|FG001|Overall Study|Lack of Efficacy|2|||
130773304|NCT02688764|470796963|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
130773305|NCT02688764|470796964|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
130773306|NCT02688764|470796963|FG000|Overall Study|Non-compliance with study drug|4|||
130773307|NCT02688764|470796964|FG001|Overall Study|Non-compliance with study drug|0|||
130773308|NCT02688764|470796963|FG000|Overall Study|Non-compl./Physician decision|2|||
130773309|NCT02688764|470796964|FG001|Overall Study|Non-compl./Physician decision|0|||
130773310|NCT02688764|470796963|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
131124104|NCT02865018|472082925|FG000|Overall Study|Withdrawal by Subject|1|||
131124105|NCT02181816|472082926|FG000|Overall Study|Case Report Forms Uncollected|38|||
131124106|NCT02181816|472082926|FG000|Overall Study|Protocol Deviation|21|||
131124107|NCT01365039|472082927|FG000|Overall Study|Study related symptoms and complaints|1|||
131124108|NCT01365039|472082928|FG001|Overall Study|Study related symptoms and complaints|0|||
131124109|NCT03807349|472082931|FG000|Overall Study|Early Study Termination|9|||
131124110|NCT00294060|472082932|FG000|Overall Study|Death|225|||
131124111|NCT00294060|472082932|FG000|Overall Study|Other|59|||
131124112|NCT00294060|472082932|FG000|Overall Study|Lost to Follow-up|55|||
131124113|NCT00294060|472082932|FG000|Overall Study|Withdrawal by Subject|11|||
131124114|NCT00294060|472082932|FG000|Overall Study|Physician Decision|797|||
131124115|NCT00294060|472082932|FG000|Overall Study|Medical condition|3|||
131124116|NCT00294060|472082932|FG000|Overall Study|Device explanted/not replaced|23|||
131124117|NCT02159729|472082940|FG000|Overall Study|Adverse Event|0|||
131124118|NCT02159729|472082941|FG001|Overall Study|Adverse Event|1|||
131124119|NCT02159729|472082940|FG000|Overall Study|Subject's Request|13|||
131124120|NCT02159729|472082941|FG001|Overall Study|Subject's Request|10|||
131124121|NCT02159729|472082940|FG000|Overall Study|Lost to Follow-up|24|||
131124122|NCT02159729|472082941|FG001|Overall Study|Lost to Follow-up|9|||
131124123|NCT02159729|472082940|FG000|Overall Study|Non compliance|2|||
131124124|NCT02159729|472082941|FG001|Overall Study|Non compliance|0|||
131124125|NCT02159729|472082940|FG000|Overall Study|Other Unspecified|3|||
131124126|NCT02159729|472082941|FG001|Overall Study|Other Unspecified|1|||
131124127|NCT02636582|472082942|FG000|Overall Study|Surgical Pathology|1|||
131124128|NCT02636582|472082943|FG001|Overall Study|Surgical Pathology|0|||
131124129|NCT05500274|472082944|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
131124130|NCT05500274|472082945|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
131124131|NCT05500274|472082944|FG000|Overall Study|Lost to Follow-up|76|||
131124132|NCT05500274|472082945|FG001|Overall Study|Lost to Follow-up|51|||
131124133|NCT01555151|472082946|FG000|Overall Study|Withdrawal by Subject|6|||
131124134|NCT01555151|472082947|FG001|Overall Study|Withdrawal by Subject|2|||
131124135|NCT01555151|472082948|FG002|Overall Study|Withdrawal by Subject|0|||
131124136|NCT01555151|472082949|FG003|Overall Study|Withdrawal by Subject|2|||
131124137|NCT01555151|472082946|FG000|Overall Study|Administrative|3|||
131124138|NCT01555151|472082947|FG001|Overall Study|Administrative|1|||
131124139|NCT01555151|472082948|FG002|Overall Study|Administrative|2|||
131124140|NCT01555151|472082949|FG003|Overall Study|Administrative|0|||
131124141|NCT01555151|472082946|FG000|Overall Study|Protocol Violation|3|||
131124142|NCT01555151|472082947|FG001|Overall Study|Protocol Violation|3|||
131124143|NCT01555151|472082948|FG002|Overall Study|Protocol Violation|3|||
131124144|NCT01555151|472082949|FG003|Overall Study|Protocol Violation|5|||
130773311|NCT02688764|470796964|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
130773312|NCT02688764|470796963|FG000|Overall Study|Non-compl./Withd. subject|0|||
130773313|NCT02688764|470796964|FG001|Overall Study|Non-compl./Withd. subject|2|||
130773314|NCT02688764|470796963|FG000|Overall Study|Phosphorus level outside safe range|0|||
130773315|NCT02688764|470796964|FG001|Overall Study|Phosphorus level outside safe range|1|||
130773316|NCT02688764|470796963|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
130773317|NCT02688764|470796964|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
131124145|NCT01555151|472082946|FG000|Overall Study|Adverse Event|1|||
131124146|NCT01555151|472082947|FG001|Overall Study|Adverse Event|2|||
130773318|NCT02688764|470796963|FG000|Overall Study|Study drug taste/Withd. parent|1|||
130773319|NCT02688764|470796964|FG001|Overall Study|Study drug taste/Withd. parent|0|||
130773320|NCT02688764|470796963|FG000|Overall Study|Subject moving out|2|||
130773321|NCT02688764|470796964|FG001|Overall Study|Subject moving out|0|||
130773322|NCT02688764|470796963|FG000|Overall Study|Subject taken off dialysis|1|||
130773323|NCT02688764|470796964|FG001|Overall Study|Subject taken off dialysis|0|||
130773324|NCT02688764|470796963|FG000|Overall Study|Withdrawal by parent|3|||
130773325|NCT02688764|470796964|FG001|Overall Study|Withdrawal by parent|0|||
130773326|NCT02113007|470796965|FG000|Overall Study|Progressive disease|2|||
130773327|NCT00885378|470796966|FG000|Overall Study|Lack of Efficacy|2|||
130773328|NCT00885378|470796967|FG001|Overall Study|Lack of Efficacy|2|||
130773329|NCT00885378|470796966|FG000|Overall Study|Withdrawal by Subject|1|||
130773330|NCT00885378|470796967|FG001|Overall Study|Withdrawal by Subject|2|||
130944189|NCT02967692|471431269|FG000|Overall Study|Progressive disease|3|||
130944190|NCT02967692|471431270|FG001|Overall Study|Progressive disease|15|||
130944191|NCT02967692|471431271|FG002|Overall Study|Progressive disease|114|||
130944192|NCT02967692|471431272|FG003|Overall Study|Progressive disease|151|||
130944193|NCT02967692|471431269|FG000|Overall Study|Subject/guardian decision|1|||
130944194|NCT02967692|471431270|FG001|Overall Study|Subject/guardian decision|1|||
130944195|NCT02967692|471431271|FG002|Overall Study|Subject/guardian decision|14|||
130944196|NCT02967692|471431272|FG003|Overall Study|Subject/guardian decision|22|||
130944197|NCT02967692|471431269|FG000|Overall Study|Death|0|||
130944198|NCT02967692|471431270|FG001|Overall Study|Death|1|||
130944199|NCT02967692|471431271|FG002|Overall Study|Death|13|||
130944200|NCT02967692|471431272|FG003|Overall Study|Death|13|||
130944201|NCT02967692|471431269|FG000|Overall Study|Protocol deviation|1|||
130944202|NCT02967692|471431270|FG001|Overall Study|Protocol deviation|0|||
130944203|NCT02967692|471431271|FG002|Overall Study|Protocol deviation|1|||
130944204|NCT02967692|471431272|FG003|Overall Study|Protocol deviation|1|||
130944205|NCT02967692|471431269|FG000|Overall Study|Lost to Follow-up|0|||
130944206|NCT02967692|471431270|FG001|Overall Study|Lost to Follow-up|0|||
130944207|NCT02967692|471431271|FG002|Overall Study|Lost to Follow-up|1|||
130944208|NCT02967692|471431272|FG003|Overall Study|Lost to Follow-up|0|||
130944209|NCT02967692|471431269|FG000|Overall Study|Physician Decision|0|||
130944210|NCT02967692|471431270|FG001|Overall Study|Physician Decision|0|||
130944211|NCT02967692|471431271|FG002|Overall Study|Physician Decision|22|||
130944212|NCT02967692|471431272|FG003|Overall Study|Physician Decision|13|||
130944213|NCT02967692|471431269|FG000|Overall Study|Adverse Event|2|||
130944214|NCT02967692|471431270|FG001|Overall Study|Adverse Event|9|||
130944215|NCT02967692|471431271|FG002|Overall Study|Adverse Event|60|||
130944216|NCT02967692|471431272|FG003|Overall Study|Adverse Event|28|||
130944217|NCT02967692|471431269|FG000|Overall Study|Study terminated by sponsor|2|||
130944218|NCT02967692|471431270|FG001|Overall Study|Study terminated by sponsor|1|||
130944219|NCT02967692|471431271|FG002|Overall Study|Study terminated by sponsor|42|||
130944220|NCT02967692|471431272|FG003|Overall Study|Study terminated by sponsor|37|||
130944221|NCT01536379|471431273|FG000|Overall Study|Adverse Event|1|||
130944222|NCT01536379|471431274|FG001|Overall Study|Adverse Event|2|||
130944223|NCT01536379|471431273|FG000|Overall Study|Withdrawal by Subject|1|||
130944224|NCT01536379|471431274|FG001|Overall Study|Withdrawal by Subject|1|||
130944225|NCT04447417|471431280|FG000|Overall Study|Withdrawal by Subject|1|||
130944226|NCT04447417|471431281|FG001|Overall Study|Withdrawal by Subject|0|||
130944227|NCT04447417|471431280|FG000|Overall Study|Failure to meet inclusion criteria|1|||
130944228|NCT04447417|471431281|FG001|Overall Study|Failure to meet inclusion criteria|0|||
130944229|NCT04447417|471431280|FG000|Overall Study|Lost to Follow-up|1|||
130944230|NCT04447417|471431281|FG001|Overall Study|Lost to Follow-up|0|||
130944231|NCT02268409|471431282|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
130944232|NCT02268409|471431282|FG000|Overall Study|Death|1|||
130944233|NCT02268409|471431282|FG000|Overall Study|Lost to Follow-up|1|||
130944234|NCT02268409|471431282|FG000|Overall Study|Protocol Violation|3|||
130944235|NCT02268409|471431282|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
130944236|NCT02268409|471431282|FG000|Overall Study|Withdrawal by Subject|5|||
130944237|NCT03102918|471431286|FG000|Overall Study|Protocol Violation|1|||
130773331|NCT00885378|470796966|FG000|Overall Study|Lost to Follow-up|1|||
130773332|NCT00885378|470796967|FG001|Overall Study|Lost to Follow-up|2|||
130773333|NCT00885378|470796966|FG000|Overall Study|Poor/Noncompliance|2|||
130944238|NCT03102918|471431287|FG001|Overall Study|Protocol Violation|0|||
130944239|NCT04765358|471431290|FG000|Overall Study|Withdrawal by Subject|1|||
130944240|NCT02731729|471431291|FG000|Overall Study|Death|2|||
130944241|NCT02731729|471431292|FG001|Overall Study|Death|2|||
131036985|NCT03024437|471768281|FG000|Overall Study|Moved out of state|0|||
130773334|NCT00885378|470796967|FG001|Overall Study|Poor/Noncompliance|2|||
130773335|NCT00885378|470796966|FG000|Overall Study|Protocol Violation|2|||
130944242|NCT02731729|471431291|FG000|Overall Study|Study terminated by Sponsor|6|||
130944243|NCT02731729|471431292|FG001|Overall Study|Study terminated by Sponsor|6|||
130944244|NCT02731729|471431291|FG000|Overall Study|Withdrawal by Subject|1|||
130944245|NCT02731729|471431292|FG001|Overall Study|Withdrawal by Subject|0|||
130773336|NCT00885378|470796967|FG001|Overall Study|Protocol Violation|0|||
130773337|NCT04750278|470796968|FG000|Overall Study|Death|9|||
130773338|NCT04750278|470796969|FG001|Overall Study|Death|10|||
130773339|NCT04750278|470796970|FG002|Overall Study|Death|10|||
130773340|NCT04750278|470796968|FG000|Overall Study|Withdrawal by Subject|4|||
130773341|NCT04750278|470796969|FG001|Overall Study|Withdrawal by Subject|1|||
130773342|NCT04750278|470796970|FG002|Overall Study|Withdrawal by Subject|2|||
130773343|NCT04750278|470796968|FG000|Overall Study|Lost to Follow-up|1|||
130773344|NCT04750278|470796969|FG001|Overall Study|Lost to Follow-up|1|||
130773345|NCT04750278|470796970|FG002|Overall Study|Lost to Follow-up|1|||
130773346|NCT04750278|470796968|FG000|Overall Study|Pregnancy|1|||
130773347|NCT04750278|470796969|FG001|Overall Study|Pregnancy|0|||
130773348|NCT04750278|470796970|FG002|Overall Study|Pregnancy|0|||
130773349|NCT04750278|470796968|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
130773350|NCT04750278|470796969|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
130773351|NCT04750278|470796970|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
130773352|NCT04750278|470796968|FG000|Overall Study|Non-compliance|0|||
130773353|NCT04750278|470796969|FG001|Overall Study|Non-compliance|0|||
130773354|NCT04750278|470796970|FG002|Overall Study|Non-compliance|1|||
130773355|NCT04750278|470796968|FG000|Overall Study|Transfer to Outside Facility|0|||
131224725|NCT02919475|472450508|FG000|Overall Study|Death|0|||
131224726|NCT02919475|472450509|FG001|Overall Study|Death|1|||
131224727|NCT02919475|472450510|FG002|Overall Study|Death|0|||
130773356|NCT04750278|470796969|FG001|Overall Study|Transfer to Outside Facility|2|||
130773357|NCT04750278|470796970|FG002|Overall Study|Transfer to Outside Facility|1|||
130773358|NCT04750278|470796968|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
130773359|NCT04750278|470796969|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
130773360|NCT04750278|470796970|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
130773361|NCT04750278|470796968|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
130773362|NCT04750278|470796969|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
130773363|NCT04750278|470796970|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
130773364|NCT02579382|470796973|FG000|Main Study Phase|Lost to Follow-up|0|||
130773365|NCT02579382|470796974|FG001|Main Study Phase|Lost to Follow-up|0|||
130773366|NCT02579382|470796975|FG002|Main Study Phase|Lost to Follow-up|2|||
130773367|NCT02579382|470796976|FG003|Main Study Phase|Lost to Follow-up|0|||
130773368|NCT02579382|470796973|FG000|Main Study Phase|Withdrew Consent|0|||
130773369|NCT02579382|470796974|FG001|Main Study Phase|Withdrew Consent|0|||
130773370|NCT02579382|470796975|FG002|Main Study Phase|Withdrew Consent|0|||
130773371|NCT02579382|470796976|FG003|Main Study Phase|Withdrew Consent|2|||
130944246|NCT03446040|471431295|FG000|Overall Study|Disease progression|3|||
130944247|NCT03446040|471431296|FG001|Overall Study|Disease progression|3|||
130944248|NCT03446040|471431297|FG002|Overall Study|Disease progression|3|||
130944249|NCT03446040|471431298|FG003|Overall Study|Disease progression|4|||
130944250|NCT03446040|471431299|FG004|Overall Study|Disease progression|4|||
130944251|NCT03446040|471431300|FG005|Overall Study|Disease progression|6|||
130944252|NCT03446040|471431301|FG006|Overall Study|Disease progression|3|||
130944253|NCT03446040|471431302|FG007|Overall Study|Disease progression|4|||
130944254|NCT03446040|471431303|FG008|Overall Study|Disease progression|2|||
130944255|NCT03446040|471431304|FG009|Overall Study|Disease progression|4|||
130944256|NCT03446040|471431305|FG010|Overall Study|Disease progression|9|||
130944257|NCT03446040|471431306|FG011|Overall Study|Disease progression|3|||
130944258|NCT03446040|471431307|FG012|Overall Study|Disease progression|7|||
130944259|NCT03446040|471431308|FG013|Overall Study|Disease progression|7|||
130944260|NCT03446040|471431295|FG000|Overall Study|Study drug toxicity|0|||
130944261|NCT03446040|471431296|FG001|Overall Study|Study drug toxicity|0|||
130944262|NCT03446040|471431297|FG002|Overall Study|Study drug toxicity|0|||
130944263|NCT03446040|471431298|FG003|Overall Study|Study drug toxicity|0|||
130944264|NCT03446040|471431299|FG004|Overall Study|Study drug toxicity|0|||
130944265|NCT03446040|471431300|FG005|Overall Study|Study drug toxicity|0|||
130944266|NCT03446040|471431301|FG006|Overall Study|Study drug toxicity|0|||
130944267|NCT03446040|471431302|FG007|Overall Study|Study drug toxicity|0|||
130944268|NCT03446040|471431303|FG008|Overall Study|Study drug toxicity|1|||
130944269|NCT03446040|471431304|FG009|Overall Study|Study drug toxicity|0|||
130944270|NCT03446040|471431305|FG010|Overall Study|Study drug toxicity|0|||
130944271|NCT03446040|471431306|FG011|Overall Study|Study drug toxicity|0|||
130944272|NCT03446040|471431307|FG012|Overall Study|Study drug toxicity|0|||
130944273|NCT03446040|471431308|FG013|Overall Study|Study drug toxicity|0|||
130944274|NCT03446040|471431295|FG000|Overall Study|Adverse Event|0|||
131224728|NCT02919475|472450511|FG003|Overall Study|Death|0|||
130944275|NCT03446040|471431296|FG001|Overall Study|Adverse Event|0|||
130944276|NCT03446040|471431297|FG002|Overall Study|Adverse Event|0|||
130944277|NCT03446040|471431298|FG003|Overall Study|Adverse Event|0|||
130944278|NCT03446040|471431299|FG004|Overall Study|Adverse Event|0|||
130944279|NCT03446040|471431300|FG005|Overall Study|Adverse Event|2|||
130944280|NCT03446040|471431301|FG006|Overall Study|Adverse Event|0|||
130944281|NCT03446040|471431302|FG007|Overall Study|Adverse Event|0|||
131224729|NCT02919475|472450512|FG004|Overall Study|Death|0|||
130773372|NCT02579382|470796973|FG000|Main Study Phase|Lack of Efficacy|0|||
130773373|NCT02579382|470796974|FG001|Main Study Phase|Lack of Efficacy|0|||
130773374|NCT02579382|470796975|FG002|Main Study Phase|Lack of Efficacy|0|||
130773375|NCT02579382|470796976|FG003|Main Study Phase|Lack of Efficacy|1|||
130773376|NCT02579382|470796973|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
130773377|NCT02579382|470796974|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
130773378|NCT02579382|470796975|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
130773379|NCT02579382|470796976|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
130773380|NCT02579382|470796973|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
130773381|NCT02579382|470796974|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
130773382|NCT02579382|470796975|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
130773383|NCT02579382|470796976|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
130773384|NCT02579382|470796973|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
130773385|NCT02579382|470796974|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
130773386|NCT02579382|470796975|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
130773387|NCT02579382|470796976|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
130773388|NCT02579382|470796973|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
130773389|NCT02579382|470796974|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
130773390|NCT02579382|470796975|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
130773391|NCT02579382|470796976|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
130773392|NCT02579382|470796973|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
130773393|NCT02579382|470796974|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
130773394|NCT02579382|470796975|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
130773395|NCT02579382|470796976|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
130773396|NCT02579382|470796973|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
130773397|NCT02579382|470796974|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
130773398|NCT02579382|470796975|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
130773399|NCT02579382|470796976|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
130773400|NCT01775787|470796977|FG000|First 7-10 Days|Adverse Event|0|||
130773401|NCT01775787|470796978|FG001|First 7-10 Days|Adverse Event|1|||
130773402|NCT01775787|470796977|FG000|First 7-10 Days|family emergency|0|||
130773403|NCT01775787|470796978|FG001|First 7-10 Days|family emergency|1|||
130773404|NCT01775787|470796977|FG000|First 7-10 Days|time commitment|0|||
130773405|NCT01775787|470796978|FG001|First 7-10 Days|time commitment|2|||
130773406|NCT01775787|470796977|FG000|First 7-10 Days|concerns with using IV|1|||
130773407|NCT01775787|470796978|FG001|First 7-10 Days|concerns with using IV|2|||
130773408|NCT01775787|470796977|FG000|Second 7-10 Days|time commitment|0|||
130773409|NCT01775787|470796978|FG001|Second 7-10 Days|time commitment|1|||
130773410|NCT01775787|470796977|FG000|Second 7-10 Days|concerns with using IV|0|||
130773411|NCT01775787|470796978|FG001|Second 7-10 Days|concerns with using IV|1|||
130773412|NCT00824655|470796984|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
130773413|NCT00824655|470796985|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
130773414|NCT00824655|470796984|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
130773415|NCT00824655|470796985|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
130773416|NCT03252145|470796986|FG000|Overall Study|Withdrawal by Subject|1|||
130773417|NCT03252145|470796987|FG001|Overall Study|Withdrawal by Subject|0|||
130773418|NCT03252145|470796986|FG000|Overall Study|Complicating Disease|1|||
130773419|NCT03252145|470796987|FG001|Overall Study|Complicating Disease|2|||
130773420|NCT03504189|470796988|FG000|Overall Study|Withdrawal by Subject|1|||
130773421|NCT03504189|470796988|FG000|Overall Study|Screening Failure|1|||
130773422|NCT03504189|470796988|FG000|Overall Study|Device Failure|2|||
130773423|NCT04336475|470796989|FG000|Overall Study|pain|1|||
130944282|NCT03446040|471431303|FG008|Overall Study|Adverse Event|1|||
130944283|NCT03446040|471431304|FG009|Overall Study|Adverse Event|0|||
130944284|NCT03446040|471431305|FG010|Overall Study|Adverse Event|0|||
130944285|NCT03446040|471431306|FG011|Overall Study|Adverse Event|0|||
130944286|NCT03446040|471431307|FG012|Overall Study|Adverse Event|0|||
130944287|NCT03446040|471431308|FG013|Overall Study|Adverse Event|0|||
130944288|NCT03446040|471431295|FG000|Overall Study|Death|0|||
130944289|NCT03446040|471431296|FG001|Overall Study|Death|0|||
130944290|NCT03446040|471431297|FG002|Overall Study|Death|0|||
130944291|NCT03446040|471431298|FG003|Overall Study|Death|0|||
130944292|NCT03446040|471431299|FG004|Overall Study|Death|0|||
130944293|NCT03446040|471431300|FG005|Overall Study|Death|0|||
130944294|NCT03446040|471431301|FG006|Overall Study|Death|0|||
130773424|NCT04336475|470796990|FG001|Overall Study|pain|0|||
130773425|NCT04336475|470796989|FG000|Overall Study|upper respiratory infection|1|||
130944295|NCT03446040|471431302|FG007|Overall Study|Death|0|||
130944296|NCT03446040|471431303|FG008|Overall Study|Death|0|||
130773426|NCT04336475|470796990|FG001|Overall Study|upper respiratory infection|0|||
130944297|NCT03446040|471431304|FG009|Overall Study|Death|0|||
130944298|NCT03446040|471431305|FG010|Overall Study|Death|1|||
130944299|NCT03446040|471431306|FG011|Overall Study|Death|0|||
130944300|NCT03446040|471431307|FG012|Overall Study|Death|0|||
130944301|NCT03446040|471431308|FG013|Overall Study|Death|2|||
130944302|NCT03446040|471431295|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
130944303|NCT03446040|471431296|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
130944304|NCT03446040|471431297|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
130944305|NCT03446040|471431298|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
130944306|NCT03446040|471431299|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
130944307|NCT03446040|471431300|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
130944308|NCT03446040|471431301|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
130944309|NCT03446040|471431302|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
130944310|NCT03446040|471431303|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
130944311|NCT03446040|471431304|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
130944312|NCT03446040|471431305|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
130944313|NCT03446040|471431306|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
130944314|NCT03446040|471431307|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
130944315|NCT03446040|471431308|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
130944316|NCT03446040|471431295|FG000|Overall Study|Participant withdrew consent|0|||
130944317|NCT03446040|471431296|FG001|Overall Study|Participant withdrew consent|0|||
130944318|NCT03446040|471431297|FG002|Overall Study|Participant withdrew consent|0|||
130944319|NCT03446040|471431298|FG003|Overall Study|Participant withdrew consent|0|||
130944320|NCT03446040|471431299|FG004|Overall Study|Participant withdrew consent|0|||
130944321|NCT03446040|471431300|FG005|Overall Study|Participant withdrew consent|1|||
130944322|NCT03446040|471431301|FG006|Overall Study|Participant withdrew consent|0|||
130944323|NCT03446040|471431302|FG007|Overall Study|Participant withdrew consent|1|||
130944324|NCT03446040|471431303|FG008|Overall Study|Participant withdrew consent|0|||
130944325|NCT03446040|471431304|FG009|Overall Study|Participant withdrew consent|0|||
130944326|NCT03446040|471431305|FG010|Overall Study|Participant withdrew consent|0|||
130944327|NCT03446040|471431306|FG011|Overall Study|Participant withdrew consent|0|||
130944328|NCT03446040|471431307|FG012|Overall Study|Participant withdrew consent|0|||
130944329|NCT03446040|471431308|FG013|Overall Study|Participant withdrew consent|0|||
130944330|NCT03446040|471431295|FG000|Overall Study|Not reported|0|||
130944331|NCT03446040|471431296|FG001|Overall Study|Not reported|0|||
130944332|NCT03446040|471431297|FG002|Overall Study|Not reported|1|||
130944333|NCT03446040|471431298|FG003|Overall Study|Not reported|0|||
130944334|NCT03446040|471431299|FG004|Overall Study|Not reported|0|||
130944335|NCT03446040|471431300|FG005|Overall Study|Not reported|0|||
130944336|NCT03446040|471431301|FG006|Overall Study|Not reported|0|||
130944337|NCT03446040|471431302|FG007|Overall Study|Not reported|0|||
130944338|NCT03446040|471431303|FG008|Overall Study|Not reported|0|||
130944339|NCT03446040|471431304|FG009|Overall Study|Not reported|0|||
130944340|NCT03446040|471431305|FG010|Overall Study|Not reported|0|||
130944341|NCT03446040|471431306|FG011|Overall Study|Not reported|0|||
130773427|NCT04336475|470796989|FG000|Overall Study|Lost to Follow-up|0|||
130773428|NCT04336475|470796990|FG001|Overall Study|Lost to Follow-up|2|||
130773429|NCT00199849|470797003|FG000|Overall Study|Unrelated illness or complication|0|||
130773430|NCT00199849|470797004|FG001|Overall Study|Unrelated illness or complication|1|||
130773431|NCT00199849|470797005|FG002|Overall Study|Unrelated illness or complication|0|||
130773432|NCT00199849|470797003|FG000|Overall Study|Progressive disease requiring intervention|0|||
130773433|NCT00199849|470797004|FG001|Overall Study|Progressive disease requiring intervention|0|||
130773434|NCT00199849|470797005|FG002|Overall Study|Progressive disease requiring intervention|1|||
130773435|NCT00199849|470797003|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
130773436|NCT00199849|470797004|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
130773437|NCT00199849|470797005|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
130773438|NCT04727528|470797006|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
130773439|NCT04727528|470797007|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
130773440|NCT04727528|470797006|FG000|Open-label Period|Randomized who did not receive treatment|1|||
130773441|NCT04727528|470797007|FG001|Open-label Period|Randomized who did not receive treatment|0|||
130773442|NCT04727528|470797006|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130773443|NCT04727528|470797007|FG001|Double-blind Treatment Phase|Adverse Event|1|||
130773444|NCT04727528|470797006|FG000|Double-blind Treatment Phase|Death|0|||
130944342|NCT03446040|471431307|FG012|Overall Study|Not reported|0|||
130944343|NCT03446040|471431308|FG013|Overall Study|Not reported|0|||
130944344|NCT02066467|471431309|FG000|Overall Study|Did not undergo implant procedure|24|||
130944345|NCT02066467|471431309|FG000|Overall Study|Attempted to implant withoput success|43|||
131036986|NCT03024437|471768282|FG001|Overall Study|Moved out of state|1|||
131036987|NCT03024437|471768283|FG002|Overall Study|Moved out of state|0|||
130773445|NCT04727528|470797007|FG001|Double-blind Treatment Phase|Death|1|||
130944346|NCT02066467|471431309|FG000|Overall Study|Consent ineligible|1|||
130944347|NCT02066467|471431309|FG000|Overall Study|Death|54|||
130944348|NCT02066467|471431309|FG000|Overall Study|Lost to Follow-up|51|||
130944349|NCT02066467|471431309|FG000|Overall Study|Adverse Event|20|||
130944350|NCT02066467|471431309|FG000|Overall Study|Withdrawal by Subject|16|||
130944351|NCT02066467|471431309|FG000|Overall Study|Physician Decision|2|||
130944352|NCT02066467|471431309|FG000|Overall Study|Not defined|4|||
130944353|NCT00456521|471431310|FG000|Overall Study|Adverse Event|150|||
130944354|NCT00456521|471431311|FG001|Overall Study|Adverse Event|25|||
130944355|NCT00456521|471431310|FG000|Overall Study|Withdrawal by Subject|43|||
130944356|NCT00456521|471431311|FG001|Overall Study|Withdrawal by Subject|24|||
130773446|NCT04727528|470797006|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
130773447|NCT04727528|470797007|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
130773448|NCT04727528|470797006|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
130773449|NCT04727528|470797007|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
130773450|NCT04727528|470797006|FG000|Double-blind Treatment Phase|Physician Decision|0|||
130773451|NCT04727528|470797007|FG001|Double-blind Treatment Phase|Physician Decision|1|||
130773452|NCT04727528|470797006|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
130773453|NCT04727528|470797007|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130773454|NCT01763827|470797014|FG000|Overall Study|Withdrawal by Subject|1|||
130773455|NCT01763827|470797015|FG001|Overall Study|Withdrawal by Subject|0|||
130773456|NCT01763827|470797016|FG002|Overall Study|Withdrawal by Subject|0|||
130773457|NCT01763827|470797017|FG003|Overall Study|Withdrawal by Subject|0|||
130773458|NCT01763827|470797018|FG004|Overall Study|Withdrawal by Subject|2|||
130773459|NCT01763827|470797019|FG005|Overall Study|Withdrawal by Subject|0|||
130773460|NCT01763827|470797014|FG000|Overall Study|Decision by sponsor|2|||
130773461|NCT01763827|470797015|FG001|Overall Study|Decision by sponsor|0|||
130773462|NCT01763827|470797016|FG002|Overall Study|Decision by sponsor|3|||
130944357|NCT00456521|471431310|FG000|Overall Study|Lost to Follow-up|22|||
130944358|NCT00456521|471431311|FG001|Overall Study|Lost to Follow-up|17|||
130944359|NCT00456521|471431310|FG000|Overall Study|Lack of Efficacy|3|||
130944360|NCT00456521|471431311|FG001|Overall Study|Lack of Efficacy|6|||
130944361|NCT00456521|471431310|FG000|Overall Study|Protocol Violation|4|||
130944362|NCT00456521|471431311|FG001|Overall Study|Protocol Violation|0|||
130944363|NCT00456521|471431310|FG000|Overall Study|Pregnancy|1|||
130944364|NCT00456521|471431311|FG001|Overall Study|Pregnancy|1|||
130944365|NCT00456521|471431310|FG000|Overall Study|Drug non-compliance, moved, other|26|||
130944366|NCT00456521|471431311|FG001|Overall Study|Drug non-compliance, moved, other|11|||
130944367|NCT01316276|471431312|FG000|Overall Study|Death|1|||
130944368|NCT01316276|471431312|FG000|Overall Study|Adverse Event|19|||
130944369|NCT01316276|471431312|FG000|Overall Study|Withdrawal of consent|24|||
130944370|NCT01316276|471431312|FG000|Overall Study|Lost to Follow-up|1|||
130944371|NCT01316276|471431312|FG000|Overall Study|Other|22|||
130773463|NCT01763827|470797017|FG003|Overall Study|Decision by sponsor|0|||
130773464|NCT01763827|470797018|FG004|Overall Study|Decision by sponsor|2|||
130773465|NCT01763827|470797019|FG005|Overall Study|Decision by sponsor|1|||
130773466|NCT01763827|470797014|FG000|Overall Study|Lost to Follow-up|0|||
130773467|NCT01763827|470797015|FG001|Overall Study|Lost to Follow-up|1|||
130773468|NCT01763827|470797016|FG002|Overall Study|Lost to Follow-up|1|||
130773469|NCT01763827|470797017|FG003|Overall Study|Lost to Follow-up|1|||
130773470|NCT01763827|470797018|FG004|Overall Study|Lost to Follow-up|2|||
130773471|NCT01763827|470797019|FG005|Overall Study|Lost to Follow-up|1|||
130773472|NCT02906579|470797022|FG000|Overall Study|Adverse Event|1|||
130773473|NCT02906579|470797022|FG000|Overall Study|Physician Decision|1|||
130773474|NCT01826981|470797023|FG000|Overall Study|Lack of Efficacy|0|||
130773475|NCT01826981|470797024|FG001|Overall Study|Lack of Efficacy|1|||
130773476|NCT01826981|470797025|FG002|Overall Study|Lack of Efficacy|0|||
130773477|NCT01826981|470797026|FG003|Overall Study|Lack of Efficacy|0|||
130773478|NCT01826981|470797027|FG004|Overall Study|Lack of Efficacy|5|||
130773479|NCT01826981|470797028|FG005|Overall Study|Lack of Efficacy|0|||
130773480|NCT01826981|470797029|FG006|Overall Study|Lack of Efficacy|0|||
130773481|NCT01826981|470797030|FG007|Overall Study|Lack of Efficacy|8|||
130773482|NCT01826981|470797031|FG008|Overall Study|Lack of Efficacy|7|||
130773483|NCT01826981|470797032|FG009|Overall Study|Lack of Efficacy|0|||
130773484|NCT01826981|470797033|FG010|Overall Study|Lack of Efficacy|1|||
130773485|NCT01826981|470797034|FG011|Overall Study|Lack of Efficacy|0|||
130773486|NCT01826981|470797035|FG012|Overall Study|Lack of Efficacy|0|||
130773487|NCT01826981|470797036|FG013|Overall Study|Lack of Efficacy|3|||
131036988|NCT03024437|471768284|FG003|Overall Study|Moved out of state|0|||
131036989|NCT03024437|471768285|FG004|Overall Study|Moved out of state|0|||
130773488|NCT01826981|470797037|FG014|Overall Study|Lack of Efficacy|0|||
130773489|NCT01826981|470797023|FG000|Overall Study|Lost to Follow-up|0|||
130944372|NCT00605475|471431313|FG000|Overall Study|Abnormal Laboratory Values|0|||
130944373|NCT00605475|471431314|FG001|Overall Study|Abnormal Laboratory Values|0|||
130944374|NCT00605475|471431315|FG002|Overall Study|Abnormal Laboratory Values|0|||
130944375|NCT00605475|471431316|FG003|Overall Study|Abnormal Laboratory Values|0|||
130944376|NCT00605475|471431317|FG004|Overall Study|Abnormal Laboratory Values|0|||
130944377|NCT00605475|471431318|FG005|Overall Study|Abnormal Laboratory Values|0|||
130773490|NCT01826981|470797024|FG001|Overall Study|Lost to Follow-up|0|||
131036990|NCT03024437|471768281|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
131036991|NCT03024437|471768282|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
131036992|NCT03024437|471768283|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
131036993|NCT03024437|471768284|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
131036994|NCT03024437|471768285|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
131036995|NCT02601313|471768286|FG000|Overall Study|Death|2|||
131036996|NCT02601313|471768287|FG001|Overall Study|Death|41|||
130944378|NCT00605475|471431319|FG006|Overall Study|Abnormal Laboratory Values|0|||
130944379|NCT00605475|471431320|FG007|Overall Study|Abnormal Laboratory Values|0|||
130944380|NCT00605475|471431321|FG008|Overall Study|Abnormal Laboratory Values|1|||
130944381|NCT00605475|471431322|FG009|Overall Study|Abnormal Laboratory Values|0|||
130944382|NCT00605475|471431313|FG000|Overall Study|Administrative problems|0|||
130944383|NCT00605475|471431314|FG001|Overall Study|Administrative problems|0|||
130944384|NCT00605475|471431315|FG002|Overall Study|Administrative problems|0|||
130944385|NCT00605475|471431316|FG003|Overall Study|Administrative problems|0|||
130944386|NCT00605475|471431317|FG004|Overall Study|Administrative problems|0|||
130944387|NCT00605475|471431318|FG005|Overall Study|Administrative problems|0|||
130944388|NCT00605475|471431319|FG006|Overall Study|Administrative problems|1|||
130944389|NCT00605475|471431320|FG007|Overall Study|Administrative problems|0|||
130944390|NCT00605475|471431321|FG008|Overall Study|Administrative problems|0|||
130944391|NCT00605475|471431322|FG009|Overall Study|Administrative problems|0|||
130944392|NCT00605475|471431313|FG000|Overall Study|Lost to Follow-up|0|||
130944393|NCT00605475|471431314|FG001|Overall Study|Lost to Follow-up|0|||
130944394|NCT00605475|471431315|FG002|Overall Study|Lost to Follow-up|0|||
130944395|NCT00605475|471431316|FG003|Overall Study|Lost to Follow-up|0|||
130944396|NCT00605475|471431317|FG004|Overall Study|Lost to Follow-up|0|||
131036997|NCT02601313|471768288|FG002|Overall Study|Death|6|||
131036998|NCT02601313|471768286|FG000|Overall Study|Enrolled but never treated|0|||
131036999|NCT02601313|471768287|FG001|Overall Study|Enrolled but never treated|6|||
131037000|NCT02601313|471768288|FG002|Overall Study|Enrolled but never treated|3|||
131037001|NCT02601313|471768286|FG000|Overall Study|Enrolled, did not initiate AC|4|||
131037002|NCT02601313|471768287|FG001|Overall Study|Enrolled, did not initiate AC|0|||
131037003|NCT02601313|471768288|FG002|Overall Study|Enrolled, did not initiate AC|0|||
131037004|NCT02601313|471768286|FG000|Overall Study|Full consent withdrawal|0|||
131037005|NCT02601313|471768287|FG001|Overall Study|Full consent withdrawal|3|||
131224730|NCT02919475|472450508|FG000|Overall Study|Lost to Follow-up|0|||
131224731|NCT02919475|472450509|FG001|Overall Study|Lost to Follow-up|0|||
131224732|NCT02919475|472450510|FG002|Overall Study|Lost to Follow-up|0|||
131224733|NCT02919475|472450511|FG003|Overall Study|Lost to Follow-up|1|||
131224734|NCT02919475|472450512|FG004|Overall Study|Lost to Follow-up|0|||
131224735|NCT02919475|472450508|FG000|Overall Study|Withdrawal by Subject|2|||
131224736|NCT02919475|472450509|FG001|Overall Study|Withdrawal by Subject|3|||
131224737|NCT02919475|472450510|FG002|Overall Study|Withdrawal by Subject|1|||
131224738|NCT02919475|472450511|FG003|Overall Study|Withdrawal by Subject|2|||
131224739|NCT02919475|472450512|FG004|Overall Study|Withdrawal by Subject|2|||
131224740|NCT02919475|472450508|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
131224741|NCT02919475|472450509|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
131224742|NCT02919475|472450510|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
131224743|NCT02919475|472450511|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
131224744|NCT02919475|472450512|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131224745|NCT00830063|472450519|FG000|Overall Study|Adverse Event|7|||
131224746|NCT00830063|472450520|FG001|Overall Study|Adverse Event|13|||
131224747|NCT00830063|472450521|FG002|Overall Study|Adverse Event|16|||
131224748|NCT00830063|472450522|FG003|Overall Study|Adverse Event|13|||
131224749|NCT00830063|472450519|FG000|Overall Study|Death|1|||
131224750|NCT00830063|472450520|FG001|Overall Study|Death|0|||
131224751|NCT00830063|472450521|FG002|Overall Study|Death|0|||
131224752|NCT00830063|472450522|FG003|Overall Study|Death|0|||
131224753|NCT00830063|472450519|FG000|Overall Study|Lost to Follow-up|0|||
130944397|NCT00605475|471431318|FG005|Overall Study|Lost to Follow-up|0|||
130944398|NCT00605475|471431319|FG006|Overall Study|Lost to Follow-up|0|||
130944399|NCT00605475|471431320|FG007|Overall Study|Lost to Follow-up|0|||
131037006|NCT02601313|471768288|FG002|Overall Study|Full consent withdrawal|2|||
130773491|NCT01826981|470797025|FG002|Overall Study|Lost to Follow-up|0|||
130944400|NCT00605475|471431321|FG008|Overall Study|Lost to Follow-up|1|||
130944401|NCT00605475|471431322|FG009|Overall Study|Lost to Follow-up|1|||
130944402|NCT00605475|471431313|FG000|Overall Study|Protocol Violation|0|||
131037007|NCT02601313|471768286|FG000|Overall Study|Lost to Follow-up|0|||
131037008|NCT02601313|471768287|FG001|Overall Study|Lost to Follow-up|1|||
131037009|NCT02601313|471768288|FG002|Overall Study|Lost to Follow-up|1|||
130944403|NCT00605475|471431314|FG001|Overall Study|Protocol Violation|0|||
131224754|NCT00830063|472450520|FG001|Overall Study|Lost to Follow-up|0|||
131224755|NCT00830063|472450521|FG002|Overall Study|Lost to Follow-up|3|||
131224756|NCT00830063|472450522|FG003|Overall Study|Lost to Follow-up|1|||
131224757|NCT00830063|472450519|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
131224758|NCT00830063|472450520|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
130773492|NCT01826981|470797026|FG003|Overall Study|Lost to Follow-up|0|||
130773493|NCT01826981|470797027|FG004|Overall Study|Lost to Follow-up|1|||
130773494|NCT01826981|470797028|FG005|Overall Study|Lost to Follow-up|1|||
130773495|NCT01826981|470797029|FG006|Overall Study|Lost to Follow-up|0|||
130773496|NCT01826981|470797030|FG007|Overall Study|Lost to Follow-up|1|||
130944404|NCT00605475|471431315|FG002|Overall Study|Protocol Violation|0|||
130944405|NCT00605475|471431316|FG003|Overall Study|Protocol Violation|0|||
130944406|NCT00605475|471431317|FG004|Overall Study|Protocol Violation|1|||
130944407|NCT00605475|471431318|FG005|Overall Study|Protocol Violation|0|||
130944408|NCT00605475|471431319|FG006|Overall Study|Protocol Violation|0|||
130944409|NCT00605475|471431320|FG007|Overall Study|Protocol Violation|0|||
130944410|NCT00605475|471431321|FG008|Overall Study|Protocol Violation|0|||
130944411|NCT00605475|471431322|FG009|Overall Study|Protocol Violation|0|||
130944412|NCT00605475|471431313|FG000|Overall Study|Withdrawal by Subject|0|||
130944413|NCT00605475|471431314|FG001|Overall Study|Withdrawal by Subject|0|||
130944414|NCT00605475|471431315|FG002|Overall Study|Withdrawal by Subject|0|||
130944415|NCT00605475|471431316|FG003|Overall Study|Withdrawal by Subject|0|||
130944416|NCT00605475|471431317|FG004|Overall Study|Withdrawal by Subject|0|||
130944417|NCT00605475|471431318|FG005|Overall Study|Withdrawal by Subject|2|||
130944418|NCT00605475|471431319|FG006|Overall Study|Withdrawal by Subject|0|||
130944419|NCT00605475|471431320|FG007|Overall Study|Withdrawal by Subject|0|||
130944420|NCT00605475|471431321|FG008|Overall Study|Withdrawal by Subject|0|||
130944421|NCT00605475|471431322|FG009|Overall Study|Withdrawal by Subject|1|||
130944422|NCT02596854|471431323|FG000|Overall Study|Withdrawn|8|||
130944423|NCT01652664|471431324|FG000|Overall Study|Treatment Failure|5|||
130944424|NCT01652664|471431325|FG001|Overall Study|Treatment Failure|1|||
130944425|NCT01652664|471431324|FG000|Overall Study|Inadequate IOP control|1|||
130944426|NCT01652664|471431325|FG001|Overall Study|Inadequate IOP control|0|||
130944427|NCT00297037|471431326|FG000|Overall Study|Withdrawal by Subject|2|||
130944428|NCT00297037|471431327|FG001|Overall Study|Withdrawal by Subject|0|||
130944429|NCT00581776|471431328|FG000|Overall Study|Disease progression or no response|3|||
130944430|NCT00464568|471431333|FG000|Overall Study|Adverse Event|2|||
130944431|NCT03615326|471431334|FG000|Overall Study|Death|266|||
130944432|NCT03615326|471431335|FG001|Overall Study|Death|286|||
130944433|NCT03615326|471431336|FG002|Overall Study|Death|14|||
130944434|NCT03615326|471431337|FG003|Overall Study|Death|17|||
130944435|NCT03615326|471431334|FG000|Overall Study|Lost to Follow-up|0|||
130944436|NCT03615326|471431335|FG001|Overall Study|Lost to Follow-up|1|||
130944437|NCT03615326|471431336|FG002|Overall Study|Lost to Follow-up|0|||
130944438|NCT03615326|471431337|FG003|Overall Study|Lost to Follow-up|0|||
130944439|NCT03615326|471431334|FG000|Overall Study|Withdrawal by Subject|1|||
130944440|NCT03615326|471431335|FG001|Overall Study|Withdrawal by Subject|3|||
130944441|NCT03615326|471431336|FG002|Overall Study|Withdrawal by Subject|0|||
130944442|NCT03615326|471431337|FG003|Overall Study|Withdrawal by Subject|0|||
130944443|NCT03615326|471431334|FG000|Overall Study|Participants Ongoing|83|||
130944444|NCT03615326|471431335|FG001|Overall Study|Participants Ongoing|58|||
130944445|NCT03615326|471431336|FG002|Overall Study|Participants Ongoing|6|||
130944446|NCT03615326|471431337|FG003|Overall Study|Participants Ongoing|3|||
130944447|NCT00405587|471431340|FG000|Overall Study|Death|0|||
130944448|NCT00405587|471431341|FG001|Overall Study|Death|0|||
130944449|NCT00405587|471431342|FG002|Overall Study|Death|0|||
130944450|NCT00405587|471431343|FG003|Overall Study|Death|1|||
130944451|NCT00405587|471431340|FG000|Overall Study|Disease Progression|22|||
130944452|NCT00405587|471431341|FG001|Overall Study|Disease Progression|23|||
130944453|NCT00405587|471431342|FG002|Overall Study|Disease Progression|21|||
130944454|NCT00405587|471431343|FG003|Overall Study|Disease Progression|17|||
130944455|NCT00405587|471431340|FG000|Overall Study|Physician Decision|3|||
130944456|NCT00405587|471431341|FG001|Overall Study|Physician Decision|2|||
130944457|NCT00405587|471431342|FG002|Overall Study|Physician Decision|0|||
130944458|NCT00405587|471431343|FG003|Overall Study|Physician Decision|0|||
130773497|NCT01826981|470797031|FG008|Overall Study|Lost to Follow-up|0|||
130773498|NCT01826981|470797032|FG009|Overall Study|Lost to Follow-up|1|||
130773499|NCT01826981|470797033|FG010|Overall Study|Lost to Follow-up|1|||
130773500|NCT01826981|470797034|FG011|Overall Study|Lost to Follow-up|1|||
130773501|NCT01826981|470797035|FG012|Overall Study|Lost to Follow-up|1|||
130944459|NCT00405587|471431340|FG000|Overall Study|Adverse Event|1|||
130944460|NCT00405587|471431341|FG001|Overall Study|Adverse Event|0|||
130944461|NCT00405587|471431342|FG002|Overall Study|Adverse Event|0|||
130944462|NCT00405587|471431343|FG003|Overall Study|Adverse Event|0|||
130944463|NCT00405587|471431340|FG000|Overall Study|Lost to Follow-up|0|||
130944464|NCT00405587|471431341|FG001|Overall Study|Lost to Follow-up|1|||
130944465|NCT00405587|471431342|FG002|Overall Study|Lost to Follow-up|1|||
130944466|NCT00405587|471431343|FG003|Overall Study|Lost to Follow-up|0|||
130944467|NCT00405587|471431340|FG000|Overall Study|Radiation induced necrosis|0|||
130944468|NCT00405587|471431341|FG001|Overall Study|Radiation induced necrosis|1|||
130944469|NCT00405587|471431342|FG002|Overall Study|Radiation induced necrosis|0|||
130944470|NCT00405587|471431343|FG003|Overall Study|Radiation induced necrosis|0|||
130944471|NCT00405587|471431340|FG000|Overall Study|Withdrawal by Subject|0|||
130944472|NCT00405587|471431341|FG001|Overall Study|Withdrawal by Subject|0|||
131045845|NCT03582033|471802282|FG004|Part C|Withdrawal by Subject|0|||
130944473|NCT00405587|471431342|FG002|Overall Study|Withdrawal by Subject|0|||
130944474|NCT00405587|471431343|FG003|Overall Study|Withdrawal by Subject|2|||
130944475|NCT00405587|471431340|FG000|Overall Study|Participant not dosed|0|||
130944476|NCT00405587|471431341|FG001|Overall Study|Participant not dosed|1|||
130944477|NCT00405587|471431342|FG002|Overall Study|Participant not dosed|0|||
130944478|NCT00405587|471431343|FG003|Overall Study|Participant not dosed|0|||
131224759|NCT00830063|472450521|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
131224760|NCT00830063|472450522|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
131224761|NCT00830063|472450519|FG000|Overall Study|Lack of Efficacy|51|||
131224762|NCT00830063|472450520|FG001|Overall Study|Lack of Efficacy|23|||
131224763|NCT00830063|472450521|FG002|Overall Study|Lack of Efficacy|25|||
131224764|NCT00830063|472450522|FG003|Overall Study|Lack of Efficacy|32|||
131224765|NCT00830063|472450519|FG000|Overall Study|Other|5|||
131224766|NCT00830063|472450520|FG001|Overall Study|Other|5|||
131224767|NCT00830063|472450521|FG002|Overall Study|Other|8|||
131224768|NCT00830063|472450522|FG003|Overall Study|Other|6|||
131224769|NCT00830063|472450519|FG000|Overall Study|Withdrawal by Subject|16|||
131224770|NCT00830063|472450520|FG001|Overall Study|Withdrawal by Subject|10|||
131224771|NCT00830063|472450521|FG002|Overall Study|Withdrawal by Subject|16|||
131224772|NCT00830063|472450522|FG003|Overall Study|Withdrawal by Subject|13|||
131224773|NCT00830063|472450519|FG000|Overall Study|Protocol Violation|1|||
131224774|NCT00830063|472450520|FG001|Overall Study|Protocol Violation|0|||
131224775|NCT00830063|472450521|FG002|Overall Study|Protocol Violation|3|||
131224776|NCT00830063|472450522|FG003|Overall Study|Protocol Violation|2|||
131224777|NCT00830063|472450519|FG000|Overall Study|Randomized But Not Treated|0|||
131224778|NCT00830063|472450520|FG001|Overall Study|Randomized But Not Treated|2|||
131224779|NCT00830063|472450521|FG002|Overall Study|Randomized But Not Treated|0|||
131224780|NCT00830063|472450522|FG003|Overall Study|Randomized But Not Treated|2|||
131224781|NCT02323295|472450523|FG000|Overall Study|Adverse Event|0|||
131224782|NCT02323295|472450524|FG001|Overall Study|Adverse Event|1|||
131224783|NCT02323295|472450523|FG000|Overall Study|Withdrawal by Subject|0|||
131224784|NCT02323295|472450524|FG001|Overall Study|Withdrawal by Subject|1|||
131224785|NCT02323295|472450523|FG000|Overall Study|Patient did not have surgery as planned.|0|||
131224786|NCT02323295|472450524|FG001|Overall Study|Patient did not have surgery as planned.|1|||
131224787|NCT00775983|472450525|FG000|Overall Study|Protocol Violation|1|||
131224788|NCT00775983|472450526|FG001|Overall Study|Protocol Violation|2|||
131224789|NCT01155063|472450527|FG000|Overall Study|Adverse Event|1|||
131224790|NCT01155063|472450527|FG000|Overall Study|Withdrawal by Subject|1|||
131224791|NCT01155063|472450527|FG000|Overall Study|Study terminated by sponsor|87|||
131224792|NCT01314703|472450528|FG000|Overall Study|screen failure and closed enrollment|8|||
131224793|NCT00881959|472450531|FG000|Overall Study|Lost to Follow-up|2|||
131224794|NCT00881959|472450532|FG001|Overall Study|Lost to Follow-up|4|||
131224795|NCT03031431|472450542|FG000|Overall Study|Infant removed by maternal request|1|||
131224796|NCT01205529|472450543|FG000|Overall Study|Procedure Cancelled|4|||
131224797|NCT01205529|472450543|FG000|Overall Study|Withdrawal by Subject|2|||
131224798|NCT01205529|472450543|FG000|Overall Study|Physician Decision|4|||
131224799|NCT01205529|472450543|FG000|Overall Study|Unstable post op|15|||
131224800|NCT01205529|472450543|FG000|Overall Study|No longer met criteria|30|||
131224801|NCT01252238|472450544|FG000|Overall Study|Sponsor terminated study|4|||
131224802|NCT01252238|472450545|FG001|Overall Study|Sponsor terminated study|4|||
131224803|NCT01252238|472450546|FG002|Overall Study|Sponsor terminated study|4|||
131224804|NCT00106028|472450556|FG000|Overall Study|Adverse Event|3|||
131224805|NCT00106028|472450557|FG001|Overall Study|Adverse Event|2|||
131224806|NCT00106028|472450556|FG000|Overall Study|Protocol Violation|1|||
131224807|NCT00106028|472450557|FG001|Overall Study|Protocol Violation|1|||
131224808|NCT00106028|472450556|FG000|Overall Study|Withdrawal by Subject|2|||
131224809|NCT00106028|472450557|FG001|Overall Study|Withdrawal by Subject|8|||
131224810|NCT00106028|472450556|FG000|Overall Study|Lost to Follow-up|0|||
131224811|NCT00106028|472450557|FG001|Overall Study|Lost to Follow-up|1|||
131224812|NCT01280981|472450558|FG000|Overall Study|Withdrawal by Subject|11|||
131224813|NCT01280981|472450558|FG000|Overall Study|Protocol Violation|2|||
131224814|NCT01280981|472450558|FG000|Overall Study|Lack of Efficacy|13|||
131224815|NCT01280981|472450558|FG000|Overall Study|Lost to Follow-up|3|||
131224816|NCT01280981|472450558|FG000|Overall Study|Adverse Event|6|||
131224817|NCT01280981|472450558|FG000|Overall Study|Irregular or discontinued menses|3|||
131224818|NCT01280981|472450558|FG000|Overall Study|Failed to return|45|||
131224819|NCT01280981|472450558|FG000|Overall Study|Non-compliance with protocol|3|||
131224820|NCT01280981|472450558|FG000|Overall Study|Withdrawal of consent|3|||
131224821|NCT01280981|472450558|FG000|Overall Study|Elective surgery|2|||
131224822|NCT01280981|472450558|FG000|Overall Study|Study site closure|1|||
131224823|NCT01610167|472450559|FG000|Overall Study|Scheduling conflict.|0|||
131045846|NCT03582033|471802283|FG005|Part C|Withdrawal by Subject|0|||
131224824|NCT01610167|472450560|FG001|Overall Study|Scheduling conflict.|0|||
131224825|NCT01610167|472450561|FG002|Overall Study|Scheduling conflict.|2|||
131224826|NCT06371079|472450563|FG000|Overall Study|Missing data|88|||
131224827|NCT06371079|472450564|FG001|Overall Study|Missing data|247|||
131224828|NCT01256398|472450565|FG000|Overall Study|Withdrawal by Subject|1|||
131037010|NCT04828005|471768289|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
130773502|NCT01826981|470797036|FG013|Overall Study|Lost to Follow-up|0|||
130773503|NCT01826981|470797037|FG014|Overall Study|Lost to Follow-up|0|||
130773504|NCT01826981|470797023|FG000|Overall Study|Withdrew Consent|0|||
130773505|NCT01826981|470797024|FG001|Overall Study|Withdrew Consent|0|||
130773506|NCT01826981|470797025|FG002|Overall Study|Withdrew Consent|0|||
130773507|NCT01826981|470797026|FG003|Overall Study|Withdrew Consent|0|||
130773508|NCT01826981|470797027|FG004|Overall Study|Withdrew Consent|0|||
130773509|NCT01826981|470797028|FG005|Overall Study|Withdrew Consent|0|||
130773510|NCT01826981|470797029|FG006|Overall Study|Withdrew Consent|1|||
130773511|NCT01826981|470797030|FG007|Overall Study|Withdrew Consent|1|||
130773512|NCT01826981|470797031|FG008|Overall Study|Withdrew Consent|0|||
130773513|NCT01826981|470797032|FG009|Overall Study|Withdrew Consent|0|||
130773514|NCT01826981|470797033|FG010|Overall Study|Withdrew Consent|0|||
130773515|NCT01826981|470797034|FG011|Overall Study|Withdrew Consent|1|||
130773516|NCT01826981|470797035|FG012|Overall Study|Withdrew Consent|0|||
130773517|NCT01826981|470797036|FG013|Overall Study|Withdrew Consent|1|||
130773518|NCT01826981|470797037|FG014|Overall Study|Withdrew Consent|0|||
130773519|NCT01826981|470797023|FG000|Overall Study|Adverse Event|0|||
130773520|NCT01826981|470797024|FG001|Overall Study|Adverse Event|0|||
130773521|NCT01826981|470797025|FG002|Overall Study|Adverse Event|0|||
130773522|NCT01826981|470797026|FG003|Overall Study|Adverse Event|0|||
130773523|NCT01826981|470797027|FG004|Overall Study|Adverse Event|1|||
130773524|NCT01826981|470797028|FG005|Overall Study|Adverse Event|0|||
130773525|NCT01826981|470797029|FG006|Overall Study|Adverse Event|0|||
130773526|NCT01826981|470797030|FG007|Overall Study|Adverse Event|0|||
130773527|NCT01826981|470797031|FG008|Overall Study|Adverse Event|0|||
130773528|NCT01826981|470797032|FG009|Overall Study|Adverse Event|0|||
130773529|NCT01826981|470797033|FG010|Overall Study|Adverse Event|0|||
130773530|NCT01826981|470797034|FG011|Overall Study|Adverse Event|0|||
130773531|NCT01826981|470797035|FG012|Overall Study|Adverse Event|0|||
130773532|NCT01826981|470797036|FG013|Overall Study|Adverse Event|0|||
130773533|NCT01826981|470797037|FG014|Overall Study|Adverse Event|0|||
130773534|NCT01826981|470797023|FG000|Overall Study|Upper G-I Haemorrhage|0|||
130773535|NCT01826981|470797024|FG001|Overall Study|Upper G-I Haemorrhage|0|||
131037011|NCT04828005|471768290|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
131037012|NCT04828005|471768291|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
131037013|NCT04828005|471768292|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
131037014|NCT04828005|471768289|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
131037015|NCT04828005|471768290|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
131037016|NCT04828005|471768291|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
131037017|NCT04828005|471768292|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
131037018|NCT04828005|471768289|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
131037019|NCT04828005|471768290|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
131037020|NCT04828005|471768291|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
130773536|NCT01826981|470797025|FG002|Overall Study|Upper G-I Haemorrhage|0|||
130773537|NCT01826981|470797026|FG003|Overall Study|Upper G-I Haemorrhage|0|||
130773538|NCT01826981|470797027|FG004|Overall Study|Upper G-I Haemorrhage|0|||
130773539|NCT01826981|470797028|FG005|Overall Study|Upper G-I Haemorrhage|0|||
130773540|NCT01826981|470797029|FG006|Overall Study|Upper G-I Haemorrhage|0|||
130773541|NCT01826981|470797030|FG007|Overall Study|Upper G-I Haemorrhage|0|||
130773542|NCT01826981|470797031|FG008|Overall Study|Upper G-I Haemorrhage|0|||
130773543|NCT01826981|470797032|FG009|Overall Study|Upper G-I Haemorrhage|0|||
130773544|NCT01826981|470797033|FG010|Overall Study|Upper G-I Haemorrhage|0|||
130773545|NCT01826981|470797034|FG011|Overall Study|Upper G-I Haemorrhage|0|||
130773546|NCT01826981|470797035|FG012|Overall Study|Upper G-I Haemorrhage|0|||
130773547|NCT01826981|470797036|FG013|Overall Study|Upper G-I Haemorrhage|1|||
130773548|NCT01826981|470797037|FG014|Overall Study|Upper G-I Haemorrhage|0|||
130773549|NCT01826981|470797023|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773550|NCT01826981|470797024|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773551|NCT01826981|470797025|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773552|NCT01826981|470797026|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773553|NCT01826981|470797027|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773554|NCT01826981|470797028|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773555|NCT01826981|470797029|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773556|NCT01826981|470797030|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
131037021|NCT04828005|471768292|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
131037022|NCT04828005|471768289|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
131037023|NCT04828005|471768290|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
130773557|NCT01826981|470797031|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773558|NCT01826981|470797032|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773559|NCT01826981|470797033|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773560|NCT01826981|470797034|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773561|NCT01826981|470797035|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773562|NCT01826981|470797036|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
130944479|NCT06027866|471431344|FG000|Overall Study|Withdrawal by Subject|2|||
130944480|NCT00507442|471431347|FG000|Overall Study|Adverse Event|8|||
130944481|NCT00507442|471431348|FG001|Overall Study|Adverse Event|11|||
131037024|NCT04828005|471768291|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
131037025|NCT04828005|471768292|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
131224829|NCT03276962|472450567|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
131224830|NCT03276962|472450568|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
130944482|NCT00507442|471431349|FG002|Overall Study|Adverse Event|4|||
130944483|NCT00507442|471431350|FG003|Overall Study|Adverse Event|1|||
130944484|NCT00507442|471431347|FG000|Overall Study|Protocol Violation|0|||
130944485|NCT00507442|471431348|FG001|Overall Study|Protocol Violation|1|||
130944486|NCT00507442|471431349|FG002|Overall Study|Protocol Violation|0|||
130944487|NCT00507442|471431350|FG003|Overall Study|Protocol Violation|0|||
130944488|NCT00507442|471431347|FG000|Overall Study|Lost to Follow-up|0|||
130944489|NCT00507442|471431348|FG001|Overall Study|Lost to Follow-up|0|||
130944490|NCT00507442|471431349|FG002|Overall Study|Lost to Follow-up|1|||
130944491|NCT00507442|471431350|FG003|Overall Study|Lost to Follow-up|0|||
130944492|NCT00507442|471431347|FG000|Overall Study|Physician Decision|0|||
130944493|NCT00507442|471431348|FG001|Overall Study|Physician Decision|2|||
130944494|NCT00507442|471431349|FG002|Overall Study|Physician Decision|4|||
130944495|NCT00507442|471431350|FG003|Overall Study|Physician Decision|1|||
130944496|NCT00507442|471431347|FG000|Overall Study|Progressive Disease|2|||
130944497|NCT00507442|471431348|FG001|Overall Study|Progressive Disease|4|||
130944498|NCT00507442|471431349|FG002|Overall Study|Progressive Disease|2|||
130944499|NCT00507442|471431350|FG003|Overall Study|Progressive Disease|0|||
130944500|NCT00507442|471431347|FG000|Overall Study|Withdrawal by Subject|4|||
130944501|NCT00507442|471431348|FG001|Overall Study|Withdrawal by Subject|4|||
130944502|NCT00507442|471431349|FG002|Overall Study|Withdrawal by Subject|2|||
130944503|NCT00507442|471431350|FG003|Overall Study|Withdrawal by Subject|1|||
130944504|NCT00507442|471431347|FG000|Overall Study|Other|2|||
130944505|NCT00507442|471431348|FG001|Overall Study|Other|5|||
130944506|NCT00507442|471431349|FG002|Overall Study|Other|2|||
130944507|NCT00507442|471431350|FG003|Overall Study|Other|2|||
130944508|NCT00930579|471431351|FG000|Overall Study|Withdrawal by Subject|1|||
130944509|NCT00930579|471431351|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
130944510|NCT03425331|471431354|FG000|Overall Study|Withdrawal by Subject|1|||
130944511|NCT03425331|471431354|FG000|Overall Study|Death|1|||
130944512|NCT03425331|471431354|FG000|Overall Study|Adverse Event|1|||
130944513|NCT03425331|471431354|FG000|Overall Study|Disease Progression|2|||
130944514|NCT02864251|471431356|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
130944515|NCT02864251|471431357|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
130944516|NCT02864251|471431358|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
130944517|NCT02864251|471431356|FG000|Pre-Treatment|Withdrawal by Participant|0|||
130944518|NCT02864251|471431357|FG001|Pre-Treatment|Withdrawal by Participant|0|||
130944519|NCT02864251|471431358|FG002|Pre-Treatment|Withdrawal by Participant|4|||
130944520|NCT02864251|471431356|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
130944521|NCT02864251|471431357|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
130944522|NCT02864251|471431358|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
130944523|NCT02864251|471431356|FG000|Pre-Treatment|Other Reasons|0|||
131224831|NCT03276962|472450569|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
131224832|NCT03276962|472450570|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
131224833|NCT03276962|472450571|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
131224834|NCT03276962|472450567|FG000|Overall Study|Protocol Deviation|2|||
131224835|NCT03276962|472450568|FG001|Overall Study|Protocol Deviation|0|||
131224836|NCT03276962|472450569|FG002|Overall Study|Protocol Deviation|1|||
131224837|NCT03276962|472450570|FG003|Overall Study|Protocol Deviation|2|||
131224838|NCT03276962|472450571|FG004|Overall Study|Protocol Deviation|1|||
131224839|NCT03276962|472450567|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
131224840|NCT03276962|472450568|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
131224841|NCT03276962|472450569|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
131224842|NCT03276962|472450570|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
131224843|NCT03276962|472450571|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
131224844|NCT03276962|472450567|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
131224845|NCT03276962|472450568|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
130944524|NCT02864251|471431357|FG001|Pre-Treatment|Other Reasons|1|||
130944525|NCT02864251|471431358|FG002|Pre-Treatment|Other Reasons|1|||
130944526|NCT02864251|471431356|FG000|Treatment|Disease Progression|109|||
130944527|NCT02864251|471431357|FG001|Treatment|Disease Progression|52|||
130944528|NCT02864251|471431358|FG002|Treatment|Disease Progression|101|||
130944529|NCT02864251|471431356|FG000|Treatment|Study Drug Toxicity|9|||
130944530|NCT02864251|471431357|FG001|Treatment|Study Drug Toxicity|4|||
130944531|NCT02864251|471431358|FG002|Treatment|Study Drug Toxicity|10|||
130944532|NCT02864251|471431356|FG000|Treatment|Death|0|||
130944533|NCT02864251|471431357|FG001|Treatment|Death|2|||
130944534|NCT02864251|471431358|FG002|Treatment|Death|3|||
130773563|NCT01826981|470797037|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
130773564|NCT02030119|470797040|FG000|Overall Study|Withdrawal by Subject|3|||
130773565|NCT02030119|470797041|FG001|Overall Study|Withdrawal by Subject|1|||
130773566|NCT02030119|470797042|FG002|Overall Study|Withdrawal by Subject|5|||
130773567|NCT02030119|470797043|FG003|Overall Study|Withdrawal by Subject|3|||
130773568|NCT02030119|470797040|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
130773569|NCT02030119|470797041|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
130773570|NCT02030119|470797042|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
130773571|NCT02030119|470797043|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
130773572|NCT00759655|470797044|FG000|Overall Study|Termination of the study by sponsor|1|||
130773573|NCT02213380|470797047|FG000|Underwent Randomization|Withdrawal by Subject|2|||
130773574|NCT02213380|470797048|FG001|Underwent Randomization|Withdrawal by Subject|0|||
130773575|NCT02213380|470797047|FG000|Underwent Randomization|Not treated|3|||
130773576|NCT02213380|470797048|FG001|Underwent Randomization|Not treated|3|||
130773577|NCT02213380|470797047|FG000|Per-protocol Analysis|Protocol Violation|32|||
130773578|NCT02213380|470797048|FG001|Per-protocol Analysis|Protocol Violation|36|||
130773579|NCT01310127|470797049|FG000|Overall Study|Protocol Violation|1|||
130773580|NCT01310127|470797050|FG001|Overall Study|Protocol Violation|1|||
130773581|NCT01310127|470797049|FG000|Overall Study|advanced psc cataract outlier|1|||
130773582|NCT01310127|470797050|FG001|Overall Study|advanced psc cataract outlier|0|||
130773583|NCT03498313|470797051|FG000|Experimental Period 1|Adverse Event|1|||
130773584|NCT03498313|470797052|FG001|Experimental Period 1|Adverse Event|0|||
130773585|NCT03498313|470797053|FG002|Experimental Period 1|Adverse Event|0|||
130773586|NCT03498313|470797054|FG003|Experimental Period 1|Adverse Event|1|||
130773587|NCT03498313|470797055|FG004|Experimental Period 1|Adverse Event|0|||
130773588|NCT03498313|470797056|FG005|Experimental Period 1|Adverse Event|0|||
130773589|NCT03498313|470797051|FG000|Experimental Period 1|Withdrawal by Subject|0|||
130773590|NCT03498313|470797052|FG001|Experimental Period 1|Withdrawal by Subject|1|||
130773591|NCT03498313|470797053|FG002|Experimental Period 1|Withdrawal by Subject|0|||
130773592|NCT03498313|470797054|FG003|Experimental Period 1|Withdrawal by Subject|0|||
130773593|NCT03498313|470797055|FG004|Experimental Period 1|Withdrawal by Subject|0|||
130773594|NCT03498313|470797056|FG005|Experimental Period 1|Withdrawal by Subject|0|||
130773595|NCT03498313|470797051|FG000|Washout Period 1|Anovulation|1|||
130773596|NCT03498313|470797052|FG001|Washout Period 1|Anovulation|0|||
130773597|NCT03498313|470797053|FG002|Washout Period 1|Anovulation|0|||
130773598|NCT03498313|470797054|FG003|Washout Period 1|Anovulation|0|||
130773599|NCT03498313|470797055|FG004|Washout Period 1|Anovulation|0|||
130773600|NCT03498313|470797056|FG005|Washout Period 1|Anovulation|0|||
130773601|NCT03498313|470797051|FG000|Washout Period 1|Withdrawal by Subject|0|||
130773602|NCT03498313|470797052|FG001|Washout Period 1|Withdrawal by Subject|3|||
130773603|NCT03498313|470797053|FG002|Washout Period 1|Withdrawal by Subject|0|||
130773604|NCT03498313|470797054|FG003|Washout Period 1|Withdrawal by Subject|1|||
130944535|NCT02864251|471431356|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
130944536|NCT02864251|471431357|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
130944537|NCT02864251|471431358|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
130944538|NCT02864251|471431356|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
130944539|NCT02864251|471431357|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
130944540|NCT02864251|471431358|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
130944541|NCT02864251|471431356|FG000|Treatment|Withdrawal by Participant|8|||
130944542|NCT02864251|471431357|FG001|Treatment|Withdrawal by Participant|5|||
130944543|NCT02864251|471431358|FG002|Treatment|Withdrawal by Participant|13|||
130944544|NCT02864251|471431356|FG000|Treatment|Maximum Clinical Benefit|1|||
130944545|NCT02864251|471431357|FG001|Treatment|Maximum Clinical Benefit|0|||
130944546|NCT02864251|471431358|FG002|Treatment|Maximum Clinical Benefit|1|||
130944547|NCT02864251|471431356|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
130944548|NCT02864251|471431357|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
130944549|NCT02864251|471431358|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
130944550|NCT02864251|471431356|FG000|Treatment|Other Reasons|1|||
130944551|NCT02864251|471431357|FG001|Treatment|Other Reasons|1|||
130944552|NCT02864251|471431358|FG002|Treatment|Other Reasons|4|||
130944553|NCT02864251|471431356|FG000|Treatment|Administrative Reason by Sponsor|1|||
130944554|NCT02864251|471431357|FG001|Treatment|Administrative Reason by Sponsor|0|||
130944555|NCT02864251|471431358|FG002|Treatment|Administrative Reason by Sponsor|0|||
130773605|NCT03498313|470797055|FG004|Washout Period 1|Withdrawal by Subject|0|||
130773606|NCT03498313|470797056|FG005|Washout Period 1|Withdrawal by Subject|1|||
130773607|NCT03498313|470797051|FG000|Experimental Period 2|Adverse Event|0|||
130773608|NCT03498313|470797052|FG001|Experimental Period 2|Adverse Event|0|||
130773609|NCT03498313|470797053|FG002|Experimental Period 2|Adverse Event|0|||
130773610|NCT03498313|470797054|FG003|Experimental Period 2|Adverse Event|0|||
130944556|NCT02410954|471431361|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
130944557|NCT02410954|471431362|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
130944558|NCT02410954|471431361|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
130944559|NCT02410954|471431362|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
130944560|NCT00949325|471431363|FG000|Overall Study|Adverse Event|0|||
130944561|NCT00949325|471431364|FG001|Overall Study|Adverse Event|2|||
130944562|NCT00949325|471431365|FG002|Overall Study|Adverse Event|0|||
130944563|NCT00791518|471431366|FG000|Overall Study|Protocol Violation|93|||
130944564|NCT01520363|471431367|FG000|Overall Study|Withdrawal by Subject|2|||
131224846|NCT03276962|472450569|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
131224847|NCT03276962|472450570|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
131224848|NCT03276962|472450571|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
131224849|NCT03276962|472450567|FG000|Overall Study|Lost to Follow-up|10|||
131224850|NCT03276962|472450568|FG001|Overall Study|Lost to Follow-up|10|||
131224851|NCT03276962|472450569|FG002|Overall Study|Lost to Follow-up|4|||
131224852|NCT03276962|472450570|FG003|Overall Study|Lost to Follow-up|6|||
131224853|NCT03276962|472450571|FG004|Overall Study|Lost to Follow-up|10|||
131224854|NCT03276962|472450567|FG000|Overall Study|Other|0|||
131224855|NCT03276962|472450568|FG001|Overall Study|Other|2|||
131224856|NCT03276962|472450569|FG002|Overall Study|Other|0|||
131224857|NCT03276962|472450570|FG003|Overall Study|Other|2|||
131224858|NCT03276962|472450571|FG004|Overall Study|Other|1|||
131224859|NCT00411762|472450572|FG000|Overall Study|Withdrawal by Subject|5|||
131224860|NCT01238211|472450573|FG000|Overall Study|Continues active treatment|31|||
131224861|NCT01238211|472450573|FG000|Overall Study|Adverse Event|7|||
131224862|NCT01238211|472450573|FG000|Overall Study|Death|4|||
131224863|NCT01238211|472450573|FG000|Overall Study|Relapse/Progression|2|||
131224864|NCT01238211|472450573|FG000|Overall Study|Withdrawal by Subject|7|||
131224865|NCT01238211|472450573|FG000|Overall Study|Non-protocol treatment|4|||
131224866|NCT01238211|472450573|FG000|Overall Study|Investigator/Patient Decision|3|||
131224867|NCT04428502|472450574|FG000|Overall Study|Did not meet entrance criteria|14|||
131224868|NCT00449930|472450585|FG000|Overall Study|Adverse Event|9|||
131224869|NCT00449930|472450586|FG001|Overall Study|Adverse Event|19|||
131224870|NCT00449930|472450585|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
131224871|NCT00449930|472450586|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
131224872|NCT00449930|472450585|FG000|Overall Study|Lack of Efficacy|10|||
131224873|NCT00449930|472450586|FG001|Overall Study|Lack of Efficacy|1|||
131224874|NCT00449930|472450585|FG000|Overall Study|Lost to Follow-up|9|||
131224875|NCT00449930|472450586|FG001|Overall Study|Lost to Follow-up|14|||
131224876|NCT00449930|472450585|FG000|Overall Study|Physician Decision|1|||
131224877|NCT00449930|472450586|FG001|Overall Study|Physician Decision|2|||
131224878|NCT00449930|472450585|FG000|Overall Study|Protocol Violation|14|||
131224879|NCT00449930|472450586|FG001|Overall Study|Protocol Violation|15|||
131224880|NCT00449930|472450585|FG000|Overall Study|Withdrawal by Subject|16|||
131224881|NCT00449930|472450586|FG001|Overall Study|Withdrawal by Subject|23|||
131224882|NCT00449930|472450585|FG000|Overall Study|Glycemic discontinuation criteria|1|||
131224883|NCT00449930|472450586|FG001|Overall Study|Glycemic discontinuation criteria|1|||
131224884|NCT03550794|472450587|FG000|Overall Study|No longer met inclusion criteria|1|||
131224885|NCT03550794|472450588|FG001|Overall Study|No longer met inclusion criteria|2|||
131224886|NCT03550794|472450587|FG000|Overall Study|Goals of care changed|1|||
131224887|NCT03550794|472450588|FG001|Overall Study|Goals of care changed|0|||
131224888|NCT03550794|472450587|FG000|Overall Study|Withdrawal by Subject|2|||
131224889|NCT03550794|472450588|FG001|Overall Study|Withdrawal by Subject|0|||
131224890|NCT03550794|472450587|FG000|Overall Study|Death|0|||
131224891|NCT03550794|472450588|FG001|Overall Study|Death|1|||
131224892|NCT01864525|472450589|FG000|Overall Study|Adverse Event|1|||
131224893|NCT01864525|472450590|FG001|Overall Study|Adverse Event|0|||
131224894|NCT01890785|472450591|FG000|Third Intervention|Withdrawal by Subject|0|||
131224895|NCT01890785|472450592|FG001|Third Intervention|Withdrawal by Subject|1|||
131224896|NCT01890785|472450593|FG002|Third Intervention|Withdrawal by Subject|0|||
131224897|NCT01890785|472450594|FG003|Third Intervention|Withdrawal by Subject|0|||
131224898|NCT01890785|472450595|FG004|Third Intervention|Withdrawal by Subject|0|||
131224899|NCT01890785|472450596|FG005|Third Intervention|Withdrawal by Subject|0|||
131224900|NCT03712228|472450597|FG000|Treatment Period 1|Lack of Efficacy|0|||
131224901|NCT03712228|472450598|FG001|Treatment Period 1|Lack of Efficacy|0|||
131224902|NCT03712228|472450599|FG002|Treatment Period 1|Lack of Efficacy|0|||
131224903|NCT03712228|472450600|FG003|Treatment Period 1|Lack of Efficacy|0|||
131224904|NCT03712228|472450601|FG004|Treatment Period 1|Lack of Efficacy|0|||
131224905|NCT03712228|472450602|FG005|Treatment Period 1|Lack of Efficacy|1|||
131224906|NCT03712228|472450597|FG000|Treatment Period 2|Pregnancy|0|||
131224907|NCT03712228|472450598|FG001|Treatment Period 2|Pregnancy|0|||
131224908|NCT03712228|472450599|FG002|Treatment Period 2|Pregnancy|0|||
131224909|NCT03712228|472450600|FG003|Treatment Period 2|Pregnancy|1|||
131224910|NCT03712228|472450601|FG004|Treatment Period 2|Pregnancy|0|||
131224911|NCT03712228|472450602|FG005|Treatment Period 2|Pregnancy|0|||
130944565|NCT01520363|471431368|FG001|Overall Study|Withdrawal by Subject|0|||
131224912|NCT03712228|472450597|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131224913|NCT03712228|472450598|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131224914|NCT03712228|472450599|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131224915|NCT03712228|472450600|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130773611|NCT03498313|470797055|FG004|Experimental Period 2|Adverse Event|1|||
130773612|NCT03498313|470797056|FG005|Experimental Period 2|Adverse Event|2|||
130773613|NCT03498313|470797051|FG000|Washout Period 2|Physician Decision|1|||
130773614|NCT03498313|470797052|FG001|Washout Period 2|Physician Decision|0|||
130773615|NCT03498313|470797053|FG002|Washout Period 2|Physician Decision|0|||
130773616|NCT03498313|470797054|FG003|Washout Period 2|Physician Decision|1|||
130773617|NCT03498313|470797055|FG004|Washout Period 2|Physician Decision|0|||
130773618|NCT03498313|470797056|FG005|Washout Period 2|Physician Decision|1|||
130773619|NCT03498313|470797051|FG000|Washout Period 2|Withdrawal by Subject|3|||
130773620|NCT03498313|470797052|FG001|Washout Period 2|Withdrawal by Subject|2|||
130773621|NCT03498313|470797053|FG002|Washout Period 2|Withdrawal by Subject|0|||
130773622|NCT03498313|470797054|FG003|Washout Period 2|Withdrawal by Subject|0|||
130773623|NCT03498313|470797055|FG004|Washout Period 2|Withdrawal by Subject|2|||
130773624|NCT03498313|470797056|FG005|Washout Period 2|Withdrawal by Subject|0|||
130773625|NCT03498313|470797051|FG000|Washout Period 2|Anovulation|0|||
130773626|NCT03498313|470797052|FG001|Washout Period 2|Anovulation|0|||
130773627|NCT03498313|470797053|FG002|Washout Period 2|Anovulation|0|||
130773628|NCT03498313|470797054|FG003|Washout Period 2|Anovulation|0|||
130773629|NCT03498313|470797055|FG004|Washout Period 2|Anovulation|0|||
130773630|NCT03498313|470797056|FG005|Washout Period 2|Anovulation|1|||
130773631|NCT00184002|470797057|FG000|Overall Study|Adverse Event|9|||
130773632|NCT00184002|470797057|FG000|Overall Study|Death|3|||
130773633|NCT00184002|470797057|FG000|Overall Study|Physician Decision|1|||
130773634|NCT00184002|470797057|FG000|Overall Study|Withdrawal by Subject|4|||
130773635|NCT02171429|470797058|FG000|Overall Study|Other|0|||
130773636|NCT02171429|470797059|FG001|Overall Study|Other|1|||
130773637|NCT02171429|470797060|FG002|Overall Study|Other|1|||
130773638|NCT02171429|470797058|FG000|Overall Study|Non-Compliance|0|||
130773639|NCT02171429|470797059|FG001|Overall Study|Non-Compliance|0|||
130773640|NCT02171429|470797060|FG002|Overall Study|Non-Compliance|1|||
130773641|NCT02171429|470797058|FG000|Overall Study|Physician Decision|0|||
130773642|NCT02171429|470797059|FG001|Overall Study|Physician Decision|0|||
130773643|NCT02171429|470797060|FG002|Overall Study|Physician Decision|1|||
130773644|NCT02171429|470797058|FG000|Overall Study|Withdrawal by Subject|1|||
130773645|NCT02171429|470797059|FG001|Overall Study|Withdrawal by Subject|1|||
130773646|NCT02171429|470797060|FG002|Overall Study|Withdrawal by Subject|1|||
130773647|NCT02171429|470797058|FG000|Overall Study|Lost to Follow-up|0|||
130773648|NCT02171429|470797059|FG001|Overall Study|Lost to Follow-up|1|||
130773649|NCT02171429|470797060|FG002|Overall Study|Lost to Follow-up|0|||
130773650|NCT02171429|470797058|FG000|Overall Study|Death|0|||
130773651|NCT02171429|470797059|FG001|Overall Study|Death|0|||
130773652|NCT02171429|470797060|FG002|Overall Study|Death|1|||
130773653|NCT02020889|470797062|FG000|Overall Study|Adverse Event|0|||
130773654|NCT02020889|470797063|FG001|Overall Study|Adverse Event|1|||
130773655|NCT02020889|470797062|FG000|Overall Study|Lack of Efficacy|1|||
130773656|NCT02020889|470797063|FG001|Overall Study|Lack of Efficacy|0|||
130773657|NCT02020889|470797062|FG000|Overall Study|Lost to Follow-up|1|||
130773658|NCT02020889|470797063|FG001|Overall Study|Lost to Follow-up|0|||
130773659|NCT02020889|470797062|FG000|Overall Study|Physician Decision|2|||
130773660|NCT02020889|470797063|FG001|Overall Study|Physician Decision|0|||
130773661|NCT02020889|470797062|FG000|Overall Study|Withdrawal by Subject|3|||
130773662|NCT02020889|470797063|FG001|Overall Study|Withdrawal by Subject|2|||
130773663|NCT02768792|470797064|FG000|Overall Study|Adverse Event|1|||
130773664|NCT05980013|470797065|FG000|Overall Study|Withdrawal by Subject|0|||
130773665|NCT05980013|470797066|FG001|Overall Study|Withdrawal by Subject|1|||
130773666|NCT05980013|470797065|FG000|Overall Study|Device Error|0|||
130773667|NCT05980013|470797066|FG001|Overall Study|Device Error|1|||
130944566|NCT00003641|471431369|FG000|Overall Study|Withdrawal by Subject|0|||
130944567|NCT00003641|471431370|FG001|Overall Study|Withdrawal by Subject|100|||
130944568|NCT00003641|471431369|FG000|Overall Study|Adverse Event|0|||
130944569|NCT00003641|471431370|FG001|Overall Study|Adverse Event|38|||
130944570|NCT00003641|471431369|FG000|Overall Study|Disease progression|0|||
130944571|NCT00003641|471431370|FG001|Overall Study|Disease progression|2|||
130944572|NCT00003641|471431369|FG000|Overall Study|Unknown/missing|0|||
130944573|NCT00003641|471431370|FG001|Overall Study|Unknown/missing|22|||
130773668|NCT01768559|470797067|FG000|Overall Study|Randomized but not treated|0|||
130773669|NCT01768559|470797068|FG001|Overall Study|Randomized but not treated|0|||
130773670|NCT01768559|470797069|FG002|Overall Study|Randomized but not treated|1|||
130773671|NCT01768559|470797067|FG000|Overall Study|Adverse Event|15|||
130773672|NCT01768559|470797068|FG001|Overall Study|Adverse Event|2|||
130773673|NCT01768559|470797069|FG002|Overall Study|Adverse Event|5|||
130773674|NCT01768559|470797067|FG000|Overall Study|Lack of Efficacy|6|||
130944574|NCT00003641|471431369|FG000|Overall Study|Should not receive interferon therapy|2|||
130773675|NCT01768559|470797068|FG001|Overall Study|Lack of Efficacy|4|||
130773676|NCT01768559|470797069|FG002|Overall Study|Lack of Efficacy|0|||
130773677|NCT01768559|470797067|FG000|Overall Study|Poor compliance to protocol|0|||
130773678|NCT01768559|470797068|FG001|Overall Study|Poor compliance to protocol|3|||
130944575|NCT00003641|471431370|FG001|Overall Study|Should not receive interferon therapy|0|||
130944576|NCT00003641|471431369|FG000|Overall Study|Never started interferon|567|||
131124147|NCT01555151|472082948|FG002|Overall Study|Adverse Event|1|||
131124148|NCT01555151|472082949|FG003|Overall Study|Adverse Event|2|||
131124149|NCT01555151|472082946|FG000|Overall Study|Lost to Follow-up|0|||
131124150|NCT01555151|472082947|FG001|Overall Study|Lost to Follow-up|0|||
130944577|NCT00003641|471431370|FG001|Overall Study|Never started interferon|12|||
130944578|NCT02154581|471431371|FG000|Overall Study|Lost to Follow-up|7|||
130944579|NCT02154581|471431372|FG001|Overall Study|Lost to Follow-up|8|||
130944580|NCT03659916|471431373|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
130944581|NCT03659916|471431374|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
130944582|NCT03659916|471431375|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
130944583|NCT03659916|471431373|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
130944584|NCT03659916|471431374|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
131124151|NCT01555151|472082948|FG002|Overall Study|Lost to Follow-up|0|||
130944585|NCT03659916|471431375|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
130944586|NCT03659916|471431373|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
130944587|NCT03659916|471431374|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
130944588|NCT03659916|471431375|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
130944589|NCT03659916|471431373|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
130944590|NCT03659916|471431374|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
131124152|NCT01555151|472082949|FG003|Overall Study|Lost to Follow-up|1|||
131124153|NCT03596866|472082950|FG000|Overall Study|Site terminated by Sponsor|64|||
131124154|NCT03596866|472082951|FG001|Overall Study|Site terminated by Sponsor|65|||
131124155|NCT03596866|472082950|FG000|Overall Study|Death|37|||
131124156|NCT03596866|472082951|FG001|Overall Study|Death|24|||
131124157|NCT03596866|472082950|FG000|Overall Study|Withdrawal by Subject|4|||
131124158|NCT03596866|472082951|FG001|Overall Study|Withdrawal by Subject|6|||
131124159|NCT03596866|472082950|FG000|Overall Study|Missing|0|||
131124160|NCT03596866|472082951|FG001|Overall Study|Missing|6|||
131124161|NCT03596866|472082950|FG000|Overall Study|Lost to Follow-up|2|||
131124162|NCT03596866|472082951|FG001|Overall Study|Lost to Follow-up|3|||
131124163|NCT03596866|472082950|FG000|Overall Study|Protocol Violation|1|||
131124164|NCT03596866|472082951|FG001|Overall Study|Protocol Violation|0|||
131124165|NCT03596866|472082950|FG000|Overall Study|Reason Not Specified|14|||
131124166|NCT03596866|472082951|FG001|Overall Study|Reason Not Specified|13|||
131124167|NCT01961349|472082952|FG000|Overall Study|Withdrawal by Subject|1|||
131124168|NCT01961349|472082953|FG001|Overall Study|Withdrawal by Subject|4|||
131124169|NCT01961349|472082954|FG002|Overall Study|Withdrawal by Subject|0|||
131124170|NCT01961349|472082952|FG000|Overall Study|Adverse Event|0|||
131124171|NCT01961349|472082953|FG001|Overall Study|Adverse Event|0|||
131124172|NCT01961349|472082954|FG002|Overall Study|Adverse Event|1|||
131124173|NCT01961349|472082952|FG000|Overall Study|registration error, personal reason etc|2|||
131124174|NCT01961349|472082953|FG001|Overall Study|registration error, personal reason etc|2|||
131124175|NCT01961349|472082954|FG002|Overall Study|registration error, personal reason etc|1|||
131124176|NCT02576444|472082955|FG000|Overall Study|Death|1|||
131124177|NCT02576444|472082956|FG001|Overall Study|Death|1|||
131124178|NCT02576444|472082957|FG002|Overall Study|Death|0|||
131124179|NCT02576444|472082958|FG003|Overall Study|Death|0|||
131124180|NCT02576444|472082955|FG000|Overall Study|Withdrawal by Subject|0|||
131124181|NCT02576444|472082956|FG001|Overall Study|Withdrawal by Subject|0|||
131124182|NCT02576444|472082957|FG002|Overall Study|Withdrawal by Subject|2|||
131124183|NCT02576444|472082958|FG003|Overall Study|Withdrawal by Subject|0|||
131124184|NCT02576444|472082955|FG000|Overall Study|Adverse Event|0|||
131124185|NCT02576444|472082956|FG001|Overall Study|Adverse Event|0|||
131124186|NCT02576444|472082957|FG002|Overall Study|Adverse Event|1|||
131124187|NCT02576444|472082958|FG003|Overall Study|Adverse Event|0|||
131124188|NCT02576444|472082955|FG000|Overall Study|Physician Decision|0|||
131124189|NCT02576444|472082956|FG001|Overall Study|Physician Decision|0|||
131124190|NCT02576444|472082957|FG002|Overall Study|Physician Decision|1|||
131124191|NCT02576444|472082958|FG003|Overall Study|Physician Decision|0|||
131124192|NCT01360554|472084411|FG000|Overall Study|Death|359|||
131124193|NCT01360554|472084412|FG001|Overall Study|Death|371|||
131124194|NCT01360554|472084411|FG000|Overall Study|Lost to Follow-up|4|||
131124195|NCT01360554|472084412|FG001|Overall Study|Lost to Follow-up|4|||
131124196|NCT01360554|472084411|FG000|Overall Study|Withdrawal by Subject|23|||
131124197|NCT01360554|472084412|FG001|Overall Study|Withdrawal by Subject|24|||
131124198|NCT01360554|472084411|FG000|Overall Study|Study terminated by sponsor|49|||
131124199|NCT01360554|472084412|FG001|Overall Study|Study terminated by sponsor|37|||
131124200|NCT01360554|472084411|FG000|Overall Study|Other, not specified|1|||
131124201|NCT01360554|472084412|FG001|Overall Study|Other, not specified|0|||
131124202|NCT01360554|472084411|FG000|Overall Study|Randomized but not treated.|3|||
131124203|NCT01360554|472084412|FG001|Overall Study|Randomized but not treated.|3|||
131124204|NCT00187096|472084414|FG000|Overall Study|unacceptable toxicity|0|||
131124205|NCT00187096|472084415|FG001|Overall Study|unacceptable toxicity|0|||
130944591|NCT03659916|471431375|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
130944592|NCT03659916|471431373|FG000|Treatment Period (72 Weeks)|Other|1|||
131124206|NCT00187096|472084416|FG002|Overall Study|unacceptable toxicity|1|||
131124207|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
130944593|NCT03659916|471431374|FG001|Treatment Period (72 Weeks)|Other|3|||
130944594|NCT03659916|471431375|FG002|Treatment Period (72 Weeks)|Other|9|||
130944595|NCT03659916|471431373|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
130944596|NCT03659916|471431374|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
130944597|NCT03659916|471431375|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
130944598|NCT03659916|471431373|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
130944599|NCT03659916|471431374|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
130944600|NCT03659916|471431375|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
130944601|NCT03659916|471431373|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
130944602|NCT03659916|471431374|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
130944603|NCT03659916|471431375|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
130944604|NCT03659916|471431373|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
130944605|NCT03659916|471431374|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
130944606|NCT03659916|471431375|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
130944607|NCT03659916|471431373|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
130944608|NCT03659916|471431374|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
130944609|NCT03659916|471431375|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
130944610|NCT03659916|471431373|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
130944611|NCT03659916|471431374|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
130944612|NCT03659916|471431375|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
130944613|NCT03886220|471431376|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
130944614|NCT03886220|471431377|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
130944615|NCT03886220|471431376|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
130944616|NCT03886220|471431377|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130944617|NCT03886220|471431376|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
130944618|NCT03886220|471431377|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130944619|NCT05497284|471431380|FG000|Overall Study|Adverse Event|1|||
130944620|NCT05497284|471431381|FG001|Overall Study|Adverse Event|0|||
130944621|NCT05497284|471431380|FG000|Overall Study|Physician Decision|0|||
130944622|NCT05497284|471431381|FG001|Overall Study|Physician Decision|1|||
130944623|NCT05497284|471431380|FG000|Overall Study|Study terminated by sponsor|7|||
130944624|NCT05497284|471431381|FG001|Overall Study|Study terminated by sponsor|4|||
131224916|NCT03712228|472450601|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131224917|NCT03712228|472450602|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131224918|NCT01964105|472450603|FG000|Overall Study|Lost to Follow-up|2|||
131224919|NCT01964105|472450604|FG001|Overall Study|Lost to Follow-up|13|||
131224920|NCT01964105|472450605|FG002|Overall Study|Lost to Follow-up|0|||
131224921|NCT00558519|472450606|FG000|Overall Study|Ph+|20|||
131224922|NCT00558519|472450606|FG000|Overall Study|Ineligible|1|||
131224923|NCT00558519|472450606|FG000|Overall Study|Insufficient data|1|||
131224924|NCT00558519|472450606|FG000|Overall Study|Never received treatment|1|||
131224925|NCT03001011|472450607|FG000|Overall Study|Adverse Event|9|||
131224926|NCT03001011|472450608|FG001|Overall Study|Adverse Event|3|||
130944625|NCT05497284|471431380|FG000|Overall Study|Subject Decision|0|||
130944626|NCT05497284|471431381|FG001|Overall Study|Subject Decision|1|||
130944627|NCT03878446|471431382|FG000|Overall Study|Withdrawn by parent or guardian|1|||
130944628|NCT03878446|471431383|FG001|Overall Study|Withdrawn by parent or guardian|0|||
130944629|NCT03878446|471431384|FG002|Overall Study|Withdrawn by parent or guardian|0|||
130944630|NCT03878446|471431385|FG003|Overall Study|Withdrawn by parent or guardian|0|||
130944631|NCT03878446|471431386|FG004|Overall Study|Withdrawn by parent or guardian|0|||
131224927|NCT03001011|472450607|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
131224928|NCT03001011|472450608|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
131224929|NCT03001011|472450607|FG000|Overall Study|Other than specified above|3|||
131224930|NCT03001011|472450608|FG001|Overall Study|Other than specified above|8|||
131224931|NCT02875067|472450609|FG000|Overall Study|Withdrawal by Subject|1|||
131224932|NCT02875067|472450609|FG000|Overall Study|Withdrawal by Termination of Study|5|||
131224933|NCT00065065|472450610|FG000|Overall Study|Adverse Event|3|||
130944632|NCT03615105|471431387|FG000|Overall Study|Protocol Violation|1|||
131037026|NCT04828005|471768289|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
131037027|NCT04828005|471768290|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
131037028|NCT04828005|471768291|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
131037029|NCT04828005|471768292|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
131224934|NCT00065065|472450611|FG001|Overall Study|Adverse Event|2|||
131224935|NCT00065065|472450610|FG000|Overall Study|Withdrawal by Subject|1|||
131224936|NCT00065065|472450611|FG001|Overall Study|Withdrawal by Subject|5|||
131224937|NCT00065065|472450610|FG000|Overall Study|Lack of Efficacy|4|||
131224938|NCT00065065|472450611|FG001|Overall Study|Lack of Efficacy|11|||
131224939|NCT00065065|472450610|FG000|Overall Study|Other|2|||
130944633|NCT03615105|471431388|FG001|Overall Study|Protocol Violation|0|||
130944634|NCT03615105|471431389|FG002|Overall Study|Protocol Violation|0|||
130944635|NCT03615105|471431387|FG000|Overall Study|Death|0|||
130944636|NCT03615105|471431388|FG001|Overall Study|Death|2|||
130944637|NCT03615105|471431389|FG002|Overall Study|Death|0|||
130944638|NCT05214768|471431390|FG000|Induction Period|Withdrawal by Subject|1|||
130944639|NCT05214768|471431391|FG001|Induction Period|Withdrawal by Subject|0|||
130944640|NCT05214768|471431392|FG002|Induction Period|Withdrawal by Subject|0|||
130944641|NCT05214768|471431393|FG003|Induction Period|Withdrawal by Subject|0|||
130944642|NCT05214768|471431394|FG004|Induction Period|Withdrawal by Subject|0|||
130944643|NCT05214768|471431395|FG005|Induction Period|Withdrawal by Subject|0|||
130944644|NCT05214768|471431390|FG000|Induction Period|Physician Decision|1|||
130944645|NCT05214768|471431391|FG001|Induction Period|Physician Decision|0|||
130773679|NCT01768559|470797069|FG002|Overall Study|Poor compliance to protocol|2|||
130773680|NCT01768559|470797067|FG000|Overall Study|Other than specified|9|||
130773681|NCT01768559|470797068|FG001|Overall Study|Other than specified|8|||
130773682|NCT01768559|470797069|FG002|Overall Study|Other than specified|5|||
130773683|NCT00398047|470797074|FG000|Overall Study|all patient progressed before completion|3|||
130773684|NCT00902746|470797075|FG000|Overall Study|Protocol Violation|7|||
130773685|NCT00902746|470797075|FG000|Overall Study|Withdrawal by Subject|16|||
130773686|NCT00902746|470797075|FG000|Overall Study|Adverse Event|8|||
130773687|NCT00902746|470797075|FG000|Overall Study|Lost to Follow-up|3|||
130773688|NCT00902746|470797075|FG000|Overall Study|Physician Decision|2|||
130773689|NCT02347072|470797080|FG000|Overall Study|Adverse Event|2|||
130773690|NCT02347072|470797080|FG000|Overall Study|Withdrawal by Subject|6|||
130773691|NCT02347072|470797080|FG000|Overall Study|Physician Decision|1|||
130773692|NCT02347072|470797080|FG000|Overall Study|Lost to Follow-up|2|||
130773693|NCT02347072|470797080|FG000|Overall Study|Protocol Violation|1|||
130773694|NCT02347072|470797080|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
130773695|NCT03762681|470797081|FG000|Part 1|Withdrawal by Subject|0|||
130773696|NCT03762681|470797082|FG001|Part 1|Withdrawal by Subject|0|||
130773697|NCT03762681|470797083|FG002|Part 1|Withdrawal by Subject|0|||
130773698|NCT03762681|470797084|FG003|Part 1|Withdrawal by Subject|1|||
130773699|NCT03762681|470797085|FG004|Part 1|Withdrawal by Subject|0|||
130773700|NCT03762681|470797086|FG005|Part 1|Withdrawal by Subject|0|||
130773701|NCT03762681|470797087|FG006|Part 1|Withdrawal by Subject|0|||
130773702|NCT03762681|470797088|FG007|Part 1|Withdrawal by Subject|0|||
130773703|NCT03762681|470797081|FG000|Part 2a|Pandemic Travel Restrictions|0|||
130773704|NCT03762681|470797082|FG001|Part 2a|Pandemic Travel Restrictions|0|||
130773705|NCT03762681|470797083|FG002|Part 2a|Pandemic Travel Restrictions|0|||
130773706|NCT03762681|470797084|FG003|Part 2a|Pandemic Travel Restrictions|0|||
130773707|NCT03762681|470797085|FG004|Part 2a|Pandemic Travel Restrictions|0|||
130773708|NCT03762681|470797086|FG005|Part 2a|Pandemic Travel Restrictions|0|||
130773709|NCT03762681|470797087|FG006|Part 2a|Pandemic Travel Restrictions|0|||
130773710|NCT03762681|470797088|FG007|Part 2a|Pandemic Travel Restrictions|1|||
130773711|NCT01216332|470797091|FG000|Overall Study|Withdrawal by Subject|4|||
130773712|NCT01216332|470797092|FG001|Overall Study|Withdrawal by Subject|0|||
130944646|NCT05214768|471431392|FG002|Induction Period|Physician Decision|0|||
130944647|NCT05214768|471431393|FG003|Induction Period|Physician Decision|0|||
130944648|NCT05214768|471431394|FG004|Induction Period|Physician Decision|0|||
130944649|NCT05214768|471431395|FG005|Induction Period|Physician Decision|0|||
130944650|NCT05214768|471431390|FG000|Maintenance Period|Other Reasons|0|||
130944651|NCT05214768|471431391|FG001|Maintenance Period|Other Reasons|0|||
130944652|NCT05214768|471431392|FG002|Maintenance Period|Other Reasons|1|||
130944653|NCT05214768|471431393|FG003|Maintenance Period|Other Reasons|1|||
130773713|NCT00636636|470797093|FG000|Overall Study|Other reason|4|||
130773714|NCT00636636|470797094|FG001|Overall Study|Other reason|6|||
130773715|NCT00636636|470797093|FG000|Overall Study|Adverse Event|19|||
130773716|NCT00636636|470797094|FG001|Overall Study|Adverse Event|8|||
130773717|NCT00636636|470797093|FG000|Overall Study|Lack of Efficacy|7|||
130773718|NCT00636636|470797094|FG001|Overall Study|Lack of Efficacy|12|||
130773719|NCT00636636|470797093|FG000|Overall Study|Protocol Violation|2|||
130773720|NCT00636636|470797094|FG001|Overall Study|Protocol Violation|2|||
130944654|NCT05214768|471431394|FG004|Maintenance Period|Other Reasons|0|||
130944655|NCT05214768|471431395|FG005|Maintenance Period|Other Reasons|0|||
130773721|NCT00636636|470797093|FG000|Overall Study|Lost to Follow-up|0|||
130773722|NCT00636636|470797094|FG001|Overall Study|Lost to Follow-up|1|||
130773723|NCT00636636|470797093|FG000|Overall Study|Death|0|||
130773724|NCT00636636|470797094|FG001|Overall Study|Death|1|||
130773725|NCT00636636|470797093|FG000|Overall Study|Withdrawal by Subject|4|||
130773726|NCT00636636|470797094|FG001|Overall Study|Withdrawal by Subject|9|||
130773727|NCT00524173|470797095|FG000|Overall Study|Lost to Follow-up|0|||
130773728|NCT00524173|470797096|FG001|Overall Study|Lost to Follow-up|1|||
130773729|NCT00524173|470797095|FG000|Overall Study|Death|1|||
130773730|NCT00524173|470797096|FG001|Overall Study|Death|0|||
130773731|NCT00524173|470797095|FG000|Overall Study|Had not reached endpoint at study close|4|||
130944656|NCT05214768|471431390|FG000|Maintenance Period|Withdrawal by Subject|0|||
130944657|NCT05214768|471431391|FG001|Maintenance Period|Withdrawal by Subject|0|||
130944658|NCT05214768|471431392|FG002|Maintenance Period|Withdrawal by Subject|0|||
130944659|NCT05214768|471431393|FG003|Maintenance Period|Withdrawal by Subject|1|||
130944660|NCT05214768|471431394|FG004|Maintenance Period|Withdrawal by Subject|0|||
130773732|NCT00524173|470797096|FG001|Overall Study|Had not reached endpoint at study close|1|||
130773733|NCT02793947|470798543|FG000|Overall Study|Death|1|||
130773734|NCT02793947|470798544|FG001|Overall Study|Death|0|||
130773735|NCT02793947|470798543|FG000|Overall Study|Physician Decision|1|||
130773736|NCT02793947|470798544|FG001|Overall Study|Physician Decision|5|||
130773737|NCT03746405|470798552|FG000|Overall Study|Withdrawal by Subject|3|||
130773738|NCT03746405|470798553|FG001|Overall Study|Withdrawal by Subject|0|||
130773739|NCT03746405|470798552|FG000|Overall Study|technical difficulties|0|||
130773740|NCT03746405|470798553|FG001|Overall Study|technical difficulties|2|||
130773741|NCT03479008|470798554|FG000|Overall Study|Withdrawal by Subject|3|||
130773742|NCT00412932|470798555|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
130773743|NCT00412932|470798555|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
130773744|NCT00412932|470798555|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
130773745|NCT00412932|470798555|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
130773746|NCT00412932|470798555|FG000|Olmesartan (Olm) 20 mg|Other|1|||
130773747|NCT00412932|470798555|FG000|Olmesartan 40 mg|Adverse Event|4|||
130944661|NCT05214768|471431395|FG005|Maintenance Period|Withdrawal by Subject|0|||
130944662|NCT05214768|471431390|FG000|Maintenance Period|Lack of Efficacy|0|||
130944663|NCT05214768|471431391|FG001|Maintenance Period|Lack of Efficacy|0|||
130944664|NCT05214768|471431392|FG002|Maintenance Period|Lack of Efficacy|1|||
130944665|NCT05214768|471431393|FG003|Maintenance Period|Lack of Efficacy|0|||
130944666|NCT05214768|471431394|FG004|Maintenance Period|Lack of Efficacy|1|||
130944667|NCT05214768|471431395|FG005|Maintenance Period|Lack of Efficacy|0|||
130944668|NCT05214768|471431390|FG000|Open Label Extension Period|Physician Decision|0|||
130944669|NCT05214768|471431391|FG001|Open Label Extension Period|Physician Decision|0|||
130944670|NCT05214768|471431392|FG002|Open Label Extension Period|Physician Decision|0|||
130944671|NCT05214768|471431393|FG003|Open Label Extension Period|Physician Decision|0|||
130944672|NCT05214768|471431394|FG004|Open Label Extension Period|Physician Decision|0|||
130944673|NCT05214768|471431395|FG005|Open Label Extension Period|Physician Decision|1|||
130944674|NCT05214768|471431390|FG000|Open Label Extension Period|Lack of Efficacy|0|||
130944675|NCT05214768|471431391|FG001|Open Label Extension Period|Lack of Efficacy|0|||
130944676|NCT05214768|471431392|FG002|Open Label Extension Period|Lack of Efficacy|0|||
130944677|NCT05214768|471431393|FG003|Open Label Extension Period|Lack of Efficacy|0|||
130944678|NCT05214768|471431394|FG004|Open Label Extension Period|Lack of Efficacy|0|||
130944679|NCT05214768|471431395|FG005|Open Label Extension Period|Lack of Efficacy|1|||
130944680|NCT05214768|471431390|FG000|Open Label Extension Period|Ongoing Study|0|||
130944681|NCT05214768|471431391|FG001|Open Label Extension Period|Ongoing Study|0|||
130944682|NCT05214768|471431392|FG002|Open Label Extension Period|Ongoing Study|0|||
130944683|NCT05214768|471431393|FG003|Open Label Extension Period|Ongoing Study|0|||
130944684|NCT05214768|471431394|FG004|Open Label Extension Period|Ongoing Study|0|||
130944685|NCT05214768|471431395|FG005|Open Label Extension Period|Ongoing Study|42|||
130944686|NCT05041322|471431396|FG000|Baseline|Withdrawal by Subject|1|||
130944687|NCT05041322|471431397|FG001|Baseline|Withdrawal by Subject|0|||
130944688|NCT05041322|471431396|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
130944689|NCT05041322|471431397|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
130944690|NCT05041322|471431396|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
130944691|NCT05041322|471431397|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
130944692|NCT01502423|471431398|FG000|Overall Study|Withdrawal by Subject|0|||
130944693|NCT01502423|471431399|FG001|Overall Study|Withdrawal by Subject|1|||
130944694|NCT00567892|471431400|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
130944695|NCT00567892|471431401|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
130944696|NCT00567892|471431402|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
130944697|NCT00567892|471431403|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
130944698|NCT00567892|471431400|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
130944699|NCT00567892|471431401|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
130944700|NCT00567892|471431402|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
130944701|NCT00567892|471431403|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
130944702|NCT04383743|471431404|FG000|Overall Study|Withdrawal by Subject|1|||
130773748|NCT00412932|470798555|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
130773749|NCT00412932|470798555|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
130773750|NCT00412932|470798555|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
130773751|NCT00412932|470798555|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
130944703|NCT04383743|471431404|FG000|Overall Study|Adverse Event|1|||
130944704|NCT03482791|471431405|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
130944705|NCT03482791|471431406|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
130944706|NCT01239368|471434097|FG000|Overall Study|Principal investigator discretion|1|||
130944707|NCT01239368|471434098|FG001|Overall Study|Principal investigator discretion|0|||
130944708|NCT01239368|471434099|FG002|Overall Study|Principal investigator discretion|0|||
131045847|NCT03582033|471802284|FG006|Part C|Withdrawal by Subject|1|||
131045848|NCT03582033|471802285|FG007|Part C|Withdrawal by Subject|2|||
131045849|NCT03582033|471802286|FG008|Part C|Withdrawal by Subject|1|||
131045850|NCT03582033|471802287|FG009|Part C|Withdrawal by Subject|0|||
131045851|NCT03582033|471802278|FG000|Part D|Death|0|||
130944709|NCT01239368|471434100|FG003|Overall Study|Principal investigator discretion|0|||
130944710|NCT01239368|471434101|FG004|Overall Study|Principal investigator discretion|1|||
130944711|NCT01239368|471434102|FG005|Overall Study|Principal investigator discretion|2|||
130944712|NCT01239368|471434103|FG006|Overall Study|Principal investigator discretion|0|||
130944713|NCT01239368|471434104|FG007|Overall Study|Principal investigator discretion|0|||
130944714|NCT01239368|471434105|FG008|Overall Study|Principal investigator discretion|0|||
130944715|NCT01239368|471434106|FG009|Overall Study|Principal investigator discretion|1|||
131037030|NCT04828005|471768289|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
131037031|NCT04828005|471768290|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
131037032|NCT04828005|471768291|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
131037033|NCT04828005|471768292|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
131037034|NCT04828005|471768289|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
131037035|NCT04828005|471768290|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
131037036|NCT04828005|471768291|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
131037037|NCT04828005|471768292|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
131037038|NCT04828005|471768289|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
131037039|NCT04828005|471768290|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
131037040|NCT04828005|471768291|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
131037041|NCT04828005|471768292|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
131037042|NCT04828005|471768289|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
131037043|NCT04828005|471768290|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
131037044|NCT04828005|471768291|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
131037045|NCT04828005|471768292|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
131037046|NCT02975882|471770465|FG000|Overall Study|Adverse Event|1|||
131037047|NCT02975882|471770466|FG001|Overall Study|Adverse Event|2|||
131037048|NCT02975882|471770467|FG002|Overall Study|Adverse Event|1|||
131037049|NCT02975882|471770468|FG003|Overall Study|Adverse Event|1|||
131037050|NCT02975882|471770465|FG000|Overall Study|Death|0|||
131037051|NCT02975882|471770466|FG001|Overall Study|Death|1|||
131037052|NCT02975882|471770467|FG002|Overall Study|Death|0|||
131037053|NCT02975882|471770468|FG003|Overall Study|Death|0|||
131037054|NCT02975882|471770465|FG000|Overall Study|Lack of Efficacy|3|||
131037055|NCT02975882|471770466|FG001|Overall Study|Lack of Efficacy|7|||
131037056|NCT02975882|471770467|FG002|Overall Study|Lack of Efficacy|4|||
131037057|NCT02975882|471770468|FG003|Overall Study|Lack of Efficacy|3|||
131037058|NCT02975882|471770465|FG000|Overall Study|Physician Decision|0|||
131037059|NCT02975882|471770466|FG001|Overall Study|Physician Decision|2|||
131037060|NCT02975882|471770467|FG002|Overall Study|Physician Decision|4|||
131037061|NCT02975882|471770468|FG003|Overall Study|Physician Decision|2|||
131037062|NCT02975882|471770465|FG000|Overall Study|Ineligible|0|||
131037063|NCT02975882|471770466|FG001|Overall Study|Ineligible|1|||
131037064|NCT02975882|471770467|FG002|Overall Study|Ineligible|0|||
131037065|NCT02975882|471770468|FG003|Overall Study|Ineligible|0|||
131037066|NCT03867500|471770469|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
131037067|NCT04802967|471770472|FG000|Part B|Withdrawal by Subject|0|||
131037068|NCT04802967|471770473|FG001|Part B|Withdrawal by Subject|0|||
131037069|NCT04802967|471770474|FG002|Part B|Withdrawal by Subject|0|||
131037070|NCT04802967|471770475|FG003|Part B|Withdrawal by Subject|0|||
131037071|NCT04802967|471770476|FG004|Part B|Withdrawal by Subject|0|||
131037072|NCT04802967|471770477|FG005|Part B|Withdrawal by Subject|1|||
131037073|NCT04802967|471770478|FG006|Part B|Withdrawal by Subject|0|||
131037074|NCT04802967|471770479|FG007|Part B|Withdrawal by Subject|0|||
131037075|NCT04802967|471770480|FG008|Part B|Withdrawal by Subject|0|||
131037076|NCT04802967|471770481|FG009|Part B|Withdrawal by Subject|0|||
131037077|NCT01824875|471770483|FG000|Overall Study|Disease progression|22|||
131037078|NCT01824875|471770484|FG001|Overall Study|Disease progression|15|||
131037079|NCT01824875|471770483|FG000|Overall Study|Withdrawal by Subject|5|||
131037080|NCT01824875|471770484|FG001|Overall Study|Withdrawal by Subject|4|||
131037081|NCT01824875|471770483|FG000|Overall Study|Adverse Event|4|||
131037082|NCT01824875|471770484|FG001|Overall Study|Adverse Event|10|||
131037083|NCT01824875|471770483|FG000|Overall Study|Alternative therapy|3|||
131037084|NCT01824875|471770484|FG001|Overall Study|Alternative therapy|0|||
131037085|NCT01824875|471770483|FG000|Overall Study|Complicating disease|1|||
131037086|NCT01824875|471770484|FG001|Overall Study|Complicating disease|0|||
131037087|NCT01824875|471770483|FG000|Overall Study|Physician Decision|0|||
131037088|NCT01824875|471770484|FG001|Overall Study|Physician Decision|1|||
131037089|NCT01824875|471770483|FG000|Overall Study|Non-compliance|1|||
131037090|NCT01824875|471770484|FG001|Overall Study|Non-compliance|1|||
131037091|NCT01824875|471770483|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
131124208|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
131124209|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
131037092|NCT01824875|471770484|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
131037093|NCT01824875|471770483|FG000|Overall Study|Administrative issues|0|||
131037094|NCT01824875|471770484|FG001|Overall Study|Administrative issues|2|||
131037095|NCT01824875|471770483|FG000|Overall Study|Ineligible or never started treatment|9|||
131037096|NCT01824875|471770484|FG001|Overall Study|Ineligible or never started treatment|5|||
131224940|NCT00065065|472450611|FG001|Overall Study|Other|2|||
131224941|NCT02713243|472450615|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
131224942|NCT02713243|472450616|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
131224943|NCT02713243|472450615|FG000|Overall Study|Administrative problems|0|||
131224944|NCT02713243|472450616|FG001|Overall Study|Administrative problems|1|||
131224945|NCT02713243|472450615|FG000|Overall Study|Protocol deviation|0|||
131224946|NCT02713243|472450616|FG001|Overall Study|Protocol deviation|1|||
131224947|NCT05288673|472450617|FG000|Overall Study|Consent withdrawn by subject|0|||
131224948|NCT05288673|472450618|FG001|Overall Study|Consent withdrawn by subject|0|||
131224949|NCT05288673|472450619|FG002|Overall Study|Consent withdrawn by subject|1|||
131224950|NCT01050673|472450620|FG000|Overall Study|Physician Decision|4|||
131224951|NCT01050673|472450621|FG001|Overall Study|Physician Decision|5|||
131224952|NCT03056352|472450622|FG000|Overall Study|Lost to Follow-up|1|||
131224953|NCT01254045|472450627|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
131224954|NCT01254045|472450628|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
131224955|NCT01254045|472450629|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
131224956|NCT01254045|472450630|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
131224957|NCT01254045|472450631|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
131224958|NCT01254045|472450632|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
131224959|NCT00597207|472450633|FG000|Overall Study|Lost to Follow-up|5|||
131224960|NCT00597207|472450634|FG001|Overall Study|Lost to Follow-up|7|||
131224961|NCT00665626|472450637|FG000|Overall Study|Lack of Efficacy|8|||
131224962|NCT00665626|472450638|FG001|Overall Study|Lack of Efficacy|5|||
131224963|NCT00665626|472450637|FG000|Overall Study|Lost to Follow-up|0|||
131224964|NCT00665626|472450638|FG001|Overall Study|Lost to Follow-up|2|||
131224965|NCT00665626|472450637|FG000|Overall Study|Withdrawal by Subject|0|||
131224966|NCT00665626|472450638|FG001|Overall Study|Withdrawal by Subject|1|||
131224967|NCT00665626|472450637|FG000|Overall Study|Protocol Violation|0|||
131224968|NCT00665626|472450638|FG001|Overall Study|Protocol Violation|2|||
131224969|NCT00665626|472450637|FG000|Overall Study|Adverse Event|1|||
131224970|NCT00665626|472450638|FG001|Overall Study|Adverse Event|9|||
131224971|NCT00665626|472450637|FG000|Overall Study|Due to exclusion criteria|0|||
131224972|NCT00665626|472450638|FG001|Overall Study|Due to exclusion criteria|1|||
131224973|NCT00665626|472450637|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
131224974|NCT00665626|472450638|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
131224975|NCT00665626|472450637|FG000|Overall Study|Unably to comply with dosing regimen|0|||
131224976|NCT00665626|472450638|FG001|Overall Study|Unably to comply with dosing regimen|1|||
131224977|NCT00665626|472450637|FG000|Overall Study|Death|1|||
131224978|NCT00665626|472450638|FG001|Overall Study|Death|0|||
131224979|NCT04147611|472450639|FG000|Overall Study|Physician Decision|0|||
131224980|NCT04147611|472450640|FG001|Overall Study|Physician Decision|1|||
131224981|NCT00435825|472450641|FG000|Overall Study|Abnormality of Laboratory Test|0|||
131224982|NCT00435825|472450642|FG001|Overall Study|Abnormality of Laboratory Test|1|||
131224983|NCT00435825|472450643|FG002|Overall Study|Abnormality of Laboratory Test|0|||
131224984|NCT00435825|472450644|FG003|Overall Study|Abnormality of Laboratory Test|0|||
131224985|NCT00435825|472450641|FG000|Overall Study|Insufficient Therapeutic Response|3|||
131224986|NCT00435825|472450642|FG001|Overall Study|Insufficient Therapeutic Response|1|||
131224987|NCT00435825|472450643|FG002|Overall Study|Insufficient Therapeutic Response|0|||
131224988|NCT00435825|472450644|FG003|Overall Study|Insufficient Therapeutic Response|3|||
131224989|NCT00435825|472450641|FG000|Overall Study|Other Protocol Violation|1|||
131224990|NCT00435825|472450642|FG001|Overall Study|Other Protocol Violation|0|||
131224991|NCT00435825|472450643|FG002|Overall Study|Other Protocol Violation|0|||
131224992|NCT00435825|472450644|FG003|Overall Study|Other Protocol Violation|0|||
131224993|NCT00435825|472450641|FG000|Overall Study|Refused treatment|2|||
131224994|NCT00435825|472450642|FG001|Overall Study|Refused treatment|0|||
131224995|NCT00435825|472450643|FG002|Overall Study|Refused treatment|0|||
131224996|NCT00435825|472450644|FG003|Overall Study|Refused treatment|5|||
131224997|NCT00435825|472450641|FG000|Overall Study|Failure to return|5|||
131224998|NCT00435825|472450642|FG001|Overall Study|Failure to return|0|||
131224999|NCT00435825|472450643|FG002|Overall Study|Failure to return|4|||
131225000|NCT00435825|472450644|FG003|Overall Study|Failure to return|0|||
131225001|NCT00435825|472450641|FG000|Overall Study|Did not receive study drug|1|||
131225002|NCT00435825|472450642|FG001|Overall Study|Did not receive study drug|0|||
131225003|NCT00435825|472450643|FG002|Overall Study|Did not receive study drug|2|||
130944716|NCT01239368|471434097|FG000|Overall Study|Disease progression on study|1|||
130944717|NCT01239368|471434098|FG001|Overall Study|Disease progression on study|1|||
131225004|NCT00435825|472450644|FG003|Overall Study|Did not receive study drug|0|||
131225005|NCT00435825|472450641|FG000|Overall Study|Did not enter follow-up|0|||
131225006|NCT00435825|472450642|FG001|Overall Study|Did not enter follow-up|4|||
131225007|NCT00435825|472450643|FG002|Overall Study|Did not enter follow-up|1|||
131225008|NCT00435825|472450644|FG003|Overall Study|Did not enter follow-up|3|||
131225009|NCT00435825|472450641|FG000|Overall Study|Did not complete full follow-up period|6|||
131225010|NCT00435825|472450642|FG001|Overall Study|Did not complete full follow-up period|6|||
130944718|NCT01239368|471434099|FG002|Overall Study|Disease progression on study|1|||
130944719|NCT01239368|471434100|FG003|Overall Study|Disease progression on study|1|||
130944720|NCT01239368|471434101|FG004|Overall Study|Disease progression on study|4|||
130944721|NCT01239368|471434102|FG005|Overall Study|Disease progression on study|2|||
130773752|NCT00412932|470798555|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
130773753|NCT00412932|470798555|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
130773754|NCT01490840|470798559|FG000|Phase 1|Lost to Follow-up|1|||
130773755|NCT01490840|470798560|FG001|Phase 1|Lost to Follow-up|0|||
130773756|NCT01490840|470798559|FG000|Phase 1|Adverse Event|2|||
130773757|NCT01490840|470798560|FG001|Phase 1|Adverse Event|1|||
130773758|NCT01490840|470798559|FG000|Phase 1|Withdrawal by Subject|6|||
130773759|NCT01490840|470798560|FG001|Phase 1|Withdrawal by Subject|5|||
130773760|NCT01490840|470798559|FG000|Phase 1|Visit 6a omitted|1|||
130773761|NCT01490840|470798560|FG001|Phase 1|Visit 6a omitted|0|||
130773762|NCT01490840|470798559|FG000|Phase 2|Withdrawal by Subject|4|||
130773763|NCT01490840|470798560|FG001|Phase 2|Withdrawal by Subject|3|||
130944722|NCT01239368|471434103|FG006|Overall Study|Disease progression on study|5|||
130944723|NCT01239368|471434104|FG007|Overall Study|Disease progression on study|0|||
130944724|NCT01239368|471434105|FG008|Overall Study|Disease progression on study|0|||
130944725|NCT01239368|471434106|FG009|Overall Study|Disease progression on study|2|||
130944726|NCT01239368|471434097|FG000|Overall Study|Refused further treatment|0|||
130773764|NCT01490840|470798559|FG000|Phase 2|Permanent interruption of fingolimod|0|||
130773765|NCT01490840|470798560|FG001|Phase 2|Permanent interruption of fingolimod|1|||
130773766|NCT01490840|470798559|FG000|Phase 2|Lost to Follow-up|1|||
130773767|NCT01490840|470798560|FG001|Phase 2|Lost to Follow-up|1|||
130773768|NCT01490840|470798559|FG000|Phase 2|Adverse Event|1|||
130773769|NCT01490840|470798560|FG001|Phase 2|Adverse Event|1|||
130773770|NCT01704755|470798561|FG000|Overall Study|Adverse Event|4|||
130773771|NCT01704755|470798562|FG001|Overall Study|Adverse Event|1|||
130773772|NCT01704755|470798561|FG000|Overall Study|Lost to Follow-up|3|||
130773773|NCT01704755|470798562|FG001|Overall Study|Lost to Follow-up|4|||
130773774|NCT01704755|470798561|FG000|Overall Study|Withdrew consent|1|||
130773775|NCT01704755|470798562|FG001|Overall Study|Withdrew consent|1|||
130773776|NCT01704755|470798561|FG000|Overall Study|Other (not specified)|3|||
130773777|NCT01704755|470798562|FG001|Overall Study|Other (not specified)|1|||
130773778|NCT01704755|470798561|FG000|Overall Study|Withdrew consent and personal issues|1|||
130773779|NCT01704755|470798562|FG001|Overall Study|Withdrew consent and personal issues|0|||
130773780|NCT04105842|470798563|FG000|Overall Study|Withdrawal by Subject|2|||
130773781|NCT02087670|470798564|FG000|Overall Study|Withdrawal by Subject|3|||
130773782|NCT02087670|470798565|FG001|Overall Study|Withdrawal by Subject|2|||
130773783|NCT01639703|470798566|FG000|Overall Study|Withdrawal by Subject|5|||
130773784|NCT01639703|470798566|FG000|Overall Study|Other reason|7|||
130773785|NCT01042392|470798567|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
130773786|NCT01042392|470798568|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
130773787|NCT01042392|470798569|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
130773788|NCT01042392|470798570|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
130773789|NCT01042392|470798567|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
130773790|NCT01042392|470798568|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
130773791|NCT01042392|470798569|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
130773792|NCT01042392|470798570|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
130773793|NCT01042392|470798567|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
130944727|NCT01239368|471434098|FG001|Overall Study|Refused further treatment|0|||
130944728|NCT01239368|471434099|FG002|Overall Study|Refused further treatment|0|||
130944729|NCT01239368|471434100|FG003|Overall Study|Refused further treatment|0|||
130944730|NCT01239368|471434101|FG004|Overall Study|Refused further treatment|0|||
131037097|NCT01824875|471770483|FG000|Overall Study|Other|0|||
131037098|NCT01824875|471770484|FG001|Overall Study|Other|2|||
131037099|NCT01098812|471770487|FG000|Overall Study|Death|2|||
131037100|NCT01098812|471770488|FG001|Overall Study|Death|0|||
131037101|NCT01098812|471770489|FG002|Overall Study|Death|1|||
130773794|NCT01042392|470798568|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
130773795|NCT01042392|470798569|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
130773796|NCT01042392|470798570|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
131037102|NCT01098812|471770487|FG000|Overall Study|Lost to Follow-up|0|||
131037103|NCT01098812|471770488|FG001|Overall Study|Lost to Follow-up|1|||
131037104|NCT01098812|471770489|FG002|Overall Study|Lost to Follow-up|0|||
131037105|NCT03379675|471770492|FG000|Overall Study|Lost to Follow-up|0|||
131037106|NCT03379675|471770493|FG001|Overall Study|Lost to Follow-up|1|||
131037107|NCT03379675|471770494|FG002|Overall Study|Lost to Follow-up|0|||
131037108|NCT03379675|471770492|FG000|Overall Study|Adverse Event|2|||
131124210|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
130944731|NCT01239368|471434102|FG005|Overall Study|Refused further treatment|0|||
130944732|NCT01239368|471434103|FG006|Overall Study|Refused further treatment|0|||
131037109|NCT03379675|471770493|FG001|Overall Study|Adverse Event|0|||
131037110|NCT03379675|471770494|FG002|Overall Study|Adverse Event|0|||
131037111|NCT03379675|471770492|FG000|Overall Study|Withdrawal by Subject|2|||
130773797|NCT01042392|470798567|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
130773798|NCT01042392|470798568|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
130773799|NCT01042392|470798569|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
130773800|NCT01042392|470798570|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
130773801|NCT01042392|470798567|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
130773802|NCT01042392|470798568|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
130773803|NCT01042392|470798569|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
130773804|NCT01042392|470798570|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
130773805|NCT01042392|470798567|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
130773806|NCT01042392|470798568|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
130773807|NCT01042392|470798569|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
130773808|NCT01042392|470798570|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
130773809|NCT01042392|470798567|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
130773810|NCT01042392|470798568|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
130773811|NCT01042392|470798569|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
130773812|NCT01042392|470798570|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
130773813|NCT01042392|470798567|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
130773814|NCT01042392|470798568|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
130773815|NCT01042392|470798569|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
130773816|NCT01042392|470798570|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
130773817|NCT01042392|470798567|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
130773818|NCT01042392|470798568|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
130773819|NCT01042392|470798569|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
130773820|NCT01042392|470798570|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
130773821|NCT00587795|470798571|FG000|Overall Study|Withdrawal by Subject|1|||
130773822|NCT00587795|470798572|FG001|Overall Study|Withdrawal by Subject|0|||
130773823|NCT02869893|470798577|FG000|Overall Study|participant aversion to IV|5|||
130773824|NCT02869893|470798577|FG000|Overall Study|participant fear of MRI scanner|2|||
130773825|NCT03146741|470798578|FG000|Overall Study|Txp with non-HCV+ heart|4|||
130773826|NCT03146741|470798578|FG000|Overall Study|Listeted for MOT|2|||
130773827|NCT03146741|470798578|FG000|Overall Study|Physician Decision|2|||
130773828|NCT03146741|470798578|FG000|Overall Study|Awaiting txp|2|||
130773829|NCT00837967|470798579|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
130773830|NCT00837967|470798580|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
130773831|NCT00551525|470798581|FG000|Overall Study|Protocol Violation|5|||
130773832|NCT04676724|470798582|FG000|Overall Study|Adverse Event|2|||
130773833|NCT04676724|470798583|FG001|Overall Study|Adverse Event|0|||
130773834|NCT04676724|470798582|FG000|Overall Study|Lost to Follow-up|1|||
130773835|NCT04676724|470798583|FG001|Overall Study|Lost to Follow-up|0|||
130773836|NCT04676724|470798582|FG000|Overall Study|Physician Decision|0|||
130773837|NCT04676724|470798583|FG001|Overall Study|Physician Decision|1|||
130773838|NCT04676724|470798582|FG000|Overall Study|Withdrawal by Subject|3|||
130773839|NCT04676724|470798583|FG001|Overall Study|Withdrawal by Subject|2|||
130773840|NCT02081001|470798589|FG000|Overall Study|Adverse Event|0|||
130773841|NCT02081001|470798590|FG001|Overall Study|Adverse Event|0|||
130773842|NCT02081001|470798591|FG002|Overall Study|Adverse Event|0|||
130773843|NCT02081001|470798592|FG003|Overall Study|Adverse Event|0|||
130773844|NCT02081001|470798593|FG004|Overall Study|Adverse Event|1|||
130773845|NCT02081001|470798594|FG005|Overall Study|Adverse Event|0|||
130773846|NCT02081001|470798595|FG006|Overall Study|Adverse Event|0|||
130773847|NCT02081001|470798596|FG007|Overall Study|Adverse Event|0|||
130773848|NCT02081001|470798597|FG008|Overall Study|Adverse Event|0|||
130773849|NCT02081001|470798598|FG009|Overall Study|Adverse Event|0|||
130773850|NCT02081001|470798599|FG010|Overall Study|Adverse Event|0|||
130773851|NCT02081001|470798600|FG011|Overall Study|Adverse Event|0|||
130773852|NCT02588092|470798620|FG000|Overall Study|Death|4|||
130773853|NCT02588092|470798621|FG001|Overall Study|Death|3|||
130773854|NCT02588092|470798622|FG002|Overall Study|Death|3|||
130773855|NCT02588092|470798623|FG003|Overall Study|Death|3|||
130773856|NCT02588092|470798624|FG004|Overall Study|Death|2|||
130773857|NCT02588092|470798625|FG005|Overall Study|Death|2|||
130773858|NCT02588092|470798626|FG006|Overall Study|Death|2|||
130773859|NCT02588092|470798627|FG007|Overall Study|Death|1|||
130773860|NCT02588092|470798628|FG008|Overall Study|Death|5|||
130773861|NCT02588092|470798629|FG009|Overall Study|Death|2|||
131037112|NCT03379675|471770493|FG001|Overall Study|Withdrawal by Subject|1|||
131037113|NCT03379675|471770494|FG002|Overall Study|Withdrawal by Subject|2|||
131037114|NCT02817776|471770496|FG000|Overall Study|Excluded|33|||
131037115|NCT02817776|471770496|FG000|Overall Study|Lost to Follow-up|20|||
131037116|NCT02817776|471770496|FG000|Overall Study|Withdrawal by Subject|33|||
131037117|NCT02817776|471770496|FG000|Overall Study|Death|2|||
131037118|NCT02598388|471770497|FG000|Overall Study|Lost to Follow-up|1|||
130773862|NCT02588092|470798620|FG000|Overall Study|Withdrawal by Subject|0|||
130944733|NCT01239368|471434104|FG007|Overall Study|Refused further treatment|0|||
130944734|NCT01239368|471434105|FG008|Overall Study|Refused further treatment|0|||
130944735|NCT01239368|471434106|FG009|Overall Study|Refused further treatment|1|||
130944736|NCT01239368|471434097|FG000|Overall Study|Death|0|||
130944737|NCT01239368|471434098|FG001|Overall Study|Death|0|||
130944738|NCT01239368|471434099|FG002|Overall Study|Death|0|||
130944739|NCT01239368|471434100|FG003|Overall Study|Death|0|||
130944740|NCT01239368|471434101|FG004|Overall Study|Death|0|||
130944741|NCT01239368|471434102|FG005|Overall Study|Death|0|||
130944742|NCT01239368|471434103|FG006|Overall Study|Death|1|||
130944743|NCT01239368|471434104|FG007|Overall Study|Death|0|||
130944744|NCT01239368|471434105|FG008|Overall Study|Death|0|||
130944745|NCT01239368|471434106|FG009|Overall Study|Death|0|||
131124211|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
131124212|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
130773863|NCT02588092|470798621|FG001|Overall Study|Withdrawal by Subject|0|||
130773864|NCT02588092|470798622|FG002|Overall Study|Withdrawal by Subject|0|||
131124213|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
131124214|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
131124215|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
131124216|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
131124217|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
131124218|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
131124219|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
131124220|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
131124221|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
131124222|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
131124223|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
131124224|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
131124225|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
131124226|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
131124227|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
131124228|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
131124229|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
131124230|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
131124231|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
131124232|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
131124233|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
131124234|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
131124235|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
131124236|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
131124237|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131124238|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
131124239|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
131124240|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
131124241|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131124242|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
131124243|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
131124244|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
131124245|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
131124246|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
131124247|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
131124248|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
131124249|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
131124250|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
131124251|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
131124252|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
131124253|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
131124254|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
131124255|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
131124256|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
131124257|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
131124258|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130944746|NCT00939809|471434107|FG000|Overall Study|Adverse Event|2|||
130944747|NCT00939809|471434107|FG000|Overall Study|Death|1|||
130944748|NCT00066066|471434108|FG000|Overall Study|Lost to Follow-up|6|||
130944749|NCT00066066|471434109|FG001|Overall Study|Lost to Follow-up|4|||
130944750|NCT00066066|471434110|FG002|Overall Study|Lost to Follow-up|7|||
131124259|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
131124260|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
131124261|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130773865|NCT02588092|470798623|FG003|Overall Study|Withdrawal by Subject|0|||
130773866|NCT02588092|470798624|FG004|Overall Study|Withdrawal by Subject|0|||
130773867|NCT02588092|470798625|FG005|Overall Study|Withdrawal by Subject|1|||
130773868|NCT02588092|470798626|FG006|Overall Study|Withdrawal by Subject|1|||
130773869|NCT02588092|470798627|FG007|Overall Study|Withdrawal by Subject|2|||
130773870|NCT02588092|470798628|FG008|Overall Study|Withdrawal by Subject|0|||
130773871|NCT02588092|470798629|FG009|Overall Study|Withdrawal by Subject|0|||
130773872|NCT02588092|470798620|FG000|Overall Study|Started Another Treatment|0|||
130773873|NCT02588092|470798621|FG001|Overall Study|Started Another Treatment|0|||
130773874|NCT02588092|470798622|FG002|Overall Study|Started Another Treatment|0|||
130773875|NCT02588092|470798623|FG003|Overall Study|Started Another Treatment|0|||
130773876|NCT02588092|470798624|FG004|Overall Study|Started Another Treatment|1|||
130773877|NCT02588092|470798625|FG005|Overall Study|Started Another Treatment|0|||
130773878|NCT02588092|470798626|FG006|Overall Study|Started Another Treatment|0|||
130773879|NCT02588092|470798627|FG007|Overall Study|Started Another Treatment|1|||
130773880|NCT02588092|470798628|FG008|Overall Study|Started Another Treatment|0|||
130773881|NCT02588092|470798629|FG009|Overall Study|Started Another Treatment|0|||
130773882|NCT02588092|470798620|FG000|Overall Study|Sponsor Decision|0|||
130773883|NCT02588092|470798621|FG001|Overall Study|Sponsor Decision|0|||
130773884|NCT02588092|470798622|FG002|Overall Study|Sponsor Decision|0|||
130773885|NCT02588092|470798623|FG003|Overall Study|Sponsor Decision|0|||
130773886|NCT02588092|470798624|FG004|Overall Study|Sponsor Decision|0|||
130773887|NCT02588092|470798625|FG005|Overall Study|Sponsor Decision|0|||
130773888|NCT02588092|470798626|FG006|Overall Study|Sponsor Decision|0|||
130773889|NCT02588092|470798627|FG007|Overall Study|Sponsor Decision|0|||
130773890|NCT02588092|470798628|FG008|Overall Study|Sponsor Decision|1|||
130773891|NCT02588092|470798629|FG009|Overall Study|Sponsor Decision|1|||
130773892|NCT01030718|470798630|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
130773893|NCT01030718|470798631|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
130773894|NCT01030718|470798632|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
130773895|NCT01030718|470798630|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
130773896|NCT01030718|470798631|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
130773897|NCT01030718|470798632|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
130773898|NCT01030718|470798630|FG000|Studies CA180-031 and -036 Combined|Death|0|||
130773899|NCT01030718|470798631|FG001|Studies CA180-031 and -036 Combined|Death|1|||
130773900|NCT01030718|470798632|FG002|Studies CA180-031 and -036 Combined|Death|0|||
130773901|NCT01030718|470798630|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
130773902|NCT01030718|470798631|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
130773903|NCT01030718|470798632|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
130773904|NCT01030718|470798630|FG000|Study CA180-036 Only|insufficient effect|1|||
130773905|NCT01030718|470798631|FG001|Study CA180-036 Only|insufficient effect|1|||
130773906|NCT01030718|470798632|FG002|Study CA180-036 Only|insufficient effect|5|||
130773907|NCT01030718|470798630|FG000|Study CA180-036 Only|Adverse Event|2|||
130773908|NCT01030718|470798631|FG001|Study CA180-036 Only|Adverse Event|3|||
130773909|NCT01030718|470798632|FG002|Study CA180-036 Only|Adverse Event|0|||
130773910|NCT01030718|470798630|FG000|Study CA180-036 Only|Death|0|||
130773911|NCT01030718|470798631|FG001|Study CA180-036 Only|Death|1|||
130773912|NCT01030718|470798632|FG002|Study CA180-036 Only|Death|0|||
130773913|NCT01030718|470798630|FG000|Study CA180-036 Only|Other Reasons|0|||
130773914|NCT01030718|470798631|FG001|Study CA180-036 Only|Other Reasons|2|||
130773915|NCT01030718|470798632|FG002|Study CA180-036 Only|Other Reasons|0|||
130773916|NCT00099632|470798633|FG000|Overall Study|Lost to Follow-up|1|||
130773917|NCT00099632|470798634|FG001|Overall Study|Lost to Follow-up|0|||
130944751|NCT00066066|471434111|FG003|Overall Study|Lost to Follow-up|4|||
130944752|NCT00066066|471434112|FG004|Overall Study|Lost to Follow-up|3|||
130944753|NCT00066066|471434113|FG005|Overall Study|Lost to Follow-up|5|||
131124262|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
130773918|NCT00099632|470798635|FG002|Overall Study|Lost to Follow-up|3|||
130944754|NCT00156533|471434116|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
130773919|NCT00099632|470798636|FG003|Overall Study|Lost to Follow-up|1|||
130773920|NCT00099632|470798637|FG004|Overall Study|Lost to Follow-up|1|||
130773921|NCT00099632|470798638|FG005|Overall Study|Lost to Follow-up|0|||
130773922|NCT00099632|470798633|FG000|Overall Study|Withdrawal by Subject|0|||
130773923|NCT00099632|470798634|FG001|Overall Study|Withdrawal by Subject|1|||
130773924|NCT00099632|470798635|FG002|Overall Study|Withdrawal by Subject|0|||
130773925|NCT00099632|470798636|FG003|Overall Study|Withdrawal by Subject|0|||
130773926|NCT00099632|470798637|FG004|Overall Study|Withdrawal by Subject|0|||
130773927|NCT00099632|470798638|FG005|Overall Study|Withdrawal by Subject|1|||
130773928|NCT00099632|470798633|FG000|Overall Study|Protocol Violation|0|||
130773929|NCT00099632|470798634|FG001|Overall Study|Protocol Violation|0|||
130773930|NCT00099632|470798635|FG002|Overall Study|Protocol Violation|0|||
130944755|NCT00156533|471434117|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
130773931|NCT00099632|470798636|FG003|Overall Study|Protocol Violation|0|||
130944756|NCT00156533|471434118|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
130944757|NCT00156533|471434119|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
130944758|NCT00156533|471434116|FG000|Overall Study|Withdrawal by Subject|1|||
130944759|NCT00156533|471434117|FG001|Overall Study|Withdrawal by Subject|0|||
130944760|NCT00156533|471434118|FG002|Overall Study|Withdrawal by Subject|0|||
130944761|NCT00156533|471434119|FG003|Overall Study|Withdrawal by Subject|1|||
130944762|NCT00156533|471434116|FG000|Overall Study|Failed Screening|1|||
130944763|NCT00156533|471434117|FG001|Overall Study|Failed Screening|0|||
130944764|NCT00156533|471434118|FG002|Overall Study|Failed Screening|1|||
130944765|NCT00156533|471434119|FG003|Overall Study|Failed Screening|1|||
130944766|NCT01254227|471434122|FG000|Overall Study|Withdrawal by Subject|6|||
130944767|NCT01254227|471434122|FG000|Overall Study|Lost to Follow-up|6|||
130944768|NCT01254227|471434122|FG000|Overall Study|Adverse Event|5|||
130944769|NCT01254227|471434122|FG000|Overall Study|Abnormal test procedure result|5|||
130944770|NCT01254227|471434122|FG000|Overall Study|Administrative problems|2|||
130944771|NCT01254227|471434122|FG000|Overall Study|Death|1|||
130944772|NCT01254227|471434122|FG000|Overall Study|Protocol deviation|1|||
130944773|NCT03265249|471434125|FG000|Overall Study|Withdrawal by Subject|0|||
130944774|NCT03265249|471434126|FG001|Overall Study|Withdrawal by Subject|1|||
130944775|NCT01614990|471434127|FG000|Overall Study|Protocol Violation|1|||
130944776|NCT01614990|471434128|FG001|Overall Study|Protocol Violation|1|||
130944777|NCT02608268|471434131|FG000|Overall Study|Adverse Event|0|||
131124263|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
131124264|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
131124265|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
131124266|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
131124267|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
131124268|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
131124269|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
131124270|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
131124271|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
131124272|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
131225011|NCT00435825|472450643|FG002|Overall Study|Did not complete full follow-up period|4|||
130944778|NCT02608268|471434132|FG001|Overall Study|Adverse Event|0|||
130944779|NCT02608268|471434133|FG002|Overall Study|Adverse Event|1|||
130944780|NCT02608268|471434134|FG003|Overall Study|Adverse Event|0|||
130944781|NCT02608268|471434135|FG004|Overall Study|Adverse Event|0|||
130944782|NCT02608268|471434136|FG005|Overall Study|Adverse Event|0|||
130944783|NCT02608268|471434137|FG006|Overall Study|Adverse Event|0|||
130944784|NCT02608268|471434138|FG007|Overall Study|Adverse Event|0|||
130944785|NCT02608268|471434139|FG008|Overall Study|Adverse Event|0|||
131124273|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
131225012|NCT00435825|472450644|FG003|Overall Study|Did not complete full follow-up period|5|||
131225013|NCT00530439|472450645|FG000|Overall Study|GDM|9|||
131225014|NCT00530439|472450646|FG001|Overall Study|GDM|3|||
131225015|NCT00530439|472450645|FG000|Overall Study|Withdraw|18|||
131225016|NCT00530439|472450646|FG001|Overall Study|Withdraw|14|||
131225017|NCT00530439|472450645|FG000|Overall Study|Missed abortion|1|||
131225018|NCT00530439|472450646|FG001|Overall Study|Missed abortion|4|||
131225019|NCT00530439|472450645|FG000|Overall Study|Misclassification|2|||
131225020|NCT00530439|472450646|FG001|Overall Study|Misclassification|0|||
131225021|NCT00530439|472450645|FG000|Overall Study|Twin pregnancy|0|||
131225022|NCT00530439|472450646|FG001|Overall Study|Twin pregnancy|2|||
131225023|NCT00530439|472450645|FG000|Overall Study|Severe malformation/abortion|0|||
131225024|NCT00530439|472450646|FG001|Overall Study|Severe malformation/abortion|3|||
131225025|NCT01529749|472450647|FG000|Overall Study|Lost to Follow-up|0|||
131225026|NCT01529749|472450648|FG001|Overall Study|Lost to Follow-up|1|||
131225027|NCT01529749|472450649|FG002|Overall Study|Lost to Follow-up|1|||
131225028|NCT01529749|472450650|FG003|Overall Study|Lost to Follow-up|0|||
130773932|NCT00099632|470798637|FG004|Overall Study|Protocol Violation|0|||
130773933|NCT00099632|470798638|FG005|Overall Study|Protocol Violation|1|||
130773934|NCT00423813|470798639|FG000|Overall Study|Adverse Event|11|||
130944786|NCT02608268|471434140|FG009|Overall Study|Adverse Event|0|||
130944787|NCT02608268|471434141|FG010|Overall Study|Adverse Event|0|||
131225029|NCT01529749|472450647|FG000|Overall Study|Physician Decision|0|||
130944788|NCT02608268|471434142|FG011|Overall Study|Adverse Event|0|||
131225030|NCT01529749|472450648|FG001|Overall Study|Physician Decision|0|||
131225031|NCT01529749|472450649|FG002|Overall Study|Physician Decision|0|||
130944789|NCT02608268|471434143|FG012|Overall Study|Adverse Event|2|||
130944790|NCT02608268|471434144|FG013|Overall Study|Adverse Event|0|||
130773935|NCT00423813|470798640|FG001|Overall Study|Adverse Event|30|||
130944791|NCT02608268|471434145|FG014|Overall Study|Adverse Event|0|||
130944792|NCT02608268|471434146|FG015|Overall Study|Adverse Event|0|||
130944793|NCT02608268|471434147|FG016|Overall Study|Adverse Event|0|||
131124274|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
131124275|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
131225032|NCT01529749|472450650|FG003|Overall Study|Physician Decision|1|||
131225033|NCT01529749|472450647|FG000|Overall Study|Withdrawal by Subject|0|||
131225034|NCT01529749|472450648|FG001|Overall Study|Withdrawal by Subject|1|||
131225035|NCT01529749|472450649|FG002|Overall Study|Withdrawal by Subject|1|||
131225036|NCT01529749|472450650|FG003|Overall Study|Withdrawal by Subject|0|||
131225037|NCT01529749|472450647|FG000|Overall Study|Protocol Violation|0|||
131225038|NCT01529749|472450648|FG001|Overall Study|Protocol Violation|0|||
131225039|NCT01529749|472450649|FG002|Overall Study|Protocol Violation|0|||
131225040|NCT01529749|472450650|FG003|Overall Study|Protocol Violation|1|||
131225041|NCT00378482|472450651|FG000|Overall Study|Lost to Follow-up|1|||
131225042|NCT00378482|472450651|FG000|Overall Study|Lack of Efficacy|8|||
131225043|NCT00378482|472450651|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
131225044|NCT00378482|472450651|FG000|Overall Study|Withdrawal by Subject|4|||
131225045|NCT00378482|472450651|FG000|Overall Study|Adverse Event|9|||
131225046|NCT01963676|472451932|FG000|Overall Study|Withdrawal by Subject|1|||
131225047|NCT01963676|472451933|FG001|Overall Study|Withdrawal by Subject|0|||
131225048|NCT01246973|472451934|FG000|Overall Study|Other|38|||
131225049|NCT01246973|472451935|FG001|Overall Study|Other|25|||
131225050|NCT01246973|472451934|FG000|Overall Study|Adverse Event|16|||
131225051|NCT01246973|472451935|FG001|Overall Study|Adverse Event|9|||
131225052|NCT01246973|472451934|FG000|Overall Study|Withdrawal by Subject|7|||
131225053|NCT01246973|472451935|FG001|Overall Study|Withdrawal by Subject|13|||
131225054|NCT00766506|472451936|FG000|Overall Study|Use rescue medication after 3 hours|3|||
131225055|NCT00766506|472451937|FG001|Overall Study|Use rescue medication after 3 hours|0|||
131225056|NCT00766506|472451936|FG000|Overall Study|Other|2|||
131225057|NCT00766506|472451937|FG001|Overall Study|Other|2|||
131225058|NCT02496221|472451938|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
131225059|NCT02496221|472451939|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
131225060|NCT02496221|472451938|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
131225061|NCT02496221|472451939|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
131225062|NCT02496221|472451938|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
131225063|NCT02496221|472451939|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
131124276|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
131124277|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
131124278|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
131124279|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
131124280|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
131124281|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
131124282|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
131124283|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
131124284|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
131124285|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
131124286|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
131124287|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
131124288|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
131124289|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
131124290|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
131124291|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
131124292|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
131124293|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
131124294|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
131124295|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
131124296|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
131124297|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
131124298|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
131124299|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
131124300|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
131124301|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
131124302|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
131124303|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
131124304|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
131225064|NCT03262233|472451940|FG000|Overall Study|Withdrawal by Subject|12|||
131225065|NCT03262233|472451941|FG001|Overall Study|Withdrawal by Subject|8|||
131225066|NCT03262233|472451942|FG002|Overall Study|Withdrawal by Subject|21|||
131225067|NCT03262233|472451943|FG003|Overall Study|Withdrawal by Subject|13|||
130773936|NCT00423813|470798641|FG002|Overall Study|Adverse Event|40|||
131124305|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
131124306|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
131124307|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
131124308|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
131124309|NCT00111800|472084417|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
131124310|NCT00111800|472084418|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
131124311|NCT00111800|472084419|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
131124312|NCT00111800|472084420|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
131124313|NCT00111800|472084421|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
131124314|NCT00111800|472084422|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
131124315|NCT00111800|472084417|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
131124316|NCT00111800|472084418|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
131124317|NCT00111800|472084419|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
131124318|NCT00111800|472084420|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
131124319|NCT00111800|472084421|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
131124320|NCT00111800|472084422|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
131124321|NCT00111800|472084417|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
131124322|NCT00111800|472084418|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
131124323|NCT00111800|472084419|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
131124324|NCT00111800|472084420|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
131124325|NCT00111800|472084421|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
131124326|NCT00111800|472084422|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
131124327|NCT00111800|472084417|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
131124328|NCT00111800|472084418|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
131124329|NCT00111800|472084419|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
131124330|NCT00111800|472084420|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
131124331|NCT00111800|472084421|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
131124332|NCT00111800|472084422|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
131124333|NCT00111800|472084417|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
131124334|NCT00111800|472084418|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
131124335|NCT00111800|472084419|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
131124336|NCT00111800|472084420|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
131124337|NCT00111800|472084421|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
131124338|NCT00111800|472084422|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
131124339|NCT00111800|472084417|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131124340|NCT00111800|472084418|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131124341|NCT00111800|472084419|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
131124342|NCT00111800|472084420|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131124343|NCT00111800|472084421|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131124344|NCT00111800|472084422|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
131124345|NCT00111800|472084417|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
131225068|NCT03262233|472451940|FG000|Overall Study|Declined due to shock|1|||
131225069|NCT03262233|472451941|FG001|Overall Study|Declined due to shock|2|||
131225070|NCT03262233|472451942|FG002|Overall Study|Declined due to shock|2|||
131225071|NCT03262233|472451943|FG003|Overall Study|Declined due to shock|3|||
131225072|NCT03262233|472451940|FG000|Overall Study|Protocol Violation|5|||
131225073|NCT03262233|472451941|FG001|Overall Study|Protocol Violation|10|||
131225074|NCT03262233|472451942|FG002|Overall Study|Protocol Violation|2|||
131225075|NCT03262233|472451943|FG003|Overall Study|Protocol Violation|13|||
131225076|NCT03262233|472451940|FG000|Overall Study|data collection artifact|0|||
130710115|NCT02791893|470564771|FG001|Blinded Phase|Withdrawal by Subject|2|||
130710116|NCT02791893|470564770|FG000|Open Label Phase|Lost to Follow-up|3|||
130710117|NCT02791893|470564771|FG001|Open Label Phase|Lost to Follow-up|0|||
130710118|NCT02791893|470564770|FG000|Open Label Phase|Withdrawal by Subject|0|||
130710119|NCT02791893|470564771|FG001|Open Label Phase|Withdrawal by Subject|2|||
130710120|NCT03438396|470564772|FG000|Overall Study|Reason Not Specified|9|||
130710121|NCT03438396|470564772|FG000|Overall Study|Withdrawal by Subject|5|||
130710122|NCT03438396|470564772|FG000|Overall Study|Lost to Follow-up|2|||
130710123|NCT03438396|470564772|FG000|Overall Study|Death|85|||
130710124|NCT03438396|470564772|FG000|Overall Study|Not treated|1|||
130710125|NCT02017860|470564775|FG000|Overall Study|Adverse Event|1|||
130710126|NCT02017860|470564775|FG000|Overall Study|Withdrawal by Subject|1|||
130710127|NCT02488330|470564776|FG000|Overall Study|Adverse Event|1|||
130710128|NCT02488330|470564776|FG000|Overall Study|Physician Decision|2|||
131225077|NCT03262233|472451941|FG001|Overall Study|data collection artifact|1|||
131225078|NCT03262233|472451942|FG002|Overall Study|data collection artifact|0|||
130710129|NCT02488330|470564776|FG000|Overall Study|Death|2|||
130710130|NCT02488330|470564776|FG000|Overall Study|Disease Progression|3|||
130710131|NCT02488330|470564776|FG000|Overall Study|Study Termination by Sponsor|4|||
130710132|NCT01206816|470564780|FG000|Overall Study|Protocol Violation|0|||
130710133|NCT01206816|470564781|FG001|Overall Study|Protocol Violation|0|||
130710134|NCT01206816|470564782|FG002|Overall Study|Protocol Violation|1|||
130710135|NCT01206816|470564783|FG003|Overall Study|Protocol Violation|0|||
130710136|NCT01206816|470564784|FG004|Overall Study|Protocol Violation|0|||
130710137|NCT01206816|470564785|FG005|Overall Study|Protocol Violation|0|||
130710138|NCT01206816|470564786|FG006|Overall Study|Protocol Violation|0|||
130710139|NCT01206816|470564780|FG000|Overall Study|Withdrawal by Subject|0|||
130710140|NCT01206816|470564781|FG001|Overall Study|Withdrawal by Subject|0|||
130710141|NCT01206816|470564782|FG002|Overall Study|Withdrawal by Subject|1|||
130710142|NCT01206816|470564783|FG003|Overall Study|Withdrawal by Subject|0|||
130710143|NCT01206816|470564784|FG004|Overall Study|Withdrawal by Subject|0|||
130710144|NCT01206816|470564785|FG005|Overall Study|Withdrawal by Subject|0|||
130710145|NCT01206816|470564786|FG006|Overall Study|Withdrawal by Subject|0|||
130710146|NCT01206816|470564780|FG000|Overall Study|Progressive disease|3|||
130710147|NCT01206816|470564781|FG001|Overall Study|Progressive disease|3|||
130710148|NCT01206816|470564782|FG002|Overall Study|Progressive disease|13|||
130710149|NCT01206816|470564783|FG003|Overall Study|Progressive disease|3|||
130710150|NCT01206816|470564784|FG004|Overall Study|Progressive disease|3|||
130710151|NCT01206816|470564785|FG005|Overall Study|Progressive disease|16|||
130710152|NCT01206816|470564786|FG006|Overall Study|Progressive disease|3|||
130710153|NCT01206816|470564780|FG000|Overall Study|Other AE|0|||
130710154|NCT01206816|470564781|FG001|Overall Study|Other AE|0|||
130710155|NCT01206816|470564782|FG002|Overall Study|Other AE|4|||
130710156|NCT01206816|470564783|FG003|Overall Study|Other AE|0|||
130710157|NCT01206816|470564784|FG004|Overall Study|Other AE|0|||
130710158|NCT01206816|470564785|FG005|Overall Study|Other AE|3|||
130710159|NCT01206816|470564786|FG006|Overall Study|Other AE|2|||
130710160|NCT01206816|470564780|FG000|Overall Study|other than stated above|0|||
130710161|NCT01206816|470564781|FG001|Overall Study|other than stated above|0|||
130710162|NCT01206816|470564782|FG002|Overall Study|other than stated above|1|||
130710163|NCT01206816|470564783|FG003|Overall Study|other than stated above|0|||
130710164|NCT01206816|470564784|FG004|Overall Study|other than stated above|0|||
130710165|NCT01206816|470564785|FG005|Overall Study|other than stated above|0|||
130710166|NCT01206816|470564786|FG006|Overall Study|other than stated above|1|||
130710167|NCT02384941|470564789|FG000|Overall Study|Adverse Event|11|||
130710168|NCT02384941|470564790|FG001|Overall Study|Adverse Event|13|||
130710169|NCT02384941|470564791|FG002|Overall Study|Adverse Event|17|||
131037119|NCT02598388|471770498|FG001|Overall Study|Lost to Follow-up|0|||
131037120|NCT02598388|471770499|FG002|Overall Study|Lost to Follow-up|1|||
131037121|NCT02598388|471770500|FG003|Overall Study|Lost to Follow-up|0|||
131037122|NCT02598388|471770501|FG004|Overall Study|Lost to Follow-up|5|||
131037123|NCT02598388|471770502|FG005|Overall Study|Lost to Follow-up|1|||
131037124|NCT02598388|471770503|FG006|Overall Study|Lost to Follow-up|2|||
131037125|NCT02598388|471770504|FG007|Overall Study|Lost to Follow-up|1|||
131037126|NCT02598388|471770505|FG008|Overall Study|Lost to Follow-up|0|||
131037127|NCT02598388|471770506|FG009|Overall Study|Lost to Follow-up|0|||
131124346|NCT00111800|472084418|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
130710170|NCT02384941|470564789|FG000|Overall Study|Lost to Follow-up|3|||
130710171|NCT02384941|470564790|FG001|Overall Study|Lost to Follow-up|2|||
130710172|NCT02384941|470564791|FG002|Overall Study|Lost to Follow-up|1|||
130710173|NCT02384941|470564789|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130710174|NCT02384941|470564790|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130710175|NCT02384941|470564791|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130710176|NCT02384941|470564789|FG000|Overall Study|Physician Decision|1|||
130710177|NCT02384941|470564790|FG001|Overall Study|Physician Decision|1|||
130710178|NCT02384941|470564791|FG002|Overall Study|Physician Decision|0|||
130710179|NCT02384941|470564789|FG000|Overall Study|Protocol Violation|3|||
130710180|NCT02384941|470564790|FG001|Overall Study|Protocol Violation|0|||
130710181|NCT02384941|470564791|FG002|Overall Study|Protocol Violation|0|||
130710182|NCT02384941|470564789|FG000|Overall Study|Withdrawal by Subject|26|||
130710183|NCT02384941|470564790|FG001|Overall Study|Withdrawal by Subject|19|||
130710184|NCT02384941|470564791|FG002|Overall Study|Withdrawal by Subject|20|||
131124347|NCT00111800|472084419|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
131037128|NCT02598388|471770507|FG010|Overall Study|Lost to Follow-up|1|||
131037129|NCT02598388|471770508|FG011|Overall Study|Lost to Follow-up|0|||
131037130|NCT02598388|471770497|FG000|Overall Study|Withdrawal by Subject|0|||
130710185|NCT02384941|470564789|FG000|Overall Study|Pregnancy|0|||
130710186|NCT02384941|470564790|FG001|Overall Study|Pregnancy|0|||
131037131|NCT02598388|471770498|FG001|Overall Study|Withdrawal by Subject|0|||
131037132|NCT02598388|471770499|FG002|Overall Study|Withdrawal by Subject|0|||
131037133|NCT02598388|471770500|FG003|Overall Study|Withdrawal by Subject|0|||
131037134|NCT02598388|471770501|FG004|Overall Study|Withdrawal by Subject|2|||
130710187|NCT02384941|470564791|FG002|Overall Study|Pregnancy|1|||
130710188|NCT02384941|470564789|FG000|Overall Study|Other than specified above|4|||
130710189|NCT02384941|470564790|FG001|Overall Study|Other than specified above|0|||
130710190|NCT02384941|470564791|FG002|Overall Study|Other than specified above|1|||
130710191|NCT02493777|470564792|FG000|Overall Study|Lost to Follow-up|0|||
130710192|NCT02493777|470564793|FG001|Overall Study|Lost to Follow-up|1|||
130710193|NCT01705236|470564794|FG000|Overall Study|Lost to Follow-up|1|||
130710194|NCT01705236|470564794|FG000|Overall Study|Administrative problems|2|||
130710195|NCT01705236|470564794|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130710196|NCT01705236|470564794|FG000|Overall Study|Protocol Violation|3|||
130710197|NCT01705236|470564794|FG000|Overall Study|Abnormal test procedure result(s)|4|||
130773937|NCT00423813|470798639|FG000|Overall Study|Withdrawal by Subject|6|||
130773938|NCT00423813|470798640|FG001|Overall Study|Withdrawal by Subject|8|||
130773939|NCT00423813|470798641|FG002|Overall Study|Withdrawal by Subject|5|||
130773940|NCT00423813|470798639|FG000|Overall Study|Lost to Follow-up|5|||
130773941|NCT00423813|470798640|FG001|Overall Study|Lost to Follow-up|4|||
130773942|NCT00423813|470798641|FG002|Overall Study|Lost to Follow-up|4|||
130773943|NCT00423813|470798639|FG000|Overall Study|Lack of Efficacy|23|||
130773944|NCT00423813|470798640|FG001|Overall Study|Lack of Efficacy|18|||
130773945|NCT00423813|470798641|FG002|Overall Study|Lack of Efficacy|19|||
130773946|NCT00423813|470798639|FG000|Overall Study|Physician Decision|2|||
130773947|NCT00423813|470798640|FG001|Overall Study|Physician Decision|0|||
130773948|NCT00423813|470798641|FG002|Overall Study|Physician Decision|0|||
130773949|NCT00423813|470798639|FG000|Overall Study|Sponsor Decision|0|||
130773950|NCT00423813|470798640|FG001|Overall Study|Sponsor Decision|1|||
130773951|NCT00423813|470798641|FG002|Overall Study|Sponsor Decision|0|||
130773952|NCT00423813|470798639|FG000|Overall Study|Protocol Violation|9|||
130773953|NCT00423813|470798640|FG001|Overall Study|Protocol Violation|4|||
130773954|NCT00423813|470798641|FG002|Overall Study|Protocol Violation|4|||
130773955|NCT00423813|470798639|FG000|Overall Study|Pregnancy|0|||
131225079|NCT03262233|472451943|FG003|Overall Study|data collection artifact|0|||
131225080|NCT01120600|472451946|FG000|Overall Study|Adverse Event|7|||
131225081|NCT01120600|472451947|FG001|Overall Study|Adverse Event|7|||
131225082|NCT01120600|472451946|FG000|Overall Study|Excessive Bone Loss|0|||
131225083|NCT01120600|472451947|FG001|Overall Study|Excessive Bone Loss|4|||
131225084|NCT01120600|472451946|FG000|Overall Study|Lost to Follow-up|1|||
131225085|NCT01120600|472451947|FG001|Overall Study|Lost to Follow-up|3|||
131225086|NCT01120600|472451946|FG000|Overall Study|Physician Decision|1|||
130710198|NCT01705236|470564794|FG000|Overall Study|Abnormal laboratory value(s)|4|||
130710199|NCT01705236|470564794|FG000|Overall Study|Withdrawal by Subject|5|||
130710200|NCT01705236|470564794|FG000|Overall Study|Adverse Event|5|||
130710201|NCT02370914|470564795|FG000|Overall Study|Protocol Violation|2|||
130773956|NCT00423813|470798640|FG001|Overall Study|Pregnancy|0|||
130773957|NCT00423813|470798641|FG002|Overall Study|Pregnancy|1|||
130773958|NCT00423813|470798639|FG000|Overall Study|Subject started night shift work|1|||
130773959|NCT00423813|470798640|FG001|Overall Study|Subject started night shift work|0|||
130773960|NCT00423813|470798641|FG002|Overall Study|Subject started night shift work|0|||
130773961|NCT00423813|470798639|FG000|Overall Study|Will start exclusionary medications|0|||
130773962|NCT00423813|470798640|FG001|Overall Study|Will start exclusionary medications|1|||
130773963|NCT00423813|470798641|FG002|Overall Study|Will start exclusionary medications|0|||
130773964|NCT00423813|470798639|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
130773965|NCT00423813|470798640|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
130773966|NCT00423813|470798641|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
130710202|NCT01341587|470564796|FG000|Overall Study|Lost to Follow-up|2|||
130710203|NCT01341587|470564797|FG001|Overall Study|Lost to Follow-up|0|||
130710204|NCT01341587|470564796|FG000|Overall Study|stopped using the meters|2|||
130710205|NCT01341587|470564797|FG001|Overall Study|stopped using the meters|10|||
130773967|NCT01386944|470798643|FG000|Overall Study|Adverse Event|26|||
130773968|NCT01386944|470798643|FG000|Overall Study|Lack of Efficacy|14|||
130773969|NCT01386944|470798643|FG000|Overall Study|Lost to Follow-up|8|||
130773970|NCT01386944|470798643|FG000|Overall Study|Unspecified reason|8|||
130773971|NCT03853291|470798644|FG000|Overall Study|Lost to Follow-up|1|||
130773972|NCT03853291|470798645|FG001|Overall Study|Lost to Follow-up|2|||
130773973|NCT03853291|470798646|FG002|Overall Study|Lost to Follow-up|0|||
130773974|NCT03853291|470798647|FG003|Overall Study|Lost to Follow-up|0|||
130773975|NCT03853291|470798648|FG004|Overall Study|Lost to Follow-up|0|||
130773976|NCT03853291|470798649|FG005|Overall Study|Lost to Follow-up|0|||
131225087|NCT01120600|472451947|FG001|Overall Study|Physician Decision|3|||
130773977|NCT03853291|470798644|FG000|Overall Study|Determined to be ineligible|1|||
130773978|NCT03853291|470798645|FG001|Overall Study|Determined to be ineligible|1|||
130773979|NCT03853291|470798646|FG002|Overall Study|Determined to be ineligible|0|||
130773980|NCT03853291|470798647|FG003|Overall Study|Determined to be ineligible|0|||
130773981|NCT03853291|470798648|FG004|Overall Study|Determined to be ineligible|0|||
130773982|NCT03853291|470798649|FG005|Overall Study|Determined to be ineligible|0|||
131225088|NCT01120600|472451946|FG000|Overall Study|Protocol Violation|0|||
130710206|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
130773983|NCT03883477|470798650|FG000|Overall Study|Death|1|||
130773984|NCT03883477|470798651|FG001|Overall Study|Death|0|||
130710207|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
130773985|NCT03883477|470798650|FG000|Overall Study|Protocol Violation|0|||
130773986|NCT03883477|470798651|FG001|Overall Study|Protocol Violation|1|||
131225089|NCT01120600|472451947|FG001|Overall Study|Protocol Violation|4|||
131225090|NCT01120600|472451946|FG000|Overall Study|Withdrawal by Subject|10|||
130944794|NCT02608268|471434148|FG017|Overall Study|Adverse Event|0|||
130944795|NCT02608268|471434149|FG018|Overall Study|Adverse Event|0|||
130944796|NCT02608268|471434150|FG019|Overall Study|Adverse Event|0|||
130944797|NCT02608268|471434151|FG020|Overall Study|Adverse Event|1|||
130944798|NCT02608268|471434152|FG021|Overall Study|Adverse Event|1|||
130944799|NCT02608268|471434153|FG022|Overall Study|Adverse Event|0|||
130944800|NCT02608268|471434154|FG023|Overall Study|Adverse Event|0|||
130944801|NCT02608268|471434155|FG024|Overall Study|Adverse Event|1|||
130944802|NCT02608268|471434156|FG025|Overall Study|Adverse Event|0|||
130944803|NCT02608268|471434157|FG026|Overall Study|Adverse Event|0|||
130944804|NCT02608268|471434158|FG027|Overall Study|Adverse Event|0|||
130944805|NCT02608268|471434159|FG028|Overall Study|Adverse Event|1|||
130944806|NCT02608268|471434160|FG029|Overall Study|Adverse Event|0|||
130944807|NCT02608268|471434131|FG000|Overall Study|Death|1|||
130944808|NCT02608268|471434132|FG001|Overall Study|Death|0|||
130710208|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
130710209|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
130710210|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
130710211|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
130773987|NCT02137226|470798657|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
130710212|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
130710213|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
130710214|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
130710215|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
130710216|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
130710217|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
130710218|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710219|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710220|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130710221|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130710222|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
130710223|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
130710224|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
130710225|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
130710226|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
130710227|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
130710228|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
130710229|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
130710230|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
130710231|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
130710232|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
130710233|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
130710234|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Death|0|||
130710235|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Death|1|||
130710236|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Death|0|||
130710237|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Death|0|||
130710238|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
130710239|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
130710240|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
130710241|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
130710242|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
130710243|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
130710244|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
130710245|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
130710246|NCT02990806|470564801|FG000|Stage 1 (22 Weeks)|Other|1|||
130710247|NCT02990806|470564802|FG001|Stage 1 (22 Weeks)|Other|3|||
130710248|NCT02990806|470564803|FG002|Stage 1 (22 Weeks)|Other|0|||
130710249|NCT02990806|470564804|FG003|Stage 1 (22 Weeks)|Other|0|||
130710250|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
130710251|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
130710252|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
130710253|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
130773988|NCT02137226|470798658|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
130944809|NCT02608268|471434133|FG002|Overall Study|Death|0|||
130944810|NCT02608268|471434134|FG003|Overall Study|Death|0|||
130944811|NCT02608268|471434135|FG004|Overall Study|Death|0|||
130944812|NCT02608268|471434136|FG005|Overall Study|Death|0|||
130944813|NCT02608268|471434137|FG006|Overall Study|Death|0|||
130944814|NCT02608268|471434138|FG007|Overall Study|Death|0|||
130944815|NCT02608268|471434139|FG008|Overall Study|Death|1|||
130944816|NCT02608268|471434140|FG009|Overall Study|Death|1|||
130710254|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Death|1|||
130710255|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Death|0|||
130710256|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Death|0|||
130944817|NCT02608268|471434141|FG010|Overall Study|Death|0|||
130944818|NCT02608268|471434142|FG011|Overall Study|Death|0|||
130944819|NCT02608268|471434143|FG012|Overall Study|Death|0|||
130944820|NCT02608268|471434144|FG013|Overall Study|Death|0|||
130944821|NCT02608268|471434145|FG014|Overall Study|Death|0|||
130944822|NCT02608268|471434146|FG015|Overall Study|Death|1|||
130944823|NCT02608268|471434147|FG016|Overall Study|Death|0|||
130944824|NCT02608268|471434148|FG017|Overall Study|Death|1|||
130944825|NCT02608268|471434149|FG018|Overall Study|Death|0|||
130944826|NCT02608268|471434150|FG019|Overall Study|Death|1|||
130944827|NCT02608268|471434151|FG020|Overall Study|Death|1|||
130944828|NCT02608268|471434152|FG021|Overall Study|Death|0|||
130944829|NCT02608268|471434153|FG022|Overall Study|Death|0|||
130944830|NCT02608268|471434154|FG023|Overall Study|Death|0|||
130944831|NCT02608268|471434155|FG024|Overall Study|Death|1|||
130944832|NCT02608268|471434156|FG025|Overall Study|Death|2|||
130944833|NCT02608268|471434157|FG026|Overall Study|Death|0|||
130944834|NCT02608268|471434158|FG027|Overall Study|Death|1|||
130944835|NCT02608268|471434159|FG028|Overall Study|Death|4|||
130944836|NCT02608268|471434160|FG029|Overall Study|Death|0|||
130944837|NCT02608268|471434131|FG000|Overall Study|Physician Decision|0|||
130944838|NCT02608268|471434132|FG001|Overall Study|Physician Decision|0|||
130944839|NCT02608268|471434133|FG002|Overall Study|Physician Decision|0|||
130944840|NCT02608268|471434134|FG003|Overall Study|Physician Decision|0|||
130944841|NCT02608268|471434135|FG004|Overall Study|Physician Decision|0|||
130944842|NCT02608268|471434136|FG005|Overall Study|Physician Decision|0|||
130944843|NCT02608268|471434137|FG006|Overall Study|Physician Decision|0|||
130944844|NCT02608268|471434138|FG007|Overall Study|Physician Decision|0|||
130944845|NCT02608268|471434139|FG008|Overall Study|Physician Decision|0|||
130944846|NCT02608268|471434140|FG009|Overall Study|Physician Decision|0|||
130944847|NCT02608268|471434141|FG010|Overall Study|Physician Decision|1|||
130944848|NCT02608268|471434142|FG011|Overall Study|Physician Decision|0|||
130944849|NCT02608268|471434143|FG012|Overall Study|Physician Decision|0|||
130944850|NCT02608268|471434144|FG013|Overall Study|Physician Decision|1|||
130944851|NCT02608268|471434145|FG014|Overall Study|Physician Decision|0|||
130944852|NCT02608268|471434146|FG015|Overall Study|Physician Decision|0|||
130944853|NCT02608268|471434147|FG016|Overall Study|Physician Decision|0|||
130944854|NCT02608268|471434148|FG017|Overall Study|Physician Decision|0|||
130944855|NCT02608268|471434149|FG018|Overall Study|Physician Decision|0|||
130944856|NCT02608268|471434150|FG019|Overall Study|Physician Decision|0|||
130944857|NCT02608268|471434151|FG020|Overall Study|Physician Decision|0|||
130944858|NCT02608268|471434152|FG021|Overall Study|Physician Decision|0|||
130944859|NCT02608268|471434153|FG022|Overall Study|Physician Decision|1|||
130944860|NCT02608268|471434154|FG023|Overall Study|Physician Decision|1|||
130944861|NCT02608268|471434155|FG024|Overall Study|Physician Decision|1|||
130944862|NCT02608268|471434156|FG025|Overall Study|Physician Decision|0|||
130944863|NCT02608268|471434157|FG026|Overall Study|Physician Decision|0|||
130944864|NCT02608268|471434158|FG027|Overall Study|Physician Decision|2|||
130944865|NCT02608268|471434159|FG028|Overall Study|Physician Decision|1|||
130944866|NCT02608268|471434160|FG029|Overall Study|Physician Decision|1|||
130944867|NCT02608268|471434131|FG000|Overall Study|Progressive disease|12|||
130944868|NCT02608268|471434132|FG001|Overall Study|Progressive disease|8|||
130944869|NCT02608268|471434133|FG002|Overall Study|Progressive disease|13|||
130944870|NCT02608268|471434134|FG003|Overall Study|Progressive disease|5|||
130944871|NCT02608268|471434135|FG004|Overall Study|Progressive disease|2|||
130944872|NCT02608268|471434136|FG005|Overall Study|Progressive disease|4|||
130944873|NCT02608268|471434137|FG006|Overall Study|Progressive disease|6|||
130944874|NCT02608268|471434138|FG007|Overall Study|Progressive disease|2|||
130710257|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Death|0|||
130710258|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
130710259|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
130710260|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
130710261|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
130710262|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
130944875|NCT02608268|471434139|FG008|Overall Study|Progressive disease|5|||
130944876|NCT02608268|471434140|FG009|Overall Study|Progressive disease|6|||
130944877|NCT02608268|471434141|FG010|Overall Study|Progressive disease|5|||
130944878|NCT02608268|471434142|FG011|Overall Study|Progressive disease|5|||
130944879|NCT02608268|471434143|FG012|Overall Study|Progressive disease|4|||
130944880|NCT02608268|471434144|FG013|Overall Study|Progressive disease|11|||
131124348|NCT00111800|472084420|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130710263|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
130944881|NCT02608268|471434145|FG014|Overall Study|Progressive disease|6|||
130944882|NCT02608268|471434146|FG015|Overall Study|Progressive disease|3|||
130944883|NCT02608268|471434147|FG016|Overall Study|Progressive disease|5|||
130944884|NCT02608268|471434148|FG017|Overall Study|Progressive disease|5|||
130710264|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
130944885|NCT02608268|471434149|FG018|Overall Study|Progressive disease|5|||
130944886|NCT02608268|471434150|FG019|Overall Study|Progressive disease|2|||
130944887|NCT02608268|471434151|FG020|Overall Study|Progressive disease|10|||
130944888|NCT02608268|471434152|FG021|Overall Study|Progressive disease|4|||
130944889|NCT02608268|471434153|FG022|Overall Study|Progressive disease|5|||
130944890|NCT02608268|471434154|FG023|Overall Study|Progressive disease|5|||
130944891|NCT02608268|471434155|FG024|Overall Study|Progressive disease|3|||
130710265|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
130710266|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
130710267|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
130944892|NCT02608268|471434156|FG025|Overall Study|Progressive disease|11|||
130944893|NCT02608268|471434157|FG026|Overall Study|Progressive disease|16|||
130944894|NCT02608268|471434158|FG027|Overall Study|Progressive disease|11|||
130944895|NCT02608268|471434159|FG028|Overall Study|Progressive disease|10|||
130944896|NCT02608268|471434160|FG029|Overall Study|Progressive disease|15|||
130944897|NCT02608268|471434131|FG000|Overall Study|Subject/guardian decision|1|||
130944898|NCT02608268|471434132|FG001|Overall Study|Subject/guardian decision|1|||
130944899|NCT02608268|471434133|FG002|Overall Study|Subject/guardian decision|2|||
130944900|NCT02608268|471434134|FG003|Overall Study|Subject/guardian decision|0|||
130944901|NCT02608268|471434135|FG004|Overall Study|Subject/guardian decision|0|||
130944902|NCT02608268|471434136|FG005|Overall Study|Subject/guardian decision|0|||
130944903|NCT02608268|471434137|FG006|Overall Study|Subject/guardian decision|0|||
130944904|NCT02608268|471434138|FG007|Overall Study|Subject/guardian decision|0|||
130944905|NCT02608268|471434139|FG008|Overall Study|Subject/guardian decision|2|||
130944906|NCT02608268|471434140|FG009|Overall Study|Subject/guardian decision|2|||
130944907|NCT02608268|471434141|FG010|Overall Study|Subject/guardian decision|0|||
130944908|NCT02608268|471434142|FG011|Overall Study|Subject/guardian decision|1|||
130944909|NCT02608268|471434143|FG012|Overall Study|Subject/guardian decision|0|||
130944910|NCT02608268|471434144|FG013|Overall Study|Subject/guardian decision|1|||
130944911|NCT02608268|471434145|FG014|Overall Study|Subject/guardian decision|0|||
130944912|NCT02608268|471434146|FG015|Overall Study|Subject/guardian decision|1|||
130944913|NCT02608268|471434147|FG016|Overall Study|Subject/guardian decision|0|||
130944914|NCT02608268|471434148|FG017|Overall Study|Subject/guardian decision|0|||
130944915|NCT02608268|471434149|FG018|Overall Study|Subject/guardian decision|1|||
130944916|NCT02608268|471434150|FG019|Overall Study|Subject/guardian decision|0|||
130944917|NCT02608268|471434151|FG020|Overall Study|Subject/guardian decision|0|||
130944918|NCT02608268|471434152|FG021|Overall Study|Subject/guardian decision|0|||
130944919|NCT02608268|471434153|FG022|Overall Study|Subject/guardian decision|1|||
130944920|NCT02608268|471434154|FG023|Overall Study|Subject/guardian decision|0|||
130944921|NCT02608268|471434155|FG024|Overall Study|Subject/guardian decision|0|||
130944922|NCT02608268|471434156|FG025|Overall Study|Subject/guardian decision|1|||
130944923|NCT02608268|471434157|FG026|Overall Study|Subject/guardian decision|1|||
130944924|NCT02608268|471434158|FG027|Overall Study|Subject/guardian decision|1|||
130944925|NCT02608268|471434159|FG028|Overall Study|Subject/guardian decision|1|||
130944926|NCT02608268|471434160|FG029|Overall Study|Subject/guardian decision|0|||
130944927|NCT01012622|471434161|FG000|Overall Study|Withdrawal by Subject|6|||
130944928|NCT01012622|471434161|FG000|Overall Study|Lost to Follow-up|5|||
130944929|NCT01012622|471434161|FG000|Overall Study|Adverse Event|7|||
130944930|NCT01012622|471434161|FG000|Overall Study|non-compliance with the drug|9|||
130944931|NCT01012622|471434161|FG000|Overall Study|Other|1|||
130944932|NCT01012622|471434161|FG000|Overall Study|screening failure|1|||
130944933|NCT01012622|471434161|FG000|Overall Study|withdrawal of consent by a parent|2|||
130944934|NCT00706641|471434162|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
130944935|NCT00706641|471434162|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
130944936|NCT00706641|471434162|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
130944937|NCT02535741|471434166|FG000|Overall Study|Adverse Event|3|||
130944938|NCT02535741|471434166|FG000|Overall Study|Withdrawal by Subject|9|||
130944939|NCT02535741|471434166|FG000|Overall Study|Lost to Follow-up|10|||
130944940|NCT02535741|471434166|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
130944941|NCT02535741|471434166|FG000|Overall Study|Missing data|6|||
130944942|NCT03873987|471434167|FG000|Overall Study|Adverse Event|1|||
130944943|NCT03873987|471434168|FG001|Overall Study|Adverse Event|0|||
130944944|NCT03873987|471434167|FG000|Overall Study|staff was unable to start a new IV line|1|||
130944945|NCT03873987|471434168|FG001|Overall Study|staff was unable to start a new IV line|0|||
130944946|NCT03873987|471434167|FG000|Overall Study|Lost to Follow-up|0|||
130944947|NCT03873987|471434168|FG001|Overall Study|Lost to Follow-up|1|||
130944948|NCT00798369|471434169|FG000|Overall Study|Subject withdrew consent|0|||
130710268|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
130710269|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
130944949|NCT00798369|471434170|FG001|Overall Study|Subject withdrew consent|0|||
130944950|NCT00798369|471434171|FG002|Overall Study|Subject withdrew consent|1|||
130944951|NCT00798369|471434172|FG003|Overall Study|Subject withdrew consent|1|||
130944952|NCT00798369|471434173|FG004|Overall Study|Subject withdrew consent|0|||
130944953|NCT00798369|471434174|FG005|Overall Study|Subject withdrew consent|2|||
130944954|NCT00798369|471434169|FG000|Overall Study|Lost to Follow-up|1|||
130944955|NCT00798369|471434170|FG001|Overall Study|Lost to Follow-up|1|||
130944956|NCT00798369|471434171|FG002|Overall Study|Lost to Follow-up|1|||
130944957|NCT00798369|471434172|FG003|Overall Study|Lost to Follow-up|0|||
130944958|NCT00798369|471434173|FG004|Overall Study|Lost to Follow-up|1|||
130944959|NCT00798369|471434174|FG005|Overall Study|Lost to Follow-up|0|||
130944960|NCT00798369|471434169|FG000|Overall Study|Adminstrative problems|0|||
130944961|NCT00798369|471434170|FG001|Overall Study|Adminstrative problems|0|||
130710270|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
130710271|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
130710272|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
130710273|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
130710274|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710275|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130710276|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
130710277|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
130944962|NCT00798369|471434171|FG002|Overall Study|Adminstrative problems|0|||
130944963|NCT00798369|471434172|FG003|Overall Study|Adminstrative problems|0|||
130944964|NCT00798369|471434173|FG004|Overall Study|Adminstrative problems|0|||
130944965|NCT00798369|471434174|FG005|Overall Study|Adminstrative problems|1|||
130944966|NCT04475588|471434175|FG000|Overall Study|Adverse Event|2|||
130944967|NCT04475588|471434176|FG001|Overall Study|Adverse Event|0|||
130944968|NCT04762680|471434177|FG000|Phase 2|Adverse Event|0|||
130944969|NCT04762680|471434178|FG001|Phase 2|Adverse Event|1|||
130944970|NCT04762680|471434179|FG002|Phase 2|Adverse Event|0|||
130944971|NCT04762680|471434180|FG003|Phase 2|Adverse Event|0|||
130944972|NCT04762680|471434181|FG004|Phase 2|Adverse Event|0|||
130944973|NCT04762680|471434182|FG005|Phase 2|Adverse Event|0|||
130944974|NCT04762680|471434183|FG006|Phase 2|Adverse Event|0|||
130944975|NCT04762680|471434184|FG007|Phase 2|Adverse Event|0|||
130944976|NCT04762680|471434185|FG008|Phase 2|Adverse Event|0|||
130944977|NCT04762680|471434186|FG009|Phase 2|Adverse Event|0|||
130944978|NCT04762680|471434187|FG010|Phase 2|Adverse Event|0|||
130944979|NCT04762680|471434188|FG011|Phase 2|Adverse Event|0|||
130944980|NCT04762680|471434189|FG012|Phase 2|Adverse Event|0|||
130944981|NCT04762680|471434190|FG013|Phase 2|Adverse Event|0|||
130944982|NCT04762680|471434191|FG014|Phase 2|Adverse Event|0|||
130944983|NCT04762680|471434192|FG015|Phase 2|Adverse Event|0|||
130944984|NCT04762680|471434193|FG016|Phase 2|Adverse Event|0|||
130944985|NCT04762680|471434194|FG017|Phase 2|Adverse Event|0|||
130944986|NCT04762680|471434195|FG018|Phase 2|Adverse Event|0|||
130944987|NCT04762680|471434196|FG019|Phase 2|Adverse Event|0|||
130944988|NCT04762680|471434197|FG020|Phase 2|Adverse Event|0|||
130944989|NCT04762680|471434198|FG021|Phase 2|Adverse Event|0|||
130944990|NCT04762680|471434177|FG000|Phase 2|Protocol Violation|5|||
130944991|NCT04762680|471434178|FG001|Phase 2|Protocol Violation|5|||
130944992|NCT04762680|471434179|FG002|Phase 2|Protocol Violation|1|||
130944993|NCT04762680|471434180|FG003|Phase 2|Protocol Violation|0|||
130944994|NCT04762680|471434181|FG004|Phase 2|Protocol Violation|0|||
130944995|NCT04762680|471434182|FG005|Phase 2|Protocol Violation|0|||
130944996|NCT04762680|471434183|FG006|Phase 2|Protocol Violation|0|||
130944997|NCT04762680|471434184|FG007|Phase 2|Protocol Violation|0|||
130944998|NCT04762680|471434185|FG008|Phase 2|Protocol Violation|0|||
130944999|NCT04762680|471434186|FG009|Phase 2|Protocol Violation|0|||
130945000|NCT04762680|471434187|FG010|Phase 2|Protocol Violation|0|||
130945001|NCT04762680|471434188|FG011|Phase 2|Protocol Violation|0|||
130945002|NCT04762680|471434189|FG012|Phase 2|Protocol Violation|0|||
130945003|NCT04762680|471434190|FG013|Phase 2|Protocol Violation|0|||
130945004|NCT04762680|471434191|FG014|Phase 2|Protocol Violation|0|||
130945005|NCT04762680|471434192|FG015|Phase 2|Protocol Violation|0|||
130945006|NCT04762680|471434193|FG016|Phase 2|Protocol Violation|0|||
130945007|NCT04762680|471434194|FG017|Phase 2|Protocol Violation|0|||
130773989|NCT02137226|470798659|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
130773990|NCT02137226|470798660|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
130773991|NCT02137226|470798661|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
130710278|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
130710279|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
130773992|NCT02137226|470798657|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
130710280|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
130773993|NCT02137226|470798658|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
130773994|NCT02137226|470798659|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
130773995|NCT02137226|470798660|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
130773996|NCT02137226|470798661|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
130945008|NCT04762680|471434195|FG018|Phase 2|Protocol Violation|0|||
130773997|NCT02137226|470798657|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
130945009|NCT04762680|471434196|FG019|Phase 2|Protocol Violation|0|||
130945010|NCT04762680|471434197|FG020|Phase 2|Protocol Violation|0|||
130945011|NCT04762680|471434198|FG021|Phase 2|Protocol Violation|0|||
130945012|NCT04762680|471434177|FG000|Phase 2|Withdrawal by Subject|23|||
130945013|NCT04762680|471434178|FG001|Phase 2|Withdrawal by Subject|21|||
130945014|NCT04762680|471434179|FG002|Phase 2|Withdrawal by Subject|28|||
130945015|NCT04762680|471434180|FG003|Phase 2|Withdrawal by Subject|0|||
130945016|NCT04762680|471434181|FG004|Phase 2|Withdrawal by Subject|0|||
130945017|NCT04762680|471434182|FG005|Phase 2|Withdrawal by Subject|0|||
130945018|NCT04762680|471434183|FG006|Phase 2|Withdrawal by Subject|0|||
130945019|NCT04762680|471434184|FG007|Phase 2|Withdrawal by Subject|0|||
130945020|NCT04762680|471434185|FG008|Phase 2|Withdrawal by Subject|0|||
130945021|NCT04762680|471434186|FG009|Phase 2|Withdrawal by Subject|0|||
130945022|NCT04762680|471434187|FG010|Phase 2|Withdrawal by Subject|0|||
130945023|NCT04762680|471434188|FG011|Phase 2|Withdrawal by Subject|0|||
130945024|NCT04762680|471434189|FG012|Phase 2|Withdrawal by Subject|0|||
130710281|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
130710282|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
130710283|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
130710284|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
130710285|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
130710286|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
130710287|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
130710288|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
130710289|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
130710290|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
130710291|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
130710292|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
130710293|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
130710294|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Other|3|||
130710295|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Other|0|||
130710296|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Other|4|||
130945025|NCT04762680|471434190|FG013|Phase 2|Withdrawal by Subject|0|||
130945026|NCT04762680|471434191|FG014|Phase 2|Withdrawal by Subject|0|||
130945027|NCT04762680|471434192|FG015|Phase 2|Withdrawal by Subject|0|||
130945028|NCT04762680|471434193|FG016|Phase 2|Withdrawal by Subject|0|||
130945029|NCT04762680|471434194|FG017|Phase 2|Withdrawal by Subject|0|||
130945030|NCT04762680|471434195|FG018|Phase 2|Withdrawal by Subject|0|||
130945031|NCT04762680|471434196|FG019|Phase 2|Withdrawal by Subject|0|||
130945032|NCT04762680|471434197|FG020|Phase 2|Withdrawal by Subject|0|||
130945033|NCT04762680|471434198|FG021|Phase 2|Withdrawal by Subject|0|||
130945034|NCT04762680|471434177|FG000|Phase 2|Lost to Follow-up|14|||
130945035|NCT04762680|471434178|FG001|Phase 2|Lost to Follow-up|8|||
130945036|NCT04762680|471434179|FG002|Phase 2|Lost to Follow-up|9|||
130945037|NCT04762680|471434180|FG003|Phase 2|Lost to Follow-up|0|||
130945038|NCT04762680|471434181|FG004|Phase 2|Lost to Follow-up|0|||
130945039|NCT04762680|471434182|FG005|Phase 2|Lost to Follow-up|0|||
130945040|NCT04762680|471434183|FG006|Phase 2|Lost to Follow-up|0|||
130945041|NCT04762680|471434184|FG007|Phase 2|Lost to Follow-up|0|||
130945042|NCT04762680|471434185|FG008|Phase 2|Lost to Follow-up|0|||
130945043|NCT04762680|471434186|FG009|Phase 2|Lost to Follow-up|0|||
130945044|NCT04762680|471434187|FG010|Phase 2|Lost to Follow-up|0|||
130945045|NCT04762680|471434188|FG011|Phase 2|Lost to Follow-up|0|||
130945046|NCT04762680|471434189|FG012|Phase 2|Lost to Follow-up|0|||
130945047|NCT04762680|471434190|FG013|Phase 2|Lost to Follow-up|0|||
130945048|NCT04762680|471434191|FG014|Phase 2|Lost to Follow-up|0|||
130945049|NCT04762680|471434192|FG015|Phase 2|Lost to Follow-up|0|||
130945050|NCT04762680|471434193|FG016|Phase 2|Lost to Follow-up|0|||
130945051|NCT04762680|471434194|FG017|Phase 2|Lost to Follow-up|0|||
130945052|NCT04762680|471434195|FG018|Phase 2|Lost to Follow-up|0|||
130945053|NCT04762680|471434196|FG019|Phase 2|Lost to Follow-up|0|||
130945054|NCT04762680|471434197|FG020|Phase 2|Lost to Follow-up|0|||
130945055|NCT04762680|471434198|FG021|Phase 2|Lost to Follow-up|0|||
130945056|NCT04762680|471434177|FG000|Phase 3|Adverse Event|0|||
130945057|NCT04762680|471434178|FG001|Phase 3|Adverse Event|0|||
130945058|NCT04762680|471434179|FG002|Phase 3|Adverse Event|0|||
130945059|NCT04762680|471434180|FG003|Phase 3|Adverse Event|1|||
130945060|NCT04762680|471434181|FG004|Phase 3|Adverse Event|0|||
131124349|NCT00111800|472084421|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130710297|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Other|1|||
130710298|NCT02990806|470564801|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
130710299|NCT02990806|470564802|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
130710300|NCT02990806|470564803|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
130710301|NCT02990806|470564804|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
130710302|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
130710303|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
130710304|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
130710305|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
130710306|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
130710307|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
130710308|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
130945061|NCT04762680|471434182|FG005|Phase 3|Adverse Event|0|||
130945062|NCT04762680|471434183|FG006|Phase 3|Adverse Event|0|||
130945063|NCT04762680|471434184|FG007|Phase 3|Adverse Event|0|||
130945064|NCT04762680|471434185|FG008|Phase 3|Adverse Event|0|||
130945065|NCT04762680|471434186|FG009|Phase 3|Adverse Event|0|||
130945066|NCT04762680|471434187|FG010|Phase 3|Adverse Event|0|||
130945067|NCT04762680|471434188|FG011|Phase 3|Adverse Event|0|||
130945068|NCT04762680|471434189|FG012|Phase 3|Adverse Event|0|||
130945069|NCT04762680|471434190|FG013|Phase 3|Adverse Event|0|||
130945070|NCT04762680|471434191|FG014|Phase 3|Adverse Event|0|||
130945071|NCT04762680|471434192|FG015|Phase 3|Adverse Event|0|||
130945072|NCT04762680|471434193|FG016|Phase 3|Adverse Event|0|||
130945073|NCT04762680|471434194|FG017|Phase 3|Adverse Event|3|||
130945074|NCT04762680|471434195|FG018|Phase 3|Adverse Event|0|||
130945075|NCT04762680|471434196|FG019|Phase 3|Adverse Event|0|||
130945076|NCT04762680|471434197|FG020|Phase 3|Adverse Event|0|||
130945077|NCT04762680|471434198|FG021|Phase 3|Adverse Event|0|||
130945078|NCT04762680|471434177|FG000|Phase 3|Protocol Violation|0|||
130945079|NCT04762680|471434178|FG001|Phase 3|Protocol Violation|0|||
130945080|NCT04762680|471434179|FG002|Phase 3|Protocol Violation|0|||
130945081|NCT04762680|471434180|FG003|Phase 3|Protocol Violation|4|||
130945082|NCT04762680|471434181|FG004|Phase 3|Protocol Violation|1|||
130945083|NCT04762680|471434182|FG005|Phase 3|Protocol Violation|5|||
130945084|NCT04762680|471434183|FG006|Phase 3|Protocol Violation|1|||
130945085|NCT04762680|471434184|FG007|Phase 3|Protocol Violation|0|||
130945086|NCT04762680|471434185|FG008|Phase 3|Protocol Violation|0|||
130945087|NCT04762680|471434186|FG009|Phase 3|Protocol Violation|0|||
130945088|NCT04762680|471434187|FG010|Phase 3|Protocol Violation|0|||
130945089|NCT04762680|471434188|FG011|Phase 3|Protocol Violation|2|||
130945090|NCT04762680|471434189|FG012|Phase 3|Protocol Violation|3|||
130945091|NCT04762680|471434190|FG013|Phase 3|Protocol Violation|0|||
130945092|NCT04762680|471434191|FG014|Phase 3|Protocol Violation|0|||
130945093|NCT04762680|471434192|FG015|Phase 3|Protocol Violation|1|||
130945094|NCT04762680|471434193|FG016|Phase 3|Protocol Violation|0|||
130945095|NCT04762680|471434194|FG017|Phase 3|Protocol Violation|10|||
130945096|NCT04762680|471434195|FG018|Phase 3|Protocol Violation|0|||
130945097|NCT04762680|471434196|FG019|Phase 3|Protocol Violation|0|||
130945098|NCT04762680|471434197|FG020|Phase 3|Protocol Violation|0|||
130945099|NCT04762680|471434198|FG021|Phase 3|Protocol Violation|0|||
130945100|NCT04762680|471434177|FG000|Phase 3|Withdrawal by Subject|0|||
130945101|NCT04762680|471434178|FG001|Phase 3|Withdrawal by Subject|0|||
130945102|NCT04762680|471434179|FG002|Phase 3|Withdrawal by Subject|0|||
130945103|NCT04762680|471434180|FG003|Phase 3|Withdrawal by Subject|13|||
130945104|NCT04762680|471434181|FG004|Phase 3|Withdrawal by Subject|17|||
130945105|NCT04762680|471434182|FG005|Phase 3|Withdrawal by Subject|12|||
130945106|NCT04762680|471434183|FG006|Phase 3|Withdrawal by Subject|8|||
130945107|NCT04762680|471434184|FG007|Phase 3|Withdrawal by Subject|3|||
130945108|NCT04762680|471434185|FG008|Phase 3|Withdrawal by Subject|2|||
130945109|NCT04762680|471434186|FG009|Phase 3|Withdrawal by Subject|4|||
130945110|NCT04762680|471434187|FG010|Phase 3|Withdrawal by Subject|3|||
130945111|NCT04762680|471434188|FG011|Phase 3|Withdrawal by Subject|1|||
130945112|NCT04762680|471434189|FG012|Phase 3|Withdrawal by Subject|3|||
130945113|NCT04762680|471434190|FG013|Phase 3|Withdrawal by Subject|2|||
130945114|NCT04762680|471434191|FG014|Phase 3|Withdrawal by Subject|1|||
130945115|NCT04762680|471434192|FG015|Phase 3|Withdrawal by Subject|4|||
130945116|NCT04762680|471434193|FG016|Phase 3|Withdrawal by Subject|6|||
130945117|NCT04762680|471434194|FG017|Phase 3|Withdrawal by Subject|32|||
130945118|NCT04762680|471434195|FG018|Phase 3|Withdrawal by Subject|0|||
130945119|NCT04762680|471434196|FG019|Phase 3|Withdrawal by Subject|0|||
130945120|NCT04762680|471434197|FG020|Phase 3|Withdrawal by Subject|0|||
130945121|NCT04762680|471434198|FG021|Phase 3|Withdrawal by Subject|0|||
130945122|NCT04762680|471434177|FG000|Phase 3|Lost to Follow-up|0|||
130945123|NCT04762680|471434178|FG001|Phase 3|Lost to Follow-up|0|||
130945124|NCT04762680|471434179|FG002|Phase 3|Lost to Follow-up|0|||
130945125|NCT04762680|471434180|FG003|Phase 3|Lost to Follow-up|9|||
130945126|NCT04762680|471434181|FG004|Phase 3|Lost to Follow-up|22|||
130945127|NCT04762680|471434182|FG005|Phase 3|Lost to Follow-up|24|||
130945128|NCT04762680|471434183|FG006|Phase 3|Lost to Follow-up|2|||
130945129|NCT04762680|471434184|FG007|Phase 3|Lost to Follow-up|4|||
130945130|NCT04762680|471434185|FG008|Phase 3|Lost to Follow-up|6|||
130945131|NCT04762680|471434186|FG009|Phase 3|Lost to Follow-up|4|||
130710309|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
130945132|NCT04762680|471434187|FG010|Phase 3|Lost to Follow-up|3|||
130945133|NCT04762680|471434188|FG011|Phase 3|Lost to Follow-up|0|||
130945134|NCT04762680|471434189|FG012|Phase 3|Lost to Follow-up|5|||
130945135|NCT04762680|471434190|FG013|Phase 3|Lost to Follow-up|4|||
130945136|NCT04762680|471434191|FG014|Phase 3|Lost to Follow-up|6|||
131124350|NCT00111800|472084422|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130720899|NCT01341782|470601558|FG001|Overall Study|Withdrawal by Subject|5|||
130945137|NCT04762680|471434192|FG015|Phase 3|Lost to Follow-up|1|||
130945138|NCT04762680|471434193|FG016|Phase 3|Lost to Follow-up|1|||
130945139|NCT04762680|471434194|FG017|Phase 3|Lost to Follow-up|66|||
130945140|NCT04762680|471434195|FG018|Phase 3|Lost to Follow-up|0|||
130945141|NCT04762680|471434196|FG019|Phase 3|Lost to Follow-up|0|||
130945142|NCT04762680|471434197|FG020|Phase 3|Lost to Follow-up|0|||
130945143|NCT04762680|471434198|FG021|Phase 3|Lost to Follow-up|0|||
130945144|NCT04762680|471434177|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945145|NCT04762680|471434178|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945146|NCT04762680|471434179|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945147|NCT04762680|471434180|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945148|NCT04762680|471434181|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945149|NCT04762680|471434182|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
131124351|NCT00111800|472084417|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
131124352|NCT00111800|472084418|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
131124353|NCT00111800|472084419|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
131124354|NCT00111800|472084420|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
131124355|NCT00111800|472084421|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
131124356|NCT00111800|472084422|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130945150|NCT04762680|471434183|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945151|NCT04762680|471434184|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945152|NCT04762680|471434185|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945153|NCT04762680|471434186|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945154|NCT04762680|471434187|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945155|NCT04762680|471434188|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945156|NCT04762680|471434189|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945157|NCT04762680|471434190|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945158|NCT04762680|471434191|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945159|NCT04762680|471434192|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945160|NCT04762680|471434193|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945161|NCT04762680|471434194|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945162|NCT04762680|471434195|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945163|NCT04762680|471434196|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945164|NCT04762680|471434197|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
130945165|NCT04762680|471434198|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
130945166|NCT04762680|471434177|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945167|NCT04762680|471434178|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945168|NCT04762680|471434179|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945169|NCT04762680|471434180|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945170|NCT04762680|471434181|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945171|NCT04762680|471434182|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945172|NCT04762680|471434183|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945173|NCT04762680|471434184|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945174|NCT04762680|471434185|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945175|NCT04762680|471434186|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945176|NCT04762680|471434187|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945177|NCT04762680|471434188|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945178|NCT04762680|471434189|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945179|NCT04762680|471434190|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945180|NCT04762680|471434191|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945181|NCT04762680|471434192|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945182|NCT04762680|471434193|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945183|NCT04762680|471434194|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945184|NCT04762680|471434195|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945185|NCT04762680|471434196|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
130945186|NCT04762680|471434197|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945187|NCT04762680|471434198|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
130945188|NCT02082210|471434199|FG000|Overall Study|Death|0|||
130945189|NCT02082210|471434200|FG001|Overall Study|Death|0|||
130945190|NCT02082210|471434201|FG002|Overall Study|Death|1|||
130945191|NCT02082210|471434202|FG003|Overall Study|Death|1|||
130945192|NCT02082210|471434203|FG004|Overall Study|Death|1|||
130945193|NCT02082210|471434204|FG005|Overall Study|Death|0|||
130945194|NCT02082210|471434199|FG000|Overall Study|Withdrawal by Subject|0|||
130945195|NCT02082210|471434200|FG001|Overall Study|Withdrawal by Subject|0|||
130945196|NCT02082210|471434201|FG002|Overall Study|Withdrawal by Subject|0|||
130945197|NCT02082210|471434202|FG003|Overall Study|Withdrawal by Subject|1|||
130945198|NCT02082210|471434203|FG004|Overall Study|Withdrawal by Subject|2|||
130945199|NCT02082210|471434204|FG005|Overall Study|Withdrawal by Subject|2|||
130945200|NCT02082210|471434199|FG000|Overall Study|Clinical Progression|0|||
130945201|NCT02082210|471434200|FG001|Overall Study|Clinical Progression|0|||
130945202|NCT02082210|471434201|FG002|Overall Study|Clinical Progression|0|||
130945203|NCT02082210|471434202|FG003|Overall Study|Clinical Progression|1|||
130945204|NCT02082210|471434203|FG004|Overall Study|Clinical Progression|0|||
130945205|NCT02082210|471434204|FG005|Overall Study|Clinical Progression|0|||
130945206|NCT02082210|471434199|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
130945207|NCT02082210|471434200|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
130945208|NCT02082210|471434201|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
130945209|NCT02082210|471434202|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
130945210|NCT02082210|471434203|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
130945211|NCT02082210|471434204|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
131124357|NCT00111800|472084417|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130945212|NCT02082210|471434199|FG000|Overall Study|Physician Decision|0|||
130945213|NCT02082210|471434200|FG001|Overall Study|Physician Decision|0|||
130945214|NCT02082210|471434201|FG002|Overall Study|Physician Decision|1|||
130945215|NCT02082210|471434202|FG003|Overall Study|Physician Decision|1|||
130945216|NCT02082210|471434203|FG004|Overall Study|Physician Decision|0|||
130945217|NCT02082210|471434204|FG005|Overall Study|Physician Decision|0|||
130945218|NCT02520011|471434209|FG000|Overall Study|Adverse Event|0|||
130945219|NCT02520011|471434210|FG001|Overall Study|Adverse Event|1|||
130945220|NCT02520011|471434211|FG002|Overall Study|Adverse Event|2|||
130945221|NCT02520011|471434209|FG000|Overall Study|Death|0|||
130945222|NCT02520011|471434210|FG001|Overall Study|Death|8|||
130945223|NCT02520011|471434211|FG002|Overall Study|Death|1|||
130945224|NCT02520011|471434209|FG000|Overall Study|Lack of Efficacy|4|||
130945225|NCT02520011|471434210|FG001|Overall Study|Lack of Efficacy|26|||
130945226|NCT02520011|471434211|FG002|Overall Study|Lack of Efficacy|4|||
130945227|NCT02520011|471434209|FG000|Overall Study|Physician Decision|0|||
130945228|NCT02520011|471434210|FG001|Overall Study|Physician Decision|2|||
130945229|NCT02520011|471434211|FG002|Overall Study|Physician Decision|0|||
130945230|NCT02520011|471434209|FG000|Overall Study|Withdrawal by Subject|1|||
130945231|NCT02520011|471434210|FG001|Overall Study|Withdrawal by Subject|3|||
130945232|NCT02520011|471434211|FG002|Overall Study|Withdrawal by Subject|0|||
130945233|NCT02520011|471434209|FG000|Overall Study|Protocol Deviation|0|||
130945234|NCT02520011|471434210|FG001|Overall Study|Protocol Deviation|1|||
130945235|NCT02520011|471434211|FG002|Overall Study|Protocol Deviation|0|||
130945236|NCT02520011|471434209|FG000|Overall Study|Patient went to hospice|0|||
130945237|NCT02520011|471434210|FG001|Overall Study|Patient went to hospice|1|||
130945238|NCT02520011|471434211|FG002|Overall Study|Patient went to hospice|0|||
130945239|NCT02520011|471434209|FG000|Overall Study|Progressive disease following response|0|||
130945240|NCT02520011|471434210|FG001|Overall Study|Progressive disease following response|4|||
130945241|NCT02520011|471434211|FG002|Overall Study|Progressive disease following response|2|||
130945242|NCT01063764|471434212|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
130945243|NCT01063764|471434212|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
130945244|NCT01063764|471434212|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
130945245|NCT01063764|471434212|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
130945246|NCT01063764|471434212|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
130945247|NCT01063764|471434212|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
130945248|NCT01063764|471434212|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
130945249|NCT00697515|471434213|FG000|Dose Optimization Period|Adverse Event|4|||
130945250|NCT00697515|471434214|FG001|Dose Optimization Period|Adverse Event|0|||
130945251|NCT00697515|471434213|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
130945252|NCT00697515|471434214|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
130945253|NCT00697515|471434213|FG000|Dose Optimization Period|Lost to Follow-up|2|||
130945254|NCT00697515|471434214|FG001|Dose Optimization Period|Lost to Follow-up|0|||
130945255|NCT00697515|471434213|FG000|Dose Optimization Period|sponsor request|2|||
130945256|NCT00697515|471434214|FG001|Dose Optimization Period|sponsor request|0|||
130945257|NCT00697515|471434213|FG000|Dose Optimization Period|called to active duty|1|||
130945258|NCT00697515|471434214|FG001|Dose Optimization Period|called to active duty|0|||
130945259|NCT00697515|471434213|FG000|Dose Optimization Period|elevated QTc|1|||
130945260|NCT00697515|471434214|FG001|Dose Optimization Period|elevated QTc|0|||
130945261|NCT00697515|471434213|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
130945262|NCT00697515|471434214|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
130945263|NCT00697515|471434213|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
130945264|NCT00697515|471434214|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
130945265|NCT00697515|471434213|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
130945266|NCT00697515|471434214|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
130945267|NCT00697515|471434213|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
130945268|NCT00697515|471434214|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
131124358|NCT00111800|472084418|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
131124359|NCT00111800|472084419|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
131124360|NCT00111800|472084420|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
131124361|NCT00111800|472084421|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
131124362|NCT00111800|472084422|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130710310|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710311|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130945269|NCT01727141|471434216|FG000|Overall Study|Physician Decision|0|||
131124363|NCT00253643|472084424|FG000|Overall Study|Withdrawal by Subject|0|||
130945270|NCT01727141|471434217|FG001|Overall Study|Physician Decision|1|||
130945271|NCT01727141|471434218|FG002|Overall Study|Physician Decision|0|||
130945272|NCT01727141|471434219|FG003|Overall Study|Physician Decision|2|||
130945273|NCT01727141|471434216|FG000|Overall Study|Lost to Follow-up|0|||
130945274|NCT01727141|471434217|FG001|Overall Study|Lost to Follow-up|2|||
130945275|NCT01727141|471434218|FG002|Overall Study|Lost to Follow-up|0|||
130945276|NCT01727141|471434219|FG003|Overall Study|Lost to Follow-up|0|||
130945277|NCT01727141|471434216|FG000|Overall Study|Death|0|||
130945278|NCT01727141|471434217|FG001|Overall Study|Death|1|||
130945279|NCT01727141|471434218|FG002|Overall Study|Death|1|||
130945280|NCT01727141|471434219|FG003|Overall Study|Death|1|||
130945281|NCT01727141|471434216|FG000|Overall Study|Protocol deviation|1|||
130945282|NCT01727141|471434217|FG001|Overall Study|Protocol deviation|1|||
130945283|NCT01727141|471434218|FG002|Overall Study|Protocol deviation|0|||
130945284|NCT01727141|471434219|FG003|Overall Study|Protocol deviation|1|||
130945285|NCT01727141|471434216|FG000|Overall Study|Withdrawal by Subject|4|||
130945286|NCT01727141|471434217|FG001|Overall Study|Withdrawal by Subject|4|||
130945287|NCT01727141|471434218|FG002|Overall Study|Withdrawal by Subject|2|||
130945288|NCT01727141|471434219|FG003|Overall Study|Withdrawal by Subject|11|||
130945289|NCT02603432|471434222|FG000|Overall Study|Adverse Event|1|||
130945290|NCT02603432|471434223|FG001|Overall Study|Adverse Event|0|||
130945291|NCT02603432|471434222|FG000|Overall Study|Death|221|||
130945292|NCT02603432|471434223|FG001|Overall Study|Death|242|||
130945293|NCT02603432|471434222|FG000|Overall Study|Lost to Follow-up|3|||
130945294|NCT02603432|471434223|FG001|Overall Study|Lost to Follow-up|9|||
130945295|NCT02603432|471434222|FG000|Overall Study|Progressive Disease|7|||
130945296|NCT02603432|471434223|FG001|Overall Study|Progressive Disease|5|||
130945297|NCT02603432|471434222|FG000|Overall Study|Withdrawal by Subject|12|||
130945298|NCT02603432|471434223|FG001|Overall Study|Withdrawal by Subject|18|||
130945299|NCT02603432|471434222|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
130945300|NCT02603432|471434223|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130945301|NCT02603432|471434222|FG000|Overall Study|Study terminated by sponsor|74|||
130945302|NCT02603432|471434223|FG001|Overall Study|Study terminated by sponsor|75|||
130945303|NCT02603432|471434222|FG000|Overall Study|Other|13|||
130945304|NCT02603432|471434223|FG001|Overall Study|Other|0|||
130945305|NCT04014075|471434224|FG000|Overall Study|Progressive Disease|53|||
130945306|NCT04014075|471434224|FG000|Overall Study|Adverse Event|15|||
130945307|NCT04014075|471434224|FG000|Overall Study|Clinical Progression|4|||
130945308|NCT04014075|471434224|FG000|Overall Study|Death|2|||
130945309|NCT04014075|471434224|FG000|Overall Study|Withdrawal by Subject|2|||
130945310|NCT04014075|471434224|FG000|Overall Study|Miscellaneous|2|||
130945311|NCT04014075|471434224|FG000|Overall Study|Physician Decision|1|||
130945312|NCT05954052|471434228|FG000|Overall Study|Adverse Event|1|||
130945313|NCT01957462|471434229|FG000|Test Period 1|Withdrawal by Subject|1|||
130945314|NCT01957462|471434230|FG001|Test Period 1|Withdrawal by Subject|0|||
130945315|NCT01957462|471434229|FG000|Test Period 1|Adverse Event|1|||
130945316|NCT01957462|471434230|FG001|Test Period 1|Adverse Event|0|||
130945317|NCT02584504|471434231|FG000|Double-blind Treatment|Participant withdrew consent|0|||
130945318|NCT02584504|471434232|FG001|Double-blind Treatment|Participant withdrew consent|0|||
130945319|NCT02584504|471434233|FG002|Double-blind Treatment|Participant withdrew consent|1|||
130945320|NCT02584504|471434231|FG000|Double-blind Treatment|Adverse Event|0|||
130945321|NCT02584504|471434232|FG001|Double-blind Treatment|Adverse Event|1|||
130945322|NCT02584504|471434233|FG002|Double-blind Treatment|Adverse Event|0|||
130945323|NCT02584504|471434231|FG000|Double-blind Treatment|Family Matter|0|||
130945324|NCT02584504|471434232|FG001|Double-blind Treatment|Family Matter|1|||
130945325|NCT02584504|471434233|FG002|Double-blind Treatment|Family Matter|0|||
130945326|NCT02584504|471434231|FG000|Open-label Treatment|Participant withdrew consent|0|||
130945327|NCT02584504|471434232|FG001|Open-label Treatment|Participant withdrew consent|0|||
130945328|NCT02584504|471434233|FG002|Open-label Treatment|Participant withdrew consent|4|||
130945329|NCT02584504|471434231|FG000|Open-label Treatment|Adverse Event|2|||
130945330|NCT02584504|471434232|FG001|Open-label Treatment|Adverse Event|2|||
130945331|NCT02584504|471434233|FG002|Open-label Treatment|Adverse Event|3|||
130945332|NCT02584504|471434231|FG000|Open-label Treatment|Physician Decision|0|||
130945333|NCT02584504|471434232|FG001|Open-label Treatment|Physician Decision|1|||
131037135|NCT02598388|471770502|FG005|Overall Study|Withdrawal by Subject|0|||
131037136|NCT02598388|471770503|FG006|Overall Study|Withdrawal by Subject|2|||
131037137|NCT02598388|471770504|FG007|Overall Study|Withdrawal by Subject|0|||
131037138|NCT02598388|471770505|FG008|Overall Study|Withdrawal by Subject|0|||
131037139|NCT02598388|471770506|FG009|Overall Study|Withdrawal by Subject|1|||
131037140|NCT02598388|471770507|FG010|Overall Study|Withdrawal by Subject|0|||
131037141|NCT02598388|471770508|FG011|Overall Study|Withdrawal by Subject|0|||
131037142|NCT02598388|471770497|FG000|Overall Study|Other|0|||
131037143|NCT02598388|471770498|FG001|Overall Study|Other|0|||
131037144|NCT02598388|471770499|FG002|Overall Study|Other|1|||
131037145|NCT02598388|471770500|FG003|Overall Study|Other|0|||
131037146|NCT02598388|471770501|FG004|Overall Study|Other|3|||
130945334|NCT02584504|471434233|FG002|Open-label Treatment|Physician Decision|0|||
130945335|NCT02584504|471434231|FG000|Open-label Treatment|Entered but not treated|0|||
130945336|NCT02584504|471434232|FG001|Open-label Treatment|Entered but not treated|1|||
130945337|NCT02584504|471434233|FG002|Open-label Treatment|Entered but not treated|1|||
130945338|NCT00076011|471434234|FG000|Overall Study|Death|1|||
130945339|NCT00076011|471434234|FG000|Overall Study|Adverse Event|10|||
130945340|NCT00076011|471434234|FG000|Overall Study|Lack of Efficacy|25|||
130945341|NCT00076011|471434234|FG000|Overall Study|Withdrawal by Subject|1|||
130945342|NCT00076011|471434234|FG000|Overall Study|Study terminated by sponsor|3|||
130945343|NCT00076011|471434234|FG000|Overall Study|Other|11|||
130945344|NCT00076011|471434234|FG000|Overall Study|Ongoing|1|||
131037147|NCT02598388|471770502|FG005|Overall Study|Other|0|||
131124364|NCT00253643|472084425|FG001|Overall Study|Withdrawal by Subject|0|||
131124365|NCT00253643|472084426|FG002|Overall Study|Withdrawal by Subject|1|||
131124366|NCT00253643|472084427|FG003|Overall Study|Withdrawal by Subject|1|||
131124367|NCT00253643|472084424|FG000|Overall Study|Non-Compliance|0|||
131124368|NCT00253643|472084425|FG001|Overall Study|Non-Compliance|0|||
130945345|NCT04461015|471434245|FG000|Overall Study|IV access lost during the study|0|||
130945346|NCT04461015|471434246|FG001|Overall Study|IV access lost during the study|1|||
130945347|NCT04461015|471434245|FG000|Overall Study|Withdrawal by Subject|0|||
131124369|NCT00253643|472084426|FG002|Overall Study|Non-Compliance|0|||
131124370|NCT00253643|472084427|FG003|Overall Study|Non-Compliance|2|||
131124371|NCT01549275|472084428|FG000|Overall Study|Lost to Follow-up|1|||
131124372|NCT01549275|472084429|FG001|Overall Study|Lost to Follow-up|0|||
131124373|NCT00365456|472084432|FG000|Trial Period I (12 Months)|Adverse Event|84|||
131124374|NCT00365456|472084433|FG001|Trial Period I (12 Months)|Adverse Event|0|||
131124375|NCT00365456|472084432|FG000|Trial Period I (12 Months)|Non-compliance|3|||
131124376|NCT00365456|472084433|FG001|Trial Period I (12 Months)|Non-compliance|0|||
131124377|NCT00365456|472084432|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
131124378|NCT00365456|472084433|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
130945348|NCT04461015|471434246|FG001|Overall Study|Withdrawal by Subject|1|||
130945349|NCT01817725|471434252|FG000|Overall Study|Withdrawal by Subject|1|||
130945350|NCT01852812|471434253|FG000|Overall Study|Adverse Event|0|||
130945351|NCT01852812|471434254|FG001|Overall Study|Adverse Event|0|||
130945352|NCT01852812|471434255|FG002|Overall Study|Adverse Event|1|||
130945353|NCT01852812|471434253|FG000|Overall Study|Non-compliance With Study Drug|0|||
130945354|NCT01852812|471434254|FG001|Overall Study|Non-compliance With Study Drug|1|||
130945355|NCT01852812|471434255|FG002|Overall Study|Non-compliance With Study Drug|0|||
130945356|NCT02250443|471434256|FG000|Overall Study|Administrative problems|7|||
130945357|NCT02250443|471434256|FG000|Overall Study|Adverse Event|3|||
130945358|NCT01549964|471434257|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
130945359|NCT01549964|471434258|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
130945360|NCT01549964|471434259|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
130945361|NCT01549964|471434260|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
130945362|NCT01549964|471434257|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
130945363|NCT01549964|471434258|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
130945364|NCT01549964|471434259|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
130945365|NCT01549964|471434260|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
130945366|NCT01549964|471434257|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
130945367|NCT01549964|471434258|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
130945368|NCT01549964|471434259|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
130945369|NCT01549964|471434260|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
130945370|NCT01549964|471434257|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
130945371|NCT01549964|471434258|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
130945372|NCT01549964|471434259|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
130945373|NCT01549964|471434260|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
130945374|NCT01549964|471434257|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
130945375|NCT01549964|471434258|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
130945376|NCT01549964|471434259|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
130945377|NCT01549964|471434260|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
130945378|NCT01549964|471434257|FG000|24-Week Treatment Period|Other|1|||
130945379|NCT01549964|471434258|FG001|24-Week Treatment Period|Other|0|||
130945380|NCT01549964|471434259|FG002|24-Week Treatment Period|Other|1|||
130945381|NCT01549964|471434260|FG003|24-Week Treatment Period|Other|0|||
130945382|NCT01549964|471434257|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
130945383|NCT01549964|471434258|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
130945384|NCT01549964|471434259|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
130945385|NCT01549964|471434260|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
130945386|NCT01549964|471434257|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
130945387|NCT01549964|471434258|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
130945388|NCT01549964|471434259|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
130945389|NCT01549964|471434260|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
131124379|NCT00365456|472084432|FG000|Trial Period I (12 Months)|Other|11|||
131124380|NCT00365456|472084433|FG001|Trial Period I (12 Months)|Other|0|||
131124381|NCT00365456|472084432|FG000|Trial Period II (12 Months)|Adverse Event|0|||
131124382|NCT00365456|472084433|FG001|Trial Period II (12 Months)|Adverse Event|6|||
131124383|NCT00365456|472084432|FG000|Trial Period II (12 Months)|Non-compliance|0|||
131124384|NCT00365456|472084433|FG001|Trial Period II (12 Months)|Non-compliance|2|||
131124385|NCT00365456|472084432|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
130945390|NCT01549964|471434257|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
130945391|NCT01549964|471434258|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
130945392|NCT01549964|471434259|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
131124386|NCT00365456|472084433|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
131124387|NCT00365456|472084432|FG000|Trial Period II (12 Months)|Other|0|||
130945393|NCT01549964|471434260|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
130945394|NCT01549964|471434257|FG000|80-Week Extension Period|Pregnancy|0|||
130945395|NCT01549964|471434258|FG001|80-Week Extension Period|Pregnancy|0|||
130945396|NCT01549964|471434259|FG002|80-Week Extension Period|Pregnancy|1|||
130945397|NCT01549964|471434260|FG003|80-Week Extension Period|Pregnancy|0|||
130945398|NCT01549964|471434257|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
130945399|NCT01549964|471434258|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
130945400|NCT01549964|471434259|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
130945401|NCT01549964|471434260|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
130945402|NCT01549964|471434257|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
130945403|NCT01549964|471434258|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
130945404|NCT01549964|471434259|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
130945405|NCT01549964|471434260|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
130945406|NCT01549964|471434257|FG000|80-Week Extension Period|Lost to Follow-up|1|||
130945407|NCT01549964|471434258|FG001|80-Week Extension Period|Lost to Follow-up|0|||
130945408|NCT01549964|471434259|FG002|80-Week Extension Period|Lost to Follow-up|2|||
130945409|NCT01549964|471434260|FG003|80-Week Extension Period|Lost to Follow-up|1|||
130945410|NCT01549964|471434257|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
130945411|NCT01549964|471434258|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
130945412|NCT01549964|471434259|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
130945413|NCT01549964|471434260|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
130945414|NCT02290821|471434261|FG000|Overall Study|Withdrawal by Subject|1|||
130945415|NCT02290821|471434262|FG001|Overall Study|Withdrawal by Subject|1|||
130945416|NCT02290821|471434261|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
130945417|NCT02290821|471434262|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
130945418|NCT02290821|471434261|FG000|Overall Study|Lost to Follow-up|3|||
130945419|NCT02290821|471434262|FG001|Overall Study|Lost to Follow-up|2|||
130945420|NCT00751348|471434267|FG000|Overall Study|Withdrawal by Subject|5|||
130945421|NCT00751348|471434268|FG001|Overall Study|Withdrawal by Subject|2|||
130945422|NCT00751348|471434267|FG000|Overall Study|Migration from study area|1|||
130945423|NCT00751348|471434268|FG001|Overall Study|Migration from study area|0|||
130945424|NCT00973479|471434275|FG000|Overall Study|Lost to Follow-up|0|||
130945425|NCT00973479|471434276|FG001|Overall Study|Lost to Follow-up|3|||
130945426|NCT00973479|471434275|FG000|Overall Study|Death|2|||
130945427|NCT00973479|471434276|FG001|Overall Study|Death|2|||
130945428|NCT00973479|471434275|FG000|Overall Study|Withdrawal by Subject|15|||
130945429|NCT00973479|471434276|FG001|Overall Study|Withdrawal by Subject|16|||
130945430|NCT00973479|471434275|FG000|Overall Study|Lack of Efficacy|5|||
130945431|NCT00973479|471434276|FG001|Overall Study|Lack of Efficacy|7|||
130945432|NCT00973479|471434275|FG000|Overall Study|Adverse Event|12|||
130945433|NCT00973479|471434276|FG001|Overall Study|Adverse Event|32|||
130945434|NCT00973479|471434275|FG000|Overall Study|Protocol Violation|2|||
130945435|NCT00973479|471434276|FG001|Overall Study|Protocol Violation|2|||
130945436|NCT00973479|471434275|FG000|Overall Study|Other|1|||
130945437|NCT00973479|471434276|FG001|Overall Study|Other|7|||
130945438|NCT00362115|471434277|FG000|Overall Study|Adverse Event|0|||
130945439|NCT00362115|471434278|FG001|Overall Study|Adverse Event|1|||
130945440|NCT00362115|471434279|FG002|Overall Study|Adverse Event|1|||
130945441|NCT00362115|471434280|FG003|Overall Study|Adverse Event|1|||
130945442|NCT00362115|471434281|FG004|Overall Study|Adverse Event|2|||
130945443|NCT00362115|471434282|FG005|Overall Study|Adverse Event|2|||
130945444|NCT00362115|471434283|FG006|Overall Study|Adverse Event|1|||
130945445|NCT00362115|471434277|FG000|Overall Study|Protocol Violation|0|||
130945446|NCT00362115|471434278|FG001|Overall Study|Protocol Violation|0|||
130945447|NCT00362115|471434279|FG002|Overall Study|Protocol Violation|0|||
130945448|NCT00362115|471434280|FG003|Overall Study|Protocol Violation|0|||
130945449|NCT00362115|471434281|FG004|Overall Study|Protocol Violation|0|||
130945450|NCT00362115|471434282|FG005|Overall Study|Protocol Violation|1|||
130945451|NCT00362115|471434283|FG006|Overall Study|Protocol Violation|0|||
130945452|NCT00362115|471434277|FG000|Overall Study|Lost to Follow-up|0|||
130945453|NCT00362115|471434278|FG001|Overall Study|Lost to Follow-up|1|||
130945454|NCT00362115|471434279|FG002|Overall Study|Lost to Follow-up|0|||
130945455|NCT00362115|471434280|FG003|Overall Study|Lost to Follow-up|0|||
130945456|NCT00362115|471434281|FG004|Overall Study|Lost to Follow-up|2|||
130945457|NCT00362115|471434282|FG005|Overall Study|Lost to Follow-up|0|||
130945458|NCT00362115|471434283|FG006|Overall Study|Lost to Follow-up|1|||
130945459|NCT00362115|471434277|FG000|Overall Study|Withdrawal by Subject|1|||
130945460|NCT00362115|471434278|FG001|Overall Study|Withdrawal by Subject|3|||
130945461|NCT00362115|471434279|FG002|Overall Study|Withdrawal by Subject|1|||
130945462|NCT00362115|471434280|FG003|Overall Study|Withdrawal by Subject|0|||
130945463|NCT00362115|471434281|FG004|Overall Study|Withdrawal by Subject|1|||
130945464|NCT00362115|471434282|FG005|Overall Study|Withdrawal by Subject|3|||
130945465|NCT00362115|471434283|FG006|Overall Study|Withdrawal by Subject|4|||
130945466|NCT00362115|471434277|FG000|Overall Study|Lack of Efficacy|1|||
130945467|NCT00362115|471434278|FG001|Overall Study|Lack of Efficacy|0|||
130945468|NCT00362115|471434279|FG002|Overall Study|Lack of Efficacy|5|||
130945469|NCT00362115|471434280|FG003|Overall Study|Lack of Efficacy|2|||
130945470|NCT00362115|471434281|FG004|Overall Study|Lack of Efficacy|2|||
130945471|NCT00362115|471434282|FG005|Overall Study|Lack of Efficacy|0|||
130945472|NCT00362115|471434283|FG006|Overall Study|Lack of Efficacy|3|||
130945473|NCT00362115|471434277|FG000|Overall Study|Physician Decision|0|||
130945474|NCT00362115|471434278|FG001|Overall Study|Physician Decision|0|||
130945475|NCT00362115|471434279|FG002|Overall Study|Physician Decision|0|||
130945476|NCT00362115|471434280|FG003|Overall Study|Physician Decision|0|||
130945477|NCT00362115|471434281|FG004|Overall Study|Physician Decision|0|||
130945478|NCT00362115|471434282|FG005|Overall Study|Physician Decision|0|||
130945479|NCT00362115|471434283|FG006|Overall Study|Physician Decision|3|||
130945480|NCT00362115|471434277|FG000|Overall Study|Other|0|||
130945481|NCT00362115|471434278|FG001|Overall Study|Other|1|||
130945482|NCT00362115|471434279|FG002|Overall Study|Other|0|||
131124388|NCT00365456|472084433|FG001|Trial Period II (12 Months)|Other|1|||
131124389|NCT00365456|472084432|FG000|Trial Period III (12 Months)|Adverse Event|13|||
131124390|NCT00365456|472084433|FG001|Trial Period III (12 Months)|Adverse Event|3|||
131124391|NCT00365456|472084432|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
131124392|NCT00365456|472084433|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
131124393|NCT00365456|472084432|FG000|Trial Period III (12 Months)|Other|1|||
131124394|NCT00365456|472084433|FG001|Trial Period III (12 Months)|Other|1|||
131124395|NCT03668600|472084434|FG000|Overall Study|Study Terminated by the Sponsor|157|||
131124396|NCT03668600|472084434|FG000|Overall Study|Protocol Violation|1|||
131124397|NCT03668600|472084434|FG000|Overall Study|Pregnancy|1|||
131124398|NCT03668600|472084434|FG000|Overall Study|Lost to Follow-up|7|||
131124399|NCT03668600|472084434|FG000|Overall Study|Withdrawal by Subject|56|||
131124400|NCT03668600|472084434|FG000|Overall Study|Lack of Efficacy|7|||
131124401|NCT03668600|472084434|FG000|Overall Study|Adverse Event|1|||
131124402|NCT01131676|472084435|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
131124403|NCT01131676|472084436|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
131124404|NCT01131676|472084437|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
131124405|NCT01131676|472084435|FG000|Discontinuation From Treatment|Not treated|4|||
131124406|NCT01131676|472084436|FG001|Discontinuation From Treatment|Not treated|2|||
131124407|NCT01131676|472084437|FG002|Discontinuation From Treatment|Not treated|2|||
131124408|NCT01131676|472084435|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
131124409|NCT01131676|472084436|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
131124410|NCT01131676|472084437|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
131124411|NCT01131676|472084435|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
131124412|NCT01131676|472084436|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
131124413|NCT01131676|472084437|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
131124414|NCT01131676|472084435|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
131124415|NCT01131676|472084436|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
131124416|NCT01131676|472084437|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
131124417|NCT01131676|472084435|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
131124418|NCT01131676|472084436|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
131124419|NCT01131676|472084437|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
131124420|NCT01131676|472084435|FG000|Discontinuation From Treatment|Other than those specified|162|||
131124421|NCT01131676|472084436|FG001|Discontinuation From Treatment|Other than those specified|142|||
131124422|NCT01131676|472084437|FG002|Discontinuation From Treatment|Other than those specified|125|||
131124423|NCT01131676|472084435|FG000|Discontinuation From Treatment|Adverse Event|303|||
131124424|NCT01131676|472084436|FG001|Discontinuation From Treatment|Adverse Event|267|||
131124425|NCT01131676|472084437|FG002|Discontinuation From Treatment|Adverse Event|273|||
131124426|NCT01131676|472084435|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
131124427|NCT01131676|472084436|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
131124428|NCT01131676|472084437|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
131124429|NCT01131676|472084435|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
131124430|NCT01131676|472084436|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
131124431|NCT01131676|472084437|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
131124432|NCT01131676|472084435|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
131124433|NCT01131676|472084436|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
131124434|NCT01131676|472084437|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
131124435|NCT01131676|472084435|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
131124436|NCT01131676|472084436|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
131124437|NCT01131676|472084437|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
131124438|NCT01131676|472084435|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
130945483|NCT00362115|471434280|FG003|Overall Study|Other|1|||
130945484|NCT00362115|471434281|FG004|Overall Study|Other|0|||
130945485|NCT00362115|471434282|FG005|Overall Study|Other|1|||
130945486|NCT00362115|471434283|FG006|Overall Study|Other|0|||
130773998|NCT02137226|470798658|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
130773999|NCT02137226|470798659|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
130774000|NCT02137226|470798660|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
130774001|NCT02137226|470798661|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
130774002|NCT02137226|470798657|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
130774003|NCT02137226|470798658|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
130774004|NCT02137226|470798659|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
130774005|NCT02137226|470798660|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
130774006|NCT02137226|470798661|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
130774007|NCT02137226|470798657|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
130774008|NCT02137226|470798658|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130774009|NCT02137226|470798659|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130774010|NCT02137226|470798660|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130774011|NCT02137226|470798661|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130774012|NCT02137226|470798657|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
130774013|NCT02137226|470798658|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
130774014|NCT02137226|470798659|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
131124439|NCT01131676|472084436|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
131124440|NCT01131676|472084437|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
131124441|NCT01131676|472084435|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
131124442|NCT01131676|472084436|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
131124443|NCT01131676|472084437|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
131124444|NCT01111851|472084440|FG000|Overall Study|All planned PET scans were not obtained.|2|||
131124445|NCT01111851|472084441|FG001|Overall Study|All planned PET scans were not obtained.|0|||
131124446|NCT01816061|472084442|FG000|Overall Study|Lost to Follow-up|13|||
131124447|NCT01816061|472084443|FG001|Overall Study|Lost to Follow-up|24|||
131124448|NCT01471015|472084445|FG000|Overall Study|Death|0|||
131124449|NCT01471015|472084446|FG001|Overall Study|Death|1|||
131124450|NCT01471015|472084447|FG002|Overall Study|Death|1|||
131124451|NCT02953340|472084448|FG000|Overall Study|Death|0|||
131124452|NCT02953340|472084449|FG001|Overall Study|Death|1|||
131124453|NCT02953340|472084448|FG000|Overall Study|Investigator Decision|3|||
131124454|NCT02953340|472084449|FG001|Overall Study|Investigator Decision|3|||
131124455|NCT02953340|472084448|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
131124456|NCT02953340|472084449|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
131124457|NCT02953340|472084448|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
131124458|NCT02953340|472084449|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
131124459|NCT02953340|472084448|FG000|Overall Study|Withdrawal by Subject|9|||
131124460|NCT02953340|472084449|FG001|Overall Study|Withdrawal by Subject|9|||
130945487|NCT03965962|471434284|FG000|Overall Study|Adverse Event|1|||
130945488|NCT03965962|471434285|FG001|Overall Study|Adverse Event|0|||
130945489|NCT03965962|471434286|FG002|Overall Study|Adverse Event|0|||
130945490|NCT03965962|471434287|FG003|Overall Study|Adverse Event|0|||
130945491|NCT03965962|471434284|FG000|Overall Study|Protocol Violation|21|||
130945492|NCT03965962|471434285|FG001|Overall Study|Protocol Violation|4|||
130945493|NCT03965962|471434286|FG002|Overall Study|Protocol Violation|10|||
130945494|NCT03965962|471434287|FG003|Overall Study|Protocol Violation|5|||
130945495|NCT03965962|471434284|FG000|Overall Study|Lost to Follow-up|0|||
130945496|NCT03965962|471434285|FG001|Overall Study|Lost to Follow-up|1|||
130945497|NCT03965962|471434286|FG002|Overall Study|Lost to Follow-up|0|||
130945498|NCT03965962|471434287|FG003|Overall Study|Lost to Follow-up|0|||
130945499|NCT03965962|471434284|FG000|Overall Study|Withdrawal by Subject|3|||
130945500|NCT03965962|471434285|FG001|Overall Study|Withdrawal by Subject|0|||
130945501|NCT03965962|471434286|FG002|Overall Study|Withdrawal by Subject|0|||
130945502|NCT03965962|471434287|FG003|Overall Study|Withdrawal by Subject|1|||
130945503|NCT02039674|471434292|FG000|Overall Study|Adverse Event|0|||
130945504|NCT02039674|471434293|FG001|Overall Study|Adverse Event|0|||
130945505|NCT02039674|471434294|FG002|Overall Study|Adverse Event|0|||
131124461|NCT02953340|472084448|FG000|Overall Study|Sponsor decision|0|||
130945506|NCT02039674|471434295|FG003|Overall Study|Adverse Event|1|||
131124462|NCT02953340|472084449|FG001|Overall Study|Sponsor decision|2|||
131225091|NCT01120600|472451947|FG001|Overall Study|Withdrawal by Subject|11|||
131225092|NCT01375010|472451948|FG000|Overall Study|Lost to Follow-up|8|||
130945507|NCT02039674|471434296|FG004|Overall Study|Adverse Event|0|||
130945508|NCT02039674|471434297|FG005|Overall Study|Adverse Event|0|||
131124463|NCT02953340|472084448|FG000|Overall Study|Lost to Follow-up|3|||
131124464|NCT02953340|472084449|FG001|Overall Study|Lost to Follow-up|2|||
131124465|NCT02953340|472084448|FG000|Overall Study|Reason not specified|2|||
130945509|NCT02039674|471434298|FG006|Overall Study|Adverse Event|0|||
130945510|NCT02039674|471434299|FG007|Overall Study|Adverse Event|0|||
130945511|NCT02039674|471434300|FG008|Overall Study|Adverse Event|2|||
130945512|NCT02039674|471434301|FG009|Overall Study|Adverse Event|1|||
130945513|NCT02039674|471434302|FG010|Overall Study|Adverse Event|0|||
131124466|NCT02953340|472084449|FG001|Overall Study|Reason not specified|2|||
131037148|NCT02598388|471770503|FG006|Overall Study|Other|1|||
131037149|NCT02598388|471770504|FG007|Overall Study|Other|0|||
131037150|NCT02598388|471770505|FG008|Overall Study|Other|0|||
131037151|NCT02598388|471770506|FG009|Overall Study|Other|0|||
131037152|NCT02598388|471770507|FG010|Overall Study|Other|0|||
131037153|NCT02598388|471770508|FG011|Overall Study|Other|0|||
131037154|NCT02979327|471770509|FG000|First Intervention|Protocol Violation|1|||
131037155|NCT02979327|471770510|FG001|First Intervention|Protocol Violation|0|||
131037156|NCT03474679|471770519|FG000|Overall Study|Death|7|||
131037157|NCT03474679|471770519|FG000|Overall Study|Withdrawal by Subject|1|||
131037158|NCT01539083|471770522|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
131037159|NCT01539083|471770523|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
131124467|NCT01376778|472084450|FG000|Overall Study|Lost to Follow-up|3|||
131124468|NCT01376778|472084451|FG001|Overall Study|Lost to Follow-up|2|||
131124469|NCT00928889|472084452|FG000|Overall Study|Lost to Follow-up|3|||
131124470|NCT00928889|472084453|FG001|Overall Study|Lost to Follow-up|1|||
131124471|NCT00928889|472084452|FG000|Overall Study|Protocol Violation|0|||
131124472|NCT00928889|472084453|FG001|Overall Study|Protocol Violation|1|||
131124473|NCT00928889|472084452|FG000|Overall Study|Adverse Event|1|||
131124474|NCT00928889|472084453|FG001|Overall Study|Adverse Event|0|||
130710312|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710313|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130710314|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
130710315|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
130710316|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
130710317|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
130710318|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
130710319|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
130710320|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
130710321|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
130710322|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
130710323|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
130710324|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
130710325|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
130710326|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
130710327|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
130710328|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
130710329|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
130710330|NCT02990806|470564801|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
130710331|NCT02990806|470564802|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
130710332|NCT02990806|470564803|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
130710333|NCT02990806|470564804|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
130710334|NCT00977431|470564805|FG000|Overall Study|Other than listed|1|||
130710335|NCT00977431|470564806|FG001|Overall Study|Other than listed|0|||
130710336|NCT00977431|470564807|FG002|Overall Study|Other than listed|0|||
130710337|NCT00977431|470564808|FG003|Overall Study|Other than listed|0|||
130710338|NCT00977431|470564809|FG004|Overall Study|Other than listed|2|||
130710339|NCT00977431|470564805|FG000|Overall Study|Protocol Violation|0|||
130710340|NCT00977431|470564806|FG001|Overall Study|Protocol Violation|0|||
130710341|NCT00977431|470564807|FG002|Overall Study|Protocol Violation|1|||
130710342|NCT00977431|470564808|FG003|Overall Study|Protocol Violation|0|||
130710343|NCT00977431|470564809|FG004|Overall Study|Protocol Violation|0|||
130710344|NCT00977431|470564805|FG000|Overall Study|Adverse Event|3|||
130710345|NCT00977431|470564806|FG001|Overall Study|Adverse Event|0|||
130710346|NCT00977431|470564807|FG002|Overall Study|Adverse Event|4|||
130710347|NCT00977431|470564808|FG003|Overall Study|Adverse Event|0|||
130710348|NCT00977431|470564809|FG004|Overall Study|Adverse Event|6|||
130710349|NCT00977431|470564805|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
130710350|NCT00977431|470564806|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
130710351|NCT00977431|470564807|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
130710352|NCT00977431|470564808|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
130710353|NCT00977431|470564809|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
131037160|NCT01539083|471770524|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
130710354|NCT00977431|470564805|FG000|Overall Study|Progressive disease|2|||
130710355|NCT00977431|470564806|FG001|Overall Study|Progressive disease|6|||
131037161|NCT01539083|471770522|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
131037162|NCT01539083|471770523|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
131037163|NCT01539083|471770524|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
131037164|NCT01539083|471770522|FG000|Before Randomization (VCD Induction)|Death|6|||
131037165|NCT01539083|471770523|FG001|Before Randomization (VCD Induction)|Death|0|||
131124475|NCT00928889|472084452|FG000|Overall Study|Other|1|||
131124476|NCT00928889|472084453|FG001|Overall Study|Other|0|||
130945514|NCT02039674|471434303|FG011|Overall Study|Adverse Event|2|||
130945515|NCT02039674|471434304|FG012|Overall Study|Adverse Event|3|||
130945516|NCT02039674|471434305|FG013|Overall Study|Adverse Event|1|||
130945517|NCT02039674|471434292|FG000|Overall Study|Death|2|||
130945518|NCT02039674|471434293|FG001|Overall Study|Death|0|||
130945519|NCT02039674|471434294|FG002|Overall Study|Death|2|||
130945520|NCT02039674|471434295|FG003|Overall Study|Death|3|||
130945521|NCT02039674|471434296|FG004|Overall Study|Death|0|||
130945522|NCT02039674|471434297|FG005|Overall Study|Death|0|||
130945523|NCT02039674|471434298|FG006|Overall Study|Death|1|||
130945524|NCT02039674|471434299|FG007|Overall Study|Death|0|||
130945525|NCT02039674|471434300|FG008|Overall Study|Death|2|||
130945526|NCT02039674|471434301|FG009|Overall Study|Death|0|||
130945527|NCT02039674|471434302|FG010|Overall Study|Death|1|||
130945528|NCT02039674|471434303|FG011|Overall Study|Death|3|||
130945529|NCT02039674|471434304|FG012|Overall Study|Death|2|||
130945530|NCT02039674|471434305|FG013|Overall Study|Death|8|||
130945531|NCT02039674|471434292|FG000|Overall Study|Excluded Medication|1|||
130945532|NCT02039674|471434293|FG001|Overall Study|Excluded Medication|1|||
130945533|NCT02039674|471434294|FG002|Overall Study|Excluded Medication|0|||
130945534|NCT02039674|471434295|FG003|Overall Study|Excluded Medication|1|||
130945535|NCT02039674|471434296|FG004|Overall Study|Excluded Medication|0|||
130945536|NCT02039674|471434297|FG005|Overall Study|Excluded Medication|1|||
130945537|NCT02039674|471434298|FG006|Overall Study|Excluded Medication|0|||
130945538|NCT02039674|471434299|FG007|Overall Study|Excluded Medication|0|||
130945539|NCT02039674|471434300|FG008|Overall Study|Excluded Medication|2|||
130945540|NCT02039674|471434301|FG009|Overall Study|Excluded Medication|3|||
130945541|NCT02039674|471434302|FG010|Overall Study|Excluded Medication|5|||
130945542|NCT02039674|471434303|FG011|Overall Study|Excluded Medication|6|||
130945543|NCT02039674|471434304|FG012|Overall Study|Excluded Medication|8|||
130945544|NCT02039674|471434305|FG013|Overall Study|Excluded Medication|3|||
130945545|NCT02039674|471434292|FG000|Overall Study|Lost to Follow-up|0|||
130945546|NCT02039674|471434293|FG001|Overall Study|Lost to Follow-up|0|||
130945547|NCT02039674|471434294|FG002|Overall Study|Lost to Follow-up|0|||
130945548|NCT02039674|471434295|FG003|Overall Study|Lost to Follow-up|0|||
130945549|NCT02039674|471434296|FG004|Overall Study|Lost to Follow-up|1|||
130945550|NCT02039674|471434297|FG005|Overall Study|Lost to Follow-up|1|||
130945551|NCT02039674|471434298|FG006|Overall Study|Lost to Follow-up|0|||
130945552|NCT02039674|471434299|FG007|Overall Study|Lost to Follow-up|0|||
130945553|NCT02039674|471434300|FG008|Overall Study|Lost to Follow-up|0|||
130945554|NCT02039674|471434301|FG009|Overall Study|Lost to Follow-up|0|||
130945555|NCT02039674|471434302|FG010|Overall Study|Lost to Follow-up|0|||
130945556|NCT02039674|471434303|FG011|Overall Study|Lost to Follow-up|2|||
130945557|NCT02039674|471434304|FG012|Overall Study|Lost to Follow-up|2|||
130945558|NCT02039674|471434305|FG013|Overall Study|Lost to Follow-up|1|||
130945559|NCT02039674|471434292|FG000|Overall Study|Physician Decision|0|||
130945560|NCT02039674|471434293|FG001|Overall Study|Physician Decision|0|||
130945561|NCT02039674|471434294|FG002|Overall Study|Physician Decision|0|||
130945562|NCT02039674|471434295|FG003|Overall Study|Physician Decision|0|||
130945563|NCT02039674|471434296|FG004|Overall Study|Physician Decision|0|||
130945564|NCT02039674|471434297|FG005|Overall Study|Physician Decision|0|||
130945565|NCT02039674|471434298|FG006|Overall Study|Physician Decision|0|||
130945566|NCT02039674|471434299|FG007|Overall Study|Physician Decision|0|||
130945567|NCT02039674|471434300|FG008|Overall Study|Physician Decision|0|||
130945568|NCT02039674|471434301|FG009|Overall Study|Physician Decision|0|||
130945569|NCT02039674|471434302|FG010|Overall Study|Physician Decision|0|||
130945570|NCT02039674|471434303|FG011|Overall Study|Physician Decision|1|||
131124477|NCT02700412|472084454|FG000|Overall Study|Adverse Event|6|||
131124478|NCT02700412|472084454|FG000|Overall Study|Death|1|||
130710356|NCT00977431|470564807|FG002|Overall Study|Progressive disease|1|||
130945571|NCT02039674|471434304|FG012|Overall Study|Physician Decision|1|||
130945572|NCT02039674|471434305|FG013|Overall Study|Physician Decision|0|||
130945573|NCT02039674|471434292|FG000|Overall Study|Progressive Disease|8|||
130945574|NCT02039674|471434293|FG001|Overall Study|Progressive Disease|8|||
130945575|NCT02039674|471434294|FG002|Overall Study|Progressive Disease|6|||
130945576|NCT02039674|471434295|FG003|Overall Study|Progressive Disease|7|||
130945577|NCT02039674|471434296|FG004|Overall Study|Progressive Disease|9|||
130945578|NCT02039674|471434297|FG005|Overall Study|Progressive Disease|10|||
130710357|NCT00977431|470564808|FG003|Overall Study|Progressive disease|3|||
130945579|NCT02039674|471434298|FG006|Overall Study|Progressive Disease|1|||
130945580|NCT02039674|471434299|FG007|Overall Study|Progressive Disease|3|||
130945581|NCT02039674|471434300|FG008|Overall Study|Progressive Disease|6|||
130945582|NCT02039674|471434301|FG009|Overall Study|Progressive Disease|4|||
130945583|NCT02039674|471434302|FG010|Overall Study|Progressive Disease|0|||
130945584|NCT02039674|471434303|FG011|Overall Study|Progressive Disease|34|||
130945585|NCT02039674|471434304|FG012|Overall Study|Progressive Disease|34|||
130945586|NCT02039674|471434305|FG013|Overall Study|Progressive Disease|18|||
130945587|NCT02039674|471434292|FG000|Overall Study|Withdrawal by Subject|1|||
130945588|NCT02039674|471434293|FG001|Overall Study|Withdrawal by Subject|2|||
130945589|NCT02039674|471434294|FG002|Overall Study|Withdrawal by Subject|3|||
130945590|NCT02039674|471434295|FG003|Overall Study|Withdrawal by Subject|0|||
130945591|NCT02039674|471434296|FG004|Overall Study|Withdrawal by Subject|1|||
131124479|NCT02700412|472084454|FG000|Overall Study|Lack of Efficacy|19|||
130945592|NCT02039674|471434297|FG005|Overall Study|Withdrawal by Subject|0|||
130945593|NCT02039674|471434298|FG006|Overall Study|Withdrawal by Subject|0|||
130945594|NCT02039674|471434299|FG007|Overall Study|Withdrawal by Subject|0|||
130945595|NCT02039674|471434300|FG008|Overall Study|Withdrawal by Subject|0|||
130945596|NCT02039674|471434301|FG009|Overall Study|Withdrawal by Subject|1|||
130945597|NCT02039674|471434302|FG010|Overall Study|Withdrawal by Subject|1|||
130945598|NCT02039674|471434303|FG011|Overall Study|Withdrawal by Subject|4|||
130945599|NCT02039674|471434304|FG012|Overall Study|Withdrawal by Subject|6|||
130945600|NCT02039674|471434305|FG013|Overall Study|Withdrawal by Subject|2|||
130945601|NCT02039674|471434292|FG000|Overall Study|Clinical Progression|0|||
130945602|NCT02039674|471434293|FG001|Overall Study|Clinical Progression|0|||
130945603|NCT02039674|471434294|FG002|Overall Study|Clinical Progression|0|||
130945604|NCT02039674|471434295|FG003|Overall Study|Clinical Progression|0|||
130945605|NCT02039674|471434296|FG004|Overall Study|Clinical Progression|0|||
130945606|NCT02039674|471434297|FG005|Overall Study|Clinical Progression|0|||
130945607|NCT02039674|471434298|FG006|Overall Study|Clinical Progression|1|||
130945608|NCT02039674|471434299|FG007|Overall Study|Clinical Progression|0|||
130945609|NCT02039674|471434300|FG008|Overall Study|Clinical Progression|0|||
130945610|NCT02039674|471434301|FG009|Overall Study|Clinical Progression|0|||
130945611|NCT02039674|471434302|FG010|Overall Study|Clinical Progression|0|||
130945612|NCT02039674|471434303|FG011|Overall Study|Clinical Progression|0|||
130945613|NCT02039674|471434304|FG012|Overall Study|Clinical Progression|1|||
130945614|NCT02039674|471434305|FG013|Overall Study|Clinical Progression|0|||
130945615|NCT02039674|471434292|FG000|Overall Study|Sponsor Decision|1|||
130945616|NCT02039674|471434293|FG001|Overall Study|Sponsor Decision|1|||
130945617|NCT02039674|471434294|FG002|Overall Study|Sponsor Decision|1|||
130945618|NCT02039674|471434295|FG003|Overall Study|Sponsor Decision|1|||
130945619|NCT02039674|471434296|FG004|Overall Study|Sponsor Decision|1|||
130945620|NCT02039674|471434297|FG005|Overall Study|Sponsor Decision|0|||
130945621|NCT02039674|471434298|FG006|Overall Study|Sponsor Decision|0|||
130945622|NCT02039674|471434299|FG007|Overall Study|Sponsor Decision|0|||
130945623|NCT02039674|471434300|FG008|Overall Study|Sponsor Decision|0|||
130945624|NCT02039674|471434301|FG009|Overall Study|Sponsor Decision|3|||
130945625|NCT02039674|471434302|FG010|Overall Study|Sponsor Decision|0|||
130945626|NCT02039674|471434303|FG011|Overall Study|Sponsor Decision|8|||
130945627|NCT02039674|471434304|FG012|Overall Study|Sponsor Decision|5|||
130945628|NCT02039674|471434305|FG013|Overall Study|Sponsor Decision|0|||
130945629|NCT02039674|471434292|FG000|Overall Study|Other|0|||
130945630|NCT02039674|471434293|FG001|Overall Study|Other|0|||
130945631|NCT02039674|471434294|FG002|Overall Study|Other|0|||
130945632|NCT02039674|471434295|FG003|Overall Study|Other|0|||
130945633|NCT02039674|471434296|FG004|Overall Study|Other|0|||
130945634|NCT02039674|471434297|FG005|Overall Study|Other|0|||
130945635|NCT02039674|471434298|FG006|Overall Study|Other|0|||
130945636|NCT02039674|471434299|FG007|Overall Study|Other|0|||
130945637|NCT02039674|471434300|FG008|Overall Study|Other|0|||
130945638|NCT02039674|471434301|FG009|Overall Study|Other|0|||
130945639|NCT02039674|471434302|FG010|Overall Study|Other|0|||
130945640|NCT02039674|471434303|FG011|Overall Study|Other|0|||
130945641|NCT02039674|471434304|FG012|Overall Study|Other|1|||
130945642|NCT02039674|471434305|FG013|Overall Study|Other|0|||
130945643|NCT01826487|471434306|FG000|Overall Study|Adverse Event|1|||
130945644|NCT01826487|471434307|FG001|Overall Study|Adverse Event|1|||
130945645|NCT01826487|471434306|FG000|Overall Study|Lost to Follow-up|1|||
130945646|NCT01826487|471434307|FG001|Overall Study|Lost to Follow-up|0|||
130945647|NCT01826487|471434306|FG000|Overall Study|Withdrawal by Subject|1|||
130945648|NCT01826487|471434307|FG001|Overall Study|Withdrawal by Subject|3|||
130945649|NCT01826487|471434306|FG000|Overall Study|Protocol Violation|1|||
130945650|NCT01826487|471434307|FG001|Overall Study|Protocol Violation|1|||
130945651|NCT01358357|471434308|FG000|Open Label Phase|Adverse Event|0|||
130945652|NCT01358357|471434309|FG001|Open Label Phase|Adverse Event|0|||
131124480|NCT02700412|472084454|FG000|Overall Study|Protocol Violation|5|||
131124481|NCT02700412|472084454|FG000|Overall Study|Withdrawal by Subject|2|||
131124482|NCT04712110|472084455|FG000|Overall Study|Lost to Follow-up|0|||
130710358|NCT00977431|470564809|FG004|Overall Study|Progressive disease|5|||
130945653|NCT01358357|471434310|FG002|Open Label Phase|Adverse Event|59|||
130945654|NCT01358357|471434308|FG000|Open Label Phase|Lack of Efficacy|0|||
130945655|NCT01358357|471434309|FG001|Open Label Phase|Lack of Efficacy|0|||
130945656|NCT01358357|471434310|FG002|Open Label Phase|Lack of Efficacy|107|||
130945657|NCT01358357|471434308|FG000|Open Label Phase|Lost to Follow-up|0|||
130945658|NCT01358357|471434309|FG001|Open Label Phase|Lost to Follow-up|0|||
130945659|NCT01358357|471434310|FG002|Open Label Phase|Lost to Follow-up|76|||
130945660|NCT01358357|471434308|FG000|Open Label Phase|Protocol Violation|0|||
130945661|NCT01358357|471434309|FG001|Open Label Phase|Protocol Violation|0|||
130945662|NCT01358357|471434310|FG002|Open Label Phase|Protocol Violation|45|||
130945663|NCT01358357|471434308|FG000|Open Label Phase|Withdrawal by Subject|0|||
130945664|NCT01358357|471434309|FG001|Open Label Phase|Withdrawal by Subject|0|||
130945665|NCT01358357|471434310|FG002|Open Label Phase|Withdrawal by Subject|112|||
130945666|NCT01358357|471434308|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
130945667|NCT01358357|471434309|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
130945668|NCT01358357|471434310|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
130945669|NCT01358357|471434308|FG000|Open Label Phase|Terminated at study completion|0|||
130945670|NCT01358357|471434309|FG001|Open Label Phase|Terminated at study completion|0|||
130945671|NCT01358357|471434310|FG002|Open Label Phase|Terminated at study completion|5|||
130945672|NCT01358357|471434308|FG000|Open Label Phase|Mood episode|0|||
130945673|NCT01358357|471434309|FG001|Open Label Phase|Mood episode|0|||
130945674|NCT01358357|471434310|FG002|Open Label Phase|Mood episode|42|||
130945675|NCT01358357|471434308|FG000|Double-Blind Phase|Adverse Event|8|||
130945676|NCT01358357|471434309|FG001|Double-Blind Phase|Adverse Event|5|||
130945677|NCT01358357|471434310|FG002|Double-Blind Phase|Adverse Event|0|||
130945678|NCT01358357|471434308|FG000|Double-Blind Phase|Lost to Follow-up|5|||
130945679|NCT01358357|471434309|FG001|Double-Blind Phase|Lost to Follow-up|7|||
130945680|NCT01358357|471434310|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130945681|NCT01358357|471434308|FG000|Double-Blind Phase|Protocol Violation|1|||
130945682|NCT01358357|471434309|FG001|Double-Blind Phase|Protocol Violation|11|||
130945683|NCT01358357|471434310|FG002|Double-Blind Phase|Protocol Violation|0|||
130945684|NCT01358357|471434308|FG000|Double-Blind Phase|Protocol Violation|16|||
130945685|NCT01358357|471434309|FG001|Double-Blind Phase|Protocol Violation|12|||
130945686|NCT01358357|471434310|FG002|Double-Blind Phase|Protocol Violation|0|||
130945687|NCT01358357|471434308|FG000|Double-Blind Phase|Terminated at study completion|2|||
130945688|NCT01358357|471434309|FG001|Double-Blind Phase|Terminated at study completion|0|||
130945689|NCT01358357|471434310|FG002|Double-Blind Phase|Terminated at study completion|0|||
130945690|NCT01358357|471434308|FG000|Double-Blind Phase|Recurrence of mood event|48|||
130945691|NCT01358357|471434309|FG001|Double-Blind Phase|Recurrence of mood event|64|||
130945692|NCT01358357|471434310|FG002|Double-Blind Phase|Recurrence of mood event|0|||
130945693|NCT01358357|471434308|FG000|Double-Blind Phase|Administrative|0|||
130945694|NCT01358357|471434309|FG001|Double-Blind Phase|Administrative|1|||
130945695|NCT01358357|471434310|FG002|Double-Blind Phase|Administrative|0|||
130945696|NCT01408030|471434311|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
130945697|NCT01408030|471434312|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
130945698|NCT01408030|471434313|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
130945699|NCT01408030|471434314|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
130945700|NCT01408030|471434311|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
130945701|NCT01408030|471434312|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
130945702|NCT01408030|471434313|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
130945703|NCT01408030|471434314|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
130945704|NCT01408030|471434311|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
130945705|NCT01408030|471434312|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
130945706|NCT01408030|471434313|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
130945707|NCT01408030|471434314|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
130945708|NCT01408030|471434311|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
130945709|NCT01408030|471434312|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
130945710|NCT01408030|471434313|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
130945711|NCT01408030|471434314|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
130945712|NCT01408030|471434311|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
130945713|NCT01408030|471434312|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
130945714|NCT01408030|471434313|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
130945715|NCT01408030|471434314|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
130945716|NCT01408030|471434311|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
130945717|NCT01408030|471434312|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
130945718|NCT01408030|471434313|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
130945719|NCT01408030|471434314|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
130945720|NCT01408030|471434311|FG000|Observation Phase (Off Drug)|Other|1|||
130945721|NCT01408030|471434312|FG001|Observation Phase (Off Drug)|Other|1|||
131124483|NCT04712110|472084456|FG001|Overall Study|Lost to Follow-up|1|||
131124484|NCT04712110|472084455|FG000|Overall Study|Withdrawal by Subject|0|||
131124485|NCT04712110|472084456|FG001|Overall Study|Withdrawal by Subject|4|||
131124486|NCT04712110|472084455|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
131124487|NCT04712110|472084456|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
130945722|NCT01408030|471434313|FG002|Observation Phase (Off Drug)|Other|1|||
130945723|NCT01408030|471434314|FG003|Observation Phase (Off Drug)|Other|1|||
130945724|NCT02136576|471434315|FG000|Overall Study|Lost to Follow-up|2|||
130945725|NCT02136576|471434316|FG001|Overall Study|Lost to Follow-up|0|||
130945726|NCT02136576|471434317|FG002|Overall Study|Lost to Follow-up|0|||
130945727|NCT02590939|471434318|FG000|Overall Study|Withdrawal by Subject|3|||
130945728|NCT02590939|471434319|FG001|Overall Study|Withdrawal by Subject|1|||
130945729|NCT02590939|471434318|FG000|Overall Study|Failed the nociceptive test|2|||
130945730|NCT02590939|471434319|FG001|Overall Study|Failed the nociceptive test|1|||
130945731|NCT02225743|471434321|FG000|Overall Study|Withdrawal by Subject|18|||
130945732|NCT00729183|471434322|FG000|Overall Study|Adverse Event|11|||
130945733|NCT00729183|471434323|FG001|Overall Study|Adverse Event|5|||
130945734|NCT00729183|471434322|FG000|Overall Study|Lack of Efficacy|0|||
130945735|NCT00729183|471434323|FG001|Overall Study|Lack of Efficacy|1|||
130945736|NCT00729183|471434322|FG000|Overall Study|Lost to Follow-up|3|||
130945737|NCT00729183|471434323|FG001|Overall Study|Lost to Follow-up|1|||
130945738|NCT00729183|471434322|FG000|Overall Study|Physician Decision|1|||
130945739|NCT00729183|471434323|FG001|Overall Study|Physician Decision|1|||
130945740|NCT00729183|471434322|FG000|Overall Study|Protocol Violation|1|||
130945741|NCT00729183|471434323|FG001|Overall Study|Protocol Violation|0|||
130945742|NCT00729183|471434322|FG000|Overall Study|Withdrawal by Subject|9|||
130945743|NCT00729183|471434323|FG001|Overall Study|Withdrawal by Subject|7|||
130945744|NCT02867709|471434326|FG000|Treatment Period|Adverse Event|1|||
130774015|NCT02137226|470798660|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
130774016|NCT02137226|470798661|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
130774017|NCT02137226|470798657|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
130945745|NCT02867709|471434327|FG001|Treatment Period|Adverse Event|1|||
130945746|NCT02867709|471434328|FG002|Treatment Period|Adverse Event|2|||
130945747|NCT02867709|471434326|FG000|Treatment Period|Withdrawal of Consent|7|||
130945748|NCT02867709|471434327|FG001|Treatment Period|Withdrawal of Consent|9|||
130945749|NCT02867709|471434328|FG002|Treatment Period|Withdrawal of Consent|8|||
130945750|NCT02867709|471434326|FG000|Treatment Period|Lost to Follow-up|17|||
130945751|NCT02867709|471434327|FG001|Treatment Period|Lost to Follow-up|20|||
130945752|NCT02867709|471434328|FG002|Treatment Period|Lost to Follow-up|20|||
130945753|NCT02867709|471434326|FG000|Treatment Period|Lack of Qualifying Event|42|||
130945754|NCT02867709|471434327|FG001|Treatment Period|Lack of Qualifying Event|55|||
130945755|NCT02867709|471434328|FG002|Treatment Period|Lack of Qualifying Event|42|||
130945756|NCT02867709|471434326|FG000|Treatment Period|Protocol Violation|3|||
130945757|NCT02867709|471434327|FG001|Treatment Period|Protocol Violation|2|||
130945758|NCT02867709|471434328|FG002|Treatment Period|Protocol Violation|3|||
130945759|NCT02867709|471434326|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
130945760|NCT02867709|471434327|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
130945761|NCT02867709|471434328|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
130945762|NCT02867709|471434326|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
130945763|NCT02867709|471434327|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
130945764|NCT02867709|471434328|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
130945765|NCT02867709|471434326|FG000|Safety Follow-up Period|Pregnancy|0|||
130945766|NCT02867709|471434327|FG001|Safety Follow-up Period|Pregnancy|1|||
130945767|NCT02867709|471434328|FG002|Safety Follow-up Period|Pregnancy|0|||
130945768|NCT02867709|471434326|FG000|Safety Follow-up Period|Protocol Violation|0|||
130945769|NCT02867709|471434327|FG001|Safety Follow-up Period|Protocol Violation|1|||
130945770|NCT02867709|471434328|FG002|Safety Follow-up Period|Protocol Violation|1|||
130945771|NCT04709575|471435945|FG000|Overall Study|Withdrawal by Subject|6|||
130945772|NCT04709575|471435946|FG001|Overall Study|Withdrawal by Subject|2|||
130945773|NCT04709575|471435945|FG000|Overall Study|Lost to Follow-up|2|||
130945774|NCT04709575|471435946|FG001|Overall Study|Lost to Follow-up|2|||
130945775|NCT04709575|471435945|FG000|Overall Study|Adverse Event|1|||
130945776|NCT04709575|471435946|FG001|Overall Study|Adverse Event|0|||
130945777|NCT04709575|471435945|FG000|Overall Study|Protocol Violation|1|||
130945778|NCT04709575|471435946|FG001|Overall Study|Protocol Violation|1|||
130945779|NCT03181399|471435947|FG000|6 Months on Treatment|Protocol non-compliance|7|||
130945780|NCT03181399|471435947|FG000|6 Months on Treatment|Adverse Event|4|||
130945781|NCT03181399|471435947|FG000|6 Months on Treatment|Tried alternative treatment|2|||
130945782|NCT03181399|471435947|FG000|6 Months on Treatment|Lost to Follow-up|2|||
130945783|NCT03181399|471435947|FG000|6 Months on Treatment|Personal reasons|1|||
130945784|NCT03181399|471435947|FG000|3 Months Off-treatment|Parent unable to travel|1|||
130945785|NCT00489853|471435950|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
130945786|NCT00489853|471435951|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
130945787|NCT00489853|471435952|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
130945788|NCT00489853|471435950|FG000|Wash-out Period 1|Adverse Event|0|||
130945789|NCT00489853|471435951|FG001|Wash-out Period 1|Adverse Event|1|||
130945790|NCT00489853|471435952|FG002|Wash-out Period 1|Adverse Event|1|||
130945791|NCT00489853|471435950|FG000|Wash-out Period 1|Protocol Violation|0|||
131037166|NCT01539083|471770524|FG002|Before Randomization (VCD Induction)|Death|0|||
130774018|NCT02137226|470798658|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
130945792|NCT00489853|471435951|FG001|Wash-out Period 1|Protocol Violation|1|||
131037167|NCT01539083|471770522|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
131037168|NCT01539083|471770523|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
130945793|NCT00489853|471435952|FG002|Wash-out Period 1|Protocol Violation|1|||
130945794|NCT00489853|471435950|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
130945795|NCT00489853|471435951|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
130945796|NCT00489853|471435952|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
130945797|NCT00489853|471435950|FG000|Wash-out Period 2|Adverse Event|1|||
130945798|NCT00489853|471435951|FG001|Wash-out Period 2|Adverse Event|1|||
130945799|NCT00489853|471435952|FG002|Wash-out Period 2|Adverse Event|0|||
130945800|NCT00489853|471435950|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
130945801|NCT00489853|471435951|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
130945802|NCT00489853|471435952|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
130945803|NCT00489853|471435950|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
130945804|NCT00489853|471435951|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
130945805|NCT00489853|471435952|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
130945806|NCT00265343|471435953|FG000|Overall Study|Adverse Event|10|||
130945807|NCT00265343|471435954|FG001|Overall Study|Adverse Event|7|||
130945808|NCT00265343|471435953|FG000|Overall Study|Withdrawal by Subject|3|||
130945809|NCT00265343|471435954|FG001|Overall Study|Withdrawal by Subject|9|||
130945810|NCT00265343|471435953|FG000|Overall Study|Other|8|||
130945811|NCT00265343|471435954|FG001|Overall Study|Other|3|||
130945812|NCT02515942|471435959|FG000|Overall Study|Adverse Event|5|||
130945813|NCT02515942|471435960|FG001|Overall Study|Adverse Event|0|||
130945814|NCT02515942|471435961|FG002|Overall Study|Adverse Event|0|||
130945815|NCT02515942|471435959|FG000|Overall Study|Death|0|||
130945816|NCT02515942|471435960|FG001|Overall Study|Death|0|||
130945817|NCT02515942|471435961|FG002|Overall Study|Death|1|||
130945818|NCT02515942|471435959|FG000|Overall Study|Lack of Efficacy|0|||
130945819|NCT02515942|471435960|FG001|Overall Study|Lack of Efficacy|0|||
130945820|NCT02515942|471435961|FG002|Overall Study|Lack of Efficacy|1|||
130945821|NCT02515942|471435959|FG000|Overall Study|Lost to Follow-up|2|||
130945822|NCT02515942|471435960|FG001|Overall Study|Lost to Follow-up|0|||
130945823|NCT02515942|471435961|FG002|Overall Study|Lost to Follow-up|0|||
130945824|NCT02515942|471435959|FG000|Overall Study|Withdrawal by Subject|0|||
130945825|NCT02515942|471435960|FG001|Overall Study|Withdrawal by Subject|3|||
130945826|NCT02515942|471435961|FG002|Overall Study|Withdrawal by Subject|2|||
130945827|NCT02510794|471435964|FG000|Overall Study|Adverse Event|0|||
130945828|NCT02510794|471435965|FG001|Overall Study|Adverse Event|1|||
130945829|NCT02510794|471435966|FG002|Overall Study|Adverse Event|0|||
130945830|NCT02510794|471435967|FG003|Overall Study|Adverse Event|0|||
130945831|NCT02510794|471435964|FG000|Overall Study|Death|1|||
130945832|NCT02510794|471435965|FG001|Overall Study|Death|2|||
130945833|NCT02510794|471435966|FG002|Overall Study|Death|1|||
130945834|NCT02510794|471435967|FG003|Overall Study|Death|1|||
130945835|NCT02510794|471435964|FG000|Overall Study|Lack of Efficacy|3|||
130945836|NCT02510794|471435965|FG001|Overall Study|Lack of Efficacy|1|||
130945837|NCT02510794|471435966|FG002|Overall Study|Lack of Efficacy|1|||
130945838|NCT02510794|471435967|FG003|Overall Study|Lack of Efficacy|0|||
130945839|NCT02510794|471435964|FG000|Overall Study|Participant moved out of the area|0|||
130945840|NCT02510794|471435965|FG001|Overall Study|Participant moved out of the area|0|||
130945841|NCT02510794|471435966|FG002|Overall Study|Participant moved out of the area|0|||
130945842|NCT02510794|471435967|FG003|Overall Study|Participant moved out of the area|1|||
130945843|NCT02510794|471435964|FG000|Overall Study|Physician Decision|3|||
130945844|NCT02510794|471435965|FG001|Overall Study|Physician Decision|0|||
130945845|NCT02510794|471435966|FG002|Overall Study|Physician Decision|0|||
130945846|NCT02510794|471435967|FG003|Overall Study|Physician Decision|0|||
130945847|NCT02510794|471435964|FG000|Overall Study|Protocol Violation|0|||
130945848|NCT02510794|471435965|FG001|Overall Study|Protocol Violation|0|||
130945849|NCT02510794|471435966|FG002|Overall Study|Protocol Violation|1|||
130945850|NCT02510794|471435967|FG003|Overall Study|Protocol Violation|0|||
130945851|NCT02510794|471435964|FG000|Overall Study|Withdrawal by Subject|1|||
130945852|NCT02510794|471435965|FG001|Overall Study|Withdrawal by Subject|2|||
130945853|NCT02510794|471435966|FG002|Overall Study|Withdrawal by Subject|4|||
130945854|NCT02510794|471435967|FG003|Overall Study|Withdrawal by Subject|3|||
130945855|NCT01649375|471435968|FG000|Up to Week 16|Adverse Event|2|||
130945856|NCT01649375|471435969|FG001|Up to Week 16|Adverse Event|5|||
130945857|NCT01649375|471435970|FG002|Up to Week 16|Adverse Event|4|||
130945858|NCT01649375|471435971|FG003|Up to Week 16|Adverse Event|0|||
130945859|NCT01649375|471435972|FG004|Up to Week 16|Adverse Event|0|||
130945860|NCT01649375|471435968|FG000|Up to Week 16|Lack of Efficacy|0|||
130945861|NCT01649375|471435969|FG001|Up to Week 16|Lack of Efficacy|0|||
130945862|NCT01649375|471435970|FG002|Up to Week 16|Lack of Efficacy|1|||
130945863|NCT01649375|471435971|FG003|Up to Week 16|Lack of Efficacy|0|||
130945864|NCT01649375|471435972|FG004|Up to Week 16|Lack of Efficacy|0|||
130945865|NCT01649375|471435968|FG000|Up to Week 16|Physician Decision|0|||
131124488|NCT01197521|472084459|FG000|Overall Study|Not reported|24|||
131124489|NCT01197521|472084460|FG001|Overall Study|Not reported|25|||
130945866|NCT01649375|471435969|FG001|Up to Week 16|Physician Decision|0|||
130945867|NCT01649375|471435970|FG002|Up to Week 16|Physician Decision|1|||
130945868|NCT01649375|471435971|FG003|Up to Week 16|Physician Decision|0|||
130945869|NCT01649375|471435972|FG004|Up to Week 16|Physician Decision|0|||
130945870|NCT01649375|471435968|FG000|Up to Week 16|Withdrawal by Subject|2|||
130945871|NCT01649375|471435969|FG001|Up to Week 16|Withdrawal by Subject|1|||
130945872|NCT01649375|471435970|FG002|Up to Week 16|Withdrawal by Subject|2|||
130945873|NCT01649375|471435971|FG003|Up to Week 16|Withdrawal by Subject|0|||
130945874|NCT01649375|471435972|FG004|Up to Week 16|Withdrawal by Subject|0|||
130945875|NCT01649375|471435968|FG000|Up to Week 16|Death|1|||
130945876|NCT01649375|471435969|FG001|Up to Week 16|Death|0|||
130945877|NCT01649375|471435970|FG002|Up to Week 16|Death|0|||
130945878|NCT01649375|471435971|FG003|Up to Week 16|Death|0|||
131037169|NCT01539083|471770524|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
131037170|NCT01539083|471770522|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
131037171|NCT01539083|471770523|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
131037172|NCT01539083|471770524|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
131037173|NCT01539083|471770522|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
131037174|NCT01539083|471770523|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
131037175|NCT01539083|471770524|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
131037176|NCT01539083|471770522|FG000|Before Randomization (VCD Induction)|Other|5|||
131037177|NCT01539083|471770523|FG001|Before Randomization (VCD Induction)|Other|0|||
131037178|NCT01539083|471770524|FG002|Before Randomization (VCD Induction)|Other|0|||
131037179|NCT01539083|471770522|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
131037180|NCT01539083|471770523|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
131037181|NCT01539083|471770524|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
131037182|NCT01539083|471770522|FG000|After Randomization (TP and VTP)|Other|0|||
131037183|NCT01539083|471770523|FG001|After Randomization (TP and VTP)|Other|1|||
131037184|NCT01539083|471770524|FG002|After Randomization (TP and VTP)|Other|1|||
131037185|NCT01539083|471770522|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
130945879|NCT01649375|471435972|FG004|Up to Week 16|Death|0|||
130945880|NCT01649375|471435968|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
130945881|NCT01649375|471435969|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
130945882|NCT01649375|471435970|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
130945883|NCT01649375|471435971|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
130945884|NCT01649375|471435972|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
130945885|NCT01649375|471435968|FG000|Week 16 up to Week 260|Non-compliance|0|||
130945886|NCT01649375|471435969|FG001|Week 16 up to Week 260|Non-compliance|1|||
130945887|NCT01649375|471435970|FG002|Week 16 up to Week 260|Non-compliance|0|||
130945888|NCT01649375|471435971|FG003|Week 16 up to Week 260|Non-compliance|1|||
130945889|NCT01649375|471435972|FG004|Week 16 up to Week 260|Non-compliance|0|||
130945890|NCT01649375|471435968|FG000|Week 16 up to Week 260|Physician Decision|0|||
130945891|NCT01649375|471435969|FG001|Week 16 up to Week 260|Physician Decision|2|||
130945892|NCT01649375|471435970|FG002|Week 16 up to Week 260|Physician Decision|0|||
130945893|NCT01649375|471435971|FG003|Week 16 up to Week 260|Physician Decision|0|||
130945894|NCT01649375|471435972|FG004|Week 16 up to Week 260|Physician Decision|0|||
130945895|NCT01649375|471435968|FG000|Week 16 up to Week 260|Technical issues|0|||
130945896|NCT01649375|471435969|FG001|Week 16 up to Week 260|Technical issues|1|||
130945897|NCT01649375|471435970|FG002|Week 16 up to Week 260|Technical issues|0|||
130945898|NCT01649375|471435971|FG003|Week 16 up to Week 260|Technical issues|1|||
130945899|NCT01649375|471435972|FG004|Week 16 up to Week 260|Technical issues|0|||
130945900|NCT01649375|471435968|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
130945901|NCT01649375|471435969|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
130945902|NCT01649375|471435970|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
130945903|NCT01649375|471435971|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
130945904|NCT01649375|471435972|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
130945905|NCT01649375|471435968|FG000|Week 16 up to Week 260|Death|1|||
130945906|NCT01649375|471435969|FG001|Week 16 up to Week 260|Death|1|||
130945907|NCT01649375|471435970|FG002|Week 16 up to Week 260|Death|0|||
130945908|NCT01649375|471435971|FG003|Week 16 up to Week 260|Death|0|||
130945909|NCT01649375|471435972|FG004|Week 16 up to Week 260|Death|0|||
130945910|NCT01649375|471435968|FG000|Week 16 up to Week 260|Adverse Event|5|||
130945911|NCT01649375|471435969|FG001|Week 16 up to Week 260|Adverse Event|2|||
130945912|NCT01649375|471435970|FG002|Week 16 up to Week 260|Adverse Event|0|||
130945913|NCT01649375|471435971|FG003|Week 16 up to Week 260|Adverse Event|3|||
130945914|NCT01649375|471435972|FG004|Week 16 up to Week 260|Adverse Event|2|||
130945915|NCT01856790|471435975|FG000|Closed Loop Control|Withdrawal by Subject|2|||
130945916|NCT01856790|471435975|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
130945917|NCT01124604|471435976|FG000|Overall Study|Adverse Event|10|||
130945918|NCT01124604|471435977|FG001|Overall Study|Adverse Event|1|||
130945919|NCT01124604|471435976|FG000|Overall Study|Lack of Efficacy|1|||
130945920|NCT01124604|471435977|FG001|Overall Study|Lack of Efficacy|0|||
131037186|NCT01539083|471770523|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
131037187|NCT01539083|471770524|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
131037188|NCT01539083|471770522|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
131037189|NCT01539083|471770523|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
131037190|NCT01539083|471770524|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
131037191|NCT01539083|471770522|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
131037192|NCT01539083|471770523|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
130945921|NCT01124604|471435976|FG000|Overall Study|Withdrawal by Subject|4|||
130945922|NCT01124604|471435977|FG001|Overall Study|Withdrawal by Subject|0|||
130945923|NCT01124604|471435976|FG000|Overall Study|Disease Progression|0|||
130945924|NCT01124604|471435977|FG001|Overall Study|Disease Progression|1|||
130945925|NCT04091646|471435978|FG000|Overall Study|Adverse Event|2|||
130945926|NCT04091646|471435979|FG001|Overall Study|Adverse Event|1|||
130945927|NCT04091646|471435978|FG000|Overall Study|Lost to Follow-up|6|||
130945928|NCT04091646|471435979|FG001|Overall Study|Lost to Follow-up|2|||
130945929|NCT04091646|471435978|FG000|Overall Study|Protocol Violation|0|||
130945930|NCT04091646|471435979|FG001|Overall Study|Protocol Violation|1|||
130945931|NCT04091646|471435978|FG000|Overall Study|Withdrawal by Subject|4|||
130945932|NCT04091646|471435979|FG001|Overall Study|Withdrawal by Subject|1|||
130945933|NCT04091646|471435978|FG000|Overall Study|Participant Incarcerated|1|||
130945934|NCT04091646|471435979|FG001|Overall Study|Participant Incarcerated|0|||
130945935|NCT01762943|471435980|FG000|Overall Study|Physician Decision|1|||
130945936|NCT01762943|471435981|FG001|Overall Study|Physician Decision|1|||
130945937|NCT01762943|471435980|FG000|Overall Study|Protocol Violation|1|||
130945938|NCT01762943|471435981|FG001|Overall Study|Protocol Violation|0|||
130945939|NCT01762943|471435980|FG000|Overall Study|Withdrawal by Subject|2|||
130945940|NCT01762943|471435981|FG001|Overall Study|Withdrawal by Subject|1|||
130945941|NCT00539838|471435982|FG000|Overall Study|Fail to return|2|||
130945942|NCT00539838|471435983|FG001|Overall Study|Fail to return|0|||
130945943|NCT00539838|471435984|FG002|Overall Study|Fail to return|0|||
130945944|NCT00539838|471435982|FG000|Overall Study|Withdrawal by Subject|0|||
130945945|NCT00539838|471435983|FG001|Overall Study|Withdrawal by Subject|4|||
130945946|NCT00539838|471435984|FG002|Overall Study|Withdrawal by Subject|0|||
130945947|NCT00539838|471435982|FG000|Overall Study|Death|0|||
130945948|NCT00539838|471435983|FG001|Overall Study|Death|2|||
130945949|NCT00539838|471435984|FG002|Overall Study|Death|0|||
130945950|NCT00539838|471435982|FG000|Overall Study|Did not cooperate|1|||
130945951|NCT00539838|471435983|FG001|Overall Study|Did not cooperate|0|||
130945952|NCT00539838|471435984|FG002|Overall Study|Did not cooperate|1|||
130945953|NCT00539838|471435982|FG000|Overall Study|Administrative|4|||
130945954|NCT00539838|471435983|FG001|Overall Study|Administrative|0|||
130945955|NCT00539838|471435984|FG002|Overall Study|Administrative|8|||
130945956|NCT03506373|471435992|FG000|Overall Study|Adverse Event|6|||
130945957|NCT03506373|471435992|FG000|Overall Study|Withdrawal by Subject|2|||
130945958|NCT03506373|471435992|FG000|Overall Study|Disease progression|5|||
130945959|NCT03506373|471435992|FG000|Overall Study|Other|3|||
130945960|NCT00885755|471435993|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
130945961|NCT00885755|471435994|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
130945962|NCT00885755|471435995|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
130945963|NCT00885755|471435993|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
130945964|NCT00885755|471435994|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
130945965|NCT00885755|471435995|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
130945966|NCT00885755|471435993|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
130945967|NCT00885755|471435994|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
130945968|NCT00885755|471435995|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
130945969|NCT00885755|471435993|FG000|Part I: Trastuzumab+Taxane|Death|0|||
130945970|NCT00885755|471435994|FG001|Part I: Trastuzumab+Taxane|Death|0|||
130945971|NCT00885755|471435995|FG002|Part I: Trastuzumab+Taxane|Death|1|||
130945972|NCT00885755|471435993|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
130945973|NCT00885755|471435994|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
130945974|NCT00885755|471435995|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
130945975|NCT04343521|471435996|FG000|Overall Study|Adverse Event|0|||
130945976|NCT04343521|471435997|FG001|Overall Study|Adverse Event|2|||
130945977|NCT04343521|471435996|FG000|Overall Study|Death|1|||
130945978|NCT04343521|471435997|FG001|Overall Study|Death|2|||
130945979|NCT04343521|471435996|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
130945980|NCT04343521|471435997|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
130945981|NCT04343521|471435996|FG000|Overall Study|Withdrawal by Subject|70|||
130945982|NCT04343521|471435997|FG001|Overall Study|Withdrawal by Subject|95|||
130945983|NCT04343521|471435996|FG000|Overall Study|Withdrawal by study team|6|||
130945984|NCT04343521|471435997|FG001|Overall Study|Withdrawal by study team|12|||
130945985|NCT00107198|471435998|FG000|Overall Study|Lack of Efficacy|28|||
130945986|NCT00107198|471435998|FG000|Overall Study|Lost to Follow-up|12|||
130945987|NCT00107198|471435998|FG000|Overall Study|Protocol Violation|1|||
130945988|NCT00107198|471435998|FG000|Overall Study|Withdrawal by Subject|6|||
130945989|NCT00107198|471435998|FG000|Overall Study|Ineligible|5|||
130945990|NCT05442554|471435999|FG000|Overall Study|Adverse Event|1|||
130945991|NCT02120950|471436000|FG000|Overall Study|Adverse Event|5|||
130945992|NCT02120950|471436001|FG001|Overall Study|Adverse Event|4|||
130945993|NCT02120950|471436002|FG002|Overall Study|Adverse Event|3|||
130945994|NCT02120950|471436000|FG000|Overall Study|Death|3|||
130945995|NCT02120950|471436001|FG001|Overall Study|Death|0|||
130945996|NCT02120950|471436002|FG002|Overall Study|Death|1|||
130945997|NCT02120950|471436000|FG000|Overall Study|Withdrawal by Subject|6|||
130945998|NCT02120950|471436001|FG001|Overall Study|Withdrawal by Subject|3|||
130945999|NCT02120950|471436002|FG002|Overall Study|Withdrawal by Subject|2|||
130946000|NCT02120950|471436000|FG000|Overall Study|Protocol Violation|1|||
130946001|NCT02120950|471436001|FG001|Overall Study|Protocol Violation|1|||
130946002|NCT02120950|471436002|FG002|Overall Study|Protocol Violation|7|||
130946003|NCT02120950|471436000|FG000|Overall Study|Other reasons|5|||
130946004|NCT02120950|471436001|FG001|Overall Study|Other reasons|4|||
130946005|NCT02120950|471436002|FG002|Overall Study|Other reasons|1|||
130946006|NCT02120950|471436000|FG000|Overall Study|Lost to Follow-up|0|||
130946007|NCT02120950|471436001|FG001|Overall Study|Lost to Follow-up|2|||
130946008|NCT02120950|471436002|FG002|Overall Study|Lost to Follow-up|1|||
130946009|NCT02424383|471436003|FG000|Overall Study|Withdrawal by Subject|32|||
130946010|NCT02424383|471436003|FG000|Overall Study|Death|170|||
130946011|NCT02424383|471436003|FG000|Overall Study|Sponsor's decision|3|||
130946012|NCT02424383|471436003|FG000|Overall Study|Investigator's decision|44|||
130946013|NCT02424383|471436003|FG000|Overall Study|Lost to Follow-up|81|||
130946014|NCT02424383|471436003|FG000|Overall Study|Other|7|||
130946015|NCT02424383|471436003|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
130946016|NCT02438722|471436006|FG000|Overall Study|Adverse Event|12|||
130946017|NCT02438722|471436007|FG001|Overall Study|Adverse Event|9|||
130946018|NCT02438722|471436006|FG000|Overall Study|Refusal unrelated to AE|2|||
130946019|NCT02438722|471436007|FG001|Overall Study|Refusal unrelated to AE|5|||
130946020|NCT02438722|471436006|FG000|Overall Study|Disease progression/relapse|46|||
130946021|NCT02438722|471436007|FG001|Overall Study|Disease progression/relapse|51|||
130946022|NCT02438722|471436006|FG000|Overall Study|Death|0|||
130946023|NCT02438722|471436007|FG001|Overall Study|Death|3|||
130946024|NCT02438722|471436006|FG000|Overall Study|Physician Decision|2|||
130946025|NCT02438722|471436007|FG001|Overall Study|Physician Decision|2|||
130946026|NCT02438722|471436006|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
130946027|NCT02438722|471436007|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
130946028|NCT02438722|471436006|FG000|Overall Study|Withdrawal by Subject|0|||
130946029|NCT02438722|471436007|FG001|Overall Study|Withdrawal by Subject|1|||
130946030|NCT02438722|471436006|FG000|Overall Study|On protocol treatment|15|||
130946031|NCT02438722|471436007|FG001|Overall Study|On protocol treatment|14|||
130946032|NCT02438722|471436006|FG000|Overall Study|Did not receive protocol treatment|5|||
130946033|NCT02438722|471436007|FG001|Overall Study|Did not receive protocol treatment|0|||
131037193|NCT01539083|471770524|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
131037194|NCT01539083|471770522|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
131037195|NCT01539083|471770523|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
131037196|NCT01539083|471770524|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
131037197|NCT01539083|471770522|FG000|After Randomization (TP and VTP)|Death|0|||
131037198|NCT01539083|471770523|FG001|After Randomization (TP and VTP)|Death|6|||
131037199|NCT01539083|471770524|FG002|After Randomization (TP and VTP)|Death|11|||
131037200|NCT02573493|471770533|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
131037201|NCT02573493|471770534|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
131037202|NCT02573493|471770535|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
131037203|NCT02573493|471770536|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
131037204|NCT04149704|471770537|FG000|Three Month Follow-up|Death|2|||
131037205|NCT04149704|471770538|FG001|Three Month Follow-up|Death|0|||
131037206|NCT04149704|471770539|FG002|Three Month Follow-up|Death|0|||
131037207|NCT04149704|471770540|FG003|Three Month Follow-up|Death|0|||
131037208|NCT04149704|471770537|FG000|Three Month Follow-up|Lost to Follow-up|1|||
131037209|NCT04149704|471770538|FG001|Three Month Follow-up|Lost to Follow-up|4|||
131037210|NCT04149704|471770539|FG002|Three Month Follow-up|Lost to Follow-up|5|||
131037211|NCT04149704|471770540|FG003|Three Month Follow-up|Lost to Follow-up|5|||
131037212|NCT04149704|471770537|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
131037213|NCT04149704|471770538|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
131037214|NCT04149704|471770539|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
131037215|NCT04149704|471770540|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
131037216|NCT04149704|471770537|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
131037217|NCT04149704|471770538|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
131037218|NCT04149704|471770539|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
131037219|NCT04149704|471770540|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
131037220|NCT04332926|471770541|FG000|Overall Study|Withdrawal by Subject|6|||
131037221|NCT04332926|471770541|FG000|Overall Study|Physician Decision|6|||
131037222|NCT05213390|471770549|FG000|Overall Study|Withdrawal by Subject|2|||
131037223|NCT05213390|471770549|FG000|Overall Study|Lost to Follow-up|12|||
131037224|NCT05213390|471770549|FG000|Overall Study|Protocol Violation|9|||
131037225|NCT05362487|471770550|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
131037226|NCT05415722|471770559|FG000|Overall Study|Lost to Follow-up|0|||
131037227|NCT05415722|471770560|FG001|Overall Study|Lost to Follow-up|2|||
131037228|NCT05415722|471770561|FG002|Overall Study|Lost to Follow-up|0|||
131037229|NCT05415722|471770562|FG003|Overall Study|Lost to Follow-up|1|||
131037230|NCT05415722|471770563|FG004|Overall Study|Lost to Follow-up|0|||
131037231|NCT05415722|471770564|FG005|Overall Study|Lost to Follow-up|0|||
130710359|NCT01010750|470564810|FG000|Second Intervention|Adverse Event|0|||
130946034|NCT00909779|471436008|FG000|Overall Study|Adverse Event|53|||
130946035|NCT00909779|471436009|FG001|Overall Study|Adverse Event|55|||
130946036|NCT00909779|471436008|FG000|Overall Study|Lack of Efficacy|7|||
131037232|NCT05415722|471770565|FG006|Overall Study|Lost to Follow-up|1|||
131037233|NCT05415722|471770559|FG000|Overall Study|Physician Decision|0|||
131037234|NCT05415722|471770560|FG001|Overall Study|Physician Decision|0|||
131037235|NCT05415722|471770561|FG002|Overall Study|Physician Decision|0|||
131037236|NCT05415722|471770562|FG003|Overall Study|Physician Decision|1|||
131037237|NCT05415722|471770563|FG004|Overall Study|Physician Decision|0|||
131037238|NCT05415722|471770564|FG005|Overall Study|Physician Decision|0|||
131037239|NCT05415722|471770565|FG006|Overall Study|Physician Decision|1|||
131037240|NCT05415722|471770559|FG000|Overall Study|Protocol Violation|0|||
131037241|NCT05415722|471770560|FG001|Overall Study|Protocol Violation|0|||
131037242|NCT05415722|471770561|FG002|Overall Study|Protocol Violation|0|||
131037243|NCT05415722|471770562|FG003|Overall Study|Protocol Violation|1|||
131037244|NCT05415722|471770563|FG004|Overall Study|Protocol Violation|0|||
131037245|NCT05415722|471770564|FG005|Overall Study|Protocol Violation|0|||
131037246|NCT05415722|471770565|FG006|Overall Study|Protocol Violation|0|||
131037247|NCT05415722|471770559|FG000|Overall Study|Sponsor Discretion|0|||
131037248|NCT05415722|471770560|FG001|Overall Study|Sponsor Discretion|0|||
130946037|NCT00909779|471436009|FG001|Overall Study|Lack of Efficacy|4|||
130946038|NCT00909779|471436008|FG000|Overall Study|Lost to Follow-up|19|||
130946039|NCT00909779|471436009|FG001|Overall Study|Lost to Follow-up|15|||
130946040|NCT00909779|471436008|FG000|Overall Study|Physician Decision|8|||
130946041|NCT00909779|471436009|FG001|Overall Study|Physician Decision|2|||
130946042|NCT00909779|471436008|FG000|Overall Study|Protocol Violation|2|||
130946043|NCT00909779|471436009|FG001|Overall Study|Protocol Violation|5|||
130946044|NCT00909779|471436008|FG000|Overall Study|Withdrawal by Subject|116|||
130946045|NCT00909779|471436009|FG001|Overall Study|Withdrawal by Subject|80|||
130946046|NCT00909779|471436008|FG000|Overall Study|Site Ceasing Operation|2|||
130946047|NCT00909779|471436009|FG001|Overall Study|Site Ceasing Operation|2|||
130946048|NCT00909779|471436008|FG000|Overall Study|Medical Monitor Decision|1|||
130946049|NCT00909779|471436009|FG001|Overall Study|Medical Monitor Decision|0|||
130946050|NCT00909779|471436008|FG000|Overall Study|Noncompliance|1|||
130946051|NCT00909779|471436009|FG001|Overall Study|Noncompliance|1|||
130946052|NCT00909779|471436008|FG000|Overall Study|Randomized in error|1|||
130946053|NCT00909779|471436009|FG001|Overall Study|Randomized in error|1|||
130946054|NCT02738333|471436013|FG000|Overall Study|Death|1|||
130946055|NCT02738333|471436014|FG001|Overall Study|Death|0|||
130946056|NCT02738333|471436015|FG002|Overall Study|Death|0|||
130946057|NCT02738333|471436013|FG000|Overall Study|Lost to Follow-up|1|||
130946058|NCT02738333|471436014|FG001|Overall Study|Lost to Follow-up|0|||
130946059|NCT02738333|471436015|FG002|Overall Study|Lost to Follow-up|0|||
130946060|NCT01498952|471436017|FG000|Overall Study|Death|2|||
130946061|NCT01498952|471436018|FG001|Overall Study|Death|2|||
130946062|NCT01498952|471436019|FG002|Overall Study|Death|0|||
130946063|NCT01498952|471436020|FG003|Overall Study|Death|0|||
130946064|NCT01498952|471436021|FG004|Overall Study|Death|0|||
130946065|NCT00579826|471436022|FG000|Overall Study|Withdrawal by Subject|5|||
130946066|NCT00579826|471436023|FG001|Overall Study|Withdrawal by Subject|3|||
130946067|NCT04191382|471436024|FG000|Overall Study|Withdrawal by Subject|1|||
130946068|NCT04191382|471436025|FG001|Overall Study|Withdrawal by Subject|0|||
130946069|NCT04191382|471436026|FG002|Overall Study|Withdrawal by Subject|0|||
130946070|NCT05237206|471436027|FG000|Overall Study|screen failure-did not receive treatment|8|||
130946071|NCT05237206|471436027|FG000|Overall Study|did not receive treatment|3|||
130946072|NCT02205333|471436033|FG000|Overall Study|Death|5|||
130946073|NCT02205333|471436034|FG001|Overall Study|Death|6|||
131037249|NCT05415722|471770561|FG002|Overall Study|Sponsor Discretion|0|||
131037250|NCT05415722|471770562|FG003|Overall Study|Sponsor Discretion|0|||
131037251|NCT05415722|471770563|FG004|Overall Study|Sponsor Discretion|1|||
131037252|NCT05415722|471770564|FG005|Overall Study|Sponsor Discretion|1|||
131037253|NCT05415722|471770565|FG006|Overall Study|Sponsor Discretion|0|||
131037254|NCT05415722|471770559|FG000|Overall Study|Withdrawal by Subject|0|||
131037255|NCT05415722|471770560|FG001|Overall Study|Withdrawal by Subject|1|||
131037256|NCT05415722|471770561|FG002|Overall Study|Withdrawal by Subject|0|||
131037257|NCT05415722|471770562|FG003|Overall Study|Withdrawal by Subject|1|||
131124490|NCT01197521|472084461|FG002|Overall Study|Not reported|21|||
130710360|NCT01010750|470564811|FG001|Second Intervention|Adverse Event|1|||
130946074|NCT02205333|471436035|FG002|Overall Study|Death|2|||
130946075|NCT02205333|471436036|FG003|Overall Study|Death|6|||
130946076|NCT02205333|471436037|FG004|Overall Study|Death|5|||
130946077|NCT02205333|471436038|FG005|Overall Study|Death|3|||
131037258|NCT05415722|471770563|FG004|Overall Study|Withdrawal by Subject|1|||
130946078|NCT02205333|471436039|FG006|Overall Study|Death|3|||
130946079|NCT02205333|471436040|FG007|Overall Study|Death|2|||
130946080|NCT02205333|471436041|FG008|Overall Study|Death|0|||
130946081|NCT02205333|471436033|FG000|Overall Study|Withdrawal by Subject|1|||
130946082|NCT02205333|471436034|FG001|Overall Study|Withdrawal by Subject|0|||
130946083|NCT02205333|471436035|FG002|Overall Study|Withdrawal by Subject|0|||
130946084|NCT02205333|471436036|FG003|Overall Study|Withdrawal by Subject|1|||
130946085|NCT02205333|471436037|FG004|Overall Study|Withdrawal by Subject|0|||
131037259|NCT05415722|471770564|FG005|Overall Study|Withdrawal by Subject|0|||
131037260|NCT05415722|471770565|FG006|Overall Study|Withdrawal by Subject|1|||
130946086|NCT02205333|471436038|FG005|Overall Study|Withdrawal by Subject|0|||
130946087|NCT02205333|471436039|FG006|Overall Study|Withdrawal by Subject|2|||
130946088|NCT02205333|471436040|FG007|Overall Study|Withdrawal by Subject|0|||
130946089|NCT02205333|471436041|FG008|Overall Study|Withdrawal by Subject|0|||
130946090|NCT00454987|471436042|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
130946091|NCT00454987|471436043|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
130946092|NCT00454987|471436044|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
130946093|NCT00454987|471436042|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
130946094|NCT00454987|471436043|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
130946095|NCT00454987|471436044|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
130946096|NCT00454987|471436042|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
130946097|NCT00454987|471436043|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
130946098|NCT00454987|471436044|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
130946099|NCT01476696|471436045|FG000|Overall Study|Sponsor decision|2|||
130946100|NCT01476696|471436046|FG001|Overall Study|Sponsor decision|1|||
130946101|NCT01476696|471436047|FG002|Overall Study|Sponsor decision|0|||
130946102|NCT01476696|471436045|FG000|Overall Study|Withdrawal by Subject|1|||
130946103|NCT01476696|471436046|FG001|Overall Study|Withdrawal by Subject|0|||
130946104|NCT01476696|471436047|FG002|Overall Study|Withdrawal by Subject|0|||
130946105|NCT02009046|471436048|FG000|Overall Study|Lost to Follow-up|256|||
130946106|NCT02009046|471436049|FG001|Overall Study|Lost to Follow-up|206|||
130946107|NCT00304356|471436055|FG000|Nitazoxanide|Physician Decision|5|||
131124491|NCT01197521|472084459|FG000|Overall Study|Enrolment in long term extension|42|||
131124492|NCT01197521|472084460|FG001|Overall Study|Enrolment in long term extension|36|||
131124493|NCT01197521|472084461|FG002|Overall Study|Enrolment in long term extension|87|||
131124494|NCT01197521|472084459|FG000|Overall Study|Severe non-compliance to protocol|1|||
131124495|NCT01197521|472084460|FG001|Overall Study|Severe non-compliance to protocol|3|||
131124496|NCT01197521|472084461|FG002|Overall Study|Severe non-compliance to protocol|3|||
131124497|NCT01197521|472084459|FG000|Overall Study|Lack of therapeutic response|2|||
131124498|NCT01197521|472084460|FG001|Overall Study|Lack of therapeutic response|3|||
131124499|NCT01197521|472084461|FG002|Overall Study|Lack of therapeutic response|4|||
130946108|NCT00304356|471436055|FG000|Nitazoxanide|Physician Decision|1|||
130946109|NCT00304356|471436055|FG000|Nitazoxanide|number is 0|1|||
130946110|NCT00304356|471436055|FG000|Nitazoxanide|Physician Decision|1|||
130946111|NCT00304356|471436055|FG000|Nitazoxanide|Physician Decision|1|||
130946112|NCT00304356|471436055|FG000|Nitazoxanide|Physician Decision|1|||
130946113|NCT01737047|471436056|FG000|Overall Study|Death|10|||
130946114|NCT01737047|471436057|FG001|Overall Study|Death|0|||
130946115|NCT01737047|471436058|FG002|Overall Study|Death|1|||
130946116|NCT01737047|471436056|FG000|Overall Study|Withdrawal by Subject|17|||
130946117|NCT01737047|471436057|FG001|Overall Study|Withdrawal by Subject|11|||
130946118|NCT01737047|471436058|FG002|Overall Study|Withdrawal by Subject|4|||
130946119|NCT00335972|471436059|FG000|Overall Study|not given treatments|0|||
130946120|NCT00335972|471436060|FG001|Overall Study|not given treatments|3|||
130946121|NCT00537381|471436063|FG000|Overall Study|Adverse Event|13|||
130946122|NCT00537381|471436064|FG001|Overall Study|Adverse Event|9|||
130946123|NCT00537381|471436063|FG000|Overall Study|Death|3|||
130946124|NCT00537381|471436064|FG001|Overall Study|Death|3|||
130946125|NCT00537381|471436063|FG000|Overall Study|Withdrawal by Subject|5|||
130946126|NCT00537381|471436064|FG001|Overall Study|Withdrawal by Subject|14|||
130946127|NCT00537381|471436063|FG000|Overall Study|Physician Decision|7|||
130946128|NCT00537381|471436064|FG001|Overall Study|Physician Decision|6|||
130946129|NCT00537381|471436063|FG000|Overall Study|Disease Progression|9|||
130946130|NCT00537381|471436064|FG001|Overall Study|Disease Progression|18|||
130946131|NCT00537381|471436063|FG000|Overall Study|Sponsor decision|14|||
130946132|NCT00537381|471436064|FG001|Overall Study|Sponsor decision|9|||
130946133|NCT00537381|471436063|FG000|Overall Study|Other|5|||
130946134|NCT00537381|471436064|FG001|Overall Study|Other|3|||
130946135|NCT02081079|471436065|FG000|Overall Study|Lack of Efficacy|3|||
130946136|NCT02081079|471436066|FG001|Overall Study|Lack of Efficacy|2|||
130946137|NCT02081079|471436065|FG000|Overall Study|Lost to Follow-up|1|||
130946138|NCT02081079|471436066|FG001|Overall Study|Lost to Follow-up|0|||
130946139|NCT04837131|471436072|FG000|Overall Study|Death|1|||
130946140|NCT04837131|471436072|FG000|Overall Study|Withdrawal by Subject|1|||
130946141|NCT04837131|471436072|FG000|Overall Study|Adverse Event|1|||
130946142|NCT04837131|471436072|FG000|Overall Study|Protocol Violation|1|||
130946143|NCT01541969|471437467|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
130946144|NCT01541969|471437468|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
130946145|NCT01541969|471437467|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
130774019|NCT02137226|470798659|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
130946146|NCT01541969|471437468|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
130946147|NCT01541969|471437467|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
130946148|NCT01541969|471437468|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
130946149|NCT01541969|471437467|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
130946150|NCT01541969|471437468|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
131037261|NCT04663737|471770569|FG000|Overall Study|Withdrawal by Subject|2|||
131037262|NCT04663737|471770570|FG001|Overall Study|Withdrawal by Subject|0|||
131037263|NCT01943409|471770574|FG000|Overall Study|resumed oral/entral|24|||
131037264|NCT01943409|471770575|FG001|Overall Study|resumed oral/entral|20|||
131037265|NCT01943409|471770574|FG000|Overall Study|Protocol Violation|14|||
130946151|NCT01541969|471437467|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
130946152|NCT01541969|471437468|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
130946153|NCT01541969|471437467|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
130946154|NCT01541969|471437468|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
130946155|NCT01541969|471437467|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
130946156|NCT01541969|471437468|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
130946157|NCT01541969|471437467|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
130946158|NCT01541969|471437468|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
130946159|NCT01541969|471437467|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
130946160|NCT01541969|471437468|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
130946161|NCT01541969|471437467|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
130946162|NCT01541969|471437468|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
130946163|NCT05123222|471437469|FG000|Overall Study|Lost to Follow-up|2|||
130946164|NCT05123222|471437470|FG001|Overall Study|Lost to Follow-up|0|||
130946165|NCT05123222|471437471|FG002|Overall Study|Lost to Follow-up|0|||
130946166|NCT05123222|471437472|FG003|Overall Study|Lost to Follow-up|0|||
130946167|NCT05123222|471437469|FG000|Overall Study|Protocol Violation|0|||
130946168|NCT05123222|471437470|FG001|Overall Study|Protocol Violation|0|||
130946169|NCT05123222|471437471|FG002|Overall Study|Protocol Violation|1|||
130946170|NCT05123222|471437472|FG003|Overall Study|Protocol Violation|0|||
130946171|NCT02255500|471437477|FG000|Overall Study|Withdrawal by Subject|1|||
130946172|NCT02255500|471437478|FG001|Overall Study|Withdrawal by Subject|0|||
130946173|NCT04865354|471437479|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
130946174|NCT04865354|471437480|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
130946175|NCT04865354|471437479|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
130946176|NCT04865354|471437480|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
130946177|NCT04865354|471437479|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
130946178|NCT04865354|471437480|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
130946179|NCT00588822|471437485|FG000|Overall Study|progression of disease|8|||
130946180|NCT04254978|471437486|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
130946181|NCT04254978|471437486|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
130946182|NCT04254978|471437486|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
130946183|NCT04254978|471437486|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
130946184|NCT04254978|471437486|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
130946185|NCT04254978|471437486|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
130946186|NCT02436759|471437487|FG000|Overall Study|Adverse Event|3|||
130946187|NCT02436759|471437488|FG001|Overall Study|Adverse Event|0|||
130946188|NCT02436759|471437487|FG000|Overall Study|Protocol Violation|1|||
130946189|NCT02436759|471437488|FG001|Overall Study|Protocol Violation|0|||
130946190|NCT02436759|471437487|FG000|Overall Study|Withdrawal by Subject|0|||
130946191|NCT02436759|471437488|FG001|Overall Study|Withdrawal by Subject|1|||
130946192|NCT00277212|471437489|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
130946193|NCT00277212|471437490|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
130946194|NCT00277212|471437491|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
130946195|NCT00277212|471437489|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
130946196|NCT00277212|471437490|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
130946197|NCT00277212|471437491|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
130946198|NCT00277212|471437489|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
130946199|NCT00277212|471437490|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
130946200|NCT00277212|471437491|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
130946201|NCT00277212|471437489|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
130946202|NCT00277212|471437490|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
130946203|NCT00277212|471437491|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
130946204|NCT00277212|471437489|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
130946205|NCT00277212|471437490|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
131037266|NCT01943409|471770575|FG001|Overall Study|Protocol Violation|24|||
131037267|NCT01943409|471770574|FG000|Overall Study|Death|3|||
131037268|NCT01943409|471770575|FG001|Overall Study|Death|1|||
131037269|NCT01943409|471770574|FG000|Overall Study|Withdrawal by Subject|4|||
131037270|NCT01943409|471770575|FG001|Overall Study|Withdrawal by Subject|3|||
131037271|NCT02310646|471770576|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
131037272|NCT02310646|471770577|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
131037273|NCT02310646|471770576|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
131037274|NCT02310646|471770577|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
131037275|NCT04700163|471770578|FG000|Overall Study|Lost to Follow-up|0|||
131037276|NCT04700163|471770579|FG001|Overall Study|Lost to Follow-up|0|||
130774020|NCT02137226|470798660|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
130774021|NCT02137226|470798661|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
130774022|NCT02137226|470798657|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
130774023|NCT02137226|470798658|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
130774024|NCT02137226|470798659|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
130774025|NCT02137226|470798660|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
130774026|NCT02137226|470798661|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
130774027|NCT02137226|470798657|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
130774028|NCT02137226|470798658|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
130774029|NCT02137226|470798659|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
130774030|NCT02137226|470798660|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
130774031|NCT02137226|470798661|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
130774032|NCT02137226|470798657|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130774033|NCT02137226|470798658|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130774034|NCT02137226|470798659|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
130774035|NCT02137226|470798660|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130774036|NCT02137226|470798661|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130774037|NCT02137226|470798657|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130774038|NCT02137226|470798658|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130774039|NCT02137226|470798659|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
130774040|NCT02137226|470798660|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130946206|NCT00277212|471437491|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
130946207|NCT00277212|471437489|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
130946208|NCT00277212|471437490|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
130946209|NCT00277212|471437491|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
130946210|NCT00277212|471437489|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
130946211|NCT00277212|471437490|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
130946212|NCT00277212|471437491|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
130946213|NCT00277212|471437489|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
130946214|NCT00277212|471437490|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
130946215|NCT00277212|471437491|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
130946216|NCT00277212|471437489|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
130946217|NCT00277212|471437490|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
130946218|NCT00277212|471437491|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
130946219|NCT00277212|471437489|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
130946220|NCT00277212|471437490|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
130946221|NCT00277212|471437491|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
130946222|NCT00277212|471437489|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
130946223|NCT00277212|471437490|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
130946224|NCT00277212|471437491|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
130946225|NCT00277212|471437489|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
130946226|NCT00277212|471437490|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
130946227|NCT00277212|471437491|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
130946228|NCT00277212|471437489|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
130946229|NCT00277212|471437490|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
130946230|NCT00277212|471437491|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
130946231|NCT00277212|471437489|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
130946232|NCT00277212|471437490|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
130946233|NCT00277212|471437491|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
130946234|NCT00277212|471437489|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
130946235|NCT00277212|471437490|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
130946236|NCT00277212|471437491|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
130946237|NCT00277212|471437489|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
130946238|NCT00277212|471437490|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
130946239|NCT00277212|471437491|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
130946240|NCT00277212|471437489|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
130946241|NCT00277212|471437490|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
131037277|NCT04700163|471770580|FG002|Overall Study|Lost to Follow-up|0|||
131037278|NCT04700163|471770581|FG003|Overall Study|Lost to Follow-up|0|||
131037279|NCT04700163|471770582|FG004|Overall Study|Lost to Follow-up|0|||
131037280|NCT04700163|471770583|FG005|Overall Study|Lost to Follow-up|1|||
131037281|NCT03848065|471770584|FG000|Overall Study|Death|0|||
131037282|NCT03848065|471770585|FG001|Overall Study|Death|1|||
131037283|NCT03848065|471770586|FG002|Overall Study|Death|0|||
130774041|NCT02137226|470798661|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130774042|NCT02137226|470798657|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
130774043|NCT02137226|470798658|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
130774044|NCT02137226|470798659|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
130946242|NCT00277212|471437491|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
130946243|NCT00277212|471437489|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
130946244|NCT00277212|471437490|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
130946245|NCT00277212|471437491|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
130946246|NCT00902564|471437492|FG000|Overall Study|Withdrawal by Subject|2|||
130946247|NCT03336216|471437493|FG000|Randomization|Not reported|2|||
130946248|NCT03336216|471437494|FG001|Randomization|Not reported|0|||
130946249|NCT03336216|471437495|FG002|Randomization|Not reported|1|||
130946250|NCT03336216|471437496|FG003|Randomization|Not reported|0|||
130946251|NCT03336216|471437493|FG000|Randomization|Other reasons|1|||
130946252|NCT03336216|471437494|FG001|Randomization|Other reasons|1|||
130946253|NCT03336216|471437495|FG002|Randomization|Other reasons|1|||
130946254|NCT03336216|471437496|FG003|Randomization|Other reasons|0|||
130946255|NCT03336216|471437493|FG000|Randomization|Participant no longer meets study criteria|0|||
130946256|NCT03336216|471437494|FG001|Randomization|Participant no longer meets study criteria|2|||
130946257|NCT03336216|471437495|FG002|Randomization|Participant no longer meets study criteria|4|||
130946258|NCT03336216|471437496|FG003|Randomization|Participant no longer meets study criteria|1|||
130946259|NCT03336216|471437493|FG000|Randomization|Lost to Follow-up|1|||
130946260|NCT03336216|471437494|FG001|Randomization|Lost to Follow-up|0|||
130946261|NCT03336216|471437495|FG002|Randomization|Lost to Follow-up|0|||
130946262|NCT03336216|471437496|FG003|Randomization|Lost to Follow-up|0|||
130946263|NCT03336216|471437493|FG000|Randomization|Participant withdrew consent|9|||
130946264|NCT03336216|471437494|FG001|Randomization|Participant withdrew consent|1|||
130946265|NCT03336216|471437495|FG002|Randomization|Participant withdrew consent|0|||
130946266|NCT03336216|471437496|FG003|Randomization|Participant withdrew consent|0|||
130946267|NCT03336216|471437493|FG000|Randomization|Adverse Event|1|||
130946268|NCT03336216|471437494|FG001|Randomization|Adverse Event|1|||
130946269|NCT03336216|471437495|FG002|Randomization|Adverse Event|0|||
130946270|NCT03336216|471437496|FG003|Randomization|Adverse Event|0|||
130946271|NCT03336216|471437493|FG000|Treatment|Adverse Event|2|||
130946272|NCT03336216|471437494|FG001|Treatment|Adverse Event|3|||
130946273|NCT03336216|471437495|FG002|Treatment|Adverse Event|4|||
130946274|NCT03336216|471437496|FG003|Treatment|Adverse Event|4|||
130946275|NCT03336216|471437493|FG000|Treatment|Participant request to discontinue treatment|2|||
130946276|NCT03336216|471437494|FG001|Treatment|Participant request to discontinue treatment|1|||
130946277|NCT03336216|471437495|FG002|Treatment|Participant request to discontinue treatment|2|||
130946278|NCT03336216|471437496|FG003|Treatment|Participant request to discontinue treatment|2|||
130946279|NCT03336216|471437493|FG000|Treatment|Participant withdrew consent|7|||
130946280|NCT03336216|471437494|FG001|Treatment|Participant withdrew consent|2|||
130946281|NCT03336216|471437495|FG002|Treatment|Participant withdrew consent|3|||
130946282|NCT03336216|471437496|FG003|Treatment|Participant withdrew consent|2|||
130946283|NCT03336216|471437493|FG000|Treatment|Death|2|||
130946284|NCT03336216|471437494|FG001|Treatment|Death|3|||
130946285|NCT03336216|471437495|FG002|Treatment|Death|3|||
130946286|NCT03336216|471437496|FG003|Treatment|Death|4|||
130946287|NCT03336216|471437493|FG000|Treatment|Participant no longer meets study criteria|0|||
130946288|NCT03336216|471437494|FG001|Treatment|Participant no longer meets study criteria|1|||
130946289|NCT03336216|471437495|FG002|Treatment|Participant no longer meets study criteria|0|||
130946290|NCT03336216|471437496|FG003|Treatment|Participant no longer meets study criteria|0|||
130946291|NCT03336216|471437493|FG000|Treatment|Other reasons|2|||
130946292|NCT03336216|471437494|FG001|Treatment|Other reasons|0|||
130946293|NCT03336216|471437495|FG002|Treatment|Other reasons|0|||
130946294|NCT03336216|471437496|FG003|Treatment|Other reasons|3|||
130946295|NCT03336216|471437493|FG000|Treatment|Disease progression|23|||
130946296|NCT03336216|471437494|FG001|Treatment|Disease progression|34|||
130946297|NCT03336216|471437495|FG002|Treatment|Disease progression|33|||
130946298|NCT03336216|471437496|FG003|Treatment|Disease progression|26|||
130946299|NCT03336216|471437493|FG000|Treatment|Study drug toxicity|0|||
130946300|NCT03336216|471437494|FG001|Treatment|Study drug toxicity|3|||
130946301|NCT03336216|471437495|FG002|Treatment|Study drug toxicity|2|||
130946302|NCT03336216|471437496|FG003|Treatment|Study drug toxicity|0|||
130946303|NCT03336216|471437493|FG000|Treatment|Adverse Event unrelated to study drug|1|||
130946304|NCT03336216|471437494|FG001|Treatment|Adverse Event unrelated to study drug|1|||
130946305|NCT03336216|471437495|FG002|Treatment|Adverse Event unrelated to study drug|1|||
130946306|NCT03336216|471437496|FG003|Treatment|Adverse Event unrelated to study drug|0|||
130946307|NCT03336216|471437493|FG000|Treatment|Disease Recurrence|1|||
130946308|NCT03336216|471437494|FG001|Treatment|Disease Recurrence|0|||
130946309|NCT03336216|471437495|FG002|Treatment|Disease Recurrence|0|||
130946310|NCT03336216|471437496|FG003|Treatment|Disease Recurrence|0|||
130946311|NCT03239470|471437497|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
130946312|NCT03239470|471437498|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
130946313|NCT00922766|471437499|FG000|Overall Study|Death|3|||
131037284|NCT03848065|471770584|FG000|Overall Study|Lost to Follow-up|0|||
131037285|NCT03848065|471770585|FG001|Overall Study|Lost to Follow-up|0|||
131037286|NCT03848065|471770586|FG002|Overall Study|Lost to Follow-up|1|||
130946314|NCT00922766|471437499|FG000|Overall Study|Withdrawal by Subject|2|||
130946315|NCT00922766|471437499|FG000|Overall Study|Other|1|||
130946316|NCT00922766|471437499|FG000|Overall Study|Adverse Event|1|||
130946317|NCT01231581|471437502|FG000|Overall Study|Lost to Follow-up|2|||
130946318|NCT01231581|471437503|FG001|Overall Study|Lost to Follow-up|2|||
130946319|NCT01231581|471437502|FG000|Overall Study|Withdrawal by Subject|6|||
130946320|NCT01231581|471437503|FG001|Overall Study|Withdrawal by Subject|9|||
130946321|NCT01231581|471437502|FG000|Overall Study|Study Closed/Terminated|6|||
130946322|NCT01231581|471437503|FG001|Overall Study|Study Closed/Terminated|5|||
130946323|NCT01231581|471437502|FG000|Overall Study|Death|65|||
130946324|NCT01231581|471437503|FG001|Overall Study|Death|64|||
130946325|NCT01231581|471437502|FG000|Overall Study|Ongoing|1|||
130946326|NCT01231581|471437503|FG001|Overall Study|Ongoing|0|||
130946327|NCT03616912|471437504|FG000|Overall Study|Adverse Event|17|||
130946328|NCT03616912|471437505|FG001|Overall Study|Adverse Event|21|||
130946329|NCT03616912|471437506|FG002|Overall Study|Adverse Event|9|||
130946330|NCT03616912|471437507|FG003|Overall Study|Adverse Event|0|||
130946331|NCT03616912|471437508|FG004|Overall Study|Adverse Event|0|||
131124500|NCT01197521|472084459|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
131124501|NCT01197521|472084460|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
131124502|NCT01197521|472084461|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
130946332|NCT03616912|471437509|FG005|Overall Study|Adverse Event|0|||
130946333|NCT03616912|471437504|FG000|Overall Study|Death|1|||
130946334|NCT03616912|471437505|FG001|Overall Study|Death|1|||
130946335|NCT03616912|471437506|FG002|Overall Study|Death|0|||
130946336|NCT03616912|471437507|FG003|Overall Study|Death|0|||
130946337|NCT03616912|471437508|FG004|Overall Study|Death|0|||
130946338|NCT03616912|471437509|FG005|Overall Study|Death|0|||
130946339|NCT03616912|471437504|FG000|Overall Study|Lack of Efficacy|13|||
130946340|NCT03616912|471437505|FG001|Overall Study|Lack of Efficacy|6|||
130946341|NCT03616912|471437506|FG002|Overall Study|Lack of Efficacy|8|||
130946342|NCT03616912|471437507|FG003|Overall Study|Lack of Efficacy|4|||
130946343|NCT03616912|471437508|FG004|Overall Study|Lack of Efficacy|5|||
130946344|NCT03616912|471437509|FG005|Overall Study|Lack of Efficacy|1|||
130946345|NCT03616912|471437504|FG000|Overall Study|Lost to Follow-up|1|||
130946346|NCT03616912|471437505|FG001|Overall Study|Lost to Follow-up|2|||
130946347|NCT03616912|471437506|FG002|Overall Study|Lost to Follow-up|3|||
130946348|NCT03616912|471437507|FG003|Overall Study|Lost to Follow-up|0|||
130946349|NCT03616912|471437508|FG004|Overall Study|Lost to Follow-up|0|||
130946350|NCT03616912|471437509|FG005|Overall Study|Lost to Follow-up|0|||
130946351|NCT03616912|471437504|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
130946352|NCT03616912|471437505|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
130946353|NCT03616912|471437506|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
130946354|NCT03616912|471437507|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
130946355|NCT03616912|471437508|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
130946356|NCT03616912|471437509|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
130946357|NCT03616912|471437504|FG000|Overall Study|Withdrawal by Subject|12|||
130946358|NCT03616912|471437505|FG001|Overall Study|Withdrawal by Subject|12|||
130946359|NCT03616912|471437506|FG002|Overall Study|Withdrawal by Subject|15|||
130946360|NCT03616912|471437507|FG003|Overall Study|Withdrawal by Subject|2|||
130946361|NCT03616912|471437508|FG004|Overall Study|Withdrawal by Subject|0|||
130946362|NCT03616912|471437509|FG005|Overall Study|Withdrawal by Subject|2|||
130946363|NCT03616912|471437504|FG000|Overall Study|Study Terminated by Sponsor|0|||
130946364|NCT03616912|471437505|FG001|Overall Study|Study Terminated by Sponsor|0|||
130946365|NCT03616912|471437506|FG002|Overall Study|Study Terminated by Sponsor|0|||
130946366|NCT03616912|471437507|FG003|Overall Study|Study Terminated by Sponsor|10|||
130946367|NCT03616912|471437508|FG004|Overall Study|Study Terminated by Sponsor|9|||
130946368|NCT03616912|471437509|FG005|Overall Study|Study Terminated by Sponsor|11|||
130946369|NCT03616912|471437504|FG000|Overall Study|Protocol Deviation|1|||
130946370|NCT03616912|471437505|FG001|Overall Study|Protocol Deviation|1|||
130946371|NCT03616912|471437506|FG002|Overall Study|Protocol Deviation|0|||
130946372|NCT03616912|471437507|FG003|Overall Study|Protocol Deviation|0|||
130946373|NCT03616912|471437508|FG004|Overall Study|Protocol Deviation|0|||
130946374|NCT03616912|471437509|FG005|Overall Study|Protocol Deviation|0|||
130946375|NCT03616912|471437504|FG000|Overall Study|Pregnancy|1|||
130946376|NCT03616912|471437505|FG001|Overall Study|Pregnancy|0|||
130946377|NCT03616912|471437506|FG002|Overall Study|Pregnancy|4|||
130946378|NCT03616912|471437507|FG003|Overall Study|Pregnancy|0|||
130946379|NCT03616912|471437508|FG004|Overall Study|Pregnancy|0|||
130946380|NCT03616912|471437509|FG005|Overall Study|Pregnancy|0|||
130946381|NCT03616912|471437504|FG000|Overall Study|Protocol Violation|1|||
130946382|NCT03616912|471437505|FG001|Overall Study|Protocol Violation|0|||
130946383|NCT03616912|471437506|FG002|Overall Study|Protocol Violation|2|||
130946384|NCT03616912|471437507|FG003|Overall Study|Protocol Violation|0|||
131124503|NCT01197521|472084459|FG000|Overall Study|Lost to Follow-up|3|||
131124504|NCT01197521|472084460|FG001|Overall Study|Lost to Follow-up|2|||
130946385|NCT03616912|471437508|FG004|Overall Study|Protocol Violation|0|||
130946386|NCT03616912|471437509|FG005|Overall Study|Protocol Violation|0|||
130946387|NCT03616912|471437504|FG000|Overall Study|Physician Decision|2|||
130946388|NCT03616912|471437505|FG001|Overall Study|Physician Decision|0|||
130710361|NCT01010750|470564812|FG002|Second Intervention|Adverse Event|0|||
130710362|NCT01010750|470564813|FG003|Second Intervention|Adverse Event|0|||
130710363|NCT01010750|470564814|FG004|Second Intervention|Adverse Event|0|||
130946389|NCT03616912|471437506|FG002|Overall Study|Physician Decision|0|||
130946390|NCT03616912|471437507|FG003|Overall Study|Physician Decision|0|||
130946391|NCT03616912|471437508|FG004|Overall Study|Physician Decision|1|||
130946392|NCT03616912|471437509|FG005|Overall Study|Physician Decision|0|||
130946393|NCT03616912|471437504|FG000|Overall Study|Randomized But Never Treated|0|||
130946394|NCT03616912|471437505|FG001|Overall Study|Randomized But Never Treated|2|||
130946395|NCT03616912|471437506|FG002|Overall Study|Randomized But Never Treated|0|||
130946396|NCT03616912|471437507|FG003|Overall Study|Randomized But Never Treated|0|||
130946397|NCT03616912|471437508|FG004|Overall Study|Randomized But Never Treated|0|||
130946398|NCT03616912|471437509|FG005|Overall Study|Randomized But Never Treated|0|||
130946399|NCT02474199|471437513|FG000|Overall Study|Lost to Follow-up|1|||
130946400|NCT02474199|471437514|FG001|Overall Study|Lost to Follow-up|0|||
130946401|NCT02474199|471437515|FG002|Overall Study|Lost to Follow-up|0|||
130946402|NCT02474199|471437516|FG003|Overall Study|Lost to Follow-up|0|||
130946403|NCT02474199|471437513|FG000|Overall Study|Withdrawal by Subject|1|||
130946404|NCT02474199|471437514|FG001|Overall Study|Withdrawal by Subject|2|||
130946405|NCT02474199|471437515|FG002|Overall Study|Withdrawal by Subject|0|||
130946406|NCT02474199|471437516|FG003|Overall Study|Withdrawal by Subject|1|||
130946407|NCT02474199|471437513|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
130946408|NCT02474199|471437514|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
130946409|NCT02474199|471437515|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
130946410|NCT02474199|471437516|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
130946411|NCT02474199|471437513|FG000|Overall Study|Did not meet eligibility criteria|0|||
130946412|NCT02474199|471437514|FG001|Overall Study|Did not meet eligibility criteria|0|||
130946413|NCT02474199|471437515|FG002|Overall Study|Did not meet eligibility criteria|2|||
130946414|NCT02474199|471437516|FG003|Overall Study|Did not meet eligibility criteria|2|||
130946415|NCT03090100|471437517|FG000|Overall Study|Adverse Event|9|||
130946416|NCT03090100|471437518|FG001|Overall Study|Adverse Event|11|||
130946417|NCT03090100|471437517|FG000|Overall Study|Pregnancy|1|||
130946418|NCT03090100|471437518|FG001|Overall Study|Pregnancy|1|||
130946419|NCT03090100|471437517|FG000|Overall Study|Lack of Efficacy|2|||
130946420|NCT03090100|471437518|FG001|Overall Study|Lack of Efficacy|7|||
130946421|NCT03090100|471437517|FG000|Overall Study|Lost to Follow-up|2|||
130946422|NCT03090100|471437518|FG001|Overall Study|Lost to Follow-up|2|||
130946423|NCT03090100|471437517|FG000|Overall Study|Withdrawal by Subject|7|||
130946424|NCT03090100|471437518|FG001|Overall Study|Withdrawal by Subject|19|||
130946425|NCT03090100|471437517|FG000|Overall Study|Protocol Violation|2|||
130946426|NCT03090100|471437518|FG001|Overall Study|Protocol Violation|6|||
130946427|NCT03090100|471437517|FG000|Overall Study|Non-compliance|2|||
130946428|NCT03090100|471437518|FG001|Overall Study|Non-compliance|0|||
130946429|NCT03090100|471437517|FG000|Overall Study|Other|2|||
130946430|NCT03090100|471437518|FG001|Overall Study|Other|2|||
130946431|NCT01660711|471437519|FG000|Overall Study|Adverse Event|7|||
130946432|NCT01660711|471437519|FG000|Overall Study|Withdrawal by Subject|1|||
130946433|NCT03253848|471437521|FG000|Overall Study|Adverse Event|7|||
130946434|NCT03253848|471437521|FG000|Overall Study|Death|5|||
130946435|NCT03253848|471437521|FG000|Overall Study|initiation of other treatments|3|||
130946436|NCT03253848|471437521|FG000|Overall Study|Other complicating disease|1|||
130946437|NCT03253848|471437521|FG000|Overall Study|Withdrawal by Subject|1|||
130946438|NCT03253848|471437521|FG000|Overall Study|Declining health|1|||
130946439|NCT03056755|471437523|FG000|Treatment- Core Phase|Progressive disease|89|||
130946440|NCT03056755|471437524|FG001|Treatment- Core Phase|Progressive disease|88|||
130946441|NCT03056755|471437525|FG002|Treatment- Core Phase|Progressive disease|90|||
130946442|NCT03056755|471437523|FG000|Treatment- Core Phase|Adverse Event|20|||
130946443|NCT03056755|471437524|FG001|Treatment- Core Phase|Adverse Event|14|||
130946444|NCT03056755|471437525|FG002|Treatment- Core Phase|Adverse Event|13|||
130946445|NCT03056755|471437523|FG000|Treatment- Core Phase|Physician Decision|7|||
130946446|NCT03056755|471437524|FG001|Treatment- Core Phase|Physician Decision|13|||
130710364|NCT01010750|470564815|FG005|Second Intervention|Adverse Event|0|||
130710365|NCT03739138|470564817|FG000|Overall Study|Death|0|||
130946447|NCT03056755|471437525|FG002|Treatment- Core Phase|Physician Decision|5|||
130946448|NCT03056755|471437523|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
130946449|NCT03056755|471437524|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
130946450|NCT03056755|471437525|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
130946451|NCT03056755|471437523|FG000|Treatment- Core Phase|Death|3|||
130946452|NCT03056755|471437524|FG001|Treatment- Core Phase|Death|2|||
130946453|NCT03056755|471437525|FG002|Treatment- Core Phase|Death|4|||
130946454|NCT03056755|471437523|FG000|Treatment- Core Phase|Protocol deviation|1|||
130946455|NCT03056755|471437524|FG001|Treatment- Core Phase|Protocol deviation|1|||
130946456|NCT03056755|471437525|FG002|Treatment- Core Phase|Protocol deviation|0|||
130946457|NCT03056755|471437523|FG000|Treatment- Core Phase|Technical problems|1|||
130946458|NCT03056755|471437524|FG001|Treatment- Core Phase|Technical problems|0|||
130710366|NCT03739138|470564818|FG001|Overall Study|Death|7|||
130946459|NCT03056755|471437525|FG002|Treatment- Core Phase|Technical problems|0|||
130946460|NCT03056755|471437523|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
130946461|NCT03056755|471437524|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
130946462|NCT03056755|471437525|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
130946463|NCT03056755|471437523|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
130946464|NCT03056755|471437524|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
130946465|NCT03056755|471437525|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
130946466|NCT03056755|471437523|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
130946467|NCT03056755|471437524|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
130946468|NCT03056755|471437525|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
130946469|NCT03056755|471437523|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
130946470|NCT03056755|471437524|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
130946471|NCT03056755|471437525|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
130946472|NCT00278954|471437526|FG000|Overall Study|Adverse Event|3|||
130946473|NCT00278954|471437526|FG000|Overall Study|Lost to Follow-up|1|||
130946474|NCT00278954|471437526|FG000|Overall Study|Withdrawal by Subject|1|||
130946475|NCT03406858|471437527|FG000|Overall Study|Failure to receive treatment drug.|1|||
130946476|NCT03406858|471437527|FG000|Overall Study|ineligible|1|||
131225093|NCT01375010|472451949|FG001|Overall Study|Lost to Follow-up|2|||
131225094|NCT01375010|472451948|FG000|Overall Study|Withdrawal by Subject|4|||
130774045|NCT02137226|470798660|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
130774046|NCT02137226|470798661|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
130946477|NCT02419742|471437530|FG000|Overall Study|Adverse Event|2|||
130946478|NCT02419742|471437531|FG001|Overall Study|Adverse Event|0|||
130946479|NCT02419742|471437530|FG000|Overall Study|Disease Progression|0|||
130946480|NCT02419742|471437531|FG001|Overall Study|Disease Progression|1|||
130946481|NCT02419742|471437530|FG000|Overall Study|Withdrew Consent|2|||
130946482|NCT02419742|471437531|FG001|Overall Study|Withdrew Consent|1|||
130946483|NCT02419742|471437530|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
130946484|NCT02419742|471437531|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
130946485|NCT05071183|471437538|FG000|Overall Study|Death|1|||
130946486|NCT05071183|471437539|FG001|Overall Study|Death|2|||
130946487|NCT05071183|471437540|FG002|Overall Study|Death|0|||
130946488|NCT05071183|471437538|FG000|Overall Study|Other Reasons|1|||
130946489|NCT05071183|471437539|FG001|Overall Study|Other Reasons|3|||
130946490|NCT05071183|471437540|FG002|Overall Study|Other Reasons|2|||
130946491|NCT01251380|471437547|FG000|Overall Study|Other (Not otherwise specified)|12|||
130946492|NCT01251380|471437547|FG000|Overall Study|Withdrawal by Subject|6|||
130946493|NCT01251380|471437547|FG000|Overall Study|Lack of Efficacy|1|||
130946494|NCT01251380|471437547|FG000|Overall Study|Adverse Event|1|||
130946495|NCT01251380|471437547|FG000|Overall Study|Lost to Follow-up|2|||
130946496|NCT01154218|471437550|FG000|Third Intervention Period|Adverse Event|0|||
130946497|NCT01154218|471437551|FG001|Third Intervention Period|Adverse Event|1|||
130946498|NCT01154218|471437552|FG002|Third Intervention Period|Adverse Event|0|||
130946499|NCT01154218|471437553|FG003|Third Intervention Period|Adverse Event|0|||
130946500|NCT01154218|471437550|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130946501|NCT01154218|471437551|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130946502|NCT01154218|471437552|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130946503|NCT01154218|471437553|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
130946504|NCT01154218|471437550|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
130946505|NCT01154218|471437551|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
130946506|NCT01154218|471437552|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
130946507|NCT01154218|471437553|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
130946508|NCT00129129|471437554|FG000|Primary Phase|Adverse Event|2|||
130946509|NCT00129129|471437555|FG001|Primary Phase|Adverse Event|1|||
130946510|NCT00129129|471437556|FG002|Primary Phase|Adverse Event|0|||
130946511|NCT00129129|471437557|FG003|Primary Phase|Adverse Event|0|||
130946512|NCT00129129|471437558|FG004|Primary Phase|Adverse Event|0|||
130774047|NCT03148067|470798664|FG000|Overall Study|Lost to Follow-up|3|||
130774048|NCT03148067|470798664|FG000|Overall Study|Death|1|||
130774049|NCT05305989|470798669|FG000|Overall Study|Other|3|||
130774050|NCT05305989|470798670|FG001|Overall Study|Other|2|||
130774051|NCT05305989|470798671|FG002|Overall Study|Other|0|||
130774052|NCT05305989|470798669|FG000|Overall Study|Sponsor decision|2|||
130946513|NCT00129129|471437554|FG000|Primary Phase|Withdrawal by Subject|12|||
130946514|NCT00129129|471437555|FG001|Primary Phase|Withdrawal by Subject|10|||
130946515|NCT00129129|471437556|FG002|Primary Phase|Withdrawal by Subject|0|||
130946516|NCT00129129|471437557|FG003|Primary Phase|Withdrawal by Subject|0|||
130946517|NCT00129129|471437558|FG004|Primary Phase|Withdrawal by Subject|0|||
131037287|NCT03848065|471770584|FG000|Overall Study|Physician Decision|0|||
131037288|NCT03848065|471770585|FG001|Overall Study|Physician Decision|0|||
130774053|NCT05305989|470798670|FG001|Overall Study|Sponsor decision|1|||
130774054|NCT05305989|470798671|FG002|Overall Study|Sponsor decision|0|||
131124505|NCT01197521|472084461|FG002|Overall Study|Lost to Follow-up|2|||
131124506|NCT01197521|472084459|FG000|Overall Study|Adverse Event|25|||
131124507|NCT01197521|472084460|FG001|Overall Study|Adverse Event|28|||
131124508|NCT01197521|472084461|FG002|Overall Study|Adverse Event|24|||
131124509|NCT01517893|472084462|FG000|Overall Study|Withdrawal by Subject|3|||
131124510|NCT01517893|472084463|FG001|Overall Study|Withdrawal by Subject|0|||
131124511|NCT02285777|472084467|FG000|Overall Study|Withdrawal by Subject|1|||
131124512|NCT02285777|472084468|FG001|Overall Study|Withdrawal by Subject|1|||
131124513|NCT02285777|472084467|FG000|Overall Study|Lost to Follow-up|4|||
130946518|NCT00129129|471437554|FG000|Primary Phase|Migration from study area|1|||
130946519|NCT00129129|471437555|FG001|Primary Phase|Migration from study area|3|||
130946520|NCT00129129|471437556|FG002|Primary Phase|Migration from study area|0|||
130946521|NCT00129129|471437557|FG003|Primary Phase|Migration from study area|0|||
130946522|NCT00129129|471437558|FG004|Primary Phase|Migration from study area|0|||
130946523|NCT00129129|471437554|FG000|Primary Phase|Lost to Follow-up|8|||
130946524|NCT00129129|471437555|FG001|Primary Phase|Lost to Follow-up|6|||
130946525|NCT00129129|471437556|FG002|Primary Phase|Lost to Follow-up|0|||
130946526|NCT00129129|471437557|FG003|Primary Phase|Lost to Follow-up|0|||
130946527|NCT00129129|471437558|FG004|Primary Phase|Lost to Follow-up|0|||
130946528|NCT00129129|471437554|FG000|Primary Phase|Other|2|||
130946529|NCT00129129|471437555|FG001|Primary Phase|Other|5|||
130946530|NCT00129129|471437556|FG002|Primary Phase|Other|0|||
130946531|NCT00129129|471437557|FG003|Primary Phase|Other|0|||
130946532|NCT00129129|471437558|FG004|Primary Phase|Other|0|||
130946533|NCT00129129|471437554|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
130946534|NCT00129129|471437555|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
130946535|NCT00129129|471437556|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
130946536|NCT00129129|471437557|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
130946537|NCT00129129|471437558|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
130946538|NCT00129129|471437554|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
130946539|NCT00129129|471437555|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
130946540|NCT00129129|471437556|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
130946541|NCT00129129|471437557|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
130946542|NCT00129129|471437558|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
130946543|NCT00129129|471437554|FG000|Fourth Dose Phase|Migration from study area|0|||
130946544|NCT00129129|471437555|FG001|Fourth Dose Phase|Migration from study area|0|||
130946545|NCT00129129|471437556|FG002|Fourth Dose Phase|Migration from study area|0|||
130946546|NCT00129129|471437557|FG003|Fourth Dose Phase|Migration from study area|0|||
131037289|NCT03848065|471770586|FG002|Overall Study|Physician Decision|1|||
131037290|NCT03865498|471770593|FG000|Overall Study|Lack of Efficacy|12|||
131037291|NCT03865498|471770594|FG001|Overall Study|Lack of Efficacy|11|||
131037292|NCT03865498|471770593|FG000|Overall Study|Lost to Follow-up|125|||
131037293|NCT03865498|471770594|FG001|Overall Study|Lost to Follow-up|133|||
131037294|NCT03865498|471770593|FG000|Overall Study|Withdrawal by Subject|2|||
131037295|NCT03865498|471770594|FG001|Overall Study|Withdrawal by Subject|4|||
131124514|NCT02285777|472084468|FG001|Overall Study|Lost to Follow-up|2|||
131124515|NCT01431274|472084476|FG000|Overall Study|Adverse Event|51|||
131124516|NCT01431274|472084477|FG001|Overall Study|Adverse Event|37|||
131124517|NCT01431274|472084478|FG002|Overall Study|Adverse Event|43|||
131124518|NCT01431274|472084479|FG003|Overall Study|Adverse Event|30|||
131124519|NCT01431274|472084480|FG004|Overall Study|Adverse Event|37|||
131124520|NCT01431274|472084476|FG000|Overall Study|Consent withdrawn not due to AE|29|||
131124521|NCT01431274|472084477|FG001|Overall Study|Consent withdrawn not due to AE|20|||
131124522|NCT01431274|472084478|FG002|Overall Study|Consent withdrawn not due to AE|17|||
131124523|NCT01431274|472084479|FG003|Overall Study|Consent withdrawn not due to AE|20|||
131124524|NCT01431274|472084480|FG004|Overall Study|Consent withdrawn not due to AE|11|||
131124525|NCT01431274|472084476|FG000|Overall Study|Non compliant with protocol|5|||
131124526|NCT01431274|472084477|FG001|Overall Study|Non compliant with protocol|8|||
131124527|NCT01431274|472084478|FG002|Overall Study|Non compliant with protocol|4|||
131124528|NCT01431274|472084479|FG003|Overall Study|Non compliant with protocol|4|||
131037311|NCT05869383|471770600|FG000|Overall Study|Withdrawal by Subject|2|||
131037312|NCT05869383|471770601|FG001|Overall Study|Withdrawal by Subject|0|||
131037313|NCT04137367|471770604|FG000|Overall Study|Lost to Follow-up|8|||
131124529|NCT01431274|472084480|FG004|Overall Study|Non compliant with protocol|4|||
131124530|NCT01431274|472084476|FG000|Overall Study|Lost to Follow-up|6|||
131037314|NCT04137367|471770605|FG001|Overall Study|Lost to Follow-up|6|||
131124531|NCT01431274|472084477|FG001|Overall Study|Lost to Follow-up|7|||
130710367|NCT03739138|470564819|FG002|Overall Study|Death|4|||
130710368|NCT03739138|470564820|FG003|Overall Study|Death|13|||
130710369|NCT03739138|470564821|FG004|Overall Study|Death|0|||
130710370|NCT03739138|470564817|FG000|Overall Study|Lost to Follow-up|0|||
130710371|NCT03739138|470564818|FG001|Overall Study|Lost to Follow-up|0|||
130710372|NCT03739138|470564819|FG002|Overall Study|Lost to Follow-up|1|||
130710373|NCT03739138|470564820|FG003|Overall Study|Lost to Follow-up|0|||
131037315|NCT04137367|471770606|FG002|Overall Study|Lost to Follow-up|4|||
130710374|NCT03739138|470564821|FG004|Overall Study|Lost to Follow-up|0|||
131037316|NCT03907878|471770607|FG000|Treatment Period|Withdrawal by Subject|5|||
131124532|NCT01431274|472084478|FG002|Overall Study|Lost to Follow-up|1|||
131037317|NCT03907878|471770607|FG000|Treatment Period|Adverse Event|4|||
131037318|NCT03907878|471770607|FG000|Treatment Period|Lack of Efficacy|1|||
131037319|NCT03907878|471770607|FG000|Treatment Period|Protocol Violation|1|||
131037320|NCT03907878|471770607|FG000|Follow-up Period|Adverse Event|3|||
131037321|NCT03907878|471770607|FG000|Follow-up Period|Withdrawal by Subject|3|||
131037322|NCT04499924|471770608|FG000|Overall Study|Study termination by sponsor|4|||
131037323|NCT04499924|471770609|FG001|Overall Study|Study termination by sponsor|6|||
131037324|NCT04499924|471770608|FG000|Overall Study|Withdrawal by Subject|1|||
131037325|NCT04499924|471770609|FG001|Overall Study|Withdrawal by Subject|3|||
131037326|NCT05144009|471770610|FG000|Overall Study|Lost to Follow-up|0|||
131037327|NCT05144009|471770611|FG001|Overall Study|Lost to Follow-up|1|||
131037328|NCT05144009|471770610|FG000|Overall Study|Study Termination by the Sponsor|11|||
131037329|NCT05144009|471770611|FG001|Overall Study|Study Termination by the Sponsor|11|||
131037330|NCT05144009|471770610|FG000|Overall Study|Disease Progression|1|||
131037331|NCT05144009|471770611|FG001|Overall Study|Disease Progression|0|||
131037332|NCT05144009|471770610|FG000|Overall Study|Participant Decision|0|||
131037333|NCT05144009|471770611|FG001|Overall Study|Participant Decision|2|||
131037334|NCT05144009|471770610|FG000|Overall Study|Death|5|||
131037335|NCT05144009|471770611|FG001|Overall Study|Death|10|||
131037336|NCT03270501|471770616|FG000|Overall Study|Screen failure|6|||
131037337|NCT03270501|471770616|FG000|Overall Study|Lost to Follow-up|2|||
131037338|NCT03270501|471770616|FG000|Overall Study|Adverse Event|1|||
131037339|NCT01648023|471770617|FG000|Overall Study|Screen Fail Post Randomization|1|||
131037340|NCT01648023|471770618|FG001|Overall Study|Screen Fail Post Randomization|2|||
131037341|NCT04074759|471770626|FG000|Overall Study|Withdrawal by Subject|0|||
131037342|NCT04074759|471770627|FG001|Overall Study|Withdrawal by Subject|0|||
131037343|NCT04074759|471770628|FG002|Overall Study|Withdrawal by Subject|0|||
131037344|NCT04074759|471770629|FG003|Overall Study|Withdrawal by Subject|0|||
131037345|NCT04074759|471770630|FG004|Overall Study|Withdrawal by Subject|0|||
131037346|NCT04074759|471770631|FG005|Overall Study|Withdrawal by Subject|2|||
131037347|NCT04074759|471770632|FG006|Overall Study|Withdrawal by Subject|0|||
131037348|NCT04074759|471770633|FG007|Overall Study|Withdrawal by Subject|2|||
131037349|NCT04074759|471770634|FG008|Overall Study|Withdrawal by Subject|1|||
131037350|NCT04074759|471770635|FG009|Overall Study|Withdrawal by Subject|2|||
131037351|NCT04074759|471770636|FG010|Overall Study|Withdrawal by Subject|9|||
131037352|NCT04074759|471770637|FG011|Overall Study|Withdrawal by Subject|2|||
131037353|NCT04074759|471770638|FG012|Overall Study|Withdrawal by Subject|1|||
131037354|NCT04074759|471770639|FG013|Overall Study|Withdrawal by Subject|3|||
131037355|NCT04074759|471770640|FG014|Overall Study|Withdrawal by Subject|2|||
131037356|NCT04074759|471770641|FG015|Overall Study|Withdrawal by Subject|0|||
131037357|NCT04074759|471770642|FG016|Overall Study|Withdrawal by Subject|0|||
131037358|NCT04074759|471770643|FG017|Overall Study|Withdrawal by Subject|3|||
131037359|NCT04074759|471770644|FG018|Overall Study|Withdrawal by Subject|1|||
131037360|NCT04074759|471770626|FG000|Overall Study|Death|1|||
131037361|NCT04074759|471770627|FG001|Overall Study|Death|0|||
131037362|NCT04074759|471770628|FG002|Overall Study|Death|1|||
131037363|NCT04074759|471770629|FG003|Overall Study|Death|1|||
131037364|NCT04074759|471770630|FG004|Overall Study|Death|2|||
131037365|NCT04074759|471770631|FG005|Overall Study|Death|0|||
131037366|NCT04074759|471770632|FG006|Overall Study|Death|1|||
131037367|NCT04074759|471770633|FG007|Overall Study|Death|0|||
131037368|NCT04074759|471770634|FG008|Overall Study|Death|3|||
131037369|NCT04074759|471770635|FG009|Overall Study|Death|2|||
131037370|NCT04074759|471770636|FG010|Overall Study|Death|4|||
131037371|NCT04074759|471770637|FG011|Overall Study|Death|1|||
131037372|NCT04074759|471770638|FG012|Overall Study|Death|0|||
131037373|NCT04074759|471770639|FG013|Overall Study|Death|2|||
131037374|NCT04074759|471770640|FG014|Overall Study|Death|1|||
131037375|NCT04074759|471770641|FG015|Overall Study|Death|0|||
131037376|NCT04074759|471770642|FG016|Overall Study|Death|1|||
131037377|NCT04074759|471770643|FG017|Overall Study|Death|0|||
131037378|NCT04074759|471770644|FG018|Overall Study|Death|1|||
131037379|NCT04074759|471770626|FG000|Overall Study|Lost to Follow-up|0|||
131037380|NCT04074759|471770627|FG001|Overall Study|Lost to Follow-up|0|||
131037381|NCT04074759|471770628|FG002|Overall Study|Lost to Follow-up|0|||
131037382|NCT04074759|471770629|FG003|Overall Study|Lost to Follow-up|0|||
131037383|NCT04074759|471770630|FG004|Overall Study|Lost to Follow-up|0|||
131037384|NCT04074759|471770631|FG005|Overall Study|Lost to Follow-up|0|||
131037385|NCT04074759|471770632|FG006|Overall Study|Lost to Follow-up|0|||
131037386|NCT04074759|471770633|FG007|Overall Study|Lost to Follow-up|0|||
131037387|NCT04074759|471770634|FG008|Overall Study|Lost to Follow-up|0|||
131037388|NCT04074759|471770635|FG009|Overall Study|Lost to Follow-up|0|||
131037389|NCT04074759|471770636|FG010|Overall Study|Lost to Follow-up|1|||
131037390|NCT04074759|471770637|FG011|Overall Study|Lost to Follow-up|0|||
131037391|NCT04074759|471770638|FG012|Overall Study|Lost to Follow-up|0|||
131037392|NCT04074759|471770639|FG013|Overall Study|Lost to Follow-up|0|||
131037393|NCT04074759|471770640|FG014|Overall Study|Lost to Follow-up|0|||
131037394|NCT04074759|471770641|FG015|Overall Study|Lost to Follow-up|0|||
131037395|NCT04074759|471770642|FG016|Overall Study|Lost to Follow-up|1|||
131037396|NCT04074759|471770643|FG017|Overall Study|Lost to Follow-up|0|||
131037397|NCT04074759|471770644|FG018|Overall Study|Lost to Follow-up|1|||
131037398|NCT04074759|471770626|FG000|Overall Study|Other|0|||
131037399|NCT04074759|471770627|FG001|Overall Study|Other|1|||
131037400|NCT04074759|471770628|FG002|Overall Study|Other|1|||
131037401|NCT04074759|471770629|FG003|Overall Study|Other|0|||
131037402|NCT04074759|471770630|FG004|Overall Study|Other|2|||
130946547|NCT00129129|471437558|FG004|Fourth Dose Phase|Migration from study area|2|||
130946548|NCT00129129|471437554|FG000|Fourth Dose Phase|Other|0|||
130946549|NCT00129129|471437555|FG001|Fourth Dose Phase|Other|0|||
130946550|NCT00129129|471437556|FG002|Fourth Dose Phase|Other|0|||
130946551|NCT00129129|471437557|FG003|Fourth Dose Phase|Other|1|||
130946552|NCT00129129|471437558|FG004|Fourth Dose Phase|Other|1|||
130946553|NCT00129129|471437554|FG000|Fourth Dose Phase|Protocol Violation|0|||
130946554|NCT00129129|471437555|FG001|Fourth Dose Phase|Protocol Violation|0|||
130946555|NCT00129129|471437556|FG002|Fourth Dose Phase|Protocol Violation|0|||
130946556|NCT00129129|471437557|FG003|Fourth Dose Phase|Protocol Violation|1|||
130946557|NCT00129129|471437558|FG004|Fourth Dose Phase|Protocol Violation|0|||
130946558|NCT02140567|471437561|FG000|Overall Study|Problems with recording equipment|6|||
130946559|NCT02882854|471437562|FG000|Overall Study|Lost to Follow-up|1|||
130946560|NCT02882854|471437563|FG001|Overall Study|Lost to Follow-up|2|||
130946561|NCT02882854|471437562|FG000|Overall Study|Physician Decision|0|||
130946562|NCT02882854|471437563|FG001|Overall Study|Physician Decision|1|||
130946563|NCT03774433|471437569|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
130946564|NCT00108160|471437570|FG000|Overall Study|Lost to Follow-up|25|||
130946565|NCT00108160|471437571|FG001|Overall Study|Lost to Follow-up|12|||
130946566|NCT00108160|471437570|FG000|Overall Study|Death|1|||
130946567|NCT00108160|471437571|FG001|Overall Study|Death|2|||
130946568|NCT00108160|471437570|FG000|Overall Study|Withdrawal by Subject|4|||
131037403|NCT04074759|471770631|FG005|Overall Study|Other|1|||
131037404|NCT04074759|471770632|FG006|Overall Study|Other|2|||
131037405|NCT04074759|471770633|FG007|Overall Study|Other|1|||
131037406|NCT04074759|471770634|FG008|Overall Study|Other|1|||
131037407|NCT04074759|471770635|FG009|Overall Study|Other|4|||
131037408|NCT04074759|471770636|FG010|Overall Study|Other|4|||
130774055|NCT05305989|470798669|FG000|Overall Study|Protocol Violation|0|||
130774056|NCT05305989|470798670|FG001|Overall Study|Protocol Violation|1|||
130774057|NCT05305989|470798671|FG002|Overall Study|Protocol Violation|0|||
130774058|NCT05305989|470798669|FG000|Overall Study|Investigator decision|1|||
131037409|NCT04074759|471770637|FG011|Overall Study|Other|2|||
131037410|NCT04074759|471770638|FG012|Overall Study|Other|0|||
131037411|NCT04074759|471770639|FG013|Overall Study|Other|0|||
131037412|NCT04074759|471770640|FG014|Overall Study|Other|0|||
131037413|NCT04074759|471770641|FG015|Overall Study|Other|1|||
131037414|NCT04074759|471770642|FG016|Overall Study|Other|0|||
131037415|NCT04074759|471770643|FG017|Overall Study|Other|0|||
131037416|NCT04074759|471770644|FG018|Overall Study|Other|0|||
131037417|NCT04074759|471770626|FG000|Overall Study|Missing end of study status|0|||
131037418|NCT04074759|471770627|FG001|Overall Study|Missing end of study status|0|||
131037419|NCT04074759|471770628|FG002|Overall Study|Missing end of study status|0|||
131037420|NCT04074759|471770629|FG003|Overall Study|Missing end of study status|0|||
130774059|NCT05305989|470798670|FG001|Overall Study|Investigator decision|2|||
130774060|NCT05305989|470798671|FG002|Overall Study|Investigator decision|0|||
130946569|NCT00108160|471437571|FG001|Overall Study|Withdrawal by Subject|2|||
130946570|NCT00108160|471437570|FG000|Overall Study|Protocol Violation|9|||
130946571|NCT00108160|471437571|FG001|Overall Study|Protocol Violation|5|||
130946572|NCT03082599|471437578|FG000|Overall Study|Lost to Follow-up|1|||
130946573|NCT03082599|471437579|FG001|Overall Study|Lost to Follow-up|0|||
130946574|NCT00578942|471437581|FG000|Overall Study|Lost to Follow-up|1|||
131037421|NCT04074759|471770630|FG004|Overall Study|Missing end of study status|0|||
131037422|NCT04074759|471770631|FG005|Overall Study|Missing end of study status|0|||
131037423|NCT04074759|471770632|FG006|Overall Study|Missing end of study status|0|||
131037424|NCT04074759|471770633|FG007|Overall Study|Missing end of study status|0|||
131037425|NCT04074759|471770634|FG008|Overall Study|Missing end of study status|0|||
131037426|NCT04074759|471770635|FG009|Overall Study|Missing end of study status|0|||
131037427|NCT04074759|471770636|FG010|Overall Study|Missing end of study status|2|||
131037428|NCT04074759|471770637|FG011|Overall Study|Missing end of study status|0|||
131037429|NCT04074759|471770638|FG012|Overall Study|Missing end of study status|0|||
131037430|NCT04074759|471770639|FG013|Overall Study|Missing end of study status|0|||
131037431|NCT04074759|471770640|FG014|Overall Study|Missing end of study status|0|||
131037432|NCT04074759|471770641|FG015|Overall Study|Missing end of study status|0|||
131037433|NCT04074759|471770642|FG016|Overall Study|Missing end of study status|1|||
131037434|NCT04074759|471770643|FG017|Overall Study|Missing end of study status|0|||
131037435|NCT04074759|471770644|FG018|Overall Study|Missing end of study status|0|||
131037436|NCT02231164|471770645|FG000|Overall Study|Adverse Event|1|||
131037437|NCT02231164|471770646|FG001|Overall Study|Adverse Event|1|||
131037438|NCT02231164|471770645|FG000|Overall Study|Lack of Efficacy|4|||
131037439|NCT02231164|471770646|FG001|Overall Study|Lack of Efficacy|3|||
131037440|NCT02231164|471770645|FG000|Overall Study|Withdrawal by Subject|1|||
131037441|NCT02231164|471770646|FG001|Overall Study|Withdrawal by Subject|2|||
131037442|NCT02547363|471770647|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
130710375|NCT03739138|470564817|FG000|Overall Study|Study Terminated By Sponsor|0|||
130710376|NCT03739138|470564818|FG001|Overall Study|Study Terminated By Sponsor|0|||
130946575|NCT00600938|471437582|FG000|Core Study|Abnormal test procedure result(s)|3|||
130946576|NCT00600938|471437583|FG001|Core Study|Abnormal test procedure result(s)|2|||
130946577|NCT00600938|471437584|FG002|Core Study|Abnormal test procedure result(s)|0|||
130946578|NCT00600938|471437585|FG003|Core Study|Abnormal test procedure result(s)|0|||
130946579|NCT00600938|471437582|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
130946580|NCT00600938|471437583|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
130946581|NCT00600938|471437584|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
130946582|NCT00600938|471437585|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
130946583|NCT00600938|471437582|FG000|Core Study|Patient withdrew consent|7|||
130946584|NCT00600938|471437583|FG001|Core Study|Patient withdrew consent|12|||
130946585|NCT00600938|471437584|FG002|Core Study|Patient withdrew consent|0|||
130946586|NCT00600938|471437585|FG003|Core Study|Patient withdrew consent|0|||
130946587|NCT00600938|471437582|FG000|Core Study|Lost to Follow-up|3|||
130946588|NCT00600938|471437583|FG001|Core Study|Lost to Follow-up|2|||
130946589|NCT00600938|471437584|FG002|Core Study|Lost to Follow-up|0|||
130946590|NCT00600938|471437585|FG003|Core Study|Lost to Follow-up|0|||
130946591|NCT00600938|471437582|FG000|Core Study|Death|1|||
130946592|NCT00600938|471437583|FG001|Core Study|Death|1|||
130946593|NCT00600938|471437584|FG002|Core Study|Death|0|||
130946594|NCT00600938|471437585|FG003|Core Study|Death|0|||
130946595|NCT00600938|471437582|FG000|Core Study|Protocol Violation|1|||
130946596|NCT00600938|471437583|FG001|Core Study|Protocol Violation|2|||
130946597|NCT00600938|471437584|FG002|Core Study|Protocol Violation|0|||
130946598|NCT00600938|471437585|FG003|Core Study|Protocol Violation|0|||
130946599|NCT00600938|471437582|FG000|Extension Study|Adverse Event|1|||
130946600|NCT00600938|471437583|FG001|Extension Study|Adverse Event|0|||
130946601|NCT00600938|471437584|FG002|Extension Study|Adverse Event|2|||
130946602|NCT00600938|471437585|FG003|Extension Study|Adverse Event|0|||
130710377|NCT03739138|470564819|FG002|Overall Study|Study Terminated By Sponsor|0|||
130710378|NCT03739138|470564820|FG003|Overall Study|Study Terminated By Sponsor|4|||
130946603|NCT00600938|471437582|FG000|Extension Study|Abnormal test procedure results|0|||
130946604|NCT00600938|471437583|FG001|Extension Study|Abnormal test procedure results|1|||
130946605|NCT00600938|471437584|FG002|Extension Study|Abnormal test procedure results|1|||
130946606|NCT00600938|471437585|FG003|Extension Study|Abnormal test procedure results|1|||
130946607|NCT00600938|471437582|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
130946608|NCT00600938|471437583|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
130946609|NCT00600938|471437584|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
130946610|NCT00600938|471437585|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
130946611|NCT00600938|471437582|FG000|Extension Study|Withdrawal by Subject|2|||
130946612|NCT00600938|471437583|FG001|Extension Study|Withdrawal by Subject|2|||
130946613|NCT00600938|471437584|FG002|Extension Study|Withdrawal by Subject|3|||
130946614|NCT00600938|471437585|FG003|Extension Study|Withdrawal by Subject|0|||
130946615|NCT00600938|471437582|FG000|Extension Study|Lost to Follow-up|1|||
130946616|NCT00600938|471437583|FG001|Extension Study|Lost to Follow-up|1|||
130946617|NCT00600938|471437584|FG002|Extension Study|Lost to Follow-up|2|||
130946618|NCT00600938|471437585|FG003|Extension Study|Lost to Follow-up|0|||
130946619|NCT00600938|471437582|FG000|Extension Study|Death|1|||
130946620|NCT00600938|471437583|FG001|Extension Study|Death|0|||
130946621|NCT00600938|471437584|FG002|Extension Study|Death|0|||
130946622|NCT00600938|471437585|FG003|Extension Study|Death|0|||
130946623|NCT04056195|471437586|FG000|Overall Study|Adverse Event|1|||
130946624|NCT04056195|471437587|FG001|Overall Study|Adverse Event|0|||
130946625|NCT04056195|471437588|FG002|Overall Study|Adverse Event|0|||
130946626|NCT04056195|471437586|FG000|Overall Study|Withdrawal by Subject|0|||
130946627|NCT04056195|471437587|FG001|Overall Study|Withdrawal by Subject|1|||
130946628|NCT04056195|471437588|FG002|Overall Study|Withdrawal by Subject|1|||
130946629|NCT04056195|471437586|FG000|Overall Study|Physician Decision|1|||
130946630|NCT04056195|471437587|FG001|Overall Study|Physician Decision|1|||
130946631|NCT04056195|471437588|FG002|Overall Study|Physician Decision|1|||
130946632|NCT00549562|471437589|FG000|Overall Study|Adverse Event|1|||
130946633|NCT00549562|471437589|FG000|Overall Study|Lack of Efficacy|1|||
130946634|NCT00323115|471437590|FG000|Vaccine Administration|Adverse Event|1|||
130946635|NCT00323115|471437590|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
130946636|NCT00004888|471439834|FG000|Overall Study|Adverse Event|5|||
130946637|NCT00004888|471439835|FG001|Overall Study|Adverse Event|10|||
130946638|NCT00004888|471439834|FG000|Overall Study|Withdrawal by Subject|0|||
130946639|NCT00004888|471439835|FG001|Overall Study|Withdrawal by Subject|3|||
130946640|NCT00004888|471439834|FG000|Overall Study|Physician Decision|1|||
130946641|NCT00004888|471439835|FG001|Overall Study|Physician Decision|1|||
130946642|NCT00004888|471439834|FG000|Overall Study|Progressive Disease|4|||
130946643|NCT00004888|471439835|FG001|Overall Study|Progressive Disease|9|||
130946644|NCT00004888|471439834|FG000|Overall Study|Death without progressive disease|0|||
130710379|NCT03739138|470564821|FG004|Overall Study|Study Terminated By Sponsor|0|||
130710380|NCT03739138|470564817|FG000|Overall Study|Withdrawal by Subject|0|||
131045852|NCT03582033|471802279|FG001|Part D|Death|0|||
130774061|NCT05305989|470798669|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
130946645|NCT00004888|471439835|FG001|Overall Study|Death without progressive disease|1|||
130946646|NCT00004888|471439834|FG000|Overall Study|Toxic death|1|||
130946647|NCT00004888|471439835|FG001|Overall Study|Toxic death|0|||
130946648|NCT02579265|471439836|FG000|Overall Study|Weaned off earlier than 28 days|44|||
130946649|NCT02579265|471439837|FG001|Overall Study|Weaned off earlier than 28 days|43|||
130946650|NCT02579265|471439836|FG000|Overall Study|Adverse Event|2|||
130946651|NCT02579265|471439837|FG001|Overall Study|Adverse Event|0|||
130946652|NCT02579265|471439836|FG000|Overall Study|Any other reason not specified|0|||
130946653|NCT02579265|471439837|FG001|Overall Study|Any other reason not specified|2|||
130946654|NCT02579265|471439836|FG000|Overall Study|Withdrawal by Subject|2|||
130946655|NCT02579265|471439837|FG001|Overall Study|Withdrawal by Subject|0|||
130946656|NCT02579265|471439836|FG000|Overall Study|Physician Decision|1|||
130946657|NCT02579265|471439837|FG001|Overall Study|Physician Decision|0|||
130946658|NCT02579265|471439836|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
130946659|NCT02579265|471439837|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
130946660|NCT02174848|471439838|FG000|Overall Study|Adverse Event|2|||
130946661|NCT02174848|471439839|FG001|Overall Study|Adverse Event|1|||
130946662|NCT02174848|471439838|FG000|Overall Study|Withdrawal by Subject|3|||
130946663|NCT02174848|471439839|FG001|Overall Study|Withdrawal by Subject|3|||
130946664|NCT02174848|471439838|FG000|Overall Study|Lost to Follow-up|0|||
130946665|NCT02174848|471439839|FG001|Overall Study|Lost to Follow-up|1|||
130946666|NCT02174848|471439838|FG000|Overall Study|Worsening of disease|1|||
130946667|NCT02174848|471439839|FG001|Overall Study|Worsening of disease|1|||
130946668|NCT02174848|471439838|FG000|Overall Study|Unable to comply with study requirements|1|||
130946669|NCT02174848|471439839|FG001|Overall Study|Unable to comply with study requirements|0|||
130946670|NCT00666757|471439842|FG000|Overall Study|Lost to Follow-up|39|||
130946671|NCT00666757|471439843|FG001|Overall Study|Lost to Follow-up|35|||
130946672|NCT00666757|471439842|FG000|Overall Study|Protocol Violation|23|||
130946673|NCT00666757|471439843|FG001|Overall Study|Protocol Violation|24|||
130946674|NCT00666757|471439842|FG000|Overall Study|Adverse Event|22|||
130946675|NCT00666757|471439843|FG001|Overall Study|Adverse Event|12|||
130946676|NCT00666757|471439842|FG000|Overall Study|Withdrawal by Subject|13|||
130946677|NCT00666757|471439843|FG001|Overall Study|Withdrawal by Subject|17|||
130946678|NCT00666757|471439842|FG000|Overall Study|Lack of Efficacy|3|||
130946679|NCT00666757|471439843|FG001|Overall Study|Lack of Efficacy|6|||
130946680|NCT00666757|471439842|FG000|Overall Study|Physician Decision|0|||
130946681|NCT00666757|471439843|FG001|Overall Study|Physician Decision|2|||
130946682|NCT00666757|471439842|FG000|Overall Study|Sponsor decision|0|||
130946683|NCT00666757|471439843|FG001|Overall Study|Sponsor decision|1|||
130946684|NCT02658890|471439848|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946685|NCT02658890|471439849|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946686|NCT02658890|471439850|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946687|NCT02658890|471439851|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946688|NCT02658890|471439852|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946689|NCT02658890|471439853|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946690|NCT02658890|471439854|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946691|NCT02658890|471439855|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946692|NCT02658890|471439856|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
130946693|NCT02658890|471439857|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946694|NCT02658890|471439858|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946695|NCT02658890|471439859|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946696|NCT02658890|471439860|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946697|NCT02658890|471439861|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946698|NCT02658890|471439862|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946699|NCT02658890|471439863|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946700|NCT02658890|471439864|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946701|NCT02658890|471439865|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946702|NCT02658890|471439866|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946703|NCT02658890|471439867|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946704|NCT02658890|471439868|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946705|NCT02658890|471439869|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946706|NCT02658890|471439870|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946707|NCT02658890|471439871|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946708|NCT02658890|471439872|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946709|NCT02658890|471439873|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946710|NCT02658890|471439874|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946711|NCT02658890|471439848|FG000|Treatment Phase|Adverse Event|0|||
130946712|NCT02658890|471439849|FG001|Treatment Phase|Adverse Event|1|||
130946713|NCT02658890|471439850|FG002|Treatment Phase|Adverse Event|2|||
130946714|NCT02658890|471439851|FG003|Treatment Phase|Adverse Event|2|||
130946715|NCT02658890|471439852|FG004|Treatment Phase|Adverse Event|1|||
130946716|NCT02658890|471439853|FG005|Treatment Phase|Adverse Event|0|||
130946717|NCT02658890|471439854|FG006|Treatment Phase|Adverse Event|0|||
130946718|NCT02658890|471439855|FG007|Treatment Phase|Adverse Event|2|||
130946719|NCT02658890|471439856|FG008|Treatment Phase|Adverse Event|1|||
130946720|NCT02658890|471439857|FG009|Treatment Phase|Adverse Event|2|||
130946721|NCT02658890|471439858|FG010|Treatment Phase|Adverse Event|3|||
130946722|NCT02658890|471439859|FG011|Treatment Phase|Adverse Event|0|||
130946723|NCT02658890|471439860|FG012|Treatment Phase|Adverse Event|1|||
130946724|NCT02658890|471439861|FG013|Treatment Phase|Adverse Event|4|||
130946725|NCT02658890|471439862|FG014|Treatment Phase|Adverse Event|0|||
130946726|NCT02658890|471439863|FG015|Treatment Phase|Adverse Event|0|||
130946727|NCT02658890|471439864|FG016|Treatment Phase|Adverse Event|0|||
130946728|NCT02658890|471439865|FG017|Treatment Phase|Adverse Event|0|||
130946729|NCT02658890|471439866|FG018|Treatment Phase|Adverse Event|5|||
130946730|NCT02658890|471439867|FG019|Treatment Phase|Adverse Event|1|||
130946731|NCT02658890|471439868|FG020|Treatment Phase|Adverse Event|3|||
130946732|NCT02658890|471439869|FG021|Treatment Phase|Adverse Event|0|||
130946733|NCT02658890|471439870|FG022|Treatment Phase|Adverse Event|5|||
130946734|NCT02658890|471439871|FG023|Treatment Phase|Adverse Event|0|||
130946735|NCT02658890|471439872|FG024|Treatment Phase|Adverse Event|0|||
130946736|NCT02658890|471439873|FG025|Treatment Phase|Adverse Event|2|||
130946737|NCT02658890|471439874|FG026|Treatment Phase|Adverse Event|1|||
130946738|NCT02658890|471439848|FG000|Treatment Phase|Death|0|||
130946739|NCT02658890|471439849|FG001|Treatment Phase|Death|0|||
130946740|NCT02658890|471439850|FG002|Treatment Phase|Death|0|||
130946741|NCT02658890|471439851|FG003|Treatment Phase|Death|0|||
130946742|NCT02658890|471439852|FG004|Treatment Phase|Death|0|||
130946743|NCT02658890|471439853|FG005|Treatment Phase|Death|0|||
130946744|NCT02658890|471439854|FG006|Treatment Phase|Death|0|||
130946745|NCT02658890|471439855|FG007|Treatment Phase|Death|0|||
130946746|NCT02658890|471439856|FG008|Treatment Phase|Death|0|||
130946747|NCT02658890|471439857|FG009|Treatment Phase|Death|0|||
130946748|NCT02658890|471439858|FG010|Treatment Phase|Death|0|||
130946749|NCT02658890|471439859|FG011|Treatment Phase|Death|0|||
130946750|NCT02658890|471439860|FG012|Treatment Phase|Death|0|||
130946751|NCT02658890|471439861|FG013|Treatment Phase|Death|0|||
130946752|NCT02658890|471439862|FG014|Treatment Phase|Death|0|||
130946753|NCT02658890|471439863|FG015|Treatment Phase|Death|0|||
130946754|NCT02658890|471439864|FG016|Treatment Phase|Death|0|||
130946755|NCT02658890|471439865|FG017|Treatment Phase|Death|0|||
130946756|NCT02658890|471439866|FG018|Treatment Phase|Death|1|||
130946757|NCT02658890|471439867|FG019|Treatment Phase|Death|0|||
130946758|NCT02658890|471439868|FG020|Treatment Phase|Death|0|||
130946759|NCT02658890|471439869|FG021|Treatment Phase|Death|0|||
130946760|NCT02658890|471439870|FG022|Treatment Phase|Death|0|||
130946761|NCT02658890|471439871|FG023|Treatment Phase|Death|0|||
130946762|NCT02658890|471439872|FG024|Treatment Phase|Death|0|||
130946763|NCT02658890|471439873|FG025|Treatment Phase|Death|0|||
130946764|NCT02658890|471439874|FG026|Treatment Phase|Death|0|||
130946765|NCT02658890|471439848|FG000|Treatment Phase|Lost to Follow-up|0|||
130946766|NCT02658890|471439849|FG001|Treatment Phase|Lost to Follow-up|0|||
131037443|NCT02547363|471770648|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
131037444|NCT02547363|471770647|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
131037445|NCT02547363|471770648|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
131037446|NCT02547363|471770647|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
131037447|NCT02547363|471770648|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
131037448|NCT02547363|471770647|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
131037449|NCT02547363|471770648|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
131037450|NCT02547363|471770647|FG000|12-month Follow-up|Withdrawal by Subject|4|||
131037451|NCT02547363|471770648|FG001|12-month Follow-up|Withdrawal by Subject|3|||
130946767|NCT02658890|471439850|FG002|Treatment Phase|Lost to Follow-up|0|||
130946768|NCT02658890|471439851|FG003|Treatment Phase|Lost to Follow-up|0|||
130946769|NCT02658890|471439852|FG004|Treatment Phase|Lost to Follow-up|0|||
130946770|NCT02658890|471439853|FG005|Treatment Phase|Lost to Follow-up|0|||
130946771|NCT02658890|471439854|FG006|Treatment Phase|Lost to Follow-up|1|||
131124533|NCT01431274|472084479|FG003|Overall Study|Lost to Follow-up|4|||
130946772|NCT02658890|471439855|FG007|Treatment Phase|Lost to Follow-up|0|||
130946773|NCT02658890|471439856|FG008|Treatment Phase|Lost to Follow-up|0|||
130946774|NCT02658890|471439857|FG009|Treatment Phase|Lost to Follow-up|0|||
130946775|NCT02658890|471439858|FG010|Treatment Phase|Lost to Follow-up|0|||
130946776|NCT02658890|471439859|FG011|Treatment Phase|Lost to Follow-up|0|||
130946777|NCT02658890|471439860|FG012|Treatment Phase|Lost to Follow-up|0|||
130946778|NCT02658890|471439861|FG013|Treatment Phase|Lost to Follow-up|0|||
130946779|NCT02658890|471439862|FG014|Treatment Phase|Lost to Follow-up|0|||
130946780|NCT02658890|471439863|FG015|Treatment Phase|Lost to Follow-up|0|||
130946781|NCT02658890|471439864|FG016|Treatment Phase|Lost to Follow-up|0|||
130946782|NCT02658890|471439865|FG017|Treatment Phase|Lost to Follow-up|0|||
130946783|NCT02658890|471439866|FG018|Treatment Phase|Lost to Follow-up|0|||
130946784|NCT02658890|471439867|FG019|Treatment Phase|Lost to Follow-up|0|||
130946785|NCT02658890|471439868|FG020|Treatment Phase|Lost to Follow-up|0|||
130946786|NCT02658890|471439869|FG021|Treatment Phase|Lost to Follow-up|0|||
130946787|NCT02658890|471439870|FG022|Treatment Phase|Lost to Follow-up|0|||
130946788|NCT02658890|471439871|FG023|Treatment Phase|Lost to Follow-up|0|||
130946789|NCT02658890|471439872|FG024|Treatment Phase|Lost to Follow-up|0|||
130946790|NCT02658890|471439873|FG025|Treatment Phase|Lost to Follow-up|0|||
130946791|NCT02658890|471439874|FG026|Treatment Phase|Lost to Follow-up|0|||
130946792|NCT02658890|471439848|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
130946793|NCT02658890|471439849|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
130946794|NCT02658890|471439850|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
130946795|NCT02658890|471439851|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
130946796|NCT02658890|471439852|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
130946797|NCT02658890|471439853|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
130946798|NCT02658890|471439854|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
130946799|NCT02658890|471439855|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
130946800|NCT02658890|471439856|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
130946801|NCT02658890|471439857|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
130946802|NCT02658890|471439858|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
130946803|NCT02658890|471439859|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
130946804|NCT02658890|471439860|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
130946805|NCT02658890|471439861|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
130946806|NCT02658890|471439862|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
130946807|NCT02658890|471439863|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
130946808|NCT02658890|471439864|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
130946809|NCT02658890|471439865|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
130946810|NCT02658890|471439866|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
130946811|NCT02658890|471439867|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
130946812|NCT02658890|471439868|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
130946813|NCT02658890|471439869|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
130946814|NCT02658890|471439870|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
130946815|NCT02658890|471439871|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
130946816|NCT02658890|471439872|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
130946817|NCT02658890|471439873|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
130946818|NCT02658890|471439874|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
130946819|NCT02658890|471439848|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
130946820|NCT02658890|471439849|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
130946821|NCT02658890|471439850|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
130946822|NCT02658890|471439851|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
130946823|NCT02658890|471439852|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
130946824|NCT02658890|471439853|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
130946825|NCT02658890|471439854|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
130946826|NCT02658890|471439855|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
130946827|NCT02658890|471439856|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
130946828|NCT02658890|471439857|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
130946829|NCT02658890|471439858|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
130946830|NCT02658890|471439859|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
130946831|NCT02658890|471439860|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
130946832|NCT02658890|471439861|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
130946833|NCT02658890|471439862|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
130946834|NCT02658890|471439863|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
130946835|NCT02658890|471439864|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
130946836|NCT02658890|471439865|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
130946837|NCT02658890|471439866|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
130946838|NCT02658890|471439867|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
130946839|NCT02658890|471439868|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
130946840|NCT02658890|471439869|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
130946841|NCT02658890|471439870|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
130946842|NCT02658890|471439871|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
130946843|NCT02658890|471439872|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
130946844|NCT02658890|471439873|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
130946845|NCT02658890|471439874|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
130946846|NCT02658890|471439848|FG000|Treatment Phase|Other Reasons|0|||
130946847|NCT02658890|471439849|FG001|Treatment Phase|Other Reasons|0|||
130946848|NCT02658890|471439850|FG002|Treatment Phase|Other Reasons|0|||
130946849|NCT02658890|471439851|FG003|Treatment Phase|Other Reasons|0|||
130946850|NCT02658890|471439852|FG004|Treatment Phase|Other Reasons|0|||
130946851|NCT02658890|471439853|FG005|Treatment Phase|Other Reasons|0|||
130946852|NCT02658890|471439854|FG006|Treatment Phase|Other Reasons|1|||
130946853|NCT02658890|471439855|FG007|Treatment Phase|Other Reasons|0|||
130946854|NCT02658890|471439856|FG008|Treatment Phase|Other Reasons|1|||
130946855|NCT02658890|471439857|FG009|Treatment Phase|Other Reasons|0|||
130946856|NCT02658890|471439858|FG010|Treatment Phase|Other Reasons|0|||
130946857|NCT02658890|471439859|FG011|Treatment Phase|Other Reasons|0|||
130946858|NCT02658890|471439860|FG012|Treatment Phase|Other Reasons|0|||
130946859|NCT02658890|471439861|FG013|Treatment Phase|Other Reasons|2|||
130946860|NCT02658890|471439862|FG014|Treatment Phase|Other Reasons|0|||
130946861|NCT02658890|471439863|FG015|Treatment Phase|Other Reasons|0|||
130946862|NCT02658890|471439864|FG016|Treatment Phase|Other Reasons|0|||
130946863|NCT02658890|471439865|FG017|Treatment Phase|Other Reasons|0|||
130946864|NCT02658890|471439866|FG018|Treatment Phase|Other Reasons|1|||
130774062|NCT05305989|470798670|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
130774063|NCT05305989|470798671|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
130774064|NCT05305989|470798669|FG000|Overall Study|Adverse Event|1|||
130774065|NCT05305989|470798670|FG001|Overall Study|Adverse Event|1|||
130774066|NCT05305989|470798671|FG002|Overall Study|Adverse Event|0|||
130774067|NCT05305989|470798669|FG000|Overall Study|Enrolled but never dosed|3|||
130774068|NCT05305989|470798670|FG001|Overall Study|Enrolled but never dosed|2|||
130774069|NCT05305989|470798671|FG002|Overall Study|Enrolled but never dosed|1|||
130774070|NCT03162328|470798672|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
130774071|NCT03162328|470798673|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
130774072|NCT03162328|470798674|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
130774073|NCT03162328|470798672|FG000|Screening Period|Withdrawal by Subject|1|||
130774074|NCT03162328|470798673|FG001|Screening Period|Withdrawal by Subject|0|||
130774075|NCT03162328|470798674|FG002|Screening Period|Withdrawal by Subject|0|||
130774076|NCT03162328|470798672|FG000|Study Period|Withdrawal by Subject|0|||
130774077|NCT03162328|470798673|FG001|Study Period|Withdrawal by Subject|0|||
130774078|NCT03162328|470798674|FG002|Study Period|Withdrawal by Subject|1|||
130774079|NCT00792116|470798675|FG000|Overall Study|Lost to Follow-up|0|||
130774080|NCT00792116|470798676|FG001|Overall Study|Lost to Follow-up|1|||
130774081|NCT00792116|470798675|FG000|Overall Study|Discontnued intervention|1|||
130774082|NCT00792116|470798676|FG001|Overall Study|Discontnued intervention|0|||
131037452|NCT02547363|471770647|FG000|12-month Follow-up|Lost to Follow-up|4|||
131037453|NCT02547363|471770648|FG001|12-month Follow-up|Lost to Follow-up|1|||
131037454|NCT02547363|471770647|FG000|12-month Follow-up|Lack of Efficacy|1|||
131037455|NCT02547363|471770648|FG001|12-month Follow-up|Lack of Efficacy|1|||
131037456|NCT02547363|471770647|FG000|12-month Follow-up|Other|1|||
131037457|NCT02547363|471770648|FG001|12-month Follow-up|Other|0|||
131037458|NCT04436276|471770651|FG000|Overall Study|Adverse Event|0|||
131037459|NCT04436276|471770652|FG001|Overall Study|Adverse Event|0|||
131124534|NCT01431274|472084480|FG004|Overall Study|Lost to Follow-up|0|||
131124535|NCT01431274|472084476|FG000|Overall Study|Other reason not stated above|6|||
131124536|NCT01431274|472084477|FG001|Overall Study|Other reason not stated above|5|||
131124537|NCT01431274|472084478|FG002|Overall Study|Other reason not stated above|7|||
131124538|NCT01431274|472084479|FG003|Overall Study|Other reason not stated above|2|||
131124539|NCT01431274|472084480|FG004|Overall Study|Other reason not stated above|4|||
130774083|NCT00492232|470798677|FG000|Placebo Run-in|Adverse Event|0|||
130774084|NCT00492232|470798678|FG001|Placebo Run-in|Adverse Event|2|||
130774085|NCT00492232|470798677|FG000|Placebo Run-in|Protocol Violation|0|||
130774086|NCT00492232|470798678|FG001|Placebo Run-in|Protocol Violation|3|||
130774087|NCT00492232|470798677|FG000|Placebo Run-in|Lost to Follow-up|0|||
130774088|NCT00492232|470798678|FG001|Placebo Run-in|Lost to Follow-up|3|||
130774089|NCT00492232|470798677|FG000|Placebo Run-in|Withdrawal by Subject|0|||
130774090|NCT00492232|470798678|FG001|Placebo Run-in|Withdrawal by Subject|8|||
130946865|NCT02658890|471439867|FG019|Treatment Phase|Other Reasons|0|||
130946866|NCT02658890|471439868|FG020|Treatment Phase|Other Reasons|0|||
130946867|NCT02658890|471439869|FG021|Treatment Phase|Other Reasons|0|||
130946868|NCT02658890|471439870|FG022|Treatment Phase|Other Reasons|0|||
130946869|NCT02658890|471439871|FG023|Treatment Phase|Other Reasons|0|||
130946870|NCT02658890|471439872|FG024|Treatment Phase|Other Reasons|1|||
130946871|NCT02658890|471439873|FG025|Treatment Phase|Other Reasons|0|||
130946872|NCT02658890|471439874|FG026|Treatment Phase|Other Reasons|1|||
130946873|NCT02658890|471439848|FG000|Treatment Phase|Progressive Disease|6|||
130946874|NCT02658890|471439849|FG001|Treatment Phase|Progressive Disease|7|||
130946875|NCT02658890|471439850|FG002|Treatment Phase|Progressive Disease|6|||
130946876|NCT02658890|471439851|FG003|Treatment Phase|Progressive Disease|12|||
130946877|NCT02658890|471439852|FG004|Treatment Phase|Progressive Disease|6|||
130946878|NCT02658890|471439853|FG005|Treatment Phase|Progressive Disease|18|||
130946879|NCT02658890|471439854|FG006|Treatment Phase|Progressive Disease|12|||
130946880|NCT02658890|471439855|FG007|Treatment Phase|Progressive Disease|19|||
130946881|NCT02658890|471439856|FG008|Treatment Phase|Progressive Disease|26|||
130946882|NCT02658890|471439857|FG009|Treatment Phase|Progressive Disease|8|||
130946883|NCT02658890|471439858|FG010|Treatment Phase|Progressive Disease|7|||
130946884|NCT02658890|471439859|FG011|Treatment Phase|Progressive Disease|9|||
130946885|NCT02658890|471439860|FG012|Treatment Phase|Progressive Disease|8|||
130946886|NCT02658890|471439861|FG013|Treatment Phase|Progressive Disease|29|||
130946887|NCT02658890|471439862|FG014|Treatment Phase|Progressive Disease|6|||
131037460|NCT04436276|471770653|FG002|Overall Study|Adverse Event|0|||
131037461|NCT04436276|471770654|FG003|Overall Study|Adverse Event|0|||
130774091|NCT00492232|470798677|FG000|Placebo Run-in|Pregnancy|0|||
131037462|NCT04436276|471770655|FG004|Overall Study|Adverse Event|0|||
130710381|NCT03739138|470564818|FG001|Overall Study|Withdrawal by Subject|0|||
130710382|NCT03739138|470564819|FG002|Overall Study|Withdrawal by Subject|0|||
130710383|NCT03739138|470564820|FG003|Overall Study|Withdrawal by Subject|1|||
130710384|NCT03739138|470564821|FG004|Overall Study|Withdrawal by Subject|0|||
130710385|NCT02654587|470564822|FG000|Overall Study|patient alive at end of study|22|||
130710386|NCT02654587|470564823|FG001|Overall Study|patient alive at end of study|8|||
130710387|NCT02654587|470564822|FG000|Overall Study|Withdrawal by Subject|1|||
130710388|NCT02654587|470564823|FG001|Overall Study|Withdrawal by Subject|7|||
130710389|NCT01825837|470564824|FG000|PART I|Withdrawal by Subject|0|||
130774092|NCT00492232|470798678|FG001|Placebo Run-in|Pregnancy|1|||
130774093|NCT00492232|470798677|FG000|Placebo Run-in|Entrance criteria not met|0|||
130774094|NCT00492232|470798678|FG001|Placebo Run-in|Entrance criteria not met|45|||
130774095|NCT00492232|470798677|FG000|Placebo Run-in|Other|0|||
130774096|NCT00492232|470798678|FG001|Placebo Run-in|Other|6|||
130774097|NCT00492232|470798677|FG000|Placebo Run-in|Missing|0|||
130710390|NCT01825837|470564825|FG001|PART I|Withdrawal by Subject|0|||
130774098|NCT00492232|470798678|FG001|Placebo Run-in|Missing|2|||
130774099|NCT00492232|470798677|FG000|Double-Blind Treatment|Adverse Event|1|||
130774100|NCT00492232|470798678|FG001|Double-Blind Treatment|Adverse Event|2|||
130774101|NCT00492232|470798677|FG000|Double-Blind Treatment|Protocol Violation|3|||
130774102|NCT00492232|470798678|FG001|Double-Blind Treatment|Protocol Violation|7|||
130774103|NCT00492232|470798677|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
130774104|NCT00492232|470798678|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
130774105|NCT00492232|470798677|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
130774106|NCT00492232|470798678|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
130774107|NCT00492232|470798677|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
130774108|NCT00492232|470798678|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
130774109|NCT00492232|470798677|FG000|Double-Blind Treatment|Other|6|||
130774110|NCT00492232|470798678|FG001|Double-Blind Treatment|Other|5|||
130774111|NCT00492232|470798677|FG000|Double-Blind Treatment|Randomized not treated|1|||
130774112|NCT00492232|470798678|FG001|Double-Blind Treatment|Randomized not treated|0|||
130946888|NCT02658890|471439863|FG015|Treatment Phase|Progressive Disease|2|||
130946889|NCT02658890|471439864|FG016|Treatment Phase|Progressive Disease|32|||
130774113|NCT00492232|470798677|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
130774114|NCT00492232|470798678|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
130774115|NCT00481767|470798680|FG000|Overall Study|Withdrawal by Subject|16|||
130774116|NCT00481767|470798681|FG001|Overall Study|Withdrawal by Subject|11|||
130774117|NCT00481767|470798680|FG000|Overall Study|Lost to Follow-up|16|||
130774118|NCT00481767|470798681|FG001|Overall Study|Lost to Follow-up|10|||
130774119|NCT01941537|470798682|FG000|Overall Study|Lack of Efficacy|1|||
130710391|NCT01825837|470564826|FG002|PART I|Withdrawal by Subject|0|||
130774120|NCT01941537|470798683|FG001|Overall Study|Lack of Efficacy|2|||
130774121|NCT01941537|470798682|FG000|Overall Study|Lost to Follow-up|1|||
130774122|NCT01941537|470798683|FG001|Overall Study|Lost to Follow-up|0|||
130774123|NCT01941537|470798682|FG000|Overall Study|Pregnancy|1|||
130774124|NCT01941537|470798683|FG001|Overall Study|Pregnancy|0|||
130774125|NCT01941537|470798682|FG000|Overall Study|Adverse Event|1|||
130774126|NCT01941537|470798683|FG001|Overall Study|Adverse Event|0|||
130774127|NCT01941537|470798682|FG000|Overall Study|Withdrawal by Subject|0|||
130946890|NCT02658890|471439865|FG017|Treatment Phase|Progressive Disease|14|||
130946891|NCT02658890|471439866|FG018|Treatment Phase|Progressive Disease|40|||
130946892|NCT02658890|471439867|FG019|Treatment Phase|Progressive Disease|32|||
130946893|NCT02658890|471439868|FG020|Treatment Phase|Progressive Disease|19|||
130946894|NCT02658890|471439869|FG021|Treatment Phase|Progressive Disease|30|||
130946895|NCT02658890|471439870|FG022|Treatment Phase|Progressive Disease|15|||
130946896|NCT02658890|471439871|FG023|Treatment Phase|Progressive Disease|0|||
130946897|NCT02658890|471439872|FG024|Treatment Phase|Progressive Disease|0|||
130946898|NCT02658890|471439873|FG025|Treatment Phase|Progressive Disease|14|||
130946899|NCT02658890|471439874|FG026|Treatment Phase|Progressive Disease|11|||
130946900|NCT02658890|471439848|FG000|Treatment Phase|Study Drug Toxicity|0|||
130946901|NCT02658890|471439849|FG001|Treatment Phase|Study Drug Toxicity|0|||
130946902|NCT02658890|471439850|FG002|Treatment Phase|Study Drug Toxicity|2|||
130946903|NCT02658890|471439851|FG003|Treatment Phase|Study Drug Toxicity|0|||
130946904|NCT02658890|471439852|FG004|Treatment Phase|Study Drug Toxicity|0|||
130946905|NCT02658890|471439853|FG005|Treatment Phase|Study Drug Toxicity|0|||
130946906|NCT02658890|471439854|FG006|Treatment Phase|Study Drug Toxicity|0|||
130946907|NCT02658890|471439855|FG007|Treatment Phase|Study Drug Toxicity|0|||
130946908|NCT02658890|471439856|FG008|Treatment Phase|Study Drug Toxicity|3|||
130946909|NCT02658890|471439857|FG009|Treatment Phase|Study Drug Toxicity|0|||
130946910|NCT02658890|471439858|FG010|Treatment Phase|Study Drug Toxicity|1|||
130946911|NCT02658890|471439859|FG011|Treatment Phase|Study Drug Toxicity|1|||
130710392|NCT01825837|470564827|FG003|PART I|Withdrawal by Subject|6|||
130710393|NCT01825837|470564824|FG000|PART I|Patient non-compliance|0|||
130774128|NCT01941537|470798683|FG001|Overall Study|Withdrawal by Subject|1|||
130774129|NCT02557516|470798685|FG000|Overall Study|Adverse Event|1|||
130774130|NCT02557516|470798686|FG001|Overall Study|Adverse Event|0|||
130774131|NCT02557516|470798687|FG002|Overall Study|Adverse Event|2|||
130946912|NCT02658890|471439860|FG012|Treatment Phase|Study Drug Toxicity|2|||
130946913|NCT02658890|471439861|FG013|Treatment Phase|Study Drug Toxicity|9|||
130946914|NCT02658890|471439862|FG014|Treatment Phase|Study Drug Toxicity|0|||
130946915|NCT02658890|471439863|FG015|Treatment Phase|Study Drug Toxicity|1|||
130946916|NCT02658890|471439864|FG016|Treatment Phase|Study Drug Toxicity|1|||
130946917|NCT02658890|471439865|FG017|Treatment Phase|Study Drug Toxicity|0|||
130946918|NCT02658890|471439866|FG018|Treatment Phase|Study Drug Toxicity|8|||
130946919|NCT02658890|471439867|FG019|Treatment Phase|Study Drug Toxicity|3|||
130946920|NCT02658890|471439868|FG020|Treatment Phase|Study Drug Toxicity|2|||
130946921|NCT02658890|471439869|FG021|Treatment Phase|Study Drug Toxicity|0|||
130946922|NCT02658890|471439870|FG022|Treatment Phase|Study Drug Toxicity|8|||
130946923|NCT02658890|471439871|FG023|Treatment Phase|Study Drug Toxicity|0|||
130946924|NCT02658890|471439872|FG024|Treatment Phase|Study Drug Toxicity|0|||
130946925|NCT02658890|471439873|FG025|Treatment Phase|Study Drug Toxicity|2|||
130946926|NCT02658890|471439874|FG026|Treatment Phase|Study Drug Toxicity|0|||
130946927|NCT02658890|471439848|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946928|NCT02658890|471439849|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946929|NCT02658890|471439850|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946930|NCT02658890|471439851|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
130946931|NCT02658890|471439852|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946932|NCT02658890|471439853|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946933|NCT02658890|471439854|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946934|NCT02658890|471439855|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946935|NCT02658890|471439856|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946936|NCT02658890|471439857|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
130946937|NCT02658890|471439858|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131037463|NCT04436276|471770656|FG005|Overall Study|Adverse Event|0|||
131037464|NCT04436276|471770657|FG006|Overall Study|Adverse Event|0|||
130710394|NCT01825837|470564825|FG001|PART I|Patient non-compliance|0|||
130710395|NCT01825837|470564826|FG002|PART I|Patient non-compliance|0|||
130710396|NCT01825837|470564827|FG003|PART I|Patient non-compliance|1|||
130710397|NCT01825837|470564824|FG000|PART I|Treatment failure|0|||
130710398|NCT01825837|470564825|FG001|PART I|Treatment failure|0|||
130710399|NCT01825837|470564826|FG002|PART I|Treatment failure|0|||
130710400|NCT01825837|470564827|FG003|PART I|Treatment failure|7|||
130710401|NCT01825837|470564824|FG000|PART I|reason unspecified|0|||
130710402|NCT01825837|470564825|FG001|PART I|reason unspecified|0|||
130710403|NCT01825837|470564826|FG002|PART I|reason unspecified|0|||
130710404|NCT01825837|470564827|FG003|PART I|reason unspecified|3|||
130710405|NCT01825837|470564824|FG000|PART II|Withdrawal by Subject|3|||
130710406|NCT01825837|470564825|FG001|PART II|Withdrawal by Subject|3|||
130710407|NCT01825837|470564826|FG002|PART II|Withdrawal by Subject|7|||
130710408|NCT01825837|470564827|FG003|PART II|Withdrawal by Subject|0|||
130710409|NCT01825837|470564824|FG000|PART II|Patient non-compliance|5|||
130710410|NCT01825837|470564825|FG001|PART II|Patient non-compliance|2|||
130710411|NCT01825837|470564826|FG002|PART II|Patient non-compliance|4|||
130710412|NCT01825837|470564827|FG003|PART II|Patient non-compliance|0|||
130710413|NCT01825837|470564824|FG000|PART II|Adverse Event|3|||
130710414|NCT01825837|470564825|FG001|PART II|Adverse Event|3|||
130710415|NCT01825837|470564826|FG002|PART II|Adverse Event|1|||
130710416|NCT01825837|470564827|FG003|PART II|Adverse Event|0|||
130710417|NCT01825837|470564824|FG000|PART II|Treatment failure|6|||
130710418|NCT01825837|470564825|FG001|PART II|Treatment failure|4|||
130710419|NCT01825837|470564826|FG002|PART II|Treatment failure|5|||
130710420|NCT01825837|470564827|FG003|PART II|Treatment failure|0|||
130710421|NCT01825837|470564824|FG000|PART II|reason unspecified|2|||
130710422|NCT01825837|470564825|FG001|PART II|reason unspecified|2|||
130710423|NCT01825837|470564826|FG002|PART II|reason unspecified|2|||
130710424|NCT01825837|470564827|FG003|PART II|reason unspecified|0|||
130710425|NCT00904748|470564828|FG000|Overall Study|Withdrawal by Subject|1|||
130710426|NCT00904748|470564829|FG001|Overall Study|Withdrawal by Subject|1|||
130710427|NCT00904748|470564830|FG002|Overall Study|Withdrawal by Subject|1|||
130710428|NCT00904748|470564831|FG003|Overall Study|Withdrawal by Subject|2|||
130710429|NCT00904748|470564832|FG004|Overall Study|Withdrawal by Subject|0|||
130710430|NCT00904748|470564833|FG005|Overall Study|Withdrawal by Subject|0|||
130710431|NCT00904748|470564828|FG000|Overall Study|Adverse Event|0|||
130710432|NCT00904748|470564829|FG001|Overall Study|Adverse Event|0|||
130710433|NCT00904748|470564830|FG002|Overall Study|Adverse Event|0|||
130710434|NCT00904748|470564831|FG003|Overall Study|Adverse Event|0|||
130710435|NCT00904748|470564832|FG004|Overall Study|Adverse Event|1|||
130710436|NCT00904748|470564833|FG005|Overall Study|Adverse Event|0|||
130710437|NCT02903238|470564840|FG000|Overall Study|Lost to Follow-up|4|||
130710438|NCT00700817|470564844|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
130710439|NCT00700817|470564845|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
130710440|NCT00700817|470564846|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
130710441|NCT00700817|470564847|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
130710442|NCT00700817|470564848|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
130946938|NCT02658890|471439859|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946939|NCT02658890|471439860|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946940|NCT02658890|471439861|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946941|NCT02658890|471439862|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946942|NCT02658890|471439863|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
131037465|NCT04436276|471770658|FG007|Overall Study|Adverse Event|0|||
130710443|NCT00700817|470564844|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
130710444|NCT00700817|470564845|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
130710445|NCT00700817|470564846|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
130710446|NCT00700817|470564847|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
130710447|NCT00700817|470564848|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
130710448|NCT00700817|470564844|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
130710449|NCT00700817|470564845|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
130710450|NCT00700817|470564846|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
130710451|NCT00700817|470564847|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
130710452|NCT00700817|470564848|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
130710453|NCT00700817|470564844|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
130710454|NCT00700817|470564845|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
130710455|NCT00700817|470564846|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
130710456|NCT00700817|470564847|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
130710457|NCT00700817|470564848|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
130710458|NCT00700817|470564844|FG000|Week 0-26 (Main Period)|Unclassified|14|||
130710459|NCT00700817|470564845|FG001|Week 0-26 (Main Period)|Unclassified|4|||
130710460|NCT00700817|470564846|FG002|Week 0-26 (Main Period)|Unclassified|8|||
130710461|NCT00700817|470564847|FG003|Week 0-26 (Main Period)|Unclassified|0|||
130710462|NCT00700817|470564848|FG004|Week 0-26 (Main Period)|Unclassified|0|||
130710463|NCT00700817|470564844|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
130710464|NCT00700817|470564845|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
130710465|NCT00700817|470564846|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
130710466|NCT00700817|470564847|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
130710467|NCT00700817|470564848|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
130710468|NCT00700817|470564844|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
130710469|NCT00700817|470564845|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
130710470|NCT00700817|470564846|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
130710471|NCT00700817|470564847|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
130710472|NCT00700817|470564848|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
130710473|NCT00700817|470564844|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
130710474|NCT00700817|470564845|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
130710475|NCT00700817|470564846|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
130710476|NCT00700817|470564847|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
130710477|NCT00700817|470564848|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
130710478|NCT00700817|470564844|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
130710479|NCT00700817|470564845|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
130710480|NCT00700817|470564846|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
130710481|NCT00700817|470564847|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
130710482|NCT00700817|470564848|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
130710483|NCT00700817|470564844|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
130710484|NCT00700817|470564845|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
130710485|NCT00700817|470564846|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
130710486|NCT00700817|470564847|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
130710487|NCT00700817|470564848|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
130710488|NCT00700817|470564844|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
130710489|NCT00700817|470564845|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
130710490|NCT00700817|470564846|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
130710491|NCT00700817|470564847|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
130710492|NCT00700817|470564848|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
130710493|NCT00700817|470564844|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
130710494|NCT00700817|470564845|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
130710495|NCT00700817|470564846|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
130710496|NCT00700817|470564847|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
130710497|NCT00700817|470564848|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
130710498|NCT00700817|470564844|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
130710499|NCT00700817|470564845|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
130710500|NCT00700817|470564846|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
130710501|NCT00700817|470564847|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
130710502|NCT00700817|470564848|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
130710503|NCT00700817|470564844|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
130710504|NCT00700817|470564845|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
130710505|NCT00700817|470564846|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
130946943|NCT02658890|471439864|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946944|NCT02658890|471439865|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946945|NCT02658890|471439866|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
130946946|NCT02658890|471439867|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946947|NCT02658890|471439868|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946948|NCT02658890|471439869|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946949|NCT02658890|471439870|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
130946950|NCT02658890|471439871|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946951|NCT02658890|471439872|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946952|NCT02658890|471439873|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946953|NCT02658890|471439874|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
130946954|NCT02658890|471439848|FG000|Treatment Phase|Withdrawal by Subject|0|||
130946955|NCT02658890|471439849|FG001|Treatment Phase|Withdrawal by Subject|1|||
130946956|NCT02658890|471439850|FG002|Treatment Phase|Withdrawal by Subject|0|||
130946957|NCT02658890|471439851|FG003|Treatment Phase|Withdrawal by Subject|0|||
130946958|NCT02658890|471439852|FG004|Treatment Phase|Withdrawal by Subject|0|||
130946959|NCT02658890|471439853|FG005|Treatment Phase|Withdrawal by Subject|0|||
130946960|NCT02658890|471439854|FG006|Treatment Phase|Withdrawal by Subject|1|||
130946961|NCT02658890|471439855|FG007|Treatment Phase|Withdrawal by Subject|0|||
130946962|NCT02658890|471439856|FG008|Treatment Phase|Withdrawal by Subject|0|||
130946963|NCT02658890|471439857|FG009|Treatment Phase|Withdrawal by Subject|1|||
130946964|NCT02658890|471439858|FG010|Treatment Phase|Withdrawal by Subject|0|||
130946965|NCT02658890|471439859|FG011|Treatment Phase|Withdrawal by Subject|0|||
130946966|NCT02658890|471439860|FG012|Treatment Phase|Withdrawal by Subject|1|||
130946967|NCT02658890|471439861|FG013|Treatment Phase|Withdrawal by Subject|3|||
130946968|NCT02658890|471439862|FG014|Treatment Phase|Withdrawal by Subject|0|||
130946969|NCT02658890|471439863|FG015|Treatment Phase|Withdrawal by Subject|0|||
130946970|NCT02658890|471439864|FG016|Treatment Phase|Withdrawal by Subject|1|||
130946971|NCT02658890|471439865|FG017|Treatment Phase|Withdrawal by Subject|0|||
130946972|NCT02658890|471439866|FG018|Treatment Phase|Withdrawal by Subject|4|||
130946973|NCT02658890|471439867|FG019|Treatment Phase|Withdrawal by Subject|3|||
130946974|NCT02658890|471439868|FG020|Treatment Phase|Withdrawal by Subject|0|||
130946975|NCT02658890|471439869|FG021|Treatment Phase|Withdrawal by Subject|4|||
130946976|NCT02658890|471439870|FG022|Treatment Phase|Withdrawal by Subject|1|||
130946977|NCT02658890|471439871|FG023|Treatment Phase|Withdrawal by Subject|1|||
131037466|NCT04436276|471770659|FG008|Overall Study|Adverse Event|0|||
131037467|NCT04436276|471770660|FG009|Overall Study|Adverse Event|0|||
131037468|NCT04436276|471770661|FG010|Overall Study|Adverse Event|0|||
131037469|NCT04436276|471770662|FG011|Overall Study|Adverse Event|0|||
131037470|NCT04436276|471770663|FG012|Overall Study|Adverse Event|0|||
130710506|NCT00700817|470564847|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
130710507|NCT00700817|470564848|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
130710508|NCT00700817|470564844|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
130710509|NCT00700817|470564845|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
130710510|NCT00700817|470564846|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
130710511|NCT00700817|470564847|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
130710512|NCT00700817|470564848|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
130710513|NCT00049842|470564860|FG000|Treatment Phase|Adverse Event|47|||
130710514|NCT00049842|470564861|FG001|Treatment Phase|Adverse Event|12|||
130710515|NCT00049842|470564860|FG000|Treatment Phase|Withdrawal by Subject|35|||
130710516|NCT00049842|470564861|FG001|Treatment Phase|Withdrawal by Subject|46|||
130710517|NCT00049842|470564860|FG000|Treatment Phase|Non-compliance with protocol|7|||
130710518|NCT00049842|470564861|FG001|Treatment Phase|Non-compliance with protocol|8|||
130710519|NCT00049842|470564860|FG000|Treatment Phase|Lost to Follow-up|4|||
130710520|NCT00049842|470564861|FG001|Treatment Phase|Lost to Follow-up|8|||
130710521|NCT00049842|470564860|FG000|Treatment Phase|Administrative|0|||
130710522|NCT00049842|470564861|FG001|Treatment Phase|Administrative|3|||
130710523|NCT00049842|470564860|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
130710524|NCT00049842|470564861|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
130710525|NCT00049842|470564860|FG000|Follow-up Phase|Adverse Event|6|||
130710526|NCT00049842|470564861|FG001|Follow-up Phase|Adverse Event|1|||
130710527|NCT00049842|470564860|FG000|Follow-up Phase|Other|1|||
130710528|NCT00049842|470564861|FG001|Follow-up Phase|Other|4|||
130710529|NCT00307931|470564862|FG000|Overall Study|Adverse Event|1|||
130710530|NCT00854373|470564863|FG000|Overall Study|Withdrawal by Subject|1|||
130710531|NCT00854373|470564864|FG001|Overall Study|Withdrawal by Subject|3|||
130710532|NCT00854373|470564863|FG000|Overall Study|Forgot to take study drug|1|||
130710533|NCT00854373|470564864|FG001|Overall Study|Forgot to take study drug|1|||
130710534|NCT00293202|470564865|FG000|Overall Study|Withdrawal by Subject|1|||
130710535|NCT00293202|470564866|FG001|Overall Study|Withdrawal by Subject|2|||
130710536|NCT00293202|470564865|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
130710537|NCT00293202|470564866|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
130710538|NCT00293202|470564865|FG000|Overall Study|on-hold due to fistula maturation time|1|||
130774132|NCT02557516|470798688|FG003|Overall Study|Adverse Event|1|||
130774133|NCT02557516|470798685|FG000|Overall Study|Disease progression|0|||
130774134|NCT02557516|470798686|FG001|Overall Study|Disease progression|2|||
130774135|NCT02557516|470798687|FG002|Overall Study|Disease progression|0|||
130774136|NCT02557516|470798688|FG003|Overall Study|Disease progression|0|||
130774137|NCT02557516|470798685|FG000|Overall Study|Physician Decision|0|||
130774138|NCT02557516|470798686|FG001|Overall Study|Physician Decision|2|||
130774139|NCT02557516|470798687|FG002|Overall Study|Physician Decision|0|||
130774140|NCT02557516|470798688|FG003|Overall Study|Physician Decision|0|||
130774141|NCT02557516|470798685|FG000|Overall Study|Sponsor decision|0|||
130774142|NCT02557516|470798686|FG001|Overall Study|Sponsor decision|1|||
130774143|NCT02557516|470798687|FG002|Overall Study|Sponsor decision|2|||
130774144|NCT02557516|470798688|FG003|Overall Study|Sponsor decision|8|||
130774145|NCT01025284|470800412|FG000|Overall Study|Investigator Decision|0|||
130774146|NCT01025284|470800413|FG001|Overall Study|Investigator Decision|1|||
130774147|NCT01025284|470800414|FG002|Overall Study|Investigator Decision|0|||
130774148|NCT01025284|470800412|FG000|Overall Study|Withdrawal by Subject|0|||
130774149|NCT01025284|470800413|FG001|Overall Study|Withdrawal by Subject|1|||
130774150|NCT01025284|470800414|FG002|Overall Study|Withdrawal by Subject|0|||
130774151|NCT00905567|470800415|FG000|Washout|Withdrawal by Subject|0|||
130946978|NCT02658890|471439872|FG024|Treatment Phase|Withdrawal by Subject|0|||
130946979|NCT02658890|471439873|FG025|Treatment Phase|Withdrawal by Subject|0|||
130946980|NCT02658890|471439874|FG026|Treatment Phase|Withdrawal by Subject|0|||
130946981|NCT00159588|471439875|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
130946982|NCT00159588|471439876|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
130946983|NCT00159588|471439877|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
130946984|NCT00952341|471439878|FG000|Cycle 1|Adverse Event|4|||
130946985|NCT00952341|471439879|FG001|Cycle 1|Adverse Event|1|||
130946986|NCT00952341|471439878|FG000|Cycle 1|Withdrawal by Subject|3|||
130946987|NCT00952341|471439879|FG001|Cycle 1|Withdrawal by Subject|8|||
130946988|NCT00952341|471439878|FG000|Cycle 1|Protocol Violation|2|||
130946989|NCT00952341|471439879|FG001|Cycle 1|Protocol Violation|1|||
130946990|NCT00952341|471439878|FG000|Cycle 1|Lost to Follow-up|11|||
130946991|NCT00952341|471439879|FG001|Cycle 1|Lost to Follow-up|2|||
130946992|NCT00952341|471439878|FG000|Cycle 1|Physician Decision|0|||
130946993|NCT00952341|471439879|FG001|Cycle 1|Physician Decision|1|||
130946994|NCT00952341|471439878|FG000|Cycle 2|Withdrawal by Subject|1|||
130946995|NCT00952341|471439879|FG001|Cycle 2|Withdrawal by Subject|1|||
130946996|NCT00952341|471439878|FG000|Cycle 2|Protocol Violation|1|||
130946997|NCT00952341|471439879|FG001|Cycle 2|Protocol Violation|0|||
130946998|NCT00952341|471439878|FG000|Cycle 2|Lost to Follow-up|6|||
130946999|NCT00952341|471439879|FG001|Cycle 2|Lost to Follow-up|9|||
130947000|NCT00952341|471439878|FG000|Cycle 2|Physician Decision|1|||
130947001|NCT00952341|471439879|FG001|Cycle 2|Physician Decision|1|||
130947002|NCT00952341|471439878|FG000|Cycle 2|Progressive Disease|0|||
130947003|NCT00952341|471439879|FG001|Cycle 2|Progressive Disease|1|||
130947004|NCT04920123|471439880|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
130947005|NCT04920123|471439881|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130947006|NCT04920123|471439882|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
130947007|NCT05352815|471439885|FG000|Overall Study|Withdrawal by Subject|28|||
130947008|NCT05352815|471439886|FG001|Overall Study|Withdrawal by Subject|24|||
130947009|NCT05352815|471439885|FG000|Overall Study|Lost to Follow-up|4|||
130947010|NCT05352815|471439886|FG001|Overall Study|Lost to Follow-up|7|||
130947011|NCT05352815|471439885|FG000|Overall Study|Death|2|||
130947012|NCT05352815|471439886|FG001|Overall Study|Death|3|||
130947013|NCT05352815|471439885|FG000|Overall Study|Site closure|1|||
130947014|NCT05352815|471439886|FG001|Overall Study|Site closure|0|||
130947015|NCT02759120|471439887|FG000|Overall Study|Death|34|||
130947016|NCT02759120|471439888|FG001|Overall Study|Death|36|||
130947017|NCT02759120|471439887|FG000|Overall Study|Lost to Follow-up|4|||
130947018|NCT02759120|471439888|FG001|Overall Study|Lost to Follow-up|7|||
130947019|NCT02759120|471439887|FG000|Overall Study|Physician Decision|3|||
130947020|NCT02759120|471439888|FG001|Overall Study|Physician Decision|0|||
130947021|NCT02759120|471439887|FG000|Overall Study|Withdrawal by Subject|28|||
130947022|NCT02759120|471439888|FG001|Overall Study|Withdrawal by Subject|15|||
130947023|NCT02759120|471439887|FG000|Overall Study|Moved out of area|3|||
130947024|NCT02759120|471439888|FG001|Overall Study|Moved out of area|4|||
130947025|NCT02759120|471439887|FG000|Overall Study|Lung transplant|3|||
130947026|NCT02759120|471439888|FG001|Overall Study|Lung transplant|5|||
130947027|NCT02759120|471439887|FG000|Overall Study|Other reason not completed|10|||
130947028|NCT02759120|471439888|FG001|Overall Study|Other reason not completed|12|||
130947029|NCT02532647|471439891|FG000|Overall Study|Did not receive trial medication|1|||
130947030|NCT02532647|471439892|FG001|Overall Study|Did not receive trial medication|0|||
130947031|NCT02532647|471439893|FG002|Overall Study|Did not receive trial medication|1|||
130947032|NCT02211131|471439897|FG000|Overall Study|Death|26|||
130947033|NCT02211131|471439898|FG001|Overall Study|Death|16|||
130774152|NCT00905567|470800416|FG001|Washout|Withdrawal by Subject|1|||
130947034|NCT02211131|471439897|FG000|Overall Study|Lost to Follow-up|4|||
130774153|NCT02753816|470800417|FG000|Overall Study|Protocol Violation|0|||
130947035|NCT02211131|471439898|FG001|Overall Study|Lost to Follow-up|3|||
130710539|NCT00293202|470564866|FG001|Overall Study|on-hold due to fistula maturation time|0|||
131124540|NCT00843518|472084481|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
131124541|NCT00843518|472084482|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
131124542|NCT00843518|472084481|FG000|Period 2 (Double-blind Treatment)|Death|0|||
131124543|NCT00843518|472084482|FG001|Period 2 (Double-blind Treatment)|Death|1|||
131124544|NCT00843518|472084481|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
131124545|NCT00843518|472084482|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
131124546|NCT00843518|472084481|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
131124547|NCT00843518|472084482|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
131124548|NCT00843518|472084481|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
131124549|NCT00843518|472084482|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
131124550|NCT00843518|472084481|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
131124551|NCT00843518|472084482|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
131124552|NCT00843518|472084481|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
131124553|NCT00843518|472084482|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
131124554|NCT00827606|472084483|FG000|Overall Study|Protocol Violation|4|||
131124555|NCT00827606|472084484|FG001|Overall Study|Protocol Violation|3|||
131124556|NCT00827606|472084483|FG000|Overall Study|Lost to Follow-up|3|||
131124557|NCT00827606|472084484|FG001|Overall Study|Lost to Follow-up|1|||
131124558|NCT00827606|472084483|FG000|Overall Study|Withdrawal by Subject|7|||
131124559|NCT00827606|472084484|FG001|Overall Study|Withdrawal by Subject|6|||
131124560|NCT00827606|472084483|FG000|Overall Study|Pregnancy|0|||
131124561|NCT00827606|472084484|FG001|Overall Study|Pregnancy|1|||
131124562|NCT00827606|472084483|FG000|Overall Study|Other|5|||
131124563|NCT00827606|472084484|FG001|Overall Study|Other|13|||
131124564|NCT00827606|472084483|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
131124565|NCT00827606|472084484|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
131124566|NCT00827606|472084483|FG000|Overall Study|Adverse Event|4|||
131124567|NCT00827606|472084484|FG001|Overall Study|Adverse Event|2|||
131124568|NCT04037748|472084487|FG000|Treatment Period 1|Withdrawal by Subject|3|||
131124569|NCT04037748|472084488|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131124570|NCT04037748|472084487|FG000|Treatment Period 1|Adverse Event|1|||
131124571|NCT04037748|472084488|FG001|Treatment Period 1|Adverse Event|1|||
131124572|NCT04037748|472084487|FG000|Treatment Period 1|Protocol Violation|4|||
131124573|NCT04037748|472084488|FG001|Treatment Period 1|Protocol Violation|5|||
131124574|NCT04037748|472084487|FG000|Treatment Period 2|Adverse Event|0|||
131124575|NCT04037748|472084488|FG001|Treatment Period 2|Adverse Event|1|||
131124576|NCT04037748|472084487|FG000|Treatment Period 2|Protocol Violation|2|||
131124577|NCT04037748|472084488|FG001|Treatment Period 2|Protocol Violation|0|||
131124578|NCT04544475|472084493|FG000|Overall Study|Withdrawal by Subject|1|||
131124579|NCT04544475|472084494|FG001|Overall Study|Withdrawal by Subject|3|||
131124580|NCT01378858|472084495|FG000|Overall Study|Withdrawal by Subject|4|||
130710540|NCT02442271|470564869|FG000|Overall Study|Adverse Event|1|||
130710541|NCT02442271|470564869|FG000|Overall Study|Withdrew Consent|1|||
130947036|NCT02211131|471439897|FG000|Overall Study|Decision by Sponsor|1|||
130947037|NCT02211131|471439898|FG001|Overall Study|Decision by Sponsor|1|||
130947038|NCT02211131|471439897|FG000|Overall Study|Withdrawal by Subject|3|||
130947039|NCT02211131|471439898|FG001|Overall Study|Withdrawal by Subject|8|||
130947040|NCT02939560|471439902|FG000|Overall Study|Withdrawal by Subject|2|||
130947041|NCT02939560|471439902|FG000|Overall Study|Protocol Violation|1|||
130947042|NCT03340025|471439905|FG000|Overall Study|Lost to Follow-up|2|||
130947043|NCT03340025|471439906|FG001|Overall Study|Lost to Follow-up|2|||
130947044|NCT02420691|471439909|FG000|Overall Study|Adverse Event|3|||
130947045|NCT02420691|471439909|FG000|Overall Study|Withdrawal by Subject|3|||
130947046|NCT03897179|471439915|FG000|Overall Study|Withdrawal by Subject|1|||
130947047|NCT01480076|471439916|FG000|Overall Study|Run-in Failure|52|||
130947048|NCT01480076|471439916|FG000|Overall Study|Adverse Event|39|||
130947049|NCT01480076|471439916|FG000|Overall Study|Death|2|||
130947050|NCT01480076|471439916|FG000|Overall Study|Disease Progression|5|||
130947051|NCT01480076|471439916|FG000|Overall Study|Non-compliance With Study Protocol|15|||
130947052|NCT01480076|471439916|FG000|Overall Study|Withdrawal by Subject|105|||
130947053|NCT01480076|471439916|FG000|Overall Study|Lost to Follow-up|7|||
130947054|NCT01480076|471439916|FG000|Overall Study|Investigator Decision|13|||
130947055|NCT01480076|471439916|FG000|Overall Study|Other|52|||
130947056|NCT00704535|471439917|FG000|Overall Study|Adverse Event|2|||
130947057|NCT00704535|471439917|FG000|Overall Study|Death|2|||
130947058|NCT00704535|471439917|FG000|Overall Study|Lost to Follow-up|8|||
130947059|NCT00704535|471439917|FG000|Overall Study|Protocol Violation|10|||
130947060|NCT00704535|471439917|FG000|Overall Study|Completed status not on Case Report Form|124|||
130947061|NCT02503332|471439919|FG000|Overall Study|Adverse Event|17|||
131124581|NCT01378858|472084496|FG001|Overall Study|Withdrawal by Subject|4|||
131124582|NCT00501007|472084497|FG000|Overall Study|Inclusion criteria not met.|29|||
131124583|NCT00501007|472084498|FG001|Overall Study|Inclusion criteria not met.|25|||
130710542|NCT02442271|470564869|FG000|Overall Study|Lost to Follow-up|1|||
130947062|NCT02503332|471439920|FG001|Overall Study|Adverse Event|5|||
130947063|NCT02503332|471439921|FG002|Overall Study|Adverse Event|3|||
131124584|NCT02973087|472084501|FG000|Overall Study|Withdrawal by Subject|2|||
131124585|NCT02973087|472084502|FG001|Overall Study|Withdrawal by Subject|1|||
131124586|NCT02973087|472084501|FG000|Overall Study|Adverse Event|1|||
130710543|NCT02442271|470564869|FG000|Overall Study|Other|1|||
130710544|NCT02080832|470564870|FG000|Overall Study|Excluded from analysis by MRI|9|||
130710545|NCT02080832|470564871|FG001|Overall Study|Excluded from analysis by MRI|10|||
130710546|NCT02080832|470564872|FG002|Overall Study|Excluded from analysis by MRI|14|||
130710547|NCT02080832|470564870|FG000|Overall Study|Lost to Follow-up|0|||
130710548|NCT02080832|470564871|FG001|Overall Study|Lost to Follow-up|2|||
130710549|NCT02080832|470564872|FG002|Overall Study|Lost to Follow-up|2|||
130947064|NCT02503332|471439922|FG003|Overall Study|Adverse Event|1|||
130947065|NCT02503332|471439919|FG000|Overall Study|Investigator's Decision|5|||
130947066|NCT02503332|471439920|FG001|Overall Study|Investigator's Decision|1|||
130947067|NCT02503332|471439921|FG002|Overall Study|Investigator's Decision|0|||
130947068|NCT02503332|471439922|FG003|Overall Study|Investigator's Decision|0|||
130947069|NCT02503332|471439919|FG000|Overall Study|Sponsor's Decision|1|||
130947070|NCT02503332|471439920|FG001|Overall Study|Sponsor's Decision|0|||
130947071|NCT02503332|471439921|FG002|Overall Study|Sponsor's Decision|0|||
130947072|NCT02503332|471439922|FG003|Overall Study|Sponsor's Decision|1|||
130947073|NCT02503332|471439919|FG000|Overall Study|Subject Request|6|||
130947074|NCT02503332|471439920|FG001|Overall Study|Subject Request|5|||
130947075|NCT02503332|471439921|FG002|Overall Study|Subject Request|2|||
130947076|NCT02503332|471439922|FG003|Overall Study|Subject Request|1|||
130947077|NCT02503332|471439919|FG000|Overall Study|Death|0|||
130947078|NCT02503332|471439920|FG001|Overall Study|Death|2|||
130947079|NCT02503332|471439921|FG002|Overall Study|Death|2|||
130947080|NCT02503332|471439922|FG003|Overall Study|Death|0|||
130947081|NCT02503332|471439919|FG000|Overall Study|Other|5|||
130947082|NCT02503332|471439920|FG001|Overall Study|Other|6|||
130947083|NCT02503332|471439921|FG002|Overall Study|Other|1|||
130947084|NCT02503332|471439922|FG003|Overall Study|Other|1|||
130947085|NCT01413360|471439923|FG000|Overall Study|Lost to Follow-up|2|||
130947086|NCT01413360|471439923|FG000|Overall Study|Adverse Event|1|||
130947087|NCT05694546|471439926|FG000|Overall Study|Lost to Follow-up|11|||
130947088|NCT01589445|471439927|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
130947089|NCT01589445|471439927|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
130947090|NCT01589445|471439927|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
130947091|NCT01589445|471439927|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
130947092|NCT01589445|471439927|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
130947093|NCT01589445|471439927|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
130947094|NCT01589445|471439927|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
130947095|NCT01589445|471439927|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
130947096|NCT01589445|471439927|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
130947097|NCT01589445|471439927|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
130947098|NCT02625090|471439938|FG000|Overall Study|Participant wants to be pregnant|2|||
130774154|NCT02753816|470800418|FG001|Overall Study|Protocol Violation|1|||
130774155|NCT02753816|470800419|FG002|Overall Study|Protocol Violation|0|||
130947099|NCT02625090|471439938|FG000|Overall Study|For the Promoter|1|||
130947100|NCT02625090|471439938|FG000|Overall Study|Sponsor's Decision|9|||
130947101|NCT02625090|471439938|FG000|Overall Study|Somnolence|1|||
130947102|NCT02625090|471439938|FG000|Overall Study|Study terminated by Sponsor|7|||
130947103|NCT02625090|471439938|FG000|Overall Study|Negative Benefit/Risk|1|||
130947104|NCT02625090|471439938|FG000|Overall Study|Protocol Deviation|2|||
130947105|NCT02625090|471439938|FG000|Overall Study|Lack of Efficacy|16|||
130947106|NCT02625090|471439938|FG000|Overall Study|Adverse Event|3|||
130947107|NCT02439320|471439939|FG000|Overall Study|Adverse Event|0|||
130947108|NCT02439320|471439940|FG001|Overall Study|Adverse Event|2|||
130947109|NCT02439320|471439941|FG002|Overall Study|Adverse Event|0|||
130947110|NCT02439320|471439939|FG000|Overall Study|Lost to Follow-up|37|||
130947111|NCT02439320|471439940|FG001|Overall Study|Lost to Follow-up|34|||
130947112|NCT02439320|471439941|FG002|Overall Study|Lost to Follow-up|42|||
130947113|NCT02439320|471439939|FG000|Overall Study|Death|0|||
130947114|NCT02439320|471439940|FG001|Overall Study|Death|1|||
130947115|NCT02439320|471439941|FG002|Overall Study|Death|0|||
130947116|NCT02439320|471439939|FG000|Overall Study|Noncompliance with Protocol|10|||
130947117|NCT02439320|471439940|FG001|Overall Study|Noncompliance with Protocol|11|||
130710550|NCT01560507|470564873|FG000|Overall Study|Lost to Follow-up|3|||
130947118|NCT02439320|471439941|FG002|Overall Study|Noncompliance with Protocol|7|||
130947119|NCT02439320|471439939|FG000|Overall Study|Pregnancy|0|||
130947120|NCT02439320|471439940|FG001|Overall Study|Pregnancy|1|||
130947121|NCT02439320|471439941|FG002|Overall Study|Pregnancy|1|||
130947122|NCT02439320|471439939|FG000|Overall Study|Withdrawal by Subject|12|||
130710551|NCT01560507|470564874|FG001|Overall Study|Lost to Follow-up|1|||
130947123|NCT02439320|471439940|FG001|Overall Study|Withdrawal by Subject|16|||
130947124|NCT02439320|471439941|FG002|Overall Study|Withdrawal by Subject|14|||
130774156|NCT01465230|470800420|FG000|Overall Study|Withdrawal by Subject|2|||
130947125|NCT02439320|471439939|FG000|Overall Study|Physician Decision|2|||
130947126|NCT02439320|471439940|FG001|Overall Study|Physician Decision|1|||
130947127|NCT02439320|471439941|FG002|Overall Study|Physician Decision|0|||
130947128|NCT02439320|471439939|FG000|Overall Study|Sponsor Request|0|||
130947129|NCT02439320|471439940|FG001|Overall Study|Sponsor Request|2|||
130947130|NCT02439320|471439941|FG002|Overall Study|Sponsor Request|1|||
130947131|NCT02439320|471439939|FG000|Overall Study|Randomization Failure|35|||
130947132|NCT02439320|471439940|FG001|Overall Study|Randomization Failure|46|||
130947133|NCT02439320|471439941|FG002|Overall Study|Randomization Failure|34|||
130947134|NCT02972632|471439942|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
130947135|NCT02972632|471439942|FG000|Overall Study|Lost to Follow-up|4|||
130947136|NCT02972632|471439942|FG000|Overall Study|Voluntary Withdrawal|10|||
130947137|NCT01488097|471439946|FG000|Overall Study|Lost to Follow-up|1|||
130947138|NCT02016482|471439950|FG000|Period A|Adverse Event|3|||
130947139|NCT02016482|471439951|FG001|Period A|Adverse Event|5|||
130947140|NCT02016482|471439950|FG000|Period A|Withdrawal by Subject|3|||
130947141|NCT02016482|471439951|FG001|Period A|Withdrawal by Subject|4|||
130947142|NCT02016482|471439950|FG000|Period A|Lost to Follow-up|3|||
130947143|NCT02016482|471439951|FG001|Period A|Lost to Follow-up|3|||
130947144|NCT02016482|471439950|FG000|Period A|Lack of Efficacy|2|||
130947145|NCT02016482|471439951|FG001|Period A|Lack of Efficacy|1|||
130947146|NCT02016482|471439950|FG000|Period A|Other|3|||
130947147|NCT02016482|471439951|FG001|Period A|Other|0|||
130947148|NCT02016482|471439950|FG000|Period A|Protocol Violation|0|||
130947149|NCT02016482|471439951|FG001|Period A|Protocol Violation|1|||
130947150|NCT02016482|471439950|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
130947151|NCT02016482|471439951|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
130947152|NCT02016482|471439950|FG000|Period B|Withdrawal by Subject|1|||
130947153|NCT02016482|471439951|FG001|Period B|Withdrawal by Subject|1|||
130947154|NCT02016482|471439950|FG000|Period B|Lost to Follow-up|2|||
130774157|NCT02542397|470800421|FG000|Overall Study|Death|2|||
130774158|NCT02542397|470800421|FG000|Overall Study|Physician Decision|6|||
130774159|NCT02542397|470800421|FG000|Overall Study|Withdrawal by Subject|6|||
130774160|NCT02542397|470800421|FG000|Overall Study|Lost to Follow-up|2|||
130774161|NCT01738919|470800428|FG000|Overall Study|Lost to Follow-up|1|||
130774162|NCT01738919|470800429|FG001|Overall Study|Lost to Follow-up|0|||
130774163|NCT01738919|470800428|FG000|Overall Study|Immigrated|0|||
130774164|NCT01738919|470800429|FG001|Overall Study|Immigrated|1|||
130774165|NCT01738919|470800428|FG000|Overall Study|Withdrawal by Subject|0|||
130774166|NCT01738919|470800429|FG001|Overall Study|Withdrawal by Subject|1|||
130774167|NCT01738919|470800428|FG000|Overall Study|Not treated in accordance to guidelines|0|||
130774168|NCT01738919|470800429|FG001|Overall Study|Not treated in accordance to guidelines|1|||
130774169|NCT01473940|470800433|FG000|Induction Therapy|Death|0|||
130774170|NCT01473940|470800434|FG001|Induction Therapy|Death|0|||
130774171|NCT01473940|470800435|FG002|Induction Therapy|Death|1|||
130774172|NCT01473940|470800436|FG003|Induction Therapy|Death|1|||
130947155|NCT02016482|471439951|FG001|Period B|Lost to Follow-up|0|||
130947156|NCT02016482|471439950|FG000|Period B|Lack of Efficacy|6|||
130947157|NCT02016482|471439951|FG001|Period B|Lack of Efficacy|4|||
130947158|NCT02016482|471439950|FG000|Period B|Other|4|||
130947159|NCT02016482|471439951|FG001|Period B|Other|0|||
130947160|NCT02016482|471439950|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
130947161|NCT02016482|471439951|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
130947162|NCT03054870|471439966|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
130947163|NCT03054870|471439966|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
130947164|NCT03089606|471439967|FG000|Overall Study|Progression after Cycle 1|1|||
130947165|NCT02802592|471439969|FG000|Overall Study|Study terminated due to loss of funding|4|||
130947166|NCT01150123|471439970|FG000|Overall Study|Withdrawal by Subject|1|||
130947167|NCT01150123|471439971|FG001|Overall Study|Withdrawal by Subject|1|||
130947168|NCT01150123|471439972|FG002|Overall Study|Withdrawal by Subject|2|||
130947169|NCT01150123|471439973|FG003|Overall Study|Withdrawal by Subject|1|||
130947170|NCT01150123|471439974|FG004|Overall Study|Withdrawal by Subject|1|||
130947171|NCT01150123|471439975|FG005|Overall Study|Withdrawal by Subject|1|||
130947172|NCT01150123|471439976|FG006|Overall Study|Withdrawal by Subject|0|||
130947173|NCT01150123|471439977|FG007|Overall Study|Withdrawal by Subject|3|||
130947174|NCT01150123|471439978|FG008|Overall Study|Withdrawal by Subject|2|||
130947175|NCT01150123|471439979|FG009|Overall Study|Withdrawal by Subject|0|||
130947176|NCT01150123|471439980|FG010|Overall Study|Withdrawal by Subject|1|||
130947177|NCT01150123|471439981|FG011|Overall Study|Withdrawal by Subject|0|||
130947178|NCT01150123|471439982|FG012|Overall Study|Withdrawal by Subject|1|||
130947179|NCT01150123|471439983|FG013|Overall Study|Withdrawal by Subject|0|||
130947180|NCT01150123|471439984|FG014|Overall Study|Withdrawal by Subject|0|||
130947181|NCT01150123|471439985|FG015|Overall Study|Withdrawal by Subject|1|||
131037471|NCT04436276|471770664|FG013|Overall Study|Adverse Event|0|||
131037472|NCT04436276|471770665|FG014|Overall Study|Adverse Event|0|||
130774173|NCT01473940|470800433|FG000|Induction Therapy|Progressive Disease|0|||
130774174|NCT01473940|470800434|FG001|Induction Therapy|Progressive Disease|1|||
131037473|NCT04436276|471770666|FG015|Overall Study|Adverse Event|0|||
131037474|NCT04436276|471770667|FG016|Overall Study|Adverse Event|1|||
131037475|NCT04436276|471770668|FG017|Overall Study|Adverse Event|0|||
131037476|NCT04436276|471770669|FG018|Overall Study|Adverse Event|0|||
131037477|NCT04436276|471770670|FG019|Overall Study|Adverse Event|0|||
130947182|NCT01150123|471439986|FG016|Overall Study|Withdrawal by Subject|0|||
130947183|NCT01150123|471439987|FG017|Overall Study|Withdrawal by Subject|1|||
130947184|NCT01150123|471439970|FG000|Overall Study|Lost to Follow-up|2|||
130947185|NCT01150123|471439971|FG001|Overall Study|Lost to Follow-up|1|||
130947186|NCT01150123|471439972|FG002|Overall Study|Lost to Follow-up|2|||
130947187|NCT01150123|471439973|FG003|Overall Study|Lost to Follow-up|2|||
130947188|NCT01150123|471439974|FG004|Overall Study|Lost to Follow-up|2|||
130947189|NCT01150123|471439975|FG005|Overall Study|Lost to Follow-up|5|||
130947190|NCT01150123|471439976|FG006|Overall Study|Lost to Follow-up|0|||
130947191|NCT01150123|471439977|FG007|Overall Study|Lost to Follow-up|0|||
130947192|NCT01150123|471439978|FG008|Overall Study|Lost to Follow-up|3|||
130947193|NCT01150123|471439979|FG009|Overall Study|Lost to Follow-up|1|||
130947194|NCT01150123|471439980|FG010|Overall Study|Lost to Follow-up|1|||
130947195|NCT01150123|471439981|FG011|Overall Study|Lost to Follow-up|1|||
130947196|NCT01150123|471439982|FG012|Overall Study|Lost to Follow-up|2|||
130947197|NCT01150123|471439983|FG013|Overall Study|Lost to Follow-up|0|||
130947198|NCT01150123|471439984|FG014|Overall Study|Lost to Follow-up|0|||
130947199|NCT01150123|471439985|FG015|Overall Study|Lost to Follow-up|0|||
130947200|NCT01150123|471439986|FG016|Overall Study|Lost to Follow-up|0|||
130947201|NCT01150123|471439987|FG017|Overall Study|Lost to Follow-up|0|||
130947202|NCT02486042|471439988|FG000|Overall Study|Physician Decision|1|||
130947203|NCT02486042|471439989|FG001|Overall Study|Physician Decision|7|||
130947204|NCT02486042|471439988|FG000|Overall Study|Hospital transfer|2|||
130710552|NCT01560507|470564875|FG002|Overall Study|Lost to Follow-up|2|||
130710553|NCT01560507|470564873|FG000|Overall Study|Withdrawal by Subject|1|||
130710554|NCT01560507|470564874|FG001|Overall Study|Withdrawal by Subject|1|||
130710555|NCT01560507|470564875|FG002|Overall Study|Withdrawal by Subject|0|||
130710556|NCT01118117|470564876|FG000|Overall Study|Death|8|||
130710557|NCT01118117|470564877|FG001|Overall Study|Death|0|||
130710558|NCT01118117|470564876|FG000|Overall Study|Lost to Follow-up|6|||
130710559|NCT01118117|470564877|FG001|Overall Study|Lost to Follow-up|0|||
130710560|NCT01118117|470564876|FG000|Overall Study|Missed 12 Month Visit|7|||
130710561|NCT01118117|470564877|FG001|Overall Study|Missed 12 Month Visit|0|||
130710562|NCT03545191|470564878|FG000|Overall Study|Death|1|||
130710563|NCT03545191|470564879|FG001|Overall Study|Death|0|||
130710564|NCT03545191|470564880|FG002|Overall Study|Death|0|||
130710565|NCT03545191|470564878|FG000|Overall Study|Adverse Event|4|||
130710566|NCT03545191|470564879|FG001|Overall Study|Adverse Event|2|||
130947205|NCT02486042|471439989|FG001|Overall Study|Hospital transfer|2|||
130947206|NCT02486042|471439988|FG000|Overall Study|Withdrawal by Subject|0|||
130947207|NCT02486042|471439989|FG001|Overall Study|Withdrawal by Subject|2|||
130947208|NCT04404855|471439992|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
130947209|NCT04404855|471439993|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
130947210|NCT00352846|471439994|FG000|Overall Study|Disease progression|0|||
130947211|NCT00352846|471439995|FG001|Overall Study|Disease progression|2|||
130947212|NCT00352846|471439994|FG000|Overall Study|Withdrawal by Subject|3|||
130947213|NCT00352846|471439995|FG001|Overall Study|Withdrawal by Subject|8|||
130947214|NCT00352846|471439994|FG000|Overall Study|Ineligible|3|||
130947215|NCT00352846|471439995|FG001|Overall Study|Ineligible|2|||
130947216|NCT00352846|471439994|FG000|Overall Study|Non-compliance|2|||
130947217|NCT00352846|471439995|FG001|Overall Study|Non-compliance|0|||
130947218|NCT00352846|471439994|FG000|Overall Study|Death|0|||
130947219|NCT00352846|471439995|FG001|Overall Study|Death|1|||
130947220|NCT00788827|471439996|FG000|Overall Study|Lack of Efficacy|2|||
130947221|NCT01527682|471440003|FG000|Overall Study|Protocol Violation|8|||
130947222|NCT03979638|471440005|FG000|Period 1|Physician Decision|1|||
130947223|NCT03979638|471440006|FG001|Period 1|Physician Decision|1|||
130947224|NCT03979638|471440005|FG000|Period 1|Withdrawal by Subject|4|||
130947225|NCT03979638|471440006|FG001|Period 1|Withdrawal by Subject|3|||
130947226|NCT03979638|471440005|FG000|Period 1|Study terminated by Sponsor|1|||
130947227|NCT03979638|471440006|FG001|Period 1|Study terminated by Sponsor|3|||
130947228|NCT03979638|471440005|FG000|Period 1|Protocol Violation|1|||
130947229|NCT03979638|471440006|FG001|Period 1|Protocol Violation|0|||
131037478|NCT04436276|471770671|FG020|Overall Study|Adverse Event|0|||
131037479|NCT04436276|471770672|FG021|Overall Study|Adverse Event|0|||
131037480|NCT04436276|471770673|FG022|Overall Study|Adverse Event|0|||
131037481|NCT04436276|471770651|FG000|Overall Study|Death|0|||
131037482|NCT04436276|471770652|FG001|Overall Study|Death|0|||
131037483|NCT04436276|471770653|FG002|Overall Study|Death|0|||
131037484|NCT04436276|471770654|FG003|Overall Study|Death|0|||
131037485|NCT04436276|471770655|FG004|Overall Study|Death|0|||
131037486|NCT04436276|471770656|FG005|Overall Study|Death|0|||
130947230|NCT03979638|471440005|FG000|Period 2|Study terminated by Sponsor|1|||
130710567|NCT03545191|470564880|FG002|Overall Study|Adverse Event|7|||
130710568|NCT03545191|470564878|FG000|Overall Study|Other reasons|3|||
130947231|NCT03979638|471440006|FG001|Period 2|Study terminated by Sponsor|1|||
130947232|NCT04248933|471440009|FG000|Overall Study|Lost to Follow-up|9|||
130947233|NCT04248933|471440009|FG000|Overall Study|Withdrawal by Subject|2|||
131037487|NCT04436276|471770657|FG006|Overall Study|Death|0|||
131037488|NCT04436276|471770658|FG007|Overall Study|Death|0|||
130947234|NCT04220411|471440020|FG000|Overall Study|Adverse Event|0|||
130947235|NCT04220411|471440021|FG001|Overall Study|Adverse Event|0|||
130947236|NCT04220411|471440022|FG002|Overall Study|Adverse Event|0|||
130947237|NCT04220411|471440023|FG003|Overall Study|Adverse Event|1|||
130947238|NCT02028988|471440024|FG000|Overall Study|Withdrawal by Subject|2|||
130947239|NCT00851799|471440025|FG000|Overall Study|Death|1|||
130947240|NCT00851799|471440026|FG001|Overall Study|Death|0|||
130947241|NCT00851799|471440027|FG002|Overall Study|Death|1|||
130947242|NCT00851799|471440025|FG000|Overall Study|Lost to Follow-up|5|||
130947243|NCT00851799|471440026|FG001|Overall Study|Lost to Follow-up|3|||
130947244|NCT00851799|471440027|FG002|Overall Study|Lost to Follow-up|10|||
130947245|NCT00851799|471440025|FG000|Overall Study|Not able to get to clinic|8|||
130947246|NCT00851799|471440026|FG001|Overall Study|Not able to get to clinic|5|||
130947247|NCT00851799|471440027|FG002|Overall Study|Not able to get to clinic|9|||
130947248|NCT00851799|471440025|FG000|Overall Study|Not willing to adhere to requirements|1|||
130947249|NCT00851799|471440026|FG001|Overall Study|Not willing to adhere to requirements|2|||
130947250|NCT00851799|471440027|FG002|Overall Study|Not willing to adhere to requirements|2|||
130947251|NCT00851799|471440025|FG000|Overall Study|Withdrew consent prior study completion|1|||
131124587|NCT02973087|472084502|FG001|Overall Study|Adverse Event|0|||
131124588|NCT02973087|472084501|FG000|Overall Study|other|1|||
131124589|NCT02973087|472084502|FG001|Overall Study|other|1|||
131124590|NCT00932360|472084503|FG000|Washout (One Week)|Withdrawal by Subject|0|||
131124591|NCT00932360|472084504|FG001|Washout (One Week)|Withdrawal by Subject|0|||
131124592|NCT00932360|472084505|FG002|Washout (One Week)|Withdrawal by Subject|0|||
131124593|NCT00932360|472084506|FG003|Washout (One Week)|Withdrawal by Subject|0|||
131124594|NCT00932360|472084507|FG004|Washout (One Week)|Withdrawal by Subject|2|||
131124595|NCT00932360|472084508|FG005|Washout (One Week)|Withdrawal by Subject|0|||
131124596|NCT04143009|472084509|FG000|Pilot Trial|Lost to Follow-up|0|||
131124597|NCT04143009|472084510|FG001|Pilot Trial|Lost to Follow-up|1|||
131124598|NCT04143009|472084511|FG002|Pilot Trial|Lost to Follow-up|1|||
131124599|NCT05003622|472084512|FG000|Overall Study|Progressive disease|2|||
131124600|NCT05003622|472084512|FG000|Overall Study|Withdrawal by Subject|1|||
130947252|NCT00851799|471440026|FG001|Overall Study|Withdrew consent prior study completion|2|||
130947253|NCT00851799|471440027|FG002|Overall Study|Withdrew consent prior study completion|1|||
130947254|NCT00851799|471440025|FG000|Overall Study|Severe Debilitation|0|||
130947255|NCT00851799|471440026|FG001|Overall Study|Severe Debilitation|1|||
130947256|NCT00851799|471440027|FG002|Overall Study|Severe Debilitation|0|||
130947257|NCT00851799|471440025|FG000|Overall Study|Completed protocol due to pregnancy|0|||
130947258|NCT00851799|471440026|FG001|Overall Study|Completed protocol due to pregnancy|0|||
130947259|NCT00851799|471440027|FG002|Overall Study|Completed protocol due to pregnancy|1|||
130947260|NCT04365556|471440041|FG000|Overall Study|No longer eligible due to treatment plan|1|||
130947261|NCT04365556|471440042|FG001|Overall Study|No longer eligible due to treatment plan|0|||
130947262|NCT04365556|471440041|FG000|Overall Study|Lost to Follow-up|3|||
130947263|NCT04365556|471440042|FG001|Overall Study|Lost to Follow-up|2|||
130947264|NCT04439318|471440043|FG000|Overall Study|Ineligible|1|||
130947265|NCT04439318|471440043|FG000|Overall Study|Never Started Treatment|3|||
130947266|NCT04439318|471440043|FG000|Overall Study|Adverse Event|10|||
130947267|NCT04439318|471440043|FG000|Overall Study|Death|2|||
130947268|NCT04439318|471440043|FG000|Overall Study|Disease Progression|25|||
130947269|NCT04439318|471440043|FG000|Overall Study|Other Complicating Disease|2|||
130947270|NCT04439318|471440043|FG000|Overall Study|Withdrawal by Subject|4|||
130947271|NCT04439318|471440043|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
130947272|NCT04439318|471440043|FG000|Overall Study|Non-Compliance|1|||
130947273|NCT04439318|471440043|FG000|Overall Study|Still on Treatment|1|||
130947274|NCT00699972|471441274|FG000|Overall Study|Adverse Event|7|||
130947275|NCT00699972|471441275|FG001|Overall Study|Adverse Event|9|||
130947276|NCT00699972|471441276|FG002|Overall Study|Adverse Event|24|||
130947277|NCT00699972|471441274|FG000|Overall Study|Lost to Follow-up|0|||
130947278|NCT00699972|471441275|FG001|Overall Study|Lost to Follow-up|2|||
130947279|NCT00699972|471441276|FG002|Overall Study|Lost to Follow-up|0|||
130947280|NCT00699972|471441274|FG000|Overall Study|Withdrawal by Subject|3|||
130947281|NCT00699972|471441275|FG001|Overall Study|Withdrawal by Subject|7|||
130947282|NCT00699972|471441276|FG002|Overall Study|Withdrawal by Subject|4|||
130947283|NCT00699972|471441274|FG000|Overall Study|Lack of Efficacy|2|||
130947284|NCT00699972|471441275|FG001|Overall Study|Lack of Efficacy|0|||
130947285|NCT00699972|471441276|FG002|Overall Study|Lack of Efficacy|2|||
130947286|NCT00699972|471441274|FG000|Overall Study|Administrative/Other|3|||
130947287|NCT00699972|471441275|FG001|Overall Study|Administrative/Other|1|||
130947288|NCT00699972|471441276|FG002|Overall Study|Administrative/Other|4|||
131124601|NCT01045798|472084518|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
130947289|NCT00699972|471441274|FG000|Overall Study|Randomized, Not Treated|1|||
130947290|NCT00699972|471441275|FG001|Overall Study|Randomized, Not Treated|0|||
130947291|NCT00699972|471441276|FG002|Overall Study|Randomized, Not Treated|1|||
131124602|NCT01045798|472084519|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
131124603|NCT01045798|472084518|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
130947292|NCT00644969|471441283|FG000|Treatment Phase|Randomized, not treated|1|||
130947293|NCT00644969|471441284|FG001|Treatment Phase|Randomized, not treated|0|||
130774175|NCT01473940|470800435|FG002|Induction Therapy|Progressive Disease|1|||
130774176|NCT01473940|470800436|FG003|Induction Therapy|Progressive Disease|0|||
130774177|NCT01473940|470800433|FG000|Maintenance Therapy|Progressive Disease|1|||
130774178|NCT01473940|470800434|FG001|Maintenance Therapy|Progressive Disease|2|||
130774179|NCT01473940|470800435|FG002|Maintenance Therapy|Progressive Disease|1|||
130774180|NCT01473940|470800436|FG003|Maintenance Therapy|Progressive Disease|4|||
130774181|NCT00547248|470800437|FG000|Overall Study|Protocol Violation|0|||
130774182|NCT00547248|470800438|FG001|Overall Study|Protocol Violation|0|||
130774183|NCT00547248|470800439|FG002|Overall Study|Protocol Violation|1|||
130774184|NCT00547248|470800440|FG003|Overall Study|Protocol Violation|1|||
130774185|NCT00547248|470800437|FG000|Overall Study|Migrated/moved from study area|0|||
130774186|NCT00547248|470800438|FG001|Overall Study|Migrated/moved from study area|0|||
130774187|NCT00547248|470800439|FG002|Overall Study|Migrated/moved from study area|2|||
130774188|NCT00547248|470800440|FG003|Overall Study|Migrated/moved from study area|0|||
130774189|NCT00547248|470800437|FG000|Overall Study|Withdrawal by Subject|0|||
130774190|NCT00547248|470800438|FG001|Overall Study|Withdrawal by Subject|0|||
130774191|NCT00547248|470800439|FG002|Overall Study|Withdrawal by Subject|7|||
130774192|NCT00547248|470800440|FG003|Overall Study|Withdrawal by Subject|1|||
130774193|NCT00534248|470800441|FG000|Overall Study|Adverse Event|19|||
130774194|NCT00534248|470800442|FG001|Overall Study|Adverse Event|29|||
130774195|NCT00534248|470800441|FG000|Overall Study|Lost to Follow-up|353|||
130947294|NCT00644969|471441283|FG000|Treatment Phase|Adverse Event|3|||
130947295|NCT00644969|471441284|FG001|Treatment Phase|Adverse Event|0|||
130947296|NCT00644969|471441283|FG000|Treatment Phase|Withdrawal by Subject|4|||
130947297|NCT00644969|471441284|FG001|Treatment Phase|Withdrawal by Subject|0|||
130947298|NCT00644969|471441283|FG000|Treatment Phase|Lost to Follow-up|2|||
130947299|NCT00644969|471441284|FG001|Treatment Phase|Lost to Follow-up|2|||
130947300|NCT00644969|471441283|FG000|Treatment Phase|Other|4|||
130947301|NCT00644969|471441284|FG001|Treatment Phase|Other|1|||
130947302|NCT00644969|471441283|FG000|Post Treatment Phase|Death|1|||
130947303|NCT00644969|471441284|FG001|Post Treatment Phase|Death|0|||
130947304|NCT00644969|471441283|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
130947305|NCT00644969|471441284|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
130947306|NCT00644969|471441283|FG000|Post Treatment Phase|Lost to Follow-up|4|||
130947307|NCT00644969|471441284|FG001|Post Treatment Phase|Lost to Follow-up|1|||
130947308|NCT00644969|471441283|FG000|Post Treatment Phase|Other|1|||
130947309|NCT00644969|471441284|FG001|Post Treatment Phase|Other|0|||
130947310|NCT03509675|471441286|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
130947311|NCT03509675|471441287|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
130947312|NCT03509675|471441286|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
130947313|NCT03509675|471441287|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
130947314|NCT03509675|471441286|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
130947315|NCT03509675|471441287|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
130947316|NCT03509675|471441286|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
130947317|NCT03509675|471441287|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
130947318|NCT01023581|471441293|FG000|Overall Study|Adverse Event|4|||
130947319|NCT01023581|471441294|FG001|Overall Study|Adverse Event|4|||
130947320|NCT01023581|471441295|FG002|Overall Study|Adverse Event|7|||
130947321|NCT01023581|471441296|FG003|Overall Study|Adverse Event|3|||
130947322|NCT01023581|471441297|FG004|Overall Study|Adverse Event|2|||
131225095|NCT01375010|472451949|FG001|Overall Study|Withdrawal by Subject|2|||
130774196|NCT00534248|470800442|FG001|Overall Study|Lost to Follow-up|375|||
130774197|NCT00534248|470800441|FG000|Overall Study|Other protocol specified criteria|13|||
130774198|NCT00534248|470800442|FG001|Overall Study|Other protocol specified criteria|3|||
130774199|NCT00534248|470800441|FG000|Overall Study|Physician Decision|10|||
130774200|NCT00534248|470800442|FG001|Overall Study|Physician Decision|7|||
130774201|NCT00534248|470800441|FG000|Overall Study|Protocol Violation|3|||
130774202|NCT00534248|470800442|FG001|Overall Study|Protocol Violation|4|||
130774203|NCT00534248|470800441|FG000|Overall Study|Withdrawal by Subject|263|||
130774204|NCT00534248|470800442|FG001|Overall Study|Withdrawal by Subject|255|||
130774205|NCT02532257|470800445|FG000|Overall Study|Adverse Event|2|||
130774206|NCT02532257|470800445|FG000|Overall Study|Physician Decision|4|||
130774207|NCT02532257|470800445|FG000|Overall Study|Withdrawal by Subject|3|||
130947323|NCT01023581|471441298|FG005|Overall Study|Adverse Event|5|||
130947324|NCT01023581|471441299|FG006|Overall Study|Adverse Event|11|||
130947325|NCT01023581|471441293|FG000|Overall Study|Major protocol deviation|2|||
130947326|NCT01023581|471441294|FG001|Overall Study|Major protocol deviation|0|||
130947327|NCT01023581|471441295|FG002|Overall Study|Major protocol deviation|3|||
130947328|NCT01023581|471441296|FG003|Overall Study|Major protocol deviation|0|||
130947329|NCT01023581|471441297|FG004|Overall Study|Major protocol deviation|0|||
130947330|NCT01023581|471441298|FG005|Overall Study|Major protocol deviation|0|||
130947331|NCT01023581|471441299|FG006|Overall Study|Major protocol deviation|0|||
130774208|NCT02532257|470800445|FG000|Overall Study|Progressive Disease|10|||
130774209|NCT02849171|470800446|FG000|Overall Study|Withdrawal by Subject|1|||
130774210|NCT02849171|470800446|FG000|Overall Study|Not treated|1|||
130774211|NCT02259400|470800449|FG000|Overall Study|Death|0|||
130774212|NCT02259400|470800450|FG001|Overall Study|Death|2|||
130710569|NCT03545191|470564879|FG001|Overall Study|Other reasons|11|||
130710570|NCT03545191|470564880|FG002|Overall Study|Other reasons|8|||
130710571|NCT03545191|470564878|FG000|Overall Study|Withdrawal by Subject|13|||
131037489|NCT04436276|471770659|FG008|Overall Study|Death|0|||
131037490|NCT04436276|471770660|FG009|Overall Study|Death|0|||
131037491|NCT04436276|471770661|FG010|Overall Study|Death|0|||
131037492|NCT04436276|471770662|FG011|Overall Study|Death|0|||
131037493|NCT04436276|471770663|FG012|Overall Study|Death|1|||
131037494|NCT04436276|471770664|FG013|Overall Study|Death|0|||
131037495|NCT04436276|471770665|FG014|Overall Study|Death|1|||
131037496|NCT04436276|471770666|FG015|Overall Study|Death|0|||
131037497|NCT04436276|471770667|FG016|Overall Study|Death|0|||
131037498|NCT04436276|471770668|FG017|Overall Study|Death|0|||
131037499|NCT04436276|471770669|FG018|Overall Study|Death|0|||
131037500|NCT04436276|471770670|FG019|Overall Study|Death|2|||
131037501|NCT04436276|471770671|FG020|Overall Study|Death|0|||
131037502|NCT04436276|471770672|FG021|Overall Study|Death|1|||
130710572|NCT03545191|470564879|FG001|Overall Study|Withdrawal by Subject|10|||
130710573|NCT03545191|470564880|FG002|Overall Study|Withdrawal by Subject|12|||
130710574|NCT03545191|470564878|FG000|Overall Study|Lost to Follow-up|1|||
131037503|NCT04436276|471770673|FG022|Overall Study|Death|0|||
131037504|NCT04436276|471770651|FG000|Overall Study|Lost to Follow-up|0|||
131124604|NCT01045798|472084519|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
131124605|NCT01045798|472084518|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
131124606|NCT01045798|472084519|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
131124607|NCT01045798|472084518|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
131124608|NCT01045798|472084519|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
131124609|NCT01484977|472084523|FG000|Overall Study|Adverse Event|8|||
131124610|NCT01484977|472084523|FG000|Overall Study|Lack of Efficacy|4|||
131124611|NCT01484977|472084523|FG000|Overall Study|Protocol Violation|6|||
131124612|NCT01484977|472084523|FG000|Overall Study|Lost to Follow-up|1|||
131124613|NCT01484977|472084523|FG000|Overall Study|Withdrawal by Subject|4|||
131124614|NCT01484977|472084523|FG000|Overall Study|Subject Protocol Non-compliant|1|||
131124615|NCT01484977|472084523|FG000|Overall Study|Moving Overseas|1|||
131124616|NCT01484977|472084523|FG000|Overall Study|Low White Blood Cell Count|1|||
131124617|NCT01484977|472084523|FG000|Overall Study|Lack of Compliance|1|||
131124618|NCT04857996|472084524|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
131124619|NCT04857996|472084525|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
131124620|NCT04857996|472084524|FG000|Overall Study|Lost to Follow-up|1|||
131124621|NCT04857996|472084525|FG001|Overall Study|Lost to Follow-up|3|||
131124622|NCT04857996|472084524|FG000|Overall Study|Site Closure|1|||
131124623|NCT04857996|472084525|FG001|Overall Study|Site Closure|0|||
131124624|NCT04857996|472084524|FG000|Overall Study|Withdrawal by Subject|1|||
131124625|NCT04857996|472084525|FG001|Overall Study|Withdrawal by Subject|0|||
131124626|NCT01538628|472084526|FG000|Overall Study|Withdrawal by Subject|1|||
131124627|NCT01538628|472084527|FG001|Overall Study|Withdrawal by Subject|1|||
131124628|NCT01538628|472084526|FG000|Overall Study|Lost to Follow-up|0|||
131124629|NCT01538628|472084527|FG001|Overall Study|Lost to Follow-up|1|||
131124630|NCT00597753|472084528|FG000|Overall Study|Adverse Event|6|||
131124631|NCT00597753|472084529|FG001|Overall Study|Adverse Event|2|||
130710575|NCT03545191|470564879|FG001|Overall Study|Lost to Follow-up|2|||
130710576|NCT03545191|470564880|FG002|Overall Study|Lost to Follow-up|3|||
130710577|NCT01277718|470564882|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
130710578|NCT01277718|470564883|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
130710579|NCT01277718|470564882|FG000|Period 2 - Second Intervention|Physician Decision|0|||
130710580|NCT01277718|470564883|FG001|Period 2 - Second Intervention|Physician Decision|2|||
131124632|NCT00597753|472084528|FG000|Overall Study|Death|55|||
131124633|NCT00597753|472084529|FG001|Overall Study|Death|29|||
131124634|NCT00597753|472084528|FG000|Overall Study|Lack of Efficacy|2|||
131124635|NCT00597753|472084529|FG001|Overall Study|Lack of Efficacy|0|||
131124636|NCT00597753|472084528|FG000|Overall Study|Lost to Follow-up|10|||
131124637|NCT00597753|472084529|FG001|Overall Study|Lost to Follow-up|3|||
131124638|NCT00597753|472084528|FG000|Overall Study|Physician Decision|5|||
131124639|NCT00597753|472084529|FG001|Overall Study|Physician Decision|1|||
131037505|NCT04436276|471770652|FG001|Overall Study|Lost to Follow-up|2|||
131037506|NCT04436276|471770653|FG002|Overall Study|Lost to Follow-up|2|||
131037507|NCT04436276|471770654|FG003|Overall Study|Lost to Follow-up|1|||
131124640|NCT00597753|472084528|FG000|Overall Study|Pregnancy|1|||
131124641|NCT00597753|472084529|FG001|Overall Study|Pregnancy|0|||
130710581|NCT01524913|470564884|FG000|Overall Study|Lost to Follow-up|4|||
130710582|NCT01524913|470564885|FG001|Overall Study|Lost to Follow-up|0|||
130710583|NCT01524913|470564886|FG002|Overall Study|Lost to Follow-up|0|||
131124642|NCT00597753|472084528|FG000|Overall Study|Withdrawal by Subject|35|||
131037508|NCT04436276|471770655|FG004|Overall Study|Lost to Follow-up|4|||
131037509|NCT04436276|471770656|FG005|Overall Study|Lost to Follow-up|1|||
131037510|NCT04436276|471770657|FG006|Overall Study|Lost to Follow-up|0|||
131037511|NCT04436276|471770658|FG007|Overall Study|Lost to Follow-up|0|||
131037512|NCT04436276|471770659|FG008|Overall Study|Lost to Follow-up|1|||
130710584|NCT02181296|470564887|FG000|Overall Study|Lost to Follow-up|7|||
130710585|NCT02181296|470564888|FG001|Overall Study|Lost to Follow-up|6|||
130710586|NCT00788593|470564891|FG000|Placebo Run-in Phase|Adverse Event|2|||
130710587|NCT00788593|470564892|FG001|Placebo Run-in Phase|Adverse Event|0|||
130710588|NCT00788593|470564893|FG002|Placebo Run-in Phase|Adverse Event|0|||
130710589|NCT00788593|470564891|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
130710590|NCT00788593|470564892|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
130774213|NCT00697593|470800454|FG000|Overall Study|Adverse Event|3|||
130774214|NCT00697593|470800454|FG000|Overall Study|Protocol Violation|1|||
130774215|NCT00697593|470800454|FG000|Overall Study|Lack of Efficacy|3|||
130774216|NCT00697593|470800454|FG000|Overall Study|Suspension of the study by sponsor|12|||
130774217|NCT02964338|470800458|FG000|Overall Study|Sponsor terminated study for futility|12|||
130774218|NCT02964338|470800459|FG001|Overall Study|Sponsor terminated study for futility|15|||
130774219|NCT02964338|470800460|FG002|Overall Study|Sponsor terminated study for futility|14|||
130774220|NCT02964338|470800458|FG000|Overall Study|Lack of Efficacy|0|||
130774221|NCT02964338|470800459|FG001|Overall Study|Lack of Efficacy|3|||
130774222|NCT02964338|470800460|FG002|Overall Study|Lack of Efficacy|0|||
130774223|NCT02964338|470800458|FG000|Overall Study|Lost to Follow-up|1|||
130774224|NCT02964338|470800459|FG001|Overall Study|Lost to Follow-up|0|||
130774225|NCT02964338|470800460|FG002|Overall Study|Lost to Follow-up|3|||
130774226|NCT02964338|470800458|FG000|Overall Study|Protocol Violation|0|||
130774227|NCT02964338|470800459|FG001|Overall Study|Protocol Violation|1|||
130774228|NCT02964338|470800460|FG002|Overall Study|Protocol Violation|0|||
130774229|NCT02964338|470800458|FG000|Overall Study|Withdrawal by Subject|1|||
130774230|NCT02964338|470800459|FG001|Overall Study|Withdrawal by Subject|3|||
130774231|NCT02964338|470800460|FG002|Overall Study|Withdrawal by Subject|1|||
130774232|NCT02964338|470800458|FG000|Overall Study|Adverse Event|2|||
130774233|NCT02964338|470800459|FG001|Overall Study|Adverse Event|1|||
130774234|NCT02964338|470800460|FG002|Overall Study|Adverse Event|1|||
130774235|NCT02964338|470800458|FG000|Overall Study|Non-compliant with e-diary|0|||
130774236|NCT02964338|470800459|FG001|Overall Study|Non-compliant with e-diary|1|||
130774237|NCT02964338|470800460|FG002|Overall Study|Non-compliant with e-diary|0|||
130774238|NCT02964338|470800458|FG000|Overall Study|Did not meet criteria|1|||
130774239|NCT02964338|470800459|FG001|Overall Study|Did not meet criteria|0|||
130774240|NCT02964338|470800460|FG002|Overall Study|Did not meet criteria|0|||
130774241|NCT02239640|470800461|FG000|Overall Study|Withdrawal by Subject|3|||
130774242|NCT02239640|470800461|FG000|Overall Study|Lost to Follow-up|72|||
130774243|NCT02239640|470800461|FG000|Overall Study|Death|142|||
130774244|NCT02372383|470800464|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
130774245|NCT02372383|470800465|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
130774246|NCT02372383|470800466|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
130774247|NCT02630563|470800467|FG000|Overall Study|Administrative|1|||
130774248|NCT00621257|470800468|FG000|Overall Study|Lost to Follow-up|4|||
130774249|NCT00621257|470800469|FG001|Overall Study|Lost to Follow-up|0|||
130774250|NCT00621257|470800470|FG002|Overall Study|Lost to Follow-up|2|||
130774251|NCT00621257|470800471|FG003|Overall Study|Lost to Follow-up|4|||
130774252|NCT00621257|470800472|FG004|Overall Study|Lost to Follow-up|7|||
130774253|NCT00621257|470800468|FG000|Overall Study|Adverse Event|0|||
130774254|NCT00621257|470800469|FG001|Overall Study|Adverse Event|1|||
130774255|NCT00621257|470800470|FG002|Overall Study|Adverse Event|1|||
130774256|NCT00621257|470800471|FG003|Overall Study|Adverse Event|0|||
130774257|NCT00621257|470800472|FG004|Overall Study|Adverse Event|0|||
130774258|NCT00621257|470800468|FG000|Overall Study|Physician Decision|0|||
130774259|NCT00621257|470800469|FG001|Overall Study|Physician Decision|2|||
130774260|NCT00621257|470800470|FG002|Overall Study|Physician Decision|0|||
130774261|NCT00621257|470800471|FG003|Overall Study|Physician Decision|1|||
130774262|NCT00621257|470800472|FG004|Overall Study|Physician Decision|1|||
130774263|NCT00621257|470800468|FG000|Overall Study|Withdrawal by Subject|0|||
130774264|NCT00621257|470800469|FG001|Overall Study|Withdrawal by Subject|0|||
130774265|NCT00621257|470800470|FG002|Overall Study|Withdrawal by Subject|0|||
130774266|NCT00621257|470800471|FG003|Overall Study|Withdrawal by Subject|1|||
130774267|NCT00621257|470800472|FG004|Overall Study|Withdrawal by Subject|1|||
130710591|NCT00788593|470564893|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
130774268|NCT01255904|470800473|FG000|Overall Study|Physician Decision|1|||
130710592|NCT00788593|470564891|FG000|Placebo Run-in Phase|Protocol Violation|2|||
130710593|NCT00788593|470564892|FG001|Placebo Run-in Phase|Protocol Violation|0|||
130774269|NCT01255904|470800474|FG001|Overall Study|Physician Decision|4|||
130774270|NCT02061813|470800478|FG000|Overall Study|Withdrawal by Subject|1|||
130710594|NCT00788593|470564893|FG002|Placebo Run-in Phase|Protocol Violation|0|||
130774271|NCT02061813|470800478|FG000|Overall Study|Protocol Violation|2|||
130774272|NCT01705080|470800481|FG000|Overall Study|Missed visit|10|||
130774273|NCT01705080|470800482|FG001|Overall Study|Missed visit|4|||
130774274|NCT01705080|470800483|FG002|Overall Study|Missed visit|1|||
130774275|NCT01705080|470800481|FG000|Overall Study|Death|4|||
130774276|NCT01705080|470800482|FG001|Overall Study|Death|4|||
130774277|NCT01705080|470800483|FG002|Overall Study|Death|6|||
130774278|NCT01705080|470800481|FG000|Overall Study|Withdrawal by Subject|61|||
130774279|NCT01705080|470800482|FG001|Overall Study|Withdrawal by Subject|44|||
130774280|NCT01705080|470800483|FG002|Overall Study|Withdrawal by Subject|9|||
130774281|NCT00206427|470800485|FG000|Overall Study|Adverse Event|2|||
130774282|NCT00632125|470800489|FG000|Overall Study|Death|82|||
130774283|NCT00632125|470800489|FG000|Overall Study|Withdrawal by Subject|44|||
130774284|NCT00632125|470800489|FG000|Overall Study|Adverse Event|36|||
130774285|NCT00632125|470800489|FG000|Overall Study|Renal transplantation|17|||
130947332|NCT01023581|471441293|FG000|Overall Study|Lost to Follow-up|4|||
130947333|NCT01023581|471441294|FG001|Overall Study|Lost to Follow-up|8|||
130947334|NCT01023581|471441295|FG002|Overall Study|Lost to Follow-up|7|||
130947335|NCT01023581|471441296|FG003|Overall Study|Lost to Follow-up|2|||
130947336|NCT01023581|471441297|FG004|Overall Study|Lost to Follow-up|5|||
130947337|NCT01023581|471441298|FG005|Overall Study|Lost to Follow-up|2|||
130947338|NCT01023581|471441299|FG006|Overall Study|Lost to Follow-up|2|||
130947339|NCT01023581|471441293|FG000|Overall Study|Withdrawal by Subject|13|||
130947340|NCT01023581|471441294|FG001|Overall Study|Withdrawal by Subject|8|||
130947341|NCT01023581|471441295|FG002|Overall Study|Withdrawal by Subject|16|||
130947342|NCT01023581|471441296|FG003|Overall Study|Withdrawal by Subject|10|||
130947343|NCT01023581|471441297|FG004|Overall Study|Withdrawal by Subject|6|||
130947344|NCT01023581|471441298|FG005|Overall Study|Withdrawal by Subject|8|||
130947345|NCT01023581|471441299|FG006|Overall Study|Withdrawal by Subject|5|||
130947346|NCT01023581|471441293|FG000|Overall Study|Pregnancy|0|||
130947347|NCT01023581|471441294|FG001|Overall Study|Pregnancy|0|||
130947348|NCT01023581|471441295|FG002|Overall Study|Pregnancy|0|||
130947349|NCT01023581|471441296|FG003|Overall Study|Pregnancy|2|||
130947350|NCT01023581|471441297|FG004|Overall Study|Pregnancy|0|||
130947351|NCT01023581|471441298|FG005|Overall Study|Pregnancy|1|||
130947352|NCT01023581|471441299|FG006|Overall Study|Pregnancy|0|||
131037513|NCT04436276|471770660|FG009|Overall Study|Lost to Follow-up|0|||
131037514|NCT04436276|471770661|FG010|Overall Study|Lost to Follow-up|5|||
131037515|NCT04436276|471770662|FG011|Overall Study|Lost to Follow-up|5|||
130774286|NCT00632125|470800489|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
130774287|NCT00632125|470800489|FG000|Overall Study|Non-compliance|8|||
130774288|NCT00632125|470800489|FG000|Overall Study|Development of uncontrolled hypertension|5|||
130774289|NCT00632125|470800489|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
130774290|NCT03130959|470800496|FG000|Overall Study|Disease progression|19|||
130774291|NCT03130959|470800497|FG001|Overall Study|Disease progression|7|||
130774292|NCT03130959|470800498|FG002|Overall Study|Disease progression|12|||
130774293|NCT03130959|470800499|FG003|Overall Study|Disease progression|7|||
130774294|NCT03130959|470800500|FG004|Overall Study|Disease progression|12|||
131037516|NCT04436276|471770663|FG012|Overall Study|Lost to Follow-up|4|||
130774295|NCT03130959|470800501|FG005|Overall Study|Disease progression|3|||
130774296|NCT03130959|470800502|FG006|Overall Study|Disease progression|6|||
131037517|NCT04436276|471770664|FG013|Overall Study|Lost to Follow-up|1|||
130774297|NCT03130959|470800503|FG007|Overall Study|Disease progression|3|||
130774298|NCT03130959|470800504|FG008|Overall Study|Disease progression|15|||
130774299|NCT03130959|470800505|FG009|Overall Study|Disease progression|8|||
130774300|NCT03130959|470800496|FG000|Overall Study|Study drug toxicity|2|||
130774301|NCT03130959|470800497|FG001|Overall Study|Study drug toxicity|2|||
130774302|NCT03130959|470800498|FG002|Overall Study|Study drug toxicity|1|||
130774303|NCT03130959|470800499|FG003|Overall Study|Study drug toxicity|2|||
130774304|NCT03130959|470800500|FG004|Overall Study|Study drug toxicity|1|||
130774305|NCT03130959|470800501|FG005|Overall Study|Study drug toxicity|1|||
131037518|NCT04436276|471770665|FG014|Overall Study|Lost to Follow-up|7|||
131037519|NCT04436276|471770666|FG015|Overall Study|Lost to Follow-up|7|||
131037520|NCT04436276|471770667|FG016|Overall Study|Lost to Follow-up|1|||
130774306|NCT03130959|470800502|FG006|Overall Study|Study drug toxicity|3|||
130774307|NCT03130959|470800503|FG007|Overall Study|Study drug toxicity|0|||
130774308|NCT03130959|470800504|FG008|Overall Study|Study drug toxicity|3|||
130774309|NCT03130959|470800505|FG009|Overall Study|Study drug toxicity|3|||
130774310|NCT03130959|470800496|FG000|Overall Study|Other reasons|0|||
130774311|NCT03130959|470800497|FG001|Overall Study|Other reasons|0|||
130774312|NCT03130959|470800498|FG002|Overall Study|Other reasons|0|||
130774313|NCT03130959|470800499|FG003|Overall Study|Other reasons|0|||
130774314|NCT03130959|470800500|FG004|Overall Study|Other reasons|0|||
130774315|NCT03130959|470800501|FG005|Overall Study|Other reasons|1|||
130774316|NCT03130959|470800502|FG006|Overall Study|Other reasons|1|||
130774317|NCT03130959|470800503|FG007|Overall Study|Other reasons|0|||
130774318|NCT03130959|470800504|FG008|Overall Study|Other reasons|0|||
130774319|NCT03130959|470800505|FG009|Overall Study|Other reasons|0|||
130774320|NCT03130959|470800496|FG000|Overall Study|Subject request to discontinue therapy|0|||
130774321|NCT03130959|470800497|FG001|Overall Study|Subject request to discontinue therapy|0|||
130947353|NCT01023581|471441293|FG000|Overall Study|Lack of Efficacy|9|||
130947354|NCT01023581|471441294|FG001|Overall Study|Lack of Efficacy|3|||
130947355|NCT01023581|471441295|FG002|Overall Study|Lack of Efficacy|6|||
130947356|NCT01023581|471441296|FG003|Overall Study|Lack of Efficacy|2|||
130947357|NCT01023581|471441297|FG004|Overall Study|Lack of Efficacy|1|||
130774322|NCT03130959|470800498|FG002|Overall Study|Subject request to discontinue therapy|1|||
130947358|NCT01023581|471441298|FG005|Overall Study|Lack of Efficacy|2|||
130947359|NCT01023581|471441299|FG006|Overall Study|Lack of Efficacy|1|||
131037521|NCT04436276|471770668|FG017|Overall Study|Lost to Follow-up|0|||
131037522|NCT04436276|471770669|FG018|Overall Study|Lost to Follow-up|1|||
131037523|NCT04436276|471770670|FG019|Overall Study|Lost to Follow-up|1|||
131037524|NCT04436276|471770671|FG020|Overall Study|Lost to Follow-up|2|||
131037525|NCT04436276|471770672|FG021|Overall Study|Lost to Follow-up|1|||
131037526|NCT04436276|471770673|FG022|Overall Study|Lost to Follow-up|1|||
131037527|NCT04436276|471770651|FG000|Overall Study|Physician Decision|1|||
131037528|NCT04436276|471770652|FG001|Overall Study|Physician Decision|0|||
131037529|NCT04436276|471770653|FG002|Overall Study|Physician Decision|2|||
131037530|NCT04436276|471770654|FG003|Overall Study|Physician Decision|1|||
131037531|NCT04436276|471770655|FG004|Overall Study|Physician Decision|0|||
131037532|NCT04436276|471770656|FG005|Overall Study|Physician Decision|0|||
131037533|NCT04436276|471770657|FG006|Overall Study|Physician Decision|0|||
131037534|NCT04436276|471770658|FG007|Overall Study|Physician Decision|0|||
131037535|NCT04436276|471770659|FG008|Overall Study|Physician Decision|0|||
131037536|NCT04436276|471770660|FG009|Overall Study|Physician Decision|0|||
131037537|NCT04436276|471770661|FG010|Overall Study|Physician Decision|0|||
131037538|NCT04436276|471770662|FG011|Overall Study|Physician Decision|1|||
131037539|NCT04436276|471770663|FG012|Overall Study|Physician Decision|2|||
131037540|NCT04436276|471770664|FG013|Overall Study|Physician Decision|0|||
131037541|NCT04436276|471770665|FG014|Overall Study|Physician Decision|0|||
131037542|NCT04436276|471770666|FG015|Overall Study|Physician Decision|0|||
131037543|NCT04436276|471770667|FG016|Overall Study|Physician Decision|0|||
131037544|NCT04436276|471770668|FG017|Overall Study|Physician Decision|0|||
131037545|NCT04436276|471770669|FG018|Overall Study|Physician Decision|0|||
131037546|NCT04436276|471770670|FG019|Overall Study|Physician Decision|0|||
131037547|NCT04436276|471770671|FG020|Overall Study|Physician Decision|1|||
131037548|NCT04436276|471770672|FG021|Overall Study|Physician Decision|2|||
131037549|NCT04436276|471770673|FG022|Overall Study|Physician Decision|0|||
131037550|NCT04436276|471770651|FG000|Overall Study|Protocol Violation|0|||
131037551|NCT04436276|471770652|FG001|Overall Study|Protocol Violation|0|||
131037552|NCT04436276|471770653|FG002|Overall Study|Protocol Violation|0|||
131037553|NCT04436276|471770654|FG003|Overall Study|Protocol Violation|0|||
131037554|NCT04436276|471770655|FG004|Overall Study|Protocol Violation|0|||
131037555|NCT04436276|471770656|FG005|Overall Study|Protocol Violation|0|||
131037556|NCT04436276|471770657|FG006|Overall Study|Protocol Violation|0|||
131037557|NCT04436276|471770658|FG007|Overall Study|Protocol Violation|0|||
131037558|NCT04436276|471770659|FG008|Overall Study|Protocol Violation|0|||
131037559|NCT04436276|471770660|FG009|Overall Study|Protocol Violation|0|||
131037560|NCT04436276|471770661|FG010|Overall Study|Protocol Violation|0|||
131037561|NCT04436276|471770662|FG011|Overall Study|Protocol Violation|0|||
131037562|NCT04436276|471770663|FG012|Overall Study|Protocol Violation|0|||
131037563|NCT04436276|471770664|FG013|Overall Study|Protocol Violation|1|||
131037564|NCT04436276|471770665|FG014|Overall Study|Protocol Violation|0|||
131037565|NCT04436276|471770666|FG015|Overall Study|Protocol Violation|1|||
131037566|NCT04436276|471770667|FG016|Overall Study|Protocol Violation|0|||
131037567|NCT04436276|471770668|FG017|Overall Study|Protocol Violation|0|||
131037568|NCT04436276|471770669|FG018|Overall Study|Protocol Violation|0|||
131037569|NCT04436276|471770670|FG019|Overall Study|Protocol Violation|0|||
131037570|NCT04436276|471770671|FG020|Overall Study|Protocol Violation|0|||
131037571|NCT04436276|471770672|FG021|Overall Study|Protocol Violation|0|||
131037572|NCT04436276|471770673|FG022|Overall Study|Protocol Violation|0|||
131037573|NCT04436276|471770651|FG000|Overall Study|Withdrawal by Subject|25|||
131037574|NCT04436276|471770652|FG001|Overall Study|Withdrawal by Subject|22|||
131037575|NCT04436276|471770653|FG002|Overall Study|Withdrawal by Subject|24|||
131037576|NCT04436276|471770654|FG003|Overall Study|Withdrawal by Subject|23|||
131037577|NCT04436276|471770655|FG004|Overall Study|Withdrawal by Subject|14|||
131037578|NCT04436276|471770656|FG005|Overall Study|Withdrawal by Subject|0|||
131037579|NCT04436276|471770657|FG006|Overall Study|Withdrawal by Subject|0|||
131037580|NCT04436276|471770658|FG007|Overall Study|Withdrawal by Subject|1|||
131037581|NCT04436276|471770659|FG008|Overall Study|Withdrawal by Subject|0|||
131037582|NCT04436276|471770660|FG009|Overall Study|Withdrawal by Subject|1|||
131037583|NCT04436276|471770661|FG010|Overall Study|Withdrawal by Subject|17|||
131037584|NCT04436276|471770662|FG011|Overall Study|Withdrawal by Subject|7|||
131037585|NCT04436276|471770663|FG012|Overall Study|Withdrawal by Subject|10|||
131037586|NCT04436276|471770664|FG013|Overall Study|Withdrawal by Subject|6|||
131037587|NCT04436276|471770665|FG014|Overall Study|Withdrawal by Subject|20|||
131037588|NCT04436276|471770666|FG015|Overall Study|Withdrawal by Subject|6|||
131037589|NCT04436276|471770667|FG016|Overall Study|Withdrawal by Subject|11|||
131037590|NCT04436276|471770668|FG017|Overall Study|Withdrawal by Subject|4|||
131037591|NCT04436276|471770669|FG018|Overall Study|Withdrawal by Subject|14|||
131037592|NCT04436276|471770670|FG019|Overall Study|Withdrawal by Subject|24|||
131037593|NCT04436276|471770671|FG020|Overall Study|Withdrawal by Subject|24|||
131037594|NCT04436276|471770672|FG021|Overall Study|Withdrawal by Subject|16|||
131037595|NCT04436276|471770673|FG022|Overall Study|Withdrawal by Subject|14|||
131037596|NCT04436276|471770651|FG000|Overall Study|Other|3|||
131037597|NCT04436276|471770652|FG001|Overall Study|Other|2|||
131037598|NCT04436276|471770653|FG002|Overall Study|Other|5|||
131037599|NCT04436276|471770654|FG003|Overall Study|Other|9|||
131037600|NCT04436276|471770655|FG004|Overall Study|Other|23|||
130710595|NCT00788593|470564891|FG000|First Intervention Period|Adverse Event|0|||
130774323|NCT03130959|470800499|FG003|Overall Study|Subject request to discontinue therapy|1|||
130774324|NCT03130959|470800500|FG004|Overall Study|Subject request to discontinue therapy|0|||
130774325|NCT03130959|470800501|FG005|Overall Study|Subject request to discontinue therapy|0|||
130774326|NCT03130959|470800502|FG006|Overall Study|Subject request to discontinue therapy|1|||
130710596|NCT00788593|470564892|FG001|First Intervention Period|Adverse Event|1|||
130710597|NCT00788593|470564893|FG002|First Intervention Period|Adverse Event|0|||
130710598|NCT00788593|470564891|FG000|Second Intervention Period|Lost to Follow-up|0|||
130710599|NCT00788593|470564892|FG001|Second Intervention Period|Lost to Follow-up|1|||
130710600|NCT00788593|470564893|FG002|Second Intervention Period|Lost to Follow-up|0|||
130710601|NCT00788593|470564891|FG000|Second Intervention Period|Other|0|||
130710602|NCT00788593|470564892|FG001|Second Intervention Period|Other|0|||
130710603|NCT00788593|470564893|FG002|Second Intervention Period|Other|1|||
130710604|NCT00515034|470564894|FG000|Overall Study|Adverse Event|2|||
130710605|NCT00515034|470564895|FG001|Overall Study|Adverse Event|0|||
130710606|NCT00515034|470564896|FG002|Overall Study|Adverse Event|1|||
130710607|NCT00515034|470564897|FG003|Overall Study|Adverse Event|0|||
130710608|NCT00515034|470564894|FG000|Overall Study|Death|4|||
130710609|NCT00515034|470564895|FG001|Overall Study|Death|2|||
130710610|NCT00515034|470564896|FG002|Overall Study|Death|1|||
130710611|NCT00515034|470564897|FG003|Overall Study|Death|3|||
130710612|NCT00515034|470564894|FG000|Overall Study|Withdrawal by Subject|1|||
130710613|NCT00515034|470564895|FG001|Overall Study|Withdrawal by Subject|0|||
130710614|NCT00515034|470564896|FG002|Overall Study|Withdrawal by Subject|3|||
130710615|NCT00515034|470564897|FG003|Overall Study|Withdrawal by Subject|0|||
130710616|NCT00515034|470564894|FG000|Overall Study|Physician Decision|0|||
130710617|NCT00515034|470564895|FG001|Overall Study|Physician Decision|0|||
130710618|NCT00515034|470564896|FG002|Overall Study|Physician Decision|1|||
130710619|NCT00515034|470564897|FG003|Overall Study|Physician Decision|1|||
130710620|NCT00515034|470564894|FG000|Overall Study|Other|1|||
130774327|NCT03130959|470800503|FG007|Overall Study|Subject request to discontinue therapy|1|||
130774328|NCT03130959|470800504|FG008|Overall Study|Subject request to discontinue therapy|0|||
130774329|NCT03130959|470800505|FG009|Overall Study|Subject request to discontinue therapy|0|||
130774330|NCT03130959|470800496|FG000|Overall Study|Not reported|0|||
130774331|NCT03130959|470800497|FG001|Overall Study|Not reported|0|||
130774332|NCT03130959|470800498|FG002|Overall Study|Not reported|0|||
130774333|NCT03130959|470800499|FG003|Overall Study|Not reported|1|||
130774334|NCT03130959|470800500|FG004|Overall Study|Not reported|0|||
130774335|NCT03130959|470800501|FG005|Overall Study|Not reported|1|||
130774336|NCT03130959|470800502|FG006|Overall Study|Not reported|0|||
130774337|NCT03130959|470800503|FG007|Overall Study|Not reported|0|||
130774338|NCT03130959|470800504|FG008|Overall Study|Not reported|0|||
130774339|NCT03130959|470800505|FG009|Overall Study|Not reported|1|||
130774340|NCT03130959|470800496|FG000|Overall Study|Adverse Event unrelated to drug|0|||
130774341|NCT03130959|470800497|FG001|Overall Study|Adverse Event unrelated to drug|0|||
130774342|NCT03130959|470800498|FG002|Overall Study|Adverse Event unrelated to drug|1|||
130774343|NCT03130959|470800499|FG003|Overall Study|Adverse Event unrelated to drug|1|||
130774344|NCT03130959|470800500|FG004|Overall Study|Adverse Event unrelated to drug|1|||
130774345|NCT03130959|470800501|FG005|Overall Study|Adverse Event unrelated to drug|0|||
130774346|NCT03130959|470800502|FG006|Overall Study|Adverse Event unrelated to drug|1|||
130774347|NCT03130959|470800503|FG007|Overall Study|Adverse Event unrelated to drug|0|||
130774348|NCT03130959|470800504|FG008|Overall Study|Adverse Event unrelated to drug|1|||
130774349|NCT03130959|470800505|FG009|Overall Study|Adverse Event unrelated to drug|1|||
130774350|NCT03130959|470800496|FG000|Overall Study|Participant withdrew consent|0|||
130774351|NCT03130959|470800497|FG001|Overall Study|Participant withdrew consent|1|||
130774352|NCT03130959|470800498|FG002|Overall Study|Participant withdrew consent|0|||
130774353|NCT03130959|470800499|FG003|Overall Study|Participant withdrew consent|2|||
130774354|NCT03130959|470800500|FG004|Overall Study|Participant withdrew consent|1|||
130774355|NCT03130959|470800501|FG005|Overall Study|Participant withdrew consent|0|||
130774356|NCT03130959|470800502|FG006|Overall Study|Participant withdrew consent|0|||
130774357|NCT03130959|470800503|FG007|Overall Study|Participant withdrew consent|0|||
130710621|NCT00515034|470564895|FG001|Overall Study|Other|0|||
130710622|NCT00515034|470564896|FG002|Overall Study|Other|2|||
130710623|NCT00515034|470564897|FG003|Overall Study|Other|1|||
130710624|NCT01688726|470564902|FG000|Overall Study|Adverse Event|1|||
130710625|NCT01688726|470564903|FG001|Overall Study|Adverse Event|0|||
130774358|NCT03130959|470800504|FG008|Overall Study|Participant withdrew consent|0|||
130774359|NCT03130959|470800505|FG009|Overall Study|Participant withdrew consent|2|||
130947360|NCT01023581|471441293|FG000|Overall Study|Physician Decision|2|||
130947361|NCT01023581|471441294|FG001|Overall Study|Physician Decision|0|||
130947362|NCT01023581|471441295|FG002|Overall Study|Physician Decision|2|||
130710626|NCT01688726|470564902|FG000|Overall Study|Relocated abroad|0|||
130710627|NCT01688726|470564903|FG001|Overall Study|Relocated abroad|1|||
130947363|NCT01023581|471441296|FG003|Overall Study|Physician Decision|1|||
130947364|NCT01023581|471441297|FG004|Overall Study|Physician Decision|1|||
130947365|NCT01023581|471441298|FG005|Overall Study|Physician Decision|1|||
131037601|NCT04436276|471770656|FG005|Overall Study|Other|1|||
131037602|NCT04436276|471770657|FG006|Overall Study|Other|0|||
131037603|NCT04436276|471770658|FG007|Overall Study|Other|0|||
131037604|NCT04436276|471770659|FG008|Overall Study|Other|0|||
131037605|NCT04436276|471770660|FG009|Overall Study|Other|0|||
131037606|NCT04436276|471770661|FG010|Overall Study|Other|3|||
131037607|NCT04436276|471770662|FG011|Overall Study|Other|1|||
131037608|NCT04436276|471770663|FG012|Overall Study|Other|1|||
131037609|NCT04436276|471770664|FG013|Overall Study|Other|2|||
131037610|NCT04436276|471770665|FG014|Overall Study|Other|3|||
131037611|NCT04436276|471770666|FG015|Overall Study|Other|0|||
131037612|NCT04436276|471770667|FG016|Overall Study|Other|0|||
131037613|NCT04436276|471770668|FG017|Overall Study|Other|6|||
131037614|NCT04436276|471770669|FG018|Overall Study|Other|1|||
131037615|NCT04436276|471770670|FG019|Overall Study|Other|0|||
131037616|NCT04436276|471770671|FG020|Overall Study|Other|2|||
131037617|NCT04436276|471770672|FG021|Overall Study|Other|2|||
131037618|NCT04436276|471770673|FG022|Overall Study|Other|60|||
131037619|NCT05281562|471770674|FG000|Overall Study|Ineligible patient|1|||
131037620|NCT05281562|471770675|FG001|Overall Study|Ineligible patient|0|||
131037621|NCT05977530|471770683|FG000|Overall Study|Withdrawal by Subject|1|||
131037622|NCT05977530|471770683|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
131037623|NCT01733316|471770684|FG000|RP103 Phase|Non-compliance|1|||
131037624|NCT01733316|471770684|FG000|Long Term Extension Phase|Adverse Event|1|||
131037625|NCT01733316|471770684|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
131037626|NCT01733316|471770684|FG000|Long Term Extension Phase|Sponsor Decision|2|||
131037627|NCT03459729|471770689|FG000|Overall Study|Physician Decision|2|||
131037628|NCT04200456|471770691|FG000|Overall Study|Physician Decision|0|||
131037629|NCT04200456|471770692|FG001|Overall Study|Physician Decision|1|||
131037630|NCT04200456|471770691|FG000|Overall Study|Withdrawal by Subject|2|||
131037631|NCT04200456|471770692|FG001|Overall Study|Withdrawal by Subject|2|||
131037632|NCT04200456|471770691|FG000|Overall Study|Lack of Efficacy|1|||
130710628|NCT03499119|470564904|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
130710629|NCT03499119|470564905|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
130710630|NCT03499119|470564906|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
130710631|NCT03499119|470564907|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
130710632|NCT03499119|470564904|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
130710633|NCT03499119|470564905|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
130710634|NCT03499119|470564906|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
131037633|NCT04200456|471770692|FG001|Overall Study|Lack of Efficacy|1|||
131037634|NCT04200456|471770691|FG000|Overall Study|Adverse event, non-fatal|0|||
131037635|NCT04200456|471770692|FG001|Overall Study|Adverse event, non-fatal|1|||
131037636|NCT04200456|471770691|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
131037637|NCT04200456|471770692|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
131037638|NCT00506519|471772715|FG000|Overall Study|Death|4|||
131037639|NCT00506519|471772716|FG001|Overall Study|Death|6|||
131037640|NCT00506519|471772717|FG002|Overall Study|Death|0|||
131037641|NCT00506519|471772715|FG000|Overall Study|Adverse Event|1|||
131037642|NCT00506519|471772716|FG001|Overall Study|Adverse Event|0|||
131037643|NCT00506519|471772717|FG002|Overall Study|Adverse Event|0|||
131037644|NCT01186367|471772718|FG000|Overall Study|Lost to Follow-up|7|||
131037645|NCT01186367|471772719|FG001|Overall Study|Lost to Follow-up|4|||
131037646|NCT01186367|471772720|FG002|Overall Study|Lost to Follow-up|7|||
131037647|NCT01186367|471772718|FG000|Overall Study|Did not receive study treatment|0|||
131037648|NCT01186367|471772719|FG001|Overall Study|Did not receive study treatment|1|||
131037649|NCT01186367|471772720|FG002|Overall Study|Did not receive study treatment|0|||
131037650|NCT03945292|471772725|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
131037651|NCT03945292|471772726|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131037652|NCT03945292|471772727|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
131037653|NCT03945292|471772728|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131037654|NCT03945292|471772729|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131037655|NCT03945292|471772730|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131037656|NCT03945292|471772731|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131037657|NCT03945292|471772732|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
131037658|NCT03945292|471772725|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131037659|NCT03945292|471772726|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131037660|NCT03945292|471772727|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
131037661|NCT03945292|471772728|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
130710635|NCT03499119|470564907|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
131037662|NCT03945292|471772729|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131037663|NCT03945292|471772730|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131037664|NCT03945292|471772731|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131037665|NCT03945292|471772732|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
131037666|NCT03945292|471772725|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130774360|NCT03130959|470800496|FG000|Overall Study|Administrative reason by sponsor|1|||
130774361|NCT03130959|470800497|FG001|Overall Study|Administrative reason by sponsor|0|||
130774362|NCT03130959|470800498|FG002|Overall Study|Administrative reason by sponsor|1|||
130774363|NCT03130959|470800499|FG003|Overall Study|Administrative reason by sponsor|0|||
130774364|NCT03130959|470800500|FG004|Overall Study|Administrative reason by sponsor|0|||
130774365|NCT03130959|470800501|FG005|Overall Study|Administrative reason by sponsor|0|||
130774366|NCT03130959|470800502|FG006|Overall Study|Administrative reason by sponsor|0|||
130774367|NCT03130959|470800503|FG007|Overall Study|Administrative reason by sponsor|0|||
130774368|NCT03130959|470800504|FG008|Overall Study|Administrative reason by sponsor|0|||
130774369|NCT03130959|470800505|FG009|Overall Study|Administrative reason by sponsor|0|||
130774370|NCT03130959|470800496|FG000|Overall Study|Lost to Follow-up|1|||
130774371|NCT03130959|470800497|FG001|Overall Study|Lost to Follow-up|0|||
130774372|NCT03130959|470800498|FG002|Overall Study|Lost to Follow-up|0|||
130774373|NCT03130959|470800499|FG003|Overall Study|Lost to Follow-up|0|||
130774374|NCT03130959|470800500|FG004|Overall Study|Lost to Follow-up|0|||
130774375|NCT03130959|470800501|FG005|Overall Study|Lost to Follow-up|0|||
130774376|NCT03130959|470800502|FG006|Overall Study|Lost to Follow-up|0|||
130774377|NCT03130959|470800503|FG007|Overall Study|Lost to Follow-up|0|||
130774378|NCT03130959|470800504|FG008|Overall Study|Lost to Follow-up|0|||
130774379|NCT03130959|470800505|FG009|Overall Study|Lost to Follow-up|0|||
130774380|NCT02384538|470800506|FG000|Overall Study|Adverse Event|1|||
130774381|NCT02384538|470800507|FG001|Overall Study|Adverse Event|4|||
130774382|NCT02384538|470800506|FG000|Overall Study|Lack of Efficacy|4|||
130774383|NCT02384538|470800507|FG001|Overall Study|Lack of Efficacy|4|||
130774384|NCT02384538|470800506|FG000|Overall Study|Withdrew Consent|0|||
130774385|NCT02384538|470800507|FG001|Overall Study|Withdrew Consent|4|||
130774386|NCT02384538|470800506|FG000|Overall Study|Other|1|||
130774387|NCT02384538|470800507|FG001|Overall Study|Other|3|||
130774388|NCT00741598|470800510|FG000|Overall Study|Lost to Follow-up|3|||
130774389|NCT00741598|470800511|FG001|Overall Study|Lost to Follow-up|4|||
130774390|NCT00741598|470800510|FG000|Overall Study|Lack of Efficacy|1|||
130774391|NCT00741598|470800511|FG001|Overall Study|Lack of Efficacy|2|||
130774392|NCT00741598|470800510|FG000|Overall Study|Physician Decision|1|||
130774393|NCT00741598|470800511|FG001|Overall Study|Physician Decision|1|||
130774394|NCT00741598|470800510|FG000|Overall Study|Pregnancy|1|||
130774395|NCT00741598|470800511|FG001|Overall Study|Pregnancy|0|||
130774396|NCT00741598|470800510|FG000|Overall Study|Withdrawal by Subject|3|||
130774397|NCT00741598|470800511|FG001|Overall Study|Withdrawal by Subject|2|||
130774398|NCT00313586|470800512|FG000|Overall Study|Disease progression|14|||
130774399|NCT00313586|470800513|FG001|Overall Study|Disease progression|19|||
130774400|NCT00313586|470800514|FG002|Overall Study|Disease progression|10|||
130774401|NCT00313586|470800515|FG003|Overall Study|Disease progression|3|||
130774402|NCT00313586|470800512|FG000|Overall Study|Adverse Event|12|||
130774403|NCT00313586|470800513|FG001|Overall Study|Adverse Event|18|||
130774404|NCT00313586|470800514|FG002|Overall Study|Adverse Event|3|||
130774405|NCT00313586|470800515|FG003|Overall Study|Adverse Event|10|||
130774406|NCT00313586|470800512|FG000|Overall Study|Death|11|||
130774407|NCT00313586|470800513|FG001|Overall Study|Death|8|||
130774408|NCT00313586|470800514|FG002|Overall Study|Death|1|||
130774409|NCT00313586|470800515|FG003|Overall Study|Death|7|||
130774410|NCT00313586|470800512|FG000|Overall Study|Withdrawal by Subject|13|||
130774411|NCT00313586|470800513|FG001|Overall Study|Withdrawal by Subject|6|||
130774412|NCT00313586|470800514|FG002|Overall Study|Withdrawal by Subject|6|||
130774413|NCT00313586|470800515|FG003|Overall Study|Withdrawal by Subject|2|||
130774414|NCT00313586|470800512|FG000|Overall Study|Alternative therapy|3|||
130774415|NCT00313586|470800513|FG001|Overall Study|Alternative therapy|6|||
130774416|NCT00313586|470800514|FG002|Overall Study|Alternative therapy|2|||
130774417|NCT00313586|470800515|FG003|Overall Study|Alternative therapy|0|||
130774418|NCT00313586|470800512|FG000|Overall Study|Other complicating disease|2|||
130774419|NCT00313586|470800513|FG001|Overall Study|Other complicating disease|2|||
130774420|NCT00313586|470800514|FG002|Overall Study|Other complicating disease|0|||
131037667|NCT03945292|471772726|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
131037668|NCT03945292|471772727|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130774421|NCT00313586|470800515|FG003|Overall Study|Other complicating disease|0|||
130774422|NCT00313586|470800512|FG000|Overall Study|Did not achieve HI-major/better response|10|||
130774423|NCT00313586|470800513|FG001|Overall Study|Did not achieve HI-major/better response|7|||
130774424|NCT00313586|470800514|FG002|Overall Study|Did not achieve HI-major/better response|2|||
130774425|NCT00313586|470800515|FG003|Overall Study|Did not achieve HI-major/better response|1|||
130774426|NCT00313586|470800512|FG000|Overall Study|Physician Decision|2|||
130774427|NCT00313586|470800513|FG001|Overall Study|Physician Decision|1|||
130774428|NCT00313586|470800514|FG002|Overall Study|Physician Decision|0|||
130774429|NCT00313586|470800515|FG003|Overall Study|Physician Decision|0|||
130774430|NCT00313586|470800512|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
130774431|NCT00313586|470800513|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
130774432|NCT00313586|470800514|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
131037669|NCT03945292|471772728|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130774433|NCT00313586|470800515|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
130710636|NCT03499119|470564904|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
130710637|NCT03499119|470564905|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
130947366|NCT01023581|471441299|FG006|Overall Study|Physician Decision|1|||
130947367|NCT01023581|471441293|FG000|Overall Study|Other|1|||
130947368|NCT01023581|471441294|FG001|Overall Study|Other|0|||
130947369|NCT01023581|471441295|FG002|Overall Study|Other|1|||
130947370|NCT01023581|471441296|FG003|Overall Study|Other|0|||
130947371|NCT01023581|471441297|FG004|Overall Study|Other|1|||
130947372|NCT01023581|471441298|FG005|Overall Study|Other|0|||
130947373|NCT01023581|471441299|FG006|Overall Study|Other|0|||
130947374|NCT01723163|471441300|FG000|Treatment Phase|Withdrawal by Subject|14|||
130947375|NCT01723163|471441301|FG001|Treatment Phase|Withdrawal by Subject|6|||
130947376|NCT01723163|471441300|FG000|Treatment Phase|Withdrawal by PI|5|||
130947377|NCT01723163|471441301|FG001|Treatment Phase|Withdrawal by PI|1|||
130947378|NCT01723163|471441300|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
130947379|NCT01723163|471441301|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
130947380|NCT01723163|471441300|FG000|3-Month Follow-up|Unable to Contact|12|||
130947381|NCT01723163|471441301|FG001|3-Month Follow-up|Unable to Contact|19|||
130947382|NCT01723163|471441300|FG000|6-Month Follow-up|Death|1|||
130947383|NCT01723163|471441301|FG001|6-Month Follow-up|Death|0|||
130947384|NCT01723163|471441300|FG000|6-Month Follow-up|Unable to Contact|17|||
130947385|NCT01723163|471441301|FG001|6-Month Follow-up|Unable to Contact|15|||
130947386|NCT01723163|471441300|FG000|12-Month Follow-up|Death|1|||
130947387|NCT01723163|471441301|FG001|12-Month Follow-up|Death|0|||
131225096|NCT02614703|472451950|FG000|Overall Study|Withdrawal by Subject|7|||
131225097|NCT02614703|472451951|FG001|Overall Study|Withdrawal by Subject|1|||
130710638|NCT03499119|470564906|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
130710639|NCT03499119|470564907|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
130710640|NCT03499119|470564904|FG000|Optional Extension Phase|Lost to Follow-up|0|||
130710641|NCT03499119|470564905|FG001|Optional Extension Phase|Lost to Follow-up|0|||
130710642|NCT03499119|470564906|FG002|Optional Extension Phase|Lost to Follow-up|0|||
130710643|NCT03499119|470564907|FG003|Optional Extension Phase|Lost to Follow-up|1|||
130710644|NCT03499119|470564904|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
130710645|NCT03499119|470564905|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
130710646|NCT03499119|470564906|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
130710647|NCT03499119|470564907|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
130710648|NCT03499119|470564904|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
130710649|NCT03499119|470564905|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
130710650|NCT03499119|470564906|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
130710651|NCT03499119|470564907|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
130710652|NCT04553913|470564908|FG000|Overall Study|patient's block resolved prior to PACU|1|||
130710653|NCT04553913|470564908|FG000|Overall Study|did not use the device properly|5|||
130710654|NCT01481324|470564909|FG000|Overall Study|Missing Data|0|||
130710655|NCT01481324|470564910|FG001|Overall Study|Missing Data|2|||
130710656|NCT01481324|470564911|FG002|Overall Study|Missing Data|2|||
130710657|NCT02427984|470564913|FG000|Overall Study|Lost to Follow-up|13|||
130710658|NCT02427984|470564914|FG001|Overall Study|Lost to Follow-up|5|||
130710659|NCT02427984|470564915|FG002|Overall Study|Lost to Follow-up|18|||
130710660|NCT04189445|470567004|FG000|Overall Study|Withdrawal of consent|8|||
130710661|NCT04189445|470567005|FG001|Overall Study|Withdrawal of consent|1|||
130710662|NCT04189445|470567006|FG002|Overall Study|Withdrawal of consent|0|||
130710663|NCT04189445|470567004|FG000|Overall Study|Study Terminated by Sponsor|25|||
130710664|NCT04189445|470567005|FG001|Overall Study|Study Terminated by Sponsor|3|||
130710665|NCT04189445|470567006|FG002|Overall Study|Study Terminated by Sponsor|0|||
130710666|NCT04189445|470567004|FG000|Overall Study|Death|54|||
130710667|NCT04189445|470567005|FG001|Overall Study|Death|24|||
130710668|NCT04189445|470567006|FG002|Overall Study|Death|0|||
130710669|NCT03959527|470567007|FG000|Overall Study|Withdrawal by Subject|8|||
130710670|NCT03959527|470567008|FG001|Overall Study|Withdrawal by Subject|3|||
130710671|NCT03959527|470567007|FG000|Overall Study|Lost to Follow-up|31|||
130710672|NCT03959527|470567008|FG001|Overall Study|Lost to Follow-up|15|||
130710673|NCT03959527|470567007|FG000|Overall Study|Did not meet eligibility criteria|1|||
130710674|NCT03959527|470567008|FG001|Overall Study|Did not meet eligibility criteria|1|||
130710675|NCT03959527|470567007|FG000|Overall Study|Protocol Violation|10|||
130710676|NCT03959527|470567008|FG001|Overall Study|Protocol Violation|5|||
130710677|NCT06029959|470567009|FG000|Overall Study|Physician Decision|6|||
130710678|NCT00099268|470567012|FG000|Overall Study|Withdrawal by Subject|46|||
130710679|NCT00099268|470567013|FG001|Overall Study|Withdrawal by Subject|28|||
130710680|NCT00099268|470567012|FG000|Overall Study|Adverse Event|19|||
130710681|NCT00099268|470567013|FG001|Overall Study|Adverse Event|19|||
130947388|NCT01723163|471441300|FG000|12-Month Follow-up|Unable to Contact|23|||
130947389|NCT01723163|471441301|FG001|12-Month Follow-up|Unable to Contact|28|||
130947390|NCT00325754|471441303|FG000|Overall Study|Adverse Event|4|||
130947391|NCT00325754|471441304|FG001|Overall Study|Adverse Event|1|||
130947392|NCT01289847|471441319|FG000|Overall Study|Patient could not comply with visits|1|||
130710682|NCT00099268|470567012|FG000|Overall Study|Protocol Violation|9|||
131225098|NCT02402933|472451952|FG000|Overall Study|Withdrawal by Subject|4|||
130947393|NCT02872116|471441322|FG000|Pre-Treatment|Disease Progression|0|||
130947394|NCT02872116|471441323|FG001|Pre-Treatment|Disease Progression|1|||
130947395|NCT02872116|471441324|FG002|Pre-Treatment|Disease Progression|0|||
130947396|NCT02872116|471441322|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
130947397|NCT02872116|471441323|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
130947398|NCT02872116|471441324|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
130947399|NCT02872116|471441322|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
130947400|NCT02872116|471441323|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
130947401|NCT02872116|471441324|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
130947402|NCT02872116|471441322|FG000|Pre-Treatment|Participant withdrew consent|2|||
130947403|NCT02872116|471441323|FG001|Pre-Treatment|Participant withdrew consent|20|||
130947404|NCT02872116|471441324|FG002|Pre-Treatment|Participant withdrew consent|3|||
130947405|NCT02872116|471441322|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
130947406|NCT02872116|471441323|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
130947407|NCT02872116|471441324|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
130947408|NCT02872116|471441322|FG000|Pre-Treatment|Other reasons|1|||
130947409|NCT02872116|471441323|FG001|Pre-Treatment|Other reasons|2|||
130947410|NCT02872116|471441324|FG002|Pre-Treatment|Other reasons|2|||
130947411|NCT02872116|471441322|FG000|Treatment|Death|121|||
131124643|NCT00597753|472084529|FG001|Overall Study|Withdrawal by Subject|12|||
131124644|NCT00597753|472084528|FG000|Overall Study|Discontinued Dialysis|0|||
131124645|NCT00597753|472084529|FG001|Overall Study|Discontinued Dialysis|1|||
131124646|NCT00597753|472084528|FG000|Overall Study|Never dosed|2|||
131124647|NCT00597753|472084529|FG001|Overall Study|Never dosed|0|||
131124648|NCT00597753|472084528|FG000|Overall Study|Noncompliance|2|||
130710683|NCT00099268|470567013|FG001|Overall Study|Protocol Violation|8|||
130710684|NCT00099268|470567012|FG000|Overall Study|Lost to Follow-up|6|||
130710685|NCT00099268|470567013|FG001|Overall Study|Lost to Follow-up|4|||
130710686|NCT00099268|470567012|FG000|Overall Study|Lack of Efficacy|5|||
130710687|NCT00099268|470567013|FG001|Overall Study|Lack of Efficacy|18|||
130710688|NCT00099268|470567012|FG000|Overall Study|Administrative problems|4|||
130710689|NCT00099268|470567013|FG001|Overall Study|Administrative problems|4|||
130710690|NCT00099268|470567012|FG000|Overall Study|Death|3|||
130710691|NCT00099268|470567013|FG001|Overall Study|Death|1|||
130710692|NCT02006628|470567015|FG000|Overall Study|Adverse Event|1|||
130710693|NCT02006628|470567016|FG001|Overall Study|Adverse Event|1|||
130710694|NCT02006628|470567015|FG000|Overall Study|Withdrawal by Subject|2|||
130710695|NCT02006628|470567016|FG001|Overall Study|Withdrawal by Subject|1|||
130710696|NCT00262041|470567017|FG000|Overall Study|Withdrawal by Subject|0|||
130710697|NCT00262041|470567018|FG001|Overall Study|Withdrawal by Subject|3|||
130710698|NCT00262041|470567019|FG002|Overall Study|Withdrawal by Subject|1|||
130710699|NCT00262041|470567017|FG000|Overall Study|Lost to Follow-up|1|||
130710700|NCT00262041|470567018|FG001|Overall Study|Lost to Follow-up|1|||
130710701|NCT00262041|470567019|FG002|Overall Study|Lost to Follow-up|5|||
130710702|NCT00262041|470567017|FG000|Overall Study|Unable to classify|1|||
130710703|NCT00262041|470567018|FG001|Overall Study|Unable to classify|0|||
130710704|NCT00262041|470567019|FG002|Overall Study|Unable to classify|0|||
130710705|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
130710706|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
130710707|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
130710708|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
130710709|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
130710710|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
130710711|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
130710712|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
130710713|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
130710714|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
130710715|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
130710716|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
130710717|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
130710718|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
130710719|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
130710720|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
130710721|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
130710722|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
130710723|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
130710724|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
130710725|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
130710726|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
130710727|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
130947412|NCT02872116|471441323|FG001|Treatment|Death|94|||
130947413|NCT02872116|471441324|FG002|Treatment|Death|68|||
130947414|NCT02872116|471441322|FG000|Treatment|Lost to Follow-up|5|||
130947415|NCT02872116|471441323|FG001|Treatment|Lost to Follow-up|7|||
130947416|NCT02872116|471441324|FG002|Treatment|Lost to Follow-up|3|||
130947417|NCT02872116|471441322|FG000|Treatment|Participant withdrew consent|20|||
130947418|NCT02872116|471441323|FG001|Treatment|Participant withdrew consent|40|||
130947419|NCT02872116|471441324|FG002|Treatment|Participant withdrew consent|8|||
130947420|NCT02872116|471441322|FG000|Treatment|Other reasons|13|||
130947421|NCT02872116|471441323|FG001|Treatment|Other reasons|12|||
130947422|NCT02872116|471441324|FG002|Treatment|Other reasons|5|||
130947423|NCT01709695|471441334|FG000|Overall Study|Withdrawal by Subject|1|||
130947424|NCT01709695|471441335|FG001|Overall Study|Withdrawal by Subject|1|||
130947425|NCT01894152|471441336|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
130947426|NCT01708174|471441337|FG000|Treatment Period|Withdrawal by Subject|1|||
130947427|NCT01708174|471441338|FG001|Treatment Period|Withdrawal by Subject|0|||
130947428|NCT01708174|471441339|FG002|Treatment Period|Withdrawal by Subject|0|||
130947429|NCT01708174|471441337|FG000|Treatment Period|Progressive disease|0|||
130947430|NCT01708174|471441338|FG001|Treatment Period|Progressive disease|1|||
130947431|NCT01708174|471441339|FG002|Treatment Period|Progressive disease|0|||
130947432|NCT01708174|471441337|FG000|Treatment Period|Death|0|||
130947433|NCT01708174|471441338|FG001|Treatment Period|Death|0|||
130947434|NCT01708174|471441339|FG002|Treatment Period|Death|1|||
130947435|NCT01708174|471441337|FG000|Treatment Period|Adverse Event|0|||
130947436|NCT01708174|471441338|FG001|Treatment Period|Adverse Event|1|||
130947437|NCT01708174|471441339|FG002|Treatment Period|Adverse Event|0|||
130947438|NCT02268812|471441340|FG000|Overall Study|Adverse Event|8|||
130947439|NCT02268812|471441341|FG001|Overall Study|Adverse Event|26|||
130947440|NCT02268812|471441342|FG002|Overall Study|Adverse Event|7|||
130947441|NCT02268812|471441343|FG003|Overall Study|Adverse Event|10|||
130947442|NCT02268812|471441340|FG000|Overall Study|Protocol deviation|0|||
130947443|NCT02268812|471441341|FG001|Overall Study|Protocol deviation|0|||
130947444|NCT02268812|471441342|FG002|Overall Study|Protocol deviation|1|||
130947445|NCT02268812|471441343|FG003|Overall Study|Protocol deviation|0|||
130947446|NCT02268812|471441340|FG000|Overall Study|Withdrawal by Subject|0|||
130947447|NCT02268812|471441341|FG001|Overall Study|Withdrawal by Subject|1|||
130947448|NCT02268812|471441342|FG002|Overall Study|Withdrawal by Subject|0|||
130947449|NCT02268812|471441343|FG003|Overall Study|Withdrawal by Subject|0|||
130947450|NCT02268812|471441340|FG000|Overall Study|Physician Decision|3|||
130947451|NCT02268812|471441341|FG001|Overall Study|Physician Decision|1|||
130947452|NCT02268812|471441342|FG002|Overall Study|Physician Decision|0|||
130947453|NCT02268812|471441343|FG003|Overall Study|Physician Decision|1|||
130947454|NCT02268812|471441340|FG000|Overall Study|Other|5|||
130947455|NCT02268812|471441341|FG001|Overall Study|Other|4|||
130947456|NCT02268812|471441342|FG002|Overall Study|Other|1|||
130947457|NCT02268812|471441343|FG003|Overall Study|Other|3|||
130947458|NCT00075582|471441344|FG000|Overall Study|Adverse Event|3|||
130947459|NCT00075582|471441345|FG001|Overall Study|Adverse Event|1|||
130947460|NCT00075582|471441344|FG000|Overall Study|Lack of Efficacy|4|||
130947461|NCT00075582|471441345|FG001|Overall Study|Lack of Efficacy|8|||
130947462|NCT00075582|471441344|FG000|Overall Study|Physician Decision|5|||
130947463|NCT00075582|471441345|FG001|Overall Study|Physician Decision|8|||
130947464|NCT00075582|471441344|FG000|Overall Study|Withdrawal by Subject|2|||
130947465|NCT00075582|471441345|FG001|Overall Study|Withdrawal by Subject|2|||
130947466|NCT00075582|471441344|FG000|Overall Study|Ineligible for study|36|||
130947467|NCT00075582|471441345|FG001|Overall Study|Ineligible for study|16|||
130947468|NCT02385084|471441346|FG000|Period 2|Protocol Violation|0|||
130947469|NCT02385084|471441347|FG001|Period 2|Protocol Violation|0|||
131037670|NCT03945292|471772729|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130710728|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
130710729|NCT01421342|470567020|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
130710730|NCT01421342|470567021|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
130710731|NCT01421342|470567022|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
130710732|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
130947470|NCT02385084|471441348|FG002|Period 2|Protocol Violation|1|||
130947471|NCT02385084|471441349|FG003|Period 2|Protocol Violation|0|||
130947472|NCT02385084|471441350|FG004|Period 2|Protocol Violation|0|||
130947473|NCT02385084|471441351|FG005|Period 2|Protocol Violation|0|||
130947474|NCT05045144|471441352|FG000|Overall Study|Lost to Follow-up|3|||
130947475|NCT05045144|471441353|FG001|Overall Study|Lost to Follow-up|2|||
130947476|NCT05045144|471441354|FG002|Overall Study|Lost to Follow-up|3|||
130947477|NCT05045144|471441355|FG003|Overall Study|Lost to Follow-up|5|||
130947478|NCT05045144|471441356|FG004|Overall Study|Lost to Follow-up|13|||
130947479|NCT05045144|471441352|FG000|Overall Study|Withdrawal by Subject|0|||
131037671|NCT03945292|471772730|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
130947480|NCT05045144|471441353|FG001|Overall Study|Withdrawal by Subject|1|||
130947481|NCT05045144|471441354|FG002|Overall Study|Withdrawal by Subject|0|||
130947482|NCT05045144|471441355|FG003|Overall Study|Withdrawal by Subject|0|||
130947483|NCT05045144|471441356|FG004|Overall Study|Withdrawal by Subject|0|||
130947484|NCT05045144|471441352|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130947485|NCT05045144|471441353|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130947486|NCT05045144|471441354|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130947487|NCT05045144|471441355|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130947488|NCT05045144|471441356|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130947489|NCT02171260|471441358|FG000|Overall Study|Death|0|||
130947490|NCT02171260|471441359|FG001|Overall Study|Death|0|||
130947491|NCT02171260|471441360|FG002|Overall Study|Death|0|||
130947492|NCT02171260|471441361|FG003|Overall Study|Death|1|||
130947493|NCT02171260|471441358|FG000|Overall Study|Physician Decision|1|||
130947494|NCT02171260|471441359|FG001|Overall Study|Physician Decision|0|||
130947495|NCT02171260|471441360|FG002|Overall Study|Physician Decision|1|||
130947496|NCT02171260|471441361|FG003|Overall Study|Physician Decision|0|||
130947497|NCT02171260|471441358|FG000|Overall Study|Withdrawal by Subject|1|||
130947498|NCT02171260|471441359|FG001|Overall Study|Withdrawal by Subject|0|||
130947499|NCT02171260|471441360|FG002|Overall Study|Withdrawal by Subject|0|||
130947500|NCT02171260|471441361|FG003|Overall Study|Withdrawal by Subject|0|||
130947501|NCT02171260|471441358|FG000|Overall Study|Evidence of progressive disease|4|||
130947502|NCT02171260|471441359|FG001|Overall Study|Evidence of progressive disease|6|||
130947503|NCT02171260|471441360|FG002|Overall Study|Evidence of progressive disease|4|||
130947504|NCT02171260|471441361|FG003|Overall Study|Evidence of progressive disease|4|||
130947505|NCT00323492|471441362|FG000|Study Phase 1|Adverse Event|2|||
130947506|NCT00323492|471441363|FG001|Study Phase 1|Adverse Event|0|||
130947507|NCT00323492|471441364|FG002|Study Phase 1|Adverse Event|0|||
130947508|NCT00323492|471441362|FG000|Study Phase 2|Adverse Event|1|||
130947509|NCT00323492|471441363|FG001|Study Phase 2|Adverse Event|0|||
130947510|NCT00323492|471441364|FG002|Study Phase 2|Adverse Event|0|||
130947511|NCT00323492|471441362|FG000|Study Phase 2|Physician Decision|1|||
130947512|NCT00323492|471441363|FG001|Study Phase 2|Physician Decision|0|||
130947513|NCT00323492|471441364|FG002|Study Phase 2|Physician Decision|0|||
130947514|NCT00323492|471441362|FG000|Study Phase 2|Lost to Follow-up|1|||
130947515|NCT00323492|471441363|FG001|Study Phase 2|Lost to Follow-up|0|||
130947516|NCT00323492|471441364|FG002|Study Phase 2|Lost to Follow-up|0|||
130947517|NCT00323492|471441362|FG000|Study Phase 2|Withdrawal by Subject|0|||
130947518|NCT00323492|471441363|FG001|Study Phase 2|Withdrawal by Subject|1|||
130947519|NCT00323492|471441364|FG002|Study Phase 2|Withdrawal by Subject|0|||
130947520|NCT00323492|471441362|FG000|Study Phase 2|Noncompliance with study schedule|0|||
130947521|NCT00323492|471441363|FG001|Study Phase 2|Noncompliance with study schedule|0|||
130947522|NCT00323492|471441364|FG002|Study Phase 2|Noncompliance with study schedule|1|||
130947523|NCT00323492|471441362|FG000|Study Phase 2|Protocol Violation|1|||
130947524|NCT00323492|471441363|FG001|Study Phase 2|Protocol Violation|0|||
130947525|NCT00323492|471441364|FG002|Study Phase 2|Protocol Violation|0|||
130947526|NCT01466387|471441365|FG000|Overall Study|Adverse Event|0|||
130947527|NCT01466387|471441366|FG001|Overall Study|Adverse Event|0|||
130947528|NCT01466387|471441367|FG002|Overall Study|Adverse Event|1|||
130947529|NCT01466387|471441368|FG003|Overall Study|Adverse Event|1|||
130947530|NCT01466387|471441369|FG004|Overall Study|Adverse Event|0|||
130947531|NCT01466387|471441370|FG005|Overall Study|Adverse Event|0|||
130947532|NCT01466387|471441365|FG000|Overall Study|Lost to Follow-up|0|||
130947533|NCT01466387|471441366|FG001|Overall Study|Lost to Follow-up|0|||
130947534|NCT01466387|471441367|FG002|Overall Study|Lost to Follow-up|0|||
130947535|NCT01466387|471441368|FG003|Overall Study|Lost to Follow-up|0|||
130947536|NCT01466387|471441369|FG004|Overall Study|Lost to Follow-up|0|||
130947537|NCT01466387|471441370|FG005|Overall Study|Lost to Follow-up|1|||
130947538|NCT01466387|471441365|FG000|Overall Study|Protocol Violation|1|||
130947539|NCT01466387|471441366|FG001|Overall Study|Protocol Violation|0|||
130947540|NCT01466387|471441367|FG002|Overall Study|Protocol Violation|0|||
130947541|NCT01466387|471441368|FG003|Overall Study|Protocol Violation|1|||
130947542|NCT01466387|471441369|FG004|Overall Study|Protocol Violation|0|||
130947543|NCT01466387|471441370|FG005|Overall Study|Protocol Violation|0|||
130947544|NCT01319877|471441371|FG000|Overall Study|Lost to Follow-up|100|||
130947545|NCT01319877|471441372|FG001|Overall Study|Lost to Follow-up|37|||
130947546|NCT01319877|471441371|FG000|Overall Study|Physician Decision|2|||
130947547|NCT01319877|471441372|FG001|Overall Study|Physician Decision|0|||
130947548|NCT01319877|471441371|FG000|Overall Study|Disease Progression|2|||
130947549|NCT01319877|471441372|FG001|Overall Study|Disease Progression|2|||
130947550|NCT01319877|471441371|FG000|Overall Study|Withdrawal by Subject|0|||
130947551|NCT01319877|471441372|FG001|Overall Study|Withdrawal by Subject|1|||
130947552|NCT01319877|471441371|FG000|Overall Study|Reason Not Specified|4|||
130947553|NCT01319877|471441372|FG001|Overall Study|Reason Not Specified|5|||
130947554|NCT02347189|471441375|FG000|Overall Study|No implant attempted of study device|9|||
130947555|NCT02347189|471441375|FG000|Overall Study|No primary outcome data available|2|||
130947556|NCT00735878|471441376|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
130947557|NCT00735878|471441377|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
130947558|NCT00735878|471441378|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
130947559|NCT00994240|471441379|FG000|Overall Study|Lost to Follow-up|3|||
130947560|NCT00994240|471441380|FG001|Overall Study|Lost to Follow-up|2|||
130947561|NCT00994240|471441379|FG000|Overall Study|Withdrawal by Subject|1|||
130947562|NCT00994240|471441380|FG001|Overall Study|Withdrawal by Subject|0|||
130947563|NCT00994240|471441379|FG000|Overall Study|study termination|2|||
130710733|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
130710734|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
130710735|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
130710736|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
130710737|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
130710738|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
130710739|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
130774434|NCT00313586|470800512|FG000|Overall Study|Lost insurance|0|||
130774435|NCT00313586|470800513|FG001|Overall Study|Lost insurance|1|||
130947564|NCT00994240|471441380|FG001|Overall Study|study termination|3|||
130947565|NCT03320564|471441381|FG000|Overall Study|Protocol Violation|1|||
130947566|NCT01586819|471441382|FG000|Overall Study|Withdrawal by Subject|1|||
130947567|NCT01586819|471441383|FG001|Overall Study|Withdrawal by Subject|0|||
130947568|NCT01359254|471441384|FG000|Overall Study|Death|1|||
130947569|NCT01359254|471441385|FG001|Overall Study|Death|0|||
130947570|NCT01124643|471441386|FG000|Overall Study|Death|1|||
130947571|NCT02680639|471441387|FG000|Screening Period|Screen Failure|7|||
130947572|NCT02680639|471441388|FG001|Screening Period|Screen Failure|0|||
130947573|NCT02680639|471441389|FG002|Screening Period|Screen Failure|0|||
130947574|NCT01063595|471441390|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
130947575|NCT01063595|471441391|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
130947576|NCT01063595|471441390|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
130947577|NCT01063595|471441391|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
130947578|NCT01063595|471441390|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
130947579|NCT01063595|471441391|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
130947580|NCT01063595|471441390|FG000|First Intervention|Adverse Event|1|||
130947581|NCT01063595|471441391|FG001|First Intervention|Adverse Event|4|||
130947582|NCT01063595|471441390|FG000|First Intervention|Withdrawal by Subject|1|||
130947583|NCT01063595|471441391|FG001|First Intervention|Withdrawal by Subject|0|||
130947584|NCT01063595|471441390|FG000|First Intervention|Reason not Specified|0|||
130947585|NCT01063595|471441391|FG001|First Intervention|Reason not Specified|1|||
130947586|NCT02678676|471441392|FG000|Overall Study|Death|619|||
130947587|NCT02678676|471441393|FG001|Overall Study|Death|649|||
130947588|NCT02678676|471441392|FG000|Overall Study|Withdrawal by Subject|13|||
130947589|NCT02678676|471441393|FG001|Overall Study|Withdrawal by Subject|5|||
130947590|NCT02678676|471441392|FG000|Overall Study|Lost to Follow-up|171|||
130947591|NCT02678676|471441393|FG001|Overall Study|Lost to Follow-up|151|||
130947592|NCT02678676|471441392|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
130947593|NCT02678676|471441393|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
130947594|NCT01342510|471441396|FG000|Overall Study|Protocol Violation|12|||
130947595|NCT01342510|471441397|FG001|Overall Study|Protocol Violation|6|||
130947596|NCT01342510|471441398|FG002|Overall Study|Protocol Violation|13|||
130947597|NCT01342510|471441399|FG003|Overall Study|Protocol Violation|11|||
130947598|NCT01449526|471441400|FG000|Overall Study|Lost to Follow-up|1|||
130947599|NCT01449526|471441401|FG001|Overall Study|Lost to Follow-up|2|||
130947600|NCT01449526|471441400|FG000|Overall Study|Withdrawal by Subject|1|||
130947601|NCT01449526|471441401|FG001|Overall Study|Withdrawal by Subject|1|||
130947602|NCT01449526|471441400|FG000|Overall Study|Symptoms/complaints|0|||
130947603|NCT01449526|471441401|FG001|Overall Study|Symptoms/complaints|1|||
131037672|NCT03945292|471772731|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
131037673|NCT03945292|471772732|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
131037674|NCT03524118|471772736|FG000|Overall Study|Lost to Follow-up|0|||
131037675|NCT03524118|471772737|FG001|Overall Study|Lost to Follow-up|0|||
131037676|NCT03524118|471772738|FG002|Overall Study|Lost to Follow-up|0|||
131037677|NCT03524118|471772739|FG003|Overall Study|Lost to Follow-up|0|||
131037678|NCT03524118|471772740|FG004|Overall Study|Lost to Follow-up|1|||
131037679|NCT03524118|471772741|FG005|Overall Study|Lost to Follow-up|0|||
130774436|NCT00313586|470800514|FG002|Overall Study|Lost insurance|0|||
130947604|NCT01449526|471441400|FG000|Overall Study|Lack of Motivation|0|||
130947605|NCT01449526|471441401|FG001|Overall Study|Lack of Motivation|1|||
130947606|NCT01449526|471441400|FG000|Overall Study|Cannot maintain visits|0|||
131037680|NCT03524118|471772736|FG000|Overall Study|Other|0|||
131037681|NCT03524118|471772737|FG001|Overall Study|Other|1|||
131037682|NCT03524118|471772738|FG002|Overall Study|Other|0|||
131037683|NCT03524118|471772739|FG003|Overall Study|Other|0|||
131037684|NCT03524118|471772740|FG004|Overall Study|Other|1|||
130774437|NCT00313586|470800515|FG003|Overall Study|Lost insurance|0|||
130947607|NCT01449526|471441401|FG001|Overall Study|Cannot maintain visits|1|||
130947608|NCT01400516|471441403|FG000|Primary Trial|Withdrawal by Subject|0|||
131037685|NCT03524118|471772741|FG005|Overall Study|Other|1|||
130947609|NCT01400516|471441404|FG001|Primary Trial|Withdrawal by Subject|2|||
130947610|NCT01132495|471441411|FG000|Overall Study|Various reasons|40|||
130947611|NCT01132495|471441412|FG001|Overall Study|Various reasons|38|||
130947612|NCT01132495|471441413|FG002|Overall Study|Various reasons|20|||
130947613|NCT01132495|471441414|FG003|Overall Study|Various reasons|12|||
130947614|NCT01796197|471441415|FG000|Overall Study|Lost to Follow-up|1|||
130947615|NCT01796197|471441415|FG000|Overall Study|Lack of Efficacy|1|||
130947616|NCT05756790|471441416|FG000|Overall Study|Withdrawal by Subject|1|||
130947617|NCT05756790|471441417|FG001|Overall Study|Withdrawal by Subject|1|||
130947618|NCT05756790|471441418|FG002|Overall Study|Withdrawal by Subject|1|||
130947619|NCT05756790|471441419|FG003|Overall Study|Withdrawal by Subject|1|||
130947620|NCT05756790|471441420|FG004|Overall Study|Withdrawal by Subject|0|||
130947621|NCT05756790|471441421|FG005|Overall Study|Withdrawal by Subject|0|||
130947622|NCT05756790|471441416|FG000|Overall Study|Protocol Violation|0|||
130947623|NCT05756790|471441417|FG001|Overall Study|Protocol Violation|0|||
130947624|NCT05756790|471441418|FG002|Overall Study|Protocol Violation|1|||
130947625|NCT05756790|471441419|FG003|Overall Study|Protocol Violation|1|||
130947626|NCT05756790|471441420|FG004|Overall Study|Protocol Violation|0|||
130947627|NCT05756790|471441421|FG005|Overall Study|Protocol Violation|0|||
130947628|NCT05756790|471441416|FG000|Overall Study|Ineligible|0|||
130947629|NCT05756790|471441417|FG001|Overall Study|Ineligible|0|||
130947630|NCT05756790|471441418|FG002|Overall Study|Ineligible|0|||
130947631|NCT05756790|471441419|FG003|Overall Study|Ineligible|0|||
130947632|NCT05756790|471441420|FG004|Overall Study|Ineligible|2|||
130947633|NCT05756790|471441421|FG005|Overall Study|Ineligible|2|||
130947634|NCT02449239|471442806|FG000|Induction Phase|Lack of Efficacy|64|||
130947635|NCT02449239|471442806|FG000|Induction Phase|Adverse Event|1|||
130947636|NCT02449239|471442806|FG000|Induction Phase|Lost to Follow-up|1|||
130947637|NCT02449239|471442806|FG000|Induction Phase|Protocol Violation|1|||
130947638|NCT02449239|471442806|FG000|Induction Phase|Physician Decision|1|||
130947639|NCT02449239|471442806|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
130947640|NCT02449239|471442806|FG000|Induction Phase|Withdrawal by Subject|1|||
130947641|NCT02449239|471442806|FG000|Maintenance Month 3|Lack of Efficacy|14|||
130947642|NCT02449239|471442806|FG000|Maintenance Month 6|Lack of Efficacy|10|||
130947643|NCT02449239|471442806|FG000|Maintenance Month 6|Adverse Event|2|||
130947644|NCT02449239|471442806|FG000|Maintenance Month 6|Physician Decision|1|||
130947645|NCT02449239|471442806|FG000|Maintenance Month 9|Lack of Efficacy|2|||
130947646|NCT02449239|471442806|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
130947647|NCT02449239|471442806|FG000|Maintenance Month 12|Lack of Efficacy|5|||
130947648|NCT02449239|471442806|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
130947649|NCT02449239|471442806|FG000|Maintenance Month 12|Subject moved from area|1|||
130947650|NCT02449239|471442806|FG000|Maintenance Month 15|Lack of Efficacy|1|||
130947651|NCT02449239|471442806|FG000|Maintenance Month 21|Lack of Efficacy|1|||
130947652|NCT02449239|471442806|FG000|Maintenance Month 21|Sponsor decision|1|||
130947653|NCT05664490|471442825|FG000|Overall Study|Withdrawal by Subject|0|||
130947654|NCT05664490|471442826|FG001|Overall Study|Withdrawal by Subject|1|||
130947655|NCT05664490|471442825|FG000|Overall Study|Lost to Follow-up|14|||
130947656|NCT05664490|471442826|FG001|Overall Study|Lost to Follow-up|22|||
130947657|NCT01990495|471442831|FG000|Overall Study|Physician Decision|5|||
130947658|NCT01990495|471442832|FG001|Overall Study|Physician Decision|4|||
130947659|NCT03412084|471442833|FG000|Overall Study|Withdrawal by Subject|2|||
130947660|NCT03412084|471442834|FG001|Overall Study|Withdrawal by Subject|0|||
130947661|NCT03412084|471442833|FG000|Overall Study|Participant moved|1|||
130947662|NCT03412084|471442834|FG001|Overall Study|Participant moved|0|||
130947663|NCT03412084|471442833|FG000|Overall Study|Lost to Follow-up|1|||
130947664|NCT03412084|471442834|FG001|Overall Study|Lost to Follow-up|1|||
130947665|NCT02023151|471442839|FG000|Overall Study|Lost to Follow-up|4|||
130947666|NCT04064294|471442840|FG000|Overall Study|Adverse Event|1|||
130947667|NCT04064294|471442841|FG001|Overall Study|Adverse Event|0|||
130947668|NCT04064294|471442842|FG002|Overall Study|Adverse Event|0|||
130947669|NCT03450707|471442843|FG000|Overall Study|Outside enrollment window|4|||
130947670|NCT03450707|471442844|FG001|Overall Study|Outside enrollment window|1|||
130947671|NCT03450707|471442843|FG000|Overall Study|Death|1|||
130947672|NCT03450707|471442844|FG001|Overall Study|Death|0|||
130947673|NCT03450707|471442843|FG000|Overall Study|Indication for thiamine|1|||
131037686|NCT03524118|471772736|FG000|Overall Study|Physician Decision|0|||
131037687|NCT03524118|471772737|FG001|Overall Study|Physician Decision|0|||
131037688|NCT03524118|471772738|FG002|Overall Study|Physician Decision|0|||
131037689|NCT03524118|471772739|FG003|Overall Study|Physician Decision|0|||
131037690|NCT03524118|471772740|FG004|Overall Study|Physician Decision|1|||
131037691|NCT03524118|471772741|FG005|Overall Study|Physician Decision|0|||
131037692|NCT03524118|471772736|FG000|Overall Study|Protocol Violation|0|||
131037693|NCT03524118|471772737|FG001|Overall Study|Protocol Violation|0|||
131037694|NCT03524118|471772738|FG002|Overall Study|Protocol Violation|1|||
131037695|NCT03524118|471772739|FG003|Overall Study|Protocol Violation|0|||
131037696|NCT03524118|471772740|FG004|Overall Study|Protocol Violation|1|||
130947674|NCT03450707|471442844|FG001|Overall Study|Indication for thiamine|1|||
130947675|NCT03450707|471442843|FG000|Overall Study|Evidence of traumatic brain injury|1|||
130947676|NCT03450707|471442844|FG001|Overall Study|Evidence of traumatic brain injury|0|||
130947677|NCT03450707|471442843|FG000|Overall Study|Following commands|0|||
130947678|NCT03450707|471442844|FG001|Overall Study|Following commands|3|||
130947679|NCT03450707|471442843|FG000|Overall Study|Lactate < 3.5|0|||
130947680|NCT03450707|471442844|FG001|Overall Study|Lactate < 3.5|2|||
130947681|NCT03450707|471442843|FG000|Overall Study|Rearrest with ECMO|0|||
130947682|NCT03450707|471442844|FG001|Overall Study|Rearrest with ECMO|1|||
130710740|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
130710741|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
130710742|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
130710743|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
130710744|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
130947683|NCT03450707|471442843|FG000|Overall Study|Indication for thiamine + head CT results|0|||
130947684|NCT03450707|471442844|FG001|Overall Study|Indication for thiamine + head CT results|1|||
130947685|NCT03450707|471442843|FG000|Overall Study|Family/patient goals of care|0|||
130947686|NCT03450707|471442844|FG001|Overall Study|Family/patient goals of care|1|||
130947687|NCT00481195|471442845|FG000|Overall Study|Adverse Event|16|||
130947688|NCT00481195|471442846|FG001|Overall Study|Adverse Event|11|||
130947689|NCT00481195|471442845|FG000|Overall Study|Lack of Efficacy|1|||
130947690|NCT00481195|471442846|FG001|Overall Study|Lack of Efficacy|3|||
130947691|NCT00481195|471442845|FG000|Overall Study|Lost to Follow-up|4|||
130947692|NCT00481195|471442846|FG001|Overall Study|Lost to Follow-up|6|||
130947693|NCT00481195|471442845|FG000|Overall Study|Physician Decision|3|||
130947694|NCT00481195|471442846|FG001|Overall Study|Physician Decision|1|||
130947695|NCT00481195|471442845|FG000|Overall Study|Protocol Violation|10|||
130947696|NCT00481195|471442846|FG001|Overall Study|Protocol Violation|7|||
130947697|NCT00481195|471442845|FG000|Overall Study|Withdrawal by Subject|3|||
130947698|NCT00481195|471442846|FG001|Overall Study|Withdrawal by Subject|9|||
130947699|NCT00481195|471442845|FG000|Overall Study|Miscellaneous|2|||
130947700|NCT00481195|471442846|FG001|Overall Study|Miscellaneous|2|||
130947701|NCT03343483|471442847|FG000|Overall Study|Death|0|||
130947702|NCT03343483|471442848|FG001|Overall Study|Death|3|||
130947703|NCT03343483|471442847|FG000|Overall Study|Lost to Follow-up|9|||
130947704|NCT03343483|471442848|FG001|Overall Study|Lost to Follow-up|13|||
130947705|NCT03343483|471442847|FG000|Overall Study|Withdrawal by Subject|8|||
130947706|NCT03343483|471442848|FG001|Overall Study|Withdrawal by Subject|17|||
130947707|NCT01505608|471442849|FG000|Phase I|Lack of Efficacy|0|||
130947708|NCT01505608|471442850|FG001|Phase I|Lack of Efficacy|4|||
130947709|NCT01505608|471442849|FG000|Phase I|Adverse Event|0|||
130947710|NCT01505608|471442850|FG001|Phase I|Adverse Event|1|||
130947711|NCT01505608|471442849|FG000|Phase I|Withdrawal by Subject|0|||
130947712|NCT01505608|471442850|FG001|Phase I|Withdrawal by Subject|1|||
130947713|NCT01505608|471442849|FG000|Phase II|Lack of Efficacy|2|||
130947714|NCT01505608|471442850|FG001|Phase II|Lack of Efficacy|1|||
130947715|NCT01505608|471442849|FG000|Phase II|Protocol Violation|0|||
130947716|NCT01505608|471442850|FG001|Phase II|Protocol Violation|1|||
130947717|NCT03975647|471442851|FG000|Overall Study|Death|71|||
130947718|NCT03975647|471442852|FG001|Overall Study|Death|63|||
130947719|NCT03975647|471442851|FG000|Overall Study|Lost to Follow-up|2|||
130947720|NCT03975647|471442852|FG001|Overall Study|Lost to Follow-up|2|||
130947721|NCT03975647|471442851|FG000|Overall Study|Subject withdrawal of consent|7|||
130947722|NCT03975647|471442852|FG001|Overall Study|Subject withdrawal of consent|11|||
130947723|NCT00439556|471442853|FG000|Overall Study|Patient was taken off study for non-comp|0|||
130947724|NCT00439556|471442854|FG001|Overall Study|Patient was taken off study for non-comp|1|||
130947725|NCT00439556|471442855|FG002|Overall Study|Patient was taken off study for non-comp|0|||
130947726|NCT02871739|471442856|FG000|Overall Study|Lost to Follow-up|3|||
130947727|NCT02871739|471442857|FG001|Overall Study|Lost to Follow-up|2|||
130947728|NCT02871739|471442858|FG002|Overall Study|Lost to Follow-up|0|||
130947729|NCT02871739|471442859|FG003|Overall Study|Lost to Follow-up|2|||
130947730|NCT01324388|471442862|FG000|Part 1 of Study|Adverse Event|2|||
130947731|NCT01324388|471442863|FG001|Part 1 of Study|Adverse Event|0|||
130947732|NCT01324388|471442864|FG002|Part 1 of Study|Adverse Event|0|||
130947733|NCT01324388|471442865|FG003|Part 1 of Study|Adverse Event|0|||
130947734|NCT01324388|471442862|FG000|Part 1 of Study|Protocol Violation|1|||
130947735|NCT01324388|471442863|FG001|Part 1 of Study|Protocol Violation|2|||
130947736|NCT01324388|471442864|FG002|Part 1 of Study|Protocol Violation|0|||
130947737|NCT01324388|471442865|FG003|Part 1 of Study|Protocol Violation|0|||
130947738|NCT01324388|471442862|FG000|Part 1 of Study|Physician Decision|1|||
130947739|NCT01324388|471442863|FG001|Part 1 of Study|Physician Decision|0|||
130947740|NCT01324388|471442864|FG002|Part 1 of Study|Physician Decision|0|||
130947741|NCT01324388|471442865|FG003|Part 1 of Study|Physician Decision|0|||
130947742|NCT01324388|471442862|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
131037697|NCT03524118|471772741|FG005|Overall Study|Protocol Violation|0|||
131037698|NCT03524118|471772736|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131037699|NCT03524118|471772737|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131037700|NCT03524118|471772738|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130947743|NCT01324388|471442863|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
130947744|NCT01324388|471442864|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
130947745|NCT01324388|471442865|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
130947746|NCT01324388|471442862|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
130947747|NCT01324388|471442863|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
130947748|NCT01324388|471442864|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
130947749|NCT01324388|471442865|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
130947750|NCT01405963|471442866|FG000|Overall Study|Moved Away|2|||
130947751|NCT01405963|471442867|FG001|Overall Study|Moved Away|0|||
130947752|NCT01405963|471442866|FG000|Overall Study|Adverse Event|0|||
130947753|NCT01405963|471442867|FG001|Overall Study|Adverse Event|1|||
130947754|NCT01405963|471442866|FG000|Overall Study|Lost to Follow-up|0|||
130947755|NCT01405963|471442867|FG001|Overall Study|Lost to Follow-up|1|||
130947756|NCT01085097|471442868|FG000|Overall Study|Adverse Event|0|||
130947757|NCT01085097|471442869|FG001|Overall Study|Adverse Event|0|||
130947758|NCT01085097|471442870|FG002|Overall Study|Adverse Event|2|||
130947759|NCT01085097|471442868|FG000|Overall Study|Treatment failure|2|||
130947760|NCT01085097|471442869|FG001|Overall Study|Treatment failure|0|||
130947761|NCT01085097|471442870|FG002|Overall Study|Treatment failure|0|||
130947762|NCT01498640|471442873|FG000|Overall Study|Lost to Follow-up|1|||
130947763|NCT01498640|471442873|FG000|Overall Study|Death|1|||
130947764|NCT01498640|471442873|FG000|Overall Study|Other|3|||
130947765|NCT02197806|471442877|FG000|Overall Study|Adverse Event|0|||
130947766|NCT02197806|471442878|FG001|Overall Study|Adverse Event|1|||
130947767|NCT02197806|471442879|FG002|Overall Study|Adverse Event|0|||
130947768|NCT02197806|471442880|FG003|Overall Study|Adverse Event|1|||
130947769|NCT03065244|471442888|FG000|Overall Study|Lost to Follow-up|1|||
130947770|NCT03065244|471442889|FG001|Overall Study|Lost to Follow-up|1|||
130947771|NCT03065244|471442888|FG000|Overall Study|Diagnosed with a different disease|1|||
130947772|NCT03065244|471442889|FG001|Overall Study|Diagnosed with a different disease|1|||
130947773|NCT03065244|471442888|FG000|Overall Study|Protocol Violation|0|||
130947774|NCT03065244|471442889|FG001|Overall Study|Protocol Violation|1|||
130947775|NCT03065244|471442888|FG000|Overall Study|Withdrawal by Subject|1|||
130774438|NCT00313586|470800512|FG000|Overall Study|Moved|0|||
130774439|NCT00313586|470800513|FG001|Overall Study|Moved|1|||
130774440|NCT00313586|470800514|FG002|Overall Study|Moved|0|||
130774441|NCT00313586|470800515|FG003|Overall Study|Moved|0|||
130774442|NCT00313586|470800512|FG000|Overall Study|Death before starting treatment|1|||
130774443|NCT00313586|470800513|FG001|Overall Study|Death before starting treatment|0|||
130774444|NCT00313586|470800514|FG002|Overall Study|Death before starting treatment|0|||
130774445|NCT00313586|470800515|FG003|Overall Study|Death before starting treatment|0|||
130774446|NCT03076996|470800516|FG000|Overall Study|Withdrawal by Subject|2|||
130947776|NCT03065244|471442889|FG001|Overall Study|Withdrawal by Subject|1|||
130947777|NCT03717480|471442890|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
130947778|NCT02965703|471442895|FG000|Overall Study|Withdrawal by Subject|6|||
130947779|NCT02965703|471442896|FG001|Overall Study|Withdrawal by Subject|3|||
130947780|NCT02965703|471442897|FG002|Overall Study|Withdrawal by Subject|1|||
130947781|NCT02965703|471442895|FG000|Overall Study|Protocol Violation|1|||
130947782|NCT02965703|471442896|FG001|Overall Study|Protocol Violation|0|||
130947783|NCT02965703|471442897|FG002|Overall Study|Protocol Violation|0|||
130947784|NCT02965703|471442895|FG000|Overall Study|Adverse Event|1|||
130947785|NCT02965703|471442896|FG001|Overall Study|Adverse Event|1|||
130947786|NCT02965703|471442897|FG002|Overall Study|Adverse Event|0|||
130947787|NCT02965703|471442895|FG000|Overall Study|Lost to Follow-up|2|||
130947788|NCT02965703|471442896|FG001|Overall Study|Lost to Follow-up|1|||
130947789|NCT02965703|471442897|FG002|Overall Study|Lost to Follow-up|1|||
130947790|NCT00768144|471442898|FG000|Overall Study|Adverse Event|13|||
130947791|NCT00768144|471442898|FG000|Overall Study|Progressive Disease|21|||
130947792|NCT00768144|471442898|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
130947793|NCT00768144|471442898|FG000|Overall Study|Pt Withdrew Consent|1|||
130947794|NCT04251221|471442899|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
130947795|NCT04251221|471442900|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
130947796|NCT02968979|471442901|FG000|Overall Study|Protocol Violation|7|||
130947797|NCT02968979|471442901|FG000|Overall Study|Withdrawal by Subject|1|||
130947798|NCT03745144|471442903|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
130947799|NCT03745144|471442904|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
131124649|NCT00597753|472084529|FG001|Overall Study|Noncompliance|1|||
131124650|NCT00597753|472084528|FG000|Overall Study|Relocation|17|||
130947800|NCT03745144|471442905|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
130947801|NCT03745144|471442903|FG000|Period 1|Other|0|||
131124651|NCT00597753|472084529|FG001|Overall Study|Relocation|6|||
131124652|NCT00597753|472084528|FG000|Overall Study|Renal transplant|10|||
131124653|NCT00597753|472084529|FG001|Overall Study|Renal transplant|3|||
130774447|NCT03076996|470800516|FG000|Overall Study|Lost to Follow-up|3|||
130774448|NCT03076996|470800516|FG000|Overall Study|Literacy precluded participation|1|||
130947802|NCT03745144|471442904|FG001|Period 1|Other|0|||
130947803|NCT03745144|471442905|FG002|Period 1|Other|1|||
130947804|NCT00896337|471442906|FG000|Overall Study|Death|7|||
130947805|NCT00896337|471442906|FG000|Overall Study|Withdrawal by Subject|7|||
131124654|NCT00597753|472084528|FG000|Overall Study|Site closed by sponsor|19|||
130774449|NCT01247350|470800517|FG000|Overall Study|Adverse Event|0|||
130947806|NCT00896337|471442906|FG000|Overall Study|Lost to Follow-up|11|||
130947807|NCT04668950|471442907|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
130947808|NCT04668950|471442908|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
131037701|NCT03524118|471772739|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
131037702|NCT03524118|471772740|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
131037703|NCT03524118|471772741|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
131037704|NCT04987320|471772742|FG000|Overall Study|Withdrawal by Subject|0|||
131037705|NCT04987320|471772743|FG001|Overall Study|Withdrawal by Subject|1|||
131037706|NCT01129102|471772744|FG000|Overall Study|No study drug treatment|2|||
131037707|NCT01129102|471772745|FG001|Overall Study|No study drug treatment|3|||
131037708|NCT01129102|471772746|FG002|Overall Study|No study drug treatment|1|||
131037709|NCT01129102|471772744|FG000|Overall Study|Withdrawal by Subject|2|||
131037710|NCT01129102|471772745|FG001|Overall Study|Withdrawal by Subject|0|||
131037711|NCT01129102|471772746|FG002|Overall Study|Withdrawal by Subject|3|||
131037712|NCT01129102|471772744|FG000|Overall Study|Protocol Violation|0|||
131037713|NCT01129102|471772745|FG001|Overall Study|Protocol Violation|1|||
131037714|NCT01129102|471772746|FG002|Overall Study|Protocol Violation|1|||
131037715|NCT01129102|471772744|FG000|Overall Study|Pregnancy|0|||
131037716|NCT01129102|471772745|FG001|Overall Study|Pregnancy|0|||
131037717|NCT01129102|471772746|FG002|Overall Study|Pregnancy|1|||
131037718|NCT01129102|471772744|FG000|Overall Study|Adverse Event|2|||
131037719|NCT01129102|471772745|FG001|Overall Study|Adverse Event|2|||
131037720|NCT01129102|471772746|FG002|Overall Study|Adverse Event|1|||
131037721|NCT01129102|471772744|FG000|Overall Study|Lost to Follow-up|2|||
131037722|NCT01129102|471772745|FG001|Overall Study|Lost to Follow-up|0|||
131037723|NCT01129102|471772746|FG002|Overall Study|Lost to Follow-up|0|||
131037724|NCT02675751|471772749|FG000|Overall Study|Lost to Follow-up|16|||
131037725|NCT03628924|471772750|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
131037726|NCT03628924|471772751|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131037727|NCT03628924|471772752|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131037728|NCT03628924|471772753|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131037729|NCT03628924|471772754|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131037730|NCT03628924|471772755|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131037731|NCT03628924|471772756|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
131037732|NCT03628924|471772750|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131037733|NCT03628924|471772751|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131037734|NCT03628924|471772752|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
131037735|NCT03628924|471772753|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131037736|NCT03628924|471772754|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131037737|NCT03628924|471772755|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131037738|NCT03628924|471772756|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131037739|NCT03628924|471772750|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
131037740|NCT03628924|471772751|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
131037741|NCT03628924|471772752|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
131037742|NCT03628924|471772753|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
131037743|NCT03628924|471772754|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
131037744|NCT03628924|471772755|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
131037745|NCT03628924|471772756|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
131037746|NCT03628924|471772750|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131037747|NCT03628924|471772751|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
131037748|NCT03628924|471772752|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131037749|NCT03628924|471772753|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131037750|NCT03628924|471772754|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131037751|NCT03628924|471772755|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131037752|NCT03628924|471772756|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131037753|NCT03628924|471772750|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
131037754|NCT03628924|471772751|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
131037755|NCT03628924|471772752|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
131037756|NCT03628924|471772753|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
131037757|NCT03628924|471772754|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
131037758|NCT03628924|471772755|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
130710745|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
130710746|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
131037759|NCT03628924|471772756|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
131037760|NCT03628924|471772750|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
131037761|NCT03628924|471772751|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
131037762|NCT03628924|471772752|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
131037763|NCT03628924|471772753|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
131037764|NCT03628924|471772754|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
131037765|NCT03628924|471772755|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
131037766|NCT03628924|471772756|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
130774450|NCT01247350|470800518|FG001|Overall Study|Adverse Event|0|||
130947809|NCT04668950|471442907|FG000|Overall Study|Could not confirm started study medication|15|||
130947810|NCT04668950|471442908|FG001|Overall Study|Could not confirm started study medication|15|||
130947811|NCT04668950|471442907|FG000|Overall Study|Could not confirm baseline status|6|||
130947812|NCT04668950|471442908|FG001|Overall Study|Could not confirm baseline status|2|||
130947813|NCT04668950|471442907|FG000|Overall Study|Drop out and did not start medication|15|||
130947814|NCT04668950|471442908|FG001|Overall Study|Drop out and did not start medication|17|||
130947815|NCT04668950|471442907|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
130947816|NCT04668950|471442908|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
130947817|NCT04668950|471442907|FG000|Overall Study|Other|2|||
130947818|NCT04668950|471442908|FG001|Overall Study|Other|4|||
130947819|NCT04059146|471442916|FG000|Overall Study|Withdrawal by Subject|0|||
130947820|NCT04059146|471442917|FG001|Overall Study|Withdrawal by Subject|1|||
130947821|NCT00747435|471442918|FG000|Overall Study|Lost to Follow-up|2|||
130947822|NCT00747435|471442918|FG000|Overall Study|Withdrawal by Subject|3|||
130947823|NCT00747435|471442918|FG000|Overall Study|Still undergoing follow up|1|||
130947824|NCT00082433|471442924|FG000|Overall Study|Adverse Event|12|||
130947825|NCT00082433|471442925|FG001|Overall Study|Adverse Event|17|||
130947826|NCT00082433|471442924|FG000|Overall Study|Death|8|||
130947827|NCT00082433|471442925|FG001|Overall Study|Death|18|||
130947828|NCT00082433|471442924|FG000|Overall Study|Disease Progression/Relapse|270|||
130947829|NCT00082433|471442925|FG001|Overall Study|Disease Progression/Relapse|388|||
130947830|NCT00082433|471442924|FG000|Overall Study|Physician Decision|50|||
130947831|NCT00082433|471442925|FG001|Overall Study|Physician Decision|61|||
130947832|NCT00082433|471442924|FG000|Overall Study|Lost to Follow-up|1|||
130947833|NCT00082433|471442925|FG001|Overall Study|Lost to Follow-up|2|||
130947834|NCT00082433|471442924|FG000|Overall Study|Study Drug Toxicity|179|||
130947835|NCT00082433|471442925|FG001|Overall Study|Study Drug Toxicity|66|||
130947836|NCT00082433|471442924|FG000|Overall Study|Withdrawal by Subject|55|||
130947837|NCT00082433|471442925|FG001|Overall Study|Withdrawal by Subject|30|||
130947838|NCT00082433|471442924|FG000|Overall Study|Still On Treatment|2|||
130947839|NCT00082433|471442925|FG001|Overall Study|Still On Treatment|1|||
130947840|NCT00082433|471442924|FG000|Overall Study|Not Treated|12|||
130947841|NCT00082433|471442925|FG001|Overall Study|Not Treated|11|||
130947842|NCT00082433|471442924|FG000|Overall Study|Ineligible|2|||
130947843|NCT00082433|471442925|FG001|Overall Study|Ineligible|1|||
130947844|NCT00082433|471442924|FG000|Overall Study|Noncompliance|2|||
130947845|NCT00082433|471442925|FG001|Overall Study|Noncompliance|1|||
130947846|NCT00082433|471442924|FG000|Overall Study|New primary cancer|1|||
130947847|NCT00082433|471442925|FG001|Overall Study|New primary cancer|0|||
130947848|NCT00082433|471442924|FG000|Overall Study|Impending surgery|0|||
130947849|NCT00082433|471442925|FG001|Overall Study|Impending surgery|1|||
130947850|NCT01380184|471442928|FG000|Part 1 (19 Days)|Adverse Event|1|||
130947851|NCT01380184|471442928|FG000|Part 2|Adverse Event|5|||
130947852|NCT01380184|471442928|FG000|Part 2|Disease Progression|8|||
130947853|NCT01380184|471442928|FG000|Part 2|Lost to Follow-up|1|||
130947854|NCT04097821|471442929|FG000|Overall Study|Subject Decision|0|||
130947855|NCT04097821|471442930|FG001|Overall Study|Subject Decision|0|||
130947856|NCT04097821|471442931|FG002|Overall Study|Subject Decision|0|||
130947857|NCT04097821|471442932|FG003|Overall Study|Subject Decision|1|||
130947858|NCT04097821|471442933|FG004|Overall Study|Subject Decision|2|||
130947859|NCT04097821|471442934|FG005|Overall Study|Subject Decision|2|||
130947860|NCT04097821|471442935|FG006|Overall Study|Subject Decision|0|||
130947861|NCT04097821|471442936|FG007|Overall Study|Subject Decision|1|||
130947862|NCT04097821|471442929|FG000|Overall Study|Death|0|||
130947863|NCT04097821|471442930|FG001|Overall Study|Death|0|||
130947864|NCT04097821|471442931|FG002|Overall Study|Death|3|||
130947865|NCT04097821|471442932|FG003|Overall Study|Death|1|||
130947866|NCT04097821|471442933|FG004|Overall Study|Death|0|||
130947867|NCT04097821|471442934|FG005|Overall Study|Death|0|||
131037767|NCT03628924|471772750|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
131037768|NCT03628924|471772751|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
131037769|NCT03628924|471772752|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
131037770|NCT03628924|471772753|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
130947868|NCT04097821|471442935|FG006|Overall Study|Death|0|||
130947869|NCT04097821|471442936|FG007|Overall Study|Death|0|||
130947870|NCT04097821|471442929|FG000|Overall Study|Physician Decision|1|||
130947871|NCT04097821|471442930|FG001|Overall Study|Physician Decision|2|||
130947872|NCT04097821|471442931|FG002|Overall Study|Physician Decision|0|||
131037771|NCT03628924|471772754|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
130947873|NCT04097821|471442932|FG003|Overall Study|Physician Decision|0|||
130947874|NCT04097821|471442933|FG004|Overall Study|Physician Decision|0|||
131037772|NCT03628924|471772755|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
131045853|NCT03582033|471802280|FG002|Part D|Death|0|||
130947875|NCT04097821|471442934|FG005|Overall Study|Physician Decision|0|||
130947876|NCT04097821|471442935|FG006|Overall Study|Physician Decision|0|||
130947877|NCT04097821|471442936|FG007|Overall Study|Physician Decision|0|||
130947878|NCT04097821|471442929|FG000|Overall Study|Adverse Event|0|||
130947879|NCT04097821|471442930|FG001|Overall Study|Adverse Event|0|||
130947880|NCT04097821|471442931|FG002|Overall Study|Adverse Event|1|||
131037773|NCT03628924|471772756|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
131037774|NCT03628924|471772750|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
131037775|NCT03628924|471772751|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
131037776|NCT03628924|471772752|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
131037777|NCT03628924|471772753|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
131037778|NCT03628924|471772754|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
131037779|NCT03628924|471772755|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
131037780|NCT03628924|471772756|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
131037781|NCT03628924|471772750|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
131037782|NCT03628924|471772751|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
131037783|NCT03628924|471772752|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
131037784|NCT03628924|471772753|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
131037785|NCT03628924|471772754|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
131037786|NCT03628924|471772755|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
131037787|NCT03628924|471772756|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
131037788|NCT03628924|471772750|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
131037789|NCT03628924|471772751|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
131037790|NCT03628924|471772752|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
131037791|NCT03628924|471772753|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
131037792|NCT03628924|471772754|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
131037793|NCT03628924|471772755|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
131037794|NCT03628924|471772756|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
131037795|NCT04016662|471772759|FG000|Run-In Phase|Death|1|||
131037796|NCT04016662|471772759|FG000|Run-In Phase|Withdrawal by Subject|11|||
131037797|NCT04016662|471772759|FG000|Run-In Phase|Not meeting screening eligibility|9|||
131037798|NCT04016662|471772759|FG000|Run-In Phase|Physician Decision|3|||
131037799|NCT04016662|471772759|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
131037800|NCT04016662|471772759|FG000|PLGS (12 Weeks)|Death|1|||
131037801|NCT04016662|471772759|FG000|SAP (12 Weeks)|Death|1|||
131037802|NCT01802788|471772760|FG000|Overall Study|Withdrawal by Subject|102|||
131037803|NCT01802788|471772761|FG001|Overall Study|Withdrawal by Subject|5|||
131037804|NCT01802788|471772760|FG000|Overall Study|Death|382|||
131037805|NCT01802788|471772761|FG001|Overall Study|Death|18|||
131037806|NCT01802788|471772760|FG000|Overall Study|Lost to Follow-up|31|||
131037807|NCT01802788|471772761|FG001|Overall Study|Lost to Follow-up|2|||
131037808|NCT01802788|471772760|FG000|Overall Study|Physician Decision|3|||
131037809|NCT01802788|471772761|FG001|Overall Study|Physician Decision|0|||
131037810|NCT01802788|471772760|FG000|Overall Study|Patient Non-Compliance|1|||
131037811|NCT01802788|471772761|FG001|Overall Study|Patient Non-Compliance|0|||
131037812|NCT01802788|471772760|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
131037813|NCT01802788|471772761|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
131037814|NCT01802788|471772760|FG000|Overall Study|Other Reasons|19|||
131037815|NCT01802788|471772761|FG001|Overall Study|Other Reasons|0|||
131037816|NCT03021096|471772762|FG000|Overall Study|Lost to Follow-up|4|||
131037817|NCT03021096|471772762|FG000|Overall Study|Protocol Violation|2|||
131037818|NCT02043678|471772765|FG000|Overall Study|Never treated|11|||
131037819|NCT02043678|471772766|FG001|Overall Study|Never treated|9|||
131037820|NCT02043678|471772765|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
131037821|NCT02043678|471772766|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
131037822|NCT02043678|471772765|FG000|Overall Study|AE without clinical PD|54|||
131037823|NCT02043678|471772766|FG001|Overall Study|AE without clinical PD|36|||
131037824|NCT02043678|471772765|FG000|Overall Study|Lost to Follow-up|1|||
131037825|NCT02043678|471772766|FG001|Overall Study|Lost to Follow-up|1|||
131037826|NCT02043678|471772765|FG000|Overall Study|Other|10|||
131037827|NCT02043678|471772766|FG001|Overall Study|Other|14|||
131037828|NCT02043678|471772765|FG000|Overall Study|Clinical PD|114|||
131037829|NCT02043678|471772766|FG001|Overall Study|Clinical PD|148|||
131037830|NCT02043678|471772765|FG000|Overall Study|Radiological PD|100|||
130710747|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
130710748|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
130710749|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
130710750|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
131037831|NCT02043678|471772766|FG001|Overall Study|Radiological PD|90|||
131037832|NCT02043678|471772765|FG000|Overall Study|Protocol-driven decision point|59|||
131037833|NCT02043678|471772766|FG001|Overall Study|Protocol-driven decision point|58|||
131037834|NCT02043678|471772765|FG000|Overall Study|Withdrawal by Subject|16|||
130710751|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
131037835|NCT02043678|471772766|FG001|Overall Study|Withdrawal by Subject|20|||
131037836|NCT02043678|471772765|FG000|Overall Study|Protocol Violation|1|||
131037837|NCT02043678|471772766|FG001|Overall Study|Protocol Violation|0|||
131037838|NCT02043678|471772765|FG000|Overall Study|Deterioration of general conditions|1|||
130774451|NCT01247350|470800519|FG002|Overall Study|Adverse Event|1|||
130947881|NCT04097821|471442932|FG003|Overall Study|Adverse Event|1|||
130947882|NCT04097821|471442933|FG004|Overall Study|Adverse Event|0|||
130947883|NCT04097821|471442934|FG005|Overall Study|Adverse Event|0|||
130947884|NCT04097821|471442935|FG006|Overall Study|Adverse Event|0|||
130947885|NCT04097821|471442936|FG007|Overall Study|Adverse Event|0|||
130947886|NCT04097821|471442929|FG000|Overall Study|New Therapy For Study Indication|0|||
130947887|NCT04097821|471442930|FG001|Overall Study|New Therapy For Study Indication|0|||
130947888|NCT04097821|471442931|FG002|Overall Study|New Therapy For Study Indication|0|||
130947889|NCT04097821|471442932|FG003|Overall Study|New Therapy For Study Indication|0|||
130947890|NCT04097821|471442933|FG004|Overall Study|New Therapy For Study Indication|0|||
130947891|NCT04097821|471442934|FG005|Overall Study|New Therapy For Study Indication|0|||
130947892|NCT04097821|471442935|FG006|Overall Study|New Therapy For Study Indication|1|||
130947893|NCT04097821|471442936|FG007|Overall Study|New Therapy For Study Indication|0|||
130947894|NCT04243538|471442937|FG000|Overall Study|Withdrawal by Subject|0|||
130947895|NCT04243538|471442938|FG001|Overall Study|Withdrawal by Subject|2|||
130947896|NCT04243538|471442937|FG000|Overall Study|Lost to Follow-up|0|||
130947897|NCT04243538|471442938|FG001|Overall Study|Lost to Follow-up|3|||
130947898|NCT03532295|471442939|FG000|Overall Study|Did not start treatment|0|||
130947899|NCT03532295|471442940|FG001|Overall Study|Did not start treatment|2|||
130947900|NCT02776917|471442941|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
130947901|NCT00502697|471444436|FG000|Overall Study|Withdrawal by Subject|3|||
130947902|NCT00502697|471444437|FG001|Overall Study|Withdrawal by Subject|1|||
130947903|NCT00502697|471444436|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
130947904|NCT00502697|471444437|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
130947905|NCT00502697|471444436|FG000|Overall Study|found not to meet eligibility criteria|3|||
130947906|NCT00502697|471444437|FG001|Overall Study|found not to meet eligibility criteria|4|||
130947907|NCT00502697|471444436|FG000|Overall Study|did not meet assignment criteria|4|||
130947908|NCT00502697|471444437|FG001|Overall Study|did not meet assignment criteria|2|||
130947909|NCT01545817|471444439|FG000|Pazopanib|Disease progression|51|||
130947910|NCT01545817|471444440|FG001|Pazopanib|Disease progression|0|||
130947911|NCT01545817|471444439|FG000|Pazopanib|Adverse Event|19|||
130947912|NCT01545817|471444440|FG001|Pazopanib|Adverse Event|0|||
130947913|NCT01545817|471444439|FG000|Pazopanib|Other reason|4|||
130947914|NCT01545817|471444440|FG001|Pazopanib|Other reason|0|||
130947915|NCT01545817|471444439|FG000|Everolimus|Other reason|0|||
130947916|NCT01545817|471444440|FG001|Everolimus|Other reason|7|||
130947917|NCT01545817|471444439|FG000|Everolimus|Disease progression|0|||
130947918|NCT01545817|471444440|FG001|Everolimus|Disease progression|25|||
130947919|NCT01545817|471444439|FG000|Everolimus|Adverse Event|0|||
130947920|NCT01545817|471444440|FG001|Everolimus|Adverse Event|6|||
131124655|NCT00597753|472084529|FG001|Overall Study|Site closed by sponsor|7|||
131124656|NCT00597753|472084528|FG000|Overall Study|Site elected to close|2|||
131124657|NCT00597753|472084529|FG001|Overall Study|Site elected to close|4|||
131124658|NCT03080883|472084530|FG000|Overall Study|Withdrawal by Subject|11|||
131037839|NCT02043678|471772766|FG001|Overall Study|Deterioration of general conditions|1|||
131037840|NCT02043678|471772765|FG000|Overall Study|Logistical difficulties|2|||
131037841|NCT02043678|471772766|FG001|Overall Study|Logistical difficulties|0|||
131037842|NCT02043678|471772765|FG000|Overall Study|Non-compliance with study drug|3|||
131037843|NCT02043678|471772766|FG001|Overall Study|Non-compliance with study drug|1|||
131037844|NCT02043678|471772765|FG000|Overall Study|Physician Decision|4|||
131037845|NCT02043678|471772766|FG001|Overall Study|Physician Decision|3|||
131037846|NCT02043678|471772765|FG000|Overall Study|Subject decision|0|||
131037847|NCT02043678|471772766|FG001|Overall Study|Subject decision|1|||
131037848|NCT02043678|471772765|FG000|Overall Study|Switching to other therapy|3|||
131037849|NCT02043678|471772766|FG001|Overall Study|Switching to other therapy|2|||
131037850|NCT02043678|471772765|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
131037851|NCT02043678|471772766|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
131037852|NCT02043678|471772765|FG000|Overall Study|Missing|1|||
131037853|NCT02043678|471772766|FG001|Overall Study|Missing|0|||
131037854|NCT02043678|471772765|FG000|Overall Study|Adverse Event|0|||
131037855|NCT02043678|471772766|FG001|Overall Study|Adverse Event|1|||
131037856|NCT05543629|471772767|FG000|Overall Study|Death|1|||
131037857|NCT05543629|471772768|FG001|Overall Study|Death|0|||
131037858|NCT05543629|471772769|FG002|Overall Study|Death|1|||
131037859|NCT05543629|471772770|FG003|Overall Study|Death|0|||
131124659|NCT03080883|472084531|FG001|Overall Study|Withdrawal by Subject|15|||
131124660|NCT03080883|472084530|FG000|Overall Study|Adverse Event|22|||
130947927|NCT02622828|471444448|FG000|Overall Study|participant withdrew|3|||
130947928|NCT02780804|471444451|FG000|Overall Study|Death|1|||
130947929|NCT02780804|471444452|FG001|Overall Study|Death|0|||
130947930|NCT02780804|471444453|FG002|Overall Study|Death|0|||
130947931|NCT02780804|471444451|FG000|Overall Study|Lack of Efficacy|5|||
130947932|NCT02780804|471444452|FG001|Overall Study|Lack of Efficacy|8|||
130947933|NCT02780804|471444453|FG002|Overall Study|Lack of Efficacy|4|||
130947934|NCT02780804|471444451|FG000|Overall Study|Physician Decision|0|||
130947935|NCT02780804|471444452|FG001|Overall Study|Physician Decision|0|||
130947936|NCT02780804|471444453|FG002|Overall Study|Physician Decision|2|||
130947937|NCT02780804|471444451|FG000|Overall Study|Withdrawal by Subject|0|||
130947938|NCT02780804|471444452|FG001|Overall Study|Withdrawal by Subject|1|||
130947939|NCT02780804|471444453|FG002|Overall Study|Withdrawal by Subject|0|||
130947940|NCT01921829|471444456|FG000|Overall Study|Withdrawal by Subject|0|||
130947941|NCT01921829|471444457|FG001|Overall Study|Withdrawal by Subject|1|||
130947942|NCT02256891|471444464|FG000|Overall Study|Death|0|||
130947943|NCT02256891|471444465|FG001|Overall Study|Death|2|||
130947944|NCT02256891|471444464|FG000|Overall Study|Lost to Follow-up|0|||
130947945|NCT02256891|471444465|FG001|Overall Study|Lost to Follow-up|3|||
130947946|NCT02256891|471444464|FG000|Overall Study|Physician Decision|7|||
130947947|NCT02256891|471444465|FG001|Overall Study|Physician Decision|3|||
130947948|NCT02256891|471444464|FG000|Overall Study|Screen Fail|5|||
130947949|NCT02256891|471444465|FG001|Overall Study|Screen Fail|4|||
130947950|NCT02256891|471444464|FG000|Overall Study|Equipment Malfunction|0|||
130947951|NCT02256891|471444465|FG001|Overall Study|Equipment Malfunction|1|||
130947952|NCT01344447|471444466|FG000|Overall Study|Adverse Event|1|||
130947953|NCT01344447|471444466|FG000|Overall Study|Protocol Violation|1|||
130947954|NCT01344447|471444466|FG000|Overall Study|Withdrawal by Subject|1|||
130947955|NCT01344447|471444466|FG000|Overall Study|The contrast was not seen|1|||
130947956|NCT01344447|471444466|FG000|Overall Study|Physician Decision|1|||
130947957|NCT01344447|471444466|FG000|Overall Study|MRA unsuccessful|1|||
130947958|NCT01344447|471444466|FG000|Overall Study|Bolus tracking failed|1|||
130947959|NCT01344447|471444466|FG000|Overall Study|Error of power injector|1|||
130947960|NCT03314584|471444474|FG000|Overall Study|Withdrawal by Subject|3|||
130947961|NCT03314584|471444475|FG001|Overall Study|Withdrawal by Subject|3|||
130947962|NCT03314584|471444474|FG000|Overall Study|Lost to Follow-up|4|||
130947963|NCT03314584|471444475|FG001|Overall Study|Lost to Follow-up|0|||
130947964|NCT06134817|471444476|FG000|Overall Study|Physician Departure - termination of study|1|||
130947965|NCT04214288|471444480|FG000|Overall Study|Ongoing in the study|41|||
130947966|NCT04214288|471444481|FG001|Overall Study|Ongoing in the study|51|||
130947967|NCT04214288|471444482|FG002|Overall Study|Ongoing in the study|12|||
130947968|NCT04214288|471444483|FG003|Overall Study|Ongoing in the study|39|||
130947969|NCT04214288|471444480|FG000|Overall Study|Adverse Event|1|||
130947970|NCT04214288|471444481|FG001|Overall Study|Adverse Event|0|||
130947971|NCT04214288|471444482|FG002|Overall Study|Adverse Event|0|||
130947972|NCT04214288|471444483|FG003|Overall Study|Adverse Event|0|||
130947973|NCT04214288|471444480|FG000|Overall Study|Death|22|||
130947974|NCT04214288|471444481|FG001|Overall Study|Death|13|||
130947975|NCT04214288|471444482|FG002|Overall Study|Death|7|||
130947976|NCT04214288|471444483|FG003|Overall Study|Death|19|||
130947977|NCT04214288|471444480|FG000|Overall Study|Lost to Follow-up|1|||
130947978|NCT04214288|471444481|FG001|Overall Study|Lost to Follow-up|2|||
130947979|NCT04214288|471444482|FG002|Overall Study|Lost to Follow-up|1|||
130947980|NCT04214288|471444483|FG003|Overall Study|Lost to Follow-up|0|||
130947981|NCT04214288|471444480|FG000|Overall Study|Other|1|||
130947982|NCT04214288|471444481|FG001|Overall Study|Other|2|||
130947983|NCT04214288|471444482|FG002|Overall Study|Other|0|||
130947984|NCT04214288|471444483|FG003|Overall Study|Other|6|||
130947985|NCT04214288|471444480|FG000|Overall Study|Protocol Violation|0|||
130947986|NCT04214288|471444481|FG001|Overall Study|Protocol Violation|1|||
130947987|NCT04214288|471444482|FG002|Overall Study|Protocol Violation|0|||
130947988|NCT04214288|471444483|FG003|Overall Study|Protocol Violation|0|||
130947989|NCT04214288|471444480|FG000|Overall Study|Withdrawal by Subject|8|||
130947990|NCT04214288|471444481|FG001|Overall Study|Withdrawal by Subject|4|||
130947991|NCT04214288|471444482|FG002|Overall Study|Withdrawal by Subject|0|||
130947992|NCT04214288|471444483|FG003|Overall Study|Withdrawal by Subject|9|||
130947993|NCT01928862|471444489|FG000|Overall Study|Lost to Follow-up|1|||
130947994|NCT01928862|471444490|FG001|Overall Study|Lost to Follow-up|0|||
130947995|NCT01928862|471444491|FG002|Overall Study|Lost to Follow-up|0|||
130947996|NCT01928862|471444492|FG003|Overall Study|Lost to Follow-up|0|||
131037860|NCT05543629|471772771|FG004|Overall Study|Death|0|||
131037861|NCT05543629|471772772|FG005|Overall Study|Death|1|||
131037862|NCT05543629|471772773|FG006|Overall Study|Death|2|||
131037863|NCT05543629|471772774|FG007|Overall Study|Death|2|||
131037864|NCT05543629|471772767|FG000|Overall Study|Other Reasons|0|||
130947997|NCT01928862|471444493|FG004|Overall Study|Lost to Follow-up|1|||
130947998|NCT04649164|471444494|FG000|Overall Study|Withdrawal by Subject|1|||
130947999|NCT04649164|471444495|FG001|Overall Study|Withdrawal by Subject|1|||
130948000|NCT04649164|471444496|FG002|Overall Study|Withdrawal by Subject|2|||
130948001|NCT04649164|471444494|FG000|Overall Study|Participant's care recipient expired|0|||
130948002|NCT04649164|471444495|FG001|Overall Study|Participant's care recipient expired|0|||
130948003|NCT04649164|471444496|FG002|Overall Study|Participant's care recipient expired|2|||
130948004|NCT03168464|471444497|FG000|Overall Study|Death|9|||
130948005|NCT03168464|471444497|FG000|Overall Study|Progression of disease|6|||
130948006|NCT02053753|471444498|FG000|Overall Study|Withdrawal by Subject|2|||
130948007|NCT02053753|471444499|FG001|Overall Study|Withdrawal by Subject|4|||
130948008|NCT02053753|471444498|FG000|Overall Study|Decision by Sponsor|1|||
130948009|NCT02053753|471444499|FG001|Overall Study|Decision by Sponsor|1|||
130948010|NCT02053753|471444498|FG000|Overall Study|Lost to Follow-up|4|||
130948011|NCT02053753|471444499|FG001|Overall Study|Lost to Follow-up|3|||
130948012|NCT02932904|471444502|FG000|Overall Study|Reason not Specified|1|||
130948013|NCT02932904|471444503|FG001|Overall Study|Reason not Specified|0|||
130948014|NCT02932904|471444504|FG002|Overall Study|Reason not Specified|2|||
130948015|NCT02932904|471444505|FG003|Overall Study|Reason not Specified|2|||
130948016|NCT02932904|471444502|FG000|Overall Study|Noncompliance with Study Drug|2|||
130948017|NCT02932904|471444503|FG001|Overall Study|Noncompliance with Study Drug|3|||
130948018|NCT02932904|471444504|FG002|Overall Study|Noncompliance with Study Drug|3|||
130948019|NCT02932904|471444505|FG003|Overall Study|Noncompliance with Study Drug|4|||
130948020|NCT02932904|471444502|FG000|Overall Study|Pregnancy|0|||
130948021|NCT02932904|471444503|FG001|Overall Study|Pregnancy|1|||
130948022|NCT02932904|471444504|FG002|Overall Study|Pregnancy|1|||
130948023|NCT02932904|471444505|FG003|Overall Study|Pregnancy|0|||
130948024|NCT02932904|471444502|FG000|Overall Study|Study Termination|0|||
130948025|NCT02932904|471444503|FG001|Overall Study|Study Termination|1|||
130948026|NCT02932904|471444504|FG002|Overall Study|Study Termination|0|||
130948027|NCT02932904|471444505|FG003|Overall Study|Study Termination|0|||
130948028|NCT02932904|471444502|FG000|Overall Study|Voluntary Withdrawal|2|||
130948029|NCT02932904|471444503|FG001|Overall Study|Voluntary Withdrawal|1|||
130948030|NCT02932904|471444504|FG002|Overall Study|Voluntary Withdrawal|4|||
130948031|NCT02932904|471444505|FG003|Overall Study|Voluntary Withdrawal|2|||
130948032|NCT02932904|471444502|FG000|Overall Study|Lost to Follow-up|5|||
130948033|NCT02932904|471444503|FG001|Overall Study|Lost to Follow-up|3|||
130948034|NCT02932904|471444504|FG002|Overall Study|Lost to Follow-up|6|||
130948035|NCT02932904|471444505|FG003|Overall Study|Lost to Follow-up|0|||
130948036|NCT02932904|471444502|FG000|Overall Study|Significant Protocol Deviation|2|||
130948037|NCT02932904|471444503|FG001|Overall Study|Significant Protocol Deviation|3|||
130948038|NCT02932904|471444504|FG002|Overall Study|Significant Protocol Deviation|6|||
130948039|NCT02932904|471444505|FG003|Overall Study|Significant Protocol Deviation|1|||
130948040|NCT02932904|471444502|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
130948041|NCT02932904|471444503|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
130948042|NCT02932904|471444504|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
130948043|NCT02932904|471444505|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
130948044|NCT02932904|471444502|FG000|Overall Study|Randomized But Not Treated|1|||
131037865|NCT05543629|471772768|FG001|Overall Study|Other Reasons|0|||
131037866|NCT05543629|471772769|FG002|Overall Study|Other Reasons|0|||
131037867|NCT05543629|471772770|FG003|Overall Study|Other Reasons|0|||
131037868|NCT05543629|471772771|FG004|Overall Study|Other Reasons|1|||
131037869|NCT05543629|471772772|FG005|Overall Study|Other Reasons|0|||
131037870|NCT05543629|471772773|FG006|Overall Study|Other Reasons|0|||
131037871|NCT05543629|471772774|FG007|Overall Study|Other Reasons|0|||
131037872|NCT05543629|471772767|FG000|Overall Study|Physician Decision|0|||
131037873|NCT05543629|471772768|FG001|Overall Study|Physician Decision|0|||
131037874|NCT05543629|471772769|FG002|Overall Study|Physician Decision|3|||
131037875|NCT05543629|471772770|FG003|Overall Study|Physician Decision|0|||
131124661|NCT03080883|472084531|FG001|Overall Study|Adverse Event|22|||
131124662|NCT03080883|472084530|FG000|Overall Study|Alternative Therapy|0|||
131124663|NCT03080883|472084531|FG001|Overall Study|Alternative Therapy|3|||
131124664|NCT03080883|472084530|FG000|Overall Study|Other Complicating Disease|9|||
131124665|NCT03080883|472084531|FG001|Overall Study|Other Complicating Disease|5|||
131124666|NCT03080883|472084530|FG000|Overall Study|Death|21|||
131124667|NCT03080883|472084531|FG001|Overall Study|Death|16|||
131124668|NCT03080883|472084530|FG000|Overall Study|Physician Decision|2|||
131124669|NCT03080883|472084531|FG001|Overall Study|Physician Decision|2|||
131124670|NCT03080883|472084530|FG000|Overall Study|Disease Progression|2|||
131124671|NCT03080883|472084531|FG001|Overall Study|Disease Progression|8|||
131124672|NCT03080883|472084530|FG000|Overall Study|Lost to Follow-up|1|||
131124673|NCT03080883|472084531|FG001|Overall Study|Lost to Follow-up|1|||
131124674|NCT04360551|472085805|FG000|Overall Study|Withdrawal by Subject|1|||
131124675|NCT04360551|472085806|FG001|Overall Study|Withdrawal by Subject|0|||
131124676|NCT00388973|472085811|FG000|Overall Study|Adverse Event|16|||
131124677|NCT00388973|472085812|FG001|Overall Study|Adverse Event|6|||
131124678|NCT00388973|472085811|FG000|Overall Study|Lack of Efficacy|1|||
131124679|NCT00388973|472085812|FG001|Overall Study|Lack of Efficacy|12|||
131124680|NCT00388973|472085811|FG000|Overall Study|Protocol Violation|3|||
131124681|NCT00388973|472085812|FG001|Overall Study|Protocol Violation|0|||
131124682|NCT00388973|472085811|FG000|Overall Study|Withdrawal by Subject|14|||
131124683|NCT00388973|472085812|FG001|Overall Study|Withdrawal by Subject|17|||
131124684|NCT00388973|472085811|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
131124685|NCT00388973|472085812|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
131124686|NCT00388973|472085811|FG000|Overall Study|Did not complete 61 days of treatment|5|||
131124687|NCT00388973|472085812|FG001|Overall Study|Did not complete 61 days of treatment|4|||
131124688|NCT00388973|472085811|FG000|Overall Study|Left region|0|||
131124689|NCT00388973|472085812|FG001|Overall Study|Left region|1|||
131124690|NCT00388973|472085811|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
131124691|NCT00388973|472085812|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
131124692|NCT00346073|472085827|FG000|Overall Study|Serious Adverse Event|2|||
131037876|NCT05543629|471772771|FG004|Overall Study|Physician Decision|0|||
131037877|NCT05543629|471772772|FG005|Overall Study|Physician Decision|0|||
131037878|NCT05543629|471772773|FG006|Overall Study|Physician Decision|1|||
131037879|NCT05543629|471772774|FG007|Overall Study|Physician Decision|0|||
131037880|NCT05543629|471772767|FG000|Overall Study|Study terminated by Sponsor|1|||
131037881|NCT05543629|471772768|FG001|Overall Study|Study terminated by Sponsor|0|||
131037882|NCT05543629|471772769|FG002|Overall Study|Study terminated by Sponsor|0|||
131037883|NCT05543629|471772770|FG003|Overall Study|Study terminated by Sponsor|1|||
131037884|NCT05543629|471772771|FG004|Overall Study|Study terminated by Sponsor|0|||
131037885|NCT05543629|471772772|FG005|Overall Study|Study terminated by Sponsor|4|||
131037886|NCT05543629|471772773|FG006|Overall Study|Study terminated by Sponsor|1|||
131124693|NCT00346073|472085828|FG001|Overall Study|Serious Adverse Event|0|||
131124694|NCT00346073|472085827|FG000|Overall Study|Lost to Follow-up|39|||
131124695|NCT00346073|472085828|FG001|Overall Study|Lost to Follow-up|24|||
131124696|NCT00914927|472085830|FG000|Overall Study|Adverse Event|0|||
131124697|NCT00914927|472085831|FG001|Overall Study|Adverse Event|0|||
130948045|NCT02932904|471444503|FG001|Overall Study|Randomized But Not Treated|1|||
130948046|NCT02932904|471444504|FG002|Overall Study|Randomized But Not Treated|0|||
130948047|NCT02932904|471444505|FG003|Overall Study|Randomized But Not Treated|2|||
130948048|NCT00337103|471444506|FG000|Overall Study|Progressive Disease|414|||
130948049|NCT00337103|471444507|FG001|Overall Study|Progressive Disease|410|||
130948050|NCT00337103|471444506|FG000|Overall Study|Adverse Event|45|||
130948051|NCT00337103|471444507|FG001|Overall Study|Adverse Event|59|||
130948052|NCT00337103|471444506|FG000|Overall Study|Subject Choice|34|||
130948053|NCT00337103|471444507|FG001|Overall Study|Subject Choice|27|||
130948054|NCT00337103|471444506|FG000|Overall Study|Clinical Progression|27|||
130948055|NCT00337103|471444507|FG001|Overall Study|Clinical Progression|24|||
130948056|NCT00337103|471444506|FG000|Overall Study|Physician Decision|15|||
130948057|NCT00337103|471444507|FG001|Overall Study|Physician Decision|14|||
130948058|NCT00337103|471444506|FG000|Overall Study|Withdrawal by Subject|8|||
130948059|NCT00337103|471444507|FG001|Overall Study|Withdrawal by Subject|5|||
130948060|NCT00337103|471444506|FG000|Overall Study|Other|5|||
130948061|NCT00337103|471444507|FG001|Overall Study|Other|6|||
130948062|NCT00337103|471444506|FG000|Overall Study|Entry Criteria Not Met|4|||
130948063|NCT00337103|471444507|FG001|Overall Study|Entry Criteria Not Met|1|||
130948064|NCT00337103|471444506|FG000|Overall Study|Lost to Follow-up|1|||
130948065|NCT00337103|471444507|FG001|Overall Study|Lost to Follow-up|2|||
130948066|NCT00337103|471444506|FG000|Overall Study|Death|1|||
130948067|NCT00337103|471444507|FG001|Overall Study|Death|0|||
130948068|NCT01577758|471444508|FG000|Dose Escalation Phase|Adverse Event|0|||
130948069|NCT01577758|471444509|FG001|Dose Escalation Phase|Adverse Event|0|||
130948070|NCT01577758|471444510|FG002|Dose Escalation Phase|Adverse Event|0|||
130948071|NCT01577758|471444511|FG003|Dose Escalation Phase|Adverse Event|0|||
130948072|NCT01577758|471444512|FG004|Dose Escalation Phase|Adverse Event|0|||
130948073|NCT01577758|471444513|FG005|Dose Escalation Phase|Adverse Event|2|||
130948074|NCT01577758|471444514|FG006|Dose Escalation Phase|Adverse Event|1|||
130948075|NCT01577758|471444515|FG007|Dose Escalation Phase|Adverse Event|0|||
130948076|NCT01577758|471444508|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
130948077|NCT01577758|471444509|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
130948078|NCT01577758|471444510|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
130948079|NCT01577758|471444511|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
130948080|NCT01577758|471444512|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
130948081|NCT01577758|471444513|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
130948082|NCT01577758|471444514|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
130948083|NCT01577758|471444515|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
130948084|NCT01577758|471444508|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130948085|NCT01577758|471444509|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
130948086|NCT01577758|471444510|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
130948087|NCT01577758|471444511|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130948088|NCT01577758|471444512|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
130948089|NCT01577758|471444513|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
131037887|NCT05543629|471772774|FG007|Overall Study|Study terminated by Sponsor|0|||
131124698|NCT00914927|472085832|FG002|Overall Study|Adverse Event|0|||
131124699|NCT00914927|472085833|FG003|Overall Study|Adverse Event|0|||
130948090|NCT01577758|471444514|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
131124700|NCT00914927|472085834|FG004|Overall Study|Adverse Event|1|||
131037888|NCT05543629|471772767|FG000|Overall Study|Withdrawal by Subject|1|||
131037889|NCT05543629|471772768|FG001|Overall Study|Withdrawal by Subject|1|||
131124701|NCT00914927|472085835|FG005|Overall Study|Adverse Event|0|||
131124702|NCT00914927|472085836|FG006|Overall Study|Adverse Event|0|||
130948091|NCT01577758|471444515|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
130948092|NCT01577758|471444508|FG000|Dose Escalation Phase|Progression Disease|2|||
131037890|NCT05543629|471772769|FG002|Overall Study|Withdrawal by Subject|0|||
130948093|NCT01577758|471444509|FG001|Dose Escalation Phase|Progression Disease|2|||
130948094|NCT01577758|471444510|FG002|Dose Escalation Phase|Progression Disease|1|||
130948095|NCT01577758|471444511|FG003|Dose Escalation Phase|Progression Disease|2|||
130948096|NCT01577758|471444512|FG004|Dose Escalation Phase|Progression Disease|5|||
130948097|NCT01577758|471444513|FG005|Dose Escalation Phase|Progression Disease|0|||
130948098|NCT01577758|471444514|FG006|Dose Escalation Phase|Progression Disease|0|||
130948099|NCT01577758|471444515|FG007|Dose Escalation Phase|Progression Disease|0|||
130948100|NCT01577758|471444508|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130948101|NCT01577758|471444509|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130948102|NCT01577758|471444510|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130948103|NCT01577758|471444511|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130948104|NCT01577758|471444512|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130948105|NCT01577758|471444513|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130948106|NCT01577758|471444514|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130948107|NCT01577758|471444515|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
130948108|NCT01577758|471444508|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
130948109|NCT01577758|471444509|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
130948110|NCT01577758|471444510|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
130948111|NCT01577758|471444511|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
130948112|NCT01577758|471444512|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
130948113|NCT01577758|471444513|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
130948114|NCT01577758|471444514|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
130948115|NCT01577758|471444515|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
130948116|NCT01577758|471444508|FG000|mCRC Expansion Phase|Progression Disease|0|||
130948117|NCT01577758|471444509|FG001|mCRC Expansion Phase|Progression Disease|0|||
130948118|NCT01577758|471444510|FG002|mCRC Expansion Phase|Progression Disease|0|||
130948119|NCT01577758|471444511|FG003|mCRC Expansion Phase|Progression Disease|0|||
130948120|NCT01577758|471444512|FG004|mCRC Expansion Phase|Progression Disease|0|||
130948121|NCT01577758|471444513|FG005|mCRC Expansion Phase|Progression Disease|0|||
130948122|NCT01577758|471444514|FG006|mCRC Expansion Phase|Progression Disease|0|||
130948123|NCT01577758|471444515|FG007|mCRC Expansion Phase|Progression Disease|19|||
130948124|NCT02404350|471444520|FG000|Overall Study|Adverse Event|2|||
130948125|NCT02404350|471444521|FG001|Overall Study|Adverse Event|2|||
130948126|NCT02404350|471444522|FG002|Overall Study|Adverse Event|3|||
130948127|NCT02404350|471444523|FG003|Overall Study|Adverse Event|9|||
130948128|NCT02404350|471444520|FG000|Overall Study|Lack of Efficacy|3|||
130948129|NCT02404350|471444521|FG001|Overall Study|Lack of Efficacy|1|||
130948130|NCT02404350|471444522|FG002|Overall Study|Lack of Efficacy|0|||
130948131|NCT02404350|471444523|FG003|Overall Study|Lack of Efficacy|3|||
130948132|NCT02404350|471444520|FG000|Overall Study|Lost to Follow-up|2|||
130948133|NCT02404350|471444521|FG001|Overall Study|Lost to Follow-up|0|||
130948134|NCT02404350|471444522|FG002|Overall Study|Lost to Follow-up|0|||
130948135|NCT02404350|471444523|FG003|Overall Study|Lost to Follow-up|1|||
130948136|NCT02404350|471444520|FG000|Overall Study|Physician Decision|1|||
130948137|NCT02404350|471444521|FG001|Overall Study|Physician Decision|0|||
131124703|NCT00914927|472085830|FG000|Overall Study|Withdrawal by Subject|0|||
131124704|NCT00914927|472085831|FG001|Overall Study|Withdrawal by Subject|1|||
131124705|NCT00914927|472085832|FG002|Overall Study|Withdrawal by Subject|0|||
131124706|NCT00914927|472085833|FG003|Overall Study|Withdrawal by Subject|1|||
131124707|NCT00914927|472085834|FG004|Overall Study|Withdrawal by Subject|0|||
131124708|NCT00914927|472085835|FG005|Overall Study|Withdrawal by Subject|0|||
131124709|NCT00914927|472085836|FG006|Overall Study|Withdrawal by Subject|0|||
131124710|NCT00914927|472085830|FG000|Overall Study|Lost to Follow-up|0|||
131124711|NCT00914927|472085831|FG001|Overall Study|Lost to Follow-up|0|||
131124712|NCT00914927|472085832|FG002|Overall Study|Lost to Follow-up|0|||
131124713|NCT00914927|472085833|FG003|Overall Study|Lost to Follow-up|1|||
131124714|NCT00914927|472085834|FG004|Overall Study|Lost to Follow-up|0|||
131124715|NCT00914927|472085835|FG005|Overall Study|Lost to Follow-up|0|||
131124716|NCT00914927|472085836|FG006|Overall Study|Lost to Follow-up|0|||
131124717|NCT00914927|472085830|FG000|Overall Study|Administrative/Other|2|||
131124718|NCT00914927|472085831|FG001|Overall Study|Administrative/Other|1|||
131124719|NCT00914927|472085832|FG002|Overall Study|Administrative/Other|0|||
131124720|NCT00914927|472085833|FG003|Overall Study|Administrative/Other|0|||
131124721|NCT00914927|472085834|FG004|Overall Study|Administrative/Other|1|||
130948138|NCT02404350|471444522|FG002|Overall Study|Physician Decision|0|||
130948139|NCT02404350|471444523|FG003|Overall Study|Physician Decision|2|||
130948140|NCT02404350|471444520|FG000|Overall Study|Pregnancy|0|||
130948141|NCT02404350|471444521|FG001|Overall Study|Pregnancy|0|||
130948142|NCT02404350|471444522|FG002|Overall Study|Pregnancy|0|||
130948143|NCT02404350|471444523|FG003|Overall Study|Pregnancy|1|||
130948144|NCT02404350|471444520|FG000|Overall Study|Withdrawal by Subject|7|||
131124722|NCT00914927|472085835|FG005|Overall Study|Administrative/Other|0|||
130948145|NCT02404350|471444521|FG001|Overall Study|Withdrawal by Subject|3|||
131124723|NCT00914927|472085836|FG006|Overall Study|Administrative/Other|0|||
131124724|NCT01648790|472085839|FG000|Treatment 3|Withdrawal by Subject|0|||
131124725|NCT01648790|472085840|FG001|Treatment 3|Withdrawal by Subject|0|||
130948146|NCT02404350|471444522|FG002|Overall Study|Withdrawal by Subject|3|||
130948147|NCT02404350|471444523|FG003|Overall Study|Withdrawal by Subject|19|||
130948148|NCT02404350|471444520|FG000|Overall Study|Due to Non-compliance with treatment|0|||
130948149|NCT02404350|471444521|FG001|Overall Study|Due to Non-compliance with treatment|0|||
130948150|NCT02404350|471444522|FG002|Overall Study|Due to Non-compliance with treatment|0|||
130948151|NCT02404350|471444523|FG003|Overall Study|Due to Non-compliance with treatment|1|||
130948152|NCT02404350|471444520|FG000|Overall Study|Due to Technical problems|0|||
130948153|NCT02404350|471444521|FG001|Overall Study|Due to Technical problems|0|||
130948154|NCT02404350|471444522|FG002|Overall Study|Due to Technical problems|0|||
130948155|NCT02404350|471444523|FG003|Overall Study|Due to Technical problems|1|||
130948156|NCT00600756|471444525|FG000|Analysis After 6 Months|Adverse Event|43|||
130948157|NCT00600756|471444526|FG001|Analysis After 6 Months|Adverse Event|33|||
130948158|NCT00600756|471444525|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
130948159|NCT00600756|471444526|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
130948160|NCT00600756|471444525|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
130948161|NCT00600756|471444526|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
130948162|NCT00600756|471444525|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
130948163|NCT00600756|471444526|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
130948164|NCT00600756|471444525|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
130948165|NCT00600756|471444526|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
130948166|NCT00600756|471444525|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
130948167|NCT00600756|471444526|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
130948168|NCT00600756|471444525|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
130948169|NCT00600756|471444526|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
130948170|NCT00600756|471444525|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
130948171|NCT00600756|471444526|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
130948172|NCT00600756|471444525|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
130948173|NCT00600756|471444526|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
130948174|NCT00600756|471444525|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
130948175|NCT00600756|471444526|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
130948176|NCT00600756|471444525|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
130948177|NCT00600756|471444526|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
130948178|NCT00600756|471444525|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
130948179|NCT00600756|471444526|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
130948180|NCT00600756|471444525|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
130948181|NCT00600756|471444526|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
130948182|NCT00600756|471444525|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
130948183|NCT00600756|471444526|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
130948184|NCT01256593|471444527|FG000|Overall Study|Protocol Violation|26|||
130948185|NCT01256593|471444527|FG000|Overall Study|No Drug Administration Information|2|||
130948186|NCT01256593|471444527|FG000|Overall Study|No Visit After Treatment|186|||
130948187|NCT04414553|471444528|FG000|Overall Study|Lost to Follow-up|20|||
130948188|NCT03969992|471444532|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
130948189|NCT03969992|471444533|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
130948190|NCT03969992|471444534|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
130948191|NCT03969992|471444532|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
130948192|NCT03969992|471444533|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
130948193|NCT03969992|471444534|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
130948194|NCT03969992|471444532|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
130948195|NCT03969992|471444533|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
130948196|NCT03969992|471444534|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
130948197|NCT03969992|471444532|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
130948198|NCT03969992|471444533|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
130948199|NCT03969992|471444534|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
130948200|NCT03969992|471444532|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
130948201|NCT03969992|471444533|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
130948202|NCT03969992|471444534|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
130948203|NCT02319031|471444544|FG000|Treatment Period|Death|1|||
130948204|NCT02319031|471444545|FG001|Treatment Period|Death|0|||
130948205|NCT03519971|471444549|FG000|Overall Study|Death|142|||
130948206|NCT03519971|471444550|FG001|Overall Study|Death|69|||
130948207|NCT03519971|471444549|FG000|Overall Study|Lost to Follow-up|0|||
130948208|NCT03519971|471444550|FG001|Overall Study|Lost to Follow-up|1|||
130948209|NCT03519971|471444549|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
130948210|NCT03519971|471444550|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
130948211|NCT03519971|471444549|FG000|Overall Study|Withdrawal by Subject|3|||
130948212|NCT03519971|471444550|FG001|Overall Study|Withdrawal by Subject|2|||
130948213|NCT03519971|471444549|FG000|Overall Study|Other|1|||
130948214|NCT03519971|471444550|FG001|Overall Study|Other|0|||
130948215|NCT01524692|471444559|FG000|Overall Study|Withdrawal by Subject|3|||
131037891|NCT05543629|471772770|FG003|Overall Study|Withdrawal by Subject|2|||
131037892|NCT05543629|471772771|FG004|Overall Study|Withdrawal by Subject|1|||
131037893|NCT05543629|471772772|FG005|Overall Study|Withdrawal by Subject|1|||
131037894|NCT05543629|471772773|FG006|Overall Study|Withdrawal by Subject|1|||
131037895|NCT05543629|471772774|FG007|Overall Study|Withdrawal by Subject|1|||
131037896|NCT05543629|471772767|FG000|Overall Study|Not Reported|2|||
131037897|NCT05543629|471772768|FG001|Overall Study|Not Reported|2|||
131037898|NCT05543629|471772769|FG002|Overall Study|Not Reported|0|||
131037899|NCT05543629|471772770|FG003|Overall Study|Not Reported|0|||
131037900|NCT05543629|471772771|FG004|Overall Study|Not Reported|1|||
131037901|NCT05543629|471772772|FG005|Overall Study|Not Reported|1|||
131037902|NCT05543629|471772773|FG006|Overall Study|Not Reported|3|||
131037903|NCT05543629|471772774|FG007|Overall Study|Not Reported|0|||
131037904|NCT03216057|471772775|FG000|Overall Study|Lost to Follow-up|2|||
131037905|NCT03216057|471772776|FG001|Overall Study|Lost to Follow-up|2|||
131037906|NCT04568603|471772777|FG000|Overall Study|Physician Decision|1|||
131037907|NCT04564742|471772778|FG000|Overall Study|Lost to Follow-up|1|||
131037908|NCT04564742|471772779|FG001|Overall Study|Lost to Follow-up|0|||
130710752|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
130710753|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
130710754|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
130710755|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
130948216|NCT04007523|471444561|FG000|Overall Study|Withdrawal by Subject|0|||
130948217|NCT04007523|471444562|FG001|Overall Study|Withdrawal by Subject|1|||
130948218|NCT04007523|471444563|FG002|Overall Study|Withdrawal by Subject|1|||
130948219|NCT04007523|471444564|FG003|Overall Study|Withdrawal by Subject|0|||
130948220|NCT04007523|471444561|FG000|Overall Study|ICU Transfer|0|||
130948221|NCT04007523|471444562|FG001|Overall Study|ICU Transfer|1|||
130948222|NCT04007523|471444563|FG002|Overall Study|ICU Transfer|0|||
130948223|NCT04007523|471444564|FG003|Overall Study|ICU Transfer|0|||
130948224|NCT04007523|471444561|FG000|Overall Study|COVID hospital closure|0|||
130948225|NCT04007523|471444562|FG001|Overall Study|COVID hospital closure|0|||
130948226|NCT04007523|471444563|FG002|Overall Study|COVID hospital closure|1|||
130948227|NCT04007523|471444564|FG003|Overall Study|COVID hospital closure|2|||
130948228|NCT04007523|471444561|FG000|Overall Study|Surgery cancelled|0|||
130948229|NCT04007523|471444562|FG001|Overall Study|Surgery cancelled|0|||
130948230|NCT04007523|471444563|FG002|Overall Study|Surgery cancelled|1|||
130948231|NCT04007523|471444564|FG003|Overall Study|Surgery cancelled|1|||
130948232|NCT01774786|471444568|FG000|Overall Study|Death|300|||
130948233|NCT01774786|471444569|FG001|Overall Study|Death|319|||
130948234|NCT01774786|471444568|FG000|Overall Study|Lost to Follow-up|6|||
130948235|NCT01774786|471444569|FG001|Overall Study|Lost to Follow-up|7|||
130948236|NCT01774786|471444568|FG000|Overall Study|Withdrawal by Subject|18|||
130948237|NCT01774786|471444569|FG001|Overall Study|Withdrawal by Subject|14|||
130948238|NCT01774786|471444568|FG000|Overall Study|Physician Decision|2|||
130948239|NCT01774786|471444569|FG001|Overall Study|Physician Decision|0|||
130948240|NCT01774786|471444568|FG000|Overall Study|Non-compliance|0|||
130948241|NCT01774786|471444569|FG001|Overall Study|Non-compliance|1|||
130948242|NCT01774786|471444568|FG000|Overall Study|Reason Not Specified|2|||
130948243|NCT01774786|471444569|FG001|Overall Study|Reason Not Specified|5|||
130948244|NCT04544293|471444570|FG000|Double-blind|Adverse Event|2|||
130948245|NCT04544293|471444571|FG001|Double-blind|Adverse Event|1|||
130948246|NCT04544293|471444570|FG000|Double-blind|Pregnancy|0|||
130948247|NCT04544293|471444571|FG001|Double-blind|Pregnancy|1|||
130948248|NCT04544293|471444570|FG000|Double-blind|Lost to Follow-up|0|||
130948249|NCT04544293|471444571|FG001|Double-blind|Lost to Follow-up|1|||
130948250|NCT04544293|471444570|FG000|Open-Label Extension|Study ongoing|79|||
130948251|NCT04544293|471444571|FG001|Open-Label Extension|Study ongoing|81|||
130948252|NCT00744627|471444573|FG000|Overall Study|Adverse Event|6|||
130948253|NCT00744627|471444574|FG001|Overall Study|Adverse Event|9|||
130948254|NCT00744627|471444573|FG000|Overall Study|Lack of Efficacy|7|||
130948255|NCT00744627|471444574|FG001|Overall Study|Lack of Efficacy|3|||
130948256|NCT00744627|471444573|FG000|Overall Study|Noncompliance|0|||
130948257|NCT00744627|471444574|FG001|Overall Study|Noncompliance|1|||
130948258|NCT00744627|471444573|FG000|Overall Study|Protocol Deviations|0|||
130948259|NCT00744627|471444574|FG001|Overall Study|Protocol Deviations|2|||
130948260|NCT00744627|471444573|FG000|Overall Study|Voluntary Withdrawal|9|||
131037909|NCT04564742|471772778|FG000|Overall Study|Consent Withdrawal|4|||
131037910|NCT04564742|471772779|FG001|Overall Study|Consent Withdrawal|4|||
131037911|NCT03313076|471772783|FG000|Overall Study|Withdrawal by Subject|2|||
130710756|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
130948261|NCT00744627|471444574|FG001|Overall Study|Voluntary Withdrawal|6|||
130948262|NCT00744627|471444573|FG000|Overall Study|Lost to Follow-up|2|||
130948263|NCT00744627|471444574|FG001|Overall Study|Lost to Follow-up|1|||
130948264|NCT00744627|471444573|FG000|Overall Study|Other|1|||
130948265|NCT00744627|471444574|FG001|Overall Study|Other|0|||
130948266|NCT02268786|471444575|FG000|Overall Study|No Euploid Embryos available|42|||
130948267|NCT02268786|471444576|FG001|Overall Study|No Euploid Embryos available|0|||
130948268|NCT02268786|471444575|FG000|Overall Study|Withdrawal by Subject|7|||
130774452|NCT01247350|470800520|FG003|Overall Study|Adverse Event|0|||
130774453|NCT01247350|470800521|FG004|Overall Study|Adverse Event|0|||
130948269|NCT02268786|471444576|FG001|Overall Study|Withdrawal by Subject|14|||
130948270|NCT02268786|471444575|FG000|Overall Study|Thaw Failure|6|||
130948271|NCT02268786|471444576|FG001|Overall Study|Thaw Failure|4|||
130948272|NCT02268786|471444575|FG000|Overall Study|Protocol Violation|1|||
130948273|NCT02268786|471444576|FG001|Overall Study|Protocol Violation|0|||
130948274|NCT00642668|471444581|FG000|Overall Study|Lost to Follow-up|1|||
130948275|NCT00642668|471444581|FG000|Overall Study|Adverse Event|2|||
130948276|NCT00642668|471444581|FG000|Overall Study|Death|2|||
130948277|NCT00642668|471444581|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130948278|NCT00642668|471444581|FG000|Overall Study|Failure to Return|1|||
130948279|NCT00642668|471444581|FG000|Overall Study|Dialysis Initiation|5|||
130948280|NCT00642668|471444581|FG000|Overall Study|Blood Transfusion|2|||
130948281|NCT03608774|471444582|FG000|Overall Study|Lost to Follow-up|5|||
130948282|NCT03608774|471444583|FG001|Overall Study|Lost to Follow-up|5|||
130948283|NCT03608774|471444582|FG000|Overall Study|Withdrawal by Subject|1|||
130948284|NCT03608774|471444583|FG001|Overall Study|Withdrawal by Subject|0|||
130948285|NCT03608774|471444582|FG000|Overall Study|Protocol Violation|1|||
130948286|NCT03608774|471444583|FG001|Overall Study|Protocol Violation|0|||
130948287|NCT03608774|471444582|FG000|Overall Study|Not eligible at enrollment|0|||
130948288|NCT03608774|471444583|FG001|Overall Study|Not eligible at enrollment|1|||
130948289|NCT03608774|471444582|FG000|Overall Study|Health related event|0|||
130948290|NCT03608774|471444583|FG001|Overall Study|Health related event|1|||
130948291|NCT01177540|471444584|FG000|Overall Study|Adverse Event|1|||
130948292|NCT01177540|471444585|FG001|Overall Study|Adverse Event|0|||
130948293|NCT02910167|471444586|FG000|Overall Study|Adverse Event|1|||
130948294|NCT02910167|471444586|FG000|Overall Study|Lost to Follow-up|18|||
130948295|NCT00589108|471446100|FG000|Overall Study|Lost to Follow-up|1|||
130948296|NCT00589108|471446101|FG001|Overall Study|Lost to Follow-up|1|||
130948297|NCT00589108|471446102|FG002|Overall Study|Lost to Follow-up|1|||
130948298|NCT00589108|471446100|FG000|Overall Study|Death|3|||
130948299|NCT00589108|471446101|FG001|Overall Study|Death|3|||
130948300|NCT00589108|471446102|FG002|Overall Study|Death|4|||
130948301|NCT03256552|471446103|FG000|Overall Study|Protocol Violation|1|||
130948302|NCT03256552|471446103|FG000|Overall Study|Physician Decision|1|||
130948303|NCT03256552|471446103|FG000|Overall Study|Adverse Event|1|||
130948304|NCT03256552|471446103|FG000|Overall Study|Withdrawal by Subject|2|||
130948305|NCT03026257|471446108|FG000|Overall Study|Adverse Event|3|||
130948306|NCT03026257|471446109|FG001|Overall Study|Adverse Event|0|||
130948307|NCT03026257|471446110|FG002|Overall Study|Adverse Event|0|||
130948308|NCT03026257|471446111|FG003|Overall Study|Adverse Event|0|||
130948309|NCT03026257|471446112|FG004|Overall Study|Adverse Event|0|||
130948310|NCT03026257|471446113|FG005|Overall Study|Adverse Event|0|||
130948311|NCT03026257|471446108|FG000|Overall Study|Lost to Follow-up|1|||
130948312|NCT03026257|471446109|FG001|Overall Study|Lost to Follow-up|0|||
130948313|NCT03026257|471446110|FG002|Overall Study|Lost to Follow-up|0|||
130948314|NCT03026257|471446111|FG003|Overall Study|Lost to Follow-up|0|||
130948315|NCT03026257|471446112|FG004|Overall Study|Lost to Follow-up|0|||
130948316|NCT03026257|471446113|FG005|Overall Study|Lost to Follow-up|0|||
130948317|NCT03026257|471446108|FG000|Overall Study|Protocol Violation|1|||
130948318|NCT03026257|471446109|FG001|Overall Study|Protocol Violation|0|||
130948319|NCT03026257|471446110|FG002|Overall Study|Protocol Violation|0|||
130948320|NCT03026257|471446111|FG003|Overall Study|Protocol Violation|1|||
130948321|NCT03026257|471446112|FG004|Overall Study|Protocol Violation|1|||
130948322|NCT03026257|471446113|FG005|Overall Study|Protocol Violation|0|||
130948323|NCT03026257|471446108|FG000|Overall Study|Withdrawal by Subject|1|||
130948324|NCT03026257|471446109|FG001|Overall Study|Withdrawal by Subject|1|||
130948325|NCT03026257|471446110|FG002|Overall Study|Withdrawal by Subject|0|||
130948326|NCT03026257|471446111|FG003|Overall Study|Withdrawal by Subject|0|||
130948327|NCT03026257|471446112|FG004|Overall Study|Withdrawal by Subject|0|||
130948328|NCT03026257|471446113|FG005|Overall Study|Withdrawal by Subject|0|||
130948329|NCT04380857|471446114|FG000|Overall Study|Lost to Follow-up|3|||
130774454|NCT01247350|470800517|FG000|Overall Study|Withdrawal by Subject|0|||
130774455|NCT01247350|470800518|FG001|Overall Study|Withdrawal by Subject|0|||
130948330|NCT04380857|471446115|FG001|Overall Study|Lost to Follow-up|3|||
130948331|NCT02558790|471446116|FG000|Overall Study|Lost to Follow-up|2|||
130948332|NCT02558790|471446116|FG000|Overall Study|Physician Decision|1|||
130948333|NCT02558790|471446116|FG000|Overall Study|Withdrawal by Subject|1|||
130948334|NCT02558790|471446116|FG000|Overall Study|Screen Fail|3|||
130948335|NCT00838201|471446117|FG000|Overall Study|Investigator decision, or other reasons|2|||
130948336|NCT00838201|471446118|FG001|Overall Study|Investigator decision, or other reasons|3|||
130948337|NCT00838201|471446117|FG000|Overall Study|Noncompliance|0|||
130948338|NCT00838201|471446118|FG001|Overall Study|Noncompliance|1|||
130948339|NCT00838201|471446117|FG000|Overall Study|Administrative decision|1|||
130948340|NCT00838201|471446118|FG001|Overall Study|Administrative decision|2|||
130948341|NCT00838201|471446117|FG000|Overall Study|Disease progression|3|||
130948342|NCT00838201|471446118|FG001|Overall Study|Disease progression|3|||
130948343|NCT00838201|471446117|FG000|Overall Study|Consent withdrawn|16|||
131037912|NCT03313076|471772784|FG001|Overall Study|Withdrawal by Subject|0|||
131037913|NCT03313076|471772785|FG002|Overall Study|Withdrawal by Subject|0|||
131037914|NCT03313076|471772786|FG003|Overall Study|Withdrawal by Subject|0|||
131037915|NCT03313076|471772783|FG000|Overall Study|Lost to Follow-up|0|||
131037916|NCT03313076|471772784|FG001|Overall Study|Lost to Follow-up|2|||
131037917|NCT03313076|471772785|FG002|Overall Study|Lost to Follow-up|2|||
131037918|NCT03313076|471772786|FG003|Overall Study|Lost to Follow-up|2|||
131037919|NCT03904147|471772789|FG000|Overall Study|Death|15|||
131037920|NCT03904147|471772790|FG001|Overall Study|Death|13|||
131037921|NCT03904147|471772791|FG002|Overall Study|Death|15|||
131037922|NCT03904147|471772789|FG000|Overall Study|Withdrawal by Subject|7|||
131037923|NCT03904147|471772790|FG001|Overall Study|Withdrawal by Subject|12|||
131037924|NCT03904147|471772791|FG002|Overall Study|Withdrawal by Subject|1|||
131037925|NCT03904147|471772789|FG000|Overall Study|1Y visit completed after 365 days|1|||
131037926|NCT03904147|471772790|FG001|Overall Study|1Y visit completed after 365 days|1|||
131037927|NCT03904147|471772791|FG002|Overall Study|1Y visit completed after 365 days|0|||
131124726|NCT01648790|472085841|FG002|Treatment 3|Withdrawal by Subject|0|||
131124727|NCT01648790|472085842|FG003|Treatment 3|Withdrawal by Subject|1|||
131124728|NCT01648790|472085843|FG004|Treatment 3|Withdrawal by Subject|0|||
131124729|NCT02969187|472085844|FG000|Overall Study|Physician Decision|12|||
130948344|NCT00838201|471446118|FG001|Overall Study|Consent withdrawn|19|||
130948345|NCT00838201|471446117|FG000|Overall Study|Lost to Follow-up|4|||
130948346|NCT00838201|471446118|FG001|Overall Study|Lost to Follow-up|3|||
130948347|NCT00838201|471446117|FG000|Overall Study|Adverse Event|5|||
130948348|NCT00838201|471446118|FG001|Overall Study|Adverse Event|9|||
130948349|NCT00838201|471446117|FG000|Overall Study|Death|11|||
130948350|NCT00838201|471446118|FG001|Overall Study|Death|13|||
130948351|NCT05083442|471446119|FG000|Overall Study|Lost to Follow-up|1|||
130948352|NCT05083442|471446120|FG001|Overall Study|Lost to Follow-up|0|||
130948353|NCT05083442|471446119|FG000|Overall Study|Lack of Efficacy|0|||
130948354|NCT05083442|471446120|FG001|Overall Study|Lack of Efficacy|1|||
130948355|NCT05083442|471446119|FG000|Overall Study|Withdrawal by Subject|1|||
130948356|NCT05083442|471446120|FG001|Overall Study|Withdrawal by Subject|3|||
130948357|NCT05083442|471446119|FG000|Overall Study|scheduling difficulties|1|||
130948358|NCT05083442|471446120|FG001|Overall Study|scheduling difficulties|2|||
130948359|NCT05620576|471446123|FG000|Overall Study|Adverse Event|1|||
130948360|NCT05620576|471446124|FG001|Overall Study|Adverse Event|1|||
130948361|NCT05620576|471446123|FG000|Overall Study|Lost to Follow-up|3|||
130948362|NCT05620576|471446124|FG001|Overall Study|Lost to Follow-up|1|||
130948363|NCT05620576|471446123|FG000|Overall Study|Physician Decision|0|||
130948364|NCT05620576|471446124|FG001|Overall Study|Physician Decision|1|||
130948365|NCT05620576|471446123|FG000|Overall Study|Protocol Deviation|1|||
130948366|NCT05620576|471446124|FG001|Overall Study|Protocol Deviation|1|||
130948367|NCT05620576|471446123|FG000|Overall Study|Withdrawal by Subject|2|||
130948368|NCT05620576|471446124|FG001|Overall Study|Withdrawal by Subject|3|||
130948369|NCT04476030|471446125|FG000|Overall Study|Withdrawal by Subject|20|||
130948370|NCT04476030|471446126|FG001|Overall Study|Withdrawal by Subject|16|||
130948371|NCT04476030|471446125|FG000|Overall Study|Adverse Event|10|||
130948372|NCT04476030|471446126|FG001|Overall Study|Adverse Event|11|||
130948373|NCT04476030|471446125|FG000|Overall Study|Lost to Follow-up|7|||
130948374|NCT04476030|471446126|FG001|Overall Study|Lost to Follow-up|4|||
130948375|NCT04476030|471446125|FG000|Overall Study|Physician Decision|1|||
130948376|NCT04476030|471446126|FG001|Overall Study|Physician Decision|1|||
130948377|NCT04476030|471446125|FG000|Overall Study|Protocol Deviation|2|||
130948378|NCT04476030|471446126|FG001|Overall Study|Protocol Deviation|0|||
130948379|NCT04476030|471446125|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
130948380|NCT04476030|471446126|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
130948381|NCT04476030|471446125|FG000|Overall Study|Randomized but not Dosed|2|||
130948382|NCT04476030|471446126|FG001|Overall Study|Randomized but not Dosed|8|||
130948383|NCT02286193|471446133|FG000|Overall Study|Referred: CRS unable to make contact|62|||
130948384|NCT02286193|471446133|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
131124730|NCT02969187|472085845|FG001|Overall Study|Physician Decision|13|||
131124731|NCT01486927|472085846|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
131037928|NCT00764751|471772799|FG000|Overall Study|Adverse Event|1|||
131124732|NCT01486927|472085846|FG000|Overall Study|Physician Decision|1|||
130948385|NCT02286193|471446133|FG000|Overall Study|Referred: Declined service|38|||
131037929|NCT00764751|471772800|FG001|Overall Study|Adverse Event|1|||
131037930|NCT00764751|471772799|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
130948386|NCT03387813|471446134|FG000|Overall Study|Death|40|||
130948387|NCT03387813|471446135|FG001|Overall Study|Death|37|||
131037931|NCT00764751|471772800|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
131037932|NCT03011333|471772806|FG000|Overall Study|Lost to Follow-up|0|||
131124733|NCT01486927|472085846|FG000|Overall Study|50 Exposure days not reached|2|||
131225099|NCT02402933|472451952|FG000|Overall Study|Discontinued; Site Termination|10|||
130948388|NCT03387813|471446136|FG002|Overall Study|Death|190|||
130948389|NCT03387813|471446134|FG000|Overall Study|Withdrawal by Subject|9|||
130948390|NCT03387813|471446135|FG001|Overall Study|Withdrawal by Subject|19|||
131037933|NCT03011333|471772807|FG001|Overall Study|Lost to Follow-up|1|||
130948391|NCT03387813|471446136|FG002|Overall Study|Withdrawal by Subject|32|||
130948392|NCT03387813|471446134|FG000|Overall Study|Lost to Follow-up|3|||
130948393|NCT03387813|471446135|FG001|Overall Study|Lost to Follow-up|9|||
130948394|NCT03387813|471446136|FG002|Overall Study|Lost to Follow-up|15|||
130948395|NCT03387813|471446134|FG000|Overall Study|Non-Compliance|6|||
130948396|NCT03387813|471446135|FG001|Overall Study|Non-Compliance|6|||
130948397|NCT03387813|471446136|FG002|Overall Study|Non-Compliance|31|||
130948398|NCT03387813|471446134|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
130948399|NCT03387813|471446135|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
130948400|NCT03387813|471446136|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
130948401|NCT01293240|471446137|FG000|Overall Study|Noncompliance|2|||
130948402|NCT03161483|471446142|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
130948403|NCT03161483|471446143|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
130948404|NCT03161483|471446144|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
130948405|NCT03161483|471446145|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
130948406|NCT03161483|471446142|FG000|Treatment Period|Death|1|||
130948407|NCT03161483|471446143|FG001|Treatment Period|Death|0|||
130948408|NCT03161483|471446144|FG002|Treatment Period|Death|0|||
130948409|NCT03161483|471446145|FG003|Treatment Period|Death|0|||
130948410|NCT03161483|471446142|FG000|Treatment Period|Adverse Event|5|||
130948411|NCT03161483|471446143|FG001|Treatment Period|Adverse Event|2|||
130948412|NCT03161483|471446144|FG002|Treatment Period|Adverse Event|1|||
130948413|NCT03161483|471446145|FG003|Treatment Period|Adverse Event|11|||
130948414|NCT03161483|471446142|FG000|Treatment Period|Pregnancy|1|||
130948415|NCT03161483|471446143|FG001|Treatment Period|Pregnancy|0|||
130948416|NCT03161483|471446144|FG002|Treatment Period|Pregnancy|0|||
130948417|NCT03161483|471446145|FG003|Treatment Period|Pregnancy|0|||
130948418|NCT03161483|471446142|FG000|Treatment Period|Lack of Efficacy|0|||
130948419|NCT03161483|471446143|FG001|Treatment Period|Lack of Efficacy|0|||
130948420|NCT03161483|471446144|FG002|Treatment Period|Lack of Efficacy|0|||
130948421|NCT03161483|471446145|FG003|Treatment Period|Lack of Efficacy|1|||
130948422|NCT03161483|471446142|FG000|Treatment Period|Withdrawal by Subject|2|||
130948423|NCT03161483|471446143|FG001|Treatment Period|Withdrawal by Subject|5|||
130948424|NCT03161483|471446144|FG002|Treatment Period|Withdrawal by Subject|2|||
130948425|NCT03161483|471446145|FG003|Treatment Period|Withdrawal by Subject|6|||
130948426|NCT03161483|471446142|FG000|Treatment Period|Lost to Follow-up|0|||
130948427|NCT03161483|471446143|FG001|Treatment Period|Lost to Follow-up|0|||
130948428|NCT03161483|471446144|FG002|Treatment Period|Lost to Follow-up|0|||
130948429|NCT03161483|471446145|FG003|Treatment Period|Lost to Follow-up|1|||
130948430|NCT03161483|471446142|FG000|Treatment Period|Protocol Violation|0|||
130948431|NCT03161483|471446143|FG001|Treatment Period|Protocol Violation|0|||
130948432|NCT03161483|471446144|FG002|Treatment Period|Protocol Violation|0|||
130948433|NCT03161483|471446145|FG003|Treatment Period|Protocol Violation|1|||
130948434|NCT03161483|471446142|FG000|Treatment Period|Other reasons|1|||
130948435|NCT03161483|471446143|FG001|Treatment Period|Other reasons|1|||
130948436|NCT03161483|471446144|FG002|Treatment Period|Other reasons|0|||
130948437|NCT03161483|471446145|FG003|Treatment Period|Other reasons|0|||
130948438|NCT04238728|471446150|FG000|Overall Study|Withdrawal by Subject|1|||
130948439|NCT04238728|471446150|FG000|Overall Study|Lost to Follow-up|2|||
130948440|NCT03261947|471446152|FG000|Overall Study|Death|10|||
130948441|NCT03261947|471446153|FG001|Overall Study|Death|13|||
130948442|NCT03261947|471446154|FG002|Overall Study|Death|17|||
130948443|NCT03261947|471446155|FG003|Overall Study|Death|12|||
130948444|NCT03261947|471446156|FG004|Overall Study|Death|8|||
130948445|NCT03261947|471446152|FG000|Overall Study|Lost to Follow-up|0|||
130948446|NCT03261947|471446153|FG001|Overall Study|Lost to Follow-up|0|||
130948447|NCT03261947|471446154|FG002|Overall Study|Lost to Follow-up|2|||
130948448|NCT03261947|471446155|FG003|Overall Study|Lost to Follow-up|1|||
130948449|NCT03261947|471446156|FG004|Overall Study|Lost to Follow-up|0|||
131037934|NCT03011333|471772808|FG002|Overall Study|Lost to Follow-up|0|||
130948450|NCT03261947|471446152|FG000|Overall Study|Withdrawal by Subject|0|||
130948451|NCT03261947|471446153|FG001|Overall Study|Withdrawal by Subject|0|||
130948452|NCT03261947|471446154|FG002|Overall Study|Withdrawal by Subject|3|||
130948453|NCT03261947|471446155|FG003|Overall Study|Withdrawal by Subject|0|||
130948454|NCT03261947|471446156|FG004|Overall Study|Withdrawal by Subject|1|||
130948455|NCT03261947|471446152|FG000|Overall Study|Site Terminated by Sponsor|0|||
130948456|NCT03261947|471446153|FG001|Overall Study|Site Terminated by Sponsor|0|||
131037935|NCT03011333|471772809|FG003|Overall Study|Lost to Follow-up|1|||
131037936|NCT03011333|471772810|FG004|Overall Study|Lost to Follow-up|4|||
130948457|NCT03261947|471446154|FG002|Overall Study|Site Terminated by Sponsor|4|||
130948458|NCT03261947|471446155|FG003|Overall Study|Site Terminated by Sponsor|7|||
130948459|NCT03261947|471446156|FG004|Overall Study|Site Terminated by Sponsor|5|||
130948460|NCT03261947|471446152|FG000|Overall Study|Reason not Specified|2|||
130948461|NCT03261947|471446153|FG001|Overall Study|Reason not Specified|0|||
130948462|NCT03261947|471446154|FG002|Overall Study|Reason not Specified|4|||
130948463|NCT03261947|471446155|FG003|Overall Study|Reason not Specified|1|||
130948464|NCT03261947|471446156|FG004|Overall Study|Reason not Specified|3|||
130948465|NCT00228917|471446157|FG000|Overall Study|Migrated/moved from study area|0|||
130948466|NCT00228917|471446158|FG001|Overall Study|Migrated/moved from study area|0|||
130948467|NCT00228917|471446159|FG002|Overall Study|Migrated/moved from study area|0|||
130948468|NCT00228917|471446160|FG003|Overall Study|Migrated/moved from study area|0|||
130948469|NCT00228917|471446161|FG004|Overall Study|Migrated/moved from study area|0|||
130948470|NCT00228917|471446162|FG005|Overall Study|Migrated/moved from study area|2|||
130948471|NCT00228917|471446163|FG006|Overall Study|Migrated/moved from study area|0|||
130948472|NCT00228917|471446164|FG007|Overall Study|Migrated/moved from study area|0|||
130948473|NCT00409617|471446165|FG000|Overall Study|Adverse Event|57|||
130948474|NCT00409617|471446165|FG000|Overall Study|Lack of Efficacy|54|||
130948475|NCT00409617|471446165|FG000|Overall Study|Lost to Follow-up|2|||
130948476|NCT00409617|471446165|FG000|Overall Study|Protocol Violation|24|||
130948477|NCT00409617|471446165|FG000|Overall Study|Withdrawal by Subject|8|||
130948478|NCT00409617|471446165|FG000|Overall Study|Administrative reasons|1|||
130948479|NCT00409617|471446165|FG000|Overall Study|Not described|14|||
130948480|NCT03373383|471446169|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
130948481|NCT03373383|471446170|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
130948482|NCT03373383|471446171|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
130948483|NCT03373383|471446172|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
130948484|NCT03373383|471446173|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
130948485|NCT03373383|471446169|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
130948486|NCT03373383|471446170|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
130948487|NCT03373383|471446171|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130948488|NCT03373383|471446172|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130948489|NCT03373383|471446173|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130948490|NCT03373383|471446169|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
130948491|NCT03373383|471446170|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
130948492|NCT03373383|471446171|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
130948493|NCT03373383|471446172|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
130948494|NCT03373383|471446173|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
130948495|NCT03373383|471446169|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
130948496|NCT03373383|471446170|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
130948497|NCT03373383|471446171|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
130948498|NCT03373383|471446172|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
130948499|NCT03373383|471446173|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
130948500|NCT03373383|471446169|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
130948501|NCT03373383|471446170|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
130948502|NCT03373383|471446171|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
130948503|NCT03373383|471446172|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
130948504|NCT03373383|471446173|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
130948505|NCT03373383|471446169|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
130948506|NCT03373383|471446170|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
130948507|NCT03373383|471446171|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
130948508|NCT03373383|471446172|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
130948509|NCT03373383|471446173|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
130948510|NCT03373383|471446169|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
130948511|NCT03373383|471446170|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
130948512|NCT03373383|471446171|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
130948513|NCT03373383|471446172|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
130948514|NCT03373383|471446173|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
130948515|NCT03373383|471446169|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
130948516|NCT03373383|471446170|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
130948517|NCT03373383|471446171|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
130948518|NCT03373383|471446172|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
130948519|NCT03373383|471446173|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
130948520|NCT03373383|471446169|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
130948521|NCT03373383|471446170|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
130948522|NCT03373383|471446171|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
130948523|NCT03373383|471446172|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
130948524|NCT03373383|471446173|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
130948525|NCT03818516|471446174|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
130948526|NCT04372602|471446175|FG000|Overall Study|Withdrawal by Subject|1|||
130948527|NCT04372602|471446176|FG001|Overall Study|Withdrawal by Subject|1|||
130948528|NCT04372602|471446175|FG000|Overall Study|Adverse Event|0|||
130948529|NCT04372602|471446176|FG001|Overall Study|Adverse Event|1|||
130948530|NCT04372602|471446175|FG000|Overall Study|Transitioned to comfort care|0|||
130948531|NCT04372602|471446176|FG001|Overall Study|Transitioned to comfort care|1|||
130948532|NCT02907359|471446177|FG000|Overall Study|Death|234|||
130948533|NCT02907359|471446178|FG001|Overall Study|Death|117|||
130948534|NCT02907359|471446177|FG000|Overall Study|Withdrawal by Subject|6|||
130948535|NCT02907359|471446178|FG001|Overall Study|Withdrawal by Subject|11|||
130948536|NCT02907359|471446177|FG000|Overall Study|Lost to Follow-up|1|||
130948537|NCT02907359|471446178|FG001|Overall Study|Lost to Follow-up|0|||
130948538|NCT02739269|471446183|FG000|Overall Study|Protocol Violation|5|||
130948539|NCT02739269|471446184|FG001|Overall Study|Protocol Violation|0|||
130948540|NCT02739269|471446183|FG000|Overall Study|Cycle cancellation|2|||
130948541|NCT02739269|471446184|FG001|Overall Study|Cycle cancellation|2|||
130948542|NCT02739269|471446183|FG000|Overall Study|Withdrawal by Subject|0|||
130948543|NCT02739269|471446184|FG001|Overall Study|Withdrawal by Subject|2|||
130948544|NCT00923559|471446185|FG000|Overall Study|Lost to Follow-up|2|||
130948545|NCT00923559|471446186|FG001|Overall Study|Lost to Follow-up|3|||
130948546|NCT01951157|471446187|FG000|Overall Study|Progressive Disease|12|||
130948547|NCT01951157|471446188|FG001|Overall Study|Progressive Disease|13|||
130948548|NCT01951157|471446189|FG002|Overall Study|Progressive Disease|10|||
130948549|NCT01951157|471446187|FG000|Overall Study|Treatment-unrelated AE|1|||
130948550|NCT01951157|471446188|FG001|Overall Study|Treatment-unrelated AE|0|||
130948551|NCT01951157|471446189|FG002|Overall Study|Treatment-unrelated AE|3|||
130948552|NCT01951157|471446187|FG000|Overall Study|Study Termination|0|||
130948553|NCT01951157|471446188|FG001|Overall Study|Study Termination|0|||
130948554|NCT01951157|471446189|FG002|Overall Study|Study Termination|1|||
130948555|NCT01951157|471446187|FG000|Overall Study|Physician Decision|5|||
130948556|NCT01951157|471446188|FG001|Overall Study|Physician Decision|3|||
130948557|NCT01951157|471446189|FG002|Overall Study|Physician Decision|2|||
130948558|NCT01951157|471446187|FG000|Overall Study|Non-treatmentrelated death|2|||
130948559|NCT01951157|471446188|FG001|Overall Study|Non-treatmentrelated death|2|||
130948560|NCT01951157|471446189|FG002|Overall Study|Non-treatmentrelated death|2|||
130948561|NCT01951157|471446187|FG000|Overall Study|No treated|0|||
130948562|NCT01951157|471446188|FG001|Overall Study|No treated|1|||
130948563|NCT01951157|471446189|FG002|Overall Study|No treated|0|||
130948564|NCT01951157|471446187|FG000|Overall Study|Treatment-related AE|2|||
130948565|NCT01951157|471446188|FG001|Overall Study|Treatment-related AE|0|||
130948566|NCT01951157|471446189|FG002|Overall Study|Treatment-related AE|4|||
130948567|NCT01951157|471446187|FG000|Overall Study|Consent withdrawn by subject|0|||
130948568|NCT01951157|471446188|FG001|Overall Study|Consent withdrawn by subject|1|||
130948569|NCT01951157|471446189|FG002|Overall Study|Consent withdrawn by subject|3|||
130948570|NCT01951157|471446187|FG000|Overall Study|Treatment-related death|0|||
130948571|NCT01951157|471446188|FG001|Overall Study|Treatment-related death|2|||
130948572|NCT01951157|471446189|FG002|Overall Study|Treatment-related death|0|||
130948573|NCT01200797|471446190|FG000|Overall Study|symptomatic deterioration|2|||
130948574|NCT01200797|471446190|FG000|Overall Study|Adverse Event|4|||
130948575|NCT01200797|471446190|FG000|Overall Study|Disease Progression|13|||
130948576|NCT01644175|471446191|FG000|Overall Study|Randomized But Not Treated|0|||
130948577|NCT01644175|471446192|FG001|Overall Study|Randomized But Not Treated|2|||
130948578|NCT01644175|471446191|FG000|Overall Study|Adverse Event|8|||
130948579|NCT01644175|471446192|FG001|Overall Study|Adverse Event|13|||
130948580|NCT01644175|471446191|FG000|Overall Study|Death|1|||
130948581|NCT01644175|471446192|FG001|Overall Study|Death|2|||
130948582|NCT01644175|471446191|FG000|Overall Study|Poor compliance to protocol|9|||
130948583|NCT01644175|471446192|FG001|Overall Study|Poor compliance to protocol|10|||
130948584|NCT01644175|471446191|FG000|Overall Study|Physician Decision|1|||
130948585|NCT01644175|471446192|FG001|Overall Study|Physician Decision|2|||
130948586|NCT01644175|471446191|FG000|Overall Study|Participant Moved|1|||
130948587|NCT01644175|471446192|FG001|Overall Study|Participant Moved|2|||
130948588|NCT01644175|471446191|FG000|Overall Study|Consent withdrawn by participant|3|||
130948589|NCT01644175|471446192|FG001|Overall Study|Consent withdrawn by participant|4|||
130948590|NCT01644175|471446191|FG000|Overall Study|Related to Autoinjector Administration|2|||
130948591|NCT01644175|471446192|FG001|Overall Study|Related to Autoinjector Administration|1|||
130948592|NCT01644175|471446191|FG000|Overall Study|Last visit outside protocol visit window|4|||
130948593|NCT01644175|471446192|FG001|Overall Study|Last visit outside protocol visit window|11|||
130948594|NCT01644175|471446191|FG000|Overall Study|Selection criteria finally not met|0|||
130948595|NCT01644175|471446192|FG001|Overall Study|Selection criteria finally not met|1|||
130710757|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
130710758|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
130948596|NCT01644175|471446191|FG000|Overall Study|Site closure|2|||
130948597|NCT01644175|471446192|FG001|Overall Study|Site closure|2|||
130948598|NCT01644175|471446191|FG000|Overall Study|Lost to Follow-up|1|||
130948599|NCT01644175|471446192|FG001|Overall Study|Lost to Follow-up|0|||
130948600|NCT01644175|471446191|FG000|Overall Study|Other than specified above|0|||
130948601|NCT01644175|471446192|FG001|Overall Study|Other than specified above|3|||
130948602|NCT02818777|471446200|FG000|Overall Study|Adverse Event|3|||
130948603|NCT01623596|471446210|FG000|Overall Study|Abnormal laboratory values|2|||
130948604|NCT01623596|471446211|FG001|Overall Study|Abnormal laboratory values|0|||
130948605|NCT01623596|471446210|FG000|Overall Study|Administrative problems|9|||
130948606|NCT01623596|471446211|FG001|Overall Study|Administrative problems|13|||
130948607|NCT01623596|471446210|FG000|Overall Study|Adverse Event|20|||
130948608|NCT01623596|471446211|FG001|Overall Study|Adverse Event|29|||
130948609|NCT01623596|471446210|FG000|Overall Study|Death|0|||
130948610|NCT01623596|471446211|FG001|Overall Study|Death|2|||
130948611|NCT01623596|471446210|FG000|Overall Study|Lost to Follow-up|12|||
130948612|NCT01623596|471446211|FG001|Overall Study|Lost to Follow-up|16|||
130948613|NCT01623596|471446210|FG000|Overall Study|Withdrawal by Subject|13|||
130948614|NCT01623596|471446211|FG001|Overall Study|Withdrawal by Subject|31|||
130948615|NCT01623596|471446210|FG000|Overall Study|Patient no longer requires study drug|1|||
130948616|NCT01623596|471446211|FG001|Overall Study|Patient no longer requires study drug|0|||
130948617|NCT01623596|471446210|FG000|Overall Study|Protocol Violation|0|||
130948618|NCT01623596|471446211|FG001|Overall Study|Protocol Violation|6|||
130948619|NCT01623596|471446210|FG000|Overall Study|Lack of Efficacy|5|||
130948620|NCT01623596|471446211|FG001|Overall Study|Lack of Efficacy|3|||
130948621|NCT01324349|471446212|FG000|Overall Study|Death|1|||
130948622|NCT01324349|471446213|FG001|Overall Study|Death|1|||
130948623|NCT01324349|471446212|FG000|Overall Study|Withdrawal by Subject|0|||
130948624|NCT01324349|471446213|FG001|Overall Study|Withdrawal by Subject|1|||
130948625|NCT00748215|471446216|FG000|Overall Study|Withdrawal by Subject|7|||
130948626|NCT00748215|471446217|FG001|Overall Study|Withdrawal by Subject|7|||
130948627|NCT00748215|471446216|FG000|Overall Study|Treatment change|2|||
130948628|NCT00748215|471446217|FG001|Overall Study|Treatment change|1|||
130948629|NCT00748215|471446216|FG000|Overall Study|Change in patient condition|0|||
130948630|NCT00748215|471446217|FG001|Overall Study|Change in patient condition|3|||
130948631|NCT00748215|471446216|FG000|Overall Study|Non-compliant|0|||
130948632|NCT00748215|471446217|FG001|Overall Study|Non-compliant|2|||
130948633|NCT00748215|471446216|FG000|Overall Study|Adverse Event|0|||
130948634|NCT00748215|471446217|FG001|Overall Study|Adverse Event|5|||
130948635|NCT03200899|471446222|FG000|Overall Study|Lost to Follow-up|10|||
130948636|NCT03200899|471446223|FG001|Overall Study|Lost to Follow-up|23|||
130948637|NCT00026793|471446225|FG000|Overall Study|Death on study due to underlying disease|4|||
130948638|NCT00026793|471446225|FG000|Overall Study|Physician Decision|2|||
130948639|NCT00026793|471446225|FG000|Overall Study|Off study|2|||
130948640|NCT04151290|471446226|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
130948641|NCT03913091|471446227|FG000|Overall Study|Lost to Follow-up|18|||
130948642|NCT03913091|471446228|FG001|Overall Study|Lost to Follow-up|11|||
130948643|NCT03913091|471446227|FG000|Overall Study|Required additional meds/surgery|1|||
130948644|NCT03913091|471446228|FG001|Overall Study|Required additional meds/surgery|2|||
130948645|NCT03913091|471446227|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
130948646|NCT03913091|471446228|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
130948647|NCT01077804|471446229|FG000|Overall Study|Unreachable|102|||
130948648|NCT01077804|471446229|FG000|Overall Study|Refused to continue|79|||
130948649|NCT01077804|471446229|FG000|Overall Study|Other|18|||
130948650|NCT02620046|471446231|FG000|Overall Study|Adverse Event|22|||
130948651|NCT02620046|471446232|FG001|Overall Study|Adverse Event|42|||
130948652|NCT02620046|471446231|FG000|Overall Study|Lost to Follow-up|4|||
130948653|NCT02620046|471446232|FG001|Overall Study|Lost to Follow-up|10|||
130948654|NCT02620046|471446231|FG000|Overall Study|Withdrawal by Subject|36|||
130948655|NCT02620046|471446232|FG001|Overall Study|Withdrawal by Subject|66|||
130948656|NCT02620046|471446231|FG000|Overall Study|Site Termination|3|||
130948657|NCT02620046|471446232|FG001|Overall Study|Site Termination|3|||
130948658|NCT02620046|471446231|FG000|Overall Study|Pregnancy|3|||
130948659|NCT02620046|471446232|FG001|Overall Study|Pregnancy|7|||
130948660|NCT02620046|471446231|FG000|Overall Study|Lack of Efficacy|81|||
130948661|NCT02620046|471446232|FG001|Overall Study|Lack of Efficacy|146|||
130948662|NCT02620046|471446231|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
130948663|NCT02620046|471446232|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
130948664|NCT02620046|471446231|FG000|Overall Study|Reason Not Specified|13|||
130948665|NCT02620046|471446232|FG001|Overall Study|Reason Not Specified|21|||
130948666|NCT02620046|471446231|FG000|Overall Study|Significant Protocol Deviation|0|||
130948667|NCT02620046|471446232|FG001|Overall Study|Significant Protocol Deviation|1|||
130948668|NCT04477304|471446233|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
130948669|NCT04477304|471446234|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
130948670|NCT00116831|471447883|FG000|Overall Study|Adverse Event|14|||
130948671|NCT00116831|471447884|FG001|Overall Study|Adverse Event|16|||
130948672|NCT00116831|471447883|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
130948673|NCT00116831|471447884|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
130948674|NCT00116831|471447883|FG000|Overall Study|Lost to Follow-up|8|||
131124734|NCT01486927|472085846|FG000|Overall Study|Withdrawal by Subject|8|||
131124735|NCT01486927|472085846|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
131124736|NCT01476475|472085848|FG000|Overall Study|Adverse Event|6|||
131124737|NCT01476475|472085849|FG001|Overall Study|Adverse Event|0|||
131124738|NCT01476475|472085848|FG000|Overall Study|Poor compliance to protocol|1|||
131124739|NCT01476475|472085849|FG001|Overall Study|Poor compliance to protocol|1|||
130948675|NCT00116831|471447884|FG001|Overall Study|Lost to Follow-up|6|||
130948676|NCT00116831|471447883|FG000|Overall Study|Protocol Violation|3|||
130948677|NCT00116831|471447884|FG001|Overall Study|Protocol Violation|6|||
130948678|NCT00116831|471447883|FG000|Overall Study|Hypoglycaemic events|1|||
130948679|NCT00116831|471447884|FG001|Overall Study|Hypoglycaemic events|0|||
130948680|NCT00116831|471447883|FG000|Overall Study|Low haemoglobin on screening|1|||
131037937|NCT03011333|471772811|FG005|Overall Study|Lost to Follow-up|4|||
131037938|NCT03011333|471772812|FG006|Overall Study|Lost to Follow-up|5|||
131037939|NCT04307355|471772813|FG000|Overall Study|Non-Compliance|3|||
131037940|NCT04307355|471772814|FG001|Overall Study|Non-Compliance|3|||
131037941|NCT04307355|471772815|FG002|Overall Study|Non-Compliance|0|||
131037942|NCT02998268|471772819|FG000|Overall Study|Adverse Event|0|||
131037943|NCT02998268|471772820|FG001|Overall Study|Adverse Event|2|||
131037944|NCT02998268|471772819|FG000|Overall Study|Withdrawal by Subject|0|||
131037945|NCT02998268|471772820|FG001|Overall Study|Withdrawal by Subject|1|||
131037946|NCT05269667|471772821|FG000|Overall Study|Study Terminated by Sponsor|4|||
131037947|NCT04413708|471772822|FG000|Overall Study|Lost to Follow-up|1|||
131037948|NCT04413708|471772823|FG001|Overall Study|Lost to Follow-up|2|||
131037949|NCT04032704|471772831|FG000|Part A|Withdrawal by Subject|0|||
131037950|NCT04032704|471772832|FG001|Part A|Withdrawal by Subject|0|||
131037951|NCT04032704|471772833|FG002|Part A|Withdrawal by Subject|3|||
131037952|NCT04032704|471772834|FG003|Part A|Withdrawal by Subject|0|||
131037953|NCT04032704|471772835|FG004|Part A|Withdrawal by Subject|1|||
131037954|NCT04032704|471772836|FG005|Part A|Withdrawal by Subject|7|||
131037955|NCT04032704|471772837|FG006|Part A|Withdrawal by Subject|0|||
131037956|NCT04032704|471772838|FG007|Part A|Withdrawal by Subject|0|||
131037957|NCT04032704|471772839|FG008|Part A|Withdrawal by Subject|0|||
131037958|NCT04032704|471772840|FG009|Part A|Withdrawal by Subject|0|||
131037959|NCT04032704|471772841|FG010|Part A|Withdrawal by Subject|0|||
131037960|NCT04032704|471772842|FG011|Part A|Withdrawal by Subject|0|||
131037961|NCT04032704|471772843|FG012|Part A|Withdrawal by Subject|0|||
131037962|NCT04032704|471772844|FG013|Part A|Withdrawal by Subject|0|||
131037963|NCT04032704|471772845|FG014|Part A|Withdrawal by Subject|0|||
131037964|NCT04032704|471772846|FG015|Part A|Withdrawal by Subject|0|||
131037965|NCT04032704|471772847|FG016|Part A|Withdrawal by Subject|0|||
131037966|NCT04032704|471772848|FG017|Part A|Withdrawal by Subject|0|||
131037967|NCT04032704|471772831|FG000|Part A|Lost to Follow-up|1|||
131037968|NCT04032704|471772832|FG001|Part A|Lost to Follow-up|0|||
131037969|NCT04032704|471772833|FG002|Part A|Lost to Follow-up|0|||
131037970|NCT04032704|471772834|FG003|Part A|Lost to Follow-up|0|||
131037971|NCT04032704|471772835|FG004|Part A|Lost to Follow-up|0|||
131037972|NCT04032704|471772836|FG005|Part A|Lost to Follow-up|0|||
131037973|NCT04032704|471772837|FG006|Part A|Lost to Follow-up|0|||
131037974|NCT04032704|471772838|FG007|Part A|Lost to Follow-up|0|||
131037975|NCT04032704|471772839|FG008|Part A|Lost to Follow-up|0|||
131037976|NCT04032704|471772840|FG009|Part A|Lost to Follow-up|0|||
131037977|NCT04032704|471772841|FG010|Part A|Lost to Follow-up|0|||
131037978|NCT04032704|471772842|FG011|Part A|Lost to Follow-up|0|||
131037979|NCT04032704|471772843|FG012|Part A|Lost to Follow-up|0|||
131037980|NCT04032704|471772844|FG013|Part A|Lost to Follow-up|0|||
131037981|NCT04032704|471772845|FG014|Part A|Lost to Follow-up|0|||
131037982|NCT04032704|471772846|FG015|Part A|Lost to Follow-up|0|||
131037983|NCT04032704|471772847|FG016|Part A|Lost to Follow-up|0|||
131037984|NCT04032704|471772848|FG017|Part A|Lost to Follow-up|0|||
131037985|NCT04032704|471772831|FG000|Part A|Death|9|||
131037986|NCT04032704|471772832|FG001|Part A|Death|2|||
131037987|NCT04032704|471772833|FG002|Part A|Death|10|||
130710759|NCT01421342|470567020|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
130710760|NCT01421342|470567021|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
130710761|NCT01421342|470567022|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
130948681|NCT00116831|471447884|FG001|Overall Study|Low haemoglobin on screening|0|||
130948682|NCT00116831|471447883|FG000|Overall Study|Withdrawn investigational product|1|||
130948683|NCT00116831|471447884|FG001|Overall Study|Withdrawn investigational product|0|||
130948684|NCT00116831|471447883|FG000|Overall Study|Withdrawal by Subject|32|||
130948685|NCT00116831|471447884|FG001|Overall Study|Withdrawal by Subject|32|||
130948686|NCT00116831|471447883|FG000|Overall Study|Insufficient therapeutic effect|0|||
130948687|NCT00116831|471447884|FG001|Overall Study|Insufficient therapeutic effect|1|||
130948688|NCT00116831|471447883|FG000|Overall Study|Missing data for participant|1|||
131037988|NCT04032704|471772834|FG003|Part A|Death|7|||
131037989|NCT04032704|471772835|FG004|Part A|Death|4|||
131037990|NCT04032704|471772836|FG005|Part A|Death|5|||
131037991|NCT04032704|471772837|FG006|Part A|Death|0|||
131037992|NCT04032704|471772838|FG007|Part A|Death|0|||
131037993|NCT04032704|471772839|FG008|Part A|Death|0|||
131037994|NCT04032704|471772840|FG009|Part A|Death|0|||
131037995|NCT04032704|471772841|FG010|Part A|Death|0|||
131037996|NCT04032704|471772842|FG011|Part A|Death|0|||
130710762|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
131037997|NCT04032704|471772843|FG012|Part A|Death|0|||
131037998|NCT04032704|471772844|FG013|Part A|Death|0|||
131124740|NCT01476475|472085848|FG000|Overall Study|Other reasons|4|||
131037999|NCT04032704|471772845|FG014|Part A|Death|0|||
131038000|NCT04032704|471772846|FG015|Part A|Death|0|||
131038001|NCT04032704|471772847|FG016|Part A|Death|0|||
131038002|NCT04032704|471772848|FG017|Part A|Death|0|||
131038003|NCT04032704|471772831|FG000|Part B|Other|0|||
131038004|NCT04032704|471772832|FG001|Part B|Other|0|||
131038005|NCT04032704|471772833|FG002|Part B|Other|0|||
131038006|NCT04032704|471772834|FG003|Part B|Other|0|||
131038007|NCT04032704|471772835|FG004|Part B|Other|0|||
130948689|NCT00116831|471447884|FG001|Overall Study|Missing data for participant|0|||
130948690|NCT02476968|471447885|FG000|Overall Study|Other|0|||
130948691|NCT02476968|471447886|FG001|Overall Study|Other|2|||
130948692|NCT02476968|471447887|FG002|Overall Study|Other|0|||
130948693|NCT02476968|471447885|FG000|Overall Study|Lost to Follow-up|10|||
130948694|NCT02476968|471447886|FG001|Overall Study|Lost to Follow-up|0|||
130948695|NCT02476968|471447887|FG002|Overall Study|Lost to Follow-up|1|||
130948696|NCT02476968|471447885|FG000|Overall Study|Death|48|||
130948697|NCT02476968|471447886|FG001|Overall Study|Death|8|||
130948698|NCT02476968|471447887|FG002|Overall Study|Death|1|||
130948699|NCT02476968|471447885|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130948700|NCT02476968|471447886|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130948701|NCT02476968|471447887|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130948702|NCT02476968|471447885|FG000|Overall Study|Patient decision|37|||
130948703|NCT02476968|471447886|FG001|Overall Study|Patient decision|8|||
130948704|NCT02476968|471447887|FG002|Overall Study|Patient decision|0|||
130948705|NCT01859507|471447888|FG000|Overall Study|left the country|4|||
130948706|NCT02404311|471447889|FG000|Part A: Month 0-18|Death|2|||
130948707|NCT02404311|471447890|FG001|Part A: Month 0-18|Death|0|||
130948708|NCT02404311|471447891|FG002|Part A: Month 0-18|Death|0|||
130948709|NCT02404311|471447892|FG003|Part A: Month 0-18|Death|0|||
130948710|NCT02404311|471447893|FG004|Part A: Month 0-18|Death|0|||
130948711|NCT02404311|471447889|FG000|Part A: Month 0-18|Physician Decision|1|||
130948712|NCT02404311|471447890|FG001|Part A: Month 0-18|Physician Decision|0|||
130948713|NCT02404311|471447891|FG002|Part A: Month 0-18|Physician Decision|0|||
130948714|NCT02404311|471447892|FG003|Part A: Month 0-18|Physician Decision|0|||
130948715|NCT02404311|471447893|FG004|Part A: Month 0-18|Physician Decision|0|||
130948716|NCT02404311|471447889|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
130948717|NCT02404311|471447890|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
130948718|NCT02404311|471447891|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
130948719|NCT02404311|471447892|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
130948720|NCT02404311|471447893|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
130948721|NCT02404311|471447889|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
130948722|NCT02404311|471447890|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
130948723|NCT02404311|471447891|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
130948724|NCT02404311|471447892|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
130948725|NCT02404311|471447893|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
130948726|NCT02404311|471447889|FG000|Part A: Month 0-18|HIV Infection|6|||
130948727|NCT02404311|471447890|FG001|Part A: Month 0-18|HIV Infection|2|||
130948728|NCT02404311|471447891|FG002|Part A: Month 0-18|HIV Infection|0|||
130948729|NCT02404311|471447892|FG003|Part A: Month 0-18|HIV Infection|0|||
130948730|NCT02404311|471447893|FG004|Part A: Month 0-18|HIV Infection|0|||
130948731|NCT02404311|471447889|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
130948732|NCT02404311|471447890|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
130948733|NCT02404311|471447891|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
130948734|NCT02404311|471447892|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
130948735|NCT02404311|471447893|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
130948736|NCT00218296|471447901|FG000|Overall Study|Lost to Follow-up|9|||
130948737|NCT00218296|471447902|FG001|Overall Study|Lost to Follow-up|7|||
130948738|NCT00218296|471447901|FG000|Overall Study|Withdrawal by Subject|36|||
130948739|NCT00218296|471447902|FG001|Overall Study|Withdrawal by Subject|47|||
130948740|NCT00218296|471447901|FG000|Overall Study|Randomized but did not enter treatment|66|||
130948741|NCT00218296|471447902|FG001|Overall Study|Randomized but did not enter treatment|67|||
130948742|NCT00097721|471447903|FG000|Overall Study|Adverse Event|8|||
130948743|NCT00097721|471447904|FG001|Overall Study|Adverse Event|1|||
130948744|NCT00097721|471447903|FG000|Overall Study|Withdrawal by Subject|6|||
130948745|NCT00097721|471447904|FG001|Overall Study|Withdrawal by Subject|1|||
130948746|NCT00097721|471447903|FG000|Overall Study|Progressive Disease|55|||
130948747|NCT00097721|471447904|FG001|Overall Study|Progressive Disease|27|||
130948748|NCT00097721|471447903|FG000|Overall Study|Physician Decision|1|||
130948749|NCT00097721|471447904|FG001|Overall Study|Physician Decision|3|||
130948750|NCT00097721|471447903|FG000|Overall Study|Reason not given|1|||
130710763|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
130948751|NCT00097721|471447904|FG001|Overall Study|Reason not given|1|||
130948752|NCT01752855|471447908|FG000|Overall Study|Adverse Event|1|||
130948753|NCT01752855|471447909|FG001|Overall Study|Adverse Event|0|||
130948754|NCT01752855|471447908|FG000|Overall Study|Withdrew Consent|0|||
130948755|NCT01752855|471447909|FG001|Overall Study|Withdrew Consent|2|||
130948756|NCT01752855|471447908|FG000|Overall Study|Lack of Efficacy|0|||
130948757|NCT01752855|471447909|FG001|Overall Study|Lack of Efficacy|2|||
130948758|NCT01478321|471447910|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
130948759|NCT01478321|471447910|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
130948760|NCT01478321|471447910|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
130948761|NCT01478321|471447910|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
130948762|NCT01478321|471447910|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
130948763|NCT01478321|471447910|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
130948764|NCT01478321|471447910|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
130948765|NCT01478321|471447910|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
130948766|NCT00634088|471447913|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
130948767|NCT00634088|471447914|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
130948768|NCT00634088|471447915|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
130948769|NCT00634088|471447916|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
130948770|NCT00634088|471447913|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
130948771|NCT00634088|471447914|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
130948772|NCT00634088|471447915|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
130948773|NCT00634088|471447916|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
130948774|NCT00634088|471447913|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
130948775|NCT00634088|471447914|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
130948776|NCT00634088|471447915|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
130948777|NCT00634088|471447916|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
130948778|NCT00634088|471447913|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
130948779|NCT00634088|471447914|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
130948780|NCT00634088|471447915|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
130948781|NCT00634088|471447916|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
130948782|NCT00634088|471447913|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
130948783|NCT00634088|471447914|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
130948784|NCT00634088|471447915|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
130948785|NCT00634088|471447916|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
130948786|NCT00634088|471447913|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
130948787|NCT00634088|471447914|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
130948788|NCT00634088|471447915|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
130948789|NCT00634088|471447916|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
130948790|NCT01203072|471447919|FG000|Overall Study|Adverse Event|5|||
130948791|NCT01203072|471447920|FG001|Overall Study|Adverse Event|3|||
130948792|NCT01203072|471447921|FG002|Overall Study|Adverse Event|2|||
130948793|NCT01203072|471447922|FG003|Overall Study|Adverse Event|4|||
130948794|NCT01203072|471447923|FG004|Overall Study|Adverse Event|2|||
130948795|NCT01203072|471447919|FG000|Overall Study|Lack of Efficacy|1|||
130948796|NCT01203072|471447920|FG001|Overall Study|Lack of Efficacy|0|||
130948797|NCT01203072|471447921|FG002|Overall Study|Lack of Efficacy|0|||
130948798|NCT01203072|471447922|FG003|Overall Study|Lack of Efficacy|0|||
130948799|NCT01203072|471447923|FG004|Overall Study|Lack of Efficacy|0|||
130948800|NCT01203072|471447919|FG000|Overall Study|Lost to Follow-up|0|||
130948801|NCT01203072|471447920|FG001|Overall Study|Lost to Follow-up|1|||
130948802|NCT01203072|471447921|FG002|Overall Study|Lost to Follow-up|0|||
130948803|NCT01203072|471447922|FG003|Overall Study|Lost to Follow-up|0|||
130948804|NCT01203072|471447923|FG004|Overall Study|Lost to Follow-up|0|||
130948805|NCT01203072|471447919|FG000|Overall Study|Protocol Violation|2|||
130948806|NCT01203072|471447920|FG001|Overall Study|Protocol Violation|0|||
130948807|NCT01203072|471447921|FG002|Overall Study|Protocol Violation|0|||
130948808|NCT01203072|471447922|FG003|Overall Study|Protocol Violation|0|||
130948809|NCT01203072|471447923|FG004|Overall Study|Protocol Violation|1|||
130948810|NCT01203072|471447919|FG000|Overall Study|Withdrawal by Subject|2|||
130948811|NCT01203072|471447920|FG001|Overall Study|Withdrawal by Subject|2|||
130948812|NCT01203072|471447921|FG002|Overall Study|Withdrawal by Subject|1|||
130948813|NCT01203072|471447922|FG003|Overall Study|Withdrawal by Subject|2|||
130948814|NCT01203072|471447923|FG004|Overall Study|Withdrawal by Subject|3|||
130948815|NCT04327999|471447931|FG000|Overall Study|Protocol Violation|1|||
130948816|NCT03735667|471447932|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
130948817|NCT03735667|471447933|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
130948818|NCT03735667|471447934|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
130948819|NCT03735667|471447932|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
130948820|NCT03735667|471447933|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
130948821|NCT03735667|471447934|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
130948822|NCT03735667|471447932|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
130948823|NCT03735667|471447933|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
130948824|NCT03735667|471447934|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
130948825|NCT03735667|471447932|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
130948826|NCT03735667|471447933|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
130948827|NCT03735667|471447934|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
130948828|NCT03735667|471447932|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
130948829|NCT03735667|471447933|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
130948830|NCT03735667|471447934|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
130948831|NCT03735667|471447932|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
130948832|NCT03735667|471447933|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
130948833|NCT03735667|471447934|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
130948834|NCT03735667|471447932|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
130948835|NCT03735667|471447933|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
131038008|NCT04032704|471772836|FG005|Part B|Other|0|||
131038009|NCT04032704|471772837|FG006|Part B|Other|0|||
130948836|NCT03735667|471447934|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
130948837|NCT03735667|471447932|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
130948838|NCT03735667|471447933|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
130948839|NCT03735667|471447934|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
130948840|NCT03735667|471447932|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
130948841|NCT03735667|471447933|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
130948842|NCT03735667|471447934|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
130948843|NCT03735667|471447932|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
130948844|NCT03735667|471447933|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
130948845|NCT03735667|471447934|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
130948846|NCT03735667|471447932|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
130948847|NCT03735667|471447933|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
130948848|NCT03735667|471447934|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
130948849|NCT03735667|471447932|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
130948850|NCT03735667|471447933|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
130948851|NCT03735667|471447934|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
130948852|NCT03792672|471447935|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
130948853|NCT03792672|471447936|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
130948854|NCT03792672|471447937|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
130948855|NCT03792672|471447938|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
130948856|NCT03792672|471447939|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
130948857|NCT03792672|471447940|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
130948858|NCT03792672|471447935|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
130948859|NCT03792672|471447936|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
130948860|NCT03792672|471447937|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
130948861|NCT03792672|471447938|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
130948862|NCT03792672|471447939|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
130948863|NCT03792672|471447940|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
130948864|NCT03792672|471447935|FG000|Treatment Period 4 (2 Days)|Other|1|||
130948865|NCT03792672|471447936|FG001|Treatment Period 4 (2 Days)|Other|0|||
130948866|NCT03792672|471447937|FG002|Treatment Period 4 (2 Days)|Other|0|||
130948867|NCT03792672|471447938|FG003|Treatment Period 4 (2 Days)|Other|0|||
130948868|NCT03792672|471447939|FG004|Treatment Period 4 (2 Days)|Other|0|||
130948869|NCT03792672|471447940|FG005|Treatment Period 4 (2 Days)|Other|0|||
130948870|NCT00006478|471447942|FG000|Overall Study|Vaccine could not be produced|1|||
130948871|NCT00006478|471447942|FG000|Overall Study|Physician Decision|6|||
130948872|NCT05389657|471447949|FG000|Overall Study|Lost to Follow-up|7|||
130948873|NCT05389657|471447950|FG001|Overall Study|Lost to Follow-up|8|||
130948874|NCT01907828|471447951|FG000|Overall Study|Exclusion criteria not met|0|||
130948875|NCT01907828|471447952|FG001|Overall Study|Exclusion criteria not met|1|||
130948876|NCT01907828|471447951|FG000|Overall Study|Withdrawal by Subject|3|||
130948877|NCT01907828|471447952|FG001|Overall Study|Withdrawal by Subject|4|||
130948878|NCT01907828|471447951|FG000|Overall Study|Lost to Follow-up|3|||
130948879|NCT01907828|471447952|FG001|Overall Study|Lost to Follow-up|0|||
130948880|NCT01907828|471447951|FG000|Overall Study|Participant refused 24-month follow-up|1|||
130948881|NCT01907828|471447952|FG001|Overall Study|Participant refused 24-month follow-up|0|||
130948882|NCT01907828|471447951|FG000|Overall Study|Participant met exclusion criteria|0|||
130948883|NCT01907828|471447952|FG001|Overall Study|Participant met exclusion criteria|1|||
130948884|NCT01073865|471447958|FG000|Overall Study|Reasons other than below|19|||
130948885|NCT01073865|471447959|FG001|Overall Study|Reasons other than below|31|||
130948886|NCT01073865|471447958|FG000|Overall Study|Lost to Follow-up|1|||
130948887|NCT01073865|471447959|FG001|Overall Study|Lost to Follow-up|1|||
130948888|NCT01073865|471447958|FG000|Overall Study|Death|3|||
130948889|NCT01073865|471447959|FG001|Overall Study|Death|2|||
130948890|NCT01073865|471447958|FG000|Overall Study|Withdrawal by Subject|5|||
130948891|NCT01073865|471447959|FG001|Overall Study|Withdrawal by Subject|5|||
130948892|NCT02547129|471447960|FG000|Overall Study|Difficulty with ongoing infection|1|||
130948893|NCT02547129|471447961|FG001|Overall Study|Difficulty with ongoing infection|0|||
130948894|NCT00805766|471447962|FG000|Screening Period|Adverse Event|1|||
130948895|NCT00805766|471447962|FG000|Screening Period|Lack of Efficacy|2|||
130948896|NCT00805766|471447962|FG000|Screening Period|Pregnancy|1|||
131124741|NCT01476475|472085849|FG001|Overall Study|Other reasons|2|||
130948897|NCT00805766|471447962|FG000|Screening Period|Responder|2|||
130948898|NCT00805766|471447962|FG000|Increased Dose Period|Adverse Event|4|||
130948899|NCT00805766|471447962|FG000|Increased Dose Period|Lack of Efficacy|7|||
130948900|NCT00805766|471447962|FG000|Increased Dose Period|Pregnancy|1|||
130948901|NCT00805766|471447962|FG000|Increased Dose Period|Withdrawal by Subject|1|||
130948902|NCT02063737|471447968|FG000|Overall Study|Lost to Follow-up|11|||
130948903|NCT02063737|471447969|FG001|Overall Study|Lost to Follow-up|4|||
130948904|NCT02159521|471447970|FG000|Overall Study|Enrolled but not treated|3|||
130948905|NCT02159521|471447970|FG000|Overall Study|Withdrawal by Subject|7|||
130948906|NCT02159521|471447970|FG000|Overall Study|Lost to Follow-up|6|||
130948907|NCT02159521|471447970|FG000|Overall Study|Death|1|||
130948908|NCT02159521|471447970|FG000|Overall Study|Other than specified|1|||
131038010|NCT04032704|471772838|FG007|Part B|Other|1|||
131038011|NCT04032704|471772839|FG008|Part B|Other|2|||
131038012|NCT04032704|471772840|FG009|Part B|Other|1|||
131038013|NCT04032704|471772841|FG010|Part B|Other|1|||
131038014|NCT04032704|471772842|FG011|Part B|Other|1|||
131038015|NCT04032704|471772843|FG012|Part B|Other|5|||
131038016|NCT04032704|471772844|FG013|Part B|Other|13|||
131038017|NCT04032704|471772845|FG014|Part B|Other|0|||
131038018|NCT04032704|471772846|FG015|Part B|Other|0|||
131038019|NCT04032704|471772847|FG016|Part B|Other|0|||
131038020|NCT04032704|471772848|FG017|Part B|Other|0|||
131038021|NCT04032704|471772831|FG000|Part B|Study termination by Sponsor|0|||
131038022|NCT04032704|471772832|FG001|Part B|Study termination by Sponsor|0|||
131038023|NCT04032704|471772833|FG002|Part B|Study termination by Sponsor|0|||
131038024|NCT04032704|471772834|FG003|Part B|Study termination by Sponsor|0|||
131038025|NCT04032704|471772835|FG004|Part B|Study termination by Sponsor|0|||
131038026|NCT04032704|471772836|FG005|Part B|Study termination by Sponsor|0|||
131038027|NCT04032704|471772837|FG006|Part B|Study termination by Sponsor|0|||
131038028|NCT04032704|471772838|FG007|Part B|Study termination by Sponsor|0|||
131038029|NCT04032704|471772839|FG008|Part B|Study termination by Sponsor|1|||
131038030|NCT04032704|471772840|FG009|Part B|Study termination by Sponsor|0|||
131038031|NCT04032704|471772841|FG010|Part B|Study termination by Sponsor|0|||
131038032|NCT04032704|471772842|FG011|Part B|Study termination by Sponsor|0|||
131038033|NCT04032704|471772843|FG012|Part B|Study termination by Sponsor|0|||
131038034|NCT04032704|471772844|FG013|Part B|Study termination by Sponsor|0|||
131038035|NCT04032704|471772845|FG014|Part B|Study termination by Sponsor|0|||
131038036|NCT04032704|471772846|FG015|Part B|Study termination by Sponsor|0|||
131038037|NCT04032704|471772847|FG016|Part B|Study termination by Sponsor|0|||
131038038|NCT04032704|471772848|FG017|Part B|Study termination by Sponsor|0|||
131038039|NCT04032704|471772831|FG000|Part B|Withdrawal by Subject|0|||
131038040|NCT04032704|471772832|FG001|Part B|Withdrawal by Subject|0|||
131038041|NCT04032704|471772833|FG002|Part B|Withdrawal by Subject|0|||
131038042|NCT04032704|471772834|FG003|Part B|Withdrawal by Subject|0|||
130948909|NCT00694369|471447973|FG000|Overall Study|Adverse Event|0|||
130948910|NCT00694369|471447974|FG001|Overall Study|Adverse Event|1|||
130948911|NCT00694369|471447975|FG002|Overall Study|Adverse Event|0|||
130948912|NCT00694369|471447976|FG003|Overall Study|Adverse Event|1|||
130948913|NCT00694369|471447977|FG004|Overall Study|Adverse Event|3|||
130948914|NCT00694369|471447973|FG000|Overall Study|Lost to Follow-up|0|||
130948915|NCT00694369|471447974|FG001|Overall Study|Lost to Follow-up|0|||
130948916|NCT00694369|471447975|FG002|Overall Study|Lost to Follow-up|1|||
130948917|NCT00694369|471447976|FG003|Overall Study|Lost to Follow-up|1|||
130948918|NCT00694369|471447977|FG004|Overall Study|Lost to Follow-up|0|||
130948919|NCT00694369|471447973|FG000|Overall Study|Physician Decision|0|||
130948920|NCT00694369|471447974|FG001|Overall Study|Physician Decision|0|||
130948921|NCT00694369|471447975|FG002|Overall Study|Physician Decision|0|||
130948922|NCT00694369|471447976|FG003|Overall Study|Physician Decision|0|||
131038043|NCT04032704|471772835|FG004|Part B|Withdrawal by Subject|0|||
131038044|NCT04032704|471772836|FG005|Part B|Withdrawal by Subject|0|||
131038045|NCT04032704|471772837|FG006|Part B|Withdrawal by Subject|3|||
131038046|NCT04032704|471772838|FG007|Part B|Withdrawal by Subject|2|||
131038047|NCT04032704|471772839|FG008|Part B|Withdrawal by Subject|2|||
131038048|NCT04032704|471772840|FG009|Part B|Withdrawal by Subject|1|||
131038049|NCT04032704|471772841|FG010|Part B|Withdrawal by Subject|4|||
131038050|NCT04032704|471772842|FG011|Part B|Withdrawal by Subject|6|||
131038051|NCT04032704|471772843|FG012|Part B|Withdrawal by Subject|2|||
131038052|NCT04032704|471772844|FG013|Part B|Withdrawal by Subject|1|||
131038053|NCT04032704|471772845|FG014|Part B|Withdrawal by Subject|0|||
131038054|NCT04032704|471772846|FG015|Part B|Withdrawal by Subject|1|||
131038055|NCT04032704|471772847|FG016|Part B|Withdrawal by Subject|0|||
131038056|NCT04032704|471772848|FG017|Part B|Withdrawal by Subject|0|||
131038057|NCT04032704|471772831|FG000|Part B|Lost to Follow-up|0|||
131038058|NCT04032704|471772832|FG001|Part B|Lost to Follow-up|0|||
131038059|NCT04032704|471772833|FG002|Part B|Lost to Follow-up|0|||
131038060|NCT04032704|471772834|FG003|Part B|Lost to Follow-up|0|||
131038061|NCT04032704|471772835|FG004|Part B|Lost to Follow-up|0|||
131038062|NCT04032704|471772836|FG005|Part B|Lost to Follow-up|0|||
131038063|NCT04032704|471772837|FG006|Part B|Lost to Follow-up|0|||
130948923|NCT00694369|471447977|FG004|Overall Study|Physician Decision|1|||
130948924|NCT00694369|471447973|FG000|Overall Study|Protocol Violation|0|||
130948925|NCT00694369|471447974|FG001|Overall Study|Protocol Violation|1|||
130948926|NCT00694369|471447975|FG002|Overall Study|Protocol Violation|0|||
131038064|NCT04032704|471772838|FG007|Part B|Lost to Follow-up|0|||
130948927|NCT00694369|471447976|FG003|Overall Study|Protocol Violation|0|||
130948928|NCT00694369|471447977|FG004|Overall Study|Protocol Violation|0|||
130948929|NCT00694369|471447973|FG000|Overall Study|Withdrawal by Subject|1|||
131038065|NCT04032704|471772839|FG008|Part B|Lost to Follow-up|0|||
131038066|NCT04032704|471772840|FG009|Part B|Lost to Follow-up|0|||
131038067|NCT04032704|471772841|FG010|Part B|Lost to Follow-up|0|||
131038068|NCT04032704|471772842|FG011|Part B|Lost to Follow-up|1|||
131038069|NCT04032704|471772843|FG012|Part B|Lost to Follow-up|0|||
131038070|NCT04032704|471772844|FG013|Part B|Lost to Follow-up|0|||
131038071|NCT04032704|471772845|FG014|Part B|Lost to Follow-up|0|||
130948930|NCT00694369|471447974|FG001|Overall Study|Withdrawal by Subject|1|||
130948931|NCT00694369|471447975|FG002|Overall Study|Withdrawal by Subject|1|||
130948932|NCT00694369|471447976|FG003|Overall Study|Withdrawal by Subject|1|||
130948933|NCT00694369|471447977|FG004|Overall Study|Withdrawal by Subject|2|||
130948934|NCT00775437|471447982|FG000|Overall Study|Loss of efficacy|2|||
130948935|NCT00775437|471447982|FG000|Overall Study|Withdrawal by Subject|3|||
130948936|NCT00775437|471447982|FG000|Overall Study|Lost to Follow-up|1|||
130948937|NCT00746941|471447985|FG000|Overall Study|Death|2|||
130948938|NCT00746941|471447986|FG001|Overall Study|Death|0|||
130948939|NCT00746941|471447987|FG002|Overall Study|Death|0|||
130948940|NCT00746941|471447988|FG003|Overall Study|Death|6|||
130948941|NCT00746941|471447985|FG000|Overall Study|Physician Decision|0|||
130948942|NCT00746941|471447986|FG001|Overall Study|Physician Decision|0|||
130948943|NCT00746941|471447987|FG002|Overall Study|Physician Decision|2|||
130948944|NCT00746941|471447988|FG003|Overall Study|Physician Decision|0|||
130948945|NCT00746941|471447985|FG000|Overall Study|Withdrawal by Subject|3|||
130948946|NCT00746941|471447986|FG001|Overall Study|Withdrawal by Subject|0|||
130948947|NCT00746941|471447987|FG002|Overall Study|Withdrawal by Subject|0|||
130948948|NCT00746941|471447988|FG003|Overall Study|Withdrawal by Subject|2|||
130948949|NCT00746941|471447985|FG000|Overall Study|Other, reason not provided|2|||
130948950|NCT00746941|471447986|FG001|Overall Study|Other, reason not provided|4|||
130948951|NCT00746941|471447987|FG002|Overall Study|Other, reason not provided|0|||
130948952|NCT00746941|471447988|FG003|Overall Study|Other, reason not provided|4|||
130948953|NCT00746941|471447985|FG000|Overall Study|Adverse Event|0|||
130948954|NCT00746941|471447986|FG001|Overall Study|Adverse Event|0|||
130948955|NCT00746941|471447987|FG002|Overall Study|Adverse Event|0|||
130948956|NCT00746941|471447988|FG003|Overall Study|Adverse Event|1|||
130948957|NCT00680901|471447991|FG000|Overall Study|Ongoing: On Study Treatment|1|||
130948958|NCT00680901|471447992|FG001|Overall Study|Ongoing: On Study Treatment|0|||
130948959|NCT00680901|471447991|FG000|Overall Study|Ongoing: In Follow Up|1|||
130948960|NCT00680901|471447992|FG001|Overall Study|Ongoing: In Follow Up|0|||
130948961|NCT00680901|471447991|FG000|Overall Study|Adverse Event|1|||
130948962|NCT00680901|471447992|FG001|Overall Study|Adverse Event|1|||
130948963|NCT00680901|471447991|FG000|Overall Study|Lost to Follow-up|3|||
130948964|NCT00680901|471447992|FG001|Overall Study|Lost to Follow-up|5|||
130948965|NCT00680901|471447991|FG000|Overall Study|Subject decided to withdraw from the study|4|||
130948966|NCT00680901|471447992|FG001|Overall Study|Subject decided to withdraw from the study|15|||
130948967|NCT00680901|471447991|FG000|Overall Study|Sponsor decision|1|||
130948968|NCT00680901|471447992|FG001|Overall Study|Sponsor decision|0|||
130948969|NCT00680901|471447991|FG000|Overall Study|Physician Decision|0|||
130948970|NCT00680901|471447992|FG001|Overall Study|Physician Decision|2|||
130948971|NCT00680901|471447991|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
130948972|NCT00680901|471447992|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
130948973|NCT00680901|471447991|FG000|Overall Study|Other protocol defined stopping criteria|17|||
130948974|NCT00680901|471447992|FG001|Overall Study|Other protocol defined stopping criteria|17|||
130948975|NCT04809220|471447995|FG000|Overall Study|Adverse Event|4|||
130948976|NCT04809220|471447996|FG001|Overall Study|Adverse Event|0|||
130948977|NCT04809220|471447995|FG000|Overall Study|Death|1|||
130948978|NCT04809220|471447996|FG001|Overall Study|Death|0|||
130948979|NCT04809220|471447995|FG000|Overall Study|Lost to Follow-up|3|||
130948980|NCT04809220|471447996|FG001|Overall Study|Lost to Follow-up|0|||
130948981|NCT04809220|471447995|FG000|Overall Study|Physician Decision|0|||
130948982|NCT04809220|471447996|FG001|Overall Study|Physician Decision|1|||
130948983|NCT04809220|471447995|FG000|Overall Study|Withdrawal by Subject|9|||
130948984|NCT04809220|471447996|FG001|Overall Study|Withdrawal by Subject|5|||
130948985|NCT04809220|471447995|FG000|Overall Study|Due to long-term overseas business trips|1|||
130948986|NCT04809220|471447996|FG001|Overall Study|Due to long-term overseas business trips|0|||
130948987|NCT01062555|471448002|FG000|Phase 1|Death|10|||
130948988|NCT01062555|471448003|FG001|Phase 1|Death|17|||
130948989|NCT01062555|471448004|FG002|Phase 1|Death|0|||
130948990|NCT01062555|471448005|FG003|Phase 1|Death|0|||
130948991|NCT01062555|471448002|FG000|Phase 1|Graft Failure|12|||
130948992|NCT01062555|471448003|FG001|Phase 1|Graft Failure|8|||
130948993|NCT01062555|471448004|FG002|Phase 1|Graft Failure|0|||
130948994|NCT01062555|471448005|FG003|Phase 1|Graft Failure|0|||
130948995|NCT01062555|471448002|FG000|Phase 1|Withdrawal by Subject|1|||
130948996|NCT01062555|471448003|FG001|Phase 1|Withdrawal by Subject|1|||
130948997|NCT01062555|471448004|FG002|Phase 1|Withdrawal by Subject|0|||
130948998|NCT01062555|471448005|FG003|Phase 1|Withdrawal by Subject|0|||
130948999|NCT01062555|471448002|FG000|Phase 2|Death|0|||
130949000|NCT01062555|471448003|FG001|Phase 2|Death|0|||
130949001|NCT01062555|471448004|FG002|Phase 2|Death|8|||
130949002|NCT01062555|471448005|FG003|Phase 2|Death|3|||
130949003|NCT01062555|471448002|FG000|Phase 2|Graft failure|0|||
130949004|NCT01062555|471448003|FG001|Phase 2|Graft failure|0|||
130949005|NCT01062555|471448004|FG002|Phase 2|Graft failure|7|||
130949006|NCT01062555|471448005|FG003|Phase 2|Graft failure|4|||
130949007|NCT01062555|471448002|FG000|Phase 2|Withdrawal by Subject|0|||
130949008|NCT01062555|471448003|FG001|Phase 2|Withdrawal by Subject|0|||
130949009|NCT01062555|471448004|FG002|Phase 2|Withdrawal by Subject|0|||
130949010|NCT01062555|471448005|FG003|Phase 2|Withdrawal by Subject|7|||
130949011|NCT01062555|471448002|FG000|Phase 2|Protocol Violation|0|||
130949012|NCT01062555|471448003|FG001|Phase 2|Protocol Violation|0|||
130949013|NCT01062555|471448004|FG002|Phase 2|Protocol Violation|0|||
130949014|NCT01062555|471448005|FG003|Phase 2|Protocol Violation|3|||
130949015|NCT01062555|471448002|FG000|Phase 2|Physician Decision|0|||
130949016|NCT01062555|471448003|FG001|Phase 2|Physician Decision|0|||
130949017|NCT01062555|471448004|FG002|Phase 2|Physician Decision|0|||
130949018|NCT01062555|471448005|FG003|Phase 2|Physician Decision|17|||
130949019|NCT00329407|471448008|FG000|Overall Study|Withdrawal by Subject|1|||
130949020|NCT00978068|471448009|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
130949021|NCT00978068|471448010|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
130949022|NCT00978068|471448009|FG000|Overall Study|Death|1|||
130949023|NCT00978068|471448010|FG001|Overall Study|Death|2|||
130949024|NCT00978068|471448009|FG000|Overall Study|Lost to Follow-up|1|||
130949025|NCT00978068|471448010|FG001|Overall Study|Lost to Follow-up|2|||
130949026|NCT00978068|471448009|FG000|Overall Study|Physician Decision|0|||
130949027|NCT00978068|471448010|FG001|Overall Study|Physician Decision|1|||
130949028|NCT00978068|471448009|FG000|Overall Study|Unable to Comply with Study|0|||
130949029|NCT00978068|471448010|FG001|Overall Study|Unable to Comply with Study|2|||
130949030|NCT03560531|471448011|FG000|Overall Study|Death|4|||
130949031|NCT03560531|471448012|FG001|Overall Study|Death|1|||
130949032|NCT03560531|471448013|FG002|Overall Study|Death|1|||
130949033|NCT03560531|471448014|FG003|Overall Study|Death|2|||
130949034|NCT03560531|471448015|FG004|Overall Study|Death|6|||
130949035|NCT03560531|471448016|FG005|Overall Study|Death|1|||
130949036|NCT03560531|471448017|FG006|Overall Study|Death|4|||
130949037|NCT03560531|471448018|FG007|Overall Study|Death|8|||
130949038|NCT03560531|471448019|FG008|Overall Study|Death|1|||
130949039|NCT03560531|471448020|FG009|Overall Study|Death|3|||
130949040|NCT03560531|471448021|FG010|Overall Study|Death|2|||
130949041|NCT03560531|471448022|FG011|Overall Study|Death|0|||
130949042|NCT03560531|471448023|FG012|Overall Study|Death|4|||
130949043|NCT03560531|471448024|FG013|Overall Study|Death|1|||
130949044|NCT03560531|471448011|FG000|Overall Study|Lost to Follow-up|1|||
130949045|NCT03560531|471448012|FG001|Overall Study|Lost to Follow-up|1|||
130949046|NCT03560531|471448013|FG002|Overall Study|Lost to Follow-up|0|||
130949047|NCT03560531|471448014|FG003|Overall Study|Lost to Follow-up|0|||
130949048|NCT03560531|471448015|FG004|Overall Study|Lost to Follow-up|0|||
130949049|NCT03560531|471448016|FG005|Overall Study|Lost to Follow-up|0|||
130949050|NCT03560531|471448017|FG006|Overall Study|Lost to Follow-up|1|||
130949051|NCT03560531|471448018|FG007|Overall Study|Lost to Follow-up|0|||
130949052|NCT03560531|471448019|FG008|Overall Study|Lost to Follow-up|0|||
130949053|NCT03560531|471448020|FG009|Overall Study|Lost to Follow-up|0|||
130949054|NCT03560531|471448021|FG010|Overall Study|Lost to Follow-up|0|||
130949055|NCT03560531|471448022|FG011|Overall Study|Lost to Follow-up|0|||
130949056|NCT03560531|471448023|FG012|Overall Study|Lost to Follow-up|0|||
130949057|NCT03560531|471448024|FG013|Overall Study|Lost to Follow-up|0|||
130949058|NCT03560531|471448011|FG000|Overall Study|Withdrawal by Subject|1|||
130949059|NCT03560531|471448012|FG001|Overall Study|Withdrawal by Subject|0|||
130949060|NCT03560531|471448013|FG002|Overall Study|Withdrawal by Subject|0|||
130949061|NCT03560531|471448014|FG003|Overall Study|Withdrawal by Subject|0|||
130949062|NCT03560531|471448015|FG004|Overall Study|Withdrawal by Subject|0|||
130949063|NCT03560531|471448016|FG005|Overall Study|Withdrawal by Subject|0|||
130949064|NCT03560531|471448017|FG006|Overall Study|Withdrawal by Subject|0|||
130949065|NCT03560531|471448018|FG007|Overall Study|Withdrawal by Subject|3|||
130949066|NCT03560531|471448019|FG008|Overall Study|Withdrawal by Subject|2|||
130949067|NCT03560531|471448020|FG009|Overall Study|Withdrawal by Subject|0|||
130949068|NCT03560531|471448021|FG010|Overall Study|Withdrawal by Subject|0|||
130949069|NCT03560531|471448022|FG011|Overall Study|Withdrawal by Subject|0|||
130949070|NCT03560531|471448023|FG012|Overall Study|Withdrawal by Subject|2|||
130949071|NCT03560531|471448024|FG013|Overall Study|Withdrawal by Subject|0|||
130949072|NCT03560531|471448011|FG000|Overall Study|Study end per-protocol|1|||
130949073|NCT03560531|471448012|FG001|Overall Study|Study end per-protocol|1|||
130949074|NCT03560531|471448013|FG002|Overall Study|Study end per-protocol|2|||
130949075|NCT03560531|471448014|FG003|Overall Study|Study end per-protocol|0|||
131124742|NCT01278745|472085850|FG000|Overall Study|Death|2|||
131124743|NCT01278745|472085851|FG001|Overall Study|Death|5|||
130949076|NCT03560531|471448015|FG004|Overall Study|Study end per-protocol|1|||
130949077|NCT03560531|471448016|FG005|Overall Study|Study end per-protocol|0|||
130710764|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
130949078|NCT03560531|471448017|FG006|Overall Study|Study end per-protocol|0|||
130949079|NCT03560531|471448018|FG007|Overall Study|Study end per-protocol|0|||
130949080|NCT03560531|471448019|FG008|Overall Study|Study end per-protocol|0|||
130949081|NCT03560531|471448020|FG009|Overall Study|Study end per-protocol|0|||
130949082|NCT03560531|471448021|FG010|Overall Study|Study end per-protocol|0|||
130949083|NCT03560531|471448022|FG011|Overall Study|Study end per-protocol|0|||
130949084|NCT03560531|471448023|FG012|Overall Study|Study end per-protocol|0|||
130949085|NCT03560531|471448024|FG013|Overall Study|Study end per-protocol|0|||
131124744|NCT01278745|472085852|FG002|Overall Study|Death|7|||
131038072|NCT04032704|471772846|FG015|Part B|Lost to Follow-up|0|||
131038073|NCT04032704|471772847|FG016|Part B|Lost to Follow-up|0|||
131038074|NCT04032704|471772848|FG017|Part B|Lost to Follow-up|0|||
131038075|NCT04032704|471772831|FG000|Part B|Death|0|||
131038076|NCT04032704|471772832|FG001|Part B|Death|0|||
131038077|NCT04032704|471772833|FG002|Part B|Death|0|||
131038078|NCT04032704|471772834|FG003|Part B|Death|0|||
131038079|NCT04032704|471772835|FG004|Part B|Death|0|||
131038080|NCT04032704|471772836|FG005|Part B|Death|0|||
131038081|NCT04032704|471772837|FG006|Part B|Death|13|||
131038082|NCT04032704|471772838|FG007|Part B|Death|13|||
131038083|NCT04032704|471772839|FG008|Part B|Death|14|||
131038084|NCT04032704|471772840|FG009|Part B|Death|12|||
131038085|NCT04032704|471772841|FG010|Part B|Death|12|||
131038086|NCT04032704|471772842|FG011|Part B|Death|13|||
131038087|NCT04032704|471772843|FG012|Part B|Death|7|||
131038088|NCT04032704|471772844|FG013|Part B|Death|17|||
131038089|NCT04032704|471772845|FG014|Part B|Death|2|||
131038090|NCT04032704|471772846|FG015|Part B|Death|1|||
131038091|NCT04032704|471772847|FG016|Part B|Death|2|||
131038092|NCT04032704|471772848|FG017|Part B|Death|2|||
131038093|NCT02861300|471772849|FG000|Overall Study|Death|0|||
131038094|NCT02861300|471772850|FG001|Overall Study|Death|0|||
131038095|NCT02861300|471772851|FG002|Overall Study|Death|0|||
131038096|NCT02861300|471772852|FG003|Overall Study|Death|0|||
131038097|NCT02861300|471772853|FG004|Overall Study|Death|0|||
131038098|NCT02861300|471772854|FG005|Overall Study|Death|0|||
131038099|NCT02861300|471772855|FG006|Overall Study|Death|24|||
131038100|NCT02861300|471772849|FG000|Overall Study|Delay in treatment|0|||
131038101|NCT02861300|471772850|FG001|Overall Study|Delay in treatment|0|||
131038102|NCT02861300|471772851|FG002|Overall Study|Delay in treatment|0|||
131038103|NCT02861300|471772852|FG003|Overall Study|Delay in treatment|0|||
131038104|NCT02861300|471772853|FG004|Overall Study|Delay in treatment|0|||
131038105|NCT02861300|471772854|FG005|Overall Study|Delay in treatment|1|||
131038106|NCT02861300|471772855|FG006|Overall Study|Delay in treatment|0|||
131038107|NCT02861300|471772849|FG000|Overall Study|Disease Progression|0|||
131038108|NCT02861300|471772850|FG001|Overall Study|Disease Progression|1|||
131038109|NCT02861300|471772851|FG002|Overall Study|Disease Progression|0|||
131038110|NCT02861300|471772852|FG003|Overall Study|Disease Progression|0|||
131038111|NCT02861300|471772853|FG004|Overall Study|Disease Progression|0|||
131038112|NCT02861300|471772854|FG005|Overall Study|Disease Progression|0|||
131038113|NCT02861300|471772855|FG006|Overall Study|Disease Progression|2|||
131038114|NCT02861300|471772849|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
131038115|NCT02861300|471772850|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
131038116|NCT02861300|471772851|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
131038117|NCT02861300|471772852|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
131038118|NCT02861300|471772853|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
131038119|NCT02861300|471772854|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
131038120|NCT02861300|471772855|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
131038121|NCT02861300|471772849|FG000|Overall Study|Clinical Complications|0|||
131038122|NCT02861300|471772850|FG001|Overall Study|Clinical Complications|0|||
131038123|NCT02861300|471772851|FG002|Overall Study|Clinical Complications|0|||
131038124|NCT02861300|471772852|FG003|Overall Study|Clinical Complications|0|||
131038125|NCT02861300|471772853|FG004|Overall Study|Clinical Complications|0|||
131038126|NCT02861300|471772854|FG005|Overall Study|Clinical Complications|0|||
131038127|NCT02861300|471772855|FG006|Overall Study|Clinical Complications|1|||
131038128|NCT02465268|471772856|FG000|Overall Study|Withdrawal by Subject|4|||
131038129|NCT02465268|471772857|FG001|Overall Study|Withdrawal by Subject|3|||
131038130|NCT02465268|471772858|FG002|Overall Study|Withdrawal by Subject|1|||
131038131|NCT02465268|471772856|FG000|Overall Study|Not evaluable per protocol criteria|3|||
131038132|NCT02465268|471772857|FG001|Overall Study|Not evaluable per protocol criteria|2|||
131038133|NCT02465268|471772858|FG002|Overall Study|Not evaluable per protocol criteria|1|||
131038134|NCT02465268|471772856|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
131038135|NCT02465268|471772857|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
131038136|NCT02465268|471772858|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
131038137|NCT02465268|471772856|FG000|Overall Study|Study drug did not pass QA/QC|1|||
131038138|NCT02465268|471772857|FG001|Overall Study|Study drug did not pass QA/QC|0|||
131038139|NCT02465268|471772858|FG002|Overall Study|Study drug did not pass QA/QC|0|||
131038140|NCT02465268|471772856|FG000|Overall Study|Adverse Event|0|||
131038141|NCT02465268|471772857|FG001|Overall Study|Adverse Event|1|||
131038142|NCT02465268|471772858|FG002|Overall Study|Adverse Event|0|||
131038143|NCT02465268|471772856|FG000|Overall Study|Physician Decision|0|||
131038144|NCT02465268|471772857|FG001|Overall Study|Physician Decision|1|||
131038145|NCT02465268|471772858|FG002|Overall Study|Physician Decision|0|||
131038146|NCT03020199|471772859|FG000|Treatment Period|Adverse Event|0|||
131038147|NCT03020199|471772860|FG001|Treatment Period|Adverse Event|2|||
131038148|NCT03020199|471772859|FG000|Treatment Period|Lack of Efficacy|1|||
131038149|NCT03020199|471772860|FG001|Treatment Period|Lack of Efficacy|6|||
131038150|NCT03020199|471772859|FG000|Treatment Period|Lost to Follow-up|1|||
131038151|NCT03020199|471772860|FG001|Treatment Period|Lost to Follow-up|6|||
131038152|NCT03020199|471772859|FG000|Treatment Period|Physician Decision|0|||
131038153|NCT03020199|471772860|FG001|Treatment Period|Physician Decision|1|||
131038154|NCT03020199|471772859|FG000|Treatment Period|Subject/guardian decision|8|||
131038155|NCT03020199|471772860|FG001|Treatment Period|Subject/guardian decision|15|||
131038156|NCT03020199|471772859|FG000|Treatment Period|Subjects not treated|3|||
131038157|NCT03020199|471772860|FG001|Treatment Period|Subjects not treated|4|||
131038158|NCT03020199|471772859|FG000|Follow-up Period|Disease relapse|32|||
131038159|NCT03020199|471772860|FG001|Follow-up Period|Disease relapse|7|||
131038160|NCT03020199|471772859|FG000|Follow-up Period|Lack of Efficacy|1|||
131038161|NCT03020199|471772860|FG001|Follow-up Period|Lack of Efficacy|2|||
131038162|NCT03020199|471772859|FG000|Follow-up Period|Lost to Follow-up|4|||
131038163|NCT03020199|471772860|FG001|Follow-up Period|Lost to Follow-up|6|||
131038164|NCT03020199|471772859|FG000|Follow-up Period|Physician Decision|2|||
131038165|NCT03020199|471772860|FG001|Follow-up Period|Physician Decision|2|||
131038166|NCT03020199|471772859|FG000|Follow-up Period|Protocol Violation|1|||
131038167|NCT03020199|471772860|FG001|Follow-up Period|Protocol Violation|2|||
131038168|NCT03020199|471772859|FG000|Follow-up Period|Study terminated by Sponsor|6|||
131038169|NCT03020199|471772860|FG001|Follow-up Period|Study terminated by Sponsor|3|||
131038170|NCT03020199|471772859|FG000|Follow-up Period|Subject/guardian decision|14|||
131038171|NCT03020199|471772860|FG001|Follow-up Period|Subject/guardian decision|9|||
131038172|NCT05386030|471772863|FG000|Overall Study|Death|1|||
131038173|NCT05386030|471772864|FG001|Overall Study|Death|0|||
131038174|NCT05386030|471772863|FG000|Overall Study|Physician Decision|2|||
131038175|NCT05386030|471772864|FG001|Overall Study|Physician Decision|1|||
131038176|NCT05386030|471772863|FG000|Overall Study|Lost to Follow-up|19|||
131038177|NCT05386030|471772864|FG001|Overall Study|Lost to Follow-up|7|||
131038178|NCT05386030|471772863|FG000|Overall Study|Withdrawal by Subject|20|||
131038179|NCT05386030|471772864|FG001|Overall Study|Withdrawal by Subject|10|||
131038180|NCT05386030|471772863|FG000|Overall Study|Eligibility criteria violation|1|||
131038181|NCT05386030|471772864|FG001|Overall Study|Eligibility criteria violation|1|||
131038182|NCT05386030|471772863|FG000|Overall Study|Personal Reasons|1|||
131038183|NCT05386030|471772864|FG001|Overall Study|Personal Reasons|0|||
131038184|NCT04719832|471772865|FG000|Overall Study|Adverse Event|2|||
131038185|NCT04719832|471772866|FG001|Overall Study|Adverse Event|0|||
131038186|NCT04719832|471772865|FG000|Overall Study|Lack of Efficacy|2|||
131038187|NCT04719832|471772866|FG001|Overall Study|Lack of Efficacy|4|||
131038188|NCT04719832|471772865|FG000|Overall Study|Lost to Follow-up|0|||
131038189|NCT04719832|471772866|FG001|Overall Study|Lost to Follow-up|2|||
131038190|NCT04719832|471772865|FG000|Overall Study|Physician Decision|0|||
131038191|NCT04719832|471772866|FG001|Overall Study|Physician Decision|1|||
131038192|NCT04719832|471772865|FG000|Overall Study|Pregnancy|1|||
131038193|NCT04719832|471772866|FG001|Overall Study|Pregnancy|1|||
131038194|NCT04719832|471772865|FG000|Overall Study|Withdrawal by Subject|5|||
131038195|NCT04719832|471772866|FG001|Overall Study|Withdrawal by Subject|5|||
131038196|NCT04719832|471772865|FG000|Overall Study|Randomized, not treated|0|||
131038197|NCT04719832|471772866|FG001|Overall Study|Randomized, not treated|2|||
131038198|NCT04719832|471772865|FG000|Overall Study|GCP violations|4|||
131038199|NCT04719832|471772866|FG001|Overall Study|GCP violations|7|||
131038200|NCT05228457|471772867|FG000|Overall Study|Withdrawal by Subject|1|||
131038201|NCT05228457|471772868|FG001|Overall Study|Withdrawal by Subject|1|||
131038202|NCT04880863|471772871|FG000|Overall Study|Adverse Event|1|||
131038203|NCT04880863|471772871|FG000|Overall Study|Patient decision|2|||
131038204|NCT04880863|471772871|FG000|Overall Study|Confirmed Disease Progression|15|||
131038205|NCT04880863|471772871|FG000|Overall Study|Death|3|||
131038206|NCT04880863|471772871|FG000|Overall Study|Physician Decision|4|||
131038207|NCT04880863|471772871|FG000|Overall Study|Unconfirmed Disease Progression|4|||
131124745|NCT01278745|472085853|FG003|Overall Study|Death|0|||
131124746|NCT01278745|472085850|FG000|Overall Study|Physician Decision|1|||
131124747|NCT01278745|472085851|FG001|Overall Study|Physician Decision|0|||
131124748|NCT01278745|472085852|FG002|Overall Study|Physician Decision|0|||
131038208|NCT04880863|471772871|FG000|Overall Study|Withdrawal by Subject|2|||
131124749|NCT01278745|472085853|FG003|Overall Study|Physician Decision|9|||
131124750|NCT01278745|472085850|FG000|Overall Study|Withdrawal by Subject|1|||
131124751|NCT01278745|472085851|FG001|Overall Study|Withdrawal by Subject|1|||
131124752|NCT01278745|472085852|FG002|Overall Study|Withdrawal by Subject|5|||
131124753|NCT01278745|472085853|FG003|Overall Study|Withdrawal by Subject|1|||
131124754|NCT01278745|472085850|FG000|Overall Study|Sponsor Decision|1|||
131038209|NCT04880863|471772871|FG000|Overall Study|Study discontinuation by the sponsor|4|||
131038210|NCT04880863|471772871|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
131038211|NCT04880863|471772871|FG000|Overall Study|Not received study drug NAP|2|||
131038212|NCT03213691|471772874|FG000|Overall Study|Adverse Event|2|||
131038213|NCT03213691|471772874|FG000|Overall Study|Death|3|||
131038214|NCT03213691|471772874|FG000|Overall Study|Physician Decision|1|||
131038215|NCT03213691|471772874|FG000|Overall Study|Progressive Disease|14|||
131038216|NCT03213691|471772874|FG000|Overall Study|Ineligible|1|||
131038217|NCT04898673|471772875|FG000|Overall Study|Screenfail|1|||
131038218|NCT04898673|471772876|FG001|Overall Study|Screenfail|0|||
131038219|NCT01152450|471772881|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
131038220|NCT01152450|471772882|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
130949086|NCT03560531|471448011|FG000|Overall Study|Early study termination by sponsor|9|||
130949087|NCT03560531|471448012|FG001|Overall Study|Early study termination by sponsor|0|||
130949088|NCT03560531|471448013|FG002|Overall Study|Early study termination by sponsor|0|||
130949089|NCT03560531|471448014|FG003|Overall Study|Early study termination by sponsor|4|||
130949090|NCT03560531|471448015|FG004|Overall Study|Early study termination by sponsor|8|||
130949091|NCT03560531|471448016|FG005|Overall Study|Early study termination by sponsor|2|||
130949092|NCT03560531|471448017|FG006|Overall Study|Early study termination by sponsor|5|||
130949093|NCT03560531|471448018|FG007|Overall Study|Early study termination by sponsor|64|||
130949094|NCT03560531|471448019|FG008|Overall Study|Early study termination by sponsor|7|||
130949095|NCT03560531|471448020|FG009|Overall Study|Early study termination by sponsor|2|||
130949096|NCT03560531|471448021|FG010|Overall Study|Early study termination by sponsor|16|||
130949097|NCT03560531|471448022|FG011|Overall Study|Early study termination by sponsor|2|||
130949098|NCT03560531|471448023|FG012|Overall Study|Early study termination by sponsor|6|||
130949099|NCT03560531|471448024|FG013|Overall Study|Early study termination by sponsor|2|||
130949100|NCT01471379|471448025|FG000|Overall Study|Adverse Event|1|||
130949101|NCT01471379|471448026|FG001|Overall Study|Adverse Event|0|||
130949102|NCT01471379|471448027|FG002|Overall Study|Adverse Event|0|||
130949103|NCT01471379|471448025|FG000|Overall Study|Study terminated|0|||
130949104|NCT01471379|471448026|FG001|Overall Study|Study terminated|1|||
130949105|NCT01471379|471448027|FG002|Overall Study|Study terminated|0|||
130949106|NCT02120794|471448030|FG000|Overall Study|Withdrawal by Subject|43|||
130949107|NCT02120794|471448030|FG000|Overall Study|Adverse Event|10|||
130949108|NCT02120794|471448030|FG000|Overall Study|Physician Decision|4|||
130949109|NCT02120794|471448030|FG000|Overall Study|Due to insurance coverage|1|||
130949110|NCT00969553|471448031|FG000|Overall Study|Progressive disease (PD)|2|||
130949111|NCT00969553|471448032|FG001|Overall Study|Progressive disease (PD)|2|||
130949112|NCT00969553|471448033|FG002|Overall Study|Progressive disease (PD)|6|||
130949113|NCT00969553|471448034|FG003|Overall Study|Progressive disease (PD)|9|||
130949114|NCT00969553|471448035|FG004|Overall Study|Progressive disease (PD)|2|||
130949115|NCT00969553|471448036|FG005|Overall Study|Progressive disease (PD)|4|||
130949116|NCT00969553|471448037|FG006|Overall Study|Progressive disease (PD)|2|||
130949117|NCT00969553|471448038|FG007|Overall Study|Progressive disease (PD)|12|||
130949118|NCT00969553|471448039|FG008|Overall Study|Progressive disease (PD)|3|||
130949119|NCT00969553|471448031|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
130949120|NCT00969553|471448032|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
130949121|NCT00969553|471448033|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
130949122|NCT00969553|471448034|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
130949123|NCT00969553|471448035|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
130949124|NCT00969553|471448036|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
130949125|NCT00969553|471448037|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
130949126|NCT00969553|471448038|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
130949127|NCT00969553|471448039|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
130949128|NCT00969553|471448031|FG000|Overall Study|Other Adverse Event|0|||
130949129|NCT00969553|471448032|FG001|Overall Study|Other Adverse Event|0|||
130949130|NCT00969553|471448033|FG002|Overall Study|Other Adverse Event|0|||
130949131|NCT00969553|471448034|FG003|Overall Study|Other Adverse Event|1|||
130949132|NCT00969553|471448035|FG004|Overall Study|Other Adverse Event|0|||
130949133|NCT00969553|471448036|FG005|Overall Study|Other Adverse Event|0|||
130949134|NCT00969553|471448037|FG006|Overall Study|Other Adverse Event|1|||
130949135|NCT00969553|471448038|FG007|Overall Study|Other Adverse Event|0|||
130949136|NCT00969553|471448039|FG008|Overall Study|Other Adverse Event|0|||
130949137|NCT00969553|471448031|FG000|Overall Study|Refused cont. medication|1|||
130949138|NCT00969553|471448032|FG001|Overall Study|Refused cont. medication|1|||
130949139|NCT00969553|471448033|FG002|Overall Study|Refused cont. medication|0|||
130949140|NCT00969553|471448034|FG003|Overall Study|Refused cont. medication|2|||
130949141|NCT00969553|471448035|FG004|Overall Study|Refused cont. medication|0|||
130949142|NCT00969553|471448036|FG005|Overall Study|Refused cont. medication|0|||
130949143|NCT00969553|471448037|FG006|Overall Study|Refused cont. medication|0|||
130949144|NCT00969553|471448038|FG007|Overall Study|Refused cont. medication|1|||
130949145|NCT00969553|471448039|FG008|Overall Study|Refused cont. medication|0|||
130949146|NCT00969553|471448031|FG000|Overall Study|Not specified above|0|||
130949147|NCT00969553|471448032|FG001|Overall Study|Not specified above|0|||
130949148|NCT00969553|471448033|FG002|Overall Study|Not specified above|0|||
130949149|NCT00969553|471448034|FG003|Overall Study|Not specified above|4|||
131038221|NCT01152450|471772883|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
130949150|NCT00969553|471448035|FG004|Overall Study|Not specified above|0|||
131038222|NCT01152450|471772884|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
130949151|NCT00969553|471448036|FG005|Overall Study|Not specified above|0|||
130949152|NCT00969553|471448037|FG006|Overall Study|Not specified above|1|||
130949153|NCT00969553|471448038|FG007|Overall Study|Not specified above|1|||
130949154|NCT00969553|471448039|FG008|Overall Study|Not specified above|0|||
130949155|NCT04327986|471448041|FG000|Overall Study|Physician Decision|2|||
130949156|NCT04327986|471448042|FG001|Overall Study|Physician Decision|0|||
130949157|NCT04327986|471448043|FG002|Overall Study|Physician Decision|0|||
130949158|NCT04327986|471448041|FG000|Overall Study|Death|1|||
130949159|NCT04327986|471448042|FG001|Overall Study|Death|0|||
130949160|NCT04327986|471448043|FG002|Overall Study|Death|0|||
130949161|NCT04248816|471448044|FG000|Overall Study|Ineligible post-randomization|7|||
130949162|NCT04248816|471448045|FG001|Overall Study|Ineligible post-randomization|21|||
130949163|NCT04248816|471448046|FG002|Overall Study|Ineligible post-randomization|25|||
130949164|NCT00655564|471448047|FG000|Overall Study|Adverse Event|1|||
130949165|NCT00655564|471448047|FG000|Overall Study|Lost to Follow-up|1|||
130949166|NCT00655564|471448047|FG000|Overall Study|Desired Alternate Therapy|1|||
130949167|NCT02917031|471448052|FG000|Overall Study|Reason not specified|7|||
130949168|NCT02917031|471448053|FG001|Overall Study|Reason not specified|5|||
130949169|NCT02917031|471448054|FG002|Overall Study|Reason not specified|6|||
130949170|NCT02917031|471448052|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
130949171|NCT02917031|471448053|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
130949172|NCT02917031|471448054|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
130949173|NCT02917031|471448052|FG000|Overall Study|Withdrawal by Subject|3|||
130949174|NCT02917031|471448053|FG001|Overall Study|Withdrawal by Subject|3|||
130949175|NCT02917031|471448054|FG002|Overall Study|Withdrawal by Subject|0|||
130949176|NCT02917031|471448052|FG000|Overall Study|Physician Decision|1|||
130949177|NCT02917031|471448053|FG001|Overall Study|Physician Decision|0|||
130949178|NCT02917031|471448054|FG002|Overall Study|Physician Decision|0|||
130949179|NCT02917031|471448052|FG000|Overall Study|Adverse Event|4|||
130949180|NCT02917031|471448053|FG001|Overall Study|Adverse Event|1|||
130949181|NCT02917031|471448054|FG002|Overall Study|Adverse Event|5|||
130949182|NCT02917031|471448052|FG000|Overall Study|Death|2|||
130949183|NCT02917031|471448053|FG001|Overall Study|Death|3|||
130949184|NCT02917031|471448054|FG002|Overall Study|Death|4|||
130949185|NCT00427635|471449671|FG000|Treatment Phase|Withdrawal by Subject|1|||
130949186|NCT00427635|471449672|FG001|Treatment Phase|Withdrawal by Subject|0|||
130949187|NCT00427635|471449671|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
130949188|NCT00427635|471449672|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
131124755|NCT01278745|472085851|FG001|Overall Study|Sponsor Decision|0|||
131124756|NCT01278745|472085852|FG002|Overall Study|Sponsor Decision|62|||
131124757|NCT01278745|472085853|FG003|Overall Study|Sponsor Decision|6|||
131124758|NCT01278745|472085850|FG000|Overall Study|Ineligible|0|||
131124759|NCT01278745|472085851|FG001|Overall Study|Ineligible|0|||
131124760|NCT01278745|472085852|FG002|Overall Study|Ineligible|42|||
131124761|NCT01278745|472085853|FG003|Overall Study|Ineligible|61|||
131124762|NCT01278745|472085850|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
131124763|NCT01278745|472085851|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
131124764|NCT01278745|472085852|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
131124765|NCT01278745|472085853|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
131124766|NCT01843842|472085854|FG000|Overall Study|Do not meet inclusion criteria|1|||
131124767|NCT01843842|472085855|FG001|Overall Study|Do not meet inclusion criteria|1|||
131124768|NCT03374189|472085858|FG000|Overall Study|Lost to Follow-up|1|||
131124769|NCT03374189|472085859|FG001|Overall Study|Lost to Follow-up|0|||
131124770|NCT02375724|472085860|FG000|Overall Study|Lack of Efficacy|1|||
131124771|NCT02375724|472085861|FG001|Overall Study|Lack of Efficacy|1|||
131124772|NCT02375724|472085860|FG000|Overall Study|Withdrawal by Subject|1|||
131124773|NCT02375724|472085861|FG001|Overall Study|Withdrawal by Subject|1|||
130949209|NCT03711162|471449677|FG000|Overall Study|Adverse Event|5|||
130949210|NCT03711162|471449678|FG001|Overall Study|Adverse Event|2|||
130949211|NCT03711162|471449679|FG002|Overall Study|Adverse Event|4|||
130949212|NCT03711162|471449677|FG000|Overall Study|Death|11|||
130949213|NCT03711162|471449678|FG001|Overall Study|Death|7|||
130949214|NCT03711162|471449679|FG002|Overall Study|Death|8|||
130949215|NCT03711162|471449677|FG000|Overall Study|Lost to Follow-up|1|||
130949216|NCT03711162|471449678|FG001|Overall Study|Lost to Follow-up|0|||
130949217|NCT03711162|471449679|FG002|Overall Study|Lost to Follow-up|1|||
130949218|NCT03711162|471449677|FG000|Overall Study|Study Terminated by Sponsor|139|||
130949219|NCT03711162|471449678|FG001|Overall Study|Study Terminated by Sponsor|152|||
130949220|NCT03711162|471449679|FG002|Overall Study|Study Terminated by Sponsor|146|||
130949221|NCT03711162|471449677|FG000|Overall Study|Withdrawal by Subject|17|||
130949222|NCT03711162|471449678|FG001|Overall Study|Withdrawal by Subject|10|||
130949223|NCT03711162|471449679|FG002|Overall Study|Withdrawal by Subject|10|||
130949224|NCT03711162|471449677|FG000|Overall Study|Miscellaneous|1|||
130949225|NCT03711162|471449678|FG001|Overall Study|Miscellaneous|2|||
130949226|NCT03711162|471449679|FG002|Overall Study|Miscellaneous|2|||
130949227|NCT03711162|471449677|FG000|Overall Study|Not Treated|1|||
130949228|NCT03711162|471449678|FG001|Overall Study|Not Treated|0|||
130949229|NCT03711162|471449679|FG002|Overall Study|Not Treated|1|||
130949230|NCT03711162|471449677|FG000|Overall Study|Physician Decision|0|||
130949231|NCT03711162|471449678|FG001|Overall Study|Physician Decision|2|||
130949232|NCT03711162|471449679|FG002|Overall Study|Physician Decision|0|||
130949233|NCT03711162|471449677|FG000|Overall Study|Lack of Efficacy|0|||
130949234|NCT03711162|471449678|FG001|Overall Study|Lack of Efficacy|0|||
130949235|NCT03711162|471449679|FG002|Overall Study|Lack of Efficacy|2|||
130949236|NCT03711162|471449677|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
130949237|NCT03711162|471449678|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
130949238|NCT03711162|471449679|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
130949239|NCT00136084|471449682|FG000|Overall Study|Death|12|||
130949240|NCT00136084|471449683|FG001|Overall Study|Death|5|||
130949241|NCT00136084|471449682|FG000|Overall Study|Unacceptable toxicity|8|||
130949242|NCT00136084|471449683|FG001|Overall Study|Unacceptable toxicity|11|||
130949243|NCT00136084|471449682|FG000|Overall Study|Relapse|20|||
130949244|NCT00136084|471449683|FG001|Overall Study|Relapse|23|||
130949245|NCT00136084|471449682|FG000|Overall Study|Lost to Follow-up|2|||
130949246|NCT00136084|471449683|FG001|Overall Study|Lost to Follow-up|0|||
130949247|NCT00136084|471449682|FG000|Overall Study|No Response|1|||
130949248|NCT00136084|471449683|FG001|Overall Study|No Response|2|||
130949249|NCT00136084|471449682|FG000|Overall Study|Withdrawal by Subject|5|||
130949250|NCT00136084|471449683|FG001|Overall Study|Withdrawal by Subject|1|||
130949251|NCT00997503|471449684|FG000|Overall Study|Death|53|||
130949252|NCT00997503|471449684|FG000|Overall Study|Withdrawal by Subject|76|||
130949253|NCT00997503|471449684|FG000|Overall Study|Lost to Follow-up|33|||
130949254|NCT00997503|471449684|FG000|Overall Study|Adverse Event|3|||
130949255|NCT00997503|471449684|FG000|Overall Study|Physician Decision|10|||
130949256|NCT00997503|471449684|FG000|Overall Study|Missed 12-month follow-up|85|||
130949257|NCT00997503|471449684|FG000|Overall Study|Other reason|13|||
130949258|NCT01933048|471449685|FG000|Overall Study|Lost to Follow-up|15|||
130949259|NCT01933048|471449686|FG001|Overall Study|Lost to Follow-up|18|||
130949260|NCT01933048|471449685|FG000|Overall Study|personal reasons|1|||
130949261|NCT01933048|471449686|FG001|Overall Study|personal reasons|1|||
130949262|NCT01933048|471449685|FG000|Overall Study|Protocol Violation|7|||
130949263|NCT01933048|471449686|FG001|Overall Study|Protocol Violation|8|||
130949264|NCT01933048|471449685|FG000|Overall Study|Physician Decision|1|||
130949265|NCT01933048|471449686|FG001|Overall Study|Physician Decision|0|||
130949266|NCT01933048|471449685|FG000|Overall Study|unknown reasons|1|||
130949267|NCT01933048|471449686|FG001|Overall Study|unknown reasons|1|||
130949268|NCT00380393|471449687|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
130949269|NCT00380393|471449688|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
130949270|NCT00380393|471449687|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
130949271|NCT00380393|471449688|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
130949272|NCT00380393|471449687|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
130949273|NCT00380393|471449688|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
130949274|NCT00380393|471449687|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
130949275|NCT00380393|471449688|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
130949276|NCT00380393|471449687|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
130949277|NCT00380393|471449688|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
130949278|NCT00380393|471449687|FG000|Month 14|Withdrawal by Subject|9|||
130949279|NCT00380393|471449688|FG001|Month 14|Withdrawal by Subject|7|||
130949280|NCT00380393|471449687|FG000|Month 14|Death|1|||
130949281|NCT00380393|471449688|FG001|Month 14|Death|0|||
130949282|NCT00380393|471449687|FG000|Month 14|Lost to Follow-up|0|||
130949283|NCT00380393|471449688|FG001|Month 14|Lost to Follow-up|1|||
130949284|NCT00380393|471449687|FG000|Month 14|Migrated/moved from study area|39|||
130949285|NCT00380393|471449688|FG001|Month 14|Migrated/moved from study area|42|||
130949286|NCT00380393|471449687|FG000|Month 14|Protocol Violation|2|||
130949287|NCT00380393|471449688|FG001|Month 14|Protocol Violation|0|||
130949288|NCT00380393|471449687|FG000|Month 14|Others|6|||
130949289|NCT00380393|471449688|FG001|Month 14|Others|6|||
130949290|NCT01446965|471449689|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
130710765|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
130710766|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
130710767|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
130710768|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
130710769|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
130710770|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
130710771|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
130710772|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
130710773|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
130710774|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
130710775|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
130710776|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
130710777|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
130710778|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
130949291|NCT01446965|471449690|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
130949292|NCT01446965|471449689|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
130949293|NCT01446965|471449690|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
130949294|NCT02852265|471449691|FG000|3-month Follow-up|Lost to Follow-up|1|||
130949295|NCT02852265|471449692|FG001|3-month Follow-up|Lost to Follow-up|1|||
130949296|NCT01828034|471449695|FG000|Overall Study|Withdrawal by Subject|0|||
130949297|NCT01828034|471449696|FG001|Overall Study|Withdrawal by Subject|0|||
130710779|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
130710780|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
130710781|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
130949298|NCT01828034|471449697|FG002|Overall Study|Withdrawal by Subject|0|||
130949299|NCT01828034|471449698|FG003|Overall Study|Withdrawal by Subject|1|||
130949300|NCT02871375|471449699|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
130949301|NCT02871375|471449700|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
130949302|NCT01988571|471449703|FG000|Overall Study|Death|3|||
130949303|NCT01988571|471449704|FG001|Overall Study|Death|1|||
130949304|NCT01988571|471449703|FG000|Overall Study|Physician Decision|2|||
130949305|NCT01988571|471449704|FG001|Overall Study|Physician Decision|1|||
130949306|NCT01988571|471449703|FG000|Overall Study|Lost to Follow-up|3|||
130949307|NCT01988571|471449704|FG001|Overall Study|Lost to Follow-up|0|||
130949308|NCT01988571|471449703|FG000|Overall Study|Withdrawal by Subject|31|||
130949309|NCT01988571|471449704|FG001|Overall Study|Withdrawal by Subject|33|||
130949310|NCT00004412|471449705|FG000|Randomized Period|Moved to Crossover Period|3|||
130949311|NCT00004412|471449706|FG001|Randomized Period|Moved to Crossover Period|0|||
130949312|NCT00004412|471449707|FG002|Randomized Period|Moved to Crossover Period|0|||
130949313|NCT02346136|471449715|FG000|Overall Study|Withdrawal by Subject|7|||
130949314|NCT02346136|471449716|FG001|Overall Study|Withdrawal by Subject|5|||
130949315|NCT02346136|471449715|FG000|Overall Study|Death|1|||
130949316|NCT02346136|471449716|FG001|Overall Study|Death|0|||
130949317|NCT02346136|471449715|FG000|Overall Study|Study termination|14|||
130949318|NCT02346136|471449716|FG001|Overall Study|Study termination|18|||
130949319|NCT00453999|471449722|FG000|Overall Study|Adverse Event|1|||
130949320|NCT00453999|471449723|FG001|Overall Study|Adverse Event|2|||
130949321|NCT00453999|471449724|FG002|Overall Study|Adverse Event|1|||
130949322|NCT00453999|471449722|FG000|Overall Study|Lost to Follow-up|0|||
130949323|NCT00453999|471449723|FG001|Overall Study|Lost to Follow-up|1|||
130949324|NCT00453999|471449724|FG002|Overall Study|Lost to Follow-up|1|||
130949325|NCT00453999|471449722|FG000|Overall Study|Withdrawal by Subject|2|||
130949326|NCT00453999|471449723|FG001|Overall Study|Withdrawal by Subject|1|||
130949327|NCT00453999|471449724|FG002|Overall Study|Withdrawal by Subject|1|||
130949328|NCT00453999|471449722|FG000|Overall Study|Subject Request|2|||
130949329|NCT00453999|471449723|FG001|Overall Study|Subject Request|1|||
130949330|NCT00453999|471449724|FG002|Overall Study|Subject Request|0|||
130949331|NCT01364428|471449734|FG000|Overall Study|Adverse Event|1|||
130949332|NCT01364428|471449735|FG001|Overall Study|Adverse Event|2|||
130949333|NCT01364428|471449734|FG000|Overall Study|Protocol Violation|2|||
130949334|NCT01364428|471449735|FG001|Overall Study|Protocol Violation|0|||
130949335|NCT01364428|471449734|FG000|Overall Study|Withdrawal Criteria|14|||
130949336|NCT01364428|471449735|FG001|Overall Study|Withdrawal Criteria|10|||
130949337|NCT01364428|471449734|FG000|Overall Study|Other|3|||
130949338|NCT01364428|471449735|FG001|Overall Study|Other|3|||
130949339|NCT01987427|471449736|FG000|Overall Study|Adverse Event|4|||
130949340|NCT01987427|471449737|FG001|Overall Study|Adverse Event|2|||
130949341|NCT01987427|471449738|FG002|Overall Study|Adverse Event|8|||
130949342|NCT01987427|471449736|FG000|Overall Study|Lost to Follow-up|6|||
130949343|NCT01987427|471449737|FG001|Overall Study|Lost to Follow-up|6|||
130949344|NCT01987427|471449738|FG002|Overall Study|Lost to Follow-up|9|||
130949345|NCT01987427|471449736|FG000|Overall Study|Withdrawal by Subject|2|||
130949346|NCT01987427|471449737|FG001|Overall Study|Withdrawal by Subject|1|||
130949347|NCT01987427|471449738|FG002|Overall Study|Withdrawal by Subject|3|||
130949348|NCT01987427|471449736|FG000|Overall Study|Lack of Efficacy|1|||
130949349|NCT01987427|471449737|FG001|Overall Study|Lack of Efficacy|0|||
130949350|NCT01987427|471449738|FG002|Overall Study|Lack of Efficacy|0|||
130949351|NCT01987427|471449736|FG000|Overall Study|Other|1|||
130949352|NCT01987427|471449737|FG001|Overall Study|Other|1|||
130949353|NCT01987427|471449738|FG002|Overall Study|Other|0|||
130710782|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
130710783|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
130710784|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
130949354|NCT00743652|471449739|FG000|Overall Study|Parent/Legal Guardian Request|3|||
130949355|NCT00743652|471449740|FG001|Overall Study|Parent/Legal Guardian Request|2|||
130949356|NCT00743652|471449741|FG002|Overall Study|Parent/Legal Guardian Request|2|||
130774456|NCT01247350|470800519|FG002|Overall Study|Withdrawal by Subject|0|||
130949357|NCT00743652|471449742|FG003|Overall Study|Parent/Legal Guardian Request|2|||
130949358|NCT00743652|471449743|FG004|Overall Study|Parent/Legal Guardian Request|0|||
130949359|NCT00743652|471449739|FG000|Overall Study|Adverse Event|3|||
130949360|NCT00743652|471449740|FG001|Overall Study|Adverse Event|0|||
130949361|NCT00743652|471449741|FG002|Overall Study|Adverse Event|0|||
130949362|NCT00743652|471449742|FG003|Overall Study|Adverse Event|0|||
130949363|NCT00743652|471449743|FG004|Overall Study|Adverse Event|0|||
130949364|NCT00743652|471449739|FG000|Overall Study|Death|2|||
130949365|NCT00743652|471449740|FG001|Overall Study|Death|0|||
130949366|NCT00743652|471449741|FG002|Overall Study|Death|0|||
130949367|NCT00743652|471449742|FG003|Overall Study|Death|0|||
130949368|NCT00743652|471449743|FG004|Overall Study|Death|0|||
130949369|NCT00743652|471449739|FG000|Overall Study|Investigator Request|0|||
130949370|NCT00743652|471449740|FG001|Overall Study|Investigator Request|0|||
130949371|NCT00743652|471449741|FG002|Overall Study|Investigator Request|0|||
130949372|NCT00743652|471449742|FG003|Overall Study|Investigator Request|2|||
130949373|NCT00743652|471449743|FG004|Overall Study|Investigator Request|0|||
130949374|NCT00743652|471449739|FG000|Overall Study|Other|1|||
130949375|NCT00743652|471449740|FG001|Overall Study|Other|1|||
130949376|NCT00743652|471449741|FG002|Overall Study|Other|0|||
130949377|NCT00743652|471449742|FG003|Overall Study|Other|0|||
130949378|NCT00743652|471449743|FG004|Overall Study|Other|0|||
130949379|NCT00743652|471449739|FG000|Overall Study|Lost to Follow-up|1|||
130949380|NCT00743652|471449740|FG001|Overall Study|Lost to Follow-up|0|||
130949381|NCT00743652|471449741|FG002|Overall Study|Lost to Follow-up|0|||
130949382|NCT00743652|471449742|FG003|Overall Study|Lost to Follow-up|0|||
130949383|NCT00743652|471449743|FG004|Overall Study|Lost to Follow-up|0|||
130949384|NCT03925324|471449747|FG000|Overall Study|Death|1|||
130949385|NCT03925324|471449748|FG001|Overall Study|Death|1|||
130949386|NCT02129803|471449751|FG000|Overall Study|Protocol Violation|4|||
130949387|NCT02129803|471449752|FG001|Overall Study|Protocol Violation|0|||
130949388|NCT02129803|471449751|FG000|Overall Study|Physician Decision|0|||
130949389|NCT02129803|471449752|FG001|Overall Study|Physician Decision|1|||
130949390|NCT02129803|471449751|FG000|Overall Study|Difficulty sleeping|1|||
130949391|NCT02129803|471449752|FG001|Overall Study|Difficulty sleeping|0|||
130949392|NCT02129803|471449751|FG000|Overall Study|Morning headache|0|||
130949393|NCT02129803|471449752|FG001|Overall Study|Morning headache|1|||
130949394|NCT02129803|471449751|FG000|Overall Study|Withdrawal by Subject|1|||
130949395|NCT02129803|471449752|FG001|Overall Study|Withdrawal by Subject|1|||
130949396|NCT00907374|471449753|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
130949397|NCT00907374|471449754|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
130949398|NCT00594464|471449755|FG000|Overall Study|Withdrawal by Subject|1|||
130949399|NCT00594464|471449755|FG000|Overall Study|Delay in operation|2|||
130949400|NCT03131440|471449756|FG000|Overall Study|Withdrawal by Subject|1|||
130949401|NCT03131440|471449757|FG001|Overall Study|Withdrawal by Subject|3|||
130949402|NCT03131440|471449758|FG002|Overall Study|Withdrawal by Subject|0|||
130949403|NCT03131440|471449759|FG003|Overall Study|Withdrawal by Subject|0|||
130949404|NCT03131440|471449760|FG004|Overall Study|Withdrawal by Subject|1|||
130949405|NCT03131440|471449761|FG005|Overall Study|Withdrawal by Subject|0|||
130949406|NCT03131440|471449762|FG006|Overall Study|Withdrawal by Subject|0|||
130949407|NCT03131440|471449763|FG007|Overall Study|Withdrawal by Subject|1|||
130949408|NCT03131440|471449764|FG008|Overall Study|Withdrawal by Subject|1|||
130949409|NCT03131440|471449765|FG009|Overall Study|Withdrawal by Subject|1|||
130949410|NCT03131440|471449766|FG010|Overall Study|Withdrawal by Subject|0|||
130949411|NCT03131440|471449767|FG011|Overall Study|Withdrawal by Subject|1|||
130949412|NCT03131440|471449768|FG012|Overall Study|Withdrawal by Subject|1|||
130949413|NCT03131440|471449769|FG013|Overall Study|Withdrawal by Subject|0|||
130949414|NCT03131440|471449770|FG014|Overall Study|Withdrawal by Subject|1|||
130949415|NCT03131440|471449771|FG015|Overall Study|Withdrawal by Subject|0|||
130949416|NCT03131440|471449772|FG016|Overall Study|Withdrawal by Subject|0|||
130949417|NCT03131440|471449773|FG017|Overall Study|Withdrawal by Subject|0|||
130949418|NCT03131440|471449774|FG018|Overall Study|Withdrawal by Subject|1|||
130949419|NCT03131440|471449775|FG019|Overall Study|Withdrawal by Subject|0|||
130949420|NCT03131440|471449776|FG020|Overall Study|Withdrawal by Subject|1|||
130949421|NCT03131440|471449777|FG021|Overall Study|Withdrawal by Subject|1|||
130949422|NCT03131440|471449778|FG022|Overall Study|Withdrawal by Subject|1|||
130949423|NCT03131440|471449779|FG023|Overall Study|Withdrawal by Subject|0|||
130949424|NCT03131440|471449780|FG024|Overall Study|Withdrawal by Subject|0|||
130949425|NCT03131440|471449781|FG025|Overall Study|Withdrawal by Subject|0|||
130949426|NCT03131440|471449782|FG026|Overall Study|Withdrawal by Subject|0|||
130949427|NCT03131440|471449783|FG027|Overall Study|Withdrawal by Subject|0|||
130949428|NCT03131440|471449784|FG028|Overall Study|Withdrawal by Subject|0|||
130949429|NCT03131440|471449785|FG029|Overall Study|Withdrawal by Subject|0|||
130949430|NCT03131440|471449786|FG030|Overall Study|Withdrawal by Subject|1|||
130949431|NCT03131440|471449787|FG031|Overall Study|Withdrawal by Subject|0|||
130949432|NCT03131440|471449756|FG000|Overall Study|Lost to Follow-up|0|||
130949433|NCT03131440|471449757|FG001|Overall Study|Lost to Follow-up|0|||
130710785|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
130949434|NCT03131440|471449758|FG002|Overall Study|Lost to Follow-up|0|||
130949435|NCT03131440|471449759|FG003|Overall Study|Lost to Follow-up|0|||
130949436|NCT03131440|471449760|FG004|Overall Study|Lost to Follow-up|0|||
130949437|NCT03131440|471449761|FG005|Overall Study|Lost to Follow-up|1|||
130949438|NCT03131440|471449762|FG006|Overall Study|Lost to Follow-up|0|||
130949439|NCT03131440|471449763|FG007|Overall Study|Lost to Follow-up|0|||
130949440|NCT03131440|471449764|FG008|Overall Study|Lost to Follow-up|0|||
130949441|NCT03131440|471449765|FG009|Overall Study|Lost to Follow-up|0|||
130949442|NCT03131440|471449766|FG010|Overall Study|Lost to Follow-up|0|||
130949443|NCT03131440|471449767|FG011|Overall Study|Lost to Follow-up|0|||
130949444|NCT03131440|471449768|FG012|Overall Study|Lost to Follow-up|0|||
130949445|NCT03131440|471449769|FG013|Overall Study|Lost to Follow-up|0|||
130949446|NCT03131440|471449770|FG014|Overall Study|Lost to Follow-up|0|||
130949447|NCT03131440|471449771|FG015|Overall Study|Lost to Follow-up|0|||
130949448|NCT03131440|471449772|FG016|Overall Study|Lost to Follow-up|0|||
130949449|NCT03131440|471449773|FG017|Overall Study|Lost to Follow-up|0|||
130949450|NCT03131440|471449774|FG018|Overall Study|Lost to Follow-up|0|||
130949451|NCT03131440|471449775|FG019|Overall Study|Lost to Follow-up|2|||
130949452|NCT03131440|471449776|FG020|Overall Study|Lost to Follow-up|1|||
130949453|NCT03131440|471449777|FG021|Overall Study|Lost to Follow-up|0|||
130949454|NCT03131440|471449778|FG022|Overall Study|Lost to Follow-up|1|||
130949455|NCT03131440|471449779|FG023|Overall Study|Lost to Follow-up|0|||
130949456|NCT03131440|471449780|FG024|Overall Study|Lost to Follow-up|1|||
130949457|NCT03131440|471449781|FG025|Overall Study|Lost to Follow-up|0|||
130949458|NCT03131440|471449782|FG026|Overall Study|Lost to Follow-up|0|||
130949459|NCT03131440|471449783|FG027|Overall Study|Lost to Follow-up|2|||
130949460|NCT03131440|471449784|FG028|Overall Study|Lost to Follow-up|0|||
130949461|NCT03131440|471449785|FG029|Overall Study|Lost to Follow-up|2|||
130949462|NCT03131440|471449786|FG030|Overall Study|Lost to Follow-up|0|||
130949463|NCT03131440|471449787|FG031|Overall Study|Lost to Follow-up|0|||
130949464|NCT03131440|471449756|FG000|Overall Study|Death|0|||
130949465|NCT03131440|471449757|FG001|Overall Study|Death|0|||
130949466|NCT03131440|471449758|FG002|Overall Study|Death|0|||
130949467|NCT03131440|471449759|FG003|Overall Study|Death|0|||
130949468|NCT03131440|471449760|FG004|Overall Study|Death|0|||
130949469|NCT03131440|471449761|FG005|Overall Study|Death|0|||
130949470|NCT03131440|471449762|FG006|Overall Study|Death|0|||
130949471|NCT03131440|471449763|FG007|Overall Study|Death|0|||
130949472|NCT03131440|471449764|FG008|Overall Study|Death|0|||
130949473|NCT03131440|471449765|FG009|Overall Study|Death|0|||
130949474|NCT03131440|471449766|FG010|Overall Study|Death|0|||
130949475|NCT03131440|471449767|FG011|Overall Study|Death|0|||
130949476|NCT03131440|471449768|FG012|Overall Study|Death|0|||
130949477|NCT03131440|471449769|FG013|Overall Study|Death|0|||
130949478|NCT03131440|471449770|FG014|Overall Study|Death|0|||
130949479|NCT03131440|471449771|FG015|Overall Study|Death|0|||
130949480|NCT03131440|471449772|FG016|Overall Study|Death|0|||
130949481|NCT03131440|471449773|FG017|Overall Study|Death|0|||
130949482|NCT03131440|471449774|FG018|Overall Study|Death|0|||
130949483|NCT03131440|471449775|FG019|Overall Study|Death|0|||
130949484|NCT03131440|471449776|FG020|Overall Study|Death|0|||
130949485|NCT03131440|471449777|FG021|Overall Study|Death|0|||
130949486|NCT03131440|471449778|FG022|Overall Study|Death|0|||
130949487|NCT03131440|471449779|FG023|Overall Study|Death|0|||
130949488|NCT03131440|471449780|FG024|Overall Study|Death|0|||
130949489|NCT03131440|471449781|FG025|Overall Study|Death|1|||
130949490|NCT03131440|471449782|FG026|Overall Study|Death|0|||
130949491|NCT03131440|471449783|FG027|Overall Study|Death|0|||
130949492|NCT03131440|471449784|FG028|Overall Study|Death|0|||
130949493|NCT03131440|471449785|FG029|Overall Study|Death|0|||
130949494|NCT03131440|471449786|FG030|Overall Study|Death|0|||
130949495|NCT03131440|471449787|FG031|Overall Study|Death|0|||
130949496|NCT03316885|471449788|FG000|Overall Study|Adverse Event|1|||
130949497|NCT03316885|471449788|FG000|Overall Study|Death|10|||
130949498|NCT03316885|471449788|FG000|Overall Study|Lost to Follow-up|4|||
130949499|NCT03316885|471449788|FG000|Overall Study|Withdrawal by Subject|9|||
130949500|NCT03316885|471449788|FG000|Overall Study|COVID related|8|||
130949501|NCT04371380|471449789|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
130949502|NCT04371380|471449790|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
130949503|NCT04371380|471449791|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
130949504|NCT06049043|471449792|FG000|Overall Study|Lost to Follow-up|11|||
130949505|NCT06049043|471449793|FG001|Overall Study|Lost to Follow-up|9|||
130949506|NCT01354496|471449803|FG000|Period 1|Adverse Event|0|||
130949507|NCT01354496|471449804|FG001|Period 1|Adverse Event|0|||
130949508|NCT01354496|471449805|FG002|Period 1|Adverse Event|1|||
130949509|NCT01354496|471449806|FG003|Period 1|Adverse Event|0|||
130949510|NCT01354496|471449807|FG004|Period 1|Adverse Event|0|||
130949511|NCT01354496|471449808|FG005|Period 1|Adverse Event|0|||
130949512|NCT01354496|471449803|FG000|Period 1|Physician Decision|0|||
130949513|NCT01354496|471449804|FG001|Period 1|Physician Decision|0|||
130949514|NCT01354496|471449805|FG002|Period 1|Physician Decision|1|||
130949515|NCT01354496|471449806|FG003|Period 1|Physician Decision|0|||
130949516|NCT01354496|471449807|FG004|Period 1|Physician Decision|0|||
130949517|NCT01354496|471449808|FG005|Period 1|Physician Decision|0|||
130949518|NCT01354496|471449803|FG000|Period 2|Adverse Event|0|||
130949519|NCT01354496|471449804|FG001|Period 2|Adverse Event|0|||
130949520|NCT01354496|471449805|FG002|Period 2|Adverse Event|0|||
130949521|NCT01354496|471449806|FG003|Period 2|Adverse Event|1|||
130949522|NCT01354496|471449807|FG004|Period 2|Adverse Event|0|||
130949523|NCT01354496|471449808|FG005|Period 2|Adverse Event|0|||
130949524|NCT01354496|471449803|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
130949525|NCT01354496|471449804|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
130949526|NCT01354496|471449805|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
131038223|NCT01152450|471772885|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
130949527|NCT01354496|471449806|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
130949528|NCT01354496|471449807|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
130949529|NCT01354496|471449808|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
130949530|NCT03216850|471449809|FG000|Overall Study|Pre-analytical error|6|||
130949531|NCT03190889|471449810|FG000|Overall Study|Lost to Follow-up|7|||
130949532|NCT03190889|471449811|FG001|Overall Study|Lost to Follow-up|7|||
130949533|NCT03190889|471449812|FG002|Overall Study|Lost to Follow-up|3|||
130949534|NCT03190889|471449810|FG000|Overall Study|Withdrawal by Subject|1|||
130949535|NCT03190889|471449811|FG001|Overall Study|Withdrawal by Subject|1|||
130949536|NCT03190889|471449812|FG002|Overall Study|Withdrawal by Subject|2|||
130949537|NCT03190889|471449810|FG000|Overall Study|Did not complete protocol|4|||
130949538|NCT03190889|471449811|FG001|Overall Study|Did not complete protocol|9|||
130949539|NCT03190889|471449812|FG002|Overall Study|Did not complete protocol|0|||
130949540|NCT03190889|471449810|FG000|Overall Study|COVID-19|1|||
130949541|NCT03190889|471449811|FG001|Overall Study|COVID-19|0|||
130949542|NCT03190889|471449812|FG002|Overall Study|COVID-19|2|||
130949543|NCT01228747|471449813|FG000|Overall Study|Adverse Event|8|||
130949544|NCT01228747|471449814|FG001|Overall Study|Adverse Event|4|||
130949545|NCT01228747|471449813|FG000|Overall Study|Lack of Efficacy|40|||
130949546|NCT01228747|471449814|FG001|Overall Study|Lack of Efficacy|27|||
130949547|NCT01228747|471449813|FG000|Overall Study|Protocol Violation|6|||
130949548|NCT01228747|471449814|FG001|Overall Study|Protocol Violation|5|||
130949549|NCT01228747|471449813|FG000|Overall Study|Lost to Follow-up|4|||
130949550|NCT01228747|471449814|FG001|Overall Study|Lost to Follow-up|3|||
130949551|NCT01228747|471449813|FG000|Overall Study|Withdrawal by Subject|5|||
130949552|NCT01228747|471449814|FG001|Overall Study|Withdrawal by Subject|1|||
130949553|NCT01228747|471449813|FG000|Overall Study|Other Reason|2|||
130949554|NCT01228747|471449814|FG001|Overall Study|Other Reason|5|||
130949555|NCT00500292|471449818|FG000|Overall Study|Adverse Event|3|||
130949556|NCT00500292|471449819|FG001|Overall Study|Adverse Event|6|||
130949557|NCT00500292|471449820|FG002|Overall Study|Adverse Event|4|||
130949558|NCT00500292|471449818|FG000|Overall Study|Condition under investigation worsened|21|||
130949559|NCT00500292|471449819|FG001|Overall Study|Condition under investigation worsened|23|||
130949560|NCT00500292|471449820|FG002|Overall Study|Condition under investigation worsened|19|||
130949561|NCT00500292|471449818|FG000|Overall Study|Withdrawal by Subject|0|||
130949562|NCT00500292|471449819|FG001|Overall Study|Withdrawal by Subject|1|||
130949563|NCT00500292|471449820|FG002|Overall Study|Withdrawal by Subject|0|||
130949564|NCT00500292|471449818|FG000|Overall Study|Other|1|||
130949565|NCT00500292|471449819|FG001|Overall Study|Other|1|||
130949566|NCT00500292|471449820|FG002|Overall Study|Other|4|||
130949567|NCT02641379|471449821|FG000|Overall Study|Exclusion criterion during screening|1|||
130949568|NCT02641379|471449822|FG001|Overall Study|Exclusion criterion during screening|0|||
130949569|NCT02641379|471449823|FG002|Overall Study|Exclusion criterion during screening|0|||
130949570|NCT02641379|471449824|FG003|Overall Study|Exclusion criterion during screening|1|||
130949571|NCT02641379|471449825|FG004|Overall Study|Exclusion criterion during screening|2|||
130949572|NCT02641379|471449826|FG005|Overall Study|Exclusion criterion during screening|0|||
130949573|NCT02641379|471449827|FG006|Overall Study|Exclusion criterion during screening|0|||
130949574|NCT02641379|471449828|FG007|Overall Study|Exclusion criterion during screening|0|||
130949575|NCT02641379|471449829|FG008|Overall Study|Exclusion criterion during screening|0|||
130949576|NCT02641379|471449830|FG009|Overall Study|Exclusion criterion during screening|0|||
130949577|NCT02641379|471449831|FG010|Overall Study|Exclusion criterion during screening|0|||
130949578|NCT02641379|471449821|FG000|Overall Study|Withdrawal of informed consent|0|||
130949579|NCT02641379|471449822|FG001|Overall Study|Withdrawal of informed consent|1|||
130949580|NCT02641379|471449823|FG002|Overall Study|Withdrawal of informed consent|0|||
130949581|NCT02641379|471449824|FG003|Overall Study|Withdrawal of informed consent|0|||
130949582|NCT02641379|471449825|FG004|Overall Study|Withdrawal of informed consent|0|||
130949583|NCT02641379|471449826|FG005|Overall Study|Withdrawal of informed consent|0|||
130949584|NCT02641379|471449827|FG006|Overall Study|Withdrawal of informed consent|0|||
130949585|NCT02641379|471449828|FG007|Overall Study|Withdrawal of informed consent|1|||
130710786|NCT01421342|470567020|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
130710787|NCT01421342|470567021|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
130710788|NCT01421342|470567022|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
130710789|NCT01642914|470567027|FG000|Overall Study|Adverse Event|11|||
130710790|NCT01642914|470567028|FG001|Overall Study|Adverse Event|7|||
130949586|NCT02641379|471449829|FG008|Overall Study|Withdrawal of informed consent|0|||
130949587|NCT02641379|471449830|FG009|Overall Study|Withdrawal of informed consent|0|||
130949588|NCT02641379|471449831|FG010|Overall Study|Withdrawal of informed consent|0|||
130949589|NCT02641379|471449821|FG000|Overall Study|Adverse Event|7|||
131038224|NCT01152450|471772886|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
130710791|NCT01642914|470567029|FG002|Overall Study|Adverse Event|15|||
130949590|NCT02641379|471449822|FG001|Overall Study|Adverse Event|8|||
130949591|NCT02641379|471449823|FG002|Overall Study|Adverse Event|2|||
131038225|NCT01152450|471772881|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
130710792|NCT01642914|470567027|FG000|Overall Study|Lack of Efficacy|9|||
130949592|NCT02641379|471449824|FG003|Overall Study|Adverse Event|2|||
130949593|NCT02641379|471449825|FG004|Overall Study|Adverse Event|5|||
130949594|NCT02641379|471449826|FG005|Overall Study|Adverse Event|1|||
130949595|NCT02641379|471449827|FG006|Overall Study|Adverse Event|5|||
130949596|NCT02641379|471449828|FG007|Overall Study|Adverse Event|0|||
130949597|NCT02641379|471449829|FG008|Overall Study|Adverse Event|1|||
130949598|NCT02641379|471449830|FG009|Overall Study|Adverse Event|1|||
130949599|NCT02641379|471449831|FG010|Overall Study|Adverse Event|5|||
130949600|NCT02641379|471449821|FG000|Overall Study|Lack of Efficacy|0|||
130949601|NCT02641379|471449822|FG001|Overall Study|Lack of Efficacy|0|||
130949602|NCT02641379|471449823|FG002|Overall Study|Lack of Efficacy|2|||
130949603|NCT02641379|471449824|FG003|Overall Study|Lack of Efficacy|0|||
130949604|NCT02641379|471449825|FG004|Overall Study|Lack of Efficacy|0|||
130949605|NCT02641379|471449826|FG005|Overall Study|Lack of Efficacy|2|||
130949606|NCT02641379|471449827|FG006|Overall Study|Lack of Efficacy|0|||
130949607|NCT02641379|471449828|FG007|Overall Study|Lack of Efficacy|5|||
130949608|NCT02641379|471449829|FG008|Overall Study|Lack of Efficacy|0|||
130949609|NCT02641379|471449830|FG009|Overall Study|Lack of Efficacy|0|||
130949610|NCT02641379|471449831|FG010|Overall Study|Lack of Efficacy|0|||
130949611|NCT02641379|471449821|FG000|Overall Study|Participant unable to attend study visit|4|||
130949612|NCT02641379|471449822|FG001|Overall Study|Participant unable to attend study visit|10|||
130949613|NCT02641379|471449823|FG002|Overall Study|Participant unable to attend study visit|1|||
130949614|NCT02641379|471449824|FG003|Overall Study|Participant unable to attend study visit|2|||
130949615|NCT02641379|471449825|FG004|Overall Study|Participant unable to attend study visit|5|||
130949616|NCT02641379|471449826|FG005|Overall Study|Participant unable to attend study visit|1|||
130949617|NCT02641379|471449827|FG006|Overall Study|Participant unable to attend study visit|1|||
130949618|NCT02641379|471449828|FG007|Overall Study|Participant unable to attend study visit|1|||
130949619|NCT02641379|471449829|FG008|Overall Study|Participant unable to attend study visit|0|||
130949620|NCT02641379|471449830|FG009|Overall Study|Participant unable to attend study visit|2|||
130949621|NCT02641379|471449831|FG010|Overall Study|Participant unable to attend study visit|0|||
130949622|NCT02641379|471449821|FG000|Overall Study|Participant's compliance|0|||
130949623|NCT02641379|471449822|FG001|Overall Study|Participant's compliance|1|||
130949624|NCT02641379|471449823|FG002|Overall Study|Participant's compliance|0|||
130949625|NCT02641379|471449824|FG003|Overall Study|Participant's compliance|1|||
130949626|NCT02641379|471449825|FG004|Overall Study|Participant's compliance|0|||
130949627|NCT02641379|471449826|FG005|Overall Study|Participant's compliance|2|||
130949628|NCT02641379|471449827|FG006|Overall Study|Participant's compliance|0|||
130949629|NCT02641379|471449828|FG007|Overall Study|Participant's compliance|0|||
130949630|NCT02641379|471449829|FG008|Overall Study|Participant's compliance|1|||
130949631|NCT02641379|471449830|FG009|Overall Study|Participant's compliance|1|||
130949632|NCT02641379|471449831|FG010|Overall Study|Participant's compliance|1|||
130949633|NCT02641379|471449821|FG000|Overall Study|Participant cannot be reached|4|||
130949634|NCT02641379|471449822|FG001|Overall Study|Participant cannot be reached|4|||
130949635|NCT02641379|471449823|FG002|Overall Study|Participant cannot be reached|0|||
130949636|NCT02641379|471449824|FG003|Overall Study|Participant cannot be reached|8|||
130949637|NCT02641379|471449825|FG004|Overall Study|Participant cannot be reached|2|||
130949638|NCT02641379|471449826|FG005|Overall Study|Participant cannot be reached|1|||
130949639|NCT02641379|471449827|FG006|Overall Study|Participant cannot be reached|0|||
130949640|NCT02641379|471449828|FG007|Overall Study|Participant cannot be reached|1|||
130949641|NCT02641379|471449829|FG008|Overall Study|Participant cannot be reached|0|||
130949642|NCT02641379|471449830|FG009|Overall Study|Participant cannot be reached|2|||
130949643|NCT02641379|471449831|FG010|Overall Study|Participant cannot be reached|1|||
130949644|NCT02641379|471449821|FG000|Overall Study|PCR positive at Week 24|15|||
131038226|NCT01152450|471772882|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
131038227|NCT01152450|471772883|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
131038228|NCT01152450|471772884|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
131038229|NCT01152450|471772885|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
131038230|NCT01152450|471772886|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
131038231|NCT01152450|471772881|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131038232|NCT01152450|471772882|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
131038233|NCT01152450|471772883|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
131038234|NCT01152450|471772884|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131038235|NCT01152450|471772885|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131038236|NCT01152450|471772886|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
131038237|NCT01544114|471772892|FG000|Overall Study|Withdrawal by Subject|0|||
131038238|NCT01544114|471772893|FG001|Overall Study|Withdrawal by Subject|0|||
131038239|NCT01544114|471772894|FG002|Overall Study|Withdrawal by Subject|3|||
131038240|NCT01544114|471772892|FG000|Overall Study|Lost to Follow-up|0|||
131038241|NCT01544114|471772893|FG001|Overall Study|Lost to Follow-up|2|||
131038242|NCT01544114|471772894|FG002|Overall Study|Lost to Follow-up|0|||
131038243|NCT01544114|471772892|FG000|Overall Study|Adverse Event|1|||
131038244|NCT01544114|471772893|FG001|Overall Study|Adverse Event|1|||
131124774|NCT02375724|472085860|FG000|Overall Study|Lost to Follow-up|1|||
131038245|NCT01544114|471772894|FG002|Overall Study|Adverse Event|2|||
131038246|NCT01544114|471772892|FG000|Overall Study|Protocol Violation|0|||
130710793|NCT01642914|470567028|FG001|Overall Study|Lack of Efficacy|4|||
130710794|NCT01642914|470567029|FG002|Overall Study|Lack of Efficacy|2|||
130710795|NCT01642914|470567027|FG000|Overall Study|Protocol Violation|15|||
130710796|NCT01642914|470567028|FG001|Overall Study|Protocol Violation|13|||
130710797|NCT01642914|470567029|FG002|Overall Study|Protocol Violation|6|||
130710798|NCT01642914|470567027|FG000|Overall Study|Withdrawal by Subject|5|||
130710799|NCT01642914|470567028|FG001|Overall Study|Withdrawal by Subject|5|||
130710800|NCT01642914|470567029|FG002|Overall Study|Withdrawal by Subject|10|||
130710801|NCT01642914|470567027|FG000|Overall Study|Lost to Follow-up|5|||
130710802|NCT01642914|470567028|FG001|Overall Study|Lost to Follow-up|3|||
130710803|NCT01642914|470567029|FG002|Overall Study|Lost to Follow-up|7|||
130710804|NCT01642914|470567027|FG000|Overall Study|Other Reason|1|||
130710805|NCT01642914|470567028|FG001|Overall Study|Other Reason|0|||
130710806|NCT01642914|470567029|FG002|Overall Study|Other Reason|0|||
130710807|NCT06005597|470567030|FG000|Overall Study|Lost to Follow-up|1|||
130710808|NCT06005597|470567031|FG001|Overall Study|Lost to Follow-up|2|||
130710809|NCT06005597|470567032|FG002|Overall Study|Lost to Follow-up|1|||
130710810|NCT06005597|470567033|FG003|Overall Study|Lost to Follow-up|2|||
130710811|NCT06005597|470567030|FG000|Overall Study|Death|1|||
130710812|NCT06005597|470567031|FG001|Overall Study|Death|1|||
130710813|NCT06005597|470567032|FG002|Overall Study|Death|1|||
130710814|NCT06005597|470567033|FG003|Overall Study|Death|0|||
130710815|NCT00754442|470567034|FG000|Overall Study|Withdrawal by Subject|5|||
130710816|NCT00754442|470567035|FG001|Overall Study|Withdrawal by Subject|3|||
130949645|NCT02641379|471449822|FG001|Overall Study|PCR positive at Week 24|21|||
130949646|NCT02641379|471449823|FG002|Overall Study|PCR positive at Week 24|62|||
130949647|NCT02641379|471449824|FG003|Overall Study|PCR positive at Week 24|0|||
130949648|NCT02641379|471449825|FG004|Overall Study|PCR positive at Week 24|0|||
130949649|NCT02641379|471449826|FG005|Overall Study|PCR positive at Week 24|6|||
130949650|NCT02641379|471449827|FG006|Overall Study|PCR positive at Week 24|3|||
130949651|NCT02641379|471449828|FG007|Overall Study|PCR positive at Week 24|8|||
130949652|NCT02641379|471449829|FG008|Overall Study|PCR positive at Week 24|0|||
130949653|NCT02641379|471449830|FG009|Overall Study|PCR positive at Week 24|1|||
130949654|NCT02641379|471449831|FG010|Overall Study|PCR positive at Week 24|0|||
130949655|NCT02641379|471449821|FG000|Overall Study|PCR positive at follow up 2|1|||
130949656|NCT02641379|471449822|FG001|Overall Study|PCR positive at follow up 2|0|||
130949657|NCT02641379|471449823|FG002|Overall Study|PCR positive at follow up 2|0|||
130949658|NCT02641379|471449824|FG003|Overall Study|PCR positive at follow up 2|0|||
130949659|NCT02641379|471449825|FG004|Overall Study|PCR positive at follow up 2|0|||
130949660|NCT02641379|471449826|FG005|Overall Study|PCR positive at follow up 2|0|||
130949661|NCT02641379|471449827|FG006|Overall Study|PCR positive at follow up 2|0|||
130949662|NCT02641379|471449828|FG007|Overall Study|PCR positive at follow up 2|0|||
130949663|NCT02641379|471449829|FG008|Overall Study|PCR positive at follow up 2|0|||
130949664|NCT02641379|471449830|FG009|Overall Study|PCR positive at follow up 2|0|||
130949665|NCT02641379|471449831|FG010|Overall Study|PCR positive at follow up 2|0|||
130949666|NCT02641379|471449821|FG000|Overall Study|Participant showed relapse|1|||
130949667|NCT02641379|471449822|FG001|Overall Study|Participant showed relapse|0|||
130949668|NCT02641379|471449823|FG002|Overall Study|Participant showed relapse|0|||
130949669|NCT02641379|471449824|FG003|Overall Study|Participant showed relapse|0|||
130949670|NCT02641379|471449825|FG004|Overall Study|Participant showed relapse|0|||
130949671|NCT02641379|471449826|FG005|Overall Study|Participant showed relapse|0|||
130949672|NCT02641379|471449827|FG006|Overall Study|Participant showed relapse|1|||
130949673|NCT02641379|471449828|FG007|Overall Study|Participant showed relapse|0|||
130949674|NCT02641379|471449829|FG008|Overall Study|Participant showed relapse|0|||
130949675|NCT02641379|471449830|FG009|Overall Study|Participant showed relapse|0|||
130710817|NCT04479475|470567036|FG000|Overall Study|Withdrawal by Subject|7|||
130710818|NCT00296491|470567037|FG000|Overall Study|Low Pollen Counts|18|||
130710819|NCT00296491|470567038|FG001|Overall Study|Low Pollen Counts|26|||
130710820|NCT00296491|470567039|FG002|Overall Study|Low Pollen Counts|25|||
130710821|NCT00296491|470567040|FG003|Overall Study|Low Pollen Counts|16|||
130710822|NCT00296491|470567037|FG000|Overall Study|Protocol Violation|4|||
130710823|NCT00296491|470567038|FG001|Overall Study|Protocol Violation|6|||
130710824|NCT00296491|470567039|FG002|Overall Study|Protocol Violation|2|||
130710825|NCT00296491|470567040|FG003|Overall Study|Protocol Violation|3|||
130710826|NCT00296491|470567037|FG000|Overall Study|Adverse Event|1|||
130710827|NCT00296491|470567038|FG001|Overall Study|Adverse Event|3|||
130710828|NCT00296491|470567039|FG002|Overall Study|Adverse Event|1|||
130949676|NCT02641379|471449831|FG010|Overall Study|Participant showed relapse|0|||
131038247|NCT01544114|471772893|FG001|Overall Study|Protocol Violation|1|||
131038248|NCT01544114|471772894|FG002|Overall Study|Protocol Violation|0|||
130710829|NCT00296491|470567040|FG003|Overall Study|Adverse Event|4|||
130710830|NCT00296491|470567037|FG000|Overall Study|Withdrawn due to Asthma|0|||
130710831|NCT00296491|470567038|FG001|Overall Study|Withdrawn due to Asthma|0|||
130710832|NCT00296491|470567039|FG002|Overall Study|Withdrawn due to Asthma|0|||
130710833|NCT00296491|470567040|FG003|Overall Study|Withdrawn due to Asthma|4|||
130710834|NCT00296491|470567037|FG000|Overall Study|Withdrawal by Subject|7|||
130710835|NCT00296491|470567038|FG001|Overall Study|Withdrawal by Subject|3|||
130710836|NCT00296491|470567039|FG002|Overall Study|Withdrawal by Subject|3|||
130710837|NCT00296491|470567040|FG003|Overall Study|Withdrawal by Subject|2|||
130710838|NCT00296491|470567037|FG000|Overall Study|Non-Compliance|12|||
130710839|NCT00296491|470567038|FG001|Overall Study|Non-Compliance|13|||
130710840|NCT00296491|470567039|FG002|Overall Study|Non-Compliance|10|||
130710841|NCT00296491|470567040|FG003|Overall Study|Non-Compliance|14|||
130710842|NCT00296491|470567037|FG000|Overall Study|Lost to Follow-up|0|||
130710843|NCT00296491|470567038|FG001|Overall Study|Lost to Follow-up|2|||
130949677|NCT02641379|471449821|FG000|Overall Study|Participant stopped study/treatment|1|||
130949678|NCT02641379|471449822|FG001|Overall Study|Participant stopped study/treatment|3|||
130949679|NCT02641379|471449823|FG002|Overall Study|Participant stopped study/treatment|1|||
130949680|NCT02641379|471449824|FG003|Overall Study|Participant stopped study/treatment|0|||
130949681|NCT02641379|471449825|FG004|Overall Study|Participant stopped study/treatment|0|||
130949682|NCT02641379|471449826|FG005|Overall Study|Participant stopped study/treatment|1|||
130949683|NCT02641379|471449827|FG006|Overall Study|Participant stopped study/treatment|2|||
130949684|NCT02641379|471449828|FG007|Overall Study|Participant stopped study/treatment|0|||
130949685|NCT02641379|471449829|FG008|Overall Study|Participant stopped study/treatment|1|||
130949686|NCT02641379|471449830|FG009|Overall Study|Participant stopped study/treatment|0|||
130949687|NCT02641379|471449831|FG010|Overall Study|Participant stopped study/treatment|0|||
130949688|NCT02641379|471449821|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
130949689|NCT02641379|471449822|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
130949690|NCT02641379|471449823|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
130949691|NCT02641379|471449824|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
130949692|NCT02641379|471449825|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
131124775|NCT02375724|472085861|FG001|Overall Study|Lost to Follow-up|0|||
131124776|NCT02375724|472085860|FG000|Overall Study|Protocol Violation|1|||
131124777|NCT02375724|472085861|FG001|Overall Study|Protocol Violation|0|||
131124778|NCT02375724|472085860|FG000|Overall Study|Adverse Event|2|||
131124779|NCT02375724|472085861|FG001|Overall Study|Adverse Event|4|||
131124780|NCT01309659|472085862|FG000|Overall Study|Protocol Violation|0|||
131124781|NCT01309659|472085863|FG001|Overall Study|Protocol Violation|1|||
131124782|NCT03462576|472085864|FG000|Overall Study|Protocol Violation|5|||
131124783|NCT03462576|472085865|FG001|Overall Study|Protocol Violation|11|||
131124784|NCT03462576|472085866|FG002|Overall Study|Protocol Violation|7|||
131124785|NCT03462576|472085864|FG000|Overall Study|Device Malfunction|0|||
131124786|NCT03462576|472085865|FG001|Overall Study|Device Malfunction|0|||
131124787|NCT03462576|472085866|FG002|Overall Study|Device Malfunction|1|||
131124788|NCT03962101|472085868|FG000|Overall Study|Adverse Event|1|||
130949693|NCT02641379|471449826|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
130949694|NCT02641379|471449827|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
130949695|NCT02641379|471449828|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
130949696|NCT02641379|471449829|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
130949697|NCT02641379|471449830|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
130949698|NCT02641379|471449831|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
130949699|NCT02641379|471449821|FG000|Overall Study|Financial problems|0|||
130774457|NCT01247350|470800520|FG003|Overall Study|Withdrawal by Subject|1|||
130774458|NCT01247350|470800521|FG004|Overall Study|Withdrawal by Subject|0|||
130774459|NCT01247350|470800517|FG000|Overall Study|Entry criteria not met|0|||
130774460|NCT01247350|470800518|FG001|Overall Study|Entry criteria not met|0|||
130949700|NCT02641379|471449822|FG001|Overall Study|Financial problems|1|||
130949701|NCT02641379|471449823|FG002|Overall Study|Financial problems|0|||
130949702|NCT02641379|471449824|FG003|Overall Study|Financial problems|0|||
130949703|NCT02641379|471449825|FG004|Overall Study|Financial problems|0|||
130949704|NCT02641379|471449826|FG005|Overall Study|Financial problems|0|||
130949705|NCT02641379|471449827|FG006|Overall Study|Financial problems|0|||
130949706|NCT02641379|471449828|FG007|Overall Study|Financial problems|0|||
131124789|NCT03962101|472085868|FG000|Overall Study|Physician Decision|2|||
130710844|NCT00296491|470567039|FG002|Overall Study|Lost to Follow-up|2|||
130710845|NCT00296491|470567040|FG003|Overall Study|Lost to Follow-up|0|||
130774461|NCT01247350|470800519|FG002|Overall Study|Entry criteria not met|0|||
130949707|NCT02641379|471449829|FG008|Overall Study|Financial problems|0|||
130949708|NCT02641379|471449830|FG009|Overall Study|Financial problems|0|||
130949709|NCT02641379|471449831|FG010|Overall Study|Financial problems|0|||
130949710|NCT02641379|471449821|FG000|Overall Study|PCR positive at Week 68|0|||
130774462|NCT01247350|470800520|FG003|Overall Study|Entry criteria not met|0|||
130710846|NCT01300052|470567041|FG000|Overall Study|Adverse Event|3|||
130710847|NCT01300052|470567042|FG001|Overall Study|Adverse Event|0|||
130710848|NCT01300052|470567041|FG000|Overall Study|Withdrawal by Subject|2|||
130949711|NCT02641379|471449822|FG001|Overall Study|PCR positive at Week 68|1|||
130949712|NCT02641379|471449823|FG002|Overall Study|PCR positive at Week 68|0|||
130949713|NCT02641379|471449824|FG003|Overall Study|PCR positive at Week 68|0|||
130949714|NCT02641379|471449825|FG004|Overall Study|PCR positive at Week 68|0|||
130949715|NCT02641379|471449826|FG005|Overall Study|PCR positive at Week 68|0|||
130774463|NCT01247350|470800521|FG004|Overall Study|Entry criteria not met|1|||
130774464|NCT00003896|470800530|FG000|Overall Study|Adverse Event|16|||
130774465|NCT00003896|470800530|FG000|Overall Study|Withdrawal by Subject|1|||
130710849|NCT01300052|470567042|FG001|Overall Study|Withdrawal by Subject|2|||
130710850|NCT01300052|470567041|FG000|Overall Study|Protocol Violation|1|||
130710851|NCT01300052|470567042|FG001|Overall Study|Protocol Violation|1|||
130710852|NCT06972251|470567043|FG000|Overall Study|Withdrawal by Subject|1|||
130710853|NCT06972251|470567044|FG001|Overall Study|Withdrawal by Subject|0|||
130710854|NCT06972251|470567043|FG000|Overall Study|Lost to Follow-up|10|||
130710855|NCT06972251|470567044|FG001|Overall Study|Lost to Follow-up|2|||
130710856|NCT01231373|470567045|FG000|Overall Study|Withdrew consent prior to randomization|2|||
130710857|NCT01231373|470567046|FG001|Overall Study|Withdrew consent prior to randomization|1|||
130710858|NCT01231373|470567047|FG002|Overall Study|Withdrew consent prior to randomization|0|||
130710859|NCT01231373|470567048|FG003|Overall Study|Withdrew consent prior to randomization|0|||
130710860|NCT01231373|470567045|FG000|Overall Study|Lost to Follow-up|0|||
130710861|NCT01231373|470567046|FG001|Overall Study|Lost to Follow-up|0|||
130710862|NCT01231373|470567047|FG002|Overall Study|Lost to Follow-up|0|||
130710863|NCT01231373|470567048|FG003|Overall Study|Lost to Follow-up|1|||
130710864|NCT01231373|470567045|FG000|Overall Study|Withdrew Consent|1|||
130710865|NCT01231373|470567046|FG001|Overall Study|Withdrew Consent|0|||
130949716|NCT02641379|471449827|FG006|Overall Study|PCR positive at Week 68|0|||
130949717|NCT02641379|471449828|FG007|Overall Study|PCR positive at Week 68|0|||
130949718|NCT02641379|471449829|FG008|Overall Study|PCR positive at Week 68|0|||
130949719|NCT02641379|471449830|FG009|Overall Study|PCR positive at Week 68|0|||
130949720|NCT02641379|471449831|FG010|Overall Study|PCR positive at Week 68|0|||
130949721|NCT02641379|471449821|FG000|Overall Study|PCR positive at Week 48|0|||
130949722|NCT02641379|471449822|FG001|Overall Study|PCR positive at Week 48|1|||
130949723|NCT02641379|471449823|FG002|Overall Study|PCR positive at Week 48|0|||
130949724|NCT02641379|471449824|FG003|Overall Study|PCR positive at Week 48|0|||
130949725|NCT02641379|471449825|FG004|Overall Study|PCR positive at Week 48|0|||
130949726|NCT02641379|471449826|FG005|Overall Study|PCR positive at Week 48|0|||
130949727|NCT02641379|471449827|FG006|Overall Study|PCR positive at Week 48|0|||
130949728|NCT02641379|471449828|FG007|Overall Study|PCR positive at Week 48|0|||
130949729|NCT02641379|471449829|FG008|Overall Study|PCR positive at Week 48|0|||
130949730|NCT02641379|471449830|FG009|Overall Study|PCR positive at Week 48|0|||
130949731|NCT02641379|471449831|FG010|Overall Study|PCR positive at Week 48|0|||
130949732|NCT02641379|471449821|FG000|Overall Study|PCR not performed at Week 12|0|||
130949733|NCT02641379|471449822|FG001|Overall Study|PCR not performed at Week 12|0|||
130949734|NCT02641379|471449823|FG002|Overall Study|PCR not performed at Week 12|1|||
130949735|NCT02641379|471449824|FG003|Overall Study|PCR not performed at Week 12|0|||
130949736|NCT02641379|471449825|FG004|Overall Study|PCR not performed at Week 12|0|||
130949737|NCT02641379|471449826|FG005|Overall Study|PCR not performed at Week 12|0|||
130949738|NCT02641379|471449827|FG006|Overall Study|PCR not performed at Week 12|0|||
130949739|NCT02641379|471449828|FG007|Overall Study|PCR not performed at Week 12|0|||
130949740|NCT02641379|471449829|FG008|Overall Study|PCR not performed at Week 12|0|||
130949741|NCT02641379|471449830|FG009|Overall Study|PCR not performed at Week 12|0|||
130949742|NCT02641379|471449831|FG010|Overall Study|PCR not performed at Week 12|0|||
130949743|NCT02641379|471449821|FG000|Overall Study|No PCR at baseline|0|||
130949744|NCT02641379|471449822|FG001|Overall Study|No PCR at baseline|0|||
130949745|NCT02641379|471449823|FG002|Overall Study|No PCR at baseline|1|||
130949746|NCT02641379|471449824|FG003|Overall Study|No PCR at baseline|0|||
130949747|NCT02641379|471449825|FG004|Overall Study|No PCR at baseline|0|||
130949748|NCT02641379|471449826|FG005|Overall Study|No PCR at baseline|0|||
130949749|NCT02641379|471449827|FG006|Overall Study|No PCR at baseline|0|||
130949750|NCT02641379|471449828|FG007|Overall Study|No PCR at baseline|0|||
130949751|NCT02641379|471449829|FG008|Overall Study|No PCR at baseline|0|||
130949752|NCT02641379|471449830|FG009|Overall Study|No PCR at baseline|0|||
130949753|NCT02641379|471449831|FG010|Overall Study|No PCR at baseline|0|||
130949754|NCT02641379|471449821|FG000|Overall Study|PCR positive at Week 28|0|||
130949755|NCT02641379|471449822|FG001|Overall Study|PCR positive at Week 28|0|||
130949756|NCT02641379|471449823|FG002|Overall Study|PCR positive at Week 28|1|||
130710866|NCT01231373|470567047|FG002|Overall Study|Withdrew Consent|0|||
130710867|NCT01231373|470567048|FG003|Overall Study|Withdrew Consent|0|||
130710868|NCT03451006|470567049|FG000|Overall Study|Withdrawal by Subject|2|||
130710869|NCT03451006|470567050|FG001|Overall Study|Withdrawal by Subject|2|||
130710870|NCT01929395|470567051|FG000|Overall Study|Did not complete - non-related toxicity|1|||
130710871|NCT01929395|470567052|FG001|Overall Study|Did not complete - non-related toxicity|0|||
130710872|NCT01929395|470567053|FG002|Overall Study|Did not complete - non-related toxicity|0|||
130949757|NCT02641379|471449824|FG003|Overall Study|PCR positive at Week 28|0|||
130949758|NCT02641379|471449825|FG004|Overall Study|PCR positive at Week 28|0|||
130949759|NCT02641379|471449826|FG005|Overall Study|PCR positive at Week 28|0|||
130949760|NCT02641379|471449827|FG006|Overall Study|PCR positive at Week 28|0|||
130949761|NCT02641379|471449828|FG007|Overall Study|PCR positive at Week 28|0|||
130949762|NCT02641379|471449829|FG008|Overall Study|PCR positive at Week 28|0|||
130949763|NCT02641379|471449830|FG009|Overall Study|PCR positive at Week 28|0|||
130949764|NCT02641379|471449831|FG010|Overall Study|PCR positive at Week 28|0|||
130949765|NCT02641379|471449821|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
130949766|NCT02641379|471449822|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
130710873|NCT01929395|470567051|FG000|Overall Study|Withdrawal by Subject|0|||
130710874|NCT01929395|470567052|FG001|Overall Study|Withdrawal by Subject|1|||
130710875|NCT01929395|470567053|FG002|Overall Study|Withdrawal by Subject|0|||
130710876|NCT01929395|470567051|FG000|Overall Study|Screen Fail|0|||
130710877|NCT01929395|470567052|FG001|Overall Study|Screen Fail|0|||
130710878|NCT01929395|470567053|FG002|Overall Study|Screen Fail|1|||
130710879|NCT02547766|470567054|FG000|Overall Study|Withdrawal by Subject|1|||
130710880|NCT03604341|470567055|FG000|Overall Study|Withdrawal by Subject|1|||
130710881|NCT03604341|470567056|FG001|Overall Study|Withdrawal by Subject|1|||
130710882|NCT03604341|470567055|FG000|Overall Study|Adverse Event|1|||
130710883|NCT03604341|470567056|FG001|Overall Study|Adverse Event|0|||
130710884|NCT03604341|470567055|FG000|Overall Study|Protocol Violation|0|||
130710885|NCT03604341|470567056|FG001|Overall Study|Protocol Violation|1|||
130710886|NCT01829113|470567060|FG000|Overall Study|Disease Progression|37|||
130710887|NCT01829113|470567061|FG001|Overall Study|Disease Progression|48|||
130710888|NCT01829113|470567060|FG000|Overall Study|Adverse Event|14|||
130710889|NCT01829113|470567061|FG001|Overall Study|Adverse Event|10|||
130710890|NCT01829113|470567060|FG000|Overall Study|Withdrawal by Subject|17|||
130710891|NCT01829113|470567061|FG001|Overall Study|Withdrawal by Subject|10|||
130710892|NCT01829113|470567060|FG000|Overall Study|Death|4|||
130710893|NCT01829113|470567061|FG001|Overall Study|Death|6|||
130710894|NCT01829113|470567060|FG000|Overall Study|Sponsor Decision|1|||
130710895|NCT01829113|470567061|FG001|Overall Study|Sponsor Decision|1|||
130710896|NCT01829113|470567060|FG000|Overall Study|No Study Treatment Received|3|||
130710897|NCT01829113|470567061|FG001|Overall Study|No Study Treatment Received|2|||
130710898|NCT01829113|470567060|FG000|Overall Study|Physician Decision|1|||
130710899|NCT01829113|470567061|FG001|Overall Study|Physician Decision|1|||
130710900|NCT04134845|470567066|FG000|Overall Study|withdrawl by PI|5|||
130710901|NCT04134845|470567067|FG001|Overall Study|withdrawl by PI|12|||
130710902|NCT02010255|470567068|FG000|Overall Study|Death|0|||
130710903|NCT02010255|470567069|FG001|Overall Study|Death|1|||
130710904|NCT02010255|470567070|FG002|Overall Study|Death|4|||
130710905|NCT02010255|470567071|FG003|Overall Study|Death|4|||
130710906|NCT02010255|470567072|FG004|Overall Study|Death|2|||
130710907|NCT02010255|470567073|FG005|Overall Study|Death|0|||
130710908|NCT02010255|470567074|FG006|Overall Study|Death|1|||
130710909|NCT02010255|470567075|FG007|Overall Study|Death|1|||
130710910|NCT02010255|470567076|FG008|Overall Study|Death|1|||
130710911|NCT02010255|470567077|FG009|Overall Study|Death|0|||
130710912|NCT02010255|470567078|FG010|Overall Study|Death|1|||
130710913|NCT02010255|470567079|FG011|Overall Study|Death|1|||
130710914|NCT02010255|470567080|FG012|Overall Study|Death|0|||
130710915|NCT02010255|470567081|FG013|Overall Study|Death|0|||
130710916|NCT02010255|470567068|FG000|Overall Study|Lack of Efficacy|4|||
130710917|NCT02010255|470567069|FG001|Overall Study|Lack of Efficacy|1|||
130710918|NCT02010255|470567070|FG002|Overall Study|Lack of Efficacy|2|||
130710919|NCT02010255|470567071|FG003|Overall Study|Lack of Efficacy|1|||
130710920|NCT02010255|470567072|FG004|Overall Study|Lack of Efficacy|1|||
130710921|NCT02010255|470567073|FG005|Overall Study|Lack of Efficacy|0|||
130710922|NCT02010255|470567074|FG006|Overall Study|Lack of Efficacy|0|||
130710923|NCT02010255|470567075|FG007|Overall Study|Lack of Efficacy|0|||
130710924|NCT02010255|470567076|FG008|Overall Study|Lack of Efficacy|0|||
130710925|NCT02010255|470567077|FG009|Overall Study|Lack of Efficacy|0|||
130949767|NCT02641379|471449823|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
130949768|NCT02641379|471449824|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
130949769|NCT02641379|471449825|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
130949770|NCT02641379|471449826|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
130949771|NCT02641379|471449827|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
130949772|NCT02641379|471449828|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
130949773|NCT02641379|471449829|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
130949774|NCT02641379|471449830|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
130949775|NCT02641379|471449831|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
130949776|NCT02641379|471449821|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
131124790|NCT03962101|472085868|FG000|Overall Study|Not related to medical events|1|||
130710926|NCT02010255|470567078|FG010|Overall Study|Lack of Efficacy|1|||
130710927|NCT02010255|470567079|FG011|Overall Study|Lack of Efficacy|0|||
130710928|NCT02010255|470567080|FG012|Overall Study|Lack of Efficacy|0|||
130710929|NCT02010255|470567081|FG013|Overall Study|Lack of Efficacy|0|||
130710930|NCT02010255|470567068|FG000|Overall Study|Withdrew Consent|1|||
130710931|NCT02010255|470567069|FG001|Overall Study|Withdrew Consent|0|||
130710932|NCT02010255|470567070|FG002|Overall Study|Withdrew Consent|0|||
130710933|NCT02010255|470567071|FG003|Overall Study|Withdrew Consent|1|||
130710934|NCT02010255|470567072|FG004|Overall Study|Withdrew Consent|0|||
130710935|NCT02010255|470567073|FG005|Overall Study|Withdrew Consent|0|||
130710936|NCT02010255|470567074|FG006|Overall Study|Withdrew Consent|0|||
130710937|NCT02010255|470567075|FG007|Overall Study|Withdrew Consent|0|||
130710938|NCT02010255|470567076|FG008|Overall Study|Withdrew Consent|0|||
130710939|NCT02010255|470567077|FG009|Overall Study|Withdrew Consent|0|||
130710940|NCT02010255|470567078|FG010|Overall Study|Withdrew Consent|0|||
130710941|NCT02010255|470567079|FG011|Overall Study|Withdrew Consent|0|||
130710942|NCT02010255|470567080|FG012|Overall Study|Withdrew Consent|0|||
130710943|NCT02010255|470567081|FG013|Overall Study|Withdrew Consent|0|||
130710944|NCT02010255|470567068|FG000|Overall Study|Adverse Event|1|||
130710945|NCT02010255|470567069|FG001|Overall Study|Adverse Event|0|||
130710946|NCT02010255|470567070|FG002|Overall Study|Adverse Event|0|||
130710947|NCT02010255|470567071|FG003|Overall Study|Adverse Event|0|||
130710948|NCT02010255|470567072|FG004|Overall Study|Adverse Event|0|||
130710949|NCT02010255|470567073|FG005|Overall Study|Adverse Event|0|||
130710950|NCT02010255|470567074|FG006|Overall Study|Adverse Event|0|||
130710951|NCT02010255|470567075|FG007|Overall Study|Adverse Event|0|||
130710952|NCT02010255|470567076|FG008|Overall Study|Adverse Event|0|||
130710953|NCT02010255|470567077|FG009|Overall Study|Adverse Event|0|||
130710954|NCT02010255|470567078|FG010|Overall Study|Adverse Event|0|||
130710955|NCT02010255|470567079|FG011|Overall Study|Adverse Event|0|||
130710956|NCT02010255|470567080|FG012|Overall Study|Adverse Event|0|||
130710957|NCT02010255|470567081|FG013|Overall Study|Adverse Event|0|||
130710958|NCT02010255|470567068|FG000|Overall Study|Lost to Follow-up|0|||
130710959|NCT02010255|470567069|FG001|Overall Study|Lost to Follow-up|0|||
130710960|NCT02010255|470567070|FG002|Overall Study|Lost to Follow-up|1|||
130710961|NCT02010255|470567071|FG003|Overall Study|Lost to Follow-up|0|||
130710962|NCT02010255|470567072|FG004|Overall Study|Lost to Follow-up|1|||
130710963|NCT02010255|470567073|FG005|Overall Study|Lost to Follow-up|0|||
130710964|NCT02010255|470567074|FG006|Overall Study|Lost to Follow-up|0|||
130710965|NCT02010255|470567075|FG007|Overall Study|Lost to Follow-up|0|||
130710966|NCT02010255|470567076|FG008|Overall Study|Lost to Follow-up|0|||
130710967|NCT02010255|470567077|FG009|Overall Study|Lost to Follow-up|0|||
130710968|NCT02010255|470567078|FG010|Overall Study|Lost to Follow-up|0|||
130710969|NCT02010255|470567079|FG011|Overall Study|Lost to Follow-up|0|||
130710970|NCT02010255|470567080|FG012|Overall Study|Lost to Follow-up|0|||
130710971|NCT02010255|470567081|FG013|Overall Study|Lost to Follow-up|0|||
130710972|NCT02010255|470567068|FG000|Overall Study|Randomized but Not Treated|0|||
130710973|NCT02010255|470567069|FG001|Overall Study|Randomized but Not Treated|0|||
130710974|NCT02010255|470567070|FG002|Overall Study|Randomized but Not Treated|0|||
130710975|NCT02010255|470567071|FG003|Overall Study|Randomized but Not Treated|0|||
130710976|NCT02010255|470567072|FG004|Overall Study|Randomized but Not Treated|0|||
130710977|NCT02010255|470567073|FG005|Overall Study|Randomized but Not Treated|0|||
130710978|NCT02010255|470567074|FG006|Overall Study|Randomized but Not Treated|0|||
130710979|NCT02010255|470567075|FG007|Overall Study|Randomized but Not Treated|0|||
130710980|NCT02010255|470567076|FG008|Overall Study|Randomized but Not Treated|0|||
130710981|NCT02010255|470567077|FG009|Overall Study|Randomized but Not Treated|0|||
130710982|NCT02010255|470567078|FG010|Overall Study|Randomized but Not Treated|0|||
130710983|NCT02010255|470567079|FG011|Overall Study|Randomized but Not Treated|0|||
130710984|NCT02010255|470567080|FG012|Overall Study|Randomized but Not Treated|0|||
130710985|NCT02010255|470567081|FG013|Overall Study|Randomized but Not Treated|1|||
130710986|NCT00767520|470567085|FG000|Overall Study|Participants still on treatment|11|||
130710987|NCT00767520|470567086|FG001|Overall Study|Participants still on treatment|15|||
130710988|NCT00767520|470567085|FG000|Overall Study|Randomized in error and Never treated|0|||
130949777|NCT02641379|471449822|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
130949778|NCT02641379|471449823|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
130949779|NCT02641379|471449824|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
130949780|NCT02641379|471449825|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
130949781|NCT02641379|471449826|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
130949782|NCT02641379|471449827|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
130949783|NCT02641379|471449828|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
130949784|NCT02641379|471449829|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
130949785|NCT02641379|471449830|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
130949786|NCT02641379|471449831|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
130949787|NCT02641379|471449821|FG000|Overall Study|Baseline viral load unavailable|0|||
130949788|NCT02641379|471449822|FG001|Overall Study|Baseline viral load unavailable|0|||
130710989|NCT00767520|470567086|FG001|Overall Study|Randomized in error and Never treated|2|||
130949789|NCT02641379|471449823|FG002|Overall Study|Baseline viral load unavailable|0|||
131124791|NCT00271596|472085871|FG000|Overall Study|Protocol Violation|1|||
130710990|NCT02777918|470567087|FG000|Overall Study|Medical reasons|1|||
130710991|NCT02777918|470567088|FG001|Overall Study|Medical reasons|2|||
130710992|NCT02777918|470567087|FG000|Overall Study|Too busy / stressed|1|||
130710993|NCT02777918|470567088|FG001|Overall Study|Too busy / stressed|1|||
130710994|NCT02777918|470567087|FG000|Overall Study|Withdrawal by Subject|1|||
130710995|NCT02777918|470567088|FG001|Overall Study|Withdrawal by Subject|1|||
130710996|NCT01338987|470567089|FG000|Overall Study|enrolled on new protocol|0|||
130710997|NCT01338987|470567090|FG001|Overall Study|enrolled on new protocol|0|||
130949790|NCT02641379|471449824|FG003|Overall Study|Baseline viral load unavailable|1|||
130710998|NCT01338987|470567091|FG002|Overall Study|enrolled on new protocol|1|||
130710999|NCT01338987|470567092|FG003|Overall Study|enrolled on new protocol|0|||
130711000|NCT01338987|470567093|FG004|Overall Study|enrolled on new protocol|0|||
130711001|NCT01338987|470567089|FG000|Overall Study|Disease progression on study|2|||
130711002|NCT01338987|470567090|FG001|Overall Study|Disease progression on study|1|||
131038249|NCT03058289|471772899|FG000|Overall Study|Radiographic Deterioration|0|||
131038250|NCT03058289|471772900|FG001|Overall Study|Radiographic Deterioration|3|||
131038251|NCT03058289|471772901|FG002|Overall Study|Radiographic Deterioration|1|||
131038252|NCT03058289|471772902|FG003|Overall Study|Radiographic Deterioration|2|||
131038253|NCT03058289|471772903|FG004|Overall Study|Radiographic Deterioration|6|||
131038254|NCT03058289|471772904|FG005|Overall Study|Radiographic Deterioration|3|||
131038255|NCT03058289|471772905|FG006|Overall Study|Radiographic Deterioration|0|||
131038256|NCT03058289|471772906|FG007|Overall Study|Radiographic Deterioration|4|||
131038257|NCT03058289|471772907|FG008|Overall Study|Radiographic Deterioration|2|||
131038258|NCT03058289|471772899|FG000|Overall Study|Adverse Event|2|||
131038259|NCT03058289|471772900|FG001|Overall Study|Adverse Event|0|||
131038260|NCT03058289|471772901|FG002|Overall Study|Adverse Event|1|||
130711003|NCT01338987|470567091|FG002|Overall Study|Disease progression on study|1|||
130711004|NCT01338987|470567092|FG003|Overall Study|Disease progression on study|0|||
130711005|NCT01338987|470567093|FG004|Overall Study|Disease progression on study|0|||
130711006|NCT00757848|470567094|FG000|Overall Study|Voluntary discontinuation|1|||
130711007|NCT00757848|470567095|FG001|Overall Study|Voluntary discontinuation|0|||
130711008|NCT00757848|470567094|FG000|Overall Study|Adverse Event|1|||
130711009|NCT00757848|470567095|FG001|Overall Study|Adverse Event|2|||
130711010|NCT00757848|470567094|FG000|Overall Study|Incorrect enrolment|1|||
130949791|NCT02641379|471449825|FG004|Overall Study|Baseline viral load unavailable|0|||
130949792|NCT02641379|471449826|FG005|Overall Study|Baseline viral load unavailable|0|||
130949793|NCT02641379|471449827|FG006|Overall Study|Baseline viral load unavailable|0|||
130949794|NCT02641379|471449828|FG007|Overall Study|Baseline viral load unavailable|0|||
130949795|NCT02641379|471449829|FG008|Overall Study|Baseline viral load unavailable|0|||
130949796|NCT02641379|471449830|FG009|Overall Study|Baseline viral load unavailable|0|||
130949797|NCT02641379|471449831|FG010|Overall Study|Baseline viral load unavailable|0|||
130949798|NCT02641379|471449821|FG000|Overall Study|Blood could not be drawn|0|||
130949799|NCT02641379|471449822|FG001|Overall Study|Blood could not be drawn|0|||
130949800|NCT02641379|471449823|FG002|Overall Study|Blood could not be drawn|0|||
130949801|NCT02641379|471449824|FG003|Overall Study|Blood could not be drawn|0|||
130949802|NCT02641379|471449825|FG004|Overall Study|Blood could not be drawn|1|||
130949803|NCT02641379|471449826|FG005|Overall Study|Blood could not be drawn|0|||
130949804|NCT02641379|471449827|FG006|Overall Study|Blood could not be drawn|0|||
130949805|NCT02641379|471449828|FG007|Overall Study|Blood could not be drawn|0|||
130949806|NCT02641379|471449829|FG008|Overall Study|Blood could not be drawn|0|||
130949807|NCT02641379|471449830|FG009|Overall Study|Blood could not be drawn|0|||
130949808|NCT02641379|471449831|FG010|Overall Study|Blood could not be drawn|0|||
130949809|NCT02641379|471449821|FG000|Overall Study|Protocol Violation|0|||
130949810|NCT02641379|471449822|FG001|Overall Study|Protocol Violation|0|||
130949811|NCT02641379|471449823|FG002|Overall Study|Protocol Violation|0|||
130949812|NCT02641379|471449824|FG003|Overall Study|Protocol Violation|0|||
130949813|NCT02641379|471449825|FG004|Overall Study|Protocol Violation|2|||
130949814|NCT02641379|471449826|FG005|Overall Study|Protocol Violation|0|||
130949815|NCT02641379|471449827|FG006|Overall Study|Protocol Violation|0|||
130949816|NCT02641379|471449828|FG007|Overall Study|Protocol Violation|0|||
130949817|NCT02641379|471449829|FG008|Overall Study|Protocol Violation|1|||
130949818|NCT02641379|471449830|FG009|Overall Study|Protocol Violation|0|||
130949819|NCT02641379|471449831|FG010|Overall Study|Protocol Violation|0|||
130949820|NCT02641379|471449821|FG000|Overall Study|Participation in sili rescue study|0|||
130949821|NCT02641379|471449822|FG001|Overall Study|Participation in sili rescue study|0|||
130949822|NCT02641379|471449823|FG002|Overall Study|Participation in sili rescue study|0|||
130949823|NCT02641379|471449824|FG003|Overall Study|Participation in sili rescue study|0|||
130949824|NCT02641379|471449825|FG004|Overall Study|Participation in sili rescue study|0|||
130949825|NCT02641379|471449826|FG005|Overall Study|Participation in sili rescue study|1|||
130949826|NCT02641379|471449827|FG006|Overall Study|Participation in sili rescue study|0|||
130949827|NCT02641379|471449828|FG007|Overall Study|Participation in sili rescue study|0|||
130949828|NCT02641379|471449829|FG008|Overall Study|Participation in sili rescue study|0|||
130949829|NCT02641379|471449830|FG009|Overall Study|Participation in sili rescue study|0|||
130949830|NCT02641379|471449831|FG010|Overall Study|Participation in sili rescue study|0|||
130949831|NCT02641379|471449821|FG000|Overall Study|Lost to Follow-up|0|||
131038261|NCT03058289|471772902|FG003|Overall Study|Adverse Event|3|||
130711011|NCT00757848|470567095|FG001|Overall Study|Incorrect enrolment|0|||
130711012|NCT00058214|470567098|FG000|Overall Study|Adverse Event|1|||
130949832|NCT02641379|471449822|FG001|Overall Study|Lost to Follow-up|0|||
130949833|NCT02641379|471449823|FG002|Overall Study|Lost to Follow-up|0|||
130949834|NCT02641379|471449824|FG003|Overall Study|Lost to Follow-up|0|||
130949835|NCT02641379|471449825|FG004|Overall Study|Lost to Follow-up|0|||
130949836|NCT02641379|471449826|FG005|Overall Study|Lost to Follow-up|0|||
130949837|NCT02641379|471449827|FG006|Overall Study|Lost to Follow-up|0|||
130949838|NCT02641379|471449828|FG007|Overall Study|Lost to Follow-up|0|||
130949839|NCT02641379|471449829|FG008|Overall Study|Lost to Follow-up|1|||
131038262|NCT03058289|471772903|FG004|Overall Study|Adverse Event|1|||
131038263|NCT03058289|471772904|FG005|Overall Study|Adverse Event|0|||
130711013|NCT00958126|470567106|FG000|Overall Study|Serious Adverse Event|0|||
130711014|NCT00958126|470567107|FG001|Overall Study|Serious Adverse Event|2|||
130711015|NCT00958126|470567108|FG002|Overall Study|Serious Adverse Event|0|||
130711016|NCT00958126|470567109|FG003|Overall Study|Serious Adverse Event|0|||
130711017|NCT00958126|470567110|FG004|Overall Study|Serious Adverse Event|0|||
130711018|NCT00958126|470567111|FG005|Overall Study|Serious Adverse Event|0|||
130711019|NCT00958126|470567112|FG006|Overall Study|Serious Adverse Event|1|||
130711020|NCT00958126|470567113|FG007|Overall Study|Serious Adverse Event|0|||
130711021|NCT00958126|470567106|FG000|Overall Study|Withdrawal by Subject|0|||
130949840|NCT02641379|471449830|FG009|Overall Study|Lost to Follow-up|0|||
130949841|NCT02641379|471449831|FG010|Overall Study|Lost to Follow-up|0|||
130949842|NCT02641379|471449821|FG000|Overall Study|Source data not found|0|||
130949843|NCT02641379|471449822|FG001|Overall Study|Source data not found|0|||
130949844|NCT02641379|471449823|FG002|Overall Study|Source data not found|0|||
130949845|NCT02641379|471449824|FG003|Overall Study|Source data not found|0|||
130949846|NCT02641379|471449825|FG004|Overall Study|Source data not found|0|||
130949847|NCT02641379|471449826|FG005|Overall Study|Source data not found|1|||
130949848|NCT02641379|471449827|FG006|Overall Study|Source data not found|0|||
130949849|NCT02641379|471449828|FG007|Overall Study|Source data not found|0|||
130949850|NCT02641379|471449829|FG008|Overall Study|Source data not found|0|||
130949851|NCT02641379|471449830|FG009|Overall Study|Source data not found|0|||
130949852|NCT02641379|471449831|FG010|Overall Study|Source data not found|0|||
130949853|NCT02641379|471449821|FG000|Overall Study|Participant showed weight reduction|0|||
130949854|NCT02641379|471449822|FG001|Overall Study|Participant showed weight reduction|0|||
130949855|NCT02641379|471449823|FG002|Overall Study|Participant showed weight reduction|0|||
130949856|NCT02641379|471449824|FG003|Overall Study|Participant showed weight reduction|0|||
130949857|NCT02641379|471449825|FG004|Overall Study|Participant showed weight reduction|0|||
130949858|NCT02641379|471449826|FG005|Overall Study|Participant showed weight reduction|0|||
130949859|NCT02641379|471449827|FG006|Overall Study|Participant showed weight reduction|0|||
130949860|NCT02641379|471449828|FG007|Overall Study|Participant showed weight reduction|1|||
130949861|NCT02641379|471449829|FG008|Overall Study|Participant showed weight reduction|0|||
130949862|NCT02641379|471449830|FG009|Overall Study|Participant showed weight reduction|0|||
130949863|NCT02641379|471449831|FG010|Overall Study|Participant showed weight reduction|0|||
130949864|NCT02641379|471449821|FG000|Overall Study|Non-response Week 12|0|||
130949865|NCT02641379|471449822|FG001|Overall Study|Non-response Week 12|0|||
130949866|NCT02641379|471449823|FG002|Overall Study|Non-response Week 12|0|||
130949867|NCT02641379|471449824|FG003|Overall Study|Non-response Week 12|0|||
130949868|NCT02641379|471449825|FG004|Overall Study|Non-response Week 12|0|||
130949869|NCT02641379|471449826|FG005|Overall Study|Non-response Week 12|0|||
130949870|NCT02641379|471449827|FG006|Overall Study|Non-response Week 12|0|||
130949871|NCT02641379|471449828|FG007|Overall Study|Non-response Week 12|1|||
130949872|NCT02641379|471449829|FG008|Overall Study|Non-response Week 12|0|||
130949873|NCT02641379|471449830|FG009|Overall Study|Non-response Week 12|0|||
130949874|NCT02641379|471449831|FG010|Overall Study|Non-response Week 12|0|||
130949875|NCT02641379|471449821|FG000|Overall Study|No 2 Log drop at Week 12|0|||
130949876|NCT02641379|471449822|FG001|Overall Study|No 2 Log drop at Week 12|0|||
130949877|NCT02641379|471449823|FG002|Overall Study|No 2 Log drop at Week 12|0|||
130949878|NCT02641379|471449824|FG003|Overall Study|No 2 Log drop at Week 12|0|||
130949879|NCT02641379|471449825|FG004|Overall Study|No 2 Log drop at Week 12|0|||
130949880|NCT02641379|471449826|FG005|Overall Study|No 2 Log drop at Week 12|0|||
130949881|NCT02641379|471449827|FG006|Overall Study|No 2 Log drop at Week 12|0|||
130949882|NCT02641379|471449828|FG007|Overall Study|No 2 Log drop at Week 12|0|||
130949883|NCT02641379|471449829|FG008|Overall Study|No 2 Log drop at Week 12|0|||
130949884|NCT02641379|471449830|FG009|Overall Study|No 2 Log drop at Week 12|0|||
130949885|NCT02641379|471449831|FG010|Overall Study|No 2 Log drop at Week 12|1|||
130949886|NCT02641379|471449821|FG000|Overall Study|Negative PCR result|0|||
130949887|NCT02641379|471449822|FG001|Overall Study|Negative PCR result|0|||
130949888|NCT02641379|471449823|FG002|Overall Study|Negative PCR result|0|||
130949889|NCT02641379|471449824|FG003|Overall Study|Negative PCR result|0|||
130949890|NCT02641379|471449825|FG004|Overall Study|Negative PCR result|0|||
130949891|NCT02641379|471449826|FG005|Overall Study|Negative PCR result|0|||
130949892|NCT02641379|471449827|FG006|Overall Study|Negative PCR result|0|||
130711022|NCT00958126|470567107|FG001|Overall Study|Withdrawal by Subject|2|||
130711023|NCT00958126|470567108|FG002|Overall Study|Withdrawal by Subject|0|||
130711024|NCT00958126|470567109|FG003|Overall Study|Withdrawal by Subject|0|||
130949893|NCT02641379|471449828|FG007|Overall Study|Negative PCR result|0|||
130949894|NCT02641379|471449829|FG008|Overall Study|Negative PCR result|0|||
130949895|NCT02641379|471449830|FG009|Overall Study|Negative PCR result|1|||
130949896|NCT02641379|471449831|FG010|Overall Study|Negative PCR result|0|||
130949897|NCT02641379|471449821|FG000|Overall Study|Participant's PCR high|0|||
130949898|NCT02641379|471449822|FG001|Overall Study|Participant's PCR high|0|||
130949899|NCT02641379|471449823|FG002|Overall Study|Participant's PCR high|0|||
130949900|NCT02641379|471449824|FG003|Overall Study|Participant's PCR high|0|||
130711025|NCT00958126|470567110|FG004|Overall Study|Withdrawal by Subject|0|||
130711026|NCT00958126|470567111|FG005|Overall Study|Withdrawal by Subject|0|||
130711027|NCT00958126|470567112|FG006|Overall Study|Withdrawal by Subject|0|||
130949901|NCT02641379|471449825|FG004|Overall Study|Participant's PCR high|0|||
130711028|NCT00958126|470567113|FG007|Overall Study|Withdrawal by Subject|0|||
130949902|NCT02641379|471449826|FG005|Overall Study|Participant's PCR high|0|||
130949903|NCT02641379|471449827|FG006|Overall Study|Participant's PCR high|0|||
130949904|NCT02641379|471449828|FG007|Overall Study|Participant's PCR high|1|||
130949905|NCT02641379|471449829|FG008|Overall Study|Participant's PCR high|0|||
130949906|NCT02641379|471449830|FG009|Overall Study|Participant's PCR high|0|||
130949907|NCT02641379|471449831|FG010|Overall Study|Participant's PCR high|0|||
130949908|NCT02641379|471449821|FG000|Overall Study|Participant treated after Week 24|0|||
130949909|NCT02641379|471449822|FG001|Overall Study|Participant treated after Week 24|0|||
130949910|NCT02641379|471449823|FG002|Overall Study|Participant treated after Week 24|0|||
130949911|NCT02641379|471449824|FG003|Overall Study|Participant treated after Week 24|0|||
130949912|NCT02641379|471449825|FG004|Overall Study|Participant treated after Week 24|0|||
130949913|NCT02641379|471449826|FG005|Overall Study|Participant treated after Week 24|0|||
130949914|NCT02641379|471449827|FG006|Overall Study|Participant treated after Week 24|0|||
130949915|NCT02641379|471449828|FG007|Overall Study|Participant treated after Week 24|0|||
130949916|NCT02641379|471449829|FG008|Overall Study|Participant treated after Week 24|1|||
130949917|NCT02641379|471449830|FG009|Overall Study|Participant treated after Week 24|0|||
130949918|NCT02641379|471449831|FG010|Overall Study|Participant treated after Week 24|0|||
130949919|NCT02641379|471449821|FG000|Overall Study|Missing PCR result at Week 8|0|||
130949920|NCT02641379|471449822|FG001|Overall Study|Missing PCR result at Week 8|0|||
130949921|NCT02641379|471449823|FG002|Overall Study|Missing PCR result at Week 8|0|||
130949922|NCT02641379|471449824|FG003|Overall Study|Missing PCR result at Week 8|0|||
130949923|NCT02641379|471449825|FG004|Overall Study|Missing PCR result at Week 8|0|||
130949924|NCT02641379|471449826|FG005|Overall Study|Missing PCR result at Week 8|0|||
130949925|NCT02641379|471449827|FG006|Overall Study|Missing PCR result at Week 8|0|||
130949926|NCT02641379|471449828|FG007|Overall Study|Missing PCR result at Week 8|0|||
130949927|NCT02641379|471449829|FG008|Overall Study|Missing PCR result at Week 8|0|||
130949928|NCT02641379|471449830|FG009|Overall Study|Missing PCR result at Week 8|1|||
130949929|NCT02641379|471449831|FG010|Overall Study|Missing PCR result at Week 8|0|||
130949930|NCT02641379|471449821|FG000|Overall Study|PCR positive|0|||
130949931|NCT02641379|471449822|FG001|Overall Study|PCR positive|0|||
130949932|NCT02641379|471449823|FG002|Overall Study|PCR positive|0|||
130949933|NCT02641379|471449824|FG003|Overall Study|PCR positive|0|||
130949934|NCT02641379|471449825|FG004|Overall Study|PCR positive|0|||
130949935|NCT02641379|471449826|FG005|Overall Study|PCR positive|0|||
130949936|NCT02641379|471449827|FG006|Overall Study|PCR positive|1|||
130949937|NCT02641379|471449828|FG007|Overall Study|PCR positive|0|||
130949938|NCT02641379|471449829|FG008|Overall Study|PCR positive|0|||
130949939|NCT02641379|471449830|FG009|Overall Study|PCR positive|0|||
130949940|NCT02641379|471449831|FG010|Overall Study|PCR positive|0|||
130949941|NCT04964128|471449832|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
130949942|NCT04964128|471449832|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
130949943|NCT00856908|471449852|FG000|Overall Study|Lost to Follow-up|1|||
130949944|NCT00856908|471449853|FG001|Overall Study|Lost to Follow-up|0|||
130949945|NCT01070316|471449859|FG000|Extension Phase|Lack of Efficacy|3|||
130949946|NCT01070316|471449859|FG000|Extension Phase|Withdrawal by Subject|1|||
130949947|NCT01712256|471449860|FG000|Overall Study|Lost to Follow-up|1|||
130949948|NCT02196324|471449865|FG000|Overall Study|Withdrawal by Subject|8|||
130949949|NCT02196324|471449866|FG001|Overall Study|Withdrawal by Subject|4|||
130949950|NCT02196324|471449865|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
130949951|NCT02196324|471449866|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
130949952|NCT02196324|471449865|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
130949953|NCT02196324|471449866|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
130949954|NCT02196324|471449865|FG000|Overall Study|Other|1|||
130949955|NCT02196324|471449866|FG001|Overall Study|Other|0|||
130949956|NCT00692770|471449867|FG000|Overall Study|Protocol Violation|2|||
130949957|NCT00692770|471449868|FG001|Overall Study|Protocol Violation|7|||
130949958|NCT00692770|471449867|FG000|Overall Study|Withdrawal by Subject|97|||
130949959|NCT00692770|471449868|FG001|Overall Study|Withdrawal by Subject|36|||
130949960|NCT00692770|471449867|FG000|Overall Study|Adverse Event|136|||
130949961|NCT00692770|471449868|FG001|Overall Study|Adverse Event|41|||
130949962|NCT00692770|471449867|FG000|Overall Study|Death|10|||
130949963|NCT00692770|471449868|FG001|Overall Study|Death|5|||
130949964|NCT00692770|471449867|FG000|Overall Study|Lost to Follow-up|7|||
130949965|NCT00692770|471449868|FG001|Overall Study|Lost to Follow-up|3|||
130949966|NCT00692770|471449867|FG000|Overall Study|Non-compliant with study medication|11|||
130949967|NCT00692770|471449868|FG001|Overall Study|Non-compliant with study medication|5|||
130949968|NCT00692770|471449867|FG000|Overall Study|Progression by clinical judgment|2|||
130949969|NCT00692770|471449868|FG001|Overall Study|Progression by clinical judgment|3|||
130949970|NCT00692770|471449867|FG000|Overall Study|Physician decision not protocol driven|10|||
130949971|NCT00692770|471449868|FG001|Overall Study|Physician decision not protocol driven|14|||
130949972|NCT00692770|471449867|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
130949973|NCT00692770|471449868|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
130949974|NCT00692770|471449867|FG000|Overall Study|Protocol driven decision point|3|||
130711029|NCT00958126|470567106|FG000|Overall Study|Moved away from study area|0|||
130711030|NCT00958126|470567107|FG001|Overall Study|Moved away from study area|0|||
130711031|NCT00958126|470567108|FG002|Overall Study|Moved away from study area|1|||
130711032|NCT00958126|470567109|FG003|Overall Study|Moved away from study area|1|||
130711033|NCT00958126|470567110|FG004|Overall Study|Moved away from study area|0|||
130711034|NCT00958126|470567111|FG005|Overall Study|Moved away from study area|0|||
130711035|NCT00958126|470567112|FG006|Overall Study|Moved away from study area|0|||
130711036|NCT00958126|470567113|FG007|Overall Study|Moved away from study area|0|||
130711037|NCT00958126|470567106|FG000|Overall Study|Lost to Follow-up|1|||
130711038|NCT00958126|470567107|FG001|Overall Study|Lost to Follow-up|5|||
130711039|NCT00958126|470567108|FG002|Overall Study|Lost to Follow-up|9|||
130711040|NCT00958126|470567109|FG003|Overall Study|Lost to Follow-up|8|||
130774466|NCT00003896|470800530|FG000|Overall Study|Lack of Efficacy|1|||
130949975|NCT00692770|471449868|FG001|Overall Study|Protocol driven decision point|7|||
130949976|NCT00692770|471449867|FG000|Overall Study|Completed all planned assessments|79|||
130949977|NCT00692770|471449868|FG001|Overall Study|Completed all planned assessments|101|||
130949978|NCT00692770|471449867|FG000|Overall Study|Radiological and clinical progression|8|||
130949979|NCT00692770|471449868|FG001|Overall Study|Radiological and clinical progression|8|||
130949980|NCT00692770|471449867|FG000|Overall Study|Clinical endpoint reached|16|||
130949981|NCT00692770|471449868|FG001|Overall Study|Clinical endpoint reached|43|||
130949982|NCT00692770|471449867|FG000|Overall Study|Study terminated by sponsor|2|||
130949983|NCT00692770|471449868|FG001|Overall Study|Study terminated by sponsor|2|||
130949984|NCT00692770|471449867|FG000|Overall Study|Randomized but not treated|3|||
130949985|NCT00692770|471449868|FG001|Overall Study|Randomized but not treated|4|||
130949986|NCT00560950|471449870|FG000|Overall Study|Lost to Follow-up|1|||
130949987|NCT00560950|471449871|FG001|Overall Study|Lost to Follow-up|0|||
130949988|NCT02181556|471451126|FG000|Overall Study|Withdrawal by Subject|1|||
130949989|NCT00394212|471451127|FG000|Overall Study|Lost to Follow-up|3|||
130949990|NCT00394212|471451128|FG001|Overall Study|Lost to Follow-up|0|||
130949991|NCT00394212|471451127|FG000|Overall Study|Withdrawal by Subject|4|||
130949992|NCT00394212|471451128|FG001|Overall Study|Withdrawal by Subject|1|||
130949993|NCT00588445|471451129|FG000|Overall Study|Protocol Violation|1|||
130949994|NCT00588445|471451129|FG000|Overall Study|Withdrawal by Subject|3|||
130949995|NCT00588445|471451129|FG000|Overall Study|Disease Progression|1|||
130949996|NCT00588445|471451129|FG000|Overall Study|Not Treated|10|||
130949997|NCT03240133|471451130|FG000|Overall Study|Withdrawal by Subject|0|||
130949998|NCT03240133|471451131|FG001|Overall Study|Withdrawal by Subject|1|||
130949999|NCT03240133|471451132|FG002|Overall Study|Withdrawal by Subject|0|||
130950000|NCT03240133|471451130|FG000|Overall Study|Adverse Event|1|||
130950001|NCT03240133|471451131|FG001|Overall Study|Adverse Event|1|||
130950002|NCT03240133|471451132|FG002|Overall Study|Adverse Event|0|||
130950003|NCT03240133|471451130|FG000|Overall Study|Rash|1|||
130950004|NCT03240133|471451131|FG001|Overall Study|Rash|0|||
130950005|NCT03240133|471451132|FG002|Overall Study|Rash|0|||
130950006|NCT03240133|471451130|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
130950007|NCT03240133|471451131|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
130950008|NCT03240133|471451132|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
130950009|NCT03240133|471451130|FG000|Overall Study|Intercurrent illness.|0|||
130950010|NCT03240133|471451131|FG001|Overall Study|Intercurrent illness.|1|||
130950011|NCT03240133|471451132|FG002|Overall Study|Intercurrent illness.|0|||
130950012|NCT03240133|471451130|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
130950013|NCT03240133|471451131|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
130950014|NCT03240133|471451132|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
130950015|NCT01176292|471451136|FG000|Overall Study|Lost to Follow-up|2|||
130950016|NCT01176292|471451137|FG001|Overall Study|Lost to Follow-up|4|||
130774467|NCT00003896|470800530|FG000|Overall Study|Death|3|||
130774468|NCT00003896|470800530|FG000|Overall Study|not protocol specified|3|||
130774469|NCT00003896|470800530|FG000|Overall Study|ineligible|5|||
130774470|NCT01398358|470800531|FG000|Overall Study|Lost to Follow-up|11|||
130774471|NCT01398358|470800532|FG001|Overall Study|Lost to Follow-up|21|||
130774472|NCT01398358|470800533|FG002|Overall Study|Lost to Follow-up|18|||
130950017|NCT01176292|471451136|FG000|Overall Study|Adverse Event|1|||
130950018|NCT01176292|471451137|FG001|Overall Study|Adverse Event|1|||
130950019|NCT01176292|471451136|FG000|Overall Study|Physician Decision|0|||
130950020|NCT01176292|471451137|FG001|Overall Study|Physician Decision|2|||
130711041|NCT00958126|470567110|FG004|Overall Study|Lost to Follow-up|0|||
130711042|NCT00958126|470567111|FG005|Overall Study|Lost to Follow-up|0|||
130711043|NCT00958126|470567112|FG006|Overall Study|Lost to Follow-up|0|||
130711044|NCT00958126|470567113|FG007|Overall Study|Lost to Follow-up|0|||
130711045|NCT00958126|470567106|FG000|Overall Study|Sponsor/Investigator decision|0|||
130950021|NCT01176292|471451136|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
130950022|NCT01176292|471451137|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
130950023|NCT00110812|471451138|FG000|Main Study|Death|0|||
130950024|NCT00110812|471451139|FG001|Main Study|Death|0|||
130950025|NCT00110812|471451140|FG002|Main Study|Death|2|||
130950026|NCT00110812|471451138|FG000|Main Study|Withdrawal by Subject|0|||
130950027|NCT00110812|471451139|FG001|Main Study|Withdrawal by Subject|0|||
130950028|NCT00110812|471451140|FG002|Main Study|Withdrawal by Subject|1|||
130950029|NCT00110812|471451138|FG000|Main Study|Lost to Follow-up|8|||
130950030|NCT00110812|471451139|FG001|Main Study|Lost to Follow-up|11|||
130950031|NCT00110812|471451140|FG002|Main Study|Lost to Follow-up|10|||
130950032|NCT00110812|471451138|FG000|Extended Follow-up|Death|1|||
130950033|NCT00110812|471451139|FG001|Extended Follow-up|Death|0|||
130950034|NCT00110812|471451140|FG002|Extended Follow-up|Death|3|||
130950035|NCT00110812|471451138|FG000|Extended Follow-up|Withdrawal by Subject|0|||
130950036|NCT00110812|471451139|FG001|Extended Follow-up|Withdrawal by Subject|1|||
130950037|NCT00110812|471451140|FG002|Extended Follow-up|Withdrawal by Subject|0|||
130950038|NCT00110812|471451138|FG000|Extended Follow-up|Lost to Follow-up|1|||
130950039|NCT00110812|471451139|FG001|Extended Follow-up|Lost to Follow-up|3|||
130950040|NCT00110812|471451140|FG002|Extended Follow-up|Lost to Follow-up|1|||
130950041|NCT02586493|471451142|FG000|Overall Study|Adverse Event|4|||
130950042|NCT02586493|471451142|FG000|Overall Study|Protocol Violation|6|||
130950043|NCT02586493|471451142|FG000|Overall Study|Lost to Follow-up|1|||
130950044|NCT02586493|471451142|FG000|Overall Study|Withdrawal by Subject|1|||
130950045|NCT03144180|471451146|FG000|Overall Study|STAT Delivery|1|||
130950046|NCT03144180|471451147|FG001|Overall Study|STAT Delivery|1|||
130950047|NCT03144180|471451146|FG000|Overall Study|Provider forgot to fill out forms|1|||
130950048|NCT03144180|471451147|FG001|Overall Study|Provider forgot to fill out forms|3|||
130950049|NCT03144180|471451146|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
130950050|NCT03144180|471451147|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
130950051|NCT03144180|471451146|FG000|Overall Study|Scrub tech removed tube cap|0|||
130950052|NCT03144180|471451147|FG001|Overall Study|Scrub tech removed tube cap|1|||
130950053|NCT02308735|471451152|FG000|Overall Study|Physician Decision|2|||
130950054|NCT02308735|471451153|FG001|Overall Study|Physician Decision|0|||
130950055|NCT02308735|471451154|FG002|Overall Study|Physician Decision|0|||
130950056|NCT02308735|471451155|FG003|Overall Study|Physician Decision|2|||
130950057|NCT04960228|471451160|FG000|Overall Study|Withdrawal by Subject|216|||
130950058|NCT04960228|471451161|FG001|Overall Study|Withdrawal by Subject|35|||
130950059|NCT04960228|471451160|FG000|Overall Study|Failed attention check|69|||
130950060|NCT04960228|471451161|FG001|Overall Study|Failed attention check|148|||
130950061|NCT04960228|471451160|FG000|Overall Study|Flagged for response quality by Dynata|3|||
130950062|NCT04960228|471451161|FG001|Overall Study|Flagged for response quality by Dynata|3|||
130950063|NCT00794196|471451163|FG000|Overall Study|Lost to Follow-up|5|||
130950064|NCT00794196|471451164|FG001|Overall Study|Lost to Follow-up|23|||
130950065|NCT02689258|471451165|FG000|Overall Study|Subject Non-Compliance|0|||
130950066|NCT02689258|471451166|FG001|Overall Study|Subject Non-Compliance|1|||
130950067|NCT02689258|471451167|FG002|Overall Study|Subject Non-Compliance|0|||
130950068|NCT02689258|471451168|FG003|Overall Study|Subject Non-Compliance|0|||
130950069|NCT02689258|471451169|FG004|Overall Study|Subject Non-Compliance|0|||
130950070|NCT02689258|471451170|FG005|Overall Study|Subject Non-Compliance|0|||
130950071|NCT02689258|471451171|FG006|Overall Study|Subject Non-Compliance|0|||
130950072|NCT02689258|471451172|FG007|Overall Study|Subject Non-Compliance|0|||
130950073|NCT02689258|471451173|FG008|Overall Study|Subject Non-Compliance|0|||
130950074|NCT02689258|471451174|FG009|Overall Study|Subject Non-Compliance|0|||
130950075|NCT02689258|471451175|FG010|Overall Study|Subject Non-Compliance|0|||
130950076|NCT02689258|471451176|FG011|Overall Study|Subject Non-Compliance|0|||
130950077|NCT02689258|471451165|FG000|Overall Study|Subject Refusal to Continue|0|||
130950078|NCT02689258|471451166|FG001|Overall Study|Subject Refusal to Continue|1|||
130950079|NCT02689258|471451167|FG002|Overall Study|Subject Refusal to Continue|0|||
130950080|NCT02689258|471451168|FG003|Overall Study|Subject Refusal to Continue|0|||
130950081|NCT02689258|471451169|FG004|Overall Study|Subject Refusal to Continue|0|||
130950082|NCT02689258|471451170|FG005|Overall Study|Subject Refusal to Continue|0|||
130950083|NCT02689258|471451171|FG006|Overall Study|Subject Refusal to Continue|0|||
130950084|NCT02689258|471451172|FG007|Overall Study|Subject Refusal to Continue|0|||
130950085|NCT02689258|471451173|FG008|Overall Study|Subject Refusal to Continue|1|||
130950086|NCT02689258|471451174|FG009|Overall Study|Subject Refusal to Continue|0|||
130950087|NCT02689258|471451175|FG010|Overall Study|Subject Refusal to Continue|0|||
131038264|NCT03058289|471772905|FG006|Overall Study|Adverse Event|1|||
131038265|NCT03058289|471772906|FG007|Overall Study|Adverse Event|3|||
130774473|NCT01398358|470800531|FG000|Overall Study|Withdrawal by Subject|3|||
130950088|NCT02689258|471451176|FG011|Overall Study|Subject Refusal to Continue|1|||
130950089|NCT02689258|471451165|FG000|Overall Study|Other|0|||
130950090|NCT02689258|471451166|FG001|Overall Study|Other|2|||
130950091|NCT02689258|471451167|FG002|Overall Study|Other|0|||
130950092|NCT02689258|471451168|FG003|Overall Study|Other|0|||
130950093|NCT02689258|471451169|FG004|Overall Study|Other|1|||
130950094|NCT02689258|471451170|FG005|Overall Study|Other|0|||
130950095|NCT02689258|471451171|FG006|Overall Study|Other|0|||
130950096|NCT02689258|471451172|FG007|Overall Study|Other|0|||
130950097|NCT02689258|471451173|FG008|Overall Study|Other|1|||
130950098|NCT02689258|471451174|FG009|Overall Study|Other|0|||
130950099|NCT02689258|471451175|FG010|Overall Study|Other|0|||
130950100|NCT02689258|471451176|FG011|Overall Study|Other|0|||
130950101|NCT03742141|471451182|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
130950102|NCT02376166|471451187|FG000|Overall Study|Adverse Event|1|||
130711046|NCT00958126|470567107|FG001|Overall Study|Sponsor/Investigator decision|0|||
130711047|NCT00958126|470567108|FG002|Overall Study|Sponsor/Investigator decision|0|||
130711048|NCT00958126|470567109|FG003|Overall Study|Sponsor/Investigator decision|1|||
130711049|NCT00958126|470567110|FG004|Overall Study|Sponsor/Investigator decision|0|||
130950103|NCT02376166|471451187|FG000|Overall Study|Discontinued metformin early|2|||
130950104|NCT04180020|471451188|FG000|Overall Study|missed visit|18|||
130950105|NCT04180020|471451189|FG001|Overall Study|missed visit|16|||
130950106|NCT04180020|471451188|FG000|Overall Study|Death|2|||
130950107|NCT04180020|471451189|FG001|Overall Study|Death|3|||
130950108|NCT04180020|471451188|FG000|Overall Study|Withdrawal by Subject|1|||
130950109|NCT04180020|471451189|FG001|Overall Study|Withdrawal by Subject|5|||
130950110|NCT04180020|471451188|FG000|Overall Study|incarcerated|1|||
130950111|NCT04180020|471451189|FG001|Overall Study|incarcerated|1|||
130950112|NCT04180020|471451188|FG000|Overall Study|Physician Decision|0|||
130950113|NCT04180020|471451189|FG001|Overall Study|Physician Decision|2|||
130950114|NCT00405548|471451190|FG000|Overall Study|Cognitive Memory problems on study day|1|||
130950115|NCT00405548|471451191|FG001|Overall Study|Cognitive Memory problems on study day|0|||
130950116|NCT00405548|471451190|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
130950117|NCT00405548|471451191|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
130950118|NCT00405548|471451190|FG000|Overall Study|Unable to self-administer shots|1|||
130950119|NCT00405548|471451191|FG001|Overall Study|Unable to self-administer shots|0|||
130950120|NCT00405548|471451190|FG000|Overall Study|Venous access failed during study day|1|||
130950121|NCT00405548|471451191|FG001|Overall Study|Venous access failed during study day|0|||
130950122|NCT00405548|471451190|FG000|Overall Study|Withdrawal by Subject|1|||
130950123|NCT00405548|471451191|FG001|Overall Study|Withdrawal by Subject|0|||
130950124|NCT03554291|471451192|FG000|Overall Study|Death|2|||
130950125|NCT03554291|471451193|FG001|Overall Study|Death|1|||
130950126|NCT03554291|471451192|FG000|Overall Study|Lost to Follow-up|1|||
130950127|NCT03554291|471451193|FG001|Overall Study|Lost to Follow-up|0|||
130950128|NCT03554291|471451192|FG000|Overall Study|Withdrawal by Subject|1|||
130950129|NCT03554291|471451193|FG001|Overall Study|Withdrawal by Subject|0|||
130950130|NCT03554291|471451192|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
130950131|NCT03554291|471451193|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
130950132|NCT02036502|471451194|FG000|Part 1:Dose Determination/Escalation|Death|3|||
130950133|NCT02036502|471451195|FG001|Part 1:Dose Determination/Escalation|Death|2|||
130950134|NCT02036502|471451196|FG002|Part 1:Dose Determination/Escalation|Death|0|||
130950135|NCT02036502|471451197|FG003|Part 1:Dose Determination/Escalation|Death|0|||
130950136|NCT02036502|471451198|FG004|Part 1:Dose Determination/Escalation|Death|0|||
130950137|NCT02036502|471451199|FG005|Part 1:Dose Determination/Escalation|Death|0|||
130950138|NCT02036502|471451200|FG006|Part 1:Dose Determination/Escalation|Death|0|||
130950139|NCT02036502|471451201|FG007|Part 1:Dose Determination/Escalation|Death|0|||
130950140|NCT02036502|471451194|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
130950141|NCT02036502|471451195|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130950142|NCT02036502|471451196|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130950143|NCT02036502|471451197|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130950144|NCT02036502|471451198|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130950145|NCT02036502|471451199|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130950146|NCT02036502|471451200|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130950147|NCT02036502|471451201|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130950148|NCT02036502|471451194|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130950149|NCT02036502|471451195|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
130950150|NCT02036502|471451196|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130950151|NCT02036502|471451197|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130950152|NCT02036502|471451198|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130950153|NCT02036502|471451199|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130950154|NCT02036502|471451200|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130950155|NCT02036502|471451201|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
130950156|NCT02036502|471451194|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
130950157|NCT02036502|471451195|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
130950158|NCT02036502|471451196|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
130950159|NCT02036502|471451197|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
130950160|NCT02036502|471451198|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
130950161|NCT02036502|471451199|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
130950162|NCT02036502|471451200|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
130950163|NCT02036502|471451201|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
130950164|NCT02036502|471451194|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130950165|NCT02036502|471451195|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130950166|NCT02036502|471451196|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
131124792|NCT00271596|472085872|FG001|Overall Study|Protocol Violation|0|||
130711050|NCT00958126|470567111|FG005|Overall Study|Sponsor/Investigator decision|0|||
130950167|NCT02036502|471451197|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
130950168|NCT02036502|471451198|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
130950169|NCT02036502|471451199|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130950170|NCT02036502|471451200|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130950171|NCT02036502|471451201|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130950172|NCT02036502|471451194|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130950173|NCT02036502|471451195|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130950174|NCT02036502|471451196|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
130950175|NCT02036502|471451197|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130950176|NCT02036502|471451198|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130950177|NCT02036502|471451199|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130950178|NCT02036502|471451200|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130950179|NCT02036502|471451201|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
130950180|NCT02036502|471451194|FG000|Part 2:Dose Confirmation|Death|0|||
130950181|NCT02036502|471451195|FG001|Part 2:Dose Confirmation|Death|0|||
130950182|NCT02036502|471451196|FG002|Part 2:Dose Confirmation|Death|1|||
130950183|NCT02036502|471451197|FG003|Part 2:Dose Confirmation|Death|0|||
130950184|NCT02036502|471451198|FG004|Part 2:Dose Confirmation|Death|0|||
130950185|NCT02036502|471451199|FG005|Part 2:Dose Confirmation|Death|0|||
130950186|NCT02036502|471451200|FG006|Part 2:Dose Confirmation|Death|0|||
130950187|NCT02036502|471451201|FG007|Part 2:Dose Confirmation|Death|0|||
130950188|NCT02036502|471451194|FG000|Part 2:Dose Confirmation|Not treated|0|||
130950189|NCT02036502|471451195|FG001|Part 2:Dose Confirmation|Not treated|0|||
130950190|NCT02036502|471451196|FG002|Part 2:Dose Confirmation|Not treated|0|||
130950191|NCT02036502|471451197|FG003|Part 2:Dose Confirmation|Not treated|1|||
130950192|NCT02036502|471451198|FG004|Part 2:Dose Confirmation|Not treated|0|||
130950193|NCT02036502|471451199|FG005|Part 2:Dose Confirmation|Not treated|0|||
130950194|NCT02036502|471451200|FG006|Part 2:Dose Confirmation|Not treated|0|||
130950195|NCT02036502|471451201|FG007|Part 2:Dose Confirmation|Not treated|0|||
130950196|NCT02036502|471451194|FG000|Part 3:Dose Expansion|Adverse Event|0|||
130950197|NCT02036502|471451195|FG001|Part 3:Dose Expansion|Adverse Event|0|||
130950198|NCT02036502|471451196|FG002|Part 3:Dose Expansion|Adverse Event|0|||
130950199|NCT02036502|471451197|FG003|Part 3:Dose Expansion|Adverse Event|0|||
130950200|NCT02036502|471451198|FG004|Part 3:Dose Expansion|Adverse Event|0|||
130950201|NCT02036502|471451199|FG005|Part 3:Dose Expansion|Adverse Event|4|||
130950202|NCT02036502|471451200|FG006|Part 3:Dose Expansion|Adverse Event|0|||
130950203|NCT02036502|471451201|FG007|Part 3:Dose Expansion|Adverse Event|2|||
130950204|NCT02036502|471451194|FG000|Part 3:Dose Expansion|Death|0|||
130950205|NCT02036502|471451195|FG001|Part 3:Dose Expansion|Death|0|||
130950206|NCT02036502|471451196|FG002|Part 3:Dose Expansion|Death|0|||
130950207|NCT02036502|471451197|FG003|Part 3:Dose Expansion|Death|0|||
130950208|NCT02036502|471451198|FG004|Part 3:Dose Expansion|Death|0|||
131038266|NCT03058289|471772907|FG008|Overall Study|Adverse Event|0|||
131038267|NCT03058289|471772899|FG000|Overall Study|Withdrawal by Subject|0|||
130950209|NCT02036502|471451199|FG005|Part 3:Dose Expansion|Death|24|||
131038268|NCT03058289|471772900|FG001|Overall Study|Withdrawal by Subject|0|||
131038269|NCT03058289|471772901|FG002|Overall Study|Withdrawal by Subject|0|||
131038270|NCT03058289|471772902|FG003|Overall Study|Withdrawal by Subject|2|||
131038271|NCT03058289|471772903|FG004|Overall Study|Withdrawal by Subject|0|||
131038272|NCT03058289|471772904|FG005|Overall Study|Withdrawal by Subject|2|||
131038273|NCT03058289|471772905|FG006|Overall Study|Withdrawal by Subject|0|||
131038274|NCT03058289|471772906|FG007|Overall Study|Withdrawal by Subject|4|||
131038275|NCT03058289|471772907|FG008|Overall Study|Withdrawal by Subject|1|||
131038276|NCT03058289|471772899|FG000|Overall Study|Physician Decision|1|||
131038277|NCT03058289|471772900|FG001|Overall Study|Physician Decision|0|||
131038278|NCT03058289|471772901|FG002|Overall Study|Physician Decision|0|||
131038279|NCT03058289|471772902|FG003|Overall Study|Physician Decision|2|||
131038280|NCT03058289|471772903|FG004|Overall Study|Physician Decision|1|||
131038281|NCT03058289|471772904|FG005|Overall Study|Physician Decision|0|||
131038282|NCT03058289|471772905|FG006|Overall Study|Physician Decision|2|||
131038283|NCT03058289|471772906|FG007|Overall Study|Physician Decision|3|||
131038284|NCT03058289|471772907|FG008|Overall Study|Physician Decision|0|||
131038285|NCT03058289|471772899|FG000|Overall Study|Clinical Deterioration|2|||
130950210|NCT02036502|471451200|FG006|Part 3:Dose Expansion|Death|0|||
131038286|NCT03058289|471772900|FG001|Overall Study|Clinical Deterioration|0|||
131225100|NCT01681771|472451955|FG000|Overall Study|Lost to Follow-up|4|||
130950211|NCT02036502|471451201|FG007|Part 3:Dose Expansion|Death|3|||
130950212|NCT02036502|471451194|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
130950213|NCT02036502|471451195|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
130950214|NCT02036502|471451196|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
131038287|NCT03058289|471772901|FG002|Overall Study|Clinical Deterioration|0|||
131038288|NCT03058289|471772902|FG003|Overall Study|Clinical Deterioration|2|||
131038289|NCT03058289|471772903|FG004|Overall Study|Clinical Deterioration|1|||
131038290|NCT03058289|471772904|FG005|Overall Study|Clinical Deterioration|1|||
131038291|NCT03058289|471772905|FG006|Overall Study|Clinical Deterioration|0|||
131038292|NCT03058289|471772906|FG007|Overall Study|Clinical Deterioration|3|||
131038293|NCT03058289|471772907|FG008|Overall Study|Clinical Deterioration|2|||
131038294|NCT03058289|471772899|FG000|Overall Study|Lost to Follow-up|0|||
131038295|NCT03058289|471772900|FG001|Overall Study|Lost to Follow-up|0|||
131038296|NCT03058289|471772901|FG002|Overall Study|Lost to Follow-up|0|||
131038297|NCT03058289|471772902|FG003|Overall Study|Lost to Follow-up|0|||
131038298|NCT03058289|471772903|FG004|Overall Study|Lost to Follow-up|1|||
131124793|NCT00271596|472085871|FG000|Overall Study|Withdrawal by Subject|0|||
131124794|NCT00271596|472085872|FG001|Overall Study|Withdrawal by Subject|1|||
131124795|NCT04707157|472085873|FG000|Overall Study|Adverse Event|12|||
131124796|NCT04707157|472085874|FG001|Overall Study|Adverse Event|3|||
131124797|NCT04707157|472085873|FG000|Overall Study|Lost to Follow-up|2|||
131124798|NCT04707157|472085874|FG001|Overall Study|Lost to Follow-up|0|||
131124799|NCT04707157|472085873|FG000|Overall Study|Sponsor's decision|1|||
131124800|NCT04707157|472085874|FG001|Overall Study|Sponsor's decision|0|||
131124801|NCT04707157|472085873|FG000|Overall Study|Physician Decision|8|||
131124802|NCT04707157|472085874|FG001|Overall Study|Physician Decision|5|||
131124803|NCT04707157|472085873|FG000|Overall Study|Protocol Deviation|1|||
131124804|NCT04707157|472085874|FG001|Overall Study|Protocol Deviation|0|||
131124805|NCT04707157|472085873|FG000|Overall Study|Withdrawal by Subject|1|||
131124806|NCT04707157|472085874|FG001|Overall Study|Withdrawal by Subject|1|||
131124807|NCT01069172|472085876|FG000|Overall Study|Withdrawal by Subject|1|||
131124808|NCT01069172|472085877|FG001|Overall Study|Withdrawal by Subject|0|||
131124809|NCT04206605|472085878|FG000|Overall Study|Adverse Event|0|||
131124810|NCT04206605|472085879|FG001|Overall Study|Adverse Event|1|||
131124811|NCT04206605|472085878|FG000|Overall Study|Withdrawal by Subject|1|||
131124812|NCT04206605|472085879|FG001|Overall Study|Withdrawal by Subject|0|||
131124813|NCT03901079|472085882|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
131124814|NCT04995055|472085885|FG000|Period 1|COVID-19 Related|1|||
130711051|NCT00958126|470567112|FG006|Overall Study|Sponsor/Investigator decision|0|||
130711052|NCT00958126|470567113|FG007|Overall Study|Sponsor/Investigator decision|0|||
130711053|NCT00958126|470567106|FG000|Overall Study|Other Reason|0|||
130711054|NCT00958126|470567107|FG001|Overall Study|Other Reason|0|||
130711055|NCT00958126|470567108|FG002|Overall Study|Other Reason|0|||
130711056|NCT00958126|470567109|FG003|Overall Study|Other Reason|1|||
131038299|NCT03058289|471772904|FG005|Overall Study|Lost to Follow-up|0|||
131038300|NCT03058289|471772905|FG006|Overall Study|Lost to Follow-up|0|||
131038301|NCT03058289|471772906|FG007|Overall Study|Lost to Follow-up|0|||
131038302|NCT03058289|471772907|FG008|Overall Study|Lost to Follow-up|0|||
131038303|NCT03058289|471772899|FG000|Overall Study|Refused Further Treatment|0|||
131038304|NCT03058289|471772900|FG001|Overall Study|Refused Further Treatment|0|||
131038305|NCT03058289|471772901|FG002|Overall Study|Refused Further Treatment|1|||
131038306|NCT03058289|471772902|FG003|Overall Study|Refused Further Treatment|0|||
131038307|NCT03058289|471772903|FG004|Overall Study|Refused Further Treatment|1|||
131038308|NCT03058289|471772904|FG005|Overall Study|Refused Further Treatment|0|||
131038309|NCT03058289|471772905|FG006|Overall Study|Refused Further Treatment|0|||
131038310|NCT03058289|471772906|FG007|Overall Study|Refused Further Treatment|0|||
131038311|NCT03058289|471772907|FG008|Overall Study|Refused Further Treatment|0|||
131038312|NCT03058289|471772899|FG000|Overall Study|Rapid Progression of Disease|0|||
131038313|NCT03058289|471772900|FG001|Overall Study|Rapid Progression of Disease|0|||
131038314|NCT03058289|471772901|FG002|Overall Study|Rapid Progression of Disease|0|||
131038315|NCT03058289|471772902|FG003|Overall Study|Rapid Progression of Disease|1|||
131038316|NCT03058289|471772903|FG004|Overall Study|Rapid Progression of Disease|0|||
131038317|NCT03058289|471772904|FG005|Overall Study|Rapid Progression of Disease|0|||
131038318|NCT03058289|471772905|FG006|Overall Study|Rapid Progression of Disease|0|||
131038319|NCT03058289|471772906|FG007|Overall Study|Rapid Progression of Disease|0|||
131038320|NCT03058289|471772907|FG008|Overall Study|Rapid Progression of Disease|0|||
131038321|NCT05239455|471772911|FG000|Overall Study|Adverse Event|1|||
131038322|NCT05239455|471772911|FG000|Overall Study|Sponsor Decision|5|||
131038323|NCT05239455|471772911|FG000|Overall Study|Incomplete Blood Collection|1|||
131038324|NCT01799265|471772912|FG000|Overall Study|Lost to Follow-up|1|||
131038325|NCT01799265|471772913|FG001|Overall Study|Lost to Follow-up|0|||
131038326|NCT01799265|471772912|FG000|Overall Study|Protocol Violation|2|||
131038327|NCT01799265|471772913|FG001|Overall Study|Protocol Violation|1|||
131038328|NCT01799265|471772912|FG000|Overall Study|inadequate sleep study|0|||
131038329|NCT01799265|471772913|FG001|Overall Study|inadequate sleep study|2|||
131038330|NCT03371381|471774716|FG000|Overall Study|Death|5|||
130711057|NCT00958126|470567110|FG004|Overall Study|Other Reason|0|||
130711058|NCT00958126|470567111|FG005|Overall Study|Other Reason|1|||
130711059|NCT00958126|470567112|FG006|Overall Study|Other Reason|0|||
131038331|NCT03371381|471774716|FG000|Overall Study|Study terminated by sponsor|3|||
131038332|NCT03371381|471774716|FG000|Overall Study|Other|4|||
131038333|NCT06019559|471774718|FG000|Overall Study|Withdrawal by Subject|7|||
131038334|NCT06019559|471774719|FG001|Overall Study|Withdrawal by Subject|6|||
131038335|NCT06019559|471774720|FG002|Overall Study|Withdrawal by Subject|5|||
131038336|NCT06019559|471774718|FG000|Overall Study|Lost to Follow-up|2|||
131038337|NCT06019559|471774719|FG001|Overall Study|Lost to Follow-up|0|||
131038338|NCT06019559|471774720|FG002|Overall Study|Lost to Follow-up|3|||
130711060|NCT00958126|470567113|FG007|Overall Study|Other Reason|0|||
130711061|NCT00720226|470567114|FG000|Overall Study|Withdrawal by Subject|7|||
130711062|NCT00720226|470567115|FG001|Overall Study|Withdrawal by Subject|4|||
130711063|NCT03401073|470567116|FG000|Overall Study|Lost to Follow-up|1|||
130711064|NCT03401073|470567117|FG001|Overall Study|Lost to Follow-up|2|||
130711065|NCT00733369|470567118|FG000|Overall Study|Lost to Follow-up|2|||
130711066|NCT00733369|470567119|FG001|Overall Study|Lost to Follow-up|1|||
130711067|NCT00733369|470567118|FG000|Overall Study|Adverse Event|4|||
130711068|NCT00733369|470567119|FG001|Overall Study|Adverse Event|4|||
130711069|NCT00733369|470567118|FG000|Overall Study|Protocol Violation|4|||
130711070|NCT00733369|470567119|FG001|Overall Study|Protocol Violation|4|||
130711071|NCT01470612|470567120|FG000|Overall Study|Adverse Event|20|||
130711072|NCT01470612|470567121|FG001|Overall Study|Adverse Event|80|||
130711073|NCT01470612|470567120|FG000|Overall Study|Death|0|||
130711074|NCT01470612|470567121|FG001|Overall Study|Death|1|||
130711075|NCT01470612|470567120|FG000|Overall Study|Lack of Efficacy|20|||
130711076|NCT01470612|470567121|FG001|Overall Study|Lack of Efficacy|326|||
130711077|NCT01470612|470567120|FG000|Overall Study|Lost to Follow-up|2|||
130711078|NCT01470612|470567121|FG001|Overall Study|Lost to Follow-up|5|||
130711079|NCT01470612|470567120|FG000|Overall Study|Did not meet entrance criteria|0|||
130711080|NCT01470612|470567121|FG001|Overall Study|Did not meet entrance criteria|1|||
130711081|NCT01470612|470567120|FG000|Overall Study|Pregnancy|2|||
130711082|NCT01470612|470567121|FG001|Overall Study|Pregnancy|10|||
130711083|NCT01470612|470567120|FG000|Overall Study|Protocol Violation|2|||
130711084|NCT01470612|470567121|FG001|Overall Study|Protocol Violation|7|||
130711085|NCT01470612|470567120|FG000|Overall Study|Withdrawal by Subject|24|||
130711086|NCT01470612|470567121|FG001|Overall Study|Withdrawal by Subject|79|||
130711087|NCT01470612|470567120|FG000|Overall Study|Other|14|||
130711088|NCT01470612|470567121|FG001|Overall Study|Other|156|||
130711089|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
130711090|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
130711091|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
130711092|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
130711093|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
130711094|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
130711095|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
130711096|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
130711097|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
130711098|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
130711099|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
130711100|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
130711101|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
130711102|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
130711103|NCT02510014|470567125|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
130711104|NCT02510014|470567126|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
130711105|NCT02510014|470567125|FG000|Treatment Period|Adverse Event|11|||
130711106|NCT02510014|470567126|FG001|Treatment Period|Adverse Event|4|||
130711107|NCT02510014|470567125|FG000|Treatment Period|Withdrawal symptoms|3|||
130711108|NCT02510014|470567126|FG001|Treatment Period|Withdrawal symptoms|0|||
130711109|NCT02510014|470567125|FG000|Treatment Period|Lost to Follow-up|80|||
130711110|NCT02510014|470567126|FG001|Treatment Period|Lost to Follow-up|19|||
130711111|NCT02510014|470567125|FG000|Treatment Period|Physician Decision|5|||
130711112|NCT02510014|470567126|FG001|Treatment Period|Physician Decision|0|||
130711113|NCT02510014|470567125|FG000|Treatment Period|Withdrawal by Subject|67|||
130711114|NCT02510014|470567126|FG001|Treatment Period|Withdrawal by Subject|24|||
130711115|NCT02510014|470567125|FG000|Treatment Period|Withdrawn by the investigator|7|||
131124815|NCT04995055|472085886|FG001|Period 1|COVID-19 Related|0|||
131124816|NCT04995055|472085885|FG000|Period 1|Withdrawal by Subject|0|||
130711116|NCT02510014|470567126|FG001|Treatment Period|Withdrawn by the investigator|1|||
130711117|NCT02510014|470567125|FG000|Treatment Period|Protocol Violation|4|||
130711118|NCT02510014|470567126|FG001|Treatment Period|Protocol Violation|4|||
131124817|NCT04995055|472085886|FG001|Period 1|Withdrawal by Subject|1|||
130711119|NCT02510014|470567125|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
130774474|NCT01398358|470800532|FG001|Overall Study|Withdrawal by Subject|2|||
130774475|NCT01398358|470800533|FG002|Overall Study|Withdrawal by Subject|2|||
130950215|NCT02036502|471451197|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
131124818|NCT04995055|472085885|FG000|Period 1|Subject discontinued due to timing|4|||
131124819|NCT04995055|472085886|FG001|Period 1|Subject discontinued due to timing|4|||
130711120|NCT02510014|470567126|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
130711121|NCT02556307|470567128|FG000|Overall Study|Premature treatment interruption|11|||
130711122|NCT02556307|470567128|FG000|Overall Study|Lost to Follow-up|36|||
130711123|NCT02556307|470567128|FG000|Overall Study|Change to triple therapy|4|||
130711124|NCT02556307|470567128|FG000|Overall Study|Enrolled but not treated|2|||
130711125|NCT00706992|470567134|FG000|Overall Study|Study termination|5|||
130711126|NCT00706992|470567135|FG001|Overall Study|Study termination|5|||
130950216|NCT02036502|471451198|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
130950217|NCT02036502|471451199|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
130950218|NCT02036502|471451200|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
130950219|NCT02036502|471451201|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
130950220|NCT02036502|471451194|FG000|Part 3:Dose Expansion|Physician Decision|0|||
130950221|NCT02036502|471451195|FG001|Part 3:Dose Expansion|Physician Decision|0|||
130950222|NCT02036502|471451196|FG002|Part 3:Dose Expansion|Physician Decision|0|||
130950223|NCT02036502|471451197|FG003|Part 3:Dose Expansion|Physician Decision|0|||
130950224|NCT02036502|471451198|FG004|Part 3:Dose Expansion|Physician Decision|0|||
130950225|NCT02036502|471451199|FG005|Part 3:Dose Expansion|Physician Decision|1|||
130950226|NCT02036502|471451200|FG006|Part 3:Dose Expansion|Physician Decision|0|||
130950227|NCT02036502|471451201|FG007|Part 3:Dose Expansion|Physician Decision|0|||
130950228|NCT02036502|471451194|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
130950229|NCT02036502|471451195|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
130950230|NCT02036502|471451196|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
130950231|NCT02036502|471451197|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
130950232|NCT02036502|471451198|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
130950233|NCT02036502|471451199|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
130950234|NCT02036502|471451200|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
130950235|NCT02036502|471451201|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
130950236|NCT02036502|471451194|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130950237|NCT02036502|471451195|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130950238|NCT02036502|471451196|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130950239|NCT02036502|471451197|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130950240|NCT02036502|471451198|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130950241|NCT02036502|471451199|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
130950242|NCT02036502|471451200|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130950243|NCT02036502|471451201|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
130950244|NCT02036502|471451194|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
130950245|NCT02036502|471451195|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
130950246|NCT02036502|471451196|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
130950247|NCT02036502|471451197|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
130950248|NCT02036502|471451198|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
130950249|NCT02036502|471451199|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
130950250|NCT02036502|471451200|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
131038339|NCT06215521|471774722|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
131038340|NCT06215521|471774723|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
131038341|NCT06215521|471774724|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
131038342|NCT06215521|471774725|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
131038343|NCT06215521|471774726|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
131038344|NCT06215521|471774727|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
130950251|NCT02036502|471451201|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
130950252|NCT02036502|471451194|FG000|Part 3:Dose Expansion|Not Treated|0|||
130950253|NCT02036502|471451195|FG001|Part 3:Dose Expansion|Not Treated|0|||
130950254|NCT02036502|471451196|FG002|Part 3:Dose Expansion|Not Treated|0|||
130950255|NCT02036502|471451197|FG003|Part 3:Dose Expansion|Not Treated|0|||
130950256|NCT02036502|471451198|FG004|Part 3:Dose Expansion|Not Treated|0|||
130950257|NCT02036502|471451199|FG005|Part 3:Dose Expansion|Not Treated|2|||
130950258|NCT02036502|471451200|FG006|Part 3:Dose Expansion|Not Treated|0|||
130950259|NCT02036502|471451201|FG007|Part 3:Dose Expansion|Not Treated|0|||
130950260|NCT02741700|471451202|FG000|Overall Study|Lost to Follow-up|17|||
130950261|NCT02741700|471451203|FG001|Overall Study|Lost to Follow-up|8|||
130950262|NCT02741700|471451202|FG000|Overall Study|Withdrawal by Subject|2|||
130950263|NCT02741700|471451203|FG001|Overall Study|Withdrawal by Subject|5|||
130950264|NCT02741700|471451202|FG000|Overall Study|Physician Decision|3|||
130950265|NCT02741700|471451203|FG001|Overall Study|Physician Decision|0|||
130950266|NCT02741700|471451202|FG000|Overall Study|Moved out of State|0|||
130950267|NCT02741700|471451203|FG001|Overall Study|Moved out of State|1|||
130950268|NCT02741700|471451202|FG000|Overall Study|Death|4|||
130950269|NCT02741700|471451203|FG001|Overall Study|Death|5|||
130950270|NCT00811577|471451204|FG000|Overall Study|Lost to Follow-up|7|||
130950271|NCT00811577|471451205|FG001|Overall Study|Lost to Follow-up|1|||
130950272|NCT00811577|471451204|FG000|Overall Study|Withdrawal by Subject|3|||
130950273|NCT00811577|471451205|FG001|Overall Study|Withdrawal by Subject|0|||
131038345|NCT04044768|471774728|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
131038346|NCT04044768|471774729|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
130950274|NCT01068509|471451206|FG000|Overall Study|Death|0|||
130950275|NCT01068509|471451207|FG001|Overall Study|Death|0|||
130950276|NCT01068509|471451208|FG002|Overall Study|Death|1|||
130950277|NCT01068509|471451206|FG000|Overall Study|Disease Progression|5|||
131038347|NCT05089019|471774733|FG000|Period 1|Withdrawal by Subject|0|||
130950278|NCT01068509|471451207|FG001|Overall Study|Disease Progression|20|||
130950279|NCT01068509|471451208|FG002|Overall Study|Disease Progression|18|||
130950280|NCT01068509|471451206|FG000|Overall Study|Lost to Follow-up|1|||
130950281|NCT01068509|471451207|FG001|Overall Study|Lost to Follow-up|0|||
130950282|NCT01068509|471451208|FG002|Overall Study|Lost to Follow-up|0|||
130711127|NCT00706992|470567136|FG002|Overall Study|Study termination|6|||
130711128|NCT00706992|470567137|FG003|Overall Study|Study termination|2|||
130711129|NCT00706992|470567138|FG004|Overall Study|Study termination|3|||
130711130|NCT00706992|470567139|FG005|Overall Study|Study termination|2|||
130711131|NCT00706992|470567140|FG006|Overall Study|Study termination|3|||
130711132|NCT00706992|470567134|FG000|Overall Study|Disease progression before treatment|0|||
130711133|NCT00706992|470567135|FG001|Overall Study|Disease progression before treatment|0|||
130711134|NCT00706992|470567136|FG002|Overall Study|Disease progression before treatment|0|||
130711135|NCT00706992|470567137|FG003|Overall Study|Disease progression before treatment|0|||
130711136|NCT00706992|470567138|FG004|Overall Study|Disease progression before treatment|1|||
130711137|NCT00706992|470567139|FG005|Overall Study|Disease progression before treatment|0|||
130711138|NCT00706992|470567140|FG006|Overall Study|Disease progression before treatment|0|||
130711139|NCT02377063|470567144|FG000|Overall Study|Non-compliance|5|||
130711140|NCT00702208|470567145|FG000|Overall Study|Lost to Follow-up|28|||
130711141|NCT00702208|470567145|FG000|Overall Study|Did not self-lavage|1|||
130774476|NCT01398358|470800531|FG000|Overall Study|no longer eligible|1|||
130774477|NCT01398358|470800532|FG001|Overall Study|no longer eligible|0|||
130950283|NCT01068509|471451206|FG000|Overall Study|Withdrew Consent|0|||
130950284|NCT01068509|471451207|FG001|Overall Study|Withdrew Consent|1|||
130950285|NCT01068509|471451208|FG002|Overall Study|Withdrew Consent|2|||
130950286|NCT01068509|471451206|FG000|Overall Study|Reason Not Specified|0|||
130950287|NCT01068509|471451207|FG001|Overall Study|Reason Not Specified|1|||
130950288|NCT01068509|471451208|FG002|Overall Study|Reason Not Specified|0|||
130950289|NCT02442778|471451210|FG000|Overall Study|Adverse Event|2|||
130950290|NCT02442778|471451211|FG001|Overall Study|Adverse Event|6|||
130950291|NCT02442778|471451212|FG002|Overall Study|Adverse Event|6|||
130950292|NCT02442778|471451210|FG000|Overall Study|Death|0|||
130950293|NCT02442778|471451211|FG001|Overall Study|Death|2|||
130950294|NCT02442778|471451212|FG002|Overall Study|Death|0|||
130950295|NCT02442778|471451210|FG000|Overall Study|Lack of Efficacy|1|||
130950296|NCT02442778|471451211|FG001|Overall Study|Lack of Efficacy|0|||
130950297|NCT02442778|471451212|FG002|Overall Study|Lack of Efficacy|0|||
130950298|NCT02442778|471451210|FG000|Overall Study|Lost to Follow-up|1|||
130950299|NCT02442778|471451211|FG001|Overall Study|Lost to Follow-up|1|||
130950300|NCT02442778|471451212|FG002|Overall Study|Lost to Follow-up|1|||
130950301|NCT02442778|471451210|FG000|Overall Study|Non-compliance with study drug|2|||
130950302|NCT02442778|471451211|FG001|Overall Study|Non-compliance with study drug|0|||
130950303|NCT02442778|471451212|FG002|Overall Study|Non-compliance with study drug|1|||
130950304|NCT02442778|471451210|FG000|Overall Study|Physician Decision|1|||
130950305|NCT02442778|471451211|FG001|Overall Study|Physician Decision|1|||
130950306|NCT02442778|471451212|FG002|Overall Study|Physician Decision|1|||
130950307|NCT02442778|471451210|FG000|Overall Study|Protocol Deviation|3|||
130950308|NCT02442778|471451211|FG001|Overall Study|Protocol Deviation|0|||
130950309|NCT02442778|471451212|FG002|Overall Study|Protocol Deviation|1|||
130950310|NCT02442778|471451210|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
130950311|NCT02442778|471451211|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
130950312|NCT02442778|471451212|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
130950313|NCT02442778|471451210|FG000|Overall Study|Withdrawal by Subject|4|||
130950314|NCT02442778|471451211|FG001|Overall Study|Withdrawal by Subject|4|||
130950315|NCT02442778|471451212|FG002|Overall Study|Withdrawal by Subject|3|||
130950316|NCT02442778|471451210|FG000|Overall Study|Reason not specified|1|||
130950317|NCT02442778|471451211|FG001|Overall Study|Reason not specified|4|||
130950318|NCT02442778|471451212|FG002|Overall Study|Reason not specified|0|||
130950319|NCT01165138|471451215|FG000|Overall Study|Adverse Event|0|||
130950320|NCT01165138|471451216|FG001|Overall Study|Adverse Event|1|||
130950321|NCT01165138|471451217|FG002|Overall Study|Adverse Event|0|||
130711142|NCT00702208|470567145|FG000|Overall Study|Unsatisfactory colposcopy|2|||
130711143|NCT02746627|470567146|FG000|Overall Study|Withdrawal by Subject|1|||
130711144|NCT02746627|470567147|FG001|Overall Study|Withdrawal by Subject|1|||
130774478|NCT01398358|470800533|FG002|Overall Study|no longer eligible|1|||
130774479|NCT00985686|470800537|FG000|Overall Study|Lost to Follow-up|1|||
130950322|NCT01165138|471451218|FG003|Overall Study|Adverse Event|2|||
130950323|NCT01165138|471451215|FG000|Overall Study|Lack of Efficacy|0|||
130950324|NCT01165138|471451216|FG001|Overall Study|Lack of Efficacy|32|||
130950325|NCT01165138|471451217|FG002|Overall Study|Lack of Efficacy|6|||
131038348|NCT05089019|471774734|FG001|Period 1|Withdrawal by Subject|1|||
130950326|NCT01165138|471451218|FG003|Overall Study|Lack of Efficacy|7|||
130950327|NCT01165138|471451215|FG000|Overall Study|Protocol Violation|0|||
130950328|NCT01165138|471451216|FG001|Overall Study|Protocol Violation|7|||
130950329|NCT01165138|471451217|FG002|Overall Study|Protocol Violation|0|||
130950330|NCT01165138|471451218|FG003|Overall Study|Protocol Violation|2|||
130950331|NCT01165138|471451215|FG000|Overall Study|Lost to Follow-up|0|||
130711145|NCT02746627|470567148|FG002|Overall Study|Withdrawal by Subject|1|||
130711146|NCT01392326|470567153|FG000|Overall Study|Death|2|||
130711147|NCT01392326|470567154|FG001|Overall Study|Death|0|||
130711148|NCT01392326|470567155|FG002|Overall Study|Death|0|||
130950332|NCT01165138|471451216|FG001|Overall Study|Lost to Follow-up|0|||
131038349|NCT05089019|471774733|FG000|Washout Period|Adverse Event|3|||
130711149|NCT01392326|470567153|FG000|Overall Study|Withdrawal by Subject|12|||
130711150|NCT01392326|470567154|FG001|Overall Study|Withdrawal by Subject|11|||
130711151|NCT01392326|470567155|FG002|Overall Study|Withdrawal by Subject|15|||
130711152|NCT01392326|470567153|FG000|Overall Study|Protocol Violation|2|||
130711153|NCT01392326|470567154|FG001|Overall Study|Protocol Violation|0|||
130711154|NCT01392326|470567155|FG002|Overall Study|Protocol Violation|0|||
130711155|NCT01392326|470567153|FG000|Overall Study|Pregnancy|0|||
130711156|NCT01392326|470567154|FG001|Overall Study|Pregnancy|0|||
130711157|NCT01392326|470567155|FG002|Overall Study|Pregnancy|1|||
130711158|NCT01392326|470567153|FG000|Overall Study|Physician Decision|7|||
130711159|NCT01392326|470567154|FG001|Overall Study|Physician Decision|5|||
130711160|NCT01392326|470567155|FG002|Overall Study|Physician Decision|2|||
130711161|NCT01392326|470567153|FG000|Overall Study|Lost to Follow-up|1|||
130711162|NCT01392326|470567154|FG001|Overall Study|Lost to Follow-up|3|||
130711163|NCT01392326|470567155|FG002|Overall Study|Lost to Follow-up|4|||
130711164|NCT01392326|470567153|FG000|Overall Study|Lack of Efficacy|14|||
130711165|NCT01392326|470567154|FG001|Overall Study|Lack of Efficacy|10|||
130711166|NCT01392326|470567155|FG002|Overall Study|Lack of Efficacy|15|||
130711167|NCT01392326|470567153|FG000|Overall Study|Adverse Event|9|||
130711168|NCT01392326|470567154|FG001|Overall Study|Adverse Event|6|||
130711169|NCT01392326|470567155|FG002|Overall Study|Adverse Event|11|||
130711170|NCT00233987|470567158|FG000|Overall Study|Withdrawal by Subject|1|||
130711171|NCT00233987|470567158|FG000|Overall Study|Lack of Efficacy|2|||
130711172|NCT00233987|470567158|FG000|Overall Study|Reason Under Review|1|||
130711173|NCT00233987|470567158|FG000|Overall Study|Other - Not Protocol Specified|5|||
130711174|NCT00233987|470567158|FG000|Overall Study|Eligible but No Treatment Received|2|||
130711175|NCT00233987|470567158|FG000|Overall Study|Ineligible|4|||
130711176|NCT00518622|470567161|FG000|Overall Study|Lost to Follow-up|0|||
130711177|NCT00518622|470567162|FG001|Overall Study|Lost to Follow-up|0|||
130711178|NCT00518622|470567163|FG002|Overall Study|Lost to Follow-up|1|||
130711179|NCT00518622|470567164|FG003|Overall Study|Lost to Follow-up|0|||
130711180|NCT00518622|470567165|FG004|Overall Study|Lost to Follow-up|0|||
130711181|NCT00518622|470567166|FG005|Overall Study|Lost to Follow-up|0|||
130711182|NCT00518622|470567167|FG006|Overall Study|Lost to Follow-up|0|||
130711183|NCT00518622|470567168|FG007|Overall Study|Lost to Follow-up|0|||
130950333|NCT01165138|471451217|FG002|Overall Study|Lost to Follow-up|1|||
130950334|NCT01165138|471451218|FG003|Overall Study|Lost to Follow-up|2|||
130950335|NCT01165138|471451215|FG000|Overall Study|Physician Decision|0|||
130950336|NCT01165138|471451216|FG001|Overall Study|Physician Decision|6|||
130950337|NCT01165138|471451217|FG002|Overall Study|Physician Decision|7|||
130950338|NCT01165138|471451218|FG003|Overall Study|Physician Decision|6|||
130950339|NCT01165138|471451215|FG000|Overall Study|Withdrawal by Subject|0|||
130950340|NCT01165138|471451216|FG001|Overall Study|Withdrawal by Subject|6|||
130950341|NCT01165138|471451217|FG002|Overall Study|Withdrawal by Subject|6|||
130950342|NCT01165138|471451218|FG003|Overall Study|Withdrawal by Subject|3|||
130950343|NCT04982250|471451219|FG000|Overall Study|Lost to Follow-up|0|||
130950344|NCT04982250|471451220|FG001|Overall Study|Lost to Follow-up|26|||
130950345|NCT04982250|471451221|FG002|Overall Study|Lost to Follow-up|0|||
130950346|NCT04982250|471451222|FG003|Overall Study|Lost to Follow-up|0|||
130950347|NCT04982250|471451223|FG004|Overall Study|Lost to Follow-up|72|||
130950348|NCT04982250|471451224|FG005|Overall Study|Lost to Follow-up|69|||
130950349|NCT04982250|471451219|FG000|Overall Study|Not Eligible to Enroll|0|||
130950350|NCT04982250|471451220|FG001|Overall Study|Not Eligible to Enroll|0|||
130950351|NCT04982250|471451221|FG002|Overall Study|Not Eligible to Enroll|0|||
130950352|NCT04982250|471451222|FG003|Overall Study|Not Eligible to Enroll|0|||
131038350|NCT05089019|471774734|FG001|Washout Period|Adverse Event|4|||
131038351|NCT05089019|471774733|FG000|Washout Period|Lost to Follow-up|1|||
131038352|NCT05089019|471774734|FG001|Washout Period|Lost to Follow-up|0|||
130711184|NCT00518622|470567161|FG000|Overall Study|Study medication taken incorrectly|0|||
130711185|NCT00518622|470567162|FG001|Overall Study|Study medication taken incorrectly|1|||
130711186|NCT00518622|470567163|FG002|Overall Study|Study medication taken incorrectly|0|||
130711187|NCT00518622|470567164|FG003|Overall Study|Study medication taken incorrectly|0|||
130711188|NCT00518622|470567165|FG004|Overall Study|Study medication taken incorrectly|0|||
130711189|NCT00518622|470567166|FG005|Overall Study|Study medication taken incorrectly|0|||
130711190|NCT00518622|470567167|FG006|Overall Study|Study medication taken incorrectly|0|||
130711191|NCT00518622|470567168|FG007|Overall Study|Study medication taken incorrectly|0|||
130711192|NCT03821272|470567929|FG000|Overall Study|Death|1|||
130711193|NCT03821272|470567930|FG001|Overall Study|Death|0|||
130711194|NCT03821272|470567929|FG000|Overall Study|Physician Decision|1|||
130711195|NCT03821272|470567930|FG001|Overall Study|Physician Decision|0|||
130711196|NCT03821272|470567929|FG000|Overall Study|Withdrawal by Subject|1|||
130711197|NCT03821272|470567930|FG001|Overall Study|Withdrawal by Subject|0|||
130950353|NCT04982250|471451223|FG004|Overall Study|Not Eligible to Enroll|10|||
130950354|NCT04982250|471451224|FG005|Overall Study|Not Eligible to Enroll|7|||
130950355|NCT01148511|471451226|FG000|Exposed to Study Drug|Protocol Violation|2|||
130950356|NCT01148511|471451227|FG001|Exposed to Study Drug|Protocol Violation|0|||
130950357|NCT01148511|471451228|FG002|Exposed to Study Drug|Protocol Violation|0|||
130950358|NCT01148511|471451226|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
130950359|NCT01148511|471451227|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
130950360|NCT01148511|471451228|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
130950361|NCT01148511|471451226|FG000|Randomized|Adverse Event|0|||
130950362|NCT01148511|471451227|FG001|Randomized|Adverse Event|1|||
130950363|NCT01148511|471451228|FG002|Randomized|Adverse Event|0|||
130950364|NCT01148511|471451226|FG000|Randomized|Protocol Violation|0|||
130950365|NCT01148511|471451227|FG001|Randomized|Protocol Violation|2|||
130950366|NCT01148511|471451228|FG002|Randomized|Protocol Violation|1|||
131124820|NCT01066585|472085887|FG000|Overall Study|Protocol Violation|1|||
130950367|NCT01148511|471451226|FG000|Randomized|Lost to Follow-up|0|||
130950368|NCT01148511|471451227|FG001|Randomized|Lost to Follow-up|1|||
130950369|NCT01148511|471451228|FG002|Randomized|Lost to Follow-up|1|||
130950370|NCT01148511|471451226|FG000|Randomized|Consent withdrawal|0|||
130950371|NCT01148511|471451227|FG001|Randomized|Consent withdrawal|5|||
130950372|NCT01148511|471451228|FG002|Randomized|Consent withdrawal|3|||
130950373|NCT01148511|471451226|FG000|Randomized|Other|0|||
130950374|NCT01148511|471451227|FG001|Randomized|Other|1|||
130950375|NCT01148511|471451228|FG002|Randomized|Other|1|||
130950376|NCT04258605|471451230|FG000|Overall Study|Death|1|||
130950377|NCT04258605|471451231|FG001|Overall Study|Death|0|||
130950378|NCT04258605|471451230|FG000|Overall Study|Early study termination|21|||
130950379|NCT04258605|471451231|FG001|Overall Study|Early study termination|2|||
130950380|NCT01418937|471451236|FG000|Overall Study|Lost to Follow-up|5|||
130950381|NCT01418937|471451236|FG000|Overall Study|Protocol Violation|1|||
130950382|NCT01418937|471451236|FG000|Overall Study|Pregnancy|1|||
130950383|NCT01418937|471451236|FG000|Overall Study|Withdrawal by Subject|1|||
130950384|NCT00962104|471451237|FG000|Overall Study|Adverse Event|10|||
130950385|NCT00962104|471451238|FG001|Overall Study|Adverse Event|3|||
130950386|NCT00962104|471451237|FG000|Overall Study|Entry Criteria Not Met|1|||
130950387|NCT00962104|471451238|FG001|Overall Study|Entry Criteria Not Met|2|||
130950388|NCT00962104|471451237|FG000|Overall Study|Lack of Efficacy|0|||
130950389|NCT00962104|471451238|FG001|Overall Study|Lack of Efficacy|1|||
130950390|NCT00962104|471451237|FG000|Overall Study|Lost to Follow-up|10|||
130950391|NCT00962104|471451238|FG001|Overall Study|Lost to Follow-up|4|||
130950392|NCT00962104|471451237|FG000|Overall Study|Physician Decision|1|||
130950393|NCT00962104|471451238|FG001|Overall Study|Physician Decision|0|||
130950394|NCT00962104|471451237|FG000|Overall Study|Protocol Violation|6|||
130950395|NCT00962104|471451238|FG001|Overall Study|Protocol Violation|8|||
130950396|NCT00962104|471451237|FG000|Overall Study|Sponsor Decision|0|||
130950397|NCT00962104|471451238|FG001|Overall Study|Sponsor Decision|1|||
130950398|NCT00962104|471451237|FG000|Overall Study|Withdrawal by Subject|10|||
130950399|NCT00962104|471451238|FG001|Overall Study|Withdrawal by Subject|6|||
130950400|NCT00962104|471451237|FG000|Overall Study|Other|2|||
130950401|NCT00962104|471451238|FG001|Overall Study|Other|0|||
130950402|NCT02013167|471451239|FG000|Overall Study|Withdrawal by Subject|15|||
130950403|NCT02013167|471451240|FG001|Overall Study|Withdrawal by Subject|14|||
130950404|NCT02013167|471451239|FG000|Overall Study|Sponsor Decision|1|||
130950405|NCT02013167|471451240|FG001|Overall Study|Sponsor Decision|3|||
131124821|NCT01066585|472085888|FG001|Overall Study|Protocol Violation|0|||
131124822|NCT01066585|472085887|FG000|Overall Study|Withdrawal by Subject|0|||
131124823|NCT01066585|472085888|FG001|Overall Study|Withdrawal by Subject|3|||
131124824|NCT00884273|472085889|FG000|Overall Study|Adverse Event|0|||
131124825|NCT00884273|472085890|FG001|Overall Study|Adverse Event|2|||
131124826|NCT00884273|472085889|FG000|Overall Study|Protocol Violation|1|||
131124827|NCT00884273|472085890|FG001|Overall Study|Protocol Violation|3|||
131124828|NCT00884273|472085889|FG000|Overall Study|Practical reasons|1|||
131124829|NCT00884273|472085890|FG001|Overall Study|Practical reasons|0|||
130950406|NCT02013167|471451239|FG000|Overall Study|Lost to Follow-up|0|||
130950407|NCT02013167|471451240|FG001|Overall Study|Lost to Follow-up|1|||
131124830|NCT00578136|472085893|FG000|Overall Study|Not given intervention|1|||
131124831|NCT00578136|472085894|FG001|Overall Study|Not given intervention|1|||
131124832|NCT02047253|472085895|FG000|Overall Study|Lost to Follow-up|8|||
131124833|NCT01987960|472085897|FG000|Period 1|Adverse Event|24|||
131124834|NCT01987960|472085898|FG001|Period 1|Adverse Event|0|||
131124835|NCT01987960|472085899|FG002|Period 1|Adverse Event|0|||
131124836|NCT01987960|472085900|FG003|Period 1|Adverse Event|0|||
131124837|NCT01987960|472085897|FG000|Period 1|Lack of Efficacy|4|||
131124838|NCT01987960|472085898|FG001|Period 1|Lack of Efficacy|0|||
131124839|NCT01987960|472085899|FG002|Period 1|Lack of Efficacy|0|||
131225101|NCT01681771|472451956|FG001|Overall Study|Lost to Follow-up|2|||
131225102|NCT01792284|472451961|FG000|Lead-in Period|Adverse Event|15|||
130711198|NCT05904769|470567931|FG000|Overall Study|Physician Decision|0|||
130950408|NCT02013167|471451239|FG000|Overall Study|Death|85|||
130950409|NCT02013167|471451240|FG001|Overall Study|Death|160|||
130950410|NCT01113879|471451241|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
130950411|NCT01113879|471451242|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
130950412|NCT00615056|471451244|FG000|Overall Study|Death|31|||
130950413|NCT00615056|471451245|FG001|Overall Study|Death|31|||
130950414|NCT00615056|471451246|FG002|Overall Study|Death|21|||
130950415|NCT00615056|471451247|FG003|Overall Study|Death|23|||
131124840|NCT01987960|472085900|FG003|Period 1|Lack of Efficacy|0|||
131225103|NCT01792284|472451962|FG001|Lead-in Period|Adverse Event|0|||
130711199|NCT05904769|470567932|FG001|Overall Study|Physician Decision|6|||
130711200|NCT01688466|470567933|FG000|Overall Study|Withdrawal by Subject|2|||
130950416|NCT00615056|471451244|FG000|Overall Study|Lost to Follow-up|1|||
130950417|NCT00615056|471451245|FG001|Overall Study|Lost to Follow-up|2|||
130950418|NCT00615056|471451246|FG002|Overall Study|Lost to Follow-up|4|||
130950419|NCT00615056|471451247|FG003|Overall Study|Lost to Follow-up|5|||
130950420|NCT00615056|471451244|FG000|Overall Study|Other|13|||
130950421|NCT00615056|471451245|FG001|Overall Study|Other|15|||
130950422|NCT00615056|471451246|FG002|Overall Study|Other|10|||
130950423|NCT00615056|471451247|FG003|Overall Study|Other|7|||
130950424|NCT00615056|471451244|FG000|Overall Study|Objective progression or relapse|0|||
130950425|NCT00615056|471451245|FG001|Overall Study|Objective progression or relapse|2|||
130950426|NCT00615056|471451246|FG002|Overall Study|Objective progression or relapse|0|||
130950427|NCT00615056|471451247|FG003|Overall Study|Objective progression or relapse|0|||
130950428|NCT00615056|471451244|FG000|Overall Study|Withdrawal by Subject|0|||
130950429|NCT00615056|471451245|FG001|Overall Study|Withdrawal by Subject|1|||
130950430|NCT00615056|471451246|FG002|Overall Study|Withdrawal by Subject|1|||
130950431|NCT00615056|471451247|FG003|Overall Study|Withdrawal by Subject|0|||
130950432|NCT00615056|471451244|FG000|Overall Study|Discontinued by Sponsor|1|||
130950433|NCT00615056|471451245|FG001|Overall Study|Discontinued by Sponsor|0|||
130950434|NCT00615056|471451246|FG002|Overall Study|Discontinued by Sponsor|0|||
130950435|NCT00615056|471451247|FG003|Overall Study|Discontinued by Sponsor|0|||
130950436|NCT00615056|471451244|FG000|Overall Study|Randomized but not treated|3|||
130950437|NCT00615056|471451245|FG001|Overall Study|Randomized but not treated|0|||
130950438|NCT00615056|471451246|FG002|Overall Study|Randomized but not treated|0|||
130950439|NCT00615056|471451247|FG003|Overall Study|Randomized but not treated|0|||
130950440|NCT00717769|471451248|FG000|Overall Study|Adverse Event|9|||
130950441|NCT00717769|471451249|FG001|Overall Study|Adverse Event|6|||
130950442|NCT00717769|471451250|FG002|Overall Study|Adverse Event|1|||
130950443|NCT00717769|471451248|FG000|Overall Study|Lack of compliance|0|||
130950444|NCT00717769|471451249|FG001|Overall Study|Lack of compliance|2|||
130950445|NCT00717769|471451250|FG002|Overall Study|Lack of compliance|0|||
130950446|NCT00717769|471451248|FG000|Overall Study|Lost to Follow-up|3|||
130950447|NCT00717769|471451249|FG001|Overall Study|Lost to Follow-up|4|||
130950448|NCT00717769|471451250|FG002|Overall Study|Lost to Follow-up|0|||
130950449|NCT00717769|471451248|FG000|Overall Study|Lack of Efficacy|1|||
130950450|NCT00717769|471451249|FG001|Overall Study|Lack of Efficacy|2|||
130950451|NCT00717769|471451250|FG002|Overall Study|Lack of Efficacy|0|||
130950452|NCT00717769|471451248|FG000|Overall Study|Protocol Violation|0|||
130950453|NCT00717769|471451249|FG001|Overall Study|Protocol Violation|2|||
130950454|NCT00717769|471451250|FG002|Overall Study|Protocol Violation|0|||
130950455|NCT00717769|471451248|FG000|Overall Study|Sponsor decision|1|||
130950456|NCT00717769|471451249|FG001|Overall Study|Sponsor decision|0|||
130950457|NCT00717769|471451250|FG002|Overall Study|Sponsor decision|10|||
130950458|NCT00717769|471451248|FG000|Overall Study|Withdrew consent|2|||
130950459|NCT00717769|471451249|FG001|Overall Study|Withdrew consent|2|||
130950460|NCT00717769|471451250|FG002|Overall Study|Withdrew consent|0|||
130950461|NCT02276612|471451251|FG000|Overall Study|Death|1|||
130950462|NCT02276612|471451252|FG001|Overall Study|Death|0|||
130950463|NCT02276612|471451251|FG000|Overall Study|Pregnancy|1|||
130950464|NCT02276612|471451252|FG001|Overall Study|Pregnancy|0|||
130950465|NCT02276612|471451251|FG000|Overall Study|Withdrew Consent|1|||
130950466|NCT02276612|471451252|FG001|Overall Study|Withdrew Consent|0|||
130950467|NCT02276612|471451251|FG000|Overall Study|Lost to Follow-up|1|||
130950468|NCT02276612|471451252|FG001|Overall Study|Lost to Follow-up|0|||
130950469|NCT00262067|471451253|FG000|Overall Study|Death|190|||
130950470|NCT00262067|471451254|FG001|Overall Study|Death|89|||
130950471|NCT00262067|471451255|FG002|Overall Study|Death|186|||
130950472|NCT00262067|471451256|FG003|Overall Study|Death|99|||
130950473|NCT00262067|471451253|FG000|Overall Study|Lost to Follow-up|5|||
130711201|NCT01688466|470567934|FG001|Overall Study|Withdrawal by Subject|1|||
130711202|NCT01688466|470567933|FG000|Overall Study|Death|0|||
130711203|NCT01688466|470567934|FG001|Overall Study|Death|1|||
130711204|NCT01688466|470567933|FG000|Overall Study|Adverse Event|0|||
130711205|NCT01688466|470567934|FG001|Overall Study|Adverse Event|4|||
130711206|NCT01688466|470567933|FG000|Overall Study|Not evaluable|0|||
130711207|NCT01688466|470567934|FG001|Overall Study|Not evaluable|1|||
130711208|NCT02960893|470567935|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
130774480|NCT00985686|470800538|FG001|Overall Study|Lost to Follow-up|1|||
130950474|NCT00262067|471451254|FG001|Overall Study|Lost to Follow-up|4|||
130950475|NCT00262067|471451255|FG002|Overall Study|Lost to Follow-up|7|||
130950476|NCT00262067|471451256|FG003|Overall Study|Lost to Follow-up|5|||
130950477|NCT00262067|471451253|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
130950478|NCT00262067|471451254|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
130950479|NCT00262067|471451255|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
130950480|NCT00262067|471451256|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
130950481|NCT00262067|471451253|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
130950482|NCT00262067|471451254|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
130950483|NCT00262067|471451255|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
131038353|NCT05089019|471774733|FG000|Washout Period|Physician Decision|2|||
131038354|NCT05089019|471774734|FG001|Washout Period|Physician Decision|0|||
131038355|NCT05089019|471774733|FG000|Washout Period|Withdrawal by Subject|6|||
131038356|NCT05089019|471774734|FG001|Washout Period|Withdrawal by Subject|3|||
131038357|NCT05089019|471774733|FG000|Period 2|Adverse Event|4|||
131038358|NCT05089019|471774734|FG001|Period 2|Adverse Event|2|||
131038359|NCT05089019|471774733|FG000|Period 2|Lost to Follow-up|1|||
131038360|NCT05089019|471774734|FG001|Period 2|Lost to Follow-up|0|||
131038361|NCT05089019|471774733|FG000|Period 2|Withdrawal by Subject|0|||
131038362|NCT05089019|471774734|FG001|Period 2|Withdrawal by Subject|1|||
131038363|NCT03858634|471774735|FG000|Overall Study|Withdrawal by Subject|1|||
131038364|NCT03858634|471774736|FG001|Overall Study|Withdrawal by Subject|0|||
131038365|NCT03858634|471774735|FG000|Overall Study|Adverse Event|1|||
131038366|NCT03858634|471774736|FG001|Overall Study|Adverse Event|0|||
131038367|NCT03858634|471774735|FG000|Overall Study|Lost to Follow-up|0|||
131038368|NCT03858634|471774736|FG001|Overall Study|Lost to Follow-up|1|||
131038369|NCT03858634|471774735|FG000|Overall Study|Other, Not Specified|1|||
131038370|NCT03858634|471774736|FG001|Overall Study|Other, Not Specified|1|||
131038371|NCT03150173|471774737|FG000|Overall Study|Lost to Follow-up|13|||
131038372|NCT03150173|471774738|FG001|Overall Study|Lost to Follow-up|5|||
131038373|NCT01593917|471774739|FG000|Overall Study|Death|67|||
131038374|NCT01593917|471774739|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
131038375|NCT01593917|471774739|FG000|Overall Study|Withdrawal by Subject|23|||
131038376|NCT01593917|471774739|FG000|Overall Study|Lost to Follow-up|12|||
131038377|NCT01593917|471774739|FG000|Overall Study|Protocol Violation|5|||
131038378|NCT01593917|471774739|FG000|Overall Study|Physician Decision|3|||
131038379|NCT04225273|471774752|FG000|Overall Study|Lost to Follow-up|3|||
131038380|NCT05270408|471774754|FG000|Started Treatment|Withdrawal by Subject|0|||
131038381|NCT05270408|471774755|FG001|Started Treatment|Withdrawal by Subject|0|||
131038382|NCT05270408|471774756|FG002|Started Treatment|Withdrawal by Subject|3|||
131038383|NCT05270408|471774754|FG000|Started Treatment|Adverse Event|0|||
131038384|NCT05270408|471774755|FG001|Started Treatment|Adverse Event|0|||
131038385|NCT05270408|471774756|FG002|Started Treatment|Adverse Event|1|||
131038386|NCT05270408|471774754|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
131038387|NCT05270408|471774755|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
131038388|NCT05270408|471774756|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
131038389|NCT03768505|471774757|FG000|Overall Study|sponsor decision|76|||
131038390|NCT03768505|471774757|FG000|Overall Study|Death|35|||
131038391|NCT03768505|471774757|FG000|Overall Study|Other -Various|30|||
131038392|NCT03768505|471774757|FG000|Overall Study|Withdrawal by Subject|22|||
131038393|NCT03768505|471774757|FG000|Overall Study|Lost to Follow-up|6|||
131038394|NCT03133546|471774762|FG000|Overall Study|Death|46|||
131038395|NCT03133546|471774763|FG001|Overall Study|Death|43|||
131038396|NCT03133546|471774762|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
131038397|NCT03133546|471774763|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
131038398|NCT02993159|471774764|FG000|Overall Study|Withdrawal by Subject|1|||
131038399|NCT02993159|471774765|FG001|Overall Study|Withdrawal by Subject|3|||
131038400|NCT02993159|471774764|FG000|Overall Study|Protocol Violation|1|||
131038401|NCT02993159|471774765|FG001|Overall Study|Protocol Violation|0|||
131038402|NCT02993159|471774764|FG000|Overall Study|Opted out of surgery|2|||
131038403|NCT02993159|471774765|FG001|Overall Study|Opted out of surgery|0|||
131038404|NCT02993159|471774764|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
131038405|NCT02993159|471774765|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
131038406|NCT02993159|471774764|FG000|Overall Study|Physician Decision|0|||
131038407|NCT02993159|471774765|FG001|Overall Study|Physician Decision|1|||
131038408|NCT05399459|471774768|FG000|Overall Study|Randomized but not treated|29|||
131038409|NCT05399459|471774769|FG001|Overall Study|Randomized but not treated|30|||
131038410|NCT05399459|471774770|FG002|Overall Study|Randomized but not treated|38|||
131038411|NCT05399459|471774768|FG000|Overall Study|Lost to Follow-up|1|||
131038412|NCT05399459|471774769|FG001|Overall Study|Lost to Follow-up|0|||
131038413|NCT05399459|471774770|FG002|Overall Study|Lost to Follow-up|0|||
131038414|NCT05583578|471774773|FG000|Overall Study|Withdrawal by Subject|2|||
131038415|NCT05583578|471774774|FG001|Overall Study|Withdrawal by Subject|0|||
131038416|NCT05201079|471774776|FG000|Overall Study|Adverse Event|7|||
131038417|NCT05201079|471774777|FG001|Overall Study|Adverse Event|11|||
131038418|NCT05201079|471774776|FG000|Overall Study|Death|1|||
131038419|NCT05201079|471774777|FG001|Overall Study|Death|1|||
131038420|NCT05201079|471774776|FG000|Overall Study|Lack of Efficacy|0|||
130774481|NCT00985686|470800539|FG002|Overall Study|Lost to Follow-up|0|||
131038421|NCT05201079|471774777|FG001|Overall Study|Lack of Efficacy|2|||
131038422|NCT05201079|471774776|FG000|Overall Study|Lost to Follow-up|0|||
131038423|NCT05201079|471774777|FG001|Overall Study|Lost to Follow-up|1|||
131038424|NCT05201079|471774776|FG000|Overall Study|Physician Decision|1|||
131038425|NCT05201079|471774777|FG001|Overall Study|Physician Decision|1|||
131038426|NCT05201079|471774776|FG000|Overall Study|Protocol Violation|1|||
131038427|NCT05201079|471774777|FG001|Overall Study|Protocol Violation|0|||
131038428|NCT05201079|471774776|FG000|Overall Study|Withdrawal by Subject|1|||
131038429|NCT05201079|471774777|FG001|Overall Study|Withdrawal by Subject|0|||
131038430|NCT05201079|471774776|FG000|Overall Study|Forbidden medication|9|||
131038431|NCT05201079|471774777|FG001|Overall Study|Forbidden medication|5|||
131038432|NCT05201079|471774776|FG000|Overall Study|Transfer to another hospital|0|||
131038433|NCT05201079|471774777|FG001|Overall Study|Transfer to another hospital|1|||
131038434|NCT05201079|471774776|FG000|Overall Study|Clinical condition|1|||
131038435|NCT05201079|471774777|FG001|Overall Study|Clinical condition|0|||
131038436|NCT05201079|471774776|FG000|Overall Study|SAE and sepsis|1|||
131038437|NCT05201079|471774777|FG001|Overall Study|SAE and sepsis|0|||
131038438|NCT04042233|471774778|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
131038439|NCT04042233|471774779|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
131038440|NCT04042233|471774778|FG000|Overall Study|Protocol Violation|0|||
131038441|NCT04042233|471774779|FG001|Overall Study|Protocol Violation|2|||
131038442|NCT04907851|471774782|FG000|Overall Study|Consent withdrawn|1|||
131038443|NCT04907851|471774783|FG001|Overall Study|Consent withdrawn|2|||
131038444|NCT04907851|471774784|FG002|Overall Study|Consent withdrawn|0|||
131038445|NCT04907851|471774782|FG000|Overall Study|Death|5|||
131038446|NCT04907851|471774783|FG001|Overall Study|Death|15|||
131038447|NCT04907851|471774784|FG002|Overall Study|Death|10|||
131038448|NCT01210807|471774791|FG000|Overall Study|Lost to Follow-up|1|||
131038449|NCT01210807|471774792|FG001|Overall Study|Lost to Follow-up|2|||
130950484|NCT00262067|471451256|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
130950485|NCT02849548|471451257|FG000|Overall Study|Lost to Follow-up|1|||
130950486|NCT02849548|471451258|FG001|Overall Study|Lost to Follow-up|2|||
130950487|NCT02849548|471451257|FG000|Overall Study|Protocol Violation|1|||
130950488|NCT02849548|471451258|FG001|Overall Study|Protocol Violation|0|||
130950489|NCT02357147|471451260|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
130950490|NCT02357147|471451261|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
130950491|NCT02357147|471451260|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
130950492|NCT02357147|471451261|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
130950493|NCT02357147|471451260|FG000|Combination Treatment Phase|Investigator Discretion|1|||
130950494|NCT02357147|471451261|FG001|Combination Treatment Phase|Investigator Discretion|1|||
130950495|NCT02357147|471451260|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
130950496|NCT02357147|471451261|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
130950497|NCT02357147|471451260|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
130950498|NCT02357147|471451261|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
130950499|NCT02357147|471451260|FG000|Combination Treatment Phase|Adverse Event|12|||
130950500|NCT02357147|471451261|FG001|Combination Treatment Phase|Adverse Event|4|||
130950501|NCT02357147|471451260|FG000|Combination Treatment Phase|Death|1|||
130950502|NCT02357147|471451261|FG001|Combination Treatment Phase|Death|1|||
130950503|NCT02357147|471451260|FG000|Combination Treatment Phase|Sponsor Decision|0|||
130950504|NCT02357147|471451261|FG001|Combination Treatment Phase|Sponsor Decision|12|||
130950505|NCT02357147|471451260|FG000|Combination Treatment Phase|Other|1|||
130950506|NCT02357147|471451261|FG001|Combination Treatment Phase|Other|0|||
130950507|NCT02357147|471451260|FG000|Combination Treatment Phase|Not treated|0|||
130950508|NCT02357147|471451261|FG001|Combination Treatment Phase|Not treated|2|||
130950509|NCT02357147|471451260|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
130950510|NCT02357147|471451261|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
130950511|NCT02357147|471451260|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130950512|NCT02357147|471451261|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
130950513|NCT02357147|471451260|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
130950514|NCT02357147|471451261|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
130950515|NCT02357147|471451260|FG000|Maintenance Treatment Phase|Adverse Event|0|||
130950516|NCT02357147|471451261|FG001|Maintenance Treatment Phase|Adverse Event|3|||
130950517|NCT02357147|471451260|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
130950518|NCT02357147|471451261|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
130950519|NCT02357147|471451260|FG000|Maintenance Treatment Phase|Not Treated|1|||
131038450|NCT01210807|471774791|FG000|Overall Study|Not implanted bilaterally|2|||
131038451|NCT01210807|471774792|FG001|Overall Study|Not implanted bilaterally|1|||
131038452|NCT05477186|471774797|FG000|Overall Study|Vaccine not administered|0|||
131038453|NCT05477186|471774798|FG001|Overall Study|Vaccine not administered|2|||
131038454|NCT05477186|471774799|FG002|Overall Study|Vaccine not administered|1|||
131038455|NCT05477186|471774800|FG003|Overall Study|Vaccine not administered|0|||
131038456|NCT05477186|471774801|FG004|Overall Study|Vaccine not administered|1|||
130711209|NCT02960893|470567936|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
130711210|NCT02960893|470567937|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
130711211|NCT02960893|470567938|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
130950520|NCT02357147|471451261|FG001|Maintenance Treatment Phase|Not Treated|0|||
130950521|NCT03962543|471451262|FG000|Treatment Phase|Death|0|||
130950522|NCT03962543|471451263|FG001|Treatment Phase|Death|1|||
131038457|NCT05477186|471774802|FG005|Overall Study|Vaccine not administered|0|||
131038458|NCT05477186|471774803|FG006|Overall Study|Vaccine not administered|0|||
131038459|NCT05477186|471774797|FG000|Overall Study|Withdrawal by Subject|1|||
130774482|NCT00985686|470800540|FG003|Overall Study|Lost to Follow-up|2|||
130774483|NCT01670045|470800541|FG000|Overall Study|Withdrawal by Subject|3|||
130774484|NCT01670045|470800541|FG000|Overall Study|Adverse Event|1|||
130774485|NCT01670045|470800541|FG000|Overall Study|Death|1|||
130774486|NCT01670045|470800541|FG000|Overall Study|Lost to Follow-up|11|||
130774487|NCT02559570|470800543|FG000|Overall Study|Adverse Event|0|||
130774488|NCT02559570|470800544|FG001|Overall Study|Adverse Event|2|||
130774489|NCT02559570|470800545|FG002|Overall Study|Adverse Event|0|||
130950523|NCT03962543|471451262|FG000|Treatment Phase|Withdrawal by Subject|3|||
130950524|NCT03962543|471451263|FG001|Treatment Phase|Withdrawal by Subject|0|||
130950525|NCT03962543|471451262|FG000|Treatment Phase|Adverse Event|3|||
130950526|NCT03962543|471451263|FG001|Treatment Phase|Adverse Event|12|||
130950527|NCT03962543|471451262|FG000|Treatment Phase|Lost to Follow-up|1|||
130950528|NCT03962543|471451263|FG001|Treatment Phase|Lost to Follow-up|2|||
130950529|NCT03962543|471451262|FG000|Treatment Phase|Radiographic PD|9|||
130950530|NCT03962543|471451263|FG001|Treatment Phase|Radiographic PD|3|||
130950531|NCT03962543|471451262|FG000|Treatment Phase|Participant Decision|3|||
130950532|NCT03962543|471451263|FG001|Treatment Phase|Participant Decision|8|||
130950533|NCT03962543|471451262|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
130950534|NCT03962543|471451263|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
130950535|NCT03962543|471451262|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
130950536|NCT03962543|471451263|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
130950537|NCT03962543|471451262|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
130950538|NCT03962543|471451263|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
130950539|NCT03962543|471451262|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
130950540|NCT03962543|471451263|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
130950541|NCT03962543|471451262|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
130950542|NCT03962543|471451263|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
130950543|NCT03962543|471451262|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
130950544|NCT03962543|471451263|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
130950545|NCT03962543|471451262|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
130950546|NCT03962543|471451263|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
130950547|NCT03962543|471451262|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
130950548|NCT03962543|471451263|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
130950549|NCT03962543|471451262|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
130950550|NCT03962543|471451263|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
130950551|NCT03962543|471451262|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
130950552|NCT03962543|471451263|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
130950553|NCT01940120|471453506|FG000|Overall Study|Death|40|||
130950554|NCT01940120|471453506|FG000|Overall Study|Withdrawal by Subject|8|||
130950555|NCT01572038|471453508|FG000|Overall Study|Death|648|||
130950556|NCT01572038|471453508|FG000|Overall Study|Withdrawal by Subject|204|||
130950557|NCT01572038|471453508|FG000|Overall Study|Lost to Follow-up|81|||
130950558|NCT01572038|471453508|FG000|Overall Study|Physician Decision|20|||
130950559|NCT01572038|471453508|FG000|Overall Study|Patient Decision|14|||
130950560|NCT01572038|471453508|FG000|Overall Study|Progressive Disease|8|||
130950561|NCT01572038|471453508|FG000|Overall Study|Site Closed Before Completing Form|6|||
130950562|NCT01572038|471453508|FG000|Overall Study|Enrolled into Another Trial|3|||
130950563|NCT01572038|471453508|FG000|Overall Study|Participated in Another Trial|3|||
130950564|NCT01572038|471453508|FG000|Overall Study|Termination by Sponsor|2|||
130950565|NCT01572038|471453508|FG000|Overall Study|Patient Deterioration|1|||
130950566|NCT01572038|471453508|FG000|Overall Study|Sponsor Decision|1|||
130950567|NCT01888497|471453509|FG000|Washout Period 1|Withdrawal by Subject|0|||
130950568|NCT01888497|471453510|FG001|Washout Period 1|Withdrawal by Subject|0|||
130950569|NCT01888497|471453511|FG002|Washout Period 1|Withdrawal by Subject|1|||
130950570|NCT01888497|471453512|FG003|Washout Period 1|Withdrawal by Subject|1|||
130950571|NCT01888497|471453509|FG000|Washout Period 2|Adverse Event|0|||
130950572|NCT01888497|471453510|FG001|Washout Period 2|Adverse Event|0|||
131124841|NCT01987960|472085897|FG000|Period 1|Non-compliance with IMP|6|||
130774490|NCT02559570|470800546|FG003|Overall Study|Adverse Event|1|||
130950573|NCT01888497|471453511|FG002|Washout Period 2|Adverse Event|0|||
130950574|NCT01888497|471453512|FG003|Washout Period 2|Adverse Event|1|||
130950575|NCT01888497|471453509|FG000|Washout Period 2|Withdrawal by Subject|0|||
130950576|NCT01888497|471453510|FG001|Washout Period 2|Withdrawal by Subject|0|||
130950577|NCT01888497|471453511|FG002|Washout Period 2|Withdrawal by Subject|0|||
130950578|NCT01888497|471453512|FG003|Washout Period 2|Withdrawal by Subject|1|||
130950579|NCT04152447|471453513|FG000|Overall Study|Lost to Follow-up|1|||
130950580|NCT04152447|471453514|FG001|Overall Study|Lost to Follow-up|0|||
130950581|NCT04152447|471453513|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
130774491|NCT02559570|470800547|FG004|Overall Study|Adverse Event|0|||
130774492|NCT02559570|470800543|FG000|Overall Study|Withdrawal of Consent|0|||
130774493|NCT02559570|470800544|FG001|Overall Study|Withdrawal of Consent|0|||
130950582|NCT04152447|471453514|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
130950583|NCT04152447|471453513|FG000|Overall Study|Withdrawal by Subject|0|||
130774494|NCT02559570|470800545|FG002|Overall Study|Withdrawal of Consent|1|||
131038460|NCT05477186|471774798|FG001|Overall Study|Withdrawal by Subject|0|||
131038461|NCT05477186|471774799|FG002|Overall Study|Withdrawal by Subject|0|||
131038462|NCT05477186|471774800|FG003|Overall Study|Withdrawal by Subject|0|||
131038463|NCT05477186|471774801|FG004|Overall Study|Withdrawal by Subject|0|||
131038464|NCT05477186|471774802|FG005|Overall Study|Withdrawal by Subject|1|||
131038465|NCT05477186|471774803|FG006|Overall Study|Withdrawal by Subject|0|||
131038466|NCT05477186|471774797|FG000|Overall Study|Lost to Follow-up|1|||
131038467|NCT05477186|471774798|FG001|Overall Study|Lost to Follow-up|0|||
131038468|NCT05477186|471774799|FG002|Overall Study|Lost to Follow-up|2|||
131038469|NCT05477186|471774800|FG003|Overall Study|Lost to Follow-up|1|||
131038470|NCT05477186|471774801|FG004|Overall Study|Lost to Follow-up|1|||
131038471|NCT05477186|471774802|FG005|Overall Study|Lost to Follow-up|0|||
131038472|NCT05477186|471774803|FG006|Overall Study|Lost to Follow-up|2|||
131038473|NCT00324805|471774804|FG000|Overall Study|Adverse Event|62|||
131038474|NCT00324805|471774805|FG001|Overall Study|Adverse Event|203|||
131038475|NCT00324805|471774804|FG000|Overall Study|Progression|7|||
131038476|NCT00324805|471774805|FG001|Overall Study|Progression|35|||
131038477|NCT00324805|471774804|FG000|Overall Study|Withdrawal by Subject|51|||
131038478|NCT00324805|471774805|FG001|Overall Study|Withdrawal by Subject|174|||
131038479|NCT00324805|471774804|FG000|Overall Study|Death|6|||
131038480|NCT00324805|471774805|FG001|Overall Study|Death|9|||
131038481|NCT00324805|471774804|FG000|Overall Study|Alternative therapy|4|||
131038482|NCT00324805|471774805|FG001|Overall Study|Alternative therapy|8|||
131038483|NCT00324805|471774804|FG000|Overall Study|Other complicating disease|1|||
131038484|NCT00324805|471774805|FG001|Overall Study|Other complicating disease|9|||
131038485|NCT00324805|471774804|FG000|Overall Study|Other reasons|7|||
131038486|NCT00324805|471774805|FG001|Overall Study|Other reasons|26|||
131038487|NCT00324805|471774804|FG000|Overall Study|Other|0|||
131038488|NCT00324805|471774805|FG001|Overall Study|Other|2|||
131038489|NCT00324805|471774804|FG000|Overall Study|Did not start therapy|12|||
131038490|NCT00324805|471774805|FG001|Overall Study|Did not start therapy|17|||
131038491|NCT05792085|471774807|FG000|Overall Study|Death|0|||
131038492|NCT05792085|471774808|FG001|Overall Study|Death|0|||
131038493|NCT05792085|471774809|FG002|Overall Study|Death|0|||
131038494|NCT05792085|471774810|FG003|Overall Study|Death|0|||
131038495|NCT05792085|471774811|FG004|Overall Study|Death|1|||
131038496|NCT01919554|471774812|FG000|Overall Study|Withdrawal by Subject|0|||
131038497|NCT01919554|471774813|FG001|Overall Study|Withdrawal by Subject|0|||
131038498|NCT01919554|471774814|FG002|Overall Study|Withdrawal by Subject|1|||
131038499|NCT01919554|471774815|FG003|Overall Study|Withdrawal by Subject|1|||
131038500|NCT04524442|471774817|FG000|Overall Study|Subject Decision|1|||
131038501|NCT01197378|471774820|FG000|Overall Study|Adverse Event|3|||
131038502|NCT01197378|471774820|FG000|Overall Study|Withdrawal by Subject|1|||
131038503|NCT01197378|471774820|FG000|Overall Study|Physician Decision|1|||
131038504|NCT01197378|471774820|FG000|Overall Study|Other|2|||
131038505|NCT05546411|471774822|FG000|Overall Study|Progressive Disease|1|||
131038506|NCT05546411|471774823|FG001|Overall Study|Progressive Disease|0|||
131038507|NCT05546411|471774822|FG000|Overall Study|Adverse Event|0|||
131038508|NCT05546411|471774823|FG001|Overall Study|Adverse Event|1|||
131038509|NCT05546411|471774822|FG000|Overall Study|Metastatic disease|1|||
131038510|NCT05546411|471774823|FG001|Overall Study|Metastatic disease|0|||
131038511|NCT02606422|471774824|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
131038512|NCT02606422|471774825|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
131038513|NCT02606422|471774824|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
131038514|NCT02606422|471774825|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
131038515|NCT02606422|471774824|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
131038516|NCT02606422|471774825|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
131038517|NCT02606422|471774824|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
131038518|NCT02606422|471774825|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
131038519|NCT04625465|471774826|FG000|Overall Study|Lost to Follow-up|2|||
130711212|NCT02960893|470567935|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
130711213|NCT02960893|470567936|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
130711214|NCT02960893|470567937|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
131038520|NCT04625465|471774827|FG001|Overall Study|Lost to Follow-up|2|||
131038521|NCT04625465|471774828|FG002|Overall Study|Lost to Follow-up|1|||
131038522|NCT04625465|471774829|FG003|Overall Study|Lost to Follow-up|0|||
131038523|NCT04625465|471774830|FG004|Overall Study|Lost to Follow-up|0|||
131038524|NCT04625465|471774831|FG005|Overall Study|Lost to Follow-up|2|||
131038525|NCT04625465|471774832|FG006|Overall Study|Lost to Follow-up|0|||
131038526|NCT04625465|471774833|FG007|Overall Study|Lost to Follow-up|0|||
131038527|NCT04625465|471774826|FG000|Overall Study|Death|1|||
131038528|NCT04625465|471774827|FG001|Overall Study|Death|0|||
131038529|NCT04625465|471774828|FG002|Overall Study|Death|0|||
131038530|NCT04625465|471774829|FG003|Overall Study|Death|0|||
131038531|NCT04625465|471774830|FG004|Overall Study|Death|0|||
131038532|NCT04625465|471774831|FG005|Overall Study|Death|0|||
131038533|NCT04625465|471774832|FG006|Overall Study|Death|0|||
131038534|NCT04625465|471774833|FG007|Overall Study|Death|0|||
131038535|NCT04625465|471774826|FG000|Overall Study|Withdrawal by Subject|1|||
130950584|NCT04152447|471453514|FG001|Overall Study|Withdrawal by Subject|1|||
130950585|NCT04152447|471453513|FG000|Overall Study|Found ineligible after enrolling|1|||
130950586|NCT04152447|471453514|FG001|Overall Study|Found ineligible after enrolling|1|||
130950587|NCT04152447|471453513|FG000|Overall Study|Did not receive VR headset in time.|0|||
130950588|NCT04152447|471453514|FG001|Overall Study|Did not receive VR headset in time.|2|||
130950589|NCT03034954|471453521|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
130950590|NCT03034954|471453522|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
130950591|NCT01275066|471453527|FG000|Overall Study|Withdrawal by Subject|0|||
130950592|NCT01275066|471453528|FG001|Overall Study|Withdrawal by Subject|0|||
130950593|NCT01275066|471453529|FG002|Overall Study|Withdrawal by Subject|1|||
130950594|NCT01275066|471453527|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
130950595|NCT01275066|471453528|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
130950596|NCT01275066|471453529|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
130950597|NCT04200248|471453532|FG000|Overall Study|Personal reasons|0|||
130950598|NCT04200248|471453533|FG001|Overall Study|Personal reasons|0|||
130950599|NCT04200248|471453534|FG002|Overall Study|Personal reasons|1|||
130950600|NCT04200248|471453532|FG000|Overall Study|Discontinued prior to treatment|3|||
130950601|NCT04200248|471453533|FG001|Overall Study|Discontinued prior to treatment|3|||
130950602|NCT04200248|471453534|FG002|Overall Study|Discontinued prior to treatment|2|||
130950603|NCT00934544|471453540|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
130950604|NCT00934544|471453541|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
130950605|NCT00934544|471453542|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
130950606|NCT00934544|471453540|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
130950607|NCT00934544|471453541|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
130950608|NCT00934544|471453542|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
130950609|NCT00934544|471453540|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
130950610|NCT00934544|471453541|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
130950611|NCT00934544|471453542|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
130950612|NCT00934544|471453540|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
130950613|NCT00934544|471453541|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
130950614|NCT00934544|471453542|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
130950615|NCT00934544|471453540|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
130950616|NCT00934544|471453541|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
130950617|NCT00934544|471453542|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
130950618|NCT00934544|471453540|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
130950619|NCT00934544|471453541|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
130950620|NCT00934544|471453542|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
130950621|NCT00934544|471453540|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
130950622|NCT00934544|471453541|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
130950623|NCT00934544|471453542|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
130950624|NCT00934544|471453540|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
130950625|NCT00934544|471453541|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
130950626|NCT00934544|471453542|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
130950627|NCT00934544|471453540|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
130950628|NCT00934544|471453541|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
130950629|NCT00934544|471453542|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
130950630|NCT00934544|471453540|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
130950631|NCT00934544|471453541|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
130950632|NCT00934544|471453542|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
130950633|NCT00934544|471453540|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
130950634|NCT00934544|471453541|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
130950635|NCT00934544|471453542|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
130950636|NCT00934544|471453540|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
130950637|NCT00934544|471453541|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
130950638|NCT00934544|471453542|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
130950639|NCT00934544|471453540|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
130950640|NCT00934544|471453541|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
130950641|NCT00934544|471453542|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
130950642|NCT00934544|471453540|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
130950643|NCT00934544|471453541|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
130950644|NCT00934544|471453542|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
130950645|NCT00934544|471453540|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
130950646|NCT00934544|471453541|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
130950647|NCT00934544|471453542|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
131045854|NCT03582033|471802281|FG003|Part D|Death|0|||
130711215|NCT02960893|470567938|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
130711216|NCT02960893|470567935|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
130711217|NCT02960893|470567936|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
130711218|NCT02960893|470567937|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
130711219|NCT02960893|470567938|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
130950648|NCT00934544|471453540|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
130950649|NCT00934544|471453541|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
130950650|NCT00934544|471453542|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
130950651|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
130950652|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
130950653|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
130950654|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
130950655|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
130950656|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
130950657|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
130950658|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
130950659|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
130950660|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
130950661|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
130950662|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
130950663|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
130950664|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
130950665|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
130950666|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
130950667|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
130950668|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
130950669|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
130950670|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
130950671|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
130950672|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
130950673|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
130950674|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
130950675|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
130950676|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
130950677|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
130950678|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
130950679|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
130950680|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
130950681|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
130950682|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
130950683|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
130950684|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
130950685|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
130950686|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
130950687|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
130950688|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
130950689|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
130950690|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
130950691|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
130950692|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
130950693|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
130950694|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
130950695|NCT01218516|471453543|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
130950696|NCT01218516|471453544|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
130950697|NCT01218516|471453545|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
130950698|NCT01218516|471453546|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
130950699|NCT04033003|471453548|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
130950700|NCT04033003|471453549|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
131045855|NCT03582033|471802282|FG004|Part D|Death|0|||
130711220|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
130711221|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
130711222|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
130950701|NCT04033003|471453548|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
130950702|NCT04033003|471453549|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
130950703|NCT04033003|471453548|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
130950704|NCT04033003|471453549|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
130950705|NCT04033003|471453548|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
130950706|NCT04033003|471453549|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
130950707|NCT04033003|471453548|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
130950708|NCT04033003|471453549|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
130950709|NCT04033003|471453548|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
130950710|NCT04033003|471453549|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
130950711|NCT04033003|471453548|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
130950712|NCT04033003|471453549|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
130950713|NCT04033003|471453548|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
130950714|NCT04033003|471453549|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
130950715|NCT04033003|471453548|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
130950716|NCT04033003|471453549|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
130950717|NCT04033003|471453548|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
130950718|NCT04033003|471453549|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
130950719|NCT04033003|471453548|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
130950720|NCT04033003|471453549|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
130950721|NCT04033003|471453548|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
130950722|NCT04033003|471453549|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
130950723|NCT04033003|471453548|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
130950724|NCT04033003|471453549|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
130950725|NCT04171414|471453550|FG000|Overall Study|Death|1|||
130950726|NCT04171414|471453550|FG000|Overall Study|Withdrawal by Subject|1|||
130950727|NCT01714310|471453551|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
130950728|NCT01714310|471453552|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
130950729|NCT01714310|471453553|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
130950730|NCT01714310|471453551|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
130950731|NCT01714310|471453552|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
130950732|NCT01714310|471453553|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
130950733|NCT01714310|471453551|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
130950734|NCT01714310|471453552|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
130950735|NCT01714310|471453553|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
130950736|NCT01714310|471453551|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
130950737|NCT01714310|471453552|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
130950738|NCT01714310|471453553|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
130950739|NCT02487394|471453562|FG000|Phase 1|Withdrawal by Subject|0|||
130950740|NCT02487394|471453563|FG001|Phase 1|Withdrawal by Subject|1|||
130950741|NCT00782210|471453568|FG000|Overall Study|Adverse Event|21|||
130950742|NCT00782210|471453569|FG001|Overall Study|Adverse Event|17|||
130950743|NCT00782210|471453570|FG002|Overall Study|Adverse Event|16|||
130950744|NCT00782210|471453568|FG000|Overall Study|Lost to Follow-up|2|||
130950745|NCT00782210|471453569|FG001|Overall Study|Lost to Follow-up|1|||
130950746|NCT00782210|471453570|FG002|Overall Study|Lost to Follow-up|2|||
130950747|NCT00782210|471453568|FG000|Overall Study|Withdrawal by Subject|11|||
130950748|NCT00782210|471453569|FG001|Overall Study|Withdrawal by Subject|8|||
130950749|NCT00782210|471453570|FG002|Overall Study|Withdrawal by Subject|11|||
130950750|NCT00782210|471453568|FG000|Overall Study|Non compliance with protocol|0|||
130950751|NCT00782210|471453569|FG001|Overall Study|Non compliance with protocol|3|||
130950752|NCT00782210|471453570|FG002|Overall Study|Non compliance with protocol|2|||
130950753|NCT00782210|471453568|FG000|Overall Study|Lack of Efficacy|13|||
130950754|NCT00782210|471453569|FG001|Overall Study|Lack of Efficacy|4|||
130950755|NCT00782210|471453570|FG002|Overall Study|Lack of Efficacy|1|||
130950756|NCT00782210|471453568|FG000|Overall Study|Other reason not described above|3|||
130950757|NCT00782210|471453569|FG001|Overall Study|Other reason not described above|2|||
130950758|NCT00782210|471453570|FG002|Overall Study|Other reason not described above|3|||
130950759|NCT00654381|471453573|FG000|1st Stage|Adverse Event|3|||
130950760|NCT00654381|471453574|FG001|1st Stage|Adverse Event|3|||
130950761|NCT00654381|471453575|FG002|1st Stage|Adverse Event|3|||
130950762|NCT00654381|471453576|FG003|1st Stage|Adverse Event|3|||
131038536|NCT04625465|471774827|FG001|Overall Study|Withdrawal by Subject|0|||
130950763|NCT00654381|471453577|FG004|1st Stage|Adverse Event|2|||
130950764|NCT00654381|471453578|FG005|1st Stage|Adverse Event|1|||
130950765|NCT00654381|471453573|FG000|1st Stage|Withdrawal by Subject|0|||
130950766|NCT00654381|471453574|FG001|1st Stage|Withdrawal by Subject|0|||
130950767|NCT00654381|471453575|FG002|1st Stage|Withdrawal by Subject|0|||
131038537|NCT04625465|471774828|FG002|Overall Study|Withdrawal by Subject|4|||
130950768|NCT00654381|471453576|FG003|1st Stage|Withdrawal by Subject|1|||
130950769|NCT00654381|471453577|FG004|1st Stage|Withdrawal by Subject|0|||
131038538|NCT04625465|471774829|FG003|Overall Study|Withdrawal by Subject|4|||
131038539|NCT04625465|471774830|FG004|Overall Study|Withdrawal by Subject|4|||
130950770|NCT00654381|471453578|FG005|1st Stage|Withdrawal by Subject|1|||
130950771|NCT00654381|471453573|FG000|1st Stage|Investigator's decision|0|||
130950772|NCT00654381|471453574|FG001|1st Stage|Investigator's decision|0|||
130950773|NCT00654381|471453575|FG002|1st Stage|Investigator's decision|0|||
130950774|NCT00654381|471453576|FG003|1st Stage|Investigator's decision|1|||
130950775|NCT00654381|471453577|FG004|1st Stage|Investigator's decision|0|||
130950776|NCT00654381|471453578|FG005|1st Stage|Investigator's decision|0|||
130950777|NCT00654381|471453573|FG000|2nd Stage|Adverse Event|2|||
130950778|NCT00654381|471453574|FG001|2nd Stage|Adverse Event|0|||
130950779|NCT00654381|471453575|FG002|2nd Stage|Adverse Event|2|||
130950780|NCT00654381|471453576|FG003|2nd Stage|Adverse Event|3|||
130950781|NCT00654381|471453577|FG004|2nd Stage|Adverse Event|7|||
130950782|NCT00654381|471453578|FG005|2nd Stage|Adverse Event|2|||
130950783|NCT00654381|471453573|FG000|2nd Stage|Withdrawal by Subject|0|||
130950784|NCT00654381|471453574|FG001|2nd Stage|Withdrawal by Subject|0|||
130950785|NCT00654381|471453575|FG002|2nd Stage|Withdrawal by Subject|0|||
130950786|NCT00654381|471453576|FG003|2nd Stage|Withdrawal by Subject|0|||
130950787|NCT00654381|471453577|FG004|2nd Stage|Withdrawal by Subject|1|||
130950788|NCT00654381|471453578|FG005|2nd Stage|Withdrawal by Subject|1|||
130950789|NCT00654381|471453573|FG000|2nd Stage|Investigator's decision|0|||
130950790|NCT00654381|471453574|FG001|2nd Stage|Investigator's decision|0|||
130950791|NCT00654381|471453575|FG002|2nd Stage|Investigator's decision|1|||
130950792|NCT00654381|471453576|FG003|2nd Stage|Investigator's decision|1|||
130950793|NCT00654381|471453577|FG004|2nd Stage|Investigator's decision|0|||
130950794|NCT00654381|471453578|FG005|2nd Stage|Investigator's decision|0|||
130950795|NCT00654381|471453573|FG000|Extension Stage|Adverse Event|1|||
130950796|NCT00654381|471453574|FG001|Extension Stage|Adverse Event|2|||
130950797|NCT00654381|471453575|FG002|Extension Stage|Adverse Event|9|||
130950798|NCT00654381|471453576|FG003|Extension Stage|Adverse Event|7|||
130950799|NCT00654381|471453577|FG004|Extension Stage|Adverse Event|1|||
130950800|NCT00654381|471453578|FG005|Extension Stage|Adverse Event|1|||
130950801|NCT00654381|471453573|FG000|Extension Stage|Protocol Violation|0|||
130950802|NCT00654381|471453574|FG001|Extension Stage|Protocol Violation|0|||
130950803|NCT00654381|471453575|FG002|Extension Stage|Protocol Violation|0|||
130950804|NCT00654381|471453576|FG003|Extension Stage|Protocol Violation|1|||
130950805|NCT00654381|471453577|FG004|Extension Stage|Protocol Violation|0|||
130950806|NCT00654381|471453578|FG005|Extension Stage|Protocol Violation|0|||
130950807|NCT00654381|471453573|FG000|Extension Stage|Lack of Efficacy|0|||
130950808|NCT00654381|471453574|FG001|Extension Stage|Lack of Efficacy|0|||
130950809|NCT00654381|471453575|FG002|Extension Stage|Lack of Efficacy|1|||
130950810|NCT00654381|471453576|FG003|Extension Stage|Lack of Efficacy|0|||
130950811|NCT00654381|471453577|FG004|Extension Stage|Lack of Efficacy|0|||
130950812|NCT00654381|471453578|FG005|Extension Stage|Lack of Efficacy|0|||
130950813|NCT00654381|471453573|FG000|Extension Stage|Withdrawal by Subject|0|||
130950814|NCT00654381|471453574|FG001|Extension Stage|Withdrawal by Subject|0|||
130950815|NCT00654381|471453575|FG002|Extension Stage|Withdrawal by Subject|1|||
130950816|NCT00654381|471453576|FG003|Extension Stage|Withdrawal by Subject|1|||
130950817|NCT00654381|471453577|FG004|Extension Stage|Withdrawal by Subject|1|||
130950818|NCT00654381|471453578|FG005|Extension Stage|Withdrawal by Subject|1|||
130950819|NCT00654381|471453573|FG000|Extension Stage|Closure of the trial site|0|||
130950820|NCT00654381|471453574|FG001|Extension Stage|Closure of the trial site|0|||
131124842|NCT01987960|472085898|FG001|Period 1|Non-compliance with IMP|0|||
131124843|NCT01987960|472085899|FG002|Period 1|Non-compliance with IMP|0|||
131124844|NCT01987960|472085900|FG003|Period 1|Non-compliance with IMP|0|||
131124845|NCT01987960|472085897|FG000|Period 1|Protocol Violation|12|||
131124846|NCT01987960|472085898|FG001|Period 1|Protocol Violation|0|||
131124847|NCT01987960|472085899|FG002|Period 1|Protocol Violation|0|||
131124848|NCT01987960|472085900|FG003|Period 1|Protocol Violation|0|||
131124849|NCT01987960|472085897|FG000|Period 1|Withdrawal by Subject|21|||
131124850|NCT01987960|472085898|FG001|Period 1|Withdrawal by Subject|0|||
131124851|NCT01987960|472085899|FG002|Period 1|Withdrawal by Subject|0|||
130950821|NCT00654381|471453575|FG002|Extension Stage|Closure of the trial site|0|||
130950822|NCT00654381|471453576|FG003|Extension Stage|Closure of the trial site|0|||
130950823|NCT00654381|471453577|FG004|Extension Stage|Closure of the trial site|1|||
130950824|NCT00654381|471453578|FG005|Extension Stage|Closure of the trial site|1|||
130950825|NCT00826267|471453581|FG000|Overall Study|Other Adverse Event|1|||
130950826|NCT00826267|471453582|FG001|Overall Study|Other Adverse Event|0|||
130950827|NCT00826267|471453583|FG002|Overall Study|Other Adverse Event|0|||
130950828|NCT01675882|471453596|FG000|Overall Study|Adverse Event|0|||
130950829|NCT01675882|471453597|FG001|Overall Study|Adverse Event|2|||
130950830|NCT01675882|471453598|FG002|Overall Study|Adverse Event|1|||
130950831|NCT01675882|471453599|FG003|Overall Study|Adverse Event|0|||
130950832|NCT01675882|471453596|FG000|Overall Study|Participant unwilling to continue|2|||
130950833|NCT01675882|471453597|FG001|Overall Study|Participant unwilling to continue|4|||
130950834|NCT01675882|471453598|FG002|Overall Study|Participant unwilling to continue|2|||
130950835|NCT01675882|471453599|FG003|Overall Study|Participant unwilling to continue|1|||
130950836|NCT01675882|471453596|FG000|Overall Study|Lost to Follow-up|0|||
130950837|NCT01675882|471453597|FG001|Overall Study|Lost to Follow-up|1|||
130950838|NCT01675882|471453598|FG002|Overall Study|Lost to Follow-up|0|||
131124852|NCT01987960|472085900|FG003|Period 1|Withdrawal by Subject|0|||
130950839|NCT01675882|471453599|FG003|Overall Study|Lost to Follow-up|0|||
130950840|NCT01675882|471453596|FG000|Overall Study|Non-compliance|0|||
130950841|NCT01675882|471453597|FG001|Overall Study|Non-compliance|0|||
130950842|NCT01675882|471453598|FG002|Overall Study|Non-compliance|0|||
130950843|NCT01675882|471453599|FG003|Overall Study|Non-compliance|1|||
130950844|NCT00994448|471453601|FG000|Overall Study|Adverse Event|1|||
130950845|NCT00994448|471453602|FG001|Overall Study|Adverse Event|0|||
130950846|NCT00994448|471453601|FG000|Overall Study|Lost to Follow-up|5|||
130950847|NCT00994448|471453602|FG001|Overall Study|Lost to Follow-up|1|||
130950848|NCT00994448|471453601|FG000|Overall Study|Withdrawal by Subject|1|||
130950849|NCT00994448|471453602|FG001|Overall Study|Withdrawal by Subject|1|||
130950850|NCT00994448|471453601|FG000|Overall Study|Physician Decision|1|||
130950851|NCT00994448|471453602|FG001|Overall Study|Physician Decision|0|||
130950852|NCT01604343|471453603|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
130950853|NCT01604343|471453604|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
130950854|NCT01604343|471453605|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
130950855|NCT01604343|471453606|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
130950856|NCT01604343|471453607|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
130950857|NCT01604343|471453603|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
130950858|NCT01604343|471453604|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
130950859|NCT01604343|471453605|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
130950860|NCT01604343|471453606|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
130950861|NCT01604343|471453607|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
130950862|NCT01604343|471453603|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
130950863|NCT01604343|471453604|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
130950864|NCT01604343|471453605|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
130950865|NCT01604343|471453606|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
130950866|NCT01604343|471453607|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
130950867|NCT01604343|471453603|FG000|Prior to W52 Administration(Through W52)|Death|5|||
130950868|NCT01604343|471453604|FG001|Prior to W52 Administration(Through W52)|Death|0|||
130950869|NCT01604343|471453605|FG002|Prior to W52 Administration(Through W52)|Death|2|||
130950870|NCT01604343|471453606|FG003|Prior to W52 Administration(Through W52)|Death|0|||
130950871|NCT01604343|471453607|FG004|Prior to W52 Administration(Through W52)|Death|4|||
130950872|NCT01604343|471453603|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
130950873|NCT01604343|471453604|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
130950874|NCT01604343|471453605|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
130950875|NCT01604343|471453606|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
130950876|NCT01604343|471453607|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
130950877|NCT01604343|471453603|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
130950878|NCT01604343|471453604|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
130950879|NCT01604343|471453605|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
130950880|NCT01604343|471453606|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
130950881|NCT01604343|471453607|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
130950882|NCT01604343|471453603|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
130950883|NCT01604343|471453604|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
130950884|NCT01604343|471453605|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
130950885|NCT01604343|471453606|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
130950886|NCT01604343|471453607|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
130950887|NCT01604343|471453603|FG000|Prior to W52 Administration(Through W52)|Other|15|||
130950888|NCT01604343|471453604|FG001|Prior to W52 Administration(Through W52)|Other|0|||
130950889|NCT01604343|471453605|FG002|Prior to W52 Administration(Through W52)|Other|10|||
130950890|NCT01604343|471453606|FG003|Prior to W52 Administration(Through W52)|Other|0|||
130950891|NCT01604343|471453607|FG004|Prior to W52 Administration(Through W52)|Other|6|||
130950892|NCT01604343|471453603|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
130950893|NCT01604343|471453604|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
130950894|NCT01604343|471453605|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
130950895|NCT01604343|471453606|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
130950896|NCT01604343|471453607|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
130950897|NCT01604343|471453603|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
130950898|NCT01604343|471453604|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
130950899|NCT01604343|471453605|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
131038540|NCT04625465|471774831|FG005|Overall Study|Withdrawal by Subject|0|||
131038541|NCT04625465|471774832|FG006|Overall Study|Withdrawal by Subject|0|||
131038542|NCT04625465|471774833|FG007|Overall Study|Withdrawal by Subject|0|||
131038543|NCT05704543|471774834|FG000|Overall Study|Withdrawal by Subject|1|||
131038544|NCT05704543|471774835|FG001|Overall Study|Withdrawal by Subject|1|||
130950900|NCT01604343|471453606|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
131038545|NCT05704543|471774836|FG002|Overall Study|Withdrawal by Subject|0|||
131038546|NCT05704543|471774837|FG003|Overall Study|Withdrawal by Subject|2|||
131038547|NCT05704543|471774834|FG000|Overall Study|Lost to Follow-up|1|||
130711223|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
130950901|NCT01604343|471453607|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
130950902|NCT01604343|471453603|FG000|Week 52 to Week 104|Adverse Event|0|||
130950903|NCT01604343|471453604|FG001|Week 52 to Week 104|Adverse Event|12|||
130950904|NCT01604343|471453605|FG002|Week 52 to Week 104|Adverse Event|26|||
130950905|NCT01604343|471453606|FG003|Week 52 to Week 104|Adverse Event|21|||
130950906|NCT01604343|471453607|FG004|Week 52 to Week 104|Adverse Event|27|||
130950907|NCT01604343|471453603|FG000|Week 52 to Week 104|Death|0|||
130950908|NCT01604343|471453604|FG001|Week 52 to Week 104|Death|4|||
130950909|NCT01604343|471453605|FG002|Week 52 to Week 104|Death|2|||
130950910|NCT01604343|471453606|FG003|Week 52 to Week 104|Death|5|||
130950911|NCT01604343|471453607|FG004|Week 52 to Week 104|Death|0|||
130950912|NCT01604343|471453603|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
130950913|NCT01604343|471453604|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
130950914|NCT01604343|471453605|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
130950915|NCT01604343|471453606|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
130950916|NCT01604343|471453607|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
130950917|NCT01604343|471453603|FG000|Week 52 to Week 104|Physician Decision|0|||
130950918|NCT01604343|471453604|FG001|Week 52 to Week 104|Physician Decision|1|||
130950919|NCT01604343|471453605|FG002|Week 52 to Week 104|Physician Decision|0|||
130950920|NCT01604343|471453606|FG003|Week 52 to Week 104|Physician Decision|0|||
130950921|NCT01604343|471453607|FG004|Week 52 to Week 104|Physician Decision|2|||
130950922|NCT01604343|471453603|FG000|Week 52 to Week 104|Pregnancy|0|||
130950923|NCT01604343|471453604|FG001|Week 52 to Week 104|Pregnancy|0|||
130950924|NCT01604343|471453605|FG002|Week 52 to Week 104|Pregnancy|1|||
130950925|NCT01604343|471453606|FG003|Week 52 to Week 104|Pregnancy|2|||
130950926|NCT01604343|471453607|FG004|Week 52 to Week 104|Pregnancy|1|||
130950927|NCT01604343|471453603|FG000|Week 52 to Week 104|Other|0|||
130950928|NCT01604343|471453604|FG001|Week 52 to Week 104|Other|11|||
130950929|NCT01604343|471453605|FG002|Week 52 to Week 104|Other|11|||
130950930|NCT01604343|471453606|FG003|Week 52 to Week 104|Other|6|||
130950931|NCT01604343|471453607|FG004|Week 52 to Week 104|Other|3|||
130950932|NCT01604343|471453603|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
130950933|NCT01604343|471453604|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
130950934|NCT01604343|471453605|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
130950935|NCT01604343|471453606|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
130950936|NCT01604343|471453607|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
130950937|NCT01604343|471453603|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
130950938|NCT01604343|471453604|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
130950939|NCT01604343|471453605|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
130950940|NCT01604343|471453606|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
130950941|NCT01604343|471453607|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
130950942|NCT01604343|471453603|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
130950943|NCT01604343|471453604|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
130950944|NCT01604343|471453605|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
130950945|NCT01604343|471453606|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
130950946|NCT01604343|471453607|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
130950947|NCT01610791|471453608|FG000|Overall Study|Lost to Follow-up|7|||
130950948|NCT01610791|471453608|FG000|Overall Study|Adverse Event|6|||
130950949|NCT01610791|471453608|FG000|Overall Study|Physician Decision|1|||
130950950|NCT01610791|471453608|FG000|Overall Study|Adverse event and Investigator decision|1|||
130950951|NCT01610791|471453608|FG000|Overall Study|Death|1|||
130950952|NCT01610791|471453608|FG000|Overall Study|Not determined|5|||
130950953|NCT02711800|471453610|FG000|Overall Study|Lost to Follow-up|1|||
130950954|NCT02711800|471453610|FG000|Overall Study|Withdrawal by Subject|1|||
130950955|NCT04164901|471453615|FG000|Overall Study|Withdrawal by Subject|4|||
130950956|NCT04164901|471453616|FG001|Overall Study|Withdrawal by Subject|4|||
130950957|NCT05040152|471453621|FG000|Overall Study|Withdrawal by Subject|5|||
130950958|NCT05040152|471453622|FG001|Overall Study|Withdrawal by Subject|0|||
130950959|NCT05040152|471453621|FG000|Overall Study|Lost to Follow-up|0|||
130950960|NCT05040152|471453622|FG001|Overall Study|Lost to Follow-up|2|||
130950961|NCT02046148|471453630|FG000|Overall Study|Lost to Follow-up|1|||
130950962|NCT02046148|471453631|FG001|Overall Study|Lost to Follow-up|1|||
130950963|NCT02046148|471453630|FG000|Overall Study|Withdrawal by Subject|0|||
130950964|NCT02046148|471453631|FG001|Overall Study|Withdrawal by Subject|2|||
130950965|NCT00314574|471453640|FG000|Overall Study|Death|3|||
130950966|NCT00314574|471453641|FG001|Overall Study|Death|0|||
130950967|NCT00314574|471453640|FG000|Overall Study|Adverse Event|11|||
131124853|NCT01987960|472085897|FG000|Period 1|Lost to Follow-up|40|||
130950968|NCT00314574|471453641|FG001|Overall Study|Adverse Event|16|||
130950969|NCT00314574|471453640|FG000|Overall Study|Lost to Follow-up|19|||
130950970|NCT00314574|471453641|FG001|Overall Study|Lost to Follow-up|25|||
130950971|NCT00314574|471453640|FG000|Overall Study|Withdrawal by Subject|33|||
130950972|NCT00314574|471453641|FG001|Overall Study|Withdrawal by Subject|22|||
130950973|NCT00314574|471453640|FG000|Overall Study|Physician Decision|22|||
130950974|NCT00314574|471453641|FG001|Overall Study|Physician Decision|15|||
131124854|NCT01987960|472085898|FG001|Period 1|Lost to Follow-up|0|||
130711224|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
130711225|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
130711226|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
130711227|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
130711228|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
130950975|NCT00314574|471453640|FG000|Overall Study|Pregnancy|6|||
130950976|NCT00314574|471453641|FG001|Overall Study|Pregnancy|4|||
130950977|NCT00314574|471453640|FG000|Overall Study|Data unknown at database lock|0|||
130950978|NCT00314574|471453641|FG001|Overall Study|Data unknown at database lock|1|||
130950979|NCT00449956|471453642|FG000|Overall Study|Adverse Event|7|||
130950980|NCT00449956|471453643|FG001|Overall Study|Adverse Event|1|||
130950981|NCT00449956|471453644|FG002|Overall Study|Adverse Event|6|||
130950982|NCT00449956|471453642|FG000|Overall Study|Lack of Efficacy|0|||
130950983|NCT00449956|471453643|FG001|Overall Study|Lack of Efficacy|0|||
130950984|NCT00449956|471453644|FG002|Overall Study|Lack of Efficacy|1|||
130950985|NCT00449956|471453642|FG000|Overall Study|Protocol Violation|1|||
130950986|NCT00449956|471453643|FG001|Overall Study|Protocol Violation|1|||
130950987|NCT00449956|471453644|FG002|Overall Study|Protocol Violation|1|||
130950988|NCT00449956|471453642|FG000|Overall Study|Withdrawal by Subject|0|||
130950989|NCT00449956|471453643|FG001|Overall Study|Withdrawal by Subject|1|||
130950990|NCT00449956|471453644|FG002|Overall Study|Withdrawal by Subject|0|||
130950991|NCT00449956|471453642|FG000|Overall Study|Physician Decision|2|||
130950992|NCT00449956|471453643|FG001|Overall Study|Physician Decision|1|||
130950993|NCT00449956|471453644|FG002|Overall Study|Physician Decision|1|||
130950994|NCT02086110|471453645|FG000|Overall Study|Withdrawal by Subject|1|||
130950995|NCT02086110|471453646|FG001|Overall Study|Withdrawal by Subject|1|||
130950996|NCT02272413|471453651|FG000|Randomized Through Treatment Start|Not treated|3|||
130950997|NCT02272413|471453652|FG001|Randomized Through Treatment Start|Not treated|5|||
130950998|NCT02272413|471453651|FG000|Pre-switch Period|Adverse Event|38|||
130950999|NCT02272413|471453652|FG001|Pre-switch Period|Adverse Event|37|||
130951000|NCT02272413|471453651|FG000|Pre-switch Period|Death|26|||
130951001|NCT02272413|471453652|FG001|Pre-switch Period|Death|26|||
130951002|NCT02272413|471453651|FG000|Pre-switch Period|Withdrawal by Subject|27|||
130951003|NCT02272413|471453652|FG001|Pre-switch Period|Withdrawal by Subject|15|||
130951004|NCT02272413|471453651|FG000|Pre-switch Period|Physician Decision|6|||
130951005|NCT02272413|471453652|FG001|Pre-switch Period|Physician Decision|18|||
130951006|NCT02272413|471453651|FG000|Pre-switch Period|Progressive disease|185|||
130951007|NCT02272413|471453652|FG001|Pre-switch Period|Progressive disease|173|||
130951008|NCT02272413|471453651|FG000|Pre-switch Period|Lost to Follow-up|0|||
130951009|NCT02272413|471453652|FG001|Pre-switch Period|Lost to Follow-up|2|||
130951010|NCT02272413|471453651|FG000|Pre-switch Period|Protocol Violation|1|||
130951011|NCT02272413|471453652|FG001|Pre-switch Period|Protocol Violation|0|||
130951012|NCT02272413|471453651|FG000|Pre-switch Period|Other than listed|10|||
130951013|NCT02272413|471453652|FG001|Pre-switch Period|Other than listed|11|||
130951014|NCT02272413|471453651|FG000|Post-switch Period|Adverse Event|4|||
130951015|NCT02272413|471453652|FG001|Post-switch Period|Adverse Event|4|||
130951016|NCT02272413|471453651|FG000|Post-switch Period|Death|3|||
130951017|NCT02272413|471453652|FG001|Post-switch Period|Death|2|||
130951018|NCT02272413|471453651|FG000|Post-switch Period|Withdrawal by Subject|1|||
130951019|NCT02272413|471453652|FG001|Post-switch Period|Withdrawal by Subject|2|||
130951020|NCT02272413|471453651|FG000|Post-switch Period|Physician Decision|1|||
130951021|NCT02272413|471453652|FG001|Post-switch Period|Physician Decision|1|||
130951022|NCT02272413|471453651|FG000|Post-switch Period|Progressive disease|21|||
130951023|NCT02272413|471453652|FG001|Post-switch Period|Progressive disease|21|||
130951024|NCT02272413|471453651|FG000|Post-switch Period|Study terminated by sponsor|8|||
130951025|NCT02272413|471453652|FG001|Post-switch Period|Study terminated by sponsor|11|||
130951026|NCT02272413|471453651|FG000|Post-switch Period|Other than listed|4|||
130951027|NCT02272413|471453652|FG001|Post-switch Period|Other than listed|5|||
130951028|NCT00606892|471453655|FG000|First Intervention|Protocol Violation|1|||
130951029|NCT00606892|471453656|FG001|First Intervention|Protocol Violation|4|||
130951030|NCT04116710|471453659|FG000|Overall Study|Death|4|||
130951031|NCT04116710|471453660|FG001|Overall Study|Death|6|||
130951032|NCT04116710|471453661|FG002|Overall Study|Death|3|||
130711229|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
130711230|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
130711231|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
130951033|NCT04116710|471453662|FG003|Overall Study|Death|1|||
131038548|NCT05704543|471774835|FG001|Overall Study|Lost to Follow-up|2|||
131038549|NCT05704543|471774836|FG002|Overall Study|Lost to Follow-up|0|||
131038550|NCT05704543|471774837|FG003|Overall Study|Lost to Follow-up|0|||
130951034|NCT04116710|471453659|FG000|Overall Study|Withdrawal by Subject|0|||
130951035|NCT04116710|471453660|FG001|Overall Study|Withdrawal by Subject|0|||
130951036|NCT04116710|471453661|FG002|Overall Study|Withdrawal by Subject|0|||
130951037|NCT04116710|471453662|FG003|Overall Study|Withdrawal by Subject|1|||
130951038|NCT00582933|471453663|FG000|Overall Study|Physician Decision|3|||
130951039|NCT00149747|471453664|FG000|Overall Study|Death|1|||
131038551|NCT03691935|471774839|FG000|Overall Study|Physician Decision|2|||
131038552|NCT03691935|471774840|FG001|Overall Study|Physician Decision|1|||
131038553|NCT03691935|471774839|FG000|Overall Study|Adverse Event|3|||
131038554|NCT03691935|471774840|FG001|Overall Study|Adverse Event|0|||
131038555|NCT02151981|471774843|FG000|Overall Study|Death|184|||
131038556|NCT02151981|471774844|FG001|Overall Study|Death|88|||
131038557|NCT02151981|471774843|FG000|Overall Study|Lost to Follow-up|7|||
131038558|NCT02151981|471774844|FG001|Overall Study|Lost to Follow-up|1|||
131038559|NCT02151981|471774843|FG000|Overall Study|Withdrawal by Subject|27|||
131038560|NCT02151981|471774844|FG001|Overall Study|Withdrawal by Subject|21|||
131038561|NCT02151981|471774843|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131038562|NCT02151981|471774844|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131038563|NCT02151981|471774843|FG000|Overall Study|Other reasons|1|||
131038564|NCT02151981|471774844|FG001|Overall Study|Other reasons|2|||
131038565|NCT05446168|471774845|FG000|Overall Study|Physician Decision|0|||
131038566|NCT05446168|471774846|FG001|Overall Study|Physician Decision|1|||
131038567|NCT01946789|471774852|FG000|Overall Study|Death|0|||
131038568|NCT01946789|471774853|FG001|Overall Study|Death|2|||
131038569|NCT01946789|471774854|FG002|Overall Study|Death|1|||
131038570|NCT01946789|471774855|FG003|Overall Study|Death|1|||
131038571|NCT01946789|471774856|FG004|Overall Study|Death|1|||
131038572|NCT01946789|471774857|FG005|Overall Study|Death|1|||
131038573|NCT01946789|471774858|FG006|Overall Study|Death|3|||
131038574|NCT01946789|471774859|FG007|Overall Study|Death|1|||
131038575|NCT01946789|471774860|FG008|Overall Study|Death|2|||
131038576|NCT01946789|471774852|FG000|Overall Study|Progressive Disease|0|||
131038577|NCT01946789|471774853|FG001|Overall Study|Progressive Disease|0|||
131038578|NCT01946789|471774854|FG002|Overall Study|Progressive Disease|1|||
131038579|NCT01946789|471774855|FG003|Overall Study|Progressive Disease|0|||
131038580|NCT01946789|471774856|FG004|Overall Study|Progressive Disease|0|||
131038581|NCT01946789|471774857|FG005|Overall Study|Progressive Disease|2|||
131038582|NCT01946789|471774858|FG006|Overall Study|Progressive Disease|0|||
131038583|NCT01946789|471774859|FG007|Overall Study|Progressive Disease|0|||
131038584|NCT01946789|471774860|FG008|Overall Study|Progressive Disease|0|||
131038585|NCT01946789|471774852|FG000|Overall Study|Withdrawal by Subject|0|||
131038586|NCT01946789|471774853|FG001|Overall Study|Withdrawal by Subject|0|||
131038587|NCT01946789|471774854|FG002|Overall Study|Withdrawal by Subject|0|||
131038588|NCT01946789|471774855|FG003|Overall Study|Withdrawal by Subject|2|||
131038589|NCT01946789|471774856|FG004|Overall Study|Withdrawal by Subject|1|||
131038590|NCT01946789|471774857|FG005|Overall Study|Withdrawal by Subject|0|||
131038591|NCT01946789|471774858|FG006|Overall Study|Withdrawal by Subject|1|||
131038592|NCT01946789|471774859|FG007|Overall Study|Withdrawal by Subject|0|||
131038593|NCT01946789|471774860|FG008|Overall Study|Withdrawal by Subject|0|||
131038594|NCT05374798|471774861|FG000|Overall Study|Lost to Follow-up|2|||
131038595|NCT05374798|471774861|FG000|Overall Study|Withdrawal by Subject|2|||
131038596|NCT05374798|471774861|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
131038597|NCT05576155|471774862|FG000|Overall Study|Withdrawal by Subject|1|||
131038598|NCT05576155|471774863|FG001|Overall Study|Withdrawal by Subject|1|||
131038599|NCT01275677|471774864|FG000|Overall Study|Not at risk for recurrence.|1|||
131038600|NCT01275677|471774865|FG001|Overall Study|Not at risk for recurrence.|1|||
131038601|NCT01275677|471774864|FG000|Overall Study|No follow-up|26|||
131038602|NCT01275677|471774865|FG001|Overall Study|No follow-up|37|||
131038603|NCT01275677|471774864|FG000|Overall Study|No clinical follow up.|1|||
131038604|NCT01275677|471774865|FG001|Overall Study|No clinical follow up.|4|||
131038605|NCT04409353|471774869|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
131038606|NCT04409353|471774870|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
131038607|NCT04409353|471774871|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
131124855|NCT01987960|472085899|FG002|Period 1|Lost to Follow-up|0|||
131124856|NCT01987960|472085900|FG003|Period 1|Lost to Follow-up|0|||
131124857|NCT01987960|472085897|FG000|Period 1|administrative or other reason|75|||
131124858|NCT01987960|472085898|FG001|Period 1|administrative or other reason|0|||
131124859|NCT01987960|472085899|FG002|Period 1|administrative or other reason|0|||
131038608|NCT04409353|471774869|FG000|Overall Study|Lost to Follow-up|6|||
131038609|NCT04409353|471774870|FG001|Overall Study|Lost to Follow-up|8|||
131038610|NCT04409353|471774871|FG002|Overall Study|Lost to Follow-up|7|||
131038611|NCT04409353|471774869|FG000|Overall Study|Major surgery during participation window|4|||
131038612|NCT04409353|471774870|FG001|Overall Study|Major surgery during participation window|3|||
131124860|NCT01987960|472085900|FG003|Period 1|administrative or other reason|0|||
131124861|NCT01987960|472085897|FG000|Period 1|Withdrawal of consent before treatment|4|||
131038613|NCT04409353|471774871|FG002|Overall Study|Major surgery during participation window|3|||
131038614|NCT04409353|471774869|FG000|Overall Study|Life event occurred during participation window|3|||
131038615|NCT04409353|471774870|FG001|Overall Study|Life event occurred during participation window|2|||
131038616|NCT04409353|471774871|FG002|Overall Study|Life event occurred during participation window|4|||
131038617|NCT04409353|471774869|FG000|Overall Study|Lack of Efficacy|4|||
131038618|NCT04409353|471774870|FG001|Overall Study|Lack of Efficacy|1|||
131038619|NCT04409353|471774871|FG002|Overall Study|Lack of Efficacy|3|||
131038620|NCT04409353|471774869|FG000|Overall Study|Adverse Event|2|||
131038621|NCT04409353|471774870|FG001|Overall Study|Adverse Event|1|||
130711232|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
130711233|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
130711234|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
130711235|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
130711236|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
130711237|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
130711238|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
130711239|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
130711240|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
130711241|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
130711242|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
130711243|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
130711244|NCT02960893|470567935|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
130711245|NCT02960893|470567936|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
130711246|NCT02960893|470567937|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
130711247|NCT02960893|470567938|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
130711248|NCT01013649|470567943|FG000|First Step|Withdrawal by Subject|36|||
130711249|NCT01013649|470567944|FG001|First Step|Withdrawal by Subject|19|||
130711250|NCT01013649|470567945|FG002|First Step|Withdrawal by Subject|0|||
130711251|NCT01013649|470567946|FG003|First Step|Withdrawal by Subject|0|||
130711252|NCT01013649|470567943|FG000|First Step|Progression|58|||
130711253|NCT01013649|470567944|FG001|First Step|Progression|23|||
130711254|NCT01013649|470567945|FG002|First Step|Progression|0|||
130711255|NCT01013649|470567946|FG003|First Step|Progression|0|||
130711256|NCT01013649|470567943|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
130711257|NCT01013649|470567944|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
130711258|NCT01013649|470567945|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
130711259|NCT01013649|470567946|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
130711260|NCT01013649|470567943|FG000|First Step|Death|3|||
130711261|NCT01013649|470567944|FG001|First Step|Death|4|||
130711262|NCT01013649|470567945|FG002|First Step|Death|0|||
130711263|NCT01013649|470567946|FG003|First Step|Death|0|||
130711264|NCT01013649|470567943|FG000|First Step|Adverse Event|9|||
130711265|NCT01013649|470567944|FG001|First Step|Adverse Event|5|||
130711266|NCT01013649|470567945|FG002|First Step|Adverse Event|0|||
130711267|NCT01013649|470567946|FG003|First Step|Adverse Event|0|||
130711268|NCT01013649|470567943|FG000|First Step|Other|4|||
130711269|NCT01013649|470567944|FG001|First Step|Other|6|||
130711270|NCT01013649|470567945|FG002|First Step|Other|0|||
130711271|NCT01013649|470567946|FG003|First Step|Other|0|||
130711272|NCT04285567|470567947|FG000|Overall Study|Death|3|||
130711273|NCT04285567|470567948|FG001|Overall Study|Death|3|||
130951040|NCT00149747|471453665|FG001|Overall Study|Death|0|||
130951041|NCT00149747|471453664|FG000|Overall Study|Withdrawal by Subject|3|||
130951042|NCT00149747|471453665|FG001|Overall Study|Withdrawal by Subject|3|||
130951043|NCT04753164|471453666|FG000|Overall Study|Adverse Event|0|||
130951044|NCT04753164|471453667|FG001|Overall Study|Adverse Event|2|||
130951045|NCT04753164|471453666|FG000|Overall Study|Withdrawal by Subject|9|||
130951046|NCT04753164|471453667|FG001|Overall Study|Withdrawal by Subject|7|||
130951047|NCT04753164|471453666|FG000|Overall Study|Lost to Follow-up|6|||
130951048|NCT04753164|471453667|FG001|Overall Study|Lost to Follow-up|6|||
130951049|NCT04753164|471453666|FG000|Overall Study|Other|12|||
130951050|NCT04753164|471453667|FG001|Overall Study|Other|5|||
130951051|NCT01183975|471453675|FG000|Overall Study|Lost to Follow-up|73|||
130951052|NCT00850395|471453682|FG000|Overall Study|Death|1|||
130951053|NCT00850395|471453682|FG000|Overall Study|Adverse Event|1|||
130711274|NCT04285567|470567947|FG000|Overall Study|Lost to Follow-up|1|||
130711275|NCT04285567|470567948|FG001|Overall Study|Lost to Follow-up|1|||
130711276|NCT04285567|470567947|FG000|Overall Study|Reason Not Specified|1|||
130711277|NCT04285567|470567948|FG001|Overall Study|Reason Not Specified|1|||
130951054|NCT00850395|471453682|FG000|Overall Study|Insufficient clinical response|3|||
130951055|NCT00850395|471453682|FG000|Overall Study|Other|5|||
130951056|NCT00842348|471453683|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
130951057|NCT00842348|471453684|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
130951058|NCT00842348|471453683|FG000|Study 729|Disease progression/death|19|||
130951059|NCT00842348|471453684|FG001|Study 729|Disease progression/death|30|||
130711278|NCT04285567|470567947|FG000|Overall Study|Physician Decision|2|||
130711279|NCT04285567|470567948|FG001|Overall Study|Physician Decision|1|||
130711280|NCT04285567|470567947|FG000|Overall Study|Withdrawal by Subject|2|||
130711281|NCT04285567|470567948|FG001|Overall Study|Withdrawal by Subject|6|||
130711282|NCT04285567|470567947|FG000|Overall Study|Adverse Event|1|||
130711283|NCT04285567|470567948|FG001|Overall Study|Adverse Event|0|||
130711284|NCT04285567|470567947|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
130711285|NCT04285567|470567948|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
130951060|NCT00842348|471453683|FG000|Study 729|Adverse Event|1|||
130951061|NCT00842348|471453684|FG001|Study 729|Adverse Event|1|||
130951062|NCT00842348|471453683|FG000|Study 729|Protocol Violation|1|||
131124862|NCT01987960|472085898|FG001|Period 1|Withdrawal of consent before treatment|0|||
131124863|NCT01987960|472085899|FG002|Period 1|Withdrawal of consent before treatment|0|||
131124864|NCT01987960|472085900|FG003|Period 1|Withdrawal of consent before treatment|0|||
131124865|NCT01987960|472085897|FG000|Period 2|Adverse Event|0|||
131124866|NCT01987960|472085898|FG001|Period 2|Adverse Event|0|||
131124867|NCT01987960|472085899|FG002|Period 2|Adverse Event|1|||
131124868|NCT01987960|472085900|FG003|Period 2|Adverse Event|0|||
131124869|NCT01987960|472085897|FG000|Period 2|Withdrawal by Subject|0|||
131124870|NCT01987960|472085898|FG001|Period 2|Withdrawal by Subject|0|||
131124871|NCT01987960|472085899|FG002|Period 2|Withdrawal by Subject|1|||
131124872|NCT01987960|472085900|FG003|Period 2|Withdrawal by Subject|0|||
131124873|NCT01987960|472085897|FG000|Period 2|Administrative or other reason|0|||
131124874|NCT01987960|472085898|FG001|Period 2|Administrative or other reason|5|||
131124875|NCT01987960|472085899|FG002|Period 2|Administrative or other reason|7|||
131124876|NCT01987960|472085900|FG003|Period 2|Administrative or other reason|0|||
131124877|NCT01987960|472085897|FG000|Period 3|Adverse Event|0|||
131124878|NCT01987960|472085898|FG001|Period 3|Adverse Event|0|||
131124879|NCT01987960|472085899|FG002|Period 3|Adverse Event|0|||
131124880|NCT01987960|472085900|FG003|Period 3|Adverse Event|7|||
131124881|NCT01987960|472085897|FG000|Period 3|Non-compliance with IMP|0|||
131124882|NCT01987960|472085898|FG001|Period 3|Non-compliance with IMP|0|||
131124883|NCT01987960|472085899|FG002|Period 3|Non-compliance with IMP|0|||
131124884|NCT01987960|472085900|FG003|Period 3|Non-compliance with IMP|1|||
131124885|NCT01987960|472085897|FG000|Period 3|Protocol Violation|0|||
131124886|NCT01987960|472085898|FG001|Period 3|Protocol Violation|0|||
131124887|NCT01987960|472085899|FG002|Period 3|Protocol Violation|0|||
131124888|NCT01987960|472085900|FG003|Period 3|Protocol Violation|6|||
130711286|NCT03578237|470567955|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
130711287|NCT03578237|470567956|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
130951063|NCT00842348|471453684|FG001|Study 729|Protocol Violation|1|||
130951064|NCT00842348|471453683|FG000|Study 729|Withdrawal by Subject|2|||
130951065|NCT00842348|471453684|FG001|Study 729|Withdrawal by Subject|4|||
130951066|NCT00842348|471453683|FG000|Study 729|Due to Sponsor stopping the study|1|||
130951067|NCT00842348|471453684|FG001|Study 729|Due to Sponsor stopping the study|1|||
130951068|NCT00842348|471453683|FG000|Study 729|Due to non-availability of IP|0|||
130951069|NCT00842348|471453684|FG001|Study 729|Due to non-availability of IP|1|||
130951070|NCT00842348|471453683|FG000|Study 729|Sponsor's decision|1|||
130951071|NCT00842348|471453684|FG001|Study 729|Sponsor's decision|0|||
130951072|NCT00842348|471453683|FG000|Study 729|Surgical resection|1|||
130951073|NCT00842348|471453684|FG001|Study 729|Surgical resection|0|||
130951074|NCT00603746|471453687|FG000|Overall Study|Adverse Event|2|||
130951075|NCT00603746|471453688|FG001|Overall Study|Adverse Event|3|||
130951076|NCT00603746|471453689|FG002|Overall Study|Adverse Event|0|||
130951077|NCT00603746|471453690|FG003|Overall Study|Adverse Event|1|||
130951078|NCT00603746|471453691|FG004|Overall Study|Adverse Event|0|||
130951079|NCT00603746|471453692|FG005|Overall Study|Adverse Event|4|||
130951080|NCT00603746|471453687|FG000|Overall Study|Lack of Efficacy|34|||
130951081|NCT00603746|471453688|FG001|Overall Study|Lack of Efficacy|11|||
130951082|NCT00603746|471453689|FG002|Overall Study|Lack of Efficacy|6|||
130951083|NCT00603746|471453690|FG003|Overall Study|Lack of Efficacy|11|||
130951084|NCT00603746|471453691|FG004|Overall Study|Lack of Efficacy|12|||
130951085|NCT00603746|471453692|FG005|Overall Study|Lack of Efficacy|8|||
130951086|NCT00603746|471453687|FG000|Overall Study|Protocol Violation|0|||
130951087|NCT00603746|471453688|FG001|Overall Study|Protocol Violation|3|||
130951088|NCT00603746|471453689|FG002|Overall Study|Protocol Violation|1|||
130951089|NCT00603746|471453690|FG003|Overall Study|Protocol Violation|0|||
130951090|NCT00603746|471453691|FG004|Overall Study|Protocol Violation|1|||
130951091|NCT00603746|471453692|FG005|Overall Study|Protocol Violation|0|||
130951092|NCT00603746|471453687|FG000|Overall Study|Lost to Follow-up|0|||
130951093|NCT00603746|471453688|FG001|Overall Study|Lost to Follow-up|1|||
130951094|NCT00603746|471453689|FG002|Overall Study|Lost to Follow-up|1|||
130951095|NCT00603746|471453690|FG003|Overall Study|Lost to Follow-up|0|||
130951096|NCT00603746|471453691|FG004|Overall Study|Lost to Follow-up|0|||
130951097|NCT00603746|471453692|FG005|Overall Study|Lost to Follow-up|0|||
130951098|NCT00603746|471453687|FG000|Overall Study|Physician Decision|1|||
130951099|NCT00603746|471453688|FG001|Overall Study|Physician Decision|0|||
131124889|NCT01987960|472085897|FG000|Period 3|Withdrawal by Subject|0|||
131124890|NCT01987960|472085898|FG001|Period 3|Withdrawal by Subject|0|||
131124891|NCT01987960|472085899|FG002|Period 3|Withdrawal by Subject|0|||
131124892|NCT01987960|472085900|FG003|Period 3|Withdrawal by Subject|9|||
131124893|NCT01987960|472085897|FG000|Period 3|Lost to Follow-up|0|||
130951100|NCT00603746|471453689|FG002|Overall Study|Physician Decision|0|||
130951101|NCT00603746|471453690|FG003|Overall Study|Physician Decision|0|||
130951102|NCT00603746|471453691|FG004|Overall Study|Physician Decision|1|||
130951103|NCT00603746|471453692|FG005|Overall Study|Physician Decision|0|||
130951104|NCT00603746|471453687|FG000|Overall Study|Withdrawal by Subject|1|||
131124894|NCT01987960|472085898|FG001|Period 3|Lost to Follow-up|0|||
131124895|NCT01987960|472085899|FG002|Period 3|Lost to Follow-up|0|||
131124896|NCT01987960|472085900|FG003|Period 3|Lost to Follow-up|5|||
130951105|NCT00603746|471453688|FG001|Overall Study|Withdrawal by Subject|0|||
130951106|NCT00603746|471453689|FG002|Overall Study|Withdrawal by Subject|0|||
130951107|NCT00603746|471453690|FG003|Overall Study|Withdrawal by Subject|1|||
130951108|NCT00603746|471453691|FG004|Overall Study|Withdrawal by Subject|3|||
130951109|NCT00603746|471453692|FG005|Overall Study|Withdrawal by Subject|1|||
130951110|NCT01524627|471453695|FG000|Overall Study|Physician Decision|0|||
130951111|NCT01524627|471453696|FG001|Overall Study|Physician Decision|1|||
130951112|NCT01524627|471453695|FG000|Overall Study|Lost to Follow-up|1|||
130951113|NCT01524627|471453696|FG001|Overall Study|Lost to Follow-up|1|||
130951114|NCT03323658|471453697|FG000|Overall Study|Adverse Event|0|||
130951115|NCT03323658|471453698|FG001|Overall Study|Adverse Event|1|||
130951116|NCT03323658|471453699|FG002|Overall Study|Adverse Event|0|||
130951117|NCT00256698|471453707|FG000|Overall Study|Withdrawal by Subject|7|||
130951118|NCT00256698|471453708|FG001|Overall Study|Withdrawal by Subject|7|||
130951119|NCT00256698|471453707|FG000|Overall Study|Adverse Event|13|||
130951120|NCT00256698|471453708|FG001|Overall Study|Adverse Event|6|||
130951121|NCT00256698|471453707|FG000|Overall Study|Protocol Violation|6|||
130951122|NCT00256698|471453708|FG001|Overall Study|Protocol Violation|5|||
130951123|NCT00256698|471453707|FG000|Overall Study|Lost to Follow-up|1|||
130951124|NCT00256698|471453708|FG001|Overall Study|Lost to Follow-up|3|||
130951125|NCT00256698|471453707|FG000|Overall Study|disease progression|97|||
130951126|NCT00256698|471453708|FG001|Overall Study|disease progression|105|||
130951127|NCT00256698|471453707|FG000|Overall Study|still ongoing at data cut-off|41|||
130951128|NCT00256698|471453708|FG001|Overall Study|still ongoing at data cut-off|46|||
130951129|NCT00256698|471453707|FG000|Overall Study|withdrawn due to osteoporosis|1|||
130951130|NCT00256698|471453708|FG001|Overall Study|withdrawn due to osteoporosis|0|||
130951131|NCT00256698|471453707|FG000|Overall Study|Prematurely Discontinued|1|||
130951132|NCT00256698|471453708|FG001|Overall Study|Prematurely Discontinued|0|||
130951133|NCT03264404|471455637|FG000|Overall Study|Death|2|||
130951134|NCT03264404|471455637|FG000|Overall Study|Physician Decision|1|||
130951135|NCT03264404|471455637|FG000|Overall Study|Disease Progression|28|||
130951136|NCT03264404|471455637|FG000|Overall Study|Adverse Event|1|||
130951137|NCT03264404|471455637|FG000|Overall Study|Off study prior to treatment|2|||
130951138|NCT03036566|471455644|FG000|Overall Study|Lost to Follow-up|3|||
130951139|NCT01852292|471455648|FG000|Overall Study|Untreated - did not receive study drug|3|||
130951140|NCT01852292|471455649|FG001|Overall Study|Untreated - did not receive study drug|1|||
130951141|NCT01852292|471455648|FG000|Overall Study|Death|9|||
130951142|NCT01852292|471455649|FG001|Overall Study|Death|8|||
130951143|NCT01852292|471455648|FG000|Overall Study|Patient/guardian decision|8|||
130951144|NCT01852292|471455649|FG001|Overall Study|Patient/guardian decision|4|||
130951145|NCT01852292|471455648|FG000|Overall Study|Adverse Event|8|||
130951146|NCT01852292|471455649|FG001|Overall Study|Adverse Event|11|||
130951147|NCT01852292|471455648|FG000|Overall Study|Physician Decision|6|||
130951148|NCT01852292|471455649|FG001|Overall Study|Physician Decision|2|||
130951149|NCT01852292|471455648|FG000|Overall Study|Protocol Violation|2|||
130951150|NCT01852292|471455649|FG001|Overall Study|Protocol Violation|0|||
130951151|NCT01852292|471455648|FG000|Overall Study|Non-compliance with study treatment|1|||
130951152|NCT01852292|471455649|FG001|Overall Study|Non-compliance with study treatment|0|||
130951153|NCT01852292|471455648|FG000|Overall Study|Study terminated by Sponsor|0|||
130951154|NCT01852292|471455649|FG001|Overall Study|Study terminated by Sponsor|1|||
130951155|NCT01852292|471455648|FG000|Overall Study|Progressive disease|42|||
130951156|NCT01852292|471455649|FG001|Overall Study|Progressive disease|52|||
130951157|NCT01914666|471455652|FG000|Treatment Period|Lack of Efficacy|0|||
130951158|NCT01914666|471455653|FG001|Treatment Period|Lack of Efficacy|0|||
130951159|NCT01914666|471455654|FG002|Treatment Period|Lack of Efficacy|2|||
130951160|NCT01914666|471455652|FG000|Treatment Period|Adverse Event|10|||
130951161|NCT01914666|471455653|FG001|Treatment Period|Adverse Event|4|||
130951162|NCT01914666|471455654|FG002|Treatment Period|Adverse Event|2|||
130951163|NCT01914666|471455652|FG000|Treatment Period|Withdrawal by Subject|3|||
130951164|NCT01914666|471455653|FG001|Treatment Period|Withdrawal by Subject|2|||
130951165|NCT01914666|471455654|FG002|Treatment Period|Withdrawal by Subject|2|||
130951166|NCT01914666|471455652|FG000|Treatment Period|Physician Decision|0|||
130951167|NCT01914666|471455653|FG001|Treatment Period|Physician Decision|0|||
131038622|NCT04409353|471774871|FG002|Overall Study|Adverse Event|1|||
131038623|NCT04409353|471774869|FG000|Overall Study|Disease burden - unable to participate|0|||
131038624|NCT04409353|471774870|FG001|Overall Study|Disease burden - unable to participate|1|||
131038625|NCT04409353|471774871|FG002|Overall Study|Disease burden - unable to participate|1|||
130951168|NCT01914666|471455654|FG002|Treatment Period|Physician Decision|2|||
130951169|NCT02586012|471455655|FG000|Overall Study|Withdrawal by Subject|1|||
130951170|NCT02586012|471455656|FG001|Overall Study|Withdrawal by Subject|1|||
130951171|NCT02586012|471455657|FG002|Overall Study|Withdrawal by Subject|0|||
130951172|NCT02586012|471455658|FG003|Overall Study|Withdrawal by Subject|1|||
130951173|NCT02586012|471455659|FG004|Overall Study|Withdrawal by Subject|0|||
130951174|NCT02586012|471455660|FG005|Overall Study|Withdrawal by Subject|2|||
130951175|NCT02586012|471455655|FG000|Overall Study|Protocol Violation|0|||
131038626|NCT04409353|471774869|FG000|Overall Study|Intervention too complicated|1|||
131038627|NCT04409353|471774870|FG001|Overall Study|Intervention too complicated|0|||
130711288|NCT00973765|470567957|FG000|Overall Study|Lost to Follow-up|8|||
130951176|NCT02586012|471455656|FG001|Overall Study|Protocol Violation|0|||
130951177|NCT02586012|471455657|FG002|Overall Study|Protocol Violation|0|||
130951178|NCT02586012|471455658|FG003|Overall Study|Protocol Violation|0|||
130951179|NCT02586012|471455659|FG004|Overall Study|Protocol Violation|0|||
130951180|NCT02586012|471455660|FG005|Overall Study|Protocol Violation|1|||
130951181|NCT02586012|471455655|FG000|Overall Study|study terminated|0|||
130951182|NCT02586012|471455656|FG001|Overall Study|study terminated|2|||
130951183|NCT02586012|471455657|FG002|Overall Study|study terminated|1|||
130951184|NCT02586012|471455658|FG003|Overall Study|study terminated|1|||
130951185|NCT02586012|471455659|FG004|Overall Study|study terminated|1|||
130951186|NCT02586012|471455660|FG005|Overall Study|study terminated|0|||
130951187|NCT03252522|471455661|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
130951188|NCT03252522|471455662|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
130951189|NCT03252522|471455663|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
130951190|NCT03252522|471455661|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
130951191|NCT03252522|471455662|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
130951192|NCT03252522|471455663|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
130951193|NCT03252522|471455661|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
130951194|NCT03252522|471455662|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
130951195|NCT03252522|471455663|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
130951196|NCT03252522|471455661|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
130951197|NCT03252522|471455662|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
130951198|NCT03252522|471455663|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
130951199|NCT03252522|471455661|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
130951200|NCT03252522|471455662|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
130951201|NCT03252522|471455663|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
130951202|NCT03252522|471455661|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
130951203|NCT03252522|471455662|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
130951204|NCT03252522|471455663|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
130951205|NCT03252522|471455661|FG000|Phase 2: Open Label|Adverse Event|0|||
130951206|NCT03252522|471455662|FG001|Phase 2: Open Label|Adverse Event|0|||
130951207|NCT03252522|471455663|FG002|Phase 2: Open Label|Adverse Event|2|||
130951208|NCT03252522|471455661|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
130951209|NCT03252522|471455662|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
130951210|NCT03252522|471455663|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
130951211|NCT03299842|471455665|FG000|Overall Study|Caregiver withdrew consent|2|||
130951212|NCT03299842|471455665|FG000|Overall Study|Child would not keep the watch on|3|||
130951213|NCT03277846|471455666|FG000|Overall Study|Inpatient stay too brief|12|||
130951214|NCT03277846|471455667|FG001|Overall Study|Inpatient stay too brief|11|||
130951215|NCT04013191|471455668|FG000|Overall Study|Adverse Event|1|||
130951216|NCT04013191|471455669|FG001|Overall Study|Adverse Event|0|||
130951217|NCT01344369|471455677|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
130951218|NCT01344369|471455678|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
130951219|NCT01344369|471455677|FG000|Washout of 28 Days|Physician Decision|0|||
130951220|NCT01344369|471455678|FG001|Washout of 28 Days|Physician Decision|1|||
130951221|NCT01344369|471455677|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
130951222|NCT01344369|471455678|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
130951223|NCT01454726|471455679|FG000|Overall Study|Withdrawal by Subject|0|||
130951224|NCT01454726|471455680|FG001|Overall Study|Withdrawal by Subject|1|||
130951225|NCT01886833|471455681|FG000|Overall Study|IgA not available from both periods|204|||
130951226|NCT03848845|471455684|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
130951227|NCT03848845|471455685|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
130951228|NCT03848845|471455686|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
130951229|NCT03848845|471455687|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
130951230|NCT03848845|471455684|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
130951231|NCT03848845|471455685|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
130951232|NCT03848845|471455686|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
130951233|NCT03848845|471455687|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
131124897|NCT01987960|472085897|FG000|Period 3|Administrative or other reason|0|||
130711289|NCT00973765|470567958|FG001|Overall Study|Lost to Follow-up|14|||
130711290|NCT02011113|470567959|FG000|Overall Study|Adverse Event|4|||
130951234|NCT03848845|471455684|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
130951235|NCT03848845|471455685|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
130951236|NCT03848845|471455686|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
130951237|NCT03848845|471455687|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
130951238|NCT03848845|471455684|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
131124898|NCT01987960|472085898|FG001|Period 3|Administrative or other reason|0|||
131124899|NCT01987960|472085899|FG002|Period 3|Administrative or other reason|0|||
131124900|NCT01987960|472085900|FG003|Period 3|Administrative or other reason|43|||
131124901|NCT02536313|472085903|FG000|Overall Study|Lack of Efficacy|0|||
130711291|NCT02011113|470567959|FG000|Overall Study|Disease Progression (DP)|16|||
131038628|NCT04409353|471774871|FG002|Overall Study|Intervention too complicated|1|||
131038629|NCT05309291|471774872|FG000|Overall Study|Adverse Event|0|||
131038630|NCT05309291|471774873|FG001|Overall Study|Adverse Event|1|||
131038631|NCT02696707|471776174|FG000|Per Protocol Population|Physician Decision|2|||
131038632|NCT02696707|471776175|FG001|Per Protocol Population|Physician Decision|1|||
131038633|NCT02696707|471776174|FG000|Per Protocol Population|Participant Decision|0|||
131038634|NCT02696707|471776175|FG001|Per Protocol Population|Participant Decision|2|||
131038635|NCT02696707|471776174|FG000|Completed Study as Planned|Reason = LVEF|2|||
131038636|NCT02696707|471776175|FG001|Completed Study as Planned|Reason = LVEF|2|||
131038637|NCT02696707|471776174|FG000|Completed Study as Planned|Protocol Violation|2|||
131038638|NCT02696707|471776175|FG001|Completed Study as Planned|Protocol Violation|6|||
131038639|NCT02696707|471776174|FG000|Completed Study as Planned|Metastatic disease|3|||
131038640|NCT02696707|471776175|FG001|Completed Study as Planned|Metastatic disease|0|||
131038641|NCT02696707|471776174|FG000|Completed Study as Planned|Location|1|||
131038642|NCT02696707|471776175|FG001|Completed Study as Planned|Location|1|||
131038643|NCT05251909|471776176|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
131038644|NCT05251909|471776177|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
131038645|NCT06181227|471776178|FG000|Overall Study|Study terminated by sponsor|7|||
131038646|NCT06181227|471776179|FG001|Overall Study|Study terminated by sponsor|9|||
131038647|NCT05543915|471776180|FG000|Overall Study|Lost to Follow-up|0|||
131038648|NCT05543915|471776181|FG001|Overall Study|Lost to Follow-up|1|||
131038649|NCT03381196|471776182|FG000|Overall Study|Withdrawal by Subject|7|||
131038650|NCT03381196|471776183|FG001|Overall Study|Withdrawal by Subject|7|||
131038651|NCT03381196|471776182|FG000|Overall Study|Other|0|||
131038652|NCT03381196|471776183|FG001|Overall Study|Other|1|||
131038653|NCT03381196|471776182|FG000|Overall Study|Lost to Follow-up|5|||
131038654|NCT03381196|471776183|FG001|Overall Study|Lost to Follow-up|4|||
131038655|NCT03381196|471776182|FG000|Overall Study|Death|0|||
131038656|NCT03381196|471776183|FG001|Overall Study|Death|1|||
131038657|NCT03381196|471776182|FG000|Overall Study|Adverse Event|1|||
131038658|NCT03381196|471776183|FG001|Overall Study|Adverse Event|0|||
131038659|NCT03381196|471776182|FG000|Overall Study|Randomized, not treated|3|||
131038660|NCT03381196|471776183|FG001|Overall Study|Randomized, not treated|6|||
131038661|NCT01574274|471776186|FG000|Overall Study|Ineligible|0|||
131038662|NCT01574274|471776187|FG001|Overall Study|Ineligible|1|||
131038663|NCT01574274|471776186|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
131038664|NCT01574274|471776187|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
131038665|NCT01574274|471776186|FG000|Overall Study|Ph+ B-ALL|3|||
131038666|NCT01574274|471776187|FG001|Overall Study|Ph+ B-ALL|4|||
131038667|NCT01574274|471776186|FG000|Overall Study|Induction Death|2|||
131038668|NCT01574274|471776187|FG001|Overall Study|Induction Death|0|||
131038669|NCT01574274|471776186|FG000|Overall Study|Induction Failure|4|||
131038670|NCT01574274|471776187|FG001|Overall Study|Induction Failure|1|||
131038671|NCT01574274|471776186|FG000|Overall Study|Adverse Event|16|||
131038672|NCT01574274|471776187|FG001|Overall Study|Adverse Event|13|||
131038673|NCT01574274|471776186|FG000|Overall Study|Remission Death|1|||
131038674|NCT01574274|471776187|FG001|Overall Study|Remission Death|0|||
131038675|NCT01574274|471776186|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
131038676|NCT01574274|471776187|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
131038677|NCT01574274|471776186|FG000|Overall Study|Other, unknown|3|||
131038678|NCT01574274|471776187|FG001|Overall Study|Other, unknown|2|||
131038679|NCT04676763|471776188|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
131038680|NCT04676763|471776189|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
131038681|NCT04676763|471776190|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
131038682|NCT04676763|471776188|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
131038683|NCT04676763|471776189|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
131038684|NCT04676763|471776190|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
131038685|NCT04676763|471776188|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
131038686|NCT04676763|471776189|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
131038687|NCT04676763|471776190|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
131038688|NCT02815566|471776195|FG000|Overall Study|Adverse Event|1|||
131038689|NCT02815566|471776196|FG001|Overall Study|Adverse Event|1|||
131038690|NCT02815566|471776195|FG000|Overall Study|Withdrawal by Subject|1|||
130711292|NCT02011113|470567959|FG000|Overall Study|Death|1|||
131038691|NCT02815566|471776196|FG001|Overall Study|Withdrawal by Subject|0|||
131038692|NCT02815566|471776195|FG000|Overall Study|Lost to Follow-up|0|||
131038693|NCT02815566|471776196|FG001|Overall Study|Lost to Follow-up|1|||
131038694|NCT03252847|471776197|FG000|Overall Study|Withdrawal by Subject|0|||
131038695|NCT03252847|471776198|FG001|Overall Study|Withdrawal by Subject|0|||
131038696|NCT03252847|471776199|FG002|Overall Study|Withdrawal by Subject|1|||
131038697|NCT03252847|471776200|FG003|Overall Study|Withdrawal by Subject|0|||
131038698|NCT03252847|471776201|FG004|Overall Study|Withdrawal by Subject|0|||
131038699|NCT03252847|471776202|FG005|Overall Study|Withdrawal by Subject|0|||
131038700|NCT03252847|471776203|FG006|Overall Study|Withdrawal by Subject|0|||
131038701|NCT03252847|471776197|FG000|Overall Study|Other: Patient decision|0|||
130711293|NCT02011113|470567959|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
130711294|NCT02011113|470567959|FG000|Overall Study|Investigator's judgement- DP|3|||
130711295|NCT02011113|470567959|FG000|Overall Study|Study terminated by sponsor|11|||
130711296|NCT00171301|470567960|FG000|Overall Study|Death|1|||
130711297|NCT00171301|470567961|FG001|Overall Study|Death|2|||
130711298|NCT00171301|470567960|FG000|Overall Study|Adverse Event|1|||
130711299|NCT00171301|470567961|FG001|Overall Study|Adverse Event|2|||
130711300|NCT00171301|470567960|FG000|Overall Study|Lost to Follow-up|6|||
130711301|NCT00171301|470567961|FG001|Overall Study|Lost to Follow-up|2|||
130711302|NCT00171301|470567960|FG000|Overall Study|Protocol Violation|0|||
130711303|NCT00171301|470567961|FG001|Overall Study|Protocol Violation|2|||
130711304|NCT00171301|470567960|FG000|Overall Study|Withdrawal by Subject|0|||
130711305|NCT00171301|470567961|FG001|Overall Study|Withdrawal by Subject|1|||
130711306|NCT04319159|470567962|FG000|Overall Study|Screening failure|13|||
130711307|NCT04319159|470567962|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
130711308|NCT04319159|470567962|FG000|Overall Study|Withdrawal by Subject|1|||
130711309|NCT02100319|470567963|FG000|Overall Study|Case Report Forms Uncollected|11|||
130711310|NCT02100319|470567963|FG000|Overall Study|Protocol Deviation|5|||
130711311|NCT03375320|470567964|FG000|Overall Study|Adverse Event|34|||
130711312|NCT03375320|470567965|FG001|Overall Study|Adverse Event|9|||
130711313|NCT03375320|470567966|FG002|Overall Study|Adverse Event|10|||
130711314|NCT03375320|470567967|FG003|Overall Study|Adverse Event|0|||
130711315|NCT03375320|470567964|FG000|Overall Study|Death|6|||
130711316|NCT03375320|470567965|FG001|Overall Study|Death|3|||
130711317|NCT03375320|470567966|FG002|Overall Study|Death|0|||
130711318|NCT03375320|470567967|FG003|Overall Study|Death|0|||
130774495|NCT02559570|470800546|FG003|Overall Study|Withdrawal of Consent|2|||
130774496|NCT02559570|470800547|FG004|Overall Study|Withdrawal of Consent|1|||
130774497|NCT02559570|470800543|FG000|Overall Study|Lost to Follow-up|1|||
130774498|NCT02559570|470800544|FG001|Overall Study|Lost to Follow-up|0|||
130774499|NCT02559570|470800545|FG002|Overall Study|Lost to Follow-up|0|||
130774500|NCT02559570|470800546|FG003|Overall Study|Lost to Follow-up|0|||
130951239|NCT03848845|471455685|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
130951240|NCT03848845|471455686|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
130951241|NCT03848845|471455687|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
130951242|NCT02223767|471455693|FG000|Overall Study|Withdrawal by Subject|4|||
130951243|NCT02223767|471455694|FG001|Overall Study|Withdrawal by Subject|4|||
130951244|NCT00706966|471455695|FG000|Overall Study|Adverse Event|1|||
130951245|NCT02884089|471455698|FG000|Period 1|Dosing error|2|||
130951246|NCT02884089|471455699|FG001|Period 1|Dosing error|2|||
130951247|NCT02884089|471455700|FG002|Period 1|Dosing error|0|||
130951248|NCT02884089|471455701|FG003|Period 1|Dosing error|0|||
130951249|NCT02884089|471455698|FG000|Washout Period 1|Lost to Follow-up|0|||
130951250|NCT02884089|471455699|FG001|Washout Period 1|Lost to Follow-up|1|||
130951251|NCT02884089|471455700|FG002|Washout Period 1|Lost to Follow-up|0|||
130951252|NCT02884089|471455701|FG003|Washout Period 1|Lost to Follow-up|1|||
130951253|NCT02884089|471455698|FG000|Washout Period 1|Withdrawal by Subject|0|||
130951254|NCT02884089|471455699|FG001|Washout Period 1|Withdrawal by Subject|1|||
130951255|NCT02884089|471455700|FG002|Washout Period 1|Withdrawal by Subject|0|||
130951256|NCT02884089|471455701|FG003|Washout Period 1|Withdrawal by Subject|0|||
130951257|NCT02884089|471455698|FG000|Period 2|Adverse Event|1|||
130951258|NCT02884089|471455699|FG001|Period 2|Adverse Event|0|||
130951259|NCT02884089|471455700|FG002|Period 2|Adverse Event|0|||
130951260|NCT02884089|471455701|FG003|Period 2|Adverse Event|0|||
130951261|NCT02884089|471455698|FG000|Period 3|Withdrawal by Subject|0|||
130951262|NCT02884089|471455699|FG001|Period 3|Withdrawal by Subject|0|||
130951263|NCT02884089|471455700|FG002|Period 3|Withdrawal by Subject|1|||
130951264|NCT02884089|471455701|FG003|Period 3|Withdrawal by Subject|0|||
130951265|NCT02884089|471455698|FG000|Washout Period 3|Withdrawal by Subject|0|||
130951266|NCT02884089|471455699|FG001|Washout Period 3|Withdrawal by Subject|0|||
130951267|NCT02884089|471455700|FG002|Washout Period 3|Withdrawal by Subject|1|||
130951268|NCT02884089|471455701|FG003|Washout Period 3|Withdrawal by Subject|0|||
130951269|NCT02884089|471455698|FG000|Washout Period 3|Lost to Follow-up|0|||
130951270|NCT02884089|471455699|FG001|Washout Period 3|Lost to Follow-up|0|||
130951271|NCT02884089|471455700|FG002|Washout Period 3|Lost to Follow-up|0|||
130951272|NCT02884089|471455701|FG003|Washout Period 3|Lost to Follow-up|1|||
130951273|NCT02884089|471455698|FG000|Period 4|Withdrawal by Subject|0|||
130951274|NCT02884089|471455699|FG001|Period 4|Withdrawal by Subject|1|||
130951275|NCT02884089|471455700|FG002|Period 4|Withdrawal by Subject|0|||
130951276|NCT02884089|471455701|FG003|Period 4|Withdrawal by Subject|0|||
130951277|NCT02884089|471455698|FG000|Period 4|Lost to Follow-up|1|||
130951278|NCT02884089|471455699|FG001|Period 4|Lost to Follow-up|0|||
130951279|NCT02884089|471455700|FG002|Period 4|Lost to Follow-up|0|||
130951280|NCT02884089|471455701|FG003|Period 4|Lost to Follow-up|0|||
130951281|NCT02884089|471455698|FG000|Follow-up Visit|Withdrawal by Subject|1|||
130951282|NCT02884089|471455699|FG001|Follow-up Visit|Withdrawal by Subject|0|||
130951283|NCT02884089|471455700|FG002|Follow-up Visit|Withdrawal by Subject|0|||
130951284|NCT02884089|471455701|FG003|Follow-up Visit|Withdrawal by Subject|1|||
130951285|NCT01631474|471455702|FG000|Overall Study|Lost to Follow-up|8|||
130711319|NCT03375320|470567964|FG000|Overall Study|Withdrawal by Subject|7|||
130711320|NCT03375320|470567965|FG001|Overall Study|Withdrawal by Subject|4|||
130711321|NCT03375320|470567966|FG002|Overall Study|Withdrawal by Subject|5|||
130711322|NCT03375320|470567967|FG003|Overall Study|Withdrawal by Subject|4|||
130711323|NCT03375320|470567964|FG000|Overall Study|Progressive disease|55|||
130711324|NCT03375320|470567965|FG001|Overall Study|Progressive disease|41|||
130711325|NCT03375320|470567966|FG002|Overall Study|Progressive disease|29|||
130951286|NCT01631474|471455703|FG001|Overall Study|Lost to Follow-up|5|||
130951287|NCT01631474|471455704|FG002|Overall Study|Lost to Follow-up|7|||
130951288|NCT01631474|471455705|FG003|Overall Study|Lost to Follow-up|5|||
130951289|NCT01631474|471455706|FG004|Overall Study|Lost to Follow-up|5|||
130711326|NCT03375320|470567967|FG003|Overall Study|Progressive disease|24|||
130951290|NCT01631474|471455702|FG000|Overall Study|Withdrawal by Subject|4|||
130951291|NCT01631474|471455703|FG001|Overall Study|Withdrawal by Subject|4|||
130951292|NCT01631474|471455704|FG002|Overall Study|Withdrawal by Subject|2|||
130951293|NCT01631474|471455705|FG003|Overall Study|Withdrawal by Subject|6|||
130951294|NCT01631474|471455706|FG004|Overall Study|Withdrawal by Subject|5|||
130951295|NCT01631474|471455702|FG000|Overall Study|Lack of Efficacy|2|||
130951296|NCT01631474|471455703|FG001|Overall Study|Lack of Efficacy|2|||
130951297|NCT01631474|471455704|FG002|Overall Study|Lack of Efficacy|0|||
130951298|NCT01631474|471455705|FG003|Overall Study|Lack of Efficacy|0|||
130951299|NCT01631474|471455706|FG004|Overall Study|Lack of Efficacy|2|||
130951300|NCT01631474|471455702|FG000|Overall Study|Noncompliance with Study Drug|0|||
130951301|NCT01631474|471455703|FG001|Overall Study|Noncompliance with Study Drug|0|||
130951302|NCT01631474|471455704|FG002|Overall Study|Noncompliance with Study Drug|0|||
130951303|NCT01631474|471455705|FG003|Overall Study|Noncompliance with Study Drug|0|||
130951304|NCT01631474|471455706|FG004|Overall Study|Noncompliance with Study Drug|1|||
130951305|NCT01631474|471455702|FG000|Overall Study|Adverse Event|0|||
130951306|NCT01631474|471455703|FG001|Overall Study|Adverse Event|1|||
130951307|NCT01631474|471455704|FG002|Overall Study|Adverse Event|0|||
130951308|NCT01631474|471455705|FG003|Overall Study|Adverse Event|0|||
130951309|NCT01631474|471455706|FG004|Overall Study|Adverse Event|0|||
130951310|NCT02624284|471455707|FG000|Overall Study|Withdrawal by Subject|3|||
130951311|NCT02624284|471455708|FG001|Overall Study|Withdrawal by Subject|6|||
130951312|NCT02624284|471455709|FG002|Overall Study|Withdrawal by Subject|3|||
130951313|NCT02624284|471455707|FG000|Overall Study|Protocol Violation|9|||
130951314|NCT02624284|471455708|FG001|Overall Study|Protocol Violation|10|||
130951315|NCT02624284|471455709|FG002|Overall Study|Protocol Violation|7|||
130951316|NCT02624284|471455707|FG000|Overall Study|Revealed exclusionary condition|2|||
130951317|NCT02624284|471455708|FG001|Overall Study|Revealed exclusionary condition|2|||
130951318|NCT02624284|471455709|FG002|Overall Study|Revealed exclusionary condition|0|||
130951319|NCT02624284|471455707|FG000|Overall Study|Adverse Event|0|||
130951320|NCT02624284|471455708|FG001|Overall Study|Adverse Event|0|||
130951321|NCT02624284|471455709|FG002|Overall Study|Adverse Event|1|||
130951322|NCT01641367|471455712|FG000|Cohorts|Death|18|||
130951323|NCT01641367|471455713|FG001|Cohorts|Death|1|||
130951324|NCT01641367|471455714|FG002|Cohorts|Death|2|||
130951325|NCT01641367|471455715|FG003|Cohorts|Death|0|||
130951326|NCT01641367|471455716|FG004|Cohorts|Death|1|||
130951327|NCT01641367|471455717|FG005|Cohorts|Death|1|||
130951328|NCT01641367|471455718|FG006|Cohorts|Death|0|||
130951329|NCT01641367|471455719|FG007|Cohorts|Death|0|||
130951330|NCT01641367|471455712|FG000|Cohorts|Lost to Follow-up|16|||
130951331|NCT01641367|471455713|FG001|Cohorts|Lost to Follow-up|0|||
130951332|NCT01641367|471455714|FG002|Cohorts|Lost to Follow-up|2|||
130951333|NCT01641367|471455715|FG003|Cohorts|Lost to Follow-up|0|||
130951334|NCT01641367|471455716|FG004|Cohorts|Lost to Follow-up|2|||
130951335|NCT01641367|471455717|FG005|Cohorts|Lost to Follow-up|0|||
130951336|NCT01641367|471455718|FG006|Cohorts|Lost to Follow-up|0|||
130951337|NCT01641367|471455719|FG007|Cohorts|Lost to Follow-up|0|||
130951338|NCT01641367|471455712|FG000|Randomized Adherence Intervention|Death|0|||
130951339|NCT01641367|471455713|FG001|Randomized Adherence Intervention|Death|0|||
131038702|NCT03252847|471776198|FG001|Overall Study|Other: Patient decision|0|||
131038703|NCT03252847|471776199|FG002|Overall Study|Other: Patient decision|0|||
131038704|NCT03252847|471776200|FG003|Overall Study|Other: Patient decision|0|||
131038705|NCT03252847|471776201|FG004|Overall Study|Other: Patient decision|1|||
131038706|NCT03252847|471776202|FG005|Overall Study|Other: Patient decision|0|||
130711327|NCT03375320|470567964|FG000|Overall Study|Alternative treatment|6|||
130951340|NCT01641367|471455714|FG002|Randomized Adherence Intervention|Death|0|||
130951341|NCT01641367|471455715|FG003|Randomized Adherence Intervention|Death|0|||
130951342|NCT01641367|471455716|FG004|Randomized Adherence Intervention|Death|0|||
131038707|NCT03252847|471776203|FG006|Overall Study|Other: Patient decision|0|||
130711328|NCT03375320|470567965|FG001|Overall Study|Alternative treatment|1|||
130951343|NCT01641367|471455717|FG005|Randomized Adherence Intervention|Death|0|||
130951344|NCT01641367|471455718|FG006|Randomized Adherence Intervention|Death|11|||
130951345|NCT01641367|471455719|FG007|Randomized Adherence Intervention|Death|12|||
130951346|NCT01641367|471455712|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
130711329|NCT03375320|470567966|FG002|Overall Study|Alternative treatment|1|||
131038708|NCT04992520|471776207|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
131038709|NCT04992520|471776208|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
131038710|NCT04992520|471776209|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
131038711|NCT04992520|471776210|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
131038712|NCT04992520|471776211|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
131038713|NCT04992520|471776212|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
131038714|NCT04992520|471776207|FG000|Part A: First Challenge|Non-compliance|0|||
131038715|NCT04992520|471776208|FG001|Part A: First Challenge|Non-compliance|0|||
131038716|NCT04992520|471776209|FG002|Part A: First Challenge|Non-compliance|0|||
131038717|NCT04992520|471776210|FG003|Part A: First Challenge|Non-compliance|1|||
131038718|NCT04992520|471776211|FG004|Part A: First Challenge|Non-compliance|0|||
130711330|NCT03375320|470567967|FG003|Overall Study|Alternative treatment|0|||
130711331|NCT03375320|470567964|FG000|Overall Study|Other disease|1|||
130711332|NCT03375320|470567965|FG001|Overall Study|Other disease|1|||
130711333|NCT03375320|470567966|FG002|Overall Study|Other disease|3|||
131038719|NCT04992520|471776212|FG005|Part A: First Challenge|Non-compliance|0|||
131038720|NCT04992520|471776207|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
131038721|NCT04992520|471776208|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
131038722|NCT04992520|471776209|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
131038723|NCT04992520|471776210|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
131038724|NCT04992520|471776211|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
131038725|NCT04992520|471776212|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
131038726|NCT04992520|471776207|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
131038727|NCT04992520|471776208|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
131038728|NCT04992520|471776209|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
131038729|NCT04992520|471776210|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
131038730|NCT04992520|471776211|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
131038731|NCT04992520|471776212|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
131038732|NCT06103188|471776215|FG000|Overall Study|Lost to Follow-up|1|||
131038733|NCT06103188|471776216|FG001|Overall Study|Lost to Follow-up|6|||
131038734|NCT06103188|471776217|FG002|Overall Study|Lost to Follow-up|4|||
131038735|NCT04979442|471776222|FG000|Overall Study|Death|43|||
131038736|NCT04979442|471776223|FG001|Overall Study|Death|30|||
131038737|NCT04979442|471776222|FG000|Overall Study|Withdrawal by Subject|8|||
131038738|NCT04979442|471776223|FG001|Overall Study|Withdrawal by Subject|13|||
131038739|NCT04979442|471776222|FG000|Overall Study|Physician Decision|1|||
131038740|NCT04979442|471776223|FG001|Overall Study|Physician Decision|1|||
131038741|NCT04979442|471776222|FG000|Overall Study|Lost to Follow-up|0|||
131038742|NCT04979442|471776223|FG001|Overall Study|Lost to Follow-up|2|||
131038743|NCT04979442|471776222|FG000|Overall Study|do not want to continue|0|||
131038744|NCT04979442|471776223|FG001|Overall Study|do not want to continue|1|||
131038745|NCT01175356|471776224|FG000|Overall Study|Death|1|||
131038746|NCT01175356|471776224|FG000|Overall Study|Lack of Efficacy|12|||
131038747|NCT01175356|471776224|FG000|Overall Study|Lost to Follow-up|1|||
130711334|NCT03375320|470567967|FG003|Overall Study|Other disease|0|||
130951347|NCT01641367|471455713|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
130951348|NCT01641367|471455714|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
130951349|NCT01641367|471455715|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
130951350|NCT01641367|471455716|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
130951351|NCT01641367|471455717|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
130951352|NCT01641367|471455718|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
130951353|NCT01641367|471455719|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
130951354|NCT03100825|471455722|FG000|Overall Study|Participant/Guardian Decision|7|||
130951355|NCT03100825|471455722|FG000|Overall Study|Physician Decision|1|||
130951356|NCT00735371|471455730|FG000|Overall Study|Adverse Event|3|||
130951357|NCT00735371|471455731|FG001|Overall Study|Adverse Event|3|||
130951358|NCT00735371|471455732|FG002|Overall Study|Adverse Event|4|||
130951359|NCT00735371|471455733|FG003|Overall Study|Adverse Event|1|||
130951360|NCT00735371|471455730|FG000|Overall Study|Protocol Violation|2|||
131038748|NCT01175356|471776224|FG000|Overall Study|Physician Decision|23|||
131038749|NCT01175356|471776224|FG000|Overall Study|Ineligible|1|||
131038750|NCT01175356|471776224|FG000|Overall Study|Treatment Slot Not Available|18|||
131038751|NCT01175356|471776224|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
131038752|NCT01175356|471776224|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
131038753|NCT01175356|471776224|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
130951361|NCT00735371|471455731|FG001|Overall Study|Protocol Violation|2|||
130951362|NCT00735371|471455732|FG002|Overall Study|Protocol Violation|0|||
131038754|NCT01175356|471776224|FG000|Overall Study|Inadequate stem cell for transplant|1|||
131038755|NCT01175356|471776224|FG000|Overall Study|Initiation other tx prior to completion|9|||
131038756|NCT04005794|471776229|FG000|Overall Study|Lost to Follow-up|0|||
131124902|NCT02536313|472085904|FG001|Overall Study|Lack of Efficacy|1|||
131124903|NCT00993265|472085915|FG000|Overall Study|Adverse Event|1|||
131038757|NCT04005794|471776230|FG001|Overall Study|Lost to Follow-up|4|||
130711335|NCT03375320|470567964|FG000|Overall Study|Withdrawal prior to initiation|2|||
131124904|NCT00993265|472085916|FG001|Overall Study|Adverse Event|0|||
131124905|NCT00993265|472085915|FG000|Overall Study|Changed dose of concomitant drug|2|||
130951363|NCT00735371|471455733|FG003|Overall Study|Protocol Violation|3|||
130951364|NCT00735371|471455730|FG000|Overall Study|Withdrawal by Subject|0|||
130951365|NCT00735371|471455731|FG001|Overall Study|Withdrawal by Subject|2|||
130951366|NCT00735371|471455732|FG002|Overall Study|Withdrawal by Subject|2|||
130951367|NCT00735371|471455733|FG003|Overall Study|Withdrawal by Subject|0|||
130951368|NCT00735371|471455730|FG000|Overall Study|Lost to Follow-up|1|||
130951369|NCT00735371|471455731|FG001|Overall Study|Lost to Follow-up|1|||
130951370|NCT00735371|471455732|FG002|Overall Study|Lost to Follow-up|3|||
130951371|NCT00735371|471455733|FG003|Overall Study|Lost to Follow-up|1|||
130951372|NCT00735371|471455730|FG000|Overall Study|Lack of Efficacy|4|||
130951373|NCT00735371|471455731|FG001|Overall Study|Lack of Efficacy|2|||
130951374|NCT00735371|471455732|FG002|Overall Study|Lack of Efficacy|0|||
130951375|NCT00735371|471455733|FG003|Overall Study|Lack of Efficacy|4|||
130951376|NCT00735371|471455730|FG000|Overall Study|Sponsor Decision|3|||
130951377|NCT00735371|471455731|FG001|Overall Study|Sponsor Decision|1|||
130951378|NCT00735371|471455732|FG002|Overall Study|Sponsor Decision|0|||
130951379|NCT00735371|471455733|FG003|Overall Study|Sponsor Decision|1|||
130951380|NCT00735371|471455730|FG000|Overall Study|Protocol Violation|0|||
130951381|NCT00735371|471455731|FG001|Overall Study|Protocol Violation|1|||
130951382|NCT00735371|471455732|FG002|Overall Study|Protocol Violation|2|||
130951383|NCT00735371|471455733|FG003|Overall Study|Protocol Violation|0|||
130951384|NCT00735371|471455730|FG000|Overall Study|Prior Vyvanse Exposure|1|||
130951385|NCT00735371|471455731|FG001|Overall Study|Prior Vyvanse Exposure|1|||
130951386|NCT00735371|471455732|FG002|Overall Study|Prior Vyvanse Exposure|0|||
130951387|NCT00735371|471455733|FG003|Overall Study|Prior Vyvanse Exposure|0|||
130951388|NCT00735371|471455730|FG000|Overall Study|Exclusion criteria|1|||
130951389|NCT00735371|471455731|FG001|Overall Study|Exclusion criteria|0|||
130951390|NCT00735371|471455732|FG002|Overall Study|Exclusion criteria|0|||
130951391|NCT00735371|471455733|FG003|Overall Study|Exclusion criteria|0|||
130951392|NCT00436748|471455738|FG000|Overall Study|Ineligibility Determined|1|||
130951393|NCT00436748|471455739|FG001|Overall Study|Ineligibility Determined|1|||
130951394|NCT00436748|471455738|FG000|Overall Study|Adverse Event|0|||
130951395|NCT00436748|471455739|FG001|Overall Study|Adverse Event|2|||
130951396|NCT00436748|471455738|FG000|Overall Study|Consent Withdrawn|1|||
130951397|NCT00436748|471455739|FG001|Overall Study|Consent Withdrawn|4|||
130951398|NCT00436748|471455738|FG000|Overall Study|Administrative Decision|1|||
130951399|NCT00436748|471455739|FG001|Overall Study|Administrative Decision|0|||
130951400|NCT00436748|471455738|FG000|Overall Study|Lost to Follow-up|0|||
130951401|NCT00436748|471455739|FG001|Overall Study|Lost to Follow-up|1|||
130951402|NCT00436748|471455738|FG000|Overall Study|Protocol-specified Criteria|5|||
130951403|NCT00436748|471455739|FG001|Overall Study|Protocol-specified Criteria|4|||
130951404|NCT00436748|471455738|FG000|Overall Study|Other|3|||
130951405|NCT00436748|471455739|FG001|Overall Study|Other|0|||
130951406|NCT00850200|471455742|FG000|Overall Study|Physician Decision|2|||
130951407|NCT00850200|471455742|FG000|Overall Study|Did not recieve treatment|2|||
130951408|NCT00850200|471455742|FG000|Overall Study|Withdrawal by Subject|1|||
130951409|NCT00048542|471455744|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130951410|NCT00048542|471455745|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
130951411|NCT00048542|471455746|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130951412|NCT00048542|471455747|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130951413|NCT00048542|471455748|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130951414|NCT00048542|471455749|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
130951415|NCT00048542|471455750|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
130951416|NCT00048542|471455751|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
130951417|NCT00048542|471455744|FG000|Double-Blind Phase|Protocol Violation|0|||
130951418|NCT00048542|471455745|FG001|Double-Blind Phase|Protocol Violation|0|||
130951419|NCT00048542|471455746|FG002|Double-Blind Phase|Protocol Violation|1|||
130951420|NCT00048542|471455747|FG003|Double-Blind Phase|Protocol Violation|0|||
130951421|NCT00048542|471455748|FG004|Double-Blind Phase|Protocol Violation|0|||
131124906|NCT00993265|472085916|FG001|Overall Study|Changed dose of concomitant drug|0|||
130951422|NCT00048542|471455749|FG005|Double-Blind Phase|Protocol Violation|0|||
130951423|NCT00048542|471455750|FG006|Double-Blind Phase|Protocol Violation|0|||
130951424|NCT00048542|471455751|FG007|Double-Blind Phase|Protocol Violation|0|||
130951425|NCT00048542|471455744|FG000|Double-Blind Phase|Sponsor request or decision|2|||
130951426|NCT00048542|471455745|FG001|Double-Blind Phase|Sponsor request or decision|0|||
131124907|NCT00993265|472085915|FG000|Overall Study|Non-compliant with study medication|1|||
131124908|NCT00993265|472085916|FG001|Overall Study|Non-compliant with study medication|0|||
130951427|NCT00048542|471455746|FG002|Double-Blind Phase|Sponsor request or decision|0|||
130951428|NCT00048542|471455747|FG003|Double-Blind Phase|Sponsor request or decision|0|||
130951429|NCT00048542|471455748|FG004|Double-Blind Phase|Sponsor request or decision|0|||
130951430|NCT00048542|471455749|FG005|Double-Blind Phase|Sponsor request or decision|0|||
131124909|NCT02321930|472085921|FG000|Overall Study|Lost to Follow-up|1|||
130951431|NCT00048542|471455750|FG006|Double-Blind Phase|Sponsor request or decision|0|||
130951432|NCT00048542|471455751|FG007|Double-Blind Phase|Sponsor request or decision|0|||
130951433|NCT00048542|471455744|FG000|Double-Blind Phase|Randomized in error|1|||
130711336|NCT03375320|470567965|FG001|Overall Study|Withdrawal prior to initiation|2|||
130711337|NCT03375320|470567966|FG002|Overall Study|Withdrawal prior to initiation|1|||
130951434|NCT00048542|471455745|FG001|Double-Blind Phase|Randomized in error|0|||
130951435|NCT00048542|471455746|FG002|Double-Blind Phase|Randomized in error|0|||
130951436|NCT00048542|471455747|FG003|Double-Blind Phase|Randomized in error|0|||
130951437|NCT00048542|471455748|FG004|Double-Blind Phase|Randomized in error|0|||
130951438|NCT00048542|471455749|FG005|Double-Blind Phase|Randomized in error|0|||
130951439|NCT00048542|471455750|FG006|Double-Blind Phase|Randomized in error|0|||
130951440|NCT00048542|471455751|FG007|Double-Blind Phase|Randomized in error|0|||
130951441|NCT00048542|471455744|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130951442|NCT00048542|471455745|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130951443|NCT00048542|471455746|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130951444|NCT00048542|471455747|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130951445|NCT00048542|471455748|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
130951446|NCT00048542|471455749|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
130951447|NCT00048542|471455750|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130951448|NCT00048542|471455751|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
130951449|NCT00048542|471455744|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
130951450|NCT00048542|471455745|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
130951451|NCT00048542|471455746|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
130951452|NCT00048542|471455747|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
130951453|NCT00048542|471455748|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
130951454|NCT00048542|471455749|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
130951455|NCT00048542|471455750|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
130951456|NCT00048542|471455751|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
130951457|NCT00048542|471455744|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130951458|NCT00048542|471455745|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130951459|NCT00048542|471455746|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130951460|NCT00048542|471455747|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130951461|NCT00048542|471455748|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
130951462|NCT00048542|471455749|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
130951463|NCT00048542|471455750|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130951464|NCT00048542|471455751|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130951465|NCT00048542|471455744|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
130951466|NCT00048542|471455745|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
130951467|NCT00048542|471455746|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
130951468|NCT00048542|471455747|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
130951469|NCT00048542|471455748|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
130951470|NCT00048542|471455749|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
130951471|NCT00048542|471455750|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
130951472|NCT00048542|471455751|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
130951473|NCT00048542|471455744|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130951474|NCT00048542|471455745|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130951475|NCT00048542|471455746|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130951476|NCT00048542|471455747|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130951477|NCT00048542|471455748|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
130951478|NCT00048542|471455749|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
130951479|NCT00048542|471455750|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130951480|NCT00048542|471455751|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
130951481|NCT00048542|471455744|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130951482|NCT00048542|471455745|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130951483|NCT00048542|471455746|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
131225104|NCT01792284|472451963|FG002|Lead-in Period|Adverse Event|0|||
130711338|NCT03375320|470567967|FG003|Overall Study|Withdrawal prior to initiation|0|||
130711339|NCT03375320|470567964|FG000|Overall Study|Physician Decision|1|||
130711340|NCT03375320|470567965|FG001|Overall Study|Physician Decision|1|||
130711341|NCT03375320|470567966|FG002|Overall Study|Physician Decision|1|||
130951484|NCT00048542|471455747|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130951485|NCT00048542|471455748|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130951486|NCT00048542|471455749|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
130951487|NCT00048542|471455750|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
130951488|NCT00048542|471455751|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
130951489|NCT00048542|471455744|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130951490|NCT00048542|471455745|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130951491|NCT00048542|471455746|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
131225105|NCT01792284|472451961|FG000|Lead-in Period|Lost to Follow-up|2|||
130711342|NCT03375320|470567967|FG003|Overall Study|Physician Decision|1|||
130711343|NCT03375320|470567964|FG000|Overall Study|Non-compliance|1|||
130774501|NCT02559570|470800547|FG004|Overall Study|Lost to Follow-up|0|||
130774502|NCT02559570|470800543|FG000|Overall Study|Protocol Violation|1|||
130951492|NCT00048542|471455747|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130951493|NCT00048542|471455748|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130951494|NCT00048542|471455749|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130951495|NCT00048542|471455750|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
130951496|NCT00048542|471455751|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
130951497|NCT00048542|471455744|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130951498|NCT00048542|471455745|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130951499|NCT00048542|471455746|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130951500|NCT00048542|471455747|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130951501|NCT00048542|471455748|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130951502|NCT00048542|471455749|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
130951503|NCT00048542|471455750|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
130951504|NCT00048542|471455751|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
130951505|NCT00048542|471455744|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130951506|NCT00048542|471455745|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130951507|NCT00048542|471455746|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130951508|NCT00048542|471455747|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130951509|NCT00048542|471455748|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130951510|NCT00048542|471455749|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
130951511|NCT00048542|471455750|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
130951512|NCT00048542|471455751|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
130951513|NCT00048542|471455744|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130951514|NCT00048542|471455745|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130951515|NCT00048542|471455746|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130951516|NCT00048542|471455747|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130951517|NCT00048542|471455748|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130951518|NCT00048542|471455749|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
130951519|NCT00048542|471455750|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
130951520|NCT00048542|471455751|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
130951521|NCT00048542|471455744|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130951522|NCT00048542|471455745|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130951523|NCT00048542|471455746|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130951524|NCT00048542|471455747|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130951525|NCT00048542|471455748|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130951526|NCT00048542|471455749|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
130951527|NCT00048542|471455750|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
130951528|NCT00048542|471455751|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
130951529|NCT01869192|471455752|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
130951530|NCT01869192|471455753|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
130951531|NCT01869192|471455752|FG000|Postoperative Chemotherapy|Physician Decision|0|||
130951532|NCT01869192|471455753|FG001|Postoperative Chemotherapy|Physician Decision|2|||
130951533|NCT00235872|471455757|FG000|Overall Study|Adverse Event|34|||
130951534|NCT00235872|471455757|FG000|Overall Study|Death|1|||
130951535|NCT00235872|471455757|FG000|Overall Study|Lost to Follow-up|1|||
130951536|NCT00235872|471455757|FG000|Overall Study|Withdrawal by Subject|50|||
130951537|NCT00235872|471455757|FG000|Overall Study|Administrative reason|61|||
130951538|NCT02126969|471455759|FG000|Overall Study|Withdrawal by Subject|1|||
130951539|NCT02126969|471455760|FG001|Overall Study|Withdrawal by Subject|2|||
130951540|NCT00423891|471455761|FG000|Enrolled|Withdrawal by Subject|0|||
130951541|NCT00423891|471455762|FG001|Enrolled|Withdrawal by Subject|0|||
130951542|NCT00423891|471455763|FG002|Enrolled|Withdrawal by Subject|1|||
130951543|NCT00423891|471455761|FG000|Enrolled|Lost to Follow-up|0|||
130951544|NCT00423891|471455762|FG001|Enrolled|Lost to Follow-up|0|||
130951545|NCT00423891|471455763|FG002|Enrolled|Lost to Follow-up|1|||
130951546|NCT00423891|471455761|FG000|Enrolled|No longer met criteria|11|||
130951547|NCT00423891|471455762|FG001|Enrolled|No longer met criteria|2|||
130951548|NCT00423891|471455763|FG002|Enrolled|No longer met criteria|1|||
130951549|NCT00423891|471455761|FG000|Treatment|Withdrawal by Subject|1|||
130951550|NCT00423891|471455762|FG001|Treatment|Withdrawal by Subject|0|||
130951551|NCT00423891|471455763|FG002|Treatment|Withdrawal by Subject|0|||
130774503|NCT02559570|470800544|FG001|Overall Study|Protocol Violation|0|||
130774504|NCT02559570|470800545|FG002|Overall Study|Protocol Violation|0|||
130774505|NCT02559570|470800546|FG003|Overall Study|Protocol Violation|0|||
130951552|NCT00423891|471455761|FG000|Treatment|Lost to Follow-up|1|||
130951553|NCT00423891|471455762|FG001|Treatment|Lost to Follow-up|0|||
130951554|NCT00423891|471455763|FG002|Treatment|Lost to Follow-up|0|||
130951555|NCT00423891|471455761|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
130951556|NCT00423891|471455762|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
130951557|NCT00423891|471455763|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
130951558|NCT00423891|471455761|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
130951559|NCT00423891|471455762|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
130951560|NCT00423891|471455763|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
130951561|NCT00696137|471455776|FG000|Overall Study|Withdrawal by Subject|2|||
130951562|NCT00785486|471455780|FG000|Midazolam Alone|Withdrawal by Subject|1|||
130951563|NCT01640366|471455784|FG000|Overall Study|Withdrawal by Subject|1|||
130951564|NCT01640366|471455784|FG000|Overall Study|Protocol Violation|16|||
130951565|NCT01640366|471455784|FG000|Overall Study|Lost to Follow-up|5|||
130951566|NCT01116232|471455787|FG000|Overall Study|Progressive diease|4|||
130951567|NCT02357940|471455790|FG000|Overall Study|Adverse Event|0|||
130951568|NCT02357940|471455791|FG001|Overall Study|Adverse Event|1|||
130951569|NCT02357940|471455790|FG000|Overall Study|Investigator's judgement|0|||
130951570|NCT02357940|471455791|FG001|Overall Study|Investigator's judgement|1|||
130951571|NCT02275481|471455792|FG000|Overall Study|Death|2|||
130951572|NCT02275481|471455793|FG001|Overall Study|Death|1|||
130951573|NCT02275481|471455792|FG000|Overall Study|Lost to Follow-up|2|||
130951574|NCT02275481|471455793|FG001|Overall Study|Lost to Follow-up|0|||
130951575|NCT02275481|471455792|FG000|Overall Study|Withdrawal by Subject|3|||
130951576|NCT02275481|471455793|FG001|Overall Study|Withdrawal by Subject|0|||
130951577|NCT02275481|471455792|FG000|Overall Study|all other reasons combined|2|||
130951578|NCT02275481|471455793|FG001|Overall Study|all other reasons combined|1|||
130951579|NCT02275481|471455792|FG000|Overall Study|Physician Decision|0|||
130951580|NCT02275481|471455793|FG001|Overall Study|Physician Decision|1|||
130951581|NCT03274986|471455794|FG000|Overall Study|Withdrawal by Subject|0|||
130951582|NCT03274986|471455795|FG001|Overall Study|Withdrawal by Subject|1|||
130951583|NCT03274986|471455794|FG000|Overall Study|Lost to Follow-up|0|||
130951584|NCT03274986|471455795|FG001|Overall Study|Lost to Follow-up|1|||
130951585|NCT00403273|471457778|FG000|Overall Study|Lost to Follow-up|3|||
130951586|NCT00403273|471457779|FG001|Overall Study|Lost to Follow-up|2|||
130951587|NCT00403273|471457778|FG000|Overall Study|Physician Decision|0|||
130951588|NCT00403273|471457779|FG001|Overall Study|Physician Decision|1|||
130951589|NCT00403273|471457778|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
130951590|NCT00403273|471457779|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
130951591|NCT00574405|471457780|FG000|Overall Study|Withdrawal by Subject|3|||
130951592|NCT00574405|471457781|FG001|Overall Study|Withdrawal by Subject|2|||
130951593|NCT01336738|471457782|FG000|Overall Study|Adverse Event|0|||
130951594|NCT01336738|471457783|FG001|Overall Study|Adverse Event|3|||
130951595|NCT01336738|471457784|FG002|Overall Study|Adverse Event|2|||
130951596|NCT01336738|471457785|FG003|Overall Study|Adverse Event|1|||
130951597|NCT01336738|471457786|FG004|Overall Study|Adverse Event|3|||
130951598|NCT01336738|471457782|FG000|Overall Study|Lost to Follow-up|2|||
130951599|NCT01336738|471457783|FG001|Overall Study|Lost to Follow-up|1|||
130951600|NCT01336738|471457784|FG002|Overall Study|Lost to Follow-up|2|||
130951601|NCT01336738|471457785|FG003|Overall Study|Lost to Follow-up|2|||
130951602|NCT01336738|471457786|FG004|Overall Study|Lost to Follow-up|2|||
130951603|NCT01336738|471457782|FG000|Overall Study|Did not meet entrance criteria|0|||
130951604|NCT01336738|471457783|FG001|Overall Study|Did not meet entrance criteria|1|||
130951605|NCT01336738|471457784|FG002|Overall Study|Did not meet entrance criteria|0|||
130951606|NCT01336738|471457785|FG003|Overall Study|Did not meet entrance criteria|0|||
130951607|NCT01336738|471457786|FG004|Overall Study|Did not meet entrance criteria|0|||
130951608|NCT01336738|471457782|FG000|Overall Study|Protocol Violation|0|||
130951609|NCT01336738|471457783|FG001|Overall Study|Protocol Violation|1|||
131038758|NCT04005794|471776231|FG002|Overall Study|Lost to Follow-up|0|||
131038759|NCT04313972|471776234|FG000|Overall Study|Withdrawal by Subject|0|||
131038760|NCT04313972|471776235|FG001|Overall Study|Withdrawal by Subject|1|||
130951610|NCT01336738|471457784|FG002|Overall Study|Protocol Violation|0|||
130951611|NCT01336738|471457785|FG003|Overall Study|Protocol Violation|0|||
130951612|NCT01336738|471457786|FG004|Overall Study|Protocol Violation|0|||
130951613|NCT01336738|471457782|FG000|Overall Study|Withdrawal by Subject|2|||
130951614|NCT01336738|471457783|FG001|Overall Study|Withdrawal by Subject|0|||
130951615|NCT01336738|471457784|FG002|Overall Study|Withdrawal by Subject|2|||
130951616|NCT01336738|471457785|FG003|Overall Study|Withdrawal by Subject|1|||
130951617|NCT01336738|471457786|FG004|Overall Study|Withdrawal by Subject|1|||
130951618|NCT01336738|471457782|FG000|Overall Study|Other|3|||
130951619|NCT01336738|471457783|FG001|Overall Study|Other|3|||
130951620|NCT01336738|471457784|FG002|Overall Study|Other|2|||
130951621|NCT01336738|471457785|FG003|Overall Study|Other|3|||
130951622|NCT01336738|471457786|FG004|Overall Study|Other|4|||
130951623|NCT03003520|471457787|FG000|Overall Study|Adverse Event|9|||
130951624|NCT03003520|471457788|FG001|Overall Study|Adverse Event|0|||
131038761|NCT04103580|471776253|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
131038762|NCT04103580|471776254|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
130951625|NCT03003520|471457787|FG000|Overall Study|Death|1|||
130951626|NCT03003520|471457788|FG001|Overall Study|Death|0|||
130951627|NCT03003520|471457787|FG000|Overall Study|Other reasons|4|||
130951628|NCT03003520|471457788|FG001|Overall Study|Other reasons|0|||
130951629|NCT03003520|471457787|FG000|Overall Study|Withdrawal by Subject|6|||
130951630|NCT03003520|471457788|FG001|Overall Study|Withdrawal by Subject|0|||
130951631|NCT03003520|471457787|FG000|Overall Study|Progressive disease|9|||
130951632|NCT03003520|471457788|FG001|Overall Study|Progressive disease|1|||
130951633|NCT01332149|471457789|FG000|Overall Study|Adverse Event|11|||
130951634|NCT01332149|471457790|FG001|Overall Study|Adverse Event|9|||
130951635|NCT01332149|471457789|FG000|Overall Study|Other unspecified|5|||
130951636|NCT01332149|471457790|FG001|Overall Study|Other unspecified|7|||
130951637|NCT01332149|471457789|FG000|Overall Study|Protocol Violation|1|||
130951638|NCT01332149|471457790|FG001|Overall Study|Protocol Violation|3|||
130951639|NCT01332149|471457789|FG000|Overall Study|Withdrawal by Subject|4|||
130951640|NCT01332149|471457790|FG001|Overall Study|Withdrawal by Subject|5|||
130951641|NCT01332149|471457789|FG000|Overall Study|Lost to Follow-up|1|||
130951642|NCT01332149|471457790|FG001|Overall Study|Lost to Follow-up|1|||
130951643|NCT01332149|471457789|FG000|Overall Study|Insufficient clinical response|4|||
130951644|NCT01332149|471457790|FG001|Overall Study|Insufficient clinical response|7|||
130951645|NCT01332149|471457789|FG000|Overall Study|Did not meet entrance criteria|3|||
130951646|NCT01332149|471457790|FG001|Overall Study|Did not meet entrance criteria|4|||
130951647|NCT01332149|471457789|FG000|Overall Study|Randomized but not treated|1|||
130951648|NCT01332149|471457790|FG001|Overall Study|Randomized but not treated|2|||
130951649|NCT04615949|471457791|FG000|Overall Study|Withdrawal by Subject|2|||
130951650|NCT04615949|471457792|FG001|Overall Study|Withdrawal by Subject|4|||
130951651|NCT04615949|471457791|FG000|Overall Study|Lost to Follow-up|2|||
130951652|NCT04615949|471457792|FG001|Overall Study|Lost to Follow-up|2|||
130951653|NCT04615949|471457791|FG000|Overall Study|Death|0|||
130951654|NCT04615949|471457792|FG001|Overall Study|Death|2|||
130951655|NCT02388737|471457794|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
130951656|NCT02388737|471457795|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
130951657|NCT02388737|471457796|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
130951658|NCT02388737|471457794|FG000|Overall Study|Major Protocol Deviation|18|||
130951659|NCT02388737|471457795|FG001|Overall Study|Major Protocol Deviation|25|||
130951660|NCT02388737|471457796|FG002|Overall Study|Major Protocol Deviation|22|||
130951661|NCT02388737|471457794|FG000|Overall Study|Lost to Follow-up|5|||
130951662|NCT02388737|471457795|FG001|Overall Study|Lost to Follow-up|1|||
130951663|NCT02388737|471457796|FG002|Overall Study|Lost to Follow-up|4|||
130951664|NCT02388737|471457794|FG000|Overall Study|Voluntary Withdrawal|10|||
130951665|NCT02388737|471457795|FG001|Overall Study|Voluntary Withdrawal|18|||
130951666|NCT02388737|471457796|FG002|Overall Study|Voluntary Withdrawal|17|||
130951667|NCT02388737|471457794|FG000|Overall Study|Lack of Efficacy|3|||
130951668|NCT02388737|471457795|FG001|Overall Study|Lack of Efficacy|0|||
130951669|NCT02388737|471457796|FG002|Overall Study|Lack of Efficacy|3|||
130951670|NCT02388737|471457794|FG000|Overall Study|Reason Not Specified|5|||
130951671|NCT02388737|471457795|FG001|Overall Study|Reason Not Specified|5|||
130951672|NCT02388737|471457796|FG002|Overall Study|Reason Not Specified|4|||
130951673|NCT01920932|471457797|FG000|Overall Study|Death|1|||
130951674|NCT01920932|471457797|FG000|Overall Study|Withdrawal of consent|1|||
130951675|NCT01816139|471457798|FG000|Overall Study|Adverse Event|6|||
130951676|NCT01816139|471457799|FG001|Overall Study|Adverse Event|8|||
130951677|NCT01816139|471457798|FG000|Overall Study|Lack of Efficacy|1|||
130951678|NCT01816139|471457799|FG001|Overall Study|Lack of Efficacy|2|||
130951679|NCT01816139|471457798|FG000|Overall Study|Lost to Follow-up|5|||
130951680|NCT01816139|471457799|FG001|Overall Study|Lost to Follow-up|3|||
130951681|NCT01816139|471457798|FG000|Overall Study|Withdrew Consent|6|||
130951682|NCT01816139|471457799|FG001|Overall Study|Withdrew Consent|4|||
130951683|NCT01816139|471457798|FG000|Overall Study|Protocol Violation|6|||
130951684|NCT01816139|471457799|FG001|Overall Study|Protocol Violation|3|||
130951685|NCT01816139|471457798|FG000|Overall Study|Reason not Specified|4|||
130951686|NCT01816139|471457799|FG001|Overall Study|Reason not Specified|2|||
130951687|NCT02342704|471457802|FG000|Overall Study|Physician Decision|0|||
130951688|NCT02342704|471457803|FG001|Overall Study|Physician Decision|3|||
130951689|NCT02342704|471457802|FG000|Overall Study|Sponsor Termination|49|||
130951690|NCT02342704|471457803|FG001|Overall Study|Sponsor Termination|43|||
130951691|NCT02342704|471457802|FG000|Overall Study|Other|0|||
130951692|NCT02342704|471457803|FG001|Overall Study|Other|1|||
130951693|NCT02342704|471457802|FG000|Overall Study|Withdrawal by Subject|1|||
130951694|NCT02342704|471457803|FG001|Overall Study|Withdrawal by Subject|0|||
130951695|NCT02342704|471457802|FG000|Overall Study|Lost to Follow-up|2|||
130951696|NCT02342704|471457803|FG001|Overall Study|Lost to Follow-up|1|||
130951697|NCT02342704|471457802|FG000|Overall Study|Adverse Event|1|||
130951698|NCT02342704|471457803|FG001|Overall Study|Adverse Event|3|||
130951699|NCT02347527|471457804|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
130951700|NCT02347527|471457805|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
130951701|NCT02347527|471457806|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
130951702|NCT02347527|471457807|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
130711344|NCT03375320|470567965|FG001|Overall Study|Non-compliance|0|||
130711345|NCT03375320|470567966|FG002|Overall Study|Non-compliance|0|||
130711346|NCT03375320|470567967|FG003|Overall Study|Non-compliance|0|||
130711347|NCT02589522|470567969|FG000|Overall Study|Physician Decision|1|||
130711348|NCT02589522|470567970|FG001|Overall Study|Physician Decision|2|||
130711349|NCT02589522|470567971|FG002|Overall Study|Physician Decision|0|||
130711350|NCT02589522|470567969|FG000|Overall Study|Did not start treatment|1|||
130711351|NCT02589522|470567970|FG001|Overall Study|Did not start treatment|0|||
130711352|NCT02589522|470567971|FG002|Overall Study|Did not start treatment|0|||
130711353|NCT05611996|470567972|FG000|Overall Study|Ineligible|1|||
130711354|NCT05611996|470567972|FG000|Overall Study|Withdrawal by Subject|9|||
130711355|NCT05560763|470567973|FG000|Overall Study|Withdrawal by Subject|4|||
130711356|NCT03228537|470567974|FG000|Neoadjuvant|Adverse Event|2|||
130711357|NCT03228537|470567974|FG000|Neoadjuvant|Progression/Relapse|4|||
130711358|NCT03228537|470567974|FG000|Neoadjuvant|Death|1|||
130711359|NCT03228537|470567974|FG000|Surgery|Death|1|||
130711360|NCT03228537|470567974|FG000|Surgery|Other - Not Protocol Specified|2|||
130711361|NCT03228537|470567974|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
130711362|NCT03228537|470567974|FG000|Maintenance|Progression/Relapse|10|||
130711363|NCT04572243|470567975|FG000|Core Study: 14 Weeks|Adverse Event|1|||
130711364|NCT04572243|470567976|FG001|Core Study: 14 Weeks|Adverse Event|2|||
130711365|NCT04572243|470567977|FG002|Core Study: 14 Weeks|Adverse Event|0|||
130951703|NCT02347527|471457804|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
131225106|NCT01792284|472451962|FG001|Lead-in Period|Lost to Follow-up|0|||
130711366|NCT04572243|470567978|FG003|Core Study: 14 Weeks|Adverse Event|0|||
130711367|NCT04572243|470567975|FG000|Core Study: 14 Weeks|Subject choice|0|||
130711368|NCT04572243|470567976|FG001|Core Study: 14 Weeks|Subject choice|2|||
130711369|NCT04572243|470567977|FG002|Core Study: 14 Weeks|Subject choice|0|||
130951704|NCT02347527|471457805|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
130951705|NCT02347527|471457806|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
130951706|NCT02347527|471457807|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
130951707|NCT02347527|471457804|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
130951708|NCT02347527|471457805|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
130951709|NCT02347527|471457806|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
130951710|NCT02347527|471457807|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
130951711|NCT02347527|471457804|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
130951712|NCT02347527|471457805|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
130951713|NCT02347527|471457806|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
130951714|NCT02347527|471457807|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
130951715|NCT02347527|471457804|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
130951716|NCT02347527|471457805|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
130951717|NCT02347527|471457806|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
130951718|NCT02347527|471457807|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
130951719|NCT00302003|471457809|FG000|Overall Study|Lack of Efficacy|62|||
130951720|NCT00302003|471457809|FG000|Overall Study|Lost to Follow-up|1|||
130951721|NCT00302003|471457809|FG000|Overall Study|Physician Decision|2|||
130951722|NCT00302003|471457809|FG000|Overall Study|Withdrawal by Subject|5|||
130951723|NCT00302003|471457809|FG000|Overall Study|Ineligible|9|||
130951724|NCT00302003|471457809|FG000|Overall Study|Protocol Violation|1|||
130951725|NCT02042924|471457810|FG000|Overall Study|Early Death|1|||
130951726|NCT00283439|471457811|FG000|Overall Study|Adverse Event|0|||
130951727|NCT00283439|471457812|FG001|Overall Study|Adverse Event|0|||
130711370|NCT04572243|470567978|FG003|Core Study: 14 Weeks|Subject choice|0|||
130711371|NCT04572243|470567975|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
130711372|NCT04572243|470567976|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
130711373|NCT04572243|470567977|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
130711374|NCT04572243|470567978|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
130711375|NCT04572243|470567975|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
130711376|NCT04572243|470567976|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
130951728|NCT00283439|471457813|FG002|Overall Study|Adverse Event|0|||
130951729|NCT00283439|471457814|FG003|Overall Study|Adverse Event|1|||
130951730|NCT00283439|471457811|FG000|Overall Study|Death|0|||
130951731|NCT00283439|471457812|FG001|Overall Study|Death|0|||
130951732|NCT00283439|471457813|FG002|Overall Study|Death|1|||
130951733|NCT00283439|471457814|FG003|Overall Study|Death|0|||
130951734|NCT00283439|471457811|FG000|Overall Study|Disease progression|0|||
130951735|NCT00283439|471457812|FG001|Overall Study|Disease progression|1|||
130951736|NCT00283439|471457813|FG002|Overall Study|Disease progression|0|||
130951737|NCT00283439|471457814|FG003|Overall Study|Disease progression|0|||
130951738|NCT00283439|471457811|FG000|Overall Study|Requirement for alternative therapy|1|||
130951739|NCT00283439|471457812|FG001|Overall Study|Requirement for alternative therapy|2|||
130951740|NCT00283439|471457813|FG002|Overall Study|Requirement for alternative therapy|5|||
130951741|NCT00283439|471457814|FG003|Overall Study|Requirement for alternative therapy|2|||
130951742|NCT00283439|471457811|FG000|Overall Study|Stem cell transplant|6|||
130951743|NCT00283439|471457812|FG001|Overall Study|Stem cell transplant|6|||
130951744|NCT00283439|471457813|FG002|Overall Study|Stem cell transplant|4|||
130951745|NCT00283439|471457814|FG003|Overall Study|Stem cell transplant|3|||
130951746|NCT00283439|471457811|FG000|Overall Study|Treatment discontinued|0|||
130951747|NCT00283439|471457812|FG001|Overall Study|Treatment discontinued|2|||
130951748|NCT00283439|471457813|FG002|Overall Study|Treatment discontinued|1|||
130951749|NCT00283439|471457814|FG003|Overall Study|Treatment discontinued|3|||
130951750|NCT00283439|471457811|FG000|Overall Study|Other|1|||
130951751|NCT00283439|471457812|FG001|Overall Study|Other|0|||
130951752|NCT00283439|471457813|FG002|Overall Study|Other|0|||
130951753|NCT00283439|471457814|FG003|Overall Study|Other|0|||
130951754|NCT01632891|471457815|FG000|Overall Study|Lost to Follow-up|0|||
130951755|NCT01632891|471457816|FG001|Overall Study|Lost to Follow-up|1|||
130951756|NCT01632891|471457815|FG000|Overall Study|Withdrawal by Subject|1|||
130951757|NCT01632891|471457816|FG001|Overall Study|Withdrawal by Subject|0|||
130951758|NCT02919670|471457817|FG000|Overall Study|Only 17 participants met compliance|43|||
130951759|NCT02919670|471457818|FG001|Overall Study|Only 17 participants met compliance|39|||
130951760|NCT00240071|471457819|FG000|Overall Study|Withdrawal by Subject|3|||
130951761|NCT01466270|471457820|FG000|Overall Study|Withdrawal by Subject|4|||
130951762|NCT01466270|471457821|FG001|Overall Study|Withdrawal by Subject|1|||
130951763|NCT01466270|471457820|FG000|Overall Study|Physician Decision|1|||
130951764|NCT01466270|471457821|FG001|Overall Study|Physician Decision|0|||
130951765|NCT01466270|471457820|FG000|Overall Study|Lost to Follow-up|1|||
130951766|NCT01466270|471457821|FG001|Overall Study|Lost to Follow-up|3|||
130951767|NCT01466270|471457820|FG000|Overall Study|Progression|1|||
130951768|NCT01466270|471457821|FG001|Overall Study|Progression|0|||
130951769|NCT01466270|471457820|FG000|Overall Study|Toxicity|4|||
130951770|NCT01466270|471457821|FG001|Overall Study|Toxicity|1|||
130951771|NCT01466270|471457820|FG000|Overall Study|Multiple|1|||
130951772|NCT01466270|471457821|FG001|Overall Study|Multiple|1|||
130951773|NCT04206293|471457826|FG000|Overall Study|Consent withdrawal|1|||
130951774|NCT01454934|471457829|FG000|Overall Study|Clinical progression|28|||
130951775|NCT01454934|471457830|FG001|Overall Study|Clinical progression|25|||
130951776|NCT01454934|471457829|FG000|Overall Study|Other|6|||
130951777|NCT01454934|471457830|FG001|Overall Study|Other|17|||
130951778|NCT01454934|471457829|FG000|Overall Study|Adverse Event|28|||
130951779|NCT01454934|471457830|FG001|Overall Study|Adverse Event|24|||
130951780|NCT01454934|471457829|FG000|Overall Study|Withdrawn consent|2|||
130951781|NCT01454934|471457830|FG001|Overall Study|Withdrawn consent|5|||
130951782|NCT01454934|471457829|FG000|Overall Study|Withdrawal by Subject|11|||
130951783|NCT01454934|471457830|FG001|Overall Study|Withdrawal by Subject|15|||
130951784|NCT01454934|471457829|FG000|Overall Study|Disease progression|194|||
130951785|NCT01454934|471457830|FG001|Overall Study|Disease progression|181|||
130951786|NCT01454934|471457829|FG000|Overall Study|Lost to Follow-up|0|||
130951787|NCT01454934|471457830|FG001|Overall Study|Lost to Follow-up|1|||
130951788|NCT01454934|471457829|FG000|Overall Study|Not treated|1|||
130951789|NCT01454934|471457830|FG001|Overall Study|Not treated|2|||
130951790|NCT00430092|471457833|FG000|Overall Study|Adverse Event|0|||
131225107|NCT01792284|472451963|FG002|Lead-in Period|Lost to Follow-up|0|||
130951791|NCT00430092|471457834|FG001|Overall Study|Adverse Event|0|||
130951792|NCT00430092|471457835|FG002|Overall Study|Adverse Event|1|||
130951793|NCT00430092|471457833|FG000|Overall Study|Lack of Efficacy|5|||
130951794|NCT00430092|471457834|FG001|Overall Study|Lack of Efficacy|2|||
130951795|NCT00430092|471457835|FG002|Overall Study|Lack of Efficacy|54|||
130951796|NCT00430092|471457833|FG000|Overall Study|Lost to Follow-up|1|||
130711377|NCT04572243|470567977|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
130711378|NCT04572243|470567978|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
130951797|NCT00430092|471457834|FG001|Overall Study|Lost to Follow-up|0|||
130711379|NCT05420012|470567979|FG000|Overall Study|Lost to Follow-up|0|||
130951798|NCT00430092|471457835|FG002|Overall Study|Lost to Follow-up|0|||
130951799|NCT00430092|471457833|FG000|Overall Study|Protocol Violation|0|||
130951800|NCT00430092|471457834|FG001|Overall Study|Protocol Violation|1|||
130951801|NCT00430092|471457835|FG002|Overall Study|Protocol Violation|1|||
130951802|NCT00430092|471457833|FG000|Overall Study|Withdrawal by Subject|0|||
130951803|NCT00430092|471457834|FG001|Overall Study|Withdrawal by Subject|1|||
131225108|NCT01792284|472451961|FG000|Lead-in Period|Protocol Violation|1|||
130711380|NCT05420012|470567980|FG001|Overall Study|Lost to Follow-up|1|||
130711381|NCT03253744|470567982|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
130711382|NCT03253744|470567983|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
130711383|NCT03253744|470567984|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
130711384|NCT03253744|470567985|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
130711385|NCT03856593|470567988|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
130711386|NCT03856593|470567989|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
130774506|NCT02559570|470800547|FG004|Overall Study|Protocol Violation|1|||
130951804|NCT00430092|471457835|FG002|Overall Study|Withdrawal by Subject|1|||
130951805|NCT02118428|471457836|FG000|Overall Study|Physician Decision|0|||
130951806|NCT02118428|471457837|FG001|Overall Study|Physician Decision|1|||
130951807|NCT02118428|471457838|FG002|Overall Study|Physician Decision|0|||
130951808|NCT02118428|471457836|FG000|Overall Study|Withdrawal by Subject|2|||
130951809|NCT02118428|471457837|FG001|Overall Study|Withdrawal by Subject|2|||
130951810|NCT02118428|471457838|FG002|Overall Study|Withdrawal by Subject|0|||
130951811|NCT02118428|471457836|FG000|Overall Study|Death|7|||
130951812|NCT02118428|471457837|FG001|Overall Study|Death|5|||
130951813|NCT02118428|471457838|FG002|Overall Study|Death|0|||
130951814|NCT02118428|471457836|FG000|Overall Study|Lost to Follow-up|3|||
130951815|NCT02118428|471457837|FG001|Overall Study|Lost to Follow-up|1|||
130951816|NCT02118428|471457838|FG002|Overall Study|Lost to Follow-up|0|||
130951817|NCT02118428|471457836|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
130951818|NCT02118428|471457837|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
130951819|NCT02118428|471457838|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
130951820|NCT00578175|471457851|FG000|Overall Study|Adverse Event|0|||
130951821|NCT00578175|471457852|FG001|Overall Study|Adverse Event|1|||
130951822|NCT00578175|471457853|FG002|Overall Study|Adverse Event|1|||
130951823|NCT00578175|471457851|FG000|Overall Study|Other reasons|70|||
130951824|NCT00578175|471457852|FG001|Overall Study|Other reasons|42|||
130951825|NCT00578175|471457853|FG002|Overall Study|Other reasons|23|||
130951826|NCT04225923|471457857|FG000|Overall Study|Protocol Violation|1|||
130951827|NCT04225923|471457858|FG001|Overall Study|Protocol Violation|0|||
130951828|NCT04225923|471457859|FG002|Overall Study|Protocol Violation|1|||
130951829|NCT04225923|471457857|FG000|Overall Study|Withdrawal by Subject|4|||
130951830|NCT04225923|471457858|FG001|Overall Study|Withdrawal by Subject|1|||
130951831|NCT04225923|471457859|FG002|Overall Study|Withdrawal by Subject|3|||
130951832|NCT04225923|471457857|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
130951833|NCT04225923|471457858|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
130951834|NCT04225923|471457859|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
130951835|NCT01417481|471457860|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
130951836|NCT01417481|471457861|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130951837|NCT00855309|471457862|FG000|Overall Study|patient never recieved drug|1|||
130951838|NCT00855309|471457863|FG001|Overall Study|patient never recieved drug|0|||
130951839|NCT00829296|471457864|FG000|Overall Study|Adverse Event|5|||
130951840|NCT00829296|471457865|FG001|Overall Study|Adverse Event|4|||
130951841|NCT03029624|471457866|FG000|Overall Study|Adverse Event|1|||
130951842|NCT03029624|471457866|FG000|Overall Study|Withdrawal by Subject|1|||
130951843|NCT03029624|471457866|FG000|Overall Study|Lack of Efficacy|1|||
130951844|NCT03029624|471457866|FG000|Overall Study|MRI need|2|||
130951845|NCT01077960|471457870|FG000|Overall Study|Adverse Event|6|||
130951846|NCT01077960|471457870|FG000|Overall Study|Protocol Violation|3|||
130951847|NCT01077960|471457870|FG000|Overall Study|Lost to Follow-up|5|||
130951848|NCT01077960|471457870|FG000|Overall Study|Subject decision|1|||
130951849|NCT01077960|471457870|FG000|Overall Study|Reason unspecified|1|||
130951850|NCT03837899|471457871|FG000|Overall Study|Death|6|||
130951851|NCT03837899|471457872|FG001|Overall Study|Death|8|||
130951852|NCT03837899|471457873|FG002|Overall Study|Death|3|||
130951853|NCT03837899|471457874|FG003|Overall Study|Death|7|||
130951854|NCT03837899|471457875|FG004|Overall Study|Death|8|||
130951855|NCT03837899|471457876|FG005|Overall Study|Death|7|||
130951856|NCT03837899|471457871|FG000|Overall Study|Moved to post-trial access program|0|||
130951857|NCT03837899|471457872|FG001|Overall Study|Moved to post-trial access program|1|||
130951858|NCT03837899|471457873|FG002|Overall Study|Moved to post-trial access program|0|||
130951859|NCT03837899|471457874|FG003|Overall Study|Moved to post-trial access program|0|||
130951860|NCT03837899|471457875|FG004|Overall Study|Moved to post-trial access program|0|||
130951861|NCT03837899|471457876|FG005|Overall Study|Moved to post-trial access program|0|||
130951862|NCT03837899|471457871|FG000|Overall Study|Other|0|||
130951863|NCT03837899|471457872|FG001|Overall Study|Other|0|||
130951864|NCT03837899|471457873|FG002|Overall Study|Other|0|||
130951865|NCT03837899|471457874|FG003|Overall Study|Other|0|||
130951866|NCT03837899|471457875|FG004|Overall Study|Other|0|||
130951867|NCT03837899|471457876|FG005|Overall Study|Other|2|||
130951868|NCT03837899|471457871|FG000|Overall Study|Lost to Follow-up|0|||
130951869|NCT03837899|471457872|FG001|Overall Study|Lost to Follow-up|1|||
130951870|NCT03837899|471457873|FG002|Overall Study|Lost to Follow-up|0|||
130951871|NCT03837899|471457874|FG003|Overall Study|Lost to Follow-up|0|||
130951872|NCT03837899|471457875|FG004|Overall Study|Lost to Follow-up|0|||
130951873|NCT03837899|471457876|FG005|Overall Study|Lost to Follow-up|0|||
130951874|NCT03837899|471457871|FG000|Overall Study|Withdrawal by Subject|0|||
130951875|NCT03837899|471457872|FG001|Overall Study|Withdrawal by Subject|0|||
130951876|NCT03837899|471457873|FG002|Overall Study|Withdrawal by Subject|0|||
130951877|NCT03837899|471457874|FG003|Overall Study|Withdrawal by Subject|1|||
130951878|NCT03837899|471457875|FG004|Overall Study|Withdrawal by Subject|0|||
130951879|NCT03837899|471457876|FG005|Overall Study|Withdrawal by Subject|0|||
130951880|NCT03837899|471457871|FG000|Overall Study|Study specific discontinuation criteria|0|||
130951881|NCT03837899|471457872|FG001|Overall Study|Study specific discontinuation criteria|1|||
130951882|NCT03837899|471457873|FG002|Overall Study|Study specific discontinuation criteria|0|||
130951883|NCT03837899|471457874|FG003|Overall Study|Study specific discontinuation criteria|0|||
130951884|NCT03837899|471457875|FG004|Overall Study|Study specific discontinuation criteria|3|||
130951885|NCT03837899|471457876|FG005|Overall Study|Study specific discontinuation criteria|1|||
130951886|NCT01371656|471457877|FG000|Overall Study|Death|7|||
130951887|NCT01371656|471457878|FG001|Overall Study|Death|4|||
130951888|NCT01371656|471457877|FG000|Overall Study|Physician Decision|46|||
130951889|NCT01371656|471457878|FG001|Overall Study|Physician Decision|7|||
130951890|NCT01371656|471457877|FG000|Overall Study|Withdrawal by Subject|7|||
130951891|NCT01371656|471457878|FG001|Overall Study|Withdrawal by Subject|0|||
130951892|NCT01371656|471457877|FG000|Overall Study|Ineligible|4|||
130951893|NCT01371656|471457878|FG001|Overall Study|Ineligible|3|||
130951894|NCT01465464|471457879|FG000|Overall Study|Adverse Event|96|||
130951895|NCT01465464|471457880|FG001|Overall Study|Adverse Event|49|||
130951896|NCT01465464|471457879|FG000|Overall Study|Lack of Efficacy|139|||
130951897|NCT01465464|471457880|FG001|Overall Study|Lack of Efficacy|190|||
130951898|NCT01465464|471457879|FG000|Overall Study|Physician Decision|13|||
130951899|NCT01465464|471457880|FG001|Overall Study|Physician Decision|5|||
130951900|NCT01465464|471457879|FG000|Overall Study|Protocol Violation|1|||
130951901|NCT01465464|471457880|FG001|Overall Study|Protocol Violation|1|||
130951902|NCT01465464|471457879|FG000|Overall Study|Withdrawal by Subject|46|||
130951903|NCT01465464|471457880|FG001|Overall Study|Withdrawal by Subject|30|||
130951904|NCT01465464|471457879|FG000|Overall Study|Other|9|||
130951905|NCT01465464|471457880|FG001|Overall Study|Other|3|||
130951906|NCT01465464|471457879|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
130951907|NCT01465464|471457880|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
130951908|NCT01554618|471457881|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
130951909|NCT01554618|471457882|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
130951910|NCT01554618|471457881|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
130951911|NCT01554618|471457882|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
130951912|NCT01554618|471457881|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
130951913|NCT01554618|471457882|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
130951914|NCT01554618|471457881|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
130951915|NCT01554618|471457882|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
130951916|NCT01554618|471457881|FG000|Open-Label Extension Period|Physician Decision|0|||
130951917|NCT01554618|471457882|FG001|Open-Label Extension Period|Physician Decision|1|||
130951918|NCT01554618|471457881|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
130951919|NCT01554618|471457882|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
130951920|NCT02244580|471457884|FG000|Overall Study|No cancer tissues available|241|||
130951921|NCT04011410|471457885|FG000|Overall Study|Withdrawal by Subject|1|||
131038763|NCT04103580|471776253|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
131038764|NCT04103580|471776254|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
131038765|NCT04103580|471776253|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
131038766|NCT04103580|471776254|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
131038767|NCT04103580|471776253|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
131038768|NCT04103580|471776254|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
131038769|NCT04103580|471776253|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
131038770|NCT04103580|471776254|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
131038771|NCT04103580|471776253|FG000|Phase 1 Active Caregiving|Other|3|||
131038772|NCT04103580|471776254|FG001|Phase 1 Active Caregiving|Other|3|||
131038773|NCT04103580|471776253|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
131038774|NCT04103580|471776254|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
131038775|NCT04103580|471776253|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
131038776|NCT04103580|471776254|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
130951922|NCT00291668|471457891|FG000|Overall Study|Lack of Efficacy|1|||
131038777|NCT04103580|471776253|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
131038778|NCT04103580|471776254|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
131225109|NCT01792284|472451962|FG001|Lead-in Period|Protocol Violation|0|||
130951923|NCT00291668|471457892|FG001|Overall Study|Lack of Efficacy|0|||
130951924|NCT00291668|471457893|FG002|Overall Study|Lack of Efficacy|0|||
130951925|NCT00291668|471457891|FG000|Overall Study|SAE, non-fatal|1|||
131038779|NCT04103580|471776253|FG000|Phase 2 Bereavement|Other|8|||
131038780|NCT04103580|471776254|FG001|Phase 2 Bereavement|Other|6|||
131038781|NCT04145440|471776255|FG000|Overall Study|Physician Decision|3|||
131038782|NCT04145440|471776256|FG001|Overall Study|Physician Decision|0|||
131038783|NCT04145440|471776255|FG000|Overall Study|Use of prohibited therapy|2|||
131038784|NCT04145440|471776256|FG001|Overall Study|Use of prohibited therapy|3|||
131038785|NCT05808257|471776259|FG000|Overall Study|Lost to Follow-up|8|||
131038786|NCT05808257|471776260|FG001|Overall Study|Lost to Follow-up|8|||
131038787|NCT04568486|471776261|FG000|Overall Study|Withdrawal by Subject|26|||
131038788|NCT04568486|471776261|FG000|Overall Study|Lost to Follow-up|7|||
131038789|NCT05297565|471776268|FG000|Overall Study|Other Reasons|0|||
131038790|NCT05297565|471776269|FG001|Overall Study|Other Reasons|1|||
131038791|NCT05297565|471776268|FG000|Overall Study|Physician Decision|0|||
131038792|NCT05297565|471776269|FG001|Overall Study|Physician Decision|1|||
131038793|NCT05297565|471776268|FG000|Overall Study|Disease recurrence|1|||
131038794|NCT05297565|471776269|FG001|Overall Study|Disease recurrence|0|||
131038795|NCT03899259|471776284|FG000|Overall Study|Adverse Event|5|||
131038796|NCT03899259|471776285|FG001|Overall Study|Adverse Event|4|||
131038797|NCT03899259|471776286|FG002|Overall Study|Adverse Event|6|||
131038798|NCT03899259|471776284|FG000|Overall Study|Lack of Efficacy|5|||
131038799|NCT03899259|471776285|FG001|Overall Study|Lack of Efficacy|0|||
131038800|NCT03899259|471776286|FG002|Overall Study|Lack of Efficacy|2|||
131038801|NCT03899259|471776284|FG000|Overall Study|Pregnancy|3|||
131038802|NCT03899259|471776285|FG001|Overall Study|Pregnancy|0|||
131038803|NCT03899259|471776286|FG002|Overall Study|Pregnancy|1|||
131038804|NCT03899259|471776284|FG000|Overall Study|Physician Decision|0|||
131038805|NCT03899259|471776285|FG001|Overall Study|Physician Decision|1|||
131038806|NCT03899259|471776286|FG002|Overall Study|Physician Decision|0|||
131038807|NCT03899259|471776284|FG000|Overall Study|Protocol Deviation|1|||
131038808|NCT03899259|471776285|FG001|Overall Study|Protocol Deviation|1|||
131038809|NCT03899259|471776286|FG002|Overall Study|Protocol Deviation|1|||
131038810|NCT03899259|471776284|FG000|Overall Study|Withdrawal by Subject|8|||
131038811|NCT03899259|471776285|FG001|Overall Study|Withdrawal by Subject|10|||
131038812|NCT03899259|471776286|FG002|Overall Study|Withdrawal by Subject|12|||
131038813|NCT03899259|471776284|FG000|Overall Study|Lost to Follow-up|5|||
131038814|NCT03899259|471776285|FG001|Overall Study|Lost to Follow-up|6|||
131038815|NCT03899259|471776286|FG002|Overall Study|Lost to Follow-up|2|||
131038816|NCT03899259|471776284|FG000|Overall Study|Lack of Adherence|1|||
131038817|NCT03899259|471776285|FG001|Overall Study|Lack of Adherence|0|||
131038818|NCT03899259|471776286|FG002|Overall Study|Lack of Adherence|0|||
131038819|NCT03899259|471776284|FG000|Overall Study|Screen Failure|1|||
131038820|NCT03899259|471776285|FG001|Overall Study|Screen Failure|0|||
131038821|NCT03899259|471776286|FG002|Overall Study|Screen Failure|0|||
131038822|NCT03899259|471776284|FG000|Overall Study|Ongoing Study Participation|127|||
131038823|NCT03899259|471776285|FG001|Overall Study|Ongoing Study Participation|134|||
131038824|NCT03899259|471776286|FG002|Overall Study|Ongoing Study Participation|210|||
131038825|NCT05139810|471776287|FG000|Overall Study|Voluntary Withdrawal|2|||
131038826|NCT05139810|471776288|FG001|Overall Study|Voluntary Withdrawal|1|||
131038827|NCT05139810|471776289|FG002|Overall Study|Voluntary Withdrawal|0|||
131038828|NCT05139810|471776287|FG000|Overall Study|Pregnancy|1|||
131038829|NCT05139810|471776288|FG001|Overall Study|Pregnancy|0|||
131038830|NCT05139810|471776289|FG002|Overall Study|Pregnancy|0|||
131038831|NCT05139810|471776287|FG000|Overall Study|Roll Over to CS7|19|||
131038832|NCT05139810|471776288|FG001|Overall Study|Roll Over to CS7|44|||
131038833|NCT05139810|471776289|FG002|Overall Study|Roll Over to CS7|20|||
131038834|NCT05566639|471776292|FG000|Overall Study|Adverse Event|1|||
131038835|NCT05566639|471776293|FG001|Overall Study|Adverse Event|1|||
131038836|NCT05566639|471776292|FG000|Overall Study|Serious Adverse Event|1|||
131038837|NCT05566639|471776293|FG001|Overall Study|Serious Adverse Event|3|||
131038838|NCT05566639|471776292|FG000|Overall Study|Death|44|||
130711387|NCT01949116|470567990|FG000|Overall Study|Death|2|||
130711388|NCT01949116|470567991|FG001|Overall Study|Death|0|||
130711389|NCT01949116|470567990|FG000|Overall Study|Lost to Follow-up|1|||
131124928|NCT00853749|472085925|FG000|Overall Study|Lost to Follow-up|0|||
131124929|NCT00853749|472085926|FG001|Overall Study|Lost to Follow-up|1|||
130711390|NCT01949116|470567991|FG001|Overall Study|Lost to Follow-up|3|||
130711391|NCT01949116|470567990|FG000|Overall Study|Withdrawal by Subject|5|||
131038839|NCT05566639|471776293|FG001|Overall Study|Death|45|||
131038840|NCT05566639|471776292|FG000|Overall Study|Lost to Follow-up|467|||
131124930|NCT02269787|472085929|FG000|Overall Study|Lost to Follow-up|20|||
131038841|NCT05566639|471776293|FG001|Overall Study|Lost to Follow-up|461|||
131038842|NCT05566639|471776292|FG000|Overall Study|Physician Decision|45|||
131038843|NCT05566639|471776293|FG001|Overall Study|Physician Decision|44|||
131038844|NCT05566639|471776292|FG000|Overall Study|Protocol Deviation|4|||
131038845|NCT05566639|471776293|FG001|Overall Study|Protocol Deviation|4|||
130711392|NCT01949116|470567991|FG001|Overall Study|Withdrawal by Subject|3|||
131038846|NCT05566639|471776292|FG000|Overall Study|Withdrawal by Subject|277|||
131038847|NCT05566639|471776293|FG001|Overall Study|Withdrawal by Subject|271|||
131038848|NCT05566639|471776292|FG000|Overall Study|Other Than Specified|52|||
131124931|NCT02269787|472085930|FG001|Overall Study|Lost to Follow-up|6|||
131038849|NCT05566639|471776293|FG001|Overall Study|Other Than Specified|64|||
131038850|NCT04159415|471776295|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131038851|NCT04159415|471776296|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131038852|NCT04159415|471776297|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131038853|NCT04159415|471776298|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131038854|NCT04159415|471776299|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131038855|NCT04159415|471776300|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
131038856|NCT04159415|471776301|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
131038857|NCT04159415|471776302|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
131038858|NCT03800654|471776303|FG000|Overall Study|Time constraints|3|||
131038859|NCT03800654|471776304|FG001|Overall Study|Time constraints|3|||
131038860|NCT03800654|471776305|FG002|Overall Study|Time constraints|3|||
131038861|NCT03800654|471776303|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
131038862|NCT03800654|471776304|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
131038863|NCT03800654|471776305|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
131038864|NCT03800654|471776303|FG000|Overall Study|Lost to Follow-up|2|||
131038865|NCT03800654|471776304|FG001|Overall Study|Lost to Follow-up|1|||
131038866|NCT03800654|471776305|FG002|Overall Study|Lost to Follow-up|6|||
131038867|NCT03800654|471776303|FG000|Overall Study|Medical Health Issue|0|||
131038868|NCT03800654|471776304|FG001|Overall Study|Medical Health Issue|0|||
131038869|NCT03800654|471776305|FG002|Overall Study|Medical Health Issue|1|||
131038870|NCT03800654|471776303|FG000|Overall Study|Personal Issues|0|||
131038871|NCT03800654|471776304|FG001|Overall Study|Personal Issues|2|||
131038872|NCT03800654|471776305|FG002|Overall Study|Personal Issues|0|||
131038873|NCT03800654|471776303|FG000|Overall Study|Protocol Violation|0|||
131038874|NCT03800654|471776304|FG001|Overall Study|Protocol Violation|1|||
131038875|NCT03800654|471776305|FG002|Overall Study|Protocol Violation|0|||
131038876|NCT06182033|471776306|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
131038877|NCT06182033|471776307|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
131038878|NCT06182033|471776306|FG000|Overall Study|Target child relocation|1|||
131038879|NCT06182033|471776307|FG001|Overall Study|Target child relocation|1|||
131038880|NCT06182033|471776306|FG000|Overall Study|Withdrawal by Subject|1|||
131038881|NCT06182033|471776307|FG001|Overall Study|Withdrawal by Subject|0|||
131038882|NCT03710603|471776309|FG000|Overall Study|Adverse Event|1|||
131038883|NCT03710603|471776310|FG001|Overall Study|Adverse Event|0|||
131038884|NCT03710603|471776309|FG000|Overall Study|Death|44|||
130951926|NCT00291668|471457892|FG001|Overall Study|SAE, non-fatal|1|||
130951927|NCT00291668|471457893|FG002|Overall Study|SAE, non-fatal|1|||
130951928|NCT00291668|471457891|FG000|Overall Study|AE, non-serious non-fatal|1|||
130951929|NCT00291668|471457892|FG001|Overall Study|AE, non-serious non-fatal|0|||
130951930|NCT00291668|471457893|FG002|Overall Study|AE, non-serious non-fatal|0|||
130951931|NCT00291668|471457891|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130951932|NCT00291668|471457892|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130951933|NCT00291668|471457893|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130951934|NCT00313612|471457896|FG000|Overall Study|Patient never received treatment|0|||
130951935|NCT00313612|471457897|FG001|Overall Study|Patient never received treatment|1|||
130951936|NCT00451035|471457898|FG000|Overall Study|Disease progression|11|||
130951937|NCT00451035|471457898|FG000|Overall Study|Death|3|||
130951938|NCT00451035|471457898|FG000|Overall Study|New anti-neoplastic therapy|3|||
130951939|NCT01393405|471457901|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
130951940|NCT01393405|471457902|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
130951941|NCT01393405|471457903|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
130951942|NCT01393405|471457901|FG000|Induction Period (week1-16)|Adverse Event|16|||
130951943|NCT01393405|471457902|FG001|Induction Period (week1-16)|Adverse Event|0|||
130951944|NCT01393405|471457903|FG002|Induction Period (week1-16)|Adverse Event|0|||
130951945|NCT01393405|471457901|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
130951946|NCT01393405|471457902|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
130951947|NCT01393405|471457903|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
130951948|NCT01393405|471457901|FG000|Maintenance Period Week|Lack of Efficacy|0|||
130951949|NCT01393405|471457902|FG001|Maintenance Period Week|Lack of Efficacy|22|||
130951950|NCT01393405|471457903|FG002|Maintenance Period Week|Lack of Efficacy|22|||
130951951|NCT01393405|471457901|FG000|Maintenance Period Week|Adverse Event|0|||
131038885|NCT03710603|471776310|FG001|Overall Study|Death|34|||
131038886|NCT03710603|471776309|FG000|Overall Study|Lost to Follow-up|3|||
131038887|NCT03710603|471776310|FG001|Overall Study|Lost to Follow-up|5|||
130951952|NCT01393405|471457902|FG001|Maintenance Period Week|Adverse Event|5|||
130951953|NCT01393405|471457903|FG002|Maintenance Period Week|Adverse Event|2|||
131038888|NCT03710603|471776309|FG000|Overall Study|Withdrawal by Subject|11|||
131038889|NCT03710603|471776310|FG001|Overall Study|Withdrawal by Subject|10|||
130951954|NCT01393405|471457901|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
131038890|NCT02723591|471776311|FG000|Overall Study|Adverse Event|48|||
131038891|NCT02723591|471776312|FG001|Overall Study|Adverse Event|40|||
131038892|NCT02723591|471776311|FG000|Overall Study|Death|2|||
131038893|NCT02723591|471776312|FG001|Overall Study|Death|2|||
131038894|NCT02723591|471776311|FG000|Overall Study|Lack of Efficacy|4|||
130951955|NCT01393405|471457902|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
130951956|NCT01393405|471457903|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
130951957|NCT01393405|471457901|FG000|Maintenance Period Week|Lost to Follow-up|0|||
130951958|NCT01393405|471457902|FG001|Maintenance Period Week|Lost to Follow-up|1|||
130951959|NCT01393405|471457903|FG002|Maintenance Period Week|Lost to Follow-up|0|||
130951960|NCT03350503|471457909|FG000|Overall Study|Adverse Event|5|||
130951961|NCT03350503|471457909|FG000|Overall Study|Withdrawal by Subject|5|||
130951962|NCT03350503|471457909|FG000|Overall Study|Continuation impossible due to move|4|||
130951963|NCT03350503|471457909|FG000|Overall Study|Physician Decision|3|||
130951964|NCT01399593|471457910|FG000|Overall Study|Physician Decision|1|||
130951965|NCT01399593|471457911|FG001|Overall Study|Physician Decision|0|||
130951966|NCT01399593|471457910|FG000|Overall Study|Adverse Event|1|||
130951967|NCT01399593|471457911|FG001|Overall Study|Adverse Event|0|||
130951968|NCT01399593|471457910|FG000|Overall Study|Death|1|||
130951969|NCT01399593|471457911|FG001|Overall Study|Death|1|||
130951970|NCT01399593|471457910|FG000|Overall Study|Transplantectomy|0|||
130951971|NCT01399593|471457911|FG001|Overall Study|Transplantectomy|1|||
130951972|NCT04536727|471457912|FG000|Overall Study|Lost to Follow-up|1|||
130951973|NCT04536727|471457913|FG001|Overall Study|Lost to Follow-up|1|||
130951974|NCT04536727|471457912|FG000|Overall Study|Death|0|||
130951975|NCT04536727|471457913|FG001|Overall Study|Death|1|||
130951976|NCT00344773|471457917|FG000|Overall Study|Adverse Event|2|||
130951977|NCT00344773|471457917|FG000|Overall Study|Objective Disease Progression|16|||
130951978|NCT00344773|471457917|FG000|Overall Study|Withdrawal by Subject|1|||
130951979|NCT00344773|471457917|FG000|Overall Study|Not Eligible for the study|2|||
130951980|NCT00244712|471457926|FG000|Overall Study|Adverse Event|20|||
130951981|NCT00244712|471457927|FG001|Overall Study|Adverse Event|21|||
130951982|NCT00244712|471457926|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
130951983|NCT00244712|471457927|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
130951984|NCT00244712|471457926|FG000|Overall Study|Lack of Compliance|10|||
130951985|NCT00244712|471457927|FG001|Overall Study|Lack of Compliance|11|||
130951986|NCT00244712|471457926|FG000|Overall Study|Lost to Follow-up|45|||
130951987|NCT00244712|471457927|FG001|Overall Study|Lost to Follow-up|52|||
130951988|NCT00244712|471457926|FG000|Overall Study|Withdrawal by Subject|13|||
130951989|NCT00244712|471457927|FG001|Overall Study|Withdrawal by Subject|23|||
130951990|NCT00244712|471457926|FG000|Overall Study|Protocol Violation, disease progression|13|||
130951991|NCT00244712|471457927|FG001|Overall Study|Protocol Violation, disease progression|11|||
130951992|NCT00500370|471457930|FG000|Overall Study|Adverse Event|9|||
130951993|NCT00500370|471457931|FG001|Overall Study|Adverse Event|3|||
130951994|NCT00500370|471457930|FG000|Overall Study|Lost to Follow-up|10|||
130951995|NCT00500370|471457931|FG001|Overall Study|Lost to Follow-up|10|||
130951996|NCT00500370|471457930|FG000|Overall Study|Protocol Violation|2|||
130951997|NCT00500370|471457931|FG001|Overall Study|Protocol Violation|4|||
130951998|NCT00500370|471457930|FG000|Overall Study|Sponsor Decision|2|||
130951999|NCT00500370|471457931|FG001|Overall Study|Sponsor Decision|0|||
130952000|NCT00500370|471457930|FG000|Overall Study|Subject Decision|10|||
130952001|NCT00500370|471457931|FG001|Overall Study|Subject Decision|17|||
130952002|NCT00714259|471457932|FG000|Overall Study|Death|2|||
130952013|NCT05627518|471457935|FG000|Treatment Period 1|Adverse Event|0|||
130952014|NCT05627518|471457936|FG001|Treatment Period 1|Adverse Event|0|||
130952015|NCT05627518|471457937|FG002|Treatment Period 1|Adverse Event|1|||
130952016|NCT05627518|471457938|FG003|Treatment Period 1|Adverse Event|0|||
130952017|NCT05627518|471457939|FG004|Treatment Period 1|Adverse Event|0|||
130952018|NCT05627518|471457940|FG005|Treatment Period 1|Adverse Event|0|||
130952019|NCT05627518|471457941|FG006|Treatment Period 1|Adverse Event|0|||
130711393|NCT02858726|470567992|FG000|Overall Study|Adverse Event|4|||
130952020|NCT05627518|471457942|FG007|Treatment Period 1|Adverse Event|1|||
130952021|NCT05627518|471457935|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130952022|NCT05627518|471457936|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130952023|NCT05627518|471457937|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130952024|NCT05627518|471457938|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130952025|NCT05627518|471457939|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130952026|NCT05627518|471457940|FG005|Treatment Period 1|Withdrawal by Subject|1|||
130952027|NCT05627518|471457941|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130952028|NCT05627518|471457942|FG007|Treatment Period 1|Withdrawal by Subject|0|||
130952029|NCT05627518|471457935|FG000|Treatment Period 1|Protocol Violation|0|||
130952030|NCT05627518|471457936|FG001|Treatment Period 1|Protocol Violation|0|||
130952031|NCT05627518|471457937|FG002|Treatment Period 1|Protocol Violation|0|||
130952032|NCT05627518|471457938|FG003|Treatment Period 1|Protocol Violation|0|||
130952033|NCT05627518|471457939|FG004|Treatment Period 1|Protocol Violation|0|||
130952034|NCT05627518|471457940|FG005|Treatment Period 1|Protocol Violation|0|||
130952035|NCT05627518|471457941|FG006|Treatment Period 1|Protocol Violation|6|||
130952036|NCT05627518|471457942|FG007|Treatment Period 1|Protocol Violation|6|||
130952037|NCT05627518|471457935|FG000|Treatment Period 2|Adverse Event|1|||
130952038|NCT05627518|471457936|FG001|Treatment Period 2|Adverse Event|0|||
130952039|NCT05627518|471457937|FG002|Treatment Period 2|Adverse Event|0|||
130952040|NCT05627518|471457938|FG003|Treatment Period 2|Adverse Event|0|||
130952041|NCT05627518|471457939|FG004|Treatment Period 2|Adverse Event|0|||
130952042|NCT05627518|471457940|FG005|Treatment Period 2|Adverse Event|0|||
130952043|NCT05627518|471457941|FG006|Treatment Period 2|Adverse Event|0|||
130952044|NCT05627518|471457942|FG007|Treatment Period 2|Adverse Event|0|||
130952045|NCT05627518|471457935|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130952046|NCT05627518|471457936|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130952047|NCT05627518|471457937|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130952048|NCT05627518|471457938|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130952049|NCT05627518|471457939|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130952050|NCT05627518|471457940|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130952051|NCT05627518|471457941|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130952052|NCT05627518|471457942|FG007|Treatment Period 2|Withdrawal by Subject|0|||
130952053|NCT04804813|471457943|FG000|Overall Study|Protocol Violation|2|||
130952054|NCT04804813|471457944|FG001|Overall Study|Protocol Violation|0|||
130952055|NCT04804813|471457943|FG000|Overall Study|Withdrawal by Subject|1|||
130952056|NCT04804813|471457944|FG001|Overall Study|Withdrawal by Subject|0|||
130952057|NCT02777125|471457948|FG000|Overall Study|Consent form violation|14|||
131124932|NCT02269787|472085929|FG000|Overall Study|Death|2|||
131124933|NCT02269787|472085930|FG001|Overall Study|Death|3|||
130711394|NCT02858726|470567993|FG001|Overall Study|Adverse Event|4|||
130711395|NCT02858726|470567994|FG002|Overall Study|Adverse Event|9|||
130711396|NCT02858726|470567995|FG003|Overall Study|Adverse Event|1|||
130711397|NCT02858726|470567992|FG000|Overall Study|Physician Decision|0|||
130952058|NCT02777125|471457949|FG001|Overall Study|Consent form violation|12|||
130952059|NCT02777125|471457948|FG000|Overall Study|Assent form violation|21|||
130952060|NCT02777125|471457949|FG001|Overall Study|Assent form violation|23|||
130952061|NCT02777125|471457948|FG000|Overall Study|Protocol Violation|8|||
130952062|NCT02777125|471457949|FG001|Overall Study|Protocol Violation|12|||
130711398|NCT02858726|470567993|FG001|Overall Study|Physician Decision|0|||
130952063|NCT06023394|471457950|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
130952064|NCT06023394|471457951|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
130952065|NCT06023394|471457950|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
130952066|NCT06023394|471457951|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
131038895|NCT02723591|471776312|FG001|Overall Study|Lack of Efficacy|3|||
131038896|NCT02723591|471776311|FG000|Overall Study|Lost to Follow-up|1|||
131038897|NCT02723591|471776312|FG001|Overall Study|Lost to Follow-up|7|||
131038898|NCT02723591|471776311|FG000|Overall Study|Protocol Violation|20|||
131038899|NCT02723591|471776312|FG001|Overall Study|Protocol Violation|23|||
131038900|NCT02723591|471776311|FG000|Overall Study|Withdrawal by Subject|4|||
131038901|NCT02723591|471776312|FG001|Overall Study|Withdrawal by Subject|8|||
131038902|NCT02723591|471776311|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
131038903|NCT02723591|471776312|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
131038904|NCT02723591|471776311|FG000|Overall Study|Miscellaneous|5|||
131038905|NCT02723591|471776312|FG001|Overall Study|Miscellaneous|6|||
131038906|NCT04081103|471776317|FG000|Overall Study|Adverse Event|1|||
131038907|NCT04081103|471776318|FG001|Overall Study|Adverse Event|1|||
131038908|NCT04081103|471776319|FG002|Overall Study|Adverse Event|1|||
131038909|NCT04081103|471776317|FG000|Overall Study|Physician Decision|0|||
131038910|NCT04081103|471776318|FG001|Overall Study|Physician Decision|0|||
131038911|NCT04081103|471776319|FG002|Overall Study|Physician Decision|1|||
131038912|NCT05209152|471776322|FG000|Overall Study|Sponsor decision|1|||
131038913|NCT05209152|471776323|FG001|Overall Study|Sponsor decision|2|||
131038914|NCT05209152|471776322|FG000|Overall Study|Death|3|||
131038915|NCT05209152|471776323|FG001|Overall Study|Death|1|||
131038916|NCT03287817|471778114|FG000|Overall Study|Progressive disease|4|||
131038917|NCT03287817|471778115|FG001|Overall Study|Progressive disease|2|||
131038918|NCT03287817|471778116|FG002|Overall Study|Progressive disease|3|||
131038919|NCT03287817|471778117|FG003|Overall Study|Progressive disease|10|||
131038920|NCT03287817|471778118|FG004|Overall Study|Progressive disease|8|||
131038921|NCT03287817|471778114|FG000|Overall Study|Death|0|||
131038922|NCT03287817|471778115|FG001|Overall Study|Death|0|||
131038923|NCT03287817|471778116|FG002|Overall Study|Death|2|||
131038924|NCT03287817|471778117|FG003|Overall Study|Death|3|||
131038925|NCT03287817|471778118|FG004|Overall Study|Death|4|||
131038926|NCT03287817|471778114|FG000|Overall Study|Physician Decision|0|||
131038927|NCT03287817|471778115|FG001|Overall Study|Physician Decision|0|||
131038928|NCT03287817|471778116|FG002|Overall Study|Physician Decision|0|||
131038929|NCT03287817|471778117|FG003|Overall Study|Physician Decision|1|||
130952067|NCT06023394|471457950|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
130952068|NCT06023394|471457951|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
130952069|NCT06023394|471457950|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
130952070|NCT06023394|471457951|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
130952071|NCT02554656|471459211|FG000|Overall Study|Protocol Violation|3|||
130952072|NCT03240575|471459212|FG000|Overall Study|Adverse Event|0|||
130952073|NCT03240575|471459213|FG001|Overall Study|Adverse Event|2|||
130952074|NCT03240575|471459214|FG002|Overall Study|Adverse Event|0|||
130952075|NCT03240575|471459215|FG003|Overall Study|Adverse Event|1|||
130952076|NCT03240575|471459212|FG000|Overall Study|Withdrawal by Subject|2|||
130952077|NCT03240575|471459213|FG001|Overall Study|Withdrawal by Subject|11|||
130952078|NCT03240575|471459214|FG002|Overall Study|Withdrawal by Subject|0|||
130952079|NCT03240575|471459215|FG003|Overall Study|Withdrawal by Subject|1|||
130952080|NCT03240575|471459212|FG000|Overall Study|Other|0|||
130952081|NCT03240575|471459213|FG001|Overall Study|Other|1|||
130952082|NCT03240575|471459214|FG002|Overall Study|Other|0|||
130952083|NCT03240575|471459215|FG003|Overall Study|Other|0|||
130952084|NCT04127786|471459218|FG000|Primary Series|Adverse Event|1|||
130952085|NCT04127786|471459219|FG001|Primary Series|Adverse Event|0|||
130952086|NCT04127786|471459220|FG002|Primary Series|Adverse Event|0|||
130952087|NCT04127786|471459221|FG003|Primary Series|Adverse Event|1|||
130952088|NCT04127786|471459222|FG004|Primary Series|Adverse Event|0|||
130952089|NCT04127786|471459223|FG005|Primary Series|Adverse Event|1|||
130952090|NCT04127786|471459218|FG000|Primary Series|Protocol Violation|5|||
130952091|NCT04127786|471459219|FG001|Primary Series|Protocol Violation|3|||
130952092|NCT04127786|471459220|FG002|Primary Series|Protocol Violation|4|||
130952093|NCT04127786|471459221|FG003|Primary Series|Protocol Violation|3|||
130952094|NCT04127786|471459222|FG004|Primary Series|Protocol Violation|2|||
130952095|NCT04127786|471459223|FG005|Primary Series|Protocol Violation|0|||
130952096|NCT04127786|471459218|FG000|Primary Series|Withdrawal by Subject|0|||
130952097|NCT04127786|471459219|FG001|Primary Series|Withdrawal by Subject|0|||
130952098|NCT04127786|471459220|FG002|Primary Series|Withdrawal by Subject|0|||
130952099|NCT04127786|471459221|FG003|Primary Series|Withdrawal by Subject|1|||
130952100|NCT04127786|471459222|FG004|Primary Series|Withdrawal by Subject|0|||
130952101|NCT04127786|471459223|FG005|Primary Series|Withdrawal by Subject|0|||
130952102|NCT04127786|471459218|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
130952103|NCT04127786|471459219|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
130952104|NCT04127786|471459220|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
130952105|NCT04127786|471459221|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
130952106|NCT04127786|471459222|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
130952107|NCT04127786|471459223|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
130952108|NCT04127786|471459218|FG000|Booster Phase|Withdrawal by Subject|2|||
130952109|NCT04127786|471459219|FG001|Booster Phase|Withdrawal by Subject|0|||
130952110|NCT04127786|471459220|FG002|Booster Phase|Withdrawal by Subject|0|||
130952111|NCT04127786|471459221|FG003|Booster Phase|Withdrawal by Subject|0|||
130952112|NCT04127786|471459222|FG004|Booster Phase|Withdrawal by Subject|0|||
130952113|NCT04127786|471459223|FG005|Booster Phase|Withdrawal by Subject|0|||
130952114|NCT03568942|471459226|FG000|Overall Study|Family emergency|1|||
130952115|NCT03568942|471459226|FG000|Overall Study|Lost to Follow-up|1|||
130952116|NCT01945489|471459227|FG000|Cycle 1|Adverse Event|2|||
130952117|NCT01945489|471459228|FG001|Cycle 1|Adverse Event|0|||
130952118|NCT01945489|471459227|FG000|Cycle 1|Lost to Follow-up|4|||
130952119|NCT01945489|471459228|FG001|Cycle 1|Lost to Follow-up|0|||
130952120|NCT01945489|471459227|FG000|Cycle 1|Personal Reasons|4|||
130952121|NCT01945489|471459228|FG001|Cycle 1|Personal Reasons|2|||
130952122|NCT01945489|471459227|FG000|Cycle 1|Protocol Violation|0|||
130952123|NCT01945489|471459228|FG001|Cycle 1|Protocol Violation|1|||
130952124|NCT01945489|471459227|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
130952125|NCT01945489|471459228|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
130952126|NCT01945489|471459227|FG000|Cycle 2|Adverse Event|1|||
130952127|NCT01945489|471459228|FG001|Cycle 2|Adverse Event|0|||
130952128|NCT01945489|471459227|FG000|Cycle 2|Lost to Follow-up|0|||
130952129|NCT01945489|471459228|FG001|Cycle 2|Lost to Follow-up|1|||
130952130|NCT00358527|471459229|FG000|Overall Study|Adverse Event|4|||
130952131|NCT00358527|471459230|FG001|Overall Study|Adverse Event|0|||
130952132|NCT00358527|471459229|FG000|Overall Study|Withdrawal by Subject|1|||
130952133|NCT00358527|471459230|FG001|Overall Study|Withdrawal by Subject|1|||
130952134|NCT00358527|471459229|FG000|Overall Study|Non-compliance with protocol|6|||
130952135|NCT00358527|471459230|FG001|Overall Study|Non-compliance with protocol|1|||
130952136|NCT00358527|471459229|FG000|Overall Study|Administrative|2|||
130952137|NCT00358527|471459230|FG001|Overall Study|Administrative|1|||
130952138|NCT04144166|471459233|FG000|Overall Study|Discharged before study start|1|||
130952139|NCT04144166|471459233|FG000|Overall Study|Pregnancy|1|||
130952140|NCT04144166|471459233|FG000|Overall Study|Nail polish could not be removed from finger|1|||
130952141|NCT00749463|471459234|FG000|Overall Study|Adverse Event|0|||
130952142|NCT00749463|471459235|FG001|Overall Study|Adverse Event|4|||
130952143|NCT00749463|471459236|FG002|Overall Study|Adverse Event|1|||
130952144|NCT00749463|471459234|FG000|Overall Study|Withdrawal by Subject|1|||
130952145|NCT00749463|471459235|FG001|Overall Study|Withdrawal by Subject|0|||
130952146|NCT00749463|471459236|FG002|Overall Study|Withdrawal by Subject|0|||
130952147|NCT00697346|471459241|FG000|Overall Study|Adverse Event|4|||
130952148|NCT00697346|471459242|FG001|Overall Study|Adverse Event|5|||
130952149|NCT00697346|471459243|FG002|Overall Study|Adverse Event|0|||
130952150|NCT00697346|471459241|FG000|Overall Study|Progressive Disease|19|||
130952151|NCT00697346|471459242|FG001|Overall Study|Progressive Disease|18|||
130952152|NCT00697346|471459243|FG002|Overall Study|Progressive Disease|0|||
130952153|NCT00697346|471459241|FG000|Overall Study|Symptomatic Deterioration|0|||
130952154|NCT00697346|471459242|FG001|Overall Study|Symptomatic Deterioration|1|||
130952155|NCT00697346|471459243|FG002|Overall Study|Symptomatic Deterioration|0|||
130952156|NCT00697346|471459241|FG000|Overall Study|Withdrawal by Subject|2|||
130952157|NCT00697346|471459242|FG001|Overall Study|Withdrawal by Subject|2|||
130952158|NCT00697346|471459243|FG002|Overall Study|Withdrawal by Subject|0|||
130952159|NCT00697346|471459241|FG000|Overall Study|Reason not Specified|3|||
130952160|NCT00697346|471459242|FG001|Overall Study|Reason not Specified|0|||
130952161|NCT00697346|471459243|FG002|Overall Study|Reason not Specified|1|||
130952162|NCT03569371|471459245|FG000|Overall Study|Lack of Efficacy|1|||
130952163|NCT03569371|471459245|FG000|Overall Study|Lost to Follow-up|1|||
130952164|NCT03569371|471459245|FG000|Overall Study|Adverse Event|1|||
130952165|NCT03643562|471459248|FG000|Overall Study|Adverse Event|1|||
130952166|NCT03643562|471459249|FG001|Overall Study|Adverse Event|0|||
130952167|NCT03643562|471459248|FG000|Overall Study|Lack of Efficacy|0|||
130952168|NCT03643562|471459249|FG001|Overall Study|Lack of Efficacy|1|||
130952169|NCT03643562|471459248|FG000|Overall Study|Physician Decision|0|||
130952170|NCT03643562|471459249|FG001|Overall Study|Physician Decision|1|||
130952171|NCT03643562|471459248|FG000|Overall Study|Study Terminated by Sponsor|2|||
130952172|NCT03643562|471459249|FG001|Overall Study|Study Terminated by Sponsor|10|||
130952173|NCT03643562|471459248|FG000|Overall Study|Withdrawal by Subject|2|||
130952174|NCT03643562|471459249|FG001|Overall Study|Withdrawal by Subject|2|||
130952175|NCT03643562|471459248|FG000|Overall Study|Other than specified|3|||
130952176|NCT03643562|471459249|FG001|Overall Study|Other than specified|2|||
130952177|NCT01982253|471459250|FG000|Overall Study|Withdrawal by Subject|1|||
130952178|NCT01982253|471459251|FG001|Overall Study|Withdrawal by Subject|0|||
130952179|NCT01982253|471459252|FG002|Overall Study|Withdrawal by Subject|0|||
130952180|NCT01982253|471459250|FG000|Overall Study|Study terminated by sponsor|1|||
130952181|NCT01982253|471459251|FG001|Overall Study|Study terminated by sponsor|4|||
130952182|NCT01982253|471459252|FG002|Overall Study|Study terminated by sponsor|4|||
130952183|NCT04145895|471459253|FG000|Overall Study|Physician Decision|2|||
130952184|NCT04145895|471459254|FG001|Overall Study|Physician Decision|0|||
130952185|NCT04145895|471459253|FG000|Overall Study|Withdrawal by Subject|0|||
130952186|NCT04145895|471459254|FG001|Overall Study|Withdrawal by Subject|2|||
130952187|NCT01236755|471459256|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
130952188|NCT01236755|471459256|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
130952189|NCT01236755|471459256|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
130952190|NCT01236755|471459256|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
130952191|NCT00913744|471459257|FG000|Overall Study|Adverse Event|2|||
130952192|NCT00913744|471459258|FG001|Overall Study|Adverse Event|0|||
130952193|NCT00913744|471459257|FG000|Overall Study|Withdrawal by Subject|2|||
130952194|NCT00913744|471459258|FG001|Overall Study|Withdrawal by Subject|1|||
130952195|NCT00913744|471459257|FG000|Overall Study|Death|1|||
130952196|NCT00913744|471459258|FG001|Overall Study|Death|0|||
130952197|NCT00805935|471459259|FG000|Overall Study|Stimulation Failure|1|||
130952198|NCT00805935|471459260|FG001|Overall Study|Stimulation Failure|5|||
130952199|NCT00805935|471459261|FG002|Overall Study|Stimulation Failure|2|||
130952200|NCT00805935|471459262|FG003|Overall Study|Stimulation Failure|2|||
130952201|NCT00805935|471459259|FG000|Overall Study|Cycle cancelled|0|||
130952202|NCT00805935|471459260|FG001|Overall Study|Cycle cancelled|0|||
130711399|NCT02858726|470567994|FG002|Overall Study|Physician Decision|1|||
130711400|NCT02858726|470567995|FG003|Overall Study|Physician Decision|0|||
130952203|NCT00805935|471459261|FG002|Overall Study|Cycle cancelled|2|||
130952204|NCT00805935|471459262|FG003|Overall Study|Cycle cancelled|0|||
130952205|NCT00805935|471459259|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
130952206|NCT00805935|471459260|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
130711401|NCT02858726|470567992|FG000|Overall Study|Protocol Violation|0|||
130711402|NCT02858726|470567993|FG001|Overall Study|Protocol Violation|0|||
130952207|NCT00805935|471459261|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
130952208|NCT00805935|471459262|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
130952209|NCT00805935|471459259|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
130952210|NCT00805935|471459260|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
130952211|NCT00805935|471459261|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
130952212|NCT00805935|471459262|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
130952213|NCT00805935|471459259|FG000|Overall Study|Lost to Follow-up|1|||
130952214|NCT00805935|471459260|FG001|Overall Study|Lost to Follow-up|0|||
130952215|NCT00805935|471459261|FG002|Overall Study|Lost to Follow-up|0|||
130952216|NCT00805935|471459262|FG003|Overall Study|Lost to Follow-up|0|||
131038930|NCT03287817|471778118|FG004|Overall Study|Physician Decision|0|||
131038931|NCT03287817|471778114|FG000|Overall Study|Withdrawal by Subject|0|||
131038932|NCT03287817|471778115|FG001|Overall Study|Withdrawal by Subject|0|||
131038933|NCT03287817|471778116|FG002|Overall Study|Withdrawal by Subject|0|||
131038934|NCT03287817|471778117|FG003|Overall Study|Withdrawal by Subject|0|||
131038935|NCT03287817|471778118|FG004|Overall Study|Withdrawal by Subject|4|||
131038936|NCT00433329|471778125|FG000|Overall Study|Adverse Event|9|||
131038937|NCT00433329|471778125|FG000|Overall Study|Death|4|||
131038938|NCT00433329|471778125|FG000|Overall Study|Withdrew consent|3|||
131038939|NCT00433329|471778125|FG000|Overall Study|Discontinued sildenafil|2|||
131038940|NCT00433329|471778125|FG000|Overall Study|Moved out of state|1|||
131038941|NCT00433329|471778125|FG000|Overall Study|Lost to Follow-up|1|||
131038942|NCT00433329|471778125|FG000|Overall Study|Physician Decision|1|||
131038943|NCT03854227|471778126|FG000|Overall Study|Adverse Event|0|||
131038944|NCT03854227|471778127|FG001|Overall Study|Adverse Event|0|||
131038945|NCT03854227|471778128|FG002|Overall Study|Adverse Event|0|||
131038946|NCT03854227|471778129|FG003|Overall Study|Adverse Event|1|||
131038947|NCT03854227|471778130|FG004|Overall Study|Adverse Event|0|||
131038948|NCT03854227|471778131|FG005|Overall Study|Adverse Event|0|||
131038949|NCT03854227|471778132|FG006|Overall Study|Adverse Event|1|||
131038950|NCT03854227|471778133|FG007|Overall Study|Adverse Event|0|||
131038951|NCT03854227|471778134|FG008|Overall Study|Adverse Event|0|||
131038952|NCT03854227|471778135|FG009|Overall Study|Adverse Event|3|||
131225110|NCT01792284|472451963|FG002|Lead-in Period|Protocol Violation|0|||
130952217|NCT00805935|471459259|FG000|Overall Study|No positive serum pregnancy|8|||
130952218|NCT00805935|471459260|FG001|Overall Study|No positive serum pregnancy|7|||
130952219|NCT00805935|471459261|FG002|Overall Study|No positive serum pregnancy|6|||
130952220|NCT00805935|471459262|FG003|Overall Study|No positive serum pregnancy|5|||
130952221|NCT00805935|471459259|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
130952222|NCT00805935|471459260|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
130952223|NCT00805935|471459261|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
130952224|NCT00805935|471459262|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
130952225|NCT00805935|471459259|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
130952226|NCT00805935|471459260|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
130952227|NCT00805935|471459261|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
130952228|NCT00805935|471459262|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
130952229|NCT00805935|471459259|FG000|Overall Study|Biochemical pregnancy|0|||
130952230|NCT00805935|471459260|FG001|Overall Study|Biochemical pregnancy|1|||
130952231|NCT00805935|471459261|FG002|Overall Study|Biochemical pregnancy|0|||
130952232|NCT00805935|471459262|FG003|Overall Study|Biochemical pregnancy|0|||
130952233|NCT00805935|471459259|FG000|Overall Study|Chemical pregnancy|0|||
130952234|NCT00805935|471459260|FG001|Overall Study|Chemical pregnancy|5|||
130952235|NCT00805935|471459261|FG002|Overall Study|Chemical pregnancy|3|||
130952236|NCT00805935|471459262|FG003|Overall Study|Chemical pregnancy|2|||
130952237|NCT00805935|471459259|FG000|Overall Study|Ectopic pregnancy|0|||
130952238|NCT00805935|471459260|FG001|Overall Study|Ectopic pregnancy|0|||
130952239|NCT00805935|471459261|FG002|Overall Study|Ectopic pregnancy|1|||
130952240|NCT00805935|471459262|FG003|Overall Study|Ectopic pregnancy|0|||
130952241|NCT00805935|471459259|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
130952242|NCT00805935|471459260|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
130952243|NCT00805935|471459261|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
130952244|NCT00805935|471459262|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
130952245|NCT04904185|471459263|FG000|Overall Study|Expansion failure|1|||
130952246|NCT04904185|471459264|FG001|Overall Study|Expansion failure|0|||
130952247|NCT04904185|471459263|FG000|Overall Study|Late response on prior treatment|1|||
130952248|NCT04904185|471459264|FG001|Overall Study|Late response on prior treatment|0|||
130952249|NCT02945410|471459265|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130952250|NCT02945410|471459266|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
130952251|NCT02945410|471459267|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130952252|NCT02945410|471459268|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130952253|NCT02945410|471459269|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130952254|NCT02945410|471459270|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130952255|NCT02945410|471459265|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
130952256|NCT02945410|471459266|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
130952257|NCT02945410|471459267|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
130952258|NCT02945410|471459268|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
130952259|NCT02945410|471459269|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
130952260|NCT02945410|471459270|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
130952261|NCT02945410|471459265|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
130952262|NCT02945410|471459266|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
130952263|NCT02945410|471459267|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
130952264|NCT02945410|471459268|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
131038953|NCT03854227|471778136|FG010|Overall Study|Adverse Event|0|||
131038954|NCT03854227|471778137|FG011|Overall Study|Adverse Event|1|||
131038955|NCT03854227|471778126|FG000|Overall Study|Death|0|||
131038956|NCT03854227|471778127|FG001|Overall Study|Death|0|||
130952265|NCT02945410|471459269|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
130952266|NCT02945410|471459270|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
130952267|NCT02433834|471459274|FG000|Overall Study|Protocol-specified criteria|7|||
130952268|NCT02433834|471459274|FG000|Overall Study|Protocol Violation|3|||
130952269|NCT02433834|471459274|FG000|Overall Study|Lost to Follow-up|6|||
130952270|NCT02433834|471459274|FG000|Overall Study|Withdrawal by Subject|14|||
130952271|NCT02433834|471459274|FG000|Overall Study|Adverse Event|6|||
130952272|NCT02433834|471459274|FG000|Overall Study|Physician Decision|1|||
130952273|NCT01539226|471459275|FG000|Overall Study|Withdrawal by Subject|24|||
130952274|NCT01539226|471459276|FG001|Overall Study|Withdrawal by Subject|54|||
130952275|NCT01539226|471459275|FG000|Overall Study|Lost to Follow-up|20|||
130952276|NCT01539226|471459276|FG001|Overall Study|Lost to Follow-up|54|||
130952277|NCT01539226|471459275|FG000|Overall Study|Death|1|||
130952278|NCT01539226|471459276|FG001|Overall Study|Death|2|||
130952279|NCT01539226|471459275|FG000|Overall Study|Adverse Event|2|||
130952280|NCT01539226|471459276|FG001|Overall Study|Adverse Event|0|||
130952281|NCT01539226|471459275|FG000|Overall Study|Pregnancy|13|||
130952282|NCT01539226|471459276|FG001|Overall Study|Pregnancy|29|||
130952283|NCT01539226|471459275|FG000|Overall Study|inappropriate enrollment|0|||
130952284|NCT01539226|471459276|FG001|Overall Study|inappropriate enrollment|1|||
130952285|NCT01539226|471459275|FG000|Overall Study|Multiple Reasons|3|||
130952286|NCT01539226|471459276|FG001|Overall Study|Multiple Reasons|1|||
130952287|NCT01539226|471459275|FG000|Overall Study|not HIV seroconversion-related|93|||
130952288|NCT01539226|471459276|FG001|Overall Study|not HIV seroconversion-related|176|||
130952289|NCT01539226|471459275|FG000|Overall Study|HIV seroconversion-related|55|||
130952290|NCT01539226|471459276|FG001|Overall Study|HIV seroconversion-related|80|||
130952291|NCT01539226|471459275|FG000|Overall Study|Non-compliance|6|||
130952292|NCT01539226|471459276|FG001|Overall Study|Non-compliance|8|||
130952293|NCT05288556|471459286|FG000|Overall Study|Protocol Violation|1|||
130952294|NCT05288556|471459286|FG000|Overall Study|Withdrawal by Subject|1|||
130952295|NCT02775344|471459287|FG000|Overall Study|No ovarian cyst identified|3|||
130952296|NCT02775344|471459288|FG001|Overall Study|No ovarian cyst identified|2|||
130952297|NCT04627064|471459289|FG000|Overall Study|Progressive disease|8|||
130952298|NCT04627064|471459290|FG001|Overall Study|Progressive disease|0|||
130952299|NCT04627064|471459289|FG000|Overall Study|Withdrawal by Subject|2|||
130952300|NCT04627064|471459290|FG001|Overall Study|Withdrawal by Subject|0|||
130952301|NCT04627064|471459289|FG000|Overall Study|Physician Decision|1|||
130952302|NCT04627064|471459290|FG001|Overall Study|Physician Decision|0|||
130952303|NCT00414661|471459291|FG000|Overall Study|Death|2|||
130952304|NCT00414661|471459292|FG001|Overall Study|Death|5|||
130952305|NCT00414661|471459293|FG002|Overall Study|Death|0|||
130952306|NCT00414661|471459294|FG003|Overall Study|Death|0|||
130952307|NCT00414661|471459291|FG000|Overall Study|Lost to Follow-up|1|||
130952308|NCT00414661|471459292|FG001|Overall Study|Lost to Follow-up|4|||
130952309|NCT00414661|471459293|FG002|Overall Study|Lost to Follow-up|0|||
130952310|NCT00414661|471459294|FG003|Overall Study|Lost to Follow-up|1|||
130952311|NCT00414661|471459291|FG000|Overall Study|Withdrawal by Subject|5|||
130952312|NCT00414661|471459292|FG001|Overall Study|Withdrawal by Subject|2|||
130952313|NCT00414661|471459293|FG002|Overall Study|Withdrawal by Subject|2|||
130952314|NCT00414661|471459294|FG003|Overall Study|Withdrawal by Subject|2|||
130952315|NCT00414661|471459291|FG000|Overall Study|Other|6|||
130952316|NCT00414661|471459292|FG001|Overall Study|Other|3|||
130952317|NCT00414661|471459293|FG002|Overall Study|Other|0|||
130952318|NCT00414661|471459294|FG003|Overall Study|Other|0|||
130952319|NCT00357370|471459295|FG000|Cohort 2|Lack of Efficacy|0|||
130952320|NCT00357370|471459296|FG001|Cohort 2|Lack of Efficacy|2|||
131124934|NCT02269787|472085929|FG000|Overall Study|Incapacitated|0|||
131124935|NCT02269787|472085930|FG001|Overall Study|Incapacitated|1|||
130952321|NCT00357370|471459297|FG002|Cohort 2|Lack of Efficacy|1|||
130952322|NCT00357370|471459295|FG000|Cohort 2|Adverse Event|1|||
131124936|NCT00798135|472085931|FG000|Overall Study|Disease progression, relapse|11|||
131124937|NCT00798135|472085931|FG000|Overall Study|Disease progression, refractory|1|||
130952323|NCT00357370|471459296|FG001|Cohort 2|Adverse Event|1|||
130952324|NCT00357370|471459297|FG002|Cohort 2|Adverse Event|1|||
130952325|NCT00357370|471459295|FG000|Cohort 2|Lost to Follow-up|0|||
130952326|NCT00357370|471459296|FG001|Cohort 2|Lost to Follow-up|1|||
130952327|NCT00357370|471459297|FG002|Cohort 2|Lost to Follow-up|0|||
130952328|NCT00357370|471459295|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
130952329|NCT00357370|471459296|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
130952330|NCT00357370|471459297|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
130952331|NCT00357370|471459295|FG000|Cohort 2|Withdrawal by Subject|0|||
130952332|NCT00357370|471459296|FG001|Cohort 2|Withdrawal by Subject|2|||
130952333|NCT00357370|471459297|FG002|Cohort 2|Withdrawal by Subject|0|||
130952334|NCT01143090|471459298|FG000|Overall Study|Lack of Efficacy|2|||
130952335|NCT01143090|471459298|FG000|Overall Study|Adverse Event|17|||
130952336|NCT01143090|471459298|FG000|Overall Study|Lost to Follow-up|9|||
130952337|NCT01143090|471459298|FG000|Overall Study|Protocol Violation|2|||
130952338|NCT01143090|471459298|FG000|Overall Study|Withdrawal by Subject|18|||
130952339|NCT01143090|471459298|FG000|Overall Study|Non-compliance with study drug|1|||
131124938|NCT00798135|472085931|FG000|Overall Study|Physician Decision|1|||
130711403|NCT02858726|470567994|FG002|Overall Study|Protocol Violation|0|||
130952340|NCT01143090|471459298|FG000|Overall Study|Failure to meet eligibility criteria|1|||
130952341|NCT01143090|471459298|FG000|Overall Study|Administrative|1|||
130952342|NCT01800916|471459299|FG000|Test Period 1 (1 Week)|Convex product user|0|||
130952343|NCT01800916|471459300|FG001|Test Period 1 (1 Week)|Convex product user|0|||
130952344|NCT01800916|471459301|FG002|Test Period 1 (1 Week)|Convex product user|0|||
130952345|NCT01800916|471459302|FG003|Test Period 1 (1 Week)|Convex product user|1|||
130952346|NCT01800916|471459303|FG004|Test Period 1 (1 Week)|Convex product user|0|||
130952347|NCT01800916|471459304|FG005|Test Period 1 (1 Week)|Convex product user|0|||
130952348|NCT01800916|471459305|FG006|Test Period 1 (1 Week)|Convex product user|0|||
130952349|NCT01800916|471459306|FG007|Test Period 1 (1 Week)|Convex product user|0|||
130952350|NCT01800916|471459307|FG008|Test Period 1 (1 Week)|Convex product user|0|||
130952351|NCT01800916|471459299|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
130952352|NCT01800916|471459300|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
130952353|NCT01800916|471459301|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
130952354|NCT01800916|471459302|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
130952355|NCT01800916|471459303|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
130952356|NCT01800916|471459304|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
130952357|NCT01800916|471459305|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
130952358|NCT01800916|471459306|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
130952359|NCT01800916|471459307|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
130952360|NCT01232296|471459308|FG000|Overall Study|Adverse Event|24|||
130952361|NCT01232296|471459309|FG001|Overall Study|Adverse Event|12|||
130952362|NCT01232296|471459308|FG000|Overall Study|Physician Decision|1|||
130952363|NCT01232296|471459309|FG001|Overall Study|Physician Decision|1|||
130952364|NCT01232296|471459308|FG000|Overall Study|Progressive disease|43|||
130952365|NCT01232296|471459309|FG001|Overall Study|Progressive disease|61|||
130952366|NCT01232296|471459308|FG000|Overall Study|Study terminated by sponsor|0|||
130952367|NCT01232296|471459309|FG001|Overall Study|Study terminated by sponsor|1|||
130952368|NCT01232296|471459308|FG000|Overall Study|Technical problems|3|||
130952369|NCT01232296|471459309|FG001|Overall Study|Technical problems|0|||
130952370|NCT01232296|471459308|FG000|Overall Study|Subject/guardian decision|10|||
130952371|NCT01232296|471459309|FG001|Overall Study|Subject/guardian decision|2|||
130952372|NCT01232296|471459308|FG000|Overall Study|Death|1|||
130952373|NCT01232296|471459309|FG001|Overall Study|Death|6|||
130952374|NCT00727714|471459312|FG000|Overall Study|Lost to Follow-up|2|||
130952375|NCT00937547|471459313|FG000|Overall Study|misdiagnosis|1|||
130952376|NCT00937547|471459314|FG001|Overall Study|misdiagnosis|6|||
130952377|NCT00937547|471459315|FG002|Overall Study|misdiagnosis|7|||
130952378|NCT00325234|471459316|FG000|Overall Study|Adverse Event|10|||
130952379|NCT00325234|471459317|FG001|Overall Study|Adverse Event|7|||
130952380|NCT00325234|471459316|FG000|Overall Study|Death due to Study Disease|1|||
130952381|NCT00325234|471459317|FG001|Overall Study|Death due to Study Disease|0|||
130952382|NCT00325234|471459316|FG000|Overall Study|Entry Criteria Not Met|1|||
130952383|NCT00325234|471459317|FG001|Overall Study|Entry Criteria Not Met|2|||
130952384|NCT00325234|471459316|FG000|Overall Study|Subject Decision|6|||
130952385|NCT00325234|471459317|FG001|Overall Study|Subject Decision|8|||
130952386|NCT00325234|471459316|FG000|Overall Study|Physician Decision|17|||
130952387|NCT00325234|471459317|FG001|Overall Study|Physician Decision|12|||
130952388|NCT00325234|471459316|FG000|Overall Study|Progressive Disease|34|||
130952389|NCT00325234|471459317|FG001|Overall Study|Progressive Disease|37|||
130952390|NCT01234467|471459318|FG000|Overall Study|Adverse Event|3|||
130952391|NCT01234467|471459318|FG000|Overall Study|Death|2|||
130952392|NCT01234467|471459318|FG000|Overall Study|Withdrawal by Subject|2|||
130952393|NCT01234467|471459318|FG000|Overall Study|Disease Progression|2|||
130952394|NCT01234467|471459318|FG000|Overall Study|Clinical deterioration|1|||
130952395|NCT01234467|471459318|FG000|Overall Study|Physician Decision|1|||
130952396|NCT01234467|471459318|FG000|Overall Study|Other complicating disease (stroke)|1|||
130952397|NCT00559962|471459321|FG000|Overall Study|Adverse Event|1|||
130952398|NCT00559962|471459322|FG001|Overall Study|Adverse Event|7|||
130952399|NCT00559962|471459323|FG002|Overall Study|Adverse Event|8|||
130952400|NCT00559962|471459324|FG003|Overall Study|Adverse Event|5|||
130952401|NCT00559962|471459325|FG004|Overall Study|Adverse Event|11|||
130711404|NCT02858726|470567995|FG003|Overall Study|Protocol Violation|1|||
130952402|NCT00559962|471459326|FG005|Overall Study|Adverse Event|4|||
131124939|NCT00687440|472085932|FG000|Overall Study|Adverse Event|3|||
131124940|NCT00687440|472085932|FG000|Overall Study|Lost to Follow-up|3|||
131124941|NCT00687440|472085932|FG000|Overall Study|Lack of Efficacy|2|||
130952403|NCT00559962|471459327|FG006|Overall Study|Adverse Event|4|||
130952404|NCT00559962|471459328|FG007|Overall Study|Adverse Event|2|||
130952405|NCT00559962|471459321|FG000|Overall Study|Lost to Follow-up|0|||
130952406|NCT00559962|471459322|FG001|Overall Study|Lost to Follow-up|1|||
130952407|NCT00559962|471459323|FG002|Overall Study|Lost to Follow-up|0|||
131124942|NCT00687440|472085932|FG000|Overall Study|Death|2|||
130952408|NCT00559962|471459324|FG003|Overall Study|Lost to Follow-up|0|||
130952409|NCT00559962|471459325|FG004|Overall Study|Lost to Follow-up|0|||
130952410|NCT00559962|471459326|FG005|Overall Study|Lost to Follow-up|0|||
131124943|NCT00687440|472085932|FG000|Overall Study|Other|1|||
130952411|NCT00559962|471459327|FG006|Overall Study|Lost to Follow-up|0|||
130952412|NCT00559962|471459328|FG007|Overall Study|Lost to Follow-up|0|||
130952413|NCT00559962|471459321|FG000|Overall Study|Withdrawal by Subject|1|||
130952414|NCT00559962|471459322|FG001|Overall Study|Withdrawal by Subject|1|||
130952415|NCT00559962|471459323|FG002|Overall Study|Withdrawal by Subject|2|||
130952416|NCT00559962|471459324|FG003|Overall Study|Withdrawal by Subject|0|||
130952417|NCT00559962|471459325|FG004|Overall Study|Withdrawal by Subject|3|||
130952418|NCT00559962|471459326|FG005|Overall Study|Withdrawal by Subject|1|||
130952419|NCT00559962|471459327|FG006|Overall Study|Withdrawal by Subject|0|||
130952420|NCT00559962|471459328|FG007|Overall Study|Withdrawal by Subject|2|||
130952421|NCT00559962|471459321|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
130952422|NCT00559962|471459322|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
130952423|NCT00559962|471459323|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
130952424|NCT00559962|471459324|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
130952425|NCT00559962|471459325|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
130952426|NCT00559962|471459326|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
130952427|NCT00559962|471459327|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
130952428|NCT00559962|471459328|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
130952429|NCT01461096|471459329|FG000|Overall Study|Death|3|||
130952430|NCT01461096|471459330|FG001|Overall Study|Death|6|||
130952431|NCT01461096|471459329|FG000|Overall Study|Severe debilitation, unable to continue|1|||
130952432|NCT01461096|471459330|FG001|Overall Study|Severe debilitation, unable to continue|1|||
130952433|NCT01461096|471459329|FG000|Overall Study|Subj not able to get to clinic|15|||
130952434|NCT01461096|471459330|FG001|Overall Study|Subj not able to get to clinic|13|||
130952435|NCT01461096|471459329|FG000|Overall Study|Site is closing|27|||
130952436|NCT01461096|471459330|FG001|Overall Study|Site is closing|30|||
130952437|NCT01461096|471459329|FG000|Overall Study|Withdrawal by Subject|5|||
130952438|NCT01461096|471459330|FG001|Overall Study|Withdrawal by Subject|3|||
130952439|NCT01461096|471459329|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
130952440|NCT01461096|471459330|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
130952441|NCT01461096|471459329|FG000|Overall Study|Lost to Follow-up|8|||
130952442|NCT01461096|471459330|FG001|Overall Study|Lost to Follow-up|4|||
130952443|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
130952444|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
130952445|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
130952446|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
130952447|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
130952448|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
130952449|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
130952450|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
130952451|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
130952452|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
130952453|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
130952454|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
130952455|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
130952456|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
130952457|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
130952458|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
130952459|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
130952460|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
130952461|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Death|0|||
130952462|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Death|0|||
130952463|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Death|1|||
130952464|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Death|0|||
130952465|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Death|0|||
130952466|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Death|0|||
130952467|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Death|0|||
130952468|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Death|0|||
130952469|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Death|0|||
130952470|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
130952471|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
130952472|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
130952473|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130711405|NCT02858726|470567992|FG000|Overall Study|Study Terminated by Sponsor|0|||
130711406|NCT02858726|470567993|FG001|Overall Study|Study Terminated by Sponsor|0|||
130952474|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130952475|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130952476|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130952477|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130952478|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130952479|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
131038957|NCT03854227|471778128|FG002|Overall Study|Death|0|||
130711407|NCT02858726|470567994|FG002|Overall Study|Study Terminated by Sponsor|0|||
130774507|NCT02559570|470800543|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130774508|NCT02559570|470800544|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130774509|NCT02559570|470800545|FG002|Overall Study|Other Miscellaneous Reasons|1|||
130952480|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
130952481|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
130952482|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130952483|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130952484|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130952485|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130952486|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130952487|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
130952488|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
130952489|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
130952490|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
130952491|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
130952492|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
130952493|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
130952494|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
130952495|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
130952496|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
130952497|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
130952498|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
130952499|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
130952500|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
130952501|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
130952502|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
130952503|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
130952504|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
130952505|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
130952506|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
130952507|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
130952508|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
130952509|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130952510|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130952511|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130952512|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130952513|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130952514|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130952515|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130952516|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
130952517|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130952518|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130952519|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130952520|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130952521|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130952522|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130952523|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
130952524|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
130952525|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
130952526|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
130774510|NCT02559570|470800546|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130774511|NCT02559570|470800547|FG004|Overall Study|Other Miscellaneous Reasons|0|||
130774512|NCT00420628|470800551|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
130774513|NCT00420628|470800552|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
130774514|NCT00420628|470800551|FG000|Overall Study|Lost to Follow-up|3|||
130774515|NCT00420628|470800552|FG001|Overall Study|Lost to Follow-up|2|||
130774516|NCT00420628|470800551|FG000|Overall Study|Adverse Event|1|||
130774517|NCT00420628|470800552|FG001|Overall Study|Adverse Event|0|||
130774518|NCT00396383|470800559|FG000|Overall Study|Death|2|||
130952527|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
130774519|NCT00396383|470800559|FG000|Overall Study|Lost to Follow-up|1|||
130774520|NCT02787083|470800560|FG000|Overall Study|Adverse Event|1|||
130952528|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
130952529|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
130952530|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
130952531|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
130952532|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
130774521|NCT02787083|470800561|FG001|Overall Study|Adverse Event|0|||
130774522|NCT02787083|470800560|FG000|Overall Study|Withdrawal by Subject|2|||
130952533|NCT00404352|471459331|FG000|Double Blind (up to 24 Month)|Other|0|||
130952534|NCT00404352|471459332|FG001|Double Blind (up to 24 Month)|Other|1|||
130952535|NCT00404352|471459333|FG002|Double Blind (up to 24 Month)|Other|0|||
130952536|NCT00404352|471459334|FG003|Double Blind (up to 24 Month)|Other|0|||
130952537|NCT00404352|471459335|FG004|Double Blind (up to 24 Month)|Other|0|||
130952538|NCT00404352|471459336|FG005|Double Blind (up to 24 Month)|Other|0|||
130952539|NCT00404352|471459337|FG006|Double Blind (up to 24 Month)|Other|0|||
130952540|NCT00404352|471459338|FG007|Double Blind (up to 24 Month)|Other|0|||
130952541|NCT00404352|471459339|FG008|Double Blind (up to 24 Month)|Other|0|||
130952542|NCT00404352|471459331|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
130952543|NCT00404352|471459332|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
130952544|NCT00404352|471459333|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
130952545|NCT00404352|471459334|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
130952546|NCT00404352|471459335|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
130952547|NCT00404352|471459336|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
130952548|NCT00404352|471459337|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
130952549|NCT00404352|471459338|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
130952550|NCT00404352|471459339|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
130952551|NCT00404352|471459331|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
130952552|NCT00404352|471459332|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
130952553|NCT00404352|471459333|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
130952554|NCT00404352|471459334|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
130952555|NCT00404352|471459335|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
130952556|NCT00404352|471459336|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
130952557|NCT00404352|471459337|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
130952558|NCT00404352|471459338|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
130952559|NCT00404352|471459339|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
130952560|NCT00404352|471459331|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130952561|NCT00404352|471459332|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130952562|NCT00404352|471459333|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130952563|NCT00404352|471459334|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130952564|NCT00404352|471459335|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
130952565|NCT00404352|471459336|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130952566|NCT00404352|471459337|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130952567|NCT00404352|471459338|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130952568|NCT00404352|471459339|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
130952569|NCT00404352|471459331|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130952570|NCT00404352|471459332|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130952571|NCT00404352|471459333|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130952572|NCT00404352|471459334|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130952573|NCT00404352|471459335|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130952574|NCT00404352|471459336|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
130952575|NCT00404352|471459337|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130952576|NCT00404352|471459338|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130952577|NCT00404352|471459339|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
130952578|NCT00404352|471459331|FG000|Open Label (up to 24 Month)|Disease progression|0|||
130952579|NCT00404352|471459332|FG001|Open Label (up to 24 Month)|Disease progression|0|||
130952580|NCT00404352|471459333|FG002|Open Label (up to 24 Month)|Disease progression|0|||
130952581|NCT00404352|471459334|FG003|Open Label (up to 24 Month)|Disease progression|1|||
130952582|NCT00404352|471459335|FG004|Open Label (up to 24 Month)|Disease progression|0|||
130952583|NCT00404352|471459336|FG005|Open Label (up to 24 Month)|Disease progression|0|||
130952584|NCT00404352|471459337|FG006|Open Label (up to 24 Month)|Disease progression|0|||
130952585|NCT00404352|471459338|FG007|Open Label (up to 24 Month)|Disease progression|0|||
130952586|NCT00404352|471459339|FG008|Open Label (up to 24 Month)|Disease progression|0|||
130952587|NCT00404352|471459331|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130952588|NCT00404352|471459332|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130952589|NCT00404352|471459333|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130952590|NCT00404352|471459334|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130952591|NCT00404352|471459335|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130952592|NCT00404352|471459336|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130952593|NCT00404352|471459337|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
130952594|NCT00404352|471459338|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
130952595|NCT00404352|471459339|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
130952596|NCT00404352|471459331|FG000|Open Label Extension (up to 36 Months)|Other|0|||
130952597|NCT00404352|471459332|FG001|Open Label Extension (up to 36 Months)|Other|0|||
130952598|NCT00404352|471459333|FG002|Open Label Extension (up to 36 Months)|Other|0|||
130952599|NCT00404352|471459334|FG003|Open Label Extension (up to 36 Months)|Other|0|||
130952600|NCT00404352|471459335|FG004|Open Label Extension (up to 36 Months)|Other|0|||
130952601|NCT00404352|471459336|FG005|Open Label Extension (up to 36 Months)|Other|0|||
130952602|NCT00404352|471459337|FG006|Open Label Extension (up to 36 Months)|Other|0|||
130952603|NCT00404352|471459338|FG007|Open Label Extension (up to 36 Months)|Other|0|||
130952604|NCT00404352|471459339|FG008|Open Label Extension (up to 36 Months)|Other|2|||
130952605|NCT04370691|471459342|FG000|Overall Study|Pending visit|48|||
130952606|NCT04370691|471459342|FG000|Overall Study|Have Not Reached Lower Window|15|||
130952607|NCT04370691|471459342|FG000|Overall Study|Termination|14|||
130952608|NCT04370691|471459342|FG000|Overall Study|Missed or Overdue|10|||
130952609|NCT00486265|471459346|FG000|Overall Study|Adverse Event|1|||
130952610|NCT00486265|471459346|FG000|Overall Study|Lack of Efficacy|8|||
130952611|NCT03047135|471459347|FG000|Overall Study|Still being treated|3|||
130952612|NCT04365699|471459348|FG000|Overall Study|Death|2|||
130952613|NCT04365699|471459349|FG001|Overall Study|Death|5|||
130952614|NCT04365699|471459350|FG002|Overall Study|Death|15|||
130952615|NCT02540954|471459351|FG000|Overall Study|Physician Decision|3|||
130952616|NCT02540954|471459352|FG001|Overall Study|Physician Decision|1|||
130952617|NCT02540954|471459351|FG000|Overall Study|Withdrawal by Subject|6|||
130952618|NCT02540954|471459352|FG001|Overall Study|Withdrawal by Subject|5|||
130952619|NCT02540954|471459351|FG000|Overall Study|Lost to Follow-up|1|||
130952620|NCT02540954|471459352|FG001|Overall Study|Lost to Follow-up|1|||
130952621|NCT02540954|471459351|FG000|Overall Study|Adverse Event|4|||
130952622|NCT02540954|471459352|FG001|Overall Study|Adverse Event|2|||
130952623|NCT02540954|471459351|FG000|Overall Study|Death|0|||
130952624|NCT02540954|471459352|FG001|Overall Study|Death|3|||
130952625|NCT02540954|471459351|FG000|Overall Study|Treatment failure|1|||
130952626|NCT02540954|471459352|FG001|Overall Study|Treatment failure|0|||
130952627|NCT02540954|471459351|FG000|Overall Study|Other reason|4|||
130952628|NCT02540954|471459352|FG001|Overall Study|Other reason|2|||
130952629|NCT00834912|471459355|FG000|Treatment Period 1|Adverse Event|0|||
130952630|NCT00834912|471459356|FG001|Treatment Period 1|Adverse Event|1|||
130952631|NCT00834912|471459357|FG002|Treatment Period 1|Adverse Event|0|||
130952632|NCT00834912|471459358|FG003|Treatment Period 1|Adverse Event|1|||
130952633|NCT00834912|471459359|FG004|Treatment Period 1|Adverse Event|0|||
130952634|NCT00834912|471459360|FG005|Treatment Period 1|Adverse Event|0|||
130952635|NCT00834912|471459355|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130952636|NCT00834912|471459356|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130952637|NCT00834912|471459357|FG002|Treatment Period 2|Withdrawal by Subject|1|||
130952638|NCT00834912|471459358|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130711408|NCT02858726|470567995|FG003|Overall Study|Study Terminated by Sponsor|1|||
130711409|NCT02858726|470567992|FG000|Overall Study|Withdrawal by Subject|1|||
130711410|NCT02858726|470567993|FG001|Overall Study|Withdrawal by Subject|2|||
130711411|NCT02858726|470567994|FG002|Overall Study|Withdrawal by Subject|1|||
130711412|NCT02858726|470567995|FG003|Overall Study|Withdrawal by Subject|0|||
130711413|NCT02858726|470567992|FG000|Overall Study|Noncompliance|0|||
130711414|NCT02858726|470567993|FG001|Overall Study|Noncompliance|1|||
130952639|NCT00834912|471459359|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130952640|NCT00834912|471459360|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130952641|NCT03829046|471459361|FG000|Overall Study|Withdrawal by Subject|1|||
130952642|NCT03829046|471459362|FG001|Overall Study|Withdrawal by Subject|0|||
130952643|NCT01581593|471460837|FG000|Overall Study|Withdrawal by Subject|1|||
130952644|NCT02970968|471460839|FG000|Overall Study|Withdrawal by Subject|3|||
130952645|NCT02970968|471460840|FG001|Overall Study|Withdrawal by Subject|3|||
130952646|NCT02970968|471460839|FG000|Overall Study|Adverse Event|1|||
130952647|NCT02970968|471460840|FG001|Overall Study|Adverse Event|2|||
130952648|NCT02970968|471460839|FG000|Overall Study|Lost to Follow-up|1|||
130952649|NCT02970968|471460840|FG001|Overall Study|Lost to Follow-up|1|||
130952650|NCT02970968|471460839|FG000|Overall Study|Non-Compliance|0|||
130952651|NCT02970968|471460840|FG001|Overall Study|Non-Compliance|1|||
130952652|NCT02565381|471460841|FG000|Overall Study|Lost to Follow-up|1|||
130952653|NCT02565381|471460842|FG001|Overall Study|Lost to Follow-up|0|||
130952654|NCT02565381|471460843|FG002|Overall Study|Lost to Follow-up|1|||
130952655|NCT05084053|471460846|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
130952656|NCT05084053|471460847|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
130952657|NCT05084053|471460848|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
130952658|NCT05084053|471460849|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
130952659|NCT05084053|471460846|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
130952660|NCT05084053|471460847|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
130952661|NCT05084053|471460848|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
130952662|NCT05084053|471460849|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
130952663|NCT05084053|471460846|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
130952664|NCT05084053|471460847|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
130952665|NCT05084053|471460848|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
130952666|NCT05084053|471460849|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
130952667|NCT00071812|471460850|FG000|24-Week Double-Blind Period|Adverse Event|2|||
130952668|NCT00071812|471460851|FG001|24-Week Double-Blind Period|Adverse Event|3|||
130952669|NCT00071812|471460852|FG002|24-Week Double-Blind Period|Adverse Event|4|||
130711415|NCT02858726|470567994|FG002|Overall Study|Noncompliance|0|||
130711416|NCT02858726|470567995|FG003|Overall Study|Noncompliance|0|||
130711417|NCT02655016|470567996|FG000|Overall Study|Disease progression|6|||
130952670|NCT00071812|471460853|FG003|24-Week Double-Blind Period|Adverse Event|4|||
130952671|NCT00071812|471460850|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
130711418|NCT02655016|470567997|FG001|Overall Study|Disease progression|4|||
130711419|NCT02655016|470567996|FG000|Overall Study|Site closed|0|||
130711420|NCT02655016|470567997|FG001|Overall Study|Site closed|1|||
130711421|NCT02655016|470567996|FG000|Overall Study|Death|30|||
130711422|NCT02655016|470567997|FG001|Overall Study|Death|48|||
130711423|NCT02655016|470567996|FG000|Overall Study|Lost to Follow-up|1|||
130711424|NCT02655016|470567997|FG001|Overall Study|Lost to Follow-up|1|||
130711425|NCT02655016|470567996|FG000|Overall Study|Withdrawal by Subject|18|||
130711426|NCT02655016|470567997|FG001|Overall Study|Withdrawal by Subject|36|||
130711427|NCT04459715|470567998|FG000|Overall Study|Adverse Event|3|||
130711428|NCT04459715|470567999|FG001|Overall Study|Adverse Event|3|||
130711429|NCT04459715|470567998|FG000|Overall Study|Death|111|||
130774523|NCT02787083|470800561|FG001|Overall Study|Withdrawal by Subject|2|||
130952672|NCT00071812|471460851|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
130952673|NCT00071812|471460852|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
130952674|NCT00071812|471460853|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
130952675|NCT00071812|471460850|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
130952676|NCT00071812|471460851|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
130952677|NCT00071812|471460852|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
130952678|NCT00071812|471460853|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
130952679|NCT00071812|471460850|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
130952680|NCT00071812|471460851|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
130952681|NCT00071812|471460852|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
130952682|NCT00071812|471460853|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
130952683|NCT00071812|471460850|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
130952684|NCT00071812|471460851|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
130952685|NCT00071812|471460852|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
130952686|NCT00071812|471460853|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
130952687|NCT00071812|471460850|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
130952688|NCT00071812|471460851|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
130952689|NCT00071812|471460852|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
130952690|NCT00071812|471460853|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
130952691|NCT00071812|471460850|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130952692|NCT00071812|471460851|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130952693|NCT00071812|471460852|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130952694|NCT00071812|471460853|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
130952695|NCT00071812|471460850|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130952696|NCT00071812|471460851|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130952697|NCT00071812|471460852|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130952698|NCT00071812|471460853|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
130952699|NCT00071812|471460850|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130952700|NCT00071812|471460851|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130952701|NCT00071812|471460852|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130952702|NCT00071812|471460853|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
130952703|NCT00071812|471460850|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
130952704|NCT00071812|471460851|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
130952705|NCT00071812|471460852|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
130952706|NCT00071812|471460853|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
130952707|NCT00846742|471460862|FG000|Overall Study|Withdrawal by Subject|1|||
130952708|NCT03795610|471460864|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
130952709|NCT03795610|471460864|FG000|Overall Study|Withdrawal by Subject|1|||
130952710|NCT03795610|471460864|FG000|Overall Study|Screen Failure (Unknown)|1|||
130952711|NCT03909165|471460869|FG000|Overall Study|Physician Decision|0|||
130952712|NCT03909165|471460870|FG001|Overall Study|Physician Decision|1|||
130952713|NCT03909165|471460871|FG002|Overall Study|Physician Decision|0|||
130952714|NCT03909165|471460872|FG003|Overall Study|Physician Decision|0|||
130952715|NCT03909165|471460873|FG004|Overall Study|Physician Decision|0|||
130952716|NCT03909165|471460869|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130952717|NCT03909165|471460870|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130952718|NCT03909165|471460871|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130952719|NCT03909165|471460872|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130952720|NCT03909165|471460873|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130952721|NCT03909165|471460869|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130952722|NCT03909165|471460870|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
130952723|NCT03909165|471460871|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
130711430|NCT04459715|470567999|FG001|Overall Study|Death|93|||
130711431|NCT04459715|470567998|FG000|Overall Study|Lost to Follow-up|10|||
130711432|NCT04459715|470567999|FG001|Overall Study|Lost to Follow-up|9|||
130711433|NCT04459715|470567998|FG000|Overall Study|Other Reasons|4|||
130711434|NCT04459715|470567999|FG001|Overall Study|Other Reasons|5|||
130711435|NCT04459715|470567998|FG000|Overall Study|PROTOCOL DEVIATION|0|||
130774524|NCT00282152|470800562|FG000|Overall Study|Withdrawal by Subject|1|||
130711436|NCT04459715|470567999|FG001|Overall Study|PROTOCOL DEVIATION|1|||
130711437|NCT04459715|470567998|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
130711438|NCT04459715|470567999|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
130711439|NCT04459715|470567998|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
130711440|NCT04459715|470567999|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
130711441|NCT04459715|470567998|FG000|Overall Study|Withdrawal by Subject|22|||
130711442|NCT04459715|470567999|FG001|Overall Study|Withdrawal by Subject|22|||
130711443|NCT02631876|470569842|FG000|Overall Study|Death|96|||
130711444|NCT02631876|470569843|FG001|Overall Study|Death|50|||
130711445|NCT02631876|470569842|FG000|Overall Study|Investigator's discretion|1|||
130711446|NCT02631876|470569843|FG001|Overall Study|Investigator's discretion|0|||
130711447|NCT02631876|470569842|FG000|Overall Study|Lost to Follow-up|2|||
130711448|NCT02631876|470569843|FG001|Overall Study|Lost to Follow-up|0|||
130711449|NCT02631876|470569842|FG000|Overall Study|Withdrawal by Subject|16|||
130711450|NCT02631876|470569843|FG001|Overall Study|Withdrawal by Subject|9|||
130952724|NCT03909165|471460872|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
130952725|NCT03909165|471460873|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
130952726|NCT03909165|471460869|FG000|Overall Study|Previous Drug Exposure|0|||
130952727|NCT03909165|471460870|FG001|Overall Study|Previous Drug Exposure|0|||
130952728|NCT03909165|471460871|FG002|Overall Study|Previous Drug Exposure|1|||
130952729|NCT03909165|471460872|FG003|Overall Study|Previous Drug Exposure|0|||
130952730|NCT03909165|471460873|FG004|Overall Study|Previous Drug Exposure|0|||
130952731|NCT03909165|471460869|FG000|Overall Study|Early Discharge|1|||
130952732|NCT03909165|471460870|FG001|Overall Study|Early Discharge|0|||
130952733|NCT03909165|471460871|FG002|Overall Study|Early Discharge|0|||
130952734|NCT03909165|471460872|FG003|Overall Study|Early Discharge|0|||
130952735|NCT03909165|471460873|FG004|Overall Study|Early Discharge|0|||
130952736|NCT04098458|471460877|FG000|Overall Study|Death|1|||
130952737|NCT04098458|471460877|FG000|Overall Study|did not meet study inclusion criteria|3|||
130952738|NCT00006489|471460878|FG000|Overall Study|Adverse Event|3|||
130952739|NCT00006489|471460879|FG001|Overall Study|Adverse Event|2|||
130952740|NCT00006489|471460880|FG002|Overall Study|Adverse Event|4|||
130952741|NCT00006489|471460881|FG003|Overall Study|Adverse Event|3|||
130952742|NCT00006489|471460878|FG000|Overall Study|Withdrawal by Subject|10|||
130952743|NCT00006489|471460879|FG001|Overall Study|Withdrawal by Subject|9|||
130952744|NCT00006489|471460880|FG002|Overall Study|Withdrawal by Subject|9|||
130952745|NCT00006489|471460881|FG003|Overall Study|Withdrawal by Subject|6|||
130952746|NCT00006489|471460878|FG000|Overall Study|Scheduling Conflict|0|||
130952747|NCT00006489|471460879|FG001|Overall Study|Scheduling Conflict|3|||
130952748|NCT00006489|471460880|FG002|Overall Study|Scheduling Conflict|2|||
130952749|NCT00006489|471460881|FG003|Overall Study|Scheduling Conflict|1|||
130952750|NCT00006489|471460878|FG000|Overall Study|Death|0|||
130952751|NCT00006489|471460879|FG001|Overall Study|Death|0|||
130952752|NCT00006489|471460880|FG002|Overall Study|Death|0|||
130952753|NCT00006489|471460881|FG003|Overall Study|Death|1|||
130952754|NCT01533246|471460884|FG000|Overall Study|Adverse Event|1|||
130952755|NCT01533246|471460884|FG000|Overall Study|Withdrawal by Subject|1|||
130952756|NCT03491150|471460885|FG000|Overall Study|Adverse Event|1|||
130952757|NCT03491150|471460886|FG001|Overall Study|Adverse Event|0|||
130952758|NCT03491150|471460885|FG000|Overall Study|Study Terminated by Sponsor|74|||
130952759|NCT03491150|471460886|FG001|Overall Study|Study Terminated by Sponsor|70|||
130952760|NCT03491150|471460885|FG000|Overall Study|Other|0|||
130952761|NCT03491150|471460886|FG001|Overall Study|Other|1|||
130952762|NCT03491150|471460885|FG000|Overall Study|Withdrawal by Subject|1|||
130952763|NCT03491150|471460886|FG001|Overall Study|Withdrawal by Subject|2|||
130952764|NCT05179421|471460890|FG000|First Infusion Day|Adverse Event|1|||
130952765|NCT05179421|471460891|FG001|First Infusion Day|Adverse Event|0|||
130952766|NCT03746522|471460901|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
130952767|NCT03746522|471460902|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
130952768|NCT03746522|471460903|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
130952769|NCT03746522|471460901|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
130952770|NCT03746522|471460902|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
130952771|NCT03746522|471460903|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
130952772|NCT03746522|471460901|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
130952773|NCT03746522|471460902|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
130952774|NCT03746522|471460903|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
130952775|NCT03746522|471460901|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
130952776|NCT03746522|471460902|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
130952777|NCT03746522|471460903|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
130952778|NCT03746522|471460901|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
130952779|NCT03746522|471460902|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
130952780|NCT03746522|471460903|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
130711451|NCT02631876|470569842|FG000|Overall Study|Other than specified|4|||
130711452|NCT02631876|470569843|FG001|Overall Study|Other than specified|4|||
130711453|NCT01408563|470569848|FG000|Overall Study|Ineligible after consent/ registration|2|||
130711454|NCT00380692|470569849|FG000|Study Period II - Double Blind|Adverse Event|1|||
130952781|NCT01479621|471460904|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
130952782|NCT01479621|471460905|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130952783|NCT01479621|471460906|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130952784|NCT01479621|471460907|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130952785|NCT01479621|471460908|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130952786|NCT01479621|471460909|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130952787|NCT01479621|471460910|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
130952788|NCT01479621|471460904|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
130952789|NCT01479621|471460905|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130952790|NCT01479621|471460906|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130952791|NCT01479621|471460907|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130952792|NCT01479621|471460908|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130952793|NCT01479621|471460909|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130952794|NCT01479621|471460910|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
130952795|NCT01479621|471460904|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
130952796|NCT01479621|471460905|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130952797|NCT01479621|471460906|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130952798|NCT01479621|471460907|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130952799|NCT01479621|471460908|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130952800|NCT01479621|471460909|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130952801|NCT01479621|471460910|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
130952802|NCT01479621|471460904|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
130952803|NCT01479621|471460905|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130952804|NCT01479621|471460906|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130952805|NCT01479621|471460907|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130952806|NCT01479621|471460908|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130952807|NCT01479621|471460909|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130952808|NCT01479621|471460910|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
130952809|NCT01479621|471460904|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
130952810|NCT01479621|471460905|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130952811|NCT01479621|471460906|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130952812|NCT01479621|471460907|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130952813|NCT01479621|471460908|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130952814|NCT01479621|471460909|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130952815|NCT01479621|471460910|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
130952816|NCT01479621|471460904|FG000|Treatment Period|Adverse Event|0|||
130952817|NCT01479621|471460905|FG001|Treatment Period|Adverse Event|0|||
130952818|NCT01479621|471460906|FG002|Treatment Period|Adverse Event|0|||
130952819|NCT01479621|471460907|FG003|Treatment Period|Adverse Event|0|||
130952820|NCT01479621|471460908|FG004|Treatment Period|Adverse Event|1|||
130952821|NCT01479621|471460909|FG005|Treatment Period|Adverse Event|2|||
130952822|NCT01479621|471460910|FG006|Treatment Period|Adverse Event|2|||
130952823|NCT01479621|471460904|FG000|Treatment Period|Withdrawal by Subject|0|||
130952824|NCT01479621|471460905|FG001|Treatment Period|Withdrawal by Subject|4|||
130952825|NCT01479621|471460906|FG002|Treatment Period|Withdrawal by Subject|2|||
130952826|NCT01479621|471460907|FG003|Treatment Period|Withdrawal by Subject|2|||
130952827|NCT01479621|471460908|FG004|Treatment Period|Withdrawal by Subject|5|||
131225111|NCT01792284|472451961|FG000|Lead-in Period|Withdrawal by Subject|10|||
130711455|NCT00380692|470569850|FG001|Study Period II - Double Blind|Adverse Event|0|||
130711456|NCT00380692|470569849|FG000|Study Period II - Double Blind|Protocol Violation|2|||
130711457|NCT00380692|470569850|FG001|Study Period II - Double Blind|Protocol Violation|2|||
130711458|NCT00380692|470569849|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
130711459|NCT00380692|470569850|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
130711460|NCT00380692|470569849|FG000|Study Period II - Double Blind|Physician Decision|0|||
130711461|NCT00380692|470569850|FG001|Study Period II - Double Blind|Physician Decision|1|||
130711462|NCT00380692|470569849|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
130711463|NCT00380692|470569850|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
130711464|NCT00380692|470569849|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
130711465|NCT00380692|470569850|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
130711466|NCT00380692|470569849|FG000|Study Period III - Open Label|Adverse Event|5|||
130711467|NCT00380692|470569850|FG001|Study Period III - Open Label|Adverse Event|3|||
130774525|NCT00282152|470800563|FG001|Overall Study|Withdrawal by Subject|0|||
130774526|NCT00585325|470800564|FG000|Overall Study|Withdrawal by Subject|1|||
130952828|NCT01479621|471460909|FG005|Treatment Period|Withdrawal by Subject|5|||
130952829|NCT01479621|471460910|FG006|Treatment Period|Withdrawal by Subject|1|||
130952830|NCT01479621|471460904|FG000|Treatment Period|Physician Decision|0|||
130952831|NCT01479621|471460905|FG001|Treatment Period|Physician Decision|0|||
130952832|NCT01479621|471460906|FG002|Treatment Period|Physician Decision|0|||
130952833|NCT01479621|471460907|FG003|Treatment Period|Physician Decision|0|||
130952834|NCT01479621|471460908|FG004|Treatment Period|Physician Decision|1|||
130952835|NCT01479621|471460909|FG005|Treatment Period|Physician Decision|1|||
130952836|NCT01479621|471460910|FG006|Treatment Period|Physician Decision|0|||
130952837|NCT01479621|471460904|FG000|Treatment Period|Non-compliance to study drug|0|||
130952838|NCT01479621|471460905|FG001|Treatment Period|Non-compliance to study drug|1|||
130952839|NCT01479621|471460906|FG002|Treatment Period|Non-compliance to study drug|0|||
130952840|NCT01479621|471460907|FG003|Treatment Period|Non-compliance to study drug|0|||
130952841|NCT01479621|471460908|FG004|Treatment Period|Non-compliance to study drug|0|||
130952842|NCT01479621|471460909|FG005|Treatment Period|Non-compliance to study drug|0|||
130952843|NCT01479621|471460910|FG006|Treatment Period|Non-compliance to study drug|1|||
130952844|NCT01479621|471460904|FG000|Treatment Period|Protocol Violation|0|||
130952845|NCT01479621|471460905|FG001|Treatment Period|Protocol Violation|9|||
130952846|NCT01479621|471460906|FG002|Treatment Period|Protocol Violation|6|||
130952847|NCT01479621|471460907|FG003|Treatment Period|Protocol Violation|5|||
130952848|NCT01479621|471460908|FG004|Treatment Period|Protocol Violation|2|||
130952849|NCT01479621|471460909|FG005|Treatment Period|Protocol Violation|10|||
130952850|NCT01479621|471460910|FG006|Treatment Period|Protocol Violation|6|||
130952851|NCT01479621|471460904|FG000|Treatment Period|Pregnancy|0|||
130952852|NCT01479621|471460905|FG001|Treatment Period|Pregnancy|0|||
130952853|NCT01479621|471460906|FG002|Treatment Period|Pregnancy|2|||
130952854|NCT01479621|471460907|FG003|Treatment Period|Pregnancy|0|||
130952855|NCT01479621|471460908|FG004|Treatment Period|Pregnancy|0|||
130952856|NCT01479621|471460909|FG005|Treatment Period|Pregnancy|0|||
130952857|NCT01479621|471460910|FG006|Treatment Period|Pregnancy|0|||
130952858|NCT01479621|471460904|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
130952859|NCT01479621|471460905|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
130952860|NCT01479621|471460906|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
130952861|NCT01479621|471460907|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
130952862|NCT01479621|471460908|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
130952863|NCT01479621|471460909|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
130952864|NCT01479621|471460910|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
130952865|NCT01479621|471460904|FG000|Treatment Period|Lost to Follow-up|0|||
130952866|NCT01479621|471460905|FG001|Treatment Period|Lost to Follow-up|0|||
130952867|NCT01479621|471460906|FG002|Treatment Period|Lost to Follow-up|1|||
130952868|NCT01479621|471460907|FG003|Treatment Period|Lost to Follow-up|0|||
130952869|NCT01479621|471460908|FG004|Treatment Period|Lost to Follow-up|2|||
130952870|NCT01479621|471460909|FG005|Treatment Period|Lost to Follow-up|2|||
130952871|NCT01479621|471460910|FG006|Treatment Period|Lost to Follow-up|1|||
130952872|NCT01479621|471460904|FG000|Treatment Period|Met stopping criteria|0|||
130952873|NCT01479621|471460905|FG001|Treatment Period|Met stopping criteria|8|||
130952874|NCT01479621|471460906|FG002|Treatment Period|Met stopping criteria|7|||
130952875|NCT01479621|471460907|FG003|Treatment Period|Met stopping criteria|4|||
130952876|NCT01479621|471460908|FG004|Treatment Period|Met stopping criteria|9|||
130952877|NCT01479621|471460909|FG005|Treatment Period|Met stopping criteria|20|||
130952878|NCT01479621|471460910|FG006|Treatment Period|Met stopping criteria|6|||
130952879|NCT01452412|471460914|FG000|Overall Study|Withdrawal by Subject|15|||
130952880|NCT01452412|471460915|FG001|Overall Study|Withdrawal by Subject|11|||
130952881|NCT01452412|471460914|FG000|Overall Study|Adverse Event|4|||
130952882|NCT01452412|471460915|FG001|Overall Study|Adverse Event|3|||
130952883|NCT01452412|471460914|FG000|Overall Study|Lost to Follow-up|5|||
130952884|NCT01452412|471460915|FG001|Overall Study|Lost to Follow-up|3|||
130711468|NCT00380692|470569849|FG000|Study Period III - Open Label|Protocol Violation|0|||
130711469|NCT00380692|470569850|FG001|Study Period III - Open Label|Protocol Violation|0|||
130711470|NCT00380692|470569849|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
130711471|NCT00380692|470569850|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
130711472|NCT00380692|470569849|FG000|Study Period III - Open Label|Physician Decision|0|||
130711473|NCT00380692|470569850|FG001|Study Period III - Open Label|Physician Decision|3|||
130711474|NCT00380692|470569849|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
130774527|NCT00585325|470800565|FG001|Overall Study|Withdrawal by Subject|1|||
130774528|NCT03301831|470800566|FG000|Overall Study|Lost to Follow-up|5|||
130952885|NCT01452412|471460914|FG000|Overall Study|Death|1|||
130952886|NCT01452412|471460915|FG001|Overall Study|Death|0|||
130952887|NCT01452412|471460914|FG000|Overall Study|Initiated dialysis|1|||
130952888|NCT01452412|471460915|FG001|Overall Study|Initiated dialysis|0|||
130952889|NCT01452412|471460914|FG000|Overall Study|Other|2|||
130952890|NCT01452412|471460915|FG001|Overall Study|Other|0|||
130952891|NCT03013543|471460916|FG000|Overall Study|Withdrawal by Subject|0|||
130952892|NCT03013543|471460917|FG001|Overall Study|Withdrawal by Subject|2|||
130952893|NCT03013543|471460918|FG002|Overall Study|Withdrawal by Subject|0|||
130711475|NCT00380692|470569850|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
130952894|NCT03013543|471460919|FG003|Overall Study|Withdrawal by Subject|5|||
131038958|NCT03854227|471778129|FG003|Overall Study|Death|0|||
131038959|NCT03854227|471778130|FG004|Overall Study|Death|0|||
130952895|NCT03013543|471460920|FG004|Overall Study|Withdrawal by Subject|6|||
130952896|NCT03013543|471460921|FG005|Overall Study|Withdrawal by Subject|2|||
130952897|NCT03013543|471460922|FG006|Overall Study|Withdrawal by Subject|3|||
130952898|NCT03013543|471460923|FG007|Overall Study|Withdrawal by Subject|1|||
130952899|NCT03013543|471460924|FG008|Overall Study|Withdrawal by Subject|0|||
130952900|NCT03013543|471460925|FG009|Overall Study|Withdrawal by Subject|4|||
130952901|NCT03013543|471460916|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
131124944|NCT00687440|472085932|FG000|Overall Study|Missing|1|||
131124945|NCT02228720|472085933|FG000|Open Label - Day 30|Lost to Follow-up|1|||
131124946|NCT01392677|472085936|FG000|Overall Study|Adverse Event|3|||
131124947|NCT01392677|472085937|FG001|Overall Study|Adverse Event|1|||
131124948|NCT01392677|472085936|FG000|Overall Study|Withdrawal by Subject|0|||
131124949|NCT01392677|472085937|FG001|Overall Study|Withdrawal by Subject|2|||
131124950|NCT01392677|472085936|FG000|Overall Study|Incorrect enrollment|2|||
131124951|NCT01392677|472085937|FG001|Overall Study|Incorrect enrollment|3|||
131124952|NCT01392677|472085936|FG000|Overall Study|Other reason|3|||
131124953|NCT01392677|472085937|FG001|Overall Study|Other reason|2|||
131124954|NCT03996876|472085938|FG000|Overall Study|Incomplete Data|2|||
131124955|NCT03996876|472085939|FG001|Overall Study|Incomplete Data|4|||
131124956|NCT05264740|472085944|FG000|Baseline|Withdrawal by Subject|0|||
131124957|NCT05264740|472085945|FG001|Baseline|Withdrawal by Subject|1|||
131124958|NCT05264740|472085944|FG000|Follow Up 1|Lost to Follow-up|1|||
131124959|NCT05264740|472085945|FG001|Follow Up 1|Lost to Follow-up|1|||
131124960|NCT05264740|472085944|FG000|Follow Up 1|Withdrawal by Subject|0|||
131124961|NCT05264740|472085945|FG001|Follow Up 1|Withdrawal by Subject|1|||
131124962|NCT05264740|472085944|FG000|Follow Up 2|Lost to Follow-up|1|||
131124963|NCT05264740|472085945|FG001|Follow Up 2|Lost to Follow-up|4|||
131124964|NCT05264740|472085944|FG000|Follow Up 3|Lost to Follow-up|7|||
131124965|NCT05264740|472085945|FG001|Follow Up 3|Lost to Follow-up|4|||
131225112|NCT01792284|472451962|FG001|Lead-in Period|Withdrawal by Subject|0|||
131225113|NCT01792284|472451963|FG002|Lead-in Period|Withdrawal by Subject|0|||
130952902|NCT03013543|471460917|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
130952903|NCT03013543|471460918|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
130774529|NCT03301831|470800567|FG001|Overall Study|Lost to Follow-up|3|||
130774530|NCT03301831|470800566|FG000|Overall Study|Protocol Violation|4|||
130774531|NCT03301831|470800567|FG001|Overall Study|Protocol Violation|0|||
130774532|NCT03301831|470800566|FG000|Overall Study|Withdrawal by Subject|11|||
130774533|NCT03301831|470800567|FG001|Overall Study|Withdrawal by Subject|0|||
130774534|NCT03092791|470800568|FG000|Overall Study|Lost to Follow-up|0|||
130774535|NCT03092791|470800569|FG001|Overall Study|Lost to Follow-up|0|||
130774536|NCT03092791|470800570|FG002|Overall Study|Lost to Follow-up|0|||
130774537|NCT03092791|470800571|FG003|Overall Study|Lost to Follow-up|0|||
130774538|NCT03092791|470800572|FG004|Overall Study|Lost to Follow-up|0|||
130774539|NCT03092791|470800573|FG005|Overall Study|Lost to Follow-up|0|||
130774540|NCT03092791|470800574|FG006|Overall Study|Lost to Follow-up|1|||
130774541|NCT03092791|470800575|FG007|Overall Study|Lost to Follow-up|0|||
130774542|NCT03092791|470800568|FG000|Overall Study|Withdrawal of Consent|0|||
130774543|NCT03092791|470800569|FG001|Overall Study|Withdrawal of Consent|0|||
130952904|NCT03013543|471460919|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
130952905|NCT03013543|471460920|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
130952906|NCT03013543|471460921|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
130952907|NCT03013543|471460922|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
130952908|NCT03013543|471460923|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
130952909|NCT03013543|471460924|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
130952910|NCT03013543|471460925|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
130952911|NCT03013543|471460916|FG000|Overall Study|Other|0|||
130952912|NCT03013543|471460917|FG001|Overall Study|Other|0|||
130952913|NCT03013543|471460918|FG002|Overall Study|Other|2|||
130952914|NCT03013543|471460919|FG003|Overall Study|Other|0|||
130952915|NCT03013543|471460920|FG004|Overall Study|Other|2|||
130952916|NCT03013543|471460921|FG005|Overall Study|Other|0|||
130952917|NCT03013543|471460922|FG006|Overall Study|Other|0|||
130952918|NCT03013543|471460923|FG007|Overall Study|Other|0|||
130952919|NCT03013543|471460924|FG008|Overall Study|Other|1|||
130952920|NCT03013543|471460925|FG009|Overall Study|Other|0|||
130952921|NCT03013543|471460916|FG000|Overall Study|Adverse Event|0|||
130952922|NCT03013543|471460917|FG001|Overall Study|Adverse Event|0|||
130952923|NCT03013543|471460918|FG002|Overall Study|Adverse Event|0|||
130952924|NCT03013543|471460919|FG003|Overall Study|Adverse Event|3|||
130952925|NCT03013543|471460920|FG004|Overall Study|Adverse Event|2|||
130952926|NCT03013543|471460921|FG005|Overall Study|Adverse Event|1|||
130952927|NCT03013543|471460922|FG006|Overall Study|Adverse Event|3|||
130952928|NCT03013543|471460923|FG007|Overall Study|Adverse Event|8|||
130952929|NCT03013543|471460924|FG008|Overall Study|Adverse Event|0|||
130952930|NCT03013543|471460925|FG009|Overall Study|Adverse Event|2|||
130952931|NCT03013543|471460916|FG000|Overall Study|Death|0|||
130952932|NCT03013543|471460917|FG001|Overall Study|Death|0|||
130952933|NCT03013543|471460918|FG002|Overall Study|Death|0|||
130952934|NCT03013543|471460919|FG003|Overall Study|Death|1|||
130952935|NCT03013543|471460920|FG004|Overall Study|Death|0|||
130952936|NCT03013543|471460921|FG005|Overall Study|Death|0|||
130952937|NCT03013543|471460922|FG006|Overall Study|Death|0|||
130952938|NCT03013543|471460923|FG007|Overall Study|Death|0|||
130952939|NCT03013543|471460924|FG008|Overall Study|Death|0|||
130952940|NCT03013543|471460925|FG009|Overall Study|Death|0|||
130952941|NCT03013543|471460916|FG000|Overall Study|Lack of Efficacy|0|||
130952942|NCT03013543|471460917|FG001|Overall Study|Lack of Efficacy|0|||
130952943|NCT03013543|471460918|FG002|Overall Study|Lack of Efficacy|0|||
130952944|NCT03013543|471460919|FG003|Overall Study|Lack of Efficacy|1|||
130952945|NCT03013543|471460920|FG004|Overall Study|Lack of Efficacy|0|||
130952946|NCT03013543|471460921|FG005|Overall Study|Lack of Efficacy|0|||
130952947|NCT03013543|471460922|FG006|Overall Study|Lack of Efficacy|0|||
130952948|NCT03013543|471460923|FG007|Overall Study|Lack of Efficacy|0|||
130952949|NCT03013543|471460924|FG008|Overall Study|Lack of Efficacy|0|||
130952950|NCT03013543|471460925|FG009|Overall Study|Lack of Efficacy|0|||
130952951|NCT03013543|471460916|FG000|Overall Study|Lost to Follow-up|0|||
130952952|NCT03013543|471460917|FG001|Overall Study|Lost to Follow-up|0|||
130952953|NCT03013543|471460918|FG002|Overall Study|Lost to Follow-up|0|||
130952954|NCT03013543|471460919|FG003|Overall Study|Lost to Follow-up|1|||
130952955|NCT03013543|471460920|FG004|Overall Study|Lost to Follow-up|0|||
130952956|NCT03013543|471460921|FG005|Overall Study|Lost to Follow-up|0|||
130952957|NCT03013543|471460922|FG006|Overall Study|Lost to Follow-up|1|||
130952958|NCT03013543|471460923|FG007|Overall Study|Lost to Follow-up|0|||
130952959|NCT03013543|471460924|FG008|Overall Study|Lost to Follow-up|0|||
130952960|NCT03013543|471460925|FG009|Overall Study|Lost to Follow-up|2|||
130952961|NCT03013543|471460916|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130952962|NCT03013543|471460917|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130952963|NCT03013543|471460918|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130952964|NCT03013543|471460919|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130952965|NCT03013543|471460920|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130774544|NCT03092791|470800570|FG002|Overall Study|Withdrawal of Consent|0|||
130774545|NCT03092791|470800571|FG003|Overall Study|Withdrawal of Consent|0|||
130952966|NCT03013543|471460921|FG005|Overall Study|Non-Compliance With Study Drug|0|||
130952967|NCT03013543|471460922|FG006|Overall Study|Non-Compliance With Study Drug|0|||
130952968|NCT03013543|471460923|FG007|Overall Study|Non-Compliance With Study Drug|0|||
130952969|NCT03013543|471460924|FG008|Overall Study|Non-Compliance With Study Drug|1|||
130952970|NCT03013543|471460925|FG009|Overall Study|Non-Compliance With Study Drug|0|||
130952971|NCT03013543|471460916|FG000|Overall Study|Physician Decision|0|||
130952972|NCT03013543|471460917|FG001|Overall Study|Physician Decision|0|||
130952973|NCT03013543|471460918|FG002|Overall Study|Physician Decision|0|||
130952974|NCT03013543|471460919|FG003|Overall Study|Physician Decision|0|||
130952975|NCT03013543|471460920|FG004|Overall Study|Physician Decision|1|||
130952976|NCT03013543|471460921|FG005|Overall Study|Physician Decision|0|||
130952977|NCT03013543|471460922|FG006|Overall Study|Physician Decision|0|||
130952978|NCT03013543|471460923|FG007|Overall Study|Physician Decision|0|||
130952979|NCT03013543|471460924|FG008|Overall Study|Physician Decision|0|||
130952980|NCT03013543|471460925|FG009|Overall Study|Physician Decision|0|||
130952981|NCT03013543|471460916|FG000|Overall Study|Protocol Violation|0|||
130952982|NCT03013543|471460917|FG001|Overall Study|Protocol Violation|0|||
130952983|NCT03013543|471460918|FG002|Overall Study|Protocol Violation|0|||
130952984|NCT03013543|471460919|FG003|Overall Study|Protocol Violation|0|||
130952985|NCT03013543|471460920|FG004|Overall Study|Protocol Violation|0|||
130952986|NCT03013543|471460921|FG005|Overall Study|Protocol Violation|0|||
130952987|NCT03013543|471460922|FG006|Overall Study|Protocol Violation|0|||
130952988|NCT03013543|471460923|FG007|Overall Study|Protocol Violation|0|||
130952989|NCT03013543|471460924|FG008|Overall Study|Protocol Violation|0|||
130952990|NCT03013543|471460925|FG009|Overall Study|Protocol Violation|1|||
130952991|NCT00323414|471460926|FG000|Overall Study|Withdrawal by Subject|0|||
130952992|NCT00323414|471460927|FG001|Overall Study|Withdrawal by Subject|1|||
130952993|NCT01537783|471460936|FG000|Overall Study|Lost to Follow-up|11|||
130952994|NCT01537783|471460937|FG001|Overall Study|Lost to Follow-up|2|||
130952995|NCT02722928|471460940|FG000|Overall Study|Standard CT was not as required per prot|5|||
130952996|NCT02722928|471460941|FG001|Overall Study|Standard CT was not as required per prot|13|||
130952997|NCT02722928|471460940|FG000|Overall Study|Required Intraoperative MRI|5|||
130952998|NCT02722928|471460941|FG001|Overall Study|Required Intraoperative MRI|7|||
130952999|NCT01838642|471460942|FG000|Overall Study|Died on study|1|||
130953000|NCT01398956|471460943|FG000|Overall Study|Withdrawal by Subject|4|||
130953001|NCT01398956|471460943|FG000|Overall Study|AE, non-serious non-fatal|4|||
130953002|NCT01398956|471460943|FG000|Overall Study|Withdrawal Criteria No.3|1|||
130953003|NCT01398956|471460943|FG000|Overall Study|Subject moved a long distance|1|||
130953004|NCT01557400|471460944|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
130953005|NCT01557400|471460944|FG000|Overall Study|Adverse Event|3|||
130953006|NCT01557400|471460944|FG000|Overall Study|Lost to Follow-up|5|||
130953007|NCT01557400|471460944|FG000|Overall Study|Withdrawal by Subject|9|||
130953008|NCT02281552|471460953|FG000|Overall Study|Medication error|1|||
130953009|NCT02281552|471460954|FG001|Overall Study|Medication error|0|||
130953010|NCT02281552|471460953|FG000|Overall Study|Insufficient clinical response|0|||
130953011|NCT02281552|471460954|FG001|Overall Study|Insufficient clinical response|1|||
130953012|NCT02281552|471460953|FG000|Overall Study|Adverse Event|3|||
130953013|NCT02281552|471460954|FG001|Overall Study|Adverse Event|9|||
130953014|NCT01224639|471460955|FG000|Overall Study|Withdrawal by Subject|0|||
130953015|NCT01224639|471460956|FG001|Overall Study|Withdrawal by Subject|0|||
130953016|NCT01224639|471460957|FG002|Overall Study|Withdrawal by Subject|0|||
130953017|NCT01224639|471460958|FG003|Overall Study|Withdrawal by Subject|0|||
130953018|NCT01224639|471460959|FG004|Overall Study|Withdrawal by Subject|2|||
130953019|NCT01224639|471460960|FG005|Overall Study|Withdrawal by Subject|0|||
130953020|NCT01224639|471460961|FG006|Overall Study|Withdrawal by Subject|1|||
130953021|NCT01224639|471460962|FG007|Overall Study|Withdrawal by Subject|1|||
131038960|NCT03854227|471778131|FG005|Overall Study|Death|1|||
131038961|NCT03854227|471778132|FG006|Overall Study|Death|0|||
130953022|NCT01224639|471460955|FG000|Overall Study|Adverse Event|0|||
130953023|NCT01224639|471460956|FG001|Overall Study|Adverse Event|0|||
130953024|NCT01224639|471460957|FG002|Overall Study|Adverse Event|0|||
130711476|NCT00380692|470569849|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
130711477|NCT00380692|470569850|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
130711478|NCT02177136|470569856|FG000|DB Phase|Withdrawal by Subject|2|||
130711479|NCT02177136|470569857|FG001|DB Phase|Withdrawal by Subject|0|||
130711480|NCT02177136|470569858|FG002|DB Phase|Withdrawal by Subject|0|||
130711481|NCT02177136|470569859|FG003|DB Phase|Withdrawal by Subject|0|||
130711482|NCT02177136|470569856|FG000|DB Phase|Discontinued Due to Pruritus|1|||
130953025|NCT01224639|471460958|FG003|Overall Study|Adverse Event|0|||
130953026|NCT01224639|471460959|FG004|Overall Study|Adverse Event|0|||
130953027|NCT01224639|471460960|FG005|Overall Study|Adverse Event|0|||
130953028|NCT01224639|471460961|FG006|Overall Study|Adverse Event|0|||
130953029|NCT01224639|471460962|FG007|Overall Study|Adverse Event|1|||
130953030|NCT03465878|471460963|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
130953031|NCT03465878|471460964|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
130711483|NCT02177136|470569857|FG001|DB Phase|Discontinued Due to Pruritus|3|||
130711484|NCT02177136|470569858|FG002|DB Phase|Discontinued Due to Pruritus|0|||
131038962|NCT03854227|471778133|FG007|Overall Study|Death|0|||
130953032|NCT03465878|471460965|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
130953033|NCT03465878|471460966|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
130953034|NCT03465878|471460963|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
130953035|NCT03465878|471460964|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
130953036|NCT03465878|471460965|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
130953037|NCT03465878|471460966|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
130953038|NCT03465878|471460963|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
130953039|NCT03465878|471460964|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
130953040|NCT03465878|471460965|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
130953041|NCT03465878|471460966|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
130953042|NCT04656132|471460967|FG000|Overall Study|Lost to Follow-up|4|||
130953043|NCT04656132|471460967|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
130953044|NCT00677807|471460968|FG000|Overall Study|Adverse Event|4|||
130953045|NCT00677807|471460969|FG001|Overall Study|Adverse Event|1|||
130953046|NCT00677807|471460970|FG002|Overall Study|Adverse Event|6|||
130953047|NCT00677807|471460968|FG000|Overall Study|Lack of Efficacy|0|||
130953048|NCT00677807|471460969|FG001|Overall Study|Lack of Efficacy|0|||
130953049|NCT00677807|471460970|FG002|Overall Study|Lack of Efficacy|2|||
130953050|NCT00677807|471460968|FG000|Overall Study|Participant no longer needs study drug|0|||
130953051|NCT00677807|471460969|FG001|Overall Study|Participant no longer needs study drug|0|||
130953052|NCT00677807|471460970|FG002|Overall Study|Participant no longer needs study drug|1|||
130953053|NCT00677807|471460968|FG000|Overall Study|Withdrawal by Subject|10|||
130953054|NCT00677807|471460969|FG001|Overall Study|Withdrawal by Subject|3|||
130953055|NCT00677807|471460970|FG002|Overall Study|Withdrawal by Subject|6|||
130953056|NCT00677807|471460968|FG000|Overall Study|Lost to Follow-up|2|||
130953057|NCT00677807|471460969|FG001|Overall Study|Lost to Follow-up|2|||
130953058|NCT00677807|471460970|FG002|Overall Study|Lost to Follow-up|2|||
130953059|NCT00677807|471460968|FG000|Overall Study|Administrative problems|1|||
130953060|NCT00677807|471460969|FG001|Overall Study|Administrative problems|1|||
130953061|NCT00677807|471460970|FG002|Overall Study|Administrative problems|2|||
130953062|NCT00677807|471460968|FG000|Overall Study|Death|0|||
130953063|NCT00677807|471460969|FG001|Overall Study|Death|1|||
130953064|NCT00677807|471460970|FG002|Overall Study|Death|1|||
130953065|NCT00677807|471460968|FG000|Overall Study|Protocol Deviation|1|||
130953066|NCT00677807|471460969|FG001|Overall Study|Protocol Deviation|3|||
130953067|NCT00677807|471460970|FG002|Overall Study|Protocol Deviation|0|||
130953068|NCT01393743|471460971|FG000|Core Study|Adverse Event|5|||
130953069|NCT01393743|471460972|FG001|Core Study|Adverse Event|9|||
130953070|NCT01393743|471460973|FG002|Core Study|Adverse Event|0|||
130953071|NCT01393743|471460971|FG000|Core Study|Lost to Follow-up|1|||
130953072|NCT01393743|471460972|FG001|Core Study|Lost to Follow-up|1|||
130953073|NCT01393743|471460973|FG002|Core Study|Lost to Follow-up|0|||
130953074|NCT01393743|471460971|FG000|Core Study|Participant's Choice|2|||
130953075|NCT01393743|471460972|FG001|Core Study|Participant's Choice|3|||
130953076|NCT01393743|471460973|FG002|Core Study|Participant's Choice|0|||
130953077|NCT01393743|471460971|FG000|Core Study|Inadequate therapeutic effect|2|||
130953078|NCT01393743|471460972|FG001|Core Study|Inadequate therapeutic effect|0|||
130953079|NCT01393743|471460973|FG002|Core Study|Inadequate therapeutic effect|0|||
130953080|NCT01393743|471460971|FG000|Extension Phase|Adverse Event|0|||
130953081|NCT01393743|471460972|FG001|Extension Phase|Adverse Event|0|||
130953082|NCT01393743|471460973|FG002|Extension Phase|Adverse Event|12|||
130953083|NCT01393743|471460971|FG000|Extension Phase|Lost to Follow-up|0|||
130953084|NCT01393743|471460972|FG001|Extension Phase|Lost to Follow-up|0|||
130953085|NCT01393743|471460973|FG002|Extension Phase|Lost to Follow-up|2|||
130711485|NCT02177136|470569859|FG003|DB Phase|Discontinued Due to Pruritus|0|||
130711486|NCT02177136|470569856|FG000|DB Phase|Adverse Event|3|||
130711487|NCT02177136|470569857|FG001|DB Phase|Adverse Event|2|||
130711488|NCT02177136|470569858|FG002|DB Phase|Adverse Event|3|||
130953086|NCT01393743|471460971|FG000|Extension Phase|Participant choice|0|||
130953087|NCT01393743|471460972|FG001|Extension Phase|Participant choice|0|||
130953088|NCT01393743|471460973|FG002|Extension Phase|Participant choice|16|||
130953089|NCT01393743|471460971|FG000|Extension Phase|Inadequate therapeutic effect|0|||
130953090|NCT01393743|471460972|FG001|Extension Phase|Inadequate therapeutic effect|0|||
130953091|NCT01393743|471460973|FG002|Extension Phase|Inadequate therapeutic effect|7|||
130953092|NCT01393743|471460971|FG000|Extension Phase|Withdrawal by Subject|0|||
130953093|NCT01393743|471460972|FG001|Extension Phase|Withdrawal by Subject|0|||
130953094|NCT01393743|471460973|FG002|Extension Phase|Withdrawal by Subject|8|||
130711489|NCT02177136|470569859|FG003|DB Phase|Adverse Event|0|||
130711490|NCT02177136|470569856|FG000|DB Phase|Protocol Violation|0|||
130953095|NCT01393743|471460971|FG000|Extension Phase|Pregnancy|0|||
130953096|NCT01393743|471460972|FG001|Extension Phase|Pregnancy|0|||
130953097|NCT01393743|471460973|FG002|Extension Phase|Pregnancy|1|||
130711491|NCT02177136|470569857|FG001|DB Phase|Protocol Violation|0|||
130953098|NCT01393743|471460971|FG000|Extension Phase|Other|0|||
130953099|NCT01393743|471460972|FG001|Extension Phase|Other|0|||
130953100|NCT01393743|471460973|FG002|Extension Phase|Other|14|||
130953101|NCT00314366|471460974|FG000|Overall Study|not treated due to patient medical condi|1|||
130953102|NCT00314366|471460975|FG001|Overall Study|not treated due to patient medical condi|0|||
130953103|NCT02321462|471460978|FG000|Overall Study|Withdrawal by Subject|5|||
130953104|NCT02321462|471460979|FG001|Overall Study|Withdrawal by Subject|2|||
130953105|NCT02321462|471460978|FG000|Overall Study|Subject withdrawn before any treatment|1|||
130953106|NCT02321462|471460979|FG001|Overall Study|Subject withdrawn before any treatment|1|||
130953107|NCT01574352|471460985|FG000|Overall Study|Withdrawal by Subject|6|||
130953108|NCT01574352|471460986|FG001|Overall Study|Withdrawal by Subject|13|||
130953109|NCT01574352|471460985|FG000|Overall Study|Injury in non-camp related sport|1|||
130953110|NCT01574352|471460986|FG001|Overall Study|Injury in non-camp related sport|0|||
130953111|NCT02283788|471460991|FG000|Overall Study|Adverse Event|1|||
130953112|NCT02283788|471460992|FG001|Overall Study|Adverse Event|3|||
130953113|NCT02283788|471460993|FG002|Overall Study|Adverse Event|5|||
130953114|NCT02283788|471460994|FG003|Overall Study|Adverse Event|1|||
130953115|NCT02283788|471460991|FG000|Overall Study|Withdrawal by Subject|0|||
130953116|NCT02283788|471460992|FG001|Overall Study|Withdrawal by Subject|1|||
130953117|NCT02283788|471460993|FG002|Overall Study|Withdrawal by Subject|0|||
130953118|NCT02283788|471460994|FG003|Overall Study|Withdrawal by Subject|1|||
130953119|NCT01083433|471462794|FG000|Overall Study|Lost to Follow-up|2|||
130953120|NCT01083433|471462795|FG001|Overall Study|Lost to Follow-up|1|||
130953121|NCT01083433|471462796|FG002|Overall Study|Lost to Follow-up|1|||
130953122|NCT01083433|471462794|FG000|Overall Study|Withdrawal by Subject|0|||
130953123|NCT01083433|471462795|FG001|Overall Study|Withdrawal by Subject|5|||
130953124|NCT01083433|471462796|FG002|Overall Study|Withdrawal by Subject|3|||
130953125|NCT01083433|471462794|FG000|Overall Study|Pregnancy|0|||
130953126|NCT01083433|471462795|FG001|Overall Study|Pregnancy|0|||
130953127|NCT01083433|471462796|FG002|Overall Study|Pregnancy|1|||
130953128|NCT04982029|471462797|FG000|Overall Study|Lost to Follow-up|2|||
130953129|NCT04982029|471462798|FG001|Overall Study|Lost to Follow-up|3|||
130953130|NCT05458856|471462799|FG000|Overall Study|Withdrawal by Subject|5|||
130953131|NCT05458856|471462799|FG000|Overall Study|Death|4|||
130953132|NCT05458856|471462799|FG000|Overall Study|Protocol Deviation|3|||
130953133|NCT05458856|471462799|FG000|Overall Study|Physician Decision|1|||
130953134|NCT01589822|471462800|FG000|Overall Study|Withdrawal by Subject|1|||
130953135|NCT01589822|471462801|FG001|Overall Study|Withdrawal by Subject|2|||
130953136|NCT01589822|471462802|FG002|Overall Study|Withdrawal by Subject|0|||
130953137|NCT01589822|471462800|FG000|Overall Study|Death|1|||
130953138|NCT01589822|471462801|FG001|Overall Study|Death|0|||
130953139|NCT01589822|471462802|FG002|Overall Study|Death|0|||
130953140|NCT01589822|471462800|FG000|Overall Study|Missed 90 day visit|2|||
130953141|NCT01589822|471462801|FG001|Overall Study|Missed 90 day visit|1|||
130953142|NCT01589822|471462802|FG002|Overall Study|Missed 90 day visit|1|||
130953143|NCT05168475|471462803|FG000|Period 1|Protocol Violation|1|||
130953144|NCT05168475|471462803|FG000|Period 1|IMP shortage|2|||
130953145|NCT05168475|471462803|FG000|Period 1|Not randomised|2|||
130953146|NCT05168475|471462803|FG000|Period 2|IMP shortage|1|||
130953147|NCT01140477|471462804|FG000|Overall Study|Lost to Follow-up|4|||
130953148|NCT01140477|471462805|FG001|Overall Study|Lost to Follow-up|0|||
130953149|NCT01140477|471462804|FG000|Overall Study|Withdrawal by Subject|1|||
130953150|NCT01140477|471462805|FG001|Overall Study|Withdrawal by Subject|4|||
130953151|NCT01140477|471462804|FG000|Overall Study|Surgical complication preventing implant|2|||
130953152|NCT01140477|471462805|FG001|Overall Study|Surgical complication preventing implant|0|||
130953153|NCT01140477|471462804|FG000|Overall Study|Death|1|||
130953154|NCT01140477|471462805|FG001|Overall Study|Death|1|||
130953155|NCT01140477|471462804|FG000|Overall Study|Subject explanted|0|||
130953156|NCT01140477|471462805|FG001|Overall Study|Subject explanted|1|||
130953157|NCT00773175|471462806|FG000|Overall Study|Adverse Event|2|||
130953158|NCT00773175|471462807|FG001|Overall Study|Adverse Event|0|||
130953159|NCT00773175|471462806|FG000|Overall Study|Consent Withdrawn|0|||
130953160|NCT00773175|471462807|FG001|Overall Study|Consent Withdrawn|2|||
130953161|NCT01904604|471462814|FG000|Overall Study|Withdrew before receiving dosing|0|||
130953162|NCT01904604|471462815|FG001|Overall Study|Withdrew before receiving dosing|1|||
130953163|NCT01904604|471462816|FG002|Overall Study|Withdrew before receiving dosing|0|||
130953164|NCT01904604|471462814|FG000|Overall Study|Non-compliance|1|||
130953165|NCT01904604|471462815|FG001|Overall Study|Non-compliance|0|||
130953166|NCT01904604|471462816|FG002|Overall Study|Non-compliance|0|||
130953167|NCT01904604|471462814|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
130953168|NCT01904604|471462815|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
130953169|NCT01904604|471462816|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
130953170|NCT01904604|471462814|FG000|Overall Study|Patch site reactions|1|||
130953171|NCT01904604|471462815|FG001|Overall Study|Patch site reactions|1|||
130953172|NCT01904604|471462816|FG002|Overall Study|Patch site reactions|0|||
130953173|NCT01904604|471462814|FG000|Overall Study|Increased syncope|0|||
130953174|NCT01904604|471462815|FG001|Overall Study|Increased syncope|1|||
130953175|NCT01904604|471462816|FG002|Overall Study|Increased syncope|0|||
130711492|NCT02177136|470569858|FG002|DB Phase|Protocol Violation|1|||
130711493|NCT02177136|470569859|FG003|DB Phase|Protocol Violation|0|||
130953176|NCT01904604|471462814|FG000|Overall Study|Unrelated illness|0|||
130953177|NCT01904604|471462815|FG001|Overall Study|Unrelated illness|1|||
130953178|NCT01904604|471462816|FG002|Overall Study|Unrelated illness|0|||
130953179|NCT01904604|471462814|FG000|Overall Study|Passed Week 52 OFC|1|||
130953180|NCT01904604|471462815|FG001|Overall Study|Passed Week 52 OFC|0|||
130953181|NCT01904604|471462816|FG002|Overall Study|Passed Week 52 OFC|0|||
130953182|NCT01904604|471462814|FG000|Overall Study|Withdrawal by Subject|1|||
130953183|NCT01904604|471462815|FG001|Overall Study|Withdrawal by Subject|2|||
130953184|NCT01904604|471462816|FG002|Overall Study|Withdrawal by Subject|0|||
130953185|NCT01904604|471462814|FG000|Overall Study|Participant Relocated|1|||
130953186|NCT01904604|471462815|FG001|Overall Study|Participant Relocated|1|||
130953187|NCT01904604|471462816|FG002|Overall Study|Participant Relocated|1|||
130953188|NCT01904604|471462814|FG000|Overall Study|Lost to Follow-up|0|||
130953189|NCT01904604|471462815|FG001|Overall Study|Lost to Follow-up|0|||
130953190|NCT01904604|471462816|FG002|Overall Study|Lost to Follow-up|1|||
130953191|NCT01481116|471462821|FG000|Overall Study|Adverse Event|26|||
130953192|NCT01481116|471462822|FG001|Overall Study|Adverse Event|26|||
131225114|NCT01792284|472451961|FG000|Lead-in Period|Physician Decision|1|||
130953193|NCT01481116|471462823|FG002|Overall Study|Adverse Event|42|||
130953194|NCT01481116|471462821|FG000|Overall Study|Major Protocol Deviation|3|||
130953195|NCT01481116|471462822|FG001|Overall Study|Major Protocol Deviation|7|||
131225115|NCT01792284|472451962|FG001|Lead-in Period|Physician Decision|0|||
130711494|NCT02177136|470569856|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
130711495|NCT02177136|470569857|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
130711496|NCT02177136|470569858|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
130711497|NCT02177136|470569859|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
130711498|NCT02177136|470569856|FG000|LTSE Phase|Withdrawal by Subject|0|||
130711499|NCT02177136|470569857|FG001|LTSE Phase|Withdrawal by Subject|0|||
130711500|NCT02177136|470569858|FG002|LTSE Phase|Withdrawal by Subject|0|||
130711501|NCT02177136|470569859|FG003|LTSE Phase|Withdrawal by Subject|6|||
130711502|NCT02177136|470569856|FG000|LTSE Phase|Adverse Event|0|||
130953196|NCT01481116|471462823|FG002|Overall Study|Major Protocol Deviation|1|||
130953197|NCT01481116|471462821|FG000|Overall Study|Lost to Follow-up|8|||
130953198|NCT01481116|471462822|FG001|Overall Study|Lost to Follow-up|12|||
130953199|NCT01481116|471462823|FG002|Overall Study|Lost to Follow-up|11|||
130953200|NCT01481116|471462821|FG000|Overall Study|Withdrawal by Subject|37|||
130953201|NCT01481116|471462822|FG001|Overall Study|Withdrawal by Subject|33|||
131038963|NCT03854227|471778134|FG008|Overall Study|Death|0|||
131038964|NCT03854227|471778135|FG009|Overall Study|Death|1|||
131038965|NCT03854227|471778136|FG010|Overall Study|Death|0|||
131038966|NCT03854227|471778137|FG011|Overall Study|Death|1|||
131038967|NCT03854227|471778126|FG000|Overall Study|Physician Decision|0|||
131038968|NCT03854227|471778127|FG001|Overall Study|Physician Decision|0|||
131038969|NCT03854227|471778128|FG002|Overall Study|Physician Decision|0|||
131038970|NCT03854227|471778129|FG003|Overall Study|Physician Decision|0|||
131038971|NCT03854227|471778130|FG004|Overall Study|Physician Decision|0|||
131038972|NCT03854227|471778131|FG005|Overall Study|Physician Decision|1|||
131038973|NCT03854227|471778132|FG006|Overall Study|Physician Decision|0|||
131038974|NCT03854227|471778133|FG007|Overall Study|Physician Decision|0|||
131038975|NCT03854227|471778134|FG008|Overall Study|Physician Decision|1|||
131038976|NCT03854227|471778135|FG009|Overall Study|Physician Decision|1|||
131038977|NCT03854227|471778136|FG010|Overall Study|Physician Decision|0|||
131038978|NCT03854227|471778137|FG011|Overall Study|Physician Decision|1|||
131038979|NCT03854227|471778126|FG000|Overall Study|Progressive disease|1|||
131038980|NCT03854227|471778127|FG001|Overall Study|Progressive disease|1|||
131038981|NCT03854227|471778128|FG002|Overall Study|Progressive disease|1|||
131038982|NCT03854227|471778129|FG003|Overall Study|Progressive disease|2|||
131038983|NCT03854227|471778130|FG004|Overall Study|Progressive disease|3|||
131038984|NCT03854227|471778131|FG005|Overall Study|Progressive disease|1|||
131038985|NCT03854227|471778132|FG006|Overall Study|Progressive disease|2|||
131038986|NCT03854227|471778133|FG007|Overall Study|Progressive disease|5|||
131038987|NCT03854227|471778134|FG008|Overall Study|Progressive disease|2|||
131038988|NCT03854227|471778135|FG009|Overall Study|Progressive disease|5|||
131038989|NCT03854227|471778136|FG010|Overall Study|Progressive disease|1|||
131225116|NCT01792284|472451963|FG002|Lead-in Period|Physician Decision|0|||
130711503|NCT02177136|470569857|FG001|LTSE Phase|Adverse Event|0|||
130711504|NCT02177136|470569858|FG002|LTSE Phase|Adverse Event|0|||
130711505|NCT02177136|470569859|FG003|LTSE Phase|Adverse Event|10|||
130953202|NCT01481116|471462823|FG002|Overall Study|Withdrawal by Subject|37|||
131038990|NCT03854227|471778137|FG011|Overall Study|Progressive disease|6|||
131038991|NCT03854227|471778126|FG000|Overall Study|Study terminated by sponsor|0|||
130711506|NCT02177136|470569856|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
131038992|NCT03854227|471778127|FG001|Overall Study|Study terminated by sponsor|0|||
131038993|NCT03854227|471778128|FG002|Overall Study|Study terminated by sponsor|0|||
130711507|NCT02177136|470569857|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
130711508|NCT02177136|470569858|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
130711509|NCT02177136|470569859|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
131038994|NCT03854227|471778129|FG003|Overall Study|Study terminated by sponsor|0|||
130953203|NCT01481116|471462821|FG000|Overall Study|Study Termination|730|||
130953204|NCT01481116|471462822|FG001|Overall Study|Study Termination|729|||
130953205|NCT01481116|471462823|FG002|Overall Study|Study Termination|713|||
130953206|NCT01481116|471462821|FG000|Overall Study|Pregnancy|0|||
130953207|NCT01481116|471462822|FG001|Overall Study|Pregnancy|0|||
130711510|NCT02177136|470569856|FG000|LTSE Phase|Physician Decision|0|||
130711511|NCT02177136|470569857|FG001|LTSE Phase|Physician Decision|0|||
130711512|NCT02177136|470569858|FG002|LTSE Phase|Physician Decision|0|||
130711513|NCT02177136|470569859|FG003|LTSE Phase|Physician Decision|2|||
130953208|NCT01481116|471462823|FG002|Overall Study|Pregnancy|1|||
130953209|NCT01481116|471462821|FG000|Overall Study|Lack of Efficacy|3|||
130953210|NCT01481116|471462822|FG001|Overall Study|Lack of Efficacy|3|||
130953211|NCT01481116|471462823|FG002|Overall Study|Lack of Efficacy|1|||
130953212|NCT01481116|471462821|FG000|Overall Study|Contraindications|1|||
130953213|NCT01481116|471462822|FG001|Overall Study|Contraindications|1|||
130953214|NCT01481116|471462823|FG002|Overall Study|Contraindications|0|||
130953215|NCT01481116|471462821|FG000|Overall Study|Other|1|||
130953216|NCT01481116|471462822|FG001|Overall Study|Other|1|||
130953217|NCT01481116|471462823|FG002|Overall Study|Other|0|||
130953218|NCT01481116|471462821|FG000|Overall Study|Participant Started Taking Glipizide|1|||
130953219|NCT01481116|471462822|FG001|Overall Study|Participant Started Taking Glipizide|0|||
130953220|NCT01481116|471462823|FG002|Overall Study|Participant Started Taking Glipizide|0|||
130953221|NCT01481116|471462821|FG000|Overall Study|Participant Moved Out of Area|2|||
130953222|NCT01481116|471462822|FG001|Overall Study|Participant Moved Out of Area|0|||
130953223|NCT01481116|471462823|FG002|Overall Study|Participant Moved Out of Area|1|||
130953224|NCT01481116|471462821|FG000|Overall Study|Participant Moved Out of Country|1|||
130953225|NCT01481116|471462822|FG001|Overall Study|Participant Moved Out of Country|0|||
130953226|NCT01481116|471462823|FG002|Overall Study|Participant Moved Out of Country|1|||
130953227|NCT01481116|471462821|FG000|Overall Study|Investigator Decision|3|||
130953228|NCT01481116|471462822|FG001|Overall Study|Investigator Decision|2|||
130953229|NCT01481116|471462823|FG002|Overall Study|Investigator Decision|1|||
130953230|NCT01481116|471462821|FG000|Overall Study|Sponsor Decision|0|||
130953231|NCT01481116|471462822|FG001|Overall Study|Sponsor Decision|1|||
130953232|NCT01481116|471462823|FG002|Overall Study|Sponsor Decision|3|||
130953233|NCT01481116|471462821|FG000|Overall Study|Non-Compliant With Study Drug|0|||
130953234|NCT01481116|471462822|FG001|Overall Study|Non-Compliant With Study Drug|1|||
130953235|NCT01481116|471462823|FG002|Overall Study|Non-Compliant With Study Drug|1|||
130953236|NCT01481116|471462821|FG000|Overall Study|Investigator's Discretion|2|||
130953237|NCT01481116|471462822|FG001|Overall Study|Investigator's Discretion|0|||
130953238|NCT01481116|471462823|FG002|Overall Study|Investigator's Discretion|0|||
130953239|NCT01481116|471462821|FG000|Overall Study|Death|2|||
130953240|NCT01481116|471462822|FG001|Overall Study|Death|1|||
130953241|NCT01481116|471462823|FG002|Overall Study|Death|0|||
130953242|NCT01481116|471462821|FG000|Overall Study|Hypoglycemic Event|4|||
130953243|NCT01481116|471462822|FG001|Overall Study|Hypoglycemic Event|0|||
130953244|NCT01481116|471462823|FG002|Overall Study|Hypoglycemic Event|0|||
130953245|NCT02643251|471462824|FG000|Overall Study|Adverse Event|3|||
130953246|NCT02643251|471462825|FG001|Overall Study|Adverse Event|1|||
130953247|NCT02643251|471462824|FG000|Overall Study|Withdrawal by Subject|2|||
130953248|NCT02643251|471462825|FG001|Overall Study|Withdrawal by Subject|0|||
130953249|NCT02643251|471462824|FG000|Overall Study|Lost to Follow-up|4|||
130953250|NCT02643251|471462825|FG001|Overall Study|Lost to Follow-up|1|||
130953251|NCT02643251|471462824|FG000|Overall Study|Protocol Violation|1|||
130953252|NCT02643251|471462825|FG001|Overall Study|Protocol Violation|0|||
130953253|NCT02643251|471462824|FG000|Overall Study|PI Decision to terminate patient|1|||
130953254|NCT02643251|471462825|FG001|Overall Study|PI Decision to terminate patient|0|||
130953255|NCT00348556|471462826|FG000|Overall Study|Adverse Event|1|||
130953256|NCT00333229|471462829|FG000|Overall Study|Lack of Efficacy|0|||
130953257|NCT00333229|471462830|FG001|Overall Study|Lack of Efficacy|1|||
130953258|NCT01944059|471462831|FG000|Overall Study|Lost to Follow-up|1|||
130953259|NCT01944059|471462831|FG000|Overall Study|Physician Decision|3|||
130953260|NCT01944059|471462831|FG000|Overall Study|Withdrawal by Subject|1|||
130711514|NCT02177136|470569856|FG000|LTSE Phase|Lost to Follow-up|0|||
130711515|NCT02177136|470569857|FG001|LTSE Phase|Lost to Follow-up|0|||
130953261|NCT01944059|471462831|FG000|Overall Study|Adverse Event|2|||
130953262|NCT02365636|471462841|FG000|Overall Study|Adverse Event|3|||
130953263|NCT02365636|471462842|FG001|Overall Study|Adverse Event|3|||
130953264|NCT02365636|471462843|FG002|Overall Study|Adverse Event|2|||
130953265|NCT02365636|471462841|FG000|Overall Study|Protocol Violation|1|||
130953266|NCT02365636|471462842|FG001|Overall Study|Protocol Violation|4|||
130953267|NCT02365636|471462843|FG002|Overall Study|Protocol Violation|0|||
130953268|NCT02365636|471462841|FG000|Overall Study|Lost to Follow-up|0|||
130953269|NCT02365636|471462842|FG001|Overall Study|Lost to Follow-up|0|||
130953270|NCT02365636|471462843|FG002|Overall Study|Lost to Follow-up|1|||
130953271|NCT02365636|471462841|FG000|Overall Study|Other|2|||
130953272|NCT02365636|471462842|FG001|Overall Study|Other|0|||
130953273|NCT02365636|471462843|FG002|Overall Study|Other|0|||
130711516|NCT02177136|470569858|FG002|LTSE Phase|Lost to Follow-up|0|||
130711517|NCT02177136|470569859|FG003|LTSE Phase|Lost to Follow-up|1|||
130953274|NCT00463060|471462854|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
130953275|NCT00463060|471462854|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
130953276|NCT01782313|471462855|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
130953277|NCT01782313|471462855|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
130953278|NCT01782313|471462855|FG000|Treated Cycle 3|Progressive Disease|21|||
130953279|NCT01782313|471462855|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
130953280|NCT01782313|471462855|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
130953281|NCT01782313|471462855|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
130953282|NCT01782313|471462855|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
130953283|NCT01782313|471462855|FG000|Survival Follow up|Lost to Follow-up|1|||
130953284|NCT01802775|471462858|FG000|Overall Study|Death|0|||
130953285|NCT01802775|471462859|FG001|Overall Study|Death|3|||
130953286|NCT01802775|471462858|FG000|Overall Study|Reason not provided|0|||
130953287|NCT01802775|471462859|FG001|Overall Study|Reason not provided|1|||
130953288|NCT01802775|471462858|FG000|Overall Study|Physician Decision|1|||
130953289|NCT01802775|471462859|FG001|Overall Study|Physician Decision|0|||
130953290|NCT01802775|471462858|FG000|Overall Study|Adverse Event|1|||
130953291|NCT01802775|471462859|FG001|Overall Study|Adverse Event|1|||
130953292|NCT01802775|471462858|FG000|Overall Study|Withdrawal by Subject|3|||
130953293|NCT01802775|471462859|FG001|Overall Study|Withdrawal by Subject|5|||
130953294|NCT01802775|471462858|FG000|Overall Study|Lost to Follow-up|1|||
130953295|NCT01802775|471462859|FG001|Overall Study|Lost to Follow-up|2|||
130953296|NCT01067352|471462866|FG000|Overall Study|Withdrawal by Subject|1|||
130953297|NCT01067352|471462867|FG001|Overall Study|Withdrawal by Subject|2|||
130953298|NCT01067352|471462868|FG002|Overall Study|Withdrawal by Subject|1|||
130953299|NCT01067352|471462866|FG000|Overall Study|Physician Decision|0|||
130953300|NCT01067352|471462867|FG001|Overall Study|Physician Decision|1|||
130953301|NCT01067352|471462868|FG002|Overall Study|Physician Decision|0|||
130953302|NCT01096784|471462869|FG000|Overall Study|Withdrawal by Subject|2|||
130953303|NCT01096784|471462870|FG001|Overall Study|Withdrawal by Subject|1|||
130953304|NCT01096784|471462869|FG000|Overall Study|Adverse Event|11|||
130953305|NCT01096784|471462870|FG001|Overall Study|Adverse Event|9|||
130953306|NCT01096784|471462869|FG000|Overall Study|Protocol Deviation|2|||
130953307|NCT01096784|471462870|FG001|Overall Study|Protocol Deviation|2|||
130953308|NCT01096784|471462869|FG000|Overall Study|Administrative Decision|0|||
130953309|NCT01096784|471462870|FG001|Overall Study|Administrative Decision|1|||
130953310|NCT01096784|471462869|FG000|Overall Study|Other Unspecified|0|||
130953311|NCT01096784|471462870|FG001|Overall Study|Other Unspecified|1|||
130953312|NCT05923229|471462871|FG000|Overall Study|Withdrawal by Subject|3|||
130953313|NCT05923229|471462872|FG001|Overall Study|Withdrawal by Subject|0|||
130953314|NCT05923229|471462871|FG000|Overall Study|Health related|2|||
130953315|NCT05923229|471462872|FG001|Overall Study|Health related|1|||
130953316|NCT03064126|471462873|FG000|Overall Study|Death|40|||
130953317|NCT03064126|471462874|FG001|Overall Study|Death|16|||
130953318|NCT03064126|471462875|FG002|Overall Study|Death|4|||
130953319|NCT03064126|471462876|FG003|Overall Study|Death|2|||
130953320|NCT03064126|471462873|FG000|Overall Study|Withdrawal by Subject|17|||
130953321|NCT03064126|471462874|FG001|Overall Study|Withdrawal by Subject|9|||
130953322|NCT03064126|471462875|FG002|Overall Study|Withdrawal by Subject|0|||
130953323|NCT03064126|471462876|FG003|Overall Study|Withdrawal by Subject|2|||
130953324|NCT03064126|471462873|FG000|Overall Study|Lost to Follow-up|7|||
130953325|NCT03064126|471462874|FG001|Overall Study|Lost to Follow-up|3|||
130953326|NCT03064126|471462875|FG002|Overall Study|Lost to Follow-up|0|||
130953327|NCT03064126|471462876|FG003|Overall Study|Lost to Follow-up|0|||
130953328|NCT03064126|471462873|FG000|Overall Study|Adverse Event|2|||
130953329|NCT03064126|471462874|FG001|Overall Study|Adverse Event|0|||
130953330|NCT03064126|471462875|FG002|Overall Study|Adverse Event|0|||
130953331|NCT03064126|471462876|FG003|Overall Study|Adverse Event|0|||
130953332|NCT03064126|471462873|FG000|Overall Study|Physician Decision|3|||
130953333|NCT03064126|471462874|FG001|Overall Study|Physician Decision|0|||
130711518|NCT02177136|470569856|FG000|LTSE Phase|Participant Moved|0|||
130711519|NCT02177136|470569857|FG001|LTSE Phase|Participant Moved|0|||
130953334|NCT03064126|471462875|FG002|Overall Study|Physician Decision|0|||
130953335|NCT03064126|471462876|FG003|Overall Study|Physician Decision|0|||
130711520|NCT02177136|470569858|FG002|LTSE Phase|Participant Moved|0|||
130953336|NCT03064126|471462873|FG000|Overall Study|Other reason for early termination|3|||
130953337|NCT03064126|471462874|FG001|Overall Study|Other reason for early termination|2|||
130953338|NCT03064126|471462875|FG002|Overall Study|Other reason for early termination|0|||
130953339|NCT03064126|471462876|FG003|Overall Study|Other reason for early termination|0|||
130953340|NCT03064126|471462873|FG000|Overall Study|Missed Visit|3|||
130953341|NCT03064126|471462874|FG001|Overall Study|Missed Visit|1|||
130953342|NCT03064126|471462875|FG002|Overall Study|Missed Visit|0|||
130711521|NCT02177136|470569859|FG003|LTSE Phase|Participant Moved|1|||
130953343|NCT03064126|471462876|FG003|Overall Study|Missed Visit|0|||
130953344|NCT02465528|471462877|FG000|Overall Study|Progressive disease|0|||
130953345|NCT02465528|471462878|FG001|Overall Study|Progressive disease|2|||
130953346|NCT02465528|471462879|FG002|Overall Study|Progressive disease|9|||
130953347|NCT02465528|471462880|FG003|Overall Study|Progressive disease|4|||
131038995|NCT03854227|471778130|FG004|Overall Study|Study terminated by sponsor|0|||
131038996|NCT03854227|471778131|FG005|Overall Study|Study terminated by sponsor|0|||
131038997|NCT03854227|471778132|FG006|Overall Study|Study terminated by sponsor|0|||
131038998|NCT03854227|471778133|FG007|Overall Study|Study terminated by sponsor|0|||
131038999|NCT03854227|471778134|FG008|Overall Study|Study terminated by sponsor|0|||
131039000|NCT03854227|471778135|FG009|Overall Study|Study terminated by sponsor|1|||
131039001|NCT03854227|471778136|FG010|Overall Study|Study terminated by sponsor|0|||
131039002|NCT03854227|471778137|FG011|Overall Study|Study terminated by sponsor|0|||
131039003|NCT03854227|471778126|FG000|Overall Study|Withdrawal by Subject|0|||
131039004|NCT03854227|471778127|FG001|Overall Study|Withdrawal by Subject|0|||
131039005|NCT03854227|471778128|FG002|Overall Study|Withdrawal by Subject|1|||
131039006|NCT03854227|471778129|FG003|Overall Study|Withdrawal by Subject|0|||
131039007|NCT03854227|471778130|FG004|Overall Study|Withdrawal by Subject|0|||
131039008|NCT03854227|471778131|FG005|Overall Study|Withdrawal by Subject|0|||
131039009|NCT03854227|471778132|FG006|Overall Study|Withdrawal by Subject|0|||
131039010|NCT03854227|471778133|FG007|Overall Study|Withdrawal by Subject|0|||
131039011|NCT03854227|471778134|FG008|Overall Study|Withdrawal by Subject|0|||
131039012|NCT03854227|471778135|FG009|Overall Study|Withdrawal by Subject|1|||
131039013|NCT03854227|471778136|FG010|Overall Study|Withdrawal by Subject|1|||
131039014|NCT03854227|471778137|FG011|Overall Study|Withdrawal by Subject|0|||
131039015|NCT03854227|471778126|FG000|Overall Study|Disease relapse|0|||
131039016|NCT03854227|471778127|FG001|Overall Study|Disease relapse|0|||
131039017|NCT03854227|471778128|FG002|Overall Study|Disease relapse|0|||
131039018|NCT03854227|471778129|FG003|Overall Study|Disease relapse|0|||
131039019|NCT03854227|471778130|FG004|Overall Study|Disease relapse|0|||
131039020|NCT03854227|471778131|FG005|Overall Study|Disease relapse|0|||
131039021|NCT03854227|471778132|FG006|Overall Study|Disease relapse|0|||
131039022|NCT03854227|471778133|FG007|Overall Study|Disease relapse|0|||
131039023|NCT03854227|471778134|FG008|Overall Study|Disease relapse|1|||
131039024|NCT03854227|471778135|FG009|Overall Study|Disease relapse|0|||
131039025|NCT03854227|471778136|FG010|Overall Study|Disease relapse|0|||
131039026|NCT03854227|471778137|FG011|Overall Study|Disease relapse|0|||
131039027|NCT03854227|471778126|FG000|Overall Study|Global deterioration of health status|0|||
131039028|NCT03854227|471778127|FG001|Overall Study|Global deterioration of health status|0|||
131039029|NCT03854227|471778128|FG002|Overall Study|Global deterioration of health status|0|||
131039030|NCT03854227|471778129|FG003|Overall Study|Global deterioration of health status|0|||
131039031|NCT03854227|471778130|FG004|Overall Study|Global deterioration of health status|0|||
131039032|NCT03854227|471778131|FG005|Overall Study|Global deterioration of health status|1|||
131225117|NCT01792284|472451961|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
131225118|NCT01792284|472451962|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
131039033|NCT03854227|471778132|FG006|Overall Study|Global deterioration of health status|0|||
131039034|NCT03854227|471778133|FG007|Overall Study|Global deterioration of health status|1|||
131039035|NCT03854227|471778134|FG008|Overall Study|Global deterioration of health status|0|||
131039036|NCT03854227|471778135|FG009|Overall Study|Global deterioration of health status|0|||
131039037|NCT03854227|471778136|FG010|Overall Study|Global deterioration of health status|0|||
131039038|NCT03854227|471778137|FG011|Overall Study|Global deterioration of health status|0|||
131039039|NCT03854227|471778126|FG000|Overall Study|Refused further treatment|0|||
131039040|NCT03854227|471778127|FG001|Overall Study|Refused further treatment|0|||
131039041|NCT03854227|471778128|FG002|Overall Study|Refused further treatment|0|||
131039042|NCT03854227|471778129|FG003|Overall Study|Refused further treatment|0|||
131039043|NCT03854227|471778130|FG004|Overall Study|Refused further treatment|0|||
131039044|NCT03854227|471778131|FG005|Overall Study|Refused further treatment|0|||
131039045|NCT03854227|471778132|FG006|Overall Study|Refused further treatment|0|||
131039046|NCT03854227|471778133|FG007|Overall Study|Refused further treatment|0|||
131039047|NCT03854227|471778134|FG008|Overall Study|Refused further treatment|0|||
131039048|NCT03854227|471778135|FG009|Overall Study|Refused further treatment|1|||
131039049|NCT03854227|471778136|FG010|Overall Study|Refused further treatment|0|||
131039050|NCT03854227|471778137|FG011|Overall Study|Refused further treatment|1|||
131039051|NCT03854227|471778126|FG000|Overall Study|Other|0|||
131039052|NCT03854227|471778127|FG001|Overall Study|Other|0|||
131039053|NCT03854227|471778128|FG002|Overall Study|Other|0|||
131039054|NCT03854227|471778129|FG003|Overall Study|Other|0|||
131039055|NCT03854227|471778130|FG004|Overall Study|Other|0|||
131039056|NCT03854227|471778131|FG005|Overall Study|Other|0|||
131039057|NCT03854227|471778132|FG006|Overall Study|Other|0|||
131039058|NCT03854227|471778133|FG007|Overall Study|Other|0|||
131039059|NCT03854227|471778134|FG008|Overall Study|Other|1|||
131039060|NCT03854227|471778135|FG009|Overall Study|Other|1|||
130953348|NCT02465528|471462877|FG000|Overall Study|Study terminated by sponsor|1|||
130953349|NCT02465528|471462878|FG001|Overall Study|Study terminated by sponsor|2|||
130953350|NCT02465528|471462879|FG002|Overall Study|Study terminated by sponsor|0|||
130953351|NCT02465528|471462880|FG003|Overall Study|Study terminated by sponsor|0|||
130953352|NCT02465528|471462877|FG000|Overall Study|Withdrawal by Subject|0|||
130953353|NCT02465528|471462878|FG001|Overall Study|Withdrawal by Subject|0|||
130953354|NCT02465528|471462879|FG002|Overall Study|Withdrawal by Subject|2|||
130953355|NCT02465528|471462880|FG003|Overall Study|Withdrawal by Subject|0|||
130953356|NCT02465528|471462877|FG000|Overall Study|Adverse Event|0|||
131225119|NCT01792284|472451963|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
131225120|NCT01792284|472451961|FG000|Randomization Period 1|Withdrawal by Subject|0|||
131225121|NCT01792284|472451962|FG001|Randomization Period 1|Withdrawal by Subject|1|||
131225122|NCT01792284|472451963|FG002|Randomization Period 1|Withdrawal by Subject|1|||
130953357|NCT02465528|471462878|FG001|Overall Study|Adverse Event|0|||
130953358|NCT02465528|471462879|FG002|Overall Study|Adverse Event|0|||
131225123|NCT01792284|472451961|FG000|Randomization Period 1|Physician Decision|0|||
131225124|NCT01792284|472451962|FG001|Randomization Period 1|Physician Decision|1|||
131225125|NCT01792284|472451963|FG002|Randomization Period 1|Physician Decision|1|||
131225126|NCT01792284|472451961|FG000|Randomization Period 1|Adverse Event|0|||
131225127|NCT01792284|472451962|FG001|Randomization Period 1|Adverse Event|0|||
131225128|NCT01792284|472451963|FG002|Randomization Period 1|Adverse Event|2|||
131225129|NCT01792284|472451961|FG000|Randomization Period 1|Lost to Follow-up|0|||
131225130|NCT01792284|472451962|FG001|Randomization Period 1|Lost to Follow-up|0|||
131225131|NCT01792284|472451963|FG002|Randomization Period 1|Lost to Follow-up|1|||
131225132|NCT01792284|472451961|FG000|Randomization Period 2|Protocol Violation|0|||
131225133|NCT01792284|472451962|FG001|Randomization Period 2|Protocol Violation|1|||
131225134|NCT01792284|472451963|FG002|Randomization Period 2|Protocol Violation|0|||
130953359|NCT02465528|471462880|FG003|Overall Study|Adverse Event|1|||
130953360|NCT02465528|471462877|FG000|Overall Study|Physician Decision|0|||
130953361|NCT02465528|471462878|FG001|Overall Study|Physician Decision|0|||
130953362|NCT02465528|471462879|FG002|Overall Study|Physician Decision|1|||
130953363|NCT02465528|471462880|FG003|Overall Study|Physician Decision|0|||
130953364|NCT04476017|471462882|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
130953365|NCT04476017|471462883|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
130953366|NCT02704364|471462884|FG000|Overall Study|Adverse Event|1|||
130953367|NCT02704364|471462885|FG001|Overall Study|Adverse Event|1|||
130953368|NCT02704364|471462886|FG002|Overall Study|Adverse Event|0|||
130953369|NCT02704364|471462884|FG000|Overall Study|Noncompliance with study drug|1|||
130953370|NCT02704364|471462885|FG001|Overall Study|Noncompliance with study drug|1|||
130953371|NCT02704364|471462886|FG002|Overall Study|Noncompliance with study drug|0|||
130953372|NCT02704364|471462884|FG000|Overall Study|Other|0|||
130953373|NCT02704364|471462885|FG001|Overall Study|Other|1|||
130953374|NCT02704364|471462886|FG002|Overall Study|Other|1|||
130953375|NCT02975934|471462887|FG000|Treatment Phase|Never initiated study drug|0|||
130953376|NCT02975934|471462888|FG001|Treatment Phase|Never initiated study drug|5|||
130953377|NCT02975934|471462889|FG002|Treatment Phase|Never initiated study drug|0|||
130953378|NCT03362502|471462890|FG000|Overall Study|Death|0|||
130953379|NCT03362502|471462891|FG001|Overall Study|Death|0|||
130953380|NCT03362502|471462892|FG002|Overall Study|Death|1|||
130953381|NCT02075840|471462893|FG000|Overall Study|Withdrawal by Subject|13|||
130953382|NCT02075840|471462894|FG001|Overall Study|Withdrawal by Subject|22|||
130953383|NCT02075840|471462893|FG000|Overall Study|Reason not specified|1|||
130953384|NCT02075840|471462894|FG001|Overall Study|Reason not specified|0|||
130953385|NCT02075840|471462893|FG000|Overall Study|Adverse Event|0|||
130953386|NCT02075840|471462894|FG001|Overall Study|Adverse Event|2|||
130953387|NCT02075840|471462893|FG000|Overall Study|Death|35|||
130953388|NCT02075840|471462894|FG001|Overall Study|Death|40|||
130953389|NCT02075840|471462893|FG000|Overall Study|Lost to Follow-up|3|||
130953390|NCT02075840|471462894|FG001|Overall Study|Lost to Follow-up|2|||
130953391|NCT02075840|471462893|FG000|Overall Study|Physician Decision|1|||
131039061|NCT03854227|471778136|FG010|Overall Study|Other|0|||
131039062|NCT03854227|471778137|FG011|Overall Study|Other|0|||
131225135|NCT01792284|472451961|FG000|Randomization Period 2|Withdrawal by Subject|0|||
131225136|NCT01792284|472451962|FG001|Randomization Period 2|Withdrawal by Subject|2|||
131225137|NCT01792284|472451963|FG002|Randomization Period 2|Withdrawal by Subject|0|||
131225138|NCT02962882|472451967|FG000|Overall Study|Adverse Event|2|||
131225139|NCT02962882|472451967|FG000|Overall Study|Withdrawal by Subject|2|||
130953392|NCT02075840|471462894|FG001|Overall Study|Physician Decision|3|||
130953393|NCT02075840|471462893|FG000|Overall Study|Ongoing at CCOD|99|||
130953394|NCT02075840|471462894|FG001|Overall Study|Ongoing at CCOD|82|||
131225140|NCT02962882|472451967|FG000|Overall Study|Transfer from ICU|32|||
131225141|NCT01663714|472451968|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
130953395|NCT04889625|471462907|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
130953396|NCT04889625|471462908|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
130953397|NCT04889625|471462907|FG000|Period 1|Subject out of window|0|||
130953398|NCT04889625|471462908|FG001|Period 1|Subject out of window|1|||
131045856|NCT03582033|471802283|FG005|Part D|Death|0|||
130953399|NCT04889625|471462907|FG000|Period 1|Wrong add power dispensed|0|||
130953400|NCT04889625|471462908|FG001|Period 1|Wrong add power dispensed|1|||
130953401|NCT04889625|471462907|FG000|Period 1|Discontinued due to fitting guide error|1|||
130953402|NCT04889625|471462908|FG001|Period 1|Discontinued due to fitting guide error|1|||
130953403|NCT04889625|471462907|FG000|Period 2|Test article no longer available|1|||
130953404|NCT04889625|471462908|FG001|Period 2|Test article no longer available|0|||
130953405|NCT04889625|471462907|FG000|Period 2|Incorrect lens dispensed|1|||
130953406|NCT04889625|471462908|FG001|Period 2|Incorrect lens dispensed|0|||
130953407|NCT04889625|471462907|FG000|Period 2|Wrong add power dispensed|0|||
130953408|NCT04889625|471462908|FG001|Period 2|Wrong add power dispensed|1|||
130953409|NCT02043015|471462914|FG000|Overall Study|Lost to Follow-up|4|||
130953410|NCT02043015|471462914|FG000|Overall Study|Withdrawal by Subject|4|||
130953411|NCT02043015|471462914|FG000|Overall Study|Removed once target enrollment reached|15|||
130953412|NCT02043015|471462914|FG000|Overall Study|Participant moved away from study city|4|||
130953413|NCT02043015|471462914|FG000|Overall Study|Incarceration|1|||
130953414|NCT04049760|471462916|FG000|Overall Study|Withdrawal by Subject|1|||
130953415|NCT01494610|471462942|FG000|Period 1|Withdrawal by Subject|1|||
130953416|NCT01494610|471462943|FG001|Period 1|Withdrawal by Subject|1|||
130953417|NCT01494610|471462942|FG000|Period 3|Adverse Event|1|||
130953418|NCT01494610|471462943|FG001|Period 3|Adverse Event|0|||
130953419|NCT01494610|471462942|FG000|Period 3|Withdrawal by Subject|1|||
130953420|NCT01494610|471462943|FG001|Period 3|Withdrawal by Subject|0|||
130953421|NCT01494610|471462942|FG000|Period 4|Protocol Violation|1|||
130953422|NCT01494610|471462943|FG001|Period 4|Protocol Violation|0|||
130953423|NCT00477672|471462947|FG000|Overall Study|Adverse Event|3|||
130953424|NCT00477672|471462948|FG001|Overall Study|Adverse Event|5|||
130953425|NCT00477672|471462949|FG002|Overall Study|Adverse Event|6|||
130953426|NCT00477672|471462947|FG000|Overall Study|Death|0|||
130953427|NCT00477672|471462948|FG001|Overall Study|Death|1|||
130953428|NCT00477672|471462949|FG002|Overall Study|Death|0|||
130953429|NCT00477672|471462947|FG000|Overall Study|Disease progression|0|||
130953430|NCT00477672|471462948|FG001|Overall Study|Disease progression|1|||
131125014|NCT05885737|472085956|FG000|DB Period|Adverse Event|4|||
131125015|NCT05885737|472085957|FG001|DB Period|Adverse Event|4|||
131125016|NCT05885737|472085956|FG000|DB Period|Lost to Follow-up|0|||
131125017|NCT05885737|472085957|FG001|DB Period|Lost to Follow-up|1|||
131125018|NCT05885737|472085956|FG000|DB Period|Physician Decision|2|||
131125019|NCT05885737|472085957|FG001|DB Period|Physician Decision|0|||
131125020|NCT05885737|472085956|FG000|DB Period|Withdrawal by Subject|12|||
131125021|NCT05885737|472085957|FG001|DB Period|Withdrawal by Subject|6|||
131125022|NCT05885737|472085956|FG000|DB Period|Other: Unspecified|2|||
131125023|NCT05885737|472085957|FG001|DB Period|Other: Unspecified|2|||
131125024|NCT05885737|472085956|FG000|OLE Period|Adverse Event|3|||
131125025|NCT05885737|472085957|FG001|OLE Period|Adverse Event|2|||
131125026|NCT05885737|472085956|FG000|OLE Period|Physician Decision|1|||
131125027|NCT05885737|472085957|FG001|OLE Period|Physician Decision|0|||
131125028|NCT05885737|472085956|FG000|OLE Period|Withdrawal by Subject|5|||
131125029|NCT05885737|472085957|FG001|OLE Period|Withdrawal by Subject|5|||
131125030|NCT05885737|472085956|FG000|OLE Period|Other: Unspecified|2|||
131125031|NCT05885737|472085957|FG001|OLE Period|Other: Unspecified|1|||
131125032|NCT03703882|472087143|FG000|Overall Study|Adverse Event|1|||
131125033|NCT03703882|472087144|FG001|Overall Study|Adverse Event|0|||
131125034|NCT03703882|472087143|FG000|Overall Study|Lost to Follow-up|0|||
131125035|NCT03703882|472087144|FG001|Overall Study|Lost to Follow-up|2|||
131125036|NCT03703882|472087143|FG000|Overall Study|Non-compliance with study drug|0|||
131125037|NCT03703882|472087144|FG001|Overall Study|Non-compliance with study drug|1|||
131125038|NCT03703882|472087143|FG000|Overall Study|Physician Decision|0|||
131125039|NCT03703882|472087144|FG001|Overall Study|Physician Decision|1|||
131125040|NCT03703882|472087143|FG000|Overall Study|Progressive disease|1|||
131125041|NCT03703882|472087144|FG001|Overall Study|Progressive disease|0|||
130953431|NCT00477672|471462949|FG002|Overall Study|Disease progression|0|||
130953432|NCT00477672|471462947|FG000|Overall Study|Physician Decision|1|||
130953433|NCT00477672|471462948|FG001|Overall Study|Physician Decision|0|||
130953434|NCT00477672|471462949|FG002|Overall Study|Physician Decision|0|||
130953435|NCT00477672|471462947|FG000|Overall Study|Protocol noncompliance|0|||
130953436|NCT00477672|471462948|FG001|Overall Study|Protocol noncompliance|2|||
130953437|NCT00477672|471462949|FG002|Overall Study|Protocol noncompliance|0|||
131125042|NCT03703882|472087143|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131125043|NCT03703882|472087144|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131125044|NCT03703882|472087143|FG000|Overall Study|Starting another treatment|0|||
130953438|NCT00477672|471462947|FG000|Overall Study|Consent withdrawn|2|||
130953439|NCT00477672|471462948|FG001|Overall Study|Consent withdrawn|5|||
130953440|NCT00477672|471462949|FG002|Overall Study|Consent withdrawn|10|||
130953441|NCT00477672|471462947|FG000|Overall Study|Discretion of Sponsor|1|||
130953442|NCT00477672|471462948|FG001|Overall Study|Discretion of Sponsor|2|||
130953443|NCT00477672|471462949|FG002|Overall Study|Discretion of Sponsor|0|||
131125045|NCT03703882|472087144|FG001|Overall Study|Starting another treatment|1|||
131125046|NCT03703882|472087143|FG000|Overall Study|noncompliance with study procedures|0|||
131125047|NCT03703882|472087144|FG001|Overall Study|noncompliance with study procedures|1|||
131225142|NCT01663714|472451968|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
130953444|NCT03571516|471462950|FG000|Overall Study|Severe diarrhea|1|||
130953445|NCT03571516|471462951|FG001|Overall Study|Severe diarrhea|0|||
130953446|NCT03571516|471462950|FG000|Overall Study|Withdrawal by Subject|0|||
130953447|NCT03571516|471462951|FG001|Overall Study|Withdrawal by Subject|1|||
130953448|NCT04019041|471462955|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
130953449|NCT04019041|471462956|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
130953450|NCT04019041|471462957|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
130953451|NCT04019041|471462958|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130953452|NCT04019041|471462959|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130953453|NCT04019041|471462960|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130953454|NCT04019041|471462955|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
130953455|NCT04019041|471462956|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
130953456|NCT04019041|471462957|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
130953457|NCT04019041|471462958|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
130953458|NCT04019041|471462959|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
130953459|NCT04019041|471462960|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
130953460|NCT04019041|471462955|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
130953461|NCT04019041|471462956|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
130953462|NCT04019041|471462957|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
130953463|NCT04019041|471462958|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130953464|NCT04019041|471462959|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130953465|NCT04019041|471462960|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130953466|NCT04019041|471462955|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
130953467|NCT04019041|471462956|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
130953468|NCT04019041|471462957|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
130953469|NCT04019041|471462958|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
130953470|NCT04019041|471462959|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
130953471|NCT04019041|471462960|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
130953472|NCT04019041|471462955|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130953473|NCT04019041|471462956|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130953474|NCT04019041|471462957|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
131045857|NCT03582033|471802284|FG006|Part D|Death|0|||
131225143|NCT01663714|472451968|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
131045858|NCT03582033|471802285|FG007|Part D|Death|0|||
131045859|NCT03582033|471802286|FG008|Part D|Death|0|||
131045860|NCT03582033|471802287|FG009|Part D|Death|1|||
131045861|NCT03582033|471802278|FG000|Part D|Study terminated by sponsor|0|||
131045862|NCT03582033|471802279|FG001|Part D|Study terminated by sponsor|0|||
131045863|NCT03582033|471802280|FG002|Part D|Study terminated by sponsor|0|||
131045864|NCT03582033|471802281|FG003|Part D|Study terminated by sponsor|0|||
131045865|NCT03582033|471802282|FG004|Part D|Study terminated by sponsor|0|||
131045866|NCT03582033|471802283|FG005|Part D|Study terminated by sponsor|0|||
131045867|NCT03582033|471802284|FG006|Part D|Study terminated by sponsor|0|||
131045868|NCT03582033|471802285|FG007|Part D|Study terminated by sponsor|0|||
131045869|NCT03582033|471802286|FG008|Part D|Study terminated by sponsor|0|||
131045870|NCT03582033|471802287|FG009|Part D|Study terminated by sponsor|4|||
131045871|NCT04631016|471802290|FG000|Overall Study|Adverse Event|3|||
131045872|NCT04631016|471802291|FG001|Overall Study|Adverse Event|0|||
131045873|NCT04631016|471802290|FG000|Overall Study|Withdrawal by Subject|5|||
131045874|NCT04631016|471802291|FG001|Overall Study|Withdrawal by Subject|4|||
131045875|NCT04631016|471802290|FG000|Overall Study|Reason unspecified|1|||
131045876|NCT04631016|471802291|FG001|Overall Study|Reason unspecified|0|||
131045877|NCT04631016|471802290|FG000|Overall Study|Failure to meet randomization criteria|2|||
131045878|NCT04631016|471802291|FG001|Overall Study|Failure to meet randomization criteria|1|||
131045879|NCT03812614|471802292|FG000|Intervention|Withdrawal by Subject|7|||
131045880|NCT03812614|471802293|FG001|Intervention|Withdrawal by Subject|2|||
131045881|NCT03812614|471802294|FG002|Intervention|Withdrawal by Subject|7|||
131045882|NCT03812614|471802295|FG003|Intervention|Withdrawal by Subject|2|||
131045883|NCT03812614|471802292|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
131045884|NCT03812614|471802293|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
131045885|NCT03812614|471802294|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
131045886|NCT03812614|471802295|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
131045887|NCT03812614|471802292|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
131045888|NCT03812614|471802293|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
131045900|NCT05205161|471802297|FG001|Overall Study|Study terminated by sponsor|3|||
130953475|NCT04019041|471462958|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
130953476|NCT04019041|471462959|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
130953477|NCT04019041|471462960|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
130953478|NCT04019041|471462955|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130953479|NCT04019041|471462956|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130953480|NCT04019041|471462957|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130953481|NCT04019041|471462958|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
130953482|NCT04019041|471462959|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130953483|NCT04019041|471462960|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130953484|NCT04019041|471462955|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
131125048|NCT01617460|472087145|FG000|Overall Study|Adverse Event|10|||
131125049|NCT01617460|472087145|FG000|Overall Study|Physician Decision|16|||
131125050|NCT01617460|472087145|FG000|Overall Study|Protocol Violation|5|||
131125051|NCT01617460|472087145|FG000|Overall Study|Withdrawal by Subject|9|||
131125052|NCT00075023|472087152|FG000|Pilot Study|Physician Decision|1|||
131125053|NCT00075023|472087153|FG001|Pilot Study|Physician Decision|2|||
131125054|NCT00075023|472087152|FG000|Pilot Study|Withdrawal by Subject|1|||
131125055|NCT00075023|472087153|FG001|Pilot Study|Withdrawal by Subject|0|||
131125056|NCT04342871|472087154|FG000|Overall Study|Death|4|||
131125057|NCT04342871|472087154|FG000|Overall Study|Clinical deterioration/illness progression|2|||
131125058|NCT04342871|472087154|FG000|Overall Study|Did not complete baseline assessments|5|||
131125059|NCT04342871|472087154|FG000|Overall Study|Lost to Follow-up|13|||
131125060|NCT03670953|472087155|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
131125061|NCT03670953|472087156|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
131125062|NCT03670953|472087157|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
131125063|NCT03670953|472087158|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
131125064|NCT03670953|472087155|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
131125065|NCT03670953|472087156|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
131125066|NCT03670953|472087157|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
131125067|NCT03670953|472087158|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
131125068|NCT03670953|472087155|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
131125069|NCT03670953|472087156|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
131125070|NCT03670953|472087157|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
131125071|NCT03670953|472087158|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
131125072|NCT03670953|472087155|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
131125073|NCT03670953|472087156|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
131125074|NCT03670953|472087157|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
131125075|NCT03670953|472087158|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
131125076|NCT03670953|472087155|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
131125077|NCT03670953|472087156|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
131125078|NCT03670953|472087157|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
131125079|NCT03670953|472087158|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
131125080|NCT03670953|472087155|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
131125081|NCT03670953|472087156|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
131125082|NCT03670953|472087157|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
131125083|NCT03670953|472087158|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
131125084|NCT03670953|472087155|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
131125085|NCT03670953|472087156|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
131125086|NCT03670953|472087157|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
131125087|NCT03670953|472087158|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
131125088|NCT03670953|472087155|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
131125089|NCT03670953|472087156|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
131125090|NCT03670953|472087157|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
131125091|NCT03670953|472087158|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
131125092|NCT03670953|472087155|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
131125093|NCT03670953|472087156|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
131125094|NCT03670953|472087157|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
131125095|NCT03670953|472087158|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
131125096|NCT03670953|472087155|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
131125097|NCT03670953|472087156|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
131125098|NCT03670953|472087157|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
130774546|NCT03092791|470800572|FG004|Overall Study|Withdrawal of Consent|4|||
130953485|NCT04019041|471462956|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
130953486|NCT04019041|471462957|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
130953487|NCT04019041|471462958|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
130953488|NCT04019041|471462959|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
130953489|NCT04019041|471462960|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
131125099|NCT03670953|472087158|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
131125100|NCT03670953|472087155|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
131125101|NCT03670953|472087156|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
131225144|NCT01663714|472451968|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
131225145|NCT01663714|472451968|FG000|Long-Term Follow-Up|Death|4|||
131225146|NCT01663714|472451968|FG000|Long-Term Follow-Up|Non-compliance|1|||
131225147|NCT00597584|472451969|FG000|Overall Study|Adverse Event|4|||
131225148|NCT00597584|472451970|FG001|Overall Study|Adverse Event|2|||
131225149|NCT00597584|472451969|FG000|Overall Study|Death|53|||
131225150|NCT00597584|472451970|FG001|Overall Study|Death|30|||
131225151|NCT00597584|472451969|FG000|Overall Study|Lack of Efficacy|1|||
131225152|NCT00597584|472451970|FG001|Overall Study|Lack of Efficacy|0|||
131225153|NCT00597584|472451969|FG000|Overall Study|Lost to Follow-up|2|||
131225154|NCT00597584|472451970|FG001|Overall Study|Lost to Follow-up|4|||
131225155|NCT00597584|472451969|FG000|Overall Study|Physician Decision|3|||
131225156|NCT00597584|472451970|FG001|Overall Study|Physician Decision|0|||
131225157|NCT00597584|472451969|FG000|Overall Study|Pregnancy|2|||
131225158|NCT00597584|472451970|FG001|Overall Study|Pregnancy|0|||
131225159|NCT00597584|472451969|FG000|Overall Study|Withdrawal by Subject|44|||
130953490|NCT04019041|471462955|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
131225160|NCT00597584|472451970|FG001|Overall Study|Withdrawal by Subject|12|||
131225161|NCT00597584|472451969|FG000|Overall Study|Discontinued Dialysis|0|||
131225162|NCT00597584|472451970|FG001|Overall Study|Discontinued Dialysis|1|||
131225163|NCT00597584|472451969|FG000|Overall Study|Lost ability to consent|1|||
131225164|NCT00597584|472451970|FG001|Overall Study|Lost ability to consent|1|||
131225165|NCT00597584|472451969|FG000|Overall Study|Never dosed|1|||
130953491|NCT04019041|471462956|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130953492|NCT04019041|471462957|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130953493|NCT04019041|471462958|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
130953494|NCT04019041|471462959|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
130953495|NCT04019041|471462960|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
130953496|NCT04019041|471462955|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130953497|NCT04019041|471462956|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130953498|NCT04019041|471462957|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130953499|NCT04019041|471462958|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130953500|NCT04019041|471462959|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
130953501|NCT04019041|471462960|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
130953502|NCT03925727|471462961|FG000|Overall Study|Adverse Event|4|||
130953503|NCT03925727|471462962|FG001|Overall Study|Adverse Event|0|||
130953504|NCT03925727|471462963|FG002|Overall Study|Adverse Event|3|||
130953505|NCT03925727|471462961|FG000|Overall Study|Protocol Violation|1|||
130953506|NCT03925727|471462962|FG001|Overall Study|Protocol Violation|2|||
130953507|NCT03925727|471462963|FG002|Overall Study|Protocol Violation|2|||
130953508|NCT03925727|471462961|FG000|Overall Study|Withdrawal by Subject|3|||
130953509|NCT03925727|471462962|FG001|Overall Study|Withdrawal by Subject|2|||
130953510|NCT03925727|471462963|FG002|Overall Study|Withdrawal by Subject|4|||
130953511|NCT03925727|471462961|FG000|Overall Study|Administrative Reasons|3|||
130953512|NCT03925727|471462962|FG001|Overall Study|Administrative Reasons|1|||
130953513|NCT03925727|471462963|FG002|Overall Study|Administrative Reasons|2|||
130953514|NCT03925727|471462961|FG000|Overall Study|Randomized in error or Disqualified|8|||
130953515|NCT03925727|471462962|FG001|Overall Study|Randomized in error or Disqualified|1|||
131225166|NCT00597584|472451970|FG001|Overall Study|Never dosed|0|||
131225167|NCT00597584|472451969|FG000|Overall Study|Relocation|8|||
131225168|NCT00597584|472451970|FG001|Overall Study|Relocation|6|||
130953516|NCT03925727|471462963|FG002|Overall Study|Randomized in error or Disqualified|7|||
131039063|NCT04376502|471778143|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
131039064|NCT03748953|471778144|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
131039065|NCT03748953|471778145|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
131039066|NCT03748953|471778144|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
131039067|NCT03748953|471778145|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
131039068|NCT03748953|471778144|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
131039069|NCT03748953|471778145|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
131039070|NCT03748953|471778144|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
131039071|NCT03748953|471778145|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
131039072|NCT03748953|471778144|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
131039073|NCT03748953|471778145|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
131039074|NCT02841579|471778146|FG000|Overall Study|Death|1|||
131039075|NCT02841579|471778146|FG000|Overall Study|Adverse Event|1|||
131039076|NCT02841579|471778146|FG000|Overall Study|Lack of Efficacy|9|||
131039077|NCT01501955|471778147|FG000|Overall Study|Withdrawal by Subject|1|||
131039078|NCT01501955|471778148|FG001|Overall Study|Withdrawal by Subject|0|||
131039079|NCT01501955|471778147|FG000|Overall Study|Adverse Event|1|||
131225169|NCT00597584|472451969|FG000|Overall Study|Renal transplant|9|||
131039080|NCT01501955|471778148|FG001|Overall Study|Adverse Event|3|||
131039081|NCT04314713|471778151|FG000|Overall Study|Lost to Follow-up|0|||
131225170|NCT00597584|472451970|FG001|Overall Study|Renal transplant|7|||
131225171|NCT00515073|472451971|FG000|Overall Study|Withdrawal by Subject|1|||
131225172|NCT00515073|472451971|FG000|Overall Study|Physician Decision|1|||
131125102|NCT03670953|472087157|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
131125103|NCT03670953|472087158|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
131125104|NCT03670953|472087155|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
131125105|NCT03670953|472087156|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
131125106|NCT03670953|472087157|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
131125107|NCT03670953|472087158|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
131125108|NCT03670953|472087155|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
130711522|NCT02054130|470569863|FG000|Overall Study|Withdrawal by Subject|4|||
130711523|NCT02054130|470569864|FG001|Overall Study|Withdrawal by Subject|4|||
130711524|NCT02054130|470569865|FG002|Overall Study|Withdrawal by Subject|7|||
130711525|NCT02054130|470569866|FG003|Overall Study|Withdrawal by Subject|10|||
130711526|NCT02054130|470569863|FG000|Overall Study|Death|0|||
130711527|NCT02054130|470569864|FG001|Overall Study|Death|1|||
130711528|NCT02054130|470569865|FG002|Overall Study|Death|0|||
130711529|NCT02054130|470569866|FG003|Overall Study|Death|0|||
130711530|NCT02054130|470569863|FG000|Overall Study|Lost to Follow-up|0|||
130711531|NCT02054130|470569864|FG001|Overall Study|Lost to Follow-up|0|||
130711532|NCT02054130|470569865|FG002|Overall Study|Lost to Follow-up|1|||
130711533|NCT02054130|470569866|FG003|Overall Study|Lost to Follow-up|2|||
130711534|NCT02054130|470569863|FG000|Overall Study|Missed dose|4|||
130711535|NCT02054130|470569864|FG001|Overall Study|Missed dose|6|||
130711536|NCT02054130|470569865|FG002|Overall Study|Missed dose|7|||
130711537|NCT02054130|470569866|FG003|Overall Study|Missed dose|10|||
130711538|NCT01386684|470569867|FG000|Overall Study|Lost to Follow-up|51|||
130711539|NCT01386684|470569867|FG000|Overall Study|Other|51|||
130711540|NCT01386684|470569867|FG000|Overall Study|Death|47|||
130711541|NCT01386684|470569867|FG000|Overall Study|Withdrawal of Consent|44|||
130711542|NCT01386684|470569867|FG000|Overall Study|Alternative Therapy Required|37|||
130711543|NCT01386684|470569867|FG000|Overall Study|Disease Progression|28|||
130711544|NCT01386684|470569867|FG000|Overall Study|Adverse Event|20|||
130711545|NCT01386684|470569867|FG000|Overall Study|Noncompliance|8|||
130711546|NCT01386684|470569867|FG000|Overall Study|Protocol Violation|4|||
130711547|NCT01386684|470569867|FG000|Overall Study|Missing|3|||
130711548|NCT00094458|470569868|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
130711549|NCT00094458|470569869|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
130711550|NCT00094458|470569870|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
130711551|NCT00094458|470569871|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
130711552|NCT00094458|470569872|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
130711553|NCT00094458|470569873|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
130711554|NCT00094458|470569868|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
130711555|NCT00094458|470569869|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
130711556|NCT00094458|470569870|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
130711557|NCT00094458|470569871|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
130953517|NCT03044197|471462972|FG000|Overall Study|Withdrawal by Subject|3|||
130953518|NCT03044197|471462973|FG001|Overall Study|Withdrawal by Subject|1|||
130953519|NCT01282424|471462977|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
130953520|NCT01282424|471462977|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
130953521|NCT01282424|471462977|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
131125109|NCT03670953|472087156|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
131125110|NCT03670953|472087157|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
131125111|NCT03670953|472087158|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
131125112|NCT03670953|472087155|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
131125113|NCT03670953|472087156|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
131125114|NCT03670953|472087157|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
131125115|NCT03670953|472087158|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
131125116|NCT03670953|472087155|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
131125117|NCT03670953|472087156|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
131125118|NCT03670953|472087157|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
131125119|NCT03670953|472087158|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
131125120|NCT03670953|472087155|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
131125121|NCT03670953|472087156|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
131125122|NCT03670953|472087157|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
131125123|NCT03670953|472087158|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
131225173|NCT00660790|472451972|FG000|Baseline to 3 Months|Death|1|||
130953522|NCT01282424|471462977|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
130953523|NCT01282424|471462977|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
130711558|NCT00094458|470569872|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
130711559|NCT00094458|470569873|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
130711560|NCT00094458|470569868|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
130711561|NCT00094458|470569869|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
130711562|NCT00094458|470569870|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
130711563|NCT00094458|470569871|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
130953524|NCT01282424|471462977|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
130953525|NCT01282424|471462977|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
130953526|NCT01282424|471462977|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
130953527|NCT05308901|471465103|FG000|Overall Study|Death|6|||
130953528|NCT00640510|471465104|FG000|Overall Study|Lack of Efficacy|0|||
130953529|NCT00640510|471465105|FG001|Overall Study|Lack of Efficacy|1|||
130953530|NCT00640510|471465104|FG000|Overall Study|Protocol Violation|1|||
130953531|NCT00640510|471465105|FG001|Overall Study|Protocol Violation|0|||
130953532|NCT00640510|471465104|FG000|Overall Study|Physician Decision|0|||
130953533|NCT00640510|471465105|FG001|Overall Study|Physician Decision|1|||
130953534|NCT00192075|471465106|FG000|Overall Study|Disease Progression|23|||
130953535|NCT00192075|471465107|FG001|Overall Study|Disease Progression|6|||
130953536|NCT00192075|471465106|FG000|Overall Study|Adverse Event|1|||
130953537|NCT00192075|471465107|FG001|Overall Study|Adverse Event|3|||
130953538|NCT00192075|471465106|FG000|Overall Study|Death|0|||
130953539|NCT00192075|471465107|FG001|Overall Study|Death|1|||
130953540|NCT00192075|471465106|FG000|Overall Study|Lack of Efficacy|0|||
130953541|NCT00192075|471465107|FG001|Overall Study|Lack of Efficacy|0|||
130953542|NCT00192075|471465106|FG000|Overall Study|Physician Decision|3|||
130953543|NCT00192075|471465107|FG001|Overall Study|Physician Decision|0|||
130953544|NCT00192075|471465106|FG000|Overall Study|Withdrawal by Subject|5|||
130953545|NCT00192075|471465107|FG001|Overall Study|Withdrawal by Subject|5|||
130953546|NCT00192075|471465106|FG000|Overall Study|Patient Non-Compliance|0|||
130953547|NCT00192075|471465107|FG001|Overall Study|Patient Non-Compliance|1|||
130953548|NCT00192075|471465106|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
130953549|NCT00192075|471465107|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
130953550|NCT00192075|471465106|FG000|Overall Study|Other|5|||
130953551|NCT00192075|471465107|FG001|Overall Study|Other|2|||
130953552|NCT00355238|471465109|FG000|Overall Study|Adverse event unrelated to study drug|2|||
130953553|NCT00355238|471465110|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130953554|NCT00355238|471465111|FG002|Overall Study|Adverse event unrelated to study drug|0|||
130953555|NCT00355238|471465112|FG003|Overall Study|Adverse event unrelated to study drug|1|||
130953556|NCT00355238|471465109|FG000|Overall Study|Death|1|||
130953557|NCT00355238|471465110|FG001|Overall Study|Death|0|||
130953558|NCT00355238|471465111|FG002|Overall Study|Death|0|||
130953559|NCT00355238|471465112|FG003|Overall Study|Death|0|||
130953560|NCT00355238|471465109|FG000|Overall Study|Disease progression|37|||
130953561|NCT00355238|471465110|FG001|Overall Study|Disease progression|36|||
130953562|NCT00355238|471465111|FG002|Overall Study|Disease progression|16|||
130953563|NCT00355238|471465112|FG003|Overall Study|Disease progression|11|||
130953564|NCT00355238|471465109|FG000|Overall Study|Study drug toxicity|11|||
130953565|NCT00355238|471465110|FG001|Overall Study|Study drug toxicity|7|||
130953566|NCT00355238|471465111|FG002|Overall Study|Study drug toxicity|5|||
130953567|NCT00355238|471465112|FG003|Overall Study|Study drug toxicity|2|||
130953568|NCT00355238|471465109|FG000|Overall Study|Participant withdrew consent|3|||
130953569|NCT00355238|471465110|FG001|Overall Study|Participant withdrew consent|1|||
130953570|NCT00355238|471465111|FG002|Overall Study|Participant withdrew consent|0|||
130953571|NCT00355238|471465112|FG003|Overall Study|Participant withdrew consent|0|||
130953572|NCT00355238|471465109|FG000|Overall Study|Participant request to discontinue study treatment|1|||
130953573|NCT00355238|471465110|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130953574|NCT00355238|471465111|FG002|Overall Study|Participant request to discontinue study treatment|1|||
130953575|NCT00355238|471465112|FG003|Overall Study|Participant request to discontinue study treatment|0|||
130953576|NCT01956110|471465113|FG000|Overall Study|Protocol Violation|25|||
130953577|NCT01956110|471465114|FG001|Overall Study|Protocol Violation|11|||
130953578|NCT01956110|471465113|FG000|Overall Study|Adverse Event|9|||
130953579|NCT01956110|471465114|FG001|Overall Study|Adverse Event|10|||
130953580|NCT01956110|471465113|FG000|Overall Study|Personal reasons|1|||
130953581|NCT01956110|471465114|FG001|Overall Study|Personal reasons|1|||
130953582|NCT03325166|471465119|FG000|Overall Study|Adverse Event|1|||
130953583|NCT01400841|471465123|FG000|Initial Study Phase (6 Months)|Death|1|||
130953584|NCT01400841|471465123|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
130953585|NCT00910715|471465126|FG000|Overall Study|Lost to Follow-up|22|||
130953586|NCT00910715|471465127|FG001|Overall Study|Lost to Follow-up|26|||
130953587|NCT00910715|471465128|FG002|Overall Study|Lost to Follow-up|0|||
130953588|NCT00770120|471465129|FG000|Overall Study|Progression|31|||
130953589|NCT00770120|471465129|FG000|Overall Study|Adverse Event|11|||
130953590|NCT00770120|471465129|FG000|Overall Study|Not Protocol Specified|11|||
131039082|NCT04314713|471778152|FG001|Overall Study|Lost to Follow-up|0|||
131039083|NCT04314713|471778153|FG002|Overall Study|Lost to Follow-up|0|||
131039084|NCT04314713|471778154|FG003|Overall Study|Lost to Follow-up|1|||
131039085|NCT04314713|471778155|FG004|Overall Study|Lost to Follow-up|0|||
131039086|NCT04314713|471778156|FG005|Overall Study|Lost to Follow-up|0|||
131039087|NCT00248287|471778158|FG000|Overall Study|Adverse Event|11|||
130953591|NCT00770120|471465129|FG000|Overall Study|Death|3|||
131039088|NCT00248287|471778159|FG001|Overall Study|Adverse Event|10|||
131039089|NCT00248287|471778158|FG000|Overall Study|Death|1|||
131039090|NCT00248287|471778159|FG001|Overall Study|Death|0|||
131039091|NCT00248287|471778158|FG000|Overall Study|Lost to Follow-up|0|||
130711564|NCT00094458|470569872|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
130711565|NCT00094458|470569873|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
130711566|NCT00094458|470569868|FG000|Main Study: Through Week 30|Adverse Event|38|||
130711567|NCT00094458|470569869|FG001|Main Study: Through Week 30|Adverse Event|20|||
130711568|NCT00094458|470569870|FG002|Main Study: Through Week 30|Adverse Event|28|||
130711569|NCT00094458|470569871|FG003|Main Study: Through Week 30|Adverse Event|0|||
130711570|NCT00094458|470569872|FG004|Main Study: Through Week 30|Adverse Event|0|||
130711571|NCT00094458|470569873|FG005|Main Study: Through Week 30|Adverse Event|0|||
130711572|NCT00094458|470569868|FG000|Main Study: Through Week 30|Death|1|||
130711573|NCT00094458|470569869|FG001|Main Study: Through Week 30|Death|0|||
130711574|NCT00094458|470569870|FG002|Main Study: Through Week 30|Death|0|||
130711575|NCT00094458|470569871|FG003|Main Study: Through Week 30|Death|0|||
130711576|NCT00094458|470569872|FG004|Main Study: Through Week 30|Death|0|||
130711577|NCT00094458|470569873|FG005|Main Study: Through Week 30|Death|0|||
130711578|NCT00094458|470569868|FG000|Main Study: Through Week 30|Other|19|||
130711579|NCT00094458|470569869|FG001|Main Study: Through Week 30|Other|16|||
130711580|NCT00094458|470569870|FG002|Main Study: Through Week 30|Other|9|||
130711581|NCT00094458|470569871|FG003|Main Study: Through Week 30|Other|0|||
130711582|NCT00094458|470569872|FG004|Main Study: Through Week 30|Other|0|||
130711583|NCT00094458|470569873|FG005|Main Study: Through Week 30|Other|0|||
130711584|NCT00094458|470569868|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
130711585|NCT00094458|470569869|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
130711586|NCT00094458|470569870|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
130711587|NCT00094458|470569871|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
130711588|NCT00094458|470569872|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
130711589|NCT00094458|470569873|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
131225174|NCT00660790|472451972|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
131225175|NCT00660790|472451972|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
131225176|NCT02791659|472451973|FG000|Overall Study|Protocol Violation|0|||
131225177|NCT02791659|472451974|FG001|Overall Study|Protocol Violation|1|||
130711590|NCT00094458|470569868|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
130711591|NCT00094458|470569869|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130711592|NCT00094458|470569870|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
130774547|NCT03092791|470800573|FG005|Overall Study|Withdrawal of Consent|12|||
130774548|NCT03092791|470800574|FG006|Overall Study|Withdrawal of Consent|6|||
130774549|NCT03092791|470800575|FG007|Overall Study|Withdrawal of Consent|4|||
130774550|NCT03092791|470800568|FG000|Overall Study|Study Termination|0|||
130774551|NCT03092791|470800569|FG001|Overall Study|Study Termination|0|||
130774552|NCT03092791|470800570|FG002|Overall Study|Study Termination|0|||
130774553|NCT03092791|470800571|FG003|Overall Study|Study Termination|0|||
130774554|NCT03092791|470800572|FG004|Overall Study|Study Termination|55|||
130774555|NCT03092791|470800573|FG005|Overall Study|Study Termination|46|||
130774556|NCT03092791|470800574|FG006|Overall Study|Study Termination|53|||
130774557|NCT03092791|470800575|FG007|Overall Study|Study Termination|55|||
130774558|NCT03092791|470800568|FG000|Overall Study|Death|0|||
130774559|NCT03092791|470800569|FG001|Overall Study|Death|0|||
130774560|NCT03092791|470800570|FG002|Overall Study|Death|0|||
130953592|NCT00770120|471465129|FG000|Overall Study|Withdrawal by Subject|2|||
130953593|NCT00770120|471465129|FG000|Overall Study|Ineligible|1|||
130953594|NCT00770120|471465129|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
130953595|NCT00770120|471465129|FG000|Overall Study|Reason under Review|1|||
130953596|NCT03761628|471465130|FG000|Overall Study|Withdrawal by Subject|3|||
130953597|NCT03761628|471465130|FG000|Overall Study|Physician Decision|1|||
131125124|NCT03670953|472087155|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
131125125|NCT03670953|472087156|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
131125126|NCT03670953|472087157|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
131125127|NCT03670953|472087158|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
131125128|NCT03670953|472087155|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
131125129|NCT03670953|472087156|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
131125130|NCT03670953|472087157|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
131125131|NCT03670953|472087158|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
131125132|NCT04179734|472087159|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
131125133|NCT04179734|472087160|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
131125134|NCT04179734|472087159|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
131225178|NCT01456052|472451975|FG000|Overall Study|Adverse Event|1|||
131225179|NCT01456052|472451976|FG001|Overall Study|Adverse Event|1|||
130711593|NCT00094458|470569871|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130774561|NCT03092791|470800571|FG003|Overall Study|Death|0|||
130774562|NCT03092791|470800572|FG004|Overall Study|Death|0|||
130953598|NCT03761628|471465130|FG000|Overall Study|Pregnancy|1|||
130953599|NCT03761628|471465130|FG000|Overall Study|Lost to Follow-up|1|||
131225180|NCT01456052|472451977|FG002|Overall Study|Adverse Event|2|||
130774563|NCT03092791|470800573|FG005|Overall Study|Death|1|||
130774564|NCT03092791|470800574|FG006|Overall Study|Death|0|||
131039092|NCT00248287|471778159|FG001|Overall Study|Lost to Follow-up|1|||
131039093|NCT00248287|471778158|FG000|Overall Study|Investigator Request|4|||
131039094|NCT00248287|471778159|FG001|Overall Study|Investigator Request|3|||
131039095|NCT00248287|471778158|FG000|Overall Study|Patient Request|5|||
131039096|NCT00248287|471778159|FG001|Overall Study|Patient Request|3|||
131039097|NCT00248287|471778158|FG000|Overall Study|Other|3|||
131039098|NCT00248287|471778159|FG001|Overall Study|Other|2|||
131039099|NCT02714257|471778160|FG000|Overall Study|Withdrawal by Subject|6|||
131039100|NCT02714257|471778161|FG001|Overall Study|Withdrawal by Subject|11|||
131039101|NCT02714257|471778160|FG000|Overall Study|Death|3|||
131039102|NCT02714257|471778161|FG001|Overall Study|Death|4|||
131039103|NCT02714257|471778160|FG000|Overall Study|Lost to Follow-up|1|||
131039104|NCT02714257|471778161|FG001|Overall Study|Lost to Follow-up|6|||
131039105|NCT00104676|471778162|FG000|Overall Study|Death|3|||
131039106|NCT00104676|471778163|FG001|Overall Study|Death|2|||
131039107|NCT00104676|471778162|FG000|Overall Study|Withdrawal by Subject|0|||
131039108|NCT00104676|471778163|FG001|Overall Study|Withdrawal by Subject|2|||
131225181|NCT01456052|472451975|FG000|Overall Study|Consent withdrawn|0|||
131225182|NCT01456052|472451976|FG001|Overall Study|Consent withdrawn|2|||
131225183|NCT01456052|472451977|FG002|Overall Study|Consent withdrawn|1|||
131225184|NCT01456052|472451975|FG000|Overall Study|Protocol Violation|0|||
131225185|NCT01456052|472451976|FG001|Overall Study|Protocol Violation|1|||
131225186|NCT01456052|472451977|FG002|Overall Study|Protocol Violation|0|||
131225187|NCT01456052|472451975|FG000|Overall Study|Physician Decision|1|||
131225188|NCT01456052|472451976|FG001|Overall Study|Physician Decision|0|||
131225189|NCT01456052|472451977|FG002|Overall Study|Physician Decision|1|||
131225190|NCT01456052|472451975|FG000|Overall Study|Treatment Failure|0|||
131225191|NCT01456052|472451976|FG001|Overall Study|Treatment Failure|1|||
131225192|NCT01456052|472451977|FG002|Overall Study|Treatment Failure|1|||
131225193|NCT01904383|472451980|FG000|Overall Study|CRF not collected|117|||
131225194|NCT01904383|472451980|FG000|Overall Study|Reason not listed|147|||
131225195|NCT01904383|472451980|FG000|Overall Study|Lost to Follow-up|674|||
131225196|NCT01904383|472451980|FG000|Overall Study|Lack of Efficacy|370|||
131225197|NCT01904383|472451980|FG000|Overall Study|Improvement|141|||
131225198|NCT01904383|472451980|FG000|Overall Study|Adverse Event|271|||
131225199|NCT01904383|472451980|FG000|Overall Study|No patient visit after entry|54|||
131225200|NCT01294592|472451981|FG000|Overall Study|Adverse Event|28|||
131225201|NCT01294592|472451982|FG001|Overall Study|Adverse Event|13|||
131225202|NCT01294592|472451981|FG000|Overall Study|Lack of Efficacy|7|||
131225203|NCT01294592|472451982|FG001|Overall Study|Lack of Efficacy|5|||
130953600|NCT05358821|471465133|FG000|Overall Study|Withdrawal by Subject|0|||
130953601|NCT05358821|471465134|FG001|Overall Study|Withdrawal by Subject|1|||
130953602|NCT05358821|471465135|FG002|Overall Study|Withdrawal by Subject|0|||
130953603|NCT05358821|471465133|FG000|Overall Study|Withdrawal of Consent|0|||
130953604|NCT05358821|471465134|FG001|Overall Study|Withdrawal of Consent|0|||
130953605|NCT05358821|471465135|FG002|Overall Study|Withdrawal of Consent|1|||
130953606|NCT03752619|471465136|FG000|Overall Study|Lost to Follow-up|2|||
130953607|NCT03752619|471465137|FG001|Overall Study|Lost to Follow-up|1|||
130953608|NCT03752619|471465136|FG000|Overall Study|Withdrawal by Subject|1|||
130953609|NCT03752619|471465137|FG001|Overall Study|Withdrawal by Subject|1|||
130953610|NCT03752619|471465136|FG000|Overall Study|Adverse Event|0|||
130953611|NCT03752619|471465137|FG001|Overall Study|Adverse Event|1|||
130953612|NCT03907683|471465138|FG000|Overall Study|Pregnancy|1|||
130953613|NCT03907683|471465138|FG000|Overall Study|Withdrawal by Subject|1|||
130953614|NCT03400332|471465139|FG000|Pre-Treatment|Other reasons|0|||
130953615|NCT03400332|471465140|FG001|Pre-Treatment|Other reasons|0|||
130953616|NCT03400332|471465141|FG002|Pre-Treatment|Other reasons|0|||
130953617|NCT03400332|471465142|FG003|Pre-Treatment|Other reasons|0|||
130953618|NCT03400332|471465143|FG004|Pre-Treatment|Other reasons|0|||
130953619|NCT03400332|471465144|FG005|Pre-Treatment|Other reasons|0|||
130953620|NCT03400332|471465145|FG006|Pre-Treatment|Other reasons|0|||
130953621|NCT03400332|471465146|FG007|Pre-Treatment|Other reasons|0|||
130953622|NCT03400332|471465147|FG008|Pre-Treatment|Other reasons|1|||
130953623|NCT03400332|471465139|FG000|Pre-Treatment|No longer met study criteria|0|||
131039109|NCT00104676|471778162|FG000|Overall Study|treatment interruption|4|||
130953624|NCT03400332|471465140|FG001|Pre-Treatment|No longer met study criteria|0|||
131039110|NCT00104676|471778163|FG001|Overall Study|treatment interruption|10|||
131039111|NCT05670587|471778164|FG000|Overall Study|Withdrawal by Subject|3|||
131039112|NCT05940194|471778165|FG000|Overall Study|Adverse Event|0|||
131039113|NCT05940194|471778166|FG001|Overall Study|Adverse Event|1|||
131039114|NCT05940194|471778167|FG002|Overall Study|Adverse Event|0|||
131039115|NCT05940194|471778165|FG000|Overall Study|Migrated/Moved from the study area|2|||
131225204|NCT01294592|472451981|FG000|Overall Study|Protocol Violation|1|||
131225205|NCT01294592|472451982|FG001|Overall Study|Protocol Violation|7|||
131225206|NCT01294592|472451981|FG000|Overall Study|Lost to Follow-up|7|||
131225207|NCT01294592|472451982|FG001|Overall Study|Lost to Follow-up|9|||
131225208|NCT01294592|472451981|FG000|Overall Study|Physician Decision|6|||
131225209|NCT01294592|472451982|FG001|Overall Study|Physician Decision|11|||
131225210|NCT01294592|472451981|FG000|Overall Study|Withdrawal by Subject|28|||
131225211|NCT01294592|472451982|FG001|Overall Study|Withdrawal by Subject|28|||
131225212|NCT02762565|472451983|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
131225213|NCT01113710|472451984|FG000|Overall Study|Adverse Event|64|||
131225214|NCT01113710|472451984|FG000|Overall Study|Lack of Efficacy|41|||
131225215|NCT01113710|472451984|FG000|Overall Study|No Information Available|40|||
131225216|NCT01113710|472451984|FG000|Overall Study|Withdrawal by Subject|28|||
131225217|NCT01113710|472451984|FG000|Overall Study|Lost to Follow-up|20|||
131225218|NCT01113710|472451984|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
131225219|NCT01113710|472451984|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
131225220|NCT01113710|472451984|FG000|Overall Study|Lack of Patient's Compliance|8|||
131225221|NCT01113710|472451984|FG000|Overall Study|Other|7|||
131225222|NCT01113710|472451984|FG000|Overall Study|Adverse Event/Other|5|||
131225223|NCT01113710|472451984|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
131225224|NCT01113710|472451984|FG000|Overall Study|Lack of Efficacy/Other|4|||
131225225|NCT01113710|472451984|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
131225226|NCT01113710|472451984|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
131225227|NCT01113710|472451984|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
131225228|NCT01113710|472451984|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
131225229|NCT01113710|472451984|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
131225230|NCT01113710|472451984|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
131225231|NCT01113710|472451984|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
131225232|NCT01113710|472451984|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
131225233|NCT01113710|472451984|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
131225234|NCT01113710|472451984|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
131225235|NCT01113710|472451984|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
131225236|NCT01113710|472451984|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
131225237|NCT01113710|472451984|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
131225238|NCT01078623|472451985|FG000|Treatment Period 1|Adverse Event|1|||
131225239|NCT01078623|472451986|FG001|Treatment Period 1|Adverse Event|1|||
131225240|NCT01078623|472451987|FG002|Treatment Period 1|Adverse Event|1|||
130774565|NCT03092791|470800575|FG007|Overall Study|Death|1|||
130774566|NCT03092791|470800568|FG000|Overall Study|Reason Not Specified|0|||
130774567|NCT03092791|470800569|FG001|Overall Study|Reason Not Specified|0|||
130953625|NCT03400332|471465141|FG002|Pre-Treatment|No longer met study criteria|0|||
130953626|NCT03400332|471465142|FG003|Pre-Treatment|No longer met study criteria|0|||
130953627|NCT03400332|471465143|FG004|Pre-Treatment|No longer met study criteria|0|||
130953628|NCT03400332|471465144|FG005|Pre-Treatment|No longer met study criteria|0|||
130953629|NCT03400332|471465145|FG006|Pre-Treatment|No longer met study criteria|0|||
130953630|NCT03400332|471465146|FG007|Pre-Treatment|No longer met study criteria|0|||
130953631|NCT03400332|471465147|FG008|Pre-Treatment|No longer met study criteria|1|||
130953632|NCT03400332|471465139|FG000|Pre-Treatment|Withdrawal by Subject|0|||
130953633|NCT03400332|471465140|FG001|Pre-Treatment|Withdrawal by Subject|0|||
130953634|NCT03400332|471465141|FG002|Pre-Treatment|Withdrawal by Subject|0|||
130953635|NCT03400332|471465142|FG003|Pre-Treatment|Withdrawal by Subject|0|||
130953636|NCT03400332|471465143|FG004|Pre-Treatment|Withdrawal by Subject|0|||
130953637|NCT03400332|471465144|FG005|Pre-Treatment|Withdrawal by Subject|0|||
130953638|NCT03400332|471465145|FG006|Pre-Treatment|Withdrawal by Subject|0|||
130953639|NCT03400332|471465146|FG007|Pre-Treatment|Withdrawal by Subject|0|||
130953640|NCT03400332|471465147|FG008|Pre-Treatment|Withdrawal by Subject|1|||
130953641|NCT03400332|471465139|FG000|Treatment|Participant withdrew consent|2|||
130953642|NCT03400332|471465140|FG001|Treatment|Participant withdrew consent|2|||
130953643|NCT03400332|471465141|FG002|Treatment|Participant withdrew consent|0|||
130953644|NCT03400332|471465142|FG003|Treatment|Participant withdrew consent|0|||
130953645|NCT03400332|471465143|FG004|Treatment|Participant withdrew consent|3|||
130953646|NCT03400332|471465144|FG005|Treatment|Participant withdrew consent|3|||
131039116|NCT05940194|471778166|FG001|Overall Study|Migrated/Moved from the study area|2|||
131039117|NCT05940194|471778167|FG002|Overall Study|Migrated/Moved from the study area|4|||
131039118|NCT04054193|471778180|FG000|Cycle 1|Physician Decision|1|||
131039119|NCT04054193|471778180|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
131039120|NCT04054193|471778180|FG000|Cycle 1|Allocated but not treated|3|||
131039121|NCT04054193|471778180|FG000|Cycles 2-3|Physician Decision|2|||
131039122|NCT04054193|471778180|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
131039123|NCT04054193|471778180|FG000|Cycles 2-3|Various reasons|17|||
131039124|NCT02966873|471778181|FG000|Overall Study|Lost to Follow-up|16|||
131039125|NCT02966873|471778182|FG001|Overall Study|Lost to Follow-up|15|||
131039126|NCT03084536|471778183|FG000|Overall Study|Determined to be ineligible|0|||
131039127|NCT03084536|471778184|FG001|Overall Study|Determined to be ineligible|0|||
131225241|NCT01078623|472451988|FG003|Treatment Period 1|Adverse Event|0|||
131225242|NCT01078623|472451989|FG004|Treatment Period 1|Adverse Event|0|||
130953647|NCT03400332|471465145|FG006|Treatment|Participant withdrew consent|1|||
130953648|NCT03400332|471465146|FG007|Treatment|Participant withdrew consent|1|||
130953649|NCT03400332|471465147|FG008|Treatment|Participant withdrew consent|1|||
131039128|NCT03084536|471778185|FG002|Overall Study|Determined to be ineligible|16|||
131039129|NCT03084536|471778183|FG000|Overall Study|Withdrawal by Subject|0|||
131225243|NCT01078623|472451990|FG005|Treatment Period 1|Adverse Event|0|||
131125135|NCT04179734|472087160|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
131125136|NCT00666458|472087162|FG000|Overall Study|Adverse Event|8|||
131125137|NCT00666458|472087163|FG001|Overall Study|Adverse Event|7|||
131125138|NCT00666458|472087162|FG000|Overall Study|Withdrawal by Subject|5|||
131125139|NCT00666458|472087163|FG001|Overall Study|Withdrawal by Subject|4|||
131125140|NCT00666458|472087162|FG000|Overall Study|Lost to Follow-up|0|||
131125141|NCT00666458|472087163|FG001|Overall Study|Lost to Follow-up|3|||
131125142|NCT00666458|472087162|FG000|Overall Study|Administrative reason by sponsor|1|||
131125143|NCT00666458|472087163|FG001|Overall Study|Administrative reason by sponsor|1|||
131125144|NCT00666458|472087162|FG000|Overall Study|Incorrect enrollment|7|||
131125145|NCT00666458|472087163|FG001|Overall Study|Incorrect enrollment|1|||
131125146|NCT00666458|472087162|FG000|Overall Study|Study specific discontinuation criteria|14|||
131125147|NCT00666458|472087163|FG001|Overall Study|Study specific discontinuation criteria|7|||
131125148|NCT00666458|472087162|FG000|Overall Study|Severe non-compliance to the protocol|1|||
131125149|NCT00666458|472087163|FG001|Overall Study|Severe non-compliance to the protocol|1|||
131125150|NCT00666458|472087162|FG000|Overall Study|Safety reasons|1|||
131125151|NCT00666458|472087163|FG001|Overall Study|Safety reasons|0|||
131125152|NCT00666458|472087162|FG000|Overall Study|Medical history of anemia|1|||
131125153|NCT00666458|472087163|FG001|Overall Study|Medical history of anemia|0|||
131125154|NCT02222207|472087165|FG000|Overall Study|Death|1|||
131125155|NCT02222207|472087165|FG000|Overall Study|Other reasons|2|||
131125156|NCT02222207|472087165|FG000|Overall Study|Adverse Event|1|||
131125157|NCT02982954|472087166|FG000|Overall Study|Death|55|||
131125158|NCT02982954|472087167|FG001|Overall Study|Death|29|||
131125159|NCT02982954|472087168|FG002|Overall Study|Death|15|||
131125160|NCT02982954|472087169|FG003|Overall Study|Death|20|||
130953650|NCT03400332|471465139|FG000|Treatment|Other reasons|0|||
130953651|NCT03400332|471465140|FG001|Treatment|Other reasons|1|||
130953652|NCT03400332|471465141|FG002|Treatment|Other reasons|1|||
130953653|NCT03400332|471465142|FG003|Treatment|Other reasons|0|||
130953654|NCT03400332|471465143|FG004|Treatment|Other reasons|3|||
130953655|NCT03400332|471465144|FG005|Treatment|Other reasons|1|||
130953656|NCT03400332|471465145|FG006|Treatment|Other reasons|2|||
130953657|NCT03400332|471465146|FG007|Treatment|Other reasons|0|||
130953658|NCT03400332|471465147|FG008|Treatment|Other reasons|1|||
130953659|NCT03400332|471465139|FG000|Treatment|Lost to Follow-up|0|||
130953660|NCT03400332|471465140|FG001|Treatment|Lost to Follow-up|1|||
130953661|NCT03400332|471465141|FG002|Treatment|Lost to Follow-up|0|||
130953662|NCT03400332|471465142|FG003|Treatment|Lost to Follow-up|0|||
130953663|NCT03400332|471465143|FG004|Treatment|Lost to Follow-up|0|||
130953664|NCT03400332|471465144|FG005|Treatment|Lost to Follow-up|0|||
130953665|NCT03400332|471465145|FG006|Treatment|Lost to Follow-up|0|||
130953666|NCT03400332|471465146|FG007|Treatment|Lost to Follow-up|0|||
130953667|NCT03400332|471465147|FG008|Treatment|Lost to Follow-up|0|||
130953668|NCT03400332|471465139|FG000|Treatment|Death|3|||
130953669|NCT03400332|471465140|FG001|Treatment|Death|1|||
130953670|NCT03400332|471465141|FG002|Treatment|Death|2|||
130953671|NCT03400332|471465142|FG003|Treatment|Death|3|||
130953672|NCT03400332|471465143|FG004|Treatment|Death|6|||
130953673|NCT03400332|471465144|FG005|Treatment|Death|2|||
130953674|NCT03400332|471465145|FG006|Treatment|Death|1|||
130953675|NCT03400332|471465146|FG007|Treatment|Death|3|||
130953676|NCT03400332|471465147|FG008|Treatment|Death|6|||
130953689|NCT02018458|471465150|FG000|Overall Study|Death|4|||
130953690|NCT02027844|471465174|FG000|Overall Study|Withdrawal by Subject|3|||
130953691|NCT02027844|471465175|FG001|Overall Study|Withdrawal by Subject|2|||
130953692|NCT02027844|471465176|FG002|Overall Study|Withdrawal by Subject|1|||
131125161|NCT02982954|472087166|FG000|Overall Study|Lost to Follow-up|2|||
131125162|NCT02982954|472087167|FG001|Overall Study|Lost to Follow-up|1|||
131125163|NCT02982954|472087168|FG002|Overall Study|Lost to Follow-up|0|||
131125164|NCT02982954|472087169|FG003|Overall Study|Lost to Follow-up|0|||
131125165|NCT02982954|472087166|FG000|Overall Study|Participant withdrew consent|7|||
130953693|NCT02027844|471465174|FG000|Overall Study|Lost to Follow-up|0|||
130953694|NCT02027844|471465175|FG001|Overall Study|Lost to Follow-up|2|||
130953695|NCT02027844|471465176|FG002|Overall Study|Lost to Follow-up|1|||
130953696|NCT02027844|471465174|FG000|Overall Study|Protocol Violation|0|||
130953697|NCT02027844|471465175|FG001|Overall Study|Protocol Violation|2|||
130953698|NCT02027844|471465176|FG002|Overall Study|Protocol Violation|0|||
131125166|NCT02982954|472087167|FG001|Overall Study|Participant withdrew consent|5|||
130953699|NCT02027844|471465174|FG000|Overall Study|Incomlete data|2|||
130953700|NCT02027844|471465175|FG001|Overall Study|Incomlete data|0|||
130953701|NCT02027844|471465176|FG002|Overall Study|Incomlete data|0|||
130953702|NCT00354172|471465177|FG000|Overall Study|Did not receive transplant|1|||
130953703|NCT01639040|471465178|FG000|Overall Study|Adverse Event|1|||
130953704|NCT01639040|471465179|FG001|Overall Study|Adverse Event|0|||
130953737|NCT02552316|471465191|FG000|Overall Study|Withdrawal by Subject|1|||
130953738|NCT02552316|471465191|FG000|Overall Study|Withdrawal due to non-compliance|1|||
130953739|NCT02659020|471465192|FG000|Overall Study|Adverse Event|0|||
130953740|NCT02659020|471465193|FG001|Overall Study|Adverse Event|0|||
130953741|NCT02659020|471465194|FG002|Overall Study|Adverse Event|0|||
130953742|NCT02659020|471465195|FG003|Overall Study|Adverse Event|2|||
130953743|NCT02659020|471465196|FG004|Overall Study|Adverse Event|0|||
130953744|NCT02659020|471465197|FG005|Overall Study|Adverse Event|0|||
130953745|NCT02659020|471465198|FG006|Overall Study|Adverse Event|2|||
130953746|NCT02659020|471465192|FG000|Overall Study|Lost to Follow-up|1|||
130953747|NCT02659020|471465193|FG001|Overall Study|Lost to Follow-up|2|||
130953748|NCT02659020|471465194|FG002|Overall Study|Lost to Follow-up|1|||
130953749|NCT02659020|471465195|FG003|Overall Study|Lost to Follow-up|6|||
130953750|NCT02659020|471465196|FG004|Overall Study|Lost to Follow-up|1|||
130953751|NCT02659020|471465197|FG005|Overall Study|Lost to Follow-up|5|||
130953752|NCT02659020|471465198|FG006|Overall Study|Lost to Follow-up|0|||
130953753|NCT02659020|471465192|FG000|Overall Study|Physician Decision|0|||
130953754|NCT02659020|471465193|FG001|Overall Study|Physician Decision|0|||
130953755|NCT02659020|471465194|FG002|Overall Study|Physician Decision|0|||
130953756|NCT02659020|471465195|FG003|Overall Study|Physician Decision|1|||
130953757|NCT02659020|471465196|FG004|Overall Study|Physician Decision|1|||
130953758|NCT02659020|471465197|FG005|Overall Study|Physician Decision|0|||
130953759|NCT02659020|471465198|FG006|Overall Study|Physician Decision|1|||
130953760|NCT02659020|471465192|FG000|Overall Study|Withdrawal by Subject|2|||
130953761|NCT02659020|471465193|FG001|Overall Study|Withdrawal by Subject|1|||
130953762|NCT02659020|471465194|FG002|Overall Study|Withdrawal by Subject|0|||
130953763|NCT02659020|471465195|FG003|Overall Study|Withdrawal by Subject|3|||
130953764|NCT02659020|471465196|FG004|Overall Study|Withdrawal by Subject|3|||
130953765|NCT02659020|471465197|FG005|Overall Study|Withdrawal by Subject|6|||
130953766|NCT02659020|471465198|FG006|Overall Study|Withdrawal by Subject|3|||
130953767|NCT02659020|471465192|FG000|Overall Study|Progressive Disease|0|||
130953768|NCT02659020|471465193|FG001|Overall Study|Progressive Disease|0|||
130953769|NCT02659020|471465194|FG002|Overall Study|Progressive Disease|0|||
130953770|NCT02659020|471465195|FG003|Overall Study|Progressive Disease|4|||
130953771|NCT02659020|471465196|FG004|Overall Study|Progressive Disease|1|||
130953772|NCT02659020|471465197|FG005|Overall Study|Progressive Disease|0|||
130953773|NCT02659020|471465198|FG006|Overall Study|Progressive Disease|2|||
130953774|NCT04382911|471465199|FG000|Overall Study|unable to be imaged prior to surgery|2|||
130953775|NCT01585766|471465200|FG000|Overall Study|Withdrawal by Subject|0|||
130953776|NCT01585766|471465201|FG001|Overall Study|Withdrawal by Subject|1|||
130953777|NCT01585766|471465202|FG002|Overall Study|Withdrawal by Subject|1|||
130953778|NCT01585766|471465203|FG003|Overall Study|Withdrawal by Subject|0|||
131225244|NCT01078623|472451991|FG006|Treatment Period 1|Adverse Event|1|||
131225245|NCT01078623|472451992|FG007|Treatment Period 1|Adverse Event|0|||
131225246|NCT01078623|472451993|FG008|Treatment Period 1|Adverse Event|1|||
131225247|NCT01078623|472451994|FG009|Treatment Period 1|Adverse Event|1|||
131225248|NCT01078623|472451995|FG010|Treatment Period 1|Adverse Event|0|||
131225249|NCT01078623|472451996|FG011|Treatment Period 1|Adverse Event|0|||
131225250|NCT01078623|472451997|FG012|Treatment Period 1|Adverse Event|0|||
131225251|NCT01078623|472451998|FG013|Treatment Period 1|Adverse Event|0|||
131225252|NCT01078623|472451999|FG014|Treatment Period 1|Adverse Event|0|||
131225253|NCT01078623|472452000|FG015|Treatment Period 1|Adverse Event|0|||
131225254|NCT01078623|472452001|FG016|Treatment Period 1|Adverse Event|0|||
131225255|NCT01078623|472452002|FG017|Treatment Period 1|Adverse Event|0|||
131225256|NCT01078623|472452003|FG018|Treatment Period 1|Adverse Event|0|||
131225257|NCT01078623|472452004|FG019|Treatment Period 1|Adverse Event|0|||
131225258|NCT01078623|472451985|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131225259|NCT01078623|472451986|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131225260|NCT01078623|472451987|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131225261|NCT01078623|472451988|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131225262|NCT01078623|472451989|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131225263|NCT01078623|472451990|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131225264|NCT01078623|472451991|FG006|Treatment Period 1|Withdrawal by Subject|0|||
131225265|NCT01078623|472451992|FG007|Treatment Period 1|Withdrawal by Subject|1|||
131225266|NCT01078623|472451993|FG008|Treatment Period 1|Withdrawal by Subject|0|||
131225267|NCT01078623|472451994|FG009|Treatment Period 1|Withdrawal by Subject|0|||
131225268|NCT01078623|472451995|FG010|Treatment Period 1|Withdrawal by Subject|1|||
131225269|NCT01078623|472451996|FG011|Treatment Period 1|Withdrawal by Subject|0|||
131225270|NCT01078623|472451997|FG012|Treatment Period 1|Withdrawal by Subject|0|||
130953779|NCT01585766|471465204|FG004|Overall Study|Withdrawal by Subject|0|||
130953780|NCT01585766|471465205|FG005|Overall Study|Withdrawal by Subject|0|||
130953781|NCT01585766|471465200|FG000|Overall Study|Death|0|||
130953782|NCT01585766|471465201|FG001|Overall Study|Death|1|||
130953783|NCT01585766|471465202|FG002|Overall Study|Death|0|||
130953784|NCT01585766|471465203|FG003|Overall Study|Death|0|||
130953785|NCT01585766|471465204|FG004|Overall Study|Death|0|||
130953786|NCT01585766|471465205|FG005|Overall Study|Death|0|||
130953787|NCT01585766|471465200|FG000|Overall Study|Physician Decision|0|||
130953788|NCT01585766|471465201|FG001|Overall Study|Physician Decision|0|||
130953789|NCT01585766|471465202|FG002|Overall Study|Physician Decision|1|||
130953790|NCT01585766|471465203|FG003|Overall Study|Physician Decision|0|||
130953791|NCT01585766|471465204|FG004|Overall Study|Physician Decision|0|||
130953792|NCT01585766|471465205|FG005|Overall Study|Physician Decision|0|||
130953793|NCT01120210|471465206|FG000|MAIN INFUSION|Adverse Event|1|||
130953794|NCT01120210|471465207|FG001|MAIN INFUSION|Adverse Event|0|||
130953795|NCT01120210|471465206|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
130953796|NCT01120210|471465207|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
130953797|NCT02052739|471465208|FG000|Overall Study|Withdrew due to Adverse Event|3|||
130953798|NCT02052739|471465209|FG001|Overall Study|Withdrew due to Adverse Event|0|||
130953799|NCT02052739|471465208|FG000|Overall Study|Participant Died|2|||
130953800|NCT02052739|471465209|FG001|Overall Study|Participant Died|1|||
130953801|NCT05619692|471465220|FG000|Overall Study|Adverse Event|2|||
130953802|NCT05619692|471465221|FG001|Overall Study|Adverse Event|2|||
130953803|NCT05619692|471465220|FG000|Overall Study|Withdrawal by Participant|3|||
130953804|NCT05619692|471465221|FG001|Overall Study|Withdrawal by Participant|4|||
130953805|NCT05619692|471465220|FG000|Overall Study|Lost to Follow-up|2|||
130953806|NCT05619692|471465221|FG001|Overall Study|Lost to Follow-up|1|||
130953807|NCT05619692|471465220|FG000|Overall Study|Randomized but not treated|1|||
130953808|NCT05619692|471465221|FG001|Overall Study|Randomized but not treated|3|||
130953809|NCT02457598|471465222|FG000|Overall Study|Progressive Disease|2|||
131225271|NCT01078623|472451998|FG013|Treatment Period 1|Withdrawal by Subject|0|||
131225272|NCT01078623|472451999|FG014|Treatment Period 1|Withdrawal by Subject|0|||
131225273|NCT01078623|472452000|FG015|Treatment Period 1|Withdrawal by Subject|0|||
131225274|NCT01078623|472452001|FG016|Treatment Period 1|Withdrawal by Subject|0|||
131225275|NCT01078623|472452002|FG017|Treatment Period 1|Withdrawal by Subject|0|||
131225276|NCT01078623|472452003|FG018|Treatment Period 1|Withdrawal by Subject|0|||
130953810|NCT02457598|471465223|FG001|Overall Study|Progressive Disease|2|||
131225277|NCT01078623|472452004|FG019|Treatment Period 1|Withdrawal by Subject|0|||
131225278|NCT01078623|472451985|FG000|Treatment Period 1|Protocol Violation|0|||
131225279|NCT01078623|472451986|FG001|Treatment Period 1|Protocol Violation|0|||
131225280|NCT01078623|472451987|FG002|Treatment Period 1|Protocol Violation|0|||
130953811|NCT02457598|471465224|FG002|Overall Study|Progressive Disease|1|||
130953812|NCT02457598|471465225|FG003|Overall Study|Progressive Disease|11|||
130953813|NCT02457598|471465226|FG004|Overall Study|Progressive Disease|7|||
130953814|NCT02457598|471465227|FG005|Overall Study|Progressive Disease|3|||
130953815|NCT02457598|471465228|FG006|Overall Study|Progressive Disease|2|||
131225281|NCT01078623|472451988|FG003|Treatment Period 1|Protocol Violation|0|||
131225282|NCT01078623|472451989|FG004|Treatment Period 1|Protocol Violation|0|||
131225283|NCT01078623|472451990|FG005|Treatment Period 1|Protocol Violation|1|||
130953816|NCT02457598|471465229|FG007|Overall Study|Progressive Disease|1|||
130953817|NCT02457598|471465230|FG008|Overall Study|Progressive Disease|1|||
131125167|NCT02982954|472087168|FG002|Overall Study|Participant withdrew consent|1|||
131125168|NCT02982954|472087169|FG003|Overall Study|Participant withdrew consent|1|||
131125169|NCT02982954|472087166|FG000|Overall Study|Other reasons|42|||
131125170|NCT02982954|472087167|FG001|Overall Study|Other reasons|17|||
131125171|NCT02982954|472087168|FG002|Overall Study|Other reasons|12|||
131125172|NCT02982954|472087169|FG003|Overall Study|Other reasons|3|||
131125173|NCT02982954|472087166|FG000|Overall Study|Premature site closure|0|||
131125174|NCT02982954|472087167|FG001|Overall Study|Premature site closure|0|||
130953818|NCT02457598|471465231|FG009|Overall Study|Progressive Disease|2|||
130953819|NCT02457598|471465232|FG010|Overall Study|Progressive Disease|45|||
130953820|NCT02457598|471465233|FG011|Overall Study|Progressive Disease|6|||
130953821|NCT02457598|471465234|FG012|Overall Study|Progressive Disease|2|||
130953822|NCT02457598|471465235|FG013|Overall Study|Progressive Disease|2|||
130953823|NCT02457598|471465236|FG014|Overall Study|Progressive Disease|10|||
130953824|NCT02457598|471465237|FG015|Overall Study|Progressive Disease|1|||
130953825|NCT02457598|471465238|FG016|Overall Study|Progressive Disease|1|||
130953826|NCT02457598|471465222|FG000|Overall Study|Investigator's Discretion|0|||
130953827|NCT02457598|471465223|FG001|Overall Study|Investigator's Discretion|2|||
130711594|NCT00094458|470569872|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130711595|NCT00094458|470569873|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130953828|NCT02457598|471465224|FG002|Overall Study|Investigator's Discretion|2|||
130953829|NCT02457598|471465225|FG003|Overall Study|Investigator's Discretion|2|||
130953830|NCT02457598|471465226|FG004|Overall Study|Investigator's Discretion|0|||
130953831|NCT02457598|471465227|FG005|Overall Study|Investigator's Discretion|0|||
130953832|NCT02457598|471465228|FG006|Overall Study|Investigator's Discretion|0|||
130953833|NCT02457598|471465229|FG007|Overall Study|Investigator's Discretion|1|||
130953834|NCT02457598|471465230|FG008|Overall Study|Investigator's Discretion|2|||
130953835|NCT02457598|471465231|FG009|Overall Study|Investigator's Discretion|0|||
130953836|NCT02457598|471465232|FG010|Overall Study|Investigator's Discretion|10|||
130953837|NCT02457598|471465233|FG011|Overall Study|Investigator's Discretion|2|||
130953838|NCT02457598|471465234|FG012|Overall Study|Investigator's Discretion|2|||
130953839|NCT02457598|471465235|FG013|Overall Study|Investigator's Discretion|1|||
130953840|NCT02457598|471465236|FG014|Overall Study|Investigator's Discretion|5|||
130953841|NCT02457598|471465237|FG015|Overall Study|Investigator's Discretion|0|||
130953842|NCT02457598|471465238|FG016|Overall Study|Investigator's Discretion|0|||
130953843|NCT02457598|471465222|FG000|Overall Study|Study Terminated by Sponsor|0|||
130953844|NCT02457598|471465223|FG001|Overall Study|Study Terminated by Sponsor|1|||
130953845|NCT02457598|471465224|FG002|Overall Study|Study Terminated by Sponsor|0|||
130953846|NCT02457598|471465225|FG003|Overall Study|Study Terminated by Sponsor|4|||
130953847|NCT02457598|471465226|FG004|Overall Study|Study Terminated by Sponsor|1|||
130953848|NCT02457598|471465227|FG005|Overall Study|Study Terminated by Sponsor|0|||
130953849|NCT02457598|471465228|FG006|Overall Study|Study Terminated by Sponsor|1|||
130953850|NCT02457598|471465229|FG007|Overall Study|Study Terminated by Sponsor|0|||
130953851|NCT02457598|471465230|FG008|Overall Study|Study Terminated by Sponsor|0|||
130953852|NCT02457598|471465231|FG009|Overall Study|Study Terminated by Sponsor|0|||
130953853|NCT02457598|471465232|FG010|Overall Study|Study Terminated by Sponsor|4|||
130953854|NCT02457598|471465233|FG011|Overall Study|Study Terminated by Sponsor|0|||
130953855|NCT02457598|471465234|FG012|Overall Study|Study Terminated by Sponsor|1|||
130953856|NCT02457598|471465235|FG013|Overall Study|Study Terminated by Sponsor|0|||
130953857|NCT02457598|471465236|FG014|Overall Study|Study Terminated by Sponsor|8|||
130953858|NCT02457598|471465237|FG015|Overall Study|Study Terminated by Sponsor|1|||
130953859|NCT02457598|471465238|FG016|Overall Study|Study Terminated by Sponsor|0|||
131125175|NCT02982954|472087168|FG002|Overall Study|Premature site closure|0|||
131125176|NCT02982954|472087169|FG003|Overall Study|Premature site closure|1|||
131125177|NCT02603120|472087170|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
131125178|NCT02603120|472087171|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
130711596|NCT00094458|470569868|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
130711597|NCT00094458|470569869|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
130711598|NCT00094458|470569870|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
130711599|NCT00094458|470569871|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
130711600|NCT00094458|470569872|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
130711601|NCT00094458|470569873|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
130711602|NCT00094458|470569868|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
130711603|NCT00094458|470569869|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
130711604|NCT00094458|470569870|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
130711605|NCT00094458|470569871|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
130711606|NCT00094458|470569872|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
130953860|NCT02457598|471465222|FG000|Overall Study|Adverse Event|0|||
130953861|NCT02457598|471465223|FG001|Overall Study|Adverse Event|1|||
130953862|NCT02457598|471465224|FG002|Overall Study|Adverse Event|1|||
130953863|NCT02457598|471465225|FG003|Overall Study|Adverse Event|4|||
130953864|NCT02457598|471465226|FG004|Overall Study|Adverse Event|1|||
130953865|NCT02457598|471465227|FG005|Overall Study|Adverse Event|0|||
130953866|NCT02457598|471465228|FG006|Overall Study|Adverse Event|0|||
130953867|NCT02457598|471465229|FG007|Overall Study|Adverse Event|1|||
130953868|NCT02457598|471465230|FG008|Overall Study|Adverse Event|0|||
130953869|NCT02457598|471465231|FG009|Overall Study|Adverse Event|1|||
130953870|NCT02457598|471465232|FG010|Overall Study|Adverse Event|6|||
130953871|NCT02457598|471465233|FG011|Overall Study|Adverse Event|0|||
130953872|NCT02457598|471465234|FG012|Overall Study|Adverse Event|0|||
130953873|NCT02457598|471465235|FG013|Overall Study|Adverse Event|1|||
130953874|NCT02457598|471465236|FG014|Overall Study|Adverse Event|2|||
130953875|NCT02457598|471465237|FG015|Overall Study|Adverse Event|0|||
130953876|NCT02457598|471465238|FG016|Overall Study|Adverse Event|0|||
130953877|NCT02457598|471465222|FG000|Overall Study|Death|0|||
130953878|NCT02457598|471465223|FG001|Overall Study|Death|0|||
130953879|NCT02457598|471465224|FG002|Overall Study|Death|0|||
130953880|NCT02457598|471465225|FG003|Overall Study|Death|3|||
130953881|NCT02457598|471465226|FG004|Overall Study|Death|0|||
130953882|NCT02457598|471465227|FG005|Overall Study|Death|1|||
130953883|NCT02457598|471465228|FG006|Overall Study|Death|0|||
130953884|NCT02457598|471465229|FG007|Overall Study|Death|0|||
130953885|NCT02457598|471465230|FG008|Overall Study|Death|0|||
130953886|NCT02457598|471465231|FG009|Overall Study|Death|0|||
130953887|NCT02457598|471465232|FG010|Overall Study|Death|3|||
130953888|NCT02457598|471465233|FG011|Overall Study|Death|0|||
130953889|NCT02457598|471465234|FG012|Overall Study|Death|0|||
130953890|NCT02457598|471465235|FG013|Overall Study|Death|1|||
130953891|NCT02457598|471465236|FG014|Overall Study|Death|2|||
130953892|NCT02457598|471465237|FG015|Overall Study|Death|0|||
130953893|NCT02457598|471465238|FG016|Overall Study|Death|1|||
130953894|NCT02457598|471465222|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
130953895|NCT02457598|471465223|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
130953896|NCT02457598|471465224|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
130953897|NCT02457598|471465225|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
130953898|NCT02457598|471465226|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
131125179|NCT02603120|472087170|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
131125180|NCT02603120|472087171|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
131125181|NCT02603120|472087170|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
131125182|NCT02603120|472087171|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
131125183|NCT02603120|472087170|FG000|Double-Blind Treatment Phase|Death|2|||
131125184|NCT02603120|472087171|FG001|Double-Blind Treatment Phase|Death|0|||
131125185|NCT02603120|472087170|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
131125186|NCT02603120|472087171|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
131125187|NCT02603120|472087170|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
131125188|NCT02603120|472087171|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
131125189|NCT02603120|472087170|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
131125190|NCT02603120|472087171|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
131125191|NCT02603120|472087170|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
131125192|NCT02603120|472087171|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
131125193|NCT02603120|472087170|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
131125194|NCT02603120|472087171|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
131125195|NCT02603120|472087170|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
131125196|NCT02603120|472087171|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
131125197|NCT02603120|472087170|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
131125198|NCT02603120|472087171|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
131125199|NCT02603120|472087170|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
131125200|NCT02603120|472087171|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
131125201|NCT02603120|472087170|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
131125202|NCT02603120|472087171|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
131125203|NCT02603120|472087170|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
131125204|NCT02603120|472087171|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
131125205|NCT00176605|472087174|FG000|Overall Study|Withdrawal by Subject|2|||
131125206|NCT01321710|472087175|FG000|Overall Study|Lost to Follow-up|4|||
131125207|NCT01321710|472087176|FG001|Overall Study|Lost to Follow-up|5|||
131125208|NCT01321710|472087177|FG002|Overall Study|Lost to Follow-up|0|||
131125209|NCT01227187|472087178|FG000|Overall Study|Physician Decision|0|||
131125210|NCT01227187|472087179|FG001|Overall Study|Physician Decision|0|||
131125211|NCT01227187|472087180|FG002|Overall Study|Physician Decision|0|||
131125212|NCT01227187|472087181|FG003|Overall Study|Physician Decision|1|||
131125213|NCT01761292|472087182|FG000|Part 1|Adverse Event|1|||
130953899|NCT02457598|471465227|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
130953900|NCT02457598|471465228|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
130953901|NCT02457598|471465229|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
130953902|NCT02457598|471465230|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
130953903|NCT02457598|471465231|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
130953904|NCT02457598|471465232|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
130953905|NCT02457598|471465233|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
130953906|NCT02457598|471465234|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
130774568|NCT03092791|470800570|FG002|Overall Study|Reason Not Specified|0|||
130953907|NCT02457598|471465235|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
130953908|NCT02457598|471465236|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
130953909|NCT02457598|471465237|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
130953910|NCT02457598|471465238|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
130953911|NCT02457598|471465222|FG000|Overall Study|Withdrew Consent|0|||
130953912|NCT02457598|471465223|FG001|Overall Study|Withdrew Consent|0|||
130953913|NCT02457598|471465224|FG002|Overall Study|Withdrew Consent|0|||
130953914|NCT02457598|471465225|FG003|Overall Study|Withdrew Consent|0|||
130953915|NCT02457598|471465226|FG004|Overall Study|Withdrew Consent|0|||
130953916|NCT02457598|471465227|FG005|Overall Study|Withdrew Consent|0|||
130953917|NCT02457598|471465228|FG006|Overall Study|Withdrew Consent|0|||
130953918|NCT02457598|471465229|FG007|Overall Study|Withdrew Consent|2|||
130953919|NCT02457598|471465230|FG008|Overall Study|Withdrew Consent|0|||
130953920|NCT02457598|471465231|FG009|Overall Study|Withdrew Consent|0|||
130953921|NCT02457598|471465232|FG010|Overall Study|Withdrew Consent|3|||
130953922|NCT02457598|471465233|FG011|Overall Study|Withdrew Consent|0|||
130953923|NCT02457598|471465234|FG012|Overall Study|Withdrew Consent|0|||
130953924|NCT02457598|471465235|FG013|Overall Study|Withdrew Consent|1|||
130953925|NCT02457598|471465236|FG014|Overall Study|Withdrew Consent|0|||
130953926|NCT02457598|471465237|FG015|Overall Study|Withdrew Consent|0|||
130953927|NCT02457598|471465238|FG016|Overall Study|Withdrew Consent|0|||
130953928|NCT02457598|471465222|FG000|Overall Study|Unacceptable Toxicity|0|||
130953929|NCT02457598|471465223|FG001|Overall Study|Unacceptable Toxicity|0|||
130953930|NCT02457598|471465224|FG002|Overall Study|Unacceptable Toxicity|0|||
131125214|NCT01761292|472087182|FG000|Part 1|not receiving treatment in Part 1|1|||
131125215|NCT01761292|472087182|FG000|Extension 1|Withdrawal by Subject|1|||
131125216|NCT00840086|472087183|FG000|Overall Study|Adverse Event|1|||
131125217|NCT00840086|472087183|FG000|Overall Study|Protocol Violation|2|||
131125218|NCT00840086|472087183|FG000|Overall Study|Lost to Follow-up|1|||
131125219|NCT03332498|472087184|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
131125220|NCT03332498|472087185|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
131125221|NCT03332498|472087186|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
131125222|NCT04036708|472087187|FG000|Overall Study|Lost to Follow-up|14|||
131125223|NCT04036708|472087188|FG001|Overall Study|Lost to Follow-up|4|||
131125224|NCT04036708|472087189|FG002|Overall Study|Lost to Follow-up|14|||
131125225|NCT04036708|472087190|FG003|Overall Study|Lost to Follow-up|4|||
131125226|NCT03577730|472087192|FG000|Overall Study|Physician Decision|3|||
131125227|NCT03577730|472087193|FG001|Overall Study|Physician Decision|1|||
131125228|NCT03577730|472087192|FG000|Overall Study|Did not receive allocated intervention|1|||
131125229|NCT03577730|472087193|FG001|Overall Study|Did not receive allocated intervention|0|||
131125230|NCT01444742|472087196|FG000|Overall Study|Death|1|||
131125231|NCT02535715|472087197|FG000|Overall Study|Withdrawal by Subject|0|||
131125232|NCT02535715|472087198|FG001|Overall Study|Withdrawal by Subject|0|||
131125233|NCT02535715|472087199|FG002|Overall Study|Withdrawal by Subject|1|||
131125234|NCT00909181|472087200|FG000|Overall Study|Lost to Follow-up|39|||
131125235|NCT00909181|472087201|FG001|Overall Study|Lost to Follow-up|18|||
131125236|NCT00909181|472087202|FG002|Overall Study|Lost to Follow-up|33|||
131125237|NCT02349048|472087204|FG000|Overall Study|Withdrawal by Subject|4|||
131125238|NCT02349048|472087205|FG001|Overall Study|Withdrawal by Subject|0|||
131125239|NCT02349048|472087204|FG000|Overall Study|Lost to Follow-up|1|||
131125240|NCT02349048|472087205|FG001|Overall Study|Lost to Follow-up|0|||
131125241|NCT00094770|472087208|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
131125242|NCT00094770|472087209|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
131125243|NCT00094770|472087208|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
131125244|NCT00094770|472087209|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
131125245|NCT00094770|472087208|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
131125246|NCT00094770|472087209|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
131125247|NCT00094770|472087208|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
131125248|NCT00094770|472087209|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
131125249|NCT00094770|472087208|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
131125250|NCT00094770|472087209|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
131125251|NCT00094770|472087208|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
130953931|NCT02457598|471465225|FG003|Overall Study|Unacceptable Toxicity|0|||
130953932|NCT02457598|471465226|FG004|Overall Study|Unacceptable Toxicity|0|||
130953933|NCT02457598|471465227|FG005|Overall Study|Unacceptable Toxicity|0|||
130953934|NCT02457598|471465228|FG006|Overall Study|Unacceptable Toxicity|0|||
130953935|NCT02457598|471465229|FG007|Overall Study|Unacceptable Toxicity|0|||
130953936|NCT02457598|471465230|FG008|Overall Study|Unacceptable Toxicity|0|||
130953937|NCT02457598|471465231|FG009|Overall Study|Unacceptable Toxicity|0|||
130953938|NCT02457598|471465232|FG010|Overall Study|Unacceptable Toxicity|1|||
130953939|NCT02457598|471465233|FG011|Overall Study|Unacceptable Toxicity|0|||
130953940|NCT02457598|471465234|FG012|Overall Study|Unacceptable Toxicity|1|||
130953941|NCT02457598|471465235|FG013|Overall Study|Unacceptable Toxicity|1|||
131125252|NCT00094770|472087209|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
131225284|NCT01078623|472451991|FG006|Treatment Period 1|Protocol Violation|0|||
131225285|NCT01078623|472451992|FG007|Treatment Period 1|Protocol Violation|0|||
131225286|NCT01078623|472451993|FG008|Treatment Period 1|Protocol Violation|0|||
131225287|NCT01078623|472451994|FG009|Treatment Period 1|Protocol Violation|0|||
131225288|NCT01078623|472451995|FG010|Treatment Period 1|Protocol Violation|0|||
131225289|NCT01078623|472451996|FG011|Treatment Period 1|Protocol Violation|0|||
131225290|NCT01078623|472451997|FG012|Treatment Period 1|Protocol Violation|0|||
131225291|NCT01078623|472451998|FG013|Treatment Period 1|Protocol Violation|0|||
131225292|NCT01078623|472451999|FG014|Treatment Period 1|Protocol Violation|0|||
131225293|NCT01078623|472452000|FG015|Treatment Period 1|Protocol Violation|0|||
130711607|NCT00094458|470569873|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
130711608|NCT00094458|470569868|FG000|OLE: Open-Label Extension|Adverse Event|0|||
130711609|NCT00094458|470569869|FG001|OLE: Open-Label Extension|Adverse Event|0|||
130711610|NCT00094458|470569870|FG002|OLE: Open-Label Extension|Adverse Event|0|||
130953942|NCT02457598|471465236|FG014|Overall Study|Unacceptable Toxicity|1|||
130953943|NCT02457598|471465237|FG015|Overall Study|Unacceptable Toxicity|0|||
130953944|NCT02457598|471465238|FG016|Overall Study|Unacceptable Toxicity|0|||
130953945|NCT02457598|471465222|FG000|Overall Study|Intercurrent Illness|0|||
130953946|NCT02457598|471465223|FG001|Overall Study|Intercurrent Illness|0|||
130953947|NCT02457598|471465224|FG002|Overall Study|Intercurrent Illness|0|||
130953948|NCT02457598|471465225|FG003|Overall Study|Intercurrent Illness|0|||
130953949|NCT02457598|471465226|FG004|Overall Study|Intercurrent Illness|0|||
130953950|NCT02457598|471465227|FG005|Overall Study|Intercurrent Illness|0|||
130953951|NCT02457598|471465228|FG006|Overall Study|Intercurrent Illness|0|||
130953952|NCT02457598|471465229|FG007|Overall Study|Intercurrent Illness|0|||
130953953|NCT02457598|471465230|FG008|Overall Study|Intercurrent Illness|0|||
130953954|NCT02457598|471465231|FG009|Overall Study|Intercurrent Illness|0|||
130953955|NCT02457598|471465232|FG010|Overall Study|Intercurrent Illness|1|||
130953956|NCT02457598|471465233|FG011|Overall Study|Intercurrent Illness|0|||
130953957|NCT02457598|471465234|FG012|Overall Study|Intercurrent Illness|0|||
130953958|NCT02457598|471465235|FG013|Overall Study|Intercurrent Illness|0|||
130953959|NCT02457598|471465236|FG014|Overall Study|Intercurrent Illness|0|||
130953960|NCT02457598|471465237|FG015|Overall Study|Intercurrent Illness|0|||
130953961|NCT02457598|471465238|FG016|Overall Study|Intercurrent Illness|0|||
130953962|NCT02457598|471465222|FG000|Overall Study|Protocol Violation|0|||
130953963|NCT02457598|471465223|FG001|Overall Study|Protocol Violation|0|||
130953964|NCT02457598|471465224|FG002|Overall Study|Protocol Violation|0|||
130953965|NCT02457598|471465225|FG003|Overall Study|Protocol Violation|0|||
130953966|NCT02457598|471465226|FG004|Overall Study|Protocol Violation|0|||
130953967|NCT02457598|471465227|FG005|Overall Study|Protocol Violation|0|||
130953968|NCT02457598|471465228|FG006|Overall Study|Protocol Violation|0|||
130953969|NCT02457598|471465229|FG007|Overall Study|Protocol Violation|0|||
130953970|NCT02457598|471465230|FG008|Overall Study|Protocol Violation|0|||
130953971|NCT02457598|471465231|FG009|Overall Study|Protocol Violation|0|||
130953972|NCT02457598|471465232|FG010|Overall Study|Protocol Violation|1|||
130953973|NCT02457598|471465233|FG011|Overall Study|Protocol Violation|0|||
130953974|NCT02457598|471465234|FG012|Overall Study|Protocol Violation|0|||
130953975|NCT02457598|471465235|FG013|Overall Study|Protocol Violation|0|||
130953976|NCT02457598|471465236|FG014|Overall Study|Protocol Violation|0|||
130953977|NCT02457598|471465237|FG015|Overall Study|Protocol Violation|0|||
130953978|NCT02457598|471465238|FG016|Overall Study|Protocol Violation|0|||
130953979|NCT01526889|471465239|FG000|Treatment Period|Adverse Event|2|||
130953980|NCT01526889|471465240|FG001|Treatment Period|Adverse Event|0|||
130953981|NCT01526889|471465239|FG000|Treatment Extension Period|Administrative problems|1|||
130953982|NCT01526889|471465240|FG001|Treatment Extension Period|Administrative problems|0|||
130953983|NCT00974571|471465243|FG000|Overall Study|Adverse Event|31|||
130953984|NCT00974571|471465244|FG001|Overall Study|Adverse Event|4|||
130953985|NCT00974571|471465245|FG002|Overall Study|Adverse Event|27|||
130953986|NCT00974571|471465243|FG000|Overall Study|Lack of Efficacy|3|||
130953987|NCT00974571|471465244|FG001|Overall Study|Lack of Efficacy|2|||
130953988|NCT00974571|471465245|FG002|Overall Study|Lack of Efficacy|9|||
130953989|NCT00974571|471465243|FG000|Overall Study|Lost to Follow-up|2|||
130953990|NCT00974571|471465244|FG001|Overall Study|Lost to Follow-up|1|||
130711611|NCT00094458|470569871|FG003|OLE: Open-Label Extension|Adverse Event|0|||
130711612|NCT00094458|470569872|FG004|OLE: Open-Label Extension|Adverse Event|3|||
130953991|NCT00974571|471465245|FG002|Overall Study|Lost to Follow-up|2|||
130953992|NCT00974571|471465243|FG000|Overall Study|Protocol Violation|13|||
131225294|NCT01078623|472452001|FG016|Treatment Period 1|Protocol Violation|0|||
131225295|NCT01078623|472452002|FG017|Treatment Period 1|Protocol Violation|0|||
130953993|NCT00974571|471465244|FG001|Overall Study|Protocol Violation|4|||
130953994|NCT00974571|471465245|FG002|Overall Study|Protocol Violation|18|||
130953995|NCT00974571|471465243|FG000|Overall Study|Withdrawal by Subject|14|||
130953996|NCT00974571|471465244|FG001|Overall Study|Withdrawal by Subject|5|||
130953997|NCT00974571|471465245|FG002|Overall Study|Withdrawal by Subject|16|||
130953998|NCT00974571|471465243|FG000|Overall Study|Patient Moved|1|||
130953999|NCT00974571|471465244|FG001|Overall Study|Patient Moved|0|||
130954000|NCT00974571|471465245|FG002|Overall Study|Patient Moved|1|||
131039130|NCT03084536|471778184|FG001|Overall Study|Withdrawal by Subject|0|||
131039131|NCT03084536|471778185|FG002|Overall Study|Withdrawal by Subject|4|||
131225296|NCT01078623|472452003|FG018|Treatment Period 1|Protocol Violation|0|||
131039132|NCT03084536|471778183|FG000|Overall Study|Physician Decision|0|||
131039133|NCT03084536|471778184|FG001|Overall Study|Physician Decision|0|||
131039134|NCT03084536|471778185|FG002|Overall Study|Physician Decision|3|||
131039135|NCT03084536|471778183|FG000|Overall Study|Death|0|||
131039136|NCT03084536|471778184|FG001|Overall Study|Death|0|||
131039137|NCT03084536|471778185|FG002|Overall Study|Death|1|||
131039138|NCT03084536|471778183|FG000|Overall Study|Lost to Follow-up|0|||
130774569|NCT03092791|470800571|FG003|Overall Study|Reason Not Specified|0|||
130774570|NCT03092791|470800572|FG004|Overall Study|Reason Not Specified|1|||
130774571|NCT03092791|470800573|FG005|Overall Study|Reason Not Specified|1|||
130774572|NCT03092791|470800574|FG006|Overall Study|Reason Not Specified|0|||
130774573|NCT03092791|470800575|FG007|Overall Study|Reason Not Specified|0|||
130774574|NCT02182830|470800577|FG000|Overall Study|Not Treated|1|||
130774575|NCT02182830|470800578|FG001|Overall Study|Not Treated|1|||
130774576|NCT02182830|470800577|FG000|Overall Study|Trial stopped, reason missing|3|||
130774577|NCT02182830|470800578|FG001|Overall Study|Trial stopped, reason missing|3|||
131039139|NCT03084536|471778184|FG001|Overall Study|Lost to Follow-up|0|||
131039140|NCT03084536|471778185|FG002|Overall Study|Lost to Follow-up|1|||
131039141|NCT03084536|471778183|FG000|Overall Study|Protocol Violation|0|||
131039142|NCT03084536|471778184|FG001|Overall Study|Protocol Violation|0|||
131039143|NCT03084536|471778185|FG002|Overall Study|Protocol Violation|1|||
131039144|NCT03084536|471778183|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
131039145|NCT03084536|471778184|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
131039146|NCT03084536|471778185|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
131039147|NCT05073458|471778188|FG000|24-week Double-blind Period|Adverse Event|1|||
131039148|NCT05073458|471778189|FG001|24-week Double-blind Period|Adverse Event|0|||
131039149|NCT05073458|471778188|FG000|24-week Double-blind Period|Physician Decision|1|||
131039150|NCT05073458|471778189|FG001|24-week Double-blind Period|Physician Decision|0|||
131039151|NCT05073458|471778188|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
131039152|NCT05073458|471778189|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
131039153|NCT05073458|471778188|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
131039154|NCT05073458|471778189|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
131039155|NCT05073458|471778188|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
131039156|NCT05073458|471778189|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
131039157|NCT05073458|471778188|FG000|24-week Open-label Period|Adverse Event|1|||
131039158|NCT05073458|471778189|FG001|24-week Open-label Period|Adverse Event|2|||
131039159|NCT03235544|471778198|FG000|Overall Study|Death|11|||
131039160|NCT03235544|471778199|FG001|Overall Study|Death|31|||
131225297|NCT01078623|472452004|FG019|Treatment Period 1|Protocol Violation|0|||
131225298|NCT01078623|472451985|FG000|Treatment Period 2|Adverse Event|0|||
131225299|NCT01078623|472451986|FG001|Treatment Period 2|Adverse Event|0|||
131225300|NCT01078623|472451987|FG002|Treatment Period 2|Adverse Event|0|||
131225301|NCT01078623|472451988|FG003|Treatment Period 2|Adverse Event|0|||
131225302|NCT01078623|472451989|FG004|Treatment Period 2|Adverse Event|0|||
131225303|NCT01078623|472451990|FG005|Treatment Period 2|Adverse Event|0|||
131225304|NCT01078623|472451991|FG006|Treatment Period 2|Adverse Event|1|||
131225305|NCT01078623|472451992|FG007|Treatment Period 2|Adverse Event|0|||
131225306|NCT01078623|472451993|FG008|Treatment Period 2|Adverse Event|0|||
131225307|NCT01078623|472451994|FG009|Treatment Period 2|Adverse Event|0|||
131225308|NCT01078623|472451995|FG010|Treatment Period 2|Adverse Event|0|||
131225309|NCT01078623|472451996|FG011|Treatment Period 2|Adverse Event|0|||
131225310|NCT01078623|472451997|FG012|Treatment Period 2|Adverse Event|0|||
131225311|NCT01078623|472451998|FG013|Treatment Period 2|Adverse Event|0|||
131225312|NCT01078623|472451999|FG014|Treatment Period 2|Adverse Event|0|||
131039161|NCT03235544|471778200|FG002|Overall Study|Death|19|||
131225313|NCT01078623|472452000|FG015|Treatment Period 2|Adverse Event|0|||
131225314|NCT01078623|472452001|FG016|Treatment Period 2|Adverse Event|0|||
131225315|NCT01078623|472452002|FG017|Treatment Period 2|Adverse Event|0|||
131225316|NCT01078623|472452003|FG018|Treatment Period 2|Adverse Event|1|||
131225317|NCT01078623|472452004|FG019|Treatment Period 2|Adverse Event|0|||
131225318|NCT01078623|472451985|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131225319|NCT01078623|472451986|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131225320|NCT01078623|472451987|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131039162|NCT03235544|471778201|FG003|Overall Study|Death|34|||
131039163|NCT03235544|471778198|FG000|Overall Study|Lost to Follow-up|0|||
131039164|NCT03235544|471778199|FG001|Overall Study|Lost to Follow-up|1|||
131039165|NCT03235544|471778200|FG002|Overall Study|Lost to Follow-up|1|||
131039166|NCT03235544|471778201|FG003|Overall Study|Lost to Follow-up|1|||
131225321|NCT01078623|472451988|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131225322|NCT01078623|472451989|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130774578|NCT02182830|470800577|FG000|Overall Study|Consent withdrawn|8|||
131039167|NCT03235544|471778198|FG000|Overall Study|Withdrawal by Subject|0|||
130774579|NCT02182830|470800578|FG001|Overall Study|Consent withdrawn|8|||
130774580|NCT02182830|470800577|FG000|Overall Study|Lost to Follow-up|3|||
131225323|NCT01078623|472451990|FG005|Treatment Period 2|Withdrawal by Subject|1|||
130954001|NCT00974571|471465243|FG000|Overall Study|Other|4|||
130954002|NCT00974571|471465244|FG001|Overall Study|Other|0|||
130954003|NCT00974571|471465245|FG002|Overall Study|Other|10|||
130954004|NCT04334460|471465252|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
130954005|NCT04334460|471465253|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
130954006|NCT04334460|471465252|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
130954007|NCT04334460|471465253|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
130954008|NCT02385799|471465256|FG000|Overall Study|Lost to Follow-up|1|||
130954009|NCT02385799|471465257|FG001|Overall Study|Lost to Follow-up|2|||
130954010|NCT02385799|471465256|FG000|Overall Study|Adverse Event|4|||
130954011|NCT02385799|471465257|FG001|Overall Study|Adverse Event|2|||
130954012|NCT02385799|471465256|FG000|Overall Study|Withdrawal by Subject|0|||
130954013|NCT02385799|471465257|FG001|Overall Study|Withdrawal by Subject|4|||
130954014|NCT00547703|471465258|FG000|Overall Study|Lost to Follow-up|1|||
130954015|NCT00547703|471465259|FG001|Overall Study|Lost to Follow-up|0|||
130954016|NCT03995953|471465262|FG000|Overall Study|Death|3|||
130954017|NCT03995953|471465263|FG001|Overall Study|Death|0|||
130954018|NCT03995953|471465264|FG002|Overall Study|Death|3|||
130954019|NCT03995953|471465265|FG003|Overall Study|Death|0|||
131039168|NCT03235544|471778199|FG001|Overall Study|Withdrawal by Subject|3|||
131039169|NCT03235544|471778200|FG002|Overall Study|Withdrawal by Subject|1|||
131039170|NCT03235544|471778201|FG003|Overall Study|Withdrawal by Subject|5|||
131039171|NCT03235544|471778198|FG000|Overall Study|Disease Progression|0|||
131039172|NCT03235544|471778199|FG001|Overall Study|Disease Progression|1|||
131039173|NCT03235544|471778200|FG002|Overall Study|Disease Progression|0|||
131039174|NCT03235544|471778201|FG003|Overall Study|Disease Progression|2|||
131039175|NCT03235544|471778198|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
131039176|NCT03235544|471778199|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
131039177|NCT03235544|471778200|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
131039178|NCT03235544|471778201|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
131039179|NCT03235544|471778198|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
131039180|NCT03235544|471778199|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
131039181|NCT03235544|471778200|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
131039182|NCT03235544|471778201|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
131039183|NCT04830800|471778202|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
131039184|NCT04830800|471778203|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
131039185|NCT04830800|471778204|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
131039186|NCT04830800|471778205|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
131039187|NCT04830800|471778206|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
131039188|NCT01456949|471778209|FG000|Enrollment|PI death- incomplete data|6|||
131039189|NCT01456949|471778209|FG000|Enrollment|Death|1|||
131039190|NCT01456949|471778209|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
131039191|NCT01456949|471778209|FG000|Enrollment|Physician Decision|10|||
131039192|NCT01456949|471778209|FG000|Enrollment|Withdrawal by Subject|7|||
131039193|NCT01456949|471778209|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
131039194|NCT01456949|471778209|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
131039195|NCT01456949|471778209|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
131039196|NCT01456949|471778209|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
131039197|NCT01456949|471778209|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
131039198|NCT01456949|471778209|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
131039199|NCT01456949|471778209|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
131039200|NCT01456949|471778209|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
131039201|NCT02626533|471778210|FG000|Overall Study|Protocol Violation|14|||
131039202|NCT02626533|471778210|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
131039203|NCT02626533|471778210|FG000|Overall Study|Withdrawal by Subject|1|||
131039204|NCT04753697|471778211|FG000|Induction Phase|Withdrawal by Subject|12|||
131039205|NCT04753697|471778212|FG001|Induction Phase|Withdrawal by Subject|5|||
131039206|NCT04753697|471778213|FG002|Induction Phase|Withdrawal by Subject|6|||
131039207|NCT04753697|471778211|FG000|Induction Phase|Physician Decision|1|||
131039208|NCT04753697|471778212|FG001|Induction Phase|Physician Decision|0|||
131039209|NCT04753697|471778213|FG002|Induction Phase|Physician Decision|0|||
131039210|NCT04753697|471778211|FG000|Induction Phase|Lost to Follow-up|2|||
131039211|NCT04753697|471778212|FG001|Induction Phase|Lost to Follow-up|2|||
131039212|NCT04753697|471778213|FG002|Induction Phase|Lost to Follow-up|1|||
131039213|NCT04753697|471778211|FG000|Induction Phase|Lack of Efficacy|1|||
130954020|NCT03995953|471465266|FG004|Overall Study|Death|3|||
130954021|NCT03995953|471465267|FG005|Overall Study|Death|0|||
130954022|NCT03995953|471465268|FG006|Overall Study|Death|0|||
130954023|NCT03995953|471465269|FG007|Overall Study|Death|0|||
130954024|NCT03995953|471465270|FG008|Overall Study|Death|1|||
130954025|NCT03995953|471465271|FG009|Overall Study|Death|0|||
130954026|NCT03995953|471465272|FG010|Overall Study|Death|0|||
130954027|NCT03995953|471465273|FG011|Overall Study|Death|0|||
130954028|NCT03995953|471465262|FG000|Overall Study|Lost to Follow-up|6|||
130954029|NCT03995953|471465263|FG001|Overall Study|Lost to Follow-up|54|||
130954030|NCT03995953|471465264|FG002|Overall Study|Lost to Follow-up|3|||
130954031|NCT03995953|471465265|FG003|Overall Study|Lost to Follow-up|32|||
130954032|NCT03995953|471465266|FG004|Overall Study|Lost to Follow-up|5|||
130954033|NCT03995953|471465267|FG005|Overall Study|Lost to Follow-up|44|||
130954034|NCT03995953|471465268|FG006|Overall Study|Lost to Follow-up|0|||
130954035|NCT03995953|471465269|FG007|Overall Study|Lost to Follow-up|31|||
130954036|NCT03995953|471465270|FG008|Overall Study|Lost to Follow-up|8|||
130954037|NCT03995953|471465271|FG009|Overall Study|Lost to Follow-up|36|||
130954038|NCT03995953|471465272|FG010|Overall Study|Lost to Follow-up|5|||
130954039|NCT03995953|471465273|FG011|Overall Study|Lost to Follow-up|41|||
130954040|NCT03995953|471465262|FG000|Overall Study|Withdrawal by Subject|4|||
130954041|NCT03995953|471465263|FG001|Overall Study|Withdrawal by Subject|0|||
130954042|NCT03995953|471465264|FG002|Overall Study|Withdrawal by Subject|1|||
130954043|NCT03995953|471465265|FG003|Overall Study|Withdrawal by Subject|0|||
130954044|NCT03995953|471465266|FG004|Overall Study|Withdrawal by Subject|1|||
130954045|NCT03995953|471465267|FG005|Overall Study|Withdrawal by Subject|0|||
130954046|NCT03995953|471465268|FG006|Overall Study|Withdrawal by Subject|1|||
130954047|NCT03995953|471465269|FG007|Overall Study|Withdrawal by Subject|0|||
130954048|NCT03995953|471465270|FG008|Overall Study|Withdrawal by Subject|3|||
130954049|NCT03995953|471465271|FG009|Overall Study|Withdrawal by Subject|0|||
130954050|NCT03995953|471465272|FG010|Overall Study|Withdrawal by Subject|3|||
130954051|NCT03995953|471465273|FG011|Overall Study|Withdrawal by Subject|0|||
130954052|NCT03995953|471465262|FG000|Overall Study|Health Issues|0|||
130954053|NCT03995953|471465263|FG001|Overall Study|Health Issues|0|||
130954054|NCT03995953|471465264|FG002|Overall Study|Health Issues|0|||
130954055|NCT03995953|471465265|FG003|Overall Study|Health Issues|0|||
130954056|NCT03995953|471465266|FG004|Overall Study|Health Issues|1|||
130954057|NCT03995953|471465267|FG005|Overall Study|Health Issues|0|||
130954058|NCT03995953|471465268|FG006|Overall Study|Health Issues|0|||
130954059|NCT03995953|471465269|FG007|Overall Study|Health Issues|0|||
130954060|NCT03995953|471465270|FG008|Overall Study|Health Issues|4|||
130954061|NCT03995953|471465271|FG009|Overall Study|Health Issues|0|||
130954062|NCT03995953|471465272|FG010|Overall Study|Health Issues|0|||
130954063|NCT03995953|471465273|FG011|Overall Study|Health Issues|0|||
130954064|NCT03995953|471465262|FG000|Overall Study|Relocated|11|||
130954065|NCT03995953|471465263|FG001|Overall Study|Relocated|0|||
131039214|NCT04753697|471778212|FG001|Induction Phase|Lack of Efficacy|0|||
131125253|NCT00094770|472087208|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
131125254|NCT00094770|472087209|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
131125255|NCT00094770|472087208|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
131125256|NCT00094770|472087209|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
131125257|NCT00094770|472087208|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
131125258|NCT00094770|472087209|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
131125259|NCT00094770|472087208|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
131125260|NCT00094770|472087209|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
131225324|NCT01078623|472451991|FG006|Treatment Period 2|Withdrawal by Subject|0|||
131225325|NCT01078623|472451992|FG007|Treatment Period 2|Withdrawal by Subject|0|||
131225326|NCT01078623|472451993|FG008|Treatment Period 2|Withdrawal by Subject|0|||
130711613|NCT00094458|470569873|FG005|OLE: Open-Label Extension|Adverse Event|4|||
130954066|NCT03995953|471465264|FG002|Overall Study|Relocated|16|||
131039215|NCT04753697|471778213|FG002|Induction Phase|Lack of Efficacy|0|||
131039216|NCT04753697|471778211|FG000|Maintenance Phase|Physician Decision|0|||
131039217|NCT04753697|471778212|FG001|Maintenance Phase|Physician Decision|0|||
131039218|NCT04753697|471778213|FG002|Maintenance Phase|Physician Decision|1|||
131039219|NCT04753697|471778211|FG000|Maintenance Phase|Withdrawal by Subject|3|||
131039220|NCT04753697|471778212|FG001|Maintenance Phase|Withdrawal by Subject|4|||
131039221|NCT04753697|471778213|FG002|Maintenance Phase|Withdrawal by Subject|6|||
130954067|NCT03995953|471465265|FG003|Overall Study|Relocated|0|||
130954068|NCT03995953|471465266|FG004|Overall Study|Relocated|14|||
130954069|NCT03995953|471465267|FG005|Overall Study|Relocated|0|||
130954070|NCT03995953|471465268|FG006|Overall Study|Relocated|16|||
130954071|NCT03995953|471465269|FG007|Overall Study|Relocated|0|||
130954072|NCT03995953|471465270|FG008|Overall Study|Relocated|14|||
130954073|NCT03995953|471465271|FG009|Overall Study|Relocated|0|||
130954074|NCT03995953|471465272|FG010|Overall Study|Relocated|15|||
130954075|NCT03995953|471465273|FG011|Overall Study|Relocated|0|||
130954076|NCT02130765|471465274|FG000|Overall Study|Did not receive treatment|4|||
131039222|NCT04753697|471778211|FG000|Maintenance Phase|Lost to Follow-up|2|||
131125261|NCT00094770|472087208|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
130954077|NCT02130765|471465275|FG001|Overall Study|Did not receive treatment|0|||
130954078|NCT02130765|471465276|FG002|Overall Study|Did not receive treatment|0|||
130954079|NCT02130765|471465277|FG003|Overall Study|Did not receive treatment|0|||
131039223|NCT04753697|471778212|FG001|Maintenance Phase|Lost to Follow-up|2|||
131039224|NCT04753697|471778213|FG002|Maintenance Phase|Lost to Follow-up|0|||
131039225|NCT04753697|471778211|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
131039226|NCT04753697|471778212|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
131039227|NCT04753697|471778213|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
131039228|NCT04753697|471778211|FG000|Maintenance Phase|Adverse Event|0|||
130711614|NCT00094458|470569868|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130711615|NCT00094458|470569869|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130711616|NCT00094458|470569870|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130711617|NCT00094458|470569871|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
130711618|NCT00094458|470569872|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
130711619|NCT00094458|470569873|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130711620|NCT00094458|470569868|FG000|OLE: Open-Label Extension|Patient decision|0|||
130711621|NCT00094458|470569869|FG001|OLE: Open-Label Extension|Patient decision|0|||
130711622|NCT00094458|470569870|FG002|OLE: Open-Label Extension|Patient decision|0|||
130711623|NCT00094458|470569871|FG003|OLE: Open-Label Extension|Patient decision|0|||
130711624|NCT00094458|470569872|FG004|OLE: Open-Label Extension|Patient decision|1|||
130711625|NCT00094458|470569873|FG005|OLE: Open-Label Extension|Patient decision|0|||
131039229|NCT04753697|471778212|FG001|Maintenance Phase|Adverse Event|1|||
131039230|NCT04753697|471778213|FG002|Maintenance Phase|Adverse Event|1|||
131039231|NCT04753697|471778211|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
131039232|NCT04753697|471778212|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
131039233|NCT04753697|471778213|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
131039234|NCT04850898|471778216|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
131039235|NCT04850898|471778217|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
131039236|NCT03701763|471778218|FG000|Placebo-controlled Phase|Adverse Event|1|||
131039237|NCT03701763|471778219|FG001|Placebo-controlled Phase|Adverse Event|5|||
131039238|NCT03701763|471778220|FG002|Placebo-controlled Phase|Adverse Event|0|||
130711626|NCT03265288|470569874|FG000|Overall Study|Adverse Event|0|||
130711627|NCT03265288|470569875|FG001|Overall Study|Adverse Event|1|||
131039239|NCT03701763|471778221|FG003|Placebo-controlled Phase|Adverse Event|0|||
131039240|NCT03701763|471778218|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
131039241|NCT03701763|471778219|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
131039242|NCT03701763|471778220|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
131039243|NCT03701763|471778221|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
131039244|NCT03701763|471778218|FG000|Placebo-controlled Phase|Miscellaneous|2|||
131039245|NCT03701763|471778219|FG001|Placebo-controlled Phase|Miscellaneous|0|||
131039246|NCT03701763|471778220|FG002|Placebo-controlled Phase|Miscellaneous|0|||
131039247|NCT03701763|471778221|FG003|Placebo-controlled Phase|Miscellaneous|0|||
131039248|NCT03701763|471778218|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
131039249|NCT03701763|471778219|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
131039250|NCT03701763|471778220|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
131039251|NCT03701763|471778221|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
131039252|NCT03701763|471778218|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
131039253|NCT03701763|471778219|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
131039254|NCT03701763|471778220|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
131039255|NCT03701763|471778221|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
131039256|NCT03701763|471778218|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
131039257|NCT03701763|471778219|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
131039258|NCT03701763|471778220|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
131039259|NCT03701763|471778221|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
131225327|NCT01078623|472451994|FG009|Treatment Period 2|Withdrawal by Subject|0|||
131225328|NCT01078623|472451995|FG010|Treatment Period 2|Withdrawal by Subject|0|||
131225329|NCT01078623|472451996|FG011|Treatment Period 2|Withdrawal by Subject|0|||
131225330|NCT01078623|472451997|FG012|Treatment Period 2|Withdrawal by Subject|0|||
131039260|NCT03701763|471778218|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
131039261|NCT03701763|471778219|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
131039262|NCT03701763|471778220|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
131039263|NCT03701763|471778221|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
131039264|NCT03701763|471778218|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
131039265|NCT03701763|471778219|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
131039266|NCT03701763|471778220|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
131039267|NCT03701763|471778221|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
131039268|NCT03701763|471778218|FG000|Apremilast Extension Phase|Adverse Event|0|||
131039269|NCT03701763|471778219|FG001|Apremilast Extension Phase|Adverse Event|0|||
131039270|NCT03701763|471778220|FG002|Apremilast Extension Phase|Adverse Event|3|||
131039271|NCT03701763|471778221|FG003|Apremilast Extension Phase|Adverse Event|1|||
131039272|NCT03701763|471778218|FG000|Apremilast Extension Phase|Miscellaneous|0|||
131039273|NCT03701763|471778219|FG001|Apremilast Extension Phase|Miscellaneous|0|||
131039274|NCT03701763|471778220|FG002|Apremilast Extension Phase|Miscellaneous|2|||
131039275|NCT03701763|471778221|FG003|Apremilast Extension Phase|Miscellaneous|1|||
130711628|NCT03265288|470569874|FG000|Overall Study|Withdrawal by Subject|13|||
130711629|NCT03265288|470569875|FG001|Overall Study|Withdrawal by Subject|5|||
130711630|NCT03265288|470569874|FG000|Overall Study|Drug Withdrawn|3|||
130711631|NCT03265288|470569875|FG001|Overall Study|Drug Withdrawn|3|||
130711632|NCT03265288|470569874|FG000|Overall Study|Any Other Reason|7|||
130711633|NCT03265288|470569875|FG001|Overall Study|Any Other Reason|3|||
130711634|NCT03197558|470569876|FG000|Overall Study|Tubes not placed|1|||
130711635|NCT00468728|470569879|FG000|Treatment|criteria for mITT population|4|||
130711636|NCT00468728|470569880|FG001|Treatment|criteria for mITT population|11|||
130711637|NCT00468728|470569879|FG000|Follow-up|mITT failure|34|||
130711638|NCT00468728|470569880|FG001|Follow-up|mITT failure|31|||
130711639|NCT03463993|470569882|FG000|Overall Study|Lost to Follow-up|7|||
130711640|NCT03463993|470569883|FG001|Overall Study|Lost to Follow-up|8|||
130711641|NCT03463993|470569882|FG000|Overall Study|Withdrawal by Subject|2|||
130711642|NCT03463993|470569883|FG001|Overall Study|Withdrawal by Subject|0|||
130711643|NCT03463993|470569882|FG000|Overall Study|Protocol Violation|4|||
130711644|NCT03463993|470569883|FG001|Overall Study|Protocol Violation|1|||
130711645|NCT03463993|470569882|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
130711646|NCT03463993|470569883|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
130711647|NCT03463993|470569882|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
130711648|NCT03463993|470569883|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
130711649|NCT01478828|470569885|FG000|Overall Study|Adverse Event|1|||
130985563|NCT04225988|471572945|FG001|Overall Study|Withdrawal by Subject|0|||
130711650|NCT02278718|470569886|FG000|Overall Study|Adverse Event|1|||
130711651|NCT02278718|470569887|FG001|Overall Study|Adverse Event|0|||
130711652|NCT02278718|470569886|FG000|Overall Study|Lost to Follow-up|2|||
130711653|NCT02278718|470569887|FG001|Overall Study|Lost to Follow-up|4|||
130711654|NCT02278718|470569886|FG000|Overall Study|Withdrawal by Subject|1|||
130711655|NCT02278718|470569887|FG001|Overall Study|Withdrawal by Subject|4|||
131039276|NCT03701763|471778218|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
131039277|NCT03701763|471778219|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
131039278|NCT03701763|471778220|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
131039279|NCT03701763|471778221|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
131039280|NCT03701763|471778218|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
131039281|NCT03701763|471778219|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
131039282|NCT03701763|471778220|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
131039283|NCT03701763|471778221|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
131039284|NCT03701763|471778218|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
131039285|NCT03701763|471778219|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
131039286|NCT03701763|471778220|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
131039287|NCT03701763|471778221|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
131039288|NCT03701763|471778218|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
131039289|NCT03701763|471778219|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
131039290|NCT03701763|471778220|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
131039291|NCT03701763|471778221|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
131039292|NCT03701763|471778218|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
131039293|NCT03701763|471778219|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
131039294|NCT03701763|471778220|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
131039295|NCT03701763|471778221|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
131039296|NCT03701763|471778218|FG000|14-Week Observational Follow-up Phase|Other|0|||
131039297|NCT03701763|471778219|FG001|14-Week Observational Follow-up Phase|Other|0|||
131039298|NCT03701763|471778220|FG002|14-Week Observational Follow-up Phase|Other|1|||
131039299|NCT03701763|471778221|FG003|14-Week Observational Follow-up Phase|Other|0|||
131039300|NCT03701763|471778218|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
131039301|NCT03701763|471778219|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
131039302|NCT03701763|471778220|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
131039303|NCT03701763|471778221|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
131039304|NCT03701763|471778218|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
131039305|NCT03701763|471778219|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
130954180|NCT01434290|471465297|FG000|Overall Study|Protocol Violation|6|||
130954181|NCT01434290|471465298|FG001|Overall Study|Protocol Violation|3|||
130954182|NCT01434290|471465297|FG000|Overall Study|No protocol treatment|2|||
130954183|NCT01434290|471465298|FG001|Overall Study|No protocol treatment|4|||
130954184|NCT00213148|471465300|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
130954185|NCT00213148|471465301|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
130954186|NCT00213148|471465302|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
130954187|NCT00213148|471465303|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
130954188|NCT00213148|471465304|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
130954189|NCT00213148|471465300|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
130954190|NCT00213148|471465301|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
130954191|NCT00213148|471465302|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
130954192|NCT00213148|471465303|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
130954193|NCT00213148|471465304|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
130954194|NCT00213148|471465300|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
130954195|NCT00213148|471465301|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
130954196|NCT00213148|471465302|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
131125262|NCT00094770|472087209|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
131125263|NCT00094770|472087208|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
131125264|NCT00094770|472087209|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
131125265|NCT00094770|472087208|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
131125266|NCT00094770|472087209|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
131125267|NCT00094770|472087208|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
131125268|NCT00094770|472087209|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
131125269|NCT00094770|472087208|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
131125270|NCT00094770|472087209|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
131125271|NCT00094770|472087208|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
131125272|NCT00094770|472087209|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
131125273|NCT00094770|472087208|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
131125274|NCT00094770|472087209|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
131125275|NCT00094770|472087208|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
131125276|NCT00094770|472087209|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
131125277|NCT01911442|472087210|FG000|Overall Study|Adverse Event|2|||
131125278|NCT01911442|472087211|FG001|Overall Study|Adverse Event|2|||
131125279|NCT01911442|472087212|FG002|Overall Study|Adverse Event|4|||
131125280|NCT01911442|472087210|FG000|Overall Study|Lack of Efficacy|1|||
131125281|NCT01911442|472087211|FG001|Overall Study|Lack of Efficacy|1|||
131125282|NCT01911442|472087212|FG002|Overall Study|Lack of Efficacy|1|||
131125283|NCT01911442|472087210|FG000|Overall Study|Lost to Follow-up|2|||
131125284|NCT01911442|472087211|FG001|Overall Study|Lost to Follow-up|0|||
131225331|NCT01078623|472451998|FG013|Treatment Period 2|Withdrawal by Subject|0|||
130774581|NCT02182830|470800578|FG001|Overall Study|Lost to Follow-up|3|||
130774582|NCT00980655|470800579|FG000|Overall Study|Adverse Event|13|||
130711656|NCT02278718|470569886|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
130711657|NCT02278718|470569887|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
130711658|NCT02278718|470569886|FG000|Overall Study|Missing|0|||
130711659|NCT02278718|470569887|FG001|Overall Study|Missing|1|||
130711660|NCT04440449|470569888|FG000|Overall Study|Lost to Follow-up|2|||
130711661|NCT04440449|470569889|FG001|Overall Study|Lost to Follow-up|0|||
130711662|NCT00897949|470569890|FG000|Overall Study|Adverse Event|1|||
130711663|NCT00897949|470569891|FG001|Overall Study|Adverse Event|1|||
130711664|NCT00897949|470569892|FG002|Overall Study|Adverse Event|0|||
130711665|NCT00897949|470569890|FG000|Overall Study|Lost to Follow-up|0|||
130711666|NCT00897949|470569891|FG001|Overall Study|Lost to Follow-up|2|||
130711667|NCT00897949|470569892|FG002|Overall Study|Lost to Follow-up|1|||
130711668|NCT00897949|470569890|FG000|Overall Study|Protocol Violation|6|||
130711669|NCT00897949|470569891|FG001|Overall Study|Protocol Violation|3|||
130711670|NCT00897949|470569892|FG002|Overall Study|Protocol Violation|1|||
130711671|NCT00897949|470569890|FG000|Overall Study|Withdrawal by Subject|1|||
130711672|NCT00897949|470569891|FG001|Overall Study|Withdrawal by Subject|2|||
130711673|NCT00897949|470569892|FG002|Overall Study|Withdrawal by Subject|0|||
130711674|NCT00897949|470569890|FG000|Overall Study|Patient Uncoorperative|0|||
130711675|NCT00897949|470569891|FG001|Overall Study|Patient Uncoorperative|2|||
130711676|NCT00897949|470569892|FG002|Overall Study|Patient Uncoorperative|1|||
130711677|NCT00897949|470569890|FG000|Overall Study|Lost to Follow-up|30|||
130711678|NCT00897949|470569891|FG001|Overall Study|Lost to Follow-up|23|||
130711679|NCT00897949|470569892|FG002|Overall Study|Lost to Follow-up|17|||
130711680|NCT00897949|470569890|FG000|Overall Study|Withdrawal by Subject|24|||
130711681|NCT00897949|470569891|FG001|Overall Study|Withdrawal by Subject|31|||
130711682|NCT00897949|470569892|FG002|Overall Study|Withdrawal by Subject|17|||
130711683|NCT00897949|470569890|FG000|Overall Study|Abnormal Prestudy Labs|2|||
130711684|NCT00897949|470569891|FG001|Overall Study|Abnormal Prestudy Labs|3|||
130711685|NCT00897949|470569892|FG002|Overall Study|Abnormal Prestudy Labs|4|||
130954197|NCT00213148|471465303|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
130954198|NCT00213148|471465304|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
130954199|NCT00213148|471465300|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
130954200|NCT00213148|471465301|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
130954201|NCT00213148|471465302|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
130954202|NCT00213148|471465303|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
130954203|NCT00213148|471465304|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
130954204|NCT00213148|471465300|FG000|Cycle 1 (1 Month)|Other|3|||
130954205|NCT00213148|471465301|FG001|Cycle 1 (1 Month)|Other|0|||
130954206|NCT00213148|471465302|FG002|Cycle 1 (1 Month)|Other|2|||
130954207|NCT00213148|471465303|FG003|Cycle 1 (1 Month)|Other|2|||
130954208|NCT00213148|471465304|FG004|Cycle 1 (1 Month)|Other|7|||
130954209|NCT00213148|471465300|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130954210|NCT00213148|471465301|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130954211|NCT00213148|471465302|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130954212|NCT00213148|471465303|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
130954213|NCT00213148|471465304|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130954214|NCT00213148|471465300|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
130954215|NCT00213148|471465301|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
130954216|NCT00213148|471465302|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
130954217|NCT00213148|471465303|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
130954218|NCT00213148|471465304|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
130954219|NCT00213148|471465300|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
130954220|NCT00213148|471465301|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
130954221|NCT00213148|471465302|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
130954222|NCT00213148|471465303|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
130954223|NCT00213148|471465304|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
130954224|NCT00213148|471465300|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
130954225|NCT00213148|471465301|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
130954226|NCT00213148|471465302|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
131125285|NCT01911442|472087212|FG002|Overall Study|Lost to Follow-up|1|||
131125286|NCT01911442|472087210|FG000|Overall Study|Withdrawal by Subject|1|||
130711686|NCT00897949|470569890|FG000|Overall Study|Abnormal Baseline ECG|2|||
130711687|NCT00897949|470569891|FG001|Overall Study|Abnormal Baseline ECG|2|||
131125287|NCT01911442|472087211|FG001|Overall Study|Withdrawal by Subject|0|||
131125288|NCT01911442|472087212|FG002|Overall Study|Withdrawal by Subject|6|||
130711688|NCT00897949|470569892|FG002|Overall Study|Abnormal Baseline ECG|4|||
130711689|NCT00897949|470569890|FG000|Overall Study|Need for Concom. Med.|0|||
130711690|NCT00897949|470569891|FG001|Overall Study|Need for Concom. Med.|1|||
130711691|NCT00897949|470569892|FG002|Overall Study|Need for Concom. Med.|1|||
130711692|NCT00897949|470569890|FG000|Overall Study|Lack of Migraine Attack|29|||
130954227|NCT00213148|471465303|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
130954228|NCT00213148|471465304|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
130954229|NCT00213148|471465300|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
130711693|NCT00897949|470569891|FG001|Overall Study|Lack of Migraine Attack|30|||
131039306|NCT03701763|471778220|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
131039307|NCT03701763|471778221|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
131039308|NCT03511664|471778227|FG000|Overall Study|Death|457|||
131039309|NCT03511664|471778228|FG001|Overall Study|Death|201|||
131039310|NCT03511664|471778229|FG002|Overall Study|Death|21|||
131039311|NCT03511664|471778227|FG000|Overall Study|Withdrew consent|40|||
131039312|NCT03511664|471778228|FG001|Overall Study|Withdrew consent|63|||
131039313|NCT03511664|471778229|FG002|Overall Study|Withdrew consent|3|||
131039314|NCT03511664|471778227|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
131039315|NCT03511664|471778228|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
131039316|NCT03511664|471778229|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
131039317|NCT03511664|471778227|FG000|Overall Study|Lost to Follow-up|8|||
131039318|NCT03511664|471778228|FG001|Overall Study|Lost to Follow-up|5|||
131039319|NCT03511664|471778229|FG002|Overall Study|Lost to Follow-up|0|||
130954230|NCT00213148|471465301|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
130954231|NCT00213148|471465302|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
130954232|NCT00213148|471465303|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
130954233|NCT00213148|471465304|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
130954234|NCT00213148|471465300|FG000|Cycle 2 (1 Month)|Other|2|||
130954235|NCT00213148|471465301|FG001|Cycle 2 (1 Month)|Other|1|||
130954236|NCT00213148|471465302|FG002|Cycle 2 (1 Month)|Other|2|||
130954237|NCT00213148|471465303|FG003|Cycle 2 (1 Month)|Other|8|||
130954238|NCT00213148|471465304|FG004|Cycle 2 (1 Month)|Other|7|||
130954239|NCT00213148|471465300|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130954240|NCT00213148|471465301|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
130954241|NCT00213148|471465302|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130954242|NCT00213148|471465303|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130954243|NCT00213148|471465304|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
130954244|NCT00213148|471465300|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
130954245|NCT00213148|471465301|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
130954246|NCT00213148|471465302|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
130954247|NCT00213148|471465303|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
130954248|NCT00213148|471465304|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
130954249|NCT00213148|471465300|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
130954250|NCT00213148|471465301|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
130954251|NCT00213148|471465302|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
130954252|NCT00213148|471465303|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
130954253|NCT00213148|471465304|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
130954254|NCT00213148|471465300|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
130954255|NCT00213148|471465301|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
130954256|NCT00213148|471465302|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
130954257|NCT00213148|471465303|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
130954258|NCT00213148|471465304|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
130954259|NCT00213148|471465300|FG000|Cycle 3 (1 Month)|Other|0|||
130954260|NCT00213148|471465301|FG001|Cycle 3 (1 Month)|Other|0|||
130954261|NCT00213148|471465302|FG002|Cycle 3 (1 Month)|Other|1|||
130954262|NCT00213148|471465303|FG003|Cycle 3 (1 Month)|Other|1|||
130954263|NCT00213148|471465304|FG004|Cycle 3 (1 Month)|Other|0|||
131039320|NCT03511664|471778227|FG000|Overall Study|Physician Decision|2|||
131039321|NCT03511664|471778228|FG001|Overall Study|Physician Decision|1|||
131039322|NCT03511664|471778229|FG002|Overall Study|Physician Decision|0|||
131039323|NCT03511664|471778227|FG000|Overall Study|Patient non-compliance|1|||
131039324|NCT03511664|471778228|FG001|Overall Study|Patient non-compliance|0|||
131039325|NCT03511664|471778229|FG002|Overall Study|Patient non-compliance|0|||
131039326|NCT06473662|471778230|FG000|Overall Study|Withdrawal by Subject|1|||
131039327|NCT06473662|471778231|FG001|Overall Study|Withdrawal by Subject|6|||
131039328|NCT06473662|471778232|FG002|Overall Study|Withdrawal by Subject|5|||
131039329|NCT06473662|471778230|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
131039330|NCT06473662|471778231|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
131039331|NCT06473662|471778232|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
131039332|NCT06473662|471778230|FG000|Overall Study|Starting HbA1c below 7%|0|||
131039333|NCT06473662|471778231|FG001|Overall Study|Starting HbA1c below 7%|1|||
131039334|NCT06473662|471778232|FG002|Overall Study|Starting HbA1c below 7%|1|||
131039335|NCT06473662|471778230|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
131039336|NCT06473662|471778231|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
131039337|NCT06473662|471778232|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
131039338|NCT06473662|471778230|FG000|Overall Study|Did not take medication|2|||
131039339|NCT06473662|471778231|FG001|Overall Study|Did not take medication|3|||
131039340|NCT06473662|471778232|FG002|Overall Study|Did not take medication|2|||
131039341|NCT04515849|471778233|FG000|Overall Study|Adverse Event|0|||
131039342|NCT04515849|471778234|FG001|Overall Study|Adverse Event|0|||
130954264|NCT00989833|471465308|FG000|Overall Study|Lost to Follow-up|0|||
130954265|NCT00989833|471465309|FG001|Overall Study|Lost to Follow-up|1|||
130954266|NCT00989833|471465310|FG002|Overall Study|Lost to Follow-up|0|||
131125289|NCT01911442|472087210|FG000|Overall Study|Mother's Work Schedule|0|||
131125290|NCT01911442|472087211|FG001|Overall Study|Mother's Work Schedule|1|||
131125291|NCT01911442|472087212|FG002|Overall Study|Mother's Work Schedule|0|||
131125292|NCT04773106|472087216|FG000|Overall Study|Withdrawal by Subject|3|||
131125293|NCT04773106|472087216|FG000|Overall Study|Death|1|||
131125294|NCT00122681|472087217|FG000|Overall Study|Adverse Event|20|||
131125295|NCT00122681|472087218|FG001|Overall Study|Adverse Event|16|||
131125296|NCT00122681|472087217|FG000|Overall Study|Lost to Follow-up|1080|||
131125297|NCT00122681|472087218|FG001|Overall Study|Lost to Follow-up|1097|||
131125298|NCT00122681|472087217|FG000|Overall Study|Protocol Violation|7|||
130774583|NCT00980655|470800580|FG001|Overall Study|Adverse Event|31|||
130774584|NCT00980655|470800579|FG000|Overall Study|Death|0|||
130954267|NCT00989833|471465308|FG000|Overall Study|Protocol Violation|1|||
130954268|NCT00989833|471465309|FG001|Overall Study|Protocol Violation|2|||
130954269|NCT00989833|471465310|FG002|Overall Study|Protocol Violation|1|||
130954270|NCT00989833|471465308|FG000|Overall Study|Withdrawal by Subject|0|||
130954271|NCT00989833|471465309|FG001|Overall Study|Withdrawal by Subject|0|||
130954272|NCT00989833|471465310|FG002|Overall Study|Withdrawal by Subject|1|||
130954273|NCT00989833|471465308|FG000|Overall Study|Incorrectly randomized|1|||
130954274|NCT00989833|471465309|FG001|Overall Study|Incorrectly randomized|0|||
130954275|NCT00989833|471465310|FG002|Overall Study|Incorrectly randomized|0|||
130954276|NCT02469610|471465311|FG000|Overall Study|Death|1|||
130954277|NCT02469610|471465312|FG001|Overall Study|Death|0|||
130954278|NCT02469610|471465311|FG000|Overall Study|Lost to Follow-up|1|||
130954279|NCT02469610|471465312|FG001|Overall Study|Lost to Follow-up|0|||
130954280|NCT02469610|471465311|FG000|Overall Study|exclusion criteria|2|||
130954281|NCT02469610|471465312|FG001|Overall Study|exclusion criteria|1|||
130954282|NCT01806896|471465313|FG000|Overall Study|Adverse Event|2|||
130954283|NCT01806896|471465314|FG001|Overall Study|Adverse Event|0|||
130954284|NCT01806896|471465313|FG000|Overall Study|Other|1|||
130954285|NCT01806896|471465314|FG001|Overall Study|Other|0|||
130954286|NCT02434770|471465315|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
130954287|NCT02434770|471465316|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
130954288|NCT02434770|471465317|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
130954289|NCT02434770|471465315|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
130954290|NCT02434770|471465316|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
130954291|NCT02434770|471465317|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
130954292|NCT02434770|471465315|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
130954293|NCT02434770|471465316|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
130954294|NCT02434770|471465317|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
130954295|NCT02434770|471465315|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
130954296|NCT02434770|471465316|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
130954297|NCT02434770|471465317|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
130954298|NCT02434770|471465315|FG000|Week 1 to Week 18|Death|1|||
130954299|NCT02434770|471465316|FG001|Week 1 to Week 18|Death|0|||
130954300|NCT02434770|471465317|FG002|Week 1 to Week 18|Death|0|||
130954301|NCT02434770|471465315|FG000|Week 18 to Week|Lost to Follow-up|2|||
130954302|NCT02434770|471465316|FG001|Week 18 to Week|Lost to Follow-up|2|||
130954303|NCT02434770|471465317|FG002|Week 18 to Week|Lost to Follow-up|1|||
130954304|NCT02434770|471465315|FG000|Week 18 to Week|Withdrawal by Subject|0|||
130954305|NCT02434770|471465316|FG001|Week 18 to Week|Withdrawal by Subject|0|||
130954306|NCT02434770|471465317|FG002|Week 18 to Week|Withdrawal by Subject|2|||
130954307|NCT02434770|471465315|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
130954308|NCT02434770|471465316|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
130954309|NCT02434770|471465317|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
130954310|NCT00245765|471465318|FG000|Overall Study|Adverse Event|1|||
130954311|NCT00245765|471465319|FG001|Overall Study|Adverse Event|1|||
130954312|NCT00245765|471465320|FG002|Overall Study|Adverse Event|0|||
130954313|NCT00245765|471465318|FG000|Overall Study|Lack of Efficacy|14|||
130954314|NCT00245765|471465319|FG001|Overall Study|Lack of Efficacy|7|||
130954315|NCT00245765|471465320|FG002|Overall Study|Lack of Efficacy|0|||
130954316|NCT00245765|471465318|FG000|Overall Study|Lost to Follow-up|1|||
130954317|NCT00245765|471465319|FG001|Overall Study|Lost to Follow-up|2|||
130954318|NCT00245765|471465320|FG002|Overall Study|Lost to Follow-up|0|||
130954319|NCT00245765|471465318|FG000|Overall Study|Withdrawal by Subject|1|||
131125299|NCT00122681|472087218|FG001|Overall Study|Protocol Violation|10|||
131125300|NCT00122681|472087217|FG000|Overall Study|Withdrawal by Subject|257|||
131125301|NCT00122681|472087218|FG001|Overall Study|Withdrawal by Subject|251|||
131125302|NCT00122681|472087217|FG000|Overall Study|Personal reasons|150|||
131125303|NCT00122681|472087218|FG001|Overall Study|Personal reasons|147|||
130954320|NCT00245765|471465319|FG001|Overall Study|Withdrawal by Subject|0|||
130954321|NCT00245765|471465320|FG002|Overall Study|Withdrawal by Subject|3|||
130954322|NCT00245765|471465318|FG000|Overall Study|Other reason|2|||
130954323|NCT00245765|471465319|FG001|Overall Study|Other reason|0|||
130954324|NCT00245765|471465320|FG002|Overall Study|Other reason|1|||
130954325|NCT00245765|471465318|FG000|Overall Study|Other|13|||
131125304|NCT01349465|472087219|FG000|Overall Study|Adverse Event|1|||
131125305|NCT01349465|472087220|FG001|Overall Study|Adverse Event|0|||
130954326|NCT00245765|471465319|FG001|Overall Study|Other|4|||
130954327|NCT00245765|471465320|FG002|Overall Study|Other|4|||
130954328|NCT00660348|471465321|FG000|Overall Study|Withdrawal by Subject|1|||
130954329|NCT00660348|471465322|FG001|Overall Study|Withdrawal by Subject|0|||
130954330|NCT03316872|471465326|FG000|Overall Study|Death|1|||
130954331|NCT04074317|471465330|FG000|Third Period|Withdrawal by Subject|0|||
130954332|NCT04074317|471465331|FG001|Third Period|Withdrawal by Subject|0|||
130954333|NCT04074317|471465332|FG002|Third Period|Withdrawal by Subject|0|||
130954334|NCT04074317|471465333|FG003|Third Period|Withdrawal by Subject|1|||
130954335|NCT04074317|471465334|FG004|Third Period|Withdrawal by Subject|0|||
130954336|NCT04074317|471465335|FG005|Third Period|Withdrawal by Subject|0|||
130954337|NCT01101841|471467170|FG000|Overall Study|Adverse Event|15|||
130954338|NCT01101841|471467171|FG001|Overall Study|Adverse Event|15|||
130954339|NCT01101841|471467170|FG000|Overall Study|Lost to Follow-up|9|||
130954340|NCT01101841|471467171|FG001|Overall Study|Lost to Follow-up|3|||
130954341|NCT01101841|471467170|FG000|Overall Study|Withdrawal by Subject|21|||
130954342|NCT01101841|471467171|FG001|Overall Study|Withdrawal by Subject|40|||
130954343|NCT01101841|471467170|FG000|Overall Study|Protocol Violation|1|||
130954344|NCT01101841|471467171|FG001|Overall Study|Protocol Violation|1|||
130954345|NCT01101841|471467170|FG000|Overall Study|Physician Decision|0|||
130954346|NCT01101841|471467171|FG001|Overall Study|Physician Decision|2|||
130954347|NCT01101841|471467170|FG000|Overall Study|Lack of Efficacy|0|||
130954348|NCT01101841|471467171|FG001|Overall Study|Lack of Efficacy|2|||
130954349|NCT01101841|471467170|FG000|Overall Study|Other|0|||
130954350|NCT01101841|471467171|FG001|Overall Study|Other|1|||
130954351|NCT01101841|471467170|FG000|Overall Study|Suicidality Tracking Scale|3|||
130954352|NCT01101841|471467171|FG001|Overall Study|Suicidality Tracking Scale|1|||
130954353|NCT01101841|471467170|FG000|Overall Study|Eligibility Criteria|1|||
130954354|NCT01101841|471467171|FG001|Overall Study|Eligibility Criteria|2|||
130954355|NCT00653224|471467176|FG000|Overall Study|Adverse Event|2|||
130954356|NCT00653224|471467177|FG001|Overall Study|Adverse Event|1|||
130954357|NCT00653224|471467176|FG000|Overall Study|Lack of Efficacy|1|||
130954358|NCT00653224|471467177|FG001|Overall Study|Lack of Efficacy|2|||
130954359|NCT00653224|471467176|FG000|Overall Study|Loss of efficacy|1|||
130954360|NCT00653224|471467177|FG001|Overall Study|Loss of efficacy|0|||
130954361|NCT00653224|471467176|FG000|Overall Study|Lost to Follow-up|1|||
130954362|NCT00653224|471467177|FG001|Overall Study|Lost to Follow-up|0|||
130954363|NCT00653224|471467176|FG000|Overall Study|Other|2|||
131225332|NCT01078623|472451999|FG014|Treatment Period 2|Withdrawal by Subject|0|||
131225333|NCT01078623|472452000|FG015|Treatment Period 2|Withdrawal by Subject|0|||
130954364|NCT00653224|471467177|FG001|Overall Study|Other|4|||
130954365|NCT03633396|471467182|FG000|Overall Study|Withdrawal by Subject|4|||
130954366|NCT03633396|471467183|FG001|Overall Study|Withdrawal by Subject|4|||
130954367|NCT03633396|471467182|FG000|Overall Study|Adverse Event|1|||
130954368|NCT03633396|471467183|FG001|Overall Study|Adverse Event|1|||
130954369|NCT03633396|471467182|FG000|Overall Study|Lack of Efficacy|1|||
130954370|NCT03633396|471467183|FG001|Overall Study|Lack of Efficacy|0|||
130954371|NCT03633396|471467182|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
130954372|NCT03633396|471467183|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
130954373|NCT01012817|471467184|FG000|Overall Study|Withdrawal by Subject|0|||
130954374|NCT01012817|471467185|FG001|Overall Study|Withdrawal by Subject|0|||
130954375|NCT01012817|471467186|FG002|Overall Study|Withdrawal by Subject|0|||
130954376|NCT01012817|471467187|FG003|Overall Study|Withdrawal by Subject|1|||
130954377|NCT01012817|471467188|FG004|Overall Study|Withdrawal by Subject|0|||
130954378|NCT01012817|471467189|FG005|Overall Study|Withdrawal by Subject|0|||
130954379|NCT01012817|471467190|FG006|Overall Study|Withdrawal by Subject|0|||
130954380|NCT01012817|471467191|FG007|Overall Study|Withdrawal by Subject|1|||
130954381|NCT01012817|471467192|FG008|Overall Study|Withdrawal by Subject|0|||
130711694|NCT00897949|470569892|FG002|Overall Study|Lack of Migraine Attack|19|||
130954382|NCT01012817|471467193|FG009|Overall Study|Withdrawal by Subject|0|||
130954383|NCT01012817|471467194|FG010|Overall Study|Withdrawal by Subject|1|||
130954384|NCT01012817|471467195|FG011|Overall Study|Withdrawal by Subject|1|||
130711695|NCT00897949|470569890|FG000|Overall Study|Did not take study drug|9|||
130711696|NCT00897949|470569891|FG001|Overall Study|Did not take study drug|3|||
130711697|NCT00897949|470569892|FG002|Overall Study|Did not take study drug|4|||
130711698|NCT01763918|470569893|FG000|Overall Study|Withdrawal by Subject|2|||
130711699|NCT01763918|470569894|FG001|Overall Study|Withdrawal by Subject|1|||
130711700|NCT01763918|470569895|FG002|Overall Study|Withdrawal by Subject|1|||
130711701|NCT01763918|470569896|FG003|Overall Study|Withdrawal by Subject|2|||
130954385|NCT01012817|471467196|FG012|Overall Study|Withdrawal by Subject|0|||
130954386|NCT01012817|471467197|FG013|Overall Study|Withdrawal by Subject|1|||
130954387|NCT01012817|471467184|FG000|Overall Study|Adverse Event|0|||
130954388|NCT01012817|471467185|FG001|Overall Study|Adverse Event|0|||
130954389|NCT01012817|471467186|FG002|Overall Study|Adverse Event|0|||
130954390|NCT01012817|471467187|FG003|Overall Study|Adverse Event|0|||
130954391|NCT01012817|471467188|FG004|Overall Study|Adverse Event|0|||
130954392|NCT01012817|471467189|FG005|Overall Study|Adverse Event|1|||
130954393|NCT01012817|471467190|FG006|Overall Study|Adverse Event|0|||
130954394|NCT01012817|471467191|FG007|Overall Study|Adverse Event|0|||
130954395|NCT01012817|471467192|FG008|Overall Study|Adverse Event|0|||
130954396|NCT01012817|471467193|FG009|Overall Study|Adverse Event|0|||
130954397|NCT01012817|471467194|FG010|Overall Study|Adverse Event|1|||
130954398|NCT01012817|471467195|FG011|Overall Study|Adverse Event|0|||
130954399|NCT01012817|471467196|FG012|Overall Study|Adverse Event|0|||
130954400|NCT01012817|471467197|FG013|Overall Study|Adverse Event|1|||
130954401|NCT03756558|471467198|FG000|Overall Study|Death|1|||
130954402|NCT03756558|471467198|FG000|Overall Study|Lost to Follow-up|2|||
130954403|NCT03756558|471467198|FG000|Overall Study|Withdrawal by Subject|2|||
130954404|NCT00978731|471467199|FG000|Overall Study|Death|4|||
130954405|NCT00978731|471467200|FG001|Overall Study|Death|1|||
130954406|NCT00978731|471467201|FG002|Overall Study|Death|1|||
130954407|NCT00978731|471467202|FG003|Overall Study|Death|0|||
130954408|NCT00978731|471467199|FG000|Overall Study|Lost to Follow-up|0|||
130954409|NCT00978731|471467200|FG001|Overall Study|Lost to Follow-up|0|||
130954410|NCT00978731|471467201|FG002|Overall Study|Lost to Follow-up|0|||
130954411|NCT00978731|471467202|FG003|Overall Study|Lost to Follow-up|1|||
130954412|NCT00978731|471467199|FG000|Overall Study|Adverse Event|5|||
130954413|NCT00978731|471467200|FG001|Overall Study|Adverse Event|2|||
130954414|NCT00978731|471467201|FG002|Overall Study|Adverse Event|0|||
130954415|NCT00978731|471467202|FG003|Overall Study|Adverse Event|0|||
130954416|NCT00978731|471467199|FG000|Overall Study|Participant's request|1|||
130954417|NCT00978731|471467200|FG001|Overall Study|Participant's request|0|||
130954418|NCT00978731|471467201|FG002|Overall Study|Participant's request|0|||
130954419|NCT00978731|471467202|FG003|Overall Study|Participant's request|0|||
130954420|NCT00978731|471467199|FG000|Overall Study|Administrative reason|3|||
130954421|NCT00978731|471467200|FG001|Overall Study|Administrative reason|3|||
130954422|NCT00978731|471467201|FG002|Overall Study|Administrative reason|1|||
130954423|NCT00978731|471467202|FG003|Overall Study|Administrative reason|0|||
130954424|NCT00978731|471467199|FG000|Overall Study|Deterioration without progression|0|||
130954425|NCT00978731|471467200|FG001|Overall Study|Deterioration without progression|1|||
130954426|NCT00978731|471467201|FG002|Overall Study|Deterioration without progression|0|||
130954427|NCT00978731|471467202|FG003|Overall Study|Deterioration without progression|0|||
130954428|NCT00978731|471467199|FG000|Overall Study|Disease progression/relapse|5|||
130954429|NCT00978731|471467200|FG001|Overall Study|Disease progression/relapse|4|||
130954430|NCT00978731|471467201|FG002|Overall Study|Disease progression/relapse|2|||
130954431|NCT00978731|471467202|FG003|Overall Study|Disease progression/relapse|2|||
130954432|NCT00978731|471467199|FG000|Overall Study|Study closure|3|||
130954433|NCT00978731|471467200|FG001|Overall Study|Study closure|4|||
130954434|NCT00978731|471467201|FG002|Overall Study|Study closure|1|||
130954435|NCT00978731|471467202|FG003|Overall Study|Study closure|1|||
130954436|NCT00978731|471467199|FG000|Overall Study|No response|1|||
130954437|NCT00978731|471467200|FG001|Overall Study|No response|0|||
130954438|NCT00978731|471467201|FG002|Overall Study|No response|0|||
130954439|NCT00978731|471467202|FG003|Overall Study|No response|0|||
130954440|NCT01896895|471467205|FG000|Double-blind MP|Physician Decision|0|||
130954441|NCT01896895|471467206|FG001|Double-blind MP|Physician Decision|0|||
130954442|NCT01896895|471467207|FG002|Double-blind MP|Physician Decision|1|||
130954443|NCT01896895|471467208|FG003|Double-blind MP|Physician Decision|0|||
130954444|NCT01896895|471467205|FG000|Double-blind MP|Withdrawal by Subject|0|||
130954445|NCT01896895|471467206|FG001|Double-blind MP|Withdrawal by Subject|2|||
130954446|NCT01896895|471467207|FG002|Double-blind MP|Withdrawal by Subject|1|||
130954447|NCT01896895|471467208|FG003|Double-blind MP|Withdrawal by Subject|0|||
130711702|NCT01763918|470569893|FG000|Overall Study|Sponsor Decision|4|||
130711703|NCT01763918|470569894|FG001|Overall Study|Sponsor Decision|0|||
130711704|NCT01763918|470569895|FG002|Overall Study|Sponsor Decision|9|||
130711705|NCT01763918|470569896|FG003|Overall Study|Sponsor Decision|0|||
130711706|NCT01553747|470569897|FG000|Overall Study|Protocol Violation|0|||
130711707|NCT01553747|470569898|FG001|Overall Study|Protocol Violation|2|||
130711708|NCT01553747|470569899|FG002|Overall Study|Protocol Violation|0|||
130711709|NCT01553747|470569897|FG000|Overall Study|Voluntarily withdrew|70|||
130711710|NCT01553747|470569898|FG001|Overall Study|Voluntarily withdrew|66|||
130711711|NCT01553747|470569899|FG002|Overall Study|Voluntarily withdrew|74|||
130711712|NCT01553747|470569897|FG000|Overall Study|Adverse event or SAE|32|||
130954448|NCT01896895|471467205|FG000|Double-blind MP|Lost to Follow-up|1|||
130954449|NCT01896895|471467206|FG001|Double-blind MP|Lost to Follow-up|0|||
130954450|NCT01896895|471467207|FG002|Double-blind MP|Lost to Follow-up|1|||
130954451|NCT01896895|471467208|FG003|Double-blind MP|Lost to Follow-up|0|||
130954452|NCT00293384|471467209|FG000|Overall Study|Non-compliance|2|||
130954453|NCT00293384|471467209|FG000|Overall Study|Missed dosage/study drug|1|||
130954454|NCT00293384|471467209|FG000|Overall Study|Ineligible|2|||
130954455|NCT04482179|471467210|FG000|Overall Study|Death|1|||
130954456|NCT04482179|471467211|FG001|Overall Study|Death|0|||
130954457|NCT04482179|471467210|FG000|Overall Study|Withdrawal by Subject|1|||
130711713|NCT01553747|470569898|FG001|Overall Study|Adverse event or SAE|28|||
130774585|NCT00980655|470800580|FG001|Overall Study|Death|7|||
130954458|NCT04482179|471467211|FG001|Overall Study|Withdrawal by Subject|0|||
130954459|NCT00145509|471467212|FG000|Overall Study|Adverse Event|10|||
130954460|NCT00145509|471467213|FG001|Overall Study|Adverse Event|3|||
130954461|NCT00145509|471467212|FG000|Overall Study|Lack of Efficacy|3|||
130954462|NCT00145509|471467213|FG001|Overall Study|Lack of Efficacy|1|||
130954463|NCT00145509|471467212|FG000|Overall Study|Lost to Follow-up|5|||
130954464|NCT00145509|471467213|FG001|Overall Study|Lost to Follow-up|9|||
130954465|NCT00145509|471467212|FG000|Overall Study|Withdrew Consent|2|||
130954466|NCT00145509|471467213|FG001|Overall Study|Withdrew Consent|7|||
130954467|NCT00145509|471467212|FG000|Overall Study|Reason not provided|2|||
130954468|NCT00145509|471467213|FG001|Overall Study|Reason not provided|1|||
131125306|NCT01349465|472087219|FG000|Overall Study|Death|3|||
131125307|NCT01349465|472087220|FG001|Overall Study|Death|0|||
131125308|NCT01349465|472087219|FG000|Overall Study|Lost to Follow-up|10|||
131125309|NCT01349465|472087220|FG001|Overall Study|Lost to Follow-up|1|||
131125310|NCT01349465|472087219|FG000|Overall Study|Withdrawal by Subject|4|||
131125311|NCT01349465|472087220|FG001|Overall Study|Withdrawal by Subject|2|||
131125312|NCT01349465|472087219|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
131125313|NCT01349465|472087220|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
131125314|NCT01265615|472087223|FG000|Overall Study|Protocol Violation|2|||
131125315|NCT01265615|472087224|FG001|Overall Study|Protocol Violation|2|||
131125316|NCT01265615|472087225|FG002|Overall Study|Protocol Violation|4|||
131125317|NCT01265615|472087226|FG003|Overall Study|Protocol Violation|3|||
131125318|NCT00632099|472087232|FG000|Overall Study|Lost to Follow-up|3|||
131125319|NCT00632099|472087233|FG001|Overall Study|Lost to Follow-up|3|||
131125320|NCT01923285|472087239|FG000|Overall Study|Withdrawal by Subject|7|||
131125321|NCT01923285|472087240|FG001|Overall Study|Withdrawal by Subject|6|||
131125322|NCT02437864|472087242|FG000|Overall Study|Protocol Violation|4|||
131125323|NCT02437864|472087243|FG001|Overall Study|Protocol Violation|0|||
131125324|NCT00807742|472087246|FG000|Overall Study|Death|9|||
131125325|NCT00807742|472087247|FG001|Overall Study|Death|2|||
131125326|NCT00807742|472087246|FG000|Overall Study|Withdrawal by Subject|2|||
131125327|NCT00807742|472087247|FG001|Overall Study|Withdrawal by Subject|1|||
131125328|NCT00807742|472087246|FG000|Overall Study|Lost to Follow-up|35|||
131125329|NCT00807742|472087247|FG001|Overall Study|Lost to Follow-up|51|||
131125330|NCT00492752|472087248|FG000|Double Blind Treatment|Death|13|||
131125331|NCT00492752|472087249|FG001|Double Blind Treatment|Death|0|||
131125332|NCT00492752|472087250|FG002|Double Blind Treatment|Death|2|||
131125333|NCT00492752|472087251|FG003|Double Blind Treatment|Death|0|||
131125334|NCT00492752|472087248|FG000|Double Blind Treatment|Adverse Event|1|||
131125335|NCT00492752|472087249|FG001|Double Blind Treatment|Adverse Event|0|||
131125336|NCT00492752|472087250|FG002|Double Blind Treatment|Adverse Event|0|||
131125337|NCT00492752|472087251|FG003|Double Blind Treatment|Adverse Event|0|||
131125338|NCT00492752|472087248|FG000|Double Blind Treatment|Protocol Violation|0|||
131125339|NCT00492752|472087249|FG001|Double Blind Treatment|Protocol Violation|0|||
131125340|NCT00492752|472087250|FG002|Double Blind Treatment|Protocol Violation|1|||
131125341|NCT00492752|472087251|FG003|Double Blind Treatment|Protocol Violation|0|||
131125342|NCT00492752|472087248|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
131125343|NCT00492752|472087249|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
131125344|NCT00492752|472087250|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
131125345|NCT00492752|472087251|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
130954469|NCT00419562|471467214|FG000|Overall Study|Lost to Follow-up|12|||
130954470|NCT00419562|471467215|FG001|Overall Study|Lost to Follow-up|13|||
130954471|NCT00419562|471467214|FG000|Overall Study|Withdrawal by Subject|20|||
130954472|NCT00419562|471467215|FG001|Overall Study|Withdrawal by Subject|18|||
130954473|NCT00419562|471467214|FG000|Overall Study|Participant Institutionalized|1|||
130954474|NCT00419562|471467215|FG001|Overall Study|Participant Institutionalized|0|||
130954475|NCT02789176|471467216|FG000|Overall Study|Death|0|||
130954476|NCT02789176|471467217|FG001|Overall Study|Death|0|||
130954477|NCT02789176|471467218|FG002|Overall Study|Death|3|||
130954478|NCT02789176|471467219|FG003|Overall Study|Death|0|||
130954479|NCT02789176|471467216|FG000|Overall Study|Withdrawal by Subject|0|||
130954480|NCT02789176|471467217|FG001|Overall Study|Withdrawal by Subject|0|||
130954481|NCT02789176|471467218|FG002|Overall Study|Withdrawal by Subject|1|||
130954482|NCT02789176|471467219|FG003|Overall Study|Withdrawal by Subject|0|||
130954483|NCT02789176|471467216|FG000|Overall Study|Lost to Follow-up|8|||
131125346|NCT00492752|472087248|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
131125347|NCT00492752|472087249|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
131125348|NCT00492752|472087250|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
131125349|NCT00492752|472087251|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
131125350|NCT00492752|472087248|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
131125351|NCT00492752|472087249|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
131125352|NCT00492752|472087250|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
131125353|NCT00492752|472087251|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
130954484|NCT02789176|471467217|FG001|Overall Study|Lost to Follow-up|2|||
130954485|NCT02789176|471467218|FG002|Overall Study|Lost to Follow-up|6|||
130954486|NCT02789176|471467219|FG003|Overall Study|Lost to Follow-up|1|||
130954487|NCT00596011|471467220|FG000|Overall Study|Withdrawal by Subject|2|||
130711714|NCT01553747|470569899|FG002|Overall Study|Adverse event or SAE|19|||
130711715|NCT01553747|470569897|FG000|Overall Study|Physician decision: other|10|||
130711716|NCT01553747|470569898|FG001|Overall Study|Physician decision: other|8|||
130711717|NCT01553747|470569899|FG002|Overall Study|Physician decision: other|7|||
130954488|NCT00596011|471467221|FG001|Overall Study|Withdrawal by Subject|3|||
130954489|NCT00596011|471467220|FG000|Overall Study|Adverse Event|11|||
130954490|NCT00596011|471467221|FG001|Overall Study|Adverse Event|7|||
130954491|NCT01633944|471467222|FG000|Open-label Titration Phase|Adverse Event|109|||
130954492|NCT01633944|471467223|FG001|Open-label Titration Phase|Adverse Event|0|||
130954493|NCT01633944|471467224|FG002|Open-label Titration Phase|Adverse Event|0|||
130954494|NCT01633944|471467222|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
130954495|NCT01633944|471467223|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
130954496|NCT01633944|471467224|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
130954497|NCT01633944|471467222|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
130954498|NCT01633944|471467223|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
130954499|NCT01633944|471467224|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
130954500|NCT01633944|471467222|FG000|Open-label Titration Phase|Protocol Violation|24|||
130954501|NCT01633944|471467223|FG001|Open-label Titration Phase|Protocol Violation|0|||
130954502|NCT01633944|471467224|FG002|Open-label Titration Phase|Protocol Violation|0|||
130954503|NCT01633944|471467222|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
130954504|NCT01633944|471467223|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
130954505|NCT01633944|471467224|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
130954506|NCT01633944|471467222|FG000|Open-label Titration Phase|Other|68|||
130954507|NCT01633944|471467223|FG001|Open-label Titration Phase|Other|0|||
130954508|NCT01633944|471467224|FG002|Open-label Titration Phase|Other|0|||
130954509|NCT01633944|471467222|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130954510|NCT01633944|471467223|FG001|Double-blind Treatment Phase|Adverse Event|13|||
130954511|NCT01633944|471467224|FG002|Double-blind Treatment Phase|Adverse Event|7|||
130954512|NCT01633944|471467222|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
130954513|NCT01633944|471467223|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
130954514|NCT01633944|471467224|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
130954515|NCT01633944|471467222|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130954516|NCT01633944|471467223|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
130954517|NCT01633944|471467224|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
130954518|NCT01633944|471467222|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
130954519|NCT01633944|471467223|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
130954520|NCT01633944|471467224|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
130954521|NCT01633944|471467222|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130954522|NCT01633944|471467223|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
130954523|NCT01633944|471467224|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
130954524|NCT01633944|471467222|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
130954525|NCT01633944|471467223|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
130954526|NCT01633944|471467224|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
130954527|NCT01633944|471467222|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
130954528|NCT01633944|471467223|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
130954529|NCT01633944|471467224|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
130954530|NCT01633944|471467222|FG000|Double-blind Treatment Phase|Other|0|||
130954531|NCT01633944|471467223|FG001|Double-blind Treatment Phase|Other|7|||
130954532|NCT01633944|471467224|FG002|Double-blind Treatment Phase|Other|0|||
130954533|NCT01467076|471467225|FG000|Overall Study|Lost to Follow-up|1|||
130954534|NCT01467076|471467226|FG001|Overall Study|Lost to Follow-up|0|||
130954535|NCT01467076|471467227|FG002|Overall Study|Lost to Follow-up|0|||
130954536|NCT02506816|471467236|FG000|Overall Study|Adverse Event|3|||
130954537|NCT03364049|471467238|FG000|Overall Study|Death|6|||
130954538|NCT03364049|471467239|FG001|Overall Study|Death|4|||
130954539|NCT03364049|471467240|FG002|Overall Study|Death|5|||
130954540|NCT03364049|471467241|FG003|Overall Study|Death|14|||
130954541|NCT03364049|471467238|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
130954542|NCT03364049|471467239|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
130954543|NCT03364049|471467240|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
131039343|NCT04515849|471778235|FG002|Overall Study|Adverse Event|0|||
130711718|NCT01553747|470569897|FG000|Overall Study|Lost to Follow-up|11|||
130711719|NCT01553747|470569898|FG001|Overall Study|Lost to Follow-up|5|||
130711720|NCT01553747|470569899|FG002|Overall Study|Lost to Follow-up|6|||
130954544|NCT03364049|471467241|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
130954545|NCT03364049|471467238|FG000|Overall Study|Withdrawal by Subject|0|||
130954546|NCT03364049|471467239|FG001|Overall Study|Withdrawal by Subject|1|||
130954547|NCT03364049|471467240|FG002|Overall Study|Withdrawal by Subject|1|||
130954548|NCT03364049|471467241|FG003|Overall Study|Withdrawal by Subject|1|||
130711721|NCT01553747|470569897|FG000|Overall Study|Sponsor decision, specify|7|||
131125354|NCT00492752|472087248|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
131125355|NCT00492752|472087249|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
131125356|NCT00492752|472087250|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
130954549|NCT00418691|471467242|FG000|Overall Study|Lost to Follow-up|1|||
130954550|NCT00418691|471467243|FG001|Overall Study|Lost to Follow-up|2|||
130954551|NCT00418691|471467244|FG002|Overall Study|Lost to Follow-up|3|||
130954552|NCT00418691|471467242|FG000|Overall Study|Started new medication voiding entry|0|||
130954553|NCT00418691|471467243|FG001|Overall Study|Started new medication voiding entry|0|||
130954554|NCT00418691|471467244|FG002|Overall Study|Started new medication voiding entry|1|||
130954555|NCT00418691|471467242|FG000|Overall Study|Progressive Disease|1|||
130954556|NCT00418691|471467243|FG001|Overall Study|Progressive Disease|0|||
130954557|NCT00418691|471467244|FG002|Overall Study|Progressive Disease|1|||
130954558|NCT02103478|471467245|FG000|Overall Study|Adverse Event|0|||
130954559|NCT02103478|471467246|FG001|Overall Study|Adverse Event|0|||
131125357|NCT00492752|472087251|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
131125358|NCT00492752|472087248|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
131125359|NCT00492752|472087249|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
131125360|NCT00492752|472087250|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
131125361|NCT00492752|472087251|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
131125362|NCT00492752|472087248|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
131125363|NCT00492752|472087249|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
131125364|NCT00492752|472087250|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
131125365|NCT00492752|472087251|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
131125366|NCT00492752|472087248|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
131125367|NCT00492752|472087249|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
131125368|NCT00492752|472087250|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
131125369|NCT00492752|472087251|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
131125370|NCT00492752|472087248|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
131125371|NCT00492752|472087249|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
131125372|NCT00492752|472087250|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
131125373|NCT00492752|472087251|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
131125374|NCT00219284|472087252|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
131125375|NCT00219284|472087253|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
131125376|NCT00219284|472087252|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
131125377|NCT00219284|472087253|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
131125378|NCT00219284|472087252|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
131125379|NCT00219284|472087253|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
131125380|NCT00219284|472087252|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
131125381|NCT00219284|472087253|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
131125382|NCT00219284|472087252|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
131125383|NCT00219284|472087253|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
131125384|NCT00219284|472087252|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
131125385|NCT00219284|472087253|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
131125386|NCT00219284|472087252|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
131125387|NCT00219284|472087253|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
131125388|NCT00219284|472087252|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
131125389|NCT00219284|472087253|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
131125390|NCT00219284|472087252|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
131125391|NCT00219284|472087253|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
131125392|NCT01357655|472087254|FG000|Overall Study|Administrative Reason by Sponsor|45|||
131125393|NCT01357655|472087255|FG001|Overall Study|Administrative Reason by Sponsor|0|||
131125394|NCT01357655|472087254|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
131125395|NCT01357655|472087255|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
131125396|NCT01357655|472087254|FG000|Overall Study|Disease Progression|1|||
131125397|NCT01357655|472087255|FG001|Overall Study|Disease Progression|0|||
131125398|NCT01357655|472087254|FG000|Overall Study|Lost to Follow-up|2|||
131125399|NCT01357655|472087255|FG001|Overall Study|Lost to Follow-up|0|||
131125400|NCT01357655|472087254|FG000|Overall Study|Maximum Clinical Benefit|2|||
131125401|NCT01357655|472087255|FG001|Overall Study|Maximum Clinical Benefit|0|||
131125402|NCT01357655|472087254|FG000|Overall Study|Reason Unspecified|1|||
130954560|NCT02103478|471467247|FG002|Overall Study|Adverse Event|1|||
130954561|NCT02103478|471467248|FG003|Overall Study|Adverse Event|1|||
130954562|NCT02103478|471467249|FG004|Overall Study|Adverse Event|2|||
130954563|NCT02103478|471467250|FG005|Overall Study|Adverse Event|1|||
130954564|NCT02103478|471467251|FG006|Overall Study|Adverse Event|0|||
130954565|NCT02103478|471467252|FG007|Overall Study|Adverse Event|0|||
130954566|NCT02103478|471467253|FG008|Overall Study|Adverse Event|0|||
130954567|NCT02103478|471467245|FG000|Overall Study|Death|2|||
130954568|NCT02103478|471467246|FG001|Overall Study|Death|2|||
130711722|NCT01553747|470569898|FG001|Overall Study|Sponsor decision, specify|5|||
130711723|NCT01553747|470569899|FG002|Overall Study|Sponsor decision, specify|0|||
130711724|NCT01553747|470569897|FG000|Overall Study|Physician decision: lack of efficacy|1|||
130711725|NCT01553747|470569898|FG001|Overall Study|Physician decision: lack of efficacy|5|||
130711726|NCT01553747|470569899|FG002|Overall Study|Physician decision: lack of efficacy|3|||
130711727|NCT01875471|470569906|FG000|Overall Study|Adverse Event|0|||
130711728|NCT01875471|470569907|FG001|Overall Study|Adverse Event|1|||
130711729|NCT01875471|470569906|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
130711730|NCT01875471|470569907|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
130711731|NCT03407118|470569911|FG000|Period 2|Withdrawal by Subject|1|||
130711732|NCT03407118|470569912|FG001|Period 2|Withdrawal by Subject|0|||
130711733|NCT02972502|470569916|FG000|Overall Study|Lost to Follow-up|3|||
130711734|NCT02972502|470569917|FG001|Overall Study|Lost to Follow-up|1|||
130711735|NCT02972502|470569916|FG000|Overall Study|Withdrawal by Subject|1|||
130711736|NCT02972502|470569917|FG001|Overall Study|Withdrawal by Subject|1|||
130711737|NCT03832738|470569918|FG000|Overall Study|Withdrawal by Subject|6|||
130711738|NCT03832738|470569919|FG001|Overall Study|Withdrawal by Subject|7|||
130711739|NCT03832738|470569920|FG002|Overall Study|Withdrawal by Subject|16|||
130711740|NCT03832738|470569918|FG000|Overall Study|Physician Decision|0|||
130711741|NCT03832738|470569919|FG001|Overall Study|Physician Decision|1|||
130711742|NCT03832738|470569920|FG002|Overall Study|Physician Decision|2|||
130711743|NCT03832738|470569918|FG000|Overall Study|Adverse Event|2|||
130711744|NCT03832738|470569919|FG001|Overall Study|Adverse Event|3|||
130711745|NCT03832738|470569920|FG002|Overall Study|Adverse Event|1|||
130711746|NCT03832738|470569918|FG000|Overall Study|Pregnancy|0|||
130711747|NCT03832738|470569919|FG001|Overall Study|Pregnancy|1|||
130774586|NCT00980655|470800579|FG000|Overall Study|Protocol Violation|2|||
130954569|NCT02103478|471467247|FG002|Overall Study|Death|1|||
130954570|NCT02103478|471467248|FG003|Overall Study|Death|1|||
130954571|NCT02103478|471467249|FG004|Overall Study|Death|5|||
130954572|NCT02103478|471467250|FG005|Overall Study|Death|15|||
130954573|NCT02103478|471467251|FG006|Overall Study|Death|14|||
130954574|NCT02103478|471467252|FG007|Overall Study|Death|10|||
130954575|NCT02103478|471467253|FG008|Overall Study|Death|11|||
130954576|NCT02103478|471467245|FG000|Overall Study|Progressive Disease|2|||
130954577|NCT02103478|471467246|FG001|Overall Study|Progressive Disease|1|||
130954578|NCT02103478|471467247|FG002|Overall Study|Progressive Disease|2|||
130954579|NCT02103478|471467248|FG003|Overall Study|Progressive Disease|0|||
131125403|NCT01357655|472087255|FG001|Overall Study|Reason Unspecified|0|||
131125404|NCT01357655|472087254|FG000|Overall Study|Study Drug Toxicity|11|||
131125405|NCT01357655|472087255|FG001|Overall Study|Study Drug Toxicity|0|||
131125406|NCT01357655|472087254|FG000|Overall Study|Subject Withdrew Consent|1|||
131125407|NCT01357655|472087255|FG001|Overall Study|Subject Withdrew Consent|0|||
131125408|NCT00609986|472087256|FG000|Overall Study|Did not receive transplant or treatment|8|||
131125409|NCT00609986|472087257|FG001|Overall Study|Did not receive transplant or treatment|3|||
131125410|NCT04722042|472087259|FG000|Overall Study|Withdrawal by Subject|2|||
131125411|NCT04722042|472087260|FG001|Overall Study|Withdrawal by Subject|1|||
131125412|NCT04722042|472087261|FG002|Overall Study|Withdrawal by Subject|0|||
131125413|NCT02090413|472087264|FG000|Overall Study|Adverse Event|11|||
131125414|NCT02090413|472087265|FG001|Overall Study|Adverse Event|15|||
131125415|NCT02090413|472087266|FG002|Overall Study|Adverse Event|20|||
131125416|NCT02090413|472087264|FG000|Overall Study|Flushing event|2|||
131125417|NCT02090413|472087265|FG001|Overall Study|Flushing event|0|||
131125418|NCT02090413|472087266|FG002|Overall Study|Flushing event|1|||
131125419|NCT02090413|472087264|FG000|Overall Study|Withdrawal by Subject|2|||
131125420|NCT02090413|472087265|FG001|Overall Study|Withdrawal by Subject|2|||
131125421|NCT02090413|472087266|FG002|Overall Study|Withdrawal by Subject|2|||
131125422|NCT02090413|472087264|FG000|Overall Study|Investigator Decision|1|||
131125423|NCT02090413|472087265|FG001|Overall Study|Investigator Decision|1|||
131125424|NCT02090413|472087266|FG002|Overall Study|Investigator Decision|0|||
131125425|NCT02090413|472087264|FG000|Overall Study|Other|2|||
130774587|NCT00980655|470800580|FG001|Overall Study|Protocol Violation|7|||
130774588|NCT00980655|470800579|FG000|Overall Study|Withdrawal by Subject|0|||
130954580|NCT02103478|471467249|FG004|Overall Study|Progressive Disease|9|||
130954581|NCT02103478|471467250|FG005|Overall Study|Progressive Disease|1|||
131125426|NCT02090413|472087265|FG001|Overall Study|Other|1|||
130711748|NCT03832738|470569920|FG002|Overall Study|Pregnancy|0|||
130954582|NCT02103478|471467251|FG006|Overall Study|Progressive Disease|2|||
130954583|NCT02103478|471467252|FG007|Overall Study|Progressive Disease|0|||
130711749|NCT01347866|470569923|FG000|Overall Study|Death|0|||
130711750|NCT01347866|470569924|FG001|Overall Study|Death|0|||
130711751|NCT01347866|470569925|FG002|Overall Study|Death|0|||
130711752|NCT01347866|470569926|FG003|Overall Study|Death|1|||
130774589|NCT00980655|470800580|FG001|Overall Study|Withdrawal by Subject|4|||
130954584|NCT02103478|471467253|FG008|Overall Study|Progressive Disease|1|||
131125427|NCT02090413|472087266|FG002|Overall Study|Other|0|||
131125428|NCT02090413|472087264|FG000|Overall Study|Lost to Follow-up|1|||
131125429|NCT02090413|472087265|FG001|Overall Study|Lost to Follow-up|1|||
131125430|NCT02090413|472087266|FG002|Overall Study|Lost to Follow-up|0|||
131125431|NCT01293968|472087267|FG000|Overall Study|non-cooperation|3|||
131225334|NCT01078623|472452001|FG016|Treatment Period 2|Withdrawal by Subject|0|||
131225335|NCT01078623|472452002|FG017|Treatment Period 2|Withdrawal by Subject|0|||
131225336|NCT01078623|472452003|FG018|Treatment Period 2|Withdrawal by Subject|0|||
131225337|NCT01078623|472452004|FG019|Treatment Period 2|Withdrawal by Subject|0|||
131225338|NCT01078623|472451985|FG000|Treatment Period 3|Adverse Event|0|||
131225339|NCT01078623|472451986|FG001|Treatment Period 3|Adverse Event|0|||
131225340|NCT01078623|472451987|FG002|Treatment Period 3|Adverse Event|0|||
131225341|NCT01078623|472451988|FG003|Treatment Period 3|Adverse Event|0|||
131225342|NCT01078623|472451989|FG004|Treatment Period 3|Adverse Event|1|||
131225343|NCT01078623|472451990|FG005|Treatment Period 3|Adverse Event|0|||
131225344|NCT01078623|472451991|FG006|Treatment Period 3|Adverse Event|0|||
131225345|NCT01078623|472451992|FG007|Treatment Period 3|Adverse Event|0|||
131225346|NCT01078623|472451993|FG008|Treatment Period 3|Adverse Event|0|||
131225347|NCT01078623|472451994|FG009|Treatment Period 3|Adverse Event|0|||
131225348|NCT01078623|472451995|FG010|Treatment Period 3|Adverse Event|0|||
131225349|NCT01078623|472451996|FG011|Treatment Period 3|Adverse Event|0|||
131225350|NCT01078623|472451997|FG012|Treatment Period 3|Adverse Event|0|||
131225351|NCT01078623|472451998|FG013|Treatment Period 3|Adverse Event|1|||
131225352|NCT01078623|472451999|FG014|Treatment Period 3|Adverse Event|0|||
131225353|NCT01078623|472452000|FG015|Treatment Period 3|Adverse Event|0|||
131225354|NCT01078623|472452001|FG016|Treatment Period 3|Adverse Event|0|||
131225355|NCT01078623|472452002|FG017|Treatment Period 3|Adverse Event|0|||
131225356|NCT01078623|472452003|FG018|Treatment Period 3|Adverse Event|0|||
131225357|NCT01078623|472452004|FG019|Treatment Period 3|Adverse Event|0|||
131225358|NCT01078623|472451985|FG000|Treatment Period 4|Adverse Event|0|||
131225359|NCT01078623|472451986|FG001|Treatment Period 4|Adverse Event|0|||
131225360|NCT01078623|472451987|FG002|Treatment Period 4|Adverse Event|1|||
131225361|NCT01078623|472451988|FG003|Treatment Period 4|Adverse Event|0|||
131225362|NCT01078623|472451989|FG004|Treatment Period 4|Adverse Event|0|||
131225363|NCT01078623|472451990|FG005|Treatment Period 4|Adverse Event|0|||
131225364|NCT01078623|472451991|FG006|Treatment Period 4|Adverse Event|0|||
131225365|NCT01078623|472451992|FG007|Treatment Period 4|Adverse Event|0|||
131225366|NCT01078623|472451993|FG008|Treatment Period 4|Adverse Event|0|||
131225367|NCT01078623|472451994|FG009|Treatment Period 4|Adverse Event|0|||
131225368|NCT01078623|472451995|FG010|Treatment Period 4|Adverse Event|0|||
131225369|NCT01078623|472451996|FG011|Treatment Period 4|Adverse Event|0|||
131225370|NCT01078623|472451997|FG012|Treatment Period 4|Adverse Event|0|||
131225371|NCT01078623|472451998|FG013|Treatment Period 4|Adverse Event|0|||
131225372|NCT01078623|472451999|FG014|Treatment Period 4|Adverse Event|0|||
131225373|NCT01078623|472452000|FG015|Treatment Period 4|Adverse Event|0|||
131225374|NCT01078623|472452001|FG016|Treatment Period 4|Adverse Event|0|||
131225375|NCT01078623|472452002|FG017|Treatment Period 4|Adverse Event|0|||
131225376|NCT01078623|472452003|FG018|Treatment Period 4|Adverse Event|0|||
131225377|NCT01078623|472452004|FG019|Treatment Period 4|Adverse Event|0|||
131225378|NCT01078623|472451985|FG000|Treatment Period 4|Withdrawal by Subject|0|||
131225379|NCT01078623|472451986|FG001|Treatment Period 4|Withdrawal by Subject|0|||
131225380|NCT01078623|472451987|FG002|Treatment Period 4|Withdrawal by Subject|0|||
131225381|NCT01078623|472451988|FG003|Treatment Period 4|Withdrawal by Subject|0|||
131225382|NCT01078623|472451989|FG004|Treatment Period 4|Withdrawal by Subject|0|||
131225383|NCT01078623|472451990|FG005|Treatment Period 4|Withdrawal by Subject|0|||
131225384|NCT01078623|472451991|FG006|Treatment Period 4|Withdrawal by Subject|0|||
131225385|NCT01078623|472451992|FG007|Treatment Period 4|Withdrawal by Subject|0|||
131125432|NCT01293968|472087268|FG001|Overall Study|non-cooperation|3|||
131125433|NCT00747643|472089046|FG000|Overall Study|Withdrawal by Subject|36|||
131125434|NCT00747643|472089047|FG001|Overall Study|Withdrawal by Subject|27|||
131125435|NCT03370120|472089048|FG000|Overall Study|Adverse event, non-fatal|24|||
131125436|NCT03370120|472089048|FG000|Overall Study|Withdrawal by Subject|6|||
131125437|NCT03370120|472089048|FG000|Overall Study|Lost to Follow-up|1|||
131125438|NCT03370120|472089048|FG000|Overall Study|Lack of Efficacy|37|||
131125439|NCT03370120|472089048|FG000|Overall Study|Per sponsor's instructions|1|||
131125440|NCT03370120|472089048|FG000|Overall Study|Study was terminated by parent company UCB|2|||
131125441|NCT03370120|472089048|FG000|Overall Study|The study was ended by the promoter|3|||
131225386|NCT01078623|472451993|FG008|Treatment Period 4|Withdrawal by Subject|0|||
131225387|NCT01078623|472451994|FG009|Treatment Period 4|Withdrawal by Subject|0|||
131225388|NCT01078623|472451995|FG010|Treatment Period 4|Withdrawal by Subject|0|||
131225389|NCT01078623|472451996|FG011|Treatment Period 4|Withdrawal by Subject|0|||
130711753|NCT01347866|470569927|FG004|Overall Study|Death|2|||
131225390|NCT01078623|472451997|FG012|Treatment Period 4|Withdrawal by Subject|0|||
131225391|NCT01078623|472451998|FG013|Treatment Period 4|Withdrawal by Subject|0|||
130711754|NCT01347866|470569928|FG005|Overall Study|Death|2|||
130711755|NCT01347866|470569929|FG006|Overall Study|Death|1|||
131225392|NCT01078623|472451999|FG014|Treatment Period 4|Withdrawal by Subject|0|||
131225393|NCT01078623|472452000|FG015|Treatment Period 4|Withdrawal by Subject|1|||
131225394|NCT01078623|472452001|FG016|Treatment Period 4|Withdrawal by Subject|0|||
130711756|NCT01347866|470569930|FG007|Overall Study|Death|0|||
131125442|NCT03370120|472089048|FG000|Overall Study|Discontinuation of drug development|3|||
131225395|NCT01078623|472452002|FG017|Treatment Period 4|Withdrawal by Subject|0|||
131225396|NCT01078623|472452003|FG018|Treatment Period 4|Withdrawal by Subject|0|||
131225397|NCT01078623|472452004|FG019|Treatment Period 4|Withdrawal by Subject|0|||
130954585|NCT02103478|471467245|FG000|Overall Study|Withdrawal by Subject|2|||
130954586|NCT02103478|471467246|FG001|Overall Study|Withdrawal by Subject|0|||
130954587|NCT02103478|471467247|FG002|Overall Study|Withdrawal by Subject|0|||
130954588|NCT02103478|471467248|FG003|Overall Study|Withdrawal by Subject|4|||
130954589|NCT02103478|471467249|FG004|Overall Study|Withdrawal by Subject|0|||
130954590|NCT02103478|471467250|FG005|Overall Study|Withdrawal by Subject|0|||
130954591|NCT02103478|471467251|FG006|Overall Study|Withdrawal by Subject|1|||
130954592|NCT02103478|471467252|FG007|Overall Study|Withdrawal by Subject|1|||
131225398|NCT00623623|472452005|FG000|Overall Study|Previous enrolment into this study|1|||
131225399|NCT00623623|472452006|FG001|Overall Study|Previous enrolment into this study|1|||
131225400|NCT02265952|472452008|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
131225401|NCT02265952|472452009|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
131225402|NCT02265952|472452008|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
131225403|NCT02265952|472452009|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
131225404|NCT01042977|472452010|FG000|Overall Study|Adverse Event|4|||
131225405|NCT01042977|472452011|FG001|Overall Study|Adverse Event|12|||
131225406|NCT01042977|472452010|FG000|Overall Study|Death|2|||
131225407|NCT01042977|472452011|FG001|Overall Study|Death|1|||
131225408|NCT01042977|472452010|FG000|Overall Study|Withdrawal by Subject|8|||
131225409|NCT01042977|472452011|FG001|Overall Study|Withdrawal by Subject|16|||
131225410|NCT01042977|472452010|FG000|Overall Study|Lost to Follow-up|0|||
131225411|NCT01042977|472452011|FG001|Overall Study|Lost to Follow-up|2|||
131225412|NCT01042977|472452010|FG000|Overall Study|Poor/non-compliance|3|||
131225413|NCT01042977|472452011|FG001|Overall Study|Poor/non-compliance|4|||
131225414|NCT01042977|472452010|FG000|Overall Study|Subject no longer meets study criteria|15|||
131225415|NCT01042977|472452011|FG001|Overall Study|Subject no longer meets study criteria|13|||
131225416|NCT01042977|472452010|FG000|Overall Study|Incorrect enrollment|6|||
131225417|NCT01042977|472452011|FG001|Overall Study|Incorrect enrollment|4|||
131225418|NCT01042977|472452010|FG000|Overall Study|Safety|0|||
131225419|NCT01042977|472452011|FG001|Overall Study|Safety|2|||
131225420|NCT01042977|472452010|FG000|Overall Study|Administrative reason by sponsor|0|||
131225421|NCT01042977|472452011|FG001|Overall Study|Administrative reason by sponsor|1|||
131225422|NCT01042977|472452010|FG000|Overall Study|Various|3|||
131225423|NCT01042977|472452011|FG001|Overall Study|Various|0|||
131225424|NCT02499354|472452012|FG000|Overall Study|Withdrawal by Subject|1|||
131225425|NCT02499354|472452013|FG001|Overall Study|Withdrawal by Subject|0|||
131225426|NCT04356573|472452016|FG000|Overall Study|Didn't Qualify|1|||
130954593|NCT02103478|471467253|FG008|Overall Study|Withdrawal by Subject|0|||
130954594|NCT02103478|471467245|FG000|Overall Study|Lost to Follow-up|0|||
130954595|NCT02103478|471467246|FG001|Overall Study|Lost to Follow-up|0|||
130954596|NCT02103478|471467247|FG002|Overall Study|Lost to Follow-up|0|||
130954597|NCT02103478|471467248|FG003|Overall Study|Lost to Follow-up|0|||
130954598|NCT02103478|471467249|FG004|Overall Study|Lost to Follow-up|0|||
130954599|NCT02103478|471467250|FG005|Overall Study|Lost to Follow-up|0|||
130954600|NCT02103478|471467251|FG006|Overall Study|Lost to Follow-up|0|||
130954601|NCT02103478|471467252|FG007|Overall Study|Lost to Follow-up|1|||
130954602|NCT02103478|471467253|FG008|Overall Study|Lost to Follow-up|0|||
130954603|NCT02103478|471467245|FG000|Overall Study|Other|1|||
130954604|NCT02103478|471467246|FG001|Overall Study|Other|3|||
130954605|NCT02103478|471467247|FG002|Overall Study|Other|2|||
130954606|NCT02103478|471467248|FG003|Overall Study|Other|0|||
130954607|NCT02103478|471467249|FG004|Overall Study|Other|3|||
130954608|NCT02103478|471467250|FG005|Overall Study|Other|8|||
130954609|NCT02103478|471467251|FG006|Overall Study|Other|8|||
130954610|NCT02103478|471467252|FG007|Overall Study|Other|4|||
130954611|NCT02103478|471467253|FG008|Overall Study|Other|2|||
130954612|NCT04182100|471467254|FG000|Overall Study|Adverse Event|1|||
130954613|NCT04182100|471467254|FG000|Overall Study|Withdrawal by Subject|1|||
131125443|NCT03370120|472089048|FG000|Overall Study|End of project|2|||
131125444|NCT03370120|472089048|FG000|Overall Study|Premature study closure|2|||
131125445|NCT03370120|472089048|FG000|Overall Study|Premature program termination|1|||
131125446|NCT03370120|472089048|FG000|Overall Study|Premature study termination|7|||
131125447|NCT03370120|472089048|FG000|Overall Study|Trial terminated by sponsor|2|||
131125448|NCT03370120|472089048|FG000|Overall Study|Trial discontinued by sponsor|2|||
131125449|NCT03370120|472089048|FG000|Overall Study|Study ended|15|||
131125450|NCT03370120|472089048|FG000|Overall Study|Clinical trial has been cancelled|1|||
131225427|NCT04356573|472452017|FG001|Overall Study|Didn't Qualify|0|||
131225428|NCT02424565|472452018|FG000|Period 1 (D0)|Protocol Violation|0|||
131225429|NCT02424565|472452019|FG001|Period 1 (D0)|Protocol Violation|1|||
130954614|NCT04988295|471467255|FG000|Overall Study|Withdrawal by Subject|9|||
130954615|NCT04988295|471467256|FG001|Overall Study|Withdrawal by Subject|29|||
130954616|NCT04988295|471467257|FG002|Overall Study|Withdrawal by Subject|6|||
130954617|NCT04988295|471467258|FG003|Overall Study|Withdrawal by Subject|0|||
130954618|NCT04988295|471467255|FG000|Overall Study|Lost to Follow-up|1|||
130954619|NCT04988295|471467256|FG001|Overall Study|Lost to Follow-up|0|||
130954620|NCT04988295|471467257|FG002|Overall Study|Lost to Follow-up|0|||
130954621|NCT04988295|471467258|FG003|Overall Study|Lost to Follow-up|0|||
130985564|NCT01984697|471574904|FG000|Overall Study|Adverse Event|0|||
130711757|NCT01347866|470569931|FG008|Overall Study|Death|4|||
130711758|NCT01347866|470569932|FG009|Overall Study|Death|1|||
130711759|NCT01347866|470569933|FG010|Overall Study|Death|3|||
130711760|NCT01347866|470569934|FG011|Overall Study|Death|1|||
130954622|NCT04988295|471467255|FG000|Overall Study|Study participation ongoing|186|||
130954623|NCT04988295|471467256|FG001|Overall Study|Study participation ongoing|169|||
130954624|NCT04988295|471467257|FG002|Overall Study|Study participation ongoing|99|||
130954625|NCT04988295|471467258|FG003|Overall Study|Study participation ongoing|119|||
130954626|NCT04649151|471467259|FG000|Overall Study|Pregnancy|0|||
130711761|NCT01347866|470569935|FG012|Overall Study|Death|2|||
130711762|NCT01347866|470569936|FG013|Overall Study|Death|0|||
130711763|NCT01347866|470569937|FG014|Overall Study|Death|0|||
130711764|NCT01347866|470569938|FG015|Overall Study|Death|1|||
130711765|NCT01347866|470569939|FG016|Overall Study|Death|0|||
130711766|NCT01347866|470569923|FG000|Overall Study|Lost to Follow-up|0|||
130711767|NCT01347866|470569924|FG001|Overall Study|Lost to Follow-up|0|||
130711768|NCT01347866|470569925|FG002|Overall Study|Lost to Follow-up|0|||
130711769|NCT01347866|470569926|FG003|Overall Study|Lost to Follow-up|0|||
130711770|NCT01347866|470569927|FG004|Overall Study|Lost to Follow-up|0|||
130711771|NCT01347866|470569928|FG005|Overall Study|Lost to Follow-up|0|||
130711772|NCT01347866|470569929|FG006|Overall Study|Lost to Follow-up|0|||
130711773|NCT01347866|470569930|FG007|Overall Study|Lost to Follow-up|1|||
130711774|NCT01347866|470569931|FG008|Overall Study|Lost to Follow-up|1|||
130954627|NCT04649151|471467260|FG001|Overall Study|Pregnancy|0|||
130954628|NCT04649151|471467261|FG002|Overall Study|Pregnancy|0|||
130954629|NCT04649151|471467262|FG003|Overall Study|Pregnancy|0|||
130954630|NCT04649151|471467263|FG004|Overall Study|Pregnancy|3|||
130954631|NCT04649151|471467259|FG000|Overall Study|Physician Decision|10|||
130954632|NCT04649151|471467260|FG001|Overall Study|Physician Decision|0|||
130954633|NCT04649151|471467261|FG002|Overall Study|Physician Decision|0|||
130954634|NCT04649151|471467262|FG003|Overall Study|Physician Decision|1|||
130954635|NCT04649151|471467263|FG004|Overall Study|Physician Decision|1|||
130954636|NCT04649151|471467259|FG000|Overall Study|Protocol Deviation|25|||
130954637|NCT04649151|471467260|FG001|Overall Study|Protocol Deviation|3|||
130954638|NCT04649151|471467261|FG002|Overall Study|Protocol Deviation|0|||
130954639|NCT04649151|471467262|FG003|Overall Study|Protocol Deviation|0|||
130954640|NCT04649151|471467263|FG004|Overall Study|Protocol Deviation|0|||
130954641|NCT04649151|471467259|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
130954642|NCT04649151|471467260|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
130954643|NCT04649151|471467261|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
130954644|NCT04649151|471467262|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
130954645|NCT04649151|471467263|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
130954646|NCT04649151|471467259|FG000|Overall Study|Withdrawal by Subject|370|||
130954647|NCT04649151|471467260|FG001|Overall Study|Withdrawal by Subject|113|||
130954648|NCT04649151|471467261|FG002|Overall Study|Withdrawal by Subject|2|||
130954649|NCT04649151|471467262|FG003|Overall Study|Withdrawal by Subject|7|||
130954650|NCT04649151|471467263|FG004|Overall Study|Withdrawal by Subject|15|||
130954651|NCT04649151|471467259|FG000|Overall Study|Adverse Event|1|||
130954652|NCT04649151|471467260|FG001|Overall Study|Adverse Event|0|||
130954653|NCT04649151|471467261|FG002|Overall Study|Adverse Event|0|||
130954654|NCT04649151|471467262|FG003|Overall Study|Adverse Event|0|||
130954655|NCT04649151|471467263|FG004|Overall Study|Adverse Event|0|||
130954656|NCT04649151|471467259|FG000|Overall Study|Lost to Follow-up|256|||
130954657|NCT04649151|471467260|FG001|Overall Study|Lost to Follow-up|29|||
130954658|NCT04649151|471467261|FG002|Overall Study|Lost to Follow-up|10|||
130954659|NCT04649151|471467262|FG003|Overall Study|Lost to Follow-up|3|||
130954660|NCT04649151|471467263|FG004|Overall Study|Lost to Follow-up|6|||
130954661|NCT04649151|471467259|FG000|Overall Study|Other than specified|59|||
130954662|NCT04649151|471467260|FG001|Overall Study|Other than specified|294|||
130954663|NCT04649151|471467261|FG002|Overall Study|Other than specified|0|||
130954664|NCT04649151|471467262|FG003|Overall Study|Other than specified|0|||
130954665|NCT04649151|471467263|FG004|Overall Study|Other than specified|4|||
130954666|NCT04649151|471467259|FG000|Overall Study|Death|0|||
130954667|NCT04649151|471467260|FG001|Overall Study|Death|0|||
130954668|NCT04649151|471467261|FG002|Overall Study|Death|0|||
130711775|NCT01347866|470569932|FG009|Overall Study|Lost to Follow-up|0|||
130711776|NCT01347866|470569933|FG010|Overall Study|Lost to Follow-up|0|||
130774590|NCT00980655|470800579|FG000|Overall Study|Lost to Follow-up|0|||
130774591|NCT00980655|470800580|FG001|Overall Study|Lost to Follow-up|1|||
130954669|NCT04649151|471467262|FG003|Overall Study|Death|0|||
130954670|NCT04649151|471467263|FG004|Overall Study|Death|1|||
130954671|NCT00433654|471467270|FG000|Overall Study|Death|4|||
130954672|NCT00433654|471467271|FG001|Overall Study|Death|0|||
130954673|NCT00433654|471467270|FG000|Overall Study|Missed visit|6|||
130954674|NCT00433654|471467271|FG001|Overall Study|Missed visit|3|||
130711777|NCT01347866|470569934|FG011|Overall Study|Lost to Follow-up|0|||
130711778|NCT01347866|470569935|FG012|Overall Study|Lost to Follow-up|0|||
130711779|NCT01347866|470569936|FG013|Overall Study|Lost to Follow-up|0|||
130711780|NCT01347866|470569937|FG014|Overall Study|Lost to Follow-up|0|||
130954675|NCT00433654|471467270|FG000|Overall Study|Subject not yet due for visit|4|||
130711781|NCT01347866|470569938|FG015|Overall Study|Lost to Follow-up|0|||
130711782|NCT01347866|470569939|FG016|Overall Study|Lost to Follow-up|0|||
130711783|NCT01347866|470569923|FG000|Overall Study|Other|3|||
130711784|NCT01347866|470569924|FG001|Overall Study|Other|1|||
130711785|NCT01347866|470569925|FG002|Overall Study|Other|1|||
130711786|NCT01347866|470569926|FG003|Overall Study|Other|4|||
130711787|NCT01347866|470569927|FG004|Overall Study|Other|5|||
130711788|NCT01347866|470569928|FG005|Overall Study|Other|0|||
130711789|NCT01347866|470569929|FG006|Overall Study|Other|5|||
130711790|NCT01347866|470569930|FG007|Overall Study|Other|3|||
130711791|NCT01347866|470569931|FG008|Overall Study|Other|22|||
130711792|NCT01347866|470569932|FG009|Overall Study|Other|5|||
130711793|NCT01347866|470569933|FG010|Overall Study|Other|0|||
130711794|NCT01347866|470569934|FG011|Overall Study|Other|3|||
130711795|NCT01347866|470569935|FG012|Overall Study|Other|4|||
130711796|NCT01347866|470569936|FG013|Overall Study|Other|4|||
130711797|NCT01347866|470569937|FG014|Overall Study|Other|2|||
130711798|NCT01347866|470569938|FG015|Overall Study|Other|3|||
130711799|NCT01347866|470569939|FG016|Overall Study|Other|0|||
130711800|NCT01347866|470569923|FG000|Overall Study|Subject refused further follow-up|2|||
130711801|NCT01347866|470569924|FG001|Overall Study|Subject refused further follow-up|0|||
130711802|NCT01347866|470569925|FG002|Overall Study|Subject refused further follow-up|0|||
130711803|NCT01347866|470569926|FG003|Overall Study|Subject refused further follow-up|2|||
130711804|NCT01347866|470569927|FG004|Overall Study|Subject refused further follow-up|0|||
130954676|NCT00433654|471467271|FG001|Overall Study|Subject not yet due for visit|0|||
130954677|NCT00433654|471467270|FG000|Overall Study|Withdrawal by Subject|1|||
130954678|NCT00433654|471467271|FG001|Overall Study|Withdrawal by Subject|2|||
130954699|NCT04033159|471467281|FG000|Washout Period|Physician Decision|0|||
130954700|NCT04033159|471467282|FG001|Washout Period|Physician Decision|1|||
130954701|NCT04033159|471467283|FG002|Washout Period|Physician Decision|0|||
130954702|NCT04033159|471467281|FG000|Washout Period|Study terminated by Sponsor|0|||
130711805|NCT01347866|470569928|FG005|Overall Study|Subject refused further follow-up|1|||
130711806|NCT01347866|470569929|FG006|Overall Study|Subject refused further follow-up|0|||
130711807|NCT01347866|470569930|FG007|Overall Study|Subject refused further follow-up|0|||
130954703|NCT04033159|471467282|FG001|Washout Period|Study terminated by Sponsor|7|||
130954704|NCT04033159|471467283|FG002|Washout Period|Study terminated by Sponsor|0|||
130954705|NCT04033159|471467281|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
130954706|NCT04033159|471467282|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
130711808|NCT01347866|470569931|FG008|Overall Study|Subject refused further follow-up|4|||
131039344|NCT04515849|471778236|FG003|Overall Study|Adverse Event|1|||
131039345|NCT04515849|471778237|FG004|Overall Study|Adverse Event|2|||
131039346|NCT04515849|471778233|FG000|Overall Study|Death|2|||
130711809|NCT01347866|470569932|FG009|Overall Study|Subject refused further follow-up|1|||
130711810|NCT01347866|470569933|FG010|Overall Study|Subject refused further follow-up|0|||
131039347|NCT04515849|471778234|FG001|Overall Study|Death|0|||
131039348|NCT04515849|471778235|FG002|Overall Study|Death|0|||
131039349|NCT04515849|471778236|FG003|Overall Study|Death|0|||
131039350|NCT04515849|471778237|FG004|Overall Study|Death|0|||
131039351|NCT04515849|471778233|FG000|Overall Study|Other:family emergency|0|||
130711811|NCT01347866|470569934|FG011|Overall Study|Subject refused further follow-up|0|||
130711812|NCT01347866|470569935|FG012|Overall Study|Subject refused further follow-up|1|||
130711813|NCT01347866|470569936|FG013|Overall Study|Subject refused further follow-up|3|||
130954707|NCT04033159|471467283|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
130954709|NCT01428193|471467285|FG000|Overall Study|Physician Decision|1|||
130954710|NCT01428193|471467285|FG000|Overall Study|Elevated screening liver enzymes|1|||
130954711|NCT03762083|471467286|FG000|Overall Study|Withdrawal by Subject|2|||
131039352|NCT04515849|471778234|FG001|Overall Study|Other:family emergency|0|||
131039353|NCT04515849|471778235|FG002|Overall Study|Other:family emergency|0|||
130954712|NCT03762083|471467286|FG000|Overall Study|Physician Decision|1|||
130711814|NCT01347866|470569937|FG014|Overall Study|Subject refused further follow-up|1|||
130711815|NCT01347866|470569938|FG015|Overall Study|Subject refused further follow-up|0|||
130711816|NCT01347866|470569939|FG016|Overall Study|Subject refused further follow-up|2|||
130711817|NCT00430950|470569940|FG000|Overall Study|Adverse Event|7|||
130711818|NCT00430950|470569941|FG001|Overall Study|Adverse Event|6|||
130711819|NCT00430950|470569940|FG000|Overall Study|Withdrawal by Subject|1|||
130711820|NCT00430950|470569941|FG001|Overall Study|Withdrawal by Subject|0|||
130711821|NCT00430950|470569940|FG000|Overall Study|concomitant medication,etc.|5|||
130711822|NCT00430950|470569941|FG001|Overall Study|concomitant medication,etc.|7|||
130711823|NCT02429934|470569942|FG000|Overall Study|Withdrawal by Subject|0|||
130711824|NCT02429934|470569943|FG001|Overall Study|Withdrawal by Subject|2|||
130954713|NCT00116558|471467287|FG000|Overall Study|Death|11|||
130954714|NCT00116558|471467288|FG001|Overall Study|Death|5|||
130954715|NCT00116558|471467289|FG002|Overall Study|Death|3|||
130954716|NCT00116558|471467287|FG000|Overall Study|Withdrawal by Subject|17|||
130954717|NCT00116558|471467288|FG001|Overall Study|Withdrawal by Subject|3|||
130954718|NCT00116558|471467289|FG002|Overall Study|Withdrawal by Subject|12|||
130954719|NCT00116558|471467287|FG000|Overall Study|disease progression|3|||
130954720|NCT00116558|471467288|FG001|Overall Study|disease progression|7|||
130954721|NCT00116558|471467289|FG002|Overall Study|disease progression|18|||
130954722|NCT00378014|471467290|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
130954723|NCT00378014|471467291|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
130954724|NCT00378014|471467290|FG000|Core (Randomization to Month 11)|Graft loss|1|||
130954725|NCT00378014|471467291|FG001|Core (Randomization to Month 11)|Graft loss|2|||
130954726|NCT00378014|471467290|FG000|Core (Randomization to Month 11)|Death|5|||
130954727|NCT00378014|471467291|FG001|Core (Randomization to Month 11)|Death|3|||
130954728|NCT00378014|471467290|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
130954729|NCT00378014|471467291|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
130954730|NCT00378014|471467290|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
130954731|NCT00378014|471467291|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
130954732|NCT00378014|471467290|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
130954733|NCT00378014|471467291|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
130954734|NCT00378014|471467290|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
130954735|NCT00378014|471467291|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
130954736|NCT00378014|471467290|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
130954737|NCT00378014|471467291|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
130954738|NCT00378014|471467290|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
130954739|NCT00378014|471467291|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
130954740|NCT00378014|471467290|FG000|Extension (Month 12 to Month 59)|Death|1|||
130954741|NCT00378014|471467291|FG001|Extension (Month 12 to Month 59)|Death|2|||
130954742|NCT00378014|471467290|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
131125451|NCT03370120|472089048|FG000|Overall Study|End of study per sponsor decision|2|||
131125452|NCT03370120|472089048|FG000|Overall Study|Promoter's decision|2|||
131125453|NCT03370120|472089048|FG000|Overall Study|The trial has been suspended|3|||
131125454|NCT03370120|472089048|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
131125455|NCT03370120|472089048|FG000|Overall Study|Early termination by order of sponsor|2|||
131125456|NCT03370120|472089048|FG000|Overall Study|Discontinuation of the study|5|||
131125457|NCT03370120|472089048|FG000|Overall Study|End of clinical trial discontinuation|1|||
131125458|NCT03370120|472089048|FG000|Overall Study|Because the clinical trial ended halfway|4|||
131125459|NCT03370120|472089048|FG000|Overall Study|Development discontinued|5|||
131125460|NCT03370120|472089048|FG000|Overall Study|Padsenovil program closed|3|||
131125461|NCT03370120|472089048|FG000|Overall Study|End of project|2|||
131125462|NCT03370120|472089048|FG000|Overall Study|Termination of project|1|||
131125463|NCT03370120|472089048|FG000|Overall Study|The study was interrupted by sponsor|4|||
131125464|NCT03370120|472089048|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
131125465|NCT03370120|472089048|FG000|Overall Study|End of sponsor decision|1|||
131125466|NCT03370120|472089048|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
131125467|NCT03370120|472089048|FG000|Overall Study|Early termination of studies|5|||
131125468|NCT03370120|472089048|FG000|Overall Study|This study is ended early|1|||
131125469|NCT03370120|472089048|FG000|Overall Study|End of padsevonil program|2|||
131125470|NCT03370120|472089048|FG000|Overall Study|Decision of sponsor|6|||
131125471|NCT03370120|472089048|FG000|Overall Study|Asked by the sponsor|3|||
131125472|NCT03370120|472089048|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
131125473|NCT03370120|472089048|FG000|Overall Study|PI decision poor compliance from participant|1|||
131125474|NCT03370120|472089048|FG000|Overall Study|Promoter ended the study|3|||
130711825|NCT02429934|470569942|FG000|Overall Study|Adverse Event|2|||
130711826|NCT02429934|470569943|FG001|Overall Study|Adverse Event|0|||
130954743|NCT00378014|471467291|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
130954744|NCT00378014|471467290|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
130954745|NCT00378014|471467291|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
130711827|NCT02429934|470569942|FG000|Overall Study|Lost to Follow-up|1|||
130954746|NCT00378014|471467290|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
130954747|NCT00378014|471467291|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
130954748|NCT00378014|471467290|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
130954749|NCT00378014|471467291|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
130954750|NCT02287896|471467297|FG000|Second Injection Visit|Withdrawal by Subject|0|||
130954751|NCT02287896|471467298|FG001|Second Injection Visit|Withdrawal by Subject|1|||
130954752|NCT05267054|471467299|FG000|Overall Study|Death|13|||
130954753|NCT05267054|471467300|FG001|Overall Study|Death|14|||
130954754|NCT05267054|471467299|FG000|Overall Study|Study Ended by Sponsor|9|||
130954755|NCT05267054|471467300|FG001|Overall Study|Study Ended by Sponsor|13|||
130954756|NCT05267054|471467299|FG000|Overall Study|Lost to Follow-up|1|||
130954757|NCT05267054|471467300|FG001|Overall Study|Lost to Follow-up|1|||
130954758|NCT05267054|471467299|FG000|Overall Study|Withdrawal by Subject|1|||
130954759|NCT05267054|471467300|FG001|Overall Study|Withdrawal by Subject|1|||
130954760|NCT01403974|471467301|FG000|Overall Study|Progressive disease according to RECIST|3|||
130954761|NCT01403974|471467302|FG001|Overall Study|Progressive disease according to RECIST|3|||
130954762|NCT01403974|471467303|FG002|Overall Study|Progressive disease according to RECIST|2|||
130954763|NCT01403974|471467304|FG003|Overall Study|Progressive disease according to RECIST|3|||
130954764|NCT01403974|471467305|FG004|Overall Study|Progressive disease according to RECIST|3|||
130954765|NCT01403974|471467306|FG005|Overall Study|Progressive disease according to RECIST|2|||
130954766|NCT01403974|471467307|FG006|Overall Study|Progressive disease according to RECIST|3|||
130954767|NCT01403974|471467308|FG007|Overall Study|Progressive disease according to RECIST|2|||
130954768|NCT01403974|471467309|FG008|Overall Study|Progressive disease according to RECIST|6|||
130954769|NCT01403974|471467310|FG009|Overall Study|Progressive disease according to RECIST|2|||
130954770|NCT01403974|471467311|FG010|Overall Study|Progressive disease according to RECIST|3|||
130954771|NCT01403974|471467312|FG011|Overall Study|Progressive disease according to RECIST|2|||
130954772|NCT01403974|471467313|FG012|Overall Study|Progressive disease according to RECIST|2|||
130954773|NCT01403974|471467314|FG013|Overall Study|Progressive disease according to RECIST|3|||
130954774|NCT01403974|471467315|FG014|Overall Study|Progressive disease according to RECIST|1|||
130954775|NCT01403974|471467316|FG015|Overall Study|Progressive disease according to RECIST|8|||
130954776|NCT01403974|471467301|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
130954777|NCT01403974|471467302|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
130954778|NCT01403974|471467303|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
130954779|NCT01403974|471467304|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
130954780|NCT01403974|471467305|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
130954781|NCT01403974|471467306|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
130954782|NCT01403974|471467307|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
131225430|NCT03650400|472452020|FG000|Overall Study|Study terminated by sponsor|0|||
131225431|NCT03650400|472452021|FG001|Overall Study|Study terminated by sponsor|5|||
130954783|NCT01403974|471467308|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
130954784|NCT01403974|471467309|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
131039354|NCT04515849|471778236|FG003|Overall Study|Other:family emergency|1|||
131039355|NCT04515849|471778237|FG004|Overall Study|Other:family emergency|0|||
131039356|NCT04515849|471778233|FG000|Overall Study|Other:randomised by error|0|||
131039357|NCT04515849|471778234|FG001|Overall Study|Other:randomised by error|1|||
131039358|NCT04515849|471778235|FG002|Overall Study|Other:randomised by error|0|||
131039359|NCT04515849|471778236|FG003|Overall Study|Other:randomised by error|0|||
131039360|NCT04515849|471778237|FG004|Overall Study|Other:randomised by error|0|||
131039361|NCT04515849|471778233|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
131039362|NCT04515849|471778234|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
131039363|NCT04515849|471778235|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
131039364|NCT04515849|471778236|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
131039365|NCT04515849|471778237|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
131039366|NCT04515849|471778233|FG000|Overall Study|Physician Decision|0|||
131039367|NCT04515849|471778234|FG001|Overall Study|Physician Decision|1|||
131039368|NCT04515849|471778235|FG002|Overall Study|Physician Decision|0|||
131039369|NCT04515849|471778236|FG003|Overall Study|Physician Decision|0|||
131039370|NCT04515849|471778237|FG004|Overall Study|Physician Decision|0|||
131039371|NCT04515849|471778233|FG000|Overall Study|Withdrawal by Subject|1|||
131039372|NCT04515849|471778234|FG001|Overall Study|Withdrawal by Subject|2|||
131039373|NCT04515849|471778235|FG002|Overall Study|Withdrawal by Subject|1|||
131039374|NCT04515849|471778236|FG003|Overall Study|Withdrawal by Subject|0|||
131039375|NCT04515849|471778237|FG004|Overall Study|Withdrawal by Subject|0|||
131039376|NCT04577963|471778251|FG000|Part 2|Death|0|||
131039377|NCT04577963|471778252|FG001|Part 2|Death|1|||
131039378|NCT04577963|471778253|FG002|Part 2|Death|8|||
131039379|NCT04577963|471778254|FG003|Part 2|Death|0|||
131039380|NCT04577963|471778255|FG004|Part 2|Death|20|||
131039381|NCT04577963|471778251|FG000|Part 2|Lost to Follow-up|0|||
131039382|NCT04577963|471778252|FG001|Part 2|Lost to Follow-up|0|||
131039383|NCT04577963|471778253|FG002|Part 2|Lost to Follow-up|0|||
130954785|NCT01403974|471467310|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
130954786|NCT01403974|471467311|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
130954787|NCT01403974|471467312|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
130954788|NCT01403974|471467313|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
130954789|NCT01403974|471467314|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
130954790|NCT01403974|471467315|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
130954791|NCT01403974|471467316|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
130954792|NCT01403974|471467301|FG000|Overall Study|Refused to continue study medication|0|||
130954793|NCT01403974|471467302|FG001|Overall Study|Refused to continue study medication|0|||
130954794|NCT01403974|471467303|FG002|Overall Study|Refused to continue study medication|0|||
130954795|NCT01403974|471467304|FG003|Overall Study|Refused to continue study medication|0|||
131125475|NCT03370120|472089048|FG000|Overall Study|Premature study close by sponsor's decision|4|||
131125476|NCT03370120|472089048|FG000|Overall Study|Study terminated by sponsor|33|||
130711828|NCT02429934|470569943|FG001|Overall Study|Lost to Follow-up|1|||
130711829|NCT02429934|470569942|FG000|Overall Study|Physician Decision|1|||
130711830|NCT02429934|470569943|FG001|Overall Study|Physician Decision|0|||
130711831|NCT01564459|470569944|FG000|Run-In|Adverse Event|7|||
130711832|NCT01564459|470569945|FG001|Run-In|Adverse Event|0|||
130711833|NCT01564459|470569946|FG002|Run-In|Adverse Event|0|||
130711834|NCT01564459|470569944|FG000|Run-In|Lost to Follow-up|1|||
130711835|NCT01564459|470569945|FG001|Run-In|Lost to Follow-up|0|||
130711836|NCT01564459|470569946|FG002|Run-In|Lost to Follow-up|0|||
130711837|NCT01564459|470569944|FG000|Run-In|Non-compliance with study drug|2|||
131125477|NCT03370120|472089048|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
130711838|NCT01564459|470569945|FG001|Run-In|Non-compliance with study drug|0|||
130711839|NCT01564459|470569946|FG002|Run-In|Non-compliance with study drug|0|||
130711840|NCT01564459|470569944|FG000|Run-In|Protocol Violation|1|||
131125478|NCT03370120|472089048|FG000|Overall Study|Sponsor decision to terminate study|63|||
131125479|NCT03370120|472089048|FG000|Overall Study|Program closure|3|||
131125480|NCT03370120|472089048|FG000|Overall Study|Study ended prematurely|1|||
131125481|NCT03370120|472089048|FG000|Overall Study|Study stopped by sponsor|2|||
131125482|NCT03370120|472089048|FG000|Overall Study|Program termination|55|||
131125483|NCT03370120|472089048|FG000|Overall Study|Sponsor decision|62|||
131125484|NCT03370120|472089048|FG000|Overall Study|Sponsor study closure|10|||
131125485|NCT00454857|472089049|FG000|Overall Study|Withdrawal by Subject|15|||
131125486|NCT00454857|472089049|FG000|Overall Study|Lost to Follow-up|16|||
131125487|NCT00454857|472089049|FG000|Overall Study|Noncompliance|6|||
131125488|NCT00454857|472089049|FG000|Overall Study|Death|5|||
131125489|NCT00454857|472089049|FG000|Overall Study|Other|11|||
131125490|NCT00454857|472089049|FG000|Overall Study|Reason unknown|1|||
131125491|NCT04206020|472089050|FG000|Overall Study|Adverse Event|1|||
131125492|NCT04206020|472089051|FG001|Overall Study|Adverse Event|4|||
131125493|NCT04206020|472089050|FG000|Overall Study|Protocol Violation|2|||
131125494|NCT04206020|472089051|FG001|Overall Study|Protocol Violation|0|||
131125495|NCT04206020|472089050|FG000|Overall Study|Withdrawal by Subject|2|||
131125496|NCT04206020|472089051|FG001|Overall Study|Withdrawal by Subject|0|||
131125497|NCT04206020|472089050|FG000|Overall Study|Lost to Follow-up|2|||
131125498|NCT04206020|472089051|FG001|Overall Study|Lost to Follow-up|0|||
131125499|NCT04206020|472089050|FG000|Overall Study|Pregnancy|0|||
131125500|NCT04206020|472089051|FG001|Overall Study|Pregnancy|1|||
131125501|NCT04206020|472089050|FG000|Overall Study|Unable to attend visits|1|||
131125502|NCT04206020|472089051|FG001|Overall Study|Unable to attend visits|2|||
131125503|NCT04416555|472089052|FG000|Overall Study|Withdrawal by Subject|0|||
131125504|NCT04416555|472089053|FG001|Overall Study|Withdrawal by Subject|3|||
131125505|NCT02004262|472089064|FG000|Overall Study|Death|67|||
130711841|NCT01564459|470569945|FG001|Run-In|Protocol Violation|0|||
130711842|NCT01564459|470569946|FG002|Run-In|Protocol Violation|0|||
130711843|NCT01564459|470569944|FG000|Run-In|Withdrawal by Subject|1|||
130711844|NCT01564459|470569945|FG001|Run-In|Withdrawal by Subject|0|||
130711845|NCT01564459|470569946|FG002|Run-In|Withdrawal by Subject|0|||
131125506|NCT02004262|472089065|FG001|Overall Study|Death|64|||
131125507|NCT02004262|472089066|FG002|Overall Study|Death|66|||
131125508|NCT02004262|472089067|FG003|Overall Study|Death|28|||
131125509|NCT02004262|472089068|FG004|Overall Study|Death|29|||
131125510|NCT02004262|472089069|FG005|Overall Study|Death|22|||
130711846|NCT01564459|470569944|FG000|Double-blind Treatment|Adverse Event|0|||
130711847|NCT01564459|470569945|FG001|Double-blind Treatment|Adverse Event|0|||
130711848|NCT01564459|470569946|FG002|Double-blind Treatment|Adverse Event|1|||
131125511|NCT02004262|472089064|FG000|Overall Study|Withdrawal by Subject|1|||
131125512|NCT02004262|472089065|FG001|Overall Study|Withdrawal by Subject|0|||
131125513|NCT02004262|472089066|FG002|Overall Study|Withdrawal by Subject|4|||
131125514|NCT02004262|472089067|FG003|Overall Study|Withdrawal by Subject|0|||
131125515|NCT02004262|472089068|FG004|Overall Study|Withdrawal by Subject|1|||
131125516|NCT02004262|472089069|FG005|Overall Study|Withdrawal by Subject|3|||
131125517|NCT02004262|472089064|FG000|Overall Study|Lost to Follow-up|1|||
130711849|NCT01138111|470569952|FG000|Overall Study|Withdrawal by Subject|5|||
130711850|NCT01138111|470569952|FG000|Overall Study|Adverse Event|1|||
130711851|NCT01138111|470569952|FG000|Overall Study|Death|1|||
131125518|NCT02004262|472089065|FG001|Overall Study|Lost to Follow-up|1|||
131125519|NCT02004262|472089066|FG002|Overall Study|Lost to Follow-up|0|||
131225432|NCT01759381|472452022|FG000|Overall Study|Death|1|||
131225433|NCT01759381|472452023|FG001|Overall Study|Death|0|||
131225434|NCT00447603|472452025|FG000|Screening|Withdrawal by Subject|1|||
130711852|NCT01138111|470569952|FG000|Overall Study|Lost to Follow-up|2|||
130711853|NCT01491035|470569953|FG000|Overall Study|Lost to Follow-up|0|||
130711854|NCT01491035|470569954|FG001|Overall Study|Lost to Follow-up|0|||
130711855|NCT01491035|470569955|FG002|Overall Study|Lost to Follow-up|0|||
130711856|NCT01491035|470569956|FG003|Overall Study|Lost to Follow-up|0|||
130711857|NCT01491035|470569957|FG004|Overall Study|Lost to Follow-up|1|||
130711858|NCT01491035|470569958|FG005|Overall Study|Lost to Follow-up|0|||
130711859|NCT01491035|470569959|FG006|Overall Study|Lost to Follow-up|0|||
131125520|NCT02004262|472089067|FG003|Overall Study|Lost to Follow-up|0|||
131125521|NCT02004262|472089068|FG004|Overall Study|Lost to Follow-up|0|||
131125522|NCT02004262|472089069|FG005|Overall Study|Lost to Follow-up|0|||
131125523|NCT02004262|472089064|FG000|Overall Study|Study Terminated by Sponsor|4|||
131125524|NCT02004262|472089065|FG001|Overall Study|Study Terminated by Sponsor|3|||
131125525|NCT02004262|472089066|FG002|Overall Study|Study Terminated by Sponsor|2|||
131125526|NCT02004262|472089067|FG003|Overall Study|Study Terminated by Sponsor|1|||
131125527|NCT02004262|472089068|FG004|Overall Study|Study Terminated by Sponsor|1|||
131125528|NCT02004262|472089069|FG005|Overall Study|Study Terminated by Sponsor|5|||
131125529|NCT03200366|472089073|FG000|Patient Navigation Intervention Given|Death|0|||
131125530|NCT03200366|472089074|FG001|Patient Navigation Intervention Given|Death|2|||
131125531|NCT03200366|472089075|FG002|Patient Navigation Intervention Given|Death|0|||
131125532|NCT03200366|472089073|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
131125533|NCT03200366|472089074|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
131125534|NCT03200366|472089075|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
131125535|NCT03200366|472089073|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
131125536|NCT03200366|472089074|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
131125537|NCT03200366|472089075|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
131125538|NCT03200366|472089073|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
131125539|NCT03200366|472089074|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
131125540|NCT03200366|472089075|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
131125541|NCT03200366|472089073|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
131125542|NCT03200366|472089074|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
130711860|NCT01491035|470569960|FG007|Overall Study|Lost to Follow-up|0|||
130711861|NCT02999477|470569968|FG000|Overall Study|found ineligible after first dose|0|||
130711862|NCT02999477|470569969|FG001|Overall Study|found ineligible after first dose|1|||
130711863|NCT02999477|470569968|FG000|Overall Study|Withdrawal by Subject|1|||
130711864|NCT02999477|470569969|FG001|Overall Study|Withdrawal by Subject|1|||
130711865|NCT04266795|470569982|FG000|Overall Study|Adverse Event|10|||
130711866|NCT04266795|470569983|FG001|Overall Study|Adverse Event|19|||
130711867|NCT04266795|470569982|FG000|Overall Study|Death|7|||
130711868|NCT04266795|470569983|FG001|Overall Study|Death|8|||
130711869|NCT04266795|470569982|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
130711870|NCT04266795|470569983|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
130711871|NCT04266795|470569982|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130711872|NCT04266795|470569983|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130711873|NCT04266795|470569982|FG000|Overall Study|Progressive Disease|12|||
130711874|NCT04266795|470569983|FG001|Overall Study|Progressive Disease|9|||
130711875|NCT04266795|470569982|FG000|Overall Study|Withdrawal by Patient|5|||
130711876|NCT04266795|470569983|FG001|Overall Study|Withdrawal by Patient|6|||
130711877|NCT04266795|470569982|FG000|Overall Study|Disease Relapse|3|||
130711878|NCT04266795|470569983|FG001|Overall Study|Disease Relapse|6|||
130954796|NCT01403974|471467305|FG004|Overall Study|Refused to continue study medication|0|||
131125543|NCT03200366|472089075|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
131125544|NCT03200366|472089073|FG000|6 Month Post-Baseline Interview|Death|1|||
131125545|NCT03200366|472089074|FG001|6 Month Post-Baseline Interview|Death|1|||
131125546|NCT03200366|472089075|FG002|6 Month Post-Baseline Interview|Death|1|||
131125547|NCT03200366|472089073|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
131125548|NCT03200366|472089074|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
131125549|NCT03200366|472089075|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
131225435|NCT00447603|472452026|FG001|Screening|Withdrawal by Subject|0|||
131225436|NCT00447603|472452027|FG002|Screening|Withdrawal by Subject|0|||
130711879|NCT04266795|470569982|FG000|Overall Study|Reason not Specified|12|||
130711880|NCT04266795|470569983|FG001|Overall Study|Reason not Specified|10|||
130711881|NCT04266795|470569982|FG000|Overall Study|Participants Ongoing on Treatment|25|||
130711882|NCT04266795|470569983|FG001|Overall Study|Participants Ongoing on Treatment|23|||
130711883|NCT03351231|470569984|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
130711884|NCT03351231|470569984|FG000|Combination Therapy Period|Disease progression|2|||
130954797|NCT01403974|471467306|FG005|Overall Study|Refused to continue study medication|1|||
130711885|NCT03351231|470569984|FG000|Combination Therapy Period|Study drug toxicity|1|||
130711886|NCT03351231|470569984|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
130954798|NCT01403974|471467307|FG006|Overall Study|Refused to continue study medication|0|||
130954799|NCT01403974|471467308|FG007|Overall Study|Refused to continue study medication|0|||
130954800|NCT01403974|471467309|FG008|Overall Study|Refused to continue study medication|1|||
130954801|NCT01403974|471467310|FG009|Overall Study|Refused to continue study medication|0|||
130954802|NCT01403974|471467311|FG010|Overall Study|Refused to continue study medication|1|||
130954803|NCT01403974|471467312|FG011|Overall Study|Refused to continue study medication|0|||
130954804|NCT01403974|471467313|FG012|Overall Study|Refused to continue study medication|0|||
130954805|NCT01403974|471467314|FG013|Overall Study|Refused to continue study medication|0|||
130954806|NCT01403974|471467315|FG014|Overall Study|Refused to continue study medication|0|||
130954807|NCT01403974|471467316|FG015|Overall Study|Refused to continue study medication|4|||
130954808|NCT01403974|471467301|FG000|Overall Study|Adverse Event|0|||
130954809|NCT01403974|471467302|FG001|Overall Study|Adverse Event|0|||
130954810|NCT01403974|471467303|FG002|Overall Study|Adverse Event|1|||
130954811|NCT01403974|471467304|FG003|Overall Study|Adverse Event|0|||
130954812|NCT01403974|471467305|FG004|Overall Study|Adverse Event|0|||
130954813|NCT01403974|471467306|FG005|Overall Study|Adverse Event|0|||
130954814|NCT01403974|471467307|FG006|Overall Study|Adverse Event|0|||
130954815|NCT01403974|471467308|FG007|Overall Study|Adverse Event|1|||
130954816|NCT01403974|471467309|FG008|Overall Study|Adverse Event|0|||
130954817|NCT01403974|471467310|FG009|Overall Study|Adverse Event|0|||
130954818|NCT01403974|471467311|FG010|Overall Study|Adverse Event|0|||
130954819|NCT01403974|471467312|FG011|Overall Study|Adverse Event|0|||
130954820|NCT01403974|471467313|FG012|Overall Study|Adverse Event|1|||
130954821|NCT01403974|471467314|FG013|Overall Study|Adverse Event|0|||
130954822|NCT01403974|471467315|FG014|Overall Study|Adverse Event|0|||
130954823|NCT01403974|471467316|FG015|Overall Study|Adverse Event|0|||
130954824|NCT01403974|471467301|FG000|Overall Study|Other than specified|0|||
130954825|NCT01403974|471467302|FG001|Overall Study|Other than specified|0|||
130954826|NCT01403974|471467303|FG002|Overall Study|Other than specified|0|||
130954827|NCT01403974|471467304|FG003|Overall Study|Other than specified|0|||
130954828|NCT01403974|471467305|FG004|Overall Study|Other than specified|0|||
130954829|NCT01403974|471467306|FG005|Overall Study|Other than specified|0|||
130954830|NCT01403974|471467307|FG006|Overall Study|Other than specified|0|||
130954831|NCT01403974|471467308|FG007|Overall Study|Other than specified|0|||
130954832|NCT01403974|471467309|FG008|Overall Study|Other than specified|0|||
130954833|NCT01403974|471467310|FG009|Overall Study|Other than specified|1|||
130954834|NCT01403974|471467311|FG010|Overall Study|Other than specified|0|||
130954835|NCT01403974|471467312|FG011|Overall Study|Other than specified|1|||
130954836|NCT01403974|471467313|FG012|Overall Study|Other than specified|0|||
130954837|NCT01403974|471467314|FG013|Overall Study|Other than specified|0|||
130954838|NCT01403974|471467315|FG014|Overall Study|Other than specified|0|||
130954839|NCT01403974|471467316|FG015|Overall Study|Other than specified|0|||
130954840|NCT04697628|471467317|FG000|Overall Study|Withdrawal by Subject|17|||
130954841|NCT04697628|471467318|FG001|Overall Study|Withdrawal by Subject|23|||
130954842|NCT04697628|471467317|FG000|Overall Study|Lost to Follow-up|0|||
130954843|NCT04697628|471467318|FG001|Overall Study|Lost to Follow-up|4|||
130954844|NCT04697628|471467317|FG000|Overall Study|On-going in study|122|||
130954845|NCT04697628|471467318|FG001|Overall Study|On-going in study|91|||
130954846|NCT02703636|471467319|FG000|Overall Study|Adverse Event|14|||
130954847|NCT02703636|471467319|FG000|Overall Study|Study stopped by sponsor|1|||
130954848|NCT02703636|471467319|FG000|Overall Study|Withdrawal by Subject|1|||
130954849|NCT00393939|471467320|FG000|Overall Study|Protocol Violation|1|||
130954850|NCT00393939|471467321|FG001|Overall Study|Protocol Violation|1|||
131125550|NCT03200366|472089073|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
131125551|NCT03200366|472089074|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
131125552|NCT03200366|472089075|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
131125553|NCT03200366|472089073|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
131125554|NCT03200366|472089074|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
131125555|NCT03200366|472089075|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
131125556|NCT03200366|472089073|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
131125557|NCT03200366|472089074|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
130711887|NCT03351231|470569984|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
130711888|NCT03351231|470569984|FG000|Safety Follow-Up Period|Other reason|2|||
130711889|NCT03487848|470569985|FG000|Overall Study|Lost to Follow-up|1|||
131125558|NCT03200366|472089075|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
131125559|NCT03200366|472089073|FG000|9 Month Post-Baseline Interview|Death|1|||
130954851|NCT00393939|471467320|FG000|Overall Study|Lost to Follow-up|2|||
130954852|NCT00393939|471467321|FG001|Overall Study|Lost to Follow-up|4|||
130954853|NCT00393939|471467320|FG000|Overall Study|Death|10|||
130954854|NCT00393939|471467321|FG001|Overall Study|Death|4|||
130954855|NCT00393939|471467320|FG000|Overall Study|Sponsor|5|||
130711890|NCT00731549|470569986|FG000|Overall Study|Lost to Follow-up|19|||
130711891|NCT00731549|470569986|FG000|Overall Study|Met withdrawal criteria|24|||
130711892|NCT00731549|470569986|FG000|Overall Study|Physician Decision|16|||
130711893|NCT00731549|470569986|FG000|Overall Study|Withdrawal by Subject|89|||
130954856|NCT00393939|471467321|FG001|Overall Study|Sponsor|13|||
130954857|NCT00393939|471467320|FG000|Overall Study|Objective progression or relapse|239|||
130954858|NCT00393939|471467321|FG001|Overall Study|Objective progression or relapse|223|||
130954859|NCT00393939|471467320|FG000|Overall Study|Withdrawal by Subject|2|||
130954860|NCT00393939|471467321|FG001|Overall Study|Withdrawal by Subject|7|||
130954861|NCT00393939|471467320|FG000|Overall Study|Other|37|||
130954862|NCT00393939|471467321|FG001|Overall Study|Other|45|||
130954863|NCT03778931|471467322|FG000|Overall Study|Withdrawal by Subject|12|||
130954864|NCT03778931|471467323|FG001|Overall Study|Withdrawal by Subject|25|||
130954865|NCT03778931|471467322|FG000|Overall Study|Physician Decision|1|||
130954866|NCT03778931|471467323|FG001|Overall Study|Physician Decision|3|||
130954867|NCT03778931|471467322|FG000|Overall Study|Participant Noncompliance|1|||
130954868|NCT03778931|471467323|FG001|Overall Study|Participant Noncompliance|1|||
130954869|NCT03778931|471467322|FG000|Overall Study|Lost to Follow-up|4|||
130954870|NCT03778931|471467323|FG001|Overall Study|Lost to Follow-up|1|||
130954871|NCT03778931|471467322|FG000|Overall Study|Death|69|||
130954872|NCT03778931|471467323|FG001|Overall Study|Death|79|||
130954873|NCT00006184|471467324|FG000|Overall Study|Death|1|||
130954874|NCT00006184|471467325|FG001|Overall Study|Death|0|||
130954875|NCT02161718|471467330|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
130954876|NCT02161718|471467331|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
130954877|NCT02161718|471467332|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
130954878|NCT02161718|471467330|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
130954879|NCT02161718|471467331|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
130954880|NCT02161718|471467332|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
130954881|NCT02161718|471467330|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
130954882|NCT02161718|471467331|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
131125560|NCT03200366|472089074|FG001|9 Month Post-Baseline Interview|Death|1|||
131125561|NCT03200366|472089075|FG002|9 Month Post-Baseline Interview|Death|1|||
131125562|NCT03200366|472089073|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
131125563|NCT03200366|472089074|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
131125564|NCT03200366|472089075|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
131125565|NCT03200366|472089073|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
131125566|NCT03200366|472089074|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
131125567|NCT03200366|472089075|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
131125568|NCT03200366|472089073|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
131125569|NCT03200366|472089074|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
131125570|NCT03200366|472089075|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
131125571|NCT02018822|472089076|FG000|Overall Study|filling replaced by crown|0|||
131125572|NCT02018822|472089077|FG001|Overall Study|filling replaced by crown|1|||
131125573|NCT02018822|472089078|FG002|Overall Study|filling replaced by crown|0|||
131125574|NCT02018822|472089076|FG000|Overall Study|Physician Decision|0|||
131125575|NCT02018822|472089077|FG001|Overall Study|Physician Decision|1|||
131125576|NCT02018822|472089078|FG002|Overall Study|Physician Decision|1|||
131125577|NCT02018822|472089076|FG000|Overall Study|Lost to Follow-up|6|||
131125578|NCT02018822|472089077|FG001|Overall Study|Lost to Follow-up|6|||
131125579|NCT02018822|472089078|FG002|Overall Study|Lost to Follow-up|5|||
131125580|NCT00715026|472089081|FG000|Overall Study|Withdrawal by Subject|5|||
131125581|NCT00715026|472089081|FG000|Overall Study|Lost to Follow-up|3|||
131125582|NCT00715026|472089081|FG000|Overall Study|Protocol Violation|1|||
131125583|NCT00715026|472089081|FG000|Overall Study|Surgery done on non-study consented hip|1|||
131125584|NCT00552175|472089082|FG000|Overall Study|Lack of Efficacy|2|||
131125585|NCT00552175|472089083|FG001|Overall Study|Lack of Efficacy|0|||
131125586|NCT00552175|472089084|FG002|Overall Study|Lack of Efficacy|1|||
131125587|NCT00552175|472089082|FG000|Overall Study|Adverse Event|9|||
131125588|NCT00552175|472089083|FG001|Overall Study|Adverse Event|9|||
131125589|NCT00552175|472089084|FG002|Overall Study|Adverse Event|10|||
131125590|NCT00552175|472089082|FG000|Overall Study|Withdrawal by Subject|2|||
131125591|NCT00552175|472089083|FG001|Overall Study|Withdrawal by Subject|2|||
131125592|NCT00552175|472089084|FG002|Overall Study|Withdrawal by Subject|1|||
130711894|NCT00731549|470569986|FG000|Overall Study|Protocol deviation|1|||
130954883|NCT02161718|471467332|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
130954884|NCT02161718|471467330|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
130954885|NCT02161718|471467331|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
130985565|NCT01984697|471574905|FG001|Overall Study|Adverse Event|0|||
131125593|NCT00552175|472089082|FG000|Overall Study|Lost to Follow-up|0|||
131125594|NCT00552175|472089083|FG001|Overall Study|Lost to Follow-up|0|||
131125595|NCT00552175|472089084|FG002|Overall Study|Lost to Follow-up|1|||
131125596|NCT00552175|472089082|FG000|Overall Study|Entry Criteria Not Met|1|||
131125597|NCT00552175|472089083|FG001|Overall Study|Entry Criteria Not Met|1|||
130711895|NCT00731549|470569986|FG000|Overall Study|Adverse Event|31|||
130711896|NCT00731549|470569986|FG000|Overall Study|Lack of efficacy with AE|37|||
131125598|NCT00552175|472089084|FG002|Overall Study|Entry Criteria Not Met|0|||
131125599|NCT00552175|472089082|FG000|Overall Study|Reason Not Specified|3|||
131125600|NCT00552175|472089083|FG001|Overall Study|Reason Not Specified|1|||
131125601|NCT00552175|472089084|FG002|Overall Study|Reason Not Specified|1|||
131125602|NCT01543828|472089087|FG000|Treatment 2|Lost to Follow-up|1|||
131125603|NCT01543828|472089088|FG001|Treatment 2|Lost to Follow-up|0|||
131125604|NCT00804570|472089090|FG000|Overall Study|Adverse Event|14|||
131125605|NCT00804570|472089091|FG001|Overall Study|Adverse Event|7|||
131125606|NCT00804570|472089090|FG000|Overall Study|Lack of Efficacy|0|||
131125607|NCT00804570|472089091|FG001|Overall Study|Lack of Efficacy|1|||
131125608|NCT00804570|472089090|FG000|Overall Study|Lost to Follow-up|18|||
131125609|NCT00804570|472089091|FG001|Overall Study|Lost to Follow-up|21|||
131125610|NCT00804570|472089090|FG000|Overall Study|Entry criteria not met|5|||
131125611|NCT00804570|472089091|FG001|Overall Study|Entry criteria not met|5|||
131125612|NCT00804570|472089090|FG000|Overall Study|Protocol Violation|12|||
131125613|NCT00804570|472089091|FG001|Overall Study|Protocol Violation|16|||
131125614|NCT00804570|472089090|FG000|Overall Study|Physician Decision|1|||
131125615|NCT00804570|472089091|FG001|Overall Study|Physician Decision|2|||
131125616|NCT00804570|472089090|FG000|Overall Study|Sponsor decision|1|||
131125617|NCT00804570|472089091|FG001|Overall Study|Sponsor decision|4|||
131125618|NCT00804570|472089090|FG000|Overall Study|Withdrawal by Subject|21|||
130954886|NCT02161718|471467332|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
130954887|NCT02161718|471467330|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
130954888|NCT02161718|471467331|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
130954889|NCT02161718|471467332|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
130954890|NCT02161718|471467330|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
130954891|NCT02161718|471467331|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
130954892|NCT02161718|471467332|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
130954893|NCT02161718|471467330|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
130954894|NCT02161718|471467331|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
130954895|NCT02161718|471467332|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
130954896|NCT02161718|471467330|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
130954897|NCT02161718|471467331|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
130954898|NCT02161718|471467332|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
130954899|NCT02161718|471467330|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
130954900|NCT02161718|471467331|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
130954901|NCT02161718|471467332|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
130954902|NCT02161718|471467330|FG000|Post- Randomization Period|Lost to Follow-up|0|||
130954903|NCT02161718|471467331|FG001|Post- Randomization Period|Lost to Follow-up|9|||
130954904|NCT02161718|471467332|FG002|Post- Randomization Period|Lost to Follow-up|15|||
130954905|NCT02161718|471467330|FG000|Post- Randomization Period|Adverse Event|0|||
130954906|NCT02161718|471467331|FG001|Post- Randomization Period|Adverse Event|9|||
130954907|NCT02161718|471467332|FG002|Post- Randomization Period|Adverse Event|10|||
130954908|NCT02161718|471467330|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
130954909|NCT02161718|471467331|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
130954910|NCT02161718|471467332|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
130954911|NCT02161718|471467330|FG000|Post- Randomization Period|Physician Decision|0|||
130954912|NCT02161718|471467331|FG001|Post- Randomization Period|Physician Decision|2|||
130954913|NCT02161718|471467332|FG002|Post- Randomization Period|Physician Decision|4|||
130954914|NCT02161718|471467330|FG000|Post- Randomization Period|Protocol Violation|0|||
130954915|NCT02161718|471467331|FG001|Post- Randomization Period|Protocol Violation|2|||
130954916|NCT02161718|471467332|FG002|Post- Randomization Period|Protocol Violation|3|||
130954917|NCT02161718|471467330|FG000|Post- Randomization Period|Lack of Efficacy|0|||
130954918|NCT02161718|471467331|FG001|Post- Randomization Period|Lack of Efficacy|0|||
130954919|NCT02161718|471467332|FG002|Post- Randomization Period|Lack of Efficacy|1|||
130954920|NCT02161718|471467330|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
130954921|NCT02161718|471467331|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
130954922|NCT02161718|471467332|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
131125619|NCT00804570|472089091|FG001|Overall Study|Withdrawal by Subject|38|||
131125620|NCT00290342|472089092|FG000|Overall Study|Other|0|||
131125621|NCT00290342|472089093|FG001|Overall Study|Other|1|||
131125622|NCT00290342|472089092|FG000|Overall Study|Withdrawal by Subject|6|||
131125623|NCT00290342|472089093|FG001|Overall Study|Withdrawal by Subject|4|||
131125624|NCT00290342|472089092|FG000|Overall Study|Lost to Follow-up|1|||
131125625|NCT00290342|472089093|FG001|Overall Study|Lost to Follow-up|0|||
131125626|NCT01056510|472089096|FG000|Overall Study|Dropout Before Start of Treatment|1|||
131125627|NCT01056510|472089097|FG001|Overall Study|Dropout Before Start of Treatment|1|||
130954923|NCT02161718|471467330|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
130954924|NCT02161718|471467331|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
130954925|NCT02161718|471467332|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
130954926|NCT02161718|471467330|FG000|Post- Randomization Period|Relocation|0|||
131125628|NCT01056510|472089096|FG000|Overall Study|Withdrawal by Subject|4|||
130954927|NCT02161718|471467331|FG001|Post- Randomization Period|Relocation|3|||
130954928|NCT02161718|471467332|FG002|Post- Randomization Period|Relocation|0|||
130954937|NCT02948842|471467337|FG000|Overall Study|Withdrawal by Subject|4|||
130954938|NCT01455012|471467339|FG000|Overall Study|Adverse Event|0|||
130954939|NCT01455012|471467340|FG001|Overall Study|Adverse Event|2|||
130954940|NCT01455012|471467339|FG000|Overall Study|Lack of Efficacy|6|||
130954941|NCT01455012|471467340|FG001|Overall Study|Lack of Efficacy|1|||
130954942|NCT01455012|471467339|FG000|Overall Study|Withdrawal by Subject|3|||
130954943|NCT01455012|471467340|FG001|Overall Study|Withdrawal by Subject|1|||
130954944|NCT01455012|471467339|FG000|Overall Study|Unknown reason|2|||
130954945|NCT01455012|471467340|FG001|Overall Study|Unknown reason|0|||
130954946|NCT01215227|471467341|FG000|Overall Study|Adverse Event|11|||
130954947|NCT01215227|471467342|FG001|Overall Study|Adverse Event|11|||
130954948|NCT01215227|471467343|FG002|Overall Study|Adverse Event|4|||
130954949|NCT01215227|471467344|FG003|Overall Study|Adverse Event|8|||
130954950|NCT01215227|471467345|FG004|Overall Study|Adverse Event|7|||
130954951|NCT01215227|471467346|FG005|Overall Study|Adverse Event|6|||
130954952|NCT01215227|471467341|FG000|Overall Study|Treatment Failure|8|||
130954953|NCT01215227|471467342|FG001|Overall Study|Treatment Failure|4|||
130954954|NCT01215227|471467343|FG002|Overall Study|Treatment Failure|1|||
130954955|NCT01215227|471467344|FG003|Overall Study|Treatment Failure|5|||
130954956|NCT01215227|471467345|FG004|Overall Study|Treatment Failure|1|||
130954957|NCT01215227|471467346|FG005|Overall Study|Treatment Failure|1|||
130954958|NCT01215227|471467341|FG000|Overall Study|Lost to Follow-up|1|||
130954959|NCT01215227|471467342|FG001|Overall Study|Lost to Follow-up|4|||
130954960|NCT01215227|471467343|FG002|Overall Study|Lost to Follow-up|1|||
130954961|NCT01215227|471467344|FG003|Overall Study|Lost to Follow-up|1|||
130954962|NCT01215227|471467345|FG004|Overall Study|Lost to Follow-up|1|||
130954963|NCT01215227|471467346|FG005|Overall Study|Lost to Follow-up|2|||
131039384|NCT04577963|471778254|FG003|Part 2|Lost to Follow-up|0|||
131039385|NCT04577963|471778255|FG004|Part 2|Lost to Follow-up|2|||
131039386|NCT04577963|471778251|FG000|Part 2|Withdrawal by Subject|0|||
131039387|NCT04577963|471778252|FG001|Part 2|Withdrawal by Subject|0|||
131039388|NCT04577963|471778253|FG002|Part 2|Withdrawal by Subject|0|||
131039389|NCT04577963|471778254|FG003|Part 2|Withdrawal by Subject|0|||
131039390|NCT04577963|471778255|FG004|Part 2|Withdrawal by Subject|10|||
131039391|NCT04577963|471778251|FG000|Part 2|Progressive disease|0|||
131039392|NCT04577963|471778252|FG001|Part 2|Progressive disease|0|||
131039393|NCT04577963|471778253|FG002|Part 2|Progressive disease|0|||
131039394|NCT04577963|471778254|FG003|Part 2|Progressive disease|0|||
131039395|NCT04577963|471778255|FG004|Part 2|Progressive disease|2|||
131039396|NCT04577963|471778251|FG000|Part 2|Investigator decision|0|||
131039397|NCT04577963|471778252|FG001|Part 2|Investigator decision|0|||
131039398|NCT04577963|471778253|FG002|Part 2|Investigator decision|0|||
131039399|NCT04577963|471778254|FG003|Part 2|Investigator decision|0|||
131039400|NCT04577963|471778255|FG004|Part 2|Investigator decision|1|||
131039401|NCT04577963|471778251|FG000|Part 2|Sponsor terminated study|0|||
131039402|NCT04577963|471778252|FG001|Part 2|Sponsor terminated study|0|||
131039403|NCT04577963|471778253|FG002|Part 2|Sponsor terminated study|3|||
131039404|NCT04577963|471778254|FG003|Part 2|Sponsor terminated study|1|||
131039405|NCT04577963|471778255|FG004|Part 2|Sponsor terminated study|4|||
131039406|NCT03034356|471778256|FG000|Baseline|Lost to Follow-up|2|||
131039407|NCT03034356|471778257|FG001|Baseline|Lost to Follow-up|4|||
131039408|NCT03034356|471778256|FG000|Baseline|Withdrawal by Subject|2|||
130711897|NCT00731549|470569986|FG000|Overall Study|Lack of efficacy without AE|6|||
130954964|NCT01215227|471467341|FG000|Overall Study|Subject Withdrew Consent|16|||
130954965|NCT01215227|471467342|FG001|Overall Study|Subject Withdrew Consent|20|||
131039409|NCT03034356|471778257|FG001|Baseline|Withdrawal by Subject|0|||
131039410|NCT03034356|471778256|FG000|Baseline|Physician Decision|0|||
130711898|NCT00588640|470569987|FG000|Overall Study|Physician Decision|1|||
130711899|NCT00588640|470569987|FG000|Overall Study|Ineligible Patient|1|||
130711900|NCT00003138|470571736|FG000|Step 1|Reasons off treatment not documented|60|||
130954966|NCT01215227|471467343|FG002|Overall Study|Subject Withdrew Consent|7|||
130954967|NCT01215227|471467344|FG003|Overall Study|Subject Withdrew Consent|10|||
130954968|NCT01215227|471467345|FG004|Overall Study|Subject Withdrew Consent|11|||
130954969|NCT01215227|471467346|FG005|Overall Study|Subject Withdrew Consent|8|||
130954970|NCT01215227|471467341|FG000|Overall Study|Non-Compliance With Protocol|2|||
130954971|NCT01215227|471467342|FG001|Overall Study|Non-Compliance With Protocol|6|||
130954972|NCT01215227|471467343|FG002|Overall Study|Non-Compliance With Protocol|1|||
131039411|NCT03034356|471778257|FG001|Baseline|Physician Decision|1|||
131039412|NCT03034356|471778256|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
131225437|NCT00447603|472452025|FG000|Screening|Protocol Violation|1|||
130711901|NCT00003138|470571737|FG001|Step 1|Reasons off treatment not documented|57|||
130711902|NCT00003138|470571736|FG000|Step 1|Never started treatment|1|||
130711903|NCT00003138|470571737|FG001|Step 1|Never started treatment|0|||
130711904|NCT00003138|470571736|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
130711905|NCT00003138|470571737|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
130711906|NCT00003138|470571736|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
130954973|NCT01215227|471467344|FG003|Overall Study|Non-Compliance With Protocol|0|||
130954974|NCT01215227|471467345|FG004|Overall Study|Non-Compliance With Protocol|0|||
130954975|NCT01215227|471467346|FG005|Overall Study|Non-Compliance With Protocol|0|||
130954976|NCT01215227|471467341|FG000|Overall Study|Administrative|83|||
130954977|NCT01215227|471467342|FG001|Overall Study|Administrative|73|||
130954978|NCT01215227|471467343|FG002|Overall Study|Administrative|42|||
130954979|NCT01215227|471467344|FG003|Overall Study|Administrative|24|||
130954980|NCT01215227|471467345|FG004|Overall Study|Administrative|28|||
130954981|NCT01215227|471467346|FG005|Overall Study|Administrative|40|||
130954982|NCT01215227|471467341|FG000|Overall Study|Missing Status|0|||
130954983|NCT01215227|471467342|FG001|Overall Study|Missing Status|1|||
130954984|NCT01215227|471467343|FG002|Overall Study|Missing Status|0|||
130954985|NCT01215227|471467344|FG003|Overall Study|Missing Status|0|||
130954986|NCT01215227|471467345|FG004|Overall Study|Missing Status|0|||
130954987|NCT01215227|471467346|FG005|Overall Study|Missing Status|0|||
130954988|NCT01215227|471467341|FG000|Overall Study|Randomized but not treated|0|||
130954989|NCT01215227|471467342|FG001|Overall Study|Randomized but not treated|0|||
130954990|NCT01215227|471467343|FG002|Overall Study|Randomized but not treated|1|||
130954991|NCT01215227|471467344|FG003|Overall Study|Randomized but not treated|1|||
130954992|NCT01215227|471467345|FG004|Overall Study|Randomized but not treated|0|||
130954993|NCT01215227|471467346|FG005|Overall Study|Randomized but not treated|1|||
130954994|NCT02253810|471467347|FG000|Overall Study|Withdrawal by Subject|2|||
130954995|NCT02253810|471467348|FG001|Overall Study|Withdrawal by Subject|1|||
130954996|NCT02253810|471467347|FG000|Overall Study|Unknown concomitant procedure|3|||
130954997|NCT02253810|471467348|FG001|Overall Study|Unknown concomitant procedure|2|||
130954998|NCT00558103|471467349|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
130954999|NCT00558103|471467350|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
130955000|NCT00558103|471467351|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
130955001|NCT00558103|471467352|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
130955002|NCT00558103|471467353|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
130955003|NCT00558103|471467354|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
130955004|NCT00558103|471467349|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
130955005|NCT00558103|471467350|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
130955006|NCT00558103|471467351|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
130955007|NCT00558103|471467352|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
130955008|NCT00558103|471467353|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
130955009|NCT00558103|471467354|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
130955010|NCT00558103|471467349|FG000|Randomized Treatment Phase|Disease Progression|1|||
130955011|NCT00558103|471467350|FG001|Randomized Treatment Phase|Disease Progression|0|||
130955012|NCT00558103|471467351|FG002|Randomized Treatment Phase|Disease Progression|1|||
130955013|NCT00558103|471467352|FG003|Randomized Treatment Phase|Disease Progression|0|||
130955014|NCT00558103|471467353|FG004|Randomized Treatment Phase|Disease Progression|0|||
130955015|NCT00558103|471467354|FG005|Randomized Treatment Phase|Disease Progression|0|||
130955016|NCT00558103|471467349|FG000|Randomized Treatment Phase|Adverse Event|0|||
130955017|NCT00558103|471467350|FG001|Randomized Treatment Phase|Adverse Event|0|||
131125629|NCT01056510|472089097|FG001|Overall Study|Withdrawal by Subject|2|||
131125630|NCT01056510|472089096|FG000|Overall Study|Death|29|||
131125631|NCT01056510|472089097|FG001|Overall Study|Death|34|||
131125632|NCT01056510|472089096|FG000|Overall Study|Noncompliance|1|||
131125633|NCT01056510|472089097|FG001|Overall Study|Noncompliance|3|||
131125634|NCT01056510|472089096|FG000|Overall Study|Physician Decision|4|||
131125635|NCT01056510|472089097|FG001|Overall Study|Physician Decision|5|||
131125636|NCT01056510|472089096|FG000|Overall Study|Lost to Follow-up|5|||
131125637|NCT01056510|472089097|FG001|Overall Study|Lost to Follow-up|6|||
131125638|NCT01056510|472089096|FG000|Overall Study|Other|10|||
130955018|NCT00558103|471467351|FG002|Randomized Treatment Phase|Adverse Event|0|||
130955019|NCT00558103|471467352|FG003|Randomized Treatment Phase|Adverse Event|1|||
131125639|NCT01056510|472089097|FG001|Overall Study|Other|12|||
131125640|NCT01056510|472089096|FG000|Overall Study|Missing|0|||
131125641|NCT01056510|472089097|FG001|Overall Study|Missing|1|||
130955020|NCT00558103|471467353|FG004|Randomized Treatment Phase|Adverse Event|1|||
130955021|NCT00558103|471467354|FG005|Randomized Treatment Phase|Adverse Event|0|||
131125642|NCT00243386|472089098|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
130955022|NCT00558103|471467349|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
130955023|NCT00558103|471467350|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
130955024|NCT00558103|471467351|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
131125643|NCT00243386|472089099|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
131125644|NCT00243386|472089100|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
131225438|NCT00447603|472452026|FG001|Screening|Protocol Violation|0|||
130955025|NCT00558103|471467352|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
130955026|NCT00558103|471467353|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
130955027|NCT00558103|471467354|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
130955028|NCT00558103|471467349|FG000|Monotherapy Extension Phase|Disease Progression|0|||
130955029|NCT00558103|471467350|FG001|Monotherapy Extension Phase|Disease Progression|0|||
130955030|NCT00558103|471467351|FG002|Monotherapy Extension Phase|Disease Progression|0|||
130955031|NCT00558103|471467352|FG003|Monotherapy Extension Phase|Disease Progression|0|||
130955032|NCT00558103|471467353|FG004|Monotherapy Extension Phase|Disease Progression|0|||
130955033|NCT00558103|471467354|FG005|Monotherapy Extension Phase|Disease Progression|8|||
130955034|NCT02741115|471467355|FG000|Overall Study|Adverse Event|1|||
130955035|NCT02741115|471467356|FG001|Overall Study|Adverse Event|0|||
130955036|NCT02741115|471467355|FG000|Overall Study|Lost to Follow-up|7|||
130955037|NCT02741115|471467356|FG001|Overall Study|Lost to Follow-up|4|||
130955038|NCT02741115|471467355|FG000|Overall Study|Withdrawal by Subject|4|||
130955039|NCT02741115|471467356|FG001|Overall Study|Withdrawal by Subject|2|||
130955040|NCT06425458|471467357|FG000|Overall Study|Removed by study team|2|||
130955041|NCT06425458|471467357|FG000|Overall Study|Lost to Follow-up|5|||
130955042|NCT00445328|471467358|FG000|Overall Study|Death|0|||
130955043|NCT00445328|471467359|FG001|Overall Study|Death|1|||
130955044|NCT00445328|471467358|FG000|Overall Study|Adverse Event|0|||
130955045|NCT00445328|471467359|FG001|Overall Study|Adverse Event|3|||
130955046|NCT00445328|471467358|FG000|Overall Study|Other|0|||
130955047|NCT00445328|471467359|FG001|Overall Study|Other|2|||
130955048|NCT00445328|471467358|FG000|Overall Study|Withdrawal by Subject|2|||
130955049|NCT00445328|471467359|FG001|Overall Study|Withdrawal by Subject|0|||
130955050|NCT00445328|471467358|FG000|Overall Study|Protocol Violation|1|||
130955051|NCT00445328|471467359|FG001|Overall Study|Protocol Violation|0|||
130955052|NCT03548584|471469072|FG000|Overall Study|Lost to Follow-up|0|||
130955053|NCT03548584|471469073|FG001|Overall Study|Lost to Follow-up|0|||
131225439|NCT00447603|472452027|FG002|Screening|Protocol Violation|0|||
131225440|NCT00447603|472452025|FG000|Screening|Screen Failure|4|||
131225441|NCT00447603|472452026|FG001|Screening|Screen Failure|0|||
131225442|NCT00447603|472452027|FG002|Screening|Screen Failure|0|||
131225443|NCT00447603|472452025|FG000|Screening|Study Terminated by Sponsor|15|||
131225444|NCT00447603|472452026|FG001|Screening|Study Terminated by Sponsor|0|||
131225445|NCT00447603|472452027|FG002|Screening|Study Terminated by Sponsor|0|||
131225446|NCT00447603|472452025|FG000|Filter Period|Adverse Event|0|||
131225447|NCT00447603|472452026|FG001|Filter Period|Adverse Event|0|||
131225448|NCT00447603|472452027|FG002|Filter Period|Adverse Event|1|||
131225449|NCT00447603|472452025|FG000|Filter Period|Screen Failure|0|||
131225450|NCT00447603|472452026|FG001|Filter Period|Screen Failure|3|||
131225451|NCT00447603|472452027|FG002|Filter Period|Screen Failure|4|||
131225452|NCT00447603|472452025|FG000|Filter Period|Study terminated by Sponsor|0|||
131225453|NCT00447603|472452026|FG001|Filter Period|Study terminated by Sponsor|1|||
131225454|NCT00447603|472452027|FG002|Filter Period|Study terminated by Sponsor|10|||
131225455|NCT02732561|472452032|FG000|Overall Study|Lost to Follow-up|1|||
131225456|NCT02732561|472452033|FG001|Overall Study|Lost to Follow-up|1|||
131225457|NCT02732561|472452032|FG000|Overall Study|Withdrawal by Subject|1|||
131225458|NCT02732561|472452033|FG001|Overall Study|Withdrawal by Subject|0|||
131225459|NCT02410837|472452035|FG000|Overall Study|Death|387|||
131225460|NCT02410837|472452035|FG000|Overall Study|Lost to Follow-up|50|||
131225461|NCT02410837|472452035|FG000|Overall Study|Withdrawal by Subject|44|||
131225462|NCT02410837|472452035|FG000|Overall Study|Physician Decision|6|||
131225463|NCT02410837|472452035|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
131225464|NCT00837577|472452036|FG000|Double-blind Period|Clinical Adverse Event|1|||
131225465|NCT00837577|472452037|FG001|Double-blind Period|Clinical Adverse Event|0|||
131225466|NCT00837577|472452036|FG000|Double-blind Period|Withdrawal by Subject|1|||
131225467|NCT00837577|472452037|FG001|Double-blind Period|Withdrawal by Subject|0|||
131225468|NCT00837577|472452036|FG000|Open-label Period|Clinical Adverse Event|2|||
130711907|NCT00003138|470571737|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
130955054|NCT03548584|471469074|FG002|Overall Study|Lost to Follow-up|1|||
130955055|NCT03548584|471469072|FG000|Overall Study|Adverse Event|1|||
130955056|NCT03548584|471469073|FG001|Overall Study|Adverse Event|11|||
130955057|NCT03548584|471469074|FG002|Overall Study|Adverse Event|5|||
131225469|NCT00837577|472452037|FG001|Open-label Period|Clinical Adverse Event|2|||
131225470|NCT00837577|472452036|FG000|Open-label Period|Laboratory Adverse Event|0|||
131225471|NCT00837577|472452037|FG001|Open-label Period|Laboratory Adverse Event|1|||
131225472|NCT00837577|472452036|FG000|Open-label Period|Lack of Efficacy|4|||
131225473|NCT00837577|472452037|FG001|Open-label Period|Lack of Efficacy|3|||
131225474|NCT00837577|472452036|FG000|Open-label Period|Withdrawal by Subject|1|||
130955058|NCT03548584|471469072|FG000|Overall Study|Site Terminated by Sponsor|1|||
131225475|NCT00837577|472452037|FG001|Open-label Period|Withdrawal by Subject|2|||
131225476|NCT00837577|472452036|FG000|Open-label Period|Other Reason|1|||
131225477|NCT00837577|472452037|FG001|Open-label Period|Other Reason|1|||
130955059|NCT03548584|471469073|FG001|Overall Study|Site Terminated by Sponsor|3|||
130955060|NCT03548584|471469074|FG002|Overall Study|Site Terminated by Sponsor|2|||
130985566|NCT01984697|471574906|FG002|Overall Study|Adverse Event|2|||
130711908|NCT00003138|470571736|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
130711909|NCT00003138|470571737|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
130711910|NCT00003138|470571736|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
130711911|NCT00003138|470571737|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
130711912|NCT04495283|470571739|FG000|Overall Study|Physician Decision|0|||
130711913|NCT04495283|470571740|FG001|Overall Study|Physician Decision|0|||
130711914|NCT04495283|470571741|FG002|Overall Study|Physician Decision|1|||
130711915|NCT04495283|470571739|FG000|Overall Study|Withdrawal by Subject|0|||
130711916|NCT04495283|470571740|FG001|Overall Study|Withdrawal by Subject|1|||
130711917|NCT04495283|470571741|FG002|Overall Study|Withdrawal by Subject|1|||
130955061|NCT03548584|471469072|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
130955062|NCT03548584|471469073|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
130955063|NCT03548584|471469074|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
130955064|NCT03548584|471469072|FG000|Overall Study|Lack of Efficacy|0|||
130955065|NCT03548584|471469073|FG001|Overall Study|Lack of Efficacy|1|||
130955066|NCT03548584|471469074|FG002|Overall Study|Lack of Efficacy|0|||
130955067|NCT03548584|471469072|FG000|Overall Study|Non-compliance with Study Drug|0|||
130955068|NCT03548584|471469073|FG001|Overall Study|Non-compliance with Study Drug|1|||
130955069|NCT03548584|471469074|FG002|Overall Study|Non-compliance with Study Drug|0|||
130955070|NCT03548584|471469072|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
130955071|NCT03548584|471469073|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
130955072|NCT03548584|471469074|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
130955073|NCT01433263|471469079|FG000|Overall Study|Adverse Event|3|||
130955074|NCT01433263|471469080|FG001|Overall Study|Adverse Event|1|||
130955075|NCT01433263|471469079|FG000|Overall Study|Death|5|||
130955076|NCT01433263|471469080|FG001|Overall Study|Death|3|||
130955077|NCT01433263|471469079|FG000|Overall Study|Lost to Follow-up|0|||
130955078|NCT01433263|471469080|FG001|Overall Study|Lost to Follow-up|1|||
130955079|NCT01433263|471469079|FG000|Overall Study|Protocol Deviation|1|||
130955080|NCT01433263|471469080|FG001|Overall Study|Protocol Deviation|0|||
130955081|NCT01433263|471469079|FG000|Overall Study|Withdrawal by Subject|10|||
130955082|NCT01433263|471469080|FG001|Overall Study|Withdrawal by Subject|7|||
130955083|NCT04709237|471469081|FG000|Overall Study|Lost to Follow-up|1|||
130955084|NCT04709237|471469082|FG001|Overall Study|Lost to Follow-up|0|||
130955085|NCT04709237|471469083|FG002|Overall Study|Lost to Follow-up|0|||
130955086|NCT01302964|471469085|FG000|Overall Study|Adverse Event|1|||
130955087|NCT01302964|471469086|FG001|Overall Study|Adverse Event|0|||
130955106|NCT05723770|471469089|FG000|Overall Study|Lost to Follow-up|4|||
130955107|NCT05723770|471469089|FG000|Overall Study|Withdrawal by Subject|2|||
130955108|NCT01359592|471469093|FG000|Initial Registration|Adverse Event|1|||
130955109|NCT01359592|471469094|FG001|Initial Registration|Adverse Event|0|||
130955110|NCT01359592|471469095|FG002|Initial Registration|Adverse Event|0|||
130955111|NCT01359592|471469096|FG003|Initial Registration|Adverse Event|0|||
130955112|NCT01359592|471469093|FG000|Initial Registration|Death|1|||
130955113|NCT01359592|471469094|FG001|Initial Registration|Death|0|||
130955114|NCT01359592|471469095|FG002|Initial Registration|Death|0|||
130955115|NCT01359592|471469096|FG003|Initial Registration|Death|0|||
130955116|NCT01359592|471469093|FG000|Initial Registration|Other reason not protocol specified|1|||
130955117|NCT01359592|471469094|FG001|Initial Registration|Other reason not protocol specified|0|||
130955118|NCT01359592|471469095|FG002|Initial Registration|Other reason not protocol specified|0|||
130955119|NCT01359592|471469096|FG003|Initial Registration|Other reason not protocol specified|0|||
130955120|NCT01359592|471469093|FG000|Initial Registration|Ineligible|26|||
130955121|NCT01359592|471469094|FG001|Initial Registration|Ineligible|0|||
130711918|NCT04495283|470571739|FG000|Overall Study|Other|1|||
130711919|NCT04495283|470571740|FG001|Overall Study|Other|0|||
130955122|NCT01359592|471469095|FG002|Initial Registration|Ineligible|0|||
130955123|NCT01359592|471469096|FG003|Initial Registration|Ineligible|0|||
130955124|NCT01359592|471469093|FG000|PET-Directed Therapy|Adverse Event|0|||
130955125|NCT01359592|471469094|FG001|PET-Directed Therapy|Adverse Event|0|||
130955126|NCT01359592|471469095|FG002|PET-Directed Therapy|Adverse Event|1|||
130955127|NCT01359592|471469096|FG003|PET-Directed Therapy|Adverse Event|0|||
130955128|NCT01359592|471469093|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
130955129|NCT01359592|471469094|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
130955130|NCT01359592|471469095|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
130955131|NCT01359592|471469096|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
130955132|NCT01359592|471469093|FG000|PET-Directed Therapy|Ineligible|0|||
130955133|NCT01359592|471469094|FG001|PET-Directed Therapy|Ineligible|0|||
130955134|NCT01359592|471469095|FG002|PET-Directed Therapy|Ineligible|24|||
130955135|NCT01359592|471469096|FG003|PET-Directed Therapy|Ineligible|0|||
130955136|NCT00779675|471469106|FG000|Treatment Period|Adverse Event|87|||
130955137|NCT00779675|471469106|FG000|Treatment Period|Treatment Failure|80|||
130955138|NCT00779675|471469106|FG000|Treatment Period|Transferred to Another Study|38|||
130955139|NCT00779675|471469106|FG000|Treatment Period|Lost to Follow-up|23|||
130955140|NCT00779675|471469106|FG000|Treatment Period|Withdrawal by Subject|46|||
130955141|NCT00779675|471469106|FG000|Treatment Period|Protocol Violation|54|||
130955142|NCT00779675|471469106|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
130955143|NCT00779675|471469106|FG000|Treatment Period|Administrative|3|||
130955144|NCT00779675|471469106|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
130955145|NCT00779675|471469106|FG000|Extended Treatment Period|Protocol Violation|13|||
130955146|NCT00779675|471469106|FG000|Extended Treatment Period|Adverse Event|6|||
130955147|NCT00779675|471469106|FG000|Extended Treatment Period|Treatment Failure|11|||
130955148|NCT00779675|471469106|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
130955149|NCT00779675|471469106|FG000|Extended Treatment Period|Lost to Follow-up|6|||
130955150|NCT02821962|471469107|FG000|Overall Study|Lost to Follow-up|2|||
130955151|NCT02821962|471469108|FG001|Overall Study|Lost to Follow-up|0|||
130955152|NCT00749775|471469113|FG000|Overall Study|Protocol Violation|24|||
130955153|NCT00749775|471469113|FG000|Overall Study|Lost to Follow-up|36|||
130955154|NCT00749775|471469113|FG000|Overall Study|No visit after first day of treatment|44|||
130955155|NCT00749775|471469113|FG000|Overall Study|No drug administration|3|||
130955156|NCT04300296|471469114|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
130955157|NCT04300296|471469115|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
130955158|NCT04300296|471469116|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
130955159|NCT04300296|471469117|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
130955160|NCT04300296|471469118|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
130955161|NCT04300296|471469119|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
130955162|NCT04300296|471469114|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
130955163|NCT04300296|471469115|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
130955164|NCT04300296|471469116|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
130955165|NCT04300296|471469117|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
130955166|NCT04300296|471469118|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
130955167|NCT04300296|471469119|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
130955168|NCT04300296|471469114|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
131125645|NCT00243386|472089098|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
131125646|NCT00243386|472089099|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
131125647|NCT00243386|472089100|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
131125648|NCT00243386|472089098|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
131125649|NCT00243386|472089099|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
131125650|NCT00243386|472089100|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
131125651|NCT00243386|472089098|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
131125652|NCT00243386|472089099|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
131125653|NCT00243386|472089100|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
131125654|NCT00243386|472089098|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
131125655|NCT00243386|472089099|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
131125656|NCT00243386|472089100|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
131125657|NCT00243386|472089098|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
131125658|NCT00243386|472089099|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
130955169|NCT04300296|471469115|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
130955170|NCT04300296|471469116|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
130955171|NCT04300296|471469117|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
130955172|NCT04300296|471469118|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
130955173|NCT04300296|471469119|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
130955174|NCT04300296|471469114|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
131133723|NCT01661140|472117174|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
131133724|NCT01661140|472117175|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
131133725|NCT01661140|472117173|FG000|Open-Label Period|Lost to Follow-up|2|||
131133726|NCT01661140|472117174|FG001|Open-Label Period|Lost to Follow-up|0|||
130711920|NCT04495283|470571741|FG002|Overall Study|Other|1|||
130955175|NCT04300296|471469115|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
130955176|NCT04300296|471469116|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
130955177|NCT04300296|471469117|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
130955178|NCT04300296|471469118|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
130955179|NCT04300296|471469119|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
130955180|NCT04300296|471469114|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
130955181|NCT04300296|471469115|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
130955182|NCT04300296|471469116|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
130955183|NCT04300296|471469117|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
130955184|NCT04300296|471469118|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
130955185|NCT04300296|471469119|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
130955186|NCT04300296|471469114|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
130955187|NCT04300296|471469115|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
130955188|NCT04300296|471469116|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
130955189|NCT04300296|471469117|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
130955190|NCT04300296|471469118|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
130955191|NCT04300296|471469119|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
130955192|NCT04300296|471469114|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
130955193|NCT04300296|471469115|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
130955194|NCT04300296|471469116|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
130955195|NCT04300296|471469117|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
130955196|NCT04300296|471469118|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
130955197|NCT04300296|471469119|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
130955198|NCT00701129|471469120|FG000|Overall Study|Death|2|||
130955199|NCT02412631|471469121|FG000|Overall Study|Adverse Event|1|||
130955200|NCT02412631|471469122|FG001|Overall Study|Adverse Event|2|||
130955201|NCT02412631|471469121|FG000|Overall Study|Lost to Follow-up|5|||
130955202|NCT02412631|471469122|FG001|Overall Study|Lost to Follow-up|9|||
130955203|NCT02412631|471469121|FG000|Overall Study|Withdrawal by Subject|9|||
130955204|NCT02412631|471469122|FG001|Overall Study|Withdrawal by Subject|3|||
130955205|NCT02412631|471469121|FG000|Overall Study|Early stop by FDA|5|||
130955206|NCT02412631|471469122|FG001|Overall Study|Early stop by FDA|2|||
130955207|NCT02412631|471469121|FG000|Overall Study|Unspecified reason|6|||
130955208|NCT02412631|471469122|FG001|Overall Study|Unspecified reason|8|||
130955209|NCT00958776|471469123|FG000|Overall Study|Adverse Event|0|||
130955210|NCT00958776|471469124|FG001|Overall Study|Adverse Event|1|||
130955211|NCT00958776|471469123|FG000|Overall Study|Physician Decision|1|||
130955212|NCT00958776|471469124|FG001|Overall Study|Physician Decision|0|||
130955213|NCT00958776|471469123|FG000|Overall Study|Lost to Follow-up|2|||
130955214|NCT00958776|471469124|FG001|Overall Study|Lost to Follow-up|6|||
130955215|NCT00958776|471469123|FG000|Overall Study|Withdrawal by Subject|7|||
130955216|NCT00958776|471469124|FG001|Overall Study|Withdrawal by Subject|16|||
130955217|NCT00958776|471469123|FG000|Overall Study|Protocol Violation|1|||
130955218|NCT00958776|471469124|FG001|Overall Study|Protocol Violation|1|||
130955219|NCT00958776|471469123|FG000|Overall Study|Death|2|||
130955220|NCT00958776|471469124|FG001|Overall Study|Death|1|||
130955221|NCT00958776|471469123|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
130955222|NCT00958776|471469124|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
130955223|NCT00958776|471469123|FG000|Overall Study|Missing|1|||
130955224|NCT00958776|471469124|FG001|Overall Study|Missing|1|||
131125659|NCT00243386|472089100|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
131125660|NCT00243386|472089098|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
131125661|NCT00243386|472089099|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
131125662|NCT00243386|472089100|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
131125663|NCT00243386|472089098|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
131125664|NCT00243386|472089099|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
130711921|NCT05142566|470571744|FG000|Overall Study|Protocol Violation|1|||
130711922|NCT01032018|470571749|FG000|Overall Study|Lost to Follow-up|6|||
130955225|NCT02583256|471469127|FG000|Overall Study|Withdrawal by Subject|0|||
130955226|NCT02583256|471469128|FG001|Overall Study|Withdrawal by Subject|1|||
130955227|NCT02583256|471469129|FG002|Overall Study|Withdrawal by Subject|1|||
131125665|NCT00243386|472089100|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
130955228|NCT02583256|471469130|FG003|Overall Study|Withdrawal by Subject|0|||
130955229|NCT02583256|471469127|FG000|Overall Study|Lost to Follow-up|1|||
131125666|NCT02285998|472089101|FG000|Overall Study|Adverse Event|9|||
131125667|NCT02285998|472089102|FG001|Overall Study|Adverse Event|8|||
131125668|NCT02285998|472089101|FG000|Overall Study|Physician Decision|1|||
130711923|NCT01032018|470571750|FG001|Overall Study|Lost to Follow-up|5|||
130955230|NCT02583256|471469128|FG001|Overall Study|Lost to Follow-up|1|||
130711924|NCT01032018|470571749|FG000|Overall Study|Death|0|||
130711925|NCT01032018|470571750|FG001|Overall Study|Death|1|||
131125669|NCT02285998|472089102|FG001|Overall Study|Physician Decision|2|||
130711926|NCT02072148|470571761|FG000|Overall Study|withdrew prior to surgery|23|||
130711927|NCT02072148|470571762|FG001|Overall Study|withdrew prior to surgery|0|||
130711928|NCT02072148|470571763|FG002|Overall Study|withdrew prior to surgery|0|||
130711929|NCT02072148|470571761|FG000|Overall Study|Death|0|||
130711930|NCT02072148|470571762|FG001|Overall Study|Death|0|||
130711931|NCT02072148|470571763|FG002|Overall Study|Death|1|||
130711932|NCT02072148|470571761|FG000|Overall Study|Withdrawal by Subject|0|||
130711933|NCT02072148|470571762|FG001|Overall Study|Withdrawal by Subject|13|||
130955231|NCT02583256|471469129|FG002|Overall Study|Lost to Follow-up|0|||
130955232|NCT02583256|471469130|FG003|Overall Study|Lost to Follow-up|1|||
130955233|NCT02583256|471469127|FG000|Overall Study|Administrative/Other|2|||
130955234|NCT02583256|471469128|FG001|Overall Study|Administrative/Other|0|||
130955235|NCT02583256|471469129|FG002|Overall Study|Administrative/Other|1|||
130955236|NCT02583256|471469130|FG003|Overall Study|Administrative/Other|2|||
130955237|NCT04537806|471469133|FG000|Overall Study|Randomized but not treated|1|||
130955238|NCT04537806|471469134|FG001|Overall Study|Randomized but not treated|0|||
130955239|NCT04537806|471469133|FG000|Overall Study|Adverse Event|1|||
130955240|NCT04537806|471469134|FG001|Overall Study|Adverse Event|1|||
130955241|NCT03019627|471469135|FG000|Overall Study|Adverse Event|8|||
130955242|NCT03019627|471469136|FG001|Overall Study|Adverse Event|0|||
130955243|NCT03019627|471469135|FG000|Overall Study|Unrelated to adverse event|1|||
130955244|NCT03019627|471469136|FG001|Overall Study|Unrelated to adverse event|3|||
130955245|NCT03019627|471469135|FG000|Overall Study|Lost to Follow-up|2|||
130955246|NCT03019627|471469136|FG001|Overall Study|Lost to Follow-up|1|||
130955247|NCT03019627|471469135|FG000|Overall Study|not compliance|2|||
130955248|NCT03019627|471469136|FG001|Overall Study|not compliance|2|||
130955249|NCT03019627|471469135|FG000|Overall Study|Other|2|||
130955250|NCT03019627|471469136|FG001|Overall Study|Other|2|||
130955251|NCT02953821|471469137|FG000|Overall Study|Adverse Event|0|||
130955252|NCT02953821|471469138|FG001|Overall Study|Adverse Event|4|||
130955253|NCT02953821|471469137|FG000|Overall Study|Death|1|||
130955254|NCT02953821|471469138|FG001|Overall Study|Death|0|||
130955255|NCT02953821|471469137|FG000|Overall Study|Progressive Disease|5|||
130955256|NCT02953821|471469138|FG001|Overall Study|Progressive Disease|1|||
130955257|NCT02953821|471469137|FG000|Overall Study|Lost to Follow-up|2|||
130955258|NCT02953821|471469138|FG001|Overall Study|Lost to Follow-up|0|||
130955259|NCT02953821|471469137|FG000|Overall Study|Physician Decision|1|||
130955260|NCT02953821|471469138|FG001|Overall Study|Physician Decision|1|||
130955261|NCT02953821|471469137|FG000|Overall Study|Withdrawal by Subject|3|||
130955262|NCT02953821|471469138|FG001|Overall Study|Withdrawal by Subject|3|||
130955263|NCT02953821|471469137|FG000|Overall Study|Change of address|0|||
130955264|NCT02953821|471469138|FG001|Overall Study|Change of address|1|||
130955265|NCT02953821|471469137|FG000|Overall Study|Lack of Efficacy|1|||
130955266|NCT02953821|471469138|FG001|Overall Study|Lack of Efficacy|0|||
131125670|NCT02285998|472089101|FG000|Overall Study|Lost to Follow-up|176|||
131125671|NCT02285998|472089102|FG001|Overall Study|Lost to Follow-up|172|||
131125672|NCT02285998|472089101|FG000|Overall Study|Withdrawal by Subject|53|||
131125673|NCT02285998|472089102|FG001|Overall Study|Withdrawal by Subject|61|||
131125674|NCT02285998|472089101|FG000|Overall Study|Other Reasons|7|||
131125675|NCT02285998|472089102|FG001|Overall Study|Other Reasons|10|||
131125676|NCT00133991|472089103|FG000|Overall Study|Death|4|||
131125677|NCT03002155|472089104|FG000|Overall Study|Lost to Follow-up|1|||
131125678|NCT03002155|472089105|FG001|Overall Study|Lost to Follow-up|2|||
131125679|NCT03002155|472089104|FG000|Overall Study|Withdrawal by Subject|1|||
131125680|NCT03002155|472089105|FG001|Overall Study|Withdrawal by Subject|0|||
131125681|NCT03002155|472089104|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
131125682|NCT03002155|472089105|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
131125683|NCT00978029|472089106|FG000|Overall Study|Adverse Event|1|||
131125684|NCT00978029|472089107|FG001|Overall Study|Adverse Event|2|||
131125685|NCT00978029|472089108|FG002|Overall Study|Adverse Event|5|||
131125686|NCT00978029|472089106|FG000|Overall Study|Withdrawal by Subject|0|||
131125687|NCT00978029|472089107|FG001|Overall Study|Withdrawal by Subject|0|||
131125688|NCT00978029|472089108|FG002|Overall Study|Withdrawal by Subject|1|||
131125689|NCT00978029|472089106|FG000|Overall Study|Protocol Violation|0|||
131125690|NCT00978029|472089107|FG001|Overall Study|Protocol Violation|1|||
130711934|NCT02072148|470571763|FG002|Overall Study|Withdrawal by Subject|12|||
130955267|NCT02953821|471469137|FG000|Overall Study|Out of state for indeterminate time|0|||
130955268|NCT02953821|471469138|FG001|Overall Study|Out of state for indeterminate time|1|||
130955269|NCT02953821|471469137|FG000|Overall Study|No improvement|0|||
130955270|NCT02953821|471469138|FG001|Overall Study|No improvement|1|||
130955271|NCT02953821|471469137|FG000|Overall Study|Refused follow-up visit|2|||
130955272|NCT02953821|471469138|FG001|Overall Study|Refused follow-up visit|1|||
131125691|NCT00978029|472089108|FG002|Overall Study|Protocol Violation|0|||
130711935|NCT02145026|470571765|FG000|Overall Study|Adverse Event|2|||
130711936|NCT02145026|470571765|FG000|Overall Study|Death|4|||
130985567|NCT01984697|471574907|FG003|Overall Study|Adverse Event|0|||
131125692|NCT00545298|472089109|FG000|Overall Study|Issues with Standard of Care|2|||
131125693|NCT00545298|472089110|FG001|Overall Study|Issues with Standard of Care|0|||
130711937|NCT02145026|470571765|FG000|Overall Study|Withdrawal by Subject|2|||
130711938|NCT02145026|470571765|FG000|Overall Study|Physician Decision|4|||
130711939|NCT04132336|470571766|FG000|Overall Study|Investigator Decision|0|||
130711940|NCT04132336|470571767|FG001|Overall Study|Investigator Decision|1|||
130711941|NCT04132336|470571768|FG002|Overall Study|Investigator Decision|0|||
130711942|NCT04132336|470571769|FG003|Overall Study|Investigator Decision|0|||
130711943|NCT04132336|470571770|FG004|Overall Study|Investigator Decision|0|||
130711944|NCT04132336|470571771|FG005|Overall Study|Investigator Decision|0|||
130711945|NCT04132336|470571772|FG006|Overall Study|Investigator Decision|0|||
130711946|NCT00584844|470571773|FG000|Overall Study|Withdrawal by Subject|59|||
130711947|NCT00584844|470571773|FG000|Overall Study|Screen Failure|20|||
130711948|NCT01939496|470571774|FG000|Overall Study|Adverse Event|2|||
130711949|NCT01939496|470571775|FG001|Overall Study|Adverse Event|0|||
130711950|NCT01939496|470571776|FG002|Overall Study|Adverse Event|0|||
130711951|NCT01939496|470571774|FG000|Overall Study|Lost to Follow-up|1|||
130711952|NCT01939496|470571775|FG001|Overall Study|Lost to Follow-up|1|||
130711953|NCT01939496|470571776|FG002|Overall Study|Lost to Follow-up|0|||
130711954|NCT01939496|470571774|FG000|Overall Study|Physician Decision|1|||
130711955|NCT01939496|470571775|FG001|Overall Study|Physician Decision|0|||
130711956|NCT01939496|470571776|FG002|Overall Study|Physician Decision|0|||
130711957|NCT01939496|470571774|FG000|Overall Study|Protocol Violation|3|||
130711958|NCT01939496|470571775|FG001|Overall Study|Protocol Violation|0|||
130711959|NCT01939496|470571776|FG002|Overall Study|Protocol Violation|0|||
130711960|NCT01939496|470571774|FG000|Overall Study|Withdrawal by Subject|0|||
130711961|NCT01939496|470571775|FG001|Overall Study|Withdrawal by Subject|1|||
130711962|NCT01939496|470571776|FG002|Overall Study|Withdrawal by Subject|1|||
130711963|NCT01939496|470571774|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
130711964|NCT01939496|470571775|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
130711965|NCT01939496|470571776|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
130711966|NCT01939496|470571774|FG000|Overall Study|Other|2|||
130711967|NCT01939496|470571775|FG001|Overall Study|Other|0|||
130711968|NCT01939496|470571776|FG002|Overall Study|Other|1|||
130711969|NCT03052322|470571777|FG000|Overall Study|Other un-specified|1|||
130711970|NCT03052322|470571778|FG001|Overall Study|Other un-specified|2|||
130711971|NCT03052322|470571777|FG000|Overall Study|Withdrawal by Subject|10|||
130711972|NCT03052322|470571778|FG001|Overall Study|Withdrawal by Subject|9|||
130711973|NCT03052322|470571777|FG000|Overall Study|Death|0|||
130711974|NCT03052322|470571778|FG001|Overall Study|Death|2|||
130711975|NCT03052322|470571777|FG000|Overall Study|Lack of Efficacy|1|||
130711976|NCT03052322|470571778|FG001|Overall Study|Lack of Efficacy|2|||
130711977|NCT03052322|470571777|FG000|Overall Study|Protocol Violation|1|||
130711978|NCT03052322|470571778|FG001|Overall Study|Protocol Violation|0|||
130711979|NCT03052322|470571777|FG000|Overall Study|Lost to Follow-up|2|||
130711980|NCT03052322|470571778|FG001|Overall Study|Lost to Follow-up|4|||
130711981|NCT03052322|470571777|FG000|Overall Study|Adverse Event|6|||
130711982|NCT03052322|470571778|FG001|Overall Study|Adverse Event|13|||
130711983|NCT04920916|470571779|FG000|Phase IIa 60 Day Study|Death|2|||
130711984|NCT04920916|470571780|FG001|Phase IIa 60 Day Study|Death|5|||
130711985|NCT04920916|470571779|FG000|1 Year Follow up (Phone Call)|Death|1|||
130955273|NCT03219333|471469139|FG000|Overall Study|Withdrawal by Subject|9|||
130955274|NCT03219333|471469140|FG001|Overall Study|Withdrawal by Subject|4|||
130955275|NCT03219333|471469139|FG000|Overall Study|Lost to Follow-up|1|||
130955276|NCT03219333|471469140|FG001|Overall Study|Lost to Follow-up|1|||
130955277|NCT03219333|471469139|FG000|Overall Study|Death|104|||
130955278|NCT03219333|471469140|FG001|Overall Study|Death|72|||
130955279|NCT03219333|471469139|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
130955280|NCT03219333|471469140|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
130955281|NCT03219333|471469139|FG000|Overall Study|Other|2|||
130955282|NCT03219333|471469140|FG001|Overall Study|Other|2|||
130955283|NCT00723606|471469141|FG000|Overall Study|Adverse Event|2|||
130955284|NCT00723606|471469142|FG001|Overall Study|Adverse Event|5|||
130711986|NCT04920916|470571780|FG001|1 Year Follow up (Phone Call)|Death|3|||
130711987|NCT04920916|470571779|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
130711988|NCT04920916|470571780|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
131225478|NCT00575328|472452038|FG000|Overall Study|Adverse Event|1|||
130711989|NCT01892657|470571783|FG000|Overall Study|Withdrawal by Subject|6|||
130711990|NCT01892657|470571783|FG000|Overall Study|Protocol Violation|12|||
130711991|NCT02712333|470571784|FG000|First Period|Withdrawal by Subject|3|||
130711992|NCT02712333|470571785|FG001|First Period|Withdrawal by Subject|2|||
130711993|NCT00136318|470571786|FG000|Overall Study|Adverse Event|5|||
130711994|NCT00136318|470571787|FG001|Overall Study|Adverse Event|5|||
130711995|NCT00136318|470571786|FG000|Overall Study|Withdrawal by Subject|2|||
130711996|NCT00136318|470571787|FG001|Overall Study|Withdrawal by Subject|2|||
130711997|NCT01546649|470571792|FG000|Overall Study|Adverse Event|4|||
130711998|NCT01546649|470571793|FG001|Overall Study|Adverse Event|5|||
130711999|NCT01546649|470571792|FG000|Overall Study|Protocol Violation|1|||
130712000|NCT01546649|470571793|FG001|Overall Study|Protocol Violation|0|||
130955285|NCT00723606|471469141|FG000|Overall Study|Other|2|||
130712001|NCT01546649|470571792|FG000|Overall Study|Lack of Efficacy|1|||
130712002|NCT01546649|470571793|FG001|Overall Study|Lack of Efficacy|0|||
130955286|NCT00723606|471469142|FG001|Overall Study|Other|0|||
130712003|NCT01546649|470571792|FG000|Overall Study|Recurrence|1|||
130712004|NCT01546649|470571793|FG001|Overall Study|Recurrence|1|||
130712005|NCT01546649|470571792|FG000|Overall Study|Discovery of secondary cancer|0|||
130712006|NCT01546649|470571793|FG001|Overall Study|Discovery of secondary cancer|1|||
130712007|NCT01546649|470571792|FG000|Overall Study|Withdrawal by Subject|1|||
130712008|NCT01546649|470571793|FG001|Overall Study|Withdrawal by Subject|2|||
130712009|NCT01134627|470571798|FG000|Overall Study|Adverse Event|47|||
130712010|NCT01134627|470571799|FG001|Overall Study|Adverse Event|31|||
130712011|NCT01134627|470571798|FG000|Overall Study|Lost to Follow-up|1|||
130712012|NCT01134627|470571799|FG001|Overall Study|Lost to Follow-up|2|||
130712013|NCT01134627|470571798|FG000|Overall Study|Protocol Violation|3|||
130712014|NCT01134627|470571799|FG001|Overall Study|Protocol Violation|5|||
130712015|NCT01134627|470571798|FG000|Overall Study|Lack of Efficacy|2|||
130712016|NCT01134627|470571799|FG001|Overall Study|Lack of Efficacy|12|||
130712017|NCT01134627|470571798|FG000|Overall Study|Withdrawal by Subject|4|||
130712018|NCT01134627|470571799|FG001|Overall Study|Withdrawal by Subject|3|||
130712019|NCT01134627|470571798|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
130712020|NCT01134627|470571799|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
130712021|NCT01134627|470571798|FG000|Overall Study|Other|11|||
130712022|NCT01134627|470571799|FG001|Overall Study|Other|14|||
130712023|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
130712024|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
130955287|NCT00723606|471469141|FG000|Overall Study|Withdrawal by Subject|0|||
130955288|NCT00723606|471469142|FG001|Overall Study|Withdrawal by Subject|2|||
130955289|NCT05107128|471469143|FG000|Overall Study|Adverse Event|2|||
130955290|NCT05107128|471469144|FG001|Overall Study|Adverse Event|0|||
130955291|NCT05107128|471469143|FG000|Overall Study|Withdrawal by Subject|3|||
130955292|NCT05107128|471469144|FG001|Overall Study|Withdrawal by Subject|3|||
130955293|NCT05107128|471469143|FG000|Overall Study|Withdrawal of Consent|0|||
130955294|NCT05107128|471469144|FG001|Overall Study|Withdrawal of Consent|1|||
130955295|NCT05107128|471469143|FG000|Overall Study|Reason Not Specified|2|||
130955296|NCT05107128|471469144|FG001|Overall Study|Reason Not Specified|0|||
130955297|NCT02350309|471469145|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
130955298|NCT02350309|471469146|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
130955299|NCT02350309|471469147|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
130955300|NCT02350309|471469148|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
130955301|NCT02350309|471469149|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
130955302|NCT02350309|471469150|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
130955303|NCT02350309|471469145|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
130955304|NCT02350309|471469146|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
130955305|NCT02350309|471469147|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
130955306|NCT02350309|471469148|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
130955307|NCT02350309|471469149|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
130955308|NCT02350309|471469150|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
130955309|NCT01256710|471469151|FG000|Overall Study|Death|449|||
130955310|NCT01256710|471469151|FG000|Overall Study|System Explant|67|||
130955311|NCT01256710|471469151|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
130955312|NCT01256710|471469151|FG000|Overall Study|Lost to Follow-up|67|||
130955313|NCT01256710|471469151|FG000|Overall Study|Withdrawal by Subject|29|||
130955314|NCT01256710|471469151|FG000|Overall Study|Physician Decision|9|||
130955315|NCT01256710|471469151|FG000|Overall Study|Subject Noncompliance|2|||
130955316|NCT01256710|471469151|FG000|Overall Study|Study Terminated by Sponsor|273|||
130955317|NCT00058825|471469152|FG000|Overall Study|Relapse|9|||
130955318|NCT00058825|471469152|FG000|Overall Study|Progressive Disease|5|||
130955319|NCT00058825|471469152|FG000|Overall Study|Graft Failure|5|||
130955320|NCT00058825|471469152|FG000|Overall Study|Death|3|||
130955321|NCT01205165|471469153|FG000|Overall Study|Lost to Follow-up|2|||
130955322|NCT02942017|471469156|FG000|Overall Study|Adverse Event|0|||
131125694|NCT00545298|472089111|FG002|Overall Study|Issues with Standard of Care|1|||
131125695|NCT01793142|472089117|FG000|Overall Study|Randomized not treated|7|||
130712025|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
130955323|NCT02942017|471469157|FG001|Overall Study|Adverse Event|1|||
130955324|NCT02942017|471469156|FG000|Overall Study|Withdrawal by Subject|0|||
130955325|NCT02942017|471469157|FG001|Overall Study|Withdrawal by Subject|1|||
131125696|NCT01820364|472089118|FG000|Part I: LGX818|Death|1|||
130712026|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
130955326|NCT02942017|471469156|FG000|Overall Study|Lost to Follow-up|1|||
130955327|NCT02942017|471469157|FG001|Overall Study|Lost to Follow-up|1|||
130712027|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
130712028|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
130712029|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
130955328|NCT02942017|471469156|FG000|Overall Study|Randomized but not dosed|1|||
130955329|NCT02942017|471469157|FG001|Overall Study|Randomized but not dosed|3|||
130955330|NCT04399161|471469158|FG000|Overall Study|Withdrawal by Subject|1|||
130955331|NCT04399161|471469159|FG001|Overall Study|Withdrawal by Subject|0|||
130955332|NCT04399161|471469160|FG002|Overall Study|Withdrawal by Subject|2|||
130955333|NCT04399161|471469158|FG000|Overall Study|Protocol Violation|1|||
130955334|NCT04399161|471469159|FG001|Overall Study|Protocol Violation|2|||
130955335|NCT04399161|471469160|FG002|Overall Study|Protocol Violation|0|||
130955336|NCT01736696|471469163|FG000|Overall Study|Withdrawal by Subject|0|||
130955337|NCT01736696|471469164|FG001|Overall Study|Withdrawal by Subject|0|||
130955338|NCT01736696|471469165|FG002|Overall Study|Withdrawal by Subject|1|||
130955339|NCT01736696|471469166|FG003|Overall Study|Withdrawal by Subject|0|||
130955340|NCT01736696|471469167|FG004|Overall Study|Withdrawal by Subject|0|||
130955341|NCT01736696|471469168|FG005|Overall Study|Withdrawal by Subject|0|||
130955342|NCT01736696|471469169|FG006|Overall Study|Withdrawal by Subject|0|||
130955343|NCT00838565|471469170|FG000|Overall Study|Withdrawal by Subject|0|||
130955344|NCT00838565|471469171|FG001|Overall Study|Withdrawal by Subject|0|||
130955345|NCT00838565|471469172|FG002|Overall Study|Withdrawal by Subject|1|||
130955346|NCT00838565|471469173|FG003|Overall Study|Withdrawal by Subject|0|||
130955347|NCT00838565|471469174|FG004|Overall Study|Withdrawal by Subject|0|||
130955348|NCT00838565|471469175|FG005|Overall Study|Withdrawal by Subject|2|||
130955349|NCT00838565|471469170|FG000|Overall Study|Other|0|||
130955350|NCT00838565|471469171|FG001|Overall Study|Other|2|||
130955351|NCT00838565|471469172|FG002|Overall Study|Other|0|||
130955352|NCT00838565|471469173|FG003|Overall Study|Other|0|||
130955353|NCT00838565|471469174|FG004|Overall Study|Other|0|||
130955354|NCT00838565|471469175|FG005|Overall Study|Other|0|||
130955355|NCT00838565|471469170|FG000|Overall Study|Randomized but not Treated|0|||
130955356|NCT00838565|471469171|FG001|Overall Study|Randomized but not Treated|1|||
130955357|NCT00838565|471469172|FG002|Overall Study|Randomized but not Treated|0|||
130955358|NCT00838565|471469173|FG003|Overall Study|Randomized but not Treated|0|||
130955359|NCT00838565|471469174|FG004|Overall Study|Randomized but not Treated|0|||
130955360|NCT00838565|471469175|FG005|Overall Study|Randomized but not Treated|0|||
130955361|NCT02114879|471469176|FG000|Overall Study|Withdrawal by Subject|9|||
130955362|NCT02114879|471469177|FG001|Overall Study|Withdrawal by Subject|5|||
130955363|NCT02114879|471469176|FG000|Overall Study|Death|6|||
130955364|NCT02114879|471469177|FG001|Overall Study|Death|11|||
130955365|NCT02114879|471469176|FG000|Overall Study|Lost to Follow-up|4|||
130955366|NCT02114879|471469177|FG001|Overall Study|Lost to Follow-up|6|||
130955367|NCT02114879|471469176|FG000|Overall Study|Physician Decision|0|||
130955368|NCT02114879|471469177|FG001|Overall Study|Physician Decision|2|||
130955369|NCT00458484|471469178|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
130955370|NCT00458484|471469179|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
130955371|NCT00458484|471469180|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
130955372|NCT00458484|471469181|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
130955373|NCT00458484|471469182|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
130955374|NCT00458484|471469183|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
130955375|NCT00458484|471469184|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
130955376|NCT05059600|471469185|FG000|Overall Study|Enrolled but not Treated|10|||
130955377|NCT04538664|471469186|FG000|Overall Study|Withdrawal by Subject|5|||
130955378|NCT04538664|471469187|FG001|Overall Study|Withdrawal by Subject|9|||
130955379|NCT04538664|471469186|FG000|Overall Study|Lost to Follow-up|2|||
130955380|NCT04538664|471469187|FG001|Overall Study|Lost to Follow-up|1|||
130955381|NCT04538664|471469186|FG000|Overall Study|Ongoing|106|||
130955382|NCT04538664|471469187|FG001|Overall Study|Ongoing|115|||
130955383|NCT04552587|471469188|FG000|Overall Study|Lost to Follow-up|4|||
130955384|NCT03400033|471469191|FG000|Overall Study|Withdrawal by Subject|1|||
130955385|NCT03400033|471469192|FG001|Overall Study|Withdrawal by Subject|2|||
130955386|NCT02448875|471469193|FG000|Overall Study|Adverse Event|2|||
130955387|NCT02448875|471469194|FG001|Overall Study|Adverse Event|1|||
130955388|NCT02448875|471469195|FG002|Overall Study|Adverse Event|0|||
130955389|NCT02448875|471469193|FG000|Overall Study|Lost to Follow-up|1|||
130955390|NCT02448875|471469194|FG001|Overall Study|Lost to Follow-up|0|||
130955391|NCT02448875|471469195|FG002|Overall Study|Lost to Follow-up|0|||
131039413|NCT03034356|471778257|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
131039414|NCT03034356|471778256|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
130955392|NCT02448875|471469193|FG000|Overall Study|Investigator Decision|3|||
130955393|NCT02448875|471469194|FG001|Overall Study|Investigator Decision|0|||
130955394|NCT02448875|471469195|FG002|Overall Study|Investigator Decision|1|||
130955395|NCT02448875|471469193|FG000|Overall Study|Withdrawal by Subject|1|||
130955396|NCT02448875|471469194|FG001|Overall Study|Withdrawal by Subject|0|||
130955397|NCT02448875|471469195|FG002|Overall Study|Withdrawal by Subject|0|||
130955398|NCT00689481|471469201|FG000|Overall Study|Adverse Event|7|||
130955399|NCT00689481|471469202|FG001|Overall Study|Adverse Event|1|||
130955400|NCT00689481|471469201|FG000|Overall Study|Lost to Follow-up|4|||
130955401|NCT00689481|471469202|FG001|Overall Study|Lost to Follow-up|3|||
130955402|NCT00689481|471469201|FG000|Overall Study|Lack of Efficacy|4|||
130955403|NCT00689481|471469202|FG001|Overall Study|Lack of Efficacy|3|||
130955404|NCT00689481|471469201|FG000|Overall Study|Non-compliance with study treatment|1|||
130955405|NCT00689481|471469202|FG001|Overall Study|Non-compliance with study treatment|1|||
130955406|NCT00689481|471469201|FG000|Overall Study|Withdrawal by Subject|8|||
130955407|NCT00689481|471469202|FG001|Overall Study|Withdrawal by Subject|4|||
130955408|NCT00689481|471469201|FG000|Overall Study|Excluded medication started during study|0|||
130955409|NCT00689481|471469202|FG001|Overall Study|Excluded medication started during study|1|||
130955410|NCT00689481|471469201|FG000|Overall Study|Subject early term, left on vacation|0|||
130955411|NCT00689481|471469202|FG001|Overall Study|Subject early term, left on vacation|1|||
130955412|NCT00316199|471469203|FG000|Overall Study|Adverse Event|2|||
130955413|NCT00316199|471469203|FG000|Overall Study|Death|8|||
130955414|NCT00316199|471469203|FG000|Overall Study|Lost to Follow-up|2|||
130955415|NCT00590954|471469204|FG000|Overall Study|Inevaluable|2|||
130955416|NCT02782949|471469205|FG000|Overall Study|Protocol Violation|1|||
130955417|NCT02782949|471469206|FG001|Overall Study|Protocol Violation|0|||
130955418|NCT02782949|471469205|FG000|Overall Study|Withdrawal by Subject|0|||
130955419|NCT02782949|471469206|FG001|Overall Study|Withdrawal by Subject|1|||
130955420|NCT00480636|471471072|FG000|Overall Study|Death|12|||
130955421|NCT00480636|471471072|FG000|Overall Study|Lost to Follow-up|4|||
130955422|NCT00480636|471471072|FG000|Overall Study|Other|2|||
130955423|NCT00480636|471471072|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
130955424|NCT00326911|471471073|FG000|Overall Study|Hospitalization prior to treatment|0|||
130955425|NCT00326911|471471074|FG001|Overall Study|Hospitalization prior to treatment|1|||
130955426|NCT00326911|471471073|FG000|Overall Study|Physician decision prior to treatment|1|||
130955427|NCT00326911|471471074|FG001|Overall Study|Physician decision prior to treatment|0|||
130955428|NCT00326911|471471073|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
130955429|NCT00326911|471471074|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
130955430|NCT01470469|471471076|FG000|Overall Study|Withdrawal by Subject|4|||
130955431|NCT01470469|471471077|FG001|Overall Study|Withdrawal by Subject|6|||
130955432|NCT01470469|471471076|FG000|Overall Study|Lack of Efficacy|1|||
130955433|NCT01470469|471471077|FG001|Overall Study|Lack of Efficacy|7|||
130955434|NCT01470469|471471076|FG000|Overall Study|Adverse Event|0|||
130955435|NCT01470469|471471077|FG001|Overall Study|Adverse Event|7|||
130955436|NCT01470469|471471076|FG000|Overall Study|Lost to Follow-up|2|||
130955437|NCT01470469|471471077|FG001|Overall Study|Lost to Follow-up|2|||
130955438|NCT01470469|471471076|FG000|Overall Study|Protocol Violation|1|||
131125697|NCT01820364|472089119|FG001|Part I: LGX818|Death|0|||
131125698|NCT01820364|472089118|FG000|Part I: LGX818|Administrative Problems|3|||
131125699|NCT01820364|472089119|FG001|Part I: LGX818|Administrative Problems|0|||
131125700|NCT01820364|472089118|FG000|Part I: LGX818|Adverse Event|6|||
131125701|NCT01820364|472089119|FG001|Part I: LGX818|Adverse Event|0|||
131125702|NCT01820364|472089118|FG000|Part I: LGX818|Disease Progression|4|||
131125703|NCT01820364|472089119|FG001|Part I: LGX818|Disease Progression|0|||
131125704|NCT01820364|472089118|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
131125705|NCT01820364|472089119|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
131125706|NCT03451084|472089122|FG000|Overall Study|Withdrawal by Subject|2|||
131125707|NCT03451084|472089123|FG001|Overall Study|Withdrawal by Subject|1|||
131125708|NCT03451084|472089124|FG002|Overall Study|Withdrawal by Subject|2|||
131125709|NCT03451084|472089125|FG003|Overall Study|Withdrawal by Subject|1|||
131125710|NCT03451084|472089122|FG000|Overall Study|Disease recurrence|0|||
131125711|NCT03451084|472089123|FG001|Overall Study|Disease recurrence|2|||
131125712|NCT03451084|472089124|FG002|Overall Study|Disease recurrence|0|||
131125713|NCT03451084|472089125|FG003|Overall Study|Disease recurrence|0|||
131125714|NCT03451084|472089122|FG000|Overall Study|Lack of Efficacy|0|||
131125715|NCT03451084|472089123|FG001|Overall Study|Lack of Efficacy|3|||
130955439|NCT01470469|471471077|FG001|Overall Study|Protocol Violation|1|||
130955440|NCT01470469|471471076|FG000|Overall Study|Other|2|||
130955441|NCT01470469|471471077|FG001|Overall Study|Other|1|||
130955442|NCT05459129|471471078|FG000|Overall Study|Death|1|||
130955443|NCT05459129|471471079|FG001|Overall Study|Death|0|||
130955444|NCT05459129|471471078|FG000|Overall Study|Study Terminated By Sponsor|5|||
130955445|NCT05459129|471471079|FG001|Overall Study|Study Terminated By Sponsor|6|||
131125716|NCT03451084|472089124|FG002|Overall Study|Lack of Efficacy|0|||
131125717|NCT03451084|472089125|FG003|Overall Study|Lack of Efficacy|1|||
131125718|NCT03451084|472089122|FG000|Overall Study|Death|1|||
131125719|NCT03451084|472089123|FG001|Overall Study|Death|0|||
131125720|NCT03451084|472089124|FG002|Overall Study|Death|2|||
131125721|NCT03451084|472089125|FG003|Overall Study|Death|0|||
131125722|NCT03451084|472089122|FG000|Overall Study|Physician Decision|0|||
131125723|NCT03451084|472089123|FG001|Overall Study|Physician Decision|0|||
131125724|NCT03451084|472089124|FG002|Overall Study|Physician Decision|2|||
131125725|NCT03451084|472089125|FG003|Overall Study|Physician Decision|2|||
131125726|NCT03451084|472089122|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
131125727|NCT03451084|472089123|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
130712030|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
130712031|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
130712032|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
131125728|NCT03451084|472089124|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
131125729|NCT03451084|472089125|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
131125730|NCT03418129|472089131|FG000|Overall Study|Lost to Follow-up|11|||
131125731|NCT03418129|472089132|FG001|Overall Study|Lost to Follow-up|20|||
131125732|NCT03418129|472089133|FG002|Overall Study|Lost to Follow-up|15|||
131125733|NCT03418129|472089131|FG000|Overall Study|Withdrawal by Subject|3|||
131125734|NCT03418129|472089132|FG001|Overall Study|Withdrawal by Subject|6|||
131125735|NCT03418129|472089133|FG002|Overall Study|Withdrawal by Subject|4|||
131125736|NCT01553188|472089136|FG000|Overall Study|Patient choice|1|||
130955462|NCT02504372|471471085|FG000|Overall Study|Death|136|||
130955463|NCT02504372|471471086|FG001|Overall Study|Death|154|||
130955464|NCT02504372|471471085|FG000|Overall Study|Lost to Follow-up|0|||
130955465|NCT02504372|471471086|FG001|Overall Study|Lost to Follow-up|2|||
130955466|NCT02504372|471471085|FG000|Overall Study|Withdrawal of consent|25|||
130955467|NCT02504372|471471086|FG001|Overall Study|Withdrawal of consent|16|||
130955468|NCT02504372|471471085|FG000|Overall Study|Participants ongoing|429|||
130955469|NCT02504372|471471086|FG001|Overall Study|Participants ongoing|415|||
130955470|NCT04530552|471471090|FG000|Overall Study|Physician Decision|0|||
130955471|NCT04530552|471471091|FG001|Overall Study|Physician Decision|1|||
130955472|NCT04530552|471471090|FG000|Overall Study|Withdrawal by Subject|0|||
130955473|NCT04530552|471471091|FG001|Overall Study|Withdrawal by Subject|1|||
130955474|NCT04530552|471471090|FG000|Overall Study|Adverse Event|0|||
130955475|NCT04530552|471471091|FG001|Overall Study|Adverse Event|1|||
130955476|NCT04530552|471471090|FG000|Overall Study|No surgery|0|||
130955477|NCT04530552|471471091|FG001|Overall Study|No surgery|1|||
131125737|NCT01553188|472089137|FG001|Overall Study|Patient choice|0|||
131125738|NCT01553188|472089138|FG002|Overall Study|Patient choice|0|||
131125739|NCT01553188|472089139|FG003|Overall Study|Patient choice|0|||
130712033|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Subject decision|1|||
130712034|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Subject decision|1|||
130712035|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
131125740|NCT01553188|472089136|FG000|Overall Study|Intercurrent illness and adverse event|0|||
131125741|NCT01553188|472089137|FG001|Overall Study|Intercurrent illness and adverse event|1|||
130712036|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
130712037|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
130712038|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
130955502|NCT00499603|471471103|FG000|Overall Study|Adverse Event|0|||
130955503|NCT00499603|471471104|FG001|Overall Study|Adverse Event|1|||
131125742|NCT01553188|472089138|FG002|Overall Study|Intercurrent illness and adverse event|2|||
131125743|NCT01553188|472089139|FG003|Overall Study|Intercurrent illness and adverse event|0|||
131125744|NCT04744207|472089141|FG000|Treatment|Withdrawal by Subject|2|||
131125745|NCT04744207|472089142|FG001|Treatment|Withdrawal by Subject|0|||
131125746|NCT04744207|472089141|FG000|Treatment|Adverse Event|1|||
131125747|NCT04744207|472089142|FG001|Treatment|Adverse Event|2|||
131125748|NCT01617070|472089145|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
130955504|NCT03323099|471471105|FG000|Overall Study|Withdrawal by Subject|6|||
130955505|NCT03323099|471471106|FG001|Overall Study|Withdrawal by Subject|12|||
130955506|NCT03323099|471471105|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
130955507|NCT03323099|471471106|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
130955508|NCT05132127|471471109|FG000|Overall Study|Adverse Event|1|||
130955509|NCT05220397|471471110|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
130955510|NCT05220397|471471111|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
130955511|NCT05220397|471471112|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
130955512|NCT05220397|471471113|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
130955513|NCT05220397|471471114|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
130955514|NCT03604692|471471117|FG000|Overall Study|Investigator's Decision|0|||
130955515|NCT03604692|471471118|FG001|Overall Study|Investigator's Decision|0|||
130955516|NCT03604692|471471119|FG002|Overall Study|Investigator's Decision|0|||
130955517|NCT03604692|471471120|FG003|Overall Study|Investigator's Decision|1|||
130955518|NCT03604692|471471121|FG004|Overall Study|Investigator's Decision|0|||
130955519|NCT03604692|471471122|FG005|Overall Study|Investigator's Decision|7|||
130955520|NCT03604692|471471117|FG000|Overall Study|Withdrawal by Subject|0|||
130955521|NCT03604692|471471118|FG001|Overall Study|Withdrawal by Subject|0|||
130955522|NCT03604692|471471119|FG002|Overall Study|Withdrawal by Subject|0|||
130955523|NCT03604692|471471120|FG003|Overall Study|Withdrawal by Subject|0|||
130955524|NCT03604692|471471121|FG004|Overall Study|Withdrawal by Subject|0|||
130955525|NCT03604692|471471122|FG005|Overall Study|Withdrawal by Subject|2|||
130955526|NCT03604692|471471117|FG000|Overall Study|Progressive Disease|1|||
130955527|NCT03604692|471471118|FG001|Overall Study|Progressive Disease|0|||
130955528|NCT03604692|471471119|FG002|Overall Study|Progressive Disease|1|||
130955529|NCT03604692|471471120|FG003|Overall Study|Progressive Disease|0|||
130955530|NCT03604692|471471121|FG004|Overall Study|Progressive Disease|3|||
130955531|NCT03604692|471471122|FG005|Overall Study|Progressive Disease|4|||
130955532|NCT03604692|471471117|FG000|Overall Study|Difficulty Coming into Site|0|||
130955533|NCT03604692|471471118|FG001|Overall Study|Difficulty Coming into Site|0|||
130955534|NCT03604692|471471119|FG002|Overall Study|Difficulty Coming into Site|0|||
130955535|NCT03604692|471471120|FG003|Overall Study|Difficulty Coming into Site|0|||
130955536|NCT03604692|471471121|FG004|Overall Study|Difficulty Coming into Site|0|||
130955537|NCT03604692|471471122|FG005|Overall Study|Difficulty Coming into Site|1|||
130955538|NCT03604692|471471117|FG000|Overall Study|Death|0|||
130955539|NCT03604692|471471118|FG001|Overall Study|Death|0|||
130955540|NCT03604692|471471119|FG002|Overall Study|Death|1|||
130955541|NCT03604692|471471120|FG003|Overall Study|Death|0|||
130955542|NCT03604692|471471121|FG004|Overall Study|Death|0|||
130955543|NCT03604692|471471122|FG005|Overall Study|Death|0|||
130955544|NCT03604692|471471117|FG000|Overall Study|Drug Intolerance|0|||
130955545|NCT03604692|471471118|FG001|Overall Study|Drug Intolerance|0|||
130955546|NCT03604692|471471119|FG002|Overall Study|Drug Intolerance|0|||
130955547|NCT03604692|471471120|FG003|Overall Study|Drug Intolerance|1|||
130955548|NCT03604692|471471121|FG004|Overall Study|Drug Intolerance|0|||
130955549|NCT03604692|471471122|FG005|Overall Study|Drug Intolerance|0|||
130955550|NCT03604692|471471117|FG000|Overall Study|Noncompliance with follow-up visit|0|||
130955551|NCT03604692|471471118|FG001|Overall Study|Noncompliance with follow-up visit|0|||
130955552|NCT03604692|471471119|FG002|Overall Study|Noncompliance with follow-up visit|0|||
130955553|NCT03604692|471471120|FG003|Overall Study|Noncompliance with follow-up visit|1|||
130955554|NCT03604692|471471121|FG004|Overall Study|Noncompliance with follow-up visit|0|||
130955555|NCT03604692|471471122|FG005|Overall Study|Noncompliance with follow-up visit|0|||
130955556|NCT03604692|471471117|FG000|Overall Study|Not Treated|0|||
131125749|NCT00777101|472089152|FG000|Overall Study|Death|48|||
131125750|NCT00777101|472089153|FG001|Overall Study|Death|43|||
131125751|NCT00777101|472089152|FG000|Overall Study|Withdrawal by Subject|11|||
131125752|NCT00777101|472089153|FG001|Overall Study|Withdrawal by Subject|6|||
131125753|NCT00777101|472089152|FG000|Overall Study|Lost to Follow-up|2|||
131225479|NCT00575328|472452039|FG001|Overall Study|Adverse Event|1|||
130712039|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
130955557|NCT03604692|471471118|FG001|Overall Study|Not Treated|0|||
130955558|NCT03604692|471471119|FG002|Overall Study|Not Treated|0|||
130955559|NCT03604692|471471120|FG003|Overall Study|Not Treated|0|||
130955560|NCT03604692|471471121|FG004|Overall Study|Not Treated|1|||
130955561|NCT03604692|471471122|FG005|Overall Study|Not Treated|0|||
131125754|NCT00777101|472089153|FG001|Overall Study|Lost to Follow-up|1|||
131125755|NCT00777101|472089152|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130955572|NCT03466411|471471125|FG000|Overall Study|Lost to Follow-up|0|||
130955573|NCT03466411|471471126|FG001|Overall Study|Lost to Follow-up|1|||
130955574|NCT03466411|471471127|FG002|Overall Study|Lost to Follow-up|1|||
130955575|NCT03466411|471471128|FG003|Overall Study|Lost to Follow-up|0|||
130955576|NCT03466411|471471129|FG004|Overall Study|Lost to Follow-up|0|||
130955577|NCT03466411|471471130|FG005|Overall Study|Lost to Follow-up|0|||
130955578|NCT03466411|471471131|FG006|Overall Study|Lost to Follow-up|1|||
130955579|NCT03466411|471471132|FG007|Overall Study|Lost to Follow-up|1|||
130955580|NCT03466411|471471133|FG008|Overall Study|Lost to Follow-up|0|||
130955581|NCT03466411|471471134|FG009|Overall Study|Lost to Follow-up|1|||
130955582|NCT03466411|471471135|FG010|Overall Study|Lost to Follow-up|1|||
130955583|NCT03466411|471471136|FG011|Overall Study|Lost to Follow-up|1|||
130955584|NCT03466411|471471137|FG012|Overall Study|Lost to Follow-up|0|||
130955585|NCT03466411|471471125|FG000|Overall Study|Withdrawal by Subject|14|||
130955586|NCT03466411|471471126|FG001|Overall Study|Withdrawal by Subject|7|||
130955587|NCT03466411|471471127|FG002|Overall Study|Withdrawal by Subject|8|||
130955588|NCT03466411|471471128|FG003|Overall Study|Withdrawal by Subject|4|||
130955589|NCT03466411|471471129|FG004|Overall Study|Withdrawal by Subject|6|||
130955590|NCT03466411|471471130|FG005|Overall Study|Withdrawal by Subject|3|||
130955591|NCT03466411|471471131|FG006|Overall Study|Withdrawal by Subject|6|||
130955592|NCT03466411|471471132|FG007|Overall Study|Withdrawal by Subject|9|||
130955593|NCT03466411|471471133|FG008|Overall Study|Withdrawal by Subject|6|||
130955594|NCT03466411|471471134|FG009|Overall Study|Withdrawal by Subject|11|||
130955595|NCT03466411|471471135|FG010|Overall Study|Withdrawal by Subject|14|||
130955596|NCT03466411|471471136|FG011|Overall Study|Withdrawal by Subject|12|||
130955597|NCT03466411|471471137|FG012|Overall Study|Withdrawal by Subject|7|||
130955598|NCT03466411|471471125|FG000|Overall Study|Other|1|||
130955599|NCT03466411|471471126|FG001|Overall Study|Other|1|||
130955600|NCT03466411|471471127|FG002|Overall Study|Other|0|||
130955601|NCT03466411|471471128|FG003|Overall Study|Other|1|||
130955602|NCT03466411|471471129|FG004|Overall Study|Other|2|||
130955603|NCT03466411|471471130|FG005|Overall Study|Other|0|||
130955604|NCT03466411|471471131|FG006|Overall Study|Other|0|||
130955605|NCT03466411|471471132|FG007|Overall Study|Other|0|||
130955606|NCT03466411|471471133|FG008|Overall Study|Other|0|||
130955607|NCT03466411|471471134|FG009|Overall Study|Other|1|||
130955608|NCT03466411|471471135|FG010|Overall Study|Other|2|||
130955609|NCT03466411|471471136|FG011|Overall Study|Other|0|||
130955610|NCT03466411|471471137|FG012|Overall Study|Other|0|||
130955611|NCT03466411|471471125|FG000|Overall Study|Randomized but not Treated|0|||
130955612|NCT03466411|471471126|FG001|Overall Study|Randomized but not Treated|0|||
130955613|NCT03466411|471471127|FG002|Overall Study|Randomized but not Treated|0|||
130955614|NCT03466411|471471128|FG003|Overall Study|Randomized but not Treated|0|||
130955615|NCT03466411|471471129|FG004|Overall Study|Randomized but not Treated|0|||
130955616|NCT03466411|471471130|FG005|Overall Study|Randomized but not Treated|0|||
130955617|NCT03466411|471471131|FG006|Overall Study|Randomized but not Treated|1|||
130955618|NCT03466411|471471132|FG007|Overall Study|Randomized but not Treated|0|||
131225480|NCT00575328|472452038|FG000|Overall Study|Lost to Follow-up|2|||
130712040|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
130955619|NCT03466411|471471133|FG008|Overall Study|Randomized but not Treated|0|||
130955620|NCT03466411|471471134|FG009|Overall Study|Randomized but not Treated|0|||
130955621|NCT03466411|471471135|FG010|Overall Study|Randomized but not Treated|0|||
130955622|NCT03466411|471471136|FG011|Overall Study|Randomized but not Treated|0|||
130955623|NCT03466411|471471137|FG012|Overall Study|Randomized but not Treated|0|||
130955624|NCT00376168|471471142|FG000|Overall Study|Adverse Event|1|||
130955625|NCT00376168|471471143|FG001|Overall Study|Adverse Event|1|||
130955626|NCT00376168|471471142|FG000|Overall Study|Pregnancy|1|||
130955627|NCT00376168|471471143|FG001|Overall Study|Pregnancy|0|||
130955636|NCT05091528|471471146|FG000|Overall Study|Study Termination by Sponsor|0|||
130955637|NCT05091528|471471147|FG001|Overall Study|Study Termination by Sponsor|1|||
130955638|NCT05091528|471471148|FG002|Overall Study|Study Termination by Sponsor|0|||
130955639|NCT05091528|471471149|FG003|Overall Study|Study Termination by Sponsor|1|||
130955640|NCT01857063|471471150|FG000|Period 1 (7 Days)|Adverse Event|0|||
130955641|NCT01857063|471471151|FG001|Period 1 (7 Days)|Adverse Event|1|||
130955642|NCT01857063|471471150|FG000|Period 1 (7 Days)|Physician Decision|1|||
130955643|NCT01857063|471471151|FG001|Period 1 (7 Days)|Physician Decision|0|||
130955644|NCT01857063|471471150|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
131039415|NCT03034356|471778257|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
130774592|NCT00980655|470800579|FG000|Overall Study|Parent/legal guardian request|1|||
130955645|NCT01857063|471471151|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
130955646|NCT01857063|471471150|FG000|Period 2 (7 Days)|Adverse Event|2|||
130955647|NCT01857063|471471151|FG001|Period 2 (7 Days)|Adverse Event|1|||
130955648|NCT01857063|471471150|FG000|Period 2 (7 Days)|Physician Decision|1|||
130955649|NCT01857063|471471151|FG001|Period 2 (7 Days)|Physician Decision|1|||
130955650|NCT01857063|471471150|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
130955651|NCT01857063|471471151|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
130955652|NCT02375672|471471154|FG000|Overall Study|remain on follow up|20|||
130955653|NCT04115358|471471155|FG000|Overall Study|exfoliation|0|||
130955654|NCT04115358|471471156|FG001|Overall Study|exfoliation|0|||
130955655|NCT04115358|471471157|FG002|Overall Study|exfoliation|1|||
130955656|NCT02346240|471471159|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955657|NCT02346240|471471160|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
130955658|NCT02346240|471471161|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
130955659|NCT02346240|471471162|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
130955660|NCT02346240|471471163|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955661|NCT02346240|471471164|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955662|NCT02346240|471471165|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955663|NCT02346240|471471166|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955664|NCT02346240|471471167|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955665|NCT02346240|471471168|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955666|NCT02346240|471471169|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955667|NCT02346240|471471170|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955668|NCT02346240|471471171|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955669|NCT02346240|471471172|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955670|NCT02346240|471471173|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955671|NCT02346240|471471174|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955672|NCT02346240|471471175|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955673|NCT02346240|471471176|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955674|NCT02346240|471471177|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955675|NCT02346240|471471178|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955676|NCT02346240|471471179|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955677|NCT02346240|471471180|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955678|NCT02346240|471471181|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955679|NCT02346240|471471182|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130955680|NCT02346240|471471159|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955681|NCT02346240|471471160|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
130955682|NCT02346240|471471161|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955683|NCT02346240|471471162|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955684|NCT02346240|471471163|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955685|NCT02346240|471471164|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
131039416|NCT03034356|471778256|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
131039417|NCT03034356|471778257|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
131039418|NCT03034356|471778256|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
131039419|NCT03034356|471778257|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
131039420|NCT02823145|471778258|FG000|Enrollment|Other|1|||
131039421|NCT02823145|471778259|FG001|Enrollment|Other|0|||
131039422|NCT02823145|471778258|FG000|Treatment|Adverse Event|0|||
131039423|NCT02823145|471778259|FG001|Treatment|Adverse Event|11|||
131039424|NCT02823145|471778258|FG000|Treatment|Death|0|||
131039425|NCT02823145|471778259|FG001|Treatment|Death|3|||
131039426|NCT02823145|471778258|FG000|Treatment|Family Decision|0|||
131039427|NCT02823145|471778259|FG001|Treatment|Family Decision|1|||
131039428|NCT02823145|471778258|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
131125756|NCT00777101|472089153|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
131125757|NCT00777101|472089152|FG000|Overall Study|Failed to Return|0|||
131125758|NCT00777101|472089153|FG001|Overall Study|Failed to Return|1|||
131125759|NCT05376215|472089154|FG000|Overall Study|Withdrawal by Subject|2|||
131125760|NCT05376215|472089155|FG001|Overall Study|Withdrawal by Subject|1|||
131125761|NCT05376215|472089154|FG000|Overall Study|Lost to Follow-up|0|||
131125762|NCT05376215|472089155|FG001|Overall Study|Lost to Follow-up|1|||
131125763|NCT01301950|472089162|FG000|Overall Study|Surgery was cancelled by patient|0|||
131125764|NCT01301950|472089163|FG001|Overall Study|Surgery was cancelled by patient|1|||
131125765|NCT00078325|472089167|FG000|Overall Study|Adverse Event|15|||
131125766|NCT00078325|472089168|FG001|Overall Study|Adverse Event|10|||
131125767|NCT00078325|472089169|FG002|Overall Study|Adverse Event|5|||
131125768|NCT00078325|472089167|FG000|Overall Study|Protocol Violation|2|||
131125769|NCT00078325|472089168|FG001|Overall Study|Protocol Violation|2|||
131039429|NCT02823145|471778259|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
131125770|NCT00078325|472089169|FG002|Overall Study|Protocol Violation|0|||
130955686|NCT02346240|471471165|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955687|NCT02346240|471471166|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955688|NCT02346240|471471167|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955689|NCT02346240|471471168|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955690|NCT02346240|471471169|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955691|NCT02346240|471471170|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955692|NCT02346240|471471171|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955693|NCT02346240|471471172|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955694|NCT02346240|471471173|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955695|NCT02346240|471471174|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955696|NCT02346240|471471175|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955697|NCT02346240|471471176|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955698|NCT02346240|471471177|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955699|NCT02346240|471471178|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955700|NCT02346240|471471179|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955701|NCT02346240|471471180|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955702|NCT02346240|471471181|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955703|NCT02346240|471471182|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
130955704|NCT02346240|471471159|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955705|NCT02346240|471471160|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
130955706|NCT02346240|471471161|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955707|NCT02346240|471471162|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955708|NCT02346240|471471163|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955709|NCT02346240|471471164|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955710|NCT02346240|471471165|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955711|NCT02346240|471471166|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955712|NCT02346240|471471167|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955713|NCT02346240|471471168|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130712041|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
130955714|NCT02346240|471471169|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955715|NCT02346240|471471170|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955716|NCT02346240|471471171|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955717|NCT02346240|471471172|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955718|NCT02346240|471471173|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955719|NCT02346240|471471174|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955720|NCT02346240|471471175|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955721|NCT02346240|471471176|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955722|NCT02346240|471471177|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955723|NCT02346240|471471178|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955724|NCT02346240|471471179|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955725|NCT02346240|471471180|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955726|NCT02346240|471471181|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955727|NCT02346240|471471182|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
130955728|NCT02346240|471471159|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
130955729|NCT02346240|471471160|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
130955730|NCT02346240|471471161|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
130955731|NCT02346240|471471162|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
130955732|NCT02346240|471471163|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955733|NCT02346240|471471164|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955734|NCT02346240|471471165|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955735|NCT02346240|471471166|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955736|NCT02346240|471471167|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130712042|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
130955737|NCT02346240|471471168|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955738|NCT02346240|471471169|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131039430|NCT02823145|471778258|FG000|Treatment|Lack of Efficacy|0|||
131039431|NCT02823145|471778259|FG001|Treatment|Lack of Efficacy|48|||
131039432|NCT02823145|471778258|FG000|Treatment|Non-Compliance With E-Diary|0|||
131039433|NCT02823145|471778259|FG001|Treatment|Non-Compliance With E-Diary|1|||
131039434|NCT02823145|471778258|FG000|Treatment|Physician Decision|0|||
131039435|NCT02823145|471778259|FG001|Treatment|Physician Decision|2|||
131039436|NCT02823145|471778258|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
131039437|NCT02823145|471778259|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
130712043|NCT00518882|470571805|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
130955739|NCT02346240|471471170|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
131039438|NCT02823145|471778258|FG000|Treatment|Subject needed to take prohibited medication|0|||
131039439|NCT02823145|471778259|FG001|Treatment|Subject needed to take prohibited medication|1|||
130955740|NCT02346240|471471171|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955741|NCT02346240|471471172|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955742|NCT02346240|471471173|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955743|NCT02346240|471471174|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955744|NCT02346240|471471175|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955745|NCT02346240|471471176|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955746|NCT02346240|471471177|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955747|NCT02346240|471471178|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955748|NCT02346240|471471179|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955749|NCT02346240|471471180|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955750|NCT02346240|471471181|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955751|NCT02346240|471471182|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130955752|NCT02346240|471471159|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
130955753|NCT02346240|471471160|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
130955754|NCT02346240|471471161|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
130955755|NCT02346240|471471162|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
130955756|NCT02346240|471471163|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955757|NCT02346240|471471164|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955758|NCT02346240|471471165|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955759|NCT02346240|471471166|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955760|NCT02346240|471471167|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955761|NCT02346240|471471168|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955762|NCT02346240|471471169|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955763|NCT02346240|471471170|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955764|NCT02346240|471471171|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955765|NCT02346240|471471172|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955766|NCT02346240|471471173|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955767|NCT02346240|471471174|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955768|NCT02346240|471471175|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955769|NCT02346240|471471176|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955770|NCT02346240|471471177|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
131039440|NCT02823145|471778258|FG000|Treatment|Subject transferred to direct access programme|0|||
131039441|NCT02823145|471778259|FG001|Treatment|Subject transferred to direct access programme|1|||
131039442|NCT02823145|471778258|FG000|Treatment|Switching to commercially available drug|0|||
131039443|NCT02823145|471778259|FG001|Treatment|Switching to commercially available drug|11|||
131039444|NCT02823145|471778258|FG000|Treatment|Transitioned to commercial supply of medication|0|||
131039445|NCT02823145|471778259|FG001|Treatment|Transitioned to commercial supply of medication|1|||
131039446|NCT02823145|471778258|FG000|Treatment|Withdrawal By Caregiver|0|||
131039447|NCT02823145|471778259|FG001|Treatment|Withdrawal By Caregiver|1|||
131039448|NCT02823145|471778258|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
131039449|NCT02823145|471778259|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
131039450|NCT02823145|471778258|FG000|Treatment|Withdrawal by Subject|0|||
131039451|NCT02823145|471778259|FG001|Treatment|Withdrawal by Subject|16|||
131039452|NCT02823145|471778258|FG000|Treatment|Reason unknown|0|||
131039453|NCT02823145|471778259|FG001|Treatment|Reason unknown|1|||
131039454|NCT05292391|471778260|FG000|Overall Study|Lost to Follow-up|0|||
131039455|NCT05292391|471778261|FG001|Overall Study|Lost to Follow-up|0|||
131039456|NCT05292391|471778262|FG002|Overall Study|Lost to Follow-up|0|||
130955771|NCT02346240|471471178|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955772|NCT02346240|471471179|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955773|NCT02346240|471471180|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955774|NCT02346240|471471181|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955775|NCT02346240|471471182|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
130955776|NCT02346240|471471159|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955777|NCT02346240|471471160|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
130955778|NCT02346240|471471161|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955779|NCT02346240|471471162|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
131039457|NCT05292391|471778263|FG003|Overall Study|Lost to Follow-up|1|||
131039458|NCT05292391|471778264|FG004|Overall Study|Lost to Follow-up|0|||
131039459|NCT04857723|471778266|FG000|Overall Study|Withdrawal by Subject|2|||
131039460|NCT05809453|471780060|FG000|Overall Study|Withdrawal by Subject|1|||
131039461|NCT05809453|471780061|FG001|Overall Study|Withdrawal by Subject|0|||
131039462|NCT05809453|471780062|FG002|Overall Study|Withdrawal by Subject|0|||
131039463|NCT05809453|471780063|FG003|Overall Study|Withdrawal by Subject|0|||
131039464|NCT03257410|471780064|FG000|Overall Study|Adverse Event|2|||
131039465|NCT03257410|471780065|FG001|Overall Study|Adverse Event|3|||
131039466|NCT03257410|471780064|FG000|Overall Study|Protocol Violation|1|||
131039467|NCT03257410|471780065|FG001|Overall Study|Protocol Violation|2|||
131039468|NCT03257410|471780064|FG000|Overall Study|Lost to Follow-up|1|||
131039469|NCT03257410|471780065|FG001|Overall Study|Lost to Follow-up|0|||
131039470|NCT03257410|471780064|FG000|Overall Study|Withdrawal by Subject|1|||
131039471|NCT03257410|471780065|FG001|Overall Study|Withdrawal by Subject|2|||
131039472|NCT03257410|471780064|FG000|Overall Study|Physician Decision|1|||
131039473|NCT03257410|471780065|FG001|Overall Study|Physician Decision|1|||
131039474|NCT03257410|471780064|FG000|Overall Study|Renal transplantation|2|||
131039475|NCT03257410|471780065|FG001|Overall Study|Renal transplantation|0|||
131039476|NCT03257410|471780064|FG000|Overall Study|Switch to peritoneal dialysis|1|||
131039477|NCT03257410|471780065|FG001|Overall Study|Switch to peritoneal dialysis|0|||
131039478|NCT03257410|471780064|FG000|Overall Study|Death|3|||
131039479|NCT03257410|471780065|FG001|Overall Study|Death|2|||
131125771|NCT00078325|472089167|FG000|Overall Study|Withdrawal by Subject|1|||
131125772|NCT00078325|472089168|FG001|Overall Study|Withdrawal by Subject|5|||
131125773|NCT00078325|472089169|FG002|Overall Study|Withdrawal by Subject|3|||
131125774|NCT00078325|472089167|FG000|Overall Study|Lost to Follow-up|0|||
131125775|NCT00078325|472089168|FG001|Overall Study|Lost to Follow-up|1|||
131125776|NCT00078325|472089169|FG002|Overall Study|Lost to Follow-up|1|||
131125777|NCT00078325|472089167|FG000|Overall Study|Physician Decision|2|||
131125778|NCT00078325|472089168|FG001|Overall Study|Physician Decision|0|||
131125779|NCT00078325|472089169|FG002|Overall Study|Physician Decision|1|||
131125780|NCT00078325|472089167|FG000|Overall Study|Miscellaneous|1|||
131125781|NCT00078325|472089168|FG001|Overall Study|Miscellaneous|1|||
131125782|NCT00078325|472089169|FG002|Overall Study|Miscellaneous|1|||
131125783|NCT04126083|472089173|FG000|Overall Study|Withdrawal by Subject|1|||
131125784|NCT03710486|472089174|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
131125785|NCT03710486|472089175|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
131125786|NCT03710486|472089174|FG000|Overall Study|Missing|0|||
131125787|NCT03710486|472089175|FG001|Overall Study|Missing|2|||
131125788|NCT01279850|472089180|FG000|Overall Study|Protocol Violation|50|||
131125789|NCT01279850|472089180|FG000|Overall Study|No Drug Administration Information|7|||
131125790|NCT01279850|472089180|FG000|Overall Study|No Visit After Treatment|34|||
131125791|NCT01131520|472089181|FG000|Overall Study|Computer problem|1|||
131125792|NCT01131520|472089182|FG001|Overall Study|Computer problem|0|||
131125793|NCT01131520|472089181|FG000|Overall Study|Counselor not available|0|||
131125794|NCT01131520|472089182|FG001|Overall Study|Counselor not available|3|||
131125795|NCT01131520|472089181|FG000|Overall Study|Subject changed history after enrollment|0|||
131125796|NCT01131520|472089182|FG001|Overall Study|Subject changed history after enrollment|1|||
131125797|NCT01147744|472089183|FG000|Overall Study|Protocol Violation|1|||
131125798|NCT01147744|472089184|FG001|Overall Study|Protocol Violation|0|||
131125799|NCT01147744|472089185|FG002|Overall Study|Protocol Violation|1|||
131125800|NCT01147744|472089186|FG003|Overall Study|Protocol Violation|0|||
131125801|NCT01147744|472089187|FG004|Overall Study|Protocol Violation|1|||
131125802|NCT01147744|472089188|FG005|Overall Study|Protocol Violation|3|||
131125803|NCT01147744|472089189|FG006|Overall Study|Protocol Violation|1|||
131125804|NCT01147744|472089183|FG000|Overall Study|Physician Decision|0|||
131125805|NCT01147744|472089184|FG001|Overall Study|Physician Decision|1|||
131125806|NCT01147744|472089185|FG002|Overall Study|Physician Decision|1|||
131125807|NCT01147744|472089186|FG003|Overall Study|Physician Decision|0|||
131125808|NCT01147744|472089187|FG004|Overall Study|Physician Decision|0|||
131125809|NCT01147744|472089188|FG005|Overall Study|Physician Decision|0|||
131125810|NCT01147744|472089189|FG006|Overall Study|Physician Decision|1|||
131125811|NCT01147744|472089183|FG000|Overall Study|Lack of Efficacy|11|||
131125812|NCT01147744|472089184|FG001|Overall Study|Lack of Efficacy|11|||
131125813|NCT01147744|472089185|FG002|Overall Study|Lack of Efficacy|9|||
131125814|NCT01147744|472089186|FG003|Overall Study|Lack of Efficacy|11|||
131125815|NCT01147744|472089187|FG004|Overall Study|Lack of Efficacy|13|||
131125816|NCT01147744|472089188|FG005|Overall Study|Lack of Efficacy|8|||
131125817|NCT01147744|472089189|FG006|Overall Study|Lack of Efficacy|7|||
131039480|NCT03257410|471780064|FG000|Overall Study|Change to another dialysis center|2|||
131039481|NCT03257410|471780065|FG001|Overall Study|Change to another dialysis center|2|||
131125818|NCT01147744|472089183|FG000|Overall Study|Adverse Event|1|||
131125819|NCT01147744|472089184|FG001|Overall Study|Adverse Event|2|||
131125820|NCT01147744|472089185|FG002|Overall Study|Adverse Event|3|||
131125821|NCT01147744|472089186|FG003|Overall Study|Adverse Event|0|||
131039482|NCT03257410|471780064|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
131039483|NCT03257410|471780065|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
131039484|NCT03257410|471780064|FG000|Overall Study|Miscellaneous|2|||
131039485|NCT03257410|471780065|FG001|Overall Study|Miscellaneous|2|||
131125822|NCT01147744|472089187|FG004|Overall Study|Adverse Event|2|||
131125823|NCT01147744|472089188|FG005|Overall Study|Adverse Event|1|||
131125824|NCT01147744|472089189|FG006|Overall Study|Adverse Event|2|||
131125825|NCT01147744|472089183|FG000|Overall Study|Withdrawal by Subject|8|||
131125826|NCT01147744|472089184|FG001|Overall Study|Withdrawal by Subject|4|||
131125827|NCT01147744|472089185|FG002|Overall Study|Withdrawal by Subject|2|||
131125828|NCT01147744|472089186|FG003|Overall Study|Withdrawal by Subject|2|||
131125829|NCT01147744|472089187|FG004|Overall Study|Withdrawal by Subject|2|||
130955780|NCT02346240|471471163|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955781|NCT02346240|471471164|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955782|NCT02346240|471471165|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955783|NCT02346240|471471166|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955784|NCT02346240|471471167|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955785|NCT02346240|471471168|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955786|NCT02346240|471471169|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955787|NCT02346240|471471170|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955788|NCT02346240|471471171|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955789|NCT02346240|471471172|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955790|NCT02346240|471471173|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955791|NCT02346240|471471174|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955792|NCT02346240|471471175|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955793|NCT02346240|471471176|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955794|NCT02346240|471471177|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955795|NCT02346240|471471178|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955796|NCT02346240|471471179|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955797|NCT02346240|471471180|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955798|NCT02346240|471471181|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955799|NCT02346240|471471182|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
130955800|NCT02346240|471471159|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955801|NCT02346240|471471160|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955802|NCT02346240|471471161|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
130955803|NCT02346240|471471162|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955804|NCT02346240|471471163|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955805|NCT02346240|471471164|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955806|NCT02346240|471471165|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955807|NCT02346240|471471166|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955808|NCT02346240|471471167|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955809|NCT02346240|471471168|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955810|NCT02346240|471471169|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955811|NCT02346240|471471170|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955812|NCT02346240|471471171|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955813|NCT02346240|471471172|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955814|NCT02346240|471471173|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955815|NCT02346240|471471174|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955816|NCT02346240|471471175|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955817|NCT02346240|471471176|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955818|NCT02346240|471471177|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955819|NCT02346240|471471178|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955820|NCT02346240|471471179|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955821|NCT02346240|471471180|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955822|NCT02346240|471471181|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955823|NCT02346240|471471182|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
130955824|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955825|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955826|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955827|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131125830|NCT01147744|472089188|FG005|Overall Study|Withdrawal by Subject|5|||
131125831|NCT01147744|472089189|FG006|Overall Study|Withdrawal by Subject|2|||
131125832|NCT01147744|472089183|FG000|Overall Study|Lost to Follow-up|0|||
131125833|NCT01147744|472089184|FG001|Overall Study|Lost to Follow-up|1|||
131125834|NCT01147744|472089185|FG002|Overall Study|Lost to Follow-up|0|||
131125835|NCT01147744|472089186|FG003|Overall Study|Lost to Follow-up|0|||
131125836|NCT01147744|472089187|FG004|Overall Study|Lost to Follow-up|0|||
130955828|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955829|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955830|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955831|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130955832|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
130955833|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955834|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955835|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955836|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131125837|NCT01147744|472089188|FG005|Overall Study|Lost to Follow-up|0|||
130712044|NCT00518882|470571806|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
130712045|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
130712046|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
130712047|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
130712048|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
130712049|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
130712050|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
130712051|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
130712052|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
130712053|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
130712054|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
130712055|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
130712056|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
130712057|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
130712058|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
130712059|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
130712060|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
130712061|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
130712062|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
130712063|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
130712064|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
130712065|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
130712066|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
130712067|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
130712068|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
130712069|NCT00518882|470571805|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
130712070|NCT00518882|470571806|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
130712071|NCT03395639|470571807|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
130712072|NCT03395639|470571808|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
130712073|NCT03395639|470571809|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
130712074|NCT03395639|470571807|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
130712075|NCT03395639|470571808|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
130712076|NCT03395639|470571809|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
130712077|NCT03395639|470571807|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
130720900|NCT01341782|470601557|FG000|Overall Study|Missed 3 consecutive doses|0|||
130955837|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130955838|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
130955839|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130955840|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
130955841|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955842|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955843|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955844|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955845|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955846|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955847|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130955848|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955849|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955850|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955851|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955852|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955853|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955854|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131039486|NCT03257410|471780064|FG000|Overall Study|Other|0|||
131039487|NCT03257410|471780065|FG001|Overall Study|Other|1|||
131039488|NCT03668236|471780066|FG000|90-day Follow-up|Withdrawal by Subject|3|||
131039489|NCT03668236|471780067|FG001|90-day Follow-up|Withdrawal by Subject|2|||
131039490|NCT03668236|471780066|FG000|90-day Follow-up|Lost to Follow-up|3|||
131039491|NCT03668236|471780067|FG001|90-day Follow-up|Lost to Follow-up|1|||
131039492|NCT03668236|471780066|FG000|Baseline Characteristics|Lost to Follow-up|9|||
131039493|NCT03668236|471780067|FG001|Baseline Characteristics|Lost to Follow-up|5|||
131039494|NCT03668236|471780066|FG000|1-year Follow-up|Withdrawal by Subject|17|||
131039495|NCT03668236|471780067|FG001|1-year Follow-up|Withdrawal by Subject|15|||
131039496|NCT06132282|471780068|FG000|Overall Study|Lost to Follow-up|31|||
131039497|NCT02276885|471780072|FG000|Overall Study|Withdrawal by Subject|2|||
131039498|NCT02276885|471780073|FG001|Overall Study|Withdrawal by Subject|0|||
131039499|NCT02276885|471780072|FG000|Overall Study|Lost to Follow-up|5|||
130955855|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955856|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955857|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955858|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955859|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955860|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955861|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
130955862|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955863|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
130955864|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955865|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955866|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955867|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955868|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955869|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955870|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955871|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130955872|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955873|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955874|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955875|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955876|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955877|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955878|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955879|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955880|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955881|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955882|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955883|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955884|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955885|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955886|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
130955887|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955888|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955889|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955890|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955891|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955892|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955893|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955894|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955895|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130955896|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955897|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955898|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955899|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955900|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955901|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130955902|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130955903|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130955904|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130955905|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955906|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130955907|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
130955908|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955909|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
130955910|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
130955911|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
130955912|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130955913|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955914|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955915|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955916|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955917|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955918|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955919|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130955920|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955921|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955922|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955923|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955924|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955925|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955926|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955927|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955928|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955929|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955930|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955931|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955932|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955933|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
130955934|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
130955935|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
130955936|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
130955937|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955938|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955939|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955940|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955941|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955942|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955943|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130955944|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955945|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955946|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955947|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955948|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955949|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955950|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
130955951|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955952|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955953|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955954|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955955|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955956|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131125838|NCT01147744|472089189|FG006|Overall Study|Lost to Follow-up|0|||
131125839|NCT01147744|472089183|FG000|Overall Study|Sponsor decision to amend protocol|7|||
131125840|NCT01147744|472089184|FG001|Overall Study|Sponsor decision to amend protocol|4|||
131125841|NCT01147744|472089185|FG002|Overall Study|Sponsor decision to amend protocol|2|||
131125842|NCT01147744|472089186|FG003|Overall Study|Sponsor decision to amend protocol|5|||
131125843|NCT01147744|472089187|FG004|Overall Study|Sponsor decision to amend protocol|7|||
131125844|NCT01147744|472089188|FG005|Overall Study|Sponsor decision to amend protocol|2|||
131125845|NCT01147744|472089189|FG006|Overall Study|Sponsor decision to amend protocol|6|||
131125846|NCT01147744|472089183|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131125847|NCT01147744|472089184|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131125848|NCT01147744|472089185|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131125849|NCT01147744|472089186|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131125850|NCT01147744|472089187|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131125851|NCT01147744|472089188|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131225481|NCT00575328|472452039|FG001|Overall Study|Lost to Follow-up|1|||
131225482|NCT00520351|472452040|FG000|First Intervention|Withdrawal by Subject|1|||
131225483|NCT00520351|472452041|FG001|First Intervention|Withdrawal by Subject|1|||
131225484|NCT03940586|472452045|FG000|Overall Study|Death|3|||
131225485|NCT03940586|472452046|FG001|Overall Study|Death|2|||
131225486|NCT03940586|472452047|FG002|Overall Study|Death|0|||
131225487|NCT03940586|472452045|FG000|Overall Study|Physician Decision|1|||
130955957|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955958|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955959|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955960|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955961|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
131225488|NCT03940586|472452046|FG001|Overall Study|Physician Decision|0|||
130955962|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955963|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955964|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955965|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955966|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955967|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
130955968|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955969|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955970|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955971|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955972|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955973|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955974|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955975|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955976|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
130955977|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955978|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955979|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
130955980|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955981|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
130955982|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
130955983|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955984|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955985|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955986|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955987|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955988|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955989|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955990|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
131039500|NCT02276885|471780073|FG001|Overall Study|Lost to Follow-up|2|||
131039501|NCT04171141|471780077|FG000|Overall Study|Adverse Event|0|||
131039502|NCT04171141|471780078|FG001|Overall Study|Adverse Event|0|||
131039503|NCT04171141|471780079|FG002|Overall Study|Adverse Event|2|||
131039504|NCT04171141|471780080|FG003|Overall Study|Adverse Event|0|||
131039505|NCT04171141|471780081|FG004|Overall Study|Adverse Event|0|||
131039506|NCT04171141|471780082|FG005|Overall Study|Adverse Event|0|||
131039507|NCT04171141|471780083|FG006|Overall Study|Adverse Event|0|||
131039508|NCT04171141|471780084|FG007|Overall Study|Adverse Event|0|||
131039509|NCT04171141|471780085|FG008|Overall Study|Adverse Event|0|||
131039510|NCT04171141|471780086|FG009|Overall Study|Adverse Event|0|||
131039511|NCT04171141|471780087|FG010|Overall Study|Adverse Event|0|||
131039512|NCT04171141|471780088|FG011|Overall Study|Adverse Event|0|||
131039513|NCT04171141|471780089|FG012|Overall Study|Adverse Event|0|||
131039514|NCT04171141|471780090|FG013|Overall Study|Adverse Event|2|||
131039515|NCT04171141|471780091|FG014|Overall Study|Adverse Event|0|||
131039516|NCT04171141|471780092|FG015|Overall Study|Adverse Event|0|||
131039517|NCT04171141|471780077|FG000|Overall Study|Physician Decision|0|||
131039518|NCT04171141|471780078|FG001|Overall Study|Physician Decision|0|||
131039519|NCT04171141|471780079|FG002|Overall Study|Physician Decision|0|||
131039520|NCT04171141|471780080|FG003|Overall Study|Physician Decision|0|||
131039521|NCT04171141|471780081|FG004|Overall Study|Physician Decision|1|||
131039522|NCT04171141|471780082|FG005|Overall Study|Physician Decision|0|||
131039523|NCT04171141|471780083|FG006|Overall Study|Physician Decision|0|||
131039524|NCT04171141|471780084|FG007|Overall Study|Physician Decision|0|||
131039525|NCT04171141|471780085|FG008|Overall Study|Physician Decision|0|||
131039526|NCT04171141|471780086|FG009|Overall Study|Physician Decision|0|||
131039527|NCT04171141|471780087|FG010|Overall Study|Physician Decision|0|||
131039528|NCT04171141|471780088|FG011|Overall Study|Physician Decision|0|||
131039529|NCT04171141|471780089|FG012|Overall Study|Physician Decision|0|||
131125852|NCT01147744|472089189|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131125853|NCT01342484|472089192|FG000|Overall Study|Other Reasons|1|||
131125854|NCT01342484|472089193|FG001|Overall Study|Other Reasons|0|||
131125855|NCT01342484|472089194|FG002|Overall Study|Other Reasons|0|||
131125856|NCT01342484|472089192|FG000|Overall Study|Protocol Violation|0|||
130955991|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
130955992|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131125857|NCT01342484|472089193|FG001|Overall Study|Protocol Violation|0|||
130712078|NCT03395639|470571808|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
130712079|NCT03395639|470571809|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
130712080|NCT03395639|470571807|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
130712081|NCT03395639|470571808|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
130712082|NCT03395639|470571809|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
130712083|NCT03395639|470571807|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
130712084|NCT03395639|470571808|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
130712085|NCT03395639|470571809|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
130712086|NCT00942331|470571810|FG000|Overall Study|Did not start treatment|15|||
130712087|NCT00942331|470571811|FG001|Overall Study|Did not start treatment|22|||
130712088|NCT00567476|470571816|FG000|Overall Study|Adverse Event|2|||
130712089|NCT00567476|470571817|FG001|Overall Study|Adverse Event|0|||
130712090|NCT00567476|470571816|FG000|Overall Study|Pregnancy|1|||
130712091|NCT00567476|470571817|FG001|Overall Study|Pregnancy|0|||
130712092|NCT00567476|470571816|FG000|Overall Study|Protocol Violation|4|||
130712093|NCT00567476|470571817|FG001|Overall Study|Protocol Violation|1|||
130712094|NCT00567476|470571816|FG000|Overall Study|Lost to Follow-up|0|||
130712095|NCT00567476|470571817|FG001|Overall Study|Lost to Follow-up|1|||
130712096|NCT00567476|470571816|FG000|Overall Study|Administrative issues|1|||
130712097|NCT00567476|470571817|FG001|Overall Study|Administrative issues|0|||
130712098|NCT00567476|470571816|FG000|Overall Study|Medical Decision|0|||
130712099|NCT00567476|470571817|FG001|Overall Study|Medical Decision|1|||
130712100|NCT00567476|470571816|FG000|Overall Study|Non-adherence to protocol|0|||
130712101|NCT00567476|470571817|FG001|Overall Study|Non-adherence to protocol|1|||
130712102|NCT02696031|470571818|FG000|Up to Week 24|Adverse Event|2|||
130712103|NCT02696031|470571819|FG001|Up to Week 24|Adverse Event|4|||
130712104|NCT02696031|470571820|FG002|Up to Week 24|Adverse Event|2|||
130712105|NCT02696031|470571821|FG003|Up to Week 24|Adverse Event|0|||
130712106|NCT02696031|470571822|FG004|Up to Week 24|Adverse Event|0|||
130712107|NCT02696031|470571823|FG005|Up to Week 24|Adverse Event|0|||
130712108|NCT02696031|470571818|FG000|Up to Week 24|Lack of Efficacy|2|||
130712109|NCT02696031|470571819|FG001|Up to Week 24|Lack of Efficacy|1|||
130712110|NCT02696031|470571820|FG002|Up to Week 24|Lack of Efficacy|2|||
130712111|NCT02696031|470571821|FG003|Up to Week 24|Lack of Efficacy|0|||
130712112|NCT02696031|470571822|FG004|Up to Week 24|Lack of Efficacy|0|||
130712113|NCT02696031|470571823|FG005|Up to Week 24|Lack of Efficacy|0|||
130712114|NCT02696031|470571818|FG000|Up to Week 24|Lost to Follow-up|0|||
130712115|NCT02696031|470571819|FG001|Up to Week 24|Lost to Follow-up|1|||
130712116|NCT02696031|470571820|FG002|Up to Week 24|Lost to Follow-up|1|||
130712117|NCT02696031|470571821|FG003|Up to Week 24|Lost to Follow-up|0|||
130712118|NCT02696031|470571822|FG004|Up to Week 24|Lost to Follow-up|0|||
130712119|NCT02696031|470571823|FG005|Up to Week 24|Lost to Follow-up|0|||
130712120|NCT02696031|470571818|FG000|Up to Week 24|Physician Decision|1|||
130712121|NCT02696031|470571819|FG001|Up to Week 24|Physician Decision|0|||
130712122|NCT02696031|470571820|FG002|Up to Week 24|Physician Decision|1|||
130712123|NCT02696031|470571821|FG003|Up to Week 24|Physician Decision|0|||
130712124|NCT02696031|470571822|FG004|Up to Week 24|Physician Decision|0|||
130712125|NCT02696031|470571823|FG005|Up to Week 24|Physician Decision|0|||
130712126|NCT02696031|470571818|FG000|Up to Week 24|Protocol Violation|1|||
130774593|NCT00980655|470800580|FG001|Overall Study|Parent/legal guardian request|0|||
130955993|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130955994|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130955995|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130955996|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130955997|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130955998|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130955999|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
131039530|NCT04171141|471780090|FG013|Overall Study|Physician Decision|0|||
131039531|NCT04171141|471780091|FG014|Overall Study|Physician Decision|0|||
131039532|NCT04171141|471780092|FG015|Overall Study|Physician Decision|1|||
130712127|NCT02696031|470571819|FG001|Up to Week 24|Protocol Violation|0|||
130774594|NCT00980655|470800579|FG000|Overall Study|Other|0|||
130712128|NCT02696031|470571820|FG002|Up to Week 24|Protocol Violation|0|||
130712129|NCT02696031|470571821|FG003|Up to Week 24|Protocol Violation|0|||
130712130|NCT02696031|470571822|FG004|Up to Week 24|Protocol Violation|0|||
130712131|NCT02696031|470571823|FG005|Up to Week 24|Protocol Violation|0|||
130774595|NCT00980655|470800580|FG001|Overall Study|Other|1|||
130712132|NCT02696031|470571818|FG000|Up to Week 24|Withdrawal by Subject|4|||
130712133|NCT02696031|470571819|FG001|Up to Week 24|Withdrawal by Subject|1|||
130712134|NCT02696031|470571820|FG002|Up to Week 24|Withdrawal by Subject|5|||
130712135|NCT02696031|470571821|FG003|Up to Week 24|Withdrawal by Subject|0|||
130774596|NCT00845676|470800586|FG000|Overall Study|Virologic breakthrough at week 20|1|||
130956000|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130712136|NCT02696031|470571822|FG004|Up to Week 24|Withdrawal by Subject|0|||
130712137|NCT02696031|470571823|FG005|Up to Week 24|Withdrawal by Subject|0|||
130712138|NCT02696031|470571818|FG000|Up to Week 52|Adverse Event|4|||
130712139|NCT02696031|470571819|FG001|Up to Week 52|Adverse Event|5|||
130712140|NCT02696031|470571820|FG002|Up to Week 52|Adverse Event|3|||
130712141|NCT02696031|470571821|FG003|Up to Week 52|Adverse Event|0|||
130712142|NCT02696031|470571822|FG004|Up to Week 52|Adverse Event|0|||
130956001|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
130956002|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956003|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956004|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956005|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956006|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956007|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956008|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956009|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956010|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956011|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956012|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956013|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956014|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130985568|NCT01984697|471574908|FG004|Overall Study|Adverse Event|0|||
131125858|NCT01342484|472089194|FG002|Overall Study|Protocol Violation|1|||
130712143|NCT02696031|470571823|FG005|Up to Week 52|Adverse Event|0|||
130712144|NCT02696031|470571818|FG000|Up to Week 52|Lack of Efficacy|10|||
130985569|NCT01984697|471574904|FG000|Overall Study|Lost to Follow-up|14|||
130985570|NCT01984697|471574905|FG001|Overall Study|Lost to Follow-up|5|||
130985571|NCT01984697|471574906|FG002|Overall Study|Lost to Follow-up|10|||
131225489|NCT03940586|472452047|FG002|Overall Study|Physician Decision|1|||
130712145|NCT02696031|470571819|FG001|Up to Week 52|Lack of Efficacy|7|||
130712146|NCT02696031|470571820|FG002|Up to Week 52|Lack of Efficacy|11|||
130985572|NCT01984697|471574907|FG003|Overall Study|Lost to Follow-up|6|||
130985573|NCT01984697|471574908|FG004|Overall Study|Lost to Follow-up|21|||
130985574|NCT01984697|471574904|FG000|Overall Study|Physician Decision|3|||
130985575|NCT01984697|471574905|FG001|Overall Study|Physician Decision|0|||
130985576|NCT01984697|471574906|FG002|Overall Study|Physician Decision|0|||
130985577|NCT01984697|471574907|FG003|Overall Study|Physician Decision|1|||
130985578|NCT01984697|471574908|FG004|Overall Study|Physician Decision|0|||
130985579|NCT01984697|471574904|FG000|Overall Study|Protocol Violation|8|||
130985580|NCT01984697|471574905|FG001|Overall Study|Protocol Violation|5|||
130985581|NCT01984697|471574906|FG002|Overall Study|Protocol Violation|3|||
130985582|NCT01984697|471574907|FG003|Overall Study|Protocol Violation|2|||
130985583|NCT01984697|471574908|FG004|Overall Study|Protocol Violation|0|||
130985584|NCT01984697|471574904|FG000|Overall Study|Withdrawal by Subject|15|||
130985585|NCT01984697|471574905|FG001|Overall Study|Withdrawal by Subject|21|||
130985586|NCT01984697|471574906|FG002|Overall Study|Withdrawal by Subject|13|||
130985587|NCT01984697|471574907|FG003|Overall Study|Withdrawal by Subject|11|||
130985588|NCT01984697|471574908|FG004|Overall Study|Withdrawal by Subject|13|||
130985589|NCT01984697|471574904|FG000|Overall Study|Missed last follow-up visit|1|||
130985590|NCT01984697|471574905|FG001|Overall Study|Missed last follow-up visit|0|||
130985591|NCT01984697|471574906|FG002|Overall Study|Missed last follow-up visit|0|||
130985592|NCT01984697|471574907|FG003|Overall Study|Missed last follow-up visit|0|||
130985593|NCT01984697|471574908|FG004|Overall Study|Missed last follow-up visit|0|||
130985594|NCT01984697|471574904|FG000|Overall Study|Death|0|||
130985595|NCT01984697|471574905|FG001|Overall Study|Death|0|||
130985596|NCT01984697|471574906|FG002|Overall Study|Death|0|||
130985597|NCT01984697|471574907|FG003|Overall Study|Death|1|||
130985598|NCT01984697|471574908|FG004|Overall Study|Death|0|||
130985599|NCT01984697|471574904|FG000|Overall Study|Pregnancy|2|||
130985600|NCT01984697|471574905|FG001|Overall Study|Pregnancy|0|||
130985601|NCT01984697|471574906|FG002|Overall Study|Pregnancy|1|||
130985602|NCT01984697|471574907|FG003|Overall Study|Pregnancy|0|||
130985603|NCT01984697|471574908|FG004|Overall Study|Pregnancy|1|||
130985604|NCT00847405|471574909|FG000|First Intervention|Adverse Event|0|||
130985605|NCT00847405|471574910|FG001|First Intervention|Adverse Event|1|||
130985606|NCT00847405|471574909|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130985607|NCT00847405|471574910|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130985608|NCT04669600|471574923|FG000|Overall Study|Withdrawal by Subject|1|||
130985609|NCT04669600|471574923|FG000|Overall Study|Other|6|||
130985610|NCT00710606|471574924|FG000|Overall Study|Adverse Event|0|||
130985611|NCT00710606|471574925|FG001|Overall Study|Adverse Event|2|||
130985612|NCT00514683|471574930|FG000|Overall Study|Not treated|2|||
130985613|NCT00514683|471574931|FG001|Overall Study|Not treated|1|||
130956015|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
130956016|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956017|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956018|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956019|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956020|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131125859|NCT01342484|472089192|FG000|Overall Study|Withdrawal by Subject|1|||
131125860|NCT01342484|472089193|FG001|Overall Study|Withdrawal by Subject|0|||
131125861|NCT01342484|472089194|FG002|Overall Study|Withdrawal by Subject|0|||
131125862|NCT01840579|472089195|FG000|Overall Study|Status not recorded|0|||
131125863|NCT01840579|472089196|FG001|Overall Study|Status not recorded|0|||
131125864|NCT01840579|472089197|FG002|Overall Study|Status not recorded|2|||
131125865|NCT01840579|472089198|FG003|Overall Study|Status not recorded|3|||
131125866|NCT01840579|472089199|FG004|Overall Study|Status not recorded|4|||
131125867|NCT01840579|472089200|FG005|Overall Study|Status not recorded|3|||
131125868|NCT01840579|472089201|FG006|Overall Study|Status not recorded|0|||
131125869|NCT01840579|472089202|FG007|Overall Study|Status not recorded|3|||
131125870|NCT01840579|472089203|FG008|Overall Study|Status not recorded|3|||
131125871|NCT01840579|472089204|FG009|Overall Study|Status not recorded|3|||
131125872|NCT01840579|472089195|FG000|Overall Study|Progressive disease|3|||
131125873|NCT01840579|472089196|FG001|Overall Study|Progressive disease|5|||
131125874|NCT01840579|472089197|FG002|Overall Study|Progressive disease|0|||
131125875|NCT01840579|472089198|FG003|Overall Study|Progressive disease|0|||
131125876|NCT01840579|472089199|FG004|Overall Study|Progressive disease|0|||
131125877|NCT01840579|472089200|FG005|Overall Study|Progressive disease|0|||
131125878|NCT01840579|472089201|FG006|Overall Study|Progressive disease|0|||
131125879|NCT01840579|472089202|FG007|Overall Study|Progressive disease|0|||
131125880|NCT01840579|472089203|FG008|Overall Study|Progressive disease|0|||
131125881|NCT01840579|472089204|FG009|Overall Study|Progressive disease|0|||
131125882|NCT01840579|472089195|FG000|Overall Study|Ongoing in study|0|||
131125883|NCT01840579|472089196|FG001|Overall Study|Ongoing in study|1|||
131125884|NCT01840579|472089197|FG002|Overall Study|Ongoing in study|0|||
131125885|NCT01840579|472089198|FG003|Overall Study|Ongoing in study|0|||
131125886|NCT01840579|472089199|FG004|Overall Study|Ongoing in study|0|||
131125887|NCT01840579|472089200|FG005|Overall Study|Ongoing in study|0|||
131125888|NCT01840579|472089201|FG006|Overall Study|Ongoing in study|0|||
131125889|NCT01840579|472089202|FG007|Overall Study|Ongoing in study|0|||
131125890|NCT01840579|472089203|FG008|Overall Study|Ongoing in study|0|||
131125891|NCT01840579|472089204|FG009|Overall Study|Ongoing in study|0|||
131125892|NCT01840579|472089195|FG000|Overall Study|Death|0|||
131125893|NCT01840579|472089196|FG001|Overall Study|Death|0|||
131125894|NCT01840579|472089197|FG002|Overall Study|Death|0|||
131125895|NCT01840579|472089198|FG003|Overall Study|Death|0|||
131125896|NCT01840579|472089199|FG004|Overall Study|Death|0|||
131125897|NCT01840579|472089200|FG005|Overall Study|Death|1|||
131125898|NCT01840579|472089201|FG006|Overall Study|Death|0|||
131125899|NCT01840579|472089202|FG007|Overall Study|Death|0|||
131125900|NCT01840579|472089203|FG008|Overall Study|Death|0|||
131125901|NCT01840579|472089204|FG009|Overall Study|Death|0|||
131125902|NCT01840579|472089195|FG000|Overall Study|Adverse Event|0|||
131125903|NCT01840579|472089196|FG001|Overall Study|Adverse Event|1|||
131125904|NCT01840579|472089197|FG002|Overall Study|Adverse Event|0|||
131125905|NCT01840579|472089198|FG003|Overall Study|Adverse Event|0|||
131125906|NCT01840579|472089199|FG004|Overall Study|Adverse Event|0|||
131125907|NCT01840579|472089200|FG005|Overall Study|Adverse Event|0|||
131125908|NCT01840579|472089201|FG006|Overall Study|Adverse Event|0|||
131125909|NCT01840579|472089202|FG007|Overall Study|Adverse Event|0|||
131125910|NCT01840579|472089203|FG008|Overall Study|Adverse Event|0|||
131125911|NCT01840579|472089204|FG009|Overall Study|Adverse Event|0|||
131125912|NCT01840579|472089195|FG000|Overall Study|Follow-up ended by Sponsor|0|||
131125913|NCT01840579|472089196|FG001|Overall Study|Follow-up ended by Sponsor|0|||
131125914|NCT01840579|472089197|FG002|Overall Study|Follow-up ended by Sponsor|0|||
131125915|NCT01840579|472089198|FG003|Overall Study|Follow-up ended by Sponsor|0|||
131125916|NCT01840579|472089199|FG004|Overall Study|Follow-up ended by Sponsor|0|||
131125917|NCT01840579|472089200|FG005|Overall Study|Follow-up ended by Sponsor|0|||
131125918|NCT01840579|472089201|FG006|Overall Study|Follow-up ended by Sponsor|2|||
130956021|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956022|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131125919|NCT01840579|472089202|FG007|Overall Study|Follow-up ended by Sponsor|0|||
131125920|NCT01840579|472089203|FG008|Overall Study|Follow-up ended by Sponsor|0|||
131125921|NCT01840579|472089204|FG009|Overall Study|Follow-up ended by Sponsor|0|||
131125922|NCT01892163|472089205|FG000|Overall Study|Death|1|||
131125923|NCT01892163|472089206|FG001|Overall Study|Death|1|||
131125924|NCT01892163|472089205|FG000|Overall Study|Lost to Follow-up|1|||
131125925|NCT01892163|472089206|FG001|Overall Study|Lost to Follow-up|0|||
131125926|NCT03302975|472089207|FG000|Overall Study|Lost to Follow-up|4|||
131125927|NCT01924182|472089208|FG000|Overall Study|Withdrawal by Subject|1|||
131125928|NCT01924182|472089209|FG001|Overall Study|Withdrawal by Subject|0|||
131225490|NCT03940586|472452045|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
131225491|NCT03940586|472452046|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
131225492|NCT03940586|472452047|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
131225493|NCT03940586|472452045|FG000|Overall Study|Not Treated|0|||
131225494|NCT03940586|472452046|FG001|Overall Study|Not Treated|2|||
131225495|NCT03940586|472452047|FG002|Overall Study|Not Treated|0|||
131225496|NCT02278952|472452048|FG000|Overall Study|Insufficient Sample|6|||
131225497|NCT03077828|472452055|FG000|Treatment Cycles|Death|1|||
131225498|NCT03077828|472452055|FG000|Treatment Cycles|Withdrawal by Subject|1|||
131225499|NCT03077828|472452055|FG000|Treatment Cycles|Screen Fail|2|||
131225500|NCT03077828|472452055|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
131225501|NCT03077828|472452055|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
131225502|NCT03077828|472452055|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
131225503|NCT03077828|472452055|FG000|Follow-up|Patients still in follow-up|15|||
131225504|NCT04288115|472452059|FG000|Overall Study|Withdrawal by Subject|0|||
131225505|NCT04288115|472452060|FG001|Overall Study|Withdrawal by Subject|1|||
131225506|NCT04288115|472452059|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
131225507|NCT04288115|472452060|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
131225508|NCT00729365|472452061|FG000|Overall Study|Physician Decision|33|||
131225509|NCT00729365|472452062|FG001|Overall Study|Physician Decision|6|||
131225510|NCT00729365|472452063|FG002|Overall Study|Physician Decision|7|||
131225511|NCT00869089|472452065|FG000|Overall Study|Lost to Follow-up|1|||
131225512|NCT00869089|472452065|FG000|Overall Study|Withdrawal by Subject|1|||
131225513|NCT00869089|472452065|FG000|Overall Study|Screen Fail|1|||
131225514|NCT05037409|472452068|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
131225515|NCT05037409|472452069|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
131225516|NCT05037409|472452070|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
131225517|NCT01559818|472452075|FG000|Overall Study|Physician Decision|1|||
131225518|NCT01559818|472452075|FG000|Overall Study|Pregnancy|1|||
131225519|NCT01559818|472452075|FG000|Overall Study|Study terminated by Sponsor|4|||
131225520|NCT01559818|472452075|FG000|Overall Study|Withdrawal by Subject|1|||
131225521|NCT04071626|472452077|FG000|Overall Study|Withdrawal by Subject|1|||
131225522|NCT04071626|472452078|FG001|Overall Study|Withdrawal by Subject|1|||
131225523|NCT04071626|472452077|FG000|Overall Study|Protocol Violation|0|||
131225524|NCT04071626|472452078|FG001|Overall Study|Protocol Violation|1|||
131225525|NCT00585039|472452087|FG000|Overall Study|medication spilled|2|||
131225526|NCT00585039|472452088|FG001|Overall Study|medication spilled|0|||
131225527|NCT01010230|472452089|FG000|Overall Study|Withdrawal by Subject|6|||
131225528|NCT01010230|472452090|FG001|Overall Study|Withdrawal by Subject|5|||
131225529|NCT01010230|472452089|FG000|Overall Study|Lost to Follow-up|4|||
131225530|NCT01010230|472452090|FG001|Overall Study|Lost to Follow-up|2|||
131225531|NCT01629693|472452091|FG000|Overall Study|Lost to Follow-up|2|||
131225532|NCT01629693|472452092|FG001|Overall Study|Lost to Follow-up|4|||
131225533|NCT01629693|472452091|FG000|Overall Study|Withdrawal by Subject|2|||
131225534|NCT01629693|472452092|FG001|Overall Study|Withdrawal by Subject|2|||
131225535|NCT01629693|472452091|FG000|Overall Study|Adverse Event|1|||
131225536|NCT01629693|472452092|FG001|Overall Study|Adverse Event|0|||
131225537|NCT01629693|472452091|FG000|Overall Study|Investigator decision|0|||
131225538|NCT01629693|472452092|FG001|Overall Study|Investigator decision|1|||
131225539|NCT01629693|472452091|FG000|Overall Study|Poor comfort of study lenses|0|||
131225540|NCT01629693|472452092|FG001|Overall Study|Poor comfort of study lenses|2|||
131225541|NCT01629693|472452091|FG000|Overall Study|Subject decision unrelated to AE|0|||
131225542|NCT01629693|472452092|FG001|Overall Study|Subject decision unrelated to AE|1|||
131225543|NCT01585831|472452099|FG000|Overall Study|Physician Decision|0|||
131225544|NCT01585831|472452100|FG001|Overall Study|Physician Decision|1|||
131225545|NCT01585831|472452099|FG000|Overall Study|Withdrawal by Subject|2|||
131225546|NCT01585831|472452100|FG001|Overall Study|Withdrawal by Subject|1|||
131225547|NCT04385199|472452101|FG000|Overall Study|Withdrawal by Subject|1|||
131225548|NCT04385199|472452102|FG001|Overall Study|Withdrawal by Subject|0|||
131225549|NCT01165242|472453550|FG000|Overall Study|Unreachable Subjects|1|||
130774597|NCT00845676|470800586|FG000|Overall Study|Adverse Event|1|||
130774598|NCT03117361|470802509|FG000|Overall Study|Progressive disease|5|||
130956023|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956024|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956025|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
131225550|NCT01165242|472453551|FG001|Overall Study|Unreachable Subjects|0|||
131225551|NCT01165242|472453552|FG002|Overall Study|Unreachable Subjects|0|||
131225552|NCT01165242|472453550|FG000|Overall Study|Incarcerated Subjects|0|||
131225553|NCT01165242|472453551|FG001|Overall Study|Incarcerated Subjects|1|||
131225554|NCT01165242|472453552|FG002|Overall Study|Incarcerated Subjects|0|||
131225555|NCT01165242|472453550|FG000|Overall Study|Visit 2 Declined by Subject|0|||
131225556|NCT01165242|472453551|FG001|Overall Study|Visit 2 Declined by Subject|0|||
131225557|NCT01165242|472453552|FG002|Overall Study|Visit 2 Declined by Subject|1|||
131225558|NCT01165242|472453550|FG000|Overall Study|Withdrawal by Subject|0|||
130712147|NCT02696031|470571821|FG003|Up to Week 52|Lack of Efficacy|0|||
131225559|NCT01165242|472453551|FG001|Overall Study|Withdrawal by Subject|2|||
131225560|NCT01165242|472453552|FG002|Overall Study|Withdrawal by Subject|2|||
131225561|NCT01165242|472453550|FG000|Overall Study|Extended Holiday|0|||
131225562|NCT01165242|472453551|FG001|Overall Study|Extended Holiday|0|||
131225563|NCT01165242|472453552|FG002|Overall Study|Extended Holiday|1|||
131225564|NCT01165242|472453550|FG000|Overall Study|Lost to Follow-up|9|||
131225565|NCT01165242|472453551|FG001|Overall Study|Lost to Follow-up|7|||
131225566|NCT01165242|472453552|FG002|Overall Study|Lost to Follow-up|10|||
131225567|NCT03770000|472453553|FG000|Overall Study|Premature discontinuation due to PD|0|||
130712148|NCT02696031|470571822|FG004|Up to Week 52|Lack of Efficacy|0|||
130712149|NCT02696031|470571823|FG005|Up to Week 52|Lack of Efficacy|0|||
130712150|NCT02696031|470571818|FG000|Up to Week 52|Lost to Follow-up|1|||
130712151|NCT02696031|470571819|FG001|Up to Week 52|Lost to Follow-up|1|||
130712152|NCT02696031|470571820|FG002|Up to Week 52|Lost to Follow-up|1|||
130712153|NCT02696031|470571821|FG003|Up to Week 52|Lost to Follow-up|0|||
130712154|NCT02696031|470571822|FG004|Up to Week 52|Lost to Follow-up|0|||
130712155|NCT02696031|470571823|FG005|Up to Week 52|Lost to Follow-up|0|||
130712156|NCT02696031|470571818|FG000|Up to Week 52|Physician Decision|1|||
130712157|NCT02696031|470571819|FG001|Up to Week 52|Physician Decision|1|||
130712158|NCT02696031|470571820|FG002|Up to Week 52|Physician Decision|2|||
130712159|NCT02696031|470571821|FG003|Up to Week 52|Physician Decision|0|||
130712160|NCT02696031|470571822|FG004|Up to Week 52|Physician Decision|0|||
130712161|NCT02696031|470571823|FG005|Up to Week 52|Physician Decision|0|||
130712162|NCT02696031|470571818|FG000|Up to Week 52|Pregnancy|0|||
130712163|NCT02696031|470571819|FG001|Up to Week 52|Pregnancy|2|||
130712164|NCT02696031|470571820|FG002|Up to Week 52|Pregnancy|0|||
130712165|NCT02696031|470571821|FG003|Up to Week 52|Pregnancy|0|||
130712166|NCT02696031|470571822|FG004|Up to Week 52|Pregnancy|0|||
130712167|NCT02696031|470571823|FG005|Up to Week 52|Pregnancy|0|||
130712168|NCT02696031|470571818|FG000|Up to Week 52|Protocol Violation|1|||
130712169|NCT02696031|470571819|FG001|Up to Week 52|Protocol Violation|0|||
130712170|NCT02696031|470571820|FG002|Up to Week 52|Protocol Violation|0|||
130712171|NCT02696031|470571821|FG003|Up to Week 52|Protocol Violation|0|||
130712172|NCT02696031|470571822|FG004|Up to Week 52|Protocol Violation|0|||
130712173|NCT02696031|470571823|FG005|Up to Week 52|Protocol Violation|0|||
130712174|NCT02696031|470571818|FG000|Up to Week 52|Withdrawal by Subject|12|||
130712175|NCT02696031|470571819|FG001|Up to Week 52|Withdrawal by Subject|3|||
130712176|NCT02696031|470571820|FG002|Up to Week 52|Withdrawal by Subject|9|||
130712177|NCT02696031|470571821|FG003|Up to Week 52|Withdrawal by Subject|0|||
130712178|NCT02696031|470571822|FG004|Up to Week 52|Withdrawal by Subject|0|||
130712179|NCT02696031|470571823|FG005|Up to Week 52|Withdrawal by Subject|0|||
130712180|NCT02696031|470571818|FG000|Up to Week 104|Pregnancy|0|||
130712181|NCT02696031|470571819|FG001|Up to Week 104|Pregnancy|2|||
130712182|NCT02696031|470571820|FG002|Up to Week 104|Pregnancy|1|||
130712183|NCT02696031|470571821|FG003|Up to Week 104|Pregnancy|0|||
130712184|NCT02696031|470571822|FG004|Up to Week 104|Pregnancy|0|||
130712185|NCT02696031|470571823|FG005|Up to Week 104|Pregnancy|0|||
130712186|NCT02696031|470571818|FG000|Up to Week 104|Withdrawal by Subject|15|||
130712187|NCT02696031|470571819|FG001|Up to Week 104|Withdrawal by Subject|10|||
130712188|NCT02696031|470571820|FG002|Up to Week 104|Withdrawal by Subject|16|||
130712189|NCT02696031|470571821|FG003|Up to Week 104|Withdrawal by Subject|0|||
130712190|NCT02696031|470571822|FG004|Up to Week 104|Withdrawal by Subject|0|||
130712191|NCT02696031|470571823|FG005|Up to Week 104|Withdrawal by Subject|0|||
130712192|NCT02696031|470571818|FG000|Up to Week 104|Protocol Violation|1|||
130712193|NCT02696031|470571819|FG001|Up to Week 104|Protocol Violation|0|||
130712194|NCT02696031|470571820|FG002|Up to Week 104|Protocol Violation|0|||
130712195|NCT02696031|470571821|FG003|Up to Week 104|Protocol Violation|0|||
130956026|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
130956027|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956028|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130985614|NCT00514683|471574932|FG002|Overall Study|Not treated|0|||
131225568|NCT03770000|472453554|FG001|Overall Study|Premature discontinuation due to PD|0|||
131225569|NCT03770000|472453555|FG002|Overall Study|Premature discontinuation due to PD|1|||
130712196|NCT02696031|470571822|FG004|Up to Week 104|Protocol Violation|0|||
130712197|NCT02696031|470571823|FG005|Up to Week 104|Protocol Violation|0|||
130712198|NCT02696031|470571818|FG000|Up to Week 104|Physician Decision|1|||
130774599|NCT03117361|470802509|FG000|Overall Study|Death|1|||
130712199|NCT02696031|470571819|FG001|Up to Week 104|Physician Decision|2|||
130712200|NCT02696031|470571820|FG002|Up to Week 104|Physician Decision|3|||
130712201|NCT02696031|470571821|FG003|Up to Week 104|Physician Decision|0|||
130712202|NCT02696031|470571822|FG004|Up to Week 104|Physician Decision|0|||
130712203|NCT02696031|470571823|FG005|Up to Week 104|Physician Decision|0|||
130712204|NCT02696031|470571818|FG000|Up to Week 104|Lost to Follow-up|2|||
130712205|NCT02696031|470571819|FG001|Up to Week 104|Lost to Follow-up|3|||
130712206|NCT02696031|470571820|FG002|Up to Week 104|Lost to Follow-up|1|||
130712207|NCT02696031|470571821|FG003|Up to Week 104|Lost to Follow-up|0|||
130712208|NCT02696031|470571822|FG004|Up to Week 104|Lost to Follow-up|0|||
131225570|NCT03770000|472453556|FG003|Overall Study|Premature discontinuation due to PD|3|||
130956029|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956030|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956031|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956032|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956033|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956034|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956035|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956036|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956037|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956038|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956039|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
130956040|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956041|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956042|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956043|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956044|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956045|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956046|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130985615|NCT00514683|471574933|FG003|Overall Study|Not treated|0|||
131125929|NCT02258451|472089210|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
131125930|NCT02258451|472089211|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
131125931|NCT02258451|472089210|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
131125932|NCT02258451|472089211|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
131125933|NCT02258451|472089210|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
131125934|NCT02258451|472089211|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
131125935|NCT02258451|472089210|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
131125936|NCT02258451|472089211|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
131125937|NCT02258451|472089210|FG000|Overall Study|Discontinuation all treatment due to death|4|||
131125938|NCT02258451|472089211|FG001|Overall Study|Discontinuation all treatment due to death|3|||
131125939|NCT02258451|472089210|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
131125940|NCT02258451|472089211|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
131125941|NCT02258451|472089210|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
131125942|NCT02258451|472089211|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
131125943|NCT02258451|472089210|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
131125944|NCT02258451|472089211|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
131125945|NCT02258451|472089210|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
131125946|NCT02258451|472089211|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
131125947|NCT02258451|472089210|FG000|Overall Study|Other reason|1|||
131125948|NCT02258451|472089211|FG001|Overall Study|Other reason|1|||
131125949|NCT02258451|472089210|FG000|Overall Study|Never treated|2|||
131125950|NCT02258451|472089211|FG001|Overall Study|Never treated|3|||
131125951|NCT05419128|472089216|FG000|Overall Study|Withdrawal by Subject|1|||
131125952|NCT05419128|472089217|FG001|Overall Study|Withdrawal by Subject|1|||
131125953|NCT05419128|472089218|FG002|Overall Study|Withdrawal by Subject|0|||
131125954|NCT05419128|472089219|FG003|Overall Study|Withdrawal by Subject|1|||
131125955|NCT05419128|472089220|FG004|Overall Study|Withdrawal by Subject|1|||
131125956|NCT05419128|472089221|FG005|Overall Study|Withdrawal by Subject|0|||
131125957|NCT05419128|472089216|FG000|Overall Study|Lost to Follow-up|0|||
131125958|NCT05419128|472089217|FG001|Overall Study|Lost to Follow-up|0|||
131125959|NCT05419128|472089218|FG002|Overall Study|Lost to Follow-up|1|||
131125960|NCT05419128|472089219|FG003|Overall Study|Lost to Follow-up|0|||
131125961|NCT05419128|472089220|FG004|Overall Study|Lost to Follow-up|0|||
131125962|NCT05419128|472089221|FG005|Overall Study|Lost to Follow-up|1|||
131125963|NCT03834519|472089222|FG000|Overall Study|Lost to Follow-up|2|||
131125964|NCT03834519|472089223|FG001|Overall Study|Lost to Follow-up|1|||
131125965|NCT03834519|472089222|FG000|Overall Study|Withdrawal by Subject|5|||
131125966|NCT03834519|472089223|FG001|Overall Study|Withdrawal by Subject|8|||
131125967|NCT03834519|472089222|FG000|Overall Study|Death|368|||
131125968|NCT03834519|472089223|FG001|Overall Study|Death|174|||
131125969|NCT03834519|472089222|FG000|Overall Study|Physician Decision|5|||
131125970|NCT03834519|472089223|FG001|Overall Study|Physician Decision|1|||
131125971|NCT03834519|472089222|FG000|Overall Study|Sponsor decision|149|||
131125972|NCT03834519|472089223|FG001|Overall Study|Sponsor decision|80|||
131125973|NCT04506086|472089224|FG000|Overall Study|Withdrawal by Subject|2|||
131039533|NCT04171141|471780077|FG000|Overall Study|Progressive disease|2|||
131039534|NCT04171141|471780078|FG001|Overall Study|Progressive disease|3|||
131039535|NCT04171141|471780079|FG002|Overall Study|Progressive disease|4|||
131039536|NCT04171141|471780080|FG003|Overall Study|Progressive disease|7|||
131039537|NCT04171141|471780081|FG004|Overall Study|Progressive disease|1|||
131039538|NCT04171141|471780082|FG005|Overall Study|Progressive disease|8|||
131039539|NCT04171141|471780083|FG006|Overall Study|Progressive disease|4|||
131039540|NCT04171141|471780084|FG007|Overall Study|Progressive disease|6|||
131039541|NCT04171141|471780085|FG008|Overall Study|Progressive disease|7|||
131039542|NCT04171141|471780086|FG009|Overall Study|Progressive disease|3|||
131039543|NCT04171141|471780087|FG010|Overall Study|Progressive disease|4|||
131039544|NCT04171141|471780088|FG011|Overall Study|Progressive disease|3|||
131039545|NCT04171141|471780089|FG012|Overall Study|Progressive disease|4|||
131039546|NCT04171141|471780090|FG013|Overall Study|Progressive disease|2|||
131039547|NCT04171141|471780091|FG014|Overall Study|Progressive disease|4|||
131039548|NCT04171141|471780092|FG015|Overall Study|Progressive disease|1|||
131039549|NCT04171141|471780077|FG000|Overall Study|Withdrawal by Subject|0|||
131039550|NCT04171141|471780078|FG001|Overall Study|Withdrawal by Subject|0|||
131039551|NCT04171141|471780079|FG002|Overall Study|Withdrawal by Subject|0|||
131039552|NCT04171141|471780080|FG003|Overall Study|Withdrawal by Subject|1|||
131039553|NCT04171141|471780081|FG004|Overall Study|Withdrawal by Subject|0|||
131039554|NCT04171141|471780082|FG005|Overall Study|Withdrawal by Subject|0|||
131039555|NCT04171141|471780083|FG006|Overall Study|Withdrawal by Subject|1|||
131039556|NCT04171141|471780084|FG007|Overall Study|Withdrawal by Subject|0|||
131039557|NCT04171141|471780085|FG008|Overall Study|Withdrawal by Subject|0|||
131039558|NCT04171141|471780086|FG009|Overall Study|Withdrawal by Subject|1|||
131039559|NCT04171141|471780087|FG010|Overall Study|Withdrawal by Subject|0|||
131039560|NCT04171141|471780088|FG011|Overall Study|Withdrawal by Subject|0|||
131039561|NCT04171141|471780089|FG012|Overall Study|Withdrawal by Subject|0|||
131039562|NCT04171141|471780090|FG013|Overall Study|Withdrawal by Subject|0|||
131039563|NCT04171141|471780091|FG014|Overall Study|Withdrawal by Subject|0|||
131039564|NCT04171141|471780092|FG015|Overall Study|Withdrawal by Subject|0|||
131039565|NCT04171141|471780077|FG000|Overall Study|Global deterioration of health status|0|||
131039566|NCT04171141|471780078|FG001|Overall Study|Global deterioration of health status|0|||
131039567|NCT04171141|471780079|FG002|Overall Study|Global deterioration of health status|0|||
131039568|NCT04171141|471780080|FG003|Overall Study|Global deterioration of health status|1|||
131039569|NCT04171141|471780081|FG004|Overall Study|Global deterioration of health status|0|||
131039570|NCT04171141|471780082|FG005|Overall Study|Global deterioration of health status|2|||
131039571|NCT04171141|471780083|FG006|Overall Study|Global deterioration of health status|1|||
131039572|NCT04171141|471780084|FG007|Overall Study|Global deterioration of health status|0|||
131039573|NCT04171141|471780085|FG008|Overall Study|Global deterioration of health status|1|||
131039574|NCT04171141|471780086|FG009|Overall Study|Global deterioration of health status|0|||
131039575|NCT04171141|471780087|FG010|Overall Study|Global deterioration of health status|0|||
131039576|NCT04171141|471780088|FG011|Overall Study|Global deterioration of health status|0|||
131039577|NCT04171141|471780089|FG012|Overall Study|Global deterioration of health status|0|||
131039578|NCT04171141|471780090|FG013|Overall Study|Global deterioration of health status|0|||
131039579|NCT04171141|471780091|FG014|Overall Study|Global deterioration of health status|1|||
131039580|NCT04171141|471780092|FG015|Overall Study|Global deterioration of health status|1|||
131039581|NCT03314454|471780095|FG000|Overall Study|Protocol Violation|1|||
131039582|NCT04119843|471780096|FG000|Overall Study|Adverse Event|3|||
131039583|NCT04119843|471780096|FG000|Overall Study|Death|1|||
131039584|NCT04233216|471780097|FG000|Overall Study|Lost to Follow-up|1|||
131039585|NCT04233216|471780098|FG001|Overall Study|Lost to Follow-up|0|||
131039586|NCT04233216|471780099|FG002|Overall Study|Lost to Follow-up|2|||
131039587|NCT04233216|471780100|FG003|Overall Study|Lost to Follow-up|0|||
131039588|NCT04233216|471780097|FG000|Overall Study|Physician Decision|0|||
131039589|NCT04233216|471780098|FG001|Overall Study|Physician Decision|3|||
131039590|NCT04233216|471780099|FG002|Overall Study|Physician Decision|0|||
131125974|NCT00517751|472089225|FG000|Overall Study|Death|3|||
131039591|NCT04233216|471780100|FG003|Overall Study|Physician Decision|2|||
131039592|NCT04233216|471780097|FG000|Overall Study|Withdrawal by Subject|0|||
131039593|NCT04233216|471780098|FG001|Overall Study|Withdrawal by Subject|2|||
131039594|NCT04233216|471780099|FG002|Overall Study|Withdrawal by Subject|1|||
131039595|NCT04233216|471780100|FG003|Overall Study|Withdrawal by Subject|0|||
131039596|NCT03652389|471780101|FG000|Overall Study|Lost to Follow-up|1|||
131039597|NCT03652389|471780102|FG001|Overall Study|Lost to Follow-up|5|||
131039598|NCT03652389|471780101|FG000|Overall Study|Withdrawal by Subject|5|||
131039599|NCT03652389|471780102|FG001|Overall Study|Withdrawal by Subject|1|||
131039600|NCT03652389|471780101|FG000|Overall Study|New diagnosis|2|||
131039601|NCT03652389|471780102|FG001|Overall Study|New diagnosis|0|||
131039602|NCT05034328|471780107|FG000|Overall Study|Protocol Violation|1|||
131039603|NCT05034328|471780108|FG001|Overall Study|Protocol Violation|0|||
131039604|NCT05034328|471780107|FG000|Overall Study|Lost to Follow-up|0|||
131039605|NCT05034328|471780108|FG001|Overall Study|Lost to Follow-up|10|||
131039606|NCT03625167|471780113|FG000|Overall Study|Protocol Violation|5|||
131125975|NCT00517751|472089225|FG000|Overall Study|Withdrawal by Subject|37|||
131039607|NCT02969707|471780114|FG000|Overall Study|Withdrawal by Subject|6|||
131225571|NCT03770000|472453557|FG004|Overall Study|Premature discontinuation due to PD|2|||
131225572|NCT01690520|472453560|FG000|Overall Study|Death|25|||
131225573|NCT01690520|472453561|FG001|Overall Study|Death|21|||
131225574|NCT01690520|472453560|FG000|Overall Study|Lost to Follow-up|2|||
131225575|NCT01690520|472453561|FG001|Overall Study|Lost to Follow-up|3|||
131225576|NCT01690520|472453560|FG000|Overall Study|Withdrawal by Subject|2|||
131225577|NCT01690520|472453561|FG001|Overall Study|Withdrawal by Subject|0|||
131225578|NCT01690520|472453560|FG000|Overall Study|Relapse|0|||
131225579|NCT01690520|472453561|FG001|Overall Study|Relapse|1|||
131225580|NCT01690520|472453560|FG000|Overall Study|Other|0|||
131225581|NCT01690520|472453561|FG001|Overall Study|Other|1|||
131225582|NCT01690520|472453560|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
131225583|NCT01690520|472453561|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
131225584|NCT01169649|472453565|FG000|Overall Study|Patient Not Treated|3|||
131225585|NCT03840811|472453566|FG000|Overall Study|Lost to Follow-up|0|||
131225586|NCT03840811|472453567|FG001|Overall Study|Lost to Follow-up|0|||
131225587|NCT03840811|472453568|FG002|Overall Study|Lost to Follow-up|1|||
131225588|NCT01625845|472453569|FG000|Overall Study|Adverse Event|1|||
131225589|NCT01625845|472453570|FG001|Overall Study|Adverse Event|2|||
131225590|NCT01625845|472453569|FG000|Overall Study|Lost to Follow-up|2|||
131225591|NCT01625845|472453570|FG001|Overall Study|Lost to Follow-up|1|||
131225592|NCT01625845|472453569|FG000|Overall Study|Withdrawal by Subject|2|||
131225593|NCT01625845|472453570|FG001|Overall Study|Withdrawal by Subject|0|||
131225594|NCT03568500|472453571|FG000|Overall Study|Lost to Follow-up|1|||
131225595|NCT03568500|472453572|FG001|Overall Study|Lost to Follow-up|1|||
131225596|NCT03568500|472453573|FG002|Overall Study|Lost to Follow-up|2|||
131225597|NCT03568500|472453571|FG000|Overall Study|Adverse Event|1|||
131225598|NCT03568500|472453572|FG001|Overall Study|Adverse Event|1|||
131225599|NCT03568500|472453573|FG002|Overall Study|Adverse Event|2|||
131225600|NCT03568500|472453571|FG000|Overall Study|Physician Decision|1|||
131225601|NCT03568500|472453572|FG001|Overall Study|Physician Decision|0|||
131225602|NCT03568500|472453573|FG002|Overall Study|Physician Decision|0|||
131225603|NCT03568500|472453571|FG000|Overall Study|Withdrawal by Subject|4|||
131225604|NCT03568500|472453572|FG001|Overall Study|Withdrawal by Subject|2|||
131225605|NCT03568500|472453573|FG002|Overall Study|Withdrawal by Subject|0|||
131225606|NCT03568500|472453571|FG000|Overall Study|Technical Problems|2|||
131225607|NCT03568500|472453572|FG001|Overall Study|Technical Problems|1|||
131225608|NCT03568500|472453573|FG002|Overall Study|Technical Problems|0|||
131225609|NCT03568500|472453571|FG000|Overall Study|Participant Noncompliance|1|||
131225610|NCT03568500|472453572|FG001|Overall Study|Participant Noncompliance|1|||
131225611|NCT03568500|472453573|FG002|Overall Study|Participant Noncompliance|0|||
131225612|NCT04132232|472453582|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
130712209|NCT02696031|470571823|FG005|Up to Week 104|Lost to Follow-up|0|||
130712210|NCT02696031|470571818|FG000|Up to Week 104|Lack of Efficacy|13|||
130712211|NCT02696031|470571819|FG001|Up to Week 104|Lack of Efficacy|12|||
130712212|NCT02696031|470571820|FG002|Up to Week 104|Lack of Efficacy|11|||
131225613|NCT04132232|472453583|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
130712213|NCT02696031|470571821|FG003|Up to Week 104|Lack of Efficacy|0|||
130712214|NCT02696031|470571822|FG004|Up to Week 104|Lack of Efficacy|0|||
131039608|NCT02969707|471780115|FG001|Overall Study|Withdrawal by Subject|5|||
131039609|NCT02969707|471780114|FG000|Overall Study|Severe anxiety|0|||
131039610|NCT02969707|471780115|FG001|Overall Study|Severe anxiety|1|||
131039611|NCT02969707|471780114|FG000|Overall Study|Positive toxicology screen|0|||
131039612|NCT02969707|471780115|FG001|Overall Study|Positive toxicology screen|2|||
131039613|NCT02969707|471780114|FG000|Overall Study|Claustrophobia|2|||
131039614|NCT02969707|471780115|FG001|Overall Study|Claustrophobia|2|||
131039615|NCT02969707|471780114|FG000|Overall Study|Non-compliance|1|||
131039616|NCT02969707|471780115|FG001|Overall Study|Non-compliance|2|||
131039617|NCT05496231|471780132|FG000|Overall Study|Adverse Event|1|||
131039618|NCT05496231|471780133|FG001|Overall Study|Adverse Event|1|||
131039619|NCT05496231|471780134|FG002|Overall Study|Adverse Event|0|||
131039620|NCT05496231|471780135|FG003|Overall Study|Adverse Event|4|||
131039621|NCT05496231|471780132|FG000|Overall Study|Withdrawal by Subject|5|||
131039622|NCT05496231|471780133|FG001|Overall Study|Withdrawal by Subject|5|||
131225614|NCT04132232|472453582|FG000|Overall Study|Lost to Follow-up|6|||
131225615|NCT04132232|472453583|FG001|Overall Study|Lost to Follow-up|7|||
131225616|NCT00368537|472453585|FG000|Randomization|No study drug dosed|13|||
131225617|NCT00368537|472453586|FG001|Randomization|No study drug dosed|6|||
130712215|NCT02696031|470571823|FG005|Up to Week 104|Lack of Efficacy|0|||
131039623|NCT05496231|471780134|FG002|Overall Study|Withdrawal by Subject|4|||
131039624|NCT05496231|471780135|FG003|Overall Study|Withdrawal by Subject|11|||
131225618|NCT00368537|472453585|FG000|Baseline Participants|Lost to Follow-up|16|||
131225619|NCT00368537|472453586|FG001|Baseline Participants|Lost to Follow-up|17|||
131225620|NCT00368537|472453585|FG000|Baseline Participants|Withdrawal by Subject|6|||
131225621|NCT00368537|472453586|FG001|Baseline Participants|Withdrawal by Subject|4|||
131225622|NCT00368537|472453585|FG000|Baseline Participants|Death|1|||
130712216|NCT02696031|470571818|FG000|Up to Week 104|Adverse Event|7|||
130712217|NCT02696031|470571819|FG001|Up to Week 104|Adverse Event|11|||
130712218|NCT02696031|470571820|FG002|Up to Week 104|Adverse Event|5|||
130712219|NCT02696031|470571821|FG003|Up to Week 104|Adverse Event|0|||
130712220|NCT02696031|470571822|FG004|Up to Week 104|Adverse Event|0|||
130712221|NCT02696031|470571823|FG005|Up to Week 104|Adverse Event|0|||
130712222|NCT02696031|470571818|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130712223|NCT02696031|470571819|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
130712224|NCT02696031|470571820|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130712225|NCT02696031|470571821|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130712226|NCT02696031|470571822|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130712227|NCT02696031|470571823|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130712228|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
130712229|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
130712230|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
130712231|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
130712232|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
130712233|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
130712234|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130712235|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130712236|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130712237|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
130712238|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
130712239|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130712240|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130712241|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130712242|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130712243|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
130712244|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130712245|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130712246|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130712247|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130712248|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130712249|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130712250|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
130712251|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130712252|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
130712253|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
130712254|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
130712255|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
130712256|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
130712257|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
130712258|NCT02696031|470571818|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
130712259|NCT02696031|470571819|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
130712260|NCT02696031|470571820|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
130712261|NCT02696031|470571821|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
130712262|NCT02696031|470571822|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
130712263|NCT02696031|470571823|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
130712264|NCT01901874|470571826|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
130712265|NCT01901874|470571826|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
130712266|NCT01901874|470571826|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
130712267|NCT01901874|470571826|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
130712268|NCT01901874|470571826|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
130712269|NCT01901874|470571826|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
130712270|NCT02595008|470571828|FG000|Overall Study|Enrolled In Error|1|||
130712271|NCT02595008|470571829|FG001|Overall Study|Enrolled In Error|0|||
130712272|NCT03078582|470571836|FG000|Overall Study|Adverse Event|0|||
130712273|NCT03078582|470571837|FG001|Overall Study|Adverse Event|8|||
130956047|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956048|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956049|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956050|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956051|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956052|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130712274|NCT01843348|470571840|FG000|Overall Study|Withdrawal by Subject|4|||
130712275|NCT01843348|470571841|FG001|Overall Study|Withdrawal by Subject|16|||
130956053|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956054|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
130956055|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956056|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956057|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956058|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956059|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956060|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956061|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956062|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956063|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
130956064|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956065|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956066|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130985616|NCT00514683|471574934|FG004|Overall Study|Not treated|1|||
131125976|NCT00517751|472089225|FG000|Overall Study|Lost to Follow-up|4|||
130985617|NCT00514683|471574930|FG000|Overall Study|Adverse Event|21|||
130985618|NCT00514683|471574931|FG001|Overall Study|Adverse Event|20|||
130985619|NCT00514683|471574932|FG002|Overall Study|Adverse Event|15|||
130985620|NCT00514683|471574933|FG003|Overall Study|Adverse Event|13|||
130985621|NCT00514683|471574934|FG004|Overall Study|Adverse Event|27|||
130985622|NCT00514683|471574930|FG000|Overall Study|Protocol Violation|1|||
130985623|NCT00514683|471574931|FG001|Overall Study|Protocol Violation|1|||
130985624|NCT00514683|471574932|FG002|Overall Study|Protocol Violation|0|||
130985625|NCT00514683|471574933|FG003|Overall Study|Protocol Violation|1|||
130985626|NCT00514683|471574934|FG004|Overall Study|Protocol Violation|0|||
130985627|NCT00514683|471574930|FG000|Overall Study|Withdrawal by Subject|2|||
130985628|NCT00514683|471574931|FG001|Overall Study|Withdrawal by Subject|2|||
130985629|NCT00514683|471574932|FG002|Overall Study|Withdrawal by Subject|1|||
130985630|NCT00514683|471574933|FG003|Overall Study|Withdrawal by Subject|0|||
130985631|NCT00514683|471574934|FG004|Overall Study|Withdrawal by Subject|4|||
130985632|NCT00514683|471574930|FG000|Overall Study|Reason other than listed above|0|||
130985633|NCT00514683|471574931|FG001|Overall Study|Reason other than listed above|1|||
130985634|NCT00514683|471574932|FG002|Overall Study|Reason other than listed above|2|||
130985635|NCT00514683|471574933|FG003|Overall Study|Reason other than listed above|0|||
130985636|NCT00514683|471574934|FG004|Overall Study|Reason other than listed above|1|||
130985637|NCT00335452|471574935|FG000|Overall Study|Death|156|||
130985638|NCT00335452|471574936|FG001|Overall Study|Death|144|||
130985639|NCT00335452|471574937|FG002|Overall Study|Death|158|||
130985640|NCT00335452|471574938|FG003|Overall Study|Death|129|||
130985641|NCT00335452|471574935|FG000|Overall Study|Lost to Follow-up|2|||
130985642|NCT00335452|471574936|FG001|Overall Study|Lost to Follow-up|3|||
130985643|NCT00335452|471574937|FG002|Overall Study|Lost to Follow-up|1|||
130985644|NCT00335452|471574938|FG003|Overall Study|Lost to Follow-up|2|||
130985645|NCT02901626|471574942|FG000|Overall Study|Lost to Follow-up|1|||
130985646|NCT02901626|471574943|FG001|Overall Study|Lost to Follow-up|1|||
130985647|NCT01373931|471574944|FG000|Lead-in Period|Adverse Event|2|||
130985648|NCT01373931|471574945|FG001|Lead-in Period|Adverse Event|0|||
130985649|NCT01373931|471574944|FG000|Period 1|Adverse Event|2|||
130985650|NCT01373931|471574945|FG001|Period 1|Adverse Event|0|||
130985651|NCT01373931|471574944|FG000|Period 1|Withdrawal by Subject|0|||
130985652|NCT01373931|471574945|FG001|Period 1|Withdrawal by Subject|2|||
130985653|NCT04857034|471574946|FG000|Placebo-Controlled Period|Request to discontinue|2|||
130985654|NCT04857034|471574947|FG001|Placebo-Controlled Period|Request to discontinue|2|||
130985655|NCT04857034|471574948|FG002|Placebo-Controlled Period|Request to discontinue|0|||
130985656|NCT04857034|471574949|FG003|Placebo-Controlled Period|Request to discontinue|0|||
130985657|NCT04857034|471574950|FG004|Placebo-Controlled Period|Request to discontinue|0|||
130985658|NCT04857034|471574946|FG000|Placebo-Controlled Period|withdrew consent|1|||
130985659|NCT04857034|471574947|FG001|Placebo-Controlled Period|withdrew consent|1|||
130985660|NCT04857034|471574948|FG002|Placebo-Controlled Period|withdrew consent|2|||
130985661|NCT04857034|471574949|FG003|Placebo-Controlled Period|withdrew consent|0|||
130985662|NCT04857034|471574950|FG004|Placebo-Controlled Period|withdrew consent|0|||
130985663|NCT04857034|471574946|FG000|Placebo-Controlled Period|Pregnancy|1|||
130985664|NCT04857034|471574947|FG001|Placebo-Controlled Period|Pregnancy|1|||
130985665|NCT04857034|471574948|FG002|Placebo-Controlled Period|Pregnancy|0|||
130985666|NCT04857034|471574949|FG003|Placebo-Controlled Period|Pregnancy|0|||
130985667|NCT04857034|471574950|FG004|Placebo-Controlled Period|Pregnancy|0|||
130985668|NCT04857034|471574946|FG000|Placebo-Controlled Period|Ongoing study period|0|||
130985669|NCT04857034|471574947|FG001|Placebo-Controlled Period|Ongoing study period|1|||
130985670|NCT04857034|471574948|FG002|Placebo-Controlled Period|Ongoing study period|0|||
130956067|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956068|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956069|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956070|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956071|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956072|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956073|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956074|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956075|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956076|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956077|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956078|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
130956079|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956080|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956081|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956082|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956083|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956084|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956085|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956086|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956087|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
130956088|NCT02346240|471471159|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956089|NCT02346240|471471160|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
131125977|NCT00517751|472089225|FG000|Overall Study|patient not over due|6|||
131125978|NCT00517751|472089225|FG000|Overall Study|Patient not due for visit|76|||
131125979|NCT00517751|472089225|FG000|Overall Study|Missing|3|||
131125980|NCT00980200|472091203|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
131125981|NCT00980200|472091204|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
131125982|NCT00980200|472091205|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
131125983|NCT00980200|472091206|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
131125984|NCT00980200|472091207|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
131125985|NCT00980200|472091203|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
131125986|NCT00980200|472091204|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
131125987|NCT00980200|472091205|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
131125988|NCT00980200|472091206|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
131125989|NCT00980200|472091207|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
131125990|NCT00457015|472091208|FG000|Overall Study|Left study site against medical advice|0|||
131125991|NCT00457015|472091209|FG001|Overall Study|Left study site against medical advice|1|||
131125992|NCT01429584|472091210|FG000|Overall Study|Withdrawal by Subject|1|||
131125993|NCT01429584|472091211|FG001|Overall Study|Withdrawal by Subject|0|||
131125994|NCT01429584|472091210|FG000|Overall Study|Protocol Violation|0|||
131125995|NCT01429584|472091211|FG001|Overall Study|Protocol Violation|1|||
131125996|NCT00750698|472091215|FG000|Overall Study|Withdrawal by Subject|1|||
131125997|NCT00750698|472091216|FG001|Overall Study|Withdrawal by Subject|0|||
131125998|NCT00750698|472091215|FG000|Overall Study|Progressive disease|5|||
131125999|NCT00750698|472091216|FG001|Overall Study|Progressive disease|2|||
131126000|NCT02263079|472091217|FG000|Overall Study|Physician Decision|1|||
131126001|NCT02263079|472091218|FG001|Overall Study|Physician Decision|0|||
131126002|NCT02263079|472091219|FG002|Overall Study|Physician Decision|0|||
131126003|NCT02263079|472091217|FG000|Overall Study|Withdrawal by Subject|2|||
131126004|NCT02263079|472091218|FG001|Overall Study|Withdrawal by Subject|8|||
131126005|NCT02263079|472091219|FG002|Overall Study|Withdrawal by Subject|0|||
131126006|NCT03557281|472091220|FG000|Overall Study|Investigator discretion|0|||
131126007|NCT03557281|472091221|FG001|Overall Study|Investigator discretion|0|||
131126008|NCT03557281|472091222|FG002|Overall Study|Investigator discretion|1|||
131126009|NCT03557281|472091223|FG003|Overall Study|Investigator discretion|0|||
131126010|NCT03557281|472091224|FG004|Overall Study|Investigator discretion|0|||
131126011|NCT03557281|472091220|FG000|Overall Study|Withdrawal by Subject|0|||
131126012|NCT03557281|472091221|FG001|Overall Study|Withdrawal by Subject|1|||
131126013|NCT03557281|472091222|FG002|Overall Study|Withdrawal by Subject|1|||
131126014|NCT03557281|472091223|FG003|Overall Study|Withdrawal by Subject|1|||
131126015|NCT03557281|472091224|FG004|Overall Study|Withdrawal by Subject|2|||
131126016|NCT03557281|472091220|FG000|Overall Study|Randomized, but did not receive treatment|0|||
131126017|NCT03557281|472091221|FG001|Overall Study|Randomized, but did not receive treatment|0|||
131126018|NCT03557281|472091222|FG002|Overall Study|Randomized, but did not receive treatment|0|||
131126019|NCT03557281|472091223|FG003|Overall Study|Randomized, but did not receive treatment|0|||
131126020|NCT03557281|472091224|FG004|Overall Study|Randomized, but did not receive treatment|1|||
131126021|NCT00402649|472091225|FG000|Overall Study|Lost to Follow-up|1|||
131126022|NCT00402649|472091225|FG000|Overall Study|Withdrawal by Subject|1|||
131225623|NCT00368537|472453586|FG001|Baseline Participants|Death|2|||
130956090|NCT02346240|471471161|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956091|NCT02346240|471471162|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956092|NCT02346240|471471163|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956093|NCT02346240|471471164|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956094|NCT02346240|471471165|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956095|NCT02346240|471471166|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956096|NCT02346240|471471167|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956097|NCT02346240|471471168|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956098|NCT02346240|471471169|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956099|NCT02346240|471471170|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956100|NCT02346240|471471171|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956101|NCT02346240|471471172|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956102|NCT02346240|471471173|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
130956103|NCT02346240|471471174|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956104|NCT02346240|471471175|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956105|NCT02346240|471471176|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956106|NCT02346240|471471177|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956107|NCT02346240|471471178|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956108|NCT02346240|471471179|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956109|NCT02346240|471471180|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956110|NCT02346240|471471181|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956111|NCT02346240|471471182|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
130956112|NCT02346240|471471159|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956113|NCT02346240|471471160|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956114|NCT02346240|471471161|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956115|NCT02346240|471471162|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956116|NCT02346240|471471163|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956117|NCT02346240|471471164|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956118|NCT02346240|471471165|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956119|NCT02346240|471471166|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956120|NCT02346240|471471167|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131225624|NCT00368537|472453585|FG000|Baseline Participants|No susceptibility|1|||
131225625|NCT00368537|472453586|FG001|Baseline Participants|No susceptibility|0|||
131225626|NCT00368537|472453585|FG000|Baseline Participants|Patient uncompliant|0|||
131225627|NCT00368537|472453586|FG001|Baseline Participants|Patient uncompliant|1|||
131225628|NCT01368276|472453598|FG000|Overall Study|Death|1|||
131225629|NCT01368276|472453599|FG001|Overall Study|Death|10|||
130956121|NCT02346240|471471168|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956122|NCT02346240|471471169|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956123|NCT02346240|471471170|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956124|NCT02346240|471471171|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956125|NCT02346240|471471172|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
131225630|NCT00685919|472453600|FG000|Overall Study|Withdrawal by Subject|0|||
131225631|NCT00685919|472453601|FG001|Overall Study|Withdrawal by Subject|0|||
131225632|NCT00685919|472453602|FG002|Overall Study|Withdrawal by Subject|1|||
131225633|NCT00685919|472453603|FG003|Overall Study|Withdrawal by Subject|0|||
131225634|NCT00685919|472453600|FG000|Overall Study|Physician Decision|1|||
131225635|NCT00685919|472453601|FG001|Overall Study|Physician Decision|0|||
131225636|NCT00685919|472453602|FG002|Overall Study|Physician Decision|0|||
131225637|NCT00685919|472453603|FG003|Overall Study|Physician Decision|0|||
130956126|NCT02346240|471471173|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956127|NCT02346240|471471174|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956128|NCT02346240|471471175|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
130956129|NCT02346240|471471176|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
130956130|NCT02346240|471471177|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
130956131|NCT02346240|471471178|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
130956132|NCT02346240|471471179|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
130956133|NCT02346240|471471180|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
131225638|NCT01886300|472453610|FG000|Overall Study|Trial terminated by sponsor|16|||
131225639|NCT00528879|472453618|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
130774600|NCT03117361|470802509|FG000|Overall Study|Physician Decision|2|||
131225640|NCT00528879|472453619|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
131225641|NCT00528879|472453620|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
131225642|NCT00528879|472453621|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
131225643|NCT00528879|472453618|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
131225644|NCT00528879|472453619|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
131225645|NCT00528879|472453620|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
131225646|NCT00528879|472453621|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
131225647|NCT00528879|472453618|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
131225648|NCT00528879|472453619|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
131225649|NCT00528879|472453620|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
131225650|NCT00528879|472453621|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
131225651|NCT00528879|472453618|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
131225652|NCT00528879|472453619|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
131225653|NCT00528879|472453620|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
131225654|NCT00528879|472453621|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
131225655|NCT00528879|472453618|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
131225656|NCT00528879|472453619|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
131225657|NCT00528879|472453620|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
131225658|NCT00528879|472453621|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
131225659|NCT00528879|472453618|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
131225660|NCT00528879|472453619|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
131225661|NCT00528879|472453620|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
131225662|NCT00528879|472453621|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
131225663|NCT00528879|472453618|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
131225664|NCT00528879|472453619|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
131225665|NCT00528879|472453620|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
131225666|NCT00528879|472453621|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
131225667|NCT00528879|472453618|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
131225668|NCT00528879|472453619|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
131225669|NCT00528879|472453620|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
131225670|NCT00528879|472453621|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
131225671|NCT00528879|472453618|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
131225672|NCT00528879|472453619|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
131225673|NCT00528879|472453620|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
131225674|NCT00528879|472453621|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
131225675|NCT00528879|472453618|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
131225676|NCT00528879|472453619|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
131225677|NCT00528879|472453620|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
131225678|NCT00528879|472453621|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
131225679|NCT00528879|472453618|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
131225680|NCT00528879|472453619|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
131225681|NCT00528879|472453620|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
131225682|NCT00528879|472453621|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
131225683|NCT00528879|472453618|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
131225684|NCT00528879|472453619|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
131225685|NCT00528879|472453620|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
131225686|NCT00528879|472453621|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
131225687|NCT00528879|472453618|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
131225688|NCT00528879|472453619|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
131225689|NCT00528879|472453620|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
131225690|NCT00528879|472453621|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
131225691|NCT00528879|472453618|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
131225692|NCT00528879|472453619|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
131225693|NCT00528879|472453620|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
131225694|NCT00528879|472453621|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
131225695|NCT00528879|472453618|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
131225696|NCT00528879|472453619|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
131225697|NCT00528879|472453620|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
131225698|NCT00528879|472453621|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
131225699|NCT00528879|472453618|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
131225700|NCT00528879|472453619|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
131225701|NCT00528879|472453620|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
131225702|NCT00528879|472453621|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
131225703|NCT04133519|472453622|FG000|Overall Study|Withdrawal by Subject|5|||
131225704|NCT04133519|472453623|FG001|Overall Study|Withdrawal by Subject|4|||
131225705|NCT04133519|472453622|FG000|Overall Study|Protocol Violation|0|||
131225706|NCT04133519|472453623|FG001|Overall Study|Protocol Violation|1|||
130956134|NCT02346240|471471181|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
130956135|NCT02346240|471471182|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
130956136|NCT02346240|471471159|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956137|NCT02346240|471471160|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956138|NCT02346240|471471161|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956139|NCT02346240|471471162|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956140|NCT02346240|471471163|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956141|NCT02346240|471471164|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956142|NCT02346240|471471165|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956143|NCT02346240|471471166|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956144|NCT02346240|471471167|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
130774601|NCT03117361|470802509|FG000|Overall Study|On study treatment at the end of study|1|||
131039625|NCT05496231|471780132|FG000|Overall Study|Migrated/moved from the study area|3|||
131039626|NCT05496231|471780133|FG001|Overall Study|Migrated/moved from the study area|5|||
131039627|NCT05496231|471780134|FG002|Overall Study|Migrated/moved from the study area|3|||
131039628|NCT05496231|471780135|FG003|Overall Study|Migrated/moved from the study area|3|||
131039629|NCT05496231|471780132|FG000|Overall Study|Lost to Follow-up|13|||
131039630|NCT05496231|471780133|FG001|Overall Study|Lost to Follow-up|6|||
131039631|NCT05496231|471780134|FG002|Overall Study|Lost to Follow-up|11|||
131039632|NCT05496231|471780135|FG003|Overall Study|Lost to Follow-up|6|||
131039633|NCT05496231|471780132|FG000|Overall Study|Other|9|||
131039634|NCT05496231|471780133|FG001|Overall Study|Other|7|||
131039635|NCT05496231|471780134|FG002|Overall Study|Other|7|||
131039636|NCT05496231|471780135|FG003|Overall Study|Other|8|||
131039637|NCT05029622|471780138|FG000|Overall Study|Lost to Follow-up|1|||
131039638|NCT03785964|471780145|FG000|Overall Study|Adverse Event|14|||
131039639|NCT03785964|471780146|FG001|Overall Study|Adverse Event|1|||
131039640|NCT03785964|471780145|FG000|Overall Study|Unqualified Clinical Progression|1|||
131039641|NCT03785964|471780146|FG001|Overall Study|Unqualified Clinical Progression|1|||
131039642|NCT03785964|471780145|FG000|Overall Study|Participant non-compliance|1|||
131039643|NCT03785964|471780146|FG001|Overall Study|Participant non-compliance|1|||
131039644|NCT03785964|471780145|FG000|Overall Study|Not treated|1|||
131039645|NCT03785964|471780146|FG001|Overall Study|Not treated|0|||
131039646|NCT03785964|471780145|FG000|Overall Study|Other reason|5|||
131039647|NCT03785964|471780146|FG001|Overall Study|Other reason|11|||
131039648|NCT03785964|471780145|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
131039649|NCT03785964|471780146|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
131039650|NCT03463044|471780154|FG000|Overall Study|Lost to Follow-up|0|||
131039651|NCT03463044|471780155|FG001|Overall Study|Lost to Follow-up|0|||
131039652|NCT03463044|471780156|FG002|Overall Study|Lost to Follow-up|0|||
131039653|NCT03463044|471780157|FG003|Overall Study|Lost to Follow-up|0|||
131039654|NCT03463044|471780158|FG004|Overall Study|Lost to Follow-up|0|||
131039655|NCT03463044|471780159|FG005|Overall Study|Lost to Follow-up|0|||
131039656|NCT03463044|471780160|FG006|Overall Study|Lost to Follow-up|0|||
131039657|NCT03463044|471780161|FG007|Overall Study|Lost to Follow-up|1|||
131039658|NCT03463044|471780162|FG008|Overall Study|Lost to Follow-up|0|||
131039659|NCT05192109|471780163|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
131039660|NCT05192109|471780164|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
131039661|NCT05192109|471780165|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131039662|NCT05192109|471780166|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131039663|NCT05192109|471780163|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
131039664|NCT05192109|471780164|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
131039665|NCT05192109|471780165|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131039666|NCT05192109|471780166|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
131039667|NCT04498390|471780167|FG000|Overall Study|Adverse Event|0|||
131039668|NCT04498390|471780168|FG001|Overall Study|Adverse Event|0|||
131039669|NCT04498390|471780169|FG002|Overall Study|Adverse Event|1|||
131039670|NCT04498390|471780170|FG003|Overall Study|Adverse Event|0|||
131039671|NCT04498390|471780171|FG004|Overall Study|Adverse Event|0|||
131039672|NCT04498390|471780167|FG000|Overall Study|Withdrawal by Subject|0|||
131039673|NCT04498390|471780168|FG001|Overall Study|Withdrawal by Subject|0|||
131039674|NCT04498390|471780169|FG002|Overall Study|Withdrawal by Subject|0|||
131039675|NCT04498390|471780170|FG003|Overall Study|Withdrawal by Subject|1|||
131039676|NCT04498390|471780171|FG004|Overall Study|Withdrawal by Subject|0|||
131039677|NCT03478956|471780172|FG000|Randomized Treatment Period|Adverse Event|1|||
131039678|NCT03478956|471780173|FG001|Randomized Treatment Period|Adverse Event|0|||
131039679|NCT03478956|471780174|FG002|Randomized Treatment Period|Adverse Event|0|||
131039680|NCT03478956|471780175|FG003|Randomized Treatment Period|Adverse Event|0|||
131039681|NCT03478956|471780172|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
131039682|NCT03478956|471780173|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
131039683|NCT03478956|471780174|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
131126023|NCT01199042|472091228|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
131126024|NCT01199042|472091228|FG000|At Home (3 Months)|Lost to Follow-up|1|||
131039684|NCT03478956|471780175|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
131039685|NCT03478956|471780172|FG000|Open Label Extension Period|Adverse Event|0|||
131039686|NCT03478956|471780173|FG001|Open Label Extension Period|Adverse Event|0|||
131039687|NCT03478956|471780174|FG002|Open Label Extension Period|Adverse Event|4|||
131039688|NCT03478956|471780175|FG003|Open Label Extension Period|Adverse Event|0|||
131039689|NCT03478956|471780172|FG000|Open Label Extension Period|Lack of Efficacy|0|||
131126025|NCT01999465|472091229|FG000|Overall Study|Lost to Follow-up|0|||
131126026|NCT01999465|472091230|FG001|Overall Study|Lost to Follow-up|2|||
131126027|NCT01999465|472091229|FG000|Overall Study|Protocol Violation|0|||
131126028|NCT01999465|472091230|FG001|Overall Study|Protocol Violation|1|||
131126029|NCT02554019|472091241|FG000|Overall Study|Withdrawal by Subject|1|||
131126030|NCT02554019|472091242|FG001|Overall Study|Withdrawal by Subject|0|||
131126031|NCT02554019|472091243|FG002|Overall Study|Withdrawal by Subject|2|||
131126032|NCT02554019|472091241|FG000|Overall Study|Adverse Event|1|||
131126033|NCT02554019|472091242|FG001|Overall Study|Adverse Event|0|||
131126034|NCT02554019|472091243|FG002|Overall Study|Adverse Event|0|||
131126035|NCT02463409|472091244|FG000|Overall Study|Withdrawal by Subject|1|||
131126036|NCT02463409|472091244|FG000|Overall Study|Screen failure|1|||
131126037|NCT00916357|472091245|FG000|Period 1|Withdrawal by Subject|1|||
131126038|NCT00916357|472091246|FG001|Period 1|Withdrawal by Subject|0|||
131126039|NCT00916357|472091247|FG002|Period 1|Withdrawal by Subject|0|||
131126040|NCT00916357|472091248|FG003|Period 1|Withdrawal by Subject|0|||
131126041|NCT00916357|472091249|FG004|Period 1|Withdrawal by Subject|0|||
131126042|NCT00916357|472091250|FG005|Period 1|Withdrawal by Subject|0|||
131126043|NCT00916357|472091245|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
131126044|NCT00916357|472091246|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
131126045|NCT00916357|472091247|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
131126046|NCT00916357|472091248|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
131126047|NCT00916357|472091249|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
131126048|NCT00916357|472091250|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
131126049|NCT01308008|472091251|FG000|4 Weeks|Illness, disinterest, time|9|||
131126050|NCT01308008|472091252|FG001|4 Weeks|Illness, disinterest, time|2|||
131126051|NCT01417195|472091253|FG000|Overall Study|Stimulation failure|1|||
131126052|NCT01417195|472091254|FG001|Overall Study|Stimulation failure|0|||
131126053|NCT01417195|472091253|FG000|Overall Study|No embryos for transfer|0|||
131126054|NCT01417195|472091254|FG001|Overall Study|No embryos for transfer|1|||
131126055|NCT01417195|472091253|FG000|Overall Study|No transfer due to risk of OHSS|1|||
131126056|NCT01417195|472091254|FG001|Overall Study|No transfer due to risk of OHSS|0|||
131126057|NCT01417195|472091253|FG000|Overall Study|No transfer due to elevated progesterone|1|||
131126058|NCT01417195|472091254|FG001|Overall Study|No transfer due to elevated progesterone|0|||
131126059|NCT03357731|472091255|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
131126060|NCT03357731|472091256|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
131126061|NCT03357731|472091257|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
131126062|NCT03357731|472091258|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
131126063|NCT03357731|472091259|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
131126064|NCT03357731|472091260|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
130774602|NCT03117361|470802509|FG000|Overall Study|Treatment-related adverse event|1|||
130774603|NCT00540644|470802514|FG000|Overall Study|Adverse Event|3|||
130774604|NCT00540644|470802515|FG001|Overall Study|Adverse Event|1|||
130774605|NCT00540644|470802514|FG000|Overall Study|Disease Progression|3|||
130774606|NCT00540644|470802515|FG001|Overall Study|Disease Progression|1|||
130774607|NCT00540644|470802514|FG000|Overall Study|Physician Decision|0|||
131039690|NCT03478956|471780173|FG001|Open Label Extension Period|Lack of Efficacy|0|||
131039691|NCT03478956|471780174|FG002|Open Label Extension Period|Lack of Efficacy|8|||
131039692|NCT03478956|471780175|FG003|Open Label Extension Period|Lack of Efficacy|0|||
131039693|NCT03478956|471780172|FG000|Open Label Extension Period|Reason Not Provided|0|||
131039694|NCT03478956|471780173|FG001|Open Label Extension Period|Reason Not Provided|0|||
131039695|NCT03478956|471780174|FG002|Open Label Extension Period|Reason Not Provided|1|||
131039696|NCT03478956|471780175|FG003|Open Label Extension Period|Reason Not Provided|0|||
131039697|NCT03478956|471780172|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
131039698|NCT03478956|471780173|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
131039699|NCT03478956|471780174|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
131039700|NCT03478956|471780175|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
131039701|NCT03478956|471780172|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
131039702|NCT03478956|471780173|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
131039703|NCT03478956|471780174|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
131126065|NCT03357731|472091255|FG000|Overall Study|Acute bradycardia and hypotension|0|||
131126066|NCT03357731|472091256|FG001|Overall Study|Acute bradycardia and hypotension|0|||
131039704|NCT03478956|471780175|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
131039705|NCT03478956|471780172|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
131126067|NCT03357731|472091257|FG002|Overall Study|Acute bradycardia and hypotension|0|||
131126068|NCT03357731|472091258|FG003|Overall Study|Acute bradycardia and hypotension|1|||
130774608|NCT00540644|470802515|FG001|Overall Study|Physician Decision|5|||
131039706|NCT03478956|471780173|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
131039707|NCT03478956|471780174|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
131039708|NCT03478956|471780175|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
131039709|NCT04865289|471780176|FG000|Overall Study|Participant ongoing in study|47|||
131039710|NCT04865289|471780177|FG001|Overall Study|Participant ongoing in study|35|||
131039711|NCT04865289|471780176|FG000|Overall Study|Death|27|||
131039712|NCT04865289|471780177|FG001|Overall Study|Death|21|||
131039713|NCT03221426|471780180|FG000|Overall Study|Ongoing in study|212|||
131039714|NCT03221426|471780181|FG001|Overall Study|Ongoing in study|193|||
131039715|NCT03221426|471780182|FG002|Overall Study|Ongoing in study|61|||
131039716|NCT03221426|471780183|FG003|Overall Study|Ongoing in study|55|||
131039717|NCT03221426|471780180|FG000|Overall Study|Withdrawal by Subject|12|||
131039718|NCT03221426|471780181|FG001|Overall Study|Withdrawal by Subject|4|||
131039719|NCT03221426|471780182|FG002|Overall Study|Withdrawal by Subject|2|||
131039720|NCT03221426|471780183|FG003|Overall Study|Withdrawal by Subject|3|||
131039721|NCT03221426|471780180|FG000|Overall Study|Lost to Follow-up|4|||
131039722|NCT03221426|471780181|FG001|Overall Study|Lost to Follow-up|1|||
131039723|NCT03221426|471780182|FG002|Overall Study|Lost to Follow-up|1|||
131039724|NCT03221426|471780183|FG003|Overall Study|Lost to Follow-up|0|||
131039725|NCT03221426|471780180|FG000|Overall Study|Death|174|||
131039726|NCT03221426|471780181|FG001|Overall Study|Death|204|||
131039727|NCT03221426|471780182|FG002|Overall Study|Death|36|||
131039728|NCT03221426|471780183|FG003|Overall Study|Death|45|||
131039729|NCT02561247|471781695|FG000|Overall Study|Protocol Violation|1|||
131039730|NCT02561247|471781695|FG000|Overall Study|Withdrawal by Subject|1|||
131039731|NCT02561247|471781695|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
131039732|NCT04858451|471781696|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
131039733|NCT04858451|471781697|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131039734|NCT04858451|471781698|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131039735|NCT04858451|471781699|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131039736|NCT04858451|471781700|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131039737|NCT04858451|471781701|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131039738|NCT04858451|471781702|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131039739|NCT04858451|471781703|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131039740|NCT04858451|471781704|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
131039741|NCT04858451|471781696|FG000|Part 2|Discontinued|0|||
131039742|NCT04858451|471781697|FG001|Part 2|Discontinued|0|||
131039743|NCT04858451|471781698|FG002|Part 2|Discontinued|0|||
131039744|NCT04858451|471781699|FG003|Part 2|Discontinued|0|||
131039745|NCT04858451|471781700|FG004|Part 2|Discontinued|0|||
131039746|NCT04858451|471781701|FG005|Part 2|Discontinued|0|||
131039747|NCT04858451|471781702|FG006|Part 2|Discontinued|0|||
131039748|NCT04858451|471781703|FG007|Part 2|Discontinued|0|||
131039749|NCT04858451|471781704|FG008|Part 2|Discontinued|63|||
131039750|NCT03663569|471781706|FG000|Overall Study|Discontinuation of study|11|||
131039751|NCT03663569|471781706|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
131039752|NCT03663569|471781706|FG000|Overall Study|Deceased patient|6|||
131039753|NCT03663569|471781706|FG000|Overall Study|Lost to Follow-up|18|||
131039754|NCT03663569|471781706|FG000|Overall Study|Withdrawal of consent|5|||
131039755|NCT03663569|471781706|FG000|Overall Study|Patient's request|11|||
131039756|NCT03663569|471781706|FG000|Overall Study|Adverse Event|4|||
131039757|NCT03663569|471781706|FG000|Overall Study|Not come to second visit|3|||
131039758|NCT03663569|471781706|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
131039759|NCT03663569|471781706|FG000|Overall Study|Serious adverse event|1|||
131039760|NCT04298983|471781708|FG000|Overall Study|Adverse Event|4|||
131039761|NCT04298983|471781708|FG000|Overall Study|Lack of Efficacy|3|||
131039762|NCT04248725|471781709|FG000|Post-Treatment|Lost to Follow-up|6|||
131039763|NCT04248725|471781710|FG001|Post-Treatment|Lost to Follow-up|5|||
131039764|NCT04248725|471781709|FG000|6-Month Follow Up|Lost to Follow-up|9|||
131039765|NCT04248725|471781710|FG001|6-Month Follow Up|Lost to Follow-up|8|||
131039766|NCT03766685|471781711|FG000|Overall Study|Lost to Follow-up|1|||
131039767|NCT03766685|471781712|FG001|Overall Study|Lost to Follow-up|1|||
131039768|NCT03766685|471781713|FG002|Overall Study|Lost to Follow-up|0|||
131039769|NCT03766685|471781714|FG003|Overall Study|Lost to Follow-up|0|||
131039770|NCT03766685|471781711|FG000|Overall Study|Adverse Event, not fatal|0|||
131039771|NCT03766685|471781712|FG001|Overall Study|Adverse Event, not fatal|1|||
131039772|NCT03766685|471781713|FG002|Overall Study|Adverse Event, not fatal|0|||
131039773|NCT03766685|471781714|FG003|Overall Study|Adverse Event, not fatal|1|||
130712276|NCT01843348|470571842|FG002|Overall Study|Withdrawal by Subject|18|||
130712277|NCT01843348|470571840|FG000|Overall Study|Lost to Follow-up|5|||
130712278|NCT01843348|470571841|FG001|Overall Study|Lost to Follow-up|4|||
131039774|NCT03766685|471781711|FG000|Overall Study|Withdrawal by Subject|0|||
131039775|NCT03766685|471781712|FG001|Overall Study|Withdrawal by Subject|2|||
131039776|NCT03766685|471781713|FG002|Overall Study|Withdrawal by Subject|0|||
131039777|NCT03766685|471781714|FG003|Overall Study|Withdrawal by Subject|0|||
131039778|NCT03766685|471781711|FG000|Overall Study|Protocol Violation|0|||
131039779|NCT03766685|471781712|FG001|Overall Study|Protocol Violation|1|||
130712279|NCT01843348|470571842|FG002|Overall Study|Lost to Follow-up|2|||
130712280|NCT01843348|470571840|FG000|Overall Study|Death|5|||
130956145|NCT02346240|471471168|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956146|NCT02346240|471471169|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956147|NCT02346240|471471170|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956148|NCT02346240|471471171|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956149|NCT02346240|471471172|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956150|NCT02346240|471471173|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956151|NCT02346240|471471174|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956152|NCT02346240|471471175|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956153|NCT02346240|471471176|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956154|NCT02346240|471471177|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
130956155|NCT02346240|471471178|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
130712281|NCT01843348|470571841|FG001|Overall Study|Death|3|||
130712282|NCT01843348|470571842|FG002|Overall Study|Death|4|||
130956156|NCT02346240|471471179|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956157|NCT02346240|471471180|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
130956158|NCT02346240|471471181|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
130956159|NCT02346240|471471182|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
130712283|NCT01843348|470571840|FG000|Overall Study|Graft loss/retransplantation|5|||
130712284|NCT01843348|470571841|FG001|Overall Study|Graft loss/retransplantation|8|||
130712285|NCT01843348|470571842|FG002|Overall Study|Graft loss/retransplantation|11|||
130712286|NCT01843348|470571840|FG000|Overall Study|Various reasons|4|||
130712287|NCT01843348|470571841|FG001|Overall Study|Various reasons|9|||
130712288|NCT01843348|470571842|FG002|Overall Study|Various reasons|6|||
130712289|NCT02039414|470571849|FG000|Overall Study|Delivered|1|||
130712290|NCT02039414|470571850|FG001|Overall Study|Delivered|1|||
130712291|NCT02039414|470571849|FG000|Overall Study|Lost to Follow-up|2|||
130712292|NCT02039414|470571850|FG001|Overall Study|Lost to Follow-up|0|||
130712293|NCT02039414|470571849|FG000|Overall Study|Protocol Violation|3|||
130712294|NCT02039414|470571850|FG001|Overall Study|Protocol Violation|1|||
130712295|NCT03977701|470571853|FG000|Overall Study|COVID-19 pandemic|0|||
130712296|NCT03977701|470571854|FG001|Overall Study|COVID-19 pandemic|0|||
130712297|NCT03977701|470571855|FG002|Overall Study|COVID-19 pandemic|0|||
130712298|NCT03977701|470571856|FG003|Overall Study|COVID-19 pandemic|0|||
130712299|NCT03977701|470571857|FG004|Overall Study|COVID-19 pandemic|0|||
130712300|NCT03977701|470571858|FG005|Overall Study|COVID-19 pandemic|1|||
130712301|NCT03977701|470571859|FG006|Overall Study|COVID-19 pandemic|0|||
130712302|NCT03977701|470571860|FG007|Overall Study|COVID-19 pandemic|1|||
130956160|NCT02346240|471471159|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956161|NCT02346240|471471160|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956162|NCT02346240|471471161|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956163|NCT02346240|471471162|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956164|NCT02346240|471471163|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956165|NCT02346240|471471164|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956166|NCT02346240|471471165|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956167|NCT02346240|471471166|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956168|NCT02346240|471471167|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956169|NCT02346240|471471168|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956170|NCT02346240|471471169|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956171|NCT02346240|471471170|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956172|NCT02346240|471471171|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956173|NCT02346240|471471172|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956174|NCT02346240|471471173|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956175|NCT02346240|471471174|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956176|NCT02346240|471471175|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956177|NCT02346240|471471176|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956178|NCT02346240|471471177|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130956179|NCT02346240|471471178|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956180|NCT02346240|471471179|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956181|NCT02346240|471471180|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130956182|NCT02346240|471471181|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956183|NCT02346240|471471182|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130956184|NCT02346240|471471159|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131039780|NCT03766685|471781713|FG002|Overall Study|Protocol Violation|0|||
131039781|NCT03766685|471781714|FG003|Overall Study|Protocol Violation|0|||
130712303|NCT03977701|470571861|FG008|Overall Study|COVID-19 pandemic|0|||
130712304|NCT03977701|470571862|FG009|Overall Study|COVID-19 pandemic|0|||
130712305|NCT00869024|470571863|FG000|Overall Study|Death|2|||
130712306|NCT00869024|470571864|FG001|Overall Study|Death|3|||
130712307|NCT00869024|470571863|FG000|Overall Study|Lost to Follow-up|0|||
130712308|NCT00869024|470571864|FG001|Overall Study|Lost to Follow-up|1|||
130712309|NCT00869024|470571863|FG000|Overall Study|Protocol Violation|0|||
130712310|NCT00869024|470571864|FG001|Overall Study|Protocol Violation|1|||
130712311|NCT00831623|470571869|FG000|Overall Study|Withdrawal by Subject|9|||
130712312|NCT00831623|470571869|FG000|Overall Study|Lost to Follow-up|1|||
130712313|NCT00831623|470571869|FG000|Overall Study|Not 2 years post-treatment|12|||
130712314|NCT00653991|470571872|FG000|3 Month Follow-up|Participant would not respond|150|||
130712315|NCT00653991|470571873|FG001|3 Month Follow-up|Participant would not respond|157|||
130712316|NCT00653991|470571872|FG000|6 Month Follow-up|Participant would not respond|133|||
131126069|NCT03357731|472091259|FG004|Overall Study|Acute bradycardia and hypotension|0|||
131126070|NCT03357731|472091260|FG005|Overall Study|Acute bradycardia and hypotension|0|||
131126071|NCT03357731|472091255|FG000|Overall Study|Adverse Event|0|||
131126072|NCT03357731|472091256|FG001|Overall Study|Adverse Event|0|||
131126073|NCT03357731|472091257|FG002|Overall Study|Adverse Event|0|||
131126074|NCT03357731|472091258|FG003|Overall Study|Adverse Event|0|||
131126075|NCT03357731|472091259|FG004|Overall Study|Adverse Event|0|||
131126076|NCT03357731|472091260|FG005|Overall Study|Adverse Event|1|||
131126077|NCT03357731|472091255|FG000|Overall Study|Hypotension|0|||
131126078|NCT03357731|472091256|FG001|Overall Study|Hypotension|0|||
131126079|NCT03357731|472091257|FG002|Overall Study|Hypotension|1|||
131126080|NCT03357731|472091258|FG003|Overall Study|Hypotension|1|||
131126081|NCT03357731|472091259|FG004|Overall Study|Hypotension|0|||
131126082|NCT03357731|472091260|FG005|Overall Study|Hypotension|0|||
131126083|NCT03357731|472091255|FG000|Overall Study|Lost to Follow-up|0|||
131126084|NCT03357731|472091256|FG001|Overall Study|Lost to Follow-up|0|||
131126085|NCT03357731|472091257|FG002|Overall Study|Lost to Follow-up|0|||
131126086|NCT03357731|472091258|FG003|Overall Study|Lost to Follow-up|1|||
131126087|NCT03357731|472091259|FG004|Overall Study|Lost to Follow-up|0|||
131126088|NCT03357731|472091260|FG005|Overall Study|Lost to Follow-up|0|||
131126089|NCT00772954|472091261|FG000|Overall Study|Adverse Event|0|||
131126090|NCT00772954|472091262|FG001|Overall Study|Adverse Event|0|||
131126091|NCT00772954|472091263|FG002|Overall Study|Adverse Event|1|||
131126092|NCT01773109|472091264|FG000|Overall Study|Symptomatic Progression|2|||
131126093|NCT01773109|472091264|FG000|Overall Study|Death|1|||
131126094|NCT01239342|472091265|FG000|Overall Study|Adverse Event|1|||
131126095|NCT01239342|472091266|FG001|Overall Study|Adverse Event|0|||
131126096|NCT01239342|472091265|FG000|Overall Study|Withdrawal by Subject|1|||
131126097|NCT01239342|472091266|FG001|Overall Study|Withdrawal by Subject|5|||
131126098|NCT01239342|472091265|FG000|Overall Study|Reason Unknown|1|||
131126099|NCT01239342|472091266|FG001|Overall Study|Reason Unknown|1|||
131126100|NCT02495844|472091267|FG000|Overall Study|Lack of Efficacy|1|||
131126101|NCT02495844|472091268|FG001|Overall Study|Lack of Efficacy|2|||
131126102|NCT02495844|472091267|FG000|Overall Study|AE, non-fatal|0|||
131126103|NCT02495844|472091268|FG001|Overall Study|AE, non-fatal|1|||
131126104|NCT02495844|472091267|FG000|Overall Study|Hepatitis Positivity|0|||
131126105|NCT02495844|472091268|FG001|Overall Study|Hepatitis Positivity|1|||
131126106|NCT02325219|472091271|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
131126107|NCT02325219|472091272|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
130712317|NCT00653991|470571873|FG001|6 Month Follow-up|Participant would not respond|141|||
130712318|NCT02939014|470571876|FG000|Overall Study|Lost to Follow-up|1|||
131126108|NCT02325219|472091273|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
131126109|NCT02325219|472091274|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
131126110|NCT02325219|472091275|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
131126111|NCT02325219|472091271|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
131126112|NCT02325219|472091272|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
131126113|NCT02325219|472091273|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131126114|NCT02325219|472091274|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131126115|NCT02325219|472091275|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
131126116|NCT02325219|472091271|FG000|Controlled Period (Week 0 - 16)|Other|0|||
131126117|NCT02325219|472091272|FG001|Controlled Period (Week 0 - 16)|Other|0|||
131126118|NCT02325219|472091273|FG002|Controlled Period (Week 0 - 16)|Other|1|||
131126119|NCT02325219|472091274|FG003|Controlled Period (Week 0 - 16)|Other|0|||
131126120|NCT02325219|472091275|FG004|Controlled Period (Week 0 - 16)|Other|0|||
131225707|NCT04133519|472453622|FG000|Overall Study|Never started treatment|1|||
131225708|NCT04133519|472453623|FG001|Overall Study|Never started treatment|1|||
131225709|NCT02217345|472453624|FG000|Overall Study|Lost to Follow-up|2|||
131225710|NCT02217345|472453625|FG001|Overall Study|Lost to Follow-up|1|||
130712319|NCT02939014|470571877|FG001|Overall Study|Lost to Follow-up|0|||
130712320|NCT02939014|470571876|FG000|Overall Study|Death|4|||
130712321|NCT02939014|470571877|FG001|Overall Study|Death|3|||
130712322|NCT03864042|470571878|FG000|DDI Phase|Adverse Event|2|||
131225711|NCT02217345|472453624|FG000|Overall Study|Withdrawal by Subject|3|||
130712323|NCT03864042|470571879|FG001|DDI Phase|Adverse Event|0|||
130712324|NCT03864042|470571880|FG002|DDI Phase|Adverse Event|0|||
131126121|NCT02325219|472091271|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
131126122|NCT02325219|472091272|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
131126123|NCT02325219|472091273|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
131126124|NCT02325219|472091274|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
131126125|NCT02325219|472091275|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
130712325|NCT03864042|470571878|FG000|DDI Phase|Physician Decision|1|||
130712326|NCT03864042|470571879|FG001|DDI Phase|Physician Decision|0|||
130712327|NCT03864042|470571880|FG002|DDI Phase|Physician Decision|0|||
130712328|NCT03864042|470571878|FG000|DDI Phase|Progressive Disease|1|||
130712329|NCT03864042|470571879|FG001|DDI Phase|Progressive Disease|0|||
130712330|NCT03864042|470571880|FG002|DDI Phase|Progressive Disease|0|||
130712331|NCT03864042|470571878|FG000|Post-DDI Phase|Adverse Event|5|||
130712332|NCT03864042|470571879|FG001|Post-DDI Phase|Adverse Event|3|||
130712333|NCT03864042|470571880|FG002|Post-DDI Phase|Adverse Event|2|||
130712334|NCT03864042|470571878|FG000|Post-DDI Phase|Progressive Disease|11|||
130712335|NCT03864042|470571879|FG001|Post-DDI Phase|Progressive Disease|6|||
130712336|NCT03864042|470571880|FG002|Post-DDI Phase|Progressive Disease|13|||
130712337|NCT03864042|470571878|FG000|Post-DDI Phase|Discretion of investigator|1|||
130712338|NCT03864042|470571879|FG001|Post-DDI Phase|Discretion of investigator|1|||
130712339|NCT03864042|470571880|FG002|Post-DDI Phase|Discretion of investigator|0|||
130712340|NCT03864042|470571878|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
130712341|NCT03864042|470571879|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
130712342|NCT03864042|470571880|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
130712343|NCT03864042|470571878|FG000|Post-DDI Phase|Withdrawal of consent|1|||
130712344|NCT03864042|470571879|FG001|Post-DDI Phase|Withdrawal of consent|2|||
130712345|NCT03864042|470571880|FG002|Post-DDI Phase|Withdrawal of consent|0|||
130712346|NCT02220725|470571881|FG000|Overall Study|Lost to Follow-up|0|||
130712347|NCT02220725|470571882|FG001|Overall Study|Lost to Follow-up|0|||
130712348|NCT02220725|470571883|FG002|Overall Study|Lost to Follow-up|0|||
130712349|NCT02220725|470571884|FG003|Overall Study|Lost to Follow-up|1|||
130712350|NCT02220725|470571881|FG000|Overall Study|Withdrawal by Subject|0|||
130712351|NCT02220725|470571882|FG001|Overall Study|Withdrawal by Subject|0|||
130712352|NCT02220725|470571883|FG002|Overall Study|Withdrawal by Subject|0|||
131225712|NCT02217345|472453625|FG001|Overall Study|Withdrawal by Subject|2|||
131225713|NCT02217345|472453624|FG000|Overall Study|Adverse Event|2|||
131225714|NCT02217345|472453625|FG001|Overall Study|Adverse Event|1|||
130774609|NCT00540644|470802514|FG000|Overall Study|Withdrawal by Subject|2|||
130712353|NCT02220725|470571884|FG003|Overall Study|Withdrawal by Subject|1|||
130712354|NCT02340221|470571887|FG000|Overall Study|Death|100|||
131225715|NCT02217345|472453624|FG000|Overall Study|Physician Decision|0|||
131225716|NCT02217345|472453625|FG001|Overall Study|Physician Decision|1|||
131225717|NCT02729194|472453626|FG000|Overall Study|Withdrawal by Subject|3|||
131225718|NCT01361607|472453627|FG000|Overall Study|Adverse Event|38|||
131225719|NCT01361607|472453628|FG001|Overall Study|Adverse Event|29|||
131225720|NCT01361607|472453627|FG000|Overall Study|Withdrawal by Subject|19|||
131225721|NCT01361607|472453628|FG001|Overall Study|Withdrawal by Subject|8|||
131225722|NCT01361607|472453627|FG000|Overall Study|Withdrawal by Investigator|5|||
131225723|NCT01361607|472453628|FG001|Overall Study|Withdrawal by Investigator|3|||
131225724|NCT01361607|472453627|FG000|Overall Study|Lost to Follow-up|1|||
131225725|NCT01361607|472453628|FG001|Overall Study|Lost to Follow-up|0|||
131225726|NCT01361607|472453627|FG000|Overall Study|Met Withdrawal Criteria|1|||
131225727|NCT01361607|472453628|FG001|Overall Study|Met Withdrawal Criteria|1|||
131225728|NCT01664494|472453631|FG000|Overall Study|Withdrawal by Subject|27|||
131225729|NCT01664494|472453631|FG000|Overall Study|Death|18|||
131225730|NCT01664494|472453631|FG000|Overall Study|Other|49|||
131225731|NCT01664494|472453631|FG000|Overall Study|Lost to Follow-up|99|||
131225732|NCT03196791|472453632|FG000|Overall Study|Protocol Violation|7|||
131225733|NCT03196791|472453633|FG001|Overall Study|Protocol Violation|3|||
131225734|NCT03196791|472453632|FG000|Overall Study|Withdrawal by Subject|3|||
131225735|NCT03196791|472453633|FG001|Overall Study|Withdrawal by Subject|2|||
131225736|NCT03412019|472453634|FG000|Overall Study|Withdrawal by Subject|1|||
131225737|NCT03412019|472453635|FG001|Overall Study|Withdrawal by Subject|1|||
131225738|NCT00373685|472453641|FG000|Overall Study|Death|2|||
131225739|NCT00373685|472453642|FG001|Overall Study|Death|1|||
131225740|NCT00373685|472453641|FG000|Overall Study|Adverse Event|278|||
130774610|NCT00540644|470802515|FG001|Overall Study|Withdrawal by Subject|2|||
130712355|NCT02340221|470571888|FG001|Overall Study|Death|197|||
131225741|NCT00373685|472453642|FG001|Overall Study|Adverse Event|253|||
130712356|NCT02340221|470571887|FG000|Overall Study|Withdrawal by Participant|24|||
130774611|NCT00540644|470802514|FG000|Overall Study|Noncomplilance|1|||
131225742|NCT00373685|472453641|FG000|Overall Study|Insufficient clinical response|169|||
131225743|NCT00373685|472453642|FG001|Overall Study|Insufficient clinical response|119|||
131225744|NCT00373685|472453641|FG000|Overall Study|Did not meet entrance criteria|167|||
131225745|NCT00373685|472453642|FG001|Overall Study|Did not meet entrance criteria|184|||
131225746|NCT00373685|472453641|FG000|Overall Study|Lost to follow up|83|||
130712357|NCT02340221|470571888|FG001|Overall Study|Withdrawal by Participant|37|||
130712358|NCT02340221|470571887|FG000|Overall Study|Lost to Follow-up|4|||
130712359|NCT02340221|470571888|FG001|Overall Study|Lost to Follow-up|15|||
130712360|NCT02340221|470571887|FG000|Overall Study|Reason Not Specified|85|||
130712361|NCT02340221|470571888|FG001|Overall Study|Reason Not Specified|165|||
130712362|NCT02340221|470571887|FG000|Overall Study|Study Terminated by Sponsor|1|||
131225747|NCT00373685|472453642|FG001|Overall Study|Lost to follow up|103|||
131225748|NCT00373685|472453641|FG000|Overall Study|No longer willing to participate|337|||
130712363|NCT02340221|470571888|FG001|Overall Study|Study Terminated by Sponsor|3|||
130712364|NCT00103402|470571889|FG000|Overall Study|Adverse Event|3|||
130712365|NCT00103402|470571890|FG001|Overall Study|Adverse Event|4|||
130712366|NCT00103402|470571889|FG000|Overall Study|Lost to Follow-up|8|||
130712367|NCT00103402|470571890|FG001|Overall Study|Lost to Follow-up|7|||
130712368|NCT00103402|470571889|FG000|Overall Study|Dissatisfied/No longer interested|6|||
130712369|NCT00103402|470571890|FG001|Overall Study|Dissatisfied/No longer interested|6|||
130712370|NCT00103402|470571889|FG000|Overall Study|Personal constraints/Other|5|||
130712371|NCT00103402|470571890|FG001|Overall Study|Personal constraints/Other|0|||
130712372|NCT01393730|470571891|FG000|Overall Study|Withdrawal by Subject|3|||
130712373|NCT01393730|470571891|FG000|Overall Study|Other|2|||
130712374|NCT01393730|470571891|FG000|Overall Study|Adverse Event|1|||
130712375|NCT02333487|470571892|FG000|Overall Study|Adverse Event|0|||
130712376|NCT02333487|470571893|FG001|Overall Study|Adverse Event|2|||
130712377|NCT02333487|470571894|FG002|Overall Study|Adverse Event|0|||
130712378|NCT01297322|470571895|FG000|Overall Study|Lost to Follow-up|1|||
130712379|NCT01297322|470571896|FG001|Overall Study|Lost to Follow-up|0|||
130712380|NCT01297322|470571895|FG000|Overall Study|Withdrawal by Subject|0|||
130712381|NCT01297322|470571896|FG001|Overall Study|Withdrawal by Subject|1|||
130712382|NCT01297322|470571895|FG000|Overall Study|Protocol Violation|0|||
130712383|NCT01297322|470571896|FG001|Overall Study|Protocol Violation|3|||
130712384|NCT01111019|470571897|FG000|Overall Study|Withdrew Prematurely|2|||
130712385|NCT01111019|470571897|FG000|Overall Study|Other|1|||
130712386|NCT01583218|470571901|FG000|Overall Study|Withdrawal by Subject|43|||
130712387|NCT01583218|470571902|FG001|Overall Study|Withdrawal by Subject|29|||
130712388|NCT01583218|470571901|FG000|Overall Study|Death|206|||
130712389|NCT01583218|470571902|FG001|Overall Study|Death|211|||
130712390|NCT01583218|470571901|FG000|Overall Study|Lost to Follow-up|11|||
130712391|NCT01583218|470571902|FG001|Overall Study|Lost to Follow-up|17|||
130712392|NCT01583218|470571901|FG000|Overall Study|Adverse event or serious adverse event|3|||
130712393|NCT01583218|470571902|FG001|Overall Study|Adverse event or serious adverse event|3|||
130774612|NCT00540644|470802515|FG001|Overall Study|Noncomplilance|0|||
131126126|NCT02325219|472091271|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
131126127|NCT02325219|472091272|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
131126128|NCT02325219|472091273|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
131126129|NCT02325219|472091274|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
131126130|NCT02325219|472091275|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
131126131|NCT02325219|472091271|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131126132|NCT02325219|472091272|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
131126133|NCT02325219|472091273|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131126134|NCT02325219|472091274|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131126135|NCT02325219|472091275|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131126136|NCT04640272|472091278|FG000|Overall Study|Subject moved out of area|1|||
131126137|NCT02819635|472091282|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
131126138|NCT02819635|472091283|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
131126139|NCT02819635|472091284|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
131126140|NCT02819635|472091285|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
131126141|NCT02819635|472091286|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
131126142|NCT02819635|472091287|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
131126143|NCT02819635|472091288|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
131126144|NCT02819635|472091289|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
131126145|NCT02819635|472091290|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
131126146|NCT02819635|472091291|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
131126147|NCT02819635|472091292|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
131126148|NCT02819635|472091293|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
131126149|NCT02819635|472091282|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131126150|NCT02819635|472091283|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131126151|NCT02819635|472091284|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131126152|NCT02819635|472091285|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131126153|NCT02819635|472091286|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
131126154|NCT02819635|472091287|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
131126155|NCT02819635|472091288|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
131126156|NCT02819635|472091289|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131126157|NCT02819635|472091290|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131126158|NCT02819635|472091291|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130712394|NCT01583218|470571901|FG000|Overall Study|Patient /Family decision|3|||
130712395|NCT01583218|470571902|FG001|Overall Study|Patient /Family decision|0|||
130712396|NCT01583218|470571901|FG000|Overall Study|Cannot contact patient directly|1|||
130712397|NCT01583218|470571902|FG001|Overall Study|Cannot contact patient directly|2|||
130712398|NCT01583218|470571901|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
130712399|NCT01583218|470571902|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
130712400|NCT01583218|470571901|FG000|Overall Study|Patient did not wish to attend visits|0|||
130712401|NCT01583218|470571902|FG001|Overall Study|Patient did not wish to attend visits|1|||
130712402|NCT01583218|470571901|FG000|Overall Study|Patient randomized but not dosed|17|||
130956185|NCT02346240|471471160|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956186|NCT02346240|471471161|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956187|NCT02346240|471471162|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956188|NCT02346240|471471163|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956189|NCT02346240|471471164|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956190|NCT02346240|471471165|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956191|NCT02346240|471471166|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956192|NCT02346240|471471167|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956193|NCT02346240|471471168|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956194|NCT02346240|471471169|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956195|NCT02346240|471471170|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956196|NCT02346240|471471171|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956197|NCT02346240|471471172|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956198|NCT02346240|471471173|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956199|NCT02346240|471471174|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
131126159|NCT02819635|472091292|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
131126160|NCT02819635|472091293|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130712403|NCT01583218|470571902|FG001|Overall Study|Patient randomized but not dosed|16|||
130712404|NCT01583218|470571901|FG000|Overall Study|Patient was assessed via phone in person|1|||
130712405|NCT01583218|470571902|FG001|Overall Study|Patient was assessed via phone in person|0|||
130712406|NCT01583218|470571901|FG000|Overall Study|Patient deemed ineligible after random|2|||
130712407|NCT01583218|470571902|FG001|Overall Study|Patient deemed ineligible after random|0|||
130712408|NCT01583218|470571901|FG000|Overall Study|Patient was early terminated from study|0|||
130712409|NCT01583218|470571902|FG001|Overall Study|Patient was early terminated from study|1|||
130712410|NCT01583218|470571901|FG000|Overall Study|Patient was randomized due to mistake|1|||
130712411|NCT01583218|470571902|FG001|Overall Study|Patient was randomized due to mistake|0|||
130712412|NCT01583218|470571901|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
130712413|NCT01583218|470571902|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
130712414|NCT01583218|470571901|FG000|Overall Study|Withdraw of consent on day of random|1|||
130712415|NCT01583218|470571902|FG001|Overall Study|Withdraw of consent on day of random|0|||
130712416|NCT03334721|470571905|FG000|Overall Study|Withdrawal by Subject|1|||
130712417|NCT03334721|470571906|FG001|Overall Study|Withdrawal by Subject|0|||
130712418|NCT03334721|470571905|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
130712419|NCT03334721|470571906|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
130712420|NCT02091141|470573371|FG000|Overall Study|Death|280|||
130712421|NCT02091141|470573372|FG001|Overall Study|Death|118|||
130712422|NCT02091141|470573373|FG002|Overall Study|Death|46|||
130712423|NCT02091141|470573374|FG003|Overall Study|Death|13|||
131126161|NCT02819635|472091282|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131126162|NCT02819635|472091283|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131126163|NCT02819635|472091284|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131126164|NCT02819635|472091285|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131126165|NCT02819635|472091286|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131126166|NCT02819635|472091287|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
131126167|NCT02819635|472091288|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
131126168|NCT02819635|472091289|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131126169|NCT02819635|472091290|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131126170|NCT02819635|472091291|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131126171|NCT02819635|472091292|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131126172|NCT02819635|472091293|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
131126173|NCT02819635|472091282|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131126174|NCT02819635|472091283|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131126175|NCT02819635|472091284|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131126176|NCT02819635|472091285|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131126177|NCT02819635|472091286|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131126178|NCT02819635|472091287|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131126179|NCT02819635|472091288|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
131126180|NCT02819635|472091289|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130712424|NCT02091141|470573375|FG004|Overall Study|Death|31|||
130712425|NCT02091141|470573376|FG005|Overall Study|Death|16|||
130712426|NCT02091141|470573377|FG006|Overall Study|Death|12|||
130956200|NCT02346240|471471175|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130712427|NCT02091141|470573371|FG000|Overall Study|Withdrawal by Subject|21|||
130712428|NCT02091141|470573372|FG001|Overall Study|Withdrawal by Subject|13|||
130712429|NCT02091141|470573373|FG002|Overall Study|Withdrawal by Subject|3|||
130712430|NCT02091141|470573374|FG003|Overall Study|Withdrawal by Subject|2|||
130712431|NCT02091141|470573375|FG004|Overall Study|Withdrawal by Subject|2|||
130712432|NCT02091141|470573376|FG005|Overall Study|Withdrawal by Subject|3|||
130712433|NCT02091141|470573377|FG006|Overall Study|Withdrawal by Subject|0|||
130712434|NCT02091141|470573371|FG000|Overall Study|Lost to Follow-up|21|||
130712435|NCT02091141|470573372|FG001|Overall Study|Lost to Follow-up|5|||
130712436|NCT02091141|470573373|FG002|Overall Study|Lost to Follow-up|1|||
130712437|NCT02091141|470573374|FG003|Overall Study|Lost to Follow-up|0|||
130712438|NCT02091141|470573375|FG004|Overall Study|Lost to Follow-up|1|||
130712439|NCT02091141|470573376|FG005|Overall Study|Lost to Follow-up|2|||
130712440|NCT02091141|470573377|FG006|Overall Study|Lost to Follow-up|0|||
130712441|NCT02091141|470573371|FG000|Overall Study|Reason Not Specified|6|||
130712442|NCT02091141|470573372|FG001|Overall Study|Reason Not Specified|5|||
130712443|NCT02091141|470573373|FG002|Overall Study|Reason Not Specified|2|||
130712444|NCT02091141|470573374|FG003|Overall Study|Reason Not Specified|0|||
130712445|NCT02091141|470573375|FG004|Overall Study|Reason Not Specified|0|||
130712446|NCT02091141|470573376|FG005|Overall Study|Reason Not Specified|0|||
130712447|NCT02091141|470573377|FG006|Overall Study|Reason Not Specified|1|||
130712448|NCT02091141|470573371|FG000|Overall Study|Study Ended by Sponsor|1|||
130712449|NCT02091141|470573372|FG001|Overall Study|Study Ended by Sponsor|9|||
130712450|NCT02091141|470573373|FG002|Overall Study|Study Ended by Sponsor|0|||
130712451|NCT02091141|470573374|FG003|Overall Study|Study Ended by Sponsor|0|||
130712452|NCT02091141|470573375|FG004|Overall Study|Study Ended by Sponsor|0|||
130712453|NCT02091141|470573376|FG005|Overall Study|Study Ended by Sponsor|0|||
130712454|NCT02091141|470573377|FG006|Overall Study|Study Ended by Sponsor|0|||
130712455|NCT02091141|470573371|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
130712456|NCT02091141|470573372|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
130712457|NCT02091141|470573373|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
130712458|NCT02091141|470573374|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
130712459|NCT02091141|470573375|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
130712460|NCT02091141|470573376|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
130956201|NCT02346240|471471176|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956202|NCT02346240|471471177|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956203|NCT02346240|471471178|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956204|NCT02346240|471471179|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956205|NCT02346240|471471180|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
130956206|NCT02346240|471471181|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956207|NCT02346240|471471182|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
130956208|NCT02346240|471471159|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956209|NCT02346240|471471160|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956210|NCT02346240|471471161|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956211|NCT02346240|471471162|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956212|NCT02346240|471471163|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956213|NCT02346240|471471164|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956214|NCT02346240|471471165|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956215|NCT02346240|471471166|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956216|NCT02346240|471471167|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956217|NCT02346240|471471168|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956218|NCT02346240|471471169|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956219|NCT02346240|471471170|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956220|NCT02346240|471471171|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956221|NCT02346240|471471172|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956222|NCT02346240|471471173|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956223|NCT02346240|471471174|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956224|NCT02346240|471471175|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956225|NCT02346240|471471176|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
130956226|NCT02346240|471471177|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
130956227|NCT02346240|471471178|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
130956228|NCT02346240|471471179|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130956229|NCT02346240|471471180|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
130956230|NCT02346240|471471181|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
130956231|NCT02346240|471471182|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
131039782|NCT03766685|471781711|FG000|Overall Study|Non-compliance|0|||
130712461|NCT02091141|470573377|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
130712462|NCT02246439|470573378|FG000|Overall Study|Adverse Event|3|||
130712463|NCT02246439|470573379|FG001|Overall Study|Adverse Event|0|||
130712464|NCT02246439|470573378|FG000|Overall Study|Lost to Follow-up|7|||
131039783|NCT03766685|471781712|FG001|Overall Study|Non-compliance|2|||
131039784|NCT03766685|471781713|FG002|Overall Study|Non-compliance|0|||
131039785|NCT03766685|471781714|FG003|Overall Study|Non-compliance|0|||
131039786|NCT02116530|471781715|FG000|Overall Study|Withdrawal by Subject|1|||
131039787|NCT02116530|471781716|FG001|Overall Study|Withdrawal by Subject|2|||
131039788|NCT02116530|471781715|FG000|Overall Study|Adverse Event|4|||
131039789|NCT02116530|471781716|FG001|Overall Study|Adverse Event|0|||
131039790|NCT02116530|471781715|FG000|Overall Study|Physician Decision|1|||
131039791|NCT02116530|471781716|FG001|Overall Study|Physician Decision|0|||
131039792|NCT02116530|471781715|FG000|Overall Study|Lost to Follow-up|1|||
131039793|NCT02116530|471781716|FG001|Overall Study|Lost to Follow-up|0|||
131039794|NCT02116530|471781715|FG000|Overall Study|Other Medical Problems|2|||
131039795|NCT02116530|471781716|FG001|Overall Study|Other Medical Problems|2|||
131039796|NCT02927236|471781719|FG000|Characterization Phase|Physician Decision|0|||
131039797|NCT02927236|471781720|FG001|Characterization Phase|Physician Decision|3|||
131039798|NCT02927236|471781721|FG002|Characterization Phase|Physician Decision|0|||
131039799|NCT02927236|471781722|FG003|Characterization Phase|Physician Decision|2|||
131039800|NCT02927236|471781719|FG000|Characterization Phase|Lost to Follow-up|0|||
131039801|NCT02927236|471781720|FG001|Characterization Phase|Lost to Follow-up|0|||
131039802|NCT02927236|471781721|FG002|Characterization Phase|Lost to Follow-up|0|||
131039803|NCT02927236|471781722|FG003|Characterization Phase|Lost to Follow-up|3|||
131039804|NCT02927236|471781719|FG000|Characterization Phase|Withdrawal by Subject|1|||
131039805|NCT02927236|471781720|FG001|Characterization Phase|Withdrawal by Subject|0|||
131039806|NCT02927236|471781721|FG002|Characterization Phase|Withdrawal by Subject|0|||
131039807|NCT02927236|471781722|FG003|Characterization Phase|Withdrawal by Subject|1|||
131039808|NCT02927236|471781719|FG000|Treatment Phase|Adverse Event|1|||
131039809|NCT02927236|471781720|FG001|Treatment Phase|Adverse Event|0|||
131039810|NCT02927236|471781721|FG002|Treatment Phase|Adverse Event|1|||
131039811|NCT02927236|471781722|FG003|Treatment Phase|Adverse Event|1|||
131039812|NCT02927236|471781719|FG000|Treatment Phase|Protocol Violation|3|||
131039813|NCT02927236|471781720|FG001|Treatment Phase|Protocol Violation|0|||
131039814|NCT02927236|471781721|FG002|Treatment Phase|Protocol Violation|0|||
131039815|NCT02927236|471781722|FG003|Treatment Phase|Protocol Violation|1|||
131039816|NCT02927236|471781719|FG000|Treatment Phase|Lost to Follow-up|1|||
131039817|NCT02927236|471781720|FG001|Treatment Phase|Lost to Follow-up|0|||
131039818|NCT02927236|471781721|FG002|Treatment Phase|Lost to Follow-up|0|||
131039819|NCT02927236|471781722|FG003|Treatment Phase|Lost to Follow-up|0|||
131039820|NCT02927236|471781719|FG000|Follow-up Phase|Lost to Follow-up|1|||
131039821|NCT02927236|471781720|FG001|Follow-up Phase|Lost to Follow-up|0|||
131039822|NCT02927236|471781721|FG002|Follow-up Phase|Lost to Follow-up|1|||
131039823|NCT02927236|471781722|FG003|Follow-up Phase|Lost to Follow-up|0|||
131039824|NCT03656510|471781726|FG000|Overall Study|Lost to Follow-up|1|||
131039825|NCT03656510|471781727|FG001|Overall Study|Lost to Follow-up|0|||
131039826|NCT03656510|471781728|FG002|Overall Study|Lost to Follow-up|0|||
131039827|NCT03656510|471781729|FG003|Overall Study|Lost to Follow-up|0|||
131039828|NCT03656510|471781730|FG004|Overall Study|Lost to Follow-up|0|||
131039829|NCT03656510|471781731|FG005|Overall Study|Lost to Follow-up|0|||
131039830|NCT03656510|471781726|FG000|Overall Study|Withdrawal by Subject|1|||
131039831|NCT03656510|471781727|FG001|Overall Study|Withdrawal by Subject|1|||
131039832|NCT03656510|471781728|FG002|Overall Study|Withdrawal by Subject|0|||
131039833|NCT03656510|471781729|FG003|Overall Study|Withdrawal by Subject|1|||
131039834|NCT03656510|471781730|FG004|Overall Study|Withdrawal by Subject|0|||
131039835|NCT03656510|471781731|FG005|Overall Study|Withdrawal by Subject|0|||
131039836|NCT03819153|471781738|FG000|Overall Study|Withdrawal by Subject|20|||
131039837|NCT03819153|471781739|FG001|Overall Study|Withdrawal by Subject|28|||
131039838|NCT03819153|471781738|FG000|Overall Study|Lost to Follow-up|23|||
131039839|NCT03819153|471781739|FG001|Overall Study|Lost to Follow-up|30|||
131039840|NCT03974178|471781740|FG000|Overall Study|Death|0|||
131039841|NCT03974178|471781741|FG001|Overall Study|Death|1|||
131039842|NCT05526430|471781742|FG000|Overall Study|Withdrawal by Subject|0|||
131039843|NCT05526430|471781743|FG001|Overall Study|Withdrawal by Subject|2|||
131039844|NCT05526430|471781744|FG002|Overall Study|Withdrawal by Subject|0|||
131039845|NCT05526430|471781745|FG003|Overall Study|Withdrawal by Subject|0|||
131039846|NCT04508309|471781746|FG000|Overall Study|Death|0|||
131039847|NCT04508309|471781747|FG001|Overall Study|Death|0|||
131039848|NCT04508309|471781748|FG002|Overall Study|Death|0|||
131039849|NCT04508309|471781749|FG003|Overall Study|Death|0|||
130712465|NCT02246439|470573379|FG001|Overall Study|Lost to Follow-up|5|||
130712466|NCT02246439|470573378|FG000|Overall Study|Protocol Violation|0|||
131039850|NCT04508309|471781750|FG004|Overall Study|Death|1|||
131039851|NCT04508309|471781746|FG000|Overall Study|Lost to Follow-up|0|||
131039852|NCT04508309|471781747|FG001|Overall Study|Lost to Follow-up|0|||
131039853|NCT04508309|471781748|FG002|Overall Study|Lost to Follow-up|1|||
131039854|NCT04508309|471781749|FG003|Overall Study|Lost to Follow-up|1|||
131039855|NCT04508309|471781750|FG004|Overall Study|Lost to Follow-up|0|||
131039856|NCT04508309|471781746|FG000|Overall Study|Withdrawal by Subject|0|||
131039857|NCT04508309|471781747|FG001|Overall Study|Withdrawal by Subject|0|||
131039858|NCT04508309|471781748|FG002|Overall Study|Withdrawal by Subject|0|||
130712467|NCT02246439|470573379|FG001|Overall Study|Protocol Violation|2|||
131126181|NCT02819635|472091290|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131126182|NCT02819635|472091291|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130712468|NCT02246439|470573378|FG000|Overall Study|Physician Decision|0|||
130712469|NCT02246439|470573379|FG001|Overall Study|Physician Decision|1|||
131126183|NCT02819635|472091292|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131126184|NCT02819635|472091293|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
131126185|NCT02819635|472091282|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
131126186|NCT02819635|472091283|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
131126187|NCT02819635|472091284|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
131126188|NCT02819635|472091285|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
130712470|NCT02246439|470573378|FG000|Overall Study|Unkonwn|1|||
130712471|NCT02246439|470573379|FG001|Overall Study|Unkonwn|3|||
130712472|NCT02246439|470573378|FG000|Overall Study|Withdrawal by Subject|1|||
130712473|NCT02246439|470573379|FG001|Overall Study|Withdrawal by Subject|0|||
130712474|NCT03439852|470573380|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
130712475|NCT03439852|470573381|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
130712476|NCT03439852|470573380|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
130712477|NCT03439852|470573381|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
130712478|NCT03439852|470573380|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
130712479|NCT03439852|470573381|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
130712480|NCT03247517|470573388|FG000|Overall Study|Adverse Event|0|||
130712481|NCT03247517|470573389|FG001|Overall Study|Adverse Event|4|||
130712482|NCT03247517|470573390|FG002|Overall Study|Adverse Event|2|||
130712483|NCT03247517|470573388|FG000|Overall Study|Lost to Follow-up|2|||
130712484|NCT03247517|470573389|FG001|Overall Study|Lost to Follow-up|6|||
130712485|NCT03247517|470573390|FG002|Overall Study|Lost to Follow-up|4|||
130712486|NCT03247517|470573388|FG000|Overall Study|Consent withdrawn by caregiver|1|||
130712487|NCT03247517|470573389|FG001|Overall Study|Consent withdrawn by caregiver|4|||
130712488|NCT03247517|470573390|FG002|Overall Study|Consent withdrawn by caregiver|7|||
130712489|NCT03247517|470573388|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
130712490|NCT03247517|470573389|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
130712491|NCT03247517|470573390|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
130712492|NCT03247517|470573388|FG000|Overall Study|Protocol Violation|0|||
130712493|NCT03247517|470573389|FG001|Overall Study|Protocol Violation|2|||
130712494|NCT03247517|470573390|FG002|Overall Study|Protocol Violation|0|||
130712495|NCT03247517|470573388|FG000|Overall Study|Multiple reasons|3|||
130712496|NCT03247517|470573389|FG001|Overall Study|Multiple reasons|1|||
130712497|NCT03247517|470573390|FG002|Overall Study|Multiple reasons|0|||
130712498|NCT01996332|470573391|FG000|Overall Study|Adverse Event|117|||
130712499|NCT01996332|470573391|FG000|Overall Study|Lack of Efficacy|1245|||
130712500|NCT01996332|470573391|FG000|Overall Study|Death|264|||
130712501|NCT01996332|470573391|FG000|Overall Study|Protocol Violation|9|||
130712502|NCT01996332|470573391|FG000|Overall Study|Withdrawal by Subject|71|||
130712503|NCT01996332|470573391|FG000|Overall Study|Other|20|||
130712504|NCT01996332|470573391|FG000|Overall Study|Clinical Deterioration|28|||
130712505|NCT01996332|470573391|FG000|Overall Study|Physician Decision|17|||
130712506|NCT01996332|470573391|FG000|Overall Study|Lost to Follow-up|34|||
130712507|NCT02113189|470573392|FG000|Overall Study|Lost to follow up|2|||
130712508|NCT02113189|470573393|FG001|Overall Study|Lost to follow up|1|||
130712509|NCT02113189|470573394|FG002|Overall Study|Lost to follow up|3|||
130956232|NCT02346240|471471159|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956233|NCT02346240|471471160|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956234|NCT02346240|471471161|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956235|NCT02346240|471471162|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956236|NCT02346240|471471163|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956237|NCT02346240|471471164|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956238|NCT02346240|471471165|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956239|NCT02346240|471471166|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130712510|NCT00931268|470573395|FG000|Overall Study|Lost to Follow-up|6|||
130712511|NCT01388166|470573396|FG000|Overall Study|Adverse Event|16|||
130712512|NCT01388166|470573396|FG000|Overall Study|Lost to Follow-up|30|||
130712513|NCT01388166|470573396|FG000|Overall Study|Others than specified above|13|||
130712514|NCT00430495|470573397|FG000|Overall Study|Adverse Event|2|||
130774613|NCT03280056|470802516|FG000|Overall Study|Withdrawal by Subject|12|||
130774614|NCT03280056|470802517|FG001|Overall Study|Withdrawal by Subject|14|||
130774615|NCT03280056|470802516|FG000|Overall Study|Death|9|||
131126189|NCT02819635|472091286|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
130712515|NCT00430495|470573398|FG001|Overall Study|Adverse Event|3|||
130712516|NCT00430495|470573399|FG002|Overall Study|Adverse Event|2|||
130712517|NCT00430495|470573400|FG003|Overall Study|Adverse Event|0|||
130712518|NCT00430495|470573397|FG000|Overall Study|Death|0|||
130712519|NCT00430495|470573398|FG001|Overall Study|Death|0|||
130712520|NCT00430495|470573399|FG002|Overall Study|Death|1|||
130712521|NCT00430495|470573400|FG003|Overall Study|Death|0|||
130712522|NCT00430495|470573397|FG000|Overall Study|Lost to Follow-up|0|||
130712523|NCT00430495|470573398|FG001|Overall Study|Lost to Follow-up|1|||
130712524|NCT00430495|470573399|FG002|Overall Study|Lost to Follow-up|4|||
130712525|NCT00430495|470573400|FG003|Overall Study|Lost to Follow-up|0|||
130712526|NCT00430495|470573397|FG000|Overall Study|Protocol Violation|1|||
130712527|NCT00430495|470573398|FG001|Overall Study|Protocol Violation|0|||
130712528|NCT00430495|470573399|FG002|Overall Study|Protocol Violation|1|||
131039859|NCT04508309|471781749|FG003|Overall Study|Withdrawal by Subject|0|||
130712529|NCT00430495|470573400|FG003|Overall Study|Protocol Violation|0|||
130712530|NCT00430495|470573397|FG000|Overall Study|Disease Progression|1|||
130712531|NCT00430495|470573398|FG001|Overall Study|Disease Progression|1|||
130712532|NCT00430495|470573399|FG002|Overall Study|Disease Progression|0|||
130712533|NCT00430495|470573400|FG003|Overall Study|Disease Progression|0|||
130712534|NCT00430495|470573397|FG000|Overall Study|Other|8|||
130712535|NCT00430495|470573398|FG001|Overall Study|Other|2|||
130712536|NCT00430495|470573399|FG002|Overall Study|Other|5|||
130712537|NCT00430495|470573400|FG003|Overall Study|Other|4|||
130712538|NCT00430495|470573397|FG000|Overall Study|Randomized but not Treated|2|||
130712539|NCT00430495|470573398|FG001|Overall Study|Randomized but not Treated|0|||
130712540|NCT00430495|470573399|FG002|Overall Study|Randomized but not Treated|0|||
130712541|NCT00430495|470573400|FG003|Overall Study|Randomized but not Treated|0|||
130712542|NCT00158756|470573405|FG000|Overall Study|Withdrawal by Subject|5|||
130712543|NCT00158756|470573406|FG001|Overall Study|Withdrawal by Subject|0|||
130712544|NCT00158756|470573407|FG002|Overall Study|Withdrawal by Subject|6|||
130712545|NCT00158756|470573408|FG003|Overall Study|Withdrawal by Subject|1|||
130712546|NCT00158756|470573409|FG004|Overall Study|Withdrawal by Subject|3|||
130712547|NCT00158756|470573405|FG000|Overall Study|Adverse Event|0|||
130712548|NCT00158756|470573406|FG001|Overall Study|Adverse Event|0|||
130712549|NCT00158756|470573407|FG002|Overall Study|Adverse Event|1|||
130712550|NCT00158756|470573408|FG003|Overall Study|Adverse Event|0|||
130712551|NCT00158756|470573409|FG004|Overall Study|Adverse Event|0|||
130712552|NCT00158756|470573405|FG000|Overall Study|Serious adverse event|0|||
130712553|NCT00158756|470573406|FG001|Overall Study|Serious adverse event|0|||
130712554|NCT00158756|470573407|FG002|Overall Study|Serious adverse event|1|||
130712555|NCT00158756|470573408|FG003|Overall Study|Serious adverse event|0|||
130712556|NCT00158756|470573409|FG004|Overall Study|Serious adverse event|0|||
130712557|NCT03656874|470573411|FG000|Overall Study|Lost to Follow-up|3|||
130712558|NCT03656874|470573412|FG001|Overall Study|Lost to Follow-up|17|||
130712559|NCT00857792|470573413|FG000|Overall Study|inadequate image quality for analysis|12|||
130712560|NCT03251963|470573424|FG000|Overall Study|inappropriate Xa level timing|6|||
130712561|NCT03251963|470573425|FG001|Overall Study|inappropriate Xa level timing|3|||
130712562|NCT03251963|470573424|FG000|Overall Study|no peak Xa level drawn|2|||
130712563|NCT03251963|470573425|FG001|Overall Study|no peak Xa level drawn|0|||
130712564|NCT03251963|470573424|FG000|Overall Study|bled prior to Xa level|1|||
130712565|NCT03251963|470573425|FG001|Overall Study|bled prior to Xa level|2|||
130712566|NCT04505293|470573426|FG000|Overall Study|Lost to Follow-up|2|||
130712567|NCT04505293|470573426|FG000|Overall Study|Withdrawal by Subject|6|||
130712568|NCT04505293|470573426|FG000|Overall Study|CT scan unreadable|277|||
130712569|NCT04295135|470573427|FG000|Overall Study|Withdrawal by Subject|2|||
130712570|NCT04295135|470573428|FG001|Overall Study|Withdrawal by Subject|1|||
130712571|NCT04295135|470573427|FG000|Overall Study|Subject left organization|8|||
130712572|NCT04295135|470573428|FG001|Overall Study|Subject left organization|4|||
130712573|NCT03484117|470573430|FG000|Overall Study|Lost to Follow-up|1|||
130712574|NCT03484117|470573431|FG001|Overall Study|Lost to Follow-up|3|||
130712575|NCT03484117|470573430|FG000|Overall Study|Declined participation in exit assess|1|||
130712576|NCT03484117|470573431|FG001|Overall Study|Declined participation in exit assess|1|||
130712577|NCT00289874|470573432|FG000|Overall Study|Adverse Event|1|||
130712578|NCT00289874|470573433|FG001|Overall Study|Adverse Event|5|||
130712579|NCT00289874|470573432|FG000|Overall Study|Lost to Follow-up|1|||
130712580|NCT00289874|470573433|FG001|Overall Study|Lost to Follow-up|1|||
130712581|NCT00289874|470573432|FG000|Overall Study|Protocol Violation|3|||
130712582|NCT00289874|470573433|FG001|Overall Study|Protocol Violation|2|||
130712583|NCT00289874|470573432|FG000|Overall Study|Did not meet eligibility|1|||
131039860|NCT04508309|471781750|FG004|Overall Study|Withdrawal by Subject|1|||
131039861|NCT03085810|471781754|FG000|Main Study|Withdrawal by Subject|77|||
131039862|NCT03085810|471781755|FG001|Main Study|Withdrawal by Subject|0|||
131039863|NCT03085810|471781756|FG002|Main Study|Withdrawal by Subject|0|||
131039864|NCT03085810|471781754|FG000|Main Study|Terminated By Sponsor|14|||
131039865|NCT03085810|471781755|FG001|Main Study|Terminated By Sponsor|0|||
131039866|NCT03085810|471781756|FG002|Main Study|Terminated By Sponsor|0|||
131039867|NCT03085810|471781754|FG000|Main Study|Protocol Violation|15|||
130712584|NCT00289874|470573433|FG001|Overall Study|Did not meet eligibility|0|||
130712585|NCT03835325|470573434|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
130712586|NCT03835325|470573434|FG000|Overall Study|Selection failure|1|||
130712587|NCT00775606|470573435|FG000|Overall Study|Study sponsor terminated funding|3|||
130712588|NCT00775606|470573436|FG001|Overall Study|Study sponsor terminated funding|0|||
130720901|NCT01341782|470601558|FG001|Overall Study|Missed 3 consecutive doses|4|||
130712589|NCT03212794|470573437|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
130712590|NCT03212794|470573438|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
130712591|NCT03212794|470573437|FG000|Overall Study|Lost to Follow-up|5|||
130712592|NCT03212794|470573438|FG001|Overall Study|Lost to Follow-up|6|||
130712593|NCT03212794|470573437|FG000|Overall Study|Incarcerated; unable to participate|2|||
130712594|NCT03212794|470573438|FG001|Overall Study|Incarcerated; unable to participate|0|||
130712595|NCT03212794|470573437|FG000|Overall Study|Withdrawal by Subject|1|||
130712596|NCT03212794|470573438|FG001|Overall Study|Withdrawal by Subject|0|||
130712597|NCT03212794|470573437|FG000|Overall Study|Death|0|||
130712598|NCT03212794|470573438|FG001|Overall Study|Death|1|||
130712599|NCT03212794|470573437|FG000|Overall Study|Found to be ineligible after allocation|0|||
130712600|NCT03212794|470573438|FG001|Overall Study|Found to be ineligible after allocation|1|||
130712601|NCT03212794|470573437|FG000|Overall Study|Relocated out of area|2|||
130712602|NCT03212794|470573438|FG001|Overall Study|Relocated out of area|0|||
130712603|NCT00597116|470573440|FG000|Overall Study|Adverse Event|2|||
130712604|NCT00597116|470573441|FG001|Overall Study|Adverse Event|1|||
130712605|NCT00597116|470573440|FG000|Overall Study|Withdrawal by Subject|0|||
130712606|NCT00597116|470573441|FG001|Overall Study|Withdrawal by Subject|2|||
130712607|NCT00597116|470573440|FG000|Overall Study|Physician Decision|0|||
130712608|NCT00597116|470573441|FG001|Overall Study|Physician Decision|1|||
130712609|NCT00597116|470573440|FG000|Overall Study|Death|0|||
130712610|NCT00597116|470573441|FG001|Overall Study|Death|1|||
130712611|NCT00597116|470573440|FG000|Overall Study|Lost to Follow-up|1|||
130712612|NCT00597116|470573441|FG001|Overall Study|Lost to Follow-up|0|||
130712613|NCT00597116|470573440|FG000|Overall Study|Progressive disease|11|||
130712614|NCT00597116|470573441|FG001|Overall Study|Progressive disease|6|||
130712615|NCT03978091|470573442|FG000|Overall Study|Lost to Follow-up|0|||
130712616|NCT03978091|470573443|FG001|Overall Study|Lost to Follow-up|0|||
130712617|NCT03978091|470573444|FG002|Overall Study|Lost to Follow-up|1|||
130712618|NCT03978091|470573445|FG003|Overall Study|Lost to Follow-up|0|||
130712619|NCT03978091|470573446|FG004|Overall Study|Lost to Follow-up|0|||
130712620|NCT03978091|470573447|FG005|Overall Study|Lost to Follow-up|0|||
130712621|NCT03978091|470573442|FG000|Overall Study|Withdrawal by Subject|0|||
130712622|NCT03978091|470573443|FG001|Overall Study|Withdrawal by Subject|0|||
130712623|NCT03978091|470573444|FG002|Overall Study|Withdrawal by Subject|0|||
130712624|NCT03978091|470573445|FG003|Overall Study|Withdrawal by Subject|1|||
130712625|NCT03978091|470573446|FG004|Overall Study|Withdrawal by Subject|1|||
130712626|NCT03978091|470573447|FG005|Overall Study|Withdrawal by Subject|0|||
130712627|NCT00257920|470573452|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
130712628|NCT00257920|470573453|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
130712629|NCT00257920|470573452|FG000|Period: Second Intervention|Other|2|||
130712630|NCT00257920|470573453|FG001|Period: Second Intervention|Other|1|||
130712631|NCT00770692|470573456|FG000|Overall Study|Withdrawal by Subject|7|||
130712632|NCT00770692|470573457|FG001|Overall Study|Withdrawal by Subject|9|||
130712633|NCT00770692|470573458|FG002|Overall Study|Withdrawal by Subject|9|||
130712634|NCT00770692|470573459|FG003|Overall Study|Withdrawal by Subject|6|||
130712635|NCT00770692|470573456|FG000|Overall Study|Adverse Event|3|||
130956240|NCT02346240|471471167|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956241|NCT02346240|471471168|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956242|NCT02346240|471471169|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956243|NCT02346240|471471170|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956244|NCT02346240|471471171|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130712636|NCT00770692|470573457|FG001|Overall Study|Adverse Event|0|||
130712637|NCT00770692|470573458|FG002|Overall Study|Adverse Event|4|||
130712638|NCT00770692|470573459|FG003|Overall Study|Adverse Event|4|||
130712639|NCT00770692|470573456|FG000|Overall Study|Investigator judgment|2|||
130712640|NCT00770692|470573457|FG001|Overall Study|Investigator judgment|0|||
130712641|NCT00770692|470573458|FG002|Overall Study|Investigator judgment|1|||
130712642|NCT00770692|470573459|FG003|Overall Study|Investigator judgment|1|||
130712643|NCT00560937|470573461|FG000|Overall Study|Withdrawal by Subject|0|||
130712644|NCT00560937|470573462|FG001|Overall Study|Withdrawal by Subject|1|||
130712645|NCT00560937|470573461|FG000|Overall Study|Physician Decision|1|||
130712646|NCT00560937|470573462|FG001|Overall Study|Physician Decision|1|||
130712647|NCT02025751|470573467|FG000|Overall Study|Lost to Follow-up|1|||
130712648|NCT02025751|470573468|FG001|Overall Study|Lost to Follow-up|0|||
130712649|NCT02025751|470573467|FG000|Overall Study|Adverse Event|0|||
130712650|NCT02025751|470573468|FG001|Overall Study|Adverse Event|1|||
130712651|NCT02025751|470573467|FG000|Overall Study|Physician Decision|0|||
130712652|NCT02025751|470573468|FG001|Overall Study|Physician Decision|1|||
130956245|NCT02346240|471471172|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130712653|NCT02025751|470573467|FG000|Overall Study|Withdrawal by Subject|0|||
130712654|NCT02025751|470573468|FG001|Overall Study|Withdrawal by Subject|1|||
130712655|NCT01846273|470573469|FG000|Overall Study|Adverse Event|9|||
130712656|NCT01846273|470573470|FG001|Overall Study|Adverse Event|7|||
130712657|NCT01846273|470573471|FG002|Overall Study|Adverse Event|0|||
130712658|NCT01846273|470573469|FG000|Overall Study|Subject withdrew consent|5|||
130712659|NCT01846273|470573470|FG001|Overall Study|Subject withdrew consent|8|||
130712660|NCT01846273|470573471|FG002|Overall Study|Subject withdrew consent|0|||
130712661|NCT01846273|470573469|FG000|Overall Study|Lost to Follow-up|2|||
130712662|NCT01846273|470573470|FG001|Overall Study|Lost to Follow-up|1|||
130712663|NCT01846273|470573471|FG002|Overall Study|Lost to Follow-up|0|||
130712664|NCT01846273|470573469|FG000|Overall Study|Administrative problems|1|||
130712665|NCT01846273|470573470|FG001|Overall Study|Administrative problems|0|||
130712666|NCT01846273|470573471|FG002|Overall Study|Administrative problems|0|||
130712667|NCT01846273|470573469|FG000|Overall Study|Death|2|||
130712668|NCT01846273|470573470|FG001|Overall Study|Death|1|||
130956246|NCT02346240|471471173|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956247|NCT02346240|471471174|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956248|NCT02346240|471471175|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956249|NCT02346240|471471176|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956250|NCT02346240|471471177|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
130956251|NCT02346240|471471178|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
130956252|NCT02346240|471471179|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130956253|NCT02346240|471471180|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
130956254|NCT02346240|471471181|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
130956255|NCT02346240|471471182|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
130956256|NCT02346240|471471159|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956257|NCT02346240|471471160|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956258|NCT02346240|471471161|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956259|NCT02346240|471471162|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956260|NCT02346240|471471163|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956261|NCT02346240|471471164|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956262|NCT02346240|471471165|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956263|NCT02346240|471471166|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131039868|NCT03085810|471781755|FG001|Main Study|Protocol Violation|0|||
131039869|NCT03085810|471781756|FG002|Main Study|Protocol Violation|0|||
131039870|NCT03085810|471781754|FG000|Main Study|Physician Decision|13|||
131039871|NCT03085810|471781755|FG001|Main Study|Physician Decision|0|||
131039872|NCT03085810|471781756|FG002|Main Study|Physician Decision|0|||
131039873|NCT03085810|471781754|FG000|Main Study|Lost to Follow-up|17|||
131039874|NCT03085810|471781755|FG001|Main Study|Lost to Follow-up|0|||
131039875|NCT03085810|471781756|FG002|Main Study|Lost to Follow-up|0|||
131039876|NCT03085810|471781754|FG000|Main Study|Adverse Event|25|||
131039877|NCT03085810|471781755|FG001|Main Study|Adverse Event|0|||
131039878|NCT03085810|471781756|FG002|Main Study|Adverse Event|0|||
131039879|NCT03085810|471781754|FG000|Main Study|Pregnancy|7|||
131039880|NCT03085810|471781755|FG001|Main Study|Pregnancy|0|||
131039881|NCT03085810|471781756|FG002|Main Study|Pregnancy|0|||
131039882|NCT03085810|471781754|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
131039883|NCT03085810|471781755|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
131039884|NCT03085810|471781756|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
131039885|NCT03085810|471781754|FG000|Main Study|Lack of Efficacy|10|||
131039886|NCT03085810|471781755|FG001|Main Study|Lack of Efficacy|0|||
131039887|NCT03085810|471781756|FG002|Main Study|Lack of Efficacy|0|||
131039888|NCT03085810|471781754|FG000|Main Study|Death|12|||
131039889|NCT03085810|471781755|FG001|Main Study|Death|0|||
131039890|NCT03085810|471781756|FG002|Main Study|Death|0|||
131039891|NCT03085810|471781754|FG000|Main Study|Disease progression|1|||
131039892|NCT03085810|471781755|FG001|Main Study|Disease progression|0|||
131039893|NCT03085810|471781756|FG002|Main Study|Disease progression|0|||
131039894|NCT03085810|471781754|FG000|Main Study|Site Closure|3|||
131039895|NCT03085810|471781755|FG001|Main Study|Site Closure|0|||
131039896|NCT03085810|471781756|FG002|Main Study|Site Closure|0|||
131039897|NCT03085810|471781754|FG000|Main Study|Planned pregnancy|17|||
131039898|NCT03085810|471781755|FG001|Main Study|Planned pregnancy|0|||
131039899|NCT03085810|471781756|FG002|Main Study|Planned pregnancy|0|||
131039900|NCT03085810|471781754|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
131039901|NCT03085810|471781755|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
131039902|NCT03085810|471781756|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
131039903|NCT03085810|471781754|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
131039904|NCT03085810|471781755|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
131039905|NCT03085810|471781756|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
130956264|NCT02346240|471471167|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131039906|NCT03085810|471781754|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
131039907|NCT03085810|471781755|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
130712669|NCT01846273|470573471|FG002|Overall Study|Death|0|||
130712670|NCT01846273|470573469|FG000|Overall Study|Disease Progression|0|||
130712671|NCT01846273|470573470|FG001|Overall Study|Disease Progression|4|||
130712672|NCT01846273|470573471|FG002|Overall Study|Disease Progression|0|||
130712673|NCT01846273|470573469|FG000|Overall Study|Protocol Deviation|2|||
130712674|NCT01846273|470573470|FG001|Overall Study|Protocol Deviation|3|||
130712675|NCT01846273|470573471|FG002|Overall Study|Protocol Deviation|0|||
130712676|NCT01846273|470573469|FG000|Overall Study|Physician Decision|1|||
130712677|NCT01846273|470573470|FG001|Overall Study|Physician Decision|2|||
130712678|NCT01846273|470573471|FG002|Overall Study|Physician Decision|0|||
130712679|NCT00891839|470573472|FG000|Overall Study|Adverse Event|2|||
130956265|NCT02346240|471471168|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956266|NCT02346240|471471169|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956267|NCT02346240|471471170|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956268|NCT02346240|471471171|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956269|NCT02346240|471471172|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956270|NCT02346240|471471173|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956271|NCT02346240|471471174|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956272|NCT02346240|471471175|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956273|NCT02346240|471471176|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
131225749|NCT00373685|472453642|FG001|Overall Study|No longer willing to participate|352|||
131225750|NCT00373685|472453641|FG000|Overall Study|Other|149|||
131225751|NCT00373685|472453642|FG001|Overall Study|Other|146|||
131225752|NCT00373685|472453641|FG000|Overall Study|Protocol Violation|191|||
131225753|NCT00373685|472453642|FG001|Overall Study|Protocol Violation|182|||
131225754|NCT00373685|472453641|FG000|Overall Study|Final Status Unknown|12|||
131225755|NCT00373685|472453642|FG001|Overall Study|Final Status Unknown|4|||
131225756|NCT00373685|472453641|FG000|Overall Study|Randomized, not treated|51|||
131225757|NCT00373685|472453642|FG001|Overall Study|Randomized, not treated|77|||
131225758|NCT02570165|472453643|FG000|Overall Study|Adverse Event|1|||
131225759|NCT02570165|472453644|FG001|Overall Study|Adverse Event|0|||
131225760|NCT02570165|472453645|FG002|Overall Study|Adverse Event|2|||
131225761|NCT02570165|472453646|FG003|Overall Study|Adverse Event|0|||
131225762|NCT02570165|472453647|FG004|Overall Study|Adverse Event|0|||
131225763|NCT02570165|472453648|FG005|Overall Study|Adverse Event|0|||
131225764|NCT02570165|472453649|FG006|Overall Study|Adverse Event|0|||
131225765|NCT02570165|472453643|FG000|Overall Study|Lack of Efficacy|0|||
131225766|NCT02570165|472453644|FG001|Overall Study|Lack of Efficacy|1|||
131225767|NCT02570165|472453645|FG002|Overall Study|Lack of Efficacy|0|||
131225768|NCT02570165|472453646|FG003|Overall Study|Lack of Efficacy|0|||
131225769|NCT02570165|472453647|FG004|Overall Study|Lack of Efficacy|4|||
131225770|NCT02570165|472453648|FG005|Overall Study|Lack of Efficacy|0|||
131225771|NCT02570165|472453649|FG006|Overall Study|Lack of Efficacy|0|||
131225772|NCT02570165|472453643|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
131225773|NCT02570165|472453644|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
131225774|NCT02570165|472453645|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
131225775|NCT02570165|472453646|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
131225776|NCT02570165|472453647|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
131225777|NCT02570165|472453648|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
131225778|NCT02570165|472453649|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
131225779|NCT02570165|472453643|FG000|Overall Study|Lost to Follow-up|0|||
131225780|NCT02570165|472453644|FG001|Overall Study|Lost to Follow-up|0|||
131225781|NCT02570165|472453645|FG002|Overall Study|Lost to Follow-up|1|||
131225782|NCT02570165|472453646|FG003|Overall Study|Lost to Follow-up|1|||
131225783|NCT02570165|472453647|FG004|Overall Study|Lost to Follow-up|0|||
131225784|NCT02570165|472453648|FG005|Overall Study|Lost to Follow-up|0|||
131225785|NCT02570165|472453649|FG006|Overall Study|Lost to Follow-up|0|||
130956274|NCT02346240|471471177|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
130956275|NCT02346240|471471178|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956276|NCT02346240|471471179|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
130956277|NCT02346240|471471180|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
131039908|NCT03085810|471781756|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
131039909|NCT03085810|471781754|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
130774616|NCT03280056|470802517|FG001|Overall Study|Death|2|||
130774617|NCT03280056|470802516|FG000|Overall Study|Adverse Event|1|||
130774618|NCT03280056|470802517|FG001|Overall Study|Adverse Event|3|||
131225786|NCT02570165|472453643|FG000|Overall Study|Physician Decision|0|||
131225787|NCT02570165|472453644|FG001|Overall Study|Physician Decision|1|||
131225788|NCT02570165|472453645|FG002|Overall Study|Physician Decision|0|||
131225789|NCT02570165|472453646|FG003|Overall Study|Physician Decision|0|||
131225790|NCT02570165|472453647|FG004|Overall Study|Physician Decision|0|||
130712680|NCT00891839|470573472|FG000|Overall Study|Withdrawal by Subject|2|||
130712681|NCT00891839|470573472|FG000|Overall Study|Disease progression|3|||
131225791|NCT02570165|472453648|FG005|Overall Study|Physician Decision|0|||
131225792|NCT02570165|472453649|FG006|Overall Study|Physician Decision|0|||
130712682|NCT05069155|470573473|FG000|Overall Study|Withdrawal by Subject|1|||
131225793|NCT02570165|472453643|FG000|Overall Study|Withdrawal by Subject|0|||
130774619|NCT03280056|470802516|FG000|Overall Study|Lost to Follow-up|1|||
131225794|NCT02570165|472453644|FG001|Overall Study|Withdrawal by Subject|0|||
131225795|NCT02570165|472453645|FG002|Overall Study|Withdrawal by Subject|0|||
130712683|NCT05069155|470573474|FG001|Overall Study|Withdrawal by Subject|3|||
130774620|NCT03280056|470802517|FG001|Overall Study|Lost to Follow-up|1|||
130774621|NCT03280056|470802516|FG000|Overall Study|Physician Decision|0|||
130774622|NCT03280056|470802517|FG001|Overall Study|Physician Decision|1|||
130774623|NCT03280056|470802516|FG000|Overall Study|Early Discontinuation|1|||
130956278|NCT02346240|471471181|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
130956279|NCT02346240|471471182|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
130956280|NCT02346240|471471159|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956281|NCT02346240|471471160|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130712684|NCT00712985|470573475|FG000|Overall Study|1 withdrew prior to start of drug|1|||
130712685|NCT00712985|470573475|FG000|Overall Study|1 patient moved out of state|1|||
130712686|NCT00712985|470573475|FG000|Overall Study|Lack of Efficacy|3|||
130712687|NCT02674061|470573476|FG000|Overall Study|Death|229|||
130712688|NCT02674061|470573477|FG001|Overall Study|Death|77|||
130712689|NCT02674061|470573476|FG000|Overall Study|Lost to Follow-up|3|||
130712690|NCT02674061|470573477|FG001|Overall Study|Lost to Follow-up|3|||
130712691|NCT02674061|470573476|FG000|Overall Study|Withdrawal by Subject|9|||
130712692|NCT02674061|470573477|FG001|Overall Study|Withdrawal by Subject|1|||
130712693|NCT02674061|470573476|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
130712694|NCT02674061|470573477|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
130712695|NCT01299805|470573480|FG000|Overall Study|Adverse Event|2|||
130712696|NCT01299805|470573481|FG001|Overall Study|Adverse Event|0|||
130956282|NCT02346240|471471161|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956283|NCT02346240|471471162|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956284|NCT02346240|471471163|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956285|NCT02346240|471471164|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956286|NCT02346240|471471165|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956287|NCT02346240|471471166|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956288|NCT02346240|471471167|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956289|NCT02346240|471471168|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956290|NCT02346240|471471169|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956291|NCT02346240|471471170|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956292|NCT02346240|471471171|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956293|NCT02346240|471471172|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956294|NCT02346240|471471173|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956295|NCT02346240|471471174|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956296|NCT02346240|471471175|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956297|NCT02346240|471471176|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956298|NCT02346240|471471177|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
130956299|NCT02346240|471471178|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956300|NCT02346240|471471179|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956301|NCT02346240|471471180|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956302|NCT02346240|471471181|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956303|NCT02346240|471471182|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
130956304|NCT01573624|471471183|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
130956305|NCT01573624|471471184|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
130956306|NCT01573624|471471185|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
130956307|NCT01573624|471471186|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
130956308|NCT01573624|471471187|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
130956309|NCT01573624|471471188|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
130956310|NCT01573624|471471189|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
130956311|NCT01573624|471471183|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
130956312|NCT01573624|471471184|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
130956313|NCT01573624|471471185|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
130956314|NCT01573624|471471186|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
130956315|NCT01573624|471471187|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
130956316|NCT01573624|471471188|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130956317|NCT01573624|471471189|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
130956318|NCT01573624|471471183|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
130956319|NCT01573624|471471184|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130956320|NCT01573624|471471185|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
131039910|NCT03085810|471781755|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
131225796|NCT02570165|472453646|FG003|Overall Study|Withdrawal by Subject|2|||
130712697|NCT00123955|470573485|FG000|Overall Study|Adverse Event|1|||
130712698|NCT00123955|470573486|FG001|Overall Study|Adverse Event|0|||
130712699|NCT00123955|470573485|FG000|Overall Study|Withdrawal by Subject|4|||
130712700|NCT00123955|470573486|FG001|Overall Study|Withdrawal by Subject|3|||
130712701|NCT00123955|470573485|FG000|Overall Study|Death|0|||
130712702|NCT00123955|470573486|FG001|Overall Study|Death|1|||
130712703|NCT04969861|470573489|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
130712704|NCT04969861|470573490|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
130712705|NCT04718194|470575165|FG000|Overall Study|Withdrawal by Subject|3|||
130712706|NCT04718194|470575166|FG001|Overall Study|Withdrawal by Subject|0|||
130712707|NCT04718194|470575165|FG000|Overall Study|Lost to Follow-up|3|||
130712708|NCT04718194|470575166|FG001|Overall Study|Lost to Follow-up|0|||
130712709|NCT04556552|470575168|FG000|Overall Study|Lost to Follow-up|1|||
130712710|NCT04556552|470575169|FG001|Overall Study|Lost to Follow-up|0|||
130712711|NCT04556552|470575168|FG000|Overall Study|Claustrophobia|0|||
130712712|NCT04556552|470575169|FG001|Overall Study|Claustrophobia|1|||
130712713|NCT04556552|470575168|FG000|Overall Study|Inability to continue|0|||
130712714|NCT04556552|470575169|FG001|Overall Study|Inability to continue|1|||
130712715|NCT01215513|470575170|FG000|Overall Study|Not completed CS42|9|||
130712716|NCT01215513|470575170|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
130712717|NCT01215513|470575170|FG000|Overall Study|Adverse event (CS42A)|2|||
130712718|NCT01215513|470575170|FG000|Overall Study|Physician decision (CS42A)|6|||
130712719|NCT01215513|470575170|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
130712720|NCT01215513|470575170|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
130712721|NCT01553279|470575171|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
130712722|NCT01553279|470575172|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
130712723|NCT01553279|470575171|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
130712724|NCT01553279|470575172|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
130712725|NCT01553279|470575171|FG000|Interim Period|Withdrawal by Subject|2|||
130712726|NCT01553279|470575172|FG001|Interim Period|Withdrawal by Subject|2|||
130712727|NCT01553279|470575171|FG000|Interim Period|Lost to Follow-up|1|||
130712728|NCT01553279|470575172|FG001|Interim Period|Lost to Follow-up|0|||
130712729|NCT01553279|470575171|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
130712730|NCT01553279|470575172|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
130712731|NCT01553279|470575171|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
130712732|NCT01553279|470575172|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
131126190|NCT02819635|472091287|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
131126191|NCT02819635|472091288|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
130712733|NCT00605865|470575173|FG000|Overall Study|Protocol Violation|115|||
130712734|NCT03955471|470575174|FG000|Overall Study|Death|22|||
130712735|NCT03955471|470575174|FG000|Overall Study|Lost to Follow-up|1|||
130712736|NCT03955471|470575174|FG000|Overall Study|Withdrawal by Subject|6|||
130712737|NCT03955471|470575174|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
130712738|NCT00793780|470575183|FG000|Overall Study|Withdrawal by Subject|2|||
130712739|NCT00793780|470575184|FG001|Overall Study|Withdrawal by Subject|1|||
130712740|NCT02858492|470575185|FG000|Overall Study|Withdrawal by Subject|0|||
130712741|NCT02858492|470575186|FG001|Overall Study|Withdrawal by Subject|1|||
130712742|NCT02858492|470575187|FG002|Overall Study|Withdrawal by Subject|0|||
130712743|NCT02858492|470575188|FG003|Overall Study|Withdrawal by Subject|1|||
130712744|NCT02858492|470575185|FG000|Overall Study|Adverse Event|0|||
130712745|NCT02858492|470575186|FG001|Overall Study|Adverse Event|0|||
130712746|NCT02858492|470575187|FG002|Overall Study|Adverse Event|0|||
130712747|NCT02858492|470575188|FG003|Overall Study|Adverse Event|3|||
130712748|NCT02858492|470575185|FG000|Overall Study|Lack of Efficacy|0|||
130712749|NCT02858492|470575186|FG001|Overall Study|Lack of Efficacy|0|||
130712750|NCT02858492|470575187|FG002|Overall Study|Lack of Efficacy|0|||
131126192|NCT02819635|472091289|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
131126193|NCT02819635|472091290|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
131126194|NCT02819635|472091291|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
131126195|NCT02819635|472091292|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
131225797|NCT02570165|472453647|FG004|Overall Study|Withdrawal by Subject|1|||
130712751|NCT02858492|470575188|FG003|Overall Study|Lack of Efficacy|1|||
130712752|NCT02858492|470575185|FG000|Overall Study|Protocol defined stopping criteria|0|||
130712753|NCT02858492|470575186|FG001|Overall Study|Protocol defined stopping criteria|0|||
130712754|NCT02858492|470575187|FG002|Overall Study|Protocol defined stopping criteria|0|||
130712755|NCT02858492|470575188|FG003|Overall Study|Protocol defined stopping criteria|1|||
131126196|NCT02819635|472091293|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
131126197|NCT02819635|472091282|FG000|Substudy 2, Part 2|Adverse Event|0|||
130712756|NCT02119286|470575195|FG000|Overall Study|Adverse Event|9|||
130712757|NCT02119286|470575196|FG001|Overall Study|Adverse Event|7|||
130712758|NCT02119286|470575197|FG002|Overall Study|Adverse Event|2|||
130712759|NCT02119286|470575195|FG000|Overall Study|Lack of Efficacy|11|||
130712760|NCT02119286|470575196|FG001|Overall Study|Lack of Efficacy|3|||
130712761|NCT02119286|470575197|FG002|Overall Study|Lack of Efficacy|4|||
131225798|NCT02570165|472453648|FG005|Overall Study|Withdrawal by Subject|0|||
131225799|NCT02570165|472453649|FG006|Overall Study|Withdrawal by Subject|0|||
131225800|NCT02570165|472453643|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
131225801|NCT02570165|472453644|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
131225802|NCT02570165|472453645|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
131225803|NCT02570165|472453646|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
131225804|NCT02570165|472453647|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
131225805|NCT02570165|472453648|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
131225806|NCT02570165|472453649|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
131225807|NCT02570165|472453643|FG000|Overall Study|Withdrawal Request by GSK|0|||
131225808|NCT02570165|472453644|FG001|Overall Study|Withdrawal Request by GSK|0|||
131225809|NCT02570165|472453645|FG002|Overall Study|Withdrawal Request by GSK|2|||
131225810|NCT02570165|472453646|FG003|Overall Study|Withdrawal Request by GSK|0|||
131225811|NCT02570165|472453647|FG004|Overall Study|Withdrawal Request by GSK|0|||
131225812|NCT02570165|472453648|FG005|Overall Study|Withdrawal Request by GSK|0|||
131225813|NCT02570165|472453649|FG006|Overall Study|Withdrawal Request by GSK|0|||
131225814|NCT01789281|472453650|FG000|Overall Study|Disease progression|15|||
131225815|NCT01789281|472453651|FG001|Overall Study|Disease progression|4|||
131225816|NCT01789281|472453650|FG000|Overall Study|Adverse Event|5|||
131225817|NCT01789281|472453651|FG001|Overall Study|Adverse Event|5|||
131225818|NCT01789281|472453650|FG000|Overall Study|Withdrawal by Subject|1|||
131225819|NCT01789281|472453651|FG001|Overall Study|Withdrawal by Subject|0|||
131225820|NCT01789281|472453650|FG000|Overall Study|Lost to Follow-up|1|||
131225821|NCT01789281|472453651|FG001|Overall Study|Lost to Follow-up|0|||
131225822|NCT01789281|472453650|FG000|Overall Study|Administrative problems|0|||
131225823|NCT01789281|472453651|FG001|Overall Study|Administrative problems|1|||
131225824|NCT01430104|472453654|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
131225825|NCT02124746|472453655|FG000|Overall Study|Adverse Event|2|||
131225826|NCT02124746|472453656|FG001|Overall Study|Adverse Event|1|||
131225827|NCT02124746|472453657|FG002|Overall Study|Adverse Event|2|||
131225828|NCT02124746|472453655|FG000|Overall Study|Death|2|||
131225829|NCT02124746|472453656|FG001|Overall Study|Death|1|||
131225830|NCT02124746|472453657|FG002|Overall Study|Death|3|||
131225831|NCT02124746|472453655|FG000|Overall Study|Lack of Efficacy|3|||
131225832|NCT02124746|472453656|FG001|Overall Study|Lack of Efficacy|2|||
131225833|NCT02124746|472453657|FG002|Overall Study|Lack of Efficacy|2|||
131225834|NCT02124746|472453655|FG000|Overall Study|Physician Decision|6|||
131225835|NCT02124746|472453656|FG001|Overall Study|Physician Decision|4|||
131225836|NCT02124746|472453657|FG002|Overall Study|Physician Decision|5|||
131225837|NCT02124746|472453655|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131225838|NCT02124746|472453656|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131039911|NCT03085810|471781756|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
131225839|NCT02124746|472453657|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131225840|NCT02124746|472453655|FG000|Overall Study|Withdrawal by Subject|3|||
131225841|NCT02124746|472453656|FG001|Overall Study|Withdrawal by Subject|3|||
131225842|NCT02124746|472453657|FG002|Overall Study|Withdrawal by Subject|0|||
131225843|NCT02124746|472453655|FG000|Overall Study|Study Terminated by Sponsor|0|||
131225844|NCT02124746|472453656|FG001|Overall Study|Study Terminated by Sponsor|0|||
131225845|NCT02124746|472453657|FG002|Overall Study|Study Terminated by Sponsor|6|||
131225846|NCT02124746|472453655|FG000|Overall Study|Disease Progression|3|||
131225847|NCT02124746|472453656|FG001|Overall Study|Disease Progression|6|||
131225848|NCT02124746|472453657|FG002|Overall Study|Disease Progression|4|||
131225849|NCT00571922|472453663|FG000|Overall Study|Completion unknown|36|||
131225850|NCT00571922|472453664|FG001|Overall Study|Completion unknown|36|||
131039912|NCT05200403|471781757|FG000|Overall Study|Withdrawal by Subject|4|||
131039913|NCT05200403|471781758|FG001|Overall Study|Withdrawal by Subject|2|||
131039914|NCT05200403|471781759|FG002|Overall Study|Withdrawal by Subject|6|||
131039915|NCT01959607|471781760|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
131039916|NCT01959607|471781761|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
131039917|NCT01959607|471781762|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
131039918|NCT01959607|471781763|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
131039919|NCT03913442|471781764|FG000|Overall Study|Adverse Event|0|||
131039920|NCT03913442|471781765|FG001|Overall Study|Adverse Event|3|||
131039921|NCT03913442|471781764|FG000|Overall Study|Withdrawal by Subject|5|||
131039922|NCT03913442|471781765|FG001|Overall Study|Withdrawal by Subject|5|||
131039923|NCT03913442|471781764|FG000|Overall Study|Terminations|2|||
131039924|NCT03913442|471781765|FG001|Overall Study|Terminations|1|||
131225851|NCT02191579|472453672|FG000|Treatment 1|Multiple Reasons Specified|27|||
131225852|NCT02191579|472453673|FG001|Treatment 1|Multiple Reasons Specified|58|||
131225853|NCT02191579|472453672|FG000|Treatment 2|Multiple Reasons Specified|0|||
131039925|NCT03913442|471781764|FG000|Overall Study|Lost to Follow-up|2|||
131039926|NCT03913442|471781765|FG001|Overall Study|Lost to Follow-up|2|||
131225854|NCT02191579|472453673|FG001|Treatment 2|Multiple Reasons Specified|25|||
131225855|NCT00964223|472453683|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
131225856|NCT00345683|472453684|FG000|Overall Study|Lost to Follow-up|19|||
131225857|NCT00345683|472453685|FG001|Overall Study|Lost to Follow-up|7|||
130712762|NCT02119286|470575195|FG000|Overall Study|Lost to Follow-up|2|||
130712763|NCT02119286|470575196|FG001|Overall Study|Lost to Follow-up|0|||
130712764|NCT02119286|470575197|FG002|Overall Study|Lost to Follow-up|1|||
130712765|NCT02119286|470575195|FG000|Overall Study|Withdrawal by Subject|4|||
130712766|NCT02119286|470575196|FG001|Overall Study|Withdrawal by Subject|1|||
130712767|NCT02119286|470575197|FG002|Overall Study|Withdrawal by Subject|0|||
130712768|NCT03310411|470575198|FG000|Period 1|Adverse Event|0|||
130712769|NCT03310411|470575199|FG001|Period 1|Adverse Event|0|||
130712770|NCT03310411|470575200|FG002|Period 1|Adverse Event|0|||
130712771|NCT03310411|470575201|FG003|Period 1|Adverse Event|1|||
130956321|NCT01573624|471471186|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130956322|NCT01573624|471471187|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130956323|NCT01573624|471471188|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130956324|NCT01573624|471471189|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
130956325|NCT01573624|471471183|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130956326|NCT01573624|471471184|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130956327|NCT01573624|471471185|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130712772|NCT00619112|470575202|FG000|Overall Study|Adverse Event|1|||
130712773|NCT00619112|470575203|FG001|Overall Study|Adverse Event|2|||
130712774|NCT03623386|470575206|FG000|Overall Study|Protocol Violation|3|||
130712775|NCT03623386|470575207|FG001|Overall Study|Protocol Violation|2|||
130712776|NCT03623386|470575208|FG002|Overall Study|Protocol Violation|0|||
130712777|NCT03623386|470575206|FG000|Overall Study|Physician Decision|1|||
130712778|NCT03623386|470575207|FG001|Overall Study|Physician Decision|1|||
130712779|NCT03623386|470575208|FG002|Overall Study|Physician Decision|0|||
130712780|NCT03623386|470575206|FG000|Overall Study|Lost to Follow-up|0|||
130712781|NCT03623386|470575207|FG001|Overall Study|Lost to Follow-up|2|||
130956328|NCT01573624|471471186|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130956329|NCT01573624|471471187|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130712782|NCT03623386|470575208|FG002|Overall Study|Lost to Follow-up|0|||
130712783|NCT03623386|470575206|FG000|Overall Study|COVID-19|0|||
130712784|NCT03623386|470575207|FG001|Overall Study|COVID-19|1|||
130712785|NCT03623386|470575208|FG002|Overall Study|COVID-19|0|||
130712786|NCT04271735|470575213|FG000|Overall Study|Physician Decision|2|||
130712787|NCT04271735|470575214|FG001|Overall Study|Physician Decision|0|||
130712788|NCT00515541|470575215|FG000|Overall Study|Physician Decision|0|||
130712789|NCT00515541|470575216|FG001|Overall Study|Physician Decision|2|||
130712790|NCT00515541|470575217|FG002|Overall Study|Physician Decision|0|||
130712791|NCT00515541|470575218|FG003|Overall Study|Physician Decision|1|||
130712792|NCT00515541|470575215|FG000|Overall Study|No show for appointments|0|||
130712793|NCT00515541|470575216|FG001|Overall Study|No show for appointments|1|||
130712794|NCT00515541|470575217|FG002|Overall Study|No show for appointments|0|||
130712795|NCT00515541|470575218|FG003|Overall Study|No show for appointments|2|||
130712796|NCT00515541|470575215|FG000|Overall Study|Withdrawal by Subject|0|||
130712797|NCT00515541|470575216|FG001|Overall Study|Withdrawal by Subject|2|||
130956330|NCT01573624|471471188|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
130956331|NCT01573624|471471189|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130956332|NCT01573624|471471183|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
130956333|NCT01573624|471471184|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
130956334|NCT01573624|471471185|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
130956335|NCT01573624|471471186|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
130956336|NCT01573624|471471187|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
130956337|NCT01573624|471471188|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
130956338|NCT01573624|471471189|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
130956339|NCT01573624|471471183|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130956340|NCT01573624|471471184|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130956341|NCT01573624|471471185|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130956342|NCT01573624|471471186|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130956343|NCT01573624|471471187|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130712798|NCT00515541|470575217|FG002|Overall Study|Withdrawal by Subject|0|||
130712799|NCT00515541|470575218|FG003|Overall Study|Withdrawal by Subject|2|||
130712800|NCT02040779|470575220|FG000|Overall Study|Adverse Event|1|||
130712801|NCT02040779|470575221|FG001|Overall Study|Adverse Event|0|||
130712802|NCT02040779|470575222|FG002|Overall Study|Adverse Event|0|||
130712803|NCT02040779|470575220|FG000|Overall Study|Withdrawal by Subject|4|||
130712804|NCT02040779|470575221|FG001|Overall Study|Withdrawal by Subject|1|||
130712805|NCT02040779|470575222|FG002|Overall Study|Withdrawal by Subject|3|||
130712806|NCT02040779|470575220|FG000|Overall Study|Non-compliance|0|||
130712807|NCT02040779|470575221|FG001|Overall Study|Non-compliance|1|||
130712808|NCT02040779|470575222|FG002|Overall Study|Non-compliance|0|||
130712809|NCT02040779|470575220|FG000|Overall Study|Protocol Violation|2|||
130712810|NCT02040779|470575221|FG001|Overall Study|Protocol Violation|1|||
130712811|NCT02040779|470575222|FG002|Overall Study|Protocol Violation|0|||
130712812|NCT02040779|470575220|FG000|Overall Study|Lost to Follow-up|1|||
130712813|NCT02040779|470575221|FG001|Overall Study|Lost to Follow-up|2|||
130956344|NCT01573624|471471188|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
130956345|NCT01573624|471471189|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
130956346|NCT01573624|471471183|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
130956347|NCT01573624|471471184|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
130956348|NCT01573624|471471185|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
130712814|NCT02040779|470575222|FG002|Overall Study|Lost to Follow-up|1|||
130712815|NCT02040779|470575220|FG000|Overall Study|Lack of Efficacy|4|||
130956349|NCT01573624|471471186|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
130956350|NCT01573624|471471187|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
130956351|NCT01573624|471471188|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
130956352|NCT01573624|471471189|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
130956353|NCT01573624|471471183|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
130956354|NCT01573624|471471184|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
131039927|NCT00950742|471781766|FG000|Overall Study|Other Adverse Event|1|||
131039928|NCT00950742|471781767|FG001|Overall Study|Other Adverse Event|0|||
130712816|NCT02040779|470575221|FG001|Overall Study|Lack of Efficacy|2|||
130712817|NCT02040779|470575222|FG002|Overall Study|Lack of Efficacy|0|||
130712818|NCT02132637|470575223|FG000|Study Period 1|Withdrawal by Subject|0|||
130712819|NCT02132637|470575224|FG001|Study Period 1|Withdrawal by Subject|4|||
130712820|NCT02132637|470575223|FG000|Study Period 1|Physician Decision|1|||
130712821|NCT02132637|470575224|FG001|Study Period 1|Physician Decision|0|||
130712822|NCT02132637|470575223|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
130712823|NCT02132637|470575224|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
130712824|NCT02132637|470575223|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
130712825|NCT02132637|470575224|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
130712826|NCT00922272|470575227|FG000|Open-label Phase|Adverse Event|5|||
130712827|NCT00922272|470575228|FG001|Open-label Phase|Adverse Event|0|||
130712828|NCT00922272|470575227|FG000|Open-label Phase|Protocol Violation|1|||
130712829|NCT00922272|470575228|FG001|Open-label Phase|Protocol Violation|0|||
130712830|NCT00922272|470575227|FG000|Open-label Phase|Withdrawal by Subject|11|||
130712831|NCT00922272|470575228|FG001|Open-label Phase|Withdrawal by Subject|0|||
130712832|NCT00922272|470575227|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
130712833|NCT00922272|470575228|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
130712834|NCT00922272|470575227|FG000|Open-label Phase|Withdrawal criteria met|5|||
130712835|NCT00922272|470575228|FG001|Open-label Phase|Withdrawal criteria met|0|||
130712836|NCT00922272|470575227|FG000|Double-blind Phase|Adverse Event|1|||
130712837|NCT00922272|470575228|FG001|Double-blind Phase|Adverse Event|1|||
130712838|NCT00922272|470575227|FG000|Double-blind Phase|Withdrawal by Subject|1|||
130712839|NCT00922272|470575228|FG001|Double-blind Phase|Withdrawal by Subject|1|||
131039929|NCT00950742|471781766|FG000|Overall Study|Withdrawal by Subject|3|||
130712840|NCT00922272|470575227|FG000|Double-blind Phase|Lost to Follow-up|2|||
130712841|NCT00922272|470575228|FG001|Double-blind Phase|Lost to Follow-up|1|||
130712842|NCT00922272|470575227|FG000|Double-blind Phase|Withdrawal criteria met|1|||
130712843|NCT00922272|470575228|FG001|Double-blind Phase|Withdrawal criteria met|1|||
131126198|NCT02819635|472091283|FG001|Substudy 2, Part 2|Adverse Event|0|||
130712844|NCT00922272|470575227|FG000|Double-blind Phase|Noncompliance|1|||
130712845|NCT00922272|470575228|FG001|Double-blind Phase|Noncompliance|1|||
130712846|NCT00922272|470575227|FG000|Double-blind Phase|Positive urine drug screen|1|||
131126199|NCT02819635|472091284|FG002|Substudy 2, Part 2|Adverse Event|0|||
131126200|NCT02819635|472091285|FG003|Substudy 2, Part 2|Adverse Event|0|||
131126201|NCT02819635|472091286|FG004|Substudy 2, Part 2|Adverse Event|0|||
131126202|NCT02819635|472091287|FG005|Substudy 2, Part 2|Adverse Event|4|||
131126203|NCT02819635|472091288|FG006|Substudy 2, Part 2|Adverse Event|0|||
131126204|NCT02819635|472091289|FG007|Substudy 2, Part 2|Adverse Event|0|||
131126205|NCT02819635|472091290|FG008|Substudy 2, Part 2|Adverse Event|0|||
131126206|NCT02819635|472091291|FG009|Substudy 2, Part 2|Adverse Event|0|||
131126207|NCT02819635|472091292|FG010|Substudy 2, Part 2|Adverse Event|0|||
131126208|NCT02819635|472091293|FG011|Substudy 2, Part 2|Adverse Event|0|||
131126209|NCT02819635|472091282|FG000|Substudy 2, Part 2|Withdrew consent|0|||
131126210|NCT02819635|472091283|FG001|Substudy 2, Part 2|Withdrew consent|0|||
131126211|NCT02819635|472091284|FG002|Substudy 2, Part 2|Withdrew consent|0|||
131126212|NCT02819635|472091285|FG003|Substudy 2, Part 2|Withdrew consent|0|||
131126213|NCT02819635|472091286|FG004|Substudy 2, Part 2|Withdrew consent|0|||
131126214|NCT02819635|472091287|FG005|Substudy 2, Part 2|Withdrew consent|3|||
131126215|NCT02819635|472091288|FG006|Substudy 2, Part 2|Withdrew consent|1|||
131126216|NCT02819635|472091289|FG007|Substudy 2, Part 2|Withdrew consent|0|||
131126217|NCT02819635|472091290|FG008|Substudy 2, Part 2|Withdrew consent|0|||
131126218|NCT02819635|472091291|FG009|Substudy 2, Part 2|Withdrew consent|0|||
131126219|NCT02819635|472091292|FG010|Substudy 2, Part 2|Withdrew consent|0|||
131126220|NCT02819635|472091293|FG011|Substudy 2, Part 2|Withdrew consent|0|||
131126221|NCT02819635|472091282|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
130712847|NCT00922272|470575228|FG001|Double-blind Phase|Positive urine drug screen|1|||
130712848|NCT02588950|470575229|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
130712849|NCT02588950|470575230|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
130712850|NCT02588950|470575231|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
130712851|NCT02588950|470575232|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
130712852|NCT02588950|470575229|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
130712853|NCT02588950|470575230|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
130712854|NCT02588950|470575231|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
130712855|NCT02588950|470575232|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
130712856|NCT00652028|470575235|FG000|Overall Study|Adverse Event|1|||
130712857|NCT00652028|470575236|FG001|Overall Study|Adverse Event|0|||
130712858|NCT00652028|470575237|FG002|Overall Study|Adverse Event|0|||
130712859|NCT00652028|470575238|FG003|Overall Study|Adverse Event|0|||
130712860|NCT00652028|470575235|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
130712861|NCT00652028|470575236|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
130712862|NCT00652028|470575237|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
130712863|NCT00652028|470575238|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
130712864|NCT00652028|470575235|FG000|Overall Study|Physician Decision|0|||
130712865|NCT00652028|470575236|FG001|Overall Study|Physician Decision|0|||
130712866|NCT00652028|470575237|FG002|Overall Study|Physician Decision|1|||
130712867|NCT00652028|470575238|FG003|Overall Study|Physician Decision|0|||
130712868|NCT02400671|470575242|FG000|Overall Study|Death|5|||
131039930|NCT00950742|471781767|FG001|Overall Study|Withdrawal by Subject|0|||
131039931|NCT00950742|471781766|FG000|Overall Study|Progressive Disease|6|||
131039932|NCT00950742|471781767|FG001|Overall Study|Progressive Disease|2|||
131039933|NCT00950742|471781766|FG000|Overall Study|Dose limiting toxicity|6|||
131039934|NCT00950742|471781767|FG001|Overall Study|Dose limiting toxicity|0|||
131039935|NCT05436262|471781768|FG000|Pre-Randomization|Withdrawal by Subject|1|||
131039936|NCT05436262|471781769|FG001|Pre-Randomization|Withdrawal by Subject|0|||
131039937|NCT05436262|471781770|FG002|Pre-Randomization|Withdrawal by Subject|0|||
131039938|NCT05436262|471781768|FG000|Randomization|Withdrawal by Subject|0|||
131039939|NCT05436262|471781769|FG001|Randomization|Withdrawal by Subject|1|||
131039940|NCT05436262|471781770|FG002|Randomization|Withdrawal by Subject|0|||
131039941|NCT00592852|471781771|FG000|Overall Study|Non-compliance|1|||
131039942|NCT00592852|471781771|FG000|Overall Study|Adverse Event|3|||
131039943|NCT00592852|471781771|FG000|Overall Study|Found ineligible|1|||
131039944|NCT00592852|471781771|FG000|Overall Study|Withdrawal by Subject|1|||
131039945|NCT05002088|471781772|FG000|Overall Study|Withdrawal by Subject|9|||
131039946|NCT05002088|471781773|FG001|Overall Study|Withdrawal by Subject|0|||
131039947|NCT05002088|471781772|FG000|Overall Study|Lost to Follow-up|0|||
131039948|NCT05002088|471781773|FG001|Overall Study|Lost to Follow-up|1|||
131039949|NCT05002088|471781772|FG000|Overall Study|Death|16|||
131039950|NCT05002088|471781773|FG001|Overall Study|Death|2|||
131039951|NCT05002088|471781772|FG000|Overall Study|Protocol Violation|25|||
131039952|NCT05002088|471781773|FG001|Overall Study|Protocol Violation|7|||
131039953|NCT04068181|471781775|FG000|Overall Study|Death|17|||
131039954|NCT04068181|471781776|FG001|Overall Study|Death|12|||
131039955|NCT04068181|471781777|FG002|Overall Study|Death|4|||
131039956|NCT04068181|471781778|FG003|Overall Study|Death|7|||
131039957|NCT04068181|471781775|FG000|Overall Study|Lost to Follow-up|1|||
131039958|NCT04068181|471781776|FG001|Overall Study|Lost to Follow-up|0|||
131039959|NCT04068181|471781777|FG002|Overall Study|Lost to Follow-up|0|||
131039960|NCT04068181|471781778|FG003|Overall Study|Lost to Follow-up|0|||
131039961|NCT04068181|471781775|FG000|Overall Study|Withdrawal of consent from study|3|||
131039962|NCT04068181|471781776|FG001|Overall Study|Withdrawal of consent from study|0|||
131039963|NCT04068181|471781777|FG002|Overall Study|Withdrawal of consent from study|0|||
131039964|NCT04068181|471781778|FG003|Overall Study|Withdrawal of consent from study|0|||
131039965|NCT04117347|471781785|FG000|Overall Study|Adverse Event|0|||
131039966|NCT04117347|471781786|FG001|Overall Study|Adverse Event|0|||
131039967|NCT04117347|471781787|FG002|Overall Study|Adverse Event|1|||
131039968|NCT04117347|471781785|FG000|Overall Study|No time for study|0|||
131039969|NCT04117347|471781786|FG001|Overall Study|No time for study|2|||
131039970|NCT04117347|471781787|FG002|Overall Study|No time for study|0|||
131039971|NCT04117347|471781785|FG000|Overall Study|Family emergency|1|||
131039972|NCT04117347|471781786|FG001|Overall Study|Family emergency|0|||
131039973|NCT04117347|471781787|FG002|Overall Study|Family emergency|0|||
131039974|NCT03687086|471781788|FG000|Overall Study|Withdrawal by Subject|3|||
130712869|NCT02400671|470575243|FG001|Overall Study|Death|3|||
130712870|NCT02400671|470575244|FG002|Overall Study|Death|4|||
131039975|NCT03687086|471781789|FG001|Overall Study|Withdrawal by Subject|4|||
130712871|NCT02400671|470575242|FG000|Overall Study|Lost to Follow-up|20|||
130712872|NCT02400671|470575243|FG001|Overall Study|Lost to Follow-up|27|||
130712873|NCT02400671|470575244|FG002|Overall Study|Lost to Follow-up|24|||
130712874|NCT02400671|470575242|FG000|Overall Study|Withdrawal by Subject|2|||
130712875|NCT02400671|470575243|FG001|Overall Study|Withdrawal by Subject|2|||
131039976|NCT03687086|471781788|FG000|Overall Study|Lost to Follow-up|1|||
131039977|NCT03687086|471781789|FG001|Overall Study|Lost to Follow-up|1|||
131039978|NCT03687086|471781788|FG000|Overall Study|Death|1|||
131039979|NCT03687086|471781789|FG001|Overall Study|Death|0|||
131126222|NCT02819635|472091283|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
131126223|NCT02819635|472091284|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
131126224|NCT02819635|472091285|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
131126225|NCT02819635|472091286|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
131126226|NCT02819635|472091287|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
131126227|NCT02819635|472091288|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
131126228|NCT02819635|472091289|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
131126229|NCT02819635|472091290|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
131126230|NCT02819635|472091291|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
131126231|NCT02819635|472091292|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
131126232|NCT02819635|472091293|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
131126233|NCT02819635|472091282|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131126234|NCT02819635|472091283|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130712876|NCT02400671|470575244|FG002|Overall Study|Withdrawal by Subject|0|||
131126235|NCT02819635|472091284|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131126236|NCT02819635|472091285|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131126237|NCT02819635|472091286|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131126238|NCT02819635|472091287|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131126239|NCT02819635|472091288|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
131126240|NCT02819635|472091289|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131126241|NCT02819635|472091290|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131126242|NCT02819635|472091291|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131126243|NCT02819635|472091292|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131126244|NCT02819635|472091293|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
131126245|NCT02819635|472091282|FG000|Substudy 2, Part 2|Other, not specified|0|||
131126246|NCT02819635|472091283|FG001|Substudy 2, Part 2|Other, not specified|0|||
131126247|NCT02819635|472091284|FG002|Substudy 2, Part 2|Other, not specified|0|||
131126248|NCT02819635|472091285|FG003|Substudy 2, Part 2|Other, not specified|0|||
131126249|NCT02819635|472091286|FG004|Substudy 2, Part 2|Other, not specified|0|||
131126250|NCT02819635|472091287|FG005|Substudy 2, Part 2|Other, not specified|4|||
131126251|NCT02819635|472091288|FG006|Substudy 2, Part 2|Other, not specified|8|||
131126252|NCT02819635|472091289|FG007|Substudy 2, Part 2|Other, not specified|0|||
131126253|NCT02819635|472091290|FG008|Substudy 2, Part 2|Other, not specified|0|||
131126254|NCT02819635|472091291|FG009|Substudy 2, Part 2|Other, not specified|0|||
131126255|NCT02819635|472091292|FG010|Substudy 2, Part 2|Other, not specified|0|||
131126256|NCT02819635|472091293|FG011|Substudy 2, Part 2|Other, not specified|0|||
131126257|NCT02819635|472091282|FG000|Substudy 3|Adverse Event|0|||
131126258|NCT02819635|472091283|FG001|Substudy 3|Adverse Event|0|||
131126259|NCT02819635|472091284|FG002|Substudy 3|Adverse Event|0|||
131126260|NCT02819635|472091285|FG003|Substudy 3|Adverse Event|0|||
131126261|NCT02819635|472091286|FG004|Substudy 3|Adverse Event|0|||
131126262|NCT02819635|472091287|FG005|Substudy 3|Adverse Event|0|||
131225858|NCT00345683|472453684|FG000|Overall Study|Other|6|||
130712877|NCT01429051|470575250|FG000|Titration Phase|Death|1|||
130712878|NCT01429051|470575250|FG000|Titration Phase|Withdrawal by Subject|7|||
130712879|NCT01429051|470575250|FG000|Titration Phase|Physician Decision|1|||
130712880|NCT01429051|470575250|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
130712881|NCT01429051|470575250|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
130712882|NCT01429051|470575250|FG000|Efficacy Phase|Adverse Event|1|||
130712883|NCT01429051|470575250|FG000|Efficacy Phase|Death|1|||
130712884|NCT01429051|470575250|FG000|Tolerability Phase|Death|5|||
130712885|NCT01429051|470575250|FG000|Tolerability Phase|Adverse Event|2|||
130712886|NCT01429051|470575250|FG000|Tolerability Phase|Withdrawal by Subject|5|||
130712887|NCT01429051|470575250|FG000|Tolerability Phase|Physician Decision|1|||
130712888|NCT01429051|470575250|FG000|Tolerability Phase|Other|2|||
130712889|NCT01797835|470575255|FG000|Overall Study|Lost to Follow-up|31|||
130712890|NCT01797835|470575256|FG001|Overall Study|Lost to Follow-up|27|||
131126263|NCT02819635|472091288|FG006|Substudy 3|Adverse Event|0|||
131126264|NCT02819635|472091289|FG007|Substudy 3|Adverse Event|0|||
131126265|NCT02819635|472091290|FG008|Substudy 3|Adverse Event|32|||
131126266|NCT02819635|472091291|FG009|Substudy 3|Adverse Event|3|||
131126267|NCT02819635|472091292|FG010|Substudy 3|Adverse Event|12|||
131126268|NCT02819635|472091293|FG011|Substudy 3|Adverse Event|18|||
131126269|NCT02819635|472091282|FG000|Substudy 3|Withdrew consent|0|||
131126270|NCT02819635|472091283|FG001|Substudy 3|Withdrew consent|0|||
131126271|NCT02819635|472091284|FG002|Substudy 3|Withdrew consent|0|||
130712891|NCT03001219|470575257|FG000|Proof of Concept|Study Termination by Sponsor|0|||
130712892|NCT03001219|470575258|FG001|Proof of Concept|Study Termination by Sponsor|1|||
130712893|NCT03001219|470575257|FG000|Proof of Concept|Withdrawal by Subject|0|||
131126272|NCT02819635|472091285|FG003|Substudy 3|Withdrew consent|0|||
131126273|NCT02819635|472091286|FG004|Substudy 3|Withdrew consent|0|||
130712894|NCT03001219|470575258|FG001|Proof of Concept|Withdrawal by Subject|4|||
130712895|NCT03001219|470575257|FG000|Proof of Concept|Protocol Deviation|0|||
131126274|NCT02819635|472091287|FG005|Substudy 3|Withdrew consent|0|||
131126275|NCT02819635|472091288|FG006|Substudy 3|Withdrew consent|0|||
131126276|NCT02819635|472091289|FG007|Substudy 3|Withdrew consent|0|||
131225859|NCT00345683|472453685|FG001|Overall Study|Other|2|||
130712896|NCT03001219|470575258|FG001|Proof of Concept|Protocol Deviation|1|||
130712897|NCT03001219|470575257|FG000|Proof of Concept|Adverse Event|1|||
130712898|NCT03001219|470575258|FG001|Proof of Concept|Adverse Event|1|||
130712899|NCT03001219|470575257|FG000|Proof of Concept|Physician Decision|1|||
130712900|NCT03001219|470575258|FG001|Proof of Concept|Physician Decision|0|||
130712901|NCT03001219|470575257|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
130712902|NCT03001219|470575258|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
130712903|NCT03001219|470575257|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
130712904|NCT03001219|470575258|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
130712905|NCT03001219|470575257|FG000|Extension Period Analysis|Physician Decision|0|||
130712906|NCT03001219|470575258|FG001|Extension Period Analysis|Physician Decision|1|||
130712907|NCT03001219|470575257|FG000|Extension Period Analysis|Adverse Event|1|||
130712908|NCT03001219|470575258|FG001|Extension Period Analysis|Adverse Event|1|||
130712909|NCT03001219|470575257|FG000|Extension Period Analysis|Protocol Deviation|0|||
130712910|NCT03001219|470575258|FG001|Extension Period Analysis|Protocol Deviation|1|||
130712911|NCT03001219|470575257|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
130712912|NCT03001219|470575258|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
130712913|NCT01195103|470575259|FG000|Overall Study|Withdrawal by Subject|1|||
130712914|NCT01195103|470575260|FG001|Overall Study|Withdrawal by Subject|0|||
130712915|NCT01195103|470575261|FG002|Overall Study|Withdrawal by Subject|0|||
130712916|NCT02528123|470575262|FG000|Overall Study|Lost to Follow-up|1|||
130712917|NCT03733210|470575263|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
130712918|NCT03733210|470575264|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
130712919|NCT03760250|470575265|FG000|Overall Study|Withdrawal by Subject|1|||
130712920|NCT03760250|470575265|FG000|Overall Study|Physician Decision|1|||
130712921|NCT04421586|470575272|FG000|Overall Study|Death|0|||
130712922|NCT04421586|470575273|FG001|Overall Study|Death|1|||
130712923|NCT04421586|470575272|FG000|Overall Study|Lost to Follow-up|2|||
130712924|NCT04421586|470575273|FG001|Overall Study|Lost to Follow-up|2|||
130712925|NCT04421586|470575272|FG000|Overall Study|Withdrawn by PI|1|||
130712926|NCT04421586|470575273|FG001|Overall Study|Withdrawn by PI|0|||
130712927|NCT04421586|470575272|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
130712928|NCT04421586|470575273|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
130712929|NCT02963441|470575274|FG000|Overall Study|Protocol violation or withdrawn|8|||
130712930|NCT02963441|470575274|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
130712931|NCT02963441|470575274|FG000|Overall Study|IDx-DR insufficient quality|33|||
130712932|NCT02669940|470575277|FG000|Overall Study|Failure to return|0|||
130712933|NCT02669940|470575278|FG001|Overall Study|Failure to return|3|||
130712934|NCT02669940|470575277|FG000|Overall Study|Insufficient follow-up data|1|||
130712935|NCT02669940|470575278|FG001|Overall Study|Insufficient follow-up data|0|||
130712936|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Adverse Event|9|||
130712937|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Adverse Event|4|||
130712938|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Adverse Event|5|||
130712939|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Adverse Event|9|||
130712940|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Adverse Event|8|||
130712941|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Adverse Event|0|||
130712942|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Adverse Event|0|||
130712943|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
130712944|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
130712945|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
130712946|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
130712947|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
130712948|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
130712949|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
130712950|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Death|1|||
130712951|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Death|1|||
130712952|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Death|1|||
130712953|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Death|1|||
130712954|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Death|0|||
130712955|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Death|0|||
130956355|NCT01573624|471471185|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
130956356|NCT01573624|471471186|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
130956357|NCT01573624|471471187|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130956358|NCT01573624|471471188|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130956359|NCT01573624|471471189|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
130956360|NCT01573624|471471183|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130956361|NCT01573624|471471184|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130712956|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Death|0|||
130712957|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
130712958|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
130712959|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
130712960|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
131225860|NCT00931385|472453686|FG000|Overall Study|Adverse Event|2|||
131225861|NCT00931385|472453687|FG001|Overall Study|Adverse Event|1|||
131225862|NCT00931385|472453688|FG002|Overall Study|Adverse Event|0|||
131225863|NCT00931385|472453689|FG003|Overall Study|Adverse Event|3|||
131225864|NCT00931385|472453686|FG000|Overall Study|Protocol Violation|0|||
131225865|NCT00931385|472453687|FG001|Overall Study|Protocol Violation|0|||
131225866|NCT00931385|472453688|FG002|Overall Study|Protocol Violation|1|||
131225867|NCT00931385|472453689|FG003|Overall Study|Protocol Violation|0|||
131225868|NCT00931385|472453686|FG000|Overall Study|Withdrawal by Subject|0|||
131225869|NCT00931385|472453687|FG001|Overall Study|Withdrawal by Subject|1|||
131225870|NCT00931385|472453688|FG002|Overall Study|Withdrawal by Subject|0|||
131225871|NCT00931385|472453689|FG003|Overall Study|Withdrawal by Subject|1|||
131225872|NCT00931385|472453686|FG000|Overall Study|Lost to Follow-up|0|||
131225873|NCT00931385|472453687|FG001|Overall Study|Lost to Follow-up|0|||
131225874|NCT00931385|472453688|FG002|Overall Study|Lost to Follow-up|0|||
131225875|NCT00931385|472453689|FG003|Overall Study|Lost to Follow-up|1|||
131225876|NCT01298596|472453691|FG000|Overall Study|Withdrawal by Subject|1|||
131225877|NCT01298596|472453692|FG001|Overall Study|Withdrawal by Subject|1|||
131225878|NCT01298596|472453691|FG000|Overall Study|Death|5|||
131225879|NCT01298596|472453692|FG001|Overall Study|Death|3|||
131225880|NCT01298596|472453691|FG000|Overall Study|Lost to Follow-up|6|||
131225881|NCT01298596|472453692|FG001|Overall Study|Lost to Follow-up|14|||
131225882|NCT01298596|472453691|FG000|Overall Study|Referred for further management|16|||
131225883|NCT01298596|472453692|FG001|Overall Study|Referred for further management|15|||
131225884|NCT04128696|472453695|FG000|Overall Study|Lost to Follow-up|3|||
131225885|NCT04128696|472453696|FG001|Overall Study|Lost to Follow-up|7|||
131225886|NCT04128696|472453695|FG000|Overall Study|Withdrawal by Subject|12|||
131225887|NCT04128696|472453696|FG001|Overall Study|Withdrawal by Subject|11|||
131225888|NCT04128696|472453695|FG000|Overall Study|Study Closed/Terminated|26|||
131225889|NCT04128696|472453696|FG001|Overall Study|Study Closed/Terminated|38|||
131225890|NCT04128696|472453695|FG000|Overall Study|Physician Decision|2|||
131225891|NCT04128696|472453696|FG001|Overall Study|Physician Decision|3|||
131225892|NCT02046369|472453699|FG000|Overall Study|Adverse Event|3|||
131225893|NCT02046369|472453700|FG001|Overall Study|Adverse Event|3|||
131225894|NCT02046369|472453699|FG000|Overall Study|Lack of Efficacy|3|||
131225895|NCT02046369|472453700|FG001|Overall Study|Lack of Efficacy|3|||
131225896|NCT02046369|472453699|FG000|Overall Study|Lost to Follow-up|3|||
131225897|NCT02046369|472453700|FG001|Overall Study|Lost to Follow-up|3|||
131225898|NCT02046369|472453699|FG000|Overall Study|Protocol Violation|1|||
131225899|NCT02046369|472453700|FG001|Overall Study|Protocol Violation|2|||
131225900|NCT02046369|472453699|FG000|Overall Study|Withdrawal by Subject|3|||
131225901|NCT02046369|472453700|FG001|Overall Study|Withdrawal by Subject|6|||
131225902|NCT02046369|472453699|FG000|Overall Study|never received study drug|0|||
131225903|NCT02046369|472453700|FG001|Overall Study|never received study drug|1|||
131225904|NCT02046369|472453699|FG000|Overall Study|non compliance|1|||
131225905|NCT02046369|472453700|FG001|Overall Study|non compliance|0|||
131225906|NCT03120520|472453701|FG000|Overall Study|Lost to Follow-up|1|||
131225907|NCT03120520|472453702|FG001|Overall Study|Lost to Follow-up|1|||
131225908|NCT03120520|472453703|FG002|Overall Study|Lost to Follow-up|1|||
131225909|NCT03120520|472453704|FG003|Overall Study|Lost to Follow-up|1|||
131225910|NCT03120520|472453701|FG000|Overall Study|Withdrawal by Subject|3|||
131225911|NCT03120520|472453702|FG001|Overall Study|Withdrawal by Subject|2|||
131225912|NCT03120520|472453703|FG002|Overall Study|Withdrawal by Subject|3|||
131225913|NCT03120520|472453704|FG003|Overall Study|Withdrawal by Subject|2|||
131225914|NCT03120520|472453701|FG000|Overall Study|Other|0|||
131225915|NCT03120520|472453702|FG001|Overall Study|Other|1|||
131225916|NCT03120520|472453703|FG002|Overall Study|Other|0|||
131225917|NCT03120520|472453704|FG003|Overall Study|Other|0|||
131225918|NCT02133352|472453708|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
131225919|NCT04444752|472453709|FG000|Overall Study|Adverse Event|1|||
130712961|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
130712962|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
130712963|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
131225920|NCT04444752|472453710|FG001|Overall Study|Adverse Event|0|||
131225921|NCT04444752|472453711|FG002|Overall Study|Adverse Event|0|||
131225922|NCT04444752|472453712|FG003|Overall Study|Adverse Event|2|||
131225923|NCT04444752|472453709|FG000|Overall Study|Lost to Follow-up|2|||
131225924|NCT04444752|472453710|FG001|Overall Study|Lost to Follow-up|6|||
131225925|NCT04444752|472453711|FG002|Overall Study|Lost to Follow-up|2|||
131225926|NCT04444752|472453712|FG003|Overall Study|Lost to Follow-up|5|||
131225927|NCT04444752|472453709|FG000|Overall Study|Physician Decision|0|||
131225928|NCT04444752|472453710|FG001|Overall Study|Physician Decision|0|||
131225929|NCT04444752|472453711|FG002|Overall Study|Physician Decision|0|||
131225930|NCT04444752|472453712|FG003|Overall Study|Physician Decision|2|||
131225931|NCT04444752|472453709|FG000|Overall Study|Pregnancy|0|||
131225932|NCT04444752|472453710|FG001|Overall Study|Pregnancy|0|||
131225933|NCT04444752|472453711|FG002|Overall Study|Pregnancy|0|||
131225934|NCT04444752|472453712|FG003|Overall Study|Pregnancy|1|||
131225935|NCT04444752|472453709|FG000|Overall Study|Withdrawal by Subject|6|||
131126277|NCT02819635|472091290|FG008|Substudy 3|Withdrew consent|11|||
131126278|NCT02819635|472091291|FG009|Substudy 3|Withdrew consent|1|||
131126279|NCT02819635|472091292|FG010|Substudy 3|Withdrew consent|4|||
131126280|NCT02819635|472091293|FG011|Substudy 3|Withdrew consent|9|||
131126281|NCT02819635|472091282|FG000|Substudy 3|Lost to Follow-up|0|||
131126282|NCT02819635|472091283|FG001|Substudy 3|Lost to Follow-up|0|||
131126283|NCT02819635|472091284|FG002|Substudy 3|Lost to Follow-up|0|||
131126284|NCT02819635|472091285|FG003|Substudy 3|Lost to Follow-up|0|||
131126285|NCT02819635|472091286|FG004|Substudy 3|Lost to Follow-up|0|||
131126286|NCT02819635|472091287|FG005|Substudy 3|Lost to Follow-up|0|||
131126287|NCT02819635|472091288|FG006|Substudy 3|Lost to Follow-up|0|||
131126288|NCT02819635|472091289|FG007|Substudy 3|Lost to Follow-up|0|||
131126289|NCT02819635|472091290|FG008|Substudy 3|Lost to Follow-up|1|||
131126290|NCT02819635|472091291|FG009|Substudy 3|Lost to Follow-up|0|||
131126291|NCT02819635|472091292|FG010|Substudy 3|Lost to Follow-up|1|||
131126292|NCT02819635|472091293|FG011|Substudy 3|Lost to Follow-up|1|||
131126293|NCT02819635|472091282|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126294|NCT02819635|472091283|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126295|NCT02819635|472091284|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126296|NCT02819635|472091285|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126297|NCT02819635|472091286|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126298|NCT02819635|472091287|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126299|NCT02819635|472091288|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126300|NCT02819635|472091289|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126301|NCT02819635|472091290|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126302|NCT02819635|472091291|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126303|NCT02819635|472091292|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
131126304|NCT02819635|472091293|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
131126305|NCT02819635|472091282|FG000|Substudy 3|Other, not specified|0|||
131126306|NCT02819635|472091283|FG001|Substudy 3|Other, not specified|0|||
131126307|NCT02819635|472091284|FG002|Substudy 3|Other, not specified|0|||
131126308|NCT02819635|472091285|FG003|Substudy 3|Other, not specified|0|||
131126309|NCT02819635|472091286|FG004|Substudy 3|Other, not specified|0|||
131126310|NCT02819635|472091287|FG005|Substudy 3|Other, not specified|0|||
131126311|NCT02819635|472091288|FG006|Substudy 3|Other, not specified|0|||
131126312|NCT02819635|472091289|FG007|Substudy 3|Other, not specified|0|||
131126313|NCT02819635|472091290|FG008|Substudy 3|Other, not specified|202|||
131126314|NCT02819635|472091291|FG009|Substudy 3|Other, not specified|5|||
131126315|NCT02819635|472091292|FG010|Substudy 3|Other, not specified|89|||
131126316|NCT02819635|472091293|FG011|Substudy 3|Other, not specified|39|||
131126317|NCT03179891|472091298|FG000|First Intervention|Withdrawal by Subject|1|||
131126318|NCT03179891|472091299|FG001|First Intervention|Withdrawal by Subject|1|||
131126319|NCT03179891|472091298|FG000|First Intervention|Unspecified reason|1|||
131126320|NCT03179891|472091299|FG001|First Intervention|Unspecified reason|0|||
131126321|NCT03179891|472091298|FG000|First Intervention|Protocol Violation|0|||
131126322|NCT03179891|472091299|FG001|First Intervention|Protocol Violation|1|||
131126323|NCT01438489|472091300|FG000|Overall Study|Lost to Follow-up|4|||
131126324|NCT01438489|472091301|FG001|Overall Study|Lost to Follow-up|2|||
131126325|NCT01438489|472091302|FG002|Overall Study|Lost to Follow-up|2|||
131126326|NCT01438489|472091300|FG000|Overall Study|Withdrawal by Subject|11|||
131126327|NCT01438489|472091301|FG001|Overall Study|Withdrawal by Subject|3|||
131126328|NCT01438489|472091302|FG002|Overall Study|Withdrawal by Subject|8|||
131126329|NCT01438489|472091300|FG000|Overall Study|Death|0|||
131126330|NCT01438489|472091301|FG001|Overall Study|Death|0|||
131126331|NCT01438489|472091302|FG002|Overall Study|Death|1|||
131126332|NCT01438489|472091300|FG000|Overall Study|Sponsor decision|4|||
131126333|NCT01438489|472091301|FG001|Overall Study|Sponsor decision|1|||
131126334|NCT01438489|472091302|FG002|Overall Study|Sponsor decision|4|||
131126335|NCT01438489|472091300|FG000|Overall Study|Subject choice/Subject moved|2|||
131126336|NCT01438489|472091301|FG001|Overall Study|Subject choice/Subject moved|1|||
131126337|NCT01438489|472091302|FG002|Overall Study|Subject choice/Subject moved|1|||
131126338|NCT01438489|472091300|FG000|Overall Study|Investigator decision|0|||
131126339|NCT01438489|472091301|FG001|Overall Study|Investigator decision|1|||
131126340|NCT01438489|472091302|FG002|Overall Study|Investigator decision|0|||
131126341|NCT01438489|472091300|FG000|Overall Study|AE/SAEs|2|||
131126342|NCT01438489|472091301|FG001|Overall Study|AE/SAEs|1|||
131126343|NCT01438489|472091302|FG002|Overall Study|AE/SAEs|1|||
131126344|NCT01438489|472091300|FG000|Overall Study|Received prohibited medication|1|||
131126345|NCT01438489|472091301|FG001|Overall Study|Received prohibited medication|0|||
131126346|NCT01438489|472091302|FG002|Overall Study|Received prohibited medication|0|||
131126347|NCT01438489|472091300|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
131126348|NCT01438489|472091301|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
131126349|NCT01438489|472091302|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
131126350|NCT01438489|472091300|FG000|Overall Study|Inadequate venous access|0|||
131126351|NCT01438489|472091301|FG001|Overall Study|Inadequate venous access|2|||
131126352|NCT01438489|472091302|FG002|Overall Study|Inadequate venous access|0|||
131126353|NCT00751400|472091303|FG000|Overall Study|Lost to Follow-up|10|||
131126354|NCT00573430|472091304|FG000|Overall Study|Incorrect enrollment of randomization|0|||
131126355|NCT00573430|472091305|FG001|Overall Study|Incorrect enrollment of randomization|4|||
131126356|NCT00573430|472091306|FG002|Overall Study|Incorrect enrollment of randomization|3|||
131126357|NCT00573430|472091304|FG000|Overall Study|Adverse Event|0|||
131126358|NCT00573430|472091305|FG001|Overall Study|Adverse Event|0|||
131126359|NCT00573430|472091306|FG002|Overall Study|Adverse Event|2|||
131126360|NCT00573430|472091304|FG000|Overall Study|Withdrawal by Subject|1|||
131126361|NCT00573430|472091305|FG001|Overall Study|Withdrawal by Subject|0|||
131126362|NCT00573430|472091306|FG002|Overall Study|Withdrawal by Subject|1|||
131126363|NCT00573430|472091304|FG000|Overall Study|Protocol Violation|0|||
131126364|NCT00573430|472091305|FG001|Overall Study|Protocol Violation|1|||
131126365|NCT00573430|472091306|FG002|Overall Study|Protocol Violation|1|||
131126366|NCT00573430|472091304|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131126367|NCT00573430|472091305|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131126368|NCT00573430|472091306|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
131126369|NCT01148537|472091312|FG000|Overall Study|Withdrawal by Subject|1|||
131126370|NCT01148537|472091313|FG001|Overall Study|Withdrawal by Subject|0|||
131126371|NCT01148537|472091314|FG002|Overall Study|Withdrawal by Subject|2|||
131126372|NCT01148537|472091312|FG000|Overall Study|Adverse Event|2|||
131126373|NCT01148537|472091313|FG001|Overall Study|Adverse Event|0|||
131126374|NCT01148537|472091314|FG002|Overall Study|Adverse Event|1|||
131126375|NCT01324232|472091315|FG000|Overall Study|Protocol Violation|0|||
131126376|NCT01324232|472091316|FG001|Overall Study|Protocol Violation|0|||
131126377|NCT01324232|472091317|FG002|Overall Study|Protocol Violation|0|||
131126378|NCT01324232|472091318|FG003|Overall Study|Protocol Violation|2|||
131126379|NCT01324232|472091315|FG000|Overall Study|Missing|0|||
131126380|NCT01324232|472091316|FG001|Overall Study|Missing|0|||
131126381|NCT01324232|472091317|FG002|Overall Study|Missing|1|||
131126382|NCT01324232|472091318|FG003|Overall Study|Missing|0|||
131126383|NCT01324232|472091315|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
131126384|NCT01324232|472091316|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
131126385|NCT01324232|472091317|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
131126386|NCT01324232|472091318|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
131126387|NCT01324232|472091315|FG000|Overall Study|Lack of Efficacy|2|||
131126388|NCT01324232|472091316|FG001|Overall Study|Lack of Efficacy|1|||
131126389|NCT01324232|472091317|FG002|Overall Study|Lack of Efficacy|2|||
131126390|NCT01324232|472091318|FG003|Overall Study|Lack of Efficacy|2|||
131126391|NCT01324232|472091315|FG000|Overall Study|Participant Refused Medication|0|||
130956362|NCT01573624|471471185|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130956363|NCT01573624|471471186|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130956364|NCT01573624|471471187|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130956365|NCT01573624|471471188|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
130956366|NCT01573624|471471189|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
130956367|NCT01573624|471471183|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130956368|NCT01573624|471471184|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130956369|NCT01573624|471471185|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130956370|NCT01573624|471471186|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
130956371|NCT01573624|471471187|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130956372|NCT01573624|471471188|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
130956373|NCT01573624|471471189|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
130956374|NCT01573624|471471183|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
130956375|NCT01573624|471471184|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
130956376|NCT01573624|471471185|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
130956377|NCT01573624|471471186|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
130956378|NCT01573624|471471187|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
130956379|NCT01573624|471471188|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
130956380|NCT01573624|471471189|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
130956381|NCT01573624|471471183|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
130956382|NCT01573624|471471184|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
130956383|NCT01573624|471471185|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
130956384|NCT01573624|471471186|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
130956385|NCT01573624|471471187|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
130956386|NCT01573624|471471188|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
130956387|NCT01573624|471471189|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
130956388|NCT01573624|471471183|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
131126392|NCT01324232|472091316|FG001|Overall Study|Participant Refused Medication|1|||
131126393|NCT01324232|472091317|FG002|Overall Study|Participant Refused Medication|0|||
131126394|NCT01324232|472091318|FG003|Overall Study|Participant Refused Medication|0|||
131126395|NCT01324232|472091315|FG000|Overall Study|Intercurrent illness|0|||
131039980|NCT03687086|471781788|FG000|Overall Study|Incomplete assessment|0|||
131039981|NCT03687086|471781789|FG001|Overall Study|Incomplete assessment|2|||
131039982|NCT02505984|471781790|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
131039983|NCT02505984|471781791|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
131039984|NCT02505984|471781790|FG000|Overall Study|Unreliable self-report data|1|||
131039985|NCT02505984|471781791|FG001|Overall Study|Unreliable self-report data|0|||
131039986|NCT02505984|471781790|FG000|Overall Study|Study blind opened during assessment|0|||
131039987|NCT02505984|471781791|FG001|Overall Study|Study blind opened during assessment|1|||
131039988|NCT02505984|471781790|FG000|Overall Study|Noncompliance with study protocol|0|||
131039989|NCT02505984|471781791|FG001|Overall Study|Noncompliance with study protocol|1|||
131039990|NCT03905798|471781813|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
131039991|NCT04433208|471781814|FG000|Overall Study|Withdrawal by Subject|0|||
131039992|NCT04433208|471781815|FG001|Overall Study|Withdrawal by Subject|1|||
131039993|NCT04433208|471781816|FG002|Overall Study|Withdrawal by Subject|1|||
131039994|NCT04433208|471781817|FG003|Overall Study|Withdrawal by Subject|0|||
131039995|NCT04433208|471781818|FG004|Overall Study|Withdrawal by Subject|2|||
131039996|NCT04433208|471781819|FG005|Overall Study|Withdrawal by Subject|1|||
131039997|NCT04433208|471781814|FG000|Overall Study|Lost to Follow-up|0|||
131039998|NCT04433208|471781815|FG001|Overall Study|Lost to Follow-up|0|||
131039999|NCT04433208|471781816|FG002|Overall Study|Lost to Follow-up|0|||
131126396|NCT01324232|472091316|FG001|Overall Study|Intercurrent illness|0|||
131126397|NCT01324232|472091317|FG002|Overall Study|Intercurrent illness|0|||
131126398|NCT01324232|472091318|FG003|Overall Study|Intercurrent illness|1|||
131126399|NCT01324232|472091315|FG000|Overall Study|Adverse Event|2|||
131126400|NCT01324232|472091316|FG001|Overall Study|Adverse Event|5|||
131126401|NCT01324232|472091317|FG002|Overall Study|Adverse Event|6|||
131126402|NCT01324232|472091318|FG003|Overall Study|Adverse Event|6|||
131126403|NCT01324232|472091315|FG000|Overall Study|Withdrawal by Subject|0|||
131126404|NCT01324232|472091316|FG001|Overall Study|Withdrawal by Subject|3|||
131126405|NCT01324232|472091317|FG002|Overall Study|Withdrawal by Subject|4|||
131126406|NCT01324232|472091318|FG003|Overall Study|Withdrawal by Subject|0|||
131126407|NCT01324232|472091315|FG000|Overall Study|Lost to Follow-up|1|||
131126408|NCT01324232|472091316|FG001|Overall Study|Lost to Follow-up|0|||
131126409|NCT01324232|472091317|FG002|Overall Study|Lost to Follow-up|0|||
131126410|NCT01324232|472091318|FG003|Overall Study|Lost to Follow-up|0|||
131126411|NCT00661531|472091319|FG000|Overall Study|Withdrawal by Subject|3|||
131126412|NCT03134599|472091321|FG000|Week 1|Lost to Follow-up|0|||
131126413|NCT03134599|472091322|FG001|Week 1|Lost to Follow-up|0|||
131126414|NCT03134599|472091323|FG002|Week 1|Lost to Follow-up|0|||
131126415|NCT03134599|472091324|FG003|Week 1|Lost to Follow-up|0|||
131126416|NCT03134599|472091325|FG004|Week 1|Lost to Follow-up|1|||
131126417|NCT03134599|472091326|FG005|Week 1|Lost to Follow-up|0|||
131126418|NCT03134599|472091321|FG000|Week 2|Lost to Follow-up|1|||
131126419|NCT03134599|472091322|FG001|Week 2|Lost to Follow-up|0|||
131126420|NCT03134599|472091323|FG002|Week 2|Lost to Follow-up|0|||
131126421|NCT03134599|472091324|FG003|Week 2|Lost to Follow-up|1|||
131126422|NCT03134599|472091325|FG004|Week 2|Lost to Follow-up|1|||
131126423|NCT03134599|472091326|FG005|Week 2|Lost to Follow-up|0|||
131126424|NCT03134599|472091321|FG000|Week 3|Lost to Follow-up|0|||
131126425|NCT03134599|472091322|FG001|Week 3|Lost to Follow-up|0|||
131126426|NCT03134599|472091323|FG002|Week 3|Lost to Follow-up|0|||
131126427|NCT03134599|472091324|FG003|Week 3|Lost to Follow-up|1|||
131126428|NCT03134599|472091325|FG004|Week 3|Lost to Follow-up|0|||
131126429|NCT03134599|472091326|FG005|Week 3|Lost to Follow-up|1|||
131126430|NCT01356407|472091329|FG000|Overall Study|Lost to Follow-up|2|||
131126431|NCT01356407|472091330|FG001|Overall Study|Lost to Follow-up|0|||
131126432|NCT01356407|472091329|FG000|Overall Study|Patient Withdrew Consent|2|||
131126433|NCT01356407|472091330|FG001|Overall Study|Patient Withdrew Consent|1|||
131126434|NCT01356407|472091329|FG000|Overall Study|Could not afford IMP administration|0|||
131126435|NCT01356407|472091330|FG001|Overall Study|Could not afford IMP administration|1|||
131126436|NCT01356407|472091329|FG000|Overall Study|Not complete Endoscopy|2|||
131126437|NCT01356407|472091330|FG001|Overall Study|Not complete Endoscopy|2|||
131126438|NCT03201458|472091331|FG000|Overall Study|No longer eligible|2|||
131040000|NCT04433208|471781817|FG003|Overall Study|Lost to Follow-up|0|||
131040001|NCT04433208|471781818|FG004|Overall Study|Lost to Follow-up|0|||
131040002|NCT04433208|471781819|FG005|Overall Study|Lost to Follow-up|1|||
131040003|NCT05170841|471781820|FG000|Single Dose Phase|Adverse Event|1|||
131040004|NCT05170841|471781821|FG001|Single Dose Phase|Adverse Event|2|||
131126439|NCT03201458|472091332|FG001|Overall Study|No longer eligible|5|||
131126440|NCT03201458|472091331|FG000|Overall Study|Health event before starting|1|||
131126441|NCT03201458|472091332|FG001|Overall Study|Health event before starting|0|||
131126442|NCT03201458|472091331|FG000|Overall Study|Physician Decision|1|||
131126443|NCT03201458|472091332|FG001|Overall Study|Physician Decision|0|||
131126444|NCT00750737|472091333|FG000|Overall Study|Withdrawal by Subject|3|||
131126445|NCT00750737|472091334|FG001|Overall Study|Withdrawal by Subject|3|||
131126446|NCT02614859|472091335|FG000|Overall Study|Physician Decision|0|||
131126447|NCT02614859|472091336|FG001|Overall Study|Physician Decision|1|||
131225936|NCT04444752|472453710|FG001|Overall Study|Withdrawal by Subject|5|||
131225937|NCT04444752|472453711|FG002|Overall Study|Withdrawal by Subject|3|||
131225938|NCT04444752|472453712|FG003|Overall Study|Withdrawal by Subject|4|||
131225939|NCT04444752|472453709|FG000|Overall Study|Protocol Violation|1|||
131225940|NCT04444752|472453710|FG001|Overall Study|Protocol Violation|1|||
131225941|NCT04444752|472453711|FG002|Overall Study|Protocol Violation|0|||
131225942|NCT04444752|472453712|FG003|Overall Study|Protocol Violation|0|||
131225943|NCT04444752|472453709|FG000|Overall Study|Patient moving out of town|1|||
131225944|NCT04444752|472453710|FG001|Overall Study|Patient moving out of town|0|||
131225945|NCT04444752|472453711|FG002|Overall Study|Patient moving out of town|0|||
131225946|NCT04444752|472453712|FG003|Overall Study|Patient moving out of town|1|||
131225947|NCT04444752|472453709|FG000|Overall Study|Lack of Efficacy|0|||
131225948|NCT04444752|472453710|FG001|Overall Study|Lack of Efficacy|0|||
131225949|NCT04444752|472453711|FG002|Overall Study|Lack of Efficacy|0|||
131225950|NCT04444752|472453712|FG003|Overall Study|Lack of Efficacy|1|||
131225951|NCT04444752|472453709|FG000|Overall Study|Death|0|||
131225952|NCT04444752|472453710|FG001|Overall Study|Death|0|||
131225953|NCT04444752|472453711|FG002|Overall Study|Death|1|||
131225954|NCT04444752|472453712|FG003|Overall Study|Death|0|||
131225955|NCT00579254|472453713|FG000|Overall Study|Lost to Follow-up|39|||
131225956|NCT00579254|472453713|FG000|Overall Study|Discontinued when study terminated|73|||
131225957|NCT02557672|472453714|FG000|Overall Study|Withdrawal by Subject|4|||
131225958|NCT02557672|472453715|FG001|Overall Study|Withdrawal by Subject|2|||
131225959|NCT03705169|472453716|FG000|Overall Study|Lost to Follow-up|0|||
131225960|NCT03705169|472453717|FG001|Overall Study|Lost to Follow-up|0|||
131225961|NCT03705169|472453718|FG002|Overall Study|Lost to Follow-up|0|||
131225962|NCT03705169|472453719|FG003|Overall Study|Lost to Follow-up|2|||
131225963|NCT03705169|472453720|FG004|Overall Study|Lost to Follow-up|0|||
131225964|NCT03705169|472453721|FG005|Overall Study|Lost to Follow-up|2|||
131225965|NCT03705169|472453722|FG006|Overall Study|Lost to Follow-up|1|||
131225966|NCT03705169|472453723|FG007|Overall Study|Lost to Follow-up|0|||
131225967|NCT03705169|472453724|FG008|Overall Study|Lost to Follow-up|0|||
131225968|NCT03705169|472453725|FG009|Overall Study|Lost to Follow-up|1|||
131225969|NCT03705169|472453716|FG000|Overall Study|Adverse Event|0|||
131225970|NCT03705169|472453717|FG001|Overall Study|Adverse Event|0|||
131225971|NCT03705169|472453718|FG002|Overall Study|Adverse Event|0|||
131225972|NCT03705169|472453719|FG003|Overall Study|Adverse Event|1|||
131225973|NCT03705169|472453720|FG004|Overall Study|Adverse Event|0|||
131225974|NCT03705169|472453721|FG005|Overall Study|Adverse Event|0|||
131225975|NCT03705169|472453722|FG006|Overall Study|Adverse Event|0|||
131225976|NCT03705169|472453723|FG007|Overall Study|Adverse Event|0|||
131225977|NCT03705169|472453724|FG008|Overall Study|Adverse Event|0|||
131225978|NCT03705169|472453725|FG009|Overall Study|Adverse Event|0|||
131225979|NCT03705169|472453716|FG000|Overall Study|Site Closure|0|||
131225980|NCT03705169|472453717|FG001|Overall Study|Site Closure|0|||
131225981|NCT03705169|472453718|FG002|Overall Study|Site Closure|0|||
131225982|NCT03705169|472453719|FG003|Overall Study|Site Closure|1|||
131225983|NCT03705169|472453720|FG004|Overall Study|Site Closure|0|||
131225984|NCT03705169|472453721|FG005|Overall Study|Site Closure|0|||
131225985|NCT03705169|472453722|FG006|Overall Study|Site Closure|0|||
131225986|NCT03705169|472453723|FG007|Overall Study|Site Closure|0|||
131225987|NCT03705169|472453724|FG008|Overall Study|Site Closure|0|||
131225988|NCT03705169|472453725|FG009|Overall Study|Site Closure|0|||
131225989|NCT03705169|472453716|FG000|Overall Study|Did not receive study treatment|0|||
131225990|NCT03705169|472453717|FG001|Overall Study|Did not receive study treatment|0|||
131225991|NCT03705169|472453718|FG002|Overall Study|Did not receive study treatment|0|||
131225992|NCT03705169|472453719|FG003|Overall Study|Did not receive study treatment|1|||
130712964|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130712965|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130712966|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
130712967|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130956389|NCT01573624|471471184|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
130956390|NCT01573624|471471185|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
130956391|NCT01573624|471471186|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
130956392|NCT01573624|471471187|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
130956393|NCT01573624|471471188|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
130956394|NCT01573624|471471189|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
130956395|NCT01573624|471471183|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
131225993|NCT03705169|472453720|FG004|Overall Study|Did not receive study treatment|0|||
131225994|NCT03705169|472453721|FG005|Overall Study|Did not receive study treatment|0|||
131225995|NCT03705169|472453722|FG006|Overall Study|Did not receive study treatment|0|||
131225996|NCT03705169|472453723|FG007|Overall Study|Did not receive study treatment|0|||
131225997|NCT03705169|472453724|FG008|Overall Study|Did not receive study treatment|0|||
131225998|NCT03705169|472453725|FG009|Overall Study|Did not receive study treatment|0|||
131225999|NCT03705169|472453716|FG000|Overall Study|Concerns about study visit compliance|0|||
130712968|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130712969|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130712970|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130712971|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
130712972|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
130712973|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
130712974|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
130712975|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
130712976|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
130712977|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
130712978|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Other|2|||
130712979|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Other|9|||
130712980|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Other|9|||
130712981|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Other|3|||
130712982|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Other|2|||
130712983|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Other|0|||
130712984|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Other|0|||
130712985|NCT00361335|470575280|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
130712986|NCT00361335|470575281|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
130712987|NCT00361335|470575282|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
130712988|NCT00361335|470575283|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
130712989|NCT00361335|470575284|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
130712990|NCT00361335|470575285|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
130712991|NCT00361335|470575286|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
130712992|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
130712993|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
130712994|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
130712995|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
130712996|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
130712997|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
130712998|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
130712999|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
130713000|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130713001|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
130713002|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130713003|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130713004|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130713005|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
130713006|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Death|0|||
130713007|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Death|0|||
130713008|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Death|0|||
130713009|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Death|0|||
130956396|NCT01573624|471471184|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130956397|NCT01573624|471471185|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130956398|NCT01573624|471471186|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130956399|NCT01573624|471471187|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130956400|NCT01573624|471471188|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130956401|NCT01573624|471471189|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
130956402|NCT01573624|471471183|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131040005|NCT05170841|471781822|FG002|Single Dose Phase|Adverse Event|0|||
131040006|NCT05170841|471781823|FG003|Single Dose Phase|Adverse Event|2|||
131040007|NCT05170841|471781820|FG000|Multiple Dose Phase|Adverse Event|1|||
131040008|NCT05170841|471781821|FG001|Multiple Dose Phase|Adverse Event|2|||
131040009|NCT05170841|471781822|FG002|Multiple Dose Phase|Adverse Event|1|||
131040010|NCT05170841|471781823|FG003|Multiple Dose Phase|Adverse Event|4|||
131040011|NCT05170841|471781820|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
131040012|NCT05170841|471781821|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
131040013|NCT05170841|471781822|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
131040014|NCT05170841|471781823|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
131040015|NCT05123586|471781826|FG000|Overall Study|Physician Decision|1|||
131040016|NCT05123586|471781827|FG001|Overall Study|Physician Decision|1|||
131040017|NCT05123586|471781826|FG000|Overall Study|Withdrawal by Subject|0|||
131040018|NCT05123586|471781827|FG001|Overall Study|Withdrawal by Subject|3|||
130713010|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Death|0|||
131040019|NCT03734679|471781833|FG000|Overall Study|Missed Visit|1|||
130713011|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Death|0|||
131040020|NCT02733159|471781835|FG000|Overall Study|Adverse Event|1|||
131040021|NCT02733159|471781835|FG000|Overall Study|Lack of disease progression|1|||
131040022|NCT06122194|471781836|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
130713012|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Death|1|||
130713013|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130713014|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
130713015|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
130713016|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
130713017|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130713018|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130713019|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130956403|NCT01573624|471471184|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
130956404|NCT01573624|471471185|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
130956405|NCT01573624|471471186|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130956406|NCT01573624|471471187|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130956407|NCT01573624|471471188|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
130956408|NCT01573624|471471189|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130956409|NCT01573624|471471183|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
130956410|NCT01573624|471471184|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130956411|NCT01573624|471471185|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130956412|NCT01573624|471471186|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130956413|NCT01573624|471471187|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130956414|NCT01573624|471471188|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130956415|NCT01573624|471471189|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
130956416|NCT01573624|471471183|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
130956417|NCT01573624|471471184|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
130956418|NCT01573624|471471185|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
130956419|NCT01573624|471471186|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
130956420|NCT01573624|471471187|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
131126448|NCT01389752|472091338|FG000|Study Period 1|Sponsor decision|0|||
131126449|NCT01389752|472091339|FG001|Study Period 1|Sponsor decision|2|||
130713020|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Other|1|||
130713021|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Other|0|||
130713022|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Other|0|||
130713023|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Other|1|||
131126450|NCT01389752|472091338|FG000|Study Period 2|Sponsor decision|1|||
130713024|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Other|0|||
131126451|NCT01389752|472091339|FG001|Study Period 2|Sponsor decision|0|||
131126452|NCT03975920|472091354|FG000|Overall Study|Lost to Follow-up|1|||
131126453|NCT03975920|472091355|FG001|Overall Study|Lost to Follow-up|2|||
131126454|NCT03975920|472091354|FG000|Overall Study|Protocol Violation|1|||
131126455|NCT03975920|472091355|FG001|Overall Study|Protocol Violation|1|||
131126456|NCT03975920|472091354|FG000|Overall Study|Did not complete survey|2|||
131126457|NCT03975920|472091355|FG001|Overall Study|Did not complete survey|1|||
131126458|NCT04251910|472091358|FG000|Overall Study|Covid 19 lockdown|0|||
131126459|NCT04251910|472091359|FG001|Overall Study|Covid 19 lockdown|5|||
131126460|NCT04251910|472091360|FG002|Overall Study|Covid 19 lockdown|0|||
131126461|NCT04251910|472091361|FG003|Overall Study|Covid 19 lockdown|4|||
131126462|NCT04251910|472091362|FG004|Overall Study|Covid 19 lockdown|0|||
131126463|NCT04251910|472091363|FG005|Overall Study|Covid 19 lockdown|0|||
131126464|NCT04251910|472091358|FG000|Overall Study|Assisted living facility was closed|0|||
131126465|NCT04251910|472091359|FG001|Overall Study|Assisted living facility was closed|0|||
131126466|NCT04251910|472091360|FG002|Overall Study|Assisted living facility was closed|0|||
131126467|NCT04251910|472091361|FG003|Overall Study|Assisted living facility was closed|0|||
131126468|NCT04251910|472091362|FG004|Overall Study|Assisted living facility was closed|1|||
131126469|NCT04251910|472091363|FG005|Overall Study|Assisted living facility was closed|0|||
131126470|NCT02230384|472091366|FG000|Phase 1|Lost to Follow-up|1|||
131126471|NCT02230384|472091367|FG001|Phase 1|Lost to Follow-up|0|||
131126472|NCT02230384|472091366|FG000|Phase 1|Physician Decision|0|||
131126473|NCT02230384|472091367|FG001|Phase 1|Physician Decision|1|||
131126474|NCT02230384|472091366|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
131126475|NCT02230384|472091367|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
131126476|NCT02230384|472091366|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
131126477|NCT02230384|472091367|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
131226000|NCT03705169|472453717|FG001|Overall Study|Concerns about study visit compliance|0|||
131226001|NCT03705169|472453718|FG002|Overall Study|Concerns about study visit compliance|0|||
130713025|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Other|1|||
130713026|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Other|2|||
130713027|NCT00361335|470575280|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130713028|NCT00361335|470575281|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
131126478|NCT02230384|472091366|FG000|Phase 2 - Switch|Adverse Event|2|||
131126479|NCT02230384|472091367|FG001|Phase 2 - Switch|Adverse Event|0|||
131126480|NCT00808236|472091368|FG000|Overall Study|Was not resuscitated|50|||
131126481|NCT00808236|472091369|FG001|Overall Study|Was not resuscitated|56|||
131126482|NCT00808236|472091368|FG000|Overall Study|Pre-defined exclusion|13|||
130713029|NCT00361335|470575282|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
131126483|NCT00808236|472091369|FG001|Overall Study|Pre-defined exclusion|3|||
131126484|NCT00808236|472091368|FG000|Overall Study|Lost to Follow-up|1|||
130713030|NCT00361335|470575283|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130713031|NCT00361335|470575284|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130713032|NCT00361335|470575285|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130713033|NCT00361335|470575286|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
130713034|NCT05065983|470575287|FG000|Overall Study|Lost to Follow-up|2|||
130956421|NCT01573624|471471188|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
130956422|NCT01573624|471471189|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
130956423|NCT01573624|471471183|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
130956424|NCT01573624|471471184|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
130956425|NCT01573624|471471185|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
130956426|NCT01573624|471471186|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
130956427|NCT01573624|471471187|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
130956428|NCT01573624|471471188|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
130956429|NCT01573624|471471189|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
130956430|NCT01573624|471471183|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130956431|NCT01573624|471471184|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
130956432|NCT01573624|471471185|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130956433|NCT01573624|471471186|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130956434|NCT01573624|471471187|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130956435|NCT01573624|471471188|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130956436|NCT01573624|471471189|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
130956437|NCT01573624|471471183|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130956438|NCT01573624|471471184|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
130956439|NCT01573624|471471185|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130956440|NCT01573624|471471186|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130956441|NCT01573624|471471187|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130956442|NCT01573624|471471188|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130956443|NCT01573624|471471189|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
130956444|NCT01573624|471471183|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130956445|NCT01573624|471471184|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130956446|NCT01573624|471471185|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130956447|NCT01573624|471471186|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130956448|NCT01573624|471471187|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
130956449|NCT01573624|471471188|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
130956450|NCT01573624|471471189|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
130956451|NCT01573624|471471183|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
130956452|NCT01573624|471471184|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
130956453|NCT01573624|471471185|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
130956454|NCT01573624|471471186|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
130956455|NCT01573624|471471187|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
130956456|NCT01573624|471471188|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
130956457|NCT01573624|471471189|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
130956458|NCT01573624|471471183|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
130956459|NCT01573624|471471184|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130956460|NCT01573624|471471185|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130956461|NCT01573624|471471186|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130956462|NCT01573624|471471187|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
130956463|NCT01573624|471471188|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
130956464|NCT01573624|471471189|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
130956465|NCT01573624|471471183|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
130956466|NCT01573624|471471184|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
130956467|NCT01573624|471471185|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
130956468|NCT01573624|471471186|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
130956469|NCT01573624|471471187|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
130956470|NCT01573624|471471188|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
130956471|NCT01573624|471471189|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
130956472|NCT01573624|471471183|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
130956473|NCT01573624|471471184|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130956474|NCT01573624|471471185|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130956475|NCT01573624|471471186|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
131040023|NCT06122194|471781837|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
131040024|NCT06122194|471781838|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
130713035|NCT01765582|470575288|FG000|Overall Study|Other|3|||
131040025|NCT06122194|471781839|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
131040026|NCT02887521|471781848|FG000|Overall Study|Withdrawal by Subject|0|||
131040027|NCT02887521|471781849|FG001|Overall Study|Withdrawal by Subject|3|||
131040028|NCT02709161|471781852|FG000|Overall Study|Withdrawal by Subject|1|||
131040029|NCT02709161|471781853|FG001|Overall Study|Withdrawal by Subject|0|||
131040030|NCT03626220|471781855|FG000|Overall Study|Withdrawal by Subject|2|||
131040031|NCT03626220|471781856|FG001|Overall Study|Withdrawal by Subject|0|||
131040032|NCT02305888|471783359|FG000|Overall Study|Lost to Follow-up|0|||
131040033|NCT02305888|471783360|FG001|Overall Study|Lost to Follow-up|0|||
131040034|NCT02305888|471783361|FG002|Overall Study|Lost to Follow-up|1|||
131040035|NCT02305888|471783359|FG000|Overall Study|Adverse Event|0|||
131040036|NCT02305888|471783360|FG001|Overall Study|Adverse Event|1|||
131040037|NCT02305888|471783361|FG002|Overall Study|Adverse Event|0|||
131040038|NCT06232590|471783362|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
131040039|NCT06232590|471783363|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
131040040|NCT04914676|471783364|FG000|Overall Study|Study termination|3|||
131040041|NCT04914676|471783365|FG001|Overall Study|Study termination|0|||
131040042|NCT03240016|471783366|FG000|Overall Study|Adverse Event|9|||
131040043|NCT03240016|471783366|FG000|Overall Study|Withdrawal by Subject|7|||
131040044|NCT03240016|471783366|FG000|Overall Study|Death|1|||
131040045|NCT03240016|471783366|FG000|Overall Study|Physician Decision|2|||
131040046|NCT03220035|471783368|FG000|Overall Study|Adverse Event|1|||
131040047|NCT03220035|471783368|FG000|Overall Study|Protocol Violation|1|||
131040048|NCT03220035|471783368|FG000|Overall Study|Progressive Disease|2|||
131040049|NCT02433379|471783372|FG000|Overall Study|Screen Failures|55|||
131040050|NCT02433379|471783372|FG000|Overall Study|Death|57|||
131040051|NCT02433379|471783372|FG000|Overall Study|Total Withdrawals|209|||
131040052|NCT05299073|471783373|FG000|Overall Study|Withdrawal by Subject|0|||
131040053|NCT05299073|471783374|FG001|Overall Study|Withdrawal by Subject|0|||
131040054|NCT05299073|471783375|FG002|Overall Study|Withdrawal by Subject|1|||
131040055|NCT05299073|471783373|FG000|Overall Study|Adverse Event|0|||
131040056|NCT05299073|471783374|FG001|Overall Study|Adverse Event|1|||
131040057|NCT05299073|471783375|FG002|Overall Study|Adverse Event|0|||
131040058|NCT05299073|471783373|FG000|Overall Study|Lost to Follow-up|0|||
131040059|NCT05299073|471783374|FG001|Overall Study|Lost to Follow-up|1|||
131040060|NCT05299073|471783375|FG002|Overall Study|Lost to Follow-up|0|||
130956476|NCT01573624|471471187|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130956477|NCT01573624|471471188|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130956478|NCT01573624|471471189|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
130956479|NCT01573624|471471183|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
130956480|NCT01573624|471471184|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
130956481|NCT01573624|471471185|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
130713036|NCT01765582|470575289|FG001|Overall Study|Other|6|||
130713037|NCT01765582|470575290|FG002|Overall Study|Other|9|||
130713038|NCT01765582|470575288|FG000|Overall Study|Lost to Follow-up|2|||
130713039|NCT01765582|470575289|FG001|Overall Study|Lost to Follow-up|2|||
130713040|NCT01765582|470575290|FG002|Overall Study|Lost to Follow-up|1|||
130713041|NCT01765582|470575288|FG000|Overall Study|Death|31|||
130713042|NCT01765582|470575289|FG001|Overall Study|Death|36|||
130713043|NCT01765582|470575290|FG002|Overall Study|Death|33|||
130956482|NCT01573624|471471186|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
130956483|NCT01573624|471471187|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
130956484|NCT01573624|471471188|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
130956485|NCT01573624|471471189|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
130956486|NCT01573624|471471183|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
130956487|NCT01573624|471471184|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130956488|NCT01573624|471471185|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130956489|NCT01573624|471471186|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130956490|NCT01573624|471471187|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130956491|NCT01573624|471471188|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
130956492|NCT01573624|471471189|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
131040061|NCT05070728|471783380|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
131040062|NCT05070728|471783381|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
131040063|NCT04770402|471783388|FG000|Overall Study|Lost to Follow-up|1|||
131040064|NCT04770402|471783389|FG001|Overall Study|Lost to Follow-up|2|||
131040065|NCT04770402|471783388|FG000|Overall Study|Non-compliance|1|||
131040066|NCT04770402|471783389|FG001|Overall Study|Non-compliance|0|||
131040067|NCT04770402|471783388|FG000|Overall Study|Withdrawal by Subject|0|||
131126485|NCT00808236|472091369|FG001|Overall Study|Lost to Follow-up|1|||
131040068|NCT04770402|471783389|FG001|Overall Study|Withdrawal by Subject|1|||
131040069|NCT02589795|471783391|FG000|Overall Study|Lost to Follow-up|1|||
131126486|NCT00808236|472091368|FG000|Overall Study|Physician Decision|0|||
130713044|NCT01765582|470575288|FG000|Overall Study|Sponsor Decision|46|||
130713045|NCT01765582|470575289|FG001|Overall Study|Sponsor Decision|42|||
130713046|NCT01765582|470575290|FG002|Overall Study|Sponsor Decision|42|||
130956493|NCT02681302|471471190|FG000|Overall Study|Withdrawal by Subject|1|||
130956494|NCT02681302|471471191|FG001|Overall Study|Withdrawal by Subject|1|||
130956495|NCT02681302|471471192|FG002|Overall Study|Withdrawal by Subject|0|||
130956496|NCT02681302|471471193|FG003|Overall Study|Withdrawal by Subject|0|||
130956497|NCT02681302|471471194|FG004|Overall Study|Withdrawal by Subject|1|||
130956498|NCT02681302|471471195|FG005|Overall Study|Withdrawal by Subject|0|||
130956499|NCT02681302|471471190|FG000|Overall Study|Screen Failure|2|||
130956500|NCT02681302|471471191|FG001|Overall Study|Screen Failure|4|||
130956501|NCT02681302|471471192|FG002|Overall Study|Screen Failure|2|||
130956502|NCT02681302|471471193|FG003|Overall Study|Screen Failure|0|||
130956503|NCT02681302|471471194|FG004|Overall Study|Screen Failure|1|||
130956504|NCT02681302|471471195|FG005|Overall Study|Screen Failure|1|||
130956505|NCT02681302|471471190|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
130956506|NCT02681302|471471191|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
130956507|NCT02681302|471471192|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
130956508|NCT02681302|471471193|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
130956509|NCT02681302|471471194|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
130956510|NCT02681302|471471195|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
130956511|NCT02115282|471471196|FG000|Overall Study|Disease progression during treatment|216|||
130956512|NCT02115282|471471197|FG001|Overall Study|Disease progression during treatment|229|||
130956513|NCT02115282|471471196|FG000|Overall Study|Adverse Event|49|||
130956514|NCT02115282|471471197|FG001|Overall Study|Adverse Event|23|||
130956515|NCT02115282|471471196|FG000|Overall Study|Death|1|||
130956516|NCT02115282|471471197|FG001|Overall Study|Death|3|||
130956517|NCT02115282|471471196|FG000|Overall Study|Alternative therapy|1|||
130956518|NCT02115282|471471197|FG001|Overall Study|Alternative therapy|1|||
130956519|NCT02115282|471471196|FG000|Overall Study|Complicating disease|0|||
130956520|NCT02115282|471471197|FG001|Overall Study|Complicating disease|3|||
130956521|NCT02115282|471471196|FG000|Overall Study|Withdrawal by Subject|12|||
130956522|NCT02115282|471471197|FG001|Overall Study|Withdrawal by Subject|10|||
130956523|NCT02115282|471471196|FG000|Overall Study|Symptomatic progression/deterioration|7|||
130956524|NCT02115282|471471197|FG001|Overall Study|Symptomatic progression/deterioration|18|||
130956525|NCT02115282|471471196|FG000|Overall Study|Non-compliance|5|||
130956526|NCT02115282|471471197|FG001|Overall Study|Non-compliance|1|||
130956527|NCT02115282|471471196|FG000|Overall Study|Protocol Violation|2|||
130956528|NCT02115282|471471197|FG001|Overall Study|Protocol Violation|2|||
130956529|NCT02115282|471471196|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
130956530|NCT02115282|471471197|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
130956531|NCT02115282|471471196|FG000|Overall Study|Not start protocol therapy|9|||
130956532|NCT02115282|471471197|FG001|Overall Study|Not start protocol therapy|10|||
130956533|NCT02152995|471471202|FG000|Overall Study|Withdrawal by Subject|1|||
130956534|NCT02152995|471471203|FG001|Overall Study|Withdrawal by Subject|0|||
130956535|NCT00480779|471471215|FG000|Overall Study|Other|2|||
130713047|NCT01765582|470575288|FG000|Overall Study|Withdrawal of Consent|11|||
130713048|NCT01765582|470575289|FG001|Overall Study|Withdrawal of Consent|6|||
130713049|NCT01765582|470575290|FG002|Overall Study|Withdrawal of Consent|10|||
130713050|NCT00986180|470575291|FG000|Overall Study|Adverse Event|21|||
130713051|NCT00986180|470575292|FG001|Overall Study|Adverse Event|23|||
130713052|NCT00986180|470575291|FG000|Overall Study|Lack of Efficacy|4|||
130713053|NCT00986180|470575292|FG001|Overall Study|Lack of Efficacy|3|||
130713054|NCT00986180|470575291|FG000|Overall Study|Lost to Follow-up|5|||
130713055|NCT00986180|470575292|FG001|Overall Study|Lost to Follow-up|7|||
130713056|NCT00986180|470575291|FG000|Overall Study|Physician Decision|1|||
130713057|NCT00986180|470575292|FG001|Overall Study|Physician Decision|3|||
130713058|NCT00986180|470575291|FG000|Overall Study|Protocol Violation|2|||
130713059|NCT00986180|470575292|FG001|Overall Study|Protocol Violation|0|||
130713060|NCT00986180|470575291|FG000|Overall Study|Withdrawal by Subject|1|||
130713061|NCT00986180|470575292|FG001|Overall Study|Withdrawal by Subject|9|||
130713062|NCT00986180|470575291|FG000|Overall Study|Miscellanies|10|||
130713063|NCT00986180|470575292|FG001|Overall Study|Miscellanies|11|||
130713064|NCT01691820|470575293|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
130713065|NCT01691820|470575294|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
130713066|NCT01691820|470575293|FG000|Overall Study|Migrated/moved from study area|7|||
130713067|NCT01691820|470575294|FG001|Overall Study|Migrated/moved from study area|4|||
130713068|NCT01691820|470575293|FG000|Overall Study|Lost to Follow-up|6|||
130956536|NCT00480779|471471216|FG001|Overall Study|Other|0|||
130956537|NCT00480779|471471215|FG000|Overall Study|Job and Health-related|0|||
130713069|NCT01691820|470575294|FG001|Overall Study|Lost to Follow-up|17|||
130956538|NCT00480779|471471216|FG001|Overall Study|Job and Health-related|3|||
131040070|NCT02589795|471783392|FG001|Overall Study|Lost to Follow-up|0|||
130713070|NCT01691820|470575293|FG000|Overall Study|Other (unspecified)|4|||
130713071|NCT01691820|470575294|FG001|Overall Study|Other (unspecified)|1|||
130713072|NCT00076804|470575299|FG000|Overall Study|Death|9|||
130713073|NCT00076804|470575300|FG001|Overall Study|Death|20|||
130713074|NCT00076804|470575299|FG000|Overall Study|Lost to Follow-up|9|||
130713075|NCT00076804|470575300|FG001|Overall Study|Lost to Follow-up|9|||
130713076|NCT00076804|470575299|FG000|Overall Study|Withdrawal by Subject|10|||
130713077|NCT00076804|470575300|FG001|Overall Study|Withdrawal by Subject|8|||
130713078|NCT00076804|470575299|FG000|Overall Study|Early study Closure|32|||
130713079|NCT00076804|470575300|FG001|Overall Study|Early study Closure|32|||
130713080|NCT02408068|470575302|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
130713081|NCT02408068|470575303|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
130956539|NCT04907032|471471217|FG000|Overall Study|Withdrawal by Subject|7|||
130956540|NCT04907032|471471218|FG001|Overall Study|Withdrawal by Subject|1|||
130956541|NCT00613509|471471220|FG000|Cycle 1|Adverse Event|2|||
130956542|NCT00613509|471471221|FG001|Cycle 1|Adverse Event|1|||
130956543|NCT00613509|471471220|FG000|Cycle 1|Disease Progression|2|||
130956544|NCT00613509|471471221|FG001|Cycle 1|Disease Progression|6|||
130956545|NCT00613509|471471220|FG000|Cycle 1|Unacceptable Toxicity|1|||
130956546|NCT00613509|471471221|FG001|Cycle 1|Unacceptable Toxicity|0|||
130956547|NCT00613509|471471220|FG000|Cycle 1|Other administrative reason|0|||
130956548|NCT00613509|471471221|FG001|Cycle 1|Other administrative reason|1|||
130713082|NCT02408068|470575304|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
130713083|NCT02408068|470575305|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
130713084|NCT02408068|470575306|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
130713085|NCT02408068|470575307|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
130713086|NCT02303041|470575308|FG000|Overall Study|Adverse Event|1|||
130713087|NCT02303041|470575309|FG001|Overall Study|Adverse Event|2|||
130713088|NCT02458092|470575315|FG000|Overall Study|Withdrawal by Subject|1|||
130713089|NCT02458092|470575316|FG001|Overall Study|Withdrawal by Subject|0|||
130713090|NCT03852459|470575319|FG000|Overall Study|Adverse Event|2|||
130713091|NCT03852459|470575320|FG001|Overall Study|Adverse Event|2|||
130713092|NCT03852459|470575319|FG000|Overall Study|Withdrawal by Subject|1|||
130713093|NCT03852459|470575320|FG001|Overall Study|Withdrawal by Subject|1|||
130713094|NCT03629028|470575321|FG000|Overall Study|Lost to Follow-up|26|||
130713095|NCT03629028|470575322|FG001|Overall Study|Lost to Follow-up|23|||
130713096|NCT03629028|470575321|FG000|Overall Study|Pregnancy|4|||
130713097|NCT03629028|470575322|FG001|Overall Study|Pregnancy|2|||
130713098|NCT03629028|470575321|FG000|Overall Study|intolerance to examination|2|||
130713099|NCT03629028|470575322|FG001|Overall Study|intolerance to examination|0|||
130713100|NCT02687360|470575323|FG000|Overall Study|Withdrawal by Subject|3|||
130713101|NCT02687360|470575324|FG001|Overall Study|Withdrawal by Subject|0|||
130713102|NCT02522403|470576853|FG000|Overall Study|Lost to Follow-up|2|||
130713103|NCT02522403|470576854|FG001|Overall Study|Lost to Follow-up|2|||
130713104|NCT02522403|470576853|FG000|Overall Study|Withdrawal by Subject|2|||
130713105|NCT02522403|470576854|FG001|Overall Study|Withdrawal by Subject|4|||
130713106|NCT03340064|470576855|FG000|First Period|Adverse Event, non-fatal|2|||
131040071|NCT02589795|471783393|FG002|Overall Study|Lost to Follow-up|0|||
131040072|NCT02589795|471783391|FG000|Overall Study|Withdrawal by Subject|0|||
131040073|NCT02589795|471783392|FG001|Overall Study|Withdrawal by Subject|0|||
131040074|NCT02589795|471783393|FG002|Overall Study|Withdrawal by Subject|2|||
131040075|NCT02589795|471783391|FG000|Overall Study|Protocol Violation|0|||
131040076|NCT02589795|471783392|FG001|Overall Study|Protocol Violation|0|||
131040077|NCT02589795|471783393|FG002|Overall Study|Protocol Violation|1|||
131040078|NCT03599661|471783395|FG000|Overall Study|Lost to Follow-up|9|||
131040079|NCT04909801|471783398|FG000|Overall Study|Lack of Efficacy|2|||
131040080|NCT04909801|471783399|FG001|Overall Study|Lack of Efficacy|1|||
131040081|NCT04909801|471783398|FG000|Overall Study|Adverse Event|1|||
131040082|NCT04909801|471783399|FG001|Overall Study|Adverse Event|2|||
131126487|NCT00808236|472091369|FG001|Overall Study|Physician Decision|1|||
131126488|NCT00808236|472091368|FG000|Overall Study|Death|18|||
131126489|NCT00808236|472091369|FG001|Overall Study|Death|30|||
131126490|NCT00961220|472091370|FG000|Overall Study|Adverse Event|3|||
131126491|NCT00961220|472091370|FG000|Overall Study|Lack of Efficacy|1|||
131126492|NCT00961220|472091370|FG000|Overall Study|No IV access for O6BG|1|||
131126493|NCT00961220|472091370|FG000|Overall Study|O6BG no longer supplied|1|||
130713107|NCT03340064|470576856|FG001|First Period|Adverse Event, non-fatal|0|||
130713108|NCT03340064|470576855|FG000|First Period|Lack of Efficacy|3|||
131040083|NCT04909801|471783398|FG000|Overall Study|Participant request to discontinue study treatment|1|||
131126494|NCT00961220|472091370|FG000|Overall Study|Complete Response prior to 12 courses|1|||
130713109|NCT03340064|470576856|FG001|First Period|Lack of Efficacy|0|||
130713110|NCT03340064|470576855|FG000|Second Period|Adverse Event, non-fatal|1|||
130956567|NCT00308711|471471241|FG000|Overall Study|Withdrawal by Subject|1|||
130956568|NCT00308711|471471242|FG001|Overall Study|Withdrawal by Subject|0|||
130956569|NCT00308711|471471243|FG002|Overall Study|Withdrawal by Subject|1|||
130956570|NCT00308711|471471241|FG000|Overall Study|Protocol Violation|0|||
130956571|NCT00308711|471471242|FG001|Overall Study|Protocol Violation|1|||
130956572|NCT00308711|471471243|FG002|Overall Study|Protocol Violation|1|||
130956573|NCT00308711|471471241|FG000|Overall Study|Lost to Follow-up|0|||
130956574|NCT00308711|471471242|FG001|Overall Study|Lost to Follow-up|1|||
130956575|NCT00308711|471471243|FG002|Overall Study|Lost to Follow-up|0|||
130956576|NCT00308711|471471241|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
130956577|NCT00308711|471471242|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
130956578|NCT00308711|471471243|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
130956579|NCT00308711|471471241|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
130956580|NCT00308711|471471242|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
131126495|NCT00825162|472091377|FG000|Overall Study|Withdrawal by Subject|11|||
131126496|NCT00825162|472091378|FG001|Overall Study|Withdrawal by Subject|13|||
131126497|NCT00825162|472091379|FG002|Overall Study|Withdrawal by Subject|3|||
131126498|NCT00825162|472091377|FG000|Overall Study|Lost to Follow-up|9|||
131126499|NCT00825162|472091378|FG001|Overall Study|Lost to Follow-up|6|||
131126500|NCT00825162|472091379|FG002|Overall Study|Lost to Follow-up|3|||
131126501|NCT00825162|472091377|FG000|Overall Study|Physician Decision|2|||
131126502|NCT00825162|472091378|FG001|Overall Study|Physician Decision|0|||
131126503|NCT00825162|472091379|FG002|Overall Study|Physician Decision|0|||
131126504|NCT00825162|472091377|FG000|Overall Study|Move away from the study area|1|||
130774624|NCT03280056|470802517|FG001|Overall Study|Early Discontinuation|0|||
130774625|NCT02144077|470802518|FG000|Overall Study|Withdrawal by Subject|3|||
130956581|NCT00308711|471471243|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
130956582|NCT02167256|471471244|FG000|Overall Study|Adverse Event|13|||
130956583|NCT02167256|471471245|FG001|Overall Study|Adverse Event|6|||
130956584|NCT02167256|471471244|FG000|Overall Study|Withdrawal by Subject|4|||
130956585|NCT02167256|471471245|FG001|Overall Study|Withdrawal by Subject|4|||
130956586|NCT02167256|471471244|FG000|Overall Study|non-compliance|3|||
130956587|NCT02167256|471471245|FG001|Overall Study|non-compliance|0|||
130956588|NCT02167256|471471244|FG000|Overall Study|Study partner unable to participate|1|||
130956589|NCT02167256|471471245|FG001|Overall Study|Study partner unable to participate|0|||
130956590|NCT01420081|471471246|FG000|Overall Study|Death|1|||
130956591|NCT01420081|471471247|FG001|Overall Study|Death|0|||
130956592|NCT01420081|471471248|FG002|Overall Study|Death|8|||
130956593|NCT01420081|471471249|FG003|Overall Study|Death|0|||
130956594|NCT01420081|471471250|FG004|Overall Study|Death|7|||
130956595|NCT01420081|471471251|FG005|Overall Study|Death|12|||
130956596|NCT01420081|471471252|FG006|Overall Study|Death|0|||
130956597|NCT01420081|471471253|FG007|Overall Study|Death|1|||
130956598|NCT01420081|471471254|FG008|Overall Study|Death|1|||
130956599|NCT01420081|471471246|FG000|Overall Study|Lost to Follow-up|0|||
130956600|NCT01420081|471471247|FG001|Overall Study|Lost to Follow-up|0|||
130956601|NCT01420081|471471248|FG002|Overall Study|Lost to Follow-up|0|||
130956602|NCT01420081|471471249|FG003|Overall Study|Lost to Follow-up|0|||
130956603|NCT01420081|471471250|FG004|Overall Study|Lost to Follow-up|1|||
130956604|NCT01420081|471471251|FG005|Overall Study|Lost to Follow-up|1|||
130956605|NCT01420081|471471252|FG006|Overall Study|Lost to Follow-up|0|||
130956606|NCT01420081|471471253|FG007|Overall Study|Lost to Follow-up|0|||
130956607|NCT01420081|471471254|FG008|Overall Study|Lost to Follow-up|0|||
130956608|NCT01420081|471471246|FG000|Overall Study|Study Terminated by Sponsor|2|||
130956609|NCT01420081|471471247|FG001|Overall Study|Study Terminated by Sponsor|1|||
130956610|NCT01420081|471471248|FG002|Overall Study|Study Terminated by Sponsor|1|||
130956611|NCT01420081|471471249|FG003|Overall Study|Study Terminated by Sponsor|3|||
130956612|NCT01420081|471471250|FG004|Overall Study|Study Terminated by Sponsor|11|||
130956613|NCT01420081|471471251|FG005|Overall Study|Study Terminated by Sponsor|7|||
130956614|NCT01420081|471471252|FG006|Overall Study|Study Terminated by Sponsor|3|||
130956615|NCT01420081|471471253|FG007|Overall Study|Study Terminated by Sponsor|2|||
130956616|NCT01420081|471471254|FG008|Overall Study|Study Terminated by Sponsor|2|||
130956617|NCT01420081|471471246|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
131126505|NCT00825162|472091378|FG001|Overall Study|Move away from the study area|0|||
131126506|NCT00825162|472091379|FG002|Overall Study|Move away from the study area|0|||
131126507|NCT00825162|472091377|FG000|Overall Study|Unable to attend the study visit|5|||
131126508|NCT00825162|472091378|FG001|Overall Study|Unable to attend the study visit|2|||
131126509|NCT00825162|472091379|FG002|Overall Study|Unable to attend the study visit|0|||
131126510|NCT00964743|472091380|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
130956618|NCT01420081|471471247|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
130956619|NCT01420081|471471248|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
130956620|NCT01420081|471471249|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
130956621|NCT01420081|471471250|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
130956622|NCT01420081|471471251|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
130956623|NCT01420081|471471252|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
130956624|NCT01420081|471471253|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
130713111|NCT03340064|470576856|FG001|Second Period|Adverse Event, non-fatal|1|||
130713112|NCT03340064|470576855|FG000|Second Period|Lack of Efficacy|11|||
130713113|NCT03340064|470576856|FG001|Second Period|Lack of Efficacy|0|||
130713114|NCT03340064|470576855|FG000|Second Period|Physician Decision|3|||
130713115|NCT03340064|470576856|FG001|Second Period|Physician Decision|0|||
130713116|NCT03340064|470576855|FG000|Second Period|Withdrawal by Subject|2|||
130774626|NCT02144077|470802519|FG001|Overall Study|Withdrawal by Subject|3|||
130774627|NCT02144077|470802518|FG000|Overall Study|Adverse Event|2|||
130774628|NCT02144077|470802519|FG001|Overall Study|Adverse Event|3|||
130774629|NCT02144077|470802518|FG000|Overall Study|Lost to Follow-up|2|||
130774630|NCT02144077|470802519|FG001|Overall Study|Lost to Follow-up|2|||
130774631|NCT02144077|470802518|FG000|Overall Study|Protocol Violation|1|||
130713117|NCT03340064|470576856|FG001|Second Period|Withdrawal by Subject|1|||
130713118|NCT03340064|470576855|FG000|Second Period|Approved Drug Available For Indication|1|||
130713119|NCT03340064|470576856|FG001|Second Period|Approved Drug Available For Indication|0|||
130713120|NCT03340064|470576855|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
130713121|NCT03340064|470576856|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
130713122|NCT00856973|470576857|FG000|Overall Study|Adverse Event|5|||
130713123|NCT00856973|470576858|FG001|Overall Study|Adverse Event|5|||
130774632|NCT02144077|470802519|FG001|Overall Study|Protocol Violation|2|||
130774633|NCT02144077|470802518|FG000|Overall Study|Death|0|||
130774634|NCT02144077|470802519|FG001|Overall Study|Death|1|||
130713124|NCT00856973|470576859|FG002|Overall Study|Adverse Event|3|||
130713125|NCT00856973|470576857|FG000|Overall Study|Lost to Follow-up|6|||
130713126|NCT00856973|470576858|FG001|Overall Study|Lost to Follow-up|3|||
130713127|NCT00856973|470576859|FG002|Overall Study|Lost to Follow-up|5|||
130713128|NCT00856973|470576857|FG000|Overall Study|Physician Decision|0|||
130713129|NCT00856973|470576858|FG001|Overall Study|Physician Decision|3|||
130713130|NCT00856973|470576859|FG002|Overall Study|Physician Decision|1|||
130713131|NCT00856973|470576857|FG000|Overall Study|Protocol Violation|1|||
130774635|NCT02144077|470802518|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
130774636|NCT02144077|470802519|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
130774637|NCT00610168|470802520|FG000|Overall Study|Withdrawal by Subject|2|||
130774638|NCT00610168|470802521|FG001|Overall Study|Withdrawal by Subject|0|||
130774639|NCT00943592|470802522|FG000|Overall Study|Death|3|||
130774640|NCT00169104|470802523|FG000|Overall Study|Withdrawal by Subject|2|||
130774641|NCT00169104|470802524|FG001|Overall Study|Withdrawal by Subject|0|||
130774642|NCT00169104|470802523|FG000|Overall Study|Protocol Violation|0|||
130713132|NCT00856973|470576858|FG001|Overall Study|Protocol Violation|2|||
130713133|NCT00856973|470576859|FG002|Overall Study|Protocol Violation|1|||
130713134|NCT00856973|470576857|FG000|Overall Study|Withdrawal by Subject|13|||
130713135|NCT00856973|470576858|FG001|Overall Study|Withdrawal by Subject|16|||
130713136|NCT00856973|470576859|FG002|Overall Study|Withdrawal by Subject|15|||
130713137|NCT00856973|470576857|FG000|Overall Study|Other|11|||
130713138|NCT00856973|470576858|FG001|Overall Study|Other|12|||
130713139|NCT00856973|470576859|FG002|Overall Study|Other|13|||
130713140|NCT02751359|470576861|FG000|Overall Study|Lost to Follow-up|1|||
130713141|NCT00912093|470576862|FG000|The Controlled Phase|Death|0|||
130713142|NCT00912093|470576863|FG001|The Controlled Phase|Death|1|||
130713143|NCT00912093|470576864|FG002|The Controlled Phase|Death|0|||
130713144|NCT00912093|470576865|FG003|The Controlled Phase|Death|0|||
130713145|NCT00912093|470576866|FG004|The Controlled Phase|Death|0|||
130713146|NCT00912093|470576862|FG000|The Controlled Phase|Medical Condition|0|||
130713147|NCT00912093|470576863|FG001|The Controlled Phase|Medical Condition|1|||
130774643|NCT00169104|470802524|FG001|Overall Study|Protocol Violation|1|||
130774644|NCT00169104|470802523|FG000|Overall Study|Physician Decision|0|||
130774645|NCT00169104|470802524|FG001|Overall Study|Physician Decision|1|||
130774646|NCT00715299|470802530|FG000|Overall Study|Withdrawal by Subject|1|||
130774647|NCT00715299|470802530|FG000|Overall Study|Adverse Event|3|||
130713148|NCT00912093|470576864|FG002|The Controlled Phase|Medical Condition|0|||
130713149|NCT00912093|470576865|FG003|The Controlled Phase|Medical Condition|0|||
130713150|NCT00912093|470576866|FG004|The Controlled Phase|Medical Condition|0|||
130713151|NCT00912093|470576862|FG000|The Controlled Phase|Lost to Follow-up|0|||
130713152|NCT00912093|470576863|FG001|The Controlled Phase|Lost to Follow-up|0|||
130713153|NCT00912093|470576864|FG002|The Controlled Phase|Lost to Follow-up|0|||
130713154|NCT00912093|470576865|FG003|The Controlled Phase|Lost to Follow-up|0|||
130713155|NCT00912093|470576866|FG004|The Controlled Phase|Lost to Follow-up|1|||
130713156|NCT04397445|470576869|FG000|Overall Study|Withdrawal by Subject|1|||
130713157|NCT04397445|470576870|FG001|Overall Study|Withdrawal by Subject|0|||
130774648|NCT00715299|470802530|FG000|Overall Study|failed the pre-screen exercise test|2|||
130774649|NCT01540981|470802531|FG000|Overall Study|Withdrawal by Subject|1|||
130713158|NCT04397445|470576871|FG002|Overall Study|Withdrawal by Subject|0|||
130713159|NCT04397445|470576872|FG003|Overall Study|Withdrawal by Subject|0|||
130713160|NCT03921151|470576873|FG000|Overall Study|Withdrawal by Subject|11|||
130713161|NCT03921151|470576874|FG001|Overall Study|Withdrawal by Subject|16|||
130713162|NCT00616941|470576875|FG000|Overall Study|Progressive Disease|1|||
130713163|NCT00616941|470576876|FG001|Overall Study|Progressive Disease|2|||
130713164|NCT00616941|470576877|FG002|Overall Study|Progressive Disease|1|||
130713165|NCT00616941|470576875|FG000|Overall Study|Adverse Event|0|||
130713166|NCT00616941|470576876|FG001|Overall Study|Adverse Event|1|||
130713167|NCT00616941|470576877|FG002|Overall Study|Adverse Event|1|||
130713168|NCT00616941|470576875|FG000|Overall Study|Subject Non-compliance|0|||
130713169|NCT00616941|470576876|FG001|Overall Study|Subject Non-compliance|0|||
130713170|NCT00616941|470576877|FG002|Overall Study|Subject Non-compliance|1|||
130713171|NCT00616941|470576875|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
130713172|NCT00616941|470576876|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
130713173|NCT00616941|470576877|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
130713174|NCT00616941|470576875|FG000|Overall Study|Vaccination Suspended|0|||
130713175|NCT00616941|470576876|FG001|Overall Study|Vaccination Suspended|0|||
130713176|NCT00616941|470576877|FG002|Overall Study|Vaccination Suspended|3|||
130713177|NCT00354341|470576885|FG000|Overall Study|Adverse Event|1|||
130713178|NCT00354341|470576886|FG001|Overall Study|Adverse Event|0|||
130713179|NCT00354341|470576885|FG000|Overall Study|Death|0|||
130713180|NCT00354341|470576886|FG001|Overall Study|Death|2|||
130713181|NCT00354341|470576885|FG000|Overall Study|Refused treatment|1|||
130774650|NCT01540981|470802532|FG001|Overall Study|Withdrawal by Subject|0|||
130774651|NCT00809094|470802534|FG000|Overall Study|Lost to Follow-up|0|||
130956625|NCT01420081|471471254|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
130956626|NCT01420081|471471246|FG000|Overall Study|Other Reasons|0|||
131126511|NCT00781911|472091384|FG000|Overall Study|Adverse Event|4|||
130713182|NCT00354341|470576886|FG001|Overall Study|Refused treatment|2|||
130774652|NCT00809094|470802535|FG001|Overall Study|Lost to Follow-up|1|||
130774653|NCT00397189|470802536|FG000|3 Weeks Period|Lost to Follow-up|5|||
130774654|NCT00397189|470802537|FG001|3 Weeks Period|Lost to Follow-up|4|||
130774655|NCT00397189|470802536|FG000|3 Weeks Period|Adverse Event|3|||
130774656|NCT00397189|470802537|FG001|3 Weeks Period|Adverse Event|2|||
130774657|NCT00397189|470802536|FG000|3 Weeks Period|Withdrawal by Subject|13|||
130774658|NCT00397189|470802537|FG001|3 Weeks Period|Withdrawal by Subject|9|||
130774659|NCT00397189|470802536|FG000|3 Weeks Period|Physician Decision|0|||
130774660|NCT00397189|470802537|FG001|3 Weeks Period|Physician Decision|2|||
130774661|NCT00397189|470802536|FG000|3 Weeks Period|Protocol Violation|0|||
130774662|NCT00397189|470802537|FG001|3 Weeks Period|Protocol Violation|3|||
130774663|NCT00397189|470802536|FG000|3 Weeks Period|Other|0|||
130774664|NCT00397189|470802537|FG001|3 Weeks Period|Other|2|||
130774665|NCT01535443|470802538|FG000|Overall Study|Physician Decision|3|||
130774666|NCT00232557|470802541|FG000|Overall Study|Lost to Follow-up|3|||
130774667|NCT00232557|470802542|FG001|Overall Study|Lost to Follow-up|5|||
130774668|NCT01059773|470802543|FG000|Overall Study|Adverse Event|2|||
130774669|NCT01059773|470802544|FG001|Overall Study|Adverse Event|2|||
130774670|NCT01059773|470802543|FG000|Overall Study|Withdrawal by Subject|1|||
130774671|NCT01059773|470802544|FG001|Overall Study|Withdrawal by Subject|5|||
130774672|NCT01059773|470802543|FG000|Overall Study|Lost to Follow-up|1|||
130774673|NCT01059773|470802544|FG001|Overall Study|Lost to Follow-up|1|||
130774674|NCT01059773|470802543|FG000|Overall Study|Pregnancy|1|||
130774675|NCT01059773|470802544|FG001|Overall Study|Pregnancy|1|||
130774676|NCT01059773|470802543|FG000|Overall Study|Protocol Violation|6|||
130774677|NCT01059773|470802544|FG001|Overall Study|Protocol Violation|2|||
130774678|NCT01059773|470802543|FG000|Overall Study|Physician Decision|5|||
130774679|NCT01059773|470802544|FG001|Overall Study|Physician Decision|4|||
130774680|NCT01059773|470802543|FG000|Overall Study|Lack of Efficacy|3|||
130774681|NCT01059773|470802544|FG001|Overall Study|Lack of Efficacy|3|||
130774682|NCT01059773|470802543|FG000|Overall Study|Death|0|||
130774683|NCT01059773|470802544|FG001|Overall Study|Death|1|||
130774684|NCT01059773|470802543|FG000|Overall Study|Malignancy including squamous cell skin|0|||
130774685|NCT01059773|470802544|FG001|Overall Study|Malignancy including squamous cell skin|1|||
130956627|NCT01420081|471471247|FG001|Overall Study|Other Reasons|0|||
130956628|NCT01420081|471471248|FG002|Overall Study|Other Reasons|1|||
130956629|NCT01420081|471471249|FG003|Overall Study|Other Reasons|0|||
130956630|NCT01420081|471471250|FG004|Overall Study|Other Reasons|0|||
130956631|NCT01420081|471471251|FG005|Overall Study|Other Reasons|0|||
131126512|NCT00781911|472091385|FG001|Overall Study|Adverse Event|4|||
130713183|NCT00354341|470576885|FG000|Overall Study|Failure to return|0|||
130713184|NCT00354341|470576886|FG001|Overall Study|Failure to return|1|||
130774686|NCT01059773|470802543|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
130774687|NCT01059773|470802544|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
130774688|NCT01059773|470802543|FG000|Overall Study|Other|1|||
130774689|NCT01059773|470802544|FG001|Overall Study|Other|3|||
130956632|NCT01420081|471471252|FG006|Overall Study|Other Reasons|0|||
130956633|NCT01420081|471471253|FG007|Overall Study|Other Reasons|0|||
131126513|NCT00781911|472091384|FG000|Overall Study|Withdrawal by Subject|1|||
130956634|NCT01420081|471471254|FG008|Overall Study|Other Reasons|0|||
130956635|NCT01723228|471471255|FG000|Overall Study|Adverse Event|2|||
130956636|NCT01723228|471471256|FG001|Overall Study|Adverse Event|6|||
130956637|NCT01723228|471471255|FG000|Overall Study|Withdrawal by Subject|2|||
130956638|NCT01723228|471471256|FG001|Overall Study|Withdrawal by Subject|1|||
130956639|NCT01723228|471471255|FG000|Overall Study|Protocol Violation|0|||
130956640|NCT01723228|471471256|FG001|Overall Study|Protocol Violation|2|||
130956641|NCT01723228|471471255|FG000|Overall Study|Lost to Follow-up|2|||
130956642|NCT01723228|471471256|FG001|Overall Study|Lost to Follow-up|1|||
130956643|NCT01723228|471471255|FG000|Overall Study|Other|2|||
130956644|NCT01723228|471471256|FG001|Overall Study|Other|1|||
130956645|NCT01451424|471471259|FG000|Overall Study|Withdrawal by Subject|1|||
130956646|NCT01451424|471471260|FG001|Overall Study|Withdrawal by Subject|1|||
130956647|NCT01451424|471471261|FG002|Overall Study|Withdrawal by Subject|0|||
130956648|NCT01451424|471471262|FG003|Overall Study|Withdrawal by Subject|2|||
130956649|NCT01451424|471471259|FG000|Overall Study|Lost to Follow-up|0|||
130956650|NCT01451424|471471260|FG001|Overall Study|Lost to Follow-up|1|||
130956651|NCT01451424|471471261|FG002|Overall Study|Lost to Follow-up|0|||
130956652|NCT01451424|471471262|FG003|Overall Study|Lost to Follow-up|1|||
130956653|NCT01451424|471471259|FG000|Overall Study|Physician Decision|0|||
130956654|NCT01451424|471471260|FG001|Overall Study|Physician Decision|0|||
130956655|NCT01451424|471471261|FG002|Overall Study|Physician Decision|1|||
130956656|NCT01451424|471471262|FG003|Overall Study|Physician Decision|1|||
130956657|NCT01451424|471471259|FG000|Overall Study|Adverse Event|0|||
130956658|NCT01451424|471471260|FG001|Overall Study|Adverse Event|0|||
130956659|NCT01451424|471471261|FG002|Overall Study|Adverse Event|0|||
130956660|NCT01451424|471471262|FG003|Overall Study|Adverse Event|1|||
130956661|NCT00528528|471471268|FG000|Overall Study|Lost to Follow-up|0|||
130956662|NCT00528528|471471269|FG001|Overall Study|Lost to Follow-up|0|||
131126514|NCT00781911|472091385|FG001|Overall Study|Withdrawal by Subject|2|||
131126515|NCT00781911|472091384|FG000|Overall Study|Physician Decision|0|||
131126516|NCT00781911|472091385|FG001|Overall Study|Physician Decision|2|||
131126517|NCT00781911|472091384|FG000|Overall Study|Sponsor Decision|1|||
131126518|NCT00781911|472091385|FG001|Overall Study|Sponsor Decision|0|||
131126519|NCT03317795|472091388|FG000|Overall Study|IUD Expulsion|1|||
131126520|NCT03317795|472091389|FG001|Overall Study|IUD Expulsion|0|||
131126521|NCT03317795|472091388|FG000|Overall Study|Lost to Follow-up|1|||
131126522|NCT03317795|472091389|FG001|Overall Study|Lost to Follow-up|3|||
131126523|NCT03317795|472091388|FG000|Overall Study|Treatment change|0|||
131126524|NCT03317795|472091389|FG001|Overall Study|Treatment change|3|||
131126525|NCT03317795|472091388|FG000|Overall Study|Intolerance of medication|0|||
131126526|NCT03317795|472091389|FG001|Overall Study|Intolerance of medication|1|||
131126527|NCT01549002|472091390|FG000|Overall Study|Excessive pain|0|||
131126528|NCT01549002|472091391|FG001|Overall Study|Excessive pain|2|||
131126529|NCT01549002|472091390|FG000|Overall Study|Moderate sedation required|0|||
131126530|NCT01549002|472091391|FG001|Overall Study|Moderate sedation required|2|||
131126531|NCT04066491|472091392|FG000|Overall Study|Randomized, not treated|0|||
131126532|NCT04066491|472091393|FG001|Overall Study|Randomized, not treated|0|||
131126533|NCT04066491|472091394|FG002|Overall Study|Randomized, not treated|2|||
131126534|NCT00495820|472091395|FG000|Overall Study|Adverse Event|1|||
131126535|NCT00495820|472091396|FG001|Overall Study|Adverse Event|1|||
131126536|NCT00820950|472091397|FG000|Overall Study|Scheduling Conflict|0|||
131126537|NCT00820950|472091398|FG001|Overall Study|Scheduling Conflict|0|||
131126538|NCT00820950|472091399|FG002|Overall Study|Scheduling Conflict|0|||
131126539|NCT00820950|472091400|FG003|Overall Study|Scheduling Conflict|0|||
131126540|NCT00820950|472091401|FG004|Overall Study|Scheduling Conflict|0|||
131126541|NCT00820950|472091402|FG005|Overall Study|Scheduling Conflict|0|||
131126542|NCT00820950|472091403|FG006|Overall Study|Scheduling Conflict|1|||
131126543|NCT00820950|472091404|FG007|Overall Study|Scheduling Conflict|1|||
131126544|NCT00820950|472091405|FG008|Overall Study|Scheduling Conflict|0|||
131126545|NCT00820950|472091406|FG009|Overall Study|Scheduling Conflict|0|||
131126546|NCT00820950|472091397|FG000|Overall Study|Protocol Violation|1|||
131126547|NCT00820950|472091398|FG001|Overall Study|Protocol Violation|1|||
131126548|NCT00820950|472091399|FG002|Overall Study|Protocol Violation|0|||
131126549|NCT00820950|472091400|FG003|Overall Study|Protocol Violation|0|||
130956663|NCT00528528|471471270|FG002|Overall Study|Lost to Follow-up|1|||
130956664|NCT00528528|471471271|FG003|Overall Study|Lost to Follow-up|1|||
130956665|NCT00528528|471471268|FG000|Overall Study|Ineligible to continue the trial|0|||
130956666|NCT00528528|471471269|FG001|Overall Study|Ineligible to continue the trial|0|||
130956667|NCT00528528|471471270|FG002|Overall Study|Ineligible to continue the trial|0|||
130956668|NCT00528528|471471271|FG003|Overall Study|Ineligible to continue the trial|1|||
130956669|NCT00528528|471471268|FG000|Overall Study|Other|0|||
130956670|NCT00528528|471471269|FG001|Overall Study|Other|1|||
130956671|NCT00528528|471471270|FG002|Overall Study|Other|0|||
130956672|NCT00528528|471471271|FG003|Overall Study|Other|0|||
131126550|NCT00820950|472091401|FG004|Overall Study|Protocol Violation|0|||
131126551|NCT00820950|472091402|FG005|Overall Study|Protocol Violation|0|||
131126552|NCT00820950|472091403|FG006|Overall Study|Protocol Violation|0|||
131126553|NCT00820950|472091404|FG007|Overall Study|Protocol Violation|0|||
131126554|NCT00820950|472091405|FG008|Overall Study|Protocol Violation|0|||
130956673|NCT00528528|471471268|FG000|Overall Study|Withdrawal by Subject|3|||
130956674|NCT00528528|471471269|FG001|Overall Study|Withdrawal by Subject|2|||
130956675|NCT00528528|471471270|FG002|Overall Study|Withdrawal by Subject|1|||
130956676|NCT00528528|471471271|FG003|Overall Study|Withdrawal by Subject|1|||
130956677|NCT00528528|471471268|FG000|Overall Study|Ongoing participant|0|||
130956678|NCT00528528|471471269|FG001|Overall Study|Ongoing participant|0|||
130956679|NCT00528528|471471270|FG002|Overall Study|Ongoing participant|1|||
130956680|NCT00528528|471471271|FG003|Overall Study|Ongoing participant|0|||
130774690|NCT00141518|470802548|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
130774691|NCT00141518|470802549|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
130774692|NCT00141518|470802550|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
130774693|NCT00141518|470802548|FG000|Overall Study|Adverse Event|7|||
130774694|NCT00141518|470802549|FG001|Overall Study|Adverse Event|5|||
130774695|NCT00141518|470802550|FG002|Overall Study|Adverse Event|2|||
130774696|NCT00141518|470802548|FG000|Overall Study|Withdrawal by Subject|2|||
130774697|NCT00141518|470802549|FG001|Overall Study|Withdrawal by Subject|0|||
130774698|NCT00141518|470802550|FG002|Overall Study|Withdrawal by Subject|2|||
130774699|NCT00141518|470802548|FG000|Overall Study|Protocol Violation|1|||
130774700|NCT00141518|470802549|FG001|Overall Study|Protocol Violation|1|||
130774701|NCT00141518|470802550|FG002|Overall Study|Protocol Violation|2|||
130774702|NCT00141518|470802548|FG000|Overall Study|Lack of Efficacy|5|||
130774703|NCT00141518|470802549|FG001|Overall Study|Lack of Efficacy|0|||
130774704|NCT00141518|470802550|FG002|Overall Study|Lack of Efficacy|0|||
130774705|NCT01806168|470802552|FG000|Overall Study|Adverse Event|1|||
130774706|NCT01806168|470802553|FG001|Overall Study|Adverse Event|0|||
130774707|NCT01806168|470802554|FG002|Overall Study|Adverse Event|0|||
130774708|NCT01806168|470802552|FG000|Overall Study|Withdrawal by Subject|0|||
130774709|NCT01806168|470802553|FG001|Overall Study|Withdrawal by Subject|1|||
130774710|NCT01806168|470802554|FG002|Overall Study|Withdrawal by Subject|2|||
130774711|NCT01806168|470802552|FG000|Overall Study|Protocol Violation|0|||
130774712|NCT01806168|470802553|FG001|Overall Study|Protocol Violation|0|||
130956682|NCT04602624|471471273|FG000|Overall Study|Protocol Deviation|1|||
130956683|NCT04602624|471471273|FG000|Overall Study|Withdrawal by Participant|1|||
130956684|NCT04084769|471471274|FG000|Overall Study|Protocol Violation|1|||
130956685|NCT04084769|471471275|FG001|Overall Study|Protocol Violation|3|||
130956686|NCT04084769|471471276|FG002|Overall Study|Protocol Violation|0|||
130956687|NCT04084769|471471277|FG003|Overall Study|Protocol Violation|1|||
130956688|NCT04084769|471471274|FG000|Overall Study|Withdrawal by Subject|0|||
130956689|NCT04084769|471471275|FG001|Overall Study|Withdrawal by Subject|1|||
130956690|NCT04084769|471471276|FG002|Overall Study|Withdrawal by Subject|0|||
130956691|NCT04084769|471471277|FG003|Overall Study|Withdrawal by Subject|0|||
130956692|NCT04084769|471471274|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130956693|NCT04084769|471471275|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130956694|NCT04084769|471471276|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130956695|NCT04084769|471471277|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130956696|NCT04084769|471471274|FG000|Overall Study|Lost to Follow-up|2|||
130956697|NCT04084769|471471275|FG001|Overall Study|Lost to Follow-up|0|||
130956698|NCT04084769|471471276|FG002|Overall Study|Lost to Follow-up|0|||
130956699|NCT04084769|471471277|FG003|Overall Study|Lost to Follow-up|0|||
130956712|NCT03508219|471471282|FG000|Overall Study|Death|2|||
131126555|NCT00820950|472091406|FG009|Overall Study|Protocol Violation|0|||
131126556|NCT01423851|472091408|FG000|Whole Study|Disease progression|2|||
131126557|NCT01423851|472091409|FG001|Whole Study|Disease progression|1|||
130774713|NCT01806168|470802554|FG002|Overall Study|Protocol Violation|1|||
130774714|NCT01029262|470802557|FG000|Overall Study|Adverse Event|9|||
130774715|NCT01029262|470802558|FG001|Overall Study|Adverse Event|52|||
130774716|NCT01029262|470802557|FG000|Overall Study|Lack of therapeutic effect|57|||
130956713|NCT03508219|471471282|FG000|Overall Study|Withdrawal by Subject|1|||
130956714|NCT03508219|471471282|FG000|Overall Study|Lost to Follow-up|4|||
130956715|NCT03508219|471471282|FG000|Overall Study|Missed visit|2|||
130956716|NCT03945981|471471283|FG000|Overall Study|Lost to Follow-up|12|||
130956717|NCT03945981|471471283|FG000|Overall Study|Physician Decision|4|||
130956718|NCT03945981|471471283|FG000|Overall Study|Withdrawal by Subject|6|||
130956719|NCT03945981|471471283|FG000|Overall Study|Protocol Violation|1|||
130956720|NCT04466891|471471284|FG000|Overall Study|Death|60|||
130956721|NCT04466891|471471285|FG001|Overall Study|Death|6|||
131040084|NCT04909801|471783399|FG001|Overall Study|Participant request to discontinue study treatment|2|||
131040085|NCT04909801|471783398|FG000|Overall Study|Withdrawal by Subject|2|||
131040086|NCT04909801|471783399|FG001|Overall Study|Withdrawal by Subject|1|||
131040087|NCT04909801|471783398|FG000|Overall Study|other reasons|1|||
131040088|NCT04909801|471783399|FG001|Overall Study|other reasons|1|||
131226002|NCT03705169|472453719|FG003|Overall Study|Concerns about study visit compliance|1|||
131226003|NCT03705169|472453720|FG004|Overall Study|Concerns about study visit compliance|0|||
131226004|NCT03705169|472453721|FG005|Overall Study|Concerns about study visit compliance|0|||
131226005|NCT03705169|472453722|FG006|Overall Study|Concerns about study visit compliance|0|||
131226006|NCT03705169|472453723|FG007|Overall Study|Concerns about study visit compliance|0|||
131226007|NCT03705169|472453724|FG008|Overall Study|Concerns about study visit compliance|0|||
131226008|NCT03705169|472453725|FG009|Overall Study|Concerns about study visit compliance|0|||
131226009|NCT01759537|472453726|FG000|Overall Study|Death|1|||
131226010|NCT01759537|472453727|FG001|Overall Study|Death|1|||
131226011|NCT01759537|472453726|FG000|Overall Study|Pregnancy|1|||
131226012|NCT01759537|472453727|FG001|Overall Study|Pregnancy|1|||
131226013|NCT01759537|472453726|FG000|Overall Study|Lost to Follow-up|9|||
131226014|NCT01759537|472453727|FG001|Overall Study|Lost to Follow-up|9|||
131226015|NCT01759537|472453726|FG000|Overall Study|Accident involving jaw fracture|1|||
131226016|NCT01759537|472453727|FG001|Overall Study|Accident involving jaw fracture|1|||
131226017|NCT01759537|472453726|FG000|Overall Study|Subcrestal implant too coronal|1|||
130956722|NCT04466891|471471284|FG000|Overall Study|Withdrawal by Subject|8|||
130956723|NCT04466891|471471285|FG001|Overall Study|Withdrawal by Subject|1|||
130956724|NCT04466891|471471284|FG000|Overall Study|Study terminated by sponsor|5|||
130956725|NCT04466891|471471285|FG001|Overall Study|Study terminated by sponsor|0|||
130956726|NCT04466891|471471284|FG000|Overall Study|Lost to Follow-up|2|||
130956727|NCT04466891|471471285|FG001|Overall Study|Lost to Follow-up|0|||
130956728|NCT04466891|471471284|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
130956729|NCT04466891|471471285|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
130956730|NCT04346615|471472701|FG000|Overall Study|Lost to Follow-up|0|||
131040089|NCT04550221|471783402|FG000|Overall Study|Lost to Follow-up|0|||
131040090|NCT04550221|471783403|FG001|Overall Study|Lost to Follow-up|4|||
130956731|NCT04346615|471472702|FG001|Overall Study|Lost to Follow-up|2|||
130956732|NCT04346615|471472701|FG000|Overall Study|Withdrawal by Subject|1|||
130956733|NCT04346615|471472702|FG001|Overall Study|Withdrawal by Subject|0|||
130956734|NCT04346615|471472701|FG000|Overall Study|Death|5|||
130956735|NCT04346615|471472702|FG001|Overall Study|Death|1|||
130956736|NCT04346615|471472701|FG000|Overall Study|Other|0|||
130956737|NCT04346615|471472702|FG001|Overall Study|Other|2|||
130956738|NCT04346615|471472701|FG000|Overall Study|Randomized not treated|1|||
130956739|NCT04346615|471472702|FG001|Overall Study|Randomized not treated|0|||
130956740|NCT03370341|471472703|FG000|Overall Study|Lost to Follow-up|0|||
130956741|NCT03370341|471472704|FG001|Overall Study|Lost to Follow-up|1|||
130956742|NCT01707004|471472707|FG000|Overall Study|Physician Decision|3|||
130956743|NCT00533949|471472708|FG000|Overall Study|Protocol Violation|12|||
130956744|NCT00533949|471472709|FG001|Overall Study|Protocol Violation|12|||
130956745|NCT00533949|471472710|FG002|Overall Study|Protocol Violation|9|||
130956746|NCT00533949|471472711|FG003|Overall Study|Protocol Violation|9|||
130956747|NCT00533949|471472708|FG000|Overall Study|Withdrawal by Subject|3|||
130956748|NCT00533949|471472709|FG001|Overall Study|Withdrawal by Subject|2|||
130956749|NCT00533949|471472710|FG002|Overall Study|Withdrawal by Subject|1|||
130956750|NCT00533949|471472711|FG003|Overall Study|Withdrawal by Subject|1|||
130956751|NCT00727194|471472712|FG000|Screening Period|Low QMG scores|0|||
130956752|NCT00727194|471472713|FG001|Screening Period|Low QMG scores|0|||
130956753|NCT00727194|471472714|FG002|Screening Period|Low QMG scores|6|||
130956754|NCT00727194|471472712|FG000|Screening Period|Lacked AChR antibodies|0|||
130956755|NCT00727194|471472713|FG001|Screening Period|Lacked AChR antibodies|0|||
131040091|NCT04550221|471783402|FG000|Overall Study|Withdrawn|3|||
131040092|NCT04550221|471783403|FG001|Overall Study|Withdrawn|0|||
130713185|NCT00354341|470576885|FG000|Overall Study|Other|1|||
131040093|NCT04550221|471783402|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
131040094|NCT04550221|471783403|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
131040095|NCT04811040|471783404|FG000|Overall Study|Lost to Follow-up|2|||
131040096|NCT04811040|471783405|FG001|Overall Study|Lost to Follow-up|0|||
131040097|NCT04811040|471783406|FG002|Overall Study|Lost to Follow-up|0|||
131040098|NCT04811040|471783407|FG003|Overall Study|Lost to Follow-up|0|||
131040099|NCT04811040|471783404|FG000|Overall Study|Withdrew consent|1|||
131040100|NCT04811040|471783405|FG001|Overall Study|Withdrew consent|1|||
131040101|NCT04811040|471783406|FG002|Overall Study|Withdrew consent|0|||
131040102|NCT04811040|471783407|FG003|Overall Study|Withdrew consent|0|||
131040103|NCT05274074|471783408|FG000|Overall Study|Lost to Follow-up|2|||
131040104|NCT05274074|471783409|FG001|Overall Study|Lost to Follow-up|3|||
131040105|NCT05274074|471783408|FG000|Overall Study|Withdrawal by Subject|1|||
131040106|NCT05274074|471783409|FG001|Overall Study|Withdrawal by Subject|2|||
131040107|NCT05194956|471783410|FG000|Washout Period|Withdrawal by Subject|0|||
131040108|NCT05194956|471783411|FG001|Washout Period|Withdrawal by Subject|2|||
130713186|NCT00354341|470576886|FG001|Overall Study|Other|2|||
130713187|NCT01732874|470576887|FG000|Overall Study|Withdrawal by Subject|5|||
130713188|NCT01732874|470576888|FG001|Overall Study|Withdrawal by Subject|1|||
130713189|NCT01732874|470576887|FG000|Overall Study|Death of Infant|3|||
130713190|NCT01732874|470576888|FG001|Overall Study|Death of Infant|2|||
130713191|NCT00557076|470576889|FG000|Overall Study|Unblinding|0|||
130713192|NCT00557076|470576890|FG001|Overall Study|Unblinding|1|||
130713193|NCT01370213|470576891|FG000|Overall Study|Early Death|1|||
130713194|NCT01370213|470576892|FG001|Overall Study|Early Death|0|||
130713195|NCT01370213|470576893|FG002|Overall Study|Early Death|0|||
130713196|NCT01370213|470576891|FG000|Overall Study|Not evaluable|0|||
130713197|NCT01370213|470576892|FG001|Overall Study|Not evaluable|2|||
130713198|NCT01370213|470576893|FG002|Overall Study|Not evaluable|0|||
130713199|NCT03097588|470576914|FG000|Overall Study|Adverse Event|1|||
130713200|NCT03456960|470576915|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130713201|NCT03456960|470576916|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130713202|NCT03456960|470576917|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
130713203|NCT03456960|470576918|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
130713204|NCT03456960|470576919|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130713205|NCT03456960|470576920|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130713206|NCT03456960|470576915|FG000|Period 2 (1 Day)|Adverse Event|1|||
130713207|NCT03456960|470576916|FG001|Period 2 (1 Day)|Adverse Event|0|||
130713208|NCT03456960|470576917|FG002|Period 2 (1 Day)|Adverse Event|0|||
130713209|NCT03456960|470576918|FG003|Period 2 (1 Day)|Adverse Event|1|||
130713210|NCT03456960|470576919|FG004|Period 2 (1 Day)|Adverse Event|0|||
130713211|NCT03456960|470576920|FG005|Period 2 (1 Day)|Adverse Event|0|||
130774717|NCT01029262|470802558|FG001|Overall Study|Lack of therapeutic effect|76|||
130956756|NCT00727194|471472714|FG002|Screening Period|Lacked AChR antibodies|5|||
130956757|NCT00727194|471472712|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
130956758|NCT00727194|471472713|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
130956759|NCT00727194|471472714|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
130956760|NCT00727194|471472712|FG000|Screening Period|Severe infections|0|||
130956761|NCT00727194|471472713|FG001|Screening Period|Severe infections|0|||
130956762|NCT00727194|471472714|FG002|Screening Period|Severe infections|2|||
130956763|NCT00727194|471472712|FG000|Screening Period|History of thymoma|0|||
130956764|NCT00727194|471472713|FG001|Screening Period|History of thymoma|0|||
130956765|NCT00727194|471472714|FG002|Screening Period|History of thymoma|1|||
130956766|NCT00727194|471472712|FG000|Treatment Period 2|Lack of Efficacy|0|||
130956767|NCT00727194|471472713|FG001|Treatment Period 2|Lack of Efficacy|1|||
130956768|NCT00727194|471472714|FG002|Treatment Period 2|Lack of Efficacy|0|||
130956769|NCT04269161|471472720|FG000|Overall Study|Change of modality and no longer eligible|3|||
130956770|NCT04269161|471472721|FG001|Overall Study|Change of modality and no longer eligible|3|||
130956771|NCT04269161|471472720|FG000|Overall Study|Required procedure outside of NICU|1|||
130956772|NCT04269161|471472721|FG001|Overall Study|Required procedure outside of NICU|0|||
130956773|NCT04269161|471472720|FG000|Overall Study|Equipment issue|1|||
130956774|NCT04269161|471472721|FG001|Overall Study|Equipment issue|1|||
130956775|NCT01677195|471472722|FG000|Overall Study|Lost to Follow-up|14|||
130956776|NCT01677195|471472723|FG001|Overall Study|Lost to Follow-up|22|||
130956777|NCT01677195|471472724|FG002|Overall Study|Lost to Follow-up|22|||
130956778|NCT01677195|471472722|FG000|Overall Study|Withdrawal by Subject|1|||
130956779|NCT01677195|471472723|FG001|Overall Study|Withdrawal by Subject|0|||
130956780|NCT01677195|471472724|FG002|Overall Study|Withdrawal by Subject|1|||
131040109|NCT01828099|471783421|FG000|Treatment Period|Adverse Event|24|||
130713212|NCT02989168|470576921|FG000|Overall Study|Withdrawal by Subject|2|||
130713213|NCT02989168|470576922|FG001|Overall Study|Withdrawal by Subject|0|||
130713214|NCT02989168|470576921|FG000|Overall Study|Physician Decision|0|||
130713215|NCT02989168|470576922|FG001|Overall Study|Physician Decision|1|||
130713216|NCT02989168|470576921|FG000|Overall Study|Adverse Event|1|||
130713217|NCT02989168|470576922|FG001|Overall Study|Adverse Event|2|||
130713218|NCT02989168|470576921|FG000|Overall Study|Sponsor stopped study.|1|||
130713219|NCT02989168|470576922|FG001|Overall Study|Sponsor stopped study.|0|||
130713220|NCT03828448|470576923|FG000|Overall Study|Sponsor's Discretion|34|||
130713221|NCT02037165|470576924|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130956781|NCT01677195|471472722|FG000|Overall Study|Adverse Event|6|||
130956782|NCT01677195|471472723|FG001|Overall Study|Adverse Event|4|||
130956783|NCT01677195|471472724|FG002|Overall Study|Adverse Event|1|||
130956784|NCT01677195|471472722|FG000|Overall Study|Physician Decision|1|||
130956785|NCT01677195|471472723|FG001|Overall Study|Physician Decision|2|||
130713222|NCT02037165|470576925|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130713223|NCT02037165|470576926|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130774718|NCT01029262|470802557|FG000|Overall Study|Withdrawal by Subject|10|||
130774719|NCT01029262|470802558|FG001|Overall Study|Withdrawal by Subject|17|||
130713224|NCT02037165|470576927|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130713225|NCT02037165|470576928|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
130713226|NCT00532935|470576929|FG000|Overall Study|Adverse Event|11|||
130956786|NCT01677195|471472724|FG002|Overall Study|Physician Decision|2|||
131226018|NCT01759537|472453727|FG001|Overall Study|Subcrestal implant too coronal|1|||
131226019|NCT00420290|472453728|FG000|Overall Study|Adverse Event|3|||
131226020|NCT00420290|472453729|FG001|Overall Study|Adverse Event|1|||
131226021|NCT00420290|472453728|FG000|Overall Study|Withdrawal by Subject|0|||
131226022|NCT00420290|472453729|FG001|Overall Study|Withdrawal by Subject|2|||
131226023|NCT00420290|472453728|FG000|Overall Study|did not meet inclusion/exclusion|1|||
131226024|NCT00420290|472453729|FG001|Overall Study|did not meet inclusion/exclusion|1|||
131226025|NCT03877237|472455633|FG000|Overall Study|Adverse Event|1|||
131226026|NCT03877237|472455634|FG001|Overall Study|Adverse Event|2|||
131226027|NCT03877237|472455633|FG000|Overall Study|Death|3|||
131226028|NCT03877237|472455634|FG001|Overall Study|Death|2|||
131226029|NCT03877237|472455633|FG000|Overall Study|Physician Decision|1|||
131226030|NCT03877237|472455634|FG001|Overall Study|Physician Decision|0|||
131226031|NCT03877237|472455633|FG000|Overall Study|Withdrawal by Subject|0|||
131226032|NCT03877237|472455634|FG001|Overall Study|Withdrawal by Subject|2|||
131226033|NCT00566098|472455637|FG000|Collection of MILs|Withdrawal by Subject|1|||
131226034|NCT00566098|472455637|FG000|Collection of MILs|Relapsed|1|||
131226035|NCT00566098|472455637|FG000|Generation of MILs Product|Relapsed|1|||
131226036|NCT00566098|472455637|FG000|Administration of ASCT+MILs|Death|10|||
131226037|NCT00566098|472455637|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
131226038|NCT02236754|472455638|FG000|Overall Study|Withdrawal by Subject|1|||
131226039|NCT02236754|472455639|FG001|Overall Study|Withdrawal by Subject|0|||
131226040|NCT04006847|472455640|FG000|Overall Study|Product issue|1|||
131226041|NCT00382291|472455641|FG000|Overall Study|Adverse Event|1|||
131226042|NCT00382291|472455642|FG001|Overall Study|Adverse Event|2|||
131226043|NCT00382291|472455643|FG002|Overall Study|Adverse Event|2|||
131226044|NCT00382291|472455641|FG000|Overall Study|Protocol Violation|1|||
131226045|NCT00382291|472455642|FG001|Overall Study|Protocol Violation|0|||
131226046|NCT00382291|472455643|FG002|Overall Study|Protocol Violation|0|||
131226047|NCT00382291|472455641|FG000|Overall Study|Temporary study suspension|2|||
131226048|NCT00382291|472455642|FG001|Overall Study|Temporary study suspension|2|||
131226049|NCT00382291|472455643|FG002|Overall Study|Temporary study suspension|5|||
131226050|NCT00382291|472455641|FG000|Overall Study|Withdrawal by Subject|0|||
131226051|NCT00382291|472455642|FG001|Overall Study|Withdrawal by Subject|2|||
131226052|NCT00382291|472455643|FG002|Overall Study|Withdrawal by Subject|0|||
131226053|NCT00382291|472455641|FG000|Overall Study|Physician Decision|0|||
131226054|NCT00382291|472455642|FG001|Overall Study|Physician Decision|1|||
131226055|NCT00382291|472455643|FG002|Overall Study|Physician Decision|0|||
131226056|NCT00382291|472455641|FG000|Overall Study|Lack of Efficacy|0|||
131226057|NCT00382291|472455642|FG001|Overall Study|Lack of Efficacy|0|||
131226058|NCT00382291|472455643|FG002|Overall Study|Lack of Efficacy|1|||
131226059|NCT02092961|472455646|FG000|Overall Study|Not reported|1|||
131226060|NCT02092961|472455647|FG001|Overall Study|Not reported|0|||
131226061|NCT02092961|472455648|FG002|Overall Study|Not reported|1|||
131226062|NCT02092961|472455646|FG000|Overall Study|Study stopped|13|||
131226063|NCT02092961|472455647|FG001|Overall Study|Study stopped|9|||
131226064|NCT02092961|472455648|FG002|Overall Study|Study stopped|12|||
131226065|NCT02092961|472455646|FG000|Overall Study|Lack of therapeutic response|2|||
131226066|NCT02092961|472455647|FG001|Overall Study|Lack of therapeutic response|1|||
131226067|NCT02092961|472455648|FG002|Overall Study|Lack of therapeutic response|3|||
131226068|NCT02092961|472455646|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
131226069|NCT02092961|472455647|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
131226070|NCT02092961|472455648|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
131226071|NCT02092961|472455646|FG000|Overall Study|Adverse Event|2|||
131226072|NCT02092961|472455647|FG001|Overall Study|Adverse Event|4|||
131226073|NCT02092961|472455648|FG002|Overall Study|Adverse Event|0|||
131226074|NCT01623830|472455652|FG000|Overall Study|Withdrawal by Subject|6|||
131226075|NCT01623830|472455653|FG001|Overall Study|Withdrawal by Subject|7|||
131226076|NCT01623830|472455652|FG000|Overall Study|Exclusion from Study|1|||
131226077|NCT01623830|472455653|FG001|Overall Study|Exclusion from Study|2|||
131226078|NCT01847313|472455654|FG000|Overall Study|Death|0|||
131226079|NCT01847313|472455655|FG001|Overall Study|Death|1|||
131226080|NCT01847313|472455654|FG000|Overall Study|Withdrawal by Subject|0|||
131226081|NCT01847313|472455655|FG001|Overall Study|Withdrawal by Subject|1|||
131226082|NCT03763331|472455656|FG000|Overall Study|Lost to Follow-up|1|||
131226083|NCT03763331|472455657|FG001|Overall Study|Lost to Follow-up|0|||
130956787|NCT01677195|471472722|FG000|Overall Study|Pregnancy|0|||
131226084|NCT03763331|472455656|FG000|Overall Study|Withdrawal by Subject|1|||
131226085|NCT03763331|472455657|FG001|Overall Study|Withdrawal by Subject|0|||
131226086|NCT03763331|472455656|FG000|Overall Study|Non-compliance|0|||
131226087|NCT03763331|472455657|FG001|Overall Study|Non-compliance|3|||
131226088|NCT04741503|472455658|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
131226089|NCT04741503|472455659|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
131226090|NCT04741503|472455660|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
131226091|NCT04741503|472455658|FG000|Initial Enrollment|Overquotas removed|0|||
131226092|NCT04741503|472455659|FG001|Initial Enrollment|Overquotas removed|0|||
131226093|NCT04741503|472455660|FG002|Initial Enrollment|Overquotas removed|186|||
130956788|NCT01677195|471472723|FG001|Overall Study|Pregnancy|1|||
130956789|NCT01677195|471472724|FG002|Overall Study|Pregnancy|0|||
130956790|NCT01677195|471472722|FG000|Overall Study|Protocol Violation|7|||
130956791|NCT01677195|471472723|FG001|Overall Study|Protocol Violation|3|||
130956792|NCT01677195|471472724|FG002|Overall Study|Protocol Violation|4|||
130956793|NCT04368429|471472725|FG000|Overall Study|Adverse Event|1|||
130956794|NCT04368429|471472726|FG001|Overall Study|Adverse Event|0|||
130956795|NCT02143414|471472728|FG000|Induction|Adverse Event|1|||
130956796|NCT02143414|471472729|FG001|Induction|Adverse Event|2|||
130956797|NCT02143414|471472728|FG000|Induction|Death|1|||
130956798|NCT02143414|471472729|FG001|Induction|Death|2|||
130956799|NCT02143414|471472728|FG000|Induction|Patient refusal|1|||
130956800|NCT02143414|471472729|FG001|Induction|Patient refusal|1|||
130956801|NCT02143414|471472728|FG000|Induction|Refractory|1|||
130956802|NCT02143414|471472729|FG001|Induction|Refractory|0|||
130956803|NCT02143414|471472728|FG000|Induction|Began alternative treatment|1|||
130956804|NCT02143414|471472729|FG001|Induction|Began alternative treatment|0|||
130956805|NCT02143414|471472728|FG000|Induction|Ineligible for postremission|5|||
130956806|NCT02143414|471472729|FG001|Induction|Ineligible for postremission|1|||
130956807|NCT02143414|471472728|FG000|Post-remission|Adverse Event|0|||
130956808|NCT02143414|471472729|FG001|Post-remission|Adverse Event|2|||
130956809|NCT02143414|471472728|FG000|Post-remission|Disease progression/relapse|5|||
130956810|NCT02143414|471472729|FG001|Post-remission|Disease progression/relapse|0|||
130956811|NCT02143414|471472728|FG000|Maintenance|Adverse Event|4|||
131226094|NCT04741503|472455658|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
131226095|NCT04741503|472455659|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
131226096|NCT04741503|472455660|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
131226097|NCT02280421|472455661|FG000|Washout (2 Weeks)|Adverse Event|0|||
131226098|NCT02280421|472455662|FG001|Washout (2 Weeks)|Adverse Event|1|||
131226099|NCT02280421|472455661|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
131226100|NCT02280421|472455662|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
131226101|NCT02853929|472455669|FG000|Overall Study|Lost to Follow-up|3|||
131226102|NCT02853929|472455670|FG001|Overall Study|Lost to Follow-up|0|||
131226103|NCT02853929|472455669|FG000|Overall Study|Withdrawal by Subject|1|||
131226104|NCT02853929|472455670|FG001|Overall Study|Withdrawal by Subject|0|||
131226105|NCT02853929|472455669|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
131226106|NCT02853929|472455670|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
131226107|NCT03549130|472455671|FG000|Overall Study|Adverse Event|0|||
131226108|NCT03549130|472455672|FG001|Overall Study|Adverse Event|1|||
130956812|NCT02143414|471472729|FG001|Maintenance|Adverse Event|6|||
131226109|NCT03549130|472455671|FG000|Overall Study|Lost to Follow-up|0|||
130956813|NCT02143414|471472728|FG000|Maintenance|Disease progression/relapse|3|||
130956814|NCT02143414|471472729|FG001|Maintenance|Disease progression/relapse|2|||
130956815|NCT02143414|471472728|FG000|Maintenance|Patient refusal|2|||
130956816|NCT02143414|471472729|FG001|Maintenance|Patient refusal|1|||
130956817|NCT02143414|471472728|FG000|Maintenance|Physician Decision|1|||
130956818|NCT02143414|471472729|FG001|Maintenance|Physician Decision|0|||
130956819|NCT02143414|471472728|FG000|Maintenance|Death|0|||
130956820|NCT02143414|471472729|FG001|Maintenance|Death|1|||
130956821|NCT02143414|471472728|FG000|Maintenance|On protocol treatment|0|||
130956822|NCT02143414|471472729|FG001|Maintenance|On protocol treatment|6|||
130956823|NCT02896400|471472733|FG000|1 Month Follow-up|Lost to Follow-up|7|||
130956824|NCT02896400|471472734|FG001|1 Month Follow-up|Lost to Follow-up|7|||
130956825|NCT02896400|471472735|FG002|1 Month Follow-up|Lost to Follow-up|5|||
130956826|NCT02896400|471472736|FG003|1 Month Follow-up|Lost to Follow-up|8|||
130956827|NCT02896400|471472737|FG004|1 Month Follow-up|Lost to Follow-up|9|||
130956828|NCT02896400|471472738|FG005|1 Month Follow-up|Lost to Follow-up|6|||
130956829|NCT02896400|471472739|FG006|1 Month Follow-up|Lost to Follow-up|5|||
130956830|NCT02896400|471472740|FG007|1 Month Follow-up|Lost to Follow-up|6|||
130956831|NCT02896400|471472741|FG008|1 Month Follow-up|Lost to Follow-up|4|||
131226110|NCT03549130|472455672|FG001|Overall Study|Lost to Follow-up|1|||
131226111|NCT00463866|472455673|FG000|Overall Study|Adverse Event|70|||
130956832|NCT02896400|471472742|FG009|1 Month Follow-up|Lost to Follow-up|7|||
130956833|NCT02896400|471472743|FG010|1 Month Follow-up|Lost to Follow-up|5|||
130956834|NCT02896400|471472744|FG011|1 Month Follow-up|Lost to Follow-up|5|||
130956835|NCT02896400|471472745|FG012|1 Month Follow-up|Lost to Follow-up|3|||
130956836|NCT02896400|471472746|FG013|1 Month Follow-up|Lost to Follow-up|4|||
130956837|NCT02896400|471472747|FG014|1 Month Follow-up|Lost to Follow-up|1|||
130956838|NCT02896400|471472748|FG015|1 Month Follow-up|Lost to Follow-up|2|||
130956839|NCT02896400|471472733|FG000|1 Month Follow-up|Death|0|||
130956840|NCT02896400|471472734|FG001|1 Month Follow-up|Death|0|||
130956841|NCT02896400|471472735|FG002|1 Month Follow-up|Death|0|||
130956842|NCT02896400|471472736|FG003|1 Month Follow-up|Death|0|||
130956843|NCT02896400|471472737|FG004|1 Month Follow-up|Death|0|||
130956844|NCT02896400|471472738|FG005|1 Month Follow-up|Death|0|||
130956845|NCT02896400|471472739|FG006|1 Month Follow-up|Death|0|||
130956846|NCT02896400|471472740|FG007|1 Month Follow-up|Death|0|||
130956847|NCT02896400|471472741|FG008|1 Month Follow-up|Death|0|||
130956848|NCT02896400|471472742|FG009|1 Month Follow-up|Death|0|||
130956849|NCT02896400|471472743|FG010|1 Month Follow-up|Death|0|||
130956850|NCT02896400|471472744|FG011|1 Month Follow-up|Death|0|||
130956851|NCT02896400|471472745|FG012|1 Month Follow-up|Death|0|||
130956852|NCT02896400|471472746|FG013|1 Month Follow-up|Death|0|||
130956853|NCT02896400|471472747|FG014|1 Month Follow-up|Death|0|||
130956854|NCT02896400|471472748|FG015|1 Month Follow-up|Death|1|||
130956855|NCT02896400|471472733|FG000|3 Month Follow-up|Lost to Follow-up|6|||
130956856|NCT02896400|471472734|FG001|3 Month Follow-up|Lost to Follow-up|3|||
130956857|NCT02896400|471472735|FG002|3 Month Follow-up|Lost to Follow-up|6|||
130956858|NCT02896400|471472736|FG003|3 Month Follow-up|Lost to Follow-up|11|||
130956859|NCT02896400|471472737|FG004|3 Month Follow-up|Lost to Follow-up|12|||
130956860|NCT02896400|471472738|FG005|3 Month Follow-up|Lost to Follow-up|6|||
130956861|NCT02896400|471472739|FG006|3 Month Follow-up|Lost to Follow-up|4|||
130956862|NCT02896400|471472740|FG007|3 Month Follow-up|Lost to Follow-up|3|||
130956863|NCT02896400|471472741|FG008|3 Month Follow-up|Lost to Follow-up|6|||
130956864|NCT02896400|471472742|FG009|3 Month Follow-up|Lost to Follow-up|5|||
130956865|NCT02896400|471472743|FG010|3 Month Follow-up|Lost to Follow-up|6|||
130956866|NCT02896400|471472744|FG011|3 Month Follow-up|Lost to Follow-up|6|||
130956867|NCT02896400|471472745|FG012|3 Month Follow-up|Lost to Follow-up|3|||
130956868|NCT02896400|471472746|FG013|3 Month Follow-up|Lost to Follow-up|5|||
130956869|NCT02896400|471472747|FG014|3 Month Follow-up|Lost to Follow-up|3|||
130956870|NCT02896400|471472748|FG015|3 Month Follow-up|Lost to Follow-up|2|||
130956871|NCT02896400|471472733|FG000|3 Month Follow-up|Death|0|||
130956872|NCT02896400|471472734|FG001|3 Month Follow-up|Death|0|||
130956873|NCT02896400|471472735|FG002|3 Month Follow-up|Death|0|||
130956874|NCT02896400|471472736|FG003|3 Month Follow-up|Death|0|||
130956875|NCT02896400|471472737|FG004|3 Month Follow-up|Death|0|||
130956876|NCT02896400|471472738|FG005|3 Month Follow-up|Death|0|||
130956877|NCT02896400|471472739|FG006|3 Month Follow-up|Death|0|||
130956878|NCT02896400|471472740|FG007|3 Month Follow-up|Death|0|||
130956879|NCT02896400|471472741|FG008|3 Month Follow-up|Death|0|||
130956880|NCT02896400|471472742|FG009|3 Month Follow-up|Death|0|||
130956881|NCT02896400|471472743|FG010|3 Month Follow-up|Death|0|||
130956882|NCT02896400|471472744|FG011|3 Month Follow-up|Death|0|||
130956883|NCT02896400|471472745|FG012|3 Month Follow-up|Death|0|||
130956884|NCT02896400|471472746|FG013|3 Month Follow-up|Death|1|||
130956885|NCT02896400|471472747|FG014|3 Month Follow-up|Death|1|||
130956886|NCT02896400|471472748|FG015|3 Month Follow-up|Death|0|||
130956887|NCT02896400|471472733|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130956888|NCT02896400|471472734|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
130956889|NCT02896400|471472735|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130956890|NCT02896400|471472736|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130956891|NCT02896400|471472737|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
130956892|NCT02896400|471472738|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130956893|NCT02896400|471472739|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
130956894|NCT02896400|471472740|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
130956895|NCT02896400|471472741|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130956896|NCT02896400|471472742|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130956897|NCT02896400|471472743|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
130956898|NCT02896400|471472744|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
130956899|NCT02896400|471472745|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130956900|NCT02896400|471472746|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
130956901|NCT02896400|471472747|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
130956902|NCT02896400|471472748|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
130956903|NCT02896400|471472733|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
130956904|NCT02896400|471472734|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
130956905|NCT02896400|471472735|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
130956906|NCT02896400|471472736|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
130956907|NCT02896400|471472737|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
130956908|NCT02896400|471472738|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
130956909|NCT02896400|471472739|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
130956910|NCT02896400|471472740|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
130956911|NCT02896400|471472741|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
130956912|NCT02896400|471472742|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
131040110|NCT01828099|471783422|FG001|Treatment Period|Adverse Event|23|||
131040111|NCT01828099|471783421|FG000|Treatment Period|Death|10|||
131226112|NCT00463866|472455674|FG001|Overall Study|Adverse Event|93|||
130956913|NCT02896400|471472743|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
130956914|NCT02896400|471472744|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
131226113|NCT00463866|472455673|FG000|Overall Study|Withdrawal by Subject|81|||
130713227|NCT00532935|470576930|FG001|Overall Study|Adverse Event|12|||
130713228|NCT00532935|470576929|FG000|Overall Study|Lack of Efficacy|0|||
130713229|NCT00532935|470576930|FG001|Overall Study|Lack of Efficacy|3|||
130713230|NCT00532935|470576929|FG000|Overall Study|Lost to Follow-up|10|||
130713231|NCT00532935|470576930|FG001|Overall Study|Lost to Follow-up|6|||
130713232|NCT00532935|470576929|FG000|Overall Study|Physician Decision|4|||
130713233|NCT00532935|470576930|FG001|Overall Study|Physician Decision|5|||
130713234|NCT00532935|470576929|FG000|Overall Study|Pregnancy|1|||
130713235|NCT00532935|470576930|FG001|Overall Study|Pregnancy|0|||
130713236|NCT00532935|470576929|FG000|Overall Study|Protocol Violation|4|||
130713237|NCT00532935|470576930|FG001|Overall Study|Protocol Violation|2|||
130713238|NCT00532935|470576929|FG000|Overall Study|Withdrawal by Subject|10|||
130713239|NCT00532935|470576930|FG001|Overall Study|Withdrawal by Subject|9|||
130713240|NCT00532935|470576929|FG000|Overall Study|Protocol Specific Criteria|11|||
130956915|NCT02896400|471472745|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
130956916|NCT02896400|471472746|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
130956917|NCT02896400|471472747|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
130956918|NCT02896400|471472748|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
130956919|NCT00634647|471472749|FG000|Overall Study|death on study|3|||
130956920|NCT00634647|471472749|FG000|Overall Study|refused further treatment|3|||
130956921|NCT00634647|471472749|FG000|Overall Study|declined to participate before treatment|1|||
130956922|NCT00646204|471472752|FG000|Overall Study|Adverse Event|3|||
130956923|NCT00646204|471472753|FG001|Overall Study|Adverse Event|0|||
130956924|NCT00646204|471472752|FG000|Overall Study|Withdrawal by Subject|1|||
130956925|NCT00646204|471472753|FG001|Overall Study|Withdrawal by Subject|0|||
130956926|NCT03107988|471472757|FG000|Overall Study|Adverse Event|0|||
130956927|NCT03107988|471472758|FG001|Overall Study|Adverse Event|0|||
130956928|NCT03107988|471472759|FG002|Overall Study|Adverse Event|0|||
130956929|NCT03107988|471472760|FG003|Overall Study|Adverse Event|1|||
130956930|NCT03107988|471472761|FG004|Overall Study|Adverse Event|0|||
130956931|NCT03107988|471472762|FG005|Overall Study|Adverse Event|1|||
130956932|NCT03107988|471472763|FG006|Overall Study|Adverse Event|0|||
130956933|NCT03107988|471472764|FG007|Overall Study|Adverse Event|1|||
130956934|NCT03107988|471472765|FG008|Overall Study|Adverse Event|0|||
130956935|NCT03107988|471472766|FG009|Overall Study|Adverse Event|0|||
130956936|NCT03107988|471472767|FG010|Overall Study|Adverse Event|0|||
130956937|NCT03107988|471472768|FG011|Overall Study|Adverse Event|0|||
130956938|NCT03107988|471472769|FG012|Overall Study|Adverse Event|0|||
130956939|NCT03107988|471472757|FG000|Overall Study|Disease Progression or Relapse|1|||
130956940|NCT03107988|471472758|FG001|Overall Study|Disease Progression or Relapse|2|||
130956941|NCT03107988|471472759|FG002|Overall Study|Disease Progression or Relapse|2|||
130956942|NCT03107988|471472760|FG003|Overall Study|Disease Progression or Relapse|5|||
130956943|NCT03107988|471472761|FG004|Overall Study|Disease Progression or Relapse|1|||
130956944|NCT03107988|471472762|FG005|Overall Study|Disease Progression or Relapse|1|||
130956945|NCT03107988|471472763|FG006|Overall Study|Disease Progression or Relapse|0|||
130956946|NCT03107988|471472764|FG007|Overall Study|Disease Progression or Relapse|0|||
130956947|NCT03107988|471472765|FG008|Overall Study|Disease Progression or Relapse|0|||
130956948|NCT03107988|471472766|FG009|Overall Study|Disease Progression or Relapse|1|||
130956949|NCT03107988|471472767|FG010|Overall Study|Disease Progression or Relapse|4|||
130956950|NCT03107988|471472768|FG011|Overall Study|Disease Progression or Relapse|0|||
130956951|NCT03107988|471472769|FG012|Overall Study|Disease Progression or Relapse|0|||
130956952|NCT03107988|471472757|FG000|Overall Study|Ineligible|0|||
130956953|NCT03107988|471472758|FG001|Overall Study|Ineligible|0|||
130956954|NCT03107988|471472759|FG002|Overall Study|Ineligible|0|||
130956955|NCT03107988|471472760|FG003|Overall Study|Ineligible|0|||
130956956|NCT03107988|471472761|FG004|Overall Study|Ineligible|0|||
130713241|NCT00532935|470576930|FG001|Overall Study|Protocol Specific Criteria|15|||
130713242|NCT00456495|470576931|FG000|Overall Study|Physician Decision|2|||
130713243|NCT02192164|470576932|FG000|Overall Study|Other|8|||
130956957|NCT03107988|471472762|FG005|Overall Study|Ineligible|0|||
130956958|NCT03107988|471472763|FG006|Overall Study|Ineligible|0|||
130956959|NCT03107988|471472764|FG007|Overall Study|Ineligible|0|||
130956960|NCT03107988|471472765|FG008|Overall Study|Ineligible|1|||
130956961|NCT03107988|471472766|FG009|Overall Study|Ineligible|0|||
130956962|NCT03107988|471472767|FG010|Overall Study|Ineligible|0|||
130956963|NCT03107988|471472768|FG011|Overall Study|Ineligible|0|||
130956964|NCT03107988|471472769|FG012|Overall Study|Ineligible|0|||
130956965|NCT00503841|471472770|FG000|Overall Study|All screen failures|44|||
131226114|NCT00463866|472455674|FG001|Overall Study|Withdrawal by Subject|79|||
130713244|NCT02192164|470576932|FG000|Overall Study|Withdrawal by Subject|1|||
130956966|NCT00326612|471472771|FG000|Overall Study|They did not have a seizure requiring tx|129|||
130956967|NCT00326612|471472772|FG001|Overall Study|They did not have a seizure requiring tx|137|||
130956968|NCT02177266|471472774|FG000|Overall Study|Adverse Event|0|||
130956969|NCT02177266|471472775|FG001|Overall Study|Adverse Event|1|||
130713245|NCT02192164|470576932|FG000|Overall Study|Physician Decision|4|||
130713246|NCT02192164|470576932|FG000|Overall Study|Did not meet the exclusion criteria|1|||
130713247|NCT01300923|470576933|FG000|Overall Study|Physician Decision|0|||
130713248|NCT01300923|470576934|FG001|Overall Study|Physician Decision|2|||
130713249|NCT01568866|470576935|FG000|Overall Study|Disease Progression|208|||
130713250|NCT01568866|470576936|FG001|Overall Study|Disease Progression|183|||
130713251|NCT01568866|470576935|FG000|Overall Study|Adverse Event|94|||
130713252|NCT01568866|470576936|FG001|Overall Study|Adverse Event|96|||
130713253|NCT01568866|470576935|FG000|Overall Study|Patient Request|55|||
130713254|NCT01568866|470576936|FG001|Overall Study|Patient Request|71|||
130713255|NCT01568866|470576935|FG000|Overall Study|Physician Decision|40|||
130713256|NCT01568866|470576936|FG001|Overall Study|Physician Decision|32|||
130713257|NCT01568866|470576935|FG000|Overall Study|Withdrawal by Subject|19|||
130713258|NCT01568866|470576936|FG001|Overall Study|Withdrawal by Subject|11|||
130713259|NCT01568866|470576935|FG000|Overall Study|Death|10|||
130713260|NCT01568866|470576936|FG001|Overall Study|Death|18|||
130713261|NCT01568866|470576935|FG000|Overall Study|Protocol Non-compliance|2|||
130774720|NCT01029262|470802557|FG000|Overall Study|Protocol Violation|2|||
130956970|NCT02177266|471472774|FG000|Overall Study|Withdrawal by Subject|1|||
130956971|NCT02177266|471472775|FG001|Overall Study|Withdrawal by Subject|0|||
130956972|NCT00546715|471472777|FG000|Overall Study|Withdrawal by Subject|0|||
130956973|NCT00546715|471472778|FG001|Overall Study|Withdrawal by Subject|1|||
130956974|NCT00546715|471472779|FG002|Overall Study|Withdrawal by Subject|0|||
130956975|NCT00546715|471472780|FG003|Overall Study|Withdrawal by Subject|0|||
130956976|NCT02331446|471472781|FG000|Overall Study|Lost to Follow-up|2|||
130956977|NCT02331446|471472782|FG001|Overall Study|Lost to Follow-up|1|||
130956978|NCT02331446|471472783|FG002|Overall Study|Lost to Follow-up|0|||
130774721|NCT01029262|470802558|FG001|Overall Study|Protocol Violation|3|||
130774722|NCT01029262|470802557|FG000|Overall Study|Miscellaneous|1|||
130956979|NCT02331446|471472784|FG003|Overall Study|Lost to Follow-up|1|||
130956980|NCT02331446|471472781|FG000|Overall Study|Personal Problem|2|||
130956981|NCT02331446|471472782|FG001|Overall Study|Personal Problem|0|||
130956982|NCT02331446|471472783|FG002|Overall Study|Personal Problem|0|||
130956983|NCT02331446|471472784|FG003|Overall Study|Personal Problem|0|||
130956984|NCT02331446|471472781|FG000|Overall Study|Disease|0|||
130774723|NCT01029262|470802558|FG001|Overall Study|Miscellaneous|9|||
130774724|NCT01029262|470802557|FG000|Overall Study|Death|0|||
130774725|NCT01029262|470802558|FG001|Overall Study|Death|3|||
130956985|NCT02331446|471472782|FG001|Overall Study|Disease|2|||
130956986|NCT02331446|471472783|FG002|Overall Study|Disease|2|||
130956987|NCT02331446|471472784|FG003|Overall Study|Disease|1|||
130956988|NCT02331446|471472781|FG000|Overall Study|Physician Decision|0|||
130956989|NCT02331446|471472782|FG001|Overall Study|Physician Decision|1|||
130774726|NCT03410992|470802559|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130774727|NCT03410992|470802560|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
130774728|NCT03410992|470802561|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130774729|NCT03410992|470802562|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130774730|NCT03410992|470802563|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130774731|NCT03410992|470802564|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130774732|NCT03410992|470802565|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130774733|NCT03410992|470802566|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130774734|NCT03410992|470802567|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130774735|NCT03410992|470802568|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130774736|NCT03410992|470802569|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130774737|NCT03410992|470802559|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
130774738|NCT03410992|470802560|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
130774739|NCT03410992|470802561|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130774740|NCT03410992|470802562|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130774741|NCT03410992|470802563|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130956990|NCT02331446|471472783|FG002|Overall Study|Physician Decision|0|||
130713262|NCT01568866|470576936|FG001|Overall Study|Protocol Non-compliance|4|||
130713263|NCT01568866|470576935|FG000|Overall Study|Lost to Follow-up|1|||
130774742|NCT03410992|470802564|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130774743|NCT03410992|470802565|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130774744|NCT03410992|470802566|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130774745|NCT03410992|470802567|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130956991|NCT02331446|471472784|FG003|Overall Study|Physician Decision|1|||
130956992|NCT02331446|471472781|FG000|Overall Study|Lost before baseline analysis|0|||
130956993|NCT02331446|471472782|FG001|Overall Study|Lost before baseline analysis|1|||
130713264|NCT01568866|470576936|FG001|Overall Study|Lost to Follow-up|0|||
130713265|NCT01568866|470576935|FG000|Overall Study|Randomized but Not Dosed|9|||
130713266|NCT01568866|470576936|FG001|Overall Study|Randomized but Not Dosed|1|||
130713267|NCT01698775|470576939|FG000|Phase A|Adverse Event|2|||
130713268|NCT01698775|470576940|FG001|Phase A|Adverse Event|1|||
130713269|NCT01698775|470576939|FG000|Phase A|Death|1|||
130956994|NCT02331446|471472783|FG002|Overall Study|Lost before baseline analysis|1|||
131040112|NCT01828099|471783422|FG001|Treatment Period|Death|12|||
131040113|NCT01828099|471783421|FG000|Treatment Period|Lost to Follow-up|2|||
131040114|NCT01828099|471783422|FG001|Treatment Period|Lost to Follow-up|1|||
130956995|NCT02331446|471472784|FG003|Overall Study|Lost before baseline analysis|0|||
130956996|NCT00976898|471472791|FG000|Overall Study|Protocol Violation|1|||
130956997|NCT00976898|471472791|FG000|Overall Study|Adverse Event|1|||
130956998|NCT00976898|471472791|FG000|Overall Study|Physician Decision|1|||
130956999|NCT00976898|471472791|FG000|Overall Study|Liver Transplant|1|||
130957000|NCT00976898|471472791|FG000|Overall Study|Progressive Disease|1|||
130957001|NCT03670810|471472794|FG000|Main Study|Adverse Event|37|||
130957002|NCT03670810|471472795|FG001|Main Study|Adverse Event|38|||
130957003|NCT03670810|471472796|FG002|Main Study|Adverse Event|3|||
130957004|NCT03670810|471472797|FG003|Main Study|Adverse Event|4|||
130957005|NCT03670810|471472798|FG004|Main Study|Adverse Event|4|||
130957006|NCT03670810|471472799|FG005|Main Study|Adverse Event|5|||
130957007|NCT03670810|471472800|FG006|Main Study|Adverse Event|0|||
130957008|NCT03670810|471472801|FG007|Main Study|Adverse Event|0|||
130957009|NCT03670810|471472802|FG008|Main Study|Adverse Event|0|||
130957010|NCT03670810|471472794|FG000|Main Study|Lack of Efficacy|8|||
130957011|NCT03670810|471472795|FG001|Main Study|Lack of Efficacy|9|||
130957012|NCT03670810|471472796|FG002|Main Study|Lack of Efficacy|3|||
130957013|NCT03670810|471472797|FG003|Main Study|Lack of Efficacy|4|||
130957014|NCT03670810|471472798|FG004|Main Study|Lack of Efficacy|0|||
130957015|NCT03670810|471472799|FG005|Main Study|Lack of Efficacy|0|||
130957016|NCT03670810|471472800|FG006|Main Study|Lack of Efficacy|0|||
130957017|NCT03670810|471472801|FG007|Main Study|Lack of Efficacy|0|||
130957018|NCT03670810|471472802|FG008|Main Study|Lack of Efficacy|0|||
130957019|NCT03670810|471472794|FG000|Main Study|Lost to Follow-up|9|||
130957020|NCT03670810|471472795|FG001|Main Study|Lost to Follow-up|7|||
130957021|NCT03670810|471472796|FG002|Main Study|Lost to Follow-up|4|||
130957022|NCT03670810|471472797|FG003|Main Study|Lost to Follow-up|6|||
130957023|NCT03670810|471472798|FG004|Main Study|Lost to Follow-up|1|||
130957024|NCT03670810|471472799|FG005|Main Study|Lost to Follow-up|0|||
130957025|NCT03670810|471472800|FG006|Main Study|Lost to Follow-up|0|||
130957026|NCT03670810|471472801|FG007|Main Study|Lost to Follow-up|0|||
130957027|NCT03670810|471472802|FG008|Main Study|Lost to Follow-up|0|||
130957028|NCT03670810|471472794|FG000|Main Study|Non-compliance with Study Drug|0|||
130957029|NCT03670810|471472795|FG001|Main Study|Non-compliance with Study Drug|2|||
130957030|NCT03670810|471472796|FG002|Main Study|Non-compliance with Study Drug|3|||
130957031|NCT03670810|471472797|FG003|Main Study|Non-compliance with Study Drug|0|||
130957032|NCT03670810|471472798|FG004|Main Study|Non-compliance with Study Drug|0|||
130957033|NCT03670810|471472799|FG005|Main Study|Non-compliance with Study Drug|0|||
130957034|NCT03670810|471472800|FG006|Main Study|Non-compliance with Study Drug|0|||
130957035|NCT03670810|471472801|FG007|Main Study|Non-compliance with Study Drug|1|||
130957036|NCT03670810|471472802|FG008|Main Study|Non-compliance with Study Drug|0|||
130957037|NCT03670810|471472794|FG000|Main Study|Physician Decision|3|||
130957038|NCT03670810|471472795|FG001|Main Study|Physician Decision|0|||
130957039|NCT03670810|471472796|FG002|Main Study|Physician Decision|1|||
130957040|NCT03670810|471472797|FG003|Main Study|Physician Decision|0|||
130957041|NCT03670810|471472798|FG004|Main Study|Physician Decision|0|||
130957042|NCT03670810|471472799|FG005|Main Study|Physician Decision|0|||
130957043|NCT03670810|471472800|FG006|Main Study|Physician Decision|1|||
130957044|NCT03670810|471472801|FG007|Main Study|Physician Decision|1|||
130957045|NCT03670810|471472802|FG008|Main Study|Physician Decision|0|||
130957046|NCT03670810|471472794|FG000|Main Study|Pregnancy|1|||
130957047|NCT03670810|471472795|FG001|Main Study|Pregnancy|2|||
130957048|NCT03670810|471472796|FG002|Main Study|Pregnancy|0|||
130957049|NCT03670810|471472797|FG003|Main Study|Pregnancy|0|||
130957050|NCT03670810|471472798|FG004|Main Study|Pregnancy|0|||
130957051|NCT03670810|471472799|FG005|Main Study|Pregnancy|0|||
130957052|NCT03670810|471472800|FG006|Main Study|Pregnancy|0|||
131040115|NCT01828099|471783421|FG000|Treatment Period|Non-compliance with study treatment|1|||
131040116|NCT01828099|471783422|FG001|Treatment Period|Non-compliance with study treatment|0|||
131040117|NCT01828099|471783421|FG000|Treatment Period|Physician Decision|17|||
130957053|NCT03670810|471472801|FG007|Main Study|Pregnancy|0|||
130957054|NCT03670810|471472802|FG008|Main Study|Pregnancy|0|||
130957055|NCT03670810|471472794|FG000|Main Study|Protocol Deviation|2|||
130957056|NCT03670810|471472795|FG001|Main Study|Protocol Deviation|12|||
130957057|NCT03670810|471472796|FG002|Main Study|Protocol Deviation|8|||
131040118|NCT01828099|471783422|FG001|Treatment Period|Physician Decision|16|||
130957058|NCT03670810|471472797|FG003|Main Study|Protocol Deviation|4|||
130957059|NCT03670810|471472798|FG004|Main Study|Protocol Deviation|0|||
130957060|NCT03670810|471472799|FG005|Main Study|Protocol Deviation|0|||
131040119|NCT01828099|471783421|FG000|Treatment Period|Progressive disease|99|||
131040120|NCT01828099|471783422|FG001|Treatment Period|Progressive disease|107|||
131040121|NCT01828099|471783421|FG000|Treatment Period|Subject/guardian decision|22|||
130957061|NCT03670810|471472800|FG006|Main Study|Protocol Deviation|0|||
130957062|NCT03670810|471472801|FG007|Main Study|Protocol Deviation|0|||
130957063|NCT03670810|471472802|FG008|Main Study|Protocol Deviation|0|||
130957064|NCT03670810|471472794|FG000|Main Study|Withdrawal by Subject|21|||
130957065|NCT03670810|471472795|FG001|Main Study|Withdrawal by Subject|21|||
130957066|NCT03670810|471472796|FG002|Main Study|Withdrawal by Subject|8|||
130957067|NCT03670810|471472797|FG003|Main Study|Withdrawal by Subject|9|||
130957068|NCT03670810|471472798|FG004|Main Study|Withdrawal by Subject|5|||
130957069|NCT03670810|471472799|FG005|Main Study|Withdrawal by Subject|2|||
131226115|NCT00463866|472455673|FG000|Overall Study|Lost to Follow-up|46|||
131226116|NCT00463866|472455674|FG001|Overall Study|Lost to Follow-up|55|||
131226117|NCT00463866|472455673|FG000|Overall Study|Incorrect Enrolment|64|||
131226118|NCT00463866|472455674|FG001|Overall Study|Incorrect Enrolment|66|||
131226119|NCT00463866|472455673|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
131226120|NCT00463866|472455674|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
131226121|NCT00463866|472455673|FG000|Overall Study|Safety Reason|1|||
131226122|NCT00463866|472455674|FG001|Overall Study|Safety Reason|3|||
131226123|NCT00463866|472455673|FG000|Overall Study|Mis-Randomization of subject|0|||
131226124|NCT00463866|472455674|FG001|Overall Study|Mis-Randomization of subject|1|||
131226125|NCT00463866|472455673|FG000|Overall Study|Other|22|||
131226126|NCT00463866|472455674|FG001|Overall Study|Other|22|||
131226127|NCT00693784|472455675|FG000|Overall Study|Lost to Follow-up|2|||
131226128|NCT00693784|472455675|FG000|Overall Study|Withdrawal by Subject|2|||
131226129|NCT00326885|472455679|FG000|Overall Study|Adverse Event|1|||
131226130|NCT00326885|472455679|FG000|Overall Study|Withdrawal by Subject|3|||
130957070|NCT03670810|471472800|FG006|Main Study|Withdrawal by Subject|1|||
130957071|NCT03670810|471472801|FG007|Main Study|Withdrawal by Subject|1|||
130957072|NCT03670810|471472802|FG008|Main Study|Withdrawal by Subject|0|||
130957073|NCT03670810|471472794|FG000|Main Study|Participant did not want to take the three other treatments|1|||
130957074|NCT03670810|471472795|FG001|Main Study|Participant did not want to take the three other treatments|0|||
130957075|NCT03670810|471472796|FG002|Main Study|Participant did not want to take the three other treatments|0|||
130957076|NCT03670810|471472797|FG003|Main Study|Participant did not want to take the three other treatments|0|||
130957077|NCT03670810|471472798|FG004|Main Study|Participant did not want to take the three other treatments|0|||
130957078|NCT03670810|471472799|FG005|Main Study|Participant did not want to take the three other treatments|0|||
130957079|NCT03670810|471472800|FG006|Main Study|Participant did not want to take the three other treatments|0|||
130957080|NCT03670810|471472801|FG007|Main Study|Participant did not want to take the three other treatments|0|||
130957081|NCT03670810|471472802|FG008|Main Study|Participant did not want to take the three other treatments|0|||
130957082|NCT03670810|471472794|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130713270|NCT01698775|470576940|FG001|Phase A|Death|1|||
130713271|NCT01698775|470576939|FG000|Phase A|Lack of Efficacy|1|||
130713272|NCT01698775|470576940|FG001|Phase A|Lack of Efficacy|0|||
130713273|NCT01698775|470576939|FG000|Phase A|Lost to Follow-up|1|||
130713274|NCT01698775|470576940|FG001|Phase A|Lost to Follow-up|2|||
130713275|NCT01698775|470576939|FG000|Phase A|Protocol Violation|1|||
130713276|NCT01698775|470576940|FG001|Phase A|Protocol Violation|0|||
130713277|NCT01698775|470576939|FG000|Phase A|Withdrawal by Subject|3|||
130713278|NCT01698775|470576940|FG001|Phase A|Withdrawal by Subject|4|||
130713279|NCT01698775|470576939|FG000|Phase A|Kidney [transplant]|0|||
130713280|NCT01698775|470576940|FG001|Phase A|Kidney [transplant]|1|||
130713281|NCT01698775|470576939|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
130713282|NCT01698775|470576940|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
130713283|NCT01698775|470576939|FG000|Phase B|Adverse Event|6|||
130713284|NCT01698775|470576940|FG001|Phase B|Adverse Event|3|||
130713285|NCT01698775|470576939|FG000|Phase B|Death|0|||
130713286|NCT01698775|470576940|FG001|Phase B|Death|1|||
130713287|NCT01698775|470576939|FG000|Phase B|Lack of Efficacy|0|||
130713288|NCT01698775|470576940|FG001|Phase B|Lack of Efficacy|1|||
130713289|NCT01698775|470576939|FG000|Phase B|Lost to Follow-up|0|||
130713290|NCT01698775|470576940|FG001|Phase B|Lost to Follow-up|1|||
130713291|NCT01698775|470576939|FG000|Phase B|Physician Decision|1|||
130713292|NCT01698775|470576940|FG001|Phase B|Physician Decision|1|||
130713293|NCT01698775|470576939|FG000|Phase B|Protocol Violation|1|||
130713294|NCT01698775|470576940|FG001|Phase B|Protocol Violation|1|||
130713295|NCT01698775|470576939|FG000|Phase B|Withdrawal by Subject|6|||
130713296|NCT01698775|470576940|FG001|Phase B|Withdrawal by Subject|2|||
130713297|NCT00359788|470576941|FG000|Overall Study|Adverse Event|11|||
130713298|NCT00359788|470576942|FG001|Overall Study|Adverse Event|10|||
130713299|NCT00359788|470576941|FG000|Overall Study|Lack of Efficacy|1|||
130713300|NCT00359788|470576942|FG001|Overall Study|Lack of Efficacy|2|||
130713301|NCT00359788|470576941|FG000|Overall Study|Lost to Follow-up|3|||
130957083|NCT03670810|471472795|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
130957084|NCT03670810|471472796|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
131040122|NCT01828099|471783422|FG001|Treatment Period|Subject/guardian decision|26|||
131226131|NCT00326885|472455679|FG000|Overall Study|Physician Decision|1|||
131226132|NCT00326885|472455679|FG000|Overall Study|Hospice withdrew consent|2|||
131226133|NCT01677910|472455681|FG000|Double-Blind Treatment Period|Adverse Event|6|||
130713302|NCT00359788|470576942|FG001|Overall Study|Lost to Follow-up|2|||
130713303|NCT00359788|470576941|FG000|Overall Study|Withdrawal by Subject|4|||
130713304|NCT00359788|470576942|FG001|Overall Study|Withdrawal by Subject|1|||
130713305|NCT00359788|470576941|FG000|Overall Study|Protocol Violation|4|||
130713306|NCT00359788|470576942|FG001|Overall Study|Protocol Violation|2|||
130713307|NCT00673933|470576945|FG000|Overall Study|Withdrawal by Subject|2|||
130713308|NCT00673933|470576945|FG000|Overall Study|Lost to Follow-up|1|||
131226134|NCT01677910|472455682|FG001|Double-Blind Treatment Period|Adverse Event|2|||
130713309|NCT04932941|470576948|FG000|Overall Study|Lost to Follow-up|3|||
130713310|NCT04932941|470576949|FG001|Overall Study|Lost to Follow-up|1|||
130713311|NCT04932941|470576948|FG000|Overall Study|Withdrawal by Subject|7|||
130713312|NCT04932941|470576949|FG001|Overall Study|Withdrawal by Subject|4|||
130713313|NCT04932941|470576948|FG000|Overall Study|Other|4|||
130713314|NCT04932941|470576949|FG001|Overall Study|Other|2|||
130713315|NCT01366443|470576950|FG000|Overall Study|Lost to Follow-up|2|||
130713316|NCT01366443|470576950|FG000|Overall Study|Under 18 yo|1|||
130713317|NCT02394730|470576956|FG000|Overall Study|Lost to Follow-up|1|||
130713318|NCT02394730|470576957|FG001|Overall Study|Lost to Follow-up|0|||
130713319|NCT02394730|470576956|FG000|Overall Study|Withdrawal by Subject|0|||
130713320|NCT02394730|470576957|FG001|Overall Study|Withdrawal by Subject|1|||
130713321|NCT02384850|470576958|FG000|Overall Study|Withdrawal by Subject|2|||
130713322|NCT02384850|470576959|FG001|Overall Study|Withdrawal by Subject|2|||
130713323|NCT01673698|470576960|FG000|Overall Study|Lost to Follow-up|51|||
130713324|NCT01673698|470576961|FG001|Overall Study|Lost to Follow-up|13|||
130713325|NCT00507546|470576962|FG000|Overall Study|Withdrawal by Subject|1|||
130713326|NCT00507546|470576963|FG001|Overall Study|Withdrawal by Subject|0|||
130713327|NCT00507546|470576962|FG000|Overall Study|Protocol Violation|1|||
130713328|NCT00507546|470576963|FG001|Overall Study|Protocol Violation|0|||
130713329|NCT00507546|470576962|FG000|Overall Study|Physician Decision|0|||
130713330|NCT00507546|470576963|FG001|Overall Study|Physician Decision|1|||
130713331|NCT00448136|470576964|FG000|Overall Study|Death|3|||
130713332|NCT00448136|470576965|FG001|Overall Study|Death|8|||
130713333|NCT00448136|470576964|FG000|Overall Study|Investigator's decision (progression)|1|||
130713334|NCT00448136|470576965|FG001|Overall Study|Investigator's decision (progression)|0|||
130713335|NCT02013375|470576966|FG000|Overall Study|Did not engraft|1|||
130713336|NCT02013375|470576966|FG000|Overall Study|Did not engraft|1|||
130713337|NCT03510182|470576969|FG000|Overall Study|Withdrawal by Subject|2|||
130713338|NCT01334710|470576976|FG000|Overall Study|Trial was terminated|3|||
130713339|NCT01558297|470576977|FG000|Overall Study|Withdrawal by Subject|2|||
130713340|NCT01558297|470576978|FG001|Overall Study|Withdrawal by Subject|2|||
130713341|NCT01558297|470576979|FG002|Overall Study|Withdrawal by Subject|1|||
130713342|NCT00375492|470576980|FG000|Overall Study|Adverse Event|4|||
130713343|NCT00375492|470576981|FG001|Overall Study|Adverse Event|5|||
130713344|NCT00375492|470576980|FG000|Overall Study|Entry Criteria Not Met|0|||
130713345|NCT00375492|470576981|FG001|Overall Study|Entry Criteria Not Met|1|||
130713346|NCT00375492|470576980|FG000|Overall Study|Loss of Glucose Control|0|||
130713347|NCT00375492|470576981|FG001|Overall Study|Loss of Glucose Control|1|||
130713348|NCT00375492|470576980|FG000|Overall Study|Lost to Follow-up|10|||
130713349|NCT00375492|470576981|FG001|Overall Study|Lost to Follow-up|5|||
130713350|NCT00375492|470576980|FG000|Overall Study|Physician Decision|0|||
130713351|NCT00375492|470576981|FG001|Overall Study|Physician Decision|4|||
130713352|NCT00375492|470576980|FG000|Overall Study|Protocol Violation|6|||
130713353|NCT00375492|470576981|FG001|Overall Study|Protocol Violation|3|||
131126558|NCT01423851|472091410|FG002|Whole Study|Disease progression|1|||
130713354|NCT00375492|470576980|FG000|Overall Study|Sponsor Decision|0|||
130713355|NCT00375492|470576981|FG001|Overall Study|Sponsor Decision|1|||
130713356|NCT00375492|470576980|FG000|Overall Study|Withdrawal by Subject|6|||
130713357|NCT00375492|470576981|FG001|Overall Study|Withdrawal by Subject|6|||
130713358|NCT01663727|470576982|FG000|Overall Study|Death|161|||
130713359|NCT01663727|470576983|FG001|Overall Study|Death|155|||
130713360|NCT01663727|470576982|FG000|Overall Study|Lost to Follow-up|10|||
130713361|NCT01663727|470576983|FG001|Overall Study|Lost to Follow-up|8|||
130713362|NCT01663727|470576982|FG000|Overall Study|Withdrawal by Subject|18|||
130713363|NCT01663727|470576983|FG001|Overall Study|Withdrawal by Subject|25|||
130713364|NCT01663727|470576982|FG000|Overall Study|Study Terminated|51|||
130713365|NCT01663727|470576983|FG001|Overall Study|Study Terminated|50|||
130713366|NCT01663727|470576982|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
130713367|NCT01663727|470576983|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
130713368|NCT01663727|470576982|FG000|Overall Study|Withdrawal prior to dosing.|1|||
130713369|NCT01663727|470576983|FG001|Overall Study|Withdrawal prior to dosing.|0|||
130713370|NCT01902628|470576984|FG000|Overall Study|Withdrawal of participant's consent|7|||
130713371|NCT01902628|470576984|FG000|Overall Study|Adverse Event|41|||
130713372|NCT01902628|470576984|FG000|Overall Study|Lost to Follow-up|35|||
130713373|NCT01232491|470576985|FG000|Overall Study|Adverse Event|13|||
130713374|NCT01232491|470576986|FG001|Overall Study|Adverse Event|8|||
130774746|NCT03410992|470802568|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130713375|NCT01232491|470576985|FG000|Overall Study|Lack of Efficacy|1|||
130713376|NCT01232491|470576986|FG001|Overall Study|Lack of Efficacy|5|||
130713377|NCT01232491|470576985|FG000|Overall Study|Protocol Violation|13|||
130774747|NCT03410992|470802569|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130713378|NCT01232491|470576986|FG001|Overall Study|Protocol Violation|11|||
130713379|NCT01232491|470576985|FG000|Overall Study|Withdrawal Criteria|12|||
130713380|NCT01232491|470576986|FG001|Overall Study|Withdrawal Criteria|21|||
130713381|NCT01232491|470576985|FG000|Overall Study|Other|21|||
130713382|NCT01232491|470576986|FG001|Overall Study|Other|18|||
130713383|NCT02932228|470576991|FG000|Overall Study|Death|8|||
130713384|NCT02932228|470576992|FG001|Overall Study|Death|23|||
130957085|NCT03670810|471472797|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130957086|NCT03670810|471472798|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130957087|NCT03670810|471472799|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130957088|NCT03670810|471472800|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130957089|NCT03670810|471472801|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130957090|NCT03670810|471472802|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
130957091|NCT03670810|471472794|FG000|Main Study|Travel and Coronavirus issues|0|||
130957092|NCT03670810|471472795|FG001|Main Study|Travel and Coronavirus issues|0|||
130957093|NCT03670810|471472796|FG002|Main Study|Travel and Coronavirus issues|0|||
130957094|NCT03670810|471472797|FG003|Main Study|Travel and Coronavirus issues|1|||
130957095|NCT03670810|471472798|FG004|Main Study|Travel and Coronavirus issues|0|||
130957096|NCT03670810|471472799|FG005|Main Study|Travel and Coronavirus issues|0|||
130957097|NCT03670810|471472800|FG006|Main Study|Travel and Coronavirus issues|0|||
130957098|NCT03670810|471472801|FG007|Main Study|Travel and Coronavirus issues|0|||
130957099|NCT03670810|471472802|FG008|Main Study|Travel and Coronavirus issues|0|||
130957100|NCT03670810|471472794|FG000|Open Label Extension|Protocol Deviation|0|||
130957101|NCT03670810|471472795|FG001|Open Label Extension|Protocol Deviation|0|||
130957102|NCT03670810|471472796|FG002|Open Label Extension|Protocol Deviation|0|||
130957103|NCT03670810|471472797|FG003|Open Label Extension|Protocol Deviation|0|||
130957104|NCT03670810|471472798|FG004|Open Label Extension|Protocol Deviation|0|||
130957105|NCT03670810|471472799|FG005|Open Label Extension|Protocol Deviation|0|||
130957106|NCT03670810|471472800|FG006|Open Label Extension|Protocol Deviation|0|||
130957107|NCT03670810|471472801|FG007|Open Label Extension|Protocol Deviation|0|||
130957108|NCT03670810|471472802|FG008|Open Label Extension|Protocol Deviation|5|||
130957109|NCT03670810|471472794|FG000|Open Label Extension|Death|0|||
130957110|NCT03670810|471472795|FG001|Open Label Extension|Death|0|||
130957111|NCT03670810|471472796|FG002|Open Label Extension|Death|0|||
130957112|NCT03670810|471472797|FG003|Open Label Extension|Death|0|||
130957113|NCT03670810|471472798|FG004|Open Label Extension|Death|0|||
130957114|NCT03670810|471472799|FG005|Open Label Extension|Death|0|||
130957115|NCT03670810|471472800|FG006|Open Label Extension|Death|0|||
130957116|NCT03670810|471472801|FG007|Open Label Extension|Death|0|||
130957117|NCT03670810|471472802|FG008|Open Label Extension|Death|1|||
130957118|NCT03670810|471472794|FG000|Open Label Extension|COVID-19|0|||
130957119|NCT03670810|471472795|FG001|Open Label Extension|COVID-19|0|||
130957120|NCT03670810|471472796|FG002|Open Label Extension|COVID-19|0|||
130957121|NCT03670810|471472797|FG003|Open Label Extension|COVID-19|0|||
130957122|NCT03670810|471472798|FG004|Open Label Extension|COVID-19|0|||
130957123|NCT03670810|471472799|FG005|Open Label Extension|COVID-19|0|||
130957124|NCT03670810|471472800|FG006|Open Label Extension|COVID-19|0|||
130957125|NCT03670810|471472801|FG007|Open Label Extension|COVID-19|0|||
130957126|NCT03670810|471472802|FG008|Open Label Extension|COVID-19|1|||
130957127|NCT03670810|471472794|FG000|Open Label Extension|Lack of Efficacy|0|||
130957128|NCT03670810|471472795|FG001|Open Label Extension|Lack of Efficacy|0|||
130957129|NCT03670810|471472796|FG002|Open Label Extension|Lack of Efficacy|0|||
130957130|NCT03670810|471472797|FG003|Open Label Extension|Lack of Efficacy|0|||
130957131|NCT03670810|471472798|FG004|Open Label Extension|Lack of Efficacy|0|||
130957132|NCT03670810|471472799|FG005|Open Label Extension|Lack of Efficacy|0|||
130957133|NCT03670810|471472800|FG006|Open Label Extension|Lack of Efficacy|0|||
130957134|NCT03670810|471472801|FG007|Open Label Extension|Lack of Efficacy|0|||
130957135|NCT03670810|471472802|FG008|Open Label Extension|Lack of Efficacy|39|||
130957136|NCT03670810|471472794|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
130957137|NCT03670810|471472795|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
130957138|NCT03670810|471472796|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
130957139|NCT03670810|471472797|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
130957140|NCT03670810|471472798|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
130957141|NCT03670810|471472799|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
130957142|NCT03670810|471472800|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
130957143|NCT03670810|471472801|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
130957144|NCT03670810|471472802|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
130957145|NCT03670810|471472794|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130957146|NCT03670810|471472795|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130957147|NCT03670810|471472796|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
131126559|NCT01423851|472091411|FG003|Whole Study|Disease progression|4|||
131126560|NCT01423851|472091412|FG004|Whole Study|Disease progression|1|||
131126561|NCT01423851|472091413|FG005|Whole Study|Disease progression|3|||
131126562|NCT01423851|472091414|FG006|Whole Study|Disease progression|1|||
131126563|NCT01423851|472091415|FG007|Whole Study|Disease progression|4|||
131126564|NCT01423851|472091416|FG008|Whole Study|Disease progression|0|||
131126565|NCT01423851|472091417|FG009|Whole Study|Disease progression|2|||
131126566|NCT01423851|472091418|FG010|Whole Study|Disease progression|10|||
131126567|NCT01423851|472091408|FG000|Whole Study|Physician Decision|0|||
130713385|NCT02932228|470576991|FG000|Overall Study|not eligible upon chart review|2|||
130713386|NCT02932228|470576992|FG001|Overall Study|not eligible upon chart review|5|||
130713387|NCT04905290|470578345|FG000|Overall Study|Adverse Event|4|||
130713388|NCT04905290|470578345|FG000|Overall Study|Death|2|||
130957148|NCT03670810|471472797|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130957149|NCT03670810|471472798|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130957150|NCT03670810|471472799|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130957151|NCT03670810|471472800|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130957152|NCT03670810|471472801|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
130957153|NCT03670810|471472802|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
130957154|NCT03670810|471472794|FG000|Open Label Extension|Withdrawal by Subject|0|||
130957155|NCT03670810|471472795|FG001|Open Label Extension|Withdrawal by Subject|0|||
130957156|NCT03670810|471472796|FG002|Open Label Extension|Withdrawal by Subject|0|||
130957157|NCT03670810|471472797|FG003|Open Label Extension|Withdrawal by Subject|0|||
130957158|NCT03670810|471472798|FG004|Open Label Extension|Withdrawal by Subject|0|||
130957159|NCT03670810|471472799|FG005|Open Label Extension|Withdrawal by Subject|0|||
130957160|NCT03670810|471472800|FG006|Open Label Extension|Withdrawal by Subject|0|||
130957161|NCT03670810|471472801|FG007|Open Label Extension|Withdrawal by Subject|0|||
130957162|NCT03670810|471472802|FG008|Open Label Extension|Withdrawal by Subject|46|||
130957163|NCT03670810|471472794|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130957164|NCT03670810|471472795|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130957165|NCT03670810|471472796|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130957166|NCT03670810|471472797|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130957167|NCT03670810|471472798|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130957168|NCT03670810|471472799|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130957169|NCT03670810|471472800|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130957170|NCT03670810|471472801|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
130957171|NCT03670810|471472802|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
130957172|NCT03670810|471472794|FG000|Open Label Extension|Physician Decision|0|||
130957173|NCT03670810|471472795|FG001|Open Label Extension|Physician Decision|0|||
130957174|NCT03670810|471472796|FG002|Open Label Extension|Physician Decision|0|||
130957175|NCT03670810|471472797|FG003|Open Label Extension|Physician Decision|0|||
130957176|NCT03670810|471472798|FG004|Open Label Extension|Physician Decision|0|||
130957177|NCT03670810|471472799|FG005|Open Label Extension|Physician Decision|0|||
130957178|NCT03670810|471472800|FG006|Open Label Extension|Physician Decision|0|||
130957179|NCT03670810|471472801|FG007|Open Label Extension|Physician Decision|0|||
130957180|NCT03670810|471472802|FG008|Open Label Extension|Physician Decision|2|||
130957181|NCT03670810|471472794|FG000|Open Label Extension|Non-compliance with study drug|0|||
130957182|NCT03670810|471472795|FG001|Open Label Extension|Non-compliance with study drug|0|||
130957183|NCT03670810|471472796|FG002|Open Label Extension|Non-compliance with study drug|0|||
130957184|NCT03670810|471472797|FG003|Open Label Extension|Non-compliance with study drug|0|||
130957185|NCT03670810|471472798|FG004|Open Label Extension|Non-compliance with study drug|0|||
130957186|NCT03670810|471472799|FG005|Open Label Extension|Non-compliance with study drug|0|||
130957187|NCT03670810|471472800|FG006|Open Label Extension|Non-compliance with study drug|0|||
130957188|NCT03670810|471472801|FG007|Open Label Extension|Non-compliance with study drug|0|||
130957189|NCT03670810|471472802|FG008|Open Label Extension|Non-compliance with study drug|5|||
130957190|NCT03670810|471472794|FG000|Open Label Extension|Pregnancy|0|||
130957191|NCT03670810|471472795|FG001|Open Label Extension|Pregnancy|0|||
130957192|NCT03670810|471472796|FG002|Open Label Extension|Pregnancy|0|||
130957193|NCT03670810|471472797|FG003|Open Label Extension|Pregnancy|0|||
130957194|NCT03670810|471472798|FG004|Open Label Extension|Pregnancy|0|||
130957195|NCT03670810|471472799|FG005|Open Label Extension|Pregnancy|0|||
130957196|NCT03670810|471472800|FG006|Open Label Extension|Pregnancy|0|||
130957197|NCT03670810|471472801|FG007|Open Label Extension|Pregnancy|0|||
130957198|NCT03670810|471472802|FG008|Open Label Extension|Pregnancy|3|||
130957199|NCT03670810|471472794|FG000|Open Label Extension|Adverse Event|0|||
130957200|NCT03670810|471472795|FG001|Open Label Extension|Adverse Event|0|||
130957201|NCT03670810|471472796|FG002|Open Label Extension|Adverse Event|0|||
130957202|NCT03670810|471472797|FG003|Open Label Extension|Adverse Event|0|||
130713389|NCT04905290|470578345|FG000|Overall Study|Withdrawal by Subject|4|||
130713390|NCT04905290|470578345|FG000|Overall Study|Physician Decision|2|||
130957203|NCT03670810|471472798|FG004|Open Label Extension|Adverse Event|0|||
130957204|NCT03670810|471472799|FG005|Open Label Extension|Adverse Event|0|||
130957205|NCT03670810|471472800|FG006|Open Label Extension|Adverse Event|0|||
130957206|NCT03670810|471472801|FG007|Open Label Extension|Adverse Event|0|||
131040123|NCT01828099|471783421|FG000|Treatment Period|Study terminated by Sponsor|13|||
130957207|NCT03670810|471472802|FG008|Open Label Extension|Adverse Event|24|||
130957208|NCT03670810|471472794|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
131040124|NCT01828099|471783422|FG001|Treatment Period|Study terminated by Sponsor|1|||
130957209|NCT03670810|471472795|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
130957210|NCT03670810|471472796|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
130957211|NCT03670810|471472797|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
130957212|NCT03670810|471472798|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
130957213|NCT03670810|471472799|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
130957214|NCT03670810|471472800|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
130957215|NCT03670810|471472801|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
130957216|NCT03670810|471472802|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
130957217|NCT03670810|471472794|FG000|Open Label Extension|Lost to Follow-up|0|||
130957218|NCT03670810|471472795|FG001|Open Label Extension|Lost to Follow-up|0|||
130957219|NCT03670810|471472796|FG002|Open Label Extension|Lost to Follow-up|0|||
130957220|NCT03670810|471472797|FG003|Open Label Extension|Lost to Follow-up|0|||
130957221|NCT03670810|471472798|FG004|Open Label Extension|Lost to Follow-up|0|||
130957222|NCT03670810|471472799|FG005|Open Label Extension|Lost to Follow-up|0|||
131226135|NCT01677910|472455683|FG002|Double-Blind Treatment Period|Adverse Event|3|||
131226136|NCT01677910|472455684|FG003|Double-Blind Treatment Period|Adverse Event|0|||
131226137|NCT01677910|472455681|FG000|Double-Blind Treatment Period|Physician Decision|0|||
131226138|NCT01677910|472455682|FG001|Double-Blind Treatment Period|Physician Decision|0|||
131226139|NCT01677910|472455683|FG002|Double-Blind Treatment Period|Physician Decision|1|||
131226140|NCT01677910|472455684|FG003|Double-Blind Treatment Period|Physician Decision|0|||
131226141|NCT01677910|472455681|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
131226142|NCT01677910|472455682|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
131226143|NCT01677910|472455683|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
131226144|NCT01677910|472455684|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
131226145|NCT01677910|472455681|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
131226146|NCT01677910|472455682|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
131226147|NCT01677910|472455683|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
131226148|NCT01677910|472455684|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
131226149|NCT01677910|472455681|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
131226150|NCT01677910|472455682|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
131226151|NCT01677910|472455683|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
131226152|NCT01677910|472455684|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
131226153|NCT01677910|472455681|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131226154|NCT01677910|472455682|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131226155|NCT01677910|472455683|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131226156|NCT01677910|472455684|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
131226157|NCT01677910|472455681|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131226158|NCT01677910|472455682|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131226159|NCT01677910|472455683|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131226160|NCT01677910|472455684|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
131226161|NCT01677910|472455681|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131226162|NCT01677910|472455682|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131226163|NCT01677910|472455683|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131226164|NCT01677910|472455684|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
131226165|NCT01677910|472455681|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
131226166|NCT01677910|472455682|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
131226167|NCT01677910|472455683|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
131226168|NCT01677910|472455684|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
131226169|NCT01677910|472455681|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
131226170|NCT01677910|472455682|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
131226171|NCT01677910|472455683|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
131226172|NCT01677910|472455684|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
131226173|NCT03341273|472455689|FG000|Overall Study|Lost to Follow-up|7|||
131226174|NCT03341273|472455690|FG001|Overall Study|Lost to Follow-up|7|||
131226175|NCT03341273|472455689|FG000|Overall Study|Withdrawal by Subject|4|||
131226176|NCT03341273|472455690|FG001|Overall Study|Withdrawal by Subject|2|||
131226177|NCT03341273|472455689|FG000|Overall Study|Physician Decision|1|||
131226178|NCT03341273|472455690|FG001|Overall Study|Physician Decision|0|||
131226179|NCT03341273|472455689|FG000|Overall Study|Protocol Violation|0|||
131226180|NCT03341273|472455690|FG001|Overall Study|Protocol Violation|1|||
131226181|NCT03341273|472455689|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
131226182|NCT03341273|472455690|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
131226183|NCT03341273|472455689|FG000|Overall Study|Became ineligible after enrollment|1|||
131226184|NCT03341273|472455690|FG001|Overall Study|Became ineligible after enrollment|0|||
130957223|NCT03670810|471472800|FG006|Open Label Extension|Lost to Follow-up|0|||
130957224|NCT03670810|471472801|FG007|Open Label Extension|Lost to Follow-up|0|||
130957225|NCT03670810|471472802|FG008|Open Label Extension|Lost to Follow-up|23|||
130957226|NCT06034496|471472804|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
130713391|NCT04905290|470578345|FG000|Overall Study|Lost to Follow-up|2|||
130713392|NCT04905290|470578345|FG000|Overall Study|Screen Failure|2|||
130957227|NCT06034496|471472805|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
130957228|NCT06034496|471472804|FG000|Overall Study|Withdrawal by Subject|5|||
130957229|NCT06034496|471472805|FG001|Overall Study|Withdrawal by Subject|4|||
130957230|NCT03277261|471472808|FG000|Overall Study|Adverse Event|17|||
130957231|NCT03277261|471472809|FG001|Overall Study|Adverse Event|1|||
130957232|NCT03277261|471472808|FG000|Overall Study|Participant Withdrawal of Consent|6|||
130957233|NCT03277261|471472809|FG001|Overall Study|Participant Withdrawal of Consent|15|||
130957234|NCT03277261|471472808|FG000|Overall Study|Investigator / Sponsor Decision|4|||
130957235|NCT03277261|471472809|FG001|Overall Study|Investigator / Sponsor Decision|2|||
130957236|NCT03277261|471472808|FG000|Overall Study|Pregnancy|2|||
130957237|NCT03277261|471472809|FG001|Overall Study|Pregnancy|0|||
130957238|NCT03277261|471472808|FG000|Overall Study|Lost to Follow-up|2|||
130957239|NCT03277261|471472809|FG001|Overall Study|Lost to Follow-up|2|||
130957240|NCT03277261|471472808|FG000|Overall Study|Lack of Efficacy|2|||
130957241|NCT03277261|471472809|FG001|Overall Study|Lack of Efficacy|2|||
130957242|NCT03277261|471472808|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
130957243|NCT03277261|471472809|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
130957244|NCT02644967|471472810|FG000|Overall Study|Death|26|||
130957245|NCT02644967|471472810|FG000|Overall Study|Physician Decision|1|||
130957246|NCT02644967|471472810|FG000|Overall Study|Withdrawal by Subject|2|||
130957247|NCT02644967|471472810|FG000|Overall Study|Protocol Violation|1|||
130957248|NCT02644967|471472810|FG000|Overall Study|Progressive Disease|1|||
130957249|NCT02644967|471472810|FG000|Overall Study|Study Terminated by Sponsor|4|||
130957250|NCT01502644|471472811|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
130957251|NCT01502644|471472812|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
130957252|NCT01502644|471472813|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
130957253|NCT01502644|471472814|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
130957254|NCT01502644|471472811|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
130957255|NCT01502644|471472812|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
130957256|NCT01502644|471472813|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
130957257|NCT01502644|471472814|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
130957258|NCT01502644|471472811|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
130957259|NCT01502644|471472812|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
130957260|NCT01502644|471472813|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
130957261|NCT01502644|471472814|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
130957262|NCT01502644|471472811|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
130957263|NCT01502644|471472812|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
130957264|NCT01502644|471472813|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
130957265|NCT01502644|471472814|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
130957266|NCT01502644|471472811|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
130957267|NCT01502644|471472812|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
130957268|NCT01502644|471472813|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
130957269|NCT01502644|471472814|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
130957270|NCT01552226|471472815|FG000|Overall Study|Withdrawal by Subject|4|||
130957271|NCT01552226|471472816|FG001|Overall Study|Withdrawal by Subject|4|||
130957272|NCT00637195|471472817|FG000|Overall Study|Lost to Follow-up|1|||
130957273|NCT00637195|471472818|FG001|Overall Study|Lost to Follow-up|0|||
130957274|NCT00637195|471472817|FG000|Overall Study|Other|2|||
130713393|NCT04905290|470578345|FG000|Overall Study|Unsuccessful Procedure|2|||
130713394|NCT06204887|470578346|FG000|Overall Study|Lost to Follow-up|3|||
130713395|NCT06204887|470578347|FG001|Overall Study|Lost to Follow-up|4|||
130713396|NCT06204887|470578348|FG002|Overall Study|Lost to Follow-up|1|||
130713397|NCT06204887|470578349|FG003|Overall Study|Lost to Follow-up|6|||
130713398|NCT00821873|470578354|FG000|Overall Study|Lost to Follow-up|4|||
130713399|NCT01995266|470578356|FG000|Overall Study|Death|1|||
130713400|NCT01995266|470578356|FG000|Overall Study|Lack of Efficacy|6|||
130713401|NCT01995266|470578356|FG000|Overall Study|Adverse Event|2|||
130774748|NCT03410992|470802559|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
130774749|NCT03410992|470802560|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
130957275|NCT00637195|471472818|FG001|Overall Study|Other|0|||
130957276|NCT00637195|471472817|FG000|Overall Study|Withdrawal by Subject|0|||
130957277|NCT00637195|471472818|FG001|Overall Study|Withdrawal by Subject|1|||
131126568|NCT01423851|472091409|FG001|Whole Study|Physician Decision|1|||
130957278|NCT02388997|471472819|FG000|Overall Study|Adverse Event|1|||
131126569|NCT01423851|472091410|FG002|Whole Study|Physician Decision|2|||
131126570|NCT01423851|472091411|FG003|Whole Study|Physician Decision|0|||
130713402|NCT00729248|470578357|FG000|Overall Study|Physician Decision|2|||
130713403|NCT04032158|470578369|FG000|Overall Study|Study Termination|2|||
130713404|NCT04032158|470578370|FG001|Overall Study|Study Termination|1|||
130713405|NCT02072824|470578371|FG000|Overall Study|Insufficient clinical response|1|||
130774750|NCT03410992|470802561|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130957279|NCT02388997|471472820|FG001|Overall Study|Adverse Event|2|||
130957280|NCT02388997|471472819|FG000|Overall Study|Withdrawal by Subject|2|||
130957281|NCT02388997|471472820|FG001|Overall Study|Withdrawal by Subject|1|||
130957282|NCT02388997|471472819|FG000|Overall Study|Lung function exclusion criteria|0|||
130957283|NCT02388997|471472820|FG001|Overall Study|Lung function exclusion criteria|2|||
130957284|NCT02388997|471472819|FG000|Overall Study|Tested positive for virus during run-in|0|||
130957285|NCT02388997|471472820|FG001|Overall Study|Tested positive for virus during run-in|1|||
130957286|NCT01110915|471472821|FG000|Overall Study|Death|2|||
130957287|NCT01110915|471472822|FG001|Overall Study|Death|1|||
130957288|NCT01110915|471472821|FG000|Overall Study|Lost to Follow-up|1|||
130957289|NCT01110915|471472822|FG001|Overall Study|Lost to Follow-up|0|||
130957290|NCT01110915|471472821|FG000|Overall Study|Withdrawal by Subject|7|||
130957291|NCT01110915|471472822|FG001|Overall Study|Withdrawal by Subject|1|||
130957292|NCT00207142|471472823|FG000|Induction Phase|Adverse Event|9|||
130957293|NCT00207142|471472824|FG001|Induction Phase|Adverse Event|0|||
130957294|NCT00207142|471472825|FG002|Induction Phase|Adverse Event|0|||
130957295|NCT00207142|471472826|FG003|Induction Phase|Adverse Event|0|||
130957296|NCT00207142|471472823|FG000|Induction Phase|Death|1|||
130957297|NCT00207142|471472824|FG001|Induction Phase|Death|0|||
130957298|NCT00207142|471472825|FG002|Induction Phase|Death|0|||
130957299|NCT00207142|471472826|FG003|Induction Phase|Death|0|||
130957300|NCT00207142|471472823|FG000|Induction Phase|Lack of Efficacy|1|||
130957301|NCT00207142|471472824|FG001|Induction Phase|Lack of Efficacy|0|||
130957302|NCT00207142|471472825|FG002|Induction Phase|Lack of Efficacy|0|||
130957303|NCT00207142|471472826|FG003|Induction Phase|Lack of Efficacy|0|||
130957304|NCT00207142|471472823|FG000|Induction Phase|Lost to Follow-up|5|||
130957305|NCT00207142|471472824|FG001|Induction Phase|Lost to Follow-up|0|||
130957306|NCT00207142|471472825|FG002|Induction Phase|Lost to Follow-up|0|||
130957307|NCT00207142|471472826|FG003|Induction Phase|Lost to Follow-up|0|||
130957308|NCT00207142|471472823|FG000|Induction Phase|Physician Decision|2|||
130957309|NCT00207142|471472824|FG001|Induction Phase|Physician Decision|0|||
130957310|NCT00207142|471472825|FG002|Induction Phase|Physician Decision|0|||
130957311|NCT00207142|471472826|FG003|Induction Phase|Physician Decision|0|||
130957312|NCT00207142|471472823|FG000|Induction Phase|Poor/noncompliance|2|||
131040125|NCT01828099|471783421|FG000|Treatment Period|Protocol deviation|1|||
131226185|NCT03341273|472455689|FG000|Overall Study|Not Eligible at Enrollment|0|||
131226186|NCT03341273|472455690|FG001|Overall Study|Not Eligible at Enrollment|1|||
130774751|NCT03410992|470802562|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130774752|NCT03410992|470802563|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130774753|NCT03410992|470802564|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130774754|NCT03410992|470802565|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130957313|NCT00207142|471472824|FG001|Induction Phase|Poor/noncompliance|0|||
130957314|NCT00207142|471472825|FG002|Induction Phase|Poor/noncompliance|0|||
130957315|NCT00207142|471472826|FG003|Induction Phase|Poor/noncompliance|0|||
130957316|NCT00207142|471472823|FG000|Induction Phase|Pregnancy|1|||
130957317|NCT00207142|471472824|FG001|Induction Phase|Pregnancy|0|||
130957318|NCT00207142|471472825|FG002|Induction Phase|Pregnancy|0|||
130957319|NCT00207142|471472826|FG003|Induction Phase|Pregnancy|0|||
130957320|NCT00207142|471472823|FG000|Induction Phase|Subject no longer meets study criteria|3|||
130957321|NCT00207142|471472824|FG001|Induction Phase|Subject no longer meets study criteria|0|||
130957322|NCT00207142|471472825|FG002|Induction Phase|Subject no longer meets study criteria|0|||
130957323|NCT00207142|471472826|FG003|Induction Phase|Subject no longer meets study criteria|0|||
130957324|NCT00207142|471472823|FG000|Induction Phase|Withdrawal by Subject|4|||
130957325|NCT00207142|471472824|FG001|Induction Phase|Withdrawal by Subject|0|||
130957326|NCT00207142|471472825|FG002|Induction Phase|Withdrawal by Subject|0|||
130957327|NCT00207142|471472826|FG003|Induction Phase|Withdrawal by Subject|0|||
130957328|NCT00207142|471472823|FG000|Induction Phase|Incarceration|1|||
130957329|NCT00207142|471472824|FG001|Induction Phase|Incarceration|0|||
130957330|NCT00207142|471472825|FG002|Induction Phase|Incarceration|0|||
130957331|NCT00207142|471472826|FG003|Induction Phase|Incarceration|0|||
130957332|NCT00207142|471472823|FG000|Induction Phase|Missing lab data|1|||
130957333|NCT00207142|471472824|FG001|Induction Phase|Missing lab data|0|||
130957334|NCT00207142|471472825|FG002|Induction Phase|Missing lab data|0|||
130957335|NCT00207142|471472826|FG003|Induction Phase|Missing lab data|0|||
131226187|NCT03341273|472455689|FG000|Overall Study|Participant incarcerated|1|||
131226188|NCT03341273|472455690|FG001|Overall Study|Participant incarcerated|0|||
130957336|NCT00207142|471472823|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
130957337|NCT00207142|471472824|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
130957338|NCT00207142|471472825|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
130957339|NCT00207142|471472826|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
130957340|NCT00207142|471472823|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
130957341|NCT00207142|471472824|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
130957342|NCT00207142|471472825|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
130957343|NCT00207142|471472826|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
131040126|NCT01828099|471783422|FG001|Treatment Period|Protocol deviation|0|||
131226189|NCT01717456|472455691|FG000|End of Treatment|Physician Decision|0|||
131226190|NCT01717456|472455692|FG001|End of Treatment|Physician Decision|1|||
131226191|NCT01717456|472455691|FG000|End of Treatment|Lost to Follow-up|0|||
131226192|NCT01717456|472455692|FG001|End of Treatment|Lost to Follow-up|1|||
131226193|NCT01717456|472455691|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
131226194|NCT01717456|472455692|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
131226195|NCT02008721|472455693|FG000|Overall Study|Withdrawal by Subject|5|||
131226196|NCT02008721|472455694|FG001|Overall Study|Withdrawal by Subject|1|||
131226197|NCT02008721|472455693|FG000|Overall Study|Death|4|||
131226198|NCT02008721|472455694|FG001|Overall Study|Death|2|||
131226199|NCT02008721|472455693|FG000|Overall Study|Adverse Event|3|||
131226200|NCT02008721|472455694|FG001|Overall Study|Adverse Event|5|||
131226201|NCT02008721|472455693|FG000|Overall Study|Protocol Violation|3|||
131226202|NCT02008721|472455694|FG001|Overall Study|Protocol Violation|2|||
131226203|NCT03870997|472455695|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
131226204|NCT03870997|472455696|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
131226205|NCT03870997|472455697|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
130774755|NCT03410992|470802566|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130774756|NCT03410992|470802567|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130957344|NCT00207142|471472823|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
130957345|NCT00207142|471472824|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
130957346|NCT00207142|471472825|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
130957347|NCT00207142|471472826|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
130957348|NCT00207142|471472823|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
130957349|NCT00207142|471472824|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
130957350|NCT00207142|471472825|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
130957351|NCT00207142|471472826|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
130957352|NCT00207142|471472823|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
130957353|NCT00207142|471472824|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
130957354|NCT00207142|471472825|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
130957355|NCT00207142|471472826|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
130957356|NCT00207142|471472823|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
130957357|NCT00207142|471472824|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
130957358|NCT00207142|471472825|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
130957359|NCT00207142|471472826|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
130957360|NCT00207142|471472823|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
130957361|NCT00207142|471472824|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
130957362|NCT00207142|471472825|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
130957363|NCT00207142|471472826|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
130957364|NCT00207142|471472823|FG000|Maintenance Phase/Rescue Phase|Death|0|||
130957365|NCT00207142|471472824|FG001|Maintenance Phase/Rescue Phase|Death|0|||
130957366|NCT00207142|471472825|FG002|Maintenance Phase/Rescue Phase|Death|0|||
130957367|NCT00207142|471472826|FG003|Maintenance Phase/Rescue Phase|Death|1|||
130957368|NCT00207142|471472823|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
130957369|NCT00207142|471472824|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
130957370|NCT00207142|471472825|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
130957371|NCT00207142|471472826|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
130957372|NCT01822132|471472827|FG000|Overall Study|Lost to Follow-up|4|||
130957373|NCT01822132|471472828|FG001|Overall Study|Lost to Follow-up|2|||
130957374|NCT02519712|471472829|FG000|Overall Study|Disease Relapse|1|||
130957375|NCT02519712|471472829|FG000|Overall Study|Disease Progression|1|||
130957376|NCT02519712|471472829|FG000|Overall Study|Accruals are donors|2|||
131226206|NCT03870997|472455698|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
130774757|NCT03410992|470802568|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130774758|NCT03410992|470802569|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130774759|NCT03410992|470802559|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
130774760|NCT03410992|470802560|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130957377|NCT01247090|471472832|FG000|Overall Study|Physician Decision|1|||
131226207|NCT03870997|472455699|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
131226208|NCT03870997|472455700|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
130774761|NCT03410992|470802561|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130957378|NCT01247090|471472833|FG001|Overall Study|Physician Decision|0|||
130957379|NCT01247090|471472834|FG002|Overall Study|Physician Decision|0|||
130957380|NCT01247090|471472832|FG000|Overall Study|Withdrawal by Subject|0|||
130957381|NCT01247090|471472833|FG001|Overall Study|Withdrawal by Subject|1|||
130957382|NCT01247090|471472834|FG002|Overall Study|Withdrawal by Subject|0|||
130957383|NCT00006916|471472836|FG000|Overall Study|Device not inserted|4|||
130957384|NCT00006916|471472836|FG000|Overall Study|Complication of device insertion|1|||
131226209|NCT00267007|472455701|FG000|Overall Study|Withdrawal by Subject|6|||
131226210|NCT00267007|472455702|FG001|Overall Study|Withdrawal by Subject|0|||
131226211|NCT00267007|472455701|FG000|Overall Study|Lost to Follow-up|1|||
130713406|NCT02072824|470578372|FG001|Overall Study|Insufficient clinical response|0|||
130713407|NCT02072824|470578373|FG002|Overall Study|Insufficient clinical response|1|||
130713408|NCT02072824|470578371|FG000|Overall Study|No longer willing to participate|1|||
130713409|NCT02072824|470578372|FG001|Overall Study|No longer willing to participate|0|||
130713410|NCT02072824|470578373|FG002|Overall Study|No longer willing to participate|1|||
130713411|NCT02072824|470578371|FG000|Overall Study|Medication error|0|||
130713412|NCT02072824|470578372|FG001|Overall Study|Medication error|1|||
130713413|NCT02072824|470578373|FG002|Overall Study|Medication error|0|||
130713414|NCT02072824|470578371|FG000|Overall Study|Adverse Event|0|||
130713415|NCT02072824|470578372|FG001|Overall Study|Adverse Event|0|||
130713416|NCT02072824|470578373|FG002|Overall Study|Adverse Event|1|||
130713417|NCT03084367|470578374|FG000|Overall Study|Lost to Follow-up|32|||
130713418|NCT03084367|470578374|FG000|Overall Study|Withdrawal by Subject|4|||
130713419|NCT03084367|470578374|FG000|Overall Study|Other|1|||
130713420|NCT00841906|470578375|FG000|Overall Study|Withdrawal by Subject|2|||
130713421|NCT00841906|470578376|FG001|Overall Study|Withdrawal by Subject|0|||
130713422|NCT02667288|470578379|FG000|Overall Study|Protocol Violation|5|||
130713423|NCT02667288|470578379|FG000|Overall Study|Lost to Follow-up|3|||
130713424|NCT02667288|470578379|FG000|Overall Study|Withdrawal by Subject|5|||
130713425|NCT01196078|470578380|FG000|Overall Study|Withdrawal by Subject|3|||
130713426|NCT01196078|470578381|FG001|Overall Study|Withdrawal by Subject|5|||
130713427|NCT01196078|470578380|FG000|Overall Study|Adverse Event|4|||
130713428|NCT01196078|470578381|FG001|Overall Study|Adverse Event|4|||
130713429|NCT01196078|470578380|FG000|Overall Study|Protocol Violation|2|||
130713430|NCT01196078|470578381|FG001|Overall Study|Protocol Violation|1|||
130713431|NCT01196078|470578380|FG000|Overall Study|Lack of Efficacy|17|||
130713432|NCT01196078|470578381|FG001|Overall Study|Lack of Efficacy|23|||
130713433|NCT01196078|470578380|FG000|Overall Study|Lost to Follow-up|1|||
130774762|NCT03410992|470802562|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
131126571|NCT01423851|472091412|FG004|Whole Study|Physician Decision|2|||
130713434|NCT01196078|470578381|FG001|Overall Study|Lost to Follow-up|0|||
130713435|NCT01196078|470578380|FG000|Overall Study|Death|6|||
130713436|NCT01196078|470578381|FG001|Overall Study|Death|4|||
130713437|NCT00127036|470578382|FG000|Overall Study|Insufficient Data for Analysis|6|||
130713438|NCT00127036|470578383|FG001|Overall Study|Insufficient Data for Analysis|11|||
130957445|NCT00414388|471472852|FG000|Overall Study|Adverse Event|1|||
130957446|NCT03591575|471472854|FG000|Overall Study|Adverse Event|2|||
130957447|NCT03591575|471472855|FG001|Overall Study|Adverse Event|0|||
131040127|NCT01828099|471783421|FG000|Treatment Period|No longer requires treatment|0|||
131040128|NCT01828099|471783422|FG001|Treatment Period|No longer requires treatment|1|||
131040129|NCT01828099|471783421|FG000|Extension-treatment Phase|Adverse Event|0|||
131040130|NCT01828099|471783422|FG001|Extension-treatment Phase|Adverse Event|17|||
130957448|NCT03591575|471472854|FG000|Overall Study|Withdrawal by Subject|4|||
130957449|NCT03591575|471472855|FG001|Overall Study|Withdrawal by Subject|1|||
130957450|NCT00218543|471472856|FG000|Overall Study|Lost to Follow-up|8|||
130713439|NCT00127036|470578382|FG000|Overall Study|Screen Failure|2|||
130713440|NCT00127036|470578383|FG001|Overall Study|Screen Failure|0|||
130713441|NCT00270257|470578390|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
130713442|NCT00270257|470578391|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
130713443|NCT01403064|470578392|FG000|Overall Study|Death|0|||
130713444|NCT01403064|470578393|FG001|Overall Study|Death|0|||
130713445|NCT01403064|470578394|FG002|Overall Study|Death|1|||
130713446|NCT01403064|470578395|FG003|Overall Study|Death|1|||
130713447|NCT01403064|470578392|FG000|Overall Study|Withdrawal by Subject|0|||
130713448|NCT01403064|470578393|FG001|Overall Study|Withdrawal by Subject|0|||
130713449|NCT01403064|470578394|FG002|Overall Study|Withdrawal by Subject|1|||
130713450|NCT01403064|470578395|FG003|Overall Study|Withdrawal by Subject|1|||
130713451|NCT01403064|470578392|FG000|Overall Study|Other|1|||
130713452|NCT01403064|470578393|FG001|Overall Study|Other|0|||
131040131|NCT01828099|471783421|FG000|Extension-treatment Phase|Death|0|||
131040132|NCT01828099|471783422|FG001|Extension-treatment Phase|Death|11|||
130713453|NCT01403064|470578394|FG002|Overall Study|Other|2|||
130713454|NCT01403064|470578395|FG003|Overall Study|Other|1|||
130713455|NCT02621034|470578396|FG000|Overall Study|Lost to Follow-up|3|||
130713456|NCT02621034|470578397|FG001|Overall Study|Lost to Follow-up|2|||
130713457|NCT02621034|470578398|FG002|Overall Study|Lost to Follow-up|5|||
130713458|NCT04688931|470578404|FG000|Overall Study|Adverse Event|4|||
130713459|NCT04688931|470578405|FG001|Overall Study|Adverse Event|1|||
130713460|NCT04688931|470578404|FG000|Overall Study|Withdrawal by Subject|5|||
130713461|NCT04688931|470578405|FG001|Overall Study|Withdrawal by Subject|16|||
130713462|NCT04688931|470578404|FG000|Overall Study|Physician Decision|3|||
130957451|NCT00218543|471472856|FG000|Overall Study|relocated|1|||
131040133|NCT01828099|471783421|FG000|Extension-treatment Phase|Physician Decision|0|||
131040134|NCT01828099|471783422|FG001|Extension-treatment Phase|Physician Decision|5|||
131040135|NCT01828099|471783421|FG000|Extension-treatment Phase|Progressive disease|0|||
131040136|NCT01828099|471783422|FG001|Extension-treatment Phase|Progressive disease|54|||
131040137|NCT01828099|471783421|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
131040138|NCT01828099|471783422|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
131040139|NCT01828099|471783421|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
131040140|NCT01828099|471783422|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
131040141|NCT05934942|471783426|FG000|Run-in Period|Not treated|1|||
131040142|NCT05934942|471783426|FG000|Run-in Period|Withdrawal by Subject|1|||
131040143|NCT04362254|471783427|FG000|Overall Study|Adverse Event|1|||
131040144|NCT04362254|471783427|FG000|Overall Study|Protocol Violation|1|||
131040145|NCT04362254|471783427|FG000|Overall Study|Due to early termination of the trial|10|||
131040146|NCT00321048|471783428|FG000|Overall Study|Withdrawal by Subject|6|||
131126572|NCT01423851|472091413|FG005|Whole Study|Physician Decision|0|||
130713463|NCT04688931|470578405|FG001|Overall Study|Physician Decision|5|||
130713464|NCT04688931|470578404|FG000|Overall Study|Noncompliance|0|||
131040147|NCT00321048|471783429|FG001|Overall Study|Withdrawal by Subject|8|||
130713465|NCT04688931|470578405|FG001|Overall Study|Noncompliance|1|||
130713466|NCT04688931|470578404|FG000|Overall Study|Lost to Follow-up|1|||
130713467|NCT04688931|470578405|FG001|Overall Study|Lost to Follow-up|3|||
130713468|NCT04688931|470578404|FG000|Overall Study|Randomization Error|3|||
130713469|NCT04688931|470578405|FG001|Overall Study|Randomization Error|0|||
130713470|NCT04688931|470578404|FG000|Overall Study|Not Eligible|1|||
130713471|NCT04688931|470578405|FG001|Overall Study|Not Eligible|3|||
130957452|NCT00218543|471472856|FG000|Overall Study|Withdrawal by Subject|1|||
130957453|NCT00218543|471472856|FG000|Overall Study|Physician Decision|3|||
130957454|NCT00218543|471472856|FG000|Overall Study|Adverse Event|2|||
130957455|NCT01864291|471472857|FG000|Overall Study|need for revision surgery|2|||
130957456|NCT01387607|471472858|FG000|Overall Study|Adverse Event|23|||
130957457|NCT01387607|471472859|FG001|Overall Study|Adverse Event|11|||
130713472|NCT04688931|470578404|FG000|Overall Study|Disease Progression|0|||
130713473|NCT04688931|470578405|FG001|Overall Study|Disease Progression|2|||
130713474|NCT04688931|470578404|FG000|Overall Study|Sponsor Requirement|1|||
130957458|NCT01387607|471472858|FG000|Overall Study|Lack of Efficacy|8|||
130957459|NCT01387607|471472859|FG001|Overall Study|Lack of Efficacy|6|||
130957460|NCT01387607|471472858|FG000|Overall Study|Lost to Follow-up|2|||
130957461|NCT01387607|471472859|FG001|Overall Study|Lost to Follow-up|1|||
130957462|NCT01387607|471472858|FG000|Overall Study|No longer meets eligibility criteria|0|||
130957463|NCT01387607|471472859|FG001|Overall Study|No longer meets eligibility criteria|1|||
130957464|NCT01387607|471472858|FG000|Overall Study|Protocol Violation|1|||
130957465|NCT01387607|471472859|FG001|Overall Study|Protocol Violation|5|||
130957466|NCT01387607|471472858|FG000|Overall Study|Withdrawal by Subject|13|||
130957467|NCT01387607|471472859|FG001|Overall Study|Withdrawal by Subject|14|||
131126573|NCT01423851|472091414|FG006|Whole Study|Physician Decision|2|||
131126574|NCT01423851|472091415|FG007|Whole Study|Physician Decision|1|||
131126575|NCT01423851|472091416|FG008|Whole Study|Physician Decision|3|||
131126576|NCT01423851|472091417|FG009|Whole Study|Physician Decision|4|||
131126577|NCT01423851|472091418|FG010|Whole Study|Physician Decision|12|||
131126578|NCT01423851|472091408|FG000|Whole Study|Withdrawal by Subject|1|||
131126579|NCT01423851|472091409|FG001|Whole Study|Withdrawal by Subject|1|||
131126580|NCT01423851|472091410|FG002|Whole Study|Withdrawal by Subject|0|||
131126581|NCT01423851|472091411|FG003|Whole Study|Withdrawal by Subject|0|||
131126582|NCT01423851|472091412|FG004|Whole Study|Withdrawal by Subject|0|||
131126583|NCT01423851|472091413|FG005|Whole Study|Withdrawal by Subject|0|||
131126584|NCT01423851|472091414|FG006|Whole Study|Withdrawal by Subject|0|||
131126585|NCT01423851|472091415|FG007|Whole Study|Withdrawal by Subject|0|||
131126586|NCT01423851|472091416|FG008|Whole Study|Withdrawal by Subject|2|||
131126587|NCT01423851|472091417|FG009|Whole Study|Withdrawal by Subject|0|||
131126588|NCT01423851|472091418|FG010|Whole Study|Withdrawal by Subject|4|||
131126589|NCT01423851|472091408|FG000|Whole Study|Adverse Event|0|||
131126590|NCT01423851|472091409|FG001|Whole Study|Adverse Event|0|||
131126591|NCT01423851|472091410|FG002|Whole Study|Adverse Event|0|||
131126592|NCT01423851|472091411|FG003|Whole Study|Adverse Event|2|||
131126593|NCT01423851|472091412|FG004|Whole Study|Adverse Event|0|||
131126594|NCT01423851|472091413|FG005|Whole Study|Adverse Event|0|||
131126595|NCT01423851|472091414|FG006|Whole Study|Adverse Event|0|||
131126596|NCT01423851|472091415|FG007|Whole Study|Adverse Event|3|||
131126597|NCT01423851|472091416|FG008|Whole Study|Adverse Event|3|||
131126598|NCT01423851|472091417|FG009|Whole Study|Adverse Event|2|||
131126599|NCT01423851|472091418|FG010|Whole Study|Adverse Event|3|||
131126600|NCT03416153|472091419|FG000|Overall Study|Physician Decision|1|||
131126601|NCT03416153|472091420|FG001|Overall Study|Physician Decision|1|||
131126602|NCT03416153|472091419|FG000|Overall Study|Withdrawal by Subject|1|||
131126603|NCT03416153|472091420|FG001|Overall Study|Withdrawal by Subject|0|||
131126604|NCT02918864|472093143|FG000|Overall Study|Withdrawal by Subject|1|||
131126605|NCT02918864|472093144|FG001|Overall Study|Withdrawal by Subject|1|||
131126606|NCT02918864|472093143|FG000|Overall Study|Lost to Follow-up|3|||
131126607|NCT02918864|472093144|FG001|Overall Study|Lost to Follow-up|2|||
131126608|NCT04766021|472093145|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
131126609|NCT04766021|472093145|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
131126610|NCT02257372|472093149|FG000|Overall Study|Adverse Event|3|||
131126611|NCT02257372|472093150|FG001|Overall Study|Adverse Event|7|||
131126612|NCT02257372|472093149|FG000|Overall Study|Lack of Efficacy|2|||
131126613|NCT02257372|472093150|FG001|Overall Study|Lack of Efficacy|1|||
131126614|NCT02257372|472093149|FG000|Overall Study|Protocol Violation|1|||
131126615|NCT02257372|472093150|FG001|Overall Study|Protocol Violation|1|||
131126616|NCT02257372|472093149|FG000|Overall Study|Lost to Follow-up|0|||
130713475|NCT04688931|470578405|FG001|Overall Study|Sponsor Requirement|1|||
130713476|NCT04688931|470578404|FG000|Overall Study|Other Reason|1|||
130957468|NCT01387607|471472858|FG000|Overall Study|Other|1|||
131126617|NCT02257372|472093150|FG001|Overall Study|Lost to Follow-up|1|||
131126618|NCT02257372|472093149|FG000|Overall Study|Withdrew consent|1|||
131126619|NCT02257372|472093150|FG001|Overall Study|Withdrew consent|0|||
131126620|NCT00789529|472093151|FG000|Overall Study|Withdrawal by Subject|0|||
131126621|NCT00789529|472093152|FG001|Overall Study|Withdrawal by Subject|1|||
131126622|NCT00789529|472093151|FG000|Overall Study|Other Reason|1|||
131126623|NCT00789529|472093152|FG001|Overall Study|Other Reason|0|||
131126624|NCT02634151|472093153|FG000|Overall Study|Withdrawal by Subject|1|||
131126625|NCT02634151|472093154|FG001|Overall Study|Withdrawal by Subject|0|||
131126626|NCT02634151|472093153|FG000|Overall Study|Non-Compliance|0|||
131126627|NCT02634151|472093154|FG001|Overall Study|Non-Compliance|1|||
131126628|NCT02634151|472093153|FG000|Overall Study|Other|0|||
131126629|NCT02634151|472093154|FG001|Overall Study|Other|1|||
131126630|NCT02347098|472093155|FG000|Overall Study|Death|1|||
130713477|NCT04688931|470578405|FG001|Overall Study|Other Reason|2|||
130957469|NCT01387607|471472859|FG001|Overall Study|Other|1|||
130957470|NCT01387607|471472858|FG000|Overall Study|Randomized, not treated|3|||
131126631|NCT02347098|472093156|FG001|Overall Study|Death|0|||
130713478|NCT00450619|470578406|FG000|Overall Study|refused treatment after randomization|2|||
130957471|NCT01387607|471472859|FG001|Overall Study|Randomized, not treated|6|||
130957472|NCT03080961|471472860|FG000|Overall Study|Withdrawal by Subject|3|||
130957473|NCT03091192|471472863|FG000|Overall Study|Study terminated by sponsor|21|||
130957474|NCT03091192|471472864|FG001|Overall Study|Study terminated by sponsor|14|||
130957475|NCT03091192|471472863|FG000|Overall Study|Death|9|||
130957476|NCT03091192|471472864|FG001|Overall Study|Death|13|||
130957477|NCT03091192|471472863|FG000|Overall Study|Withdrawal by Subject|2|||
130957478|NCT03091192|471472864|FG001|Overall Study|Withdrawal by Subject|0|||
130957479|NCT03091192|471472863|FG000|Overall Study|Lost to Follow-up|1|||
130957480|NCT03091192|471472864|FG001|Overall Study|Lost to Follow-up|0|||
130957490|NCT05645432|471472870|FG000|Overall Study|Withdrawal by Subject|1|||
130957491|NCT03195478|471472871|FG000|Overall Study|Disease Progression|5|||
130957492|NCT03195478|471472872|FG001|Overall Study|Disease Progression|4|||
130957493|NCT03195478|471472873|FG002|Overall Study|Disease Progression|6|||
130957494|NCT03195478|471472874|FG003|Overall Study|Disease Progression|1|||
130957495|NCT03195478|471472871|FG000|Overall Study|Study Drug Toxicity|2|||
130957496|NCT03195478|471472872|FG001|Overall Study|Study Drug Toxicity|0|||
130957497|NCT03195478|471472873|FG002|Overall Study|Study Drug Toxicity|0|||
130957498|NCT03195478|471472874|FG003|Overall Study|Study Drug Toxicity|1|||
130957499|NCT03195478|471472871|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
130957500|NCT03195478|471472872|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
130957501|NCT03195478|471472873|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
130957502|NCT03195478|471472874|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
130957503|NCT03195478|471472871|FG000|Overall Study|Participant Withdrew Consent|1|||
130957504|NCT03195478|471472872|FG001|Overall Study|Participant Withdrew Consent|0|||
130957505|NCT03195478|471472873|FG002|Overall Study|Participant Withdrew Consent|0|||
130957506|NCT03195478|471472874|FG003|Overall Study|Participant Withdrew Consent|0|||
130957507|NCT03195478|471472871|FG000|Overall Study|Maximum Clinical benefit|0|||
130957508|NCT03195478|471472872|FG001|Overall Study|Maximum Clinical benefit|0|||
130957509|NCT03195478|471472873|FG002|Overall Study|Maximum Clinical benefit|1|||
130957510|NCT03195478|471472874|FG003|Overall Study|Maximum Clinical benefit|0|||
130957511|NCT03195478|471472871|FG000|Overall Study|Other Reasons|0|||
130957512|NCT03195478|471472872|FG001|Overall Study|Other Reasons|0|||
130957513|NCT03195478|471472873|FG002|Overall Study|Other Reasons|1|||
130957514|NCT03195478|471472874|FG003|Overall Study|Other Reasons|0|||
130957515|NCT03890367|471472875|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130957516|NCT03890367|471472876|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130957517|NCT03890367|471472877|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130957518|NCT03890367|471472875|FG000|Overall Study|Protocol deviation|2|||
130957519|NCT03890367|471472876|FG001|Overall Study|Protocol deviation|2|||
130957520|NCT03890367|471472877|FG002|Overall Study|Protocol deviation|1|||
130957521|NCT03890367|471472875|FG000|Overall Study|Lost to Follow-up|1|||
130957522|NCT03890367|471472876|FG001|Overall Study|Lost to Follow-up|1|||
130957523|NCT03890367|471472877|FG002|Overall Study|Lost to Follow-up|0|||
130957524|NCT02472756|471473981|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
130957525|NCT02472756|471473981|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
130957526|NCT02472756|471473981|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
130957527|NCT02472756|471473981|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
130957528|NCT02472756|471473981|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
130957529|NCT00110266|471473983|FG000|Overall Study|Adverse Event|27|||
130957530|NCT00110266|471473983|FG000|Overall Study|Abnormal laboratory value|15|||
130957531|NCT00110266|471473983|FG000|Overall Study|Withdrawal by Subject|16|||
130957532|NCT00110266|471473983|FG000|Overall Study|Death|17|||
130957533|NCT00110266|471473983|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130957534|NCT00110266|471473983|FG000|Overall Study|Participant condition no longer requires study drug|1|||
130957535|NCT02984020|471473984|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
130957536|NCT02984020|471473984|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
130957537|NCT02984020|471473984|FG000|Overall Study|Other significant protocol violation|2|||
130957538|NCT00667342|471473985|FG000|Overall Study|Protocol Violation|1|||
130957539|NCT00667342|471473986|FG001|Overall Study|Protocol Violation|0|||
130957540|NCT00667342|471473987|FG002|Overall Study|Protocol Violation|0|||
130957541|NCT00667342|471473985|FG000|Overall Study|Withdrawal by Subject|1|||
130957542|NCT00667342|471473986|FG001|Overall Study|Withdrawal by Subject|0|||
130957543|NCT00667342|471473987|FG002|Overall Study|Withdrawal by Subject|0|||
130957544|NCT00667342|471473985|FG000|Overall Study|Physician Decision|3|||
130713479|NCT00450619|470578407|FG001|Overall Study|refused treatment after randomization|0|||
130713480|NCT00450619|470578406|FG000|Overall Study|did not progress; refused further trmt|1|||
130713481|NCT00450619|470578407|FG001|Overall Study|did not progress; refused further trmt|1|||
130713482|NCT00450619|470578406|FG000|Overall Study|Adverse Event|1|||
130713483|NCT00450619|470578407|FG001|Overall Study|Adverse Event|0|||
130713484|NCT00714493|470578419|FG000|Overall Study|Adverse Event|11|||
130713485|NCT00714493|470578419|FG000|Overall Study|Death|3|||
130713486|NCT00714493|470578419|FG000|Overall Study|Lack of Efficacy|10|||
130713487|NCT00714493|470578419|FG000|Overall Study|Lost to Follow-up|3|||
130713488|NCT00714493|470578419|FG000|Overall Study|Protocol Violation|12|||
130713489|NCT00714493|470578419|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
130713490|NCT00714493|470578419|FG000|Overall Study|OTHER|2|||
130713491|NCT02372071|470578420|FG000|Overall Study|Protocol Violation|18|||
130713492|NCT00506129|470578421|FG000|Overall Study|Disease Progression/Relapse|15|||
130713493|NCT00506129|470578421|FG000|Overall Study|Death|7|||
130713494|NCT01968694|470578422|FG000|Washout (1 Month)|Lost to Follow-up|0|||
130713495|NCT01968694|470578423|FG001|Washout (1 Month)|Lost to Follow-up|1|||
130713496|NCT00251719|470578424|FG000|Overall Study|Adverse Event|14|||
130713497|NCT00251719|470578425|FG001|Overall Study|Adverse Event|8|||
130713498|NCT00251719|470578426|FG002|Overall Study|Adverse Event|7|||
130713499|NCT00251719|470578424|FG000|Overall Study|Protocol Violation|1|||
130713500|NCT00251719|470578425|FG001|Overall Study|Protocol Violation|1|||
130713501|NCT00251719|470578426|FG002|Overall Study|Protocol Violation|1|||
130713502|NCT00251719|470578424|FG000|Overall Study|Lost to Follow-up|5|||
130713503|NCT00251719|470578425|FG001|Overall Study|Lost to Follow-up|11|||
130713504|NCT00251719|470578426|FG002|Overall Study|Lost to Follow-up|8|||
130713505|NCT00251719|470578424|FG000|Overall Study|Withdrawal by Subject|14|||
130713506|NCT00251719|470578425|FG001|Overall Study|Withdrawal by Subject|12|||
130713507|NCT00251719|470578426|FG002|Overall Study|Withdrawal by Subject|11|||
130713508|NCT00251719|470578424|FG000|Overall Study|Lack of Efficacy|2|||
130713509|NCT00251719|470578425|FG001|Overall Study|Lack of Efficacy|1|||
130713510|NCT00251719|470578426|FG002|Overall Study|Lack of Efficacy|0|||
130713511|NCT00251719|470578424|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
130713512|NCT00251719|470578425|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
130713513|NCT00251719|470578426|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
130713514|NCT00251719|470578424|FG000|Overall Study|Investigator decision|1|||
130713515|NCT00251719|470578425|FG001|Overall Study|Investigator decision|1|||
130713516|NCT00251719|470578426|FG002|Overall Study|Investigator decision|0|||
130713517|NCT00251719|470578424|FG000|Overall Study|Noncompliance|2|||
130713518|NCT00251719|470578425|FG001|Overall Study|Noncompliance|3|||
130713519|NCT00251719|470578426|FG002|Overall Study|Noncompliance|1|||
130713520|NCT00251719|470578424|FG000|Overall Study|Barrett's esophagus|2|||
130713521|NCT00251719|470578425|FG001|Overall Study|Barrett's esophagus|2|||
130713522|NCT00251719|470578426|FG002|Overall Study|Barrett's esophagus|0|||
130713523|NCT00688376|470578431|FG000|Double-Blind Phase|Adverse Event|4|||
130713524|NCT00688376|470578432|FG001|Double-Blind Phase|Adverse Event|4|||
130713525|NCT00688376|470578431|FG000|Double-Blind Phase|Protocol Violation|1|||
130713526|NCT00688376|470578432|FG001|Double-Blind Phase|Protocol Violation|2|||
130713527|NCT00688376|470578431|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
130713528|NCT00688376|470578432|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
130713529|NCT00688376|470578431|FG000|Double-Blind Phase|Not treated|0|||
130713530|NCT00688376|470578432|FG001|Double-Blind Phase|Not treated|1|||
130713531|NCT00688376|470578431|FG000|Blinded Extension Phase|Adverse Event|3|||
130713532|NCT00688376|470578432|FG001|Blinded Extension Phase|Adverse Event|4|||
130713533|NCT00688376|470578431|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
130713534|NCT00688376|470578432|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
130713535|NCT00688376|470578431|FG000|Blinded Extension Phase|Physician Decision|1|||
130713536|NCT00688376|470578432|FG001|Blinded Extension Phase|Physician Decision|0|||
130713537|NCT00688376|470578431|FG000|Blinded Extension Phase|Other|1|||
130713538|NCT00688376|470578432|FG001|Blinded Extension Phase|Other|0|||
130713539|NCT04392583|470578433|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
130713540|NCT01070771|470578437|FG000|Overall Study|Adverse Event|2|||
130713541|NCT01070771|470578437|FG000|Overall Study|Protocol Violation|1|||
130713542|NCT00857259|470578440|FG000|Overall Study|Protocol Violation|1|||
130713543|NCT00857259|470578441|FG001|Overall Study|Protocol Violation|0|||
130713544|NCT00857259|470578442|FG002|Overall Study|Protocol Violation|1|||
130713545|NCT02701413|470578443|FG000|Overall Study|Withdrawal by Subject|7|||
130713546|NCT02701413|470578444|FG001|Overall Study|Withdrawal by Subject|11|||
130713547|NCT01621191|470578447|FG000|Overall Study|Adverse Event|9|||
130713548|NCT01621191|470578447|FG000|Overall Study|Withdrawal by Subject|8|||
130713549|NCT01621191|470578447|FG000|Overall Study|Lack of Efficacy|6|||
130713550|NCT01621191|470578447|FG000|Overall Study|Lost to Follow-up|1|||
130713551|NCT01621191|470578447|FG000|Overall Study|Site Removed From Study|1|||
130713552|NCT00706381|470578448|FG000|Overall Study|Lost to Follow-up|0|||
130713553|NCT00706381|470578449|FG001|Overall Study|Lost to Follow-up|1|||
130713554|NCT00706381|470578450|FG002|Overall Study|Lost to Follow-up|1|||
130713555|NCT00706381|470578451|FG003|Overall Study|Lost to Follow-up|0|||
130957545|NCT00667342|471473986|FG001|Overall Study|Physician Decision|0|||
130957546|NCT00667342|471473987|FG002|Overall Study|Physician Decision|0|||
130957547|NCT00667342|471473985|FG000|Overall Study|Relapse or tumor progression|9|||
130957548|NCT00667342|471473986|FG001|Overall Study|Relapse or tumor progression|0|||
130957549|NCT00667342|471473987|FG002|Overall Study|Relapse or tumor progression|7|||
130957550|NCT00667342|471473985|FG000|Overall Study|Adverse Event|0|||
130957551|NCT00667342|471473986|FG001|Overall Study|Adverse Event|0|||
130957552|NCT00667342|471473987|FG002|Overall Study|Adverse Event|1|||
130957553|NCT00667342|471473985|FG000|Overall Study|Ineligible|0|||
130957554|NCT00667342|471473986|FG001|Overall Study|Ineligible|0|||
130957555|NCT00667342|471473987|FG002|Overall Study|Ineligible|1|||
130957556|NCT01207778|471473988|FG000|Overall Study|Lost to Follow-up|0|||
130957557|NCT01207778|471473989|FG001|Overall Study|Lost to Follow-up|3|||
130957558|NCT01207778|471473990|FG002|Overall Study|Lost to Follow-up|3|||
130957559|NCT02610192|471473994|FG000|Overall Study|Received other treatment|8|||
130957560|NCT02610192|471473994|FG000|Overall Study|Physician Decision|1|||
130957561|NCT01440322|471473995|FG000|Overall Study|Discomfort|2|||
130957562|NCT01440322|471473996|FG001|Overall Study|Discomfort|0|||
130957563|NCT01440322|471473995|FG000|Overall Study|Biomicroscopy|1|||
130957564|NCT01440322|471473996|FG001|Overall Study|Biomicroscopy|0|||
130957565|NCT01440322|471473995|FG000|Overall Study|Symptoms and Problems|1|||
130957566|NCT01440322|471473996|FG001|Overall Study|Symptoms and Problems|0|||
130957567|NCT01440322|471473995|FG000|Overall Study|Unacceptable Subjective Vision|1|||
130957568|NCT01440322|471473996|FG001|Overall Study|Unacceptable Subjective Vision|0|||
130957569|NCT01440322|471473995|FG000|Overall Study|Other Product Related|1|||
130957570|NCT01440322|471473996|FG001|Overall Study|Other Product Related|0|||
130957571|NCT01440322|471473995|FG000|Overall Study|Unrelated Medical Problem|0|||
130957572|NCT01440322|471473996|FG001|Overall Study|Unrelated Medical Problem|1|||
130957573|NCT01440322|471473995|FG000|Overall Study|Other Non-Product Related|1|||
130957574|NCT01440322|471473996|FG001|Overall Study|Other Non-Product Related|0|||
130957575|NCT00548808|471473997|FG000|Overall Study|Lost to Follow-up|9|||
130957576|NCT00548808|471473998|FG001|Overall Study|Lost to Follow-up|3|||
130957577|NCT00548808|471473997|FG000|Overall Study|Protocol Violation|8|||
130957578|NCT00548808|471473998|FG001|Overall Study|Protocol Violation|8|||
130957579|NCT00548808|471473997|FG000|Overall Study|Withdrawal by Subject|8|||
130957580|NCT00548808|471473998|FG001|Overall Study|Withdrawal by Subject|4|||
130957581|NCT00548808|471473997|FG000|Overall Study|Physician Decision|6|||
131126632|NCT02347098|472093155|FG000|Overall Study|Withdrawal by Subject|1|||
131126633|NCT02347098|472093156|FG001|Overall Study|Withdrawal by Subject|0|||
131126634|NCT02347098|472093155|FG000|Overall Study|Lost to Follow-up|2|||
131126635|NCT02347098|472093156|FG001|Overall Study|Lost to Follow-up|2|||
131126636|NCT02347098|472093155|FG000|Overall Study|Refuse Follow-up Visit|1|||
131126637|NCT02347098|472093156|FG001|Overall Study|Refuse Follow-up Visit|5|||
131126638|NCT02347098|472093155|FG000|Overall Study|no visit due to illness|2|||
131126639|NCT02347098|472093156|FG001|Overall Study|no visit due to illness|1|||
131126640|NCT02187172|472093157|FG000|Overall Study|Lost to Follow-up|1|||
131126641|NCT02187172|472093158|FG001|Overall Study|Lost to Follow-up|2|||
131126642|NCT02187172|472093157|FG000|Overall Study|Lack of Efficacy|1|||
131126643|NCT02187172|472093158|FG001|Overall Study|Lack of Efficacy|2|||
131126644|NCT02187172|472093157|FG000|Overall Study|Adverse Event|0|||
131126645|NCT02187172|472093158|FG001|Overall Study|Adverse Event|1|||
131126646|NCT02187172|472093157|FG000|Overall Study|Physician Decision|1|||
131126647|NCT02187172|472093158|FG001|Overall Study|Physician Decision|1|||
131126648|NCT00880399|472093159|FG000|Overall Study|Adverse Event|4|||
131126649|NCT00880399|472093160|FG001|Overall Study|Adverse Event|6|||
131126650|NCT00880399|472093161|FG002|Overall Study|Adverse Event|5|||
131126651|NCT00880399|472093159|FG000|Overall Study|Lack of Efficacy|1|||
131126652|NCT00880399|472093160|FG001|Overall Study|Lack of Efficacy|4|||
131126653|NCT00880399|472093161|FG002|Overall Study|Lack of Efficacy|2|||
131126654|NCT00880399|472093159|FG000|Overall Study|Protocol Violation|4|||
131126655|NCT00880399|472093160|FG001|Overall Study|Protocol Violation|4|||
131126656|NCT00880399|472093161|FG002|Overall Study|Protocol Violation|6|||
131126657|NCT00880399|472093159|FG000|Overall Study|Study closed/terminated|3|||
131126658|NCT00880399|472093160|FG001|Overall Study|Study closed/terminated|7|||
131126659|NCT00880399|472093161|FG002|Overall Study|Study closed/terminated|4|||
131126660|NCT00880399|472093159|FG000|Overall Study|Lost to Follow-up|8|||
130957582|NCT00548808|471473998|FG001|Overall Study|Physician Decision|3|||
130957583|NCT00548808|471473997|FG000|Overall Study|Adverse Event|4|||
130957584|NCT00548808|471473998|FG001|Overall Study|Adverse Event|5|||
131126661|NCT00880399|472093160|FG001|Overall Study|Lost to Follow-up|5|||
131126662|NCT00880399|472093161|FG002|Overall Study|Lost to Follow-up|3|||
131126663|NCT00880399|472093159|FG000|Overall Study|Physician Decision|5|||
131126664|NCT00880399|472093160|FG001|Overall Study|Physician Decision|0|||
131126665|NCT00880399|472093161|FG002|Overall Study|Physician Decision|3|||
131126666|NCT00880399|472093159|FG000|Overall Study|Withdrawal by Subject|6|||
131126667|NCT00880399|472093160|FG001|Overall Study|Withdrawal by Subject|3|||
131126668|NCT00880399|472093161|FG002|Overall Study|Withdrawal by Subject|3|||
131126669|NCT04353284|472093166|FG000|Overall Study|Adverse Event|1|||
131126670|NCT04353284|472093167|FG001|Overall Study|Adverse Event|1|||
131126671|NCT04353284|472093166|FG000|Overall Study|Lost to Follow-up|1|||
131126672|NCT04353284|472093167|FG001|Overall Study|Lost to Follow-up|0|||
131126673|NCT00766532|472093180|FG000|Overall Study|Protocol Violation|2|||
131126674|NCT00841568|472093182|FG000|Overall Study|Adverse Event|1|||
131126675|NCT00841568|472093182|FG000|Overall Study|Death|1|||
130957585|NCT00548808|471473997|FG000|Overall Study|Death|2|||
130957586|NCT00548808|471473998|FG001|Overall Study|Death|0|||
130957587|NCT00548808|471473997|FG000|Overall Study|Entry Criteria Not Met|2|||
130957588|NCT00548808|471473998|FG001|Overall Study|Entry Criteria Not Met|2|||
130957589|NCT00548808|471473997|FG000|Overall Study|Lack of Efficacy|2|||
130957590|NCT00548808|471473998|FG001|Overall Study|Lack of Efficacy|0|||
130957591|NCT00548808|471473997|FG000|Overall Study|Sponsor Decision|1|||
130957592|NCT00548808|471473998|FG001|Overall Study|Sponsor Decision|1|||
130957593|NCT05044234|471474000|FG000|Overall Study|Lost to Follow-up|2|||
130957594|NCT05044234|471474001|FG001|Overall Study|Lost to Follow-up|1|||
130957595|NCT05044234|471474002|FG002|Overall Study|Lost to Follow-up|1|||
130957596|NCT05044234|471474003|FG003|Overall Study|Lost to Follow-up|2|||
130957597|NCT05044234|471474000|FG000|Overall Study|Withdrawal by Subject|6|||
130957598|NCT05044234|471474001|FG001|Overall Study|Withdrawal by Subject|4|||
130957599|NCT05044234|471474002|FG002|Overall Study|Withdrawal by Subject|5|||
130957600|NCT05044234|471474003|FG003|Overall Study|Withdrawal by Subject|8|||
130957601|NCT05044234|471474000|FG000|Overall Study|Study terminated by Sponsor|21|||
130957602|NCT05044234|471474001|FG001|Overall Study|Study terminated by Sponsor|21|||
130957603|NCT05044234|471474002|FG002|Overall Study|Study terminated by Sponsor|20|||
130957604|NCT05044234|471474003|FG003|Overall Study|Study terminated by Sponsor|14|||
130957605|NCT05044234|471474000|FG000|Overall Study|Other, not specified|0|||
130957606|NCT05044234|471474001|FG001|Overall Study|Other, not specified|0|||
130957607|NCT05044234|471474002|FG002|Overall Study|Other, not specified|1|||
130957608|NCT05044234|471474003|FG003|Overall Study|Other, not specified|2|||
130957609|NCT05044234|471474000|FG000|Overall Study|Delayed data entry|0|||
130957610|NCT05044234|471474001|FG001|Overall Study|Delayed data entry|0|||
130957611|NCT05044234|471474002|FG002|Overall Study|Delayed data entry|0|||
130957612|NCT05044234|471474003|FG003|Overall Study|Delayed data entry|1|||
130957613|NCT02896127|471474004|FG000|COMPLETED WEEK 52|Adverse Event|9|||
130957614|NCT02896127|471474005|FG001|COMPLETED WEEK 52|Adverse Event|2|||
130957615|NCT02896127|471474004|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
130957616|NCT02896127|471474005|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
130957617|NCT02896127|471474004|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
130957618|NCT02896127|471474005|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
130957619|NCT02896127|471474004|FG000|COMPLETED WEEK 52|Physician Decision|1|||
130957620|NCT02896127|471474005|FG001|COMPLETED WEEK 52|Physician Decision|1|||
130957621|NCT02896127|471474004|FG000|COMPLETED WEEK 52|Pregnancy|2|||
130957622|NCT02896127|471474005|FG001|COMPLETED WEEK 52|Pregnancy|0|||
130957623|NCT02896127|471474004|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
130957624|NCT02896127|471474005|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
130957625|NCT02896127|471474004|FG000|COMPLETED WEEK 52|Technical problems|1|||
130957626|NCT02896127|471474005|FG001|COMPLETED WEEK 52|Technical problems|0|||
130957627|NCT02896127|471474004|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
130957628|NCT02896127|471474005|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
130957629|NCT02896127|471474004|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
130957630|NCT02896127|471474005|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
130957631|NCT02896127|471474004|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
130957632|NCT02896127|471474005|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
130957633|NCT02896127|471474004|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
130957634|NCT02896127|471474005|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
130957635|NCT02896127|471474004|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
130957636|NCT02896127|471474005|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
130957637|NCT00279708|471474006|FG000|Overall Study|Withdrawal by Subject|2|||
130957638|NCT00279708|471474007|FG001|Overall Study|Withdrawal by Subject|3|||
130957639|NCT00279708|471474006|FG000|Overall Study|Adverse Event|1|||
130957640|NCT00279708|471474007|FG001|Overall Study|Adverse Event|1|||
130957641|NCT03354429|471474008|FG000|Overall Study|Withdrawal by Subject|8|||
130957642|NCT03354429|471474009|FG001|Overall Study|Withdrawal by Subject|7|||
130957643|NCT03354429|471474008|FG000|Overall Study|Lost to Follow-up|1|||
130957644|NCT03354429|471474009|FG001|Overall Study|Lost to Follow-up|0|||
130957645|NCT02488629|471474010|FG000|Overall Study|Lack of Efficacy|3|||
130957646|NCT02488629|471474011|FG001|Overall Study|Lack of Efficacy|1|||
130957647|NCT02488629|471474012|FG002|Overall Study|Lack of Efficacy|0|||
130957648|NCT02488629|471474013|FG003|Overall Study|Lack of Efficacy|0|||
130957649|NCT02488629|471474010|FG000|Overall Study|Withdrawal by Subject|0|||
130957650|NCT02488629|471474011|FG001|Overall Study|Withdrawal by Subject|1|||
130957651|NCT02488629|471474012|FG002|Overall Study|Withdrawal by Subject|0|||
130957652|NCT02488629|471474013|FG003|Overall Study|Withdrawal by Subject|0|||
130957653|NCT02940691|471474014|FG000|Overall Study|Lost to Follow-up|5|||
130957654|NCT02940691|471474014|FG000|Overall Study|Incarceration|1|||
130957655|NCT03912233|471474015|FG000|Overall Study|Adverse Event|1|||
131126676|NCT00841568|472093182|FG000|Overall Study|Withdrawal by Subject|2|||
130713556|NCT00160641|470578455|FG000|Overall Study|Adverse Event|102|||
130713557|NCT00160641|470578455|FG000|Overall Study|Withdrawal by Subject|87|||
130713558|NCT00160641|470578455|FG000|Overall Study|Lost to Follow-up|8|||
130713559|NCT00160641|470578455|FG000|Overall Study|Lack of Efficacy|12|||
130713560|NCT00160641|470578455|FG000|Overall Study|Protocol Violation|3|||
130713561|NCT00160641|470578455|FG000|Overall Study|Other|9|||
130713562|NCT01782482|470578460|FG000|Overall Study|Adverse Event|2|||
130713563|NCT01782482|470578461|FG001|Overall Study|Adverse Event|1|||
130713564|NCT01782482|470578460|FG000|Overall Study|Lost to Follow-up|2|||
130713565|NCT01782482|470578461|FG001|Overall Study|Lost to Follow-up|3|||
130713566|NCT01782482|470578460|FG000|Overall Study|Physician Decision|1|||
130713567|NCT01782482|470578461|FG001|Overall Study|Physician Decision|0|||
130713568|NCT01782482|470578460|FG000|Overall Study|Protocol Violation|1|||
130713569|NCT01782482|470578461|FG001|Overall Study|Protocol Violation|0|||
130713570|NCT01782482|470578460|FG000|Overall Study|Withdrawal by Subject|2|||
130713571|NCT01782482|470578461|FG001|Overall Study|Withdrawal by Subject|3|||
130713572|NCT01782482|470578460|FG000|Overall Study|Randomized in Error|2|||
130713573|NCT01782482|470578461|FG001|Overall Study|Randomized in Error|2|||
130713574|NCT01782482|470578460|FG000|Overall Study|Habitually wearing toric lens OS|0|||
130713575|NCT01782482|470578461|FG001|Overall Study|Habitually wearing toric lens OS|1|||
130713576|NCT00038649|470578463|FG000|Overall Study|Adverse Event|9|||
130713577|NCT00995085|470578464|FG000|Overall Study|Withdrawal by Subject|5|||
130713578|NCT01640873|470578470|FG000|Overall Study|Protocol Violation|2|||
130713579|NCT01640873|470578471|FG001|Overall Study|Protocol Violation|1|||
130713580|NCT01321008|470578472|FG000|Overall Study|Early Study Termination|1|||
130713581|NCT02749292|470578473|FG000|Overall Study|Physician Decision|1|||
130713582|NCT02749292|470578474|FG001|Overall Study|Physician Decision|0|||
130713583|NCT02749292|470578473|FG000|Overall Study|Withdrawal by Subject|5|||
130713584|NCT02749292|470578474|FG001|Overall Study|Withdrawal by Subject|7|||
130713585|NCT02749292|470578473|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
130713586|NCT02749292|470578474|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
130713587|NCT02749292|470578473|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
130713588|NCT02749292|470578474|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
130713589|NCT02749292|470578473|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
130713590|NCT02749292|470578474|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
130713591|NCT02749292|470578473|FG000|Overall Study|Adverse Event|4|||
130713592|NCT02749292|470578474|FG001|Overall Study|Adverse Event|1|||
130957656|NCT03912233|471474016|FG001|Overall Study|Adverse Event|0|||
130957657|NCT03912233|471474017|FG002|Overall Study|Adverse Event|0|||
130957658|NCT03912233|471474018|FG003|Overall Study|Adverse Event|0|||
130957659|NCT03912233|471474019|FG004|Overall Study|Adverse Event|0|||
130957660|NCT03912233|471474020|FG005|Overall Study|Adverse Event|0|||
130957661|NCT03912233|471474015|FG000|Overall Study|Physician Decision|1|||
130957662|NCT03912233|471474016|FG001|Overall Study|Physician Decision|0|||
130957663|NCT03912233|471474017|FG002|Overall Study|Physician Decision|0|||
130957664|NCT03912233|471474018|FG003|Overall Study|Physician Decision|0|||
130957665|NCT03912233|471474019|FG004|Overall Study|Physician Decision|0|||
130957666|NCT03912233|471474020|FG005|Overall Study|Physician Decision|0|||
130957667|NCT03912233|471474015|FG000|Overall Study|Other|0|||
130957668|NCT03912233|471474016|FG001|Overall Study|Other|0|||
130957669|NCT03912233|471474017|FG002|Overall Study|Other|0|||
130957670|NCT03912233|471474018|FG003|Overall Study|Other|0|||
130957671|NCT03912233|471474019|FG004|Overall Study|Other|7|||
130957672|NCT03912233|471474020|FG005|Overall Study|Other|12|||
130957673|NCT00654628|471474021|FG000|6-week Active Treatment Period|Adverse Event|9|||
130957674|NCT00654628|471474021|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
130957675|NCT00654628|471474021|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
130713593|NCT02749292|470578473|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
130713594|NCT02749292|470578474|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
130957676|NCT00654628|471474021|FG000|6-week Active Treatment Period|Out of window period|1|||
131040148|NCT04971109|471783430|FG000|Overall Study|Adverse Event|4|||
130713595|NCT02749292|470578473|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
130713596|NCT02749292|470578474|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
130713597|NCT02749292|470578473|FG000|Overall Study|Requiring glucocorticoids|0|||
130713598|NCT02749292|470578474|FG001|Overall Study|Requiring glucocorticoids|3|||
130713599|NCT02749292|470578473|FG000|Overall Study|Cancer|1|||
130713600|NCT02749292|470578474|FG001|Overall Study|Cancer|0|||
130713601|NCT00251641|470578475|FG000|Overall Study|Adverse Event|80|||
130957677|NCT00654628|471474021|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
130957678|NCT00654628|471474021|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
130957679|NCT00953329|471474026|FG000|Overall Study|Lack of Efficacy|1|||
130957680|NCT02477020|471474029|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
130957681|NCT02477020|471474030|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
131040149|NCT04971109|471783431|FG001|Overall Study|Adverse Event|3|||
130713602|NCT00251641|470578476|FG001|Overall Study|Adverse Event|8|||
130713603|NCT00251641|470578475|FG000|Overall Study|Lack of Efficacy|2|||
131126677|NCT00841568|472093182|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
131126678|NCT01087775|472093183|FG000|Overall Study|failed inclusion criteria|2|||
131126679|NCT05289570|472093185|FG000|Overall Study|Physician Decision|1|||
131126680|NCT02424253|472093188|FG000|Overall Study|Other, unspecified|1|||
130957682|NCT02477020|471474029|FG000|Overall Study|Voluntary Withdrawal|7|||
131126681|NCT02424253|472093189|FG001|Overall Study|Other, unspecified|0|||
130957683|NCT02477020|471474030|FG001|Overall Study|Voluntary Withdrawal|16|||
130957684|NCT02477020|471474029|FG000|Overall Study|Reason not Specified|3|||
130957685|NCT02477020|471474030|FG001|Overall Study|Reason not Specified|1|||
130957686|NCT02477020|471474029|FG000|Overall Study|Lack of Efficacy|14|||
130957687|NCT02477020|471474030|FG001|Overall Study|Lack of Efficacy|5|||
130957688|NCT01465802|471474032|FG000|Overall Study|Study terminated by sponsor|1|||
130957689|NCT01465802|471474033|FG001|Overall Study|Study terminated by sponsor|0|||
130957690|NCT01465802|471474034|FG002|Overall Study|Study terminated by sponsor|0|||
130957691|NCT01465802|471474035|FG003|Overall Study|Study terminated by sponsor|1|||
130957692|NCT01465802|471474036|FG004|Overall Study|Study terminated by sponsor|7|||
130957693|NCT01465802|471474032|FG000|Overall Study|Withdrawal by Subject|7|||
130957694|NCT01465802|471474033|FG001|Overall Study|Withdrawal by Subject|7|||
130957695|NCT01465802|471474034|FG002|Overall Study|Withdrawal by Subject|0|||
130957696|NCT01465802|471474035|FG003|Overall Study|Withdrawal by Subject|8|||
130957697|NCT01465802|471474036|FG004|Overall Study|Withdrawal by Subject|1|||
130957698|NCT01465802|471474032|FG000|Overall Study|Lost to Follow-up|1|||
130957699|NCT01465802|471474033|FG001|Overall Study|Lost to Follow-up|1|||
130957700|NCT01465802|471474034|FG002|Overall Study|Lost to Follow-up|0|||
130957701|NCT01465802|471474035|FG003|Overall Study|Lost to Follow-up|0|||
130957702|NCT01465802|471474036|FG004|Overall Study|Lost to Follow-up|0|||
130957703|NCT01465802|471474032|FG000|Overall Study|Reason not specified|9|||
130957704|NCT01465802|471474033|FG001|Overall Study|Reason not specified|4|||
130957705|NCT01465802|471474034|FG002|Overall Study|Reason not specified|0|||
130957706|NCT01465802|471474035|FG003|Overall Study|Reason not specified|10|||
130957707|NCT01465802|471474036|FG004|Overall Study|Reason not specified|2|||
130957708|NCT01465802|471474032|FG000|Overall Study|Death|15|||
130957709|NCT01465802|471474033|FG001|Overall Study|Death|12|||
130957710|NCT01465802|471474034|FG002|Overall Study|Death|0|||
130957711|NCT01465802|471474035|FG003|Overall Study|Death|10|||
130957712|NCT01465802|471474036|FG004|Overall Study|Death|2|||
130957713|NCT01340976|471474037|FG000|Overall Study|Physician Decision|2|||
130957714|NCT01340976|471474038|FG001|Overall Study|Physician Decision|0|||
131126682|NCT02424253|472093188|FG000|Overall Study|Compliance problems|1|||
131126683|NCT02424253|472093189|FG001|Overall Study|Compliance problems|0|||
131126684|NCT02424253|472093188|FG000|Overall Study|Physician Decision|2|||
131126685|NCT02424253|472093189|FG001|Overall Study|Physician Decision|0|||
131126686|NCT02424253|472093188|FG000|Overall Study|Lack of Efficacy|0|||
131126687|NCT02424253|472093189|FG001|Overall Study|Lack of Efficacy|7|||
131126688|NCT02424253|472093188|FG000|Overall Study|Adverse Event|2|||
131126689|NCT02424253|472093189|FG001|Overall Study|Adverse Event|0|||
131126690|NCT02424253|472093188|FG000|Overall Study|Consent withdrawn by subject|4|||
131126691|NCT02424253|472093189|FG001|Overall Study|Consent withdrawn by subject|1|||
131126692|NCT02424253|472093188|FG000|Overall Study|Lost to Follow-up|1|||
131126693|NCT02424253|472093189|FG001|Overall Study|Lost to Follow-up|1|||
131126694|NCT02370615|472093192|FG000|Overall Study|Adverse Event|1|||
131126695|NCT02370615|472093193|FG001|Overall Study|Adverse Event|0|||
131126696|NCT02290873|472093194|FG000|Overall Study|Withdrawal by Subject|0|||
131126697|NCT02290873|472093195|FG001|Overall Study|Withdrawal by Subject|1|||
131126698|NCT02290873|472093196|FG002|Overall Study|Withdrawal by Subject|1|||
131126699|NCT02290873|472093194|FG000|Overall Study|Nellcor device error|1|||
131126700|NCT02290873|472093195|FG001|Overall Study|Nellcor device error|0|||
131126701|NCT02290873|472093196|FG002|Overall Study|Nellcor device error|0|||
131126702|NCT02290873|472093194|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
131126703|NCT02290873|472093195|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
130713604|NCT00251641|470578476|FG001|Overall Study|Lack of Efficacy|1|||
130713605|NCT00251641|470578475|FG000|Overall Study|Progression of Disease|0|||
130957715|NCT01340976|471474039|FG002|Overall Study|Physician Decision|1|||
130957716|NCT01340976|471474040|FG003|Overall Study|Physician Decision|1|||
130957717|NCT01340976|471474041|FG004|Overall Study|Physician Decision|1|||
130957718|NCT01340976|471474042|FG005|Overall Study|Physician Decision|0|||
130957719|NCT01340976|471474037|FG000|Overall Study|Death|0|||
130957720|NCT01340976|471474038|FG001|Overall Study|Death|1|||
131126704|NCT02290873|472093196|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
131126705|NCT02290873|472093194|FG000|Overall Study|Protocol Violation|0|||
131126706|NCT02290873|472093195|FG001|Overall Study|Protocol Violation|0|||
131126707|NCT02290873|472093196|FG002|Overall Study|Protocol Violation|1|||
131126708|NCT01378104|472093197|FG000|Overall Study|Adverse Event|8|||
131126709|NCT01378104|472093198|FG001|Overall Study|Adverse Event|8|||
130957721|NCT01340976|471474039|FG002|Overall Study|Death|0|||
130957722|NCT01340976|471474040|FG003|Overall Study|Death|0|||
130957723|NCT01340976|471474041|FG004|Overall Study|Death|0|||
131126710|NCT01378104|472093197|FG000|Overall Study|Lack of Efficacy|7|||
131126711|NCT01378104|472093198|FG001|Overall Study|Lack of Efficacy|5|||
131040150|NCT04971109|471783430|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
131040151|NCT04971109|471783431|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
131040152|NCT04971109|471783430|FG000|Overall Study|Lost to Follow-up|8|||
131040153|NCT04971109|471783431|FG001|Overall Study|Lost to Follow-up|2|||
131040154|NCT04971109|471783430|FG000|Overall Study|Physician Decision|5|||
131040155|NCT04971109|471783431|FG001|Overall Study|Physician Decision|0|||
131040156|NCT04971109|471783430|FG000|Overall Study|Protocol Violation|0|||
131040157|NCT04971109|471783431|FG001|Overall Study|Protocol Violation|1|||
131040158|NCT04971109|471783430|FG000|Overall Study|Withdrawal by Subject|18|||
131040159|NCT04971109|471783431|FG001|Overall Study|Withdrawal by Subject|3|||
131040160|NCT04971109|471783430|FG000|Overall Study|Subject was randomized in error|1|||
131040161|NCT04971109|471783431|FG001|Overall Study|Subject was randomized in error|0|||
131040162|NCT05293171|471783433|FG000|Washout 5 to 7 Days|Adverse Event|1|||
131040163|NCT05293171|471783434|FG001|Washout 5 to 7 Days|Adverse Event|1|||
131040164|NCT05293171|471783435|FG002|Washout 5 to 7 Days|Adverse Event|0|||
131040165|NCT05293171|471783436|FG003|Washout 5 to 7 Days|Adverse Event|0|||
131040166|NCT05293171|471783437|FG004|Washout 5 to 7 Days|Adverse Event|0|||
131040167|NCT05293171|471783438|FG005|Washout 5 to 7 Days|Adverse Event|0|||
131040168|NCT05293171|471783439|FG006|Washout 5 to 7 Days|Adverse Event|0|||
131040169|NCT05293171|471783440|FG007|Washout 5 to 7 Days|Adverse Event|0|||
131040170|NCT05293171|471783441|FG008|Washout 5 to 7 Days|Adverse Event|0|||
131040171|NCT05293171|471783442|FG009|Washout 5 to 7 Days|Adverse Event|0|||
131040172|NCT05293171|471783443|FG010|Washout 5 to 7 Days|Adverse Event|0|||
131040173|NCT05293171|471783444|FG011|Washout 5 to 7 Days|Adverse Event|0|||
131040174|NCT05293171|471783433|FG000|Washout 5 to 7 Days|Adverse Event|0|||
131040175|NCT05293171|471783434|FG001|Washout 5 to 7 Days|Adverse Event|0|||
131040176|NCT05293171|471783435|FG002|Washout 5 to 7 Days|Adverse Event|0|||
131040177|NCT05293171|471783436|FG003|Washout 5 to 7 Days|Adverse Event|0|||
131040178|NCT05293171|471783437|FG004|Washout 5 to 7 Days|Adverse Event|0|||
131040179|NCT05293171|471783438|FG005|Washout 5 to 7 Days|Adverse Event|1|||
130957724|NCT01340976|471474042|FG005|Overall Study|Death|0|||
130957725|NCT01340976|471474037|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
130957726|NCT01340976|471474038|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
130957727|NCT01340976|471474039|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
130957728|NCT01340976|471474040|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
130957729|NCT01340976|471474041|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
130957730|NCT01340976|471474042|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
130957731|NCT01340976|471474037|FG000|Overall Study|Withdrawal by Subject|0|||
130957732|NCT01340976|471474038|FG001|Overall Study|Withdrawal by Subject|0|||
130957733|NCT01340976|471474039|FG002|Overall Study|Withdrawal by Subject|0|||
130957734|NCT01340976|471474040|FG003|Overall Study|Withdrawal by Subject|1|||
130957735|NCT01340976|471474041|FG004|Overall Study|Withdrawal by Subject|1|||
130957736|NCT01340976|471474042|FG005|Overall Study|Withdrawal by Subject|0|||
130957737|NCT01340976|471474037|FG000|Overall Study|Other anemia treatment|1|||
130957738|NCT01340976|471474038|FG001|Overall Study|Other anemia treatment|0|||
130957739|NCT01340976|471474039|FG002|Overall Study|Other anemia treatment|2|||
130957740|NCT01340976|471474040|FG003|Overall Study|Other anemia treatment|1|||
130957741|NCT01340976|471474041|FG004|Overall Study|Other anemia treatment|0|||
130957742|NCT01340976|471474042|FG005|Overall Study|Other anemia treatment|1|||
130957743|NCT01340976|471474037|FG000|Overall Study|Adverse Event|0|||
130957744|NCT01340976|471474038|FG001|Overall Study|Adverse Event|1|||
130957745|NCT01340976|471474039|FG002|Overall Study|Adverse Event|0|||
130957746|NCT01340976|471474040|FG003|Overall Study|Adverse Event|0|||
130957747|NCT01340976|471474041|FG004|Overall Study|Adverse Event|0|||
130957748|NCT01340976|471474042|FG005|Overall Study|Adverse Event|0|||
130957749|NCT01358981|471474043|FG000|Period 1|Withdrawal by Subject|0|||
130957750|NCT01358981|471474044|FG001|Period 1|Withdrawal by Subject|0|||
130957751|NCT01358981|471474045|FG002|Period 1|Withdrawal by Subject|0|||
130957752|NCT01358981|471474046|FG003|Period 1|Withdrawal by Subject|1|||
130957753|NCT01358981|471474047|FG004|Period 1|Withdrawal by Subject|0|||
130957754|NCT01358981|471474048|FG005|Period 1|Withdrawal by Subject|0|||
130957755|NCT01358981|471474049|FG006|Period 1|Withdrawal by Subject|0|||
130957756|NCT03306264|471474059|FG000|Overall Study|Death|33|||
130957757|NCT03306264|471474060|FG001|Overall Study|Death|25|||
130957758|NCT03306264|471474061|FG002|Overall Study|Death|34|||
130957759|NCT03306264|471474062|FG003|Overall Study|Death|34|||
130957760|NCT03306264|471474059|FG000|Overall Study|Complete Consent Withdrawal|4|||
130957761|NCT03306264|471474060|FG001|Overall Study|Complete Consent Withdrawal|4|||
131040180|NCT05293171|471783439|FG006|Washout 5 to 7 Days|Adverse Event|0|||
131040181|NCT05293171|471783440|FG007|Washout 5 to 7 Days|Adverse Event|0|||
131040182|NCT05293171|471783441|FG008|Washout 5 to 7 Days|Adverse Event|0|||
131040183|NCT05293171|471783442|FG009|Washout 5 to 7 Days|Adverse Event|0|||
131040184|NCT05293171|471783443|FG010|Washout 5 to 7 Days|Adverse Event|0|||
131040185|NCT05293171|471783444|FG011|Washout 5 to 7 Days|Adverse Event|0|||
131040186|NCT01712490|471783450|FG000|Overall Study|Ongoing|601|||
131040187|NCT01712490|471783451|FG001|Overall Study|Ongoing|586|||
130957762|NCT03306264|471474061|FG002|Overall Study|Complete Consent Withdrawal|1|||
130957763|NCT03306264|471474062|FG003|Overall Study|Complete Consent Withdrawal|8|||
131040188|NCT01712490|471783450|FG000|Overall Study|Other|11|||
131040189|NCT01712490|471783451|FG001|Overall Study|Other|11|||
131040190|NCT01712490|471783450|FG000|Overall Study|Withdrawal by Subject|36|||
131040191|NCT01712490|471783451|FG001|Overall Study|Withdrawal by Subject|44|||
131040192|NCT01712490|471783450|FG000|Overall Study|Lost to Follow-up|16|||
131040193|NCT01712490|471783451|FG001|Overall Study|Lost to Follow-up|29|||
131040194|NCT03987022|471783454|FG000|Overall Study|Lost to Follow-up|2|||
131040195|NCT03987022|471783455|FG001|Overall Study|Lost to Follow-up|2|||
131040196|NCT03987022|471783454|FG000|Overall Study|Withdrawal by Subject|1|||
131040197|NCT03987022|471783455|FG001|Overall Study|Withdrawal by Subject|0|||
131040198|NCT04800211|471783456|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
131040199|NCT04800211|471783457|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
131040200|NCT04800211|471783458|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
131040201|NCT04800211|471783456|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
131040202|NCT04800211|471783457|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
131040203|NCT04800211|471783458|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
131040204|NCT04800211|471783456|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
130713606|NCT00251641|470578476|FG001|Overall Study|Progression of Disease|2|||
130713607|NCT00251641|470578475|FG000|Overall Study|Lost to Follow-up|3|||
130713608|NCT00251641|470578476|FG001|Overall Study|Lost to Follow-up|3|||
130713609|NCT00251641|470578475|FG000|Overall Study|Withdrawal by Subject|6|||
131040205|NCT04800211|471783457|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
131040206|NCT04800211|471783458|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
131040207|NCT04800211|471783456|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
130713610|NCT00251641|470578476|FG001|Overall Study|Withdrawal by Subject|8|||
130957764|NCT03306264|471474059|FG000|Overall Study|Lost to Follow-up|1|||
130957765|NCT03306264|471474060|FG001|Overall Study|Lost to Follow-up|0|||
130957766|NCT03306264|471474061|FG002|Overall Study|Lost to Follow-up|1|||
130957767|NCT03306264|471474062|FG003|Overall Study|Lost to Follow-up|0|||
130957768|NCT03306264|471474059|FG000|Overall Study|Rollover to ASTX727-06|10|||
130957769|NCT03306264|471474060|FG001|Overall Study|Rollover to ASTX727-06|18|||
130957770|NCT03306264|471474061|FG002|Overall Study|Rollover to ASTX727-06|4|||
130957771|NCT03306264|471474062|FG003|Overall Study|Rollover to ASTX727-06|2|||
130957772|NCT03306264|471474059|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
130957773|NCT03306264|471474060|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
130957774|NCT03306264|471474061|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
130957775|NCT03306264|471474062|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
130957776|NCT01574703|471474063|FG000|Overall Study|Adverse Event|0|||
130957777|NCT01574703|471474064|FG001|Overall Study|Adverse Event|2|||
130957778|NCT01574703|471474065|FG002|Overall Study|Adverse Event|1|||
131040208|NCT04800211|471783457|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
131040209|NCT04800211|471783458|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
131040210|NCT04800211|471783456|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
131040211|NCT04800211|471783457|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
131040212|NCT04800211|471783458|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
131040213|NCT04800211|471783456|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
131040214|NCT04800211|471783457|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
131040215|NCT04800211|471783458|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
131040216|NCT04800211|471783456|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
131040217|NCT04800211|471783457|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
131040218|NCT04800211|471783458|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
131040219|NCT04800211|471783456|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
131040220|NCT04800211|471783457|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
131040221|NCT04800211|471783458|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
131040222|NCT04800211|471783456|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
131040223|NCT04800211|471783457|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
131040224|NCT04800211|471783458|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
131040225|NCT04800211|471783456|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
131040226|NCT04800211|471783457|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
131040227|NCT04800211|471783458|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
131040228|NCT04800211|471783456|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
131040229|NCT04800211|471783457|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
131040230|NCT04800211|471783458|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
131040231|NCT02724969|471783476|FG000|Overall Study|Lost to Follow-up|12|||
131040232|NCT02724969|471783477|FG001|Overall Study|Lost to Follow-up|6|||
131040233|NCT02724969|471783476|FG000|Overall Study|Withdrawal by Subject|3|||
131040234|NCT02724969|471783477|FG001|Overall Study|Withdrawal by Subject|3|||
131040235|NCT02724969|471783476|FG000|Overall Study|Infant demise|0|||
131040236|NCT02724969|471783477|FG001|Overall Study|Infant demise|2|||
131040237|NCT01346540|471783478|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
131040238|NCT01346540|471783479|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
130713611|NCT00251641|470578475|FG000|Overall Study|Protocol Violation|10|||
130713612|NCT00251641|470578476|FG001|Overall Study|Protocol Violation|2|||
130713613|NCT00251641|470578475|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
130713614|NCT00251641|470578476|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
130957779|NCT01574703|471474066|FG003|Overall Study|Adverse Event|1|||
130957780|NCT01574703|471474063|FG000|Overall Study|Protocol Violation|0|||
130957781|NCT01574703|471474064|FG001|Overall Study|Protocol Violation|0|||
130957782|NCT01574703|471474065|FG002|Overall Study|Protocol Violation|0|||
130957783|NCT01574703|471474066|FG003|Overall Study|Protocol Violation|1|||
130957784|NCT01574703|471474063|FG000|Overall Study|Unspecified Reason|27|||
130713615|NCT00251641|470578475|FG000|Overall Study|Switched Treatment|9|||
130713616|NCT00251641|470578476|FG001|Overall Study|Switched Treatment|63|||
130713617|NCT02093221|470578477|FG000|Overall Study|Adverse Event|1|||
130713618|NCT02093221|470578478|FG001|Overall Study|Adverse Event|0|||
130713619|NCT02093221|470578479|FG002|Overall Study|Adverse Event|0|||
130713620|NCT02093221|470578480|FG003|Overall Study|Adverse Event|0|||
130713621|NCT02093221|470578481|FG004|Overall Study|Adverse Event|0|||
130713622|NCT02093221|470578477|FG000|Overall Study|Withdrawal by Subject|1|||
130713623|NCT02093221|470578478|FG001|Overall Study|Withdrawal by Subject|1|||
130713624|NCT02093221|470578479|FG002|Overall Study|Withdrawal by Subject|4|||
130713625|NCT02093221|470578480|FG003|Overall Study|Withdrawal by Subject|1|||
130713626|NCT02093221|470578481|FG004|Overall Study|Withdrawal by Subject|1|||
130713627|NCT02093221|470578477|FG000|Overall Study|Lost to Follow-up|2|||
130713628|NCT02093221|470578478|FG001|Overall Study|Lost to Follow-up|0|||
130713629|NCT02093221|470578479|FG002|Overall Study|Lost to Follow-up|1|||
130713630|NCT02093221|470578480|FG003|Overall Study|Lost to Follow-up|1|||
130713631|NCT02093221|470578481|FG004|Overall Study|Lost to Follow-up|0|||
130713632|NCT02093221|470578477|FG000|Overall Study|Death|0|||
130713633|NCT02093221|470578478|FG001|Overall Study|Death|1|||
130713634|NCT02093221|470578479|FG002|Overall Study|Death|0|||
130713635|NCT02093221|470578480|FG003|Overall Study|Death|0|||
130713636|NCT02093221|470578481|FG004|Overall Study|Death|0|||
130713637|NCT02093221|470578477|FG000|Overall Study|Protocol Violation|0|||
130713638|NCT02093221|470578478|FG001|Overall Study|Protocol Violation|1|||
130713639|NCT02093221|470578479|FG002|Overall Study|Protocol Violation|0|||
130713640|NCT02093221|470578480|FG003|Overall Study|Protocol Violation|0|||
130713641|NCT02093221|470578481|FG004|Overall Study|Protocol Violation|0|||
130713642|NCT02093221|470578477|FG000|Overall Study|Study termination|6|||
130713643|NCT02093221|470578478|FG001|Overall Study|Study termination|5|||
130713644|NCT02093221|470578479|FG002|Overall Study|Study termination|4|||
130713645|NCT02093221|470578480|FG003|Overall Study|Study termination|6|||
130713646|NCT02093221|470578481|FG004|Overall Study|Study termination|7|||
130713647|NCT00062751|470578482|FG000|Overall Study|Disease progression|24|||
130713648|NCT00062751|470578483|FG001|Overall Study|Disease progression|17|||
130713649|NCT00062751|470578484|FG002|Overall Study|Disease progression|24|||
130713650|NCT00062751|470578485|FG003|Overall Study|Disease progression|2|||
130713651|NCT00062751|470578486|FG004|Overall Study|Disease progression|2|||
130713652|NCT00062751|470578482|FG000|Overall Study|Adverse Event|4|||
130713653|NCT00062751|470578483|FG001|Overall Study|Adverse Event|7|||
130713654|NCT00062751|470578484|FG002|Overall Study|Adverse Event|2|||
130713655|NCT00062751|470578485|FG003|Overall Study|Adverse Event|2|||
130713656|NCT00062751|470578486|FG004|Overall Study|Adverse Event|2|||
130713657|NCT00062751|470578482|FG000|Overall Study|Other|2|||
130713658|NCT00062751|470578483|FG001|Overall Study|Other|3|||
130713659|NCT00062751|470578484|FG002|Overall Study|Other|1|||
130713660|NCT00062751|470578485|FG003|Overall Study|Other|0|||
130713661|NCT00062751|470578486|FG004|Overall Study|Other|1|||
130713662|NCT00062751|470578482|FG000|Overall Study|Withdrawal by Subject|1|||
130713663|NCT00062751|470578483|FG001|Overall Study|Withdrawal by Subject|2|||
130713664|NCT00062751|470578484|FG002|Overall Study|Withdrawal by Subject|2|||
130713665|NCT00062751|470578485|FG003|Overall Study|Withdrawal by Subject|1|||
130957785|NCT01574703|471474064|FG001|Overall Study|Unspecified Reason|15|||
130957786|NCT01574703|471474065|FG002|Overall Study|Unspecified Reason|20|||
130957787|NCT01574703|471474066|FG003|Overall Study|Unspecified Reason|16|||
130713666|NCT00062751|470578486|FG004|Overall Study|Withdrawal by Subject|0|||
130713667|NCT00062751|470578482|FG000|Overall Study|Symptomatic deterioration|1|||
130713668|NCT00062751|470578483|FG001|Overall Study|Symptomatic deterioration|1|||
130713669|NCT00062751|470578484|FG002|Overall Study|Symptomatic deterioration|0|||
130713670|NCT00062751|470578485|FG003|Overall Study|Symptomatic deterioration|0|||
130713671|NCT00062751|470578486|FG004|Overall Study|Symptomatic deterioration|1|||
130713672|NCT00062751|470578482|FG000|Overall Study|Death|1|||
130713673|NCT00062751|470578483|FG001|Overall Study|Death|0|||
130713674|NCT00062751|470578484|FG002|Overall Study|Death|1|||
130713675|NCT00062751|470578485|FG003|Overall Study|Death|0|||
130713676|NCT00062751|470578486|FG004|Overall Study|Death|0|||
130957788|NCT01574703|471474063|FG000|Overall Study|Withdrawal by Subject|53|||
130713677|NCT00851643|470578487|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
130713678|NCT00851643|470578488|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130713679|NCT00851643|470578489|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130957789|NCT01574703|471474064|FG001|Overall Study|Withdrawal by Subject|52|||
130957790|NCT01574703|471474065|FG002|Overall Study|Withdrawal by Subject|36|||
130957791|NCT01574703|471474066|FG003|Overall Study|Withdrawal by Subject|61|||
130957792|NCT01574703|471474063|FG000|Overall Study|Met Withdrawal Criteria|0|||
130957793|NCT01574703|471474064|FG001|Overall Study|Met Withdrawal Criteria|1|||
130957794|NCT01574703|471474065|FG002|Overall Study|Met Withdrawal Criteria|1|||
130713680|NCT00851643|470578490|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130713681|NCT00851643|470578491|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130713682|NCT00851643|470578492|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130713683|NCT00851643|470578487|FG000|Base Study (Up to 12 Months)|Other|0|||
130713684|NCT00851643|470578488|FG001|Base Study (Up to 12 Months)|Other|0|||
130713685|NCT00851643|470578489|FG002|Base Study (Up to 12 Months)|Other|0|||
130713686|NCT00851643|470578490|FG003|Base Study (Up to 12 Months)|Other|0|||
130713687|NCT00851643|470578491|FG004|Base Study (Up to 12 Months)|Other|0|||
130713688|NCT00851643|470578492|FG005|Base Study (Up to 12 Months)|Other|1|||
130713689|NCT00851643|470578487|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
130713690|NCT00851643|470578488|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
130713691|NCT00851643|470578489|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
130713692|NCT00851643|470578490|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
130713693|NCT00851643|470578491|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
130713694|NCT00851643|470578492|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
130713695|NCT00851643|470578487|FG000|Extension Study (Up to 36 Months)|Moved|0|||
130713696|NCT00851643|470578488|FG001|Extension Study (Up to 36 Months)|Moved|2|||
130713697|NCT00851643|470578489|FG002|Extension Study (Up to 36 Months)|Moved|1|||
130713698|NCT00851643|470578490|FG003|Extension Study (Up to 36 Months)|Moved|1|||
130713699|NCT00851643|470578491|FG004|Extension Study (Up to 36 Months)|Moved|0|||
130713700|NCT00851643|470578492|FG005|Extension Study (Up to 36 Months)|Moved|1|||
130713701|NCT02143583|470578495|FG000|Overall Study|Withdrawal by Subject|1|||
130713702|NCT02143583|470578496|FG001|Overall Study|Withdrawal by Subject|0|||
130713703|NCT02143583|470578497|FG002|Overall Study|Withdrawal by Subject|1|||
130713704|NCT02143583|470578495|FG000|Overall Study|husband illness|0|||
130713705|NCT02143583|470578496|FG001|Overall Study|husband illness|0|||
130713706|NCT02143583|470578497|FG002|Overall Study|husband illness|1|||
130713707|NCT01244061|470578498|FG000|Overall Study|Death|1|||
130713708|NCT01244061|470578499|FG001|Overall Study|Death|0|||
130713709|NCT01244061|470578498|FG000|Overall Study|Did not meet entrance criteria|1|||
130713710|NCT01244061|470578499|FG001|Overall Study|Did not meet entrance criteria|0|||
130713711|NCT01244061|470578498|FG000|Overall Study|Lack of Efficacy|1|||
130713712|NCT01244061|470578499|FG001|Overall Study|Lack of Efficacy|3|||
130713713|NCT01244061|470578498|FG000|Overall Study|Lost to Follow-up|34|||
130713714|NCT01244061|470578499|FG001|Overall Study|Lost to Follow-up|30|||
130713715|NCT01244061|470578498|FG000|Overall Study|Withdrawal by Subject|29|||
130713716|NCT01244061|470578499|FG001|Overall Study|Withdrawal by Subject|46|||
130713717|NCT01244061|470578498|FG000|Overall Study|Other|8|||
130713718|NCT01244061|470578499|FG001|Overall Study|Other|19|||
130713719|NCT01244061|470578498|FG000|Overall Study|Protocol Violation|1|||
130713720|NCT01244061|470578499|FG001|Overall Study|Protocol Violation|1|||
130713721|NCT01244061|470578498|FG000|Overall Study|Adverse Event|5|||
130713722|NCT01244061|470578499|FG001|Overall Study|Adverse Event|2|||
130713723|NCT01244061|470578498|FG000|Overall Study|Randomized but not treated|2|||
130713724|NCT01244061|470578499|FG001|Overall Study|Randomized but not treated|2|||
130713725|NCT01641133|470578500|FG000|Overall Study|Protocol Violation|0|||
130713726|NCT01641133|470578501|FG001|Overall Study|Protocol Violation|1|||
130713727|NCT01641133|470578502|FG002|Overall Study|Protocol Violation|1|||
130713728|NCT01641133|470578500|FG000|Overall Study|Migrated/moved from study area|5|||
130713729|NCT01641133|470578501|FG001|Overall Study|Migrated/moved from study area|3|||
130713730|NCT01641133|470578502|FG002|Overall Study|Migrated/moved from study area|1|||
130713731|NCT01641133|470578500|FG000|Overall Study|Adverse Event|0|||
130713732|NCT01641133|470578501|FG001|Overall Study|Adverse Event|0|||
130713733|NCT01641133|470578502|FG002|Overall Study|Adverse Event|1|||
130713734|NCT01641133|470578500|FG000|Overall Study|Withdrawal by Subject|5|||
130713735|NCT01641133|470578501|FG001|Overall Study|Withdrawal by Subject|3|||
130713736|NCT01641133|470578502|FG002|Overall Study|Withdrawal by Subject|3|||
130957795|NCT01574703|471474066|FG003|Overall Study|Met Withdrawal Criteria|0|||
130713737|NCT01641133|470578500|FG000|Overall Study|Lost to Follow-up|0|||
130713738|NCT01641133|470578501|FG001|Overall Study|Lost to Follow-up|2|||
130713739|NCT01641133|470578502|FG002|Overall Study|Lost to Follow-up|2|||
130713740|NCT01929031|470578503|FG000|Overall Study|Adverse Event|3|||
130713741|NCT01929031|470578504|FG001|Overall Study|Adverse Event|1|||
130713742|NCT01929031|470578505|FG002|Overall Study|Adverse Event|1|||
130713743|NCT01929031|470578506|FG003|Overall Study|Adverse Event|0|||
130713744|NCT01929031|470578507|FG004|Overall Study|Adverse Event|0|||
130713745|NCT01929031|470578508|FG005|Overall Study|Adverse Event|0|||
130713746|NCT01929031|470578503|FG000|Overall Study|Protocol Violation|1|||
130713747|NCT01929031|470578504|FG001|Overall Study|Protocol Violation|0|||
130713748|NCT01929031|470578505|FG002|Overall Study|Protocol Violation|0|||
130713749|NCT01929031|470578506|FG003|Overall Study|Protocol Violation|0|||
130713750|NCT01929031|470578507|FG004|Overall Study|Protocol Violation|0|||
130957796|NCT01574703|471474063|FG000|Overall Study|Lost to Follow-up|43|||
130957797|NCT01574703|471474064|FG001|Overall Study|Lost to Follow-up|41|||
130957798|NCT01574703|471474065|FG002|Overall Study|Lost to Follow-up|46|||
130957799|NCT01574703|471474066|FG003|Overall Study|Lost to Follow-up|35|||
130957800|NCT01574703|471474063|FG000|Overall Study|Death|2|||
130957801|NCT01574703|471474064|FG001|Overall Study|Death|1|||
130957802|NCT01574703|471474065|FG002|Overall Study|Death|1|||
130957803|NCT01574703|471474066|FG003|Overall Study|Death|0|||
130957804|NCT01524770|471474067|FG000|First Intervention|Withdrawal by Subject|1|||
130957805|NCT01524770|471474068|FG001|First Intervention|Withdrawal by Subject|0|||
130957806|NCT01524770|471474067|FG000|First Intervention|Adverse Event|1|||
130957807|NCT01524770|471474068|FG001|First Intervention|Adverse Event|1|||
130957808|NCT01524770|471474067|FG000|First Intervention|Protocol Violation|1|||
130957809|NCT01524770|471474068|FG001|First Intervention|Protocol Violation|0|||
130957810|NCT03467425|471474069|FG000|Overall Study|Adverse Event|9|||
130957811|NCT03467425|471474070|FG001|Overall Study|Adverse Event|9|||
130957812|NCT03467425|471474069|FG000|Overall Study|Lack of Efficacy|3|||
130957813|NCT03467425|471474070|FG001|Overall Study|Lack of Efficacy|1|||
130957814|NCT03467425|471474069|FG000|Overall Study|Protocol Violation|0|||
130957815|NCT03467425|471474070|FG001|Overall Study|Protocol Violation|1|||
130957816|NCT03467425|471474069|FG000|Overall Study|Lost to Follow-up|18|||
130713751|NCT01929031|470578508|FG005|Overall Study|Protocol Violation|1|||
130713752|NCT01929031|470578503|FG000|Overall Study|Reason other than specified above|0|||
130713753|NCT01929031|470578504|FG001|Overall Study|Reason other than specified above|1|||
130713754|NCT01929031|470578505|FG002|Overall Study|Reason other than specified above|0|||
130713755|NCT01929031|470578506|FG003|Overall Study|Reason other than specified above|0|||
130713756|NCT01929031|470578507|FG004|Overall Study|Reason other than specified above|1|||
130713757|NCT01929031|470578508|FG005|Overall Study|Reason other than specified above|0|||
130713758|NCT05816200|470578511|FG000|Overall Study|Lost to Follow-up|2|||
130713759|NCT05816200|470578512|FG001|Overall Study|Lost to Follow-up|1|||
130713760|NCT00369382|470578513|FG000|Overall Study|Death|0|||
130713761|NCT00369382|470578514|FG001|Overall Study|Death|2|||
130713762|NCT00369382|470578513|FG000|Overall Study|Physician Decision|2|||
130713763|NCT00369382|470578514|FG001|Overall Study|Physician Decision|1|||
130713764|NCT00369382|470578513|FG000|Overall Study|Withdrawal by Subject|5|||
130713765|NCT00369382|470578514|FG001|Overall Study|Withdrawal by Subject|0|||
130713766|NCT00369382|470578513|FG000|Overall Study|Randomized, not treated|2|||
130713767|NCT00369382|470578514|FG001|Overall Study|Randomized, not treated|0|||
130713768|NCT00369382|470578513|FG000|Overall Study|Other|1|||
130713769|NCT00369382|470578514|FG001|Overall Study|Other|0|||
130713770|NCT00609466|470578518|FG000|Overall Study|Withdrawal by Subject|0|||
130713771|NCT00609466|470578519|FG001|Overall Study|Withdrawal by Subject|1|||
130713772|NCT00609466|470578520|FG002|Overall Study|Withdrawal by Subject|1|||
130713773|NCT00609466|470578518|FG000|Overall Study|Adverse Event|2|||
130713774|NCT00609466|470578519|FG001|Overall Study|Adverse Event|3|||
130713775|NCT00609466|470578520|FG002|Overall Study|Adverse Event|1|||
130713776|NCT00609466|470578518|FG000|Overall Study|Lack of Efficacy|0|||
130713777|NCT00609466|470578519|FG001|Overall Study|Lack of Efficacy|2|||
130713778|NCT00609466|470578520|FG002|Overall Study|Lack of Efficacy|2|||
130713779|NCT03512262|470578521|FG000|Overall Study|Adverse Event|8|||
130713780|NCT03512262|470578522|FG001|Overall Study|Adverse Event|3|||
130713781|NCT03512262|470578521|FG000|Overall Study|Death (non-treatment emergent)|1|||
130713782|NCT03512262|470578522|FG001|Overall Study|Death (non-treatment emergent)|0|||
130713783|NCT03512262|470578521|FG000|Overall Study|Withdrawal by Subject|17|||
130713784|NCT03512262|470578522|FG001|Overall Study|Withdrawal by Subject|9|||
130957817|NCT03467425|471474070|FG001|Overall Study|Lost to Follow-up|25|||
130957818|NCT03467425|471474069|FG000|Overall Study|Physician Decision|2|||
130957819|NCT03467425|471474070|FG001|Overall Study|Physician Decision|1|||
130957820|NCT03467425|471474069|FG000|Overall Study|Withdrawal by Subject|15|||
130957821|NCT03467425|471474070|FG001|Overall Study|Withdrawal by Subject|17|||
130957822|NCT02318693|471474071|FG000|Overall Study|Protocol Violation|0|||
130957823|NCT02318693|471474072|FG001|Overall Study|Protocol Violation|1|||
130957824|NCT01282216|471474073|FG000|Overall Study|Graft failure|0|||
130713785|NCT03512262|470578521|FG000|Overall Study|Lost to Follow-up|7|||
130713786|NCT03512262|470578522|FG001|Overall Study|Lost to Follow-up|1|||
130713787|NCT03512262|470578521|FG000|Overall Study|Other than Specified|2|||
130713788|NCT03512262|470578522|FG001|Overall Study|Other than Specified|2|||
130957825|NCT01282216|471474074|FG001|Overall Study|Graft failure|0|||
130957826|NCT01282216|471474075|FG002|Overall Study|Graft failure|3|||
130957827|NCT01282216|471474076|FG003|Overall Study|Graft failure|2|||
130957828|NCT01282216|471474073|FG000|Overall Study|Physician Decision|0|||
130957829|NCT01282216|471474074|FG001|Overall Study|Physician Decision|0|||
130713789|NCT03407430|470578523|FG000|Washout|Protocol Violation|1|||
130713790|NCT03407430|470578524|FG001|Washout|Protocol Violation|0|||
130957830|NCT01282216|471474075|FG002|Overall Study|Physician Decision|11|||
130957831|NCT01282216|471474076|FG003|Overall Study|Physician Decision|0|||
130957832|NCT01282216|471474073|FG000|Overall Study|Relapse|0|||
131040239|NCT01346540|471783478|FG000|Overall Study|Adverse Event|0|||
131040240|NCT01346540|471783479|FG001|Overall Study|Adverse Event|4|||
130957833|NCT01282216|471474074|FG001|Overall Study|Relapse|0|||
130957834|NCT01282216|471474075|FG002|Overall Study|Relapse|17|||
130957835|NCT01282216|471474076|FG003|Overall Study|Relapse|6|||
130957836|NCT01282216|471474073|FG000|Overall Study|Death|0|||
130713791|NCT01195272|470578525|FG000|Overall Study|Adverse Event|1|||
130713792|NCT01195272|470578525|FG000|Overall Study|Lack of Efficacy|3|||
130713793|NCT03295318|470580000|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
130713794|NCT03295318|470580001|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
130713795|NCT03295318|470580002|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
130713796|NCT03295318|470580000|FG000|Overall Study|Death|1|||
130713797|NCT03295318|470580001|FG001|Overall Study|Death|1|||
130713798|NCT03295318|470580002|FG002|Overall Study|Death|1|||
130713799|NCT03295318|470580000|FG000|Overall Study|Protocol Violation|4|||
130713800|NCT03295318|470580001|FG001|Overall Study|Protocol Violation|3|||
130713801|NCT03295318|470580002|FG002|Overall Study|Protocol Violation|3|||
130713802|NCT03295318|470580000|FG000|Overall Study|Withdrawal by Subject|0|||
130713803|NCT03295318|470580001|FG001|Overall Study|Withdrawal by Subject|0|||
130713804|NCT03295318|470580002|FG002|Overall Study|Withdrawal by Subject|1|||
130713805|NCT03295318|470580000|FG000|Overall Study|Subject discontinued due to travel|0|||
130713806|NCT03295318|470580001|FG001|Overall Study|Subject discontinued due to travel|1|||
130713807|NCT03295318|470580002|FG002|Overall Study|Subject discontinued due to travel|0|||
130713808|NCT04319718|470580003|FG000|Overall Study|Adverse Event|0|||
130713809|NCT04319718|470580004|FG001|Overall Study|Adverse Event|2|||
130713810|NCT04319718|470580003|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
130713811|NCT04319718|470580004|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
130713812|NCT01288053|470580005|FG000|Overall Study|Death|1|||
130713813|NCT00144781|470580006|FG000|Overall Study|Adverse Event|0|||
130713814|NCT00144781|470580007|FG001|Overall Study|Adverse Event|1|||
130713815|NCT00144781|470580008|FG002|Overall Study|Adverse Event|0|||
130713816|NCT00144781|470580009|FG003|Overall Study|Adverse Event|0|||
130713817|NCT00144781|470580006|FG000|Overall Study|Non-compliant|0|||
130713818|NCT00144781|470580007|FG001|Overall Study|Non-compliant|1|||
130713819|NCT00144781|470580008|FG002|Overall Study|Non-compliant|0|||
130713820|NCT00144781|470580009|FG003|Overall Study|Non-compliant|0|||
130713821|NCT02068092|470580010|FG000|Overall Study|Physician Decision|2|||
130713822|NCT02068092|470580010|FG000|Overall Study|Adverse Event|2|||
130713823|NCT02068092|470580010|FG000|Overall Study|Lost to Follow-up|4|||
130713824|NCT02068092|470580010|FG000|Overall Study|Withdrawal by Subject|2|||
130713825|NCT01045421|470580011|FG000|Phase 1|Progressive Disease|0|||
130713826|NCT01045421|470580012|FG001|Phase 1|Progressive Disease|0|||
130713827|NCT01045421|470580013|FG002|Phase 1|Progressive Disease|0|||
130713828|NCT01045421|470580014|FG003|Phase 1|Progressive Disease|0|||
130713829|NCT01045421|470580015|FG004|Phase 1|Progressive Disease|1|||
130713830|NCT01045421|470580016|FG005|Phase 1|Progressive Disease|0|||
130713831|NCT01045421|470580017|FG006|Phase 1|Progressive Disease|0|||
130713832|NCT01045421|470580018|FG007|Phase 1|Progressive Disease|0|||
130713833|NCT01045421|470580019|FG008|Phase 1|Progressive Disease|0|||
130713834|NCT01045421|470580020|FG009|Phase 1|Progressive Disease|0|||
130713835|NCT01045421|470580021|FG010|Phase 1|Progressive Disease|0|||
130713836|NCT01045421|470580011|FG000|Phase 1|Withdrawal by Subject|0|||
130713837|NCT01045421|470580012|FG001|Phase 1|Withdrawal by Subject|0|||
130713838|NCT01045421|470580013|FG002|Phase 1|Withdrawal by Subject|0|||
130713839|NCT01045421|470580014|FG003|Phase 1|Withdrawal by Subject|1|||
130713840|NCT01045421|470580015|FG004|Phase 1|Withdrawal by Subject|0|||
130713841|NCT01045421|470580016|FG005|Phase 1|Withdrawal by Subject|0|||
130713842|NCT01045421|470580017|FG006|Phase 1|Withdrawal by Subject|0|||
130713843|NCT01045421|470580018|FG007|Phase 1|Withdrawal by Subject|0|||
130713844|NCT01045421|470580019|FG008|Phase 1|Withdrawal by Subject|0|||
130713845|NCT01045421|470580020|FG009|Phase 1|Withdrawal by Subject|0|||
130713846|NCT01045421|470580021|FG010|Phase 1|Withdrawal by Subject|0|||
130713847|NCT01045421|470580011|FG000|Phase 2|Progressive Disease|0|||
130957837|NCT01282216|471474074|FG001|Overall Study|Death|0|||
130713848|NCT01045421|470580012|FG001|Phase 2|Progressive Disease|0|||
130713849|NCT01045421|470580013|FG002|Phase 2|Progressive Disease|0|||
130713850|NCT01045421|470580014|FG003|Phase 2|Progressive Disease|0|||
130713851|NCT01045421|470580015|FG004|Phase 2|Progressive Disease|0|||
130713852|NCT01045421|470580016|FG005|Phase 2|Progressive Disease|0|||
130713853|NCT01045421|470580017|FG006|Phase 2|Progressive Disease|0|||
130713854|NCT01045421|470580018|FG007|Phase 2|Progressive Disease|1|||
130713855|NCT01045421|470580019|FG008|Phase 2|Progressive Disease|1|||
130713856|NCT01045421|470580020|FG009|Phase 2|Progressive Disease|1|||
130713857|NCT01045421|470580021|FG010|Phase 2|Progressive Disease|1|||
130957838|NCT01282216|471474075|FG002|Overall Study|Death|2|||
130957839|NCT01282216|471474076|FG003|Overall Study|Death|0|||
130713858|NCT01045421|470580011|FG000|Phase 2|Death|0|||
130713859|NCT01045421|470580012|FG001|Phase 2|Death|0|||
130713860|NCT01045421|470580013|FG002|Phase 2|Death|0|||
130713861|NCT01045421|470580014|FG003|Phase 2|Death|0|||
130713862|NCT01045421|470580015|FG004|Phase 2|Death|0|||
130713863|NCT01045421|470580016|FG005|Phase 2|Death|0|||
130713864|NCT01045421|470580017|FG006|Phase 2|Death|0|||
130713865|NCT01045421|470580018|FG007|Phase 2|Death|1|||
130713866|NCT01045421|470580019|FG008|Phase 2|Death|1|||
130713867|NCT01045421|470580020|FG009|Phase 2|Death|2|||
130713868|NCT01045421|470580021|FG010|Phase 2|Death|0|||
130713869|NCT01045421|470580011|FG000|Phase 2|Other|0|||
130713870|NCT01045421|470580012|FG001|Phase 2|Other|0|||
130713871|NCT01045421|470580013|FG002|Phase 2|Other|0|||
130713872|NCT01045421|470580014|FG003|Phase 2|Other|0|||
130713873|NCT01045421|470580015|FG004|Phase 2|Other|0|||
130713874|NCT01045421|470580016|FG005|Phase 2|Other|0|||
130713875|NCT01045421|470580017|FG006|Phase 2|Other|0|||
130713876|NCT01045421|470580018|FG007|Phase 2|Other|3|||
130713877|NCT01045421|470580019|FG008|Phase 2|Other|0|||
130713878|NCT01045421|470580020|FG009|Phase 2|Other|0|||
130713879|NCT01045421|470580021|FG010|Phase 2|Other|1|||
130713880|NCT04551911|470580022|FG000|Overall Study|Lost to Follow-up|2|||
130713881|NCT04551911|470580023|FG001|Overall Study|Lost to Follow-up|1|||
130713882|NCT04551911|470580022|FG000|Overall Study|Withdrawal by Subject|10|||
130713883|NCT04551911|470580023|FG001|Overall Study|Withdrawal by Subject|10|||
130713884|NCT04551911|470580022|FG000|Overall Study|Did not receive the study drug|3|||
130713885|NCT04551911|470580023|FG001|Overall Study|Did not receive the study drug|4|||
130713886|NCT01030341|470580024|FG000|Overall Study|Withdrawal by Subject|1|||
130713887|NCT01030341|470580024|FG000|Overall Study|Lost to Follow-up|2|||
130713888|NCT03596151|470580026|FG000|Overall Study|Withdrawal by Subject|1|||
130713889|NCT04280705|470580029|FG000|Overall Study|Enrolled but not treated|4|||
130957855|NCT03665038|471474084|FG000|Overall Study|Lost to Follow-up|0|||
130957856|NCT03665038|471474085|FG001|Overall Study|Lost to Follow-up|0|||
130957857|NCT03665038|471474086|FG002|Overall Study|Lost to Follow-up|1|||
130957858|NCT04579679|471474087|FG000|Overall Study|New Antitumor Therapy|6|||
130957859|NCT04579679|471474088|FG001|Overall Study|New Antitumor Therapy|4|||
130957860|NCT04579679|471474089|FG002|Overall Study|New Antitumor Therapy|7|||
130957861|NCT04579679|471474090|FG003|Overall Study|New Antitumor Therapy|0|||
130957862|NCT04579679|471474087|FG000|Overall Study|Withdrawal of Consent|1|||
130957863|NCT04579679|471474088|FG001|Overall Study|Withdrawal of Consent|1|||
130957864|NCT04579679|471474089|FG002|Overall Study|Withdrawal of Consent|2|||
130957865|NCT04579679|471474090|FG003|Overall Study|Withdrawal of Consent|4|||
130957866|NCT04579679|471474087|FG000|Overall Study|Death|2|||
130957867|NCT04579679|471474088|FG001|Overall Study|Death|2|||
130957868|NCT04579679|471474089|FG002|Overall Study|Death|2|||
130957869|NCT04579679|471474090|FG003|Overall Study|Death|0|||
130957870|NCT04579679|471474087|FG000|Overall Study|Adverse Event|0|||
130957871|NCT04579679|471474088|FG001|Overall Study|Adverse Event|4|||
130957872|NCT04579679|471474089|FG002|Overall Study|Adverse Event|0|||
130957873|NCT04579679|471474090|FG003|Overall Study|Adverse Event|0|||
130957874|NCT04579679|471474087|FG000|Overall Study|Disease Progression|9|||
130713890|NCT04280705|470580030|FG001|Overall Study|Enrolled but not treated|10|||
130957875|NCT04579679|471474088|FG001|Overall Study|Disease Progression|13|||
130957876|NCT04579679|471474089|FG002|Overall Study|Disease Progression|7|||
130957877|NCT04579679|471474090|FG003|Overall Study|Disease Progression|0|||
130957878|NCT04579679|471474087|FG000|Overall Study|Physician Decision|0|||
130957879|NCT04579679|471474088|FG001|Overall Study|Physician Decision|0|||
130957880|NCT04579679|471474089|FG002|Overall Study|Physician Decision|1|||
130957881|NCT04579679|471474090|FG003|Overall Study|Physician Decision|0|||
130957882|NCT04579679|471474087|FG000|Overall Study|Study Terminated by Sponsor|2|||
130957883|NCT04579679|471474088|FG001|Overall Study|Study Terminated by Sponsor|7|||
130957884|NCT04579679|471474089|FG002|Overall Study|Study Terminated by Sponsor|1|||
130957885|NCT04579679|471474090|FG003|Overall Study|Study Terminated by Sponsor|0|||
131126712|NCT01378104|472093197|FG000|Overall Study|Withdrawal by Subject|12|||
130713891|NCT04280705|470580029|FG000|Overall Study|Physician Decision|1|||
130713892|NCT04280705|470580030|FG001|Overall Study|Physician Decision|0|||
130713893|NCT04280705|470580029|FG000|Overall Study|Withdrawal by Subject|7|||
130713894|NCT04280705|470580030|FG001|Overall Study|Withdrawal by Subject|9|||
130713895|NCT04280705|470580029|FG000|Overall Study|Adverse Event|0|||
130713896|NCT04280705|470580030|FG001|Overall Study|Adverse Event|4|||
131126713|NCT01378104|472093198|FG001|Overall Study|Withdrawal by Subject|13|||
131126714|NCT02700997|472093199|FG000|Overall Study|Did not undergo CT imaging|1|||
131126715|NCT02700997|472093199|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
131126716|NCT01519765|472093200|FG000|Overall Study|Adverse Event|0|||
131126717|NCT01519765|472093201|FG001|Overall Study|Adverse Event|1|||
131126718|NCT01519765|472093200|FG000|Overall Study|Lack of Efficacy|2|||
131126719|NCT01519765|472093201|FG001|Overall Study|Lack of Efficacy|0|||
130957894|NCT03238911|471474093|FG000|Overall Study|Withdrawal by Subject|1|||
130957895|NCT03238911|471474094|FG001|Overall Study|Withdrawal by Subject|2|||
130957896|NCT03238911|471474093|FG000|Overall Study|Lost to Follow-up|2|||
130957897|NCT03238911|471474094|FG001|Overall Study|Lost to Follow-up|1|||
130957898|NCT02239536|471474095|FG000|Overall Study|Non-neoplastic polyp|23|||
130957899|NCT02239536|471474096|FG001|Overall Study|Non-neoplastic polyp|17|||
130957900|NCT01700179|471475735|FG000|Overall Study|Physician Decision|2|||
130957901|NCT00679341|471475736|FG000|Overall Study|Disease progression|42|||
130957902|NCT00679341|471475737|FG001|Overall Study|Disease progression|36|||
130957903|NCT00679341|471475736|FG000|Overall Study|Adverse Event|5|||
130957904|NCT00679341|471475737|FG001|Overall Study|Adverse Event|6|||
131126720|NCT01519765|472093200|FG000|Overall Study|Protocol Violation|1|||
131126721|NCT01519765|472093201|FG001|Overall Study|Protocol Violation|0|||
131126722|NCT01519765|472093200|FG000|Overall Study|Withdrawal by Subject|0|||
131126723|NCT01519765|472093201|FG001|Overall Study|Withdrawal by Subject|1|||
131126724|NCT03610724|472093202|FG000|Overall Study|Death|17|||
131126725|NCT03610724|472093202|FG000|Overall Study|Lost to Follow-up|1|||
131126726|NCT03610724|472093202|FG000|Overall Study|Physician Decision|1|||
131126727|NCT03610724|472093202|FG000|Overall Study|Died prior to infusion|1|||
131126728|NCT01473563|472093203|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
130957905|NCT00679341|471475736|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
130957906|NCT00679341|471475737|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
130957907|NCT00679341|471475736|FG000|Overall Study|Death|1|||
130957908|NCT00679341|471475737|FG001|Overall Study|Death|1|||
130957909|NCT00679341|471475736|FG000|Overall Study|Other|1|||
130957910|NCT00679341|471475737|FG001|Overall Study|Other|0|||
130957911|NCT00679341|471475736|FG000|Overall Study|Physician Decision|1|||
130957912|NCT00679341|471475737|FG001|Overall Study|Physician Decision|0|||
130957913|NCT00679341|471475736|FG000|Overall Study|Not treated|0|||
130957914|NCT00679341|471475737|FG001|Overall Study|Not treated|2|||
130957915|NCT00679341|471475736|FG000|Overall Study|Physician/patient decision to withdraw|0|||
130957916|NCT00679341|471475737|FG001|Overall Study|Physician/patient decision to withdraw|6|||
130957917|NCT01049919|471475739|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
130957918|NCT01049919|471475740|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
130957919|NCT01049919|471475739|FG000|Overall Study|Withdrawal by Subject|5|||
130957920|NCT01049919|471475740|FG001|Overall Study|Withdrawal by Subject|0|||
130957921|NCT01049919|471475739|FG000|Overall Study|Lost to Follow-up|6|||
130957922|NCT01049919|471475740|FG001|Overall Study|Lost to Follow-up|1|||
130957923|NCT01049919|471475739|FG000|Overall Study|Physician Decision|2|||
130957924|NCT01049919|471475740|FG001|Overall Study|Physician Decision|0|||
130957925|NCT01049919|471475739|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
130957926|NCT01049919|471475740|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
130957927|NCT01049919|471475739|FG000|Overall Study|Early study termination by sponsor.|2|||
130957928|NCT01049919|471475740|FG001|Overall Study|Early study termination by sponsor.|0|||
130957929|NCT02566759|471475745|FG000|All Parts|Withdrawal by Subject|0|||
130957930|NCT02566759|471475746|FG001|All Parts|Withdrawal by Subject|1|||
130957931|NCT02566759|471475747|FG002|All Parts|Withdrawal by Subject|0|||
130957932|NCT02566759|471475748|FG003|All Parts|Withdrawal by Subject|0|||
130957933|NCT02566759|471475749|FG004|All Parts|Withdrawal by Subject|0|||
130957934|NCT02566759|471475750|FG005|All Parts|Withdrawal by Subject|0|||
130957935|NCT02566759|471475751|FG006|All Parts|Withdrawal by Subject|0|||
130957936|NCT02566759|471475752|FG007|All Parts|Withdrawal by Subject|0|||
130957937|NCT02566759|471475753|FG008|All Parts|Withdrawal by Subject|0|||
130957938|NCT02566759|471475754|FG009|All Parts|Withdrawal by Subject|0|||
130957939|NCT02566759|471475755|FG010|All Parts|Withdrawal by Subject|0|||
130957940|NCT02566759|471475756|FG011|All Parts|Withdrawal by Subject|0|||
130957941|NCT02566759|471475757|FG012|All Parts|Withdrawal by Subject|0|||
130957942|NCT02566759|471475758|FG013|All Parts|Withdrawal by Subject|0|||
130957943|NCT02566759|471475759|FG014|All Parts|Withdrawal by Subject|0|||
130957944|NCT02566759|471475760|FG015|All Parts|Withdrawal by Subject|0|||
130957945|NCT02566759|471475761|FG016|All Parts|Withdrawal by Subject|0|||
130957946|NCT02566759|471475745|FG000|All Parts|Adverse Event|0|||
130957947|NCT02566759|471475746|FG001|All Parts|Adverse Event|0|||
130957948|NCT02566759|471475747|FG002|All Parts|Adverse Event|0|||
130957949|NCT02566759|471475748|FG003|All Parts|Adverse Event|0|||
131126729|NCT02354222|472093204|FG000|Overall Study|Adverse Event|0|||
130957950|NCT02566759|471475749|FG004|All Parts|Adverse Event|0|||
130957951|NCT02566759|471475750|FG005|All Parts|Adverse Event|0|||
130957952|NCT02566759|471475751|FG006|All Parts|Adverse Event|0|||
130957953|NCT02566759|471475752|FG007|All Parts|Adverse Event|0|||
130957954|NCT02566759|471475753|FG008|All Parts|Adverse Event|0|||
131126730|NCT02354222|472093205|FG001|Overall Study|Adverse Event|3|||
131126731|NCT02354222|472093204|FG000|Overall Study|Physician Decision|1|||
131126732|NCT02354222|472093205|FG001|Overall Study|Physician Decision|1|||
131126733|NCT02354222|472093204|FG000|Overall Study|Pregnancy|1|||
130713897|NCT04280705|470580029|FG000|Overall Study|Transferred to another hospital|1|||
130713898|NCT04280705|470580030|FG001|Overall Study|Transferred to another hospital|1|||
130957955|NCT02566759|471475754|FG009|All Parts|Adverse Event|0|||
130957956|NCT02566759|471475755|FG010|All Parts|Adverse Event|0|||
130957957|NCT02566759|471475756|FG011|All Parts|Adverse Event|0|||
130957958|NCT02566759|471475757|FG012|All Parts|Adverse Event|1|||
130957959|NCT02566759|471475758|FG013|All Parts|Adverse Event|3|||
130957960|NCT02566759|471475759|FG014|All Parts|Adverse Event|0|||
130957961|NCT02566759|471475760|FG015|All Parts|Adverse Event|0|||
130957962|NCT02566759|471475761|FG016|All Parts|Adverse Event|0|||
130957963|NCT02566759|471475745|FG000|All Parts|Other|0|||
130957964|NCT02566759|471475746|FG001|All Parts|Other|0|||
130957965|NCT02566759|471475747|FG002|All Parts|Other|0|||
130957966|NCT02566759|471475748|FG003|All Parts|Other|0|||
130957967|NCT02566759|471475749|FG004|All Parts|Other|0|||
130957968|NCT02566759|471475750|FG005|All Parts|Other|0|||
130957969|NCT02566759|471475751|FG006|All Parts|Other|0|||
130957970|NCT02566759|471475752|FG007|All Parts|Other|0|||
130957971|NCT02566759|471475753|FG008|All Parts|Other|0|||
130957972|NCT02566759|471475754|FG009|All Parts|Other|0|||
130957973|NCT02566759|471475755|FG010|All Parts|Other|0|||
130957974|NCT02566759|471475756|FG011|All Parts|Other|0|||
130957975|NCT02566759|471475757|FG012|All Parts|Other|0|||
130957976|NCT02566759|471475758|FG013|All Parts|Other|2|||
131126734|NCT02354222|472093205|FG001|Overall Study|Pregnancy|0|||
131126735|NCT02354222|472093204|FG000|Overall Study|Withdrawal by Subject|2|||
131126736|NCT02354222|472093205|FG001|Overall Study|Withdrawal by Subject|3|||
131126737|NCT02354222|472093204|FG000|Overall Study|Conflict with the stopping criteria|0|||
131126738|NCT02354222|472093205|FG001|Overall Study|Conflict with the stopping criteria|4|||
131126739|NCT00786565|472093206|FG000|Enrollment Prior to Surgery|Site Closed|3|||
131126740|NCT00786565|472093206|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
131126741|NCT00786565|472093206|FG000|Post Surgery|Abnormal macular pucker|1|||
131126742|NCT00786565|472093206|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
131126743|NCT00432042|472093216|FG000|Overall Study|Protocol Violation|2|||
131126744|NCT00432042|472093217|FG001|Overall Study|Protocol Violation|0|||
131126745|NCT00432042|472093218|FG002|Overall Study|Protocol Violation|0|||
131126746|NCT00432042|472093216|FG000|Overall Study|Withdrawal by Subject|0|||
131126747|NCT00432042|472093217|FG001|Overall Study|Withdrawal by Subject|0|||
131126748|NCT00432042|472093218|FG002|Overall Study|Withdrawal by Subject|2|||
131126749|NCT00432042|472093216|FG000|Overall Study|Lost to Follow-up|5|||
131126750|NCT00432042|472093217|FG001|Overall Study|Lost to Follow-up|1|||
131126751|NCT00432042|472093218|FG002|Overall Study|Lost to Follow-up|0|||
131126752|NCT01585272|472093220|FG000|Overall Study|Adverse Event|22|||
131126753|NCT01585272|472093220|FG000|Overall Study|Protocol Violation|7|||
131126754|NCT01585272|472093220|FG000|Overall Study|Withdrawal by Subject|10|||
130713899|NCT03222583|470580031|FG000|Overall Study|Withdrawal by Subject|3|||
130713900|NCT03222583|470580032|FG001|Overall Study|Withdrawal by Subject|3|||
130957977|NCT02566759|471475759|FG014|All Parts|Other|0|||
130957978|NCT02566759|471475760|FG015|All Parts|Other|0|||
130957979|NCT02566759|471475761|FG016|All Parts|Other|0|||
130957980|NCT02566759|471475745|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957981|NCT02566759|471475746|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957982|NCT02566759|471475747|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957983|NCT02566759|471475748|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957984|NCT02566759|471475749|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957985|NCT02566759|471475750|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957986|NCT02566759|471475751|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957987|NCT02566759|471475752|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957988|NCT02566759|471475753|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957989|NCT02566759|471475754|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957990|NCT02566759|471475755|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957991|NCT02566759|471475756|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957992|NCT02566759|471475757|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957993|NCT02566759|471475758|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957994|NCT02566759|471475759|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130713901|NCT03222583|470580031|FG000|Overall Study|Lost to Follow-up|1|||
130957995|NCT02566759|471475760|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
130957996|NCT02566759|471475761|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
130957997|NCT01126541|471475762|FG000|Overall Study|Adverse Event|0|||
130957998|NCT01126541|471475763|FG001|Overall Study|Adverse Event|2|||
130957999|NCT01126541|471475764|FG002|Overall Study|Adverse Event|4|||
131126755|NCT03765138|472093225|FG000|Overall Study|Lost to Follow-up|1|||
130958000|NCT01126541|471475762|FG000|Overall Study|Death|0|||
130958001|NCT01126541|471475763|FG001|Overall Study|Death|1|||
130958002|NCT01126541|471475764|FG002|Overall Study|Death|0|||
130958003|NCT01126541|471475762|FG000|Overall Study|Lack of Efficacy|6|||
131126756|NCT03803059|472093227|FG000|Overall Study|Protocol Violation|2|||
131126757|NCT03803059|472093227|FG000|Overall Study|Lost to Follow-up|1|||
131126758|NCT04013529|472093230|FG000|Overall Study|Withdrawal by Subject|1|||
131126759|NCT04013529|472093231|FG001|Overall Study|Withdrawal by Subject|1|||
131126760|NCT03116698|472093232|FG000|Overall Study|Adverse Event|1|||
131126761|NCT03116698|472093233|FG001|Overall Study|Adverse Event|1|||
131126762|NCT03116698|472093234|FG002|Overall Study|Adverse Event|1|||
131126763|NCT03116698|472093235|FG003|Overall Study|Adverse Event|0|||
131126764|NCT03116698|472093232|FG000|Overall Study|Withdrawal by Subject|1|||
131126765|NCT03116698|472093233|FG001|Overall Study|Withdrawal by Subject|4|||
131126766|NCT03116698|472093234|FG002|Overall Study|Withdrawal by Subject|5|||
131126767|NCT03116698|472093235|FG003|Overall Study|Withdrawal by Subject|2|||
131126768|NCT03116698|472093232|FG000|Overall Study|Lost to Follow-up|2|||
131126769|NCT03116698|472093233|FG001|Overall Study|Lost to Follow-up|0|||
131126770|NCT03116698|472093234|FG002|Overall Study|Lost to Follow-up|0|||
131126771|NCT03116698|472093235|FG003|Overall Study|Lost to Follow-up|0|||
131126772|NCT03116698|472093232|FG000|Overall Study|Physician Decision|1|||
131126773|NCT03116698|472093233|FG001|Overall Study|Physician Decision|1|||
131126774|NCT03116698|472093234|FG002|Overall Study|Physician Decision|0|||
131126775|NCT03116698|472093235|FG003|Overall Study|Physician Decision|0|||
131126776|NCT03116698|472093232|FG000|Overall Study|Protocol Violation|1|||
131126777|NCT03116698|472093233|FG001|Overall Study|Protocol Violation|0|||
131126778|NCT03116698|472093234|FG002|Overall Study|Protocol Violation|0|||
131126779|NCT03116698|472093235|FG003|Overall Study|Protocol Violation|0|||
131126780|NCT03116698|472093232|FG000|Overall Study|Death|0|||
131126781|NCT03116698|472093233|FG001|Overall Study|Death|0|||
131126782|NCT03116698|472093234|FG002|Overall Study|Death|2|||
131126783|NCT03116698|472093235|FG003|Overall Study|Death|0|||
131126784|NCT00788372|472093236|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
131126785|NCT00788372|472093236|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
131126786|NCT00788372|472093236|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
131126787|NCT00788372|472093236|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
131126788|NCT00788372|472093236|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
131126789|NCT00788372|472093236|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
131126790|NCT00788372|472093236|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
131126791|NCT03099187|472093243|FG000|Double-blind Treatment|Adverse Event|19|||
131126792|NCT03099187|472093244|FG001|Double-blind Treatment|Adverse Event|1|||
131126793|NCT03099187|472093245|FG002|Double-blind Treatment|Adverse Event|0|||
131126794|NCT03099187|472093246|FG003|Double-blind Treatment|Adverse Event|0|||
131126795|NCT03099187|472093243|FG000|Double-blind Treatment|Death|1|||
131126796|NCT03099187|472093244|FG001|Double-blind Treatment|Death|3|||
131126797|NCT03099187|472093245|FG002|Double-blind Treatment|Death|0|||
131126798|NCT03099187|472093246|FG003|Double-blind Treatment|Death|0|||
131126799|NCT03099187|472093243|FG000|Double-blind Treatment|Lack of Efficacy|1|||
131126800|NCT03099187|472093244|FG001|Double-blind Treatment|Lack of Efficacy|0|||
131126801|NCT03099187|472093245|FG002|Double-blind Treatment|Lack of Efficacy|0|||
131126802|NCT03099187|472093246|FG003|Double-blind Treatment|Lack of Efficacy|0|||
131126803|NCT03099187|472093243|FG000|Double-blind Treatment|Physician Decision|2|||
131126804|NCT03099187|472093244|FG001|Double-blind Treatment|Physician Decision|1|||
131126805|NCT03099187|472093245|FG002|Double-blind Treatment|Physician Decision|0|||
131126806|NCT03099187|472093246|FG003|Double-blind Treatment|Physician Decision|0|||
131126807|NCT03099187|472093243|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
131126808|NCT03099187|472093244|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
131126809|NCT03099187|472093245|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
131126810|NCT03099187|472093246|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
131126811|NCT03099187|472093243|FG000|Double-blind Treatment|Lung transplantation|0|||
131126812|NCT03099187|472093244|FG001|Double-blind Treatment|Lung transplantation|1|||
131126813|NCT03099187|472093245|FG002|Double-blind Treatment|Lung transplantation|0|||
131126814|NCT03099187|472093246|FG003|Double-blind Treatment|Lung transplantation|0|||
131126815|NCT03099187|472093243|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
131126816|NCT03099187|472093244|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
131126817|NCT03099187|472093245|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
131126818|NCT03099187|472093246|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
131126819|NCT03099187|472093243|FG000|Double-blind Treatment|Disease progression|0|||
131126820|NCT03099187|472093244|FG001|Double-blind Treatment|Disease progression|1|||
131126821|NCT03099187|472093245|FG002|Double-blind Treatment|Disease progression|0|||
130713902|NCT03222583|470580032|FG001|Overall Study|Lost to Follow-up|0|||
131126822|NCT03099187|472093246|FG003|Double-blind Treatment|Disease progression|0|||
131126823|NCT03099187|472093243|FG000|Double-blind Treatment|Randomization error|0|||
131126824|NCT03099187|472093244|FG001|Double-blind Treatment|Randomization error|2|||
131126825|NCT03099187|472093245|FG002|Double-blind Treatment|Randomization error|0|||
131126826|NCT03099187|472093246|FG003|Double-blind Treatment|Randomization error|0|||
131126827|NCT03099187|472093243|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
131126828|NCT03099187|472093244|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
131126829|NCT03099187|472093245|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
131126830|NCT03099187|472093246|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
131126831|NCT03099187|472093243|FG000|12-month Safety Follow-up|Adverse Event|0|||
130958004|NCT01126541|471475763|FG001|Overall Study|Lack of Efficacy|1|||
131226212|NCT00267007|472455702|FG001|Overall Study|Lost to Follow-up|0|||
131226213|NCT00267007|472455701|FG000|Overall Study|Non-compliance|0|||
131226214|NCT00267007|472455702|FG001|Overall Study|Non-compliance|1|||
131226215|NCT00267007|472455701|FG000|Overall Study|Adverse Event|1|||
130958005|NCT01126541|471475764|FG002|Overall Study|Lack of Efficacy|11|||
130958006|NCT01126541|471475762|FG000|Overall Study|Lost to Follow-up|1|||
130958007|NCT01126541|471475763|FG001|Overall Study|Lost to Follow-up|2|||
130958008|NCT01126541|471475764|FG002|Overall Study|Lost to Follow-up|2|||
131226216|NCT00267007|472455702|FG001|Overall Study|Adverse Event|0|||
131226217|NCT01825876|472455705|FG000|Period 2|Withdrawal by Subject|0|||
131226218|NCT01825876|472455706|FG001|Period 2|Withdrawal by Subject|1|||
131226219|NCT03751020|472455707|FG000|Overall Study|Withdrawal by Subject|2|||
131226220|NCT03751020|472455708|FG001|Overall Study|Withdrawal by Subject|0|||
131226221|NCT03751020|472455709|FG002|Overall Study|Withdrawal by Subject|0|||
131226222|NCT03751020|472455707|FG000|Overall Study|Lost to Follow-up|7|||
131226223|NCT03751020|472455708|FG001|Overall Study|Lost to Follow-up|4|||
131226224|NCT03751020|472455709|FG002|Overall Study|Lost to Follow-up|10|||
131226225|NCT00667719|472455712|FG000|Overall Study|Adverse Event|39|||
130713903|NCT03222583|470580031|FG000|Overall Study|Other|1|||
130713904|NCT03222583|470580032|FG001|Overall Study|Other|3|||
130713905|NCT03573505|470580033|FG000|Overall Study|Adverse Event|1|||
130713906|NCT03573505|470580034|FG001|Overall Study|Adverse Event|1|||
130713907|NCT03573505|470580033|FG000|Overall Study|Consent withdrawn|0|||
130713908|NCT03573505|470580034|FG001|Overall Study|Consent withdrawn|1|||
130713909|NCT03573505|470580033|FG000|Overall Study|Disease progression|0|||
130713910|NCT03573505|470580034|FG001|Overall Study|Disease progression|1|||
130713911|NCT03573505|470580033|FG000|Overall Study|Site Terminated by Sponsor|1|||
130713912|NCT03573505|470580034|FG001|Overall Study|Site Terminated by Sponsor|1|||
130713913|NCT03573505|470580033|FG000|Overall Study|Study terminated by sponsor|50|||
130713914|NCT03573505|470580034|FG001|Overall Study|Study terminated by sponsor|45|||
130713915|NCT03573505|470580033|FG000|Overall Study|Reason not specified|0|||
130713916|NCT03573505|470580034|FG001|Overall Study|Reason not specified|1|||
130713917|NCT03573505|470580033|FG000|Overall Study|Death|0|||
130713918|NCT03573505|470580034|FG001|Overall Study|Death|4|||
130713919|NCT04268316|470580035|FG000|Overall Study|Withdrawal by Subject|2|||
130713920|NCT04268316|470580036|FG001|Overall Study|Withdrawal by Subject|1|||
130713921|NCT04268316|470580037|FG002|Overall Study|Withdrawal by Subject|0|||
130713922|NCT03188718|470580038|FG000|Overall Study|Participant noncompliance|4|||
130713923|NCT03188718|470580038|FG000|Overall Study|Withdrawal by Subject|1|||
130713924|NCT03188718|470580038|FG000|Overall Study|Device failure|3|||
130713925|NCT01400919|470580040|FG000|Overall Study|Withdrawal by Subject|4|||
130713926|NCT01400919|470580040|FG000|Overall Study|Lost to Follow-up|2|||
130713927|NCT01400919|470580040|FG000|Overall Study|Missed visit|2|||
130713928|NCT02923674|470580041|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
130713929|NCT02923674|470580042|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
130713930|NCT02923674|470580043|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
130713931|NCT02923674|470580041|FG000|Overall Study|Lost to Follow-up|7|||
130713932|NCT02923674|470580042|FG001|Overall Study|Lost to Follow-up|12|||
130713933|NCT02923674|470580043|FG002|Overall Study|Lost to Follow-up|7|||
130713934|NCT02923674|470580041|FG000|Overall Study|Problem with intervention|2|||
130713935|NCT02923674|470580042|FG001|Overall Study|Problem with intervention|2|||
130713936|NCT02923674|470580043|FG002|Overall Study|Problem with intervention|1|||
130713937|NCT02923674|470580041|FG000|Overall Study|Adverse Event|3|||
130713938|NCT02923674|470580042|FG001|Overall Study|Adverse Event|1|||
130713939|NCT02923674|470580043|FG002|Overall Study|Adverse Event|1|||
130713940|NCT02923674|470580041|FG000|Overall Study|Withdrawal by Subject|2|||
130713941|NCT02923674|470580042|FG001|Overall Study|Withdrawal by Subject|2|||
130713942|NCT02923674|470580043|FG002|Overall Study|Withdrawal by Subject|2|||
130713943|NCT00158600|470580046|FG000|Overall Study|unable to commit time to study|0|||
130713944|NCT00158600|470580047|FG001|Overall Study|unable to commit time to study|1|||
130713945|NCT00158600|470580046|FG000|Overall Study|Adverse Event|2|||
130713946|NCT00158600|470580047|FG001|Overall Study|Adverse Event|1|||
130713947|NCT00158600|470580046|FG000|Overall Study|Death|1|||
130713948|NCT00158600|470580047|FG001|Overall Study|Death|0|||
130713949|NCT00158600|470580046|FG000|Overall Study|Withdrawal by Subject|2|||
130713950|NCT00158600|470580047|FG001|Overall Study|Withdrawal by Subject|2|||
130713951|NCT00846521|470580056|FG000|Overall Study|Withdrawal by Subject|5|||
130713952|NCT00846521|470580056|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
130958009|NCT01126541|471475762|FG000|Overall Study|Withdrawal by Subject|2|||
130713953|NCT00846521|470580056|FG000|Overall Study|Protocol Violation|1|||
130713954|NCT02618408|470580057|FG000|Overall Study|Withdrawal by Subject|1|||
130713955|NCT02618408|470580058|FG001|Overall Study|Withdrawal by Subject|0|||
130958010|NCT01126541|471475763|FG001|Overall Study|Withdrawal by Subject|5|||
131226226|NCT00667719|472455712|FG000|Overall Study|Abnormal Test Procedure|1|||
130713956|NCT02618408|470580059|FG002|Overall Study|Withdrawal by Subject|4|||
131226227|NCT00667719|472455712|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131226228|NCT00667719|472455712|FG000|Overall Study|Protocol Violation|3|||
130713957|NCT02618408|470580057|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
130713958|NCT02618408|470580058|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
130713959|NCT02618408|470580059|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
130713960|NCT02618408|470580057|FG000|Overall Study|Lost to Follow-up|4|||
130713961|NCT02618408|470580058|FG001|Overall Study|Lost to Follow-up|2|||
130713962|NCT02618408|470580059|FG002|Overall Study|Lost to Follow-up|6|||
130713963|NCT02618408|470580057|FG000|Overall Study|Adverse Event|4|||
130713964|NCT02618408|470580058|FG001|Overall Study|Adverse Event|0|||
130713965|NCT02618408|470580059|FG002|Overall Study|Adverse Event|10|||
130713966|NCT02618408|470580057|FG000|Overall Study|Physician Decision|1|||
130713967|NCT02618408|470580058|FG001|Overall Study|Physician Decision|1|||
130713968|NCT02618408|470580059|FG002|Overall Study|Physician Decision|2|||
130713969|NCT02618408|470580057|FG000|Overall Study|Protocol Violation|1|||
130713970|NCT02618408|470580058|FG001|Overall Study|Protocol Violation|1|||
130713971|NCT02618408|470580059|FG002|Overall Study|Protocol Violation|2|||
130713972|NCT02618408|470580057|FG000|Overall Study|Other, Multiple Categories|0|||
130713973|NCT02618408|470580058|FG001|Overall Study|Other, Multiple Categories|0|||
130713974|NCT02618408|470580059|FG002|Overall Study|Other, Multiple Categories|4|||
130713975|NCT00003875|470580069|FG000|Overall Study|Screen Failed|1|||
130713976|NCT01780987|470580070|FG000|Overall Study|Adverse Event|0|||
130713977|NCT01780987|470580071|FG001|Overall Study|Adverse Event|4|||
130713978|NCT01780987|470580070|FG000|Overall Study|Withdrawal by Subject|2|||
130713979|NCT01780987|470580071|FG001|Overall Study|Withdrawal by Subject|0|||
130713980|NCT01780987|470580070|FG000|Overall Study|Request of Changing Hospital|0|||
130713981|NCT01780987|470580071|FG001|Overall Study|Request of Changing Hospital|1|||
130713982|NCT01780987|470580070|FG000|Overall Study|Changing Residence|1|||
130713983|NCT01780987|470580071|FG001|Overall Study|Changing Residence|0|||
130713984|NCT01780987|470580070|FG000|Overall Study|Not Receiving any Study Medication|0|||
130713985|NCT01780987|470580071|FG001|Overall Study|Not Receiving any Study Medication|1|||
130713986|NCT04168190|470580072|FG000|Overall Study|Lost to Follow-up|0|||
130713987|NCT04168190|470580073|FG001|Overall Study|Lost to Follow-up|1|||
130713988|NCT04168190|470580074|FG002|Overall Study|Lost to Follow-up|0|||
130713989|NCT04168190|470580075|FG003|Overall Study|Lost to Follow-up|7|||
130713990|NCT04168190|470580076|FG004|Overall Study|Lost to Follow-up|5|||
130713991|NCT04168190|470580072|FG000|Overall Study|Withdrawal by Subject|1|||
130713992|NCT04168190|470580073|FG001|Overall Study|Withdrawal by Subject|0|||
130713993|NCT04168190|470580074|FG002|Overall Study|Withdrawal by Subject|0|||
130713994|NCT04168190|470580075|FG003|Overall Study|Withdrawal by Subject|2|||
130713995|NCT04168190|470580076|FG004|Overall Study|Withdrawal by Subject|4|||
130713996|NCT04168190|470580072|FG000|Overall Study|Death|0|||
130713997|NCT04168190|470580073|FG001|Overall Study|Death|0|||
130713998|NCT04168190|470580074|FG002|Overall Study|Death|0|||
130713999|NCT04168190|470580075|FG003|Overall Study|Death|1|||
130714000|NCT04168190|470580076|FG004|Overall Study|Death|0|||
130714001|NCT00629265|470580077|FG000|Overall Study|Lost to Follow-up|4|||
130714002|NCT00629265|470580078|FG001|Overall Study|Lost to Follow-up|5|||
130714003|NCT00629265|470580077|FG000|Overall Study|Withdrawal by Subject|11|||
130714004|NCT00629265|470580078|FG001|Overall Study|Withdrawal by Subject|8|||
130714005|NCT00629265|470580077|FG000|Overall Study|Death|1|||
130958011|NCT01126541|471475764|FG002|Overall Study|Withdrawal by Subject|6|||
130958012|NCT01126541|471475762|FG000|Overall Study|Protocol Violation|0|||
130958013|NCT01126541|471475763|FG001|Overall Study|Protocol Violation|0|||
130958014|NCT01126541|471475764|FG002|Overall Study|Protocol Violation|1|||
130958015|NCT01126541|471475762|FG000|Overall Study|Administrative reason or other|1|||
130958016|NCT01126541|471475763|FG001|Overall Study|Administrative reason or other|1|||
130958017|NCT01126541|471475764|FG002|Overall Study|Administrative reason or other|2|||
130714006|NCT00629265|470580078|FG001|Overall Study|Death|0|||
130714007|NCT00629265|470580077|FG000|Overall Study|Adverse Event|2|||
130714008|NCT00629265|470580078|FG001|Overall Study|Adverse Event|0|||
130958018|NCT01532687|471475765|FG000|Overall Study|Death|2|||
130958019|NCT01532687|471475766|FG001|Overall Study|Death|0|||
130958020|NCT01532687|471475765|FG000|Overall Study|Adverse Event|6|||
130958021|NCT01532687|471475766|FG001|Overall Study|Adverse Event|1|||
130958022|NCT01532687|471475765|FG000|Overall Study|Withdrawal by Subject|1|||
130958023|NCT01532687|471475766|FG001|Overall Study|Withdrawal by Subject|0|||
130958024|NCT01532687|471475765|FG000|Overall Study|Physician Decision|2|||
130958025|NCT01532687|471475766|FG001|Overall Study|Physician Decision|1|||
130958026|NCT01532687|471475765|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
130714009|NCT00629265|470580077|FG000|Overall Study|HNC Recurrence|4|||
130714010|NCT00629265|470580078|FG001|Overall Study|HNC Recurrence|0|||
130714011|NCT00629265|470580077|FG000|Overall Study|Other CA Requiring Treatment|1|||
130714012|NCT00629265|470580078|FG001|Overall Study|Other CA Requiring Treatment|3|||
130714013|NCT00629265|470580077|FG000|Overall Study|Needed Esophageal Dilation|4|||
130714014|NCT00629265|470580078|FG001|Overall Study|Needed Esophageal Dilation|1|||
130958027|NCT01532687|471475766|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
130958028|NCT03160703|471475767|FG000|Overall Study|Withdrawal by Subject|0|||
130714015|NCT00629265|470580077|FG000|Overall Study|Unrelated Medical Complications|3|||
130714016|NCT00629265|470580078|FG001|Overall Study|Unrelated Medical Complications|1|||
130958029|NCT03160703|471475768|FG001|Overall Study|Withdrawal by Subject|0|||
130958030|NCT03160703|471475769|FG002|Overall Study|Withdrawal by Subject|0|||
130958031|NCT03160703|471475770|FG003|Overall Study|Withdrawal by Subject|1|||
130958032|NCT00226941|471475771|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
130958033|NCT00226941|471475772|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
130958034|NCT00226941|471475773|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
130958035|NCT00226941|471475774|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
130958036|NCT00226941|471475771|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
130958037|NCT00226941|471475772|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
130958038|NCT00226941|471475773|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
130958039|NCT00226941|471475774|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
130958040|NCT01513291|471475775|FG000|Treatment Period|Adverse Event|8|||
130958041|NCT01513291|471475776|FG001|Treatment Period|Adverse Event|4|||
130958042|NCT01513291|471475777|FG002|Treatment Period|Adverse Event|0|||
130958043|NCT01513291|471475778|FG003|Treatment Period|Adverse Event|0|||
130958044|NCT01513291|471475779|FG004|Treatment Period|Adverse Event|0|||
130958045|NCT01513291|471475775|FG000|Treatment Period|Lack of Efficacy|3|||
130958046|NCT01513291|471475776|FG001|Treatment Period|Lack of Efficacy|0|||
130958047|NCT01513291|471475777|FG002|Treatment Period|Lack of Efficacy|0|||
130958048|NCT01513291|471475778|FG003|Treatment Period|Lack of Efficacy|0|||
130958049|NCT01513291|471475779|FG004|Treatment Period|Lack of Efficacy|0|||
130958050|NCT01513291|471475775|FG000|Treatment Period|Lost to Follow-up|2|||
130958051|NCT01513291|471475776|FG001|Treatment Period|Lost to Follow-up|3|||
130958052|NCT01513291|471475777|FG002|Treatment Period|Lost to Follow-up|0|||
130958053|NCT01513291|471475778|FG003|Treatment Period|Lost to Follow-up|0|||
130958054|NCT01513291|471475779|FG004|Treatment Period|Lost to Follow-up|0|||
130958055|NCT01513291|471475775|FG000|Treatment Period|Physician Decision|1|||
130958056|NCT01513291|471475776|FG001|Treatment Period|Physician Decision|0|||
130958057|NCT01513291|471475777|FG002|Treatment Period|Physician Decision|0|||
130958058|NCT01513291|471475778|FG003|Treatment Period|Physician Decision|0|||
130958059|NCT01513291|471475779|FG004|Treatment Period|Physician Decision|0|||
130958060|NCT01513291|471475775|FG000|Treatment Period|Protocol Violation|1|||
130958061|NCT01513291|471475776|FG001|Treatment Period|Protocol Violation|2|||
130958062|NCT01513291|471475777|FG002|Treatment Period|Protocol Violation|0|||
130958063|NCT01513291|471475778|FG003|Treatment Period|Protocol Violation|0|||
130958064|NCT01513291|471475779|FG004|Treatment Period|Protocol Violation|0|||
130958065|NCT01513291|471475775|FG000|Treatment Period|Withdrawal by Subject|8|||
130958066|NCT01513291|471475776|FG001|Treatment Period|Withdrawal by Subject|5|||
130958067|NCT01513291|471475777|FG002|Treatment Period|Withdrawal by Subject|0|||
130958068|NCT01513291|471475778|FG003|Treatment Period|Withdrawal by Subject|0|||
130958069|NCT01513291|471475779|FG004|Treatment Period|Withdrawal by Subject|0|||
130958070|NCT01513291|471475775|FG000|Treatment Period|Randomized not treated|0|||
130958071|NCT01513291|471475776|FG001|Treatment Period|Randomized not treated|2|||
130958072|NCT01513291|471475777|FG002|Treatment Period|Randomized not treated|0|||
130958073|NCT01513291|471475778|FG003|Treatment Period|Randomized not treated|0|||
130958074|NCT01513291|471475779|FG004|Treatment Period|Randomized not treated|0|||
130958075|NCT01513291|471475775|FG000|Run-out Period|Lost to Follow-up|0|||
130958076|NCT01513291|471475776|FG001|Run-out Period|Lost to Follow-up|0|||
130958077|NCT01513291|471475777|FG002|Run-out Period|Lost to Follow-up|0|||
130958078|NCT01513291|471475778|FG003|Run-out Period|Lost to Follow-up|1|||
130958079|NCT01513291|471475779|FG004|Run-out Period|Lost to Follow-up|0|||
130958080|NCT01513291|471475775|FG000|Run-out Period|Withdrawal by Subject|0|||
130958081|NCT01513291|471475776|FG001|Run-out Period|Withdrawal by Subject|0|||
130958082|NCT01513291|471475777|FG002|Run-out Period|Withdrawal by Subject|0|||
130958083|NCT01513291|471475778|FG003|Run-out Period|Withdrawal by Subject|1|||
130958084|NCT01513291|471475779|FG004|Run-out Period|Withdrawal by Subject|0|||
130958085|NCT03732638|471475780|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
130958086|NCT03732638|471475781|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
130958087|NCT03732638|471475780|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
130958088|NCT03732638|471475781|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
130958089|NCT03732638|471475780|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
130958090|NCT03732638|471475781|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
130958091|NCT03732638|471475780|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
130958092|NCT03732638|471475781|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
130958093|NCT03732638|471475780|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
130958094|NCT03732638|471475781|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
130714017|NCT00629265|470580077|FG000|Overall Study|Unknown Reason|2|||
130714018|NCT00629265|470580078|FG001|Overall Study|Unknown Reason|2|||
130958095|NCT03732638|471475780|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
130958096|NCT03732638|471475781|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
130714019|NCT04465630|470580079|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
130958097|NCT03732638|471475780|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
130958098|NCT03732638|471475781|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
131226229|NCT00667719|472455712|FG000|Overall Study|Withdrawal by Subject|17|||
130958099|NCT03732638|471475780|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
130958100|NCT03732638|471475781|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
130958101|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
130958102|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
130958103|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
130958104|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
130958105|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
130958106|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
130958107|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
130958108|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
130958109|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
130958110|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
130958111|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
130958112|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
130958113|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
130958114|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
130958115|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
130958116|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
130958117|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
130958118|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
130958119|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
130958120|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
130958121|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
130958122|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
130958123|NCT03732638|471475780|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
130958124|NCT03732638|471475781|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
130958125|NCT03732638|471475780|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
130958126|NCT03732638|471475781|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
130958127|NCT03732638|471475780|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
130958128|NCT03732638|471475781|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
130958129|NCT03732638|471475780|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
130958130|NCT03732638|471475781|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
130958131|NCT03732638|471475780|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
130958132|NCT03732638|471475781|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
130958133|NCT03728582|471475782|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
130958134|NCT03728582|471475783|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
130958135|NCT03728582|471475782|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
130958136|NCT03728582|471475783|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
130958137|NCT01018264|471475784|FG000|Overall Study|Withdrawal by Subject|1|||
130958138|NCT01018264|471475785|FG001|Overall Study|Withdrawal by Subject|0|||
131126832|NCT03099187|472093244|FG001|12-month Safety Follow-up|Adverse Event|0|||
131126833|NCT03099187|472093245|FG002|12-month Safety Follow-up|Adverse Event|5|||
131126834|NCT03099187|472093246|FG003|12-month Safety Follow-up|Adverse Event|12|||
131126835|NCT03099187|472093243|FG000|12-month Safety Follow-up|Death|0|||
131126836|NCT03099187|472093244|FG001|12-month Safety Follow-up|Death|0|||
131126837|NCT03099187|472093245|FG002|12-month Safety Follow-up|Death|7|||
131126838|NCT03099187|472093246|FG003|12-month Safety Follow-up|Death|9|||
130774763|NCT03410992|470802563|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130774764|NCT03410992|470802564|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130774765|NCT03410992|470802565|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130774766|NCT03410992|470802566|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130774767|NCT03410992|470802567|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130774768|NCT03410992|470802568|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130774769|NCT03410992|470802569|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130774770|NCT03410992|470802559|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
130774771|NCT03410992|470802560|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
130958139|NCT01018264|471475784|FG000|Overall Study|Lost to Follow-up|0|||
130958140|NCT01018264|471475785|FG001|Overall Study|Lost to Follow-up|1|||
130958141|NCT01785524|471475786|FG000|Overall Study|Withdrawal by Subject|2|||
130958142|NCT01785524|471475787|FG001|Overall Study|Withdrawal by Subject|2|||
130958143|NCT00767676|471475790|FG000|Overall Study|Investigator error|54|||
130958144|NCT00617240|471475791|FG000|Overall Study|Lack of Efficacy|1|||
130958145|NCT00617240|471475792|FG001|Overall Study|Lack of Efficacy|0|||
130958146|NCT03969212|471475793|FG000|Overall Study|Adverse Event|1|||
131126839|NCT03099187|472093243|FG000|12-month Safety Follow-up|Lung transplantation|0|||
131126840|NCT03099187|472093244|FG001|12-month Safety Follow-up|Lung transplantation|0|||
131126841|NCT03099187|472093245|FG002|12-month Safety Follow-up|Lung transplantation|2|||
131126842|NCT03099187|472093246|FG003|12-month Safety Follow-up|Lung transplantation|1|||
131126843|NCT03099187|472093243|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
131126844|NCT03099187|472093244|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
130714020|NCT04465630|470580079|FG000|Overall Study|Screen failure|8|||
130714021|NCT04465630|470580079|FG000|Overall Study|Baseline failure|16|||
130714022|NCT02032706|470580082|FG000|Overall Study|Did not qualify|5|||
130714023|NCT02032706|470580082|FG000|Overall Study|Protocol Violation|1|||
130714024|NCT00895947|470580083|FG000|Overall Study|Adverse Event|3|||
130714025|NCT00895947|470580084|FG001|Overall Study|Adverse Event|4|||
130714026|NCT00895947|470580083|FG000|Overall Study|Lost to Follow-up|3|||
130714027|NCT00895947|470580084|FG001|Overall Study|Lost to Follow-up|4|||
130714028|NCT00895947|470580083|FG000|Overall Study|Protocol Violation|4|||
130714029|NCT00895947|470580084|FG001|Overall Study|Protocol Violation|2|||
130714030|NCT00895947|470580083|FG000|Overall Study|Withdrawal by Subject|2|||
130714031|NCT00895947|470580084|FG001|Overall Study|Withdrawal by Subject|0|||
130714032|NCT04620135|470580087|FG000|Study Completion|Adverse Event|2|||
130958147|NCT03969212|471475794|FG001|Overall Study|Adverse Event|0|||
130958148|NCT03969212|471475795|FG002|Overall Study|Adverse Event|0|||
130714033|NCT04620135|470580088|FG001|Study Completion|Adverse Event|3|||
130714034|NCT04620135|470580087|FG000|Study Completion|Withdrawal by Subject|2|||
130714035|NCT04620135|470580088|FG001|Study Completion|Withdrawal by Subject|0|||
130714036|NCT02005887|470580092|FG000|Overall Study|Protocol Violation|0|||
130714037|NCT02005887|470580093|FG001|Overall Study|Protocol Violation|2|||
130714038|NCT01615263|470580094|FG000|Overall Study|Post-randomization exclusion|0|||
130714039|NCT01615263|470580095|FG001|Overall Study|Post-randomization exclusion|2|||
130714040|NCT02138136|470580096|FG000|Overall Study|Protocol Violation|4|||
130714041|NCT02138136|470580096|FG000|Overall Study|Physician Decision|7|||
130714042|NCT02138136|470580096|FG000|Overall Study|Lack of Efficacy|35|||
130714043|NCT02138136|470580096|FG000|Overall Study|Pregnancy|2|||
130714044|NCT02138136|470580096|FG000|Overall Study|Adverse Event|18|||
130714045|NCT02138136|470580096|FG000|Overall Study|Withdrawal by Subject|36|||
130714046|NCT02138136|470580096|FG000|Overall Study|Lost to Follow-up|32|||
130714047|NCT02138136|470580096|FG000|Overall Study|Withdrawn by Sponsor|5|||
130714048|NCT01660334|470580099|FG000|Overall Study|Lost to Follow-up|1|||
130714049|NCT04355663|470580100|FG000|Overall Study|Physician Decision|2|||
130714050|NCT04355663|470580101|FG001|Overall Study|Physician Decision|7|||
130714051|NCT04355663|470580102|FG002|Overall Study|Physician Decision|0|||
130774772|NCT03410992|470802561|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130958149|NCT03969212|471475796|FG003|Overall Study|Adverse Event|0|||
130958150|NCT03969212|471475793|FG000|Overall Study|Lost to Follow-up|2|||
130958151|NCT03969212|471475794|FG001|Overall Study|Lost to Follow-up|2|||
130958152|NCT03969212|471475795|FG002|Overall Study|Lost to Follow-up|2|||
130958153|NCT03969212|471475796|FG003|Overall Study|Lost to Follow-up|2|||
130958154|NCT03969212|471475793|FG000|Overall Study|Protocol Violation|0|||
130958155|NCT03969212|471475794|FG001|Overall Study|Protocol Violation|0|||
131126845|NCT03099187|472093245|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
131126846|NCT03099187|472093246|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
131126847|NCT03099187|472093243|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
131126848|NCT03099187|472093244|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
131126849|NCT03099187|472093245|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
131126850|NCT03099187|472093246|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
131126851|NCT03099187|472093243|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
130958156|NCT03969212|471475795|FG002|Overall Study|Protocol Violation|0|||
130958157|NCT03969212|471475796|FG003|Overall Study|Protocol Violation|1|||
130958158|NCT03969212|471475793|FG000|Overall Study|Withdrawal by Subject|7|||
130958159|NCT03969212|471475794|FG001|Overall Study|Withdrawal by Subject|13|||
130958160|NCT03969212|471475795|FG002|Overall Study|Withdrawal by Subject|5|||
130958161|NCT03969212|471475796|FG003|Overall Study|Withdrawal by Subject|11|||
130958162|NCT03969212|471475793|FG000|Overall Study|Physician Decision|0|||
130958163|NCT03969212|471475794|FG001|Overall Study|Physician Decision|0|||
130958164|NCT03969212|471475795|FG002|Overall Study|Physician Decision|1|||
130958165|NCT03969212|471475796|FG003|Overall Study|Physician Decision|0|||
130958166|NCT03969212|471475793|FG000|Overall Study|Reason not Specified|22|||
130958167|NCT03969212|471475794|FG001|Overall Study|Reason not Specified|23|||
130958168|NCT03969212|471475795|FG002|Overall Study|Reason not Specified|28|||
130958169|NCT03969212|471475796|FG003|Overall Study|Reason not Specified|26|||
130958170|NCT00280566|471475797|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
130714052|NCT04355663|470580100|FG000|Overall Study|Adverse Event|0|||
130714053|NCT04355663|470580101|FG001|Overall Study|Adverse Event|0|||
130714054|NCT04355663|470580102|FG002|Overall Study|Adverse Event|1|||
130774773|NCT03410992|470802562|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130958171|NCT00280566|471475798|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
130958172|NCT00280566|471475799|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
130958173|NCT00280566|471475797|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
130714055|NCT04355663|470580100|FG000|Overall Study|Withdrawal by Subject|0|||
130714056|NCT04355663|470580101|FG001|Overall Study|Withdrawal by Subject|8|||
130714057|NCT04355663|470580102|FG002|Overall Study|Withdrawal by Subject|3|||
130714058|NCT03096847|470580103|FG000|Overall Study|Other|2|||
130714059|NCT03096847|470580104|FG001|Overall Study|Other|1|||
130714060|NCT03096847|470580105|FG002|Overall Study|Other|2|||
130958174|NCT00280566|471475798|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
130958175|NCT00280566|471475799|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
130958176|NCT00280566|471475797|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
130958177|NCT00280566|471475798|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
130958178|NCT00280566|471475799|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
130958179|NCT00280566|471475797|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
130958180|NCT00280566|471475798|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
130958181|NCT00280566|471475799|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
130958182|NCT00280566|471475797|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
130958183|NCT00280566|471475798|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
130958184|NCT00280566|471475799|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
130958185|NCT00280566|471475797|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
130958186|NCT00280566|471475798|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
130958187|NCT00280566|471475799|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
130958188|NCT00280566|471475797|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
130958189|NCT00280566|471475798|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
130958190|NCT00280566|471475799|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
130958191|NCT00280566|471475797|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
130958192|NCT00280566|471475798|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
130958193|NCT00280566|471475799|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
130958194|NCT00280566|471475797|FG000|Period 2 Double Blind|Adverse Event|0|||
130958195|NCT00280566|471475798|FG001|Period 2 Double Blind|Adverse Event|11|||
130958196|NCT00280566|471475799|FG002|Period 2 Double Blind|Adverse Event|15|||
130958197|NCT00280566|471475797|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
130958198|NCT00280566|471475798|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
130958199|NCT00280566|471475799|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
130958200|NCT00280566|471475797|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
130958201|NCT00280566|471475798|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
130958202|NCT00280566|471475799|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
130958203|NCT00280566|471475797|FG000|Period 2 Double Blind|miscellaneous|0|||
130958204|NCT00280566|471475798|FG001|Period 2 Double Blind|miscellaneous|10|||
130958205|NCT00280566|471475799|FG002|Period 2 Double Blind|miscellaneous|5|||
130958206|NCT00353366|471475800|FG000|Overall Study|Adverse Event|8|||
130958207|NCT00353366|471475800|FG000|Overall Study|Protocol Violation|12|||
130958208|NCT00353366|471475800|FG000|Overall Study|Withdrawal by Subject|12|||
130958209|NCT00353366|471475800|FG000|Overall Study|Lost to Follow-up|92|||
130958210|NCT00353366|471475800|FG000|Overall Study|Other|19|||
130958211|NCT01302392|471475803|FG000|Overall Study|Lost to Follow-up|1|||
130958212|NCT01302392|471475804|FG001|Overall Study|Lost to Follow-up|0|||
130958213|NCT01302392|471475803|FG000|Overall Study|Withdrawal by Subject|6|||
130958214|NCT01302392|471475804|FG001|Overall Study|Withdrawal by Subject|1|||
130958215|NCT00259857|471475805|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
130958216|NCT00259857|471475806|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
130958217|NCT00259857|471475805|FG000|24 Months Treatment|Lost to Follow-up|0|||
130958218|NCT00259857|471475806|FG001|24 Months Treatment|Lost to Follow-up|3|||
130958219|NCT00670228|471475807|FG000|Overall Study|Adverse Event|1|||
130958220|NCT00670228|471475808|FG001|Overall Study|Adverse Event|0|||
130958221|NCT00670228|471475807|FG000|Overall Study|Death or MACE|0|||
130958222|NCT00670228|471475808|FG001|Overall Study|Death or MACE|1|||
130958223|NCT00670228|471475807|FG000|Overall Study|Not treated|2|||
130958224|NCT00670228|471475808|FG001|Overall Study|Not treated|2|||
130958225|NCT00670228|471475807|FG000|Overall Study|Not meeting the selection criteria|2|||
131126852|NCT03099187|472093244|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
131126853|NCT03099187|472093245|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
131126854|NCT03099187|472093246|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
131126855|NCT03099187|472093243|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
131126856|NCT03099187|472093244|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
131126857|NCT03099187|472093245|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
131126858|NCT03099187|472093246|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
131126859|NCT05248295|472093247|FG000|Overall Study|found ineligible|4|||
131126860|NCT05248295|472093248|FG001|Overall Study|found ineligible|1|||
130958226|NCT00670228|471475808|FG001|Overall Study|Not meeting the selection criteria|0|||
130958227|NCT01813019|471475816|FG000|Overall Study|Adverse Event|0|||
130958228|NCT01813019|471475817|FG001|Overall Study|Adverse Event|3|||
130958229|NCT01813019|471475816|FG000|Overall Study|Withdrawal by Subject|3|||
130958230|NCT01813019|471475817|FG001|Overall Study|Withdrawal by Subject|2|||
130958231|NCT01813019|471475816|FG000|Overall Study|administrative problems|2|||
130958232|NCT01813019|471475817|FG001|Overall Study|administrative problems|0|||
130958233|NCT01813019|471475816|FG000|Overall Study|Protocol Deviation|2|||
130958234|NCT01813019|471475817|FG001|Overall Study|Protocol Deviation|1|||
130958235|NCT03025828|471475818|FG000|Overall Study|Lost to Follow-up|1|||
130958236|NCT01020019|471475819|FG000|Overall Study|Lost to Follow-up|21|||
130958237|NCT01020019|471475820|FG001|Overall Study|Lost to Follow-up|18|||
130958238|NCT01020019|471475819|FG000|Overall Study|Adverse Event|1|||
130958239|NCT01020019|471475820|FG001|Overall Study|Adverse Event|5|||
130958240|NCT01020019|471475819|FG000|Overall Study|not interested in treatment|4|||
130958241|NCT01020019|471475820|FG001|Overall Study|not interested in treatment|4|||
130958242|NCT01020019|471475819|FG000|Overall Study|moving|0|||
130958243|NCT01020019|471475820|FG001|Overall Study|moving|2|||
130958244|NCT04958109|471475821|FG000|Overall Study|Withdrawal by Subject|0|||
130958245|NCT04958109|471475822|FG001|Overall Study|Withdrawal by Subject|1|||
130958246|NCT04958109|471475821|FG000|Overall Study|Lost to Follow-up|0|||
130958247|NCT04958109|471475822|FG001|Overall Study|Lost to Follow-up|1|||
130958248|NCT02214121|471475823|FG000|Part A|Patient decision|2|||
131126861|NCT05248295|472093247|FG000|Overall Study|Withdrawal by Subject|0|||
130958249|NCT02214121|471475824|FG001|Part A|Patient decision|0|||
130958250|NCT02214121|471475825|FG002|Part A|Patient decision|0|||
130958251|NCT02214121|471475823|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
130958252|NCT02214121|471475824|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
130958253|NCT02214121|471475825|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
130958254|NCT02214121|471475823|FG000|Part A|Other|1|||
130958255|NCT02214121|471475824|FG001|Part A|Other|0|||
130958256|NCT02214121|471475825|FG002|Part A|Other|0|||
130958257|NCT02214121|471475823|FG000|Part B|Patient decision|0|||
130958258|NCT02214121|471475824|FG001|Part B|Patient decision|1|||
130958259|NCT02214121|471475825|FG002|Part B|Patient decision|0|||
130958260|NCT02214121|471475823|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
130958261|NCT02214121|471475824|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
130958262|NCT02214121|471475825|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
130958263|NCT02214121|471475823|FG000|Part B|Lost to Follow-up|0|||
130958264|NCT02214121|471475824|FG001|Part B|Lost to Follow-up|0|||
130958265|NCT02214121|471475825|FG002|Part B|Lost to Follow-up|1|||
130958266|NCT00715793|471475826|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
130958267|NCT00715793|471475827|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
130958268|NCT00715793|471475826|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
130958269|NCT00715793|471475827|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
130958270|NCT01559311|471475828|FG000|Overall Study|Protocol Violation|0|||
130958271|NCT01559311|471475829|FG001|Overall Study|Protocol Violation|0|||
130958272|NCT01559311|471475830|FG002|Overall Study|Protocol Violation|2|||
130958273|NCT01559311|471475828|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
130958274|NCT01559311|471475829|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
130958275|NCT01559311|471475830|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
130958276|NCT01559311|471475828|FG000|Overall Study|Withdrawal by Subject|2|||
130958277|NCT01559311|471475829|FG001|Overall Study|Withdrawal by Subject|1|||
130958278|NCT01559311|471475830|FG002|Overall Study|Withdrawal by Subject|0|||
130958279|NCT01559311|471475828|FG000|Overall Study|Death|0|||
130958280|NCT01559311|471475829|FG001|Overall Study|Death|2|||
130958281|NCT01559311|471475830|FG002|Overall Study|Death|3|||
130958282|NCT01559311|471475828|FG000|Overall Study|Lost to Follow-up|0|||
130958283|NCT01559311|471475829|FG001|Overall Study|Lost to Follow-up|3|||
130958284|NCT01559311|471475830|FG002|Overall Study|Lost to Follow-up|2|||
130958285|NCT01559311|471475828|FG000|Overall Study|Adverse Event|0|||
130958286|NCT01559311|471475829|FG001|Overall Study|Adverse Event|0|||
130958287|NCT01559311|471475830|FG002|Overall Study|Adverse Event|1|||
130958288|NCT01849588|471475833|FG000|Overall Study|Lack of Efficacy|3|||
130958289|NCT03417141|471475835|FG000|Overall Study|Withdrawal by Subject|1|||
130958290|NCT03417141|471475835|FG000|Overall Study|Protocol Violation|3|||
130958291|NCT03706690|471475837|FG000|Overall Study|Withdrawal by Subject|8|||
130958292|NCT03706690|471475838|FG001|Overall Study|Withdrawal by Subject|8|||
130958293|NCT03706690|471475837|FG000|Overall Study|Death|143|||
130958294|NCT03706690|471475838|FG001|Overall Study|Death|75|||
130958295|NCT03706690|471475837|FG000|Overall Study|Ongoing at DCO|121|||
131126862|NCT05248295|472093248|FG001|Overall Study|Withdrawal by Subject|1|||
131126863|NCT05248295|472093247|FG000|Overall Study|Data loss: audio recording error|1|||
130714061|NCT03096847|470580103|FG000|Overall Study|Lost to Follow-up|1|||
130958296|NCT03706690|471475838|FG001|Overall Study|Ongoing at DCO|52|||
130958297|NCT02098109|471475839|FG000|Overall Study|Protocol Violation|3|||
130958298|NCT02098109|471475840|FG001|Overall Study|Protocol Violation|0|||
130958299|NCT02143843|471475841|FG000|Overall Study|Adverse Event|8|||
130958300|NCT02143843|471475841|FG000|Overall Study|Lack of Efficacy|2|||
130958301|NCT02143843|471475841|FG000|Overall Study|Withdrawal by Subject|2|||
130958302|NCT01462357|471475847|FG000|Overall Study|Death|0|||
130958303|NCT01462357|471475848|FG001|Overall Study|Death|0|||
130958304|NCT01462357|471475849|FG002|Overall Study|Death|1|||
130958305|NCT01462357|471475847|FG000|Overall Study|Withdrawal by Subject|3|||
130958306|NCT01462357|471475848|FG001|Overall Study|Withdrawal by Subject|11|||
130958307|NCT01462357|471475849|FG002|Overall Study|Withdrawal by Subject|3|||
130958308|NCT01462357|471475847|FG000|Overall Study|Migrated/moved from study area|2|||
130958309|NCT01462357|471475848|FG001|Overall Study|Migrated/moved from study area|3|||
130958310|NCT01462357|471475849|FG002|Overall Study|Migrated/moved from study area|1|||
130958311|NCT01462357|471475847|FG000|Overall Study|Lost to Follow-up|3|||
130958312|NCT01462357|471475848|FG001|Overall Study|Lost to Follow-up|5|||
130958313|NCT01462357|471475849|FG002|Overall Study|Lost to Follow-up|7|||
130958314|NCT01482767|471475851|FG000|Overall Study|Death|1|||
130958315|NCT01482767|471475852|FG001|Overall Study|Death|1|||
130958316|NCT01482767|471475851|FG000|Overall Study|Withdrawal by Subject|7|||
130958317|NCT01482767|471475852|FG001|Overall Study|Withdrawal by Subject|5|||
130958318|NCT01482767|471475851|FG000|Overall Study|Lost to Follow-up|12|||
130958319|NCT01482767|471475852|FG001|Overall Study|Lost to Follow-up|6|||
130958320|NCT01482767|471475851|FG000|Overall Study|Adverse Event|0|||
130958321|NCT01482767|471475852|FG001|Overall Study|Adverse Event|3|||
130958322|NCT01482767|471475851|FG000|Overall Study|Site closure|22|||
130958323|NCT01482767|471475852|FG001|Overall Study|Site closure|14|||
130958324|NCT01482767|471475851|FG000|Overall Study|Non-adherence to study requirements|4|||
130958325|NCT01482767|471475852|FG001|Overall Study|Non-adherence to study requirements|7|||
130958326|NCT01482767|471475851|FG000|Overall Study|Alternate HCV treatment|7|||
130958327|NCT01482767|471475852|FG001|Overall Study|Alternate HCV treatment|8|||
130958328|NCT01482767|471475851|FG000|Overall Study|Ineligible|0|||
130958329|NCT01482767|471475852|FG001|Overall Study|Ineligible|5|||
130958330|NCT01482767|471475851|FG000|Overall Study|Nurse error|1|||
130958331|NCT01482767|471475852|FG001|Overall Study|Nurse error|0|||
130958332|NCT03385239|471475857|FG000|Overall Study|Voluntary Withdrawal|2|||
130958333|NCT03385239|471475858|FG001|Overall Study|Voluntary Withdrawal|3|||
130958334|NCT03385239|471475859|FG002|Overall Study|Voluntary Withdrawal|2|||
130958335|NCT03385239|471475860|FG003|Overall Study|Voluntary Withdrawal|3|||
130958336|NCT03385239|471475861|FG004|Overall Study|Voluntary Withdrawal|0|||
130958337|NCT03385239|471475857|FG000|Overall Study|Adverse Event|0|||
130958338|NCT03385239|471475858|FG001|Overall Study|Adverse Event|0|||
130958339|NCT03385239|471475859|FG002|Overall Study|Adverse Event|1|||
131040241|NCT03362476|471783484|FG000|Overall Study|Withdrawal by Subject|0|||
131226230|NCT00667719|472455712|FG000|Overall Study|Lost to Follow-up|8|||
131226231|NCT00078819|472455713|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
131226232|NCT00078819|472455714|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
131226233|NCT00078819|472455715|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
131226234|NCT00078819|472455716|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
131226235|NCT00078819|472455713|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
131226236|NCT00078819|472455714|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
131226237|NCT00078819|472455715|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
131226238|NCT00078819|472455716|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
131226239|NCT00078819|472455713|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
131226240|NCT00078819|472455714|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
131226241|NCT00078819|472455715|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
131226242|NCT00078819|472455716|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
131226243|NCT00078819|472455713|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
131226244|NCT00078819|472455714|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
131226245|NCT00078819|472455715|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
131226246|NCT00078819|472455716|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
131226247|NCT00078819|472455713|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
131226248|NCT00078819|472455714|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
131226249|NCT00078819|472455715|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
131226250|NCT00078819|472455716|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
131226251|NCT00078819|472455713|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
131226252|NCT00078819|472455714|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
131226253|NCT00078819|472455715|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
131226254|NCT00078819|472455716|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
131226255|NCT00078819|472455713|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
131226256|NCT00078819|472455714|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
130714062|NCT03096847|470580104|FG001|Overall Study|Lost to Follow-up|0|||
130714063|NCT03096847|470580105|FG002|Overall Study|Lost to Follow-up|1|||
130714064|NCT03096847|470580103|FG000|Overall Study|Death|6|||
130958340|NCT03385239|471475860|FG003|Overall Study|Adverse Event|0|||
130958341|NCT03385239|471475861|FG004|Overall Study|Adverse Event|0|||
130958342|NCT03385239|471475857|FG000|Overall Study|Other|0|||
130958343|NCT03385239|471475858|FG001|Overall Study|Other|0|||
130958344|NCT03385239|471475859|FG002|Overall Study|Other|0|||
130958345|NCT03385239|471475860|FG003|Overall Study|Other|1|||
130958346|NCT03385239|471475861|FG004|Overall Study|Other|0|||
130958347|NCT00025883|471475862|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
130958348|NCT00025883|471475862|FG000|Overall Study|no baseline data|1|||
130958349|NCT00025883|471475862|FG000|Overall Study|Death|1|||
130714065|NCT03096847|470580104|FG001|Overall Study|Death|0|||
130714066|NCT03096847|470580105|FG002|Overall Study|Death|2|||
130958350|NCT00025883|471475862|FG000|Overall Study|Adverse Event|1|||
130958351|NCT00025883|471475862|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
131040242|NCT03362476|471783485|FG001|Overall Study|Withdrawal by Subject|1|||
130714067|NCT03096847|470580103|FG000|Overall Study|Protocol Violation|3|||
130714068|NCT03096847|470580104|FG001|Overall Study|Protocol Violation|0|||
130714069|NCT03096847|470580105|FG002|Overall Study|Protocol Violation|6|||
130714070|NCT03096847|470580103|FG000|Overall Study|Physician Decision|12|||
131126864|NCT05248295|472093248|FG001|Overall Study|Data loss: audio recording error|1|||
131126865|NCT03021499|472093251|FG000|Overall Study|Adverse Event|1|||
131126866|NCT03021499|472093252|FG001|Overall Study|Adverse Event|0|||
131126867|NCT03021499|472093251|FG000|Overall Study|Death|1|||
131126868|NCT03021499|472093252|FG001|Overall Study|Death|5|||
131126869|NCT03021499|472093251|FG000|Overall Study|Lack of Efficacy|0|||
131126870|NCT03021499|472093252|FG001|Overall Study|Lack of Efficacy|1|||
131126871|NCT03021499|472093251|FG000|Overall Study|Lost to Follow-up|1|||
131126872|NCT03021499|472093252|FG001|Overall Study|Lost to Follow-up|3|||
131126873|NCT03021499|472093251|FG000|Overall Study|Physician Decision|2|||
131126874|NCT03021499|472093252|FG001|Overall Study|Physician Decision|3|||
131126875|NCT03021499|472093251|FG000|Overall Study|Pregnancy|1|||
131126876|NCT03021499|472093252|FG001|Overall Study|Pregnancy|0|||
131126877|NCT03021499|472093251|FG000|Overall Study|Withdrawal by Subject|7|||
131126878|NCT03021499|472093252|FG001|Overall Study|Withdrawal by Subject|14|||
131126879|NCT03021499|472093251|FG000|Overall Study|Prohibited medication required|1|||
131126880|NCT03021499|472093252|FG001|Overall Study|Prohibited medication required|0|||
131126881|NCT03021499|472093251|FG000|Overall Study|Protocol non-compliance|1|||
131126882|NCT03021499|472093252|FG001|Overall Study|Protocol non-compliance|1|||
131126883|NCT03021499|472093251|FG000|Overall Study|None of the above|0|||
131126884|NCT03021499|472093252|FG001|Overall Study|None of the above|4|||
131126885|NCT03021499|472093251|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
131126886|NCT03021499|472093252|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
131126887|NCT01210690|472093253|FG000|Overall Study|Adverse Event|7|||
131126888|NCT01210690|472093253|FG000|Overall Study|Lack of Efficacy|12|||
131126889|NCT01210690|472093253|FG000|Overall Study|Lost to Follow-up|3|||
131126890|NCT01210690|472093253|FG000|Overall Study|Disease Remission|1|||
131126891|NCT01210690|472093253|FG000|Overall Study|Withdrawal by Subject|1|||
131126892|NCT01210690|472093253|FG000|Overall Study|Patient refused to swallow|1|||
131126893|NCT01210690|472093253|FG000|Overall Study|Patient could not take glucose|1|||
131126894|NCT00470054|472093254|FG000|Overall Study|Ineligible|1|||
131126895|NCT04869345|472093261|FG000|Overall Study|Lost to Follow-up|8|||
131126896|NCT04869345|472093262|FG001|Overall Study|Lost to Follow-up|3|||
131126897|NCT00528021|472093266|FG000|Overall Study|Lack of Efficacy|17|||
131126898|NCT00528021|472093267|FG001|Overall Study|Lack of Efficacy|13|||
131126899|NCT00528021|472093268|FG002|Overall Study|Lack of Efficacy|7|||
131126900|NCT00528021|472093269|FG003|Overall Study|Lack of Efficacy|9|||
131126901|NCT04050982|472093270|FG000|Overall Study|Did not meet eligibility criteria|0|||
131126902|NCT04050982|472093271|FG001|Overall Study|Did not meet eligibility criteria|1|||
131126903|NCT04050982|472093272|FG002|Overall Study|Did not meet eligibility criteria|0|||
131126904|NCT04050982|472093270|FG000|Overall Study|Withdrawal by Subject|1|||
131126905|NCT04050982|472093271|FG001|Overall Study|Withdrawal by Subject|0|||
131126906|NCT04050982|472093272|FG002|Overall Study|Withdrawal by Subject|0|||
131126907|NCT04050982|472093270|FG000|Overall Study|Unable to enroll on platform|1|||
131126908|NCT04050982|472093271|FG001|Overall Study|Unable to enroll on platform|0|||
131126909|NCT04050982|472093272|FG002|Overall Study|Unable to enroll on platform|0|||
131126910|NCT01246583|472093273|FG000|Overall Study|Lost to Follow-up|0|||
131126911|NCT01246583|472093274|FG001|Overall Study|Lost to Follow-up|0|||
131126912|NCT01246583|472093275|FG002|Overall Study|Lost to Follow-up|0|||
131126913|NCT01246583|472093276|FG003|Overall Study|Lost to Follow-up|1|||
131126914|NCT01246583|472093273|FG000|Overall Study|Protocol Violation|0|||
131126915|NCT01246583|472093274|FG001|Overall Study|Protocol Violation|0|||
131126916|NCT01246583|472093275|FG002|Overall Study|Protocol Violation|1|||
131126917|NCT01246583|472093276|FG003|Overall Study|Protocol Violation|0|||
131126918|NCT01246583|472093273|FG000|Overall Study|Withdrawal by Subject|1|||
131126919|NCT01246583|472093274|FG001|Overall Study|Withdrawal by Subject|0|||
131126920|NCT01246583|472093275|FG002|Overall Study|Withdrawal by Subject|0|||
131126921|NCT01246583|472093276|FG003|Overall Study|Withdrawal by Subject|0|||
131126922|NCT05054114|472093277|FG000|Overall Study|Protocol Violation|13|||
131126923|NCT05054114|472093278|FG001|Overall Study|Protocol Violation|1|||
131126924|NCT05054114|472093277|FG000|Overall Study|Pregnancy|0|||
131126925|NCT05054114|472093278|FG001|Overall Study|Pregnancy|1|||
131126926|NCT02116777|472093281|FG000|Overall Study|Adverse Event|0|||
131126927|NCT02116777|472093282|FG001|Overall Study|Adverse Event|0|||
131126928|NCT02116777|472093283|FG002|Overall Study|Adverse Event|0|||
131126929|NCT02116777|472093284|FG003|Overall Study|Adverse Event|0|||
131126930|NCT02116777|472093285|FG004|Overall Study|Adverse Event|2|||
131126931|NCT02116777|472093286|FG005|Overall Study|Adverse Event|2|||
131126932|NCT02116777|472093287|FG006|Overall Study|Adverse Event|0|||
131126933|NCT02116777|472093281|FG000|Overall Study|Death|0|||
131126934|NCT02116777|472093282|FG001|Overall Study|Death|0|||
131126935|NCT02116777|472093283|FG002|Overall Study|Death|0|||
131126936|NCT02116777|472093284|FG003|Overall Study|Death|1|||
131126937|NCT02116777|472093285|FG004|Overall Study|Death|0|||
131126938|NCT02116777|472093286|FG005|Overall Study|Death|0|||
130958352|NCT02908529|471475864|FG000|Overall Study|Lost to Follow-up|0|||
130958353|NCT02908529|471475865|FG001|Overall Study|Lost to Follow-up|2|||
130958354|NCT02553421|471475866|FG000|Overall Study|Lost to Follow-up|21|||
130958355|NCT02553421|471475867|FG001|Overall Study|Lost to Follow-up|1|||
130958356|NCT02553421|471475866|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
130958357|NCT02553421|471475867|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
130958358|NCT02553421|471475866|FG000|Overall Study|Improper Device Placement|3|||
130958359|NCT02553421|471475867|FG001|Overall Study|Improper Device Placement|0|||
130958362|NCT05569954|471475872|FG000|Overall Study|Lost to Follow-up|3|||
130958363|NCT05569954|471475873|FG001|Overall Study|Lost to Follow-up|4|||
130958364|NCT05569954|471475872|FG000|Overall Study|Protocol Violation|1|||
130958365|NCT05569954|471475873|FG001|Overall Study|Protocol Violation|2|||
130958366|NCT05569954|471475872|FG000|Overall Study|Withdrawal by Subject|4|||
130958367|NCT05569954|471475873|FG001|Overall Study|Withdrawal by Subject|2|||
130958368|NCT01660412|471475874|FG000|Overall Study|Protocol Violation|0|||
130958369|NCT01660412|471475875|FG001|Overall Study|Protocol Violation|3|||
130958370|NCT03013491|471475876|FG000|Main Study|Death|2|||
130958371|NCT03013491|471475877|FG001|Main Study|Death|2|||
130958372|NCT03013491|471475878|FG002|Main Study|Death|5|||
130958373|NCT03013491|471475879|FG003|Main Study|Death|3|||
130958374|NCT03013491|471475880|FG004|Main Study|Death|9|||
130958375|NCT03013491|471475881|FG005|Main Study|Death|12|||
130958376|NCT03013491|471475882|FG006|Main Study|Death|3|||
130958377|NCT03013491|471475883|FG007|Main Study|Death|5|||
130958378|NCT03013491|471475884|FG008|Main Study|Death|1|||
130958379|NCT03013491|471475885|FG009|Main Study|Death|2|||
130958380|NCT03013491|471475886|FG010|Main Study|Death|4|||
130958381|NCT03013491|471475887|FG011|Main Study|Death|1|||
130958382|NCT03013491|471475888|FG012|Main Study|Death|1|||
130958383|NCT03013491|471475889|FG013|Main Study|Death|4|||
130958384|NCT03013491|471475890|FG014|Main Study|Death|0|||
130958385|NCT03013491|471475891|FG015|Main Study|Death|3|||
130958386|NCT03013491|471475892|FG016|Main Study|Death|5|||
130958387|NCT03013491|471475893|FG017|Main Study|Death|1|||
130958388|NCT03013491|471475894|FG018|Main Study|Death|47|||
130958389|NCT03013491|471475876|FG000|Main Study|Lost to Follow-up|0|||
130958390|NCT03013491|471475877|FG001|Main Study|Lost to Follow-up|0|||
130958391|NCT03013491|471475878|FG002|Main Study|Lost to Follow-up|1|||
130958392|NCT03013491|471475879|FG003|Main Study|Lost to Follow-up|0|||
130958393|NCT03013491|471475880|FG004|Main Study|Lost to Follow-up|1|||
130958394|NCT03013491|471475881|FG005|Main Study|Lost to Follow-up|0|||
130958395|NCT03013491|471475882|FG006|Main Study|Lost to Follow-up|0|||
130958396|NCT03013491|471475883|FG007|Main Study|Lost to Follow-up|0|||
130958397|NCT03013491|471475884|FG008|Main Study|Lost to Follow-up|0|||
130958398|NCT03013491|471475885|FG009|Main Study|Lost to Follow-up|0|||
130958399|NCT03013491|471475886|FG010|Main Study|Lost to Follow-up|0|||
130958400|NCT03013491|471475887|FG011|Main Study|Lost to Follow-up|0|||
130958401|NCT03013491|471475888|FG012|Main Study|Lost to Follow-up|0|||
130958402|NCT03013491|471475889|FG013|Main Study|Lost to Follow-up|0|||
130958403|NCT03013491|471475890|FG014|Main Study|Lost to Follow-up|0|||
130958404|NCT03013491|471475891|FG015|Main Study|Lost to Follow-up|0|||
130958405|NCT03013491|471475892|FG016|Main Study|Lost to Follow-up|0|||
130958406|NCT03013491|471475893|FG017|Main Study|Lost to Follow-up|0|||
130958407|NCT03013491|471475894|FG018|Main Study|Lost to Follow-up|3|||
130958408|NCT03013491|471475876|FG000|Main Study|Termination of the study by Sponsor|0|||
130958409|NCT03013491|471475877|FG001|Main Study|Termination of the study by Sponsor|0|||
130714071|NCT03096847|470580104|FG001|Overall Study|Physician Decision|2|||
130714072|NCT03096847|470580105|FG002|Overall Study|Physician Decision|8|||
130958410|NCT03013491|471475878|FG002|Main Study|Termination of the study by Sponsor|2|||
130958411|NCT03013491|471475879|FG003|Main Study|Termination of the study by Sponsor|0|||
130958412|NCT03013491|471475880|FG004|Main Study|Termination of the study by Sponsor|1|||
130958413|NCT03013491|471475881|FG005|Main Study|Termination of the study by Sponsor|2|||
130958414|NCT03013491|471475882|FG006|Main Study|Termination of the study by Sponsor|0|||
130958415|NCT03013491|471475883|FG007|Main Study|Termination of the study by Sponsor|0|||
130958416|NCT03013491|471475884|FG008|Main Study|Termination of the study by Sponsor|1|||
130958417|NCT03013491|471475885|FG009|Main Study|Termination of the study by Sponsor|1|||
130958418|NCT03013491|471475886|FG010|Main Study|Termination of the study by Sponsor|1|||
130958419|NCT03013491|471475887|FG011|Main Study|Termination of the study by Sponsor|2|||
130958420|NCT03013491|471475888|FG012|Main Study|Termination of the study by Sponsor|0|||
130958421|NCT03013491|471475889|FG013|Main Study|Termination of the study by Sponsor|0|||
131040243|NCT03672916|471783487|FG000|Overall Study|Death|6|||
131040244|NCT03672916|471783487|FG000|Overall Study|Lost to Follow-up|29|||
131040245|NCT03672916|471783487|FG000|Overall Study|Adverse Event|6|||
131040246|NCT03672916|471783487|FG000|Overall Study|Withdrawal by Subject|11|||
131040247|NCT04141891|471783490|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
131040248|NCT04141891|471783491|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
131040249|NCT04141891|471783490|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
130714073|NCT03096847|470580103|FG000|Overall Study|Withdrawal by Subject|24|||
130714074|NCT03096847|470580104|FG001|Overall Study|Withdrawal by Subject|1|||
130714075|NCT03096847|470580105|FG002|Overall Study|Withdrawal by Subject|12|||
130714076|NCT03096847|470580103|FG000|Overall Study|Adverse Event|72|||
130714077|NCT03096847|470580104|FG001|Overall Study|Adverse Event|6|||
130714078|NCT03096847|470580105|FG002|Overall Study|Adverse Event|28|||
130714079|NCT03096847|470580103|FG000|Overall Study|Progressive disease|97|||
130714080|NCT03096847|470580104|FG001|Overall Study|Progressive disease|10|||
130714081|NCT03096847|470580105|FG002|Overall Study|Progressive disease|78|||
130958422|NCT03013491|471475890|FG014|Main Study|Termination of the study by Sponsor|0|||
130958423|NCT03013491|471475891|FG015|Main Study|Termination of the study by Sponsor|0|||
130958424|NCT03013491|471475892|FG016|Main Study|Termination of the study by Sponsor|0|||
130958425|NCT03013491|471475893|FG017|Main Study|Termination of the study by Sponsor|1|||
130714082|NCT03096847|470580103|FG000|Overall Study|Non-compliance with study medication|1|||
130714083|NCT03096847|470580104|FG001|Overall Study|Non-compliance with study medication|0|||
130714084|NCT03096847|470580105|FG002|Overall Study|Non-compliance with study medication|0|||
130714085|NCT03096847|470580103|FG000|Overall Study|New therapy for study indication|1|||
130714086|NCT03096847|470580104|FG001|Overall Study|New therapy for study indication|0|||
130714087|NCT03096847|470580105|FG002|Overall Study|New therapy for study indication|1|||
130714088|NCT00876018|470580108|FG000|Overall Study|Lost to Follow-up|0|||
130714089|NCT00876018|470580109|FG001|Overall Study|Lost to Follow-up|1|||
130714090|NCT00876018|470580110|FG002|Overall Study|Lost to Follow-up|1|||
130714091|NCT00876018|470580108|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
130714092|NCT00876018|470580109|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
130714093|NCT00876018|470580110|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
130714094|NCT01230892|470580111|FG000|Overall Study|Withdrawal by Subject|1|||
130714095|NCT01230892|470580112|FG001|Overall Study|Withdrawal by Subject|1|||
130714096|NCT01230892|470580111|FG000|Overall Study|Lost to Follow-up|2|||
130714097|NCT01230892|470580112|FG001|Overall Study|Lost to Follow-up|0|||
130714098|NCT00679913|470580113|FG000|Overall Study|Protocol Violation|18|||
130714099|NCT00679913|470580114|FG001|Overall Study|Protocol Violation|13|||
130714100|NCT00725621|470580115|FG000|Overall Study|Adverse Event|25|||
130714101|NCT00725621|470580115|FG000|Overall Study|Lack of Efficacy|46|||
130714102|NCT00725621|470580115|FG000|Overall Study|Withdrawal by Subject|57|||
130714103|NCT00725621|470580115|FG000|Overall Study|Physician Decision|19|||
130774774|NCT03410992|470802563|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130958426|NCT03013491|471475894|FG018|Main Study|Termination of the study by Sponsor|13|||
130958427|NCT03013491|471475876|FG000|Main Study|Withdrawal by Subject|0|||
130958428|NCT03013491|471475877|FG001|Main Study|Withdrawal by Subject|0|||
130958429|NCT03013491|471475878|FG002|Main Study|Withdrawal by Subject|0|||
130958430|NCT03013491|471475879|FG003|Main Study|Withdrawal by Subject|4|||
130958431|NCT03013491|471475880|FG004|Main Study|Withdrawal by Subject|2|||
130958432|NCT03013491|471475881|FG005|Main Study|Withdrawal by Subject|1|||
130958433|NCT03013491|471475882|FG006|Main Study|Withdrawal by Subject|0|||
130958434|NCT03013491|471475883|FG007|Main Study|Withdrawal by Subject|0|||
130958435|NCT03013491|471475884|FG008|Main Study|Withdrawal by Subject|0|||
130958436|NCT03013491|471475885|FG009|Main Study|Withdrawal by Subject|0|||
130958437|NCT03013491|471475886|FG010|Main Study|Withdrawal by Subject|1|||
130958438|NCT03013491|471475887|FG011|Main Study|Withdrawal by Subject|2|||
130958439|NCT03013491|471475888|FG012|Main Study|Withdrawal by Subject|0|||
130958440|NCT03013491|471475889|FG013|Main Study|Withdrawal by Subject|2|||
131040250|NCT04141891|471783491|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
131040251|NCT04141891|471783490|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
131040252|NCT04141891|471783491|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
131040253|NCT04141891|471783490|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
131040254|NCT04141891|471783491|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
131040255|NCT04141891|471783490|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
131040256|NCT04141891|471783491|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
131040257|NCT04141891|471783490|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
131040258|NCT04141891|471783491|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
131040259|NCT04141891|471783490|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
131040260|NCT04141891|471783491|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
131040261|NCT04141891|471783490|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
131040262|NCT04141891|471783491|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
131040263|NCT04141891|471783490|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
131040264|NCT04141891|471783491|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
131040265|NCT04141891|471783490|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
131126939|NCT02116777|472093287|FG006|Overall Study|Death|0|||
130714104|NCT00725621|470580115|FG000|Overall Study|Lost to Follow-up|52|||
130714105|NCT00725621|470580115|FG000|Overall Study|Non-compliance|8|||
130714106|NCT00725621|470580115|FG000|Overall Study|Continued treatment by other physician|6|||
130714107|NCT00725621|470580115|FG000|Overall Study|Switched to other study|1|||
130714108|NCT00725621|470580115|FG000|Overall Study|Switched to other drug|1|||
130714109|NCT00725621|470580115|FG000|Overall Study|Prepared for elective surgery|1|||
130958441|NCT03013491|471475890|FG014|Main Study|Withdrawal by Subject|0|||
130958442|NCT03013491|471475891|FG015|Main Study|Withdrawal by Subject|0|||
130958443|NCT03013491|471475892|FG016|Main Study|Withdrawal by Subject|0|||
130958444|NCT03013491|471475893|FG017|Main Study|Withdrawal by Subject|0|||
130958445|NCT03013491|471475894|FG018|Main Study|Withdrawal by Subject|18|||
130958446|NCT03013491|471475876|FG000|Main Study|Disease progression|0|||
130958447|NCT03013491|471475877|FG001|Main Study|Disease progression|0|||
130958448|NCT03013491|471475878|FG002|Main Study|Disease progression|0|||
130958449|NCT03013491|471475879|FG003|Main Study|Disease progression|1|||
130958450|NCT03013491|471475880|FG004|Main Study|Disease progression|0|||
130958451|NCT03013491|471475881|FG005|Main Study|Disease progression|0|||
130958452|NCT03013491|471475882|FG006|Main Study|Disease progression|0|||
130958453|NCT03013491|471475883|FG007|Main Study|Disease progression|0|||
130958454|NCT03013491|471475884|FG008|Main Study|Disease progression|1|||
130958455|NCT03013491|471475885|FG009|Main Study|Disease progression|0|||
130958456|NCT03013491|471475886|FG010|Main Study|Disease progression|1|||
130958457|NCT03013491|471475887|FG011|Main Study|Disease progression|0|||
130958458|NCT03013491|471475888|FG012|Main Study|Disease progression|0|||
130958459|NCT03013491|471475889|FG013|Main Study|Disease progression|0|||
131126940|NCT02116777|472093281|FG000|Overall Study|Lack of Efficacy|3|||
131126941|NCT02116777|472093282|FG001|Overall Study|Lack of Efficacy|3|||
131126942|NCT02116777|472093283|FG002|Overall Study|Lack of Efficacy|3|||
131126943|NCT02116777|472093284|FG003|Overall Study|Lack of Efficacy|8|||
131126944|NCT02116777|472093285|FG004|Overall Study|Lack of Efficacy|4|||
131126945|NCT02116777|472093286|FG005|Overall Study|Lack of Efficacy|1|||
131126946|NCT02116777|472093287|FG006|Overall Study|Lack of Efficacy|9|||
131126947|NCT02116777|472093281|FG000|Overall Study|Physician Decision|0|||
131126948|NCT02116777|472093282|FG001|Overall Study|Physician Decision|0|||
131126949|NCT02116777|472093283|FG002|Overall Study|Physician Decision|0|||
131126950|NCT02116777|472093284|FG003|Overall Study|Physician Decision|2|||
131126951|NCT02116777|472093285|FG004|Overall Study|Physician Decision|0|||
131126952|NCT02116777|472093286|FG005|Overall Study|Physician Decision|0|||
130958460|NCT03013491|471475890|FG014|Main Study|Disease progression|0|||
130958461|NCT03013491|471475891|FG015|Main Study|Disease progression|0|||
130958462|NCT03013491|471475892|FG016|Main Study|Disease progression|0|||
130958463|NCT03013491|471475893|FG017|Main Study|Disease progression|0|||
130958464|NCT03013491|471475894|FG018|Main Study|Disease progression|4|||
130958465|NCT03013491|471475876|FG000|Main Study|Symptomatic deterioration|0|||
130958466|NCT03013491|471475877|FG001|Main Study|Symptomatic deterioration|0|||
131040266|NCT04141891|471783491|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
131040267|NCT04141891|471783490|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
131040268|NCT04141891|471783491|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
131040269|NCT04141891|471783490|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
131040270|NCT04141891|471783491|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
131040271|NCT04141891|471783490|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
131040272|NCT04141891|471783491|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
131040273|NCT04141891|471783490|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
131040274|NCT04141891|471783491|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
131040275|NCT04737330|471783492|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
131040276|NCT04737330|471783493|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
131040277|NCT04737330|471783492|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
131040278|NCT04737330|471783493|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
131040279|NCT04737330|471783492|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
131040280|NCT04737330|471783493|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
131040281|NCT04737330|471783492|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
131040282|NCT04737330|471783493|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
131040283|NCT04737330|471783492|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
131040284|NCT04737330|471783493|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
131040285|NCT04737330|471783492|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
131040286|NCT04737330|471783493|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
131040287|NCT01651403|471783498|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
131040288|NCT01651403|471783499|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
131040289|NCT01651403|471783498|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
131040290|NCT01651403|471783499|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
131040291|NCT01651403|471783498|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
131040292|NCT01651403|471783499|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
131040293|NCT01651403|471783498|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
131040294|NCT01651403|471783499|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
131040295|NCT01651403|471783498|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
131040296|NCT01651403|471783499|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
131040297|NCT01651403|471783498|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
130714110|NCT00725621|470580115|FG000|Overall Study|Reason not specified|55|||
130714111|NCT01189500|470580116|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
130714112|NCT01189500|470580116|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
130714113|NCT01144364|470580126|FG000|Induction Phase|Disease progression|14|||
130714114|NCT01144364|470580127|FG001|Induction Phase|Disease progression|0|||
130714115|NCT01144364|470580128|FG002|Induction Phase|Disease progression|0|||
130714116|NCT01144364|470580126|FG000|Induction Phase|Adverse Event|9|||
130714117|NCT01144364|470580127|FG001|Induction Phase|Adverse Event|0|||
130714118|NCT01144364|470580128|FG002|Induction Phase|Adverse Event|0|||
130714119|NCT01144364|470580126|FG000|Induction Phase|Death|1|||
130714120|NCT01144364|470580127|FG001|Induction Phase|Death|0|||
130714121|NCT01144364|470580128|FG002|Induction Phase|Death|0|||
130714122|NCT01144364|470580126|FG000|Induction Phase|Withdrawal by Subject|1|||
130714123|NCT01144364|470580127|FG001|Induction Phase|Withdrawal by Subject|0|||
130714124|NCT01144364|470580128|FG002|Induction Phase|Withdrawal by Subject|0|||
130714125|NCT01144364|470580126|FG000|Induction Phase|Lost to Follow-up|2|||
130714126|NCT01144364|470580127|FG001|Induction Phase|Lost to Follow-up|0|||
130714127|NCT01144364|470580128|FG002|Induction Phase|Lost to Follow-up|0|||
130714128|NCT01144364|470580126|FG000|Induction Phase|Physician Decision|1|||
130714129|NCT01144364|470580127|FG001|Induction Phase|Physician Decision|0|||
130714130|NCT01144364|470580128|FG002|Induction Phase|Physician Decision|0|||
130714131|NCT01144364|470580126|FG000|Induction Phase|Stable disease|2|||
130714132|NCT01144364|470580127|FG001|Induction Phase|Stable disease|0|||
130714133|NCT01144364|470580128|FG002|Induction Phase|Stable disease|0|||
130714134|NCT01144364|470580126|FG000|Induction Phase|Secondary neoplasia|1|||
130714135|NCT01144364|470580127|FG001|Induction Phase|Secondary neoplasia|0|||
130714136|NCT01144364|470580128|FG002|Induction Phase|Secondary neoplasia|0|||
130714137|NCT01144364|470580126|FG000|Induction Phase|Protocol Violation|1|||
130714138|NCT01144364|470580127|FG001|Induction Phase|Protocol Violation|0|||
130714139|NCT01144364|470580128|FG002|Induction Phase|Protocol Violation|0|||
130714140|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
130714141|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
130714142|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
130714143|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
130714144|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
130714145|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
130714146|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Death|0|||
130714147|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Death|2|||
130714148|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Death|0|||
130714149|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
130714150|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
130714151|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
130714152|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
130714153|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
130714154|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
130714155|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
130714156|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
130958467|NCT03013491|471475878|FG002|Main Study|Symptomatic deterioration|0|||
130958468|NCT03013491|471475879|FG003|Main Study|Symptomatic deterioration|0|||
130958469|NCT03013491|471475880|FG004|Main Study|Symptomatic deterioration|0|||
130958470|NCT03013491|471475881|FG005|Main Study|Symptomatic deterioration|1|||
130958471|NCT03013491|471475882|FG006|Main Study|Symptomatic deterioration|0|||
130958472|NCT03013491|471475883|FG007|Main Study|Symptomatic deterioration|0|||
130958473|NCT03013491|471475884|FG008|Main Study|Symptomatic deterioration|0|||
130958474|NCT03013491|471475885|FG009|Main Study|Symptomatic deterioration|0|||
130958475|NCT03013491|471475886|FG010|Main Study|Symptomatic deterioration|0|||
130958476|NCT03013491|471475887|FG011|Main Study|Symptomatic deterioration|0|||
130958477|NCT03013491|471475888|FG012|Main Study|Symptomatic deterioration|0|||
130958478|NCT03013491|471475889|FG013|Main Study|Symptomatic deterioration|0|||
130958479|NCT03013491|471475890|FG014|Main Study|Symptomatic deterioration|0|||
130958480|NCT03013491|471475891|FG015|Main Study|Symptomatic deterioration|0|||
131040298|NCT01651403|471783499|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
130714157|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
130714158|NCT01144364|470580126|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
131040299|NCT04231149|471785272|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
130714159|NCT01144364|470580127|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
130774775|NCT03410992|470802564|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130958481|NCT03013491|471475892|FG016|Main Study|Symptomatic deterioration|0|||
130958482|NCT03013491|471475893|FG017|Main Study|Symptomatic deterioration|0|||
131040300|NCT04231149|471785273|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
130714160|NCT01144364|470580128|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
130714161|NCT01301508|470580131|FG000|Overall Study|Withdrawal by Subject|1|||
130714162|NCT01301508|470580132|FG001|Overall Study|Withdrawal by Subject|2|||
130714163|NCT01301508|470580131|FG000|Overall Study|Lost to Follow-up|0|||
130958483|NCT03013491|471475894|FG018|Main Study|Symptomatic deterioration|0|||
131226257|NCT00078819|472455715|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
131226258|NCT00078819|472455716|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
131226259|NCT00078819|472455713|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
131226260|NCT00078819|472455714|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
131226261|NCT00078819|472455715|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
131226262|NCT00078819|472455716|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
131226263|NCT00323609|472455717|FG000|Overall Study|Death|16|||
131226264|NCT00323609|472455718|FG001|Overall Study|Death|21|||
131226265|NCT00323609|472455719|FG002|Overall Study|Death|0|||
131226266|NCT00323609|472455720|FG003|Overall Study|Death|0|||
131226267|NCT00323609|472455717|FG000|Overall Study|Lost to Follow-up|9|||
131226268|NCT00323609|472455718|FG001|Overall Study|Lost to Follow-up|10|||
131226269|NCT00323609|472455719|FG002|Overall Study|Lost to Follow-up|0|||
131226270|NCT00323609|472455720|FG003|Overall Study|Lost to Follow-up|0|||
131226271|NCT00323609|472455717|FG000|Overall Study|Physician Decision|2|||
131226272|NCT00323609|472455718|FG001|Overall Study|Physician Decision|0|||
131226273|NCT00323609|472455719|FG002|Overall Study|Physician Decision|0|||
131226274|NCT00323609|472455720|FG003|Overall Study|Physician Decision|1|||
131226275|NCT00323609|472455717|FG000|Overall Study|Withdrawal by Subject|11|||
131226276|NCT00323609|472455718|FG001|Overall Study|Withdrawal by Subject|23|||
131226277|NCT00323609|472455719|FG002|Overall Study|Withdrawal by Subject|4|||
131226278|NCT00323609|472455720|FG003|Overall Study|Withdrawal by Subject|4|||
131226279|NCT00323609|472455717|FG000|Overall Study|Other non-VCF-related medical condition|3|||
131226280|NCT00323609|472455718|FG001|Overall Study|Other non-VCF-related medical condition|2|||
131226281|NCT00323609|472455719|FG002|Overall Study|Other non-VCF-related medical condition|0|||
131226282|NCT00323609|472455720|FG003|Overall Study|Other non-VCF-related medical condition|0|||
131226283|NCT00323609|472455717|FG000|Overall Study|Sponsor discontinued trial|29|||
131226284|NCT00323609|472455718|FG001|Overall Study|Sponsor discontinued trial|29|||
131226285|NCT00323609|472455719|FG002|Overall Study|Sponsor discontinued trial|0|||
131226286|NCT00323609|472455720|FG003|Overall Study|Sponsor discontinued trial|0|||
131226287|NCT00323609|472455717|FG000|Overall Study|Unrelenting or severe back pain|1|||
131226288|NCT00323609|472455718|FG001|Overall Study|Unrelenting or severe back pain|1|||
131226289|NCT00323609|472455719|FG002|Overall Study|Unrelenting or severe back pain|0|||
131226290|NCT00323609|472455720|FG003|Overall Study|Unrelenting or severe back pain|0|||
131226291|NCT00323609|472455717|FG000|Overall Study|Logistical withdrawal|9|||
131226292|NCT00323609|472455718|FG001|Overall Study|Logistical withdrawal|5|||
131226293|NCT00323609|472455719|FG002|Overall Study|Logistical withdrawal|0|||
131226294|NCT00323609|472455720|FG003|Overall Study|Logistical withdrawal|1|||
130714164|NCT01301508|470580132|FG001|Overall Study|Lost to Follow-up|1|||
130714165|NCT01940497|470580133|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
130714166|NCT01940497|470580134|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
130714167|NCT01940497|470580133|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
130714168|NCT01940497|470580134|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
130714169|NCT01940497|470580133|FG000|Overall Study|Violation of Entry Criteria|1|||
130958484|NCT03013491|471475876|FG000|Main Study|Protocol version 8.0 approval|0|||
130958485|NCT03013491|471475877|FG001|Main Study|Protocol version 8.0 approval|0|||
130958486|NCT03013491|471475878|FG002|Main Study|Protocol version 8.0 approval|0|||
130958487|NCT03013491|471475879|FG003|Main Study|Protocol version 8.0 approval|0|||
130958488|NCT03013491|471475880|FG004|Main Study|Protocol version 8.0 approval|0|||
130958489|NCT03013491|471475881|FG005|Main Study|Protocol version 8.0 approval|0|||
130958490|NCT03013491|471475882|FG006|Main Study|Protocol version 8.0 approval|0|||
130958491|NCT03013491|471475883|FG007|Main Study|Protocol version 8.0 approval|0|||
130958492|NCT03013491|471475884|FG008|Main Study|Protocol version 8.0 approval|0|||
130958493|NCT03013491|471475885|FG009|Main Study|Protocol version 8.0 approval|0|||
130958494|NCT03013491|471475886|FG010|Main Study|Protocol version 8.0 approval|1|||
130958495|NCT03013491|471475887|FG011|Main Study|Protocol version 8.0 approval|0|||
130958496|NCT03013491|471475888|FG012|Main Study|Protocol version 8.0 approval|0|||
130958497|NCT03013491|471475889|FG013|Main Study|Protocol version 8.0 approval|0|||
130958498|NCT03013491|471475890|FG014|Main Study|Protocol version 8.0 approval|0|||
130958499|NCT03013491|471475891|FG015|Main Study|Protocol version 8.0 approval|0|||
130958500|NCT03013491|471475892|FG016|Main Study|Protocol version 8.0 approval|0|||
130958501|NCT03013491|471475893|FG017|Main Study|Protocol version 8.0 approval|0|||
130958502|NCT03013491|471475894|FG018|Main Study|Protocol version 8.0 approval|0|||
130958503|NCT03013491|471475876|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
130958504|NCT03013491|471475877|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
130958505|NCT03013491|471475878|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
130958506|NCT03013491|471475879|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
130958507|NCT03013491|471475880|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
131226295|NCT00323609|472455717|FG000|Overall Study|Other reason|11|||
131226296|NCT00323609|472455718|FG001|Overall Study|Other reason|8|||
131226297|NCT00323609|472455719|FG002|Overall Study|Other reason|4|||
131226298|NCT00323609|472455720|FG003|Overall Study|Other reason|9|||
131226299|NCT00950599|472455724|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130958508|NCT03013491|471475881|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
130958509|NCT03013491|471475882|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
130958510|NCT03013491|471475883|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
130958511|NCT03013491|471475884|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
130958512|NCT03013491|471475885|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
130958513|NCT03013491|471475886|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
130958514|NCT03013491|471475887|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
130958515|NCT03013491|471475888|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
130958516|NCT03013491|471475889|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
131040301|NCT04231149|471785274|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
131040302|NCT04231149|471785275|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
131040303|NCT04231149|471785276|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
131040304|NCT05877976|471785277|FG000|Overall Study|Lost to Follow-up|31|||
131040305|NCT05622812|471785278|FG000|Overall Study|Withdrawal by Subject|1|||
131040306|NCT05622812|471785279|FG001|Overall Study|Withdrawal by Subject|4|||
131040307|NCT05622812|471785278|FG000|Overall Study|Lost to Follow-up|2|||
131040308|NCT05622812|471785279|FG001|Overall Study|Lost to Follow-up|1|||
131040309|NCT03916185|471785280|FG000|Overall Study|Lost to Follow-up|0|||
131040310|NCT03916185|471785281|FG001|Overall Study|Lost to Follow-up|1|||
131040311|NCT03916185|471785282|FG002|Overall Study|Lost to Follow-up|0|||
131040312|NCT03916185|471785283|FG003|Overall Study|Lost to Follow-up|0|||
131040313|NCT03916185|471785280|FG000|Overall Study|Moved|1|||
131040314|NCT03916185|471785281|FG001|Overall Study|Moved|0|||
131040315|NCT03916185|471785282|FG002|Overall Study|Moved|0|||
131040316|NCT03916185|471785283|FG003|Overall Study|Moved|1|||
131040317|NCT03916185|471785280|FG000|Overall Study|Not Able to Get to Clinic|1|||
131040318|NCT03916185|471785281|FG001|Overall Study|Not Able to Get to Clinic|0|||
131040319|NCT03916185|471785282|FG002|Overall Study|Not Able to Get to Clinic|0|||
131040320|NCT03916185|471785283|FG003|Overall Study|Not Able to Get to Clinic|0|||
131040321|NCT02844465|471785285|FG000|Overall Study|Screen Failure|36|||
131040322|NCT02844465|471785285|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
131040323|NCT02844465|471785285|FG000|Overall Study|Withdrawal by Subject|5|||
131040324|NCT02844465|471785285|FG000|Overall Study|Lost to Follow-up|1|||
131040325|NCT02844465|471785285|FG000|Overall Study|Retreatment|1|||
131040326|NCT05671653|471785286|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
131040327|NCT05671653|471785287|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
131040328|NCT05671653|471785288|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
131040329|NCT05671653|471785289|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
131040330|NCT05671653|471785290|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
131040331|NCT05671653|471785291|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
131040332|NCT05671653|471785292|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
131040333|NCT05671653|471785293|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
131040334|NCT05671653|471785294|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
131040335|NCT05671653|471785295|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
131040336|NCT05671653|471785296|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
131040337|NCT05671653|471785297|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
131040338|NCT05671653|471785298|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
131040339|NCT05671653|471785286|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040340|NCT05671653|471785287|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040341|NCT05671653|471785288|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040342|NCT05671653|471785289|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040343|NCT05671653|471785290|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040344|NCT05671653|471785291|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
131040345|NCT05671653|471785292|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040346|NCT05671653|471785293|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040347|NCT05671653|471785294|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040348|NCT05671653|471785295|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040349|NCT05671653|471785296|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040350|NCT05671653|471785297|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040351|NCT05671653|471785298|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
131040352|NCT05671653|471785286|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040353|NCT05671653|471785287|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040354|NCT05671653|471785288|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040355|NCT05671653|471785289|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040356|NCT05671653|471785290|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040357|NCT05671653|471785291|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
131040358|NCT05671653|471785292|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040359|NCT05671653|471785293|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040360|NCT05671653|471785294|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040361|NCT05671653|471785295|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040362|NCT05671653|471785296|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131126953|NCT02116777|472093287|FG006|Overall Study|Physician Decision|0|||
130714170|NCT01940497|470580134|FG001|Overall Study|Violation of Entry Criteria|1|||
130714171|NCT01940497|470580133|FG000|Overall Study|Refused Treatment|1|||
130714172|NCT01940497|470580134|FG001|Overall Study|Refused Treatment|3|||
130714173|NCT01940497|470580133|FG000|Overall Study|Withdrew Consent|6|||
130774776|NCT03410992|470802565|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130774777|NCT03410992|470802566|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130774778|NCT03410992|470802567|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130774779|NCT03410992|470802568|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130714174|NCT01940497|470580134|FG001|Overall Study|Withdrew Consent|2|||
130714175|NCT01940497|470580133|FG000|Overall Study|Administrative/Other|1|||
130714176|NCT01940497|470580134|FG001|Overall Study|Administrative/Other|1|||
130714177|NCT02707861|470580135|FG000|Overall Study|Went onto commercial drug|30|||
130714178|NCT02707861|470580136|FG001|Overall Study|Went onto commercial drug|23|||
130714179|NCT02707861|470580135|FG000|Overall Study|Adverse Event|2|||
130714180|NCT02707861|470580136|FG001|Overall Study|Adverse Event|3|||
130714181|NCT02707861|470580135|FG000|Overall Study|Death|5|||
130714182|NCT02707861|470580136|FG001|Overall Study|Death|2|||
130714183|NCT02707861|470580135|FG000|Overall Study|Lack of Efficacy|0|||
130714184|NCT02707861|470580136|FG001|Overall Study|Lack of Efficacy|2|||
130714185|NCT02707861|470580135|FG000|Overall Study|Physician Decision|1|||
130714186|NCT02707861|470580136|FG001|Overall Study|Physician Decision|4|||
130714187|NCT02707861|470580135|FG000|Overall Study|Withdrawal by Subject|2|||
130714188|NCT02707861|470580136|FG001|Overall Study|Withdrawal by Subject|1|||
130714189|NCT02707861|470580135|FG000|Overall Study|Lost to Follow-up|1|||
130714190|NCT02707861|470580136|FG001|Overall Study|Lost to Follow-up|3|||
130714191|NCT03123861|470580137|FG000|Overall Study|Protocol Violation|1|||
130714192|NCT03123861|470580138|FG001|Overall Study|Protocol Violation|1|||
130714193|NCT03123861|470580137|FG000|Overall Study|Withdrawal by Subject|2|||
130714194|NCT03123861|470580138|FG001|Overall Study|Withdrawal by Subject|2|||
130714195|NCT02206620|470580139|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
130714196|NCT02206620|470580140|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
130714197|NCT02206620|470580139|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
130714198|NCT02206620|470580140|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
130714199|NCT03188666|470581644|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
130714200|NCT03188666|470581645|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
130714201|NCT03188666|470581646|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
130714202|NCT03188666|470581647|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
130714203|NCT03188666|470581644|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
130714204|NCT03188666|470581645|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
130714205|NCT03188666|470581646|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
130714206|NCT03188666|470581647|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
130714207|NCT03188666|470581644|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
130714208|NCT03188666|470581645|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
130714209|NCT03188666|470581646|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
130714210|NCT03188666|470581647|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
130714211|NCT03188666|470581644|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
130714212|NCT03188666|470581645|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
130714213|NCT03188666|470581646|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
130714214|NCT03188666|470581647|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
130714215|NCT03696953|470581648|FG000|Overall Study|Withdrawal by Subject|6|||
130714216|NCT03696953|470581649|FG001|Overall Study|Withdrawal by Subject|1|||
130714217|NCT03696953|470581648|FG000|Overall Study|missed GBS swabs|2|||
130714218|NCT03696953|470581649|FG001|Overall Study|missed GBS swabs|2|||
130714219|NCT03696953|470581648|FG000|Overall Study|lost study bottle containing capsules|2|||
130714220|NCT03696953|470581649|FG001|Overall Study|lost study bottle containing capsules|0|||
130714221|NCT03696953|470581648|FG000|Overall Study|Premature birth|1|||
130714222|NCT03696953|470581649|FG001|Overall Study|Premature birth|4|||
130714223|NCT03696953|470581648|FG000|Overall Study|Gestational hypertension|1|||
130774780|NCT03410992|470802569|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130774781|NCT03410992|470802559|FG000|Week 16 Assessment|Incorrect escapers|0|||
130774782|NCT03410992|470802560|FG001|Week 16 Assessment|Incorrect escapers|6|||
130774783|NCT03410992|470802561|FG002|Week 16 Assessment|Incorrect escapers|0|||
130774784|NCT03410992|470802562|FG003|Week 16 Assessment|Incorrect escapers|0|||
130774785|NCT03410992|470802563|FG004|Week 16 Assessment|Incorrect escapers|0|||
130958517|NCT03013491|471475890|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
130958518|NCT03013491|471475891|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
130958519|NCT03013491|471475892|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
130714224|NCT03696953|470581649|FG001|Overall Study|Gestational hypertension|1|||
130714225|NCT03696953|470581648|FG000|Overall Study|Gestational diabetes|2|||
130714226|NCT03696953|470581649|FG001|Overall Study|Gestational diabetes|1|||
130774786|NCT03410992|470802564|FG005|Week 16 Assessment|Incorrect escapers|0|||
130774787|NCT03410992|470802565|FG006|Week 16 Assessment|Incorrect escapers|0|||
130958520|NCT03013491|471475893|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
131126954|NCT02116777|472093281|FG000|Overall Study|Protocol Violation|0|||
131126955|NCT02116777|472093282|FG001|Overall Study|Protocol Violation|0|||
131126956|NCT02116777|472093283|FG002|Overall Study|Protocol Violation|0|||
131126957|NCT02116777|472093284|FG003|Overall Study|Protocol Violation|1|||
131126958|NCT02116777|472093285|FG004|Overall Study|Protocol Violation|0|||
131126959|NCT02116777|472093286|FG005|Overall Study|Protocol Violation|0|||
131126960|NCT02116777|472093287|FG006|Overall Study|Protocol Violation|0|||
131126961|NCT02116777|472093281|FG000|Overall Study|Withdrawal by Subject|0|||
131126962|NCT02116777|472093282|FG001|Overall Study|Withdrawal by Subject|0|||
131126963|NCT02116777|472093283|FG002|Overall Study|Withdrawal by Subject|0|||
131126964|NCT02116777|472093284|FG003|Overall Study|Withdrawal by Subject|1|||
131126965|NCT02116777|472093285|FG004|Overall Study|Withdrawal by Subject|0|||
131126966|NCT02116777|472093286|FG005|Overall Study|Withdrawal by Subject|0|||
131126967|NCT02116777|472093287|FG006|Overall Study|Withdrawal by Subject|0|||
131126968|NCT00733954|472093288|FG000|Overall Study|Lost to Follow-up|5|||
130714227|NCT03696953|470581648|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
130714228|NCT03696953|470581649|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
130714229|NCT03696953|470581648|FG000|Overall Study|Changed prenatal provider|1|||
130714230|NCT03696953|470581649|FG001|Overall Study|Changed prenatal provider|1|||
130714231|NCT03502707|470581650|FG000|Overall Study|Adverse Event|0|||
130714232|NCT03502707|470581651|FG001|Overall Study|Adverse Event|0|||
130714233|NCT03502707|470581652|FG002|Overall Study|Adverse Event|0|||
130714234|NCT03502707|470581653|FG003|Overall Study|Adverse Event|0|||
130714235|NCT03502707|470581654|FG004|Overall Study|Adverse Event|0|||
130714236|NCT03502707|470581655|FG005|Overall Study|Adverse Event|0|||
130714237|NCT03502707|470581656|FG006|Overall Study|Adverse Event|0|||
130714238|NCT03502707|470581657|FG007|Overall Study|Adverse Event|0|||
130714239|NCT03502707|470581658|FG008|Overall Study|Adverse Event|0|||
130714240|NCT03502707|470581659|FG009|Overall Study|Adverse Event|0|||
130714241|NCT03502707|470581660|FG010|Overall Study|Adverse Event|0|||
130714242|NCT03502707|470581661|FG011|Overall Study|Adverse Event|0|||
130714243|NCT03502707|470581662|FG012|Overall Study|Adverse Event|0|||
130714244|NCT03502707|470581663|FG013|Overall Study|Adverse Event|0|||
130714245|NCT03502707|470581664|FG014|Overall Study|Adverse Event|0|||
130714246|NCT03502707|470581665|FG015|Overall Study|Adverse Event|1|||
130714247|NCT03502707|470581666|FG016|Overall Study|Adverse Event|5|||
130714248|NCT03502707|470581667|FG017|Overall Study|Adverse Event|0|||
130958521|NCT03013491|471475894|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
130958522|NCT03013491|471475876|FG000|Main Study|Start of new anticancer therapy|0|||
130958523|NCT03013491|471475877|FG001|Main Study|Start of new anticancer therapy|0|||
130958524|NCT03013491|471475878|FG002|Main Study|Start of new anticancer therapy|0|||
130958525|NCT03013491|471475879|FG003|Main Study|Start of new anticancer therapy|0|||
130958526|NCT03013491|471475880|FG004|Main Study|Start of new anticancer therapy|0|||
130958527|NCT03013491|471475881|FG005|Main Study|Start of new anticancer therapy|0|||
130958528|NCT03013491|471475882|FG006|Main Study|Start of new anticancer therapy|0|||
130958529|NCT03013491|471475883|FG007|Main Study|Start of new anticancer therapy|0|||
130958530|NCT03013491|471475884|FG008|Main Study|Start of new anticancer therapy|0|||
130958531|NCT03013491|471475885|FG009|Main Study|Start of new anticancer therapy|0|||
130958532|NCT03013491|471475886|FG010|Main Study|Start of new anticancer therapy|0|||
130958533|NCT03013491|471475887|FG011|Main Study|Start of new anticancer therapy|0|||
130958534|NCT03013491|471475888|FG012|Main Study|Start of new anticancer therapy|0|||
130958535|NCT03013491|471475889|FG013|Main Study|Start of new anticancer therapy|0|||
130958536|NCT03013491|471475890|FG014|Main Study|Start of new anticancer therapy|0|||
130958537|NCT03013491|471475891|FG015|Main Study|Start of new anticancer therapy|0|||
130958538|NCT03013491|471475892|FG016|Main Study|Start of new anticancer therapy|0|||
130958539|NCT03013491|471475893|FG017|Main Study|Start of new anticancer therapy|0|||
130958540|NCT03013491|471475894|FG018|Main Study|Start of new anticancer therapy|2|||
130958541|NCT03013491|471475876|FG000|Long-term Extension|Disease progression|0|||
130958542|NCT03013491|471475877|FG001|Long-term Extension|Disease progression|0|||
130958543|NCT03013491|471475878|FG002|Long-term Extension|Disease progression|0|||
130958544|NCT03013491|471475879|FG003|Long-term Extension|Disease progression|1|||
130958545|NCT03013491|471475880|FG004|Long-term Extension|Disease progression|0|||
130958546|NCT03013491|471475881|FG005|Long-term Extension|Disease progression|0|||
130958547|NCT03013491|471475882|FG006|Long-term Extension|Disease progression|0|||
130958548|NCT03013491|471475883|FG007|Long-term Extension|Disease progression|0|||
130958549|NCT03013491|471475884|FG008|Long-term Extension|Disease progression|0|||
130958550|NCT03013491|471475885|FG009|Long-term Extension|Disease progression|0|||
130958551|NCT03013491|471475886|FG010|Long-term Extension|Disease progression|0|||
130958552|NCT03013491|471475887|FG011|Long-term Extension|Disease progression|0|||
130958553|NCT03013491|471475888|FG012|Long-term Extension|Disease progression|0|||
130958554|NCT03013491|471475889|FG013|Long-term Extension|Disease progression|0|||
130958555|NCT03013491|471475890|FG014|Long-term Extension|Disease progression|0|||
130958556|NCT03013491|471475891|FG015|Long-term Extension|Disease progression|0|||
130958557|NCT03013491|471475892|FG016|Long-term Extension|Disease progression|0|||
130958558|NCT03013491|471475893|FG017|Long-term Extension|Disease progression|0|||
130958559|NCT03013491|471475894|FG018|Long-term Extension|Disease progression|1|||
130958560|NCT03013491|471475876|FG000|Long-term Extension|Withdrawal by Subject|0|||
130958561|NCT03013491|471475877|FG001|Long-term Extension|Withdrawal by Subject|0|||
130958562|NCT03013491|471475878|FG002|Long-term Extension|Withdrawal by Subject|0|||
130958563|NCT03013491|471475879|FG003|Long-term Extension|Withdrawal by Subject|0|||
130958564|NCT03013491|471475880|FG004|Long-term Extension|Withdrawal by Subject|0|||
130958565|NCT03013491|471475881|FG005|Long-term Extension|Withdrawal by Subject|0|||
130958566|NCT03013491|471475882|FG006|Long-term Extension|Withdrawal by Subject|0|||
130958567|NCT03013491|471475883|FG007|Long-term Extension|Withdrawal by Subject|1|||
130958568|NCT03013491|471475884|FG008|Long-term Extension|Withdrawal by Subject|0|||
130958569|NCT03013491|471475885|FG009|Long-term Extension|Withdrawal by Subject|0|||
130714249|NCT03502707|470581650|FG000|Overall Study|Death|0|||
130714250|NCT03502707|470581651|FG001|Overall Study|Death|0|||
130958570|NCT03013491|471475886|FG010|Long-term Extension|Withdrawal by Subject|0|||
130958571|NCT03013491|471475887|FG011|Long-term Extension|Withdrawal by Subject|0|||
130958572|NCT03013491|471475888|FG012|Long-term Extension|Withdrawal by Subject|0|||
130958573|NCT03013491|471475889|FG013|Long-term Extension|Withdrawal by Subject|0|||
130958574|NCT03013491|471475890|FG014|Long-term Extension|Withdrawal by Subject|0|||
130958575|NCT03013491|471475891|FG015|Long-term Extension|Withdrawal by Subject|0|||
130958576|NCT03013491|471475892|FG016|Long-term Extension|Withdrawal by Subject|0|||
130958577|NCT03013491|471475893|FG017|Long-term Extension|Withdrawal by Subject|0|||
130958578|NCT03013491|471475894|FG018|Long-term Extension|Withdrawal by Subject|0|||
130958579|NCT03013491|471475876|FG000|Long-term Extension|Adverse Event|0|||
130958580|NCT03013491|471475877|FG001|Long-term Extension|Adverse Event|0|||
130958581|NCT03013491|471475878|FG002|Long-term Extension|Adverse Event|0|||
130958582|NCT03013491|471475879|FG003|Long-term Extension|Adverse Event|0|||
130958583|NCT03013491|471475880|FG004|Long-term Extension|Adverse Event|0|||
130958584|NCT03013491|471475881|FG005|Long-term Extension|Adverse Event|0|||
130958585|NCT03013491|471475882|FG006|Long-term Extension|Adverse Event|0|||
130958586|NCT03013491|471475883|FG007|Long-term Extension|Adverse Event|0|||
130958587|NCT03013491|471475884|FG008|Long-term Extension|Adverse Event|0|||
130958588|NCT03013491|471475885|FG009|Long-term Extension|Adverse Event|0|||
130958589|NCT03013491|471475886|FG010|Long-term Extension|Adverse Event|0|||
130958590|NCT03013491|471475887|FG011|Long-term Extension|Adverse Event|0|||
130958591|NCT03013491|471475888|FG012|Long-term Extension|Adverse Event|0|||
130958592|NCT03013491|471475889|FG013|Long-term Extension|Adverse Event|0|||
130958593|NCT03013491|471475890|FG014|Long-term Extension|Adverse Event|0|||
130958594|NCT03013491|471475891|FG015|Long-term Extension|Adverse Event|0|||
130958595|NCT03013491|471475892|FG016|Long-term Extension|Adverse Event|0|||
130958596|NCT03013491|471475893|FG017|Long-term Extension|Adverse Event|0|||
130958597|NCT03013491|471475894|FG018|Long-term Extension|Adverse Event|1|||
130958598|NCT03013491|471475876|FG000|Long-term Extension|Death|0|||
130958599|NCT03013491|471475877|FG001|Long-term Extension|Death|0|||
130958600|NCT03013491|471475878|FG002|Long-term Extension|Death|0|||
130958601|NCT03013491|471475879|FG003|Long-term Extension|Death|0|||
130958602|NCT03013491|471475880|FG004|Long-term Extension|Death|0|||
130958603|NCT03013491|471475881|FG005|Long-term Extension|Death|0|||
130958604|NCT03013491|471475882|FG006|Long-term Extension|Death|0|||
131040363|NCT05671653|471785297|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040364|NCT05671653|471785298|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
131040365|NCT05671653|471785286|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040366|NCT05671653|471785287|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040367|NCT05671653|471785288|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040368|NCT05671653|471785289|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040369|NCT05671653|471785290|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040370|NCT05671653|471785291|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040371|NCT05671653|471785292|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040372|NCT05671653|471785293|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040373|NCT05671653|471785294|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
131040374|NCT05671653|471785295|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040375|NCT05671653|471785296|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040376|NCT05671653|471785297|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040377|NCT05671653|471785298|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
131040378|NCT05671653|471785286|FG000|Cohort 2 Period 2|Adverse Event|0|||
131040379|NCT05671653|471785287|FG001|Cohort 2 Period 2|Adverse Event|0|||
131040380|NCT05671653|471785288|FG002|Cohort 2 Period 2|Adverse Event|0|||
131040381|NCT05671653|471785289|FG003|Cohort 2 Period 2|Adverse Event|0|||
131040382|NCT05671653|471785290|FG004|Cohort 2 Period 2|Adverse Event|0|||
131040383|NCT05671653|471785291|FG005|Cohort 2 Period 2|Adverse Event|0|||
131040384|NCT05671653|471785292|FG006|Cohort 2 Period 2|Adverse Event|0|||
130958605|NCT03013491|471475883|FG007|Long-term Extension|Death|0|||
130958606|NCT03013491|471475884|FG008|Long-term Extension|Death|0|||
130958607|NCT03013491|471475885|FG009|Long-term Extension|Death|0|||
130958608|NCT03013491|471475886|FG010|Long-term Extension|Death|0|||
130958609|NCT03013491|471475887|FG011|Long-term Extension|Death|0|||
130958610|NCT03013491|471475888|FG012|Long-term Extension|Death|0|||
131040385|NCT05671653|471785293|FG007|Cohort 2 Period 2|Adverse Event|0|||
131040386|NCT05671653|471785294|FG008|Cohort 2 Period 2|Adverse Event|0|||
131040387|NCT05671653|471785295|FG009|Cohort 2 Period 2|Adverse Event|0|||
130958611|NCT03013491|471475889|FG013|Long-term Extension|Death|0|||
130958612|NCT03013491|471475890|FG014|Long-term Extension|Death|0|||
130958613|NCT03013491|471475891|FG015|Long-term Extension|Death|0|||
130958614|NCT03013491|471475892|FG016|Long-term Extension|Death|0|||
130958615|NCT03013491|471475893|FG017|Long-term Extension|Death|0|||
130958616|NCT03013491|471475894|FG018|Long-term Extension|Death|1|||
130958617|NCT01038778|471475900|FG000|Overall Study|Withdrawal by Subject|0|||
130958618|NCT01038778|471475901|FG001|Overall Study|Withdrawal by Subject|2|||
130958619|NCT01038778|471475902|FG002|Overall Study|Withdrawal by Subject|3|||
130958620|NCT04740034|471475903|FG000|Overall Study|Death|0|||
130958621|NCT04740034|471475904|FG001|Overall Study|Death|1|||
130958622|NCT04740034|471475905|FG002|Overall Study|Death|2|||
130958623|NCT04740034|471475906|FG003|Overall Study|Death|3|||
130958624|NCT04740034|471475907|FG004|Overall Study|Death|4|||
130958625|NCT04740034|471475908|FG005|Overall Study|Death|4|||
130958626|NCT04740034|471475909|FG006|Overall Study|Death|2|||
130958627|NCT04740034|471475910|FG007|Overall Study|Death|2|||
130958628|NCT04740034|471475911|FG008|Overall Study|Death|2|||
130958629|NCT04740034|471475912|FG009|Overall Study|Death|4|||
130958630|NCT04740034|471475913|FG010|Overall Study|Death|0|||
130958631|NCT04740034|471475903|FG000|Overall Study|Lost to Follow-up|0|||
130958632|NCT04740034|471475904|FG001|Overall Study|Lost to Follow-up|0|||
130958633|NCT04740034|471475905|FG002|Overall Study|Lost to Follow-up|0|||
130958634|NCT04740034|471475906|FG003|Overall Study|Lost to Follow-up|1|||
130958635|NCT04740034|471475907|FG004|Overall Study|Lost to Follow-up|2|||
130958636|NCT04740034|471475908|FG005|Overall Study|Lost to Follow-up|2|||
130958637|NCT04740034|471475909|FG006|Overall Study|Lost to Follow-up|0|||
130958638|NCT04740034|471475910|FG007|Overall Study|Lost to Follow-up|0|||
130958639|NCT04740034|471475911|FG008|Overall Study|Lost to Follow-up|0|||
130958640|NCT04740034|471475912|FG009|Overall Study|Lost to Follow-up|1|||
130714251|NCT03502707|470581652|FG002|Overall Study|Death|0|||
130714252|NCT03502707|470581653|FG003|Overall Study|Death|1|||
130714253|NCT03502707|470581654|FG004|Overall Study|Death|0|||
130714254|NCT03502707|470581655|FG005|Overall Study|Death|0|||
130714255|NCT03502707|470581656|FG006|Overall Study|Death|0|||
130714256|NCT03502707|470581657|FG007|Overall Study|Death|0|||
130714257|NCT03502707|470581658|FG008|Overall Study|Death|1|||
130714258|NCT03502707|470581659|FG009|Overall Study|Death|1|||
130714259|NCT03502707|470581660|FG010|Overall Study|Death|0|||
130958641|NCT04740034|471475913|FG010|Overall Study|Lost to Follow-up|0|||
130958642|NCT04740034|471475903|FG000|Overall Study|Withdrawal by Subject|1|||
130958643|NCT04740034|471475904|FG001|Overall Study|Withdrawal by Subject|0|||
130958644|NCT04740034|471475905|FG002|Overall Study|Withdrawal by Subject|0|||
130958645|NCT04740034|471475906|FG003|Overall Study|Withdrawal by Subject|0|||
130958646|NCT04740034|471475907|FG004|Overall Study|Withdrawal by Subject|0|||
130958647|NCT04740034|471475908|FG005|Overall Study|Withdrawal by Subject|0|||
130958648|NCT04740034|471475909|FG006|Overall Study|Withdrawal by Subject|0|||
130958649|NCT04740034|471475910|FG007|Overall Study|Withdrawal by Subject|1|||
130958650|NCT04740034|471475911|FG008|Overall Study|Withdrawal by Subject|0|||
130958651|NCT04740034|471475912|FG009|Overall Study|Withdrawal by Subject|1|||
130958652|NCT04740034|471475913|FG010|Overall Study|Withdrawal by Subject|0|||
130958653|NCT04740034|471475903|FG000|Overall Study|Decision by sponsor|0|||
130958654|NCT04740034|471475904|FG001|Overall Study|Decision by sponsor|0|||
130958655|NCT04740034|471475905|FG002|Overall Study|Decision by sponsor|1|||
130958656|NCT04740034|471475906|FG003|Overall Study|Decision by sponsor|0|||
130958657|NCT04740034|471475907|FG004|Overall Study|Decision by sponsor|0|||
130958658|NCT04740034|471475908|FG005|Overall Study|Decision by sponsor|0|||
130958659|NCT04740034|471475909|FG006|Overall Study|Decision by sponsor|1|||
130958660|NCT04740034|471475910|FG007|Overall Study|Decision by sponsor|2|||
130958661|NCT04740034|471475911|FG008|Overall Study|Decision by sponsor|1|||
130958662|NCT04740034|471475912|FG009|Overall Study|Decision by sponsor|1|||
130958663|NCT04740034|471475913|FG010|Overall Study|Decision by sponsor|2|||
130958664|NCT03285646|471477524|FG000|Overall Study|Adverse Event|1|||
130958665|NCT03285646|471477525|FG001|Overall Study|Adverse Event|0|||
130958666|NCT03285646|471477524|FG000|Overall Study|Withdrawal by Subject|10|||
130958667|NCT03285646|471477525|FG001|Overall Study|Withdrawal by Subject|2|||
130958668|NCT03285646|471477524|FG000|Overall Study|Lost to Follow-up|2|||
130958669|NCT03285646|471477525|FG001|Overall Study|Lost to Follow-up|1|||
130958670|NCT03285646|471477524|FG000|Overall Study|Investigator/Sponsor Decision|0|||
131226300|NCT00950599|472455725|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130958671|NCT03285646|471477525|FG001|Overall Study|Investigator/Sponsor Decision|1|||
130714260|NCT03502707|470581661|FG011|Overall Study|Death|0|||
130714261|NCT03502707|470581662|FG012|Overall Study|Death|1|||
130714262|NCT03502707|470581663|FG013|Overall Study|Death|0|||
130958672|NCT01344057|471477526|FG000|Overall Study|Premature Withdrawal|1|||
130714263|NCT03502707|470581664|FG014|Overall Study|Death|0|||
130714264|NCT03502707|470581665|FG015|Overall Study|Death|1|||
130714265|NCT03502707|470581666|FG016|Overall Study|Death|0|||
130958673|NCT00306592|471477527|FG000|Overall Study|Adverse Event|8|||
130958674|NCT00306592|471477528|FG001|Overall Study|Adverse Event|15|||
130958675|NCT00306592|471477527|FG000|Overall Study|Lost to Follow-up|1|||
130958676|NCT00306592|471477528|FG001|Overall Study|Lost to Follow-up|0|||
130958677|NCT00306592|471477527|FG000|Overall Study|Noncompliance|0|||
130958678|NCT00306592|471477528|FG001|Overall Study|Noncompliance|2|||
130958679|NCT00306592|471477527|FG000|Overall Study|Persistent Antibodies|6|||
130958680|NCT00306592|471477528|FG001|Overall Study|Persistent Antibodies|3|||
130958681|NCT00306592|471477527|FG000|Overall Study|Voluntary|10|||
130958682|NCT00306592|471477528|FG001|Overall Study|Voluntary|6|||
130958683|NCT00306592|471477527|FG000|Overall Study|Other|5|||
130958684|NCT00306592|471477528|FG001|Overall Study|Other|10|||
130958685|NCT00306592|471477527|FG000|Overall Study|Other|1|||
130958686|NCT00306592|471477528|FG001|Overall Study|Other|2|||
130958687|NCT00306592|471477527|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
130958688|NCT00306592|471477528|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
130958689|NCT02652624|471477529|FG000|Randomized Phase|Pregnancy|3|||
130958690|NCT02652624|471477530|FG001|Randomized Phase|Pregnancy|1|||
130958691|NCT02652624|471477529|FG000|Randomized Phase|Investigator's Discretion|0|||
130958692|NCT02652624|471477530|FG001|Randomized Phase|Investigator's Discretion|2|||
130958693|NCT02652624|471477529|FG000|Randomized Phase|Death|0|||
130958694|NCT02652624|471477530|FG001|Randomized Phase|Death|1|||
130958695|NCT02652624|471477529|FG000|Randomized Phase|Lost to Follow-up|0|||
130958696|NCT02652624|471477530|FG001|Randomized Phase|Lost to Follow-up|1|||
130958697|NCT02652624|471477529|FG000|Extension Phase|Lost to Follow-up|3|||
130958698|NCT02652624|471477530|FG001|Extension Phase|Lost to Follow-up|1|||
130958699|NCT02652624|471477529|FG000|Extension Phase|Pregnancy|1|||
130958700|NCT02652624|471477530|FG001|Extension Phase|Pregnancy|1|||
130958701|NCT02652624|471477529|FG000|Extension Phase|Adverse Event|0|||
130958702|NCT02652624|471477530|FG001|Extension Phase|Adverse Event|1|||
130958703|NCT02652624|471477529|FG000|Extension Phase|Withdrew Consent|0|||
130958704|NCT02652624|471477530|FG001|Extension Phase|Withdrew Consent|1|||
130958705|NCT01023659|471477531|FG000|Overall Study|Lost to Follow-up|73|||
130958706|NCT01023659|471477532|FG001|Overall Study|Lost to Follow-up|228|||
130958707|NCT01023659|471477533|FG002|Overall Study|Lost to Follow-up|99|||
130958708|NCT00912405|471477536|FG000|Overall Study|Lost to Follow-up|5|||
130958709|NCT00519649|471477537|FG000|Overall Study|Withdrawal by Subject|1|||
130958710|NCT00501540|471477538|FG000|Overall Study|Death|5|||
130958711|NCT04879745|471477539|FG000|Overall Study|Lost to Follow-up|4|||
130958712|NCT04879745|471477540|FG001|Overall Study|Lost to Follow-up|1|||
130958713|NCT03592641|471477543|FG000|Overall Study|Withdrawal by Subject|1|||
130958714|NCT00436280|471477544|FG000|Period 1: Induction|Adverse Event|8|||
130958715|NCT00436280|471477544|FG000|Period 1: Induction|Progressive Disease|12|||
130958716|NCT00436280|471477544|FG000|Period 1: Induction|Stable Disease|6|||
130958717|NCT00436280|471477544|FG000|Period 1: Induction|Withdrawal by Subject|1|||
130958718|NCT00436280|471477544|FG000|Period 1: Induction|Death|1|||
130958719|NCT00436280|471477544|FG000|Period 2: Consolidation|Adverse Event|1|||
130958720|NCT00436280|471477544|FG000|Period 2: Consolidation|Progressive Disease|10|||
130958721|NCT00436280|471477544|FG000|Period 2: Consolidation|Stable Disease|1|||
130958722|NCT00436280|471477544|FG000|Period 2: Consolidation|Physician Decision|2|||
130958723|NCT00436280|471477544|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
130958724|NCT00436280|471477544|FG000|Period 2: Consolidation|Death|1|||
130958725|NCT00436280|471477544|FG000|Period 3: Maintenance|Adverse Event|6|||
130958726|NCT00436280|471477544|FG000|Period 3: Maintenance|Progressive Disease|12|||
130958727|NCT02984995|471477547|FG000|Overall Study|Required stem cell transplant|13|||
130958728|NCT02984995|471477548|FG001|Overall Study|Required stem cell transplant|2|||
130958729|NCT02984995|471477547|FG000|Overall Study|Progressive disease|11|||
130958730|NCT02984995|471477548|FG001|Overall Study|Progressive disease|1|||
130958731|NCT02984995|471477547|FG000|Overall Study|Adverse Event|1|||
130958732|NCT02984995|471477548|FG001|Overall Study|Adverse Event|0|||
130958733|NCT01034397|471477549|FG000|Overall Study|Lack of compliance|0|||
130958734|NCT01034397|471477550|FG001|Overall Study|Lack of compliance|1|||
130958735|NCT01034397|471477549|FG000|Overall Study|Lack of Efficacy|3|||
130958736|NCT01034397|471477550|FG001|Overall Study|Lack of Efficacy|0|||
130958737|NCT01034397|471477549|FG000|Overall Study|Adverse Event|4|||
130958738|NCT01034397|471477550|FG001|Overall Study|Adverse Event|0|||
131126969|NCT00733954|472093289|FG001|Overall Study|Lost to Follow-up|2|||
131126970|NCT00733954|472093288|FG000|Overall Study|Protocol Violation|1|||
131126971|NCT00733954|472093289|FG001|Overall Study|Protocol Violation|0|||
131126972|NCT00733954|472093288|FG000|Overall Study|Withdrawal by Subject|2|||
131126973|NCT00733954|472093289|FG001|Overall Study|Withdrawal by Subject|0|||
131126974|NCT02663453|472093290|FG000|Overall Study|Death|4|||
130774788|NCT03410992|470802566|FG007|Week 16 Assessment|Incorrect escapers|0|||
131126975|NCT02663453|472093291|FG001|Overall Study|Death|4|||
131126976|NCT02663453|472093290|FG000|Overall Study|Withdrawal by Subject|1|||
130958739|NCT01034397|471477549|FG000|Overall Study|Other|0|||
130958740|NCT01034397|471477550|FG001|Overall Study|Other|1|||
130958741|NCT03217136|471477553|FG000|Overall Study|Lost to Follow-up|2|||
130958742|NCT03217136|471477554|FG001|Overall Study|Lost to Follow-up|1|||
130958743|NCT03217136|471477553|FG000|Overall Study|Site Randomized Participant in Error|0|||
130958744|NCT03217136|471477554|FG001|Overall Study|Site Randomized Participant in Error|1|||
130958745|NCT03217136|471477553|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
130958746|NCT03217136|471477554|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
130958747|NCT03217136|471477553|FG000|Overall Study|Dispensing Error|1|||
130958748|NCT03217136|471477554|FG001|Overall Study|Dispensing Error|0|||
130958749|NCT03217136|471477553|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130958750|NCT03217136|471477554|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130958751|NCT03192150|471477555|FG000|Overall Study|Adverse Event|14|||
130958752|NCT03192150|471477556|FG001|Overall Study|Adverse Event|12|||
130958753|NCT03192150|471477555|FG000|Overall Study|Lack of Efficacy|23|||
130958754|NCT03192150|471477556|FG001|Overall Study|Lack of Efficacy|30|||
131226301|NCT00950599|472455726|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131226302|NCT00950599|472455727|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
131226303|NCT00950599|472455728|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131226304|NCT00950599|472455729|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131226305|NCT00950599|472455730|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131226306|NCT00950599|472455731|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130958755|NCT03192150|471477555|FG000|Overall Study|Lost to Follow-up|1|||
130958756|NCT03192150|471477556|FG001|Overall Study|Lost to Follow-up|1|||
130958757|NCT03192150|471477555|FG000|Overall Study|Withdrawal by Subject|4|||
130958758|NCT03192150|471477556|FG001|Overall Study|Withdrawal by Subject|2|||
130958759|NCT03192150|471477555|FG000|Overall Study|Protocol Violation|5|||
131226307|NCT00950599|472455732|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131226308|NCT00950599|472455733|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
131226309|NCT00950599|472455724|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131226310|NCT00950599|472455725|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130958760|NCT03192150|471477556|FG001|Overall Study|Protocol Violation|2|||
130958761|NCT03192150|471477555|FG000|Overall Study|Surgery Canceled|6|||
130958762|NCT03192150|471477556|FG001|Overall Study|Surgery Canceled|2|||
130958763|NCT03192150|471477555|FG000|Overall Study|Other-Various Administrative Reasons|2|||
130958764|NCT03192150|471477556|FG001|Overall Study|Other-Various Administrative Reasons|5|||
130958765|NCT02579616|471477557|FG000|Overall Study|Participants did not receive treatment|3|||
130958766|NCT00482391|471477558|FG000|Overall Study|Withdrawal by Subject|1|||
130958767|NCT00482391|471477558|FG000|Overall Study|Adverse Event|1|||
130958768|NCT00482391|471477558|FG000|Overall Study|Death|1|||
130958769|NCT01448850|471477559|FG000|Overall Study|Death|3|||
130958770|NCT01448850|471477560|FG001|Overall Study|Death|6|||
130958771|NCT01448850|471477559|FG000|Overall Study|Withdrawal by Subject|13|||
130958772|NCT01448850|471477560|FG001|Overall Study|Withdrawal by Subject|21|||
130958773|NCT01448850|471477559|FG000|Overall Study|Lost to Follow-up|3|||
130958774|NCT01448850|471477560|FG001|Overall Study|Lost to Follow-up|1|||
130958775|NCT01448850|471477559|FG000|Overall Study|Other|15|||
130958776|NCT01448850|471477560|FG001|Overall Study|Other|12|||
130958777|NCT02939404|471477561|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
130958778|NCT02939404|471477562|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
131040388|NCT05671653|471785296|FG010|Cohort 2 Period 2|Adverse Event|1|||
131040389|NCT05671653|471785297|FG011|Cohort 2 Period 2|Adverse Event|0|||
131040390|NCT05671653|471785298|FG012|Cohort 2 Period 2|Adverse Event|0|||
131040391|NCT05671653|471785286|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
131040392|NCT05671653|471785287|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
131040393|NCT05671653|471785288|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
131040394|NCT05671653|471785289|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
131040395|NCT05671653|471785290|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
131040396|NCT05671653|471785291|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
131040397|NCT05671653|471785292|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
131040398|NCT05671653|471785293|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
131040399|NCT05671653|471785294|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
131040400|NCT05671653|471785295|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
131040401|NCT05671653|471785296|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
131040402|NCT05671653|471785297|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
131040403|NCT05671653|471785298|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
131040404|NCT05671653|471785286|FG000|Cohort 2 Period 2|Pregnancy|0|||
131040405|NCT05671653|471785287|FG001|Cohort 2 Period 2|Pregnancy|0|||
131040406|NCT05671653|471785288|FG002|Cohort 2 Period 2|Pregnancy|0|||
131040407|NCT05671653|471785289|FG003|Cohort 2 Period 2|Pregnancy|0|||
131040408|NCT05671653|471785290|FG004|Cohort 2 Period 2|Pregnancy|0|||
131040409|NCT05671653|471785291|FG005|Cohort 2 Period 2|Pregnancy|0|||
131040410|NCT05671653|471785292|FG006|Cohort 2 Period 2|Pregnancy|0|||
131040411|NCT05671653|471785293|FG007|Cohort 2 Period 2|Pregnancy|0|||
130958779|NCT02939404|471477561|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
130958780|NCT02939404|471477562|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
130958781|NCT04304001|471477567|FG000|Overall Study|Lost to Follow-up|13|||
130958782|NCT04304001|471477568|FG001|Overall Study|Lost to Follow-up|9|||
130958783|NCT06640829|471477578|FG000|Overall Study|Withdrawal by Subject|1|||
130958784|NCT06640829|471477578|FG000|Overall Study|Lost to Follow-up|1|||
131040412|NCT05671653|471785294|FG008|Cohort 2 Period 2|Pregnancy|0|||
131040413|NCT05671653|471785295|FG009|Cohort 2 Period 2|Pregnancy|0|||
131040414|NCT05671653|471785296|FG010|Cohort 2 Period 2|Pregnancy|1|||
131040415|NCT05671653|471785297|FG011|Cohort 2 Period 2|Pregnancy|0|||
130958785|NCT01350128|471477588|FG000|Overall Study|Withdrawal by Subject|3|||
130958786|NCT01350128|471477588|FG000|Overall Study|Protocol discontinuation criteria|8|||
130958787|NCT01350128|471477588|FG000|Overall Study|Physician Decision|1|||
130958788|NCT01350128|471477588|FG000|Overall Study|Lost to Follow-up|2|||
130958789|NCT00261716|471477590|FG000|Overall Study|Withdrawal by Subject|6|||
130958790|NCT00261716|471477591|FG001|Overall Study|Withdrawal by Subject|8|||
130958791|NCT00261716|471477590|FG000|Overall Study|Lost to Follow-up|0|||
130958792|NCT00261716|471477591|FG001|Overall Study|Lost to Follow-up|2|||
130958793|NCT01611259|471477592|FG000|Overall Study|Physician Decision|1|||
130958794|NCT01611259|471477592|FG000|Overall Study|Lack of Efficacy|2|||
130958795|NCT01611259|471477592|FG000|Overall Study|Adverse Event|4|||
130958796|NCT01611259|471477592|FG000|Overall Study|Withdrawal by Subject|7|||
130958797|NCT04936685|471477593|FG000|Overall Study|Protocol Violation|1|||
130958798|NCT04936685|471477594|FG001|Overall Study|Protocol Violation|0|||
130958799|NCT01147653|471477599|FG000|Year 2|Withdrawal by Subject|2|||
130958800|NCT01147653|471477600|FG001|Year 2|Withdrawal by Subject|3|||
130958801|NCT01109316|471477601|FG000|Study Period 1|Adverse Event|0|||
130958802|NCT01109316|471477602|FG001|Study Period 1|Adverse Event|0|||
130958803|NCT01109316|471477603|FG002|Study Period 1|Adverse Event|1|||
130958804|NCT01109316|471477604|FG003|Study Period 1|Adverse Event|0|||
130958805|NCT01109316|471477605|FG004|Study Period 1|Adverse Event|0|||
130958806|NCT01109316|471477606|FG005|Study Period 1|Adverse Event|0|||
130958807|NCT01109316|471477601|FG000|Study Period 1|Lost to Follow-up|0|||
130958808|NCT01109316|471477602|FG001|Study Period 1|Lost to Follow-up|0|||
130958809|NCT01109316|471477603|FG002|Study Period 1|Lost to Follow-up|1|||
130958810|NCT01109316|471477604|FG003|Study Period 1|Lost to Follow-up|1|||
130958811|NCT01109316|471477605|FG004|Study Period 1|Lost to Follow-up|0|||
130958812|NCT01109316|471477606|FG005|Study Period 1|Lost to Follow-up|0|||
130958813|NCT01109316|471477601|FG000|Study Period 1|Withdrawal by Subject|0|||
130958814|NCT01109316|471477602|FG001|Study Period 1|Withdrawal by Subject|0|||
130958815|NCT01109316|471477603|FG002|Study Period 1|Withdrawal by Subject|1|||
130958816|NCT01109316|471477604|FG003|Study Period 1|Withdrawal by Subject|0|||
130958817|NCT01109316|471477605|FG004|Study Period 1|Withdrawal by Subject|2|||
130958818|NCT01109316|471477606|FG005|Study Period 1|Withdrawal by Subject|0|||
130958819|NCT01109316|471477601|FG000|Study Period 1|Sponsor Decision|0|||
130958820|NCT01109316|471477602|FG001|Study Period 1|Sponsor Decision|0|||
130958821|NCT01109316|471477603|FG002|Study Period 1|Sponsor Decision|0|||
130958822|NCT01109316|471477604|FG003|Study Period 1|Sponsor Decision|0|||
130958823|NCT01109316|471477605|FG004|Study Period 1|Sponsor Decision|0|||
130958824|NCT01109316|471477606|FG005|Study Period 1|Sponsor Decision|2|||
130958825|NCT01109316|471477601|FG000|Study Period 2|Entry Criteria Not Met|0|||
130958826|NCT01109316|471477602|FG001|Study Period 2|Entry Criteria Not Met|1|||
130958827|NCT01109316|471477603|FG002|Study Period 2|Entry Criteria Not Met|0|||
130958828|NCT01109316|471477604|FG003|Study Period 2|Entry Criteria Not Met|0|||
130958829|NCT01109316|471477605|FG004|Study Period 2|Entry Criteria Not Met|0|||
130958830|NCT01109316|471477606|FG005|Study Period 2|Entry Criteria Not Met|0|||
130958831|NCT01109316|471477601|FG000|Study Period 2|Physician Decision|0|||
130958832|NCT01109316|471477602|FG001|Study Period 2|Physician Decision|0|||
130958833|NCT01109316|471477603|FG002|Study Period 2|Physician Decision|0|||
130958834|NCT01109316|471477604|FG003|Study Period 2|Physician Decision|1|||
130958835|NCT01109316|471477605|FG004|Study Period 2|Physician Decision|0|||
130958836|NCT01109316|471477606|FG005|Study Period 2|Physician Decision|0|||
130958837|NCT01109316|471477601|FG000|Study Period 2|Protocol Violation|1|||
130958838|NCT01109316|471477602|FG001|Study Period 2|Protocol Violation|0|||
130958839|NCT01109316|471477603|FG002|Study Period 2|Protocol Violation|0|||
130958840|NCT01109316|471477604|FG003|Study Period 2|Protocol Violation|0|||
130958841|NCT01109316|471477605|FG004|Study Period 2|Protocol Violation|0|||
130958842|NCT01109316|471477606|FG005|Study Period 2|Protocol Violation|0|||
130958843|NCT01109316|471477601|FG000|Study Period 2|Withdrawal by Subject|0|||
130958844|NCT01109316|471477602|FG001|Study Period 2|Withdrawal by Subject|0|||
130958845|NCT01109316|471477603|FG002|Study Period 2|Withdrawal by Subject|1|||
130958846|NCT01109316|471477604|FG003|Study Period 2|Withdrawal by Subject|0|||
130958847|NCT01109316|471477605|FG004|Study Period 2|Withdrawal by Subject|0|||
130958848|NCT01109316|471477606|FG005|Study Period 2|Withdrawal by Subject|1|||
130958849|NCT01109316|471477601|FG000|Study Period 3|Lost to Follow-up|0|||
130958850|NCT01109316|471477602|FG001|Study Period 3|Lost to Follow-up|0|||
130958851|NCT01109316|471477603|FG002|Study Period 3|Lost to Follow-up|0|||
130958852|NCT01109316|471477604|FG003|Study Period 3|Lost to Follow-up|0|||
130958853|NCT01109316|471477605|FG004|Study Period 3|Lost to Follow-up|1|||
130958854|NCT01109316|471477606|FG005|Study Period 3|Lost to Follow-up|0|||
130958855|NCT01109316|471477601|FG000|Study Period 3|Withdrawal by Subject|1|||
130958856|NCT01109316|471477602|FG001|Study Period 3|Withdrawal by Subject|0|||
130958857|NCT01109316|471477603|FG002|Study Period 3|Withdrawal by Subject|0|||
130958858|NCT01109316|471477604|FG003|Study Period 3|Withdrawal by Subject|0|||
130958859|NCT01109316|471477605|FG004|Study Period 3|Withdrawal by Subject|1|||
130958860|NCT01109316|471477606|FG005|Study Period 3|Withdrawal by Subject|0|||
130958861|NCT00094653|471477616|FG000|Overall Study|Death|306|||
130958862|NCT00094653|471477617|FG001|Overall Study|Death|100|||
130958863|NCT00094653|471477618|FG002|Overall Study|Death|119|||
130714266|NCT03502707|470581667|FG017|Overall Study|Death|0|||
130714267|NCT03502707|470581650|FG000|Overall Study|Lost to Follow-up|0|||
130714268|NCT03502707|470581651|FG001|Overall Study|Lost to Follow-up|0|||
130714269|NCT03502707|470581652|FG002|Overall Study|Lost to Follow-up|0|||
130958864|NCT00094653|471477616|FG000|Overall Study|Subject Withdrew Consent|10|||
130958865|NCT00094653|471477617|FG001|Overall Study|Subject Withdrew Consent|2|||
130958866|NCT00094653|471477618|FG002|Overall Study|Subject Withdrew Consent|3|||
130958867|NCT00094653|471477616|FG000|Overall Study|Other|2|||
130958868|NCT00094653|471477617|FG001|Overall Study|Other|2|||
130958869|NCT00094653|471477618|FG002|Overall Study|Other|2|||
130958870|NCT00094653|471477616|FG000|Overall Study|Lost to Follow-up|3|||
130958871|NCT00094653|471477617|FG001|Overall Study|Lost to Follow-up|2|||
130958872|NCT00094653|471477618|FG002|Overall Study|Lost to Follow-up|1|||
130958873|NCT00094653|471477616|FG000|Overall Study|Protocol Violation|0|||
130958874|NCT00094653|471477617|FG001|Overall Study|Protocol Violation|0|||
130714270|NCT03502707|470581653|FG003|Overall Study|Lost to Follow-up|0|||
130714271|NCT03502707|470581654|FG004|Overall Study|Lost to Follow-up|0|||
130714272|NCT03502707|470581655|FG005|Overall Study|Lost to Follow-up|0|||
130714273|NCT03502707|470581656|FG006|Overall Study|Lost to Follow-up|0|||
130714274|NCT03502707|470581657|FG007|Overall Study|Lost to Follow-up|5|||
130714275|NCT03502707|470581658|FG008|Overall Study|Lost to Follow-up|0|||
130714276|NCT03502707|470581659|FG009|Overall Study|Lost to Follow-up|2|||
130714277|NCT03502707|470581660|FG010|Overall Study|Lost to Follow-up|1|||
130714278|NCT03502707|470581661|FG011|Overall Study|Lost to Follow-up|2|||
130714279|NCT03502707|470581662|FG012|Overall Study|Lost to Follow-up|1|||
130714280|NCT03502707|470581663|FG013|Overall Study|Lost to Follow-up|1|||
130714281|NCT03502707|470581664|FG014|Overall Study|Lost to Follow-up|0|||
130714282|NCT03502707|470581665|FG015|Overall Study|Lost to Follow-up|4|||
130714283|NCT03502707|470581666|FG016|Overall Study|Lost to Follow-up|9|||
130714284|NCT03502707|470581667|FG017|Overall Study|Lost to Follow-up|2|||
130714285|NCT03502707|470581650|FG000|Overall Study|Physician Decision|0|||
130714286|NCT03502707|470581651|FG001|Overall Study|Physician Decision|0|||
130714287|NCT03502707|470581652|FG002|Overall Study|Physician Decision|0|||
130714288|NCT03502707|470581653|FG003|Overall Study|Physician Decision|0|||
130714289|NCT03502707|470581654|FG004|Overall Study|Physician Decision|0|||
130714290|NCT03502707|470581655|FG005|Overall Study|Physician Decision|0|||
130714291|NCT03502707|470581656|FG006|Overall Study|Physician Decision|0|||
130714292|NCT03502707|470581657|FG007|Overall Study|Physician Decision|0|||
130714293|NCT03502707|470581658|FG008|Overall Study|Physician Decision|2|||
130714294|NCT03502707|470581659|FG009|Overall Study|Physician Decision|1|||
130714295|NCT03502707|470581660|FG010|Overall Study|Physician Decision|0|||
130714296|NCT03502707|470581661|FG011|Overall Study|Physician Decision|0|||
130714297|NCT03502707|470581662|FG012|Overall Study|Physician Decision|0|||
130714298|NCT03502707|470581663|FG013|Overall Study|Physician Decision|0|||
130714299|NCT03502707|470581664|FG014|Overall Study|Physician Decision|1|||
130714300|NCT03502707|470581665|FG015|Overall Study|Physician Decision|3|||
130714301|NCT03502707|470581666|FG016|Overall Study|Physician Decision|0|||
130714302|NCT03502707|470581667|FG017|Overall Study|Physician Decision|0|||
130714303|NCT03502707|470581650|FG000|Overall Study|Protocol Violation|0|||
130714304|NCT03502707|470581651|FG001|Overall Study|Protocol Violation|0|||
130714305|NCT03502707|470581652|FG002|Overall Study|Protocol Violation|0|||
130714306|NCT03502707|470581653|FG003|Overall Study|Protocol Violation|0|||
130714307|NCT03502707|470581654|FG004|Overall Study|Protocol Violation|0|||
130714308|NCT03502707|470581655|FG005|Overall Study|Protocol Violation|0|||
130714309|NCT03502707|470581656|FG006|Overall Study|Protocol Violation|0|||
130714310|NCT03502707|470581657|FG007|Overall Study|Protocol Violation|0|||
130714311|NCT03502707|470581658|FG008|Overall Study|Protocol Violation|0|||
130714312|NCT03502707|470581659|FG009|Overall Study|Protocol Violation|0|||
130714313|NCT03502707|470581660|FG010|Overall Study|Protocol Violation|0|||
130714314|NCT03502707|470581661|FG011|Overall Study|Protocol Violation|0|||
130714315|NCT03502707|470581662|FG012|Overall Study|Protocol Violation|0|||
130714316|NCT03502707|470581663|FG013|Overall Study|Protocol Violation|0|||
130714317|NCT03502707|470581664|FG014|Overall Study|Protocol Violation|0|||
130714318|NCT03502707|470581665|FG015|Overall Study|Protocol Violation|1|||
130714319|NCT03502707|470581666|FG016|Overall Study|Protocol Violation|0|||
130714320|NCT03502707|470581667|FG017|Overall Study|Protocol Violation|0|||
130714321|NCT03502707|470581650|FG000|Overall Study|Withdrawal by Subject|1|||
130714322|NCT03502707|470581651|FG001|Overall Study|Withdrawal by Subject|1|||
130714323|NCT03502707|470581652|FG002|Overall Study|Withdrawal by Subject|0|||
130714324|NCT03502707|470581653|FG003|Overall Study|Withdrawal by Subject|0|||
130714325|NCT03502707|470581654|FG004|Overall Study|Withdrawal by Subject|0|||
130714326|NCT03502707|470581655|FG005|Overall Study|Withdrawal by Subject|2|||
130714327|NCT03502707|470581656|FG006|Overall Study|Withdrawal by Subject|0|||
130714328|NCT03502707|470581657|FG007|Overall Study|Withdrawal by Subject|3|||
130714329|NCT03502707|470581658|FG008|Overall Study|Withdrawal by Subject|1|||
130714330|NCT03502707|470581659|FG009|Overall Study|Withdrawal by Subject|2|||
130714331|NCT03502707|470581660|FG010|Overall Study|Withdrawal by Subject|12|||
130958875|NCT00094653|471477618|FG002|Overall Study|Protocol Violation|1|||
130958876|NCT03921411|471477619|FG000|Overall Study|Withdrawal by Subject|1|||
130958877|NCT03921411|471477619|FG000|Overall Study|Protocol Deviation|2|||
130714332|NCT03502707|470581661|FG011|Overall Study|Withdrawal by Subject|23|||
130714333|NCT03502707|470581662|FG012|Overall Study|Withdrawal by Subject|5|||
130714334|NCT03502707|470581663|FG013|Overall Study|Withdrawal by Subject|3|||
130714335|NCT03502707|470581664|FG014|Overall Study|Withdrawal by Subject|3|||
130958878|NCT03921411|471477619|FG000|Overall Study|Enrolled, but never treated|2|||
130958879|NCT01541826|471477622|FG000|Overall Study|Lost to Follow-up|2|||
130958880|NCT01541826|471477623|FG001|Overall Study|Lost to Follow-up|3|||
130958881|NCT01541826|471477624|FG002|Overall Study|Lost to Follow-up|0|||
130958882|NCT01541826|471477622|FG000|Overall Study|Withdrawal by Subject|2|||
130958883|NCT01541826|471477623|FG001|Overall Study|Withdrawal by Subject|0|||
130958884|NCT01541826|471477624|FG002|Overall Study|Withdrawal by Subject|0|||
130958885|NCT01365273|471477627|FG000|Overall Study|Lost to Follow-up|1|||
130958886|NCT01365273|471477628|FG001|Overall Study|Lost to Follow-up|0|||
130958887|NCT01365273|471477627|FG000|Overall Study|Protocol Violation|0|||
130958888|NCT01365273|471477628|FG001|Overall Study|Protocol Violation|1|||
130958889|NCT01365273|471477627|FG000|Overall Study|Physician Decision|1|||
130958890|NCT01365273|471477628|FG001|Overall Study|Physician Decision|0|||
130958891|NCT00854581|471477631|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
130958892|NCT00854581|471477631|FG000|Induction (Up to Day 21)|Death|1|||
130958893|NCT00854581|471477631|FG000|Induction (Up to Day 21)|Physician Decision|1|||
130958894|NCT00854581|471477631|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
130958895|NCT01339390|471477632|FG000|Overall Study|Death|32|||
130958896|NCT01339390|471477633|FG001|Overall Study|Death|29|||
130958897|NCT01339390|471477632|FG000|Overall Study|Lost to Follow-up|125|||
130958898|NCT01339390|471477633|FG001|Overall Study|Lost to Follow-up|127|||
130958899|NCT04847674|471477634|FG000|Overall Study|Withdrawal by Subject|0|||
130958900|NCT04847674|471477635|FG001|Overall Study|Withdrawal by Subject|1|||
130958901|NCT04847674|471477636|FG002|Overall Study|Withdrawal by Subject|0|||
130958902|NCT04847674|471477634|FG000|Overall Study|Lost to Follow-up|0|||
130958903|NCT04847674|471477635|FG001|Overall Study|Lost to Follow-up|0|||
130958904|NCT04847674|471477636|FG002|Overall Study|Lost to Follow-up|2|||
130958905|NCT04847674|471477634|FG000|Overall Study|Other than specified|21|||
130958906|NCT04847674|471477635|FG001|Overall Study|Other than specified|20|||
130958907|NCT04847674|471477636|FG002|Overall Study|Other than specified|20|||
130958908|NCT02563028|471477638|FG000|Overall Study|Lack of equipment|1|||
130958909|NCT02563028|471477638|FG000|Overall Study|Unable to elicit VEP post induction|1|||
130958910|NCT03254134|471477639|FG000|Overall Study|Not eligible patients|599|||
130958911|NCT03254134|471477640|FG001|Overall Study|Not eligible patients|3630|||
130958912|NCT03337724|471477645|FG000|Overall Study|Reason not Specified|12|||
131040416|NCT05671653|471785298|FG012|Cohort 2 Period 2|Pregnancy|0|||
131040417|NCT05671653|471785286|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040418|NCT05671653|471785287|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040419|NCT05671653|471785288|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040420|NCT05671653|471785289|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040421|NCT05671653|471785290|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040422|NCT05671653|471785291|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040423|NCT05671653|471785292|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040424|NCT05671653|471785293|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040425|NCT05671653|471785294|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040426|NCT05671653|471785295|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040427|NCT05671653|471785296|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
131040428|NCT05671653|471785297|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040429|NCT05671653|471785298|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
131040430|NCT05671653|471785286|FG000|Cohort 2 Period 2|Other|0|||
131040431|NCT05671653|471785287|FG001|Cohort 2 Period 2|Other|0|||
131040432|NCT05671653|471785288|FG002|Cohort 2 Period 2|Other|0|||
131040433|NCT05671653|471785289|FG003|Cohort 2 Period 2|Other|0|||
131040434|NCT05671653|471785290|FG004|Cohort 2 Period 2|Other|0|||
131040435|NCT05671653|471785291|FG005|Cohort 2 Period 2|Other|0|||
131040436|NCT05671653|471785292|FG006|Cohort 2 Period 2|Other|0|||
131040437|NCT05671653|471785293|FG007|Cohort 2 Period 2|Other|0|||
131040438|NCT05671653|471785294|FG008|Cohort 2 Period 2|Other|0|||
131040439|NCT05671653|471785295|FG009|Cohort 2 Period 2|Other|0|||
131040440|NCT05671653|471785296|FG010|Cohort 2 Period 2|Other|1|||
130958913|NCT03337724|471477646|FG001|Overall Study|Reason not Specified|21|||
130958914|NCT03337724|471477647|FG002|Overall Study|Reason not Specified|9|||
130958915|NCT03337724|471477648|FG003|Overall Study|Reason not Specified|9|||
130958916|NCT03337724|471477649|FG004|Overall Study|Reason not Specified|29|||
131040441|NCT05671653|471785297|FG011|Cohort 2 Period 2|Other|0|||
131040442|NCT05671653|471785298|FG012|Cohort 2 Period 2|Other|0|||
131040443|NCT05671653|471785286|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131040444|NCT05671653|471785287|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131040445|NCT05671653|471785288|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131040446|NCT05671653|471785289|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131126977|NCT02663453|472093291|FG001|Overall Study|Withdrawal by Subject|0|||
130958917|NCT03337724|471477645|FG000|Overall Study|Withdrawal by Subject|13|||
130958918|NCT03337724|471477646|FG001|Overall Study|Withdrawal by Subject|15|||
131040447|NCT05671653|471785290|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
130714336|NCT03502707|470581665|FG015|Overall Study|Withdrawal by Subject|43|||
130714337|NCT03502707|470581666|FG016|Overall Study|Withdrawal by Subject|44|||
130714338|NCT03502707|470581667|FG017|Overall Study|Withdrawal by Subject|18|||
130714339|NCT03502707|470581650|FG000|Overall Study|Sponsor's Decision|1|||
130714340|NCT03502707|470581651|FG001|Overall Study|Sponsor's Decision|0|||
130714341|NCT03502707|470581652|FG002|Overall Study|Sponsor's Decision|0|||
130714342|NCT03502707|470581653|FG003|Overall Study|Sponsor's Decision|0|||
130714343|NCT03502707|470581654|FG004|Overall Study|Sponsor's Decision|0|||
130714344|NCT03502707|470581655|FG005|Overall Study|Sponsor's Decision|0|||
130714345|NCT03502707|470581656|FG006|Overall Study|Sponsor's Decision|0|||
130714346|NCT03502707|470581657|FG007|Overall Study|Sponsor's Decision|0|||
130714347|NCT03502707|470581658|FG008|Overall Study|Sponsor's Decision|0|||
130714348|NCT03502707|470581659|FG009|Overall Study|Sponsor's Decision|1|||
130714349|NCT03502707|470581660|FG010|Overall Study|Sponsor's Decision|0|||
130714350|NCT03502707|470581661|FG011|Overall Study|Sponsor's Decision|0|||
130714351|NCT03502707|470581662|FG012|Overall Study|Sponsor's Decision|0|||
130714352|NCT03502707|470581663|FG013|Overall Study|Sponsor's Decision|0|||
130774789|NCT03410992|470802567|FG008|Week 16 Assessment|Incorrect escapers|0|||
130774790|NCT03410992|470802568|FG009|Week 16 Assessment|Incorrect escapers|0|||
130958919|NCT03337724|471477647|FG002|Overall Study|Withdrawal by Subject|4|||
130958920|NCT03337724|471477648|FG003|Overall Study|Withdrawal by Subject|15|||
130958921|NCT03337724|471477649|FG004|Overall Study|Withdrawal by Subject|6|||
130958922|NCT03337724|471477645|FG000|Overall Study|Protocol Deviation|0|||
130958923|NCT03337724|471477646|FG001|Overall Study|Protocol Deviation|1|||
130958924|NCT03337724|471477647|FG002|Overall Study|Protocol Deviation|1|||
130958925|NCT03337724|471477648|FG003|Overall Study|Protocol Deviation|1|||
130958926|NCT03337724|471477649|FG004|Overall Study|Protocol Deviation|0|||
130958927|NCT03337724|471477645|FG000|Overall Study|Adverse Event|1|||
130958928|NCT03337724|471477646|FG001|Overall Study|Adverse Event|1|||
130958929|NCT03337724|471477647|FG002|Overall Study|Adverse Event|0|||
130958930|NCT03337724|471477648|FG003|Overall Study|Adverse Event|1|||
130958931|NCT03337724|471477649|FG004|Overall Study|Adverse Event|0|||
130958932|NCT03337724|471477645|FG000|Overall Study|Death|40|||
130958933|NCT03337724|471477646|FG001|Overall Study|Death|89|||
130958934|NCT03337724|471477647|FG002|Overall Study|Death|43|||
130958935|NCT03337724|471477648|FG003|Overall Study|Death|76|||
130958936|NCT03337724|471477649|FG004|Overall Study|Death|50|||
130958937|NCT03337724|471477645|FG000|Overall Study|Lost to Follow-up|5|||
130958938|NCT03337724|471477646|FG001|Overall Study|Lost to Follow-up|5|||
130958939|NCT03337724|471477647|FG002|Overall Study|Lost to Follow-up|4|||
130958940|NCT03337724|471477648|FG003|Overall Study|Lost to Follow-up|7|||
130958941|NCT03337724|471477649|FG004|Overall Study|Lost to Follow-up|4|||
130958942|NCT03337724|471477645|FG000|Overall Study|Physician Decision|16|||
130958943|NCT03337724|471477646|FG001|Overall Study|Physician Decision|34|||
130958944|NCT03337724|471477647|FG002|Overall Study|Physician Decision|14|||
130958945|NCT03337724|471477648|FG003|Overall Study|Physician Decision|34|||
130958946|NCT03337724|471477649|FG004|Overall Study|Physician Decision|13|||
130958947|NCT03337724|471477645|FG000|Overall Study|Progressive Disease|0|||
130958948|NCT03337724|471477646|FG001|Overall Study|Progressive Disease|2|||
130958949|NCT03337724|471477647|FG002|Overall Study|Progressive Disease|1|||
131040448|NCT05671653|471785291|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131040449|NCT05671653|471785292|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131040450|NCT05671653|471785293|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131040451|NCT05671653|471785294|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131040452|NCT05671653|471785295|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131040453|NCT05671653|471785296|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131040454|NCT05671653|471785297|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
131040455|NCT05671653|471785298|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
131040456|NCT02460458|471785299|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
131040457|NCT02460458|471785299|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
130714353|NCT03502707|470581664|FG014|Overall Study|Sponsor's Decision|0|||
130714354|NCT03502707|470581665|FG015|Overall Study|Sponsor's Decision|2|||
130714355|NCT03502707|470581666|FG016|Overall Study|Sponsor's Decision|1|||
130958950|NCT03337724|471477648|FG003|Overall Study|Progressive Disease|2|||
130958951|NCT03337724|471477649|FG004|Overall Study|Progressive Disease|0|||
130958952|NCT03337724|471477645|FG000|Overall Study|Symptomatic Deterioration|0|||
130714356|NCT03502707|470581667|FG017|Overall Study|Sponsor's Decision|0|||
130714357|NCT03502707|470581650|FG000|Overall Study|Initiated Prohibited Medication|0|||
130958953|NCT03337724|471477646|FG001|Overall Study|Symptomatic Deterioration|0|||
130958954|NCT03337724|471477647|FG002|Overall Study|Symptomatic Deterioration|0|||
130958955|NCT03337724|471477648|FG003|Overall Study|Symptomatic Deterioration|1|||
130958956|NCT03337724|471477649|FG004|Overall Study|Symptomatic Deterioration|0|||
130958957|NCT03551210|471477651|FG000|Overall Study|Adverse Event|5|||
130958958|NCT03551210|471477652|FG001|Overall Study|Adverse Event|6|||
130958959|NCT03551210|471477651|FG000|Overall Study|Withdrawal by Subject|1|||
130958960|NCT03551210|471477652|FG001|Overall Study|Withdrawal by Subject|7|||
130958961|NCT03551210|471477651|FG000|Overall Study|Needed in other antibiotic treatment|2|||
131040458|NCT02460458|471785299|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
130958962|NCT03551210|471477652|FG001|Overall Study|Needed in other antibiotic treatment|5|||
130958963|NCT03551210|471477651|FG000|Overall Study|Lost to Follow-up|1|||
130958964|NCT03551210|471477652|FG001|Overall Study|Lost to Follow-up|1|||
130958965|NCT03551210|471477651|FG000|Overall Study|Absence of visit 4 and 5|1|||
130958966|NCT03551210|471477652|FG001|Overall Study|Absence of visit 4 and 5|0|||
130958967|NCT03551210|471477651|FG000|Overall Study|No drug for dispensing|0|||
130958968|NCT03551210|471477652|FG001|Overall Study|No drug for dispensing|1|||
130958969|NCT03265119|471477653|FG000|Overall Study|Adverse Event|2|||
130958970|NCT03265119|471477654|FG001|Overall Study|Adverse Event|1|||
130958971|NCT03265119|471477653|FG000|Overall Study|Lack of Efficacy|3|||
130958972|NCT03265119|471477654|FG001|Overall Study|Lack of Efficacy|0|||
130958973|NCT03265119|471477653|FG000|Overall Study|Protocol Violation|1|||
130958974|NCT03265119|471477654|FG001|Overall Study|Protocol Violation|2|||
130958975|NCT03265119|471477653|FG000|Overall Study|Withdrawal by Subject|2|||
131226311|NCT00950599|472455726|FG002|Double-Blind Treatment Period|Adverse Event|1|||
131226312|NCT00950599|472455727|FG003|Double-Blind Treatment Period|Adverse Event|1|||
131226313|NCT00950599|472455728|FG004|Double-Blind Treatment Period|Adverse Event|1|||
131226314|NCT00950599|472455729|FG005|Double-Blind Treatment Period|Adverse Event|1|||
131226315|NCT00950599|472455730|FG006|Double-Blind Treatment Period|Adverse Event|0|||
131226316|NCT00950599|472455731|FG007|Double-Blind Treatment Period|Adverse Event|0|||
131226317|NCT00950599|472455732|FG008|Double-Blind Treatment Period|Adverse Event|0|||
131226318|NCT00950599|472455733|FG009|Double-Blind Treatment Period|Adverse Event|0|||
131226319|NCT00950599|472455724|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
131226320|NCT00950599|472455725|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
131226321|NCT00950599|472455726|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
131226322|NCT00950599|472455727|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
130958976|NCT03265119|471477654|FG001|Overall Study|Withdrawal by Subject|4|||
130958977|NCT03265119|471477653|FG000|Overall Study|Lost to Follow-up|1|||
130958978|NCT03265119|471477654|FG001|Overall Study|Lost to Follow-up|0|||
130958979|NCT03265119|471477653|FG000|Overall Study|Lack of Compliance|1|||
130958980|NCT03265119|471477654|FG001|Overall Study|Lack of Compliance|0|||
130958981|NCT04524403|471478829|FG000|Overall Study|Withdrawal by Subject|10|||
130958982|NCT04524403|471478830|FG001|Overall Study|Withdrawal by Subject|3|||
130958983|NCT04524403|471478831|FG002|Overall Study|Withdrawal by Subject|8|||
130958984|NCT04524403|471478829|FG000|Overall Study|Lost to Follow-up|3|||
130958985|NCT04524403|471478830|FG001|Overall Study|Lost to Follow-up|4|||
130958986|NCT04524403|471478831|FG002|Overall Study|Lost to Follow-up|3|||
130958987|NCT04524403|471478829|FG000|Overall Study|Adverse Event|3|||
130958988|NCT04524403|471478830|FG001|Overall Study|Adverse Event|1|||
130958989|NCT04524403|471478831|FG002|Overall Study|Adverse Event|4|||
130958990|NCT04524403|471478829|FG000|Overall Study|Non-compliant with study drug|1|||
130958991|NCT04524403|471478830|FG001|Overall Study|Non-compliant with study drug|2|||
130958992|NCT04524403|471478831|FG002|Overall Study|Non-compliant with study drug|3|||
130958993|NCT04524403|471478829|FG000|Overall Study|Moved|0|||
130958994|NCT04524403|471478830|FG001|Overall Study|Moved|1|||
130958995|NCT04524403|471478831|FG002|Overall Study|Moved|0|||
130958996|NCT02383758|471478834|FG000|Overall Study|Withdrawal by Subject|0|||
130958997|NCT02383758|471478835|FG001|Overall Study|Withdrawal by Subject|2|||
130958998|NCT03085927|471478836|FG000|Overall Study|Withdrawal by Subject|1|||
130958999|NCT03085927|471478837|FG001|Overall Study|Withdrawal by Subject|4|||
130959000|NCT03085927|471478836|FG000|Overall Study|Lost to Follow-up|3|||
130959001|NCT03085927|471478837|FG001|Overall Study|Lost to Follow-up|1|||
130959002|NCT03085927|471478836|FG000|Overall Study|Death|1|||
130959003|NCT03085927|471478837|FG001|Overall Study|Death|0|||
130959004|NCT03085927|471478836|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
130959005|NCT03085927|471478837|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
130959006|NCT03085927|471478836|FG000|Overall Study|Dyad Became Ineligible|0|||
130959007|NCT03085927|471478837|FG001|Overall Study|Dyad Became Ineligible|1|||
130959008|NCT02349711|471478839|FG000|Overall Study|Withdrawal by Subject|2|||
130959009|NCT02349711|471478840|FG001|Overall Study|Withdrawal by Subject|1|||
130959010|NCT02349711|471478839|FG000|Overall Study|Lost to Follow-up|1|||
130959011|NCT02349711|471478840|FG001|Overall Study|Lost to Follow-up|1|||
130959012|NCT00194012|471478841|FG000|Randomized Phase|Lack of Efficacy|8|||
130959013|NCT00194012|471478842|FG001|Randomized Phase|Lack of Efficacy|18|||
130959014|NCT00194012|471478841|FG000|Randomized Phase|Study nonadherence|2|||
130959015|NCT00194012|471478842|FG001|Randomized Phase|Study nonadherence|1|||
130959016|NCT00194012|471478841|FG000|Randomized Phase|Withdrawal by Subject|3|||
130959017|NCT00194012|471478842|FG001|Randomized Phase|Withdrawal by Subject|3|||
130959018|NCT00194012|471478841|FG000|Randomized Phase|Adverse Event|2|||
130959019|NCT00194012|471478842|FG001|Randomized Phase|Adverse Event|1|||
130959020|NCT00194012|471478841|FG000|Randomized Phase|Participant reported having a rash|1|||
130959021|NCT00194012|471478842|FG001|Randomized Phase|Participant reported having a rash|0|||
131226323|NCT00950599|472455728|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
130959022|NCT00194012|471478841|FG000|Randomized Phase|Emesis and enuresis|0|||
131226324|NCT00950599|472455729|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
131226325|NCT00950599|472455730|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
131126978|NCT01849874|472094678|FG000|Overall Study|Death|89|||
131126979|NCT01849874|472094679|FG001|Overall Study|Death|42|||
130959023|NCT00194012|471478842|FG001|Randomized Phase|Emesis and enuresis|1|||
130959024|NCT00194012|471478841|FG000|Randomized Phase|Oral/nasal twitching|0|||
130959025|NCT00194012|471478842|FG001|Randomized Phase|Oral/nasal twitching|1|||
130959026|NCT00194012|471478841|FG000|Open Label Extension (OLE)|Weight Gain|1|||
130959027|NCT00194012|471478842|FG001|Open Label Extension (OLE)|Weight Gain|0|||
130959028|NCT00194012|471478841|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
130959029|NCT00194012|471478842|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
130959030|NCT00194012|471478841|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
130959031|NCT00194012|471478842|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
130959032|NCT00194012|471478841|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
130959033|NCT00194012|471478842|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
130959034|NCT01513317|471478848|FG000|Overall Study|Withdrawal by Subject|15|||
130959035|NCT01513317|471478849|FG001|Overall Study|Withdrawal by Subject|4|||
130959036|NCT01513317|471478848|FG000|Overall Study|Death|1|||
130959037|NCT01513317|471478849|FG001|Overall Study|Death|1|||
130959038|NCT01513317|471478848|FG000|Overall Study|Study terminated by sponsor|18|||
130959039|NCT01513317|471478849|FG001|Overall Study|Study terminated by sponsor|18|||
130959040|NCT01513317|471478848|FG000|Overall Study|Other|0|||
130959041|NCT01513317|471478849|FG001|Overall Study|Other|1|||
130959042|NCT02564198|471478850|FG000|Overall Study|Withdrawal by Subject|2|||
130959043|NCT02564198|471478851|FG001|Overall Study|Withdrawal by Subject|4|||
130959044|NCT02564198|471478852|FG002|Overall Study|Withdrawal by Subject|0|||
130959045|NCT02564198|471478850|FG000|Overall Study|Adverse Event|0|||
130959046|NCT02564198|471478851|FG001|Overall Study|Adverse Event|1|||
130959047|NCT02564198|471478852|FG002|Overall Study|Adverse Event|0|||
131126980|NCT01849874|472094678|FG000|Overall Study|Withdrawal by Subject|17|||
131126981|NCT01849874|472094679|FG001|Overall Study|Withdrawal by Subject|16|||
131126982|NCT01849874|472094678|FG000|Overall Study|Lost to Follow-up|3|||
131126983|NCT01849874|472094679|FG001|Overall Study|Lost to Follow-up|2|||
131126984|NCT01849874|472094678|FG000|Overall Study|Study Termination By Sponsor|93|||
131126985|NCT01849874|472094679|FG001|Overall Study|Study Termination By Sponsor|48|||
131126986|NCT01849874|472094678|FG000|Overall Study|Completed as per protocol amendment 6|3|||
131126987|NCT01849874|472094679|FG001|Overall Study|Completed as per protocol amendment 6|0|||
131126988|NCT01849874|472094678|FG000|Overall Study|Physician Decision|7|||
131126989|NCT01849874|472094679|FG001|Overall Study|Physician Decision|1|||
131126990|NCT01849874|472094678|FG000|Overall Study|Other|16|||
131126991|NCT01849874|472094679|FG001|Overall Study|Other|4|||
131126992|NCT02830880|472094688|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
131126993|NCT02830880|472094688|FG000|Overall Study|Death|1|||
131126994|NCT02830880|472094688|FG000|Overall Study|Physician Decision|1|||
131126995|NCT03551509|472094689|FG000|Overall Study|Lost to Follow-up|0|||
131126996|NCT03551509|472094690|FG001|Overall Study|Lost to Follow-up|1|||
131126997|NCT03551509|472094691|FG002|Overall Study|Lost to Follow-up|0|||
131126998|NCT01040351|472094692|FG000|Overall Study|poor ovarian response|1|||
131126999|NCT01040351|472094693|FG001|Overall Study|poor ovarian response|2|||
131127000|NCT01230307|472094694|FG000|Overall Study|LVAD Placement|0|||
131127001|NCT01230307|472094695|FG001|Overall Study|LVAD Placement|2|||
131127002|NCT00530894|472094699|FG000|Overall Study|Death|84|||
131127003|NCT00530894|472094700|FG001|Overall Study|Death|89|||
131127004|NCT00530894|472094701|FG002|Overall Study|Death|55|||
131127005|NCT00530894|472094702|FG003|Overall Study|Death|89|||
131127006|NCT00530894|472094699|FG000|Overall Study|Lost to Follow-up|1|||
131127007|NCT00530894|472094700|FG001|Overall Study|Lost to Follow-up|3|||
131127008|NCT00530894|472094701|FG002|Overall Study|Lost to Follow-up|0|||
131127009|NCT00530894|472094702|FG003|Overall Study|Lost to Follow-up|0|||
131127010|NCT00530894|472094699|FG000|Overall Study|Withdrawal by Subject|1|||
131127011|NCT00530894|472094700|FG001|Overall Study|Withdrawal by Subject|23|||
130714358|NCT03502707|470581651|FG001|Overall Study|Initiated Prohibited Medication|0|||
130714359|NCT03502707|470581652|FG002|Overall Study|Initiated Prohibited Medication|0|||
130959048|NCT02200042|471478853|FG000|Overall Study|Withdrawal by Subject|0|||
130959049|NCT02200042|471478854|FG001|Overall Study|Withdrawal by Subject|1|||
130959050|NCT02097134|471478855|FG000|Overall Study|Physician Decision|4|||
130959051|NCT02097134|471478855|FG000|Overall Study|Non-Protocol Therapy|1|||
130959052|NCT02097134|471478855|FG000|Overall Study|Progressive Disease|3|||
130959053|NCT02097134|471478855|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
130959054|NCT00298896|471478863|FG000|Overall Study|Death|3|||
130959055|NCT00298896|471478863|FG000|Overall Study|Physician Decision|2|||
130959056|NCT00298896|471478863|FG000|Overall Study|Intercurrent Illness|1|||
130959057|NCT00298896|471478863|FG000|Overall Study|Disease Progression|41|||
130959058|NCT00298896|471478863|FG000|Overall Study|Withdrawal by Subject|2|||
130959059|NCT00298896|471478863|FG000|Overall Study|Assigned to treatment in error|1|||
130959060|NCT02649972|471478866|FG000|Overall Study|Not treated|1|||
130959061|NCT03394391|471478869|FG000|Overall Study|Lost to Follow-up|1|||
130959062|NCT03394391|471478870|FG001|Overall Study|Lost to Follow-up|2|||
131127012|NCT00530894|472094701|FG002|Overall Study|Withdrawal by Subject|0|||
131127013|NCT00530894|472094702|FG003|Overall Study|Withdrawal by Subject|5|||
131040459|NCT02460458|471785299|FG000|First Prospective Phase|Lost to Follow-up|84|||
131040460|NCT02460458|471785299|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
131040461|NCT03952338|471785300|FG000|Overall Study|Lost to Follow-up|11|||
131040462|NCT03952338|471785301|FG001|Overall Study|Lost to Follow-up|17|||
131040463|NCT03952338|471785300|FG000|Overall Study|Withdrawal by Subject|1|||
131040464|NCT03952338|471785301|FG001|Overall Study|Withdrawal by Subject|1|||
131040465|NCT03952338|471785300|FG000|Overall Study|Protocol Violation|1|||
131040466|NCT03952338|471785301|FG001|Overall Study|Protocol Violation|0|||
131040467|NCT04568434|471785302|FG000|Overall Study|Voluntary Withdrawal|0|||
131040468|NCT04568434|471785303|FG001|Overall Study|Voluntary Withdrawal|1|||
131040469|NCT04568434|471785304|FG002|Overall Study|Voluntary Withdrawal|1|||
131040470|NCT04568434|471785302|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
131040471|NCT04568434|471785303|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
131040472|NCT04568434|471785304|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
131040473|NCT04568434|471785302|FG000|Overall Study|Investigator Judgement|1|||
131040474|NCT04568434|471785303|FG001|Overall Study|Investigator Judgement|0|||
131040475|NCT04568434|471785304|FG002|Overall Study|Investigator Judgement|0|||
131040476|NCT05469464|471785305|FG000|Overall Study|Withdrawal by Subject|8|||
131040477|NCT05469464|471785306|FG001|Overall Study|Withdrawal by Subject|7|||
131040478|NCT05469464|471785307|FG002|Overall Study|Withdrawal by Subject|4|||
131040479|NCT05469464|471785308|FG003|Overall Study|Withdrawal by Subject|5|||
131040480|NCT05469464|471785305|FG000|Overall Study|Adverse Event|8|||
131040481|NCT05469464|471785306|FG001|Overall Study|Adverse Event|14|||
131040482|NCT05469464|471785307|FG002|Overall Study|Adverse Event|13|||
131040483|NCT05469464|471785308|FG003|Overall Study|Adverse Event|2|||
131040484|NCT05469464|471785305|FG000|Overall Study|Lost to Follow-up|2|||
131040485|NCT05469464|471785306|FG001|Overall Study|Lost to Follow-up|5|||
131040486|NCT05469464|471785307|FG002|Overall Study|Lost to Follow-up|3|||
131040487|NCT05469464|471785308|FG003|Overall Study|Lost to Follow-up|3|||
131040488|NCT05469464|471785305|FG000|Overall Study|Lack of Efficacy|4|||
131040489|NCT05469464|471785306|FG001|Overall Study|Lack of Efficacy|1|||
131040490|NCT05469464|471785307|FG002|Overall Study|Lack of Efficacy|2|||
130714360|NCT03502707|470581653|FG003|Overall Study|Initiated Prohibited Medication|0|||
130714361|NCT03502707|470581654|FG004|Overall Study|Initiated Prohibited Medication|0|||
130714362|NCT03502707|470581655|FG005|Overall Study|Initiated Prohibited Medication|0|||
131040491|NCT05469464|471785308|FG003|Overall Study|Lack of Efficacy|2|||
131040492|NCT05469464|471785305|FG000|Overall Study|Physician Decision|0|||
131040493|NCT05469464|471785306|FG001|Overall Study|Physician Decision|0|||
131040494|NCT05469464|471785307|FG002|Overall Study|Physician Decision|0|||
131040495|NCT05469464|471785308|FG003|Overall Study|Physician Decision|1|||
131040496|NCT04076618|471785309|FG000|Overall Study|Lost to Follow-up|2|||
131040497|NCT04076618|471785310|FG001|Overall Study|Lost to Follow-up|1|||
131040498|NCT04076618|471785311|FG002|Overall Study|Lost to Follow-up|3|||
131040499|NCT04076618|471785309|FG000|Overall Study|Withdrawal by Subject|3|||
131040500|NCT04076618|471785310|FG001|Overall Study|Withdrawal by Subject|1|||
131040501|NCT04076618|471785311|FG002|Overall Study|Withdrawal by Subject|2|||
131040502|NCT04076618|471785309|FG000|Overall Study|Relocated out of state|0|||
131040503|NCT04076618|471785310|FG001|Overall Study|Relocated out of state|2|||
131040504|NCT04076618|471785311|FG002|Overall Study|Relocated out of state|0|||
131040505|NCT04076618|471785309|FG000|Overall Study|COVID concerns|0|||
131040506|NCT04076618|471785310|FG001|Overall Study|COVID concerns|1|||
131040507|NCT04076618|471785311|FG002|Overall Study|COVID concerns|0|||
131040508|NCT04076618|471785309|FG000|Overall Study|Adverse Event|0|||
131040509|NCT04076618|471785310|FG001|Overall Study|Adverse Event|0|||
131040510|NCT04076618|471785311|FG002|Overall Study|Adverse Event|2|||
131040511|NCT01928394|471785312|FG000|Treatment Period|Disease progression|17|||
131040512|NCT01928394|471785313|FG001|Treatment Period|Disease progression|2|||
131040513|NCT01928394|471785314|FG002|Treatment Period|Disease progression|12|||
131040514|NCT01928394|471785315|FG003|Treatment Period|Disease progression|48|||
131040515|NCT01928394|471785316|FG004|Treatment Period|Disease progression|3|||
131040516|NCT01928394|471785317|FG005|Treatment Period|Disease progression|25|||
131040517|NCT01928394|471785318|FG006|Treatment Period|Disease progression|38|||
131040518|NCT01928394|471785319|FG007|Treatment Period|Disease progression|16|||
131040519|NCT01928394|471785320|FG008|Treatment Period|Disease progression|3|||
131040520|NCT01928394|471785321|FG009|Treatment Period|Disease progression|11|||
131040521|NCT01928394|471785322|FG010|Treatment Period|Disease progression|22|||
131040522|NCT01928394|471785323|FG011|Treatment Period|Disease progression|73|||
131040523|NCT01928394|471785324|FG012|Treatment Period|Disease progression|38|||
131040524|NCT01928394|471785325|FG013|Treatment Period|Disease progression|118|||
131040525|NCT01928394|471785326|FG014|Treatment Period|Disease progression|59|||
131040526|NCT01928394|471785327|FG015|Treatment Period|Disease progression|1|||
131040527|NCT01928394|471785328|FG016|Treatment Period|Disease progression|43|||
131040528|NCT01928394|471785329|FG017|Treatment Period|Disease progression|56|||
131040529|NCT01928394|471785330|FG018|Treatment Period|Disease progression|50|||
131040530|NCT01928394|471785331|FG019|Treatment Period|Disease progression|71|||
131040531|NCT01928394|471785332|FG020|Treatment Period|Disease progression|30|||
130959063|NCT01434823|471478871|FG000|Overall Study|Incomplete data in medical record|4|||
130959064|NCT01434823|471478872|FG001|Overall Study|Incomplete data in medical record|7|||
130959065|NCT01797536|471478873|FG000|Overall Study|Adverse Event|0|||
130959066|NCT01797536|471478874|FG001|Overall Study|Adverse Event|1|||
130959067|NCT01797536|471478875|FG002|Overall Study|Adverse Event|0|||
130959068|NCT01797536|471478876|FG003|Overall Study|Adverse Event|0|||
130959069|NCT00120042|471478877|FG000|Overall Study|all completed protocl|0|||
130959070|NCT00120042|471478878|FG001|Overall Study|all completed protocl|0|||
130959071|NCT00120042|471478879|FG002|Overall Study|all completed protocl|0|||
130959072|NCT01263873|471478882|FG000|Overall Study|One provider unable to complete numbers|1|||
130959073|NCT01263873|471478883|FG001|Overall Study|One provider unable to complete numbers|1|||
130959074|NCT00047463|471478884|FG000|Overall Study|Withdrawal by Subject|0|||
130959075|NCT00047463|471478885|FG001|Overall Study|Withdrawal by Subject|3|||
130959076|NCT01401530|471478887|FG000|Overall Study|Disease Progression|1|||
130959077|NCT01401530|471478888|FG001|Overall Study|Disease Progression|2|||
130959078|NCT01401530|471478889|FG002|Overall Study|Disease Progression|1|||
130959079|NCT01401530|471478887|FG000|Overall Study|Adverse Event|1|||
130959080|NCT01401530|471478888|FG001|Overall Study|Adverse Event|1|||
130959081|NCT01401530|471478889|FG002|Overall Study|Adverse Event|1|||
130959082|NCT01401530|471478887|FG000|Overall Study|Participant Choice|1|||
130959083|NCT01401530|471478888|FG001|Overall Study|Participant Choice|2|||
130959084|NCT01401530|471478889|FG002|Overall Study|Participant Choice|1|||
130959085|NCT01401530|471478887|FG000|Overall Study|Physician Decision|0|||
130959086|NCT01401530|471478888|FG001|Overall Study|Physician Decision|1|||
130959087|NCT01401530|471478889|FG002|Overall Study|Physician Decision|0|||
130959088|NCT01252290|471478896|FG000|Overall Study|Withdrawal by Subject|1|||
130959089|NCT02075437|471478900|FG000|Overall Study|Withdrawal by Subject|5|||
130959090|NCT02075437|471478900|FG000|Overall Study|Lost to Follow-up|1|||
130959091|NCT02047110|471478901|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
130959092|NCT02047110|471478902|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
130959093|NCT02047110|471478903|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
130959094|NCT02047110|471478904|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
130959095|NCT02047110|471478901|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
130959096|NCT02047110|471478902|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
130959097|NCT02047110|471478903|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
130959098|NCT02047110|471478904|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
130959099|NCT02047110|471478901|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
130959100|NCT02047110|471478902|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
130959101|NCT02047110|471478903|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
130959102|NCT02047110|471478904|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
130959103|NCT02047110|471478901|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
130959104|NCT02047110|471478902|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
130959105|NCT02047110|471478903|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
130959106|NCT02047110|471478904|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
131127014|NCT00530894|472094699|FG000|Overall Study|Alive and censored prior to 1 year|2|||
131127015|NCT00530894|472094700|FG001|Overall Study|Alive and censored prior to 1 year|0|||
131127016|NCT00530894|472094701|FG002|Overall Study|Alive and censored prior to 1 year|0|||
131127017|NCT00530894|472094702|FG003|Overall Study|Alive and censored prior to 1 year|0|||
131127018|NCT01230242|472094703|FG000|Overall Study|Physician Decision|2|||
131127019|NCT01230242|472094703|FG000|Overall Study|Withdrawal by Subject|1|||
131127020|NCT02256540|472094704|FG000|Overall Study|Withdrawal by Subject|0|||
131127021|NCT02256540|472094705|FG001|Overall Study|Withdrawal by Subject|1|||
131127022|NCT02256540|472094706|FG002|Overall Study|Withdrawal by Subject|1|||
131127023|NCT02256540|472094704|FG000|Overall Study|Back pain preventing exercise|0|||
131127024|NCT02256540|472094705|FG001|Overall Study|Back pain preventing exercise|0|||
131127025|NCT02256540|472094706|FG002|Overall Study|Back pain preventing exercise|1|||
131127026|NCT04329702|472094713|FG000|Overall Study|illness|3|||
131127027|NCT04329702|472094714|FG001|Overall Study|illness|4|||
131127028|NCT04329702|472094715|FG002|Overall Study|illness|0|||
131127029|NCT04329702|472094713|FG000|Overall Study|Lost to Follow-up|0|||
131127030|NCT04329702|472094714|FG001|Overall Study|Lost to Follow-up|0|||
131127031|NCT04329702|472094715|FG002|Overall Study|Lost to Follow-up|2|||
130959107|NCT02047110|471478901|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
130959108|NCT02047110|471478902|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
131127032|NCT04329702|472094713|FG000|Overall Study|Death|0|||
131127033|NCT04329702|472094714|FG001|Overall Study|Death|2|||
131127034|NCT04329702|472094715|FG002|Overall Study|Death|0|||
131127035|NCT03719690|472094720|FG000|Overall Study|Withdrawal by Subject|5|||
130959109|NCT02047110|471478903|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
130959110|NCT02047110|471478904|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
130959111|NCT02047110|471478901|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
130959112|NCT02047110|471478902|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
130959113|NCT02047110|471478903|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
131127036|NCT03719690|472094721|FG001|Overall Study|Withdrawal by Subject|10|||
131040532|NCT01928394|471785333|FG021|Treatment Period|Disease progression|31|||
131040533|NCT01928394|471785334|FG022|Treatment Period|Disease progression|31|||
130959114|NCT02047110|471478904|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
130959115|NCT02047110|471478901|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
130959116|NCT02047110|471478902|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
130959117|NCT02047110|471478903|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
131040534|NCT01928394|471785312|FG000|Treatment Period|Study drug toxicity|1|||
131040535|NCT01928394|471785313|FG001|Treatment Period|Study drug toxicity|1|||
131040536|NCT01928394|471785314|FG002|Treatment Period|Study drug toxicity|3|||
131040537|NCT01928394|471785315|FG003|Treatment Period|Study drug toxicity|3|||
131040538|NCT01928394|471785316|FG004|Treatment Period|Study drug toxicity|0|||
131040539|NCT01928394|471785317|FG005|Treatment Period|Study drug toxicity|9|||
131040540|NCT01928394|471785318|FG006|Treatment Period|Study drug toxicity|7|||
131040541|NCT01928394|471785319|FG007|Treatment Period|Study drug toxicity|1|||
130959118|NCT02047110|471478904|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
130959119|NCT02047110|471478901|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
130959120|NCT02047110|471478902|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
130959121|NCT02047110|471478903|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
131040542|NCT01928394|471785320|FG008|Treatment Period|Study drug toxicity|0|||
131040543|NCT01928394|471785321|FG009|Treatment Period|Study drug toxicity|5|||
131040544|NCT01928394|471785322|FG010|Treatment Period|Study drug toxicity|2|||
131040545|NCT01928394|471785323|FG011|Treatment Period|Study drug toxicity|3|||
131040546|NCT01928394|471785324|FG012|Treatment Period|Study drug toxicity|7|||
131040547|NCT01928394|471785325|FG013|Treatment Period|Study drug toxicity|5|||
131040548|NCT01928394|471785326|FG014|Treatment Period|Study drug toxicity|12|||
131040549|NCT01928394|471785327|FG015|Treatment Period|Study drug toxicity|0|||
131040550|NCT01928394|471785328|FG016|Treatment Period|Study drug toxicity|3|||
131040551|NCT01928394|471785329|FG017|Treatment Period|Study drug toxicity|3|||
131040552|NCT01928394|471785330|FG018|Treatment Period|Study drug toxicity|12|||
131040553|NCT01928394|471785331|FG019|Treatment Period|Study drug toxicity|15|||
131040554|NCT01928394|471785332|FG020|Treatment Period|Study drug toxicity|4|||
131040555|NCT01928394|471785333|FG021|Treatment Period|Study drug toxicity|7|||
131040556|NCT01928394|471785334|FG022|Treatment Period|Study drug toxicity|4|||
131040557|NCT01928394|471785312|FG000|Treatment Period|AE unrelated to study drug|0|||
131040558|NCT01928394|471785313|FG001|Treatment Period|AE unrelated to study drug|0|||
131040559|NCT01928394|471785314|FG002|Treatment Period|AE unrelated to study drug|2|||
131040560|NCT01928394|471785315|FG003|Treatment Period|AE unrelated to study drug|3|||
131040561|NCT01928394|471785316|FG004|Treatment Period|AE unrelated to study drug|0|||
131040562|NCT01928394|471785317|FG005|Treatment Period|AE unrelated to study drug|5|||
131040563|NCT01928394|471785318|FG006|Treatment Period|AE unrelated to study drug|1|||
131040564|NCT01928394|471785319|FG007|Treatment Period|AE unrelated to study drug|0|||
131040565|NCT01928394|471785320|FG008|Treatment Period|AE unrelated to study drug|0|||
131040566|NCT01928394|471785321|FG009|Treatment Period|AE unrelated to study drug|2|||
131040567|NCT01928394|471785322|FG010|Treatment Period|AE unrelated to study drug|0|||
131040568|NCT01928394|471785323|FG011|Treatment Period|AE unrelated to study drug|12|||
131040569|NCT01928394|471785324|FG012|Treatment Period|AE unrelated to study drug|6|||
131040570|NCT01928394|471785325|FG013|Treatment Period|AE unrelated to study drug|13|||
131040571|NCT01928394|471785326|FG014|Treatment Period|AE unrelated to study drug|6|||
131040572|NCT01928394|471785327|FG015|Treatment Period|AE unrelated to study drug|1|||
131040573|NCT01928394|471785328|FG016|Treatment Period|AE unrelated to study drug|1|||
131040574|NCT01928394|471785329|FG017|Treatment Period|AE unrelated to study drug|6|||
131040575|NCT01928394|471785330|FG018|Treatment Period|AE unrelated to study drug|3|||
131040576|NCT01928394|471785331|FG019|Treatment Period|AE unrelated to study drug|5|||
130959122|NCT02047110|471478904|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
130959123|NCT02047110|471478901|FG000|Escape Treatment Period|Adverse Event|1|||
130959124|NCT02047110|471478902|FG001|Escape Treatment Period|Adverse Event|2|||
130959125|NCT02047110|471478903|FG002|Escape Treatment Period|Adverse Event|2|||
130959126|NCT02047110|471478904|FG003|Escape Treatment Period|Adverse Event|0|||
130959127|NCT02047110|471478901|FG000|Escape Treatment Period|Other than specified|1|||
131040577|NCT01928394|471785332|FG020|Treatment Period|AE unrelated to study drug|1|||
131040578|NCT01928394|471785333|FG021|Treatment Period|AE unrelated to study drug|1|||
131040579|NCT01928394|471785334|FG022|Treatment Period|AE unrelated to study drug|0|||
131040580|NCT01928394|471785312|FG000|Treatment Period|Participant request to stop therapy|0|||
131040581|NCT01928394|471785313|FG001|Treatment Period|Participant request to stop therapy|0|||
131127037|NCT03719690|472094720|FG000|Overall Study|Death|40|||
131127038|NCT03719690|472094721|FG001|Overall Study|Death|149|||
131127039|NCT03719690|472094720|FG000|Overall Study|Miscellaneous|12|||
131127040|NCT03719690|472094721|FG001|Overall Study|Miscellaneous|56|||
131127041|NCT03719690|472094720|FG000|Overall Study|Lost to Follow-up|2|||
131040582|NCT01928394|471785314|FG002|Treatment Period|Participant request to stop therapy|0|||
131040583|NCT01928394|471785315|FG003|Treatment Period|Participant request to stop therapy|0|||
131040584|NCT01928394|471785316|FG004|Treatment Period|Participant request to stop therapy|0|||
131127042|NCT03719690|472094721|FG001|Overall Study|Lost to Follow-up|18|||
130959128|NCT02047110|471478902|FG001|Escape Treatment Period|Other than specified|2|||
130959129|NCT02047110|471478903|FG002|Escape Treatment Period|Other than specified|0|||
130959130|NCT02047110|471478904|FG003|Escape Treatment Period|Other than specified|1|||
130959131|NCT02047110|471478901|FG000|OLE Treatment Period|Other than specified|0|||
130959132|NCT02047110|471478902|FG001|OLE Treatment Period|Other than specified|0|||
130959133|NCT02047110|471478903|FG002|OLE Treatment Period|Other than specified|1|||
130959134|NCT02047110|471478904|FG003|OLE Treatment Period|Other than specified|0|||
130959135|NCT04439240|471478905|FG000|Overall Study|Ineligible|2|||
130959136|NCT04439240|471478905|FG000|Overall Study|Never started treatment|2|||
130959137|NCT04439240|471478905|FG000|Overall Study|Adverse Event|12|||
130959138|NCT04439240|471478905|FG000|Overall Study|Death|2|||
130959139|NCT04439240|471478905|FG000|Overall Study|Disease progression|25|||
130959140|NCT04439240|471478905|FG000|Overall Study|Other diseases|2|||
130959141|NCT04439240|471478905|FG000|Overall Study|Withdrawal by Subject|3|||
130959142|NCT04439240|471478905|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
130959143|NCT04439240|471478905|FG000|Overall Study|Symptomatic decline|1|||
130959144|NCT04439240|471478905|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
130959145|NCT04439240|471478905|FG000|Overall Study|Clinical progression|1|||
130959146|NCT00673452|471478906|FG000|Acute Double-Blind Phase|Adverse Event|41|||
130959147|NCT00673452|471478907|FG001|Acute Double-Blind Phase|Adverse Event|24|||
130959148|NCT00673452|471478906|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
130959149|NCT00673452|471478907|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
130959150|NCT00673452|471478906|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
130959151|NCT00673452|471478907|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
130959152|NCT00673452|471478906|FG000|Acute Double-Blind Phase|Physician Decision|0|||
130959153|NCT00673452|471478907|FG001|Acute Double-Blind Phase|Physician Decision|6|||
130959154|NCT00673452|471478906|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
130959155|NCT00673452|471478907|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
130959156|NCT00673452|471478906|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
130959157|NCT00673452|471478907|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
130959158|NCT00673452|471478906|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
130959159|NCT00673452|471478907|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
130959160|NCT00673452|471478906|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
130959161|NCT00673452|471478907|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
130959162|NCT00673452|471478906|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
130959163|NCT00673452|471478907|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
130959164|NCT00673452|471478906|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
130959165|NCT00673452|471478907|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
130959166|NCT00673452|471478906|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
130959167|NCT00673452|471478907|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
130959168|NCT00673452|471478906|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
130959169|NCT00673452|471478907|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
130959170|NCT00673452|471478906|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
130959171|NCT00673452|471478907|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
130959172|NCT00673452|471478906|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
130959173|NCT00673452|471478907|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
130959174|NCT00673452|471478906|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
130959175|NCT00673452|471478907|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
130959176|NCT00813124|471478908|FG000|Overall Study|Death|2|||
130959177|NCT00813124|471478908|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
130959178|NCT00813124|471478908|FG000|Overall Study|Withdrawal by Subject|1|||
130959179|NCT00079274|471478913|FG000|Overall Study|Withdrawal by Subject|111|||
130959180|NCT00079274|471478914|FG001|Overall Study|Withdrawal by Subject|10|||
130959181|NCT00079274|471478915|FG002|Overall Study|Withdrawal by Subject|12|||
130959182|NCT00079274|471478916|FG003|Overall Study|Withdrawal by Subject|163|||
130959183|NCT00079274|471478917|FG004|Overall Study|Withdrawal by Subject|7|||
130959184|NCT00079274|471478918|FG005|Overall Study|Withdrawal by Subject|8|||
130959185|NCT00079274|471478919|FG006|Overall Study|Withdrawal by Subject|0|||
130959186|NCT00079274|471478913|FG000|Overall Study|Adverse Event|130|||
130959187|NCT00079274|471478914|FG001|Overall Study|Adverse Event|8|||
130959188|NCT00079274|471478915|FG002|Overall Study|Adverse Event|8|||
130959189|NCT00079274|471478916|FG003|Overall Study|Adverse Event|184|||
130959190|NCT00079274|471478917|FG004|Overall Study|Adverse Event|7|||
130959191|NCT00079274|471478918|FG005|Overall Study|Adverse Event|8|||
130959192|NCT00079274|471478919|FG006|Overall Study|Adverse Event|0|||
130959193|NCT00079274|471478913|FG000|Overall Study|Recurrence|21|||
130959194|NCT00079274|471478914|FG001|Overall Study|Recurrence|0|||
130959195|NCT00079274|471478915|FG002|Overall Study|Recurrence|1|||
130959196|NCT00079274|471478916|FG003|Overall Study|Recurrence|15|||
130959197|NCT00079274|471478917|FG004|Overall Study|Recurrence|0|||
130959198|NCT00079274|471478918|FG005|Overall Study|Recurrence|2|||
130959199|NCT00079274|471478919|FG006|Overall Study|Recurrence|0|||
130959200|NCT00079274|471478913|FG000|Overall Study|Alternate Treatment|6|||
130959201|NCT00079274|471478914|FG001|Overall Study|Alternate Treatment|1|||
130714363|NCT03502707|470581656|FG006|Overall Study|Initiated Prohibited Medication|0|||
130714364|NCT03502707|470581657|FG007|Overall Study|Initiated Prohibited Medication|0|||
130714365|NCT03502707|470581658|FG008|Overall Study|Initiated Prohibited Medication|0|||
130714366|NCT03502707|470581659|FG009|Overall Study|Initiated Prohibited Medication|0|||
130714367|NCT03502707|470581660|FG010|Overall Study|Initiated Prohibited Medication|0|||
130959202|NCT00079274|471478915|FG002|Overall Study|Alternate Treatment|0|||
130959203|NCT00079274|471478916|FG003|Overall Study|Alternate Treatment|3|||
130959204|NCT00079274|471478917|FG004|Overall Study|Alternate Treatment|0|||
130959205|NCT00079274|471478918|FG005|Overall Study|Alternate Treatment|0|||
130959206|NCT00079274|471478919|FG006|Overall Study|Alternate Treatment|0|||
130959207|NCT00079274|471478913|FG000|Overall Study|Other Medical Problems|6|||
130959208|NCT00079274|471478914|FG001|Overall Study|Other Medical Problems|1|||
130959209|NCT00079274|471478915|FG002|Overall Study|Other Medical Problems|0|||
130959210|NCT00079274|471478916|FG003|Overall Study|Other Medical Problems|7|||
130959211|NCT00079274|471478917|FG004|Overall Study|Other Medical Problems|0|||
130959212|NCT00079274|471478918|FG005|Overall Study|Other Medical Problems|0|||
130959213|NCT00079274|471478919|FG006|Overall Study|Other Medical Problems|0|||
130959214|NCT00079274|471478913|FG000|Overall Study|Death|4|||
130959215|NCT00079274|471478914|FG001|Overall Study|Death|0|||
130959216|NCT00079274|471478915|FG002|Overall Study|Death|1|||
130959217|NCT00079274|471478916|FG003|Overall Study|Death|15|||
130959218|NCT00079274|471478917|FG004|Overall Study|Death|0|||
130959219|NCT00079274|471478918|FG005|Overall Study|Death|0|||
130959220|NCT00079274|471478919|FG006|Overall Study|Death|0|||
130959221|NCT00079274|471478913|FG000|Overall Study|Cytogenetic resistance|0|||
130959222|NCT00079274|471478914|FG001|Overall Study|Cytogenetic resistance|0|||
130959223|NCT00079274|471478915|FG002|Overall Study|Cytogenetic resistance|0|||
130959224|NCT00079274|471478916|FG003|Overall Study|Cytogenetic resistance|2|||
130959225|NCT00079274|471478917|FG004|Overall Study|Cytogenetic resistance|0|||
130959226|NCT00079274|471478918|FG005|Overall Study|Cytogenetic resistance|0|||
130959227|NCT00079274|471478919|FG006|Overall Study|Cytogenetic resistance|0|||
130959228|NCT00079274|471478913|FG000|Overall Study|Other|43|||
130959229|NCT00079274|471478914|FG001|Overall Study|Other|7|||
130959230|NCT00079274|471478915|FG002|Overall Study|Other|5|||
130959231|NCT00079274|471478916|FG003|Overall Study|Other|55|||
130959232|NCT00079274|471478917|FG004|Overall Study|Other|1|||
130959233|NCT00079274|471478918|FG005|Overall Study|Other|2|||
130959234|NCT00079274|471478919|FG006|Overall Study|Other|0|||
130959235|NCT02075320|471478920|FG000|Overall Study|Withdrawal by Subject|2|||
130959236|NCT03773757|471478922|FG000|Overall Study|Withdrawal by Subject|2|||
130959237|NCT03773757|471478923|FG001|Overall Study|Withdrawal by Subject|4|||
130959238|NCT04542070|471478924|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
130959239|NCT04542070|471478925|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
130959240|NCT04542070|471478926|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
130959241|NCT04542070|471478927|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
130959242|NCT04542070|471478924|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
130959243|NCT04542070|471478925|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
130959244|NCT04542070|471478926|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
130959245|NCT04542070|471478927|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
130959246|NCT04542070|471478924|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
130959247|NCT04542070|471478925|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
130959248|NCT04542070|471478926|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
130959249|NCT04542070|471478927|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
130959250|NCT04542070|471478924|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
130959251|NCT04542070|471478925|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
130959252|NCT04542070|471478926|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
130959253|NCT04542070|471478927|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
130959254|NCT04542070|471478924|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
130959255|NCT04542070|471478925|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
130959256|NCT04542070|471478926|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
130959257|NCT04542070|471478927|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
130959258|NCT04542070|471478924|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
130959259|NCT04542070|471478925|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
130959260|NCT04542070|471478926|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
130959261|NCT04542070|471478927|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
130959262|NCT04542070|471478924|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
130959263|NCT04542070|471478925|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
130959264|NCT04542070|471478926|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
130959265|NCT04542070|471478927|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
130959266|NCT04542070|471478924|FG000|Maintenance + Extension Period|Adverse Event|10|||
130959267|NCT04542070|471478925|FG001|Maintenance + Extension Period|Adverse Event|2|||
130959268|NCT04542070|471478926|FG002|Maintenance + Extension Period|Adverse Event|0|||
130959269|NCT04542070|471478927|FG003|Maintenance + Extension Period|Adverse Event|0|||
130959270|NCT04542070|471478924|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
130959271|NCT04542070|471478925|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
130959272|NCT04542070|471478926|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
130959273|NCT04542070|471478927|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
130959274|NCT04542070|471478924|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
130959275|NCT04542070|471478925|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
130959276|NCT04542070|471478926|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
130959277|NCT04542070|471478927|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
130959278|NCT04542070|471478924|FG000|Maintenance + Extension Period|Physician Decision|1|||
130959279|NCT04542070|471478925|FG001|Maintenance + Extension Period|Physician Decision|1|||
130959280|NCT04542070|471478926|FG002|Maintenance + Extension Period|Physician Decision|0|||
130959281|NCT04542070|471478927|FG003|Maintenance + Extension Period|Physician Decision|0|||
130959282|NCT04542070|471478924|FG000|Maintenance + Extension Period|Protocol Violation|2|||
130959283|NCT04542070|471478925|FG001|Maintenance + Extension Period|Protocol Violation|5|||
130959284|NCT04542070|471478926|FG002|Maintenance + Extension Period|Protocol Violation|0|||
130959285|NCT04542070|471478927|FG003|Maintenance + Extension Period|Protocol Violation|0|||
130959286|NCT04542070|471478924|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
130959287|NCT04542070|471478925|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
130959288|NCT04542070|471478926|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
130959289|NCT04542070|471478927|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
130959290|NCT04542070|471478924|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
130959291|NCT04542070|471478925|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
130959292|NCT04542070|471478926|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
130959293|NCT04542070|471478927|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
130959294|NCT04542070|471478924|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
130959295|NCT04542070|471478925|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
130959296|NCT04542070|471478926|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
130959297|NCT04542070|471478927|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
130959298|NCT04542070|471478924|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
130959299|NCT04542070|471478925|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
130959300|NCT04542070|471478926|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
130959301|NCT04542070|471478927|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
130959302|NCT04542070|471478924|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
130959303|NCT04542070|471478925|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
130959304|NCT04542070|471478926|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
130959305|NCT04542070|471478927|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
130959306|NCT04542070|471478924|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
130959307|NCT04542070|471478925|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
130959308|NCT04542070|471478926|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
130959309|NCT04542070|471478927|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
130959310|NCT04542070|471478924|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
130959311|NCT04542070|471478925|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
130959312|NCT04542070|471478926|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
130959313|NCT04542070|471478927|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
130959314|NCT03049813|471478929|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
130959315|NCT03049813|471478930|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
130959316|NCT03049813|471478931|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
130959317|NCT03049813|471478932|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
130959318|NCT03049813|471478929|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
130959319|NCT03049813|471478930|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
130959320|NCT03049813|471478931|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
130959321|NCT03049813|471478932|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
130959322|NCT03049813|471478929|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
130959323|NCT03049813|471478930|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
130959324|NCT03049813|471478931|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
130959325|NCT03049813|471478932|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
130959326|NCT03049813|471478929|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
130959327|NCT03049813|471478930|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
130959328|NCT03049813|471478931|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
130774791|NCT03410992|470802569|FG010|Week 16 Assessment|Incorrect escapers|0|||
131040585|NCT01928394|471785317|FG005|Treatment Period|Participant request to stop therapy|3|||
130959329|NCT03049813|471478932|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
130959330|NCT00550836|471478933|FG000|Overall Study|Withdrawal by Subject|3|||
130959331|NCT00550836|471478934|FG001|Overall Study|Withdrawal by Subject|9|||
130959332|NCT03120013|471478935|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
130959333|NCT03120013|471478936|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130959334|NCT00378703|471478937|FG000|Overall Study|Disease progression|59|||
130959335|NCT00378703|471478938|FG001|Overall Study|Disease progression|43|||
130959336|NCT00378703|471478939|FG002|Overall Study|Disease progression|48|||
130959337|NCT00378703|471478940|FG003|Overall Study|Disease progression|49|||
130959338|NCT00378703|471478937|FG000|Overall Study|Adverse Event|11|||
130959339|NCT00378703|471478938|FG001|Overall Study|Adverse Event|17|||
130959340|NCT00378703|471478939|FG002|Overall Study|Adverse Event|20|||
130959341|NCT00378703|471478940|FG003|Overall Study|Adverse Event|18|||
130959342|NCT00378703|471478937|FG000|Overall Study|Death|2|||
130959343|NCT00378703|471478938|FG001|Overall Study|Death|2|||
130959344|NCT00378703|471478939|FG002|Overall Study|Death|4|||
130959345|NCT00378703|471478940|FG003|Overall Study|Death|3|||
130959346|NCT00378703|471478937|FG000|Overall Study|Withdrawal by Subject|4|||
130959347|NCT00378703|471478938|FG001|Overall Study|Withdrawal by Subject|8|||
130959348|NCT00378703|471478939|FG002|Overall Study|Withdrawal by Subject|5|||
130959349|NCT00378703|471478940|FG003|Overall Study|Withdrawal by Subject|7|||
130959350|NCT00378703|471478937|FG000|Overall Study|Physician Decision|1|||
130959351|NCT00378703|471478938|FG001|Overall Study|Physician Decision|4|||
130959352|NCT00378703|471478939|FG002|Overall Study|Physician Decision|1|||
130959353|NCT00378703|471478940|FG003|Overall Study|Physician Decision|0|||
130959354|NCT00378703|471478937|FG000|Overall Study|Alternative therapy|4|||
130959355|NCT00378703|471478938|FG001|Overall Study|Alternative therapy|2|||
130959356|NCT00378703|471478939|FG002|Overall Study|Alternative therapy|0|||
130959357|NCT00378703|471478940|FG003|Overall Study|Alternative therapy|0|||
130959358|NCT00378703|471478937|FG000|Overall Study|Other complicated disease|0|||
130959359|NCT00378703|471478938|FG001|Overall Study|Other complicated disease|2|||
130959360|NCT00378703|471478939|FG002|Overall Study|Other complicated disease|2|||
130959361|NCT00378703|471478940|FG003|Overall Study|Other complicated disease|0|||
130959362|NCT00378703|471478937|FG000|Overall Study|Symptomatic deterioration|0|||
130959363|NCT00378703|471478938|FG001|Overall Study|Symptomatic deterioration|1|||
130959364|NCT00378703|471478939|FG002|Overall Study|Symptomatic deterioration|0|||
130959365|NCT00378703|471478940|FG003|Overall Study|Symptomatic deterioration|2|||
130959366|NCT00378703|471478937|FG000|Overall Study|Surgery|1|||
130959367|NCT00378703|471478938|FG001|Overall Study|Surgery|0|||
130959368|NCT00378703|471478939|FG002|Overall Study|Surgery|0|||
130959369|NCT00378703|471478940|FG003|Overall Study|Surgery|1|||
130959370|NCT00378703|471478937|FG000|Overall Study|Joint decision of physician and patient|1|||
130959371|NCT00378703|471478938|FG001|Overall Study|Joint decision of physician and patient|0|||
130959372|NCT00378703|471478939|FG002|Overall Study|Joint decision of physician and patient|0|||
130959373|NCT00378703|471478940|FG003|Overall Study|Joint decision of physician and patient|0|||
130959374|NCT00378703|471478937|FG000|Overall Study|Adverse events and progressive disease|0|||
130959375|NCT00378703|471478938|FG001|Overall Study|Adverse events and progressive disease|0|||
131040586|NCT01928394|471785318|FG006|Treatment Period|Participant request to stop therapy|3|||
130959376|NCT00378703|471478939|FG002|Overall Study|Adverse events and progressive disease|0|||
130959377|NCT00378703|471478940|FG003|Overall Study|Adverse events and progressive disease|1|||
130959378|NCT00378703|471478937|FG000|Overall Study|Relocation|0|||
130959379|NCT00378703|471478938|FG001|Overall Study|Relocation|0|||
130959380|NCT00378703|471478939|FG002|Overall Study|Relocation|1|||
130959381|NCT00378703|471478940|FG003|Overall Study|Relocation|0|||
130959382|NCT00378703|471478937|FG000|Overall Study|Ineligible|4|||
130959383|NCT00378703|471478938|FG001|Overall Study|Ineligible|7|||
130959384|NCT00378703|471478939|FG002|Overall Study|Ineligible|7|||
130959385|NCT00378703|471478940|FG003|Overall Study|Ineligible|7|||
130959386|NCT00378703|471478937|FG000|Overall Study|Never started treatment|1|||
130959387|NCT00378703|471478938|FG001|Overall Study|Never started treatment|4|||
130959388|NCT00378703|471478939|FG002|Overall Study|Never started treatment|0|||
130959389|NCT00378703|471478940|FG003|Overall Study|Never started treatment|0|||
130959390|NCT00378703|471478937|FG000|Overall Study|Other|1|||
130959391|NCT00378703|471478938|FG001|Overall Study|Other|1|||
130959392|NCT00378703|471478939|FG002|Overall Study|Other|2|||
130959393|NCT00378703|471478940|FG003|Overall Study|Other|3|||
130959394|NCT02705820|471478941|FG000|Overall Study|Death|2|||
131040587|NCT01928394|471785319|FG007|Treatment Period|Participant request to stop therapy|0|||
130959395|NCT02705820|471478941|FG000|Overall Study|Disease Progression|34|||
130959396|NCT02705820|471478941|FG000|Overall Study|Clinical Deterioration|3|||
130959397|NCT02702401|471478942|FG000|Overall Study|Death|242|||
130959398|NCT02702401|471478943|FG001|Overall Study|Death|125|||
130959399|NCT02702401|471478942|FG000|Overall Study|Withdrawal by Subject|15|||
130959400|NCT02702401|471478943|FG001|Overall Study|Withdrawal by Subject|5|||
130959401|NCT02702401|471478942|FG000|Overall Study|Sponsor Decision|19|||
130959402|NCT02702401|471478943|FG001|Overall Study|Sponsor Decision|3|||
130959403|NCT02702401|471478942|FG000|Overall Study|Physician Decision|1|||
130959404|NCT02702401|471478943|FG001|Overall Study|Physician Decision|2|||
130959405|NCT02702401|471478942|FG000|Overall Study|Lost to Follow-up|1|||
130959406|NCT02702401|471478943|FG001|Overall Study|Lost to Follow-up|0|||
130959407|NCT04292730|471478953|FG000|Overall Study|Lost to Follow-up|8|||
131040588|NCT01928394|471785320|FG008|Treatment Period|Participant request to stop therapy|0|||
131040589|NCT01928394|471785321|FG009|Treatment Period|Participant request to stop therapy|0|||
131040590|NCT01928394|471785322|FG010|Treatment Period|Participant request to stop therapy|3|||
131040591|NCT01928394|471785323|FG011|Treatment Period|Participant request to stop therapy|2|||
131040592|NCT01928394|471785324|FG012|Treatment Period|Participant request to stop therapy|1|||
131040593|NCT01928394|471785325|FG013|Treatment Period|Participant request to stop therapy|2|||
131040594|NCT01928394|471785326|FG014|Treatment Period|Participant request to stop therapy|4|||
131040595|NCT01928394|471785327|FG015|Treatment Period|Participant request to stop therapy|0|||
131040596|NCT01928394|471785328|FG016|Treatment Period|Participant request to stop therapy|1|||
131226326|NCT00950599|472455731|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
131226327|NCT00950599|472455732|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
131226328|NCT00950599|472455733|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
131226329|NCT00950599|472455724|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131226330|NCT00950599|472455725|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
131226331|NCT00950599|472455726|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
130714368|NCT03502707|470581661|FG011|Overall Study|Initiated Prohibited Medication|0|||
130714369|NCT03502707|470581662|FG012|Overall Study|Initiated Prohibited Medication|0|||
130714370|NCT03502707|470581663|FG013|Overall Study|Initiated Prohibited Medication|0|||
130714371|NCT03502707|470581664|FG014|Overall Study|Initiated Prohibited Medication|0|||
130714372|NCT03502707|470581665|FG015|Overall Study|Initiated Prohibited Medication|0|||
130714373|NCT03502707|470581666|FG016|Overall Study|Initiated Prohibited Medication|1|||
130714374|NCT03502707|470581667|FG017|Overall Study|Initiated Prohibited Medication|0|||
130714375|NCT03502707|470581650|FG000|Overall Study|Other|0|||
130714376|NCT03502707|470581651|FG001|Overall Study|Other|0|||
130714377|NCT03502707|470581652|FG002|Overall Study|Other|0|||
130714378|NCT03502707|470581653|FG003|Overall Study|Other|0|||
130714379|NCT03502707|470581654|FG004|Overall Study|Other|0|||
130714380|NCT03502707|470581655|FG005|Overall Study|Other|0|||
130714381|NCT03502707|470581656|FG006|Overall Study|Other|0|||
130959408|NCT04292730|471478954|FG001|Overall Study|Lost to Follow-up|12|||
130959409|NCT04292730|471478955|FG002|Overall Study|Lost to Follow-up|12|||
130959410|NCT04292730|471478956|FG003|Overall Study|Lost to Follow-up|48|||
130959411|NCT04292730|471478953|FG000|Overall Study|Death|2|||
130959412|NCT04292730|471478954|FG001|Overall Study|Death|2|||
130959413|NCT04292730|471478955|FG002|Overall Study|Death|4|||
130959414|NCT04292730|471478956|FG003|Overall Study|Death|12|||
130959415|NCT04292730|471478953|FG000|Overall Study|Withdrew Consent|2|||
130959416|NCT04292730|471478954|FG001|Overall Study|Withdrew Consent|2|||
130959417|NCT04292730|471478955|FG002|Overall Study|Withdrew Consent|5|||
130959418|NCT04292730|471478956|FG003|Overall Study|Withdrew Consent|6|||
130959419|NCT04292730|471478953|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130959420|NCT04292730|471478954|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130959421|NCT04292730|471478955|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130959422|NCT04292730|471478956|FG003|Overall Study|Non-Compliance with Study Drug|0|||
130959423|NCT04292730|471478953|FG000|Overall Study|Protocol Violation|0|||
130959424|NCT04292730|471478954|FG001|Overall Study|Protocol Violation|0|||
130959425|NCT04292730|471478955|FG002|Overall Study|Protocol Violation|1|||
130959426|NCT04292730|471478956|FG003|Overall Study|Protocol Violation|0|||
130959427|NCT04292730|471478953|FG000|Overall Study|Randomized but not Treated|8|||
130959428|NCT04292730|471478954|FG001|Overall Study|Randomized but not Treated|4|||
130959429|NCT04292730|471478955|FG002|Overall Study|Randomized but not Treated|0|||
130959430|NCT04292730|471478956|FG003|Overall Study|Randomized but not Treated|14|||
130959431|NCT01527292|471478957|FG000|Overall Study|Physician Decision|0|||
130959432|NCT01527292|471478958|FG001|Overall Study|Physician Decision|3|||
130959433|NCT00806546|471478959|FG000|Overall Study|Enrolled, not treated|35|||
130959434|NCT00806546|471478959|FG000|Overall Study|Lost to Follow-up|32|||
130959435|NCT00806546|471478959|FG000|Overall Study|Adverse Event|74|||
130959436|NCT00806546|471478959|FG000|Overall Study|Withdrawal by Subject|75|||
130959437|NCT00806546|471478959|FG000|Overall Study|Protocol Violation|49|||
130959438|NCT00806546|471478959|FG000|Overall Study|Various|42|||
130959439|NCT02751983|471478962|FG000|Treatment|Stopped ACT, but Remained in study|2|||
130959440|NCT02751983|471478963|FG001|Treatment|Stopped ACT, but Remained in study|0|||
130959441|NCT02751983|471478962|FG000|Treatment|Discharged prior to beginning ACT|2|||
130959442|NCT02751983|471478963|FG001|Treatment|Discharged prior to beginning ACT|0|||
130959443|NCT02751983|471478962|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
131226332|NCT00950599|472455727|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
130714382|NCT03502707|470581657|FG007|Overall Study|Other|0|||
130714383|NCT03502707|470581658|FG008|Overall Study|Other|1|||
130714384|NCT03502707|470581659|FG009|Overall Study|Other|1|||
130714385|NCT03502707|470581660|FG010|Overall Study|Other|2|||
130714386|NCT03502707|470581661|FG011|Overall Study|Other|0|||
130959444|NCT02751983|471478963|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
130959445|NCT02751983|471478962|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
130959446|NCT02751983|471478963|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
130959447|NCT02751983|471478962|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
130959448|NCT02751983|471478963|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
130959449|NCT00096044|471478964|FG000|Overall Study|Withdrawal by Subject|9|||
130959450|NCT00096044|471478964|FG000|Overall Study|Adverse Event|21|||
130959451|NCT00096044|471478964|FG000|Overall Study|Disease Progression|4|||
130959452|NCT03139916|471478967|FG000|Overall Study|Withdrawal by Subject|2|||
130959453|NCT03139916|471478967|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
130959454|NCT04587193|471478968|FG000|Overall Study|Screen failure after consent|3|||
130959455|NCT04587193|471478969|FG001|Overall Study|Screen failure after consent|0|||
131040597|NCT01928394|471785329|FG017|Treatment Period|Participant request to stop therapy|3|||
131040598|NCT01928394|471785330|FG018|Treatment Period|Participant request to stop therapy|1|||
131040599|NCT01928394|471785331|FG019|Treatment Period|Participant request to stop therapy|1|||
131040600|NCT01928394|471785332|FG020|Treatment Period|Participant request to stop therapy|3|||
131040601|NCT01928394|471785333|FG021|Treatment Period|Participant request to stop therapy|1|||
131040602|NCT01928394|471785334|FG022|Treatment Period|Participant request to stop therapy|3|||
130959456|NCT04587193|471478968|FG000|Overall Study|Device broke during study|3|||
130959457|NCT04587193|471478969|FG001|Overall Study|Device broke during study|2|||
130959458|NCT00813358|471478970|FG000|Overall Study|Death|32|||
130959459|NCT00813358|471478970|FG000|Overall Study|Lost to Follow-up|12|||
130959460|NCT00813358|471478970|FG000|Overall Study|other endpoints|5|||
130959461|NCT00813358|471478970|FG000|Overall Study|Withdrawal by Subject|20|||
130959462|NCT00004031|471478971|FG000|Overall Study|Adverse Event|5|||
130959463|NCT00004031|471478972|FG001|Overall Study|Adverse Event|0|||
131040603|NCT01928394|471785312|FG000|Treatment Period|Participant withdrew consent|0|||
131040604|NCT01928394|471785313|FG001|Treatment Period|Participant withdrew consent|0|||
131040605|NCT01928394|471785314|FG002|Treatment Period|Participant withdrew consent|1|||
131127043|NCT03719690|472094720|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
131127044|NCT03719690|472094721|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
131127045|NCT01918007|472094725|FG000|Overall Study|Baseline oximetry not acceptable|11|||
131127046|NCT01918007|472094726|FG001|Overall Study|Baseline oximetry not acceptable|7|||
131127047|NCT01918007|472094725|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
131127048|NCT01918007|472094726|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
131127049|NCT01918007|472094725|FG000|Overall Study|Lost to Follow-up|4|||
131127050|NCT01918007|472094726|FG001|Overall Study|Lost to Follow-up|7|||
131127051|NCT02037295|472094728|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
131127052|NCT02037295|472094729|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
131127053|NCT02037295|472094730|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
131127054|NCT02037295|472094731|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
131127055|NCT01140451|472094732|FG000|Overall Study|Withdrawal by Subject|26|||
131127056|NCT01140451|472094733|FG001|Overall Study|Withdrawal by Subject|33|||
131127057|NCT01140451|472094732|FG000|Overall Study|Adverse Event|2|||
131127058|NCT01140451|472094733|FG001|Overall Study|Adverse Event|6|||
131127059|NCT01140451|472094732|FG000|Overall Study|Physician Decision|5|||
131127060|NCT01140451|472094733|FG001|Overall Study|Physician Decision|3|||
131127061|NCT01140451|472094732|FG000|Overall Study|Lost to Follow-up|2|||
131127062|NCT01140451|472094733|FG001|Overall Study|Lost to Follow-up|0|||
131127063|NCT01140451|472094732|FG000|Overall Study|Participants Planning Pregnancy|3|||
131127064|NCT01140451|472094733|FG001|Overall Study|Participants Planning Pregnancy|0|||
131127065|NCT00441974|472094734|FG000|Overall Study|Adverse Event|6|||
131127066|NCT00441974|472094734|FG000|Overall Study|Consent Withdrawn|35|||
131127067|NCT00441974|472094734|FG000|Overall Study|Lost to Follow-up|80|||
131127068|NCT00441974|472094734|FG000|Overall Study|Protocol Violation|7|||
131127069|NCT02770547|472094735|FG000|Overall Study|Patient non-compliant|1|||
131127070|NCT02770547|472094736|FG001|Overall Study|Patient non-compliant|0|||
131127071|NCT02770547|472094735|FG000|Overall Study|Adverse Event|0|||
131127072|NCT02770547|472094736|FG001|Overall Study|Adverse Event|1|||
131127073|NCT00393887|472094737|FG000|Overall Study|Physician Decision|5|||
131127074|NCT00393887|472094738|FG001|Overall Study|Physician Decision|0|||
131127075|NCT00393887|472094737|FG000|Overall Study|Lost to Follow-up|11|||
131127076|NCT00393887|472094738|FG001|Overall Study|Lost to Follow-up|9|||
131127077|NCT04962022|472094741|FG000|Period 1|Withdrawal by Subject|1|||
131127078|NCT04962022|472094742|FG001|Period 1|Withdrawal by Subject|0|||
131127079|NCT01146873|472094746|FG000|Overall Study|Transfer out|0|||
131127080|NCT01146873|472094747|FG001|Overall Study|Transfer out|6|||
131127081|NCT01967628|472094748|FG000|Overall Study|Withdrawal by Subject|2|||
131127082|NCT01967628|472094749|FG001|Overall Study|Withdrawal by Subject|0|||
131127083|NCT01967628|472094748|FG000|Overall Study|Unable to complete bronchoscopy|4|||
131127084|NCT01967628|472094749|FG001|Overall Study|Unable to complete bronchoscopy|6|||
131127085|NCT01967628|472094748|FG000|Overall Study|Lost to Follow-up|1|||
131127086|NCT01967628|472094749|FG001|Overall Study|Lost to Follow-up|0|||
131127087|NCT01967628|472094748|FG000|Overall Study|Low protein concentration in sample|20|||
130774792|NCT03410992|470802559|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130959464|NCT00004031|471478971|FG000|Overall Study|Refusal unrelated to adverse events|2|||
130959465|NCT00004031|471478972|FG001|Overall Study|Refusal unrelated to adverse events|11|||
130714387|NCT03502707|470581662|FG012|Overall Study|Other|0|||
130714388|NCT03502707|470581663|FG013|Overall Study|Other|0|||
130714389|NCT03502707|470581664|FG014|Overall Study|Other|0|||
130714390|NCT03502707|470581665|FG015|Overall Study|Other|4|||
130714391|NCT03502707|470581666|FG016|Overall Study|Other|1|||
130959466|NCT00004031|471478971|FG000|Overall Study|Progression/relapse|9|||
130959467|NCT00004031|471478972|FG001|Overall Study|Progression/relapse|4|||
130959468|NCT00004031|471478971|FG000|Overall Study|Death|3|||
130959469|NCT00004031|471478972|FG001|Overall Study|Death|1|||
130959470|NCT00004031|471478971|FG000|Overall Study|Other- not protocol specified|3|||
130959471|NCT00004031|471478972|FG001|Overall Study|Other- not protocol specified|3|||
130959472|NCT00004031|471478971|FG000|Overall Study|Reason under review|3|||
130959473|NCT00004031|471478972|FG001|Overall Study|Reason under review|2|||
130959474|NCT03851016|471478975|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130959475|NCT03851016|471478976|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
130959476|NCT00586469|471478977|FG000|Overall Study|Adverse Event|0|||
130959477|NCT00586469|471478978|FG001|Overall Study|Adverse Event|1|||
130959478|NCT00991302|471481247|FG000|Overall Study|Death|0|||
130959479|NCT00991302|471481248|FG001|Overall Study|Death|1|||
130959480|NCT00991302|471481247|FG000|Overall Study|Lost to Follow-up|14|||
130959481|NCT00991302|471481248|FG001|Overall Study|Lost to Follow-up|12|||
130959482|NCT01709318|471481249|FG000|Overall Study|Adverse Event|3|||
130959483|NCT01709318|471481250|FG001|Overall Study|Adverse Event|4|||
130959484|NCT01709318|471481251|FG002|Overall Study|Adverse Event|2|||
130959485|NCT01709318|471481252|FG003|Overall Study|Adverse Event|2|||
130959486|NCT01709318|471481253|FG004|Overall Study|Adverse Event|0|||
130959487|NCT01709318|471481254|FG005|Overall Study|Adverse Event|1|||
130959488|NCT01709318|471481255|FG006|Overall Study|Adverse Event|2|||
130959489|NCT01709318|471481249|FG000|Overall Study|Lost to Follow-up|2|||
130959490|NCT01709318|471481250|FG001|Overall Study|Lost to Follow-up|0|||
130959491|NCT01709318|471481251|FG002|Overall Study|Lost to Follow-up|0|||
130959492|NCT01709318|471481252|FG003|Overall Study|Lost to Follow-up|0|||
130959493|NCT01709318|471481253|FG004|Overall Study|Lost to Follow-up|1|||
130959494|NCT01709318|471481254|FG005|Overall Study|Lost to Follow-up|1|||
130959495|NCT01709318|471481255|FG006|Overall Study|Lost to Follow-up|1|||
130959496|NCT01709318|471481249|FG000|Overall Study|Non-compliance with Study Drug|0|||
130959497|NCT01709318|471481250|FG001|Overall Study|Non-compliance with Study Drug|2|||
130959498|NCT01709318|471481251|FG002|Overall Study|Non-compliance with Study Drug|1|||
130959499|NCT01709318|471481252|FG003|Overall Study|Non-compliance with Study Drug|1|||
130959500|NCT01709318|471481253|FG004|Overall Study|Non-compliance with Study Drug|0|||
130959501|NCT01709318|471481254|FG005|Overall Study|Non-compliance with Study Drug|0|||
130959502|NCT01709318|471481255|FG006|Overall Study|Non-compliance with Study Drug|2|||
130959503|NCT01709318|471481249|FG000|Overall Study|Physician Decision|0|||
130959504|NCT01709318|471481250|FG001|Overall Study|Physician Decision|0|||
130959505|NCT01709318|471481251|FG002|Overall Study|Physician Decision|0|||
130959506|NCT01709318|471481252|FG003|Overall Study|Physician Decision|0|||
130959507|NCT01709318|471481253|FG004|Overall Study|Physician Decision|0|||
130959508|NCT01709318|471481254|FG005|Overall Study|Physician Decision|0|||
130959509|NCT01709318|471481255|FG006|Overall Study|Physician Decision|1|||
130959510|NCT01709318|471481249|FG000|Overall Study|Pregnancy|0|||
130959511|NCT01709318|471481250|FG001|Overall Study|Pregnancy|0|||
130959512|NCT01709318|471481251|FG002|Overall Study|Pregnancy|0|||
130959513|NCT01709318|471481252|FG003|Overall Study|Pregnancy|0|||
130959514|NCT01709318|471481253|FG004|Overall Study|Pregnancy|1|||
130959515|NCT01709318|471481254|FG005|Overall Study|Pregnancy|0|||
130959516|NCT01709318|471481255|FG006|Overall Study|Pregnancy|0|||
130959517|NCT01709318|471481249|FG000|Overall Study|Protocol Violation|0|||
130959518|NCT01709318|471481250|FG001|Overall Study|Protocol Violation|0|||
130959519|NCT01709318|471481251|FG002|Overall Study|Protocol Violation|0|||
130959520|NCT01709318|471481252|FG003|Overall Study|Protocol Violation|0|||
130959521|NCT01709318|471481253|FG004|Overall Study|Protocol Violation|2|||
130959522|NCT01709318|471481254|FG005|Overall Study|Protocol Violation|0|||
130959523|NCT01709318|471481255|FG006|Overall Study|Protocol Violation|1|||
130959524|NCT01709318|471481249|FG000|Overall Study|Technical Problems|1|||
130959525|NCT01709318|471481250|FG001|Overall Study|Technical Problems|0|||
131226333|NCT00950599|472455728|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
130714392|NCT03502707|470581667|FG017|Overall Study|Other|0|||
130959526|NCT01709318|471481251|FG002|Overall Study|Technical Problems|0|||
131226334|NCT00950599|472455729|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
130714393|NCT03502707|470581650|FG000|Overall Study|Randomized but not vaccinated|0|||
130959527|NCT01709318|471481252|FG003|Overall Study|Technical Problems|0|||
130959528|NCT01709318|471481253|FG004|Overall Study|Technical Problems|0|||
130959529|NCT01709318|471481254|FG005|Overall Study|Technical Problems|0|||
130959530|NCT01709318|471481255|FG006|Overall Study|Technical Problems|0|||
130959531|NCT01709318|471481249|FG000|Overall Study|Withdrawal by Subject|3|||
130959532|NCT01709318|471481250|FG001|Overall Study|Withdrawal by Subject|0|||
130959533|NCT01709318|471481251|FG002|Overall Study|Withdrawal by Subject|3|||
130959534|NCT01709318|471481252|FG003|Overall Study|Withdrawal by Subject|3|||
130959535|NCT01709318|471481253|FG004|Overall Study|Withdrawal by Subject|0|||
130959536|NCT01709318|471481254|FG005|Overall Study|Withdrawal by Subject|2|||
131040606|NCT01928394|471785315|FG003|Treatment Period|Participant withdrew consent|1|||
131040607|NCT01928394|471785316|FG004|Treatment Period|Participant withdrew consent|0|||
131040608|NCT01928394|471785317|FG005|Treatment Period|Participant withdrew consent|1|||
130959537|NCT01709318|471481255|FG006|Overall Study|Withdrawal by Subject|4|||
130959538|NCT01709318|471481249|FG000|Overall Study|Other Protocol Specified Criteria|0|||
130959539|NCT01709318|471481250|FG001|Overall Study|Other Protocol Specified Criteria|1|||
130959540|NCT01709318|471481251|FG002|Overall Study|Other Protocol Specified Criteria|0|||
130959541|NCT01709318|471481252|FG003|Overall Study|Other Protocol Specified Criteria|0|||
130959542|NCT01709318|471481253|FG004|Overall Study|Other Protocol Specified Criteria|0|||
130959543|NCT01709318|471481254|FG005|Overall Study|Other Protocol Specified Criteria|0|||
130959544|NCT01709318|471481255|FG006|Overall Study|Other Protocol Specified Criteria|0|||
130959545|NCT03228680|471481261|FG000|Overall Study|Adverse Event|13|||
130959546|NCT03228680|471481262|FG001|Overall Study|Adverse Event|18|||
130959547|NCT03228680|471481261|FG000|Overall Study|Randomization failure|0|||
131040609|NCT01928394|471785318|FG006|Treatment Period|Participant withdrew consent|0|||
131040610|NCT01928394|471785319|FG007|Treatment Period|Participant withdrew consent|1|||
131226335|NCT00950599|472455730|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
131226336|NCT00950599|472455731|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
131040611|NCT01928394|471785320|FG008|Treatment Period|Participant withdrew consent|0|||
131040612|NCT01928394|471785321|FG009|Treatment Period|Participant withdrew consent|0|||
131040613|NCT01928394|471785322|FG010|Treatment Period|Participant withdrew consent|1|||
131040614|NCT01928394|471785323|FG011|Treatment Period|Participant withdrew consent|1|||
131040615|NCT01928394|471785324|FG012|Treatment Period|Participant withdrew consent|1|||
131040616|NCT01928394|471785325|FG013|Treatment Period|Participant withdrew consent|0|||
131040617|NCT01928394|471785326|FG014|Treatment Period|Participant withdrew consent|2|||
131040618|NCT01928394|471785327|FG015|Treatment Period|Participant withdrew consent|0|||
131040619|NCT01928394|471785328|FG016|Treatment Period|Participant withdrew consent|2|||
131040620|NCT01928394|471785329|FG017|Treatment Period|Participant withdrew consent|1|||
131040621|NCT01928394|471785330|FG018|Treatment Period|Participant withdrew consent|1|||
131040622|NCT01928394|471785331|FG019|Treatment Period|Participant withdrew consent|1|||
131040623|NCT01928394|471785332|FG020|Treatment Period|Participant withdrew consent|0|||
131040624|NCT01928394|471785333|FG021|Treatment Period|Participant withdrew consent|2|||
131040625|NCT01928394|471785334|FG022|Treatment Period|Participant withdrew consent|0|||
131040626|NCT01928394|471785312|FG000|Treatment Period|Poor/non-compliance|0|||
131040627|NCT01928394|471785313|FG001|Treatment Period|Poor/non-compliance|0|||
131040628|NCT01928394|471785314|FG002|Treatment Period|Poor/non-compliance|0|||
131040629|NCT01928394|471785315|FG003|Treatment Period|Poor/non-compliance|1|||
131040630|NCT01928394|471785316|FG004|Treatment Period|Poor/non-compliance|0|||
131040631|NCT01928394|471785317|FG005|Treatment Period|Poor/non-compliance|0|||
131226337|NCT00950599|472455732|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
130959548|NCT03228680|471481262|FG001|Overall Study|Randomization failure|1|||
131040632|NCT01928394|471785318|FG006|Treatment Period|Poor/non-compliance|0|||
130959549|NCT03228680|471481261|FG000|Overall Study|Withdrawal by Subject|1|||
130959550|NCT03228680|471481262|FG001|Overall Study|Withdrawal by Subject|0|||
130959551|NCT03228680|471481261|FG000|Overall Study|Other|9|||
130959552|NCT03228680|471481262|FG001|Overall Study|Other|16|||
130959553|NCT02148003|471481263|FG000|Overall Study|Failed inclusion criteria|1|||
130959554|NCT02148003|471481264|FG001|Overall Study|Failed inclusion criteria|0|||
130959555|NCT02148003|471481263|FG000|Overall Study|Met exclusion criteria|0|||
130959556|NCT02148003|471481264|FG001|Overall Study|Met exclusion criteria|1|||
130959557|NCT02148003|471481263|FG000|Overall Study|Withdrawal by Subject|0|||
130959558|NCT02148003|471481264|FG001|Overall Study|Withdrawal by Subject|1|||
130959559|NCT02489981|471481265|FG000|Overall Study|Adverse Event|21|||
130959560|NCT02489981|471481265|FG000|Overall Study|Insufficient effectiveness|16|||
130959561|NCT02489981|471481265|FG000|Overall Study|Improved|31|||
130959562|NCT02489981|471481265|FG000|Overall Study|Lost to Follow-up|31|||
130959563|NCT02489981|471481265|FG000|Overall Study|Other than listed|28|||
130959564|NCT00796861|471481266|FG000|Overall Study|Withdrawal by Subject|2|||
130959565|NCT00796861|471481266|FG000|Overall Study|Death|2|||
130959566|NCT03852316|471481269|FG000|Overall Study|Protocol Violation|1|||
130959567|NCT03852316|471481269|FG000|Overall Study|Withdrawal by Subject|2|||
130959568|NCT03852316|471481269|FG000|Overall Study|Enrolled but Device not Utilized|1|||
130959569|NCT02664038|471481273|FG000|13 Week|Lost to Follow-up|7|||
130959570|NCT02664038|471481274|FG001|13 Week|Lost to Follow-up|14|||
131040633|NCT01928394|471785319|FG007|Treatment Period|Poor/non-compliance|0|||
131040634|NCT01928394|471785320|FG008|Treatment Period|Poor/non-compliance|0|||
130959571|NCT02664038|471481273|FG000|13 Week|Withdrawal by Subject|1|||
131040635|NCT01928394|471785321|FG009|Treatment Period|Poor/non-compliance|0|||
131040636|NCT01928394|471785322|FG010|Treatment Period|Poor/non-compliance|0|||
130959572|NCT02664038|471481274|FG001|13 Week|Withdrawal by Subject|0|||
130959573|NCT02664038|471481273|FG000|26 Week|Lost to Follow-up|5|||
130959574|NCT02664038|471481274|FG001|26 Week|Lost to Follow-up|4|||
130959575|NCT02606136|471481279|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
130959576|NCT02606136|471481279|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
130959577|NCT02606136|471481279|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
130714394|NCT03502707|470581651|FG001|Overall Study|Randomized but not vaccinated|0|||
130714395|NCT03502707|470581652|FG002|Overall Study|Randomized but not vaccinated|0|||
130714396|NCT03502707|470581653|FG003|Overall Study|Randomized but not vaccinated|0|||
130714397|NCT03502707|470581654|FG004|Overall Study|Randomized but not vaccinated|0|||
130714398|NCT03502707|470581655|FG005|Overall Study|Randomized but not vaccinated|0|||
130714399|NCT03502707|470581656|FG006|Overall Study|Randomized but not vaccinated|0|||
130714400|NCT03502707|470581657|FG007|Overall Study|Randomized but not vaccinated|0|||
130714401|NCT03502707|470581658|FG008|Overall Study|Randomized but not vaccinated|0|||
130714402|NCT03502707|470581659|FG009|Overall Study|Randomized but not vaccinated|0|||
130714403|NCT03502707|470581660|FG010|Overall Study|Randomized but not vaccinated|0|||
130714404|NCT03502707|470581661|FG011|Overall Study|Randomized but not vaccinated|1|||
130714405|NCT03502707|470581662|FG012|Overall Study|Randomized but not vaccinated|0|||
130714406|NCT03502707|470581663|FG013|Overall Study|Randomized but not vaccinated|0|||
130714407|NCT03502707|470581664|FG014|Overall Study|Randomized but not vaccinated|0|||
130714408|NCT03502707|470581665|FG015|Overall Study|Randomized but not vaccinated|0|||
130714409|NCT03502707|470581666|FG016|Overall Study|Randomized but not vaccinated|0|||
130714410|NCT03502707|470581667|FG017|Overall Study|Randomized but not vaccinated|1|||
130714411|NCT04908683|470581668|FG000|Overall Study|Failure to meet continuation criteria|34|||
130714412|NCT04908683|470581669|FG001|Overall Study|Failure to meet continuation criteria|22|||
130714413|NCT04908683|470581668|FG000|Overall Study|Initiated prohibited medication|3|||
130714414|NCT04908683|470581669|FG001|Overall Study|Initiated prohibited medication|0|||
130714415|NCT04908683|470581668|FG000|Overall Study|Randomized by mistake|1|||
130714416|NCT04908683|470581669|FG001|Overall Study|Randomized by mistake|0|||
130714417|NCT04908683|470581668|FG000|Overall Study|Lost to Follow-up|679|||
130714418|NCT04908683|470581669|FG001|Overall Study|Lost to Follow-up|341|||
130714419|NCT04908683|470581668|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
130714420|NCT04908683|470581669|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
130714421|NCT04908683|470581668|FG000|Overall Study|Physician Decision|44|||
130714422|NCT04908683|470581669|FG001|Overall Study|Physician Decision|35|||
130714423|NCT04908683|470581668|FG000|Overall Study|Technical problems|12|||
130714424|NCT04908683|470581669|FG001|Overall Study|Technical problems|9|||
130714425|NCT04908683|470581668|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
130959578|NCT02606136|471481279|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
130959579|NCT03296696|471481280|FG000|Overall Study|Started Other Antitumor Therapy|1|||
130959580|NCT03296696|471481281|FG001|Overall Study|Started Other Antitumor Therapy|2|||
130959581|NCT03296696|471481282|FG002|Overall Study|Started Other Antitumor Therapy|1|||
130959582|NCT03296696|471481283|FG003|Overall Study|Started Other Antitumor Therapy|2|||
130959583|NCT03296696|471481284|FG004|Overall Study|Started Other Antitumor Therapy|1|||
130959584|NCT03296696|471481285|FG005|Overall Study|Started Other Antitumor Therapy|1|||
130959585|NCT03296696|471481286|FG006|Overall Study|Started Other Antitumor Therapy|2|||
130959586|NCT03296696|471481287|FG007|Overall Study|Started Other Antitumor Therapy|3|||
130959587|NCT03296696|471481288|FG008|Overall Study|Started Other Antitumor Therapy|1|||
130959588|NCT03296696|471481289|FG009|Overall Study|Started Other Antitumor Therapy|0|||
130959589|NCT03296696|471481280|FG000|Overall Study|Death|0|||
130959590|NCT03296696|471481281|FG001|Overall Study|Death|1|||
130959591|NCT03296696|471481282|FG002|Overall Study|Death|1|||
130959592|NCT03296696|471481283|FG003|Overall Study|Death|2|||
130959593|NCT03296696|471481284|FG004|Overall Study|Death|2|||
130959594|NCT03296696|471481285|FG005|Overall Study|Death|3|||
130959595|NCT03296696|471481286|FG006|Overall Study|Death|1|||
130959596|NCT03296696|471481287|FG007|Overall Study|Death|2|||
130959597|NCT03296696|471481288|FG008|Overall Study|Death|0|||
130959598|NCT03296696|471481289|FG009|Overall Study|Death|0|||
130959599|NCT03296696|471481280|FG000|Overall Study|Withdrawal by Subject|0|||
130959600|NCT03296696|471481281|FG001|Overall Study|Withdrawal by Subject|0|||
130959601|NCT03296696|471481282|FG002|Overall Study|Withdrawal by Subject|1|||
130959602|NCT03296696|471481283|FG003|Overall Study|Withdrawal by Subject|0|||
130714426|NCT04908683|470581669|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
130959603|NCT03296696|471481284|FG004|Overall Study|Withdrawal by Subject|1|||
130959604|NCT03296696|471481285|FG005|Overall Study|Withdrawal by Subject|0|||
130959605|NCT03296696|471481286|FG006|Overall Study|Withdrawal by Subject|0|||
130714427|NCT04908683|470581668|FG000|Overall Study|Protocol Violation|2|||
130714428|NCT04908683|470581669|FG001|Overall Study|Protocol Violation|0|||
130959606|NCT03296696|471481287|FG007|Overall Study|Withdrawal by Subject|0|||
130959607|NCT03296696|471481288|FG008|Overall Study|Withdrawal by Subject|0|||
130959608|NCT03296696|471481289|FG009|Overall Study|Withdrawal by Subject|1|||
130959609|NCT04694131|471481293|FG000|Overall Study|Withdrawal by Subject|7|||
130959610|NCT04694131|471481293|FG000|Overall Study|Screen Failure|1|||
130959611|NCT04694131|471481293|FG000|Overall Study|High stimulation threshold|3|||
130959612|NCT04456699|471481294|FG000|Overall Study|Death|48|||
130714429|NCT04908683|470581668|FG000|Overall Study|Withdrawal by Subject|1188|||
130714430|NCT04908683|470581669|FG001|Overall Study|Withdrawal by Subject|570|||
130714431|NCT04908683|470581668|FG000|Overall Study|Site Closure by Sponsor|6|||
130959613|NCT04456699|471481295|FG001|Overall Study|Death|50|||
130959614|NCT04456699|471481296|FG002|Overall Study|Death|52|||
130959615|NCT04456699|471481294|FG000|Overall Study|Physician Decision|0|||
130959616|NCT04456699|471481295|FG001|Overall Study|Physician Decision|0|||
130959617|NCT04456699|471481296|FG002|Overall Study|Physician Decision|2|||
130959618|NCT04456699|471481294|FG000|Overall Study|Sponsor Decision|55|||
130959619|NCT04456699|471481295|FG001|Overall Study|Sponsor Decision|61|||
130959620|NCT04456699|471481296|FG002|Overall Study|Sponsor Decision|50|||
130959621|NCT04456699|471481294|FG000|Overall Study|Withdrawal by Subject|8|||
130959622|NCT04456699|471481295|FG001|Overall Study|Withdrawal by Subject|4|||
130959623|NCT04456699|471481296|FG002|Overall Study|Withdrawal by Subject|5|||
130959624|NCT04112810|471481297|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
130959625|NCT01859715|471481302|FG000|Overall Study|No 2nd VAS|16|||
130959626|NCT01859715|471481303|FG001|Overall Study|No 2nd VAS|8|||
130959627|NCT01859715|471481304|FG002|Overall Study|No 2nd VAS|23|||
130959628|NCT00086580|471481305|FG000|Treatment Period|Disease progression|9|||
130959629|NCT00086580|471481306|FG001|Treatment Period|Disease progression|8|||
130959630|NCT00086580|471481305|FG000|Treatment Period|Unable to comply with protocol|3|||
130959631|NCT00086580|471481306|FG001|Treatment Period|Unable to comply with protocol|1|||
130959632|NCT00086580|471481305|FG000|Treatment Period|Withdrawal by Subject|7|||
130959633|NCT00086580|471481306|FG001|Treatment Period|Withdrawal by Subject|8|||
130959634|NCT00086580|471481305|FG000|Treatment Period|Physician Decision|13|||
130959635|NCT00086580|471481306|FG001|Treatment Period|Physician Decision|7|||
130959636|NCT00086580|471481305|FG000|Treatment Period|AE - not treatment related|7|||
130959637|NCT00086580|471481306|FG001|Treatment Period|AE - not treatment related|7|||
130959638|NCT00086580|471481305|FG000|Treatment Period|Toxicity - treatment related|15|||
130959639|NCT00086580|471481306|FG001|Treatment Period|Toxicity - treatment related|15|||
130959640|NCT00086580|471481305|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
130959641|NCT00086580|471481306|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
130959642|NCT00086580|471481305|FG000|Treatment Period|Death|5|||
130959643|NCT00086580|471481306|FG001|Treatment Period|Death|7|||
130959644|NCT00086580|471481305|FG000|Treatment Period|Other|5|||
130959645|NCT00086580|471481306|FG001|Treatment Period|Other|3|||
130959646|NCT00086580|471481305|FG000|Follow-up Period|Disease progression|72|||
130959647|NCT00086580|471481306|FG001|Follow-up Period|Disease progression|99|||
130959648|NCT00086580|471481305|FG000|Follow-up Period|Unable to comply with protocol|5|||
130959649|NCT00086580|471481306|FG001|Follow-up Period|Unable to comply with protocol|0|||
130959650|NCT00086580|471481305|FG000|Follow-up Period|Withdrawal by Subject|6|||
130959651|NCT00086580|471481306|FG001|Follow-up Period|Withdrawal by Subject|6|||
130959652|NCT00086580|471481305|FG000|Follow-up Period|Physician Decision|0|||
130959653|NCT00086580|471481306|FG001|Follow-up Period|Physician Decision|1|||
130959654|NCT00086580|471481305|FG000|Follow-up Period|AE - not related|1|||
130959655|NCT00086580|471481306|FG001|Follow-up Period|AE - not related|0|||
130959656|NCT00086580|471481305|FG000|Follow-up Period|Death|13|||
130959657|NCT00086580|471481306|FG001|Follow-up Period|Death|7|||
130959658|NCT00086580|471481305|FG000|Follow-up Period|Other|7|||
130959659|NCT00086580|471481306|FG001|Follow-up Period|Other|6|||
130959660|NCT00086580|471481305|FG000|Observation Period|Unable to comply with protocol|1|||
130959661|NCT00086580|471481306|FG001|Observation Period|Unable to comply with protocol|1|||
130959662|NCT00086580|471481305|FG000|Observation Period|Withdrawal by Subject|4|||
130959663|NCT00086580|471481306|FG001|Observation Period|Withdrawal by Subject|2|||
130959664|NCT00086580|471481305|FG000|Observation Period|Death|33|||
130959665|NCT00086580|471481306|FG001|Observation Period|Death|55|||
130959666|NCT00086580|471481305|FG000|Observation Period|Other|8|||
130959667|NCT00086580|471481306|FG001|Observation Period|Other|7|||
130959668|NCT01000051|471481307|FG000|Overall Study|Withdrawal by Subject|1|||
130959669|NCT01000051|471481308|FG001|Overall Study|Withdrawal by Subject|1|||
130959670|NCT01000051|471481307|FG000|Overall Study|Disease Progression|1|||
130959671|NCT01000051|471481308|FG001|Overall Study|Disease Progression|0|||
130959672|NCT01000051|471481307|FG000|Overall Study|Serious noncompliance|1|||
130959673|NCT01000051|471481308|FG001|Overall Study|Serious noncompliance|0|||
130959674|NCT02247349|471481309|FG000|Overall Study|Disease Progression|7|||
130959675|NCT02247349|471481310|FG001|Overall Study|Disease Progression|4|||
130959676|NCT02247349|471481311|FG002|Overall Study|Disease Progression|26|||
130959677|NCT02247349|471481312|FG003|Overall Study|Disease Progression|31|||
131127088|NCT01967628|472094749|FG001|Overall Study|Low protein concentration in sample|25|||
130959678|NCT02247349|471481313|FG004|Overall Study|Disease Progression|16|||
130959679|NCT02247349|471481314|FG005|Overall Study|Disease Progression|6|||
130959680|NCT02247349|471481309|FG000|Overall Study|Study drug toxicity|0|||
130959681|NCT02247349|471481310|FG001|Overall Study|Study drug toxicity|1|||
131127089|NCT02055820|472094752|FG000|Phase I: Dose-Finding|Death|1|||
130959682|NCT02247349|471481311|FG002|Overall Study|Study drug toxicity|1|||
130959683|NCT02247349|471481312|FG003|Overall Study|Study drug toxicity|1|||
130959684|NCT02247349|471481313|FG004|Overall Study|Study drug toxicity|2|||
130959685|NCT02247349|471481314|FG005|Overall Study|Study drug toxicity|2|||
131127090|NCT02055820|472094753|FG001|Phase I: Dose-Finding|Death|0|||
130959686|NCT02247349|471481309|FG000|Overall Study|Death|0|||
130959687|NCT02247349|471481310|FG001|Overall Study|Death|0|||
130959688|NCT02247349|471481311|FG002|Overall Study|Death|0|||
130959689|NCT02247349|471481312|FG003|Overall Study|Death|1|||
130959690|NCT02247349|471481313|FG004|Overall Study|Death|0|||
130959691|NCT02247349|471481314|FG005|Overall Study|Death|0|||
130959692|NCT02247349|471481309|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
130959693|NCT02247349|471481310|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
130959694|NCT02247349|471481311|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
130959695|NCT02247349|471481312|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
130959696|NCT02247349|471481313|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
130959697|NCT02247349|471481314|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
130959698|NCT02247349|471481309|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130959699|NCT02247349|471481310|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130959700|NCT02247349|471481311|FG002|Overall Study|Participant request to discontinue study treatment|1|||
130959701|NCT02247349|471481312|FG003|Overall Study|Participant request to discontinue study treatment|2|||
130959702|NCT02247349|471481313|FG004|Overall Study|Participant request to discontinue study treatment|1|||
130959703|NCT02247349|471481314|FG005|Overall Study|Participant request to discontinue study treatment|0|||
130959704|NCT02247349|471481309|FG000|Overall Study|Withdrawal by Subject|0|||
130959705|NCT02247349|471481310|FG001|Overall Study|Withdrawal by Subject|1|||
130959706|NCT02247349|471481311|FG002|Overall Study|Withdrawal by Subject|0|||
130959707|NCT02247349|471481312|FG003|Overall Study|Withdrawal by Subject|0|||
130959708|NCT02247349|471481313|FG004|Overall Study|Withdrawal by Subject|0|||
130959709|NCT02247349|471481314|FG005|Overall Study|Withdrawal by Subject|0|||
130959710|NCT02247349|471481309|FG000|Overall Study|Administrative reason by sponsor|0|||
130959711|NCT02247349|471481310|FG001|Overall Study|Administrative reason by sponsor|0|||
130959712|NCT02247349|471481311|FG002|Overall Study|Administrative reason by sponsor|0|||
130959713|NCT02247349|471481312|FG003|Overall Study|Administrative reason by sponsor|0|||
130959714|NCT02247349|471481313|FG004|Overall Study|Administrative reason by sponsor|1|||
130959715|NCT02247349|471481314|FG005|Overall Study|Administrative reason by sponsor|0|||
130959716|NCT02247349|471481309|FG000|Overall Study|Other reasons|0|||
130959717|NCT02247349|471481310|FG001|Overall Study|Other reasons|0|||
130959718|NCT02247349|471481311|FG002|Overall Study|Other reasons|1|||
130959719|NCT02247349|471481312|FG003|Overall Study|Other reasons|0|||
130959720|NCT02247349|471481313|FG004|Overall Study|Other reasons|0|||
130959721|NCT02247349|471481314|FG005|Overall Study|Other reasons|0|||
130959722|NCT01959581|471481315|FG000|Overall Study|Lost to Follow-up|5|||
130959723|NCT00057746|471481316|FG000|Overall Study|Withdrawal by Subject|0|||
130959724|NCT00057746|471481317|FG001|Overall Study|Withdrawal by Subject|0|||
130959725|NCT00057746|471481318|FG002|Overall Study|Withdrawal by Subject|1|||
130959726|NCT01469065|471481324|FG000|Overall Study|Lack of Efficacy|0|||
130959727|NCT01469065|471481325|FG001|Overall Study|Lack of Efficacy|0|||
130959728|NCT01469065|471481326|FG002|Overall Study|Lack of Efficacy|0|||
130959729|NCT01469065|471481327|FG003|Overall Study|Lack of Efficacy|0|||
130959730|NCT01469065|471481328|FG004|Overall Study|Lack of Efficacy|1|||
130959731|NCT01469065|471481324|FG000|Overall Study|Other|0|||
130959732|NCT01469065|471481325|FG001|Overall Study|Other|1|||
130959733|NCT01469065|471481326|FG002|Overall Study|Other|0|||
130959734|NCT01469065|471481327|FG003|Overall Study|Other|0|||
130959735|NCT01469065|471481328|FG004|Overall Study|Other|0|||
130959736|NCT00179413|471481329|FG000|Overall Study|Adverse Event|38|||
130959737|NCT00179413|471481330|FG001|Overall Study|Adverse Event|20|||
130959738|NCT00179413|471481329|FG000|Overall Study|Withdrawal by Subject|87|||
130959739|NCT00179413|471481330|FG001|Overall Study|Withdrawal by Subject|95|||
130959740|NCT03075644|471481331|FG000|Overall Study|Withdrawal by Subject|1|||
130959741|NCT03075644|471481332|FG001|Overall Study|Withdrawal by Subject|1|||
130959742|NCT01696032|471481333|FG000|Overall Study|Withdrawal by Subject|0|||
130959743|NCT01696032|471481334|FG001|Overall Study|Withdrawal by Subject|0|||
130959744|NCT01696032|471481335|FG002|Overall Study|Withdrawal by Subject|1|||
131040637|NCT01928394|471785323|FG011|Treatment Period|Poor/non-compliance|0|||
131040638|NCT01928394|471785324|FG012|Treatment Period|Poor/non-compliance|1|||
131040639|NCT01928394|471785325|FG013|Treatment Period|Poor/non-compliance|0|||
131040640|NCT01928394|471785326|FG014|Treatment Period|Poor/non-compliance|1|||
131040641|NCT01928394|471785327|FG015|Treatment Period|Poor/non-compliance|0|||
131040642|NCT01928394|471785328|FG016|Treatment Period|Poor/non-compliance|0|||
131040643|NCT01928394|471785329|FG017|Treatment Period|Poor/non-compliance|1|||
131040644|NCT01928394|471785330|FG018|Treatment Period|Poor/non-compliance|0|||
131040645|NCT01928394|471785331|FG019|Treatment Period|Poor/non-compliance|1|||
131040646|NCT01928394|471785332|FG020|Treatment Period|Poor/non-compliance|0|||
130714432|NCT04908683|470581669|FG001|Overall Study|Site Closure by Sponsor|3|||
131040647|NCT01928394|471785333|FG021|Treatment Period|Poor/non-compliance|0|||
130714433|NCT04908683|470581668|FG000|Overall Study|Adverse Event|21|||
130959745|NCT01696032|471481336|FG003|Overall Study|Withdrawal by Subject|2|||
130959746|NCT01696032|471481333|FG000|Overall Study|Death|14|||
130959747|NCT01696032|471481334|FG001|Overall Study|Death|4|||
130959748|NCT01696032|471481335|FG002|Overall Study|Death|43|||
131040648|NCT01928394|471785334|FG022|Treatment Period|Poor/non-compliance|0|||
131040649|NCT01928394|471785312|FG000|Treatment Period|other reason|0|||
131040650|NCT01928394|471785313|FG001|Treatment Period|other reason|0|||
131040651|NCT01928394|471785314|FG002|Treatment Period|other reason|0|||
131040652|NCT01928394|471785315|FG003|Treatment Period|other reason|0|||
131040653|NCT01928394|471785316|FG004|Treatment Period|other reason|0|||
131040654|NCT01928394|471785317|FG005|Treatment Period|other reason|0|||
131040655|NCT01928394|471785318|FG006|Treatment Period|other reason|0|||
131040656|NCT01928394|471785319|FG007|Treatment Period|other reason|0|||
131040657|NCT01928394|471785320|FG008|Treatment Period|other reason|0|||
131040658|NCT01928394|471785321|FG009|Treatment Period|other reason|0|||
131040659|NCT01928394|471785322|FG010|Treatment Period|other reason|1|||
131040660|NCT01928394|471785323|FG011|Treatment Period|other reason|1|||
131040661|NCT01928394|471785324|FG012|Treatment Period|other reason|1|||
131040662|NCT01928394|471785325|FG013|Treatment Period|other reason|0|||
131040663|NCT01928394|471785326|FG014|Treatment Period|other reason|1|||
131040664|NCT01928394|471785327|FG015|Treatment Period|other reason|0|||
131040665|NCT01928394|471785328|FG016|Treatment Period|other reason|0|||
131040666|NCT01928394|471785329|FG017|Treatment Period|other reason|0|||
131040667|NCT01928394|471785330|FG018|Treatment Period|other reason|2|||
131040668|NCT01928394|471785331|FG019|Treatment Period|other reason|2|||
131040669|NCT01928394|471785332|FG020|Treatment Period|other reason|0|||
131040670|NCT01928394|471785333|FG021|Treatment Period|other reason|0|||
131040671|NCT01928394|471785334|FG022|Treatment Period|other reason|0|||
131040672|NCT01928394|471785312|FG000|Treatment Period|Maximum clinical benefit|0|||
131040673|NCT01928394|471785313|FG001|Treatment Period|Maximum clinical benefit|0|||
131040674|NCT01928394|471785314|FG002|Treatment Period|Maximum clinical benefit|0|||
131040675|NCT01928394|471785315|FG003|Treatment Period|Maximum clinical benefit|0|||
130959749|NCT01696032|471481336|FG003|Overall Study|Death|18|||
130959750|NCT01696032|471481333|FG000|Overall Study|Lost to Follow-up|0|||
130959751|NCT01696032|471481334|FG001|Overall Study|Lost to Follow-up|1|||
130959752|NCT01696032|471481335|FG002|Overall Study|Lost to Follow-up|0|||
130959753|NCT01696032|471481336|FG003|Overall Study|Lost to Follow-up|0|||
130959754|NCT01696032|471481333|FG000|Overall Study|Database lock|0|||
130959755|NCT01696032|471481334|FG001|Overall Study|Database lock|1|||
130959756|NCT01696032|471481335|FG002|Overall Study|Database lock|7|||
130959757|NCT01696032|471481336|FG003|Overall Study|Database lock|2|||
130959758|NCT00578565|471481339|FG000|Overall Study|Adverse Event|3|||
130959759|NCT01192152|471481340|FG000|Period 1|left prematurely (while on treatment B)|0|||
130959760|NCT01192152|471481341|FG001|Period 1|left prematurely (while on treatment B)|1|||
130959761|NCT01192152|471481340|FG000|Period 3|family emergency|1|||
130959762|NCT01192152|471481341|FG001|Period 3|family emergency|0|||
130959763|NCT02203591|471481343|FG000|Overall Study|Did not meet treatment day baseline|147|||
130959764|NCT02203591|471481344|FG001|Overall Study|Did not meet treatment day baseline|141|||
130959765|NCT02203591|471481345|FG002|Overall Study|Did not meet treatment day baseline|150|||
130959766|NCT02203591|471481346|FG003|Overall Study|Did not meet treatment day baseline|45|||
130959767|NCT02203591|471481347|FG004|Overall Study|Did not meet treatment day baseline|33|||
130959768|NCT02203591|471481348|FG005|Overall Study|Did not meet treatment day baseline|35|||
130959769|NCT02203591|471481349|FG006|Overall Study|Did not meet treatment day baseline|29|||
130959770|NCT02203591|471481350|FG007|Overall Study|Did not meet treatment day baseline|12|||
130959771|NCT02203591|471481343|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
130959772|NCT02203591|471481344|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
131040676|NCT01928394|471785316|FG004|Treatment Period|Maximum clinical benefit|0|||
131040677|NCT01928394|471785317|FG005|Treatment Period|Maximum clinical benefit|0|||
131040678|NCT01928394|471785318|FG006|Treatment Period|Maximum clinical benefit|0|||
130959773|NCT02203591|471481345|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
130959774|NCT02203591|471481346|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
130959775|NCT02203591|471481347|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
130959776|NCT02203591|471481348|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
130959777|NCT02203591|471481349|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
130959778|NCT02203591|471481350|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
131040679|NCT01928394|471785319|FG007|Treatment Period|Maximum clinical benefit|0|||
131040680|NCT01928394|471785320|FG008|Treatment Period|Maximum clinical benefit|0|||
131040681|NCT01928394|471785321|FG009|Treatment Period|Maximum clinical benefit|0|||
131040682|NCT01928394|471785322|FG010|Treatment Period|Maximum clinical benefit|1|||
131040683|NCT01928394|471785323|FG011|Treatment Period|Maximum clinical benefit|1|||
131127091|NCT02055820|472094754|FG002|Phase I: Dose-Finding|Death|1|||
131040684|NCT01928394|471785324|FG012|Treatment Period|Maximum clinical benefit|0|||
131040685|NCT01928394|471785325|FG013|Treatment Period|Maximum clinical benefit|0|||
131040686|NCT01928394|471785326|FG014|Treatment Period|Maximum clinical benefit|1|||
131040687|NCT01928394|471785327|FG015|Treatment Period|Maximum clinical benefit|0|||
131040688|NCT01928394|471785328|FG016|Treatment Period|Maximum clinical benefit|0|||
131040689|NCT01928394|471785329|FG017|Treatment Period|Maximum clinical benefit|1|||
131040690|NCT01928394|471785330|FG018|Treatment Period|Maximum clinical benefit|1|||
131040691|NCT01928394|471785331|FG019|Treatment Period|Maximum clinical benefit|0|||
131127092|NCT02055820|472094755|FG003|Phase I: Dose-Finding|Death|2|||
131040692|NCT01928394|471785332|FG020|Treatment Period|Maximum clinical benefit|2|||
131127093|NCT02055820|472094756|FG004|Phase I: Dose-Finding|Death|0|||
130714434|NCT04908683|470581669|FG001|Overall Study|Adverse Event|11|||
131127094|NCT02055820|472094757|FG005|Phase I: Dose-Finding|Death|1|||
131127095|NCT02055820|472094758|FG006|Phase I: Dose-Finding|Death|1|||
131127096|NCT02055820|472094759|FG007|Phase I: Dose-Finding|Death|0|||
131127097|NCT02055820|472094760|FG008|Phase I: Dose-Finding|Death|0|||
131127098|NCT02055820|472094761|FG009|Phase I: Dose-Finding|Death|0|||
131127099|NCT02055820|472094752|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131127100|NCT02055820|472094753|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131127101|NCT02055820|472094754|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131127102|NCT02055820|472094755|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131127103|NCT02055820|472094756|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131127104|NCT02055820|472094757|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
131127105|NCT02055820|472094758|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131127106|NCT02055820|472094759|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131127107|NCT02055820|472094760|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131127108|NCT02055820|472094761|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
131127109|NCT02055820|472094752|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
131127110|NCT02055820|472094753|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
131127111|NCT02055820|472094754|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
131127112|NCT02055820|472094755|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
131127113|NCT02055820|472094756|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
131127114|NCT02055820|472094757|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
130959803|NCT01565291|471481354|FG000|Overall Study|Withdrawal by Subject|1|||
130959804|NCT01565291|471481355|FG001|Overall Study|Withdrawal by Subject|0|||
130959805|NCT00515827|471481356|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
130959806|NCT00515827|471481357|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
130959807|NCT00515827|471481356|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
130959808|NCT00515827|471481357|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
130959809|NCT01009099|471481360|FG000|Overall Study|Lost to Follow-up|1|||
130959810|NCT01009099|471481361|FG001|Overall Study|Lost to Follow-up|0|||
130959811|NCT01009099|471481360|FG000|Overall Study|Physician Decision|3|||
130959812|NCT01009099|471481361|FG001|Overall Study|Physician Decision|2|||
130959813|NCT01009099|471481360|FG000|Overall Study|Withdrawal by Subject|1|||
130959814|NCT01009099|471481361|FG001|Overall Study|Withdrawal by Subject|1|||
130959815|NCT01009099|471481360|FG000|Overall Study|Death|0|||
130959816|NCT01009099|471481361|FG001|Overall Study|Death|1|||
130959817|NCT01856543|471481375|FG000|Overall Study|Treatment discontinued|6|||
130959818|NCT01856543|471481376|FG001|Overall Study|Treatment discontinued|3|||
130959819|NCT01856543|471481375|FG000|Overall Study|Withdrawn before start|7|||
130959820|NCT01856543|471481376|FG001|Overall Study|Withdrawn before start|3|||
130959821|NCT02457325|471481381|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
130959822|NCT02457325|471481382|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
130959823|NCT01541930|471481383|FG000|Overall Study|Withdrawal by Subject|1|||
130959824|NCT02501096|471481384|FG000|Overall Study|Lost to Follow-up|0|||
130959825|NCT02501096|471481385|FG001|Overall Study|Lost to Follow-up|0|||
130959826|NCT02501096|471481386|FG002|Overall Study|Lost to Follow-up|0|||
130959827|NCT02501096|471481387|FG003|Overall Study|Lost to Follow-up|0|||
130959828|NCT02501096|471481388|FG004|Overall Study|Lost to Follow-up|1|||
130959829|NCT02501096|471481389|FG005|Overall Study|Lost to Follow-up|1|||
130959830|NCT02501096|471481390|FG006|Overall Study|Lost to Follow-up|3|||
130959831|NCT02501096|471481391|FG007|Overall Study|Lost to Follow-up|0|||
130959832|NCT02501096|471481392|FG008|Overall Study|Lost to Follow-up|0|||
130959833|NCT02501096|471481384|FG000|Overall Study|Withdrawal by Subject|1|||
130959834|NCT02501096|471481385|FG001|Overall Study|Withdrawal by Subject|0|||
130959835|NCT02501096|471481386|FG002|Overall Study|Withdrawal by Subject|7|||
130959836|NCT02501096|471481387|FG003|Overall Study|Withdrawal by Subject|13|||
130959837|NCT02501096|471481388|FG004|Overall Study|Withdrawal by Subject|2|||
130959838|NCT02501096|471481389|FG005|Overall Study|Withdrawal by Subject|2|||
130959839|NCT02501096|471481390|FG006|Overall Study|Withdrawal by Subject|2|||
130959840|NCT02501096|471481391|FG007|Overall Study|Withdrawal by Subject|3|||
130959841|NCT02501096|471481392|FG008|Overall Study|Withdrawal by Subject|0|||
130959842|NCT02501096|471481384|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
130959843|NCT02501096|471481385|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
130959844|NCT02501096|471481386|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
130959845|NCT02501096|471481387|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
130959846|NCT02501096|471481388|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
130959847|NCT02501096|471481389|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
130959848|NCT02501096|471481390|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
130959849|NCT02501096|471481391|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
130959850|NCT02501096|471481392|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
130959851|NCT02501096|471481384|FG000|Overall Study|Death|1|||
131040693|NCT01928394|471785333|FG021|Treatment Period|Maximum clinical benefit|0|||
131040694|NCT01928394|471785334|FG022|Treatment Period|Maximum clinical benefit|0|||
131040695|NCT01928394|471785312|FG000|Treatment Period|Lost to Follow-up|0|||
130959852|NCT02501096|471481385|FG001|Overall Study|Death|1|||
130959853|NCT02501096|471481386|FG002|Overall Study|Death|88|||
130959854|NCT02501096|471481387|FG003|Overall Study|Death|74|||
130959855|NCT02501096|471481388|FG004|Overall Study|Death|15|||
130959856|NCT02501096|471481389|FG005|Overall Study|Death|16|||
130959857|NCT02501096|471481390|FG006|Overall Study|Death|15|||
130959858|NCT02501096|471481391|FG007|Overall Study|Death|16|||
130959859|NCT02501096|471481392|FG008|Overall Study|Death|1|||
130959860|NCT04187196|471481393|FG000|Overall Study|Screen Failure|2|||
130959861|NCT04187196|471481394|FG001|Overall Study|Screen Failure|0|||
130959862|NCT03149237|471481395|FG000|Overall Study|Withdrawal by Subject|4|||
130959863|NCT03149237|471481396|FG001|Overall Study|Withdrawal by Subject|5|||
130959864|NCT01957475|471481397|FG000|Test Period 1|Withdrawal by Subject|1|||
130959865|NCT01957475|471481398|FG001|Test Period 1|Withdrawal by Subject|0|||
130959866|NCT01957475|471481397|FG000|Test Period 1|Other|1|||
130959867|NCT01957475|471481398|FG001|Test Period 1|Other|0|||
130959868|NCT01957475|471481397|FG000|Test Period 1|Lack of Efficacy|0|||
130959869|NCT01957475|471481398|FG001|Test Period 1|Lack of Efficacy|1|||
130959870|NCT01957475|471481397|FG000|Test Period 2|Adverse Event|1|||
130959871|NCT01957475|471481398|FG001|Test Period 2|Adverse Event|0|||
130959872|NCT01552772|471481399|FG000|Overall Study|Lost to Follow-up|2|||
130959873|NCT01552772|471481399|FG000|Overall Study|Adverse Event|1|||
130959874|NCT01552772|471481399|FG000|Overall Study|Protocol Deviation|1|||
130959875|NCT01466192|471481400|FG000|Overall Study|Physician Decision|1|||
130959876|NCT01466192|471481400|FG000|Overall Study|Withdrawal by Subject|3|||
130959877|NCT02920983|471481403|FG000|Dispense 1|Unacceptable Lens Fit|0|||
130959878|NCT02920983|471481404|FG001|Dispense 1|Unacceptable Lens Fit|0|||
130959879|NCT02920983|471481405|FG002|Dispense 1|Unacceptable Lens Fit|0|||
130959880|NCT02920983|471481406|FG003|Dispense 1|Unacceptable Lens Fit|0|||
130959881|NCT02920983|471481407|FG004|Dispense 1|Unacceptable Lens Fit|1|||
130959882|NCT02920983|471481408|FG005|Dispense 1|Unacceptable Lens Fit|0|||
130959883|NCT02920983|471481403|FG000|Dispense 2|Unscceptable lens fit|1|||
130959884|NCT02920983|471481404|FG001|Dispense 2|Unscceptable lens fit|0|||
130959885|NCT02920983|471481405|FG002|Dispense 2|Unscceptable lens fit|0|||
130959886|NCT02920983|471481406|FG003|Dispense 2|Unscceptable lens fit|0|||
130959887|NCT02920983|471481407|FG004|Dispense 2|Unscceptable lens fit|1|||
130959888|NCT02920983|471481408|FG005|Dispense 2|Unscceptable lens fit|0|||
130959889|NCT02920983|471481403|FG000|Dispense 3|Unacceptable Lens Fit|1|||
130959890|NCT02920983|471481404|FG001|Dispense 3|Unacceptable Lens Fit|1|||
130959891|NCT02920983|471481405|FG002|Dispense 3|Unacceptable Lens Fit|0|||
130959892|NCT02920983|471481406|FG003|Dispense 3|Unacceptable Lens Fit|0|||
130959893|NCT02920983|471481407|FG004|Dispense 3|Unacceptable Lens Fit|1|||
130959894|NCT02920983|471481408|FG005|Dispense 3|Unacceptable Lens Fit|0|||
130959895|NCT03878134|471481409|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
130959896|NCT01227512|471481411|FG000|Overall Study|Physician Decision|6|||
130959897|NCT01227512|471481412|FG001|Overall Study|Physician Decision|6|||
130959898|NCT01227512|471481411|FG000|Overall Study|Adverse Event|4|||
130959899|NCT01227512|471481412|FG001|Overall Study|Adverse Event|3|||
130959900|NCT01227512|471481411|FG000|Overall Study|Withdrawal by Subject|3|||
130959901|NCT01227512|471481412|FG001|Overall Study|Withdrawal by Subject|0|||
130959902|NCT01227512|471481411|FG000|Overall Study|Participant met withdrawal criteria|0|||
130959903|NCT01227512|471481412|FG001|Overall Study|Participant met withdrawal criteria|1|||
130959904|NCT04055116|471481413|FG000|First Intervention|Physician Decision|2|||
130959905|NCT04055116|471481414|FG001|First Intervention|Physician Decision|7|||
130959906|NCT02774681|471481421|FG000|Treatment on Study|Progressive Disease|7|||
130959907|NCT02774681|471481421|FG000|Follow-Up for 3 Years|Death|11|||
130959908|NCT02774681|471481421|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
130959909|NCT04497987|471481422|FG000|Overall Study|Adverse Event|1|||
130959910|NCT04497987|471481423|FG001|Overall Study|Adverse Event|0|||
130959911|NCT04497987|471481422|FG000|Overall Study|Death|21|||
130959912|NCT04497987|471481423|FG001|Overall Study|Death|13|||
130959913|NCT04497987|471481422|FG000|Overall Study|Lost to Follow-up|19|||
130959914|NCT04497987|471481423|FG001|Overall Study|Lost to Follow-up|17|||
130959915|NCT04497987|471481422|FG000|Overall Study|Other - as reported by the investigator|22|||
130959916|NCT04497987|471481423|FG001|Overall Study|Other - as reported by the investigator|16|||
130959917|NCT04497987|471481422|FG000|Overall Study|Physician Decision|1|||
130959918|NCT04497987|471481423|FG001|Overall Study|Physician Decision|0|||
130959919|NCT04497987|471481422|FG000|Overall Study|Withdrawal by Subject|35|||
130959920|NCT04497987|471481423|FG001|Overall Study|Withdrawal by Subject|21|||
130959921|NCT00773097|471481424|FG000|Overall Study|Withdrawal by Subject|1|||
130714435|NCT04908683|470581668|FG000|Overall Study|Death|101|||
131040696|NCT01928394|471785313|FG001|Treatment Period|Lost to Follow-up|0|||
131040697|NCT01928394|471785314|FG002|Treatment Period|Lost to Follow-up|0|||
130959922|NCT00773097|471481424|FG000|Overall Study|Physician Decision|6|||
130959923|NCT02707640|471481425|FG000|Overall Study|Adverse Event|4|||
130959924|NCT02707640|471481426|FG001|Overall Study|Adverse Event|2|||
130959925|NCT02707640|471481425|FG000|Overall Study|Death|1|||
130959926|NCT02707640|471481426|FG001|Overall Study|Death|2|||
130959927|NCT02707640|471481425|FG000|Overall Study|Physician Decision|2|||
130959928|NCT02707640|471481426|FG001|Overall Study|Physician Decision|0|||
130714436|NCT04908683|470581669|FG001|Overall Study|Death|61|||
130714437|NCT04908683|470581668|FG000|Overall Study|Sponsor's decision|14398|||
130714438|NCT04908683|470581669|FG001|Overall Study|Sponsor's decision|7205|||
130714439|NCT04908683|470581668|FG000|Overall Study|Other|92|||
130714440|NCT04908683|470581669|FG001|Overall Study|Other|50|||
130714441|NCT04908683|470581668|FG000|Overall Study|Randomized not vaccinated|108|||
130959929|NCT02707640|471481425|FG000|Overall Study|Withdrawal by Subject|0|||
130959930|NCT02707640|471481426|FG001|Overall Study|Withdrawal by Subject|1|||
130959931|NCT02707640|471481425|FG000|Overall Study|Participant's Personal Decision|1|||
130959932|NCT02707640|471481426|FG001|Overall Study|Participant's Personal Decision|2|||
130959933|NCT02707640|471481425|FG000|Overall Study|Sponsor Discretion|1|||
131127115|NCT02055820|472094758|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
131127116|NCT02055820|472094759|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
131127117|NCT02055820|472094760|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
131127118|NCT02055820|472094761|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
131127119|NCT02055820|472094752|FG000|Phase II: Expansion|Death|0|||
131127120|NCT02055820|472094753|FG001|Phase II: Expansion|Death|0|||
131127121|NCT02055820|472094754|FG002|Phase II: Expansion|Death|0|||
131127122|NCT02055820|472094755|FG003|Phase II: Expansion|Death|0|||
131127123|NCT02055820|472094756|FG004|Phase II: Expansion|Death|33|||
131127124|NCT02055820|472094757|FG005|Phase II: Expansion|Death|0|||
131127125|NCT02055820|472094758|FG006|Phase II: Expansion|Death|0|||
131127126|NCT02055820|472094759|FG007|Phase II: Expansion|Death|0|||
131127127|NCT02055820|472094760|FG008|Phase II: Expansion|Death|0|||
131127128|NCT02055820|472094761|FG009|Phase II: Expansion|Death|0|||
131127129|NCT02055820|472094752|FG000|Phase II: Expansion|Lost to Follow-up|0|||
131127130|NCT02055820|472094753|FG001|Phase II: Expansion|Lost to Follow-up|0|||
131127131|NCT02055820|472094754|FG002|Phase II: Expansion|Lost to Follow-up|0|||
131127132|NCT02055820|472094755|FG003|Phase II: Expansion|Lost to Follow-up|0|||
131127133|NCT02055820|472094756|FG004|Phase II: Expansion|Lost to Follow-up|4|||
131127134|NCT02055820|472094757|FG005|Phase II: Expansion|Lost to Follow-up|0|||
131127135|NCT02055820|472094758|FG006|Phase II: Expansion|Lost to Follow-up|0|||
131127136|NCT02055820|472094759|FG007|Phase II: Expansion|Lost to Follow-up|0|||
131127137|NCT02055820|472094760|FG008|Phase II: Expansion|Lost to Follow-up|0|||
131127138|NCT02055820|472094761|FG009|Phase II: Expansion|Lost to Follow-up|0|||
131127139|NCT02055820|472094752|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
131127140|NCT02055820|472094753|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
131127141|NCT02055820|472094754|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
131127142|NCT02055820|472094755|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
131127143|NCT02055820|472094756|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
131127144|NCT02055820|472094757|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
131127145|NCT02055820|472094758|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
131127146|NCT02055820|472094759|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
131127147|NCT02055820|472094760|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
131127148|NCT02055820|472094761|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
131127149|NCT01399788|472094763|FG000|First Intervention Period|Adverse Event|1|||
131127150|NCT01399788|472094764|FG001|First Intervention Period|Adverse Event|0|||
131127151|NCT02919436|472094765|FG000|Overall Study|Did not undergo surgery|16|||
131127152|NCT02919436|472094766|FG001|Overall Study|Did not undergo surgery|20|||
131127153|NCT02919436|472094765|FG000|Overall Study|Enrolled before trial registration|44|||
131127154|NCT02919436|472094766|FG001|Overall Study|Enrolled before trial registration|33|||
131127155|NCT03699007|472094767|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
131127156|NCT03699007|472094768|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
131127157|NCT03699007|472094767|FG000|6-month Follow Up|Lost to Follow-up|2|||
131127158|NCT03699007|472094768|FG001|6-month Follow Up|Lost to Follow-up|3|||
131127159|NCT04718974|472094769|FG000|Overall Study|Death|0|||
131127160|NCT04718974|472094770|FG001|Overall Study|Death|2|||
131127161|NCT04718974|472094769|FG000|Overall Study|Lost to Follow-up|10|||
131127162|NCT04718974|472094770|FG001|Overall Study|Lost to Follow-up|20|||
131127163|NCT04718974|472094769|FG000|Overall Study|Transferred out|2|||
131127164|NCT04718974|472094770|FG001|Overall Study|Transferred out|4|||
131127165|NCT01157364|472094771|FG000|Overall Study|Other Reasons|1|||
131127166|NCT01157364|472094772|FG001|Overall Study|Other Reasons|1|||
131127167|NCT01157364|472094773|FG002|Overall Study|Other Reasons|2|||
131127168|NCT01157364|472094774|FG003|Overall Study|Other Reasons|1|||
131127169|NCT01157364|472094775|FG004|Overall Study|Other Reasons|0|||
131127170|NCT01157364|472094776|FG005|Overall Study|Other Reasons|0|||
131127171|NCT01157364|472094771|FG000|Overall Study|Personal Reasons|0|||
131127172|NCT01157364|472094772|FG001|Overall Study|Personal Reasons|2|||
131127173|NCT01157364|472094773|FG002|Overall Study|Personal Reasons|0|||
131127174|NCT01157364|472094774|FG003|Overall Study|Personal Reasons|0|||
130774793|NCT03410992|470802560|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130959934|NCT02707640|471481426|FG001|Overall Study|Sponsor Discretion|0|||
131127175|NCT01157364|472094775|FG004|Overall Study|Personal Reasons|1|||
131127176|NCT01157364|472094776|FG005|Overall Study|Personal Reasons|1|||
131127177|NCT01157364|472094771|FG000|Overall Study|Lost to Follow-up|1|||
130714442|NCT04908683|470581669|FG001|Overall Study|Randomized not vaccinated|52|||
130714443|NCT02221037|470581671|FG000|Overall Study|Physician Decision|0|||
130959935|NCT01755416|471481428|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
130959936|NCT01755416|471481429|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
130959937|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
130959938|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
130959939|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
130959940|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Death|1|||
130959941|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Death|0|||
130959942|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Death|0|||
130959943|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
130959944|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
130959945|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
130959946|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
130959947|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
130959948|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
130959949|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
130959950|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
130959951|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
130959952|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
130959953|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
130959954|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
130959955|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
130959956|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
131127178|NCT01157364|472094772|FG001|Overall Study|Lost to Follow-up|0|||
131127179|NCT01157364|472094773|FG002|Overall Study|Lost to Follow-up|1|||
131127180|NCT01157364|472094774|FG003|Overall Study|Lost to Follow-up|0|||
131127181|NCT01157364|472094775|FG004|Overall Study|Lost to Follow-up|0|||
131127182|NCT01157364|472094776|FG005|Overall Study|Lost to Follow-up|0|||
131127183|NCT01157364|472094771|FG000|Overall Study|Lack of Efficacy|0|||
131127184|NCT01157364|472094772|FG001|Overall Study|Lack of Efficacy|0|||
131127185|NCT01157364|472094773|FG002|Overall Study|Lack of Efficacy|0|||
131127186|NCT01157364|472094774|FG003|Overall Study|Lack of Efficacy|1|||
131127187|NCT01157364|472094775|FG004|Overall Study|Lack of Efficacy|0|||
131127188|NCT01157364|472094776|FG005|Overall Study|Lack of Efficacy|0|||
131127189|NCT01157364|472094771|FG000|Overall Study|Adverse Event|0|||
131127190|NCT01157364|472094772|FG001|Overall Study|Adverse Event|1|||
131127191|NCT01157364|472094773|FG002|Overall Study|Adverse Event|1|||
131127192|NCT01157364|472094774|FG003|Overall Study|Adverse Event|0|||
131127193|NCT01157364|472094775|FG004|Overall Study|Adverse Event|1|||
130959957|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
130959958|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
130959959|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
130959960|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
130959961|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
130959962|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
130959963|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
130959964|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
130959965|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
130959966|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
130959967|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
130959968|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
130959969|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
130959970|NCT03655236|471481430|FG000|Subject Disposition in Part 1 Period|Other|0|||
130959971|NCT03655236|471481431|FG001|Subject Disposition in Part 1 Period|Other|2|||
130959972|NCT03655236|471481432|FG002|Subject Disposition in Part 1 Period|Other|2|||
130959973|NCT03655236|471481430|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
130959974|NCT03655236|471481431|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
130959975|NCT03655236|471481432|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
130959976|NCT03655236|471481430|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
130959977|NCT03655236|471481431|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
130959978|NCT03655236|471481432|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
130959979|NCT03655236|471481430|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
130959980|NCT03655236|471481431|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
131127194|NCT01157364|472094776|FG005|Overall Study|Adverse Event|0|||
131127195|NCT03259074|472094777|FG000|Overall Study|Adverse Event|9|||
131127196|NCT03259074|472094778|FG001|Overall Study|Adverse Event|12|||
131127197|NCT03259074|472094779|FG002|Overall Study|Adverse Event|8|||
131127198|NCT03259074|472094777|FG000|Overall Study|Death|1|||
131127199|NCT03259074|472094778|FG001|Overall Study|Death|1|||
131127200|NCT03259074|472094779|FG002|Overall Study|Death|3|||
130714444|NCT02221037|470581672|FG001|Overall Study|Physician Decision|0|||
130714445|NCT02221037|470581673|FG002|Overall Study|Physician Decision|1|||
130714446|NCT02221037|470581674|FG003|Overall Study|Physician Decision|0|||
130714447|NCT01293539|470581680|FG000|Overall Study|Physician Decision|1|||
130714448|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Death|89|||
130714449|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Death|193|||
130714450|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Death|198|||
130959981|NCT03655236|471481432|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
130714451|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
130714452|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
130714453|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
130959982|NCT03655236|471481430|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
130959983|NCT03655236|471481431|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
130959984|NCT03655236|471481432|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
130959985|NCT03655236|471481430|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
130959986|NCT03655236|471481431|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
130959987|NCT03655236|471481432|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
130959988|NCT03655236|471481430|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
130959989|NCT03655236|471481431|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
130959990|NCT03655236|471481432|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
130959991|NCT03655236|471481430|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
130959992|NCT03655236|471481431|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
130959993|NCT03655236|471481432|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
130959994|NCT03655236|471481430|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
130959995|NCT03655236|471481431|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
130959996|NCT03655236|471481432|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
130959997|NCT03655236|471481430|FG000|Subject Disposition in Part 2 Period|Other|1|||
130959998|NCT03655236|471481431|FG001|Subject Disposition in Part 2 Period|Other|0|||
130959999|NCT03655236|471481432|FG002|Subject Disposition in Part 2 Period|Other|0|||
130960000|NCT02742103|471483071|FG000|Overall Study|Protocol Violation|1|||
130960001|NCT02742103|471483072|FG001|Overall Study|Protocol Violation|0|||
130960002|NCT02742103|471483071|FG000|Overall Study|Death|2|||
130960003|NCT02742103|471483072|FG001|Overall Study|Death|2|||
130960004|NCT02742103|471483071|FG000|Overall Study|Adverse Event|1|||
130960005|NCT02742103|471483072|FG001|Overall Study|Adverse Event|0|||
130960006|NCT02742103|471483071|FG000|Overall Study|Moved to another town|0|||
130960007|NCT02742103|471483072|FG001|Overall Study|Moved to another town|1|||
130714454|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
130960008|NCT02742103|471483071|FG000|Overall Study|Withdrawal by Subject|5|||
130960009|NCT02742103|471483072|FG001|Overall Study|Withdrawal by Subject|2|||
130960010|NCT02573324|471483073|FG000|Overall Study|Withdrawal by Subject|26|||
130960011|NCT02573324|471483074|FG001|Overall Study|Withdrawal by Subject|23|||
130960012|NCT02573324|471483075|FG002|Overall Study|Withdrawal by Subject|3|||
130960013|NCT02573324|471483073|FG000|Overall Study|Lost to Follow-up|4|||
130960014|NCT02573324|471483074|FG001|Overall Study|Lost to Follow-up|5|||
130960015|NCT02573324|471483075|FG002|Overall Study|Lost to Follow-up|0|||
130960016|NCT02573324|471483073|FG000|Overall Study|Study Terminated by Sponsor|107|||
130960017|NCT02573324|471483074|FG001|Overall Study|Study Terminated by Sponsor|89|||
130960018|NCT02573324|471483075|FG002|Overall Study|Study Terminated by Sponsor|2|||
130960019|NCT02573324|471483073|FG000|Overall Study|Death|182|||
130960020|NCT02573324|471483074|FG001|Overall Study|Death|200|||
130960021|NCT02573324|471483075|FG002|Overall Study|Death|1|||
130960022|NCT02573324|471483073|FG000|Overall Study|Other, Not Specified|20|||
130960023|NCT02573324|471483074|FG001|Overall Study|Other, Not Specified|27|||
130960024|NCT02573324|471483075|FG002|Overall Study|Other, Not Specified|0|||
130960025|NCT02573324|471483073|FG000|Overall Study|Unknown Reason|2|||
130960026|NCT02573324|471483074|FG001|Overall Study|Unknown Reason|0|||
130960027|NCT02573324|471483075|FG002|Overall Study|Unknown Reason|0|||
130960028|NCT00600821|471483076|FG000|Overall Study|Death|45|||
130960029|NCT00600821|471483077|FG001|Overall Study|Death|46|||
130960030|NCT00600821|471483076|FG000|Overall Study|Lost to Follow-up|2|||
130960031|NCT00600821|471483077|FG001|Overall Study|Lost to Follow-up|2|||
130960032|NCT00600821|471483076|FG000|Overall Study|Withdrawal by Subject|1|||
130960033|NCT00600821|471483077|FG001|Overall Study|Withdrawal by Subject|1|||
130960034|NCT00600821|471483076|FG000|Overall Study|Terminated by sponsor|8|||
130960035|NCT00600821|471483077|FG001|Overall Study|Terminated by sponsor|6|||
130960036|NCT00600821|471483076|FG000|Overall Study|Objective progression or relapse|0|||
130960037|NCT00600821|471483077|FG001|Overall Study|Objective progression or relapse|1|||
130960038|NCT00600821|471483076|FG000|Overall Study|Randomized but not treated|0|||
130960039|NCT00600821|471483077|FG001|Overall Study|Randomized but not treated|1|||
130960040|NCT00600821|471483076|FG000|Overall Study|Other|2|||
130960041|NCT00600821|471483077|FG001|Overall Study|Other|3|||
130960042|NCT01607905|471483078|FG000|Overall Study|Withdrawal by participant|7|||
130960043|NCT01607905|471483079|FG001|Overall Study|Withdrawal by participant|2|||
130960044|NCT01607905|471483080|FG002|Overall Study|Withdrawal by participant|4|||
130960045|NCT01607905|471483081|FG003|Overall Study|Withdrawal by participant|6|||
130960046|NCT01607905|471483082|FG004|Overall Study|Withdrawal by participant|0|||
130960047|NCT01607905|471483083|FG005|Overall Study|Withdrawal by participant|4|||
130960048|NCT01607905|471483084|FG006|Overall Study|Withdrawal by participant|12|||
130960049|NCT01607905|471483078|FG000|Overall Study|Incidence or severity of AEs|5|||
130960050|NCT01607905|471483079|FG001|Overall Study|Incidence or severity of AEs|1|||
131040698|NCT01928394|471785315|FG003|Treatment Period|Lost to Follow-up|0|||
131226338|NCT00950599|472455733|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
131226339|NCT00950599|472455724|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
131226340|NCT00950599|472455725|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
131226341|NCT00950599|472455726|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131226342|NCT00950599|472455727|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131226343|NCT00950599|472455728|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131226344|NCT00950599|472455729|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131226345|NCT00950599|472455730|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131226346|NCT00950599|472455731|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
131226347|NCT00950599|472455732|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131226348|NCT00950599|472455733|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
131226349|NCT00950599|472455724|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131226350|NCT00950599|472455725|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131226351|NCT00950599|472455726|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131226352|NCT00950599|472455727|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131226353|NCT00950599|472455728|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
131226354|NCT00950599|472455729|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
131226355|NCT00950599|472455730|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131226356|NCT00950599|472455731|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131226357|NCT00950599|472455732|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131226358|NCT00950599|472455733|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
131226359|NCT00950599|472455724|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
131226360|NCT00950599|472455725|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
131226361|NCT00950599|472455726|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
131226362|NCT00950599|472455727|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
131226363|NCT00950599|472455728|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
131226364|NCT00950599|472455729|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
131226365|NCT00950599|472455730|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
131226366|NCT00950599|472455731|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
131226367|NCT00950599|472455732|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
131040699|NCT01928394|471785316|FG004|Treatment Period|Lost to Follow-up|0|||
131040700|NCT01928394|471785317|FG005|Treatment Period|Lost to Follow-up|0|||
131040701|NCT01928394|471785318|FG006|Treatment Period|Lost to Follow-up|0|||
131040702|NCT01928394|471785319|FG007|Treatment Period|Lost to Follow-up|0|||
131040703|NCT01928394|471785320|FG008|Treatment Period|Lost to Follow-up|0|||
131040704|NCT01928394|471785321|FG009|Treatment Period|Lost to Follow-up|0|||
131040705|NCT01928394|471785322|FG010|Treatment Period|Lost to Follow-up|0|||
131040706|NCT01928394|471785323|FG011|Treatment Period|Lost to Follow-up|0|||
131040707|NCT01928394|471785324|FG012|Treatment Period|Lost to Follow-up|0|||
131040708|NCT01928394|471785325|FG013|Treatment Period|Lost to Follow-up|0|||
131040709|NCT01928394|471785326|FG014|Treatment Period|Lost to Follow-up|0|||
130714455|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
130714456|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
130714457|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
130714458|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
130714459|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
130714460|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
130714461|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
130714462|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
130714463|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
130714464|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
130714465|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
131040710|NCT01928394|471785327|FG015|Treatment Period|Lost to Follow-up|0|||
131040711|NCT01928394|471785328|FG016|Treatment Period|Lost to Follow-up|0|||
131040712|NCT01928394|471785329|FG017|Treatment Period|Lost to Follow-up|0|||
131040713|NCT01928394|471785330|FG018|Treatment Period|Lost to Follow-up|0|||
131040714|NCT01928394|471785331|FG019|Treatment Period|Lost to Follow-up|0|||
130960051|NCT01607905|471483080|FG002|Overall Study|Incidence or severity of AEs|1|||
130960052|NCT01607905|471483081|FG003|Overall Study|Incidence or severity of AEs|3|||
130960053|NCT01607905|471483082|FG004|Overall Study|Incidence or severity of AEs|0|||
130960054|NCT01607905|471483083|FG005|Overall Study|Incidence or severity of AEs|2|||
130960055|NCT01607905|471483084|FG006|Overall Study|Incidence or severity of AEs|8|||
130960056|NCT01607905|471483078|FG000|Overall Study|Disease progression|44|||
130960057|NCT01607905|471483079|FG001|Overall Study|Disease progression|16|||
130960058|NCT01607905|471483080|FG002|Overall Study|Disease progression|15|||
130960059|NCT01607905|471483081|FG003|Overall Study|Disease progression|11|||
130960060|NCT01607905|471483082|FG004|Overall Study|Disease progression|6|||
130960061|NCT01607905|471483083|FG005|Overall Study|Disease progression|7|||
130960062|NCT01607905|471483084|FG006|Overall Study|Disease progression|21|||
130960063|NCT01607905|471483078|FG000|Overall Study|Non-compliance with study procedures|0|||
130960064|NCT01607905|471483079|FG001|Overall Study|Non-compliance with study procedures|0|||
130960065|NCT01607905|471483080|FG002|Overall Study|Non-compliance with study procedures|0|||
130960066|NCT01607905|471483081|FG003|Overall Study|Non-compliance with study procedures|0|||
130960067|NCT01607905|471483082|FG004|Overall Study|Non-compliance with study procedures|0|||
130960068|NCT01607905|471483083|FG005|Overall Study|Non-compliance with study procedures|0|||
130960069|NCT01607905|471483084|FG006|Overall Study|Non-compliance with study procedures|1|||
130960070|NCT01607905|471483078|FG000|Overall Study|Death|1|||
130960071|NCT01607905|471483079|FG001|Overall Study|Death|1|||
130960072|NCT01607905|471483080|FG002|Overall Study|Death|1|||
130960073|NCT01607905|471483081|FG003|Overall Study|Death|1|||
130960074|NCT01607905|471483082|FG004|Overall Study|Death|0|||
130960075|NCT01607905|471483083|FG005|Overall Study|Death|0|||
130960076|NCT01607905|471483084|FG006|Overall Study|Death|3|||
130960077|NCT01607905|471483078|FG000|Overall Study|Other treatments become available|1|||
130960078|NCT01607905|471483079|FG001|Overall Study|Other treatments become available|0|||
130960079|NCT01607905|471483080|FG002|Overall Study|Other treatments become available|0|||
130960080|NCT01607905|471483081|FG003|Overall Study|Other treatments become available|0|||
130960081|NCT01607905|471483082|FG004|Overall Study|Other treatments become available|0|||
130960082|NCT01607905|471483083|FG005|Overall Study|Other treatments become available|0|||
130960083|NCT01607905|471483084|FG006|Overall Study|Other treatments become available|1|||
130960084|NCT01607905|471483078|FG000|Overall Study|Investigator discretion|0|||
130960085|NCT01607905|471483079|FG001|Overall Study|Investigator discretion|0|||
130960086|NCT01607905|471483080|FG002|Overall Study|Investigator discretion|0|||
130960087|NCT01607905|471483081|FG003|Overall Study|Investigator discretion|0|||
130714466|NCT02031458|470581681|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
130714467|NCT02031458|470581682|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
130714468|NCT02031458|470581683|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
130960088|NCT01607905|471483082|FG004|Overall Study|Investigator discretion|0|||
130960089|NCT01607905|471483083|FG005|Overall Study|Investigator discretion|1|||
130960090|NCT01607905|471483084|FG006|Overall Study|Investigator discretion|0|||
130960091|NCT01607905|471483078|FG000|Overall Study|Other|1|||
130960092|NCT01607905|471483079|FG001|Overall Study|Other|0|||
130960093|NCT01607905|471483080|FG002|Overall Study|Other|0|||
131040715|NCT01928394|471785332|FG020|Treatment Period|Lost to Follow-up|0|||
131040716|NCT01928394|471785333|FG021|Treatment Period|Lost to Follow-up|0|||
131040717|NCT01928394|471785334|FG022|Treatment Period|Lost to Follow-up|1|||
131040718|NCT01928394|471785312|FG000|Treatment Period|Death|0|||
131040719|NCT01928394|471785313|FG001|Treatment Period|Death|0|||
131040720|NCT01928394|471785314|FG002|Treatment Period|Death|0|||
131040721|NCT01928394|471785315|FG003|Treatment Period|Death|0|||
131040722|NCT01928394|471785316|FG004|Treatment Period|Death|0|||
131040723|NCT01928394|471785317|FG005|Treatment Period|Death|0|||
131040724|NCT01928394|471785318|FG006|Treatment Period|Death|0|||
131040725|NCT01928394|471785319|FG007|Treatment Period|Death|0|||
131040726|NCT01928394|471785320|FG008|Treatment Period|Death|0|||
131040727|NCT01928394|471785321|FG009|Treatment Period|Death|0|||
131040728|NCT01928394|471785322|FG010|Treatment Period|Death|0|||
131040729|NCT01928394|471785323|FG011|Treatment Period|Death|0|||
131040730|NCT01928394|471785324|FG012|Treatment Period|Death|0|||
131040731|NCT01928394|471785325|FG013|Treatment Period|Death|1|||
131040732|NCT01928394|471785326|FG014|Treatment Period|Death|2|||
131040733|NCT01928394|471785327|FG015|Treatment Period|Death|0|||
131040734|NCT01928394|471785328|FG016|Treatment Period|Death|0|||
131040735|NCT01928394|471785329|FG017|Treatment Period|Death|0|||
131040736|NCT01928394|471785330|FG018|Treatment Period|Death|0|||
131040737|NCT01928394|471785331|FG019|Treatment Period|Death|0|||
130960094|NCT01607905|471483081|FG003|Overall Study|Other|0|||
131127201|NCT03259074|472094777|FG000|Overall Study|Lost to Follow-up|2|||
131127202|NCT03259074|472094778|FG001|Overall Study|Lost to Follow-up|4|||
130960095|NCT01607905|471483082|FG004|Overall Study|Other|0|||
131040738|NCT01928394|471785332|FG020|Treatment Period|Death|0|||
131040739|NCT01928394|471785333|FG021|Treatment Period|Death|0|||
131040740|NCT01928394|471785334|FG022|Treatment Period|Death|0|||
131040741|NCT01928394|471785312|FG000|Follow-up Period|Participant withdrew consent|3|||
131040742|NCT01928394|471785313|FG001|Follow-up Period|Participant withdrew consent|0|||
131127203|NCT03259074|472094779|FG002|Overall Study|Lost to Follow-up|3|||
130960096|NCT01607905|471483083|FG005|Overall Study|Other|0|||
130960097|NCT01607905|471483084|FG006|Overall Study|Other|1|||
130960098|NCT01607905|471483078|FG000|Overall Study|Randomized but not treated|1|||
130960099|NCT01607905|471483079|FG001|Overall Study|Randomized but not treated|0|||
130960100|NCT01607905|471483080|FG002|Overall Study|Randomized but not treated|0|||
130960101|NCT01607905|471483081|FG003|Overall Study|Randomized but not treated|0|||
130960102|NCT01607905|471483082|FG004|Overall Study|Randomized but not treated|1|||
130960103|NCT01607905|471483083|FG005|Overall Study|Randomized but not treated|1|||
130960104|NCT01607905|471483084|FG006|Overall Study|Randomized but not treated|0|||
130960105|NCT01105533|471483085|FG000|Overall Study|Death|0|||
130960106|NCT01105533|471483086|FG001|Overall Study|Death|0|||
130960107|NCT01105533|471483087|FG002|Overall Study|Death|0|||
130960108|NCT01105533|471483088|FG003|Overall Study|Death|0|||
130960109|NCT01105533|471483089|FG004|Overall Study|Death|1|||
130960110|NCT01105533|471483090|FG005|Overall Study|Death|0|||
130960111|NCT01105533|471483091|FG006|Overall Study|Death|0|||
130960112|NCT01105533|471483092|FG007|Overall Study|Death|0|||
130960113|NCT01105533|471483093|FG008|Overall Study|Death|0|||
130960114|NCT01105533|471483085|FG000|Overall Study|Lack of Efficacy|1|||
130960115|NCT01105533|471483086|FG001|Overall Study|Lack of Efficacy|1|||
130960116|NCT01105533|471483087|FG002|Overall Study|Lack of Efficacy|3|||
130960117|NCT01105533|471483088|FG003|Overall Study|Lack of Efficacy|3|||
130960118|NCT01105533|471483089|FG004|Overall Study|Lack of Efficacy|4|||
130960119|NCT01105533|471483090|FG005|Overall Study|Lack of Efficacy|5|||
130960120|NCT01105533|471483091|FG006|Overall Study|Lack of Efficacy|3|||
130960121|NCT01105533|471483092|FG007|Overall Study|Lack of Efficacy|2|||
130960122|NCT01105533|471483093|FG008|Overall Study|Lack of Efficacy|9|||
130960123|NCT01105533|471483085|FG000|Overall Study|Adverse Event|0|||
130960124|NCT01105533|471483086|FG001|Overall Study|Adverse Event|0|||
130960125|NCT01105533|471483087|FG002|Overall Study|Adverse Event|0|||
130960126|NCT01105533|471483088|FG003|Overall Study|Adverse Event|0|||
130960127|NCT01105533|471483089|FG004|Overall Study|Adverse Event|1|||
130960128|NCT01105533|471483090|FG005|Overall Study|Adverse Event|2|||
130960129|NCT01105533|471483091|FG006|Overall Study|Adverse Event|2|||
130960130|NCT01105533|471483092|FG007|Overall Study|Adverse Event|0|||
130960131|NCT01105533|471483093|FG008|Overall Study|Adverse Event|1|||
130960132|NCT01105533|471483085|FG000|Overall Study|Other|0|||
130960133|NCT01105533|471483086|FG001|Overall Study|Other|0|||
130960134|NCT01105533|471483087|FG002|Overall Study|Other|0|||
130960135|NCT01105533|471483088|FG003|Overall Study|Other|0|||
130960136|NCT01105533|471483089|FG004|Overall Study|Other|1|||
131040743|NCT01928394|471785314|FG002|Follow-up Period|Participant withdrew consent|1|||
131040744|NCT01928394|471785315|FG003|Follow-up Period|Participant withdrew consent|4|||
131040745|NCT01928394|471785316|FG004|Follow-up Period|Participant withdrew consent|0|||
131040746|NCT01928394|471785317|FG005|Follow-up Period|Participant withdrew consent|2|||
131040747|NCT01928394|471785318|FG006|Follow-up Period|Participant withdrew consent|5|||
131040748|NCT01928394|471785319|FG007|Follow-up Period|Participant withdrew consent|1|||
131040749|NCT01928394|471785320|FG008|Follow-up Period|Participant withdrew consent|0|||
131040750|NCT01928394|471785321|FG009|Follow-up Period|Participant withdrew consent|0|||
131040751|NCT01928394|471785322|FG010|Follow-up Period|Participant withdrew consent|5|||
131040752|NCT01928394|471785323|FG011|Follow-up Period|Participant withdrew consent|8|||
131040753|NCT01928394|471785324|FG012|Follow-up Period|Participant withdrew consent|2|||
131040754|NCT01928394|471785325|FG013|Follow-up Period|Participant withdrew consent|12|||
131040755|NCT01928394|471785326|FG014|Follow-up Period|Participant withdrew consent|7|||
131040756|NCT01928394|471785327|FG015|Follow-up Period|Participant withdrew consent|0|||
131040757|NCT01928394|471785328|FG016|Follow-up Period|Participant withdrew consent|5|||
131040758|NCT01928394|471785329|FG017|Follow-up Period|Participant withdrew consent|3|||
131040759|NCT01928394|471785330|FG018|Follow-up Period|Participant withdrew consent|2|||
131040760|NCT01928394|471785331|FG019|Follow-up Period|Participant withdrew consent|7|||
131040761|NCT01928394|471785332|FG020|Follow-up Period|Participant withdrew consent|4|||
131040762|NCT01928394|471785333|FG021|Follow-up Period|Participant withdrew consent|6|||
131040763|NCT01928394|471785334|FG022|Follow-up Period|Participant withdrew consent|2|||
131040764|NCT01928394|471785312|FG000|Follow-up Period|Death|0|||
131040765|NCT01928394|471785313|FG001|Follow-up Period|Death|0|||
130714469|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Death|36|||
130960137|NCT01105533|471483090|FG005|Overall Study|Other|0|||
130960138|NCT01105533|471483091|FG006|Overall Study|Other|3|||
130960139|NCT01105533|471483092|FG007|Overall Study|Other|1|||
130960140|NCT01105533|471483093|FG008|Overall Study|Other|2|||
130960141|NCT01105533|471483085|FG000|Overall Study|Physician Decision|0|||
130960142|NCT01105533|471483086|FG001|Overall Study|Physician Decision|0|||
130960143|NCT01105533|471483087|FG002|Overall Study|Physician Decision|0|||
130960144|NCT01105533|471483088|FG003|Overall Study|Physician Decision|0|||
130960145|NCT01105533|471483089|FG004|Overall Study|Physician Decision|0|||
131040766|NCT01928394|471785314|FG002|Follow-up Period|Death|2|||
131040767|NCT01928394|471785315|FG003|Follow-up Period|Death|6|||
130960146|NCT01105533|471483090|FG005|Overall Study|Physician Decision|0|||
130960147|NCT01105533|471483091|FG006|Overall Study|Physician Decision|0|||
130960148|NCT01105533|471483092|FG007|Overall Study|Physician Decision|1|||
130960149|NCT01105533|471483093|FG008|Overall Study|Physician Decision|0|||
130960150|NCT02096835|471483095|FG000|Overall Study|Withdrawal by Subject|1|||
130960151|NCT02096835|471483096|FG001|Overall Study|Withdrawal by Subject|0|||
130960152|NCT02096835|471483097|FG002|Overall Study|Withdrawal by Subject|0|||
130960153|NCT02096835|471483095|FG000|Overall Study|converted to open procedures|1|||
130960154|NCT02096835|471483096|FG001|Overall Study|converted to open procedures|0|||
130960155|NCT02096835|471483097|FG002|Overall Study|converted to open procedures|0|||
130960156|NCT02096835|471483095|FG000|Overall Study|Lost to Follow-up|1|||
130960157|NCT02096835|471483096|FG001|Overall Study|Lost to Follow-up|0|||
130960158|NCT02096835|471483097|FG002|Overall Study|Lost to Follow-up|1|||
130960159|NCT03892889|471483098|FG000|Overall Study|Adverse Event|17|||
130960160|NCT03892889|471483098|FG000|Overall Study|Lack of Efficacy|1|||
130960161|NCT03892889|471483098|FG000|Overall Study|Lost to Follow-up|46|||
130960162|NCT03892889|471483098|FG000|Overall Study|Non-compliance with study drug|22|||
130960163|NCT03892889|471483098|FG000|Overall Study|Pregnancy|1|||
130960164|NCT03892889|471483098|FG000|Overall Study|Protocol Deviation|3|||
130960165|NCT03892889|471483098|FG000|Overall Study|Withdrawal by Subject|50|||
130960166|NCT03892889|471483098|FG000|Overall Study|Withdrawal by Caregiver|1|||
130960167|NCT03892889|471483098|FG000|Overall Study|Study Terminated by Sponsor|50|||
130960168|NCT03892889|471483098|FG000|Overall Study|Physician Decision|8|||
130960169|NCT03892889|471483098|FG000|Overall Study|Reason not Specified|5|||
130960170|NCT04101526|471483108|FG000|Overall Study|Did not complete all sleep diary entries|0|||
130960171|NCT04101526|471483109|FG001|Overall Study|Did not complete all sleep diary entries|1|||
130960172|NCT00424372|471483110|FG000|Overall Study|Death|1|||
130960173|NCT00424372|471483110|FG000|Overall Study|Adverse Event|18|||
130960174|NCT00424372|471483110|FG000|Overall Study|Lack of Efficacy|6|||
131127204|NCT03259074|472094777|FG000|Overall Study|New Therapy For Study Indication|1|||
131127205|NCT03259074|472094778|FG001|Overall Study|New Therapy For Study Indication|2|||
131127206|NCT03259074|472094779|FG002|Overall Study|New Therapy For Study Indication|2|||
131127207|NCT03259074|472094777|FG000|Overall Study|Physician Decision|4|||
131127208|NCT03259074|472094778|FG001|Overall Study|Physician Decision|12|||
131127209|NCT03259074|472094779|FG002|Overall Study|Physician Decision|10|||
131127210|NCT03259074|472094777|FG000|Overall Study|Pregnancy|1|||
131127211|NCT03259074|472094778|FG001|Overall Study|Pregnancy|1|||
131127212|NCT03259074|472094779|FG002|Overall Study|Pregnancy|0|||
131127213|NCT03259074|472094777|FG000|Overall Study|Progressive Disease|1|||
131127214|NCT03259074|472094778|FG001|Overall Study|Progressive Disease|0|||
131127215|NCT03259074|472094779|FG002|Overall Study|Progressive Disease|0|||
131127216|NCT03259074|472094777|FG000|Overall Study|Protocol Deviation|1|||
131127217|NCT03259074|472094778|FG001|Overall Study|Protocol Deviation|1|||
131127218|NCT03259074|472094779|FG002|Overall Study|Protocol Deviation|3|||
130960175|NCT00424372|471483110|FG000|Overall Study|Withdrawal by Subject|4|||
130960176|NCT00424372|471483110|FG000|Overall Study|Protocol Violation|1|||
130960177|NCT00424372|471483110|FG000|Overall Study|Health deterioration|1|||
130960178|NCT04622254|471483111|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
130960179|NCT04622254|471483112|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
130960180|NCT04622254|471483113|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
131127219|NCT03259074|472094777|FG000|Overall Study|Subject/Guardian Decision|13|||
131127220|NCT03259074|472094778|FG001|Overall Study|Subject/Guardian Decision|16|||
131127221|NCT03259074|472094779|FG002|Overall Study|Subject/Guardian Decision|14|||
131127222|NCT01780662|472094780|FG000|Overall Study|Adverse Event|1|||
131127223|NCT01780662|472094781|FG001|Overall Study|Adverse Event|0|||
131127224|NCT01780662|472094782|FG002|Overall Study|Adverse Event|2|||
130960181|NCT04622254|471483114|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
130960182|NCT04622254|471483115|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
130960183|NCT04622254|471483116|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
130960184|NCT04622254|471483111|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
130960185|NCT04622254|471483112|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
130960186|NCT04622254|471483113|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
130960187|NCT04622254|471483114|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130960188|NCT04622254|471483115|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130960189|NCT04622254|471483116|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130960190|NCT04622254|471483111|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
130960191|NCT04622254|471483112|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
130960192|NCT04622254|471483113|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
130960193|NCT04622254|471483114|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
130960194|NCT04622254|471483115|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
130960195|NCT04622254|471483116|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
131127225|NCT01780662|472094780|FG000|Overall Study|Physician Decision|0|||
131127226|NCT01780662|472094781|FG001|Overall Study|Physician Decision|5|||
131127227|NCT01780662|472094782|FG002|Overall Study|Physician Decision|7|||
130960196|NCT04622254|471483111|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130960197|NCT04622254|471483112|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
130960198|NCT04622254|471483113|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
131127228|NCT01780662|472094780|FG000|Overall Study|Protocol Violation|0|||
131040768|NCT01928394|471785316|FG004|Follow-up Period|Death|0|||
131040769|NCT01928394|471785317|FG005|Follow-up Period|Death|6|||
131040770|NCT01928394|471785318|FG006|Follow-up Period|Death|6|||
131040771|NCT01928394|471785319|FG007|Follow-up Period|Death|2|||
131040772|NCT01928394|471785320|FG008|Follow-up Period|Death|1|||
131040773|NCT01928394|471785321|FG009|Follow-up Period|Death|2|||
131040774|NCT01928394|471785322|FG010|Follow-up Period|Death|4|||
131040775|NCT01928394|471785323|FG011|Follow-up Period|Death|12|||
131040776|NCT01928394|471785324|FG012|Follow-up Period|Death|11|||
131040777|NCT01928394|471785325|FG013|Follow-up Period|Death|25|||
130960199|NCT04622254|471483114|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131040778|NCT01928394|471785326|FG014|Follow-up Period|Death|18|||
131040779|NCT01928394|471785327|FG015|Follow-up Period|Death|0|||
131040780|NCT01928394|471785328|FG016|Follow-up Period|Death|6|||
131040781|NCT01928394|471785329|FG017|Follow-up Period|Death|5|||
131040782|NCT01928394|471785330|FG018|Follow-up Period|Death|13|||
131040783|NCT01928394|471785331|FG019|Follow-up Period|Death|13|||
131040784|NCT01928394|471785332|FG020|Follow-up Period|Death|5|||
131040785|NCT01928394|471785333|FG021|Follow-up Period|Death|3|||
131040786|NCT01928394|471785334|FG022|Follow-up Period|Death|2|||
131040787|NCT01928394|471785312|FG000|Follow-up Period|other reason|0|||
131040788|NCT01928394|471785313|FG001|Follow-up Period|other reason|0|||
131040789|NCT01928394|471785314|FG002|Follow-up Period|other reason|0|||
131040790|NCT01928394|471785315|FG003|Follow-up Period|other reason|0|||
131040791|NCT01928394|471785316|FG004|Follow-up Period|other reason|0|||
131040792|NCT01928394|471785317|FG005|Follow-up Period|other reason|0|||
130960200|NCT04622254|471483115|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130960201|NCT04622254|471483116|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130960202|NCT04622254|471483111|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130960203|NCT04622254|471483112|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130960204|NCT04622254|471483113|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130960205|NCT04622254|471483114|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
130960206|NCT04622254|471483115|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130960207|NCT04622254|471483116|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130960208|NCT04622254|471483111|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130960209|NCT04622254|471483112|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130960210|NCT04622254|471483113|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131040793|NCT01928394|471785318|FG006|Follow-up Period|other reason|1|||
131040794|NCT01928394|471785319|FG007|Follow-up Period|other reason|3|||
131040795|NCT01928394|471785320|FG008|Follow-up Period|other reason|0|||
131040796|NCT01928394|471785321|FG009|Follow-up Period|other reason|0|||
131040797|NCT01928394|471785322|FG010|Follow-up Period|other reason|2|||
131040798|NCT01928394|471785323|FG011|Follow-up Period|other reason|1|||
131040799|NCT01928394|471785324|FG012|Follow-up Period|other reason|0|||
131040800|NCT01928394|471785325|FG013|Follow-up Period|other reason|1|||
131040801|NCT01928394|471785326|FG014|Follow-up Period|other reason|4|||
131040802|NCT01928394|471785327|FG015|Follow-up Period|other reason|0|||
131040803|NCT01928394|471785328|FG016|Follow-up Period|other reason|2|||
131040804|NCT01928394|471785329|FG017|Follow-up Period|other reason|0|||
131040805|NCT01928394|471785330|FG018|Follow-up Period|other reason|1|||
131040806|NCT01928394|471785331|FG019|Follow-up Period|other reason|1|||
131040807|NCT01928394|471785332|FG020|Follow-up Period|other reason|0|||
131040808|NCT01928394|471785333|FG021|Follow-up Period|other reason|0|||
131040809|NCT01928394|471785334|FG022|Follow-up Period|other reason|1|||
131040810|NCT01928394|471785312|FG000|Follow-up Period|Lost to Follow-up|0|||
131040811|NCT01928394|471785313|FG001|Follow-up Period|Lost to Follow-up|0|||
131040812|NCT01928394|471785314|FG002|Follow-up Period|Lost to Follow-up|0|||
131040813|NCT01928394|471785315|FG003|Follow-up Period|Lost to Follow-up|0|||
131040814|NCT01928394|471785316|FG004|Follow-up Period|Lost to Follow-up|0|||
131040815|NCT01928394|471785317|FG005|Follow-up Period|Lost to Follow-up|0|||
131040816|NCT01928394|471785318|FG006|Follow-up Period|Lost to Follow-up|0|||
131040817|NCT01928394|471785319|FG007|Follow-up Period|Lost to Follow-up|0|||
131040818|NCT01928394|471785320|FG008|Follow-up Period|Lost to Follow-up|0|||
131040819|NCT01928394|471785321|FG009|Follow-up Period|Lost to Follow-up|0|||
130960211|NCT04622254|471483114|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
130960212|NCT04622254|471483115|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131040820|NCT01928394|471785322|FG010|Follow-up Period|Lost to Follow-up|0|||
131040821|NCT01928394|471785323|FG011|Follow-up Period|Lost to Follow-up|1|||
131040822|NCT01928394|471785324|FG012|Follow-up Period|Lost to Follow-up|1|||
131040823|NCT01928394|471785325|FG013|Follow-up Period|Lost to Follow-up|0|||
131040824|NCT01928394|471785326|FG014|Follow-up Period|Lost to Follow-up|1|||
131040825|NCT01928394|471785327|FG015|Follow-up Period|Lost to Follow-up|0|||
131040826|NCT01928394|471785328|FG016|Follow-up Period|Lost to Follow-up|1|||
131040827|NCT01928394|471785329|FG017|Follow-up Period|Lost to Follow-up|0|||
131040828|NCT01928394|471785330|FG018|Follow-up Period|Lost to Follow-up|0|||
131040829|NCT01928394|471785331|FG019|Follow-up Period|Lost to Follow-up|0|||
131040830|NCT01928394|471785332|FG020|Follow-up Period|Lost to Follow-up|0|||
131040831|NCT01928394|471785333|FG021|Follow-up Period|Lost to Follow-up|0|||
131040832|NCT01928394|471785334|FG022|Follow-up Period|Lost to Follow-up|1|||
130960213|NCT04622254|471483116|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
130960214|NCT04622254|471483111|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130960215|NCT04622254|471483112|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130960216|NCT04622254|471483113|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130960217|NCT04622254|471483114|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
130960218|NCT04622254|471483115|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130960219|NCT04622254|471483116|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130960220|NCT04622254|471483111|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130960221|NCT04622254|471483112|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130960222|NCT04622254|471483113|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130960223|NCT04622254|471483114|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
130960224|NCT04622254|471483115|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130960225|NCT04622254|471483116|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130960226|NCT04622254|471483111|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130960227|NCT04622254|471483112|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130960228|NCT04622254|471483113|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130960229|NCT04622254|471483114|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
130960230|NCT04622254|471483115|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
130960231|NCT04622254|471483116|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
130960232|NCT04622254|471483111|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130960233|NCT04622254|471483112|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130960234|NCT04622254|471483113|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130960235|NCT04622254|471483114|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
130960236|NCT04622254|471483115|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
130960237|NCT04622254|471483116|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
130960238|NCT04622254|471483111|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
130960239|NCT04622254|471483112|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
130960240|NCT04622254|471483113|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
130960241|NCT04622254|471483114|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
130960242|NCT04622254|471483115|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
130960243|NCT04622254|471483116|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
130960244|NCT00098839|471483117|FG000|Overall Study|Adverse Event|5|||
130960245|NCT00098839|471483118|FG001|Overall Study|Adverse Event|2|||
130960246|NCT00098839|471483117|FG000|Overall Study|Death|1|||
130960247|NCT00098839|471483118|FG001|Overall Study|Death|2|||
130960248|NCT00098839|471483117|FG000|Overall Study|Physician Decision|4|||
130960249|NCT00098839|471483118|FG001|Overall Study|Physician Decision|14|||
130960250|NCT00098839|471483117|FG000|Overall Study|Withdrawal by Subject|1|||
130960251|NCT00098839|471483118|FG001|Overall Study|Withdrawal by Subject|0|||
130960252|NCT00098839|471483117|FG000|Overall Study|Refusal of further protocol therapy|3|||
130960253|NCT00098839|471483118|FG001|Overall Study|Refusal of further protocol therapy|1|||
130960254|NCT00098839|471483117|FG000|Overall Study|Relapse|6|||
130960255|NCT00098839|471483118|FG001|Overall Study|Relapse|3|||
130960256|NCT00098839|471483117|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
130960257|NCT00098839|471483118|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
130960258|NCT00098839|471483117|FG000|Overall Study|Ineligible|2|||
130960259|NCT00098839|471483118|FG001|Overall Study|Ineligible|0|||
130960260|NCT02167035|471483119|FG000|Overall Study|Adverse Event|2|||
130960261|NCT02167035|471483120|FG001|Overall Study|Adverse Event|2|||
130960262|NCT02167035|471483119|FG000|Overall Study|Lost to Follow-up|3|||
130960263|NCT02167035|471483120|FG001|Overall Study|Lost to Follow-up|3|||
130960264|NCT02167035|471483119|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
130960265|NCT02167035|471483120|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
130960266|NCT02039427|471483121|FG000|Overall Study|Duration of surgery > 3h|1|||
130960267|NCT02039427|471483122|FG001|Overall Study|Duration of surgery > 3h|1|||
130960268|NCT02039427|471483123|FG002|Overall Study|Duration of surgery > 3h|0|||
130960269|NCT02039427|471483124|FG003|Overall Study|Duration of surgery > 3h|0|||
130960270|NCT02039427|471483121|FG000|Overall Study|Withdrawal on concent|0|||
130960271|NCT02039427|471483122|FG001|Overall Study|Withdrawal on concent|0|||
130960272|NCT02039427|471483123|FG002|Overall Study|Withdrawal on concent|0|||
130960273|NCT02039427|471483124|FG003|Overall Study|Withdrawal on concent|1|||
130960274|NCT02039427|471483121|FG000|Overall Study|Cancellation of surgery|0|||
130960275|NCT02039427|471483122|FG001|Overall Study|Cancellation of surgery|0|||
130960276|NCT02039427|471483123|FG002|Overall Study|Cancellation of surgery|1|||
130960277|NCT02039427|471483124|FG003|Overall Study|Cancellation of surgery|0|||
130960278|NCT02039427|471483121|FG000|Overall Study|Loss of follow - up|1|||
130960279|NCT02039427|471483122|FG001|Overall Study|Loss of follow - up|0|||
130960280|NCT02039427|471483123|FG002|Overall Study|Loss of follow - up|2|||
130960281|NCT02039427|471483124|FG003|Overall Study|Loss of follow - up|4|||
131127229|NCT01780662|472094781|FG001|Overall Study|Protocol Violation|1|||
130960282|NCT02039427|471483121|FG000|Overall Study|Steroid Use|1|||
130960283|NCT02039427|471483122|FG001|Overall Study|Steroid Use|0|||
130960284|NCT02039427|471483123|FG002|Overall Study|Steroid Use|0|||
130960285|NCT02039427|471483124|FG003|Overall Study|Steroid Use|0|||
130960286|NCT00844545|471483125|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
130960287|NCT00844545|471483125|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
130960288|NCT00844545|471483125|FG000|Extension Treatment Period|Adverse Event|2|||
130960289|NCT00844545|471483125|FG000|Post Treatment Period|Withdrawal by Subject|1|||
130960290|NCT01743092|471483126|FG000|Overall Study|Lost to Follow-up|14|||
130960291|NCT01743092|471483127|FG001|Overall Study|Lost to Follow-up|15|||
130960292|NCT03586869|471483133|FG000|Overall Study|Progressive Disease|3|||
130960293|NCT00403455|471483134|FG000|Overall Study|Withdrawal by Subject|1|||
130960294|NCT00087568|471483135|FG000|Overall Study|Adverse Event|4|||
130960295|NCT00087568|471483136|FG001|Overall Study|Adverse Event|0|||
130960296|NCT00087568|471483135|FG000|Overall Study|Withdrawal by Subject|1|||
130960297|NCT00087568|471483136|FG001|Overall Study|Withdrawal by Subject|1|||
130960298|NCT00087568|471483135|FG000|Overall Study|Lost to Follow-up|1|||
130960299|NCT00087568|471483136|FG001|Overall Study|Lost to Follow-up|0|||
130960300|NCT00087568|471483135|FG000|Overall Study|Lack of Efficacy|24|||
130960301|NCT00087568|471483136|FG001|Overall Study|Lack of Efficacy|1|||
130960302|NCT04354831|471483141|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
130960303|NCT04354831|471483142|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
130960304|NCT02732847|471483143|FG000|Overall Study|some filled early|42|||
130960305|NCT02732847|471483144|FG001|Overall Study|some filled early|42|||
130960306|NCT01430585|471483145|FG000|Overall Study|Death|1|||
130960307|NCT01430585|471483145|FG000|Overall Study|Objective Progression or Relapse|3|||
130960308|NCT01430585|471483145|FG000|Overall Study|Study Terminated by Sponsor|3|||
130960309|NCT01430585|471483145|FG000|Overall Study|Other|7|||
130960310|NCT01274637|471483148|FG000|Overall Study|Withdrawal by Subject|0|||
130960311|NCT01274637|471483149|FG001|Overall Study|Withdrawal by Subject|1|||
130960312|NCT01274637|471483148|FG000|Overall Study|Lost to Follow-up|0|||
130960313|NCT01274637|471483149|FG001|Overall Study|Lost to Follow-up|1|||
130960314|NCT02357576|471483152|FG000|Treatment Period|Withdrawal by Subject|0|||
130960315|NCT02357576|471483153|FG001|Treatment Period|Withdrawal by Subject|1|||
130960316|NCT02357576|471483152|FG000|Treatment Period|Physician Decision|0|||
130960317|NCT02357576|471483153|FG001|Treatment Period|Physician Decision|1|||
130960318|NCT02357576|471483152|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
130960319|NCT02357576|471483153|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
130960320|NCT02357576|471483152|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
130960321|NCT02357576|471483153|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
130960322|NCT02357576|471483152|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
130960323|NCT02357576|471483153|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
130960324|NCT02357576|471483152|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
130960325|NCT02357576|471483153|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
130960326|NCT00699699|471483156|FG000|Overall Study|Adverse Event|36|||
130960327|NCT00699699|471483156|FG000|Overall Study|Individual different reasons|21|||
130960328|NCT01632800|471483159|FG000|Overall Study|Subject did not fit in apparatus|1|||
130960329|NCT00720876|471483161|FG000|Overall Study|found to be ineligible after starting tx|2|||
130960330|NCT03495908|471483163|FG000|Overall Study|Withdrawal by Subject|3|||
130960331|NCT03495908|471483164|FG001|Overall Study|Withdrawal by Subject|1|||
130960332|NCT03495908|471483163|FG000|Overall Study|Lost to Follow-up|1|||
130960333|NCT03495908|471483164|FG001|Overall Study|Lost to Follow-up|4|||
130960334|NCT03495908|471483163|FG000|Overall Study|Adverse Event|0|||
130960335|NCT03495908|471483164|FG001|Overall Study|Adverse Event|2|||
130960336|NCT03495908|471483163|FG000|Overall Study|Death|1|||
130960337|NCT03495908|471483164|FG001|Overall Study|Death|0|||
130960338|NCT03495908|471483163|FG000|Overall Study|Physician Decision|5|||
130960339|NCT03495908|471483164|FG001|Overall Study|Physician Decision|4|||
130960340|NCT03495908|471483163|FG000|Overall Study|No documented reason|0|||
130960341|NCT03495908|471483164|FG001|Overall Study|No documented reason|2|||
130960342|NCT03511560|471483170|FG000|Overall Study|Death|0|||
130960343|NCT03511560|471483171|FG001|Overall Study|Death|1|||
130960344|NCT03511560|471483170|FG000|Overall Study|Adverse Event|0|||
130960345|NCT03511560|471483171|FG001|Overall Study|Adverse Event|2|||
130960346|NCT03511560|471483170|FG000|Overall Study|Transplant cancelled|0|||
130960347|NCT03511560|471483171|FG001|Overall Study|Transplant cancelled|1|||
130960348|NCT03511560|471483170|FG000|Overall Study|Patient switched to another drug|1|||
130960349|NCT03511560|471483171|FG001|Overall Study|Patient switched to another drug|0|||
130960350|NCT02985736|471483176|FG000|Overall Study|Lost to Follow-up|3|||
130960351|NCT00382733|471483177|FG000|Overall Study|Withdrawal by Subject|0|||
130960352|NCT00382733|471483178|FG001|Overall Study|Withdrawal by Subject|1|||
131040833|NCT04707625|471785335|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
131040834|NCT05485779|471785338|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
130960353|NCT00382733|471483179|FG002|Overall Study|Withdrawal by Subject|0|||
130960354|NCT00382733|471483180|FG003|Overall Study|Withdrawal by Subject|0|||
130960355|NCT00382733|471483181|FG004|Overall Study|Withdrawal by Subject|0|||
130960356|NCT00439140|471483186|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
131040835|NCT05485779|471785339|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
131226368|NCT00950599|472455733|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
131226369|NCT00950599|472455724|FG000|Follow-Up Period|Adverse Event|0|||
131226370|NCT00950599|472455725|FG001|Follow-Up Period|Adverse Event|0|||
131226371|NCT00950599|472455726|FG002|Follow-Up Period|Adverse Event|0|||
131226372|NCT00950599|472455727|FG003|Follow-Up Period|Adverse Event|0|||
130960357|NCT00439140|471483187|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
130960358|NCT00439140|471483188|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
130960359|NCT00439140|471483186|FG000|Treatment Cycle 1|Personal reasons|0|||
130960360|NCT00439140|471483187|FG001|Treatment Cycle 1|Personal reasons|2|||
130960361|NCT00439140|471483188|FG002|Treatment Cycle 1|Personal reasons|0|||
130960362|NCT00439140|471483186|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
130960363|NCT00439140|471483187|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
130960364|NCT00439140|471483188|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
130960365|NCT00439140|471483186|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
130960366|NCT00439140|471483187|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
130960367|NCT00439140|471483188|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
130960368|NCT00439140|471483186|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
130960369|NCT00439140|471483187|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
130960370|NCT00439140|471483188|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
130960371|NCT01458171|471483189|FG000|Overall Study|Adverse Event|1|||
130960372|NCT01193556|471483190|FG000|Overall Study|Study termination|26|||
130960373|NCT01193556|471483191|FG001|Overall Study|Study termination|25|||
130960374|NCT05013905|471483192|FG000|Overall Study|Adverse Event|1|||
130960375|NCT05013905|471483192|FG000|Overall Study|Lack of Efficacy|1|||
130960376|NCT03286140|471483196|FG000|Overall Study|Withdrawal by Subject|10|||
130960377|NCT03286140|471483197|FG001|Overall Study|Withdrawal by Subject|5|||
130960378|NCT03286140|471483196|FG000|Overall Study|Lost to Follow-up|5|||
130960379|NCT03286140|471483197|FG001|Overall Study|Lost to Follow-up|10|||
130960380|NCT03286140|471483196|FG000|Overall Study|Failure to comply|0|||
130960381|NCT03286140|471483197|FG001|Overall Study|Failure to comply|1|||
130960382|NCT05402995|471483198|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
130960383|NCT05402995|471483199|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
130960384|NCT05402995|471483200|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
130960385|NCT05402995|471483201|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
130960386|NCT02188485|471483202|FG000|Overall Study|Withdrawal by Subject|2|||
130960387|NCT02188485|471483203|FG001|Overall Study|Withdrawal by Subject|1|||
130960388|NCT02188485|471483202|FG000|Overall Study|PI withdrew, lack of capacity|0|||
130960389|NCT02188485|471483203|FG001|Overall Study|PI withdrew, lack of capacity|2|||
130960390|NCT00512096|471483209|FG000|Overall Study|Adverse Event|2|||
130960391|NCT00512096|471483209|FG000|Overall Study|Withdrawal by Subject|2|||
130960392|NCT00512096|471483209|FG000|Overall Study|Lack of Efficacy|3|||
130960393|NCT01069289|471483213|FG000|Overall Study|Withdrawal by Subject|15|||
130960394|NCT01069289|471483214|FG001|Overall Study|Withdrawal by Subject|26|||
130960395|NCT01069289|471483213|FG000|Overall Study|Adverse Event|21|||
130960396|NCT01069289|471483214|FG001|Overall Study|Adverse Event|28|||
130960397|NCT01069289|471483213|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130960398|NCT01069289|471483214|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130960399|NCT01069289|471483213|FG000|Overall Study|Severe non-compliance to protocol|3|||
130960400|NCT01069289|471483214|FG001|Overall Study|Severe non-compliance to protocol|2|||
130960401|NCT01069289|471483213|FG000|Overall Study|Due to deteriorating health condition|1|||
130960402|NCT01069289|471483214|FG001|Overall Study|Due to deteriorating health condition|0|||
130960403|NCT00298038|471483215|FG000|Overall Study|Lost to Follow-up|0|||
130960404|NCT00298038|471483216|FG001|Overall Study|Lost to Follow-up|1|||
130960405|NCT00298038|471483215|FG000|Overall Study|Liver Transplant|0|||
130960406|NCT00298038|471483216|FG001|Overall Study|Liver Transplant|1|||
130960407|NCT00298038|471483215|FG000|Overall Study|Protocol Violation|1|||
130960408|NCT00298038|471483216|FG001|Overall Study|Protocol Violation|3|||
130960409|NCT00298038|471483215|FG000|Overall Study|Death|6|||
130960410|NCT00298038|471483216|FG001|Overall Study|Death|3|||
130960411|NCT00298038|471483215|FG000|Overall Study|Withdrawal by Subject|6|||
130960412|NCT00298038|471483216|FG001|Overall Study|Withdrawal by Subject|9|||
130960413|NCT00298038|471483215|FG000|Overall Study|Adverse Event|8|||
130960414|NCT00298038|471483216|FG001|Overall Study|Adverse Event|7|||
130960415|NCT00298038|471483215|FG000|Overall Study|Breakthrough overt HE episode|28|||
130960416|NCT00298038|471483216|FG001|Overall Study|Breakthrough overt HE episode|69|||
130960417|NCT00298038|471483215|FG000|Overall Study|Noncompliance|1|||
130960418|NCT00298038|471483216|FG001|Overall Study|Noncompliance|0|||
130960419|NCT00298038|471483215|FG000|Overall Study|Cocaine Abuse|1|||
130960420|NCT00298038|471483216|FG001|Overall Study|Cocaine Abuse|0|||
130960421|NCT00298038|471483215|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
130960422|NCT00298038|471483216|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
130960423|NCT02696096|471483217|FG000|Overall Study|ruled out at screening|1|||
130960424|NCT02696096|471483217|FG000|Overall Study|did not attend second fMRI|1|||
130960425|NCT02047604|471483218|FG000|Overall Study|Withdrawal by Subject|0|||
130960426|NCT02047604|471483219|FG001|Overall Study|Withdrawal by Subject|0|||
131226373|NCT00950599|472455728|FG004|Follow-Up Period|Adverse Event|0|||
130960427|NCT02047604|471483220|FG002|Overall Study|Withdrawal by Subject|0|||
130960428|NCT02047604|471483221|FG003|Overall Study|Withdrawal by Subject|0|||
130960429|NCT02047604|471483222|FG004|Overall Study|Withdrawal by Subject|1|||
130960430|NCT02047604|471483223|FG005|Overall Study|Withdrawal by Subject|1|||
130960431|NCT02517905|471483224|FG000|Overall Study|Lost to Follow-up|4|||
130960432|NCT02517905|471483225|FG001|Overall Study|Lost to Follow-up|0|||
130960433|NCT02517905|471483224|FG000|Overall Study|Withdrawal by Subject|4|||
130960434|NCT02517905|471483225|FG001|Overall Study|Withdrawal by Subject|0|||
130960435|NCT02517905|471483224|FG000|Overall Study|Screen failure|2|||
130960436|NCT02517905|471483225|FG001|Overall Study|Screen failure|2|||
130985671|NCT04857034|471574949|FG003|Placebo-Controlled Period|Ongoing study period|0|||
130985672|NCT04857034|471574950|FG004|Placebo-Controlled Period|Ongoing study period|0|||
130985673|NCT04857034|471574946|FG000|Active Treatment Period|Lack of Efficacy|1|||
130985674|NCT04857034|471574947|FG001|Active Treatment Period|Lack of Efficacy|0|||
130985675|NCT04857034|471574948|FG002|Active Treatment Period|Lack of Efficacy|0|||
130985676|NCT04857034|471574949|FG003|Active Treatment Period|Lack of Efficacy|0|||
130985677|NCT04857034|471574950|FG004|Active Treatment Period|Lack of Efficacy|0|||
130985678|NCT04857034|471574946|FG000|Active Treatment Period|request to discontinue|0|||
130985679|NCT04857034|471574947|FG001|Active Treatment Period|request to discontinue|1|||
130985680|NCT04857034|471574948|FG002|Active Treatment Period|request to discontinue|0|||
130985681|NCT04857034|471574949|FG003|Active Treatment Period|request to discontinue|1|||
130985682|NCT04857034|471574950|FG004|Active Treatment Period|request to discontinue|0|||
130985683|NCT04857034|471574946|FG000|Active Treatment Period|administrative reason by sponsor|1|||
130985684|NCT04857034|471574947|FG001|Active Treatment Period|administrative reason by sponsor|5|||
130985685|NCT04857034|471574948|FG002|Active Treatment Period|administrative reason by sponsor|0|||
130985686|NCT04857034|471574949|FG003|Active Treatment Period|administrative reason by sponsor|2|||
130985687|NCT04857034|471574950|FG004|Active Treatment Period|administrative reason by sponsor|2|||
130985688|NCT04857034|471574946|FG000|Active Treatment Period|other reasons|1|||
130985689|NCT04857034|471574947|FG001|Active Treatment Period|other reasons|1|||
130985690|NCT04857034|471574948|FG002|Active Treatment Period|other reasons|0|||
130985691|NCT04857034|471574949|FG003|Active Treatment Period|other reasons|0|||
131226374|NCT00950599|472455729|FG005|Follow-Up Period|Adverse Event|0|||
131226375|NCT00950599|472455730|FG006|Follow-Up Period|Adverse Event|0|||
131226376|NCT00950599|472455731|FG007|Follow-Up Period|Adverse Event|0|||
131226377|NCT00950599|472455732|FG008|Follow-Up Period|Adverse Event|1|||
131226378|NCT00950599|472455733|FG009|Follow-Up Period|Adverse Event|0|||
131226379|NCT00950599|472455724|FG000|Follow-Up Period|Lack of Efficacy|0|||
131226380|NCT00950599|472455725|FG001|Follow-Up Period|Lack of Efficacy|0|||
131226381|NCT00950599|472455726|FG002|Follow-Up Period|Lack of Efficacy|0|||
131226382|NCT00950599|472455727|FG003|Follow-Up Period|Lack of Efficacy|0|||
131226383|NCT00950599|472455728|FG004|Follow-Up Period|Lack of Efficacy|0|||
131226384|NCT00950599|472455729|FG005|Follow-Up Period|Lack of Efficacy|0|||
131226385|NCT00950599|472455730|FG006|Follow-Up Period|Lack of Efficacy|0|||
131226386|NCT00950599|472455731|FG007|Follow-Up Period|Lack of Efficacy|0|||
131226387|NCT00950599|472455732|FG008|Follow-Up Period|Lack of Efficacy|3|||
131226388|NCT00950599|472455733|FG009|Follow-Up Period|Lack of Efficacy|0|||
130985692|NCT04857034|471574950|FG004|Active Treatment Period|other reasons|1|||
130985693|NCT04857034|471574946|FG000|Active Treatment Period|Ongoing Study Period|2|||
130985694|NCT04857034|471574947|FG001|Active Treatment Period|Ongoing Study Period|4|||
130985695|NCT04857034|471574948|FG002|Active Treatment Period|Ongoing Study Period|0|||
130985696|NCT04857034|471574949|FG003|Active Treatment Period|Ongoing Study Period|1|||
130985697|NCT04857034|471574950|FG004|Active Treatment Period|Ongoing Study Period|0|||
130985698|NCT05674890|471574955|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
130985699|NCT05674890|471574956|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
130985700|NCT05674890|471574955|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
130985701|NCT05674890|471574956|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
130985702|NCT05674890|471574955|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
130985703|NCT05674890|471574956|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
130985704|NCT00827541|471574957|FG000|Overall Study|Exitus|1|||
130985705|NCT00827541|471574958|FG001|Overall Study|Exitus|8|||
130985706|NCT00827541|471574957|FG000|Overall Study|Other|1|||
130985707|NCT00827541|471574958|FG001|Overall Study|Other|3|||
130985708|NCT00827541|471574957|FG000|Overall Study|Pathogen not susceptible|1|||
130985709|NCT00827541|471574958|FG001|Overall Study|Pathogen not susceptible|0|||
130985710|NCT00827541|471574957|FG000|Overall Study|Lack of effectiveness|1|||
130985711|NCT00827541|471574958|FG001|Overall Study|Lack of effectiveness|0|||
130985712|NCT01649232|471574959|FG000|Overall Study|Physician Decision|2|||
130985713|NCT01649232|471574960|FG001|Overall Study|Physician Decision|0|||
130985714|NCT04810221|471574961|FG000|Overall Study|Physician Decision|3|||
130985715|NCT03642938|471574962|FG000|Overall Study|Withdrawal by Subject|0|||
130985716|NCT03642938|471574963|FG001|Overall Study|Withdrawal by Subject|0|||
131226389|NCT00950599|472455724|FG000|Follow-Up Period|Lost to Follow-up|0|||
130960437|NCT02556710|471485256|FG000|Overall Study|Surgical treatment|3|||
130960438|NCT02556710|471485257|FG001|Overall Study|Surgical treatment|0|||
130960439|NCT02556710|471485256|FG000|Overall Study|Required proscribed pain medication|2|||
130960440|NCT02556710|471485257|FG001|Overall Study|Required proscribed pain medication|1|||
130960441|NCT02556710|471485256|FG000|Overall Study|Lack of Efficacy|1|||
130960442|NCT02556710|471485257|FG001|Overall Study|Lack of Efficacy|0|||
130960443|NCT02556710|471485256|FG000|Overall Study|Worsening osteoarthritis|1|||
130960444|NCT02556710|471485257|FG001|Overall Study|Worsening osteoarthritis|0|||
130960445|NCT02556710|471485256|FG000|Overall Study|Moved out of state|1|||
130960446|NCT02556710|471485257|FG001|Overall Study|Moved out of state|0|||
130960447|NCT02556710|471485256|FG000|Overall Study|Missing reason|3|||
130960448|NCT02556710|471485257|FG001|Overall Study|Missing reason|1|||
130960449|NCT02556710|471485256|FG000|Overall Study|Pain as lack of efficacy|0|||
130960450|NCT02556710|471485257|FG001|Overall Study|Pain as lack of efficacy|4|||
130960451|NCT03042312|471485258|FG000|Overall Study|Administrative Reason|1|||
130960452|NCT03042312|471485259|FG001|Overall Study|Administrative Reason|1|||
130960453|NCT03042312|471485258|FG000|Overall Study|Adverse Event|0|||
130960454|NCT03042312|471485259|FG001|Overall Study|Adverse Event|1|||
130960455|NCT03042312|471485258|FG000|Overall Study|Lost to Follow-up|1|||
130960456|NCT03042312|471485259|FG001|Overall Study|Lost to Follow-up|3|||
130960457|NCT03042312|471485258|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
130960458|NCT03042312|471485259|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
130960459|NCT03042312|471485258|FG000|Overall Study|Withdrawal by Subject|4|||
130960460|NCT03042312|471485259|FG001|Overall Study|Withdrawal by Subject|5|||
130960461|NCT00646958|471485262|FG000|Overall Study|Lack of Efficacy|1|||
130960462|NCT00646958|471485263|FG001|Overall Study|Lack of Efficacy|0|||
130960463|NCT00646958|471485264|FG002|Overall Study|Lack of Efficacy|0|||
130960464|NCT00646958|471485262|FG000|Overall Study|Adverse Event|4|||
130960465|NCT00646958|471485263|FG001|Overall Study|Adverse Event|0|||
130960466|NCT00646958|471485264|FG002|Overall Study|Adverse Event|0|||
130960467|NCT00646958|471485262|FG000|Overall Study|Lost to Follow-up|1|||
130960468|NCT00646958|471485263|FG001|Overall Study|Lost to Follow-up|5|||
130960469|NCT00646958|471485264|FG002|Overall Study|Lost to Follow-up|7|||
130960470|NCT00646958|471485262|FG000|Overall Study|Protocol Violation|1|||
130960471|NCT00646958|471485263|FG001|Overall Study|Protocol Violation|1|||
130960472|NCT00646958|471485264|FG002|Overall Study|Protocol Violation|0|||
130960473|NCT00646958|471485262|FG000|Overall Study|Abnormal screening lab tests|1|||
130960474|NCT00646958|471485263|FG001|Overall Study|Abnormal screening lab tests|1|||
130960475|NCT00646958|471485264|FG002|Overall Study|Abnormal screening lab tests|0|||
130960476|NCT00646958|471485262|FG000|Overall Study|Withdrawal by Subject|1|||
130960477|NCT00646958|471485263|FG001|Overall Study|Withdrawal by Subject|2|||
130960478|NCT00646958|471485264|FG002|Overall Study|Withdrawal by Subject|0|||
130960479|NCT00646958|471485262|FG000|Overall Study|Did not receive study drug|2|||
130960480|NCT00646958|471485263|FG001|Overall Study|Did not receive study drug|0|||
130960481|NCT00646958|471485264|FG002|Overall Study|Did not receive study drug|2|||
130960482|NCT04260191|471485266|FG000|Overall Study|Decision by Sponsor|0|||
130960483|NCT04260191|471485267|FG001|Overall Study|Decision by Sponsor|1|||
130960484|NCT04260191|471485268|FG002|Overall Study|Decision by Sponsor|0|||
130960485|NCT04260191|471485266|FG000|Overall Study|Withdrawal by Subject|1|||
130960486|NCT04260191|471485267|FG001|Overall Study|Withdrawal by Subject|0|||
130960487|NCT04260191|471485268|FG002|Overall Study|Withdrawal by Subject|3|||
130960488|NCT04260191|471485266|FG000|Overall Study|Death|4|||
130960489|NCT04260191|471485267|FG001|Overall Study|Death|3|||
130960490|NCT04260191|471485268|FG002|Overall Study|Death|2|||
130960491|NCT01312909|471485271|FG000|Overall Study|Randomized but not treated|1|||
130960492|NCT01312909|471485272|FG001|Overall Study|Randomized but not treated|3|||
130960493|NCT01312909|471485273|FG002|Overall Study|Randomized but not treated|1|||
130960494|NCT01312909|471485271|FG000|Overall Study|Adverse Event|1|||
130960495|NCT01312909|471485272|FG001|Overall Study|Adverse Event|0|||
130960496|NCT01312909|471485273|FG002|Overall Study|Adverse Event|3|||
130960497|NCT01312909|471485271|FG000|Overall Study|Protocol Violation|2|||
130960498|NCT01312909|471485272|FG001|Overall Study|Protocol Violation|0|||
130960499|NCT01312909|471485273|FG002|Overall Study|Protocol Violation|2|||
130960500|NCT01312909|471485271|FG000|Overall Study|Other|9|||
130960501|NCT01312909|471485272|FG001|Overall Study|Other|6|||
130714470|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Death|87|||
130960502|NCT01312909|471485273|FG002|Overall Study|Other|11|||
130960503|NCT01312909|471485271|FG000|Overall Study|Withdrawal by Subject|8|||
130960504|NCT01312909|471485272|FG001|Overall Study|Withdrawal by Subject|10|||
130960505|NCT01312909|471485273|FG002|Overall Study|Withdrawal by Subject|7|||
130960506|NCT01312909|471485271|FG000|Overall Study|Lost to Follow-up|21|||
130960507|NCT01312909|471485272|FG001|Overall Study|Lost to Follow-up|17|||
130960508|NCT01312909|471485273|FG002|Overall Study|Lost to Follow-up|20|||
130960509|NCT01312909|471485271|FG000|Overall Study|Insufficient clinical response|0|||
130960510|NCT01312909|471485272|FG001|Overall Study|Insufficient clinical response|0|||
130960511|NCT01312909|471485273|FG002|Overall Study|Insufficient clinical response|1|||
130960512|NCT01312909|471485271|FG000|Overall Study|Entrance criteria not met|0|||
130960513|NCT01312909|471485272|FG001|Overall Study|Entrance criteria not met|0|||
130960514|NCT01312909|471485273|FG002|Overall Study|Entrance criteria not met|2|||
130960515|NCT00659646|471485276|FG000|Overall Study|Protocol Violation|12|||
130960516|NCT00659646|471485277|FG001|Overall Study|Protocol Violation|8|||
130960517|NCT00659646|471485276|FG000|Overall Study|Adverse Event|1|||
130960518|NCT00659646|471485277|FG001|Overall Study|Adverse Event|0|||
130960519|NCT00659646|471485276|FG000|Overall Study|Lost to Follow-up|1|||
130960520|NCT00659646|471485277|FG001|Overall Study|Lost to Follow-up|0|||
130960521|NCT00659646|471485276|FG000|Overall Study|protocol noncompliance after randomized|1|||
130960522|NCT00659646|471485277|FG001|Overall Study|protocol noncompliance after randomized|0|||
130960523|NCT00023673|471485278|FG000|Overall Study|Ineligible / no protocol treatment|0|||
130960524|NCT00023673|471485279|FG001|Overall Study|Ineligible / no protocol treatment|0|||
130960525|NCT00023673|471485280|FG002|Overall Study|Ineligible / no protocol treatment|0|||
130960526|NCT00023673|471485281|FG003|Overall Study|Ineligible / no protocol treatment|1|||
131127230|NCT01780662|472094782|FG002|Overall Study|Protocol Violation|0|||
130960527|NCT00023673|471485278|FG000|Overall Study|Patient withdrew consent|0|||
130960528|NCT00023673|471485279|FG001|Overall Study|Patient withdrew consent|0|||
130960529|NCT00023673|471485280|FG002|Overall Study|Patient withdrew consent|0|||
130960530|NCT00023673|471485281|FG003|Overall Study|Patient withdrew consent|1|||
130960531|NCT02453594|471485282|FG000|Overall Study|Protocol Violation|0|||
130960532|NCT02453594|471485283|FG001|Overall Study|Protocol Violation|0|||
130960533|NCT02453594|471485284|FG002|Overall Study|Protocol Violation|1|||
130960534|NCT02453594|471485282|FG000|Overall Study|Cohort Was Closed|17|||
130960535|NCT02453594|471485283|FG001|Overall Study|Cohort Was Closed|21|||
130960536|NCT02453594|471485284|FG002|Overall Study|Cohort Was Closed|14|||
130960537|NCT02453594|471485282|FG000|Overall Study|Death|20|||
130960538|NCT02453594|471485283|FG001|Overall Study|Death|24|||
130960539|NCT02453594|471485284|FG002|Overall Study|Death|16|||
130960540|NCT02453594|471485282|FG000|Overall Study|Lost to Follow-up|6|||
130960541|NCT02453594|471485283|FG001|Overall Study|Lost to Follow-up|14|||
130960542|NCT02453594|471485284|FG002|Overall Study|Lost to Follow-up|2|||
130960543|NCT02453594|471485282|FG000|Overall Study|Physician Decision|2|||
130960544|NCT02453594|471485283|FG001|Overall Study|Physician Decision|4|||
130960545|NCT02453594|471485284|FG002|Overall Study|Physician Decision|0|||
130960546|NCT02453594|471485282|FG000|Overall Study|Site Terminated by Sponsor|1|||
130960547|NCT02453594|471485283|FG001|Overall Study|Site Terminated by Sponsor|0|||
130960548|NCT02453594|471485284|FG002|Overall Study|Site Terminated by Sponsor|1|||
130960549|NCT02453594|471485282|FG000|Overall Study|Transitioned to Extension Study|16|||
130960550|NCT02453594|471485283|FG001|Overall Study|Transitioned to Extension Study|9|||
130960551|NCT02453594|471485284|FG002|Overall Study|Transitioned to Extension Study|16|||
130960552|NCT02453594|471485282|FG000|Overall Study|Withdrawal by Subject|7|||
130960553|NCT02453594|471485283|FG001|Overall Study|Withdrawal by Subject|9|||
131127231|NCT01780662|472094780|FG000|Overall Study|Ineligible|0|||
131127232|NCT01780662|472094781|FG001|Overall Study|Ineligible|0|||
131127233|NCT01780662|472094782|FG002|Overall Study|Ineligible|1|||
131127234|NCT00053417|472094783|FG000|Overall Study|Adverse Event|1|||
131127235|NCT00053417|472094784|FG001|Overall Study|Adverse Event|0|||
131127236|NCT00053417|472094785|FG002|Overall Study|Adverse Event|1|||
131127237|NCT00053417|472094786|FG003|Overall Study|Adverse Event|5|||
131127238|NCT00053417|472094783|FG000|Overall Study|Non-Compliance|0|||
131127239|NCT00053417|472094784|FG001|Overall Study|Non-Compliance|0|||
131127240|NCT00053417|472094785|FG002|Overall Study|Non-Compliance|0|||
131127241|NCT00053417|472094786|FG003|Overall Study|Non-Compliance|1|||
131127242|NCT00053417|472094783|FG000|Overall Study|Withdrawal by Subject|0|||
131127243|NCT00053417|472094784|FG001|Overall Study|Withdrawal by Subject|1|||
131127244|NCT00053417|472094785|FG002|Overall Study|Withdrawal by Subject|0|||
131127245|NCT00053417|472094786|FG003|Overall Study|Withdrawal by Subject|0|||
131127246|NCT00053417|472094783|FG000|Overall Study|Lost to Follow-up|1|||
130960554|NCT02453594|471485284|FG002|Overall Study|Withdrawal by Subject|11|||
130960555|NCT02086591|471485285|FG000|Overall Study|Adverse Event|1|||
130960556|NCT02086591|471485285|FG000|Overall Study|Withdrawal by Subject|1|||
130960557|NCT02086591|471485285|FG000|Overall Study|protocol terminated|3|||
130960558|NCT02660359|471485286|FG000|Overall Study|Protocol Deviation|0|||
130960559|NCT02660359|471485287|FG001|Overall Study|Protocol Deviation|0|||
130960560|NCT02660359|471485288|FG002|Overall Study|Protocol Deviation|1|||
130960561|NCT02660359|471485286|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
130960562|NCT02660359|471485287|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
131127247|NCT00053417|472094784|FG001|Overall Study|Lost to Follow-up|1|||
131127248|NCT00053417|472094785|FG002|Overall Study|Lost to Follow-up|0|||
131127249|NCT00053417|472094786|FG003|Overall Study|Lost to Follow-up|0|||
131127250|NCT04081363|472094789|FG000|Overall Study|Withdrawal by Subject|1|||
130960563|NCT02660359|471485288|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
130960564|NCT02660359|471485286|FG000|Overall Study|Lack of Efficacy|1|||
130960565|NCT02660359|471485287|FG001|Overall Study|Lack of Efficacy|1|||
130960566|NCT02660359|471485288|FG002|Overall Study|Lack of Efficacy|1|||
131127251|NCT04081363|472094790|FG001|Overall Study|Withdrawal by Subject|0|||
131127252|NCT00939783|472094795|FG000|Overall Study|Death|6|||
130960567|NCT02660359|471485286|FG000|Overall Study|Adverse Event|0|||
130714471|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Death|100|||
130714472|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
130714473|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
130714474|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
130960568|NCT02660359|471485287|FG001|Overall Study|Adverse Event|1|||
130960569|NCT02660359|471485288|FG002|Overall Study|Adverse Event|0|||
130960570|NCT02660359|471485286|FG000|Overall Study|Other|2|||
130960571|NCT02660359|471485287|FG001|Overall Study|Other|1|||
130960572|NCT02660359|471485288|FG002|Overall Study|Other|3|||
130960573|NCT02660359|471485286|FG000|Overall Study|Withdrawal by Subject|7|||
130960574|NCT02660359|471485287|FG001|Overall Study|Withdrawal by Subject|5|||
130960575|NCT02660359|471485288|FG002|Overall Study|Withdrawal by Subject|8|||
130960576|NCT02660359|471485286|FG000|Overall Study|Lost to Follow-up|3|||
130960577|NCT02660359|471485287|FG001|Overall Study|Lost to Follow-up|3|||
130960578|NCT02660359|471485288|FG002|Overall Study|Lost to Follow-up|0|||
130960579|NCT00529386|471485290|FG000|Overall Study|Lost to Follow-up|1|||
130960580|NCT04532112|471485291|FG000|Overall Study|Adverse Event|3|||
130960581|NCT04532112|471485292|FG001|Overall Study|Adverse Event|0|||
130960582|NCT03348904|471485293|FG000|Overall Study|Administrative reason by the sponsor|0|||
130960583|NCT03348904|471485294|FG001|Overall Study|Administrative reason by the sponsor|1|||
130960584|NCT03348904|471485295|FG002|Overall Study|Administrative reason by the sponsor|0|||
130960585|NCT04086472|471485296|FG000|Overall Study|Lost to Follow-up|1|||
130960586|NCT04086472|471485297|FG001|Overall Study|Lost to Follow-up|0|||
130960587|NCT04086472|471485298|FG002|Overall Study|Lost to Follow-up|0|||
130960588|NCT04086472|471485299|FG003|Overall Study|Lost to Follow-up|0|||
130960589|NCT04086472|471485300|FG004|Overall Study|Lost to Follow-up|1|||
130960590|NCT04086472|471485296|FG000|Overall Study|Physician Decision|0|||
130960591|NCT04086472|471485297|FG001|Overall Study|Physician Decision|1|||
130960592|NCT04086472|471485298|FG002|Overall Study|Physician Decision|1|||
130960593|NCT04086472|471485299|FG003|Overall Study|Physician Decision|0|||
130960594|NCT04086472|471485300|FG004|Overall Study|Physician Decision|0|||
130960595|NCT04086472|471485296|FG000|Overall Study|Withdrawal by Subject|1|||
130960596|NCT04086472|471485297|FG001|Overall Study|Withdrawal by Subject|1|||
130960597|NCT04086472|471485298|FG002|Overall Study|Withdrawal by Subject|1|||
130714475|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Physician Decision|0|||
130960598|NCT04086472|471485299|FG003|Overall Study|Withdrawal by Subject|0|||
130960599|NCT04086472|471485300|FG004|Overall Study|Withdrawal by Subject|0|||
130960600|NCT04086472|471485296|FG000|Overall Study|Various reasons|2|||
130960601|NCT04086472|471485297|FG001|Overall Study|Various reasons|0|||
130960602|NCT04086472|471485298|FG002|Overall Study|Various reasons|0|||
130960603|NCT04086472|471485299|FG003|Overall Study|Various reasons|3|||
130960604|NCT04086472|471485300|FG004|Overall Study|Various reasons|1|||
130960605|NCT00048724|471485306|FG000|Overall Study|Adverse Event|53|||
130960606|NCT00048724|471485307|FG001|Overall Study|Adverse Event|12|||
130960607|NCT00048724|471485306|FG000|Overall Study|Withdrawal by Subject|34|||
130960608|NCT00048724|471485307|FG001|Overall Study|Withdrawal by Subject|54|||
130960609|NCT00048724|471485306|FG000|Overall Study|Lost to Follow-up|5|||
130960610|NCT00048724|471485307|FG001|Overall Study|Lost to Follow-up|5|||
130960611|NCT00048724|471485306|FG000|Overall Study|Protocol-defined Clinical Event|17|||
130960612|NCT00048724|471485307|FG001|Overall Study|Protocol-defined Clinical Event|32|||
130960613|NCT00048724|471485306|FG000|Overall Study|Noncompliance With Protocol|4|||
130960614|NCT00048724|471485307|FG001|Overall Study|Noncompliance With Protocol|12|||
130960615|NCT00048724|471485306|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
130960616|NCT00048724|471485307|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
130960617|NCT00048724|471485306|FG000|Overall Study|Administrative|1|||
130960618|NCT00048724|471485307|FG001|Overall Study|Administrative|1|||
130960619|NCT04394351|471485316|FG000|Part A (16 Weeks)|Adverse Event|1|||
130960620|NCT04394351|471485317|FG001|Part A (16 Weeks)|Adverse Event|0|||
130960621|NCT04394351|471485318|FG002|Part A (16 Weeks)|Adverse Event|0|||
130960622|NCT04394351|471485319|FG003|Part A (16 Weeks)|Adverse Event|0|||
130960623|NCT04394351|471485320|FG004|Part A (16 Weeks)|Adverse Event|0|||
130960624|NCT04394351|471485321|FG005|Part A (16 Weeks)|Adverse Event|0|||
130960625|NCT04394351|471485322|FG006|Part A (16 Weeks)|Adverse Event|0|||
130960626|NCT04394351|471485323|FG007|Part A (16 Weeks)|Adverse Event|0|||
130960627|NCT04394351|471485316|FG000|Part A (16 Weeks)|Physician Decision|0|||
130960628|NCT04394351|471485317|FG001|Part A (16 Weeks)|Physician Decision|1|||
130960629|NCT04394351|471485318|FG002|Part A (16 Weeks)|Physician Decision|0|||
130960630|NCT04394351|471485319|FG003|Part A (16 Weeks)|Physician Decision|0|||
130960631|NCT04394351|471485320|FG004|Part A (16 Weeks)|Physician Decision|0|||
130960632|NCT04394351|471485321|FG005|Part A (16 Weeks)|Physician Decision|0|||
130960633|NCT04394351|471485322|FG006|Part A (16 Weeks)|Physician Decision|0|||
130960634|NCT04394351|471485323|FG007|Part A (16 Weeks)|Physician Decision|0|||
130960635|NCT04394351|471485316|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
130960636|NCT04394351|471485317|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
130960637|NCT04394351|471485318|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
130960638|NCT04394351|471485319|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
130960639|NCT04394351|471485320|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
130714476|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Physician Decision|1|||
130714477|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Physician Decision|0|||
130714478|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
130714479|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
130714480|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
130714481|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
130714482|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
130714483|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
130714484|NCT02031458|470581681|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
130714485|NCT02031458|470581682|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
130714486|NCT02031458|470581683|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
130714487|NCT02031458|470581681|FG000|Baseline to May 8, 2015|On Treatment|43|||
130714488|NCT02031458|470581682|FG001|Baseline to May 8, 2015|On Treatment|81|||
130714489|NCT02031458|470581683|FG002|Baseline to May 8, 2015|On Treatment|73|||
130714490|NCT02031458|470581681|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
130714491|NCT02031458|470581682|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
130714492|NCT02031458|470581683|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
130714493|NCT00059787|470581684|FG000|Overall Study|Adverse Event|13|||
130714494|NCT00059787|470581684|FG000|Overall Study|disease progression|2|||
130714495|NCT00059787|470581684|FG000|Overall Study|ineligible|1|||
130714496|NCT00059787|470581684|FG000|Overall Study|Other|4|||
130714497|NCT00292188|470581685|FG000|Single-Blind|Adverse Event|14|||
130714498|NCT00292188|470581686|FG001|Single-Blind|Adverse Event|0|||
130714499|NCT00292188|470581687|FG002|Single-Blind|Adverse Event|0|||
130714500|NCT00292188|470581685|FG000|Single-Blind|Lack of Efficacy|2|||
130714501|NCT00292188|470581686|FG001|Single-Blind|Lack of Efficacy|0|||
130714502|NCT00292188|470581687|FG002|Single-Blind|Lack of Efficacy|0|||
130714503|NCT00292188|470581685|FG000|Single-Blind|Laboratory Abnormality|5|||
130714504|NCT00292188|470581686|FG001|Single-Blind|Laboratory Abnormality|0|||
130714505|NCT00292188|470581687|FG002|Single-Blind|Laboratory Abnormality|0|||
130714506|NCT00292188|470581685|FG000|Single-Blind|Lost to Follow-up|3|||
130714507|NCT00292188|470581686|FG001|Single-Blind|Lost to Follow-up|0|||
130714508|NCT00292188|470581687|FG002|Single-Blind|Lost to Follow-up|0|||
130714509|NCT00292188|470581685|FG000|Single-Blind|Other|77|||
130714510|NCT00292188|470581686|FG001|Single-Blind|Other|0|||
130714511|NCT00292188|470581687|FG002|Single-Blind|Other|0|||
130714512|NCT00292188|470581685|FG000|Single-Blind|Withdrawal by Subject|12|||
130714513|NCT00292188|470581686|FG001|Single-Blind|Withdrawal by Subject|0|||
130714514|NCT00292188|470581687|FG002|Single-Blind|Withdrawal by Subject|0|||
130714515|NCT00292188|470581685|FG000|Single-Blind|Did not receive treatment|1|||
130714516|NCT00292188|470581686|FG001|Single-Blind|Did not receive treatment|0|||
130714517|NCT00292188|470581687|FG002|Single-Blind|Did not receive treatment|0|||
130714518|NCT00292188|470581685|FG000|Double-Blind|Adverse Event|0|||
130714519|NCT00292188|470581686|FG001|Double-Blind|Adverse Event|25|||
130714520|NCT00292188|470581687|FG002|Double-Blind|Adverse Event|9|||
130714521|NCT00292188|470581685|FG000|Double-Blind|Lack of Efficacy|0|||
130714522|NCT00292188|470581686|FG001|Double-Blind|Lack of Efficacy|2|||
130714523|NCT00292188|470581687|FG002|Double-Blind|Lack of Efficacy|12|||
130714524|NCT00292188|470581685|FG000|Double-Blind|Lost to Follow-up|0|||
130714525|NCT00292188|470581686|FG001|Double-Blind|Lost to Follow-up|1|||
130714526|NCT00292188|470581687|FG002|Double-Blind|Lost to Follow-up|0|||
130714527|NCT00292188|470581685|FG000|Double-Blind|Other|0|||
130714528|NCT00292188|470581686|FG001|Double-Blind|Other|3|||
130960640|NCT04394351|471485321|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
130960641|NCT04394351|471485322|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
130960642|NCT04394351|471485323|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
130960643|NCT04394351|471485316|FG000|Part B (36 Weeks)|Adverse Event|0|||
130960644|NCT04394351|471485317|FG001|Part B (36 Weeks)|Adverse Event|0|||
130960645|NCT04394351|471485318|FG002|Part B (36 Weeks)|Adverse Event|0|||
130960646|NCT04394351|471485319|FG003|Part B (36 Weeks)|Adverse Event|0|||
130714529|NCT00292188|470581687|FG002|Double-Blind|Other|4|||
130960647|NCT04394351|471485320|FG004|Part B (36 Weeks)|Adverse Event|0|||
130714530|NCT00292188|470581685|FG000|Double-Blind|Withdrawal by Subject|0|||
130714531|NCT00292188|470581686|FG001|Double-Blind|Withdrawal by Subject|0|||
130714532|NCT00292188|470581687|FG002|Double-Blind|Withdrawal by Subject|3|||
130714533|NCT00292188|470581685|FG000|Double-Blind|Laboratory Abnormality|0|||
130714534|NCT00292188|470581686|FG001|Double-Blind|Laboratory Abnormality|0|||
130714535|NCT00292188|470581687|FG002|Double-Blind|Laboratory Abnormality|1|||
130714536|NCT00824616|470581688|FG000|Overall Study|Adverse Event|2|||
130714537|NCT00824616|470581689|FG001|Overall Study|Adverse Event|1|||
130774794|NCT03410992|470802561|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130714538|NCT00824616|470581688|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
130714539|NCT00824616|470581689|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
130714540|NCT00824616|470581688|FG000|Overall Study|Hyperglycemia|1|||
130714541|NCT00824616|470581689|FG001|Overall Study|Hyperglycemia|1|||
130960648|NCT04394351|471485321|FG005|Part B (36 Weeks)|Adverse Event|0|||
130960649|NCT04394351|471485322|FG006|Part B (36 Weeks)|Adverse Event|1|||
130960650|NCT04394351|471485323|FG007|Part B (36 Weeks)|Adverse Event|0|||
130714542|NCT00824616|470581688|FG000|Overall Study|Lack of Efficacy|2|||
130714543|NCT00824616|470581689|FG001|Overall Study|Lack of Efficacy|1|||
130714544|NCT00824616|470581688|FG000|Overall Study|Lost to Follow-up|0|||
130714545|NCT00824616|470581689|FG001|Overall Study|Lost to Follow-up|1|||
130714546|NCT00824616|470581688|FG000|Overall Study|Withdrawal by Subject|1|||
130714547|NCT00824616|470581689|FG001|Overall Study|Withdrawal by Subject|1|||
130714548|NCT04322149|470581690|FG000|Overall Study|Adverse Event|1|||
130714549|NCT04322149|470581691|FG001|Overall Study|Adverse Event|1|||
130714550|NCT04322149|470581692|FG002|Overall Study|Adverse Event|0|||
130714551|NCT04322149|470581693|FG003|Overall Study|Adverse Event|0|||
130714552|NCT04322149|470581690|FG000|Overall Study|Withdrawal by Subject|0|||
130714553|NCT04322149|470581691|FG001|Overall Study|Withdrawal by Subject|0|||
130714554|NCT04322149|470581692|FG002|Overall Study|Withdrawal by Subject|0|||
130714555|NCT04322149|470581693|FG003|Overall Study|Withdrawal by Subject|2|||
130714556|NCT04322149|470581690|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
130714557|NCT04322149|470581691|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
130714558|NCT04322149|470581692|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
130714559|NCT04322149|470581693|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
130714560|NCT00103311|470581702|FG000|Overall Study|Lost to Follow-up|1|||
130960651|NCT02738775|471485324|FG000|Overall Study|Withdrawal by Subject|0|||
130960652|NCT02738775|471485325|FG001|Overall Study|Withdrawal by Subject|1|||
130960653|NCT02738775|471485326|FG002|Overall Study|Withdrawal by Subject|0|||
130960654|NCT02738775|471485327|FG003|Overall Study|Withdrawal by Subject|0|||
130960655|NCT02738775|471485328|FG004|Overall Study|Withdrawal by Subject|0|||
130960656|NCT02738775|471485329|FG005|Overall Study|Withdrawal by Subject|0|||
130960657|NCT02738775|471485324|FG000|Overall Study|Adverse Event|0|||
130960658|NCT02738775|471485325|FG001|Overall Study|Adverse Event|0|||
130960659|NCT02738775|471485326|FG002|Overall Study|Adverse Event|0|||
130960660|NCT02738775|471485327|FG003|Overall Study|Adverse Event|1|||
130960661|NCT02738775|471485328|FG004|Overall Study|Adverse Event|0|||
130960662|NCT02738775|471485329|FG005|Overall Study|Adverse Event|0|||
130960663|NCT02738775|471485324|FG000|Overall Study|Pregnancy|0|||
130960664|NCT02738775|471485325|FG001|Overall Study|Pregnancy|1|||
130960665|NCT02738775|471485326|FG002|Overall Study|Pregnancy|0|||
130960666|NCT02738775|471485327|FG003|Overall Study|Pregnancy|0|||
130960667|NCT02738775|471485328|FG004|Overall Study|Pregnancy|0|||
130960668|NCT02738775|471485329|FG005|Overall Study|Pregnancy|0|||
130960669|NCT02738775|471485324|FG000|Overall Study|Missing|0|||
130960670|NCT02738775|471485325|FG001|Overall Study|Missing|0|||
130960671|NCT02738775|471485326|FG002|Overall Study|Missing|0|||
130960672|NCT02738775|471485327|FG003|Overall Study|Missing|0|||
130960673|NCT02738775|471485328|FG004|Overall Study|Missing|0|||
130960674|NCT02738775|471485329|FG005|Overall Study|Missing|1|||
130960675|NCT02992899|471485330|FG000|Overall Study|Withdrawal by Subject|1|||
130960676|NCT02992899|471485331|FG001|Overall Study|Withdrawal by Subject|0|||
130960677|NCT02992899|471485330|FG000|Overall Study|Lost to Follow-up|1|||
130960678|NCT02992899|471485331|FG001|Overall Study|Lost to Follow-up|3|||
130960679|NCT02370888|471485332|FG000|Overall Study|disease progression|2|||
130960680|NCT02370888|471485332|FG000|Overall Study|did not meet chimerism criteria|6|||
130960681|NCT04574362|471485333|FG000|Overall Study|Other|0|||
130960682|NCT04574362|471485334|FG001|Overall Study|Other|5|||
130960683|NCT04574362|471485333|FG000|Overall Study|COVID-19|0|||
130960684|NCT04574362|471485334|FG001|Overall Study|COVID-19|1|||
130960685|NCT04574362|471485333|FG000|Overall Study|Adverse Event|1|||
130960686|NCT04574362|471485334|FG001|Overall Study|Adverse Event|1|||
130960687|NCT04574362|471485333|FG000|Overall Study|Withdrawal by Subject|2|||
130960688|NCT04574362|471485334|FG001|Overall Study|Withdrawal by Subject|4|||
130960689|NCT04574362|471485333|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
130714561|NCT00103311|470581703|FG001|Overall Study|Lost to Follow-up|0|||
130714562|NCT00103311|470581702|FG000|Overall Study|Withdrawal by Subject|2|||
130960690|NCT04574362|471485334|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
131040836|NCT05485779|471785340|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
131040837|NCT05485779|471785341|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
131040838|NCT05485779|471785342|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
131040839|NCT05485779|471785343|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
130714563|NCT00103311|470581703|FG001|Overall Study|Withdrawal by Subject|1|||
130960691|NCT04574362|471485333|FG000|Overall Study|Participant refused to come to the hospital|1|||
130960692|NCT04574362|471485334|FG001|Overall Study|Participant refused to come to the hospital|0|||
130960693|NCT04574362|471485333|FG000|Overall Study|Participant refused the visit|1|||
130960694|NCT04574362|471485334|FG001|Overall Study|Participant refused the visit|0|||
130960695|NCT04574362|471485333|FG000|Overall Study|Participant quit early because of business trip|1|||
130960696|NCT04574362|471485334|FG001|Overall Study|Participant quit early because of business trip|0|||
130960697|NCT01060384|471485335|FG000|Overall Study|Withdrawal by Subject|0|||
130960698|NCT01060384|471485336|FG001|Overall Study|Withdrawal by Subject|1|||
130960699|NCT01060384|471485337|FG002|Overall Study|Withdrawal by Subject|0|||
130774795|NCT03410992|470802562|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
130960700|NCT01060384|471485338|FG003|Overall Study|Withdrawal by Subject|0|||
130960701|NCT01060384|471485339|FG004|Overall Study|Withdrawal by Subject|0|||
130960702|NCT01060384|471485335|FG000|Overall Study|Death|0|||
130960703|NCT01060384|471485336|FG001|Overall Study|Death|0|||
130960704|NCT01060384|471485337|FG002|Overall Study|Death|0|||
130960705|NCT01060384|471485338|FG003|Overall Study|Death|0|||
130960706|NCT01060384|471485339|FG004|Overall Study|Death|1|||
130960707|NCT01060384|471485335|FG000|Overall Study|Intercurrent illness|0|||
130960708|NCT01060384|471485336|FG001|Overall Study|Intercurrent illness|0|||
130960709|NCT01060384|471485337|FG002|Overall Study|Intercurrent illness|0|||
130960710|NCT01060384|471485338|FG003|Overall Study|Intercurrent illness|0|||
130960711|NCT01060384|471485339|FG004|Overall Study|Intercurrent illness|1|||
130960712|NCT00812929|471485343|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
130960713|NCT00812929|471485344|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
130960714|NCT00812929|471485345|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
130960715|NCT00812929|471485346|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
130960716|NCT00812929|471485347|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
130960717|NCT00812929|471485348|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
130960718|NCT00812929|471485349|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
130960719|NCT00812929|471485350|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
130960720|NCT00812929|471485351|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
130960721|NCT00812929|471485352|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
130960722|NCT00812929|471485343|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
130960723|NCT00812929|471485344|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
130960724|NCT00812929|471485345|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
130960725|NCT00812929|471485346|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
130960726|NCT00812929|471485347|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
130960727|NCT00812929|471485348|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
130960728|NCT00812929|471485349|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
130960729|NCT00812929|471485350|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
130960730|NCT00812929|471485351|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
130960731|NCT00812929|471485352|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
130960732|NCT00812929|471485343|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
130960733|NCT00812929|471485344|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
130960734|NCT00812929|471485345|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
130960735|NCT00812929|471485346|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
130960736|NCT00812929|471485347|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
130960737|NCT00812929|471485348|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
130960738|NCT00812929|471485349|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
130960739|NCT00812929|471485350|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
130960740|NCT00812929|471485351|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
130960741|NCT00812929|471485352|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
130960742|NCT00211081|471485353|FG000|Overall Study|Withdrawal by Subject|2|||
131226390|NCT00950599|472455725|FG001|Follow-Up Period|Lost to Follow-up|0|||
130960743|NCT01332305|471485354|FG000|Overall Study|Adverse Event|1|||
130960744|NCT01332305|471485355|FG001|Overall Study|Adverse Event|4|||
130960745|NCT01332305|471485356|FG002|Overall Study|Adverse Event|6|||
130960746|NCT01332305|471485357|FG003|Overall Study|Adverse Event|3|||
130960747|NCT01332305|471485358|FG004|Overall Study|Adverse Event|5|||
130960748|NCT01332305|471485354|FG000|Overall Study|Withdrawal by Subject|6|||
130960749|NCT01332305|471485355|FG001|Overall Study|Withdrawal by Subject|5|||
130960750|NCT01332305|471485356|FG002|Overall Study|Withdrawal by Subject|4|||
130960751|NCT01332305|471485357|FG003|Overall Study|Withdrawal by Subject|1|||
130960752|NCT01332305|471485358|FG004|Overall Study|Withdrawal by Subject|0|||
130960753|NCT01332305|471485354|FG000|Overall Study|Lost to Follow-up|0|||
130960754|NCT01332305|471485355|FG001|Overall Study|Lost to Follow-up|2|||
130960755|NCT01332305|471485356|FG002|Overall Study|Lost to Follow-up|3|||
130960756|NCT01332305|471485357|FG003|Overall Study|Lost to Follow-up|2|||
130960757|NCT01332305|471485358|FG004|Overall Study|Lost to Follow-up|3|||
130960758|NCT01332305|471485354|FG000|Overall Study|Protocol Violation|1|||
130960759|NCT01332305|471485355|FG001|Overall Study|Protocol Violation|2|||
130960760|NCT01332305|471485356|FG002|Overall Study|Protocol Violation|1|||
130960761|NCT01332305|471485357|FG003|Overall Study|Protocol Violation|0|||
130960762|NCT01332305|471485358|FG004|Overall Study|Protocol Violation|3|||
130960763|NCT01332305|471485354|FG000|Overall Study|Withdrawal by Sponsor|1|||
130960764|NCT01332305|471485355|FG001|Overall Study|Withdrawal by Sponsor|0|||
130960765|NCT01332305|471485356|FG002|Overall Study|Withdrawal by Sponsor|0|||
130960766|NCT01332305|471485357|FG003|Overall Study|Withdrawal by Sponsor|1|||
130960767|NCT01332305|471485358|FG004|Overall Study|Withdrawal by Sponsor|1|||
130960768|NCT01332305|471485354|FG000|Overall Study|Treatment Failure|1|||
130960769|NCT01332305|471485355|FG001|Overall Study|Treatment Failure|1|||
130960770|NCT01332305|471485356|FG002|Overall Study|Treatment Failure|0|||
131226391|NCT00950599|472455726|FG002|Follow-Up Period|Lost to Follow-up|0|||
130960771|NCT01332305|471485357|FG003|Overall Study|Treatment Failure|0|||
130960772|NCT01332305|471485358|FG004|Overall Study|Treatment Failure|0|||
131040840|NCT05485779|471785344|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
131040841|NCT05485779|471785345|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
131040842|NCT05485779|471785346|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
131040843|NCT05485779|471785347|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
131040844|NCT05485779|471785348|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
131040845|NCT05485779|471785338|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
131040846|NCT05485779|471785339|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
131040847|NCT05485779|471785340|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
131040848|NCT05485779|471785341|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
131040849|NCT05485779|471785342|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
131040850|NCT05485779|471785343|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
131040851|NCT05485779|471785344|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
131040852|NCT05485779|471785345|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
131040853|NCT05485779|471785346|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
131040854|NCT05485779|471785347|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
131040855|NCT05485779|471785348|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
131040856|NCT05485779|471785338|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131040857|NCT05485779|471785339|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131040858|NCT05485779|471785340|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131040859|NCT05485779|471785341|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
131040860|NCT05485779|471785342|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131040861|NCT05485779|471785343|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131040862|NCT05485779|471785344|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131040863|NCT05485779|471785345|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131040864|NCT05485779|471785346|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131040865|NCT05485779|471785347|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131040866|NCT05485779|471785348|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
131040867|NCT04471246|471785351|FG000|Overall Study|Lost to Follow-up|2|||
131040868|NCT04471246|471785352|FG001|Overall Study|Lost to Follow-up|2|||
131040869|NCT05764525|471785353|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
131040870|NCT05764525|471785354|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
131040871|NCT05764525|471785353|FG000|Overall Study|Withdrawal by Subject|4|||
131040872|NCT05764525|471785354|FG001|Overall Study|Withdrawal by Subject|8|||
131040873|NCT05764525|471785353|FG000|Overall Study|Physician Decision|1|||
131040874|NCT05764525|471785354|FG001|Overall Study|Physician Decision|0|||
131040875|NCT03334630|471785355|FG000|Overall Study|Withdrawal by Subject|7|||
131040876|NCT03334630|471785356|FG001|Overall Study|Withdrawal by Subject|7|||
131040877|NCT03334630|471785355|FG000|Overall Study|Lost to Follow-up|3|||
131040878|NCT03334630|471785356|FG001|Overall Study|Lost to Follow-up|1|||
131040879|NCT03334630|471785355|FG000|Overall Study|Adverse Event|0|||
131040880|NCT03334630|471785356|FG001|Overall Study|Adverse Event|1|||
131040881|NCT03334630|471785355|FG000|Overall Study|Physician Decision|1|||
131040882|NCT03334630|471785356|FG001|Overall Study|Physician Decision|1|||
131040883|NCT03334630|471785355|FG000|Overall Study|Enrollment closed|2|||
131040884|NCT03334630|471785356|FG001|Overall Study|Enrollment closed|1|||
131040885|NCT03334630|471785355|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
131040886|NCT03334630|471785356|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
131040887|NCT03334630|471785355|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
131040888|NCT03334630|471785356|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
131040889|NCT03030261|471785358|FG000|Overall Study|Still receiving continuation therapy|5|||
131040890|NCT03386578|471785362|FG000|PK Component|Lost to Follow-up|0|||
131040891|NCT03386578|471785363|FG001|PK Component|Lost to Follow-up|1|||
131040892|NCT03386578|471785364|FG002|PK Component|Lost to Follow-up|0|||
131040893|NCT03386578|471785365|FG003|PK Component|Lost to Follow-up|0|||
131040894|NCT03386578|471785366|FG004|PK Component|Lost to Follow-up|0|||
131040895|NCT03386578|471785367|FG005|PK Component|Lost to Follow-up|0|||
131040896|NCT03386578|471785368|FG006|PK Component|Lost to Follow-up|1|||
131040897|NCT03386578|471785369|FG007|PK Component|Lost to Follow-up|0|||
131040898|NCT03386578|471785370|FG008|PK Component|Lost to Follow-up|0|||
131040899|NCT03386578|471785371|FG009|PK Component|Lost to Follow-up|0|||
131040900|NCT03386578|471785362|FG000|PK Component|Stillbirth/Abortion|0|||
131040901|NCT03386578|471785363|FG001|PK Component|Stillbirth/Abortion|0|||
131040902|NCT03386578|471785364|FG002|PK Component|Stillbirth/Abortion|0|||
131040903|NCT03386578|471785365|FG003|PK Component|Stillbirth/Abortion|0|||
131040904|NCT03386578|471785366|FG004|PK Component|Stillbirth/Abortion|0|||
131226392|NCT00950599|472455727|FG003|Follow-Up Period|Lost to Follow-up|0|||
130960773|NCT01332305|471485354|FG000|Overall Study|Physician Decision|0|||
130960774|NCT01332305|471485355|FG001|Overall Study|Physician Decision|0|||
130960775|NCT01332305|471485356|FG002|Overall Study|Physician Decision|0|||
131127253|NCT00939783|472094795|FG000|Overall Study|Adverse Event|39|||
131127254|NCT00939783|472094795|FG000|Overall Study|Study Terminated by Sponsor|498|||
131127255|NCT00939783|472094795|FG000|Overall Study|Withdrawal by Subject|78|||
130714564|NCT00103311|470581702|FG000|Overall Study|Adverse Event|1|||
130714565|NCT00103311|470581703|FG001|Overall Study|Adverse Event|0|||
130714566|NCT00974974|470581711|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
130714567|NCT00974974|470581712|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
130714568|NCT00974974|470581711|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
130714569|NCT00974974|470581712|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
130960776|NCT01332305|471485357|FG003|Overall Study|Physician Decision|1|||
130960777|NCT01332305|471485358|FG004|Overall Study|Physician Decision|0|||
130960778|NCT01600040|471485359|FG000|Overall Study|Withdrawal by Subject|1|||
130960779|NCT04027686|471485360|FG000|Overall Study|Lost to Follow-up|2|||
130960780|NCT04027686|471485361|FG001|Overall Study|Lost to Follow-up|0|||
130960781|NCT04027686|471485360|FG000|Overall Study|Withdrawal by Subject|0|||
130960782|NCT04027686|471485361|FG001|Overall Study|Withdrawal by Subject|1|||
130960783|NCT03755765|471485371|FG000|Overall Study|Withdrawal by Subject|2|||
130960784|NCT03755765|471485372|FG001|Overall Study|Withdrawal by Subject|4|||
130960785|NCT03755765|471485373|FG002|Overall Study|Withdrawal by Subject|4|||
130960786|NCT02104557|471485374|FG000|Overall Study|Adverse Event|24|||
130960787|NCT02104557|471485374|FG000|Overall Study|Lost to Follow-up|34|||
130960788|NCT02104557|471485374|FG000|Overall Study|Violated the usage and dosage|14|||
130960789|NCT02104557|471485374|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
130960790|NCT02104557|471485374|FG000|Overall Study|Administered Sayana prior to the contract|1|||
130960791|NCT02104557|471485374|FG000|Overall Study|Other|17|||
130960792|NCT02104557|471485374|FG000|Overall Study|Change to other contraception methods|5|||
130960793|NCT02104557|471485374|FG000|Overall Study|Discontinuation due to no pain|1|||
130960794|NCT02104557|471485374|FG000|Overall Study|Withdrawal consent|2|||
130960795|NCT02104557|471485374|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
130960796|NCT02104557|471485374|FG000|Overall Study|Discontinuation of contraception|9|||
130960797|NCT00111228|471485378|FG000|Overall Study|Withdrawal by Subject|5|||
130960798|NCT00111228|471485379|FG001|Overall Study|Withdrawal by Subject|1|||
130960799|NCT00111228|471485380|FG002|Overall Study|Withdrawal by Subject|0|||
130960800|NCT00678691|471485381|FG000|Overall Study|Adverse Event|6|||
130960801|NCT00678691|471485382|FG001|Overall Study|Adverse Event|4|||
130960802|NCT02178475|471485389|FG000|Overall Study|Withdrawal by Subject|7|||
130960803|NCT02178475|471485389|FG000|Overall Study|Lost to Follow-up|10|||
130960804|NCT02178475|471485389|FG000|Overall Study|Death|13|||
130960805|NCT02178475|471485389|FG000|Overall Study|Protocol-specified Criteria|99|||
130960806|NCT00779766|471485390|FG000|Month 24|Serious Adverse Event|2|||
130960807|NCT00779766|471485391|FG001|Month 24|Serious Adverse Event|3|||
130960808|NCT00779766|471485390|FG000|Month 24|Adverse Event|3|||
130960809|NCT00779766|471485391|FG001|Month 24|Adverse Event|3|||
130960810|NCT00779766|471485390|FG000|Month 24|Protocol Violation|3|||
130960811|NCT00779766|471485391|FG001|Month 24|Protocol Violation|1|||
130960812|NCT00779766|471485390|FG000|Month 24|Withdrawal by Subject|159|||
130960813|NCT00779766|471485391|FG001|Month 24|Withdrawal by Subject|127|||
130960814|NCT00779766|471485390|FG000|Month 24|Migrated/moved from study area|138|||
130960815|NCT00779766|471485391|FG001|Month 24|Migrated/moved from study area|162|||
130960816|NCT00779766|471485390|FG000|Month 24|Lost to Follow-up|9|||
130960817|NCT00779766|471485391|FG001|Month 24|Lost to Follow-up|9|||
130960818|NCT00779766|471485390|FG000|Month 24|Other|18|||
130960819|NCT00779766|471485391|FG001|Month 24|Other|27|||
130960820|NCT00779766|471485390|FG000|Month 48|Withdrawal by Subject|68|||
130960821|NCT00779766|471485391|FG001|Month 48|Withdrawal by Subject|63|||
130960822|NCT00779766|471485390|FG000|Month 48|Migrated/moved from study area|76|||
130960823|NCT00779766|471485391|FG001|Month 48|Migrated/moved from study area|75|||
130960824|NCT00779766|471485390|FG000|Month 48|Lost to Follow-up|29|||
131127256|NCT00939783|472094795|FG000|Overall Study|Other|16|||
131127257|NCT00939783|472094795|FG000|Overall Study|Lost to Follow-up|8|||
131127258|NCT00939783|472094795|FG000|Overall Study|Protocol Violation|3|||
131127259|NCT00939783|472094795|FG000|Overall Study|Enrolled but not treated|1|||
131127260|NCT00645593|472094801|FG000|Overall Study|Later found to be ineligible|1|||
131127261|NCT00645593|472094802|FG001|Overall Study|Later found to be ineligible|0|||
130714570|NCT00974974|470581711|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
130960825|NCT00779766|471485391|FG001|Month 48|Lost to Follow-up|30|||
130960826|NCT00779766|471485390|FG000|Month 48|Other|1|||
130960827|NCT00779766|471485391|FG001|Month 48|Other|0|||
130960828|NCT00779766|471485390|FG000|Month 72|Withdrawal by Subject|55|||
130960829|NCT00779766|471485391|FG001|Month 72|Withdrawal by Subject|71|||
130960830|NCT00779766|471485390|FG000|Month 72|Migrated/moved from study area|124|||
130960831|NCT00779766|471485391|FG001|Month 72|Migrated/moved from study area|109|||
130960832|NCT00779766|471485390|FG000|Month 72|Lost to Follow-up|6|||
130960833|NCT00779766|471485391|FG001|Month 72|Lost to Follow-up|8|||
131127262|NCT04218201|472095920|FG000|Overall Study|Death|0|||
130960834|NCT00779766|471485390|FG000|Month 72|Other|0|||
130960835|NCT00779766|471485391|FG001|Month 72|Other|1|||
130960836|NCT03235024|471485395|FG000|Overall Study|Adverse Event|2|||
130960837|NCT03235024|471485396|FG001|Overall Study|Adverse Event|2|||
130960838|NCT03235024|471485395|FG000|Overall Study|Death|1|||
130960839|NCT03235024|471485396|FG001|Overall Study|Death|0|||
130960840|NCT03235024|471485395|FG000|Overall Study|Lost to Follow-up|2|||
130960841|NCT03235024|471485396|FG001|Overall Study|Lost to Follow-up|5|||
130960842|NCT03235024|471485395|FG000|Overall Study|Protocol Violation|1|||
130960843|NCT03235024|471485396|FG001|Overall Study|Protocol Violation|0|||
130960844|NCT03235024|471485395|FG000|Overall Study|Withdrawal by Subject|0|||
130960845|NCT03235024|471485396|FG001|Overall Study|Withdrawal by Subject|3|||
130960846|NCT00414050|471485397|FG000|Overall Study|Adverse Event|1|||
130960847|NCT00414050|471485398|FG001|Overall Study|Adverse Event|1|||
130960848|NCT00414050|471485399|FG002|Overall Study|Adverse Event|1|||
130960849|NCT00414050|471485400|FG003|Overall Study|Adverse Event|1|||
130960850|NCT00414050|471485397|FG000|Overall Study|Lost to Follow-up|2|||
130960851|NCT00414050|471485398|FG001|Overall Study|Lost to Follow-up|2|||
130960852|NCT00414050|471485399|FG002|Overall Study|Lost to Follow-up|1|||
130960853|NCT00414050|471485400|FG003|Overall Study|Lost to Follow-up|1|||
130960854|NCT00414050|471485397|FG000|Overall Study|Withdrawal by Subject|5|||
130960855|NCT00414050|471485398|FG001|Overall Study|Withdrawal by Subject|3|||
130960856|NCT00414050|471485399|FG002|Overall Study|Withdrawal by Subject|2|||
130960857|NCT00414050|471485400|FG003|Overall Study|Withdrawal by Subject|4|||
130960858|NCT00414050|471485397|FG000|Overall Study|Subject discontinued for other reason|1|||
130960859|NCT00414050|471485398|FG001|Overall Study|Subject discontinued for other reason|2|||
130960860|NCT00414050|471485399|FG002|Overall Study|Subject discontinued for other reason|2|||
130960861|NCT00414050|471485400|FG003|Overall Study|Subject discontinued for other reason|1|||
130960862|NCT00414050|471485397|FG000|Overall Study|Subject Moved|0|||
130960863|NCT00414050|471485398|FG001|Overall Study|Subject Moved|0|||
130960864|NCT00414050|471485399|FG002|Overall Study|Subject Moved|0|||
130960865|NCT00414050|471485400|FG003|Overall Study|Subject Moved|1|||
130960866|NCT03304379|471485405|FG000|Overall Study|Protocol Violation|8|||
130960867|NCT03304379|471485406|FG001|Overall Study|Protocol Violation|10|||
130960868|NCT03304379|471485407|FG002|Overall Study|Protocol Violation|5|||
130960869|NCT03304379|471485408|FG003|Overall Study|Protocol Violation|0|||
130960870|NCT03304379|471485409|FG004|Overall Study|Protocol Violation|2|||
130960871|NCT03304379|471485405|FG000|Overall Study|Adverse Event|4|||
130960872|NCT03304379|471485406|FG001|Overall Study|Adverse Event|20|||
130960873|NCT03304379|471485407|FG002|Overall Study|Adverse Event|17|||
130960874|NCT03304379|471485408|FG003|Overall Study|Adverse Event|1|||
130960875|NCT03304379|471485409|FG004|Overall Study|Adverse Event|0|||
130960876|NCT03304379|471485405|FG000|Overall Study|Lack of Efficacy|17|||
130960877|NCT03304379|471485406|FG001|Overall Study|Lack of Efficacy|16|||
130960878|NCT03304379|471485407|FG002|Overall Study|Lack of Efficacy|20|||
130960879|NCT03304379|471485408|FG003|Overall Study|Lack of Efficacy|0|||
130960880|NCT03304379|471485409|FG004|Overall Study|Lack of Efficacy|0|||
130960881|NCT03304379|471485405|FG000|Overall Study|Physician Decision|6|||
130960882|NCT03304379|471485406|FG001|Overall Study|Physician Decision|10|||
130960883|NCT03304379|471485407|FG002|Overall Study|Physician Decision|6|||
130960884|NCT03304379|471485408|FG003|Overall Study|Physician Decision|9|||
130960885|NCT03304379|471485409|FG004|Overall Study|Physician Decision|10|||
130960886|NCT03304379|471485405|FG000|Overall Study|Withdrawal by Subject|26|||
130960887|NCT03304379|471485406|FG001|Overall Study|Withdrawal by Subject|58|||
130960888|NCT03304379|471485407|FG002|Overall Study|Withdrawal by Subject|66|||
130960889|NCT03304379|471485408|FG003|Overall Study|Withdrawal by Subject|3|||
130960890|NCT03304379|471485409|FG004|Overall Study|Withdrawal by Subject|5|||
130960891|NCT03304379|471485405|FG000|Overall Study|Lost to Follow-up|8|||
131127263|NCT04218201|472095921|FG001|Overall Study|Death|0|||
131127264|NCT04218201|472095922|FG002|Overall Study|Death|2|||
131127265|NCT04218201|472095923|FG003|Overall Study|Death|0|||
131127266|NCT04218201|472095920|FG000|Overall Study|Unable to contact participant|4|||
131127267|NCT04218201|472095921|FG001|Overall Study|Unable to contact participant|0|||
131127268|NCT04218201|472095922|FG002|Overall Study|Unable to contact participant|3|||
131127269|NCT04218201|472095923|FG003|Overall Study|Unable to contact participant|0|||
130960892|NCT03304379|471485406|FG001|Overall Study|Lost to Follow-up|24|||
130960893|NCT03304379|471485407|FG002|Overall Study|Lost to Follow-up|35|||
130960894|NCT03304379|471485408|FG003|Overall Study|Lost to Follow-up|4|||
130960895|NCT03304379|471485409|FG004|Overall Study|Lost to Follow-up|0|||
130960896|NCT03304379|471485405|FG000|Overall Study|Death|1|||
130960897|NCT03304379|471485406|FG001|Overall Study|Death|2|||
130960898|NCT03304379|471485407|FG002|Overall Study|Death|0|||
131127270|NCT04218201|472095920|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
131127271|NCT04218201|472095921|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
130960899|NCT03304379|471485408|FG003|Overall Study|Death|0|||
130960900|NCT03304379|471485409|FG004|Overall Study|Death|0|||
130960901|NCT03304379|471485405|FG000|Overall Study|Other|0|||
130960902|NCT03304379|471485406|FG001|Overall Study|Other|1|||
130960903|NCT03304379|471485407|FG002|Overall Study|Other|0|||
130960904|NCT03304379|471485408|FG003|Overall Study|Other|0|||
130960905|NCT03304379|471485409|FG004|Overall Study|Other|0|||
130960906|NCT00835406|471485418|FG000|Period: First Intervention|Adverse Event|0|||
130960907|NCT00835406|471485419|FG001|Period: First Intervention|Adverse Event|1|||
130960908|NCT00835406|471485418|FG000|Period: First Intervention|Withdrawal by Subject|2|||
130960909|NCT00835406|471485419|FG001|Period: First Intervention|Withdrawal by Subject|0|||
130960910|NCT00835406|471485418|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
130960911|NCT00835406|471485419|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
130960912|NCT02550652|471485420|FG000|Overall Study|Death|1|||
130960913|NCT02550652|471485421|FG001|Overall Study|Death|4|||
130960914|NCT02550652|471485420|FG000|Overall Study|Lack of Efficacy|1|||
130960915|NCT02550652|471485421|FG001|Overall Study|Lack of Efficacy|0|||
130960916|NCT02550652|471485420|FG000|Overall Study|Withdrawal by Subject|4|||
130960917|NCT02550652|471485421|FG001|Overall Study|Withdrawal by Subject|7|||
130960918|NCT02550652|471485420|FG000|Overall Study|Post Trial Access|1|||
130960919|NCT02550652|471485421|FG001|Overall Study|Post Trial Access|0|||
130960920|NCT02550652|471485420|FG000|Overall Study|Lost to Follow-up|1|||
130960921|NCT02550652|471485421|FG001|Overall Study|Lost to Follow-up|3|||
130960922|NCT02550652|471485420|FG000|Overall Study|Physician Decision|0|||
130960923|NCT02550652|471485421|FG001|Overall Study|Physician Decision|2|||
130960924|NCT02550652|471485420|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
130960925|NCT02550652|471485421|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
130960926|NCT01706250|471485422|FG000|Overall Study|Lost to Follow-up|2|||
130960927|NCT02486406|471485423|FG000|Overall Study|Withdrew consent|1|||
130960928|NCT02486406|471485424|FG001|Overall Study|Withdrew consent|0|||
130960929|NCT02486406|471485425|FG002|Overall Study|Withdrew consent|0|||
130960930|NCT02486406|471485426|FG003|Overall Study|Withdrew consent|1|||
130960931|NCT02486406|471485423|FG000|Overall Study|Lost to Follow-up|1|||
130960932|NCT02486406|471485424|FG001|Overall Study|Lost to Follow-up|3|||
130960933|NCT02486406|471485425|FG002|Overall Study|Lost to Follow-up|1|||
130960934|NCT02486406|471485426|FG003|Overall Study|Lost to Follow-up|3|||
130960935|NCT02486406|471485423|FG000|Overall Study|Other, not specified|0|||
130960936|NCT02486406|471485424|FG001|Overall Study|Other, not specified|0|||
130960937|NCT02486406|471485425|FG002|Overall Study|Other, not specified|1|||
130960938|NCT02486406|471485426|FG003|Overall Study|Other, not specified|0|||
130960939|NCT01826825|471485427|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
130960940|NCT01826825|471485428|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
130960941|NCT01858194|471485429|FG000|Overall Study|Total Artificial Heart Implant|0|||
130960942|NCT01858194|471485430|FG001|Overall Study|Total Artificial Heart Implant|1|||
130960943|NCT01858194|471485429|FG000|Overall Study|Lost to Follow-up|0|||
130960944|NCT01858194|471485430|FG001|Overall Study|Lost to Follow-up|1|||
130960945|NCT00799617|471485434|FG000|Main Testosterone Trial|Randomized in error|1|||
130960946|NCT00799617|471485435|FG001|Main Testosterone Trial|Randomized in error|1|||
130960947|NCT00799617|471485434|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
130960948|NCT00799617|471485435|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
130960949|NCT00799617|471485434|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
130960950|NCT00799617|471485435|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
130960951|NCT00799617|471485434|FG000|Sexual Funtion Trial|No Baseline Data|4|||
130960952|NCT00799617|471485435|FG001|Sexual Funtion Trial|No Baseline Data|7|||
130960953|NCT00799617|471485434|FG000|Physical Function Trial|Lost to Follow-up|6|||
130960954|NCT00799617|471485435|FG001|Physical Function Trial|Lost to Follow-up|11|||
130960955|NCT00799617|471485434|FG000|Vitality Trial|Lost to Follow-up|7|||
130960956|NCT00799617|471485435|FG001|Vitality Trial|Lost to Follow-up|22|||
130960957|NCT00799617|471485434|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
130960958|NCT00799617|471485435|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
130960959|NCT00799617|471485434|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
130960960|NCT00799617|471485435|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
130960961|NCT00799617|471485434|FG000|Bone Trial|Month 12 scan not available|6|||
130960962|NCT00799617|471485435|FG001|Bone Trial|Month 12 scan not available|16|||
130960963|NCT00799617|471485434|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
130774796|NCT03410992|470802563|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
130774797|NCT03410992|470802564|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130774798|NCT03410992|470802565|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130774799|NCT03410992|470802566|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130960964|NCT00799617|471485435|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
130960965|NCT00799617|471485434|FG000|Anemia Trial|Withdrawal by Subject|3|||
130960966|NCT00799617|471485435|FG001|Anemia Trial|Withdrawal by Subject|3|||
131040905|NCT03386578|471785367|FG005|PK Component|Stillbirth/Abortion|2|||
130774800|NCT03410992|470802567|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130960967|NCT04545515|471485436|FG000|Overall Study|Adverse Event|1|||
130960968|NCT04545515|471485436|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
130960969|NCT04545515|471485436|FG000|Overall Study|Commercial drug is available for participant|7|||
130960970|NCT01848990|471485437|FG000|Overall Study|Adverse Event|6|||
130960971|NCT01848990|471485438|FG001|Overall Study|Adverse Event|2|||
130960972|NCT01848990|471485439|FG002|Overall Study|Adverse Event|0|||
130960973|NCT01848990|471485437|FG000|Overall Study|Lost to Follow-up|6|||
130960974|NCT01848990|471485438|FG001|Overall Study|Lost to Follow-up|2|||
130960975|NCT01848990|471485439|FG002|Overall Study|Lost to Follow-up|2|||
130960976|NCT01848990|471485437|FG000|Overall Study|Protocol Violation|1|||
130960977|NCT01848990|471485438|FG001|Overall Study|Protocol Violation|1|||
130960978|NCT01848990|471485439|FG002|Overall Study|Protocol Violation|0|||
130960979|NCT01848990|471485437|FG000|Overall Study|Withdrawal by Subject|29|||
130960980|NCT01848990|471485438|FG001|Overall Study|Withdrawal by Subject|10|||
130960981|NCT01848990|471485439|FG002|Overall Study|Withdrawal by Subject|11|||
130960982|NCT01848990|471485437|FG000|Overall Study|Physician Decision|1|||
130960983|NCT01848990|471485438|FG001|Overall Study|Physician Decision|1|||
130960984|NCT01848990|471485439|FG002|Overall Study|Physician Decision|0|||
130960985|NCT01848990|471485437|FG000|Overall Study|Non Compliance|1|||
130960986|NCT01848990|471485438|FG001|Overall Study|Non Compliance|0|||
130960987|NCT01848990|471485439|FG002|Overall Study|Non Compliance|0|||
130960988|NCT01848990|471485437|FG000|Overall Study|Death|1|||
130960989|NCT01848990|471485438|FG001|Overall Study|Death|0|||
130960990|NCT01848990|471485439|FG002|Overall Study|Death|1|||
130960991|NCT01848990|471485437|FG000|Overall Study|Other|1|||
130960992|NCT01848990|471485438|FG001|Overall Study|Other|4|||
130960993|NCT01848990|471485439|FG002|Overall Study|Other|2|||
130960994|NCT00958880|471485440|FG000|Overall Study|Lost to Follow-up|2|||
130960995|NCT00958880|471485441|FG001|Overall Study|Lost to Follow-up|2|||
130960996|NCT01712984|471485444|FG000|Overall Study|Adverse Event|0|||
130960997|NCT01712984|471485445|FG001|Overall Study|Adverse Event|0|||
130960998|NCT01712984|471485446|FG002|Overall Study|Adverse Event|1|||
130960999|NCT01712984|471485444|FG000|Overall Study|Protocol Violation|2|||
130961000|NCT01712984|471485445|FG001|Overall Study|Protocol Violation|0|||
130961001|NCT01712984|471485446|FG002|Overall Study|Protocol Violation|1|||
130961002|NCT01712984|471485444|FG000|Overall Study|Lost to Follow-up|8|||
130961003|NCT01712984|471485445|FG001|Overall Study|Lost to Follow-up|10|||
130961004|NCT01712984|471485446|FG002|Overall Study|Lost to Follow-up|1|||
130961005|NCT01712984|471485444|FG000|Overall Study|Withdrawal by Subject|6|||
130961006|NCT01712984|471485445|FG001|Overall Study|Withdrawal by Subject|6|||
130961007|NCT01712984|471485446|FG002|Overall Study|Withdrawal by Subject|7|||
130961008|NCT00678561|471485451|FG000|Overall Study|Adverse Event|0|||
130961009|NCT00678561|471485452|FG001|Overall Study|Adverse Event|1|||
130961010|NCT00678561|471485453|FG002|Overall Study|Adverse Event|1|||
130961011|NCT00678561|471485454|FG003|Overall Study|Adverse Event|0|||
130961012|NCT00678561|471485455|FG004|Overall Study|Adverse Event|1|||
130961013|NCT00678561|471485456|FG005|Overall Study|Adverse Event|0|||
130961014|NCT00678561|471485457|FG006|Overall Study|Adverse Event|0|||
130961015|NCT00678561|471485458|FG007|Overall Study|Adverse Event|0|||
130961016|NCT00678561|471485451|FG000|Overall Study|Protocol Violation|0|||
130961017|NCT00678561|471485452|FG001|Overall Study|Protocol Violation|0|||
130961018|NCT00678561|471485453|FG002|Overall Study|Protocol Violation|0|||
130961019|NCT00678561|471485454|FG003|Overall Study|Protocol Violation|0|||
130961020|NCT00678561|471485455|FG004|Overall Study|Protocol Violation|1|||
130961021|NCT00678561|471485456|FG005|Overall Study|Protocol Violation|1|||
130961022|NCT00678561|471485457|FG006|Overall Study|Protocol Violation|0|||
130961023|NCT00678561|471485458|FG007|Overall Study|Protocol Violation|0|||
130961024|NCT00678561|471485451|FG000|Overall Study|Withdrawal by Subject|0|||
130961025|NCT00678561|471485452|FG001|Overall Study|Withdrawal by Subject|0|||
130961026|NCT00678561|471485453|FG002|Overall Study|Withdrawal by Subject|0|||
130961027|NCT00678561|471485454|FG003|Overall Study|Withdrawal by Subject|0|||
130961028|NCT00678561|471485455|FG004|Overall Study|Withdrawal by Subject|0|||
130961029|NCT00678561|471485456|FG005|Overall Study|Withdrawal by Subject|0|||
130961030|NCT00678561|471485457|FG006|Overall Study|Withdrawal by Subject|0|||
130961031|NCT00678561|471485458|FG007|Overall Study|Withdrawal by Subject|1|||
130961032|NCT00437034|471485459|FG000|Overall Study|Adverse Event|1|||
130961033|NCT00437034|471485459|FG000|Overall Study|Disease progression during treatment|5|||
130961034|NCT04258839|471487095|FG000|Overall Study|Adverse Event|2|||
130961035|NCT04258839|471487096|FG001|Overall Study|Adverse Event|4|||
130961036|NCT04258839|471487095|FG000|Overall Study|Lack of Efficacy|0|||
130961037|NCT04258839|471487096|FG001|Overall Study|Lack of Efficacy|2|||
130961038|NCT04258839|471487095|FG000|Overall Study|Lost to Follow-up|2|||
130961039|NCT04258839|471487096|FG001|Overall Study|Lost to Follow-up|0|||
130961040|NCT04258839|471487095|FG000|Overall Study|Withdrawal by Subject|1|||
130961041|NCT04258839|471487096|FG001|Overall Study|Withdrawal by Subject|2|||
130961042|NCT04258839|471487095|FG000|Overall Study|Withdrawal by Caregiver|5|||
130961043|NCT04258839|471487096|FG001|Overall Study|Withdrawal by Caregiver|6|||
131040906|NCT03386578|471785368|FG006|PK Component|Stillbirth/Abortion|0|||
130961044|NCT04258839|471487095|FG000|Overall Study|Reason not Specified|0|||
130961045|NCT04258839|471487096|FG001|Overall Study|Reason not Specified|1|||
130961046|NCT02602288|471487101|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
130961047|NCT02602288|471487102|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
130961048|NCT02602288|471487101|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
130961049|NCT02602288|471487102|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
130961050|NCT02602288|471487101|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
130961051|NCT02602288|471487102|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
130961052|NCT02602288|471487101|FG000|12 Month Follow-up|Lost to Follow-up|0|||
130961053|NCT02602288|471487102|FG001|12 Month Follow-up|Lost to Follow-up|4|||
130961054|NCT02602288|471487101|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
130961055|NCT02602288|471487102|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
130961056|NCT01310413|471487103|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
130961057|NCT01310413|471487104|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
130961058|NCT01310413|471487105|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
130961059|NCT01310413|471487106|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
130961060|NCT01310413|471487107|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
130961061|NCT01310413|471487108|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
130961062|NCT01310413|471487109|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
130961063|NCT01310413|471487103|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
130961064|NCT01310413|471487104|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
130961065|NCT01310413|471487105|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
130961066|NCT01310413|471487106|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
130961067|NCT01310413|471487107|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
130961068|NCT01310413|471487108|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
130961069|NCT01310413|471487109|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
130961070|NCT01310413|471487103|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
130961071|NCT01310413|471487104|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
130961072|NCT01310413|471487105|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
130961073|NCT01310413|471487106|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
130961074|NCT01310413|471487107|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
130961075|NCT01310413|471487108|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
130961076|NCT01310413|471487109|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
130961077|NCT01310413|471487103|FG000|Day 0 to Day 385|Other|1|||
130961078|NCT01310413|471487104|FG001|Day 0 to Day 385|Other|0|||
130961079|NCT01310413|471487105|FG002|Day 0 to Day 385|Other|3|||
130961080|NCT01310413|471487106|FG003|Day 0 to Day 385|Other|0|||
130961081|NCT01310413|471487107|FG004|Day 0 to Day 385|Other|0|||
130961082|NCT01310413|471487108|FG005|Day 0 to Day 385|Other|0|||
130961083|NCT01310413|471487109|FG006|Day 0 to Day 385|Other|0|||
130961084|NCT01310413|471487103|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
130961085|NCT01310413|471487104|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
130961086|NCT01310413|471487105|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
130961087|NCT01310413|471487106|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
130961088|NCT01310413|471487107|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
130961089|NCT01310413|471487108|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
130961090|NCT01310413|471487109|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
130961091|NCT01310413|471487103|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
130961092|NCT01310413|471487104|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
130961093|NCT01310413|471487105|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
130961094|NCT01310413|471487106|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
130961095|NCT01310413|471487107|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
130961096|NCT01310413|471487108|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
130961097|NCT01310413|471487109|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
130961098|NCT00612066|471487110|FG000|Overall Study|Adverse Event|1|||
130961099|NCT00630877|471487111|FG000|Overall Study|Adverse Event|11|||
130961100|NCT00630877|471487112|FG001|Overall Study|Adverse Event|8|||
130961101|NCT00630877|471487113|FG002|Overall Study|Adverse Event|7|||
130961102|NCT00630877|471487111|FG000|Overall Study|Withdrawal by Subject|3|||
130961103|NCT00630877|471487112|FG001|Overall Study|Withdrawal by Subject|4|||
130961104|NCT00630877|471487113|FG002|Overall Study|Withdrawal by Subject|0|||
130961105|NCT00630877|471487111|FG000|Overall Study|Lost to Follow-up|2|||
130961106|NCT00630877|471487112|FG001|Overall Study|Lost to Follow-up|0|||
130961107|NCT00630877|471487113|FG002|Overall Study|Lost to Follow-up|0|||
130961108|NCT00630877|471487111|FG000|Overall Study|Noncompliance|2|||
130961109|NCT00630877|471487112|FG001|Overall Study|Noncompliance|3|||
130961110|NCT00630877|471487113|FG002|Overall Study|Noncompliance|1|||
131127272|NCT04218201|472095922|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
130961111|NCT00630877|471487111|FG000|Overall Study|Protocol violation|1|||
130961112|NCT00630877|471487112|FG001|Overall Study|Protocol violation|0|||
130961113|NCT00630877|471487113|FG002|Overall Study|Protocol violation|1|||
130961114|NCT00630877|471487111|FG000|Overall Study|Personal reasons|0|||
130961115|NCT00630877|471487112|FG001|Overall Study|Personal reasons|0|||
130961116|NCT00630877|471487113|FG002|Overall Study|Personal reasons|1|||
130961117|NCT01519518|471487114|FG000|Overall Study|Consent not available|7|||
130961118|NCT01519518|471487115|FG001|Overall Study|Consent not available|10|||
130961119|NCT02033889|471487116|FG000|Overall Study|Adverse Event|3|||
130961120|NCT02033889|471487117|FG001|Overall Study|Adverse Event|1|||
130961121|NCT02033889|471487118|FG002|Overall Study|Adverse Event|3|||
131133727|NCT01661140|472117175|FG002|Open-Label Period|Lost to Follow-up|0|||
130961122|NCT02033889|471487116|FG000|Overall Study|Death|3|||
130961123|NCT02033889|471487117|FG001|Overall Study|Death|1|||
130961124|NCT02033889|471487118|FG002|Overall Study|Death|2|||
130961125|NCT02033889|471487116|FG000|Overall Study|Excluded Medication|1|||
130961126|NCT02033889|471487117|FG001|Overall Study|Excluded Medication|1|||
130961127|NCT02033889|471487118|FG002|Overall Study|Excluded Medication|0|||
130961128|NCT02033889|471487116|FG000|Overall Study|Lost to Follow-up|8|||
130961129|NCT02033889|471487117|FG001|Overall Study|Lost to Follow-up|5|||
130961130|NCT02033889|471487118|FG002|Overall Study|Lost to Follow-up|6|||
130961131|NCT02033889|471487116|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130961132|NCT02033889|471487117|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130961133|NCT02033889|471487118|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130961134|NCT02033889|471487116|FG000|Overall Study|Physician Decision|0|||
130961135|NCT02033889|471487117|FG001|Overall Study|Physician Decision|1|||
130961136|NCT02033889|471487118|FG002|Overall Study|Physician Decision|1|||
130961137|NCT02033889|471487116|FG000|Overall Study|Participant moved|0|||
130961138|NCT02033889|471487117|FG001|Overall Study|Participant moved|1|||
130961139|NCT02033889|471487118|FG002|Overall Study|Participant moved|0|||
130961140|NCT02033889|471487116|FG000|Overall Study|Withdrawal by Subject|18|||
130961141|NCT02033889|471487117|FG001|Overall Study|Withdrawal by Subject|10|||
130961142|NCT02033889|471487118|FG002|Overall Study|Withdrawal by Subject|13|||
130961143|NCT01913041|471487120|FG000|Overall Study|Protocol Violation|35|||
130961144|NCT01913041|471487120|FG000|Overall Study|Withdrawal by Subject|3|||
130961145|NCT01913041|471487120|FG000|Overall Study|Physician Decision|1|||
130961146|NCT01610700|471487122|FG000|Overall Study|Adverse Event|3|||
130961147|NCT01610700|471487123|FG001|Overall Study|Adverse Event|1|||
130961148|NCT01610700|471487122|FG000|Overall Study|Withdrawal by Subject|0|||
130961149|NCT01610700|471487123|FG001|Overall Study|Withdrawal by Subject|1|||
130961150|NCT01610700|471487122|FG000|Overall Study|subject took one dose of street cannabis|0|||
130961151|NCT01610700|471487123|FG001|Overall Study|subject took one dose of street cannabis|1|||
130961152|NCT00938431|471487130|FG000|Overall Study|Adverse Event|5|||
130961153|NCT00938431|471487131|FG001|Overall Study|Adverse Event|8|||
130961154|NCT00938431|471487132|FG002|Overall Study|Adverse Event|6|||
130961155|NCT00938431|471487130|FG000|Overall Study|Lack of Efficacy|0|||
130961156|NCT00938431|471487131|FG001|Overall Study|Lack of Efficacy|1|||
130961157|NCT00938431|471487132|FG002|Overall Study|Lack of Efficacy|0|||
130961158|NCT00938431|471487130|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
130961159|NCT00938431|471487131|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
130961160|NCT00938431|471487132|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
130961161|NCT00938431|471487130|FG000|Overall Study|Dosing compliance issue|0|||
130961162|NCT00938431|471487131|FG001|Overall Study|Dosing compliance issue|0|||
130961163|NCT00938431|471487132|FG002|Overall Study|Dosing compliance issue|1|||
130961164|NCT00938431|471487130|FG000|Overall Study|Reached maximum dose early|0|||
130961165|NCT00938431|471487131|FG001|Overall Study|Reached maximum dose early|0|||
130961166|NCT00938431|471487132|FG002|Overall Study|Reached maximum dose early|1|||
130961167|NCT01529645|471487133|FG000|Overall Study|Lost to Follow-up|0|||
130961168|NCT01529645|471487134|FG001|Overall Study|Lost to Follow-up|1|||
130961169|NCT01529645|471487135|FG002|Overall Study|Lost to Follow-up|1|||
130961170|NCT01529645|471487136|FG003|Overall Study|Lost to Follow-up|1|||
130961171|NCT01529645|471487137|FG004|Overall Study|Lost to Follow-up|1|||
130961172|NCT01529645|471487138|FG005|Overall Study|Lost to Follow-up|0|||
130961173|NCT01529645|471487139|FG006|Overall Study|Lost to Follow-up|2|||
130961174|NCT01529645|471487140|FG007|Overall Study|Lost to Follow-up|0|||
130961175|NCT01529645|471487141|FG008|Overall Study|Lost to Follow-up|1|||
130961176|NCT01529645|471487142|FG009|Overall Study|Lost to Follow-up|0|||
130961177|NCT01529645|471487133|FG000|Overall Study|SAE - Premature contractions|0|||
130961178|NCT01529645|471487134|FG001|Overall Study|SAE - Premature contractions|0|||
130961179|NCT01529645|471487135|FG002|Overall Study|SAE - Premature contractions|1|||
130961180|NCT01529645|471487136|FG003|Overall Study|SAE - Premature contractions|0|||
130961181|NCT01529645|471487137|FG004|Overall Study|SAE - Premature contractions|0|||
130961182|NCT01529645|471487138|FG005|Overall Study|SAE - Premature contractions|0|||
130961183|NCT01529645|471487139|FG006|Overall Study|SAE - Premature contractions|0|||
130961184|NCT01529645|471487140|FG007|Overall Study|SAE - Premature contractions|0|||
130961185|NCT01529645|471487141|FG008|Overall Study|SAE - Premature contractions|0|||
130961186|NCT01529645|471487142|FG009|Overall Study|SAE - Premature contractions|0|||
130961187|NCT01529645|471487133|FG000|Overall Study|Withdrawal by Subject|2|||
130961188|NCT01529645|471487134|FG001|Overall Study|Withdrawal by Subject|0|||
130961189|NCT01529645|471487135|FG002|Overall Study|Withdrawal by Subject|0|||
130961190|NCT01529645|471487136|FG003|Overall Study|Withdrawal by Subject|1|||
130961191|NCT01529645|471487137|FG004|Overall Study|Withdrawal by Subject|1|||
130961192|NCT01529645|471487138|FG005|Overall Study|Withdrawal by Subject|1|||
131127273|NCT04218201|472095923|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
130961193|NCT01529645|471487139|FG006|Overall Study|Withdrawal by Subject|0|||
130961194|NCT01529645|471487140|FG007|Overall Study|Withdrawal by Subject|0|||
130961195|NCT01529645|471487141|FG008|Overall Study|Withdrawal by Subject|0|||
130961196|NCT01529645|471487142|FG009|Overall Study|Withdrawal by Subject|0|||
130961197|NCT01774903|471487143|FG000|Overall Study|Adverse Event|7|||
131040907|NCT03386578|471785369|FG007|PK Component|Stillbirth/Abortion|0|||
131040908|NCT03386578|471785370|FG008|PK Component|Stillbirth/Abortion|0|||
131040909|NCT03386578|471785371|FG009|PK Component|Stillbirth/Abortion|0|||
131040910|NCT03386578|471785362|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131040911|NCT03386578|471785363|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131040912|NCT03386578|471785364|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
131040913|NCT03386578|471785365|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
131040914|NCT03386578|471785366|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131040915|NCT03386578|471785367|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131040916|NCT03386578|471785368|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131040917|NCT03386578|471785369|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
131040918|NCT03386578|471785370|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
131040919|NCT03386578|471785371|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
131040920|NCT03386578|471785362|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131040921|NCT03386578|471785363|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131040922|NCT03386578|471785364|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
131040923|NCT03386578|471785365|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
131040924|NCT03386578|471785366|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131040925|NCT03386578|471785367|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131040926|NCT03386578|471785368|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131040927|NCT03386578|471785369|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
131040928|NCT03386578|471785370|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
131040929|NCT03386578|471785371|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
131040930|NCT03386578|471785362|FG000|PrEP Comparison Component Step 1|Death|0|||
131040931|NCT03386578|471785363|FG001|PrEP Comparison Component Step 1|Death|0|||
131040932|NCT03386578|471785364|FG002|PrEP Comparison Component Step 1|Death|1|||
131040933|NCT03386578|471785365|FG003|PrEP Comparison Component Step 1|Death|0|||
131040934|NCT03386578|471785366|FG004|PrEP Comparison Component Step 1|Death|0|||
131040935|NCT03386578|471785367|FG005|PrEP Comparison Component Step 1|Death|0|||
131040936|NCT03386578|471785368|FG006|PrEP Comparison Component Step 1|Death|0|||
131040937|NCT03386578|471785369|FG007|PrEP Comparison Component Step 1|Death|9|||
131040938|NCT03386578|471785370|FG008|PrEP Comparison Component Step 1|Death|5|||
131040939|NCT03386578|471785371|FG009|PrEP Comparison Component Step 1|Death|0|||
131040940|NCT03386578|471785362|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131040941|NCT03386578|471785363|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131040942|NCT03386578|471785364|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131040943|NCT03386578|471785365|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
131040944|NCT03386578|471785366|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131040945|NCT03386578|471785367|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131040946|NCT03386578|471785368|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131040947|NCT03386578|471785369|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131040948|NCT03386578|471785370|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
131040949|NCT03386578|471785371|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
131040950|NCT03386578|471785362|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131040951|NCT03386578|471785363|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131040952|NCT03386578|471785364|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131040953|NCT03386578|471785365|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131040954|NCT03386578|471785366|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131040955|NCT03386578|471785367|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131040956|NCT03386578|471785368|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131040957|NCT03386578|471785369|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
131040958|NCT03386578|471785370|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
131040959|NCT03386578|471785371|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
131040960|NCT03386578|471785362|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131040961|NCT03386578|471785363|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131040962|NCT03386578|471785364|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131040963|NCT03386578|471785365|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131040964|NCT03386578|471785366|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131040965|NCT03386578|471785367|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131040966|NCT03386578|471785368|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131040967|NCT03386578|471785369|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
131040968|NCT03386578|471785370|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
131040969|NCT03386578|471785371|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
131040970|NCT05907174|471785374|FG000|3-Month Assessment|Withdrawal by Subject|0|||
131040971|NCT05907174|471785375|FG001|3-Month Assessment|Withdrawal by Subject|0|||
131040972|NCT05907174|471785376|FG002|3-Month Assessment|Withdrawal by Subject|0|||
131226393|NCT00950599|472455728|FG004|Follow-Up Period|Lost to Follow-up|0|||
131226394|NCT00950599|472455729|FG005|Follow-Up Period|Lost to Follow-up|0|||
131226395|NCT00950599|472455730|FG006|Follow-Up Period|Lost to Follow-up|0|||
131226396|NCT00950599|472455731|FG007|Follow-Up Period|Lost to Follow-up|0|||
131226397|NCT00950599|472455732|FG008|Follow-Up Period|Lost to Follow-up|5|||
131226398|NCT00950599|472455733|FG009|Follow-Up Period|Lost to Follow-up|1|||
131226399|NCT00950599|472455724|FG000|Follow-Up Period|Physician Decision|0|||
131226400|NCT00950599|472455725|FG001|Follow-Up Period|Physician Decision|0|||
131226401|NCT00950599|472455726|FG002|Follow-Up Period|Physician Decision|0|||
131226402|NCT00950599|472455727|FG003|Follow-Up Period|Physician Decision|0|||
131226403|NCT00950599|472455728|FG004|Follow-Up Period|Physician Decision|0|||
131226404|NCT00950599|472455729|FG005|Follow-Up Period|Physician Decision|0|||
131226405|NCT00950599|472455730|FG006|Follow-Up Period|Physician Decision|0|||
131226406|NCT00950599|472455731|FG007|Follow-Up Period|Physician Decision|0|||
131226407|NCT00950599|472455732|FG008|Follow-Up Period|Physician Decision|1|||
131226408|NCT00950599|472455733|FG009|Follow-Up Period|Physician Decision|0|||
131226409|NCT00950599|472455724|FG000|Follow-Up Period|Poor/Noncompliance|0|||
131226410|NCT00950599|472455725|FG001|Follow-Up Period|Poor/Noncompliance|0|||
131226411|NCT00950599|472455726|FG002|Follow-Up Period|Poor/Noncompliance|0|||
131226412|NCT00950599|472455727|FG003|Follow-Up Period|Poor/Noncompliance|0|||
131226413|NCT00950599|472455728|FG004|Follow-Up Period|Poor/Noncompliance|0|||
131226414|NCT00950599|472455729|FG005|Follow-Up Period|Poor/Noncompliance|0|||
131226415|NCT00950599|472455730|FG006|Follow-Up Period|Poor/Noncompliance|0|||
131226416|NCT00950599|472455731|FG007|Follow-Up Period|Poor/Noncompliance|0|||
131226417|NCT00950599|472455732|FG008|Follow-Up Period|Poor/Noncompliance|1|||
131226418|NCT00950599|472455733|FG009|Follow-Up Period|Poor/Noncompliance|0|||
130714571|NCT00974974|470581712|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
130714572|NCT00974974|470581711|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
130714573|NCT00974974|470581712|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
130961198|NCT01774903|471487143|FG000|Overall Study|Withdrawal by Subject|2|||
130961199|NCT01774903|471487143|FG000|Overall Study|Lack of Efficacy|1|||
130961200|NCT01774903|471487143|FG000|Overall Study|Ineligible to continue the trial|1|||
130961201|NCT01602315|471487144|FG000|Overall Study|Protocol Violation|0|||
130961202|NCT01602315|471487145|FG001|Overall Study|Protocol Violation|0|||
130961203|NCT01602315|471487146|FG002|Overall Study|Protocol Violation|0|||
130961204|NCT01602315|471487147|FG003|Overall Study|Protocol Violation|0|||
130961205|NCT01602315|471487148|FG004|Overall Study|Protocol Violation|0|||
130961206|NCT01602315|471487149|FG005|Overall Study|Protocol Violation|1|||
130961207|NCT01602315|471487150|FG006|Overall Study|Protocol Violation|0|||
130961208|NCT01602315|471487144|FG000|Overall Study|Physician Decision|2|||
130961209|NCT01602315|471487145|FG001|Overall Study|Physician Decision|0|||
130961210|NCT01602315|471487146|FG002|Overall Study|Physician Decision|0|||
130961211|NCT01602315|471487147|FG003|Overall Study|Physician Decision|0|||
130961212|NCT01602315|471487148|FG004|Overall Study|Physician Decision|2|||
130961213|NCT01602315|471487149|FG005|Overall Study|Physician Decision|1|||
130961214|NCT01602315|471487150|FG006|Overall Study|Physician Decision|1|||
130961215|NCT01602315|471487144|FG000|Overall Study|Disease progression|6|||
130961216|NCT01602315|471487145|FG001|Overall Study|Disease progression|3|||
130961217|NCT01602315|471487146|FG002|Overall Study|Disease progression|10|||
130961218|NCT01602315|471487147|FG003|Overall Study|Disease progression|1|||
130961219|NCT01602315|471487148|FG004|Overall Study|Disease progression|41|||
130961220|NCT01602315|471487149|FG005|Overall Study|Disease progression|12|||
130961221|NCT01602315|471487150|FG006|Overall Study|Disease progression|15|||
130961222|NCT01602315|471487144|FG000|Overall Study|Death|1|||
130961223|NCT01602315|471487145|FG001|Overall Study|Death|1|||
130961224|NCT01602315|471487146|FG002|Overall Study|Death|1|||
130961225|NCT01602315|471487147|FG003|Overall Study|Death|1|||
130961226|NCT01602315|471487148|FG004|Overall Study|Death|7|||
130961227|NCT01602315|471487149|FG005|Overall Study|Death|2|||
130961228|NCT01602315|471487150|FG006|Overall Study|Death|2|||
130961229|NCT01602315|471487144|FG000|Overall Study|Withdrawal by Subject|2|||
130961230|NCT01602315|471487145|FG001|Overall Study|Withdrawal by Subject|0|||
130961231|NCT01602315|471487146|FG002|Overall Study|Withdrawal by Subject|2|||
130961232|NCT01602315|471487147|FG003|Overall Study|Withdrawal by Subject|0|||
130961233|NCT01602315|471487148|FG004|Overall Study|Withdrawal by Subject|6|||
130961234|NCT01602315|471487149|FG005|Overall Study|Withdrawal by Subject|0|||
130961235|NCT01602315|471487150|FG006|Overall Study|Withdrawal by Subject|1|||
130961236|NCT01602315|471487144|FG000|Overall Study|Adverse Event|5|||
130961237|NCT01602315|471487145|FG001|Overall Study|Adverse Event|1|||
130961238|NCT01602315|471487146|FG002|Overall Study|Adverse Event|5|||
130961239|NCT01602315|471487147|FG003|Overall Study|Adverse Event|4|||
130961240|NCT01602315|471487148|FG004|Overall Study|Adverse Event|15|||
130961241|NCT01602315|471487149|FG005|Overall Study|Adverse Event|3|||
130961242|NCT01602315|471487150|FG006|Overall Study|Adverse Event|9|||
130961243|NCT01602315|471487144|FG000|Overall Study|Subject/guardian decision|0|||
130961244|NCT01602315|471487145|FG001|Overall Study|Subject/guardian decision|0|||
131226419|NCT00950599|472455724|FG000|Follow-Up Period|Subject withdrew Consent|0|||
131226420|NCT00950599|472455725|FG001|Follow-Up Period|Subject withdrew Consent|0|||
130714574|NCT00974974|470581711|FG000|IR CD-LD Dose Adjustment|Various|0|||
130714575|NCT00974974|470581712|FG001|IR CD-LD Dose Adjustment|Various|9|||
130714576|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Adverse Event|23|||
130714577|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Adverse Event|0|||
130714578|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Death|2|||
130714579|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Death|0|||
130714580|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
130714581|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
130714582|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
130714583|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
130714584|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Various|3|||
130714585|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Various|0|||
130714586|NCT00974974|470581711|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
130714587|NCT00974974|470581712|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
130714588|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
130714589|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
130714590|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
130714591|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
130714592|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
130714593|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
130714594|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
130714595|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
130714596|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
130714597|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
130714598|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
130714599|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
130714600|NCT00974974|470581711|FG000|Maintenance - Double Blind Treatment|Various|4|||
130714601|NCT00974974|470581712|FG001|Maintenance - Double Blind Treatment|Various|0|||
130714602|NCT01959035|470581713|FG000|Overall Study|Adverse Event|5|||
130714603|NCT01959035|470581713|FG000|Overall Study|Withdrawal by Subject|4|||
130714604|NCT01959035|470581713|FG000|Overall Study|Lost to Follow-up|1|||
130714605|NCT01959035|470581713|FG000|Overall Study|Other (no primary reason given)|1|||
130714606|NCT02034058|470581714|FG000|Overall Study|Death|3|||
130714607|NCT03254602|470581715|FG000|Overall Study|Lost to Follow-up|4|||
130714608|NCT02963311|470581720|FG000|Overall Study|Withdrawal by Subject|1|||
130714609|NCT02963311|470581720|FG000|Overall Study|Screen Failure|4|||
130714610|NCT02836496|470581723|FG000|Overall Study|Adverse Event|2|||
130714611|NCT02836496|470581724|FG001|Overall Study|Adverse Event|1|||
130714612|NCT02836496|470581723|FG000|Overall Study|Withdrawal by Subject|0|||
130714613|NCT02836496|470581724|FG001|Overall Study|Withdrawal by Subject|1|||
130961245|NCT01602315|471487146|FG002|Overall Study|Subject/guardian decision|0|||
130961246|NCT01602315|471487147|FG003|Overall Study|Subject/guardian decision|0|||
130961247|NCT01602315|471487148|FG004|Overall Study|Subject/guardian decision|0|||
130961248|NCT01602315|471487149|FG005|Overall Study|Subject/guardian decision|0|||
130961249|NCT01602315|471487150|FG006|Overall Study|Subject/guardian decision|1|||
130961250|NCT01602315|471487144|FG000|Overall Study|Cross-over patients to combo treatment|0|||
130961251|NCT01602315|471487145|FG001|Overall Study|Cross-over patients to combo treatment|0|||
130961252|NCT01602315|471487146|FG002|Overall Study|Cross-over patients to combo treatment|0|||
130961253|NCT01602315|471487147|FG003|Overall Study|Cross-over patients to combo treatment|0|||
130961254|NCT01602315|471487148|FG004|Overall Study|Cross-over patients to combo treatment|0|||
130961255|NCT01602315|471487149|FG005|Overall Study|Cross-over patients to combo treatment|16|||
130961256|NCT01602315|471487150|FG006|Overall Study|Cross-over patients to combo treatment|0|||
130961257|NCT02212730|471487153|FG000|Overall Study|Tumor not of the required cell histology|1|||
130961258|NCT02212730|471487154|FG001|Overall Study|Tumor not of the required cell histology|0|||
130961259|NCT02212730|471487153|FG000|Overall Study|Withdrawal by Subject|1|||
130961260|NCT02212730|471487154|FG001|Overall Study|Withdrawal by Subject|0|||
130961261|NCT02212730|471487153|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
130961262|NCT02212730|471487154|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
131226421|NCT00950599|472455726|FG002|Follow-Up Period|Subject withdrew Consent|0|||
130961263|NCT02880371|471487155|FG000|Phase 1b|Lost to Follow-up|1|||
130961264|NCT02880371|471487156|FG001|Phase 1b|Lost to Follow-up|0|||
130961265|NCT02880371|471487157|FG002|Phase 1b|Lost to Follow-up|0|||
130961266|NCT02880371|471487158|FG003|Phase 1b|Lost to Follow-up|0|||
130961267|NCT02880371|471487159|FG004|Phase 1b|Lost to Follow-up|0|||
130961268|NCT02880371|471487160|FG005|Phase 1b|Lost to Follow-up|0|||
130961269|NCT02880371|471487161|FG006|Phase 1b|Lost to Follow-up|0|||
130961270|NCT02880371|471487162|FG007|Phase 1b|Lost to Follow-up|0|||
130961271|NCT02880371|471487155|FG000|Phase 1b|Participants terminated by Sponsor|1|||
130961272|NCT02880371|471487156|FG001|Phase 1b|Participants terminated by Sponsor|0|||
130961273|NCT02880371|471487157|FG002|Phase 1b|Participants terminated by Sponsor|0|||
130961274|NCT02880371|471487158|FG003|Phase 1b|Participants terminated by Sponsor|0|||
130961275|NCT02880371|471487159|FG004|Phase 1b|Participants terminated by Sponsor|0|||
130961276|NCT02880371|471487160|FG005|Phase 1b|Participants terminated by Sponsor|0|||
130961277|NCT02880371|471487161|FG006|Phase 1b|Participants terminated by Sponsor|0|||
131127274|NCT04218201|472095920|FG000|Overall Study|Withdrawal by Subject|2|||
131127275|NCT04218201|472095921|FG001|Overall Study|Withdrawal by Subject|0|||
131127276|NCT04218201|472095922|FG002|Overall Study|Withdrawal by Subject|0|||
131127277|NCT04218201|472095923|FG003|Overall Study|Withdrawal by Subject|0|||
131127278|NCT04218201|472095920|FG000|Overall Study|PCP plans to leave practice|0|||
131127279|NCT04218201|472095921|FG001|Overall Study|PCP plans to leave practice|8|||
131127280|NCT04218201|472095922|FG002|Overall Study|PCP plans to leave practice|0|||
131127281|NCT04218201|472095923|FG003|Overall Study|PCP plans to leave practice|5|||
131127282|NCT04218201|472095920|FG000|Overall Study|Reduced panel|0|||
131127283|NCT04218201|472095921|FG001|Overall Study|Reduced panel|0|||
131127284|NCT04218201|472095922|FG002|Overall Study|Reduced panel|0|||
131127285|NCT04218201|472095923|FG003|Overall Study|Reduced panel|1|||
131127286|NCT04218201|472095920|FG000|Overall Study|No longer interested in participating|0|||
131127287|NCT04218201|472095921|FG001|Overall Study|No longer interested in participating|1|||
131127288|NCT04218201|472095922|FG002|Overall Study|No longer interested in participating|0|||
130961278|NCT02880371|471487162|FG007|Phase 1b|Participants terminated by Sponsor|0|||
130961279|NCT02880371|471487155|FG000|Phase 1b|Withdrawal by Subject|0|||
130961280|NCT02880371|471487156|FG001|Phase 1b|Withdrawal by Subject|0|||
130961281|NCT02880371|471487157|FG002|Phase 1b|Withdrawal by Subject|1|||
130961282|NCT02880371|471487158|FG003|Phase 1b|Withdrawal by Subject|0|||
130961283|NCT02880371|471487159|FG004|Phase 1b|Withdrawal by Subject|0|||
130961284|NCT02880371|471487160|FG005|Phase 1b|Withdrawal by Subject|0|||
130961285|NCT02880371|471487161|FG006|Phase 1b|Withdrawal by Subject|0|||
130961286|NCT02880371|471487162|FG007|Phase 1b|Withdrawal by Subject|0|||
130961287|NCT02880371|471487155|FG000|Phase 1b|Death|4|||
130961288|NCT02880371|471487156|FG001|Phase 1b|Death|6|||
130961289|NCT02880371|471487157|FG002|Phase 1b|Death|5|||
130961290|NCT02880371|471487158|FG003|Phase 1b|Death|1|||
130961291|NCT02880371|471487159|FG004|Phase 1b|Death|0|||
130961292|NCT02880371|471487160|FG005|Phase 1b|Death|0|||
130961293|NCT02880371|471487161|FG006|Phase 1b|Death|0|||
130961294|NCT02880371|471487162|FG007|Phase 1b|Death|0|||
130961295|NCT02880371|471487155|FG000|Phase 1b|Enrolled but not Treated|0|||
130961296|NCT02880371|471487156|FG001|Phase 1b|Enrolled but not Treated|1|||
130961297|NCT02880371|471487157|FG002|Phase 1b|Enrolled but not Treated|0|||
130961298|NCT02880371|471487158|FG003|Phase 1b|Enrolled but not Treated|0|||
130961299|NCT02880371|471487159|FG004|Phase 1b|Enrolled but not Treated|0|||
130961300|NCT02880371|471487160|FG005|Phase 1b|Enrolled but not Treated|0|||
130961301|NCT02880371|471487161|FG006|Phase 1b|Enrolled but not Treated|0|||
130961302|NCT02880371|471487162|FG007|Phase 1b|Enrolled but not Treated|0|||
130961303|NCT02880371|471487155|FG000|Phase 2|Enrolled but not Treated|0|||
130961304|NCT02880371|471487156|FG001|Phase 2|Enrolled but not Treated|0|||
130961305|NCT02880371|471487157|FG002|Phase 2|Enrolled but not Treated|0|||
130961306|NCT02880371|471487158|FG003|Phase 2|Enrolled but not Treated|0|||
130961307|NCT02880371|471487159|FG004|Phase 2|Enrolled but not Treated|0|||
130961308|NCT02880371|471487160|FG005|Phase 2|Enrolled but not Treated|1|||
130961309|NCT02880371|471487161|FG006|Phase 2|Enrolled but not Treated|1|||
130961310|NCT02880371|471487162|FG007|Phase 2|Enrolled but not Treated|0|||
131127289|NCT04218201|472095923|FG003|Overall Study|No longer interested in participating|0|||
131127290|NCT03723707|472095924|FG000|Overall Study|Death|32|||
131127291|NCT03723707|472095925|FG001|Overall Study|Death|32|||
131127292|NCT03723707|472095924|FG000|Overall Study|Admitted to long term care|12|||
130961311|NCT02880371|471487155|FG000|Phase 2|Other|0|||
130961312|NCT02880371|471487156|FG001|Phase 2|Other|0|||
130961313|NCT02880371|471487157|FG002|Phase 2|Other|0|||
130961314|NCT02880371|471487158|FG003|Phase 2|Other|0|||
130961315|NCT02880371|471487159|FG004|Phase 2|Other|0|||
130961316|NCT02880371|471487160|FG005|Phase 2|Other|1|||
130961317|NCT02880371|471487161|FG006|Phase 2|Other|2|||
130961318|NCT02880371|471487162|FG007|Phase 2|Other|1|||
131127293|NCT03723707|472095925|FG001|Overall Study|Admitted to long term care|12|||
131127294|NCT03723707|472095924|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
131127295|NCT03723707|472095925|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
130961319|NCT02880371|471487155|FG000|Phase 2|Participants terminated by Sponsor|0|||
130961320|NCT02880371|471487156|FG001|Phase 2|Participants terminated by Sponsor|0|||
130961321|NCT02880371|471487157|FG002|Phase 2|Participants terminated by Sponsor|0|||
130961322|NCT02880371|471487158|FG003|Phase 2|Participants terminated by Sponsor|0|||
130961323|NCT02880371|471487159|FG004|Phase 2|Participants terminated by Sponsor|1|||
130961324|NCT02880371|471487160|FG005|Phase 2|Participants terminated by Sponsor|6|||
130961325|NCT02880371|471487161|FG006|Phase 2|Participants terminated by Sponsor|1|||
130961326|NCT02880371|471487162|FG007|Phase 2|Participants terminated by Sponsor|5|||
130961327|NCT02880371|471487155|FG000|Phase 2|Death|0|||
130961328|NCT02880371|471487156|FG001|Phase 2|Death|0|||
130961329|NCT02880371|471487157|FG002|Phase 2|Death|0|||
130961330|NCT02880371|471487158|FG003|Phase 2|Death|0|||
130961331|NCT02880371|471487159|FG004|Phase 2|Death|1|||
130961332|NCT02880371|471487160|FG005|Phase 2|Death|10|||
130961333|NCT02880371|471487161|FG006|Phase 2|Death|20|||
130961334|NCT02880371|471487162|FG007|Phase 2|Death|5|||
130961335|NCT02880371|471487155|FG000|Phase 2|Lost to Follow-up|0|||
130961336|NCT02880371|471487156|FG001|Phase 2|Lost to Follow-up|0|||
130961337|NCT02880371|471487157|FG002|Phase 2|Lost to Follow-up|0|||
130961338|NCT02880371|471487158|FG003|Phase 2|Lost to Follow-up|0|||
130961339|NCT02880371|471487159|FG004|Phase 2|Lost to Follow-up|0|||
130961340|NCT02880371|471487160|FG005|Phase 2|Lost to Follow-up|0|||
130961341|NCT02880371|471487161|FG006|Phase 2|Lost to Follow-up|3|||
130961342|NCT02880371|471487162|FG007|Phase 2|Lost to Follow-up|0|||
130961343|NCT02880371|471487155|FG000|Phase 2|Withdrawal by Subject|0|||
130961344|NCT02880371|471487156|FG001|Phase 2|Withdrawal by Subject|0|||
130961345|NCT02880371|471487157|FG002|Phase 2|Withdrawal by Subject|0|||
130961346|NCT02880371|471487158|FG003|Phase 2|Withdrawal by Subject|0|||
130961347|NCT02880371|471487159|FG004|Phase 2|Withdrawal by Subject|0|||
131127296|NCT03723707|472095924|FG000|Overall Study|Lost to Follow-up|40|||
131127297|NCT03723707|472095925|FG001|Overall Study|Lost to Follow-up|22|||
131127298|NCT03723707|472095924|FG000|Overall Study|Discontinued after study closure|24|||
131127299|NCT03723707|472095925|FG001|Overall Study|Discontinued after study closure|12|||
131127300|NCT01611974|472095926|FG000|Overall Study|Death|10|||
131127301|NCT01611974|472095927|FG001|Overall Study|Death|12|||
131127302|NCT01611974|472095928|FG002|Overall Study|Death|10|||
131127303|NCT01611974|472095926|FG000|Overall Study|Lost to Follow-up|0|||
131127304|NCT01611974|472095927|FG001|Overall Study|Lost to Follow-up|1|||
131127305|NCT01611974|472095928|FG002|Overall Study|Lost to Follow-up|0|||
131127306|NCT01611974|472095926|FG000|Overall Study|Physician Decision|5|||
131127307|NCT01611974|472095927|FG001|Overall Study|Physician Decision|1|||
131127308|NCT01611974|472095928|FG002|Overall Study|Physician Decision|2|||
131127309|NCT01611974|472095926|FG000|Overall Study|Withdrawal by Subject|0|||
131127310|NCT01611974|472095927|FG001|Overall Study|Withdrawal by Subject|1|||
131127311|NCT01611974|472095928|FG002|Overall Study|Withdrawal by Subject|4|||
131226422|NCT00950599|472455727|FG003|Follow-Up Period|Subject withdrew Consent|0|||
130961348|NCT02880371|471487160|FG005|Phase 2|Withdrawal by Subject|1|||
130961349|NCT02880371|471487161|FG006|Phase 2|Withdrawal by Subject|1|||
131040973|NCT05907174|471785377|FG003|3-Month Assessment|Withdrawal by Subject|1|||
130961350|NCT02880371|471487162|FG007|Phase 2|Withdrawal by Subject|0|||
130961351|NCT02880371|471487155|FG000|Phase 2|End of Study page not completed by error|0|||
130961352|NCT02880371|471487156|FG001|Phase 2|End of Study page not completed by error|0|||
130961353|NCT02880371|471487157|FG002|Phase 2|End of Study page not completed by error|0|||
131040974|NCT05907174|471785374|FG000|3-Month Assessment|Lost to Follow-up|1|||
131040975|NCT05907174|471785375|FG001|3-Month Assessment|Lost to Follow-up|1|||
131040976|NCT05907174|471785376|FG002|3-Month Assessment|Lost to Follow-up|1|||
131040977|NCT05907174|471785377|FG003|3-Month Assessment|Lost to Follow-up|1|||
131040978|NCT05907174|471785374|FG000|6-Month Assessment|Death|0|||
131040979|NCT05907174|471785375|FG001|6-Month Assessment|Death|0|||
131040980|NCT05907174|471785376|FG002|6-Month Assessment|Death|3|||
131040981|NCT05907174|471785377|FG003|6-Month Assessment|Death|0|||
131040982|NCT05907174|471785374|FG000|6-Month Assessment|Withdrawal by Subject|0|||
131040983|NCT05907174|471785375|FG001|6-Month Assessment|Withdrawal by Subject|0|||
131040984|NCT05907174|471785376|FG002|6-Month Assessment|Withdrawal by Subject|1|||
131040985|NCT05907174|471785377|FG003|6-Month Assessment|Withdrawal by Subject|1|||
131040986|NCT05907174|471785374|FG000|6-Month Assessment|Lost to Follow-up|0|||
131127312|NCT00530270|472095936|FG000|Overall Study|Protocol Violation|1|||
131127313|NCT00530270|472095937|FG001|Overall Study|Protocol Violation|0|||
131127314|NCT00838331|472095941|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
131127315|NCT03972969|472095943|FG000|3-month Follow-up|Death|1|||
131127316|NCT03972969|472095944|FG001|3-month Follow-up|Death|1|||
131127317|NCT03972969|472095945|FG002|3-month Follow-up|Death|0|||
131127318|NCT03972969|472095943|FG000|6-month Follow-up|Death|1|||
131127319|NCT03972969|472095944|FG001|6-month Follow-up|Death|1|||
131127320|NCT03972969|472095945|FG002|6-month Follow-up|Death|1|||
130961354|NCT02880371|471487158|FG003|Phase 2|End of Study page not completed by error|0|||
130961355|NCT02880371|471487159|FG004|Phase 2|End of Study page not completed by error|0|||
130961356|NCT02880371|471487160|FG005|Phase 2|End of Study page not completed by error|1|||
130961357|NCT02880371|471487161|FG006|Phase 2|End of Study page not completed by error|0|||
130961358|NCT02880371|471487162|FG007|Phase 2|End of Study page not completed by error|0|||
130961359|NCT01777997|471487165|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
131127321|NCT03972969|472095943|FG000|6-month Follow-up|Lost to Follow-up|2|||
131127322|NCT03972969|472095944|FG001|6-month Follow-up|Lost to Follow-up|2|||
131040987|NCT05907174|471785375|FG001|6-Month Assessment|Lost to Follow-up|1|||
131040988|NCT05907174|471785376|FG002|6-Month Assessment|Lost to Follow-up|1|||
131040989|NCT05907174|471785377|FG003|6-Month Assessment|Lost to Follow-up|1|||
130961360|NCT01777997|471487165|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
130961361|NCT01777997|471487165|FG000|Weeks 48 to 72/96 on ART|Death|1|||
130961362|NCT01777997|471487165|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
130961363|NCT02932891|471487171|FG000|Overall Study|Lost to Follow-up|2|||
130961364|NCT02932891|471487171|FG000|Overall Study|HPA Suppress|2|||
130961365|NCT00451282|471487174|FG000|Overall Study|Lost to Follow-up|6|||
131040990|NCT05370040|471785382|FG000|Overall Study|Lost to Follow-up|0|||
131040991|NCT05370040|471785383|FG001|Overall Study|Lost to Follow-up|0|||
131040992|NCT05370040|471785384|FG002|Overall Study|Lost to Follow-up|1|||
131040993|NCT05370040|471785385|FG003|Overall Study|Lost to Follow-up|0|||
131040994|NCT05370040|471785386|FG004|Overall Study|Lost to Follow-up|1|||
131040995|NCT05370040|471785387|FG005|Overall Study|Lost to Follow-up|0|||
131040996|NCT05093842|471785390|FG000|Overall Study|Pregnancy loss|1|||
131040997|NCT05093842|471785391|FG001|Overall Study|Pregnancy loss|1|||
131040998|NCT05093842|471785390|FG000|Overall Study|Lost to Follow-up|6|||
131040999|NCT05093842|471785391|FG001|Overall Study|Lost to Follow-up|0|||
131041000|NCT05093842|471785390|FG000|Overall Study|Physician Decision|0|||
131041001|NCT05093842|471785391|FG001|Overall Study|Physician Decision|1|||
131041002|NCT03910478|471785392|FG000|Overall Study|Death|13|||
131041003|NCT03910478|471785393|FG001|Overall Study|Death|6|||
131041004|NCT03910478|471785392|FG000|Overall Study|Withdrawal by Subject|23|||
131041005|NCT03910478|471785393|FG001|Overall Study|Withdrawal by Subject|2|||
131041006|NCT03910478|471785392|FG000|Overall Study|Physician Decision|5|||
131041007|NCT03910478|471785393|FG001|Overall Study|Physician Decision|0|||
131041008|NCT03910478|471785392|FG000|Overall Study|Protocol Violation|1|||
131041009|NCT03910478|471785393|FG001|Overall Study|Protocol Violation|0|||
131041010|NCT03910478|471785392|FG000|Overall Study|Failure to meet continuation criteria|2|||
131041011|NCT03910478|471785393|FG001|Overall Study|Failure to meet continuation criteria|0|||
131041012|NCT03910478|471785392|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
131041013|NCT03910478|471785393|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
131041014|NCT05147116|471785399|FG000|Overall Study|Withdrawal by Subject|0|||
131041015|NCT05147116|471785400|FG001|Overall Study|Withdrawal by Subject|1|||
130961366|NCT00451282|471487175|FG001|Overall Study|Lost to Follow-up|5|||
131127323|NCT03972969|472095945|FG002|6-month Follow-up|Lost to Follow-up|2|||
131127324|NCT00732303|472095946|FG000|Overall Study|Study Terminated|2|||
131127325|NCT00264875|472095947|FG000|Overall Study|Adverse Event|6|||
131127326|NCT00264875|472095947|FG000|Overall Study|Lost to Follow-up|6|||
131127327|NCT00264875|472095947|FG000|Overall Study|Protocol Violation|11|||
131226423|NCT00950599|472455728|FG004|Follow-Up Period|Subject withdrew Consent|0|||
130961367|NCT00577122|471487176|FG000|Overall Study|Adverse Event|0|||
130961368|NCT00577122|471487177|FG001|Overall Study|Adverse Event|2|||
130961369|NCT00577122|471487176|FG000|Overall Study|Progression, relapse during active trt|6|||
130961370|NCT00577122|471487177|FG001|Overall Study|Progression, relapse during active trt|8|||
130961371|NCT00577122|471487176|FG000|Overall Study|Prog, refract disease during active trt|8|||
130961372|NCT00577122|471487177|FG001|Overall Study|Prog, refract disease during active trt|5|||
130961373|NCT00577122|471487176|FG000|Overall Study|Alternative Therapy|0|||
130961374|NCT00577122|471487177|FG001|Overall Study|Alternative Therapy|1|||
130961375|NCT00440271|471487179|FG000|Overall Study|Protocol Violation|1|||
130961376|NCT00440271|471487180|FG001|Overall Study|Protocol Violation|1|||
130961377|NCT00440271|471487179|FG000|Overall Study|Adverse Event|0|||
130961378|NCT00440271|471487180|FG001|Overall Study|Adverse Event|1|||
130961379|NCT00440271|471487179|FG000|Overall Study|Lost to Follow-up|1|||
130961380|NCT00440271|471487180|FG001|Overall Study|Lost to Follow-up|0|||
130961381|NCT00440271|471487179|FG000|Overall Study|Withdrawal by Subject|0|||
130961382|NCT00440271|471487180|FG001|Overall Study|Withdrawal by Subject|2|||
130961383|NCT00440271|471487179|FG000|Overall Study|Lack of Efficacy|0|||
130961384|NCT00440271|471487180|FG001|Overall Study|Lack of Efficacy|1|||
130961385|NCT00440271|471487179|FG000|Overall Study|Due to closure of trial|8|||
130961386|NCT00440271|471487180|FG001|Overall Study|Due to closure of trial|10|||
131041016|NCT04197336|471785401|FG000|Overall Study|Withdrawal by Subject|1|||
131041017|NCT05868382|471785402|FG000|Overall Study|Lost to Follow-up|5|||
131127328|NCT00264875|472095947|FG000|Overall Study|Withdrawal by Subject|7|||
131127329|NCT01074190|472095948|FG000|Overall Study|Emergency Cesarean Delivery|1|||
131127330|NCT01074190|472095949|FG001|Overall Study|Emergency Cesarean Delivery|2|||
130961387|NCT00440271|471487179|FG000|Overall Study|Other|2|||
130961388|NCT00440271|471487180|FG001|Overall Study|Other|0|||
130961389|NCT00723801|471487188|FG000|Overall Study|Lost to Follow-up|1|||
130961390|NCT00723801|471487189|FG001|Overall Study|Lost to Follow-up|2|||
130961391|NCT00723801|471487188|FG000|Overall Study|Protocol Violation|2|||
131041018|NCT05868382|471785403|FG001|Overall Study|Lost to Follow-up|0|||
131041019|NCT05868382|471785404|FG002|Overall Study|Lost to Follow-up|6|||
131041020|NCT05868382|471785405|FG003|Overall Study|Lost to Follow-up|4|||
131041021|NCT05868382|471785406|FG004|Overall Study|Lost to Follow-up|2|||
131041022|NCT05868382|471785407|FG005|Overall Study|Lost to Follow-up|6|||
130961392|NCT00723801|471487189|FG001|Overall Study|Protocol Violation|1|||
130961393|NCT01565993|471487198|FG000|Overall Study|Physician Decision|0|||
130961394|NCT01565993|471487199|FG001|Overall Study|Physician Decision|3|||
130961395|NCT01824303|471487200|FG000|Randomized Study|Withdrawal by Subject|1|||
130961396|NCT01824303|471487201|FG001|Randomized Study|Withdrawal by Subject|1|||
130961397|NCT01824303|471487200|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
130961398|NCT01824303|471487201|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
130961399|NCT02809976|471487202|FG000|Overall Study|Lost to Follow-up|1|||
130961400|NCT02809976|471487202|FG000|Overall Study|Withdrawal by Subject|1|||
130961401|NCT00113516|471487203|FG000|Part 1|Adverse Event|6|||
130961402|NCT00113516|471487204|FG001|Part 1|Adverse Event|0|||
130961403|NCT00113516|471487203|FG000|Part 1|Death|3|||
131041023|NCT05868382|471785402|FG000|Overall Study|Withdrawal by Subject|1|||
131041024|NCT05868382|471785403|FG001|Overall Study|Withdrawal by Subject|0|||
131041025|NCT05868382|471785404|FG002|Overall Study|Withdrawal by Subject|0|||
131041026|NCT05868382|471785405|FG003|Overall Study|Withdrawal by Subject|0|||
131041027|NCT05868382|471785406|FG004|Overall Study|Withdrawal by Subject|1|||
131041028|NCT05868382|471785407|FG005|Overall Study|Withdrawal by Subject|0|||
131041029|NCT04585815|471785408|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
131041030|NCT04585815|471785409|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
131041031|NCT04585815|471785410|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
131041032|NCT04585815|471785411|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
131041033|NCT04585815|471785412|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
131041034|NCT04585815|471785413|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
131041035|NCT04585815|471785414|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
131041036|NCT04585815|471785408|FG000|Sub-study A- Treatment Phase|Death|0|||
131041037|NCT04585815|471785409|FG001|Sub-study A- Treatment Phase|Death|1|||
131041038|NCT04585815|471785410|FG002|Sub-study A- Treatment Phase|Death|0|||
131041039|NCT04585815|471785411|FG003|Sub-study A- Treatment Phase|Death|0|||
131041040|NCT04585815|471785412|FG004|Sub-study A- Treatment Phase|Death|0|||
131041041|NCT04585815|471785413|FG005|Sub-study A- Treatment Phase|Death|0|||
131041042|NCT04585815|471785414|FG006|Sub-study A- Treatment Phase|Death|0|||
131041043|NCT04585815|471785408|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
131041044|NCT04585815|471785409|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131041045|NCT04585815|471785410|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131041046|NCT04585815|471785411|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131041047|NCT04585815|471785412|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131041048|NCT04585815|471785413|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131041049|NCT04585815|471785414|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
131041050|NCT04585815|471785408|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131041051|NCT04585815|471785409|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
131041052|NCT04585815|471785410|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131041053|NCT04585815|471785411|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131041054|NCT04585815|471785412|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131041055|NCT04585815|471785413|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131041056|NCT04585815|471785414|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
131041057|NCT04585815|471785408|FG000|Sub-study A- Treatment Phase|Other|1|||
131041058|NCT04585815|471785409|FG001|Sub-study A- Treatment Phase|Other|0|||
131041059|NCT04585815|471785410|FG002|Sub-study A- Treatment Phase|Other|0|||
131041060|NCT04585815|471785411|FG003|Sub-study A- Treatment Phase|Other|0|||
131041061|NCT04585815|471785412|FG004|Sub-study A- Treatment Phase|Other|0|||
131041062|NCT04585815|471785413|FG005|Sub-study A- Treatment Phase|Other|0|||
131041063|NCT04585815|471785414|FG006|Sub-study A- Treatment Phase|Other|0|||
131041064|NCT04585815|471785408|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
131041065|NCT04585815|471785409|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
131041066|NCT04585815|471785410|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
131041067|NCT04585815|471785411|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
131041068|NCT04585815|471785412|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
131041069|NCT04585815|471785413|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
131041070|NCT04585815|471785414|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
131041071|NCT04585815|471785408|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131041072|NCT04585815|471785409|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
131041073|NCT04585815|471785410|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131041074|NCT04585815|471785411|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131041075|NCT04585815|471785412|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131041076|NCT04585815|471785413|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131041077|NCT04585815|471785414|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
131041078|NCT04585815|471785408|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
130961404|NCT00113516|471487204|FG001|Part 1|Death|0|||
130961405|NCT00113516|471487203|FG000|Part 1|Other|3|||
130961406|NCT00113516|471487204|FG001|Part 1|Other|0|||
130961407|NCT00113516|471487203|FG000|Part 1|Withdrawal by Subject|2|||
130961408|NCT00113516|471487204|FG001|Part 1|Withdrawal by Subject|0|||
130961409|NCT00113516|471487203|FG000|Part 1|Lack of Efficacy|2|||
130961410|NCT00113516|471487204|FG001|Part 1|Lack of Efficacy|0|||
130961411|NCT00113516|471487203|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
130961412|NCT00113516|471487204|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
130961413|NCT00113516|471487203|FG000|Part 1|Laboratory Abnormality|1|||
130961414|NCT00113516|471487204|FG001|Part 1|Laboratory Abnormality|0|||
130961415|NCT00113516|471487203|FG000|Part 1|Ongoing|1|||
130961416|NCT00113516|471487204|FG001|Part 1|Ongoing|0|||
130961417|NCT00113516|471487203|FG000|Part 1|Missing|65|||
130961418|NCT00113516|471487204|FG001|Part 1|Missing|0|||
130961419|NCT00113516|471487203|FG000|Part 2|Adverse Event|0|||
130961420|NCT00113516|471487204|FG001|Part 2|Adverse Event|16|||
130961421|NCT00113516|471487203|FG000|Part 2|Death|0|||
130961422|NCT00113516|471487204|FG001|Part 2|Death|5|||
130961423|NCT00113516|471487203|FG000|Part 2|Lack of Efficacy|0|||
130961424|NCT00113516|471487204|FG001|Part 2|Lack of Efficacy|37|||
130961425|NCT00113516|471487203|FG000|Part 2|Withdrawal by Subject|0|||
130961426|NCT00113516|471487204|FG001|Part 2|Withdrawal by Subject|3|||
130961427|NCT00113516|471487203|FG000|Part 2|Other|0|||
130961428|NCT00113516|471487204|FG001|Part 2|Other|3|||
130961429|NCT00113516|471487203|FG000|Part 2|Laboratory Abnormality|0|||
130961430|NCT00113516|471487204|FG001|Part 2|Laboratory Abnormality|1|||
130961431|NCT00113516|471487203|FG000|Part 2|Ongoing|0|||
130961432|NCT00113516|471487204|FG001|Part 2|Ongoing|1|||
130961433|NCT00642304|471487205|FG000|Overall Study|Adverse Event|1|||
130961434|NCT00642304|471487205|FG000|Overall Study|Death|1|||
130961435|NCT00642304|471487205|FG000|Overall Study|Blood transfusion|2|||
130961436|NCT00642304|471487205|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
130961437|NCT00642304|471487205|FG000|Overall Study|Transplantation|1|||
130961438|NCT00812812|471487206|FG000|Overall Study|Adverse Event|2|||
130961439|NCT00812812|471487207|FG001|Overall Study|Adverse Event|1|||
130961440|NCT00812812|471487206|FG000|Overall Study|Lack of Efficacy|1|||
130961441|NCT00812812|471487207|FG001|Overall Study|Lack of Efficacy|0|||
130961442|NCT00812812|471487206|FG000|Overall Study|Lost to Follow-up|0|||
130961443|NCT00812812|471487207|FG001|Overall Study|Lost to Follow-up|1|||
130961444|NCT00812812|471487206|FG000|Overall Study|Withdrawal by Subject|0|||
130961445|NCT00812812|471487207|FG001|Overall Study|Withdrawal by Subject|2|||
130961446|NCT01412424|471487211|FG000|Core Treatment Period|Treatment Failure|24|||
130961447|NCT01412424|471487211|FG000|Core Treatment Period|Adverse Event|21|||
130961448|NCT01412424|471487211|FG000|Core Treatment Period|Patient Request|5|||
130961449|NCT01412424|471487211|FG000|Core Treatment Period|Lost to Follow-up|2|||
130961450|NCT01412424|471487211|FG000|Core Treatment Period|Sponsor Request|1|||
130961451|NCT01412424|471487211|FG000|Extension Treatment Period|Adverse Event|2|||
130961452|NCT01412424|471487211|FG000|Extension Treatment Period|Treatment Failure|2|||
130961453|NCT01412424|471487211|FG000|Extension Treatment Period|Patient Request|2|||
130961454|NCT00684424|471487220|FG000|Overall Study|Adverse Event|1|||
130961455|NCT00684424|471487220|FG000|Overall Study|Lost to Follow-up|2|||
130961456|NCT00684424|471487220|FG000|Overall Study|Other|2|||
130961457|NCT02410811|471487221|FG000|Overall Study|Withdrawal by Subject|0|||
130961458|NCT02410811|471487222|FG001|Overall Study|Withdrawal by Subject|0|||
130961459|NCT02410811|471487223|FG002|Overall Study|Withdrawal by Subject|1|||
130961460|NCT02410811|471487224|FG003|Overall Study|Withdrawal by Subject|0|||
130961461|NCT01752933|471487227|FG000|Treatment|Disease Progression|3|||
130961462|NCT01752933|471487228|FG001|Treatment|Disease Progression|29|||
130961463|NCT01752933|471487227|FG000|Treatment|Withdrawal by Subject|0|||
130961464|NCT01752933|471487228|FG001|Treatment|Withdrawal by Subject|5|||
130961465|NCT01752933|471487227|FG000|Treatment|Adverse Event|1|||
130961466|NCT01752933|471487228|FG001|Treatment|Adverse Event|4|||
130961467|NCT01752933|471487227|FG000|Treatment|Physician Decision|0|||
130961468|NCT01752933|471487228|FG001|Treatment|Physician Decision|3|||
130961469|NCT01752933|471487227|FG000|Treatment|Death|0|||
130961470|NCT01752933|471487228|FG001|Treatment|Death|2|||
130961471|NCT01752933|471487227|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
130961472|NCT01752933|471487228|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
130961473|NCT01752933|471487227|FG000|Treatment|Patient noncompliant|0|||
130961474|NCT01752933|471487228|FG001|Treatment|Patient noncompliant|1|||
130961475|NCT01752933|471487227|FG000|Treatment|Patient unable to travel to appointments|0|||
130961476|NCT01752933|471487228|FG001|Treatment|Patient unable to travel to appointments|1|||
130961477|NCT01752933|471487227|FG000|Overall Study and Follow-up|Death|4|||
130961478|NCT01752933|471487228|FG001|Overall Study and Follow-up|Death|34|||
130961479|NCT01752933|471487227|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
130961480|NCT01752933|471487228|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
130961481|NCT01752933|471487227|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
130961482|NCT01752933|471487228|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
130961483|NCT01752933|471487227|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
130961484|NCT01752933|471487228|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
130961485|NCT03181542|471487229|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
130714630|NCT01246011|470581728|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
130714631|NCT01246011|470581729|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
130714632|NCT01246011|470581730|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
130714633|NCT01246011|470581728|FG000|Overall Study|Withdrawal by Subject|0|||
130714634|NCT01246011|470581729|FG001|Overall Study|Withdrawal by Subject|0|||
130714635|NCT01246011|470581730|FG002|Overall Study|Withdrawal by Subject|1|||
130714636|NCT04492020|470581731|FG000|Overall Study|Adverse Event|1|||
130714637|NCT04492020|470581732|FG001|Overall Study|Adverse Event|3|||
130714638|NCT04492020|470581731|FG000|Overall Study|Withdrawal by Subject|4|||
130714639|NCT04492020|470581732|FG001|Overall Study|Withdrawal by Subject|3|||
130714640|NCT04492020|470581731|FG000|Overall Study|Lost to Follow-up|4|||
130714641|NCT04492020|470581732|FG001|Overall Study|Lost to Follow-up|3|||
130714642|NCT04492020|470581731|FG000|Overall Study|Protocol Violation|5|||
130714643|NCT04492020|470581732|FG001|Overall Study|Protocol Violation|2|||
130714644|NCT04492020|470581731|FG000|Overall Study|Lack of Qualifying Event|25|||
130714645|NCT04492020|470581732|FG001|Overall Study|Lack of Qualifying Event|27|||
130714646|NCT04492020|470581731|FG000|Overall Study|Non-compliance with Study Drug|2|||
130714647|NCT04492020|470581732|FG001|Overall Study|Non-compliance with Study Drug|1|||
130714648|NCT02792959|470581737|FG000|Overall Study|Protocol Violation|1|||
130714649|NCT03914950|470581741|FG000|Overall Study|Physician Decision|54|||
130714650|NCT02575911|470581742|FG000|Overall Study|Lost to Follow-up|1|||
130714651|NCT01249365|470581743|FG000|Overall Study|Lost to Follow-up|1|||
130714652|NCT01460901|470581744|FG000|Overall Study|Withdrawal by Subject|2|||
130714653|NCT02566993|470581745|FG000|Overall Study|Randomized but not treated|5|||
130714654|NCT02566993|470581746|FG001|Overall Study|Randomized but not treated|16|||
130714655|NCT02566993|470581745|FG000|Overall Study|Progressive disease|213|||
130714656|NCT02566993|470581746|FG001|Overall Study|Progressive disease|152|||
130714657|NCT02566993|470581745|FG000|Overall Study|Withdrawal by Subject|12|||
130714658|NCT02566993|470581746|FG001|Overall Study|Withdrawal by Subject|28|||
130714659|NCT02566993|470581745|FG000|Overall Study|Death|17|||
130714660|NCT02566993|470581746|FG001|Overall Study|Death|23|||
130714661|NCT02566993|470581745|FG000|Overall Study|Physician Decision|10|||
130714662|NCT02566993|470581746|FG001|Overall Study|Physician Decision|17|||
130714663|NCT02566993|470581745|FG000|Overall Study|Study drug-related adverse event|20|||
130714664|NCT02566993|470581746|FG001|Overall Study|Study drug-related adverse event|41|||
130714665|NCT02566993|470581745|FG000|Overall Study|Non study drug-related adverse event|9|||
130961486|NCT03181542|471487230|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
130961487|NCT01071512|471487231|FG000|Overall Study|Adverse Event|1|||
130961488|NCT01071512|471487231|FG000|Overall Study|Development of antibodies to drug|2|||
130961489|NCT01071512|471487231|FG000|Overall Study|positive anti-JC virus antibody test|2|||
130961490|NCT00853658|471487237|FG000|Overall Study|Death|713|||
130961491|NCT00853658|471487238|FG001|Overall Study|Death|768|||
130961492|NCT00853658|471487239|FG002|Overall Study|Death|753|||
130961493|NCT00853658|471487237|FG000|Overall Study|Lost to Follow-up|11|||
130961494|NCT00853658|471487238|FG001|Overall Study|Lost to Follow-up|6|||
130961495|NCT00853658|471487239|FG002|Overall Study|Lost to Follow-up|11|||
130961496|NCT00853658|471487237|FG000|Overall Study|H.A. Request|26|||
130961497|NCT00853658|471487238|FG001|Overall Study|H.A. Request|23|||
130961498|NCT00853658|471487239|FG002|Overall Study|H.A. Request|19|||
131127331|NCT01074190|472095950|FG002|Overall Study|Emergency Cesarean Delivery|1|||
131127332|NCT01074190|472095948|FG000|Overall Study|Protocol Violation|2|||
131127333|NCT01074190|472095949|FG001|Overall Study|Protocol Violation|1|||
131127334|NCT01074190|472095950|FG002|Overall Study|Protocol Violation|0|||
131127335|NCT01074190|472095948|FG000|Overall Study|Delivered in under 90 minutes|0|||
131127336|NCT01074190|472095949|FG001|Overall Study|Delivered in under 90 minutes|2|||
130714666|NCT02566993|470581746|FG001|Overall Study|Non study drug-related adverse event|9|||
130961499|NCT00853658|471487237|FG000|Overall Study|IRB request|0|||
130961500|NCT00853658|471487238|FG001|Overall Study|IRB request|0|||
130961501|NCT00853658|471487239|FG002|Overall Study|IRB request|2|||
130961502|NCT00853658|471487237|FG000|Overall Study|Vital Status known (alive) at study end|2|||
130961503|NCT00853658|471487238|FG001|Overall Study|Vital Status known (alive) at study end|3|||
130714667|NCT02566993|470581745|FG000|Overall Study|Symptomatic deterioration|9|||
130714668|NCT02566993|470581746|FG001|Overall Study|Symptomatic deterioration|16|||
130714669|NCT02566993|470581745|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
130720902|NCT01341782|470601557|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
130961504|NCT00853658|471487239|FG002|Overall Study|Vital Status known (alive) at study end|3|||
131127337|NCT01074190|472095950|FG002|Overall Study|Delivered in under 90 minutes|1|||
131127338|NCT01074190|472095948|FG000|Overall Study|Subject withdrew consent|1|||
131127339|NCT01074190|472095949|FG001|Overall Study|Subject withdrew consent|1|||
131041079|NCT04585815|471785409|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
131041080|NCT04585815|471785410|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
131041081|NCT04585815|471785411|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
131041082|NCT04585815|471785412|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
131041083|NCT04585815|471785413|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
131041084|NCT04585815|471785414|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
131041085|NCT04585815|471785408|FG000|Sub-study B- Treatment Phase|Death|0|||
131041086|NCT04585815|471785409|FG001|Sub-study B- Treatment Phase|Death|0|||
131041087|NCT04585815|471785410|FG002|Sub-study B- Treatment Phase|Death|0|||
131041088|NCT04585815|471785411|FG003|Sub-study B- Treatment Phase|Death|1|||
131041089|NCT04585815|471785412|FG004|Sub-study B- Treatment Phase|Death|0|||
131041090|NCT04585815|471785413|FG005|Sub-study B- Treatment Phase|Death|0|||
131041091|NCT04585815|471785414|FG006|Sub-study B- Treatment Phase|Death|0|||
131041092|NCT04585815|471785408|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
131041093|NCT04585815|471785409|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
131041094|NCT04585815|471785410|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
131041095|NCT04585815|471785411|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
131041096|NCT04585815|471785412|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
131041097|NCT04585815|471785413|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
131041098|NCT04585815|471785414|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
131041099|NCT04585815|471785408|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131041100|NCT04585815|471785409|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131041101|NCT04585815|471785410|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131041102|NCT04585815|471785411|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
131041103|NCT04585815|471785412|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131041104|NCT04585815|471785413|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131041105|NCT04585815|471785414|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
131041106|NCT04585815|471785408|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131041107|NCT04585815|471785409|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131041108|NCT04585815|471785410|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131041109|NCT04585815|471785411|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131041110|NCT04585815|471785412|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131041111|NCT04585815|471785413|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
131041112|NCT04585815|471785414|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
131041113|NCT04585815|471785408|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
131041114|NCT04585815|471785409|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
131041115|NCT04585815|471785410|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
131041116|NCT04585815|471785411|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
131041117|NCT04585815|471785412|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
131041118|NCT04585815|471785413|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
131041119|NCT04585815|471785414|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
131041120|NCT04585815|471785408|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
131127340|NCT01074190|472095950|FG002|Overall Study|Subject withdrew consent|1|||
131127341|NCT02409290|472095954|FG000|Overall Study|Protocol Violation|3|||
131127342|NCT02409290|472095955|FG001|Overall Study|Protocol Violation|6|||
131127343|NCT02409290|472095956|FG002|Overall Study|Protocol Violation|9|||
131127344|NCT02409290|472095957|FG003|Overall Study|Protocol Violation|4|||
131127345|NCT02409290|472095954|FG000|Overall Study|No positive culture/no baseline sample|3|||
131127346|NCT02409290|472095955|FG001|Overall Study|No positive culture/no baseline sample|9|||
131127347|NCT02409290|472095956|FG002|Overall Study|No positive culture/no baseline sample|6|||
131127348|NCT02409290|472095957|FG003|Overall Study|No positive culture/no baseline sample|5|||
131127349|NCT02409290|472095954|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
131127350|NCT02409290|472095955|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
131127351|NCT02409290|472095956|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
131127352|NCT02409290|472095957|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
131127353|NCT00708500|472095958|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
131127354|NCT00708500|472095959|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
131127355|NCT00708500|472095960|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
131127356|NCT00708500|472095958|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
131127357|NCT00708500|472095959|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
131127358|NCT00708500|472095960|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
131127359|NCT00708500|472095958|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
131041121|NCT04585815|471785409|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
131041122|NCT04585815|471785410|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
131041123|NCT04585815|471785411|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
131041124|NCT04585815|471785412|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
131041125|NCT04585815|471785413|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
130961505|NCT00853658|471487237|FG000|Overall Study|Vital Status unknown at study end|1|||
130961506|NCT00853658|471487238|FG001|Overall Study|Vital Status unknown at study end|1|||
130961507|NCT00853658|471487239|FG002|Overall Study|Vital Status unknown at study end|0|||
130961508|NCT00853658|471487237|FG000|Overall Study|Vital Status at study end N/A|8|||
130714670|NCT02566993|470581746|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
130961509|NCT00853658|471487238|FG001|Overall Study|Vital Status at study end N/A|10|||
130961510|NCT00853658|471487239|FG002|Overall Study|Vital Status at study end N/A|10|||
130961511|NCT00853658|471487237|FG000|Overall Study|Patient's request|21|||
130961512|NCT00853658|471487238|FG001|Overall Study|Patient's request|17|||
131041126|NCT04585815|471785414|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
131041127|NCT04585815|471785408|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
131041128|NCT04585815|471785409|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
131041129|NCT04585815|471785410|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
131041130|NCT04585815|471785411|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
131041131|NCT04585815|471785412|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
131041132|NCT04585815|471785413|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
131041133|NCT04585815|471785414|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
131041134|NCT04585815|471785408|FG000|Sub-study B- Follow-up Phase|Death|0|||
131041135|NCT04585815|471785409|FG001|Sub-study B- Follow-up Phase|Death|0|||
131041136|NCT04585815|471785410|FG002|Sub-study B- Follow-up Phase|Death|1|||
131041137|NCT04585815|471785411|FG003|Sub-study B- Follow-up Phase|Death|3|||
131041138|NCT04585815|471785412|FG004|Sub-study B- Follow-up Phase|Death|0|||
131041139|NCT04585815|471785413|FG005|Sub-study B- Follow-up Phase|Death|0|||
131041140|NCT04585815|471785414|FG006|Sub-study B- Follow-up Phase|Death|1|||
131041141|NCT01221948|471785422|FG000|Overall Study|Physician Decision|5|||
131041142|NCT01221948|471785422|FG000|Overall Study|Withdrawal by Subject|2|||
131041143|NCT01221948|471785422|FG000|Overall Study|not disclosed|2|||
131041144|NCT01221948|471785422|FG000|Overall Study|Death|1|||
131041145|NCT01221948|471785422|FG000|Overall Study|Protocol Violation|4|||
131041146|NCT00746096|471785423|FG000|Overall Study|Adverse Event|1|||
131041147|NCT00746096|471785424|FG001|Overall Study|Adverse Event|0|||
131041148|NCT00746096|471785423|FG000|Overall Study|Withdrawal by Subject|5|||
131041149|NCT00746096|471785424|FG001|Overall Study|Withdrawal by Subject|1|||
131041150|NCT00746096|471785423|FG000|Overall Study|Lost to Follow-up|2|||
131041151|NCT00746096|471785424|FG001|Overall Study|Lost to Follow-up|1|||
131041152|NCT00746096|471785423|FG000|Overall Study|Protocol Violation|1|||
131041153|NCT00746096|471785424|FG001|Overall Study|Protocol Violation|0|||
131041154|NCT00746096|471785423|FG000|Overall Study|No study drug treatment|1|||
131041155|NCT00746096|471785424|FG001|Overall Study|No study drug treatment|1|||
131041156|NCT04295512|471785425|FG000|Overall Study|Lack of family response to schedule assessment|0|||
131041157|NCT04295512|471785426|FG001|Overall Study|Lack of family response to schedule assessment|0|||
131041158|NCT04295512|471785427|FG002|Overall Study|Lack of family response to schedule assessment|0|||
131041159|NCT04295512|471785428|FG003|Overall Study|Lack of family response to schedule assessment|2|||
131041160|NCT04295512|471785425|FG000|Overall Study|Therapist did not refer eligible family|7|||
131041161|NCT04295512|471785426|FG001|Overall Study|Therapist did not refer eligible family|7|||
131041162|NCT04295512|471785427|FG002|Overall Study|Therapist did not refer eligible family|0|||
131041163|NCT04295512|471785428|FG003|Overall Study|Therapist did not refer eligible family|0|||
131041164|NCT03571581|471785433|FG000|Overall Study|Death|2|||
131041165|NCT03571581|471785433|FG000|Overall Study|Withdrawal by Subject|2|||
131041166|NCT01309672|471785435|FG000|Overall Study|Lack of Efficacy|20|||
131041167|NCT01309672|471785435|FG000|Overall Study|Other|9|||
131041168|NCT01309672|471785435|FG000|Overall Study|Adverse Event|5|||
131041169|NCT01309672|471785435|FG000|Overall Study|Withdrawal by Subject|3|||
131041170|NCT05623228|471785437|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
131041171|NCT05623228|471785438|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131041172|NCT05623228|471785439|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131041173|NCT05623228|471785440|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131041174|NCT05623228|471785441|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131041175|NCT05623228|471785442|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131041176|NCT05623228|471785443|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131041177|NCT05623228|471785444|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
131041178|NCT05623228|471785437|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
131041179|NCT05623228|471785438|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
131041180|NCT05623228|471785439|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
131226424|NCT00950599|472455729|FG005|Follow-Up Period|Subject withdrew Consent|0|||
131041181|NCT05623228|471785440|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
131041182|NCT05623228|471785441|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
131041183|NCT05623228|471785442|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
131041184|NCT05623228|471785443|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
131041185|NCT05623228|471785444|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
130720903|NCT01341782|470601558|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
131041186|NCT04625725|471785445|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
130961513|NCT00853658|471487239|FG002|Overall Study|Patient's request|11|||
130961514|NCT00853658|471487237|FG000|Overall Study|Missing study completion information|5|||
130961515|NCT00853658|471487238|FG001|Overall Study|Missing study completion information|4|||
130961516|NCT00853658|471487239|FG002|Overall Study|Missing study completion information|6|||
130961517|NCT01643473|471489541|FG000|Overall Study|Lost to Follow-up|1|||
130961518|NCT01643473|471489542|FG001|Overall Study|Lost to Follow-up|0|||
130961519|NCT02343458|471489546|FG000|Overall Study|Adverse Event|15|||
130961520|NCT02343458|471489547|FG001|Overall Study|Adverse Event|14|||
130961521|NCT02343458|471489548|FG002|Overall Study|Adverse Event|15|||
130961522|NCT02343458|471489549|FG003|Overall Study|Adverse Event|3|||
130961523|NCT02343458|471489546|FG000|Overall Study|Lack of Efficacy|3|||
130961524|NCT02343458|471489547|FG001|Overall Study|Lack of Efficacy|8|||
130961525|NCT02343458|471489548|FG002|Overall Study|Lack of Efficacy|4|||
130961526|NCT02343458|471489549|FG003|Overall Study|Lack of Efficacy|8|||
130961527|NCT02343458|471489546|FG000|Overall Study|Withdrawal by Subject|18|||
130961528|NCT02343458|471489547|FG001|Overall Study|Withdrawal by Subject|17|||
130961529|NCT02343458|471489548|FG002|Overall Study|Withdrawal by Subject|23|||
130961530|NCT02343458|471489549|FG003|Overall Study|Withdrawal by Subject|14|||
131127360|NCT00708500|472095959|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
130961531|NCT02343458|471489546|FG000|Overall Study|Physician Decision|1|||
131127361|NCT00708500|472095960|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
131127362|NCT00708500|472095958|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
131127363|NCT00708500|472095959|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
131127364|NCT00708500|472095960|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
131127365|NCT00708500|472095958|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
131127366|NCT00708500|472095959|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
130961532|NCT02343458|471489547|FG001|Overall Study|Physician Decision|4|||
130961533|NCT02343458|471489548|FG002|Overall Study|Physician Decision|2|||
130961534|NCT02343458|471489549|FG003|Overall Study|Physician Decision|2|||
130961535|NCT02343458|471489546|FG000|Overall Study|Lost to Follow-up|5|||
130961536|NCT02343458|471489547|FG001|Overall Study|Lost to Follow-up|5|||
130961537|NCT02343458|471489548|FG002|Overall Study|Lost to Follow-up|3|||
130961538|NCT02343458|471489549|FG003|Overall Study|Lost to Follow-up|1|||
130961539|NCT02343458|471489546|FG000|Overall Study|Protocol Violation|2|||
130961540|NCT02343458|471489547|FG001|Overall Study|Protocol Violation|5|||
130961541|NCT02343458|471489548|FG002|Overall Study|Protocol Violation|2|||
130961542|NCT02343458|471489549|FG003|Overall Study|Protocol Violation|2|||
130961543|NCT02343458|471489546|FG000|Overall Study|Protocol Specified Criteria|17|||
130961544|NCT02343458|471489547|FG001|Overall Study|Protocol Specified Criteria|13|||
130961545|NCT02343458|471489548|FG002|Overall Study|Protocol Specified Criteria|14|||
130961546|NCT02343458|471489549|FG003|Overall Study|Protocol Specified Criteria|8|||
130961547|NCT01265953|471489550|FG000|Overall Study|Non compliance|5|||
130961548|NCT01265953|471489551|FG001|Overall Study|Non compliance|3|||
130961549|NCT02648698|471489553|FG000|Overall Study|Protocol Violation|1|||
130961550|NCT02648698|471489554|FG001|Overall Study|Protocol Violation|5|||
130961551|NCT01640301|471489555|FG000|Overall Study|Death|0|||
130961552|NCT01640301|471489556|FG001|Overall Study|Death|8|||
130961553|NCT02391948|471489561|FG000|6-month Assessment|Death|0|||
130961554|NCT02391948|471489562|FG001|6-month Assessment|Death|0|||
130961555|NCT02391948|471489563|FG002|6-month Assessment|Death|0|||
130961556|NCT02391948|471489564|FG003|6-month Assessment|Death|0|||
130961557|NCT02391948|471489565|FG004|6-month Assessment|Death|1|||
130961558|NCT02391948|471489561|FG000|6-month Assessment|Withdrawal by Subject|0|||
130961559|NCT02391948|471489562|FG001|6-month Assessment|Withdrawal by Subject|0|||
130961560|NCT02391948|471489563|FG002|6-month Assessment|Withdrawal by Subject|1|||
130961561|NCT02391948|471489564|FG003|6-month Assessment|Withdrawal by Subject|2|||
130961562|NCT02391948|471489565|FG004|6-month Assessment|Withdrawal by Subject|0|||
130961563|NCT02391948|471489561|FG000|6-month Assessment|Lost to Follow-up|4|||
130961564|NCT02391948|471489562|FG001|6-month Assessment|Lost to Follow-up|5|||
130961565|NCT02391948|471489563|FG002|6-month Assessment|Lost to Follow-up|2|||
130961566|NCT02391948|471489564|FG003|6-month Assessment|Lost to Follow-up|3|||
130961567|NCT02391948|471489565|FG004|6-month Assessment|Lost to Follow-up|1|||
131127367|NCT00708500|472095960|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
130961568|NCT02391948|471489561|FG000|6-month Assessment|Medical issue/illness|1|||
130961569|NCT02391948|471489562|FG001|6-month Assessment|Medical issue/illness|1|||
130961570|NCT02391948|471489563|FG002|6-month Assessment|Medical issue/illness|0|||
130961571|NCT02391948|471489564|FG003|6-month Assessment|Medical issue/illness|0|||
130961572|NCT02391948|471489565|FG004|6-month Assessment|Medical issue/illness|0|||
130961573|NCT02391948|471489561|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
130961574|NCT02391948|471489562|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
130961575|NCT02391948|471489563|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
130961576|NCT02391948|471489564|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
130961577|NCT02391948|471489565|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
130961578|NCT02391948|471489561|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
130714671|NCT02566993|470581745|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
130714672|NCT02566993|470581746|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
130714673|NCT02566993|470581745|FG000|Overall Study|Screening failure|2|||
130714674|NCT02566993|470581746|FG001|Overall Study|Screening failure|0|||
130714675|NCT02566993|470581745|FG000|Overall Study|Lost to Follow-up|0|||
130714676|NCT02566993|470581746|FG001|Overall Study|Lost to Follow-up|1|||
130714677|NCT02566993|470581745|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
130714678|NCT02566993|470581746|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
130714679|NCT01169532|470581748|FG000|Overall Study|Withdrawal by Subject|1|||
130714680|NCT03127644|470581759|FG000|Overall Study|Study-specific withdrawal criteria|0|||
130714681|NCT03127644|470581760|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130714682|NCT03127644|470581761|FG002|Overall Study|Study-specific withdrawal criteria|2|||
130714683|NCT01550744|470581762|FG000|Open-Label|Lost to Follow-up|7|||
130714684|NCT01550744|470581763|FG001|Open-Label|Lost to Follow-up|0|||
130961579|NCT02391948|471489562|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
130714685|NCT01550744|470581764|FG002|Open-Label|Lost to Follow-up|0|||
130714686|NCT01550744|470581762|FG000|Open-Label|Withdrawal by Subject|13|||
130714687|NCT01550744|470581763|FG001|Open-Label|Withdrawal by Subject|0|||
130714688|NCT01550744|470581764|FG002|Open-Label|Withdrawal by Subject|0|||
130714689|NCT01550744|470581762|FG000|Open-Label|Adverse Event|11|||
130714690|NCT01550744|470581763|FG001|Open-Label|Adverse Event|0|||
130714691|NCT01550744|470581764|FG002|Open-Label|Adverse Event|0|||
130714692|NCT01550744|470581762|FG000|Open-Label|Lack of Efficacy|4|||
130714693|NCT01550744|470581763|FG001|Open-Label|Lack of Efficacy|0|||
130714694|NCT01550744|470581764|FG002|Open-Label|Lack of Efficacy|0|||
130714695|NCT01550744|470581762|FG000|Open-Label|Protocol Violation|4|||
130714696|NCT01550744|470581763|FG001|Open-Label|Protocol Violation|0|||
130714697|NCT01550744|470581764|FG002|Open-Label|Protocol Violation|0|||
130714698|NCT01550744|470581762|FG000|Open-Label|Not all 3 study drug injections received|2|||
130714699|NCT01550744|470581763|FG001|Open-Label|Not all 3 study drug injections received|0|||
130961580|NCT02391948|471489563|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
130961581|NCT02391948|471489564|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
130961582|NCT02391948|471489565|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
130961583|NCT02391948|471489561|FG000|12-month Assessment|Death|0|||
131226425|NCT00950599|472455730|FG006|Follow-Up Period|Subject withdrew Consent|0|||
131226426|NCT00950599|472455731|FG007|Follow-Up Period|Subject withdrew Consent|0|||
131226427|NCT00950599|472455732|FG008|Follow-Up Period|Subject withdrew Consent|2|||
131226428|NCT00950599|472455733|FG009|Follow-Up Period|Subject withdrew Consent|1|||
131226429|NCT00971204|472455734|FG000|Overall Study|Did not meet all criteria-not treated|14|||
131226430|NCT00971204|472455734|FG000|Overall Study|Lost to Follow-up|10|||
131226431|NCT02436135|472455735|FG000|Overall Study|Progressive Disease|3|||
131226432|NCT02436135|472455736|FG001|Overall Study|Progressive Disease|1|||
131226433|NCT02436135|472455735|FG000|Overall Study|Investigator Discretion|1|||
131226434|NCT02436135|472455736|FG001|Overall Study|Investigator Discretion|2|||
131226435|NCT02436135|472455735|FG000|Overall Study|Adverse Event|1|||
131226436|NCT02436135|472455736|FG001|Overall Study|Adverse Event|0|||
131226437|NCT02436135|472455735|FG000|Overall Study|Withdrawal by Participant|1|||
131226438|NCT02436135|472455736|FG001|Overall Study|Withdrawal by Participant|0|||
131226439|NCT02436135|472455735|FG000|Overall Study|Study Terminated By Sponsor|0|||
131226440|NCT02436135|472455736|FG001|Overall Study|Study Terminated By Sponsor|1|||
131226441|NCT00475852|472455737|FG000|Overall Study|Death|444|||
130714700|NCT01550744|470581764|FG002|Open-Label|Not all 3 study drug injections received|0|||
130714701|NCT01550744|470581762|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
130714702|NCT01550744|470581763|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
130714703|NCT01550744|470581764|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
130714704|NCT01550744|470581762|FG000|Open-Label|Other|1|||
130714705|NCT01550744|470581763|FG001|Open-Label|Other|0|||
130714706|NCT01550744|470581764|FG002|Open-Label|Other|0|||
130714707|NCT01550744|470581762|FG000|Double-Blind|Lost to Follow-up|0|||
130714708|NCT01550744|470581763|FG001|Double-Blind|Lost to Follow-up|6|||
130714709|NCT01550744|470581764|FG002|Double-Blind|Lost to Follow-up|12|||
130714710|NCT01550744|470581762|FG000|Double-Blind|Withdrawal by Subject|0|||
130714711|NCT01550744|470581763|FG001|Double-Blind|Withdrawal by Subject|2|||
130961584|NCT02391948|471489562|FG001|12-month Assessment|Death|0|||
131226442|NCT00475852|472455738|FG001|Overall Study|Death|456|||
131226443|NCT00475852|472455737|FG000|Overall Study|Withdrawal by Subject|19|||
131226444|NCT00475852|472455738|FG001|Overall Study|Withdrawal by Subject|24|||
131226445|NCT00475852|472455737|FG000|Overall Study|Lost to Follow-up|54|||
131226446|NCT00475852|472455738|FG001|Overall Study|Lost to Follow-up|68|||
130961585|NCT02391948|471489563|FG002|12-month Assessment|Death|0|||
130714712|NCT01550744|470581764|FG002|Double-Blind|Withdrawal by Subject|15|||
130714713|NCT01550744|470581762|FG000|Double-Blind|Adverse Event|0|||
130714714|NCT01550744|470581763|FG001|Double-Blind|Adverse Event|4|||
130714715|NCT01550744|470581764|FG002|Double-Blind|Adverse Event|15|||
130961586|NCT02391948|471489564|FG003|12-month Assessment|Death|1|||
130961587|NCT02391948|471489565|FG004|12-month Assessment|Death|0|||
130961588|NCT02391948|471489561|FG000|12-month Assessment|Withdrawal by Subject|1|||
130961589|NCT02391948|471489562|FG001|12-month Assessment|Withdrawal by Subject|0|||
130961590|NCT02391948|471489563|FG002|12-month Assessment|Withdrawal by Subject|0|||
130961591|NCT02391948|471489564|FG003|12-month Assessment|Withdrawal by Subject|1|||
130961592|NCT02391948|471489565|FG004|12-month Assessment|Withdrawal by Subject|0|||
130961593|NCT02391948|471489561|FG000|12-month Assessment|Lost to Follow-up|5|||
130961594|NCT02391948|471489562|FG001|12-month Assessment|Lost to Follow-up|4|||
130961595|NCT02391948|471489563|FG002|12-month Assessment|Lost to Follow-up|4|||
130961596|NCT02391948|471489564|FG003|12-month Assessment|Lost to Follow-up|4|||
130961597|NCT02391948|471489565|FG004|12-month Assessment|Lost to Follow-up|5|||
130961598|NCT02391948|471489561|FG000|12-month Assessment|Medical issue/illness|0|||
130961599|NCT02391948|471489562|FG001|12-month Assessment|Medical issue/illness|1|||
130961600|NCT02391948|471489563|FG002|12-month Assessment|Medical issue/illness|0|||
130961601|NCT02391948|471489564|FG003|12-month Assessment|Medical issue/illness|1|||
130961602|NCT02391948|471489565|FG004|12-month Assessment|Medical issue/illness|0|||
130961603|NCT02391948|471489561|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
130961604|NCT02391948|471489562|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
130961605|NCT02391948|471489563|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
130961606|NCT02391948|471489564|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
130961607|NCT02391948|471489565|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
130961608|NCT02391948|471489561|FG000|18-month Assessment|Death|0|||
130961609|NCT02391948|471489562|FG001|18-month Assessment|Death|0|||
130961610|NCT02391948|471489563|FG002|18-month Assessment|Death|0|||
130961611|NCT02391948|471489564|FG003|18-month Assessment|Death|1|||
130961612|NCT02391948|471489565|FG004|18-month Assessment|Death|1|||
130961613|NCT02391948|471489561|FG000|18-month Assessment|Withdrawal by Subject|1|||
130961614|NCT02391948|471489562|FG001|18-month Assessment|Withdrawal by Subject|0|||
130961615|NCT02391948|471489563|FG002|18-month Assessment|Withdrawal by Subject|0|||
130961616|NCT02391948|471489564|FG003|18-month Assessment|Withdrawal by Subject|1|||
130961617|NCT02391948|471489565|FG004|18-month Assessment|Withdrawal by Subject|0|||
130961618|NCT02391948|471489561|FG000|18-month Assessment|Lost to Follow-up|2|||
130961619|NCT02391948|471489562|FG001|18-month Assessment|Lost to Follow-up|6|||
130961620|NCT02391948|471489563|FG002|18-month Assessment|Lost to Follow-up|2|||
130961621|NCT02391948|471489564|FG003|18-month Assessment|Lost to Follow-up|2|||
130961622|NCT02391948|471489565|FG004|18-month Assessment|Lost to Follow-up|3|||
130961623|NCT02391948|471489561|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
130961624|NCT02391948|471489562|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
130961625|NCT02391948|471489563|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
130961626|NCT02391948|471489564|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
130961627|NCT02391948|471489565|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
130961628|NCT02391948|471489561|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
130961629|NCT02391948|471489562|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
130961630|NCT02391948|471489563|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
130961631|NCT02391948|471489564|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
130961632|NCT02391948|471489565|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
130961633|NCT02391948|471489561|FG000|24-month Assessment|Death|0|||
130961634|NCT02391948|471489562|FG001|24-month Assessment|Death|0|||
130961635|NCT02391948|471489563|FG002|24-month Assessment|Death|0|||
130961636|NCT02391948|471489564|FG003|24-month Assessment|Death|0|||
130961637|NCT02391948|471489565|FG004|24-month Assessment|Death|1|||
130961638|NCT02391948|471489561|FG000|24-month Assessment|Withdrawal by Subject|1|||
130961639|NCT02391948|471489562|FG001|24-month Assessment|Withdrawal by Subject|1|||
130961640|NCT02391948|471489563|FG002|24-month Assessment|Withdrawal by Subject|0|||
130961641|NCT02391948|471489564|FG003|24-month Assessment|Withdrawal by Subject|0|||
130961642|NCT02391948|471489565|FG004|24-month Assessment|Withdrawal by Subject|1|||
130961643|NCT02391948|471489561|FG000|24-month Assessment|Lost to Follow-up|5|||
130961644|NCT02391948|471489562|FG001|24-month Assessment|Lost to Follow-up|4|||
130961645|NCT02391948|471489563|FG002|24-month Assessment|Lost to Follow-up|0|||
130961646|NCT02391948|471489564|FG003|24-month Assessment|Lost to Follow-up|0|||
130961647|NCT02391948|471489565|FG004|24-month Assessment|Lost to Follow-up|0|||
130961648|NCT02391948|471489561|FG000|24-month Assessment|Medical issue/illness|0|||
130961649|NCT02391948|471489562|FG001|24-month Assessment|Medical issue/illness|0|||
130961650|NCT02391948|471489563|FG002|24-month Assessment|Medical issue/illness|1|||
130961651|NCT02391948|471489564|FG003|24-month Assessment|Medical issue/illness|0|||
130961652|NCT02391948|471489565|FG004|24-month Assessment|Medical issue/illness|0|||
130961653|NCT02391948|471489561|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
131041187|NCT04625725|471785446|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
130961654|NCT02391948|471489562|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
130961655|NCT02391948|471489563|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
130961656|NCT02391948|471489564|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
130961657|NCT02391948|471489565|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
131041188|NCT04625725|471785447|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
130714716|NCT01550744|470581762|FG000|Double-Blind|Death|0|||
130714717|NCT01550744|470581763|FG001|Double-Blind|Death|1|||
130714718|NCT01550744|470581764|FG002|Double-Blind|Death|0|||
130961658|NCT01639001|471489566|FG000|Overall Study|Refused further follow-up|9|||
130961659|NCT01639001|471489567|FG001|Overall Study|Refused further follow-up|12|||
130961660|NCT01639001|471489566|FG000|Overall Study|Lost to Follow-up|3|||
130961661|NCT01639001|471489567|FG001|Overall Study|Lost to Follow-up|0|||
130961662|NCT01639001|471489566|FG000|Overall Study|Death|62|||
130961663|NCT01639001|471489567|FG001|Overall Study|Death|61|||
130961664|NCT01639001|471489566|FG000|Overall Study|Randomized but not treated|0|||
130961665|NCT01639001|471489567|FG001|Overall Study|Randomized but not treated|2|||
130961666|NCT01639001|471489566|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
130961667|NCT01639001|471489567|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
130961668|NCT01969838|471489568|FG000|Double-blind Phase|Adverse Event|10|||
130961669|NCT01969838|471489569|FG001|Double-blind Phase|Adverse Event|4|||
130961670|NCT01969838|471489570|FG002|Double-blind Phase|Adverse Event|0|||
130961671|NCT01969838|471489571|FG003|Double-blind Phase|Adverse Event|0|||
130961672|NCT01969838|471489568|FG000|Double-blind Phase|Death|5|||
130961673|NCT01969838|471489569|FG001|Double-blind Phase|Death|2|||
130961674|NCT01969838|471489570|FG002|Double-blind Phase|Death|0|||
130961675|NCT01969838|471489571|FG003|Double-blind Phase|Death|0|||
130961676|NCT01969838|471489568|FG000|Double-blind Phase|Physician Decision|5|||
130961677|NCT01969838|471489569|FG001|Double-blind Phase|Physician Decision|1|||
130961678|NCT01969838|471489570|FG002|Double-blind Phase|Physician Decision|0|||
130961679|NCT01969838|471489571|FG003|Double-blind Phase|Physician Decision|0|||
130961680|NCT01969838|471489568|FG000|Double-blind Phase|Subject Decision|4|||
130961681|NCT01969838|471489569|FG001|Double-blind Phase|Subject Decision|2|||
130961682|NCT01969838|471489570|FG002|Double-blind Phase|Subject Decision|0|||
130961683|NCT01969838|471489571|FG003|Double-blind Phase|Subject Decision|0|||
130961684|NCT01969838|471489568|FG000|Double-blind Phase|Disease Progression|2|||
130961685|NCT01969838|471489569|FG001|Double-blind Phase|Disease Progression|0|||
130961686|NCT01969838|471489570|FG002|Double-blind Phase|Disease Progression|0|||
130961687|NCT01969838|471489571|FG003|Double-blind Phase|Disease Progression|0|||
130961688|NCT01969838|471489568|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
130961689|NCT01969838|471489569|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
130961690|NCT01969838|471489570|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
130961691|NCT01969838|471489571|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
130961692|NCT01969838|471489568|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
130961693|NCT01969838|471489569|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
130961694|NCT01969838|471489570|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
130961695|NCT01969838|471489571|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
130961696|NCT01969838|471489568|FG000|Open-label Phase|Adverse Event|0|||
130961697|NCT01969838|471489569|FG001|Open-label Phase|Adverse Event|0|||
130961698|NCT01969838|471489570|FG002|Open-label Phase|Adverse Event|37|||
130961699|NCT01969838|471489571|FG003|Open-label Phase|Adverse Event|49|||
130961700|NCT01969838|471489568|FG000|Open-label Phase|Disease Progression|0|||
130961701|NCT01969838|471489569|FG001|Open-label Phase|Disease Progression|0|||
130961702|NCT01969838|471489570|FG002|Open-label Phase|Disease Progression|26|||
130961703|NCT01969838|471489571|FG003|Open-label Phase|Disease Progression|27|||
130961704|NCT01969838|471489568|FG000|Open-label Phase|Lack of Efficacy|0|||
130961705|NCT01969838|471489569|FG001|Open-label Phase|Lack of Efficacy|0|||
130961706|NCT01969838|471489570|FG002|Open-label Phase|Lack of Efficacy|17|||
130961707|NCT01969838|471489571|FG003|Open-label Phase|Lack of Efficacy|19|||
130961708|NCT01969838|471489568|FG000|Open-label Phase|Subject Decision|0|||
130961709|NCT01969838|471489569|FG001|Open-label Phase|Subject Decision|0|||
130961710|NCT01969838|471489570|FG002|Open-label Phase|Subject Decision|14|||
130961711|NCT01969838|471489571|FG003|Open-label Phase|Subject Decision|15|||
130961712|NCT01969838|471489568|FG000|Open-label Phase|Death|0|||
130961713|NCT01969838|471489569|FG001|Open-label Phase|Death|0|||
130961714|NCT01969838|471489570|FG002|Open-label Phase|Death|13|||
130961715|NCT01969838|471489571|FG003|Open-label Phase|Death|11|||
130961716|NCT01969838|471489568|FG000|Open-label Phase|Physician Decision|0|||
130961717|NCT01969838|471489569|FG001|Open-label Phase|Physician Decision|0|||
130961718|NCT01969838|471489570|FG002|Open-label Phase|Physician Decision|9|||
130961719|NCT01969838|471489571|FG003|Open-label Phase|Physician Decision|14|||
130961720|NCT01969838|471489568|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
130961721|NCT01969838|471489569|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
131127368|NCT00708500|472095958|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
131127369|NCT00708500|472095959|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
131127370|NCT00708500|472095960|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
131127371|NCT00708500|472095958|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
131127372|NCT00708500|472095959|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
131127373|NCT00708500|472095960|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
131127374|NCT00708500|472095958|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
130714719|NCT01550744|470581762|FG000|Double-Blind|Lack of Efficacy|0|||
130961722|NCT01969838|471489570|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
130961723|NCT01969838|471489571|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
130961724|NCT02944578|471489574|FG000|Overall Study|Physician Decision|1|||
130961725|NCT02944578|471489575|FG001|Overall Study|Physician Decision|0|||
130961726|NCT00807092|471489576|FG000|Overall Study|Adverse Event|0|||
130961727|NCT00807092|471489577|FG001|Overall Study|Adverse Event|1|||
130961728|NCT00807092|471489576|FG000|Overall Study|Protocol Violation|0|||
130961729|NCT00807092|471489577|FG001|Overall Study|Protocol Violation|2|||
130961730|NCT00807092|471489576|FG000|Overall Study|Withdrawal by Subject|1|||
130961731|NCT00807092|471489577|FG001|Overall Study|Withdrawal by Subject|0|||
130961732|NCT00807092|471489576|FG000|Overall Study|CGMS data collection failed|0|||
130961733|NCT00807092|471489577|FG001|Overall Study|CGMS data collection failed|1|||
130961734|NCT04116229|471489578|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
130961735|NCT04116229|471489579|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
130961736|NCT04116229|471489578|FG000|Overall Study|Scheduling not possible.|0|||
130961737|NCT04116229|471489579|FG001|Overall Study|Scheduling not possible.|1|||
130961738|NCT02863354|471489585|FG000|Year 1|Lost to Follow-up|1|||
130961739|NCT02863354|471489586|FG001|Year 1|Lost to Follow-up|1|||
130961740|NCT02863354|471489585|FG000|Year 1|Withdrawal by Subject|3|||
130961741|NCT02863354|471489586|FG001|Year 1|Withdrawal by Subject|0|||
130961742|NCT02863354|471489585|FG000|Year 1|Death|0|||
130961743|NCT02863354|471489586|FG001|Year 1|Death|1|||
130961744|NCT02863354|471489585|FG000|Year 2|Lost to Follow-up|2|||
130961745|NCT02863354|471489586|FG001|Year 2|Lost to Follow-up|2|||
130961746|NCT00705575|471489590|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130961747|NCT00705575|471489591|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130961748|NCT00705575|471489590|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130961749|NCT00705575|471489591|FG001|Overall Study|Abnormal test procedure result(s)|12|||
130961750|NCT00705575|471489590|FG000|Overall Study|Adverse Event|11|||
130961751|NCT00705575|471489591|FG001|Overall Study|Adverse Event|15|||
130961752|NCT00705575|471489590|FG000|Overall Study|Lost to Follow-up|3|||
130961753|NCT00705575|471489591|FG001|Overall Study|Lost to Follow-up|4|||
130961754|NCT00705575|471489590|FG000|Overall Study|Protocol Violation|2|||
130961755|NCT00705575|471489591|FG001|Overall Study|Protocol Violation|2|||
131226447|NCT00297479|472455740|FG000|Overall Study|Lost to Follow-up|37|||
130961756|NCT00705575|471489590|FG000|Overall Study|Withdrawal by Subject|5|||
130961757|NCT00705575|471489591|FG001|Overall Study|Withdrawal by Subject|10|||
130961758|NCT02170727|471489592|FG000|Overall Study|Lost to Follow-up|1|||
130961759|NCT02170727|471489593|FG001|Overall Study|Lost to Follow-up|0|||
130961760|NCT02170727|471489592|FG000|Overall Study|Withdrawal by Subject|2|||
130961761|NCT02170727|471489593|FG001|Overall Study|Withdrawal by Subject|0|||
130961762|NCT01599650|471489594|FG000|Overall Study|Administrative issue|1|||
130961763|NCT01599650|471489595|FG001|Overall Study|Administrative issue|0|||
130961764|NCT01599650|471489596|FG002|Overall Study|Administrative issue|1|||
130961765|NCT01599650|471489594|FG000|Overall Study|Physician Decision|2|||
130961766|NCT01599650|471489595|FG001|Overall Study|Physician Decision|0|||
130961767|NCT01599650|471489596|FG002|Overall Study|Physician Decision|7|||
130961768|NCT01599650|471489594|FG000|Overall Study|Protocol Violation|0|||
130961769|NCT01599650|471489595|FG001|Overall Study|Protocol Violation|3|||
130961770|NCT01599650|471489596|FG002|Overall Study|Protocol Violation|0|||
130961771|NCT01599650|471489594|FG000|Overall Study|Death|2|||
130961772|NCT01599650|471489595|FG001|Overall Study|Death|1|||
130961773|NCT01599650|471489596|FG002|Overall Study|Death|2|||
130961774|NCT01599650|471489594|FG000|Overall Study|Lost to Follow-up|3|||
130961775|NCT01599650|471489595|FG001|Overall Study|Lost to Follow-up|3|||
130961776|NCT01599650|471489596|FG002|Overall Study|Lost to Follow-up|3|||
130961777|NCT01599650|471489594|FG000|Overall Study|Withdrawal by Subject|11|||
130961778|NCT01599650|471489595|FG001|Overall Study|Withdrawal by Subject|11|||
130961779|NCT01599650|471489596|FG002|Overall Study|Withdrawal by Subject|10|||
130961780|NCT01599650|471489594|FG000|Overall Study|Adverse Event|3|||
130961781|NCT01599650|471489595|FG001|Overall Study|Adverse Event|8|||
130961782|NCT01599650|471489596|FG002|Overall Study|Adverse Event|4|||
130961783|NCT00179647|471489604|FG000|Overall Study|Adverse Event|294|||
130961784|NCT00179647|471489604|FG000|Overall Study|Lack of Efficacy|478|||
131041189|NCT04625725|471785448|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
131041190|NCT04625725|471785449|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
131041191|NCT04625725|471785450|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
131041192|NCT04625725|471785445|FG000|Provent Main Study|Withdrawal by Subject|242|||
131041193|NCT04625725|471785446|FG001|Provent Main Study|Withdrawal by Subject|144|||
131041194|NCT04625725|471785447|FG002|Provent Main Study|Withdrawal by Subject|0|||
131041195|NCT04625725|471785448|FG003|Provent Main Study|Withdrawal by Subject|0|||
131226448|NCT00297479|472455741|FG001|Overall Study|Lost to Follow-up|54|||
130961785|NCT00179647|471489604|FG000|Overall Study|Withdrawal by Subject|83|||
130961786|NCT00179647|471489604|FG000|Overall Study|Lost to Follow-up|4|||
130961787|NCT00179647|471489604|FG000|Overall Study|Death|94|||
130961788|NCT00179647|471489604|FG000|Overall Study|Other|960|||
130961789|NCT04154631|471489605|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
131041196|NCT04625725|471785449|FG004|Provent Main Study|Withdrawal by Subject|0|||
131041197|NCT04625725|471785450|FG005|Provent Main Study|Withdrawal by Subject|0|||
131041198|NCT04625725|471785445|FG000|Provent Main Study|Physician Decision|5|||
131041199|NCT04625725|471785446|FG001|Provent Main Study|Physician Decision|0|||
131041200|NCT04625725|471785447|FG002|Provent Main Study|Physician Decision|0|||
131041201|NCT04625725|471785448|FG003|Provent Main Study|Physician Decision|0|||
131041202|NCT04625725|471785449|FG004|Provent Main Study|Physician Decision|0|||
131041203|NCT04625725|471785450|FG005|Provent Main Study|Physician Decision|0|||
131041204|NCT04625725|471785445|FG000|Provent Main Study|Protocol Violation|1|||
131041205|NCT04625725|471785446|FG001|Provent Main Study|Protocol Violation|0|||
131041206|NCT04625725|471785447|FG002|Provent Main Study|Protocol Violation|0|||
131041207|NCT04625725|471785448|FG003|Provent Main Study|Protocol Violation|0|||
131041208|NCT04625725|471785449|FG004|Provent Main Study|Protocol Violation|0|||
131041209|NCT04625725|471785450|FG005|Provent Main Study|Protocol Violation|0|||
131041210|NCT04625725|471785445|FG000|Provent Main Study|Lost to Follow-up|357|||
131041211|NCT04625725|471785446|FG001|Provent Main Study|Lost to Follow-up|200|||
131041212|NCT04625725|471785447|FG002|Provent Main Study|Lost to Follow-up|0|||
131041213|NCT04625725|471785448|FG003|Provent Main Study|Lost to Follow-up|0|||
131041214|NCT04625725|471785449|FG004|Provent Main Study|Lost to Follow-up|0|||
131041215|NCT04625725|471785450|FG005|Provent Main Study|Lost to Follow-up|0|||
131041216|NCT04625725|471785445|FG000|Provent Main Study|Death|22|||
131041217|NCT04625725|471785446|FG001|Provent Main Study|Death|10|||
131041218|NCT04625725|471785447|FG002|Provent Main Study|Death|0|||
131041219|NCT04625725|471785448|FG003|Provent Main Study|Death|0|||
131041220|NCT04625725|471785449|FG004|Provent Main Study|Death|0|||
131041221|NCT04625725|471785450|FG005|Provent Main Study|Death|0|||
131041222|NCT04625725|471785445|FG000|Provent Main Study|Adverse Event|2|||
131041223|NCT04625725|471785446|FG001|Provent Main Study|Adverse Event|1|||
131041224|NCT04625725|471785447|FG002|Provent Main Study|Adverse Event|0|||
131041225|NCT04625725|471785448|FG003|Provent Main Study|Adverse Event|0|||
131127375|NCT00708500|472095959|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
131127376|NCT00708500|472095960|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
131127377|NCT00708500|472095958|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
131127378|NCT00708500|472095959|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
131127379|NCT00708500|472095960|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
131127380|NCT00708500|472095958|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
131127381|NCT00708500|472095959|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
130714720|NCT01550744|470581763|FG001|Double-Blind|Lack of Efficacy|2|||
130714721|NCT01550744|470581764|FG002|Double-Blind|Lack of Efficacy|8|||
130714722|NCT01550744|470581762|FG000|Double-Blind|Protocol Violation|0|||
130714723|NCT01550744|470581763|FG001|Double-Blind|Protocol Violation|0|||
130714724|NCT01550744|470581764|FG002|Double-Blind|Protocol Violation|4|||
130714725|NCT01550744|470581762|FG000|Double-Blind|Pregnancy|0|||
131127382|NCT00708500|472095960|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
131127383|NCT00708500|472095958|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
131127384|NCT00708500|472095959|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
131127385|NCT00708500|472095960|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
131127386|NCT00708500|472095958|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
131127387|NCT00708500|472095959|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
131127388|NCT00708500|472095960|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
131127389|NCT00708500|472095958|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
131127390|NCT00708500|472095959|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
131127391|NCT00708500|472095960|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
131127392|NCT00708500|472095958|FG000|FOLLOWUP|Adverse Event|0|||
131127393|NCT00708500|472095959|FG001|FOLLOWUP|Adverse Event|1|||
131127394|NCT00708500|472095960|FG002|FOLLOWUP|Adverse Event|0|||
131127395|NCT00708500|472095958|FG000|FOLLOWUP|Lost to Follow-up|1|||
131127396|NCT00708500|472095959|FG001|FOLLOWUP|Lost to Follow-up|6|||
131127397|NCT00708500|472095960|FG002|FOLLOWUP|Lost to Follow-up|4|||
131127398|NCT00708500|472095958|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
131127399|NCT00708500|472095959|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
131127400|NCT00708500|472095960|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
131127401|NCT00708500|472095958|FG000|FOLLOWUP|Subject withdrew consent|31|||
131127402|NCT00708500|472095959|FG001|FOLLOWUP|Subject withdrew consent|4|||
131127403|NCT00708500|472095960|FG002|FOLLOWUP|Subject withdrew consent|5|||
131127404|NCT00708500|472095958|FG000|FOLLOWUP|Non-compliance with protocol|5|||
131041226|NCT04625725|471785449|FG004|Provent Main Study|Adverse Event|0|||
131041227|NCT04625725|471785450|FG005|Provent Main Study|Adverse Event|0|||
131041228|NCT04625725|471785445|FG000|Provent Main Study|Participants dosed in sub-study|310|||
131127405|NCT00708500|472095959|FG001|FOLLOWUP|Non-compliance with protocol|0|||
130714726|NCT01550744|470581763|FG001|Double-Blind|Pregnancy|0|||
130714727|NCT01550744|470581764|FG002|Double-Blind|Pregnancy|3|||
131041229|NCT04625725|471785446|FG001|Provent Main Study|Participants dosed in sub-study|193|||
131041230|NCT04625725|471785447|FG002|Provent Main Study|Participants dosed in sub-study|0|||
130961790|NCT04154631|471489606|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
130961791|NCT02138214|471489609|FG000|Overall Study|Withdrawal by Subject|0|||
130961792|NCT02138214|471489610|FG001|Overall Study|Withdrawal by Subject|1|||
130961793|NCT02138214|471489611|FG002|Overall Study|Withdrawal by Subject|0|||
130961794|NCT02138214|471489609|FG000|Overall Study|Lost to Follow-up|0|||
130961795|NCT02138214|471489610|FG001|Overall Study|Lost to Follow-up|2|||
130961796|NCT02138214|471489611|FG002|Overall Study|Lost to Follow-up|4|||
130961797|NCT02138214|471489609|FG000|Overall Study|Screen Failure|0|||
130961798|NCT02138214|471489610|FG001|Overall Study|Screen Failure|1|||
130961799|NCT02138214|471489611|FG002|Overall Study|Screen Failure|0|||
130961800|NCT02185768|471489612|FG000|Overall Study|Patients were not treated|2|||
130961801|NCT02158039|471489623|FG000|Overall Study|Withdrawal by Subject|1|||
130961802|NCT02158039|471489623|FG000|Overall Study|Screen Failure|9|||
130961803|NCT03062891|471489635|FG000|Overall Study|Withdrawal by Subject|2|||
130961804|NCT03062891|471489636|FG001|Overall Study|Withdrawal by Subject|0|||
130961805|NCT03062891|471489635|FG000|Overall Study|Lost to Follow-up|50|||
130961806|NCT03062891|471489636|FG001|Overall Study|Lost to Follow-up|38|||
130961807|NCT02127307|471489637|FG000|Overall Study|Protocol Violation|36|||
130961808|NCT02127307|471489637|FG000|Overall Study|Lost to Follow-up|2|||
130961809|NCT02127307|471489637|FG000|Overall Study|Death|101|||
130961810|NCT02127307|471489637|FG000|Overall Study|Other than specified above|169|||
130961811|NCT03509948|471489638|FG000|Overall Study|Protocol Violation|0|||
130961812|NCT03509948|471489639|FG001|Overall Study|Protocol Violation|1|||
130961813|NCT03221257|471489640|FG000|Overall Study|Lost to Follow-up|0|||
130961814|NCT03221257|471489641|FG001|Overall Study|Lost to Follow-up|1|||
130961815|NCT03221257|471489640|FG000|Overall Study|Withdrawal by Subject|1|||
130961816|NCT03221257|471489641|FG001|Overall Study|Withdrawal by Subject|1|||
130961817|NCT01334866|471489645|FG000|Overall Study|Withdrawal by Subject|10|||
130961818|NCT01334866|471489645|FG000|Overall Study|Lost to Follow-up|3|||
130961819|NCT01334866|471489645|FG000|Overall Study|Physician Decision|3|||
130961820|NCT01334866|471489645|FG000|Overall Study|medically necessary prior to procedure|2|||
130961821|NCT01334866|471489645|FG000|Overall Study|medically necessary post-procedure|1|||
130961822|NCT01687166|471489658|FG000|Overall Study|Attempt subject|2|||
130961823|NCT01687166|471489659|FG001|Overall Study|Attempt subject|3|||
130961824|NCT01687166|471489660|FG002|Overall Study|Attempt subject|2|||
130961825|NCT01687166|471489661|FG003|Overall Study|Attempt subject|0|||
130961826|NCT01687166|471489658|FG000|Overall Study|Did not meet eligibility criteria|4|||
130961827|NCT01687166|471489659|FG001|Overall Study|Did not meet eligibility criteria|6|||
130961828|NCT01687166|471489660|FG002|Overall Study|Did not meet eligibility criteria|1|||
130961829|NCT01687166|471489661|FG003|Overall Study|Did not meet eligibility criteria|1|||
130961830|NCT01687166|471489658|FG000|Overall Study|Adverse Event|2|||
130961831|NCT01687166|471489659|FG001|Overall Study|Adverse Event|1|||
130961832|NCT01687166|471489660|FG002|Overall Study|Adverse Event|0|||
130961833|NCT01687166|471489661|FG003|Overall Study|Adverse Event|0|||
131041231|NCT04625725|471785448|FG003|Provent Main Study|Participants dosed in sub-study|0|||
130961834|NCT01687166|471489658|FG000|Overall Study|Physician Decision|3|||
130961835|NCT01687166|471489659|FG001|Overall Study|Physician Decision|2|||
130961836|NCT01687166|471489660|FG002|Overall Study|Physician Decision|1|||
130961837|NCT01687166|471489661|FG003|Overall Study|Physician Decision|0|||
130961838|NCT01687166|471489658|FG000|Overall Study|Withdrawal by Subject|11|||
130961839|NCT01687166|471489659|FG001|Overall Study|Withdrawal by Subject|4|||
130961840|NCT01687166|471489660|FG002|Overall Study|Withdrawal by Subject|3|||
130961841|NCT01687166|471489661|FG003|Overall Study|Withdrawal by Subject|0|||
130961842|NCT01687166|471489658|FG000|Overall Study|Lost to Follow-up|2|||
130961843|NCT01687166|471489659|FG001|Overall Study|Lost to Follow-up|5|||
130961844|NCT01687166|471489660|FG002|Overall Study|Lost to Follow-up|1|||
130961845|NCT01687166|471489661|FG003|Overall Study|Lost to Follow-up|0|||
130961846|NCT01687166|471489658|FG000|Overall Study|Equipment/Device Availability|0|||
130961847|NCT01687166|471489659|FG001|Overall Study|Equipment/Device Availability|1|||
130961848|NCT01687166|471489660|FG002|Overall Study|Equipment/Device Availability|0|||
130961849|NCT01687166|471489661|FG003|Overall Study|Equipment/Device Availability|0|||
130961850|NCT01687166|471489658|FG000|Overall Study|Death|1|||
130961851|NCT01687166|471489659|FG001|Overall Study|Death|1|||
130961852|NCT01687166|471489660|FG002|Overall Study|Death|0|||
130961853|NCT01687166|471489661|FG003|Overall Study|Death|0|||
130961854|NCT01687166|471489658|FG000|Overall Study|Protocol Violation|1|||
130961855|NCT01687166|471489659|FG001|Overall Study|Protocol Violation|1|||
130961856|NCT01687166|471489660|FG002|Overall Study|Protocol Violation|1|||
130961857|NCT01687166|471489661|FG003|Overall Study|Protocol Violation|0|||
130961858|NCT01687166|471489658|FG000|Overall Study|Subject moved out of state|0|||
130961859|NCT01687166|471489659|FG001|Overall Study|Subject moved out of state|1|||
130961860|NCT01687166|471489660|FG002|Overall Study|Subject moved out of state|0|||
130961861|NCT01687166|471489661|FG003|Overall Study|Subject moved out of state|0|||
130961862|NCT01687166|471489658|FG000|Overall Study|Patient unable to be compliant|1|||
130961863|NCT01687166|471489659|FG001|Overall Study|Patient unable to be compliant|0|||
130961864|NCT01687166|471489660|FG002|Overall Study|Patient unable to be compliant|0|||
130961865|NCT01687166|471489661|FG003|Overall Study|Patient unable to be compliant|0|||
130961866|NCT01687166|471489658|FG000|Overall Study|Physician choice to use different device|1|||
130961867|NCT01687166|471489659|FG001|Overall Study|Physician choice to use different device|2|||
130961868|NCT01687166|471489660|FG002|Overall Study|Physician choice to use different device|4|||
130961869|NCT01687166|471489661|FG003|Overall Study|Physician choice to use different device|0|||
130961870|NCT01687166|471489658|FG000|Overall Study|Insurance|0|||
130961871|NCT01687166|471489659|FG001|Overall Study|Insurance|0|||
130961872|NCT01687166|471489660|FG002|Overall Study|Insurance|1|||
130961873|NCT01687166|471489661|FG003|Overall Study|Insurance|1|||
130961874|NCT02755831|471489662|FG000|Overall Study|Lost to Follow-up|3|||
130961875|NCT02755831|471489663|FG001|Overall Study|Lost to Follow-up|3|||
130961876|NCT02296112|471489664|FG000|Overall Study|Disease progression|7|||
130961877|NCT02296112|471489664|FG000|Overall Study|Toxicity|1|||
131226449|NCT00297479|472455742|FG002|Overall Study|Lost to Follow-up|51|||
131226450|NCT03063632|472455743|FG000|Overall Study|Death|4|||
131226451|NCT03063632|472455744|FG001|Overall Study|Death|6|||
131226452|NCT03063632|472455743|FG000|Overall Study|Lost to Follow-up|0|||
131226453|NCT03063632|472455744|FG001|Overall Study|Lost to Follow-up|1|||
131226454|NCT03063632|472455743|FG000|Overall Study|Withdrawal by Subject|0|||
131226455|NCT03063632|472455744|FG001|Overall Study|Withdrawal by Subject|2|||
131226456|NCT03063632|472455743|FG000|Overall Study|Physician Decision|2|||
131226457|NCT03063632|472455744|FG001|Overall Study|Physician Decision|0|||
131226458|NCT03063632|472455743|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
131226459|NCT03063632|472455744|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
131226460|NCT02746705|472455749|FG000|Overall Study|Physician Decision|1|||
131226461|NCT02746705|472455750|FG001|Overall Study|Physician Decision|1|||
131226462|NCT02746705|472455749|FG000|Overall Study|Lost to Follow-up|1|||
131226463|NCT02746705|472455750|FG001|Overall Study|Lost to Follow-up|0|||
131226464|NCT02746705|472455749|FG000|Overall Study|outlier scores deemed not valid|0|||
131226465|NCT02746705|472455750|FG001|Overall Study|outlier scores deemed not valid|1|||
131226466|NCT00479401|472455751|FG000|Overall Study|Adverse Event|24|||
131226467|NCT00479401|472455752|FG001|Overall Study|Adverse Event|20|||
131226468|NCT00479401|472455753|FG002|Overall Study|Adverse Event|4|||
131226469|NCT00479401|472455751|FG000|Overall Study|Lack of Efficacy|2|||
131226470|NCT00479401|472455752|FG001|Overall Study|Lack of Efficacy|2|||
131226471|NCT00479401|472455753|FG002|Overall Study|Lack of Efficacy|4|||
131226472|NCT00479401|472455751|FG000|Overall Study|Protocol Violation|2|||
131226473|NCT00479401|472455752|FG001|Overall Study|Protocol Violation|1|||
131226474|NCT00479401|472455753|FG002|Overall Study|Protocol Violation|1|||
131226475|NCT00479401|472455751|FG000|Overall Study|Lost to Follow-up|1|||
131226476|NCT00479401|472455752|FG001|Overall Study|Lost to Follow-up|1|||
131226477|NCT00479401|472455753|FG002|Overall Study|Lost to Follow-up|1|||
131226478|NCT00479401|472455751|FG000|Overall Study|Withdrawal by Subject|16|||
131226479|NCT00479401|472455752|FG001|Overall Study|Withdrawal by Subject|10|||
131226480|NCT00479401|472455753|FG002|Overall Study|Withdrawal by Subject|2|||
131226481|NCT00479401|472455751|FG000|Overall Study|Exclusion criteria, relocation|4|||
131226482|NCT00479401|472455752|FG001|Overall Study|Exclusion criteria, relocation|3|||
131226483|NCT00479401|472455753|FG002|Overall Study|Exclusion criteria, relocation|0|||
131226484|NCT04304950|472455758|FG000|Overall Study|Lost to Follow-up|1|||
131226485|NCT04304950|472455759|FG001|Overall Study|Lost to Follow-up|1|||
131226486|NCT02418910|472455760|FG000|Overall Study|Lost to Follow-up|3|||
131226487|NCT02418910|472455760|FG000|Overall Study|Withdrawal by Subject|4|||
131226488|NCT03634488|472455762|FG000|Overall Study|Death|1|||
131226489|NCT03634488|472455763|FG001|Overall Study|Death|0|||
131226490|NCT03634488|472455764|FG002|Overall Study|Death|0|||
131226491|NCT03634488|472455762|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
130714728|NCT01550744|470581762|FG000|Double-Blind|Other|0|||
130961878|NCT02296112|471489664|FG000|Overall Study|Began an alternate therapy|1|||
130961879|NCT02442830|471489665|FG000|Overall Study|Technical Failure|0|||
130961880|NCT02442830|471489666|FG001|Overall Study|Technical Failure|1|||
130961881|NCT00183872|471489667|FG000|Overall Study|Death|3|||
130961882|NCT00183872|471489667|FG000|Overall Study|Adverse Event|9|||
130961883|NCT00183872|471489667|FG000|Overall Study|Withdrawal by Subject|2|||
130961884|NCT00183872|471489667|FG000|Overall Study|Drug delayed more than 28 days|2|||
130961885|NCT01516879|471489668|FG000|Overall Study|Withdrawal by Subject|9|||
130961886|NCT01516879|471489669|FG001|Overall Study|Withdrawal by Subject|11|||
130961887|NCT01516879|471489668|FG000|Overall Study|Death|0|||
130961888|NCT01516879|471489669|FG001|Overall Study|Death|2|||
130961889|NCT01516879|471489668|FG000|Overall Study|Lost to Follow-up|2|||
131226492|NCT03634488|472455763|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
131226493|NCT03634488|472455764|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
131226494|NCT03182686|472455765|FG000|Overall Study|Lost to Follow-up|2|||
130961890|NCT01516879|471489669|FG001|Overall Study|Lost to Follow-up|11|||
130961891|NCT01516879|471489668|FG000|Overall Study|Other|5|||
131226495|NCT03182686|472455766|FG001|Overall Study|Lost to Follow-up|0|||
130714729|NCT01550744|470581763|FG001|Double-Blind|Other|2|||
130714730|NCT01550744|470581764|FG002|Double-Blind|Other|10|||
130961892|NCT01516879|471489669|FG001|Overall Study|Other|10|||
130961893|NCT01720069|471489670|FG000|Overall Study|Could not use e-diary correctly|0|||
130961894|NCT01720069|471489671|FG001|Overall Study|Could not use e-diary correctly|1|||
130961895|NCT01720069|471489672|FG002|Overall Study|Could not use e-diary correctly|1|||
130961896|NCT01720069|471489670|FG000|Overall Study|Randomised without baseline values|0|||
130961897|NCT01720069|471489671|FG001|Overall Study|Randomised without baseline values|0|||
130961898|NCT01720069|471489672|FG002|Overall Study|Randomised without baseline values|1|||
130961899|NCT01720069|471489670|FG000|Overall Study|Adverse Event|0|||
130961900|NCT01720069|471489671|FG001|Overall Study|Adverse Event|0|||
130961901|NCT01720069|471489672|FG002|Overall Study|Adverse Event|1|||
130961902|NCT01720069|471489670|FG000|Overall Study|Lack of Efficacy|0|||
130961903|NCT01720069|471489671|FG001|Overall Study|Lack of Efficacy|4|||
130961904|NCT01720069|471489672|FG002|Overall Study|Lack of Efficacy|0|||
130961905|NCT01720069|471489670|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
130961906|NCT01720069|471489671|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
130961907|NCT01720069|471489672|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
130961908|NCT01720069|471489670|FG000|Overall Study|Withdrawal by Subject|0|||
130961909|NCT01720069|471489671|FG001|Overall Study|Withdrawal by Subject|2|||
130961910|NCT01720069|471489672|FG002|Overall Study|Withdrawal by Subject|1|||
130961911|NCT01720069|471489670|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
130961912|NCT01720069|471489671|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
130961913|NCT01720069|471489672|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
130961914|NCT01720069|471489670|FG000|Overall Study|Non-compliance on using e-diary|0|||
130961915|NCT01720069|471489671|FG001|Overall Study|Non-compliance on using e-diary|0|||
130961916|NCT01720069|471489672|FG002|Overall Study|Non-compliance on using e-diary|1|||
130961917|NCT01720069|471489670|FG000|Overall Study|Lost to Follow-up|0|||
130961918|NCT01720069|471489671|FG001|Overall Study|Lost to Follow-up|0|||
130961919|NCT01720069|471489672|FG002|Overall Study|Lost to Follow-up|1|||
130961920|NCT00508742|471489673|FG000|Period 1: Infant Series|Adverse Event|5|||
130961921|NCT00508742|471489674|FG001|Period 1: Infant Series|Adverse Event|4|||
130961922|NCT00508742|471489673|FG000|Period 1: Infant Series|Protocol Violation|1|||
130961923|NCT00508742|471489674|FG001|Period 1: Infant Series|Protocol Violation|0|||
130961924|NCT00508742|471489673|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
130961925|NCT00508742|471489674|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
130961926|NCT00508742|471489673|FG000|Period 1: Infant Series|Physician Decision|1|||
130961927|NCT00508742|471489674|FG001|Period 1: Infant Series|Physician Decision|0|||
130961928|NCT00508742|471489673|FG000|Period 1: Infant Series|Other|4|||
130961929|NCT00508742|471489674|FG001|Period 1: Infant Series|Other|1|||
130961930|NCT00508742|471489673|FG000|Period 2: After Infant Series|Adverse Event|2|||
130961931|NCT00508742|471489674|FG001|Period 2: After Infant Series|Adverse Event|6|||
130961932|NCT00508742|471489673|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
130961933|NCT00508742|471489674|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
130961934|NCT00508742|471489673|FG000|Period 2: After Infant Series|Protocol Violation|1|||
130961935|NCT00508742|471489674|FG001|Period 2: After Infant Series|Protocol Violation|0|||
130961936|NCT00508742|471489673|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
130961937|NCT00508742|471489674|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
130961938|NCT00508742|471489673|FG000|Period 2: After Infant Series|Failed to Return|1|||
130961939|NCT00508742|471489674|FG001|Period 2: After Infant Series|Failed to Return|0|||
130714731|NCT00311311|470581765|FG000|Overall Study|Adverse Event|3|||
130961940|NCT00508742|471489673|FG000|Period 2: After Infant Series|Other|2|||
130961941|NCT00508742|471489674|FG001|Period 2: After Infant Series|Other|1|||
130961942|NCT00508742|471489673|FG000|Period 3: Toddler Dose|Adverse Event|1|||
130961943|NCT00508742|471489674|FG001|Period 3: Toddler Dose|Adverse Event|0|||
130961944|NCT00508742|471489673|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
130961945|NCT00508742|471489674|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
130961946|NCT00508742|471489673|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
130961947|NCT00508742|471489674|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
130961948|NCT00508742|471489673|FG000|Period 3: Toddler Dose|Other|5|||
130961949|NCT00508742|471489674|FG001|Period 3: Toddler Dose|Other|4|||
130961950|NCT04568122|471489675|FG000|Overall Study|Lost to Follow-up|48|||
130961951|NCT04568122|471489676|FG001|Overall Study|Lost to Follow-up|44|||
130961952|NCT04568122|471489677|FG002|Overall Study|Lost to Follow-up|4|||
130961953|NCT04568122|471489678|FG003|Overall Study|Lost to Follow-up|0|||
130961954|NCT04568122|471489679|FG004|Overall Study|Lost to Follow-up|0|||
130961955|NCT00700011|471489685|FG000|Overall Study|Death|0|||
130961956|NCT00700011|471489686|FG001|Overall Study|Death|1|||
130961957|NCT02460224|471489688|FG000|Overall Study|Adverse Event|0|||
130961958|NCT02460224|471489689|FG001|Overall Study|Adverse Event|0|||
130961959|NCT02460224|471489690|FG002|Overall Study|Adverse Event|0|||
130961960|NCT02460224|471489691|FG003|Overall Study|Adverse Event|0|||
130961961|NCT02460224|471489692|FG004|Overall Study|Adverse Event|0|||
130961962|NCT02460224|471489693|FG005|Overall Study|Adverse Event|0|||
130961963|NCT02460224|471489694|FG006|Overall Study|Adverse Event|1|||
130961964|NCT02460224|471489695|FG007|Overall Study|Adverse Event|0|||
131041232|NCT04625725|471785449|FG004|Provent Main Study|Participants dosed in sub-study|0|||
130961965|NCT02460224|471489696|FG008|Overall Study|Adverse Event|0|||
130961966|NCT02460224|471489697|FG009|Overall Study|Adverse Event|0|||
130961967|NCT02460224|471489698|FG010|Overall Study|Adverse Event|0|||
130961968|NCT02460224|471489699|FG011|Overall Study|Adverse Event|0|||
130961969|NCT02460224|471489700|FG012|Overall Study|Adverse Event|1|||
130961970|NCT02460224|471489701|FG013|Overall Study|Adverse Event|0|||
130961971|NCT02460224|471489702|FG014|Overall Study|Adverse Event|0|||
130961972|NCT02460224|471489703|FG015|Overall Study|Adverse Event|0|||
130961973|NCT02460224|471489704|FG016|Overall Study|Adverse Event|1|||
131127406|NCT00708500|472095960|FG002|FOLLOWUP|Non-compliance with protocol|1|||
131127407|NCT00705783|472095967|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
131127408|NCT00705783|472095968|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
131127409|NCT00705783|472095969|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
131127410|NCT00705783|472095967|FG000|Conversion Phase|Lost to Follow-up|13|||
131127411|NCT00705783|472095968|FG001|Conversion Phase|Lost to Follow-up|0|||
131127412|NCT00705783|472095969|FG002|Conversion Phase|Lost to Follow-up|0|||
131127413|NCT00705783|472095967|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
131127414|NCT00705783|472095968|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
131127415|NCT00705783|472095969|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
131127416|NCT00705783|472095967|FG000|Conversion Phase|Withdrawn by Investigator|4|||
131127417|NCT00705783|472095968|FG001|Conversion Phase|Withdrawn by Investigator|0|||
131127418|NCT00705783|472095969|FG002|Conversion Phase|Withdrawn by Investigator|0|||
131127419|NCT00705783|472095967|FG000|Conversion Phase|Withdrew Consent|24|||
131127420|NCT00705783|472095968|FG001|Conversion Phase|Withdrew Consent|0|||
131127421|NCT00705783|472095969|FG002|Conversion Phase|Withdrew Consent|0|||
131127422|NCT00705783|472095967|FG000|Conversion Phase|Protocol Deviation|2|||
131127423|NCT00705783|472095968|FG001|Conversion Phase|Protocol Deviation|0|||
131127424|NCT00705783|472095969|FG002|Conversion Phase|Protocol Deviation|0|||
131127425|NCT00705783|472095967|FG000|Conversion Phase|Adverse Event|11|||
131127426|NCT00705783|472095968|FG001|Conversion Phase|Adverse Event|0|||
131127427|NCT00705783|472095969|FG002|Conversion Phase|Adverse Event|0|||
130961974|NCT02460224|471489705|FG017|Overall Study|Adverse Event|0|||
130961975|NCT02460224|471489706|FG018|Overall Study|Adverse Event|1|||
130961976|NCT02460224|471489707|FG019|Overall Study|Adverse Event|0|||
130961977|NCT02460224|471489708|FG020|Overall Study|Adverse Event|1|||
130961978|NCT02460224|471489709|FG021|Overall Study|Adverse Event|1|||
130961979|NCT02460224|471489710|FG022|Overall Study|Adverse Event|1|||
130961980|NCT02460224|471489711|FG023|Overall Study|Adverse Event|0|||
130961981|NCT02460224|471489712|FG024|Overall Study|Adverse Event|0|||
130961982|NCT02460224|471489713|FG025|Overall Study|Adverse Event|0|||
130961983|NCT02460224|471489714|FG026|Overall Study|Adverse Event|11|||
130961984|NCT02460224|471489715|FG027|Overall Study|Adverse Event|1|||
130961985|NCT02460224|471489716|FG028|Overall Study|Adverse Event|6|||
130961986|NCT02460224|471489688|FG000|Overall Study|Death|0|||
130961987|NCT02460224|471489689|FG001|Overall Study|Death|0|||
130961988|NCT02460224|471489690|FG002|Overall Study|Death|0|||
130961989|NCT02460224|471489691|FG003|Overall Study|Death|0|||
130961990|NCT02460224|471489692|FG004|Overall Study|Death|0|||
130961991|NCT02460224|471489693|FG005|Overall Study|Death|2|||
130961992|NCT02460224|471489694|FG006|Overall Study|Death|1|||
130961993|NCT02460224|471489695|FG007|Overall Study|Death|0|||
130961994|NCT02460224|471489696|FG008|Overall Study|Death|0|||
130961995|NCT02460224|471489697|FG009|Overall Study|Death|1|||
130961996|NCT02460224|471489698|FG010|Overall Study|Death|0|||
130961997|NCT02460224|471489699|FG011|Overall Study|Death|0|||
130961998|NCT02460224|471489700|FG012|Overall Study|Death|0|||
130961999|NCT02460224|471489701|FG013|Overall Study|Death|1|||
130962000|NCT02460224|471489702|FG014|Overall Study|Death|0|||
130962001|NCT02460224|471489703|FG015|Overall Study|Death|0|||
130962002|NCT02460224|471489704|FG016|Overall Study|Death|2|||
130962003|NCT02460224|471489705|FG017|Overall Study|Death|1|||
130962004|NCT02460224|471489706|FG018|Overall Study|Death|0|||
130962005|NCT02460224|471489707|FG019|Overall Study|Death|2|||
130962006|NCT02460224|471489708|FG020|Overall Study|Death|0|||
130962007|NCT02460224|471489709|FG021|Overall Study|Death|0|||
131127428|NCT00705783|472095967|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
131127429|NCT00705783|472095968|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
131127430|NCT00705783|472095969|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
130962008|NCT02460224|471489710|FG022|Overall Study|Death|0|||
130962009|NCT02460224|471489711|FG023|Overall Study|Death|0|||
131127431|NCT00705783|472095967|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
131127432|NCT00705783|472095968|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
131226496|NCT03182686|472455765|FG000|Overall Study|Adverse Event|2|||
130962010|NCT02460224|471489712|FG024|Overall Study|Death|1|||
130962011|NCT02460224|471489713|FG025|Overall Study|Death|1|||
130962012|NCT02460224|471489714|FG026|Overall Study|Death|5|||
130962013|NCT02460224|471489715|FG027|Overall Study|Death|0|||
130962014|NCT02460224|471489716|FG028|Overall Study|Death|1|||
130962015|NCT02460224|471489688|FG000|Overall Study|Lost to Follow-up|0|||
130962016|NCT02460224|471489689|FG001|Overall Study|Lost to Follow-up|0|||
130962017|NCT02460224|471489690|FG002|Overall Study|Lost to Follow-up|0|||
130962018|NCT02460224|471489691|FG003|Overall Study|Lost to Follow-up|0|||
130962019|NCT02460224|471489692|FG004|Overall Study|Lost to Follow-up|0|||
130962020|NCT02460224|471489693|FG005|Overall Study|Lost to Follow-up|0|||
130962021|NCT02460224|471489694|FG006|Overall Study|Lost to Follow-up|0|||
130962022|NCT02460224|471489695|FG007|Overall Study|Lost to Follow-up|0|||
131226497|NCT03182686|472455766|FG001|Overall Study|Adverse Event|0|||
131226498|NCT03182686|472455765|FG000|Overall Study|Withdrawal by Subject|3|||
131226499|NCT03182686|472455766|FG001|Overall Study|Withdrawal by Subject|0|||
131226500|NCT00529568|472455767|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
131226501|NCT00529568|472455768|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
131226502|NCT00529568|472455769|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
131226503|NCT00529568|472455767|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
131226504|NCT00529568|472455768|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
131226505|NCT00529568|472455769|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
131226506|NCT00529568|472455767|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
131226507|NCT00529568|472455768|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
131226508|NCT00529568|472455769|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
131226509|NCT00529568|472455767|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
131226510|NCT00529568|472455768|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
131226511|NCT00529568|472455769|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
131226512|NCT00529568|472455767|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
131226513|NCT00529568|472455768|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
131226514|NCT00529568|472455769|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
131226515|NCT00529568|472455767|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
130962023|NCT02460224|471489696|FG008|Overall Study|Lost to Follow-up|0|||
130962024|NCT02460224|471489697|FG009|Overall Study|Lost to Follow-up|0|||
131226516|NCT00529568|472455768|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
131226517|NCT00529568|472455769|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
131226518|NCT00529568|472455767|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
131226519|NCT00529568|472455768|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
131226520|NCT00529568|472455769|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
131226521|NCT00529568|472455767|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
131226522|NCT00529568|472455768|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
131226523|NCT00529568|472455769|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
131226524|NCT00529568|472455767|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
131226525|NCT00529568|472455768|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
131226526|NCT00529568|472455769|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
131226527|NCT00529568|472455767|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
131226528|NCT00529568|472455768|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
131226529|NCT00529568|472455769|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
131226530|NCT00529568|472455767|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
131226531|NCT00529568|472455768|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
131226532|NCT00529568|472455769|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
131226533|NCT01201356|472455770|FG000|Overall Study|Adverse Event|170|||
131226534|NCT01201356|472455770|FG000|Overall Study|Abnormal laboratory value(s)|51|||
131226535|NCT01201356|472455770|FG000|Overall Study|Abnormal test procedure result(s)|3|||
131226536|NCT01201356|472455770|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
131226537|NCT01201356|472455770|FG000|Overall Study|Condition no longer requires study drug|12|||
131226538|NCT01201356|472455770|FG000|Overall Study|Withdrawal by Subject|144|||
131226539|NCT01201356|472455770|FG000|Overall Study|Lost to Follow-up|50|||
131226540|NCT01201356|472455770|FG000|Overall Study|administrative problems|74|||
131226541|NCT01201356|472455770|FG000|Overall Study|Death|16|||
131226542|NCT01201356|472455770|FG000|Overall Study|Protocol Violation|12|||
131226543|NCT00811070|472455771|FG000|Overall Study|Death|0|||
131226544|NCT00811070|472455772|FG001|Overall Study|Death|0|||
131226545|NCT00811070|472455773|FG002|Overall Study|Death|0|||
131226546|NCT00811070|472455774|FG003|Overall Study|Death|2|||
131226547|NCT00811070|472455775|FG004|Overall Study|Death|5|||
131226548|NCT00811070|472455776|FG005|Overall Study|Death|0|||
131226549|NCT00811070|472455771|FG000|Overall Study|Other|1|||
131226550|NCT00811070|472455772|FG001|Overall Study|Other|0|||
130962025|NCT02460224|471489698|FG010|Overall Study|Lost to Follow-up|0|||
130962026|NCT02460224|471489699|FG011|Overall Study|Lost to Follow-up|0|||
131226551|NCT00811070|472455773|FG002|Overall Study|Other|0|||
131226552|NCT00811070|472455774|FG003|Overall Study|Other|0|||
131226553|NCT00811070|472455775|FG004|Overall Study|Other|0|||
131226554|NCT00811070|472455776|FG005|Overall Study|Other|0|||
130962027|NCT02460224|471489700|FG012|Overall Study|Lost to Follow-up|0|||
130962028|NCT02460224|471489701|FG013|Overall Study|Lost to Follow-up|0|||
130962029|NCT02460224|471489702|FG014|Overall Study|Lost to Follow-up|0|||
130962030|NCT02460224|471489703|FG015|Overall Study|Lost to Follow-up|0|||
130962031|NCT02460224|471489704|FG016|Overall Study|Lost to Follow-up|0|||
130962032|NCT02460224|471489705|FG017|Overall Study|Lost to Follow-up|0|||
130962033|NCT02460224|471489706|FG018|Overall Study|Lost to Follow-up|0|||
130962034|NCT02460224|471489707|FG019|Overall Study|Lost to Follow-up|0|||
130962035|NCT02460224|471489708|FG020|Overall Study|Lost to Follow-up|0|||
130962036|NCT02460224|471489709|FG021|Overall Study|Lost to Follow-up|0|||
130962037|NCT02460224|471489710|FG022|Overall Study|Lost to Follow-up|1|||
130962038|NCT02460224|471489711|FG023|Overall Study|Lost to Follow-up|0|||
130962039|NCT02460224|471489712|FG024|Overall Study|Lost to Follow-up|0|||
130962040|NCT02460224|471489713|FG025|Overall Study|Lost to Follow-up|0|||
130962041|NCT02460224|471489714|FG026|Overall Study|Lost to Follow-up|0|||
130962042|NCT02460224|471489715|FG027|Overall Study|Lost to Follow-up|0|||
130962043|NCT02460224|471489716|FG028|Overall Study|Lost to Follow-up|0|||
130962044|NCT02460224|471489688|FG000|Overall Study|Physician Decision|0|||
130962045|NCT02460224|471489689|FG001|Overall Study|Physician Decision|1|||
130962046|NCT02460224|471489690|FG002|Overall Study|Physician Decision|0|||
130962047|NCT02460224|471489691|FG003|Overall Study|Physician Decision|0|||
130962048|NCT02460224|471489692|FG004|Overall Study|Physician Decision|1|||
130962049|NCT02460224|471489693|FG005|Overall Study|Physician Decision|0|||
130962050|NCT02460224|471489694|FG006|Overall Study|Physician Decision|0|||
130962051|NCT02460224|471489695|FG007|Overall Study|Physician Decision|1|||
130962052|NCT02460224|471489696|FG008|Overall Study|Physician Decision|0|||
130962053|NCT02460224|471489697|FG009|Overall Study|Physician Decision|0|||
130962054|NCT02460224|471489698|FG010|Overall Study|Physician Decision|0|||
130962055|NCT02460224|471489699|FG011|Overall Study|Physician Decision|1|||
130962056|NCT02460224|471489700|FG012|Overall Study|Physician Decision|0|||
130962057|NCT02460224|471489701|FG013|Overall Study|Physician Decision|1|||
130962058|NCT02460224|471489702|FG014|Overall Study|Physician Decision|0|||
130962059|NCT02460224|471489703|FG015|Overall Study|Physician Decision|0|||
130962060|NCT02460224|471489704|FG016|Overall Study|Physician Decision|2|||
130962061|NCT02460224|471489705|FG017|Overall Study|Physician Decision|1|||
130962062|NCT02460224|471489706|FG018|Overall Study|Physician Decision|1|||
130962063|NCT02460224|471489707|FG019|Overall Study|Physician Decision|2|||
130962064|NCT02460224|471489708|FG020|Overall Study|Physician Decision|1|||
130962065|NCT02460224|471489709|FG021|Overall Study|Physician Decision|1|||
130962066|NCT02460224|471489710|FG022|Overall Study|Physician Decision|0|||
130962067|NCT02460224|471489711|FG023|Overall Study|Physician Decision|0|||
130962068|NCT02460224|471489712|FG024|Overall Study|Physician Decision|1|||
130962069|NCT02460224|471489713|FG025|Overall Study|Physician Decision|0|||
130962070|NCT02460224|471489714|FG026|Overall Study|Physician Decision|14|||
130962071|NCT02460224|471489715|FG027|Overall Study|Physician Decision|1|||
130962072|NCT02460224|471489716|FG028|Overall Study|Physician Decision|6|||
131127433|NCT00705783|472095969|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
131127434|NCT00705783|472095967|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
131127435|NCT00705783|472095968|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
131127436|NCT00705783|472095969|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
131127437|NCT00705783|472095967|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
131127438|NCT00705783|472095968|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
131127439|NCT00705783|472095969|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
131127440|NCT00705783|472095967|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
131127441|NCT00705783|472095968|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
131127442|NCT00705783|472095969|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
131127443|NCT00705783|472095967|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
131127444|NCT00705783|472095968|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
131127445|NCT00705783|472095969|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
131127446|NCT00705783|472095967|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
131127447|NCT00705783|472095968|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
131127448|NCT00705783|472095969|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
131127449|NCT00705783|472095967|FG000|Oral Stabilization Phase|Adverse Event|14|||
131127450|NCT00705783|472095968|FG001|Oral Stabilization Phase|Adverse Event|0|||
130962073|NCT02460224|471489688|FG000|Overall Study|Progressive disease|15|||
130962074|NCT02460224|471489689|FG001|Overall Study|Progressive disease|11|||
130962075|NCT02460224|471489690|FG002|Overall Study|Progressive disease|5|||
130962076|NCT02460224|471489691|FG003|Overall Study|Progressive disease|6|||
130962077|NCT02460224|471489692|FG004|Overall Study|Progressive disease|3|||
130962078|NCT02460224|471489693|FG005|Overall Study|Progressive disease|26|||
130962079|NCT02460224|471489694|FG006|Overall Study|Progressive disease|28|||
130962080|NCT02460224|471489695|FG007|Overall Study|Progressive disease|4|||
131127451|NCT00705783|472095969|FG002|Oral Stabilization Phase|Adverse Event|0|||
131127452|NCT00705783|472095967|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
131127453|NCT00705783|472095968|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130962081|NCT02460224|471489696|FG008|Overall Study|Progressive disease|5|||
130962082|NCT02460224|471489697|FG009|Overall Study|Progressive disease|9|||
130962083|NCT02460224|471489698|FG010|Overall Study|Progressive disease|5|||
130962084|NCT02460224|471489699|FG011|Overall Study|Progressive disease|4|||
130962085|NCT02460224|471489700|FG012|Overall Study|Progressive disease|5|||
130962086|NCT02460224|471489701|FG013|Overall Study|Progressive disease|4|||
130714732|NCT00311311|470581766|FG001|Overall Study|Adverse Event|2|||
130714733|NCT00311311|470581765|FG000|Overall Study|Withdrawal by Subject|1|||
130714734|NCT00311311|470581766|FG001|Overall Study|Withdrawal by Subject|1|||
130714735|NCT00311311|470581765|FG000|Overall Study|Noncompliance|0|||
130714736|NCT00311311|470581766|FG001|Overall Study|Noncompliance|1|||
130714737|NCT00311311|470581765|FG000|Overall Study|Study Termination by Sponsor|3|||
130714738|NCT00311311|470581766|FG001|Overall Study|Study Termination by Sponsor|4|||
130714739|NCT00311311|470581765|FG000|Overall Study|Death|1|||
130714740|NCT00311311|470581766|FG001|Overall Study|Death|0|||
130714741|NCT00311311|470581765|FG000|Overall Study|Lack of ancillary assistance|0|||
130714742|NCT00311311|470581766|FG001|Overall Study|Lack of ancillary assistance|1|||
130714743|NCT03979820|470581769|FG000|Overall Study|Protocol Violation|1|||
130714744|NCT03979820|470581770|FG001|Overall Study|Protocol Violation|0|||
130714745|NCT03979820|470581771|FG002|Overall Study|Protocol Violation|0|||
130714746|NCT03979820|470581772|FG003|Overall Study|Protocol Violation|0|||
130714747|NCT03979820|470581769|FG000|Overall Study|Withdrawal by Subject|0|||
130714748|NCT03979820|470581770|FG001|Overall Study|Withdrawal by Subject|0|||
130714749|NCT03979820|470581771|FG002|Overall Study|Withdrawal by Subject|1|||
131226555|NCT00811070|472455771|FG000|Overall Study|Withdrawal by Subject|0|||
131226556|NCT00811070|472455772|FG001|Overall Study|Withdrawal by Subject|1|||
131226557|NCT00811070|472455773|FG002|Overall Study|Withdrawal by Subject|0|||
131226558|NCT00811070|472455774|FG003|Overall Study|Withdrawal by Subject|0|||
131226559|NCT00811070|472455775|FG004|Overall Study|Withdrawal by Subject|0|||
131226560|NCT00811070|472455776|FG005|Overall Study|Withdrawal by Subject|0|||
131226561|NCT00811070|472455771|FG000|Overall Study|Physician Decision|0|||
131226562|NCT00811070|472455772|FG001|Overall Study|Physician Decision|0|||
131226563|NCT00811070|472455773|FG002|Overall Study|Physician Decision|0|||
131226564|NCT00811070|472455774|FG003|Overall Study|Physician Decision|0|||
131226565|NCT00811070|472455775|FG004|Overall Study|Physician Decision|0|||
131226566|NCT00811070|472455776|FG005|Overall Study|Physician Decision|1|||
131226567|NCT01025193|472455777|FG000|Overall Study|Protocol Violation|1|||
131226568|NCT01025193|472455777|FG000|Overall Study|Adverse Event|3|||
131226569|NCT04079842|472455778|FG000|Overall Study|Request of subject|2|||
131226570|NCT04079842|472455778|FG000|Overall Study|Unable to draw Arterial samples|1|||
131226571|NCT02904200|472455779|FG000|Overall Study|Withdrawal by Subject|1|||
131226572|NCT02904200|472455780|FG001|Overall Study|Withdrawal by Subject|0|||
130714750|NCT03979820|470581772|FG003|Overall Study|Withdrawal by Subject|0|||
130714751|NCT03979820|470581769|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
130962087|NCT02460224|471489702|FG014|Overall Study|Progressive disease|5|||
131127454|NCT00705783|472095969|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131127455|NCT00705783|472095967|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
131127456|NCT00705783|472095968|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131127457|NCT00705783|472095969|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131127458|NCT00705783|472095967|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
131127459|NCT00705783|472095968|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
131127460|NCT00705783|472095969|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
131127461|NCT00705783|472095967|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
131127462|NCT00705783|472095968|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
131127463|NCT00705783|472095969|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
131127464|NCT00705783|472095967|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
131127465|NCT00705783|472095968|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
131127466|NCT00705783|472095969|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
131127467|NCT00705783|472095967|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
131127468|NCT00705783|472095968|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
131127469|NCT00705783|472095969|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
131127470|NCT00705783|472095967|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
131127471|NCT00705783|472095968|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
131127472|NCT00705783|472095969|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
131127473|NCT00705783|472095967|FG000|Depot Stabilization Phase|Adverse Event|17|||
131127474|NCT00705783|472095968|FG001|Depot Stabilization Phase|Adverse Event|0|||
131127475|NCT00705783|472095969|FG002|Depot Stabilization Phase|Adverse Event|0|||
131127476|NCT00705783|472095967|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
131127477|NCT00705783|472095968|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131127478|NCT00705783|472095969|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131127479|NCT00705783|472095967|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
131127480|NCT00705783|472095968|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131226573|NCT00185211|472455781|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
131226574|NCT00185211|472455782|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
130714752|NCT03979820|470581770|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
130714753|NCT03979820|470581771|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
130962088|NCT02460224|471489703|FG015|Overall Study|Progressive disease|5|||
130962089|NCT02460224|471489704|FG016|Overall Study|Progressive disease|15|||
130962090|NCT02460224|471489705|FG017|Overall Study|Progressive disease|3|||
130962091|NCT02460224|471489706|FG018|Overall Study|Progressive disease|8|||
130962092|NCT02460224|471489707|FG019|Overall Study|Progressive disease|3|||
130962093|NCT02460224|471489708|FG020|Overall Study|Progressive disease|4|||
130962094|NCT02460224|471489709|FG021|Overall Study|Progressive disease|9|||
130962095|NCT02460224|471489710|FG022|Overall Study|Progressive disease|4|||
130962096|NCT02460224|471489711|FG023|Overall Study|Progressive disease|11|||
130962097|NCT02460224|471489712|FG024|Overall Study|Progressive disease|4|||
131127481|NCT00705783|472095969|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131127482|NCT00705783|472095967|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
131127483|NCT00705783|472095968|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
131127484|NCT00705783|472095969|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
131127485|NCT00705783|472095967|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
131127486|NCT00705783|472095968|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
131127487|NCT00705783|472095969|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
131127488|NCT00705783|472095967|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
131127489|NCT00705783|472095968|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
131127490|NCT00705783|472095969|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
131127491|NCT00705783|472095967|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
131127492|NCT00705783|472095968|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
131127493|NCT00705783|472095969|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
131127494|NCT00705783|472095967|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
131127495|NCT00705783|472095968|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
131127496|NCT00705783|472095969|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
130962098|NCT02460224|471489713|FG025|Overall Study|Progressive disease|5|||
130962099|NCT02460224|471489714|FG026|Overall Study|Progressive disease|85|||
130962100|NCT02460224|471489715|FG027|Overall Study|Progressive disease|17|||
130962101|NCT02460224|471489716|FG028|Overall Study|Progressive disease|77|||
130962102|NCT02460224|471489688|FG000|Overall Study|Subject/guardian decision|2|||
130962103|NCT02460224|471489689|FG001|Overall Study|Subject/guardian decision|0|||
130962104|NCT02460224|471489690|FG002|Overall Study|Subject/guardian decision|1|||
130962105|NCT02460224|471489691|FG003|Overall Study|Subject/guardian decision|0|||
130962106|NCT02460224|471489692|FG004|Overall Study|Subject/guardian decision|2|||
130962107|NCT02460224|471489693|FG005|Overall Study|Subject/guardian decision|2|||
130962108|NCT02460224|471489694|FG006|Overall Study|Subject/guardian decision|0|||
130962109|NCT02460224|471489695|FG007|Overall Study|Subject/guardian decision|0|||
130962110|NCT02460224|471489696|FG008|Overall Study|Subject/guardian decision|1|||
130962111|NCT02460224|471489697|FG009|Overall Study|Subject/guardian decision|1|||
130962112|NCT02460224|471489698|FG010|Overall Study|Subject/guardian decision|0|||
131041233|NCT04625725|471785450|FG005|Provent Main Study|Participants dosed in sub-study|0|||
131041234|NCT04625725|471785445|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
131041235|NCT04625725|471785446|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
131127497|NCT00705783|472095967|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
131127498|NCT00705783|472095968|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
131127499|NCT00705783|472095969|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
131127500|NCT00705783|472095967|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
131127501|NCT00705783|472095968|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
131127502|NCT00705783|472095969|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
131127503|NCT00705783|472095967|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
131127504|NCT00705783|472095968|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
131127505|NCT00705783|472095969|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
131226575|NCT00185211|472455781|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
131226576|NCT00185211|472455782|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
130774801|NCT03410992|470802568|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130774802|NCT03410992|470802569|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130774803|NCT03410992|470802559|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130962113|NCT02460224|471489699|FG011|Overall Study|Subject/guardian decision|1|||
130962114|NCT02460224|471489700|FG012|Overall Study|Subject/guardian decision|0|||
130962115|NCT02460224|471489701|FG013|Overall Study|Subject/guardian decision|0|||
130962116|NCT02460224|471489702|FG014|Overall Study|Subject/guardian decision|0|||
130962117|NCT02460224|471489703|FG015|Overall Study|Subject/guardian decision|1|||
130962118|NCT02460224|471489704|FG016|Overall Study|Subject/guardian decision|0|||
131041236|NCT04625725|471785447|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
131041237|NCT04625725|471785448|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
131041238|NCT04625725|471785449|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
131041239|NCT04625725|471785450|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
131041240|NCT04625725|471785445|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
131127506|NCT00705783|472095967|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
131127507|NCT00705783|472095968|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
131127508|NCT00705783|472095969|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
130714754|NCT03979820|470581772|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
130714755|NCT00988065|470581773|FG000|Overall Study|Adverse Event|4|||
130714756|NCT00988065|470581774|FG001|Overall Study|Adverse Event|10|||
130714757|NCT00988065|470581775|FG002|Overall Study|Adverse Event|2|||
130714758|NCT00988065|470581773|FG000|Overall Study|Lost to Follow-up|1|||
130714759|NCT00988065|470581774|FG001|Overall Study|Lost to Follow-up|2|||
130714760|NCT00988065|470581775|FG002|Overall Study|Lost to Follow-up|2|||
130962119|NCT02460224|471489705|FG017|Overall Study|Subject/guardian decision|1|||
130962120|NCT02460224|471489706|FG018|Overall Study|Subject/guardian decision|2|||
130962121|NCT02460224|471489707|FG019|Overall Study|Subject/guardian decision|0|||
130962122|NCT02460224|471489708|FG020|Overall Study|Subject/guardian decision|0|||
130962123|NCT02460224|471489709|FG021|Overall Study|Subject/guardian decision|1|||
130962124|NCT02460224|471489710|FG022|Overall Study|Subject/guardian decision|0|||
130714761|NCT00988065|470581773|FG000|Overall Study|Subject withdrew consent|3|||
130714762|NCT00988065|470581774|FG001|Overall Study|Subject withdrew consent|5|||
130714763|NCT00988065|470581775|FG002|Overall Study|Subject withdrew consent|2|||
130714764|NCT00988065|470581773|FG000|Overall Study|Noncompliance with protocol|5|||
130714765|NCT00988065|470581774|FG001|Overall Study|Noncompliance with protocol|6|||
130714766|NCT00988065|470581775|FG002|Overall Study|Noncompliance with protocol|9|||
130714767|NCT02685202|470581776|FG000|Overall Study|Lost to Follow-up|9|||
130714768|NCT01229735|470581777|FG000|Overall Study|Lack of Efficacy|8|||
130714769|NCT01229735|470581778|FG001|Overall Study|Lack of Efficacy|8|||
130714770|NCT01229735|470581777|FG000|Overall Study|Protocol Violation|13|||
130714771|NCT01229735|470581778|FG001|Overall Study|Protocol Violation|8|||
130714772|NCT01229735|470581777|FG000|Overall Study|Lost to Follow-up|0|||
130962125|NCT02460224|471489711|FG023|Overall Study|Subject/guardian decision|0|||
130962126|NCT02460224|471489712|FG024|Overall Study|Subject/guardian decision|0|||
130962127|NCT02460224|471489713|FG025|Overall Study|Subject/guardian decision|0|||
130962128|NCT02460224|471489714|FG026|Overall Study|Subject/guardian decision|6|||
130962129|NCT02460224|471489715|FG027|Overall Study|Subject/guardian decision|2|||
130962130|NCT02460224|471489716|FG028|Overall Study|Subject/guardian decision|3|||
130962131|NCT02797262|471489717|FG000|Overall Study|Withdrawal by Subject|5|||
130962132|NCT02797262|471489718|FG001|Overall Study|Withdrawal by Subject|1|||
130962133|NCT02797262|471489717|FG000|Overall Study|Lost to Follow-up|10|||
131127509|NCT02182687|472095970|FG000|Overall Study|Withdrawal by Subject|4|||
131127510|NCT02182687|472095971|FG001|Overall Study|Withdrawal by Subject|0|||
131127511|NCT02182687|472095970|FG000|Overall Study|Adverse Event|1|||
131127512|NCT02182687|472095971|FG001|Overall Study|Adverse Event|0|||
131127513|NCT02182687|472095970|FG000|Overall Study|Lost to Follow-up|0|||
131127514|NCT02182687|472095971|FG001|Overall Study|Lost to Follow-up|1|||
131127515|NCT02184195|472095974|FG000|Overall Study|Patient decision|5|||
131127516|NCT02184195|472095975|FG001|Overall Study|Patient decision|2|||
131127517|NCT02184195|472095974|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131127518|NCT02184195|472095975|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
131127519|NCT02184195|472095974|FG000|Overall Study|Death|67|||
131226577|NCT00185211|472455781|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
130714773|NCT01229735|470581778|FG001|Overall Study|Lost to Follow-up|2|||
130714774|NCT01229735|470581777|FG000|Overall Study|Withdrawal by Subject|18|||
130714775|NCT01229735|470581778|FG001|Overall Study|Withdrawal by Subject|17|||
130962134|NCT02797262|471489718|FG001|Overall Study|Lost to Follow-up|7|||
130962135|NCT02797262|471489717|FG000|Overall Study|Death|1|||
130962136|NCT02797262|471489718|FG001|Overall Study|Death|2|||
130962137|NCT02797262|471489717|FG000|Overall Study|Adverse Event|1|||
130962138|NCT02797262|471489718|FG001|Overall Study|Adverse Event|0|||
130962139|NCT02797262|471489717|FG000|Overall Study|COVID-19|2|||
130962140|NCT02797262|471489718|FG001|Overall Study|COVID-19|1|||
130962141|NCT02797262|471489717|FG000|Overall Study|Out-of-country|1|||
130714776|NCT01229735|470581777|FG000|Overall Study|Other Reason|13|||
130714777|NCT01229735|470581778|FG001|Overall Study|Other Reason|10|||
130714778|NCT01229735|470581777|FG000|Overall Study|SAE, non-fatal|0|||
130962142|NCT02797262|471489718|FG001|Overall Study|Out-of-country|0|||
130962143|NCT01600586|471489719|FG000|Overall Study|Physician Decision|3|||
130962144|NCT01600586|471489720|FG001|Overall Study|Physician Decision|3|||
130962145|NCT03146650|471489722|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
130962146|NCT03146650|471489722|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
130962147|NCT03146650|471489722|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
130962148|NCT03146650|471489722|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
130962149|NCT03146650|471489722|FG000|2 Year Follow-up|Death|11|||
130962150|NCT03146650|471489722|FG000|2 Year Follow-up|Still in follow-up|7|||
130962151|NCT03146650|471489722|FG000|2 Year Follow-up|Lost to Follow-up|1|||
131127520|NCT02184195|472095975|FG001|Overall Study|Death|44|||
131127521|NCT02184195|472095974|FG000|Overall Study|Lost to Follow-up|1|||
131127522|NCT02184195|472095975|FG001|Overall Study|Lost to Follow-up|5|||
131127523|NCT02184195|472095974|FG000|Overall Study|Other|0|||
130714779|NCT01229735|470581778|FG001|Overall Study|SAE, non-fatal|4|||
130714780|NCT01229735|470581777|FG000|Overall Study|AE, non-serious non-fatal|13|||
130714781|NCT01229735|470581778|FG001|Overall Study|AE, non-serious non-fatal|17|||
130962152|NCT00983814|471489725|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
130962153|NCT00983814|471489726|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
130962154|NCT00983814|471489727|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
130962155|NCT00983814|471489725|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
130962156|NCT00983814|471489726|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
130962157|NCT00983814|471489727|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
130962158|NCT00983814|471489725|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
130962159|NCT00983814|471489726|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
130962160|NCT00983814|471489727|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
130962161|NCT00983814|471489725|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
130962162|NCT00983814|471489726|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
130962163|NCT00983814|471489727|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
130962164|NCT00983814|471489725|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
130962165|NCT00983814|471489726|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
130962166|NCT00983814|471489727|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
130962167|NCT03333486|471489728|FG000|Overall Study|Withdrawal by Subject|1|||
130962168|NCT03333486|471489728|FG000|Overall Study|Lost to Follow-up|1|||
130962169|NCT01976845|471489731|FG000|Overall Study|Physician Decision|8|||
130962170|NCT01976845|471489732|FG001|Overall Study|Physician Decision|8|||
130962171|NCT01976845|471489733|FG002|Overall Study|Physician Decision|3|||
130962172|NCT03246529|471489734|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
130962173|NCT03246529|471489735|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
130962174|NCT03246529|471489736|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
130962175|NCT03246529|471489734|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
130962176|NCT03246529|471489735|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
130962177|NCT03246529|471489736|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
130962178|NCT03246529|471489734|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
130962179|NCT03246529|471489735|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
130962180|NCT03246529|471489736|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
130962181|NCT03246529|471489734|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
130962182|NCT03246529|471489735|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
130962183|NCT03246529|471489736|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
130962184|NCT03246529|471489734|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
130962185|NCT03246529|471489735|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
130962186|NCT03246529|471489736|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
130962187|NCT03246529|471489734|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
130962188|NCT03246529|471489735|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
130962189|NCT03246529|471489736|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
130962190|NCT03246529|471489734|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
130962191|NCT03246529|471489735|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
130962192|NCT03246529|471489736|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
131041241|NCT04625725|471785446|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
130774804|NCT03410992|470802560|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
131041242|NCT04625725|471785447|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
131041243|NCT04625725|471785448|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
131041244|NCT04625725|471785449|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
131041245|NCT04625725|471785450|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
131041246|NCT04625725|471785445|FG000|Provent Main Study|INCARCERATION|3|||
131041247|NCT04625725|471785446|FG001|Provent Main Study|INCARCERATION|0|||
131041248|NCT04625725|471785447|FG002|Provent Main Study|INCARCERATION|0|||
131041249|NCT04625725|471785448|FG003|Provent Main Study|INCARCERATION|0|||
131041250|NCT04625725|471785449|FG004|Provent Main Study|INCARCERATION|0|||
131041251|NCT04625725|471785450|FG005|Provent Main Study|INCARCERATION|0|||
131041252|NCT04625725|471785445|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
131041253|NCT04625725|471785446|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
131041254|NCT04625725|471785447|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
131041255|NCT04625725|471785448|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
131041256|NCT04625725|471785449|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
131041257|NCT04625725|471785450|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
131041258|NCT04625725|471785445|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
131041259|NCT04625725|471785446|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
131041260|NCT04625725|471785447|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
131041261|NCT04625725|471785448|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
130962193|NCT03246529|471489734|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
130962194|NCT03246529|471489735|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
130962195|NCT03246529|471489736|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
131041262|NCT04625725|471785449|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
131041263|NCT04625725|471785450|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
131041264|NCT04625725|471785445|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
130962196|NCT03246529|471489734|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
130962197|NCT03246529|471489735|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
130962198|NCT03246529|471489736|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
130962199|NCT01209624|471489737|FG000|Overall Study|Death|2|||
130962200|NCT01209624|471489737|FG000|Overall Study|Adverse Event|13|||
130962201|NCT01209624|471489737|FG000|Overall Study|Lack of Efficacy|17|||
130962202|NCT01209624|471489737|FG000|Overall Study|Lost to Follow-up|290|||
130962203|NCT01209624|471489737|FG000|Overall Study|Other|4|||
130962204|NCT01818336|471491005|FG000|Overall Study|Declined retest visit|0|||
130962205|NCT01818336|471491006|FG001|Overall Study|Declined retest visit|11|||
130962206|NCT01818336|471491005|FG000|Overall Study|Lost to Follow-up|0|||
130962207|NCT01818336|471491006|FG001|Overall Study|Lost to Follow-up|1|||
130962208|NCT00827372|471491011|FG000|Overall Study|Adverse Event|5|||
130962209|NCT00827372|471491011|FG000|Overall Study|Lack of Efficacy|3|||
130962210|NCT02139644|471491012|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
130962211|NCT02139644|471491013|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130962212|NCT02139644|471491014|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130962213|NCT02139644|471491015|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130962214|NCT02139644|471491016|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130962215|NCT02139644|471491017|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130962216|NCT02139644|471491012|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
130962217|NCT02139644|471491013|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130962218|NCT02139644|471491014|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130962219|NCT02139644|471491015|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130962220|NCT02139644|471491016|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130962221|NCT02139644|471491017|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130962222|NCT02139644|471491012|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
130962223|NCT02139644|471491013|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130962224|NCT02139644|471491014|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130962225|NCT02139644|471491015|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130962226|NCT02139644|471491016|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130962227|NCT02139644|471491017|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130962228|NCT02139644|471491012|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
130962229|NCT02139644|471491013|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130962230|NCT02139644|471491014|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130962231|NCT02139644|471491015|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130962232|NCT02139644|471491016|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130962233|NCT02139644|471491017|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130962234|NCT02139644|471491012|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
130962235|NCT02139644|471491013|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130962236|NCT02139644|471491014|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130962237|NCT02139644|471491015|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130962238|NCT02139644|471491016|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130962239|NCT02139644|471491017|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130962240|NCT02139644|471491012|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
130962241|NCT02139644|471491013|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
130962242|NCT02139644|471491014|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
130962243|NCT02139644|471491015|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
131041265|NCT04625725|471785446|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
131041266|NCT04625725|471785447|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
131041267|NCT04625725|471785448|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
131041268|NCT04625725|471785449|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
131041269|NCT04625725|471785450|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
131041270|NCT04625725|471785445|FG000|Provent Main Study|MISSING REASON|0|||
131041271|NCT04625725|471785446|FG001|Provent Main Study|MISSING REASON|1|||
131041272|NCT04625725|471785447|FG002|Provent Main Study|MISSING REASON|0|||
131041273|NCT04625725|471785448|FG003|Provent Main Study|MISSING REASON|0|||
131041274|NCT04625725|471785449|FG004|Provent Main Study|MISSING REASON|0|||
131041275|NCT04625725|471785450|FG005|Provent Main Study|MISSING REASON|0|||
131041276|NCT04625725|471785445|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
131041277|NCT04625725|471785446|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
131041278|NCT04625725|471785447|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
131041279|NCT04625725|471785448|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
131041280|NCT04625725|471785449|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
131041281|NCT04625725|471785450|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
131041282|NCT04625725|471785445|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
131041283|NCT04625725|471785446|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
131041284|NCT04625725|471785447|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
131041285|NCT04625725|471785448|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
130714782|NCT01229735|470581777|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130962244|NCT02139644|471491016|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
130962245|NCT02139644|471491017|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
130962246|NCT02139644|471491012|FG000|Run-In Period (Pre-assignment)|Other|6|||
130962247|NCT02139644|471491013|FG001|Run-In Period (Pre-assignment)|Other|0|||
130962248|NCT02139644|471491014|FG002|Run-In Period (Pre-assignment)|Other|0|||
130962249|NCT02139644|471491015|FG003|Run-In Period (Pre-assignment)|Other|0|||
130962250|NCT02139644|471491016|FG004|Run-In Period (Pre-assignment)|Other|0|||
130962251|NCT02139644|471491017|FG005|Run-In Period (Pre-assignment)|Other|0|||
130962252|NCT02139644|471491012|FG000|Treatment Period|Adverse Event|0|||
130962253|NCT02139644|471491013|FG001|Treatment Period|Adverse Event|0|||
130962254|NCT02139644|471491014|FG002|Treatment Period|Adverse Event|3|||
130962255|NCT02139644|471491015|FG003|Treatment Period|Adverse Event|2|||
130962256|NCT02139644|471491016|FG004|Treatment Period|Adverse Event|1|||
130962257|NCT02139644|471491017|FG005|Treatment Period|Adverse Event|6|||
130962258|NCT02139644|471491012|FG000|Treatment Period|Withdrawal by Subject|0|||
130962259|NCT02139644|471491013|FG001|Treatment Period|Withdrawal by Subject|0|||
130962260|NCT02139644|471491014|FG002|Treatment Period|Withdrawal by Subject|2|||
130962261|NCT02139644|471491015|FG003|Treatment Period|Withdrawal by Subject|2|||
130962262|NCT02139644|471491016|FG004|Treatment Period|Withdrawal by Subject|3|||
130962263|NCT02139644|471491017|FG005|Treatment Period|Withdrawal by Subject|2|||
130962264|NCT02139644|471491012|FG000|Treatment Period|Non-compliance|0|||
130962265|NCT02139644|471491013|FG001|Treatment Period|Non-compliance|0|||
130962266|NCT02139644|471491014|FG002|Treatment Period|Non-compliance|0|||
130962267|NCT02139644|471491015|FG003|Treatment Period|Non-compliance|1|||
130962268|NCT02139644|471491016|FG004|Treatment Period|Non-compliance|0|||
130962269|NCT02139644|471491017|FG005|Treatment Period|Non-compliance|0|||
130962270|NCT02139644|471491012|FG000|Treatment Period|Protocol Violation|0|||
130962271|NCT02139644|471491013|FG001|Treatment Period|Protocol Violation|0|||
130962272|NCT02139644|471491014|FG002|Treatment Period|Protocol Violation|0|||
130962273|NCT02139644|471491015|FG003|Treatment Period|Protocol Violation|1|||
130962274|NCT02139644|471491016|FG004|Treatment Period|Protocol Violation|1|||
130962275|NCT02139644|471491017|FG005|Treatment Period|Protocol Violation|1|||
130962276|NCT02139644|471491012|FG000|Treatment Period|Disease progression|0|||
130962277|NCT02139644|471491013|FG001|Treatment Period|Disease progression|0|||
130962278|NCT02139644|471491014|FG002|Treatment Period|Disease progression|0|||
130962279|NCT02139644|471491015|FG003|Treatment Period|Disease progression|1|||
130962280|NCT02139644|471491016|FG004|Treatment Period|Disease progression|1|||
130962281|NCT02139644|471491017|FG005|Treatment Period|Disease progression|2|||
130962282|NCT02139644|471491012|FG000|Treatment Period|Lost to Follow-up|0|||
130962283|NCT02139644|471491013|FG001|Treatment Period|Lost to Follow-up|0|||
130962284|NCT02139644|471491014|FG002|Treatment Period|Lost to Follow-up|1|||
130962285|NCT02139644|471491015|FG003|Treatment Period|Lost to Follow-up|1|||
130962286|NCT02139644|471491016|FG004|Treatment Period|Lost to Follow-up|1|||
130962287|NCT02139644|471491017|FG005|Treatment Period|Lost to Follow-up|1|||
130962288|NCT02139644|471491012|FG000|Treatment Period|Lack of Efficacy|0|||
130962289|NCT02139644|471491013|FG001|Treatment Period|Lack of Efficacy|0|||
130962290|NCT02139644|471491014|FG002|Treatment Period|Lack of Efficacy|1|||
130962291|NCT02139644|471491015|FG003|Treatment Period|Lack of Efficacy|0|||
130962292|NCT02139644|471491016|FG004|Treatment Period|Lack of Efficacy|1|||
130962293|NCT02139644|471491017|FG005|Treatment Period|Lack of Efficacy|4|||
130962294|NCT02139644|471491012|FG000|Treatment Period|Other|0|||
130962295|NCT02139644|471491013|FG001|Treatment Period|Other|3|||
130962296|NCT02139644|471491014|FG002|Treatment Period|Other|1|||
130962297|NCT02139644|471491015|FG003|Treatment Period|Other|1|||
130962298|NCT02139644|471491016|FG004|Treatment Period|Other|0|||
130962299|NCT02139644|471491017|FG005|Treatment Period|Other|1|||
130962300|NCT03328897|471491018|FG000|Randomized-treatment Epoch|Adverse Event|4|||
130962301|NCT03328897|471491019|FG001|Randomized-treatment Epoch|Adverse Event|1|||
130962302|NCT03328897|471491020|FG002|Randomized-treatment Epoch|Adverse Event|1|||
130962303|NCT03328897|471491018|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
130714783|NCT01229735|470581778|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130962304|NCT03328897|471491019|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
130962305|NCT03328897|471491020|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
130962306|NCT03328897|471491018|FG000|Randomized-treatment Epoch|Pregnancy|3|||
130962307|NCT03328897|471491019|FG001|Randomized-treatment Epoch|Pregnancy|0|||
130962308|NCT03328897|471491020|FG002|Randomized-treatment Epoch|Pregnancy|0|||
130962309|NCT03328897|471491018|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
130962310|NCT03328897|471491019|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
130962311|NCT03328897|471491020|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
130962312|NCT03328897|471491018|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
130962313|NCT03328897|471491019|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
130962314|NCT03328897|471491020|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
130962315|NCT03328897|471491018|FG000|Follow-up Epoch|Adverse Event|4|||
130962316|NCT03328897|471491019|FG001|Follow-up Epoch|Adverse Event|0|||
130962317|NCT03328897|471491020|FG002|Follow-up Epoch|Adverse Event|1|||
131226578|NCT00185211|472455782|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
131226579|NCT00185211|472455781|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
131226580|NCT00185211|472455782|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
131226581|NCT00185211|472455781|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
131226582|NCT00185211|472455782|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
131226583|NCT00185211|472455781|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
131226584|NCT00185211|472455782|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
131226585|NCT00185211|472455781|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
130714784|NCT02787408|470581779|FG000|Overall Study|Death|16|||
130714785|NCT02787408|470581779|FG000|Overall Study|Withdrawal by Subject|1|||
131226586|NCT00185211|472455782|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
131226587|NCT00185211|472455781|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
130714786|NCT02787408|470581779|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
130714787|NCT00985712|470581780|FG000|Overall Study|Adverse Event|0|||
130714788|NCT00985712|470581781|FG001|Overall Study|Adverse Event|1|||
130714789|NCT00985712|470581780|FG000|Overall Study|Lost to Follow-up|2|||
130714790|NCT00985712|470581781|FG001|Overall Study|Lost to Follow-up|2|||
130714791|NCT00985712|470581780|FG000|Overall Study|Protocol Violation|0|||
130714792|NCT00985712|470581781|FG001|Overall Study|Protocol Violation|1|||
130714793|NCT00985712|470581780|FG000|Overall Study|Withdrawal by Subject|4|||
130714794|NCT00985712|470581781|FG001|Overall Study|Withdrawal by Subject|1|||
130714795|NCT00985712|470581780|FG000|Overall Study|Sponsor decision|0|||
130714796|NCT00985712|470581781|FG001|Overall Study|Sponsor decision|2|||
130714797|NCT01000493|470581782|FG000|Overall Study|Adverse Event|3|||
130714798|NCT01000493|470581783|FG001|Overall Study|Adverse Event|6|||
130714799|NCT01000493|470581782|FG000|Overall Study|Lack of Efficacy|1|||
130714800|NCT01000493|470581783|FG001|Overall Study|Lack of Efficacy|1|||
130962318|NCT03328897|471491018|FG000|Follow-up Epoch|Lack of Efficacy|1|||
130962319|NCT03328897|471491019|FG001|Follow-up Epoch|Lack of Efficacy|1|||
130962320|NCT03328897|471491020|FG002|Follow-up Epoch|Lack of Efficacy|1|||
130962321|NCT03328897|471491018|FG000|Follow-up Epoch|Lost to Follow-up|0|||
130962322|NCT03328897|471491019|FG001|Follow-up Epoch|Lost to Follow-up|1|||
130962323|NCT03328897|471491020|FG002|Follow-up Epoch|Lost to Follow-up|0|||
130962324|NCT03328897|471491018|FG000|Follow-up Epoch|Pregnancy|1|||
130962325|NCT03328897|471491019|FG001|Follow-up Epoch|Pregnancy|0|||
130962326|NCT03328897|471491020|FG002|Follow-up Epoch|Pregnancy|0|||
130962327|NCT03328897|471491018|FG000|Follow-up Epoch|Patient/guardian decision|2|||
130962328|NCT03328897|471491019|FG001|Follow-up Epoch|Patient/guardian decision|1|||
130962329|NCT03328897|471491020|FG002|Follow-up Epoch|Patient/guardian decision|0|||
130962330|NCT00941733|471491021|FG000|Overall Study|Death|24|||
130962331|NCT00941733|471491022|FG001|Overall Study|Death|10|||
130962332|NCT00941733|471491021|FG000|Overall Study|Withdrawal by Subject|14|||
130962333|NCT00941733|471491022|FG001|Overall Study|Withdrawal by Subject|6|||
130962334|NCT00941733|471491021|FG000|Overall Study|Adverse Event|20|||
130962335|NCT00941733|471491022|FG001|Overall Study|Adverse Event|4|||
130962336|NCT00941733|471491021|FG000|Overall Study|Lost to Follow-up|1|||
130962337|NCT00941733|471491022|FG001|Overall Study|Lost to Follow-up|2|||
130962338|NCT00941733|471491021|FG000|Overall Study|Protocol Violation|15|||
130962339|NCT00941733|471491022|FG001|Overall Study|Protocol Violation|6|||
130962340|NCT02080091|471491023|FG000|Overall Study|Study Terminated|22|||
130962341|NCT02080091|471491023|FG000|Overall Study|Death|1|||
130962342|NCT02080091|471491023|FG000|Overall Study|Withdrawal by Subject|1|||
130962343|NCT02080091|471491023|FG000|Overall Study|Other|1|||
130962344|NCT00408993|471491028|FG000|Overall Study|Adverse Event|15|||
130962345|NCT00408993|471491029|FG001|Overall Study|Adverse Event|4|||
130962346|NCT00408993|471491028|FG000|Overall Study|Protocol Violation|1|||
130962347|NCT00408993|471491029|FG001|Overall Study|Protocol Violation|6|||
130962348|NCT00408993|471491028|FG000|Overall Study|Lack of Efficacy|1|||
130962349|NCT00408993|471491029|FG001|Overall Study|Lack of Efficacy|4|||
130714801|NCT01000493|470581782|FG000|Overall Study|Protocol Violation|1|||
130714802|NCT01000493|470581783|FG001|Overall Study|Protocol Violation|8|||
130714803|NCT01000493|470581782|FG000|Overall Study|Study closed/terminated|25|||
130714804|NCT01000493|470581783|FG001|Overall Study|Study closed/terminated|23|||
130962350|NCT00408993|471491028|FG000|Overall Study|Withdrawal by Subject|2|||
130962351|NCT00408993|471491029|FG001|Overall Study|Withdrawal by Subject|3|||
130962352|NCT03738865|471491030|FG000|Overall Study|Withdrawal by Subject|3|||
130714805|NCT01000493|470581782|FG000|Overall Study|Lost to Follow-up|5|||
130714806|NCT01000493|470581783|FG001|Overall Study|Lost to Follow-up|9|||
130714807|NCT01000493|470581782|FG000|Overall Study|Physician Decision|1|||
130714808|NCT01000493|470581783|FG001|Overall Study|Physician Decision|1|||
130714809|NCT01000493|470581782|FG000|Overall Study|Withdrawal by Subject|3|||
130714810|NCT01000493|470581783|FG001|Overall Study|Withdrawal by Subject|7|||
130714811|NCT01346774|470581784|FG000|Overall Study|Did not take a single dose|6|||
130962353|NCT03738865|471491031|FG001|Overall Study|Withdrawal by Subject|3|||
130962354|NCT03738865|471491030|FG000|Overall Study|Adverse Event|2|||
130962355|NCT03738865|471491031|FG001|Overall Study|Adverse Event|0|||
130962356|NCT03738865|471491030|FG000|Overall Study|Physician Decision|0|||
130714812|NCT01346774|470581785|FG001|Overall Study|Did not take a single dose|4|||
130714813|NCT01346774|470581784|FG000|Overall Study|Lost to Follow-up|3|||
130714814|NCT01346774|470581785|FG001|Overall Study|Lost to Follow-up|4|||
130714815|NCT01346774|470581784|FG000|Overall Study|Withdrawal by Subject|1|||
130714816|NCT01346774|470581785|FG001|Overall Study|Withdrawal by Subject|4|||
130962357|NCT03738865|471491031|FG001|Overall Study|Physician Decision|1|||
130962358|NCT00961259|471491032|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
130962359|NCT00961259|471491033|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
130962360|NCT00961259|471491034|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
130962361|NCT02691455|471491035|FG000|Overall Study|Withdrawal by Subject|1|||
130962362|NCT02691455|471491036|FG001|Overall Study|Withdrawal by Subject|2|||
130962363|NCT02691455|471491035|FG000|Overall Study|Lost to Follow-up|15|||
130962364|NCT02691455|471491036|FG001|Overall Study|Lost to Follow-up|15|||
130962365|NCT01863446|471491038|FG000|Overall Study|Withdrawal by Subject|1|||
130962366|NCT01863446|471491039|FG001|Overall Study|Withdrawal by Subject|0|||
130962367|NCT01863446|471491040|FG002|Overall Study|Withdrawal by Subject|1|||
130962368|NCT01863446|471491041|FG003|Overall Study|Withdrawal by Subject|2|||
130962369|NCT01863446|471491038|FG000|Overall Study|Physician Decision|0|||
130962370|NCT01863446|471491039|FG001|Overall Study|Physician Decision|0|||
130962371|NCT01863446|471491040|FG002|Overall Study|Physician Decision|1|||
130962372|NCT01863446|471491041|FG003|Overall Study|Physician Decision|0|||
130962373|NCT02252081|471491042|FG000|Overall Study|Withdrawal by Subject|2|||
130962374|NCT02252081|471491043|FG001|Overall Study|Withdrawal by Subject|1|||
130962375|NCT02252081|471491042|FG000|Overall Study|Adverse Event|4|||
130962376|NCT02252081|471491043|FG001|Overall Study|Adverse Event|1|||
130962377|NCT02252081|471491042|FG000|Overall Study|non compliance & others|0|||
130962378|NCT02252081|471491043|FG001|Overall Study|non compliance & others|2|||
130962379|NCT01276327|471491050|FG000|Overall Study|Adverse Event|1|||
130962380|NCT01276327|471491051|FG001|Overall Study|Adverse Event|3|||
130962381|NCT01276327|471491050|FG000|Overall Study|Withdrawal by Subject|1|||
130962382|NCT01276327|471491051|FG001|Overall Study|Withdrawal by Subject|0|||
130962383|NCT01794949|471491052|FG000|Overall Study|Lost to Follow-up|1|||
130962384|NCT01794949|471491053|FG001|Overall Study|Lost to Follow-up|0|||
130962385|NCT04713748|471491055|FG000|Overall Study|Not enough kits allocated|35|||
130962386|NCT01410110|471491062|FG000|Overall Study|Withdrawal by Subject|4|||
130962387|NCT01410110|471491063|FG001|Overall Study|Withdrawal by Subject|2|||
130962388|NCT02802345|471491067|FG000|Overall Study|Not Treated|0|||
130962389|NCT02802345|471491068|FG001|Overall Study|Not Treated|1|||
130962390|NCT02802345|471491067|FG000|Overall Study|Adverse Event|28|||
130962391|NCT02802345|471491068|FG001|Overall Study|Adverse Event|20|||
130962392|NCT02802345|471491067|FG000|Overall Study|Withdrawal by Subject|3|||
130962393|NCT02802345|471491068|FG001|Overall Study|Withdrawal by Subject|3|||
130962394|NCT02802345|471491067|FG000|Overall Study|Protocol Violation|0|||
130962395|NCT02802345|471491068|FG001|Overall Study|Protocol Violation|1|||
130962396|NCT02802345|471491067|FG000|Overall Study|Other than listed|1|||
130962397|NCT02802345|471491068|FG001|Overall Study|Other than listed|5|||
130962398|NCT04632940|471491069|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
130962399|NCT04632940|471491070|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
130962400|NCT04632940|471491069|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
130962401|NCT04632940|471491070|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
130962402|NCT04632940|471491069|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
130962403|NCT04632940|471491070|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
130962404|NCT04632940|471491069|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
130962405|NCT04632940|471491070|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
130962406|NCT04632940|471491069|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
130962407|NCT04632940|471491070|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
130962408|NCT04632940|471491069|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
130962409|NCT04632940|471491070|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
130962410|NCT04632940|471491069|FG000|OLE Period (52 Weeks)|Other than specified|0|||
130962411|NCT04632940|471491070|FG001|OLE Period (52 Weeks)|Other than specified|1|||
130962412|NCT04632940|471491069|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
130714817|NCT01346774|470581784|FG000|Overall Study|Protocol Violation|2|||
130962413|NCT04632940|471491070|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
130962414|NCT05857527|471491073|FG000|Overall Study|Withdrawal by Subject|0|||
130962415|NCT05857527|471491074|FG001|Overall Study|Withdrawal by Subject|1|||
130714818|NCT01346774|470581785|FG001|Overall Study|Protocol Violation|3|||
130714819|NCT01346774|470581784|FG000|Overall Study|Adverse Event|1|||
130714820|NCT01346774|470581785|FG001|Overall Study|Adverse Event|2|||
130962416|NCT02799082|471491075|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
130962417|NCT02799082|471491076|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
130962418|NCT02799082|471491075|FG000|Overall Study|Protocol Violation|0|||
130962419|NCT02799082|471491076|FG001|Overall Study|Protocol Violation|1|||
130962420|NCT01748994|471491083|FG000|Overall Study|Lost to Follow-up|8|||
130962421|NCT01748994|471491084|FG001|Overall Study|Lost to Follow-up|6|||
130962422|NCT02520531|471491087|FG000|Overall Study|Revision of study device components|2|||
130962423|NCT02520531|471491088|FG001|Overall Study|Revision of study device components|2|||
130962424|NCT02520531|471491087|FG000|Overall Study|Death|1|||
130962425|NCT02520531|471491088|FG001|Overall Study|Death|2|||
130962426|NCT02520531|471491087|FG000|Overall Study|Lost to Follow-up|1|||
130962427|NCT02520531|471491088|FG001|Overall Study|Lost to Follow-up|1|||
131226588|NCT00185211|472455782|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
131226589|NCT00185211|472455781|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
131226590|NCT00185211|472455782|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
131226591|NCT00185211|472455781|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
131226592|NCT00185211|472455782|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
131226593|NCT00185211|472455781|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
131226594|NCT00185211|472455782|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
131226595|NCT00185211|472455781|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
131226596|NCT00185211|472455782|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
131226597|NCT02266706|472457624|FG000|Overall Study|Withdrawal by Subject|0|||
130962428|NCT02520531|471491087|FG000|Overall Study|Meet exclusion criterion|0|||
130962429|NCT02520531|471491088|FG001|Overall Study|Meet exclusion criterion|1|||
131226598|NCT02266706|472457625|FG001|Overall Study|Withdrawal by Subject|1|||
130962430|NCT02520531|471491087|FG000|Overall Study|Withdrawal by Subject|1|||
130962431|NCT02520531|471491088|FG001|Overall Study|Withdrawal by Subject|0|||
130962432|NCT02520531|471491087|FG000|Overall Study|Not study device|1|||
130962433|NCT02520531|471491088|FG001|Overall Study|Not study device|0|||
130962434|NCT01723904|471491092|FG000|Overall Study|Noncompliant|3|||
130962435|NCT01723904|471491092|FG000|Overall Study|Adverse Event|5|||
130962436|NCT01723904|471491092|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
130962437|NCT01649856|471491103|FG000|Overall Study|Withdrawal by Subject|14|||
130962438|NCT01649856|471491104|FG001|Overall Study|Withdrawal by Subject|14|||
130962439|NCT01649856|471491103|FG000|Overall Study|Protocol Violation|4|||
130962440|NCT01649856|471491104|FG001|Overall Study|Protocol Violation|4|||
130962441|NCT01649856|471491103|FG000|Overall Study|Treatment Failure|1|||
130962442|NCT01649856|471491104|FG001|Overall Study|Treatment Failure|1|||
130962443|NCT01649856|471491103|FG000|Overall Study|Death|69|||
130962444|NCT01649856|471491104|FG001|Overall Study|Death|34|||
130962445|NCT01649856|471491103|FG000|Overall Study|Stable or Progressed Disease|5|||
130962446|NCT01649856|471491104|FG001|Overall Study|Stable or Progressed Disease|3|||
130962447|NCT01649856|471491103|FG000|Overall Study|Lost to Follow-up|20|||
130962448|NCT01649856|471491104|FG001|Overall Study|Lost to Follow-up|16|||
130962449|NCT01649856|471491103|FG000|Overall Study|Lack of Compliance|6|||
131226599|NCT02266706|472457626|FG002|Overall Study|Withdrawal by Subject|1|||
131226600|NCT02266706|472457627|FG003|Overall Study|Withdrawal by Subject|0|||
131226601|NCT02266706|472457628|FG004|Overall Study|Withdrawal by Subject|0|||
131226602|NCT02266706|472457629|FG005|Overall Study|Withdrawal by Subject|1|||
130714821|NCT00321737|470581788|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
130714822|NCT00321737|470581789|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
130714823|NCT00321737|470581790|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
130962450|NCT01649856|471491104|FG001|Overall Study|Lack of Compliance|1|||
130962451|NCT01649856|471491103|FG000|Overall Study|Other|20|||
130962452|NCT01649856|471491104|FG001|Overall Study|Other|5|||
130962453|NCT00622635|471491105|FG000|Treatment Period 1|Adverse Event|0|||
130962454|NCT00622635|471491106|FG001|Treatment Period 1|Adverse Event|0|||
130962455|NCT00622635|471491107|FG002|Treatment Period 1|Adverse Event|1|||
130962456|NCT00622635|471491108|FG003|Treatment Period 1|Adverse Event|0|||
130962457|NCT00622635|471491109|FG004|Treatment Period 1|Adverse Event|0|||
130962458|NCT00622635|471491110|FG005|Treatment Period 1|Adverse Event|0|||
130962459|NCT00622635|471491105|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130962460|NCT00622635|471491106|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130962461|NCT00622635|471491107|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130962462|NCT00622635|471491108|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131226603|NCT02266706|472457630|FG006|Overall Study|Withdrawal by Subject|0|||
131226604|NCT02266706|472457631|FG007|Overall Study|Withdrawal by Subject|0|||
130962463|NCT00622635|471491109|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131226605|NCT02266706|472457632|FG008|Overall Study|Withdrawal by Subject|0|||
131226606|NCT02266706|472457624|FG000|Overall Study|Screen failure|0|||
131226607|NCT02266706|472457625|FG001|Overall Study|Screen failure|0|||
130962464|NCT00622635|471491110|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130962465|NCT00622635|471491105|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
130962466|NCT00622635|471491106|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
130962467|NCT00622635|471491107|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
131226608|NCT02266706|472457626|FG002|Overall Study|Screen failure|0|||
130714824|NCT00321737|470581788|FG000|Overall Study|Adverse Event|11|||
130962468|NCT00622635|471491108|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
130962469|NCT00622635|471491109|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
130962470|NCT00622635|471491110|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
130962471|NCT00622635|471491105|FG000|Treatment Period 2|Adverse Event|1|||
130962472|NCT00622635|471491106|FG001|Treatment Period 2|Adverse Event|0|||
130962473|NCT00622635|471491107|FG002|Treatment Period 2|Adverse Event|0|||
130962474|NCT00622635|471491108|FG003|Treatment Period 2|Adverse Event|0|||
130962475|NCT00622635|471491109|FG004|Treatment Period 2|Adverse Event|0|||
130962476|NCT00622635|471491110|FG005|Treatment Period 2|Adverse Event|0|||
130962477|NCT00622635|471491105|FG000|Treatment Period 3|Adverse Event|0|||
130962478|NCT00622635|471491106|FG001|Treatment Period 3|Adverse Event|0|||
130962479|NCT00622635|471491107|FG002|Treatment Period 3|Adverse Event|0|||
130962480|NCT00622635|471491108|FG003|Treatment Period 3|Adverse Event|2|||
130962481|NCT00622635|471491109|FG004|Treatment Period 3|Adverse Event|0|||
130962482|NCT00622635|471491110|FG005|Treatment Period 3|Adverse Event|0|||
130962483|NCT00622635|471491105|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130962484|NCT00622635|471491106|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130962485|NCT00622635|471491107|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130962486|NCT00622635|471491108|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130962487|NCT00622635|471491109|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130962488|NCT00622635|471491110|FG005|Treatment Period 3|Withdrawal by Subject|0|||
130962489|NCT03027466|471491111|FG000|Overall Study|Opting out of the app|1869|||
130962490|NCT03027466|471491112|FG001|Overall Study|Opting out of the app|1819|||
130962491|NCT03027466|471491113|FG002|Overall Study|Opting out of the app|1743|||
130962492|NCT03027466|471491114|FG003|Overall Study|Opting out of the app|1821|||
130962493|NCT00931307|471491119|FG000|Overall Study|Lack of Efficacy|12|||
130962494|NCT00931307|471491119|FG000|Overall Study|Biomicroscopy|1|||
130962495|NCT02447991|471491122|FG000|Overall Study|Withdrawn by subject - no data|0|||
130962496|NCT02447991|471491123|FG001|Overall Study|Withdrawn by subject - no data|2|||
130962497|NCT02447991|471491122|FG000|Overall Study|Withdrawn by Subject - with data|4|||
130962498|NCT02447991|471491123|FG001|Overall Study|Withdrawn by Subject - with data|4|||
130962499|NCT02447991|471491122|FG000|Overall Study|Lost to Follow-up - no data|3|||
130962500|NCT02447991|471491123|FG001|Overall Study|Lost to Follow-up - no data|6|||
130962501|NCT02447991|471491122|FG000|Overall Study|Lost to follow-up - with data|0|||
130962502|NCT02447991|471491123|FG001|Overall Study|Lost to follow-up - with data|3|||
130962503|NCT02447991|471491122|FG000|Overall Study|End of study - no treatment results|3|||
130962504|NCT02447991|471491123|FG001|Overall Study|End of study - no treatment results|6|||
130962505|NCT02447991|471491122|FG000|Overall Study|End of study - partial treatment results|0|||
130962506|NCT02447991|471491123|FG001|Overall Study|End of study - partial treatment results|9|||
130962507|NCT00459134|471491124|FG000|Overall Study|Physician Decision|1|||
130962508|NCT00459134|471491125|FG001|Overall Study|Physician Decision|1|||
130962509|NCT00459134|471491124|FG000|Overall Study|Withdrawal by Subject|8|||
130962510|NCT00459134|471491125|FG001|Overall Study|Withdrawal by Subject|7|||
130962511|NCT00459134|471491124|FG000|Overall Study|Lost to Follow-up|6|||
130962512|NCT00459134|471491125|FG001|Overall Study|Lost to Follow-up|7|||
130962513|NCT00459134|471491124|FG000|Overall Study|Surgery|1|||
130962514|NCT00459134|471491125|FG001|Overall Study|Surgery|2|||
130962515|NCT00459134|471491124|FG000|Overall Study|Toxicity|4|||
130962516|NCT00459134|471491125|FG001|Overall Study|Toxicity|5|||
130962517|NCT00459134|471491124|FG000|Overall Study|Progression|1|||
130962518|NCT00459134|471491125|FG001|Overall Study|Progression|0|||
130962519|NCT00459134|471491124|FG000|Overall Study|Multiple Reasons|2|||
130962520|NCT00459134|471491125|FG001|Overall Study|Multiple Reasons|3|||
130962521|NCT00829621|471491126|FG000|Overall Study|Death|1|||
130962522|NCT00829621|471491127|FG001|Overall Study|Death|0|||
130962523|NCT00829621|471491126|FG000|Overall Study|Lost to Follow-up|3|||
130962524|NCT00829621|471491127|FG001|Overall Study|Lost to Follow-up|4|||
130962525|NCT00774995|471491128|FG000|Overall Study|Protocol Violation|0|||
130962526|NCT00774995|471491129|FG001|Overall Study|Protocol Violation|0|||
130962527|NCT00774995|471491130|FG002|Overall Study|Protocol Violation|1|||
130962528|NCT00774995|471491131|FG003|Overall Study|Protocol Violation|0|||
130962529|NCT00441337|471491138|FG000|Overall Study|Disease Progression|6|||
130962530|NCT00441337|471491139|FG001|Overall Study|Disease Progression|6|||
130962531|NCT00441337|471491140|FG002|Overall Study|Disease Progression|4|||
130962532|NCT00441337|471491141|FG003|Overall Study|Disease Progression|18|||
130962533|NCT00441337|471491138|FG000|Overall Study|Lost to Follow-up|0|||
130962534|NCT00441337|471491139|FG001|Overall Study|Lost to Follow-up|0|||
131041286|NCT04625725|471785449|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
130962535|NCT00441337|471491140|FG002|Overall Study|Lost to Follow-up|0|||
130962536|NCT00441337|471491141|FG003|Overall Study|Lost to Follow-up|1|||
130962537|NCT00441337|471491138|FG000|Overall Study|Sponsor Decision|0|||
130962538|NCT00441337|471491139|FG001|Overall Study|Sponsor Decision|0|||
130962539|NCT00441337|471491140|FG002|Overall Study|Sponsor Decision|1|||
130962540|NCT00441337|471491141|FG003|Overall Study|Sponsor Decision|2|||
130962541|NCT00441337|471491138|FG000|Overall Study|Did not meet inclusion criteria|0|||
130962542|NCT00441337|471491139|FG001|Overall Study|Did not meet inclusion criteria|0|||
130962543|NCT00441337|471491140|FG002|Overall Study|Did not meet inclusion criteria|1|||
130962544|NCT00441337|471491141|FG003|Overall Study|Did not meet inclusion criteria|0|||
130962545|NCT06748040|471491142|FG000|Overall Study|Death|3|||
130962546|NCT06748040|471491143|FG001|Overall Study|Death|4|||
130962547|NCT06748040|471491142|FG000|Overall Study|Lost to Follow-up|134|||
131041287|NCT04625725|471785450|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
131041288|NCT04625725|471785445|FG000|Provent Sub Study|Lost to Follow-up|0|||
130962548|NCT06748040|471491143|FG001|Overall Study|Lost to Follow-up|132|||
130962549|NCT06748040|471491142|FG000|Overall Study|Withdrawal by Subject|3|||
130962550|NCT06748040|471491143|FG001|Overall Study|Withdrawal by Subject|5|||
130962551|NCT02293005|471492945|FG000|Overall Study|Adverse Event|2|||
130962552|NCT02293005|471492945|FG000|Overall Study|Death|4|||
130962553|NCT02293005|471492945|FG000|Overall Study|Lost to Follow-up|1|||
130962554|NCT02293005|471492945|FG000|Overall Study|Withdrawal by Subject|2|||
130962555|NCT02293005|471492945|FG000|Overall Study|Progression|17|||
130962556|NCT00608829|471492947|FG000|Overall Study|Death|6|||
130962557|NCT00608829|471492947|FG000|Overall Study|Withdrawal by Subject|4|||
130962558|NCT00608829|471492947|FG000|Overall Study|Subject refuses to follow up or return.|5|||
130962559|NCT02564471|471492950|FG000|Overall Study|Adverse Event|1|||
130962560|NCT02564471|471492951|FG001|Overall Study|Adverse Event|0|||
130962561|NCT02564471|471492952|FG002|Overall Study|Adverse Event|0|||
130962562|NCT02564471|471492953|FG003|Overall Study|Adverse Event|0|||
130962563|NCT02564471|471492950|FG000|Overall Study|Withdrawal by Subject|2|||
130962564|NCT02564471|471492951|FG001|Overall Study|Withdrawal by Subject|1|||
130962565|NCT02564471|471492952|FG002|Overall Study|Withdrawal by Subject|3|||
130962566|NCT02564471|471492953|FG003|Overall Study|Withdrawal by Subject|0|||
130962567|NCT02564471|471492950|FG000|Overall Study|Lost to Follow-up|0|||
130962568|NCT02564471|471492951|FG001|Overall Study|Lost to Follow-up|2|||
130962569|NCT02564471|471492952|FG002|Overall Study|Lost to Follow-up|0|||
130962570|NCT02564471|471492953|FG003|Overall Study|Lost to Follow-up|0|||
130962571|NCT02805257|471492954|FG000|Overall Study|Lost to Follow-up|7|||
130962572|NCT02805257|471492955|FG001|Overall Study|Lost to Follow-up|6|||
130962573|NCT02805257|471492954|FG000|Overall Study|Death|0|||
130962574|NCT02805257|471492955|FG001|Overall Study|Death|1|||
130962575|NCT02766608|471492961|FG000|Overall Study|Adverse Event|27|||
130962576|NCT02766608|471492962|FG001|Overall Study|Adverse Event|22|||
130962577|NCT02766608|471492963|FG002|Overall Study|Adverse Event|17|||
130962578|NCT02766608|471492964|FG003|Overall Study|Adverse Event|13|||
130962579|NCT02766608|471492965|FG004|Overall Study|Adverse Event|12|||
130962580|NCT02766608|471492961|FG000|Overall Study|Withdrawal by Subject|21|||
130962581|NCT02766608|471492962|FG001|Overall Study|Withdrawal by Subject|20|||
130962582|NCT02766608|471492963|FG002|Overall Study|Withdrawal by Subject|24|||
130962583|NCT02766608|471492964|FG003|Overall Study|Withdrawal by Subject|13|||
130962584|NCT02766608|471492965|FG004|Overall Study|Withdrawal by Subject|10|||
130962585|NCT02766608|471492961|FG000|Overall Study|Lack of Efficacy|16|||
130962586|NCT02766608|471492962|FG001|Overall Study|Lack of Efficacy|15|||
130962587|NCT02766608|471492963|FG002|Overall Study|Lack of Efficacy|32|||
130962588|NCT02766608|471492964|FG003|Overall Study|Lack of Efficacy|8|||
130962589|NCT02766608|471492965|FG004|Overall Study|Lack of Efficacy|2|||
130962590|NCT02766608|471492961|FG000|Overall Study|Lost to Follow-up|6|||
130962591|NCT02766608|471492962|FG001|Overall Study|Lost to Follow-up|3|||
130962592|NCT02766608|471492963|FG002|Overall Study|Lost to Follow-up|5|||
130962593|NCT02766608|471492964|FG003|Overall Study|Lost to Follow-up|2|||
130962594|NCT02766608|471492965|FG004|Overall Study|Lost to Follow-up|2|||
130962595|NCT02766608|471492961|FG000|Overall Study|Physician Decision|3|||
130962596|NCT02766608|471492962|FG001|Overall Study|Physician Decision|2|||
130962597|NCT02766608|471492963|FG002|Overall Study|Physician Decision|3|||
130962598|NCT02766608|471492964|FG003|Overall Study|Physician Decision|1|||
130962599|NCT02766608|471492965|FG004|Overall Study|Physician Decision|2|||
130962600|NCT02766608|471492961|FG000|Overall Study|Protocol disc criteria|3|||
130962601|NCT02766608|471492962|FG001|Overall Study|Protocol disc criteria|3|||
130962602|NCT02766608|471492963|FG002|Overall Study|Protocol disc criteria|4|||
130962603|NCT02766608|471492964|FG003|Overall Study|Protocol disc criteria|0|||
130962604|NCT02766608|471492965|FG004|Overall Study|Protocol disc criteria|0|||
130962605|NCT02766608|471492961|FG000|Overall Study|Protocol Violation|0|||
130962606|NCT02766608|471492962|FG001|Overall Study|Protocol Violation|4|||
130962607|NCT02766608|471492963|FG002|Overall Study|Protocol Violation|4|||
130962608|NCT02766608|471492964|FG003|Overall Study|Protocol Violation|0|||
130962609|NCT02766608|471492965|FG004|Overall Study|Protocol Violation|1|||
130962610|NCT02766608|471492961|FG000|Overall Study|Administrative Reasons|3|||
130962611|NCT02766608|471492962|FG001|Overall Study|Administrative Reasons|1|||
130962612|NCT02766608|471492963|FG002|Overall Study|Administrative Reasons|1|||
130962613|NCT02766608|471492964|FG003|Overall Study|Administrative Reasons|0|||
130962614|NCT02766608|471492965|FG004|Overall Study|Administrative Reasons|0|||
130962615|NCT02066298|471492966|FG000|Overall Study|Lost to Follow-up|3|||
130962616|NCT02066298|471492967|FG001|Overall Study|Lost to Follow-up|2|||
130962617|NCT02066298|471492968|FG002|Overall Study|Lost to Follow-up|3|||
130962618|NCT02066298|471492969|FG003|Overall Study|Lost to Follow-up|2|||
130962619|NCT02066298|471492970|FG004|Overall Study|Lost to Follow-up|3|||
130962620|NCT02066298|471492971|FG005|Overall Study|Lost to Follow-up|4|||
130962621|NCT02066298|471492966|FG000|Overall Study|Withdrawal by Subject|6|||
130962622|NCT02066298|471492967|FG001|Overall Study|Withdrawal by Subject|6|||
130962623|NCT02066298|471492968|FG002|Overall Study|Withdrawal by Subject|6|||
130962624|NCT02066298|471492969|FG003|Overall Study|Withdrawal by Subject|4|||
130962625|NCT02066298|471492970|FG004|Overall Study|Withdrawal by Subject|5|||
130962626|NCT02066298|471492971|FG005|Overall Study|Withdrawal by Subject|8|||
130714825|NCT00321737|470581789|FG001|Overall Study|Adverse Event|3|||
130962627|NCT02066298|471492966|FG000|Overall Study|Physician Decision|0|||
130962628|NCT02066298|471492967|FG001|Overall Study|Physician Decision|0|||
130962629|NCT02066298|471492968|FG002|Overall Study|Physician Decision|1|||
130962630|NCT02066298|471492969|FG003|Overall Study|Physician Decision|0|||
130962631|NCT02066298|471492970|FG004|Overall Study|Physician Decision|1|||
130962632|NCT02066298|471492971|FG005|Overall Study|Physician Decision|0|||
130962633|NCT03143829|471492973|FG000|Overall Study|Withdrawal by Subject|2|||
130962634|NCT03143829|471492974|FG001|Overall Study|Withdrawal by Subject|5|||
130962635|NCT03143829|471492973|FG000|Overall Study|Lost to Follow-up|0|||
130962636|NCT03143829|471492974|FG001|Overall Study|Lost to Follow-up|2|||
130962637|NCT03143829|471492973|FG000|Overall Study|Death|1|||
130962638|NCT03143829|471492974|FG001|Overall Study|Death|1|||
130962639|NCT03143829|471492973|FG000|Overall Study|changed treatment, no longer eligible|2|||
130962640|NCT03143829|471492974|FG001|Overall Study|changed treatment, no longer eligible|2|||
130962641|NCT00672477|471492976|FG000|Overall Study|Adverse Event|10|||
130962642|NCT00672477|471492977|FG001|Overall Study|Adverse Event|7|||
130962643|NCT00672477|471492976|FG000|Overall Study|Death|7|||
130962644|NCT00672477|471492977|FG001|Overall Study|Death|11|||
130962645|NCT00672477|471492976|FG000|Overall Study|Physician Decision|2|||
130962646|NCT00672477|471492977|FG001|Overall Study|Physician Decision|0|||
130962647|NCT00672477|471492976|FG000|Overall Study|Protocol Violation|1|||
130962648|NCT00672477|471492977|FG001|Overall Study|Protocol Violation|1|||
130962649|NCT00672477|471492976|FG000|Overall Study|Withdrawal by Subject|5|||
130962650|NCT00672477|471492977|FG001|Overall Study|Withdrawal by Subject|3|||
130962651|NCT00672477|471492976|FG000|Overall Study|Lack of Efficacy|1|||
130962652|NCT00672477|471492977|FG001|Overall Study|Lack of Efficacy|1|||
130962653|NCT00672477|471492976|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
130962654|NCT00672477|471492977|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
130962655|NCT02348489|471492978|FG000|Overall Study|Death|336|||
130962656|NCT02348489|471492979|FG001|Overall Study|Death|335|||
130962657|NCT02348489|471492978|FG000|Overall Study|Withdrawal by Subject|14|||
130962658|NCT02348489|471492979|FG001|Overall Study|Withdrawal by Subject|27|||
130962659|NCT02348489|471492978|FG000|Overall Study|Lost to Follow-up|3|||
130962660|NCT02348489|471492979|FG001|Overall Study|Lost to Follow-up|5|||
130962661|NCT02866682|471492980|FG000|Overall Study|Death|0|||
130962662|NCT02866682|471492981|FG001|Overall Study|Death|1|||
130962663|NCT02866682|471492980|FG000|Overall Study|Lost to Follow-up|0|||
130962664|NCT02866682|471492981|FG001|Overall Study|Lost to Follow-up|4|||
130962665|NCT02866682|471492980|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
130962666|NCT02866682|471492981|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
130962667|NCT02866682|471492980|FG000|Overall Study|Other|0|||
130962668|NCT02866682|471492981|FG001|Overall Study|Other|1|||
130962669|NCT01750268|471492983|FG000|Overall Study|Lost to Follow-up|0|||
130962670|NCT01750268|471492984|FG001|Overall Study|Lost to Follow-up|2|||
130962671|NCT01750268|471492983|FG000|Overall Study|Physician Decision|0|||
130962672|NCT01750268|471492984|FG001|Overall Study|Physician Decision|3|||
130962673|NCT01750268|471492983|FG000|Overall Study|Withdrawal by Subject|2|||
131127524|NCT02184195|472095975|FG001|Overall Study|Other|3|||
131127525|NCT00282334|472095978|FG000|Overall Study|Withdrawal by Subject|8|||
131127526|NCT00282334|472095979|FG001|Overall Study|Withdrawal by Subject|5|||
131127527|NCT04041284|472095980|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
131127528|NCT04041284|472095981|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
131127529|NCT04041284|472095980|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
131127530|NCT04041284|472095981|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
131127531|NCT04041284|472095980|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
131127532|NCT04041284|472095981|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
131127533|NCT04041284|472095980|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
131127534|NCT04041284|472095981|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
131127535|NCT04041284|472095980|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
131127536|NCT04041284|472095981|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
131127537|NCT04041284|472095980|FG000|DB Phase (12 Weeks)|Other than specified|1|||
131127538|NCT04041284|472095981|FG001|DB Phase (12 Weeks)|Other than specified|0|||
131127539|NCT04041284|472095980|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
130962674|NCT01750268|471492984|FG001|Overall Study|Withdrawal by Subject|0|||
130962675|NCT02886572|471492987|FG000|Overall Study|Death|8|||
130962676|NCT03087591|471492988|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
131127540|NCT04041284|472095981|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
130962677|NCT03087591|471492988|FG000|Overall Study|Withdrawal by Subject|1|||
130962678|NCT02621606|471492989|FG000|Overall Study|Withdrawal by Subject|0|||
130962679|NCT02621606|471492990|FG001|Overall Study|Withdrawal by Subject|1|||
130962680|NCT02621606|471492991|FG002|Overall Study|Withdrawal by Subject|0|||
131127541|NCT04041284|472095980|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
130962681|NCT00274716|471492992|FG000|Phase A|Other non-reported reason|4|||
130962682|NCT00274716|471492993|FG001|Phase A|Other non-reported reason|2|||
130962683|NCT00274716|471492994|FG002|Phase A|Other non-reported reason|1|||
131127542|NCT04041284|472095981|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
131127543|NCT04041284|472095980|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
130962684|NCT00274716|471492995|FG003|Phase A|Other non-reported reason|2|||
130962685|NCT00274716|471492996|FG004|Phase A|Other non-reported reason|0|||
130962686|NCT00274716|471492997|FG005|Phase A|Other non-reported reason|1|||
130962687|NCT00274716|471492992|FG000|Phase A|Participant moved|0|||
130962688|NCT00274716|471492993|FG001|Phase A|Participant moved|0|||
130962689|NCT00274716|471492994|FG002|Phase A|Participant moved|1|||
130962690|NCT00274716|471492995|FG003|Phase A|Participant moved|0|||
130962691|NCT00274716|471492996|FG004|Phase A|Participant moved|0|||
130962692|NCT00274716|471492997|FG005|Phase A|Participant moved|1|||
130962693|NCT00274716|471492992|FG000|Phase A|Site Terminated|0|||
130962694|NCT00274716|471492993|FG001|Phase A|Site Terminated|0|||
130962695|NCT00274716|471492994|FG002|Phase A|Site Terminated|0|||
130962696|NCT00274716|471492995|FG003|Phase A|Site Terminated|1|||
130962697|NCT00274716|471492996|FG004|Phase A|Site Terminated|0|||
130962698|NCT00274716|471492997|FG005|Phase A|Site Terminated|0|||
130962699|NCT00274716|471492992|FG000|Phase A|Protocol Violation|1|||
130962700|NCT00274716|471492993|FG001|Phase A|Protocol Violation|0|||
130962701|NCT00274716|471492994|FG002|Phase A|Protocol Violation|0|||
130962702|NCT00274716|471492995|FG003|Phase A|Protocol Violation|1|||
130962703|NCT00274716|471492996|FG004|Phase A|Protocol Violation|0|||
130962704|NCT00274716|471492997|FG005|Phase A|Protocol Violation|0|||
130962705|NCT00274716|471492992|FG000|Phase A|Met criteria for discontinuation|1|||
130962706|NCT00274716|471492993|FG001|Phase A|Met criteria for discontinuation|1|||
130962707|NCT00274716|471492994|FG002|Phase A|Met criteria for discontinuation|0|||
130962708|NCT00274716|471492995|FG003|Phase A|Met criteria for discontinuation|0|||
130962709|NCT00274716|471492996|FG004|Phase A|Met criteria for discontinuation|0|||
130962710|NCT00274716|471492997|FG005|Phase A|Met criteria for discontinuation|0|||
130962711|NCT00274716|471492992|FG000|Phase A|Withdrawal by Subject|2|||
130962712|NCT00274716|471492993|FG001|Phase A|Withdrawal by Subject|2|||
130962713|NCT00274716|471492994|FG002|Phase A|Withdrawal by Subject|1|||
130962714|NCT00274716|471492995|FG003|Phase A|Withdrawal by Subject|3|||
130962715|NCT00274716|471492996|FG004|Phase A|Withdrawal by Subject|0|||
130962716|NCT00274716|471492997|FG005|Phase A|Withdrawal by Subject|1|||
130962717|NCT00274716|471492992|FG000|Phase A|Adverse Event|2|||
130962718|NCT00274716|471492993|FG001|Phase A|Adverse Event|3|||
130962719|NCT00274716|471492994|FG002|Phase A|Adverse Event|3|||
130962720|NCT00274716|471492995|FG003|Phase A|Adverse Event|0|||
130962721|NCT00274716|471492996|FG004|Phase A|Adverse Event|2|||
130962722|NCT00274716|471492997|FG005|Phase A|Adverse Event|0|||
130962723|NCT00274716|471492992|FG000|Phase A|Completed but did not enter Phase B|1|||
130962724|NCT00274716|471492993|FG001|Phase A|Completed but did not enter Phase B|2|||
130962725|NCT00274716|471492994|FG002|Phase A|Completed but did not enter Phase B|2|||
130962726|NCT00274716|471492995|FG003|Phase A|Completed but did not enter Phase B|2|||
130962727|NCT00274716|471492996|FG004|Phase A|Completed but did not enter Phase B|1|||
130962728|NCT00274716|471492997|FG005|Phase A|Completed but did not enter Phase B|1|||
130962729|NCT00274716|471492992|FG000|Phase B|Adverse Event|0|||
130962730|NCT00274716|471492993|FG001|Phase B|Adverse Event|0|||
130962731|NCT00274716|471492994|FG002|Phase B|Adverse Event|2|||
130962732|NCT00274716|471492995|FG003|Phase B|Adverse Event|0|||
130962733|NCT00274716|471492996|FG004|Phase B|Adverse Event|0|||
130962734|NCT00274716|471492997|FG005|Phase B|Adverse Event|1|||
130962735|NCT00274716|471492992|FG000|Phase B|Protocol Violation|0|||
130962736|NCT00274716|471492993|FG001|Phase B|Protocol Violation|2|||
130962737|NCT00274716|471492994|FG002|Phase B|Protocol Violation|0|||
130962738|NCT00274716|471492995|FG003|Phase B|Protocol Violation|0|||
130962739|NCT00274716|471492996|FG004|Phase B|Protocol Violation|0|||
130962740|NCT00274716|471492997|FG005|Phase B|Protocol Violation|0|||
130962741|NCT00274716|471492992|FG000|Phase B|Withdrawal by Subject|0|||
130962742|NCT00274716|471492993|FG001|Phase B|Withdrawal by Subject|1|||
130962743|NCT00274716|471492994|FG002|Phase B|Withdrawal by Subject|0|||
130962744|NCT00274716|471492995|FG003|Phase B|Withdrawal by Subject|0|||
130962745|NCT00274716|471492996|FG004|Phase B|Withdrawal by Subject|0|||
130962746|NCT00274716|471492997|FG005|Phase B|Withdrawal by Subject|0|||
130962747|NCT00274716|471492992|FG000|Phase B|Participant moved|1|||
130962748|NCT00274716|471492993|FG001|Phase B|Participant moved|0|||
130962749|NCT00274716|471492994|FG002|Phase B|Participant moved|0|||
130962750|NCT00274716|471492995|FG003|Phase B|Participant moved|0|||
130962751|NCT00274716|471492996|FG004|Phase B|Participant moved|0|||
130962752|NCT00274716|471492997|FG005|Phase B|Participant moved|0|||
130962753|NCT00274716|471492992|FG000|Phase B|Other non-reported reason|0|||
130962754|NCT00274716|471492993|FG001|Phase B|Other non-reported reason|0|||
131127544|NCT04041284|472095981|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
131127545|NCT04041284|472095980|FG000|OL Phase (12 Weeks)|Other than specified|6|||
130962755|NCT00274716|471492994|FG002|Phase B|Other non-reported reason|1|||
130962756|NCT00274716|471492995|FG003|Phase B|Other non-reported reason|1|||
130962757|NCT00274716|471492996|FG004|Phase B|Other non-reported reason|0|||
130962758|NCT00274716|471492997|FG005|Phase B|Other non-reported reason|0|||
130962759|NCT00274716|471492992|FG000|Phase B|Lost to Follow-up|0|||
130962760|NCT00274716|471492993|FG001|Phase B|Lost to Follow-up|1|||
130962761|NCT00274716|471492994|FG002|Phase B|Lost to Follow-up|0|||
130962762|NCT00274716|471492995|FG003|Phase B|Lost to Follow-up|0|||
130962763|NCT00274716|471492996|FG004|Phase B|Lost to Follow-up|0|||
130962764|NCT00274716|471492997|FG005|Phase B|Lost to Follow-up|0|||
130962765|NCT00982319|471493000|FG000|Overall Study|Surgery date change|1|||
130962766|NCT00982319|471493001|FG001|Overall Study|Surgery date change|0|||
130962767|NCT00982319|471493000|FG000|Overall Study|Preop values out of acceptable range|1|||
130962768|NCT00982319|471493001|FG001|Overall Study|Preop values out of acceptable range|1|||
130962769|NCT00982319|471493000|FG000|Overall Study|Pregnancy|0|||
130962770|NCT00982319|471493001|FG001|Overall Study|Pregnancy|1|||
130962771|NCT01694706|471493002|FG000|Overall Study|Adverse Event|0|||
130962772|NCT01694706|471493003|FG001|Overall Study|Adverse Event|1|||
130962773|NCT01694706|471493004|FG002|Overall Study|Adverse Event|0|||
130962774|NCT01694706|471493002|FG000|Overall Study|other reason not defined above|1|||
130962775|NCT01694706|471493003|FG001|Overall Study|other reason not defined above|0|||
130962776|NCT01694706|471493004|FG002|Overall Study|other reason not defined above|0|||
130962777|NCT00975975|471493005|FG000|Overall Study|Death|6|||
130962778|NCT01252251|471493006|FG000|Overall Study|Withdrawal by Subject|1|||
130962779|NCT01324024|471493007|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
130962780|NCT01324024|471493008|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130962781|NCT01923181|471493009|FG000|Overall Study|Protocol Violation|2|||
130962782|NCT01923181|471493010|FG001|Overall Study|Protocol Violation|2|||
130962783|NCT01923181|471493011|FG002|Overall Study|Protocol Violation|0|||
130962784|NCT01923181|471493012|FG003|Overall Study|Protocol Violation|2|||
130962785|NCT01923181|471493013|FG004|Overall Study|Protocol Violation|2|||
130962786|NCT01923181|471493014|FG005|Overall Study|Protocol Violation|1|||
130962787|NCT01923181|471493015|FG006|Overall Study|Protocol Violation|1|||
130962788|NCT01923181|471493016|FG007|Overall Study|Protocol Violation|2|||
130962789|NCT01923181|471493017|FG008|Overall Study|Protocol Violation|1|||
130962790|NCT01923181|471493009|FG000|Overall Study|Withdrawal by Subject|0|||
130962791|NCT01923181|471493010|FG001|Overall Study|Withdrawal by Subject|1|||
130962792|NCT01923181|471493011|FG002|Overall Study|Withdrawal by Subject|0|||
130962793|NCT01923181|471493012|FG003|Overall Study|Withdrawal by Subject|1|||
130962794|NCT01923181|471493013|FG004|Overall Study|Withdrawal by Subject|4|||
130962795|NCT01923181|471493014|FG005|Overall Study|Withdrawal by Subject|2|||
130962796|NCT01923181|471493015|FG006|Overall Study|Withdrawal by Subject|4|||
130962797|NCT01923181|471493016|FG007|Overall Study|Withdrawal by Subject|3|||
130962798|NCT01923181|471493017|FG008|Overall Study|Withdrawal by Subject|1|||
130962799|NCT01923181|471493009|FG000|Overall Study|Other|1|||
130962800|NCT01923181|471493010|FG001|Overall Study|Other|0|||
130962801|NCT01923181|471493011|FG002|Overall Study|Other|0|||
130962802|NCT01923181|471493012|FG003|Overall Study|Other|1|||
130962803|NCT01923181|471493013|FG004|Overall Study|Other|0|||
130962804|NCT01923181|471493014|FG005|Overall Study|Other|0|||
130962805|NCT01923181|471493015|FG006|Overall Study|Other|0|||
130962806|NCT01923181|471493016|FG007|Overall Study|Other|0|||
130962807|NCT01923181|471493017|FG008|Overall Study|Other|0|||
130962808|NCT01923181|471493009|FG000|Overall Study|Lost to Follow-up|0|||
130962809|NCT01923181|471493010|FG001|Overall Study|Lost to Follow-up|3|||
130962810|NCT01923181|471493011|FG002|Overall Study|Lost to Follow-up|2|||
130962811|NCT01923181|471493012|FG003|Overall Study|Lost to Follow-up|1|||
130962812|NCT01923181|471493013|FG004|Overall Study|Lost to Follow-up|2|||
130962813|NCT01923181|471493014|FG005|Overall Study|Lost to Follow-up|1|||
130962814|NCT01923181|471493015|FG006|Overall Study|Lost to Follow-up|3|||
130962815|NCT01923181|471493016|FG007|Overall Study|Lost to Follow-up|3|||
130962816|NCT01923181|471493017|FG008|Overall Study|Lost to Follow-up|1|||
130962817|NCT01257204|471493018|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
130962818|NCT01257204|471493019|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
130962819|NCT01257204|471493020|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
130962820|NCT01257204|471493018|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
130962821|NCT01257204|471493019|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
131041289|NCT04625725|471785446|FG001|Provent Sub Study|Lost to Follow-up|0|||
131041290|NCT04625725|471785447|FG002|Provent Sub Study|Lost to Follow-up|20|||
131041291|NCT04625725|471785448|FG003|Provent Sub Study|Lost to Follow-up|10|||
131041292|NCT04625725|471785449|FG004|Provent Sub Study|Lost to Follow-up|6|||
131041293|NCT04625725|471785450|FG005|Provent Sub Study|Lost to Follow-up|4|||
131041294|NCT04625725|471785445|FG000|Provent Sub Study|Death|0|||
131041295|NCT04625725|471785446|FG001|Provent Sub Study|Death|0|||
131226609|NCT02266706|472457627|FG003|Overall Study|Screen failure|0|||
131226610|NCT02266706|472457628|FG004|Overall Study|Screen failure|0|||
130962822|NCT01257204|471493020|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
131041296|NCT04625725|471785447|FG002|Provent Sub Study|Death|8|||
130962823|NCT01257204|471493018|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
130962824|NCT01257204|471493019|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
131041297|NCT04625725|471785448|FG003|Provent Sub Study|Death|5|||
130962825|NCT01257204|471493020|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
130962826|NCT01257204|471493018|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
130962827|NCT01257204|471493019|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
130962828|NCT01257204|471493020|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
130962829|NCT01257204|471493018|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
130962830|NCT01257204|471493019|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
130962831|NCT01257204|471493020|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
130962832|NCT01257204|471493018|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
130962833|NCT01257204|471493019|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
130962834|NCT01257204|471493020|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
130962835|NCT01257204|471493018|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
130962836|NCT01257204|471493019|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
130962837|NCT01257204|471493020|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
130962838|NCT01257204|471493018|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
130962839|NCT01257204|471493019|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
130962840|NCT01257204|471493020|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
130962841|NCT01257204|471493018|FG000|Follow-up Period (up to Week 48)|Other|0|||
130962842|NCT01257204|471493019|FG001|Follow-up Period (up to Week 48)|Other|0|||
130962843|NCT01257204|471493020|FG002|Follow-up Period (up to Week 48)|Other|5|||
130962844|NCT02840877|471493021|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
130962845|NCT02840877|471493021|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
130962846|NCT02840877|471493021|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
130962847|NCT02840877|471493021|FG000|Baseline to 12 Weeks|Death|1|||
130962848|NCT02840877|471493021|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
130962849|NCT02840877|471493021|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
130962850|NCT02840877|471493021|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
130962851|NCT02840877|471493021|FG000|12 Weeks to 6 Months|Treatment failure|1|||
130962852|NCT02840877|471493021|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
130962853|NCT02840877|471493021|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
130962854|NCT02840877|471493021|FG000|12 Weeks to 6 Months|Death|1|||
130962855|NCT02840877|471493021|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
130962856|NCT02840877|471493021|FG000|6 Months to 18 Months|Treatment failure|7|||
130962857|NCT02840877|471493021|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
130962858|NCT02840877|471493021|FG000|6 Months to 18 Months|Moved/transferred out|6|||
130962859|NCT02840877|471493021|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
130962860|NCT02840877|471493021|FG000|6 Months to 18 Months|Death|4|||
130962861|NCT02840877|471493021|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
130962862|NCT02840877|471493021|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
130962863|NCT02840877|471493021|FG000|6 Months to 18 Months|Still in study.|14|||
130962864|NCT03766646|471493024|FG000|Overall Study|Withdrawal by Subject|1|||
130962865|NCT03766646|471493025|FG001|Overall Study|Withdrawal by Subject|0|||
130962866|NCT03766646|471493024|FG000|Overall Study|Protocol Violation|0|||
130962867|NCT03766646|471493025|FG001|Overall Study|Protocol Violation|3|||
130962868|NCT03224468|471493049|FG000|Overall Study|Did not obtain MM card|53|||
130962869|NCT03224468|471493050|FG001|Overall Study|Did not obtain MM card|0|||
130962870|NCT03224468|471493049|FG000|Overall Study|Lost to Follow-up|4|||
130962871|NCT03224468|471493050|FG001|Overall Study|Lost to Follow-up|11|||
130962872|NCT03224468|471493049|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
130962873|NCT03224468|471493050|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
130962874|NCT03295201|471493051|FG000|Overall Study|Lost to Follow-up|1|||
130962875|NCT03295201|471493052|FG001|Overall Study|Lost to Follow-up|1|||
130962876|NCT03295201|471493051|FG000|Overall Study|Hospital admission|0|||
130962877|NCT03295201|471493052|FG001|Overall Study|Hospital admission|1|||
130962878|NCT03251924|471493053|FG000|Overall Study|Disease Progression|6|||
130962879|NCT03251924|471493054|FG001|Overall Study|Disease Progression|6|||
130962880|NCT03251924|471493055|FG002|Overall Study|Disease Progression|7|||
131127546|NCT04041284|472095981|FG001|OL Phase (12 Weeks)|Other than specified|2|||
130962881|NCT03251924|471493056|FG003|Overall Study|Disease Progression|8|||
130962882|NCT03251924|471493057|FG004|Overall Study|Disease Progression|8|||
130962883|NCT03251924|471493058|FG005|Overall Study|Disease Progression|7|||
130962884|NCT03251924|471493059|FG006|Overall Study|Disease Progression|6|||
130962885|NCT03251924|471493060|FG007|Overall Study|Disease Progression|10|||
130962886|NCT03251924|471493061|FG008|Overall Study|Disease Progression|6|||
130962887|NCT03251924|471493053|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
130962888|NCT03251924|471493054|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
131127547|NCT02255409|472095990|FG000|Overall Study|Administrative Reason|3|||
130962889|NCT03251924|471493055|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
131127548|NCT02255409|472095991|FG001|Overall Study|Administrative Reason|7|||
130962890|NCT03251924|471493056|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
130962891|NCT03251924|471493057|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
130962892|NCT03251924|471493058|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
130962893|NCT03251924|471493059|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
130962894|NCT03251924|471493060|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
130962895|NCT03251924|471493061|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
130962896|NCT03251924|471493053|FG000|Overall Study|Death|0|||
130962897|NCT03251924|471493054|FG001|Overall Study|Death|1|||
130962898|NCT03251924|471493055|FG002|Overall Study|Death|0|||
130962899|NCT03251924|471493056|FG003|Overall Study|Death|1|||
130714826|NCT00321737|470581790|FG002|Overall Study|Adverse Event|6|||
130714827|NCT00321737|470581788|FG000|Overall Study|Lost to Follow-up|5|||
130962900|NCT03251924|471493057|FG004|Overall Study|Death|1|||
130962901|NCT03251924|471493058|FG005|Overall Study|Death|1|||
130962902|NCT03251924|471493059|FG006|Overall Study|Death|0|||
130962903|NCT03251924|471493060|FG007|Overall Study|Death|0|||
130962904|NCT03251924|471493061|FG008|Overall Study|Death|0|||
130962905|NCT03251924|471493053|FG000|Overall Study|Study Drug Toxicity|0|||
130962906|NCT03251924|471493054|FG001|Overall Study|Study Drug Toxicity|0|||
130962907|NCT03251924|471493055|FG002|Overall Study|Study Drug Toxicity|0|||
130962908|NCT03251924|471493056|FG003|Overall Study|Study Drug Toxicity|1|||
130962909|NCT03251924|471493057|FG004|Overall Study|Study Drug Toxicity|0|||
130962910|NCT03251924|471493058|FG005|Overall Study|Study Drug Toxicity|0|||
130962911|NCT03251924|471493059|FG006|Overall Study|Study Drug Toxicity|0|||
130962912|NCT03251924|471493060|FG007|Overall Study|Study Drug Toxicity|0|||
130962913|NCT03251924|471493061|FG008|Overall Study|Study Drug Toxicity|1|||
130962914|NCT03251924|471493053|FG000|Overall Study|Other Reasons|0|||
130962915|NCT03251924|471493054|FG001|Overall Study|Other Reasons|0|||
130962916|NCT03251924|471493055|FG002|Overall Study|Other Reasons|0|||
130962917|NCT03251924|471493056|FG003|Overall Study|Other Reasons|0|||
130962918|NCT03251924|471493057|FG004|Overall Study|Other Reasons|0|||
130962919|NCT03251924|471493058|FG005|Overall Study|Other Reasons|0|||
130962920|NCT03251924|471493059|FG006|Overall Study|Other Reasons|0|||
130962921|NCT03251924|471493060|FG007|Overall Study|Other Reasons|0|||
130962922|NCT03251924|471493061|FG008|Overall Study|Other Reasons|1|||
130962923|NCT03251924|471493053|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130962924|NCT03251924|471493054|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130962925|NCT03251924|471493055|FG002|Overall Study|Participant request to discontinue study treatment|0|||
130962926|NCT03251924|471493056|FG003|Overall Study|Participant request to discontinue study treatment|0|||
130962927|NCT03251924|471493057|FG004|Overall Study|Participant request to discontinue study treatment|0|||
130962928|NCT03251924|471493058|FG005|Overall Study|Participant request to discontinue study treatment|0|||
130962929|NCT03251924|471493059|FG006|Overall Study|Participant request to discontinue study treatment|0|||
130962930|NCT03251924|471493060|FG007|Overall Study|Participant request to discontinue study treatment|1|||
130962931|NCT03251924|471493061|FG008|Overall Study|Participant request to discontinue study treatment|0|||
130962932|NCT00153101|471493062|FG000|Overall Study|Lost to Follow-up|14|||
130962933|NCT00153101|471493063|FG001|Overall Study|Lost to Follow-up|14|||
130962934|NCT00153101|471493064|FG002|Overall Study|Lost to Follow-up|12|||
130962935|NCT00153101|471493065|FG003|Overall Study|Lost to Follow-up|5|||
130962936|NCT00153101|471493066|FG004|Overall Study|Lost to Follow-up|5|||
130962937|NCT00153101|471493062|FG000|Overall Study|Withdrawal by Subject|3|||
130962938|NCT00153101|471493063|FG001|Overall Study|Withdrawal by Subject|4|||
130962939|NCT00153101|471493064|FG002|Overall Study|Withdrawal by Subject|3|||
130962940|NCT00153101|471493065|FG003|Overall Study|Withdrawal by Subject|3|||
130962941|NCT00153101|471493066|FG004|Overall Study|Withdrawal by Subject|5|||
130962942|NCT02610140|471493067|FG000|Randomization and Treatment Period|Radiological progression|23|||
130962943|NCT02610140|471493068|FG001|Randomization and Treatment Period|Radiological progression|15|||
130962944|NCT02610140|471493067|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
130962945|NCT02610140|471493068|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
130962946|NCT02610140|471493067|FG000|Randomization and Treatment Period|Protocol Violation|1|||
130962947|NCT02610140|471493068|FG001|Randomization and Treatment Period|Protocol Violation|0|||
130962948|NCT02610140|471493067|FG000|Randomization and Treatment Period|Physician Decision|0|||
130962949|NCT02610140|471493068|FG001|Randomization and Treatment Period|Physician Decision|1|||
130962950|NCT02610140|471493067|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
130962951|NCT02610140|471493068|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
130962952|NCT02610140|471493067|FG000|Randomization and Treatment Period|Death|7|||
130962953|NCT02610140|471493068|FG001|Randomization and Treatment Period|Death|1|||
130962954|NCT02610140|471493067|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
130962955|NCT02610140|471493068|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
130962956|NCT02610140|471493067|FG000|Randomization and Treatment Period|Adverse Event|44|||
130962957|NCT02610140|471493068|FG001|Randomization and Treatment Period|Adverse Event|13|||
130962958|NCT02610140|471493067|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
130962959|NCT02610140|471493068|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
131226611|NCT02266706|472457629|FG005|Overall Study|Screen failure|1|||
130714828|NCT00321737|470581789|FG001|Overall Study|Lost to Follow-up|5|||
130962960|NCT02610140|471493067|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
130962961|NCT02610140|471493068|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
130962962|NCT02610140|471493067|FG000|Randomization and Treatment Period|Not treated|3|||
130962963|NCT02610140|471493068|FG001|Randomization and Treatment Period|Not treated|10|||
130714829|NCT00321737|470581790|FG002|Overall Study|Lost to Follow-up|6|||
130962964|NCT02610140|471493067|FG000|Safety Follow-up|Other|0|||
130962965|NCT02610140|471493068|FG001|Safety Follow-up|Other|2|||
130962966|NCT02610140|471493067|FG000|Safety Follow-up|Lost to Follow-up|1|||
130962967|NCT02610140|471493068|FG001|Safety Follow-up|Lost to Follow-up|0|||
130962968|NCT02610140|471493067|FG000|Safety Follow-up|No follow-up|5|||
130962969|NCT02610140|471493068|FG001|Safety Follow-up|No follow-up|3|||
130962970|NCT02610140|471493067|FG000|Safety Follow-up|Death|12|||
130962971|NCT02610140|471493068|FG001|Safety Follow-up|Death|2|||
130962972|NCT02610140|471493067|FG000|Safety Follow-up|Deterioration of general conditions|15|||
130962973|NCT02610140|471493068|FG001|Safety Follow-up|Deterioration of general conditions|5|||
130962974|NCT02610140|471493067|FG000|Safety Follow-up|Withdrawal by Subject|12|||
130962975|NCT02610140|471493068|FG001|Safety Follow-up|Withdrawal by Subject|12|||
130962976|NCT02610140|471493067|FG000|Active Follow-up|Progressive disease - radiological|30|||
130962977|NCT02610140|471493068|FG001|Active Follow-up|Progressive disease - radiological|22|||
130962978|NCT02610140|471493067|FG000|Active Follow-up|Death|8|||
130962979|NCT02610140|471493068|FG001|Active Follow-up|Death|1|||
130962980|NCT02610140|471493067|FG000|Active Follow-up|Withdrawal by Subject|4|||
130962981|NCT02610140|471493068|FG001|Active Follow-up|Withdrawal by Subject|0|||
130962982|NCT02610140|471493067|FG000|Active Follow-up|Progressive disease - clinical|1|||
130962983|NCT02610140|471493068|FG001|Active Follow-up|Progressive disease - clinical|2|||
130962984|NCT02610140|471493067|FG000|Active Follow-up|Deterioration of general conditions|1|||
130962985|NCT02610140|471493068|FG001|Active Follow-up|Deterioration of general conditions|0|||
130962986|NCT02610140|471493067|FG000|Active Follow-up|Ongoing but not completed|4|||
130962987|NCT02610140|471493068|FG001|Active Follow-up|Ongoing but not completed|1|||
130962988|NCT02610140|471493067|FG000|Long-term Follow-up|Death|86|||
130962989|NCT02610140|471493068|FG001|Long-term Follow-up|Death|44|||
130962990|NCT02610140|471493067|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
130962991|NCT02610140|471493068|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
130962992|NCT02610140|471493067|FG000|Long-term Follow-up|Lost to Follow-up|1|||
130962993|NCT02610140|471493068|FG001|Long-term Follow-up|Lost to Follow-up|2|||
130962994|NCT02610140|471493067|FG000|Long-term Follow-up|Ongoing but not completed|30|||
130962995|NCT02610140|471493068|FG001|Long-term Follow-up|Ongoing but not completed|17|||
130962996|NCT03169153|471493069|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
130962997|NCT03169153|471493070|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
130962998|NCT03169153|471493069|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
130962999|NCT03169153|471493070|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
130963000|NCT03169153|471493069|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
130963001|NCT03169153|471493070|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
130963002|NCT03169153|471493069|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
130963003|NCT03169153|471493070|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
130963004|NCT00887341|471493071|FG000|Overall Study|Refused treatment|1|||
130963005|NCT00887341|471493072|FG001|Overall Study|Refused treatment|0|||
130963006|NCT00887341|471493071|FG000|Overall Study|Withdrawal by Subject|1|||
130963007|NCT00887341|471493072|FG001|Overall Study|Withdrawal by Subject|1|||
130963008|NCT00887341|471493071|FG000|Overall Study|Adverse Event|0|||
130963009|NCT00887341|471493072|FG001|Overall Study|Adverse Event|1|||
130963010|NCT00887341|471493071|FG000|Overall Study|Lost to Follow-up|0|||
130963011|NCT00887341|471493072|FG001|Overall Study|Lost to Follow-up|1|||
130963012|NCT02617589|471493073|FG000|Randomization|Request to Discontinue Study Treatment|1|||
130963013|NCT02617589|471493074|FG001|Randomization|Request to Discontinue Study Treatment|3|||
130963014|NCT02617589|471493073|FG000|Randomization|Participant Withdrew Consent|1|||
130963015|NCT02617589|471493074|FG001|Randomization|Participant Withdrew Consent|2|||
130963016|NCT02617589|471493073|FG000|Treatment|Other Reasons|3|||
130963017|NCT02617589|471493074|FG001|Treatment|Other Reasons|3|||
130963018|NCT02617589|471493073|FG000|Treatment|Poor/Non Compliance|1|||
130963019|NCT02617589|471493074|FG001|Treatment|Poor/Non Compliance|1|||
130963020|NCT02617589|471493073|FG000|Treatment|Maximum Clinical Benefit|0|||
130963021|NCT02617589|471493074|FG001|Treatment|Maximum Clinical Benefit|2|||
130963022|NCT02617589|471493073|FG000|Treatment|Participant Withdrew Consent|2|||
130963023|NCT02617589|471493074|FG001|Treatment|Participant Withdrew Consent|6|||
130963024|NCT02617589|471493073|FG000|Treatment|Participant Request to Discontinue|12|||
130963025|NCT02617589|471493074|FG001|Treatment|Participant Request to Discontinue|21|||
131127549|NCT02255409|472095990|FG000|Overall Study|Withdrawal by Subject|1|||
131127550|NCT02255409|472095991|FG001|Overall Study|Withdrawal by Subject|5|||
131127551|NCT02255409|472095990|FG000|Overall Study|Lost to Follow-up|10|||
131127552|NCT02255409|472095991|FG001|Overall Study|Lost to Follow-up|19|||
131127553|NCT01251367|472095992|FG000|Overall Study|Protocol Violation|1|||
131127554|NCT01251367|472095992|FG000|Overall Study|Lack of Efficacy|2|||
130963026|NCT02617589|471493073|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
130963027|NCT02617589|471493074|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
130963028|NCT02617589|471493073|FG000|Treatment|Death|1|||
130963029|NCT02617589|471493074|FG001|Treatment|Death|1|||
130963030|NCT02617589|471493073|FG000|Treatment|Study Drug Toxicity|27|||
130963031|NCT02617589|471493074|FG001|Treatment|Study Drug Toxicity|20|||
130963032|NCT02617589|471493073|FG000|Treatment|Disease Progression|216|||
130963033|NCT02617589|471493074|FG001|Treatment|Disease Progression|136|||
131127555|NCT01251367|472095992|FG000|Overall Study|Adverse Event|19|||
131127556|NCT01251367|472095992|FG000|Overall Study|Withdrawal by Subject|36|||
131127557|NCT01251367|472095992|FG000|Overall Study|Lost to Follow-up|5|||
130963034|NCT01591681|471493077|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
130963035|NCT01591681|471493077|FG000|Overall Study|Failed to use system during run-in|1|||
130963036|NCT00281840|471493080|FG000|Overall Study|Adverse Event|12|||
130963037|NCT00281840|471493080|FG000|Overall Study|Physician Decision|6|||
130963038|NCT00281840|471493080|FG000|Overall Study|Withdrawal by Subject|3|||
130963039|NCT00281840|471493080|FG000|Overall Study|Disease Progression|2|||
130963040|NCT00281840|471493080|FG000|Overall Study|exceed maximum delay in treatment|1|||
130963041|NCT00281840|471493080|FG000|Overall Study|Complicating Disease|1|||
130963042|NCT01079234|471493083|FG000|Main: Week 0 to 26|Adverse Event|5|||
130963043|NCT01079234|471493084|FG001|Main: Week 0 to 26|Adverse Event|4|||
130963044|NCT01079234|471493085|FG002|Main: Week 0 to 26|Adverse Event|1|||
130963045|NCT01079234|471493086|FG003|Main: Week 0 to 26|Adverse Event|0|||
130963046|NCT01079234|471493083|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
130963047|NCT01079234|471493084|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
130963048|NCT01079234|471493085|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
130963049|NCT01079234|471493086|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
130963050|NCT01079234|471493083|FG000|Main: Week 0 to 26|Protocol Violation|6|||
130963051|NCT01079234|471493084|FG001|Main: Week 0 to 26|Protocol Violation|2|||
130963052|NCT01079234|471493085|FG002|Main: Week 0 to 26|Protocol Violation|4|||
130963053|NCT01079234|471493086|FG003|Main: Week 0 to 26|Protocol Violation|0|||
130963054|NCT01079234|471493083|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
130963055|NCT01079234|471493084|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
130963056|NCT01079234|471493085|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
130963057|NCT01079234|471493086|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
130963058|NCT01079234|471493083|FG000|Main: Week 0 to 26|Unclassified|7|||
130963059|NCT01079234|471493084|FG001|Main: Week 0 to 26|Unclassified|13|||
130963060|NCT01079234|471493085|FG002|Main: Week 0 to 26|Unclassified|4|||
130963061|NCT01079234|471493086|FG003|Main: Week 0 to 26|Unclassified|0|||
130963062|NCT01079234|471493083|FG000|Extension: Week 27 to 52|Adverse Event|0|||
130963063|NCT01079234|471493084|FG001|Extension: Week 27 to 52|Adverse Event|0|||
130963064|NCT01079234|471493085|FG002|Extension: Week 27 to 52|Adverse Event|1|||
130963065|NCT01079234|471493086|FG003|Extension: Week 27 to 52|Adverse Event|0|||
130963066|NCT01079234|471493083|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
130963067|NCT01079234|471493084|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
130963068|NCT01079234|471493085|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
130963069|NCT01079234|471493086|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
130963070|NCT01079234|471493083|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
130963071|NCT01079234|471493084|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
130963072|NCT01079234|471493085|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
130963073|NCT01079234|471493086|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
130963074|NCT01079234|471493083|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
130963075|NCT01079234|471493084|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
130963076|NCT01079234|471493085|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
130963077|NCT01079234|471493086|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
130963078|NCT01079234|471493083|FG000|Extension: Week 27 to 52|Unclassified|0|||
130963079|NCT01079234|471493084|FG001|Extension: Week 27 to 52|Unclassified|0|||
130963080|NCT01079234|471493085|FG002|Extension: Week 27 to 52|Unclassified|4|||
130963081|NCT01079234|471493086|FG003|Extension: Week 27 to 52|Unclassified|7|||
130963082|NCT01312961|471493092|FG000|Overall Study|Adverse Event|3|||
130963083|NCT01312961|471493093|FG001|Overall Study|Adverse Event|3|||
130963084|NCT01312961|471493092|FG000|Overall Study|Lack of Efficacy|11|||
130963085|NCT01312961|471493093|FG001|Overall Study|Lack of Efficacy|1|||
130963086|NCT01312961|471493092|FG000|Overall Study|Poor compliance to protocol|1|||
130963087|NCT01312961|471493093|FG001|Overall Study|Poor compliance to protocol|0|||
130963088|NCT01312961|471493092|FG000|Overall Study|Other than specified above|2|||
130963089|NCT01312961|471493093|FG001|Overall Study|Other than specified above|3|||
131127558|NCT01251367|472095992|FG000|Overall Study|Subject Required Alternative Treatment|7|||
131127559|NCT01251367|472095992|FG000|Overall Study|No Study Drug Available|1|||
131127560|NCT01251367|472095992|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
131127561|NCT01251367|472095992|FG000|Overall Study|End of Study Visit Performed in Error|1|||
131127562|NCT03775421|472095996|FG000|Overall Study|Lost to Follow-up|2|||
131127563|NCT03775421|472095996|FG000|Overall Study|Withdrawal by Subject|10|||
131127564|NCT03775421|472095996|FG000|Overall Study|Physician Decision|3|||
131127565|NCT03775421|472095996|FG000|Overall Study|Death|1|||
131127566|NCT03775421|472095996|FG000|Overall Study|Study Terminated by Sponsor|94|||
131127567|NCT03917823|472095997|FG000|Overall Study|Lost to Follow-up|1|||
131127568|NCT03917823|472095998|FG001|Overall Study|Lost to Follow-up|1|||
130963102|NCT00205712|471493098|FG000|Overall Study|Lost to Follow-up|0|||
130963103|NCT00205712|471493099|FG001|Overall Study|Lost to Follow-up|1|||
130963104|NCT01337297|471493109|FG000|Overall Study|They entered to single anodal tDCS|4|||
130963105|NCT01337297|471493110|FG001|Overall Study|They entered to single anodal tDCS|3|||
130963106|NCT01337297|471493109|FG000|Overall Study|Lost to Follow-up|1|||
130963107|NCT01337297|471493110|FG001|Overall Study|Lost to Follow-up|3|||
130963108|NCT01898793|471493113|FG000|Overall Study|Death|2|||
130963109|NCT01898793|471493114|FG001|Overall Study|Death|1|||
130963110|NCT01898793|471493115|FG002|Overall Study|Death|4|||
130963111|NCT01898793|471493116|FG003|Overall Study|Death|0|||
130963112|NCT01898793|471493117|FG004|Overall Study|Death|0|||
130963113|NCT01898793|471493118|FG005|Overall Study|Death|0|||
130963114|NCT01898793|471493119|FG006|Overall Study|Death|0|||
130963115|NCT00965848|471493124|FG000|Overall Study|Protocol Violation|3|||
130963116|NCT00965848|471493125|FG001|Overall Study|Protocol Violation|0|||
130963117|NCT00965848|471493126|FG002|Overall Study|Protocol Violation|1|||
130963118|NCT00965848|471493124|FG000|Overall Study|Death|11|||
130963119|NCT00965848|471493125|FG001|Overall Study|Death|1|||
130963120|NCT00965848|471493126|FG002|Overall Study|Death|5|||
130963121|NCT00965848|471493124|FG000|Overall Study|Lost to Follow-up|0|||
130963122|NCT00965848|471493125|FG001|Overall Study|Lost to Follow-up|0|||
130963123|NCT00965848|471493126|FG002|Overall Study|Lost to Follow-up|1|||
130963124|NCT00965848|471493124|FG000|Overall Study|Withdrawal by Subject|1|||
130963125|NCT00965848|471493125|FG001|Overall Study|Withdrawal by Subject|0|||
130963126|NCT00965848|471493126|FG002|Overall Study|Withdrawal by Subject|0|||
130963127|NCT00965848|471493124|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
130963128|NCT00965848|471493125|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
130963129|NCT00965848|471493126|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
130963130|NCT00965848|471493124|FG000|Overall Study|Not Clinically Evaluable|7|||
130963131|NCT00965848|471493125|FG001|Overall Study|Not Clinically Evaluable|1|||
130963132|NCT00965848|471493126|FG002|Overall Study|Not Clinically Evaluable|1|||
130963133|NCT00965848|471493124|FG000|Overall Study|Other|5|||
130963134|NCT00965848|471493125|FG001|Overall Study|Other|0|||
130963135|NCT00965848|471493126|FG002|Overall Study|Other|1|||
130963136|NCT01208233|471493127|FG000|Overall Study|Adverse Event|0|||
130963137|NCT01208233|471493128|FG001|Overall Study|Adverse Event|1|||
130963138|NCT01208233|471493129|FG002|Overall Study|Adverse Event|2|||
130963139|NCT01208233|471493130|FG003|Overall Study|Adverse Event|0|||
130963140|NCT01208233|471493131|FG004|Overall Study|Adverse Event|3|||
130963141|NCT01208233|471493132|FG005|Overall Study|Adverse Event|5|||
130963142|NCT01208233|471493127|FG000|Overall Study|Death|0|||
130963143|NCT01208233|471493128|FG001|Overall Study|Death|0|||
130963144|NCT01208233|471493129|FG002|Overall Study|Death|0|||
130963145|NCT01208233|471493130|FG003|Overall Study|Death|0|||
130963146|NCT01208233|471493131|FG004|Overall Study|Death|3|||
130963147|NCT01208233|471493132|FG005|Overall Study|Death|5|||
130963148|NCT01208233|471493127|FG000|Overall Study|Did not meet entrance criteria|2|||
130963149|NCT01208233|471493128|FG001|Overall Study|Did not meet entrance criteria|1|||
130963150|NCT01208233|471493129|FG002|Overall Study|Did not meet entrance criteria|1|||
130963151|NCT01208233|471493130|FG003|Overall Study|Did not meet entrance criteria|0|||
130963152|NCT01208233|471493131|FG004|Overall Study|Did not meet entrance criteria|1|||
130963153|NCT01208233|471493132|FG005|Overall Study|Did not meet entrance criteria|0|||
130963154|NCT01208233|471493127|FG000|Overall Study|Medication error without adverse event|0|||
130963155|NCT01208233|471493128|FG001|Overall Study|Medication error without adverse event|0|||
130963156|NCT01208233|471493129|FG002|Overall Study|Medication error without adverse event|0|||
130963157|NCT01208233|471493130|FG003|Overall Study|Medication error without adverse event|0|||
130963158|NCT01208233|471493131|FG004|Overall Study|Medication error without adverse event|0|||
130963159|NCT01208233|471493132|FG005|Overall Study|Medication error without adverse event|1|||
130963160|NCT01208233|471493127|FG000|Overall Study|Study terminated by sponsor|0|||
130963161|NCT01208233|471493128|FG001|Overall Study|Study terminated by sponsor|0|||
130963162|NCT01208233|471493129|FG002|Overall Study|Study terminated by sponsor|0|||
130963163|NCT01208233|471493130|FG003|Overall Study|Study terminated by sponsor|0|||
130963164|NCT01208233|471493131|FG004|Overall Study|Study terminated by sponsor|10|||
130963165|NCT01208233|471493132|FG005|Overall Study|Study terminated by sponsor|7|||
131226612|NCT02266706|472457630|FG006|Overall Study|Screen failure|1|||
131226613|NCT02266706|472457631|FG007|Overall Study|Screen failure|0|||
130963166|NCT01208233|471493127|FG000|Overall Study|Protocol Violation|0|||
130963167|NCT01208233|471493128|FG001|Overall Study|Protocol Violation|0|||
130963168|NCT01208233|471493129|FG002|Overall Study|Protocol Violation|0|||
130963169|NCT01208233|471493130|FG003|Overall Study|Protocol Violation|0|||
130963170|NCT01208233|471493131|FG004|Overall Study|Protocol Violation|3|||
130963171|NCT01208233|471493132|FG005|Overall Study|Protocol Violation|0|||
130963172|NCT01208233|471493127|FG000|Overall Study|Other|2|||
131041298|NCT04625725|471785449|FG004|Provent Sub Study|Death|0|||
131041299|NCT04625725|471785450|FG005|Provent Sub Study|Death|1|||
131041300|NCT04625725|471785445|FG000|Provent Sub Study|Adverse Event|0|||
131041301|NCT04625725|471785446|FG001|Provent Sub Study|Adverse Event|0|||
131041302|NCT04625725|471785447|FG002|Provent Sub Study|Adverse Event|0|||
131041303|NCT04625725|471785448|FG003|Provent Sub Study|Adverse Event|0|||
131041304|NCT04625725|471785449|FG004|Provent Sub Study|Adverse Event|0|||
130963173|NCT01208233|471493128|FG001|Overall Study|Other|1|||
131041305|NCT04625725|471785450|FG005|Provent Sub Study|Adverse Event|1|||
131041306|NCT04625725|471785445|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
130963174|NCT01208233|471493129|FG002|Overall Study|Other|0|||
130963175|NCT01208233|471493130|FG003|Overall Study|Other|0|||
130963176|NCT01208233|471493131|FG004|Overall Study|Other|0|||
130963177|NCT01208233|471493132|FG005|Overall Study|Other|1|||
131226614|NCT02266706|472457632|FG008|Overall Study|Screen failure|0|||
131226615|NCT02266706|472457624|FG000|Overall Study|Enrollment in another study|0|||
131226616|NCT02266706|472457625|FG001|Overall Study|Enrollment in another study|0|||
131226617|NCT02266706|472457626|FG002|Overall Study|Enrollment in another study|0|||
131226618|NCT02266706|472457627|FG003|Overall Study|Enrollment in another study|1|||
131226619|NCT02266706|472457628|FG004|Overall Study|Enrollment in another study|0|||
130963178|NCT01208233|471493127|FG000|Overall Study|Withdrawal by Subject|1|||
130963179|NCT01208233|471493128|FG001|Overall Study|Withdrawal by Subject|0|||
130963180|NCT01208233|471493129|FG002|Overall Study|Withdrawal by Subject|1|||
130963181|NCT01208233|471493130|FG003|Overall Study|Withdrawal by Subject|1|||
130963182|NCT01208233|471493131|FG004|Overall Study|Withdrawal by Subject|4|||
130963183|NCT01208233|471493132|FG005|Overall Study|Withdrawal by Subject|2|||
130963184|NCT03964454|471493133|FG000|Overall Study|Lost to Follow-up|13|||
130963185|NCT03964454|471493134|FG001|Overall Study|Lost to Follow-up|7|||
130963186|NCT03964454|471493133|FG000|Overall Study|Withdrawal by Subject|4|||
130963187|NCT03964454|471493134|FG001|Overall Study|Withdrawal by Subject|11|||
130963188|NCT01076400|471495117|FG000|Overall Study|Adverse Event|2|||
130963189|NCT01076400|471495118|FG001|Overall Study|Adverse Event|0|||
130963190|NCT01076400|471495119|FG002|Overall Study|Adverse Event|0|||
130963191|NCT01076400|471495117|FG000|Overall Study|Progressive Disease|5|||
130963192|NCT01076400|471495118|FG001|Overall Study|Progressive Disease|0|||
130963193|NCT01076400|471495119|FG002|Overall Study|Progressive Disease|0|||
130963194|NCT03019536|471495121|FG000|Overall Study|Withdrawal by Subject|1|||
130963195|NCT03019536|471495122|FG001|Overall Study|Withdrawal by Subject|1|||
130963196|NCT03019536|471495123|FG002|Overall Study|Withdrawal by Subject|0|||
130963197|NCT03019536|471495121|FG000|Overall Study|Adverse Event|0|||
130963198|NCT03019536|471495122|FG001|Overall Study|Adverse Event|0|||
130963199|NCT03019536|471495123|FG002|Overall Study|Adverse Event|2|||
130963200|NCT00182689|471495131|FG000|Overall Study|Adverse Event|8|||
130963201|NCT00182689|471495132|FG001|Overall Study|Adverse Event|11|||
130963202|NCT00182689|471495131|FG000|Overall Study|Withdrawal by Subject|2|||
130963203|NCT00182689|471495132|FG001|Overall Study|Withdrawal by Subject|2|||
130963204|NCT00182689|471495131|FG000|Overall Study|Progression|27|||
131041307|NCT04625725|471785446|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
131041308|NCT04625725|471785447|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
131041309|NCT04625725|471785448|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
131041310|NCT04625725|471785449|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
131041311|NCT04625725|471785450|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
131041312|NCT04625725|471785445|FG000|Provent Sub Study|Withdrawal by Subject|0|||
131041313|NCT04625725|471785446|FG001|Provent Sub Study|Withdrawal by Subject|0|||
131041314|NCT04625725|471785447|FG002|Provent Sub Study|Withdrawal by Subject|11|||
131041315|NCT04625725|471785448|FG003|Provent Sub Study|Withdrawal by Subject|13|||
131041316|NCT04625725|471785449|FG004|Provent Sub Study|Withdrawal by Subject|5|||
131041317|NCT04625725|471785450|FG005|Provent Sub Study|Withdrawal by Subject|6|||
131041318|NCT04625725|471785445|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
131041319|NCT04625725|471785446|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
131041320|NCT04625725|471785447|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
131041321|NCT04625725|471785448|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
131041322|NCT04625725|471785449|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
131041323|NCT04625725|471785450|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
131041324|NCT05090683|471785454|FG000|Overall Study|Lost to Follow-up|10|||
131041325|NCT05090683|471785455|FG001|Overall Study|Lost to Follow-up|2|||
131041326|NCT05090683|471785454|FG000|Overall Study|Withdrawal by Subject|15|||
131041327|NCT05090683|471785455|FG001|Overall Study|Withdrawal by Subject|0|||
131041328|NCT05299723|471786520|FG000|Overall Study|Withdrawal by Subject|0|||
131041329|NCT05299723|471786521|FG001|Overall Study|Withdrawal by Subject|2|||
131041330|NCT05299723|471786522|FG002|Overall Study|Withdrawal by Subject|0|||
131041331|NCT02593773|471786523|FG000|Overall Study|Voluntary Withdrawal|3|||
131041332|NCT02593773|471786523|FG000|Overall Study|Study Terminated by Sponsor|31|||
131041333|NCT02593773|471786523|FG000|Overall Study|Death|1|||
131041334|NCT01208662|471786526|FG000|Induction and Consolidation|Disease Progression|23|||
131041335|NCT01208662|471786527|FG001|Induction and Consolidation|Disease Progression|13|||
131041336|NCT01208662|471786528|FG002|Induction and Consolidation|Disease Progression|0|||
131041337|NCT01208662|471786526|FG000|Induction and Consolidation|Adverse Event|16|||
131041338|NCT01208662|471786527|FG001|Induction and Consolidation|Adverse Event|18|||
131041339|NCT01208662|471786528|FG002|Induction and Consolidation|Adverse Event|2|||
131041340|NCT01208662|471786526|FG000|Induction and Consolidation|MD or Participant Decision|16|||
131041341|NCT01208662|471786527|FG001|Induction and Consolidation|MD or Participant Decision|34|||
131041342|NCT01208662|471786528|FG002|Induction and Consolidation|MD or Participant Decision|4|||
131041343|NCT01208662|471786526|FG000|Induction and Consolidation|Death|1|||
131041344|NCT01208662|471786527|FG001|Induction and Consolidation|Death|3|||
131041345|NCT01208662|471786528|FG002|Induction and Consolidation|Death|1|||
130714830|NCT00321737|470581788|FG000|Overall Study|Withdrawal by Subject|19|||
130714831|NCT00321737|470581789|FG001|Overall Study|Withdrawal by Subject|12|||
130714832|NCT00321737|470581790|FG002|Overall Study|Withdrawal by Subject|17|||
130714833|NCT00321737|470581788|FG000|Overall Study|Protocol Violation|0|||
130714834|NCT00321737|470581789|FG001|Overall Study|Protocol Violation|0|||
130714835|NCT00321737|470581790|FG002|Overall Study|Protocol Violation|1|||
130714836|NCT00321737|470581788|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
130714837|NCT00321737|470581789|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130714838|NCT00321737|470581790|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130714839|NCT00321737|470581788|FG000|Overall Study|Possible Barrett's Esophagus|2|||
130714840|NCT00321737|470581789|FG001|Overall Study|Possible Barrett's Esophagus|1|||
130714841|NCT00321737|470581790|FG002|Overall Study|Possible Barrett's Esophagus|1|||
130714842|NCT00321737|470581788|FG000|Overall Study|Therapeutic Failure|6|||
130714843|NCT00321737|470581789|FG001|Overall Study|Therapeutic Failure|0|||
130714844|NCT00321737|470581790|FG002|Overall Study|Therapeutic Failure|2|||
130714845|NCT00321737|470581788|FG000|Overall Study|Pregnancy|0|||
130714846|NCT00321737|470581789|FG001|Overall Study|Pregnancy|2|||
130714847|NCT00321737|470581790|FG002|Overall Study|Pregnancy|0|||
130714848|NCT00321737|470581788|FG000|Overall Study|Noncompliance|2|||
130714849|NCT00321737|470581789|FG001|Overall Study|Noncompliance|0|||
130963205|NCT00182689|471495132|FG001|Overall Study|Progression|29|||
130963206|NCT00182689|471495131|FG000|Overall Study|Death|1|||
130714850|NCT00321737|470581790|FG002|Overall Study|Noncompliance|0|||
130963207|NCT00182689|471495132|FG001|Overall Study|Death|0|||
130963208|NCT00182689|471495131|FG000|Overall Study|not protocol specified|0|||
130963209|NCT00182689|471495132|FG001|Overall Study|not protocol specified|3|||
130963210|NCT00182689|471495131|FG000|Overall Study|Ineligible|1|||
130963211|NCT00182689|471495132|FG001|Overall Study|Ineligible|4|||
130963212|NCT00182689|471495131|FG000|Overall Study|Never received treatment|1|||
130963213|NCT00182689|471495132|FG001|Overall Study|Never received treatment|0|||
130963214|NCT00201006|471495133|FG000|Overall Study|Withdrawal by Subject|7|||
130963215|NCT00201006|471495134|FG001|Overall Study|Withdrawal by Subject|2|||
130963216|NCT00201006|471495135|FG002|Overall Study|Withdrawal by Subject|3|||
130963217|NCT00201006|471495133|FG000|Overall Study|Adverse Event|1|||
130963218|NCT00201006|471495134|FG001|Overall Study|Adverse Event|0|||
130714851|NCT00321737|470581788|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
130963219|NCT00201006|471495135|FG002|Overall Study|Adverse Event|1|||
130963220|NCT01040871|471495136|FG000|Overall Study|Adverse Event|6|||
130963221|NCT01040871|471495137|FG001|Overall Study|Adverse Event|2|||
130963222|NCT01040871|471495136|FG000|Overall Study|Withdrawal by Subject|2|||
130963223|NCT01040871|471495137|FG001|Overall Study|Withdrawal by Subject|0|||
130963224|NCT01040871|471495136|FG000|Overall Study|Death|1|||
130963225|NCT01040871|471495137|FG001|Overall Study|Death|3|||
130963226|NCT01040871|471495136|FG000|Overall Study|Lack of Efficacy|1|||
130963227|NCT01040871|471495137|FG001|Overall Study|Lack of Efficacy|1|||
130714852|NCT00321737|470581789|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
130714853|NCT00321737|470581790|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
130714854|NCT01769339|470581791|FG000|Overall Study|Lost to Follow-up|42|||
130714855|NCT01769339|470581791|FG000|Overall Study|Adverse Event|1|||
130714856|NCT00290251|470581792|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130714857|NCT00290251|470581793|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130714858|NCT00290251|470581794|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130714859|NCT00290251|470581795|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130714860|NCT00290251|470581796|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130714861|NCT00290251|470581797|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
130714862|NCT00290251|470581792|FG000|Treatment 1 (Months 2-4)|headache|0|||
130714863|NCT00290251|470581793|FG001|Treatment 1 (Months 2-4)|headache|0|||
130714864|NCT00290251|470581794|FG002|Treatment 1 (Months 2-4)|headache|0|||
130714865|NCT00290251|470581795|FG003|Treatment 1 (Months 2-4)|headache|0|||
130714866|NCT00290251|470581796|FG004|Treatment 1 (Months 2-4)|headache|1|||
130714867|NCT00290251|470581797|FG005|Treatment 1 (Months 2-4)|headache|0|||
130714868|NCT00290251|470581792|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
130714869|NCT00290251|470581793|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
130714870|NCT00290251|470581794|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
130714871|NCT00290251|470581795|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
130714872|NCT00290251|470581796|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
130714873|NCT00290251|470581797|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
130714874|NCT04062448|470583898|FG000|Overall Study|Lost to Follow-up|1|||
130714875|NCT04062448|470583898|FG000|Overall Study|Withdrawal by Subject|2|||
130714876|NCT05101486|470583899|FG000|Overall Study|Death|1|||
130714877|NCT05101486|470583900|FG001|Overall Study|Death|0|||
130714878|NCT05101486|470583901|FG002|Overall Study|Death|1|||
130963228|NCT01040871|471495136|FG000|Overall Study|drug supply issue|1|||
130963229|NCT01040871|471495137|FG001|Overall Study|drug supply issue|0|||
130963230|NCT01040871|471495136|FG000|Overall Study|Randomized and Not Treated|2|||
130963231|NCT01040871|471495137|FG001|Overall Study|Randomized and Not Treated|1|||
130963232|NCT00673049|471495141|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
131226620|NCT02266706|472457629|FG005|Overall Study|Enrollment in another study|0|||
131226621|NCT02266706|472457630|FG006|Overall Study|Enrollment in another study|0|||
130963233|NCT00673049|471495142|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
130963234|NCT00673049|471495143|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
130963235|NCT00673049|471495144|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
130963236|NCT00673049|471495141|FG000|Before Progression on Erlotinib|Death|235|||
130963237|NCT00673049|471495142|FG001|Before Progression on Erlotinib|Death|167|||
130963238|NCT00673049|471495143|FG002|Before Progression on Erlotinib|Death|1|||
130963239|NCT00673049|471495144|FG003|Before Progression on Erlotinib|Death|0|||
130963240|NCT00673049|471495141|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
130963241|NCT00673049|471495142|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
130963242|NCT00673049|471495143|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
130963243|NCT00673049|471495144|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
130963244|NCT00673049|471495141|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
130963245|NCT00673049|471495142|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
130963246|NCT00673049|471495143|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
130963247|NCT00673049|471495144|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
130963248|NCT00673049|471495141|FG000|Before Progression on Erlotinib|Other|1|||
130963249|NCT00673049|471495142|FG001|Before Progression on Erlotinib|Other|2|||
130963250|NCT00673049|471495143|FG002|Before Progression on Erlotinib|Other|0|||
130963251|NCT00673049|471495144|FG003|Before Progression on Erlotinib|Other|0|||
130963252|NCT00673049|471495141|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
130963253|NCT00673049|471495142|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
130963254|NCT00673049|471495143|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
130963255|NCT00673049|471495144|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
130963256|NCT00673049|471495141|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
130963257|NCT00673049|471495142|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
130963258|NCT00673049|471495143|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
130963259|NCT00673049|471495144|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
130963260|NCT00673049|471495141|FG000|After Progression on Erlotinib|Death|0|||
130963261|NCT00673049|471495142|FG001|After Progression on Erlotinib|Death|0|||
130963262|NCT00673049|471495143|FG002|After Progression on Erlotinib|Death|0|||
130963263|NCT00673049|471495144|FG003|After Progression on Erlotinib|Death|71|||
130963264|NCT00673049|471495141|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
130963265|NCT00673049|471495142|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
130963266|NCT00673049|471495143|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
130963267|NCT00673049|471495144|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
130963268|NCT00673049|471495141|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
130963269|NCT00673049|471495142|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
130963270|NCT00673049|471495143|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
130963271|NCT00673049|471495144|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
130963272|NCT00673049|471495141|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
130963273|NCT00673049|471495142|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
130963274|NCT00673049|471495143|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
131226622|NCT02266706|472457631|FG007|Overall Study|Enrollment in another study|0|||
131226623|NCT02266706|472457632|FG008|Overall Study|Enrollment in another study|0|||
131226624|NCT02544633|472457633|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
130963275|NCT00673049|471495144|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
130963276|NCT00924950|471495145|FG000|Overall Study|Lost to Follow-up|2|||
130963277|NCT04193202|471495146|FG000|Overall Study|Adverse Event|2|||
130963278|NCT04193202|471495147|FG001|Overall Study|Adverse Event|1|||
130963279|NCT04193202|471495146|FG000|Overall Study|Death|0|||
130963280|NCT04193202|471495147|FG001|Overall Study|Death|1|||
130963281|NCT04193202|471495146|FG000|Overall Study|Physician Decision|1|||
130963282|NCT04193202|471495147|FG001|Overall Study|Physician Decision|1|||
130963283|NCT04193202|471495146|FG000|Overall Study|Protocol Violation|2|||
130963284|NCT04193202|471495147|FG001|Overall Study|Protocol Violation|2|||
130963285|NCT04193202|471495146|FG000|Overall Study|Withdrawal by Subject|11|||
130963286|NCT04193202|471495147|FG001|Overall Study|Withdrawal by Subject|5|||
131041346|NCT01208662|471786526|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
131041347|NCT01208662|471786527|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
131041348|NCT01208662|471786528|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
131041349|NCT01208662|471786526|FG000|Maintenance|Disease Progression|156|||
131041350|NCT01208662|471786527|FG001|Maintenance|Disease Progression|102|||
131041351|NCT01208662|471786528|FG002|Maintenance|Disease Progression|0|||
131226625|NCT02544633|472457634|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
130963287|NCT02979535|471495148|FG000|Overall Study|Non compliance with the protocol|78|||
130963288|NCT02979535|471495149|FG001|Overall Study|Non compliance with the protocol|82|||
131041352|NCT01208662|471786526|FG000|Maintenance|Adverse Event|12|||
131041353|NCT01208662|471786527|FG001|Maintenance|Adverse Event|28|||
131226626|NCT02544633|472457635|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
131226627|NCT02544633|472457636|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
131226628|NCT02544633|472457633|FG000|Treatment Period|Adverse Event|7|||
131226629|NCT02544633|472457634|FG001|Treatment Period|Adverse Event|4|||
131226630|NCT02544633|472457635|FG002|Treatment Period|Adverse Event|0|||
131226631|NCT02544633|472457636|FG003|Treatment Period|Adverse Event|5|||
131226632|NCT02544633|472457633|FG000|Treatment Period|Lack of Efficacy|17|||
131226633|NCT02544633|472457634|FG001|Treatment Period|Lack of Efficacy|11|||
131226634|NCT02544633|472457635|FG002|Treatment Period|Lack of Efficacy|5|||
131226635|NCT02544633|472457636|FG003|Treatment Period|Lack of Efficacy|5|||
131226636|NCT02544633|472457633|FG000|Treatment Period|Global Deterioration of Health|3|||
131226637|NCT02544633|472457634|FG001|Treatment Period|Global Deterioration of Health|3|||
131226638|NCT02544633|472457635|FG002|Treatment Period|Global Deterioration of Health|0|||
131226639|NCT02544633|472457636|FG003|Treatment Period|Global Deterioration of Health|1|||
131226640|NCT02544633|472457633|FG000|Treatment Period|Withdrawal by Subject|1|||
131226641|NCT02544633|472457634|FG001|Treatment Period|Withdrawal by Subject|0|||
131226642|NCT02544633|472457635|FG002|Treatment Period|Withdrawal by Subject|0|||
131226643|NCT02544633|472457636|FG003|Treatment Period|Withdrawal by Subject|0|||
131226644|NCT02544633|472457633|FG000|Treatment Period|Lost to Follow-up|0|||
131226645|NCT02544633|472457634|FG001|Treatment Period|Lost to Follow-up|1|||
131226646|NCT02544633|472457635|FG002|Treatment Period|Lost to Follow-up|0|||
131226647|NCT02544633|472457636|FG003|Treatment Period|Lost to Follow-up|0|||
131226648|NCT02544633|472457633|FG000|Treatment Period|Death|0|||
131226649|NCT02544633|472457634|FG001|Treatment Period|Death|0|||
131226650|NCT02544633|472457635|FG002|Treatment Period|Death|1|||
130963289|NCT02979535|471495148|FG000|Overall Study|Consent withdrawn by participant|11|||
130963290|NCT02979535|471495149|FG001|Overall Study|Consent withdrawn by participant|18|||
130963291|NCT02979535|471495148|FG000|Overall Study|Lost to Follow-up|6|||
131226651|NCT02544633|472457636|FG003|Treatment Period|Death|0|||
131226652|NCT02544633|472457633|FG000|Treatment Period|Non-compliance|0|||
131226653|NCT02544633|472457634|FG001|Treatment Period|Non-compliance|0|||
131226654|NCT02544633|472457635|FG002|Treatment Period|Non-compliance|1|||
130963292|NCT02979535|471495149|FG001|Overall Study|Lost to Follow-up|1|||
130963293|NCT02057757|471495156|FG000|Overall Study|Withdrawal by Subject|3|||
130963294|NCT02057757|471495157|FG001|Overall Study|Withdrawal by Subject|5|||
130963295|NCT02057757|471495156|FG000|Overall Study|Death|2|||
130963296|NCT02057757|471495157|FG001|Overall Study|Death|0|||
130963297|NCT02057757|471495156|FG000|Overall Study|Lost to Follow-up|8|||
130963298|NCT02057757|471495157|FG001|Overall Study|Lost to Follow-up|3|||
130963299|NCT02057757|471495156|FG000|Overall Study|Non-compliance|1|||
130963300|NCT02057757|471495157|FG001|Overall Study|Non-compliance|0|||
130963301|NCT03614793|471495158|FG000|Overall Study|Lost to Follow-up|1|||
130963302|NCT03614793|471495159|FG001|Overall Study|Lost to Follow-up|2|||
130963303|NCT03614793|471495158|FG000|Overall Study|Lack of Efficacy|0|||
130963304|NCT03614793|471495159|FG001|Overall Study|Lack of Efficacy|5|||
130963305|NCT03614793|471495158|FG000|Overall Study|Withdrawal by Subject|0|||
130963306|NCT03614793|471495159|FG001|Overall Study|Withdrawal by Subject|1|||
130963307|NCT03614793|471495158|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
130963308|NCT03614793|471495159|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
130963309|NCT02082522|471495160|FG000|Overall Study|Sponsor termination|5|||
130963310|NCT02082522|471495161|FG001|Overall Study|Sponsor termination|3|||
130963311|NCT02082522|471495160|FG000|Overall Study|Withdrawal by Subject|2|||
130963312|NCT02082522|471495161|FG001|Overall Study|Withdrawal by Subject|4|||
130963313|NCT02082522|471495160|FG000|Overall Study|Death|1|||
130963314|NCT02082522|471495161|FG001|Overall Study|Death|0|||
130963315|NCT02082522|471495160|FG000|Overall Study|Lost to Follow-up|1|||
130963316|NCT02082522|471495161|FG001|Overall Study|Lost to Follow-up|0|||
130963317|NCT02082522|471495160|FG000|Overall Study|Physician Decision|3|||
130963318|NCT02082522|471495161|FG001|Overall Study|Physician Decision|1|||
130963319|NCT02082522|471495160|FG000|Overall Study|Disease progression|2|||
130963320|NCT02082522|471495161|FG001|Overall Study|Disease progression|2|||
131226655|NCT02544633|472457636|FG003|Treatment Period|Non-compliance|0|||
131226656|NCT02544633|472457633|FG000|Treatment Period|Clinical Disease Progression|0|||
131226657|NCT02544633|472457634|FG001|Treatment Period|Clinical Disease Progression|0|||
131226658|NCT02544633|472457635|FG002|Treatment Period|Clinical Disease Progression|0|||
131226659|NCT02544633|472457636|FG003|Treatment Period|Clinical Disease Progression|1|||
130963321|NCT02082522|471495160|FG000|Overall Study|Chemotherapy change|1|||
130963322|NCT02082522|471495161|FG001|Overall Study|Chemotherapy change|3|||
131226660|NCT02544633|472457633|FG000|Survival Follow-up Period|Death|12|||
130963323|NCT00456092|471495162|FG000|Extension Phase|Grade 2 or Greater AE|2|||
130963324|NCT00456092|471495163|FG001|Extension Phase|Grade 2 or Greater AE|2|||
131226661|NCT02544633|472457634|FG001|Survival Follow-up Period|Death|14|||
131226662|NCT02544633|472457635|FG002|Survival Follow-up Period|Death|3|||
131226663|NCT02544633|472457636|FG003|Survival Follow-up Period|Death|9|||
131226664|NCT02544633|472457633|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
130963325|NCT00456092|471495164|FG002|Extension Phase|Grade 2 or Greater AE|0|||
130963326|NCT00456092|471495165|FG003|Extension Phase|Grade 2 or Greater AE|0|||
130963327|NCT00456092|471495166|FG004|Extension Phase|Grade 2 or Greater AE|2|||
131226665|NCT02544633|472457634|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
131226666|NCT02544633|472457635|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
131226667|NCT02544633|472457636|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
131226668|NCT02544633|472457633|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
131226669|NCT02544633|472457634|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
131226670|NCT02544633|472457635|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
131226671|NCT02544633|472457636|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
131226672|NCT02544633|472457633|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
130714879|NCT05101486|470583899|FG000|Overall Study|Lost to Follow-up|12|||
130714880|NCT05101486|470583900|FG001|Overall Study|Lost to Follow-up|8|||
130714881|NCT05101486|470583901|FG002|Overall Study|Lost to Follow-up|17|||
130714882|NCT05101486|470583899|FG000|Overall Study|Physician Decision|1|||
130714883|NCT05101486|470583900|FG001|Overall Study|Physician Decision|0|||
130714884|NCT05101486|470583901|FG002|Overall Study|Physician Decision|0|||
130714885|NCT05101486|470583899|FG000|Overall Study|Protocol Violation|0|||
130963328|NCT00456092|471495162|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
130963329|NCT00456092|471495163|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
130963330|NCT00456092|471495164|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
130963331|NCT00456092|471495165|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
130963332|NCT00456092|471495166|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
130963333|NCT00456092|471495162|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
130963334|NCT00456092|471495163|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
130963335|NCT00456092|471495164|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
130963336|NCT00456092|471495165|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
130963337|NCT00456092|471495166|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
130963338|NCT00456092|471495162|FG000|Extension Phase|Withdrew Consent|2|||
130963339|NCT00456092|471495163|FG001|Extension Phase|Withdrew Consent|0|||
130963340|NCT00456092|471495164|FG002|Extension Phase|Withdrew Consent|0|||
130963341|NCT00456092|471495165|FG003|Extension Phase|Withdrew Consent|0|||
130963342|NCT00456092|471495166|FG004|Extension Phase|Withdrew Consent|0|||
130963343|NCT00456092|471495162|FG000|Extension Phase|Lost to Follow-up|1|||
130963344|NCT00456092|471495163|FG001|Extension Phase|Lost to Follow-up|1|||
130963345|NCT00456092|471495164|FG002|Extension Phase|Lost to Follow-up|0|||
130963346|NCT00456092|471495165|FG003|Extension Phase|Lost to Follow-up|0|||
130963347|NCT00456092|471495166|FG004|Extension Phase|Lost to Follow-up|1|||
130963348|NCT00456092|471495162|FG000|Extension Phase|Other|2|||
130963349|NCT00456092|471495163|FG001|Extension Phase|Other|0|||
130963350|NCT00456092|471495164|FG002|Extension Phase|Other|0|||
130963351|NCT00456092|471495165|FG003|Extension Phase|Other|1|||
130963352|NCT00456092|471495166|FG004|Extension Phase|Other|1|||
130963353|NCT00456092|471495162|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
130963354|NCT00456092|471495163|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
130963355|NCT00456092|471495164|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
130963356|NCT00456092|471495165|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
130963357|NCT00456092|471495166|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
130963358|NCT00456092|471495162|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
130963359|NCT00456092|471495163|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
130963360|NCT00456092|471495164|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
130963361|NCT00456092|471495165|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
130963362|NCT00456092|471495166|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
130963363|NCT00456092|471495162|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
130963364|NCT00456092|471495163|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
130963365|NCT00456092|471495164|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
130963366|NCT00456092|471495165|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
130963367|NCT00456092|471495166|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
130963368|NCT00456092|471495162|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
130963369|NCT00456092|471495163|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
130963370|NCT00456092|471495164|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
130963371|NCT00456092|471495165|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
130963372|NCT00456092|471495166|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
130963373|NCT00456092|471495162|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
130963374|NCT00456092|471495163|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
130963375|NCT00456092|471495164|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
130963376|NCT00456092|471495165|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
130963377|NCT00456092|471495166|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
130963378|NCT00456092|471495162|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
130963379|NCT00456092|471495163|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
130963380|NCT00456092|471495164|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
130963381|NCT00456092|471495165|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
130963382|NCT00456092|471495166|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
131041354|NCT01208662|471786528|FG002|Maintenance|Adverse Event|0|||
130963383|NCT00456092|471495162|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
130963384|NCT00456092|471495163|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
130963385|NCT00456092|471495164|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
130963386|NCT00456092|471495165|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
130963387|NCT00456092|471495166|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
130963388|NCT00456092|471495162|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130963389|NCT00456092|471495163|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
130963390|NCT00456092|471495164|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
130963391|NCT00456092|471495165|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130963392|NCT00456092|471495166|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130963393|NCT00456092|471495162|FG000|Treatment Phase (12 Weeks)|Other|1|||
130963394|NCT00456092|471495163|FG001|Treatment Phase (12 Weeks)|Other|0|||
130963395|NCT00456092|471495164|FG002|Treatment Phase (12 Weeks)|Other|1|||
130963396|NCT00456092|471495165|FG003|Treatment Phase (12 Weeks)|Other|0|||
130963397|NCT00456092|471495166|FG004|Treatment Phase (12 Weeks)|Other|0|||
130963398|NCT01168999|471495167|FG000|Overall Study|Lost to Follow-up|2|||
130963399|NCT01168999|471495168|FG001|Overall Study|Lost to Follow-up|1|||
130963400|NCT01168999|471495169|FG002|Overall Study|Lost to Follow-up|0|||
130963401|NCT01168999|471495170|FG003|Overall Study|Lost to Follow-up|0|||
130963402|NCT03603964|471495171|FG000|Overall Study|Death|9|||
130963403|NCT03603964|471495171|FG000|Overall Study|Withdrawal by participant|7|||
130963404|NCT03603964|471495171|FG000|Overall Study|Study terminated by Sponsor|19|||
130963405|NCT04317586|471495172|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
130963406|NCT04317586|471495172|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
130963407|NCT00563797|471495173|FG000|Overall Study|Lost to Follow-up|7|||
130963408|NCT00563797|471495174|FG001|Overall Study|Lost to Follow-up|2|||
130963409|NCT03003676|471495175|FG000|Overall Study|Lack of Efficacy|5|||
130963410|NCT03003676|471495176|FG001|Overall Study|Lack of Efficacy|7|||
130963411|NCT03003676|471495175|FG000|Overall Study|Withdrawal by Subject|0|||
130963412|NCT03003676|471495176|FG001|Overall Study|Withdrawal by Subject|1|||
130963413|NCT03003676|471495175|FG000|Overall Study|Hepatitis B infection|1|||
130963414|NCT03003676|471495176|FG001|Overall Study|Hepatitis B infection|0|||
130963415|NCT00530023|471495182|FG000|Overall Study|Withdrawal by Subject|0|||
130963416|NCT00530023|471495183|FG001|Overall Study|Withdrawal by Subject|1|||
130963417|NCT02461589|471495184|FG000|Overall Study|Withdrawal by Subject|5|||
130963418|NCT02461589|471495185|FG001|Overall Study|Withdrawal by Subject|1|||
130963419|NCT02461589|471495186|FG002|Overall Study|Withdrawal by Subject|3|||
130963420|NCT02461589|471495187|FG003|Overall Study|Withdrawal by Subject|2|||
130963421|NCT02461589|471495188|FG004|Overall Study|Withdrawal by Subject|1|||
130963422|NCT02461589|471495189|FG005|Overall Study|Withdrawal by Subject|2|||
130963423|NCT02461589|471495190|FG006|Overall Study|Withdrawal by Subject|1|||
130963424|NCT02461589|471495191|FG007|Overall Study|Withdrawal by Subject|3|||
130963425|NCT02461589|471495192|FG008|Overall Study|Withdrawal by Subject|3|||
130963426|NCT02461589|471495193|FG009|Overall Study|Withdrawal by Subject|1|||
130963427|NCT02461589|471495184|FG000|Overall Study|Lost to Follow-up|0|||
130963428|NCT02461589|471495185|FG001|Overall Study|Lost to Follow-up|0|||
130963429|NCT02461589|471495186|FG002|Overall Study|Lost to Follow-up|2|||
130963430|NCT02461589|471495187|FG003|Overall Study|Lost to Follow-up|3|||
130963431|NCT02461589|471495188|FG004|Overall Study|Lost to Follow-up|1|||
130963432|NCT02461589|471495189|FG005|Overall Study|Lost to Follow-up|1|||
130963433|NCT02461589|471495190|FG006|Overall Study|Lost to Follow-up|3|||
130963434|NCT02461589|471495191|FG007|Overall Study|Lost to Follow-up|1|||
130963435|NCT02461589|471495192|FG008|Overall Study|Lost to Follow-up|3|||
130963436|NCT02461589|471495193|FG009|Overall Study|Lost to Follow-up|1|||
130963437|NCT02461589|471495184|FG000|Overall Study|Death|0|||
130963438|NCT02461589|471495185|FG001|Overall Study|Death|0|||
130963439|NCT02461589|471495186|FG002|Overall Study|Death|0|||
130963440|NCT02461589|471495187|FG003|Overall Study|Death|0|||
130963441|NCT02461589|471495188|FG004|Overall Study|Death|0|||
130963442|NCT02461589|471495189|FG005|Overall Study|Death|0|||
130963443|NCT02461589|471495190|FG006|Overall Study|Death|0|||
130963444|NCT02461589|471495191|FG007|Overall Study|Death|1|||
130963445|NCT02461589|471495192|FG008|Overall Study|Death|0|||
130963446|NCT02461589|471495193|FG009|Overall Study|Death|0|||
130963447|NCT02461589|471495184|FG000|Overall Study|Unclassified|0|||
130963448|NCT02461589|471495185|FG001|Overall Study|Unclassified|0|||
130963449|NCT02461589|471495186|FG002|Overall Study|Unclassified|0|||
130963450|NCT02461589|471495187|FG003|Overall Study|Unclassified|0|||
130963451|NCT02461589|471495188|FG004|Overall Study|Unclassified|0|||
130963452|NCT02461589|471495189|FG005|Overall Study|Unclassified|0|||
130963453|NCT02461589|471495190|FG006|Overall Study|Unclassified|1|||
130963454|NCT02461589|471495191|FG007|Overall Study|Unclassified|0|||
130963455|NCT02461589|471495192|FG008|Overall Study|Unclassified|0|||
130963456|NCT02461589|471495193|FG009|Overall Study|Unclassified|2|||
130963457|NCT02461589|471495184|FG000|Overall Study|Missing follow-up information|1|||
130963458|NCT02461589|471495185|FG001|Overall Study|Missing follow-up information|1|||
130963459|NCT02461589|471495186|FG002|Overall Study|Missing follow-up information|0|||
130963460|NCT02461589|471495187|FG003|Overall Study|Missing follow-up information|0|||
130963461|NCT02461589|471495188|FG004|Overall Study|Missing follow-up information|0|||
130963462|NCT02461589|471495189|FG005|Overall Study|Missing follow-up information|0|||
130963463|NCT02461589|471495190|FG006|Overall Study|Missing follow-up information|1|||
130963464|NCT02461589|471495191|FG007|Overall Study|Missing follow-up information|0|||
130963465|NCT02461589|471495192|FG008|Overall Study|Missing follow-up information|0|||
130963466|NCT02461589|471495193|FG009|Overall Study|Missing follow-up information|0|||
130963467|NCT02461589|471495184|FG000|Overall Study|Withdrawal from trial before exposure|0|||
130963468|NCT02461589|471495185|FG001|Overall Study|Withdrawal from trial before exposure|0|||
130963469|NCT02461589|471495186|FG002|Overall Study|Withdrawal from trial before exposure|0|||
130963470|NCT02461589|471495187|FG003|Overall Study|Withdrawal from trial before exposure|0|||
130963471|NCT02461589|471495188|FG004|Overall Study|Withdrawal from trial before exposure|0|||
130963472|NCT02461589|471495189|FG005|Overall Study|Withdrawal from trial before exposure|0|||
130963473|NCT02461589|471495190|FG006|Overall Study|Withdrawal from trial before exposure|0|||
130963474|NCT02461589|471495191|FG007|Overall Study|Withdrawal from trial before exposure|0|||
130963475|NCT02461589|471495192|FG008|Overall Study|Withdrawal from trial before exposure|0|||
130963476|NCT02461589|471495193|FG009|Overall Study|Withdrawal from trial before exposure|1|||
130963477|NCT04067141|471495194|FG000|First Intervention|Withdrawal by Subject|0|||
130963478|NCT04067141|471495195|FG001|First Intervention|Withdrawal by Subject|1|||
130963479|NCT04067141|471495194|FG000|Second Intervention|Adverse Event|0|||
130963480|NCT04067141|471495195|FG001|Second Intervention|Adverse Event|2|||
130963481|NCT01038921|471495196|FG000|Overall Study|Withdrawal by Subject|1|||
130963482|NCT01038921|471495197|FG001|Overall Study|Withdrawal by Subject|0|||
130963483|NCT01038921|471495196|FG000|Overall Study|Physician Decision|1|||
130963484|NCT01038921|471495197|FG001|Overall Study|Physician Decision|0|||
130963485|NCT01978119|471495198|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
130963486|NCT01978119|471495199|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
130963487|NCT01978119|471495198|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
130963488|NCT01978119|471495199|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130963489|NCT01978119|471495198|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130963490|NCT01978119|471495199|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
130963491|NCT04327934|471495200|FG000|Overall Study|Did not qualify|7|||
130963492|NCT04327934|471495201|FG001|Overall Study|Did not qualify|4|||
130963493|NCT04327934|471495200|FG000|Overall Study|Physician Decision|0|||
130963494|NCT04327934|471495201|FG001|Overall Study|Physician Decision|1|||
130963495|NCT03095417|471495206|FG000|Overall Study|missed|1|||
130963496|NCT03095417|471495207|FG001|Overall Study|missed|2|||
130963497|NCT03095417|471495208|FG002|Overall Study|missed|0|||
130963498|NCT03095417|471495209|FG003|Overall Study|missed|1|||
130963499|NCT03095417|471495206|FG000|Overall Study|Lost to Follow-up|2|||
130963500|NCT03095417|471495207|FG001|Overall Study|Lost to Follow-up|2|||
130963501|NCT03095417|471495208|FG002|Overall Study|Lost to Follow-up|1|||
130963502|NCT03095417|471495209|FG003|Overall Study|Lost to Follow-up|0|||
130963503|NCT03095417|471495206|FG000|Overall Study|refusal|0|||
130963504|NCT03095417|471495207|FG001|Overall Study|refusal|1|||
130963505|NCT03095417|471495208|FG002|Overall Study|refusal|0|||
130963506|NCT03095417|471495209|FG003|Overall Study|refusal|1|||
130963507|NCT03095417|471495206|FG000|Overall Study|Withdrawal by Subject|8|||
130963508|NCT03095417|471495207|FG001|Overall Study|Withdrawal by Subject|2|||
130963509|NCT03095417|471495208|FG002|Overall Study|Withdrawal by Subject|5|||
130963510|NCT03095417|471495209|FG003|Overall Study|Withdrawal by Subject|4|||
130963511|NCT03095417|471495206|FG000|Overall Study|Physician Decision|1|||
130963512|NCT03095417|471495207|FG001|Overall Study|Physician Decision|2|||
130963513|NCT03095417|471495208|FG002|Overall Study|Physician Decision|2|||
130963514|NCT03095417|471495209|FG003|Overall Study|Physician Decision|2|||
130963515|NCT03095417|471495206|FG000|Overall Study|Death|1|||
130963516|NCT03095417|471495207|FG001|Overall Study|Death|2|||
130963517|NCT03095417|471495208|FG002|Overall Study|Death|1|||
130963518|NCT03095417|471495209|FG003|Overall Study|Death|3|||
130963519|NCT01490060|471495210|FG000|Cycle 1|Change of Treatment|0|||
130963520|NCT01490060|471495211|FG001|Cycle 1|Change of Treatment|1|||
130963521|NCT01490060|471495212|FG002|Cycle 1|Change of Treatment|1|||
130963522|NCT01490060|471495213|FG003|Cycle 1|Change of Treatment|1|||
130963523|NCT01490060|471495210|FG000|Cycle 1|Insurance Denied|0|||
130963524|NCT01490060|471495211|FG001|Cycle 1|Insurance Denied|0|||
130963525|NCT01490060|471495212|FG002|Cycle 1|Insurance Denied|2|||
130963526|NCT01490060|471495213|FG003|Cycle 1|Insurance Denied|0|||
130963527|NCT01490060|471495210|FG000|Cycle 1|Withdrawal by Subject|0|||
130963528|NCT01490060|471495211|FG001|Cycle 1|Withdrawal by Subject|0|||
130963529|NCT01490060|471495212|FG002|Cycle 1|Withdrawal by Subject|0|||
130963530|NCT01490060|471495213|FG003|Cycle 1|Withdrawal by Subject|1|||
130963531|NCT01490060|471495210|FG000|Cycle 1|Treatment at Another Facility|0|||
130963532|NCT01490060|471495211|FG001|Cycle 1|Treatment at Another Facility|0|||
130963533|NCT01490060|471495212|FG002|Cycle 1|Treatment at Another Facility|0|||
130963534|NCT01490060|471495213|FG003|Cycle 1|Treatment at Another Facility|1|||
130963535|NCT01490060|471495210|FG000|Cycle 2|Change of Treatment|1|||
131041355|NCT01208662|471786526|FG000|Maintenance|MD or Participant Decision|24|||
131226673|NCT02544633|472457634|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
131226674|NCT02544633|472457635|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
131226675|NCT02544633|472457636|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
131226676|NCT01977352|472457637|FG000|Overall Study|Lost to Follow-up|1|||
131226677|NCT01977352|472457638|FG001|Overall Study|Lost to Follow-up|2|||
131226678|NCT00409188|472457639|FG000|Overall Study|Ongoing at data cut-off|383|||
131226679|NCT00409188|472457640|FG001|Overall Study|Ongoing at data cut-off|175|||
131226680|NCT02270983|472457641|FG000|Overall Study|Adverse Event|3|||
131226681|NCT02270983|472457642|FG001|Overall Study|Adverse Event|2|||
131226682|NCT02270983|472457643|FG002|Overall Study|Adverse Event|6|||
131226683|NCT02270983|472457641|FG000|Overall Study|Lack of Efficacy|2|||
131226684|NCT02270983|472457642|FG001|Overall Study|Lack of Efficacy|1|||
131226685|NCT02270983|472457643|FG002|Overall Study|Lack of Efficacy|1|||
131226686|NCT02270983|472457641|FG000|Overall Study|Withdrawal by Subject|1|||
131226687|NCT02270983|472457642|FG001|Overall Study|Withdrawal by Subject|0|||
131226688|NCT02270983|472457643|FG002|Overall Study|Withdrawal by Subject|2|||
130963536|NCT01490060|471495211|FG001|Cycle 2|Change of Treatment|1|||
130963537|NCT01490060|471495212|FG002|Cycle 2|Change of Treatment|0|||
130963538|NCT01490060|471495213|FG003|Cycle 2|Change of Treatment|0|||
130963539|NCT01490060|471495210|FG000|Cycle 2|Non-Compliance|0|||
130963540|NCT01490060|471495211|FG001|Cycle 2|Non-Compliance|0|||
130963541|NCT01490060|471495212|FG002|Cycle 2|Non-Compliance|1|||
130963542|NCT01490060|471495213|FG003|Cycle 2|Non-Compliance|0|||
130963543|NCT01490060|471495210|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
130963544|NCT01490060|471495211|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
130963545|NCT01490060|471495212|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
130963546|NCT01490060|471495213|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
130963547|NCT01877421|471495214|FG000|Phase 2|Lost to Follow-up|0|||
130963548|NCT01877421|471495215|FG001|Phase 2|Lost to Follow-up|0|||
130963549|NCT01877421|471495216|FG002|Phase 2|Lost to Follow-up|0|||
130963550|NCT01877421|471495217|FG003|Phase 2|Lost to Follow-up|0|||
130963551|NCT01877421|471495218|FG004|Phase 2|Lost to Follow-up|0|||
130963552|NCT01877421|471495219|FG005|Phase 2|Lost to Follow-up|0|||
130963553|NCT01877421|471495220|FG006|Phase 2|Lost to Follow-up|1|||
130963554|NCT01877421|471495221|FG007|Phase 2|Lost to Follow-up|0|||
130963555|NCT01877421|471495222|FG008|Phase 2|Lost to Follow-up|0|||
130963556|NCT01877421|471495223|FG009|Phase 2|Lost to Follow-up|0|||
130963557|NCT01877421|471495224|FG010|Phase 2|Lost to Follow-up|0|||
130963558|NCT01877421|471495225|FG011|Phase 2|Lost to Follow-up|0|||
130963559|NCT01877421|471495226|FG012|Phase 2|Lost to Follow-up|0|||
130963560|NCT01877421|471495227|FG013|Phase 2|Lost to Follow-up|0|||
130963561|NCT01877421|471495228|FG014|Phase 2|Lost to Follow-up|0|||
130963562|NCT01877421|471495229|FG015|Phase 2|Lost to Follow-up|0|||
130963563|NCT01877421|471495230|FG016|Phase 2|Lost to Follow-up|0|||
130963564|NCT01877421|471495231|FG017|Phase 2|Lost to Follow-up|0|||
130963565|NCT01877421|471495214|FG000|Phase 2|Withdrawal by Subject|0|||
130963566|NCT01877421|471495215|FG001|Phase 2|Withdrawal by Subject|0|||
130963567|NCT01877421|471495216|FG002|Phase 2|Withdrawal by Subject|0|||
130963568|NCT01877421|471495217|FG003|Phase 2|Withdrawal by Subject|0|||
130963569|NCT01877421|471495218|FG004|Phase 2|Withdrawal by Subject|0|||
130963570|NCT01877421|471495219|FG005|Phase 2|Withdrawal by Subject|0|||
130963571|NCT01877421|471495220|FG006|Phase 2|Withdrawal by Subject|0|||
130963572|NCT01877421|471495221|FG007|Phase 2|Withdrawal by Subject|0|||
130963573|NCT01877421|471495222|FG008|Phase 2|Withdrawal by Subject|1|||
130963574|NCT01877421|471495223|FG009|Phase 2|Withdrawal by Subject|0|||
130963575|NCT01877421|471495224|FG010|Phase 2|Withdrawal by Subject|1|||
130963576|NCT01877421|471495225|FG011|Phase 2|Withdrawal by Subject|0|||
130963577|NCT01877421|471495226|FG012|Phase 2|Withdrawal by Subject|1|||
130963578|NCT01877421|471495227|FG013|Phase 2|Withdrawal by Subject|0|||
130963579|NCT01877421|471495228|FG014|Phase 2|Withdrawal by Subject|0|||
130963580|NCT01877421|471495229|FG015|Phase 2|Withdrawal by Subject|1|||
130963581|NCT01877421|471495230|FG016|Phase 2|Withdrawal by Subject|0|||
130963582|NCT01877421|471495231|FG017|Phase 2|Withdrawal by Subject|0|||
130963583|NCT01877421|471495214|FG000|Phase 2|Protocol Violation|0|||
130963584|NCT01877421|471495215|FG001|Phase 2|Protocol Violation|0|||
130714886|NCT05101486|470583900|FG001|Overall Study|Protocol Violation|0|||
130963585|NCT01877421|471495216|FG002|Phase 2|Protocol Violation|0|||
130963586|NCT01877421|471495217|FG003|Phase 2|Protocol Violation|0|||
130714887|NCT05101486|470583901|FG002|Overall Study|Protocol Violation|1|||
131226689|NCT02270983|472457641|FG000|Overall Study|Lost to Follow-up|1|||
131226690|NCT02270983|472457642|FG001|Overall Study|Lost to Follow-up|1|||
131226691|NCT02270983|472457643|FG002|Overall Study|Lost to Follow-up|2|||
130714888|NCT05101486|470583899|FG000|Overall Study|Withdrawal by Subject|5|||
130963587|NCT01877421|471495218|FG004|Phase 2|Protocol Violation|0|||
130963588|NCT01877421|471495219|FG005|Phase 2|Protocol Violation|0|||
130963589|NCT01877421|471495220|FG006|Phase 2|Protocol Violation|0|||
130714889|NCT05101486|470583900|FG001|Overall Study|Withdrawal by Subject|2|||
130963590|NCT01877421|471495221|FG007|Phase 2|Protocol Violation|0|||
130963591|NCT01877421|471495222|FG008|Phase 2|Protocol Violation|0|||
130963592|NCT01877421|471495223|FG009|Phase 2|Protocol Violation|0|||
130963593|NCT01877421|471495224|FG010|Phase 2|Protocol Violation|1|||
130963594|NCT01877421|471495225|FG011|Phase 2|Protocol Violation|0|||
130963595|NCT01877421|471495226|FG012|Phase 2|Protocol Violation|0|||
130963596|NCT01877421|471495227|FG013|Phase 2|Protocol Violation|0|||
130963597|NCT01877421|471495228|FG014|Phase 2|Protocol Violation|0|||
130963598|NCT01877421|471495229|FG015|Phase 2|Protocol Violation|0|||
130963599|NCT01877421|471495230|FG016|Phase 2|Protocol Violation|0|||
130963600|NCT01877421|471495231|FG017|Phase 2|Protocol Violation|0|||
130963601|NCT01047683|471495232|FG000|Overall Study|Adverse Event|3|||
130963602|NCT01047683|471495233|FG001|Overall Study|Adverse Event|1|||
130963603|NCT01047683|471495234|FG002|Overall Study|Adverse Event|0|||
130963604|NCT01047683|471495232|FG000|Overall Study|Withdrew Consent|1|||
130963605|NCT01047683|471495233|FG001|Overall Study|Withdrew Consent|4|||
130963606|NCT01047683|471495234|FG002|Overall Study|Withdrew Consent|2|||
130963607|NCT01047683|471495232|FG000|Overall Study|Lost to Follow-up|0|||
130963608|NCT01047683|471495233|FG001|Overall Study|Lost to Follow-up|1|||
130963609|NCT01047683|471495234|FG002|Overall Study|Lost to Follow-up|0|||
130963610|NCT01047683|471495232|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
130963611|NCT01047683|471495233|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
130963612|NCT01047683|471495234|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
130963613|NCT03698773|471495236|FG000|Overall Study|Lost to Follow-up|2|||
130963614|NCT03698773|471495237|FG001|Overall Study|Lost to Follow-up|1|||
130963615|NCT00908960|471495238|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
130963616|NCT00908960|471495239|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
130963617|NCT00908960|471495240|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
130963638|NCT01158924|471495246|FG000|Overall Study|Withdrawal by Subject|1|||
131127569|NCT03917823|472095997|FG000|Overall Study|Withdrawal by Subject|0|||
131127570|NCT03917823|472095998|FG001|Overall Study|Withdrawal by Subject|1|||
131127571|NCT00135668|472095999|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
131127572|NCT00135668|472096000|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
131127573|NCT00135668|472096001|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
131127574|NCT00135668|472096002|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
131127575|NCT02016820|472096003|FG000|Overall Study|Lost to Follow-up|2|||
131127576|NCT02016820|472096004|FG001|Overall Study|Lost to Follow-up|4|||
131127577|NCT01227044|472096007|FG000|Overall Study|Lost to Follow-up|5|||
131127578|NCT01227044|472096008|FG001|Overall Study|Lost to Follow-up|7|||
131127579|NCT01227044|472096007|FG000|Overall Study|Discontinued Intervention|1|||
131127580|NCT01227044|472096008|FG001|Overall Study|Discontinued Intervention|2|||
131127581|NCT00583362|472096009|FG000|Overall Study|Adverse Event|44|||
131127582|NCT00583362|472096009|FG000|Overall Study|Lack of Efficacy|22|||
131127583|NCT00583362|472096009|FG000|Overall Study|Lost to Follow-up|4|||
131127584|NCT00583362|472096009|FG000|Overall Study|Non-compliance with study drug|28|||
131127585|NCT00583362|472096009|FG000|Overall Study|Pregnancy|7|||
131127586|NCT00583362|472096009|FG000|Overall Study|Miscommunication of visit window|5|||
131127587|NCT00583362|472096009|FG000|Overall Study|Current site closed|7|||
131127588|NCT00583362|472096009|FG000|Overall Study|Subject not dosed in LBSL99|1|||
131127589|NCT00583362|472096009|FG000|Overall Study|Subject moved out of the country/state|2|||
131127590|NCT00583362|472096009|FG000|Overall Study|Missed visits due to staff changes|1|||
131127591|NCT00583362|472096009|FG000|Overall Study|Misunderstanding of protocol|1|||
130963639|NCT01158924|471495247|FG001|Overall Study|Withdrawal by Subject|2|||
130963640|NCT01158924|471495246|FG000|Overall Study|Lost to Follow-up|0|||
130963641|NCT01158924|471495247|FG001|Overall Study|Lost to Follow-up|1|||
130963642|NCT03795922|471495248|FG000|Overall Study|Adverse Event|2|||
130963643|NCT03795922|471495249|FG001|Overall Study|Adverse Event|1|||
130963644|NCT03795922|471495248|FG000|Overall Study|Withdrawal by Subject|5|||
130963645|NCT03795922|471495249|FG001|Overall Study|Withdrawal by Subject|13|||
130963646|NCT03795922|471495248|FG000|Overall Study|Lost to Follow-up|2|||
130963647|NCT03795922|471495249|FG001|Overall Study|Lost to Follow-up|3|||
130963648|NCT03795922|471495248|FG000|Overall Study|Pregnancy|0|||
130714890|NCT05101486|470583901|FG002|Overall Study|Withdrawal by Subject|4|||
130714891|NCT05101486|470583899|FG000|Overall Study|Randomized but not vaccinated|1|||
130714892|NCT05101486|470583900|FG001|Overall Study|Randomized but not vaccinated|1|||
130714893|NCT05101486|470583901|FG002|Overall Study|Randomized but not vaccinated|1|||
130714894|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
130714895|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
130714896|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
130714897|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
130714898|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
130714899|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
130714900|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
130714901|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
130714902|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
130714903|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
130714904|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
130714905|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
130714906|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
130714907|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
130714908|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
130714909|NCT02788045|470583902|FG000|Main Study (Up to Week 72)|Other|3|||
130714910|NCT02788045|470583903|FG001|Main Study (Up to Week 72)|Other|0|||
130714911|NCT02788045|470583904|FG002|Main Study (Up to Week 72)|Other|0|||
130714912|NCT02788045|470583902|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
130714913|NCT02788045|470583903|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
130714914|NCT02788045|470583904|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
130714915|NCT02788045|470583902|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
130714916|NCT02788045|470583903|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
130714917|NCT02788045|470583904|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
130714918|NCT02788045|470583902|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
130714919|NCT02788045|470583903|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
130714920|NCT02788045|470583904|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
130714921|NCT01884311|470583905|FG000|Overall Study|Withdrawal by Subject|3|||
130714922|NCT01884311|470583905|FG000|Overall Study|withdrew consent due to AEs|1|||
130714923|NCT01884311|470583905|FG000|Overall Study|Precautionary measure|1|||
130714924|NCT02307266|470583906|FG000|Overall Study|Adverse Event|3|||
130714925|NCT02307266|470583907|FG001|Overall Study|Adverse Event|1|||
130714926|NCT02307266|470583908|FG002|Overall Study|Adverse Event|5|||
130714927|NCT02307266|470583906|FG000|Overall Study|Withdrawal by Subject|2|||
130714928|NCT02307266|470583907|FG001|Overall Study|Withdrawal by Subject|0|||
130963649|NCT03795922|471495249|FG001|Overall Study|Pregnancy|1|||
130963650|NCT03795922|471495248|FG000|Overall Study|Physician Decision|1|||
130963651|NCT03795922|471495249|FG001|Overall Study|Physician Decision|2|||
130963652|NCT03795922|471495248|FG000|Overall Study|Protocol Violation|0|||
130963653|NCT03795922|471495249|FG001|Overall Study|Protocol Violation|1|||
130963654|NCT03795922|471495248|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
130963655|NCT03795922|471495249|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
130963656|NCT00724451|471495253|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
130963657|NCT00724451|471495253|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
130963658|NCT00724451|471495253|FG000|Overall Study|Not Eligible for Treatment|431|||
130963659|NCT00724451|471495253|FG000|Overall Study|Participant Refused Treatment|89|||
130963660|NCT00724451|471495253|FG000|Overall Study|Never Started Treatment|89|||
130963661|NCT00724451|471495253|FG000|Overall Study|Unknown; No Data Sources Available|9|||
130963662|NCT00724451|471495253|FG000|Overall Study|Physician Decision|116|||
130963663|NCT00724451|471495253|FG000|Overall Study|Withdrawal by Subject|45|||
130963664|NCT00724451|471495253|FG000|Overall Study|Investigator + Participant Decision|13|||
130963665|NCT01260922|471495255|FG000|First Intervention|Withdrawal by Subject|0|||
130963666|NCT01260922|471495256|FG001|First Intervention|Withdrawal by Subject|1|||
130963667|NCT01260922|471495255|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
130963668|NCT01260922|471495256|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
130963669|NCT01260922|471495255|FG000|Second Intervention|Emesis|0|||
130963670|NCT01260922|471495256|FG001|Second Intervention|Emesis|2|||
130963671|NCT02822794|471495261|FG000|Overall Study|Withdrew Consent|1|||
130963672|NCT02822794|471495262|FG001|Overall Study|Withdrew Consent|0|||
130963673|NCT00733824|471495263|FG000|Phase I|Withdrawal by Subject|1|||
130714929|NCT02307266|470583908|FG002|Overall Study|Withdrawal by Subject|1|||
130714930|NCT02307266|470583906|FG000|Overall Study|Lost to Follow-up|3|||
130714931|NCT02307266|470583907|FG001|Overall Study|Lost to Follow-up|0|||
130714932|NCT02307266|470583908|FG002|Overall Study|Lost to Follow-up|0|||
130714933|NCT01183221|470583913|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
130714934|NCT01183221|470583914|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
130963674|NCT00733824|471495264|FG001|Phase I|Withdrawal by Subject|0|||
130963675|NCT00733824|471495265|FG002|Phase I|Withdrawal by Subject|0|||
130963676|NCT00733824|471495266|FG003|Phase I|Withdrawal by Subject|0|||
130963677|NCT00733824|471495267|FG004|Phase I|Withdrawal by Subject|0|||
130963678|NCT01243944|471495268|FG000|Overall Study|Adverse Event|15|||
130963679|NCT01243944|471495269|FG001|Overall Study|Adverse Event|13|||
130963680|NCT01243944|471495268|FG000|Overall Study|Lost to Follow-up|2|||
130963681|NCT01243944|471495269|FG001|Overall Study|Lost to Follow-up|1|||
130963682|NCT01243944|471495268|FG000|Overall Study|Physician Decision|2|||
130963683|NCT01243944|471495269|FG001|Overall Study|Physician Decision|7|||
130963684|NCT01243944|471495268|FG000|Overall Study|Disease progression|12|||
130963685|NCT01243944|471495269|FG001|Overall Study|Disease progression|11|||
130963686|NCT01243944|471495268|FG000|Overall Study|Protocol deviation|1|||
130963687|NCT01243944|471495269|FG001|Overall Study|Protocol deviation|1|||
130963688|NCT01243944|471495268|FG000|Overall Study|Participant decision|10|||
130963689|NCT01243944|471495269|FG001|Overall Study|Participant decision|15|||
130963690|NCT01243944|471495268|FG000|Overall Study|Death|2|||
130963691|NCT01243944|471495269|FG001|Overall Study|Death|3|||
130963692|NCT01243944|471495268|FG000|Overall Study|Non-compliance with study treatment|1|||
130963693|NCT01243944|471495269|FG001|Overall Study|Non-compliance with study treatment|0|||
130963694|NCT01416805|471495270|FG000|Overall Study|Lost to Follow-up|4|||
130963695|NCT01416805|471495271|FG001|Overall Study|Lost to Follow-up|4|||
130963696|NCT02480621|471495272|FG000|Randomization|Withdrawal by Subject|1|||
130963697|NCT02480621|471495273|FG001|Randomization|Withdrawal by Subject|0|||
130963698|NCT02480621|471495272|FG000|Randomization|Surgeon did not give intervention|0|||
130963699|NCT02480621|471495273|FG001|Randomization|Surgeon did not give intervention|1|||
130963700|NCT02480621|471495272|FG000|Follow Up|Lost to Follow-up|4|||
130963701|NCT02480621|471495273|FG001|Follow Up|Lost to Follow-up|2|||
130963702|NCT03056690|471495274|FG000|Overall Study|Adverse Event|3|||
130963703|NCT03056690|471495275|FG001|Overall Study|Adverse Event|2|||
130963704|NCT03056690|471495274|FG000|Overall Study|Lack of Efficacy|1|||
130963705|NCT03056690|471495275|FG001|Overall Study|Lack of Efficacy|2|||
130963706|NCT03056690|471495274|FG000|Overall Study|Lost to Follow-up|3|||
130963707|NCT03056690|471495275|FG001|Overall Study|Lost to Follow-up|2|||
130963708|NCT03056690|471495274|FG000|Overall Study|Protocol Violation|2|||
130963709|NCT03056690|471495275|FG001|Overall Study|Protocol Violation|2|||
130963710|NCT03056690|471495274|FG000|Overall Study|Withdrawal by Subject|3|||
130963711|NCT03056690|471495275|FG001|Overall Study|Withdrawal by Subject|6|||
130963712|NCT03056690|471495274|FG000|Overall Study|Non-compliance with Study Drug|1|||
130963713|NCT03056690|471495275|FG001|Overall Study|Non-compliance with Study Drug|0|||
130963714|NCT03056690|471495274|FG000|Overall Study|Miscellaneous|1|||
130963715|NCT03056690|471495275|FG001|Overall Study|Miscellaneous|2|||
130963716|NCT01652716|471495282|FG000|Overall Study|Loss of glucose control|1|||
130963717|NCT01652716|471495283|FG001|Overall Study|Loss of glucose control|0|||
130963718|NCT01652716|471495282|FG000|Overall Study|Administrative|0|||
130963719|NCT01652716|471495283|FG001|Overall Study|Administrative|2|||
130963720|NCT01652716|471495282|FG000|Overall Study|Investigator decision|1|||
130963721|NCT01652716|471495283|FG001|Overall Study|Investigator decision|4|||
130963722|NCT01652716|471495282|FG000|Overall Study|Lost to Follow-up|12|||
130963723|NCT01652716|471495283|FG001|Overall Study|Lost to Follow-up|11|||
130963724|NCT01652716|471495282|FG000|Overall Study|Protocol Violation|2|||
130963725|NCT01652716|471495283|FG001|Overall Study|Protocol Violation|1|||
130963726|NCT01652716|471495282|FG000|Overall Study|Adverse Event|7|||
130963727|NCT01652716|471495283|FG001|Overall Study|Adverse Event|10|||
130963728|NCT01652716|471495282|FG000|Overall Study|Withdrawal by Subject|33|||
130963729|NCT01652716|471495283|FG001|Overall Study|Withdrawal by Subject|18|||
130963730|NCT02778204|471495284|FG000|Overall Study|Adverse Event|1|||
130963731|NCT02778204|471495285|FG001|Overall Study|Adverse Event|0|||
130963732|NCT02778204|471495286|FG002|Overall Study|Adverse Event|0|||
130963733|NCT02778204|471495287|FG003|Overall Study|Adverse Event|0|||
130963734|NCT02778204|471495284|FG000|Overall Study|Withdrawal by Subject|0|||
130714935|NCT02504671|470583922|FG000|Overall Study|Withdrawal by Subject|1|||
130963735|NCT02778204|471495285|FG001|Overall Study|Withdrawal by Subject|0|||
130963736|NCT02778204|471495286|FG002|Overall Study|Withdrawal by Subject|1|||
130963737|NCT02778204|471495287|FG003|Overall Study|Withdrawal by Subject|2|||
130963738|NCT02778204|471495284|FG000|Overall Study|Lost to Follow-up|1|||
130963739|NCT02778204|471495285|FG001|Overall Study|Lost to Follow-up|0|||
130714936|NCT02504671|470583923|FG001|Overall Study|Withdrawal by Subject|5|||
130963740|NCT02778204|471495286|FG002|Overall Study|Lost to Follow-up|2|||
130963741|NCT02778204|471495287|FG003|Overall Study|Lost to Follow-up|1|||
130963742|NCT02778204|471495284|FG000|Overall Study|Protocol Violation|0|||
130963743|NCT02778204|471495285|FG001|Overall Study|Protocol Violation|0|||
130963744|NCT02778204|471495286|FG002|Overall Study|Protocol Violation|1|||
130963745|NCT02778204|471495287|FG003|Overall Study|Protocol Violation|0|||
130963746|NCT02778204|471495284|FG000|Overall Study|Eligibility Violation|0|||
130963747|NCT02778204|471495285|FG001|Overall Study|Eligibility Violation|0|||
130963748|NCT02778204|471495286|FG002|Overall Study|Eligibility Violation|0|||
130963749|NCT02778204|471495287|FG003|Overall Study|Eligibility Violation|1|||
130963750|NCT02052466|471495288|FG000|Overall Study|Withdrawal by Subject|1|||
130963751|NCT02052466|471495288|FG000|Overall Study|Acromial fracture|1|||
130963752|NCT01328002|471495292|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
130963753|NCT01328002|471495293|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
130963754|NCT01328002|471495292|FG000|Open-Label Period|Adverse Event|8|||
130963755|NCT01328002|471495293|FG001|Open-Label Period|Adverse Event|0|||
130963756|NCT01328002|471495292|FG000|Open-Label Period|Lack of Efficacy|3|||
130963757|NCT01328002|471495293|FG001|Open-Label Period|Lack of Efficacy|0|||
130963758|NCT01328002|471495292|FG000|Open-Label Period|Protocol Violation|2|||
130963759|NCT01328002|471495293|FG001|Open-Label Period|Protocol Violation|0|||
130963760|NCT01328002|471495292|FG000|Open-Label Period|Withdrawal by Subject|9|||
130963761|NCT01328002|471495293|FG001|Open-Label Period|Withdrawal by Subject|0|||
130963762|NCT01328002|471495292|FG000|Open-Label Period|Lost to Follow-up|6|||
130963763|NCT01328002|471495293|FG001|Open-Label Period|Lost to Follow-up|0|||
130963764|NCT01328002|471495292|FG000|Open-Label Period|Other Reason|2|||
130963765|NCT01328002|471495293|FG001|Open-Label Period|Other Reason|0|||
130963766|NCT01328002|471495292|FG000|Double-Blind Period|Adverse Event|1|||
130963767|NCT01328002|471495293|FG001|Double-Blind Period|Adverse Event|0|||
130963768|NCT01328002|471495292|FG000|Double-Blind Period|Lack of Efficacy|1|||
130963769|NCT01328002|471495293|FG001|Double-Blind Period|Lack of Efficacy|0|||
130963770|NCT00813761|471495294|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
130963771|NCT00813761|471495295|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
130963772|NCT00813761|471495296|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
130963773|NCT00813761|471495297|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
130963774|NCT00813761|471495294|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
130963775|NCT00813761|471495295|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
130963776|NCT00813761|471495296|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
130963777|NCT00813761|471495297|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
130963778|NCT00813761|471495294|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
130963779|NCT00813761|471495295|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
130963780|NCT00813761|471495296|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
130963781|NCT00813761|471495297|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
130963782|NCT00813761|471495294|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
130963783|NCT00813761|471495295|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
130963784|NCT00813761|471495296|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
130963785|NCT00813761|471495297|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
130963786|NCT00813761|471495294|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
130963787|NCT00813761|471495295|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
130963788|NCT00813761|471495296|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
130963789|NCT00813761|471495297|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
130963790|NCT00813761|471495294|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
130963791|NCT00813761|471495295|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
130963792|NCT00813761|471495296|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
130963793|NCT00813761|471495297|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
130963794|NCT00813761|471495294|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
130963795|NCT00813761|471495295|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
130963796|NCT00813761|471495296|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
130963797|NCT00813761|471495297|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
130963798|NCT00813761|471495294|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
130963799|NCT00813761|471495295|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
130963800|NCT00813761|471495296|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
130963801|NCT00813761|471495297|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
130963802|NCT00813761|471495294|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
130963803|NCT00813761|471495295|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
130963804|NCT00813761|471495296|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
130963805|NCT00813761|471495297|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
130963806|NCT00813761|471495294|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
130963807|NCT00813761|471495295|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
130963808|NCT00813761|471495296|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
130963809|NCT00813761|471495297|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
130963810|NCT00813761|471495294|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
130963811|NCT00813761|471495295|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
130963812|NCT00813761|471495296|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
130963813|NCT00813761|471495297|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
130963814|NCT00813761|471495294|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
130963815|NCT00813761|471495295|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
130963816|NCT00813761|471495296|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
130963817|NCT00813761|471495297|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
130963818|NCT01181895|471495299|FG000|Overall Study|Adverse Event|3|||
130963819|NCT01181895|471495300|FG001|Overall Study|Adverse Event|1|||
130963820|NCT01181895|471495301|FG002|Overall Study|Adverse Event|1|||
130963821|NCT01181895|471495299|FG000|Overall Study|Lack of Efficacy|8|||
130963822|NCT01181895|471495300|FG001|Overall Study|Lack of Efficacy|9|||
130963823|NCT01181895|471495301|FG002|Overall Study|Lack of Efficacy|9|||
130963824|NCT01181895|471495299|FG000|Overall Study|Protocol Violation|2|||
130963825|NCT01181895|471495300|FG001|Overall Study|Protocol Violation|1|||
130963826|NCT01181895|471495301|FG002|Overall Study|Protocol Violation|0|||
130963827|NCT01181895|471495299|FG000|Overall Study|Lost to Follow-up|0|||
130963828|NCT01181895|471495300|FG001|Overall Study|Lost to Follow-up|1|||
130963829|NCT01181895|471495301|FG002|Overall Study|Lost to Follow-up|2|||
130963830|NCT01181895|471495299|FG000|Overall Study|Investigator Discretion|1|||
130963831|NCT01181895|471495300|FG001|Overall Study|Investigator Discretion|2|||
130963832|NCT01181895|471495301|FG002|Overall Study|Investigator Discretion|1|||
130963833|NCT01181895|471495299|FG000|Overall Study|Withdrawal by Subject|3|||
130963834|NCT01181895|471495300|FG001|Overall Study|Withdrawal by Subject|0|||
130963835|NCT01181895|471495301|FG002|Overall Study|Withdrawal by Subject|5|||
130963836|NCT01114516|471495307|FG000|Overall Study|Lost to Follow-up|2|||
130963837|NCT01114516|471495308|FG001|Overall Study|Lost to Follow-up|1|||
130963838|NCT00061048|471495309|FG000|Overall Study|Adverse Event|2|||
130963839|NCT00061048|471495309|FG000|Overall Study|disease progression|20|||
130963840|NCT01609556|471495314|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963841|NCT01609556|471495315|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963842|NCT01609556|471495316|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963843|NCT01609556|471495317|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963844|NCT01609556|471495318|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
130963845|NCT01609556|471495319|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963846|NCT01609556|471495320|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963847|NCT01609556|471495321|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
130963848|NCT01609556|471495322|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
130963849|NCT01609556|471495323|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963850|NCT01609556|471495324|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
130963851|NCT01609556|471495325|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
130963852|NCT01609556|471495326|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963853|NCT01609556|471495327|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963854|NCT01609556|471495328|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963855|NCT01609556|471495329|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
130963856|NCT01609556|471495314|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
130963857|NCT01609556|471495315|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
130963858|NCT01609556|471495316|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
130963859|NCT01609556|471495317|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
130963860|NCT01609556|471495318|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
130963861|NCT01609556|471495319|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
130963862|NCT01609556|471495320|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
130963863|NCT01609556|471495321|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
130963864|NCT01609556|471495322|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
130963865|NCT01609556|471495323|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
130963866|NCT01609556|471495324|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
130963867|NCT01609556|471495325|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
131041356|NCT01208662|471786527|FG001|Maintenance|MD or Participant Decision|36|||
131041357|NCT01208662|471786528|FG002|Maintenance|MD or Participant Decision|0|||
131041358|NCT01208662|471786526|FG000|Maintenance|Death|0|||
131041359|NCT01208662|471786527|FG001|Maintenance|Death|3|||
131041360|NCT01208662|471786528|FG002|Maintenance|Death|0|||
131041361|NCT01208662|471786526|FG000|Maintenance|Discontinued for other reasons|21|||
131041362|NCT01208662|471786527|FG001|Maintenance|Discontinued for other reasons|31|||
131041363|NCT01208662|471786528|FG002|Maintenance|Discontinued for other reasons|0|||
131041364|NCT01208662|471786526|FG000|Maintenance|Still on Treatment|78|||
131041365|NCT01208662|471786527|FG001|Maintenance|Still on Treatment|89|||
131041366|NCT01208662|471786528|FG002|Maintenance|Still on Treatment|0|||
130963868|NCT01609556|471495326|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
130963869|NCT01609556|471495327|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
130963870|NCT01609556|471495328|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
130963871|NCT01609556|471495329|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
130963872|NCT01609556|471495314|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
131041367|NCT04066205|471786538|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
131045901|NCT05205161|471802298|FG002|Overall Study|Study terminated by sponsor|1|||
131045902|NCT03248479|471802300|FG000|Overall Study|Death|12|||
131045903|NCT03248479|471802301|FG001|Overall Study|Death|44|||
131045904|NCT03248479|471802302|FG002|Overall Study|Death|1|||
131045905|NCT03248479|471802303|FG003|Overall Study|Death|72|||
131045906|NCT03248479|471802304|FG004|Overall Study|Death|17|||
131045907|NCT03248479|471802305|FG005|Overall Study|Death|6|||
131045908|NCT03248479|471802306|FG006|Overall Study|Death|1|||
131045909|NCT03248479|471802307|FG007|Overall Study|Death|14|||
131045910|NCT03248479|471802308|FG008|Overall Study|Death|3|||
131045911|NCT03248479|471802309|FG009|Overall Study|Death|7|||
131045912|NCT03248479|471802310|FG010|Overall Study|Death|3|||
131045913|NCT03248479|471802311|FG011|Overall Study|Death|1|||
131045914|NCT03248479|471802312|FG012|Overall Study|Death|1|||
131045915|NCT03248479|471802300|FG000|Overall Study|Study terminated by sponsor|12|||
130963873|NCT01609556|471495315|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130963874|NCT01609556|471495316|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130963875|NCT01609556|471495317|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130963876|NCT01609556|471495318|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130963877|NCT01609556|471495319|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
130963878|NCT01609556|471495320|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
130963879|NCT01609556|471495321|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130963880|NCT01609556|471495322|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130963881|NCT01609556|471495323|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
130963882|NCT01609556|471495324|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
130963883|NCT01609556|471495325|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
130963884|NCT01609556|471495326|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130963885|NCT01609556|471495327|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130963886|NCT01609556|471495328|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130963887|NCT01609556|471495329|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
130963888|NCT01609556|471495314|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963889|NCT01609556|471495315|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963890|NCT01609556|471495316|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963891|NCT01609556|471495317|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963892|NCT01609556|471495318|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963893|NCT01609556|471495319|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
130963894|NCT01609556|471495320|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963895|NCT01609556|471495321|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963896|NCT01609556|471495322|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963897|NCT01609556|471495323|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963898|NCT01609556|471495324|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963899|NCT01609556|471495325|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
130963900|NCT01609556|471495326|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963901|NCT01609556|471495327|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963902|NCT01609556|471495328|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963903|NCT01609556|471495329|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
130963904|NCT01609556|471495314|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963905|NCT01609556|471495315|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963906|NCT01609556|471495316|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963907|NCT01609556|471495317|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963908|NCT01609556|471495318|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963909|NCT01609556|471495319|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
130963910|NCT01609556|471495320|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963911|NCT01609556|471495321|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963912|NCT01609556|471495322|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963913|NCT01609556|471495323|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963914|NCT01609556|471495324|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963915|NCT01609556|471495325|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963916|NCT01609556|471495326|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963917|NCT01609556|471495327|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963918|NCT01609556|471495328|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963919|NCT01609556|471495329|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
130963920|NCT01609556|471495314|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963921|NCT01609556|471495315|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131127592|NCT00583362|472096009|FG000|Overall Study|Behavioral problems and non-compliance|1|||
131127593|NCT00583362|472096009|FG000|Overall Study|Sponsor request due to missed doses|1|||
131127594|NCT00583362|472096009|FG000|Overall Study|Physician Decision|19|||
131127595|NCT00583362|472096009|FG000|Overall Study|Protocol Violation|2|||
131127596|NCT00583362|472096009|FG000|Overall Study|Withdrawal by Subject|57|||
131127597|NCT00473343|472096010|FG000|Overall Study|Adverse Event|9|||
131127598|NCT00473343|472096010|FG000|Overall Study|Lost to Follow-up|8|||
131127599|NCT00473343|472096010|FG000|Overall Study|Treatment failure|27|||
131127600|NCT00473343|472096010|FG000|Overall Study|Withdrew consent|3|||
131127601|NCT00473343|472096010|FG000|Overall Study|Other un-specified reason|3|||
131127602|NCT04247061|472096013|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
131127603|NCT04247061|472096013|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
131127604|NCT04247061|472096013|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
131226692|NCT02270983|472457641|FG000|Overall Study|Protocol Violation|1|||
130963922|NCT01609556|471495316|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
131226693|NCT02270983|472457642|FG001|Overall Study|Protocol Violation|1|||
131226694|NCT02270983|472457643|FG002|Overall Study|Protocol Violation|1|||
131226695|NCT02270983|472457641|FG000|Overall Study|family emergency|0|||
131226696|NCT02270983|472457642|FG001|Overall Study|family emergency|1|||
131226697|NCT02270983|472457643|FG002|Overall Study|family emergency|0|||
131226698|NCT02270983|472457641|FG000|Overall Study|study procedure non-compliance|1|||
131226699|NCT02270983|472457642|FG001|Overall Study|study procedure non-compliance|0|||
131226700|NCT02270983|472457643|FG002|Overall Study|study procedure non-compliance|0|||
131226701|NCT02270983|472457641|FG000|Overall Study|moved away from study site|0|||
131226702|NCT02270983|472457642|FG001|Overall Study|moved away from study site|1|||
131226703|NCT02270983|472457643|FG002|Overall Study|moved away from study site|0|||
131226704|NCT00854620|472457646|FG000|Overall Study|Adverse Event|1|||
131226705|NCT00928252|472457647|FG000|Overall Study|Physician Decision|3|||
131226706|NCT01605461|472457649|FG000|Overall Study|Lost to Follow-up|3|||
131226707|NCT01605461|472457649|FG000|Overall Study|Withdrawal by Subject|1|||
131226708|NCT02024698|472457650|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
131226709|NCT02024698|472457651|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
131226710|NCT01393990|472457652|FG000|Overall Study|Adverse Event|0|||
131226711|NCT01393990|472457653|FG001|Overall Study|Adverse Event|0|||
131226712|NCT01393990|472457654|FG002|Overall Study|Adverse Event|0|||
131226713|NCT01393990|472457655|FG003|Overall Study|Adverse Event|0|||
131226714|NCT01393990|472457656|FG004|Overall Study|Adverse Event|0|||
131226715|NCT01393990|472457657|FG005|Overall Study|Adverse Event|0|||
131226716|NCT01393990|472457658|FG006|Overall Study|Adverse Event|0|||
131226717|NCT01393990|472457659|FG007|Overall Study|Adverse Event|0|||
131226718|NCT01393990|472457660|FG008|Overall Study|Adverse Event|0|||
131226719|NCT01393990|472457661|FG009|Overall Study|Adverse Event|0|||
131226720|NCT01393990|472457662|FG010|Overall Study|Adverse Event|0|||
131226721|NCT01393990|472457663|FG011|Overall Study|Adverse Event|0|||
131226722|NCT01393990|472457664|FG012|Overall Study|Adverse Event|0|||
131226723|NCT01393990|472457665|FG013|Overall Study|Adverse Event|0|||
131226724|NCT01393990|472457666|FG014|Overall Study|Adverse Event|1|||
131226725|NCT01393990|472457667|FG015|Overall Study|Adverse Event|1|||
131226726|NCT01393990|472457668|FG016|Overall Study|Adverse Event|0|||
131226727|NCT01393990|472457669|FG017|Overall Study|Adverse Event|0|||
131226728|NCT01393990|472457652|FG000|Overall Study|Progressive Disease|1|||
131226729|NCT01393990|472457653|FG001|Overall Study|Progressive Disease|0|||
131226730|NCT01393990|472457654|FG002|Overall Study|Progressive Disease|0|||
131226731|NCT01393990|472457655|FG003|Overall Study|Progressive Disease|1|||
131226732|NCT01393990|472457656|FG004|Overall Study|Progressive Disease|1|||
131226733|NCT01393990|472457657|FG005|Overall Study|Progressive Disease|1|||
131226734|NCT01393990|472457658|FG006|Overall Study|Progressive Disease|1|||
131226735|NCT01393990|472457659|FG007|Overall Study|Progressive Disease|1|||
130963923|NCT01609556|471495317|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963924|NCT01609556|471495318|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963925|NCT01609556|471495319|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963926|NCT01609556|471495320|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963927|NCT01609556|471495321|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963928|NCT01609556|471495322|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
130963929|NCT01609556|471495323|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963930|NCT01609556|471495324|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963931|NCT01609556|471495325|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963932|NCT01609556|471495326|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963933|NCT01609556|471495327|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963934|NCT01609556|471495328|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963935|NCT01609556|471495329|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
130963936|NCT01609556|471495314|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
130963937|NCT01609556|471495315|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963938|NCT01609556|471495316|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963939|NCT01609556|471495317|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963940|NCT01609556|471495318|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963941|NCT01609556|471495319|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
131226736|NCT01393990|472457660|FG008|Overall Study|Progressive Disease|3|||
131226737|NCT01393990|472457661|FG009|Overall Study|Progressive Disease|1|||
131226738|NCT01393990|472457662|FG010|Overall Study|Progressive Disease|0|||
131226739|NCT01393990|472457663|FG011|Overall Study|Progressive Disease|0|||
130774805|NCT03410992|470802561|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130963942|NCT01609556|471495320|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963943|NCT01609556|471495321|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
131226740|NCT01393990|472457664|FG012|Overall Study|Progressive Disease|0|||
131226741|NCT01393990|472457665|FG013|Overall Study|Progressive Disease|1|||
131226742|NCT01393990|472457666|FG014|Overall Study|Progressive Disease|6|||
131226743|NCT01393990|472457667|FG015|Overall Study|Progressive Disease|1|||
131226744|NCT01393990|472457668|FG016|Overall Study|Progressive Disease|0|||
130714937|NCT02504671|470583924|FG002|Overall Study|Withdrawal by Subject|4|||
130963944|NCT01609556|471495322|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963945|NCT01609556|471495323|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963946|NCT01609556|471495324|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
130963947|NCT01609556|471495325|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963948|NCT01609556|471495326|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963949|NCT01609556|471495327|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963950|NCT01609556|471495328|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963951|NCT01609556|471495329|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
130963952|NCT01609556|471495314|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963953|NCT01609556|471495315|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963954|NCT01609556|471495316|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963955|NCT01609556|471495317|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963956|NCT01609556|471495318|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963957|NCT01609556|471495319|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963958|NCT01609556|471495320|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963959|NCT01609556|471495321|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963960|NCT01609556|471495322|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963961|NCT01609556|471495323|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963962|NCT01609556|471495324|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963963|NCT01609556|471495325|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
130963964|NCT01609556|471495326|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
130963965|NCT01609556|471495327|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
130963966|NCT01609556|471495328|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
130963967|NCT01609556|471495329|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
130963968|NCT01609556|471495314|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963969|NCT01609556|471495315|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963970|NCT01609556|471495316|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963971|NCT01609556|471495317|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963972|NCT01609556|471495318|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963973|NCT01609556|471495319|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963974|NCT01609556|471495320|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963975|NCT01609556|471495321|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963976|NCT01609556|471495322|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963977|NCT01609556|471495323|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963978|NCT01609556|471495324|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963979|NCT01609556|471495325|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
130963980|NCT01609556|471495326|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
130963981|NCT01609556|471495327|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
130963982|NCT01609556|471495328|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
130963983|NCT01609556|471495329|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
130963984|NCT01609556|471495314|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963985|NCT01609556|471495315|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963986|NCT01609556|471495316|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963987|NCT01609556|471495317|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963988|NCT01609556|471495318|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963989|NCT01609556|471495319|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963990|NCT01609556|471495320|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963991|NCT01609556|471495321|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963992|NCT01609556|471495322|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963993|NCT01609556|471495323|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963994|NCT01609556|471495324|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963995|NCT01609556|471495325|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
130963996|NCT01609556|471495326|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
130963997|NCT01609556|471495327|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
130963998|NCT01609556|471495328|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
130963999|NCT01609556|471495329|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
130964000|NCT01609556|471495314|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964001|NCT01609556|471495315|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964002|NCT01609556|471495316|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964003|NCT01609556|471495317|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964004|NCT01609556|471495318|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964005|NCT01609556|471495319|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964006|NCT01609556|471495320|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964007|NCT01609556|471495321|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964008|NCT01609556|471495322|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131226745|NCT01393990|472457669|FG017|Overall Study|Progressive Disease|0|||
130964009|NCT01609556|471495323|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
131226746|NCT01393990|472457652|FG000|Overall Study|Death|0|||
131226747|NCT01393990|472457653|FG001|Overall Study|Death|0|||
131226748|NCT01393990|472457654|FG002|Overall Study|Death|0|||
131226749|NCT01393990|472457655|FG003|Overall Study|Death|0|||
131226750|NCT01393990|472457656|FG004|Overall Study|Death|1|||
131226751|NCT01393990|472457657|FG005|Overall Study|Death|0|||
131226752|NCT01393990|472457658|FG006|Overall Study|Death|0|||
131226753|NCT01393990|472457659|FG007|Overall Study|Death|0|||
131226754|NCT01393990|472457660|FG008|Overall Study|Death|0|||
131226755|NCT01393990|472457661|FG009|Overall Study|Death|0|||
131226756|NCT01393990|472457662|FG010|Overall Study|Death|0|||
131226757|NCT01393990|472457663|FG011|Overall Study|Death|0|||
131226758|NCT01393990|472457664|FG012|Overall Study|Death|0|||
131226759|NCT01393990|472457665|FG013|Overall Study|Death|1|||
130964010|NCT01609556|471495324|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964011|NCT01609556|471495325|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964012|NCT01609556|471495326|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
130964013|NCT01609556|471495327|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964014|NCT01609556|471495328|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964015|NCT01609556|471495329|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
130964016|NCT01609556|471495314|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130964017|NCT01609556|471495315|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130964018|NCT01609556|471495316|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130964019|NCT01609556|471495317|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130964020|NCT01609556|471495318|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130964021|NCT01609556|471495319|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130964022|NCT01609556|471495320|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130964023|NCT01609556|471495321|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131226760|NCT01393990|472457666|FG014|Overall Study|Death|1|||
131226761|NCT01393990|472457667|FG015|Overall Study|Death|0|||
131226762|NCT01393990|472457668|FG016|Overall Study|Death|0|||
131226763|NCT01393990|472457669|FG017|Overall Study|Death|0|||
130714938|NCT02504671|470583925|FG003|Overall Study|Withdrawal by Subject|4|||
130714939|NCT02504671|470583926|FG004|Overall Study|Withdrawal by Subject|5|||
130714940|NCT02504671|470583927|FG005|Overall Study|Withdrawal by Subject|3|||
130714941|NCT02504671|470583922|FG000|Overall Study|Lack of Efficacy|1|||
130714942|NCT02504671|470583923|FG001|Overall Study|Lack of Efficacy|3|||
130714943|NCT02504671|470583924|FG002|Overall Study|Lack of Efficacy|1|||
130714944|NCT02504671|470583925|FG003|Overall Study|Lack of Efficacy|0|||
130714945|NCT02504671|470583926|FG004|Overall Study|Lack of Efficacy|4|||
130714946|NCT02504671|470583927|FG005|Overall Study|Lack of Efficacy|4|||
130714947|NCT02504671|470583922|FG000|Overall Study|Adverse Event|1|||
130714948|NCT02504671|470583923|FG001|Overall Study|Adverse Event|1|||
130714949|NCT02504671|470583924|FG002|Overall Study|Adverse Event|0|||
130714950|NCT02504671|470583925|FG003|Overall Study|Adverse Event|1|||
130714951|NCT02504671|470583926|FG004|Overall Study|Adverse Event|0|||
130714952|NCT02504671|470583927|FG005|Overall Study|Adverse Event|2|||
130714953|NCT02504671|470583922|FG000|Overall Study|Protocol Violation|2|||
130714954|NCT02504671|470583923|FG001|Overall Study|Protocol Violation|1|||
130714955|NCT02504671|470583924|FG002|Overall Study|Protocol Violation|0|||
130714956|NCT02504671|470583925|FG003|Overall Study|Protocol Violation|0|||
130714957|NCT02504671|470583926|FG004|Overall Study|Protocol Violation|0|||
130714958|NCT02504671|470583927|FG005|Overall Study|Protocol Violation|1|||
130714959|NCT02504671|470583922|FG000|Overall Study|Lost to Follow-up|0|||
130714960|NCT02504671|470583923|FG001|Overall Study|Lost to Follow-up|0|||
130714961|NCT02504671|470583924|FG002|Overall Study|Lost to Follow-up|2|||
130714962|NCT02504671|470583925|FG003|Overall Study|Lost to Follow-up|0|||
130714963|NCT02504671|470583926|FG004|Overall Study|Lost to Follow-up|0|||
130714964|NCT02504671|470583927|FG005|Overall Study|Lost to Follow-up|1|||
130714965|NCT02504671|470583922|FG000|Overall Study|Protocol defined stopping criteria|7|||
130714966|NCT02504671|470583923|FG001|Overall Study|Protocol defined stopping criteria|4|||
130714967|NCT02504671|470583924|FG002|Overall Study|Protocol defined stopping criteria|3|||
130714968|NCT02504671|470583925|FG003|Overall Study|Protocol defined stopping criteria|5|||
130714969|NCT02504671|470583926|FG004|Overall Study|Protocol defined stopping criteria|3|||
130714970|NCT02504671|470583927|FG005|Overall Study|Protocol defined stopping criteria|3|||
130714971|NCT02518919|470583928|FG000|Overall Study|Protocol Violation|1|||
130714972|NCT02518919|470583929|FG001|Overall Study|Protocol Violation|1|||
130964024|NCT01609556|471495322|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
131226764|NCT01393990|472457652|FG000|Overall Study|Withdrawal by Subject|0|||
131226765|NCT01393990|472457653|FG001|Overall Study|Withdrawal by Subject|0|||
130714973|NCT02518919|470583930|FG002|Overall Study|Protocol Violation|2|||
130714974|NCT00866658|470583931|FG000|Overall Study|Adverse Event|5|||
131226766|NCT01393990|472457654|FG002|Overall Study|Withdrawal by Subject|0|||
131226767|NCT01393990|472457655|FG003|Overall Study|Withdrawal by Subject|0|||
131226768|NCT01393990|472457656|FG004|Overall Study|Withdrawal by Subject|0|||
131226769|NCT01393990|472457657|FG005|Overall Study|Withdrawal by Subject|0|||
131226770|NCT01393990|472457658|FG006|Overall Study|Withdrawal by Subject|0|||
131226771|NCT01393990|472457659|FG007|Overall Study|Withdrawal by Subject|0|||
131226772|NCT01393990|472457660|FG008|Overall Study|Withdrawal by Subject|0|||
131226773|NCT01393990|472457661|FG009|Overall Study|Withdrawal by Subject|0|||
131226774|NCT01393990|472457662|FG010|Overall Study|Withdrawal by Subject|0|||
131226775|NCT01393990|472457663|FG011|Overall Study|Withdrawal by Subject|0|||
130714975|NCT00866658|470583932|FG001|Overall Study|Adverse Event|14|||
130714976|NCT00866658|470583931|FG000|Overall Study|Lack of Efficacy|2|||
130964025|NCT01609556|471495323|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130964026|NCT01609556|471495324|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130964027|NCT01609556|471495325|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
130964028|NCT01609556|471495326|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
130964029|NCT01609556|471495327|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
130964030|NCT01609556|471495328|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
130964031|NCT01609556|471495329|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
130964032|NCT01609556|471495314|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964033|NCT01609556|471495315|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964034|NCT01609556|471495316|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964035|NCT01609556|471495317|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964036|NCT01609556|471495318|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964037|NCT01609556|471495319|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964038|NCT01609556|471495320|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964039|NCT01609556|471495321|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964040|NCT01609556|471495322|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964041|NCT01609556|471495323|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964042|NCT01609556|471495324|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964043|NCT01609556|471495325|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964044|NCT01609556|471495326|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964045|NCT01609556|471495327|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964046|NCT01609556|471495328|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
130964047|NCT01609556|471495329|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
130964048|NCT01609556|471495314|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964049|NCT01609556|471495315|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964050|NCT01609556|471495316|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964051|NCT01609556|471495317|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964052|NCT01609556|471495318|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964053|NCT01609556|471495319|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964054|NCT01609556|471495320|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964055|NCT01609556|471495321|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
131127605|NCT01136655|472096021|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
131127606|NCT01136655|472096021|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
131127607|NCT01136655|472096021|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
131127608|NCT01136655|472096021|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
131127609|NCT02287623|472096024|FG000|Overall Study|Protocol Violation|0|||
131127610|NCT02287623|472096025|FG001|Overall Study|Protocol Violation|1|||
131127611|NCT00455013|472096027|FG000|Short Term Period|Adverse Event|2|||
131127612|NCT00455013|472096028|FG001|Short Term Period|Adverse Event|5|||
131127613|NCT00455013|472096029|FG002|Short Term Period|Adverse Event|0|||
131127614|NCT00455013|472096027|FG000|Short Term Period|Withdrawal by Subject|0|||
131226776|NCT01393990|472457664|FG012|Overall Study|Withdrawal by Subject|0|||
130714977|NCT00866658|470583932|FG001|Overall Study|Lack of Efficacy|1|||
130714978|NCT00866658|470583931|FG000|Overall Study|Withdrawal by Subject|1|||
130714979|NCT00866658|470583932|FG001|Overall Study|Withdrawal by Subject|0|||
130714980|NCT00866658|470583931|FG000|Overall Study|Protocol Violation|1|||
130714981|NCT00866658|470583932|FG001|Overall Study|Protocol Violation|1|||
130714982|NCT00866658|470583931|FG000|Overall Study|Familial and Personal Reasons|4|||
130714983|NCT00866658|470583932|FG001|Overall Study|Familial and Personal Reasons|5|||
130714984|NCT00609518|470583934|FG000|Overall Study|Death from Study Disease|32|||
130714985|NCT00609518|470583935|FG001|Overall Study|Death from Study Disease|32|||
130714986|NCT00609518|470583934|FG000|Overall Study|Withdrawal by Subject|5|||
130714987|NCT00609518|470583935|FG001|Overall Study|Withdrawal by Subject|3|||
130714988|NCT00609518|470583934|FG000|Overall Study|Lost to Follow-up|3|||
130714989|NCT00609518|470583935|FG001|Overall Study|Lost to Follow-up|0|||
130964056|NCT01609556|471495322|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964057|NCT01609556|471495323|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964058|NCT01609556|471495324|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964059|NCT01609556|471495325|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964060|NCT01609556|471495326|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
131226777|NCT01393990|472457665|FG013|Overall Study|Withdrawal by Subject|0|||
131226778|NCT01393990|472457666|FG014|Overall Study|Withdrawal by Subject|1|||
130714990|NCT00609518|470583934|FG000|Overall Study|Physician Decision|1|||
130714991|NCT00609518|470583935|FG001|Overall Study|Physician Decision|3|||
130714992|NCT00609518|470583934|FG000|Overall Study|Death from Adverse Event|2|||
130964061|NCT01609556|471495327|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
130964062|NCT01609556|471495328|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
130964063|NCT01609556|471495329|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
130964064|NCT01609556|471495314|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964065|NCT01609556|471495315|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964066|NCT01609556|471495316|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964067|NCT01609556|471495317|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130774806|NCT03410992|470802562|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
130774807|NCT03410992|470802563|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
130774808|NCT03410992|470802564|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
130774809|NCT03410992|470802565|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130774810|NCT03410992|470802566|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130774811|NCT03410992|470802567|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130774812|NCT03410992|470802568|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130774813|NCT03410992|470802569|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130774814|NCT03410992|470802559|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130774815|NCT03410992|470802560|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130774816|NCT03410992|470802561|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130774817|NCT03410992|470802562|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130774818|NCT03410992|470802563|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130774819|NCT03410992|470802564|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
130774820|NCT03410992|470802565|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130774821|NCT03410992|470802566|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130774822|NCT03410992|470802567|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130774823|NCT03410992|470802568|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130774824|NCT03410992|470802569|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130774825|NCT03410992|470802559|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130774826|NCT03410992|470802560|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130774827|NCT03410992|470802561|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130774828|NCT03410992|470802562|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
130774829|NCT03410992|470802563|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
130774830|NCT03410992|470802564|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
130774831|NCT03410992|470802565|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130774832|NCT03410992|470802566|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130774833|NCT03410992|470802567|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130774834|NCT03410992|470802568|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130774835|NCT03410992|470802569|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130774836|NCT03410992|470802559|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
130774837|NCT03410992|470802560|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
130774838|NCT03410992|470802561|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
130774839|NCT03410992|470802562|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
130774840|NCT03410992|470802563|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
130774841|NCT03410992|470802564|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
130774842|NCT03410992|470802565|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
130774843|NCT03410992|470802566|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
130774844|NCT03410992|470802567|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
130774845|NCT03410992|470802568|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
130774846|NCT03410992|470802569|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
130774847|NCT03410992|470802559|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130774848|NCT03410992|470802560|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130774849|NCT03410992|470802561|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130774850|NCT03410992|470802562|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
131127615|NCT00455013|472096028|FG001|Short Term Period|Withdrawal by Subject|0|||
131127616|NCT00455013|472096029|FG002|Short Term Period|Withdrawal by Subject|1|||
130714993|NCT00609518|470583935|FG001|Overall Study|Death from Adverse Event|2|||
130714994|NCT01687478|470583936|FG000|Overall Study|Adverse Event|3|||
130714995|NCT01687478|470583937|FG001|Overall Study|Adverse Event|10|||
130714996|NCT01687478|470583936|FG000|Overall Study|Lost to Follow-up|1|||
130714997|NCT01687478|470583937|FG001|Overall Study|Lost to Follow-up|3|||
130714998|NCT01687478|470583936|FG000|Overall Study|Protocol Violation|0|||
131127617|NCT00455013|472096027|FG000|Short Term Period|Lack of Efficacy|4|||
131127618|NCT00455013|472096028|FG001|Short Term Period|Lack of Efficacy|0|||
131127619|NCT00455013|472096029|FG002|Short Term Period|Lack of Efficacy|0|||
131127620|NCT00455013|472096027|FG000|Short Term Period|Other|0|||
130714999|NCT01687478|470583937|FG001|Overall Study|Protocol Violation|2|||
130715000|NCT01687478|470583936|FG000|Overall Study|Withdrawal by Subject|21|||
130964068|NCT01609556|471495318|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964069|NCT01609556|471495319|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964070|NCT01609556|471495320|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964071|NCT01609556|471495321|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964072|NCT01609556|471495322|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964073|NCT01609556|471495323|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964074|NCT01609556|471495324|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964075|NCT01609556|471495325|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964076|NCT01609556|471495326|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
131226779|NCT01393990|472457667|FG015|Overall Study|Withdrawal by Subject|1|||
131226780|NCT01393990|472457668|FG016|Overall Study|Withdrawal by Subject|0|||
131226781|NCT01393990|472457669|FG017|Overall Study|Withdrawal by Subject|0|||
131226782|NCT00275028|472457670|FG000|Overall Study|Withdrew consent before treatment began|1|||
131226783|NCT00275028|472457670|FG000|Overall Study|Withdrawal by Subject|5|||
131226784|NCT00275028|472457670|FG000|Overall Study|Adverse Event|9|||
131226785|NCT00275028|472457670|FG000|Overall Study|Progressive Disease|30|||
131226786|NCT00275028|472457670|FG000|Overall Study|Physician Decision|2|||
131226787|NCT00331630|472457674|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
131226788|NCT00331630|472457674|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
131226789|NCT00331630|472457674|FG000|Follow up for 5 Years|Death|5|||
131226790|NCT00331630|472457674|FG000|Follow up for 5 Years|Data collection was stopped|24|||
131226791|NCT02370784|472457675|FG000|Overall Study|Patient started prohibited medication|0|||
131226792|NCT02370784|472457676|FG001|Overall Study|Patient started prohibited medication|1|||
131226793|NCT01312779|472457679|FG000|Overall Study|Withdrawal by Subject|2|||
131226794|NCT01312779|472457679|FG000|Overall Study|Death|3|||
131226795|NCT01312779|472457679|FG000|Overall Study|Not Implanted with Device|27|||
131226796|NCT01859390|472457682|FG000|Overall Study|Insufficient Sputum Collected|1|||
131226797|NCT01859390|472457683|FG001|Overall Study|Insufficient Sputum Collected|3|||
131226798|NCT01859390|472457682|FG000|Overall Study|Sample Missing Collection Date|0|||
131226799|NCT01859390|472457683|FG001|Overall Study|Sample Missing Collection Date|1|||
131226800|NCT01859390|472457682|FG000|Overall Study|Tube Cracked|0|||
131226801|NCT01859390|472457683|FG001|Overall Study|Tube Cracked|2|||
131226802|NCT01859390|472457682|FG000|Overall Study|Shipment Error|0|||
131226803|NCT01859390|472457683|FG001|Overall Study|Shipment Error|1|||
131226804|NCT02764489|472457688|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
131226805|NCT02764489|472457689|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
131226806|NCT02764489|472457688|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
131226807|NCT02764489|472457689|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
131226808|NCT02764489|472457688|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
131226809|NCT02764489|472457689|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
131226810|NCT02764489|472457688|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
131226811|NCT02764489|472457689|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
130715001|NCT01687478|470583937|FG001|Overall Study|Withdrawal by Subject|19|||
130715002|NCT01687478|470583936|FG000|Overall Study|Physician Decision|1|||
130715003|NCT01687478|470583937|FG001|Overall Study|Physician Decision|3|||
130715004|NCT01687478|470583936|FG000|Overall Study|Entry Criteria Not Met|6|||
130715005|NCT01687478|470583937|FG001|Overall Study|Entry Criteria Not Met|2|||
130715006|NCT05855616|470583941|FG000|Overall Study|Lost to Follow-up|1|||
130715007|NCT05855616|470583942|FG001|Overall Study|Lost to Follow-up|2|||
130715008|NCT01859130|470583945|FG000|Overall Study|Death|4|||
130715009|NCT01859130|470583945|FG000|Overall Study|Lost to Follow-up|16|||
130715010|NCT01859130|470583945|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
130715011|NCT01859130|470583945|FG000|Overall Study|Physician Decision|6|||
130715012|NCT01859130|470583945|FG000|Overall Study|Withdrawal by Subject|17|||
130715013|NCT01859130|470583945|FG000|Overall Study|Adverse Event|11|||
130715014|NCT04442490|470583950|FG000|Overall Study|Withdrawal by Subject|18|||
130715015|NCT04442490|470583951|FG001|Overall Study|Withdrawal by Subject|10|||
130715016|NCT04442490|470583950|FG000|Overall Study|Lost to Follow-up|7|||
130715017|NCT04442490|470583951|FG001|Overall Study|Lost to Follow-up|7|||
130715018|NCT04442490|470583950|FG000|Overall Study|Adverse Event|2|||
130715019|NCT04442490|470583951|FG001|Overall Study|Adverse Event|6|||
130715020|NCT04442490|470583950|FG000|Overall Study|Noncompliance|3|||
130715021|NCT04442490|470583951|FG001|Overall Study|Noncompliance|1|||
130715022|NCT04442490|470583950|FG000|Overall Study|Physician Decision|2|||
130715023|NCT04442490|470583951|FG001|Overall Study|Physician Decision|1|||
130715024|NCT04442490|470583950|FG000|Overall Study|Reason not Specified|2|||
130715025|NCT04442490|470583951|FG001|Overall Study|Reason not Specified|1|||
130715026|NCT04442490|470583950|FG000|Overall Study|Randomized but not Treated|3|||
130774851|NCT03410992|470802563|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130964077|NCT01609556|471495327|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
131045916|NCT03248479|471802301|FG001|Overall Study|Study terminated by sponsor|15|||
131226812|NCT01706198|472457690|FG000|Overall Study|Adverse Event|12|||
131226813|NCT01706198|472457691|FG001|Overall Study|Adverse Event|15|||
131226814|NCT01706198|472457690|FG000|Overall Study|Protocol Violation|7|||
130964078|NCT01609556|471495328|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964079|NCT01609556|471495329|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
130964080|NCT01175824|471497018|FG000|Overall Study|Adverse Event|2|||
130964081|NCT01175824|471497019|FG001|Overall Study|Adverse Event|1|||
130964082|NCT01175824|471497018|FG000|Overall Study|Lack of Efficacy|2|||
130964083|NCT01175824|471497019|FG001|Overall Study|Lack of Efficacy|0|||
130964084|NCT01175824|471497018|FG000|Overall Study|Lost to Follow-up|0|||
130964085|NCT01175824|471497019|FG001|Overall Study|Lost to Follow-up|1|||
130964086|NCT01175824|471497018|FG000|Overall Study|Physician Decision|0|||
130964087|NCT01175824|471497019|FG001|Overall Study|Physician Decision|4|||
130964088|NCT01175824|471497018|FG000|Overall Study|Protocol Violation|2|||
130964089|NCT01175824|471497019|FG001|Overall Study|Protocol Violation|5|||
130964090|NCT01175824|471497018|FG000|Overall Study|Withdrawal by Subject|3|||
130964091|NCT01175824|471497019|FG001|Overall Study|Withdrawal by Subject|7|||
130964092|NCT01175824|471497018|FG000|Overall Study|Sponsor Decision|1|||
130964093|NCT01175824|471497019|FG001|Overall Study|Sponsor Decision|0|||
130964094|NCT01175824|471497018|FG000|Overall Study|Entry Criteria Not Met|6|||
130964095|NCT01175824|471497019|FG001|Overall Study|Entry Criteria Not Met|4|||
130964096|NCT04820673|471497020|FG000|Overall Study|Adverse Event|6|||
130964097|NCT04820673|471497020|FG000|Overall Study|Due to Lack of Effectiveness|1|||
130964098|NCT04820673|471497020|FG000|Overall Study|Pregnancy|1|||
130964099|NCT04820673|471497020|FG000|Overall Study|Voluntary Withdrawal|20|||
130964100|NCT04820673|471497020|FG000|Overall Study|Lost to Follow-up|10|||
130964101|NCT01172938|471497021|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
130964102|NCT01172938|471497022|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
130964103|NCT01172938|471497023|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
130964104|NCT01172938|471497024|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130964105|NCT01172938|471497025|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130964106|NCT01172938|471497026|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130964107|NCT01172938|471497027|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130964108|NCT01172938|471497028|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130964109|NCT01172938|471497029|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130964110|NCT01172938|471497021|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
130964111|NCT01172938|471497022|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
130964112|NCT01172938|471497023|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
130964113|NCT01172938|471497024|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130964114|NCT01172938|471497025|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130964115|NCT01172938|471497026|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130964116|NCT01172938|471497027|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130964117|NCT01172938|471497028|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130964118|NCT01172938|471497029|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130964119|NCT01172938|471497021|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130964120|NCT01172938|471497022|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
130964121|NCT01172938|471497023|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
130964122|NCT01172938|471497024|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130964123|NCT01172938|471497025|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130964124|NCT01172938|471497026|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130964125|NCT01172938|471497027|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130964126|NCT01172938|471497028|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130964127|NCT01172938|471497029|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130964128|NCT01172938|471497021|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
130964129|NCT01172938|471497022|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
131127621|NCT00455013|472096028|FG001|Short Term Period|Other|0|||
131127622|NCT00455013|472096029|FG002|Short Term Period|Other|1|||
131127623|NCT00455013|472096027|FG000|Long Term Extension (LTE)|Adverse Event|0|||
131127624|NCT00455013|472096028|FG001|Long Term Extension (LTE)|Adverse Event|1|||
131127625|NCT00455013|472096029|FG002|Long Term Extension (LTE)|Adverse Event|1|||
131127626|NCT00455013|472096027|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
131127627|NCT00455013|472096028|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
131127628|NCT00455013|472096029|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
131127629|NCT00455013|472096027|FG000|Long Term Extension (LTE)|Death|1|||
131127630|NCT00455013|472096028|FG001|Long Term Extension (LTE)|Death|1|||
130964130|NCT01172938|471497023|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
130964131|NCT01172938|471497024|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130964132|NCT01172938|471497025|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130964133|NCT01172938|471497026|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130964134|NCT01172938|471497027|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130964135|NCT01172938|471497028|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131127631|NCT00455013|472096029|FG002|Long Term Extension (LTE)|Death|0|||
130964136|NCT01172938|471497029|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130964137|NCT01172938|471497021|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
130964138|NCT01172938|471497022|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
130964139|NCT01172938|471497023|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
130964140|NCT01172938|471497024|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
130964141|NCT01172938|471497025|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
130964142|NCT01172938|471497026|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
130964143|NCT01172938|471497027|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
130964144|NCT01172938|471497028|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
130964145|NCT01172938|471497029|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
130964146|NCT01172938|471497021|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
130964147|NCT01172938|471497022|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130964148|NCT01172938|471497023|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130964149|NCT01172938|471497024|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130964150|NCT01172938|471497025|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130964151|NCT01172938|471497026|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130964152|NCT01172938|471497027|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130964153|NCT01172938|471497028|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130964154|NCT01172938|471497029|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130964155|NCT01172938|471497021|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
130964156|NCT01172938|471497022|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
130964157|NCT01172938|471497023|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
130964158|NCT01172938|471497024|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
130964159|NCT01172938|471497025|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
130964160|NCT01172938|471497026|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
130964161|NCT01172938|471497027|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
130964162|NCT01172938|471497028|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
131127632|NCT00455013|472096027|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
131127633|NCT00455013|472096028|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
131127634|NCT00455013|472096029|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
130715027|NCT04442490|470583951|FG001|Overall Study|Randomized but not Treated|3|||
130964163|NCT01172938|471497029|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
130964164|NCT01172938|471497021|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
130964165|NCT01172938|471497022|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
130964166|NCT01172938|471497023|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
130964167|NCT01172938|471497024|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
130964168|NCT01172938|471497025|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
130964169|NCT01172938|471497026|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
130964170|NCT01172938|471497027|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
130964171|NCT01172938|471497028|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
130964172|NCT01172938|471497029|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
130964173|NCT01172938|471497021|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
130964174|NCT01172938|471497022|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
130964175|NCT01172938|471497023|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
130964176|NCT01172938|471497024|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
130964177|NCT01172938|471497025|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
130964178|NCT01172938|471497026|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
130964179|NCT01172938|471497027|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
130964180|NCT01172938|471497028|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
130964181|NCT01172938|471497029|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
130964182|NCT01172938|471497021|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130964183|NCT01172938|471497022|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130964184|NCT01172938|471497023|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
130964185|NCT01172938|471497024|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130964186|NCT01172938|471497025|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130964187|NCT01172938|471497026|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130964188|NCT01172938|471497027|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130964189|NCT01172938|471497028|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130964190|NCT01172938|471497029|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
130964191|NCT01172938|471497021|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
130964192|NCT01172938|471497022|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
130964193|NCT01172938|471497023|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
131127635|NCT00455013|472096027|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
131127636|NCT00455013|472096028|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
131127637|NCT00455013|472096029|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
131127638|NCT00455013|472096027|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
130964194|NCT01172938|471497024|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
130964195|NCT01172938|471497025|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
130964196|NCT01172938|471497026|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
130964197|NCT01172938|471497027|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
130964198|NCT01172938|471497028|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
130964199|NCT01172938|471497029|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
130715028|NCT02227147|470583952|FG000|Controlled Treatment Period|Adverse Event|4|||
130715029|NCT02227147|470583953|FG001|Controlled Treatment Period|Adverse Event|3|||
130715030|NCT02227147|470583952|FG000|Controlled Treatment Period|Other|2|||
130715031|NCT02227147|470583953|FG001|Controlled Treatment Period|Other|0|||
130715032|NCT02227147|470583952|FG000|Follow-up Period|Other|3|||
130964200|NCT01172938|471497021|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130964201|NCT01172938|471497022|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
130964202|NCT01172938|471497023|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
130964203|NCT01172938|471497024|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
130964204|NCT01172938|471497025|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130964205|NCT01172938|471497026|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130964206|NCT01172938|471497027|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130964207|NCT01172938|471497028|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130964208|NCT01172938|471497029|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
130964209|NCT01172938|471497021|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
130964210|NCT01172938|471497022|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
130964211|NCT01172938|471497023|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
130964212|NCT01172938|471497024|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
130964213|NCT01172938|471497025|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
130964214|NCT01172938|471497026|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
130964215|NCT01172938|471497027|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
130964216|NCT01172938|471497028|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
130964217|NCT01172938|471497029|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
130964218|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
130964219|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
130964220|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
130964221|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
130964222|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
130964223|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
130964224|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
130964225|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
130964226|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
130964227|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130964228|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
130964229|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
130964230|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130964231|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130964232|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130964233|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130964234|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
130964235|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
130964236|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130964237|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130964238|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
130964239|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130964240|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130964241|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130964242|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130964243|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130964244|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130964245|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
130964246|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
130964247|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
130964248|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
130964249|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
130964250|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
130715033|NCT02227147|470583953|FG001|Follow-up Period|Other|5|||
130715034|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
130715035|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
131041368|NCT04066205|471786539|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
131041369|NCT04066205|471786538|FG000|T2 Immediate Post-Intervention|did not respond|5|||
131041370|NCT04066205|471786539|FG001|T2 Immediate Post-Intervention|did not respond|3|||
131041371|NCT02052882|471786540|FG000|Overall Study|Not treated|11|||
131041372|NCT02052882|471786540|FG000|Overall Study|Protocol Violation|1|||
131041373|NCT02052882|471786540|FG000|Overall Study|Inadequate testing|1|||
131041374|NCT04314778|471786547|FG000|Overall Study|Lost to Follow-up|5|||
131041375|NCT04314778|471786548|FG001|Overall Study|Lost to Follow-up|3|||
131041376|NCT04024020|471786551|FG000|Overall Study|Withdrawal by Subject|2|||
131041377|NCT04024020|471786552|FG001|Overall Study|Withdrawal by Subject|2|||
131041378|NCT05646355|471786553|FG000|Overall Study|Lost to Follow-up|1|||
131041379|NCT05646355|471786554|FG001|Overall Study|Lost to Follow-up|0|||
131041380|NCT05646355|471786553|FG000|Overall Study|translated materials not available for pilot|2|||
131127639|NCT00455013|472096028|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
131127640|NCT00455013|472096029|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
131127641|NCT00455013|472096027|FG000|Long Term Extension (LTE)|non-specified|0|||
131127642|NCT00455013|472096028|FG001|Long Term Extension (LTE)|non-specified|0|||
131127643|NCT00455013|472096029|FG002|Long Term Extension (LTE)|non-specified|1|||
131127644|NCT02739620|472096032|FG000|Overall Study|Lost to Follow-up|3|||
131127645|NCT02739620|472096033|FG001|Overall Study|Lost to Follow-up|1|||
131127646|NCT02739620|472096032|FG000|Overall Study|Adverse Event|0|||
131127647|NCT02739620|472096033|FG001|Overall Study|Adverse Event|1|||
131127648|NCT00754793|472096034|FG000|Overall Study|voluntary withdrawn from study|0|||
131127649|NCT00754793|472096035|FG001|Overall Study|voluntary withdrawn from study|1|||
131127650|NCT02577146|472096036|FG000|Overall Study|Lost to Follow-up|8|||
131127651|NCT02577146|472096036|FG000|Overall Study|Physician Decision|3|||
131127652|NCT02577146|472096036|FG000|Overall Study|Screen Failure|17|||
131127653|NCT01970501|472096037|FG000|Overall Study|Discontinuation of study by sponsor|16|||
131127654|NCT01970501|472096038|FG001|Overall Study|Discontinuation of study by sponsor|14|||
131127655|NCT01970501|472096037|FG000|Overall Study|Withdrawal by Subject|6|||
131127656|NCT01970501|472096038|FG001|Overall Study|Withdrawal by Subject|7|||
131127657|NCT01970501|472096037|FG000|Overall Study|Adverse Event|2|||
131127658|NCT01970501|472096038|FG001|Overall Study|Adverse Event|4|||
131127659|NCT01970501|472096037|FG000|Overall Study|Death|1|||
131127660|NCT01970501|472096038|FG001|Overall Study|Death|3|||
131127661|NCT01970501|472096037|FG000|Overall Study|Physician Decision|2|||
131127662|NCT01970501|472096038|FG001|Overall Study|Physician Decision|0|||
131127663|NCT01439555|472096042|FG000|Overall Study|Protocol Violation|1|||
131127664|NCT00102960|472096044|FG000|Overall Study|Death|23|||
131127665|NCT00102960|472096045|FG001|Overall Study|Death|11|||
131127666|NCT00102960|472096046|FG002|Overall Study|Death|11|||
131127667|NCT00102960|472096044|FG000|Overall Study|Lost to Follow-up|6|||
131127668|NCT00102960|472096045|FG001|Overall Study|Lost to Follow-up|12|||
131127669|NCT00102960|472096046|FG002|Overall Study|Lost to Follow-up|16|||
131127670|NCT00102960|472096044|FG000|Overall Study|Withdrawal by Subject|1|||
131127671|NCT00102960|472096045|FG001|Overall Study|Withdrawal by Subject|0|||
131127672|NCT00102960|472096046|FG002|Overall Study|Withdrawal by Subject|1|||
131127673|NCT05121480|472097590|FG000|Overall Study|Lack of Efficacy|2|||
131127674|NCT05121480|472097591|FG001|Overall Study|Lack of Efficacy|2|||
131127675|NCT05121480|472097592|FG002|Overall Study|Lack of Efficacy|1|||
131127676|NCT05121480|472097593|FG003|Overall Study|Lack of Efficacy|4|||
131127677|NCT05121480|472097594|FG004|Overall Study|Lack of Efficacy|0|||
131127678|NCT05121480|472097595|FG005|Overall Study|Lack of Efficacy|1|||
131127679|NCT05121480|472097596|FG006|Overall Study|Lack of Efficacy|0|||
131127680|NCT05121480|472097597|FG007|Overall Study|Lack of Efficacy|2|||
131127681|NCT05121480|472097590|FG000|Overall Study|Treatment Failure|0|||
131127682|NCT05121480|472097591|FG001|Overall Study|Treatment Failure|2|||
131127683|NCT05121480|472097592|FG002|Overall Study|Treatment Failure|0|||
131127684|NCT05121480|472097593|FG003|Overall Study|Treatment Failure|1|||
131127685|NCT05121480|472097594|FG004|Overall Study|Treatment Failure|0|||
131127686|NCT05121480|472097595|FG005|Overall Study|Treatment Failure|0|||
131127687|NCT05121480|472097596|FG006|Overall Study|Treatment Failure|0|||
131127688|NCT05121480|472097597|FG007|Overall Study|Treatment Failure|0|||
131127689|NCT05121480|472097590|FG000|Overall Study|Adverse Event|0|||
131127690|NCT05121480|472097591|FG001|Overall Study|Adverse Event|1|||
131041381|NCT05646355|471786554|FG001|Overall Study|translated materials not available for pilot|0|||
131041382|NCT05646355|471786553|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
131127691|NCT05121480|472097592|FG002|Overall Study|Adverse Event|0|||
131127692|NCT05121480|472097593|FG003|Overall Study|Adverse Event|5|||
131127693|NCT05121480|472097594|FG004|Overall Study|Adverse Event|3|||
131127694|NCT05121480|472097595|FG005|Overall Study|Adverse Event|2|||
131127695|NCT05121480|472097596|FG006|Overall Study|Adverse Event|0|||
131127696|NCT05121480|472097597|FG007|Overall Study|Adverse Event|4|||
131127697|NCT05121480|472097590|FG000|Overall Study|Withdrawal by Subject|4|||
131127698|NCT05121480|472097591|FG001|Overall Study|Withdrawal by Subject|9|||
130715036|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
131127699|NCT05121480|472097592|FG002|Overall Study|Withdrawal by Subject|1|||
131226815|NCT01706198|472457691|FG001|Overall Study|Protocol Violation|5|||
130715037|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
130715038|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
130715039|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
130715040|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
130715041|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
130715042|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
130715043|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
130964251|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
130964252|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
130964253|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
130964254|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130964255|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130964256|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
130964257|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130964258|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130964259|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130964260|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130964261|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130964262|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
130964263|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130964264|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
130964265|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
130964266|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130964267|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130964268|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130964269|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130964270|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
130964271|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
130964272|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130964273|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
130715044|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
130715045|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
130715046|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
130715047|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
130715048|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
130715049|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
130715050|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
130715051|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
130715052|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
130715053|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
130715054|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
130715055|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
130715056|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
130715057|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
130715058|NCT03514641|470583954|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
130715059|NCT03514641|470583955|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
130715060|NCT03514641|470583956|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
130715061|NCT03514641|470583957|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
130715062|NCT03514641|470583954|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
130715063|NCT03514641|470583955|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
130715064|NCT03514641|470583956|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
130715065|NCT03514641|470583957|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
130715066|NCT03514641|470583954|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
130715067|NCT03514641|470583955|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
130715068|NCT03514641|470583956|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
130715069|NCT03514641|470583957|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
130715070|NCT03514641|470583954|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
130715071|NCT03514641|470583955|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
130964274|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130964275|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130964276|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130964277|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130964278|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130964279|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
130964280|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
130964281|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130964282|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
130774852|NCT03410992|470802564|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130774853|NCT03410992|470802565|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130774854|NCT03410992|470802566|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130774855|NCT03410992|470802567|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
130774856|NCT03410992|470802568|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130774857|NCT03410992|470802569|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130774858|NCT02438280|470802570|FG000|Overall Study|Physician Decision|1|||
130774859|NCT02438280|470802571|FG001|Overall Study|Physician Decision|0|||
130774860|NCT02260817|470802572|FG000|Overall Study|Lost to Follow-up|0|||
130774861|NCT02260817|470802573|FG001|Overall Study|Lost to Follow-up|14|||
130774862|NCT02260817|470802572|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
130774863|NCT02260817|470802573|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
130774864|NCT02260817|470802572|FG000|Overall Study|Observation, no biopsy|0|||
130774865|NCT02260817|470802573|FG001|Overall Study|Observation, no biopsy|1|||
130774866|NCT02260817|470802572|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
130774867|NCT02260817|470802573|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
130774868|NCT02260817|470802572|FG000|Overall Study|Protocol Violation|0|||
130774869|NCT02260817|470802573|FG001|Overall Study|Protocol Violation|14|||
130774870|NCT03299101|470802574|FG000|Overall Study|Lost to Follow-up|1|||
130774871|NCT03299101|470802574|FG000|Overall Study|Withdrawal by Subject|5|||
130774872|NCT03299101|470802574|FG000|Overall Study|Surgery was changed|3|||
130774873|NCT03299101|470802574|FG000|Overall Study|Not enough time to complete prehab|1|||
130774874|NCT01882803|470802576|FG000|Overall Study|Disease Progression|1|||
130774875|NCT01882803|470802576|FG000|Overall Study|Withdrawal by Subject|9|||
130774876|NCT01882803|470802576|FG000|Overall Study|Death|68|||
130774877|NCT01882803|470802576|FG000|Overall Study|Physician Decision|3|||
130774878|NCT01882803|470802576|FG000|Overall Study|Lost to Follow-up|3|||
130774879|NCT01882803|470802576|FG000|Overall Study|Follow-up Completed|39|||
130774880|NCT01882803|470802576|FG000|Overall Study|Study Terminated by the Sponsor|6|||
130774881|NCT01563913|470802577|FG000|Overall Study|Physician Decision|1|||
130774882|NCT01563913|470802578|FG001|Overall Study|Physician Decision|0|||
130774883|NCT01563913|470802577|FG000|Overall Study|Spouse Passed Away|1|||
130774884|NCT01563913|470802578|FG001|Overall Study|Spouse Passed Away|0|||
130774885|NCT03066778|470802579|FG000|Overall Study|Death|195|||
130774886|NCT03066778|470802580|FG001|Overall Study|Death|205|||
130774887|NCT03066778|470802579|FG000|Overall Study|Withdrawal by Subject|5|||
130774888|NCT03066778|470802580|FG001|Overall Study|Withdrawal by Subject|7|||
130774889|NCT02091414|470802581|FG000|Overall Study|Withdrawal by Subject|2|||
130774890|NCT02091414|470802581|FG000|Overall Study|Death|2|||
130774891|NCT03665077|470802582|FG000|Overall Study|Lost to Follow-up|2|||
130774892|NCT03665077|470802582|FG000|Overall Study|Physician Decision|2|||
130774893|NCT00435461|470802585|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
130774894|NCT00435461|470802586|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
130774895|NCT00435461|470802587|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
130774896|NCT00435461|470802585|FG000|Overall Study|Protocol Violation|6|||
130774897|NCT00435461|470802586|FG001|Overall Study|Protocol Violation|9|||
130774898|NCT00435461|470802587|FG002|Overall Study|Protocol Violation|10|||
130774899|NCT00435461|470802585|FG000|Overall Study|Participant randomized(inadequate score)|1|||
130774900|NCT00435461|470802586|FG001|Overall Study|Participant randomized(inadequate score)|0|||
130774901|NCT00435461|470802587|FG002|Overall Study|Participant randomized(inadequate score)|0|||
130774902|NCT00435461|470802585|FG000|Overall Study|Compliance less than 80 percent|1|||
130774903|NCT00435461|470802586|FG001|Overall Study|Compliance less than 80 percent|0|||
130774904|NCT00435461|470802587|FG002|Overall Study|Compliance less than 80 percent|0|||
130774905|NCT00435461|470802585|FG000|Overall Study|In error, two study medications switched|1|||
130774906|NCT00435461|470802586|FG001|Overall Study|In error, two study medications switched|0|||
130774907|NCT00435461|470802587|FG002|Overall Study|In error, two study medications switched|0|||
131127700|NCT05121480|472097593|FG003|Overall Study|Withdrawal by Subject|8|||
131127701|NCT05121480|472097594|FG004|Overall Study|Withdrawal by Subject|0|||
131127702|NCT05121480|472097595|FG005|Overall Study|Withdrawal by Subject|9|||
131127703|NCT05121480|472097596|FG006|Overall Study|Withdrawal by Subject|0|||
130774908|NCT00435461|470802585|FG000|Overall Study|Lack of Efficacy|2|||
131127704|NCT05121480|472097597|FG007|Overall Study|Withdrawal by Subject|4|||
130774909|NCT00435461|470802586|FG001|Overall Study|Lack of Efficacy|1|||
130774910|NCT00435461|470802587|FG002|Overall Study|Lack of Efficacy|0|||
130964283|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130964284|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130964285|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130964286|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
131127705|NCT05121480|472097590|FG000|Overall Study|Non-compliance with the protocol|0|||
130774911|NCT00435461|470802585|FG000|Overall Study|Withdrawal by Subject|1|||
130774912|NCT00435461|470802586|FG001|Overall Study|Withdrawal by Subject|0|||
130774913|NCT00435461|470802587|FG002|Overall Study|Withdrawal by Subject|2|||
130774914|NCT00435461|470802585|FG000|Overall Study|Randomized in error|1|||
130774915|NCT00435461|470802586|FG001|Overall Study|Randomized in error|0|||
130715072|NCT03514641|470583956|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
130964287|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130964288|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130964289|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
130964290|NCT01172938|471497021|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130964291|NCT01172938|471497022|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130964292|NCT01172938|471497023|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130964293|NCT01172938|471497024|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130715073|NCT03514641|470583957|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
130715074|NCT03514641|470583954|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
130715075|NCT03514641|470583955|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
130715076|NCT03514641|470583956|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
130715077|NCT03514641|470583957|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
130715078|NCT03514641|470583954|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
130715079|NCT03514641|470583955|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
130715080|NCT03514641|470583956|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
130715081|NCT03514641|470583957|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
130715082|NCT01449279|470583958|FG000|Overall Study|Lack of Efficacy|5|||
130715083|NCT01449279|470583958|FG000|Overall Study|Toxicity|2|||
130715084|NCT04234984|470583959|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
130715085|NCT04234984|470583959|FG000|Follow-up at the Second Time Point|Death|1|||
130715086|NCT04234984|470583959|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
130715087|NCT01055132|470583960|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
130715088|NCT01055132|470583961|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
130715089|NCT01055132|470583960|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
130715090|NCT01055132|470583961|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
130715091|NCT02038907|470583962|FG000|Overall Study|Protocol Violation|0|||
130715092|NCT02038907|470583963|FG001|Overall Study|Protocol Violation|0|||
130715093|NCT02038907|470583964|FG002|Overall Study|Protocol Violation|0|||
130715094|NCT02038907|470583965|FG003|Overall Study|Protocol Violation|0|||
130715095|NCT02038907|470583966|FG004|Overall Study|Protocol Violation|0|||
130715096|NCT02038907|470583967|FG005|Overall Study|Protocol Violation|0|||
130715097|NCT02038907|470583968|FG006|Overall Study|Protocol Violation|0|||
130715098|NCT02038907|470583969|FG007|Overall Study|Protocol Violation|0|||
130715099|NCT02038907|470583970|FG008|Overall Study|Protocol Violation|0|||
130715100|NCT02038907|470583971|FG009|Overall Study|Protocol Violation|0|||
130715101|NCT02038907|470583972|FG010|Overall Study|Protocol Violation|1|||
130715102|NCT02038907|470583973|FG011|Overall Study|Protocol Violation|0|||
130715103|NCT02038907|470583974|FG012|Overall Study|Protocol Violation|0|||
130715104|NCT02038907|470583975|FG013|Overall Study|Protocol Violation|0|||
130715105|NCT02038907|470583962|FG000|Overall Study|Withdrawal by Subject|0|||
130715106|NCT02038907|470583963|FG001|Overall Study|Withdrawal by Subject|0|||
130715107|NCT02038907|470583964|FG002|Overall Study|Withdrawal by Subject|0|||
130715108|NCT02038907|470583965|FG003|Overall Study|Withdrawal by Subject|0|||
130715109|NCT02038907|470583966|FG004|Overall Study|Withdrawal by Subject|0|||
130715110|NCT02038907|470583967|FG005|Overall Study|Withdrawal by Subject|0|||
130715111|NCT02038907|470583968|FG006|Overall Study|Withdrawal by Subject|0|||
130715112|NCT02038907|470583969|FG007|Overall Study|Withdrawal by Subject|0|||
130715113|NCT02038907|470583970|FG008|Overall Study|Withdrawal by Subject|0|||
130715114|NCT02038907|470583971|FG009|Overall Study|Withdrawal by Subject|0|||
130715115|NCT02038907|470583972|FG010|Overall Study|Withdrawal by Subject|1|||
130715116|NCT02038907|470583973|FG011|Overall Study|Withdrawal by Subject|0|||
130715117|NCT02038907|470583974|FG012|Overall Study|Withdrawal by Subject|0|||
130715118|NCT02038907|470583975|FG013|Overall Study|Withdrawal by Subject|0|||
130715119|NCT01156142|470583979|FG000|Overall Study|Withdrawal by Subject|8|||
130715120|NCT01156142|470583980|FG001|Overall Study|Withdrawal by Subject|6|||
130715121|NCT01156142|470583979|FG000|Overall Study|Ineligible|0|||
130715122|NCT01156142|470583980|FG001|Overall Study|Ineligible|1|||
130715123|NCT00893737|470583981|FG000|Overall Study|Adverse Event|4|||
130715124|NCT00893737|470583981|FG000|Overall Study|Withdrawal by Subject|2|||
130715125|NCT00893737|470583981|FG000|Overall Study|Lost to Follow-up|6|||
130964294|NCT01172938|471497025|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130964295|NCT01172938|471497026|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130964296|NCT01172938|471497027|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130964297|NCT01172938|471497028|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
130964298|NCT01172938|471497029|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
130964299|NCT01172938|471497021|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
130964300|NCT01172938|471497022|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
130964301|NCT01172938|471497023|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
130964302|NCT01172938|471497024|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
130964303|NCT01172938|471497025|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
130964304|NCT01172938|471497026|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
130774916|NCT00435461|470802587|FG002|Overall Study|Randomized in error|0|||
130774917|NCT00435461|470802585|FG000|Overall Study|Participant could not tolerate symptoms|0|||
130774918|NCT00435461|470802586|FG001|Overall Study|Participant could not tolerate symptoms|0|||
130774919|NCT00435461|470802587|FG002|Overall Study|Participant could not tolerate symptoms|1|||
130774920|NCT00435461|470802585|FG000|Overall Study|Participant could not swallow capsule|0|||
130774921|NCT00435461|470802586|FG001|Overall Study|Participant could not swallow capsule|0|||
130774922|NCT00435461|470802587|FG002|Overall Study|Participant could not swallow capsule|1|||
130774923|NCT00435461|470802585|FG000|Overall Study|Pregnancy|2|||
130774924|NCT00435461|470802586|FG001|Overall Study|Pregnancy|0|||
130774925|NCT00435461|470802587|FG002|Overall Study|Pregnancy|0|||
130774926|NCT00435461|470802585|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
130774927|NCT00435461|470802586|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
130774928|NCT00435461|470802587|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
130774929|NCT00435461|470802585|FG000|Overall Study|Participant ended study one day early|1|||
130774930|NCT00435461|470802586|FG001|Overall Study|Participant ended study one day early|0|||
130774931|NCT00435461|470802587|FG002|Overall Study|Participant ended study one day early|0|||
130774932|NCT00435461|470802585|FG000|Overall Study|Noncompliance with study requirements|1|||
130774933|NCT00435461|470802586|FG001|Overall Study|Noncompliance with study requirements|1|||
130774934|NCT00435461|470802587|FG002|Overall Study|Noncompliance with study requirements|1|||
130774935|NCT00435461|470802585|FG000|Overall Study|Adverse Event|1|||
130774936|NCT00435461|470802586|FG001|Overall Study|Adverse Event|2|||
130774937|NCT00435461|470802587|FG002|Overall Study|Adverse Event|6|||
130774938|NCT00435461|470802585|FG000|Overall Study|Non-Compliance of diary|2|||
130774939|NCT00435461|470802586|FG001|Overall Study|Non-Compliance of diary|0|||
130774940|NCT00435461|470802587|FG002|Overall Study|Non-Compliance of diary|1|||
130774941|NCT00435461|470802585|FG000|Overall Study|Lost to Follow-up|1|||
130774942|NCT00435461|470802586|FG001|Overall Study|Lost to Follow-up|1|||
130774943|NCT00435461|470802587|FG002|Overall Study|Lost to Follow-up|2|||
130774944|NCT02306850|470802590|FG000|Overall Study|Lack of Efficacy|2|||
130774945|NCT00237692|470802591|FG000|Overall Study|Lost to Follow-up|9|||
130774946|NCT00237692|470802592|FG001|Overall Study|Lost to Follow-up|3|||
130774947|NCT00237692|470802593|FG002|Overall Study|Lost to Follow-up|5|||
130774948|NCT00237692|470802594|FG003|Overall Study|Lost to Follow-up|3|||
130774949|NCT00237692|470802591|FG000|Overall Study|Death|1|||
130774950|NCT00237692|470802592|FG001|Overall Study|Death|2|||
130774951|NCT00237692|470802593|FG002|Overall Study|Death|2|||
130774952|NCT00237692|470802594|FG003|Overall Study|Death|3|||
130774953|NCT00237692|470802591|FG000|Overall Study|Excluded - did not meet criteria|4|||
130774954|NCT00237692|470802592|FG001|Overall Study|Excluded - did not meet criteria|3|||
130774955|NCT00237692|470802593|FG002|Overall Study|Excluded - did not meet criteria|5|||
130774956|NCT00237692|470802594|FG003|Overall Study|Excluded - did not meet criteria|9|||
130774957|NCT00237692|470802591|FG000|Overall Study|Withdrawal by Subject|4|||
130774958|NCT00237692|470802592|FG001|Overall Study|Withdrawal by Subject|6|||
130774959|NCT00237692|470802593|FG002|Overall Study|Withdrawal by Subject|10|||
130774960|NCT00237692|470802594|FG003|Overall Study|Withdrawal by Subject|4|||
130774961|NCT02420262|470802595|FG000|Overall Study|Adverse Event|1|||
130774962|NCT02420262|470802596|FG001|Overall Study|Adverse Event|0|||
131226816|NCT01706198|472457690|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
131226817|NCT01706198|472457691|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
130774963|NCT02420262|470802595|FG000|Overall Study|Withdrawal by Subject|1|||
131041383|NCT05646355|471786554|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
131041384|NCT04685135|471786555|FG000|Overall Study|Death|126|||
131041385|NCT04685135|471786556|FG001|Overall Study|Death|53|||
131041386|NCT04685135|471786555|FG000|Overall Study|Withdrawal by Subject|12|||
131041387|NCT04685135|471786556|FG001|Overall Study|Withdrawal by Subject|16|||
131041388|NCT05216406|471786557|FG000|Overall Study|Lost to Follow-up|8|||
131041389|NCT05216406|471786558|FG001|Overall Study|Lost to Follow-up|9|||
131041390|NCT03711474|471786561|FG000|Overall Study|Physician Decision|2|||
131041391|NCT03711474|471786562|FG001|Overall Study|Physician Decision|0|||
131041392|NCT01236781|471786570|FG000|Overall Study|Ineligible|2|||
131041393|NCT01236781|471786571|FG001|Overall Study|Ineligible|1|||
131041394|NCT01236781|471786570|FG000|Overall Study|Did not complete study imaging|5|||
131041395|NCT01236781|471786571|FG001|Overall Study|Did not complete study imaging|0|||
131041396|NCT04059185|471786572|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
131041397|NCT04059185|471786573|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
131041398|NCT04059185|471786574|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
131041399|NCT04059185|471786572|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
131226818|NCT01706198|472457690|FG000|Overall Study|Lost to Follow-up|97|||
130774964|NCT02420262|470802596|FG001|Overall Study|Withdrawal by Subject|4|||
130774965|NCT02420262|470802595|FG000|Overall Study|Unclassified|0|||
130774966|NCT02420262|470802596|FG001|Overall Study|Unclassified|1|||
130774967|NCT05446142|470802612|FG000|Period 2|Adverse Event|1|||
130774968|NCT05446142|470802613|FG001|Period 2|Adverse Event|0|||
130774969|NCT05446142|470802614|FG002|Period 2|Adverse Event|0|||
130774970|NCT05446142|470802615|FG003|Period 2|Adverse Event|0|||
131041400|NCT04059185|471786573|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
131041401|NCT04059185|471786574|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
131041402|NCT04059185|471786572|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
131041403|NCT04059185|471786573|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
131041404|NCT04059185|471786574|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
131041405|NCT04059185|471786572|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
131041406|NCT04059185|471786573|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
131041407|NCT04059185|471786574|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
131041408|NCT04059185|471786572|FG000|Longitudinal Assessment-Adults Only|Death|4|||
131041409|NCT04059185|471786573|FG001|Longitudinal Assessment-Adults Only|Death|4|||
131041410|NCT04059185|471786574|FG002|Longitudinal Assessment-Adults Only|Death|3|||
131041411|NCT03756662|471786575|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
131041412|NCT04587453|471786576|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
131041413|NCT04587453|471786577|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
131041414|NCT04032847|471786590|FG000|Overall Study|Study termination by sponsor|8|||
130715126|NCT02140411|470583982|FG000|Overall Study|Adverse Event|1|||
130715127|NCT03981419|470583985|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
130715128|NCT03981419|470583986|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
130715129|NCT01330459|470583990|FG000|Overall Study|Physician Decision|0|||
130715130|NCT01330459|470583991|FG001|Overall Study|Physician Decision|2|||
130715131|NCT01359644|470584006|FG000|Treatment Period|Lack of Efficacy|0|||
130715132|NCT01359644|470584007|FG001|Treatment Period|Lack of Efficacy|1|||
130715133|NCT01359644|470584008|FG002|Treatment Period|Lack of Efficacy|0|||
130715134|NCT01359644|470584009|FG003|Treatment Period|Lack of Efficacy|0|||
130715135|NCT01359644|470584010|FG004|Treatment Period|Lack of Efficacy|0|||
130715136|NCT01359644|470584011|FG005|Treatment Period|Lack of Efficacy|0|||
130715137|NCT01359644|470584012|FG006|Treatment Period|Lack of Efficacy|0|||
130774971|NCT05446142|470802616|FG004|Period 2|Adverse Event|0|||
130774972|NCT05446142|470802617|FG005|Period 2|Adverse Event|0|||
130774973|NCT02098395|470802618|FG000|Overall Study|Protocol Violation|2|||
130774974|NCT02098395|470802619|FG001|Overall Study|Protocol Violation|2|||
130774975|NCT02098395|470802620|FG002|Overall Study|Protocol Violation|0|||
130774976|NCT02098395|470802621|FG003|Overall Study|Protocol Violation|7|||
130774977|NCT02098395|470802618|FG000|Overall Study|Withdrawal by Subject|10|||
130774978|NCT02098395|470802619|FG001|Overall Study|Withdrawal by Subject|10|||
130774979|NCT02098395|470802620|FG002|Overall Study|Withdrawal by Subject|5|||
130774980|NCT02098395|470802621|FG003|Overall Study|Withdrawal by Subject|13|||
130774981|NCT02098395|470802618|FG000|Overall Study|Adverse Event|12|||
130774982|NCT02098395|470802619|FG001|Overall Study|Adverse Event|19|||
130774983|NCT02098395|470802620|FG002|Overall Study|Adverse Event|34|||
130774984|NCT02098395|470802621|FG003|Overall Study|Adverse Event|2|||
130774985|NCT02098395|470802618|FG000|Overall Study|Lost to Follow-up|2|||
130774986|NCT02098395|470802619|FG001|Overall Study|Lost to Follow-up|1|||
130774987|NCT02098395|470802620|FG002|Overall Study|Lost to Follow-up|0|||
130774988|NCT02098395|470802621|FG003|Overall Study|Lost to Follow-up|3|||
130774989|NCT02098395|470802618|FG000|Overall Study|Unclassified|0|||
130774990|NCT02098395|470802619|FG001|Overall Study|Unclassified|0|||
130774991|NCT02098395|470802620|FG002|Overall Study|Unclassified|3|||
130774992|NCT02098395|470802621|FG003|Overall Study|Unclassified|2|||
130774993|NCT00110357|470802624|FG000|Overall Study|Deterioration without progression|2|||
130774994|NCT00110357|470802625|FG001|Overall Study|Deterioration without progression|0|||
130774995|NCT00110357|470802624|FG000|Overall Study|Disease progression/relapse|20|||
130774996|NCT00110357|470802625|FG001|Overall Study|Disease progression/relapse|15|||
130774997|NCT00110357|470802624|FG000|Overall Study|Study Closure|1|||
130774998|NCT00110357|470802625|FG001|Overall Study|Study Closure|0|||
130774999|NCT00110357|470802624|FG000|Overall Study|Study Drug Toxicity|1|||
130775000|NCT00110357|470802625|FG001|Overall Study|Study Drug Toxicity|3|||
130775001|NCT00110357|470802624|FG000|Overall Study|Withdrawal by Subject|3|||
130775002|NCT00110357|470802625|FG001|Overall Study|Withdrawal by Subject|1|||
130775003|NCT03382418|470802626|FG000|Overall Study|Withdrawal by Subject|1|||
130775004|NCT03382418|470802627|FG001|Overall Study|Withdrawal by Subject|0|||
130775005|NCT03382418|470802628|FG002|Overall Study|Withdrawal by Subject|0|||
130775006|NCT03382418|470802626|FG000|Overall Study|Lost to Follow-up|2|||
130775007|NCT03382418|470802627|FG001|Overall Study|Lost to Follow-up|3|||
130775008|NCT03382418|470802628|FG002|Overall Study|Lost to Follow-up|0|||
130715138|NCT01359644|470584013|FG007|Treatment Period|Lack of Efficacy|0|||
130775009|NCT04633226|470802629|FG000|Overall Study|Withdrawal by parent/guardian|4|||
130715139|NCT01359644|470584014|FG008|Treatment Period|Lack of Efficacy|0|||
130775010|NCT04633226|470802629|FG000|Overall Study|Randomized by mistake without study treatment|1|||
130775011|NCT01151345|470802630|FG000|First Intervention Period|Protocol Violation|0|||
130775012|NCT01151345|470802631|FG001|First Intervention Period|Protocol Violation|1|||
130775013|NCT01348100|470802634|FG000|Overall Study|Subject Withdrew Consent|0|||
130775014|NCT01348100|470802635|FG001|Overall Study|Subject Withdrew Consent|0|||
130715140|NCT01359644|470584015|FG009|Treatment Period|Lack of Efficacy|0|||
130775015|NCT01348100|470802636|FG002|Overall Study|Subject Withdrew Consent|2|||
130775016|NCT01348100|470802637|FG003|Overall Study|Subject Withdrew Consent|0|||
130775017|NCT01348100|470802638|FG004|Overall Study|Subject Withdrew Consent|1|||
130775018|NCT01348100|470802639|FG005|Overall Study|Subject Withdrew Consent|0|||
130775019|NCT01348100|470802640|FG006|Overall Study|Subject Withdrew Consent|1|||
130775020|NCT01348100|470802634|FG000|Overall Study|Protocol Deviation|0|||
130775021|NCT01348100|470802635|FG001|Overall Study|Protocol Deviation|0|||
130775022|NCT01348100|470802636|FG002|Overall Study|Protocol Deviation|0|||
130775023|NCT01348100|470802637|FG003|Overall Study|Protocol Deviation|1|||
130775024|NCT01348100|470802638|FG004|Overall Study|Protocol Deviation|0|||
130775025|NCT01348100|470802639|FG005|Overall Study|Protocol Deviation|0|||
130775026|NCT01348100|470802640|FG006|Overall Study|Protocol Deviation|0|||
130775027|NCT01348100|470802634|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130775028|NCT01348100|470802635|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130775029|NCT01348100|470802636|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130775030|NCT01348100|470802637|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130775031|NCT01348100|470802638|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130775032|NCT01348100|470802639|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130775033|NCT01348100|470802640|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130775034|NCT01348100|470802634|FG000|Overall Study|Lost to Follow-up|0|||
130775035|NCT01348100|470802635|FG001|Overall Study|Lost to Follow-up|0|||
130775036|NCT01348100|470802636|FG002|Overall Study|Lost to Follow-up|0|||
130775037|NCT01348100|470802637|FG003|Overall Study|Lost to Follow-up|0|||
130775038|NCT01348100|470802638|FG004|Overall Study|Lost to Follow-up|0|||
130775039|NCT01348100|470802639|FG005|Overall Study|Lost to Follow-up|0|||
130775040|NCT01348100|470802640|FG006|Overall Study|Lost to Follow-up|1|||
130775041|NCT01348100|470802634|FG000|Overall Study|Administrative Problems|0|||
130775042|NCT01348100|470802635|FG001|Overall Study|Administrative Problems|0|||
130775043|NCT01348100|470802636|FG002|Overall Study|Administrative Problems|0|||
130775044|NCT01348100|470802637|FG003|Overall Study|Administrative Problems|0|||
130775045|NCT01348100|470802638|FG004|Overall Study|Administrative Problems|0|||
130775046|NCT01348100|470802639|FG005|Overall Study|Administrative Problems|1|||
130775047|NCT01348100|470802640|FG006|Overall Study|Administrative Problems|1|||
130964305|NCT01172938|471497027|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
130775048|NCT03882957|470802643|FG000|Overall Study|Did not complete all three arms|1|||
130775049|NCT01134393|470802645|FG000|Overall Study|Adverse Event|18|||
130775050|NCT01134393|470802645|FG000|Overall Study|Lack of Efficacy|2|||
130775051|NCT01134393|470802645|FG000|Overall Study|Protocol Violation|12|||
130775052|NCT01134393|470802645|FG000|Overall Study|Lost to Follow-up|3|||
130775053|NCT01134393|470802645|FG000|Overall Study|Withdrawal by Subject|11|||
130775054|NCT01134393|470802645|FG000|Overall Study|Other|6|||
130775055|NCT03134911|470802646|FG000|Overall Study|Screen failure|31|||
130775056|NCT03134911|470802646|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
130775057|NCT02710084|470802653|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
130775058|NCT02710084|470802654|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
130775059|NCT00154375|470802655|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
130775060|NCT00154375|470802656|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
130775061|NCT00154375|470802655|FG000|Overall Study|Adverse Event|18|||
130775062|NCT00154375|470802656|FG001|Overall Study|Adverse Event|20|||
130964306|NCT01172938|471497028|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
130964307|NCT01172938|471497029|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
130964308|NCT01172938|471497021|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
130964309|NCT01172938|471497022|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
130964310|NCT01172938|471497023|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
130964311|NCT01172938|471497024|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
130964312|NCT01172938|471497025|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
130964313|NCT01172938|471497026|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
130964314|NCT01172938|471497027|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
130964315|NCT01172938|471497028|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
130964316|NCT01172938|471497029|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
131226819|NCT01706198|472457691|FG001|Overall Study|Lost to Follow-up|93|||
130775063|NCT00154375|470802655|FG000|Overall Study|Withdrawal by Subject|14|||
130775064|NCT00154375|470802656|FG001|Overall Study|Withdrawal by Subject|10|||
130775065|NCT00154375|470802655|FG000|Overall Study|Death|5|||
130775066|NCT00154375|470802656|FG001|Overall Study|Death|13|||
130775067|NCT00154375|470802655|FG000|Overall Study|Study drug no longer required|5|||
130775068|NCT00154375|470802656|FG001|Overall Study|Study drug no longer required|3|||
130775069|NCT00154375|470802655|FG000|Overall Study|Lost to Follow-up|2|||
130775070|NCT00154375|470802656|FG001|Overall Study|Lost to Follow-up|1|||
130775071|NCT00154375|470802655|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130775072|NCT00154375|470802656|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130775073|NCT00154375|470802655|FG000|Overall Study|Protocol Violation|0|||
130775074|NCT00154375|470802656|FG001|Overall Study|Protocol Violation|1|||
130775075|NCT00154375|470802655|FG000|Overall Study|Suspected progression of disease|44|||
130775076|NCT00154375|470802656|FG001|Overall Study|Suspected progression of disease|30|||
130775077|NCT02348008|470802657|FG000|Overall Study|Adverse Event|2|||
130775078|NCT02348008|470802658|FG001|Overall Study|Adverse Event|3|||
130775079|NCT02348008|470802659|FG002|Overall Study|Adverse Event|3|||
130775080|NCT02348008|470802657|FG000|Overall Study|Disease Progression|1|||
130775081|NCT02348008|470802658|FG001|Overall Study|Disease Progression|5|||
130775082|NCT02348008|470802659|FG002|Overall Study|Disease Progression|16|||
130775083|NCT02348008|470802657|FG000|Overall Study|Withdrawal by Subject|0|||
130775084|NCT02348008|470802658|FG001|Overall Study|Withdrawal by Subject|1|||
130775085|NCT02348008|470802659|FG002|Overall Study|Withdrawal by Subject|0|||
131226820|NCT01706198|472457690|FG000|Overall Study|Physician Decision|23|||
130775086|NCT02348008|470802657|FG000|Overall Study|Symptomatic Deterioration|0|||
130775087|NCT02348008|470802658|FG001|Overall Study|Symptomatic Deterioration|1|||
130775088|NCT02348008|470802659|FG002|Overall Study|Symptomatic Deterioration|0|||
130775089|NCT00334295|470802665|FG000|Overall Study|Patients received fewer than 3 injection|5|||
130775090|NCT03268005|470802666|FG000|Overall Study|Death|2|||
131041415|NCT04032847|471786591|FG001|Overall Study|Study termination by sponsor|0|||
131041416|NCT04032847|471786592|FG002|Overall Study|Study termination by sponsor|4|||
131041417|NCT04032847|471786590|FG000|Overall Study|Death|12|||
131041418|NCT04032847|471786591|FG001|Overall Study|Death|0|||
131041419|NCT04032847|471786592|FG002|Overall Study|Death|0|||
131041420|NCT04032847|471786590|FG000|Overall Study|Progressive disease|2|||
131041421|NCT04032847|471786591|FG001|Overall Study|Progressive disease|0|||
131041422|NCT04032847|471786592|FG002|Overall Study|Progressive disease|1|||
131041423|NCT03213665|471786593|FG000|Overall Study|Adverse Event|1|||
131041424|NCT03213665|471786593|FG000|Overall Study|Physician Decision|2|||
131041425|NCT03213665|471786593|FG000|Overall Study|Withdrawal by Subject|3|||
131041426|NCT03213665|471786593|FG000|Overall Study|Progressive Disease|13|||
131041427|NCT03056573|471786594|FG000|Overall Study|Death|2|||
131041428|NCT03056573|471786595|FG001|Overall Study|Death|4|||
131041429|NCT03056573|471786594|FG000|Overall Study|Withdrawal by Subject|2|||
131041430|NCT03056573|471786595|FG001|Overall Study|Withdrawal by Subject|0|||
131041431|NCT03056573|471786594|FG000|Overall Study|Lost to Follow-up|1|||
131041432|NCT03056573|471786595|FG001|Overall Study|Lost to Follow-up|1|||
131041433|NCT05873556|471786596|FG000|Overall Study|Lost to Follow-up|4|||
131041434|NCT05873556|471786597|FG001|Overall Study|Lost to Follow-up|1|||
131041435|NCT02684227|471786598|FG000|Overall Study|Adverse Event|1|||
131041436|NCT02684227|471786599|FG001|Overall Study|Adverse Event|7|||
131041437|NCT02684227|471786598|FG000|Overall Study|Death|0|||
131041438|NCT02684227|471786599|FG001|Overall Study|Death|2|||
131041439|NCT02684227|471786598|FG000|Overall Study|Withdrawal by Subject|0|||
131041440|NCT02684227|471786599|FG001|Overall Study|Withdrawal by Subject|1|||
131041441|NCT02684227|471786598|FG000|Overall Study|Progressive Disease|0|||
131041442|NCT02684227|471786599|FG001|Overall Study|Progressive Disease|2|||
131041443|NCT03606408|471786601|FG000|Overall Study|Adverse Event|13|||
131041444|NCT03606408|471786601|FG000|Overall Study|Withdrawal by Subject|7|||
131041445|NCT03606408|471786601|FG000|Overall Study|Physician Decision|4|||
131041446|NCT03606408|471786601|FG000|Overall Study|Lack of Efficacy|2|||
131041447|NCT03606408|471786601|FG000|Overall Study|Death|1|||
131041448|NCT03606408|471786601|FG000|Overall Study|new therapy for study indication|1|||
131041449|NCT04689256|471786602|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
131041450|NCT04689256|471786603|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
131041451|NCT05104463|471786604|FG000|Overall Study|Adverse Event|1|||
131041452|NCT05104463|471786605|FG001|Overall Study|Adverse Event|1|||
131041453|NCT05104463|471786604|FG000|Overall Study|Lost to Follow-up|1|||
131041454|NCT05104463|471786605|FG001|Overall Study|Lost to Follow-up|1|||
131041455|NCT05104463|471786604|FG000|Overall Study|Physician Decision|1|||
131041456|NCT05104463|471786605|FG001|Overall Study|Physician Decision|0|||
131041457|NCT05104463|471786604|FG000|Overall Study|Protocol Violation|0|||
131041458|NCT05104463|471786605|FG001|Overall Study|Protocol Violation|2|||
131041459|NCT05104463|471786604|FG000|Overall Study|Withdrawal by Subject|1|||
131041460|NCT05104463|471786605|FG001|Overall Study|Withdrawal by Subject|1|||
131041461|NCT05267470|471786607|FG000|Overall Study|Decision by sponsor|0|||
131041462|NCT05267470|471786608|FG001|Overall Study|Decision by sponsor|3|||
131041463|NCT05267470|471786609|FG002|Overall Study|Decision by sponsor|19|||
131041464|NCT05267470|471786610|FG003|Overall Study|Decision by sponsor|7|||
131041465|NCT05267470|471786611|FG004|Overall Study|Decision by sponsor|3|||
131041466|NCT05267470|471786607|FG000|Overall Study|Withdrawal by Subject|1|||
131041467|NCT05267470|471786608|FG001|Overall Study|Withdrawal by Subject|1|||
131041468|NCT05267470|471786609|FG002|Overall Study|Withdrawal by Subject|2|||
131041469|NCT05267470|471786610|FG003|Overall Study|Withdrawal by Subject|2|||
131041470|NCT05267470|471786611|FG004|Overall Study|Withdrawal by Subject|0|||
131041471|NCT05267470|471786607|FG000|Overall Study|Death|3|||
131041472|NCT05267470|471786608|FG001|Overall Study|Death|5|||
131041473|NCT05267470|471786609|FG002|Overall Study|Death|8|||
131041474|NCT05267470|471786610|FG003|Overall Study|Death|18|||
131041475|NCT05267470|471786611|FG004|Overall Study|Death|1|||
131041476|NCT05267470|471786607|FG000|Overall Study|Lost to Follow-up|0|||
131041477|NCT05267470|471786608|FG001|Overall Study|Lost to Follow-up|0|||
130715141|NCT01359644|470584006|FG000|Treatment Period|Adverse Event|0|||
130715142|NCT01359644|470584007|FG001|Treatment Period|Adverse Event|0|||
130715143|NCT01359644|470584008|FG002|Treatment Period|Adverse Event|1|||
130715144|NCT01359644|470584009|FG003|Treatment Period|Adverse Event|0|||
130715145|NCT01359644|470584010|FG004|Treatment Period|Adverse Event|0|||
130715146|NCT01359644|470584011|FG005|Treatment Period|Adverse Event|1|||
130715147|NCT01359644|470584012|FG006|Treatment Period|Adverse Event|0|||
130715148|NCT01359644|470584013|FG007|Treatment Period|Adverse Event|0|||
130715149|NCT01359644|470584014|FG008|Treatment Period|Adverse Event|0|||
130715150|NCT01359644|470584015|FG009|Treatment Period|Adverse Event|0|||
130715151|NCT01359644|470584006|FG000|Treatment Period|Lost to Follow-up|0|||
130715152|NCT01359644|470584007|FG001|Treatment Period|Lost to Follow-up|0|||
130715153|NCT01359644|470584008|FG002|Treatment Period|Lost to Follow-up|0|||
130715154|NCT01359644|470584009|FG003|Treatment Period|Lost to Follow-up|0|||
130715155|NCT01359644|470584010|FG004|Treatment Period|Lost to Follow-up|0|||
130715156|NCT01359644|470584011|FG005|Treatment Period|Lost to Follow-up|1|||
130715157|NCT01359644|470584012|FG006|Treatment Period|Lost to Follow-up|0|||
130715158|NCT01359644|470584013|FG007|Treatment Period|Lost to Follow-up|0|||
130715159|NCT01359644|470584014|FG008|Treatment Period|Lost to Follow-up|0|||
130715160|NCT01359644|470584015|FG009|Treatment Period|Lost to Follow-up|0|||
130715161|NCT01359644|470584006|FG000|Follow-up Period|Withdrawal by Subject|0|||
130715162|NCT01359644|470584007|FG001|Follow-up Period|Withdrawal by Subject|0|||
130715163|NCT01359644|470584008|FG002|Follow-up Period|Withdrawal by Subject|0|||
130715164|NCT01359644|470584009|FG003|Follow-up Period|Withdrawal by Subject|0|||
130715165|NCT01359644|470584010|FG004|Follow-up Period|Withdrawal by Subject|0|||
130715166|NCT01359644|470584011|FG005|Follow-up Period|Withdrawal by Subject|1|||
130715167|NCT01359644|470584012|FG006|Follow-up Period|Withdrawal by Subject|0|||
130715168|NCT01359644|470584013|FG007|Follow-up Period|Withdrawal by Subject|0|||
130715169|NCT01359644|470584014|FG008|Follow-up Period|Withdrawal by Subject|0|||
130715170|NCT01359644|470584015|FG009|Follow-up Period|Withdrawal by Subject|0|||
130715171|NCT01359644|470584006|FG000|Follow-up Period|Lost to Follow-up|0|||
130715172|NCT01359644|470584007|FG001|Follow-up Period|Lost to Follow-up|0|||
130715173|NCT01359644|470584008|FG002|Follow-up Period|Lost to Follow-up|0|||
130715174|NCT01359644|470584009|FG003|Follow-up Period|Lost to Follow-up|0|||
130715175|NCT01359644|470584010|FG004|Follow-up Period|Lost to Follow-up|0|||
130715176|NCT01359644|470584011|FG005|Follow-up Period|Lost to Follow-up|0|||
130715177|NCT01359644|470584012|FG006|Follow-up Period|Lost to Follow-up|1|||
130715178|NCT01359644|470584013|FG007|Follow-up Period|Lost to Follow-up|2|||
130715179|NCT01359644|470584014|FG008|Follow-up Period|Lost to Follow-up|0|||
130715180|NCT01359644|470584015|FG009|Follow-up Period|Lost to Follow-up|0|||
130715181|NCT02130882|470584017|FG000|Overall Study|Withdrawal by Subject|0|||
130715182|NCT02130882|470584018|FG001|Overall Study|Withdrawal by Subject|1|||
130715183|NCT01355159|470584029|FG000|Overall Study|Withdrew consent|39|||
130715184|NCT01355159|470584030|FG001|Overall Study|Withdrew consent|47|||
130715185|NCT01355159|470584029|FG000|Overall Study|No primary outcome data|17|||
130775091|NCT03268005|470802667|FG001|Overall Study|Death|1|||
130775092|NCT03268005|470802666|FG000|Overall Study|Lost to Follow-up|2|||
130775093|NCT03268005|470802667|FG001|Overall Study|Lost to Follow-up|2|||
131041478|NCT05267470|471786609|FG002|Overall Study|Lost to Follow-up|0|||
131041479|NCT05267470|471786610|FG003|Overall Study|Lost to Follow-up|1|||
131041480|NCT05267470|471786611|FG004|Overall Study|Lost to Follow-up|0|||
131041481|NCT03381586|471786614|FG000|Overall Study|Adverse Event|1|||
131041482|NCT03381586|471786615|FG001|Overall Study|Adverse Event|1|||
131041483|NCT03381586|471786614|FG000|Overall Study|Protocol Violation|1|||
131041484|NCT03381586|471786615|FG001|Overall Study|Protocol Violation|0|||
131041485|NCT03381586|471786614|FG000|Overall Study|Withdrawal by Subject|1|||
131041486|NCT03381586|471786615|FG001|Overall Study|Withdrawal by Subject|2|||
131041487|NCT00696111|471789213|FG000|Overall Study|Withdrawal by Subject|17|||
131041488|NCT05452460|471789215|FG000|Overall Study|Lost to Follow-up|3|||
131041489|NCT05452460|471789216|FG001|Overall Study|Lost to Follow-up|3|||
131041490|NCT05452460|471789215|FG000|Overall Study|Did not receive intervention|1|||
131041491|NCT05452460|471789216|FG001|Overall Study|Did not receive intervention|0|||
131041492|NCT05645757|471789217|FG000|Overall Study|Enrolled but treatment not administered|0|||
131041493|NCT05645757|471789218|FG001|Overall Study|Enrolled but treatment not administered|0|||
131041494|NCT05645757|471789219|FG002|Overall Study|Enrolled but treatment not administered|0|||
131041495|NCT05645757|471789220|FG003|Overall Study|Enrolled but treatment not administered|0|||
131041496|NCT05645757|471789221|FG004|Overall Study|Enrolled but treatment not administered|1|||
131041497|NCT05645757|471789222|FG005|Overall Study|Enrolled but treatment not administered|1|||
131041498|NCT05645757|471789223|FG006|Overall Study|Enrolled but treatment not administered|0|||
131041499|NCT05645757|471789224|FG007|Overall Study|Enrolled but treatment not administered|0|||
131041500|NCT03924635|471789225|FG000|Overall Study|Withdrawal by Subject|2|||
131041501|NCT03924635|471789226|FG001|Overall Study|Withdrawal by Subject|4|||
131041502|NCT00539591|471789227|FG000|Overall Study|Toxicity|3|||
131041503|NCT00539591|471789228|FG001|Overall Study|Toxicity|0|||
131041504|NCT00539591|471789229|FG002|Overall Study|Toxicity|0|||
131041505|NCT00539591|471789227|FG000|Overall Study|Disease progression|2|||
130715186|NCT01355159|470584030|FG001|Overall Study|No primary outcome data|11|||
130715187|NCT01355159|470584029|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
130715188|NCT01355159|470584030|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
130715189|NCT01355159|470584029|FG000|Overall Study|Early intrauterine fetal death|6|||
130715190|NCT01355159|470584030|FG001|Overall Study|Early intrauterine fetal death|6|||
130715191|NCT01194973|470584031|FG000|Screening Period|Screen Failure|3|||
130715192|NCT01194973|470584031|FG000|26 Week Treatment Period|Adverse Event|1|||
130715193|NCT01194973|470584031|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
130715194|NCT01194973|470584031|FG000|26 Week Treatment Period|Pregnancy|1|||
130715195|NCT00359632|470584034|FG000|Overall Study|Death|2|||
130715196|NCT00359632|470584035|FG001|Overall Study|Death|0|||
130715197|NCT00359632|470584034|FG000|Overall Study|Adverse Event|1|||
130715198|NCT00359632|470584035|FG001|Overall Study|Adverse Event|0|||
130715199|NCT00359632|470584034|FG000|Overall Study|Non-compliance with visit schedule|1|||
130715200|NCT00359632|470584035|FG001|Overall Study|Non-compliance with visit schedule|0|||
130715201|NCT04700280|470584036|FG000|Overall Study|Adverse Event|4|||
130715202|NCT04700280|470584037|FG001|Overall Study|Adverse Event|0|||
130715203|NCT04700280|470584036|FG000|Overall Study|Lack of Efficacy|1|||
130715204|NCT04700280|470584037|FG001|Overall Study|Lack of Efficacy|0|||
130715205|NCT04700280|470584036|FG000|Overall Study|Study terminated by sponsor|5|||
130715206|NCT04700280|470584037|FG001|Overall Study|Study terminated by sponsor|3|||
130715207|NCT04700280|470584036|FG000|Overall Study|Other than specified|1|||
130715208|NCT04700280|470584037|FG001|Overall Study|Other than specified|0|||
130715209|NCT02615171|470584038|FG000|Overall Study|Lost to Follow-up|2|||
130715210|NCT02615171|470584039|FG001|Overall Study|Lost to Follow-up|1|||
130715211|NCT00444457|470584049|FG000|Infant Series|Other|0|||
130715212|NCT00444457|470584050|FG001|Infant Series|Other|1|||
130715213|NCT00444457|470584051|FG002|Infant Series|Other|0|||
130715214|NCT00444457|470584052|FG003|Infant Series|Other|0|||
130715215|NCT00444457|470584049|FG000|Infant Series|Parent or legal guardian request|18|||
130715216|NCT00444457|470584050|FG001|Infant Series|Parent or legal guardian request|29|||
130715217|NCT00444457|470584051|FG002|Infant Series|Parent or legal guardian request|34|||
130715218|NCT00444457|470584052|FG003|Infant Series|Parent or legal guardian request|14|||
130715219|NCT00444457|470584049|FG000|Infant Series|Lost to Follow-up|10|||
130715220|NCT00444457|470584050|FG001|Infant Series|Lost to Follow-up|11|||
130715221|NCT00444457|470584051|FG002|Infant Series|Lost to Follow-up|7|||
130964317|NCT01172938|471497021|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
130964318|NCT01172938|471497022|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
131041506|NCT00539591|471789228|FG001|Overall Study|Disease progression|2|||
130715222|NCT00444457|470584052|FG003|Infant Series|Lost to Follow-up|6|||
130715223|NCT00444457|470584049|FG000|Infant Series|Protocol Violation|16|||
130715224|NCT00444457|470584050|FG001|Infant Series|Protocol Violation|8|||
130715225|NCT00444457|470584051|FG002|Infant Series|Protocol Violation|6|||
130715226|NCT00444457|470584052|FG003|Infant Series|Protocol Violation|3|||
130715227|NCT00444457|470584049|FG000|Infant Series|Failed to return|5|||
130715228|NCT00444457|470584050|FG001|Infant Series|Failed to return|4|||
130715229|NCT00444457|470584051|FG002|Infant Series|Failed to return|4|||
130715230|NCT00444457|470584052|FG003|Infant Series|Failed to return|2|||
131041507|NCT00539591|471789229|FG002|Overall Study|Disease progression|3|||
131041508|NCT04447040|471789230|FG000|Overall Study|Lost to Follow-up|2|||
131041509|NCT04447040|471789231|FG001|Overall Study|Lost to Follow-up|1|||
131041510|NCT04447040|471789232|FG002|Overall Study|Lost to Follow-up|3|||
131041511|NCT04447040|471789233|FG003|Overall Study|Lost to Follow-up|3|||
131041512|NCT04447040|471789234|FG004|Overall Study|Lost to Follow-up|1|||
131041513|NCT04447040|471789235|FG005|Overall Study|Lost to Follow-up|3|||
131041514|NCT04447040|471789230|FG000|Overall Study|Withdrawal by Subject|0|||
131041515|NCT04447040|471789231|FG001|Overall Study|Withdrawal by Subject|1|||
131041516|NCT04447040|471789232|FG002|Overall Study|Withdrawal by Subject|1|||
131041517|NCT04447040|471789233|FG003|Overall Study|Withdrawal by Subject|1|||
131041518|NCT04447040|471789234|FG004|Overall Study|Withdrawal by Subject|0|||
131041519|NCT04447040|471789235|FG005|Overall Study|Withdrawal by Subject|0|||
131041520|NCT02038777|471789238|FG000|Overall Study|Death|0|||
131041521|NCT02038777|471789239|FG001|Overall Study|Death|2|||
131041522|NCT02038777|471789240|FG002|Overall Study|Death|0|||
131041523|NCT02038777|471789241|FG003|Overall Study|Death|1|||
131041524|NCT02038777|471789242|FG004|Overall Study|Death|2|||
131041525|NCT02038777|471789243|FG005|Overall Study|Death|4|||
131041526|NCT02038777|471789244|FG006|Overall Study|Death|0|||
131041527|NCT02038777|471789245|FG007|Overall Study|Death|11|||
131041528|NCT02038777|471789238|FG000|Overall Study|Lost to Follow-up|0|||
131041529|NCT02038777|471789239|FG001|Overall Study|Lost to Follow-up|0|||
131041530|NCT02038777|471789240|FG002|Overall Study|Lost to Follow-up|0|||
131041531|NCT02038777|471789241|FG003|Overall Study|Lost to Follow-up|1|||
131041532|NCT02038777|471789242|FG004|Overall Study|Lost to Follow-up|0|||
131041533|NCT02038777|471789243|FG005|Overall Study|Lost to Follow-up|0|||
131041534|NCT02038777|471789244|FG006|Overall Study|Lost to Follow-up|0|||
131041535|NCT02038777|471789245|FG007|Overall Study|Lost to Follow-up|0|||
131041536|NCT02038777|471789238|FG000|Overall Study|Other|0|||
130775094|NCT03268005|470802666|FG000|Overall Study|Withdrawal by Subject|11|||
130775095|NCT03268005|470802667|FG001|Overall Study|Withdrawal by Subject|11|||
130775096|NCT04378569|470804426|FG000|Overall Study|Adverse Event|0|||
130775097|NCT04378569|470804427|FG001|Overall Study|Adverse Event|0|||
130775098|NCT04378569|470804428|FG002|Overall Study|Adverse Event|2|||
130775099|NCT04378569|470804429|FG003|Overall Study|Adverse Event|0|||
130775100|NCT04378569|470804430|FG004|Overall Study|Adverse Event|3|||
130775101|NCT04378569|470804431|FG005|Overall Study|Adverse Event|3|||
130775102|NCT04378569|470804426|FG000|Overall Study|Lost to Follow-up|0|||
130775103|NCT04378569|470804427|FG001|Overall Study|Lost to Follow-up|3|||
130775104|NCT04378569|470804428|FG002|Overall Study|Lost to Follow-up|1|||
130775105|NCT04378569|470804429|FG003|Overall Study|Lost to Follow-up|0|||
130964319|NCT01172938|471497023|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
130964320|NCT01172938|471497024|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
130964321|NCT01172938|471497025|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
130964322|NCT01172938|471497026|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
130964323|NCT01172938|471497027|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
130964324|NCT01172938|471497028|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
130964325|NCT01172938|471497029|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
130964326|NCT01172938|471497021|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130964327|NCT01172938|471497022|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
130964328|NCT01172938|471497023|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130964329|NCT01172938|471497024|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130964330|NCT01172938|471497025|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130964331|NCT01172938|471497026|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130964332|NCT01172938|471497027|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130964333|NCT01172938|471497028|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130964334|NCT01172938|471497029|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
130964335|NCT01172938|471497021|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130964336|NCT01172938|471497022|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130964337|NCT01172938|471497023|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
130964338|NCT01172938|471497024|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130964339|NCT01172938|471497025|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130964340|NCT01172938|471497026|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130964341|NCT01172938|471497027|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130964342|NCT01172938|471497028|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130964343|NCT01172938|471497029|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
130964344|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130964345|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
130964346|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
130964347|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130964348|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130964349|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130964350|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130964351|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
130964352|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
130964353|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
130964354|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
130964355|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
130964356|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
130964357|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
130964358|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
130964359|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
130964360|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
130964361|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
130964362|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
130964363|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
130964364|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
130964365|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
131041537|NCT02038777|471789239|FG001|Overall Study|Other|1|||
130964366|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
130964367|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
131041538|NCT02038777|471789240|FG002|Overall Study|Other|0|||
130775106|NCT04378569|470804430|FG004|Overall Study|Lost to Follow-up|1|||
130964368|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
131041539|NCT02038777|471789241|FG003|Overall Study|Other|2|||
131041540|NCT02038777|471789242|FG004|Overall Study|Other|1|||
130775107|NCT04378569|470804431|FG005|Overall Study|Lost to Follow-up|1|||
130775108|NCT04378569|470804426|FG000|Overall Study|Protocol Violation|0|||
130715231|NCT00444457|470584049|FG000|Infant Series|Investigator request|4|||
130715232|NCT00444457|470584050|FG001|Infant Series|Investigator request|3|||
130715233|NCT00444457|470584051|FG002|Infant Series|Investigator request|3|||
130715234|NCT00444457|470584052|FG003|Infant Series|Investigator request|2|||
130715235|NCT00444457|470584049|FG000|Infant Series|Other|0|||
130715236|NCT00444457|470584050|FG001|Infant Series|Other|2|||
130715237|NCT00444457|470584051|FG002|Infant Series|Other|4|||
130715238|NCT00444457|470584052|FG003|Infant Series|Other|0|||
130715239|NCT00444457|470584049|FG000|Infant Series|Adverse Event|1|||
130715240|NCT00444457|470584050|FG001|Infant Series|Adverse Event|2|||
130715241|NCT00444457|470584051|FG002|Infant Series|Adverse Event|2|||
130715242|NCT00444457|470584052|FG003|Infant Series|Adverse Event|0|||
130715243|NCT00444457|470584049|FG000|Infant Series|Death|0|||
130715244|NCT00444457|470584050|FG001|Infant Series|Death|1|||
130715245|NCT00444457|470584051|FG002|Infant Series|Death|1|||
130715246|NCT00444457|470584052|FG003|Infant Series|Death|1|||
130715247|NCT00444457|470584049|FG000|After Infant Series|Other|0|||
130715248|NCT00444457|470584050|FG001|After Infant Series|Other|1|||
130715249|NCT00444457|470584051|FG002|After Infant Series|Other|1|||
130715250|NCT00444457|470584052|FG003|After Infant Series|Other|1|||
130715251|NCT00444457|470584049|FG000|After Infant Series|Parent or legal guardian request|4|||
130715252|NCT00444457|470584050|FG001|After Infant Series|Parent or legal guardian request|11|||
130715253|NCT00444457|470584051|FG002|After Infant Series|Parent or legal guardian request|6|||
130715254|NCT00444457|470584052|FG003|After Infant Series|Parent or legal guardian request|3|||
130715255|NCT00444457|470584049|FG000|After Infant Series|Failed to return|7|||
130715256|NCT00444457|470584050|FG001|After Infant Series|Failed to return|6|||
130715257|NCT00444457|470584051|FG002|After Infant Series|Failed to return|5|||
130715258|NCT00444457|470584052|FG003|After Infant Series|Failed to return|1|||
130715259|NCT00444457|470584049|FG000|After Infant Series|Lost to Follow-up|5|||
130715260|NCT00444457|470584050|FG001|After Infant Series|Lost to Follow-up|5|||
130715261|NCT00444457|470584051|FG002|After Infant Series|Lost to Follow-up|5|||
130715262|NCT00444457|470584052|FG003|After Infant Series|Lost to Follow-up|2|||
130715263|NCT00444457|470584049|FG000|After Infant Series|Protocol Violation|2|||
130715264|NCT00444457|470584050|FG001|After Infant Series|Protocol Violation|4|||
130715265|NCT00444457|470584051|FG002|After Infant Series|Protocol Violation|2|||
130715266|NCT00444457|470584052|FG003|After Infant Series|Protocol Violation|2|||
130715267|NCT00444457|470584049|FG000|After Infant Series|Adverse Event|2|||
130715268|NCT00444457|470584050|FG001|After Infant Series|Adverse Event|2|||
130715269|NCT00444457|470584051|FG002|After Infant Series|Adverse Event|0|||
130715270|NCT00444457|470584052|FG003|After Infant Series|Adverse Event|0|||
130715271|NCT00444457|470584049|FG000|After Infant Series|Investigator request|0|||
130775109|NCT04378569|470804427|FG001|Overall Study|Protocol Violation|0|||
130775110|NCT04378569|470804428|FG002|Overall Study|Protocol Violation|0|||
130775111|NCT04378569|470804429|FG003|Overall Study|Protocol Violation|0|||
130775112|NCT04378569|470804430|FG004|Overall Study|Protocol Violation|0|||
130775113|NCT04378569|470804431|FG005|Overall Study|Protocol Violation|1|||
130775114|NCT04378569|470804426|FG000|Overall Study|Withdrawal by Subject|0|||
130775115|NCT04378569|470804427|FG001|Overall Study|Withdrawal by Subject|6|||
130775116|NCT04378569|470804428|FG002|Overall Study|Withdrawal by Subject|7|||
130775117|NCT04378569|470804429|FG003|Overall Study|Withdrawal by Subject|4|||
130775118|NCT04378569|470804430|FG004|Overall Study|Withdrawal by Subject|5|||
130775119|NCT04378569|470804431|FG005|Overall Study|Withdrawal by Subject|4|||
130775120|NCT04378569|470804426|FG000|Overall Study|Lack of response|0|||
130775121|NCT04378569|470804427|FG001|Overall Study|Lack of response|0|||
130775122|NCT04378569|470804428|FG002|Overall Study|Lack of response|1|||
130775123|NCT04378569|470804429|FG003|Overall Study|Lack of response|0|||
130775124|NCT04378569|470804430|FG004|Overall Study|Lack of response|1|||
130775125|NCT04378569|470804431|FG005|Overall Study|Lack of response|1|||
130775126|NCT01962948|470804432|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
130775127|NCT01962948|470804433|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
130775128|NCT01962948|470804434|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
130715272|NCT00444457|470584050|FG001|After Infant Series|Investigator request|0|||
130715273|NCT00444457|470584051|FG002|After Infant Series|Investigator request|0|||
130715274|NCT00444457|470584052|FG003|After Infant Series|Investigator request|1|||
130715275|NCT00444457|470584049|FG000|After Infant Series|Other|0|||
130715276|NCT00444457|470584050|FG001|After Infant Series|Other|1|||
130715277|NCT00444457|470584051|FG002|After Infant Series|Other|0|||
130715278|NCT00444457|470584052|FG003|After Infant Series|Other|0|||
130715279|NCT00444457|470584049|FG000|Toddler Dose|Lost to Follow-up|4|||
130775129|NCT01962948|470804435|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
130775130|NCT03335813|470804442|FG000|Overall Study|Withdrawal by Subject|1|||
130775131|NCT00281697|470804446|FG000|Overall Study|> 60 days since last dose of study drug|4|||
130715280|NCT00444457|470584050|FG001|Toddler Dose|Lost to Follow-up|1|||
130715281|NCT00444457|470584051|FG002|Toddler Dose|Lost to Follow-up|1|||
130715282|NCT00444457|470584052|FG003|Toddler Dose|Lost to Follow-up|3|||
130715283|NCT00444457|470584049|FG000|Toddler Dose|Failed to return|2|||
131041541|NCT02038777|471789243|FG005|Overall Study|Other|0|||
131041542|NCT02038777|471789244|FG006|Overall Study|Other|0|||
131041543|NCT02038777|471789245|FG007|Overall Study|Other|0|||
131041544|NCT02038777|471789238|FG000|Overall Study|Randomized but not treated|0|||
131041545|NCT02038777|471789239|FG001|Overall Study|Randomized but not treated|1|||
131041546|NCT02038777|471789240|FG002|Overall Study|Randomized but not treated|0|||
131041547|NCT02038777|471789241|FG003|Overall Study|Randomized but not treated|0|||
131041548|NCT02038777|471789242|FG004|Overall Study|Randomized but not treated|0|||
131041549|NCT02038777|471789243|FG005|Overall Study|Randomized but not treated|0|||
131041550|NCT02038777|471789244|FG006|Overall Study|Randomized but not treated|0|||
131041551|NCT02038777|471789245|FG007|Overall Study|Randomized but not treated|0|||
131041552|NCT02038777|471789238|FG000|Overall Study|Started Chemotherapy|1|||
131041553|NCT02038777|471789239|FG001|Overall Study|Started Chemotherapy|0|||
131041554|NCT02038777|471789240|FG002|Overall Study|Started Chemotherapy|3|||
131041555|NCT02038777|471789241|FG003|Overall Study|Started Chemotherapy|0|||
131041556|NCT02038777|471789242|FG004|Overall Study|Started Chemotherapy|0|||
131041557|NCT02038777|471789243|FG005|Overall Study|Started Chemotherapy|0|||
131041558|NCT02038777|471789244|FG006|Overall Study|Started Chemotherapy|0|||
131041559|NCT02038777|471789245|FG007|Overall Study|Started Chemotherapy|0|||
131041560|NCT02038777|471789238|FG000|Overall Study|participation terminated by sponsor|0|||
131041561|NCT02038777|471789239|FG001|Overall Study|participation terminated by sponsor|0|||
131041562|NCT02038777|471789240|FG002|Overall Study|participation terminated by sponsor|0|||
131041563|NCT02038777|471789241|FG003|Overall Study|participation terminated by sponsor|0|||
131041564|NCT02038777|471789242|FG004|Overall Study|participation terminated by sponsor|0|||
130715284|NCT00444457|470584050|FG001|Toddler Dose|Failed to return|2|||
130715285|NCT00444457|470584051|FG002|Toddler Dose|Failed to return|1|||
130715286|NCT00444457|470584052|FG003|Toddler Dose|Failed to return|3|||
130715287|NCT00444457|470584049|FG000|Toddler Dose|Parent or legal guardian request|0|||
130715288|NCT00444457|470584050|FG001|Toddler Dose|Parent or legal guardian request|3|||
130715289|NCT00444457|470584051|FG002|Toddler Dose|Parent or legal guardian request|2|||
130715290|NCT00444457|470584052|FG003|Toddler Dose|Parent or legal guardian request|1|||
130715291|NCT00444457|470584049|FG000|Toddler Dose|Protocol Violation|1|||
130715292|NCT00444457|470584050|FG001|Toddler Dose|Protocol Violation|0|||
130715293|NCT00444457|470584051|FG002|Toddler Dose|Protocol Violation|0|||
130715294|NCT00444457|470584052|FG003|Toddler Dose|Protocol Violation|1|||
130715295|NCT01121666|470584055|FG000|Overall Study|Protocol Violation|29|||
130715296|NCT01121666|470584056|FG001|Overall Study|Protocol Violation|10|||
130715297|NCT03176459|470584059|FG000|Overall Study|Lost to Follow-up|5|||
130715298|NCT03176459|470584060|FG001|Overall Study|Lost to Follow-up|7|||
130715299|NCT01602965|470584061|FG000|Overall Study|Lost to Follow-up|4|||
130715300|NCT01602965|470584062|FG001|Overall Study|Lost to Follow-up|2|||
130715301|NCT02283294|470584063|FG000|Overall Study|Lost to Follow-up|1|||
130715302|NCT02283294|470584064|FG001|Overall Study|Lost to Follow-up|1|||
130715303|NCT02283294|470584063|FG000|Overall Study|Withdrawal by Subject|1|||
130715304|NCT02283294|470584064|FG001|Overall Study|Withdrawal by Subject|6|||
130715305|NCT02283294|470584063|FG000|Overall Study|Protocol Violation|1|||
130715306|NCT02283294|470584064|FG001|Overall Study|Protocol Violation|0|||
130715307|NCT02283294|470584063|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
130715308|NCT02283294|470584064|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
130715309|NCT03047473|470586885|FG000|Overall Study|Lost to Follow-up|2|||
130715310|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
130715311|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130715312|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130715313|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130715314|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130715315|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
130715316|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
130715317|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
130715318|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
130715319|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
130715320|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130715321|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
130715322|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130715323|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130715324|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130715325|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
130715326|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
130715327|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
130715328|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
130715329|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
130715330|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
130715331|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
130715332|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
131041565|NCT02038777|471789243|FG005|Overall Study|participation terminated by sponsor|0|||
131041566|NCT02038777|471789244|FG006|Overall Study|participation terminated by sponsor|1|||
130715333|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
130715334|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
130715335|NCT02935686|470586886|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130715336|NCT02935686|470586887|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
130715337|NCT02935686|470586888|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130715338|NCT02935686|470586889|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130715339|NCT02935686|470586890|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130715340|NCT02935686|470586886|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
130715341|NCT02935686|470586887|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
130715342|NCT02935686|470586888|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
130715343|NCT02935686|470586889|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
130715344|NCT02935686|470586890|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
130715345|NCT02935686|470586886|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130715346|NCT02935686|470586887|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
130715347|NCT02935686|470586888|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130715348|NCT02935686|470586889|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130715349|NCT02935686|470586890|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130715350|NCT02935686|470586886|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130715351|NCT02935686|470586887|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
130715352|NCT02935686|470586888|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130715353|NCT02935686|470586889|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130715354|NCT02935686|470586890|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130715355|NCT02935686|470586886|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130715356|NCT02935686|470586887|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130715357|NCT02935686|470586888|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130715358|NCT02935686|470586889|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130715359|NCT02935686|470586890|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
130715360|NCT02935686|470586886|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
130715361|NCT02935686|470586887|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
130715362|NCT02935686|470586888|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
130715363|NCT02935686|470586889|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
130715364|NCT02935686|470586890|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
130715365|NCT00541970|470586896|FG000|Month 7|Protocol Violation|9|||
130715366|NCT00541970|470586897|FG001|Month 7|Protocol Violation|13|||
130715367|NCT00541970|470586898|FG002|Month 7|Protocol Violation|11|||
130715368|NCT00541970|470586899|FG003|Month 7|Protocol Violation|5|||
130715369|NCT00541970|470586896|FG000|Month 12|Adverse Event|0|||
130715370|NCT00541970|470586897|FG001|Month 12|Adverse Event|1|||
130715371|NCT00541970|470586898|FG002|Month 12|Adverse Event|1|||
130715372|NCT00541970|470586899|FG003|Month 12|Adverse Event|1|||
130715373|NCT00541970|470586896|FG000|Month 12|Protocol Violation|12|||
130715374|NCT00541970|470586897|FG001|Month 12|Protocol Violation|21|||
130715375|NCT00541970|470586898|FG002|Month 12|Protocol Violation|20|||
130715376|NCT00541970|470586899|FG003|Month 12|Protocol Violation|15|||
130715377|NCT00541970|470586896|FG000|Month 18|Adverse Event|0|||
130715378|NCT00541970|470586897|FG001|Month 18|Adverse Event|1|||
130715379|NCT00541970|470586898|FG002|Month 18|Adverse Event|1|||
130715380|NCT00541970|470586899|FG003|Month 18|Adverse Event|1|||
130715381|NCT00541970|470586896|FG000|Month 18|Protocol Violation|14|||
130715382|NCT00541970|470586897|FG001|Month 18|Protocol Violation|23|||
130715383|NCT00541970|470586898|FG002|Month 18|Protocol Violation|24|||
130715384|NCT00541970|470586899|FG003|Month 18|Protocol Violation|16|||
131041567|NCT02038777|471789245|FG007|Overall Study|participation terminated by sponsor|1|||
131041568|NCT04299464|471789246|FG000|Overall Study|Adverse Event|1|||
131041569|NCT04299464|471789247|FG001|Overall Study|Adverse Event|0|||
131041570|NCT04299464|471789248|FG002|Overall Study|Adverse Event|2|||
131041571|NCT04299464|471789246|FG000|Overall Study|Non-compliance with Study Drug|1|||
131041572|NCT04299464|471789247|FG001|Overall Study|Non-compliance with Study Drug|0|||
131041573|NCT04299464|471789248|FG002|Overall Study|Non-compliance with Study Drug|0|||
131041574|NCT04299464|471789246|FG000|Overall Study|Reason not Specified|0|||
131041575|NCT04299464|471789247|FG001|Overall Study|Reason not Specified|1|||
131041576|NCT04299464|471789248|FG002|Overall Study|Reason not Specified|3|||
131041577|NCT04299464|471789246|FG000|Overall Study|Physician Decision|0|||
131041578|NCT04299464|471789247|FG001|Overall Study|Physician Decision|1|||
131041579|NCT04299464|471789248|FG002|Overall Study|Physician Decision|1|||
131041580|NCT04299464|471789246|FG000|Overall Study|Withdrawal by Subject|0|||
130715385|NCT00541970|470586896|FG000|Month 24|Adverse Event|0|||
131041581|NCT04299464|471789247|FG001|Overall Study|Withdrawal by Subject|2|||
131041582|NCT04299464|471789248|FG002|Overall Study|Withdrawal by Subject|1|||
131041583|NCT03676192|471789249|FG000|Induction Study Period|Adverse Event|21|||
131041584|NCT03676192|471789250|FG001|Induction Study Period|Adverse Event|20|||
131127706|NCT05121480|472097591|FG001|Overall Study|Non-compliance with the protocol|0|||
130715386|NCT00541970|470586897|FG001|Month 24|Adverse Event|1|||
130715387|NCT00541970|470586898|FG002|Month 24|Adverse Event|1|||
130715388|NCT00541970|470586899|FG003|Month 24|Adverse Event|1|||
130715389|NCT00541970|470586896|FG000|Month 24|Protocol Violation|29|||
130715390|NCT00541970|470586897|FG001|Month 24|Protocol Violation|31|||
130715391|NCT00541970|470586898|FG002|Month 24|Protocol Violation|31|||
130715392|NCT00541970|470586899|FG003|Month 24|Protocol Violation|21|||
130715393|NCT00541970|470586896|FG000|Month 36|Protocol Violation|61|||
130715394|NCT00541970|470586897|FG001|Month 36|Protocol Violation|66|||
130715395|NCT00541970|470586898|FG002|Month 36|Protocol Violation|66|||
130715396|NCT00541970|470586899|FG003|Month 36|Protocol Violation|60|||
130715397|NCT00541970|470586896|FG000|Month 48|Withdrawal by Subject|2|||
130715398|NCT00541970|470586897|FG001|Month 48|Withdrawal by Subject|4|||
130715399|NCT00541970|470586898|FG002|Month 48|Withdrawal by Subject|4|||
130715400|NCT00541970|470586899|FG003|Month 48|Withdrawal by Subject|2|||
130715401|NCT00541970|470586896|FG000|Month 48|Other|3|||
130715402|NCT00541970|470586897|FG001|Month 48|Other|1|||
130715403|NCT00541970|470586898|FG002|Month 48|Other|1|||
130715404|NCT00541970|470586899|FG003|Month 48|Other|0|||
130715405|NCT00541970|470586896|FG000|Month 48|Lost to Follow-up|66|||
130715406|NCT00541970|470586897|FG001|Month 48|Lost to Follow-up|68|||
130715407|NCT00541970|470586898|FG002|Month 48|Lost to Follow-up|68|||
130715408|NCT00541970|470586899|FG003|Month 48|Lost to Follow-up|73|||
130715409|NCT00541970|470586896|FG000|Month 60|Protocol Violation|78|||
130715410|NCT00541970|470586897|FG001|Month 60|Protocol Violation|77|||
130715411|NCT00541970|470586898|FG002|Month 60|Protocol Violation|82|||
130715412|NCT00541970|470586899|FG003|Month 60|Protocol Violation|72|||
130715413|NCT00321828|470586900|FG000|Overall Study|Ineligible|3|||
130715414|NCT00321828|470586900|FG000|Overall Study|No follow up data|1|||
130715415|NCT00062010|470586903|FG000|Overall Study|Ineligible|3|||
130715416|NCT02856880|470586904|FG000|Overall Study|Withdrawal of consent|1|||
130715417|NCT00573157|470586905|FG000|Overall Study|Adverse Event|3|||
130715418|NCT00573157|470586906|FG001|Overall Study|Adverse Event|1|||
130715419|NCT00573157|470586905|FG000|Overall Study|Other|1|||
130715420|NCT00573157|470586906|FG001|Overall Study|Other|1|||
130715421|NCT02944383|470586907|FG000|Overall Study|Lost to Follow-up|0|||
130715422|NCT02944383|470586908|FG001|Overall Study|Lost to Follow-up|0|||
130715423|NCT02944383|470586909|FG002|Overall Study|Lost to Follow-up|1|||
130715424|NCT02944383|470586907|FG000|Overall Study|Withdrawal by Subject|1|||
130715425|NCT02944383|470586908|FG001|Overall Study|Withdrawal by Subject|0|||
130715426|NCT02944383|470586909|FG002|Overall Study|Withdrawal by Subject|0|||
130715427|NCT00858143|470586914|FG000|Overall Study|Adverse Event|16|||
130715428|NCT00858143|470586914|FG000|Overall Study|Lack of Efficacy|4|||
130715429|NCT00858143|470586914|FG000|Overall Study|Death|7|||
130715430|NCT00858143|470586914|FG000|Overall Study|Other|23|||
130715431|NCT00852969|470586915|FG000|Overall Study|Adverse Event|0|||
130715432|NCT00852969|470586916|FG001|Overall Study|Adverse Event|1|||
130715433|NCT00852969|470586915|FG000|Overall Study|Lost to Follow-up|0|||
130715434|NCT00852969|470586916|FG001|Overall Study|Lost to Follow-up|1|||
130715435|NCT03853148|470586917|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
130715436|NCT03853148|470586918|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
130715437|NCT03853148|470586919|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
130715438|NCT03853148|470586920|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
130715439|NCT00658658|470586921|FG000|Overall Study|Withdrawal by Subject|0|||
130715440|NCT00658658|470586922|FG001|Overall Study|Withdrawal by Subject|1|||
130715441|NCT00658658|470586923|FG002|Overall Study|Withdrawal by Subject|0|||
130715442|NCT00658658|470586924|FG003|Overall Study|Withdrawal by Subject|0|||
130715443|NCT00658658|470586925|FG004|Overall Study|Withdrawal by Subject|0|||
130715444|NCT00658658|470586921|FG000|Overall Study|Death|4|||
130715445|NCT00658658|470586922|FG001|Overall Study|Death|0|||
130715446|NCT00658658|470586923|FG002|Overall Study|Death|0|||
130964369|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
130964370|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
130715447|NCT00658658|470586924|FG003|Overall Study|Death|1|||
130715448|NCT00658658|470586925|FG004|Overall Study|Death|1|||
130715449|NCT00658658|470586921|FG000|Overall Study|Disease Progression|0|||
130715450|NCT00658658|470586922|FG001|Overall Study|Disease Progression|1|||
130715451|NCT00658658|470586923|FG002|Overall Study|Disease Progression|0|||
130715452|NCT00658658|470586924|FG003|Overall Study|Disease Progression|1|||
130715453|NCT00658658|470586925|FG004|Overall Study|Disease Progression|3|||
130715454|NCT00658658|470586921|FG000|Overall Study|Protocol-specified Criteria|1|||
130715455|NCT00658658|470586922|FG001|Overall Study|Protocol-specified Criteria|0|||
130715456|NCT00658658|470586923|FG002|Overall Study|Protocol-specified Criteria|0|||
130715457|NCT00658658|470586924|FG003|Overall Study|Protocol-specified Criteria|0|||
130715458|NCT00658658|470586925|FG004|Overall Study|Protocol-specified Criteria|0|||
130715459|NCT00658658|470586921|FG000|Overall Study|Other|0|||
130715460|NCT00658658|470586922|FG001|Overall Study|Other|0|||
130715461|NCT00658658|470586923|FG002|Overall Study|Other|0|||
130715462|NCT00658658|470586924|FG003|Overall Study|Other|0|||
130715463|NCT00658658|470586925|FG004|Overall Study|Other|1|||
130715464|NCT00678041|470586926|FG000|Overall Study|Physician Decision|5|||
130715465|NCT00678041|470586927|FG001|Overall Study|Physician Decision|5|||
130715466|NCT02358343|470586928|FG000|Screening Intervention|Death|0|||
131127707|NCT05121480|472097592|FG002|Overall Study|Non-compliance with the protocol|0|||
131127708|NCT05121480|472097593|FG003|Overall Study|Non-compliance with the protocol|0|||
131127709|NCT05121480|472097594|FG004|Overall Study|Non-compliance with the protocol|1|||
131127710|NCT05121480|472097595|FG005|Overall Study|Non-compliance with the protocol|6|||
131127711|NCT05121480|472097596|FG006|Overall Study|Non-compliance with the protocol|0|||
131127712|NCT05121480|472097597|FG007|Overall Study|Non-compliance with the protocol|1|||
131127713|NCT05121480|472097590|FG000|Overall Study|Lost to Follow-up|0|||
131127714|NCT05121480|472097591|FG001|Overall Study|Lost to Follow-up|4|||
131127715|NCT05121480|472097592|FG002|Overall Study|Lost to Follow-up|1|||
131127716|NCT05121480|472097593|FG003|Overall Study|Lost to Follow-up|3|||
131127717|NCT05121480|472097594|FG004|Overall Study|Lost to Follow-up|1|||
131127718|NCT05121480|472097595|FG005|Overall Study|Lost to Follow-up|1|||
131127719|NCT05121480|472097596|FG006|Overall Study|Lost to Follow-up|1|||
131127720|NCT05121480|472097597|FG007|Overall Study|Lost to Follow-up|4|||
131127721|NCT05121480|472097590|FG000|Overall Study|Physician Decision|0|||
131127722|NCT05121480|472097591|FG001|Overall Study|Physician Decision|0|||
131127723|NCT05121480|472097592|FG002|Overall Study|Physician Decision|0|||
131127724|NCT05121480|472097593|FG003|Overall Study|Physician Decision|0|||
131127725|NCT05121480|472097594|FG004|Overall Study|Physician Decision|0|||
131127726|NCT05121480|472097595|FG005|Overall Study|Physician Decision|1|||
131127727|NCT05121480|472097596|FG006|Overall Study|Physician Decision|0|||
131127728|NCT05121480|472097597|FG007|Overall Study|Physician Decision|1|||
131127729|NCT05121480|472097590|FG000|Overall Study|Other Reason|0|||
131127730|NCT05121480|472097591|FG001|Overall Study|Other Reason|0|||
131127731|NCT05121480|472097592|FG002|Overall Study|Other Reason|0|||
131127732|NCT05121480|472097593|FG003|Overall Study|Other Reason|0|||
131127733|NCT05121480|472097594|FG004|Overall Study|Other Reason|0|||
131127734|NCT05121480|472097595|FG005|Overall Study|Other Reason|1|||
131127735|NCT05121480|472097596|FG006|Overall Study|Other Reason|1|||
131127736|NCT05121480|472097597|FG007|Overall Study|Other Reason|1|||
131127737|NCT02831673|472097600|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
131127738|NCT02831673|472097601|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
131127739|NCT02831673|472097602|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
131127740|NCT02831673|472097603|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
131127741|NCT02831673|472097604|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
131127742|NCT02831673|472097600|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
130715467|NCT02358343|470586929|FG001|Screening Intervention|Death|2|||
130715468|NCT02358343|470586930|FG002|Screening Intervention|Death|0|||
130715469|NCT02358343|470586931|FG003|Screening Intervention|Death|0|||
130715470|NCT02358343|470586932|FG004|Screening Intervention|Death|0|||
130715471|NCT02358343|470586928|FG000|Screening Intervention|Withdrawal by Subject|1|||
130715472|NCT02358343|470586929|FG001|Screening Intervention|Withdrawal by Subject|0|||
130715473|NCT02358343|470586930|FG002|Screening Intervention|Withdrawal by Subject|0|||
130715474|NCT02358343|470586931|FG003|Screening Intervention|Withdrawal by Subject|0|||
130715475|NCT02358343|470586932|FG004|Screening Intervention|Withdrawal by Subject|0|||
130715476|NCT02358343|470586928|FG000|Screening Intervention|Determined Ineligible|5|||
130715477|NCT02358343|470586929|FG001|Screening Intervention|Determined Ineligible|6|||
130715478|NCT02358343|470586930|FG002|Screening Intervention|Determined Ineligible|0|||
130715479|NCT02358343|470586931|FG003|Screening Intervention|Determined Ineligible|0|||
130715480|NCT02358343|470586932|FG004|Screening Intervention|Determined Ineligible|0|||
130715481|NCT02358343|470586928|FG000|Comparative Efficacy Trial / Observation|Death|0|||
130715482|NCT02358343|470586929|FG001|Comparative Efficacy Trial / Observation|Death|0|||
130715483|NCT02358343|470586930|FG002|Comparative Efficacy Trial / Observation|Death|2|||
130715484|NCT02358343|470586931|FG003|Comparative Efficacy Trial / Observation|Death|0|||
130715485|NCT02358343|470586932|FG004|Comparative Efficacy Trial / Observation|Death|0|||
130715486|NCT02358343|470586928|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
131041585|NCT03676192|471789249|FG000|Induction Study Period|Death|23|||
131041586|NCT03676192|471789250|FG001|Induction Study Period|Death|20|||
131041587|NCT03676192|471789249|FG000|Induction Study Period|Lost to Follow-up|3|||
131041588|NCT03676192|471789250|FG001|Induction Study Period|Lost to Follow-up|3|||
131041589|NCT03676192|471789249|FG000|Induction Study Period|Physician Decision|6|||
131041590|NCT03676192|471789250|FG001|Induction Study Period|Physician Decision|3|||
131041591|NCT03676192|471789249|FG000|Induction Study Period|Progressive Disease|32|||
131041592|NCT03676192|471789250|FG001|Induction Study Period|Progressive Disease|21|||
131041593|NCT03676192|471789249|FG000|Induction Study Period|Protocol Violation|1|||
131041594|NCT03676192|471789250|FG001|Induction Study Period|Protocol Violation|2|||
131041595|NCT03676192|471789249|FG000|Induction Study Period|Withdrawal by Subject|20|||
131041596|NCT03676192|471789250|FG001|Induction Study Period|Withdrawal by Subject|15|||
131041597|NCT04079218|471789251|FG000|Overall Study|Death|1|||
131041598|NCT04079218|471789252|FG001|Overall Study|Death|0|||
131041599|NCT04079218|471789251|FG000|Overall Study|Withdrawal by Subject|3|||
130775132|NCT00281697|470804447|FG001|Overall Study|> 60 days since last dose of study drug|4|||
130775133|NCT00281697|470804446|FG000|Overall Study|Adverse Event|54|||
130775134|NCT00281697|470804447|FG001|Overall Study|Adverse Event|15|||
130775135|NCT00281697|470804446|FG000|Overall Study|Death|8|||
130775136|NCT00281697|470804447|FG001|Overall Study|Death|3|||
130775137|NCT00281697|470804446|FG000|Overall Study|Disease progression|279|||
130775138|NCT00281697|470804447|FG001|Overall Study|Disease progression|149|||
130775139|NCT00281697|470804446|FG000|Overall Study|Other|5|||
130775140|NCT00281697|470804447|FG001|Overall Study|Other|6|||
130775141|NCT00281697|470804446|FG000|Overall Study|Physician's decision to withdraw|15|||
130775142|NCT00281697|470804447|FG001|Overall Study|Physician's decision to withdraw|12|||
130775143|NCT00281697|470804446|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
130775144|NCT00281697|470804447|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
130775145|NCT00281697|470804446|FG000|Overall Study|Did not receive study drug|3|||
130775146|NCT00281697|470804447|FG001|Overall Study|Did not receive study drug|2|||
130775147|NCT04446429|470804448|FG000|Overall Study|Lost to Follow-up|6|||
130775148|NCT04446429|470804449|FG001|Overall Study|Lost to Follow-up|0|||
130775149|NCT02256917|470804450|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
130775150|NCT02256917|470804450|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
130775151|NCT02256917|470804450|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
130775152|NCT02256917|470804450|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
130775153|NCT02256917|470804450|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
130775154|NCT01896193|470804454|FG000|Overall Study|Lack of Efficacy|20|||
130775155|NCT01896193|470804455|FG001|Overall Study|Lack of Efficacy|11|||
130775156|NCT01896193|470804454|FG000|Overall Study|Protocol Violation|0|||
130775157|NCT01896193|470804455|FG001|Overall Study|Protocol Violation|1|||
130775158|NCT01896193|470804454|FG000|Overall Study|Withdrew Consent|1|||
130775159|NCT01896193|470804455|FG001|Overall Study|Withdrew Consent|0|||
130775160|NCT01300247|470804457|FG000|Overall Study|Death|1|||
130775161|NCT01300247|470804458|FG001|Overall Study|Death|1|||
130775162|NCT01300247|470804457|FG000|Overall Study|Lost to Follow-up|2|||
130775163|NCT01300247|470804458|FG001|Overall Study|Lost to Follow-up|0|||
130775164|NCT01300247|470804457|FG000|Overall Study|Withdrawal by Subject|1|||
130775165|NCT01300247|470804458|FG001|Overall Study|Withdrawal by Subject|0|||
130775166|NCT01300247|470804457|FG000|Overall Study|Non-Compliance|0|||
130775167|NCT01300247|470804458|FG001|Overall Study|Non-Compliance|1|||
130775168|NCT05359952|470804459|FG000|Overall Study|Lost to Follow-up|1|||
130775169|NCT05359952|470804460|FG001|Overall Study|Lost to Follow-up|0|||
130775170|NCT01556932|470804461|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
131127743|NCT02831673|472097601|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
131127744|NCT02831673|472097602|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
130775171|NCT01556932|470804462|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
130775172|NCT02328937|470804463|FG000|Period 1|Lost to Follow-up|0|||
130775173|NCT02328937|470804464|FG001|Period 1|Lost to Follow-up|0|||
130964371|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130964372|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130964373|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
130964374|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130964375|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130964376|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130964377|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130964378|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
130964379|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
130964380|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130964381|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130964382|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130964383|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130964384|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130964385|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130964386|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130964387|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
130964388|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
130964389|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130964390|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130964391|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
130775174|NCT02328937|470804465|FG002|Period 1|Lost to Follow-up|0|||
130775175|NCT02328937|470804466|FG003|Period 1|Lost to Follow-up|1|||
130775176|NCT02328937|470804467|FG004|Period 1|Lost to Follow-up|0|||
130964392|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130964393|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130775177|NCT02328937|470804468|FG005|Period 1|Lost to Follow-up|0|||
130775178|NCT02328937|470804463|FG000|Period 2|Adverse Event|0|||
130775179|NCT02328937|470804464|FG001|Period 2|Adverse Event|0|||
130775180|NCT02328937|470804465|FG002|Period 2|Adverse Event|1|||
130775181|NCT02328937|470804466|FG003|Period 2|Adverse Event|0|||
130775182|NCT02328937|470804467|FG004|Period 2|Adverse Event|0|||
130775183|NCT02328937|470804468|FG005|Period 2|Adverse Event|0|||
130775184|NCT00996034|470804471|FG000|Overall Study|Lost to Follow-up|2|||
130775185|NCT00996034|470804471|FG000|Overall Study|withdrawn by PI|1|||
130775186|NCT03231306|470804472|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
130775187|NCT03231306|470804472|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
130775188|NCT03231306|470804472|FG000|Overall Study|Treatment delay > 21 days|2|||
130775189|NCT03231306|470804472|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
130775190|NCT03231306|470804472|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
130964394|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130964395|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
130964396|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
130964397|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
130964398|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130964399|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130964400|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
130964401|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130964402|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130964403|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130964404|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130964405|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130964406|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
130964407|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130964408|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
130964409|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130964410|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130964411|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130964412|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130964413|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130964414|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
130964415|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
130964416|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130964417|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
130964418|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
130964419|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130964420|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130964421|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130964422|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130964423|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
130964424|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
130964425|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130964426|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130775191|NCT03231306|470804472|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
130775192|NCT03231306|470804472|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
130775193|NCT03231306|470804472|FG000|Overall Study|More than 1 Reason|2|||
130775194|NCT00685360|470804473|FG000|Overall Study|Lost to Follow-up|0|||
130775195|NCT00685360|470804474|FG001|Overall Study|Lost to Follow-up|1|||
130775196|NCT00685360|470804475|FG002|Overall Study|Lost to Follow-up|2|||
130775197|NCT00685360|470804473|FG000|Overall Study|Adverse Event|4|||
130775198|NCT00685360|470804474|FG001|Overall Study|Adverse Event|6|||
130775199|NCT00685360|470804475|FG002|Overall Study|Adverse Event|4|||
130775200|NCT00685360|470804473|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
130775201|NCT00685360|470804474|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
130775202|NCT00685360|470804475|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
130775203|NCT00685360|470804473|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
130775204|NCT00685360|470804474|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
130778872|NCT03428100|470817450|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130964427|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
130964428|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130964429|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130964430|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130964431|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130964432|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130964433|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
130964434|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130964435|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130964436|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
130964437|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130964438|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
131127745|NCT02831673|472097603|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
131127746|NCT02831673|472097604|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
131127747|NCT02831673|472097600|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
131127748|NCT02831673|472097601|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
131127749|NCT02831673|472097602|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
131127750|NCT02831673|472097603|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
131127751|NCT02831673|472097604|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
131127752|NCT02831673|472097600|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
131127753|NCT02831673|472097601|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
131127754|NCT02831673|472097602|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
131127755|NCT02831673|472097603|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
131127756|NCT02831673|472097604|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
131127757|NCT02831673|472097600|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
130715487|NCT02358343|470586929|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
130715488|NCT02358343|470586930|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
130715489|NCT02358343|470586931|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
130715490|NCT02358343|470586932|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
130715491|NCT02358343|470586928|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130715492|NCT02358343|470586929|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130715493|NCT02358343|470586930|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
130715494|NCT02358343|470586931|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130715495|NCT02358343|470586932|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130715496|NCT00090610|470586935|FG000|Overall Study|Withdrawal by Subject|1|||
130715497|NCT00090610|470586936|FG001|Overall Study|Withdrawal by Subject|1|||
130715498|NCT00807248|470586937|FG000|Overall Study|Adverse Event|1|||
130715499|NCT00807248|470586938|FG001|Overall Study|Adverse Event|2|||
130715500|NCT00807248|470586939|FG002|Overall Study|Adverse Event|2|||
130715501|NCT00807248|470586940|FG003|Overall Study|Adverse Event|6|||
130715502|NCT00807248|470586937|FG000|Overall Study|Lack of Efficacy|14|||
130715503|NCT00807248|470586938|FG001|Overall Study|Lack of Efficacy|4|||
130715504|NCT00807248|470586939|FG002|Overall Study|Lack of Efficacy|8|||
130715505|NCT00807248|470586940|FG003|Overall Study|Lack of Efficacy|3|||
130715506|NCT00807248|470586937|FG000|Overall Study|Protocol Violation|0|||
130715507|NCT00807248|470586938|FG001|Overall Study|Protocol Violation|1|||
130715508|NCT00807248|470586939|FG002|Overall Study|Protocol Violation|1|||
130715509|NCT00807248|470586940|FG003|Overall Study|Protocol Violation|0|||
130715510|NCT00807248|470586937|FG000|Overall Study|Withdrawal of Consent|5|||
130715511|NCT00807248|470586938|FG001|Overall Study|Withdrawal of Consent|5|||
130715512|NCT00807248|470586939|FG002|Overall Study|Withdrawal of Consent|5|||
130715513|NCT00807248|470586940|FG003|Overall Study|Withdrawal of Consent|5|||
130715514|NCT00807248|470586937|FG000|Overall Study|Lost to Follow-up|1|||
130715515|NCT00807248|470586938|FG001|Overall Study|Lost to Follow-up|0|||
130715516|NCT00807248|470586939|FG002|Overall Study|Lost to Follow-up|0|||
130715517|NCT00807248|470586940|FG003|Overall Study|Lost to Follow-up|0|||
130715518|NCT00807248|470586937|FG000|Overall Study|Other Reason|0|||
130715519|NCT00807248|470586938|FG001|Overall Study|Other Reason|0|||
130715520|NCT00807248|470586939|FG002|Overall Study|Other Reason|2|||
130715521|NCT00807248|470586940|FG003|Overall Study|Other Reason|0|||
130715522|NCT02444793|470586941|FG000|Overall Study|Lost to Follow-up|2|||
130715523|NCT02444793|470586942|FG001|Overall Study|Lost to Follow-up|2|||
130715524|NCT02444793|470586943|FG002|Overall Study|Lost to Follow-up|0|||
130715525|NCT02444793|470586944|FG003|Overall Study|Lost to Follow-up|0|||
130715526|NCT02444793|470586941|FG000|Overall Study|Death|0|||
130715527|NCT02444793|470586942|FG001|Overall Study|Death|3|||
130964439|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130715528|NCT02444793|470586943|FG002|Overall Study|Death|0|||
130715529|NCT02444793|470586944|FG003|Overall Study|Death|0|||
130715530|NCT02444793|470586941|FG000|Overall Study|Other|0|||
130715531|NCT02444793|470586942|FG001|Overall Study|Other|0|||
130715532|NCT02444793|470586943|FG002|Overall Study|Other|2|||
130715533|NCT02444793|470586944|FG003|Overall Study|Other|0|||
130715534|NCT02444793|470586941|FG000|Overall Study|Objective progression or relapse|9|||
130715535|NCT02444793|470586942|FG001|Overall Study|Objective progression or relapse|1|||
130715536|NCT02444793|470586943|FG002|Overall Study|Objective progression or relapse|2|||
130715537|NCT02444793|470586944|FG003|Overall Study|Objective progression or relapse|3|||
130964440|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130715538|NCT00210249|470586946|FG000|Overall Study|Lost to Follow-up|5|||
130715539|NCT00210249|470586946|FG000|Overall Study|Protocol Violation|11|||
130964441|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130964442|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
130964443|NCT01172938|471497021|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130964444|NCT01172938|471497022|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130964445|NCT01172938|471497023|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130964446|NCT01172938|471497024|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130964447|NCT01172938|471497025|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130964448|NCT01172938|471497026|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130964449|NCT01172938|471497027|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130964450|NCT01172938|471497028|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
130964451|NCT01172938|471497029|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
131041600|NCT04079218|471789252|FG001|Overall Study|Withdrawal by Subject|0|||
131041601|NCT04079218|471789251|FG000|Overall Study|Physician Decision|4|||
130964452|NCT00003498|471497030|FG000|Overall Study|Not evaluable.|4|||
131041602|NCT04079218|471789252|FG001|Overall Study|Physician Decision|0|||
131041603|NCT04079218|471789251|FG000|Overall Study|Lost to Follow-up|0|||
131041604|NCT04079218|471789252|FG001|Overall Study|Lost to Follow-up|1|||
131041605|NCT02424617|471789257|FG000|Overall Study|Adverse Event|0|||
131041606|NCT02424617|471789258|FG001|Overall Study|Adverse Event|1|||
131041607|NCT02424617|471789259|FG002|Overall Study|Adverse Event|0|||
131041608|NCT02424617|471789260|FG003|Overall Study|Adverse Event|0|||
131041609|NCT02424617|471789257|FG000|Overall Study|Investigator Decision|0|||
131041610|NCT02424617|471789258|FG001|Overall Study|Investigator Decision|0|||
131041611|NCT02424617|471789259|FG002|Overall Study|Investigator Decision|0|||
131041612|NCT02424617|471789260|FG003|Overall Study|Investigator Decision|1|||
131041613|NCT02424617|471789257|FG000|Overall Study|Withdrawal by Subject|1|||
131041614|NCT02424617|471789258|FG001|Overall Study|Withdrawal by Subject|1|||
131041615|NCT02424617|471789259|FG002|Overall Study|Withdrawal by Subject|0|||
131041616|NCT02424617|471789260|FG003|Overall Study|Withdrawal by Subject|1|||
131041617|NCT02424617|471789257|FG000|Overall Study|Progressive Disease|7|||
130715540|NCT04498403|470586947|FG000|Overall Study|Adverse Event|1|||
130715541|NCT04498403|470586948|FG001|Overall Study|Adverse Event|0|||
130715542|NCT04498403|470586947|FG000|Overall Study|Study Terminated By Sponsor|29|||
130715543|NCT04498403|470586948|FG001|Overall Study|Study Terminated By Sponsor|10|||
130715544|NCT00599521|470586949|FG000|Overall Study|Lack of Efficacy|4|||
130715545|NCT00599521|470586950|FG001|Overall Study|Lack of Efficacy|8|||
131041618|NCT02424617|471789258|FG001|Overall Study|Progressive Disease|6|||
131041619|NCT02424617|471789259|FG002|Overall Study|Progressive Disease|11|||
131041620|NCT02424617|471789260|FG003|Overall Study|Progressive Disease|10|||
131041621|NCT02424617|471789257|FG000|Overall Study|Other|0|||
131041622|NCT02424617|471789258|FG001|Overall Study|Other|0|||
131041623|NCT02424617|471789259|FG002|Overall Study|Other|0|||
131041624|NCT02424617|471789260|FG003|Overall Study|Other|1|||
131041625|NCT02694822|471789261|FG000|Phase 1|Death|2|||
131041626|NCT02694822|471789262|FG001|Phase 1|Death|1|||
131041627|NCT02694822|471789263|FG002|Phase 1|Death|6|||
130715546|NCT00599521|470586949|FG000|Overall Study|Adverse Event|4|||
130715547|NCT00599521|470586950|FG001|Overall Study|Adverse Event|1|||
130715548|NCT00599521|470586949|FG000|Overall Study|Withdrawal by Subject|28|||
130715549|NCT00599521|470586950|FG001|Overall Study|Withdrawal by Subject|34|||
130715550|NCT00599521|470586949|FG000|Overall Study|Protocol Violation|1|||
130715551|NCT00599521|470586950|FG001|Overall Study|Protocol Violation|1|||
130715552|NCT00599521|470586949|FG000|Overall Study|Lost to Follow-up|23|||
130715553|NCT00599521|470586950|FG001|Overall Study|Lost to Follow-up|23|||
130715554|NCT00599521|470586949|FG000|Overall Study|Pregnancy|0|||
130715555|NCT00599521|470586950|FG001|Overall Study|Pregnancy|2|||
130715556|NCT01700049|470586952|FG000|Overall Study|Withdrawal by Subject|1|||
130715557|NCT01248013|470586953|FG000|Overall Study|Withdrawal by Subject|14|||
130715558|NCT00307034|470586954|FG000|Overall Study|Adverse Event|1|||
130715559|NCT00307034|470586955|FG001|Overall Study|Adverse Event|2|||
130715560|NCT00307034|470586954|FG000|Overall Study|Withdrawal by Subject|1|||
130715561|NCT00307034|470586955|FG001|Overall Study|Withdrawal by Subject|2|||
130715562|NCT00307034|470586954|FG000|Overall Study|Lost to Follow-up|0|||
130715563|NCT00307034|470586955|FG001|Overall Study|Lost to Follow-up|3|||
130715564|NCT04594707|470586956|FG000|Overall Study|Adverse Event|0|||
131041628|NCT02694822|471789264|FG003|Phase 1|Death|6|||
130715565|NCT04594707|470586957|FG001|Overall Study|Adverse Event|0|||
131041629|NCT02694822|471789265|FG004|Phase 1|Death|3|||
130715566|NCT04594707|470586958|FG002|Overall Study|Adverse Event|1|||
130715567|NCT04594707|470586956|FG000|Overall Study|Death|0|||
130715568|NCT04594707|470586957|FG001|Overall Study|Death|2|||
130715569|NCT04594707|470586958|FG002|Overall Study|Death|2|||
130715570|NCT04594707|470586956|FG000|Overall Study|Lung Transplant|0|||
130715571|NCT04594707|470586957|FG001|Overall Study|Lung Transplant|0|||
131041630|NCT02694822|471789266|FG005|Phase 1|Death|0|||
131041631|NCT02694822|471789261|FG000|Phase 1|Withdrawal by Subject|2|||
131041632|NCT02694822|471789262|FG001|Phase 1|Withdrawal by Subject|2|||
130775205|NCT00685360|470804475|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
130775206|NCT00685360|470804473|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
130775207|NCT00685360|470804474|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
130775208|NCT00685360|470804475|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
130775209|NCT00685360|470804473|FG000|Overall Study|Protocol Deviation|0|||
130775210|NCT00685360|470804474|FG001|Overall Study|Protocol Deviation|1|||
130964453|NCT05282004|471497034|FG000|Overall Study|Adverse Event|2|||
130964454|NCT00889421|471497035|FG000|Overall Study|Lack of Efficacy|3|||
130964455|NCT01958918|471497036|FG000|Overall Study|Death|1|||
130964456|NCT01958918|471497037|FG001|Overall Study|Death|3|||
130964457|NCT01958918|471497036|FG000|Overall Study|Lost to Follow-up|4|||
130964458|NCT01958918|471497037|FG001|Overall Study|Lost to Follow-up|7|||
130964459|NCT01958918|471497036|FG000|Overall Study|Withdrawal by Subject|13|||
130964460|NCT01958918|471497037|FG001|Overall Study|Withdrawal by Subject|8|||
130964461|NCT01958918|471497036|FG000|Overall Study|Lack of Efficacy|13|||
130964462|NCT01958918|471497037|FG001|Overall Study|Lack of Efficacy|10|||
130964463|NCT01958918|471497036|FG000|Overall Study|Adverse Event|12|||
130964464|NCT01958918|471497037|FG001|Overall Study|Adverse Event|12|||
130964465|NCT01958918|471497036|FG000|Overall Study|administrative problems|0|||
130964466|NCT01958918|471497037|FG001|Overall Study|administrative problems|2|||
130715572|NCT04594707|470586958|FG002|Overall Study|Lung Transplant|1|||
130715573|NCT04594707|470586956|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
130715574|NCT04594707|470586957|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
130715575|NCT04594707|470586958|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
130715576|NCT04594707|470586956|FG000|Overall Study|Study Terminated By Sponsor|19|||
130715577|NCT04594707|470586957|FG001|Overall Study|Study Terminated By Sponsor|47|||
130715578|NCT04594707|470586958|FG002|Overall Study|Study Terminated By Sponsor|41|||
130715579|NCT04594707|470586956|FG000|Overall Study|Withdrawal by Subject|1|||
130964467|NCT02013765|471497041|FG000|Overall Study|Trial was terminated by sponsor|1|||
130964468|NCT00659269|471497042|FG000|Overall Study|Physician Decision|1|||
130964469|NCT00659269|471497043|FG001|Overall Study|Physician Decision|1|||
130964470|NCT01158222|471497044|FG000|Overall Study|Not eligible for intermediate phase|17|||
130964471|NCT00718042|471497045|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
130964472|NCT00718042|471497046|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
130715580|NCT04594707|470586957|FG001|Overall Study|Withdrawal by Subject|0|||
130964473|NCT00718042|471497047|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
130964474|NCT00718042|471497048|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
130964475|NCT00718042|471497049|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
130964476|NCT00718042|471497050|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
130964477|NCT00718042|471497045|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
130964478|NCT00718042|471497046|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
130964479|NCT00718042|471497047|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
130964480|NCT00718042|471497048|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
130964481|NCT00718042|471497049|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
130964482|NCT00718042|471497050|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
130964483|NCT00718042|471497045|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
130964484|NCT00718042|471497046|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
130964485|NCT00718042|471497047|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
130964486|NCT00718042|471497048|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
130964487|NCT00718042|471497049|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
130964488|NCT00718042|471497050|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
130964489|NCT00718042|471497045|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
130964490|NCT00718042|471497046|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
130964491|NCT00718042|471497047|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
130964492|NCT00718042|471497048|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
130964493|NCT00718042|471497049|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
130964494|NCT00718042|471497050|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
130964495|NCT00718042|471497045|FG000|Donor Follow-up|Lost to Follow-up|13|||
130964496|NCT00718042|471497046|FG001|Donor Follow-up|Lost to Follow-up|0|||
130964497|NCT00718042|471497047|FG002|Donor Follow-up|Lost to Follow-up|0|||
130964498|NCT00718042|471497048|FG003|Donor Follow-up|Lost to Follow-up|0|||
130964499|NCT00718042|471497049|FG004|Donor Follow-up|Lost to Follow-up|19|||
130964500|NCT00718042|471497050|FG005|Donor Follow-up|Lost to Follow-up|0|||
130964501|NCT02443298|471497051|FG000|Overall Study|Adverse Event|3|||
130964502|NCT02443298|471497052|FG001|Overall Study|Adverse Event|3|||
130964503|NCT02443298|471497051|FG000|Overall Study|Withdrawal by Subject|1|||
130964504|NCT02443298|471497052|FG001|Overall Study|Withdrawal by Subject|2|||
130964505|NCT02464969|471497053|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
130964506|NCT02464969|471497054|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
130964507|NCT02464969|471497053|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
130964508|NCT02464969|471497054|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
130964509|NCT02464969|471497053|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
130964510|NCT02464969|471497054|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
130775211|NCT00685360|470804475|FG002|Overall Study|Protocol Deviation|1|||
130775212|NCT04865419|470804476|FG000|Overall Study|Other|1|||
130775213|NCT04865419|470804477|FG001|Overall Study|Other|2|||
130775214|NCT04865419|470804478|FG002|Overall Study|Other|2|||
130775215|NCT04865419|470804479|FG003|Overall Study|Other|1|||
130775216|NCT04865419|470804480|FG004|Overall Study|Other|3|||
130775217|NCT04865419|470804481|FG005|Overall Study|Other|0|||
130775218|NCT04865419|470804482|FG006|Overall Study|Other|0|||
130775219|NCT04865419|470804483|FG007|Overall Study|Other|1|||
130775220|NCT04865419|470804484|FG008|Overall Study|Other|0|||
130775221|NCT04865419|470804485|FG009|Overall Study|Other|0|||
130775222|NCT04865419|470804486|FG010|Overall Study|Other|0|||
130775223|NCT04865419|470804476|FG000|Overall Study|Withdrawal by Subject|0|||
130775224|NCT04865419|470804477|FG001|Overall Study|Withdrawal by Subject|1|||
130775225|NCT04865419|470804478|FG002|Overall Study|Withdrawal by Subject|1|||
130775226|NCT04865419|470804479|FG003|Overall Study|Withdrawal by Subject|0|||
130775227|NCT04865419|470804480|FG004|Overall Study|Withdrawal by Subject|0|||
130775228|NCT04865419|470804481|FG005|Overall Study|Withdrawal by Subject|0|||
130775229|NCT04865419|470804482|FG006|Overall Study|Withdrawal by Subject|0|||
130775230|NCT04865419|470804483|FG007|Overall Study|Withdrawal by Subject|1|||
130775231|NCT04865419|470804484|FG008|Overall Study|Withdrawal by Subject|2|||
130775232|NCT04865419|470804485|FG009|Overall Study|Withdrawal by Subject|1|||
130775233|NCT04865419|470804486|FG010|Overall Study|Withdrawal by Subject|0|||
130775234|NCT04865419|470804476|FG000|Overall Study|Study terminated by Sponsor|0|||
130775235|NCT04865419|470804477|FG001|Overall Study|Study terminated by Sponsor|0|||
130775236|NCT04865419|470804478|FG002|Overall Study|Study terminated by Sponsor|0|||
130775237|NCT04865419|470804479|FG003|Overall Study|Study terminated by Sponsor|2|||
130964511|NCT02464969|471497053|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
130964512|NCT02464969|471497054|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
130964513|NCT02464969|471497053|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
130964514|NCT02464969|471497054|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
130775238|NCT04865419|470804480|FG004|Overall Study|Study terminated by Sponsor|2|||
130775239|NCT04865419|470804481|FG005|Overall Study|Study terminated by Sponsor|0|||
130775240|NCT04865419|470804482|FG006|Overall Study|Study terminated by Sponsor|0|||
130775241|NCT04865419|470804483|FG007|Overall Study|Study terminated by Sponsor|0|||
130775242|NCT04865419|470804484|FG008|Overall Study|Study terminated by Sponsor|0|||
130775243|NCT04865419|470804485|FG009|Overall Study|Study terminated by Sponsor|0|||
130964515|NCT02464969|471497053|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
130964516|NCT02464969|471497054|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
130964517|NCT02464969|471497053|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
130964518|NCT02464969|471497054|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
130964519|NCT02464969|471497053|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
130964520|NCT02464969|471497054|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
130964521|NCT02464969|471497053|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
130964522|NCT02464969|471497054|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
130964523|NCT02464969|471497053|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
130964524|NCT02464969|471497054|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
130964525|NCT02464969|471497053|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
130964526|NCT02464969|471497054|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
130964527|NCT02399085|471497059|FG000|Overall Study|Adverse Event|16|||
130964528|NCT02399085|471497059|FG000|Overall Study|Death|2|||
130964529|NCT02399085|471497059|FG000|Overall Study|Withdrawal by Subject|8|||
130964530|NCT02399085|471497059|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
130964531|NCT02399085|471497059|FG000|Overall Study|Physician Decision|5|||
131041633|NCT02694822|471789263|FG002|Phase 1|Withdrawal by Subject|4|||
131226821|NCT01706198|472457691|FG001|Overall Study|Physician Decision|37|||
131226822|NCT01706198|472457690|FG000|Overall Study|Withdrawal by Subject|23|||
131226823|NCT01706198|472457691|FG001|Overall Study|Withdrawal by Subject|31|||
130775244|NCT04865419|470804486|FG010|Overall Study|Study terminated by Sponsor|1|||
130775245|NCT04865419|470804476|FG000|Overall Study|Death|3|||
130775246|NCT04865419|470804477|FG001|Overall Study|Death|1|||
130775247|NCT04865419|470804478|FG002|Overall Study|Death|4|||
130775248|NCT04865419|470804479|FG003|Overall Study|Death|2|||
130775249|NCT04865419|470804480|FG004|Overall Study|Death|5|||
130775250|NCT04865419|470804481|FG005|Overall Study|Death|2|||
130964532|NCT00833924|471497060|FG000|Overall Study|Death|21|||
131041634|NCT02694822|471789264|FG003|Phase 1|Withdrawal by Subject|8|||
130964533|NCT00833924|471497060|FG000|Overall Study|Conversion|2|||
130964534|NCT00833924|471497060|FG000|Overall Study|Lost to Follow-up|2|||
131041635|NCT02694822|471789265|FG004|Phase 1|Withdrawal by Subject|1|||
130775251|NCT04865419|470804482|FG006|Overall Study|Death|1|||
130775252|NCT04865419|470804483|FG007|Overall Study|Death|1|||
130775253|NCT04865419|470804484|FG008|Overall Study|Death|2|||
130775254|NCT04865419|470804485|FG009|Overall Study|Death|2|||
130775255|NCT04865419|470804486|FG010|Overall Study|Death|1|||
130775256|NCT04865419|470804476|FG000|Overall Study|Lost to Follow-up|0|||
131226824|NCT04313283|472457692|FG000|Overall Study|did not complete intervention|4|||
131226825|NCT01473758|472457697|FG000|Cycle 1|Adverse Event|10|||
131226826|NCT01473758|472457698|FG001|Cycle 1|Adverse Event|2|||
131226827|NCT01473758|472457699|FG002|Cycle 1|Adverse Event|0|||
131226828|NCT01473758|472457700|FG003|Cycle 1|Adverse Event|0|||
131226829|NCT01473758|472457697|FG000|Cycle 1|Withdrawal by Subject|1|||
131226830|NCT01473758|472457698|FG001|Cycle 1|Withdrawal by Subject|1|||
131226831|NCT01473758|472457699|FG002|Cycle 1|Withdrawal by Subject|0|||
131226832|NCT01473758|472457700|FG003|Cycle 1|Withdrawal by Subject|0|||
131226833|NCT01473758|472457697|FG000|Cycle 2|Adverse Event|0|||
131226834|NCT01473758|472457698|FG001|Cycle 2|Adverse Event|0|||
131226835|NCT01473758|472457699|FG002|Cycle 2|Adverse Event|5|||
131226836|NCT01473758|472457700|FG003|Cycle 2|Adverse Event|0|||
131226837|NCT02480010|472457701|FG000|Overall Study|Adverse Event|3|||
131226838|NCT02480010|472457702|FG001|Overall Study|Adverse Event|1|||
131226839|NCT02480010|472457701|FG000|Overall Study|Death|1|||
131226840|NCT02480010|472457702|FG001|Overall Study|Death|0|||
131226841|NCT02480010|472457701|FG000|Overall Study|Insufficient therapeutic response|31|||
131226842|NCT02480010|472457702|FG001|Overall Study|Insufficient therapeutic response|29|||
131226843|NCT02480010|472457701|FG000|Overall Study|Refused Treatment|0|||
131226844|NCT02480010|472457702|FG001|Overall Study|Refused Treatment|3|||
131226845|NCT00606684|472457712|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
131226846|NCT00606684|472457713|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131226847|NCT00606684|472457714|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131226848|NCT00606684|472457715|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131226849|NCT00606684|472457716|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131226850|NCT00606684|472457717|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131226851|NCT00606684|472457718|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
131226852|NCT00606684|472457712|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
131226853|NCT00606684|472457713|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131226854|NCT00606684|472457714|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131226855|NCT00606684|472457715|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131226856|NCT00606684|472457716|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131226857|NCT00606684|472457717|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131226858|NCT00606684|472457718|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
131226859|NCT00606684|472457712|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
131226860|NCT00606684|472457713|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
131226861|NCT00606684|472457714|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
131226862|NCT00606684|472457715|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
131226863|NCT00606684|472457716|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
131226864|NCT00606684|472457717|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
130715581|NCT04594707|470586958|FG002|Overall Study|Withdrawal by Subject|2|||
130715582|NCT01593696|470586959|FG000|Dose Escalation|Progressive Disease|2|||
130715583|NCT01593696|470586960|FG001|Dose Escalation|Progressive Disease|0|||
130715584|NCT01593696|470586961|FG002|Dose Escalation|Progressive Disease|0|||
130715585|NCT01593696|470586962|FG003|Dose Escalation|Progressive Disease|0|||
130715586|NCT01593696|470586959|FG000|Dose Expansion|Fungal infection|0|||
130715587|NCT01593696|470586960|FG001|Dose Expansion|Fungal infection|0|||
130715588|NCT01593696|470586961|FG002|Dose Expansion|Fungal infection|1|||
130715589|NCT01593696|470586962|FG003|Dose Expansion|Fungal infection|0|||
130715590|NCT01936623|470586963|FG000|Overall Study|Lost to Follow-up|0|||
130715591|NCT01936623|470586964|FG001|Overall Study|Lost to Follow-up|5|||
130715592|NCT01340768|470586965|FG000|Overall Study|Lost to Follow-up|10|||
130715593|NCT01340768|470586966|FG001|Overall Study|Lost to Follow-up|4|||
130715594|NCT01340768|470586965|FG000|Overall Study|Withdrawal by Subject|5|||
130715595|NCT01340768|470586966|FG001|Overall Study|Withdrawal by Subject|1|||
130715596|NCT01340768|470586965|FG000|Overall Study|Other|2|||
130715597|NCT01340768|470586966|FG001|Overall Study|Other|0|||
130715598|NCT03052959|470586971|FG000|Overall Study|Lost to Follow-up|4|||
130715599|NCT03052959|470586972|FG001|Overall Study|Lost to Follow-up|5|||
130715600|NCT00950963|470586973|FG000|Overall Study|Lost to Follow-up|29|||
130715601|NCT00950963|470586974|FG001|Overall Study|Lost to Follow-up|24|||
130715602|NCT00655876|470586975|FG000|Overall Study|Protocol Violation|9|||
130715603|NCT00655876|470586976|FG001|Overall Study|Protocol Violation|7|||
130715604|NCT01831765|470586977|FG000|Overall Study|Lack of Efficacy|1|||
130715605|NCT01831765|470586978|FG001|Overall Study|Lack of Efficacy|0|||
130715606|NCT01831765|470586979|FG002|Overall Study|Lack of Efficacy|0|||
130715607|NCT01831765|470586977|FG000|Overall Study|Other, sponsor withdrew subject|0|||
130715608|NCT01831765|470586978|FG001|Overall Study|Other, sponsor withdrew subject|1|||
131226865|NCT00606684|472457718|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
131226866|NCT00606684|472457712|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
130715609|NCT01831765|470586979|FG002|Overall Study|Other, sponsor withdrew subject|0|||
130715610|NCT01831765|470586977|FG000|Overall Study|Pregnancy|1|||
131226867|NCT00606684|472457713|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
131226868|NCT00606684|472457714|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130715611|NCT01831765|470586978|FG001|Overall Study|Pregnancy|1|||
130775257|NCT04865419|470804477|FG001|Overall Study|Lost to Follow-up|0|||
130775258|NCT04865419|470804478|FG002|Overall Study|Lost to Follow-up|0|||
130775259|NCT04865419|470804479|FG003|Overall Study|Lost to Follow-up|0|||
130775260|NCT04865419|470804480|FG004|Overall Study|Lost to Follow-up|0|||
130775261|NCT04865419|470804481|FG005|Overall Study|Lost to Follow-up|0|||
130775262|NCT04865419|470804482|FG006|Overall Study|Lost to Follow-up|0|||
130775263|NCT04865419|470804483|FG007|Overall Study|Lost to Follow-up|0|||
130775264|NCT04865419|470804484|FG008|Overall Study|Lost to Follow-up|0|||
130775265|NCT04865419|470804485|FG009|Overall Study|Lost to Follow-up|1|||
130775266|NCT04865419|470804486|FG010|Overall Study|Lost to Follow-up|0|||
130775267|NCT00547157|470804487|FG000|Overall Study|Other|1|||
130775268|NCT00547157|470804488|FG001|Overall Study|Other|0|||
130775269|NCT00547157|470804487|FG000|Overall Study|Death|38|||
130964535|NCT00833924|471497060|FG000|Overall Study|Withdrawal by Subject|13|||
130964536|NCT00833924|471497060|FG000|Overall Study|In study follow-up|71|||
130964537|NCT03732248|471497061|FG000|Overall Study|Withdrawal by Subject|1|||
130964538|NCT03732248|471497062|FG001|Overall Study|Withdrawal by Subject|0|||
130964539|NCT01525082|471497067|FG000|Overall Study|Death|1|||
130964540|NCT02543346|471497072|FG000|Second Priming Visit|Withdrawal by Subject|0|||
131226869|NCT00606684|472457715|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130715612|NCT01831765|470586979|FG002|Overall Study|Pregnancy|2|||
130715613|NCT01831765|470586977|FG000|Overall Study|Death|0|||
130715614|NCT01831765|470586978|FG001|Overall Study|Death|1|||
130715615|NCT01831765|470586979|FG002|Overall Study|Death|1|||
130715616|NCT01831765|470586977|FG000|Overall Study|Other, site closed|1|||
130715617|NCT01831765|470586978|FG001|Overall Study|Other, site closed|1|||
130715618|NCT01831765|470586979|FG002|Overall Study|Other, site closed|0|||
130715619|NCT01831765|470586977|FG000|Overall Study|Adverse Event|5|||
130715620|NCT01831765|470586978|FG001|Overall Study|Adverse Event|3|||
130715621|NCT01831765|470586979|FG002|Overall Study|Adverse Event|3|||
130715622|NCT01831765|470586977|FG000|Overall Study|Withdrawal by Subject|22|||
130715623|NCT01831765|470586978|FG001|Overall Study|Withdrawal by Subject|7|||
130715624|NCT01831765|470586979|FG002|Overall Study|Withdrawal by Subject|17|||
130715625|NCT01831765|470586977|FG000|Overall Study|Withdrawal criteria|12|||
130715626|NCT01831765|470586978|FG001|Overall Study|Withdrawal criteria|10|||
130715627|NCT01831765|470586979|FG002|Overall Study|Withdrawal criteria|16|||
130715628|NCT01831765|470586977|FG000|Overall Study|Lost to Follow-up|2|||
130715629|NCT01831765|470586978|FG001|Overall Study|Lost to Follow-up|3|||
130715630|NCT01831765|470586979|FG002|Overall Study|Lost to Follow-up|3|||
130715631|NCT00859586|470586980|FG000|Overall Study|Donors|4|||
130715632|NCT00706511|470586981|FG000|Overall Study|Withdrawal by Subject|1|||
130715633|NCT00706511|470586982|FG001|Overall Study|Withdrawal by Subject|0|||
130715634|NCT00706511|470586983|FG002|Overall Study|Withdrawal by Subject|0|||
130715635|NCT00706511|470586984|FG003|Overall Study|Withdrawal by Subject|0|||
130715636|NCT01732484|470586987|FG000|Overall Study|Death|7|||
130715637|NCT01732484|470586987|FG000|Overall Study|Lost to Follow-up|14|||
130715638|NCT01732484|470586987|FG000|Overall Study|chronical illness|5|||
130715639|NCT01087489|470586988|FG000|Overall Study|enrolled in another VA study|0|||
130715640|NCT01087489|470586989|FG001|Overall Study|enrolled in another VA study|1|||
130715641|NCT01087489|470586988|FG000|Overall Study|Death|0|||
130715642|NCT01087489|470586989|FG001|Overall Study|Death|1|||
130715643|NCT01087489|470586988|FG000|Overall Study|unable to survey by telephone|0|||
130715644|NCT01087489|470586989|FG001|Overall Study|unable to survey by telephone|1|||
130715645|NCT00928707|470586990|FG000|Overall Study|Protocol Violation|1|||
130715646|NCT00928707|470586991|FG001|Overall Study|Protocol Violation|0|||
130715647|NCT00132028|470586992|FG000|Overall Study|Adverse Event|7|||
130715648|NCT00132028|470586992|FG000|Overall Study|Death|2|||
130715649|NCT00132028|470586992|FG000|Overall Study|Lack of Efficacy|11|||
130715650|NCT00132028|470586992|FG000|Overall Study|Withdrawal by Subject|2|||
130715651|NCT00132028|470586992|FG000|Overall Study|not eligible|2|||
130715652|NCT00132028|470586992|FG000|Overall Study|Physician Decision|3|||
130715653|NCT02731326|470586993|FG000|Overall Study|Withdrawal by Subject|4|||
130715654|NCT02731326|470586994|FG001|Overall Study|Withdrawal by Subject|1|||
130715655|NCT02731326|470586993|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
130775270|NCT00547157|470804488|FG001|Overall Study|Death|18|||
130715656|NCT02731326|470586994|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
130715657|NCT02731326|470586993|FG000|Overall Study|Discharged without AliveCor|10|||
130715658|NCT02731326|470586994|FG001|Overall Study|Discharged without AliveCor|0|||
130715659|NCT02731326|470586993|FG000|Overall Study|Duplicate Participant|1|||
130715660|NCT02731326|470586994|FG001|Overall Study|Duplicate Participant|1|||
130715661|NCT02272634|470586996|FG000|Overall Study|Adverse Event|1|||
130715662|NCT02272634|470586997|FG001|Overall Study|Adverse Event|0|||
130715663|NCT02272634|470586998|FG002|Overall Study|Adverse Event|0|||
130964541|NCT02543346|471497073|FG001|Second Priming Visit|Withdrawal by Subject|2|||
130775271|NCT00547157|470804487|FG000|Overall Study|Withdrawal by Subject|3|||
130775272|NCT00547157|470804488|FG001|Overall Study|Withdrawal by Subject|1|||
130964542|NCT02543346|471497074|FG002|Second Priming Visit|Withdrawal by Subject|2|||
130715664|NCT02272634|470586996|FG000|Overall Study|Protocol Violation|0|||
130775273|NCT00547157|470804487|FG000|Overall Study|Administrative decision|3|||
130775274|NCT00547157|470804488|FG001|Overall Study|Administrative decision|2|||
130775275|NCT00547157|470804487|FG000|Overall Study|Lost to Follow-up|4|||
130964543|NCT02543346|471497075|FG003|Second Priming Visit|Withdrawal by Subject|2|||
130964544|NCT02543346|471497072|FG000|Second Priming Visit|Adverse Event|1|||
130775276|NCT00547157|470804488|FG001|Overall Study|Lost to Follow-up|2|||
130775277|NCT05464420|470804489|FG000|Overall Study|Death|0|||
130964545|NCT02543346|471497073|FG001|Second Priming Visit|Adverse Event|0|||
130964546|NCT02543346|471497074|FG002|Second Priming Visit|Adverse Event|0|||
130964547|NCT02543346|471497075|FG003|Second Priming Visit|Adverse Event|0|||
130964548|NCT01767116|471497076|FG000|Overall Study|Lost to Follow-up|2|||
130964549|NCT01767116|471497077|FG001|Overall Study|Lost to Follow-up|2|||
130964550|NCT02141516|471497082|FG000|Overall Study|Adverse Event|0|||
130775278|NCT05464420|470804490|FG001|Overall Study|Death|0|||
130775279|NCT05464420|470804491|FG002|Overall Study|Death|0|||
130775280|NCT05464420|470804492|FG003|Overall Study|Death|1|||
130775281|NCT05464420|470804489|FG000|Overall Study|Lost to Follow-up|16|||
130775282|NCT05464420|470804490|FG001|Overall Study|Lost to Follow-up|11|||
130775283|NCT05464420|470804491|FG002|Overall Study|Lost to Follow-up|11|||
130775284|NCT05464420|470804492|FG003|Overall Study|Lost to Follow-up|11|||
130775285|NCT05464420|470804489|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
130775286|NCT05464420|470804490|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
130775287|NCT05464420|470804491|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
130775288|NCT05464420|470804492|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
130964551|NCT02141516|471497083|FG001|Overall Study|Adverse Event|1|||
130964552|NCT02141516|471497084|FG002|Overall Study|Adverse Event|0|||
130775289|NCT05464420|470804489|FG000|Overall Study|Withdrawal by Subject|4|||
130775290|NCT05464420|470804490|FG001|Overall Study|Withdrawal by Subject|8|||
130775291|NCT05464420|470804491|FG002|Overall Study|Withdrawal by Subject|3|||
130775292|NCT05464420|470804492|FG003|Overall Study|Withdrawal by Subject|1|||
130775293|NCT05464420|470804489|FG000|Overall Study|Protocol Violation|0|||
130775294|NCT05464420|470804490|FG001|Overall Study|Protocol Violation|0|||
130775295|NCT05464420|470804491|FG002|Overall Study|Protocol Violation|1|||
130775296|NCT05464420|470804492|FG003|Overall Study|Protocol Violation|1|||
130775297|NCT05464420|470804489|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
130775298|NCT05464420|470804490|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
130775299|NCT05464420|470804491|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
130775300|NCT05464420|470804492|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
130775301|NCT01383018|470804493|FG000|Overall Study|Adverse Event|14|||
130775302|NCT01383018|470804493|FG000|Overall Study|Death|10|||
130964553|NCT02141516|471497082|FG000|Overall Study|Lost to Follow-up|0|||
130964554|NCT02141516|471497083|FG001|Overall Study|Lost to Follow-up|1|||
130964555|NCT02141516|471497084|FG002|Overall Study|Lost to Follow-up|0|||
130964556|NCT02141516|471497082|FG000|Overall Study|Other|0|||
130964557|NCT02141516|471497083|FG001|Overall Study|Other|3|||
130964558|NCT02141516|471497084|FG002|Overall Study|Other|0|||
130964559|NCT01440946|471497085|FG000|Overall Study|Lost to Follow-up|1|||
130964560|NCT01440946|471497086|FG001|Overall Study|Lost to Follow-up|1|||
130964561|NCT01440946|471497085|FG000|Overall Study|Physician Decision|1|||
130964562|NCT01440946|471497086|FG001|Overall Study|Physician Decision|0|||
130964563|NCT01975389|471497087|FG000|Overall Study|Adverse Event|10|||
130964564|NCT01975389|471497088|FG001|Overall Study|Adverse Event|6|||
130964565|NCT01975389|471497087|FG000|Overall Study|Death|61|||
130964566|NCT01975389|471497088|FG001|Overall Study|Death|54|||
130964567|NCT01975389|471497087|FG000|Overall Study|Lost to Follow-up|81|||
130964568|NCT01975389|471497088|FG001|Overall Study|Lost to Follow-up|86|||
130964569|NCT01975389|471497087|FG000|Overall Study|Withdrawal by Subject|90|||
130964570|NCT01975389|471497088|FG001|Overall Study|Withdrawal by Subject|76|||
130964571|NCT01975389|471497087|FG000|Overall Study|Other|6|||
130775303|NCT01383018|470804493|FG000|Overall Study|Lost to Follow-up|5|||
130775304|NCT01383018|470804493|FG000|Overall Study|Physician Decision|5|||
130964572|NCT01975389|471497088|FG001|Overall Study|Other|9|||
130964573|NCT01975389|471497087|FG000|Overall Study|Randomized, not treated|4|||
130964574|NCT01975389|471497088|FG001|Overall Study|Randomized, not treated|5|||
130964575|NCT03299192|471497089|FG000|Overall Study|Fell before classes started|1|||
130964576|NCT03299192|471497090|FG001|Overall Study|Fell before classes started|0|||
130964577|NCT03299192|471497091|FG002|Overall Study|Fell before classes started|0|||
130964578|NCT03299192|471497089|FG000|Overall Study|Other|0|||
130964579|NCT03299192|471497090|FG001|Overall Study|Other|2|||
130964580|NCT03299192|471497091|FG002|Overall Study|Other|1|||
130964581|NCT00235989|471497097|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
131127758|NCT02831673|472097601|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
131127759|NCT02831673|472097602|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
130964582|NCT00235989|471497098|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
130964583|NCT00235989|471497099|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
130964584|NCT00235989|471497100|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
130964585|NCT00235989|471497101|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
130964586|NCT00235989|471497102|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
130715665|NCT02272634|470586997|FG001|Overall Study|Protocol Violation|0|||
130715666|NCT02272634|470586998|FG002|Overall Study|Protocol Violation|1|||
130715667|NCT02272634|470586996|FG000|Overall Study|Withdrawal by Subject|0|||
130964587|NCT00235989|471497097|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
130964588|NCT00235989|471497098|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
130964589|NCT00235989|471497099|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
130964590|NCT00235989|471497100|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
130964591|NCT00235989|471497101|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
130964592|NCT00235989|471497102|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
130964593|NCT00235989|471497097|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
130964594|NCT00235989|471497098|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
130964595|NCT00235989|471497099|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
130964596|NCT00235989|471497100|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
130964597|NCT00235989|471497101|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
130964598|NCT00235989|471497102|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
130964599|NCT00235989|471497097|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
130964600|NCT00235989|471497098|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
130964601|NCT00235989|471497099|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
130964602|NCT00235989|471497100|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
130964603|NCT00235989|471497101|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
130964604|NCT00235989|471497102|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
130964605|NCT00235989|471497097|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
130964606|NCT00235989|471497098|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
130964607|NCT00235989|471497099|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
130964608|NCT00235989|471497100|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
130964609|NCT00235989|471497101|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
130964610|NCT00235989|471497102|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
130964611|NCT00983580|471497104|FG000|Overall Study|Cancel Prior to treatment|1|||
130964612|NCT00983580|471497105|FG001|Overall Study|Cancel Prior to treatment|3|||
130964613|NCT00983580|471497104|FG000|Overall Study|Protocol Violation|1|||
130964614|NCT00983580|471497105|FG001|Overall Study|Protocol Violation|1|||
130964615|NCT00983580|471497104|FG000|Overall Study|Ineligible|3|||
130964616|NCT00983580|471497105|FG001|Overall Study|Ineligible|0|||
130964617|NCT02316717|471497110|FG000|Overall Study|Adverse Event|2|||
130964618|NCT02316717|471497111|FG001|Overall Study|Adverse Event|2|||
130964619|NCT02316717|471497112|FG002|Overall Study|Adverse Event|0|||
130964620|NCT02316717|471497110|FG000|Overall Study|Lost to Follow-up|1|||
130715668|NCT02272634|470586997|FG001|Overall Study|Withdrawal by Subject|1|||
130715669|NCT02272634|470586998|FG002|Overall Study|Withdrawal by Subject|0|||
130715670|NCT04647721|470586999|FG000|Overall Study|Withdrawal by Subject|0|||
130715671|NCT04647721|470587000|FG001|Overall Study|Withdrawal by Subject|2|||
130964621|NCT02316717|471497111|FG001|Overall Study|Lost to Follow-up|2|||
130964622|NCT02316717|471497112|FG002|Overall Study|Lost to Follow-up|1|||
130964623|NCT02316717|471497110|FG000|Overall Study|Non compliance|3|||
130964624|NCT02316717|471497111|FG001|Overall Study|Non compliance|1|||
130964625|NCT02316717|471497112|FG002|Overall Study|Non compliance|0|||
130964626|NCT02316717|471497110|FG000|Overall Study|Protocol Violation|2|||
130964627|NCT02316717|471497111|FG001|Overall Study|Protocol Violation|0|||
130964628|NCT02316717|471497112|FG002|Overall Study|Protocol Violation|0|||
130964629|NCT02316717|471497110|FG000|Overall Study|Withdrawal by Subject|2|||
130964630|NCT02316717|471497111|FG001|Overall Study|Withdrawal by Subject|1|||
131041636|NCT02694822|471789266|FG005|Phase 1|Withdrawal by Subject|0|||
131041637|NCT02694822|471789261|FG000|Phase 2|Death|0|||
131041638|NCT02694822|471789262|FG001|Phase 2|Death|0|||
131041639|NCT02694822|471789263|FG002|Phase 2|Death|0|||
131041640|NCT02694822|471789264|FG003|Phase 2|Death|0|||
131041641|NCT02694822|471789265|FG004|Phase 2|Death|0|||
131041642|NCT02694822|471789266|FG005|Phase 2|Death|26|||
131041643|NCT02694822|471789261|FG000|Phase 2|Withdrawal by Subject|0|||
131041644|NCT02694822|471789262|FG001|Phase 2|Withdrawal by Subject|0|||
131041645|NCT02694822|471789263|FG002|Phase 2|Withdrawal by Subject|0|||
131041646|NCT02694822|471789264|FG003|Phase 2|Withdrawal by Subject|0|||
131041647|NCT02694822|471789265|FG004|Phase 2|Withdrawal by Subject|0|||
131041648|NCT02694822|471789266|FG005|Phase 2|Withdrawal by Subject|13|||
131041649|NCT02694822|471789261|FG000|Phase 2|Administrative Study Closure|0|||
131041650|NCT02694822|471789262|FG001|Phase 2|Administrative Study Closure|0|||
131041651|NCT02694822|471789263|FG002|Phase 2|Administrative Study Closure|0|||
131041652|NCT02694822|471789264|FG003|Phase 2|Administrative Study Closure|0|||
131041653|NCT02694822|471789265|FG004|Phase 2|Administrative Study Closure|0|||
131041654|NCT02694822|471789266|FG005|Phase 2|Administrative Study Closure|2|||
131041655|NCT02694822|471789261|FG000|Phase 2|Lost to Follow-up|0|||
131041656|NCT02694822|471789262|FG001|Phase 2|Lost to Follow-up|0|||
131041657|NCT02694822|471789263|FG002|Phase 2|Lost to Follow-up|0|||
131041658|NCT02694822|471789264|FG003|Phase 2|Lost to Follow-up|0|||
131041659|NCT02694822|471789265|FG004|Phase 2|Lost to Follow-up|0|||
130964631|NCT02316717|471497112|FG002|Overall Study|Withdrawal by Subject|1|||
130964632|NCT02316717|471497110|FG000|Overall Study|Death|0|||
130964633|NCT02316717|471497111|FG001|Overall Study|Death|0|||
130964634|NCT02316717|471497112|FG002|Overall Study|Death|1|||
130964635|NCT02316717|471497110|FG000|Overall Study|Physician Decision|0|||
130964636|NCT02316717|471497111|FG001|Overall Study|Physician Decision|1|||
130964637|NCT02316717|471497112|FG002|Overall Study|Physician Decision|0|||
130964638|NCT02316717|471497110|FG000|Overall Study|TBC|1|||
130964639|NCT02316717|471497111|FG001|Overall Study|TBC|0|||
130964640|NCT02316717|471497112|FG002|Overall Study|TBC|0|||
130964641|NCT04122443|471497113|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
130964642|NCT04122443|471497114|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
130964643|NCT04122443|471497115|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
130964644|NCT04122443|471497113|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
130964645|NCT04122443|471497114|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
130964646|NCT04122443|471497115|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
130964647|NCT00298831|471497116|FG000|Overall Study|Adverse Event|1|||
130964648|NCT00298831|471497116|FG000|Overall Study|Lost to Follow-up|3|||
130964649|NCT00298831|471497116|FG000|Overall Study|Withdrawal by Subject|1|||
130964650|NCT00298831|471497116|FG000|Overall Study|Participants did not receive treatment|27|||
130964651|NCT01072201|471497117|FG000|Overall Study|Lost to Follow-up|0|||
130964652|NCT01072201|471497118|FG001|Overall Study|Lost to Follow-up|1|||
130964653|NCT00360334|471497119|FG000|Overall Study|Adverse Event|7|||
130964654|NCT00360334|471497120|FG001|Overall Study|Adverse Event|4|||
130964655|NCT00360334|471497119|FG000|Overall Study|Protocol Violation|1|||
130964656|NCT00360334|471497120|FG001|Overall Study|Protocol Violation|1|||
130964657|NCT00360334|471497119|FG000|Overall Study|Physician Decision|2|||
130964658|NCT00360334|471497120|FG001|Overall Study|Physician Decision|3|||
130964659|NCT00360334|471497119|FG000|Overall Study|Lack of Efficacy|0|||
130964660|NCT00360334|471497120|FG001|Overall Study|Lack of Efficacy|1|||
130964661|NCT00360334|471497119|FG000|Overall Study|Entry criterion not met|1|||
130964662|NCT00360334|471497120|FG001|Overall Study|Entry criterion not met|2|||
130964663|NCT00360334|471497119|FG000|Overall Study|Subject decision|8|||
130964664|NCT00360334|471497120|FG001|Overall Study|Subject decision|2|||
130964665|NCT00595582|471497121|FG000|Overall Study|Pilot study that PI terminated|2|||
130964666|NCT00595582|471497121|FG000|Overall Study|Lost to Follow-up|1|||
130964667|NCT00595582|471497121|FG000|Overall Study|Adverse Event|2|||
130964668|NCT00595582|471497121|FG000|Overall Study|Physician Decision|5|||
130964669|NCT01978184|471497123|FG000|Overall Study|Progressive disease|5|||
130964670|NCT01978184|471497124|FG001|Overall Study|Progressive disease|5|||
130964671|NCT01978184|471497123|FG000|Overall Study|Other than PDA|2|||
130964672|NCT01978184|471497124|FG001|Overall Study|Other than PDA|2|||
130964673|NCT01978184|471497123|FG000|Overall Study|Physician Decision|0|||
130964674|NCT01978184|471497124|FG001|Overall Study|Physician Decision|3|||
130964675|NCT01978184|471497123|FG000|Overall Study|Noncompliance|1|||
130964676|NCT01978184|471497124|FG001|Overall Study|Noncompliance|2|||
130964677|NCT01978184|471497123|FG000|Overall Study|Death|1|||
130964678|NCT01978184|471497124|FG001|Overall Study|Death|0|||
130964679|NCT01978184|471497123|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
130964680|NCT01978184|471497124|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
130964681|NCT00691210|471497129|FG000|Overall Study|Progression of Disease|0|||
130964682|NCT00691210|471497130|FG001|Overall Study|Progression of Disease|0|||
130964683|NCT00691210|471497131|FG002|Overall Study|Progression of Disease|0|||
130964684|NCT00691210|471497132|FG003|Overall Study|Progression of Disease|2|||
130964685|NCT00691210|471497133|FG004|Overall Study|Progression of Disease|0|||
130964686|NCT00691210|471497134|FG005|Overall Study|Progression of Disease|0|||
130964687|NCT00691210|471497135|FG006|Overall Study|Progression of Disease|0|||
130964688|NCT00691210|471497136|FG007|Overall Study|Progression of Disease|0|||
130964689|NCT00691210|471497129|FG000|Overall Study|Lack of Efficacy|0|||
130964690|NCT00691210|471497130|FG001|Overall Study|Lack of Efficacy|0|||
130964691|NCT00691210|471497131|FG002|Overall Study|Lack of Efficacy|0|||
130964692|NCT00691210|471497132|FG003|Overall Study|Lack of Efficacy|1|||
130964693|NCT00691210|471497133|FG004|Overall Study|Lack of Efficacy|0|||
130964694|NCT00691210|471497134|FG005|Overall Study|Lack of Efficacy|1|||
131041660|NCT02694822|471789266|FG005|Phase 2|Lost to Follow-up|1|||
131041661|NCT02694822|471789261|FG000|Phase 2|Participant Transferred to Another Site|0|||
131041662|NCT02694822|471789262|FG001|Phase 2|Participant Transferred to Another Site|0|||
131041663|NCT02694822|471789263|FG002|Phase 2|Participant Transferred to Another Site|0|||
131041664|NCT02694822|471789264|FG003|Phase 2|Participant Transferred to Another Site|0|||
131041665|NCT02694822|471789265|FG004|Phase 2|Participant Transferred to Another Site|0|||
131041666|NCT02694822|471789266|FG005|Phase 2|Participant Transferred to Another Site|1|||
131041667|NCT01868997|471789267|FG000|Overall Study|Adverse Event|2|||
131041668|NCT01868997|471789268|FG001|Overall Study|Adverse Event|5|||
131041669|NCT01868997|471789267|FG000|Overall Study|Lack of Efficacy|2|||
131041670|NCT01868997|471789268|FG001|Overall Study|Lack of Efficacy|0|||
131041671|NCT01868997|471789267|FG000|Overall Study|Other|3|||
131041672|NCT01868997|471789268|FG001|Overall Study|Other|1|||
130964695|NCT00691210|471497135|FG006|Overall Study|Lack of Efficacy|0|||
130964696|NCT00691210|471497136|FG007|Overall Study|Lack of Efficacy|0|||
130964697|NCT01306617|471497137|FG000|Overall Study|Adverse Event|1|||
130964698|NCT01306617|471497138|FG001|Overall Study|Adverse Event|0|||
130775305|NCT01383018|470804493|FG000|Overall Study|Withdrawal by Subject|9|||
130775306|NCT01383018|470804493|FG000|Overall Study|Subject not implanted|76|||
130775307|NCT01383018|470804493|FG000|Overall Study|Missed Visit|247|||
130775308|NCT01383018|470804493|FG000|Overall Study|Site closed early-not compliance related|7|||
130775309|NCT01383018|470804493|FG000|Overall Study|Patient moved away from site|1|||
130775310|NCT01383018|470804493|FG000|Overall Study|Subject Incarcerated|1|||
130775311|NCT01765569|470804495|FG000|Period B|Withdrawal by Subject|1|||
130775312|NCT01765569|470804495|FG000|Period C|Death|1|||
130775313|NCT04533438|470804496|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
130775314|NCT04533438|470804497|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
130775315|NCT04208412|470804498|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
130775316|NCT04208412|470804499|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
130775317|NCT04208412|470804498|FG000|Overall Study|Withdrawal by Subject|1|||
130775318|NCT04208412|470804499|FG001|Overall Study|Withdrawal by Subject|0|||
130775319|NCT04208412|470804498|FG000|Overall Study|Lost to Follow-up|0|||
130775320|NCT04208412|470804499|FG001|Overall Study|Lost to Follow-up|1|||
130775321|NCT05415462|470804502|FG000|Overall Study|Death|18|||
130775322|NCT05415462|470804503|FG001|Overall Study|Death|10|||
130775323|NCT05415462|470804502|FG000|Overall Study|Lost to Follow-up|72|||
130775324|NCT05415462|470804503|FG001|Overall Study|Lost to Follow-up|64|||
130775325|NCT05415462|470804502|FG000|Overall Study|Physician Decision|5|||
130775326|NCT05415462|470804503|FG001|Overall Study|Physician Decision|5|||
130775327|NCT05415462|470804502|FG000|Overall Study|Protocol Deviation|1|||
130775328|NCT05415462|470804503|FG001|Overall Study|Protocol Deviation|0|||
130775329|NCT05415462|470804502|FG000|Overall Study|Withdrawal by Subject|129|||
130775330|NCT05415462|470804503|FG001|Overall Study|Withdrawal by Subject|101|||
130775331|NCT05415462|470804502|FG000|Overall Study|Other Than Specified|8|||
130775332|NCT05415462|470804503|FG001|Overall Study|Other Than Specified|8|||
130775333|NCT04186221|470804504|FG000|Overall Study|Death|1|||
130775334|NCT01904032|470804507|FG000|Overall Study|Adverse Event|3|||
130775335|NCT01904032|470804508|FG001|Overall Study|Adverse Event|1|||
130775336|NCT01904032|470804507|FG000|Overall Study|Lost to Follow-up|4|||
130775337|NCT01904032|470804508|FG001|Overall Study|Lost to Follow-up|2|||
130775338|NCT00531947|470804515|FG000|Overall Study|Adverse Event|5|||
130775339|NCT00531947|470804516|FG001|Overall Study|Adverse Event|10|||
130775340|NCT00531947|470804515|FG000|Overall Study|Lost to Follow-up|12|||
130775341|NCT00531947|470804516|FG001|Overall Study|Lost to Follow-up|9|||
130775342|NCT00531947|470804515|FG000|Overall Study|Withdrawal by Subject|14|||
130775343|NCT00531947|470804516|FG001|Overall Study|Withdrawal by Subject|19|||
130775344|NCT00531947|470804515|FG000|Overall Study|Protocol Violation|2|||
130775345|NCT00531947|470804516|FG001|Overall Study|Protocol Violation|1|||
130775346|NCT00531947|470804515|FG000|Overall Study|Non-Compliance|4|||
130775347|NCT00531947|470804516|FG001|Overall Study|Non-Compliance|7|||
130775348|NCT00531947|470804515|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
130775349|NCT00531947|470804516|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
130775350|NCT01087203|470804521|FG000|Overall Study|Lost to Follow-up|2|||
131226870|NCT00606684|472457716|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130775351|NCT01087203|470804522|FG001|Overall Study|Lost to Follow-up|0|||
130775352|NCT01087203|470804521|FG000|Overall Study|Withdrawal by Subject|2|||
130775353|NCT01087203|470804522|FG001|Overall Study|Withdrawal by Subject|6|||
130775354|NCT01087203|470804521|FG000|Overall Study|Lack of Efficacy|1|||
130964699|NCT01306617|471497139|FG002|Overall Study|Adverse Event|0|||
130964700|NCT01306617|471497137|FG000|Overall Study|Virologic Failure|0|||
130964701|NCT01306617|471497138|FG001|Overall Study|Virologic Failure|0|||
130964702|NCT01306617|471497139|FG002|Overall Study|Virologic Failure|5|||
130964703|NCT01306617|471497137|FG000|Overall Study|Non-compliance|0|||
130964704|NCT01306617|471497138|FG001|Overall Study|Non-compliance|1|||
130964705|NCT01306617|471497139|FG002|Overall Study|Non-compliance|0|||
130964706|NCT04028388|471497149|FG000|Overall Study|Evaluations missing|3|||
130964707|NCT04028388|471497150|FG001|Overall Study|Evaluations missing|6|||
130964708|NCT04028388|471497149|FG000|Overall Study|Not started|2|||
130964709|NCT04028388|471497150|FG001|Overall Study|Not started|0|||
130964710|NCT00555438|471497153|FG000|10 Days Post-operative|Death|4|||
130964711|NCT00555438|471497153|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
130964712|NCT01431508|471497154|FG000|Overall Study|Lack of Efficacy|1|||
130964713|NCT01431508|471497154|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
130775355|NCT01087203|470804522|FG001|Overall Study|Lack of Efficacy|2|||
130775356|NCT01087203|470804521|FG000|Overall Study|Study terminated by sponsor|27|||
130775357|NCT01087203|470804522|FG001|Overall Study|Study terminated by sponsor|27|||
130964714|NCT00129259|471497155|FG000|Overall Study|Lost to Follow-up|1|||
130964715|NCT00129259|471497156|FG001|Overall Study|Lost to Follow-up|1|||
130964716|NCT00129259|471497155|FG000|Overall Study|Withdrawal by Subject|2|||
130964717|NCT00129259|471497156|FG001|Overall Study|Withdrawal by Subject|1|||
130775358|NCT04074330|470804534|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
130775359|NCT04074330|470804535|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
130775360|NCT04074330|470804536|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
130775361|NCT04074330|470804537|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
130775362|NCT04074330|470804538|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
130775363|NCT04074330|470804539|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
130775364|NCT04074330|470804540|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
130775365|NCT04074330|470804541|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
130775366|NCT04074330|470804542|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
130775367|NCT04074330|470804543|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
130775368|NCT04074330|470804534|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130775369|NCT04074330|470804535|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130775370|NCT04074330|470804536|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130775371|NCT04074330|470804537|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
130775372|NCT04074330|470804538|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130775373|NCT04074330|470804539|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130775374|NCT04074330|470804540|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
130775375|NCT04074330|470804541|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130775376|NCT04074330|470804542|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130775377|NCT04074330|470804543|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130775378|NCT04074330|470804534|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130775379|NCT04074330|470804535|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130775380|NCT04074330|470804536|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
130775381|NCT04074330|470804537|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130775382|NCT04074330|470804538|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130775383|NCT04074330|470804539|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130775384|NCT04074330|470804540|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130775385|NCT04074330|470804541|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130775386|NCT04074330|470804542|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130775387|NCT04074330|470804543|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130775388|NCT04074330|470804534|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130775389|NCT04074330|470804535|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130775390|NCT04074330|470804536|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130775391|NCT04074330|470804537|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130775392|NCT04074330|470804538|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130775393|NCT04074330|470804539|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
130775394|NCT04074330|470804540|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130775395|NCT04074330|470804541|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
131127760|NCT02831673|472097603|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
131127761|NCT02831673|472097604|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
131127762|NCT02831673|472097600|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
131127763|NCT02831673|472097601|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
131127764|NCT02831673|472097602|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
131127765|NCT02831673|472097603|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
131127766|NCT02831673|472097604|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
131127767|NCT02831673|472097600|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
131127768|NCT02831673|472097601|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
131127769|NCT02831673|472097602|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
131127770|NCT02831673|472097603|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
131127771|NCT02831673|472097604|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
131127772|NCT02831673|472097600|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
131127773|NCT02831673|472097601|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
131127774|NCT02831673|472097602|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
131127775|NCT02831673|472097603|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
131127776|NCT02831673|472097604|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
131127777|NCT02831673|472097600|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
131127778|NCT02831673|472097601|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
131127779|NCT02831673|472097602|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
131127780|NCT02831673|472097603|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
131127781|NCT02831673|472097604|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
131127782|NCT02831673|472097600|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
131127783|NCT02831673|472097601|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
131127784|NCT02831673|472097602|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
131127785|NCT02831673|472097603|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
130715672|NCT04647721|470586999|FG000|Overall Study|Lost to Follow-up|2|||
130715673|NCT04647721|470587000|FG001|Overall Study|Lost to Follow-up|0|||
130715674|NCT05070546|470587001|FG000|Overall Study|Death|0|||
130715675|NCT05070546|470587002|FG001|Overall Study|Death|0|||
130715676|NCT05070546|470587003|FG002|Overall Study|Death|0|||
130715677|NCT05070546|470587004|FG003|Overall Study|Death|0|||
130715678|NCT05070546|470587005|FG004|Overall Study|Death|0|||
130715679|NCT05070546|470587006|FG005|Overall Study|Death|1|||
130775396|NCT04074330|470804542|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130775397|NCT04074330|470804543|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130775398|NCT04074330|470804534|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130775399|NCT04074330|470804535|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130775400|NCT04074330|470804536|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130775401|NCT04074330|470804537|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130775402|NCT04074330|470804538|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
130775403|NCT04074330|470804539|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130775404|NCT04074330|470804540|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130775405|NCT04074330|470804541|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130775406|NCT04074330|470804542|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130775407|NCT04074330|470804543|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130775408|NCT04074330|470804534|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130775409|NCT04074330|470804535|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130775410|NCT04074330|470804536|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130775411|NCT04074330|470804537|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130775412|NCT04074330|470804538|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130775413|NCT04074330|470804539|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130775414|NCT04074330|470804540|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130775415|NCT04074330|470804541|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130775416|NCT04074330|470804542|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130775417|NCT04074330|470804543|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130775418|NCT04074330|470804534|FG000|Dose Expansion (up to 42 Months)|Death|0|||
130775419|NCT04074330|470804535|FG001|Dose Expansion (up to 42 Months)|Death|0|||
130775420|NCT04074330|470804536|FG002|Dose Expansion (up to 42 Months)|Death|0|||
130775421|NCT04074330|470804537|FG003|Dose Expansion (up to 42 Months)|Death|0|||
130775422|NCT04074330|470804538|FG004|Dose Expansion (up to 42 Months)|Death|0|||
130775423|NCT04074330|470804539|FG005|Dose Expansion (up to 42 Months)|Death|0|||
130775424|NCT04074330|470804540|FG006|Dose Expansion (up to 42 Months)|Death|0|||
130775425|NCT04074330|470804541|FG007|Dose Expansion (up to 42 Months)|Death|0|||
130775426|NCT04074330|470804542|FG008|Dose Expansion (up to 42 Months)|Death|1|||
130775427|NCT04074330|470804543|FG009|Dose Expansion (up to 42 Months)|Death|0|||
130775428|NCT04074330|470804534|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130775429|NCT04074330|470804535|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130775430|NCT04074330|470804536|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130775431|NCT04074330|470804537|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130775432|NCT04074330|470804538|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130775433|NCT04074330|470804539|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130775434|NCT04074330|470804540|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130775435|NCT04074330|470804541|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130775436|NCT04074330|470804542|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
130775437|NCT04074330|470804543|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
130775438|NCT00184093|470804544|FG000|Overall Study|Adverse Event|3|||
130775439|NCT00184093|470804544|FG000|Overall Study|Lost to Follow-up|3|||
130775440|NCT00184093|470804544|FG000|Overall Study|Physician Decision|1|||
130964718|NCT00129259|471497155|FG000|Overall Study|Only available minimal phone assessments|0|||
130964719|NCT00129259|471497156|FG001|Overall Study|Only available minimal phone assessments|1|||
130964720|NCT00023452|471497157|FG000|Overall Study|Ineligible for Study|163|||
130964721|NCT00023452|471497158|FG001|Overall Study|Ineligible for Study|159|||
130964722|NCT00023452|471497157|FG000|Overall Study|Out of Window|129|||
130964723|NCT00023452|471497158|FG001|Overall Study|Out of Window|69|||
130964724|NCT00023452|471497157|FG000|Overall Study|Death|2|||
130964725|NCT00023452|471497158|FG001|Overall Study|Death|0|||
130775441|NCT00184093|470804544|FG000|Overall Study|Withdrawal by Subject|2|||
130775442|NCT05095311|470804547|FG000|Overall Study|Lost to Follow-up|7|||
130775443|NCT05095311|470804548|FG001|Overall Study|Lost to Follow-up|0|||
130775444|NCT05095311|470804549|FG002|Overall Study|Lost to Follow-up|0|||
130964726|NCT00023452|471497157|FG000|Overall Study|Withdrawal by Subject|66|||
130715680|NCT05070546|470587001|FG000|Overall Study|Lost to Follow-up|8|||
130964727|NCT00023452|471497158|FG001|Overall Study|Withdrawal by Subject|54|||
130964728|NCT00023452|471497157|FG000|Overall Study|Adverse Event|139|||
130715681|NCT05070546|470587002|FG001|Overall Study|Lost to Follow-up|2|||
130715682|NCT05070546|470587003|FG002|Overall Study|Lost to Follow-up|7|||
130715683|NCT05070546|470587004|FG003|Overall Study|Lost to Follow-up|1|||
130964729|NCT00023452|471497158|FG001|Overall Study|Adverse Event|196|||
130964730|NCT00023452|471497157|FG000|Overall Study|Lost to Follow-up|293|||
130964731|NCT00023452|471497158|FG001|Overall Study|Lost to Follow-up|60|||
130964732|NCT00023452|471497157|FG000|Overall Study|Physician Decision|49|||
130964733|NCT00023452|471497158|FG001|Overall Study|Physician Decision|21|||
130964734|NCT00023452|471497157|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
130964735|NCT00023452|471497158|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
130964736|NCT00023452|471497157|FG000|Overall Study|Pregnant|53|||
130964737|NCT00023452|471497158|FG001|Overall Study|Pregnant|20|||
130964738|NCT00023452|471497157|FG000|Overall Study|Other|204|||
130964739|NCT00023452|471497158|FG001|Overall Study|Other|69|||
130964740|NCT05789875|471497159|FG000|Overall Study|Lost to Follow-up|6|||
130964741|NCT01994395|471497160|FG000|Overall Study|Withdrawal by Subject|1|||
130964742|NCT01994395|471497161|FG001|Overall Study|Withdrawal by Subject|2|||
130964743|NCT01940705|471497163|FG000|Overall Study|Lost to Follow-up|1|||
130964744|NCT01940705|471497164|FG001|Overall Study|Lost to Follow-up|3|||
130964745|NCT01940705|471497165|FG002|Overall Study|Lost to Follow-up|2|||
130964746|NCT01940705|471497166|FG003|Overall Study|Lost to Follow-up|2|||
130964747|NCT01940705|471497163|FG000|Overall Study|Withdrawal by Subject|2|||
130964748|NCT01940705|471497164|FG001|Overall Study|Withdrawal by Subject|2|||
130964749|NCT01940705|471497165|FG002|Overall Study|Withdrawal by Subject|3|||
130964750|NCT01940705|471497166|FG003|Overall Study|Withdrawal by Subject|2|||
130964751|NCT01940705|471497163|FG000|Overall Study|Intervention not given|0|||
130775445|NCT00972283|470804550|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
130964752|NCT01940705|471497164|FG001|Overall Study|Intervention not given|3|||
130964753|NCT01940705|471497165|FG002|Overall Study|Intervention not given|3|||
130964754|NCT01940705|471497166|FG003|Overall Study|Intervention not given|0|||
130964755|NCT01940705|471497163|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
130964756|NCT01940705|471497164|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
130964757|NCT01940705|471497165|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
130964758|NCT01940705|471497166|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
130964759|NCT03779841|471497169|FG000|Randomized Population|Did Not Receive Treatment|3|||
130964760|NCT03779841|471497170|FG001|Randomized Population|Did Not Receive Treatment|1|||
130715684|NCT05070546|470587005|FG004|Overall Study|Lost to Follow-up|2|||
130715685|NCT05070546|470587006|FG005|Overall Study|Lost to Follow-up|0|||
130715686|NCT05070546|470587001|FG000|Overall Study|Withdrawal by Subject|1|||
130715687|NCT05070546|470587002|FG001|Overall Study|Withdrawal by Subject|1|||
130715688|NCT05070546|470587003|FG002|Overall Study|Withdrawal by Subject|3|||
130715689|NCT05070546|470587004|FG003|Overall Study|Withdrawal by Subject|0|||
130715690|NCT05070546|470587005|FG004|Overall Study|Withdrawal by Subject|0|||
130715691|NCT05070546|470587006|FG005|Overall Study|Withdrawal by Subject|0|||
130715692|NCT05070546|470587001|FG000|Overall Study|Other|0|||
130715693|NCT05070546|470587002|FG001|Overall Study|Other|0|||
130715694|NCT05070546|470587003|FG002|Overall Study|Other|0|||
130715695|NCT05070546|470587004|FG003|Overall Study|Other|0|||
130715696|NCT05070546|470587005|FG004|Overall Study|Other|3|||
130715697|NCT05070546|470587006|FG005|Overall Study|Other|0|||
130715698|NCT05070546|470587001|FG000|Overall Study|Randomized but not vaccinated|1|||
130715699|NCT05070546|470587002|FG001|Overall Study|Randomized but not vaccinated|0|||
130715700|NCT05070546|470587003|FG002|Overall Study|Randomized but not vaccinated|1|||
130715701|NCT05070546|470587004|FG003|Overall Study|Randomized but not vaccinated|1|||
130715702|NCT05070546|470587005|FG004|Overall Study|Randomized but not vaccinated|3|||
130715703|NCT05070546|470587006|FG005|Overall Study|Randomized but not vaccinated|0|||
130715704|NCT00302081|470587007|FG000|Overall Study|Adverse Event|6|||
130715705|NCT00302081|470587008|FG001|Overall Study|Adverse Event|5|||
130715706|NCT00302081|470587009|FG002|Overall Study|Adverse Event|4|||
130715707|NCT00302081|470587007|FG000|Overall Study|Lost to Follow-up|21|||
130715708|NCT00302081|470587008|FG001|Overall Study|Lost to Follow-up|18|||
130715709|NCT00302081|470587009|FG002|Overall Study|Lost to Follow-up|28|||
130715710|NCT00302081|470587007|FG000|Overall Study|Withdrawal by Subject|8|||
130715711|NCT00302081|470587008|FG001|Overall Study|Withdrawal by Subject|12|||
130775446|NCT00972283|470804551|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
130964761|NCT03779841|471497171|FG002|Randomized Population|Did Not Receive Treatment|0|||
130964762|NCT03779841|471497169|FG000|Treated (Safety) Population|Adverse Event|1|||
130964763|NCT03779841|471497170|FG001|Treated (Safety) Population|Adverse Event|1|||
130964764|NCT03779841|471497171|FG002|Treated (Safety) Population|Adverse Event|0|||
130964765|NCT03779841|471497169|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
130964766|NCT03779841|471497170|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
130715712|NCT00302081|470587009|FG002|Overall Study|Withdrawal by Subject|8|||
130715713|NCT00302081|470587007|FG000|Overall Study|Protocol Violation|5|||
130964767|NCT03779841|471497171|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
130964768|NCT03779841|471497169|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
130964769|NCT03779841|471497170|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
130964770|NCT03779841|471497171|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
130964771|NCT03779841|471497169|FG000|Treated (Safety) Population|Death|1|||
130775447|NCT00972283|470804550|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
130775448|NCT00972283|470804551|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
130775449|NCT00972283|470804550|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
130775450|NCT00972283|470804551|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
130775451|NCT00972283|470804550|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
130775452|NCT00972283|470804551|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
130775453|NCT00972283|470804550|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
130775454|NCT00972283|470804551|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
130775455|NCT00972283|470804550|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
130775456|NCT00972283|470804551|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
130775457|NCT00972283|470804550|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
130775458|NCT00972283|470804551|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
130775459|NCT00972283|470804550|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
130775460|NCT00972283|470804551|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
130775461|NCT00972283|470804550|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
130775462|NCT00972283|470804551|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
130775463|NCT00972283|470804550|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
130775464|NCT00972283|470804551|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
130775465|NCT01868165|470804555|FG000|Overall Study|Withdrawal by Subject|36|||
130775466|NCT01868165|470804555|FG000|Overall Study|Physician Decision|2|||
130775467|NCT01868165|470804555|FG000|Overall Study|Lost to Follow-up|3|||
130775468|NCT01868165|470804555|FG000|Overall Study|Death|4|||
130775469|NCT02588664|470804558|FG000|Overall Study|Death|56|||
130775470|NCT02588664|470804559|FG001|Overall Study|Death|55|||
130964772|NCT03779841|471497170|FG001|Treated (Safety) Population|Death|0|||
130964773|NCT03779841|471497171|FG002|Treated (Safety) Population|Death|2|||
130964774|NCT01632579|471497172|FG000|Washout Period|Adverse Event|1|||
130964775|NCT01632579|471497173|FG001|Washout Period|Adverse Event|0|||
130964776|NCT01632579|471497174|FG002|Washout Period|Adverse Event|0|||
130964777|NCT01632579|471497175|FG003|Washout Period|Adverse Event|0|||
130964778|NCT01632579|471497176|FG004|Washout Period|Adverse Event|0|||
130964779|NCT01632579|471497177|FG005|Washout Period|Adverse Event|0|||
130964780|NCT01632579|471497178|FG006|Washout Period|Adverse Event|0|||
130964781|NCT01632579|471497179|FG007|Washout Period|Adverse Event|0|||
130964782|NCT01632579|471497180|FG008|Washout Period|Adverse Event|0|||
130964783|NCT01632579|471497172|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
130964784|NCT01632579|471497173|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
130964785|NCT01632579|471497174|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
130775471|NCT02588664|470804558|FG000|Overall Study|Lost to Follow-up|1305|||
130775472|NCT02588664|470804559|FG001|Overall Study|Lost to Follow-up|990|||
130775473|NCT01429298|470804560|FG000|Overall Study|Protocol Violation|4|||
130775474|NCT01429298|470804561|FG001|Overall Study|Protocol Violation|6|||
130775475|NCT02903420|470804562|FG000|Overall Study|Death|3|||
130775476|NCT01588405|470804564|FG000|Overall Study|Adverse Event|1|||
130775477|NCT01588405|470804564|FG000|Overall Study|Clinical Worsening|1|||
130775478|NCT01124292|470804565|FG000|Overall Study|Lost to Follow-up|2|||
130775479|NCT01124292|470804566|FG001|Overall Study|Lost to Follow-up|4|||
130775480|NCT01124292|470804567|FG002|Overall Study|Lost to Follow-up|3|||
130775481|NCT01124292|470804565|FG000|Overall Study|Physician Decision|0|||
130775482|NCT01124292|470804566|FG001|Overall Study|Physician Decision|3|||
130775483|NCT01124292|470804567|FG002|Overall Study|Physician Decision|2|||
130775484|NCT01124292|470804565|FG000|Overall Study|Withdrawal by Subject|0|||
130775485|NCT01124292|470804566|FG001|Overall Study|Withdrawal by Subject|6|||
130775486|NCT01124292|470804567|FG002|Overall Study|Withdrawal by Subject|2|||
130775487|NCT01124292|470804565|FG000|Overall Study|medical issue unrelated to the study|0|||
130775488|NCT01124292|470804566|FG001|Overall Study|medical issue unrelated to the study|0|||
130775489|NCT01124292|470804567|FG002|Overall Study|medical issue unrelated to the study|2|||
130964786|NCT01632579|471497175|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
130964787|NCT01632579|471497176|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
130964788|NCT01632579|471497177|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
130964789|NCT01632579|471497178|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
130964790|NCT01632579|471497179|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
131127786|NCT02831673|472097604|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
131127787|NCT02831673|472097600|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
131127788|NCT02831673|472097601|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
131127789|NCT02831673|472097602|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130775490|NCT01124292|470804565|FG000|Overall Study|piercing track closed|0|||
130775491|NCT01124292|470804566|FG001|Overall Study|piercing track closed|2|||
130964791|NCT01632579|471497180|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
130964792|NCT02788175|471497181|FG000|Overall Study|Protocol Violation|3|||
130964793|NCT02788175|471497181|FG000|Overall Study|Withdrawal by Subject|4|||
130964794|NCT02788175|471497181|FG000|Overall Study|Ineligible prior to study agent|6|||
130964795|NCT03403634|471497186|FG000|Overall Study|Disease progression|3|||
130775492|NCT01124292|470804567|FG002|Overall Study|piercing track closed|1|||
130775493|NCT03373461|470804568|FG000|Part 2|Adverse Event|0|||
130775494|NCT03373461|470804569|FG001|Part 2|Adverse Event|1|||
130775495|NCT03373461|470804570|FG002|Part 2|Adverse Event|0|||
130775496|NCT03373461|470804571|FG003|Part 2|Adverse Event|0|||
131127790|NCT02831673|472097603|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
131127791|NCT02831673|472097604|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
131127792|NCT02831673|472097600|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
131127793|NCT02831673|472097601|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
131127794|NCT02831673|472097602|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
131127795|NCT02831673|472097603|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
131127796|NCT02831673|472097604|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
131127797|NCT02831673|472097600|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130775497|NCT03373461|470804572|FG004|Part 2|Adverse Event|1|||
130775498|NCT03300180|470804573|FG000|Baseline|Withdrawal by Subject|4|||
130775499|NCT03300180|470804574|FG001|Baseline|Withdrawal by Subject|6|||
130775500|NCT03300180|470804575|FG002|Baseline|Withdrawal by Subject|4|||
130775501|NCT03300180|470804573|FG000|6 Month Outcome|Withdrawal by Subject|12|||
130775502|NCT03300180|470804574|FG001|6 Month Outcome|Withdrawal by Subject|12|||
130775503|NCT03300180|470804575|FG002|6 Month Outcome|Withdrawal by Subject|19|||
130775504|NCT03300180|470804573|FG000|6 Month Outcome|Death|2|||
130775505|NCT03300180|470804574|FG001|6 Month Outcome|Death|4|||
130775506|NCT03300180|470804575|FG002|6 Month Outcome|Death|3|||
130775507|NCT03300180|470804573|FG000|6 Month Outcome|Missed Assessment|43|||
130775508|NCT03300180|470804574|FG001|6 Month Outcome|Missed Assessment|52|||
130775509|NCT03300180|470804575|FG002|6 Month Outcome|Missed Assessment|46|||
130715714|NCT00302081|470587008|FG001|Overall Study|Protocol Violation|1|||
130715715|NCT00302081|470587009|FG002|Overall Study|Protocol Violation|2|||
130715716|NCT00302081|470587007|FG000|Overall Study|Lack of Efficacy|1|||
130715717|NCT00302081|470587008|FG001|Overall Study|Lack of Efficacy|0|||
130715718|NCT00302081|470587009|FG002|Overall Study|Lack of Efficacy|5|||
130715719|NCT00302081|470587007|FG000|Overall Study|Death|2|||
130715720|NCT00302081|470587008|FG001|Overall Study|Death|1|||
130715721|NCT00302081|470587009|FG002|Overall Study|Death|0|||
130715722|NCT00302081|470587007|FG000|Overall Study|Other|13|||
130715723|NCT00302081|470587008|FG001|Overall Study|Other|6|||
130775510|NCT03300180|470804573|FG000|12 Month Outcome|Withdrawal by Subject|3|||
130775511|NCT03300180|470804574|FG001|12 Month Outcome|Withdrawal by Subject|6|||
130775512|NCT03300180|470804575|FG002|12 Month Outcome|Withdrawal by Subject|6|||
130775513|NCT03300180|470804573|FG000|12 Month Outcome|Death|9|||
130775514|NCT03300180|470804574|FG001|12 Month Outcome|Death|6|||
130775515|NCT03300180|470804575|FG002|12 Month Outcome|Death|6|||
130775516|NCT03300180|470804573|FG000|12 Month Outcome|Missed Assessment|62|||
130964796|NCT03403634|471497186|FG000|Overall Study|Did not meet eligibility criteria|4|||
130964797|NCT01043874|471499538|FG000|Overall Study|Adverse Event|3|||
130964798|NCT01043874|471499538|FG000|Overall Study|Withdrawal by Subject|1|||
130964799|NCT01043874|471499538|FG000|Overall Study|Lack of Efficacy|1|||
130964800|NCT01043874|471499538|FG000|Overall Study|Administrative Problems|1|||
130964801|NCT03422003|471499539|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
130964802|NCT03422003|471499540|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
130964803|NCT03422003|471499539|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
130964804|NCT03422003|471499540|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
130964805|NCT00966940|471499541|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
130964806|NCT00966940|471499542|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
130964807|NCT00966940|471499541|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
130964808|NCT00966940|471499542|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
130964809|NCT02696850|471499545|FG000|Overall Study|Withdrawal by Subject|3|||
130964810|NCT02696850|471499546|FG001|Overall Study|Withdrawal by Subject|3|||
131041673|NCT01960452|471789269|FG000|Overall Study|Withdrawal by Subject|2|||
131041674|NCT01960452|471789270|FG001|Overall Study|Withdrawal by Subject|1|||
131041675|NCT01960452|471789269|FG000|Overall Study|Sleep apnea in Night 1|1|||
131041676|NCT01960452|471789270|FG001|Overall Study|Sleep apnea in Night 1|0|||
131041677|NCT01960452|471789269|FG000|Overall Study|Poor Sleep in Night 1|0|||
131041678|NCT01960452|471789270|FG001|Overall Study|Poor Sleep in Night 1|2|||
131041679|NCT01960452|471789269|FG000|Overall Study|No Sex/Age Match Night 1|1|||
131041680|NCT01960452|471789270|FG001|Overall Study|No Sex/Age Match Night 1|0|||
131041681|NCT01960452|471789269|FG000|Overall Study|No Sex/Age Match Night 2|0|||
130715724|NCT00302081|470587009|FG002|Overall Study|Other|5|||
130775517|NCT03300180|470804574|FG001|12 Month Outcome|Missed Assessment|59|||
130775518|NCT03300180|470804575|FG002|12 Month Outcome|Missed Assessment|58|||
130775519|NCT03300180|470804573|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
130775520|NCT03300180|470804574|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
130775521|NCT03300180|470804575|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
130775522|NCT03300180|470804573|FG000|18 Month Outcome Assessment|Death|8|||
131127798|NCT02831673|472097601|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
131127799|NCT02831673|472097602|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
131127800|NCT02831673|472097603|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
131127801|NCT02831673|472097604|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
131127802|NCT02831673|472097600|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
131127803|NCT02831673|472097601|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130775523|NCT03300180|470804574|FG001|18 Month Outcome Assessment|Death|5|||
130775524|NCT03300180|470804575|FG002|18 Month Outcome Assessment|Death|5|||
131127804|NCT02831673|472097602|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
131127805|NCT02831673|472097603|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
131127806|NCT02831673|472097604|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
131127807|NCT02831673|472097600|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
131127808|NCT02831673|472097601|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
131127809|NCT02831673|472097602|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
130775525|NCT03300180|470804573|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
130775526|NCT03300180|470804574|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
130964811|NCT02696850|471499545|FG000|Overall Study|Lost to Follow-up|8|||
130964812|NCT02696850|471499546|FG001|Overall Study|Lost to Follow-up|5|||
130964813|NCT03455855|471499547|FG000|Overall Study|Lost to Follow-up|4|||
130964814|NCT03455855|471499548|FG001|Overall Study|Lost to Follow-up|2|||
130964815|NCT00767000|471499555|FG000|54-week Study|Adverse Event|4|||
130964816|NCT00767000|471499556|FG001|54-week Study|Adverse Event|6|||
130964817|NCT00767000|471499557|FG002|54-week Study|Adverse Event|6|||
130964818|NCT00767000|471499558|FG003|54-week Study|Adverse Event|8|||
131127810|NCT02831673|472097603|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
131127811|NCT02831673|472097604|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
131127812|NCT02831673|472097600|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
131127813|NCT02831673|472097601|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
131127814|NCT02831673|472097602|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
131127815|NCT02831673|472097603|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
130964819|NCT00767000|471499559|FG004|54-week Study|Adverse Event|4|||
130964820|NCT00767000|471499555|FG000|54-week Study|Creaninine/creatinine clearance|2|||
130964821|NCT00767000|471499556|FG001|54-week Study|Creaninine/creatinine clearance|1|||
130964822|NCT00767000|471499557|FG002|54-week Study|Creaninine/creatinine clearance|2|||
130964823|NCT00767000|471499558|FG003|54-week Study|Creaninine/creatinine clearance|2|||
131127816|NCT02831673|472097604|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
131127817|NCT02831673|472097600|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131226871|NCT00606684|472457717|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
131226872|NCT00606684|472457718|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
131226873|NCT00606684|472457712|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
130964824|NCT00767000|471499559|FG004|54-week Study|Creaninine/creatinine clearance|4|||
130964825|NCT00767000|471499555|FG000|54-week Study|Hyperglycemia|0|||
130964826|NCT00767000|471499556|FG001|54-week Study|Hyperglycemia|0|||
130964827|NCT00767000|471499557|FG002|54-week Study|Hyperglycemia|1|||
130964828|NCT00767000|471499558|FG003|54-week Study|Hyperglycemia|0|||
130964829|NCT00767000|471499559|FG004|54-week Study|Hyperglycemia|1|||
130964830|NCT00767000|471499555|FG000|54-week Study|Hypoglycemia|0|||
130964831|NCT00767000|471499556|FG001|54-week Study|Hypoglycemia|1|||
130964832|NCT00767000|471499557|FG002|54-week Study|Hypoglycemia|0|||
130964833|NCT00767000|471499558|FG003|54-week Study|Hypoglycemia|0|||
130964834|NCT00767000|471499559|FG004|54-week Study|Hypoglycemia|0|||
130964835|NCT00767000|471499555|FG000|54-week Study|Interruption of study medication|0|||
130964836|NCT00767000|471499556|FG001|54-week Study|Interruption of study medication|0|||
130964837|NCT00767000|471499557|FG002|54-week Study|Interruption of study medication|1|||
131226874|NCT00606684|472457713|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130715725|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
130715726|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
130715727|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
130715728|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
130715729|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
130715730|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
130775527|NCT03300180|470804575|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
130775528|NCT03300180|470804573|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
130964838|NCT00767000|471499558|FG003|54-week Study|Interruption of study medication|0|||
130964839|NCT00767000|471499559|FG004|54-week Study|Interruption of study medication|0|||
130964840|NCT00767000|471499555|FG000|54-week Study|Lack of Efficacy|2|||
130964841|NCT00767000|471499556|FG001|54-week Study|Lack of Efficacy|0|||
130964842|NCT00767000|471499557|FG002|54-week Study|Lack of Efficacy|1|||
130715731|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
130715732|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
130715733|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
130715734|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
130715735|NCT04771403|470587010|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
130715736|NCT04771403|470587011|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
130715737|NCT04771403|470587010|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
130775529|NCT03300180|470804574|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
130775530|NCT03300180|470804575|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
130775531|NCT03300180|470804573|FG000|24 Month Outcome Assessment|Death|13|||
130775532|NCT03300180|470804574|FG001|24 Month Outcome Assessment|Death|13|||
130775533|NCT03300180|470804575|FG002|24 Month Outcome Assessment|Death|3|||
130775534|NCT03300180|470804573|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
130775535|NCT03300180|470804574|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
130775536|NCT03300180|470804575|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
130775537|NCT03654729|470806491|FG000|Overall Study|Death|9|||
130775538|NCT03654729|470806492|FG001|Overall Study|Death|9|||
130775539|NCT03654729|470806493|FG002|Overall Study|Death|16|||
130775540|NCT03654729|470806491|FG000|Overall Study|Withdrawal by Subject|8|||
130775541|NCT03654729|470806492|FG001|Overall Study|Withdrawal by Subject|6|||
130775542|NCT03654729|470806493|FG002|Overall Study|Withdrawal by Subject|4|||
130775543|NCT03654729|470806491|FG000|Overall Study|Study terminated by Sponsor|3|||
130964843|NCT00767000|471499558|FG003|54-week Study|Lack of Efficacy|0|||
130964844|NCT00767000|471499559|FG004|54-week Study|Lack of Efficacy|5|||
130964845|NCT00767000|471499555|FG000|54-week Study|Lost to Follow-up|4|||
130964846|NCT00767000|471499556|FG001|54-week Study|Lost to Follow-up|0|||
130964847|NCT00767000|471499557|FG002|54-week Study|Lost to Follow-up|1|||
130964848|NCT00767000|471499558|FG003|54-week Study|Lost to Follow-up|4|||
131127818|NCT02831673|472097601|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131127819|NCT02831673|472097602|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131127820|NCT02831673|472097603|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
131127821|NCT02831673|472097604|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
131127822|NCT02831673|472097600|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131127823|NCT02831673|472097601|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131127824|NCT02831673|472097602|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131127825|NCT02831673|472097603|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
131127826|NCT02831673|472097604|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
131127827|NCT02831673|472097600|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131127828|NCT02831673|472097601|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131127829|NCT02831673|472097602|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131127830|NCT02831673|472097603|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
131127831|NCT02831673|472097604|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
131127832|NCT02831673|472097600|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131127833|NCT02831673|472097601|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131127834|NCT02831673|472097602|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131127835|NCT02831673|472097603|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
131127836|NCT02831673|472097604|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
131127837|NCT02356562|472097605|FG000|Overall Study|Withdrawal by Subject|0|||
131127838|NCT02356562|472097606|FG001|Overall Study|Withdrawal by Subject|1|||
131127839|NCT02356562|472097605|FG000|Overall Study|Re-entered treatment in a previous study|1|||
131127840|NCT02356562|472097606|FG001|Overall Study|Re-entered treatment in a previous study|0|||
131127841|NCT02356562|472097605|FG000|Overall Study|site closure|1|||
131127842|NCT02356562|472097606|FG001|Overall Study|site closure|0|||
130964849|NCT00767000|471499559|FG004|54-week Study|Lost to Follow-up|2|||
130964850|NCT00767000|471499555|FG000|54-week Study|Physician Decision|4|||
130964851|NCT00767000|471499556|FG001|54-week Study|Physician Decision|0|||
130964852|NCT00767000|471499557|FG002|54-week Study|Physician Decision|1|||
130964853|NCT00767000|471499558|FG003|54-week Study|Physician Decision|1|||
130964854|NCT00767000|471499559|FG004|54-week Study|Physician Decision|1|||
130964855|NCT00767000|471499555|FG000|54-week Study|Progressive disease|0|||
130964856|NCT00767000|471499556|FG001|54-week Study|Progressive disease|0|||
130964857|NCT00767000|471499557|FG002|54-week Study|Progressive disease|1|||
130964858|NCT00767000|471499558|FG003|54-week Study|Progressive disease|0|||
130775544|NCT03654729|470806492|FG001|Overall Study|Study terminated by Sponsor|5|||
130964859|NCT00767000|471499559|FG004|54-week Study|Progressive disease|0|||
130964860|NCT00767000|471499555|FG000|54-week Study|Protocol Violation|0|||
130964861|NCT00767000|471499556|FG001|54-week Study|Protocol Violation|0|||
130964862|NCT00767000|471499557|FG002|54-week Study|Protocol Violation|1|||
131041682|NCT01960452|471789270|FG001|Overall Study|No Sex/Age Match Night 2|2|||
131041683|NCT01960452|471789269|FG000|Overall Study|Technical Difficulties Night 2|2|||
131041684|NCT01960452|471789270|FG001|Overall Study|Technical Difficulties Night 2|0|||
131041685|NCT03209973|471789276|FG000|Overall Study|Withdrawal by Subject|7|||
131041686|NCT03209973|471789276|FG000|Overall Study|Lost to Follow-up|2|||
131041687|NCT03209973|471789276|FG000|Overall Study|Death|8|||
131041688|NCT03209973|471789276|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
131041689|NCT03209973|471789276|FG000|Overall Study|Sponsor Decision|18|||
131041690|NCT03209973|471789276|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
131041691|NCT03209973|471789276|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
131041692|NCT04766892|471789277|FG000|Overall Study|Withdrawal by Subject|1|||
131041693|NCT04766892|471789277|FG000|Overall Study|Lost to Follow-up|1|||
131041694|NCT04766892|471789277|FG000|Overall Study|Adverse Event|3|||
131041695|NCT04766892|471789277|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
131041696|NCT04778397|471789278|FG000|Overall Study|Death|59|||
131041697|NCT04778397|471789279|FG001|Overall Study|Death|54|||
131041698|NCT04778397|471789280|FG002|Overall Study|Death|11|||
131041699|NCT04778397|471789281|FG003|Overall Study|Death|9|||
131041700|NCT04778397|471789278|FG000|Overall Study|Study Terminated by Sponsor|34|||
131041701|NCT04778397|471789279|FG001|Overall Study|Study Terminated by Sponsor|42|||
131041702|NCT04778397|471789280|FG002|Overall Study|Study Terminated by Sponsor|15|||
131041703|NCT04778397|471789281|FG003|Overall Study|Study Terminated by Sponsor|12|||
131041704|NCT04778397|471789278|FG000|Overall Study|Withdrew Consent|5|||
131041705|NCT04778397|471789279|FG001|Overall Study|Withdrew Consent|4|||
131041706|NCT04778397|471789280|FG002|Overall Study|Withdrew Consent|1|||
131041707|NCT04778397|471789281|FG003|Overall Study|Withdrew Consent|1|||
131041708|NCT04778397|471789278|FG000|Overall Study|Reason Not Specified|1|||
131041709|NCT04778397|471789279|FG001|Overall Study|Reason Not Specified|3|||
131041710|NCT04778397|471789280|FG002|Overall Study|Reason Not Specified|0|||
131041711|NCT04778397|471789281|FG003|Overall Study|Reason Not Specified|2|||
131041712|NCT04778397|471789278|FG000|Overall Study|Lost to Follow-up|2|||
131041713|NCT04778397|471789279|FG001|Overall Study|Lost to Follow-up|1|||
131041714|NCT04778397|471789280|FG002|Overall Study|Lost to Follow-up|0|||
131041715|NCT04778397|471789281|FG003|Overall Study|Lost to Follow-up|1|||
131041716|NCT03249090|471789282|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
131041717|NCT03249090|471789283|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
131041718|NCT03249090|471789282|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
131041719|NCT03249090|471789283|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
131041720|NCT03249090|471789282|FG000|3 Month Time Point|Voluntary withdrawal|6|||
131041721|NCT03249090|471789283|FG001|3 Month Time Point|Voluntary withdrawal|3|||
131041722|NCT03249090|471789282|FG000|3 Month Time Point|Changed oncology practice|4|||
131041723|NCT03249090|471789283|FG001|3 Month Time Point|Changed oncology practice|2|||
131041724|NCT03249090|471789282|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
131041725|NCT03249090|471789283|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
131041726|NCT03249090|471789282|FG000|12 Month Time Point|Voluntary withdrawal|35|||
131041727|NCT03249090|471789283|FG001|12 Month Time Point|Voluntary withdrawal|4|||
131041728|NCT03249090|471789282|FG000|12 Month Time Point|Changed oncology practice|20|||
131041729|NCT03249090|471789283|FG001|12 Month Time Point|Changed oncology practice|9|||
131127843|NCT00412750|472097608|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131127844|NCT00412750|472097609|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131127845|NCT00412750|472097610|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131127846|NCT00412750|472097608|FG000|Overall Study|Administrative problems|21|||
131127847|NCT00412750|472097609|FG001|Overall Study|Administrative problems|17|||
131127848|NCT00412750|472097610|FG002|Overall Study|Administrative problems|14|||
131127849|NCT00412750|472097608|FG000|Overall Study|Adverse Event|8|||
131127850|NCT00412750|472097609|FG001|Overall Study|Adverse Event|3|||
131127851|NCT00412750|472097610|FG002|Overall Study|Adverse Event|3|||
131127852|NCT00412750|472097608|FG000|Overall Study|Lost to Follow-up|1|||
131127853|NCT00412750|472097609|FG001|Overall Study|Lost to Follow-up|0|||
131127854|NCT00412750|472097610|FG002|Overall Study|Lost to Follow-up|1|||
131127855|NCT00412750|472097608|FG000|Overall Study|Withdrawal by Subject|0|||
130715738|NCT04771403|470587011|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
131041730|NCT04359654|471789287|FG000|Overall Study|Withdrawal by Subject|1|||
131041731|NCT04359654|471789288|FG001|Overall Study|Withdrawal by Subject|0|||
131041732|NCT04359654|471789287|FG000|Overall Study|Adverse Event|0|||
131041733|NCT04359654|471789288|FG001|Overall Study|Adverse Event|1|||
131041734|NCT03523572|471789289|FG000|Dose Escalation|Progressive disease|1|||
131041735|NCT03523572|471789290|FG001|Dose Escalation|Progressive disease|0|||
131041736|NCT03523572|471789291|FG002|Dose Escalation|Progressive disease|0|||
131041737|NCT03523572|471789292|FG003|Dose Escalation|Progressive disease|0|||
131041738|NCT03523572|471789293|FG004|Dose Escalation|Progressive disease|0|||
131127856|NCT00412750|472097609|FG001|Overall Study|Withdrawal by Subject|1|||
131127857|NCT00412750|472097610|FG002|Overall Study|Withdrawal by Subject|2|||
131127858|NCT00412750|472097608|FG000|Overall Study|Lack of Efficacy|0|||
130715739|NCT04771403|470587010|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
130715740|NCT04771403|470587011|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
130715741|NCT00816361|470587012|FG000|Overall Study|Withdrawal by Subject|0|||
130715742|NCT00816361|470587013|FG001|Overall Study|Withdrawal by Subject|0|||
130715743|NCT00816361|470587014|FG002|Overall Study|Withdrawal by Subject|0|||
130715744|NCT00816361|470587015|FG003|Overall Study|Withdrawal by Subject|0|||
130715745|NCT00816361|470587016|FG004|Overall Study|Withdrawal by Subject|1|||
130715746|NCT00816361|470587017|FG005|Overall Study|Withdrawal by Subject|2|||
130715747|NCT00816361|470587018|FG006|Overall Study|Withdrawal by Subject|0|||
130715748|NCT00816361|470587019|FG007|Overall Study|Withdrawal by Subject|2|||
130715749|NCT00816361|470587020|FG008|Overall Study|Withdrawal by Subject|1|||
130715750|NCT00816361|470587012|FG000|Overall Study|Death|4|||
130715751|NCT00816361|470587013|FG001|Overall Study|Death|3|||
130715752|NCT00816361|470587014|FG002|Overall Study|Death|3|||
130715753|NCT00816361|470587015|FG003|Overall Study|Death|3|||
131127859|NCT00412750|472097609|FG001|Overall Study|Lack of Efficacy|0|||
131127860|NCT00412750|472097610|FG002|Overall Study|Lack of Efficacy|3|||
131127861|NCT01135498|472097618|FG000|Overall Study|Adverse Event|20|||
131127862|NCT01135498|472097618|FG000|Overall Study|Progressive disease|38|||
131127863|NCT01135498|472097618|FG000|Overall Study|Investigator judgement|25|||
131127864|NCT01135498|472097618|FG000|Overall Study|Withdrawal by Subject|4|||
131127865|NCT01135498|472097618|FG000|Overall Study|Death|1|||
131127866|NCT01135498|472097618|FG000|Overall Study|Ongoing at time of analysis|2|||
131127867|NCT02104583|472097619|FG000|Overall Study|New ICD or CRT-D implanted|2|||
131127868|NCT02104583|472097620|FG001|Overall Study|New ICD or CRT-D implanted|0|||
131127869|NCT02104583|472097621|FG002|Overall Study|New ICD or CRT-D implanted|1|||
131127870|NCT02104583|472097622|FG003|Overall Study|New ICD or CRT-D implanted|0|||
131127871|NCT02104583|472097623|FG004|Overall Study|New ICD or CRT-D implanted|0|||
131127872|NCT02104583|472097619|FG000|Overall Study|Death|2|||
131127873|NCT02104583|472097620|FG001|Overall Study|Death|1|||
131127874|NCT02104583|472097621|FG002|Overall Study|Death|3|||
131127875|NCT02104583|472097622|FG003|Overall Study|Death|3|||
131127876|NCT02104583|472097623|FG004|Overall Study|Death|5|||
131127877|NCT02104583|472097619|FG000|Overall Study|Subject required cardiac ablation|6|||
131127878|NCT02104583|472097620|FG001|Overall Study|Subject required cardiac ablation|4|||
131127879|NCT02104583|472097621|FG002|Overall Study|Subject required cardiac ablation|4|||
130715754|NCT00816361|470587016|FG004|Overall Study|Death|1|||
130715755|NCT00816361|470587017|FG005|Overall Study|Death|1|||
130715756|NCT00816361|470587018|FG006|Overall Study|Death|3|||
131127880|NCT02104583|472097622|FG003|Overall Study|Subject required cardiac ablation|5|||
130715757|NCT00816361|470587019|FG007|Overall Study|Death|7|||
130715758|NCT00816361|470587020|FG008|Overall Study|Death|8|||
130715759|NCT00816361|470587012|FG000|Overall Study|Other|0|||
130715760|NCT00816361|470587013|FG001|Overall Study|Other|0|||
130715761|NCT00816361|470587014|FG002|Overall Study|Other|0|||
130715762|NCT00816361|470587015|FG003|Overall Study|Other|0|||
130715763|NCT00816361|470587016|FG004|Overall Study|Other|0|||
130715764|NCT00816361|470587017|FG005|Overall Study|Other|0|||
130715765|NCT00816361|470587018|FG006|Overall Study|Other|0|||
130715766|NCT00816361|470587019|FG007|Overall Study|Other|0|||
130715767|NCT00816361|470587020|FG008|Overall Study|Other|1|||
130715768|NCT00546572|470587021|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
130715769|NCT00546572|470587022|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
130715770|NCT00546572|470587021|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
130715771|NCT00546572|470587022|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
130715772|NCT00546572|470587021|FG000|Vax 1 / Year 0|Protocol Violation|3|||
130715773|NCT00546572|470587022|FG001|Vax 1 / Year 0|Protocol Violation|4|||
130715774|NCT00546572|470587021|FG000|Vax 1 / Year 0|Death|2|||
130715775|NCT00546572|470587022|FG001|Vax 1 / Year 0|Death|2|||
130715776|NCT00546572|470587021|FG000|Vax 1 / Year 0|Adverse Event|0|||
130715777|NCT00546572|470587022|FG001|Vax 1 / Year 0|Adverse Event|1|||
130715778|NCT00546572|470587021|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
130715779|NCT00546572|470587022|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
130715780|NCT00546572|470587021|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
130715781|NCT00546572|470587022|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
130715782|NCT00546572|470587021|FG000|Vax 2 / Year 1|Other|1|||
130715783|NCT00546572|470587022|FG001|Vax 2 / Year 1|Other|1|||
130715784|NCT00546572|470587021|FG000|Vax 2 / Year 1|Adverse Event|1|||
130715785|NCT00546572|470587022|FG001|Vax 2 / Year 1|Adverse Event|0|||
130715786|NCT00546572|470587021|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
130964863|NCT00767000|471499558|FG003|54-week Study|Protocol Violation|2|||
131127881|NCT02104583|472097623|FG004|Overall Study|Subject required cardiac ablation|4|||
131226875|NCT00606684|472457714|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
131127882|NCT02104583|472097619|FG000|Overall Study|Subject required prohibited medication|0|||
131127883|NCT02104583|472097620|FG001|Overall Study|Subject required prohibited medication|1|||
131127884|NCT02104583|472097621|FG002|Overall Study|Subject required prohibited medication|1|||
131127885|NCT02104583|472097622|FG003|Overall Study|Subject required prohibited medication|0|||
130715787|NCT00546572|470587022|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
130715788|NCT00741936|470587027|FG000|Overall Study|Lost to Follow-up|1|||
130715789|NCT00741936|470587028|FG001|Overall Study|Lost to Follow-up|1|||
130715790|NCT00741936|470587027|FG000|Overall Study|Adverse Event|3|||
130715791|NCT00741936|470587028|FG001|Overall Study|Adverse Event|4|||
130715792|NCT00741936|470587027|FG000|Overall Study|Pregnancy|0|||
130715793|NCT00741936|470587028|FG001|Overall Study|Pregnancy|1|||
130715794|NCT00741936|470587027|FG000|Overall Study|Protocol Violation|2|||
130715795|NCT00741936|470587028|FG001|Overall Study|Protocol Violation|0|||
130715796|NCT00741936|470587027|FG000|Overall Study|Lack of Efficacy|0|||
130715797|NCT00741936|470587028|FG001|Overall Study|Lack of Efficacy|2|||
130715798|NCT00741936|470587027|FG000|Overall Study|Low compliance|3|||
130715799|NCT00741936|470587028|FG001|Overall Study|Low compliance|0|||
130715800|NCT01408628|470587029|FG000|Consented|Withdrawal by Subject|12|||
130775545|NCT03654729|470806493|FG002|Overall Study|Study terminated by Sponsor|4|||
130775546|NCT03654729|470806491|FG000|Overall Study|Not reported|2|||
130775547|NCT03654729|470806492|FG001|Overall Study|Not reported|4|||
130775548|NCT03654729|470806493|FG002|Overall Study|Not reported|5|||
130775549|NCT03654729|470806491|FG000|Overall Study|Progressive disease|3|||
130775550|NCT03654729|470806492|FG001|Overall Study|Progressive disease|0|||
130775551|NCT03654729|470806493|FG002|Overall Study|Progressive disease|0|||
130775552|NCT03654729|470806491|FG000|Overall Study|Lost to Follow-up|2|||
130775553|NCT03654729|470806492|FG001|Overall Study|Lost to Follow-up|0|||
130775554|NCT03654729|470806493|FG002|Overall Study|Lost to Follow-up|0|||
130775555|NCT03654729|470806491|FG000|Overall Study|Physician Decision|2|||
130775556|NCT03654729|470806492|FG001|Overall Study|Physician Decision|0|||
130775557|NCT03654729|470806493|FG002|Overall Study|Physician Decision|0|||
130775558|NCT03654729|470806491|FG000|Overall Study|Protocol Violation|1|||
130775559|NCT03654729|470806492|FG001|Overall Study|Protocol Violation|1|||
130775560|NCT03654729|470806493|FG002|Overall Study|Protocol Violation|0|||
130775561|NCT03654729|470806491|FG000|Overall Study|Non-compliance with study drug|0|||
130775562|NCT03654729|470806492|FG001|Overall Study|Non-compliance with study drug|1|||
130775563|NCT03654729|470806493|FG002|Overall Study|Non-compliance with study drug|0|||
130964864|NCT00767000|471499559|FG004|54-week Study|Protocol Violation|0|||
130964865|NCT00767000|471499555|FG000|54-week Study|Withdrawal by Subject|2|||
130964866|NCT00767000|471499556|FG001|54-week Study|Withdrawal by Subject|3|||
130964867|NCT00767000|471499557|FG002|54-week Study|Withdrawal by Subject|5|||
130964868|NCT00767000|471499558|FG003|54-week Study|Withdrawal by Subject|11|||
130964869|NCT00767000|471499559|FG004|54-week Study|Withdrawal by Subject|13|||
130964870|NCT00767000|471499555|FG000|54-week Study|Study terminated by sponsor|90|||
130964871|NCT00767000|471499556|FG001|54-week Study|Study terminated by sponsor|102|||
130964872|NCT00767000|471499557|FG002|54-week Study|Study terminated by sponsor|89|||
130964873|NCT00767000|471499558|FG003|54-week Study|Study terminated by sponsor|196|||
130964874|NCT00767000|471499559|FG004|54-week Study|Study terminated by sponsor|194|||
130964875|NCT00767000|471499555|FG000|54-week Study|Reason not reported|0|||
130964876|NCT00767000|471499556|FG001|54-week Study|Reason not reported|0|||
130964877|NCT00767000|471499557|FG002|54-week Study|Reason not reported|0|||
130964878|NCT00767000|471499558|FG003|54-week Study|Reason not reported|1|||
130964879|NCT00767000|471499559|FG004|54-week Study|Reason not reported|0|||
130715801|NCT01408628|470587029|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
130775564|NCT03654729|470806491|FG000|Overall Study|Site terminated by Sponsor|1|||
130775565|NCT03654729|470806492|FG001|Overall Study|Site terminated by Sponsor|0|||
130775566|NCT03654729|470806493|FG002|Overall Study|Site terminated by Sponsor|0|||
130775567|NCT04530838|470806494|FG000|Overall Study|Other|2|||
130775568|NCT04530838|470806495|FG001|Overall Study|Other|1|||
130775569|NCT04530838|470806496|FG002|Overall Study|Other|0|||
130775570|NCT04530838|470806494|FG000|Overall Study|Physician Decision|0|||
130715802|NCT01408628|470587029|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
130715803|NCT01408628|470587029|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
130715804|NCT01941940|470587030|FG000|Overall Study|Adverse Event|11|||
130775571|NCT04530838|470806495|FG001|Overall Study|Physician Decision|0|||
130775572|NCT04530838|470806496|FG002|Overall Study|Physician Decision|1|||
130775573|NCT04530838|470806494|FG000|Overall Study|Death|0|||
130775574|NCT04530838|470806495|FG001|Overall Study|Death|0|||
130775575|NCT04530838|470806496|FG002|Overall Study|Death|1|||
130715805|NCT01941940|470587030|FG000|Overall Study|Lost to Follow-up|2|||
130715806|NCT01941940|470587030|FG000|Overall Study|Physician Decision|2|||
130775576|NCT04530838|470806494|FG000|Overall Study|Adverse Event|0|||
130775577|NCT04530838|470806495|FG001|Overall Study|Adverse Event|1|||
130775578|NCT04530838|470806496|FG002|Overall Study|Adverse Event|0|||
130775579|NCT04530838|470806494|FG000|Overall Study|No longer meets eligibility criteria|1|||
130775580|NCT04530838|470806495|FG001|Overall Study|No longer meets eligibility criteria|0|||
130775581|NCT04530838|470806496|FG002|Overall Study|No longer meets eligibility criteria|2|||
130775582|NCT04530838|470806494|FG000|Overall Study|Withdrawal by parent/guardian|5|||
130775583|NCT04530838|470806495|FG001|Overall Study|Withdrawal by parent/guardian|2|||
130964880|NCT00767000|471499555|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
130964881|NCT00767000|471499556|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
130964882|NCT00767000|471499557|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
131127886|NCT02104583|472097623|FG004|Overall Study|Subject required prohibited medication|1|||
131127887|NCT02104583|472097619|FG000|Overall Study|Withdrew Consent|3|||
131127888|NCT02104583|472097620|FG001|Overall Study|Withdrew Consent|2|||
131127889|NCT02104583|472097621|FG002|Overall Study|Withdrew Consent|0|||
131127890|NCT02104583|472097622|FG003|Overall Study|Withdrew Consent|2|||
131127891|NCT02104583|472097623|FG004|Overall Study|Withdrew Consent|1|||
131127892|NCT02104583|472097619|FG000|Overall Study|Investigator's Discretion|1|||
131127893|NCT02104583|472097620|FG001|Overall Study|Investigator's Discretion|0|||
131127894|NCT02104583|472097621|FG002|Overall Study|Investigator's Discretion|0|||
131127895|NCT02104583|472097622|FG003|Overall Study|Investigator's Discretion|0|||
131127896|NCT02104583|472097623|FG004|Overall Study|Investigator's Discretion|0|||
131127897|NCT02104583|472097619|FG000|Overall Study|Protocol Violation|0|||
130775584|NCT04530838|470806496|FG002|Overall Study|Withdrawal by parent/guardian|2|||
130775585|NCT00803712|470806497|FG000|Overall Study|Noncompliance|3|||
130775586|NCT00803712|470806498|FG001|Overall Study|Noncompliance|0|||
130775587|NCT00803712|470806497|FG000|Overall Study|Adverse Event|5|||
130775588|NCT00803712|470806498|FG001|Overall Study|Adverse Event|0|||
130775589|NCT00803712|470806497|FG000|Overall Study|Death|8|||
130775590|NCT00803712|470806498|FG001|Overall Study|Death|7|||
130775591|NCT00803712|470806497|FG000|Overall Study|Lost to Follow-up|3|||
130775592|NCT00803712|470806498|FG001|Overall Study|Lost to Follow-up|1|||
130775593|NCT00803712|470806497|FG000|Overall Study|Withdrawal by Subject|2|||
130775594|NCT00803712|470806498|FG001|Overall Study|Withdrawal by Subject|4|||
130775595|NCT00803712|470806497|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
130775596|NCT00803712|470806498|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
130775597|NCT00803712|470806497|FG000|Overall Study|Protocol criteria (other)|0|||
130775598|NCT00803712|470806498|FG001|Overall Study|Protocol criteria (other)|2|||
130775599|NCT00803712|470806497|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
130775600|NCT00803712|470806498|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
130775601|NCT00803712|470806497|FG000|Overall Study|Administrative decision|2|||
130964883|NCT00767000|471499558|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
131127898|NCT02104583|472097620|FG001|Overall Study|Protocol Violation|0|||
130775602|NCT00803712|470806498|FG001|Overall Study|Administrative decision|3|||
130775603|NCT00803712|470806497|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
130775604|NCT00803712|470806498|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
131127899|NCT02104583|472097621|FG002|Overall Study|Protocol Violation|1|||
131127900|NCT02104583|472097622|FG003|Overall Study|Protocol Violation|0|||
131127901|NCT02104583|472097623|FG004|Overall Study|Protocol Violation|0|||
131127902|NCT02104583|472097619|FG000|Overall Study|Adverse Event|3|||
131127903|NCT02104583|472097620|FG001|Overall Study|Adverse Event|3|||
131127904|NCT02104583|472097621|FG002|Overall Study|Adverse Event|6|||
131127905|NCT02104583|472097622|FG003|Overall Study|Adverse Event|6|||
131127906|NCT02104583|472097623|FG004|Overall Study|Adverse Event|1|||
131127907|NCT02104583|472097619|FG000|Overall Study|Lost to Follow-up|1|||
131127908|NCT02104583|472097620|FG001|Overall Study|Lost to Follow-up|0|||
131127909|NCT02104583|472097621|FG002|Overall Study|Lost to Follow-up|0|||
131127910|NCT02104583|472097622|FG003|Overall Study|Lost to Follow-up|0|||
131127911|NCT02104583|472097623|FG004|Overall Study|Lost to Follow-up|0|||
131127912|NCT02104583|472097619|FG000|Overall Study|Randomized but Never Treated|0|||
131226876|NCT00606684|472457715|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130775605|NCT01919164|470806509|FG000|Overall Study|Adverse Event|6|||
130775606|NCT01919164|470806510|FG001|Overall Study|Adverse Event|4|||
130775607|NCT01919164|470806511|FG002|Overall Study|Adverse Event|9|||
130775608|NCT01919164|470806512|FG003|Overall Study|Adverse Event|3|||
130775609|NCT01919164|470806513|FG004|Overall Study|Adverse Event|2|||
130775610|NCT01919164|470806509|FG000|Overall Study|Lost to Follow-up|2|||
130775611|NCT01919164|470806510|FG001|Overall Study|Lost to Follow-up|2|||
130775612|NCT01919164|470806511|FG002|Overall Study|Lost to Follow-up|2|||
130775613|NCT01919164|470806512|FG003|Overall Study|Lost to Follow-up|0|||
130775614|NCT01919164|470806513|FG004|Overall Study|Lost to Follow-up|4|||
130775615|NCT01919164|470806509|FG000|Overall Study|Death|1|||
130775616|NCT01919164|470806510|FG001|Overall Study|Death|0|||
130964884|NCT00767000|471499559|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
131127913|NCT02104583|472097620|FG001|Overall Study|Randomized but Never Treated|0|||
131127914|NCT02104583|472097621|FG002|Overall Study|Randomized but Never Treated|0|||
131127915|NCT02104583|472097622|FG003|Overall Study|Randomized but Never Treated|1|||
130775617|NCT01919164|470806511|FG002|Overall Study|Death|0|||
130775618|NCT01919164|470806512|FG003|Overall Study|Death|0|||
130775619|NCT01919164|470806513|FG004|Overall Study|Death|0|||
130775620|NCT01919164|470806509|FG000|Overall Study|Protocol Violation|6|||
130775621|NCT01919164|470806510|FG001|Overall Study|Protocol Violation|0|||
130775622|NCT01919164|470806511|FG002|Overall Study|Protocol Violation|3|||
130775623|NCT01919164|470806512|FG003|Overall Study|Protocol Violation|2|||
130775624|NCT01919164|470806513|FG004|Overall Study|Protocol Violation|2|||
131127916|NCT02104583|472097623|FG004|Overall Study|Randomized but Never Treated|0|||
131127917|NCT01351389|472097624|FG000|Overall Study|Withdrawal by Subject|7|||
131127918|NCT01351389|472097625|FG001|Overall Study|Withdrawal by Subject|0|||
131041739|NCT03523572|471789294|FG005|Dose Escalation|Progressive disease|0|||
130715807|NCT01941940|470587030|FG000|Overall Study|Withdrawal by Subject|15|||
130715808|NCT01941940|470587030|FG000|Overall Study|Death|1|||
130715809|NCT01941940|470587030|FG000|Overall Study|Other|1|||
130715810|NCT01941940|470587030|FG000|Overall Study|Other|1|||
130715811|NCT00750308|470587031|FG000|First Treatment|Adverse Event|0|||
130715812|NCT00750308|470587032|FG001|First Treatment|Adverse Event|1|||
130715813|NCT00750308|470587033|FG002|First Treatment|Adverse Event|0|||
130715814|NCT00750308|470587034|FG003|First Treatment|Adverse Event|0|||
130715815|NCT00750308|470587035|FG004|First Treatment|Adverse Event|0|||
130715816|NCT00750308|470587036|FG005|First Treatment|Adverse Event|0|||
130715817|NCT00750308|470587037|FG006|First Treatment|Adverse Event|0|||
130715818|NCT00750308|470587038|FG007|First Treatment|Adverse Event|0|||
130715819|NCT00750308|470587039|FG008|First Treatment|Adverse Event|0|||
130715820|NCT00750308|470587040|FG009|First Treatment|Adverse Event|0|||
130715821|NCT00750308|470587041|FG010|First Treatment|Adverse Event|1|||
130715822|NCT00750308|470587042|FG011|First Treatment|Adverse Event|1|||
130715823|NCT00750308|470587031|FG000|First Treatment|Withdrawal by Subject|0|||
130715824|NCT00750308|470587032|FG001|First Treatment|Withdrawal by Subject|0|||
130715825|NCT00750308|470587033|FG002|First Treatment|Withdrawal by Subject|0|||
130715826|NCT00750308|470587034|FG003|First Treatment|Withdrawal by Subject|1|||
130715827|NCT00750308|470587035|FG004|First Treatment|Withdrawal by Subject|0|||
130715828|NCT00750308|470587036|FG005|First Treatment|Withdrawal by Subject|0|||
130715829|NCT00750308|470587037|FG006|First Treatment|Withdrawal by Subject|0|||
130715830|NCT00750308|470587038|FG007|First Treatment|Withdrawal by Subject|1|||
130715831|NCT00750308|470587039|FG008|First Treatment|Withdrawal by Subject|0|||
130715832|NCT00750308|470587040|FG009|First Treatment|Withdrawal by Subject|0|||
130715833|NCT00750308|470587041|FG010|First Treatment|Withdrawal by Subject|0|||
130715834|NCT00750308|470587042|FG011|First Treatment|Withdrawal by Subject|0|||
130715835|NCT00750308|470587031|FG000|Second Treatment|Adverse Event|0|||
130715836|NCT00750308|470587032|FG001|Second Treatment|Adverse Event|0|||
130715837|NCT00750308|470587033|FG002|Second Treatment|Adverse Event|0|||
130715838|NCT00750308|470587034|FG003|Second Treatment|Adverse Event|0|||
130715839|NCT00750308|470587035|FG004|Second Treatment|Adverse Event|0|||
130715840|NCT00750308|470587036|FG005|Second Treatment|Adverse Event|1|||
130715841|NCT00750308|470587037|FG006|Second Treatment|Adverse Event|0|||
130715842|NCT00750308|470587038|FG007|Second Treatment|Adverse Event|0|||
130715843|NCT00750308|470587039|FG008|Second Treatment|Adverse Event|1|||
130715844|NCT00750308|470587040|FG009|Second Treatment|Adverse Event|0|||
130715845|NCT00750308|470587041|FG010|Second Treatment|Adverse Event|0|||
130715846|NCT00750308|470587042|FG011|Second Treatment|Adverse Event|0|||
130715847|NCT00750308|470587031|FG000|Second Treatment|Withdrawal by Subject|0|||
130715848|NCT00750308|470587032|FG001|Second Treatment|Withdrawal by Subject|0|||
130715849|NCT00750308|470587033|FG002|Second Treatment|Withdrawal by Subject|0|||
130715850|NCT00750308|470587034|FG003|Second Treatment|Withdrawal by Subject|0|||
130715851|NCT00750308|470587035|FG004|Second Treatment|Withdrawal by Subject|1|||
130715852|NCT00750308|470587036|FG005|Second Treatment|Withdrawal by Subject|0|||
130715853|NCT00750308|470587037|FG006|Second Treatment|Withdrawal by Subject|0|||
130715854|NCT00750308|470587038|FG007|Second Treatment|Withdrawal by Subject|0|||
130715855|NCT00750308|470587039|FG008|Second Treatment|Withdrawal by Subject|0|||
130715856|NCT00750308|470587040|FG009|Second Treatment|Withdrawal by Subject|0|||
130715857|NCT00750308|470587041|FG010|Second Treatment|Withdrawal by Subject|0|||
130715858|NCT00750308|470587042|FG011|Second Treatment|Withdrawal by Subject|0|||
130715859|NCT00750308|470587031|FG000|Third Treatment|Withdrawal by Subject|0|||
130715860|NCT00750308|470587032|FG001|Third Treatment|Withdrawal by Subject|1|||
130715861|NCT00750308|470587033|FG002|Third Treatment|Withdrawal by Subject|0|||
130715862|NCT00750308|470587034|FG003|Third Treatment|Withdrawal by Subject|0|||
130715863|NCT00750308|470587035|FG004|Third Treatment|Withdrawal by Subject|0|||
130715864|NCT00750308|470587036|FG005|Third Treatment|Withdrawal by Subject|0|||
131041740|NCT03523572|471789289|FG000|Dose Escalation|Clinical Progression|0|||
131041741|NCT03523572|471789290|FG001|Dose Escalation|Clinical Progression|1|||
131041742|NCT03523572|471789291|FG002|Dose Escalation|Clinical Progression|0|||
130715865|NCT00750308|470587037|FG006|Third Treatment|Withdrawal by Subject|0|||
130715866|NCT00750308|470587038|FG007|Third Treatment|Withdrawal by Subject|0|||
130715867|NCT00750308|470587039|FG008|Third Treatment|Withdrawal by Subject|0|||
130715868|NCT00750308|470587040|FG009|Third Treatment|Withdrawal by Subject|0|||
130715869|NCT00750308|470587041|FG010|Third Treatment|Withdrawal by Subject|0|||
130715870|NCT00750308|470587042|FG011|Third Treatment|Withdrawal by Subject|0|||
130715871|NCT00513682|470587043|FG000|Washout Phase|Adverse Event|2|||
130715872|NCT02450526|470587044|FG000|DB Period (Cycle 1)|Adverse Event|0|||
130715873|NCT02450526|470587045|FG001|DB Period (Cycle 1)|Adverse Event|0|||
130715874|NCT02450526|470587046|FG002|DB Period (Cycle 1)|Adverse Event|2|||
130715875|NCT02450526|470587047|FG003|DB Period (Cycle 1)|Adverse Event|0|||
131041743|NCT03523572|471789292|FG003|Dose Escalation|Clinical Progression|0|||
130715876|NCT02450526|470587048|FG004|DB Period (Cycle 1)|Adverse Event|0|||
130715877|NCT02450526|470587044|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
130715878|NCT02450526|470587045|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
130715879|NCT02450526|470587046|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
130775625|NCT01919164|470806509|FG000|Overall Study|Disease progression|2|||
130775626|NCT01919164|470806510|FG001|Overall Study|Disease progression|2|||
130775627|NCT01919164|470806511|FG002|Overall Study|Disease progression|1|||
130775628|NCT01919164|470806512|FG003|Overall Study|Disease progression|2|||
130775629|NCT01919164|470806513|FG004|Overall Study|Disease progression|1|||
130775630|NCT01919164|470806509|FG000|Overall Study|Withdrew consent|13|||
130775631|NCT01919164|470806510|FG001|Overall Study|Withdrew consent|13|||
130775632|NCT01919164|470806511|FG002|Overall Study|Withdrew consent|14|||
130775633|NCT01919164|470806512|FG003|Overall Study|Withdrew consent|14|||
130775634|NCT01919164|470806513|FG004|Overall Study|Withdrew consent|9|||
130775635|NCT01919164|470806509|FG000|Overall Study|Other Un-specified|13|||
130775636|NCT01919164|470806510|FG001|Overall Study|Other Un-specified|9|||
130775637|NCT01919164|470806511|FG002|Overall Study|Other Un-specified|8|||
130964885|NCT02530619|471499560|FG000|Registered for Study|Withdrawal by Subject|2|||
130964886|NCT02530619|471499560|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
130964887|NCT02530619|471499560|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
130964888|NCT02530619|471499560|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
130964889|NCT02530619|471499560|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
130964890|NCT02530619|471499560|FG000|Follow-up Period (6 Months)|Death|4|||
130964891|NCT02530619|471499560|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
130964892|NCT02530619|471499560|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
130964893|NCT00009737|471499562|FG000|Overall Study|Adverse Event|112|||
130964894|NCT00009737|471499563|FG001|Overall Study|Adverse Event|75|||
130964895|NCT00009737|471499562|FG000|Overall Study|Death|4|||
130964896|NCT00009737|471499563|FG001|Overall Study|Death|6|||
130964897|NCT00009737|471499562|FG000|Overall Study|Lack of Efficacy|17|||
130964898|NCT00009737|471499563|FG001|Overall Study|Lack of Efficacy|15|||
130964899|NCT00009737|471499562|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
130964900|NCT00009737|471499563|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
130964901|NCT00009737|471499562|FG000|Overall Study|Other Protocol Violation|1|||
130964902|NCT00009737|471499563|FG001|Overall Study|Other Protocol Violation|0|||
130964903|NCT00009737|471499562|FG000|Overall Study|Refused Treatment|15|||
130964904|NCT00009737|471499563|FG001|Overall Study|Refused Treatment|16|||
130964905|NCT00009737|471499562|FG000|Overall Study|Lost to Follow-up|1|||
130964906|NCT00009737|471499563|FG001|Overall Study|Lost to Follow-up|1|||
130964907|NCT00009737|471499562|FG000|Overall Study|Administrative/Other Reasons|7|||
130964908|NCT00009737|471499563|FG001|Overall Study|Administrative/Other Reasons|1|||
130775638|NCT01919164|470806512|FG003|Overall Study|Other Un-specified|7|||
130775639|NCT01919164|470806513|FG004|Overall Study|Other Un-specified|15|||
130775640|NCT00588146|470806515|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
130775641|NCT00588146|470806516|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
130775642|NCT02100839|470806517|FG000|Multiple Ascending Dose|Adverse Event|2|||
130775643|NCT02100839|470806518|FG001|Multiple Ascending Dose|Adverse Event|0|||
130775644|NCT02100839|470806517|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
130775645|NCT02100839|470806518|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
130964909|NCT01163682|471499567|FG000|Overall Study|Lost to Follow-up|6|||
130964910|NCT01163682|471499568|FG001|Overall Study|Lost to Follow-up|9|||
131041744|NCT03523572|471789293|FG004|Dose Escalation|Clinical Progression|0|||
131041745|NCT03523572|471789294|FG005|Dose Escalation|Clinical Progression|0|||
131041746|NCT03523572|471789289|FG000|Dose Escalation|Adverse Event|2|||
131041747|NCT03523572|471789290|FG001|Dose Escalation|Adverse Event|0|||
131041748|NCT03523572|471789291|FG002|Dose Escalation|Adverse Event|0|||
131041749|NCT03523572|471789292|FG003|Dose Escalation|Adverse Event|0|||
131041750|NCT03523572|471789293|FG004|Dose Escalation|Adverse Event|0|||
131041751|NCT03523572|471789294|FG005|Dose Escalation|Adverse Event|0|||
131041752|NCT03523572|471789289|FG000|Dose Escalation|Physician Decision|1|||
131041753|NCT03523572|471789290|FG001|Dose Escalation|Physician Decision|1|||
131041754|NCT03523572|471789291|FG002|Dose Escalation|Physician Decision|0|||
131041755|NCT03523572|471789292|FG003|Dose Escalation|Physician Decision|0|||
131041756|NCT03523572|471789293|FG004|Dose Escalation|Physician Decision|0|||
131041757|NCT03523572|471789294|FG005|Dose Escalation|Physician Decision|0|||
131041758|NCT03523572|471789289|FG000|Dose Expansion|Progressive Disease|0|||
131041759|NCT03523572|471789290|FG001|Dose Expansion|Progressive Disease|0|||
131041760|NCT03523572|471789291|FG002|Dose Expansion|Progressive Disease|9|||
131041761|NCT03523572|471789292|FG003|Dose Expansion|Progressive Disease|11|||
131041762|NCT03523572|471789293|FG004|Dose Expansion|Progressive Disease|15|||
131041763|NCT03523572|471789294|FG005|Dose Expansion|Progressive Disease|2|||
131041764|NCT03523572|471789289|FG000|Dose Expansion|Clinical Progression|0|||
130775646|NCT02823470|470806519|FG000|Overall Study|Adverse Event|1|||
130775647|NCT02823470|470806520|FG001|Overall Study|Adverse Event|0|||
130775648|NCT02823470|470806519|FG000|Overall Study|Study terminated by sponsor|8|||
130964911|NCT00359762|471499571|FG000|Period II|Adverse Event|17|||
130964912|NCT00359762|471499572|FG001|Period II|Adverse Event|0|||
130964913|NCT00359762|471499573|FG002|Period II|Adverse Event|0|||
130964914|NCT00359762|471499574|FG003|Period II|Adverse Event|0|||
131041765|NCT03523572|471789290|FG001|Dose Expansion|Clinical Progression|0|||
130964915|NCT00359762|471499575|FG004|Period II|Adverse Event|49|||
130964916|NCT00359762|471499571|FG000|Period II|Protocol Violation|18|||
130964917|NCT00359762|471499572|FG001|Period II|Protocol Violation|0|||
130964918|NCT00359762|471499573|FG002|Period II|Protocol Violation|0|||
130964919|NCT00359762|471499574|FG003|Period II|Protocol Violation|0|||
130964920|NCT00359762|471499575|FG004|Period II|Protocol Violation|11|||
130964921|NCT00359762|471499571|FG000|Period II|Physician Decision|17|||
130964922|NCT00359762|471499572|FG001|Period II|Physician Decision|0|||
130964923|NCT00359762|471499573|FG002|Period II|Physician Decision|0|||
130964924|NCT00359762|471499574|FG003|Period II|Physician Decision|0|||
130964925|NCT00359762|471499575|FG004|Period II|Physician Decision|23|||
130964926|NCT00359762|471499571|FG000|Period II|Death|2|||
130964927|NCT00359762|471499572|FG001|Period II|Death|0|||
130964928|NCT00359762|471499573|FG002|Period II|Death|0|||
130964929|NCT00359762|471499574|FG003|Period II|Death|0|||
130964930|NCT00359762|471499575|FG004|Period II|Death|4|||
130964931|NCT00359762|471499571|FG000|Period II|Lack of Efficacy|11|||
130964932|NCT00359762|471499572|FG001|Period II|Lack of Efficacy|0|||
130964933|NCT00359762|471499573|FG002|Period II|Lack of Efficacy|0|||
130964934|NCT00359762|471499574|FG003|Period II|Lack of Efficacy|0|||
130964935|NCT00359762|471499575|FG004|Period II|Lack of Efficacy|8|||
130964936|NCT00359762|471499571|FG000|Period II|Lost to follow up|5|||
130964937|NCT00359762|471499572|FG001|Period II|Lost to follow up|0|||
130964938|NCT00359762|471499573|FG002|Period II|Lost to follow up|0|||
130964939|NCT00359762|471499574|FG003|Period II|Lost to follow up|0|||
130964940|NCT00359762|471499575|FG004|Period II|Lost to follow up|5|||
130964941|NCT00359762|471499571|FG000|Period II|Entry Criteria Not Met|8|||
130964942|NCT00359762|471499572|FG001|Period II|Entry Criteria Not Met|0|||
130964943|NCT00359762|471499573|FG002|Period II|Entry Criteria Not Met|0|||
130964944|NCT00359762|471499574|FG003|Period II|Entry Criteria Not Met|0|||
130964945|NCT00359762|471499575|FG004|Period II|Entry Criteria Not Met|4|||
130964946|NCT00359762|471499571|FG000|Period II|Subject Decision|50|||
130964947|NCT00359762|471499572|FG001|Period II|Subject Decision|0|||
130964948|NCT00359762|471499573|FG002|Period II|Subject Decision|0|||
131041766|NCT03523572|471789291|FG002|Dose Expansion|Clinical Progression|2|||
131041767|NCT03523572|471789292|FG003|Dose Expansion|Clinical Progression|2|||
131041768|NCT03523572|471789293|FG004|Dose Expansion|Clinical Progression|2|||
130715880|NCT02450526|470587047|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
130715881|NCT02450526|470587048|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
130715882|NCT02450526|470587044|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
130715883|NCT02450526|470587045|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
130715884|NCT02450526|470587046|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
130715885|NCT02450526|470587047|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
130715886|NCT02450526|470587048|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
130715887|NCT02450526|470587044|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
130715888|NCT02450526|470587045|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
130715889|NCT02450526|470587046|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
130715890|NCT02450526|470587047|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
130715891|NCT02450526|470587048|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
130715892|NCT02450526|470587044|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
130715893|NCT02450526|470587045|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
130715894|NCT02450526|470587046|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
130715895|NCT02450526|470587047|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
130715896|NCT02450526|470587048|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
130715897|NCT02450526|470587044|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130715898|NCT02450526|470587045|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130715899|NCT02450526|470587046|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130715900|NCT02450526|470587047|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130715901|NCT02450526|470587048|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
130715902|NCT02450526|470587044|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130715903|NCT02450526|470587045|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130715904|NCT02450526|470587046|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130715905|NCT02450526|470587047|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130715906|NCT02450526|470587048|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
130715907|NCT02450526|470587044|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
130715908|NCT02450526|470587045|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
130715909|NCT02450526|470587046|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
130964949|NCT00359762|471499574|FG003|Period II|Subject Decision|0|||
130964950|NCT00359762|471499575|FG004|Period II|Subject Decision|70|||
130964951|NCT00359762|471499571|FG000|Period III|Protocol Violation|0|||
130964952|NCT00359762|471499572|FG001|Period III|Protocol Violation|5|||
130964953|NCT00359762|471499573|FG002|Period III|Protocol Violation|3|||
130964954|NCT00359762|471499574|FG003|Period III|Protocol Violation|8|||
130964955|NCT00359762|471499575|FG004|Period III|Protocol Violation|0|||
130964956|NCT00359762|471499571|FG000|Period III|Adverse Event|0|||
130964957|NCT00359762|471499572|FG001|Period III|Adverse Event|3|||
130964958|NCT00359762|471499573|FG002|Period III|Adverse Event|4|||
130964959|NCT00359762|471499574|FG003|Period III|Adverse Event|10|||
130964960|NCT00359762|471499575|FG004|Period III|Adverse Event|0|||
130964961|NCT00359762|471499571|FG000|Period III|Physician Decision|0|||
130964962|NCT00359762|471499572|FG001|Period III|Physician Decision|5|||
130964963|NCT00359762|471499573|FG002|Period III|Physician Decision|9|||
130964964|NCT00359762|471499574|FG003|Period III|Physician Decision|15|||
130964965|NCT00359762|471499575|FG004|Period III|Physician Decision|0|||
130964966|NCT00359762|471499571|FG000|Period III|Lack of Efficacy|0|||
130964967|NCT00359762|471499572|FG001|Period III|Lack of Efficacy|7|||
130964968|NCT00359762|471499573|FG002|Period III|Lack of Efficacy|5|||
130964969|NCT00359762|471499574|FG003|Period III|Lack of Efficacy|9|||
130964970|NCT00359762|471499575|FG004|Period III|Lack of Efficacy|0|||
130964971|NCT00359762|471499571|FG000|Period III|Lost to follow up|0|||
130964972|NCT00359762|471499572|FG001|Period III|Lost to follow up|1|||
130964973|NCT00359762|471499573|FG002|Period III|Lost to follow up|1|||
130964974|NCT00359762|471499574|FG003|Period III|Lost to follow up|2|||
130964975|NCT00359762|471499575|FG004|Period III|Lost to follow up|0|||
130964976|NCT00359762|471499571|FG000|Period III|Entry Criteria Not Met|0|||
130964977|NCT00359762|471499572|FG001|Period III|Entry Criteria Not Met|1|||
130964978|NCT00359762|471499573|FG002|Period III|Entry Criteria Not Met|0|||
130964979|NCT00359762|471499574|FG003|Period III|Entry Criteria Not Met|1|||
130964980|NCT00359762|471499575|FG004|Period III|Entry Criteria Not Met|0|||
131226877|NCT00606684|472457716|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
131226878|NCT00606684|472457717|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
131226879|NCT00606684|472457718|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
131226880|NCT00606684|472457712|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
131226881|NCT00606684|472457713|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
131226882|NCT00606684|472457714|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
131226883|NCT00606684|472457715|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
131226884|NCT00606684|472457716|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
131226885|NCT00606684|472457717|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
130964981|NCT00359762|471499571|FG000|Period III|Subject Decision|0|||
130964982|NCT00359762|471499572|FG001|Period III|Subject Decision|7|||
130715910|NCT02450526|470587047|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
130715911|NCT02450526|470587048|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
130715912|NCT00502801|470587049|FG000|Treatment Period|Withdrawal by Subject|3|||
130715913|NCT00502801|470587049|FG000|Treatment Period|Adverse Event|7|||
130715914|NCT00502801|470587049|FG000|Treatment Period|Death|14|||
130715915|NCT00502801|470587049|FG000|Treatment Period|OTHER|30|||
130715916|NCT00502801|470587049|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
130715917|NCT00502801|470587049|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
130715918|NCT00502801|470587049|FG000|End of Therapy to Test of Cure|Death|3|||
130715919|NCT00502801|470587049|FG000|End of Therapy to Test of Cure|OTHER|2|||
130715920|NCT03212521|470587053|FG000|Overall Study|Adverse Event|1|||
130715921|NCT03212521|470587053|FG000|Overall Study|Lost to Follow-up|4|||
130715922|NCT03212521|470587053|FG000|Overall Study|Withdrawal by Subject|1|||
130715923|NCT03212521|470587053|FG000|Overall Study|Other|1|||
130715924|NCT02435836|470587054|FG000|Overall Study|Lost to Follow-up|21|||
130715925|NCT02435836|470587054|FG000|Overall Study|Lack of Efficacy|1|||
130715926|NCT02435836|470587054|FG000|Overall Study|Withdrawal by Subject|236|||
130715927|NCT02435836|470587054|FG000|Overall Study|Insufficient Clinical Response|26|||
130715928|NCT02435836|470587054|FG000|Overall Study|Adverse Event|44|||
130715929|NCT02435836|470587054|FG000|Overall Study|Sponsor discontinued trial|167|||
130715930|NCT02435836|470587054|FG000|Overall Study|Noncompliance|27|||
130715931|NCT02435836|470587054|FG000|Overall Study|Protocol Violation|6|||
130715932|NCT02435836|470587054|FG000|Overall Study|Met Withdrawal Criteria|7|||
130715933|NCT02435836|470587054|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
130715934|NCT01970865|470587055|FG000|Overall Study|Death|3|||
130715935|NCT01970865|470587056|FG001|Overall Study|Death|2|||
130715936|NCT01970865|470587057|FG002|Overall Study|Death|3|||
130715937|NCT01970865|470587058|FG003|Overall Study|Death|6|||
130715938|NCT01970865|470587059|FG004|Overall Study|Death|9|||
130715939|NCT01970865|470587060|FG005|Overall Study|Death|3|||
130715940|NCT01970865|470587061|FG006|Overall Study|Death|2|||
130715941|NCT01970865|470587062|FG007|Overall Study|Death|3|||
130715942|NCT01970865|470587063|FG008|Overall Study|Death|2|||
130964983|NCT00359762|471499573|FG002|Period III|Subject Decision|8|||
130715943|NCT01970865|470587064|FG009|Overall Study|Death|2|||
130715944|NCT01970865|470587065|FG010|Overall Study|Death|8|||
130715945|NCT01970865|470587066|FG011|Overall Study|Death|13|||
130715946|NCT01970865|470587067|FG012|Overall Study|Death|25|||
130964984|NCT00359762|471499574|FG003|Period III|Subject Decision|20|||
130715947|NCT01970865|470587068|FG013|Overall Study|Death|46|||
130715948|NCT01970865|470587069|FG014|Overall Study|Death|37|||
130715949|NCT01970865|470587070|FG015|Overall Study|Death|22|||
130964985|NCT00359762|471499575|FG004|Period III|Subject Decision|0|||
130964986|NCT01033747|471499579|FG000|Overall Study|Adverse Event|9|||
130964987|NCT01033747|471499580|FG001|Overall Study|Adverse Event|4|||
130964988|NCT01033747|471499579|FG000|Overall Study|Abnormal Laboratory Value|1|||
130715950|NCT01970865|470587071|FG016|Overall Study|Death|1|||
130964989|NCT01033747|471499580|FG001|Overall Study|Abnormal Laboratory Value|0|||
130715951|NCT01970865|470587072|FG017|Overall Study|Death|17|||
130715952|NCT01970865|470587055|FG000|Overall Study|Lost to Follow-up|0|||
130964990|NCT01033747|471499579|FG000|Overall Study|Abnormal test procedure|0|||
130964991|NCT01033747|471499580|FG001|Overall Study|Abnormal test procedure|1|||
130964992|NCT01033747|471499579|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
130964993|NCT01033747|471499580|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130964994|NCT01033747|471499579|FG000|Overall Study|Protocol Violation|1|||
130964995|NCT01033747|471499580|FG001|Overall Study|Protocol Violation|0|||
130964996|NCT01033747|471499579|FG000|Overall Study|Withdrawal by Subject|9|||
130964997|NCT01033747|471499580|FG001|Overall Study|Withdrawal by Subject|6|||
131127919|NCT01351389|472097624|FG000|Overall Study|did not complete intervention|23|||
131127920|NCT01351389|472097625|FG001|Overall Study|did not complete intervention|15|||
131127921|NCT02646982|472097626|FG000|Overall Study|Adverse Event|1|||
131127922|NCT02646982|472097627|FG001|Overall Study|Adverse Event|1|||
131127923|NCT02646982|472097626|FG000|Overall Study|Withdrawal by Subject|2|||
131127924|NCT02646982|472097627|FG001|Overall Study|Withdrawal by Subject|1|||
131127925|NCT00713700|472097628|FG000|Overall Study|Lost to Follow-up|3|||
131127926|NCT00713700|472097628|FG000|Overall Study|Withdrawal by Subject|1|||
131127927|NCT01594853|472097629|FG000|Overall Study|Withdrawal by Subject|1|||
131127928|NCT01594853|472097630|FG001|Overall Study|Withdrawal by Subject|1|||
131127929|NCT01594853|472097629|FG000|Overall Study|Lost to Follow-up|1|||
131127930|NCT01594853|472097630|FG001|Overall Study|Lost to Follow-up|1|||
131127931|NCT01594853|472097629|FG000|Overall Study|noncompliance with exercise|0|||
131127932|NCT01594853|472097630|FG001|Overall Study|noncompliance with exercise|1|||
131127933|NCT03923426|472097632|FG000|Overall Study|Other|19|||
130715953|NCT01970865|470587056|FG001|Overall Study|Lost to Follow-up|0|||
130715954|NCT01970865|470587057|FG002|Overall Study|Lost to Follow-up|0|||
130715955|NCT01970865|470587058|FG003|Overall Study|Lost to Follow-up|1|||
130715956|NCT01970865|470587059|FG004|Overall Study|Lost to Follow-up|1|||
130715957|NCT01970865|470587060|FG005|Overall Study|Lost to Follow-up|0|||
130715958|NCT01970865|470587061|FG006|Overall Study|Lost to Follow-up|0|||
130715959|NCT01970865|470587062|FG007|Overall Study|Lost to Follow-up|0|||
130715960|NCT01970865|470587063|FG008|Overall Study|Lost to Follow-up|0|||
130715961|NCT01970865|470587064|FG009|Overall Study|Lost to Follow-up|0|||
130715962|NCT01970865|470587065|FG010|Overall Study|Lost to Follow-up|1|||
130715963|NCT01970865|470587066|FG011|Overall Study|Lost to Follow-up|0|||
130715964|NCT01970865|470587067|FG012|Overall Study|Lost to Follow-up|2|||
130715965|NCT01970865|470587068|FG013|Overall Study|Lost to Follow-up|0|||
130715966|NCT01970865|470587069|FG014|Overall Study|Lost to Follow-up|1|||
130715967|NCT01970865|470587070|FG015|Overall Study|Lost to Follow-up|4|||
130715968|NCT01970865|470587071|FG016|Overall Study|Lost to Follow-up|0|||
130715969|NCT01970865|470587072|FG017|Overall Study|Lost to Follow-up|1|||
130715970|NCT01970865|470587055|FG000|Overall Study|Other|0|||
130715971|NCT01970865|470587056|FG001|Overall Study|Other|1|||
130715972|NCT01970865|470587057|FG002|Overall Study|Other|0|||
130715973|NCT01970865|470587058|FG003|Overall Study|Other|1|||
130715974|NCT01970865|470587059|FG004|Overall Study|Other|1|||
130715975|NCT01970865|470587060|FG005|Overall Study|Other|0|||
130715976|NCT01970865|470587061|FG006|Overall Study|Other|1|||
130715977|NCT01970865|470587062|FG007|Overall Study|Other|0|||
130715978|NCT01970865|470587063|FG008|Overall Study|Other|0|||
130715979|NCT01970865|470587064|FG009|Overall Study|Other|0|||
130715980|NCT01970865|470587065|FG010|Overall Study|Other|2|||
130715981|NCT01970865|470587066|FG011|Overall Study|Other|3|||
130715982|NCT01970865|470587067|FG012|Overall Study|Other|8|||
130715983|NCT01970865|470587068|FG013|Overall Study|Other|3|||
130715984|NCT01970865|470587069|FG014|Overall Study|Other|2|||
130715985|NCT01970865|470587070|FG015|Overall Study|Other|3|||
130715986|NCT01970865|470587071|FG016|Overall Study|Other|0|||
130715987|NCT01970865|470587072|FG017|Overall Study|Other|2|||
130715988|NCT01970865|470587055|FG000|Overall Study|Participant refused further follow-up|0|||
130715989|NCT01970865|470587056|FG001|Overall Study|Participant refused further follow-up|0|||
130715990|NCT01970865|470587057|FG002|Overall Study|Participant refused further follow-up|0|||
130715991|NCT01970865|470587058|FG003|Overall Study|Participant refused further follow-up|2|||
130715992|NCT01970865|470587059|FG004|Overall Study|Participant refused further follow-up|3|||
130715993|NCT01970865|470587060|FG005|Overall Study|Participant refused further follow-up|0|||
130715994|NCT01970865|470587061|FG006|Overall Study|Participant refused further follow-up|0|||
130964998|NCT01033747|471499579|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
130715995|NCT01970865|470587062|FG007|Overall Study|Participant refused further follow-up|0|||
130715996|NCT01970865|470587063|FG008|Overall Study|Participant refused further follow-up|0|||
130715997|NCT01970865|470587064|FG009|Overall Study|Participant refused further follow-up|0|||
130715998|NCT01970865|470587065|FG010|Overall Study|Participant refused further follow-up|1|||
130715999|NCT01970865|470587066|FG011|Overall Study|Participant refused further follow-up|4|||
130964999|NCT01033747|471499580|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
131127934|NCT03923426|472097632|FG000|Overall Study|Lost to Follow-up|16|||
131127935|NCT03923426|472097632|FG000|Overall Study|Death|107|||
131127936|NCT03923426|472097632|FG000|Overall Study|Incomplete response to question|13|||
130965000|NCT01033747|471499579|FG000|Overall Study|Stopped at end of Extension 1|2|||
130965001|NCT01033747|471499580|FG001|Overall Study|Stopped at end of Extension 1|0|||
130965002|NCT02956629|471499581|FG000|Overall Study|Adverse Event|0|||
130965003|NCT02956629|471499582|FG001|Overall Study|Adverse Event|0|||
130965004|NCT02956629|471499583|FG002|Overall Study|Adverse Event|1|||
130965005|NCT02956629|471499584|FG003|Overall Study|Adverse Event|0|||
130965006|NCT02956629|471499585|FG004|Overall Study|Adverse Event|0|||
130965007|NCT02956629|471499586|FG005|Overall Study|Adverse Event|0|||
130716000|NCT01970865|470587067|FG012|Overall Study|Participant refused further follow-up|7|||
130716001|NCT01970865|470587068|FG013|Overall Study|Participant refused further follow-up|8|||
130716002|NCT01970865|470587069|FG014|Overall Study|Participant refused further follow-up|3|||
130716003|NCT01970865|470587070|FG015|Overall Study|Participant refused further follow-up|11|||
130716004|NCT01970865|470587071|FG016|Overall Study|Participant refused further follow-up|0|||
130716005|NCT01970865|470587072|FG017|Overall Study|Participant refused further follow-up|6|||
130716006|NCT02041091|470587075|FG000|Treatment|Adverse Event|3|||
130716007|NCT02041091|470587076|FG001|Treatment|Adverse Event|3|||
130716008|NCT02041091|470587075|FG000|Treatment|Withdrawal by Subject|2|||
130716009|NCT02041091|470587076|FG001|Treatment|Withdrawal by Subject|4|||
130716010|NCT02041091|470587075|FG000|Treatment|Physician Decision|1|||
130716011|NCT02041091|470587076|FG001|Treatment|Physician Decision|0|||
130716012|NCT02041091|470587075|FG000|Treatment|Sponsor Decision|15|||
130716013|NCT02041091|470587076|FG001|Treatment|Sponsor Decision|16|||
130716014|NCT02041091|470587075|FG000|Treatment|Lost to Follow-up|1|||
130716015|NCT02041091|470587076|FG001|Treatment|Lost to Follow-up|0|||
130716016|NCT02041091|470587075|FG000|Optional Safety Extension Period|Adverse Event|4|||
130716017|NCT02041091|470587076|FG001|Optional Safety Extension Period|Adverse Event|2|||
130716018|NCT02041091|470587075|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
130716019|NCT02041091|470587076|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
130716020|NCT02041091|470587075|FG000|Optional Safety Extension Period|Protocol Violation|2|||
130716021|NCT02041091|470587076|FG001|Optional Safety Extension Period|Protocol Violation|0|||
130716022|NCT02041091|470587075|FG000|Optional Safety Extension Period|Physician Decision|2|||
130716023|NCT02041091|470587076|FG001|Optional Safety Extension Period|Physician Decision|1|||
130716024|NCT02041091|470587075|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
130716025|NCT02041091|470587076|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
130716026|NCT02041091|470587075|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
130716027|NCT02041091|470587076|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
130716028|NCT01855074|470587077|FG000|Overall Study|Adverse Event|1|||
130716029|NCT01855074|470587077|FG000|Overall Study|Lost to Follow-up|4|||
130716030|NCT01855074|470587077|FG000|Overall Study|Withdrawal by Subject|8|||
130716031|NCT01855074|470587077|FG000|Overall Study|Started but not treated|1|||
130716032|NCT01150890|470587078|FG000|Overall Study|Other|0|||
130716033|NCT01150890|470587079|FG001|Overall Study|Other|1|||
130716034|NCT01150890|470587080|FG002|Overall Study|Other|0|||
130716035|NCT01150890|470587081|FG003|Overall Study|Other|2|||
130716036|NCT01150890|470587078|FG000|Overall Study|Pregnancy|0|||
130716037|NCT01150890|470587079|FG001|Overall Study|Pregnancy|0|||
130716038|NCT01150890|470587080|FG002|Overall Study|Pregnancy|0|||
130716039|NCT01150890|470587081|FG003|Overall Study|Pregnancy|1|||
130716040|NCT01150890|470587078|FG000|Overall Study|Administrative Decision|4|||
130716041|NCT01150890|470587079|FG001|Overall Study|Administrative Decision|4|||
130716042|NCT01150890|470587080|FG002|Overall Study|Administrative Decision|5|||
130716043|NCT01150890|470587081|FG003|Overall Study|Administrative Decision|6|||
130716044|NCT01150890|470587078|FG000|Overall Study|Ineligibility determined|0|||
130716045|NCT01150890|470587079|FG001|Overall Study|Ineligibility determined|1|||
130716046|NCT01150890|470587080|FG002|Overall Study|Ineligibility determined|0|||
130965008|NCT02956629|471499581|FG000|Overall Study|Lost to Follow-up|2|||
130965009|NCT02956629|471499582|FG001|Overall Study|Lost to Follow-up|5|||
130965010|NCT02956629|471499583|FG002|Overall Study|Lost to Follow-up|3|||
130965011|NCT02956629|471499584|FG003|Overall Study|Lost to Follow-up|1|||
130965012|NCT02956629|471499585|FG004|Overall Study|Lost to Follow-up|0|||
130965013|NCT02956629|471499586|FG005|Overall Study|Lost to Follow-up|1|||
130965014|NCT02956629|471499581|FG000|Overall Study|Withdrawal by Subject|3|||
130965015|NCT02956629|471499582|FG001|Overall Study|Withdrawal by Subject|1|||
130965016|NCT02956629|471499583|FG002|Overall Study|Withdrawal by Subject|0|||
130965017|NCT02956629|471499584|FG003|Overall Study|Withdrawal by Subject|0|||
130965018|NCT02956629|471499585|FG004|Overall Study|Withdrawal by Subject|0|||
130965019|NCT02956629|471499586|FG005|Overall Study|Withdrawal by Subject|0|||
130965020|NCT04808609|471499591|FG000|Overall Study|Lost to Follow-up|0|||
130965021|NCT04808609|471499592|FG001|Overall Study|Lost to Follow-up|2|||
130965022|NCT04808609|471499591|FG000|Overall Study|Administrative Withdrawal|0|||
130965023|NCT04808609|471499592|FG001|Overall Study|Administrative Withdrawal|1|||
130965024|NCT01993719|471499595|FG000|First Drug Administration|Not treated|1|||
130965025|NCT01993719|471499596|FG001|First Drug Administration|Not treated|0|||
130965026|NCT01993719|471499597|FG002|First Drug Administration|Not treated|0|||
130965027|NCT01993719|471499598|FG003|First Drug Administration|Not treated|0|||
131041769|NCT03523572|471789294|FG005|Dose Expansion|Clinical Progression|0|||
130965028|NCT01993719|471499599|FG004|First Drug Administration|Not treated|0|||
130965029|NCT01931839|471499603|FG000|Overall Study|Death|0|||
130965030|NCT01931839|471499604|FG001|Overall Study|Death|1|||
130965031|NCT01931839|471499605|FG002|Overall Study|Death|2|||
130965032|NCT01931839|471499606|FG003|Overall Study|Death|0|||
130965033|NCT01931839|471499607|FG004|Overall Study|Death|0|||
130965034|NCT01931839|471499608|FG005|Overall Study|Death|0|||
130965035|NCT01931839|471499609|FG006|Overall Study|Death|0|||
130965036|NCT01931839|471499603|FG000|Overall Study|Physician Decision|1|||
130965037|NCT01931839|471499604|FG001|Overall Study|Physician Decision|0|||
130965038|NCT01931839|471499605|FG002|Overall Study|Physician Decision|1|||
130965039|NCT01931839|471499606|FG003|Overall Study|Physician Decision|0|||
130965040|NCT01931839|471499607|FG004|Overall Study|Physician Decision|0|||
130965041|NCT01931839|471499608|FG005|Overall Study|Physician Decision|0|||
130965042|NCT01931839|471499609|FG006|Overall Study|Physician Decision|1|||
130965043|NCT01931839|471499603|FG000|Overall Study|Withdrawal of consent|0|||
130965044|NCT01931839|471499604|FG001|Overall Study|Withdrawal of consent|0|||
130965045|NCT01931839|471499605|FG002|Overall Study|Withdrawal of consent|0|||
130965046|NCT01931839|471499606|FG003|Overall Study|Withdrawal of consent|0|||
130965047|NCT01931839|471499607|FG004|Overall Study|Withdrawal of consent|1|||
130965048|NCT01931839|471499608|FG005|Overall Study|Withdrawal of consent|0|||
130965049|NCT01931839|471499609|FG006|Overall Study|Withdrawal of consent|0|||
130965050|NCT01931839|471499603|FG000|Overall Study|Adverse Event|9|||
130965051|NCT01931839|471499604|FG001|Overall Study|Adverse Event|4|||
130965052|NCT01931839|471499605|FG002|Overall Study|Adverse Event|1|||
130965053|NCT01931839|471499606|FG003|Overall Study|Adverse Event|3|||
130965054|NCT01931839|471499607|FG004|Overall Study|Adverse Event|0|||
130965055|NCT01931839|471499608|FG005|Overall Study|Adverse Event|0|||
130965056|NCT01931839|471499609|FG006|Overall Study|Adverse Event|1|||
130965057|NCT01931839|471499603|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
130965058|NCT01931839|471499604|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
130965059|NCT01931839|471499605|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
130965060|NCT01931839|471499606|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
130965061|NCT01931839|471499607|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
130965062|NCT01931839|471499608|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
130965063|NCT01931839|471499609|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
130965064|NCT01931839|471499603|FG000|Overall Study|Other non-compliance|15|||
130965065|NCT01931839|471499604|FG001|Overall Study|Other non-compliance|9|||
130965066|NCT01931839|471499605|FG002|Overall Study|Other non-compliance|12|||
130965067|NCT01931839|471499606|FG003|Overall Study|Other non-compliance|3|||
130965068|NCT01931839|471499607|FG004|Overall Study|Other non-compliance|0|||
130965069|NCT01931839|471499608|FG005|Overall Study|Other non-compliance|3|||
130965070|NCT01931839|471499609|FG006|Overall Study|Other non-compliance|0|||
130965071|NCT01931839|471499603|FG000|Overall Study|Lost to Follow-up|1|||
130965072|NCT01931839|471499604|FG001|Overall Study|Lost to Follow-up|2|||
130965073|NCT01931839|471499605|FG002|Overall Study|Lost to Follow-up|4|||
130965074|NCT01931839|471499606|FG003|Overall Study|Lost to Follow-up|5|||
130965075|NCT01931839|471499607|FG004|Overall Study|Lost to Follow-up|0|||
130965076|NCT01931839|471499608|FG005|Overall Study|Lost to Follow-up|0|||
130965077|NCT01931839|471499609|FG006|Overall Study|Lost to Follow-up|0|||
131041770|NCT03523572|471789289|FG000|Dose Expansion|Adverse Event|0|||
131041771|NCT03523572|471789290|FG001|Dose Expansion|Adverse Event|0|||
131041772|NCT03523572|471789291|FG002|Dose Expansion|Adverse Event|10|||
131041773|NCT03523572|471789292|FG003|Dose Expansion|Adverse Event|1|||
131041774|NCT03523572|471789293|FG004|Dose Expansion|Adverse Event|5|||
131041775|NCT03523572|471789294|FG005|Dose Expansion|Adverse Event|2|||
131127937|NCT00769002|472097633|FG000|Overall Study|Study was not completed, no data|9|||
131127938|NCT00769002|472097634|FG001|Overall Study|Study was not completed, no data|9|||
131127939|NCT00960661|472097640|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
130965078|NCT01931839|471499603|FG000|Overall Study|Other|4|||
131041776|NCT03523572|471789289|FG000|Dose Expansion|Withdrawal by Subject|0|||
131041777|NCT03523572|471789290|FG001|Dose Expansion|Withdrawal by Subject|0|||
131041778|NCT03523572|471789291|FG002|Dose Expansion|Withdrawal by Subject|1|||
131041779|NCT03523572|471789292|FG003|Dose Expansion|Withdrawal by Subject|1|||
131041780|NCT03523572|471789293|FG004|Dose Expansion|Withdrawal by Subject|0|||
131041781|NCT03523572|471789294|FG005|Dose Expansion|Withdrawal by Subject|0|||
130965079|NCT01931839|471499604|FG001|Overall Study|Other|2|||
130965080|NCT01931839|471499605|FG002|Overall Study|Other|6|||
130965081|NCT01931839|471499606|FG003|Overall Study|Other|0|||
130965082|NCT01931839|471499607|FG004|Overall Study|Other|0|||
130965083|NCT01931839|471499608|FG005|Overall Study|Other|0|||
130965084|NCT01931839|471499609|FG006|Overall Study|Other|0|||
131041782|NCT03523572|471789289|FG000|Dose Expansion|Physician Decision|0|||
131041783|NCT03523572|471789290|FG001|Dose Expansion|Physician Decision|0|||
131041784|NCT03523572|471789291|FG002|Dose Expansion|Physician Decision|1|||
130965085|NCT04382326|471499610|FG000|Overall Study|Adverse Event, not serious|1|||
130965086|NCT04382326|471499611|FG001|Overall Study|Adverse Event, not serious|2|||
131127940|NCT00960661|472097641|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
130965087|NCT04382326|471499610|FG000|Overall Study|Other|1|||
130965088|NCT04382326|471499611|FG001|Overall Study|Other|0|||
130965089|NCT04382326|471499610|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
130965090|NCT04382326|471499611|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
130965091|NCT04382326|471499610|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
130965092|NCT04382326|471499611|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
130965093|NCT04382326|471499610|FG000|Overall Study|Protocol Violation|29|||
130965094|NCT04382326|471499611|FG001|Overall Study|Protocol Violation|23|||
130965095|NCT04382326|471499610|FG000|Overall Study|Physician Decision|0|||
130965096|NCT04382326|471499611|FG001|Overall Study|Physician Decision|1|||
130965097|NCT04382326|471499610|FG000|Overall Study|Lost to Follow-up|48|||
130965098|NCT04382326|471499611|FG001|Overall Study|Lost to Follow-up|63|||
130965099|NCT04382326|471499610|FG000|Overall Study|Adverse Event, non-fatal|1|||
130965100|NCT04382326|471499611|FG001|Overall Study|Adverse Event, non-fatal|1|||
130965101|NCT01762761|471499612|FG000|Overall Study|Adverse Event|15|||
130965102|NCT01762761|471499613|FG001|Overall Study|Adverse Event|17|||
130965103|NCT01762761|471499612|FG000|Overall Study|Lack of Efficacy|9|||
130965104|NCT01762761|471499613|FG001|Overall Study|Lack of Efficacy|25|||
130965105|NCT01762761|471499612|FG000|Overall Study|Protocol Violation|1|||
130965106|NCT01762761|471499613|FG001|Overall Study|Protocol Violation|1|||
130965107|NCT01762761|471499612|FG000|Overall Study|Study closed/terminated|0|||
130965108|NCT01762761|471499613|FG001|Overall Study|Study closed/terminated|2|||
130965109|NCT01762761|471499612|FG000|Overall Study|Lost to Follow-up|3|||
130965110|NCT01762761|471499613|FG001|Overall Study|Lost to Follow-up|6|||
130965111|NCT01762761|471499612|FG000|Overall Study|Physician Decision|4|||
130965112|NCT01762761|471499613|FG001|Overall Study|Physician Decision|6|||
130965113|NCT01762761|471499612|FG000|Overall Study|Withdrawal by Subject|7|||
130965114|NCT01762761|471499613|FG001|Overall Study|Withdrawal by Subject|8|||
130965115|NCT02352493|471499614|FG000|Overall Study|Pregnancy|0|||
130965116|NCT02352493|471499615|FG001|Overall Study|Pregnancy|0|||
130965117|NCT02352493|471499616|FG002|Overall Study|Pregnancy|0|||
130965118|NCT02352493|471499617|FG003|Overall Study|Pregnancy|0|||
130965119|NCT02352493|471499618|FG004|Overall Study|Pregnancy|0|||
130965120|NCT02352493|471499619|FG005|Overall Study|Pregnancy|0|||
130965121|NCT02352493|471499620|FG006|Overall Study|Pregnancy|1|||
130965122|NCT02352493|471499621|FG007|Overall Study|Pregnancy|0|||
130965123|NCT02352493|471499622|FG008|Overall Study|Pregnancy|1|||
130965124|NCT02352493|471499623|FG009|Overall Study|Pregnancy|0|||
130965125|NCT02352493|471499624|FG010|Overall Study|Pregnancy|0|||
130965126|NCT02352493|471499625|FG011|Overall Study|Pregnancy|0|||
130965127|NCT02352493|471499626|FG012|Overall Study|Pregnancy|0|||
130965128|NCT02352493|471499627|FG013|Overall Study|Pregnancy|0|||
130965129|NCT02352493|471499628|FG014|Overall Study|Pregnancy|0|||
130965130|NCT02352493|471499629|FG015|Overall Study|Pregnancy|0|||
130965131|NCT02352493|471499630|FG016|Overall Study|Pregnancy|0|||
130965132|NCT02352493|471499631|FG017|Overall Study|Pregnancy|0|||
130965133|NCT02352493|471499614|FG000|Overall Study|Withdrawal by Subject|0|||
130965134|NCT02352493|471499615|FG001|Overall Study|Withdrawal by Subject|0|||
130965135|NCT02352493|471499616|FG002|Overall Study|Withdrawal by Subject|0|||
130965136|NCT02352493|471499617|FG003|Overall Study|Withdrawal by Subject|0|||
130965137|NCT02352493|471499618|FG004|Overall Study|Withdrawal by Subject|0|||
130965138|NCT02352493|471499619|FG005|Overall Study|Withdrawal by Subject|0|||
130965139|NCT02352493|471499620|FG006|Overall Study|Withdrawal by Subject|0|||
130965140|NCT02352493|471499621|FG007|Overall Study|Withdrawal by Subject|0|||
130965141|NCT02352493|471499622|FG008|Overall Study|Withdrawal by Subject|1|||
130965142|NCT02352493|471499623|FG009|Overall Study|Withdrawal by Subject|0|||
130965143|NCT02352493|471499624|FG010|Overall Study|Withdrawal by Subject|0|||
131127941|NCT00960661|472097642|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
131127942|NCT00960661|472097640|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
131127943|NCT00960661|472097641|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
131127944|NCT00960661|472097642|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
131127945|NCT00960661|472097640|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
130965144|NCT02352493|471499625|FG011|Overall Study|Withdrawal by Subject|0|||
130965145|NCT02352493|471499626|FG012|Overall Study|Withdrawal by Subject|0|||
130965146|NCT02352493|471499627|FG013|Overall Study|Withdrawal by Subject|0|||
130965147|NCT02352493|471499628|FG014|Overall Study|Withdrawal by Subject|1|||
130965148|NCT02352493|471499629|FG015|Overall Study|Withdrawal by Subject|0|||
130965149|NCT02352493|471499630|FG016|Overall Study|Withdrawal by Subject|0|||
130965150|NCT02352493|471499631|FG017|Overall Study|Withdrawal by Subject|0|||
130965151|NCT02352493|471499614|FG000|Overall Study|Lost to Follow-up|0|||
130965152|NCT02352493|471499615|FG001|Overall Study|Lost to Follow-up|0|||
130965153|NCT02352493|471499616|FG002|Overall Study|Lost to Follow-up|0|||
130965154|NCT02352493|471499617|FG003|Overall Study|Lost to Follow-up|0|||
130965155|NCT02352493|471499618|FG004|Overall Study|Lost to Follow-up|0|||
130965156|NCT02352493|471499619|FG005|Overall Study|Lost to Follow-up|0|||
130965157|NCT02352493|471499620|FG006|Overall Study|Lost to Follow-up|0|||
130965158|NCT02352493|471499621|FG007|Overall Study|Lost to Follow-up|0|||
130965159|NCT02352493|471499622|FG008|Overall Study|Lost to Follow-up|0|||
130965160|NCT02352493|471499623|FG009|Overall Study|Lost to Follow-up|1|||
130965161|NCT02352493|471499624|FG010|Overall Study|Lost to Follow-up|0|||
130965162|NCT02352493|471499625|FG011|Overall Study|Lost to Follow-up|0|||
130965163|NCT02352493|471499626|FG012|Overall Study|Lost to Follow-up|1|||
130965164|NCT02352493|471499627|FG013|Overall Study|Lost to Follow-up|2|||
130965165|NCT02352493|471499628|FG014|Overall Study|Lost to Follow-up|0|||
130965166|NCT02352493|471499629|FG015|Overall Study|Lost to Follow-up|0|||
130965167|NCT02352493|471499630|FG016|Overall Study|Lost to Follow-up|0|||
130965168|NCT02352493|471499631|FG017|Overall Study|Lost to Follow-up|0|||
130965169|NCT01465334|471499632|FG000|Overall Study|Disease Progression|1|||
130965170|NCT01465334|471499633|FG001|Overall Study|Disease Progression|0|||
130965171|NCT01465334|471499632|FG000|Overall Study|Adverse Event|1|||
130965172|NCT01465334|471499633|FG001|Overall Study|Adverse Event|0|||
130965173|NCT01465334|471499632|FG000|Overall Study|Richter's transformation|0|||
130965174|NCT01465334|471499633|FG001|Overall Study|Richter's transformation|3|||
130965175|NCT01465334|471499632|FG000|Overall Study|Refractory Disease|0|||
130965176|NCT01465334|471499633|FG001|Overall Study|Refractory Disease|3|||
130965177|NCT00572572|471499634|FG000|Overall Study|Withdrawal by Subject|3|||
130965178|NCT00572572|471499635|FG001|Overall Study|Withdrawal by Subject|6|||
130965179|NCT01831089|471499636|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
130965180|NCT01831089|471499637|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
130965181|NCT01831089|471499638|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
130965182|NCT01831089|471499639|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
130965183|NCT01831089|471499640|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
130965184|NCT01831089|471499641|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
130965185|NCT01831089|471499636|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
130965186|NCT01831089|471499637|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
130965187|NCT01831089|471499638|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
130965188|NCT01831089|471499639|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
130965189|NCT01831089|471499640|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
130965190|NCT01831089|471499641|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
130965191|NCT01831089|471499636|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130965192|NCT01831089|471499637|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
130965193|NCT01831089|471499638|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130965194|NCT01831089|471499639|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130965195|NCT01831089|471499640|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130965196|NCT01831089|471499641|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130965197|NCT01831089|471499636|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
130965198|NCT01831089|471499637|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
130965199|NCT01831089|471499638|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
130965200|NCT01831089|471499639|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
130965201|NCT01831089|471499640|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
130965202|NCT01831089|471499641|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
130965203|NCT01831089|471499636|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
130965204|NCT01831089|471499637|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
130965205|NCT01831089|471499638|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
130965206|NCT01831089|471499639|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
130965207|NCT01831089|471499640|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
130965208|NCT01831089|471499641|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
130965209|NCT01831089|471499636|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
130965210|NCT01831089|471499637|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
131041785|NCT03523572|471789292|FG003|Dose Expansion|Physician Decision|0|||
131041786|NCT03523572|471789293|FG004|Dose Expansion|Physician Decision|1|||
131041787|NCT03523572|471789294|FG005|Dose Expansion|Physician Decision|0|||
131041788|NCT03523572|471789289|FG000|Dose Expansion|Miscellaneous|0|||
131041789|NCT03523572|471789290|FG001|Dose Expansion|Miscellaneous|0|||
131041790|NCT03523572|471789291|FG002|Dose Expansion|Miscellaneous|0|||
131041791|NCT03523572|471789292|FG003|Dose Expansion|Miscellaneous|0|||
131041792|NCT03523572|471789293|FG004|Dose Expansion|Miscellaneous|3|||
131041793|NCT03523572|471789294|FG005|Dose Expansion|Miscellaneous|0|||
131041794|NCT02240238|471789310|FG000|Phase 1|Adverse Event|0|||
131041795|NCT02240238|471789311|FG001|Phase 1|Adverse Event|0|||
131041796|NCT02240238|471789312|FG002|Phase 1|Adverse Event|0|||
131041797|NCT02240238|471789313|FG003|Phase 1|Adverse Event|0|||
130965211|NCT01831089|471499638|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
130965212|NCT01831089|471499639|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
130965213|NCT01831089|471499640|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
130965214|NCT01831089|471499641|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
130965215|NCT01831089|471499636|FG000|Cohort III: Dose Level 3|Global end of study|0|||
130965216|NCT01831089|471499637|FG001|Cohort III: Dose Level 3|Global end of study|0|||
130965217|NCT01831089|471499638|FG002|Cohort III: Dose Level 3|Global end of study|1|||
130965218|NCT01831089|471499639|FG003|Cohort III: Dose Level 3|Global end of study|0|||
130965219|NCT01831089|471499640|FG004|Cohort III: Dose Level 3|Global end of study|0|||
131041798|NCT02240238|471789314|FG004|Phase 1|Adverse Event|0|||
131041799|NCT02240238|471789315|FG005|Phase 1|Adverse Event|0|||
130965220|NCT01831089|471499641|FG005|Cohort III: Dose Level 3|Global end of study|0|||
130965221|NCT01831089|471499636|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
130965222|NCT01831089|471499637|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
130965223|NCT01831089|471499638|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
131226886|NCT00606684|472457718|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
131226887|NCT00606684|472457712|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
131226888|NCT00606684|472457713|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130965224|NCT01831089|471499639|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
130965225|NCT01831089|471499640|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
130965226|NCT01831089|471499641|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
130965227|NCT01831089|471499636|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
130965228|NCT01831089|471499637|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
130965229|NCT01831089|471499638|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
130965230|NCT01831089|471499639|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
130965231|NCT01831089|471499640|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
130965232|NCT01831089|471499641|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
130965233|NCT01831089|471499636|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
130965234|NCT01831089|471499637|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
130965235|NCT01831089|471499638|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
130965236|NCT01831089|471499639|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
130965237|NCT01831089|471499640|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
130965238|NCT01831089|471499641|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
130965239|NCT01831089|471499636|FG000|Cohort V: Dose Level 5|Death|0|||
130965240|NCT01831089|471499637|FG001|Cohort V: Dose Level 5|Death|0|||
130965241|NCT01831089|471499638|FG002|Cohort V: Dose Level 5|Death|0|||
130965242|NCT01831089|471499639|FG003|Cohort V: Dose Level 5|Death|0|||
130965243|NCT01831089|471499640|FG004|Cohort V: Dose Level 5|Death|1|||
130965244|NCT01831089|471499641|FG005|Cohort V: Dose Level 5|Death|0|||
130965245|NCT01831089|471499636|FG000|Cohort V: Dose Level 5|Global end of study|0|||
130965246|NCT01831089|471499637|FG001|Cohort V: Dose Level 5|Global end of study|0|||
130965247|NCT01831089|471499638|FG002|Cohort V: Dose Level 5|Global end of study|0|||
130965248|NCT01831089|471499639|FG003|Cohort V: Dose Level 5|Global end of study|0|||
130965249|NCT01831089|471499640|FG004|Cohort V: Dose Level 5|Global end of study|2|||
130965250|NCT01831089|471499641|FG005|Cohort V: Dose Level 5|Global end of study|0|||
130965251|NCT01831089|471499636|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
130965252|NCT01831089|471499637|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
130965253|NCT01831089|471499638|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
130965254|NCT01831089|471499639|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
130965255|NCT01831089|471499640|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
130965256|NCT01831089|471499641|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
130965257|NCT01831089|471499636|FG000|Cohort B: Arm B|Progressive disease|0|||
130965258|NCT01831089|471499637|FG001|Cohort B: Arm B|Progressive disease|0|||
130965259|NCT01831089|471499638|FG002|Cohort B: Arm B|Progressive disease|0|||
130965260|NCT01831089|471499639|FG003|Cohort B: Arm B|Progressive disease|0|||
130965261|NCT01831089|471499640|FG004|Cohort B: Arm B|Progressive disease|0|||
130965262|NCT01831089|471499641|FG005|Cohort B: Arm B|Progressive disease|8|||
130965263|NCT01831089|471499636|FG000|Cohort B: Arm B|Physician Decision|0|||
130965264|NCT01831089|471499637|FG001|Cohort B: Arm B|Physician Decision|0|||
130965265|NCT01831089|471499638|FG002|Cohort B: Arm B|Physician Decision|0|||
131226889|NCT00606684|472457714|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131226890|NCT00606684|472457715|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131226891|NCT00606684|472457716|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131226892|NCT00606684|472457717|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131226893|NCT00606684|472457718|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
131226894|NCT00606684|472457712|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131226895|NCT00606684|472457713|FG001|Double-Blind Treatment Period|Adverse Event|3|||
131226896|NCT00606684|472457714|FG002|Double-Blind Treatment Period|Adverse Event|2|||
131226897|NCT00606684|472457715|FG003|Double-Blind Treatment Period|Adverse Event|4|||
131226898|NCT00606684|472457716|FG004|Double-Blind Treatment Period|Adverse Event|2|||
130965266|NCT01831089|471499639|FG003|Cohort B: Arm B|Physician Decision|0|||
130965267|NCT01831089|471499640|FG004|Cohort B: Arm B|Physician Decision|0|||
131041800|NCT02240238|471789316|FG006|Phase 1|Adverse Event|3|||
131041801|NCT02240238|471789317|FG007|Phase 1|Adverse Event|1|||
130965268|NCT01831089|471499641|FG005|Cohort B: Arm B|Physician Decision|2|||
130965269|NCT01831089|471499636|FG000|Cohort B: Arm B|Never treated|0|||
130965270|NCT01831089|471499637|FG001|Cohort B: Arm B|Never treated|0|||
130965271|NCT01831089|471499638|FG002|Cohort B: Arm B|Never treated|0|||
131226899|NCT00606684|472457717|FG005|Double-Blind Treatment Period|Adverse Event|0|||
130965272|NCT01831089|471499639|FG003|Cohort B: Arm B|Never treated|0|||
130965273|NCT01831089|471499640|FG004|Cohort B: Arm B|Never treated|0|||
130965274|NCT01831089|471499641|FG005|Cohort B: Arm B|Never treated|2|||
130965275|NCT01831089|471499636|FG000|Cohort B: Arm B|Adverse Event|0|||
131041802|NCT02240238|471789318|FG008|Phase 1|Adverse Event|0|||
131041803|NCT02240238|471789319|FG009|Phase 1|Adverse Event|0|||
131041804|NCT02240238|471789320|FG010|Phase 1|Adverse Event|0|||
131041805|NCT02240238|471789321|FG011|Phase 1|Adverse Event|0|||
131041806|NCT02240238|471789310|FG000|Phase 1|Death|0|||
131041807|NCT02240238|471789311|FG001|Phase 1|Death|0|||
131041808|NCT02240238|471789312|FG002|Phase 1|Death|0|||
131041809|NCT02240238|471789313|FG003|Phase 1|Death|0|||
131041810|NCT02240238|471789314|FG004|Phase 1|Death|0|||
131041811|NCT02240238|471789315|FG005|Phase 1|Death|1|||
131041812|NCT02240238|471789316|FG006|Phase 1|Death|0|||
131041813|NCT02240238|471789317|FG007|Phase 1|Death|0|||
131041814|NCT02240238|471789318|FG008|Phase 1|Death|0|||
131041815|NCT02240238|471789319|FG009|Phase 1|Death|0|||
131041816|NCT02240238|471789320|FG010|Phase 1|Death|0|||
131041817|NCT02240238|471789321|FG011|Phase 1|Death|0|||
131041818|NCT02240238|471789310|FG000|Phase 1|Sponsor termination|0|||
131041819|NCT02240238|471789311|FG001|Phase 1|Sponsor termination|0|||
131041820|NCT02240238|471789312|FG002|Phase 1|Sponsor termination|0|||
131041821|NCT02240238|471789313|FG003|Phase 1|Sponsor termination|0|||
131041822|NCT02240238|471789314|FG004|Phase 1|Sponsor termination|0|||
131041823|NCT02240238|471789315|FG005|Phase 1|Sponsor termination|1|||
131041824|NCT02240238|471789316|FG006|Phase 1|Sponsor termination|0|||
131041825|NCT02240238|471789317|FG007|Phase 1|Sponsor termination|0|||
131041826|NCT02240238|471789318|FG008|Phase 1|Sponsor termination|0|||
131041827|NCT02240238|471789319|FG009|Phase 1|Sponsor termination|0|||
131041828|NCT02240238|471789320|FG010|Phase 1|Sponsor termination|0|||
131041829|NCT02240238|471789321|FG011|Phase 1|Sponsor termination|0|||
131041830|NCT02240238|471789310|FG000|Phase 1|Withdrawal by Subject|0|||
131041831|NCT02240238|471789311|FG001|Phase 1|Withdrawal by Subject|0|||
131041832|NCT02240238|471789312|FG002|Phase 1|Withdrawal by Subject|0|||
130716047|NCT01150890|470587081|FG003|Overall Study|Ineligibility determined|0|||
131041833|NCT02240238|471789313|FG003|Phase 1|Withdrawal by Subject|0|||
131041834|NCT02240238|471789314|FG004|Phase 1|Withdrawal by Subject|0|||
131041835|NCT02240238|471789315|FG005|Phase 1|Withdrawal by Subject|2|||
131041836|NCT02240238|471789316|FG006|Phase 1|Withdrawal by Subject|0|||
130716048|NCT01150890|470587078|FG000|Overall Study|Adverse Event|0|||
131041837|NCT02240238|471789317|FG007|Phase 1|Withdrawal by Subject|0|||
131041838|NCT02240238|471789318|FG008|Phase 1|Withdrawal by Subject|0|||
131041839|NCT02240238|471789319|FG009|Phase 1|Withdrawal by Subject|0|||
131041840|NCT02240238|471789320|FG010|Phase 1|Withdrawal by Subject|0|||
131041841|NCT02240238|471789321|FG011|Phase 1|Withdrawal by Subject|0|||
131041842|NCT02240238|471789310|FG000|Phase 1|Physician Decision|0|||
131041843|NCT02240238|471789311|FG001|Phase 1|Physician Decision|0|||
131041844|NCT02240238|471789312|FG002|Phase 1|Physician Decision|0|||
131041845|NCT02240238|471789313|FG003|Phase 1|Physician Decision|0|||
131041846|NCT02240238|471789314|FG004|Phase 1|Physician Decision|0|||
131041847|NCT02240238|471789315|FG005|Phase 1|Physician Decision|2|||
131041848|NCT02240238|471789316|FG006|Phase 1|Physician Decision|0|||
131041849|NCT02240238|471789317|FG007|Phase 1|Physician Decision|0|||
131041850|NCT02240238|471789318|FG008|Phase 1|Physician Decision|0|||
131041851|NCT02240238|471789319|FG009|Phase 1|Physician Decision|0|||
131041852|NCT02240238|471789320|FG010|Phase 1|Physician Decision|0|||
131041853|NCT02240238|471789321|FG011|Phase 1|Physician Decision|0|||
131041854|NCT02240238|471789310|FG000|Phase 2|Adverse Event|0|||
131041855|NCT02240238|471789311|FG001|Phase 2|Adverse Event|0|||
131041856|NCT02240238|471789312|FG002|Phase 2|Adverse Event|0|||
131041857|NCT02240238|471789313|FG003|Phase 2|Adverse Event|0|||
131041858|NCT02240238|471789314|FG004|Phase 2|Adverse Event|0|||
131041859|NCT02240238|471789315|FG005|Phase 2|Adverse Event|0|||
131041860|NCT02240238|471789316|FG006|Phase 2|Adverse Event|0|||
131041861|NCT02240238|471789317|FG007|Phase 2|Adverse Event|0|||
131041862|NCT02240238|471789318|FG008|Phase 2|Adverse Event|0|||
131041863|NCT02240238|471789319|FG009|Phase 2|Adverse Event|7|||
131041864|NCT02240238|471789320|FG010|Phase 2|Adverse Event|14|||
131041865|NCT02240238|471789321|FG011|Phase 2|Adverse Event|2|||
131041866|NCT02240238|471789310|FG000|Phase 2|Death|0|||
131041867|NCT02240238|471789311|FG001|Phase 2|Death|0|||
131041868|NCT02240238|471789312|FG002|Phase 2|Death|0|||
131041869|NCT02240238|471789313|FG003|Phase 2|Death|0|||
131041870|NCT02240238|471789314|FG004|Phase 2|Death|0|||
131041871|NCT02240238|471789315|FG005|Phase 2|Death|0|||
131041872|NCT02240238|471789316|FG006|Phase 2|Death|0|||
131041873|NCT02240238|471789317|FG007|Phase 2|Death|0|||
131041874|NCT02240238|471789318|FG008|Phase 2|Death|0|||
131041875|NCT02240238|471789319|FG009|Phase 2|Death|3|||
131041876|NCT02240238|471789320|FG010|Phase 2|Death|2|||
131041877|NCT02240238|471789321|FG011|Phase 2|Death|1|||
131041878|NCT02240238|471789310|FG000|Phase 2|Disease progression|0|||
131041879|NCT02240238|471789311|FG001|Phase 2|Disease progression|0|||
131041880|NCT02240238|471789312|FG002|Phase 2|Disease progression|0|||
131041881|NCT02240238|471789313|FG003|Phase 2|Disease progression|0|||
131041882|NCT02240238|471789314|FG004|Phase 2|Disease progression|0|||
131041883|NCT02240238|471789315|FG005|Phase 2|Disease progression|0|||
131041884|NCT02240238|471789316|FG006|Phase 2|Disease progression|0|||
131041885|NCT02240238|471789317|FG007|Phase 2|Disease progression|0|||
130965276|NCT01831089|471499637|FG001|Cohort B: Arm B|Adverse Event|0|||
130965277|NCT01831089|471499638|FG002|Cohort B: Arm B|Adverse Event|0|||
130965278|NCT01831089|471499639|FG003|Cohort B: Arm B|Adverse Event|0|||
130965279|NCT01831089|471499640|FG004|Cohort B: Arm B|Adverse Event|0|||
130965280|NCT01831089|471499641|FG005|Cohort B: Arm B|Adverse Event|1|||
130965281|NCT01831089|471499636|FG000|Cohort B: Arm B|Global end of study|0|||
130965282|NCT01831089|471499637|FG001|Cohort B: Arm B|Global end of study|0|||
130965283|NCT01831089|471499638|FG002|Cohort B: Arm B|Global end of study|0|||
130965284|NCT01831089|471499639|FG003|Cohort B: Arm B|Global end of study|0|||
130965285|NCT01831089|471499640|FG004|Cohort B: Arm B|Global end of study|0|||
130965286|NCT01831089|471499641|FG005|Cohort B: Arm B|Global end of study|1|||
130965287|NCT02114892|471499647|FG000|Overall Study|Lost to Follow-up|1|||
130965288|NCT02114892|471499648|FG001|Overall Study|Lost to Follow-up|2|||
130965289|NCT03525834|471499651|FG000|Overall Study|Progressive disease|1|||
130965290|NCT01751568|471499664|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
130965291|NCT01751568|471499665|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
130965292|NCT01751568|471499666|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
130965293|NCT02660944|471499667|FG000|Overall Study|Adverse Event|3|||
130965294|NCT02660944|471499668|FG001|Overall Study|Adverse Event|4|||
130965295|NCT02660944|471499667|FG000|Overall Study|Physician Decision|3|||
130965296|NCT02660944|471499668|FG001|Overall Study|Physician Decision|1|||
130965297|NCT02660944|471499667|FG000|Overall Study|Withdrawal by Subject|5|||
130965298|NCT02660944|471499668|FG001|Overall Study|Withdrawal by Subject|3|||
130965299|NCT02660944|471499667|FG000|Overall Study|Lost to Follow-up|4|||
130965300|NCT02660944|471499668|FG001|Overall Study|Lost to Follow-up|1|||
130965301|NCT02660944|471499667|FG000|Overall Study|Subject schedule|0|||
130965302|NCT02660944|471499668|FG001|Overall Study|Subject schedule|1|||
130965303|NCT02660944|471499667|FG000|Overall Study|Exclusion criteria met|2|||
130965304|NCT02660944|471499668|FG001|Overall Study|Exclusion criteria met|0|||
130965305|NCT03586999|471499669|FG000|Overall Study|Lack of Efficacy|2|||
130965306|NCT04096560|471499670|FG000|Overall Study|Reason not Specified|1|||
130965307|NCT04096560|471499671|FG001|Overall Study|Reason not Specified|0|||
130965308|NCT04096560|471499672|FG002|Overall Study|Reason not Specified|0|||
130965309|NCT04096560|471499673|FG003|Overall Study|Reason not Specified|0|||
130965310|NCT04096560|471499674|FG004|Overall Study|Reason not Specified|1|||
130965311|NCT04096560|471499675|FG005|Overall Study|Reason not Specified|1|||
130965312|NCT04096560|471499676|FG006|Overall Study|Reason not Specified|1|||
130965313|NCT04096560|471499677|FG007|Overall Study|Reason not Specified|0|||
130965314|NCT04096560|471499670|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130965315|NCT04096560|471499671|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130965316|NCT04096560|471499672|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130965317|NCT04096560|471499673|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130965318|NCT04096560|471499674|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130965319|NCT04096560|471499675|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
130965320|NCT04096560|471499676|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
130965321|NCT04096560|471499677|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
130965322|NCT04096560|471499670|FG000|Overall Study|Study Terminated by Sponsor|0|||
130965323|NCT04096560|471499671|FG001|Overall Study|Study Terminated by Sponsor|0|||
130965324|NCT04096560|471499672|FG002|Overall Study|Study Terminated by Sponsor|0|||
130965325|NCT04096560|471499673|FG003|Overall Study|Study Terminated by Sponsor|5|||
130965326|NCT04096560|471499674|FG004|Overall Study|Study Terminated by Sponsor|6|||
130965327|NCT04096560|471499675|FG005|Overall Study|Study Terminated by Sponsor|4|||
130965328|NCT04096560|471499676|FG006|Overall Study|Study Terminated by Sponsor|6|||
130965329|NCT04096560|471499677|FG007|Overall Study|Study Terminated by Sponsor|1|||
130965330|NCT04096560|471499670|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130965331|NCT04096560|471499671|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130965332|NCT04096560|471499672|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130965333|NCT04096560|471499673|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130965334|NCT04096560|471499674|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130965335|NCT04096560|471499675|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130965336|NCT04096560|471499676|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
130965337|NCT04096560|471499677|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
130965338|NCT01485861|471499678|FG000|Phase Ib|Death|1|||
130965339|NCT01485861|471499679|FG001|Phase Ib|Death|0|||
130965340|NCT01485861|471499680|FG002|Phase Ib|Death|0|||
130965341|NCT01485861|471499681|FG003|Phase Ib|Death|0|||
130965342|NCT01485861|471499682|FG004|Phase Ib|Death|0|||
130965343|NCT01485861|471499683|FG005|Phase Ib|Death|0|||
130965344|NCT01485861|471499678|FG000|Phase Ib|Physician Decision|1|||
130965345|NCT01485861|471499679|FG001|Phase Ib|Physician Decision|1|||
130965346|NCT01485861|471499680|FG002|Phase Ib|Physician Decision|0|||
130965347|NCT01485861|471499681|FG003|Phase Ib|Physician Decision|0|||
130965348|NCT01485861|471499682|FG004|Phase Ib|Physician Decision|0|||
130965349|NCT01485861|471499683|FG005|Phase Ib|Physician Decision|0|||
130965350|NCT01485861|471499678|FG000|Phase Ib|Adverse Event|0|||
130965351|NCT01485861|471499679|FG001|Phase Ib|Adverse Event|4|||
130965352|NCT01485861|471499680|FG002|Phase Ib|Adverse Event|0|||
130965353|NCT01485861|471499681|FG003|Phase Ib|Adverse Event|0|||
130965354|NCT01485861|471499682|FG004|Phase Ib|Adverse Event|0|||
130965355|NCT01485861|471499683|FG005|Phase Ib|Adverse Event|0|||
130965356|NCT01485861|471499678|FG000|Phase Ib|Progression of disease|5|||
130965357|NCT01485861|471499679|FG001|Phase Ib|Progression of disease|0|||
130965358|NCT01485861|471499680|FG002|Phase Ib|Progression of disease|0|||
130965359|NCT01485861|471499681|FG003|Phase Ib|Progression of disease|0|||
130965360|NCT01485861|471499682|FG004|Phase Ib|Progression of disease|0|||
130965361|NCT01485861|471499683|FG005|Phase Ib|Progression of disease|0|||
130965362|NCT01485861|471499678|FG000|Phase Ib|Other|3|||
130965363|NCT01485861|471499679|FG001|Phase Ib|Other|0|||
130965364|NCT01485861|471499680|FG002|Phase Ib|Other|0|||
130965365|NCT01485861|471499681|FG003|Phase Ib|Other|0|||
130965366|NCT01485861|471499682|FG004|Phase Ib|Other|0|||
130965367|NCT01485861|471499683|FG005|Phase Ib|Other|0|||
130965368|NCT01485861|471499678|FG000|Phase Ib|Withdrawal by Subject|4|||
130965369|NCT01485861|471499679|FG001|Phase Ib|Withdrawal by Subject|1|||
130965370|NCT01485861|471499680|FG002|Phase Ib|Withdrawal by Subject|0|||
130965371|NCT01485861|471499681|FG003|Phase Ib|Withdrawal by Subject|0|||
130965372|NCT01485861|471499682|FG004|Phase Ib|Withdrawal by Subject|0|||
130965373|NCT01485861|471499683|FG005|Phase Ib|Withdrawal by Subject|0|||
130965374|NCT01485861|471499678|FG000|Phase II|Death|0|||
130965375|NCT01485861|471499679|FG001|Phase II|Death|0|||
130965376|NCT01485861|471499680|FG002|Phase II|Death|67|||
130965377|NCT01485861|471499681|FG003|Phase II|Death|71|||
130965378|NCT01485861|471499682|FG004|Phase II|Death|68|||
130965379|NCT01485861|471499683|FG005|Phase II|Death|0|||
130965380|NCT01485861|471499678|FG000|Phase II|Progression of Disease|0|||
130965381|NCT01485861|471499679|FG001|Phase II|Progression of Disease|0|||
130965382|NCT01485861|471499680|FG002|Phase II|Progression of Disease|1|||
130965383|NCT01485861|471499681|FG003|Phase II|Progression of Disease|0|||
130965384|NCT01485861|471499682|FG004|Phase II|Progression of Disease|0|||
130965385|NCT01485861|471499683|FG005|Phase II|Progression of Disease|0|||
130965386|NCT01485861|471499678|FG000|Phase II|Other|0|||
130965387|NCT01485861|471499679|FG001|Phase II|Other|0|||
130965388|NCT01485861|471499680|FG002|Phase II|Other|0|||
130965389|NCT01485861|471499681|FG003|Phase II|Other|1|||
130965390|NCT01485861|471499682|FG004|Phase II|Other|0|||
130965391|NCT01485861|471499683|FG005|Phase II|Other|0|||
130965392|NCT01485861|471499678|FG000|Phase II|Withdrawal by Subject|0|||
130965393|NCT01485861|471499679|FG001|Phase II|Withdrawal by Subject|0|||
130965394|NCT01485861|471499680|FG002|Phase II|Withdrawal by Subject|6|||
130965395|NCT01485861|471499681|FG003|Phase II|Withdrawal by Subject|3|||
130965396|NCT01485861|471499682|FG004|Phase II|Withdrawal by Subject|4|||
130965397|NCT01485861|471499683|FG005|Phase II|Withdrawal by Subject|0|||
130965398|NCT01485861|471499678|FG000|Phase II|Lost to Follow-up|0|||
130965399|NCT01485861|471499679|FG001|Phase II|Lost to Follow-up|0|||
130965400|NCT01485861|471499680|FG002|Phase II|Lost to Follow-up|2|||
130965401|NCT01485861|471499681|FG003|Phase II|Lost to Follow-up|3|||
130965402|NCT01485861|471499682|FG004|Phase II|Lost to Follow-up|5|||
130965403|NCT01485861|471499683|FG005|Phase II|Lost to Follow-up|0|||
130965404|NCT01485861|471499678|FG000|Phase II|Study Ended|0|||
130965405|NCT01485861|471499679|FG001|Phase II|Study Ended|0|||
130965406|NCT01485861|471499680|FG002|Phase II|Study Ended|7|||
130965407|NCT01485861|471499681|FG003|Phase II|Study Ended|8|||
130965408|NCT01485861|471499682|FG004|Phase II|Study Ended|6|||
130965409|NCT01485861|471499683|FG005|Phase II|Study Ended|0|||
130965410|NCT01485861|471499678|FG000|Safety Phase|Death|0|||
130965411|NCT01485861|471499679|FG001|Safety Phase|Death|0|||
130965412|NCT01485861|471499680|FG002|Safety Phase|Death|0|||
130965413|NCT01485861|471499681|FG003|Safety Phase|Death|0|||
130965414|NCT01485861|471499682|FG004|Safety Phase|Death|0|||
130965415|NCT01485861|471499683|FG005|Safety Phase|Death|2|||
130965416|NCT01485861|471499678|FG000|Safety Phase|Adverse Event|0|||
130965417|NCT01485861|471499679|FG001|Safety Phase|Adverse Event|0|||
130965418|NCT01485861|471499680|FG002|Safety Phase|Adverse Event|0|||
130965419|NCT01485861|471499681|FG003|Safety Phase|Adverse Event|0|||
130965420|NCT01485861|471499682|FG004|Safety Phase|Adverse Event|0|||
130965421|NCT01485861|471499683|FG005|Safety Phase|Adverse Event|1|||
130965422|NCT01485861|471499678|FG000|Safety Phase|Other|0|||
130965423|NCT01485861|471499679|FG001|Safety Phase|Other|0|||
130965424|NCT01485861|471499680|FG002|Safety Phase|Other|0|||
130965425|NCT01485861|471499681|FG003|Safety Phase|Other|0|||
130965426|NCT01485861|471499682|FG004|Safety Phase|Other|0|||
130965427|NCT01485861|471499683|FG005|Safety Phase|Other|5|||
130965428|NCT01485861|471499678|FG000|Safety Phase|Progression of Disease|0|||
130965429|NCT01485861|471499679|FG001|Safety Phase|Progression of Disease|0|||
130965430|NCT01485861|471499680|FG002|Safety Phase|Progression of Disease|0|||
130965431|NCT01485861|471499681|FG003|Safety Phase|Progression of Disease|0|||
130965432|NCT01485861|471499682|FG004|Safety Phase|Progression of Disease|0|||
130965433|NCT01485861|471499683|FG005|Safety Phase|Progression of Disease|9|||
130965434|NCT01485861|471499678|FG000|Safety Phase|Withdrawal by Subject|0|||
130965435|NCT01485861|471499679|FG001|Safety Phase|Withdrawal by Subject|0|||
130965436|NCT01485861|471499680|FG002|Safety Phase|Withdrawal by Subject|0|||
130965437|NCT01485861|471499681|FG003|Safety Phase|Withdrawal by Subject|0|||
130965438|NCT01485861|471499682|FG004|Safety Phase|Withdrawal by Subject|0|||
130965439|NCT01485861|471499683|FG005|Safety Phase|Withdrawal by Subject|6|||
130965440|NCT01485861|471499678|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
130965441|NCT01485861|471499679|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
130965442|NCT01485861|471499680|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
130965443|NCT01485861|471499681|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
130965444|NCT01485861|471499682|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
130965445|NCT01485861|471499683|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
130965446|NCT01229436|471499684|FG000|Overall Study|Withdrawal by Subject|2|||
130965447|NCT01229436|471499684|FG000|Overall Study|Lost to Follow-up|3|||
130965448|NCT02266381|471499687|FG000|Overall Study|Physician Decision|3|||
130965449|NCT02266381|471499688|FG001|Overall Study|Physician Decision|5|||
130965450|NCT02266381|471499689|FG002|Overall Study|Physician Decision|4|||
130965451|NCT01731171|471499707|FG000|Overall Study|Withdrawal by Subject|4|||
130965452|NCT01731171|471499708|FG001|Overall Study|Withdrawal by Subject|1|||
130965453|NCT01731171|471499707|FG000|Overall Study|Lost to Follow-up|3|||
130965454|NCT01731171|471499708|FG001|Overall Study|Lost to Follow-up|2|||
130965455|NCT01731171|471499707|FG000|Overall Study|Moved out of Area|0|||
130965456|NCT01731171|471499708|FG001|Overall Study|Moved out of Area|2|||
130965457|NCT01731171|471499707|FG000|Overall Study|Terminated for Lack of Adherence|0|||
130965458|NCT01731171|471499708|FG001|Overall Study|Terminated for Lack of Adherence|1|||
130965459|NCT01731171|471499707|FG000|Overall Study|Terminated for Safety Reasons|0|||
130965460|NCT01731171|471499708|FG001|Overall Study|Terminated for Safety Reasons|1|||
130965461|NCT03653429|471499711|FG000|Overall Study|Physician Decision|4|||
130965462|NCT03653429|471499712|FG001|Overall Study|Physician Decision|10|||
130965463|NCT00403546|471499713|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
130965464|NCT00403546|471499714|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
130965465|NCT00403546|471499715|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
130965466|NCT00403546|471499713|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
130965467|NCT00403546|471499714|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
130965468|NCT00403546|471499715|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
130965469|NCT00403546|471499713|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
130965470|NCT00403546|471499714|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
130965471|NCT00403546|471499715|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
130965472|NCT00403546|471499713|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
130965473|NCT00403546|471499714|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
130965474|NCT00403546|471499715|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
130965475|NCT00403546|471499713|FG000|Screening Phase|Screening Failure|22|||
130965476|NCT00403546|471499714|FG001|Screening Phase|Screening Failure|0|||
130965477|NCT00403546|471499715|FG002|Screening Phase|Screening Failure|0|||
130965478|NCT00403546|471499713|FG000|Screening Phase|Adverse Event|1|||
130965479|NCT00403546|471499714|FG001|Screening Phase|Adverse Event|0|||
130965480|NCT00403546|471499715|FG002|Screening Phase|Adverse Event|0|||
130965481|NCT00403546|471499713|FG000|Screening Phase|Terminated Prior to Randomization|5|||
130965482|NCT00403546|471499714|FG001|Screening Phase|Terminated Prior to Randomization|0|||
130965483|NCT00403546|471499715|FG002|Screening Phase|Terminated Prior to Randomization|0|||
130965484|NCT00403546|471499713|FG000|Randomized Trial|Early Terminations|0|||
130965485|NCT00403546|471499714|FG001|Randomized Trial|Early Terminations|17|||
130965486|NCT00403546|471499715|FG002|Randomized Trial|Early Terminations|16|||
130965487|NCT02604589|471499719|FG000|Overall Study|catheter dislodgement|0|||
130965488|NCT02604589|471499720|FG001|Overall Study|catheter dislodgement|0|||
131041886|NCT02240238|471789318|FG008|Phase 2|Disease progression|0|||
131041887|NCT02240238|471789319|FG009|Phase 2|Disease progression|5|||
131041888|NCT02240238|471789320|FG010|Phase 2|Disease progression|11|||
131041889|NCT02240238|471789321|FG011|Phase 2|Disease progression|1|||
131041890|NCT02240238|471789310|FG000|Phase 2|Withdrawal by Subject|0|||
131041891|NCT02240238|471789311|FG001|Phase 2|Withdrawal by Subject|0|||
131041892|NCT02240238|471789312|FG002|Phase 2|Withdrawal by Subject|0|||
131041893|NCT02240238|471789313|FG003|Phase 2|Withdrawal by Subject|0|||
131041894|NCT02240238|471789314|FG004|Phase 2|Withdrawal by Subject|0|||
131041895|NCT02240238|471789315|FG005|Phase 2|Withdrawal by Subject|0|||
131041896|NCT02240238|471789316|FG006|Phase 2|Withdrawal by Subject|0|||
131041897|NCT02240238|471789317|FG007|Phase 2|Withdrawal by Subject|0|||
131041898|NCT02240238|471789318|FG008|Phase 2|Withdrawal by Subject|0|||
131041899|NCT02240238|471789319|FG009|Phase 2|Withdrawal by Subject|1|||
131041900|NCT02240238|471789320|FG010|Phase 2|Withdrawal by Subject|1|||
131041901|NCT02240238|471789321|FG011|Phase 2|Withdrawal by Subject|0|||
130965489|NCT02604589|471499721|FG002|Overall Study|catheter dislodgement|1|||
131041902|NCT02240238|471789310|FG000|Phase 2|Physician Decision|0|||
131041903|NCT02240238|471789311|FG001|Phase 2|Physician Decision|0|||
131041904|NCT02240238|471789312|FG002|Phase 2|Physician Decision|0|||
130965490|NCT00793910|471499724|FG000|Overall Study|discarded study pills|0|||
130965491|NCT00793910|471499725|FG001|Overall Study|discarded study pills|1|||
130965492|NCT00793910|471499724|FG000|Overall Study|did not pick up medications|1|||
130965493|NCT00793910|471499725|FG001|Overall Study|did not pick up medications|1|||
130965494|NCT00793910|471499724|FG000|Overall Study|ineligible based on entry criteria|2|||
130965495|NCT00793910|471499725|FG001|Overall Study|ineligible based on entry criteria|3|||
130965496|NCT00793910|471499724|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
130965497|NCT00793910|471499725|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
130965498|NCT00793910|471499724|FG000|Overall Study|Withdrawal by Subject|0|||
130965499|NCT00793910|471499725|FG001|Overall Study|Withdrawal by Subject|1|||
130965500|NCT01700946|471499726|FG000|Overall Study|Lost to Follow-up|1|||
130965501|NCT01700946|471499727|FG001|Overall Study|Lost to Follow-up|0|||
130965502|NCT01700946|471499726|FG000|Overall Study|Physician Decision|7|||
130965503|NCT01700946|471499727|FG001|Overall Study|Physician Decision|12|||
130965504|NCT01700946|471499726|FG000|Overall Study|Withdrawal by Subject|0|||
130965505|NCT01700946|471499727|FG001|Overall Study|Withdrawal by Subject|2|||
130965506|NCT01700946|471499726|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
130965507|NCT01700946|471499727|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
130965508|NCT01700946|471499726|FG000|Overall Study|Relapse|2|||
130965509|NCT01700946|471499727|FG001|Overall Study|Relapse|1|||
130965510|NCT01700946|471499726|FG000|Overall Study|Unacceptable toxicity|1|||
130965511|NCT01700946|471499727|FG001|Overall Study|Unacceptable toxicity|0|||
130965512|NCT03321981|471499737|FG000|Overall Study|Progressive Disease (PD)|15|||
130965513|NCT03321981|471499738|FG001|Overall Study|Progressive Disease (PD)|30|||
130965514|NCT03321981|471499739|FG002|Overall Study|Progressive Disease (PD)|47|||
130965515|NCT03321981|471499737|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
130965516|NCT03321981|471499738|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
130965517|NCT03321981|471499739|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
130965518|NCT03321981|471499737|FG000|Overall Study|Adverse Event|0|||
130965519|NCT03321981|471499738|FG001|Overall Study|Adverse Event|0|||
130965520|NCT03321981|471499739|FG002|Overall Study|Adverse Event|2|||
130965521|NCT03321981|471499737|FG000|Overall Study|symptomatic deterioration|0|||
130965522|NCT03321981|471499738|FG001|Overall Study|symptomatic deterioration|1|||
130965523|NCT03321981|471499739|FG002|Overall Study|symptomatic deterioration|1|||
130965524|NCT03321981|471499737|FG000|Overall Study|Lack of compliance|0|||
130965525|NCT03321981|471499738|FG001|Overall Study|Lack of compliance|1|||
130965526|NCT03321981|471499739|FG002|Overall Study|Lack of compliance|0|||
130965527|NCT03321981|471499737|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
130965528|NCT03321981|471499738|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
130965529|NCT03321981|471499739|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
130965530|NCT03321981|471499737|FG000|Overall Study|Death|0|||
130965531|NCT03321981|471499738|FG001|Overall Study|Death|1|||
131127946|NCT00960661|472097641|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
131127947|NCT00960661|472097642|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
131127948|NCT00960661|472097640|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
131127949|NCT00960661|472097641|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
131127950|NCT00960661|472097642|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
131127951|NCT00960661|472097640|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
131127952|NCT00960661|472097641|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
131127953|NCT00960661|472097642|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
131127954|NCT00960661|472097640|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
131127955|NCT00960661|472097641|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
131127956|NCT00960661|472097642|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
131127957|NCT00960661|472097640|FG000|Interventional Phase|Adverse Event|0|||
131127958|NCT00960661|472097641|FG001|Interventional Phase|Adverse Event|17|||
131127959|NCT00960661|472097642|FG002|Interventional Phase|Adverse Event|8|||
131127960|NCT00960661|472097640|FG000|Interventional Phase|Death|0|||
131127961|NCT00960661|472097641|FG001|Interventional Phase|Death|1|||
131127962|NCT00960661|472097642|FG002|Interventional Phase|Death|0|||
131127963|NCT00960661|472097640|FG000|Interventional Phase|Lost to Follow-up|0|||
131127964|NCT00960661|472097641|FG001|Interventional Phase|Lost to Follow-up|0|||
131127965|NCT00960661|472097642|FG002|Interventional Phase|Lost to Follow-up|2|||
130965532|NCT03321981|471499739|FG002|Overall Study|Death|0|||
131127966|NCT00960661|472097640|FG000|Interventional Phase|entry criteria not met|0|||
130965533|NCT03321981|471499737|FG000|Overall Study|Subject withdrawal of investigational product|0|||
130965534|NCT03321981|471499738|FG001|Overall Study|Subject withdrawal of investigational product|1|||
130965535|NCT03321981|471499739|FG002|Overall Study|Subject withdrawal of investigational product|0|||
131127967|NCT00960661|472097641|FG001|Interventional Phase|entry criteria not met|3|||
131127968|NCT00960661|472097642|FG002|Interventional Phase|entry criteria not met|0|||
131127969|NCT00960661|472097640|FG000|Interventional Phase|Protocol Violation|0|||
130965536|NCT03321981|471499737|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
130965537|NCT03321981|471499738|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
130965538|NCT03321981|471499739|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
130965539|NCT03321981|471499737|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
130965540|NCT03321981|471499738|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
130965541|NCT03321981|471499739|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
130965542|NCT05061446|471499741|FG000|Overall Study|Adverse Event|2|||
130965543|NCT05061446|471499742|FG001|Overall Study|Adverse Event|0|||
130965544|NCT05061446|471499743|FG002|Overall Study|Adverse Event|0|||
130965545|NCT05061446|471499741|FG000|Overall Study|Participant no longer available due to personal reason|0|||
130965546|NCT05061446|471499742|FG001|Overall Study|Participant no longer available due to personal reason|1|||
130965547|NCT05061446|471499743|FG002|Overall Study|Participant no longer available due to personal reason|0|||
130965548|NCT03880578|471499744|FG000|Overall Study|Withdrawal by Subject|0|||
130965549|NCT03880578|471499745|FG001|Overall Study|Withdrawal by Subject|3|||
130965550|NCT03880578|471499746|FG002|Overall Study|Withdrawal by Subject|1|||
130965551|NCT03880578|471499744|FG000|Overall Study|Death|0|||
130965552|NCT03880578|471499745|FG001|Overall Study|Death|1|||
130965553|NCT03880578|471499746|FG002|Overall Study|Death|0|||
130965554|NCT04934670|471499747|FG000|Overall Study|Death|4|||
130965555|NCT04934670|471499748|FG001|Overall Study|Death|0|||
130965556|NCT04934670|471499747|FG000|Overall Study|Lost to Follow-up|1|||
130965557|NCT04934670|471499748|FG001|Overall Study|Lost to Follow-up|4|||
130965558|NCT00861341|471499749|FG000|Overall Study|Withdrawal by Subject|2|||
130965559|NCT01916304|471499750|FG000|Overall Study|Screening failure|17|||
130965560|NCT03149328|471499751|FG000|Overall Study|Withdrawal by Subject|30|||
130965561|NCT03149328|471499752|FG001|Overall Study|Withdrawal by Subject|26|||
130965562|NCT03149328|471499751|FG000|Overall Study|Changed Dialysis Modality|18|||
130965563|NCT03149328|471499752|FG001|Overall Study|Changed Dialysis Modality|1|||
130965564|NCT03149328|471499751|FG000|Overall Study|Transplant|9|||
130965565|NCT03149328|471499752|FG001|Overall Study|Transplant|1|||
130965566|NCT03149328|471499751|FG000|Overall Study|Lost to Follow-up|25|||
130965567|NCT03149328|471499752|FG001|Overall Study|Lost to Follow-up|16|||
130965568|NCT03149328|471499751|FG000|Overall Study|Left Study Site|1|||
130965569|NCT03149328|471499752|FG001|Overall Study|Left Study Site|2|||
130965570|NCT03149328|471499751|FG000|Overall Study|Language Barrier|1|||
130965571|NCT03149328|471499752|FG001|Overall Study|Language Barrier|0|||
130965572|NCT02758236|471499753|FG000|Overall Study|Investigator discretion|43|||
130965573|NCT00162136|471499754|FG000|Overall Study|Adverse Event|1|||
130965574|NCT00162136|471499754|FG000|Overall Study|Death|1|||
130965575|NCT00162136|471499754|FG000|Overall Study|Disease Progression/Relapse|23|||
130965576|NCT00162136|471499754|FG000|Overall Study|Investigator Request|5|||
130965577|NCT00162136|471499754|FG000|Overall Study|Study Drug Toxicity|4|||
130965578|NCT00162136|471499754|FG000|Overall Study|Withdrawal by Subject|1|||
130965579|NCT03930745|471499755|FG000|Overall Study|Lost to Follow-up|10|||
130965580|NCT03930745|471499756|FG001|Overall Study|Lost to Follow-up|5|||
130965581|NCT03930745|471499755|FG000|Overall Study|Withdrawal by Subject|1|||
130965582|NCT03930745|471499756|FG001|Overall Study|Withdrawal by Subject|2|||
130965583|NCT03930745|471499755|FG000|Overall Study|Protocol Violation|2|||
130965584|NCT03930745|471499756|FG001|Overall Study|Protocol Violation|2|||
130965585|NCT03930745|471499755|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
130965586|NCT03930745|471499756|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
130965587|NCT03930745|471499755|FG000|Overall Study|Adverse Event|0|||
130965588|NCT03930745|471499756|FG001|Overall Study|Adverse Event|1|||
130965589|NCT03930745|471499755|FG000|Overall Study|Pregnancy|0|||
130965590|NCT03930745|471499756|FG001|Overall Study|Pregnancy|1|||
130965591|NCT00818441|471499761|FG000|Overall Study|Death|69|||
130965592|NCT00818441|471499762|FG001|Overall Study|Death|26|||
130965593|NCT00818441|471499761|FG000|Overall Study|Other|5|||
130965594|NCT00818441|471499762|FG001|Overall Study|Other|0|||
130965595|NCT00818441|471499761|FG000|Overall Study|Lost to Follow-up|2|||
130965596|NCT00818441|471499762|FG001|Overall Study|Lost to Follow-up|1|||
130965597|NCT00818441|471499761|FG000|Overall Study|Withdrawal by Subject|2|||
130965598|NCT00818441|471499762|FG001|Overall Study|Withdrawal by Subject|0|||
130965599|NCT00818441|471499761|FG000|Overall Study|Adverse Event|0|||
130965600|NCT00818441|471499762|FG001|Overall Study|Adverse Event|1|||
130965601|NCT00818441|471499761|FG000|Overall Study|Study terminated by sponsor|11|||
130965602|NCT00818441|471499762|FG001|Overall Study|Study terminated by sponsor|2|||
130965603|NCT03483623|471499775|FG000|Overall Study|43 complete sets achieved|1|||
130965604|NCT02770391|471499776|FG000|Overall Study|Lost to Follow-up|2|||
130965605|NCT02770391|471499776|FG000|Overall Study|Withdrawal by Subject|1|||
130965606|NCT02770391|471499776|FG000|Overall Study|Surgery delayed unevaluable|2|||
130965607|NCT02770391|471499776|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
130965608|NCT00612313|471499781|FG000|Overall Study|Withdrawal by Subject|6|||
130965609|NCT00612313|471499782|FG001|Overall Study|Withdrawal by Subject|9|||
131226900|NCT00606684|472457718|FG006|Double-Blind Treatment Period|Adverse Event|1|||
130716049|NCT01150890|470587079|FG001|Overall Study|Adverse Event|0|||
130716050|NCT01150890|470587080|FG002|Overall Study|Adverse Event|2|||
130716051|NCT01150890|470587081|FG003|Overall Study|Adverse Event|0|||
130716052|NCT01150890|470587078|FG000|Overall Study|Withdrawal by Subject|0|||
130965610|NCT00612313|471499781|FG000|Overall Study|Lost to Follow-up|11|||
130965611|NCT00612313|471499782|FG001|Overall Study|Lost to Follow-up|4|||
130965612|NCT03136068|471500990|FG000|Overall Study|Lost to Follow-up|1|||
130965613|NCT03136068|471500991|FG001|Overall Study|Lost to Follow-up|1|||
130965614|NCT03136068|471500990|FG000|Overall Study|Protocol Violation|1|||
130965615|NCT03136068|471500991|FG001|Overall Study|Protocol Violation|0|||
130965616|NCT00432380|471500997|FG000|Overall Study|Migrated/moved from study area|3|||
130965617|NCT00432380|471500998|FG001|Overall Study|Migrated/moved from study area|4|||
130965618|NCT00432380|471500999|FG002|Overall Study|Migrated/moved from study area|1|||
130965619|NCT00432380|471500997|FG000|Overall Study|Adverse Event|1|||
130965620|NCT00432380|471500998|FG001|Overall Study|Adverse Event|0|||
130965621|NCT00432380|471500999|FG002|Overall Study|Adverse Event|0|||
130965622|NCT01337089|471501000|FG000|Overall Study|Adverse Event|237|||
130965623|NCT01337089|471501000|FG000|Overall Study|Withdrawal by Subject|129|||
130965624|NCT01337089|471501000|FG000|Overall Study|Withdrawal by Investigator|33|||
130965625|NCT01337089|471501000|FG000|Overall Study|Met Withdrawal Criteria|3|||
130965626|NCT01337089|471501000|FG000|Overall Study|Lost to Follow-up|2|||
130965627|NCT01627249|471501001|FG000|Overall Study|Death|3|||
130965628|NCT01627249|471501002|FG001|Overall Study|Death|5|||
130965629|NCT01627249|471501003|FG002|Overall Study|Death|3|||
130965630|NCT01627249|471501001|FG000|Overall Study|Withdrawal by Subject|12|||
130965631|NCT01627249|471501002|FG001|Overall Study|Withdrawal by Subject|6|||
130965632|NCT01627249|471501003|FG002|Overall Study|Withdrawal by Subject|9|||
130965633|NCT01627249|471501001|FG000|Overall Study|Missed Visit|1|||
131127970|NCT00960661|472097641|FG001|Interventional Phase|Protocol Violation|7|||
131127971|NCT00960661|472097642|FG002|Interventional Phase|Protocol Violation|2|||
131127972|NCT00960661|472097640|FG000|Interventional Phase|Withdrawal by Subject|0|||
131127973|NCT00960661|472097641|FG001|Interventional Phase|Withdrawal by Subject|18|||
131127974|NCT00960661|472097642|FG002|Interventional Phase|Withdrawal by Subject|29|||
131127975|NCT00960661|472097640|FG000|Interventional Phase|Physician Decision|0|||
131127976|NCT00960661|472097641|FG001|Interventional Phase|Physician Decision|3|||
131127977|NCT00960661|472097642|FG002|Interventional Phase|Physician Decision|5|||
131127978|NCT00960661|472097640|FG000|Interventional Phase|sponsor decision|0|||
131127979|NCT00960661|472097641|FG001|Interventional Phase|sponsor decision|1|||
131127980|NCT00960661|472097642|FG002|Interventional Phase|sponsor decision|0|||
131127981|NCT00960661|472097640|FG000|Interventional Phase|Lack of Efficacy|0|||
131127982|NCT00960661|472097641|FG001|Interventional Phase|Lack of Efficacy|2|||
131127983|NCT00960661|472097642|FG002|Interventional Phase|Lack of Efficacy|0|||
131127984|NCT02699892|472097643|FG000|Overall Study|Other|36|||
131127985|NCT00847912|472097653|FG000|Overall Study|Protocol Violation|6|||
131127986|NCT00847912|472097654|FG001|Overall Study|Protocol Violation|7|||
131127987|NCT00847912|472097653|FG000|Overall Study|Withdrawal by Subject|3|||
131127988|NCT00847912|472097654|FG001|Overall Study|Withdrawal by Subject|6|||
131127989|NCT01732796|472097661|FG000|Overall Study|Adverse Event|16|||
131127990|NCT01732796|472097662|FG001|Overall Study|Adverse Event|16|||
131127991|NCT01732796|472097663|FG002|Overall Study|Adverse Event|4|||
131127992|NCT01732796|472097661|FG000|Overall Study|Lack of Efficacy|21|||
131127993|NCT01732796|472097662|FG001|Overall Study|Lack of Efficacy|18|||
131127994|NCT01732796|472097663|FG002|Overall Study|Lack of Efficacy|5|||
131127995|NCT01732796|472097661|FG000|Overall Study|Lost to Follow-up|2|||
131127996|NCT01732796|472097662|FG001|Overall Study|Lost to Follow-up|0|||
131127997|NCT01732796|472097663|FG002|Overall Study|Lost to Follow-up|0|||
131127998|NCT01732796|472097661|FG000|Overall Study|Withdrawal by Subject|6|||
131127999|NCT01732796|472097662|FG001|Overall Study|Withdrawal by Subject|8|||
131128000|NCT01732796|472097663|FG002|Overall Study|Withdrawal by Subject|2|||
131128001|NCT01732796|472097661|FG000|Overall Study|Other reason not defined above|1|||
131128002|NCT01732796|472097662|FG001|Overall Study|Other reason not defined above|0|||
131128003|NCT01732796|472097663|FG002|Overall Study|Other reason not defined above|2|||
131128004|NCT00930761|472097666|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
131128005|NCT00930761|472097667|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
131128006|NCT00930761|472097666|FG000|Overall Study|less than 3 music therapy sessions|0|||
131226901|NCT00606684|472457712|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130965634|NCT01627249|471501002|FG001|Overall Study|Missed Visit|1|||
130965635|NCT01627249|471501003|FG002|Overall Study|Missed Visit|0|||
130965636|NCT02627677|471501005|FG000|Overall Study|Adverse event (not progressive disease)|1|||
130965637|NCT02627677|471501006|FG001|Overall Study|Adverse event (not progressive disease)|4|||
131128007|NCT00930761|472097667|FG001|Overall Study|less than 3 music therapy sessions|3|||
130965638|NCT02627677|471501007|FG002|Overall Study|Adverse event (not progressive disease)|1|||
130965639|NCT02627677|471501005|FG000|Overall Study|Progressive disease|1|||
131128008|NCT01500278|472097674|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
131128009|NCT01500278|472097675|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
130965640|NCT02627677|471501006|FG001|Overall Study|Progressive disease|3|||
130965641|NCT02627677|471501007|FG002|Overall Study|Progressive disease|0|||
130965642|NCT02627677|471501005|FG000|Overall Study|Lack of Efficacy|1|||
130965643|NCT02627677|471501006|FG001|Overall Study|Lack of Efficacy|2|||
130965644|NCT02627677|471501007|FG002|Overall Study|Lack of Efficacy|0|||
130965645|NCT02627677|471501005|FG000|Overall Study|Lost to Follow-up|0|||
130965646|NCT02627677|471501006|FG001|Overall Study|Lost to Follow-up|0|||
130965647|NCT02627677|471501007|FG002|Overall Study|Lost to Follow-up|1|||
130965648|NCT02627677|471501005|FG000|Overall Study|Pregnancy|0|||
130965649|NCT02627677|471501006|FG001|Overall Study|Pregnancy|1|||
130965650|NCT02627677|471501007|FG002|Overall Study|Pregnancy|0|||
130965651|NCT02627677|471501005|FG000|Overall Study|Study Terminated by Sponsor|5|||
130965652|NCT02627677|471501006|FG001|Overall Study|Study Terminated by Sponsor|10|||
130965653|NCT02627677|471501007|FG002|Overall Study|Study Terminated by Sponsor|6|||
130965654|NCT02627677|471501005|FG000|Overall Study|Physician Decision|0|||
130965655|NCT02627677|471501006|FG001|Overall Study|Physician Decision|0|||
130965656|NCT02627677|471501007|FG002|Overall Study|Physician Decision|2|||
130965657|NCT02627677|471501005|FG000|Overall Study|Withdrawal by Subject|2|||
130965658|NCT02627677|471501006|FG001|Overall Study|Withdrawal by Subject|1|||
130965659|NCT02627677|471501007|FG002|Overall Study|Withdrawal by Subject|1|||
130965660|NCT02627677|471501005|FG000|Overall Study|Reason not Specified|0|||
130965661|NCT02627677|471501006|FG001|Overall Study|Reason not Specified|0|||
130965662|NCT02627677|471501007|FG002|Overall Study|Reason not Specified|1|||
130965663|NCT02627677|471501005|FG000|Overall Study|Randomized but not Treated|1|||
130965664|NCT02627677|471501006|FG001|Overall Study|Randomized but not Treated|0|||
130965665|NCT02627677|471501007|FG002|Overall Study|Randomized but not Treated|0|||
130965666|NCT02044510|471501008|FG000|Overall Study|Adverse Event|1|||
130965667|NCT02044510|471501009|FG001|Overall Study|Adverse Event|2|||
130965668|NCT00581945|471501012|FG000|Overall Study|Adverse Event|4|||
130965669|NCT00581945|471501013|FG001|Overall Study|Adverse Event|4|||
130965670|NCT00581945|471501012|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130965671|NCT00581945|471501013|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130965672|NCT00581945|471501012|FG000|Overall Study|Withdrawal by Subject|2|||
130965673|NCT00581945|471501013|FG001|Overall Study|Withdrawal by Subject|6|||
130965674|NCT00581945|471501012|FG000|Overall Study|Death|1|||
130965675|NCT00581945|471501013|FG001|Overall Study|Death|0|||
130965676|NCT00587587|471501016|FG000|Overall Study|Lost to Follow-up|6|||
130965677|NCT00587587|471501017|FG001|Overall Study|Lost to Follow-up|1|||
130965678|NCT02039505|471501019|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
130965679|NCT02039505|471501020|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
130965680|NCT02039505|471501021|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
130965681|NCT02039505|471501022|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
130965682|NCT02039505|471501023|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
130965683|NCT02039505|471501024|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
130965684|NCT02039505|471501025|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
130965685|NCT02039505|471501019|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
130965686|NCT02039505|471501020|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
130965687|NCT02039505|471501021|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
130965688|NCT02039505|471501022|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
130965689|NCT02039505|471501023|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
130965690|NCT02039505|471501024|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
130965691|NCT02039505|471501025|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
130965692|NCT02039505|471501019|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
130965693|NCT02039505|471501020|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130965694|NCT02039505|471501021|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130965695|NCT02039505|471501022|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130965696|NCT02039505|471501023|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130965697|NCT02039505|471501024|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130965698|NCT02039505|471501025|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
130965699|NCT02039505|471501019|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
130965700|NCT02039505|471501020|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
130965701|NCT02039505|471501021|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
130965702|NCT02039505|471501022|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
130965703|NCT02039505|471501023|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
130965704|NCT02039505|471501024|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
130965705|NCT02039505|471501025|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
130965706|NCT02039505|471501019|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
130965707|NCT02039505|471501020|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
130965708|NCT02039505|471501021|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
130965709|NCT02039505|471501022|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
131041905|NCT02240238|471789313|FG003|Phase 2|Physician Decision|0|||
131041906|NCT02240238|471789314|FG004|Phase 2|Physician Decision|0|||
131041907|NCT02240238|471789315|FG005|Phase 2|Physician Decision|0|||
131041908|NCT02240238|471789316|FG006|Phase 2|Physician Decision|0|||
131041909|NCT02240238|471789317|FG007|Phase 2|Physician Decision|0|||
130965710|NCT02039505|471501023|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
131041910|NCT02240238|471789318|FG008|Phase 2|Physician Decision|0|||
131041911|NCT02240238|471789319|FG009|Phase 2|Physician Decision|1|||
131041912|NCT02240238|471789320|FG010|Phase 2|Physician Decision|3|||
131041913|NCT02240238|471789321|FG011|Phase 2|Physician Decision|0|||
131041914|NCT02240238|471789310|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041915|NCT02240238|471789311|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041916|NCT02240238|471789312|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041917|NCT02240238|471789313|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041918|NCT02240238|471789314|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041919|NCT02240238|471789315|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041920|NCT02240238|471789316|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041921|NCT02240238|471789317|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041922|NCT02240238|471789318|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041923|NCT02240238|471789319|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
131041924|NCT02240238|471789320|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041925|NCT02240238|471789321|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
131041926|NCT02240238|471789310|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041927|NCT02240238|471789311|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041928|NCT02240238|471789312|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041929|NCT02240238|471789313|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041930|NCT02240238|471789314|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041931|NCT02240238|471789315|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041932|NCT02240238|471789316|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041933|NCT02240238|471789317|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041934|NCT02240238|471789318|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041935|NCT02240238|471789319|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
131041936|NCT02240238|471789320|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041937|NCT02240238|471789321|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
131041938|NCT02240238|471789310|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131041939|NCT02240238|471789311|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131041940|NCT02240238|471789312|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131041941|NCT02240238|471789313|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131041942|NCT02240238|471789314|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131041943|NCT02240238|471789315|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131041944|NCT02240238|471789316|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131041945|NCT02240238|471789317|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131041946|NCT02240238|471789318|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131041947|NCT02240238|471789319|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131128010|NCT01500278|472097674|FG000|Week 0 - Week 12|Protocol Violation|10|||
130965711|NCT02039505|471501024|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
130965712|NCT02039505|471501025|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
131128011|NCT01500278|472097675|FG001|Week 0 - Week 12|Protocol Violation|16|||
131128012|NCT01500278|472097674|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
131128013|NCT01500278|472097675|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
130965713|NCT02039505|471501019|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
130965714|NCT02039505|471501020|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
130965715|NCT02039505|471501021|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
130965716|NCT02039505|471501022|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
130965717|NCT02039505|471501023|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
130965718|NCT02039505|471501024|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
130965719|NCT02039505|471501025|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
130965720|NCT02039505|471501019|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130965721|NCT02039505|471501020|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130965722|NCT02039505|471501021|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
131226902|NCT00606684|472457713|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
131226903|NCT00606684|472457714|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
131226904|NCT00606684|472457715|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
131226905|NCT00606684|472457716|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
131226906|NCT00606684|472457717|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
131226907|NCT00606684|472457718|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
131226908|NCT00606684|472457712|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
131226909|NCT00606684|472457713|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
131226910|NCT00606684|472457714|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
131226911|NCT00606684|472457715|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
131226912|NCT00606684|472457716|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
131226913|NCT00606684|472457717|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
131226914|NCT00606684|472457718|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
131226915|NCT00606684|472457712|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
131226916|NCT00606684|472457713|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
131226917|NCT00606684|472457714|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
131226918|NCT00606684|472457715|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
131226919|NCT00606684|472457716|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
131226920|NCT00606684|472457717|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
131226921|NCT00606684|472457718|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
131226922|NCT00606684|472457712|FG000|Double-Blind Treatment Period|Physician Decision|0|||
131226923|NCT00606684|472457713|FG001|Double-Blind Treatment Period|Physician Decision|5|||
131226924|NCT00606684|472457714|FG002|Double-Blind Treatment Period|Physician Decision|1|||
131226925|NCT00606684|472457715|FG003|Double-Blind Treatment Period|Physician Decision|0|||
131226926|NCT00606684|472457716|FG004|Double-Blind Treatment Period|Physician Decision|3|||
131226927|NCT00606684|472457717|FG005|Double-Blind Treatment Period|Physician Decision|1|||
131226928|NCT00606684|472457718|FG006|Double-Blind Treatment Period|Physician Decision|2|||
131226929|NCT00606684|472457712|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131226930|NCT00606684|472457713|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130965723|NCT02039505|471501022|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
130965724|NCT02039505|471501023|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130965725|NCT02039505|471501024|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130965726|NCT02039505|471501025|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130965727|NCT02039505|471501019|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130965728|NCT02039505|471501020|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130965729|NCT02039505|471501021|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130965730|NCT02039505|471501022|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130965731|NCT02039505|471501023|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130965732|NCT02039505|471501024|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
130965733|NCT02039505|471501025|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
130965734|NCT02039505|471501019|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130965735|NCT02039505|471501020|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130965736|NCT02039505|471501021|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130965737|NCT02039505|471501022|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130965738|NCT02039505|471501023|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130965739|NCT02039505|471501024|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
130965740|NCT02039505|471501025|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
130965741|NCT02039505|471501019|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130965742|NCT02039505|471501020|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130965743|NCT02039505|471501021|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130965744|NCT02039505|471501022|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130965745|NCT02039505|471501023|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130965746|NCT02039505|471501024|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
130965747|NCT02039505|471501025|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
130965748|NCT02039505|471501019|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130965749|NCT02039505|471501020|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130965750|NCT02039505|471501021|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130965751|NCT02039505|471501022|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130965752|NCT02039505|471501023|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
130965753|NCT02039505|471501024|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
131226931|NCT00606684|472457714|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131226932|NCT00606684|472457715|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130716053|NCT01150890|470587079|FG001|Overall Study|Withdrawal by Subject|0|||
130716054|NCT01150890|470587080|FG002|Overall Study|Withdrawal by Subject|2|||
130716055|NCT01150890|470587081|FG003|Overall Study|Withdrawal by Subject|1|||
130716056|NCT01150890|470587078|FG000|Overall Study|Disease progression|0|||
130716057|NCT01150890|470587079|FG001|Overall Study|Disease progression|7|||
130716058|NCT01150890|470587080|FG002|Overall Study|Disease progression|3|||
130716059|NCT01150890|470587081|FG003|Overall Study|Disease progression|7|||
130716060|NCT00922987|470587082|FG000|Overall Study|Insufficient clinical response|1|||
130716061|NCT00922987|470587082|FG000|Overall Study|Protocol Violation|2|||
130716062|NCT00922987|470587082|FG000|Overall Study|Adverse Event|1|||
130716063|NCT00446199|470587083|FG000|Overall Study|Adverse Event|7|||
130965754|NCT02039505|471501025|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
130965755|NCT00633984|471501026|FG000|Overall Study|Lost to Follow-up|0|||
130965756|NCT00633984|471501027|FG001|Overall Study|Lost to Follow-up|6|||
130965757|NCT00633984|471501026|FG000|Overall Study|Withdrawal by Subject|8|||
130965758|NCT00633984|471501027|FG001|Overall Study|Withdrawal by Subject|7|||
130965759|NCT00633984|471501026|FG000|Overall Study|Hospitalized|1|||
130965760|NCT00633984|471501027|FG001|Overall Study|Hospitalized|0|||
130965761|NCT02496884|471501028|FG000|Overall Study|Counted twice as enrolled|2|||
130965762|NCT02496884|471501029|FG001|Overall Study|Counted twice as enrolled|0|||
130965763|NCT02496884|471501030|FG002|Overall Study|Counted twice as enrolled|0|||
130965764|NCT02496884|471501031|FG003|Overall Study|Counted twice as enrolled|0|||
130965765|NCT02496884|471501028|FG000|Overall Study|Withdrawal by Subject|0|||
130965766|NCT02496884|471501029|FG001|Overall Study|Withdrawal by Subject|3|||
130965767|NCT02496884|471501030|FG002|Overall Study|Withdrawal by Subject|0|||
130965768|NCT02496884|471501031|FG003|Overall Study|Withdrawal by Subject|0|||
130965769|NCT00097591|471501032|FG000|Overall Study|Withdrawal of consent|342|||
130965770|NCT00097591|471501033|FG001|Overall Study|Withdrawal of consent|323|||
130965771|NCT00097591|471501032|FG000|Overall Study|Less than 6 months on study drug|9|||
130965772|NCT00097591|471501033|FG001|Overall Study|Less than 6 months on study drug|7|||
130965773|NCT00097591|471501032|FG000|Overall Study|Unable to attend termination visit|53|||
130965774|NCT00097591|471501033|FG001|Overall Study|Unable to attend termination visit|51|||
130965775|NCT00097591|471501032|FG000|Overall Study|Lost to follow up|6|||
130965776|NCT00097591|471501033|FG001|Overall Study|Lost to follow up|10|||
130965777|NCT00097591|471501032|FG000|Overall Study|Other|0|||
130965778|NCT00097591|471501033|FG001|Overall Study|Other|3|||
130965779|NCT01557946|471501040|FG000|Overall Study|Adverse Event|3|||
130965780|NCT01557946|471501041|FG001|Overall Study|Adverse Event|0|||
130965781|NCT00575588|471501045|FG000|Overall Study|Adverse Event|11|||
130965782|NCT00575588|471501046|FG001|Overall Study|Adverse Event|13|||
130965783|NCT00575588|471501045|FG000|Overall Study|Withdrawal by Subject|27|||
130965784|NCT00575588|471501046|FG001|Overall Study|Withdrawal by Subject|31|||
130716064|NCT00446199|470587084|FG001|Overall Study|Adverse Event|4|||
130716065|NCT00446199|470587085|FG002|Overall Study|Adverse Event|6|||
130716066|NCT00446199|470587086|FG003|Overall Study|Adverse Event|4|||
130716067|NCT00446199|470587083|FG000|Overall Study|Lost to Follow-up|4|||
130716068|NCT00446199|470587084|FG001|Overall Study|Lost to Follow-up|5|||
130716069|NCT00446199|470587085|FG002|Overall Study|Lost to Follow-up|2|||
130716070|NCT00446199|470587086|FG003|Overall Study|Lost to Follow-up|6|||
130716071|NCT00446199|470587083|FG000|Overall Study|Protocol Violation|1|||
130965785|NCT00575588|471501045|FG000|Overall Study|Lost to Follow-up|1|||
130965786|NCT00575588|471501046|FG001|Overall Study|Lost to Follow-up|3|||
130965787|NCT00575588|471501045|FG000|Overall Study|Death|4|||
130965788|NCT00575588|471501046|FG001|Overall Study|Death|2|||
130965789|NCT00575588|471501045|FG000|Overall Study|Incorrect enrollment|8|||
130965790|NCT00575588|471501046|FG001|Overall Study|Incorrect enrollment|4|||
130965791|NCT00575588|471501045|FG000|Overall Study|Study specific discontinuation criteria|203|||
130965792|NCT00575588|471501046|FG001|Overall Study|Study specific discontinuation criteria|218|||
130965793|NCT00575588|471501045|FG000|Overall Study|Severe non-compliance to protocol|5|||
130965794|NCT00575588|471501046|FG001|Overall Study|Severe non-compliance to protocol|7|||
130965795|NCT00575588|471501045|FG000|Overall Study|Safety reasons|2|||
130965796|NCT00575588|471501046|FG001|Overall Study|Safety reasons|1|||
130965797|NCT00575588|471501045|FG000|Overall Study|Elevated triglyceride|1|||
130965798|NCT00575588|471501046|FG001|Overall Study|Elevated triglyceride|0|||
130965799|NCT00575588|471501045|FG000|Overall Study|Patient moved|1|||
131128014|NCT01500278|472097674|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
131128015|NCT01500278|472097675|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
131128016|NCT01500278|472097674|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
131128017|NCT01500278|472097675|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
131128018|NCT01500278|472097674|FG000|Week 0 - Week 12|Patient decision|1|||
131128019|NCT01500278|472097675|FG001|Week 0 - Week 12|Patient decision|0|||
131128020|NCT01500278|472097674|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
131128021|NCT01500278|472097675|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
131128022|NCT01500278|472097674|FG000|Week 0 - Week 12|Investigator decision|1|||
131128023|NCT01500278|472097675|FG001|Week 0 - Week 12|Investigator decision|0|||
131128024|NCT01500278|472097674|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
130716072|NCT00446199|470587084|FG001|Overall Study|Protocol Violation|2|||
130716073|NCT00446199|470587085|FG002|Overall Study|Protocol Violation|1|||
130965800|NCT00575588|471501046|FG001|Overall Study|Patient moved|3|||
131128025|NCT01500278|472097675|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
130965801|NCT00575588|471501045|FG000|Overall Study|Impossible to determine HbA1c|0|||
130965802|NCT00575588|471501046|FG001|Overall Study|Impossible to determine HbA1c|1|||
130965803|NCT00614939|471501047|FG000|Overall Study|Withdrawal by Subject|10|||
130965804|NCT00614939|471501048|FG001|Overall Study|Withdrawal by Subject|17|||
130965805|NCT00614939|471501047|FG000|Overall Study|Study specific discontinuation criteris|13|||
130965806|NCT00614939|471501048|FG001|Overall Study|Study specific discontinuation criteris|16|||
130965807|NCT00614939|471501047|FG000|Overall Study|Adverse Event|2|||
130965808|NCT00614939|471501048|FG001|Overall Study|Adverse Event|5|||
130965809|NCT00614939|471501047|FG000|Overall Study|Incorrect enrollment|1|||
130965810|NCT00614939|471501048|FG001|Overall Study|Incorrect enrollment|2|||
130965811|NCT00614939|471501047|FG000|Overall Study|Death|4|||
130965812|NCT00614939|471501048|FG001|Overall Study|Death|3|||
130965813|NCT00614939|471501047|FG000|Overall Study|Poor/non-compliance|4|||
130965814|NCT00614939|471501048|FG001|Overall Study|Poor/non-compliance|0|||
130965815|NCT00614939|471501047|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
130965816|NCT00614939|471501048|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
130965817|NCT00840970|471501049|FG000|Overall Study|Adverse Event|0|||
130965818|NCT00840970|471501050|FG001|Overall Study|Adverse Event|0|||
130965819|NCT00840970|471501051|FG002|Overall Study|Adverse Event|1|||
130965820|NCT00504829|471501052|FG000|Overall Study|Protocol Violation|6|||
130965821|NCT00504829|471501053|FG001|Overall Study|Protocol Violation|4|||
130965822|NCT00504829|471501054|FG002|Overall Study|Protocol Violation|10|||
130965823|NCT01854827|471501055|FG000|Overall Study|Death|1|||
130965824|NCT02571452|471501056|FG000|Overall Study Treatment|Protocol Violation|0|||
130965825|NCT02571452|471501057|FG001|Overall Study Treatment|Protocol Violation|1|||
130965826|NCT02571452|471501056|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
130965827|NCT02571452|471501057|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
130965828|NCT02571452|471501056|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
130965829|NCT02571452|471501057|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
130965830|NCT00534352|471501058|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
130965831|NCT00534352|471501058|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
130965832|NCT00534352|471501058|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
131041948|NCT02240238|471789320|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
131041949|NCT02240238|471789321|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
131041950|NCT02240238|471789310|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041951|NCT02240238|471789311|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041952|NCT02240238|471789312|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041953|NCT02240238|471789313|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041954|NCT02240238|471789314|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041955|NCT02240238|471789315|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041956|NCT02240238|471789316|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041957|NCT02240238|471789317|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041958|NCT02240238|471789318|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041959|NCT02240238|471789319|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041960|NCT02240238|471789320|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
131041961|NCT02240238|471789321|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
131041962|NCT02240238|471789310|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041963|NCT02240238|471789311|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041964|NCT02240238|471789312|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041965|NCT02240238|471789313|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041966|NCT02240238|471789314|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041967|NCT02240238|471789315|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041968|NCT02240238|471789316|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041969|NCT02240238|471789317|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041970|NCT02240238|471789318|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041971|NCT02240238|471789319|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041972|NCT02240238|471789320|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
131041973|NCT02240238|471789321|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
131041974|NCT02240238|471789310|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131041975|NCT02240238|471789311|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131041976|NCT02240238|471789312|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131041977|NCT02240238|471789313|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131041978|NCT02240238|471789314|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131045917|NCT03248479|471802302|FG002|Overall Study|Study terminated by sponsor|0|||
130965833|NCT00534352|471501058|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
130965834|NCT00534352|471501058|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
130965835|NCT00534352|471501058|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
130965836|NCT04788147|471501059|FG000|Overall Study|Screen Failure|3|||
130965837|NCT04788147|471501060|FG001|Overall Study|Screen Failure|10|||
130965838|NCT04788147|471501059|FG000|Overall Study|Incomplete RMRS image session|2|||
130965839|NCT04788147|471501060|FG001|Overall Study|Incomplete RMRS image session|0|||
130965840|NCT05101252|471501063|FG000|Overall Study|Unsatisfactory Test Article|1|||
130965841|NCT05101252|471501064|FG001|Overall Study|Unsatisfactory Test Article|0|||
130965842|NCT05101252|471501063|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130965843|NCT05101252|471501064|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
130965844|NCT05101252|471501063|FG000|Overall Study|Withdrew Consent during study|0|||
130965845|NCT05101252|471501064|FG001|Overall Study|Withdrew Consent during study|1|||
130965846|NCT05101252|471501063|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
130965847|NCT05101252|471501064|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
130965848|NCT04796610|471501065|FG000|Overall Study|Withdrawal by Subject|1|||
130965849|NCT04796610|471501066|FG001|Overall Study|Withdrawal by Subject|0|||
130965850|NCT04796610|471501067|FG002|Overall Study|Withdrawal by Subject|0|||
130965851|NCT04796610|471501068|FG003|Overall Study|Withdrawal by Subject|0|||
130965852|NCT04796610|471501065|FG000|Overall Study|Lost to Follow-up|2|||
130965853|NCT04796610|471501066|FG001|Overall Study|Lost to Follow-up|0|||
130965854|NCT04796610|471501067|FG002|Overall Study|Lost to Follow-up|1|||
130965855|NCT04796610|471501068|FG003|Overall Study|Lost to Follow-up|1|||
130965856|NCT02401672|471501069|FG000|Overall Study|Withdrawal by Subject|1|||
130965857|NCT02401672|471501070|FG001|Overall Study|Withdrawal by Subject|3|||
130965858|NCT00701051|471501071|FG000|Screening|Failed Screening|40|||
130965859|NCT00701051|471501072|FG001|Screening|Failed Screening|0|||
130965860|NCT00701051|471501073|FG002|Screening|Failed Screening|0|||
130965861|NCT00701051|471501071|FG000|Screening|Time conflicts|19|||
130965862|NCT00701051|471501072|FG001|Screening|Time conflicts|0|||
130965863|NCT00701051|471501073|FG002|Screening|Time conflicts|0|||
130965864|NCT00701051|471501071|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
130965865|NCT00701051|471501072|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
130965866|NCT00701051|471501073|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
130965867|NCT02059148|471501074|FG000|Treatment 1|Protocol Violation|0|||
130965868|NCT02059148|471501075|FG001|Treatment 1|Protocol Violation|0|||
130965869|NCT02059148|471501076|FG002|Treatment 1|Protocol Violation|0|||
130965870|NCT02059148|471501077|FG003|Treatment 1|Protocol Violation|0|||
130965871|NCT02059148|471501078|FG004|Treatment 1|Protocol Violation|0|||
130965872|NCT02059148|471501079|FG005|Treatment 1|Protocol Violation|1|||
130965873|NCT04111497|471501081|FG000|Overall Study|relapse of primary disease|1|||
130965874|NCT04111497|471501081|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
130965875|NCT02460198|471501082|FG000|Overall Study|Adverse Event|1|||
130965876|NCT02460198|471501083|FG001|Overall Study|Adverse Event|3|||
130965877|NCT02460198|471501082|FG000|Overall Study|Death|36|||
130965878|NCT02460198|471501083|FG001|Overall Study|Death|28|||
130965879|NCT02460198|471501082|FG000|Overall Study|Lost to Follow-up|1|||
130965880|NCT02460198|471501083|FG001|Overall Study|Lost to Follow-up|1|||
130965881|NCT02460198|471501082|FG000|Overall Study|Transferred to Extension Study|15|||
130965882|NCT02460198|471501083|FG001|Overall Study|Transferred to Extension Study|15|||
130965883|NCT02460198|471501082|FG000|Overall Study|Withdrawal by Subject|2|||
130965884|NCT02460198|471501083|FG001|Overall Study|Withdrawal by Subject|4|||
130965885|NCT02460198|471501082|FG000|Overall Study|Site Terminated By Sponsor|0|||
130965886|NCT02460198|471501083|FG001|Overall Study|Site Terminated By Sponsor|1|||
130965887|NCT02460198|471501082|FG000|Overall Study|Did Not Continue on Extension Study|6|||
130965888|NCT02460198|471501083|FG001|Overall Study|Did Not Continue on Extension Study|11|||
130965889|NCT04382612|471501084|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
131128026|NCT01500278|472097674|FG000|Week 0 - Week 12|Sponsor decision|1|||
131128027|NCT01500278|472097675|FG001|Week 0 - Week 12|Sponsor decision|0|||
131128028|NCT01500278|472097674|FG000|Week 0 - Week 12|Personal reason|0|||
131128029|NCT01500278|472097675|FG001|Week 0 - Week 12|Personal reason|1|||
131128030|NCT01500278|472097674|FG000|Week 0 - Week 12|Other serious disease|0|||
131128031|NCT01500278|472097675|FG001|Week 0 - Week 12|Other serious disease|1|||
130775649|NCT02823470|470806520|FG001|Overall Study|Study terminated by sponsor|15|||
130775650|NCT00463801|470806526|FG000|Overall Study|Protocol Violation|1|||
130775651|NCT00463801|470806526|FG000|Overall Study|Lack of Efficacy|2|||
130965890|NCT04666441|471501085|FG000|Overall Study|Lost to Follow-up|1|||
130965891|NCT04666441|471501086|FG001|Overall Study|Lost to Follow-up|4|||
130965892|NCT04666441|471501087|FG002|Overall Study|Lost to Follow-up|1|||
130965893|NCT04666441|471501088|FG003|Overall Study|Lost to Follow-up|3|||
130965894|NCT04666441|471501089|FG004|Overall Study|Lost to Follow-up|0|||
130965895|NCT04666441|471501090|FG005|Overall Study|Lost to Follow-up|2|||
130775652|NCT00463801|470806526|FG000|Overall Study|Adverse Event|4|||
130775653|NCT00463801|470806526|FG000|Overall Study|Lost to Follow-up|5|||
130965896|NCT04666441|471501091|FG006|Overall Study|Lost to Follow-up|2|||
130965897|NCT04666441|471501092|FG007|Overall Study|Lost to Follow-up|2|||
130965898|NCT04666441|471501085|FG000|Overall Study|Subject Decision|1|||
131128032|NCT01500278|472097674|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
131128033|NCT01500278|472097675|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
130965899|NCT04666441|471501086|FG001|Overall Study|Subject Decision|1|||
130965900|NCT04666441|471501087|FG002|Overall Study|Subject Decision|3|||
130965901|NCT04666441|471501088|FG003|Overall Study|Subject Decision|1|||
130965902|NCT04666441|471501089|FG004|Overall Study|Subject Decision|0|||
130965903|NCT04666441|471501090|FG005|Overall Study|Subject Decision|1|||
130965904|NCT04666441|471501091|FG006|Overall Study|Subject Decision|3|||
130965905|NCT04666441|471501092|FG007|Overall Study|Subject Decision|2|||
130965906|NCT03285477|471501094|FG000|Treatment and Response Assessment Period|Death|1|||
130965907|NCT03285477|471501095|FG001|Treatment and Response Assessment Period|Death|0|||
130965908|NCT03285477|471501094|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
130965909|NCT03285477|471501095|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
130965910|NCT03285477|471501094|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
130965911|NCT03285477|471501095|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
130965912|NCT03285477|471501094|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
130965913|NCT03285477|471501095|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
130716074|NCT00446199|470587086|FG003|Overall Study|Protocol Violation|3|||
130716075|NCT00446199|470587083|FG000|Overall Study|Withdrawal by Subject|2|||
130965914|NCT03285477|471501094|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
130965915|NCT03285477|471501095|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
130965916|NCT00836875|471501102|FG000|Overall Study|Death|3|||
130965917|NCT00836875|471501103|FG001|Overall Study|Death|2|||
130965918|NCT00836875|471501102|FG000|Overall Study|Withdrawal by Subject|0|||
130965919|NCT00836875|471501103|FG001|Overall Study|Withdrawal by Subject|1|||
130965920|NCT01045447|471503138|FG000|Overall Study|Adverse Event|0|||
130965921|NCT01045447|471503139|FG001|Overall Study|Adverse Event|1|||
130965922|NCT01045447|471503138|FG000|Overall Study|Lack of Efficacy|3|||
130965923|NCT01045447|471503139|FG001|Overall Study|Lack of Efficacy|1|||
130965924|NCT01045447|471503138|FG000|Overall Study|Protocol Violation|6|||
130965925|NCT01045447|471503139|FG001|Overall Study|Protocol Violation|3|||
130965926|NCT01045447|471503138|FG000|Overall Study|Withdrawal Criteria|10|||
130965927|NCT01045447|471503139|FG001|Overall Study|Withdrawal Criteria|10|||
130965928|NCT01045447|471503138|FG000|Overall Study|Unclassified|17|||
130965929|NCT01045447|471503139|FG001|Overall Study|Unclassified|13|||
130965930|NCT00129987|471503141|FG000|1st Educational Session|Withdrawal by Subject|141|||
130965931|NCT00129987|471503142|FG001|1st Educational Session|Withdrawal by Subject|109|||
130965932|NCT00129987|471503141|FG000|1 Year|Withdrawal by Subject|32|||
130965933|NCT00129987|471503142|FG001|1 Year|Withdrawal by Subject|21|||
130965934|NCT00116805|471503146|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
130965935|NCT00116805|471503147|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
130965936|NCT00116805|471503146|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
130965937|NCT00116805|471503147|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
130965938|NCT00116805|471503146|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
130965939|NCT00116805|471503147|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
130965940|NCT00116805|471503146|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
130965941|NCT00116805|471503147|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
130965942|NCT00116805|471503146|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
130965943|NCT00116805|471503147|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
130965944|NCT00116805|471503146|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
130965945|NCT00116805|471503147|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
130965946|NCT00116805|471503146|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
130965947|NCT00116805|471503147|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
130965948|NCT00116805|471503146|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
130965949|NCT00116805|471503147|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
131128034|NCT01500278|472097674|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
131128035|NCT01500278|472097675|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
131128036|NCT01500278|472097674|FG000|Week 13 - Week 104|Protocol Violation|6|||
131128037|NCT01500278|472097675|FG001|Week 13 - Week 104|Protocol Violation|6|||
131128038|NCT01500278|472097674|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
131128039|NCT01500278|472097675|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
131128040|NCT01500278|472097674|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
131128041|NCT01500278|472097675|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
131128042|NCT01500278|472097674|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
131128043|NCT01500278|472097675|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
131128044|NCT01500278|472097674|FG000|Week 13 - Week 104|Non/bad compliance|7|||
131128045|NCT01500278|472097675|FG001|Week 13 - Week 104|Non/bad compliance|5|||
131226933|NCT00606684|472457716|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131226934|NCT00606684|472457717|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130965950|NCT00116805|471503146|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
130965951|NCT00116805|471503147|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
130965952|NCT00116805|471503146|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
130965953|NCT00116805|471503147|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
130965954|NCT00116805|471503146|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
131128046|NCT01500278|472097674|FG000|Week 13 - Week 104|Recurrent infections|1|||
131226935|NCT00606684|472457718|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130716076|NCT00446199|470587084|FG001|Overall Study|Withdrawal by Subject|5|||
131226936|NCT02763579|472457719|FG000|Global Period|Death|167|||
131226937|NCT02763579|472457720|FG001|Global Period|Death|151|||
131226938|NCT02763579|472457721|FG002|Global Period|Death|0|||
131226939|NCT02763579|472457722|FG003|Global Period|Death|0|||
131226940|NCT02763579|472457719|FG000|Global Period|Lost to Follow-up|2|||
131226941|NCT02763579|472457720|FG001|Global Period|Lost to Follow-up|4|||
131226942|NCT02763579|472457721|FG002|Global Period|Lost to Follow-up|0|||
131226943|NCT02763579|472457722|FG003|Global Period|Lost to Follow-up|0|||
131226944|NCT02763579|472457719|FG000|Global Period|Physician Decision|0|||
130965955|NCT00116805|471503147|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
130965956|NCT00116805|471503146|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
130965957|NCT00116805|471503147|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
130965958|NCT00116805|471503146|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
130965959|NCT00116805|471503147|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
130965960|NCT00116805|471503146|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
130965961|NCT00116805|471503147|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
130965962|NCT00116805|471503146|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
130965963|NCT00116805|471503147|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
130965964|NCT00116805|471503146|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
130965965|NCT00116805|471503147|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
130965966|NCT00116805|471503146|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
130965967|NCT00116805|471503147|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
130965968|NCT00116805|471503146|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
130965969|NCT00116805|471503147|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
130965970|NCT00116805|471503146|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
130965971|NCT00116805|471503147|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
130965972|NCT00116805|471503146|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
130965973|NCT00116805|471503147|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
130965974|NCT00116805|471503146|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
130965975|NCT00116805|471503147|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
130965976|NCT00116805|471503146|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
130965977|NCT00116805|471503147|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
130965978|NCT00116805|471503146|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
130965979|NCT00116805|471503147|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
130965980|NCT00116805|471503146|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
130965981|NCT00116805|471503147|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
130965982|NCT00116805|471503146|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
130965983|NCT00116805|471503147|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
130965984|NCT00116805|471503146|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
130965985|NCT00116805|471503147|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
130965986|NCT00116805|471503146|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
130965987|NCT00116805|471503147|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
130965988|NCT00116805|471503146|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
130965989|NCT00116805|471503147|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
130965990|NCT00116805|471503146|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
130965991|NCT00116805|471503147|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
130965992|NCT00116805|471503146|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
130965993|NCT00116805|471503147|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
130965994|NCT00116805|471503146|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
130965995|NCT00116805|471503147|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
130965996|NCT00116805|471503146|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
130965997|NCT00116805|471503147|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
131226945|NCT02763579|472457720|FG001|Global Period|Physician Decision|2|||
130716077|NCT00446199|470587085|FG002|Overall Study|Withdrawal by Subject|9|||
130965998|NCT00116805|471503146|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
130965999|NCT00116805|471503147|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
130966000|NCT00116805|471503146|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
130966001|NCT00116805|471503147|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
130966002|NCT00116805|471503146|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
130966003|NCT00116805|471503147|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
130966004|NCT00116805|471503146|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
130966005|NCT00116805|471503147|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
130966006|NCT00116805|471503146|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
131045918|NCT03248479|471802303|FG003|Overall Study|Study terminated by sponsor|5|||
131226946|NCT02763579|472457721|FG002|Global Period|Physician Decision|0|||
131226947|NCT02763579|472457722|FG003|Global Period|Physician Decision|0|||
131226948|NCT02763579|472457719|FG000|Global Period|Study Terminated By Sponsor|21|||
130716078|NCT00446199|470587086|FG003|Overall Study|Withdrawal by Subject|10|||
130716079|NCT00446199|470587083|FG000|Overall Study|Site termination|2|||
130716080|NCT00446199|470587084|FG001|Overall Study|Site termination|0|||
130716081|NCT00446199|470587085|FG002|Overall Study|Site termination|0|||
130966007|NCT00116805|471503147|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
130966008|NCT00116805|471503146|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
130966009|NCT00116805|471503147|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
130966010|NCT00116805|471503146|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
130966011|NCT00116805|471503147|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
130966012|NCT00116805|471503146|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
130966013|NCT00116805|471503147|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
130966014|NCT00116805|471503146|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
130966015|NCT00116805|471503147|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
130966016|NCT00116805|471503146|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
130966017|NCT00116805|471503147|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
131128047|NCT01500278|472097675|FG001|Week 13 - Week 104|Recurrent infections|0|||
131128048|NCT01500278|472097674|FG000|Week 13 - Week 104|False positive test|1|||
131128049|NCT01500278|472097675|FG001|Week 13 - Week 104|False positive test|2|||
131128050|NCT01500278|472097674|FG000|Week 13 - Week 104|Sponsor request|4|||
131128051|NCT01500278|472097675|FG001|Week 13 - Week 104|Sponsor request|0|||
131128052|NCT01500278|472097674|FG000|Week 13 - Week 104|Withdrawn in error|1|||
131128053|NCT01500278|472097675|FG001|Week 13 - Week 104|Withdrawn in error|0|||
131128054|NCT01500278|472097674|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
131128055|NCT01500278|472097675|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
131128056|NCT01500278|472097674|FG000|Week 13 - Week 104|Protocol deviation|1|||
131128057|NCT01500278|472097675|FG001|Week 13 - Week 104|Protocol deviation|0|||
131128058|NCT01500278|472097674|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
131128059|NCT01500278|472097675|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
131128060|NCT01500278|472097674|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
131128061|NCT01500278|472097675|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
131128062|NCT01500278|472097674|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
131128063|NCT01500278|472097675|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
131128064|NCT01500278|472097674|FG000|Week 13 - Week 104|Relocation|0|||
131128065|NCT01500278|472097675|FG001|Week 13 - Week 104|Relocation|1|||
131128066|NCT01500278|472097674|FG000|Week 13 - Week 104|Sponsor decision|0|||
131128067|NCT01500278|472097675|FG001|Week 13 - Week 104|Sponsor decision|2|||
131128068|NCT01500278|472097674|FG000|Week 13 - Week 104|Medical monitor decision|0|||
131128069|NCT01500278|472097675|FG001|Week 13 - Week 104|Medical monitor decision|2|||
131128070|NCT01500278|472097674|FG000|Week 13 - Week 104|Personal reason|0|||
131128071|NCT01500278|472097675|FG001|Week 13 - Week 104|Personal reason|1|||
131128072|NCT01500278|472097674|FG000|Week 13 - Week 104|Not completed|0|||
131128073|NCT01500278|472097675|FG001|Week 13 - Week 104|Not completed|1|||
131128074|NCT01500278|472097674|FG000|Week 13 - Week 104|Death|2|||
131128075|NCT01500278|472097675|FG001|Week 13 - Week 104|Death|4|||
131128076|NCT01500278|472097674|FG000|Week 13 - Week 104|Adverse Event|54|||
131128077|NCT01500278|472097675|FG001|Week 13 - Week 104|Adverse Event|54|||
131128078|NCT00283595|472097676|FG000|Overall Study|Withdrawal by Subject|1|||
131128079|NCT00283595|472097677|FG001|Overall Study|Withdrawal by Subject|2|||
131128080|NCT01709435|472097681|FG000|Overall Study|Adverse Event|1|||
131128081|NCT01709435|472097682|FG001|Overall Study|Adverse Event|1|||
131128082|NCT01709435|472097683|FG002|Overall Study|Adverse Event|1|||
131128083|NCT01709435|472097684|FG003|Overall Study|Adverse Event|0|||
131128084|NCT01709435|472097685|FG004|Overall Study|Adverse Event|0|||
131128085|NCT01709435|472097686|FG005|Overall Study|Adverse Event|1|||
131128086|NCT01709435|472097681|FG000|Overall Study|Lack of Efficacy|5|||
131128087|NCT01709435|472097682|FG001|Overall Study|Lack of Efficacy|7|||
131128088|NCT01709435|472097683|FG002|Overall Study|Lack of Efficacy|2|||
131128089|NCT01709435|472097684|FG003|Overall Study|Lack of Efficacy|2|||
131128090|NCT01709435|472097685|FG004|Overall Study|Lack of Efficacy|6|||
131128091|NCT01709435|472097686|FG005|Overall Study|Lack of Efficacy|3|||
130716082|NCT00446199|470587086|FG003|Overall Study|Site termination|1|||
130716083|NCT00446199|470587083|FG000|Overall Study|Randomization in Error|2|||
130716084|NCT00446199|470587084|FG001|Overall Study|Randomization in Error|0|||
130716085|NCT00446199|470587085|FG002|Overall Study|Randomization in Error|1|||
130716086|NCT00446199|470587086|FG003|Overall Study|Randomization in Error|1|||
131128092|NCT01709435|472097681|FG000|Overall Study|Physician Decision|0|||
131128093|NCT01709435|472097682|FG001|Overall Study|Physician Decision|1|||
131128094|NCT01709435|472097683|FG002|Overall Study|Physician Decision|0|||
131128095|NCT01709435|472097684|FG003|Overall Study|Physician Decision|1|||
131128096|NCT01709435|472097685|FG004|Overall Study|Physician Decision|2|||
131128097|NCT01709435|472097686|FG005|Overall Study|Physician Decision|0|||
131128098|NCT01709435|472097681|FG000|Overall Study|Withdrawal by Subject|0|||
130716087|NCT00446199|470587083|FG000|Overall Study|Lack of Efficacy|1|||
130716088|NCT00446199|470587084|FG001|Overall Study|Lack of Efficacy|0|||
130966018|NCT00116805|471503146|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
130966019|NCT00116805|471503147|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
130966020|NCT00116805|471503146|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
130966021|NCT00116805|471503147|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
130966022|NCT00116805|471503146|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
130966023|NCT00116805|471503147|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
130966024|NCT01782131|471503148|FG000|Overall Study|Death|93|||
130966025|NCT01782131|471503149|FG001|Overall Study|Death|96|||
130966026|NCT01782131|471503148|FG000|Overall Study|Lost to Follow-up|1|||
130966027|NCT01782131|471503149|FG001|Overall Study|Lost to Follow-up|3|||
130966028|NCT01782131|471503148|FG000|Overall Study|Withdrawal by Subject|10|||
130966029|NCT01782131|471503149|FG001|Overall Study|Withdrawal by Subject|10|||
130966030|NCT01782131|471503148|FG000|Overall Study|Randomized but not treated|5|||
130966031|NCT01782131|471503149|FG001|Overall Study|Randomized but not treated|5|||
130966032|NCT01782131|471503148|FG000|Overall Study|Reason not provided|0|||
130966033|NCT01782131|471503149|FG001|Overall Study|Reason not provided|1|||
130966034|NCT00796718|471503150|FG000|Overall Study|Adverse Event|2|||
130966035|NCT00796718|471503150|FG000|Overall Study|Exclusion Criteria|1|||
130966036|NCT00796718|471503150|FG000|Overall Study|Lost to Follow-up|5|||
130966037|NCT00796718|471503150|FG000|Overall Study|Withdrawal by Informed Consent|1|||
130966038|NCT03266588|471503151|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
130966039|NCT03266588|471503152|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
130966040|NCT03266588|471503153|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
130966041|NCT03266588|471503151|FG000|Observational Period|Withdrawal by Subject|44|||
130966042|NCT03266588|471503152|FG001|Observational Period|Withdrawal by Subject|22|||
130966043|NCT03266588|471503153|FG002|Observational Period|Withdrawal by Subject|13|||
131128099|NCT01709435|472097682|FG001|Overall Study|Withdrawal by Subject|0|||
131128100|NCT01709435|472097683|FG002|Overall Study|Withdrawal by Subject|3|||
131128101|NCT01709435|472097684|FG003|Overall Study|Withdrawal by Subject|0|||
131128102|NCT01709435|472097685|FG004|Overall Study|Withdrawal by Subject|2|||
131128103|NCT01709435|472097686|FG005|Overall Study|Withdrawal by Subject|2|||
131128104|NCT00183274|472097687|FG000|Phase 1: Open-Label|Adverse Event|31|||
131128105|NCT00183274|472097688|FG001|Phase 1: Open-Label|Adverse Event|0|||
131128106|NCT00183274|472097689|FG002|Phase 1: Open-Label|Adverse Event|0|||
131128107|NCT00183274|472097690|FG003|Phase 1: Open-Label|Adverse Event|0|||
131128108|NCT00183274|472097691|FG004|Phase 1: Open-Label|Adverse Event|0|||
131128109|NCT00183274|472097692|FG005|Phase 1: Open-Label|Adverse Event|0|||
131128110|NCT00183274|472097687|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
131128111|NCT00183274|472097688|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
131128112|NCT00183274|472097689|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
131128113|NCT00183274|472097690|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
131128114|NCT00183274|472097691|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
131128115|NCT00183274|472097692|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
131128116|NCT00183274|472097687|FG000|Phase 1: Open-Label|Protocol Violation|11|||
131226949|NCT02763579|472457720|FG001|Global Period|Study Terminated By Sponsor|26|||
131226950|NCT02763579|472457721|FG002|Global Period|Study Terminated By Sponsor|0|||
130966044|NCT03266588|471503151|FG000|Observational Period|Non-compliance|18|||
130966045|NCT03266588|471503152|FG001|Observational Period|Non-compliance|12|||
130966046|NCT03266588|471503153|FG002|Observational Period|Non-compliance|10|||
130966047|NCT03266588|471503151|FG000|Observational Period|Lost to Follow-up|8|||
130966048|NCT03266588|471503152|FG001|Observational Period|Lost to Follow-up|12|||
130966049|NCT03266588|471503153|FG002|Observational Period|Lost to Follow-up|4|||
130966050|NCT03266588|471503151|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
131041979|NCT02240238|471789315|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131041980|NCT02240238|471789316|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131041981|NCT02240238|471789317|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131041982|NCT02240238|471789318|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131041983|NCT02240238|471789319|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131041984|NCT02240238|471789320|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
131041985|NCT02240238|471789321|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
131041986|NCT02240238|471789310|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131041987|NCT02240238|471789311|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131041988|NCT02240238|471789312|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131041989|NCT02240238|471789313|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131128117|NCT00183274|472097688|FG001|Phase 1: Open-Label|Protocol Violation|0|||
131128118|NCT00183274|472097689|FG002|Phase 1: Open-Label|Protocol Violation|0|||
131128119|NCT00183274|472097690|FG003|Phase 1: Open-Label|Protocol Violation|0|||
131128120|NCT00183274|472097691|FG004|Phase 1: Open-Label|Protocol Violation|0|||
131226951|NCT02763579|472457722|FG003|Global Period|Study Terminated By Sponsor|0|||
130966051|NCT03266588|471503152|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
130966052|NCT03266588|471503153|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
130966053|NCT03266588|471503151|FG000|Observational Period|Protocol Deviation|1|||
130966054|NCT03266588|471503152|FG001|Observational Period|Protocol Deviation|0|||
130966055|NCT03266588|471503153|FG002|Observational Period|Protocol Deviation|0|||
130966056|NCT03266588|471503151|FG000|Observational Period|Other Reasons|3|||
130966057|NCT03266588|471503152|FG001|Observational Period|Other Reasons|0|||
130966058|NCT03266588|471503153|FG002|Observational Period|Other Reasons|1|||
130966059|NCT03266588|471503151|FG000|Long-term Treatment Period|Adverse Event|33|||
130966060|NCT03266588|471503152|FG001|Long-term Treatment Period|Adverse Event|17|||
130966061|NCT03266588|471503153|FG002|Long-term Treatment Period|Adverse Event|8|||
130966062|NCT03266588|471503151|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
130966063|NCT03266588|471503152|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
130966064|NCT03266588|471503153|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
130966065|NCT03266588|471503151|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
130966066|NCT03266588|471503152|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
130966067|NCT03266588|471503153|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
130966068|NCT03266588|471503151|FG000|Long-term Treatment Period|Non-Compliance|126|||
130966069|NCT03266588|471503152|FG001|Long-term Treatment Period|Non-Compliance|57|||
130966070|NCT03266588|471503153|FG002|Long-term Treatment Period|Non-Compliance|7|||
130966071|NCT03266588|471503151|FG000|Long-term Treatment Period|Pregnancy|11|||
130966072|NCT03266588|471503152|FG001|Long-term Treatment Period|Pregnancy|5|||
130966073|NCT03266588|471503153|FG002|Long-term Treatment Period|Pregnancy|0|||
130966074|NCT03266588|471503151|FG000|Long-term Treatment Period|Protocol Deviation|17|||
130966075|NCT03266588|471503152|FG001|Long-term Treatment Period|Protocol Deviation|10|||
130966076|NCT03266588|471503153|FG002|Long-term Treatment Period|Protocol Deviation|4|||
130966077|NCT03266588|471503151|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
130966078|NCT03266588|471503152|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
130966079|NCT03266588|471503153|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
130966080|NCT03266588|471503151|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
130966081|NCT03266588|471503152|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
130966082|NCT03266588|471503153|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
130966083|NCT03266588|471503151|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
130966084|NCT03266588|471503152|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
130966085|NCT03266588|471503153|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
130966086|NCT03266588|471503151|FG000|Long-term Treatment Period|Other Reasons|5|||
130966087|NCT03266588|471503152|FG001|Long-term Treatment Period|Other Reasons|0|||
130966088|NCT03266588|471503153|FG002|Long-term Treatment Period|Other Reasons|0|||
130966089|NCT03266588|471503151|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
130966090|NCT03266588|471503152|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
130966091|NCT03266588|471503153|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
130966092|NCT00317772|471503154|FG000|Overall Study|Adverse Event|0|||
130966093|NCT00317772|471503155|FG001|Overall Study|Adverse Event|0|||
130966094|NCT00317772|471503156|FG002|Overall Study|Adverse Event|0|||
130966095|NCT00317772|471503157|FG003|Overall Study|Adverse Event|2|||
130966096|NCT00317772|471503154|FG000|Overall Study|Disease Progression|2|||
130966097|NCT00317772|471503155|FG001|Overall Study|Disease Progression|2|||
130966098|NCT00317772|471503156|FG002|Overall Study|Disease Progression|1|||
130966099|NCT00317772|471503157|FG003|Overall Study|Disease Progression|7|||
130966100|NCT01075321|471503164|FG000|Overall Study|Withdrawal by Subject|0|||
130966101|NCT01075321|471503165|FG001|Overall Study|Withdrawal by Subject|0|||
130966102|NCT01075321|471503166|FG002|Overall Study|Withdrawal by Subject|1|||
130966103|NCT01075321|471503167|FG003|Overall Study|Withdrawal by Subject|1|||
130966104|NCT01075321|471503164|FG000|Overall Study|Protocol Violation|0|||
130966105|NCT01075321|471503165|FG001|Overall Study|Protocol Violation|0|||
130966106|NCT01075321|471503166|FG002|Overall Study|Protocol Violation|1|||
130966107|NCT01075321|471503167|FG003|Overall Study|Protocol Violation|0|||
130966108|NCT01075321|471503164|FG000|Overall Study|Treatment Incomplete due to progression|1|||
130966109|NCT01075321|471503165|FG001|Overall Study|Treatment Incomplete due to progression|0|||
130966110|NCT01075321|471503166|FG002|Overall Study|Treatment Incomplete due to progression|0|||
130966111|NCT01075321|471503167|FG003|Overall Study|Treatment Incomplete due to progression|0|||
130966112|NCT01075321|471503164|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
130966113|NCT01075321|471503165|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
130966114|NCT01075321|471503166|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
130966115|NCT01075321|471503167|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
130966116|NCT01933334|471503171|FG000|Overall Study|Adverse Event|5|||
130966117|NCT01933334|471503172|FG001|Overall Study|Adverse Event|1|||
130966118|NCT01933334|471503171|FG000|Overall Study|Withdrawal by Subject|0|||
130966119|NCT01933334|471503172|FG001|Overall Study|Withdrawal by Subject|1|||
130966120|NCT02032901|471503173|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
130966121|NCT02032901|471503174|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
130966122|NCT02032901|471503173|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
130966123|NCT02032901|471503174|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
130966124|NCT01722331|471503175|FG000|Part 1|Adverse Event|5|||
130966125|NCT01722331|471503176|FG001|Part 1|Adverse Event|0|||
130966126|NCT01722331|471503177|FG002|Part 1|Adverse Event|0|||
130966127|NCT01722331|471503178|FG003|Part 1|Adverse Event|0|||
130966128|NCT01722331|471503179|FG004|Part 1|Adverse Event|0|||
130966129|NCT01722331|471503180|FG005|Part 1|Adverse Event|0|||
130966130|NCT01722331|471503181|FG006|Part 1|Adverse Event|0|||
130966131|NCT01722331|471503175|FG000|Part 1|Lack of Efficacy|0|||
130966132|NCT01722331|471503176|FG001|Part 1|Lack of Efficacy|0|||
130966133|NCT01722331|471503177|FG002|Part 1|Lack of Efficacy|1|||
130966134|NCT01722331|471503178|FG003|Part 1|Lack of Efficacy|0|||
130966135|NCT01722331|471503179|FG004|Part 1|Lack of Efficacy|2|||
130966136|NCT01722331|471503180|FG005|Part 1|Lack of Efficacy|0|||
130966137|NCT01722331|471503181|FG006|Part 1|Lack of Efficacy|0|||
130966138|NCT01722331|471503175|FG000|Part 1|Lost to Follow-up|1|||
130966139|NCT01722331|471503176|FG001|Part 1|Lost to Follow-up|0|||
130966140|NCT01722331|471503177|FG002|Part 1|Lost to Follow-up|2|||
130966141|NCT01722331|471503178|FG003|Part 1|Lost to Follow-up|0|||
130966142|NCT01722331|471503179|FG004|Part 1|Lost to Follow-up|1|||
130966143|NCT01722331|471503180|FG005|Part 1|Lost to Follow-up|0|||
130966144|NCT01722331|471503181|FG006|Part 1|Lost to Follow-up|0|||
130966145|NCT01722331|471503175|FG000|Part 1|Physician Decision|0|||
130966146|NCT01722331|471503176|FG001|Part 1|Physician Decision|0|||
130966147|NCT01722331|471503177|FG002|Part 1|Physician Decision|3|||
130966148|NCT01722331|471503178|FG003|Part 1|Physician Decision|0|||
130966149|NCT01722331|471503179|FG004|Part 1|Physician Decision|1|||
130966150|NCT01722331|471503180|FG005|Part 1|Physician Decision|0|||
130966151|NCT01722331|471503181|FG006|Part 1|Physician Decision|0|||
130966152|NCT01722331|471503175|FG000|Part 1|Pregnancy|1|||
130966153|NCT01722331|471503176|FG001|Part 1|Pregnancy|0|||
131128121|NCT00183274|472097692|FG005|Phase 1: Open-Label|Protocol Violation|0|||
131128122|NCT00183274|472097687|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
130716089|NCT00446199|470587085|FG002|Overall Study|Lack of Efficacy|0|||
130716090|NCT00446199|470587086|FG003|Overall Study|Lack of Efficacy|1|||
130716091|NCT00446199|470587083|FG000|Overall Study|Non-compliant with study drug|1|||
130716092|NCT00446199|470587084|FG001|Overall Study|Non-compliant with study drug|0|||
130716093|NCT00446199|470587085|FG002|Overall Study|Non-compliant with study drug|5|||
130716094|NCT00446199|470587086|FG003|Overall Study|Non-compliant with study drug|0|||
130716095|NCT00446199|470587083|FG000|Overall Study|Non-compliant with visit schedule|1|||
130716096|NCT00446199|470587084|FG001|Overall Study|Non-compliant with visit schedule|1|||
130716097|NCT00446199|470587085|FG002|Overall Study|Non-compliant with visit schedule|1|||
130716098|NCT00446199|470587086|FG003|Overall Study|Non-compliant with visit schedule|2|||
130716099|NCT00446199|470587083|FG000|Overall Study|Hormone fear|0|||
130716100|NCT00446199|470587084|FG001|Overall Study|Hormone fear|0|||
130716101|NCT00446199|470587085|FG002|Overall Study|Hormone fear|0|||
130716102|NCT00446199|470587086|FG003|Overall Study|Hormone fear|1|||
130716103|NCT00446199|470587083|FG000|Overall Study|Lost interest in study participation|0|||
130716104|NCT00446199|470587084|FG001|Overall Study|Lost interest in study participation|1|||
130716105|NCT00446199|470587085|FG002|Overall Study|Lost interest in study participation|0|||
130716106|NCT00446199|470587086|FG003|Overall Study|Lost interest in study participation|0|||
130716107|NCT00446199|470587083|FG000|Overall Study|In-/Exclusion criterion violated|2|||
130716108|NCT00446199|470587084|FG001|Overall Study|In-/Exclusion criterion violated|1|||
130716109|NCT00446199|470587085|FG002|Overall Study|In-/Exclusion criterion violated|2|||
130716110|NCT00446199|470587086|FG003|Overall Study|In-/Exclusion criterion violated|1|||
130716111|NCT00446199|470587083|FG000|Overall Study|Move|0|||
131128123|NCT00183274|472097688|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
131128124|NCT00183274|472097689|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
131128125|NCT00183274|472097690|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
131128126|NCT00183274|472097691|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
131128127|NCT00183274|472097692|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
131128128|NCT00183274|472097687|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
131128129|NCT00183274|472097688|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
130716112|NCT00446199|470587084|FG001|Overall Study|Move|1|||
130716113|NCT00446199|470587085|FG002|Overall Study|Move|0|||
130716114|NCT00446199|470587086|FG003|Overall Study|Move|0|||
130716115|NCT03071094|470587090|FG000|Overall Study|Death|1|||
130966154|NCT01722331|471503177|FG002|Part 1|Pregnancy|0|||
130966155|NCT01722331|471503178|FG003|Part 1|Pregnancy|0|||
130966156|NCT01722331|471503179|FG004|Part 1|Pregnancy|0|||
130966157|NCT01722331|471503180|FG005|Part 1|Pregnancy|0|||
130966158|NCT01722331|471503181|FG006|Part 1|Pregnancy|0|||
130966159|NCT01722331|471503175|FG000|Part 1|Progressive Disease|0|||
130966160|NCT01722331|471503176|FG001|Part 1|Progressive Disease|0|||
130966161|NCT01722331|471503177|FG002|Part 1|Progressive Disease|0|||
130966162|NCT01722331|471503178|FG003|Part 1|Progressive Disease|0|||
130966163|NCT01722331|471503179|FG004|Part 1|Progressive Disease|1|||
130966164|NCT01722331|471503180|FG005|Part 1|Progressive Disease|0|||
130966165|NCT01722331|471503181|FG006|Part 1|Progressive Disease|0|||
130966166|NCT01722331|471503175|FG000|Part 1|Protocol Violation|1|||
130966167|NCT01722331|471503176|FG001|Part 1|Protocol Violation|0|||
130966168|NCT01722331|471503177|FG002|Part 1|Protocol Violation|0|||
130966169|NCT01722331|471503178|FG003|Part 1|Protocol Violation|0|||
130966170|NCT01722331|471503179|FG004|Part 1|Protocol Violation|1|||
130966171|NCT01722331|471503180|FG005|Part 1|Protocol Violation|0|||
130966172|NCT01722331|471503181|FG006|Part 1|Protocol Violation|0|||
130966173|NCT01722331|471503175|FG000|Part 1|Withdrawal by Subject|2|||
130966174|NCT01722331|471503176|FG001|Part 1|Withdrawal by Subject|0|||
130966175|NCT01722331|471503177|FG002|Part 1|Withdrawal by Subject|3|||
130966176|NCT01722331|471503178|FG003|Part 1|Withdrawal by Subject|0|||
130966177|NCT01722331|471503179|FG004|Part 1|Withdrawal by Subject|3|||
130966178|NCT01722331|471503180|FG005|Part 1|Withdrawal by Subject|0|||
130966179|NCT01722331|471503181|FG006|Part 1|Withdrawal by Subject|0|||
130966180|NCT01722331|471503175|FG000|Part 2|Adverse Event|3|||
130966181|NCT01722331|471503176|FG001|Part 2|Adverse Event|0|||
130966182|NCT01722331|471503177|FG002|Part 2|Adverse Event|0|||
130966183|NCT01722331|471503178|FG003|Part 2|Adverse Event|0|||
130966184|NCT01722331|471503179|FG004|Part 2|Adverse Event|0|||
130966185|NCT01722331|471503180|FG005|Part 2|Adverse Event|1|||
130966186|NCT01722331|471503181|FG006|Part 2|Adverse Event|0|||
130966187|NCT01722331|471503175|FG000|Part 2|Lack of Efficacy|3|||
130966188|NCT01722331|471503176|FG001|Part 2|Lack of Efficacy|0|||
130966189|NCT01722331|471503177|FG002|Part 2|Lack of Efficacy|11|||
130966190|NCT01722331|471503178|FG003|Part 2|Lack of Efficacy|0|||
130966191|NCT01722331|471503179|FG004|Part 2|Lack of Efficacy|0|||
130966192|NCT01722331|471503180|FG005|Part 2|Lack of Efficacy|3|||
130966193|NCT01722331|471503181|FG006|Part 2|Lack of Efficacy|3|||
130966194|NCT01722331|471503175|FG000|Part 2|Lost to Follow-up|0|||
130966195|NCT01722331|471503176|FG001|Part 2|Lost to Follow-up|0|||
130966196|NCT01722331|471503177|FG002|Part 2|Lost to Follow-up|3|||
130966197|NCT01722331|471503178|FG003|Part 2|Lost to Follow-up|0|||
130966198|NCT01722331|471503179|FG004|Part 2|Lost to Follow-up|0|||
130966199|NCT01722331|471503180|FG005|Part 2|Lost to Follow-up|1|||
130966200|NCT01722331|471503181|FG006|Part 2|Lost to Follow-up|1|||
130966201|NCT01722331|471503175|FG000|Part 2|Non-Compliance with Study Drug|1|||
130966202|NCT01722331|471503176|FG001|Part 2|Non-Compliance with Study Drug|0|||
130966203|NCT01722331|471503177|FG002|Part 2|Non-Compliance with Study Drug|1|||
130966204|NCT01722331|471503178|FG003|Part 2|Non-Compliance with Study Drug|0|||
130966205|NCT01722331|471503179|FG004|Part 2|Non-Compliance with Study Drug|0|||
130966206|NCT01722331|471503180|FG005|Part 2|Non-Compliance with Study Drug|0|||
130966207|NCT01722331|471503181|FG006|Part 2|Non-Compliance with Study Drug|0|||
130966208|NCT01722331|471503175|FG000|Part 2|Physician Decision|0|||
130966209|NCT01722331|471503176|FG001|Part 2|Physician Decision|0|||
130966210|NCT01722331|471503177|FG002|Part 2|Physician Decision|2|||
130966211|NCT01722331|471503178|FG003|Part 2|Physician Decision|0|||
130966212|NCT01722331|471503179|FG004|Part 2|Physician Decision|0|||
130966213|NCT01722331|471503180|FG005|Part 2|Physician Decision|0|||
130966214|NCT01722331|471503181|FG006|Part 2|Physician Decision|0|||
130966215|NCT01722331|471503175|FG000|Part 2|Pregnancy|0|||
130966216|NCT01722331|471503176|FG001|Part 2|Pregnancy|0|||
130966217|NCT01722331|471503177|FG002|Part 2|Pregnancy|0|||
130966218|NCT01722331|471503178|FG003|Part 2|Pregnancy|0|||
130966219|NCT01722331|471503179|FG004|Part 2|Pregnancy|0|||
130966220|NCT01722331|471503180|FG005|Part 2|Pregnancy|1|||
130966221|NCT01722331|471503181|FG006|Part 2|Pregnancy|0|||
130775654|NCT00463801|470806526|FG000|Overall Study|No longer require therapy|1|||
130775655|NCT00669318|470806527|FG000|Overall Study|Withdrawal by Subject|2|||
130775656|NCT01073163|470806528|FG000|Overall Study|Adverse Event|1|||
130775657|NCT01073163|470806528|FG000|Overall Study|Disease Progression|1|||
130966222|NCT01722331|471503175|FG000|Part 2|Progressive Disease|0|||
130966223|NCT01722331|471503176|FG001|Part 2|Progressive Disease|0|||
130966224|NCT01722331|471503177|FG002|Part 2|Progressive Disease|1|||
130966225|NCT01722331|471503178|FG003|Part 2|Progressive Disease|0|||
130966226|NCT01722331|471503179|FG004|Part 2|Progressive Disease|0|||
130966227|NCT01722331|471503180|FG005|Part 2|Progressive Disease|0|||
130966228|NCT01722331|471503181|FG006|Part 2|Progressive Disease|0|||
130966229|NCT01722331|471503175|FG000|Part 2|Protocol Violation|1|||
130966230|NCT01722331|471503176|FG001|Part 2|Protocol Violation|0|||
130966231|NCT01722331|471503177|FG002|Part 2|Protocol Violation|0|||
130966232|NCT01722331|471503178|FG003|Part 2|Protocol Violation|0|||
130966233|NCT01722331|471503179|FG004|Part 2|Protocol Violation|0|||
130966234|NCT01722331|471503180|FG005|Part 2|Protocol Violation|0|||
130966235|NCT01722331|471503181|FG006|Part 2|Protocol Violation|0|||
130966236|NCT01722331|471503175|FG000|Part 2|Withdrawal by Subject|5|||
130966237|NCT01722331|471503176|FG001|Part 2|Withdrawal by Subject|0|||
130966238|NCT01722331|471503177|FG002|Part 2|Withdrawal by Subject|3|||
130966239|NCT01722331|471503178|FG003|Part 2|Withdrawal by Subject|0|||
130966240|NCT01722331|471503179|FG004|Part 2|Withdrawal by Subject|0|||
130966241|NCT01722331|471503180|FG005|Part 2|Withdrawal by Subject|2|||
130966242|NCT01722331|471503181|FG006|Part 2|Withdrawal by Subject|2|||
130966243|NCT01722331|471503175|FG000|Part 2|Other Protocol Specified Criteria|6|||
130966244|NCT01722331|471503176|FG001|Part 2|Other Protocol Specified Criteria|0|||
130966245|NCT01722331|471503177|FG002|Part 2|Other Protocol Specified Criteria|10|||
130966246|NCT01722331|471503178|FG003|Part 2|Other Protocol Specified Criteria|0|||
130966247|NCT01722331|471503179|FG004|Part 2|Other Protocol Specified Criteria|0|||
130966248|NCT01722331|471503180|FG005|Part 2|Other Protocol Specified Criteria|2|||
130966249|NCT01722331|471503181|FG006|Part 2|Other Protocol Specified Criteria|1|||
130966250|NCT01722331|471503175|FG000|Part 3|Adverse Event|2|||
130966251|NCT01722331|471503176|FG001|Part 3|Adverse Event|2|||
130966252|NCT01722331|471503177|FG002|Part 3|Adverse Event|0|||
130966253|NCT01722331|471503178|FG003|Part 3|Adverse Event|1|||
130966254|NCT01722331|471503179|FG004|Part 3|Adverse Event|0|||
130966255|NCT01722331|471503180|FG005|Part 3|Adverse Event|0|||
130966256|NCT01722331|471503181|FG006|Part 3|Adverse Event|0|||
130966257|NCT01722331|471503175|FG000|Part 3|Death|1|||
130966258|NCT01722331|471503176|FG001|Part 3|Death|0|||
130966259|NCT01722331|471503177|FG002|Part 3|Death|0|||
130966260|NCT01722331|471503178|FG003|Part 3|Death|0|||
130966261|NCT01722331|471503179|FG004|Part 3|Death|0|||
130966262|NCT01722331|471503180|FG005|Part 3|Death|0|||
130966263|NCT01722331|471503181|FG006|Part 3|Death|0|||
130966264|NCT01722331|471503175|FG000|Part 3|Lack of Efficacy|1|||
130966265|NCT01722331|471503176|FG001|Part 3|Lack of Efficacy|0|||
130966266|NCT01722331|471503177|FG002|Part 3|Lack of Efficacy|0|||
130966267|NCT01722331|471503178|FG003|Part 3|Lack of Efficacy|0|||
130966268|NCT01722331|471503179|FG004|Part 3|Lack of Efficacy|0|||
130966269|NCT01722331|471503180|FG005|Part 3|Lack of Efficacy|0|||
130966270|NCT01722331|471503181|FG006|Part 3|Lack of Efficacy|0|||
130966271|NCT01722331|471503175|FG000|Part 3|Lost to Follow-up|3|||
130966272|NCT01722331|471503176|FG001|Part 3|Lost to Follow-up|4|||
130966273|NCT01722331|471503177|FG002|Part 3|Lost to Follow-up|0|||
130966274|NCT01722331|471503178|FG003|Part 3|Lost to Follow-up|0|||
130966275|NCT01722331|471503179|FG004|Part 3|Lost to Follow-up|0|||
130966276|NCT01722331|471503180|FG005|Part 3|Lost to Follow-up|1|||
130966277|NCT01722331|471503181|FG006|Part 3|Lost to Follow-up|0|||
130966278|NCT01722331|471503175|FG000|Part 3|Non-Compliance with Study Drug|0|||
130966279|NCT01722331|471503176|FG001|Part 3|Non-Compliance with Study Drug|1|||
130966280|NCT01722331|471503177|FG002|Part 3|Non-Compliance with Study Drug|0|||
130966281|NCT01722331|471503178|FG003|Part 3|Non-Compliance with Study Drug|0|||
130966282|NCT01722331|471503179|FG004|Part 3|Non-Compliance with Study Drug|0|||
130966283|NCT01722331|471503180|FG005|Part 3|Non-Compliance with Study Drug|0|||
130966284|NCT01722331|471503181|FG006|Part 3|Non-Compliance with Study Drug|0|||
130966285|NCT01722331|471503175|FG000|Part 3|Physician Decision|1|||
130966286|NCT01722331|471503176|FG001|Part 3|Physician Decision|1|||
130966287|NCT01722331|471503177|FG002|Part 3|Physician Decision|0|||
130966288|NCT01722331|471503178|FG003|Part 3|Physician Decision|0|||
130966289|NCT01722331|471503179|FG004|Part 3|Physician Decision|0|||
130966290|NCT01722331|471503180|FG005|Part 3|Physician Decision|0|||
130966291|NCT01722331|471503181|FG006|Part 3|Physician Decision|1|||
130966292|NCT01722331|471503175|FG000|Part 3|Protocol Violation|2|||
130966293|NCT01722331|471503176|FG001|Part 3|Protocol Violation|1|||
130966294|NCT01722331|471503177|FG002|Part 3|Protocol Violation|0|||
131041990|NCT02240238|471789314|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131041991|NCT02240238|471789315|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131041992|NCT02240238|471789316|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131226952|NCT02763579|472457719|FG000|Global Period|Withdrawal by Subject|12|||
131226953|NCT02763579|472457720|FG001|Global Period|Withdrawal by Subject|18|||
131226954|NCT02763579|472457721|FG002|Global Period|Withdrawal by Subject|0|||
131226955|NCT02763579|472457722|FG003|Global Period|Withdrawal by Subject|0|||
131226956|NCT02763579|472457719|FG000|China Period|Death|0|||
131226957|NCT02763579|472457720|FG001|China Period|Death|0|||
131226958|NCT02763579|472457721|FG002|China Period|Death|46|||
130716116|NCT03071094|470587091|FG001|Overall Study|Death|1|||
130716117|NCT03071094|470587090|FG000|Overall Study|Adverse Event|1|||
130966295|NCT01722331|471503178|FG003|Part 3|Protocol Violation|0|||
130966296|NCT01722331|471503179|FG004|Part 3|Protocol Violation|0|||
130966297|NCT01722331|471503180|FG005|Part 3|Protocol Violation|0|||
130966298|NCT01722331|471503181|FG006|Part 3|Protocol Violation|0|||
130966299|NCT01722331|471503175|FG000|Part 3|Withdrawal by Subject|4|||
130966300|NCT01722331|471503176|FG001|Part 3|Withdrawal by Subject|7|||
130966301|NCT01722331|471503177|FG002|Part 3|Withdrawal by Subject|0|||
130966302|NCT01722331|471503178|FG003|Part 3|Withdrawal by Subject|0|||
130966303|NCT01722331|471503179|FG004|Part 3|Withdrawal by Subject|0|||
130966304|NCT01722331|471503180|FG005|Part 3|Withdrawal by Subject|2|||
130966305|NCT01722331|471503181|FG006|Part 3|Withdrawal by Subject|1|||
130966306|NCT01722331|471503175|FG000|Part 3|Other Protocol Specified Criteria|1|||
130966307|NCT01722331|471503176|FG001|Part 3|Other Protocol Specified Criteria|1|||
130966308|NCT01722331|471503177|FG002|Part 3|Other Protocol Specified Criteria|0|||
130966309|NCT01722331|471503178|FG003|Part 3|Other Protocol Specified Criteria|0|||
130966310|NCT01722331|471503179|FG004|Part 3|Other Protocol Specified Criteria|0|||
130966311|NCT01722331|471503180|FG005|Part 3|Other Protocol Specified Criteria|0|||
130966312|NCT01722331|471503181|FG006|Part 3|Other Protocol Specified Criteria|0|||
130966313|NCT00262834|471503182|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
130966314|NCT00262834|471503183|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
130966315|NCT00003457|471503186|FG000|Overall Study|Not evaluable|9|||
130966316|NCT02525133|471503192|FG000|Overall Study|Adverse Event|0|||
130966317|NCT02525133|471503193|FG001|Overall Study|Adverse Event|1|||
130966318|NCT02525133|471503192|FG000|Overall Study|Death|0|||
130966319|NCT02525133|471503193|FG001|Overall Study|Death|1|||
130966320|NCT02525133|471503192|FG000|Overall Study|did not meet randomization criteria|1|||
130966321|NCT02525133|471503193|FG001|Overall Study|did not meet randomization criteria|0|||
130966322|NCT02525133|471503192|FG000|Overall Study|Lost to Follow-up|5|||
130966323|NCT02525133|471503193|FG001|Overall Study|Lost to Follow-up|1|||
130966324|NCT02525133|471503192|FG000|Overall Study|randomized not enrolled|3|||
130966325|NCT02525133|471503193|FG001|Overall Study|randomized not enrolled|0|||
130716118|NCT03071094|470587091|FG001|Overall Study|Adverse Event|0|||
130716119|NCT02312063|470587092|FG000|Overall Study|Withdrawal by Subject|0|||
130716120|NCT02312063|470587093|FG001|Overall Study|Withdrawal by Subject|1|||
130716121|NCT01079832|470587094|FG000|Overall Study|Withdrawal by Subject|1|||
130716122|NCT01951885|470588760|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
130716123|NCT01951885|470588761|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
130716124|NCT01951885|470588760|FG000|Overall Study|Adverse Event|1|||
130716125|NCT01951885|470588761|FG001|Overall Study|Adverse Event|0|||
130716126|NCT01951885|470588760|FG000|Overall Study|Withdrawal by Subject|0|||
130716127|NCT01951885|470588761|FG001|Overall Study|Withdrawal by Subject|1|||
130716128|NCT01951885|470588760|FG000|Overall Study|ineligible due to a change in donor|0|||
130716129|NCT01951885|470588761|FG001|Overall Study|ineligible due to a change in donor|1|||
130716130|NCT01951885|470588760|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
130716131|NCT01951885|470588761|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
130716132|NCT00577395|470588764|FG000|Overall Study|Study was terminated early by Sponsor|7|||
130716133|NCT00577395|470588765|FG001|Overall Study|Study was terminated early by Sponsor|6|||
130716134|NCT01206101|470588768|FG000|Overall Study|Adverse Event|1|||
130716135|NCT01206101|470588769|FG001|Overall Study|Adverse Event|0|||
130716136|NCT01206101|470588768|FG000|Overall Study|Physician Decision|0|||
130716137|NCT01206101|470588769|FG001|Overall Study|Physician Decision|1|||
131128130|NCT00183274|472097689|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
131128131|NCT00183274|472097690|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
131128132|NCT00183274|472097691|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
131128133|NCT00183274|472097692|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
131128134|NCT00183274|472097687|FG000|Phase 1: Open-Label|Other|9|||
131128135|NCT00183274|472097688|FG001|Phase 1: Open-Label|Other|0|||
131128136|NCT00183274|472097689|FG002|Phase 1: Open-Label|Other|0|||
131128137|NCT00183274|472097690|FG003|Phase 1: Open-Label|Other|0|||
131128138|NCT00183274|472097691|FG004|Phase 1: Open-Label|Other|0|||
131128139|NCT00183274|472097692|FG005|Phase 1: Open-Label|Other|0|||
131128140|NCT00183274|472097687|FG000|Phase 2: Double-Blind|Relapsed|0|||
131128141|NCT00183274|472097688|FG001|Phase 2: Double-Blind|Relapsed|8|||
131128142|NCT00183274|472097689|FG002|Phase 2: Double-Blind|Relapsed|29|||
131128143|NCT00183274|472097690|FG003|Phase 2: Double-Blind|Relapsed|0|||
131128144|NCT00183274|472097691|FG004|Phase 2: Double-Blind|Relapsed|0|||
130716138|NCT01206101|470588768|FG000|Overall Study|Unclassified|1|||
130716139|NCT01206101|470588769|FG001|Overall Study|Unclassified|0|||
130716140|NCT04709835|470588772|FG000|Overall Study|Withdrawal by Subject|0|||
130716141|NCT04709835|470588773|FG001|Overall Study|Withdrawal by Subject|1|||
130966326|NCT02525133|471503192|FG000|Overall Study|Withdrawal by Subject|1|||
130966327|NCT02525133|471503193|FG001|Overall Study|Withdrawal by Subject|0|||
130966328|NCT01075074|471503194|FG000|Overall Study|Surgeon changed to open incisional case|1|||
130966329|NCT01075074|471503195|FG001|Overall Study|Surgeon changed to open incisional case|2|||
131128145|NCT00183274|472097692|FG005|Phase 2: Double-Blind|Relapsed|0|||
131128146|NCT00183274|472097687|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
131128147|NCT00183274|472097688|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
131128148|NCT00183274|472097689|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
131128149|NCT00183274|472097690|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
131128150|NCT00183274|472097691|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
131128151|NCT00183274|472097692|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
131128152|NCT00183274|472097687|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
131128153|NCT00183274|472097688|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
131128154|NCT00183274|472097689|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
131128155|NCT00183274|472097690|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
131128156|NCT00183274|472097691|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
130716142|NCT04709835|470588774|FG002|Overall Study|Withdrawal by Subject|0|||
130716143|NCT04325204|470588775|FG000|Overall Study|Death|0|||
130716144|NCT04325204|470588776|FG001|Overall Study|Death|1|||
131128157|NCT00183274|472097692|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
130716145|NCT04325204|470588775|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
130716146|NCT04325204|470588776|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
130716147|NCT04325204|470588775|FG000|Overall Study|Lost to Follow-up|8|||
130716148|NCT04325204|470588776|FG001|Overall Study|Lost to Follow-up|8|||
130966330|NCT01075074|471503196|FG002|Overall Study|Surgeon changed to open incisional case|2|||
130966331|NCT01054729|471503197|FG000|Overall Study|Randomized but Not Treated|0|||
130966332|NCT01054729|471503198|FG001|Overall Study|Randomized but Not Treated|1|||
130966333|NCT01054729|471503199|FG002|Overall Study|Randomized but Not Treated|0|||
130966334|NCT01054729|471503200|FG003|Overall Study|Randomized but Not Treated|0|||
130966335|NCT01054729|471503197|FG000|Overall Study|Adverse Event|1|||
130966336|NCT01054729|471503198|FG001|Overall Study|Adverse Event|1|||
130966337|NCT01054729|471503199|FG002|Overall Study|Adverse Event|2|||
130966338|NCT01054729|471503200|FG003|Overall Study|Adverse Event|1|||
130966339|NCT01054729|471503197|FG000|Overall Study|Withdrawal by Subject|1|||
130966340|NCT01054729|471503198|FG001|Overall Study|Withdrawal by Subject|0|||
130966341|NCT01054729|471503199|FG002|Overall Study|Withdrawal by Subject|1|||
130966342|NCT01054729|471503200|FG003|Overall Study|Withdrawal by Subject|0|||
130966343|NCT01054729|471503197|FG000|Overall Study|Lost to Follow-up|0|||
130966344|NCT01054729|471503198|FG001|Overall Study|Lost to Follow-up|1|||
130966345|NCT01054729|471503199|FG002|Overall Study|Lost to Follow-up|0|||
130966346|NCT01054729|471503200|FG003|Overall Study|Lost to Follow-up|0|||
130966347|NCT01054729|471503197|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
130966348|NCT01054729|471503198|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
130966349|NCT01054729|471503199|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
130966350|NCT01054729|471503200|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
130966351|NCT01054729|471503197|FG000|Overall Study|Non-responder|1|||
130966352|NCT01054729|471503198|FG001|Overall Study|Non-responder|0|||
130966353|NCT01054729|471503199|FG002|Overall Study|Non-responder|1|||
130966354|NCT01054729|471503200|FG003|Overall Study|Non-responder|1|||
130966355|NCT01054729|471503197|FG000|Overall Study|PEG/RBV Non-responder|1|||
130966356|NCT01054729|471503198|FG001|Overall Study|PEG/RBV Non-responder|0|||
130966357|NCT01054729|471503199|FG002|Overall Study|PEG/RBV Non-responder|1|||
130966358|NCT01054729|471503200|FG003|Overall Study|PEG/RBV Non-responder|0|||
130966359|NCT01054729|471503197|FG000|Overall Study|Personal/Obligations|0|||
130966360|NCT01054729|471503198|FG001|Overall Study|Personal/Obligations|1|||
130966361|NCT01054729|471503199|FG002|Overall Study|Personal/Obligations|0|||
130966362|NCT01054729|471503200|FG003|Overall Study|Personal/Obligations|0|||
130966363|NCT01054729|471503197|FG000|Overall Study|Subject moved|0|||
130966364|NCT01054729|471503198|FG001|Overall Study|Subject moved|0|||
130966365|NCT01054729|471503199|FG002|Overall Study|Subject moved|1|||
130966366|NCT01054729|471503200|FG003|Overall Study|Subject moved|0|||
130966367|NCT01054729|471503197|FG000|Overall Study|Lack of Efficacy|0|||
130966368|NCT01054729|471503198|FG001|Overall Study|Lack of Efficacy|0|||
130966369|NCT01054729|471503199|FG002|Overall Study|Lack of Efficacy|0|||
130966370|NCT01054729|471503200|FG003|Overall Study|Lack of Efficacy|1|||
130966371|NCT04265755|471503201|FG000|Overall Study|Withdrawal by Subject|39|||
130966372|NCT04265755|471503201|FG000|Overall Study|Decision by sponsor|2|||
130966373|NCT04265755|471503201|FG000|Overall Study|Lost to Follow-up|11|||
130966374|NCT04265755|471503201|FG000|Overall Study|Death|1|||
130966375|NCT01575561|471503202|FG000|Overall Study|Adverse Event|9|||
130966376|NCT01575561|471503202|FG000|Overall Study|Lack of Efficacy|8|||
130966377|NCT01575561|471503202|FG000|Overall Study|Lost to Follow-up|6|||
130966378|NCT01575561|471503202|FG000|Overall Study|Protocol Violation|4|||
130966379|NCT01575561|471503202|FG000|Overall Study|Withdrawal by Subject|11|||
130966380|NCT01575561|471503202|FG000|Overall Study|administration|1|||
130966381|NCT01992536|471503203|FG000|Overall Study|Administrative Reason|0|||
130966382|NCT01992536|471503204|FG001|Overall Study|Administrative Reason|0|||
130966383|NCT01992536|471503205|FG002|Overall Study|Administrative Reason|0|||
130966384|NCT01992536|471503206|FG003|Overall Study|Administrative Reason|0|||
130966385|NCT01992536|471503207|FG004|Overall Study|Administrative Reason|0|||
130966386|NCT01992536|471503208|FG005|Overall Study|Administrative Reason|0|||
130966387|NCT01992536|471503209|FG006|Overall Study|Administrative Reason|7|||
130966388|NCT01992536|471503210|FG007|Overall Study|Administrative Reason|0|||
130966389|NCT01992536|471503211|FG008|Overall Study|Administrative Reason|0|||
130966390|NCT01992536|471503212|FG009|Overall Study|Administrative Reason|0|||
130966391|NCT01992536|471503203|FG000|Overall Study|Lost to Follow-up|4|||
130966392|NCT01992536|471503204|FG001|Overall Study|Lost to Follow-up|2|||
130716149|NCT04325204|470588775|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
130966393|NCT01992536|471503205|FG002|Overall Study|Lost to Follow-up|1|||
130966394|NCT01992536|471503206|FG003|Overall Study|Lost to Follow-up|0|||
130966395|NCT01992536|471503207|FG004|Overall Study|Lost to Follow-up|0|||
130966396|NCT01992536|471503208|FG005|Overall Study|Lost to Follow-up|1|||
130966397|NCT01992536|471503209|FG006|Overall Study|Lost to Follow-up|0|||
130966398|NCT01992536|471503210|FG007|Overall Study|Lost to Follow-up|0|||
130966399|NCT01992536|471503211|FG008|Overall Study|Lost to Follow-up|1|||
130966400|NCT01992536|471503212|FG009|Overall Study|Lost to Follow-up|1|||
130966401|NCT01992536|471503203|FG000|Overall Study|Withdrawal by Subject|0|||
130966402|NCT01992536|471503204|FG001|Overall Study|Withdrawal by Subject|1|||
130966403|NCT01992536|471503205|FG002|Overall Study|Withdrawal by Subject|0|||
130966404|NCT01992536|471503206|FG003|Overall Study|Withdrawal by Subject|2|||
130966405|NCT01992536|471503207|FG004|Overall Study|Withdrawal by Subject|0|||
130966406|NCT01992536|471503208|FG005|Overall Study|Withdrawal by Subject|0|||
130966407|NCT01992536|471503209|FG006|Overall Study|Withdrawal by Subject|0|||
130966408|NCT01992536|471503210|FG007|Overall Study|Withdrawal by Subject|0|||
130966409|NCT01992536|471503211|FG008|Overall Study|Withdrawal by Subject|0|||
130966410|NCT01992536|471503212|FG009|Overall Study|Withdrawal by Subject|0|||
130966411|NCT00406029|471503220|FG000|Overall Study|Adverse Event|12|||
130966412|NCT00406029|471503221|FG001|Overall Study|Adverse Event|2|||
130966413|NCT00406029|471503222|FG002|Overall Study|Adverse Event|5|||
130966414|NCT00406029|471503223|FG003|Overall Study|Adverse Event|10|||
130966415|NCT00406029|471503224|FG004|Overall Study|Adverse Event|7|||
130966416|NCT00406029|471503220|FG000|Overall Study|Withdrawal by Subject|3|||
130966417|NCT00406029|471503221|FG001|Overall Study|Withdrawal by Subject|4|||
130966418|NCT00406029|471503222|FG002|Overall Study|Withdrawal by Subject|2|||
130966419|NCT00406029|471503223|FG003|Overall Study|Withdrawal by Subject|2|||
130966420|NCT00406029|471503224|FG004|Overall Study|Withdrawal by Subject|0|||
130966421|NCT00406029|471503220|FG000|Overall Study|Protocol Violation|1|||
130966422|NCT00406029|471503221|FG001|Overall Study|Protocol Violation|2|||
130966423|NCT00406029|471503222|FG002|Overall Study|Protocol Violation|0|||
130966424|NCT00406029|471503223|FG003|Overall Study|Protocol Violation|2|||
130966425|NCT00406029|471503224|FG004|Overall Study|Protocol Violation|0|||
130966426|NCT00406029|471503220|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
130966427|NCT00406029|471503221|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
130966428|NCT00406029|471503222|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
130966429|NCT00406029|471503223|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
130966430|NCT00406029|471503224|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
130966431|NCT00406029|471503220|FG000|Overall Study|Randomized in Error|0|||
130966432|NCT00406029|471503221|FG001|Overall Study|Randomized in Error|0|||
130966433|NCT00406029|471503222|FG002|Overall Study|Randomized in Error|2|||
130966434|NCT00406029|471503223|FG003|Overall Study|Randomized in Error|3|||
130966435|NCT00406029|471503224|FG004|Overall Study|Randomized in Error|1|||
130966436|NCT03669081|471503225|FG000|Overall Study|Data could not be validated|1|||
130966437|NCT03669081|471503226|FG001|Overall Study|Data could not be validated|1|||
130966438|NCT01925183|471503227|FG000|Overall Study|Adverse Event|1|||
130966439|NCT01925183|471503228|FG001|Overall Study|Adverse Event|0|||
130966440|NCT01046110|471503229|FG000|Overall Study|Adverse Event|9|||
130966441|NCT01046110|471503230|FG001|Overall Study|Adverse Event|2|||
130966442|NCT01046110|471503229|FG000|Overall Study|Lack of Efficacy|0|||
130966443|NCT01046110|471503230|FG001|Overall Study|Lack of Efficacy|1|||
130966444|NCT01046110|471503229|FG000|Overall Study|Protocol Violation|7|||
130966445|NCT01046110|471503230|FG001|Overall Study|Protocol Violation|12|||
130966446|NCT01046110|471503229|FG000|Overall Study|Withdrawal Criteria|3|||
130966447|NCT01046110|471503230|FG001|Overall Study|Withdrawal Criteria|5|||
130966448|NCT01046110|471503229|FG000|Overall Study|Unclassified|36|||
130966449|NCT01046110|471503230|FG001|Overall Study|Unclassified|35|||
130966450|NCT04079933|471503235|FG000|Overall Study|Withdrawal by Subject|3|||
130966451|NCT04079933|471503236|FG001|Overall Study|Withdrawal by Subject|4|||
130966452|NCT04079933|471503235|FG000|Overall Study|Lost to Follow-up|0|||
130966453|NCT04079933|471503236|FG001|Overall Study|Lost to Follow-up|1|||
130966454|NCT01459796|471503237|FG000|Overall Study|Non compliance with protocol|2|||
130966455|NCT01459796|471503238|FG001|Overall Study|Non compliance with protocol|4|||
130966456|NCT01459796|471503237|FG000|Overall Study|Adverse Event|5|||
130966457|NCT01459796|471503238|FG001|Overall Study|Adverse Event|5|||
130966458|NCT01459796|471503237|FG000|Overall Study|Withdrawal by Subject|6|||
130966459|NCT01459796|471503238|FG001|Overall Study|Withdrawal by Subject|3|||
130966460|NCT01459796|471503237|FG000|Overall Study|Lost to Follow-up|5|||
130966461|NCT01459796|471503238|FG001|Overall Study|Lost to Follow-up|4|||
130966462|NCT01459796|471503237|FG000|Overall Study|Reason unspecified|1|||
130966463|NCT01459796|471503238|FG001|Overall Study|Reason unspecified|2|||
130966464|NCT01459796|471503237|FG000|Overall Study|Decision by the sponsor|75|||
130966465|NCT01459796|471503238|FG001|Overall Study|Decision by the sponsor|108|||
130966466|NCT00345579|471503239|FG000|Overall Study|Adverse Event|9|||
130966467|NCT00345579|471503240|FG001|Overall Study|Adverse Event|6|||
130966468|NCT00345579|471503239|FG000|Overall Study|Protocol Violation|14|||
130966469|NCT00345579|471503240|FG001|Overall Study|Protocol Violation|5|||
130966470|NCT00345579|471503239|FG000|Overall Study|Withdrawal by Subject|50|||
130966471|NCT00345579|471503240|FG001|Overall Study|Withdrawal by Subject|17|||
130966472|NCT00345579|471503239|FG000|Overall Study|Lost to Follow-up|82|||
130966473|NCT00345579|471503240|FG001|Overall Study|Lost to Follow-up|36|||
130966474|NCT00345579|471503239|FG000|Overall Study|Other|9|||
130966475|NCT00345579|471503240|FG001|Overall Study|Other|1|||
130966476|NCT00413413|471503241|FG000|Single-Blind|Adverse Event|0|||
130966477|NCT00413413|471503242|FG001|Single-Blind|Adverse Event|9|||
130966478|NCT00413413|471503243|FG002|Single-Blind|Adverse Event|0|||
130966479|NCT00413413|471503241|FG000|Single-Blind|Lack of Efficacy|0|||
130966480|NCT00413413|471503242|FG001|Single-Blind|Lack of Efficacy|5|||
130966481|NCT00413413|471503243|FG002|Single-Blind|Lack of Efficacy|0|||
130966482|NCT00413413|471503241|FG000|Single-Blind|Subject no longer requires study drug|0|||
130966483|NCT00413413|471503242|FG001|Single-Blind|Subject no longer requires study drug|151|||
130966484|NCT00413413|471503243|FG002|Single-Blind|Subject no longer requires study drug|0|||
130966485|NCT00413413|471503241|FG000|Single-Blind|Protocol Violation|0|||
130966486|NCT00413413|471503242|FG001|Single-Blind|Protocol Violation|16|||
130966487|NCT00413413|471503243|FG002|Single-Blind|Protocol Violation|0|||
130966488|NCT00413413|471503241|FG000|Single-Blind|Withdrawal by Subject|0|||
130966489|NCT00413413|471503242|FG001|Single-Blind|Withdrawal by Subject|27|||
130966490|NCT00413413|471503243|FG002|Single-Blind|Withdrawal by Subject|0|||
130966491|NCT00413413|471503241|FG000|Single-Blind|Lost to Follow-up|0|||
130966492|NCT00413413|471503242|FG001|Single-Blind|Lost to Follow-up|8|||
130966493|NCT00413413|471503243|FG002|Single-Blind|Lost to Follow-up|0|||
130966494|NCT00413413|471503241|FG000|Double-Blind|Adverse Event|6|||
130966495|NCT00413413|471503242|FG001|Double-Blind|Adverse Event|0|||
130966496|NCT00413413|471503243|FG002|Double-Blind|Adverse Event|5|||
130966497|NCT00413413|471503241|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
130966498|NCT00413413|471503242|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
130966499|NCT00413413|471503243|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
130966500|NCT00413413|471503241|FG000|Double-Blind|Protocol deviation|1|||
130966501|NCT00413413|471503242|FG001|Double-Blind|Protocol deviation|2|||
130966502|NCT00413413|471503243|FG002|Double-Blind|Protocol deviation|1|||
130966503|NCT00413413|471503241|FG000|Double-Blind|Subject withdrew consent|4|||
130966504|NCT00413413|471503242|FG001|Double-Blind|Subject withdrew consent|6|||
130966505|NCT00413413|471503243|FG002|Double-Blind|Subject withdrew consent|9|||
130966506|NCT00413413|471503241|FG000|Double-Blind|Lost to Follow-up|3|||
130966507|NCT00413413|471503242|FG001|Double-Blind|Lost to Follow-up|4|||
130966508|NCT00413413|471503243|FG002|Double-Blind|Lost to Follow-up|2|||
130966509|NCT03207750|471503244|FG000|Overall Study|Adverse Event|3|||
130966510|NCT03207750|471503245|FG001|Overall Study|Adverse Event|2|||
130966511|NCT03207750|471503244|FG000|Overall Study|Lost to Follow-up|21|||
130966512|NCT03207750|471503245|FG001|Overall Study|Lost to Follow-up|29|||
130966513|NCT03207750|471503244|FG000|Overall Study|Protocol Violation|0|||
130966514|NCT03207750|471503245|FG001|Overall Study|Protocol Violation|1|||
130966515|NCT03207750|471503244|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
130966516|NCT03207750|471503245|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
130966517|NCT03207750|471503244|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
130966518|NCT03207750|471503245|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
130966519|NCT03207750|471503244|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
130966520|NCT03207750|471503245|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
130966521|NCT03207750|471503244|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
130966522|NCT03207750|471503245|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
130966523|NCT03207750|471503244|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
130966524|NCT03207750|471503245|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
130966525|NCT02673697|471503248|FG000|Overall Study|Adverse Event|2|||
130966526|NCT02673697|471503249|FG001|Overall Study|Adverse Event|0|||
130966527|NCT02673697|471503248|FG000|Overall Study|Death|32|||
130966528|NCT02673697|471503249|FG001|Overall Study|Death|24|||
130966529|NCT02673697|471503248|FG000|Overall Study|Lost to Follow-up|5|||
130966530|NCT02673697|471503249|FG001|Overall Study|Lost to Follow-up|2|||
130966531|NCT02673697|471503248|FG000|Overall Study|Physician Decision|2|||
130966532|NCT02673697|471503249|FG001|Overall Study|Physician Decision|1|||
130966533|NCT02673697|471503248|FG000|Overall Study|Withdrawal by Subject|10|||
130966534|NCT02673697|471503249|FG001|Overall Study|Withdrawal by Subject|7|||
130966535|NCT02673697|471503248|FG000|Overall Study|Change subj medical status|1|||
130966536|NCT02673697|471503249|FG001|Overall Study|Change subj medical status|2|||
130966537|NCT02673697|471503248|FG000|Overall Study|Explant|10|||
130966538|NCT02673697|471503249|FG001|Overall Study|Explant|5|||
130966539|NCT02673697|471503248|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
130966540|NCT02673697|471503249|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
130966541|NCT00437489|471503250|FG000|Overall Study|Study terminated by sponsor|23|||
130966542|NCT00437489|471503251|FG001|Overall Study|Study terminated by sponsor|21|||
130966543|NCT00437489|471503250|FG000|Overall Study|Lost to Follow-up|0|||
130966544|NCT00437489|471503251|FG001|Overall Study|Lost to Follow-up|1|||
130966545|NCT03893448|471503256|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
130775658|NCT01073163|470806528|FG000|Overall Study|Early termination|1|||
130775659|NCT00703677|470806529|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
130775660|NCT00940888|470806530|FG000|Overall Study|Unsuccessful Implant|4|||
130775661|NCT00940888|470806530|FG000|Overall Study|Death|461|||
130966546|NCT03893448|471503257|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
130966547|NCT03893448|471503256|FG000|Overall Study|Physician Decision|8|||
130966548|NCT03893448|471503257|FG001|Overall Study|Physician Decision|14|||
130775662|NCT00940888|470806530|FG000|Overall Study|Withdrawn - Non-Death|364|||
130966549|NCT03893448|471503256|FG000|Overall Study|Lost to Follow-up|34|||
130966550|NCT03893448|471503257|FG001|Overall Study|Lost to Follow-up|27|||
130966551|NCT03893448|471503256|FG000|Overall Study|Death|1|||
130966552|NCT03893448|471503257|FG001|Overall Study|Death|0|||
130966553|NCT03634579|471503261|FG000|Overall Study|study termination|9|||
130966554|NCT03321019|471503269|FG000|Overall Study|Withdrawal by Subject|0|||
130966555|NCT03321019|471503270|FG001|Overall Study|Withdrawal by Subject|6|||
130966556|NCT03321019|471503269|FG000|Overall Study|Lost to Follow-up|0|||
130966557|NCT03321019|471503270|FG001|Overall Study|Lost to Follow-up|22|||
131128158|NCT00183274|472097687|FG000|Phase 3: Double-Blind|Relapsed|0|||
130775663|NCT00940888|470806530|FG000|Overall Study|Lost to Follow-up|6|||
130775664|NCT04441788|470806533|FG000|Overall Study|Voluntary Withdrawl|0|||
130775665|NCT04441788|470806534|FG001|Overall Study|Voluntary Withdrawl|1|||
130775666|NCT04441788|470806535|FG002|Overall Study|Voluntary Withdrawl|0|||
130775667|NCT04441788|470806533|FG000|Overall Study|Ineligibility|1|||
130775668|NCT04441788|470806534|FG001|Overall Study|Ineligibility|0|||
130775669|NCT04441788|470806535|FG002|Overall Study|Ineligibility|0|||
130775670|NCT04441788|470806533|FG000|Overall Study|Adverse Event|0|||
130775671|NCT04441788|470806534|FG001|Overall Study|Adverse Event|0|||
130775672|NCT04441788|470806535|FG002|Overall Study|Adverse Event|4|||
130775673|NCT04441788|470806533|FG000|Overall Study|Study Terminated by Sponsor|16|||
130775674|NCT04441788|470806534|FG001|Overall Study|Study Terminated by Sponsor|16|||
130775675|NCT04441788|470806535|FG002|Overall Study|Study Terminated by Sponsor|12|||
130775676|NCT03859648|470806540|FG000|Overall Study|Lost to Follow-up|1|||
130775677|NCT03859648|470806540|FG000|Overall Study|Adverse Event|1|||
130775678|NCT02315664|470806541|FG000|Overall Study|Lost to Follow-up|1|||
130775679|NCT02315664|470806542|FG001|Overall Study|Lost to Follow-up|1|||
130775680|NCT02315664|470806541|FG000|Overall Study|Withdrawal by Subject|0|||
130775681|NCT02315664|470806542|FG001|Overall Study|Withdrawal by Subject|3|||
130775682|NCT01677182|470806543|FG000|Overall Study|Adverse Event|2|||
130966558|NCT03783923|471503271|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
130966559|NCT03783923|471503272|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
130966560|NCT03783923|471503271|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
130966561|NCT03783923|471503272|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
130966562|NCT03783923|471503271|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
130966563|NCT03783923|471503272|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
130966564|NCT03783923|471503271|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
130966565|NCT03783923|471503272|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
130966566|NCT03783923|471503271|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
130966567|NCT03783923|471503272|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
130966568|NCT00817089|471503273|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
130966569|NCT00817089|471503274|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
130966570|NCT00817089|471503275|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
130966571|NCT00817089|471503276|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
130966572|NCT00817089|471503273|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
130966573|NCT00817089|471503274|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
130966574|NCT00817089|471503275|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
130966575|NCT00817089|471503276|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
130966576|NCT01592708|471503277|FG000|Overall Study|Protocol Violation|3|||
130966577|NCT01592708|471503278|FG001|Overall Study|Protocol Violation|0|||
130966578|NCT01785602|471503282|FG000|Overall Study|Withdrawal by Subject|2|||
130966579|NCT01785602|471503283|FG001|Overall Study|Withdrawal by Subject|0|||
130966580|NCT01785602|471503282|FG000|Overall Study|Lost to Follow-up|1|||
130966581|NCT01785602|471503283|FG001|Overall Study|Lost to Follow-up|1|||
130966582|NCT01785602|471503282|FG000|Overall Study|Adverse Event|3|||
130966583|NCT01785602|471503283|FG001|Overall Study|Adverse Event|5|||
130966584|NCT01785602|471503282|FG000|Overall Study|Administrative problems|7|||
130966585|NCT01785602|471503283|FG001|Overall Study|Administrative problems|3|||
130966586|NCT02041429|471503285|FG000|Overall Study|Progressive Disease|2|||
130966587|NCT02041429|471503286|FG001|Overall Study|Progressive Disease|2|||
130966588|NCT02041429|471503287|FG002|Overall Study|Progressive Disease|3|||
130966589|NCT02041429|471503288|FG003|Overall Study|Progressive Disease|2|||
130966590|NCT02041429|471503285|FG000|Overall Study|Toxicity|0|||
130966591|NCT02041429|471503286|FG001|Overall Study|Toxicity|1|||
130966592|NCT02041429|471503287|FG002|Overall Study|Toxicity|4|||
130966593|NCT02041429|471503288|FG003|Overall Study|Toxicity|2|||
130966594|NCT02041429|471503285|FG000|Overall Study|Withdrawal by Subject|0|||
130966595|NCT02041429|471503286|FG001|Overall Study|Withdrawal by Subject|1|||
130966596|NCT02041429|471503287|FG002|Overall Study|Withdrawal by Subject|0|||
130966597|NCT02041429|471503288|FG003|Overall Study|Withdrawal by Subject|0|||
130966598|NCT02041429|471503285|FG000|Overall Study|On Maintenance Therapy|1|||
131128159|NCT00183274|472097688|FG001|Phase 3: Double-Blind|Relapsed|0|||
131128160|NCT00183274|472097689|FG002|Phase 3: Double-Blind|Relapsed|0|||
131128161|NCT00183274|472097690|FG003|Phase 3: Double-Blind|Relapsed|1|||
131128162|NCT00183274|472097691|FG004|Phase 3: Double-Blind|Relapsed|11|||
130775683|NCT01677182|470806544|FG001|Overall Study|Adverse Event|1|||
130775684|NCT01677182|470806545|FG002|Overall Study|Adverse Event|8|||
130775685|NCT01677182|470806543|FG000|Overall Study|Protocol Violation|5|||
130775686|NCT01677182|470806544|FG001|Overall Study|Protocol Violation|1|||
130966599|NCT02041429|471503286|FG001|Overall Study|On Maintenance Therapy|0|||
130966600|NCT02041429|471503287|FG002|Overall Study|On Maintenance Therapy|0|||
130966601|NCT02041429|471503288|FG003|Overall Study|On Maintenance Therapy|2|||
130966602|NCT00101101|471503289|FG000|Overall Study|never received vaccine|20|||
130775687|NCT01677182|470806545|FG002|Overall Study|Protocol Violation|4|||
130966603|NCT01418209|471503290|FG000|Overall Study|Withdrawal by Subject|1|||
130966604|NCT01418209|471503291|FG001|Overall Study|Withdrawal by Subject|0|||
131128163|NCT00183274|472097692|FG005|Phase 3: Double-Blind|Relapsed|2|||
130966605|NCT01418209|471503292|FG002|Overall Study|Withdrawal by Subject|1|||
130966606|NCT01418209|471503290|FG000|Overall Study|Did not provide hot flash diary data|1|||
130966607|NCT01418209|471503291|FG001|Overall Study|Did not provide hot flash diary data|3|||
130966608|NCT01418209|471503292|FG002|Overall Study|Did not provide hot flash diary data|3|||
130966609|NCT01603875|471503294|FG000|Overall Study|Preexisting rabies antibody|3|||
130966610|NCT01603875|471503295|FG001|Overall Study|Preexisting rabies antibody|4|||
130966611|NCT01603875|471503296|FG002|Overall Study|Preexisting rabies antibody|3|||
130966612|NCT01603875|471503294|FG000|Overall Study|Lost to Follow-up|4|||
130966613|NCT01603875|471503295|FG001|Overall Study|Lost to Follow-up|3|||
130966614|NCT01603875|471503296|FG002|Overall Study|Lost to Follow-up|6|||
130966615|NCT01603875|471503294|FG000|Overall Study|Protocol Violation|0|||
130966616|NCT01603875|471503295|FG001|Overall Study|Protocol Violation|1|||
130966617|NCT01603875|471503296|FG002|Overall Study|Protocol Violation|0|||
130966618|NCT01971346|471503297|FG000|Overall Study|Protocol Violation|3|||
130966619|NCT01971346|471503297|FG000|Overall Study|Lost to Follow-up|2|||
130966620|NCT01971346|471503297|FG000|Overall Study|Withdrawal by Subject|2|||
130966621|NCT01971346|471503297|FG000|Overall Study|Physician Decision|1|||
130966622|NCT01578551|471503303|FG000|Overall Study|Adverse Event|1|||
130966623|NCT01578551|471503304|FG001|Overall Study|Adverse Event|0|||
130966624|NCT00766415|471503305|FG000|Overall Study|Withdrawal by Subject|0|||
130966625|NCT00766415|471503306|FG001|Overall Study|Withdrawal by Subject|1|||
130966626|NCT01312467|471503307|FG000|Overall Study|Adverse Event|4|||
130966627|NCT01312467|471503307|FG000|Overall Study|Lost to Follow-up|1|||
130966628|NCT01312467|471503307|FG000|Overall Study|Withdrawal by Subject|2|||
130966629|NCT01312467|471503307|FG000|Overall Study|Deported to country of origin|1|||
130966630|NCT01312467|471503307|FG000|Overall Study|Another medical condition|1|||
130966631|NCT01312467|471503307|FG000|Overall Study|Ineligible|4|||
130966632|NCT02752048|471503308|FG000|Overall Study|Withdrawal by Subject|0|||
130966633|NCT02752048|471503309|FG001|Overall Study|Withdrawal by Subject|0|||
130966634|NCT02752048|471503310|FG002|Overall Study|Withdrawal by Subject|3|||
130966635|NCT00132769|471503313|FG000|Overall Study|Withdrawal by Subject|1|||
130966636|NCT00132769|471503314|FG001|Overall Study|Withdrawal by Subject|3|||
130966637|NCT00132769|471503313|FG000|Overall Study|Lack of Efficacy|7|||
130966638|NCT00132769|471503314|FG001|Overall Study|Lack of Efficacy|6|||
130966639|NCT00132769|471503313|FG000|Overall Study|Adverse Event|2|||
130966640|NCT00132769|471503314|FG001|Overall Study|Adverse Event|1|||
130966641|NCT00132769|471503313|FG000|Overall Study|Protocol Violation|1|||
130966642|NCT00132769|471503314|FG001|Overall Study|Protocol Violation|1|||
130966643|NCT04452344|471503315|FG000|Overall Study|Withdrawal by Subject|3|||
130966644|NCT04452344|471503316|FG001|Overall Study|Withdrawal by Subject|6|||
130966645|NCT04452344|471503315|FG000|Overall Study|Adverse Event|1|||
130966646|NCT04452344|471503316|FG001|Overall Study|Adverse Event|2|||
130966647|NCT04452344|471503315|FG000|Overall Study|Lost to Follow-up|2|||
130966648|NCT04452344|471503316|FG001|Overall Study|Lost to Follow-up|2|||
130966649|NCT04452344|471503315|FG000|Overall Study|No Post-Op Visit|6|||
130966650|NCT04452344|471503316|FG001|Overall Study|No Post-Op Visit|7|||
130966651|NCT04095858|471503322|FG000|Overall Study|Death|1|||
130966652|NCT04095858|471503323|FG001|Overall Study|Death|0|||
130966653|NCT04095858|471503322|FG000|Overall Study|Study terminated by Sponsor|2|||
130966654|NCT04095858|471503323|FG001|Overall Study|Study terminated by Sponsor|4|||
130966655|NCT01344460|471503324|FG000|Overall Study|Withdrawal by Subject|1|||
130966656|NCT01344460|471503324|FG000|Overall Study|Lost to Follow-up|2|||
130966657|NCT00560833|471503325|FG000|Overall Study|Adverse Event|16|||
130966658|NCT00560833|471503326|FG001|Overall Study|Adverse Event|10|||
131041993|NCT02240238|471789317|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131041994|NCT02240238|471789318|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131041995|NCT02240238|471789319|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131041996|NCT02240238|471789320|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
131041997|NCT02240238|471789321|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
131041998|NCT02240238|471789310|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131041999|NCT02240238|471789311|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131042000|NCT02240238|471789312|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131042001|NCT02240238|471789313|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131042002|NCT02240238|471789314|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131042003|NCT02240238|471789315|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131042004|NCT02240238|471789316|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131042005|NCT02240238|471789317|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130775688|NCT01677182|470806543|FG000|Overall Study|Lost to Follow-up|4|||
130966659|NCT00560833|471503327|FG002|Overall Study|Adverse Event|25|||
130966660|NCT00560833|471503328|FG003|Overall Study|Adverse Event|23|||
130966661|NCT00560833|471503329|FG004|Overall Study|Adverse Event|35|||
130966662|NCT00560833|471503325|FG000|Overall Study|Lost to Follow-up|0|||
130966663|NCT00560833|471503326|FG001|Overall Study|Lost to Follow-up|0|||
130966664|NCT00560833|471503327|FG002|Overall Study|Lost to Follow-up|1|||
130966665|NCT00560833|471503328|FG003|Overall Study|Lost to Follow-up|0|||
131042006|NCT02240238|471789318|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130966666|NCT00560833|471503329|FG004|Overall Study|Lost to Follow-up|0|||
130966667|NCT00560833|471503325|FG000|Overall Study|Lack of Efficacy|22|||
130966668|NCT00560833|471503326|FG001|Overall Study|Lack of Efficacy|9|||
130966669|NCT00560833|471503327|FG002|Overall Study|Lack of Efficacy|6|||
130966670|NCT00560833|471503328|FG003|Overall Study|Lack of Efficacy|4|||
131226959|NCT02763579|472457722|FG003|China Period|Death|48|||
131226960|NCT02763579|472457719|FG000|China Period|Lost to Follow-up|0|||
131226961|NCT02763579|472457720|FG001|China Period|Lost to Follow-up|0|||
131226962|NCT02763579|472457721|FG002|China Period|Lost to Follow-up|1|||
131226963|NCT02763579|472457722|FG003|China Period|Lost to Follow-up|1|||
131226964|NCT02763579|472457719|FG000|China Period|Physician Decision|0|||
131226965|NCT02763579|472457720|FG001|China Period|Physician Decision|0|||
130716150|NCT04325204|470588776|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
130716151|NCT04710979|470588778|FG000|Overall Study|Lost to Follow-up|2|||
130716152|NCT04710979|470588779|FG001|Overall Study|Lost to Follow-up|4|||
130716153|NCT04710979|470588778|FG000|Overall Study|Withdrawal by Subject|1|||
130966671|NCT00560833|471503329|FG004|Overall Study|Lack of Efficacy|4|||
130966672|NCT00560833|471503325|FG000|Overall Study|Participant uncooperative|5|||
130966673|NCT00560833|471503326|FG001|Overall Study|Participant uncooperative|5|||
130966674|NCT00560833|471503327|FG002|Overall Study|Participant uncooperative|4|||
130966675|NCT00560833|471503328|FG003|Overall Study|Participant uncooperative|4|||
130966676|NCT00560833|471503329|FG004|Overall Study|Participant uncooperative|2|||
130966677|NCT00560833|471503325|FG000|Overall Study|Other|1|||
130966678|NCT00560833|471503326|FG001|Overall Study|Other|1|||
130966679|NCT00560833|471503327|FG002|Overall Study|Other|3|||
130966680|NCT00560833|471503328|FG003|Overall Study|Other|0|||
130966681|NCT00560833|471503329|FG004|Overall Study|Other|0|||
130966682|NCT00560833|471503325|FG000|Overall Study|Never received drug|0|||
130966683|NCT00560833|471503326|FG001|Overall Study|Never received drug|1|||
130966684|NCT00560833|471503327|FG002|Overall Study|Never received drug|0|||
130966685|NCT00560833|471503328|FG003|Overall Study|Never received drug|0|||
130966686|NCT00560833|471503329|FG004|Overall Study|Never received drug|1|||
130966687|NCT00898677|471503332|FG000|Overall Study|Adverse Event|0|||
130966688|NCT00898677|471503333|FG001|Overall Study|Adverse Event|0|||
130966689|NCT00898677|471503334|FG002|Overall Study|Adverse Event|1|||
130966690|NCT00898677|471503335|FG003|Overall Study|Adverse Event|0|||
130966691|NCT00898677|471503332|FG000|Overall Study|Lost to Follow-up|0|||
130966692|NCT00898677|471503333|FG001|Overall Study|Lost to Follow-up|0|||
130966693|NCT00898677|471503334|FG002|Overall Study|Lost to Follow-up|2|||
130966694|NCT00898677|471503335|FG003|Overall Study|Lost to Follow-up|0|||
130966695|NCT00898677|471503332|FG000|Overall Study|Protocol Violation|1|||
130966696|NCT00898677|471503333|FG001|Overall Study|Protocol Violation|1|||
131128164|NCT00618410|472097695|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
130716154|NCT04710979|470588779|FG001|Overall Study|Withdrawal by Subject|0|||
130716155|NCT01462318|470588785|FG000|Main Study / TP-DI Study|Other|2|||
130716156|NCT01462318|470588786|FG001|Main Study / TP-DI Study|Other|0|||
130716157|NCT01462318|470588787|FG002|Main Study / TP-DI Study|Other|0|||
130716158|NCT01462318|470588785|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
130775689|NCT01677182|470806544|FG001|Overall Study|Lost to Follow-up|0|||
130775690|NCT01677182|470806545|FG002|Overall Study|Lost to Follow-up|3|||
130966697|NCT00898677|471503334|FG002|Overall Study|Protocol Violation|2|||
130966698|NCT00898677|471503335|FG003|Overall Study|Protocol Violation|0|||
131128165|NCT00618410|472097696|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
131128166|NCT01297270|472097703|FG000|Overall Study|Adverse Event|19|||
131128167|NCT01297270|472097704|FG001|Overall Study|Adverse Event|32|||
131128168|NCT01297270|472097705|FG002|Overall Study|Adverse Event|5|||
130775691|NCT01677182|470806543|FG000|Overall Study|Withdrawal by Subject|7|||
131128169|NCT01297270|472097703|FG000|Overall Study|Lack of Efficacy|15|||
131128170|NCT01297270|472097704|FG001|Overall Study|Lack of Efficacy|17|||
131128171|NCT01297270|472097705|FG002|Overall Study|Lack of Efficacy|15|||
131128172|NCT01297270|472097703|FG000|Overall Study|Lost to Follow-up|1|||
131128173|NCT01297270|472097704|FG001|Overall Study|Lost to Follow-up|2|||
131128174|NCT01297270|472097705|FG002|Overall Study|Lost to Follow-up|1|||
131128175|NCT01297270|472097703|FG000|Overall Study|Protocol Violation|0|||
131128176|NCT01297270|472097704|FG001|Overall Study|Protocol Violation|2|||
130716159|NCT01462318|470588786|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
130966699|NCT00898677|471503332|FG000|Overall Study|Withdrawal by Subject|0|||
130966700|NCT00898677|471503333|FG001|Overall Study|Withdrawal by Subject|0|||
130966701|NCT00898677|471503334|FG002|Overall Study|Withdrawal by Subject|0|||
130966702|NCT00898677|471503335|FG003|Overall Study|Withdrawal by Subject|1|||
130966703|NCT00898677|471503332|FG000|Overall Study|Not Treated: Adverse Event|0|||
131226966|NCT02763579|472457721|FG002|China Period|Physician Decision|0|||
131226967|NCT02763579|472457722|FG003|China Period|Physician Decision|1|||
130775692|NCT01677182|470806544|FG001|Overall Study|Withdrawal by Subject|12|||
130966704|NCT00898677|471503333|FG001|Overall Study|Not Treated: Adverse Event|2|||
130966705|NCT00898677|471503334|FG002|Overall Study|Not Treated: Adverse Event|1|||
130966706|NCT00898677|471503335|FG003|Overall Study|Not Treated: Adverse Event|0|||
131226968|NCT02763579|472457719|FG000|China Period|Study Terminated By Sponsor|0|||
130966707|NCT00898677|471503332|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
130966708|NCT00898677|471503333|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
130966709|NCT00898677|471503334|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
130966710|NCT00898677|471503335|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
130966711|NCT00898677|471503332|FG000|Overall Study|Not Treated: Pregnancy|0|||
130966712|NCT00898677|471503333|FG001|Overall Study|Not Treated: Pregnancy|0|||
130966713|NCT00898677|471503334|FG002|Overall Study|Not Treated: Pregnancy|1|||
130966714|NCT00898677|471503335|FG003|Overall Study|Not Treated: Pregnancy|0|||
130966715|NCT00898677|471503332|FG000|Overall Study|Not Treated: Protocol Violation|2|||
130966716|NCT00898677|471503333|FG001|Overall Study|Not Treated: Protocol Violation|0|||
130966717|NCT00898677|471503334|FG002|Overall Study|Not Treated: Protocol Violation|2|||
130966718|NCT00898677|471503335|FG003|Overall Study|Not Treated: Protocol Violation|0|||
130966719|NCT00898677|471503332|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
130966720|NCT00898677|471503333|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
130966721|NCT00898677|471503334|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
130966722|NCT00898677|471503335|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
130966723|NCT00898677|471503332|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
130966724|NCT00898677|471503333|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
130966725|NCT00898677|471503334|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
130966726|NCT00898677|471503335|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
130966727|NCT00898677|471503332|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
131128177|NCT01297270|472097705|FG002|Overall Study|Protocol Violation|0|||
130966728|NCT00898677|471503333|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
130966729|NCT00898677|471503334|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
131128178|NCT01297270|472097703|FG000|Overall Study|Withdrawal by Subject|7|||
131128179|NCT01297270|472097704|FG001|Overall Study|Withdrawal by Subject|15|||
131128180|NCT01297270|472097705|FG002|Overall Study|Withdrawal by Subject|7|||
131128181|NCT01297270|472097703|FG000|Overall Study|Other reason not defined above|3|||
131128182|NCT01297270|472097704|FG001|Overall Study|Other reason not defined above|3|||
131128183|NCT01297270|472097705|FG002|Overall Study|Other reason not defined above|1|||
131128184|NCT01297270|472097703|FG000|Overall Study|Not treated|0|||
131128185|NCT01297270|472097704|FG001|Overall Study|Not treated|1|||
131128186|NCT01297270|472097705|FG002|Overall Study|Not treated|0|||
131128187|NCT03882970|472097708|FG000|Overall Study|Adverse Event|5|||
131128188|NCT03882970|472097709|FG001|Overall Study|Adverse Event|7|||
131128189|NCT03882970|472097710|FG002|Overall Study|Adverse Event|3|||
131128190|NCT03882970|472097711|FG003|Overall Study|Adverse Event|1|||
131128191|NCT03882970|472097708|FG000|Overall Study|Death|1|||
131128192|NCT03882970|472097709|FG001|Overall Study|Death|2|||
131128193|NCT03882970|472097710|FG002|Overall Study|Death|1|||
131128194|NCT03882970|472097711|FG003|Overall Study|Death|1|||
131128195|NCT03882970|472097708|FG000|Overall Study|Lost to Follow-up|8|||
131128196|NCT03882970|472097709|FG001|Overall Study|Lost to Follow-up|9|||
131128197|NCT03882970|472097710|FG002|Overall Study|Lost to Follow-up|5|||
131128198|NCT03882970|472097711|FG003|Overall Study|Lost to Follow-up|5|||
131128199|NCT03882970|472097708|FG000|Overall Study|Physician Decision|0|||
131128200|NCT03882970|472097709|FG001|Overall Study|Physician Decision|2|||
131128201|NCT03882970|472097710|FG002|Overall Study|Physician Decision|2|||
131128202|NCT03882970|472097711|FG003|Overall Study|Physician Decision|2|||
131128203|NCT03882970|472097708|FG000|Overall Study|Protocol Violation|2|||
131128204|NCT03882970|472097709|FG001|Overall Study|Protocol Violation|0|||
131128205|NCT03882970|472097710|FG002|Overall Study|Protocol Violation|0|||
131128206|NCT03882970|472097711|FG003|Overall Study|Protocol Violation|0|||
131128207|NCT03882970|472097708|FG000|Overall Study|Withdrawal by Subject|8|||
131128208|NCT03882970|472097709|FG001|Overall Study|Withdrawal by Subject|17|||
131128209|NCT03882970|472097710|FG002|Overall Study|Withdrawal by Subject|7|||
131128210|NCT03882970|472097711|FG003|Overall Study|Withdrawal by Subject|22|||
130775693|NCT01677182|470806545|FG002|Overall Study|Withdrawal by Subject|10|||
130966730|NCT00898677|471503335|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
130966731|NCT00898677|471503332|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
130966732|NCT00898677|471503333|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
130966733|NCT00898677|471503334|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
130966734|NCT00898677|471503335|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
130966735|NCT00898677|471503332|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
131128211|NCT03882970|472097708|FG000|Overall Study|Personal Reason|2|||
131128212|NCT03882970|472097709|FG001|Overall Study|Personal Reason|3|||
131128213|NCT03882970|472097710|FG002|Overall Study|Personal Reason|1|||
131128214|NCT03882970|472097711|FG003|Overall Study|Personal Reason|3|||
131128215|NCT02863809|472097713|FG000|Overall Study|Adverse Event|8|||
131128216|NCT02863809|472097714|FG001|Overall Study|Adverse Event|8|||
131128217|NCT02863809|472097713|FG000|Overall Study|Withdrawal by Subject|0|||
131128218|NCT02863809|472097714|FG001|Overall Study|Withdrawal by Subject|1|||
131128219|NCT02863809|472097713|FG000|Overall Study|Lost to Follow-up|1|||
131128220|NCT02863809|472097714|FG001|Overall Study|Lost to Follow-up|1|||
131128221|NCT02863809|472097713|FG000|Overall Study|Death|1|||
131128222|NCT02863809|472097714|FG001|Overall Study|Death|0|||
131128223|NCT02830776|472097715|FG000|Overall Study|Lost to Follow-up|1|||
131226969|NCT02763579|472457720|FG001|China Period|Study Terminated By Sponsor|0|||
131226970|NCT02763579|472457721|FG002|China Period|Study Terminated By Sponsor|3|||
131226971|NCT02763579|472457722|FG003|China Period|Study Terminated By Sponsor|4|||
131226972|NCT02763579|472457719|FG000|China Period|Withdrawal by Subject|0|||
131226973|NCT02763579|472457720|FG001|China Period|Withdrawal by Subject|0|||
131226974|NCT02763579|472457721|FG002|China Period|Withdrawal by Subject|3|||
131226975|NCT02763579|472457722|FG003|China Period|Withdrawal by Subject|3|||
131226976|NCT00910858|472457728|FG000|Pharmacokinetic Phase|Adverse Event|1|||
131226977|NCT00910858|472457729|FG001|Pharmacokinetic Phase|Adverse Event|0|||
131226978|NCT00910858|472457730|FG002|Pharmacokinetic Phase|Adverse Event|0|||
131226979|NCT00910858|472457728|FG000|Monotherapy Phase|Adverse Event|3|||
131226980|NCT00910858|472457729|FG001|Monotherapy Phase|Adverse Event|2|||
131128224|NCT03029143|472097716|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
131128225|NCT03029143|472097717|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
131128226|NCT03029143|472097718|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
131128227|NCT03029143|472097716|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
131128228|NCT03029143|472097717|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
131128229|NCT03029143|472097718|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
131128230|NCT03029143|472097716|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
131128231|NCT03029143|472097717|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
131128232|NCT03029143|472097718|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
131226981|NCT00910858|472457730|FG002|Monotherapy Phase|Adverse Event|0|||
130716160|NCT01462318|470588787|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
130966736|NCT00898677|471503333|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
130966737|NCT00898677|471503334|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
130966738|NCT00898677|471503335|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
130966739|NCT00898677|471503332|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
130966740|NCT00898677|471503333|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
130966741|NCT00898677|471503334|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
130966742|NCT00898677|471503335|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
130966743|NCT00898677|471503332|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
130966744|NCT00898677|471503333|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
130966745|NCT00898677|471503334|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
130966746|NCT00898677|471503335|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
130966747|NCT01071395|471505296|FG000|Overall Study|Withdrawal by Subject|2|||
130966748|NCT01071395|471505297|FG001|Overall Study|Withdrawal by Subject|1|||
130966749|NCT01071395|471505296|FG000|Overall Study|Adverse Event|3|||
130966750|NCT01071395|471505297|FG001|Overall Study|Adverse Event|1|||
130966751|NCT01539291|471505298|FG000|Study GS-US-312-0116|Adverse Event|9|||
130966752|NCT01539291|471505299|FG001|Study GS-US-312-0116|Adverse Event|0|||
130966753|NCT01539291|471505300|FG002|Study GS-US-312-0116|Adverse Event|0|||
130966754|NCT01539291|471505301|FG003|Study GS-US-312-0116|Adverse Event|0|||
130966755|NCT01539291|471505298|FG000|Study GS-US-312-0116|Physician Decision|1|||
130966756|NCT01539291|471505299|FG001|Study GS-US-312-0116|Physician Decision|0|||
130966757|NCT01539291|471505300|FG002|Study GS-US-312-0116|Physician Decision|0|||
130966758|NCT01539291|471505301|FG003|Study GS-US-312-0116|Physician Decision|0|||
130966759|NCT01539291|471505298|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
130966760|NCT01539291|471505299|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
130966761|NCT01539291|471505300|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
130966762|NCT01539291|471505301|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
130966763|NCT01539291|471505298|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
130966764|NCT01539291|471505299|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
130966765|NCT01539291|471505300|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
130966766|NCT01539291|471505301|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
130966767|NCT01539291|471505298|FG000|Study GS-US-312-0116|Other|1|||
130966768|NCT01539291|471505299|FG001|Study GS-US-312-0116|Other|0|||
130966769|NCT01539291|471505300|FG002|Study GS-US-312-0116|Other|0|||
130966770|NCT01539291|471505301|FG003|Study GS-US-312-0116|Other|0|||
130966771|NCT01539291|471505298|FG000|Study GS-US-312-0117|Adverse Event|22|||
130966772|NCT01539291|471505299|FG001|Study GS-US-312-0117|Adverse Event|1|||
130966773|NCT01539291|471505300|FG002|Study GS-US-312-0117|Adverse Event|9|||
130966774|NCT01539291|471505301|FG003|Study GS-US-312-0117|Adverse Event|12|||
130966775|NCT01539291|471505298|FG000|Study GS-US-312-0117|Physician Decision|9|||
130966776|NCT01539291|471505299|FG001|Study GS-US-312-0117|Physician Decision|0|||
130966777|NCT01539291|471505300|FG002|Study GS-US-312-0117|Physician Decision|6|||
130966778|NCT01539291|471505301|FG003|Study GS-US-312-0117|Physician Decision|4|||
130966779|NCT01539291|471505298|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
131128233|NCT03029143|472097716|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
131226982|NCT00910858|472457728|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
131226983|NCT00910858|472457729|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
130716161|NCT01462318|470588785|FG000|Main Study / TP-DI Study|Adverse Event|4|||
130966780|NCT01539291|471505299|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
131226984|NCT00910858|472457730|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
131226985|NCT00910858|472457728|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
131226986|NCT00910858|472457729|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
131226987|NCT00910858|472457730|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
131226988|NCT00910858|472457728|FG000|Monotherapy Phase|Protocol Violation|1|||
131226989|NCT00910858|472457729|FG001|Monotherapy Phase|Protocol Violation|0|||
131226990|NCT00910858|472457730|FG002|Monotherapy Phase|Protocol Violation|0|||
131226991|NCT00910858|472457728|FG000|Monotherapy Phase|Other|3|||
131226992|NCT00910858|472457729|FG001|Monotherapy Phase|Other|4|||
131226993|NCT00910858|472457730|FG002|Monotherapy Phase|Other|2|||
131226994|NCT00910858|472457728|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
131226995|NCT00910858|472457729|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
131226996|NCT00910858|472457730|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
131226997|NCT00910858|472457728|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
131226998|NCT00910858|472457729|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
131226999|NCT00910858|472457730|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
131227000|NCT00910858|472457728|FG000|Combined Treatment Phase|Protocol Violation|1|||
131227001|NCT00910858|472457729|FG001|Combined Treatment Phase|Protocol Violation|0|||
131227002|NCT00910858|472457730|FG002|Combined Treatment Phase|Protocol Violation|0|||
131227003|NCT00910858|472457728|FG000|Combined Treatment Phase|Other|0|||
131227004|NCT00910858|472457729|FG001|Combined Treatment Phase|Other|2|||
131227005|NCT00910858|472457730|FG002|Combined Treatment Phase|Other|1|||
131227006|NCT01703741|472457737|FG000|Overall Study|Withdrawal by Subject|6|||
131227007|NCT01703741|472457737|FG000|Overall Study|Adverse Event|2|||
131227008|NCT01703741|472457737|FG000|Overall Study|Physician Decision|2|||
131227009|NCT01703741|472457737|FG000|Overall Study|Protocol Violation|1|||
131227010|NCT01703741|472457737|FG000|Overall Study|Lost to Follow-up|3|||
131227011|NCT01703741|472457737|FG000|Overall Study|Subject did not want to continue|2|||
131227012|NCT01703741|472457737|FG000|Overall Study|Subject cannot comply with study visits|1|||
130966781|NCT01539291|471505300|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
130966782|NCT01539291|471505301|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
130966783|NCT01539291|471505298|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
130966784|NCT01539291|471505299|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
130966785|NCT01539291|471505300|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
130966786|NCT01539291|471505301|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
130966787|NCT01539291|471505298|FG000|Study GS-US-312-0117|Other|2|||
130966788|NCT01539291|471505299|FG001|Study GS-US-312-0117|Other|1|||
130966789|NCT01539291|471505300|FG002|Study GS-US-312-0117|Other|1|||
130966790|NCT01539291|471505301|FG003|Study GS-US-312-0117|Other|1|||
130966791|NCT02239510|471505304|FG000|Overall Study|Lost to Follow-up|2|||
130966792|NCT02239510|471505305|FG001|Overall Study|Lost to Follow-up|1|||
130966793|NCT03859323|471505308|FG000|Overall Study|Lost to Follow-up|0|||
130966794|NCT03859323|471505309|FG001|Overall Study|Lost to Follow-up|0|||
130966795|NCT03859323|471505310|FG002|Overall Study|Lost to Follow-up|0|||
130966796|NCT03859323|471505311|FG003|Overall Study|Lost to Follow-up|0|||
130966797|NCT03859323|471505312|FG004|Overall Study|Lost to Follow-up|0|||
130966798|NCT03859323|471505313|FG005|Overall Study|Lost to Follow-up|0|||
130966799|NCT03859323|471505314|FG006|Overall Study|Lost to Follow-up|1|||
130966800|NCT03859323|471505315|FG007|Overall Study|Lost to Follow-up|0|||
130966801|NCT03859323|471505316|FG008|Overall Study|Lost to Follow-up|0|||
130966802|NCT03859323|471505317|FG009|Overall Study|Lost to Follow-up|0|||
130966803|NCT03859323|471505318|FG010|Overall Study|Lost to Follow-up|0|||
130966804|NCT03859323|471505319|FG011|Overall Study|Lost to Follow-up|0|||
130966805|NCT03859323|471505320|FG012|Overall Study|Lost to Follow-up|0|||
130966806|NCT03859323|471505308|FG000|Overall Study|Withdrawal by Subject|0|||
130966807|NCT03859323|471505309|FG001|Overall Study|Withdrawal by Subject|0|||
130966808|NCT03859323|471505310|FG002|Overall Study|Withdrawal by Subject|1|||
130966809|NCT03859323|471505311|FG003|Overall Study|Withdrawal by Subject|0|||
130966810|NCT03859323|471505312|FG004|Overall Study|Withdrawal by Subject|0|||
130966811|NCT03859323|471505313|FG005|Overall Study|Withdrawal by Subject|1|||
130966812|NCT03859323|471505314|FG006|Overall Study|Withdrawal by Subject|0|||
130966813|NCT03859323|471505315|FG007|Overall Study|Withdrawal by Subject|0|||
130966814|NCT03859323|471505316|FG008|Overall Study|Withdrawal by Subject|0|||
131227013|NCT01703741|472457737|FG000|Overall Study|Subject started testosterone injections|1|||
131227014|NCT01170364|472457738|FG000|Overall Study|Protocol Violation|4|||
131227015|NCT01170364|472457739|FG001|Overall Study|Protocol Violation|1|||
131227016|NCT02041494|472457740|FG000|Overall Study|Death|1|||
131227017|NCT02041494|472457741|FG001|Overall Study|Death|3|||
130966815|NCT03859323|471505317|FG009|Overall Study|Withdrawal by Subject|1|||
130966816|NCT03859323|471505318|FG010|Overall Study|Withdrawal by Subject|1|||
130966817|NCT03859323|471505319|FG011|Overall Study|Withdrawal by Subject|2|||
130966818|NCT03859323|471505320|FG012|Overall Study|Withdrawal by Subject|1|||
130966819|NCT03859323|471505308|FG000|Overall Study|Pregnancy|0|||
130966820|NCT03859323|471505309|FG001|Overall Study|Pregnancy|0|||
131227018|NCT02041494|472457740|FG000|Overall Study|Lost to Follow-up|2|||
131227019|NCT02041494|472457741|FG001|Overall Study|Lost to Follow-up|6|||
131227020|NCT02041494|472457740|FG000|Overall Study|study terminated|16|||
130966821|NCT03859323|471505310|FG002|Overall Study|Pregnancy|0|||
130966822|NCT03859323|471505311|FG003|Overall Study|Pregnancy|0|||
130966823|NCT03859323|471505312|FG004|Overall Study|Pregnancy|0|||
130966824|NCT03859323|471505313|FG005|Overall Study|Pregnancy|0|||
130966825|NCT03859323|471505314|FG006|Overall Study|Pregnancy|0|||
130966826|NCT03859323|471505315|FG007|Overall Study|Pregnancy|0|||
130966827|NCT03859323|471505316|FG008|Overall Study|Pregnancy|0|||
130966828|NCT03859323|471505317|FG009|Overall Study|Pregnancy|1|||
130966829|NCT03859323|471505318|FG010|Overall Study|Pregnancy|0|||
130966830|NCT03859323|471505319|FG011|Overall Study|Pregnancy|0|||
130966831|NCT03859323|471505320|FG012|Overall Study|Pregnancy|0|||
130966832|NCT01404312|471505323|FG000|Overall Study|Death|21|||
130966833|NCT01404312|471505324|FG001|Overall Study|Death|27|||
130966834|NCT01404312|471505323|FG000|Overall Study|Withdrawal by Subject|15|||
130966835|NCT01404312|471505324|FG001|Overall Study|Withdrawal by Subject|18|||
130966836|NCT01404312|471505323|FG000|Overall Study|Participant Unable to get to clinic|93|||
130966837|NCT01404312|471505324|FG001|Overall Study|Participant Unable to get to clinic|103|||
130966838|NCT01404312|471505323|FG000|Overall Study|Lost to Follow-up|115|||
130966839|NCT01404312|471505324|FG001|Overall Study|Lost to Follow-up|111|||
130966840|NCT01404312|471505323|FG000|Overall Study|Site closed|22|||
130966841|NCT01404312|471505324|FG001|Overall Study|Site closed|21|||
130966842|NCT01404312|471505323|FG000|Overall Study|Participant not willing to adhere to req|31|||
130966843|NCT01404312|471505324|FG001|Overall Study|Participant not willing to adhere to req|29|||
130966844|NCT01404312|471505323|FG000|Overall Study|Severe debilitation, unable to continue|1|||
130966845|NCT01404312|471505324|FG001|Overall Study|Severe debilitation, unable to continue|2|||
130966846|NCT04419493|471505325|FG000|Wash-out After Period 1|Adverse Event|1|||
130966847|NCT04419493|471505326|FG001|Wash-out After Period 1|Adverse Event|2|||
130966848|NCT04419493|471505327|FG002|Wash-out After Period 1|Adverse Event|1|||
130966849|NCT04419493|471505328|FG003|Wash-out After Period 1|Adverse Event|0|||
130966850|NCT00524134|471505329|FG000|Overall Study|Withdrawal by Subject|1|||
130966851|NCT00524134|471505329|FG000|Overall Study|Physician Decision|1|||
130966852|NCT03794089|471505330|FG000|Overall Study|Lost to Follow-up|4|||
130966853|NCT03794089|471505331|FG001|Overall Study|Lost to Follow-up|1|||
130966854|NCT03794089|471505330|FG000|Overall Study|Withdrawal by Subject|2|||
131227021|NCT02041494|472457741|FG001|Overall Study|study terminated|11|||
130775694|NCT01677182|470806543|FG000|Overall Study|Study termination|12|||
130775695|NCT01677182|470806544|FG001|Overall Study|Study termination|9|||
130775696|NCT01677182|470806545|FG002|Overall Study|Study termination|11|||
130966855|NCT03794089|471505331|FG001|Overall Study|Withdrawal by Subject|0|||
130966856|NCT03985423|471505332|FG000|Overall Study|Adverse Event|1|||
130966857|NCT03985423|471505332|FG000|Overall Study|Death|2|||
130966858|NCT03985423|471505332|FG000|Overall Study|Physician Decision|1|||
130966859|NCT03985423|471505332|FG000|Overall Study|Withdrawal by Subject|2|||
130966860|NCT03985423|471505332|FG000|Overall Study|Lack of insurance and citizenship|1|||
130966861|NCT01073618|471505335|FG000|Overall Study|Death|208|||
130966862|NCT01073618|471505335|FG000|Overall Study|Adverse Event|19|||
130966863|NCT01073618|471505335|FG000|Overall Study|Other|80|||
130966864|NCT00982020|471505336|FG000|Overall Study|Adverse Event|19|||
130966865|NCT00982020|471505337|FG001|Overall Study|Adverse Event|15|||
130966866|NCT00982020|471505336|FG000|Overall Study|Withdrawal by Subject|11|||
130966867|NCT00982020|471505337|FG001|Overall Study|Withdrawal by Subject|14|||
130966868|NCT00982020|471505336|FG000|Overall Study|Lost to Follow-up|5|||
130966869|NCT00982020|471505337|FG001|Overall Study|Lost to Follow-up|11|||
130966870|NCT00982020|471505336|FG000|Overall Study|Lack of Efficacy|10|||
130966871|NCT00982020|471505337|FG001|Overall Study|Lack of Efficacy|4|||
130966872|NCT00982020|471505336|FG000|Overall Study|Parent/Caregiver Decision|5|||
130966873|NCT00982020|471505337|FG001|Overall Study|Parent/Caregiver Decision|5|||
130966874|NCT00982020|471505336|FG000|Overall Study|Treatment Non-compliance|3|||
130966875|NCT00982020|471505337|FG001|Overall Study|Treatment Non-compliance|6|||
130966876|NCT00982020|471505336|FG000|Overall Study|Physician Decision|2|||
130966877|NCT00982020|471505337|FG001|Overall Study|Physician Decision|5|||
130966878|NCT00982020|471505336|FG000|Overall Study|Entry Criteria Not Met|2|||
130966879|NCT00982020|471505337|FG001|Overall Study|Entry Criteria Not Met|1|||
130966880|NCT00982020|471505336|FG000|Overall Study|Protocol Violation|0|||
130966881|NCT00982020|471505337|FG001|Overall Study|Protocol Violation|2|||
130966882|NCT00982020|471505336|FG000|Overall Study|Clinical Relapse|0|||
130966883|NCT00982020|471505337|FG001|Overall Study|Clinical Relapse|1|||
130775697|NCT01677182|470806543|FG000|Overall Study|Lack of Efficacy|3|||
130966884|NCT00466193|471505338|FG000|Overall Study|Adverse Event|0|||
130966885|NCT00466193|471505339|FG001|Overall Study|Adverse Event|1|||
130966886|NCT00466193|471505338|FG000|Overall Study|Lost to Follow-up|2|||
130966887|NCT00466193|471505339|FG001|Overall Study|Lost to Follow-up|4|||
130966888|NCT00466193|471505338|FG000|Overall Study|Physician Decision|1|||
130966889|NCT00466193|471505339|FG001|Overall Study|Physician Decision|0|||
130966890|NCT00466193|471505338|FG000|Overall Study|Protocol Violation|1|||
130966891|NCT00466193|471505339|FG001|Overall Study|Protocol Violation|1|||
130966892|NCT00466193|471505338|FG000|Overall Study|Withdrawal by Subject|7|||
130966893|NCT00466193|471505339|FG001|Overall Study|Withdrawal by Subject|2|||
130966894|NCT00466193|471505338|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
130966895|NCT00466193|471505339|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
130966896|NCT02246998|471505340|FG000|Overall Study|Adverse Event|0|||
130966897|NCT02246998|471505341|FG001|Overall Study|Adverse Event|1|||
130966898|NCT02246998|471505342|FG002|Overall Study|Adverse Event|1|||
130966899|NCT02246998|471505343|FG003|Overall Study|Adverse Event|0|||
130966900|NCT02246998|471505340|FG000|Overall Study|Lost to Follow-up|1|||
130966901|NCT02246998|471505341|FG001|Overall Study|Lost to Follow-up|0|||
130966902|NCT02246998|471505342|FG002|Overall Study|Lost to Follow-up|0|||
130966903|NCT02246998|471505343|FG003|Overall Study|Lost to Follow-up|1|||
130966904|NCT02246998|471505340|FG000|Overall Study|Randomized but Never Dosed|1|||
130966905|NCT02246998|471505341|FG001|Overall Study|Randomized but Never Dosed|2|||
130966906|NCT02246998|471505342|FG002|Overall Study|Randomized but Never Dosed|2|||
130966907|NCT02246998|471505343|FG003|Overall Study|Randomized but Never Dosed|1|||
130966908|NCT01343082|471505346|FG000|The run-in Period|Not meeting criteria|3|||
130966909|NCT01343082|471505347|FG001|The run-in Period|Not meeting criteria|4|||
130966910|NCT01343082|471505348|FG002|The run-in Period|Not meeting criteria|5|||
130966911|NCT01343082|471505346|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
130966912|NCT01343082|471505347|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
130966913|NCT01343082|471505348|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
130966914|NCT01343082|471505346|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
130966915|NCT01343082|471505347|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
130966916|NCT01343082|471505348|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
130966917|NCT01343082|471505346|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
130966918|NCT01343082|471505347|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
130966919|NCT01343082|471505348|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
130966920|NCT01343082|471505346|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
130966921|NCT01343082|471505347|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
130966922|NCT01343082|471505348|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
130966923|NCT02554773|471505349|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
130966924|NCT02554773|471505350|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
130966925|NCT02554773|471505349|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
130966926|NCT02554773|471505350|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
130966927|NCT02554773|471505349|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
130966928|NCT02554773|471505350|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
130966929|NCT02554773|471505349|FG000|Original Dose Regimen (SAS 1)|Death|1|||
130966930|NCT02554773|471505350|FG001|Original Dose Regimen (SAS 1)|Death|0|||
131128234|NCT03029143|472097717|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
131128235|NCT03029143|472097718|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
131128236|NCT03029143|472097716|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
131128237|NCT03029143|472097717|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
131128238|NCT03029143|472097718|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
131128239|NCT03029143|472097716|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
131128240|NCT03029143|472097717|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
131128241|NCT03029143|472097718|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
131128242|NCT03029143|472097716|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
131128243|NCT03029143|472097717|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
131128244|NCT03029143|472097718|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
131128245|NCT03029143|472097716|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131128246|NCT03029143|472097717|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131128247|NCT03029143|472097718|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
131128248|NCT03029143|472097716|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
131128249|NCT03029143|472097717|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
131128250|NCT03029143|472097718|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
131128251|NCT03029143|472097716|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131128252|NCT03029143|472097717|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
131128253|NCT03029143|472097718|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
131128254|NCT03029143|472097716|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
131128255|NCT03029143|472097717|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
131128256|NCT03029143|472097718|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
131128257|NCT00607386|472097719|FG000|Overall Study|Physician Decision|1|||
131128258|NCT00974675|472097720|FG000|Overall Study|Adverse Event|2|||
131128259|NCT00974675|472097721|FG001|Overall Study|Adverse Event|1|||
130966931|NCT02554773|471505349|FG000|Original Dose Regimen (SAS 1)|Other|4|||
131128260|NCT00974675|472097722|FG002|Overall Study|Adverse Event|1|||
131128261|NCT00974675|472097723|FG003|Overall Study|Adverse Event|1|||
130966932|NCT02554773|471505350|FG001|Original Dose Regimen (SAS 1)|Other|0|||
130966933|NCT02554773|471505349|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
130966934|NCT02554773|471505350|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
130716162|NCT01462318|470588786|FG001|Main Study / TP-DI Study|Adverse Event|0|||
130716163|NCT01462318|470588787|FG002|Main Study / TP-DI Study|Adverse Event|0|||
130716164|NCT01462318|470588785|FG000|Extension Phase|Lost to Follow-up|0|||
130716165|NCT01462318|470588786|FG001|Extension Phase|Lost to Follow-up|0|||
130966935|NCT02554773|471505349|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
130966936|NCT02554773|471505350|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
130966937|NCT02554773|471505349|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
130966938|NCT02554773|471505350|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
130966939|NCT02554773|471505349|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
130966940|NCT02554773|471505350|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
130966941|NCT01854554|471505351|FG000|Overall Study|Denial of Insurance Coverage|12|||
130966942|NCT01854554|471505352|FG001|Overall Study|Denial of Insurance Coverage|0|||
130966943|NCT01854554|471505351|FG000|Overall Study|Decided to get treatment locally|1|||
130966944|NCT01854554|471505352|FG001|Overall Study|Decided to get treatment locally|5|||
130966945|NCT01854554|471505351|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
130966946|NCT01854554|471505352|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
130966947|NCT01854554|471505351|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
130966948|NCT01854554|471505352|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
130966949|NCT01854554|471505351|FG000|Overall Study|Progression|0|||
130966950|NCT01854554|471505352|FG001|Overall Study|Progression|1|||
130966951|NCT01854554|471505351|FG000|Overall Study|Lost to Follow-up|0|||
130966952|NCT01854554|471505352|FG001|Overall Study|Lost to Follow-up|1|||
130966953|NCT02819726|471505353|FG000|Part A (All Participants)|Lost to Follow-up|0|||
130966954|NCT02819726|471505354|FG001|Part A (All Participants)|Lost to Follow-up|1|||
130966955|NCT02819726|471505355|FG002|Part A (All Participants)|Lost to Follow-up|0|||
130966956|NCT02819726|471505356|FG003|Part A (All Participants)|Lost to Follow-up|0|||
130966957|NCT02819726|471505353|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
130966958|NCT02819726|471505354|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
130966959|NCT02819726|471505355|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
130966960|NCT02819726|471505356|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
130966961|NCT02819726|471505353|FG000|Part A (All Participants)|Protocol non-compliance|3|||
130966962|NCT02819726|471505354|FG001|Part A (All Participants)|Protocol non-compliance|4|||
131042007|NCT02240238|471789319|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
131042008|NCT02240238|471789320|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
130716166|NCT01462318|470588787|FG002|Extension Phase|Lost to Follow-up|1|||
130716167|NCT01462318|470588785|FG000|Extension Phase|Other|0|||
130966963|NCT02819726|471505355|FG002|Part A (All Participants)|Protocol non-compliance|5|||
131042009|NCT02240238|471789321|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
131042010|NCT03519178|471789322|FG000|PF-06873600 Treatment|Adverse Event|0|||
131042011|NCT03519178|471789323|FG001|PF-06873600 Treatment|Adverse Event|0|||
131042012|NCT03519178|471789324|FG002|PF-06873600 Treatment|Adverse Event|0|||
131042013|NCT03519178|471789325|FG003|PF-06873600 Treatment|Adverse Event|0|||
131042014|NCT03519178|471789326|FG004|PF-06873600 Treatment|Adverse Event|0|||
131042015|NCT03519178|471789327|FG005|PF-06873600 Treatment|Adverse Event|0|||
131042016|NCT03519178|471789328|FG006|PF-06873600 Treatment|Adverse Event|0|||
131042017|NCT03519178|471789329|FG007|PF-06873600 Treatment|Adverse Event|2|||
131042018|NCT03519178|471789330|FG008|PF-06873600 Treatment|Adverse Event|1|||
131042019|NCT03519178|471789331|FG009|PF-06873600 Treatment|Adverse Event|0|||
131042020|NCT03519178|471789332|FG010|PF-06873600 Treatment|Adverse Event|0|||
131042021|NCT03519178|471789333|FG011|PF-06873600 Treatment|Adverse Event|0|||
131042022|NCT03519178|471789334|FG012|PF-06873600 Treatment|Adverse Event|1|||
131042023|NCT03519178|471789335|FG013|PF-06873600 Treatment|Adverse Event|3|||
131042024|NCT03519178|471789336|FG014|PF-06873600 Treatment|Adverse Event|2|||
131042025|NCT03519178|471789322|FG000|PF-06873600 Treatment|Death|0|||
131042026|NCT03519178|471789323|FG001|PF-06873600 Treatment|Death|0|||
131042027|NCT03519178|471789324|FG002|PF-06873600 Treatment|Death|0|||
131042028|NCT03519178|471789325|FG003|PF-06873600 Treatment|Death|0|||
131042029|NCT03519178|471789326|FG004|PF-06873600 Treatment|Death|0|||
131042030|NCT03519178|471789327|FG005|PF-06873600 Treatment|Death|0|||
131042031|NCT03519178|471789328|FG006|PF-06873600 Treatment|Death|0|||
130716168|NCT01462318|470588786|FG001|Extension Phase|Other|0|||
130775698|NCT01677182|470806544|FG001|Overall Study|Lack of Efficacy|0|||
131042032|NCT03519178|471789329|FG007|PF-06873600 Treatment|Death|0|||
131042033|NCT03519178|471789330|FG008|PF-06873600 Treatment|Death|1|||
131042034|NCT03519178|471789331|FG009|PF-06873600 Treatment|Death|1|||
130716169|NCT01462318|470588787|FG002|Extension Phase|Other|1|||
130966964|NCT02819726|471505356|FG003|Part A (All Participants)|Protocol non-compliance|0|||
131042035|NCT03519178|471789332|FG010|PF-06873600 Treatment|Death|0|||
130775699|NCT01677182|470806545|FG002|Overall Study|Lack of Efficacy|1|||
131042036|NCT03519178|471789333|FG011|PF-06873600 Treatment|Death|0|||
131042037|NCT03519178|471789334|FG012|PF-06873600 Treatment|Death|0|||
131042038|NCT03519178|471789335|FG013|PF-06873600 Treatment|Death|0|||
131042039|NCT03519178|471789336|FG014|PF-06873600 Treatment|Death|1|||
131042040|NCT03519178|471789322|FG000|PF-06873600 Treatment|Physician Decision|0|||
131042041|NCT03519178|471789323|FG001|PF-06873600 Treatment|Physician Decision|0|||
131128262|NCT00974675|472097720|FG000|Overall Study|Physician Decision|0|||
131128263|NCT00974675|472097721|FG001|Overall Study|Physician Decision|0|||
131128264|NCT00974675|472097722|FG002|Overall Study|Physician Decision|1|||
131128265|NCT00974675|472097723|FG003|Overall Study|Physician Decision|0|||
131128266|NCT00974675|472097720|FG000|Overall Study|Participant on holiday; unable to attend|0|||
131128267|NCT00974675|472097721|FG001|Overall Study|Participant on holiday; unable to attend|0|||
131128268|NCT00974675|472097722|FG002|Overall Study|Participant on holiday; unable to attend|0|||
131128269|NCT00974675|472097723|FG003|Overall Study|Participant on holiday; unable to attend|1|||
131128270|NCT02121262|472097726|FG000|Overall Study|Adverse Event|6|||
130716170|NCT01462318|470588785|FG000|Extension Phase|Disease Progression|0|||
130716171|NCT01462318|470588786|FG001|Extension Phase|Disease Progression|0|||
130966965|NCT02819726|471505353|FG000|Part B (All Participants)|Lost to Follow-up|1|||
130966966|NCT02819726|471505354|FG001|Part B (All Participants)|Lost to Follow-up|1|||
130966967|NCT02819726|471505355|FG002|Part B (All Participants)|Lost to Follow-up|2|||
130966968|NCT02819726|471505356|FG003|Part B (All Participants)|Lost to Follow-up|2|||
130966969|NCT02819726|471505353|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
130966970|NCT02819726|471505354|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
130966971|NCT02819726|471505355|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
130966972|NCT02819726|471505356|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
130966973|NCT02819726|471505353|FG000|Part B (All Participants)|Protocol non-compliance|0|||
130966974|NCT02819726|471505354|FG001|Part B (All Participants)|Protocol non-compliance|0|||
130966975|NCT02819726|471505355|FG002|Part B (All Participants)|Protocol non-compliance|1|||
130966976|NCT02819726|471505356|FG003|Part B (All Participants)|Protocol non-compliance|0|||
130966977|NCT02613481|471505357|FG000|Overall Study|Lost to Follow-up|7|||
130966978|NCT02613481|471505357|FG000|Overall Study|Withdrawal by Subject|2|||
130966979|NCT00844194|471505358|FG000|Overall Study|Adverse Event|17|||
130966980|NCT00844194|471505359|FG001|Overall Study|Adverse Event|5|||
130966981|NCT00844194|471505358|FG000|Overall Study|Protocol Violation|1|||
130966982|NCT00844194|471505359|FG001|Overall Study|Protocol Violation|1|||
130966983|NCT00844194|471505358|FG000|Overall Study|Lost to Follow-up|1|||
130966984|NCT00844194|471505359|FG001|Overall Study|Lost to Follow-up|1|||
130966985|NCT00844194|471505358|FG000|Overall Study|Withdrawal by Subject|2|||
130966986|NCT00844194|471505359|FG001|Overall Study|Withdrawal by Subject|1|||
130966987|NCT00844194|471505358|FG000|Overall Study|Lack of Efficacy|3|||
130966988|NCT00844194|471505359|FG001|Overall Study|Lack of Efficacy|0|||
130966989|NCT00844194|471505358|FG000|Overall Study|Other reason (not specified)|1|||
130966990|NCT00844194|471505359|FG001|Overall Study|Other reason (not specified)|0|||
130966991|NCT00803023|471505360|FG000|Overall Study|Adverse Event|5|||
130966992|NCT00803023|471505361|FG001|Overall Study|Adverse Event|4|||
130966993|NCT00803023|471505362|FG002|Overall Study|Adverse Event|8|||
130966994|NCT00803023|471505363|FG003|Overall Study|Adverse Event|6|||
130966995|NCT00803023|471505360|FG000|Overall Study|Withdrawal by Subject|0|||
130966996|NCT00803023|471505361|FG001|Overall Study|Withdrawal by Subject|2|||
130966997|NCT00803023|471505362|FG002|Overall Study|Withdrawal by Subject|0|||
130966998|NCT00803023|471505363|FG003|Overall Study|Withdrawal by Subject|0|||
130966999|NCT00803023|471505360|FG000|Overall Study|Lost to Follow-up|0|||
130967000|NCT00803023|471505361|FG001|Overall Study|Lost to Follow-up|1|||
130967001|NCT00803023|471505362|FG002|Overall Study|Lost to Follow-up|2|||
130967002|NCT00803023|471505363|FG003|Overall Study|Lost to Follow-up|1|||
130967003|NCT00803023|471505360|FG000|Overall Study|Lack of Efficacy|0|||
130967004|NCT00803023|471505361|FG001|Overall Study|Lack of Efficacy|1|||
130967005|NCT00803023|471505362|FG002|Overall Study|Lack of Efficacy|1|||
130967006|NCT00803023|471505363|FG003|Overall Study|Lack of Efficacy|1|||
130967007|NCT02647658|471505364|FG000|Overall Study|Consent refusal|15|||
130967008|NCT02647658|471505365|FG001|Overall Study|Consent refusal|24|||
130967009|NCT01542528|471505366|FG000|Overall Study|Lost to Follow-up|2|||
130967010|NCT01542528|471505367|FG001|Overall Study|Lost to Follow-up|1|||
130967011|NCT01542528|471505366|FG000|Overall Study|Physician Decision|1|||
130967012|NCT01542528|471505367|FG001|Overall Study|Physician Decision|0|||
130967013|NCT01542528|471505366|FG000|Overall Study|Withdrawal by Subject|9|||
130967014|NCT01542528|471505367|FG001|Overall Study|Withdrawal by Subject|6|||
130967015|NCT01709227|471505374|FG000|Overall Study|Physician Decision|1|||
130967016|NCT01709227|471505375|FG001|Overall Study|Physician Decision|0|||
130967017|NCT01709227|471505374|FG000|Overall Study|Pleural Peritoneal communication|0|||
131227022|NCT00608205|472457742|FG000|Overall Study|Adverse Event|3|||
130967018|NCT01709227|471505375|FG001|Overall Study|Pleural Peritoneal communication|9|||
130967019|NCT00389324|471505378|FG000|Run-In Phase|Adverse Event|1|||
130967020|NCT00389324|471505378|FG000|Run-In Phase|Lost to Follow-up|1|||
130967021|NCT00389324|471505378|FG000|Run-In Phase|Withdrawal by Subject|1|||
131128271|NCT02121262|472097727|FG001|Overall Study|Adverse Event|3|||
131227023|NCT00608205|472457743|FG001|Overall Study|Adverse Event|2|||
130967022|NCT00389324|471505378|FG000|Subcutaneous Phase|Adverse Event|2|||
130967023|NCT00389324|471505378|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
131128272|NCT02121262|472097726|FG000|Overall Study|Lack of Efficacy|3|||
130967024|NCT00389324|471505378|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
130967025|NCT00389324|471505378|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
131128273|NCT02121262|472097727|FG001|Overall Study|Lack of Efficacy|0|||
131128274|NCT02121262|472097726|FG000|Overall Study|Personal Reasons|19|||
131128275|NCT02121262|472097727|FG001|Overall Study|Personal Reasons|5|||
130967026|NCT02317575|471505379|FG000|Period 1|Difficulty with venous cannulation|0|||
130967027|NCT02317575|471505380|FG001|Period 1|Difficulty with venous cannulation|1|||
130967028|NCT02317575|471505381|FG002|Period 1|Difficulty with venous cannulation|0|||
130967029|NCT02317575|471505382|FG003|Period 1|Difficulty with venous cannulation|0|||
130967030|NCT02317575|471505383|FG004|Period 1|Difficulty with venous cannulation|0|||
130967031|NCT02317575|471505379|FG000|Period 1|Withdrawal by Subject|1|||
130967032|NCT02317575|471505380|FG001|Period 1|Withdrawal by Subject|0|||
130967033|NCT02317575|471505381|FG002|Period 1|Withdrawal by Subject|0|||
130967034|NCT02317575|471505382|FG003|Period 1|Withdrawal by Subject|0|||
130967035|NCT02317575|471505383|FG004|Period 1|Withdrawal by Subject|0|||
130967036|NCT01666002|471505388|FG000|Overall Study|Lost to Follow-up|5|||
130967037|NCT01666002|471505389|FG001|Overall Study|Lost to Follow-up|0|||
130967038|NCT01233817|471505392|FG000|Overall Study|Lost to Follow-up|1|||
130967039|NCT01233817|471505392|FG000|Overall Study|Withdrawal by Subject|2|||
130967040|NCT02159482|471505393|FG000|Overall Study|Withdrawal by Subject|2|||
130967041|NCT02159482|471505393|FG000|Overall Study|Physician Decision|3|||
130967042|NCT01248884|471505394|FG000|Overall Study|Withdrawal by Subject|1|||
130967043|NCT01248884|471505395|FG001|Overall Study|Withdrawal by Subject|3|||
130967044|NCT01248884|471505396|FG002|Overall Study|Withdrawal by Subject|1|||
130967045|NCT01248884|471505394|FG000|Overall Study|Adverse Event|1|||
130967046|NCT01248884|471505395|FG001|Overall Study|Adverse Event|0|||
130967047|NCT01248884|471505396|FG002|Overall Study|Adverse Event|0|||
130967048|NCT02511431|471505397|FG000|Treatment|Lost to Follow-up|0|||
130967049|NCT02511431|471505398|FG001|Treatment|Lost to Follow-up|0|||
130967050|NCT02511431|471505399|FG002|Treatment|Lost to Follow-up|1|||
130967051|NCT02511431|471505400|FG003|Treatment|Lost to Follow-up|0|||
130967052|NCT02511431|471505401|FG004|Treatment|Lost to Follow-up|0|||
130967053|NCT02511431|471505402|FG005|Treatment|Lost to Follow-up|1|||
130967054|NCT04479618|471505403|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
130967055|NCT04479618|471505404|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
130967056|NCT04479618|471505405|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
130967057|NCT04479618|471505403|FG000|Overall Study|Lack of Efficacy|1|||
130967058|NCT04479618|471505404|FG001|Overall Study|Lack of Efficacy|0|||
130967059|NCT04479618|471505405|FG002|Overall Study|Lack of Efficacy|0|||
130967060|NCT04479618|471505403|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
130967061|NCT04479618|471505404|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
130967062|NCT04479618|471505405|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
130967063|NCT04479618|471505403|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
130967064|NCT04479618|471505404|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
130967065|NCT04479618|471505405|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
131128276|NCT02121262|472097726|FG000|Overall Study|Protocol Violation|1|||
131128277|NCT02121262|472097727|FG001|Overall Study|Protocol Violation|1|||
131128278|NCT02121262|472097726|FG000|Overall Study|Participant Dropped-out|0|||
131128279|NCT02121262|472097727|FG001|Overall Study|Participant Dropped-out|1|||
131128280|NCT02121262|472097726|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
131128281|NCT02121262|472097727|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
131128282|NCT02121262|472097726|FG000|Overall Study|Consent Withdrawn|1|||
131128283|NCT02121262|472097727|FG001|Overall Study|Consent Withdrawn|0|||
131128284|NCT01765920|472097731|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
131128285|NCT01765920|472097732|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
131128286|NCT01765920|472097731|FG000|Overall Study|Patient code disclosure|0|||
131128287|NCT01765920|472097732|FG001|Overall Study|Patient code disclosure|1|||
131128288|NCT01081249|472097733|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
131128289|NCT01081249|472097734|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
131128290|NCT02411539|472097735|FG000|Overall Study|Lost to Follow-up|2|||
130967066|NCT04479618|471505403|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
130967067|NCT04479618|471505404|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
131128291|NCT02411539|472097736|FG001|Overall Study|Lost to Follow-up|0|||
131128292|NCT02411539|472097735|FG000|Overall Study|Confounding medical condition|0|||
131128293|NCT02411539|472097736|FG001|Overall Study|Confounding medical condition|1|||
130967068|NCT04479618|471505405|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
130967069|NCT04479618|471505403|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
131128294|NCT00886600|472097737|FG000|Double-blind Monotherapy|Adverse Event|1|||
131128295|NCT00886600|472097738|FG001|Double-blind Monotherapy|Adverse Event|1|||
131128296|NCT00886600|472097739|FG002|Double-blind Monotherapy|Adverse Event|1|||
131128297|NCT00886600|472097740|FG003|Double-blind Monotherapy|Adverse Event|1|||
131128298|NCT00886600|472097737|FG000|Double-blind Monotherapy|Protocol Violation|0|||
130967070|NCT04479618|471505404|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
130967071|NCT04479618|471505405|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
130967072|NCT01202773|471505406|FG000|Overall Study|Adverse Event|4|||
130967073|NCT01202773|471505407|FG001|Overall Study|Adverse Event|5|||
130967074|NCT01202773|471505408|FG002|Overall Study|Adverse Event|5|||
130967075|NCT01202773|471505406|FG000|Overall Study|Lack of Efficacy|5|||
130967076|NCT01202773|471505407|FG001|Overall Study|Lack of Efficacy|4|||
130967077|NCT01202773|471505408|FG002|Overall Study|Lack of Efficacy|9|||
130967078|NCT01202773|471505406|FG000|Overall Study|Entry Criteria Not Met|2|||
130967079|NCT01202773|471505407|FG001|Overall Study|Entry Criteria Not Met|0|||
130967080|NCT01202773|471505408|FG002|Overall Study|Entry Criteria Not Met|1|||
130967081|NCT01202773|471505406|FG000|Overall Study|Lost to Follow-up|1|||
131227024|NCT00608205|472457742|FG000|Overall Study|Patient non-compliant|0|||
131227025|NCT00608205|472457743|FG001|Overall Study|Patient non-compliant|1|||
131227026|NCT01797120|472457746|FG000|Overall Study|Disesae progression|37|||
131227027|NCT01797120|472457747|FG001|Overall Study|Disesae progression|49|||
131227028|NCT01797120|472457746|FG000|Overall Study|Adverse Event|13|||
131227029|NCT01797120|472457747|FG001|Overall Study|Adverse Event|5|||
131227030|NCT01797120|472457746|FG000|Overall Study|Withdrawal by Subject|6|||
131227031|NCT01797120|472457747|FG001|Overall Study|Withdrawal by Subject|6|||
131227032|NCT01797120|472457746|FG000|Overall Study|Symptomatic progression|2|||
131227033|NCT01797120|472457747|FG001|Overall Study|Symptomatic progression|1|||
131227034|NCT01797120|472457746|FG000|Overall Study|Non-compliance|1|||
130967082|NCT01202773|471505407|FG001|Overall Study|Lost to Follow-up|2|||
130967083|NCT01202773|471505408|FG002|Overall Study|Lost to Follow-up|2|||
130967084|NCT01202773|471505406|FG000|Overall Study|Withdrawal by Subject|13|||
130967085|NCT01202773|471505407|FG001|Overall Study|Withdrawal by Subject|6|||
130967086|NCT01202773|471505408|FG002|Overall Study|Withdrawal by Subject|5|||
130967087|NCT01202773|471505406|FG000|Overall Study|Physician Decision|2|||
130967088|NCT01202773|471505407|FG001|Overall Study|Physician Decision|0|||
130967089|NCT01202773|471505408|FG002|Overall Study|Physician Decision|0|||
130967090|NCT01202773|471505406|FG000|Overall Study|Protocol Violation|11|||
130967091|NCT01202773|471505407|FG001|Overall Study|Protocol Violation|6|||
130967092|NCT01202773|471505408|FG002|Overall Study|Protocol Violation|10|||
130967093|NCT01202773|471505406|FG000|Overall Study|Sponsor Decision|19|||
130967094|NCT01202773|471505407|FG001|Overall Study|Sponsor Decision|20|||
130967095|NCT01202773|471505408|FG002|Overall Study|Sponsor Decision|23|||
130967096|NCT01430130|471505413|FG000|Overall Study|Lost to Follow-up|1|||
130967097|NCT01430130|471505413|FG000|Overall Study|Infection on Control Side of Incision|1|||
131227035|NCT01797120|472457747|FG001|Overall Study|Non-compliance|0|||
131227036|NCT01797120|472457746|FG000|Overall Study|Physician Decision|3|||
131227037|NCT01797120|472457747|FG001|Overall Study|Physician Decision|0|||
131227038|NCT01797120|472457746|FG000|Overall Study|still on treatment|2|||
131227039|NCT01797120|472457747|FG001|Overall Study|still on treatment|4|||
131227040|NCT01797120|472457746|FG000|Overall Study|never start protocol therapy|2|||
131227041|NCT01797120|472457747|FG001|Overall Study|never start protocol therapy|0|||
131227042|NCT02965820|472457749|FG000|Period 2, Second 30 Days|Adverse Event|1|||
131227043|NCT02965820|472457750|FG001|Period 2, Second 30 Days|Adverse Event|1|||
131227044|NCT01967888|472457751|FG000|Overall Study|Lost to Follow-up|6|||
131227045|NCT01967888|472457752|FG001|Overall Study|Lost to Follow-up|4|||
131227046|NCT01967888|472457751|FG000|Overall Study|Withdrawal by Subject|1|||
130716172|NCT01462318|470588787|FG002|Extension Phase|Disease Progression|1|||
130716173|NCT01462318|470588785|FG000|Extension Phase|Withdrawal by Subject|0|||
130716174|NCT01462318|470588786|FG001|Extension Phase|Withdrawal by Subject|0|||
130716175|NCT01462318|470588787|FG002|Extension Phase|Withdrawal by Subject|15|||
130716176|NCT01462318|470588785|FG000|Extension Phase|Investigator Decision|0|||
130716177|NCT01462318|470588786|FG001|Extension Phase|Investigator Decision|0|||
130716178|NCT01462318|470588787|FG002|Extension Phase|Investigator Decision|5|||
130716179|NCT01462318|470588785|FG000|Extension Phase|Adverse Event|0|||
130716180|NCT01462318|470588786|FG001|Extension Phase|Adverse Event|0|||
130716181|NCT01462318|470588787|FG002|Extension Phase|Adverse Event|22|||
130716182|NCT03827564|470588788|FG000|Overall Study|Discontinued due to Study Termination|1|||
130716183|NCT03827564|470588789|FG001|Overall Study|Discontinued due to Study Termination|0|||
130967098|NCT02828111|471505417|FG000|Overall Study|Withdrawal by Subject|0|||
130967099|NCT02828111|471505418|FG001|Overall Study|Withdrawal by Subject|0|||
130967100|NCT02828111|471505419|FG002|Overall Study|Withdrawal by Subject|2|||
130967101|NCT02828111|471505420|FG003|Overall Study|Withdrawal by Subject|0|||
130967102|NCT02828111|471505421|FG004|Overall Study|Withdrawal by Subject|0|||
130967103|NCT02828111|471505417|FG000|Overall Study|Lost to Follow-up|0|||
131227047|NCT01967888|472457752|FG001|Overall Study|Withdrawal by Subject|1|||
131227048|NCT01967888|472457751|FG000|Overall Study|Did Not Have Transplant|1|||
131227049|NCT01967888|472457752|FG001|Overall Study|Did Not Have Transplant|0|||
131227050|NCT01967888|472457751|FG000|Overall Study|Research visit not done, data recorded|1|||
131227051|NCT01967888|472457752|FG001|Overall Study|Research visit not done, data recorded|0|||
130967104|NCT02828111|471505418|FG001|Overall Study|Lost to Follow-up|0|||
130716184|NCT00891371|470588790|FG000|Pre-assignment|Inclusion/exclusion|5|||
130716185|NCT00891371|470588790|FG000|Pre-assignment|Consent withdrawal|1|||
130716186|NCT00891371|470588790|FG000|Treatment|Lack of Efficacy|5|||
130967105|NCT02828111|471505419|FG002|Overall Study|Lost to Follow-up|0|||
130967106|NCT02828111|471505420|FG003|Overall Study|Lost to Follow-up|1|||
130967107|NCT02828111|471505421|FG004|Overall Study|Lost to Follow-up|1|||
130967108|NCT02667912|471505424|FG000|Overall Study|Death|3|||
130967109|NCT02667912|471505425|FG001|Overall Study|Death|1|||
130967110|NCT02667912|471505424|FG000|Overall Study|Withdrawal by Subject|1|||
130967111|NCT02667912|471505425|FG001|Overall Study|Withdrawal by Subject|2|||
130967112|NCT02667912|471505424|FG000|Overall Study|Withdrawal by Subject|1|||
130967113|NCT02667912|471505425|FG001|Overall Study|Withdrawal by Subject|0|||
130967114|NCT04443218|471505426|FG000|Overall Study|Exited study for other reasons|9|||
130967115|NCT04443218|471505426|FG000|Overall Study|Withdrawal by Subject|1|||
130967116|NCT04443218|471505426|FG000|Overall Study|Lost to Follow-up|4|||
130967117|NCT04443218|471505426|FG000|Overall Study|Death|19|||
130967118|NCT02843568|471505427|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
130967119|NCT02843568|471505428|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
130967120|NCT02843568|471505427|FG000|Overall Study|Death|3|||
130967121|NCT02843568|471505428|FG001|Overall Study|Death|3|||
130967122|NCT02843568|471505427|FG000|Overall Study|Withdrawal by Subject|1|||
130967123|NCT02843568|471505428|FG001|Overall Study|Withdrawal by Subject|1|||
130967124|NCT02843568|471505427|FG000|Overall Study|Lost to Follow-up|2|||
130967125|NCT02843568|471505428|FG001|Overall Study|Lost to Follow-up|0|||
130967126|NCT02199691|471505447|FG000|Overall Study|Protocol Violation|3|||
130967127|NCT02199691|471505448|FG001|Overall Study|Protocol Violation|3|||
130967128|NCT02199691|471505449|FG002|Overall Study|Protocol Violation|6|||
130967129|NCT02199691|471505450|FG003|Overall Study|Protocol Violation|7|||
130967130|NCT02199691|471505447|FG000|Overall Study|Withdrawal by Subject|5|||
130967131|NCT02199691|471505448|FG001|Overall Study|Withdrawal by Subject|3|||
130967132|NCT02199691|471505449|FG002|Overall Study|Withdrawal by Subject|12|||
130967133|NCT02199691|471505450|FG003|Overall Study|Withdrawal by Subject|13|||
130967134|NCT02199691|471505447|FG000|Overall Study|Lost to Follow-up|2|||
130967135|NCT02199691|471505448|FG001|Overall Study|Lost to Follow-up|1|||
130967136|NCT02199691|471505449|FG002|Overall Study|Lost to Follow-up|9|||
130967137|NCT02199691|471505450|FG003|Overall Study|Lost to Follow-up|10|||
130967138|NCT03823651|471505451|FG000|Overall Study|Death|5|||
130967139|NCT03823651|471505452|FG001|Overall Study|Death|0|||
130967140|NCT03823651|471505451|FG000|Overall Study|Physician Decision|1|||
130967141|NCT03823651|471505452|FG001|Overall Study|Physician Decision|0|||
130967142|NCT03823651|471505451|FG000|Overall Study|Caregiver to patient who died|0|||
130967143|NCT03823651|471505452|FG001|Overall Study|Caregiver to patient who died|5|||
130967144|NCT03823651|471505451|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
130967145|NCT03823651|471505452|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
130967146|NCT00428610|471505453|FG000|Overall Study|Death Due to Adverse Event|3|||
130967147|NCT00428610|471505454|FG001|Overall Study|Death Due to Adverse Event|0|||
131128299|NCT00886600|472097738|FG001|Double-blind Monotherapy|Protocol Violation|0|||
131128300|NCT00886600|472097739|FG002|Double-blind Monotherapy|Protocol Violation|0|||
131128301|NCT00886600|472097740|FG003|Double-blind Monotherapy|Protocol Violation|1|||
131128302|NCT00886600|472097737|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
131128303|NCT00886600|472097738|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
131128304|NCT00886600|472097739|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
131128305|NCT00886600|472097740|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
131128306|NCT00886600|472097737|FG000|Combination Therapy Period|Adverse Event|0|||
131128307|NCT00886600|472097738|FG001|Combination Therapy Period|Adverse Event|0|||
131128308|NCT00886600|472097739|FG002|Combination Therapy Period|Adverse Event|1|||
131128309|NCT00886600|472097740|FG003|Combination Therapy Period|Adverse Event|0|||
131128310|NCT00886600|472097737|FG000|Combination Therapy Period|Protocol Violation|0|||
131128311|NCT00886600|472097738|FG001|Combination Therapy Period|Protocol Violation|0|||
131128312|NCT00886600|472097739|FG002|Combination Therapy Period|Protocol Violation|1|||
131128313|NCT00886600|472097740|FG003|Combination Therapy Period|Protocol Violation|0|||
130967148|NCT00428610|471505455|FG002|Overall Study|Death Due to Adverse Event|5|||
130967149|NCT00428610|471505453|FG000|Overall Study|Death Due to Progressive Disease|0|||
130967150|NCT00428610|471505454|FG001|Overall Study|Death Due to Progressive Disease|0|||
130967151|NCT00428610|471505455|FG002|Overall Study|Death Due to Progressive Disease|2|||
131128314|NCT01439204|472097741|FG000|Overall Study|Withdrawal by Subject|0|||
130967152|NCT00428610|471505453|FG000|Overall Study|Adverse Event|2|||
130967153|NCT00428610|471505454|FG001|Overall Study|Adverse Event|3|||
131128315|NCT01439204|472097742|FG001|Overall Study|Withdrawal by Subject|1|||
131227052|NCT01967888|472457751|FG000|Overall Study|Subject excluded after randomization|1|||
130967154|NCT00428610|471505455|FG002|Overall Study|Adverse Event|2|||
130967155|NCT00428610|471505453|FG000|Overall Study|Investigator Decision|2|||
131128316|NCT01439204|472097741|FG000|Overall Study|Lost to Follow-up|0|||
130967156|NCT00428610|471505454|FG001|Overall Study|Investigator Decision|1|||
130967157|NCT00428610|471505455|FG002|Overall Study|Investigator Decision|1|||
131042042|NCT03519178|471789324|FG002|PF-06873600 Treatment|Physician Decision|0|||
131042043|NCT03519178|471789325|FG003|PF-06873600 Treatment|Physician Decision|0|||
131042044|NCT03519178|471789326|FG004|PF-06873600 Treatment|Physician Decision|0|||
131042045|NCT03519178|471789327|FG005|PF-06873600 Treatment|Physician Decision|0|||
131042046|NCT03519178|471789328|FG006|PF-06873600 Treatment|Physician Decision|0|||
131042047|NCT03519178|471789329|FG007|PF-06873600 Treatment|Physician Decision|1|||
131042048|NCT03519178|471789330|FG008|PF-06873600 Treatment|Physician Decision|0|||
131042049|NCT03519178|471789331|FG009|PF-06873600 Treatment|Physician Decision|0|||
131042050|NCT03519178|471789332|FG010|PF-06873600 Treatment|Physician Decision|1|||
131042051|NCT03519178|471789333|FG011|PF-06873600 Treatment|Physician Decision|0|||
131042052|NCT03519178|471789334|FG012|PF-06873600 Treatment|Physician Decision|0|||
131042053|NCT03519178|471789335|FG013|PF-06873600 Treatment|Physician Decision|4|||
131042054|NCT03519178|471789336|FG014|PF-06873600 Treatment|Physician Decision|1|||
131042055|NCT03519178|471789322|FG000|PF-06873600 Treatment|Progressive disease|1|||
131042056|NCT03519178|471789323|FG001|PF-06873600 Treatment|Progressive disease|1|||
131042057|NCT03519178|471789324|FG002|PF-06873600 Treatment|Progressive disease|1|||
131042058|NCT03519178|471789325|FG003|PF-06873600 Treatment|Progressive disease|1|||
131042059|NCT03519178|471789326|FG004|PF-06873600 Treatment|Progressive disease|6|||
131042060|NCT03519178|471789327|FG005|PF-06873600 Treatment|Progressive disease|7|||
131042061|NCT03519178|471789328|FG006|PF-06873600 Treatment|Progressive disease|3|||
131042062|NCT03519178|471789329|FG007|PF-06873600 Treatment|Progressive disease|7|||
131042063|NCT03519178|471789330|FG008|PF-06873600 Treatment|Progressive disease|3|||
131042064|NCT03519178|471789331|FG009|PF-06873600 Treatment|Progressive disease|5|||
131042065|NCT03519178|471789332|FG010|PF-06873600 Treatment|Progressive disease|4|||
131042066|NCT03519178|471789333|FG011|PF-06873600 Treatment|Progressive disease|3|||
131042067|NCT03519178|471789334|FG012|PF-06873600 Treatment|Progressive disease|4|||
131042068|NCT03519178|471789335|FG013|PF-06873600 Treatment|Progressive disease|28|||
131042069|NCT03519178|471789336|FG014|PF-06873600 Treatment|Progressive disease|7|||
131042070|NCT03519178|471789322|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
131042071|NCT03519178|471789323|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
131042072|NCT03519178|471789324|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
131042073|NCT03519178|471789325|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
131042074|NCT03519178|471789326|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
131042075|NCT03519178|471789327|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
131042076|NCT03519178|471789328|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
131042077|NCT03519178|471789329|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
131042078|NCT03519178|471789330|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
131042079|NCT03519178|471789331|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
131042080|NCT03519178|471789332|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
131042081|NCT03519178|471789333|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
131042082|NCT03519178|471789334|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
131042083|NCT03519178|471789335|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
131042084|NCT03519178|471789336|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
131042085|NCT03519178|471789322|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
131042086|NCT03519178|471789323|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
131042087|NCT03519178|471789324|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
131042088|NCT03519178|471789325|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
131042089|NCT03519178|471789326|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
131042090|NCT03519178|471789327|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
131042091|NCT03519178|471789328|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
131042092|NCT03519178|471789329|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
131042093|NCT03519178|471789330|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
131042094|NCT03519178|471789331|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
131042095|NCT03519178|471789332|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
131227053|NCT01967888|472457752|FG001|Overall Study|Subject excluded after randomization|0|||
131227054|NCT01967888|472457751|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
131227055|NCT01967888|472457752|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
131227056|NCT01967888|472457751|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
131227057|NCT01967888|472457752|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
131227058|NCT00553540|472457753|FG000|Overall Study|discharged after first visit|2|||
130716187|NCT00891371|470588790|FG000|Treatment|Adverse Event|2|||
130716188|NCT00891371|470588790|FG000|Treatment|Death|1|||
131227059|NCT00553540|472457754|FG001|Overall Study|discharged after first visit|5|||
130716189|NCT00891371|470588790|FG000|Treatment|Lost to Follow-up|1|||
130716190|NCT02622113|470588791|FG000|Overall Study|Adverse Event|4|||
131042096|NCT03519178|471789333|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
131042097|NCT03519178|471789334|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
131042098|NCT03519178|471789335|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
131042099|NCT03519178|471789336|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
131042100|NCT03519178|471789322|FG000|PF-06873600 Treatment|Refused further treatment|0|||
131128317|NCT01439204|472097742|FG001|Overall Study|Lost to Follow-up|2|||
131128318|NCT01439204|472097741|FG000|Overall Study|No longer meets study criteria|1|||
131128319|NCT01439204|472097742|FG001|Overall Study|No longer meets study criteria|0|||
131128320|NCT01439204|472097741|FG000|Overall Study|poor/non-compliance|3|||
131128321|NCT01439204|472097742|FG001|Overall Study|poor/non-compliance|0|||
131128322|NCT05440539|472099495|FG000|Overall Study|Lost to Follow-up|4|||
131128323|NCT05440539|472099496|FG001|Overall Study|Lost to Follow-up|4|||
131128324|NCT05440539|472099495|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
130967158|NCT00428610|471505453|FG000|Overall Study|Progressive Disease|42|||
130967159|NCT00428610|471505454|FG001|Overall Study|Progressive Disease|14|||
130967160|NCT00428610|471505455|FG002|Overall Study|Progressive Disease|22|||
130967161|NCT00428610|471505453|FG000|Overall Study|Withdrawal by Subject|4|||
130967162|NCT00428610|471505454|FG001|Overall Study|Withdrawal by Subject|0|||
130967163|NCT00428610|471505455|FG002|Overall Study|Withdrawal by Subject|0|||
130967164|NCT05350449|471505456|FG000|Overall Study|Withdrawal by Subject|4|||
130967165|NCT05350449|471505457|FG001|Overall Study|Withdrawal by Subject|8|||
130967166|NCT01921348|471507399|FG000|Overall Study|Withdrawal by Subject|1|||
130967167|NCT01921348|471507400|FG001|Overall Study|Withdrawal by Subject|0|||
130967168|NCT01921348|471507399|FG000|Overall Study|Lost to Follow-up|0|||
130967169|NCT01921348|471507400|FG001|Overall Study|Lost to Follow-up|2|||
130967170|NCT04831736|471507403|FG000|Overall Study|Withdrawal by Subject|0|||
130967171|NCT04831736|471507404|FG001|Overall Study|Withdrawal by Subject|1|||
130967172|NCT00795600|471507408|FG000|Overall Study|Adverse Event|1|||
130967173|NCT00795600|471507409|FG001|Overall Study|Adverse Event|1|||
130967174|NCT00795600|471507408|FG000|Overall Study|Protocol Violation|1|||
130967175|NCT00795600|471507409|FG001|Overall Study|Protocol Violation|2|||
130967176|NCT00795600|471507408|FG000|Overall Study|Withdrawal by Subject|1|||
130967177|NCT00795600|471507409|FG001|Overall Study|Withdrawal by Subject|0|||
130967178|NCT00795600|471507408|FG000|Overall Study|Unclassified|1|||
130967179|NCT00795600|471507409|FG001|Overall Study|Unclassified|1|||
130967180|NCT03936244|471507410|FG000|Overall Study|Lost to Follow-up|5|||
130967181|NCT03936244|471507411|FG001|Overall Study|Lost to Follow-up|1|||
131128325|NCT05440539|472099496|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
131128326|NCT03808077|472099497|FG000|Overall Study|Physician Decision|2|||
131128327|NCT03808077|472099498|FG001|Overall Study|Physician Decision|3|||
131128328|NCT03808077|472099497|FG000|Overall Study|Withdrawal by Subject|1|||
131128329|NCT03808077|472099498|FG001|Overall Study|Withdrawal by Subject|0|||
131128330|NCT03808077|472099497|FG000|Overall Study|Equipment Issues|2|||
131128331|NCT03808077|472099498|FG001|Overall Study|Equipment Issues|1|||
131128332|NCT00631020|472099499|FG000|Overall Study|Lost to Follow-up|7|||
131128333|NCT00631020|472099499|FG000|Overall Study|Incarcerated|1|||
131128334|NCT03548935|472099500|FG000|Overall Study|Withdrawal by Subject|26|||
131128335|NCT03548935|472099501|FG001|Overall Study|Withdrawal by Subject|17|||
131128336|NCT03548935|472099500|FG000|Overall Study|Lost to Follow-up|39|||
131128337|NCT03548935|472099501|FG001|Overall Study|Lost to Follow-up|28|||
131128338|NCT03548935|472099500|FG000|Overall Study|Death|1|||
131128339|NCT03548935|472099501|FG001|Overall Study|Death|1|||
131128340|NCT03571646|472099502|FG000|Overall Study|Adverse Event|1|||
131128341|NCT03571646|472099503|FG001|Overall Study|Adverse Event|0|||
131128342|NCT03571646|472099502|FG000|Overall Study|Withdrawal by Subject|1|||
131128343|NCT03571646|472099503|FG001|Overall Study|Withdrawal by Subject|1|||
131128344|NCT04677959|472099504|FG000|Overall Study|Adverse Event|1|||
131128345|NCT04677959|472099505|FG001|Overall Study|Adverse Event|9|||
131128346|NCT04677959|472099504|FG000|Overall Study|Withdrawal by Subject|2|||
130775700|NCT01677182|470806543|FG000|Overall Study|Other reasons|1|||
130967182|NCT03936244|471507410|FG000|Overall Study|Physician Decision|7|||
130967183|NCT03936244|471507411|FG001|Overall Study|Physician Decision|3|||
130967184|NCT01114646|471507412|FG000|Overall Study|Withdrawal by Subject|3|||
130967185|NCT01114646|471507413|FG001|Overall Study|Withdrawal by Subject|2|||
130967186|NCT00462384|471507421|FG000|Overall Study|Adverse Event|2|||
130967187|NCT00462384|471507421|FG000|Overall Study|Death|2|||
130967188|NCT00462384|471507421|FG000|Overall Study|Withdrawal by Subject|1|||
130967189|NCT00462384|471507421|FG000|Overall Study|Other|4|||
130967190|NCT00346034|471507422|FG000|Overall Study|Adverse Event|34|||
130967191|NCT00346034|471507422|FG000|Overall Study|Lack of Efficacy|8|||
130967192|NCT00346034|471507422|FG000|Overall Study|Withdrawal by Subject|13|||
130967193|NCT00346034|471507422|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
130967194|NCT00346034|471507422|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
131128347|NCT04677959|472099505|FG001|Overall Study|Withdrawal by Subject|15|||
131128348|NCT04677959|472099504|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131227060|NCT02622074|472457755|FG000|Overall Study|Death|4|||
130967195|NCT03029208|471507423|FG000|Overall Study|Withdrawal by Subject|2|||
130967196|NCT03029208|471507424|FG001|Overall Study|Withdrawal by Subject|3|||
130967197|NCT03029208|471507423|FG000|Overall Study|Lost to Follow-up|0|||
130967198|NCT03029208|471507424|FG001|Overall Study|Lost to Follow-up|1|||
131128349|NCT04677959|472099505|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131128350|NCT04677959|472099504|FG000|Overall Study|Non-compliance with study drug|0|||
131128351|NCT04677959|472099505|FG001|Overall Study|Non-compliance with study drug|2|||
131128352|NCT04677959|472099504|FG000|Overall Study|Protocol deviation|0|||
131128353|NCT04677959|472099505|FG001|Overall Study|Protocol deviation|11|||
131128354|NCT04677959|472099504|FG000|Overall Study|Lost to Follow-up|9|||
131128355|NCT04677959|472099505|FG001|Overall Study|Lost to Follow-up|13|||
131128356|NCT04677959|472099504|FG000|Overall Study|Other than specified|0|||
130716191|NCT02622113|470588792|FG001|Overall Study|Adverse Event|4|||
130967199|NCT01732835|471507427|FG000|6-month Primary Endpoint|Did not receive device|19|||
130967200|NCT01732835|471507427|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
130967201|NCT01732835|471507427|FG000|6-month Primary Endpoint|Adverse Event|3|||
130967202|NCT01732835|471507427|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
130967203|NCT01732835|471507427|FG000|2-year Extended Follow-up|Adverse Event|3|||
130967204|NCT01732835|471507427|FG000|2-year Extended Follow-up|Death|1|||
130967205|NCT02493361|471507428|FG000|Overall Study|Withdrawal by Subject|3|||
130967206|NCT02334748|471507429|FG000|Overall Study|Adverse Event|1|||
130967207|NCT02334748|471507429|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
130967208|NCT02334748|471507429|FG000|Overall Study|Patient no longer required study drug|2|||
130967209|NCT02334748|471507429|FG000|Overall Study|Lack of Efficacy|4|||
130967210|NCT01046643|471507430|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
130967211|NCT01046643|471507431|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
130967212|NCT01046643|471507432|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
130967213|NCT01046643|471507433|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
130967214|NCT00022516|471507434|FG000|Overall Study|Adverse Event|0|||
130967215|NCT00022516|471507435|FG001|Overall Study|Adverse Event|59|||
130967216|NCT00022516|471507434|FG000|Overall Study|Lack of Efficacy|0|||
130967217|NCT00022516|471507435|FG001|Overall Study|Lack of Efficacy|27|||
130967218|NCT00022516|471507434|FG000|Overall Study|Physician Decision|0|||
130967219|NCT00022516|471507435|FG001|Overall Study|Physician Decision|1|||
130967220|NCT00022516|471507434|FG000|Overall Study|Protocol Violation|1|||
130967221|NCT00022516|471507435|FG001|Overall Study|Protocol Violation|3|||
130967222|NCT00022516|471507434|FG000|Overall Study|Withdrawal by Subject|2|||
130967223|NCT00022516|471507435|FG001|Overall Study|Withdrawal by Subject|113|||
130967224|NCT00022516|471507434|FG000|Overall Study|Incomplete documentation|0|||
130967225|NCT00022516|471507435|FG001|Overall Study|Incomplete documentation|27|||
130967226|NCT03067441|471507437|FG000|Overall Study|Withdrawal by Subject|16|||
130967227|NCT03067441|471507438|FG001|Overall Study|Withdrawal by Subject|34|||
130967228|NCT03067441|471507437|FG000|Overall Study|Lost to Follow-up|7|||
130967229|NCT03067441|471507438|FG001|Overall Study|Lost to Follow-up|5|||
130967230|NCT03067441|471507437|FG000|Overall Study|Adverse Event|7|||
130967231|NCT03067441|471507438|FG001|Overall Study|Adverse Event|14|||
130967232|NCT03067441|471507437|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
130967233|NCT03067441|471507438|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
130967234|NCT03067441|471507437|FG000|Overall Study|Physician Decision|1|||
130967235|NCT03067441|471507438|FG001|Overall Study|Physician Decision|3|||
130967236|NCT03067441|471507437|FG000|Overall Study|Other|1|||
130967237|NCT03067441|471507438|FG001|Overall Study|Other|1|||
130967238|NCT02056301|471507446|FG000|Overall Study|Protocol Violation|1|||
130967239|NCT02056301|471507447|FG001|Overall Study|Protocol Violation|2|||
130967240|NCT02056301|471507446|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
130967241|NCT02056301|471507447|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
130967242|NCT02056301|471507446|FG000|Overall Study|Withdrawal by Subject|0|||
130967243|NCT02056301|471507447|FG001|Overall Study|Withdrawal by Subject|1|||
130967244|NCT02056301|471507446|FG000|Overall Study|Issues with epidural|0|||
130967245|NCT02056301|471507447|FG001|Overall Study|Issues with epidural|3|||
130967246|NCT02209324|471507451|FG000|Overall Study|Adverse Event|2|||
130967247|NCT02209324|471507451|FG000|Overall Study|Lack of Efficacy|1|||
130967248|NCT02209324|471507451|FG000|Overall Study|Lost to Follow-up|1|||
130967249|NCT02209324|471507451|FG000|Overall Study|Physician Decision|3|||
130967250|NCT02209324|471507451|FG000|Overall Study|Protocol Violation|14|||
130967251|NCT02209324|471507451|FG000|Overall Study|Withdrawal by Subject|8|||
130967252|NCT02209324|471507451|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
130967253|NCT02209324|471507451|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
130967254|NCT02209324|471507451|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
130967255|NCT03433456|471507452|FG000|Overall Study|Death|1|||
130967256|NCT03433456|471507453|FG001|Overall Study|Death|1|||
130967257|NCT03433456|471507452|FG000|Overall Study|Lost to Follow-up|14|||
130967258|NCT03433456|471507453|FG001|Overall Study|Lost to Follow-up|11|||
130967259|NCT03433456|471507452|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
131128357|NCT04677959|472099505|FG001|Overall Study|Other than specified|8|||
130967260|NCT03433456|471507453|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
130967261|NCT05799495|471507454|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
130967262|NCT05799495|471507455|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
130967263|NCT05799495|471507456|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
130967264|NCT05799495|471507457|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
130967265|NCT05799495|471507454|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
131128358|NCT00763815|472099506|FG000|Overall Study|Adverse Event|14|||
130967266|NCT05799495|471507455|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
130967267|NCT05799495|471507456|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
130967268|NCT05799495|471507457|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
130967269|NCT05799495|471507454|FG000|Treatment (Up to 5 Days)|Other|0|||
130967270|NCT05799495|471507455|FG001|Treatment (Up to 5 Days)|Other|1|||
130967271|NCT05799495|471507456|FG002|Treatment (Up to 5 Days)|Other|0|||
130967272|NCT05799495|471507457|FG003|Treatment (Up to 5 Days)|Other|0|||
130967273|NCT05799495|471507454|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
130967274|NCT05799495|471507455|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
130967275|NCT05799495|471507456|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
130967276|NCT05799495|471507457|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
130967277|NCT05799495|471507454|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
130967278|NCT05799495|471507455|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
130967279|NCT05799495|471507456|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
130967280|NCT05799495|471507457|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
130967281|NCT05799495|471507454|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130967282|NCT05799495|471507455|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130967283|NCT05799495|471507456|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
130967284|NCT05799495|471507457|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130967285|NCT03105362|471507458|FG000|Overall Study|Withdrawal by Subject|1|||
130967286|NCT03105362|471507458|FG000|Overall Study|Lost to Follow-up|1|||
130967287|NCT01198600|471507459|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
130967288|NCT01198600|471507460|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
130967289|NCT01198600|471507461|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
130967290|NCT01198600|471507462|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
130967291|NCT01198600|471507459|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
130967292|NCT01198600|471507460|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
130967293|NCT01198600|471507461|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
130967294|NCT01198600|471507462|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
130967295|NCT01198600|471507459|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
130967296|NCT01198600|471507460|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
130967297|NCT01198600|471507461|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
130967298|NCT01198600|471507462|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
130967299|NCT01198600|471507459|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
130967300|NCT01198600|471507460|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
130967301|NCT01198600|471507461|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
130967302|NCT01198600|471507462|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
130967303|NCT01198600|471507459|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
130967304|NCT01198600|471507460|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
131128359|NCT00763815|472099507|FG001|Overall Study|Adverse Event|29|||
131128360|NCT00763815|472099506|FG000|Overall Study|Lack of Efficacy|10|||
131128361|NCT00763815|472099507|FG001|Overall Study|Lack of Efficacy|11|||
131128362|NCT00763815|472099506|FG000|Overall Study|Poor Compliance to Protocol|6|||
131128363|NCT00763815|472099507|FG001|Overall Study|Poor Compliance to Protocol|6|||
131128364|NCT00763815|472099506|FG000|Overall Study|Lost to Follow-up|2|||
131128365|NCT00763815|472099507|FG001|Overall Study|Lost to Follow-up|4|||
131128366|NCT00763815|472099506|FG000|Overall Study|Early Termination|1|||
131128367|NCT00763815|472099507|FG001|Overall Study|Early Termination|0|||
131128368|NCT00763815|472099506|FG000|Overall Study|Familial and Personal Reasons|9|||
131128369|NCT00763815|472099507|FG001|Overall Study|Familial and Personal Reasons|16|||
131128370|NCT00763815|472099506|FG000|Overall Study|Physician Decision|1|||
131128371|NCT00763815|472099507|FG001|Overall Study|Physician Decision|0|||
131128372|NCT00763815|472099506|FG000|Overall Study|Withdrawal by Subject|7|||
131128373|NCT00763815|472099507|FG001|Overall Study|Withdrawal by Subject|12|||
131128374|NCT00763815|472099506|FG000|Overall Study|Protocol Violation|2|||
131128375|NCT00763815|472099507|FG001|Overall Study|Protocol Violation|5|||
131128376|NCT00763815|472099506|FG000|Overall Study|Sponsor's Decision|0|||
131128377|NCT00763815|472099507|FG001|Overall Study|Sponsor's Decision|1|||
131128378|NCT01970995|472099508|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
131128379|NCT01970995|472099509|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
131128380|NCT01970995|472099510|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
131128381|NCT01970995|472099508|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
131128382|NCT01970995|472099509|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
131128383|NCT01970995|472099510|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
131128384|NCT01263639|472099511|FG000|Overall Study|Lost to Follow-up|66|||
131128385|NCT01263639|472099512|FG001|Overall Study|Lost to Follow-up|70|||
131128386|NCT01263639|472099511|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
131128387|NCT01263639|472099512|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
131128388|NCT01576549|472099513|FG000|Overall Study|Sponsor Decision|2|||
131128389|NCT00586495|472099514|FG000|Treatment Period|Adverse Event|11|||
131227061|NCT02622074|472457756|FG001|Overall Study|Death|0|||
130716192|NCT02622113|470588791|FG000|Overall Study|Physician Decision|0|||
130967305|NCT01198600|471507461|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
130967306|NCT01198600|471507462|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
130967307|NCT01198600|471507459|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
130967308|NCT01198600|471507460|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
130967309|NCT01198600|471507461|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
130967310|NCT01198600|471507462|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
130967311|NCT01198600|471507459|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
130967312|NCT01198600|471507460|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
130967313|NCT01198600|471507461|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
130967314|NCT01198600|471507462|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
130967315|NCT03694548|471507463|FG000|Part A Survey|Protocol Violation|3|||
130967316|NCT03694548|471507464|FG001|Part A Survey|Protocol Violation|3|||
130967317|NCT03694548|471507465|FG002|Part A Survey|Protocol Violation|0|||
130967318|NCT03694548|471507463|FG000|Part B Yoga Program|Protocol Violation|0|||
130967319|NCT03694548|471507464|FG001|Part B Yoga Program|Protocol Violation|0|||
130967320|NCT03694548|471507465|FG002|Part B Yoga Program|Protocol Violation|3|||
130967321|NCT03694548|471507463|FG000|Part B Yoga Program|Did not attend intervention|0|||
130967322|NCT03694548|471507464|FG001|Part B Yoga Program|Did not attend intervention|0|||
130967323|NCT03694548|471507465|FG002|Part B Yoga Program|Did not attend intervention|8|||
130967324|NCT04177108|471507466|FG000|Overall Study|Withdrawal by Subject|4|||
130967325|NCT04177108|471507467|FG001|Overall Study|Withdrawal by Subject|8|||
130967326|NCT04177108|471507468|FG002|Overall Study|Withdrawal by Subject|9|||
130967327|NCT04177108|471507469|FG003|Overall Study|Withdrawal by Subject|11|||
130967328|NCT04177108|471507470|FG004|Overall Study|Withdrawal by Subject|13|||
130967329|NCT04177108|471507466|FG000|Overall Study|Physician Decision|23|||
130967330|NCT04177108|471507467|FG001|Overall Study|Physician Decision|15|||
130967331|NCT04177108|471507468|FG002|Overall Study|Physician Decision|18|||
130967332|NCT04177108|471507469|FG003|Overall Study|Physician Decision|29|||
130967333|NCT04177108|471507470|FG004|Overall Study|Physician Decision|23|||
130967334|NCT04177108|471507466|FG000|Overall Study|Reason Not Specified|0|||
130967335|NCT04177108|471507467|FG001|Overall Study|Reason Not Specified|1|||
130967336|NCT04177108|471507468|FG002|Overall Study|Reason Not Specified|0|||
130967337|NCT04177108|471507469|FG003|Overall Study|Reason Not Specified|0|||
130967338|NCT04177108|471507470|FG004|Overall Study|Reason Not Specified|2|||
130967339|NCT04177108|471507466|FG000|Overall Study|Lost to Follow-up|0|||
130967340|NCT04177108|471507467|FG001|Overall Study|Lost to Follow-up|0|||
130967341|NCT04177108|471507468|FG002|Overall Study|Lost to Follow-up|1|||
130967342|NCT04177108|471507469|FG003|Overall Study|Lost to Follow-up|1|||
130967343|NCT04177108|471507470|FG004|Overall Study|Lost to Follow-up|1|||
130967344|NCT04177108|471507466|FG000|Overall Study|Death|16|||
130967345|NCT04177108|471507467|FG001|Overall Study|Death|19|||
130967346|NCT04177108|471507468|FG002|Overall Study|Death|13|||
130967347|NCT04177108|471507469|FG003|Overall Study|Death|17|||
130967348|NCT04177108|471507470|FG004|Overall Study|Death|18|||
130967349|NCT04496258|471507474|FG000|Overall Study|Withdrawal by Subject|2|||
130967350|NCT04496258|471507475|FG001|Overall Study|Withdrawal by Subject|1|||
130967351|NCT01427712|471507476|FG000|Overall Study|Transfer to a different hospital|2|||
130967352|NCT01427712|471507476|FG000|Overall Study|Lost to Follow-up|1|||
130967353|NCT01427712|471507476|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
130967354|NCT01427712|471507476|FG000|Overall Study|Failure to visit|1|||
130967355|NCT04798586|471507479|FG000|Overall Study|Death|2|||
130967356|NCT04433767|471507480|FG000|Overall Study|Adverse Event|1|||
130967357|NCT00661492|471507485|FG000|Overall Study|Adverse Event|16|||
130967358|NCT00661492|471507486|FG001|Overall Study|Adverse Event|13|||
130967359|NCT00661492|471507485|FG000|Overall Study|Disease Progression|44|||
130967360|NCT00661492|471507486|FG001|Overall Study|Disease Progression|14|||
130967361|NCT00661492|471507485|FG000|Overall Study|Patient Request|6|||
130967362|NCT00661492|471507486|FG001|Overall Study|Patient Request|1|||
130967363|NCT00661492|471507485|FG000|Overall Study|Investigator Request|1|||
130967364|NCT00661492|471507486|FG001|Overall Study|Investigator Request|0|||
130967365|NCT00661492|471507485|FG000|Overall Study|Lost to Follow-up|0|||
130967366|NCT00661492|471507486|FG001|Overall Study|Lost to Follow-up|1|||
130967367|NCT00661492|471507485|FG000|Overall Study|Other|1|||
130967368|NCT00661492|471507486|FG001|Overall Study|Other|0|||
130967369|NCT03855189|471507487|FG000|Overall Study|Adverse Event|5|||
130967370|NCT03855189|471507488|FG001|Overall Study|Adverse Event|2|||
130967371|NCT03855189|471507489|FG002|Overall Study|Adverse Event|4|||
130967372|NCT03855189|471507487|FG000|Overall Study|Treatment Failure|1|||
130967373|NCT03855189|471507488|FG001|Overall Study|Treatment Failure|1|||
130967374|NCT03855189|471507489|FG002|Overall Study|Treatment Failure|2|||
130967375|NCT03855189|471507487|FG000|Overall Study|Noncompliance with Protocol|0|||
130967376|NCT03855189|471507488|FG001|Overall Study|Noncompliance with Protocol|1|||
130967377|NCT03855189|471507489|FG002|Overall Study|Noncompliance with Protocol|0|||
130967378|NCT03855189|471507487|FG000|Overall Study|Did Not Return|4|||
130967379|NCT03855189|471507488|FG001|Overall Study|Did Not Return|3|||
130967380|NCT03855189|471507489|FG002|Overall Study|Did Not Return|0|||
130967381|NCT00099983|471507490|FG000|Overall Study|Lost to Follow-up|2|||
130716193|NCT02622113|470588792|FG001|Overall Study|Physician Decision|1|||
130716194|NCT02622113|470588791|FG000|Overall Study|Withdrawal by Subject|0|||
130716195|NCT02622113|470588792|FG001|Overall Study|Withdrawal by Subject|2|||
130967382|NCT00099983|471507491|FG001|Overall Study|Lost to Follow-up|3|||
130967383|NCT00099983|471507490|FG000|Overall Study|Missing Source Documents|14|||
130967384|NCT00099983|471507491|FG001|Overall Study|Missing Source Documents|15|||
130967385|NCT00099983|471507490|FG000|Overall Study|Withdrawal by Subject|3|||
130967386|NCT00099983|471507491|FG001|Overall Study|Withdrawal by Subject|2|||
130967387|NCT00099983|471507490|FG000|Overall Study|Adverse Event|1|||
130967388|NCT00099983|471507491|FG001|Overall Study|Adverse Event|1|||
130967389|NCT00099983|471507490|FG000|Overall Study|Lack of Efficacy|0|||
130967390|NCT00099983|471507491|FG001|Overall Study|Lack of Efficacy|1|||
130967391|NCT00099983|471507490|FG000|Overall Study|Unable to return for appointments|1|||
130967392|NCT00099983|471507491|FG001|Overall Study|Unable to return for appointments|1|||
130967393|NCT00099983|471507490|FG000|Overall Study|Moved|1|||
130967394|NCT00099983|471507491|FG001|Overall Study|Moved|0|||
130967395|NCT00099983|471507490|FG000|Overall Study|Other psychiatric problem|1|||
130967396|NCT00099983|471507491|FG001|Overall Study|Other psychiatric problem|0|||
130967397|NCT00099983|471507490|FG000|Overall Study|Incarcerated|0|||
130967398|NCT00099983|471507491|FG001|Overall Study|Incarcerated|1|||
130967399|NCT00099983|471507490|FG000|Overall Study|Intolerant of burden of visits|0|||
130967400|NCT00099983|471507491|FG001|Overall Study|Intolerant of burden of visits|1|||
130967401|NCT00099983|471507490|FG000|Overall Study|Other issue|1|||
130967402|NCT00099983|471507491|FG001|Overall Study|Other issue|0|||
131128390|NCT00586495|472099514|FG000|Treatment Period|Death|1|||
130967403|NCT00803634|471507492|FG000|Overall Study|Withdrew Consent|1|||
130967404|NCT00803634|471507493|FG001|Overall Study|Withdrew Consent|0|||
130967405|NCT00803634|471507492|FG000|Overall Study|Lost to Follow-up|2|||
130967406|NCT00803634|471507493|FG001|Overall Study|Lost to Follow-up|3|||
131128391|NCT00586495|472099514|FG000|Treatment Period|Protocol Violation|1|||
130967407|NCT00803634|471507492|FG000|Overall Study|Death|3|||
130967408|NCT00803634|471507493|FG001|Overall Study|Death|2|||
130967409|NCT04307186|471507494|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
130967410|NCT04307186|471507494|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
130967411|NCT04307186|471507494|FG000|Washout 3-14 Days|Progressive disease|1|||
130967412|NCT04307186|471507494|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
130967413|NCT04307186|471507494|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
130967414|NCT03238001|471507498|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
130967415|NCT03238001|471507498|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
130967416|NCT03238001|471507498|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
130967417|NCT03238001|471507498|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
131128392|NCT00586495|472099514|FG000|Treatment Period|Withdrawal by Subject|1|||
131128393|NCT00586495|472099514|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
131128394|NCT00586495|472099514|FG000|Treatment Period|Switch to commercial drug|10|||
131128395|NCT00586495|472099514|FG000|Follow-up|Death|40|||
131128396|NCT00586495|472099514|FG000|Follow-up|Lost to Follow-up|1|||
131128397|NCT00586495|472099514|FG000|Follow-up|Withdrawal by Subject|4|||
131128398|NCT00586495|472099514|FG000|Follow-up|Protocol driven decision point|37|||
131128399|NCT00586495|472099514|FG000|Follow-up|Switch to commercial drug|10|||
131128400|NCT02716987|472099527|FG000|Overall Study|Ligand synthesis failure|0|||
131128401|NCT02716987|472099528|FG001|Overall Study|Ligand synthesis failure|0|||
131128402|NCT02716987|472099529|FG002|Overall Study|Ligand synthesis failure|1|||
131128403|NCT02716987|472099530|FG003|Overall Study|Ligand synthesis failure|0|||
131128404|NCT02716987|472099531|FG004|Overall Study|Ligand synthesis failure|0|||
131128405|NCT02716987|472099532|FG005|Overall Study|Ligand synthesis failure|0|||
131128406|NCT02716987|472099527|FG000|Overall Study|Withdrawal by Subject|0|||
131128407|NCT02716987|472099528|FG001|Overall Study|Withdrawal by Subject|0|||
130716196|NCT02622113|470588791|FG000|Overall Study|Stopping Criteria|1|||
130967418|NCT03238001|471507498|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
130967419|NCT03238001|471507498|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
131128408|NCT02716987|472099529|FG002|Overall Study|Withdrawal by Subject|0|||
131128409|NCT02716987|472099530|FG003|Overall Study|Withdrawal by Subject|0|||
131128410|NCT02716987|472099531|FG004|Overall Study|Withdrawal by Subject|1|||
130716197|NCT02622113|470588792|FG001|Overall Study|Stopping Criteria|3|||
131128411|NCT02716987|472099532|FG005|Overall Study|Withdrawal by Subject|1|||
131128412|NCT02829138|472099533|FG000|Overall Study|Withdrawal by Subject|1|||
130967420|NCT03238001|471507498|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
130967421|NCT03238001|471507498|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
130967422|NCT01827904|471507499|FG000|Main Study|Withdrawal by Subject|1|||
130967423|NCT01827904|471507500|FG001|Main Study|Withdrawal by Subject|0|||
130967424|NCT01827904|471507501|FG002|Main Study|Withdrawal by Subject|0|||
130967425|NCT01827904|471507499|FG000|Main Study|Adverse Event|1|||
131128413|NCT02829138|472099534|FG001|Overall Study|Withdrawal by Subject|0|||
131128414|NCT01394627|472099535|FG000|First Intervention (1 Day)|poor intravenous access|0|||
131128415|NCT01394627|472099536|FG001|First Intervention (1 Day)|poor intravenous access|1|||
130967426|NCT01827904|471507500|FG001|Main Study|Adverse Event|0|||
130967427|NCT01827904|471507501|FG002|Main Study|Adverse Event|0|||
130967428|NCT01827904|471507499|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
130967429|NCT01827904|471507500|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
130967430|NCT01827904|471507501|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
130967431|NCT01827904|471507499|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
130967432|NCT01827904|471507500|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
130967433|NCT01827904|471507501|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
130967434|NCT01827904|471507499|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
130967435|NCT01827904|471507500|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
130967436|NCT01827904|471507501|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
130967437|NCT01827904|471507499|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
130967438|NCT01827904|471507500|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
130967439|NCT01827904|471507501|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
130967440|NCT01827904|471507499|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
130967441|NCT01827904|471507500|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
130967442|NCT01827904|471507501|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
130967443|NCT01827904|471507499|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
130967444|NCT01827904|471507500|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
130967445|NCT01827904|471507501|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
130967446|NCT01827904|471507499|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
130967447|NCT01827904|471507500|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
130967448|NCT01827904|471507501|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
130967449|NCT01827904|471507499|FG000|Long-term Annual Follow-up|Physician Decision|1|||
130967450|NCT01827904|471507500|FG001|Long-term Annual Follow-up|Physician Decision|0|||
130967451|NCT01827904|471507501|FG002|Long-term Annual Follow-up|Physician Decision|0|||
130967452|NCT01827904|471507499|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
130967453|NCT01827904|471507500|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
130967454|NCT01827904|471507501|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
130967455|NCT01827904|471507499|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
130967456|NCT01827904|471507500|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
130967457|NCT01827904|471507501|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
130967458|NCT01866709|471507505|FG000|Overall Study|Adverse Event|1|||
130967459|NCT01866709|471507506|FG001|Overall Study|Adverse Event|0|||
130967460|NCT03791398|471507507|FG000|Overall Study|Progression of Disease Under Study|2|||
130967461|NCT03791398|471507508|FG001|Overall Study|Progression of Disease Under Study|0|||
130967462|NCT03791398|471507509|FG002|Overall Study|Progression of Disease Under Study|0|||
130967463|NCT02207829|471507510|FG000|Overall Study|Adverse Event|10|||
130967464|NCT02207829|471507511|FG001|Overall Study|Adverse Event|9|||
130967465|NCT02207829|471507510|FG000|Overall Study|Lack of Efficacy|7|||
130967466|NCT02207829|471507511|FG001|Overall Study|Lack of Efficacy|5|||
130967467|NCT02207829|471507510|FG000|Overall Study|Lost to Follow-up|2|||
130967468|NCT02207829|471507511|FG001|Overall Study|Lost to Follow-up|2|||
130967469|NCT02207829|471507510|FG000|Overall Study|Protocol deviation|5|||
130967470|NCT02207829|471507511|FG001|Overall Study|Protocol deviation|4|||
130967471|NCT02207829|471507510|FG000|Overall Study|Withdrew consent|18|||
130967472|NCT02207829|471507511|FG001|Overall Study|Withdrew consent|14|||
130967473|NCT00766376|471507512|FG000|Overall Study|Withdrawal by Subject|27|||
130967474|NCT01800903|471507513|FG000|Second Test Period|unable to catheterise|1|||
130967475|NCT01800903|471507514|FG001|Second Test Period|unable to catheterise|0|||
130967476|NCT01800903|471507515|FG002|Second Test Period|unable to catheterise|0|||
130967477|NCT01800903|471507516|FG003|Second Test Period|unable to catheterise|0|||
130967478|NCT01800903|471507517|FG004|Second Test Period|unable to catheterise|0|||
131042101|NCT03519178|471789323|FG001|PF-06873600 Treatment|Refused further treatment|1|||
130967479|NCT01800903|471507518|FG005|Second Test Period|unable to catheterise|0|||
130967480|NCT01110239|471507523|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
130967481|NCT01110239|471507524|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
130967482|NCT01110239|471507525|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
131042102|NCT03519178|471789324|FG002|PF-06873600 Treatment|Refused further treatment|0|||
131042103|NCT03519178|471789325|FG003|PF-06873600 Treatment|Refused further treatment|0|||
131042104|NCT03519178|471789326|FG004|PF-06873600 Treatment|Refused further treatment|1|||
131042105|NCT03519178|471789327|FG005|PF-06873600 Treatment|Refused further treatment|0|||
131042106|NCT03519178|471789328|FG006|PF-06873600 Treatment|Refused further treatment|0|||
131042107|NCT03519178|471789329|FG007|PF-06873600 Treatment|Refused further treatment|0|||
130967483|NCT01110239|471507526|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
130967484|NCT01110239|471507523|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
130967485|NCT01110239|471507524|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
130967486|NCT01110239|471507525|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
130967487|NCT01110239|471507526|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
130967488|NCT00080223|471507529|FG000|Overall Study|Adverse Event|23|||
130967489|NCT00080223|471507529|FG000|Overall Study|Death|21|||
131042108|NCT03519178|471789330|FG008|PF-06873600 Treatment|Refused further treatment|0|||
130967490|NCT00080223|471507529|FG000|Overall Study|Withdrawal by Subject|13|||
130967491|NCT00080223|471507529|FG000|Overall Study|Lung Transplantation|9|||
130967492|NCT00080223|471507529|FG000|Overall Study|Non-compliance With Study Treatment|7|||
130967493|NCT00080223|471507529|FG000|Overall Study|Participant unwilling to continue|2|||
130967494|NCT00080223|471507529|FG000|Overall Study|Physician Decision|1|||
130967495|NCT04369469|471507538|FG000|Overall Study|Lost to Follow-up|2|||
130967496|NCT04369469|471507539|FG001|Overall Study|Lost to Follow-up|4|||
130967497|NCT04369469|471507538|FG000|Overall Study|Physician Decision|2|||
130967498|NCT04369469|471507539|FG001|Overall Study|Physician Decision|1|||
130967499|NCT04369469|471507538|FG000|Overall Study|Withdrawal by Subject|2|||
130967500|NCT04369469|471507539|FG001|Overall Study|Withdrawal by Subject|3|||
130967501|NCT04369469|471507538|FG000|Overall Study|Adverse Event|1|||
130967502|NCT04369469|471507539|FG001|Overall Study|Adverse Event|0|||
130967503|NCT04369469|471507538|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
130967504|NCT04369469|471507539|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
130967505|NCT04369469|471507538|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
130967506|NCT04369469|471507539|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
130967507|NCT04369469|471507538|FG000|Overall Study|Unable to Provide Consent|0|||
130967508|NCT04369469|471507539|FG001|Overall Study|Unable to Provide Consent|1|||
130967509|NCT05204134|471507540|FG000|Overall Study|Withdrawal by Subject|3|||
130967510|NCT05204134|471507540|FG000|Overall Study|Physician Decision|1|||
130967511|NCT03099382|471507544|FG000|Overall Study|Protocol Violation|2|||
130967512|NCT03099382|471507545|FG001|Overall Study|Protocol Violation|3|||
130967513|NCT00499369|471507546|FG000|Overall Study|Adverse Event|2|||
130967514|NCT00499369|471507547|FG001|Overall Study|Adverse Event|2|||
130967515|NCT00499369|471507548|FG002|Overall Study|Adverse Event|3|||
130967516|NCT00499369|471507549|FG003|Overall Study|Adverse Event|1|||
130967517|NCT00499369|471507550|FG004|Overall Study|Adverse Event|2|||
130967518|NCT00499369|471507546|FG000|Overall Study|Withdrawal by Subject|0|||
130967519|NCT00499369|471507547|FG001|Overall Study|Withdrawal by Subject|1|||
130967520|NCT00499369|471507548|FG002|Overall Study|Withdrawal by Subject|1|||
130967521|NCT00499369|471507549|FG003|Overall Study|Withdrawal by Subject|0|||
130967522|NCT00499369|471507550|FG004|Overall Study|Withdrawal by Subject|0|||
130967523|NCT00499369|471507546|FG000|Overall Study|Progression|10|||
130967524|NCT00499369|471507547|FG001|Overall Study|Progression|12|||
130967525|NCT00499369|471507548|FG002|Overall Study|Progression|9|||
130967526|NCT00499369|471507549|FG003|Overall Study|Progression|6|||
130967527|NCT00499369|471507550|FG004|Overall Study|Progression|10|||
130967528|NCT00499369|471507546|FG000|Overall Study|Death|0|||
130967529|NCT00499369|471507547|FG001|Overall Study|Death|1|||
130967530|NCT00499369|471507548|FG002|Overall Study|Death|0|||
130967531|NCT00499369|471507549|FG003|Overall Study|Death|0|||
130967532|NCT00499369|471507550|FG004|Overall Study|Death|0|||
130967533|NCT00499369|471507546|FG000|Overall Study|Not protocol specified|2|||
130967534|NCT00499369|471507547|FG001|Overall Study|Not protocol specified|0|||
130967535|NCT00499369|471507548|FG002|Overall Study|Not protocol specified|3|||
130967536|NCT00499369|471507549|FG003|Overall Study|Not protocol specified|1|||
130967537|NCT00499369|471507550|FG004|Overall Study|Not protocol specified|0|||
130967538|NCT00499369|471507546|FG000|Overall Study|Ineligible|2|||
130967539|NCT00499369|471507547|FG001|Overall Study|Ineligible|2|||
130716198|NCT00667810|470588793|FG000|Overall Study|Adverse Event|13|||
130716199|NCT00667810|470588794|FG001|Overall Study|Adverse Event|14|||
130716200|NCT00667810|470588795|FG002|Overall Study|Adverse Event|19|||
130967540|NCT00499369|471507548|FG002|Overall Study|Ineligible|1|||
130967541|NCT00499369|471507549|FG003|Overall Study|Ineligible|1|||
130967542|NCT00499369|471507550|FG004|Overall Study|Ineligible|0|||
130967543|NCT01802411|471507551|FG000|Overall Study|Death|2|||
130967544|NCT01802411|471507552|FG001|Overall Study|Death|1|||
130967545|NCT01802411|471507551|FG000|Overall Study|Adverse Event|2|||
130967546|NCT01802411|471507552|FG001|Overall Study|Adverse Event|7|||
130967547|NCT01802411|471507551|FG000|Overall Study|Lack of Efficacy|8|||
130967548|NCT01802411|471507552|FG001|Overall Study|Lack of Efficacy|10|||
130967549|NCT01802411|471507551|FG000|Overall Study|Withdrawal by Subject|0|||
130967550|NCT01802411|471507552|FG001|Overall Study|Withdrawal by Subject|2|||
130967551|NCT01802411|471507551|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
130967552|NCT01802411|471507552|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
130967553|NCT01802411|471507551|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
130967554|NCT01802411|471507552|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
130967555|NCT01802411|471507551|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
130967556|NCT01802411|471507552|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
130967557|NCT03283670|471507553|FG000|Placebo Gas|Withdrawal by Subject|2|||
130967558|NCT03283670|471507553|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
130967559|NCT03283670|471507553|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
131227062|NCT02622074|472457757|FG002|Overall Study|Death|0|||
130967560|NCT01059617|471507556|FG000|Overall Study|Other|7|||
130967561|NCT01059617|471507557|FG001|Overall Study|Other|1|||
130967562|NCT01059617|471507558|FG002|Overall Study|Other|8|||
130967563|NCT01059617|471507559|FG003|Overall Study|Other|6|||
130967564|NCT00852397|471507561|FG000|Overall Study|Adverse Event|4|||
130967565|NCT00852397|471507562|FG001|Overall Study|Adverse Event|6|||
130967566|NCT00852397|471507563|FG002|Overall Study|Adverse Event|4|||
130967567|NCT00852397|471507561|FG000|Overall Study|Death|0|||
130967568|NCT00852397|471507562|FG001|Overall Study|Death|0|||
130967569|NCT00852397|471507563|FG002|Overall Study|Death|1|||
130967570|NCT00852397|471507561|FG000|Overall Study|Withdrawal by Subject|4|||
130967571|NCT00852397|471507562|FG001|Overall Study|Withdrawal by Subject|1|||
130967572|NCT00852397|471507563|FG002|Overall Study|Withdrawal by Subject|2|||
130967573|NCT00852397|471507561|FG000|Overall Study|Study terminated by sponsor|2|||
130967574|NCT00852397|471507562|FG001|Overall Study|Study terminated by sponsor|1|||
130967575|NCT00852397|471507563|FG002|Overall Study|Study terminated by sponsor|6|||
130967576|NCT00852397|471507561|FG000|Overall Study|Difficulty in study site visit|1|||
130967577|NCT00852397|471507562|FG001|Overall Study|Difficulty in study site visit|0|||
130967578|NCT00852397|471507563|FG002|Overall Study|Difficulty in study site visit|0|||
130967579|NCT00852397|471507561|FG000|Overall Study|Protocol Violation|0|||
130967580|NCT00852397|471507562|FG001|Overall Study|Protocol Violation|0|||
130967581|NCT00852397|471507563|FG002|Overall Study|Protocol Violation|1|||
130967582|NCT03864614|471507570|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
130967583|NCT03864614|471507571|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
130967584|NCT03864614|471507572|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
130967585|NCT03864614|471507573|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
130967586|NCT03864614|471507570|FG000|Overall Study|Withdrawal by Subject|72|||
130967587|NCT03864614|471507571|FG001|Overall Study|Withdrawal by Subject|100|||
130967588|NCT03864614|471507572|FG002|Overall Study|Withdrawal by Subject|1|||
130967589|NCT03864614|471507573|FG003|Overall Study|Withdrawal by Subject|21|||
130967590|NCT03864614|471507570|FG000|Overall Study|Lost to Follow-up|45|||
130967591|NCT03864614|471507571|FG001|Overall Study|Lost to Follow-up|54|||
130967592|NCT03864614|471507572|FG002|Overall Study|Lost to Follow-up|0|||
130967593|NCT03864614|471507573|FG003|Overall Study|Lost to Follow-up|9|||
130967594|NCT03864614|471507570|FG000|Overall Study|Adverse Event|42|||
130967595|NCT03864614|471507571|FG001|Overall Study|Adverse Event|30|||
130967596|NCT03864614|471507572|FG002|Overall Study|Adverse Event|1|||
130967597|NCT03864614|471507573|FG003|Overall Study|Adverse Event|9|||
130967598|NCT03864614|471507570|FG000|Overall Study|Protocol Deviation|6|||
130967599|NCT03864614|471507571|FG001|Overall Study|Protocol Deviation|26|||
130967600|NCT03864614|471507572|FG002|Overall Study|Protocol Deviation|0|||
130967601|NCT03864614|471507573|FG003|Overall Study|Protocol Deviation|1|||
130967602|NCT03864614|471507570|FG000|Overall Study|Physician Decision|7|||
130967603|NCT03864614|471507571|FG001|Overall Study|Physician Decision|10|||
130967604|NCT03864614|471507572|FG002|Overall Study|Physician Decision|1|||
130967605|NCT03864614|471507573|FG003|Overall Study|Physician Decision|5|||
130967606|NCT03864614|471507570|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
130967607|NCT03864614|471507571|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
130967608|NCT03864614|471507572|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
130967609|NCT03864614|471507573|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
130967610|NCT03864614|471507570|FG000|Overall Study|Sponsor Decision|1|||
130967611|NCT03864614|471507571|FG001|Overall Study|Sponsor Decision|2|||
130967612|NCT03864614|471507572|FG002|Overall Study|Sponsor Decision|0|||
130967613|NCT03864614|471507573|FG003|Overall Study|Sponsor Decision|0|||
130967614|NCT03864614|471507570|FG000|Overall Study|Pregnancy|0|||
130967615|NCT03864614|471507571|FG001|Overall Study|Pregnancy|1|||
130967616|NCT03864614|471507572|FG002|Overall Study|Pregnancy|0|||
130967617|NCT03864614|471507573|FG003|Overall Study|Pregnancy|0|||
130967618|NCT03864614|471507570|FG000|Overall Study|Other|7|||
130967619|NCT03864614|471507571|FG001|Overall Study|Other|9|||
130967620|NCT03864614|471507572|FG002|Overall Study|Other|1|||
130967621|NCT03864614|471507573|FG003|Overall Study|Other|4|||
130967622|NCT03864614|471507570|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
130967623|NCT03864614|471507571|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
130967624|NCT03864614|471507572|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
130967625|NCT03864614|471507573|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
130967626|NCT01850004|471507574|FG000|Overall Study|Poor/Non-compliance|1|||
130967627|NCT01850004|471507574|FG000|Overall Study|Participant Withdrew Consent|9|||
130967628|NCT01850004|471507574|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
130967629|NCT01850004|471507574|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
130967630|NCT01850004|471507574|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
130967631|NCT01850004|471507574|FG000|Overall Study|Other Reasons|2|||
130967632|NCT01850004|471507574|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
130967633|NCT01850004|471507574|FG000|Overall Study|Maximum Clinical Benefit|4|||
130967634|NCT01760954|471509314|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
130967635|NCT01760954|471509315|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
130967636|NCT01760954|471509316|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
130967637|NCT01760954|471509317|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
130967638|NCT01760954|471509314|FG000|Treatment Period (6 Months)|Adverse Event|5|||
130967639|NCT01760954|471509315|FG001|Treatment Period (6 Months)|Adverse Event|3|||
130967640|NCT01760954|471509316|FG002|Treatment Period (6 Months)|Adverse Event|4|||
131227063|NCT02622074|472457758|FG003|Overall Study|Death|1|||
131227064|NCT02622074|472457759|FG004|Overall Study|Death|1|||
131227065|NCT02622074|472457760|FG005|Overall Study|Death|0|||
131227066|NCT02622074|472457755|FG000|Overall Study|Withdrawal by Subject|0|||
131227067|NCT02622074|472457756|FG001|Overall Study|Withdrawal by Subject|1|||
131227068|NCT02622074|472457757|FG002|Overall Study|Withdrawal by Subject|0|||
131227069|NCT02622074|472457758|FG003|Overall Study|Withdrawal by Subject|0|||
131227070|NCT02622074|472457759|FG004|Overall Study|Withdrawal by Subject|0|||
131227071|NCT02622074|472457760|FG005|Overall Study|Withdrawal by Subject|0|||
131227072|NCT02114931|472457761|FG000|Overall Study|Withdrawal by Subject|15|||
131227073|NCT02114931|472457762|FG001|Overall Study|Withdrawal by Subject|18|||
130716201|NCT00667810|470588796|FG003|Overall Study|Adverse Event|1|||
130716202|NCT00667810|470588793|FG000|Overall Study|Death|1|||
130716203|NCT00667810|470588794|FG001|Overall Study|Death|1|||
130716204|NCT00667810|470588795|FG002|Overall Study|Death|3|||
130716205|NCT00667810|470588796|FG003|Overall Study|Death|0|||
130716206|NCT00667810|470588793|FG000|Overall Study|Lack of Efficacy|1|||
130716207|NCT00667810|470588794|FG001|Overall Study|Lack of Efficacy|0|||
130716208|NCT00667810|470588795|FG002|Overall Study|Lack of Efficacy|2|||
130716209|NCT00667810|470588796|FG003|Overall Study|Lack of Efficacy|0|||
130716210|NCT00667810|470588793|FG000|Overall Study|Lost to Follow-up|1|||
130716211|NCT00667810|470588794|FG001|Overall Study|Lost to Follow-up|4|||
130716212|NCT00667810|470588795|FG002|Overall Study|Lost to Follow-up|2|||
130716213|NCT00667810|470588796|FG003|Overall Study|Lost to Follow-up|0|||
130716214|NCT00667810|470588793|FG000|Overall Study|Physician Decision|1|||
130716215|NCT00667810|470588794|FG001|Overall Study|Physician Decision|1|||
130716216|NCT00667810|470588795|FG002|Overall Study|Physician Decision|2|||
130716217|NCT00667810|470588796|FG003|Overall Study|Physician Decision|0|||
130716218|NCT00667810|470588793|FG000|Overall Study|Protocol Violation|0|||
130716219|NCT00667810|470588794|FG001|Overall Study|Protocol Violation|2|||
130716220|NCT00667810|470588795|FG002|Overall Study|Protocol Violation|0|||
130716221|NCT00667810|470588796|FG003|Overall Study|Protocol Violation|0|||
130716222|NCT00667810|470588793|FG000|Overall Study|Withdrawal by Subject|14|||
130716223|NCT00667810|470588794|FG001|Overall Study|Withdrawal by Subject|20|||
130716224|NCT00667810|470588795|FG002|Overall Study|Withdrawal by Subject|29|||
130716225|NCT00667810|470588796|FG003|Overall Study|Withdrawal by Subject|1|||
130716226|NCT00667810|470588793|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
130967641|NCT01760954|471509317|FG003|Treatment Period (6 Months)|Adverse Event|10|||
130967642|NCT01760954|471509314|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
130967643|NCT01760954|471509315|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
130967644|NCT01760954|471509316|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
130967645|NCT01760954|471509317|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
130967646|NCT01760954|471509314|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
130967647|NCT01760954|471509315|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
130967648|NCT01760954|471509316|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
130967649|NCT01760954|471509317|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
130967650|NCT01760954|471509314|FG000|Treatment Period (6 Months)|Pregnancy|5|||
130967651|NCT01760954|471509315|FG001|Treatment Period (6 Months)|Pregnancy|0|||
130967652|NCT01760954|471509316|FG002|Treatment Period (6 Months)|Pregnancy|3|||
130967653|NCT01760954|471509317|FG003|Treatment Period (6 Months)|Pregnancy|2|||
130967654|NCT01760954|471509314|FG000|Treatment Period (6 Months)|Non-compliance|1|||
130967655|NCT01760954|471509315|FG001|Treatment Period (6 Months)|Non-compliance|4|||
130967656|NCT01760954|471509316|FG002|Treatment Period (6 Months)|Non-compliance|0|||
130967657|NCT01760954|471509317|FG003|Treatment Period (6 Months)|Non-compliance|3|||
130967658|NCT01760954|471509314|FG000|Treatment Period (6 Months)|Other|0|||
130967659|NCT01760954|471509315|FG001|Treatment Period (6 Months)|Other|3|||
130716227|NCT00667810|470588794|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
130716228|NCT00667810|470588795|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
130967660|NCT01760954|471509316|FG002|Treatment Period (6 Months)|Other|3|||
130967661|NCT01760954|471509317|FG003|Treatment Period (6 Months)|Other|1|||
130967662|NCT01760954|471509314|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
130967663|NCT01760954|471509315|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
131227074|NCT02114931|472457761|FG000|Overall Study|Adverse Event|4|||
131227075|NCT02114931|472457762|FG001|Overall Study|Adverse Event|6|||
131227076|NCT02114931|472457761|FG000|Overall Study|Lost to Follow-up|3|||
131227077|NCT02114931|472457762|FG001|Overall Study|Lost to Follow-up|3|||
131227078|NCT02114931|472457761|FG000|Overall Study|Physician Decision|1|||
130716229|NCT00667810|470588796|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
130716230|NCT00667810|470588793|FG000|Overall Study|Failed to Return|0|||
130967664|NCT01760954|471509316|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
130967665|NCT01760954|471509317|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
131227079|NCT02114931|472457762|FG001|Overall Study|Physician Decision|2|||
131227080|NCT02114931|472457761|FG000|Overall Study|Other|2|||
130716231|NCT00667810|470588794|FG001|Overall Study|Failed to Return|0|||
130716232|NCT00667810|470588795|FG002|Overall Study|Failed to Return|2|||
130716233|NCT00667810|470588796|FG003|Overall Study|Failed to Return|0|||
130967666|NCT01760954|471509314|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
130967667|NCT01760954|471509315|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
130967668|NCT01760954|471509316|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
130967669|NCT01760954|471509317|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
130967670|NCT01760954|471509314|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
130967671|NCT01760954|471509315|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
130967672|NCT01760954|471509316|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
130967673|NCT01760954|471509317|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
130967674|NCT01760954|471509314|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
130967675|NCT01760954|471509315|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
130967676|NCT01760954|471509316|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
130967677|NCT01760954|471509317|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
130967678|NCT01760954|471509314|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
130967679|NCT01760954|471509315|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
130967680|NCT01760954|471509316|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
130967681|NCT01760954|471509317|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
130967682|NCT01760954|471509314|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
130967683|NCT01760954|471509315|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
130967684|NCT01760954|471509316|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
130967685|NCT01760954|471509317|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
130967686|NCT01760954|471509314|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
130967687|NCT01760954|471509315|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
130967688|NCT01760954|471509316|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
130967689|NCT01760954|471509317|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
130967690|NCT01760954|471509314|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
130967691|NCT01760954|471509315|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
130967692|NCT01760954|471509316|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
130967693|NCT01760954|471509317|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
130967694|NCT03320070|471509318|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
130967695|NCT03320070|471509319|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
130967696|NCT03320070|471509318|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
130967697|NCT03320070|471509319|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
130967698|NCT03320070|471509318|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
130967699|NCT03320070|471509319|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
130967700|NCT03320070|471509318|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
130967701|NCT03320070|471509319|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
130967702|NCT03320070|471509318|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
130967703|NCT03320070|471509319|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
130967704|NCT03320070|471509318|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
130967705|NCT03320070|471509319|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
130967706|NCT00353704|471509336|FG000|Overall Study|Protocol Violation|3|||
130967707|NCT00353704|471509337|FG001|Overall Study|Protocol Violation|1|||
130967708|NCT02473614|471509338|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
130967709|NCT02473614|471509339|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
130967710|NCT01154166|471509340|FG000|Overall Study|Adverse Event|14|||
130967711|NCT01154166|471509341|FG001|Overall Study|Adverse Event|9|||
130967712|NCT01154166|471509340|FG000|Overall Study|Lost to Follow-up|1|||
130967713|NCT01154166|471509341|FG001|Overall Study|Lost to Follow-up|1|||
130967714|NCT01154166|471509340|FG000|Overall Study|Protocol Violation|4|||
130967715|NCT01154166|471509341|FG001|Overall Study|Protocol Violation|1|||
130967716|NCT01154166|471509340|FG000|Overall Study|Withdrawal by Subject|10|||
130967717|NCT01154166|471509341|FG001|Overall Study|Withdrawal by Subject|1|||
130967718|NCT01154166|471509340|FG000|Overall Study|Lack of Efficacy|3|||
130967719|NCT01154166|471509341|FG001|Overall Study|Lack of Efficacy|0|||
130967720|NCT01154166|471509340|FG000|Overall Study|Disease Progression|1|||
130967721|NCT01154166|471509341|FG001|Overall Study|Disease Progression|0|||
130967722|NCT01154166|471509340|FG000|Overall Study|Poor Compliance|1|||
130967723|NCT01154166|471509341|FG001|Overall Study|Poor Compliance|0|||
130967724|NCT01375049|471509342|FG000|Overall Study|Adverse Event|2|||
130967725|NCT01375049|471509342|FG000|Overall Study|Lost to Follow-up|1|||
130716234|NCT00667810|470588793|FG000|Overall Study|Loss of Caregiver|0|||
130716235|NCT00667810|470588794|FG001|Overall Study|Loss of Caregiver|1|||
130716236|NCT00667810|470588795|FG002|Overall Study|Loss of Caregiver|3|||
130716237|NCT00667810|470588796|FG003|Overall Study|Loss of Caregiver|0|||
130716238|NCT00667810|470588793|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
130716239|NCT00667810|470588794|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
130716240|NCT00667810|470588795|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
130716241|NCT00667810|470588796|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
130967726|NCT01375049|471509342|FG000|Overall Study|Withdrawal by Subject|2|||
130967727|NCT01375049|471509342|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
130967728|NCT04121962|471509345|FG000|Overall Study|Lost to Follow-up|42|||
130967729|NCT04121962|471509346|FG001|Overall Study|Lost to Follow-up|39|||
130967730|NCT01175382|471509347|FG000|Overall Study|Lost to Follow-up|4|||
130967731|NCT01175382|471509348|FG001|Overall Study|Lost to Follow-up|3|||
130967732|NCT01175382|471509349|FG002|Overall Study|Lost to Follow-up|1|||
130967733|NCT01175382|471509347|FG000|Overall Study|Physician Decision|0|||
130967734|NCT01175382|471509348|FG001|Overall Study|Physician Decision|1|||
130967735|NCT01175382|471509349|FG002|Overall Study|Physician Decision|0|||
130967736|NCT01175382|471509347|FG000|Overall Study|Withdrawal by Subject|0|||
130967737|NCT01175382|471509348|FG001|Overall Study|Withdrawal by Subject|0|||
130967738|NCT01175382|471509349|FG002|Overall Study|Withdrawal by Subject|1|||
130967739|NCT01175382|471509347|FG000|Overall Study|No longer having problem|1|||
130967740|NCT01175382|471509348|FG001|Overall Study|No longer having problem|0|||
130967741|NCT01175382|471509349|FG002|Overall Study|No longer having problem|1|||
130967742|NCT01175382|471509347|FG000|Overall Study|Unable/unwilling to attend visits|3|||
130967743|NCT01175382|471509348|FG001|Overall Study|Unable/unwilling to attend visits|1|||
130967744|NCT01175382|471509349|FG002|Overall Study|Unable/unwilling to attend visits|2|||
130967745|NCT01175382|471509347|FG000|Overall Study|Unwilling to follow protocol|0|||
130967746|NCT01175382|471509348|FG001|Overall Study|Unwilling to follow protocol|1|||
130967747|NCT01175382|471509349|FG002|Overall Study|Unwilling to follow protocol|0|||
130967748|NCT01175382|471509347|FG000|Overall Study|Unable to tolerate study meds|0|||
130967749|NCT01175382|471509348|FG001|Overall Study|Unable to tolerate study meds|1|||
130967750|NCT01175382|471509349|FG002|Overall Study|Unable to tolerate study meds|1|||
130967751|NCT00774787|471509350|FG000|Overall Study|Lost to Follow-up|1|||
130967752|NCT02019719|471509351|FG000|Overall Study|Adverse Event|1|||
130967753|NCT02019719|471509352|FG001|Overall Study|Adverse Event|0|||
130967754|NCT02019719|471509353|FG002|Overall Study|Adverse Event|0|||
130967755|NCT02019719|471509354|FG003|Overall Study|Adverse Event|1|||
130967756|NCT02019719|471509355|FG004|Overall Study|Adverse Event|1|||
130967757|NCT02019719|471509351|FG000|Overall Study|Protocol Violation|1|||
130967758|NCT02019719|471509352|FG001|Overall Study|Protocol Violation|1|||
130967759|NCT02019719|471509353|FG002|Overall Study|Protocol Violation|0|||
131128416|NCT01394627|472099535|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
131128417|NCT01394627|472099536|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
131128418|NCT03223428|472099539|FG000|Overall Study|No longer taking Xermelo|27|||
131128419|NCT03223428|472099539|FG000|Overall Study|Declined Consent|1|||
131128420|NCT03223428|472099539|FG000|Overall Study|Non-responders|56|||
131128421|NCT03223428|472099539|FG000|Overall Study|Withdrawal by Subject|14|||
131128422|NCT02025907|472099540|FG000|Overall Study|Lack of Efficacy|1|||
131128423|NCT02025907|472099541|FG001|Overall Study|Lack of Efficacy|0|||
131128424|NCT02025907|472099540|FG000|Overall Study|Withdrawal by Subject|15|||
131128425|NCT02025907|472099541|FG001|Overall Study|Withdrawal by Subject|8|||
131128426|NCT02025907|472099540|FG000|Overall Study|Protocol Violation|2|||
131128427|NCT02025907|472099541|FG001|Overall Study|Protocol Violation|0|||
131128428|NCT02025907|472099540|FG000|Overall Study|Physician Decision|2|||
131128429|NCT02025907|472099541|FG001|Overall Study|Physician Decision|0|||
131128430|NCT02025907|472099540|FG000|Overall Study|Lost to Follow-up|2|||
131128431|NCT02025907|472099541|FG001|Overall Study|Lost to Follow-up|2|||
131128432|NCT02025907|472099540|FG000|Overall Study|Adverse Event|3|||
131128433|NCT02025907|472099541|FG001|Overall Study|Adverse Event|1|||
131128434|NCT02025907|472099540|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
131128435|NCT02025907|472099541|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
131128436|NCT03681119|472099545|FG000|Overall Study|No specific reason|4|||
131128437|NCT03681119|472099546|FG001|Overall Study|No specific reason|0|||
131128438|NCT03681119|472099545|FG000|Overall Study|Sickness|2|||
131128439|NCT03681119|472099546|FG001|Overall Study|Sickness|0|||
131128440|NCT02980224|472099550|FG000|Overall Study|Adverse Event|4|||
131128441|NCT02980224|472099551|FG001|Overall Study|Adverse Event|1|||
131128442|NCT02980224|472099550|FG000|Overall Study|Withdrawal by Subject|0|||
130967760|NCT02019719|471509354|FG003|Overall Study|Protocol Violation|0|||
130967761|NCT02019719|471509355|FG004|Overall Study|Protocol Violation|0|||
130967762|NCT02019719|471509351|FG000|Overall Study|Protocol defined stopping criteria|2|||
130967763|NCT02019719|471509352|FG001|Overall Study|Protocol defined stopping criteria|0|||
130967764|NCT02019719|471509353|FG002|Overall Study|Protocol defined stopping criteria|0|||
130967765|NCT02019719|471509354|FG003|Overall Study|Protocol defined stopping criteria|1|||
130967766|NCT02019719|471509355|FG004|Overall Study|Protocol defined stopping criteria|1|||
130967767|NCT02019719|471509351|FG000|Overall Study|Physician Decision|2|||
130967768|NCT02019719|471509352|FG001|Overall Study|Physician Decision|0|||
130967769|NCT02019719|471509353|FG002|Overall Study|Physician Decision|0|||
130967770|NCT02019719|471509354|FG003|Overall Study|Physician Decision|0|||
130967771|NCT02019719|471509355|FG004|Overall Study|Physician Decision|0|||
130967772|NCT02731131|471509359|FG000|Overall Study|Psychiatric Disorder|0|||
130967773|NCT02731131|471509360|FG001|Overall Study|Psychiatric Disorder|1|||
131128443|NCT02980224|472099551|FG001|Overall Study|Withdrawal by Subject|2|||
131128444|NCT00563186|472099552|FG000|Overall Study|LOS<48 hours|97|||
131128445|NCT00563186|472099553|FG001|Overall Study|LOS<48 hours|74|||
131128446|NCT00563186|472099552|FG000|Overall Study|Incomplete data|1|||
131128447|NCT00563186|472099553|FG001|Overall Study|Incomplete data|1|||
131128448|NCT00879645|472099554|FG000|Overall Study|Adverse Event|1|||
131128449|NCT00879645|472099555|FG001|Overall Study|Adverse Event|0|||
131128450|NCT00879645|472099556|FG002|Overall Study|Adverse Event|0|||
131128451|NCT00879645|472099557|FG003|Overall Study|Adverse Event|0|||
131128452|NCT03631732|472099558|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
131128453|NCT03631732|472099559|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
131128454|NCT03631732|472099558|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
131128455|NCT03631732|472099559|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
131128456|NCT03631732|472099558|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
131128457|NCT03631732|472099559|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
131128458|NCT03631732|472099558|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
131128459|NCT03631732|472099559|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
131128460|NCT03631732|472099558|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
131128461|NCT03631732|472099559|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
131128462|NCT03631732|472099558|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
131128463|NCT03631732|472099559|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
131128464|NCT03631732|472099558|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
131128465|NCT03631732|472099559|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
131128466|NCT03631732|472099558|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
131128467|NCT03631732|472099559|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
131128468|NCT03631732|472099558|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
131128469|NCT03631732|472099559|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
131128470|NCT03631732|472099558|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
131128471|NCT03631732|472099559|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
131128472|NCT04288154|472099560|FG000|Overall Study|Withdrawal by Subject|9|||
131128473|NCT04288154|472099561|FG001|Overall Study|Withdrawal by Subject|9|||
131128474|NCT02873936|472099562|FG000|Overall Study|Withdrew Consent|4|||
131128475|NCT02873936|472099563|FG001|Overall Study|Withdrew Consent|11|||
131128476|NCT02873936|472099564|FG002|Overall Study|Withdrew Consent|20|||
131128477|NCT02873936|472099562|FG000|Overall Study|Investigator's Discretion|3|||
131128478|NCT02873936|472099563|FG001|Overall Study|Investigator's Discretion|5|||
131128479|NCT02873936|472099564|FG002|Overall Study|Investigator's Discretion|4|||
130967774|NCT02731131|471509359|FG000|Overall Study|Refused Therapy|0|||
130967775|NCT02731131|471509360|FG001|Overall Study|Refused Therapy|1|||
130967776|NCT02348216|471509365|FG000|Overall Study|Death|5|||
130967777|NCT02348216|471509366|FG001|Overall Study|Death|53|||
130967778|NCT02348216|471509367|FG002|Overall Study|Death|11|||
130967779|NCT02348216|471509368|FG003|Overall Study|Death|20|||
130967780|NCT02348216|471509369|FG004|Overall Study|Death|16|||
130967781|NCT02348216|471509370|FG005|Overall Study|Death|32|||
130967782|NCT02348216|471509371|FG006|Overall Study|Death|17|||
130967783|NCT02348216|471509365|FG000|Overall Study|Full consent withdrawal|0|||
130967784|NCT02348216|471509366|FG001|Overall Study|Full consent withdrawal|0|||
130967785|NCT02348216|471509367|FG002|Overall Study|Full consent withdrawal|0|||
130967786|NCT02348216|471509368|FG003|Overall Study|Full consent withdrawal|1|||
130967787|NCT02348216|471509369|FG004|Overall Study|Full consent withdrawal|3|||
130967788|NCT02348216|471509370|FG005|Overall Study|Full consent withdrawal|0|||
130967789|NCT02348216|471509371|FG006|Overall Study|Full consent withdrawal|3|||
130967790|NCT02348216|471509365|FG000|Overall Study|Lost to Follow-up|0|||
130967791|NCT02348216|471509366|FG001|Overall Study|Lost to Follow-up|5|||
130967792|NCT02348216|471509367|FG002|Overall Study|Lost to Follow-up|2|||
130967793|NCT02348216|471509368|FG003|Overall Study|Lost to Follow-up|0|||
130967794|NCT02348216|471509369|FG004|Overall Study|Lost to Follow-up|1|||
130967795|NCT02348216|471509370|FG005|Overall Study|Lost to Follow-up|1|||
130967796|NCT02348216|471509371|FG006|Overall Study|Lost to Follow-up|1|||
130967797|NCT02348216|471509365|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
130967798|NCT02348216|471509366|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
130967799|NCT02348216|471509367|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
131128480|NCT02873936|472099562|FG000|Overall Study|Adverse Event|3|||
131128481|NCT02873936|472099563|FG001|Overall Study|Adverse Event|5|||
131128482|NCT02873936|472099564|FG002|Overall Study|Adverse Event|3|||
131128483|NCT02873936|472099562|FG000|Overall Study|Protocol Violation|0|||
131128484|NCT02873936|472099563|FG001|Overall Study|Protocol Violation|1|||
131128485|NCT02873936|472099564|FG002|Overall Study|Protocol Violation|3|||
131128486|NCT02873936|472099562|FG000|Overall Study|Lost to Follow-up|1|||
131128487|NCT02873936|472099563|FG001|Overall Study|Lost to Follow-up|1|||
131128488|NCT02873936|472099564|FG002|Overall Study|Lost to Follow-up|1|||
131128489|NCT02873936|472099562|FG000|Overall Study|Non-compliance With Study Drug|1|||
130967800|NCT02348216|471509368|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
130967801|NCT02348216|471509369|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
130967802|NCT02348216|471509370|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
130967803|NCT02348216|471509371|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
130967804|NCT02348216|471509365|FG000|Overall Study|Reason not specified|2|||
130967805|NCT02348216|471509366|FG001|Overall Study|Reason not specified|19|||
130967806|NCT02348216|471509367|FG002|Overall Study|Reason not specified|11|||
130967807|NCT02348216|471509368|FG003|Overall Study|Reason not specified|17|||
130967808|NCT02348216|471509369|FG004|Overall Study|Reason not specified|21|||
130967809|NCT02348216|471509370|FG005|Overall Study|Reason not specified|17|||
130967810|NCT02348216|471509371|FG006|Overall Study|Reason not specified|19|||
130967811|NCT01055639|471509372|FG000|Overall Study|Adverse Event|0|||
130967812|NCT01055639|471509373|FG001|Overall Study|Adverse Event|1|||
130967813|NCT01055639|471509372|FG000|Overall Study|Lack of Efficacy|0|||
130967814|NCT01055639|471509373|FG001|Overall Study|Lack of Efficacy|1|||
130967815|NCT01055639|471509372|FG000|Overall Study|Lost to Follow-up|8|||
130967816|NCT01055639|471509373|FG001|Overall Study|Lost to Follow-up|11|||
130967817|NCT01055639|471509372|FG000|Overall Study|Protocol Violation|5|||
130967818|NCT01055639|471509373|FG001|Overall Study|Protocol Violation|5|||
130967819|NCT01055639|471509372|FG000|Overall Study|Withdrawal by Subject|8|||
130967820|NCT01055639|471509373|FG001|Overall Study|Withdrawal by Subject|11|||
130967821|NCT00562159|471509374|FG000|Overall Study|Adverse Event|11|||
130967822|NCT00562159|471509375|FG001|Overall Study|Adverse Event|8|||
130967823|NCT00562159|471509374|FG000|Overall Study|Lost to Follow-up|5|||
130967824|NCT00562159|471509375|FG001|Overall Study|Lost to Follow-up|4|||
130967825|NCT00562159|471509374|FG000|Overall Study|Withdrawal by Subject|9|||
130967826|NCT00562159|471509375|FG001|Overall Study|Withdrawal by Subject|8|||
130967827|NCT00562159|471509374|FG000|Overall Study|Protocol Violation|12|||
130967828|NCT00562159|471509375|FG001|Overall Study|Protocol Violation|12|||
130967829|NCT00562159|471509374|FG000|Overall Study|Did not meet protocol eligibility|1|||
130967830|NCT00562159|471509375|FG001|Overall Study|Did not meet protocol eligibility|1|||
130967831|NCT00765245|471509376|FG000|Overall Study|disease progression|3|||
130967832|NCT00765245|471509377|FG001|Overall Study|disease progression|2|||
130967833|NCT00765245|471509376|FG000|Overall Study|Withdrawal by Subject|3|||
130967834|NCT00765245|471509377|FG001|Overall Study|Withdrawal by Subject|0|||
130967835|NCT00765245|471509376|FG000|Overall Study|Adverse Event|5|||
130967836|NCT00765245|471509377|FG001|Overall Study|Adverse Event|0|||
130967837|NCT00765245|471509376|FG000|Overall Study|Physician Decision|1|||
130967838|NCT00765245|471509377|FG001|Overall Study|Physician Decision|0|||
130967839|NCT00765245|471509376|FG000|Overall Study|Death|1|||
130967840|NCT00765245|471509377|FG001|Overall Study|Death|0|||
130967841|NCT01181921|471509381|FG000|Overall Study|Lost to Follow-up|1|||
130967842|NCT02162810|471509382|FG000|Overall Study|Protocol Violation|1|||
130967843|NCT02162810|471509383|FG001|Overall Study|Protocol Violation|0|||
130967844|NCT02162810|471509382|FG000|Overall Study|patients did not report compliance|4|||
131128490|NCT02873936|472099563|FG001|Overall Study|Non-compliance With Study Drug|0|||
131128491|NCT02873936|472099564|FG002|Overall Study|Non-compliance With Study Drug|1|||
131128492|NCT02873936|472099562|FG000|Overall Study|Randomized but not Dosed|1|||
131128493|NCT02873936|472099563|FG001|Overall Study|Randomized but not Dosed|0|||
131128494|NCT02873936|472099564|FG002|Overall Study|Randomized but not Dosed|0|||
131128495|NCT02943564|472099565|FG000|Overall Study|Miscellaneous Reasons|0|||
131128496|NCT02943564|472099566|FG001|Overall Study|Miscellaneous Reasons|0|||
131128497|NCT02943564|472099567|FG002|Overall Study|Miscellaneous Reasons|3|||
131128498|NCT02943564|472099565|FG000|Overall Study|Site terminated by sponsor|0|||
131128499|NCT02943564|472099566|FG001|Overall Study|Site terminated by sponsor|1|||
131128500|NCT02943564|472099567|FG002|Overall Study|Site terminated by sponsor|0|||
131128501|NCT02943564|472099565|FG000|Overall Study|Non-compliance with study drug|0|||
131128502|NCT02943564|472099566|FG001|Overall Study|Non-compliance with study drug|1|||
131128503|NCT02943564|472099567|FG002|Overall Study|Non-compliance with study drug|0|||
131128504|NCT02943564|472099565|FG000|Overall Study|Pregnancy|0|||
131128505|NCT02943564|472099566|FG001|Overall Study|Pregnancy|1|||
130716242|NCT00667810|470588793|FG000|Overall Study|Other|6|||
130716243|NCT00667810|470588794|FG001|Overall Study|Other|6|||
130967845|NCT02162810|471509383|FG001|Overall Study|patients did not report compliance|1|||
130716244|NCT00667810|470588795|FG002|Overall Study|Other|5|||
130967846|NCT02519504|471509388|FG000|Overall Study|Protocol Violation|6|||
130967847|NCT02519504|471509389|FG001|Overall Study|Protocol Violation|5|||
130716245|NCT00667810|470588796|FG003|Overall Study|Other|0|||
130967848|NCT02519504|471509388|FG000|Overall Study|Ineligible for direct testing|12|||
130967849|NCT02519504|471509389|FG001|Overall Study|Ineligible for direct testing|12|||
130716246|NCT00505375|470588799|FG000|Overall Study|Death|1|||
130967850|NCT02519504|471509388|FG000|Overall Study|Did not participate in direct testing|95|||
130967851|NCT02519504|471509389|FG001|Overall Study|Did not participate in direct testing|86|||
130967852|NCT02546544|471509390|FG000|Overall Study|Disease Progression|14|||
130967853|NCT02546544|471509390|FG000|Overall Study|Adverse Event|1|||
130967854|NCT02546544|471509390|FG000|Overall Study|Withdrawal by Subject|1|||
130967855|NCT02223390|471509391|FG000|Overall Study|Lost to Follow-up|9|||
130967856|NCT02223390|471509392|FG001|Overall Study|Lost to Follow-up|4|||
130967857|NCT02548962|471509394|FG000|Overall Study|Withdrawal by Subject|1|||
131128506|NCT02943564|472099567|FG002|Overall Study|Pregnancy|1|||
130967858|NCT02548962|471509395|FG001|Overall Study|Withdrawal by Subject|0|||
130967859|NCT00736996|471509399|FG000|Overall Study|Lost to Follow-up|1|||
130967860|NCT00736996|471509400|FG001|Overall Study|Lost to Follow-up|9|||
130967861|NCT00736996|471509401|FG002|Overall Study|Lost to Follow-up|2|||
130967862|NCT01131312|471509402|FG000|Overall Study|Lost to Follow-up|425|||
130967863|NCT01131312|471509403|FG001|Overall Study|Lost to Follow-up|229|||
130967864|NCT01131312|471509404|FG002|Overall Study|Lost to Follow-up|351|||
130967865|NCT03447769|471509405|FG000|Overall Study|Progressive disease|138|||
130967866|NCT03447769|471509406|FG001|Overall Study|Progressive disease|148|||
130967867|NCT03447769|471509405|FG000|Overall Study|Study terminated by Sponsor|60|||
130967868|NCT03447769|471509406|FG001|Overall Study|Study terminated by Sponsor|44|||
130967869|NCT03447769|471509405|FG000|Overall Study|Adverse Event|34|||
130967870|NCT03447769|471509406|FG001|Overall Study|Adverse Event|31|||
130967871|NCT03447769|471509405|FG000|Overall Study|Patient decision|27|||
130967872|NCT03447769|471509406|FG001|Overall Study|Patient decision|27|||
130967873|NCT03447769|471509405|FG000|Overall Study|Protocol deviation|4|||
130967874|NCT03447769|471509406|FG001|Overall Study|Protocol deviation|6|||
130967875|NCT03447769|471509405|FG000|Overall Study|Death|2|||
130967876|NCT03447769|471509406|FG001|Overall Study|Death|7|||
130967877|NCT03447769|471509405|FG000|Overall Study|Technical problems|1|||
130967878|NCT03447769|471509406|FG001|Overall Study|Technical problems|0|||
130967879|NCT03447769|471509405|FG000|Overall Study|Lost to Follow-up|0|||
130967880|NCT03447769|471509406|FG001|Overall Study|Lost to Follow-up|1|||
130967881|NCT03447769|471509405|FG000|Overall Study|Physician Decision|13|||
130967882|NCT03447769|471509406|FG001|Overall Study|Physician Decision|5|||
130967883|NCT01255358|471509407|FG000|Overall Study|Adverse Event|2|||
130967884|NCT01255358|471509407|FG000|Overall Study|Protocol Violation|2|||
130967885|NCT01343407|471509408|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
130967886|NCT01343407|471509409|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
130967887|NCT01343407|471509410|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
130967888|NCT01343407|471509411|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
130967889|NCT01343407|471509412|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
130967890|NCT01343407|471509413|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
130967891|NCT01343407|471509408|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
130967892|NCT01343407|471509409|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
130967893|NCT01343407|471509410|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
130967894|NCT01343407|471509411|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
131128507|NCT02943564|472099565|FG000|Overall Study|Protocol Violation|2|||
131128508|NCT02943564|472099566|FG001|Overall Study|Protocol Violation|2|||
131128509|NCT02943564|472099567|FG002|Overall Study|Protocol Violation|2|||
131128510|NCT02943564|472099565|FG000|Overall Study|Lost to Follow-up|1|||
131128511|NCT02943564|472099566|FG001|Overall Study|Lost to Follow-up|0|||
131128512|NCT02943564|472099567|FG002|Overall Study|Lost to Follow-up|0|||
131128513|NCT02943564|472099565|FG000|Overall Study|Withdrawal by Subject|6|||
131128514|NCT02943564|472099566|FG001|Overall Study|Withdrawal by Subject|5|||
131128515|NCT02943564|472099567|FG002|Overall Study|Withdrawal by Subject|2|||
131128516|NCT02943564|472099565|FG000|Overall Study|Adverse Event|1|||
131128517|NCT02943564|472099566|FG001|Overall Study|Adverse Event|2|||
131128518|NCT02943564|472099567|FG002|Overall Study|Adverse Event|1|||
131128519|NCT02943564|472099565|FG000|Overall Study|Lack of Efficacy|0|||
131128520|NCT02943564|472099566|FG001|Overall Study|Lack of Efficacy|1|||
131128521|NCT02943564|472099567|FG002|Overall Study|Lack of Efficacy|0|||
131128522|NCT01225731|472099571|FG000|Part 1|Did not meet eligibility criteria|1|||
131128523|NCT01225731|472099572|FG001|Part 1|Did not meet eligibility criteria|0|||
131128524|NCT01225731|472099573|FG002|Part 1|Did not meet eligibility criteria|0|||
131128525|NCT01225731|472099574|FG003|Part 1|Did not meet eligibility criteria|0|||
131128526|NCT01225731|472099575|FG004|Part 1|Did not meet eligibility criteria|1|||
131128527|NCT01225731|472099576|FG005|Part 1|Did not meet eligibility criteria|0|||
131128528|NCT01225731|472099577|FG006|Part 1|Did not meet eligibility criteria|0|||
131128529|NCT01225731|472099578|FG007|Part 1|Did not meet eligibility criteria|0|||
131128530|NCT01225731|472099579|FG008|Part 1|Did not meet eligibility criteria|0|||
131128531|NCT01225731|472099580|FG009|Part 1|Did not meet eligibility criteria|0|||
131128532|NCT01225731|472099581|FG010|Part 1|Did not meet eligibility criteria|0|||
131128533|NCT01225731|472099582|FG011|Part 1|Did not meet eligibility criteria|0|||
131128534|NCT01225731|472099583|FG012|Part 1|Did not meet eligibility criteria|0|||
131128535|NCT01225731|472099571|FG000|Part 1|Adverse Event|1|||
131128536|NCT01225731|472099572|FG001|Part 1|Adverse Event|2|||
131128537|NCT01225731|472099573|FG002|Part 1|Adverse Event|1|||
131128538|NCT01225731|472099574|FG003|Part 1|Adverse Event|1|||
131227081|NCT02114931|472457762|FG001|Overall Study|Other|1|||
130967895|NCT01343407|471509412|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
130967896|NCT01343407|471509413|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
130967897|NCT03950739|471509414|FG000|Treatment Phase|Adverse Event|2|||
130967898|NCT03950739|471509414|FG000|Optional Extension Phase|Death|1|||
130967899|NCT03950739|471509414|FG000|Optional Extension Phase|Progressive Disease|5|||
130967900|NCT03950739|471509414|FG000|Optional Extension Phase|Adverse Event|7|||
130967901|NCT03950739|471509414|FG000|Optional Extension Phase|Lost to Follow-up|2|||
131128539|NCT01225731|472099575|FG004|Part 1|Adverse Event|1|||
131227082|NCT03565211|472457764|FG000|Overall Study|Withdrawal by Subject|2|||
131227083|NCT03565211|472457764|FG000|Overall Study|Lost to Follow-up|1|||
131227084|NCT03565211|472457764|FG000|Overall Study|Adverse Event|44|||
131227085|NCT03565211|472457764|FG000|Overall Study|Personal issues|1|||
131227086|NCT01894984|472457768|FG000|Overall Study|Other|314|||
131227087|NCT01894984|472457769|FG001|Overall Study|Other|175|||
131227088|NCT00033631|472457774|FG000|Overall Study|Protocol Violation|14|||
131227089|NCT00033631|472457775|FG001|Overall Study|Protocol Violation|11|||
131227090|NCT00033631|472457774|FG000|Overall Study|Withdrawal by Subject|4|||
131227091|NCT00033631|472457775|FG001|Overall Study|Withdrawal by Subject|4|||
131227092|NCT01827371|472457777|FG000|Overall Study|Adverse Event|0|||
131227093|NCT01827371|472457778|FG001|Overall Study|Adverse Event|0|||
131227094|NCT01827371|472457779|FG002|Overall Study|Adverse Event|4|||
130716247|NCT00505375|470588800|FG001|Overall Study|Death|0|||
130716248|NCT00505375|470588799|FG000|Overall Study|Withdrawal by Subject|2|||
130716249|NCT00505375|470588800|FG001|Overall Study|Withdrawal by Subject|2|||
130716250|NCT00505375|470588799|FG000|Overall Study|Lost to Follow-up|0|||
130716251|NCT00505375|470588800|FG001|Overall Study|Lost to Follow-up|2|||
130716252|NCT00505375|470588799|FG000|Overall Study|Pregnancy|1|||
130716253|NCT00505375|470588800|FG001|Overall Study|Pregnancy|0|||
130716254|NCT00505375|470588799|FG000|Overall Study|Travel issues|0|||
130716255|NCT00505375|470588800|FG001|Overall Study|Travel issues|1|||
130716256|NCT01561430|470588803|FG000|Overall Study|Adverse Event|0|||
130716257|NCT01561430|470588804|FG001|Overall Study|Adverse Event|0|||
130716258|NCT01561430|470588805|FG002|Overall Study|Adverse Event|3|||
130716259|NCT01561430|470588806|FG003|Overall Study|Adverse Event|1|||
130716260|NCT01561430|470588803|FG000|Overall Study|Withdrawal by Subject|0|||
130716261|NCT01561430|470588804|FG001|Overall Study|Withdrawal by Subject|0|||
130716262|NCT01561430|470588805|FG002|Overall Study|Withdrawal by Subject|1|||
130716263|NCT01561430|470588806|FG003|Overall Study|Withdrawal by Subject|0|||
130716264|NCT01561430|470588803|FG000|Overall Study|Physician Decision|0|||
130716265|NCT01561430|470588804|FG001|Overall Study|Physician Decision|1|||
130716266|NCT01561430|470588805|FG002|Overall Study|Physician Decision|0|||
130716267|NCT01561430|470588806|FG003|Overall Study|Physician Decision|0|||
130716268|NCT01561430|470588803|FG000|Overall Study|Sponsor Decision|1|||
130716269|NCT01561430|470588804|FG001|Overall Study|Sponsor Decision|14|||
130716270|NCT01561430|470588805|FG002|Overall Study|Sponsor Decision|13|||
130775701|NCT01677182|470806544|FG001|Overall Study|Other reasons|5|||
130967902|NCT03950739|471509414|FG000|Optional Extension Phase|Site Closure|2|||
130967903|NCT03950739|471509414|FG000|Optional Extension Phase|Pregnancy|1|||
130967904|NCT00797667|471509417|FG000|Overall Study|Lack of Efficacy|0|||
130967905|NCT00797667|471509418|FG001|Overall Study|Lack of Efficacy|1|||
130967906|NCT00797667|471509419|FG002|Overall Study|Lack of Efficacy|0|||
130967907|NCT00797667|471509417|FG000|Overall Study|Lost to Follow-up|8|||
130967908|NCT00797667|471509418|FG001|Overall Study|Lost to Follow-up|12|||
130967909|NCT00797667|471509419|FG002|Overall Study|Lost to Follow-up|2|||
130967910|NCT00797667|471509417|FG000|Overall Study|Physician Decision|3|||
130967911|NCT00797667|471509418|FG001|Overall Study|Physician Decision|1|||
130967912|NCT00797667|471509419|FG002|Overall Study|Physician Decision|0|||
130967913|NCT00797667|471509417|FG000|Overall Study|Pregnancy|2|||
130967914|NCT00797667|471509418|FG001|Overall Study|Pregnancy|0|||
130967915|NCT00797667|471509419|FG002|Overall Study|Pregnancy|0|||
130967916|NCT00797667|471509417|FG000|Overall Study|Protocol Violation|2|||
130967917|NCT00797667|471509418|FG001|Overall Study|Protocol Violation|7|||
130967918|NCT00797667|471509419|FG002|Overall Study|Protocol Violation|0|||
130967919|NCT00797667|471509417|FG000|Overall Study|Study Terminated by Sponsor|217|||
130967920|NCT00797667|471509418|FG001|Overall Study|Study Terminated by Sponsor|216|||
130967921|NCT00797667|471509419|FG002|Overall Study|Study Terminated by Sponsor|115|||
130967922|NCT00797667|471509417|FG000|Overall Study|Withdrawal by Subject|9|||
130967923|NCT00797667|471509418|FG001|Overall Study|Withdrawal by Subject|14|||
130967924|NCT00797667|471509419|FG002|Overall Study|Withdrawal by Subject|2|||
130967925|NCT00797667|471509417|FG000|Overall Study|Adverse Event|19|||
130967926|NCT00797667|471509418|FG001|Overall Study|Adverse Event|8|||
130967927|NCT00797667|471509419|FG002|Overall Study|Adverse Event|8|||
130967928|NCT01986829|471509420|FG000|Overall Study|Death|1|||
130967929|NCT02504866|471509421|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
131227095|NCT01827371|472457780|FG003|Overall Study|Adverse Event|2|||
131227096|NCT01827371|472457777|FG000|Overall Study|Lost to Follow-up|0|||
131227097|NCT01827371|472457778|FG001|Overall Study|Lost to Follow-up|2|||
130716271|NCT01561430|470588806|FG003|Overall Study|Sponsor Decision|12|||
130716272|NCT03709823|470588807|FG000|Overall Study|Adverse Event|0|||
130716273|NCT03709823|470588808|FG001|Overall Study|Adverse Event|0|||
130967930|NCT02504866|471509422|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
130967931|NCT02504866|471509423|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
130967932|NCT00781326|471509426|FG000|Phase I|Adverse Event|1|||
130967933|NCT00781326|471509426|FG000|Phase I|Withdrawal by Subject|1|||
130967934|NCT00781326|471509426|FG000|Phase I|Physician Decision|2|||
130967935|NCT00096941|471509427|FG000|Overall Study|disease progression|3|||
130967936|NCT01343056|471509428|FG000|Overall Study|Lost to Follow-up|7|||
131227098|NCT01827371|472457779|FG002|Overall Study|Lost to Follow-up|0|||
130967937|NCT01343056|471509429|FG001|Overall Study|Lost to Follow-up|5|||
130967938|NCT01343056|471509430|FG002|Overall Study|Lost to Follow-up|3|||
130967939|NCT01343056|471509431|FG003|Overall Study|Lost to Follow-up|9|||
130967940|NCT03231371|471509432|FG000|Overall Study|Withdrawal by Subject|1|||
130967941|NCT03231371|471509432|FG000|Overall Study|chose or were ineligible to have MRI|12|||
130967942|NCT01669343|471509436|FG000|Part A: All Patients|Withdrawal by Subject|7|||
130967943|NCT01669343|471509436|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
130967944|NCT01669343|471509436|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
130967945|NCT01669343|471509436|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
130967946|NCT01669343|471509436|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
130967947|NCT02371369|471509437|FG000|Part 1|Physician Decision|0|||
130967948|NCT02371369|471509438|FG001|Part 1|Physician Decision|3|||
130967949|NCT02371369|471509437|FG000|Part 1|Adverse Event|8|||
130967950|NCT02371369|471509438|FG001|Part 1|Adverse Event|0|||
130967951|NCT02371369|471509437|FG000|Part 1|Withdrawal by Subject|1|||
130967952|NCT02371369|471509438|FG001|Part 1|Withdrawal by Subject|6|||
130967953|NCT02371369|471509437|FG000|Part 1|Disease progression|0|||
130967954|NCT02371369|471509438|FG001|Part 1|Disease progression|1|||
130967955|NCT02371369|471509437|FG000|Part 1|Protocol Violation|0|||
130967956|NCT02371369|471509438|FG001|Part 1|Protocol Violation|1|||
130967957|NCT02371369|471509437|FG000|Part 2|Adverse Event|6|||
130967958|NCT02371369|471509438|FG001|Part 2|Adverse Event|5|||
130967959|NCT02371369|471509437|FG000|Part 2|Withdrawal by Subject|16|||
130967960|NCT02371369|471509438|FG001|Part 2|Withdrawal by Subject|6|||
130967961|NCT02371369|471509437|FG000|Part 2|Investigator decision|1|||
130967962|NCT02371369|471509438|FG001|Part 2|Investigator decision|2|||
130967963|NCT02371369|471509437|FG000|Part 2|Death|0|||
130967964|NCT02371369|471509438|FG001|Part 2|Death|1|||
130967965|NCT02371369|471509437|FG000|Part 2|Disease progression|1|||
130967966|NCT02371369|471509438|FG001|Part 2|Disease progression|0|||
130967967|NCT02371369|471509437|FG000|Part 2|Subject Noncompliance|1|||
130967968|NCT02371369|471509438|FG001|Part 2|Subject Noncompliance|0|||
130967969|NCT02371369|471509437|FG000|Part 2|Lost to Follow-up|1|||
130967970|NCT02371369|471509438|FG001|Part 2|Lost to Follow-up|1|||
130967971|NCT02371369|471509437|FG000|Part 2|Subject transitioned to commercial supply|6|||
130967972|NCT02371369|471509438|FG001|Part 2|Subject transitioned to commercial supply|4|||
130967973|NCT02371369|471509437|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
130967974|NCT02371369|471509438|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
130967975|NCT02371369|471509437|FG000|Part 2|Surgical resection of tumor|1|||
130967976|NCT02371369|471509438|FG001|Part 2|Surgical resection of tumor|1|||
130967977|NCT02371369|471509437|FG000|Part 2|Other|0|||
130967978|NCT02371369|471509438|FG001|Part 2|Other|1|||
130967979|NCT00439777|471509442|FG000|Treatment Period|Death|29|||
130967980|NCT00439777|471509443|FG001|Treatment Period|Death|21|||
130967981|NCT00439777|471509442|FG000|Treatment Period|Study terminated by sponsor|125|||
130967982|NCT00439777|471509443|FG001|Treatment Period|Study terminated by sponsor|132|||
130967983|NCT00439777|471509442|FG000|Treatment Period|Site closed by investigator|0|||
130967984|NCT00439777|471509443|FG001|Treatment Period|Site closed by investigator|1|||
130967985|NCT00439777|471509442|FG000|Treatment Period|Did not take study treatment|7|||
130967986|NCT00439777|471509443|FG001|Treatment Period|Did not take study treatment|8|||
130967987|NCT00439777|471509442|FG000|Treatment Period|Adverse Event|111|||
131128540|NCT01225731|472099576|FG005|Part 1|Adverse Event|0|||
131128541|NCT01225731|472099577|FG006|Part 1|Adverse Event|0|||
131128542|NCT01225731|472099578|FG007|Part 1|Adverse Event|0|||
131128543|NCT01225731|472099579|FG008|Part 1|Adverse Event|0|||
131128544|NCT01225731|472099580|FG009|Part 1|Adverse Event|0|||
131128545|NCT01225731|472099581|FG010|Part 1|Adverse Event|0|||
131128546|NCT01225731|472099582|FG011|Part 1|Adverse Event|0|||
131128547|NCT01225731|472099583|FG012|Part 1|Adverse Event|0|||
131128548|NCT01225731|472099571|FG000|Part 1|Withdrawal by Subject|0|||
131128549|NCT01225731|472099572|FG001|Part 1|Withdrawal by Subject|3|||
131128550|NCT01225731|472099573|FG002|Part 1|Withdrawal by Subject|0|||
131128551|NCT01225731|472099574|FG003|Part 1|Withdrawal by Subject|0|||
131128552|NCT01225731|472099575|FG004|Part 1|Withdrawal by Subject|4|||
131227099|NCT01827371|472457780|FG003|Overall Study|Lost to Follow-up|4|||
131227100|NCT01827371|472457777|FG000|Overall Study|Protocol Violation|1|||
130967988|NCT00439777|471509443|FG001|Treatment Period|Adverse Event|92|||
130967989|NCT00439777|471509442|FG000|Treatment Period|Protocol Violation|23|||
130967990|NCT00439777|471509443|FG001|Treatment Period|Protocol Violation|30|||
130967991|NCT00439777|471509442|FG000|Treatment Period|Withdrawal by Subject|66|||
130967992|NCT00439777|471509443|FG001|Treatment Period|Withdrawal by Subject|118|||
130967993|NCT00439777|471509442|FG000|Treatment Period|Lack of Efficacy|1|||
130967994|NCT00439777|471509443|FG001|Treatment Period|Lack of Efficacy|4|||
130967995|NCT00439777|471509442|FG000|Treatment Period|Lost to Follow-up|8|||
130967996|NCT00439777|471509443|FG001|Treatment Period|Lost to Follow-up|10|||
130967997|NCT00439777|471509442|FG000|Treatment Period|Protocol driven decision point|1|||
130967998|NCT00439777|471509443|FG001|Treatment Period|Protocol driven decision point|3|||
131128553|NCT01225731|472099576|FG005|Part 1|Withdrawal by Subject|0|||
131227101|NCT01827371|472457778|FG001|Overall Study|Protocol Violation|0|||
130967999|NCT00439777|471509442|FG000|Treatment Period|Physician Decision|7|||
130968000|NCT00439777|471509443|FG001|Treatment Period|Physician Decision|18|||
130968001|NCT00439777|471509442|FG000|Treatment Period|Clinical endpoint reached|26|||
130968002|NCT00439777|471509443|FG001|Treatment Period|Clinical endpoint reached|13|||
130968003|NCT00439777|471509442|FG000|Treatment Period|Technical problems|3|||
130968004|NCT00439777|471509443|FG001|Treatment Period|Technical problems|1|||
130968005|NCT00439777|471509442|FG000|Treatment Period|Participant convenience|12|||
130968006|NCT00439777|471509443|FG001|Treatment Period|Participant convenience|8|||
130968007|NCT00439777|471509442|FG000|Observational Period|Protocol Violation|0|||
130968008|NCT00439777|471509443|FG001|Observational Period|Protocol Violation|2|||
130968009|NCT00439777|471509442|FG000|Observational Period|Withdrawal by Subject|9|||
130968010|NCT00439777|471509443|FG001|Observational Period|Withdrawal by Subject|5|||
130968011|NCT00439777|471509442|FG000|Observational Period|Lost to Follow-up|1|||
130968012|NCT00439777|471509443|FG001|Observational Period|Lost to Follow-up|11|||
130968013|NCT00439777|471509442|FG000|Observational Period|Death|27|||
130968014|NCT00439777|471509443|FG001|Observational Period|Death|20|||
130968015|NCT00439777|471509442|FG000|Observational Period|Study terminated by sponsor|3|||
130968016|NCT00439777|471509443|FG001|Observational Period|Study terminated by sponsor|1|||
130968017|NCT00439777|471509442|FG000|Observational Period|Protocol driven decision point|0|||
130968018|NCT00439777|471509443|FG001|Observational Period|Protocol driven decision point|1|||
130968019|NCT00439777|471509442|FG000|Observational Period|Lack of Efficacy|1|||
130968020|NCT00439777|471509443|FG001|Observational Period|Lack of Efficacy|0|||
130968021|NCT00439777|471509442|FG000|Observational Period|Technical problems|0|||
130968022|NCT00439777|471509443|FG001|Observational Period|Technical problems|1|||
130968023|NCT01024387|471509444|FG000|Overall Study|Radiographic Progression|29|||
130968024|NCT01024387|471509444|FG000|Overall Study|Symptomatic Progression|10|||
130968025|NCT01024387|471509444|FG000|Overall Study|Physician Decision|5|||
130968026|NCT01024387|471509444|FG000|Overall Study|Withdrawal by Subject|5|||
130968027|NCT01024387|471509444|FG000|Overall Study|Death|2|||
130968028|NCT01024387|471509444|FG000|Overall Study|Prolonged Treatment Delay|1|||
130968029|NCT01024387|471509444|FG000|Overall Study|Adverse Event|3|||
130968030|NCT01024387|471509444|FG000|Overall Study|Other|5|||
130968031|NCT01143259|471509445|FG000|Overall Study|Withdrawal by Subject|3|||
130968032|NCT01143259|471509446|FG001|Overall Study|Withdrawal by Subject|2|||
130968033|NCT01143259|471509445|FG000|Overall Study|Protocol Violation|13|||
130968034|NCT01143259|471509446|FG001|Overall Study|Protocol Violation|9|||
130968035|NCT01143259|471509445|FG000|Overall Study|Screen Failure|7|||
130968036|NCT01143259|471509446|FG001|Overall Study|Screen Failure|9|||
130968037|NCT02641080|471509447|FG000|Overall Study|Physician Decision|2|||
130968038|NCT02641080|471509448|FG001|Overall Study|Physician Decision|0|||
130968039|NCT02641080|471509447|FG000|Overall Study|Withdrawal by Subject|0|||
130968040|NCT02641080|471509448|FG001|Overall Study|Withdrawal by Subject|1|||
130968041|NCT02641080|471509447|FG000|Overall Study|Rehab Center denied use of pumps|0|||
130968042|NCT02641080|471509448|FG001|Overall Study|Rehab Center denied use of pumps|3|||
130968043|NCT02641080|471509447|FG000|Overall Study|Lost to Follow-up|0|||
130968044|NCT02641080|471509448|FG001|Overall Study|Lost to Follow-up|3|||
130968045|NCT03864900|471509455|FG000|Overall Study|Withdrawal by Subject|1|||
130968046|NCT03864900|471509456|FG001|Overall Study|Withdrawal by Subject|1|||
130968047|NCT03864900|471509455|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
130968048|NCT03864900|471509456|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
130968049|NCT03165045|471509458|FG000|Visit 1|No registration after visit 1|9|||
131042109|NCT03519178|471789331|FG009|PF-06873600 Treatment|Refused further treatment|0|||
130968050|NCT03165045|471509458|FG000|Visit 1|No treatment documented|10|||
130968051|NCT03165045|471509458|FG000|Visit 1|No visit 1|10|||
130968052|NCT03165045|471509458|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
130968053|NCT03165045|471509458|FG000|Visit 2|No available total CCQ score at all|29|||
130968054|NCT03165045|471509458|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
130968055|NCT00759109|471509459|FG000|Overall Study|Adverse Event|17|||
130968056|NCT00759109|471509460|FG001|Overall Study|Adverse Event|12|||
130968057|NCT00759109|471509459|FG000|Overall Study|Inability to comply|1|||
130968058|NCT00759109|471509460|FG001|Overall Study|Inability to comply|1|||
130968059|NCT00759109|471509459|FG000|Overall Study|Withdrawal by Subject|9|||
130968060|NCT00759109|471509460|FG001|Overall Study|Withdrawal by Subject|5|||
130968061|NCT00759109|471509459|FG000|Overall Study|Death|4|||
130968062|NCT00759109|471509460|FG001|Overall Study|Death|3|||
130968063|NCT00759109|471509459|FG000|Overall Study|Lost to Follow-up|4|||
130968064|NCT00759109|471509460|FG001|Overall Study|Lost to Follow-up|6|||
130968065|NCT00759109|471509459|FG000|Overall Study|Started new therapy|2|||
130968066|NCT00759109|471509460|FG001|Overall Study|Started new therapy|6|||
130968067|NCT00759109|471509459|FG000|Overall Study|HCV RNA negative|1|||
130968068|NCT00759109|471509460|FG001|Overall Study|HCV RNA negative|0|||
130968069|NCT00759109|471509459|FG000|Overall Study|Participant moved to a different city|0|||
130968070|NCT00759109|471509460|FG001|Overall Study|Participant moved to a different city|1|||
130968071|NCT00759109|471509459|FG000|Overall Study|Participant had a liver transplant|0|||
131042110|NCT03519178|471789332|FG010|PF-06873600 Treatment|Refused further treatment|0|||
130968072|NCT00759109|471509460|FG001|Overall Study|Participant had a liver transplant|1|||
130968073|NCT00759109|471509459|FG000|Overall Study|Lost during study|1|||
130968074|NCT00759109|471509460|FG001|Overall Study|Lost during study|0|||
130968075|NCT03191903|471509464|FG000|Overall Study|Withdrawal by Subject|6|||
130968076|NCT03191903|471509465|FG001|Overall Study|Withdrawal by Subject|5|||
130968077|NCT03191903|471509466|FG002|Overall Study|Withdrawal by Subject|4|||
130968078|NCT03191903|471509464|FG000|Overall Study|Adverse Event|1|||
130968079|NCT03191903|471509465|FG001|Overall Study|Adverse Event|0|||
130968080|NCT03191903|471509466|FG002|Overall Study|Adverse Event|0|||
130968081|NCT00503685|471509470|FG000|Overall Study|Adverse Event|0|||
130968082|NCT00503685|471509471|FG001|Overall Study|Adverse Event|0|||
130968083|NCT00503685|471509472|FG002|Overall Study|Adverse Event|2|||
130968084|NCT00503685|471509470|FG000|Overall Study|Withdrawal by Subject|0|||
130968085|NCT00503685|471509471|FG001|Overall Study|Withdrawal by Subject|1|||
130968086|NCT00503685|471509472|FG002|Overall Study|Withdrawal by Subject|0|||
130968087|NCT00503685|471509470|FG000|Overall Study|Protocol Violation|0|||
130968088|NCT00503685|471509471|FG001|Overall Study|Protocol Violation|1|||
130968089|NCT00503685|471509472|FG002|Overall Study|Protocol Violation|0|||
130968090|NCT00503685|471509470|FG000|Overall Study|Eligibility Criteria Not Met|0|||
130968091|NCT00503685|471509471|FG001|Overall Study|Eligibility Criteria Not Met|1|||
130968092|NCT00503685|471509472|FG002|Overall Study|Eligibility Criteria Not Met|0|||
130968093|NCT00927927|471509473|FG000|Overall Study|Withdrawal by Subject|0|||
130968094|NCT00927927|471509474|FG001|Overall Study|Withdrawal by Subject|0|||
130968095|NCT00927927|471509475|FG002|Overall Study|Withdrawal by Subject|0|||
130968096|NCT00927927|471509476|FG003|Overall Study|Withdrawal by Subject|0|||
130968097|NCT00927927|471509477|FG004|Overall Study|Withdrawal by Subject|0|||
130968098|NCT00927927|471509478|FG005|Overall Study|Withdrawal by Subject|0|||
130968099|NCT00927927|471509479|FG006|Overall Study|Withdrawal by Subject|0|||
130968100|NCT00927927|471509480|FG007|Overall Study|Withdrawal by Subject|2|||
130968101|NCT00927927|471509481|FG008|Overall Study|Withdrawal by Subject|0|||
130968102|NCT00927927|471509482|FG009|Overall Study|Withdrawal by Subject|0|||
130968103|NCT00927927|471509483|FG010|Overall Study|Withdrawal by Subject|0|||
130968104|NCT00927927|471509484|FG011|Overall Study|Withdrawal by Subject|2|||
130968105|NCT00927927|471509485|FG012|Overall Study|Withdrawal by Subject|0|||
130968106|NCT00927927|471509486|FG013|Overall Study|Withdrawal by Subject|0|||
130968107|NCT00927927|471509487|FG014|Overall Study|Withdrawal by Subject|0|||
130968108|NCT02838017|471509490|FG000|Overall Study|Lost to Follow-up|14|||
130968109|NCT02838017|471509491|FG001|Overall Study|Lost to Follow-up|11|||
130968110|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
130968111|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
130968112|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
130968113|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
130968114|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
130968115|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
130968116|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
130968117|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
130968118|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
130968119|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
130968120|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
130968121|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
130968122|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
130968123|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
130968124|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
130968125|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
130968126|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
131042111|NCT03519178|471789333|FG011|PF-06873600 Treatment|Refused further treatment|0|||
131042112|NCT03519178|471789334|FG012|PF-06873600 Treatment|Refused further treatment|0|||
131042113|NCT03519178|471789335|FG013|PF-06873600 Treatment|Refused further treatment|0|||
131042114|NCT03519178|471789336|FG014|PF-06873600 Treatment|Refused further treatment|1|||
131042115|NCT03519178|471789322|FG000|PF-06873600 Treatment|Other|0|||
131042116|NCT03519178|471789323|FG001|PF-06873600 Treatment|Other|0|||
131042117|NCT03519178|471789324|FG002|PF-06873600 Treatment|Other|0|||
131042118|NCT03519178|471789325|FG003|PF-06873600 Treatment|Other|0|||
131042119|NCT03519178|471789326|FG004|PF-06873600 Treatment|Other|0|||
131042120|NCT03519178|471789327|FG005|PF-06873600 Treatment|Other|0|||
131042121|NCT03519178|471789328|FG006|PF-06873600 Treatment|Other|0|||
131042122|NCT03519178|471789329|FG007|PF-06873600 Treatment|Other|0|||
130968127|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
130968128|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
131042123|NCT03519178|471789330|FG008|PF-06873600 Treatment|Other|1|||
131042124|NCT03519178|471789331|FG009|PF-06873600 Treatment|Other|0|||
131042125|NCT03519178|471789332|FG010|PF-06873600 Treatment|Other|0|||
131128554|NCT01225731|472099577|FG006|Part 1|Withdrawal by Subject|0|||
131128555|NCT01225731|472099578|FG007|Part 1|Withdrawal by Subject|0|||
130968129|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
130968130|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
130968131|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
130968132|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
130968133|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
130968134|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
130968135|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
130968136|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
130968137|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
130968138|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
130968139|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
130968140|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
130968141|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
130968142|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
130968143|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
130968144|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
130968145|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
130968146|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
130968147|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
130968148|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
130968149|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
130968150|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
130968151|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
130968152|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
130968153|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
130968154|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
130968155|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
130968156|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
130968157|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
130968158|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
130968159|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
130968160|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
130968161|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
130968162|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
130968163|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
130968164|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
130968165|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
130968166|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
131042126|NCT03519178|471789333|FG011|PF-06873600 Treatment|Other|0|||
131042127|NCT03519178|471789334|FG012|PF-06873600 Treatment|Other|0|||
131042128|NCT03519178|471789335|FG013|PF-06873600 Treatment|Other|1|||
131042129|NCT03519178|471789336|FG014|PF-06873600 Treatment|Other|3|||
131042130|NCT03519178|471789322|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
131042131|NCT03519178|471789323|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
131042132|NCT03519178|471789324|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
131042133|NCT03519178|471789325|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
131042134|NCT03519178|471789326|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
131042135|NCT03519178|471789327|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
131128556|NCT01225731|472099579|FG008|Part 1|Withdrawal by Subject|0|||
131128557|NCT01225731|472099580|FG009|Part 1|Withdrawal by Subject|0|||
131128558|NCT01225731|472099581|FG010|Part 1|Withdrawal by Subject|0|||
131128559|NCT01225731|472099582|FG011|Part 1|Withdrawal by Subject|0|||
131128560|NCT01225731|472099583|FG012|Part 1|Withdrawal by Subject|0|||
131128561|NCT01225731|472099571|FG000|Part 1|Protocol Violation|0|||
131128562|NCT01225731|472099572|FG001|Part 1|Protocol Violation|0|||
131128563|NCT01225731|472099573|FG002|Part 1|Protocol Violation|0|||
131128564|NCT01225731|472099574|FG003|Part 1|Protocol Violation|1|||
131128565|NCT01225731|472099575|FG004|Part 1|Protocol Violation|0|||
131128566|NCT01225731|472099576|FG005|Part 1|Protocol Violation|0|||
131128567|NCT01225731|472099577|FG006|Part 1|Protocol Violation|0|||
131128568|NCT01225731|472099578|FG007|Part 1|Protocol Violation|0|||
131128569|NCT01225731|472099579|FG008|Part 1|Protocol Violation|0|||
131128570|NCT01225731|472099580|FG009|Part 1|Protocol Violation|0|||
131128571|NCT01225731|472099581|FG010|Part 1|Protocol Violation|0|||
131128572|NCT01225731|472099582|FG011|Part 1|Protocol Violation|0|||
131128573|NCT01225731|472099583|FG012|Part 1|Protocol Violation|0|||
131128574|NCT01225731|472099571|FG000|Part 2|Protocol Violation|0|||
131128575|NCT01225731|472099572|FG001|Part 2|Protocol Violation|0|||
131128576|NCT01225731|472099573|FG002|Part 2|Protocol Violation|0|||
131128577|NCT01225731|472099574|FG003|Part 2|Protocol Violation|0|||
130716274|NCT03709823|470588809|FG002|Overall Study|Adverse Event|1|||
130968167|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
130968168|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
130968169|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
130968170|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
130968171|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
130968172|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
130968173|NCT01884350|471509492|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
130968174|NCT01884350|471509493|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
130968175|NCT01884350|471509494|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
130968176|NCT02345512|471509495|FG000|Overall Study|Adverse Event|1|||
130968177|NCT02345512|471509495|FG000|Overall Study|Withdrawal by Subject|1|||
130968178|NCT01968434|471509498|FG000|Overall Study|Lost to Follow-up|3|||
130968179|NCT01968434|471509499|FG001|Overall Study|Lost to Follow-up|6|||
130968180|NCT00074282|471511090|FG000|Step 1|Adverse Event|32|||
130968181|NCT00074282|471511091|FG001|Step 1|Adverse Event|0|||
130968182|NCT00074282|471511092|FG002|Step 1|Adverse Event|0|||
130968183|NCT00074282|471511090|FG000|Step 1|Death|6|||
130968184|NCT00074282|471511091|FG001|Step 1|Death|0|||
130968185|NCT00074282|471511092|FG002|Step 1|Death|0|||
130968186|NCT00074282|471511090|FG000|Step 1|Withdrawal by Subject|7|||
130968187|NCT00074282|471511091|FG001|Step 1|Withdrawal by Subject|0|||
130968188|NCT00074282|471511092|FG002|Step 1|Withdrawal by Subject|0|||
130968189|NCT00074282|471511090|FG000|Step 1|Disease progression|2|||
130968190|NCT00074282|471511091|FG001|Step 1|Disease progression|0|||
130968191|NCT00074282|471511092|FG002|Step 1|Disease progression|0|||
130968192|NCT00074282|471511090|FG000|Step 1|Alternative therapy|2|||
130968193|NCT00074282|471511091|FG001|Step 1|Alternative therapy|0|||
130968194|NCT00074282|471511092|FG002|Step 1|Alternative therapy|0|||
130968195|NCT00074282|471511090|FG000|Step 1|Other complicating disease|2|||
130968196|NCT00074282|471511091|FG001|Step 1|Other complicating disease|0|||
130968197|NCT00074282|471511092|FG002|Step 1|Other complicating disease|0|||
130968198|NCT00074282|471511090|FG000|Step 1|Physician Decision|1|||
130968199|NCT00074282|471511091|FG001|Step 1|Physician Decision|0|||
130968200|NCT00074282|471511092|FG002|Step 1|Physician Decision|0|||
130968201|NCT00074282|471511090|FG000|Step 1|Ineligible|4|||
130968202|NCT00074282|471511091|FG001|Step 1|Ineligible|0|||
130968203|NCT00074282|471511092|FG002|Step 1|Ineligible|0|||
130968204|NCT00074282|471511090|FG000|Step 1|Never started treatment|2|||
130968205|NCT00074282|471511091|FG001|Step 1|Never started treatment|0|||
130968206|NCT00074282|471511092|FG002|Step 1|Never started treatment|0|||
130968207|NCT00074282|471511090|FG000|Step 2|Adverse Event|0|||
130968208|NCT00074282|471511091|FG001|Step 2|Adverse Event|2|||
130968209|NCT00074282|471511092|FG002|Step 2|Adverse Event|12|||
130968210|NCT00074282|471511090|FG000|Step 2|Disease progression|0|||
130968211|NCT00074282|471511091|FG001|Step 2|Disease progression|0|||
130968212|NCT00074282|471511092|FG002|Step 2|Disease progression|5|||
130968213|NCT00074282|471511090|FG000|Step 2|Death|0|||
130968214|NCT00074282|471511091|FG001|Step 2|Death|0|||
130968215|NCT00074282|471511092|FG002|Step 2|Death|3|||
130968216|NCT00074282|471511090|FG000|Step 2|Withdrawal by Subject|0|||
130968217|NCT00074282|471511091|FG001|Step 2|Withdrawal by Subject|0|||
130968218|NCT00074282|471511092|FG002|Step 2|Withdrawal by Subject|2|||
130968219|NCT00074282|471511090|FG000|Step 2|Physician Decision|0|||
130968220|NCT00074282|471511091|FG001|Step 2|Physician Decision|0|||
130968221|NCT00074282|471511092|FG002|Step 2|Physician Decision|1|||
130968222|NCT00074282|471511090|FG000|Step 2|Ineligible|0|||
130968223|NCT00074282|471511091|FG001|Step 2|Ineligible|0|||
130968224|NCT00074282|471511092|FG002|Step 2|Ineligible|1|||
130716275|NCT03709823|470588810|FG003|Overall Study|Adverse Event|0|||
130968225|NCT00464542|471511093|FG000|Pre-treatment|Withdrawal by Subject|2|||
130968226|NCT02055352|471511094|FG000|Overall Study|Adverse Event|0|||
130968227|NCT02055352|471511095|FG001|Overall Study|Adverse Event|1|||
130968228|NCT02055352|471511094|FG000|Overall Study|Non-eligible|0|||
131128578|NCT01225731|472099575|FG004|Part 2|Protocol Violation|0|||
130968229|NCT02055352|471511095|FG001|Overall Study|Non-eligible|1|||
131128579|NCT01225731|472099576|FG005|Part 2|Protocol Violation|1|||
130968230|NCT02055352|471511094|FG000|Overall Study|Poor compliance|1|||
130968231|NCT02055352|471511095|FG001|Overall Study|Poor compliance|1|||
130968232|NCT02055352|471511094|FG000|Overall Study|Death|1|||
130968233|NCT02055352|471511095|FG001|Overall Study|Death|2|||
130968234|NCT02055352|471511094|FG000|Overall Study|Patient decision|1|||
130968235|NCT02055352|471511095|FG001|Overall Study|Patient decision|1|||
130968236|NCT02055352|471511094|FG000|Overall Study|Use of prohibited treatment|0|||
130968237|NCT02055352|471511095|FG001|Overall Study|Use of prohibited treatment|3|||
130716276|NCT03709823|470588811|FG004|Overall Study|Adverse Event|0|||
130968238|NCT02055352|471511094|FG000|Overall Study|AE, study drug would be detrimental|1|||
131128580|NCT01225731|472099577|FG006|Part 2|Protocol Violation|0|||
131128581|NCT01225731|472099578|FG007|Part 2|Protocol Violation|0|||
130716277|NCT03709823|470588812|FG005|Overall Study|Adverse Event|0|||
130716278|NCT03709823|470588807|FG000|Overall Study|Lost to Follow-up|2|||
131042136|NCT03519178|471789328|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
131042137|NCT03519178|471789329|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
131042138|NCT03519178|471789330|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
131042139|NCT03519178|471789331|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
131042140|NCT03519178|471789332|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
131042141|NCT03519178|471789333|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
131042142|NCT03519178|471789334|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
131042143|NCT03519178|471789335|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
131042144|NCT03519178|471789336|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
131042145|NCT03519178|471789322|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042146|NCT03519178|471789323|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042147|NCT03519178|471789324|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042148|NCT03519178|471789325|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042149|NCT03519178|471789326|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042150|NCT03519178|471789327|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042151|NCT03519178|471789328|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042152|NCT03519178|471789329|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042153|NCT03519178|471789330|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042154|NCT03519178|471789331|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042155|NCT03519178|471789332|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042156|NCT03519178|471789333|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042157|NCT03519178|471789334|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
131042158|NCT03519178|471789335|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
131042159|NCT03519178|471789336|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
131042160|NCT03519178|471789322|FG000|PF-06873600 Treatment|Ongoing|0|||
130716279|NCT03709823|470588808|FG001|Overall Study|Lost to Follow-up|2|||
130716280|NCT03709823|470588809|FG002|Overall Study|Lost to Follow-up|2|||
131042161|NCT03519178|471789323|FG001|PF-06873600 Treatment|Ongoing|0|||
131042162|NCT03519178|471789324|FG002|PF-06873600 Treatment|Ongoing|0|||
131042163|NCT03519178|471789325|FG003|PF-06873600 Treatment|Ongoing|0|||
131042164|NCT03519178|471789326|FG004|PF-06873600 Treatment|Ongoing|0|||
131042165|NCT03519178|471789327|FG005|PF-06873600 Treatment|Ongoing|0|||
131042166|NCT03519178|471789328|FG006|PF-06873600 Treatment|Ongoing|0|||
131042167|NCT03519178|471789329|FG007|PF-06873600 Treatment|Ongoing|0|||
131042168|NCT03519178|471789330|FG008|PF-06873600 Treatment|Ongoing|0|||
131042169|NCT03519178|471789331|FG009|PF-06873600 Treatment|Ongoing|0|||
131042170|NCT03519178|471789332|FG010|PF-06873600 Treatment|Ongoing|0|||
131042171|NCT03519178|471789333|FG011|PF-06873600 Treatment|Ongoing|0|||
131042172|NCT03519178|471789334|FG012|PF-06873600 Treatment|Ongoing|0|||
131042173|NCT03519178|471789335|FG013|PF-06873600 Treatment|Ongoing|1|||
131042174|NCT03519178|471789336|FG014|PF-06873600 Treatment|Ongoing|6|||
131042175|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042176|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042177|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042178|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042179|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042180|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042181|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042182|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042183|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042184|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042185|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042186|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042187|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042188|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
131042189|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
131042190|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Death|0|||
131042191|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Death|0|||
131042192|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Death|0|||
131042193|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Death|0|||
131042194|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Death|0|||
131042195|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Death|0|||
131042196|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Death|0|||
131042197|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Death|0|||
131042198|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Death|0|||
131042199|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Death|1|||
131042200|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Death|0|||
131042201|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Death|0|||
131042202|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Death|0|||
131042203|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Death|0|||
130968239|NCT02055352|471511095|FG001|Overall Study|AE, study drug would be detrimental|3|||
130968240|NCT02055352|471511094|FG000|Overall Study|Withdrawal of informed consent|1|||
130968241|NCT02055352|471511095|FG001|Overall Study|Withdrawal of informed consent|0|||
130968242|NCT02055352|471511094|FG000|Overall Study|Reason unknown|1|||
130968243|NCT02055352|471511095|FG001|Overall Study|Reason unknown|5|||
130968244|NCT02707055|471511102|FG000|Phase 1|Withdrawal by Subject|1|||
130968245|NCT02707055|471511103|FG001|Phase 1|Withdrawal by Subject|2|||
130968246|NCT02707055|471511102|FG000|Phase 1|Physician Decision|0|||
130716281|NCT03709823|470588810|FG003|Overall Study|Lost to Follow-up|1|||
130716282|NCT03709823|470588811|FG004|Overall Study|Lost to Follow-up|1|||
130716283|NCT03709823|470588812|FG005|Overall Study|Lost to Follow-up|0|||
130716284|NCT03709823|470588807|FG000|Overall Study|Withdrawal by Subject|1|||
130968247|NCT02707055|471511103|FG001|Phase 1|Physician Decision|1|||
130968248|NCT02707055|471511102|FG000|Phase 2|Adverse Event|1|||
130968249|NCT02707055|471511103|FG001|Phase 2|Adverse Event|2|||
130968250|NCT01159938|471511104|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
130968251|NCT01159938|471511105|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
130968252|NCT01159938|471511106|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
130968253|NCT01159938|471511107|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
130968254|NCT01159938|471511108|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
130968255|NCT02416791|471511109|FG000|6 Months|Lost to Follow-up|0|||
130716285|NCT03709823|470588808|FG001|Overall Study|Withdrawal by Subject|3|||
130716286|NCT03709823|470588809|FG002|Overall Study|Withdrawal by Subject|0|||
130716287|NCT03709823|470588810|FG003|Overall Study|Withdrawal by Subject|0|||
130716288|NCT03709823|470588811|FG004|Overall Study|Withdrawal by Subject|0|||
130968256|NCT02416791|471511110|FG001|6 Months|Lost to Follow-up|0|||
130968257|NCT02416791|471511111|FG002|6 Months|Lost to Follow-up|1|||
130968258|NCT02417246|471511112|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
130968259|NCT02417246|471511113|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
130968260|NCT02417246|471511112|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
130968261|NCT02417246|471511113|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
130968262|NCT02417246|471511112|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
130968263|NCT02417246|471511113|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
130968264|NCT02417246|471511112|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
130968265|NCT02417246|471511113|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
130968266|NCT01197950|471511116|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
130968267|NCT01197950|471511117|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
130968268|NCT01197950|471511118|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
130968269|NCT02553330|471511119|FG000|Overall Study|Study Terminated by Sponsor|2|||
130968270|NCT02553330|471511120|FG001|Overall Study|Study Terminated by Sponsor|13|||
130968271|NCT02553330|471511121|FG002|Overall Study|Study Terminated by Sponsor|12|||
130968272|NCT02553330|471511119|FG000|Overall Study|Withdrawal by Subject|3|||
130968273|NCT02553330|471511120|FG001|Overall Study|Withdrawal by Subject|19|||
130968274|NCT02553330|471511121|FG002|Overall Study|Withdrawal by Subject|21|||
130968275|NCT02553330|471511119|FG000|Overall Study|Other|0|||
130968276|NCT02553330|471511120|FG001|Overall Study|Other|1|||
130968277|NCT02553330|471511121|FG002|Overall Study|Other|0|||
130968278|NCT02553330|471511119|FG000|Overall Study|Non compliance to study treatment|0|||
130968279|NCT02553330|471511120|FG001|Overall Study|Non compliance to study treatment|1|||
130968280|NCT02553330|471511121|FG002|Overall Study|Non compliance to study treatment|0|||
130968281|NCT02553330|471511119|FG000|Overall Study|Adverse Event|0|||
130968282|NCT02553330|471511120|FG001|Overall Study|Adverse Event|1|||
130968283|NCT02553330|471511121|FG002|Overall Study|Adverse Event|0|||
130968284|NCT02553330|471511119|FG000|Overall Study|Lost to Follow-up|0|||
130968285|NCT02553330|471511120|FG001|Overall Study|Lost to Follow-up|4|||
130968286|NCT02553330|471511121|FG002|Overall Study|Lost to Follow-up|4|||
130968287|NCT03551938|471511122|FG000|3-Month Follow Up|Lost to Follow-up|39|||
130968288|NCT03551938|471511123|FG001|3-Month Follow Up|Lost to Follow-up|38|||
130968289|NCT03551938|471511122|FG000|6-Month Follow Up|Lost to Follow-up|46|||
130968290|NCT03551938|471511123|FG001|6-Month Follow Up|Lost to Follow-up|42|||
130968291|NCT03551938|471511122|FG000|9-Month Follow Up|Lost to Follow-up|44|||
130968292|NCT03551938|471511123|FG001|9-Month Follow Up|Lost to Follow-up|43|||
130968293|NCT04137380|471511129|FG000|Overall Study|Physician Decision|0|||
130968294|NCT04137380|471511130|FG001|Overall Study|Physician Decision|0|||
130968295|NCT04137380|471511131|FG002|Overall Study|Physician Decision|0|||
130968296|NCT04137380|471511132|FG003|Overall Study|Physician Decision|1|||
130968297|NCT04137380|471511133|FG004|Overall Study|Physician Decision|0|||
130968298|NCT04137380|471511134|FG005|Overall Study|Physician Decision|0|||
130968299|NCT04137380|471511135|FG006|Overall Study|Physician Decision|0|||
130968300|NCT02265705|471511141|FG000|Treatment Period Week 0-24|Adverse Event|3|||
130968301|NCT02265705|471511142|FG001|Treatment Period Week 0-24|Adverse Event|2|||
130968302|NCT02265705|471511143|FG002|Treatment Period Week 0-24|Adverse Event|0|||
130716289|NCT03709823|470588812|FG005|Overall Study|Withdrawal by Subject|0|||
130716290|NCT03709823|470588807|FG000|Overall Study|Other, Not Specified|0|||
130716291|NCT03709823|470588808|FG001|Overall Study|Other, Not Specified|0|||
130716292|NCT03709823|470588809|FG002|Overall Study|Other, Not Specified|0|||
130716293|NCT03709823|470588810|FG003|Overall Study|Other, Not Specified|1|||
130716294|NCT03709823|470588811|FG004|Overall Study|Other, Not Specified|0|||
130716295|NCT03709823|470588812|FG005|Overall Study|Other, Not Specified|0|||
130716296|NCT02746471|470588813|FG000|Overall Study|Death|43|||
130716297|NCT02746471|470588813|FG000|Overall Study|Exited before 36 months|1119|||
130716298|NCT03201250|470588819|FG000|Overall Study|screen failures|3|||
130716299|NCT03201250|470588820|FG001|Overall Study|screen failures|0|||
130716300|NCT03201250|470588821|FG002|Overall Study|screen failures|0|||
130716301|NCT03167723|470588822|FG000|Overall Study|Protocol Violation|4|||
130716302|NCT03167723|470588823|FG001|Overall Study|Protocol Violation|6|||
130716303|NCT01175811|470588824|FG000|Overall Study|Adverse Event|1|||
130716304|NCT01175811|470588825|FG001|Overall Study|Adverse Event|1|||
130716305|NCT01175811|470588824|FG000|Overall Study|Entry criteria not met|3|||
130968303|NCT02265705|471511144|FG003|Treatment Period Week 0-24|Adverse Event|0|||
130968304|NCT02265705|471511145|FG004|Treatment Period Week 0-24|Adverse Event|0|||
130968305|NCT02265705|471511146|FG005|Treatment Period Week 0-24|Adverse Event|0|||
130968306|NCT02265705|471511147|FG006|Treatment Period Week 0-24|Adverse Event|0|||
130968307|NCT02265705|471511141|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
130968308|NCT02265705|471511142|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
130968309|NCT02265705|471511143|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
130968310|NCT02265705|471511144|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
130968311|NCT02265705|471511145|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
130968312|NCT02265705|471511146|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
130968313|NCT02265705|471511147|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
130968314|NCT02265705|471511141|FG000|Treatment Period Week 0-24|Physician Decision|1|||
130968315|NCT02265705|471511142|FG001|Treatment Period Week 0-24|Physician Decision|0|||
130968316|NCT02265705|471511143|FG002|Treatment Period Week 0-24|Physician Decision|0|||
130968317|NCT02265705|471511144|FG003|Treatment Period Week 0-24|Physician Decision|0|||
130968318|NCT02265705|471511145|FG004|Treatment Period Week 0-24|Physician Decision|0|||
130968319|NCT02265705|471511146|FG005|Treatment Period Week 0-24|Physician Decision|0|||
130968320|NCT02265705|471511147|FG006|Treatment Period Week 0-24|Physician Decision|0|||
130968321|NCT02265705|471511141|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
130968322|NCT02265705|471511142|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
130968323|NCT02265705|471511143|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
130968324|NCT02265705|471511144|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
130968325|NCT02265705|471511145|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
130968326|NCT02265705|471511146|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
130968327|NCT02265705|471511147|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
130968328|NCT02265705|471511141|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
130968329|NCT02265705|471511142|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
130968330|NCT02265705|471511143|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
130968331|NCT02265705|471511144|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
130968332|NCT02265705|471511145|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
130968333|NCT02265705|471511146|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
130968334|NCT02265705|471511147|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
130968335|NCT02265705|471511141|FG000|Rescue Period|Withdrawal by Subject|0|||
130968336|NCT02265705|471511142|FG001|Rescue Period|Withdrawal by Subject|0|||
130968337|NCT02265705|471511143|FG002|Rescue Period|Withdrawal by Subject|1|||
130968338|NCT02265705|471511144|FG003|Rescue Period|Withdrawal by Subject|0|||
130968339|NCT02265705|471511145|FG004|Rescue Period|Withdrawal by Subject|0|||
130968340|NCT02265705|471511146|FG005|Rescue Period|Withdrawal by Subject|0|||
130968341|NCT02265705|471511147|FG006|Rescue Period|Withdrawal by Subject|0|||
130968342|NCT02265705|471511141|FG000|Rescue Period|Death|0|||
130968343|NCT02265705|471511142|FG001|Rescue Period|Death|0|||
130968344|NCT02265705|471511143|FG002|Rescue Period|Death|1|||
130968345|NCT02265705|471511144|FG003|Rescue Period|Death|0|||
130968346|NCT02265705|471511145|FG004|Rescue Period|Death|0|||
130968347|NCT02265705|471511146|FG005|Rescue Period|Death|0|||
130968348|NCT02265705|471511147|FG006|Rescue Period|Death|0|||
130968349|NCT02265705|471511141|FG000|Rescue Period|Lack of Efficacy|0|||
130968350|NCT02265705|471511142|FG001|Rescue Period|Lack of Efficacy|0|||
130968351|NCT02265705|471511143|FG002|Rescue Period|Lack of Efficacy|1|||
130968352|NCT02265705|471511144|FG003|Rescue Period|Lack of Efficacy|0|||
130968353|NCT02265705|471511145|FG004|Rescue Period|Lack of Efficacy|0|||
130968354|NCT02265705|471511146|FG005|Rescue Period|Lack of Efficacy|0|||
131042204|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Death|1|||
131042205|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130716306|NCT01175811|470588825|FG001|Overall Study|Entry criteria not met|1|||
130716307|NCT01175811|470588824|FG000|Overall Study|Lack of Efficacy|1|||
130716308|NCT01175811|470588825|FG001|Overall Study|Lack of Efficacy|0|||
130716309|NCT01175811|470588824|FG000|Overall Study|Lost to Follow-up|3|||
130968355|NCT02265705|471511147|FG006|Rescue Period|Lack of Efficacy|0|||
130968356|NCT02265705|471511141|FG000|Open Label Period|Adverse Event|0|||
130968357|NCT02265705|471511142|FG001|Open Label Period|Adverse Event|0|||
130968358|NCT02265705|471511143|FG002|Open Label Period|Adverse Event|0|||
130968359|NCT02265705|471511144|FG003|Open Label Period|Adverse Event|2|||
130968360|NCT02265705|471511145|FG004|Open Label Period|Adverse Event|2|||
130968361|NCT02265705|471511146|FG005|Open Label Period|Adverse Event|0|||
130968362|NCT02265705|471511147|FG006|Open Label Period|Adverse Event|0|||
130968363|NCT02265705|471511141|FG000|Open Label Period|Physician Decision|0|||
130968364|NCT02265705|471511142|FG001|Open Label Period|Physician Decision|0|||
130968365|NCT02265705|471511143|FG002|Open Label Period|Physician Decision|0|||
130968366|NCT02265705|471511144|FG003|Open Label Period|Physician Decision|0|||
130968367|NCT02265705|471511145|FG004|Open Label Period|Physician Decision|1|||
130968368|NCT02265705|471511146|FG005|Open Label Period|Physician Decision|0|||
130968369|NCT02265705|471511147|FG006|Open Label Period|Physician Decision|0|||
130716310|NCT01175811|470588825|FG001|Overall Study|Lost to Follow-up|2|||
130716311|NCT01175811|470588824|FG000|Overall Study|Physician Decision|1|||
130968370|NCT02265705|471511141|FG000|Open Label Period|Withdrawal by Subject|0|||
130968371|NCT02265705|471511142|FG001|Open Label Period|Withdrawal by Subject|0|||
130968372|NCT02265705|471511143|FG002|Open Label Period|Withdrawal by Subject|0|||
130968373|NCT02265705|471511144|FG003|Open Label Period|Withdrawal by Subject|0|||
130968374|NCT02265705|471511145|FG004|Open Label Period|Withdrawal by Subject|2|||
130968375|NCT02265705|471511146|FG005|Open Label Period|Withdrawal by Subject|0|||
130968376|NCT02265705|471511147|FG006|Open Label Period|Withdrawal by Subject|0|||
130968377|NCT02265705|471511141|FG000|Follow-up Period|Sponsor Decision|0|||
130968378|NCT02265705|471511142|FG001|Follow-up Period|Sponsor Decision|0|||
130968379|NCT02265705|471511143|FG002|Follow-up Period|Sponsor Decision|0|||
130968380|NCT02265705|471511144|FG003|Follow-up Period|Sponsor Decision|0|||
130968381|NCT02265705|471511145|FG004|Follow-up Period|Sponsor Decision|0|||
130968382|NCT02265705|471511146|FG005|Follow-up Period|Sponsor Decision|1|||
130968383|NCT02265705|471511147|FG006|Follow-up Period|Sponsor Decision|6|||
130968384|NCT02265705|471511141|FG000|Follow-up Period|Adverse Event|0|||
130968385|NCT02265705|471511142|FG001|Follow-up Period|Adverse Event|0|||
130968386|NCT02265705|471511143|FG002|Follow-up Period|Adverse Event|0|||
130968387|NCT02265705|471511144|FG003|Follow-up Period|Adverse Event|0|||
130968388|NCT02265705|471511145|FG004|Follow-up Period|Adverse Event|0|||
130968389|NCT02265705|471511146|FG005|Follow-up Period|Adverse Event|0|||
130968390|NCT02265705|471511147|FG006|Follow-up Period|Adverse Event|3|||
130968391|NCT02265705|471511141|FG000|Follow-up Period|Physician Decision|0|||
130968392|NCT02265705|471511142|FG001|Follow-up Period|Physician Decision|0|||
130968393|NCT02265705|471511143|FG002|Follow-up Period|Physician Decision|0|||
130968394|NCT02265705|471511144|FG003|Follow-up Period|Physician Decision|0|||
130968395|NCT02265705|471511145|FG004|Follow-up Period|Physician Decision|0|||
130716312|NCT01175811|470588825|FG001|Overall Study|Physician Decision|1|||
130716313|NCT01175811|470588824|FG000|Overall Study|Protocol Violation|1|||
130716314|NCT01175811|470588825|FG001|Overall Study|Protocol Violation|2|||
130716315|NCT01175811|470588824|FG000|Overall Study|Withdrawal by Subject|6|||
130716316|NCT01175811|470588825|FG001|Overall Study|Withdrawal by Subject|7|||
130716317|NCT03579966|470588826|FG000|Overall Study|Adverse Event|6|||
130716318|NCT03579966|470588826|FG000|Overall Study|Lost to Follow-up|4|||
130716319|NCT03579966|470588826|FG000|Overall Study|Physician Decision|10|||
130716320|NCT03579966|470588826|FG000|Overall Study|Pregnancy|1|||
130716321|NCT03579966|470588826|FG000|Overall Study|Withdrawal by Subject|16|||
130716322|NCT03579966|470588826|FG000|Overall Study|Study terminated by Sponsor|22|||
130716323|NCT03579966|470588826|FG000|Overall Study|Protocol Violation|1|||
130716324|NCT00415194|470588827|FG000|Overall Study|Adverse Event|37|||
130716325|NCT00415194|470588828|FG001|Overall Study|Adverse Event|32|||
130968396|NCT02265705|471511146|FG005|Follow-up Period|Physician Decision|0|||
130968397|NCT02265705|471511147|FG006|Follow-up Period|Physician Decision|1|||
131042206|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
130716326|NCT00415194|470588827|FG000|Overall Study|Entry Criteria Not Met|4|||
130775702|NCT01677182|470806545|FG002|Overall Study|Other reasons|2|||
130775703|NCT02501161|470806548|FG000|Overall Study|Adverse Event|2|||
130775704|NCT02501161|470806549|FG001|Overall Study|Adverse Event|6|||
130968398|NCT02265705|471511141|FG000|Follow-up Period|Withdrawal by Subject|0|||
130968399|NCT02265705|471511142|FG001|Follow-up Period|Withdrawal by Subject|0|||
130968400|NCT02265705|471511143|FG002|Follow-up Period|Withdrawal by Subject|0|||
130968401|NCT02265705|471511144|FG003|Follow-up Period|Withdrawal by Subject|0|||
130968402|NCT02265705|471511145|FG004|Follow-up Period|Withdrawal by Subject|0|||
130968403|NCT02265705|471511146|FG005|Follow-up Period|Withdrawal by Subject|0|||
130968404|NCT02265705|471511147|FG006|Follow-up Period|Withdrawal by Subject|1|||
130968405|NCT00779246|471511148|FG000|Overall Study|Missing sufficient data for analysis|33|||
130968406|NCT00779246|471511149|FG001|Overall Study|Missing sufficient data for analysis|53|||
130968407|NCT03465540|471511150|FG000|Overall Study|Withdrawal by Subject|0|||
130968408|NCT03465540|471511151|FG001|Overall Study|Withdrawal by Subject|0|||
130968409|NCT03465540|471511152|FG002|Overall Study|Withdrawal by Subject|1|||
130968410|NCT03465540|471511153|FG003|Overall Study|Withdrawal by Subject|1|||
130716327|NCT00415194|470588828|FG001|Overall Study|Entry Criteria Not Met|8|||
130968411|NCT03465540|471511154|FG004|Overall Study|Withdrawal by Subject|1|||
130968412|NCT03465540|471511155|FG005|Overall Study|Withdrawal by Subject|0|||
130968413|NCT03465540|471511150|FG000|Overall Study|Lost to Follow-up|0|||
130968414|NCT03465540|471511151|FG001|Overall Study|Lost to Follow-up|1|||
130968415|NCT03465540|471511152|FG002|Overall Study|Lost to Follow-up|0|||
130968416|NCT03465540|471511153|FG003|Overall Study|Lost to Follow-up|0|||
130968417|NCT03465540|471511154|FG004|Overall Study|Lost to Follow-up|1|||
130968418|NCT03465540|471511155|FG005|Overall Study|Lost to Follow-up|0|||
130968419|NCT03465540|471511150|FG000|Overall Study|Death|1|||
130968420|NCT03465540|471511151|FG001|Overall Study|Death|1|||
130968421|NCT03465540|471511152|FG002|Overall Study|Death|0|||
130968422|NCT03465540|471511153|FG003|Overall Study|Death|2|||
130968423|NCT03465540|471511154|FG004|Overall Study|Death|0|||
130968424|NCT03465540|471511155|FG005|Overall Study|Death|2|||
130968425|NCT03465540|471511150|FG000|Overall Study|Protocol specified criteria|0|||
130968426|NCT03465540|471511151|FG001|Overall Study|Protocol specified criteria|2|||
130968427|NCT03465540|471511152|FG002|Overall Study|Protocol specified criteria|2|||
130968428|NCT03465540|471511153|FG003|Overall Study|Protocol specified criteria|0|||
130968429|NCT03465540|471511154|FG004|Overall Study|Protocol specified criteria|2|||
130968430|NCT03465540|471511155|FG005|Overall Study|Protocol specified criteria|0|||
130968431|NCT02844946|471511156|FG000|Overall Study|Lost to Follow-up|7|||
130968432|NCT02844946|471511157|FG001|Overall Study|Lost to Follow-up|0|||
130968433|NCT02806986|471511158|FG000|Treatment Stage 1|Adverse Event|1|||
130968434|NCT02806986|471511158|FG000|Treatment Stage 2|Adverse Event|3|||
131042207|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042208|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042209|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042210|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042211|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042212|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042213|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042214|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042215|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042216|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042217|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042218|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
131042219|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
131042220|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042221|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042222|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042223|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042224|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042225|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042226|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042227|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042228|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042229|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042230|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042231|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042232|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
131042233|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
131042234|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
131128582|NCT01225731|472099579|FG008|Part 2|Protocol Violation|1|||
131128583|NCT01225731|472099580|FG009|Part 2|Protocol Violation|0|||
131128584|NCT01225731|472099581|FG010|Part 2|Protocol Violation|0|||
131128585|NCT01225731|472099582|FG011|Part 2|Protocol Violation|0|||
131128586|NCT01225731|472099583|FG012|Part 2|Protocol Violation|0|||
131128587|NCT01225731|472099571|FG000|Part 2|Adverse Event|0|||
131128588|NCT01225731|472099572|FG001|Part 2|Adverse Event|0|||
131128589|NCT01225731|472099573|FG002|Part 2|Adverse Event|0|||
131128590|NCT01225731|472099574|FG003|Part 2|Adverse Event|0|||
131128591|NCT01225731|472099575|FG004|Part 2|Adverse Event|0|||
131128592|NCT01225731|472099576|FG005|Part 2|Adverse Event|0|||
130968435|NCT02806986|471511158|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
130968436|NCT04000165|471511159|FG000|Overall Study|Physician Decision|1|||
130968437|NCT04000165|471511159|FG000|Overall Study|Withdrawal by Subject|1|||
130968438|NCT02079805|471511160|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130968439|NCT02079805|471511161|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
130968440|NCT02079805|471511160|FG000|Overall Study|Voluntary Withdrawal|0|||
130968441|NCT02079805|471511161|FG001|Overall Study|Voluntary Withdrawal|1|||
130968442|NCT01753193|471511162|FG000|Overall Study|Withdrawal by Subject|23|||
131042235|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042236|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131128593|NCT01225731|472099577|FG006|Part 2|Adverse Event|4|||
131128594|NCT01225731|472099578|FG007|Part 2|Adverse Event|4|||
131128595|NCT01225731|472099579|FG008|Part 2|Adverse Event|2|||
131128596|NCT01225731|472099580|FG009|Part 2|Adverse Event|0|||
131128597|NCT01225731|472099581|FG010|Part 2|Adverse Event|0|||
130716328|NCT00415194|470588827|FG000|Overall Study|Lost to Follow-up|1|||
130716329|NCT00415194|470588828|FG001|Overall Study|Lost to Follow-up|0|||
130968443|NCT01753193|471511162|FG000|Overall Study|Lost to Follow-up|6|||
130968444|NCT01753193|471511162|FG000|Overall Study|Death|1|||
130968445|NCT01753193|471511162|FG000|Overall Study|Other|16|||
130968446|NCT00383435|471511163|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
130968447|NCT00383435|471511164|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
130968448|NCT00383435|471511165|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
130968449|NCT00383435|471511166|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
130968450|NCT00383435|471511167|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
130968451|NCT00383435|471511163|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
130968452|NCT00383435|471511164|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
130968453|NCT00383435|471511165|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
130968454|NCT00383435|471511166|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
130968455|NCT00383435|471511167|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
130968456|NCT00383435|471511163|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
130968457|NCT00383435|471511164|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
130968458|NCT00383435|471511165|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
130968459|NCT00383435|471511166|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
130968460|NCT00383435|471511167|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
130968461|NCT00383435|471511163|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
130968462|NCT00383435|471511164|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
130968463|NCT00383435|471511165|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
130968464|NCT00383435|471511166|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
130968465|NCT00383435|471511167|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
130968466|NCT00383435|471511163|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
130968467|NCT00383435|471511164|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
130968468|NCT00383435|471511165|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
130968469|NCT00383435|471511166|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
130968470|NCT00383435|471511167|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
130968471|NCT00383435|471511163|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
130968472|NCT00383435|471511164|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
130968473|NCT00383435|471511165|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
130968474|NCT00383435|471511166|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
130968475|NCT00383435|471511167|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
130968476|NCT00383435|471511163|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
130968477|NCT00383435|471511164|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
130968478|NCT00383435|471511165|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
130968479|NCT00383435|471511166|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
130968480|NCT00383435|471511167|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
131042237|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042238|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042239|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042240|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042241|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042242|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042243|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042244|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
131042245|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042246|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042247|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
131042248|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
131042249|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
131042250|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042251|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042252|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
130716330|NCT00415194|470588827|FG000|Overall Study|Physician Decision|10|||
130716331|NCT00415194|470588828|FG001|Overall Study|Physician Decision|16|||
131042253|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042254|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131128598|NCT01225731|472099582|FG011|Part 2|Adverse Event|0|||
131128599|NCT01225731|472099583|FG012|Part 2|Adverse Event|0|||
131042255|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042256|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042257|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042258|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042259|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042260|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042261|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042262|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
131042263|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
131042264|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
131042265|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042266|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042267|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042268|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042269|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042270|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042271|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042272|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042273|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042274|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
131042275|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042276|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042277|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
131042278|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
131042279|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
131042280|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042281|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042282|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042283|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042284|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042285|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042286|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042287|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042288|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042289|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
131042290|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042291|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042292|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042293|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
131042294|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
131042295|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042296|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042297|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042298|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042299|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042300|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042301|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042302|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130968481|NCT00383435|471511163|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
130968482|NCT00383435|471511164|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
130968483|NCT00383435|471511165|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
130968484|NCT00383435|471511166|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
130968485|NCT00383435|471511167|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
130968486|NCT00383435|471511163|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
130968487|NCT00383435|471511164|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
130968488|NCT00383435|471511165|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
131042303|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042304|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131128600|NCT01225731|472099571|FG000|Part 2|Lack of Efficacy|0|||
130968489|NCT00383435|471511166|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
130968490|NCT00383435|471511167|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
130968491|NCT00383435|471511163|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
130968492|NCT00383435|471511164|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
130968493|NCT00383435|471511165|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
130968494|NCT00383435|471511166|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
130968495|NCT00383435|471511167|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
130968496|NCT00383435|471511163|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
130968497|NCT00383435|471511164|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
130968498|NCT00383435|471511165|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
130968499|NCT00383435|471511166|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
130968500|NCT00383435|471511167|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
130968501|NCT00383435|471511163|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
130968502|NCT00383435|471511164|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
130968503|NCT00383435|471511165|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
130968504|NCT00383435|471511166|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
130968505|NCT00383435|471511167|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
130968506|NCT00383435|471511163|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130968507|NCT00383435|471511164|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
130968508|NCT00383435|471511165|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
130968509|NCT00383435|471511166|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
130968510|NCT00383435|471511167|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130968511|NCT00383435|471511163|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
130968512|NCT00383435|471511164|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
130968513|NCT00383435|471511165|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
130968514|NCT00383435|471511166|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
130968515|NCT00383435|471511167|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
130968516|NCT00383435|471511163|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
130968517|NCT00383435|471511164|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
130968518|NCT00383435|471511165|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
130968519|NCT00383435|471511166|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
130968520|NCT00383435|471511167|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
130968521|NCT00383435|471511163|FG000|26-Week Treatment Safety Extension|Administrative|1|||
130968522|NCT00383435|471511164|FG001|26-Week Treatment Safety Extension|Administrative|1|||
130968523|NCT00383435|471511165|FG002|26-Week Treatment Safety Extension|Administrative|0|||
130968524|NCT00383435|471511166|FG003|26-Week Treatment Safety Extension|Administrative|1|||
130968525|NCT00383435|471511167|FG004|26-Week Treatment Safety Extension|Administrative|0|||
130968526|NCT02682264|471511168|FG000|Overall Study|Withdrawal by Subject|56|||
130968527|NCT02682264|471511169|FG001|Overall Study|Withdrawal by Subject|45|||
130968528|NCT02682264|471511168|FG000|Overall Study|Lost to Follow-up|49|||
130968529|NCT02682264|471511169|FG001|Overall Study|Lost to Follow-up|41|||
130968530|NCT02682264|471511168|FG000|Overall Study|Lack of Efficacy|14|||
130968531|NCT02682264|471511169|FG001|Overall Study|Lack of Efficacy|16|||
130968532|NCT02682264|471511168|FG000|Overall Study|Withdrawal by Parent|6|||
130968533|NCT02682264|471511169|FG001|Overall Study|Withdrawal by Parent|7|||
130968534|NCT02682264|471511168|FG000|Overall Study|Adverse Event|9|||
130968535|NCT02682264|471511169|FG001|Overall Study|Adverse Event|0|||
130968536|NCT02682264|471511168|FG000|Overall Study|Noncompliance with study drug|1|||
130968537|NCT02682264|471511169|FG001|Overall Study|Noncompliance with study drug|4|||
130968538|NCT02682264|471511168|FG000|Overall Study|Pregnancy|1|||
130968539|NCT02682264|471511169|FG001|Overall Study|Pregnancy|2|||
130968540|NCT02682264|471511168|FG000|Overall Study|Recovery|1|||
130968541|NCT02682264|471511169|FG001|Overall Study|Recovery|2|||
130968542|NCT02682264|471511168|FG000|Overall Study|Progressive Disease|1|||
130968543|NCT02682264|471511169|FG001|Overall Study|Progressive Disease|0|||
130968544|NCT02682264|471511168|FG000|Overall Study|Technical Problems|0|||
130968545|NCT02682264|471511169|FG001|Overall Study|Technical Problems|1|||
130968546|NCT02682264|471511168|FG000|Overall Study|Moved abroad and unable to continue|0|||
130968547|NCT02682264|471511169|FG001|Overall Study|Moved abroad and unable to continue|3|||
130968548|NCT02682264|471511168|FG000|Overall Study|Stopped test article application|0|||
130968549|NCT02682264|471511169|FG001|Overall Study|Stopped test article application|1|||
130968550|NCT03264989|471511173|FG000|Overall Study|Lost to Follow-up|1|||
130968551|NCT03264989|471511174|FG001|Overall Study|Lost to Follow-up|0|||
130968552|NCT03264989|471511173|FG000|Overall Study|New Therapy for study Indication|1|||
130968553|NCT03264989|471511174|FG001|Overall Study|New Therapy for study Indication|0|||
130968554|NCT03264989|471511173|FG000|Overall Study|Protocol Violation|0|||
130968555|NCT03264989|471511174|FG001|Overall Study|Protocol Violation|1|||
130968556|NCT03264989|471511173|FG000|Overall Study|Patient decision|13|||
130968557|NCT03264989|471511174|FG001|Overall Study|Patient decision|0|||
130968558|NCT03264989|471511173|FG000|Overall Study|Physician Decision|6|||
130968559|NCT03264989|471511174|FG001|Overall Study|Physician Decision|4|||
130968560|NCT03264989|471511173|FG000|Overall Study|Adverse Event|2|||
130968561|NCT03264989|471511174|FG001|Overall Study|Adverse Event|1|||
130968562|NCT03264989|471511173|FG000|Overall Study|Death|1|||
130968563|NCT03264989|471511174|FG001|Overall Study|Death|1|||
130968564|NCT03264989|471511173|FG000|Overall Study|Pregnancy|2|||
130968565|NCT03264989|471511174|FG001|Overall Study|Pregnancy|0|||
130968566|NCT03264989|471511173|FG000|Overall Study|End of Study|19|||
130968567|NCT03264989|471511174|FG001|Overall Study|End of Study|5|||
130968568|NCT01775137|471511175|FG000|Overall Study|Death|1|||
130968569|NCT01775137|471511175|FG000|Overall Study|Protocol deviation|2|||
130968570|NCT01775137|471511175|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130968571|NCT01775137|471511175|FG000|Overall Study|Adverse Event|1|||
130968572|NCT01775137|471511175|FG000|Overall Study|Withdrawal by participants|5|||
130968573|NCT00096135|471511184|FG000|Overall Study|Physician Decision|20|||
130968574|NCT00096135|471511185|FG001|Overall Study|Physician Decision|4|||
130968575|NCT00096135|471511184|FG000|Overall Study|Refusal of further protocol therapy|4|||
130968576|NCT00096135|471511185|FG001|Overall Study|Refusal of further protocol therapy|1|||
130968577|NCT00096135|471511184|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
130968578|NCT00096135|471511185|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
130968579|NCT00096135|471511184|FG000|Overall Study|Other, specify|15|||
130968580|NCT00096135|471511185|FG001|Overall Study|Other, specify|3|||
130968581|NCT00096135|471511184|FG000|Overall Study|Ineligible|2|||
130968582|NCT00096135|471511185|FG001|Overall Study|Ineligible|0|||
130968583|NCT00874029|471511187|FG000|Overall Study|Withdrawal by Subject|10|||
130968584|NCT00874029|471511187|FG000|Overall Study|Pregnancy|4|||
130968585|NCT00874029|471511187|FG000|Overall Study|Physician Decision|1|||
130968586|NCT00874029|471511187|FG000|Overall Study|Adverse Event|1|||
130968587|NCT00874029|471511187|FG000|Overall Study|Lost to Follow-up|5|||
130968588|NCT00856583|471511188|FG000|Overall Study|Lack of Efficacy|389|||
130968589|NCT00856583|471511189|FG001|Overall Study|Lack of Efficacy|377|||
130968590|NCT00856583|471511188|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
130968591|NCT00856583|471511189|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
130968592|NCT00856583|471511188|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
130968593|NCT00856583|471511189|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
130968594|NCT00856583|471511188|FG000|Overall Study|Non-compliance|305|||
130968595|NCT00856583|471511189|FG001|Overall Study|Non-compliance|262|||
130968596|NCT00856583|471511188|FG000|Overall Study|Withdrawal by Subject|1092|||
130968597|NCT00856583|471511189|FG001|Overall Study|Withdrawal by Subject|919|||
130968598|NCT00856583|471511188|FG000|Overall Study|Physician Decision|59|||
130968599|NCT00856583|471511189|FG001|Overall Study|Physician Decision|82|||
130968600|NCT00856583|471511188|FG000|Overall Study|Pregnancy|14|||
130968601|NCT00856583|471511189|FG001|Overall Study|Pregnancy|5|||
130968602|NCT00856583|471511188|FG000|Overall Study|Other|92|||
130968603|NCT00856583|471511189|FG001|Overall Study|Other|104|||
130968604|NCT00856583|471511188|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
130968605|NCT00856583|471511189|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
130968606|NCT02328326|471511194|FG000|Overall Study|Withdrawal by Subject|10|||
130968607|NCT02328326|471511195|FG001|Overall Study|Withdrawal by Subject|3|||
130968608|NCT02328326|471511194|FG000|Overall Study|Death|2|||
130968609|NCT02328326|471511195|FG001|Overall Study|Death|1|||
130968610|NCT02328326|471511194|FG000|Overall Study|Lost to Follow-up|10|||
130968611|NCT02328326|471511195|FG001|Overall Study|Lost to Follow-up|4|||
130968612|NCT00305058|471511207|FG000|Overall Study|Participant too young|1|||
130968613|NCT00305058|471511208|FG001|Overall Study|Participant too young|0|||
130968614|NCT00305058|471511207|FG000|Overall Study|Missing data collection instrument|3|||
130968615|NCT00305058|471511208|FG001|Overall Study|Missing data collection instrument|2|||
130968616|NCT00305058|471511207|FG000|Overall Study|Missing outcome data|3|||
130968617|NCT00305058|471511208|FG001|Overall Study|Missing outcome data|2|||
130968618|NCT04102501|471511211|FG000|Overall Study|Withdrawal by Subject|7|||
130968619|NCT04102501|471511212|FG001|Overall Study|Withdrawal by Subject|9|||
130968620|NCT04102501|471511211|FG000|Overall Study|Adverse Event|1|||
130968621|NCT04102501|471511212|FG001|Overall Study|Adverse Event|3|||
130968622|NCT00968617|471511213|FG000|Overall Study|Study terminated by sponsor|6|||
130968623|NCT00784043|471511216|FG000|Overall Study|Withdrawal by Subject|8|||
130968624|NCT00784043|471511217|FG001|Overall Study|Withdrawal by Subject|5|||
130968625|NCT00784043|471511216|FG000|Overall Study|Protocol Terminated|23|||
130968626|NCT00784043|471511217|FG001|Overall Study|Protocol Terminated|1|||
130968627|NCT03965052|471511219|FG000|Overall Study|Protocol Violation|1|||
130968628|NCT03965052|471511220|FG001|Overall Study|Protocol Violation|0|||
130968629|NCT00499889|471511226|FG000|Overall Study|Infection prior to treatment|1|||
131227102|NCT01827371|472457779|FG002|Overall Study|Protocol Violation|0|||
130968630|NCT00142909|471511230|FG000|Randomization|Various Reasons|7|||
130968631|NCT00142909|471511231|FG001|Randomization|Various Reasons|10|||
130968632|NCT00142909|471511230|FG000|Medications Begin|Protocol Violation|2|||
130968633|NCT00142909|471511231|FG001|Medications Begin|Protocol Violation|0|||
130968634|NCT00142909|471511230|FG000|Medications Begin|Withdrawal by Subject|5|||
130968635|NCT00142909|471511231|FG001|Medications Begin|Withdrawal by Subject|3|||
130968636|NCT00142909|471511230|FG000|Medications Begin|Withdrawal by Subject|2|||
130968637|NCT00142909|471511231|FG001|Medications Begin|Withdrawal by Subject|0|||
131128601|NCT01225731|472099572|FG001|Part 2|Lack of Efficacy|0|||
131128602|NCT01225731|472099573|FG002|Part 2|Lack of Efficacy|0|||
131128603|NCT01225731|472099574|FG003|Part 2|Lack of Efficacy|0|||
131128604|NCT01225731|472099575|FG004|Part 2|Lack of Efficacy|0|||
131128605|NCT01225731|472099576|FG005|Part 2|Lack of Efficacy|1|||
131128606|NCT01225731|472099577|FG006|Part 2|Lack of Efficacy|0|||
131128607|NCT01225731|472099578|FG007|Part 2|Lack of Efficacy|12|||
131128608|NCT01225731|472099579|FG008|Part 2|Lack of Efficacy|3|||
131128609|NCT01225731|472099580|FG009|Part 2|Lack of Efficacy|0|||
131128610|NCT01225731|472099581|FG010|Part 2|Lack of Efficacy|0|||
131128611|NCT01225731|472099582|FG011|Part 2|Lack of Efficacy|0|||
131128612|NCT01225731|472099583|FG012|Part 2|Lack of Efficacy|0|||
131128613|NCT01225731|472099571|FG000|Part 2|Pregnancy|0|||
131128614|NCT01225731|472099572|FG001|Part 2|Pregnancy|0|||
131227103|NCT01827371|472457780|FG003|Overall Study|Protocol Violation|0|||
131227104|NCT01827371|472457777|FG000|Overall Study|Withdrawal by Subject|1|||
130716332|NCT00415194|470588827|FG000|Overall Study|Progressive Disease|180|||
130968638|NCT03135522|471511232|FG000|Overall Study|Adverse Event|1|||
130968639|NCT03135522|471511233|FG001|Overall Study|Adverse Event|0|||
130968640|NCT01898195|471511234|FG000|Smoking Abstinence|Did not have good measurements|35|||
130968641|NCT01898195|471511235|FG001|Smoking Abstinence|Did not have good measurements|38|||
130968642|NCT01898195|471511236|FG002|Smoking Abstinence|Did not have good measurements|36|||
130968643|NCT02120924|471511237|FG000|Overall Study|Lack of Efficacy|1|||
130968644|NCT02120924|471511238|FG001|Overall Study|Lack of Efficacy|2|||
130968645|NCT02120924|471511239|FG002|Overall Study|Lack of Efficacy|3|||
130968646|NCT02120924|471511237|FG000|Overall Study|Adverse Event|0|||
130968647|NCT02120924|471511238|FG001|Overall Study|Adverse Event|1|||
130968648|NCT02120924|471511239|FG002|Overall Study|Adverse Event|3|||
130968649|NCT02120924|471511237|FG000|Overall Study|Withdrawal by Subject|16|||
130968650|NCT02120924|471511238|FG001|Overall Study|Withdrawal by Subject|20|||
130968651|NCT02120924|471511239|FG002|Overall Study|Withdrawal by Subject|8|||
130968652|NCT02120924|471511237|FG000|Overall Study|Lost to Follow-up|14|||
130968653|NCT02120924|471511238|FG001|Overall Study|Lost to Follow-up|14|||
130968654|NCT02120924|471511239|FG002|Overall Study|Lost to Follow-up|11|||
130968655|NCT02120924|471511237|FG000|Overall Study|Pregnancy|2|||
130968656|NCT02120924|471511238|FG001|Overall Study|Pregnancy|0|||
130968657|NCT02120924|471511239|FG002|Overall Study|Pregnancy|0|||
130968658|NCT02120924|471511237|FG000|Overall Study|Protocol Violation|3|||
130968659|NCT02120924|471511238|FG001|Overall Study|Protocol Violation|7|||
130968660|NCT02120924|471511239|FG002|Overall Study|Protocol Violation|2|||
130968661|NCT02120924|471511237|FG000|Overall Study|Physician Decision|0|||
130968662|NCT02120924|471511238|FG001|Overall Study|Physician Decision|1|||
130968663|NCT02120924|471511239|FG002|Overall Study|Physician Decision|1|||
130968664|NCT02120924|471511237|FG000|Overall Study|Death|1|||
130968665|NCT02120924|471511238|FG001|Overall Study|Death|0|||
130968666|NCT02120924|471511239|FG002|Overall Study|Death|0|||
130968667|NCT02120924|471511237|FG000|Overall Study|Compliance with IP|5|||
130968668|NCT02120924|471511238|FG001|Overall Study|Compliance with IP|1|||
130968669|NCT02120924|471511239|FG002|Overall Study|Compliance with IP|1|||
130968670|NCT00136955|471513034|FG000|Overall Study|Adverse Event|8|||
130968671|NCT00136955|471513034|FG000|Overall Study|Lost to Follow-up|1|||
130968672|NCT00136955|471513034|FG000|Overall Study|Withdrawal by Subject|2|||
130968673|NCT00136955|471513034|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
130968674|NCT04450264|471513035|FG000|Overall Study|Incomplete survey|13|||
130968675|NCT04450264|471513036|FG001|Overall Study|Incomplete survey|19|||
130968676|NCT01773226|471513039|FG000|Overall Study|Withdrawal by Subject|1|||
130968677|NCT04401579|471513049|FG000|Overall Study|Death|23|||
130968678|NCT04401579|471513050|FG001|Overall Study|Death|36|||
130968679|NCT04401579|471513049|FG000|Overall Study|Lost to Follow-up|40|||
130968680|NCT04401579|471513050|FG001|Overall Study|Lost to Follow-up|41|||
130968681|NCT04401579|471513049|FG000|Overall Study|Withdrawal by Subject|8|||
130968682|NCT04401579|471513050|FG001|Overall Study|Withdrawal by Subject|16|||
130968683|NCT04401579|471513049|FG000|Overall Study|Physician Decision|1|||
130968684|NCT04401579|471513050|FG001|Overall Study|Physician Decision|2|||
130968685|NCT04401579|471513049|FG000|Overall Study|Became ineligible after enrollment|1|||
130968686|NCT04401579|471513050|FG001|Overall Study|Became ineligible after enrollment|1|||
130968687|NCT04401579|471513049|FG000|Overall Study|Enrolled but treatment not administered|7|||
130968688|NCT04401579|471513050|FG001|Overall Study|Enrolled but treatment not administered|9|||
131128615|NCT01225731|472099573|FG002|Part 2|Pregnancy|0|||
131128616|NCT01225731|472099574|FG003|Part 2|Pregnancy|0|||
130968689|NCT04401579|471513049|FG000|Overall Study|Adverse Event|2|||
130968690|NCT04401579|471513050|FG001|Overall Study|Adverse Event|1|||
130968691|NCT04401579|471513049|FG000|Overall Study|Scheduling error|1|||
130968692|NCT04401579|471513050|FG001|Overall Study|Scheduling error|2|||
130968693|NCT04401579|471513049|FG000|Overall Study|Transferred to another hospital|1|||
130968694|NCT04401579|471513050|FG001|Overall Study|Transferred to another hospital|2|||
130968695|NCT00489970|471513051|FG000|Persistence Year 9|Lost to Follow-up|2|||
130968696|NCT00489970|471513052|FG001|Persistence Year 9|Lost to Follow-up|2|||
131128617|NCT01225731|472099575|FG004|Part 2|Pregnancy|0|||
131128618|NCT01225731|472099576|FG005|Part 2|Pregnancy|0|||
131128619|NCT01225731|472099577|FG006|Part 2|Pregnancy|1|||
130968697|NCT00489970|471513053|FG002|Persistence Year 9|Lost to Follow-up|3|||
130968698|NCT00489970|471513051|FG000|Persistence Year 9|Other|1|||
130968699|NCT00489970|471513052|FG001|Persistence Year 9|Other|0|||
130968700|NCT00489970|471513053|FG002|Persistence Year 9|Other|2|||
130968701|NCT03564496|471513056|FG000|Overall Study|Withdrawal by Subject|1|||
130968702|NCT03564496|471513057|FG001|Overall Study|Withdrawal by Subject|1|||
130968703|NCT03564496|471513058|FG002|Overall Study|Withdrawal by Subject|0|||
130968704|NCT03564496|471513056|FG000|Overall Study|Screen failure|0|||
130968705|NCT03564496|471513057|FG001|Overall Study|Screen failure|3|||
130968706|NCT03564496|471513058|FG002|Overall Study|Screen failure|0|||
130968707|NCT03521635|471513059|FG000|Overall Study|Adverse Event|1|||
130968708|NCT03521635|471513060|FG001|Overall Study|Adverse Event|1|||
130968709|NCT03521635|471513059|FG000|Overall Study|Refused to complete study visit|1|||
130968710|NCT03521635|471513060|FG001|Overall Study|Refused to complete study visit|0|||
130968711|NCT03521635|471513059|FG000|Overall Study|Refused to continue trial medication|2|||
130968712|NCT03521635|471513060|FG001|Overall Study|Refused to continue trial medication|2|||
130968713|NCT03521635|471513059|FG000|Overall Study|Lost to Follow-up|0|||
130968714|NCT03521635|471513060|FG001|Overall Study|Lost to Follow-up|1|||
130968715|NCT03521635|471513059|FG000|Overall Study|Meet exclusion criteria|0|||
130968716|NCT03521635|471513060|FG001|Overall Study|Meet exclusion criteria|1|||
130968717|NCT03521635|471513059|FG000|Overall Study|Patient not taken study medicine|0|||
130968718|NCT03521635|471513060|FG001|Overall Study|Patient not taken study medicine|1|||
130968719|NCT00071487|471513064|FG000|52-Week Double-Blind Period|Adverse Event|5|||
130968720|NCT00071487|471513065|FG001|52-Week Double-Blind Period|Adverse Event|8|||
130968721|NCT00071487|471513066|FG002|52-Week Double-Blind Period|Adverse Event|4|||
130968722|NCT00071487|471513067|FG003|52-Week Double-Blind Period|Adverse Event|8|||
130968723|NCT00071487|471513064|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
130968724|NCT00071487|471513065|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
130968725|NCT00071487|471513066|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
130968726|NCT00071487|471513067|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
130968727|NCT00071487|471513064|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
130968728|NCT00071487|471513065|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
130968729|NCT00071487|471513066|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
130968730|NCT00071487|471513067|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
130968731|NCT00071487|471513064|FG000|52-Week Double-Blind Period|Physician Decision|1|||
130968732|NCT00071487|471513065|FG001|52-Week Double-Blind Period|Physician Decision|0|||
130968733|NCT00071487|471513066|FG002|52-Week Double-Blind Period|Physician Decision|0|||
130968734|NCT00071487|471513067|FG003|52-Week Double-Blind Period|Physician Decision|0|||
130968735|NCT00071487|471513064|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
130968736|NCT00071487|471513065|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
130968737|NCT00071487|471513066|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
130968738|NCT00071487|471513067|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
130968739|NCT00071487|471513064|FG000|52-Week Double-Blind Period|Pregnancy|0|||
130968740|NCT00071487|471513065|FG001|52-Week Double-Blind Period|Pregnancy|1|||
130968741|NCT00071487|471513066|FG002|52-Week Double-Blind Period|Pregnancy|0|||
130968742|NCT00071487|471513067|FG003|52-Week Double-Blind Period|Pregnancy|0|||
130968743|NCT00071487|471513064|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
130968744|NCT00071487|471513065|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
130968745|NCT00071487|471513066|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
130968746|NCT00071487|471513067|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
130968747|NCT00071487|471513064|FG000|52-Week Double-Blind Period|Death|0|||
130968748|NCT00071487|471513065|FG001|52-Week Double-Blind Period|Death|1|||
130968749|NCT00071487|471513066|FG002|52-Week Double-Blind Period|Death|0|||
130968750|NCT00071487|471513067|FG003|52-Week Double-Blind Period|Death|0|||
130968751|NCT00071487|471513064|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
130968752|NCT00071487|471513065|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
130968753|NCT00071487|471513066|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
130968754|NCT00071487|471513067|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
130968755|NCT00071487|471513064|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
130968756|NCT00071487|471513065|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
130968757|NCT00071487|471513066|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
130968758|NCT00071487|471513067|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
130968759|NCT00071487|471513064|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130968760|NCT00071487|471513065|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130968761|NCT00071487|471513066|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
130968762|NCT00071487|471513067|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
130968763|NCT00071487|471513064|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130968764|NCT00071487|471513065|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130716333|NCT00415194|470588828|FG001|Overall Study|Progressive Disease|217|||
130968765|NCT00071487|471513066|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
130968766|NCT00071487|471513067|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
130968767|NCT00071487|471513064|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
131128620|NCT01225731|472099578|FG007|Part 2|Pregnancy|0|||
130968768|NCT00071487|471513065|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
130968769|NCT00071487|471513066|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
130968770|NCT00071487|471513067|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
130968771|NCT00071487|471513064|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130968772|NCT00071487|471513065|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130968773|NCT00071487|471513066|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
130968774|NCT00071487|471513067|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
130968775|NCT00071487|471513064|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
130968776|NCT00071487|471513065|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
130968777|NCT00071487|471513066|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
130968778|NCT00071487|471513067|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
130968779|NCT02318329|471513068|FG000|Overall Study|Progressive Disease|2|||
130968780|NCT02318329|471513069|FG001|Overall Study|Progressive Disease|3|||
130968781|NCT02318329|471513070|FG002|Overall Study|Progressive Disease|2|||
130968782|NCT02318329|471513071|FG003|Overall Study|Progressive Disease|3|||
130968783|NCT02318329|471513072|FG004|Overall Study|Progressive Disease|3|||
130968784|NCT02318329|471513073|FG005|Overall Study|Progressive Disease|3|||
130968785|NCT02318329|471513074|FG006|Overall Study|Progressive Disease|1|||
130968786|NCT02318329|471513075|FG007|Overall Study|Progressive Disease|1|||
130968787|NCT02318329|471513076|FG008|Overall Study|Progressive Disease|5|||
130968788|NCT02318329|471513077|FG009|Overall Study|Progressive Disease|39|||
130968789|NCT02318329|471513068|FG000|Overall Study|Death|0|||
130968790|NCT02318329|471513069|FG001|Overall Study|Death|0|||
130968791|NCT02318329|471513070|FG002|Overall Study|Death|0|||
130968792|NCT02318329|471513071|FG003|Overall Study|Death|0|||
131042305|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042306|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042307|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042308|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
131042309|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
131042310|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Other|0|||
131042311|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Other|0|||
131042312|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Other|0|||
131042313|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Other|0|||
131042314|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Other|0|||
131042315|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Other|0|||
131042316|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Other|0|||
131042317|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Other|0|||
131042318|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Other|0|||
131042319|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Other|0|||
131042320|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Other|0|||
131042321|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Other|0|||
131042322|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Other|0|||
131042323|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Other|1|||
131042324|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Other|3|||
131042325|NCT03519178|471789322|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042326|NCT03519178|471789323|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042327|NCT03519178|471789324|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042328|NCT03519178|471789325|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042329|NCT03519178|471789326|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042330|NCT03519178|471789327|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042331|NCT03519178|471789328|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042332|NCT03519178|471789329|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042333|NCT03519178|471789330|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042334|NCT03519178|471789331|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042335|NCT03519178|471789332|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042336|NCT03519178|471789333|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042337|NCT03519178|471789334|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
131042338|NCT03519178|471789335|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
131042339|NCT03519178|471789336|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
131042340|NCT03519178|471789322|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
131042341|NCT03519178|471789323|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
131042342|NCT03519178|471789324|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
131042343|NCT03519178|471789325|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
131042344|NCT03519178|471789326|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
131128621|NCT01225731|472099579|FG008|Part 2|Pregnancy|1|||
131128622|NCT01225731|472099580|FG009|Part 2|Pregnancy|0|||
131042345|NCT03519178|471789327|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
130968793|NCT02318329|471513072|FG004|Overall Study|Death|0|||
130968794|NCT02318329|471513073|FG005|Overall Study|Death|0|||
130968795|NCT02318329|471513074|FG006|Overall Study|Death|0|||
130968796|NCT02318329|471513075|FG007|Overall Study|Death|0|||
130968797|NCT02318329|471513076|FG008|Overall Study|Death|0|||
130968798|NCT02318329|471513077|FG009|Overall Study|Death|5|||
130968799|NCT02318329|471513068|FG000|Overall Study|Lost to Follow-up|0|||
130968800|NCT02318329|471513069|FG001|Overall Study|Lost to Follow-up|0|||
130968801|NCT02318329|471513070|FG002|Overall Study|Lost to Follow-up|0|||
130968802|NCT02318329|471513071|FG003|Overall Study|Lost to Follow-up|0|||
130968803|NCT02318329|471513072|FG004|Overall Study|Lost to Follow-up|0|||
130968804|NCT02318329|471513073|FG005|Overall Study|Lost to Follow-up|0|||
130968805|NCT02318329|471513074|FG006|Overall Study|Lost to Follow-up|0|||
130968806|NCT02318329|471513075|FG007|Overall Study|Lost to Follow-up|0|||
130968807|NCT02318329|471513076|FG008|Overall Study|Lost to Follow-up|0|||
130968808|NCT02318329|471513077|FG009|Overall Study|Lost to Follow-up|1|||
130968809|NCT02318329|471513068|FG000|Overall Study|Withdrawal by Subject|0|||
130968810|NCT02318329|471513069|FG001|Overall Study|Withdrawal by Subject|0|||
130968811|NCT02318329|471513070|FG002|Overall Study|Withdrawal by Subject|0|||
130968812|NCT02318329|471513071|FG003|Overall Study|Withdrawal by Subject|0|||
130968813|NCT02318329|471513072|FG004|Overall Study|Withdrawal by Subject|0|||
130968814|NCT02318329|471513073|FG005|Overall Study|Withdrawal by Subject|0|||
130968815|NCT02318329|471513074|FG006|Overall Study|Withdrawal by Subject|0|||
130968816|NCT02318329|471513075|FG007|Overall Study|Withdrawal by Subject|0|||
130968817|NCT02318329|471513076|FG008|Overall Study|Withdrawal by Subject|0|||
130968818|NCT02318329|471513077|FG009|Overall Study|Withdrawal by Subject|6|||
130968819|NCT02318329|471513068|FG000|Overall Study|Other|1|||
130968820|NCT02318329|471513069|FG001|Overall Study|Other|1|||
130968821|NCT02318329|471513070|FG002|Overall Study|Other|1|||
130968822|NCT02318329|471513071|FG003|Overall Study|Other|0|||
130968823|NCT02318329|471513072|FG004|Overall Study|Other|0|||
130968824|NCT02318329|471513073|FG005|Overall Study|Other|0|||
130968825|NCT02318329|471513074|FG006|Overall Study|Other|0|||
130968826|NCT02318329|471513075|FG007|Overall Study|Other|0|||
130968827|NCT02318329|471513076|FG008|Overall Study|Other|1|||
130968828|NCT02318329|471513077|FG009|Overall Study|Other|1|||
130968829|NCT00086346|471513078|FG000|Randomization|Did not receive test article|4|||
130968830|NCT00086346|471513079|FG001|Randomization|Did not receive test article|4|||
130968831|NCT00086346|471513078|FG000|Patients Dosed With Test Article|Adverse Event|94|||
130968832|NCT00086346|471513079|FG001|Patients Dosed With Test Article|Adverse Event|11|||
130968833|NCT00086346|471513078|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
130968834|NCT00086346|471513079|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
131042346|NCT03519178|471789328|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
131042347|NCT03519178|471789329|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
131042348|NCT03519178|471789330|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
131042349|NCT03519178|471789331|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
131042350|NCT03519178|471789332|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
131042351|NCT03519178|471789333|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
131042352|NCT03519178|471789334|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
131042353|NCT03519178|471789335|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
131042354|NCT03519178|471789336|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
131042355|NCT03519178|471789322|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
131042356|NCT03519178|471789323|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
131042357|NCT03519178|471789324|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
131042358|NCT03519178|471789325|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
131042359|NCT03519178|471789326|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
131042360|NCT03519178|471789327|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
131042361|NCT03519178|471789328|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
131042362|NCT03519178|471789329|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
131042363|NCT03519178|471789330|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
131042364|NCT03519178|471789331|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
131042365|NCT03519178|471789332|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
131042366|NCT03519178|471789333|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
131042367|NCT03519178|471789334|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
131042368|NCT03519178|471789335|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
131042369|NCT03519178|471789336|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
131042370|NCT03519178|471789322|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042371|NCT03519178|471789323|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042372|NCT03519178|471789324|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130716334|NCT00415194|470588827|FG000|Overall Study|Protocol Violation|4|||
130716335|NCT00415194|470588828|FG001|Overall Study|Protocol Violation|2|||
130968835|NCT00086346|471513078|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
130968836|NCT00086346|471513079|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
130968837|NCT00086346|471513078|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
130968838|NCT00086346|471513079|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
130968839|NCT00086346|471513078|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
131128623|NCT01225731|472099581|FG010|Part 2|Pregnancy|0|||
131128624|NCT01225731|472099582|FG011|Part 2|Pregnancy|0|||
131128625|NCT01225731|472099583|FG012|Part 2|Pregnancy|0|||
131128626|NCT01225731|472099571|FG000|Part 2|Lost to Follow-up|0|||
131128627|NCT01225731|472099572|FG001|Part 2|Lost to Follow-up|0|||
131128628|NCT01225731|472099573|FG002|Part 2|Lost to Follow-up|0|||
131128629|NCT01225731|472099574|FG003|Part 2|Lost to Follow-up|0|||
131128630|NCT01225731|472099575|FG004|Part 2|Lost to Follow-up|0|||
131128631|NCT01225731|472099576|FG005|Part 2|Lost to Follow-up|0|||
131128632|NCT01225731|472099577|FG006|Part 2|Lost to Follow-up|0|||
131128633|NCT01225731|472099578|FG007|Part 2|Lost to Follow-up|3|||
131128634|NCT01225731|472099579|FG008|Part 2|Lost to Follow-up|1|||
131128635|NCT01225731|472099580|FG009|Part 2|Lost to Follow-up|0|||
131128636|NCT01225731|472099581|FG010|Part 2|Lost to Follow-up|0|||
131128637|NCT01225731|472099582|FG011|Part 2|Lost to Follow-up|0|||
131128638|NCT01225731|472099583|FG012|Part 2|Lost to Follow-up|0|||
131128639|NCT01225731|472099571|FG000|Part 2|Physician Decision|0|||
131128640|NCT01225731|472099572|FG001|Part 2|Physician Decision|0|||
131128641|NCT01225731|472099573|FG002|Part 2|Physician Decision|0|||
131128642|NCT01225731|472099574|FG003|Part 2|Physician Decision|0|||
131128643|NCT01225731|472099575|FG004|Part 2|Physician Decision|0|||
131128644|NCT01225731|472099576|FG005|Part 2|Physician Decision|0|||
131128645|NCT01225731|472099577|FG006|Part 2|Physician Decision|0|||
131128646|NCT01225731|472099578|FG007|Part 2|Physician Decision|2|||
131128647|NCT01225731|472099579|FG008|Part 2|Physician Decision|2|||
131128648|NCT01225731|472099580|FG009|Part 2|Physician Decision|0|||
131128649|NCT01225731|472099581|FG010|Part 2|Physician Decision|0|||
131128650|NCT01225731|472099582|FG011|Part 2|Physician Decision|0|||
131128651|NCT01225731|472099583|FG012|Part 2|Physician Decision|0|||
131128652|NCT01225731|472099571|FG000|Part 2|Withdrawal by Subject|0|||
131128653|NCT01225731|472099572|FG001|Part 2|Withdrawal by Subject|0|||
131128654|NCT01225731|472099573|FG002|Part 2|Withdrawal by Subject|0|||
131128655|NCT01225731|472099574|FG003|Part 2|Withdrawal by Subject|0|||
131128656|NCT01225731|472099575|FG004|Part 2|Withdrawal by Subject|0|||
131128657|NCT01225731|472099576|FG005|Part 2|Withdrawal by Subject|1|||
131128658|NCT01225731|472099577|FG006|Part 2|Withdrawal by Subject|3|||
131128659|NCT01225731|472099578|FG007|Part 2|Withdrawal by Subject|4|||
131128660|NCT01225731|472099579|FG008|Part 2|Withdrawal by Subject|1|||
131128661|NCT01225731|472099580|FG009|Part 2|Withdrawal by Subject|0|||
131128662|NCT01225731|472099581|FG010|Part 2|Withdrawal by Subject|0|||
131128663|NCT01225731|472099582|FG011|Part 2|Withdrawal by Subject|0|||
131128664|NCT01225731|472099583|FG012|Part 2|Withdrawal by Subject|0|||
131128665|NCT01225731|472099571|FG000|Part 3|Adverse Event|0|||
131128666|NCT01225731|472099572|FG001|Part 3|Adverse Event|0|||
131128667|NCT01225731|472099573|FG002|Part 3|Adverse Event|0|||
131128668|NCT01225731|472099574|FG003|Part 3|Adverse Event|0|||
131128669|NCT01225731|472099575|FG004|Part 3|Adverse Event|0|||
131128670|NCT01225731|472099576|FG005|Part 3|Adverse Event|0|||
131128671|NCT01225731|472099577|FG006|Part 3|Adverse Event|0|||
131128672|NCT01225731|472099578|FG007|Part 3|Adverse Event|0|||
131128673|NCT01225731|472099579|FG008|Part 3|Adverse Event|0|||
131128674|NCT01225731|472099580|FG009|Part 3|Adverse Event|0|||
131128675|NCT01225731|472099581|FG010|Part 3|Adverse Event|1|||
131128676|NCT01225731|472099582|FG011|Part 3|Adverse Event|1|||
131128677|NCT01225731|472099583|FG012|Part 3|Adverse Event|0|||
131128678|NCT01225731|472099571|FG000|Part 3|Lost to Follow-up|0|||
131128679|NCT01225731|472099572|FG001|Part 3|Lost to Follow-up|0|||
131128680|NCT01225731|472099573|FG002|Part 3|Lost to Follow-up|0|||
131128681|NCT01225731|472099574|FG003|Part 3|Lost to Follow-up|0|||
131128682|NCT01225731|472099575|FG004|Part 3|Lost to Follow-up|0|||
130968840|NCT00086346|471513079|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
130968841|NCT00086346|471513078|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
131128683|NCT01225731|472099576|FG005|Part 3|Lost to Follow-up|0|||
131128684|NCT01225731|472099577|FG006|Part 3|Lost to Follow-up|0|||
131128685|NCT01225731|472099578|FG007|Part 3|Lost to Follow-up|0|||
131128686|NCT01225731|472099579|FG008|Part 3|Lost to Follow-up|0|||
131128687|NCT01225731|472099580|FG009|Part 3|Lost to Follow-up|0|||
131128688|NCT01225731|472099581|FG010|Part 3|Lost to Follow-up|1|||
131128689|NCT01225731|472099582|FG011|Part 3|Lost to Follow-up|2|||
131128690|NCT01225731|472099583|FG012|Part 3|Lost to Follow-up|1|||
130716336|NCT00415194|470588827|FG000|Overall Study|Withdrawal by Subject|28|||
131128691|NCT01225731|472099571|FG000|Part 3|Physician Decision|0|||
131128692|NCT01225731|472099572|FG001|Part 3|Physician Decision|0|||
131128693|NCT01225731|472099573|FG002|Part 3|Physician Decision|0|||
131128694|NCT01225731|472099574|FG003|Part 3|Physician Decision|0|||
130716337|NCT00415194|470588828|FG001|Overall Study|Withdrawal by Subject|21|||
130716338|NCT00415194|470588827|FG000|Overall Study|Death Due to Study Disease|26|||
131128695|NCT01225731|472099575|FG004|Part 3|Physician Decision|0|||
131128696|NCT01225731|472099576|FG005|Part 3|Physician Decision|0|||
131128697|NCT01225731|472099577|FG006|Part 3|Physician Decision|0|||
131128698|NCT01225731|472099578|FG007|Part 3|Physician Decision|0|||
131128699|NCT01225731|472099579|FG008|Part 3|Physician Decision|0|||
131128700|NCT01225731|472099580|FG009|Part 3|Physician Decision|0|||
131128701|NCT01225731|472099581|FG010|Part 3|Physician Decision|0|||
131128702|NCT01225731|472099582|FG011|Part 3|Physician Decision|1|||
131128703|NCT01225731|472099583|FG012|Part 3|Physician Decision|2|||
131128704|NCT01225731|472099571|FG000|Part 3|Withdrawal by Subject|0|||
131128705|NCT01225731|472099572|FG001|Part 3|Withdrawal by Subject|0|||
131128706|NCT01225731|472099573|FG002|Part 3|Withdrawal by Subject|0|||
131128707|NCT01225731|472099574|FG003|Part 3|Withdrawal by Subject|0|||
131128708|NCT01225731|472099575|FG004|Part 3|Withdrawal by Subject|0|||
131128709|NCT01225731|472099576|FG005|Part 3|Withdrawal by Subject|0|||
131128710|NCT01225731|472099577|FG006|Part 3|Withdrawal by Subject|0|||
131128711|NCT01225731|472099578|FG007|Part 3|Withdrawal by Subject|0|||
131128712|NCT01225731|472099579|FG008|Part 3|Withdrawal by Subject|0|||
131128713|NCT01225731|472099580|FG009|Part 3|Withdrawal by Subject|0|||
131128714|NCT01225731|472099581|FG010|Part 3|Withdrawal by Subject|4|||
131128715|NCT01225731|472099582|FG011|Part 3|Withdrawal by Subject|6|||
131128716|NCT01225731|472099583|FG012|Part 3|Withdrawal by Subject|4|||
131128717|NCT01073267|472099584|FG000|Overall Study|Disease Progression|3|||
131128718|NCT00577642|472099585|FG000|Overall Study|Clinical Disease Progression|1|||
131128719|NCT00917150|472099590|FG000|Overall Study|Adverse Event|12|||
131128720|NCT00917150|472099591|FG001|Overall Study|Adverse Event|7|||
131128721|NCT00917150|472099592|FG002|Overall Study|Adverse Event|12|||
131128722|NCT00917150|472099593|FG003|Overall Study|Adverse Event|11|||
131128723|NCT00917150|472099590|FG000|Overall Study|Death|1|||
131128724|NCT00917150|472099591|FG001|Overall Study|Death|4|||
131128725|NCT00917150|472099592|FG002|Overall Study|Death|3|||
131128726|NCT00917150|472099593|FG003|Overall Study|Death|2|||
131128727|NCT00917150|472099590|FG000|Overall Study|Lost to Follow-up|1|||
131128728|NCT00917150|472099591|FG001|Overall Study|Lost to Follow-up|0|||
131128729|NCT00917150|472099592|FG002|Overall Study|Lost to Follow-up|4|||
131128730|NCT00917150|472099593|FG003|Overall Study|Lost to Follow-up|2|||
131128731|NCT00917150|472099590|FG000|Overall Study|Physician Decision|0|||
131128732|NCT00917150|472099591|FG001|Overall Study|Physician Decision|2|||
131128733|NCT00917150|472099592|FG002|Overall Study|Physician Decision|0|||
131128734|NCT00917150|472099593|FG003|Overall Study|Physician Decision|1|||
131128735|NCT00917150|472099590|FG000|Overall Study|Protocol Violation|5|||
131128736|NCT00917150|472099591|FG001|Overall Study|Protocol Violation|5|||
131128737|NCT00917150|472099592|FG002|Overall Study|Protocol Violation|3|||
131128738|NCT00917150|472099593|FG003|Overall Study|Protocol Violation|5|||
131128739|NCT00917150|472099590|FG000|Overall Study|Withdrawal by Subject|15|||
131128740|NCT00917150|472099591|FG001|Overall Study|Withdrawal by Subject|16|||
131128741|NCT00917150|472099592|FG002|Overall Study|Withdrawal by Subject|18|||
131128742|NCT00917150|472099593|FG003|Overall Study|Withdrawal by Subject|11|||
131128743|NCT00917150|472099590|FG000|Overall Study|Other than specified|3|||
131128744|NCT00917150|472099591|FG001|Overall Study|Other than specified|3|||
131128745|NCT00917150|472099592|FG002|Overall Study|Other than specified|2|||
131128746|NCT00917150|472099593|FG003|Overall Study|Other than specified|2|||
131128747|NCT03891264|472099594|FG000|Overall Study|Adverse Event|1|||
131128748|NCT03891264|472099594|FG000|Overall Study|Withdrawal by Subject|2|||
131128749|NCT03891264|472099594|FG000|Overall Study|Physician Decision|2|||
131128750|NCT01505634|472099599|FG000|Overall Study|Withdrawal by Subject|2|||
131128751|NCT01505634|472099600|FG001|Overall Study|Withdrawal by Subject|5|||
131128752|NCT01505634|472099601|FG002|Overall Study|Withdrawal by Subject|1|||
131128753|NCT01505634|472099599|FG000|Overall Study|Physician Decision|1|||
131128754|NCT01505634|472099600|FG001|Overall Study|Physician Decision|1|||
131128755|NCT01505634|472099601|FG002|Overall Study|Physician Decision|0|||
131128756|NCT01505634|472099599|FG000|Overall Study|Adverse Event|1|||
131128757|NCT01505634|472099600|FG001|Overall Study|Adverse Event|0|||
131128758|NCT01505634|472099601|FG002|Overall Study|Adverse Event|0|||
131128759|NCT01505634|472099599|FG000|Overall Study|Insufficient supply of drug at site|1|||
131128760|NCT01505634|472099600|FG001|Overall Study|Insufficient supply of drug at site|0|||
130716339|NCT00415194|470588828|FG001|Overall Study|Death Due to Study Disease|29|||
130716340|NCT00415194|470588827|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
130716341|NCT00415194|470588828|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
130716342|NCT00415194|470588827|FG000|Overall Study|Death Due to Procedural Related AE|0|||
131128761|NCT01505634|472099601|FG002|Overall Study|Insufficient supply of drug at site|0|||
131128762|NCT01505634|472099599|FG000|Overall Study|Protocol Violation|2|||
131128763|NCT01505634|472099600|FG001|Overall Study|Protocol Violation|0|||
131128764|NCT01505634|472099601|FG002|Overall Study|Protocol Violation|0|||
131128765|NCT01505634|472099599|FG000|Overall Study|Lost to Follow-up|1|||
131128766|NCT01505634|472099600|FG001|Overall Study|Lost to Follow-up|4|||
131128767|NCT01505634|472099601|FG002|Overall Study|Lost to Follow-up|4|||
131128768|NCT01505634|472099599|FG000|Overall Study|Death|1|||
131128769|NCT01505634|472099600|FG001|Overall Study|Death|0|||
131128770|NCT01505634|472099601|FG002|Overall Study|Death|0|||
131128771|NCT01505634|472099599|FG000|Overall Study|In a conflict zone|0|||
131128772|NCT01505634|472099600|FG001|Overall Study|In a conflict zone|0|||
131128773|NCT01505634|472099601|FG002|Overall Study|In a conflict zone|1|||
131128774|NCT02054897|472099602|FG000|Overall Study|Withdrawal by Subject|2|||
131128775|NCT02054897|472099603|FG001|Overall Study|Withdrawal by Subject|0|||
131128776|NCT02054897|472099604|FG002|Overall Study|Withdrawal by Subject|2|||
131128777|NCT02054897|472099602|FG000|Overall Study|Missing follow-up information|3|||
131128778|NCT02054897|472099603|FG001|Overall Study|Missing follow-up information|5|||
130716343|NCT00415194|470588828|FG001|Overall Study|Death Due to Procedural Related AE|1|||
130716344|NCT00415194|470588827|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
130716345|NCT00415194|470588828|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
130716346|NCT01297465|470588829|FG000|Overall Study|Lack of Ovarian Response|1|||
130716347|NCT01297465|470588830|FG001|Overall Study|Lack of Ovarian Response|1|||
130716348|NCT01297465|470588829|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
130716349|NCT01297465|470588830|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
130716350|NCT01297465|470588829|FG000|Overall Study|No Oocytes Retrieved|1|||
130716351|NCT01297465|470588830|FG001|Overall Study|No Oocytes Retrieved|1|||
130716352|NCT01297465|470588829|FG000|Overall Study|Poor oocyte quality|0|||
130968842|NCT00086346|471513079|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
130968843|NCT04495374|471513080|FG000|Overall Study|Protocol Violation|2|||
130968844|NCT04495374|471513081|FG001|Overall Study|Protocol Violation|1|||
130968845|NCT01303627|471513082|FG000|Overall Study|the failure while performing URS|0|||
130968846|NCT01303627|471513083|FG001|Overall Study|the failure while performing URS|1|||
130968847|NCT01054820|471513085|FG000|Overall Study|Withdrawal by Subject|2|||
130968848|NCT00996996|471513087|FG000|Overall Study|Progressive Disease|10|||
130968849|NCT00996996|471513087|FG000|Overall Study|Non-compliance|8|||
130968850|NCT00996996|471513087|FG000|Overall Study|Lost to Follow-up|9|||
130968851|NCT00996996|471513087|FG000|Overall Study|Death|5|||
130968852|NCT00996996|471513087|FG000|Overall Study|Did Not Receive Study Medications|1|||
130968853|NCT04535037|471513090|FG000|Overall Study|Protocol Violation|1|||
130968854|NCT04535037|471513091|FG001|Overall Study|Protocol Violation|0|||
130968855|NCT04535037|471513090|FG000|Overall Study|Withdrawal by Subject|8|||
130968856|NCT04535037|471513091|FG001|Overall Study|Withdrawal by Subject|9|||
130968857|NCT04535037|471513090|FG000|Overall Study|Migrated / moved from the study area|1|||
130968858|NCT04535037|471513091|FG001|Overall Study|Migrated / moved from the study area|4|||
130968859|NCT04535037|471513090|FG000|Overall Study|Other|2|||
130968860|NCT04535037|471513091|FG001|Overall Study|Other|5|||
130968861|NCT02031276|471513092|FG000|Period 1 Double-blind IV|Adverse Event|6|||
130968862|NCT02031276|471513093|FG001|Period 1 Double-blind IV|Adverse Event|5|||
130968863|NCT02031276|471513094|FG002|Period 1 Double-blind IV|Adverse Event|1|||
130968864|NCT02031276|471513092|FG000|Period 1 Double-blind IV|Other|0|||
130968865|NCT02031276|471513093|FG001|Period 1 Double-blind IV|Other|1|||
130968866|NCT02031276|471513094|FG002|Period 1 Double-blind IV|Other|0|||
130968867|NCT02031276|471513092|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
130968868|NCT02031276|471513093|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
130968869|NCT02031276|471513094|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
130968870|NCT02031276|471513092|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
130968871|NCT02031276|471513093|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
130968872|NCT02031276|471513094|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
130968873|NCT02031276|471513092|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
130968874|NCT02031276|471513093|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
130968875|NCT02031276|471513094|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
130968876|NCT02031276|471513092|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
130968877|NCT02031276|471513093|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
130968878|NCT02031276|471513094|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
130968879|NCT02031276|471513092|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
130968880|NCT02031276|471513093|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
130968881|NCT02031276|471513094|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
130968882|NCT02031276|471513092|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
130968883|NCT02031276|471513093|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
130968884|NCT02031276|471513094|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
130968885|NCT02031276|471513092|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
130968886|NCT02031276|471513093|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
130968887|NCT02031276|471513094|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
130968888|NCT01148810|471513095|FG000|Overall Study|Adverse Event|0|||
130968889|NCT01148810|471513096|FG001|Overall Study|Adverse Event|2|||
130968890|NCT01148810|471513095|FG000|Overall Study|Lack of Efficacy|0|||
130968891|NCT01148810|471513096|FG001|Overall Study|Lack of Efficacy|1|||
130968892|NCT01148810|471513095|FG000|Overall Study|Withdrawal by Subject|0|||
130968893|NCT01148810|471513096|FG001|Overall Study|Withdrawal by Subject|2|||
131128779|NCT02054897|472099604|FG002|Overall Study|Missing follow-up information|3|||
130716353|NCT01297465|470588830|FG001|Overall Study|Poor oocyte quality|1|||
130716354|NCT01297465|470588829|FG000|Overall Study|No Fertilization|6|||
130716355|NCT01297465|470588830|FG001|Overall Study|No Fertilization|4|||
131128780|NCT02054897|472099602|FG000|Overall Study|Lost to Follow-up|4|||
131128781|NCT02054897|472099603|FG001|Overall Study|Lost to Follow-up|2|||
130716356|NCT01297465|470588829|FG000|Overall Study|All Embryos Discarded|0|||
130716357|NCT01297465|470588830|FG001|Overall Study|All Embryos Discarded|1|||
130716358|NCT01297465|470588829|FG000|Overall Study|Intention to Freeze all Embryos|0|||
130968894|NCT01148810|471513095|FG000|Overall Study|Protocol Violation|1|||
130968895|NCT01148810|471513096|FG001|Overall Study|Protocol Violation|0|||
131128782|NCT02054897|472099604|FG002|Overall Study|Lost to Follow-up|7|||
130968896|NCT04408469|471513103|FG000|Overall Study|Lost to Follow-up|6|||
130968897|NCT04408469|471513104|FG001|Overall Study|Lost to Follow-up|9|||
130968898|NCT04408469|471513103|FG000|Overall Study|Withdrawal by Subject|6|||
130968899|NCT04408469|471513104|FG001|Overall Study|Withdrawal by Subject|1|||
130968900|NCT04408469|471513103|FG000|Overall Study|Dismissal due to ineligibility|0|||
130968901|NCT04408469|471513104|FG001|Overall Study|Dismissal due to ineligibility|1|||
130968902|NCT04321460|471513105|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
130968903|NCT04321460|471513106|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
130968904|NCT01308749|471513107|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
130968905|NCT01308749|471513108|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
130968906|NCT01308749|471513107|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
130968907|NCT01308749|471513108|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
130968908|NCT01308749|471513107|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
130968909|NCT01308749|471513108|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
130968910|NCT04726709|471513109|FG000|Overall Study|Withdrawal by Subject|2|||
130968911|NCT04726709|471513110|FG001|Overall Study|Withdrawal by Subject|2|||
130968912|NCT03434119|471513113|FG000|Overall Study|Randomized but not treated|1|||
130968913|NCT03434119|471513114|FG001|Overall Study|Randomized but not treated|0|||
130968914|NCT03434119|471513113|FG000|Overall Study|Adverse Event|1|||
130968915|NCT03434119|471513114|FG001|Overall Study|Adverse Event|0|||
130968916|NCT03434119|471513113|FG000|Overall Study|Poor Compliance to Protocol|0|||
130968917|NCT03434119|471513114|FG001|Overall Study|Poor Compliance to Protocol|1|||
130968918|NCT03434119|471513113|FG000|Overall Study|Study Terminated by Sponsor|91|||
130968919|NCT03434119|471513114|FG001|Overall Study|Study Terminated by Sponsor|102|||
130968920|NCT03434119|471513113|FG000|Overall Study|Withdrawal by Subject|7|||
130968921|NCT03434119|471513114|FG001|Overall Study|Withdrawal by Subject|5|||
130968922|NCT03434119|471513113|FG000|Overall Study|Other than specified|7|||
130968923|NCT03434119|471513114|FG001|Overall Study|Other than specified|5|||
130968924|NCT00148343|471513116|FG000|Overall Study|Withdrawal by Subject|12|||
130968925|NCT00148343|471513117|FG001|Overall Study|Withdrawal by Subject|7|||
131128783|NCT02054897|472099602|FG000|Overall Study|Randomized but not exposed|1|||
131128784|NCT02054897|472099603|FG001|Overall Study|Randomized but not exposed|0|||
130968926|NCT00148343|471513116|FG000|Overall Study|Physician Decision|3|||
130968927|NCT00148343|471513117|FG001|Overall Study|Physician Decision|4|||
130968928|NCT03579459|471513118|FG000|Overall Study|Adverse Event|7|||
130968929|NCT03579459|471513119|FG001|Overall Study|Adverse Event|6|||
130968930|NCT03579459|471513120|FG002|Overall Study|Adverse Event|2|||
130968931|NCT03579459|471513121|FG003|Overall Study|Adverse Event|6|||
130968932|NCT03579459|471513118|FG000|Overall Study|Death|1|||
130968933|NCT03579459|471513119|FG001|Overall Study|Death|0|||
130968934|NCT03579459|471513120|FG002|Overall Study|Death|1|||
130968935|NCT03579459|471513121|FG003|Overall Study|Death|2|||
130968936|NCT03579459|471513118|FG000|Overall Study|Lost to Follow-up|6|||
130968937|NCT03579459|471513119|FG001|Overall Study|Lost to Follow-up|2|||
130968938|NCT03579459|471513120|FG002|Overall Study|Lost to Follow-up|4|||
130968939|NCT03579459|471513121|FG003|Overall Study|Lost to Follow-up|1|||
130968940|NCT03579459|471513118|FG000|Overall Study|Physician Decision|0|||
131128785|NCT02054897|472099604|FG002|Overall Study|Randomized but not exposed|0|||
131128786|NCT00794157|472099605|FG000|Overall Study|Adverse Event|4|||
131128787|NCT00794157|472099606|FG001|Overall Study|Adverse Event|1|||
131128788|NCT00794157|472099607|FG002|Overall Study|Adverse Event|8|||
131128789|NCT00794157|472099605|FG000|Overall Study|Subject withdrew consent|2|||
131128790|NCT00794157|472099606|FG001|Overall Study|Subject withdrew consent|0|||
131128791|NCT00794157|472099607|FG002|Overall Study|Subject withdrew consent|3|||
131128792|NCT00794157|472099605|FG000|Overall Study|Lost to Follow-up|2|||
131128793|NCT00794157|472099606|FG001|Overall Study|Lost to Follow-up|0|||
131128794|NCT00794157|472099607|FG002|Overall Study|Lost to Follow-up|1|||
131128795|NCT00794157|472099605|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131128796|NCT00794157|472099606|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131227105|NCT01827371|472457778|FG001|Overall Study|Withdrawal by Subject|2|||
131227106|NCT01827371|472457779|FG002|Overall Study|Withdrawal by Subject|2|||
130968941|NCT03579459|471513119|FG001|Overall Study|Physician Decision|1|||
130968942|NCT03579459|471513120|FG002|Overall Study|Physician Decision|0|||
130968943|NCT03579459|471513121|FG003|Overall Study|Physician Decision|1|||
130968944|NCT03579459|471513118|FG000|Overall Study|Protocol Violation|1|||
130968945|NCT03579459|471513119|FG001|Overall Study|Protocol Violation|2|||
130968946|NCT03579459|471513120|FG002|Overall Study|Protocol Violation|3|||
130968947|NCT03579459|471513121|FG003|Overall Study|Protocol Violation|5|||
130968948|NCT03579459|471513118|FG000|Overall Study|Withdrawal by Subject|12|||
130968949|NCT03579459|471513119|FG001|Overall Study|Withdrawal by Subject|8|||
130968950|NCT03579459|471513120|FG002|Overall Study|Withdrawal by Subject|11|||
130968951|NCT03579459|471513121|FG003|Overall Study|Withdrawal by Subject|8|||
131128797|NCT00794157|472099607|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
131128798|NCT00794157|472099605|FG000|Overall Study|Administrative problems|1|||
131128799|NCT00794157|472099606|FG001|Overall Study|Administrative problems|7|||
131128800|NCT00794157|472099607|FG002|Overall Study|Administrative problems|4|||
130968952|NCT03579459|471513118|FG000|Overall Study|Medication error without associated adverse event|2|||
130968953|NCT03579459|471513119|FG001|Overall Study|Medication error without associated adverse event|1|||
130968954|NCT03579459|471513120|FG002|Overall Study|Medication error without associated adverse event|1|||
130968955|NCT03579459|471513121|FG003|Overall Study|Medication error without associated adverse event|0|||
130968956|NCT03579459|471513118|FG000|Overall Study|Other|0|||
130968957|NCT03579459|471513119|FG001|Overall Study|Other|1|||
130968958|NCT03579459|471513120|FG002|Overall Study|Other|1|||
130968959|NCT03579459|471513121|FG003|Overall Study|Other|0|||
130968960|NCT03579459|471513118|FG000|Overall Study|Randomized not vaccinated|0|||
130968961|NCT03579459|471513119|FG001|Overall Study|Randomized not vaccinated|2|||
130968962|NCT03579459|471513120|FG002|Overall Study|Randomized not vaccinated|0|||
130968963|NCT03579459|471513121|FG003|Overall Study|Randomized not vaccinated|1|||
130968964|NCT02528214|471513129|FG000|Overall Study|Protocol Violation|0|||
130968965|NCT02528214|471513130|FG001|Overall Study|Protocol Violation|1|||
130968966|NCT02528214|471513129|FG000|Overall Study|Adverse Event|0|||
130968967|NCT02528214|471513130|FG001|Overall Study|Adverse Event|1|||
130968968|NCT02528214|471513129|FG000|Overall Study|Other than specified above|0|||
130968969|NCT02528214|471513130|FG001|Overall Study|Other than specified above|1|||
130968970|NCT00407537|471513131|FG000|Overall Study|Death|5|||
130968971|NCT00407537|471513132|FG001|Overall Study|Death|2|||
130968972|NCT00407537|471513131|FG000|Overall Study|Adverse Event|36|||
130968973|NCT00407537|471513132|FG001|Overall Study|Adverse Event|0|||
130968974|NCT00407537|471513131|FG000|Overall Study|Lost to Follow-up|12|||
130968975|NCT00407537|471513132|FG001|Overall Study|Lost to Follow-up|19|||
130968976|NCT00407537|471513131|FG000|Overall Study|Other|6|||
130968977|NCT00407537|471513132|FG001|Overall Study|Other|7|||
130968978|NCT00407537|471513131|FG000|Overall Study|Withdrawal by Subject|34|||
130968979|NCT00407537|471513132|FG001|Overall Study|Withdrawal by Subject|16|||
130968980|NCT00583557|471513133|FG000|Overall Study|Withdrawal by Subject|18|||
130968981|NCT00583557|471513133|FG000|Overall Study|Adverse Event|9|||
130968982|NCT00583557|471513133|FG000|Overall Study|Lack of Efficacy|31|||
130968983|NCT00583557|471513133|FG000|Overall Study|Lack of Compliance|5|||
130968984|NCT00583557|471513133|FG000|Overall Study|Other|5|||
130968985|NCT00583557|471513133|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
130968986|NCT01040130|471513141|FG000|Overall Study|Adverse Event|1|||
130968987|NCT01040130|471513142|FG001|Overall Study|Adverse Event|1|||
130968988|NCT01040130|471513143|FG002|Overall Study|Adverse Event|0|||
130968989|NCT01040130|471513144|FG003|Overall Study|Adverse Event|5|||
130968990|NCT01040130|471513145|FG004|Overall Study|Adverse Event|0|||
130968991|NCT01040130|471513146|FG005|Overall Study|Adverse Event|3|||
130968992|NCT01040130|471513141|FG000|Overall Study|Protocol Violation|0|||
130968993|NCT01040130|471513142|FG001|Overall Study|Protocol Violation|0|||
130968994|NCT01040130|471513143|FG002|Overall Study|Protocol Violation|2|||
130968995|NCT01040130|471513144|FG003|Overall Study|Protocol Violation|0|||
130968996|NCT01040130|471513145|FG004|Overall Study|Protocol Violation|0|||
130968997|NCT01040130|471513146|FG005|Overall Study|Protocol Violation|0|||
130968998|NCT01040130|471513141|FG000|Overall Study|Withdrawal by Subject|0|||
130968999|NCT01040130|471513142|FG001|Overall Study|Withdrawal by Subject|2|||
130969000|NCT01040130|471513143|FG002|Overall Study|Withdrawal by Subject|0|||
130969001|NCT01040130|471513144|FG003|Overall Study|Withdrawal by Subject|0|||
130969002|NCT01040130|471513145|FG004|Overall Study|Withdrawal by Subject|0|||
130969003|NCT01040130|471513146|FG005|Overall Study|Withdrawal by Subject|1|||
130969004|NCT01040130|471513141|FG000|Overall Study|Other reasons not listed above|2|||
130969005|NCT01040130|471513142|FG001|Overall Study|Other reasons not listed above|0|||
130969006|NCT01040130|471513143|FG002|Overall Study|Other reasons not listed above|0|||
130969007|NCT01040130|471513144|FG003|Overall Study|Other reasons not listed above|0|||
130969008|NCT01040130|471513145|FG004|Overall Study|Other reasons not listed above|0|||
130969009|NCT01040130|471513146|FG005|Overall Study|Other reasons not listed above|0|||
130969010|NCT01310036|471513149|FG000|Overall Study|Administrative/other|10|||
130969011|NCT01310036|471513149|FG000|Overall Study|Withdrew Consent|11|||
130969012|NCT01310036|471513149|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
130969013|NCT01310036|471513149|FG000|Overall Study|Progression of Disease|164|||
130969014|NCT01310036|471513149|FG000|Overall Study|Death|1|||
130969015|NCT01310036|471513149|FG000|Overall Study|Adverse event or intercurrent illness|12|||
130969016|NCT00553267|471513150|FG000|Overall Study|Adverse Event|8|||
130969017|NCT00553267|471513151|FG001|Overall Study|Adverse Event|10|||
130969018|NCT00553267|471513152|FG002|Overall Study|Adverse Event|5|||
130969019|NCT00553267|471513150|FG000|Overall Study|Non compliant with protocol|3|||
130969020|NCT00553267|471513151|FG001|Overall Study|Non compliant with protocol|3|||
130969021|NCT00553267|471513152|FG002|Overall Study|Non compliant with protocol|2|||
130969022|NCT00553267|471513150|FG000|Overall Study|Lost to Follow-up|0|||
130969023|NCT00553267|471513151|FG001|Overall Study|Lost to Follow-up|0|||
131042373|NCT03519178|471789325|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042374|NCT03519178|471789326|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130969024|NCT00553267|471513152|FG002|Overall Study|Lost to Follow-up|1|||
130969025|NCT00553267|471513150|FG000|Overall Study|Consent withdrawn|2|||
130969026|NCT00553267|471513151|FG001|Overall Study|Consent withdrawn|3|||
130716359|NCT01297465|470588830|FG001|Overall Study|Intention to Freeze all Embryos|1|||
130716360|NCT00369655|470588831|FG000|Overall Study|Refusal of further treatment|2|||
130716361|NCT04049617|470588832|FG000|Overall Study|Adverse Event|0|||
130716362|NCT04049617|470588833|FG001|Overall Study|Adverse Event|0|||
130716363|NCT04049617|470588834|FG002|Overall Study|Adverse Event|0|||
130716364|NCT04049617|470588835|FG003|Overall Study|Adverse Event|1|||
130716365|NCT04049617|470588836|FG004|Overall Study|Adverse Event|0|||
130716366|NCT04049617|470588837|FG005|Overall Study|Adverse Event|0|||
130716367|NCT04049617|470588832|FG000|Overall Study|Death|0|||
130716368|NCT04049617|470588833|FG001|Overall Study|Death|0|||
130716369|NCT04049617|470588834|FG002|Overall Study|Death|0|||
130716370|NCT04049617|470588835|FG003|Overall Study|Death|0|||
130716371|NCT04049617|470588836|FG004|Overall Study|Death|0|||
130716372|NCT04049617|470588837|FG005|Overall Study|Death|1|||
130716373|NCT04049617|470588832|FG000|Overall Study|Lost to Follow-up|0|||
130969027|NCT00553267|471513152|FG002|Overall Study|Consent withdrawn|1|||
130969028|NCT00553267|471513150|FG000|Overall Study|Specified category|1|||
130969029|NCT00553267|471513151|FG001|Overall Study|Specified category|2|||
130969030|NCT00553267|471513152|FG002|Overall Study|Specified category|1|||
130969031|NCT01175668|471513153|FG000|Overall Study|Withdrawal by Subject|2|||
130969032|NCT01175668|471513154|FG001|Overall Study|Withdrawal by Subject|0|||
130969033|NCT02937545|471513156|FG000|Overall Study|Withdrawal by Subject|1|||
130969034|NCT02937545|471513157|FG001|Overall Study|Withdrawal by Subject|2|||
130969035|NCT02937545|471513158|FG002|Overall Study|Withdrawal by Subject|6|||
130969036|NCT02937545|471513159|FG003|Overall Study|Withdrawal by Subject|7|||
130969037|NCT02937545|471513156|FG000|Overall Study|Lost to Follow-up|1|||
130969038|NCT02937545|471513157|FG001|Overall Study|Lost to Follow-up|0|||
130969039|NCT02937545|471513158|FG002|Overall Study|Lost to Follow-up|0|||
130969040|NCT02937545|471513159|FG003|Overall Study|Lost to Follow-up|0|||
130969041|NCT01985126|471513164|FG000|Overall Study|Death|15|||
130969042|NCT01985126|471513165|FG001|Overall Study|Death|69|||
130969043|NCT01985126|471513164|FG000|Overall Study|Lost to Follow-up|0|||
130969044|NCT01985126|471513165|FG001|Overall Study|Lost to Follow-up|8|||
130969045|NCT01985126|471513164|FG000|Overall Study|Study Terminated By Sponsor|1|||
130969046|NCT01985126|471513165|FG001|Overall Study|Study Terminated By Sponsor|22|||
130969047|NCT01985126|471513164|FG000|Overall Study|Withdrawal by Subject|2|||
130969048|NCT01985126|471513165|FG001|Overall Study|Withdrawal by Subject|7|||
130969049|NCT01618838|471513166|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
130969050|NCT03835533|471513169|FG000|Overall Study|Death|5|||
130969051|NCT03835533|471513170|FG001|Overall Study|Death|10|||
130969052|NCT03835533|471513171|FG002|Overall Study|Death|9|||
130969053|NCT03835533|471513169|FG000|Overall Study|Withdrawal by Subject|2|||
130969054|NCT03835533|471513170|FG001|Overall Study|Withdrawal by Subject|2|||
130969055|NCT03835533|471513171|FG002|Overall Study|Withdrawal by Subject|2|||
130969056|NCT03835533|471513169|FG000|Overall Study|Lost to Follow-up|1|||
130969057|NCT03835533|471513170|FG001|Overall Study|Lost to Follow-up|0|||
130969058|NCT03835533|471513171|FG002|Overall Study|Lost to Follow-up|0|||
130969059|NCT01136291|471513172|FG000|Overall Study|Lost to Follow-up|1|||
130969060|NCT01136291|471513173|FG001|Overall Study|Lost to Follow-up|1|||
130969061|NCT01870843|471513184|FG000|Overall Study|Adverse Event|10|||
130969062|NCT01870843|471513184|FG000|Overall Study|Lost to Follow-up|24|||
130969063|NCT01870843|471513184|FG000|Overall Study|Death|1|||
130969064|NCT01870843|471513184|FG000|Overall Study|Withdrawal by Subject|18|||
130969065|NCT01910519|471513187|FG000|Overall Study|Withdrawal by Subject|2|||
130969066|NCT01910519|471513188|FG001|Overall Study|Withdrawal by Subject|0|||
131227107|NCT01827371|472457780|FG003|Overall Study|Withdrawal by Subject|3|||
131227108|NCT01827371|472457777|FG000|Overall Study|Physician Decision|0|||
130716374|NCT04049617|470588833|FG001|Overall Study|Lost to Follow-up|0|||
130716375|NCT04049617|470588834|FG002|Overall Study|Lost to Follow-up|0|||
130716376|NCT04049617|470588835|FG003|Overall Study|Lost to Follow-up|1|||
130716377|NCT04049617|470588836|FG004|Overall Study|Lost to Follow-up|0|||
130716378|NCT04049617|470588837|FG005|Overall Study|Lost to Follow-up|0|||
130716379|NCT04049617|470588832|FG000|Overall Study|Withdrew consent|0|||
130716380|NCT04049617|470588833|FG001|Overall Study|Withdrew consent|0|||
130969067|NCT01910519|471513187|FG000|Overall Study|Adverse Event|2|||
130969068|NCT01910519|471513188|FG001|Overall Study|Adverse Event|0|||
130969069|NCT01664078|471513189|FG000|Overall Study|Death|9|||
130969070|NCT01664078|471513189|FG000|Overall Study|Withdrawal by Subject|4|||
130969071|NCT01664078|471513189|FG000|Overall Study|Lost to Follow-up|2|||
130969072|NCT01664078|471513189|FG000|Overall Study|missed 5 year visit|1|||
130969073|NCT01664078|471513189|FG000|Overall Study|Other|53|||
130969074|NCT02720484|471513192|FG000|Treatment on Study|Adverse Event|1|||
130969075|NCT02720484|471513192|FG000|Treatment on Study|Withdrawal by Subject|1|||
130969076|NCT02720484|471513192|FG000|Treatment on Study|Progressive Disease|4|||
130969077|NCT02720484|471513192|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
130969078|NCT02720484|471513192|FG000|Follow Up for 2 Years|Death|3|||
130969079|NCT02720484|471513192|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
130716381|NCT04049617|470588834|FG002|Overall Study|Withdrew consent|1|||
130716382|NCT04049617|470588835|FG003|Overall Study|Withdrew consent|0|||
130969080|NCT05070897|471513198|FG000|Overall Study|Protocol Violation|123|||
130716383|NCT04049617|470588836|FG004|Overall Study|Withdrew consent|0|||
130716384|NCT04049617|470588837|FG005|Overall Study|Withdrew consent|0|||
130716385|NCT03551496|470588838|FG000|Overall Study|Death|11|||
130969081|NCT05070897|471513199|FG001|Overall Study|Protocol Violation|68|||
130969082|NCT01617629|471513200|FG000|Overall Study|Death|2|||
130969083|NCT01617629|471513200|FG000|Overall Study|Investigator's Clinical Judgement|1|||
130969084|NCT01617629|471513200|FG000|Overall Study|Reason Not Specified|1|||
130969085|NCT01617629|471513200|FG000|Overall Study|Participant Withdrew Consent|2|||
130969086|NCT01337245|471513201|FG000|Overall Study|Lost to Follow-up|1|||
130969087|NCT01663636|471513202|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
130969088|NCT01663636|471513203|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
130969089|NCT03832946|471513204|FG000|Overall Study|Adverse Event|3|||
130969090|NCT03832946|471513205|FG001|Overall Study|Adverse Event|1|||
130969091|NCT03832946|471513204|FG000|Overall Study|Lost to Follow-up|1|||
130969092|NCT03832946|471513205|FG001|Overall Study|Lost to Follow-up|0|||
130969093|NCT03832946|471513204|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
130969094|NCT03832946|471513205|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
130969095|NCT03832946|471513204|FG000|Overall Study|Lack of Efficacy|1|||
130969096|NCT03832946|471513205|FG001|Overall Study|Lack of Efficacy|0|||
130969097|NCT03832946|471513204|FG000|Overall Study|Withdrawal by Subject|12|||
130969098|NCT03832946|471513205|FG001|Overall Study|Withdrawal by Subject|9|||
130969099|NCT02863991|471513210|FG000|Overall Study|Death|0|||
130969100|NCT02863991|471513211|FG001|Overall Study|Death|3|||
130969101|NCT02863991|471513210|FG000|Overall Study|Lack of Efficacy|0|||
130969102|NCT02863991|471513211|FG001|Overall Study|Lack of Efficacy|1|||
130969103|NCT02863991|471513210|FG000|Overall Study|Study Terminated|2|||
130969104|NCT02863991|471513211|FG001|Overall Study|Study Terminated|8|||
130969105|NCT00364858|471513212|FG000|Overall Study|Adverse Event|1|||
130969106|NCT00364858|471513213|FG001|Overall Study|Adverse Event|5|||
130969107|NCT00364858|471513212|FG000|Overall Study|Withdrawal by Subject|1|||
130969108|NCT00364858|471513213|FG001|Overall Study|Withdrawal by Subject|1|||
130969109|NCT00364858|471513212|FG000|Overall Study|Pregnancy|1|||
130969110|NCT00364858|471513213|FG001|Overall Study|Pregnancy|1|||
130969111|NCT00364858|471513212|FG000|Overall Study|Clinical failure|2|||
130969112|NCT00364858|471513213|FG001|Overall Study|Clinical failure|13|||
130969113|NCT00364858|471513212|FG000|Overall Study|Discontinuation at baseline|1|||
130969114|NCT00364858|471513213|FG001|Overall Study|Discontinuation at baseline|0|||
130969115|NCT00364858|471513212|FG000|Overall Study|Non-compliant|1|||
130969116|NCT00364858|471513213|FG001|Overall Study|Non-compliant|0|||
130969117|NCT00364858|471513212|FG000|Overall Study|Return to Q2 regimen|0|||
130969118|NCT00364858|471513213|FG001|Overall Study|Return to Q2 regimen|1|||
130969119|NCT00364858|471513212|FG000|Overall Study|Clinical baseline issue|0|||
130969120|NCT00364858|471513213|FG001|Overall Study|Clinical baseline issue|1|||
130969121|NCT01307501|471513214|FG000|Overall Study|Treatment Failure|1|||
130969122|NCT01307501|471513214|FG000|Overall Study|Death|20|||
130969123|NCT01307501|471513214|FG000|Overall Study|Lost to Follow-up|1|||
130969124|NCT01307501|471513214|FG000|Overall Study|Starting Hospice|1|||
130969125|NCT02730819|471513215|FG000|Overall Study|Lost to Follow-up|9|||
130969126|NCT01660906|471513216|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
130969127|NCT01438541|471513219|FG000|Overall Study|Physician Decision|1|||
130969128|NCT01438541|471513219|FG000|Overall Study|Withdrawal by Subject|1|||
130716386|NCT03551496|470588839|FG001|Overall Study|Death|7|||
130716387|NCT03551496|470588838|FG000|Overall Study|Withdrawal by Subject|4|||
130716388|NCT03551496|470588839|FG001|Overall Study|Withdrawal by Subject|3|||
130716389|NCT03551496|470588838|FG000|Overall Study|Other Reasons|1|||
130716390|NCT03551496|470588839|FG001|Overall Study|Other Reasons|0|||
130775705|NCT02501161|470806548|FG000|Overall Study|Lost to Follow-up|7|||
130775706|NCT02501161|470806549|FG001|Overall Study|Lost to Follow-up|4|||
130775707|NCT02501161|470806548|FG000|Overall Study|Withdrawal by Subject|10|||
130969129|NCT01438541|471513219|FG000|Overall Study|discharge from the hospital|5|||
130969130|NCT05349617|471515528|FG000|Overall Study|Death|1|||
130969131|NCT05349617|471515529|FG001|Overall Study|Death|1|||
130969132|NCT05349617|471515528|FG000|Overall Study|Lost to Follow-up|3|||
130969133|NCT05349617|471515529|FG001|Overall Study|Lost to Follow-up|8|||
130969134|NCT05349617|471515528|FG000|Overall Study|Withdrawal by Subject|2|||
130969135|NCT05349617|471515529|FG001|Overall Study|Withdrawal by Subject|10|||
130969136|NCT02367911|471515532|FG000|Overall Study|Withdrawal by Subject|3|||
130969137|NCT02367911|471515533|FG001|Overall Study|Withdrawal by Subject|2|||
130969138|NCT02367911|471515532|FG000|Overall Study|Lost to Follow-up|2|||
130969139|NCT02367911|471515533|FG001|Overall Study|Lost to Follow-up|2|||
130969140|NCT00902304|471515534|FG000|Overall Study|Adverse Event|4|||
130969141|NCT00902304|471515535|FG001|Overall Study|Adverse Event|10|||
130969142|NCT00902304|471515536|FG002|Overall Study|Adverse Event|25|||
130969143|NCT00902304|471515534|FG000|Overall Study|Investigator discretion|3|||
130969144|NCT00902304|471515535|FG001|Overall Study|Investigator discretion|5|||
130969145|NCT00902304|471515536|FG002|Overall Study|Investigator discretion|13|||
130969146|NCT00902304|471515534|FG000|Overall Study|Lost to Follow-up|7|||
130716391|NCT00140426|470588840|FG000|Overall Study|Withdrawal by Subject|0|||
130969147|NCT00902304|471515535|FG001|Overall Study|Lost to Follow-up|7|||
130969148|NCT00902304|471515536|FG002|Overall Study|Lost to Follow-up|7|||
130969149|NCT00902304|471515534|FG000|Overall Study|Protocol Violation|9|||
130969150|NCT00902304|471515535|FG001|Overall Study|Protocol Violation|18|||
130969151|NCT00902304|471515536|FG002|Overall Study|Protocol Violation|20|||
130969152|NCT00902304|471515534|FG000|Overall Study|Withdrawal by Subject|32|||
130969153|NCT00902304|471515535|FG001|Overall Study|Withdrawal by Subject|22|||
130969154|NCT00902304|471515536|FG002|Overall Study|Withdrawal by Subject|43|||
130969155|NCT00902304|471515534|FG000|Overall Study|includes pregnancy|3|||
130969156|NCT00902304|471515535|FG001|Overall Study|includes pregnancy|9|||
130969157|NCT00902304|471515536|FG002|Overall Study|includes pregnancy|2|||
130969158|NCT05706506|471515537|FG000|Overall Study|Adverse Event|1|||
130969159|NCT05706506|471515537|FG000|Overall Study|Withdrawal by Subject|4|||
130969160|NCT05706506|471515537|FG000|Overall Study|Lost to Follow-up|2|||
130969161|NCT05706506|471515537|FG000|Overall Study|Inadvertent Enrolment|12|||
130969162|NCT05706506|471515537|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
130969163|NCT05706506|471515537|FG000|Overall Study|Participant Moved Out of State|1|||
130969164|NCT05732454|471515538|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
130969165|NCT05732454|471515539|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
130969166|NCT05732454|471515538|FG000|Part 1: DB Period|Adverse Event|1|||
130969167|NCT05732454|471515539|FG001|Part 1: DB Period|Adverse Event|0|||
130969168|NCT05732454|471515538|FG000|Part 1: DB Period|Lost to Follow-up|1|||
130969169|NCT05732454|471515539|FG001|Part 1: DB Period|Lost to Follow-up|0|||
130969170|NCT05732454|471515538|FG000|Part 1: DB Period|Protocol Violation|0|||
130969171|NCT05732454|471515539|FG001|Part 1: DB Period|Protocol Violation|1|||
130969172|NCT05732454|471515538|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
130969173|NCT05732454|471515539|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
130969174|NCT05732454|471515538|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
130969175|NCT05732454|471515539|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
130969176|NCT05732454|471515538|FG000|Part 1: OLE Period|Adverse Event|0|||
130969177|NCT05732454|471515539|FG001|Part 1: OLE Period|Adverse Event|1|||
130969178|NCT05732454|471515538|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
130969179|NCT05732454|471515539|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
130969180|NCT01153633|471515540|FG000|Overall Study|Protocol Violation|1|||
130969181|NCT01153633|471515541|FG001|Overall Study|Protocol Violation|1|||
130969182|NCT01153633|471515540|FG000|Overall Study|Therapeutic failure|3|||
130969183|NCT01153633|471515541|FG001|Overall Study|Therapeutic failure|3|||
130969184|NCT04837482|471515542|FG000|Period 2|Withdrawal by Subject|0|||
130969185|NCT04837482|471515543|FG001|Period 2|Withdrawal by Subject|1|||
130969186|NCT02646423|471515544|FG000|Overall Study|Adverse Event|5|||
130969187|NCT02646423|471515545|FG001|Overall Study|Adverse Event|7|||
130716392|NCT00140426|470588841|FG001|Overall Study|Withdrawal by Subject|3|||
130716393|NCT02149108|470588842|FG000|Overall Study|Not treated|1|||
130716394|NCT02149108|470588843|FG001|Overall Study|Not treated|2|||
130969188|NCT02646423|471515544|FG000|Overall Study|Ineligible|2|||
130969189|NCT02646423|471515545|FG001|Overall Study|Ineligible|1|||
130969190|NCT02807948|471515546|FG000|Overall Study|Physician Decision|1|||
130969191|NCT02807948|471515547|FG001|Overall Study|Physician Decision|0|||
131128801|NCT00794157|472099605|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131128802|NCT00794157|472099606|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131128803|NCT00794157|472099607|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131128804|NCT00794157|472099605|FG000|Overall Study|Protocol deviation|0|||
131128805|NCT00794157|472099606|FG001|Overall Study|Protocol deviation|1|||
131128806|NCT00794157|472099607|FG002|Overall Study|Protocol deviation|1|||
130716395|NCT02149108|470588842|FG000|Overall Study|Progressive Disease (PD)|324|||
130716396|NCT02149108|470588843|FG001|Overall Study|Progressive Disease (PD)|318|||
130716397|NCT02149108|470588842|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
130716398|NCT02149108|470588843|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
130969192|NCT00760929|471515551|FG000|Overall Study|Adverse Event|2|||
130969193|NCT00760929|471515552|FG001|Overall Study|Adverse Event|0|||
130969194|NCT00760929|471515553|FG002|Overall Study|Adverse Event|6|||
130969195|NCT00760929|471515554|FG003|Overall Study|Adverse Event|10|||
130969196|NCT00760929|471515551|FG000|Overall Study|Lack of Efficacy|0|||
130969197|NCT00760929|471515552|FG001|Overall Study|Lack of Efficacy|2|||
130969198|NCT00760929|471515553|FG002|Overall Study|Lack of Efficacy|1|||
130969199|NCT00760929|471515554|FG003|Overall Study|Lack of Efficacy|0|||
130969200|NCT00760929|471515551|FG000|Overall Study|Withdrawal by Subject|1|||
130969201|NCT00760929|471515552|FG001|Overall Study|Withdrawal by Subject|0|||
130969202|NCT00760929|471515553|FG002|Overall Study|Withdrawal by Subject|9|||
130969203|NCT00760929|471515554|FG003|Overall Study|Withdrawal by Subject|1|||
130969204|NCT00760929|471515551|FG000|Overall Study|Lost to Follow-up|0|||
130969205|NCT00760929|471515552|FG001|Overall Study|Lost to Follow-up|0|||
130969206|NCT00760929|471515553|FG002|Overall Study|Lost to Follow-up|1|||
130969207|NCT00760929|471515554|FG003|Overall Study|Lost to Follow-up|0|||
130969208|NCT00760929|471515551|FG000|Overall Study|Progression of Disease|21|||
131128807|NCT01692275|472099608|FG000|Overall Study|Lost to Follow-up|57|||
131128808|NCT01692275|472099609|FG001|Overall Study|Lost to Follow-up|48|||
130969209|NCT00760929|471515552|FG001|Overall Study|Progression of Disease|26|||
130716399|NCT02149108|470588842|FG000|Overall Study|Other Adverse Event (AE)|8|||
130716400|NCT02149108|470588843|FG001|Overall Study|Other Adverse Event (AE)|18|||
130716401|NCT02149108|470588842|FG000|Overall Study|Other not defined above|0|||
130969210|NCT00760929|471515553|FG002|Overall Study|Progression of Disease|38|||
130969211|NCT00760929|471515554|FG003|Overall Study|Progression of Disease|42|||
130969212|NCT00760929|471515551|FG000|Overall Study|Other|2|||
130969213|NCT00760929|471515552|FG001|Overall Study|Other|0|||
130969214|NCT00760929|471515553|FG002|Overall Study|Other|2|||
130969215|NCT00760929|471515554|FG003|Overall Study|Other|1|||
130969216|NCT00760929|471515551|FG000|Overall Study|Death|0|||
130969217|NCT00760929|471515552|FG001|Overall Study|Death|0|||
130969218|NCT00760929|471515553|FG002|Overall Study|Death|1|||
130969219|NCT00760929|471515554|FG003|Overall Study|Death|0|||
130969220|NCT00760929|471515551|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
130969221|NCT00760929|471515552|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
130969222|NCT00760929|471515553|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
130969223|NCT00760929|471515554|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
130969224|NCT01227889|471515555|FG000|Randomized Phase (RP)|Adverse Event|13|||
130969225|NCT01227889|471515556|FG001|Randomized Phase (RP)|Adverse Event|0|||
130969226|NCT01227889|471515555|FG000|Randomized Phase (RP)|Physician Decision|13|||
130969227|NCT01227889|471515556|FG001|Randomized Phase (RP)|Physician Decision|5|||
130969228|NCT01227889|471515555|FG000|Randomized Phase (RP)|Progressive Disease|135|||
130969229|NCT01227889|471515556|FG001|Randomized Phase (RP)|Progressive Disease|52|||
130969230|NCT01227889|471515555|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
130969231|NCT01227889|471515556|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
130969232|NCT01227889|471515555|FG000|Randomized Phase (RP)|Missing|1|||
130969233|NCT01227889|471515556|FG001|Randomized Phase (RP)|Missing|3|||
130969234|NCT01227889|471515555|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
130969235|NCT01227889|471515556|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
130969236|NCT01227889|471515555|FG000|Crossover Phase|Adverse Event|0|||
130969237|NCT01227889|471515556|FG001|Crossover Phase|Adverse Event|1|||
130969238|NCT01227889|471515555|FG000|Crossover Phase|Physician Decision|0|||
130969239|NCT01227889|471515556|FG001|Crossover Phase|Physician Decision|3|||
130969240|NCT01227889|471515555|FG000|Crossover Phase|Progressive Disease|0|||
130969241|NCT01227889|471515556|FG001|Crossover Phase|Progressive Disease|31|||
130969242|NCT01227889|471515555|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
130969243|NCT01227889|471515556|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
130969244|NCT01227889|471515555|FG000|Crossover Phase|Withdrawal by Subject|0|||
130969245|NCT01227889|471515556|FG001|Crossover Phase|Withdrawal by Subject|1|||
130969246|NCT03268811|471515557|FG000|Overall Study|Adverse Event|0|||
130969247|NCT03268811|471515558|FG001|Overall Study|Adverse Event|1|||
130969248|NCT04827212|471515566|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
130969249|NCT04827212|471515567|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
130969250|NCT04827212|471515566|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
130969251|NCT04827212|471515567|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
130969252|NCT00941603|471515578|FG000|Overall Study|Adverse Event|10|||
130969253|NCT00941603|471515579|FG001|Overall Study|Adverse Event|15|||
130969254|NCT00941603|471515580|FG002|Overall Study|Adverse Event|5|||
130969255|NCT00941603|471515581|FG003|Overall Study|Adverse Event|1|||
130969256|NCT00941603|471515582|FG004|Overall Study|Adverse Event|4|||
130969257|NCT00941603|471515583|FG005|Overall Study|Adverse Event|0|||
130969258|NCT00941603|471515578|FG000|Overall Study|Lost to Follow-up|0|||
130969259|NCT00941603|471515579|FG001|Overall Study|Lost to Follow-up|0|||
130969260|NCT00941603|471515580|FG002|Overall Study|Lost to Follow-up|0|||
130969261|NCT00941603|471515581|FG003|Overall Study|Lost to Follow-up|1|||
130969262|NCT00941603|471515582|FG004|Overall Study|Lost to Follow-up|0|||
130969263|NCT00941603|471515583|FG005|Overall Study|Lost to Follow-up|2|||
130969264|NCT00941603|471515578|FG000|Overall Study|Withdrawal by Subject|0|||
131042375|NCT03519178|471789327|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042376|NCT03519178|471789328|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042377|NCT03519178|471789329|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042378|NCT03519178|471789330|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042379|NCT03519178|471789331|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042380|NCT03519178|471789332|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
131042381|NCT03519178|471789333|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042382|NCT03519178|471789334|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
130716402|NCT02149108|470588843|FG001|Overall Study|Other not defined above|2|||
130716403|NCT02149108|470588842|FG000|Overall Study|Refusal to continue trial medication|15|||
130969265|NCT00941603|471515579|FG001|Overall Study|Withdrawal by Subject|0|||
130969266|NCT00941603|471515580|FG002|Overall Study|Withdrawal by Subject|0|||
130969267|NCT00941603|471515581|FG003|Overall Study|Withdrawal by Subject|2|||
130969268|NCT00941603|471515582|FG004|Overall Study|Withdrawal by Subject|0|||
130969269|NCT00941603|471515583|FG005|Overall Study|Withdrawal by Subject|1|||
130969270|NCT00941603|471515578|FG000|Overall Study|Protocol Violation|0|||
131128809|NCT01692275|472099608|FG000|Overall Study|Withdrawal by Subject|9|||
131128810|NCT01692275|472099609|FG001|Overall Study|Withdrawal by Subject|11|||
131128811|NCT01624662|472099612|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
131042383|NCT03519178|471789335|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042384|NCT03519178|471789336|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
131042385|NCT03519178|471789322|FG000|Follow-Up|Death|0|||
131042386|NCT03519178|471789323|FG001|Follow-Up|Death|0|||
131042387|NCT03519178|471789324|FG002|Follow-Up|Death|1|||
131042388|NCT03519178|471789325|FG003|Follow-Up|Death|0|||
131042389|NCT03519178|471789326|FG004|Follow-Up|Death|0|||
131042390|NCT03519178|471789327|FG005|Follow-Up|Death|0|||
131042391|NCT03519178|471789328|FG006|Follow-Up|Death|0|||
131042392|NCT03519178|471789329|FG007|Follow-Up|Death|0|||
131042393|NCT03519178|471789330|FG008|Follow-Up|Death|3|||
131042394|NCT03519178|471789331|FG009|Follow-Up|Death|1|||
131042395|NCT03519178|471789332|FG010|Follow-Up|Death|0|||
131042396|NCT03519178|471789333|FG011|Follow-Up|Death|0|||
131042397|NCT03519178|471789334|FG012|Follow-Up|Death|2|||
131042398|NCT03519178|471789335|FG013|Follow-Up|Death|0|||
131042399|NCT03519178|471789336|FG014|Follow-Up|Death|0|||
131042400|NCT03519178|471789322|FG000|Follow-Up|Lost to Follow-up|0|||
131042401|NCT03519178|471789323|FG001|Follow-Up|Lost to Follow-up|0|||
131042402|NCT03519178|471789324|FG002|Follow-Up|Lost to Follow-up|0|||
131042403|NCT03519178|471789325|FG003|Follow-Up|Lost to Follow-up|0|||
131042404|NCT03519178|471789326|FG004|Follow-Up|Lost to Follow-up|0|||
131042405|NCT03519178|471789327|FG005|Follow-Up|Lost to Follow-up|3|||
131128812|NCT01624662|472099613|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
131128813|NCT01624662|472099614|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
131128814|NCT01624662|472099615|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
131128815|NCT01624662|472099612|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
131128816|NCT01624662|472099613|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
131128817|NCT01624662|472099614|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
130969271|NCT00941603|471515579|FG001|Overall Study|Protocol Violation|1|||
130969272|NCT00941603|471515580|FG002|Overall Study|Protocol Violation|0|||
130969273|NCT00941603|471515581|FG003|Overall Study|Protocol Violation|0|||
130969274|NCT00941603|471515582|FG004|Overall Study|Protocol Violation|0|||
130969275|NCT00941603|471515583|FG005|Overall Study|Protocol Violation|0|||
130969276|NCT00941603|471515578|FG000|Overall Study|Did not meet protocol eligibility|1|||
130969277|NCT00941603|471515579|FG001|Overall Study|Did not meet protocol eligibility|0|||
130969278|NCT00941603|471515580|FG002|Overall Study|Did not meet protocol eligibility|0|||
130969279|NCT00941603|471515581|FG003|Overall Study|Did not meet protocol eligibility|0|||
130969280|NCT00941603|471515582|FG004|Overall Study|Did not meet protocol eligibility|0|||
130969281|NCT00941603|471515583|FG005|Overall Study|Did not meet protocol eligibility|0|||
130969282|NCT02014116|471515585|FG000|Overall Study|Progressive Disease|3|||
130969283|NCT02014116|471515586|FG001|Overall Study|Progressive Disease|4|||
130969284|NCT02014116|471515587|FG002|Overall Study|Progressive Disease|2|||
130969285|NCT02014116|471515588|FG003|Overall Study|Progressive Disease|6|||
130969286|NCT02014116|471515589|FG004|Overall Study|Progressive Disease|1|||
130969287|NCT02014116|471515590|FG005|Overall Study|Progressive Disease|13|||
130969288|NCT02014116|471515591|FG006|Overall Study|Progressive Disease|1|||
130969289|NCT02014116|471515592|FG007|Overall Study|Progressive Disease|3|||
130969290|NCT02014116|471515593|FG008|Overall Study|Progressive Disease|7|||
130969291|NCT02014116|471515585|FG000|Overall Study|Adverse Event|0|||
130969292|NCT02014116|471515586|FG001|Overall Study|Adverse Event|0|||
130969293|NCT02014116|471515587|FG002|Overall Study|Adverse Event|0|||
130969294|NCT02014116|471515588|FG003|Overall Study|Adverse Event|0|||
130969295|NCT02014116|471515589|FG004|Overall Study|Adverse Event|1|||
130969296|NCT02014116|471515590|FG005|Overall Study|Adverse Event|0|||
130969297|NCT02014116|471515591|FG006|Overall Study|Adverse Event|0|||
130969298|NCT02014116|471515592|FG007|Overall Study|Adverse Event|1|||
130969299|NCT02014116|471515593|FG008|Overall Study|Adverse Event|0|||
131042406|NCT03519178|471789328|FG006|Follow-Up|Lost to Follow-up|1|||
131042407|NCT03519178|471789329|FG007|Follow-Up|Lost to Follow-up|4|||
131042408|NCT03519178|471789330|FG008|Follow-Up|Lost to Follow-up|1|||
131042409|NCT03519178|471789331|FG009|Follow-Up|Lost to Follow-up|0|||
130969300|NCT02014116|471515585|FG000|Overall Study|Lost to Follow-up|0|||
130969301|NCT02014116|471515586|FG001|Overall Study|Lost to Follow-up|0|||
130969302|NCT02014116|471515587|FG002|Overall Study|Lost to Follow-up|0|||
130969303|NCT02014116|471515588|FG003|Overall Study|Lost to Follow-up|0|||
130969304|NCT02014116|471515589|FG004|Overall Study|Lost to Follow-up|0|||
130969305|NCT02014116|471515590|FG005|Overall Study|Lost to Follow-up|1|||
130969306|NCT02014116|471515591|FG006|Overall Study|Lost to Follow-up|0|||
130969307|NCT02014116|471515592|FG007|Overall Study|Lost to Follow-up|0|||
130969308|NCT02014116|471515593|FG008|Overall Study|Lost to Follow-up|1|||
130969309|NCT02014116|471515585|FG000|Overall Study|Death|0|||
131042410|NCT03519178|471789332|FG010|Follow-Up|Lost to Follow-up|0|||
131042411|NCT03519178|471789333|FG011|Follow-Up|Lost to Follow-up|0|||
131042412|NCT03519178|471789334|FG012|Follow-Up|Lost to Follow-up|0|||
131042413|NCT03519178|471789335|FG013|Follow-Up|Lost to Follow-up|0|||
131042414|NCT03519178|471789336|FG014|Follow-Up|Lost to Follow-up|0|||
130716404|NCT02149108|470588843|FG001|Overall Study|Refusal to continue trial medication|11|||
130716405|NCT02149108|470588842|FG000|Overall Study|Lost to Follow-up|1|||
130716406|NCT02149108|470588843|FG001|Overall Study|Lost to Follow-up|0|||
130969310|NCT02014116|471515586|FG001|Overall Study|Death|0|||
130969311|NCT02014116|471515587|FG002|Overall Study|Death|0|||
130969312|NCT02014116|471515588|FG003|Overall Study|Death|0|||
130969313|NCT02014116|471515589|FG004|Overall Study|Death|0|||
130969314|NCT02014116|471515590|FG005|Overall Study|Death|0|||
130969315|NCT02014116|471515591|FG006|Overall Study|Death|0|||
130969316|NCT02014116|471515592|FG007|Overall Study|Death|1|||
130969317|NCT02014116|471515593|FG008|Overall Study|Death|1|||
130969318|NCT02014116|471515585|FG000|Overall Study|Withdrawal by Subject|0|||
130969319|NCT02014116|471515586|FG001|Overall Study|Withdrawal by Subject|0|||
130969320|NCT02014116|471515587|FG002|Overall Study|Withdrawal by Subject|1|||
130969321|NCT02014116|471515588|FG003|Overall Study|Withdrawal by Subject|1|||
130969322|NCT02014116|471515589|FG004|Overall Study|Withdrawal by Subject|0|||
130969323|NCT02014116|471515590|FG005|Overall Study|Withdrawal by Subject|1|||
130969324|NCT02014116|471515591|FG006|Overall Study|Withdrawal by Subject|0|||
130969325|NCT02014116|471515592|FG007|Overall Study|Withdrawal by Subject|0|||
130969326|NCT02014116|471515593|FG008|Overall Study|Withdrawal by Subject|0|||
130969327|NCT02014116|471515585|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
130969328|NCT02014116|471515586|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
130969329|NCT02014116|471515587|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
130969330|NCT02014116|471515588|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
130969331|NCT02014116|471515589|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
130969332|NCT02014116|471515590|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
130969333|NCT02014116|471515591|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
130969334|NCT02014116|471515592|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
130969335|NCT02014116|471515593|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
130969336|NCT02014116|471515585|FG000|Overall Study|Physician Decision|0|||
130969337|NCT02014116|471515586|FG001|Overall Study|Physician Decision|0|||
130969338|NCT02014116|471515587|FG002|Overall Study|Physician Decision|0|||
130969339|NCT02014116|471515588|FG003|Overall Study|Physician Decision|0|||
130969340|NCT02014116|471515589|FG004|Overall Study|Physician Decision|0|||
130969341|NCT02014116|471515590|FG005|Overall Study|Physician Decision|0|||
130969342|NCT02014116|471515591|FG006|Overall Study|Physician Decision|0|||
130969343|NCT02014116|471515592|FG007|Overall Study|Physician Decision|0|||
130969344|NCT02014116|471515593|FG008|Overall Study|Physician Decision|1|||
130969345|NCT02347761|471515594|FG000|All Collected|Death|1|||
130969346|NCT02347761|471515595|FG001|All Collected|Death|0|||
130969347|NCT02347761|471515596|FG002|All Collected|Death|0|||
130969348|NCT02347761|471515594|FG000|All Collected|Lost to Follow-up|3|||
130969349|NCT02347761|471515595|FG001|All Collected|Lost to Follow-up|2|||
130969350|NCT02347761|471515596|FG002|All Collected|Lost to Follow-up|3|||
130969351|NCT02347761|471515594|FG000|All Collected|Withdrawal by Subject|11|||
130969352|NCT02347761|471515595|FG001|All Collected|Withdrawal by Subject|11|||
130969353|NCT02347761|471515596|FG002|All Collected|Withdrawal by Subject|22|||
130969354|NCT02347761|471515594|FG000|All Collected|invetigator disretion|2|||
130969355|NCT02347761|471515595|FG001|All Collected|invetigator disretion|0|||
130969356|NCT02347761|471515596|FG002|All Collected|invetigator disretion|0|||
130969357|NCT02347761|471515594|FG000|All Collected|instillation site pain|0|||
130969358|NCT02347761|471515595|FG001|All Collected|instillation site pain|0|||
130969359|NCT02347761|471515596|FG002|All Collected|instillation site pain|1|||
130969360|NCT02347761|471515594|FG000|All Collected|exacerbation of COPD|0|||
130969361|NCT02347761|471515595|FG001|All Collected|exacerbation of COPD|0|||
130969362|NCT02347761|471515596|FG002|All Collected|exacerbation of COPD|1|||
130969363|NCT02347761|471515594|FG000|All Collected|moved/travel|0|||
130969364|NCT02347761|471515595|FG001|All Collected|moved/travel|1|||
130969365|NCT02347761|471515596|FG002|All Collected|moved/travel|0|||
130969366|NCT02347761|471515594|FG000|On Study Treatment|Lack of Efficacy|2|||
130716407|NCT04765384|470588844|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
130716408|NCT04765384|470588845|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
130716409|NCT04765384|470588846|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
130716410|NCT04765384|470588847|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
130969367|NCT02347761|471515595|FG001|On Study Treatment|Lack of Efficacy|3|||
130969368|NCT02347761|471515596|FG002|On Study Treatment|Lack of Efficacy|4|||
130969369|NCT02347761|471515594|FG000|On Study Treatment|non-compliance with study medication|0|||
130969370|NCT02347761|471515595|FG001|On Study Treatment|non-compliance with study medication|0|||
130969371|NCT02347761|471515596|FG002|On Study Treatment|non-compliance with study medication|2|||
130969372|NCT02347761|471515594|FG000|On Study Treatment|Withdrawal by Subject|7|||
130969373|NCT02347761|471515595|FG001|On Study Treatment|Withdrawal by Subject|3|||
130716411|NCT04765384|470588848|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
130969374|NCT02347761|471515596|FG002|On Study Treatment|Withdrawal by Subject|5|||
130969375|NCT02347761|471515594|FG000|On Study Treatment|move/travel|2|||
130969376|NCT02347761|471515595|FG001|On Study Treatment|move/travel|6|||
130969377|NCT02347761|471515596|FG002|On Study Treatment|move/travel|5|||
130969378|NCT02347761|471515594|FG000|On Study Treatment|dissastisfaction with device|2|||
131128818|NCT01624662|472099615|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
130969379|NCT02347761|471515595|FG001|On Study Treatment|dissastisfaction with device|1|||
130969380|NCT02347761|471515596|FG002|On Study Treatment|dissastisfaction with device|4|||
130969381|NCT02347761|471515594|FG000|On Study Treatment|Lost to Follow-up|2|||
130969382|NCT02347761|471515595|FG001|On Study Treatment|Lost to Follow-up|1|||
130969383|NCT02347761|471515596|FG002|On Study Treatment|Lost to Follow-up|1|||
130969384|NCT02347761|471515594|FG000|On Study Treatment|investigator discretion|2|||
130969385|NCT02347761|471515595|FG001|On Study Treatment|investigator discretion|0|||
130969386|NCT02347761|471515596|FG002|On Study Treatment|investigator discretion|0|||
130969387|NCT02347761|471515594|FG000|On Study Treatment|durg not working|0|||
130969388|NCT02347761|471515595|FG001|On Study Treatment|durg not working|1|||
130969389|NCT02347761|471515596|FG002|On Study Treatment|durg not working|1|||
130969390|NCT02347761|471515594|FG000|On Study Treatment|Adverse Event|10|||
130969391|NCT02347761|471515595|FG001|On Study Treatment|Adverse Event|8|||
130969392|NCT02347761|471515596|FG002|On Study Treatment|Adverse Event|20|||
130969393|NCT03879798|471515597|FG000|Overall Study|Adverse Event|0|||
130969394|NCT03879798|471515598|FG001|Overall Study|Adverse Event|0|||
130969395|NCT03879798|471515599|FG002|Overall Study|Adverse Event|0|||
130969396|NCT03879798|471515600|FG003|Overall Study|Adverse Event|0|||
130969397|NCT03879798|471515601|FG004|Overall Study|Adverse Event|0|||
130969398|NCT03879798|471515602|FG005|Overall Study|Adverse Event|1|||
130969399|NCT03879798|471515597|FG000|Overall Study|Lack of Efficacy|0|||
130969400|NCT03879798|471515598|FG001|Overall Study|Lack of Efficacy|0|||
130969401|NCT03879798|471515599|FG002|Overall Study|Lack of Efficacy|0|||
130969402|NCT03879798|471515600|FG003|Overall Study|Lack of Efficacy|0|||
130969403|NCT03879798|471515601|FG004|Overall Study|Lack of Efficacy|0|||
130969404|NCT03879798|471515602|FG005|Overall Study|Lack of Efficacy|1|||
130969405|NCT03879798|471515597|FG000|Overall Study|Withdrawal by Subject|0|||
130969406|NCT03879798|471515598|FG001|Overall Study|Withdrawal by Subject|0|||
130969407|NCT03879798|471515599|FG002|Overall Study|Withdrawal by Subject|0|||
130969408|NCT03879798|471515600|FG003|Overall Study|Withdrawal by Subject|0|||
130969409|NCT03879798|471515601|FG004|Overall Study|Withdrawal by Subject|0|||
130969410|NCT03879798|471515602|FG005|Overall Study|Withdrawal by Subject|1|||
130969411|NCT03625570|471515603|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
130969412|NCT03625570|471515604|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
130969413|NCT03625570|471515603|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
130969414|NCT03625570|471515604|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
130969415|NCT03625570|471515603|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
130969416|NCT03625570|471515604|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
130969417|NCT05348681|471515608|FG000|Overall Study|Study terminated by Sponsor|8|||
130969418|NCT05348681|471515609|FG001|Overall Study|Study terminated by Sponsor|3|||
130969419|NCT05348681|471515608|FG000|Overall Study|Withdrawal by Subject|1|||
130969420|NCT05348681|471515609|FG001|Overall Study|Withdrawal by Subject|1|||
130969421|NCT05348681|471515608|FG000|Overall Study|Lost to Follow-up|1|||
130969422|NCT05348681|471515609|FG001|Overall Study|Lost to Follow-up|1|||
130969423|NCT05348681|471515608|FG000|Overall Study|Adverse Event|1|||
130969424|NCT05348681|471515609|FG001|Overall Study|Adverse Event|0|||
130969425|NCT05348681|471515608|FG000|Overall Study|Other|2|||
130969426|NCT05348681|471515609|FG001|Overall Study|Other|1|||
130969427|NCT00782340|471515610|FG000|Open Label Titration|Adverse Event|12|||
130969428|NCT00782340|471515611|FG001|Open Label Titration|Adverse Event|0|||
130969429|NCT00782340|471515612|FG002|Open Label Titration|Adverse Event|0|||
130969430|NCT00782340|471515610|FG000|Open Label Titration|Treatment failure|50|||
130969431|NCT00782340|471515611|FG001|Open Label Titration|Treatment failure|0|||
130969432|NCT00782340|471515612|FG002|Open Label Titration|Treatment failure|0|||
130969433|NCT00782340|471515610|FG000|Open Label Titration|Protocol Violation|5|||
130969434|NCT00782340|471515611|FG001|Open Label Titration|Protocol Violation|0|||
130969435|NCT00782340|471515612|FG002|Open Label Titration|Protocol Violation|0|||
130969436|NCT00782340|471515610|FG000|Open Label Titration|Withdrawal by Subject|5|||
130969437|NCT00782340|471515611|FG001|Open Label Titration|Withdrawal by Subject|0|||
130969438|NCT00782340|471515612|FG002|Open Label Titration|Withdrawal by Subject|0|||
130969439|NCT00782340|471515610|FG000|Open Label Titration|Enrollment capped|16|||
130969440|NCT00782340|471515611|FG001|Open Label Titration|Enrollment capped|0|||
131128819|NCT01624662|472099612|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130969441|NCT00782340|471515612|FG002|Open Label Titration|Enrollment capped|0|||
130969442|NCT00782340|471515610|FG000|Open Label Titration|Did not meet responder criteria|2|||
130969443|NCT00782340|471515611|FG001|Open Label Titration|Did not meet responder criteria|0|||
130969444|NCT00782340|471515612|FG002|Open Label Titration|Did not meet responder criteria|0|||
130969445|NCT00782340|471515610|FG000|Open Label Titration|Lost to Follow-up|5|||
130969446|NCT00782340|471515611|FG001|Open Label Titration|Lost to Follow-up|0|||
130969447|NCT00782340|471515612|FG002|Open Label Titration|Lost to Follow-up|0|||
130969448|NCT00782340|471515610|FG000|Open Label Titration|Randomized in error|6|||
130969449|NCT00782340|471515611|FG001|Open Label Titration|Randomized in error|0|||
130969450|NCT00782340|471515612|FG002|Open Label Titration|Randomized in error|0|||
131042415|NCT03519178|471789322|FG000|Follow-Up|Withdrawal by Subject|1|||
131042416|NCT03519178|471789323|FG001|Follow-Up|Withdrawal by Subject|2|||
131042417|NCT03519178|471789324|FG002|Follow-Up|Withdrawal by Subject|2|||
131042418|NCT03519178|471789325|FG003|Follow-Up|Withdrawal by Subject|3|||
131042419|NCT03519178|471789326|FG004|Follow-Up|Withdrawal by Subject|5|||
131042420|NCT03519178|471789327|FG005|Follow-Up|Withdrawal by Subject|1|||
131042421|NCT03519178|471789328|FG006|Follow-Up|Withdrawal by Subject|2|||
131042422|NCT03519178|471789329|FG007|Follow-Up|Withdrawal by Subject|6|||
131042423|NCT03519178|471789330|FG008|Follow-Up|Withdrawal by Subject|5|||
131042424|NCT03519178|471789331|FG009|Follow-Up|Withdrawal by Subject|2|||
131042425|NCT03519178|471789332|FG010|Follow-Up|Withdrawal by Subject|3|||
131042426|NCT03519178|471789333|FG011|Follow-Up|Withdrawal by Subject|5|||
131042427|NCT03519178|471789334|FG012|Follow-Up|Withdrawal by Subject|2|||
131042428|NCT03519178|471789335|FG013|Follow-Up|Withdrawal by Subject|0|||
131042429|NCT03519178|471789336|FG014|Follow-Up|Withdrawal by Subject|0|||
131042430|NCT03519178|471789322|FG000|Follow-Up|Other|0|||
131042431|NCT03519178|471789323|FG001|Follow-Up|Other|0|||
131042432|NCT03519178|471789324|FG002|Follow-Up|Other|0|||
131042433|NCT03519178|471789325|FG003|Follow-Up|Other|0|||
131042434|NCT03519178|471789326|FG004|Follow-Up|Other|0|||
131042435|NCT03519178|471789327|FG005|Follow-Up|Other|0|||
131042436|NCT03519178|471789328|FG006|Follow-Up|Other|0|||
131042437|NCT03519178|471789329|FG007|Follow-Up|Other|1|||
131042438|NCT03519178|471789330|FG008|Follow-Up|Other|0|||
131042439|NCT03519178|471789331|FG009|Follow-Up|Other|0|||
131042440|NCT03519178|471789332|FG010|Follow-Up|Other|0|||
131042441|NCT03519178|471789333|FG011|Follow-Up|Other|0|||
131042442|NCT03519178|471789334|FG012|Follow-Up|Other|0|||
131042443|NCT03519178|471789335|FG013|Follow-Up|Other|0|||
131042444|NCT03519178|471789336|FG014|Follow-Up|Other|0|||
131042445|NCT03519178|471789322|FG000|Long-term Follow-up|Death|0|||
131042446|NCT03519178|471789323|FG001|Long-term Follow-up|Death|0|||
131042447|NCT03519178|471789324|FG002|Long-term Follow-up|Death|0|||
131042448|NCT03519178|471789325|FG003|Long-term Follow-up|Death|0|||
131042449|NCT03519178|471789326|FG004|Long-term Follow-up|Death|0|||
131042450|NCT03519178|471789327|FG005|Long-term Follow-up|Death|0|||
131042451|NCT03519178|471789328|FG006|Long-term Follow-up|Death|0|||
131042452|NCT03519178|471789329|FG007|Long-term Follow-up|Death|0|||
131042453|NCT03519178|471789330|FG008|Long-term Follow-up|Death|0|||
131042454|NCT03519178|471789331|FG009|Long-term Follow-up|Death|0|||
131042455|NCT03519178|471789332|FG010|Long-term Follow-up|Death|0|||
131042456|NCT03519178|471789333|FG011|Long-term Follow-up|Death|0|||
131042457|NCT03519178|471789334|FG012|Long-term Follow-up|Death|0|||
131042458|NCT03519178|471789335|FG013|Long-term Follow-up|Death|4|||
131042459|NCT03519178|471789336|FG014|Long-term Follow-up|Death|4|||
131042460|NCT03519178|471789322|FG000|Long-term Follow-up|Lost to Follow-up|0|||
131042461|NCT03519178|471789323|FG001|Long-term Follow-up|Lost to Follow-up|0|||
131042462|NCT03519178|471789324|FG002|Long-term Follow-up|Lost to Follow-up|0|||
131042463|NCT03519178|471789325|FG003|Long-term Follow-up|Lost to Follow-up|0|||
131042464|NCT03519178|471789326|FG004|Long-term Follow-up|Lost to Follow-up|0|||
131042465|NCT03519178|471789327|FG005|Long-term Follow-up|Lost to Follow-up|0|||
131042466|NCT03519178|471789328|FG006|Long-term Follow-up|Lost to Follow-up|0|||
131042467|NCT03519178|471789329|FG007|Long-term Follow-up|Lost to Follow-up|0|||
131042468|NCT03519178|471789330|FG008|Long-term Follow-up|Lost to Follow-up|0|||
131042469|NCT03519178|471789331|FG009|Long-term Follow-up|Lost to Follow-up|0|||
131042470|NCT03519178|471789332|FG010|Long-term Follow-up|Lost to Follow-up|0|||
131042471|NCT03519178|471789333|FG011|Long-term Follow-up|Lost to Follow-up|0|||
131042472|NCT03519178|471789334|FG012|Long-term Follow-up|Lost to Follow-up|0|||
131042473|NCT03519178|471789335|FG013|Long-term Follow-up|Lost to Follow-up|1|||
131042474|NCT03519178|471789336|FG014|Long-term Follow-up|Lost to Follow-up|1|||
131042475|NCT03519178|471789322|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
131042476|NCT03519178|471789323|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
130775708|NCT02501161|470806549|FG001|Overall Study|Withdrawal by Subject|15|||
131042477|NCT03519178|471789324|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
131042478|NCT03519178|471789325|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
131042479|NCT03519178|471789326|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
131042480|NCT03519178|471789327|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
131042481|NCT03519178|471789328|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
131042482|NCT03519178|471789329|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
131042483|NCT03519178|471789330|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
131042484|NCT03519178|471789331|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
131042485|NCT03519178|471789332|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
131042486|NCT03519178|471789333|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
131042487|NCT03519178|471789334|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
131042488|NCT03519178|471789335|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
131042489|NCT03519178|471789336|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
131042490|NCT03519178|471789322|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
131042491|NCT03519178|471789323|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
131042492|NCT03519178|471789324|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
131042493|NCT03519178|471789325|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
131042494|NCT03519178|471789326|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
130969451|NCT01568047|471515618|FG000|Overall Study|Ineligibility|1|||
130969452|NCT01568047|471515619|FG001|Overall Study|Ineligibility|0|||
130969453|NCT01568047|471515620|FG002|Overall Study|Ineligibility|0|||
130969454|NCT01568047|471515621|FG003|Overall Study|Ineligibility|0|||
130969455|NCT01568047|471515618|FG000|Overall Study|Withdrawal by Subject|0|||
130969456|NCT01568047|471515619|FG001|Overall Study|Withdrawal by Subject|1|||
130969457|NCT01568047|471515620|FG002|Overall Study|Withdrawal by Subject|0|||
130969458|NCT01568047|471515621|FG003|Overall Study|Withdrawal by Subject|0|||
130969459|NCT01568047|471515618|FG000|Overall Study|Adverse Event|0|||
130969460|NCT01568047|471515619|FG001|Overall Study|Adverse Event|0|||
130969461|NCT01568047|471515620|FG002|Overall Study|Adverse Event|1|||
130969462|NCT01568047|471515621|FG003|Overall Study|Adverse Event|1|||
130969463|NCT01944046|471515622|FG000|Randomized to DB|Adverse Event|5|||
130969464|NCT01944046|471515623|FG001|Randomized to DB|Adverse Event|2|||
130969465|NCT01944046|471515622|FG000|Randomized to DB|Clinical Worsening|3|||
130969466|NCT01944046|471515623|FG001|Randomized to DB|Clinical Worsening|2|||
130969467|NCT01944046|471515622|FG000|Randomized to DB|Lost to Follow-up|3|||
130969468|NCT01944046|471515623|FG001|Randomized to DB|Lost to Follow-up|3|||
130969469|NCT01944046|471515622|FG000|Randomized to DB|Withdrawal by Subject|2|||
130969470|NCT01944046|471515623|FG001|Randomized to DB|Withdrawal by Subject|4|||
130969471|NCT01944046|471515622|FG000|Randomized to DB|Physician Decision|1|||
130969472|NCT01944046|471515623|FG001|Randomized to DB|Physician Decision|2|||
130969473|NCT01944046|471515622|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
130969474|NCT01944046|471515623|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
130969475|NCT01944046|471515622|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
130969476|NCT01944046|471515623|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
130969477|NCT01944046|471515622|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
130969478|NCT01944046|471515623|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
130969479|NCT01944046|471515622|FG000|Open Label Eligible and Consented|Adverse Event|6|||
130969480|NCT01944046|471515623|FG001|Open Label Eligible and Consented|Adverse Event|1|||
130969481|NCT01944046|471515622|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
130969482|NCT01944046|471515623|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
130969483|NCT01944046|471515622|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
130969484|NCT01944046|471515623|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
130969485|NCT02007577|471515625|FG000|Overall Study|Adverse Event|1|||
130969486|NCT02007577|471515626|FG001|Overall Study|Adverse Event|0|||
130969487|NCT02007577|471515625|FG000|Overall Study|Withdrawal by Subject|0|||
130969488|NCT02007577|471515626|FG001|Overall Study|Withdrawal by Subject|1|||
130969489|NCT02504294|471515627|FG000|Overall Study|Adverse Event|15|||
130969490|NCT02504294|471515628|FG001|Overall Study|Adverse Event|12|||
130969491|NCT02504294|471515627|FG000|Overall Study|Withdrawal by Subject|7|||
130969492|NCT02504294|471515628|FG001|Overall Study|Withdrawal by Subject|1|||
130969493|NCT02504294|471515627|FG000|Overall Study|Protocol Violation|27|||
130969494|NCT02504294|471515628|FG001|Overall Study|Protocol Violation|26|||
130969495|NCT02504294|471515627|FG000|Overall Study|Physician Decision|1|||
130969496|NCT02504294|471515628|FG001|Overall Study|Physician Decision|2|||
130969497|NCT02504294|471515627|FG000|Overall Study|Lost to Follow-up|6|||
130969498|NCT02504294|471515628|FG001|Overall Study|Lost to Follow-up|7|||
130969499|NCT01953926|471515629|FG000|Overall Study|Withdrawal by Subject|23|||
130969500|NCT01953926|471515630|FG001|Overall Study|Withdrawal by Subject|3|||
130969501|NCT01953926|471515631|FG002|Overall Study|Withdrawal by Subject|3|||
130969502|NCT01953926|471515632|FG003|Overall Study|Withdrawal by Subject|5|||
130969503|NCT01953926|471515633|FG004|Overall Study|Withdrawal by Subject|6|||
130969504|NCT01953926|471515634|FG005|Overall Study|Withdrawal by Subject|0|||
130969505|NCT01953926|471515635|FG006|Overall Study|Withdrawal by Subject|1|||
130969506|NCT01953926|471515629|FG000|Overall Study|Physician Decision|1|||
130969507|NCT01953926|471515630|FG001|Overall Study|Physician Decision|0|||
130969508|NCT01953926|471515631|FG002|Overall Study|Physician Decision|0|||
130969509|NCT01953926|471515632|FG003|Overall Study|Physician Decision|0|||
130969510|NCT01953926|471515633|FG004|Overall Study|Physician Decision|2|||
130969511|NCT01953926|471515634|FG005|Overall Study|Physician Decision|0|||
130969512|NCT01953926|471515635|FG006|Overall Study|Physician Decision|0|||
130969513|NCT01953926|471515629|FG000|Overall Study|Lost to Follow-up|18|||
130969514|NCT01953926|471515630|FG001|Overall Study|Lost to Follow-up|3|||
130969515|NCT01953926|471515631|FG002|Overall Study|Lost to Follow-up|0|||
130969516|NCT01953926|471515632|FG003|Overall Study|Lost to Follow-up|5|||
130969517|NCT01953926|471515633|FG004|Overall Study|Lost to Follow-up|3|||
130969518|NCT01953926|471515634|FG005|Overall Study|Lost to Follow-up|0|||
130969519|NCT01953926|471515635|FG006|Overall Study|Lost to Follow-up|0|||
130969520|NCT01953926|471515629|FG000|Overall Study|Protocol Violation|1|||
130969521|NCT01953926|471515630|FG001|Overall Study|Protocol Violation|0|||
130969522|NCT01953926|471515631|FG002|Overall Study|Protocol Violation|0|||
130969523|NCT01953926|471515632|FG003|Overall Study|Protocol Violation|0|||
130969524|NCT01953926|471515633|FG004|Overall Study|Protocol Violation|0|||
130969525|NCT01953926|471515634|FG005|Overall Study|Protocol Violation|0|||
130969526|NCT01953926|471515635|FG006|Overall Study|Protocol Violation|0|||
130969527|NCT01953926|471515629|FG000|Overall Study|Other, Disease progression|2|||
131128820|NCT01624662|472099613|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
131128821|NCT01624662|472099614|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
131128822|NCT01624662|472099615|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
131128823|NCT01624662|472099612|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
131128824|NCT01624662|472099613|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
131128825|NCT01624662|472099614|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
130969528|NCT01953926|471515630|FG001|Overall Study|Other, Disease progression|1|||
130969529|NCT01953926|471515631|FG002|Overall Study|Other, Disease progression|0|||
130969530|NCT01953926|471515632|FG003|Overall Study|Other, Disease progression|0|||
130969531|NCT01953926|471515633|FG004|Overall Study|Other, Disease progression|1|||
130969532|NCT01953926|471515634|FG005|Overall Study|Other, Disease progression|0|||
130969533|NCT01953926|471515635|FG006|Overall Study|Other, Disease progression|0|||
130969534|NCT01953926|471515629|FG000|Overall Study|Discontinuation of study by sponsor|41|||
130969535|NCT01953926|471515630|FG001|Overall Study|Discontinuation of study by sponsor|7|||
130969536|NCT01953926|471515631|FG002|Overall Study|Discontinuation of study by sponsor|5|||
130969537|NCT01953926|471515632|FG003|Overall Study|Discontinuation of study by sponsor|12|||
130969538|NCT01953926|471515633|FG004|Overall Study|Discontinuation of study by sponsor|46|||
130969539|NCT01953926|471515634|FG005|Overall Study|Discontinuation of study by sponsor|5|||
130969540|NCT01953926|471515635|FG006|Overall Study|Discontinuation of study by sponsor|6|||
130969541|NCT01953926|471515629|FG000|Overall Study|Not Treated|1|||
130969542|NCT01953926|471515630|FG001|Overall Study|Not Treated|0|||
130969543|NCT01953926|471515631|FG002|Overall Study|Not Treated|1|||
130969544|NCT01953926|471515632|FG003|Overall Study|Not Treated|0|||
130969545|NCT01953926|471515633|FG004|Overall Study|Not Treated|0|||
130969546|NCT01953926|471515634|FG005|Overall Study|Not Treated|0|||
130969547|NCT01953926|471515635|FG006|Overall Study|Not Treated|0|||
130969548|NCT02338362|471515636|FG000|Overall Study|Withdrawal by Subject|1|||
130969549|NCT02338362|471515637|FG001|Overall Study|Withdrawal by Subject|1|||
130969550|NCT06281548|471515638|FG000|Overall Study|Lost to Follow-up|3|||
130969551|NCT00288587|471515639|FG000|Overall Study|Death|4|||
130969552|NCT00288587|471515640|FG001|Overall Study|Death|4|||
130969553|NCT00288587|471515639|FG000|Overall Study|Transplant|0|||
130969554|NCT00288587|471515640|FG001|Overall Study|Transplant|3|||
130969555|NCT00288587|471515639|FG000|Overall Study|Adverse Event|0|||
130969556|NCT00288587|471515640|FG001|Overall Study|Adverse Event|1|||
130969557|NCT00288587|471515639|FG000|Overall Study|Physician Decision|0|||
130969558|NCT00288587|471515640|FG001|Overall Study|Physician Decision|2|||
130969559|NCT00288587|471515639|FG000|Overall Study|Severe Aortic Stenosis|1|||
130969560|NCT00288587|471515640|FG001|Overall Study|Severe Aortic Stenosis|0|||
130969561|NCT03538626|471515641|FG000|Overall Study|Withdrawal by Subject|0|||
130969562|NCT03538626|471515642|FG001|Overall Study|Withdrawal by Subject|1|||
130969563|NCT03538626|471515643|FG002|Overall Study|Withdrawal by Subject|0|||
130969564|NCT03538626|471515644|FG003|Overall Study|Withdrawal by Subject|0|||
130969565|NCT03538626|471515645|FG004|Overall Study|Withdrawal by Subject|0|||
130969566|NCT03538626|471515646|FG005|Overall Study|Withdrawal by Subject|0|||
130969567|NCT03538626|471515647|FG006|Overall Study|Withdrawal by Subject|0|||
130969568|NCT03538626|471515648|FG007|Overall Study|Withdrawal by Subject|0|||
130969569|NCT03538626|471515641|FG000|Overall Study|Lost to Follow-up|0|||
130969570|NCT03538626|471515642|FG001|Overall Study|Lost to Follow-up|0|||
130969571|NCT03538626|471515643|FG002|Overall Study|Lost to Follow-up|0|||
130969572|NCT03538626|471515644|FG003|Overall Study|Lost to Follow-up|0|||
130969573|NCT03538626|471515645|FG004|Overall Study|Lost to Follow-up|0|||
130969574|NCT03538626|471515646|FG005|Overall Study|Lost to Follow-up|0|||
130969575|NCT03538626|471515647|FG006|Overall Study|Lost to Follow-up|1|||
130969576|NCT03538626|471515648|FG007|Overall Study|Lost to Follow-up|0|||
130969577|NCT01434602|471515653|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
130969578|NCT01434602|471515654|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
130969579|NCT01434602|471515655|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
130969580|NCT01434602|471515656|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
131128826|NCT01624662|472099615|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
131128827|NCT01624662|472099612|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
131128828|NCT01624662|472099613|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
131128829|NCT01624662|472099614|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
131128830|NCT01624662|472099615|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
130969581|NCT01434602|471515657|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
130969582|NCT01434602|471515653|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
130969583|NCT01434602|471515654|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
130969584|NCT01434602|471515655|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
130969585|NCT01434602|471515656|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
131128831|NCT01624662|472099612|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130969586|NCT01434602|471515657|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
130969587|NCT01434602|471515653|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
130969588|NCT01434602|471515654|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
130969589|NCT01434602|471515655|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
130969590|NCT01434602|471515656|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
130969591|NCT01434602|471515657|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
130969592|NCT01434602|471515653|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
130969593|NCT01434602|471515654|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
130969594|NCT01434602|471515655|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
130969595|NCT01434602|471515656|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
130969596|NCT01434602|471515657|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
130969597|NCT01434602|471515653|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
130969598|NCT01434602|471515654|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
130969599|NCT01434602|471515655|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
130969600|NCT01434602|471515656|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
130969601|NCT01434602|471515657|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
130969602|NCT01434602|471515653|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
130969603|NCT01434602|471515654|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
130969604|NCT01434602|471515655|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
130969605|NCT01434602|471515656|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
130969606|NCT01434602|471515657|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
130969607|NCT01434602|471515653|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
130969608|NCT01434602|471515654|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
130969609|NCT01434602|471515655|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
130969610|NCT01434602|471515656|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
130969611|NCT01434602|471515657|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
130969612|NCT01434602|471515653|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
130969613|NCT01434602|471515654|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
130969614|NCT01434602|471515655|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
130969615|NCT01434602|471515656|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
130969616|NCT01434602|471515657|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
130969617|NCT01434602|471515653|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
130969618|NCT01434602|471515654|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
130969619|NCT01434602|471515655|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
130969620|NCT01434602|471515656|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
130969621|NCT01434602|471515657|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
130969622|NCT01434602|471515653|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
130969623|NCT01434602|471515654|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
130969624|NCT01434602|471515655|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
130969625|NCT01434602|471515656|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
130969626|NCT01434602|471515657|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
130969627|NCT01764945|471515663|FG000|Overall Study|Adverse Event|0|||
130969628|NCT01764945|471515664|FG001|Overall Study|Adverse Event|1|||
130969629|NCT01764945|471515665|FG002|Overall Study|Adverse Event|0|||
130969630|NCT01764945|471515666|FG003|Overall Study|Adverse Event|0|||
130969631|NCT01764945|471515667|FG004|Overall Study|Adverse Event|0|||
130969632|NCT01764945|471515668|FG005|Overall Study|Adverse Event|0|||
130969633|NCT01764945|471515669|FG006|Overall Study|Adverse Event|1|||
131042495|NCT03519178|471789327|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
131042496|NCT03519178|471789328|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
131042497|NCT03519178|471789329|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
131042498|NCT03519178|471789330|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
131042499|NCT03519178|471789331|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
131042500|NCT03519178|471789332|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
131042501|NCT03519178|471789333|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
131042502|NCT03519178|471789334|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
131042503|NCT03519178|471789335|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
131042504|NCT03519178|471789336|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
130716412|NCT04765384|470588849|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
130716413|NCT04765384|470588844|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
130716414|NCT04765384|470588845|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
130716415|NCT04765384|470588846|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
130716416|NCT04765384|470588847|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
130716417|NCT04765384|470588848|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
130969634|NCT01764945|471515670|FG007|Overall Study|Adverse Event|0|||
130969635|NCT05077267|471515672|FG000|Treatment Period|Lost to Follow-up|0|||
130969636|NCT05077267|471515673|FG001|Treatment Period|Lost to Follow-up|1|||
130969637|NCT05077267|471515674|FG002|Treatment Period|Lost to Follow-up|0|||
130969638|NCT05077267|471515672|FG000|Treatment Period|Withdrawal by Subject|0|||
130969639|NCT05077267|471515673|FG001|Treatment Period|Withdrawal by Subject|1|||
130969640|NCT05077267|471515674|FG002|Treatment Period|Withdrawal by Subject|0|||
130969641|NCT05077267|471515672|FG000|Follow-up Period|Lost to Follow-up|0|||
130969642|NCT05077267|471515673|FG001|Follow-up Period|Lost to Follow-up|5|||
130969643|NCT05077267|471515674|FG002|Follow-up Period|Lost to Follow-up|7|||
130969644|NCT05077267|471515672|FG000|Follow-up Period|Withdrawal by Subject|0|||
130969645|NCT05077267|471515673|FG001|Follow-up Period|Withdrawal by Subject|2|||
130969646|NCT05077267|471515674|FG002|Follow-up Period|Withdrawal by Subject|5|||
130969647|NCT05077267|471515672|FG000|Follow-up Period|Study terminated by sponsor|0|||
130969648|NCT05077267|471515673|FG001|Follow-up Period|Study terminated by sponsor|27|||
130969649|NCT05077267|471515674|FG002|Follow-up Period|Study terminated by sponsor|23|||
130969650|NCT05077267|471515672|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
130969651|NCT05077267|471515673|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
130969652|NCT05077267|471515674|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
130969653|NCT05077267|471515672|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
130969654|NCT05077267|471515673|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
130969655|NCT05077267|471515674|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
130969656|NCT02911948|471515675|FG000|Overall Study|Protocol Violation|0|||
130969657|NCT02911948|471515676|FG001|Overall Study|Protocol Violation|1|||
130969658|NCT02911948|471515675|FG000|Overall Study|Withdrawal by Subject|0|||
130969659|NCT02911948|471515676|FG001|Overall Study|Withdrawal by Subject|2|||
130969660|NCT02911948|471515675|FG000|Overall Study|Lack of Efficacy|0|||
130969661|NCT02911948|471515676|FG001|Overall Study|Lack of Efficacy|1|||
130969662|NCT02911948|471515675|FG000|Overall Study|Unclassified|0|||
130969663|NCT02911948|471515676|FG001|Overall Study|Unclassified|3|||
130969664|NCT00586105|471515677|FG000|Overall Study|Adverse Event|4|||
130969665|NCT00586105|471515677|FG000|Overall Study|Death|2|||
130969666|NCT00586105|471515677|FG000|Overall Study|Protocol Violation|1|||
130969667|NCT00586105|471515677|FG000|Overall Study|Withdrawal by Subject|3|||
130969668|NCT00586105|471515677|FG000|Overall Study|Disease progression|19|||
130969669|NCT00586105|471515677|FG000|Overall Study|Switched to commercial drug|9|||
130969670|NCT00586105|471515677|FG000|Overall Study|Reason not reported|1|||
130969671|NCT02308033|471515680|FG000|Overall Study|Normal Gram stain at Baseline|13|||
130969672|NCT02308033|471515681|FG001|Overall Study|Normal Gram stain at Baseline|10|||
130969673|NCT02308033|471515680|FG000|Overall Study|Positive for STD at Baseline|7|||
130969674|NCT02308033|471515681|FG001|Overall Study|Positive for STD at Baseline|4|||
130969675|NCT02308033|471515680|FG000|Overall Study|Lost to Follow-up|6|||
130969676|NCT02308033|471515681|FG001|Overall Study|Lost to Follow-up|5|||
130969677|NCT00345397|471515682|FG000|Overall Study|Death|1|||
130969678|NCT04266028|471515683|FG000|Overall Study|Adverse Event|0|||
130969679|NCT04266028|471515684|FG001|Overall Study|Adverse Event|0|||
130969680|NCT04266028|471515685|FG002|Overall Study|Adverse Event|1|||
130969681|NCT04266028|471515686|FG003|Overall Study|Adverse Event|0|||
130969682|NCT04266028|471515687|FG004|Overall Study|Adverse Event|1|||
130969683|NCT04266028|471515688|FG005|Overall Study|Adverse Event|0|||
130969684|NCT04266028|471515689|FG006|Overall Study|Adverse Event|2|||
130969685|NCT04266028|471515690|FG007|Overall Study|Adverse Event|0|||
130969686|NCT04266028|471515683|FG000|Overall Study|temporary halt of the study|0|||
130969687|NCT04266028|471515684|FG001|Overall Study|temporary halt of the study|0|||
130969688|NCT04266028|471515685|FG002|Overall Study|temporary halt of the study|0|||
130969689|NCT04266028|471515686|FG003|Overall Study|temporary halt of the study|0|||
130969690|NCT04266028|471515687|FG004|Overall Study|temporary halt of the study|0|||
131042505|NCT03519178|471789322|FG000|Long-term Follow-up|Other|0|||
130969691|NCT04266028|471515688|FG005|Overall Study|temporary halt of the study|0|||
130969692|NCT04266028|471515689|FG006|Overall Study|temporary halt of the study|2|||
130969693|NCT04266028|471515690|FG007|Overall Study|temporary halt of the study|1|||
130969694|NCT04266028|471515683|FG000|Overall Study|Onset of birch pollen season|0|||
130969695|NCT04266028|471515684|FG001|Overall Study|Onset of birch pollen season|0|||
130969696|NCT04266028|471515685|FG002|Overall Study|Onset of birch pollen season|0|||
131042506|NCT03519178|471789323|FG001|Long-term Follow-up|Other|0|||
131042507|NCT03519178|471789324|FG002|Long-term Follow-up|Other|0|||
130969697|NCT04266028|471515686|FG003|Overall Study|Onset of birch pollen season|0|||
130969698|NCT04266028|471515687|FG004|Overall Study|Onset of birch pollen season|1|||
130969699|NCT04266028|471515688|FG005|Overall Study|Onset of birch pollen season|0|||
130969700|NCT04266028|471515689|FG006|Overall Study|Onset of birch pollen season|0|||
130969701|NCT04266028|471515690|FG007|Overall Study|Onset of birch pollen season|0|||
130969702|NCT03021187|471515693|FG000|Overall Study|Death|0|||
131042508|NCT03519178|471789325|FG003|Long-term Follow-up|Other|0|||
131042509|NCT03519178|471789326|FG004|Long-term Follow-up|Other|0|||
131042510|NCT03519178|471789327|FG005|Long-term Follow-up|Other|0|||
131227109|NCT01827371|472457778|FG001|Overall Study|Physician Decision|1|||
130775709|NCT02501161|470806548|FG000|Overall Study|Other|3|||
130775710|NCT02501161|470806549|FG001|Overall Study|Other|0|||
130775711|NCT00667992|470806552|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
130775712|NCT00667992|470806553|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
130775713|NCT00667992|470806552|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
130775714|NCT00667992|470806553|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
130775715|NCT00667992|470806552|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
130775716|NCT00667992|470806553|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
130775717|NCT00667992|470806552|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
130775718|NCT00667992|470806553|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
130775719|NCT00667992|470806552|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
130775720|NCT00667992|470806553|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
130775721|NCT00667992|470806552|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
130775722|NCT00667992|470806553|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
130775723|NCT00667992|470806552|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
130775724|NCT00667992|470806553|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
130775725|NCT00667992|470806552|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
130775726|NCT00667992|470806553|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
130775727|NCT00667992|470806552|FG000|Wash-out|Not within one doubling dilution|4|||
130775728|NCT00667992|470806553|FG001|Wash-out|Not within one doubling dilution|3|||
130775729|NCT00667992|470806552|FG000|Wash-out|Failure to wash-out|2|||
130775730|NCT00667992|470806553|FG001|Wash-out|Failure to wash-out|2|||
130969703|NCT03021187|471515694|FG001|Overall Study|Death|0|||
130969704|NCT03021187|471515695|FG002|Overall Study|Death|3|||
130969705|NCT03021187|471515696|FG003|Overall Study|Death|0|||
130969706|NCT03021187|471515693|FG000|Overall Study|Withdrawal by Subject|0|||
130969707|NCT03021187|471515694|FG001|Overall Study|Withdrawal by Subject|6|||
130969708|NCT03021187|471515695|FG002|Overall Study|Withdrawal by Subject|2|||
130969709|NCT03021187|471515696|FG003|Overall Study|Withdrawal by Subject|5|||
130969710|NCT03021187|471515693|FG000|Overall Study|Lost to Follow-up|10|||
130969711|NCT03021187|471515694|FG001|Overall Study|Lost to Follow-up|3|||
130969712|NCT03021187|471515695|FG002|Overall Study|Lost to Follow-up|1|||
130969713|NCT03021187|471515696|FG003|Overall Study|Lost to Follow-up|4|||
130969714|NCT03351049|471515699|FG000|Overall Study|Withdrawal|26|||
130969715|NCT03351049|471515700|FG001|Overall Study|Withdrawal|22|||
130969716|NCT00558285|471515704|FG000|Overall Study|Adverse Event|1|||
130969717|NCT00558285|471515705|FG001|Overall Study|Adverse Event|1|||
130969718|NCT00558285|471515706|FG002|Overall Study|Adverse Event|4|||
130969719|NCT00558285|471515707|FG003|Overall Study|Adverse Event|1|||
130969720|NCT00558285|471515708|FG004|Overall Study|Adverse Event|2|||
130969721|NCT00558285|471515704|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130969722|NCT00558285|471515705|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130969723|NCT00558285|471515706|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130969724|NCT00558285|471515707|FG003|Overall Study|Abnormal test procedure result(s)|0|||
130969725|NCT00558285|471515708|FG004|Overall Study|Abnormal test procedure result(s)|0|||
130969726|NCT00558285|471515704|FG000|Overall Study|Subject withdrew consent|2|||
130969727|NCT00558285|471515705|FG001|Overall Study|Subject withdrew consent|0|||
130969728|NCT00558285|471515706|FG002|Overall Study|Subject withdrew consent|1|||
130969729|NCT00558285|471515707|FG003|Overall Study|Subject withdrew consent|1|||
130969730|NCT00558285|471515708|FG004|Overall Study|Subject withdrew consent|1|||
130969731|NCT00558285|471515704|FG000|Overall Study|Lost to Follow-up|1|||
130969732|NCT00558285|471515705|FG001|Overall Study|Lost to Follow-up|1|||
130969733|NCT00558285|471515706|FG002|Overall Study|Lost to Follow-up|0|||
130969734|NCT00558285|471515707|FG003|Overall Study|Lost to Follow-up|0|||
130969735|NCT00558285|471515708|FG004|Overall Study|Lost to Follow-up|0|||
130969736|NCT00558285|471515704|FG000|Overall Study|Administrative problems|0|||
130969737|NCT00558285|471515705|FG001|Overall Study|Administrative problems|0|||
130969738|NCT00558285|471515706|FG002|Overall Study|Administrative problems|0|||
130969739|NCT00558285|471515707|FG003|Overall Study|Administrative problems|1|||
130969740|NCT00558285|471515708|FG004|Overall Study|Administrative problems|1|||
130969741|NCT00558285|471515704|FG000|Overall Study|Protocol deviation|1|||
130969742|NCT00558285|471515705|FG001|Overall Study|Protocol deviation|1|||
130969743|NCT00558285|471515706|FG002|Overall Study|Protocol deviation|0|||
130969744|NCT00558285|471515707|FG003|Overall Study|Protocol deviation|1|||
130969745|NCT00558285|471515708|FG004|Overall Study|Protocol deviation|0|||
130969746|NCT02121847|471515709|FG000|Overall Study|Administrative Reasons|1|||
130969747|NCT02121847|471515709|FG000|Overall Study|Adverse Event|2|||
130969748|NCT02663817|471515710|FG000|Overall Study|Screen failure|2|||
130969749|NCT03478891|471515711|FG000|Overall Study|Enrolled, but product never administered|0|||
130969750|NCT03478891|471515712|FG001|Overall Study|Enrolled, but product never administered|0|||
130969751|NCT03478891|471515713|FG002|Overall Study|Enrolled, but product never administered|1|||
130969752|NCT03478891|471515711|FG000|Overall Study|Moved from area|0|||
131227110|NCT01827371|472457779|FG002|Overall Study|Physician Decision|0|||
131227111|NCT01827371|472457780|FG003|Overall Study|Physician Decision|1|||
130969753|NCT03478891|471515712|FG001|Overall Study|Moved from area|0|||
130969754|NCT03478891|471515713|FG002|Overall Study|Moved from area|1|||
130969755|NCT03478891|471515711|FG000|Overall Study|Lost to Follow-up|1|||
130969756|NCT03478891|471515712|FG001|Overall Study|Lost to Follow-up|0|||
130969757|NCT03478891|471515713|FG002|Overall Study|Lost to Follow-up|1|||
130969758|NCT00809757|471515714|FG000|Overall Study|Adverse Event|2|||
130969759|NCT00809757|471515715|FG001|Overall Study|Adverse Event|3|||
130969760|NCT00809757|471515716|FG002|Overall Study|Adverse Event|3|||
130969761|NCT00809757|471515714|FG000|Overall Study|Lost to Follow-up|0|||
130969762|NCT00809757|471515715|FG001|Overall Study|Lost to Follow-up|0|||
130969763|NCT00809757|471515716|FG002|Overall Study|Lost to Follow-up|1|||
130969764|NCT00809757|471515714|FG000|Overall Study|Protocol Violation|1|||
130969765|NCT00809757|471515715|FG001|Overall Study|Protocol Violation|1|||
130969766|NCT00809757|471515716|FG002|Overall Study|Protocol Violation|1|||
130969767|NCT00809757|471515714|FG000|Overall Study|Withdrawal by Subject|2|||
130969768|NCT00809757|471515715|FG001|Overall Study|Withdrawal by Subject|1|||
130969769|NCT00809757|471515716|FG002|Overall Study|Withdrawal by Subject|3|||
130969770|NCT00809757|471515714|FG000|Overall Study|Subject Uncooperative|1|||
130969771|NCT00809757|471515715|FG001|Overall Study|Subject Uncooperative|0|||
130969772|NCT00809757|471515716|FG002|Overall Study|Subject Uncooperative|2|||
130969773|NCT00809757|471515714|FG000|Overall Study|Noncompliance with Medication|0|||
130969774|NCT00809757|471515715|FG001|Overall Study|Noncompliance with Medication|0|||
130969775|NCT00809757|471515716|FG002|Overall Study|Noncompliance with Medication|1|||
130969776|NCT00253864|471515717|FG000|Overall Study|Lost to Follow-up|5|||
130969777|NCT00253864|471515718|FG001|Overall Study|Lost to Follow-up|8|||
130969778|NCT01410448|471515722|FG000|Overall Study|No conversion to everolimus|0|||
130969779|NCT01410448|471515723|FG001|Overall Study|No conversion to everolimus|24|||
130969780|NCT01410448|471515722|FG000|Overall Study|Graft loss|4|||
130969781|NCT01410448|471515723|FG001|Overall Study|Graft loss|1|||
130969782|NCT01410448|471515722|FG000|Overall Study|Administrative issues|2|||
130969783|NCT01410448|471515723|FG001|Overall Study|Administrative issues|1|||
130969784|NCT01410448|471515722|FG000|Overall Study|Lost to Follow-up|1|||
130969785|NCT01410448|471515723|FG001|Overall Study|Lost to Follow-up|0|||
130969786|NCT01410448|471515722|FG000|Overall Study|Withdrawal by Subject|3|||
130969787|NCT01410448|471515723|FG001|Overall Study|Withdrawal by Subject|2|||
130969788|NCT01410448|471515722|FG000|Overall Study|Protocol Violation|0|||
130969789|NCT01410448|471515723|FG001|Overall Study|Protocol Violation|4|||
130969790|NCT01410448|471515722|FG000|Overall Study|Death|2|||
130969791|NCT01410448|471515723|FG001|Overall Study|Death|3|||
130969792|NCT00360529|471515724|FG000|Overall Study|Adverse Event|10|||
130969793|NCT00360529|471515725|FG001|Overall Study|Adverse Event|23|||
130969794|NCT00360529|471515726|FG002|Overall Study|Adverse Event|33|||
130969795|NCT00360529|471515724|FG000|Overall Study|Protocol Violation|3|||
130969796|NCT00360529|471515725|FG001|Overall Study|Protocol Violation|3|||
130969797|NCT00360529|471515726|FG002|Overall Study|Protocol Violation|11|||
130969798|NCT00360529|471515724|FG000|Overall Study|Lost to Follow-up|14|||
130969799|NCT00360529|471515725|FG001|Overall Study|Lost to Follow-up|10|||
130969800|NCT00360529|471515726|FG002|Overall Study|Lost to Follow-up|13|||
130969801|NCT00360529|471515724|FG000|Overall Study|Withdrawal by Subject|22|||
130969802|NCT00360529|471515725|FG001|Overall Study|Withdrawal by Subject|14|||
130969803|NCT00360529|471515726|FG002|Overall Study|Withdrawal by Subject|18|||
130969804|NCT00360529|471515724|FG000|Overall Study|Lack of Efficacy|8|||
130969805|NCT00360529|471515725|FG001|Overall Study|Lack of Efficacy|6|||
130969806|NCT00360529|471515726|FG002|Overall Study|Lack of Efficacy|5|||
130969807|NCT00360529|471515724|FG000|Overall Study|Reason discontinued not explained above|4|||
130969808|NCT00360529|471515725|FG001|Overall Study|Reason discontinued not explained above|9|||
130969809|NCT00360529|471515726|FG002|Overall Study|Reason discontinued not explained above|11|||
130969810|NCT03712917|471515729|FG000|Overall Study|Pregnancy|0|||
130969811|NCT03712917|471515730|FG001|Overall Study|Pregnancy|0|||
130969812|NCT03712917|471515731|FG002|Overall Study|Pregnancy|1|||
131042511|NCT03519178|471789328|FG006|Long-term Follow-up|Other|0|||
131042512|NCT03519178|471789329|FG007|Long-term Follow-up|Other|0|||
130969813|NCT03712917|471515729|FG000|Overall Study|Adverse Event|0|||
130969814|NCT03712917|471515730|FG001|Overall Study|Adverse Event|4|||
130969815|NCT03712917|471515731|FG002|Overall Study|Adverse Event|3|||
130969816|NCT03712917|471515729|FG000|Overall Study|Lost to Follow-up|9|||
130969817|NCT03712917|471515730|FG001|Overall Study|Lost to Follow-up|4|||
130969818|NCT03712917|471515731|FG002|Overall Study|Lost to Follow-up|5|||
130969819|NCT02091167|471515733|FG000|Overall Study|Lost to Follow-up|0|||
130969820|NCT02091167|471515734|FG001|Overall Study|Lost to Follow-up|2|||
130969821|NCT03096782|471515735|FG000|Overall Study|Death|1|||
131042513|NCT03519178|471789330|FG008|Long-term Follow-up|Other|0|||
130969822|NCT03096782|471515735|FG000|Overall Study|Participant Relapsed|1|||
130969823|NCT00932893|471515742|FG000|Overall Study|Death|115|||
130969824|NCT00932893|471515743|FG001|Overall Study|Death|24|||
130969825|NCT00932893|471515742|FG000|Overall Study|Lost to Follow-up|8|||
130969826|NCT00932893|471515743|FG001|Overall Study|Lost to Follow-up|0|||
130969827|NCT00932893|471515742|FG000|Overall Study|Withdrawal by Subject|5|||
130969828|NCT00932893|471515743|FG001|Overall Study|Withdrawal by Subject|2|||
131042514|NCT03519178|471789331|FG009|Long-term Follow-up|Other|0|||
130969829|NCT00932893|471515742|FG000|Overall Study|Other|5|||
130969830|NCT00932893|471515743|FG001|Overall Study|Other|144|||
130969831|NCT00724282|471517749|FG000|Overall Study|Withdrawal by Subject|3|||
130969832|NCT00724282|471517749|FG000|Overall Study|Physician Decision|1|||
130969833|NCT00993447|471517750|FG000|Overall Study|Withdrawal by Subject|23|||
130969834|NCT00993447|471517751|FG001|Overall Study|Withdrawal by Subject|8|||
130969835|NCT00993447|471517750|FG000|Overall Study|Protocol Violation|12|||
130969836|NCT00993447|471517751|FG001|Overall Study|Protocol Violation|8|||
130969837|NCT00993447|471517750|FG000|Overall Study|Lost to Follow-up|1|||
130969838|NCT00993447|471517751|FG001|Overall Study|Lost to Follow-up|3|||
130969839|NCT00993447|471517750|FG000|Overall Study|Adverse Event|1|||
130969840|NCT00993447|471517751|FG001|Overall Study|Adverse Event|0|||
130969841|NCT00970502|471517753|FG000|Overall Study|Withdrawal by Subject|1|||
130969842|NCT03811912|471517754|FG000|Overall Study|Withdrew Consent|4|||
130969843|NCT03811912|471517755|FG001|Overall Study|Withdrew Consent|2|||
130969844|NCT01438411|471517756|FG000|Overall Study|Adverse Event|8|||
130969845|NCT01438411|471517756|FG000|Overall Study|Lost to Follow-up|1|||
130969846|NCT01438411|471517756|FG000|Overall Study|Lack of Efficacy|1|||
130969847|NCT01438411|471517756|FG000|Overall Study|Withdrawal by Subject|3|||
130969848|NCT01863680|471517757|FG000|Overall Study|Adverse Event|17|||
130969849|NCT01863680|471517757|FG000|Overall Study|Risk of OHSS|17|||
130969850|NCT01863680|471517757|FG000|Overall Study|Spontaneous pregnancy|2|||
130969851|NCT01863680|471517757|FG000|Overall Study|Withdrawal by Subject|1|||
130969852|NCT01863680|471517757|FG000|Overall Study|Did not undergo IVF/ET|14|||
130969853|NCT01863680|471517757|FG000|Overall Study|Other|6|||
130969854|NCT00618514|471517758|FG000|Overall Study|Lost to Follow-up|11|||
130969855|NCT00618514|471517759|FG001|Overall Study|Lost to Follow-up|12|||
130969856|NCT00618514|471517760|FG002|Overall Study|Lost to Follow-up|4|||
130969857|NCT00566228|471517761|FG000|Overall Study|Withdrawal by Subject|1|||
130969858|NCT00566228|471517762|FG001|Overall Study|Withdrawal by Subject|0|||
130969859|NCT00566228|471517761|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
130969860|NCT00566228|471517762|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
130969861|NCT00566228|471517761|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
130969862|NCT00566228|471517762|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
130969863|NCT00566228|471517761|FG000|Overall Study|progressed before infusion could occur|0|||
130969864|NCT00566228|471517762|FG001|Overall Study|progressed before infusion could occur|1|||
130969865|NCT02053350|471517765|FG000|Overall Study|Withdrawal by Subject|1|||
130969866|NCT02053350|471517765|FG000|Overall Study|Adverse Event|4|||
130969867|NCT02244944|471517766|FG000|Overall Study|Withdrawal by Subject|1|||
130969868|NCT02244944|471517766|FG000|Overall Study|Study Terminated|1|||
130969869|NCT01159691|471517767|FG000|Overall Study|Lost to Follow-up|2|||
130969870|NCT01159691|471517767|FG000|Overall Study|Unknown reasons|1|||
130969871|NCT01159691|471517767|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
130969872|NCT01159691|471517767|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
130969873|NCT01159691|471517767|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
130969874|NCT01159691|471517767|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
131042515|NCT03519178|471789332|FG010|Long-term Follow-up|Other|0|||
131042516|NCT03519178|471789333|FG011|Long-term Follow-up|Other|0|||
131042517|NCT03519178|471789334|FG012|Long-term Follow-up|Other|0|||
131042518|NCT03519178|471789335|FG013|Long-term Follow-up|Other|0|||
131042519|NCT03519178|471789336|FG014|Long-term Follow-up|Other|1|||
131042520|NCT03519178|471789322|FG000|Long-term Follow-up|Ongoing|0|||
131042521|NCT03519178|471789323|FG001|Long-term Follow-up|Ongoing|0|||
131042522|NCT03519178|471789324|FG002|Long-term Follow-up|Ongoing|0|||
131042523|NCT03519178|471789325|FG003|Long-term Follow-up|Ongoing|0|||
131042524|NCT03519178|471789326|FG004|Long-term Follow-up|Ongoing|0|||
131042525|NCT03519178|471789327|FG005|Long-term Follow-up|Ongoing|0|||
131042526|NCT03519178|471789328|FG006|Long-term Follow-up|Ongoing|0|||
131042527|NCT03519178|471789329|FG007|Long-term Follow-up|Ongoing|0|||
131042528|NCT03519178|471789330|FG008|Long-term Follow-up|Ongoing|0|||
131042529|NCT03519178|471789331|FG009|Long-term Follow-up|Ongoing|0|||
131042530|NCT03519178|471789332|FG010|Long-term Follow-up|Ongoing|0|||
131042531|NCT03519178|471789333|FG011|Long-term Follow-up|Ongoing|0|||
131042532|NCT03519178|471789334|FG012|Long-term Follow-up|Ongoing|0|||
131042533|NCT03519178|471789335|FG013|Long-term Follow-up|Ongoing|1|||
131042534|NCT03519178|471789336|FG014|Long-term Follow-up|Ongoing|0|||
131042535|NCT02315703|471789337|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
131042536|NCT02315703|471789338|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
131042537|NCT02315703|471789339|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
131227112|NCT01827371|472457777|FG000|Overall Study|Temporary study halt to vaccinations|11|||
130775731|NCT00667992|470806552|FG000|Wash-out|Withdrawal by Subject|1|||
130969875|NCT01159691|471517767|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
131042538|NCT02315703|471789340|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
131042539|NCT02315703|471789341|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
131042540|NCT02315703|471789342|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
131042541|NCT02315703|471789343|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
130969876|NCT01159691|471517767|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
130969877|NCT01928719|471517768|FG000|Overall Study|Lost to Follow-up|26|||
130969878|NCT01928719|471517769|FG001|Overall Study|Lost to Follow-up|11|||
130969879|NCT01928719|471517768|FG000|Overall Study|Withdrawal by Subject|22|||
130969880|NCT01928719|471517769|FG001|Overall Study|Withdrawal by Subject|7|||
130969881|NCT01928719|471517768|FG000|Overall Study|Protocol Violation|3|||
130969882|NCT01928719|471517769|FG001|Overall Study|Protocol Violation|1|||
130969883|NCT01928719|471517768|FG000|Overall Study|Adverse Event|1|||
130969884|NCT01928719|471517769|FG001|Overall Study|Adverse Event|0|||
130969885|NCT04579757|471517772|FG000|Overall Study|Adverse Event|0|||
130969886|NCT04579757|471517773|FG001|Overall Study|Adverse Event|0|||
130969887|NCT04579757|471517774|FG002|Overall Study|Adverse Event|0|||
130969888|NCT04579757|471517775|FG003|Overall Study|Adverse Event|2|||
130969889|NCT04579757|471517776|FG004|Overall Study|Adverse Event|1|||
130969890|NCT04579757|471517777|FG005|Overall Study|Adverse Event|1|||
130969891|NCT04579757|471517778|FG006|Overall Study|Adverse Event|0|||
130969892|NCT04579757|471517779|FG007|Overall Study|Adverse Event|0|||
130969893|NCT04579757|471517780|FG008|Overall Study|Adverse Event|0|||
130969894|NCT04579757|471517772|FG000|Overall Study|Death|4|||
130969895|NCT04579757|471517773|FG001|Overall Study|Death|1|||
130969896|NCT04579757|471517774|FG002|Overall Study|Death|14|||
130969897|NCT04579757|471517775|FG003|Overall Study|Death|3|||
130969898|NCT04579757|471517776|FG004|Overall Study|Death|2|||
130969899|NCT04579757|471517777|FG005|Overall Study|Death|7|||
130969900|NCT04579757|471517778|FG006|Overall Study|Death|0|||
130969901|NCT04579757|471517779|FG007|Overall Study|Death|1|||
130969902|NCT04579757|471517780|FG008|Overall Study|Death|3|||
130969903|NCT04579757|471517772|FG000|Overall Study|Physician Decision|0|||
130969904|NCT04579757|471517773|FG001|Overall Study|Physician Decision|0|||
130969905|NCT04579757|471517774|FG002|Overall Study|Physician Decision|0|||
130969906|NCT04579757|471517775|FG003|Overall Study|Physician Decision|2|||
130969907|NCT04579757|471517776|FG004|Overall Study|Physician Decision|1|||
130969908|NCT04579757|471517777|FG005|Overall Study|Physician Decision|1|||
130969909|NCT04579757|471517778|FG006|Overall Study|Physician Decision|1|||
130969910|NCT04579757|471517779|FG007|Overall Study|Physician Decision|0|||
130969911|NCT04579757|471517780|FG008|Overall Study|Physician Decision|0|||
130969912|NCT04579757|471517772|FG000|Overall Study|Study Terminated By Sponsor|0|||
130969913|NCT04579757|471517773|FG001|Overall Study|Study Terminated By Sponsor|0|||
130969914|NCT04579757|471517774|FG002|Overall Study|Study Terminated By Sponsor|0|||
130969915|NCT04579757|471517775|FG003|Overall Study|Study Terminated By Sponsor|0|||
130969916|NCT04579757|471517776|FG004|Overall Study|Study Terminated By Sponsor|2|||
130969917|NCT04579757|471517777|FG005|Overall Study|Study Terminated By Sponsor|0|||
130969918|NCT04579757|471517778|FG006|Overall Study|Study Terminated By Sponsor|0|||
130969919|NCT04579757|471517779|FG007|Overall Study|Study Terminated By Sponsor|2|||
130969920|NCT04579757|471517780|FG008|Overall Study|Study Terminated By Sponsor|0|||
130969921|NCT04579757|471517772|FG000|Overall Study|Withdrawal by Subject|1|||
130969922|NCT04579757|471517773|FG001|Overall Study|Withdrawal by Subject|1|||
130969923|NCT04579757|471517774|FG002|Overall Study|Withdrawal by Subject|0|||
130969924|NCT04579757|471517775|FG003|Overall Study|Withdrawal by Subject|0|||
130969925|NCT04579757|471517776|FG004|Overall Study|Withdrawal by Subject|2|||
130969926|NCT04579757|471517777|FG005|Overall Study|Withdrawal by Subject|1|||
130969927|NCT04579757|471517778|FG006|Overall Study|Withdrawal by Subject|0|||
130969928|NCT04579757|471517779|FG007|Overall Study|Withdrawal by Subject|3|||
130969929|NCT04579757|471517780|FG008|Overall Study|Withdrawal by Subject|0|||
130969930|NCT04579757|471517772|FG000|Overall Study|Radiological or Clinical PD|1|||
130969931|NCT04579757|471517773|FG001|Overall Study|Radiological or Clinical PD|4|||
130969932|NCT04579757|471517774|FG002|Overall Study|Radiological or Clinical PD|1|||
130969933|NCT04579757|471517775|FG003|Overall Study|Radiological or Clinical PD|3|||
130969934|NCT04579757|471517776|FG004|Overall Study|Radiological or Clinical PD|9|||
130969935|NCT04579757|471517777|FG005|Overall Study|Radiological or Clinical PD|4|||
130969936|NCT04579757|471517778|FG006|Overall Study|Radiological or Clinical PD|2|||
130969937|NCT04579757|471517779|FG007|Overall Study|Radiological or Clinical PD|2|||
130969938|NCT04579757|471517780|FG008|Overall Study|Radiological or Clinical PD|0|||
130969939|NCT04579757|471517772|FG000|Overall Study|Start of New Therapy|0|||
130969940|NCT04579757|471517773|FG001|Overall Study|Start of New Therapy|0|||
130969941|NCT04579757|471517774|FG002|Overall Study|Start of New Therapy|0|||
130969942|NCT04579757|471517775|FG003|Overall Study|Start of New Therapy|0|||
130969943|NCT04579757|471517776|FG004|Overall Study|Start of New Therapy|2|||
130969944|NCT04579757|471517777|FG005|Overall Study|Start of New Therapy|1|||
130969945|NCT04579757|471517778|FG006|Overall Study|Start of New Therapy|0|||
130969946|NCT04579757|471517779|FG007|Overall Study|Start of New Therapy|0|||
130969947|NCT04579757|471517780|FG008|Overall Study|Start of New Therapy|0|||
130969948|NCT02332720|471517781|FG000|Part A and Part B|Lost to Follow-up|1|||
130969949|NCT02332720|471517782|FG001|Part A and Part B|Lost to Follow-up|0|||
130969950|NCT02332720|471517783|FG002|Part A and Part B|Lost to Follow-up|0|||
130969951|NCT02332720|471517784|FG003|Part A and Part B|Lost to Follow-up|0|||
130969952|NCT02332720|471517785|FG004|Part A and Part B|Lost to Follow-up|0|||
130969953|NCT02332720|471517786|FG005|Part A and Part B|Lost to Follow-up|2|||
130969954|NCT02332720|471517787|FG006|Part A and Part B|Lost to Follow-up|1|||
130969955|NCT02332720|471517788|FG007|Part A and Part B|Lost to Follow-up|1|||
130969956|NCT02332720|471517789|FG008|Part A and Part B|Lost to Follow-up|0|||
130969957|NCT02332720|471517790|FG009|Part A and Part B|Lost to Follow-up|0|||
130969958|NCT02332720|471517791|FG010|Part A and Part B|Lost to Follow-up|0|||
130969959|NCT02332720|471517792|FG011|Part A and Part B|Lost to Follow-up|0|||
130969960|NCT02332720|471517793|FG012|Part A and Part B|Lost to Follow-up|0|||
130969961|NCT02332720|471517794|FG013|Part A and Part B|Lost to Follow-up|0|||
130969962|NCT02332720|471517795|FG014|Part A and Part B|Lost to Follow-up|0|||
130969963|NCT02332720|471517796|FG015|Part A and Part B|Lost to Follow-up|1|||
130969964|NCT02332720|471517797|FG016|Part A and Part B|Lost to Follow-up|0|||
130969965|NCT02332720|471517798|FG017|Part A and Part B|Lost to Follow-up|0|||
130969966|NCT02332720|471517799|FG018|Part A and Part B|Lost to Follow-up|0|||
130969967|NCT02332720|471517800|FG019|Part A and Part B|Lost to Follow-up|0|||
130969968|NCT02332720|471517801|FG020|Part A and Part B|Lost to Follow-up|0|||
130969969|NCT02332720|471517802|FG021|Part A and Part B|Lost to Follow-up|0|||
130969970|NCT02332720|471517803|FG022|Part A and Part B|Lost to Follow-up|0|||
130969971|NCT02332720|471517781|FG000|Part A and Part B|Adverse Event|0|||
130969972|NCT02332720|471517782|FG001|Part A and Part B|Adverse Event|0|||
130969973|NCT02332720|471517783|FG002|Part A and Part B|Adverse Event|0|||
130969974|NCT02332720|471517784|FG003|Part A and Part B|Adverse Event|0|||
130969975|NCT02332720|471517785|FG004|Part A and Part B|Adverse Event|0|||
130969976|NCT02332720|471517786|FG005|Part A and Part B|Adverse Event|0|||
130969977|NCT02332720|471517787|FG006|Part A and Part B|Adverse Event|0|||
130969978|NCT02332720|471517788|FG007|Part A and Part B|Adverse Event|0|||
130969979|NCT02332720|471517789|FG008|Part A and Part B|Adverse Event|0|||
130969980|NCT02332720|471517790|FG009|Part A and Part B|Adverse Event|0|||
130969981|NCT02332720|471517791|FG010|Part A and Part B|Adverse Event|0|||
130969982|NCT02332720|471517792|FG011|Part A and Part B|Adverse Event|0|||
130969983|NCT02332720|471517793|FG012|Part A and Part B|Adverse Event|0|||
130969984|NCT02332720|471517794|FG013|Part A and Part B|Adverse Event|0|||
130969985|NCT02332720|471517795|FG014|Part A and Part B|Adverse Event|0|||
130969986|NCT02332720|471517796|FG015|Part A and Part B|Adverse Event|0|||
130969987|NCT02332720|471517797|FG016|Part A and Part B|Adverse Event|0|||
130969988|NCT02332720|471517798|FG017|Part A and Part B|Adverse Event|1|||
130969989|NCT02332720|471517799|FG018|Part A and Part B|Adverse Event|0|||
130969990|NCT02332720|471517800|FG019|Part A and Part B|Adverse Event|0|||
130969991|NCT02332720|471517801|FG020|Part A and Part B|Adverse Event|0|||
130969992|NCT02332720|471517802|FG021|Part A and Part B|Adverse Event|0|||
130969993|NCT02332720|471517803|FG022|Part A and Part B|Adverse Event|0|||
130969994|NCT02332720|471517781|FG000|Part A and Part B|Physician Decision|0|||
130969995|NCT02332720|471517782|FG001|Part A and Part B|Physician Decision|0|||
130969996|NCT02332720|471517783|FG002|Part A and Part B|Physician Decision|0|||
130969997|NCT02332720|471517784|FG003|Part A and Part B|Physician Decision|0|||
130969998|NCT02332720|471517785|FG004|Part A and Part B|Physician Decision|0|||
130969999|NCT02332720|471517786|FG005|Part A and Part B|Physician Decision|0|||
130970000|NCT02332720|471517787|FG006|Part A and Part B|Physician Decision|0|||
130970001|NCT02332720|471517788|FG007|Part A and Part B|Physician Decision|0|||
130970002|NCT02332720|471517789|FG008|Part A and Part B|Physician Decision|0|||
130970003|NCT02332720|471517790|FG009|Part A and Part B|Physician Decision|0|||
130970004|NCT02332720|471517791|FG010|Part A and Part B|Physician Decision|0|||
130970005|NCT02332720|471517792|FG011|Part A and Part B|Physician Decision|0|||
130970006|NCT02332720|471517793|FG012|Part A and Part B|Physician Decision|0|||
130970007|NCT02332720|471517794|FG013|Part A and Part B|Physician Decision|0|||
130970008|NCT02332720|471517795|FG014|Part A and Part B|Physician Decision|0|||
130970009|NCT02332720|471517796|FG015|Part A and Part B|Physician Decision|0|||
130970010|NCT02332720|471517797|FG016|Part A and Part B|Physician Decision|0|||
130970011|NCT02332720|471517798|FG017|Part A and Part B|Physician Decision|0|||
130970012|NCT02332720|471517799|FG018|Part A and Part B|Physician Decision|1|||
130970013|NCT02332720|471517800|FG019|Part A and Part B|Physician Decision|0|||
131042542|NCT02315703|471789344|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
131227113|NCT01827371|472457778|FG001|Overall Study|Temporary study halt to vaccinations|2|||
130970014|NCT02332720|471517801|FG020|Part A and Part B|Physician Decision|0|||
130970015|NCT02332720|471517802|FG021|Part A and Part B|Physician Decision|0|||
130970016|NCT02332720|471517803|FG022|Part A and Part B|Physician Decision|0|||
130970017|NCT02332720|471517781|FG000|Part A and Part B|Withdrawal by Subject|0|||
130970018|NCT02332720|471517782|FG001|Part A and Part B|Withdrawal by Subject|0|||
130970019|NCT02332720|471517783|FG002|Part A and Part B|Withdrawal by Subject|0|||
130970020|NCT02332720|471517784|FG003|Part A and Part B|Withdrawal by Subject|0|||
130970021|NCT02332720|471517785|FG004|Part A and Part B|Withdrawal by Subject|0|||
130970022|NCT02332720|471517786|FG005|Part A and Part B|Withdrawal by Subject|1|||
130970023|NCT02332720|471517787|FG006|Part A and Part B|Withdrawal by Subject|0|||
130970024|NCT02332720|471517788|FG007|Part A and Part B|Withdrawal by Subject|0|||
130970025|NCT02332720|471517789|FG008|Part A and Part B|Withdrawal by Subject|0|||
130970026|NCT02332720|471517790|FG009|Part A and Part B|Withdrawal by Subject|0|||
130970027|NCT02332720|471517791|FG010|Part A and Part B|Withdrawal by Subject|0|||
130970028|NCT02332720|471517792|FG011|Part A and Part B|Withdrawal by Subject|0|||
130970029|NCT02332720|471517793|FG012|Part A and Part B|Withdrawal by Subject|0|||
130970030|NCT02332720|471517794|FG013|Part A and Part B|Withdrawal by Subject|0|||
130970031|NCT02332720|471517795|FG014|Part A and Part B|Withdrawal by Subject|0|||
130970032|NCT02332720|471517796|FG015|Part A and Part B|Withdrawal by Subject|0|||
130970033|NCT02332720|471517797|FG016|Part A and Part B|Withdrawal by Subject|0|||
130970034|NCT02332720|471517798|FG017|Part A and Part B|Withdrawal by Subject|0|||
130970035|NCT02332720|471517799|FG018|Part A and Part B|Withdrawal by Subject|0|||
130970036|NCT02332720|471517800|FG019|Part A and Part B|Withdrawal by Subject|1|||
130970037|NCT02332720|471517801|FG020|Part A and Part B|Withdrawal by Subject|0|||
130970038|NCT02332720|471517802|FG021|Part A and Part B|Withdrawal by Subject|0|||
130970039|NCT02332720|471517803|FG022|Part A and Part B|Withdrawal by Subject|0|||
130970040|NCT00384085|471517804|FG000|Overall Study|Adverse Event|5|||
130970041|NCT00384085|471517805|FG001|Overall Study|Adverse Event|5|||
130970042|NCT00384085|471517806|FG002|Overall Study|Adverse Event|4|||
130970043|NCT00384085|471517804|FG000|Overall Study|Lack of Efficacy|0|||
130970044|NCT00384085|471517805|FG001|Overall Study|Lack of Efficacy|3|||
130970045|NCT00384085|471517806|FG002|Overall Study|Lack of Efficacy|2|||
130970046|NCT00384085|471517804|FG000|Overall Study|No longer Requires Study Treatment|1|||
130970047|NCT00384085|471517805|FG001|Overall Study|No longer Requires Study Treatment|0|||
130970048|NCT00384085|471517806|FG002|Overall Study|No longer Requires Study Treatment|1|||
130970049|NCT00384085|471517804|FG000|Overall Study|Protocol Violation|2|||
130970050|NCT00384085|471517805|FG001|Overall Study|Protocol Violation|2|||
130970051|NCT00384085|471517806|FG002|Overall Study|Protocol Violation|2|||
130970052|NCT00384085|471517804|FG000|Overall Study|Lost to Follow-up|9|||
130970053|NCT00384085|471517805|FG001|Overall Study|Lost to Follow-up|9|||
130970054|NCT00384085|471517806|FG002|Overall Study|Lost to Follow-up|10|||
130970055|NCT00384085|471517804|FG000|Overall Study|Progressive Disease|0|||
130970056|NCT00384085|471517805|FG001|Overall Study|Progressive Disease|1|||
130970057|NCT00384085|471517806|FG002|Overall Study|Progressive Disease|0|||
130970058|NCT00384085|471517804|FG000|Overall Study|Withdrawal by Subject|14|||
130970059|NCT00384085|471517805|FG001|Overall Study|Withdrawal by Subject|19|||
130970060|NCT00384085|471517806|FG002|Overall Study|Withdrawal by Subject|29|||
130970061|NCT00384085|471517804|FG000|Overall Study|Patient non-compliant|4|||
130970062|NCT00384085|471517805|FG001|Overall Study|Patient non-compliant|4|||
130970063|NCT00384085|471517806|FG002|Overall Study|Patient non-compliant|5|||
130970064|NCT00384085|471517804|FG000|Overall Study|Physician Decision|1|||
130970065|NCT00384085|471517805|FG001|Overall Study|Physician Decision|0|||
130970066|NCT00384085|471517806|FG002|Overall Study|Physician Decision|0|||
130970067|NCT00384085|471517804|FG000|Overall Study|Loss of site personnel|1|||
130970068|NCT00384085|471517805|FG001|Overall Study|Loss of site personnel|0|||
130970069|NCT00384085|471517806|FG002|Overall Study|Loss of site personnel|1|||
130970070|NCT00384085|471517804|FG000|Overall Study|Sponsor decision|1|||
130970071|NCT00384085|471517805|FG001|Overall Study|Sponsor decision|2|||
130970072|NCT00384085|471517806|FG002|Overall Study|Sponsor decision|1|||
130970073|NCT00384085|471517804|FG000|Overall Study|Patient moved|1|||
130970074|NCT00384085|471517805|FG001|Overall Study|Patient moved|0|||
130970075|NCT00384085|471517806|FG002|Overall Study|Patient moved|1|||
130970076|NCT00384085|471517804|FG000|Overall Study|Patient required surgery|0|||
130970077|NCT00384085|471517805|FG001|Overall Study|Patient required surgery|1|||
130970078|NCT00384085|471517806|FG002|Overall Study|Patient required surgery|0|||
130970079|NCT03725982|471517809|FG000|First Intervention|Withdrawal by Subject|0|||
130970080|NCT03725982|471517810|FG001|First Intervention|Withdrawal by Subject|1|||
130970081|NCT03725982|471517809|FG000|First Intervention|Physician Decision|1|||
130970082|NCT03725982|471517810|FG001|First Intervention|Physician Decision|1|||
130970083|NCT03832010|471517813|FG000|Overall Study|Withdrawal by Subject|2|||
130970084|NCT03832010|471517814|FG001|Overall Study|Withdrawal by Subject|1|||
130970085|NCT03832010|471517815|FG002|Overall Study|Withdrawal by Subject|0|||
130970086|NCT03832010|471517813|FG000|Overall Study|Lost to Follow-up|2|||
130970087|NCT03832010|471517814|FG001|Overall Study|Lost to Follow-up|1|||
130970088|NCT03832010|471517815|FG002|Overall Study|Lost to Follow-up|1|||
130970089|NCT00352365|471517816|FG000|Induction Therapy|Adverse Event|7|||
130970090|NCT00352365|471517816|FG000|Induction Therapy|Progression/Relapse|8|||
130970091|NCT00352365|471517816|FG000|Induction Therapy|Death|7|||
130970092|NCT00352365|471517816|FG000|Induction Therapy|Not protocol specified|1|||
130970093|NCT00352365|471517816|FG000|Induction Therapy|Not eligible|3|||
130970094|NCT00352365|471517816|FG000|Induction Therapy|Death before starting protocol therapy|1|||
130970095|NCT00352365|471517816|FG000|Maintenance Therapy|Progression/Relapse|3|||
130970096|NCT00352365|471517816|FG000|Maintenance Therapy|Death|2|||
131227114|NCT01827371|472457779|FG002|Overall Study|Temporary study halt to vaccinations|5|||
131227115|NCT01827371|472457780|FG003|Overall Study|Temporary study halt to vaccinations|13|||
130775732|NCT00667992|470806553|FG001|Wash-out|Withdrawal by Subject|0|||
130970097|NCT00352365|471517816|FG000|Maintenance Therapy|Not protocol specified|3|||
130970098|NCT00352365|471517816|FG000|Maintenance Therapy|Not eligible|4|||
130970099|NCT00987467|471517820|FG000|Overall Study|Lost to Follow-up|2|||
130970100|NCT00512135|471517821|FG000|Overall Study|Not Treated|5|||
130970101|NCT00512135|471517821|FG000|Overall Study|Lack of Efficacy|2|||
130716418|NCT04765384|470588849|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
130716419|NCT04765384|470588844|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130970102|NCT00512135|471517821|FG000|Overall Study|Adverse Event|6|||
130970103|NCT00512135|471517821|FG000|Overall Study|Withdrawal by Subject|22|||
130970104|NCT00512135|471517821|FG000|Overall Study|Lost to Follow-up|27|||
130970105|NCT00512135|471517821|FG000|Overall Study|Other|22|||
130970106|NCT00377819|471517822|FG000|Overall Study|Adverse Event|2|||
130970107|NCT00377819|471517823|FG001|Overall Study|Adverse Event|3|||
130970108|NCT00377819|471517822|FG000|Overall Study|Withdrawal by Subject|10|||
130970109|NCT00377819|471517823|FG001|Overall Study|Withdrawal by Subject|4|||
130970110|NCT00377819|471517822|FG000|Overall Study|Death|0|||
130970111|NCT00377819|471517823|FG001|Overall Study|Death|1|||
130970112|NCT00377819|471517822|FG000|Overall Study|Lost to Follow-up|0|||
130970113|NCT00377819|471517823|FG001|Overall Study|Lost to Follow-up|1|||
130970114|NCT00377819|471517822|FG000|Overall Study|Protocol Violation|1|||
130970115|NCT00377819|471517823|FG001|Overall Study|Protocol Violation|1|||
130970116|NCT03727750|471517824|FG000|Overall Study|Death|45|||
130970117|NCT03727750|471517824|FG000|Overall Study|Withdrawal by Subject|2|||
130970118|NCT03727750|471517824|FG000|Overall Study|Lost to Follow-up|1|||
130970119|NCT03727750|471517824|FG000|Overall Study|Other|1|||
130970120|NCT02624804|471517825|FG000|Overall Study|Screen Failure|5|||
130970121|NCT03073603|471517829|FG000|Overall Study|Noncompliance|3|||
130970122|NCT03073603|471517830|FG001|Overall Study|Noncompliance|1|||
130970123|NCT03073603|471517829|FG000|Overall Study|Adverse Event|5|||
130970124|NCT03073603|471517830|FG001|Overall Study|Adverse Event|3|||
130970125|NCT03073603|471517829|FG000|Overall Study|Physician Decision|1|||
130970126|NCT03073603|471517830|FG001|Overall Study|Physician Decision|2|||
130970127|NCT03073603|471517829|FG000|Overall Study|Required treatment not allowed by protocol|1|||
130970128|NCT03073603|471517830|FG001|Overall Study|Required treatment not allowed by protocol|0|||
130970129|NCT03073603|471517829|FG000|Overall Study|Financial or insurance-related|8|||
130970130|NCT03073603|471517830|FG001|Overall Study|Financial or insurance-related|0|||
130970131|NCT03073603|471517829|FG000|Overall Study|Withdrawal by Subject|0|||
130970132|NCT03073603|471517830|FG001|Overall Study|Withdrawal by Subject|1|||
130970133|NCT03073603|471517829|FG000|Overall Study|Discontinued DMT|4|||
130970134|NCT03073603|471517830|FG001|Overall Study|Discontinued DMT|0|||
130970135|NCT03073603|471517829|FG000|Overall Study|Restarted DMT|0|||
130970136|NCT03073603|471517830|FG001|Overall Study|Restarted DMT|1|||
130970137|NCT01659021|471517831|FG000|Main Study|Adverse Event|2|||
130970138|NCT01659021|471517832|FG001|Main Study|Adverse Event|3|||
130970139|NCT01659021|471517831|FG000|Main Study|Lost to Follow-up|1|||
130970140|NCT01659021|471517832|FG001|Main Study|Lost to Follow-up|0|||
130970141|NCT01659021|471517831|FG000|Main Study|Unknown Reasons|2|||
130970142|NCT01659021|471517832|FG001|Main Study|Unknown Reasons|1|||
130970143|NCT01659021|471517831|FG000|Main Study|Physician Decision|34|||
130970144|NCT01659021|471517832|FG001|Main Study|Physician Decision|16|||
130970145|NCT01659021|471517831|FG000|Main Study|Withdrawal by Subject|19|||
130970146|NCT01659021|471517832|FG001|Main Study|Withdrawal by Subject|16|||
130970147|NCT01659021|471517831|FG000|Main Study|Study Terminated by Sponsor|16|||
130970148|NCT01659021|471517832|FG001|Main Study|Study Terminated by Sponsor|1|||
130970149|NCT01659021|471517831|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
130970150|NCT01659021|471517832|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
130970151|NCT01659021|471517831|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
130970152|NCT01659021|471517832|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
130970153|NCT03058679|471517838|FG000|Baseline to Week 6|Lost to Follow-up|3|||
130970154|NCT03058679|471517839|FG001|Baseline to Week 6|Lost to Follow-up|2|||
130970155|NCT03058679|471517838|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
130970156|NCT03058679|471517839|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
130970157|NCT03058679|471517838|FG000|Baseline to Week 6|Adverse Event|6|||
130970158|NCT03058679|471517839|FG001|Baseline to Week 6|Adverse Event|6|||
130970159|NCT03058679|471517838|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
130970160|NCT03058679|471517839|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
130970161|NCT03058679|471517838|FG000|Baseline to Week 6|Difficulty following the diet|0|||
130970162|NCT03058679|471517839|FG001|Baseline to Week 6|Difficulty following the diet|2|||
130970163|NCT03058679|471517838|FG000|Baseline to Week 6|Physician Decision|1|||
130970164|NCT03058679|471517839|FG001|Baseline to Week 6|Physician Decision|0|||
130716420|NCT04765384|470588845|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130970165|NCT03058679|471517838|FG000|Week 6 to Week 12|Change in medication|5|||
130970166|NCT03058679|471517839|FG001|Week 6 to Week 12|Change in medication|7|||
130970167|NCT03058679|471517838|FG000|Week 6 to Week 12|Adverse Event|4|||
130970168|NCT03058679|471517839|FG001|Week 6 to Week 12|Adverse Event|3|||
131042543|NCT02315703|471789337|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
130970169|NCT03058679|471517838|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
130970170|NCT03058679|471517839|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
130970171|NCT03058679|471517838|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
130970172|NCT03058679|471517839|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
130970173|NCT00574080|471517840|FG000|Overall Study|Death|10|||
130970174|NCT00574080|471517841|FG001|Overall Study|Death|10|||
130970175|NCT00599326|471517842|FG000|Overall Study|Lost to Follow-up|1|||
130970176|NCT00599326|471517842|FG000|Overall Study|Noncompliant|1|||
130970177|NCT00784810|471517845|FG000|Overall Study|Adverse Event|32|||
130970178|NCT00784810|471517846|FG001|Overall Study|Adverse Event|20|||
130970179|NCT00784810|471517845|FG000|Overall Study|Lack of Efficacy|14|||
130970180|NCT00784810|471517846|FG001|Overall Study|Lack of Efficacy|11|||
130970181|NCT00784810|471517845|FG000|Overall Study|Withdrawal by Subject|11|||
130970182|NCT00784810|471517846|FG001|Overall Study|Withdrawal by Subject|9|||
130970183|NCT00784810|471517845|FG000|Overall Study|Administrative|5|||
130970184|NCT00784810|471517846|FG001|Overall Study|Administrative|8|||
130970185|NCT00784810|471517845|FG000|Overall Study|Lost to Follow-up|1|||
130970186|NCT00784810|471517846|FG001|Overall Study|Lost to Follow-up|1|||
130970187|NCT02862106|471517847|FG000|Overall Study|Adverse Event|4|||
130970188|NCT02862106|471517848|FG001|Overall Study|Adverse Event|0|||
130970189|NCT02862106|471517847|FG000|Overall Study|Protocol Violation|16|||
130970190|NCT02862106|471517848|FG001|Overall Study|Protocol Violation|1|||
130970191|NCT02862106|471517847|FG000|Overall Study|Lost to Follow-up|15|||
130970192|NCT02862106|471517848|FG001|Overall Study|Lost to Follow-up|5|||
130970193|NCT02862106|471517847|FG000|Overall Study|Withdrawal by Subject|2|||
130970194|NCT02862106|471517848|FG001|Overall Study|Withdrawal by Subject|0|||
130970195|NCT02862106|471517847|FG000|Overall Study|Subjects moved to other city|1|||
130970196|NCT02862106|471517848|FG001|Overall Study|Subjects moved to other city|0|||
130970197|NCT00563784|471517851|FG000|Overall Study|Withdrawal by Subject|2|||
130970198|NCT00563784|471517851|FG000|Overall Study|Screen Failures|20|||
130970199|NCT04360824|471517852|FG000|Overall Study|Withdrawal by Subject|2|||
130970200|NCT04360824|471517853|FG001|Overall Study|Withdrawal by Subject|1|||
130970201|NCT04360824|471517852|FG000|Overall Study|Did not receive assigned treatment|1|||
130970202|NCT04360824|471517853|FG001|Overall Study|Did not receive assigned treatment|3|||
130970203|NCT00304070|471517854|FG000|Overall Study|Death|0|||
130970204|NCT00304070|471517855|FG001|Overall Study|Death|0|||
130970205|NCT00304070|471517856|FG002|Overall Study|Death|3|||
130970206|NCT00304070|471517854|FG000|Overall Study|Lost to Follow-up|0|||
130970207|NCT00304070|471517855|FG001|Overall Study|Lost to Follow-up|0|||
130970208|NCT00304070|471517856|FG002|Overall Study|Lost to Follow-up|1|||
130970209|NCT00304070|471517854|FG000|Overall Study|Physician Decision|0|||
130970210|NCT00304070|471517855|FG001|Overall Study|Physician Decision|0|||
130970211|NCT00304070|471517856|FG002|Overall Study|Physician Decision|3|||
130970212|NCT00304070|471517854|FG000|Overall Study|Withdrawal by Subject|0|||
130970213|NCT00304070|471517855|FG001|Overall Study|Withdrawal by Subject|0|||
130970214|NCT00304070|471517856|FG002|Overall Study|Withdrawal by Subject|1|||
130970215|NCT00304070|471517854|FG000|Overall Study|Progressive Disease|3|||
130970216|NCT00304070|471517855|FG001|Overall Study|Progressive Disease|7|||
130970217|NCT00304070|471517856|FG002|Overall Study|Progressive Disease|4|||
130970218|NCT00320216|471517857|FG000|Overall Study|Adverse Event|0|||
130970219|NCT00320216|471517858|FG001|Overall Study|Adverse Event|6|||
130970220|NCT00320216|471517859|FG002|Overall Study|Adverse Event|0|||
130970221|NCT00320216|471517860|FG003|Overall Study|Adverse Event|2|||
130970222|NCT00320216|471517861|FG004|Overall Study|Adverse Event|2|||
130970223|NCT00320216|471517857|FG000|Overall Study|Lack of Efficacy|6|||
130970224|NCT00320216|471517858|FG001|Overall Study|Lack of Efficacy|2|||
130970225|NCT00320216|471517859|FG002|Overall Study|Lack of Efficacy|1|||
130970226|NCT00320216|471517860|FG003|Overall Study|Lack of Efficacy|0|||
130970227|NCT00320216|471517861|FG004|Overall Study|Lack of Efficacy|1|||
130970228|NCT00320216|471517857|FG000|Overall Study|Lost to Follow-up|3|||
130970229|NCT00320216|471517858|FG001|Overall Study|Lost to Follow-up|0|||
130970230|NCT00320216|471517859|FG002|Overall Study|Lost to Follow-up|0|||
130970231|NCT00320216|471517860|FG003|Overall Study|Lost to Follow-up|0|||
130970232|NCT00320216|471517861|FG004|Overall Study|Lost to Follow-up|0|||
130970233|NCT00320216|471517857|FG000|Overall Study|Other|7|||
130970234|NCT00320216|471517858|FG001|Overall Study|Other|2|||
130970235|NCT00320216|471517859|FG002|Overall Study|Other|5|||
130970236|NCT00320216|471517860|FG003|Overall Study|Other|1|||
130970237|NCT00320216|471517861|FG004|Overall Study|Other|3|||
130970238|NCT00377676|471517862|FG000|Overall Study|Adverse Event|498|||
130970239|NCT00377676|471517863|FG001|Overall Study|Adverse Event|107|||
130970240|NCT00377676|471517862|FG000|Overall Study|Protocol Violation|33|||
130970241|NCT00377676|471517863|FG001|Overall Study|Protocol Violation|27|||
130716421|NCT04765384|470588846|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130970242|NCT00377676|471517862|FG000|Overall Study|Death|5|||
130970243|NCT00377676|471517863|FG001|Overall Study|Death|2|||
130970244|NCT00377676|471517862|FG000|Overall Study|Withdrawal by Subject|187|||
130716422|NCT04765384|470588847|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130970245|NCT00377676|471517863|FG001|Overall Study|Withdrawal by Subject|72|||
130970246|NCT00377676|471517862|FG000|Overall Study|Lost to Follow-up|120|||
130970247|NCT00377676|471517863|FG001|Overall Study|Lost to Follow-up|56|||
130970248|NCT00377676|471517862|FG000|Overall Study|Other|118|||
130970249|NCT00377676|471517863|FG001|Overall Study|Other|58|||
130970250|NCT01380327|471517868|FG000|Overall Study|Lost to Follow-up|0|||
130970251|NCT01380327|471517869|FG001|Overall Study|Lost to Follow-up|1|||
130970252|NCT01380327|471517870|FG002|Overall Study|Lost to Follow-up|1|||
130970253|NCT01380327|471517868|FG000|Overall Study|Protocol Violation|3|||
130970254|NCT01380327|471517869|FG001|Overall Study|Protocol Violation|2|||
130970255|NCT01380327|471517870|FG002|Overall Study|Protocol Violation|3|||
130970256|NCT01380327|471517868|FG000|Overall Study|Withdrawal by Subject|0|||
130970257|NCT01380327|471517869|FG001|Overall Study|Withdrawal by Subject|0|||
130970258|NCT01380327|471517870|FG002|Overall Study|Withdrawal by Subject|1|||
130970259|NCT01380327|471517868|FG000|Overall Study|Housing situation precluded ability to k|0|||
130970260|NCT01380327|471517869|FG001|Overall Study|Housing situation precluded ability to k|0|||
130970261|NCT01380327|471517870|FG002|Overall Study|Housing situation precluded ability to k|1|||
130970262|NCT01380327|471517868|FG000|Overall Study|Questionable onset of epilepsy|0|||
130970263|NCT01380327|471517869|FG001|Overall Study|Questionable onset of epilepsy|0|||
130970264|NCT01380327|471517870|FG002|Overall Study|Questionable onset of epilepsy|1|||
130970265|NCT03646513|471517874|FG000|Overall Study|Premature study termination|4|||
130970266|NCT03359096|471517875|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
130970267|NCT03359096|471517876|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
130970268|NCT03359096|471517875|FG000|First Intervention (4 Weeks)|Death|1|||
130970269|NCT03359096|471517876|FG001|First Intervention (4 Weeks)|Death|0|||
130970270|NCT03359096|471517875|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
130970271|NCT03359096|471517876|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
130970272|NCT03585244|471517881|FG000|Overall Study|Withdrawal by Subject|15|||
130970273|NCT01587651|471517884|FG000|Overall Study|Adverse Event|0|||
130970274|NCT01587651|471517885|FG001|Overall Study|Adverse Event|1|||
130970275|NCT01587651|471517886|FG002|Overall Study|Adverse Event|0|||
130970276|NCT01587651|471517884|FG000|Overall Study|Protocol Violation|0|||
130970277|NCT01587651|471517885|FG001|Overall Study|Protocol Violation|1|||
130970278|NCT01587651|471517886|FG002|Overall Study|Protocol Violation|1|||
130970279|NCT01587651|471517884|FG000|Overall Study|Withdrawal by Subject|0|||
130970280|NCT01587651|471517885|FG001|Overall Study|Withdrawal by Subject|1|||
130970281|NCT01587651|471517886|FG002|Overall Study|Withdrawal by Subject|0|||
130970282|NCT03325712|471517887|FG000|Overall Study|Protocol Violation|0|||
130970283|NCT03325712|471517888|FG001|Overall Study|Protocol Violation|0|||
130970284|NCT03325712|471517889|FG002|Overall Study|Protocol Violation|0|||
130970285|NCT03325712|471517890|FG003|Overall Study|Protocol Violation|0|||
130970286|NCT03325712|471517891|FG004|Overall Study|Protocol Violation|1|||
130970287|NCT03325712|471517892|FG005|Overall Study|Protocol Violation|0|||
130970288|NCT03325712|471517893|FG006|Overall Study|Protocol Violation|0|||
130970289|NCT03325712|471517894|FG007|Overall Study|Protocol Violation|0|||
130970290|NCT03325712|471517887|FG000|Overall Study|Adverse Event|0|||
130970291|NCT03325712|471517888|FG001|Overall Study|Adverse Event|0|||
130970292|NCT03325712|471517889|FG002|Overall Study|Adverse Event|0|||
130970293|NCT03325712|471517890|FG003|Overall Study|Adverse Event|0|||
130970294|NCT03325712|471517891|FG004|Overall Study|Adverse Event|1|||
130970295|NCT03325712|471517892|FG005|Overall Study|Adverse Event|0|||
130970296|NCT03325712|471517893|FG006|Overall Study|Adverse Event|0|||
130970297|NCT03325712|471517894|FG007|Overall Study|Adverse Event|0|||
130970298|NCT03550313|471517895|FG000|Overall Study|Adverse Event|0|||
130970299|NCT03550313|471517896|FG001|Overall Study|Adverse Event|1|||
130970300|NCT03550313|471517897|FG002|Overall Study|Adverse Event|0|||
130970301|NCT03550313|471517895|FG000|Overall Study|Lost to Follow-up|5|||
130970302|NCT03550313|471517896|FG001|Overall Study|Lost to Follow-up|7|||
130970303|NCT03550313|471517897|FG002|Overall Study|Lost to Follow-up|12|||
130970304|NCT03550313|471517895|FG000|Overall Study|Study terminated by sponsor|44|||
130970305|NCT03550313|471517896|FG001|Overall Study|Study terminated by sponsor|37|||
130970306|NCT03550313|471517897|FG002|Overall Study|Study terminated by sponsor|48|||
130970307|NCT03550313|471517895|FG000|Overall Study|No longer met eligibility criteria|3|||
130970308|NCT03550313|471517896|FG001|Overall Study|No longer met eligibility criteria|5|||
130970309|NCT03550313|471517897|FG002|Overall Study|No longer met eligibility criteria|6|||
130970310|NCT03550313|471517895|FG000|Overall Study|Withdrawal by parent/guardian|20|||
130970311|NCT03550313|471517896|FG001|Overall Study|Withdrawal by parent/guardian|18|||
130970312|NCT03550313|471517897|FG002|Overall Study|Withdrawal by parent/guardian|26|||
130970313|NCT03550313|471517895|FG000|Overall Study|Other|4|||
130970314|NCT03550313|471517896|FG001|Overall Study|Other|2|||
130970315|NCT03550313|471517897|FG002|Overall Study|Other|2|||
131042544|NCT02315703|471789338|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
131042545|NCT02315703|471789339|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
131042546|NCT02315703|471789340|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
131042547|NCT02315703|471789341|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
130970316|NCT03550313|471517895|FG000|Overall Study|Randomized but not vaccinated|3|||
130970317|NCT03550313|471517896|FG001|Overall Study|Randomized but not vaccinated|23|||
130970318|NCT03550313|471517897|FG002|Overall Study|Randomized but not vaccinated|2|||
130970319|NCT03550313|471517895|FG000|Overall Study|Sites terminated due to quality issues|18|||
130970320|NCT03550313|471517896|FG001|Overall Study|Sites terminated due to quality issues|17|||
130970321|NCT03550313|471517897|FG002|Overall Study|Sites terminated due to quality issues|18|||
130970322|NCT00380068|471517899|FG000|Overall Study|Adverse Event|40|||
130970323|NCT00380068|471517899|FG000|Overall Study|Withdrawal by Subject|10|||
130970324|NCT00380068|471517899|FG000|Overall Study|Not compliant|6|||
130970325|NCT00380068|471517899|FG000|Overall Study|Lost to Follow-up|1|||
130970326|NCT00380068|471517899|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
130970327|NCT00380068|471517899|FG000|Overall Study|Lung transplant|3|||
130970328|NCT00380068|471517899|FG000|Overall Study|Physician Decision|2|||
130970329|NCT00380068|471517899|FG000|Overall Study|Partipant moved away|1|||
130970330|NCT00380068|471517899|FG000|Overall Study|Lack of Efficacy|5|||
130970331|NCT01297062|471517900|FG000|Overall Study|Adverse Event|2|||
130970332|NCT01297062|471517901|FG001|Overall Study|Adverse Event|0|||
130970333|NCT01297062|471517902|FG002|Overall Study|Adverse Event|1|||
130970334|NCT01297062|471517903|FG003|Overall Study|Adverse Event|0|||
130970335|NCT01297062|471517904|FG004|Overall Study|Adverse Event|0|||
130970336|NCT01297062|471517905|FG005|Overall Study|Adverse Event|0|||
130970337|NCT01297062|471517906|FG006|Overall Study|Adverse Event|0|||
130970338|NCT01297062|471517900|FG000|Overall Study|Physician Decision|1|||
130970339|NCT01297062|471517901|FG001|Overall Study|Physician Decision|0|||
130970340|NCT01297062|471517902|FG002|Overall Study|Physician Decision|1|||
130970341|NCT01297062|471517903|FG003|Overall Study|Physician Decision|0|||
130970342|NCT01297062|471517904|FG004|Overall Study|Physician Decision|0|||
130970343|NCT01297062|471517905|FG005|Overall Study|Physician Decision|0|||
130970344|NCT01297062|471517906|FG006|Overall Study|Physician Decision|6|||
130970345|NCT01297062|471517900|FG000|Overall Study|Protocol Violation|0|||
130970346|NCT01297062|471517901|FG001|Overall Study|Protocol Violation|0|||
130970347|NCT01297062|471517902|FG002|Overall Study|Protocol Violation|0|||
130970348|NCT01297062|471517903|FG003|Overall Study|Protocol Violation|0|||
130970349|NCT01297062|471517904|FG004|Overall Study|Protocol Violation|1|||
130970350|NCT01297062|471517905|FG005|Overall Study|Protocol Violation|0|||
130970351|NCT01297062|471517906|FG006|Overall Study|Protocol Violation|0|||
130970352|NCT01297062|471517900|FG000|Overall Study|Subject Decision|1|||
130970353|NCT01297062|471517901|FG001|Overall Study|Subject Decision|1|||
130970354|NCT01297062|471517902|FG002|Overall Study|Subject Decision|0|||
130970355|NCT01297062|471517903|FG003|Overall Study|Subject Decision|1|||
130970356|NCT01297062|471517904|FG004|Overall Study|Subject Decision|1|||
130970357|NCT01297062|471517905|FG005|Overall Study|Subject Decision|1|||
130970358|NCT01297062|471517906|FG006|Overall Study|Subject Decision|2|||
130970359|NCT04964089|471517907|FG000|Overall Study|Adverse Event|8|||
130970360|NCT04964089|471517908|FG001|Overall Study|Adverse Event|6|||
130970361|NCT04964089|471517907|FG000|Overall Study|Non-compliance with study schedule|1|||
130970362|NCT04964089|471517908|FG001|Overall Study|Non-compliance with study schedule|0|||
130970363|NCT04964089|471517907|FG000|Overall Study|Withdrawal by Subject|6|||
130970364|NCT04964089|471517908|FG001|Overall Study|Withdrawal by Subject|5|||
130970365|NCT04964089|471517907|FG000|Overall Study|Lost to Follow-up|1|||
130970366|NCT04964089|471517908|FG001|Overall Study|Lost to Follow-up|1|||
130970367|NCT04964089|471517907|FG000|Overall Study|Progressive disease|4|||
130970368|NCT04964089|471517908|FG001|Overall Study|Progressive disease|0|||
130970369|NCT04964089|471517907|FG000|Overall Study|Physician Decision|1|||
130970370|NCT04964089|471517908|FG001|Overall Study|Physician Decision|0|||
130970371|NCT04964089|471517907|FG000|Overall Study|Participant did not want to continue study treatment|1|||
130970372|NCT04964089|471517908|FG001|Overall Study|Participant did not want to continue study treatment|0|||
130970373|NCT04964089|471517907|FG000|Overall Study|Participant moved to different state|1|||
130970374|NCT04964089|471517908|FG001|Overall Study|Participant moved to different state|0|||
130970375|NCT04964089|471517907|FG000|Overall Study|Participant decided to discontinue|0|||
130970376|NCT04964089|471517908|FG001|Overall Study|Participant decided to discontinue|1|||
130970377|NCT01165281|471517914|FG000|Overall Study|Adverse Event|12|||
130970378|NCT01165281|471517915|FG001|Overall Study|Adverse Event|14|||
130970379|NCT01165281|471517914|FG000|Overall Study|Death|3|||
130970380|NCT01165281|471517915|FG001|Overall Study|Death|4|||
130970381|NCT01165281|471517914|FG000|Overall Study|Lack of Efficacy|4|||
130970382|NCT01165281|471517915|FG001|Overall Study|Lack of Efficacy|1|||
130970383|NCT01165281|471517914|FG000|Overall Study|Lost to Follow-up|0|||
130970384|NCT01165281|471517915|FG001|Overall Study|Lost to Follow-up|1|||
130970385|NCT01165281|471517914|FG000|Overall Study|Physician Decision|8|||
130970386|NCT01165281|471517915|FG001|Overall Study|Physician Decision|1|||
130970387|NCT01165281|471517914|FG000|Overall Study|Protocol Violation|6|||
130970388|NCT01165281|471517915|FG001|Overall Study|Protocol Violation|5|||
130970389|NCT01165281|471517914|FG000|Overall Study|Withdrawal by Subject|8|||
130970390|NCT01165281|471517915|FG001|Overall Study|Withdrawal by Subject|7|||
130970391|NCT01165281|471517914|FG000|Overall Study|Noncompliance with Study Drug|1|||
130970392|NCT01165281|471517915|FG001|Overall Study|Noncompliance with Study Drug|4|||
130970393|NCT01165281|471517914|FG000|Overall Study|Progressive Disease|10|||
130970394|NCT01165281|471517915|FG001|Overall Study|Progressive Disease|14|||
130970395|NCT01165281|471517914|FG000|Overall Study|Other|6|||
130970396|NCT01165281|471517915|FG001|Overall Study|Other|0|||
130970397|NCT02005471|471517920|FG000|Main Study|Adverse Event|0|||
130970398|NCT02005471|471517921|FG001|Main Study|Adverse Event|1|||
130970399|NCT02005471|471517922|FG002|Main Study|Adverse Event|0|||
130970400|NCT02005471|471517923|FG003|Main Study|Adverse Event|0|||
130970401|NCT02005471|471517920|FG000|Main Study|Death|83|||
130970402|NCT02005471|471517921|FG001|Main Study|Death|52|||
130970403|NCT02005471|471517922|FG002|Main Study|Death|0|||
130970404|NCT02005471|471517923|FG003|Main Study|Death|0|||
130970405|NCT02005471|471517920|FG000|Main Study|Lost to Follow-up|4|||
130970406|NCT02005471|471517921|FG001|Main Study|Lost to Follow-up|5|||
130970407|NCT02005471|471517922|FG002|Main Study|Lost to Follow-up|0|||
130970408|NCT02005471|471517923|FG003|Main Study|Lost to Follow-up|0|||
130970409|NCT02005471|471517920|FG000|Main Study|Physician Decision|3|||
130970410|NCT02005471|471517921|FG001|Main Study|Physician Decision|1|||
130970411|NCT02005471|471517922|FG002|Main Study|Physician Decision|0|||
130970412|NCT02005471|471517923|FG003|Main Study|Physician Decision|0|||
130970413|NCT02005471|471517920|FG000|Main Study|Withdrawal by Subject|26|||
130970414|NCT02005471|471517921|FG001|Main Study|Withdrawal by Subject|11|||
130970415|NCT02005471|471517922|FG002|Main Study|Withdrawal by Subject|0|||
130970416|NCT02005471|471517923|FG003|Main Study|Withdrawal by Subject|0|||
130970417|NCT02005471|471517920|FG000|Main Study|Reason not Specified|0|||
130970418|NCT02005471|471517921|FG001|Main Study|Reason not Specified|6|||
130970419|NCT02005471|471517922|FG002|Main Study|Reason not Specified|0|||
130970420|NCT02005471|471517923|FG003|Main Study|Reason not Specified|0|||
130970421|NCT02005471|471517920|FG000|Main Study|Randomized but not Dosed|8|||
130970422|NCT02005471|471517921|FG001|Main Study|Randomized but not Dosed|0|||
130970423|NCT02005471|471517922|FG002|Main Study|Randomized but not Dosed|0|||
130970424|NCT02005471|471517923|FG003|Main Study|Randomized but not Dosed|0|||
130970425|NCT02005471|471517920|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
130970426|NCT02005471|471517921|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
130970427|NCT02005471|471517922|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
130970428|NCT02005471|471517923|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
130970429|NCT02005471|471517920|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
130970430|NCT02005471|471517921|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
130970431|NCT02005471|471517922|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
130970432|NCT02005471|471517923|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
130970433|NCT02005471|471517920|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
130970434|NCT02005471|471517921|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
130970435|NCT02005471|471517922|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
130970436|NCT02005471|471517923|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
130970437|NCT00363766|471517924|FG000|Overall Study|Progressive Disease|15|||
130970438|NCT00363766|471517925|FG001|Overall Study|Progressive Disease|9|||
130970439|NCT00363766|471517924|FG000|Overall Study|Adverse Event|10|||
130970440|NCT00363766|471517925|FG001|Overall Study|Adverse Event|2|||
130970441|NCT00363766|471517924|FG000|Overall Study|Disease Related Death|1|||
130970442|NCT00363766|471517925|FG001|Overall Study|Disease Related Death|3|||
130970443|NCT00363766|471517924|FG000|Overall Study|Not Disease Related Death|3|||
130970444|NCT00363766|471517925|FG001|Overall Study|Not Disease Related Death|4|||
130970445|NCT00363766|471517924|FG000|Overall Study|Withdrawal by Subject|2|||
130970446|NCT00363766|471517925|FG001|Overall Study|Withdrawal by Subject|0|||
130970447|NCT00363766|471517924|FG000|Overall Study|Physician Decision|1|||
130970448|NCT00363766|471517925|FG001|Overall Study|Physician Decision|2|||
130970449|NCT00627705|471517926|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
130970450|NCT00627705|471517927|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
130970451|NCT00627705|471517926|FG000|Overall Study|Adverse Event|1|||
130970452|NCT00627705|471517927|FG001|Overall Study|Adverse Event|0|||
130970453|NCT00627705|471517926|FG000|Overall Study|Withdrawal by Subject|0|||
130970454|NCT00627705|471517927|FG001|Overall Study|Withdrawal by Subject|2|||
130970455|NCT00627705|471517926|FG000|Overall Study|Lost to Follow-up|0|||
130970456|NCT00627705|471517927|FG001|Overall Study|Lost to Follow-up|1|||
130970457|NCT01218438|471517936|FG000|Epoch 1|Physician Decision|2|||
130970458|NCT01218438|471517936|FG000|Epoch 1|Adverse Event|1|||
130970459|NCT01218438|471517936|FG000|Epoch 3|Withdrawal by Subject|3|||
130970460|NCT01218438|471517936|FG000|Epoch 3|Adverse Event|1|||
130970461|NCT01218438|471517936|FG000|Epoch 4|Physician Decision|1|||
130970462|NCT01218438|471517936|FG000|Epoch 4|Withdrawal by Subject|2|||
130970463|NCT03662750|471517937|FG000|Overall Study|Withdrawal by Subject|1|||
130970464|NCT04295564|471520165|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
130970465|NCT04295564|471520166|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
130970466|NCT01682460|471520167|FG000|Overall Study|Withdrawal by Subject|2|||
130970467|NCT01682460|471520167|FG000|Overall Study|Did not meet inclusion criteria|2|||
130970468|NCT02105116|471520168|FG000|Overall Study|not eligible for step 2 of trial|5|||
130970469|NCT02105116|471520168|FG000|Overall Study|Death|1|||
130970470|NCT00773968|471520169|FG000|Overall Study|Adverse Event|2|||
130970471|NCT00773968|471520169|FG000|Overall Study|Death|1|||
130970472|NCT00773968|471520169|FG000|Overall Study|Failure to Return|2|||
130970473|NCT00773968|471520169|FG000|Overall Study|Lack of Efficacy|3|||
130970474|NCT00773968|471520169|FG000|Overall Study|Protocol Violation|1|||
130970475|NCT00773968|471520169|FG000|Overall Study|Withdrawal by Subject|11|||
130970476|NCT00773968|471520169|FG000|Overall Study|Screen Failure|17|||
130970477|NCT00773968|471520169|FG000|Overall Study|Other|8|||
130970478|NCT00263666|471520170|FG000|Overall Study|Adverse Event|6|||
130716423|NCT04765384|470588848|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130970479|NCT00263666|471520171|FG001|Overall Study|Adverse Event|8|||
130970480|NCT00263666|471520170|FG000|Overall Study|Lost to Follow-up|1|||
130970481|NCT00263666|471520171|FG001|Overall Study|Lost to Follow-up|2|||
130970482|NCT00263666|471520170|FG000|Overall Study|Withdrawal by Subject|0|||
130970483|NCT00263666|471520171|FG001|Overall Study|Withdrawal by Subject|1|||
130970484|NCT02492100|471520172|FG000|Overall Study|Death|1|||
130970485|NCT04743908|471520173|FG000|Overall Study|Death|1|||
130970486|NCT04743908|471520174|FG001|Overall Study|Death|0|||
130970487|NCT04743908|471520173|FG000|Overall Study|Lost to Follow-up|181|||
130970488|NCT04743908|471520174|FG001|Overall Study|Lost to Follow-up|180|||
130970489|NCT04743908|471520173|FG000|Overall Study|Withdrawal by Subject|1|||
130970490|NCT04743908|471520174|FG001|Overall Study|Withdrawal by Subject|2|||
130970491|NCT00328510|471520175|FG000|Overall Study|Gag disorder, could not use frame|4|||
130970492|NCT00328510|471520176|FG001|Overall Study|Gag disorder, could not use frame|0|||
130970493|NCT00328510|471520175|FG000|Overall Study|Dentition problems, could not use frame|1|||
130970494|NCT00328510|471520176|FG001|Overall Study|Dentition problems, could not use frame|0|||
130970495|NCT00328510|471520175|FG000|Overall Study|Withdrawal by Subject|4|||
130716424|NCT04765384|470588849|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
130716425|NCT04765384|470588844|FG000|Post-natal: Neonates and Infants|Death|0|||
130716426|NCT04765384|470588845|FG001|Post-natal: Neonates and Infants|Death|0|||
130716427|NCT04765384|470588846|FG002|Post-natal: Neonates and Infants|Death|0|||
130716428|NCT04765384|470588847|FG003|Post-natal: Neonates and Infants|Death|1|||
130716429|NCT04765384|470588848|FG004|Post-natal: Neonates and Infants|Death|0|||
130716430|NCT04765384|470588849|FG005|Post-natal: Neonates and Infants|Death|0|||
130970496|NCT00328510|471520176|FG001|Overall Study|Withdrawal by Subject|2|||
130970497|NCT00328510|471520175|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
130970498|NCT00328510|471520176|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
130970499|NCT00328510|471520175|FG000|Overall Study|Treatment changed to a single fraction|1|||
130970500|NCT00328510|471520176|FG001|Overall Study|Treatment changed to a single fraction|1|||
130970501|NCT03240588|471520180|FG000|Overall Study|Death|3|||
130970502|NCT03240588|471520181|FG001|Overall Study|Death|0|||
130970503|NCT03240588|471520182|FG002|Overall Study|Death|0|||
130970504|NCT03240588|471520180|FG000|Overall Study|Adverse Event|5|||
130970505|NCT03240588|471520181|FG001|Overall Study|Adverse Event|4|||
130970506|NCT03240588|471520182|FG002|Overall Study|Adverse Event|0|||
130970507|NCT03240588|471520180|FG000|Overall Study|Lost to Follow-up|9|||
130970508|NCT03240588|471520181|FG001|Overall Study|Lost to Follow-up|4|||
130970509|NCT03240588|471520182|FG002|Overall Study|Lost to Follow-up|0|||
130970510|NCT03240588|471520180|FG000|Overall Study|Physician Decision|3|||
130970511|NCT03240588|471520181|FG001|Overall Study|Physician Decision|2|||
130970512|NCT03240588|471520182|FG002|Overall Study|Physician Decision|0|||
130970513|NCT03240588|471520180|FG000|Overall Study|Did not meet eligibility criteria|0|||
130970514|NCT03240588|471520181|FG001|Overall Study|Did not meet eligibility criteria|6|||
130970515|NCT03240588|471520182|FG002|Overall Study|Did not meet eligibility criteria|0|||
130970516|NCT03240588|471520180|FG000|Overall Study|No longer meets protocol criteria|12|||
130970517|NCT03240588|471520181|FG001|Overall Study|No longer meets protocol criteria|7|||
130970518|NCT03240588|471520182|FG002|Overall Study|No longer meets protocol criteria|0|||
130970519|NCT03240588|471520180|FG000|Overall Study|Withdrawal by Subject|60|||
130970520|NCT03240588|471520181|FG001|Overall Study|Withdrawal by Subject|52|||
130970521|NCT03240588|471520182|FG002|Overall Study|Withdrawal by Subject|7|||
130970522|NCT03240588|471520180|FG000|Overall Study|Other, additional details not available.|0|||
130970523|NCT03240588|471520181|FG001|Overall Study|Other, additional details not available.|12|||
130970524|NCT03240588|471520182|FG002|Overall Study|Other, additional details not available.|1|||
130970525|NCT03240588|471520180|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
130970526|NCT03240588|471520181|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
130970527|NCT03240588|471520182|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
130970528|NCT03240588|471520180|FG000|Overall Study|Closure of study|55|||
130970529|NCT03240588|471520181|FG001|Overall Study|Closure of study|3|||
131042548|NCT02315703|471789342|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
131042549|NCT02315703|471789343|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
130716431|NCT04765384|470588844|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130970530|NCT03240588|471520182|FG002|Overall Study|Closure of study|0|||
131042550|NCT02315703|471789344|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
130970531|NCT03240588|471520180|FG000|Overall Study|Subject non-compliance|23|||
130970532|NCT03240588|471520181|FG001|Overall Study|Subject non-compliance|2|||
130970533|NCT03240588|471520182|FG002|Overall Study|Subject non-compliance|1|||
130970534|NCT03240588|471520180|FG000|Overall Study|Device Deficiency|1|||
130970535|NCT03240588|471520181|FG001|Overall Study|Device Deficiency|0|||
130970536|NCT03240588|471520182|FG002|Overall Study|Device Deficiency|0|||
130970537|NCT03240588|471520180|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
130970538|NCT03240588|471520181|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
130970539|NCT03240588|471520182|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
130970540|NCT03422250|471520183|FG000|Intervention|Adverse Event|0|||
130970541|NCT03422250|471520184|FG001|Intervention|Adverse Event|1|||
130970542|NCT03422250|471520185|FG002|Intervention|Adverse Event|0|||
130970543|NCT03422250|471520186|FG003|Intervention|Adverse Event|1|||
130970544|NCT03422250|471520183|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
130970545|NCT03422250|471520184|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
130970546|NCT03422250|471520185|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
130970547|NCT03422250|471520186|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
130970548|NCT03422250|471520183|FG000|Follow-up|Withdrawal by Subject|0|||
130970549|NCT03422250|471520184|FG001|Follow-up|Withdrawal by Subject|0|||
130970550|NCT03422250|471520185|FG002|Follow-up|Withdrawal by Subject|0|||
130970551|NCT03422250|471520186|FG003|Follow-up|Withdrawal by Subject|1|||
130970552|NCT03422250|471520183|FG000|Follow-up|Adverse Event|0|||
130970553|NCT03422250|471520184|FG001|Follow-up|Adverse Event|0|||
130970554|NCT03422250|471520185|FG002|Follow-up|Adverse Event|0|||
130970555|NCT03422250|471520186|FG003|Follow-up|Adverse Event|1|||
130970556|NCT02091726|471520189|FG000|Overall Study|Lost to Follow-up|6|||
130970557|NCT00467870|471520190|FG000|Overall Study|Adverse Event|13|||
130970558|NCT00467870|471520191|FG001|Overall Study|Adverse Event|9|||
130970559|NCT00467870|471520192|FG002|Overall Study|Adverse Event|1|||
130970560|NCT00467870|471520193|FG003|Overall Study|Adverse Event|15|||
130970561|NCT00467870|471520194|FG004|Overall Study|Adverse Event|15|||
130970562|NCT00467870|471520195|FG005|Overall Study|Adverse Event|1|||
130970563|NCT00467870|471520190|FG000|Overall Study|Protocol Violation|2|||
130970564|NCT00467870|471520191|FG001|Overall Study|Protocol Violation|1|||
130970565|NCT00467870|471520192|FG002|Overall Study|Protocol Violation|1|||
130970566|NCT00467870|471520193|FG003|Overall Study|Protocol Violation|2|||
130970567|NCT00467870|471520194|FG004|Overall Study|Protocol Violation|0|||
130970568|NCT00467870|471520195|FG005|Overall Study|Protocol Violation|0|||
130970569|NCT00467870|471520190|FG000|Overall Study|Withdrawal by Subject|14|||
130970570|NCT00467870|471520191|FG001|Overall Study|Withdrawal by Subject|21|||
130970571|NCT00467870|471520192|FG002|Overall Study|Withdrawal by Subject|0|||
130970572|NCT00467870|471520193|FG003|Overall Study|Withdrawal by Subject|9|||
130970573|NCT00467870|471520194|FG004|Overall Study|Withdrawal by Subject|10|||
130970574|NCT00467870|471520195|FG005|Overall Study|Withdrawal by Subject|1|||
130970575|NCT00467870|471520190|FG000|Overall Study|Lost to Follow-up|5|||
130970576|NCT00467870|471520191|FG001|Overall Study|Lost to Follow-up|3|||
131042551|NCT02315703|471789337|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131042552|NCT02315703|471789338|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131042553|NCT02315703|471789339|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131042554|NCT02315703|471789340|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131042555|NCT02315703|471789341|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131042556|NCT02315703|471789342|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
131042557|NCT02315703|471789343|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
131042558|NCT02315703|471789344|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
131042559|NCT02315703|471789337|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131042560|NCT02315703|471789338|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131042561|NCT02315703|471789339|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131042562|NCT02315703|471789340|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131042563|NCT02315703|471789341|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131042564|NCT02315703|471789342|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131042565|NCT02315703|471789343|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
131042566|NCT02315703|471789344|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
131042567|NCT02315703|471789337|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
131042568|NCT02315703|471789338|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
130970577|NCT00467870|471520192|FG002|Overall Study|Lost to Follow-up|1|||
130970578|NCT00467870|471520193|FG003|Overall Study|Lost to Follow-up|1|||
130970579|NCT00467870|471520194|FG004|Overall Study|Lost to Follow-up|3|||
131042569|NCT02315703|471789339|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
131042570|NCT02315703|471789340|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
131128832|NCT01624662|472099613|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
130970580|NCT00467870|471520195|FG005|Overall Study|Lost to Follow-up|0|||
131042571|NCT02315703|471789341|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
131042572|NCT02315703|471789342|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
131042573|NCT02315703|471789343|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
130970581|NCT00467870|471520190|FG000|Overall Study|Subject Non-compliance|3|||
130970582|NCT00467870|471520191|FG001|Overall Study|Subject Non-compliance|4|||
130970583|NCT00467870|471520192|FG002|Overall Study|Subject Non-compliance|0|||
130970584|NCT00467870|471520193|FG003|Overall Study|Subject Non-compliance|1|||
130970585|NCT00467870|471520194|FG004|Overall Study|Subject Non-compliance|5|||
130970586|NCT00467870|471520195|FG005|Overall Study|Subject Non-compliance|0|||
130970587|NCT00467870|471520190|FG000|Overall Study|Other/Unknown|8|||
130970588|NCT00467870|471520191|FG001|Overall Study|Other/Unknown|5|||
130970589|NCT00467870|471520192|FG002|Overall Study|Other/Unknown|1|||
130970590|NCT00467870|471520193|FG003|Overall Study|Other/Unknown|5|||
130970591|NCT00467870|471520194|FG004|Overall Study|Other/Unknown|4|||
130970592|NCT00467870|471520195|FG005|Overall Study|Other/Unknown|0|||
130970593|NCT00321919|471520196|FG000|Overall Study|Adverse Event|17|||
130970594|NCT00321919|471520197|FG001|Overall Study|Adverse Event|10|||
130970595|NCT00321919|471520196|FG000|Overall Study|Death|21|||
130970596|NCT00321919|471520197|FG001|Overall Study|Death|17|||
130970597|NCT00321919|471520196|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130970598|NCT00321919|471520197|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130970599|NCT00321919|471520196|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130970600|NCT00321919|471520197|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130970601|NCT00321919|471520196|FG000|Overall Study|Refused Treatment|23|||
130970602|NCT00321919|471520197|FG001|Overall Study|Refused Treatment|14|||
130970603|NCT00321919|471520196|FG000|Overall Study|Other Protocol Violation|2|||
130970604|NCT00321919|471520197|FG001|Overall Study|Other Protocol Violation|3|||
130970605|NCT00321919|471520196|FG000|Overall Study|Failure to Return|3|||
130970606|NCT00321919|471520197|FG001|Overall Study|Failure to Return|1|||
130970607|NCT00321919|471520196|FG000|Overall Study|Other withdrawal reason|7|||
130970608|NCT00321919|471520197|FG001|Overall Study|Other withdrawal reason|6|||
130970609|NCT04757649|471520201|FG000|Overall Study|Withdrawal by Subject|1|||
130970610|NCT04757649|471520201|FG000|Overall Study|Adverse Event|1|||
130970611|NCT01286779|471520202|FG000|Overall Study|Withdrawal by Subject|9|||
130970612|NCT01286779|471520202|FG000|Overall Study|Protocol Violation|5|||
130970613|NCT01286779|471520202|FG000|Overall Study|Physician Decision|2|||
130970614|NCT01286779|471520202|FG000|Overall Study|Participant had scheduled surgery|1|||
130970615|NCT01286779|471520202|FG000|Overall Study|Participant moved to another country|1|||
130970616|NCT01286779|471520202|FG000|Overall Study|Discontinued by sponsor|1|||
130970617|NCT02896855|471520205|FG000|Overall Study|Death|50|||
130970618|NCT02896855|471520206|FG001|Overall Study|Death|40|||
130970619|NCT02896855|471520205|FG000|Overall Study|Lost to Follow-up|15|||
130970620|NCT02896855|471520206|FG001|Overall Study|Lost to Follow-up|9|||
130970621|NCT02896855|471520205|FG000|Overall Study|Withdrawal by Subject|7|||
130970622|NCT02896855|471520206|FG001|Overall Study|Withdrawal by Subject|4|||
130970623|NCT02508311|471520209|FG000|Overall Study|Withdrawal by Subject|1|||
130970624|NCT02508311|471520210|FG001|Overall Study|Withdrawal by Subject|0|||
130970625|NCT01205685|471520211|FG000|Overall Study|Disease Progression|10|||
130970626|NCT01205685|471520211|FG000|Overall Study|Withdrawal by Subject|1|||
130970627|NCT02169674|471520212|FG000|Overall Study|Withdrawal by Subject|2|||
130970628|NCT02169674|471520213|FG001|Overall Study|Withdrawal by Subject|1|||
130970629|NCT02169674|471520212|FG000|Overall Study|Seroprotected|30|||
130970630|NCT02169674|471520213|FG001|Overall Study|Seroprotected|76|||
130970631|NCT02169674|471520212|FG000|Overall Study|Lost to Follow-up|0|||
130970632|NCT02169674|471520213|FG001|Overall Study|Lost to Follow-up|1|||
130970633|NCT02219932|471520218|FG000|Overall Study|Other|5|||
130970634|NCT02219932|471520219|FG001|Overall Study|Other|11|||
130970635|NCT02219932|471520218|FG000|Overall Study|Death|1|||
130970636|NCT02219932|471520219|FG001|Overall Study|Death|1|||
130970637|NCT02219932|471520218|FG000|Overall Study|Investigator Decision|0|||
130970638|NCT02219932|471520219|FG001|Overall Study|Investigator Decision|1|||
130970639|NCT02219932|471520218|FG000|Overall Study|Consent Withdrawn|11|||
130970640|NCT02219932|471520219|FG001|Overall Study|Consent Withdrawn|7|||
130970641|NCT02219932|471520218|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
130970642|NCT02219932|471520219|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
130970643|NCT02219932|471520218|FG000|Overall Study|Protocol Violation|10|||
130970644|NCT02219932|471520219|FG001|Overall Study|Protocol Violation|6|||
130970645|NCT02219932|471520218|FG000|Overall Study|Pregnancy|1|||
130970646|NCT02219932|471520219|FG001|Overall Study|Pregnancy|0|||
130970647|NCT02219932|471520218|FG000|Overall Study|Lost to Follow-up|4|||
130970648|NCT02219932|471520219|FG001|Overall Study|Lost to Follow-up|2|||
130970649|NCT02219932|471520218|FG000|Overall Study|Adverse Event|23|||
130970650|NCT02219932|471520219|FG001|Overall Study|Adverse Event|21|||
130970651|NCT00093145|471520221|FG000|Overall Study|Unacceptable Toxicity Only|2|||
130970652|NCT00093145|471520221|FG000|Overall Study|Physician Decision|5|||
130970653|NCT00093145|471520221|FG000|Overall Study|Withdrawal by Subject|9|||
130970654|NCT00093145|471520221|FG000|Overall Study|Other|1|||
130970655|NCT04389840|471520222|FG000|Overall Study|Adverse Event|0|||
130970656|NCT04389840|471520223|FG001|Overall Study|Adverse Event|0|||
130970657|NCT04389840|471520224|FG002|Overall Study|Adverse Event|0|||
130970658|NCT04389840|471520225|FG003|Overall Study|Adverse Event|1|||
130970659|NCT04389840|471520226|FG004|Overall Study|Adverse Event|0|||
130970660|NCT04389840|471520227|FG005|Overall Study|Adverse Event|0|||
130970661|NCT04389840|471520222|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
130970662|NCT04389840|471520223|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
130970663|NCT04389840|471520224|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
130970664|NCT04389840|471520225|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
130970665|NCT04389840|471520226|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
130970666|NCT04389840|471520227|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
130970667|NCT04389840|471520222|FG000|Overall Study|Death|0|||
131128833|NCT01624662|472099614|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131042574|NCT02315703|471789344|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
131042575|NCT02315703|471789337|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
131042576|NCT02315703|471789338|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
131042577|NCT02315703|471789339|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
131042578|NCT02315703|471789340|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
131042579|NCT02315703|471789341|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
131042580|NCT02315703|471789342|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
131042581|NCT02315703|471789343|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
131042582|NCT02315703|471789344|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
130970668|NCT04389840|471520223|FG001|Overall Study|Death|1|||
130970669|NCT04389840|471520224|FG002|Overall Study|Death|0|||
130970670|NCT04389840|471520225|FG003|Overall Study|Death|0|||
130970671|NCT04389840|471520226|FG004|Overall Study|Death|0|||
130970672|NCT04389840|471520227|FG005|Overall Study|Death|0|||
130970673|NCT02365467|471520228|FG000|Overall Study|Death|3|||
130970674|NCT02043782|471520229|FG000|Period 1|Adverse Event|0|||
130970675|NCT02043782|471520230|FG001|Period 1|Adverse Event|0|||
130970676|NCT02043782|471520231|FG002|Period 1|Adverse Event|1|||
130970677|NCT02043782|471520232|FG003|Period 1|Adverse Event|0|||
130970678|NCT02043782|471520233|FG004|Period 1|Adverse Event|0|||
130970679|NCT02043782|471520234|FG005|Period 1|Adverse Event|0|||
131042583|NCT02315703|471789337|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
131042584|NCT02315703|471789338|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
131042585|NCT02315703|471789339|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131042586|NCT02315703|471789340|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131042587|NCT02315703|471789341|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131042588|NCT02315703|471789342|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131042589|NCT02315703|471789343|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131042590|NCT02315703|471789344|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
131042591|NCT02315703|471789337|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131042592|NCT02315703|471789338|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
131042593|NCT02315703|471789339|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131042594|NCT02315703|471789340|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131042595|NCT02315703|471789341|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131042596|NCT02315703|471789342|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131042597|NCT02315703|471789343|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131042598|NCT02315703|471789344|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
131042599|NCT02315703|471789337|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
131042600|NCT02315703|471789338|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
131042601|NCT02315703|471789339|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
131042602|NCT02315703|471789340|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
131042603|NCT02315703|471789341|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
131042604|NCT02315703|471789342|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
131042605|NCT02315703|471789343|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
131042606|NCT02315703|471789344|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
131042607|NCT03476343|471789355|FG000|Overall Study|Clinical exam moved to another scanner|7|||
131042608|NCT03476343|471789355|FG000|Overall Study|Clinical order cancelled|4|||
131042609|NCT03476343|471789355|FG000|Overall Study|Neonate did not settle down for the scan|1|||
130970680|NCT01306162|471520237|FG000|Period 1|Adverse Event|0|||
131042610|NCT03088878|471789358|FG000|Overall Study|Adverse Event|0|||
131042611|NCT03088878|471789359|FG001|Overall Study|Adverse Event|0|||
131042612|NCT03088878|471789360|FG002|Overall Study|Adverse Event|0|||
131042613|NCT03088878|471789361|FG003|Overall Study|Adverse Event|0|||
131042614|NCT03088878|471789362|FG004|Overall Study|Adverse Event|4|||
131042615|NCT03088878|471789363|FG005|Overall Study|Adverse Event|2|||
131042616|NCT03088878|471789364|FG006|Overall Study|Adverse Event|1|||
131042617|NCT03088878|471789365|FG007|Overall Study|Adverse Event|0|||
131042618|NCT03088878|471789366|FG008|Overall Study|Adverse Event|0|||
131042619|NCT03088878|471789367|FG009|Overall Study|Adverse Event|0|||
131128834|NCT01624662|472099615|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131128835|NCT01624662|472099612|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
131042620|NCT03088878|471789368|FG010|Overall Study|Adverse Event|0|||
131042621|NCT03088878|471789369|FG011|Overall Study|Adverse Event|0|||
131042622|NCT03088878|471789370|FG012|Overall Study|Adverse Event|5|||
131042623|NCT03088878|471789371|FG013|Overall Study|Adverse Event|3|||
130970681|NCT01306162|471520238|FG001|Period 1|Adverse Event|0|||
130970682|NCT01306162|471520239|FG002|Period 1|Adverse Event|0|||
130970683|NCT01306162|471520240|FG003|Period 1|Adverse Event|1|||
130970684|NCT01306162|471520237|FG000|Washout 1|Non-compliance to protocol|0|||
130970685|NCT01306162|471520238|FG001|Washout 1|Non-compliance to protocol|1|||
130970686|NCT01306162|471520239|FG002|Washout 1|Non-compliance to protocol|0|||
130970687|NCT01306162|471520240|FG003|Washout 1|Non-compliance to protocol|0|||
130970688|NCT02959437|471520241|FG000|Overall Study|Death|33|||
130970689|NCT02959437|471520242|FG001|Overall Study|Death|3|||
130970690|NCT02959437|471520243|FG002|Overall Study|Death|0|||
130970691|NCT02959437|471520244|FG003|Overall Study|Death|0|||
130970692|NCT02959437|471520241|FG000|Overall Study|Lost to Follow-up|3|||
130970693|NCT02959437|471520242|FG001|Overall Study|Lost to Follow-up|1|||
130970694|NCT02959437|471520243|FG002|Overall Study|Lost to Follow-up|0|||
130970695|NCT02959437|471520244|FG003|Overall Study|Lost to Follow-up|0|||
130970696|NCT02959437|471520241|FG000|Overall Study|Withdrawal by Subject|11|||
130970697|NCT02959437|471520242|FG001|Overall Study|Withdrawal by Subject|3|||
130970698|NCT02959437|471520243|FG002|Overall Study|Withdrawal by Subject|0|||
130970699|NCT02959437|471520244|FG003|Overall Study|Withdrawal by Subject|0|||
130970700|NCT02959437|471520241|FG000|Overall Study|Progressive Disease|9|||
130970701|NCT02959437|471520242|FG001|Overall Study|Progressive Disease|1|||
130970702|NCT02959437|471520243|FG002|Overall Study|Progressive Disease|0|||
130970703|NCT02959437|471520244|FG003|Overall Study|Progressive Disease|0|||
130970704|NCT02959437|471520241|FG000|Overall Study|Study Terminated by Sponsor|4|||
130970705|NCT02959437|471520242|FG001|Overall Study|Study Terminated by Sponsor|0|||
130970706|NCT02959437|471520243|FG002|Overall Study|Study Terminated by Sponsor|0|||
130970707|NCT02959437|471520244|FG003|Overall Study|Study Terminated by Sponsor|0|||
130970708|NCT02959437|471520241|FG000|Overall Study|Other Unspecified|2|||
130970709|NCT02959437|471520242|FG001|Overall Study|Other Unspecified|0|||
130970710|NCT02959437|471520243|FG002|Overall Study|Other Unspecified|0|||
130970711|NCT02959437|471520244|FG003|Overall Study|Other Unspecified|0|||
130970712|NCT02252211|471520248|FG000|Overall Study|Adverse Event|0|||
130970713|NCT02252211|471520249|FG001|Overall Study|Adverse Event|1|||
130970714|NCT02252211|471520250|FG002|Overall Study|Adverse Event|0|||
130970715|NCT02252211|471520248|FG000|Overall Study|Progressive disease|3|||
130970716|NCT02252211|471520249|FG001|Overall Study|Progressive disease|2|||
130970717|NCT02252211|471520250|FG002|Overall Study|Progressive disease|0|||
130970718|NCT02252211|471520248|FG000|Overall Study|Withdrawal by Subject|1|||
130970719|NCT02252211|471520249|FG001|Overall Study|Withdrawal by Subject|0|||
130970720|NCT02252211|471520250|FG002|Overall Study|Withdrawal by Subject|0|||
130970721|NCT02252211|471520248|FG000|Overall Study|Serious Adverse Event During Screening|1|||
130970722|NCT02252211|471520249|FG001|Overall Study|Serious Adverse Event During Screening|0|||
130970723|NCT02252211|471520250|FG002|Overall Study|Serious Adverse Event During Screening|1|||
130970724|NCT00968669|471520251|FG000|Overall Study|Lost to Follow-up|5|||
130970725|NCT00968669|471520252|FG001|Overall Study|Lost to Follow-up|2|||
130970726|NCT00968669|471520253|FG002|Overall Study|Lost to Follow-up|1|||
130970727|NCT00968669|471520254|FG003|Overall Study|Lost to Follow-up|4|||
130970728|NCT00968669|471520251|FG000|Overall Study|Withdrawal by Subject|9|||
130970729|NCT00968669|471520252|FG001|Overall Study|Withdrawal by Subject|7|||
130970730|NCT00968669|471520253|FG002|Overall Study|Withdrawal by Subject|5|||
130970731|NCT00968669|471520254|FG003|Overall Study|Withdrawal by Subject|3|||
130970732|NCT00968669|471520251|FG000|Overall Study|Pregnancy|0|||
130970733|NCT00968669|471520252|FG001|Overall Study|Pregnancy|0|||
130970734|NCT00968669|471520253|FG002|Overall Study|Pregnancy|2|||
130970735|NCT00968669|471520254|FG003|Overall Study|Pregnancy|0|||
130970736|NCT00968669|471520251|FG000|Overall Study|AE|1|||
130970737|NCT00968669|471520252|FG001|Overall Study|AE|0|||
130970738|NCT00968669|471520253|FG002|Overall Study|AE|0|||
130970739|NCT00968669|471520254|FG003|Overall Study|AE|0|||
130970740|NCT00968669|471520251|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
130970741|NCT00968669|471520252|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
130970742|NCT00968669|471520253|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
130970743|NCT00968669|471520254|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
130970744|NCT00968669|471520251|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
130970745|NCT00968669|471520252|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
130970746|NCT00968669|471520253|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
130970747|NCT00968669|471520254|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
130970748|NCT00968669|471520251|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
130970749|NCT00968669|471520252|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
130970750|NCT00968669|471520253|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
130970751|NCT00968669|471520254|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
130970752|NCT00968669|471520251|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
130970753|NCT00968669|471520252|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
130970754|NCT00968669|471520253|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
130970755|NCT00968669|471520254|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
130970756|NCT00968669|471520251|FG000|Overall Study|EARLY WITHDRAWAL|0|||
130970757|NCT00968669|471520252|FG001|Overall Study|EARLY WITHDRAWAL|1|||
130970758|NCT00968669|471520253|FG002|Overall Study|EARLY WITHDRAWAL|0|||
130970759|NCT00968669|471520254|FG003|Overall Study|EARLY WITHDRAWAL|0|||
130970760|NCT00968669|471520251|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
130970761|NCT00968669|471520252|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
130970762|NCT00968669|471520253|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
131227116|NCT01427803|472457785|FG000|Overall Study|Lost to Follow-up|32|||
131227117|NCT01427803|472457786|FG001|Overall Study|Lost to Follow-up|26|||
131227118|NCT01427803|472457785|FG000|Overall Study|Withdrawal by Subject|20|||
131227119|NCT01427803|472457786|FG001|Overall Study|Withdrawal by Subject|0|||
131227120|NCT01427803|472457785|FG000|Overall Study|Unable to complete full treatment period|6|||
130775733|NCT00667992|470806552|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
130775734|NCT00667992|470806553|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
130970763|NCT00968669|471520254|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
130970764|NCT00968669|471520251|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
130970765|NCT00968669|471520252|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
130970766|NCT00968669|471520253|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
130970767|NCT00968669|471520254|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
130970768|NCT00968669|471520251|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
130970769|NCT00968669|471520252|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
130970770|NCT00968669|471520253|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
130970771|NCT00968669|471520254|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
130970772|NCT00968669|471520251|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
130970773|NCT00968669|471520252|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
130970774|NCT00968669|471520253|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
130970775|NCT00968669|471520254|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
130970776|NCT00968669|471520251|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
130970777|NCT00968669|471520252|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
130970778|NCT00968669|471520253|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
130970779|NCT00968669|471520254|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
130970780|NCT00968669|471520251|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
130970781|NCT00968669|471520252|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
130970782|NCT00968669|471520253|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
130970783|NCT00968669|471520254|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
130970784|NCT00968669|471520251|FG000|Overall Study|SPONSOR DECISION|0|||
130970785|NCT00968669|471520252|FG001|Overall Study|SPONSOR DECISION|1|||
130970786|NCT00968669|471520253|FG002|Overall Study|SPONSOR DECISION|0|||
130970787|NCT00968669|471520254|FG003|Overall Study|SPONSOR DECISION|0|||
130970788|NCT00968669|471520251|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
130970789|NCT00968669|471520252|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
130970790|NCT00968669|471520253|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
130970791|NCT00968669|471520254|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
130970792|NCT00968669|471520251|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
130970793|NCT00968669|471520252|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
130970794|NCT00968669|471520253|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
130970795|NCT00968669|471520254|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
130970796|NCT00968669|471520251|FG000|Overall Study|SUBJECT INCARCERATED|0|||
130970797|NCT00968669|471520252|FG001|Overall Study|SUBJECT INCARCERATED|1|||
130970798|NCT00968669|471520253|FG002|Overall Study|SUBJECT INCARCERATED|0|||
130970799|NCT00968669|471520254|FG003|Overall Study|SUBJECT INCARCERATED|0|||
130970800|NCT00968669|471520251|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
130970801|NCT00968669|471520252|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
130970802|NCT00968669|471520253|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
130970803|NCT00968669|471520254|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
130970804|NCT00968669|471520251|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
130970805|NCT00968669|471520252|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
130970806|NCT00968669|471520253|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
131042624|NCT03088878|471789358|FG000|Overall Study|Clinical Progression|0|||
131042625|NCT03088878|471789359|FG001|Overall Study|Clinical Progression|0|||
131042626|NCT03088878|471789360|FG002|Overall Study|Clinical Progression|0|||
131042627|NCT03088878|471789361|FG003|Overall Study|Clinical Progression|0|||
131042628|NCT03088878|471789362|FG004|Overall Study|Clinical Progression|2|||
131042629|NCT03088878|471789363|FG005|Overall Study|Clinical Progression|0|||
131042630|NCT03088878|471789364|FG006|Overall Study|Clinical Progression|0|||
131042631|NCT03088878|471789365|FG007|Overall Study|Clinical Progression|0|||
131042632|NCT03088878|471789366|FG008|Overall Study|Clinical Progression|0|||
131042633|NCT03088878|471789367|FG009|Overall Study|Clinical Progression|0|||
131042634|NCT03088878|471789368|FG010|Overall Study|Clinical Progression|0|||
131042635|NCT03088878|471789369|FG011|Overall Study|Clinical Progression|0|||
131042636|NCT03088878|471789370|FG012|Overall Study|Clinical Progression|0|||
131042637|NCT03088878|471789371|FG013|Overall Study|Clinical Progression|0|||
130970807|NCT00968669|471520254|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
130970808|NCT00833989|471520256|FG000|Overall Study|Physician Decision|0|||
130970809|NCT00833989|471520257|FG001|Overall Study|Physician Decision|0|||
130970810|NCT00833989|471520258|FG002|Overall Study|Physician Decision|0|||
131042638|NCT03088878|471789358|FG000|Overall Study|Death|0|||
131042639|NCT03088878|471789359|FG001|Overall Study|Death|0|||
131042640|NCT03088878|471789360|FG002|Overall Study|Death|0|||
131128836|NCT01624662|472099613|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
131128837|NCT01624662|472099614|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
131128838|NCT01624662|472099615|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
131128839|NCT00361270|472099616|FG000|Overall Study|Death|0|||
131128840|NCT00361270|472099617|FG001|Overall Study|Death|0|||
131128841|NCT00361270|472099618|FG002|Overall Study|Death|0|||
130970811|NCT00833989|471520259|FG003|Overall Study|Physician Decision|1|||
130970812|NCT00833989|471520256|FG000|Overall Study|Withdrawal by Subject|3|||
130970813|NCT00833989|471520257|FG001|Overall Study|Withdrawal by Subject|0|||
130970814|NCT00833989|471520258|FG002|Overall Study|Withdrawal by Subject|1|||
130970815|NCT00833989|471520259|FG003|Overall Study|Withdrawal by Subject|1|||
130970816|NCT01949480|471520260|FG000|Overall Study|Physician Decision|5|||
130970817|NCT01949480|471520261|FG001|Overall Study|Physician Decision|8|||
130970818|NCT00144339|471520262|FG000|Overall Study|Adverse Event|746|||
130970819|NCT00144339|471520263|FG001|Overall Study|Adverse Event|627|||
130970820|NCT00144339|471520262|FG000|Overall Study|Protocol Violation|75|||
130970821|NCT00144339|471520263|FG001|Overall Study|Protocol Violation|48|||
130970822|NCT00144339|471520262|FG000|Overall Study|Withdrawal by Subject|403|||
130970823|NCT00144339|471520263|FG001|Overall Study|Withdrawal by Subject|300|||
130970824|NCT00144339|471520262|FG000|Overall Study|Lost to Follow-up|76|||
130970825|NCT00144339|471520263|FG001|Overall Study|Lost to Follow-up|64|||
130970826|NCT00144339|471520262|FG000|Overall Study|Other|58|||
130970827|NCT00144339|471520263|FG001|Overall Study|Other|60|||
130970828|NCT01109992|471520264|FG000|Overall Study|Withdrawal by Subject|0|||
130970829|NCT01109992|471520265|FG001|Overall Study|Withdrawal by Subject|1|||
130970830|NCT01109992|471520264|FG000|Overall Study|Movement during rest scan.|0|||
130970831|NCT01109992|471520265|FG001|Overall Study|Movement during rest scan.|1|||
130970832|NCT00690755|471520266|FG000|Overall Study|Physician Decision|2|||
130970833|NCT00690755|471520267|FG001|Overall Study|Physician Decision|0|||
130970834|NCT00690755|471520268|FG002|Overall Study|Physician Decision|46|||
130970835|NCT00690755|471520269|FG003|Overall Study|Physician Decision|5|||
130970836|NCT00690755|471520270|FG004|Overall Study|Physician Decision|0|||
130970837|NCT00690755|471520271|FG005|Overall Study|Physician Decision|4|||
130970838|NCT00690755|471520272|FG006|Overall Study|Physician Decision|0|||
130970839|NCT02952924|471520273|FG000|Overall Study|Protocol Violation|0|||
130970840|NCT02952924|471520274|FG001|Overall Study|Protocol Violation|0|||
130970841|NCT02952924|471520275|FG002|Overall Study|Protocol Violation|0|||
130970842|NCT02952924|471520276|FG003|Overall Study|Protocol Violation|0|||
130970843|NCT02952924|471520277|FG004|Overall Study|Protocol Violation|0|||
130970844|NCT02952924|471520278|FG005|Overall Study|Protocol Violation|0|||
130970845|NCT02952924|471520279|FG006|Overall Study|Protocol Violation|0|||
130970846|NCT02952924|471520280|FG007|Overall Study|Protocol Violation|0|||
130970847|NCT02952924|471520281|FG008|Overall Study|Protocol Violation|0|||
130970848|NCT02952924|471520282|FG009|Overall Study|Protocol Violation|0|||
130970849|NCT02952924|471520283|FG010|Overall Study|Protocol Violation|0|||
130970850|NCT02952924|471520284|FG011|Overall Study|Protocol Violation|0|||
130970851|NCT02952924|471520285|FG012|Overall Study|Protocol Violation|0|||
130970852|NCT02952924|471520286|FG013|Overall Study|Protocol Violation|0|||
130970853|NCT02952924|471520287|FG014|Overall Study|Protocol Violation|0|||
130970854|NCT02952924|471520288|FG015|Overall Study|Protocol Violation|0|||
130970855|NCT02952924|471520289|FG016|Overall Study|Protocol Violation|0|||
130970856|NCT02952924|471520290|FG017|Overall Study|Protocol Violation|0|||
130970857|NCT02952924|471520291|FG018|Overall Study|Protocol Violation|0|||
130970858|NCT02952924|471520292|FG019|Overall Study|Protocol Violation|1|||
130970859|NCT02952924|471520293|FG020|Overall Study|Protocol Violation|0|||
130970860|NCT02952924|471520294|FG021|Overall Study|Protocol Violation|0|||
130970861|NCT02952924|471520273|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
130970862|NCT02952924|471520274|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
130970863|NCT02952924|471520275|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
130970864|NCT02952924|471520276|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
131128842|NCT00361270|472099619|FG003|Overall Study|Death|2|||
131128843|NCT00361270|472099616|FG000|Overall Study|Lost to Follow-up|4|||
131227121|NCT01427803|472457786|FG001|Overall Study|Unable to complete full treatment period|0|||
131227122|NCT01427803|472457785|FG000|Overall Study|Protocol Violation|1|||
131227123|NCT01427803|472457786|FG001|Overall Study|Protocol Violation|0|||
131227124|NCT01427803|472457785|FG000|Overall Study|Physician Decision|3|||
131227125|NCT01427803|472457786|FG001|Overall Study|Physician Decision|0|||
130970865|NCT02952924|471520277|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
130970866|NCT02952924|471520278|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
130970867|NCT02952924|471520279|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
130970868|NCT02952924|471520280|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
130970869|NCT02952924|471520281|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
130970870|NCT02952924|471520282|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
130970871|NCT02952924|471520283|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
130970872|NCT02952924|471520284|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
130970873|NCT02952924|471520285|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
130970874|NCT02952924|471520286|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
130970875|NCT02952924|471520287|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
130970876|NCT02952924|471520288|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
130970877|NCT02952924|471520289|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
130970878|NCT02952924|471520290|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
130970879|NCT02952924|471520291|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
130970880|NCT02952924|471520292|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
130970881|NCT02952924|471520293|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
130970882|NCT02952924|471520294|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
130970883|NCT02952924|471520273|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970884|NCT02952924|471520274|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970885|NCT02952924|471520275|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970886|NCT02952924|471520276|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970887|NCT02952924|471520277|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970888|NCT02952924|471520278|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970889|NCT02952924|471520279|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970890|NCT02952924|471520280|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970891|NCT02952924|471520281|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970892|NCT02952924|471520282|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970893|NCT02952924|471520283|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970894|NCT02952924|471520284|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970895|NCT02952924|471520285|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970896|NCT02952924|471520286|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970897|NCT02952924|471520287|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970898|NCT02952924|471520288|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970899|NCT02952924|471520289|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970900|NCT02952924|471520290|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970901|NCT02952924|471520291|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970902|NCT02952924|471520292|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970903|NCT02952924|471520293|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
130970904|NCT02952924|471520294|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
130970905|NCT02952924|471520273|FG000|Overall Study|Noncompliance with study drug|0|||
130970906|NCT02952924|471520274|FG001|Overall Study|Noncompliance with study drug|0|||
130970907|NCT02952924|471520275|FG002|Overall Study|Noncompliance with study drug|0|||
130970908|NCT02952924|471520276|FG003|Overall Study|Noncompliance with study drug|0|||
130970909|NCT02952924|471520277|FG004|Overall Study|Noncompliance with study drug|0|||
130970910|NCT02952924|471520278|FG005|Overall Study|Noncompliance with study drug|0|||
130970911|NCT02952924|471520279|FG006|Overall Study|Noncompliance with study drug|0|||
130970912|NCT02952924|471520280|FG007|Overall Study|Noncompliance with study drug|0|||
130970913|NCT02952924|471520281|FG008|Overall Study|Noncompliance with study drug|0|||
130970914|NCT02952924|471520282|FG009|Overall Study|Noncompliance with study drug|0|||
130970915|NCT02952924|471520283|FG010|Overall Study|Noncompliance with study drug|0|||
130970916|NCT02952924|471520284|FG011|Overall Study|Noncompliance with study drug|0|||
130970917|NCT02952924|471520285|FG012|Overall Study|Noncompliance with study drug|0|||
130970918|NCT02952924|471520286|FG013|Overall Study|Noncompliance with study drug|0|||
130970919|NCT02952924|471520287|FG014|Overall Study|Noncompliance with study drug|0|||
130970920|NCT02952924|471520288|FG015|Overall Study|Noncompliance with study drug|0|||
130970921|NCT02952924|471520289|FG016|Overall Study|Noncompliance with study drug|0|||
130970922|NCT02952924|471520290|FG017|Overall Study|Noncompliance with study drug|0|||
130970923|NCT02952924|471520291|FG018|Overall Study|Noncompliance with study drug|0|||
130970924|NCT02952924|471520292|FG019|Overall Study|Noncompliance with study drug|0|||
131042641|NCT03088878|471789361|FG003|Overall Study|Death|0|||
131042642|NCT03088878|471789362|FG004|Overall Study|Death|2|||
131042643|NCT03088878|471789363|FG005|Overall Study|Death|0|||
131042644|NCT03088878|471789364|FG006|Overall Study|Death|0|||
131042645|NCT03088878|471789365|FG007|Overall Study|Death|0|||
131042646|NCT03088878|471789366|FG008|Overall Study|Death|0|||
131042647|NCT03088878|471789367|FG009|Overall Study|Death|0|||
131042648|NCT03088878|471789368|FG010|Overall Study|Death|0|||
131042649|NCT03088878|471789369|FG011|Overall Study|Death|1|||
131042650|NCT03088878|471789370|FG012|Overall Study|Death|0|||
131042651|NCT03088878|471789371|FG013|Overall Study|Death|0|||
131042652|NCT03088878|471789358|FG000|Overall Study|Disease Progression|1|||
131042653|NCT03088878|471789359|FG001|Overall Study|Disease Progression|2|||
131042654|NCT03088878|471789360|FG002|Overall Study|Disease Progression|3|||
131042655|NCT03088878|471789361|FG003|Overall Study|Disease Progression|0|||
131042656|NCT03088878|471789362|FG004|Overall Study|Disease Progression|3|||
131128844|NCT00361270|472099617|FG001|Overall Study|Lost to Follow-up|1|||
131128845|NCT00361270|472099618|FG002|Overall Study|Lost to Follow-up|0|||
131128846|NCT00361270|472099619|FG003|Overall Study|Lost to Follow-up|0|||
131128847|NCT00361270|472099616|FG000|Overall Study|Physician Decision|0|||
131128848|NCT00361270|472099617|FG001|Overall Study|Physician Decision|0|||
131128849|NCT00361270|472099618|FG002|Overall Study|Physician Decision|1|||
131128850|NCT00361270|472099619|FG003|Overall Study|Physician Decision|0|||
131128851|NCT00361270|472099616|FG000|Overall Study|Protocol Violation|9|||
131128852|NCT00361270|472099617|FG001|Overall Study|Protocol Violation|4|||
131128853|NCT00361270|472099618|FG002|Overall Study|Protocol Violation|5|||
131128854|NCT00361270|472099619|FG003|Overall Study|Protocol Violation|4|||
131128855|NCT00361270|472099616|FG000|Overall Study|Withdrawal by Subject|6|||
131128856|NCT00361270|472099617|FG001|Overall Study|Withdrawal by Subject|6|||
131128857|NCT00361270|472099618|FG002|Overall Study|Withdrawal by Subject|3|||
131128858|NCT00361270|472099619|FG003|Overall Study|Withdrawal by Subject|7|||
131128859|NCT00361270|472099616|FG000|Overall Study|Afraid of Hypnosis|1|||
131128860|NCT00361270|472099617|FG001|Overall Study|Afraid of Hypnosis|2|||
131128861|NCT00361270|472099618|FG002|Overall Study|Afraid of Hypnosis|0|||
131128862|NCT00361270|472099619|FG003|Overall Study|Afraid of Hypnosis|0|||
131128863|NCT00361270|472099616|FG000|Overall Study|Problems with Transportation|4|||
130970925|NCT02952924|471520293|FG020|Overall Study|Noncompliance with study drug|0|||
130970926|NCT02952924|471520294|FG021|Overall Study|Noncompliance with study drug|1|||
130970927|NCT02105948|471520299|FG000|Overall Study|Adverse Event|10|||
130970928|NCT02105948|471520300|FG001|Overall Study|Adverse Event|7|||
130970929|NCT02105948|471520301|FG002|Overall Study|Adverse Event|11|||
130970930|NCT02105948|471520302|FG003|Overall Study|Adverse Event|11|||
130970931|NCT02105948|471520299|FG000|Overall Study|Lack of Efficacy|0|||
130970932|NCT02105948|471520300|FG001|Overall Study|Lack of Efficacy|1|||
130970933|NCT02105948|471520301|FG002|Overall Study|Lack of Efficacy|3|||
130970934|NCT02105948|471520302|FG003|Overall Study|Lack of Efficacy|2|||
130970935|NCT02105948|471520299|FG000|Overall Study|Lost to Follow-up|0|||
130970936|NCT02105948|471520300|FG001|Overall Study|Lost to Follow-up|0|||
130970937|NCT02105948|471520301|FG002|Overall Study|Lost to Follow-up|2|||
130970938|NCT02105948|471520302|FG003|Overall Study|Lost to Follow-up|1|||
130970939|NCT02105948|471520299|FG000|Overall Study|Physician Decision|2|||
130970940|NCT02105948|471520300|FG001|Overall Study|Physician Decision|2|||
130970941|NCT02105948|471520301|FG002|Overall Study|Physician Decision|2|||
130970942|NCT02105948|471520302|FG003|Overall Study|Physician Decision|2|||
130970943|NCT02105948|471520299|FG000|Overall Study|Withdrawal by Subject|15|||
130970944|NCT02105948|471520300|FG001|Overall Study|Withdrawal by Subject|10|||
130970945|NCT02105948|471520301|FG002|Overall Study|Withdrawal by Subject|10|||
130970946|NCT02105948|471520302|FG003|Overall Study|Withdrawal by Subject|11|||
130970947|NCT01934218|471520304|FG000|Double-blind Phase|Adverse Event|8|||
130970948|NCT01934218|471520305|FG001|Double-blind Phase|Adverse Event|8|||
130970949|NCT01934218|471520304|FG000|Double-blind Phase|Lack of Efficacy|6|||
130970950|NCT01934218|471520305|FG001|Double-blind Phase|Lack of Efficacy|7|||
130970951|NCT01934218|471520304|FG000|Double-blind Phase|Lost to Follow-up|7|||
130970952|NCT01934218|471520305|FG001|Double-blind Phase|Lost to Follow-up|14|||
130970953|NCT01934218|471520304|FG000|Double-blind Phase|Physician Decision|1|||
130970954|NCT01934218|471520305|FG001|Double-blind Phase|Physician Decision|2|||
130970955|NCT01934218|471520304|FG000|Double-blind Phase|Protocol Violation|4|||
130970956|NCT01934218|471520305|FG001|Double-blind Phase|Protocol Violation|0|||
130970957|NCT01934218|471520304|FG000|Double-blind Phase|Withdrawal by Subject|16|||
130970958|NCT01934218|471520305|FG001|Double-blind Phase|Withdrawal by Subject|13|||
131128864|NCT00361270|472099617|FG001|Overall Study|Problems with Transportation|0|||
131128865|NCT00361270|472099618|FG002|Overall Study|Problems with Transportation|0|||
131128866|NCT00361270|472099619|FG003|Overall Study|Problems with Transportation|0|||
131128867|NCT00361270|472099616|FG000|Overall Study|Adverse Event|0|||
130970959|NCT01934218|471520304|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
130970960|NCT01934218|471520305|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
130970961|NCT01934218|471520304|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
130970962|NCT01934218|471520305|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
130970963|NCT01934218|471520304|FG000|Open-Label Phase|Adverse Event|2|||
130970964|NCT01934218|471520305|FG001|Open-Label Phase|Adverse Event|4|||
130970965|NCT01934218|471520304|FG000|Open-Label Phase|Lack of Efficacy|1|||
131128868|NCT00361270|472099617|FG001|Overall Study|Adverse Event|1|||
130970966|NCT01934218|471520305|FG001|Open-Label Phase|Lack of Efficacy|4|||
131128869|NCT00361270|472099618|FG002|Overall Study|Adverse Event|1|||
130970967|NCT01934218|471520304|FG000|Open-Label Phase|Lost to Follow-up|4|||
131128870|NCT00361270|472099619|FG003|Overall Study|Adverse Event|0|||
131128871|NCT01033825|472099621|FG000|Overall Study|Withdrawal by Subject|2|||
131128872|NCT01033825|472099622|FG001|Overall Study|Withdrawal by Subject|3|||
130970968|NCT01934218|471520305|FG001|Open-Label Phase|Lost to Follow-up|2|||
130970969|NCT01934218|471520304|FG000|Open-Label Phase|Physician Decision|1|||
130970970|NCT01934218|471520305|FG001|Open-Label Phase|Physician Decision|0|||
130970971|NCT01934218|471520304|FG000|Open-Label Phase|Protocol Violation|1|||
131128873|NCT01033825|472099623|FG002|Overall Study|Withdrawal by Subject|2|||
130970972|NCT01934218|471520305|FG001|Open-Label Phase|Protocol Violation|0|||
130970973|NCT01934218|471520304|FG000|Open-Label Phase|Withdrawal by Subject|13|||
130970974|NCT01934218|471520305|FG001|Open-Label Phase|Withdrawal by Subject|11|||
130970975|NCT01934218|471520304|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
130970976|NCT01934218|471520305|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
130970977|NCT01934218|471520304|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
130970978|NCT01934218|471520305|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
130970979|NCT02232893|471520306|FG000|Overall Study|Withdrawal by Subject|4|||
130970980|NCT02232893|471520307|FG001|Overall Study|Withdrawal by Subject|1|||
130970981|NCT02232893|471520306|FG000|Overall Study|Adverse Event|0|||
130970982|NCT02232893|471520307|FG001|Overall Study|Adverse Event|1|||
130970983|NCT02232893|471520306|FG000|Overall Study|Sponsor request early termination|0|||
130970984|NCT02232893|471520307|FG001|Overall Study|Sponsor request early termination|1|||
130970985|NCT02232893|471520306|FG000|Overall Study|Developed exclusion criteria|0|||
130970986|NCT02232893|471520307|FG001|Overall Study|Developed exclusion criteria|1|||
130970987|NCT02232893|471520306|FG000|Overall Study|Other|0|||
130970988|NCT02232893|471520307|FG001|Overall Study|Other|3|||
130970989|NCT03867734|471520311|FG000|Overall Study|Lost to Follow-up|2|||
130970990|NCT04323436|471520317|FG000|Overall Study|Adverse Event|7|||
130970991|NCT04323436|471520318|FG001|Overall Study|Adverse Event|0|||
130970992|NCT04323436|471520319|FG002|Overall Study|Adverse Event|0|||
130970993|NCT04323436|471520317|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
130970994|NCT04323436|471520318|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
130970995|NCT04323436|471520319|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
130970996|NCT04323436|471520317|FG000|Overall Study|Death|1|||
130970997|NCT04323436|471520318|FG001|Overall Study|Death|0|||
130970998|NCT04323436|471520319|FG002|Overall Study|Death|0|||
130970999|NCT04323436|471520317|FG000|Overall Study|Physician Decision|2|||
130971000|NCT04323436|471520318|FG001|Overall Study|Physician Decision|0|||
130971001|NCT04323436|471520319|FG002|Overall Study|Physician Decision|0|||
130971002|NCT04323436|471520317|FG000|Overall Study|Progressive disease|10|||
130971003|NCT04323436|471520318|FG001|Overall Study|Progressive disease|0|||
130971004|NCT04323436|471520319|FG002|Overall Study|Progressive disease|0|||
130971005|NCT04323436|471520317|FG000|Overall Study|Subject decision|3|||
130971006|NCT04323436|471520318|FG001|Overall Study|Subject decision|0|||
130971007|NCT04323436|471520319|FG002|Overall Study|Subject decision|0|||
130971008|NCT01660763|471520323|FG000|Overall Study|Lack of Efficacy|45|||
130971009|NCT01660763|471520324|FG001|Overall Study|Lack of Efficacy|50|||
130971010|NCT01660763|471520323|FG000|Overall Study|Adverse Event|22|||
130971011|NCT01660763|471520324|FG001|Overall Study|Adverse Event|7|||
130971012|NCT01660763|471520323|FG000|Overall Study|Protocol Violation|1|||
130971013|NCT01660763|471520324|FG001|Overall Study|Protocol Violation|0|||
130971014|NCT01660763|471520323|FG000|Overall Study|Withdrawal by Subject|4|||
130971015|NCT01660763|471520324|FG001|Overall Study|Withdrawal by Subject|0|||
130971016|NCT01660763|471520323|FG000|Overall Study|Patient ready for early discharge|28|||
130971017|NCT01660763|471520324|FG001|Overall Study|Patient ready for early discharge|4|||
130971018|NCT02265237|471520326|FG000|As Treated (Overall Study)|Adverse Event|1|||
130971019|NCT02265237|471520327|FG001|As Treated (Overall Study)|Adverse Event|1|||
130971020|NCT02265237|471520328|FG002|As Treated (Overall Study)|Adverse Event|0|||
130971021|NCT02265237|471520329|FG003|As Treated (Overall Study)|Adverse Event|0|||
130971022|NCT02265237|471520326|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
130971023|NCT02265237|471520327|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
130971024|NCT02265237|471520328|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
130971025|NCT02265237|471520329|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
130971026|NCT02265237|471520326|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
130971027|NCT02265237|471520327|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
130971028|NCT02265237|471520328|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
130971029|NCT02265237|471520329|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
130971030|NCT02265237|471520326|FG000|As Treated (Overall Study)|Other|2|||
130971031|NCT02265237|471520327|FG001|As Treated (Overall Study)|Other|0|||
130971032|NCT02265237|471520328|FG002|As Treated (Overall Study)|Other|3|||
131128874|NCT01033825|472099624|FG003|Overall Study|Withdrawal by Subject|1|||
130971033|NCT02265237|471520329|FG003|As Treated (Overall Study)|Other|1|||
131128875|NCT01033825|472099625|FG004|Overall Study|Withdrawal by Subject|1|||
131128876|NCT01033825|472099626|FG005|Overall Study|Withdrawal by Subject|0|||
131128877|NCT01033825|472099627|FG006|Overall Study|Withdrawal by Subject|0|||
130971034|NCT01178853|471520331|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
130971035|NCT01178853|471520332|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
130971036|NCT01178853|471520331|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
130971037|NCT01178853|471520332|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
131128878|NCT01033825|472099621|FG000|Overall Study|Adverse Event|0|||
130971038|NCT01178853|471520331|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
130971039|NCT01178853|471520332|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
131128879|NCT01033825|472099622|FG001|Overall Study|Adverse Event|0|||
130971040|NCT01178853|471520331|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
130971041|NCT01178853|471520332|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
130971042|NCT01178853|471520331|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
130971043|NCT01178853|471520332|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
130971044|NCT00839072|471520333|FG000|First Intervention Period|Withdrawal by Subject|1|||
130971045|NCT00839072|471520334|FG001|First Intervention Period|Withdrawal by Subject|0|||
130971046|NCT00839072|471520333|FG000|First Intervention Period|Adverse Event|1|||
130971047|NCT00839072|471520334|FG001|First Intervention Period|Adverse Event|1|||
130971048|NCT00839072|471520333|FG000|Second Intervention Period|Withdrawal by Subject|1|||
130971049|NCT00839072|471520334|FG001|Second Intervention Period|Withdrawal by Subject|0|||
130971050|NCT01458574|471520335|FG000|Overall Study|Adverse Event|5|||
130971051|NCT01458574|471520336|FG001|Overall Study|Adverse Event|9|||
130971052|NCT01458574|471520337|FG002|Overall Study|Adverse Event|7|||
130971053|NCT01458574|471520335|FG000|Overall Study|Lack of Efficacy|70|||
130971054|NCT01458574|471520336|FG001|Overall Study|Lack of Efficacy|53|||
130971055|NCT01458574|471520337|FG002|Overall Study|Lack of Efficacy|132|||
130971056|NCT01458574|471520335|FG000|Overall Study|Lost to Follow-up|3|||
130971057|NCT01458574|471520336|FG001|Overall Study|Lost to Follow-up|2|||
130971058|NCT01458574|471520337|FG002|Overall Study|Lost to Follow-up|1|||
130971059|NCT01458574|471520335|FG000|Overall Study|Pregnancy|1|||
130971060|NCT01458574|471520336|FG001|Overall Study|Pregnancy|1|||
130971061|NCT01458574|471520337|FG002|Overall Study|Pregnancy|0|||
130971062|NCT01458574|471520335|FG000|Overall Study|Protocol Violation|0|||
130971063|NCT01458574|471520336|FG001|Overall Study|Protocol Violation|1|||
130971064|NCT01458574|471520337|FG002|Overall Study|Protocol Violation|0|||
130971065|NCT01458574|471520335|FG000|Overall Study|Withdrawal by Subject|6|||
130971066|NCT01458574|471520336|FG001|Overall Study|Withdrawal by Subject|3|||
130971067|NCT01458574|471520337|FG002|Overall Study|Withdrawal by Subject|5|||
130971068|NCT01458574|471520335|FG000|Overall Study|Other|2|||
130971069|NCT01458574|471520336|FG001|Overall Study|Other|1|||
130971070|NCT01458574|471520337|FG002|Overall Study|Other|0|||
130971071|NCT01458574|471520335|FG000|Overall Study|Randomized but not treated|0|||
130971072|NCT01458574|471520336|FG001|Overall Study|Randomized but not treated|1|||
130971073|NCT01458574|471520337|FG002|Overall Study|Randomized but not treated|0|||
130971074|NCT02125786|471520338|FG000|Overall Study|Still in Follow-up|3|||
130971075|NCT02125786|471520338|FG000|Overall Study|Screen Failure|2|||
130971076|NCT02125786|471520338|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
130971077|NCT02125786|471520338|FG000|Overall Study|Progressive Disease|44|||
130971078|NCT02125786|471520338|FG000|Overall Study|Death|8|||
130971079|NCT01682837|471520339|FG000|Baseline|Withdrawal by Subject|5|||
130971080|NCT04782323|471520342|FG000|Overall Study|Death|1|||
130971081|NCT04782323|471520343|FG001|Overall Study|Death|0|||
130971082|NCT04782323|471520344|FG002|Overall Study|Death|0|||
130971083|NCT04782323|471520345|FG003|Overall Study|Death|0|||
130971084|NCT04782323|471520346|FG004|Overall Study|Death|1|||
130971085|NCT04782323|471520347|FG005|Overall Study|Death|1|||
130971086|NCT04782323|471520348|FG006|Overall Study|Death|1|||
130971087|NCT04782323|471520349|FG007|Overall Study|Death|0|||
130971088|NCT04782323|471520342|FG000|Overall Study|Withdrawal by Subject|0|||
130971089|NCT04782323|471520343|FG001|Overall Study|Withdrawal by Subject|0|||
130971090|NCT04782323|471520344|FG002|Overall Study|Withdrawal by Subject|1|||
130971091|NCT04782323|471520345|FG003|Overall Study|Withdrawal by Subject|0|||
130971092|NCT04782323|471520346|FG004|Overall Study|Withdrawal by Subject|0|||
130971093|NCT04782323|471520347|FG005|Overall Study|Withdrawal by Subject|1|||
130971094|NCT04782323|471520348|FG006|Overall Study|Withdrawal by Subject|0|||
130971095|NCT04782323|471520349|FG007|Overall Study|Withdrawal by Subject|1|||
130971096|NCT04782323|471520342|FG000|Overall Study|Lost to Follow-up|0|||
130971097|NCT04782323|471520343|FG001|Overall Study|Lost to Follow-up|1|||
130971098|NCT04782323|471520344|FG002|Overall Study|Lost to Follow-up|1|||
130971099|NCT04782323|471520345|FG003|Overall Study|Lost to Follow-up|0|||
130971100|NCT04782323|471520346|FG004|Overall Study|Lost to Follow-up|0|||
130971101|NCT04782323|471520347|FG005|Overall Study|Lost to Follow-up|1|||
130971102|NCT04782323|471520348|FG006|Overall Study|Lost to Follow-up|1|||
130971103|NCT04782323|471520349|FG007|Overall Study|Lost to Follow-up|2|||
130971104|NCT04782323|471520342|FG000|Overall Study|randomization in error|1|||
130971105|NCT04782323|471520343|FG001|Overall Study|randomization in error|0|||
130971106|NCT04782323|471520344|FG002|Overall Study|randomization in error|0|||
130971107|NCT04782323|471520345|FG003|Overall Study|randomization in error|0|||
130971108|NCT04782323|471520346|FG004|Overall Study|randomization in error|0|||
130971109|NCT04782323|471520347|FG005|Overall Study|randomization in error|0|||
130971110|NCT04782323|471520348|FG006|Overall Study|randomization in error|0|||
130971111|NCT04782323|471520349|FG007|Overall Study|randomization in error|0|||
130971112|NCT03832192|471520354|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
130971113|NCT03832192|471520355|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
130971114|NCT03738150|471520356|FG000|Base Study|Withdrawal by Subject|1|||
130971115|NCT03738150|471520356|FG000|Extension Study|Withdrawal by Subject|1|||
130971116|NCT00838110|471522108|FG000|Overall Study|Death|0|||
130971117|NCT00838110|471522109|FG001|Overall Study|Death|0|||
130971118|NCT00838110|471522110|FG002|Overall Study|Death|1|||
130971119|NCT00838110|471522111|FG003|Overall Study|Death|2|||
130971120|NCT00838110|471522108|FG000|Overall Study|Adverse Event|11|||
130971121|NCT00838110|471522109|FG001|Overall Study|Adverse Event|10|||
130971122|NCT00838110|471522110|FG002|Overall Study|Adverse Event|8|||
130971123|NCT00838110|471522111|FG003|Overall Study|Adverse Event|7|||
130971124|NCT00838110|471522108|FG000|Overall Study|Withdrawal by Subject|5|||
130971125|NCT00838110|471522109|FG001|Overall Study|Withdrawal by Subject|6|||
130971126|NCT00838110|471522110|FG002|Overall Study|Withdrawal by Subject|3|||
130971127|NCT00838110|471522111|FG003|Overall Study|Withdrawal by Subject|4|||
130971128|NCT00838110|471522108|FG000|Overall Study|Other|3|||
130971129|NCT00838110|471522109|FG001|Overall Study|Other|3|||
130971130|NCT00838110|471522110|FG002|Overall Study|Other|3|||
130971131|NCT00838110|471522111|FG003|Overall Study|Other|2|||
130971132|NCT00838110|471522108|FG000|Overall Study|Protocol Violation|0|||
130971133|NCT00838110|471522109|FG001|Overall Study|Protocol Violation|2|||
130971134|NCT00838110|471522110|FG002|Overall Study|Protocol Violation|1|||
130971135|NCT00838110|471522111|FG003|Overall Study|Protocol Violation|1|||
130971136|NCT00838110|471522108|FG000|Overall Study|Lost to Follow-up|3|||
130971137|NCT00838110|471522109|FG001|Overall Study|Lost to Follow-up|0|||
130971138|NCT00838110|471522110|FG002|Overall Study|Lost to Follow-up|0|||
130971139|NCT00838110|471522111|FG003|Overall Study|Lost to Follow-up|0|||
130971140|NCT00838110|471522108|FG000|Overall Study|Did not meet eligibility criteria|0|||
130971141|NCT00838110|471522109|FG001|Overall Study|Did not meet eligibility criteria|0|||
130971142|NCT00838110|471522110|FG002|Overall Study|Did not meet eligibility criteria|1|||
130971143|NCT00838110|471522111|FG003|Overall Study|Did not meet eligibility criteria|2|||
130971144|NCT00838110|471522108|FG000|Overall Study|Randomized but not treated|0|||
130971145|NCT00838110|471522109|FG001|Overall Study|Randomized but not treated|1|||
130971146|NCT00838110|471522110|FG002|Overall Study|Randomized but not treated|0|||
130971147|NCT00838110|471522111|FG003|Overall Study|Randomized but not treated|0|||
130971148|NCT01262651|471522112|FG000|Overall Study|Adverse Event|40|||
130971149|NCT01262651|471522113|FG001|Overall Study|Adverse Event|35|||
130971150|NCT01262651|471522112|FG000|Overall Study|Withdrawal by Subject|15|||
130971151|NCT01262651|471522113|FG001|Overall Study|Withdrawal by Subject|11|||
130971152|NCT01262651|471522112|FG000|Overall Study|Withdrawal by Investigator|2|||
130971153|NCT01262651|471522113|FG001|Overall Study|Withdrawal by Investigator|2|||
130971154|NCT01262651|471522112|FG000|Overall Study|Met Withdrawal Criteria|1|||
130971155|NCT01262651|471522113|FG001|Overall Study|Met Withdrawal Criteria|0|||
130971156|NCT04969783|471522119|FG000|Overall Study|Lost to Follow-up|2|||
130971157|NCT04969783|471522120|FG001|Overall Study|Lost to Follow-up|0|||
130971158|NCT04969783|471522119|FG000|Overall Study|Withdrawal by Subject|4|||
130971159|NCT04969783|471522120|FG001|Overall Study|Withdrawal by Subject|0|||
130971160|NCT04969783|471522119|FG000|Overall Study|Physician Decision|6|||
130971161|NCT04969783|471522120|FG001|Overall Study|Physician Decision|0|||
130971162|NCT02349295|471522121|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
130971163|NCT02349295|471522122|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
130971164|NCT02349295|471522123|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
130971165|NCT02349295|471522124|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130971166|NCT02349295|471522125|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130971167|NCT02349295|471522126|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130971168|NCT02349295|471522127|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130971169|NCT02349295|471522128|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130971170|NCT02349295|471522129|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130971171|NCT02349295|471522130|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130971172|NCT02349295|471522131|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130971173|NCT02349295|471522132|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130971174|NCT02349295|471522133|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
131042657|NCT03088878|471789363|FG005|Overall Study|Disease Progression|0|||
131042658|NCT03088878|471789364|FG006|Overall Study|Disease Progression|0|||
131042659|NCT03088878|471789365|FG007|Overall Study|Disease Progression|0|||
131042660|NCT03088878|471789366|FG008|Overall Study|Disease Progression|0|||
131042661|NCT03088878|471789367|FG009|Overall Study|Disease Progression|0|||
131042662|NCT03088878|471789368|FG010|Overall Study|Disease Progression|0|||
131042663|NCT03088878|471789369|FG011|Overall Study|Disease Progression|0|||
131042664|NCT03088878|471789370|FG012|Overall Study|Disease Progression|1|||
131042665|NCT03088878|471789371|FG013|Overall Study|Disease Progression|1|||
131042666|NCT03088878|471789358|FG000|Overall Study|Initiation of Alternative Treatment|0|||
131042667|NCT03088878|471789359|FG001|Overall Study|Initiation of Alternative Treatment|0|||
131042668|NCT03088878|471789360|FG002|Overall Study|Initiation of Alternative Treatment|0|||
130971175|NCT02349295|471522134|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
130971176|NCT02349295|471522121|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
130971177|NCT02349295|471522122|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
130971178|NCT02349295|471522123|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
130971179|NCT02349295|471522124|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130971180|NCT02349295|471522125|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
131042669|NCT03088878|471789361|FG003|Overall Study|Initiation of Alternative Treatment|1|||
131128880|NCT01033825|472099623|FG002|Overall Study|Adverse Event|0|||
131128881|NCT01033825|472099624|FG003|Overall Study|Adverse Event|1|||
130971181|NCT02349295|471522126|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130971182|NCT02349295|471522127|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130971183|NCT02349295|471522128|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130971184|NCT02349295|471522129|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130971185|NCT02349295|471522130|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130971186|NCT02349295|471522131|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130971187|NCT02349295|471522132|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130971188|NCT02349295|471522133|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130971189|NCT02349295|471522134|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
130971190|NCT02349295|471522121|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
130971191|NCT02349295|471522122|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
130971192|NCT02349295|471522123|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
130971193|NCT02349295|471522124|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971194|NCT02349295|471522125|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971195|NCT02349295|471522126|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971196|NCT02349295|471522127|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971197|NCT02349295|471522128|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971198|NCT02349295|471522129|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971199|NCT02349295|471522130|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971200|NCT02349295|471522131|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971201|NCT02349295|471522132|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971202|NCT02349295|471522133|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971203|NCT02349295|471522134|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
130971204|NCT02349295|471522121|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
130971205|NCT02349295|471522122|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
130971206|NCT02349295|471522123|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
130971207|NCT02349295|471522124|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971208|NCT02349295|471522125|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971209|NCT02349295|471522126|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971210|NCT02349295|471522127|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971211|NCT02349295|471522128|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971212|NCT02349295|471522129|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971213|NCT02349295|471522130|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971214|NCT02349295|471522131|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971215|NCT02349295|471522132|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971216|NCT02349295|471522133|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971217|NCT02349295|471522134|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
130971218|NCT02349295|471522121|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971219|NCT02349295|471522122|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
130971220|NCT02349295|471522123|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
130971221|NCT02349295|471522124|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971222|NCT02349295|471522125|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971223|NCT02349295|471522126|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971224|NCT02349295|471522127|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971225|NCT02349295|471522128|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971226|NCT02349295|471522129|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971227|NCT02349295|471522130|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971228|NCT02349295|471522131|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971229|NCT02349295|471522132|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971230|NCT02349295|471522133|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971231|NCT02349295|471522134|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
130971232|NCT02349295|471522121|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
130971233|NCT02349295|471522122|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
130971234|NCT02349295|471522123|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
130971235|NCT02349295|471522124|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
130971236|NCT02349295|471522125|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
130971237|NCT02349295|471522126|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
130971238|NCT02349295|471522127|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
130971239|NCT02349295|471522128|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
130971240|NCT02349295|471522129|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
130971241|NCT02349295|471522130|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
130971242|NCT02349295|471522131|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
130971243|NCT02349295|471522132|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
130971244|NCT02349295|471522133|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
130971245|NCT02349295|471522134|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
131128882|NCT01033825|472099625|FG004|Overall Study|Adverse Event|0|||
130971246|NCT02349295|471522121|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130971247|NCT02349295|471522122|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130971248|NCT02349295|471522123|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130971249|NCT02349295|471522124|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130971250|NCT02349295|471522125|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130971251|NCT02349295|471522126|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130971252|NCT02349295|471522127|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130971253|NCT02349295|471522128|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
130971254|NCT02349295|471522129|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
130971255|NCT02349295|471522130|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
130971256|NCT02349295|471522131|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
130971257|NCT02349295|471522132|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130971258|NCT02349295|471522133|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130971259|NCT02349295|471522134|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
130971260|NCT02349295|471522121|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130971261|NCT02349295|471522122|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130971262|NCT02349295|471522123|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130971263|NCT02349295|471522124|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130971264|NCT02349295|471522125|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130971265|NCT02349295|471522126|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130971266|NCT02349295|471522127|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130971267|NCT02349295|471522128|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
130971268|NCT02349295|471522129|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
130971269|NCT02349295|471522130|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
130971270|NCT02349295|471522131|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
130971271|NCT02349295|471522132|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130971272|NCT02349295|471522133|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130971273|NCT02349295|471522134|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
130971274|NCT02349295|471522121|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971275|NCT02349295|471522122|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971276|NCT02349295|471522123|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971277|NCT02349295|471522124|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971278|NCT02349295|471522125|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971279|NCT02349295|471522126|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971280|NCT02349295|471522127|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971281|NCT02349295|471522128|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
130971282|NCT02349295|471522129|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971283|NCT02349295|471522130|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
130971284|NCT02349295|471522131|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971285|NCT02349295|471522132|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971286|NCT02349295|471522133|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971287|NCT02349295|471522134|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
130971288|NCT02349295|471522121|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
130971289|NCT02349295|471522122|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
130971290|NCT02349295|471522123|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
130971291|NCT02349295|471522124|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
130971292|NCT02349295|471522125|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
130971293|NCT02349295|471522126|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
130971294|NCT02349295|471522127|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
130971295|NCT02349295|471522128|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
130971296|NCT02349295|471522129|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
130971297|NCT02349295|471522130|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
130971298|NCT02349295|471522131|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
130971299|NCT02349295|471522132|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
130971300|NCT02349295|471522133|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
130971301|NCT02349295|471522134|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
130971302|NCT02349295|471522121|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130971303|NCT02349295|471522122|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130971304|NCT02349295|471522123|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131042670|NCT03088878|471789362|FG004|Overall Study|Initiation of Alternative Treatment|0|||
130971305|NCT02349295|471522124|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130971306|NCT02349295|471522125|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130971307|NCT02349295|471522126|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
131042671|NCT03088878|471789363|FG005|Overall Study|Initiation of Alternative Treatment|0|||
131042672|NCT03088878|471789364|FG006|Overall Study|Initiation of Alternative Treatment|0|||
131042673|NCT03088878|471789365|FG007|Overall Study|Initiation of Alternative Treatment|1|||
130971308|NCT02349295|471522127|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130971309|NCT02349295|471522128|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
130971310|NCT02349295|471522129|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
130971311|NCT02349295|471522130|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
130971312|NCT02349295|471522131|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
130971313|NCT02349295|471522132|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130971314|NCT02349295|471522133|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130971315|NCT02349295|471522134|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
130971316|NCT02349295|471522121|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971317|NCT02349295|471522122|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971318|NCT02349295|471522123|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971319|NCT02349295|471522124|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971320|NCT02349295|471522125|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971321|NCT02349295|471522126|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971322|NCT02349295|471522127|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971323|NCT02349295|471522128|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
130971324|NCT02349295|471522129|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
130971325|NCT02349295|471522130|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971326|NCT02349295|471522131|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971327|NCT02349295|471522132|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971328|NCT02349295|471522133|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971329|NCT02349295|471522134|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
130971330|NCT02349295|471522121|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971331|NCT02349295|471522122|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971332|NCT02349295|471522123|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130716432|NCT04765384|470588845|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130716433|NCT04765384|470588846|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130716434|NCT04765384|470588847|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130971333|NCT02349295|471522124|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971334|NCT02349295|471522125|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971335|NCT02349295|471522126|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971336|NCT02349295|471522127|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971337|NCT02349295|471522128|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
130971338|NCT02349295|471522129|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
130971339|NCT02349295|471522130|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971340|NCT02349295|471522131|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971341|NCT02349295|471522132|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971342|NCT02349295|471522133|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971343|NCT02349295|471522134|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
130971344|NCT02349295|471522121|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971345|NCT02349295|471522122|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971346|NCT02349295|471522123|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971347|NCT02349295|471522124|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971348|NCT02349295|471522125|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971349|NCT02349295|471522126|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971350|NCT02349295|471522127|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971351|NCT02349295|471522128|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971352|NCT02349295|471522129|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971353|NCT02349295|471522130|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971354|NCT02349295|471522131|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
130971355|NCT02349295|471522132|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
130971356|NCT02349295|471522133|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
130971357|NCT02349295|471522134|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
130971358|NCT02349295|471522121|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971359|NCT02349295|471522122|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971360|NCT02349295|471522123|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971361|NCT02349295|471522124|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971362|NCT02349295|471522125|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971363|NCT02349295|471522126|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971364|NCT02349295|471522127|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971365|NCT02349295|471522128|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971366|NCT02349295|471522129|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
131227126|NCT01427803|472457785|FG000|Overall Study|did not take product|1|||
131227127|NCT01427803|472457786|FG001|Overall Study|did not take product|0|||
130971367|NCT02349295|471522130|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971368|NCT02349295|471522131|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971369|NCT02349295|471522132|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
130971370|NCT02349295|471522133|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
130971371|NCT02349295|471522134|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
130971372|NCT02349295|471522121|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971373|NCT02349295|471522122|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971374|NCT02349295|471522123|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971375|NCT02349295|471522124|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971376|NCT02349295|471522125|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971377|NCT02349295|471522126|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971378|NCT02349295|471522127|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971379|NCT02349295|471522128|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971380|NCT02349295|471522129|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971381|NCT02349295|471522130|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971382|NCT02349295|471522131|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971383|NCT02349295|471522132|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
130971384|NCT02349295|471522133|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
130971385|NCT02349295|471522134|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
130971386|NCT02349295|471522121|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971387|NCT02349295|471522122|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971388|NCT02349295|471522123|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971389|NCT02349295|471522124|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971390|NCT02349295|471522125|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971391|NCT02349295|471522126|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971392|NCT02349295|471522127|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971393|NCT02349295|471522128|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971394|NCT02349295|471522129|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971395|NCT02349295|471522130|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971396|NCT02349295|471522131|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971397|NCT02349295|471522132|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
130971398|NCT02349295|471522133|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971399|NCT02349295|471522134|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
130971400|NCT02349295|471522121|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971401|NCT02349295|471522122|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971402|NCT02349295|471522123|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971403|NCT02349295|471522124|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971404|NCT02349295|471522125|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971405|NCT02349295|471522126|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971406|NCT02349295|471522127|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971407|NCT02349295|471522128|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971408|NCT02349295|471522129|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971409|NCT02349295|471522130|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971410|NCT02349295|471522131|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971411|NCT02349295|471522132|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
130971412|NCT02349295|471522133|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971413|NCT02349295|471522134|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
130971414|NCT02863926|471522135|FG000|Overall Study|Physician Decision|1|||
130971415|NCT02863926|471522136|FG001|Overall Study|Physician Decision|0|||
130971416|NCT02863926|471522135|FG000|Overall Study|Lost to Follow-up|1|||
130971417|NCT02863926|471522136|FG001|Overall Study|Lost to Follow-up|1|||
131042674|NCT03088878|471789366|FG008|Overall Study|Initiation of Alternative Treatment|1|||
131042675|NCT03088878|471789367|FG009|Overall Study|Initiation of Alternative Treatment|0|||
131042676|NCT03088878|471789368|FG010|Overall Study|Initiation of Alternative Treatment|0|||
131042677|NCT03088878|471789369|FG011|Overall Study|Initiation of Alternative Treatment|0|||
131042678|NCT03088878|471789370|FG012|Overall Study|Initiation of Alternative Treatment|0|||
131042679|NCT03088878|471789371|FG013|Overall Study|Initiation of Alternative Treatment|0|||
131042680|NCT03088878|471789358|FG000|Overall Study|Withdrawal by Subject|0|||
131042681|NCT03088878|471789359|FG001|Overall Study|Withdrawal by Subject|0|||
131042682|NCT03088878|471789360|FG002|Overall Study|Withdrawal by Subject|0|||
131042683|NCT03088878|471789361|FG003|Overall Study|Withdrawal by Subject|1|||
131227128|NCT01571635|472457787|FG000|Overall Study|Adverse Event|3|||
130971418|NCT01914926|471522152|FG000|Overall Study|Adverse Event|1|||
130971419|NCT01914926|471522153|FG001|Overall Study|Adverse Event|0|||
130971420|NCT01914926|471522152|FG000|Overall Study|uncooperative, agitated and removed|0|||
131227129|NCT01571635|472457788|FG001|Overall Study|Adverse Event|0|||
130971421|NCT01914926|471522153|FG001|Overall Study|uncooperative, agitated and removed|1|||
130971422|NCT02261363|471522154|FG000|Overall Study|Lost to Follow-up|21|||
130971423|NCT01517802|471522155|FG000|Overall Study|Death|1|||
130971424|NCT02590354|471522156|FG000|Phase 1|Active hepatitis B or C infection|1|||
130971425|NCT02590354|471522156|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
130971426|NCT02590354|471522156|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
130971427|NCT02590354|471522156|FG000|Phase 1|Subject does not want to participate|20|||
130971428|NCT02590354|471522156|FG000|Phase 1|Lost to Follow-up|1|||
130971429|NCT02590354|471522156|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
130971430|NCT02099838|471522157|FG000|Overall Study|Death|1|||
130971431|NCT02099838|471522158|FG001|Overall Study|Death|0|||
130971432|NCT02099838|471522157|FG000|Overall Study|Lost to Follow-up|3|||
130971433|NCT02099838|471522158|FG001|Overall Study|Lost to Follow-up|1|||
130971434|NCT02099838|471522157|FG000|Overall Study|Withdrawal by Subject|0|||
130971435|NCT02099838|471522158|FG001|Overall Study|Withdrawal by Subject|1|||
130971436|NCT02301143|471522159|FG000|Induction Period|Enrolled But Not Treated|1|||
130971437|NCT02301143|471522160|FG001|Induction Period|Enrolled But Not Treated|0|||
130971438|NCT02301143|471522159|FG000|Induction Period|Death|1|||
130971439|NCT02301143|471522160|FG001|Induction Period|Death|0|||
130971440|NCT02301143|471522159|FG000|Induction Period|Adverse Event|22|||
130971441|NCT02301143|471522160|FG001|Induction Period|Adverse Event|0|||
130971442|NCT02301143|471522159|FG000|Induction Period|Progressive Disease|8|||
130971443|NCT02301143|471522160|FG001|Induction Period|Progressive Disease|0|||
130971444|NCT02301143|471522159|FG000|Induction Period|Withdrawal by Subject|3|||
130971445|NCT02301143|471522160|FG001|Induction Period|Withdrawal by Subject|0|||
130971446|NCT02301143|471522159|FG000|Induction Period|Noncompliance with Study Drug|1|||
130971447|NCT02301143|471522160|FG001|Induction Period|Noncompliance with Study Drug|0|||
130971448|NCT02301143|471522159|FG000|Induction Period|Physician Decision|4|||
130971449|NCT02301143|471522160|FG001|Induction Period|Physician Decision|0|||
130971450|NCT02301143|471522159|FG000|Induction Period|Symptomatic Deterioration|2|||
130971451|NCT02301143|471522160|FG001|Induction Period|Symptomatic Deterioration|0|||
130971452|NCT02301143|471522159|FG000|Induction Period|Protocol Violation|2|||
130971453|NCT02301143|471522160|FG001|Induction Period|Protocol Violation|0|||
130971454|NCT02301143|471522159|FG000|Induction Period|Other|1|||
130971455|NCT02301143|471522160|FG001|Induction Period|Other|0|||
130971456|NCT02301143|471522159|FG000|Investigator's Choice|Adverse Event|0|||
130971457|NCT02301143|471522160|FG001|Investigator's Choice|Adverse Event|3|||
130971458|NCT02301143|471522159|FG000|Investigator's Choice|Progressive Disease|0|||
130971459|NCT02301143|471522160|FG001|Investigator's Choice|Progressive Disease|3|||
130971460|NCT02301143|471522159|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
130971461|NCT02301143|471522160|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
130971462|NCT02301143|471522159|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
130971463|NCT02301143|471522160|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
130971464|NCT02301143|471522159|FG000|Investigator's Choice|Other|0|||
130971465|NCT02301143|471522160|FG001|Investigator's Choice|Other|1|||
131042684|NCT03088878|471789362|FG004|Overall Study|Withdrawal by Subject|4|||
131042685|NCT03088878|471789363|FG005|Overall Study|Withdrawal by Subject|1|||
131042686|NCT03088878|471789364|FG006|Overall Study|Withdrawal by Subject|1|||
131042687|NCT03088878|471789365|FG007|Overall Study|Withdrawal by Subject|0|||
131042688|NCT03088878|471789366|FG008|Overall Study|Withdrawal by Subject|1|||
131042689|NCT03088878|471789367|FG009|Overall Study|Withdrawal by Subject|2|||
131042690|NCT03088878|471789368|FG010|Overall Study|Withdrawal by Subject|0|||
131042691|NCT03088878|471789369|FG011|Overall Study|Withdrawal by Subject|2|||
131042692|NCT03088878|471789370|FG012|Overall Study|Withdrawal by Subject|1|||
131042693|NCT03088878|471789371|FG013|Overall Study|Withdrawal by Subject|0|||
131042694|NCT03088878|471789358|FG000|Overall Study|Terminated by Sponsor|2|||
131042695|NCT03088878|471789359|FG001|Overall Study|Terminated by Sponsor|1|||
131042696|NCT03088878|471789360|FG002|Overall Study|Terminated by Sponsor|0|||
131042697|NCT03088878|471789361|FG003|Overall Study|Terminated by Sponsor|1|||
131042698|NCT03088878|471789362|FG004|Overall Study|Terminated by Sponsor|6|||
131042699|NCT03088878|471789363|FG005|Overall Study|Terminated by Sponsor|0|||
131042700|NCT03088878|471789364|FG006|Overall Study|Terminated by Sponsor|0|||
131042701|NCT03088878|471789365|FG007|Overall Study|Terminated by Sponsor|0|||
131042702|NCT03088878|471789366|FG008|Overall Study|Terminated by Sponsor|0|||
131042703|NCT03088878|471789367|FG009|Overall Study|Terminated by Sponsor|0|||
131042704|NCT03088878|471789368|FG010|Overall Study|Terminated by Sponsor|3|||
131227130|NCT01571635|472457789|FG002|Overall Study|Adverse Event|2|||
130971466|NCT02301143|471522159|FG000|Investigator's Choice|Unresectable Surgery|0|||
130971467|NCT02301143|471522160|FG001|Investigator's Choice|Unresectable Surgery|1|||
130971468|NCT02536508|471522163|FG000|Overall Study|Withdrawal by Subject|18|||
130971469|NCT02536508|471522164|FG001|Overall Study|Withdrawal by Subject|13|||
130971470|NCT02536508|471522165|FG002|Overall Study|Withdrawal by Subject|7|||
130971471|NCT02536508|471522163|FG000|Overall Study|Adverse Event|14|||
130971472|NCT02536508|471522164|FG001|Overall Study|Adverse Event|13|||
131042705|NCT03088878|471789369|FG011|Overall Study|Terminated by Sponsor|13|||
131042706|NCT03088878|471789370|FG012|Overall Study|Terminated by Sponsor|2|||
130971473|NCT02536508|471522165|FG002|Overall Study|Adverse Event|6|||
130971474|NCT02536508|471522163|FG000|Overall Study|Lost to Follow-up|12|||
130971475|NCT02536508|471522164|FG001|Overall Study|Lost to Follow-up|4|||
130971476|NCT02536508|471522165|FG002|Overall Study|Lost to Follow-up|0|||
130971477|NCT02536508|471522163|FG000|Overall Study|Lack of Efficacy|3|||
130971478|NCT02536508|471522164|FG001|Overall Study|Lack of Efficacy|5|||
130971479|NCT02536508|471522165|FG002|Overall Study|Lack of Efficacy|4|||
130971480|NCT02536508|471522163|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
130971481|NCT02536508|471522164|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
130971482|NCT02536508|471522165|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
130971483|NCT02536508|471522163|FG000|Overall Study|Physician Decision|0|||
130971484|NCT02536508|471522164|FG001|Overall Study|Physician Decision|4|||
130971485|NCT02536508|471522165|FG002|Overall Study|Physician Decision|2|||
130971486|NCT02536508|471522163|FG000|Overall Study|Major Protocol Deviation|2|||
130971487|NCT02536508|471522164|FG001|Overall Study|Major Protocol Deviation|2|||
130971488|NCT02536508|471522165|FG002|Overall Study|Major Protocol Deviation|2|||
130971489|NCT02536508|471522163|FG000|Overall Study|Administrative Reasons|0|||
130971490|NCT02536508|471522164|FG001|Overall Study|Administrative Reasons|1|||
130971491|NCT02536508|471522165|FG002|Overall Study|Administrative Reasons|0|||
130971492|NCT00823719|471522168|FG000|Overall Study|Adverse Event|1|||
130971493|NCT00823719|471522169|FG001|Overall Study|Adverse Event|2|||
130971494|NCT00823719|471522168|FG000|Overall Study|Physician Decision|1|||
130971495|NCT00823719|471522169|FG001|Overall Study|Physician Decision|4|||
130971496|NCT00823719|471522168|FG000|Overall Study|Withdrawal by Subject|0|||
130971497|NCT00823719|471522169|FG001|Overall Study|Withdrawal by Subject|1|||
130971498|NCT00823719|471522168|FG000|Overall Study|Disease Progression|4|||
130971499|NCT00823719|471522169|FG001|Overall Study|Disease Progression|4|||
130971500|NCT06027216|471522172|FG000|Overall Study|Did not qualify|8|||
130971501|NCT04287920|471522173|FG000|Overall Study|Lost to Follow-up|1|||
130971502|NCT04287920|471522174|FG001|Overall Study|Lost to Follow-up|1|||
130971503|NCT04287920|471522173|FG000|Overall Study|Withdrawal by Subject|0|||
130971504|NCT04287920|471522174|FG001|Overall Study|Withdrawal by Subject|3|||
130971505|NCT04313634|471522175|FG000|Overall Study|Adverse Event|2|||
130971506|NCT04313634|471522176|FG001|Overall Study|Adverse Event|2|||
130971507|NCT04313634|471522177|FG002|Overall Study|Adverse Event|0|||
130971508|NCT04313634|471522175|FG000|Overall Study|Withdrawal by Subject|1|||
130971509|NCT04313634|471522176|FG001|Overall Study|Withdrawal by Subject|0|||
130971510|NCT04313634|471522177|FG002|Overall Study|Withdrawal by Subject|1|||
130971511|NCT04313634|471522175|FG000|Overall Study|Protocol Violation|0|||
130971512|NCT04313634|471522176|FG001|Overall Study|Protocol Violation|0|||
130971513|NCT04313634|471522177|FG002|Overall Study|Protocol Violation|1|||
130971514|NCT01220557|471522179|FG000|Overall Study|Lost to Follow-up|5|||
130971515|NCT01220557|471522180|FG001|Overall Study|Lost to Follow-up|3|||
130971516|NCT01220557|471522179|FG000|Overall Study|attended less than 6 lessons|1|||
130971517|NCT01220557|471522180|FG001|Overall Study|attended less than 6 lessons|2|||
130971518|NCT01196975|471522183|FG000|Overall Study|Adverse Event|2|||
130971519|NCT01196975|471522184|FG001|Overall Study|Adverse Event|2|||
130971520|NCT01196975|471522185|FG002|Overall Study|Adverse Event|0|||
130971521|NCT01196975|471522186|FG003|Overall Study|Adverse Event|0|||
130971522|NCT01196975|471522187|FG004|Overall Study|Adverse Event|2|||
130971523|NCT01196975|471522183|FG000|Overall Study|Withdrawal by Subject|2|||
130971524|NCT01196975|471522184|FG001|Overall Study|Withdrawal by Subject|1|||
130971525|NCT01196975|471522185|FG002|Overall Study|Withdrawal by Subject|0|||
130971526|NCT01196975|471522186|FG003|Overall Study|Withdrawal by Subject|1|||
130971527|NCT01196975|471522187|FG004|Overall Study|Withdrawal by Subject|0|||
130971528|NCT01196975|471522183|FG000|Overall Study|Lost to Follow-up|11|||
130971529|NCT01196975|471522184|FG001|Overall Study|Lost to Follow-up|6|||
130971530|NCT01196975|471522185|FG002|Overall Study|Lost to Follow-up|5|||
130971531|NCT01196975|471522186|FG003|Overall Study|Lost to Follow-up|5|||
130971532|NCT01196975|471522187|FG004|Overall Study|Lost to Follow-up|11|||
130971533|NCT01365494|471522188|FG000|Overall Study|Adverse Event|1|||
130971534|NCT01365494|471522189|FG001|Overall Study|Adverse Event|0|||
130971535|NCT01365494|471522188|FG000|Overall Study|Withdrawal by Subject|0|||
130971536|NCT01365494|471522189|FG001|Overall Study|Withdrawal by Subject|1|||
131042707|NCT03088878|471789371|FG013|Overall Study|Terminated by Sponsor|1|||
130971537|NCT01365494|471522188|FG000|Overall Study|Lost to Follow-up|1|||
130971538|NCT01365494|471522189|FG001|Overall Study|Lost to Follow-up|2|||
130971539|NCT04558346|471522200|FG000|Overall Study|Withdrawal by Subject|2|||
130971540|NCT04558346|471522201|FG001|Overall Study|Withdrawal by Subject|0|||
130971541|NCT04558346|471522200|FG000|Overall Study|Lost to Follow-up|0|||
130971542|NCT04558346|471522201|FG001|Overall Study|Lost to Follow-up|1|||
130971543|NCT04558346|471522200|FG000|Overall Study|Adverse Event|0|||
130971544|NCT04558346|471522201|FG001|Overall Study|Adverse Event|1|||
130971545|NCT02715765|471522202|FG000|Overall Study|Study Termination|3|||
130971546|NCT02715765|471522203|FG001|Overall Study|Study Termination|0|||
130971547|NCT02715765|471522204|FG002|Overall Study|Study Termination|0|||
130971548|NCT00724971|471522205|FG000|Overall Study|Adverse Event|5|||
130971549|NCT00724971|471522205|FG000|Overall Study|Withdrawal by Subject|1|||
130971550|NCT01462344|471522206|FG000|Overall Study|Withdrawal by Subject|245|||
130971551|NCT01462344|471522207|FG001|Overall Study|Withdrawal by Subject|226|||
130971552|NCT01462344|471522206|FG000|Overall Study|Adverse Event|24|||
130971553|NCT01462344|471522207|FG001|Overall Study|Adverse Event|23|||
130971554|NCT01462344|471522206|FG000|Overall Study|Asthma Exacerbation|34|||
130971555|NCT01462344|471522207|FG001|Overall Study|Asthma Exacerbation|35|||
130971556|NCT01462344|471522206|FG000|Overall Study|Lack of Efficacy|5|||
130971557|NCT01462344|471522207|FG001|Overall Study|Lack of Efficacy|6|||
130971558|NCT01462344|471522206|FG000|Overall Study|Protocol Violation|68|||
130971559|NCT01462344|471522207|FG001|Overall Study|Protocol Violation|53|||
130971560|NCT01462344|471522206|FG000|Overall Study|Lost to Follow-up|7|||
130971561|NCT01462344|471522207|FG001|Overall Study|Lost to Follow-up|7|||
130971562|NCT01003249|471522210|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130971563|NCT01003249|471522211|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130971564|NCT01003249|471522210|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
130971565|NCT01003249|471522211|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
130971566|NCT01003249|471522210|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130971567|NCT01003249|471522211|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130971568|NCT01003249|471522210|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
130971569|NCT01003249|471522211|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
130971570|NCT01962974|471522212|FG000|Overall Study|Study termination|7|||
130971571|NCT01692197|471522214|FG000|Overall Study|Failed Screening|3|||
130971572|NCT03086447|471522216|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130971573|NCT03086447|471522217|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
130971574|NCT03086447|471522216|FG000|Overall Study|Lost Lens|2|||
130971575|NCT03086447|471522217|FG001|Overall Study|Lost Lens|5|||
130971576|NCT03086447|471522216|FG000|Overall Study|Product quality complaint|0|||
130971577|NCT03086447|471522217|FG001|Overall Study|Product quality complaint|1|||
130971578|NCT03086447|471522216|FG000|Overall Study|Lens Damage|1|||
130971579|NCT03086447|471522217|FG001|Overall Study|Lens Damage|6|||
130971580|NCT03086447|471522216|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
130971581|NCT03086447|471522217|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
130971582|NCT03086447|471522216|FG000|Overall Study|Test Article No Longer Available|1|||
130971583|NCT03086447|471522217|FG001|Overall Study|Test Article No Longer Available|0|||
130971584|NCT03086447|471522216|FG000|Overall Study|Protocol Violation|2|||
130971585|NCT03086447|471522217|FG001|Overall Study|Protocol Violation|4|||
130971586|NCT03086447|471522216|FG000|Overall Study|Lost to Follow-up|0|||
130971587|NCT03086447|471522217|FG001|Overall Study|Lost to Follow-up|1|||
130971588|NCT03086447|471522216|FG000|Overall Study|Adverse Event|3|||
130971589|NCT03086447|471522217|FG001|Overall Study|Adverse Event|0|||
130971590|NCT03086447|471522216|FG000|Overall Study|Lens Discomfort|2|||
130971591|NCT03086447|471522217|FG001|Overall Study|Lens Discomfort|1|||
130971592|NCT03394924|471522220|FG000|Overall Study|Adverse Event|0|||
130971593|NCT03394924|471522221|FG001|Overall Study|Adverse Event|5|||
130971594|NCT03394924|471522222|FG002|Overall Study|Adverse Event|0|||
130971595|NCT03394924|471522220|FG000|Overall Study|Withdrawal by Subject|2|||
130971596|NCT03394924|471522221|FG001|Overall Study|Withdrawal by Subject|0|||
130971597|NCT03394924|471522222|FG002|Overall Study|Withdrawal by Subject|0|||
130971598|NCT03394924|471522220|FG000|Overall Study|Lost to Follow-up|0|||
130971599|NCT03394924|471522221|FG001|Overall Study|Lost to Follow-up|1|||
130971600|NCT03394924|471522222|FG002|Overall Study|Lost to Follow-up|0|||
130971601|NCT03394924|471522220|FG000|Overall Study|Did not meet all inclusion criteria|1|||
130971602|NCT03394924|471522221|FG001|Overall Study|Did not meet all inclusion criteria|0|||
130971603|NCT03394924|471522222|FG002|Overall Study|Did not meet all inclusion criteria|0|||
130971604|NCT03588572|471522225|FG000|Visitation 1|Lack of Efficacy|1|||
130971605|NCT03588572|471522226|FG001|Visitation 1|Lack of Efficacy|1|||
130971606|NCT03588572|471522225|FG000|Visitation 2|Lost to Follow-up|1|||
130971607|NCT03588572|471522226|FG001|Visitation 2|Lost to Follow-up|1|||
130971608|NCT03588572|471522225|FG000|Visitation 2|Lack of Efficacy|0|||
130971609|NCT03588572|471522226|FG001|Visitation 2|Lack of Efficacy|1|||
130971610|NCT03588572|471522225|FG000|Visitation 2|Withdrawal by Subject|1|||
130971611|NCT03588572|471522226|FG001|Visitation 2|Withdrawal by Subject|0|||
130971612|NCT03588572|471522225|FG000|Visitation 3|Lost to Follow-up|1|||
130971613|NCT03588572|471522226|FG001|Visitation 3|Lost to Follow-up|1|||
130971614|NCT03588572|471522225|FG000|Visitation 3|Physician Decision|1|||
130971615|NCT03588572|471522226|FG001|Visitation 3|Physician Decision|1|||
130971616|NCT03588572|471522225|FG000|Visitation 3|Withdrawal by Subject|1|||
130971617|NCT03588572|471522226|FG001|Visitation 3|Withdrawal by Subject|0|||
130971618|NCT02276482|471522227|FG000|Overall Study|Adverse Event|1|||
130971619|NCT02276482|471522228|FG001|Overall Study|Adverse Event|0|||
130971620|NCT02276482|471522227|FG000|Overall Study|Withdrawal by Subject|1|||
130971621|NCT02276482|471522228|FG001|Overall Study|Withdrawal by Subject|0|||
130971622|NCT02276482|471522227|FG000|Overall Study|Gram-negative infection|1|||
130971623|NCT02276482|471522228|FG001|Overall Study|Gram-negative infection|0|||
130971624|NCT02276482|471522227|FG000|Overall Study|Reason not specified|0|||
130971625|NCT02276482|471522228|FG001|Overall Study|Reason not specified|1|||
130971626|NCT03387852|471522229|FG000|Overall Study|Adverse event (AE)|3|||
130971627|NCT03387852|471522230|FG001|Overall Study|Adverse event (AE)|0|||
130971628|NCT03387852|471522231|FG002|Overall Study|Adverse event (AE)|2|||
130971629|NCT03387852|471522232|FG003|Overall Study|Adverse event (AE)|0|||
130971630|NCT03387852|471522229|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
130971631|NCT03387852|471522230|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
130971632|NCT03387852|471522231|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
130971633|NCT03387852|471522232|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
130971634|NCT03387852|471522229|FG000|Overall Study|Withdrawal by participant|1|||
130971635|NCT03387852|471522230|FG001|Overall Study|Withdrawal by participant|1|||
130971636|NCT03387852|471522231|FG002|Overall Study|Withdrawal by participant|3|||
130971637|NCT03387852|471522232|FG003|Overall Study|Withdrawal by participant|2|||
130971638|NCT03387852|471522229|FG000|Overall Study|Other- Unspecified|1|||
130971639|NCT03387852|471522230|FG001|Overall Study|Other- Unspecified|1|||
130971640|NCT03387852|471522231|FG002|Overall Study|Other- Unspecified|2|||
130971641|NCT03387852|471522232|FG003|Overall Study|Other- Unspecified|1|||
130971642|NCT03387852|471522229|FG000|Overall Study|Poor compliance to protocol|0|||
130971643|NCT03387852|471522230|FG001|Overall Study|Poor compliance to protocol|0|||
130971644|NCT03387852|471522231|FG002|Overall Study|Poor compliance to protocol|0|||
130971645|NCT03387852|471522232|FG003|Overall Study|Poor compliance to protocol|1|||
130971646|NCT03387852|471522229|FG000|Overall Study|Randomized and not treated|0|||
130971647|NCT03387852|471522230|FG001|Overall Study|Randomized and not treated|0|||
130971648|NCT03387852|471522231|FG002|Overall Study|Randomized and not treated|0|||
130971649|NCT03387852|471522232|FG003|Overall Study|Randomized and not treated|1|||
130971650|NCT00659334|471522240|FG000|Overall Study|Screen Failure|8|||
130971651|NCT00659334|471522241|FG001|Overall Study|Screen Failure|5|||
130971652|NCT00659334|471522242|FG002|Overall Study|Screen Failure|0|||
130971653|NCT00659334|471522243|FG003|Overall Study|Screen Failure|0|||
130971654|NCT00659334|471522244|FG004|Overall Study|Screen Failure|0|||
130971655|NCT00659334|471522245|FG005|Overall Study|Screen Failure|0|||
130971656|NCT00659334|471522246|FG006|Overall Study|Screen Failure|1|||
130971657|NCT04177758|471522247|FG000|Overall Study|Lost to Follow-up|19|||
130971658|NCT04177758|471522248|FG001|Overall Study|Lost to Follow-up|11|||
130971659|NCT01174342|471522249|FG000|Overall Study|Conversion to cesarean section|4|||
130971660|NCT01308580|471522250|FG000|Overall Study|Lost to Follow-up|12|||
130971661|NCT01308580|471522251|FG001|Overall Study|Lost to Follow-up|7|||
130971662|NCT02535065|471522252|FG000|Overall Study|Death|13|||
130971663|NCT02535065|471522252|FG000|Overall Study|Lost to Follow-up|1|||
130971664|NCT02535065|471522252|FG000|Overall Study|Withdrawal by Subject|6|||
131128883|NCT01033825|472099626|FG005|Overall Study|Adverse Event|0|||
131128884|NCT01033825|472099627|FG006|Overall Study|Adverse Event|0|||
131128885|NCT01033825|472099621|FG000|Overall Study|Protocol Violation|1|||
131128886|NCT01033825|472099622|FG001|Overall Study|Protocol Violation|0|||
131128887|NCT01033825|472099623|FG002|Overall Study|Protocol Violation|0|||
131128888|NCT01033825|472099624|FG003|Overall Study|Protocol Violation|0|||
131128889|NCT01033825|472099625|FG004|Overall Study|Protocol Violation|0|||
131128890|NCT01033825|472099626|FG005|Overall Study|Protocol Violation|0|||
131128891|NCT01033825|472099627|FG006|Overall Study|Protocol Violation|0|||
131128892|NCT01033825|472099621|FG000|Overall Study|Other|0|||
131128893|NCT01033825|472099622|FG001|Overall Study|Other|0|||
131128894|NCT01033825|472099623|FG002|Overall Study|Other|0|||
131128895|NCT01033825|472099624|FG003|Overall Study|Other|0|||
131227131|NCT01571635|472457790|FG003|Overall Study|Adverse Event|3|||
131227132|NCT01571635|472457791|FG004|Overall Study|Adverse Event|5|||
131227133|NCT01571635|472457787|FG000|Overall Study|Other reasons|2|||
131227134|NCT01571635|472457788|FG001|Overall Study|Other reasons|1|||
131227135|NCT01571635|472457789|FG002|Overall Study|Other reasons|2|||
131227136|NCT01571635|472457790|FG003|Overall Study|Other reasons|2|||
131227137|NCT01571635|472457791|FG004|Overall Study|Other reasons|1|||
131227138|NCT01571635|472457787|FG000|Overall Study|Study terminated by sponsor|0|||
131227139|NCT01571635|472457788|FG001|Overall Study|Study terminated by sponsor|4|||
131227140|NCT01571635|472457789|FG002|Overall Study|Study terminated by sponsor|1|||
131227141|NCT01571635|472457790|FG003|Overall Study|Study terminated by sponsor|3|||
131227142|NCT01571635|472457791|FG004|Overall Study|Study terminated by sponsor|1|||
130971665|NCT00110617|471522254|FG000|Overall Study|Adverse Event|2|||
131227143|NCT01571635|472457787|FG000|Overall Study|Withdrew consent|1|||
130971666|NCT00110617|471522255|FG001|Overall Study|Adverse Event|4|||
130971667|NCT00110617|471522254|FG000|Overall Study|Abnormal Laboratory Value|4|||
131227144|NCT01571635|472457788|FG001|Overall Study|Withdrew consent|1|||
130971668|NCT00110617|471522255|FG001|Overall Study|Abnormal Laboratory Value|2|||
130971669|NCT00110617|471522254|FG000|Overall Study|Lack of Efficacy|1|||
130971670|NCT00110617|471522255|FG001|Overall Study|Lack of Efficacy|0|||
130971671|NCT00110617|471522254|FG000|Overall Study|Patient no longer requires study drug|1|||
130971672|NCT00110617|471522255|FG001|Overall Study|Patient no longer requires study drug|0|||
130971673|NCT00110617|471522254|FG000|Overall Study|Protocol Violation|5|||
131227145|NCT01571635|472457789|FG002|Overall Study|Withdrew consent|2|||
131227146|NCT01571635|472457790|FG003|Overall Study|Withdrew consent|3|||
131128896|NCT01033825|472099625|FG004|Overall Study|Other|1|||
131128897|NCT01033825|472099626|FG005|Overall Study|Other|0|||
131128898|NCT01033825|472099627|FG006|Overall Study|Other|0|||
130716435|NCT04765384|470588848|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130716436|NCT04765384|470588849|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
130716437|NCT01971970|470588850|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
130716438|NCT01971970|470588851|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
130716439|NCT01971970|470588850|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
130716440|NCT01971970|470588851|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
130716441|NCT01971970|470588850|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
130716442|NCT01971970|470588851|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
130971674|NCT00110617|471522255|FG001|Overall Study|Protocol Violation|0|||
130971675|NCT00110617|471522254|FG000|Overall Study|Withdrawal by Subject|10|||
130971676|NCT00110617|471522255|FG001|Overall Study|Withdrawal by Subject|4|||
130971677|NCT00110617|471522254|FG000|Overall Study|Lost to Follow-up|9|||
131227147|NCT01571635|472457791|FG004|Overall Study|Withdrew consent|0|||
130716443|NCT01971970|470588850|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
130716444|NCT01971970|470588851|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
130716445|NCT01971970|470588850|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
130971678|NCT00110617|471522255|FG001|Overall Study|Lost to Follow-up|1|||
130971679|NCT00110617|471522254|FG000|Overall Study|Administrative problems|6|||
130971680|NCT00110617|471522255|FG001|Overall Study|Administrative problems|5|||
130971681|NCT00110617|471522254|FG000|Overall Study|Death|1|||
130971682|NCT00110617|471522255|FG001|Overall Study|Death|1|||
130971683|NCT00110617|471522254|FG000|Overall Study|Did not receive study drug|0|||
130971684|NCT00110617|471522255|FG001|Overall Study|Did not receive study drug|12|||
130971685|NCT01781572|471522257|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
130971686|NCT01781572|471522258|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
130971687|NCT01781572|471522259|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
130971688|NCT01781572|471522257|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
130716446|NCT01971970|470588851|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
130971689|NCT01781572|471522258|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
130971690|NCT01781572|471522259|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
130971691|NCT01781572|471522257|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
130971692|NCT01781572|471522258|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
130971693|NCT01781572|471522259|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
130971694|NCT01781572|471522257|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
130971695|NCT01781572|471522258|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
130971696|NCT01781572|471522259|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
130971697|NCT01781572|471522257|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
130971698|NCT01781572|471522258|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
130971699|NCT01781572|471522259|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
130971700|NCT01781572|471522257|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
130971701|NCT01781572|471522258|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
130971702|NCT01781572|471522259|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
130971703|NCT01781572|471522257|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
130716447|NCT01971970|470588850|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
130716448|NCT01971970|470588851|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
130716449|NCT01971970|470588850|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
130716450|NCT01971970|470588851|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
130971704|NCT01781572|471522258|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
130971705|NCT01781572|471522259|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
130971706|NCT01781572|471522257|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
130971707|NCT01781572|471522258|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
130971708|NCT01781572|471522259|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
130971709|NCT01781572|471522257|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
130971710|NCT01781572|471522258|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
130971711|NCT01781572|471522259|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
130971712|NCT01781572|471522257|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
130971713|NCT01781572|471522258|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
130971714|NCT01781572|471522259|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
130971715|NCT01781572|471522257|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
130971716|NCT01781572|471522258|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
130971717|NCT01781572|471522259|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
130971718|NCT01781572|471522257|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
130971719|NCT01781572|471522258|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
130971720|NCT01781572|471522259|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
130971721|NCT01781572|471522257|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
130971722|NCT01781572|471522258|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
130971723|NCT01781572|471522259|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
130971724|NCT01781572|471522257|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
130971725|NCT01781572|471522258|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
131227148|NCT01571635|472457787|FG000|Overall Study|Lack of Efficacy|0|||
131042708|NCT03088878|471789358|FG000|Overall Study|Completed 2 years of Treatment|0|||
131042709|NCT03088878|471789359|FG001|Overall Study|Completed 2 years of Treatment|0|||
131042710|NCT03088878|471789360|FG002|Overall Study|Completed 2 years of Treatment|0|||
131042711|NCT03088878|471789361|FG003|Overall Study|Completed 2 years of Treatment|0|||
131042712|NCT03088878|471789362|FG004|Overall Study|Completed 2 years of Treatment|0|||
131042713|NCT03088878|471789363|FG005|Overall Study|Completed 2 years of Treatment|0|||
131042714|NCT03088878|471789364|FG006|Overall Study|Completed 2 years of Treatment|1|||
131227149|NCT01571635|472457788|FG001|Overall Study|Lack of Efficacy|2|||
131227150|NCT01571635|472457789|FG002|Overall Study|Lack of Efficacy|0|||
131227151|NCT01571635|472457790|FG003|Overall Study|Lack of Efficacy|1|||
131227152|NCT01571635|472457791|FG004|Overall Study|Lack of Efficacy|2|||
131227153|NCT01154127|472457800|FG000|Period 1 (21 Days)|Adverse Event|3|||
131227154|NCT01154127|472457801|FG001|Period 1 (21 Days)|Adverse Event|4|||
131227155|NCT01154127|472457800|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
131227156|NCT01154127|472457801|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
131227157|NCT01154127|472457800|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
131227158|NCT01154127|472457801|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
131227159|NCT01154127|472457800|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
131227160|NCT01154127|472457801|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
131227161|NCT01154127|472457800|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
131227162|NCT01154127|472457801|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
131227163|NCT01697449|472457802|FG000|Overall Study|Disease progression|47|||
131227164|NCT01697449|472457802|FG000|Overall Study|Adverse Event|7|||
131227165|NCT01697449|472457802|FG000|Overall Study|Lost to Follow-up|5|||
131227166|NCT01697449|472457802|FG000|Overall Study|Withdrawal by Subject|2|||
131227167|NCT01697449|472457802|FG000|Overall Study|Physician Decision|1|||
131227168|NCT01697449|472457802|FG000|Overall Study|Death|2|||
131227169|NCT01697449|472457802|FG000|Overall Study|Other|1|||
131227170|NCT01697449|472457802|FG000|Overall Study|Missing|25|||
131227171|NCT02390219|472457803|FG000|Overall Study|Death|1|||
131227172|NCT02390219|472457803|FG000|Overall Study|Physician Decision|1|||
131227173|NCT02390219|472457803|FG000|Overall Study|Adverse Event|6|||
131227174|NCT02390219|472457803|FG000|Overall Study|Withdrawal by Subject|1|||
131227175|NCT02390219|472457803|FG000|Overall Study|Lost to Follow-up|2|||
131227176|NCT02390219|472457803|FG000|Overall Study|Other|2|||
131227177|NCT01169844|472457804|FG000|Overall Study|Adverse Event|0|||
131227178|NCT01169844|472457805|FG001|Overall Study|Adverse Event|1|||
131227179|NCT01169844|472457804|FG000|Overall Study|Patient withdrew consent|4|||
130971726|NCT01781572|471522259|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
130971727|NCT01781572|471522257|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
130971728|NCT01781572|471522258|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
130971729|NCT01781572|471522259|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
130971730|NCT01781572|471522257|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
130971731|NCT01781572|471522258|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
130971732|NCT01781572|471522259|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
130971733|NCT01781572|471522257|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
130971734|NCT01781572|471522258|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
130971735|NCT01781572|471522259|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
130971736|NCT01781572|471522257|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
130971737|NCT01781572|471522258|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
130971738|NCT01781572|471522259|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
130971739|NCT00045110|471522260|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
130971740|NCT00045110|471522261|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
130971741|NCT00045110|471522262|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
130971742|NCT00045110|471522260|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
130971743|NCT00045110|471522261|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
130971744|NCT00045110|471522262|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
130971745|NCT00045110|471522260|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
130971746|NCT00045110|471522261|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
130971747|NCT00045110|471522262|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
130971748|NCT01218646|471522263|FG000|Overall Study|Adverse Event|0|||
130971749|NCT01218646|471522264|FG001|Overall Study|Adverse Event|0|||
130971750|NCT01218646|471522265|FG002|Overall Study|Adverse Event|1|||
130971751|NCT01218646|471522266|FG003|Overall Study|Adverse Event|0|||
130971752|NCT01218646|471522263|FG000|Overall Study|Lost to Follow-up|1|||
131042715|NCT03088878|471789365|FG007|Overall Study|Completed 2 years of Treatment|0|||
131042716|NCT03088878|471789366|FG008|Overall Study|Completed 2 years of Treatment|0|||
130971753|NCT01218646|471522264|FG001|Overall Study|Lost to Follow-up|0|||
130971754|NCT01218646|471522265|FG002|Overall Study|Lost to Follow-up|0|||
130971755|NCT01218646|471522266|FG003|Overall Study|Lost to Follow-up|0|||
130971756|NCT01218646|471522263|FG000|Overall Study|Protocol Violation|0|||
131042717|NCT03088878|471789367|FG009|Overall Study|Completed 2 years of Treatment|1|||
131227180|NCT01169844|472457805|FG001|Overall Study|Patient withdrew consent|0|||
131227181|NCT01169844|472457804|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130971757|NCT01218646|471522264|FG001|Overall Study|Protocol Violation|0|||
130971758|NCT01218646|471522265|FG002|Overall Study|Protocol Violation|1|||
130971759|NCT01218646|471522266|FG003|Overall Study|Protocol Violation|1|||
130971760|NCT03156023|471522272|FG000|Overall Study|Withdrawal by Subject|1|||
130971761|NCT03156023|471522273|FG001|Overall Study|Withdrawal by Subject|0|||
130971762|NCT03156023|471522274|FG002|Overall Study|Withdrawal by Subject|2|||
130971763|NCT03156023|471522275|FG003|Overall Study|Withdrawal by Subject|1|||
130971764|NCT03156023|471522276|FG004|Overall Study|Withdrawal by Subject|1|||
130971765|NCT03156023|471522272|FG000|Overall Study|Lost to Follow-up|0|||
130971766|NCT03156023|471522273|FG001|Overall Study|Lost to Follow-up|0|||
130971767|NCT03156023|471522274|FG002|Overall Study|Lost to Follow-up|0|||
130971768|NCT03156023|471522275|FG003|Overall Study|Lost to Follow-up|0|||
130971769|NCT03156023|471522276|FG004|Overall Study|Lost to Follow-up|1|||
130971770|NCT00726752|471522277|FG000|Overall Study|Lack of Efficacy|6|||
130971771|NCT04827576|471524849|FG000|Overall Study|Death|5|||
130971772|NCT04827576|471524850|FG001|Overall Study|Death|17|||
130971773|NCT04827576|471524851|FG002|Overall Study|Death|17|||
130971774|NCT04827576|471524852|FG003|Overall Study|Death|32|||
130971775|NCT04827576|471524849|FG000|Overall Study|Study Terminated by Sponsor|2|||
130971776|NCT04827576|471524850|FG001|Overall Study|Study Terminated by Sponsor|9|||
130971777|NCT04827576|471524851|FG002|Overall Study|Study Terminated by Sponsor|7|||
130971778|NCT04827576|471524852|FG003|Overall Study|Study Terminated by Sponsor|5|||
130971779|NCT04827576|471524849|FG000|Overall Study|Investigator's Discretion|1|||
130971780|NCT04827576|471524850|FG001|Overall Study|Investigator's Discretion|0|||
130971781|NCT04827576|471524851|FG002|Overall Study|Investigator's Discretion|2|||
130971782|NCT04827576|471524852|FG003|Overall Study|Investigator's Discretion|5|||
130971783|NCT04827576|471524849|FG000|Overall Study|Withdrew Consent|0|||
130971784|NCT04827576|471524850|FG001|Overall Study|Withdrew Consent|3|||
130971785|NCT04827576|471524851|FG002|Overall Study|Withdrew Consent|0|||
130971786|NCT04827576|471524852|FG003|Overall Study|Withdrew Consent|0|||
130971787|NCT04827576|471524849|FG000|Overall Study|Lost to Follow-up|1|||
130971788|NCT04827576|471524850|FG001|Overall Study|Lost to Follow-up|0|||
130971789|NCT04827576|471524851|FG002|Overall Study|Lost to Follow-up|0|||
130971790|NCT04827576|471524852|FG003|Overall Study|Lost to Follow-up|0|||
130971791|NCT04537923|471524853|FG000|Overall Study|Adverse Event|2|||
130971792|NCT04537923|471524854|FG001|Overall Study|Adverse Event|1|||
130971793|NCT04537923|471524855|FG002|Overall Study|Adverse Event|2|||
130971794|NCT04537923|471524856|FG003|Overall Study|Adverse Event|4|||
130971795|NCT04537923|471524853|FG000|Overall Study|Death|3|||
130971796|NCT04537923|471524854|FG001|Overall Study|Death|3|||
130971797|NCT04537923|471524855|FG002|Overall Study|Death|1|||
130971798|NCT04537923|471524856|FG003|Overall Study|Death|11|||
130971799|NCT04537923|471524853|FG000|Overall Study|Lost to Follow-up|1|||
130971800|NCT04537923|471524854|FG001|Overall Study|Lost to Follow-up|2|||
130971801|NCT04537923|471524855|FG002|Overall Study|Lost to Follow-up|1|||
130971802|NCT04537923|471524856|FG003|Overall Study|Lost to Follow-up|6|||
130971803|NCT04537923|471524853|FG000|Overall Study|Physician Decision|1|||
130971804|NCT04537923|471524854|FG001|Overall Study|Physician Decision|0|||
130971805|NCT04537923|471524855|FG002|Overall Study|Physician Decision|2|||
130971806|NCT04537923|471524856|FG003|Overall Study|Physician Decision|5|||
130971807|NCT04537923|471524853|FG000|Overall Study|Pregnancy|1|||
130971808|NCT04537923|471524854|FG001|Overall Study|Pregnancy|0|||
130971809|NCT04537923|471524855|FG002|Overall Study|Pregnancy|0|||
130971810|NCT04537923|471524856|FG003|Overall Study|Pregnancy|0|||
130971811|NCT04537923|471524853|FG000|Overall Study|Withdrawal by Subject|4|||
130971812|NCT04537923|471524854|FG001|Overall Study|Withdrawal by Subject|4|||
130971813|NCT04537923|471524855|FG002|Overall Study|Withdrawal by Subject|4|||
131042718|NCT03088878|471789368|FG010|Overall Study|Completed 2 years of Treatment|0|||
131227182|NCT01169844|472457805|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130716451|NCT00848107|470588852|FG000|Overall Study|Lost to Follow-up|2|||
130716452|NCT00848107|470588852|FG000|Overall Study|Withdrawal by Subject|8|||
130716453|NCT00848107|470588852|FG000|Overall Study|Adverse Event|9|||
130716454|NCT00848107|470588852|FG000|Overall Study|Death|1|||
130716455|NCT00848107|470588852|FG000|Overall Study|Pregnancy|1|||
130716456|NCT02335983|470588853|FG000|Overall Study|Sponsor Decision|0|||
130971814|NCT04537923|471524856|FG003|Overall Study|Withdrawal by Subject|58|||
130971815|NCT04537923|471524853|FG000|Overall Study|Missed study visits|2|||
130971816|NCT04537923|471524854|FG001|Overall Study|Missed study visits|0|||
130971817|NCT04537923|471524855|FG002|Overall Study|Missed study visits|0|||
130716457|NCT02335983|470588854|FG001|Overall Study|Sponsor Decision|0|||
130716458|NCT02335983|470588855|FG002|Overall Study|Sponsor Decision|1|||
130971818|NCT04537923|471524856|FG003|Overall Study|Missed study visits|3|||
130971819|NCT04537923|471524853|FG000|Overall Study|Sponsor's decision|0|||
130971820|NCT04537923|471524854|FG001|Overall Study|Sponsor's decision|0|||
130971821|NCT04537923|471524855|FG002|Overall Study|Sponsor's decision|1|||
130971822|NCT04537923|471524856|FG003|Overall Study|Sponsor's decision|1|||
130971823|NCT04537923|471524853|FG000|Overall Study|Safety reasons|1|||
130971824|NCT04537923|471524854|FG001|Overall Study|Safety reasons|0|||
130971825|NCT04537923|471524855|FG002|Overall Study|Safety reasons|0|||
130971826|NCT04537923|471524856|FG003|Overall Study|Safety reasons|0|||
131227183|NCT03372083|472459651|FG000|Overall Study|Adverse Event|3|||
130971827|NCT01261611|471524857|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
130971828|NCT01261611|471524858|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
130971829|NCT01261611|471524859|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
130971830|NCT01261611|471524857|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
130971831|NCT01261611|471524858|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
130971832|NCT01261611|471524859|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
130971833|NCT01261611|471524857|FG000|Treatment Cycle 1|Adverse Event|0|||
130971834|NCT01261611|471524858|FG001|Treatment Cycle 1|Adverse Event|1|||
130971835|NCT01261611|471524859|FG002|Treatment Cycle 1|Adverse Event|0|||
130971836|NCT01261611|471524857|FG000|Treatment Cycle 1|Protocol Violation|0|||
130971837|NCT01261611|471524858|FG001|Treatment Cycle 1|Protocol Violation|0|||
130971838|NCT01261611|471524859|FG002|Treatment Cycle 1|Protocol Violation|2|||
131128899|NCT01100437|472099630|FG000|Titration/Stabilization|Adverse Event|0|||
131128900|NCT01100437|472099631|FG001|Titration/Stabilization|Adverse Event|0|||
131128901|NCT01100437|472099632|FG002|Titration/Stabilization|Adverse Event|4|||
130971839|NCT01261611|471524857|FG000|Treatment Cycle 2|Completed study|4|||
130971840|NCT01261611|471524858|FG001|Treatment Cycle 2|Completed study|0|||
130971841|NCT01261611|471524859|FG002|Treatment Cycle 2|Completed study|0|||
130971842|NCT01261611|471524857|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
130971843|NCT01261611|471524858|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
130971844|NCT01261611|471524859|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
130971845|NCT01261611|471524857|FG000|Treatment Cycle 2|Adverse Event|1|||
130971846|NCT01261611|471524858|FG001|Treatment Cycle 2|Adverse Event|0|||
130971847|NCT01261611|471524859|FG002|Treatment Cycle 2|Adverse Event|0|||
130971848|NCT01261611|471524857|FG000|Treatment Cycle 2|Protocol Violation|2|||
130971849|NCT01261611|471524858|FG001|Treatment Cycle 2|Protocol Violation|0|||
130971850|NCT01261611|471524859|FG002|Treatment Cycle 2|Protocol Violation|0|||
130971851|NCT01261611|471524857|FG000|Treatment Cycle 2|Not otherwise specified|2|||
130971852|NCT01261611|471524858|FG001|Treatment Cycle 2|Not otherwise specified|0|||
130971853|NCT01261611|471524859|FG002|Treatment Cycle 2|Not otherwise specified|0|||
130971854|NCT01261611|471524857|FG000|Treatment Cycle 3|Completed study|24|||
130971855|NCT01261611|471524858|FG001|Treatment Cycle 3|Completed study|0|||
130971856|NCT01261611|471524859|FG002|Treatment Cycle 3|Completed study|0|||
130971857|NCT01261611|471524857|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
130971858|NCT01261611|471524858|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
130971859|NCT01261611|471524859|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
130971860|NCT01261611|471524857|FG000|Treatment Cycle 3|Adverse Event|1|||
130971861|NCT01261611|471524858|FG001|Treatment Cycle 3|Adverse Event|0|||
130971862|NCT01261611|471524859|FG002|Treatment Cycle 3|Adverse Event|0|||
130971863|NCT01261611|471524857|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
130971864|NCT01261611|471524858|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
130971865|NCT01261611|471524859|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
130971866|NCT01261611|471524857|FG000|Treatment Cycle 4|Completed study|87|||
130971867|NCT01261611|471524858|FG001|Treatment Cycle 4|Completed study|0|||
130971868|NCT01261611|471524859|FG002|Treatment Cycle 4|Completed study|0|||
131128902|NCT01100437|472099630|FG000|Titration/Stabilization|Non-compliance|0|||
131128903|NCT01100437|472099631|FG001|Titration/Stabilization|Non-compliance|0|||
131128904|NCT01100437|472099632|FG002|Titration/Stabilization|Non-compliance|1|||
131128905|NCT01100437|472099630|FG000|Titration/Stabilization|Sponsor canceled study|0|||
131128906|NCT01100437|472099631|FG001|Titration/Stabilization|Sponsor canceled study|0|||
131128907|NCT01100437|472099632|FG002|Titration/Stabilization|Sponsor canceled study|1|||
131128908|NCT01100437|472099630|FG000|Maintenance|Withdrawal by Subject|0|||
131128909|NCT01100437|472099631|FG001|Maintenance|Withdrawal by Subject|0|||
131128910|NCT01100437|472099632|FG002|Maintenance|Withdrawal by Subject|1|||
131128911|NCT01100437|472099630|FG000|Maintenance|Sponsor termination of study|0|||
131128912|NCT01100437|472099631|FG001|Maintenance|Sponsor termination of study|0|||
131128913|NCT01100437|472099632|FG002|Maintenance|Sponsor termination of study|1|||
131128914|NCT02581202|472099646|FG000|Overall Study|Lack of Efficacy|2|||
131128915|NCT02581202|472099646|FG000|Overall Study|Withdrawal by Subject|4|||
130775735|NCT00667992|470806552|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
130775736|NCT00667992|470806553|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
130775737|NCT00762762|470806556|FG000|Overall Study|Did not return for appointments|6|||
130775738|NCT00762762|470806557|FG001|Overall Study|Did not return for appointments|8|||
130775739|NCT02489448|470806558|FG000|Overall Study|Death|3|||
130775740|NCT02489448|470806558|FG000|Overall Study|Withdrawal by Subject|2|||
130775741|NCT02748057|470806559|FG000|Overall Study|Adverse Event|1|||
130775742|NCT02748057|470806560|FG001|Overall Study|Adverse Event|0|||
130971869|NCT01261611|471524857|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
130971870|NCT01261611|471524858|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
130971871|NCT01261611|471524859|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
130971872|NCT01261611|471524857|FG000|Treatment Cycle 4|Adverse Event|1|||
130971873|NCT01261611|471524858|FG001|Treatment Cycle 4|Adverse Event|0|||
130971874|NCT01261611|471524859|FG002|Treatment Cycle 4|Adverse Event|0|||
130971875|NCT01261611|471524857|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
131128916|NCT02581202|472099646|FG000|Overall Study|Lost to Follow-up|5|||
131128917|NCT02581202|472099646|FG000|Overall Study|Pregnancy|3|||
131128918|NCT01806779|472099649|FG000|Overall Study|Physician Decision|2|||
130971876|NCT01261611|471524858|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
130971877|NCT01261611|471524859|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
130971878|NCT01261611|471524857|FG000|Treatment Cycle 4|Not otherwise specified|3|||
130971879|NCT01261611|471524858|FG001|Treatment Cycle 4|Not otherwise specified|0|||
131128919|NCT01806779|472099650|FG001|Overall Study|Physician Decision|0|||
131128920|NCT01806779|472099651|FG002|Overall Study|Physician Decision|1|||
131128921|NCT01806779|472099649|FG000|Overall Study|Lack of Efficacy|1|||
131128922|NCT01806779|472099650|FG001|Overall Study|Lack of Efficacy|1|||
131128923|NCT01806779|472099651|FG002|Overall Study|Lack of Efficacy|0|||
131128924|NCT01806779|472099649|FG000|Overall Study|Lost to Follow-up|19|||
130716459|NCT02335983|470588856|FG003|Overall Study|Sponsor Decision|1|||
130716460|NCT02335983|470588857|FG004|Overall Study|Sponsor Decision|0|||
130716461|NCT02335983|470588858|FG005|Overall Study|Sponsor Decision|1|||
130716462|NCT02335983|470588853|FG000|Overall Study|Withdrawal by Subject|3|||
130971880|NCT01261611|471524859|FG002|Treatment Cycle 4|Not otherwise specified|0|||
130971881|NCT01261611|471524857|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
130971882|NCT01261611|471524858|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
130971883|NCT01261611|471524859|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
130971884|NCT01261611|471524857|FG000|Treatment Cycle 5|Adverse Event|1|||
130971885|NCT01261611|471524858|FG001|Treatment Cycle 5|Adverse Event|0|||
130971886|NCT01261611|471524859|FG002|Treatment Cycle 5|Adverse Event|0|||
130971887|NCT01261611|471524857|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
130971888|NCT01261611|471524858|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
130971889|NCT01261611|471524859|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
130971890|NCT02527798|471524860|FG000|Overall Study|Physician Decision|1|||
130971891|NCT02527798|471524861|FG001|Overall Study|Physician Decision|0|||
130971892|NCT02527798|471524862|FG002|Overall Study|Physician Decision|1|||
130971893|NCT02527798|471524863|FG003|Overall Study|Physician Decision|1|||
130971894|NCT02527798|471524864|FG004|Overall Study|Physician Decision|0|||
130971895|NCT02527798|471524865|FG005|Overall Study|Physician Decision|0|||
130971896|NCT02527798|471524860|FG000|Overall Study|Death|0|||
130971897|NCT02527798|471524861|FG001|Overall Study|Death|0|||
130971898|NCT02527798|471524862|FG002|Overall Study|Death|1|||
130971899|NCT02527798|471524863|FG003|Overall Study|Death|0|||
130971900|NCT02527798|471524864|FG004|Overall Study|Death|0|||
130971901|NCT02527798|471524865|FG005|Overall Study|Death|0|||
130971902|NCT02527798|471524860|FG000|Overall Study|Withdrawal by Subject|0|||
130971903|NCT02527798|471524861|FG001|Overall Study|Withdrawal by Subject|1|||
130971904|NCT02527798|471524862|FG002|Overall Study|Withdrawal by Subject|2|||
130971905|NCT02527798|471524863|FG003|Overall Study|Withdrawal by Subject|0|||
130971906|NCT02527798|471524864|FG004|Overall Study|Withdrawal by Subject|0|||
130971907|NCT02527798|471524865|FG005|Overall Study|Withdrawal by Subject|0|||
130971908|NCT02527798|471524860|FG000|Overall Study|Reason undisclosed|1|||
130971909|NCT02527798|471524861|FG001|Overall Study|Reason undisclosed|0|||
130971910|NCT02527798|471524862|FG002|Overall Study|Reason undisclosed|1|||
130971911|NCT02527798|471524863|FG003|Overall Study|Reason undisclosed|0|||
130971912|NCT02527798|471524864|FG004|Overall Study|Reason undisclosed|0|||
130971913|NCT02527798|471524865|FG005|Overall Study|Reason undisclosed|0|||
130971914|NCT02527798|471524860|FG000|Overall Study|Did not receive intervention|1|||
130971915|NCT02527798|471524861|FG001|Overall Study|Did not receive intervention|1|||
130971916|NCT02527798|471524862|FG002|Overall Study|Did not receive intervention|0|||
130971917|NCT02527798|471524863|FG003|Overall Study|Did not receive intervention|0|||
130971918|NCT02527798|471524864|FG004|Overall Study|Did not receive intervention|0|||
130971919|NCT02527798|471524865|FG005|Overall Study|Did not receive intervention|0|||
130971920|NCT02041195|471524868|FG000|Overall Study|Adverse Event|1|||
130971921|NCT02041195|471524869|FG001|Overall Study|Adverse Event|2|||
130971922|NCT02041195|471524870|FG002|Overall Study|Adverse Event|0|||
130971923|NCT02041195|471524871|FG003|Overall Study|Adverse Event|0|||
130971924|NCT02041195|471524872|FG004|Overall Study|Adverse Event|0|||
131128925|NCT01806779|472099650|FG001|Overall Study|Lost to Follow-up|20|||
130716463|NCT02335983|470588854|FG001|Overall Study|Withdrawal by Subject|2|||
130716464|NCT02335983|470588855|FG002|Overall Study|Withdrawal by Subject|2|||
130716465|NCT02335983|470588856|FG003|Overall Study|Withdrawal by Subject|1|||
130971925|NCT02041195|471524873|FG005|Overall Study|Adverse Event|0|||
130971926|NCT02041195|471524874|FG006|Overall Study|Adverse Event|3|||
130971927|NCT02041195|471524875|FG007|Overall Study|Adverse Event|0|||
130971928|NCT02041195|471524868|FG000|Overall Study|Withdrawal by Subject|1|||
130971929|NCT02041195|471524869|FG001|Overall Study|Withdrawal by Subject|0|||
130971930|NCT02041195|471524870|FG002|Overall Study|Withdrawal by Subject|0|||
130971931|NCT02041195|471524871|FG003|Overall Study|Withdrawal by Subject|0|||
130971932|NCT02041195|471524872|FG004|Overall Study|Withdrawal by Subject|0|||
130971933|NCT02041195|471524873|FG005|Overall Study|Withdrawal by Subject|0|||
130971934|NCT02041195|471524874|FG006|Overall Study|Withdrawal by Subject|4|||
130971935|NCT02041195|471524875|FG007|Overall Study|Withdrawal by Subject|3|||
131227184|NCT03372083|472459651|FG000|Overall Study|Physician Decision|1|||
130971936|NCT02041195|471524868|FG000|Overall Study|Unable to comply with study visits|0|||
130971937|NCT02041195|471524869|FG001|Overall Study|Unable to comply with study visits|1|||
131128926|NCT01806779|472099651|FG002|Overall Study|Lost to Follow-up|0|||
130716466|NCT02335983|470588857|FG004|Overall Study|Withdrawal by Subject|3|||
130716467|NCT02335983|470588858|FG005|Overall Study|Withdrawal by Subject|9|||
130716468|NCT02335983|470588853|FG000|Overall Study|Death|0|||
130716469|NCT02335983|470588854|FG001|Overall Study|Death|0|||
130716470|NCT02335983|470588855|FG002|Overall Study|Death|2|||
130716471|NCT02335983|470588856|FG003|Overall Study|Death|0|||
130716472|NCT02335983|470588857|FG004|Overall Study|Death|0|||
130716473|NCT02335983|470588858|FG005|Overall Study|Death|0|||
130716474|NCT02335983|470588853|FG000|Overall Study|Lost to Follow-up|0|||
130716475|NCT02335983|470588854|FG001|Overall Study|Lost to Follow-up|0|||
130716476|NCT02335983|470588855|FG002|Overall Study|Lost to Follow-up|0|||
130716477|NCT02335983|470588856|FG003|Overall Study|Lost to Follow-up|0|||
130716478|NCT02335983|470588857|FG004|Overall Study|Lost to Follow-up|0|||
130716479|NCT02335983|470588858|FG005|Overall Study|Lost to Follow-up|1|||
130716480|NCT02335983|470588853|FG000|Overall Study|Protocol Specified Criteria|5|||
130716481|NCT02335983|470588854|FG001|Overall Study|Protocol Specified Criteria|7|||
130716482|NCT02335983|470588855|FG002|Overall Study|Protocol Specified Criteria|27|||
130716483|NCT02335983|470588856|FG003|Overall Study|Protocol Specified Criteria|7|||
130716484|NCT02335983|470588857|FG004|Overall Study|Protocol Specified Criteria|5|||
130716485|NCT02335983|470588858|FG005|Overall Study|Protocol Specified Criteria|21|||
130716486|NCT00987389|470588859|FG000|Overall Study|Ineligible|0|||
130716487|NCT00987389|470588860|FG001|Overall Study|Ineligible|3|||
130716488|NCT00987389|470588861|FG002|Overall Study|Ineligible|0|||
130716489|NCT00987389|470588862|FG003|Overall Study|Ineligible|0|||
130716490|NCT00987389|470588859|FG000|Overall Study|Lost to Follow-up|4|||
130716491|NCT00987389|470588860|FG001|Overall Study|Lost to Follow-up|1|||
130716492|NCT00987389|470588861|FG002|Overall Study|Lost to Follow-up|3|||
130716493|NCT00987389|470588862|FG003|Overall Study|Lost to Follow-up|1|||
130716494|NCT00987389|470588859|FG000|Overall Study|Withdrawal by Subject|4|||
130716495|NCT00987389|470588860|FG001|Overall Study|Withdrawal by Subject|3|||
130716496|NCT00987389|470588861|FG002|Overall Study|Withdrawal by Subject|2|||
130716497|NCT00987389|470588862|FG003|Overall Study|Withdrawal by Subject|1|||
130716498|NCT00987389|470588859|FG000|Overall Study|Withdrawn from Treatment|0|||
130716499|NCT00987389|470588860|FG001|Overall Study|Withdrawn from Treatment|1|||
130716500|NCT00987389|470588861|FG002|Overall Study|Withdrawn from Treatment|0|||
130716501|NCT00987389|470588862|FG003|Overall Study|Withdrawn from Treatment|0|||
130716502|NCT00987389|470588859|FG000|Overall Study|Multiple different reasons|1|||
130716503|NCT00987389|470588860|FG001|Overall Study|Multiple different reasons|0|||
130716504|NCT00987389|470588861|FG002|Overall Study|Multiple different reasons|3|||
130716505|NCT00987389|470588862|FG003|Overall Study|Multiple different reasons|1|||
130716506|NCT00326963|470588863|FG000|Overall Study|Adverse Event|2|||
130716507|NCT00326963|470588863|FG000|Overall Study|Injection site reaction|1|||
130716508|NCT00326963|470588863|FG000|Overall Study|Death|1|||
130716509|NCT00326963|470588863|FG000|Overall Study|Failure to return|10|||
130716510|NCT00326963|470588863|FG000|Overall Study|Withdrawal by Subject|10|||
130716511|NCT00326963|470588863|FG000|Overall Study|Refused treatment / did not cooperate|5|||
130716512|NCT00326963|470588863|FG000|Overall Study|Violation of selection criteria at entry|2|||
130716513|NCT00326963|470588863|FG000|Overall Study|Other protocol violation|1|||
130716514|NCT00326963|470588863|FG000|Overall Study|Administrative / other|1|||
130716515|NCT02524730|470588864|FG000|Overall Study|Lost to Follow-up|5|||
130716516|NCT02524730|470588864|FG000|Overall Study|Withdrawal by Subject|18|||
130716517|NCT02524730|470588864|FG000|Overall Study|Death|10|||
130716518|NCT02524730|470588864|FG000|Overall Study|Adverse Event|8|||
130716519|NCT02524730|470588864|FG000|Overall Study|Protocol Violation|1|||
130775743|NCT02748057|470806559|FG000|Overall Study|Physician Decision|0|||
130775744|NCT02748057|470806560|FG001|Overall Study|Physician Decision|1|||
130775745|NCT02748057|470806559|FG000|Overall Study|Protocol Violation|2|||
130971938|NCT02041195|471524870|FG002|Overall Study|Unable to comply with study visits|0|||
130971939|NCT02041195|471524871|FG003|Overall Study|Unable to comply with study visits|0|||
130971940|NCT02041195|471524872|FG004|Overall Study|Unable to comply with study visits|1|||
130971941|NCT02041195|471524873|FG005|Overall Study|Unable to comply with study visits|0|||
130971942|NCT02041195|471524874|FG006|Overall Study|Unable to comply with study visits|0|||
130971943|NCT02041195|471524875|FG007|Overall Study|Unable to comply with study visits|0|||
130971944|NCT00674986|471524876|FG000|Overall Study|Adverse Event|2|||
131227185|NCT03372083|472459651|FG000|Overall Study|Withdrawal by Subject|1|||
130716520|NCT02524730|470588864|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
130716521|NCT00507130|470588865|FG000|Overall Study|Lost to Follow-up|0|||
130716522|NCT00507130|470588866|FG001|Overall Study|Lost to Follow-up|0|||
130716523|NCT00507130|470588867|FG002|Overall Study|Lost to Follow-up|1|||
130716524|NCT00507130|470588868|FG003|Overall Study|Lost to Follow-up|1|||
130716525|NCT00507130|470588865|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
130716526|NCT00507130|470588866|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
130716527|NCT00507130|470588867|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
130716528|NCT00507130|470588868|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
130716529|NCT00080938|470588873|FG000|Overall Study|Adverse Event|3|||
130716530|NCT00080938|470588873|FG000|Overall Study|Withdrawal by Subject|6|||
130716531|NCT00080938|470588873|FG000|Overall Study|Death|2|||
131128927|NCT01806779|472099649|FG000|Overall Study|Withdrawal by Subject|20|||
131128928|NCT01806779|472099650|FG001|Overall Study|Withdrawal by Subject|23|||
131128929|NCT01806779|472099651|FG002|Overall Study|Withdrawal by Subject|22|||
131128930|NCT02595450|472099654|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
131128931|NCT02595450|472099654|FG000|Overall Study|Enrolled, but not treated|8|||
131128932|NCT04294901|472099656|FG000|Overall Study|Death|86|||
131128933|NCT04294901|472099657|FG001|Overall Study|Death|110|||
131128934|NCT04294901|472099656|FG000|Overall Study|Provider did not have historical control patients|581|||
131128935|NCT04294901|472099657|FG001|Overall Study|Provider did not have historical control patients|0|||
131128936|NCT04294901|472099656|FG000|Overall Study|Provider did not have intervention patients|0|||
131128937|NCT04294901|472099657|FG001|Overall Study|Provider did not have intervention patients|98|||
131128938|NCT01934556|472099660|FG000|Overall Study|Withdrawal by Subject|0|||
131128939|NCT01934556|472099661|FG001|Overall Study|Withdrawal by Subject|1|||
131128940|NCT01934556|472099662|FG002|Overall Study|Withdrawal by Subject|1|||
131128941|NCT01934556|472099660|FG000|Overall Study|Lost to Follow-up|4|||
131128942|NCT01934556|472099661|FG001|Overall Study|Lost to Follow-up|10|||
131128943|NCT01934556|472099662|FG002|Overall Study|Lost to Follow-up|7|||
131128944|NCT01934556|472099660|FG000|Overall Study|Death|1|||
131128945|NCT01934556|472099661|FG001|Overall Study|Death|5|||
131128946|NCT01934556|472099662|FG002|Overall Study|Death|2|||
131128947|NCT05038020|472099666|FG000|Overall Study|Early Termination|3|||
131128948|NCT05038020|472099667|FG001|Overall Study|Early Termination|0|||
131128949|NCT03770260|472101601|FG000|Overall Study|Disease progression|0|||
131128950|NCT03770260|472101602|FG001|Overall Study|Disease progression|1|||
131128951|NCT03770260|472101603|FG002|Overall Study|Disease progression|0|||
131128952|NCT03770260|472101604|FG003|Overall Study|Disease progression|0|||
131128953|NCT02484911|472101605|FG000|Overall Study|Withdrawal by Subject|2|||
131128954|NCT02484911|472101606|FG001|Overall Study|Withdrawal by Subject|1|||
131128955|NCT02484911|472101605|FG000|Overall Study|Protocol Violation|2|||
131128956|NCT02484911|472101606|FG001|Overall Study|Protocol Violation|1|||
131128957|NCT00075400|472101611|FG000|Overall Study|Ineligible: wrong primary|1|||
131128958|NCT00075400|472101611|FG000|Overall Study|Never treated|2|||
131128959|NCT01652885|472101612|FG000|Overall Study|Adverse Event|1|||
131128960|NCT00490568|472101613|FG000|Overall Study|Adverse Event|116|||
131128961|NCT00490568|472101613|FG000|Overall Study|Lost to Follow-up|13|||
131128962|NCT00490568|472101613|FG000|Overall Study|Protocol Violation|45|||
131128963|NCT00490568|472101613|FG000|Overall Study|Withdrawal by Subject|135|||
131128964|NCT00490568|472101613|FG000|Overall Study|Still in the study at termination|974|||
131128965|NCT00490568|472101613|FG000|Overall Study|Other|1|||
131128966|NCT00490568|472101613|FG000|Overall Study|Exclusion criteria met|1|||
131128967|NCT00490568|472101613|FG000|Overall Study|Caregiver related|20|||
131128968|NCT00490568|472101613|FG000|Overall Study|Abnormal ECG|25|||
131128969|NCT00490568|472101613|FG000|Overall Study|Participant refused follow-up|9|||
131128970|NCT00490568|472101613|FG000|Overall Study|Legal representative withdrew consent|1|||
131128971|NCT00490568|472101613|FG000|Overall Study|Disease progression|4|||
131128972|NCT00490568|472101613|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
131128973|NCT00490568|472101613|FG000|Overall Study|Investigator decision|3|||
131128974|NCT00490568|472101613|FG000|Overall Study|Non-Compliance|7|||
131128975|NCT00490568|472101613|FG000|Overall Study|Efficacy related|3|||
131128976|NCT00490568|472101613|FG000|Overall Study|Participant died|1|||
131128977|NCT00490568|472101613|FG000|Overall Study|Participant withdrawal due to surgery|1|||
131128978|NCT01395394|472101614|FG000|Baseline Study Visit|Protocol Violation|1|||
131128979|NCT01395394|472101615|FG001|Baseline Study Visit|Protocol Violation|0|||
131128980|NCT01395394|472101616|FG002|Baseline Study Visit|Protocol Violation|0|||
131128981|NCT03451773|472101619|FG000|Overall Study|Death on study|1|||
131128982|NCT03451773|472101620|FG001|Overall Study|Death on study|5|||
131128983|NCT03451773|472101619|FG000|Overall Study|Death during follow-up period|0|||
131128984|NCT03451773|472101620|FG001|Overall Study|Death during follow-up period|1|||
131128985|NCT03468855|472101621|FG000|Overall Study|Adverse Event|2|||
131128986|NCT03468855|472101621|FG000|Overall Study|Lost to Follow-up|5|||
131128987|NCT03468855|472101621|FG000|Overall Study|Withdrawal by Subject|3|||
131128988|NCT03468855|472101621|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
131128989|NCT00390546|472101622|FG000|Overall Study|Renal impairment|1|||
131128990|NCT00390546|472101623|FG001|Overall Study|Renal impairment|0|||
131128991|NCT00390546|472101622|FG000|Overall Study|Physician Decision|5|||
131128992|NCT00390546|472101623|FG001|Overall Study|Physician Decision|5|||
131128993|NCT00812214|472101629|FG000|Overall Study|Lost to Follow-up|3|||
131128994|NCT00812214|472101630|FG001|Overall Study|Lost to Follow-up|1|||
131128995|NCT02145741|472101631|FG000|Overall Study|Progressive disease|3|||
131128996|NCT02145741|472101632|FG001|Overall Study|Progressive disease|6|||
131128997|NCT02145741|472101633|FG002|Overall Study|Progressive disease|6|||
131128998|NCT02145741|472101631|FG000|Overall Study|quality issue with the administered drug|3|||
131128999|NCT02145741|472101632|FG001|Overall Study|quality issue with the administered drug|0|||
131129000|NCT02145741|472101633|FG002|Overall Study|quality issue with the administered drug|0|||
131129001|NCT01192022|472101634|FG000|Overall Study|Withdrawal of Consent|3|||
131129002|NCT01192022|472101635|FG001|Overall Study|Withdrawal of Consent|1|||
131129003|NCT01192022|472101636|FG002|Overall Study|Withdrawal of Consent|0|||
131129004|NCT01192022|472101637|FG003|Overall Study|Withdrawal of Consent|0|||
131129005|NCT01192022|472101638|FG004|Overall Study|Withdrawal of Consent|0|||
131129006|NCT01192022|472101634|FG000|Overall Study|Lost to Follow-up|4|||
131129007|NCT01192022|472101635|FG001|Overall Study|Lost to Follow-up|2|||
131129008|NCT01192022|472101636|FG002|Overall Study|Lost to Follow-up|1|||
131129009|NCT01192022|472101637|FG003|Overall Study|Lost to Follow-up|1|||
131129010|NCT01192022|472101638|FG004|Overall Study|Lost to Follow-up|0|||
131129011|NCT01192022|472101634|FG000|Overall Study|Adverse Event|1|||
131129012|NCT01192022|472101635|FG001|Overall Study|Adverse Event|0|||
130971945|NCT00674986|471524877|FG001|Overall Study|Adverse Event|1|||
130971946|NCT00674986|471524876|FG000|Overall Study|Subject withdrew consent|12|||
130971947|NCT00674986|471524877|FG001|Overall Study|Subject withdrew consent|19|||
130971948|NCT00674986|471524876|FG000|Overall Study|Lost to Follow-up|25|||
130971949|NCT00674986|471524877|FG001|Overall Study|Lost to Follow-up|53|||
130971950|NCT00674986|471524876|FG000|Overall Study|Other reasons|4|||
130971951|NCT00674986|471524877|FG001|Overall Study|Other reasons|8|||
130971952|NCT04546581|471524880|FG000|Overall Study|Adverse Event|9|||
130971953|NCT04546581|471524881|FG001|Overall Study|Adverse Event|3|||
130971954|NCT04546581|471524880|FG000|Overall Study|Physician Decision|0|||
130971955|NCT04546581|471524881|FG001|Overall Study|Physician Decision|1|||
130971956|NCT04546581|471524880|FG000|Overall Study|Protocol Violation|1|||
130971957|NCT04546581|471524881|FG001|Overall Study|Protocol Violation|2|||
130971958|NCT04546581|471524880|FG000|Overall Study|Withdrawal by Subject|3|||
130971959|NCT04546581|471524881|FG001|Overall Study|Withdrawal by Subject|7|||
130971960|NCT01585103|471524883|FG000|Overall Study|Unable to swallow Cytosponge|6|||
130971961|NCT01349569|471524885|FG000|Overall Study|Lack of Efficacy|4|||
130971962|NCT01747772|471524886|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
130971963|NCT00626522|471524887|FG000|Overall Study|Protocol Violation|0|||
130971964|NCT00626522|471524888|FG001|Overall Study|Protocol Violation|0|||
130971965|NCT00626522|471524889|FG002|Overall Study|Protocol Violation|0|||
130971966|NCT00626522|471524890|FG003|Overall Study|Protocol Violation|0|||
130971967|NCT00626522|471524891|FG004|Overall Study|Protocol Violation|1|||
130971968|NCT00626522|471524892|FG005|Overall Study|Protocol Violation|0|||
130971969|NCT00626522|471524887|FG000|Overall Study|Adverse Event|2|||
130971970|NCT00626522|471524888|FG001|Overall Study|Adverse Event|1|||
130971971|NCT00626522|471524889|FG002|Overall Study|Adverse Event|2|||
130971972|NCT00626522|471524890|FG003|Overall Study|Adverse Event|0|||
130971973|NCT00626522|471524891|FG004|Overall Study|Adverse Event|1|||
130971974|NCT00626522|471524892|FG005|Overall Study|Adverse Event|1|||
130971975|NCT00626522|471524887|FG000|Overall Study|Withdrawal by Subject|2|||
130971976|NCT00626522|471524888|FG001|Overall Study|Withdrawal by Subject|5|||
130971977|NCT00626522|471524889|FG002|Overall Study|Withdrawal by Subject|5|||
130971978|NCT00626522|471524890|FG003|Overall Study|Withdrawal by Subject|0|||
130971979|NCT00626522|471524891|FG004|Overall Study|Withdrawal by Subject|4|||
130971980|NCT00626522|471524892|FG005|Overall Study|Withdrawal by Subject|1|||
130971981|NCT00626522|471524887|FG000|Overall Study|COPD exacerbation|0|||
130971982|NCT00626522|471524888|FG001|Overall Study|COPD exacerbation|0|||
130971983|NCT00626522|471524889|FG002|Overall Study|COPD exacerbation|0|||
130971984|NCT00626522|471524890|FG003|Overall Study|COPD exacerbation|1|||
130971985|NCT00626522|471524891|FG004|Overall Study|COPD exacerbation|1|||
130971986|NCT00626522|471524892|FG005|Overall Study|COPD exacerbation|0|||
130971987|NCT00626522|471524887|FG000|Overall Study|Lost to Follow-up|0|||
130971988|NCT00626522|471524888|FG001|Overall Study|Lost to Follow-up|1|||
130971989|NCT00626522|471524889|FG002|Overall Study|Lost to Follow-up|0|||
130971990|NCT00626522|471524890|FG003|Overall Study|Lost to Follow-up|0|||
130971991|NCT00626522|471524891|FG004|Overall Study|Lost to Follow-up|0|||
130971992|NCT00626522|471524892|FG005|Overall Study|Lost to Follow-up|0|||
130971993|NCT00626522|471524887|FG000|Overall Study|Inconsistent reason reported|1|||
130971994|NCT00626522|471524888|FG001|Overall Study|Inconsistent reason reported|0|||
131129013|NCT01192022|472101636|FG002|Overall Study|Adverse Event|0|||
131227186|NCT02257632|472459657|FG000|Overall Study|Withdrawal by Subject|0|||
131227187|NCT02257632|472459658|FG001|Overall Study|Withdrawal by Subject|1|||
131227188|NCT02257632|472459657|FG000|Overall Study|Adverse Event|1|||
130971995|NCT00626522|471524889|FG002|Overall Study|Inconsistent reason reported|0|||
130971996|NCT00626522|471524890|FG003|Overall Study|Inconsistent reason reported|0|||
130971997|NCT00626522|471524891|FG004|Overall Study|Inconsistent reason reported|0|||
130971998|NCT00626522|471524892|FG005|Overall Study|Inconsistent reason reported|0|||
130971999|NCT00626522|471524887|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
131129014|NCT01192022|472101637|FG003|Overall Study|Adverse Event|0|||
131129015|NCT01192022|472101638|FG004|Overall Study|Adverse Event|0|||
131129016|NCT01192022|472101634|FG000|Overall Study|Fatal Adverse Event|4|||
131129017|NCT01192022|472101635|FG001|Overall Study|Fatal Adverse Event|6|||
131129018|NCT01192022|472101636|FG002|Overall Study|Fatal Adverse Event|0|||
130972000|NCT00626522|471524888|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
130972001|NCT00626522|471524889|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
130972002|NCT00626522|471524890|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
131129019|NCT01192022|472101637|FG003|Overall Study|Fatal Adverse Event|0|||
131129020|NCT01192022|472101638|FG004|Overall Study|Fatal Adverse Event|1|||
131129021|NCT01192022|472101634|FG000|Overall Study|Physician withdrew-patient hardship|1|||
131129022|NCT01192022|472101635|FG001|Overall Study|Physician withdrew-patient hardship|0|||
131129023|NCT01192022|472101636|FG002|Overall Study|Physician withdrew-patient hardship|0|||
131129024|NCT01192022|472101637|FG003|Overall Study|Physician withdrew-patient hardship|0|||
131129025|NCT01192022|472101638|FG004|Overall Study|Physician withdrew-patient hardship|0|||
131129026|NCT01192022|472101634|FG000|Overall Study|Patient too sick from chemotherapy|0|||
131129027|NCT01192022|472101635|FG001|Overall Study|Patient too sick from chemotherapy|1|||
131129028|NCT01192022|472101636|FG002|Overall Study|Patient too sick from chemotherapy|0|||
131129029|NCT01192022|472101637|FG003|Overall Study|Patient too sick from chemotherapy|0|||
131129030|NCT01192022|472101638|FG004|Overall Study|Patient too sick from chemotherapy|0|||
131129031|NCT01192022|472101634|FG000|Overall Study|Patient needed surgery|0|||
131129032|NCT01192022|472101635|FG001|Overall Study|Patient needed surgery|1|||
131129033|NCT01192022|472101636|FG002|Overall Study|Patient needed surgery|0|||
131129034|NCT01192022|472101637|FG003|Overall Study|Patient needed surgery|0|||
130972003|NCT00626522|471524891|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
130972004|NCT00626522|471524892|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
130972005|NCT02280044|471524893|FG000|Overall Study|Planned alternate|0|||
130972006|NCT02280044|471524894|FG001|Overall Study|Planned alternate|2|||
130972007|NCT00896168|471524896|FG000|Overall Study|Adverse Event|4|||
130972008|NCT00896168|471524897|FG001|Overall Study|Adverse Event|7|||
130972009|NCT00896168|471524896|FG000|Overall Study|Treatment failure|8|||
130972010|NCT00896168|471524897|FG001|Overall Study|Treatment failure|10|||
130972011|NCT00896168|471524896|FG000|Overall Study|Lost to Follow-up|1|||
130972012|NCT00896168|471524897|FG001|Overall Study|Lost to Follow-up|1|||
130972013|NCT00896168|471524896|FG000|Overall Study|Other|1|||
130972014|NCT00896168|471524897|FG001|Overall Study|Other|1|||
130972015|NCT01944631|471524906|FG000|Overall Study|Adverse Event|1|||
130972016|NCT01944631|471524907|FG001|Overall Study|Adverse Event|0|||
130972017|NCT01944631|471524906|FG000|Overall Study|Lost to Follow-up|3|||
130972018|NCT01944631|471524907|FG001|Overall Study|Lost to Follow-up|1|||
130972019|NCT01944631|471524906|FG000|Overall Study|Withdrawal by Subject|0|||
130972020|NCT01944631|471524907|FG001|Overall Study|Withdrawal by Subject|1|||
130972021|NCT03822533|471524909|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
130972022|NCT03822533|471524910|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
130972023|NCT03822533|471524909|FG000|3 Month Follow-up|Lost to Follow-up|2|||
130972024|NCT03822533|471524910|FG001|3 Month Follow-up|Lost to Follow-up|2|||
130972025|NCT03822533|471524909|FG000|6 Month Follow-up|Lost to Follow-up|3|||
130972026|NCT03822533|471524910|FG001|6 Month Follow-up|Lost to Follow-up|0|||
130972027|NCT03822533|471524909|FG000|12 Month Follow-up|Lost to Follow-up|2|||
131129035|NCT01192022|472101638|FG004|Overall Study|Patient needed surgery|0|||
131129036|NCT01192022|472101634|FG000|Overall Study|Parents did not allow all follow up|0|||
131129037|NCT01192022|472101635|FG001|Overall Study|Parents did not allow all follow up|0|||
130972028|NCT03822533|471524910|FG001|12 Month Follow-up|Lost to Follow-up|3|||
130972029|NCT03822533|471524909|FG000|12 Month Follow-up|Pregnancy|0|||
131129038|NCT01192022|472101636|FG002|Overall Study|Parents did not allow all follow up|0|||
131129039|NCT01192022|472101637|FG003|Overall Study|Parents did not allow all follow up|1|||
131129040|NCT01192022|472101638|FG004|Overall Study|Parents did not allow all follow up|0|||
131129041|NCT00129766|472101640|FG000|Overall Study|Death|3|||
131129042|NCT00129766|472101641|FG001|Overall Study|Death|8|||
131129043|NCT00129766|472101640|FG000|Overall Study|Withdrawal of consent|31|||
131129044|NCT00129766|472101641|FG001|Overall Study|Withdrawal of consent|30|||
131129045|NCT00129766|472101640|FG000|Overall Study|Lost to Follow-up|26|||
131129046|NCT00129766|472101641|FG001|Overall Study|Lost to Follow-up|21|||
131129047|NCT00781456|472101643|FG000|Overall Study|Adverse Event|3|||
131129048|NCT00781456|472101644|FG001|Overall Study|Adverse Event|3|||
131129049|NCT00781456|472101643|FG000|Overall Study|Withdrawal by Subject|3|||
131129050|NCT00781456|472101644|FG001|Overall Study|Withdrawal by Subject|5|||
130972030|NCT03822533|471524910|FG001|12 Month Follow-up|Pregnancy|1|||
130972031|NCT03822533|471524909|FG000|12 Month Follow-up|Surgery|2|||
131129051|NCT00781456|472101643|FG000|Overall Study|Protocol Violation|4|||
131129052|NCT00781456|472101644|FG001|Overall Study|Protocol Violation|1|||
131129053|NCT00781456|472101643|FG000|Overall Study|Noncompliance With Protocol|1|||
131129054|NCT00781456|472101644|FG001|Overall Study|Noncompliance With Protocol|1|||
131129055|NCT00781456|472101643|FG000|Overall Study|Lost to Follow-up|10|||
130972032|NCT03822533|471524910|FG001|12 Month Follow-up|Surgery|0|||
131129056|NCT00781456|472101644|FG001|Overall Study|Lost to Follow-up|5|||
131129057|NCT00781456|472101643|FG000|Overall Study|Other Reason, Unknown|0|||
131129058|NCT00781456|472101644|FG001|Overall Study|Other Reason, Unknown|1|||
131129059|NCT04091087|472101645|FG000|Overall Study|Not treated|1|||
131129060|NCT04091087|472101646|FG001|Overall Study|Not treated|0|||
131129061|NCT04091087|472101645|FG000|Overall Study|Adverse Event|4|||
130972033|NCT03822533|471524909|FG000|12 Month Follow-up|Wrong address|1|||
130972034|NCT03822533|471524910|FG001|12 Month Follow-up|Wrong address|0|||
130972035|NCT03822533|471524909|FG000|12 Month Follow-up|No symptoms|1|||
130972036|NCT03822533|471524910|FG001|12 Month Follow-up|No symptoms|0|||
131129062|NCT04091087|472101646|FG001|Overall Study|Adverse Event|4|||
131227189|NCT02257632|472459658|FG001|Overall Study|Adverse Event|2|||
131227190|NCT02038634|472459659|FG000|Overall Study|Lost to Follow-up|0|||
130716532|NCT00080938|470588873|FG000|Overall Study|Lack of Efficacy|7|||
130716533|NCT00080938|470588873|FG000|Overall Study|other disease|1|||
130716534|NCT00080938|470588873|FG000|Overall Study|Not started protocol therapy|1|||
130716535|NCT00080938|470588873|FG000|Overall Study|Ineligible|4|||
130716536|NCT00977379|470588874|FG000|Overall Study|Withdrawal by Subject|1|||
130716537|NCT00977379|470588875|FG001|Overall Study|Withdrawal by Subject|1|||
130716538|NCT00977379|470588874|FG000|Overall Study|Death|7|||
130716539|NCT00977379|470588875|FG001|Overall Study|Death|9|||
130716540|NCT00977379|470588874|FG000|Overall Study|Premature Study Termination|4|||
130716541|NCT00977379|470588875|FG001|Overall Study|Premature Study Termination|0|||
130716542|NCT00977379|470588874|FG000|Overall Study|Participant Moving House|0|||
130716543|NCT00977379|470588875|FG001|Overall Study|Participant Moving House|1|||
130716544|NCT00977379|470588874|FG000|Overall Study|Randomization Error|0|||
130716545|NCT00977379|470588875|FG001|Overall Study|Randomization Error|1|||
130716546|NCT02992418|470588883|FG000|Overall Study|Withdrawal by Subject|11|||
130716547|NCT02992418|470588884|FG001|Overall Study|Withdrawal by Subject|12|||
130716548|NCT02992418|470588883|FG000|Overall Study|Non-compliance with the protocol|308|||
130716549|NCT02992418|470588884|FG001|Overall Study|Non-compliance with the protocol|308|||
130716550|NCT02992418|470588883|FG000|Overall Study|Lost to Follow-up|27|||
130716551|NCT02992418|470588884|FG001|Overall Study|Lost to Follow-up|22|||
130972037|NCT03822533|471524909|FG000|12 Month Follow-up|Changed primary care center|0|||
130972038|NCT03822533|471524910|FG001|12 Month Follow-up|Changed primary care center|1|||
130972039|NCT02489500|471524911|FG000|Overall Study|Death|1|||
130972040|NCT02489500|471524912|FG001|Overall Study|Death|1|||
130972041|NCT01917526|471524913|FG000|Overall Study|Protocol Violation|1|||
130972042|NCT01917526|471524914|FG001|Overall Study|Protocol Violation|1|||
130972043|NCT04717596|471524915|FG000|Overall Study|Withdrawal by Subject|4|||
130972044|NCT02460991|471524917|FG000|Overall Study|Withdrawal by Subject|0|||
130972045|NCT02460991|471524918|FG001|Overall Study|Withdrawal by Subject|2|||
130972046|NCT00434057|471524919|FG000|Overall Study|Withdrawal by Subject|1|||
130972047|NCT02473952|471524921|FG000|Overall Study|Adverse Event|2|||
130972048|NCT02473952|471524922|FG001|Overall Study|Adverse Event|2|||
130972049|NCT02473952|471524921|FG000|Overall Study|Withdrawal by Subject|0|||
130972050|NCT02473952|471524922|FG001|Overall Study|Withdrawal by Subject|6|||
130972051|NCT00455195|471524923|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
130972052|NCT00455195|471524924|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
130972053|NCT00455195|471524923|FG000|Double-blind Study AGLU02704|Death|1|||
130972054|NCT00455195|471524924|FG001|Double-blind Study AGLU02704|Death|0|||
130972055|NCT00455195|471524923|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
130972056|NCT00455195|471524924|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
130972057|NCT00455195|471524923|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
130972058|NCT00455195|471524924|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
130972059|NCT02117570|471524925|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
130972060|NCT02117570|471524926|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
130972061|NCT02117570|471524927|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
130972062|NCT02117570|471524925|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
131042719|NCT03088878|471789369|FG011|Overall Study|Completed 2 years of Treatment|0|||
130972063|NCT02117570|471524926|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
130972064|NCT02117570|471524927|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
130972065|NCT02117570|471524925|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
130972066|NCT02117570|471524926|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
131042720|NCT03088878|471789370|FG012|Overall Study|Completed 2 years of Treatment|8|||
131042721|NCT03088878|471789371|FG013|Overall Study|Completed 2 years of Treatment|3|||
131042722|NCT03088878|471789358|FG000|Overall Study|Physician Decision|0|||
131042723|NCT03088878|471789359|FG001|Overall Study|Physician Decision|0|||
131042724|NCT03088878|471789360|FG002|Overall Study|Physician Decision|0|||
131042725|NCT03088878|471789361|FG003|Overall Study|Physician Decision|0|||
131042726|NCT03088878|471789362|FG004|Overall Study|Physician Decision|0|||
130972067|NCT02117570|471524927|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
131042727|NCT03088878|471789363|FG005|Overall Study|Physician Decision|0|||
131042728|NCT03088878|471789364|FG006|Overall Study|Physician Decision|0|||
131042729|NCT03088878|471789365|FG007|Overall Study|Physician Decision|2|||
131042730|NCT03088878|471789366|FG008|Overall Study|Physician Decision|1|||
131227191|NCT02038634|472459660|FG001|Overall Study|Lost to Follow-up|1|||
130716552|NCT03246126|470588889|FG000|Overall Study|Withdrawal by Subject|0|||
130716553|NCT03246126|470588890|FG001|Overall Study|Withdrawal by Subject|1|||
130716554|NCT05297578|470588900|FG000|Overall Study|Lost to Follow-up|1|||
130716555|NCT05297578|470588901|FG001|Overall Study|Lost to Follow-up|1|||
130716556|NCT05297578|470588902|FG002|Overall Study|Lost to Follow-up|2|||
130716557|NCT05297578|470588903|FG003|Overall Study|Lost to Follow-up|1|||
130716558|NCT05297578|470588900|FG000|Overall Study|Death|0|||
130775746|NCT02748057|470806560|FG001|Overall Study|Protocol Violation|1|||
131042731|NCT03088878|471789367|FG009|Overall Study|Physician Decision|0|||
130972068|NCT02117570|471524925|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
130972069|NCT02117570|471524926|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
130972070|NCT02117570|471524927|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
130972071|NCT02117570|471524925|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
130972072|NCT02117570|471524926|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
130972073|NCT02117570|471524927|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
130972074|NCT02117570|471524925|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
130972075|NCT02117570|471524926|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
130972076|NCT02117570|471524927|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
130972077|NCT02117570|471524925|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
130972078|NCT02117570|471524926|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
130972079|NCT02117570|471524927|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
130972080|NCT02148250|471524928|FG000|Screening|Withdrawal by Subject|5|||
130972081|NCT02148250|471524929|FG001|Screening|Withdrawal by Subject|0|||
130972082|NCT03701555|471524930|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
130972083|NCT03701555|471524931|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
130972084|NCT03701555|471524932|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
130972085|NCT03701555|471524933|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
130972086|NCT03701555|471524934|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
130972087|NCT03701555|471524935|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
130972088|NCT03701555|471524936|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
130972089|NCT03701555|471524937|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
130972090|NCT03701555|471524938|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
130972091|NCT03701555|471524939|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
130972092|NCT03701555|471524940|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
130972093|NCT03701555|471524941|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
130972094|NCT03701555|471524942|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
130972095|NCT03701555|471524943|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
130972096|NCT03701555|471524944|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
130972097|NCT03701555|471524945|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
130972098|NCT03701555|471524946|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
130972099|NCT03701555|471524947|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
130972100|NCT03701555|471524948|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
130972101|NCT03701555|471524949|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
130972102|NCT03701555|471524950|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
130972103|NCT03701555|471524951|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
130972104|NCT03701555|471524952|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
130972105|NCT03701555|471524953|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
130972106|NCT03701555|471524954|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
130972107|NCT03701555|471524955|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
130972108|NCT03701555|471524956|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
130972109|NCT03701555|471524957|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
130972110|NCT03701555|471524958|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
131129063|NCT04091087|472101645|FG000|Overall Study|Protocol Violation|0|||
131129064|NCT04091087|472101646|FG001|Overall Study|Protocol Violation|1|||
131129065|NCT04091087|472101645|FG000|Overall Study|Withdrawal by Subject|5|||
131129066|NCT04091087|472101646|FG001|Overall Study|Withdrawal by Subject|2|||
131129067|NCT04152161|472101647|FG000|Overall Study|Death|0|||
131129068|NCT04152161|472101648|FG001|Overall Study|Death|1|||
131129069|NCT04152161|472101647|FG000|Overall Study|Physician Decision|0|||
131129070|NCT04152161|472101648|FG001|Overall Study|Physician Decision|1|||
131129071|NCT04152161|472101647|FG000|Overall Study|Lost to Follow-up|9|||
131129072|NCT04152161|472101648|FG001|Overall Study|Lost to Follow-up|3|||
131129073|NCT04152161|472101647|FG000|Overall Study|Protocol Violation|1|||
131129074|NCT04152161|472101648|FG001|Overall Study|Protocol Violation|0|||
131129075|NCT04152161|472101647|FG000|Overall Study|Withdrawal by Subject|29|||
131129076|NCT04152161|472101648|FG001|Overall Study|Withdrawal by Subject|28|||
131129077|NCT04152161|472101647|FG000|Overall Study|Sponsor termination of study|750|||
131129078|NCT04152161|472101648|FG001|Overall Study|Sponsor termination of study|755|||
131129079|NCT04152161|472101647|FG000|Overall Study|Other|20|||
131129080|NCT04152161|472101648|FG001|Overall Study|Other|18|||
131129081|NCT03246958|472101649|FG000|Overall Study|Withdrawal by Subject|0|||
130716559|NCT05297578|470588901|FG001|Overall Study|Death|1|||
130972111|NCT03701555|471524959|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
130972112|NCT03701555|471524960|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
130972113|NCT03701555|471524961|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
130972114|NCT03701555|471524962|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
130972115|NCT03701555|471524963|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
130972116|NCT03701555|471524964|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
130972117|NCT03701555|471524965|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
130972118|NCT03701555|471524930|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
130972119|NCT03701555|471524931|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
131129082|NCT03246958|472101650|FG001|Overall Study|Withdrawal by Subject|1|||
131129083|NCT03246958|472101651|FG002|Overall Study|Withdrawal by Subject|0|||
131129084|NCT03246958|472101652|FG003|Overall Study|Withdrawal by Subject|0|||
131129085|NCT03246958|472101653|FG004|Overall Study|Withdrawal by Subject|0|||
131129086|NCT03246958|472101654|FG005|Overall Study|Withdrawal by Subject|1|||
131129087|NCT03246958|472101655|FG006|Overall Study|Withdrawal by Subject|0|||
131129088|NCT03246958|472101649|FG000|Overall Study|Progression|13|||
131129089|NCT03246958|472101650|FG001|Overall Study|Progression|9|||
131129090|NCT03246958|472101651|FG002|Overall Study|Progression|3|||
131129091|NCT03246958|472101652|FG003|Overall Study|Progression|2|||
131129092|NCT03246958|472101653|FG004|Overall Study|Progression|1|||
131129093|NCT03246958|472101654|FG005|Overall Study|Progression|2|||
131129094|NCT03246958|472101655|FG006|Overall Study|Progression|1|||
131129095|NCT03246958|472101649|FG000|Overall Study|Adverse Event|2|||
131129096|NCT03246958|472101650|FG001|Overall Study|Adverse Event|2|||
131129097|NCT03246958|472101651|FG002|Overall Study|Adverse Event|0|||
131129098|NCT03246958|472101652|FG003|Overall Study|Adverse Event|1|||
131129099|NCT03246958|472101653|FG004|Overall Study|Adverse Event|1|||
131129100|NCT03246958|472101654|FG005|Overall Study|Adverse Event|0|||
131129101|NCT03246958|472101655|FG006|Overall Study|Adverse Event|2|||
131129102|NCT03246958|472101649|FG000|Overall Study|Death|0|||
131129103|NCT03246958|472101650|FG001|Overall Study|Death|1|||
131129104|NCT03246958|472101651|FG002|Overall Study|Death|0|||
131129105|NCT03246958|472101652|FG003|Overall Study|Death|0|||
131129106|NCT03246958|472101653|FG004|Overall Study|Death|0|||
131129107|NCT03246958|472101654|FG005|Overall Study|Death|0|||
131129108|NCT03246958|472101655|FG006|Overall Study|Death|0|||
131129109|NCT03246958|472101649|FG000|Overall Study|Physician Decision|0|||
131129110|NCT03246958|472101650|FG001|Overall Study|Physician Decision|0|||
131129111|NCT03246958|472101651|FG002|Overall Study|Physician Decision|0|||
131129112|NCT03246958|472101652|FG003|Overall Study|Physician Decision|1|||
131129113|NCT03246958|472101653|FG004|Overall Study|Physician Decision|0|||
131129114|NCT03246958|472101654|FG005|Overall Study|Physician Decision|0|||
131129115|NCT03246958|472101655|FG006|Overall Study|Physician Decision|0|||
130716560|NCT05297578|470588902|FG002|Overall Study|Death|0|||
130716561|NCT05297578|470588903|FG003|Overall Study|Death|0|||
130716562|NCT05297578|470588900|FG000|Overall Study|Withdrawal by Subject|0|||
130716563|NCT05297578|470588901|FG001|Overall Study|Withdrawal by Subject|0|||
130716564|NCT05297578|470588902|FG002|Overall Study|Withdrawal by Subject|1|||
131129116|NCT03246958|472101649|FG000|Overall Study|Never start treatment|1|||
130716565|NCT05297578|470588903|FG003|Overall Study|Withdrawal by Subject|0|||
130716566|NCT02266134|470588904|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
130716567|NCT02266134|470588905|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
130716568|NCT02266134|470588906|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
130716569|NCT02266134|470588907|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
130716570|NCT02266134|470588904|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
130716571|NCT02266134|470588905|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
130716572|NCT02266134|470588906|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
130716573|NCT02266134|470588907|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
130716574|NCT02266134|470588904|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
130716575|NCT02266134|470588905|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
130716576|NCT02266134|470588906|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
130716577|NCT02266134|470588907|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
130716578|NCT02266134|470588904|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
130716579|NCT02266134|470588905|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
130716580|NCT02266134|470588906|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
130716581|NCT02266134|470588907|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
130972120|NCT03701555|471524932|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
130972121|NCT03701555|471524933|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
131129117|NCT03246958|472101650|FG001|Overall Study|Never start treatment|0|||
131129118|NCT03246958|472101651|FG002|Overall Study|Never start treatment|0|||
131129119|NCT03246958|472101652|FG003|Overall Study|Never start treatment|0|||
131129120|NCT03246958|472101653|FG004|Overall Study|Never start treatment|0|||
130716582|NCT02266134|470588904|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
130716583|NCT02266134|470588905|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
130716584|NCT02266134|470588906|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
130716585|NCT02266134|470588907|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
130716586|NCT02266134|470588904|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
130972122|NCT03701555|471524934|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
131129121|NCT03246958|472101654|FG005|Overall Study|Never start treatment|0|||
131129122|NCT03246958|472101655|FG006|Overall Study|Never start treatment|0|||
130716587|NCT02266134|470588905|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
130716588|NCT02266134|470588906|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
130972123|NCT03701555|471524935|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
131129123|NCT03246958|472101649|FG000|Overall Study|Over enrollment|0|||
131129124|NCT03246958|472101650|FG001|Overall Study|Over enrollment|2|||
131129125|NCT03246958|472101651|FG002|Overall Study|Over enrollment|0|||
131129126|NCT03246958|472101652|FG003|Overall Study|Over enrollment|0|||
131129127|NCT03246958|472101653|FG004|Overall Study|Over enrollment|0|||
131129128|NCT03246958|472101654|FG005|Overall Study|Over enrollment|0|||
131129129|NCT03246958|472101655|FG006|Overall Study|Over enrollment|0|||
131129130|NCT03703102|472101658|FG000|Overall Study|Adverse Event|4|||
131129131|NCT03703102|472101659|FG001|Overall Study|Adverse Event|3|||
131129132|NCT03703102|472101660|FG002|Overall Study|Adverse Event|7|||
131129133|NCT03703102|472101661|FG003|Overall Study|Adverse Event|3|||
131129134|NCT03703102|472101662|FG004|Overall Study|Adverse Event|13|||
131129135|NCT03703102|472101658|FG000|Overall Study|Lack of Efficacy|4|||
131129136|NCT03703102|472101659|FG001|Overall Study|Lack of Efficacy|0|||
131129137|NCT03703102|472101660|FG002|Overall Study|Lack of Efficacy|1|||
131129138|NCT03703102|472101661|FG003|Overall Study|Lack of Efficacy|4|||
131227192|NCT01664052|472459661|FG000|Phase 1|No device placement|6|||
131227193|NCT01664052|472459662|FG001|Phase 1|No device placement|0|||
131227194|NCT01664052|472459661|FG000|Phase 1|No HSG 1 hr post placement|1|||
131227195|NCT01664052|472459662|FG001|Phase 1|No HSG 1 hr post placement|0|||
131227196|NCT01664052|472459661|FG000|Phase 2|No device placement|0|||
131227197|NCT01664052|472459662|FG001|Phase 2|No device placement|4|||
131227198|NCT01084005|472459663|FG000|Overall Study|Adverse Event|1|||
131129139|NCT03703102|472101662|FG004|Overall Study|Lack of Efficacy|1|||
131129140|NCT03703102|472101658|FG000|Overall Study|Lost to Follow-up|0|||
131129141|NCT03703102|472101659|FG001|Overall Study|Lost to Follow-up|0|||
131129142|NCT03703102|472101660|FG002|Overall Study|Lost to Follow-up|1|||
131129143|NCT03703102|472101661|FG003|Overall Study|Lost to Follow-up|2|||
131129144|NCT03703102|472101662|FG004|Overall Study|Lost to Follow-up|2|||
131129145|NCT03703102|472101658|FG000|Overall Study|Physician Decision|2|||
131129146|NCT03703102|472101659|FG001|Overall Study|Physician Decision|2|||
131129147|NCT03703102|472101660|FG002|Overall Study|Physician Decision|2|||
131129148|NCT03703102|472101661|FG003|Overall Study|Physician Decision|2|||
131129149|NCT03703102|472101662|FG004|Overall Study|Physician Decision|4|||
131129150|NCT03703102|472101658|FG000|Overall Study|Withdrawal by Subject|7|||
131129151|NCT03703102|472101659|FG001|Overall Study|Withdrawal by Subject|5|||
131129152|NCT03703102|472101660|FG002|Overall Study|Withdrawal by Subject|5|||
131129153|NCT03703102|472101661|FG003|Overall Study|Withdrawal by Subject|5|||
131129154|NCT03703102|472101662|FG004|Overall Study|Withdrawal by Subject|9|||
131129155|NCT03703102|472101658|FG000|Overall Study|Ineligibility|0|||
131129156|NCT03703102|472101659|FG001|Overall Study|Ineligibility|0|||
131129157|NCT03703102|472101660|FG002|Overall Study|Ineligibility|1|||
131129158|NCT03703102|472101661|FG003|Overall Study|Ineligibility|0|||
131129159|NCT03703102|472101662|FG004|Overall Study|Ineligibility|0|||
131129160|NCT03703102|472101658|FG000|Overall Study|Protocol Deviation|4|||
131129161|NCT03703102|472101659|FG001|Overall Study|Protocol Deviation|4|||
131129162|NCT03703102|472101660|FG002|Overall Study|Protocol Deviation|3|||
131129163|NCT03703102|472101661|FG003|Overall Study|Protocol Deviation|0|||
130972124|NCT03701555|471524936|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
130972125|NCT03701555|471524937|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
130972126|NCT03701555|471524938|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
130972127|NCT03701555|471524939|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
130972128|NCT03701555|471524940|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
130972129|NCT03701555|471524941|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
130972130|NCT03701555|471524942|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
130972131|NCT03701555|471524943|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
130972132|NCT03701555|471524944|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
130972133|NCT03701555|471524945|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
130972134|NCT03701555|471524946|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
130972135|NCT03701555|471524947|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
130972136|NCT03701555|471524948|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
130972137|NCT03701555|471524949|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
130972138|NCT03701555|471524950|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
130972139|NCT03701555|471524951|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
130972140|NCT03701555|471524952|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
131129164|NCT03703102|472101662|FG004|Overall Study|Protocol Deviation|0|||
131129165|NCT03703102|472101658|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131129166|NCT03703102|472101659|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131129167|NCT03703102|472101660|FG002|Overall Study|Non-Compliance with Study Drug|2|||
131129168|NCT03703102|472101661|FG003|Overall Study|Non-Compliance with Study Drug|1|||
131227199|NCT01084005|472459664|FG001|Overall Study|Adverse Event|8|||
131227200|NCT01084005|472459663|FG000|Overall Study|Protocol Violation|3|||
131227201|NCT01084005|472459664|FG001|Overall Study|Protocol Violation|7|||
130775747|NCT02748057|470806559|FG000|Overall Study|Participant Moved|1|||
131129169|NCT03703102|472101662|FG004|Overall Study|Non-Compliance with Study Drug|4|||
130972141|NCT03701555|471524953|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
130972142|NCT03701555|471524954|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
130972143|NCT03701555|471524955|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
130972144|NCT03701555|471524956|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
130972145|NCT03701555|471524957|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
131129170|NCT00876187|472101663|FG000|Overall Study|Adverse Event|14|||
131129171|NCT00876187|472101664|FG001|Overall Study|Adverse Event|12|||
131227202|NCT01084005|472459663|FG000|Overall Study|Withdrawal by Subject|1|||
131227203|NCT01084005|472459664|FG001|Overall Study|Withdrawal by Subject|1|||
131227204|NCT00549198|472459665|FG000|Overall Study|Adverse Event|28|||
131129172|NCT00876187|472101665|FG002|Overall Study|Adverse Event|19|||
131129173|NCT00876187|472101666|FG003|Overall Study|Adverse Event|29|||
131129174|NCT00876187|472101667|FG004|Overall Study|Adverse Event|10|||
131129175|NCT00876187|472101663|FG000|Overall Study|Lack of Efficacy|59|||
131129176|NCT00876187|472101664|FG001|Overall Study|Lack of Efficacy|34|||
131129177|NCT00876187|472101665|FG002|Overall Study|Lack of Efficacy|45|||
131129178|NCT00876187|472101666|FG003|Overall Study|Lack of Efficacy|34|||
131129179|NCT00876187|472101667|FG004|Overall Study|Lack of Efficacy|59|||
131129180|NCT00876187|472101663|FG000|Overall Study|Lost to Follow-up|9|||
131129181|NCT00876187|472101664|FG001|Overall Study|Lost to Follow-up|10|||
131129182|NCT00876187|472101665|FG002|Overall Study|Lost to Follow-up|8|||
131129183|NCT00876187|472101666|FG003|Overall Study|Lost to Follow-up|8|||
131129184|NCT00876187|472101667|FG004|Overall Study|Lost to Follow-up|11|||
131129185|NCT00876187|472101663|FG000|Overall Study|Protocol Violation|6|||
131129186|NCT00876187|472101664|FG001|Overall Study|Protocol Violation|7|||
131129187|NCT00876187|472101665|FG002|Overall Study|Protocol Violation|7|||
131129188|NCT00876187|472101666|FG003|Overall Study|Protocol Violation|6|||
131129189|NCT00876187|472101667|FG004|Overall Study|Protocol Violation|3|||
131129190|NCT00876187|472101663|FG000|Overall Study|Withdrawal by Subject|16|||
131129191|NCT00876187|472101664|FG001|Overall Study|Withdrawal by Subject|26|||
131129192|NCT00876187|472101665|FG002|Overall Study|Withdrawal by Subject|32|||
131129193|NCT00876187|472101666|FG003|Overall Study|Withdrawal by Subject|38|||
131129194|NCT00876187|472101667|FG004|Overall Study|Withdrawal by Subject|37|||
131129195|NCT00876187|472101663|FG000|Overall Study|Entered extension study|101|||
131129196|NCT00876187|472101664|FG001|Overall Study|Entered extension study|120|||
131129197|NCT00876187|472101665|FG002|Overall Study|Entered extension study|156|||
131129198|NCT00876187|472101666|FG003|Overall Study|Entered extension study|151|||
131129199|NCT00876187|472101667|FG004|Overall Study|Entered extension study|144|||
131129200|NCT00876187|472101663|FG000|Overall Study|Randomized but not treated|3|||
131129201|NCT00876187|472101664|FG001|Overall Study|Randomized but not treated|1|||
131129202|NCT00876187|472101665|FG002|Overall Study|Randomized but not treated|3|||
131129203|NCT00876187|472101666|FG003|Overall Study|Randomized but not treated|2|||
131129204|NCT00876187|472101667|FG004|Overall Study|Randomized but not treated|3|||
131129205|NCT00876187|472101663|FG000|Overall Study|Other|2|||
131129206|NCT00876187|472101664|FG001|Overall Study|Other|5|||
131129207|NCT00876187|472101665|FG002|Overall Study|Other|9|||
131129208|NCT00876187|472101666|FG003|Overall Study|Other|7|||
131129209|NCT00876187|472101667|FG004|Overall Study|Other|4|||
131129210|NCT01379274|472101668|FG000|Overall Study|funding withdrawn|1|||
131129211|NCT00405067|472101669|FG000|Overall Study|Adverse Event|4|||
131129212|NCT00405067|472101670|FG001|Overall Study|Adverse Event|9|||
131129213|NCT00405067|472101671|FG002|Overall Study|Adverse Event|4|||
131129214|NCT00405067|472101669|FG000|Overall Study|Lost to Follow-up|0|||
131129215|NCT00405067|472101670|FG001|Overall Study|Lost to Follow-up|0|||
131129216|NCT00405067|472101671|FG002|Overall Study|Lost to Follow-up|1|||
131129217|NCT01650636|472101672|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
131129218|NCT01650636|472101673|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
131129219|NCT01650636|472101672|FG000|Washout up to 5 Months|Physician Decision|2|||
130972146|NCT03701555|471524958|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
130972147|NCT03701555|471524959|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
130972148|NCT03701555|471524960|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
130972149|NCT03701555|471524961|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
130972150|NCT03701555|471524962|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
130972151|NCT03701555|471524963|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
130972152|NCT03701555|471524964|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
130972153|NCT03701555|471524965|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
130972154|NCT03701555|471524930|FG000|Part 2 (Day 1)|Other|0|||
130972155|NCT03701555|471524931|FG001|Part 2 (Day 1)|Other|0|||
131129220|NCT01650636|472101673|FG001|Washout up to 5 Months|Physician Decision|2|||
131129221|NCT01650636|472101672|FG000|Washout up to 5 Months|Death|1|||
131129222|NCT01650636|472101673|FG001|Washout up to 5 Months|Death|0|||
131129223|NCT01650636|472101672|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
131129224|NCT01650636|472101673|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
131129225|NCT01650636|472101672|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
130972156|NCT03701555|471524932|FG002|Part 2 (Day 1)|Other|0|||
131129226|NCT01650636|472101673|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
130716589|NCT02266134|470588907|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
130972157|NCT03701555|471524933|FG003|Part 2 (Day 1)|Other|0|||
130972158|NCT03701555|471524934|FG004|Part 2 (Day 1)|Other|0|||
131129227|NCT01650636|472101672|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
131129228|NCT01650636|472101673|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
131129229|NCT03287219|472101675|FG000|Overall Study|Protocol Violation|0|||
131129230|NCT03287219|472101676|FG001|Overall Study|Protocol Violation|2|||
131129231|NCT03221751|472101677|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
131129232|NCT03221751|472101678|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
131129233|NCT00440947|472101679|FG000|36-Week Induction Phase|Adverse Event|16|||
131129234|NCT00440947|472101680|FG001|36-Week Induction Phase|Adverse Event|0|||
131129235|NCT00440947|472101681|FG002|36-Week Induction Phase|Adverse Event|0|||
131129236|NCT00440947|472101682|FG003|36-Week Induction Phase|Adverse Event|0|||
131129237|NCT00440947|472101683|FG004|36-Week Induction Phase|Adverse Event|0|||
131129238|NCT00440947|472101679|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
131129239|NCT00440947|472101680|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
131129240|NCT00440947|472101681|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
131129241|NCT00440947|472101682|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
131129242|NCT00440947|472101683|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
131129243|NCT00440947|472101679|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
131129244|NCT00440947|472101680|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
131129245|NCT00440947|472101681|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
131129246|NCT00440947|472101682|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
131129247|NCT00440947|472101683|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
131129248|NCT00440947|472101679|FG000|36-Week Induction Phase|Non-compliance|10|||
131129249|NCT00440947|472101680|FG001|36-Week Induction Phase|Non-compliance|0|||
131129250|NCT00440947|472101681|FG002|36-Week Induction Phase|Non-compliance|0|||
131129251|NCT00440947|472101682|FG003|36-Week Induction Phase|Non-compliance|0|||
131129252|NCT00440947|472101683|FG004|36-Week Induction Phase|Non-compliance|0|||
131129253|NCT00440947|472101679|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
131129254|NCT00440947|472101680|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
131129255|NCT00440947|472101681|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
131129256|NCT00440947|472101682|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
131129257|NCT00440947|472101683|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
131129258|NCT00440947|472101679|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
131129259|NCT00440947|472101680|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
131129260|NCT00440947|472101681|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
131129261|NCT00440947|472101682|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
131129262|NCT00440947|472101683|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
131129263|NCT00440947|472101679|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
131129264|NCT00440947|472101680|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
131129265|NCT00440947|472101681|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
131129266|NCT00440947|472101682|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
131129267|NCT00440947|472101683|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
131129268|NCT00440947|472101679|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
131129269|NCT00440947|472101680|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
131129270|NCT00440947|472101681|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
131129271|NCT00440947|472101682|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
131129272|NCT00440947|472101683|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
131129273|NCT00440947|472101679|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
131129274|NCT00440947|472101680|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
131129275|NCT00440947|472101681|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
131129276|NCT00440947|472101682|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
131129277|NCT00440947|472101683|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
131129278|NCT00440947|472101679|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
131129279|NCT00440947|472101680|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
131129280|NCT00440947|472101681|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
131129281|NCT00440947|472101682|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
131129282|NCT00440947|472101683|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
131129283|NCT00440947|472101679|FG000|36-Week Induction Phase|Incarceration|3|||
131129284|NCT00440947|472101680|FG001|36-Week Induction Phase|Incarceration|0|||
131129285|NCT00440947|472101681|FG002|36-Week Induction Phase|Incarceration|0|||
131129286|NCT00440947|472101682|FG003|36-Week Induction Phase|Incarceration|0|||
131129287|NCT00440947|472101683|FG004|36-Week Induction Phase|Incarceration|0|||
131129288|NCT00440947|472101679|FG000|36-Week Induction Phase|Pregnancy|1|||
131129289|NCT00440947|472101680|FG001|36-Week Induction Phase|Pregnancy|0|||
131129290|NCT00440947|472101681|FG002|36-Week Induction Phase|Pregnancy|0|||
130775748|NCT02748057|470806560|FG001|Overall Study|Participant Moved|0|||
130972159|NCT03701555|471524935|FG005|Part 2 (Day 1)|Other|0|||
130972160|NCT03701555|471524936|FG006|Part 2 (Day 1)|Other|0|||
130972161|NCT03701555|471524937|FG007|Part 2 (Day 1)|Other|0|||
131129291|NCT00440947|472101682|FG003|36-Week Induction Phase|Pregnancy|0|||
131129292|NCT00440947|472101683|FG004|36-Week Induction Phase|Pregnancy|0|||
131129293|NCT00440947|472101679|FG000|48-Week Randomization Phase|Adverse Event|0|||
131129294|NCT00440947|472101680|FG001|48-Week Randomization Phase|Adverse Event|2|||
130972162|NCT03701555|471524938|FG008|Part 2 (Day 1)|Other|0|||
131129295|NCT00440947|472101681|FG002|48-Week Randomization Phase|Adverse Event|5|||
131129296|NCT00440947|472101682|FG003|48-Week Randomization Phase|Adverse Event|0|||
131129297|NCT00440947|472101683|FG004|48-Week Randomization Phase|Adverse Event|0|||
131129298|NCT00440947|472101679|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
130972163|NCT03701555|471524939|FG009|Part 2 (Day 1)|Other|0|||
130972164|NCT03701555|471524940|FG010|Part 2 (Day 1)|Other|3|||
130972165|NCT03701555|471524941|FG011|Part 2 (Day 1)|Other|1|||
130972166|NCT03701555|471524942|FG012|Part 2 (Day 1)|Other|0|||
130972167|NCT03701555|471524943|FG013|Part 2 (Day 1)|Other|1|||
130972168|NCT03701555|471524944|FG014|Part 2 (Day 1)|Other|0|||
130972169|NCT03701555|471524945|FG015|Part 2 (Day 1)|Other|2|||
130972170|NCT03701555|471524946|FG016|Part 2 (Day 1)|Other|2|||
130972171|NCT03701555|471524947|FG017|Part 2 (Day 1)|Other|0|||
130972172|NCT03701555|471524948|FG018|Part 2 (Day 1)|Other|0|||
130972173|NCT03701555|471524949|FG019|Part 2 (Day 1)|Other|0|||
130972174|NCT03701555|471524950|FG020|Part 2 (Day 1)|Other|0|||
131042732|NCT03088878|471789368|FG010|Overall Study|Physician Decision|0|||
131042733|NCT03088878|471789369|FG011|Overall Study|Physician Decision|0|||
131042734|NCT03088878|471789370|FG012|Overall Study|Physician Decision|0|||
131042735|NCT03088878|471789371|FG013|Overall Study|Physician Decision|1|||
131042736|NCT03088878|471789358|FG000|Overall Study|COVID Related noncompliance|0|||
131042737|NCT03088878|471789359|FG001|Overall Study|COVID Related noncompliance|0|||
131042738|NCT03088878|471789360|FG002|Overall Study|COVID Related noncompliance|0|||
131042739|NCT03088878|471789361|FG003|Overall Study|COVID Related noncompliance|0|||
131042740|NCT03088878|471789362|FG004|Overall Study|COVID Related noncompliance|0|||
131042741|NCT03088878|471789363|FG005|Overall Study|COVID Related noncompliance|0|||
131042742|NCT03088878|471789364|FG006|Overall Study|COVID Related noncompliance|0|||
131042743|NCT03088878|471789365|FG007|Overall Study|COVID Related noncompliance|0|||
131042744|NCT03088878|471789366|FG008|Overall Study|COVID Related noncompliance|0|||
131042745|NCT03088878|471789367|FG009|Overall Study|COVID Related noncompliance|0|||
131042746|NCT03088878|471789368|FG010|Overall Study|COVID Related noncompliance|0|||
131042747|NCT03088878|471789369|FG011|Overall Study|COVID Related noncompliance|0|||
131042748|NCT03088878|471789370|FG012|Overall Study|COVID Related noncompliance|0|||
131042749|NCT03088878|471789371|FG013|Overall Study|COVID Related noncompliance|1|||
131042750|NCT03088878|471789358|FG000|Overall Study|Drug or Study Noncompliance|0|||
131042751|NCT03088878|471789359|FG001|Overall Study|Drug or Study Noncompliance|0|||
131042752|NCT03088878|471789360|FG002|Overall Study|Drug or Study Noncompliance|0|||
131042753|NCT03088878|471789361|FG003|Overall Study|Drug or Study Noncompliance|0|||
131042754|NCT03088878|471789362|FG004|Overall Study|Drug or Study Noncompliance|0|||
131042755|NCT03088878|471789363|FG005|Overall Study|Drug or Study Noncompliance|0|||
131042756|NCT03088878|471789364|FG006|Overall Study|Drug or Study Noncompliance|0|||
131042757|NCT03088878|471789365|FG007|Overall Study|Drug or Study Noncompliance|0|||
131042758|NCT03088878|471789366|FG008|Overall Study|Drug or Study Noncompliance|0|||
131042759|NCT03088878|471789367|FG009|Overall Study|Drug or Study Noncompliance|0|||
131042760|NCT03088878|471789368|FG010|Overall Study|Drug or Study Noncompliance|0|||
131129299|NCT00440947|472101680|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
131129300|NCT00440947|472101681|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
131129301|NCT00440947|472101682|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
131129302|NCT00440947|472101683|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
131129303|NCT00440947|472101679|FG000|48-Week Randomization Phase|Non-compliance|0|||
131129304|NCT00440947|472101680|FG001|48-Week Randomization Phase|Non-compliance|3|||
131129305|NCT00440947|472101681|FG002|48-Week Randomization Phase|Non-compliance|4|||
131129306|NCT00440947|472101682|FG003|48-Week Randomization Phase|Non-compliance|0|||
131129307|NCT00440947|472101683|FG004|48-Week Randomization Phase|Non-compliance|0|||
131129308|NCT00440947|472101679|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
131129309|NCT00440947|472101680|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
131129310|NCT00440947|472101681|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
131129311|NCT00440947|472101682|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
131129312|NCT00440947|472101683|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
131129313|NCT00440947|472101679|FG000|48-Week Randomization Phase|Protocol Violation|0|||
131129314|NCT00440947|472101680|FG001|48-Week Randomization Phase|Protocol Violation|0|||
131129315|NCT00440947|472101681|FG002|48-Week Randomization Phase|Protocol Violation|1|||
131129316|NCT00440947|472101682|FG003|48-Week Randomization Phase|Protocol Violation|0|||
131129317|NCT00440947|472101683|FG004|48-Week Randomization Phase|Protocol Violation|0|||
131129318|NCT00440947|472101679|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
131129319|NCT00440947|472101680|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
131129320|NCT00440947|472101681|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
131129321|NCT00440947|472101682|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
131129322|NCT00440947|472101683|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
131129323|NCT00440947|472101679|FG000|48-Week Randomization Phase|Pregnancy|0|||
131129324|NCT00440947|472101680|FG001|48-Week Randomization Phase|Pregnancy|0|||
131129325|NCT00440947|472101681|FG002|48-Week Randomization Phase|Pregnancy|1|||
131129326|NCT00440947|472101682|FG003|48-Week Randomization Phase|Pregnancy|0|||
130972175|NCT03701555|471524951|FG021|Part 2 (Day 1)|Other|0|||
131042761|NCT03088878|471789369|FG011|Overall Study|Drug or Study Noncompliance|0|||
131042762|NCT03088878|471789370|FG012|Overall Study|Drug or Study Noncompliance|1|||
131042763|NCT03088878|471789371|FG013|Overall Study|Drug or Study Noncompliance|0|||
131042764|NCT04690582|471789372|FG000|Overall Study|Withdrawal by Subject|6|||
131129327|NCT00440947|472101683|FG004|48-Week Randomization Phase|Pregnancy|0|||
131129328|NCT00440947|472101679|FG000|48-Week Randomization Phase|Incarceration|0|||
131129329|NCT00440947|472101680|FG001|48-Week Randomization Phase|Incarceration|3|||
130972176|NCT03701555|471524952|FG022|Part 2 (Day 1)|Other|0|||
130972177|NCT03701555|471524953|FG023|Part 2 (Day 1)|Other|0|||
131129330|NCT00440947|472101681|FG002|48-Week Randomization Phase|Incarceration|0|||
131129331|NCT00440947|472101682|FG003|48-Week Randomization Phase|Incarceration|0|||
131129332|NCT00440947|472101683|FG004|48-Week Randomization Phase|Incarceration|0|||
131129333|NCT00440947|472101679|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
131129334|NCT00440947|472101680|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
131129335|NCT00440947|472101681|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
131129336|NCT00440947|472101682|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
131129337|NCT00440947|472101683|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
131129338|NCT00440947|472101679|FG000|48-Week Randomization Phase|Physician Decision|0|||
131129339|NCT00440947|472101680|FG001|48-Week Randomization Phase|Physician Decision|2|||
130972178|NCT03701555|471524954|FG024|Part 2 (Day 1)|Other|0|||
130972179|NCT03701555|471524955|FG025|Part 2 (Day 1)|Other|0|||
130972180|NCT03701555|471524956|FG026|Part 2 (Day 1)|Other|0|||
130972181|NCT03701555|471524957|FG027|Part 2 (Day 1)|Other|0|||
130972182|NCT03701555|471524958|FG028|Part 2 (Day 1)|Other|0|||
130972183|NCT03701555|471524959|FG029|Part 2 (Day 1)|Other|0|||
130972184|NCT03701555|471524960|FG030|Part 2 (Day 1)|Other|0|||
130972185|NCT03701555|471524961|FG031|Part 2 (Day 1)|Other|0|||
130972186|NCT03701555|471524962|FG032|Part 2 (Day 1)|Other|0|||
130972187|NCT03701555|471524963|FG033|Part 2 (Day 1)|Other|0|||
130972188|NCT03701555|471524964|FG034|Part 2 (Day 1)|Other|0|||
130972189|NCT03701555|471524965|FG035|Part 2 (Day 1)|Other|0|||
130972190|NCT03701555|471524930|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
130972191|NCT03701555|471524931|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
130972192|NCT03701555|471524932|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
131129340|NCT00440947|472101681|FG002|48-Week Randomization Phase|Physician Decision|0|||
131129341|NCT00440947|472101682|FG003|48-Week Randomization Phase|Physician Decision|0|||
131129342|NCT00440947|472101683|FG004|48-Week Randomization Phase|Physician Decision|0|||
130972193|NCT03701555|471524933|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
130972194|NCT03701555|471524934|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
130972195|NCT03701555|471524935|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
130972196|NCT03701555|471524936|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
130972197|NCT03701555|471524937|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
130972198|NCT03701555|471524938|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
130972199|NCT03701555|471524939|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
130972200|NCT03701555|471524940|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
130972201|NCT03701555|471524941|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
130972202|NCT03701555|471524942|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
130972203|NCT03701555|471524943|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
130972204|NCT03701555|471524944|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
130972205|NCT03701555|471524945|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
130972206|NCT03701555|471524946|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
130972207|NCT03701555|471524947|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
130972208|NCT03701555|471524948|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
130972209|NCT03701555|471524949|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
130972210|NCT03701555|471524950|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
130972211|NCT03701555|471524951|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
130972212|NCT03701555|471524952|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
130972213|NCT03701555|471524953|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
130972214|NCT03701555|471524954|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
130972215|NCT03701555|471524955|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
130972216|NCT03701555|471524956|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
130972217|NCT03701555|471524957|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
130972218|NCT03701555|471524958|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
130972219|NCT03701555|471524959|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
130972220|NCT03701555|471524960|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
130716590|NCT01437943|470588908|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
131129343|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
131129344|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
131129345|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
131129346|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
131129347|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
130716591|NCT01437943|470588909|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
131129348|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
131227205|NCT00549198|472459666|FG001|Overall Study|Adverse Event|26|||
130972221|NCT03701555|471524961|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
130972222|NCT03701555|471524962|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
130972223|NCT03701555|471524963|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
130972224|NCT03701555|471524964|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
130972225|NCT03701555|471524965|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
130972226|NCT03701555|471524930|FG000|Part 3 (Day 1)|Subject Decision|0|||
130972227|NCT03701555|471524931|FG001|Part 3 (Day 1)|Subject Decision|0|||
130972228|NCT03701555|471524932|FG002|Part 3 (Day 1)|Subject Decision|0|||
130972229|NCT03701555|471524933|FG003|Part 3 (Day 1)|Subject Decision|0|||
130716592|NCT01437943|470588908|FG000|Overall Study|Subject expressed pregnancy plans|1|||
130716593|NCT01437943|470588909|FG001|Overall Study|Subject expressed pregnancy plans|0|||
130716594|NCT01437943|470588908|FG000|Overall Study|Adverse Event|2|||
130716595|NCT01437943|470588909|FG001|Overall Study|Adverse Event|0|||
130716596|NCT04740814|470588910|FG000|Overall Study|Adverse Event|3|||
130716597|NCT04740814|470588910|FG000|Overall Study|Protocol Violation|2|||
130716598|NCT04740814|470588910|FG000|Overall Study|Lost to Follow-up|2|||
130716599|NCT04740814|470588910|FG000|Overall Study|Withdrawal by Subject|3|||
130716600|NCT02500641|470588913|FG000|Overall Study|Adverse Event|0|||
130716601|NCT02500641|470588914|FG001|Overall Study|Adverse Event|2|||
130716602|NCT02500641|470588913|FG000|Overall Study|Withdrawal by Subject|4|||
130716603|NCT02500641|470588914|FG001|Overall Study|Withdrawal by Subject|5|||
130716604|NCT02500641|470588913|FG000|Overall Study|Unable to follow study procedures|3|||
130716605|NCT02500641|470588914|FG001|Overall Study|Unable to follow study procedures|2|||
130716606|NCT02500641|470588913|FG000|Overall Study|Protocol Violation|1|||
130716607|NCT02500641|470588914|FG001|Overall Study|Protocol Violation|2|||
130716608|NCT02500641|470588913|FG000|Overall Study|Lost to Follow-up|1|||
130716609|NCT02500641|470588914|FG001|Overall Study|Lost to Follow-up|0|||
130716610|NCT02500641|470588913|FG000|Overall Study|Sponsor decision|1|||
130716611|NCT02500641|470588914|FG001|Overall Study|Sponsor decision|0|||
130716612|NCT02500641|470588913|FG000|Overall Study|Non compliance to study drug|0|||
130716613|NCT02500641|470588914|FG001|Overall Study|Non compliance to study drug|1|||
130716614|NCT02331368|470588919|FG000|Overall Study|Withdrawal by Subject|3|||
130716615|NCT01763684|470588924|FG000|Overall Study|Study terminated early due to low enrollment|126|||
130716616|NCT01763684|470588925|FG001|Overall Study|Study terminated early due to low enrollment|127|||
130716617|NCT01763684|470588924|FG000|Overall Study|Study surgery not performed|7|||
130716618|NCT01763684|470588925|FG001|Overall Study|Study surgery not performed|6|||
130716619|NCT00643565|470588926|FG000|Overall Study|Death|12|||
130716620|NCT00643565|470588927|FG001|Overall Study|Death|11|||
130716621|NCT00643565|470588926|FG000|Overall Study|Withdrawal by Subject|4|||
130972230|NCT03701555|471524934|FG004|Part 3 (Day 1)|Subject Decision|0|||
130972231|NCT03701555|471524935|FG005|Part 3 (Day 1)|Subject Decision|0|||
130972232|NCT03701555|471524936|FG006|Part 3 (Day 1)|Subject Decision|0|||
130972233|NCT03701555|471524937|FG007|Part 3 (Day 1)|Subject Decision|0|||
130972234|NCT03701555|471524938|FG008|Part 3 (Day 1)|Subject Decision|0|||
130972235|NCT03701555|471524939|FG009|Part 3 (Day 1)|Subject Decision|0|||
130972236|NCT03701555|471524940|FG010|Part 3 (Day 1)|Subject Decision|0|||
130972237|NCT03701555|471524941|FG011|Part 3 (Day 1)|Subject Decision|0|||
130972238|NCT03701555|471524942|FG012|Part 3 (Day 1)|Subject Decision|0|||
130972239|NCT03701555|471524943|FG013|Part 3 (Day 1)|Subject Decision|0|||
130972240|NCT03701555|471524944|FG014|Part 3 (Day 1)|Subject Decision|0|||
130972241|NCT03701555|471524945|FG015|Part 3 (Day 1)|Subject Decision|0|||
130972242|NCT03701555|471524946|FG016|Part 3 (Day 1)|Subject Decision|0|||
130972243|NCT03701555|471524947|FG017|Part 3 (Day 1)|Subject Decision|0|||
130972244|NCT03701555|471524948|FG018|Part 3 (Day 1)|Subject Decision|0|||
130972245|NCT03701555|471524949|FG019|Part 3 (Day 1)|Subject Decision|0|||
130972246|NCT03701555|471524950|FG020|Part 3 (Day 1)|Subject Decision|0|||
130972247|NCT03701555|471524951|FG021|Part 3 (Day 1)|Subject Decision|0|||
131227206|NCT00549198|472459665|FG000|Overall Study|Insufficient Viral Load Response|4|||
131227207|NCT00549198|472459666|FG001|Overall Study|Insufficient Viral Load Response|2|||
131227208|NCT00549198|472459665|FG000|Overall Study|Protocol-defined Virological Failure|7|||
131227209|NCT00549198|472459666|FG001|Overall Study|Protocol-defined Virological Failure|0|||
131227210|NCT00549198|472459665|FG000|Overall Study|Non-compliance|2|||
131227211|NCT00549198|472459666|FG001|Overall Study|Non-compliance|4|||
131227212|NCT00549198|472459665|FG000|Overall Study|Lost to Follow-up|7|||
131227213|NCT00549198|472459666|FG001|Overall Study|Lost to Follow-up|8|||
131227214|NCT00549198|472459665|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
131227215|NCT00549198|472459666|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
131227216|NCT00549198|472459665|FG000|Overall Study|Protocol Violation|7|||
131227217|NCT00549198|472459666|FG001|Overall Study|Protocol Violation|2|||
131227218|NCT00549198|472459665|FG000|Overall Study|Investigator Decision|4|||
131227219|NCT00549198|472459666|FG001|Overall Study|Investigator Decision|3|||
131227220|NCT00549198|472459665|FG000|Overall Study|Withdrawal by Subject|7|||
131227221|NCT00549198|472459666|FG001|Overall Study|Withdrawal by Subject|7|||
131227222|NCT00549198|472459665|FG000|Overall Study|Disease Progression|1|||
130716622|NCT00643565|470588927|FG001|Overall Study|Withdrawal by Subject|1|||
130972248|NCT03701555|471524952|FG022|Part 3 (Day 1)|Subject Decision|0|||
130972249|NCT03701555|471524953|FG023|Part 3 (Day 1)|Subject Decision|0|||
130972250|NCT03701555|471524954|FG024|Part 3 (Day 1)|Subject Decision|0|||
130972251|NCT03701555|471524955|FG025|Part 3 (Day 1)|Subject Decision|0|||
131227223|NCT00549198|472459666|FG001|Overall Study|Disease Progression|0|||
131227224|NCT00549198|472459665|FG000|Overall Study|Participant Moved|2|||
130716623|NCT00643565|470588926|FG000|Overall Study|Lost to Follow-up|0|||
130716624|NCT00643565|470588927|FG001|Overall Study|Lost to Follow-up|6|||
130716625|NCT00643565|470588926|FG000|Overall Study|Other|7|||
130716626|NCT00643565|470588927|FG001|Overall Study|Other|8|||
130716627|NCT00643565|470588926|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
131129349|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
131129350|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
131129351|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
131129352|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
131129353|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
131129354|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
131129355|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
131129356|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
131129357|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
131129358|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
131129359|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
131129360|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
131129361|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
131129362|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
131129363|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
131129364|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
131129365|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
131129366|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
131129367|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
131129368|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
131129369|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
131129370|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
131129371|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
131129372|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
131129373|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
131129374|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
131129375|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
131129376|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
131129377|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
131129378|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
131129379|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
131129380|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
131129381|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
131129382|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
131129383|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
131129384|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
131129385|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
131129386|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
131129387|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
131129388|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
131129389|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
131129390|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
131129391|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
131129392|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
131129393|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
131129394|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
131129395|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
131129396|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
131129397|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
131129398|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Other|0|||
131129399|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Other|0|||
131129400|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Other|0|||
131129401|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Other|1|||
131227225|NCT00549198|472459666|FG001|Overall Study|Participant Moved|0|||
131227226|NCT00549198|472459665|FG000|Overall Study|Participant not able to perform Week 96|1|||
130972252|NCT03701555|471524956|FG026|Part 3 (Day 1)|Subject Decision|1|||
130972253|NCT03701555|471524957|FG027|Part 3 (Day 1)|Subject Decision|0|||
130972254|NCT03701555|471524958|FG028|Part 3 (Day 1)|Subject Decision|0|||
130972255|NCT03701555|471524959|FG029|Part 3 (Day 1)|Subject Decision|0|||
130972256|NCT03701555|471524960|FG030|Part 3 (Day 1)|Subject Decision|0|||
130972257|NCT03701555|471524961|FG031|Part 3 (Day 1)|Subject Decision|2|||
130972258|NCT03701555|471524962|FG032|Part 3 (Day 1)|Subject Decision|1|||
130972259|NCT03701555|471524963|FG033|Part 3 (Day 1)|Subject Decision|1|||
130972260|NCT03701555|471524964|FG034|Part 3 (Day 1)|Subject Decision|0|||
130972261|NCT03701555|471524965|FG035|Part 3 (Day 1)|Subject Decision|0|||
130972262|NCT03701555|471524930|FG000|Part 3 (Day 1)|Other|0|||
130972263|NCT03701555|471524931|FG001|Part 3 (Day 1)|Other|0|||
130972264|NCT03701555|471524932|FG002|Part 3 (Day 1)|Other|0|||
130972265|NCT03701555|471524933|FG003|Part 3 (Day 1)|Other|0|||
131129402|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Other|0|||
131129403|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
131129404|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
131129405|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
131129406|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
131129407|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
131129408|NCT00440947|472101679|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
131129409|NCT00440947|472101680|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
131129410|NCT00440947|472101681|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
131129411|NCT00440947|472101682|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
131129412|NCT00440947|472101683|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
131129413|NCT01834274|472101687|FG000|Overall Study|Study Termination|41|||
131129414|NCT01834274|472101688|FG001|Overall Study|Study Termination|38|||
131129415|NCT01834274|472101687|FG000|Overall Study|Withdrawal by Subject|1|||
131129416|NCT01834274|472101688|FG001|Overall Study|Withdrawal by Subject|1|||
131129417|NCT01834274|472101687|FG000|Overall Study|Lost to Follow-up|3|||
131129418|NCT01834274|472101688|FG001|Overall Study|Lost to Follow-up|1|||
131129419|NCT01834274|472101687|FG000|Overall Study|Other|2|||
131129420|NCT01834274|472101688|FG001|Overall Study|Other|1|||
131129421|NCT02813694|472101694|FG000|Overall Study|Physician Decision|0|||
131129422|NCT02813694|472101695|FG001|Overall Study|Physician Decision|1|||
131129423|NCT02813694|472101694|FG000|Overall Study|Withdrawal by Subject|10|||
131129424|NCT02813694|472101695|FG001|Overall Study|Withdrawal by Subject|9|||
131129425|NCT02813694|472101694|FG000|Overall Study|Lost to Follow-up|1|||
131129426|NCT02813694|472101695|FG001|Overall Study|Lost to Follow-up|1|||
131129427|NCT02813694|472101694|FG000|Overall Study|Death|3|||
131129428|NCT02813694|472101695|FG001|Overall Study|Death|3|||
131129429|NCT02813694|472101694|FG000|Overall Study|Randomized- did not receive study drug|2|||
131227227|NCT00549198|472459666|FG001|Overall Study|Participant not able to perform Week 96|0|||
130775749|NCT02748057|470806559|FG000|Overall Study|Withdrawal by Subject|1|||
130775750|NCT02748057|470806560|FG001|Overall Study|Withdrawal by Subject|0|||
130775751|NCT01990573|470806561|FG000|Overall Study|Physician Decision|0|||
130775752|NCT01990573|470806562|FG001|Overall Study|Physician Decision|0|||
130775753|NCT01990573|470806563|FG002|Overall Study|Physician Decision|1|||
130775754|NCT00524771|470806572|FG000|Overall Study|Protocol Violation|220|||
130775755|NCT00524771|470806573|FG001|Overall Study|Protocol Violation|585|||
130775756|NCT02492165|470806574|FG000|Overall Study|Withdrawal by Subject|0|||
130972266|NCT03701555|471524934|FG004|Part 3 (Day 1)|Other|0|||
130972267|NCT03701555|471524935|FG005|Part 3 (Day 1)|Other|0|||
130972268|NCT03701555|471524936|FG006|Part 3 (Day 1)|Other|0|||
130972269|NCT03701555|471524937|FG007|Part 3 (Day 1)|Other|0|||
130775757|NCT02492165|470806575|FG001|Overall Study|Withdrawal by Subject|1|||
130775758|NCT02492165|470806576|FG002|Overall Study|Withdrawal by Subject|0|||
130775759|NCT02492165|470806577|FG003|Overall Study|Withdrawal by Subject|0|||
130775760|NCT01957579|470806579|FG000|Overall Study|Withdrawal of concent|0|||
130775761|NCT01957579|470806580|FG001|Overall Study|Withdrawal of concent|1|||
130775762|NCT01957579|470806581|FG002|Overall Study|Withdrawal of concent|0|||
130775763|NCT01957579|470806582|FG003|Overall Study|Withdrawal of concent|0|||
130775764|NCT01957579|470806579|FG000|Overall Study|Death|0|||
130775765|NCT01957579|470806580|FG001|Overall Study|Death|0|||
130775766|NCT01957579|470806581|FG002|Overall Study|Death|2|||
130775767|NCT01957579|470806582|FG003|Overall Study|Death|0|||
130775768|NCT01639144|470806583|FG000|Overall Study|Withdrawal by Subject|4|||
130775769|NCT01639144|470806584|FG001|Overall Study|Withdrawal by Subject|2|||
130775770|NCT01639144|470806583|FG000|Overall Study|Physician Decision|2|||
130775771|NCT01639144|470806584|FG001|Overall Study|Physician Decision|0|||
130775772|NCT01639144|470806583|FG000|Overall Study|Met postoperative exclusion criteria|4|||
130972270|NCT03701555|471524938|FG008|Part 3 (Day 1)|Other|0|||
130972271|NCT03701555|471524939|FG009|Part 3 (Day 1)|Other|0|||
130972272|NCT03701555|471524940|FG010|Part 3 (Day 1)|Other|0|||
130972273|NCT03701555|471524941|FG011|Part 3 (Day 1)|Other|0|||
130972274|NCT03701555|471524942|FG012|Part 3 (Day 1)|Other|0|||
130775773|NCT01639144|470806584|FG001|Overall Study|Met postoperative exclusion criteria|3|||
130775774|NCT01000974|470806585|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
130972275|NCT03701555|471524943|FG013|Part 3 (Day 1)|Other|0|||
131129430|NCT02813694|472101695|FG001|Overall Study|Randomized- did not receive study drug|0|||
131129431|NCT02813694|472101694|FG000|Overall Study|Patient hospitalized|1|||
130972276|NCT03701555|471524944|FG014|Part 3 (Day 1)|Other|0|||
130972277|NCT03701555|471524945|FG015|Part 3 (Day 1)|Other|0|||
131129432|NCT02813694|472101695|FG001|Overall Study|Patient hospitalized|0|||
131129433|NCT01422915|472101698|FG000|Overall Study|Adverse Event|1|||
131129434|NCT01265797|472101699|FG000|Run-in Month|Withdrawal by Subject|0|||
130972278|NCT03701555|471524946|FG016|Part 3 (Day 1)|Other|0|||
130972279|NCT03701555|471524947|FG017|Part 3 (Day 1)|Other|0|||
130775775|NCT01000974|470806586|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
130775776|NCT01000974|470806587|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
130972280|NCT03701555|471524948|FG018|Part 3 (Day 1)|Other|0|||
131129435|NCT01265797|472101700|FG001|Run-in Month|Withdrawal by Subject|4|||
131129436|NCT01265797|472101699|FG000|Run-in Month|1st seizure during run-in month|0|||
131129437|NCT01265797|472101700|FG001|Run-in Month|1st seizure during run-in month|1|||
131129438|NCT01265797|472101699|FG000|Blinded Month|Lack of Efficacy|5|||
131129439|NCT01265797|472101700|FG001|Blinded Month|Lack of Efficacy|0|||
131129440|NCT01265797|472101699|FG000|Blinded Month|Lost to Follow-up|1|||
131129441|NCT01265797|472101700|FG001|Blinded Month|Lost to Follow-up|0|||
131129442|NCT01265797|472101699|FG000|Blinded Month|Protocol Violation|2|||
130972281|NCT03701555|471524949|FG019|Part 3 (Day 1)|Other|0|||
130972282|NCT03701555|471524950|FG020|Part 3 (Day 1)|Other|0|||
130972283|NCT03701555|471524951|FG021|Part 3 (Day 1)|Other|0|||
130972284|NCT03701555|471524952|FG022|Part 3 (Day 1)|Other|0|||
130972285|NCT03701555|471524953|FG023|Part 3 (Day 1)|Other|0|||
130972286|NCT03701555|471524954|FG024|Part 3 (Day 1)|Other|1|||
130972287|NCT03701555|471524955|FG025|Part 3 (Day 1)|Other|1|||
130972288|NCT03701555|471524956|FG026|Part 3 (Day 1)|Other|0|||
130972289|NCT03701555|471524957|FG027|Part 3 (Day 1)|Other|0|||
130972290|NCT03701555|471524958|FG028|Part 3 (Day 1)|Other|0|||
130972291|NCT03701555|471524959|FG029|Part 3 (Day 1)|Other|1|||
130972292|NCT03701555|471524960|FG030|Part 3 (Day 1)|Other|1|||
130972293|NCT03701555|471524961|FG031|Part 3 (Day 1)|Other|0|||
130972294|NCT03701555|471524962|FG032|Part 3 (Day 1)|Other|1|||
130972295|NCT03701555|471524963|FG033|Part 3 (Day 1)|Other|1|||
131129443|NCT01265797|472101700|FG001|Blinded Month|Protocol Violation|1|||
131129444|NCT01265797|472101699|FG000|Blinded Month|Adverse Event|2|||
131129445|NCT01265797|472101700|FG001|Blinded Month|Adverse Event|0|||
131129446|NCT01265797|472101699|FG000|Blinded Month|Diary data incomplete|0|||
131129447|NCT01265797|472101700|FG001|Blinded Month|Diary data incomplete|1|||
131129448|NCT01265797|472101699|FG000|Open Label Month|Lost to Follow-up|0|||
131129449|NCT01265797|472101700|FG001|Open Label Month|Lost to Follow-up|1|||
131129450|NCT00606320|472101701|FG000|Overall Study|Adverse Event|3|||
131129451|NCT00606320|472101701|FG000|Overall Study|Lack of Efficacy|5|||
131129452|NCT00606320|472101701|FG000|Overall Study|Physician Decision|7|||
131129453|NCT00606320|472101701|FG000|Overall Study|Protocol Violation|8|||
131129454|NCT00606320|472101701|FG000|Overall Study|Withdrawal by Subject|10|||
131129455|NCT00606320|472101701|FG000|Overall Study|Progression to depressive phase|4|||
131129456|NCT01152021|472101702|FG000|Overall Study|Adverse Event|4|||
131129457|NCT01152021|472101703|FG001|Overall Study|Adverse Event|4|||
131129458|NCT01152021|472101702|FG000|Overall Study|Study drug had expired|1|||
131129459|NCT01152021|472101703|FG001|Overall Study|Study drug had expired|0|||
130716628|NCT00643565|470588927|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
130716629|NCT00643565|470588926|FG000|Overall Study|Recurrence of Disease|2|||
130716630|NCT00643565|470588927|FG001|Overall Study|Recurrence of Disease|1|||
130716631|NCT00643565|470588926|FG000|Overall Study|Progression of Disease|18|||
130716632|NCT00643565|470588927|FG001|Overall Study|Progression of Disease|14|||
130716633|NCT00643565|470588926|FG000|Overall Study|Protocol Violation|3|||
130716634|NCT00643565|470588927|FG001|Overall Study|Protocol Violation|0|||
130716635|NCT00643565|470588926|FG000|Overall Study|Did Not Cooperate|0|||
130716636|NCT00643565|470588927|FG001|Overall Study|Did Not Cooperate|1|||
130716637|NCT00643565|470588926|FG000|Overall Study|Administrative|22|||
130716638|NCT00643565|470588927|FG001|Overall Study|Administrative|16|||
130716639|NCT00643565|470588926|FG000|Overall Study|Adverse Event|5|||
130716640|NCT00643565|470588927|FG001|Overall Study|Adverse Event|8|||
130716641|NCT02317614|470588928|FG000|Overall Study|Lost to Follow-up|1|||
130716642|NCT02317614|470588929|FG001|Overall Study|Lost to Follow-up|1|||
130716643|NCT02317614|470588928|FG000|Overall Study|Withdrawal by Subject|1|||
130716644|NCT02317614|470588929|FG001|Overall Study|Withdrawal by Subject|0|||
130716645|NCT02317614|470588928|FG000|Overall Study|Death|1|||
130716646|NCT02317614|470588929|FG001|Overall Study|Death|1|||
130716647|NCT00669071|470588934|FG000|Overall Study|Lost to Follow-up|3|||
130716648|NCT00669071|470588934|FG000|Overall Study|Final visit 40 days out of window|1|||
130716649|NCT06077487|470590886|FG000|Overall Study|Withdrawal by Subject|0|||
130716650|NCT06077487|470590887|FG001|Overall Study|Withdrawal by Subject|1|||
130716651|NCT00759902|470590889|FG000|Overall Study|Adverse Event|0|||
130716652|NCT00759902|470590890|FG001|Overall Study|Adverse Event|1|||
131129460|NCT01152021|472101702|FG000|Overall Study|Physician Decision|1|||
130716653|NCT02128217|470590893|FG000|Overall Study|Lost to Follow-up|0|||
130716654|NCT02128217|470590894|FG001|Overall Study|Lost to Follow-up|1|||
130972296|NCT03701555|471524964|FG034|Part 3 (Day 1)|Other|0|||
130972297|NCT03701555|471524965|FG035|Part 3 (Day 1)|Other|0|||
130972298|NCT02370602|471524968|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
131129461|NCT01152021|472101703|FG001|Overall Study|Physician Decision|1|||
131129462|NCT01152021|472101702|FG000|Overall Study|No access to study drug in Pharmacy|0|||
130716655|NCT05071313|470590895|FG000|Overall Study|Lost to Follow-up|17|||
130716656|NCT05071313|470590896|FG001|Overall Study|Lost to Follow-up|10|||
130972299|NCT02370602|471524969|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
131129463|NCT01152021|472101703|FG001|Overall Study|No access to study drug in Pharmacy|1|||
131129464|NCT02595723|472101704|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
130716657|NCT05071313|470590895|FG000|Overall Study|Physician Decision|1|||
130972300|NCT02370602|471524970|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131129465|NCT02595723|472101705|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
131129466|NCT02595723|472101706|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
131129467|NCT02595723|472101704|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
131129468|NCT02595723|472101705|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
131129469|NCT02595723|472101706|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
131129470|NCT04839380|472101707|FG000|Overall Study|Withdrawal by Subject|2|||
131129471|NCT04839380|472101707|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
131129472|NCT01087905|472101708|FG000|Overall Study|Lost to Follow-up|24|||
131129473|NCT01087905|472101709|FG001|Overall Study|Lost to Follow-up|28|||
131129474|NCT01087905|472101710|FG002|Overall Study|Lost to Follow-up|18|||
131129475|NCT01087905|472101711|FG003|Overall Study|Lost to Follow-up|31|||
131129476|NCT01087905|472101712|FG004|Overall Study|Lost to Follow-up|27|||
131129477|NCT01087905|472101713|FG005|Overall Study|Lost to Follow-up|25|||
131129478|NCT01087905|472101714|FG006|Overall Study|Lost to Follow-up|20|||
131129479|NCT01087905|472101715|FG007|Overall Study|Lost to Follow-up|24|||
131129480|NCT01087905|472101708|FG000|Overall Study|Withdrawal by Subject|5|||
131129481|NCT01087905|472101709|FG001|Overall Study|Withdrawal by Subject|4|||
131129482|NCT01087905|472101710|FG002|Overall Study|Withdrawal by Subject|4|||
131129483|NCT01087905|472101711|FG003|Overall Study|Withdrawal by Subject|5|||
131129484|NCT01087905|472101712|FG004|Overall Study|Withdrawal by Subject|4|||
131129485|NCT01087905|472101713|FG005|Overall Study|Withdrawal by Subject|3|||
131129486|NCT01087905|472101714|FG006|Overall Study|Withdrawal by Subject|3|||
131129487|NCT01087905|472101715|FG007|Overall Study|Withdrawal by Subject|5|||
131129488|NCT01347554|472101716|FG000|Overall Study|Lack of Efficacy|7|||
131129489|NCT01347554|472101717|FG001|Overall Study|Lack of Efficacy|11|||
131129490|NCT00004259|472101719|FG000|Overall Study|Protocol Violation|1|||
131129491|NCT00004259|472101720|FG001|Overall Study|Protocol Violation|2|||
131129492|NCT00004259|472101721|FG002|Overall Study|Protocol Violation|0|||
131129493|NCT00004259|472101722|FG003|Overall Study|Protocol Violation|0|||
131129494|NCT00004259|472101719|FG000|Overall Study|Withdrawal by Subject|0|||
131129495|NCT00004259|472101720|FG001|Overall Study|Withdrawal by Subject|2|||
131129496|NCT00004259|472101721|FG002|Overall Study|Withdrawal by Subject|0|||
131129497|NCT00004259|472101722|FG003|Overall Study|Withdrawal by Subject|0|||
131129498|NCT00996944|472101723|FG000|Double-blind Treatment Period|Adverse Event|2|||
131129499|NCT00996944|472101724|FG001|Double-blind Treatment Period|Adverse Event|1|||
131129500|NCT00996944|472101723|FG000|Double-blind Treatment Period|Protocol Violation|1|||
131129501|NCT00996944|472101724|FG001|Double-blind Treatment Period|Protocol Violation|0|||
131129502|NCT00996944|472101723|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
131129503|NCT00996944|472101724|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
131129504|NCT00996944|472101723|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
131129505|NCT00996944|472101724|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
131129506|NCT00996944|472101723|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
131129507|NCT00996944|472101724|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
131129508|NCT00769184|472101725|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
131129509|NCT00769184|472101726|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
131129510|NCT00769184|472101725|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
131129511|NCT00769184|472101726|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
131129512|NCT00769184|472101725|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
131129513|NCT00769184|472101726|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
131129514|NCT00385255|472101727|FG000|Overall Study|Serious Adverse Event|1|||
131129515|NCT00385255|472101728|FG001|Overall Study|Serious Adverse Event|2|||
131129516|NCT00385255|472101727|FG000|Overall Study|Protocol Violation|0|||
131129517|NCT00385255|472101728|FG001|Overall Study|Protocol Violation|4|||
131129518|NCT00385255|472101727|FG000|Overall Study|Withdrawal by Subject|0|||
131129519|NCT00385255|472101728|FG001|Overall Study|Withdrawal by Subject|8|||
131129520|NCT00385255|472101727|FG000|Overall Study|Migrated/moved from study area|0|||
131129521|NCT00385255|472101728|FG001|Overall Study|Migrated/moved from study area|1|||
131227228|NCT00549198|472459665|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
131227229|NCT00549198|472459666|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
131227230|NCT00549198|472459665|FG000|Overall Study|Prohibited Medication|1|||
130716658|NCT05071313|470590896|FG001|Overall Study|Physician Decision|6|||
130716659|NCT05071313|470590895|FG000|Overall Study|Death|1|||
130716660|NCT05071313|470590896|FG001|Overall Study|Death|0|||
130716661|NCT05071313|470590895|FG000|Overall Study|Withdrawal by Subject|10|||
130716662|NCT05071313|470590896|FG001|Overall Study|Withdrawal by Subject|15|||
130716663|NCT05071313|470590895|FG000|Overall Study|Other|1|||
130716664|NCT05071313|470590896|FG001|Overall Study|Other|0|||
130716665|NCT05071313|470590895|FG000|Overall Study|Randomized but not vaccinated|4|||
130716666|NCT05071313|470590896|FG001|Overall Study|Randomized but not vaccinated|2|||
130716667|NCT03107026|470590897|FG000|Overall Study|Adverse Event|2|||
130716668|NCT03107026|470590898|FG001|Overall Study|Adverse Event|14|||
130716669|NCT03107026|470590899|FG002|Overall Study|Adverse Event|23|||
130716670|NCT03107026|470590897|FG000|Overall Study|Lost to Follow-up|12|||
130716671|NCT03107026|470590898|FG001|Overall Study|Lost to Follow-up|12|||
131129522|NCT00385255|472101727|FG000|Overall Study|Lost to Follow-up|20|||
131129523|NCT00385255|472101728|FG001|Overall Study|Lost to Follow-up|58|||
131129524|NCT02443883|472101729|FG000|Overall Study|Adverse Event|0|||
131129525|NCT02443883|472101730|FG001|Overall Study|Adverse Event|1|||
131129526|NCT02443883|472101731|FG002|Overall Study|Adverse Event|0|||
131129527|NCT02443883|472101732|FG003|Overall Study|Adverse Event|0|||
131129528|NCT02443883|472101729|FG000|Overall Study|Lost to Follow-up|3|||
131129529|NCT02443883|472101730|FG001|Overall Study|Lost to Follow-up|2|||
131129530|NCT02443883|472101731|FG002|Overall Study|Lost to Follow-up|1|||
131129531|NCT02443883|472101732|FG003|Overall Study|Lost to Follow-up|0|||
131129532|NCT02443883|472101729|FG000|Overall Study|Physician Decision|1|||
131129533|NCT02443883|472101730|FG001|Overall Study|Physician Decision|1|||
131129534|NCT02443883|472101731|FG002|Overall Study|Physician Decision|0|||
130972301|NCT02370602|471524971|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
130972302|NCT02370602|471524972|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
130972303|NCT02370602|471524973|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
130972304|NCT03349710|471524974|FG000|Treatment Period|Death|0|||
130972305|NCT03349710|471524975|FG001|Treatment Period|Death|0|||
130972306|NCT03349710|471524976|FG002|Treatment Period|Death|1|||
131129535|NCT02443883|472101732|FG003|Overall Study|Physician Decision|3|||
131129536|NCT02443883|472101729|FG000|Overall Study|Withdrawal by Subject|1|||
131129537|NCT02443883|472101730|FG001|Overall Study|Withdrawal by Subject|0|||
131129538|NCT02443883|472101731|FG002|Overall Study|Withdrawal by Subject|0|||
131129539|NCT02443883|472101732|FG003|Overall Study|Withdrawal by Subject|2|||
131129540|NCT02443883|472101729|FG000|Overall Study|Randomized, but never treated|1|||
131129541|NCT02443883|472101730|FG001|Overall Study|Randomized, but never treated|0|||
131129542|NCT02443883|472101731|FG002|Overall Study|Randomized, but never treated|0|||
131129543|NCT02443883|472101732|FG003|Overall Study|Randomized, but never treated|0|||
131129544|NCT02937818|472101733|FG000|Overall Study|Participants decision|2|||
131129545|NCT02937818|472101734|FG001|Overall Study|Participants decision|1|||
131129546|NCT02937818|472101735|FG002|Overall Study|Participants decision|1|||
131129547|NCT02937818|472101736|FG003|Overall Study|Participants decision|1|||
131129548|NCT02937818|472101733|FG000|Overall Study|Adverse Event|2|||
131129549|NCT02937818|472101734|FG001|Overall Study|Adverse Event|4|||
131129550|NCT02937818|472101735|FG002|Overall Study|Adverse Event|1|||
131129551|NCT02937818|472101736|FG003|Overall Study|Adverse Event|1|||
131129552|NCT02937818|472101733|FG000|Overall Study|Disease progression|17|||
131129553|NCT02937818|472101734|FG001|Overall Study|Disease progression|15|||
131129554|NCT02937818|472101735|FG002|Overall Study|Disease progression|7|||
131129555|NCT02937818|472101736|FG003|Overall Study|Disease progression|19|||
131129556|NCT02937818|472101733|FG000|Overall Study|Condition under investigation worsened|0|||
131129557|NCT02937818|472101734|FG001|Overall Study|Condition under investigation worsened|0|||
131129558|NCT02937818|472101735|FG002|Overall Study|Condition under investigation worsened|1|||
131129559|NCT02937818|472101736|FG003|Overall Study|Condition under investigation worsened|0|||
131129560|NCT00205855|472101745|FG000|Overall Study|Only received temporary implants|16|||
131129561|NCT00205855|472101745|FG000|Overall Study|Withdrawal by Subject|5|||
131129562|NCT00506883|472101750|FG000|Overall Study|Lost to Follow-up|1|||
131129563|NCT00506883|472101751|FG001|Overall Study|Lost to Follow-up|1|||
131129564|NCT00506883|472101752|FG002|Overall Study|Lost to Follow-up|1|||
131129565|NCT00506883|472101750|FG000|Overall Study|Withdrawal by Subject|1|||
131129566|NCT00506883|472101751|FG001|Overall Study|Withdrawal by Subject|0|||
131129567|NCT00506883|472101752|FG002|Overall Study|Withdrawal by Subject|1|||
131129568|NCT00506883|472101750|FG000|Overall Study|Lack of Efficacy|0|||
131129569|NCT00506883|472101751|FG001|Overall Study|Lack of Efficacy|1|||
131129570|NCT00506883|472101752|FG002|Overall Study|Lack of Efficacy|1|||
131129571|NCT00506883|472101750|FG000|Overall Study|Other|5|||
131129572|NCT00506883|472101751|FG001|Overall Study|Other|1|||
131129573|NCT00506883|472101752|FG002|Overall Study|Other|1|||
131129574|NCT01445951|472101753|FG000|Overall Study|Adverse Event|16|||
131129575|NCT01445951|472101754|FG001|Overall Study|Adverse Event|9|||
131129576|NCT01445951|472101755|FG002|Overall Study|Adverse Event|0|||
131129577|NCT01445951|472101753|FG000|Overall Study|Protocol Violation|2|||
130775777|NCT01000974|470806585|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
130972307|NCT03349710|471524977|FG003|Treatment Period|Death|0|||
130972308|NCT03349710|471524974|FG000|Treatment Period|Disease Progression|0|||
131129578|NCT01445951|472101754|FG001|Overall Study|Protocol Violation|2|||
131129579|NCT01445951|472101755|FG002|Overall Study|Protocol Violation|2|||
131129580|NCT01445951|472101753|FG000|Overall Study|Withdrawal by Subject|21|||
130972309|NCT03349710|471524975|FG001|Treatment Period|Disease Progression|2|||
131129581|NCT01445951|472101754|FG001|Overall Study|Withdrawal by Subject|16|||
131129582|NCT01445951|472101755|FG002|Overall Study|Withdrawal by Subject|8|||
131129583|NCT01445951|472101753|FG000|Overall Study|Physician Decision|3|||
131129584|NCT01445951|472101754|FG001|Overall Study|Physician Decision|1|||
131129585|NCT01445951|472101755|FG002|Overall Study|Physician Decision|0|||
131129586|NCT01445951|472101753|FG000|Overall Study|Lost to Follow-up|1|||
131129587|NCT01445951|472101754|FG001|Overall Study|Lost to Follow-up|2|||
130775778|NCT01000974|470806586|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
131129588|NCT01445951|472101755|FG002|Overall Study|Lost to Follow-up|4|||
131129589|NCT01445951|472101753|FG000|Overall Study|Pregnancy|0|||
131129590|NCT01445951|472101754|FG001|Overall Study|Pregnancy|1|||
131129591|NCT01445951|472101755|FG002|Overall Study|Pregnancy|4|||
131129592|NCT01445951|472101753|FG000|Overall Study|Death|0|||
131129593|NCT01445951|472101754|FG001|Overall Study|Death|0|||
131129594|NCT01445951|472101755|FG002|Overall Study|Death|1|||
131129595|NCT01445951|472101753|FG000|Overall Study|Non-compliance with study drug|1|||
131129596|NCT01445951|472101754|FG001|Overall Study|Non-compliance with study drug|2|||
131129597|NCT01445951|472101755|FG002|Overall Study|Non-compliance with study drug|0|||
131129598|NCT01445951|472101753|FG000|Overall Study|Non-compliance with protocol|0|||
131129599|NCT01445951|472101754|FG001|Overall Study|Non-compliance with protocol|1|||
131129600|NCT01445951|472101755|FG002|Overall Study|Non-compliance with protocol|0|||
131129601|NCT01445951|472101753|FG000|Overall Study|Sponsor decision - subject travel|0|||
131129602|NCT01445951|472101754|FG001|Overall Study|Sponsor decision - subject travel|1|||
131129603|NCT01445951|472101755|FG002|Overall Study|Sponsor decision - subject travel|0|||
131129604|NCT01445951|472101753|FG000|Overall Study|Cough|0|||
131129605|NCT01445951|472101754|FG001|Overall Study|Cough|1|||
131129606|NCT01445951|472101755|FG002|Overall Study|Cough|0|||
131129607|NCT05513625|472101756|FG000|Overall Study|Withdrawal by Subject|1|||
131129608|NCT01015768|472101757|FG000|Overall Study|Some subject data unuseable|4|||
131129609|NCT01015768|472101758|FG001|Overall Study|Some subject data unuseable|4|||
131129610|NCT01627860|472101759|FG000|Overall Study|Adverse Event|9|||
131129611|NCT01627860|472101760|FG001|Overall Study|Adverse Event|4|||
131129612|NCT01627860|472101759|FG000|Overall Study|Withdrawal by Subject|2|||
131129613|NCT01627860|472101760|FG001|Overall Study|Withdrawal by Subject|1|||
131129614|NCT01627860|472101759|FG000|Overall Study|Seizure frequency doubled|0|||
131129615|NCT01627860|472101760|FG001|Overall Study|Seizure frequency doubled|1|||
131129616|NCT01627860|472101759|FG000|Overall Study|Protocol Violation|1|||
131129617|NCT01627860|472101760|FG001|Overall Study|Protocol Violation|0|||
131129618|NCT00677014|472101766|FG000|Overall Study|Lost to Follow-up|20|||
131129619|NCT00677014|472101767|FG001|Overall Study|Lost to Follow-up|12|||
131129620|NCT00677014|472101768|FG002|Overall Study|Lost to Follow-up|24|||
131129621|NCT00677014|472101766|FG000|Overall Study|Death|6|||
131129622|NCT00677014|472101767|FG001|Overall Study|Death|15|||
131129623|NCT00677014|472101768|FG002|Overall Study|Death|7|||
131129624|NCT00677014|472101766|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
131129625|NCT00677014|472101767|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
131129626|NCT00677014|472101768|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
131129627|NCT00640328|472101769|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
131129628|NCT00640328|472101770|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
131129629|NCT00640328|472101771|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
131129630|NCT00640328|472101772|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
131129631|NCT00640328|472101773|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
131129632|NCT00640328|472101774|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
131129633|NCT00640328|472101769|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
131129634|NCT00640328|472101770|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
131129635|NCT00640328|472101771|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
131129636|NCT00640328|472101772|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
131129637|NCT00640328|472101773|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
131129638|NCT00640328|472101774|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
131129639|NCT00640328|472101769|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
131129640|NCT00640328|472101770|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
131129641|NCT00640328|472101771|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
131129642|NCT00640328|472101772|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
131129643|NCT00640328|472101773|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
131129644|NCT00640328|472101774|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
131129645|NCT00640328|472101769|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
131129646|NCT00640328|472101770|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
131129647|NCT00640328|472101771|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
131129648|NCT00640328|472101772|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
131129649|NCT00640328|472101773|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
131129650|NCT00640328|472101774|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
131129651|NCT02374099|472101775|FG000|Overall Study|Adverse Event|1|||
131129652|NCT02374099|472101776|FG001|Overall Study|Adverse Event|0|||
131129653|NCT02374099|472101775|FG000|Overall Study|Progressive Disease|35|||
130972310|NCT03349710|471524976|FG002|Treatment Period|Disease Progression|0|||
130972311|NCT03349710|471524977|FG003|Treatment Period|Disease Progression|1|||
130972312|NCT03349710|471524974|FG000|Treatment Period|Study Drug Toxicity|1|||
131129654|NCT02374099|472101776|FG001|Overall Study|Progressive Disease|40|||
130972313|NCT03349710|471524975|FG001|Treatment Period|Study Drug Toxicity|0|||
130972314|NCT03349710|471524976|FG002|Treatment Period|Study Drug Toxicity|1|||
131129655|NCT02374099|472101775|FG000|Overall Study|Withdrawal by Subject|5|||
131129656|NCT02374099|472101776|FG001|Overall Study|Withdrawal by Subject|1|||
131129657|NCT02374099|472101775|FG000|Overall Study|Miscellaneous|2|||
131129658|NCT02374099|472101776|FG001|Overall Study|Miscellaneous|3|||
131129659|NCT02374099|472101775|FG000|Overall Study|Randomized, but not treated|2|||
131129660|NCT02374099|472101776|FG001|Overall Study|Randomized, but not treated|1|||
131129661|NCT02374099|472101775|FG000|Overall Study|Study Terminated by Sponsor|3|||
131227231|NCT00549198|472459666|FG001|Overall Study|Prohibited Medication|2|||
131227232|NCT00549198|472459665|FG000|Overall Study|Participant planning pregnancy|1|||
131227233|NCT00549198|472459666|FG001|Overall Study|Participant planning pregnancy|0|||
131227234|NCT00549198|472459665|FG000|Overall Study|Participant overweight, no scan possible|1|||
131227235|NCT00549198|472459666|FG001|Overall Study|Participant overweight, no scan possible|0|||
131227236|NCT00549198|472459665|FG000|Overall Study|No scan facilities|0|||
131227237|NCT00549198|472459666|FG001|Overall Study|No scan facilities|2|||
131227238|NCT00549198|472459665|FG000|Overall Study|Pregnancy|0|||
131227239|NCT00549198|472459666|FG001|Overall Study|Pregnancy|3|||
131227240|NCT00549198|472459665|FG000|Overall Study|Not Exposed to Study Drug|3|||
131227241|NCT00549198|472459666|FG001|Overall Study|Not Exposed to Study Drug|4|||
131227242|NCT01381900|472459667|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
131227243|NCT01381900|472459668|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
131227244|NCT01381900|472459669|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
131227245|NCT01381900|472459667|FG000|Overall Study|Adverse Event|4|||
131227246|NCT01381900|472459668|FG001|Overall Study|Adverse Event|6|||
131227247|NCT01381900|472459669|FG002|Overall Study|Adverse Event|7|||
131227248|NCT01381900|472459667|FG000|Overall Study|Noncompliance with study drug|0|||
131227249|NCT01381900|472459668|FG001|Overall Study|Noncompliance with study drug|0|||
131227250|NCT01381900|472459669|FG002|Overall Study|Noncompliance with study drug|1|||
131227251|NCT01381900|472459667|FG000|Overall Study|Physician Decision|0|||
131227252|NCT01381900|472459668|FG001|Overall Study|Physician Decision|1|||
131227253|NCT01381900|472459669|FG002|Overall Study|Physician Decision|1|||
131227254|NCT01381900|472459667|FG000|Overall Study|Protocol Violation|0|||
131227255|NCT01381900|472459668|FG001|Overall Study|Protocol Violation|1|||
131227256|NCT01381900|472459669|FG002|Overall Study|Protocol Violation|1|||
131227257|NCT01381900|472459667|FG000|Overall Study|Withdrawal by Subject|0|||
131227258|NCT01381900|472459668|FG001|Overall Study|Withdrawal by Subject|0|||
131227259|NCT01381900|472459669|FG002|Overall Study|Withdrawal by Subject|1|||
130716672|NCT03107026|470590899|FG002|Overall Study|Lost to Follow-up|13|||
131129662|NCT02374099|472101776|FG001|Overall Study|Study Terminated by Sponsor|4|||
130972315|NCT03349710|471524977|FG003|Treatment Period|Study Drug Toxicity|1|||
130972316|NCT03349710|471524974|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
130972317|NCT03349710|471524975|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
130972318|NCT03349710|471524976|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
130972319|NCT03349710|471524977|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
130972320|NCT03349710|471524974|FG000|Treatment Period|admin reason by sponsor|0|||
130972321|NCT03349710|471524975|FG001|Treatment Period|admin reason by sponsor|7|||
130972322|NCT03349710|471524976|FG002|Treatment Period|admin reason by sponsor|0|||
130972323|NCT03349710|471524977|FG003|Treatment Period|admin reason by sponsor|19|||
131129663|NCT01326546|472101777|FG000|Overall Study|Lost to Follow-up|8|||
131129664|NCT01326546|472101778|FG001|Overall Study|Lost to Follow-up|7|||
131129665|NCT01326546|472101777|FG000|Overall Study|Protocol Violation|3|||
131129666|NCT01326546|472101778|FG001|Overall Study|Protocol Violation|4|||
131129667|NCT01326546|472101777|FG000|Overall Study|Pregnancy|0|||
131129668|NCT01326546|472101778|FG001|Overall Study|Pregnancy|1|||
130716673|NCT03107026|470590897|FG000|Overall Study|Protocol Violation|1|||
130972324|NCT03349710|471524974|FG000|Treatment Period|Other Reason|2|||
130972325|NCT03349710|471524975|FG001|Treatment Period|Other Reason|0|||
130972326|NCT03349710|471524976|FG002|Treatment Period|Other Reason|2|||
130972327|NCT03349710|471524977|FG003|Treatment Period|Other Reason|1|||
130972328|NCT03349710|471524974|FG000|Treatment Period|completed|6|||
130972329|NCT03349710|471524975|FG001|Treatment Period|completed|0|||
131129669|NCT01326546|472101777|FG000|Overall Study|Adverse Event|1|||
131129670|NCT01326546|472101778|FG001|Overall Study|Adverse Event|0|||
131129671|NCT01326546|472101777|FG000|Overall Study|Withdrawal by Subject|5|||
130716674|NCT03107026|470590898|FG001|Overall Study|Protocol Violation|2|||
131129672|NCT01326546|472101778|FG001|Overall Study|Withdrawal by Subject|1|||
130716675|NCT03107026|470590899|FG002|Overall Study|Protocol Violation|0|||
130716676|NCT03107026|470590897|FG000|Overall Study|Pregnancy|1|||
130716677|NCT03107026|470590898|FG001|Overall Study|Pregnancy|0|||
130972330|NCT03349710|471524976|FG002|Treatment Period|completed|18|||
130972331|NCT03349710|471524977|FG003|Treatment Period|completed|1|||
130972332|NCT03349710|471524974|FG000|Treatment Period|participant request to discontinue|0|||
131129673|NCT04294719|472101779|FG000|Overall Study|Withdrawal by Subject|1|||
131129674|NCT00081159|472101780|FG000|Overall Study|Withdrawal by Subject|0|||
131129675|NCT00081159|472101781|FG001|Overall Study|Withdrawal by Subject|3|||
131227260|NCT01381900|472459667|FG000|Overall Study|Early withdraw|3|||
130716678|NCT03107026|470590899|FG002|Overall Study|Pregnancy|0|||
131227261|NCT01381900|472459668|FG001|Overall Study|Early withdraw|1|||
131129676|NCT00081159|472101780|FG000|Overall Study|Myelosuppression prior to treatment|0|||
131129677|NCT00081159|472101781|FG001|Overall Study|Myelosuppression prior to treatment|1|||
131129678|NCT00081159|472101780|FG000|Overall Study|Lost to Follow-up|2|||
131129679|NCT00081159|472101781|FG001|Overall Study|Lost to Follow-up|1|||
131129680|NCT01714687|472101784|FG000|Overall Study|Withdrawal by Subject|1|||
131129681|NCT01714687|472101785|FG001|Overall Study|Withdrawal by Subject|0|||
131129682|NCT01714687|472101784|FG000|Overall Study|Lost to Follow-up|2|||
131129683|NCT01714687|472101785|FG001|Overall Study|Lost to Follow-up|4|||
131129684|NCT01553136|472101786|FG000|Overall Study|Adverse Event|3|||
131129685|NCT01553136|472101787|FG001|Overall Study|Adverse Event|2|||
131129686|NCT01553136|472101786|FG000|Overall Study|Withdrawal by Subject|2|||
131129687|NCT01553136|472101787|FG001|Overall Study|Withdrawal by Subject|3|||
131129688|NCT01553136|472101786|FG000|Overall Study|Lost to Follow-up|4|||
131129689|NCT01553136|472101787|FG001|Overall Study|Lost to Follow-up|10|||
131129690|NCT01553136|472101786|FG000|Overall Study|Physician Decision|2|||
131129691|NCT01553136|472101787|FG001|Overall Study|Physician Decision|3|||
131129692|NCT01553136|472101786|FG000|Overall Study|Scheduling Difficulties|5|||
131129693|NCT01553136|472101787|FG001|Overall Study|Scheduling Difficulties|4|||
131129694|NCT00894556|472101790|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
131129695|NCT00894556|472101791|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
131129696|NCT00894556|472101792|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
131129697|NCT00894556|472101793|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
131129698|NCT00894556|472101790|FG000|Treatment Phase|Lost to Follow-up|2|||
131129699|NCT00894556|472101791|FG001|Treatment Phase|Lost to Follow-up|3|||
131129700|NCT00894556|472101792|FG002|Treatment Phase|Lost to Follow-up|1|||
131129701|NCT00894556|472101793|FG003|Treatment Phase|Lost to Follow-up|0|||
131129702|NCT00894556|472101790|FG000|Treatment Phase|Lack of Qualifying Event|2|||
131129703|NCT00894556|472101791|FG001|Treatment Phase|Lack of Qualifying Event|1|||
131129704|NCT00894556|472101792|FG002|Treatment Phase|Lack of Qualifying Event|0|||
131129705|NCT00894556|472101793|FG003|Treatment Phase|Lack of Qualifying Event|0|||
131129706|NCT01979536|472101796|FG000|Overall Study|Physician Decision|2|||
131129707|NCT01979536|472101797|FG001|Overall Study|Physician Decision|3|||
131129708|NCT01979536|472101796|FG000|Overall Study|Withdrawal by Subject|0|||
131129709|NCT01979536|472101797|FG001|Overall Study|Withdrawal by Subject|1|||
131129710|NCT01979536|472101796|FG000|Overall Study|Refusal|0|||
131129711|NCT01979536|472101797|FG001|Overall Study|Refusal|1|||
131129712|NCT01979536|472101796|FG000|Overall Study|Relapse|0|||
131129713|NCT01979536|472101797|FG001|Overall Study|Relapse|1|||
131129714|NCT01979536|472101796|FG000|Overall Study|Study terminated by Sponsor|0|||
131129715|NCT01979536|472101797|FG001|Overall Study|Study terminated by Sponsor|1|||
131129716|NCT01979536|472101796|FG000|Overall Study|Did not start treatment|0|||
131129717|NCT01979536|472101797|FG001|Overall Study|Did not start treatment|1|||
131129718|NCT03077685|472101798|FG000|Overall Study|Lost to Follow-up|0|||
131129719|NCT03077685|472101799|FG001|Overall Study|Lost to Follow-up|0|||
131129720|NCT03077685|472101800|FG002|Overall Study|Lost to Follow-up|0|||
131129721|NCT03077685|472101801|FG003|Overall Study|Lost to Follow-up|0|||
131129722|NCT03077685|472101802|FG004|Overall Study|Lost to Follow-up|1|||
131129723|NCT03077685|472101798|FG000|Overall Study|Death|0|||
131129724|NCT03077685|472101799|FG001|Overall Study|Death|0|||
131129725|NCT03077685|472101800|FG002|Overall Study|Death|1|||
131129726|NCT03077685|472101801|FG003|Overall Study|Death|1|||
131129727|NCT03077685|472101802|FG004|Overall Study|Death|3|||
131129728|NCT03077685|472101798|FG000|Overall Study|Withdrawal by Subject|0|||
131129729|NCT03077685|472101799|FG001|Overall Study|Withdrawal by Subject|0|||
131129730|NCT03077685|472101800|FG002|Overall Study|Withdrawal by Subject|0|||
131129731|NCT03077685|472101801|FG003|Overall Study|Withdrawal by Subject|2|||
131129732|NCT03077685|472101802|FG004|Overall Study|Withdrawal by Subject|1|||
131129733|NCT03077685|472101798|FG000|Overall Study|Physician Decision|0|||
131129734|NCT03077685|472101799|FG001|Overall Study|Physician Decision|0|||
131129735|NCT03077685|472101800|FG002|Overall Study|Physician Decision|1|||
131129736|NCT03077685|472101801|FG003|Overall Study|Physician Decision|0|||
131129737|NCT03077685|472101802|FG004|Overall Study|Physician Decision|3|||
131129738|NCT03077685|472101798|FG000|Overall Study|Disease Progression|1|||
131129739|NCT03077685|472101799|FG001|Overall Study|Disease Progression|0|||
131129740|NCT03077685|472101800|FG002|Overall Study|Disease Progression|0|||
131129741|NCT03077685|472101801|FG003|Overall Study|Disease Progression|2|||
131129742|NCT03077685|472101802|FG004|Overall Study|Disease Progression|1|||
131129743|NCT03077685|472101798|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
130716679|NCT03107026|470590897|FG000|Overall Study|Withdrawal by Subject|13|||
131129744|NCT03077685|472101799|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
131129745|NCT03077685|472101800|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
131129746|NCT03077685|472101801|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
131129747|NCT03077685|472101802|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
131129748|NCT03077685|472101798|FG000|Overall Study|Subject entered hospice care|0|||
131129749|NCT03077685|472101799|FG001|Overall Study|Subject entered hospice care|0|||
131129750|NCT03077685|472101800|FG002|Overall Study|Subject entered hospice care|0|||
131129751|NCT03077685|472101801|FG003|Overall Study|Subject entered hospice care|0|||
130775779|NCT01000974|470806587|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
131042765|NCT04690582|471789373|FG001|Overall Study|Withdrawal by Subject|4|||
131042766|NCT05974501|471789374|FG000|Overall Study|Physician Decision|0|||
131042767|NCT05974501|471789375|FG001|Overall Study|Physician Decision|1|||
131042768|NCT04270942|471789378|FG000|Overall Study|Death|1|||
131042769|NCT03625115|471789380|FG000|Overall Study|Withdrawal by Subject|4|||
131042770|NCT03625115|471789381|FG001|Overall Study|Withdrawal by Subject|7|||
131042771|NCT03625115|471789380|FG000|Overall Study|Lost to Follow-up|17|||
131042772|NCT03625115|471789381|FG001|Overall Study|Lost to Follow-up|24|||
131042773|NCT04797195|471789382|FG000|Overall Study|Death|8|||
131042774|NCT04797195|471789383|FG001|Overall Study|Death|15|||
131042775|NCT04797195|471789382|FG000|Overall Study|Change from PD|15|||
131042776|NCT04797195|471789383|FG001|Overall Study|Change from PD|15|||
131042777|NCT04797195|471789382|FG000|Overall Study|Withdrawal by Subject|3|||
131042778|NCT04797195|471789383|FG001|Overall Study|Withdrawal by Subject|2|||
131042779|NCT04101357|471789384|FG000|Overall Study|Death|1|||
131042780|NCT04101357|471789385|FG001|Overall Study|Death|1|||
131042781|NCT04101357|471789386|FG002|Overall Study|Death|1|||
131042782|NCT04101357|471789387|FG003|Overall Study|Death|2|||
131042783|NCT04101357|471789388|FG004|Overall Study|Death|4|||
131042784|NCT04101357|471789389|FG005|Overall Study|Death|11|||
131042785|NCT04101357|471789390|FG006|Overall Study|Death|4|||
131042786|NCT04101357|471789391|FG007|Overall Study|Death|4|||
131042787|NCT04101357|471789392|FG008|Overall Study|Death|5|||
131042788|NCT04101357|471789393|FG009|Overall Study|Death|2|||
131042789|NCT04101357|471789394|FG010|Overall Study|Death|3|||
131042790|NCT04101357|471789384|FG000|Overall Study|Trial closure|0|||
131042791|NCT04101357|471789385|FG001|Overall Study|Trial closure|0|||
131042792|NCT04101357|471789386|FG002|Overall Study|Trial closure|0|||
131042793|NCT04101357|471789387|FG003|Overall Study|Trial closure|0|||
131042794|NCT04101357|471789388|FG004|Overall Study|Trial closure|0|||
131042795|NCT04101357|471789389|FG005|Overall Study|Trial closure|2|||
131042796|NCT04101357|471789390|FG006|Overall Study|Trial closure|2|||
131042797|NCT04101357|471789391|FG007|Overall Study|Trial closure|0|||
131042798|NCT04101357|471789392|FG008|Overall Study|Trial closure|0|||
131042799|NCT04101357|471789393|FG009|Overall Study|Trial closure|0|||
131042800|NCT04101357|471789394|FG010|Overall Study|Trial closure|1|||
131042801|NCT04101357|471789384|FG000|Overall Study|Lost to Follow-up|0|||
131042802|NCT04101357|471789385|FG001|Overall Study|Lost to Follow-up|0|||
131042803|NCT04101357|471789386|FG002|Overall Study|Lost to Follow-up|0|||
131042804|NCT04101357|471789387|FG003|Overall Study|Lost to Follow-up|1|||
131042805|NCT04101357|471789388|FG004|Overall Study|Lost to Follow-up|0|||
131042806|NCT04101357|471789389|FG005|Overall Study|Lost to Follow-up|0|||
131042807|NCT04101357|471789390|FG006|Overall Study|Lost to Follow-up|0|||
131042808|NCT04101357|471789391|FG007|Overall Study|Lost to Follow-up|1|||
131042809|NCT04101357|471789392|FG008|Overall Study|Lost to Follow-up|0|||
131042810|NCT04101357|471789393|FG009|Overall Study|Lost to Follow-up|0|||
131042811|NCT04101357|471789394|FG010|Overall Study|Lost to Follow-up|0|||
131042812|NCT04101357|471789384|FG000|Overall Study|Withdrawal by Subject|1|||
131042813|NCT04101357|471789385|FG001|Overall Study|Withdrawal by Subject|0|||
131042814|NCT04101357|471789386|FG002|Overall Study|Withdrawal by Subject|0|||
131042815|NCT04101357|471789387|FG003|Overall Study|Withdrawal by Subject|0|||
131042816|NCT04101357|471789388|FG004|Overall Study|Withdrawal by Subject|0|||
131042817|NCT04101357|471789389|FG005|Overall Study|Withdrawal by Subject|0|||
131042818|NCT04101357|471789390|FG006|Overall Study|Withdrawal by Subject|0|||
131042819|NCT04101357|471789391|FG007|Overall Study|Withdrawal by Subject|0|||
131042820|NCT04101357|471789392|FG008|Overall Study|Withdrawal by Subject|1|||
131042821|NCT04101357|471789393|FG009|Overall Study|Withdrawal by Subject|1|||
131042822|NCT04101357|471789394|FG010|Overall Study|Withdrawal by Subject|0|||
131042823|NCT04101357|471789384|FG000|Overall Study|Other|0|||
131042824|NCT04101357|471789385|FG001|Overall Study|Other|0|||
131042825|NCT04101357|471789386|FG002|Overall Study|Other|0|||
131042826|NCT04101357|471789387|FG003|Overall Study|Other|0|||
131042827|NCT04101357|471789388|FG004|Overall Study|Other|0|||
131042828|NCT04101357|471789389|FG005|Overall Study|Other|1|||
131042829|NCT04101357|471789390|FG006|Overall Study|Other|2|||
131042830|NCT04101357|471789391|FG007|Overall Study|Other|1|||
131042831|NCT04101357|471789392|FG008|Overall Study|Other|0|||
131042832|NCT04101357|471789393|FG009|Overall Study|Other|0|||
131042833|NCT04101357|471789394|FG010|Overall Study|Other|0|||
131042834|NCT04101357|471789384|FG000|Overall Study|Enrolled but not treated|0|||
131042835|NCT04101357|471789385|FG001|Overall Study|Enrolled but not treated|0|||
131042836|NCT04101357|471789386|FG002|Overall Study|Enrolled but not treated|0|||
131042837|NCT04101357|471789387|FG003|Overall Study|Enrolled but not treated|0|||
131042838|NCT04101357|471789388|FG004|Overall Study|Enrolled but not treated|0|||
131042839|NCT04101357|471789389|FG005|Overall Study|Enrolled but not treated|1|||
131042840|NCT04101357|471789390|FG006|Overall Study|Enrolled but not treated|1|||
131042841|NCT04101357|471789391|FG007|Overall Study|Enrolled but not treated|0|||
131042842|NCT04101357|471789392|FG008|Overall Study|Enrolled but not treated|0|||
131042843|NCT04101357|471789393|FG009|Overall Study|Enrolled but not treated|0|||
131042844|NCT04101357|471789394|FG010|Overall Study|Enrolled but not treated|0|||
131129752|NCT03077685|472101802|FG004|Overall Study|Subject entered hospice care|1|||
131129753|NCT04649255|472103292|FG000|Overall Study|Death|9|||
131129754|NCT04649255|472103292|FG000|Overall Study|Withdrawal by Subject|1|||
131129755|NCT04129528|472103293|FG000|Overall Study|Adverse Event|1|||
131129756|NCT04129528|472103294|FG001|Overall Study|Adverse Event|0|||
131129757|NCT04129528|472103293|FG000|Overall Study|Physician Decision|1|||
131129758|NCT04129528|472103294|FG001|Overall Study|Physician Decision|1|||
131129759|NCT04129528|472103293|FG000|Overall Study|Withdrawal by Subject|1|||
130972333|NCT03349710|471524975|FG001|Treatment Period|participant request to discontinue|0|||
130972334|NCT03349710|471524976|FG002|Treatment Period|participant request to discontinue|4|||
130972335|NCT03349710|471524977|FG003|Treatment Period|participant request to discontinue|0|||
130972336|NCT03349710|471524974|FG000|Treatment Period|participant withdrew consent|1|||
130972337|NCT03349710|471524975|FG001|Treatment Period|participant withdrew consent|0|||
130972338|NCT03349710|471524976|FG002|Treatment Period|participant withdrew consent|0|||
130972339|NCT03349710|471524977|FG003|Treatment Period|participant withdrew consent|0|||
130972340|NCT01296568|471524978|FG000|Continued Access Phase|Lost to Follow-up|1|||
130972341|NCT01296568|471524978|FG000|Continued Access Phase|Withdrawal by Subject|1|||
130972342|NCT01296568|471524978|FG000|Continued Access Phase|Disease Progression|1|||
130972343|NCT00237744|471524979|FG000|Overall Study|Withdrawal by Subject|3|||
130972344|NCT00237744|471524980|FG001|Overall Study|Withdrawal by Subject|1|||
130972345|NCT00237744|471524981|FG002|Overall Study|Withdrawal by Subject|0|||
130972346|NCT04258020|471524982|FG000|Overall Study|Withdrawal by Subject|1|||
130972347|NCT04258020|471524983|FG001|Overall Study|Withdrawal by Subject|0|||
130972348|NCT02097472|471524984|FG000|Received Vaccination 2|Adverse Event|0|||
130972349|NCT02097472|471524985|FG001|Received Vaccination 2|Adverse Event|0|||
130972350|NCT02097472|471524986|FG002|Received Vaccination 2|Adverse Event|0|||
130972351|NCT02097472|471524987|FG003|Received Vaccination 2|Adverse Event|0|||
130972352|NCT02097472|471524988|FG004|Received Vaccination 2|Adverse Event|0|||
130972353|NCT02097472|471524989|FG005|Received Vaccination 2|Adverse Event|0|||
130972354|NCT02097472|471524990|FG006|Received Vaccination 2|Adverse Event|1|||
130972355|NCT02097472|471524991|FG007|Received Vaccination 2|Adverse Event|0|||
130972356|NCT03305016|471524992|FG000|Overall Study|Withdrawal by Subject|2|||
131129760|NCT04129528|472103294|FG001|Overall Study|Withdrawal by Subject|1|||
131129761|NCT01964352|472103295|FG000|Overall Study|Adverse Event|13|||
131129762|NCT01964352|472103296|FG001|Overall Study|Adverse Event|3|||
131129763|NCT01964352|472103297|FG002|Overall Study|Adverse Event|4|||
131129764|NCT01964352|472103298|FG003|Overall Study|Adverse Event|3|||
131129765|NCT01964352|472103295|FG000|Overall Study|Lack of Efficacy|6|||
131129766|NCT01964352|472103296|FG001|Overall Study|Lack of Efficacy|0|||
131129767|NCT01964352|472103297|FG002|Overall Study|Lack of Efficacy|0|||
131129768|NCT01964352|472103298|FG003|Overall Study|Lack of Efficacy|0|||
131129769|NCT01964352|472103295|FG000|Overall Study|Protocol Violation|2|||
131129770|NCT01964352|472103296|FG001|Overall Study|Protocol Violation|4|||
131129771|NCT01964352|472103297|FG002|Overall Study|Protocol Violation|0|||
131129772|NCT01964352|472103298|FG003|Overall Study|Protocol Violation|2|||
131129773|NCT01964352|472103295|FG000|Overall Study|Lost to Follow-up|1|||
131129774|NCT01964352|472103296|FG001|Overall Study|Lost to Follow-up|0|||
131129775|NCT01964352|472103297|FG002|Overall Study|Lost to Follow-up|0|||
131129776|NCT01964352|472103298|FG003|Overall Study|Lost to Follow-up|1|||
131129777|NCT01964352|472103295|FG000|Overall Study|Withdrawal by Subject|4|||
131129778|NCT01964352|472103296|FG001|Overall Study|Withdrawal by Subject|2|||
131129779|NCT01964352|472103297|FG002|Overall Study|Withdrawal by Subject|1|||
131129780|NCT01964352|472103298|FG003|Overall Study|Withdrawal by Subject|0|||
131129781|NCT01964352|472103295|FG000|Overall Study|Other than stated above|0|||
131129782|NCT01964352|472103296|FG001|Overall Study|Other than stated above|2|||
131129783|NCT01964352|472103297|FG002|Overall Study|Other than stated above|1|||
131129784|NCT01964352|472103298|FG003|Overall Study|Other than stated above|2|||
130972357|NCT02119416|471524993|FG000|Overall Study|Protocol Violation|1|||
130972358|NCT02119416|471524994|FG001|Overall Study|Protocol Violation|1|||
130972359|NCT02119416|471524995|FG002|Overall Study|Protocol Violation|1|||
130972360|NCT02119416|471524993|FG000|Overall Study|wrong pubertal stage|1|||
130972361|NCT02119416|471524994|FG001|Overall Study|wrong pubertal stage|0|||
130972362|NCT02119416|471524995|FG002|Overall Study|wrong pubertal stage|1|||
130972363|NCT01519206|471524998|FG000|Overall Study|Lost to Follow-up|3|||
130972364|NCT01519206|471524998|FG000|Overall Study|Missed Visit|2|||
131129785|NCT01908101|472103299|FG000|Overall Study|Physician Decision|1|||
131129786|NCT01908101|472103299|FG000|Overall Study|Withdrawal by Subject|1|||
131129787|NCT01908101|472103299|FG000|Overall Study|Incorrect Diagnosis|2|||
131129788|NCT01908101|472103299|FG000|Overall Study|Incorrect Starting Dose|1|||
131129789|NCT01908101|472103299|FG000|Overall Study|Did not complete the first cycle|4|||
130716680|NCT03107026|470590898|FG001|Overall Study|Withdrawal by Subject|5|||
130716681|NCT03107026|470590899|FG002|Overall Study|Withdrawal by Subject|17|||
130972365|NCT03043664|471524999|FG000|Overall Study|Lost to Follow-up|1|||
130972366|NCT03593655|471525000|FG000|First Product Use Period|Withdrawal by Subject|1|||
131129790|NCT00477165|472103303|FG000|Overall Study|Adverse Event|7|||
131129791|NCT00477165|472103304|FG001|Overall Study|Adverse Event|2|||
131129792|NCT00105443|472103306|FG000|Double-Blind Treatment|Adverse Event|1|||
131129793|NCT00105443|472103307|FG001|Double-Blind Treatment|Adverse Event|0|||
131129794|NCT00105443|472103308|FG002|Double-Blind Treatment|Adverse Event|0|||
131129795|NCT00105443|472103309|FG003|Double-Blind Treatment|Adverse Event|0|||
131129796|NCT00105443|472103306|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
131129797|NCT00105443|472103307|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
131129798|NCT00105443|472103308|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
131129799|NCT00105443|472103309|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
131129800|NCT00105443|472103306|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
131129801|NCT00105443|472103307|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
131129802|NCT00105443|472103308|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
131129803|NCT00105443|472103309|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
131129804|NCT00105443|472103306|FG000|Double-Blind Treatment|Physician Decision|1|||
131129805|NCT00105443|472103307|FG001|Double-Blind Treatment|Physician Decision|0|||
131129806|NCT00105443|472103308|FG002|Double-Blind Treatment|Physician Decision|2|||
131129807|NCT00105443|472103309|FG003|Double-Blind Treatment|Physician Decision|0|||
131129808|NCT00105443|472103306|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
131129809|NCT00105443|472103307|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
131129810|NCT00105443|472103308|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
131129811|NCT00105443|472103309|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
131129812|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
131129813|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
131129814|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
131129815|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
131129816|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
131129817|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
131129818|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
131129819|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
131129820|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
131129821|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
131129822|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
131129823|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
131129824|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
131129825|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
131129826|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
131129827|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
131129828|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
131129829|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
131129830|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
131129831|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
131129832|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
131129833|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
130972367|NCT03593655|471525001|FG001|First Product Use Period|Withdrawal by Subject|1|||
130972368|NCT03593655|471525000|FG000|First Product Use Period|Lost to Follow-up|1|||
130972369|NCT03593655|471525001|FG001|First Product Use Period|Lost to Follow-up|3|||
130972370|NCT03593655|471525000|FG000|Second Product Use Period|Withdrawal by Subject|1|||
130972371|NCT03593655|471525001|FG001|Second Product Use Period|Withdrawal by Subject|1|||
130972372|NCT03593655|471525000|FG000|Second Product Use Period|Lost to Follow-up|1|||
130972373|NCT03593655|471525001|FG001|Second Product Use Period|Lost to Follow-up|0|||
130972374|NCT03593655|471525000|FG000|Third Product Use Period|Lost to Follow-up|1|||
130972375|NCT03593655|471525001|FG001|Third Product Use Period|Lost to Follow-up|2|||
130972376|NCT03593655|471525000|FG000|Third Product Use Period|Physician Decision|0|||
130972377|NCT03593655|471525001|FG001|Third Product Use Period|Physician Decision|1|||
130972378|NCT03593655|471525000|FG000|Third Product Use Period|Withdrawal by Subject|0|||
130972379|NCT03593655|471525001|FG001|Third Product Use Period|Withdrawal by Subject|1|||
130972380|NCT05046795|471525004|FG000|Overall Study|Adverse Event|13|||
130972381|NCT05046795|471525005|FG001|Overall Study|Adverse Event|15|||
130972382|NCT05046795|471525004|FG000|Overall Study|Withdrawal by Subject|4|||
130972383|NCT05046795|471525005|FG001|Overall Study|Withdrawal by Subject|7|||
130972384|NCT05046795|471525004|FG000|Overall Study|Physician Decision|1|||
130972385|NCT05046795|471525005|FG001|Overall Study|Physician Decision|2|||
130972386|NCT05046795|471525004|FG000|Overall Study|Protocol Violation|1|||
130972387|NCT05046795|471525005|FG001|Overall Study|Protocol Violation|2|||
130972388|NCT05046795|471525004|FG000|Overall Study|Death|1|||
130972389|NCT05046795|471525005|FG001|Overall Study|Death|0|||
130972390|NCT05046795|471525004|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
130972391|NCT05046795|471525005|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
130972392|NCT02864082|471525006|FG000|Overall Study|Adverse Event|1|||
130972393|NCT02864082|471525007|FG001|Overall Study|Adverse Event|1|||
130972394|NCT02864082|471525006|FG000|Overall Study|Lost to Follow-up|0|||
130972395|NCT02864082|471525007|FG001|Overall Study|Lost to Follow-up|1|||
131129834|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
131129835|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
131129836|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
131129837|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
131129838|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
131129839|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
131129840|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
131129841|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
131129842|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
131129843|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
131129844|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
131129845|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
131129846|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
131129847|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
131129848|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
131129849|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
131129850|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
131129851|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
131129852|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
131129853|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
131129854|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
131129855|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
131129856|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
131129857|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
131129858|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
131129859|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
131129860|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
131129861|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
131129862|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
131129863|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
131129864|NCT00105443|472103306|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
131129865|NCT00105443|472103307|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
131129866|NCT00105443|472103308|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
131129867|NCT00105443|472103309|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
131129868|NCT02135692|472103310|FG000|Overall Study|Adverse Event|3|||
131129869|NCT02135692|472103310|FG000|Overall Study|Lack of Efficacy|2|||
131129870|NCT02135692|472103310|FG000|Overall Study|Protocol Violation|2|||
131129871|NCT02135692|472103310|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
131129872|NCT02135692|472103310|FG000|Overall Study|Product commercially available|159|||
131129873|NCT02135692|472103310|FG000|Overall Study|Study closed/terminated|153|||
131129874|NCT02135692|472103310|FG000|Overall Study|Lost to Follow-up|4|||
131129875|NCT02135692|472103310|FG000|Overall Study|Withdrawal by Subject|15|||
131129876|NCT01157078|472103311|FG000|Overall Study|Withdrawal by Subject|12|||
131129877|NCT01157078|472103312|FG001|Overall Study|Withdrawal by Subject|14|||
131129878|NCT01157078|472103311|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
131129879|NCT01157078|472103312|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
131129880|NCT01157078|472103311|FG000|Overall Study|Adverse Event|6|||
131129881|NCT01157078|472103312|FG001|Overall Study|Adverse Event|6|||
131129882|NCT01157078|472103311|FG000|Overall Study|Severe non-compliance to protocol|2|||
131129883|NCT01157078|472103312|FG001|Overall Study|Severe non-compliance to protocol|4|||
131129884|NCT01157078|472103311|FG000|Overall Study|Condition under investigation worsened|0|||
131129885|NCT01157078|472103312|FG001|Overall Study|Condition under investigation worsened|1|||
131129886|NCT01157078|472103311|FG000|Overall Study|Lack of Efficacy|2|||
131129887|NCT01157078|472103312|FG001|Overall Study|Lack of Efficacy|0|||
131129888|NCT01157078|472103311|FG000|Overall Study|Study-specific withdrawal criteria|2|||
131129889|NCT01157078|472103312|FG001|Overall Study|Study-specific withdrawal criteria|2|||
131129890|NCT01157078|472103311|FG000|Overall Study|Lost to Follow-up|7|||
131129891|NCT01157078|472103312|FG001|Overall Study|Lost to Follow-up|5|||
131129892|NCT01157078|472103311|FG000|Overall Study|Other|2|||
131129893|NCT01157078|472103312|FG001|Overall Study|Other|4|||
131129894|NCT04682405|472103315|FG000|Overall Study|Adverse Event|0|||
131129895|NCT04682405|472103316|FG001|Overall Study|Adverse Event|1|||
131129896|NCT04429061|472103317|FG000|Overall Study|Lost to Follow-up|62|||
131129897|NCT04429061|472103318|FG001|Overall Study|Lost to Follow-up|87|||
131129898|NCT04429061|472103317|FG000|Overall Study|Withdrawal by Subject|3|||
130972396|NCT02864082|471525006|FG000|Overall Study|Withdrawal by Subject|2|||
131129899|NCT04429061|472103318|FG001|Overall Study|Withdrawal by Subject|4|||
131129900|NCT00879229|472103325|FG000|Overall Study|Study terminated by Sponsor|13|||
131129901|NCT00879229|472103326|FG001|Overall Study|Study terminated by Sponsor|12|||
131129902|NCT00879229|472103325|FG000|Overall Study|Death|4|||
131129903|NCT00879229|472103326|FG001|Overall Study|Death|2|||
131129904|NCT00879229|472103325|FG000|Overall Study|Adverse Event|2|||
131129905|NCT00879229|472103326|FG001|Overall Study|Adverse Event|0|||
131129906|NCT00879229|472103325|FG000|Overall Study|Withdrawal by Subject|1|||
131129907|NCT00879229|472103326|FG001|Overall Study|Withdrawal by Subject|0|||
131129908|NCT00879229|472103325|FG000|Overall Study|Clinical status did not improve|1|||
131129909|NCT00879229|472103326|FG001|Overall Study|Clinical status did not improve|0|||
131129910|NCT00879229|472103325|FG000|Overall Study|Other|1|||
131129911|NCT00879229|472103326|FG001|Overall Study|Other|0|||
131129912|NCT01097746|472103327|FG000|Overall Study|Adverse Event|4|||
131129913|NCT01097746|472103327|FG000|Overall Study|taken off study before any treatment given|1|||
131129914|NCT00631371|472103334|FG000|Overall Study|Lost to Follow-up|24|||
131129915|NCT00631371|472103335|FG001|Overall Study|Lost to Follow-up|19|||
131129916|NCT00631371|472103334|FG000|Overall Study|Other reason|5|||
131129917|NCT00631371|472103335|FG001|Overall Study|Other reason|12|||
131129918|NCT00631371|472103334|FG000|Overall Study|subject request|38|||
131129919|NCT00631371|472103335|FG001|Overall Study|subject request|45|||
131129920|NCT00631371|472103334|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
131129921|NCT00631371|472103335|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
131129922|NCT00631371|472103334|FG000|Overall Study|Death|263|||
131129923|NCT00631371|472103335|FG001|Overall Study|Death|239|||
131129924|NCT02095535|472103336|FG000|Recruitment|Protocol Violation|2|||
131129925|NCT00623480|472103337|FG000|Overall Study|Lost to Follow-up|0|||
131129926|NCT00623480|472103338|FG001|Overall Study|Lost to Follow-up|1|||
131129927|NCT00623480|472103337|FG000|Overall Study|Withdrawal by Subject|2|||
131129928|NCT00623480|472103338|FG001|Overall Study|Withdrawal by Subject|4|||
131129929|NCT00623480|472103337|FG000|Overall Study|Lack of Efficacy|1|||
131129930|NCT00623480|472103338|FG001|Overall Study|Lack of Efficacy|0|||
131129931|NCT00623480|472103337|FG000|Overall Study|Non-compliant with study medication|4|||
131129932|NCT00623480|472103338|FG001|Overall Study|Non-compliant with study medication|0|||
131129933|NCT00623480|472103337|FG000|Overall Study|Protocol Violation|0|||
131129934|NCT00623480|472103338|FG001|Overall Study|Protocol Violation|1|||
131129935|NCT00623480|472103337|FG000|Overall Study|Site closed by sponsor|0|||
131129936|NCT00623480|472103338|FG001|Overall Study|Site closed by sponsor|1|||
131129937|NCT03709654|472103339|FG000|Overall Study|Lost to Follow-up|1|||
131129938|NCT03709654|472103340|FG001|Overall Study|Lost to Follow-up|1|||
131129939|NCT03709654|472103339|FG000|Overall Study|Withdrawal by Subject|1|||
131129940|NCT03709654|472103340|FG001|Overall Study|Withdrawal by Subject|1|||
131129941|NCT03709654|472103339|FG000|Overall Study|Adverse Event|1|||
131129942|NCT03709654|472103340|FG001|Overall Study|Adverse Event|0|||
131129943|NCT01902966|472103341|FG000|Overall Study|Death|1|||
131129944|NCT01902966|472103341|FG000|Overall Study|Physician Decision|1|||
131129945|NCT01902966|472103341|FG000|Overall Study|Withdrawal by Subject|1|||
131129946|NCT02631200|472103342|FG000|First Period|Death|1|||
131129947|NCT02631200|472103343|FG001|First Period|Death|2|||
131129948|NCT02631200|472103342|FG000|First Period|Patient ill-health|2|||
131129949|NCT02631200|472103343|FG001|First Period|Patient ill-health|4|||
131129950|NCT02631200|472103342|FG000|First Period|Withdrawal by Subject|4|||
131129951|NCT02631200|472103343|FG001|First Period|Withdrawal by Subject|1|||
131129952|NCT02631200|472103342|FG000|Deferred Period|Death|0|||
131129953|NCT02631200|472103343|FG001|Deferred Period|Death|1|||
130972397|NCT02864082|471525007|FG001|Overall Study|Withdrawal by Subject|2|||
131129954|NCT02631200|472103342|FG000|Deferred Period|Received kidney transplant|0|||
131129955|NCT02631200|472103343|FG001|Deferred Period|Received kidney transplant|1|||
131129956|NCT02631200|472103342|FG000|Deferred Period|Withdrawal by Subject|0|||
130716682|NCT03107026|470590897|FG000|Overall Study|non compliance with study visits|1|||
130716683|NCT03107026|470590898|FG001|Overall Study|non compliance with study visits|2|||
130716684|NCT03107026|470590899|FG002|Overall Study|non compliance with study visits|0|||
130716685|NCT03107026|470590897|FG000|Overall Study|non-compliance with study drug|2|||
130716686|NCT03107026|470590898|FG001|Overall Study|non-compliance with study drug|2|||
130716687|NCT03107026|470590899|FG002|Overall Study|non-compliance with study drug|3|||
130716688|NCT03107026|470590897|FG000|Overall Study|Physician Decision|0|||
130716689|NCT03107026|470590898|FG001|Overall Study|Physician Decision|1|||
130972398|NCT01127178|471525008|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
131129957|NCT02631200|472103343|FG001|Deferred Period|Withdrawal by Subject|2|||
131129958|NCT02631200|472103342|FG000|Deferred Period|Lost to Follow-up|0|||
131129959|NCT02631200|472103343|FG001|Deferred Period|Lost to Follow-up|1|||
131129960|NCT01081912|472103344|FG000|Conversion/Titration|Adverse Event|47|||
131129961|NCT01081912|472103345|FG001|Conversion/Titration|Adverse Event|0|||
131129962|NCT01081912|472103346|FG002|Conversion/Titration|Adverse Event|0|||
131129963|NCT01081912|472103344|FG000|Conversion/Titration|Lack of Efficacy|17|||
131129964|NCT01081912|472103345|FG001|Conversion/Titration|Lack of Efficacy|0|||
131129965|NCT01081912|472103346|FG002|Conversion/Titration|Lack of Efficacy|0|||
131129966|NCT01081912|472103344|FG000|Conversion/Titration|Lost to Follow-up|5|||
131129967|NCT01081912|472103345|FG001|Conversion/Titration|Lost to Follow-up|0|||
131129968|NCT01081912|472103346|FG002|Conversion/Titration|Lost to Follow-up|0|||
131129969|NCT01081912|472103344|FG000|Conversion/Titration|Physician Decision|2|||
131129970|NCT01081912|472103345|FG001|Conversion/Titration|Physician Decision|0|||
131129971|NCT01081912|472103346|FG002|Conversion/Titration|Physician Decision|0|||
131129972|NCT01081912|472103344|FG000|Conversion/Titration|Protocol Violation|67|||
131129973|NCT01081912|472103345|FG001|Conversion/Titration|Protocol Violation|0|||
131129974|NCT01081912|472103346|FG002|Conversion/Titration|Protocol Violation|0|||
131129975|NCT01081912|472103344|FG000|Conversion/Titration|Withdrawal by Subject|23|||
131129976|NCT01081912|472103345|FG001|Conversion/Titration|Withdrawal by Subject|0|||
131129977|NCT01081912|472103346|FG002|Conversion/Titration|Withdrawal by Subject|0|||
131129978|NCT01081912|472103344|FG000|Conversion/Titration|Non-Compliance|47|||
131129979|NCT01081912|472103345|FG001|Conversion/Titration|Non-Compliance|0|||
131129980|NCT01081912|472103346|FG002|Conversion/Titration|Non-Compliance|0|||
131129981|NCT01081912|472103344|FG000|Maintenance Treatment|Adverse Event|0|||
131129982|NCT01081912|472103345|FG001|Maintenance Treatment|Adverse Event|2|||
131129983|NCT01081912|472103346|FG002|Maintenance Treatment|Adverse Event|12|||
131129984|NCT01081912|472103344|FG000|Maintenance Treatment|Lack of Efficacy|0|||
131129985|NCT01081912|472103345|FG001|Maintenance Treatment|Lack of Efficacy|14|||
131129986|NCT01081912|472103346|FG002|Maintenance Treatment|Lack of Efficacy|64|||
131129987|NCT01081912|472103344|FG000|Maintenance Treatment|Lost to Follow-up|0|||
131129988|NCT01081912|472103345|FG001|Maintenance Treatment|Lost to Follow-up|1|||
131129989|NCT01081912|472103346|FG002|Maintenance Treatment|Lost to Follow-up|0|||
131129990|NCT01081912|472103344|FG000|Maintenance Treatment|Physician Decision|0|||
131129991|NCT01081912|472103345|FG001|Maintenance Treatment|Physician Decision|0|||
131129992|NCT01081912|472103346|FG002|Maintenance Treatment|Physician Decision|1|||
131129993|NCT01081912|472103344|FG000|Maintenance Treatment|Protocol Violation|0|||
131129994|NCT01081912|472103345|FG001|Maintenance Treatment|Protocol Violation|1|||
131129995|NCT01081912|472103346|FG002|Maintenance Treatment|Protocol Violation|2|||
131129996|NCT01081912|472103344|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
131129997|NCT01081912|472103345|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
131129998|NCT01081912|472103346|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
131129999|NCT01081912|472103344|FG000|Maintenance Treatment|Non-Compliance|0|||
131130000|NCT01081912|472103345|FG001|Maintenance Treatment|Non-Compliance|4|||
131130001|NCT01081912|472103346|FG002|Maintenance Treatment|Non-Compliance|7|||
131130002|NCT01081912|472103344|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
131130003|NCT01081912|472103345|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
131130004|NCT01081912|472103346|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
131130005|NCT04677712|472103348|FG000|Overall Study|Lost to Follow-up|0|||
131130006|NCT04677712|472103349|FG001|Overall Study|Lost to Follow-up|1|||
131130007|NCT04677712|472103350|FG002|Overall Study|Lost to Follow-up|0|||
131130008|NCT04677712|472103351|FG003|Overall Study|Lost to Follow-up|0|||
131130009|NCT04677712|472103352|FG004|Overall Study|Lost to Follow-up|0|||
131130010|NCT04677712|472103353|FG005|Overall Study|Lost to Follow-up|0|||
131130011|NCT00711100|472103354|FG000|Overall Study|Lack of Efficacy|5|||
131130012|NCT00711100|472103354|FG000|Overall Study|Withdrawal by Subject|8|||
131130013|NCT00783094|472103355|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
131130014|NCT00783094|472103356|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
131130015|NCT00783094|472103357|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
131130016|NCT00783094|472103355|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
131130017|NCT00783094|472103356|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
131130018|NCT00783094|472103357|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
131130019|NCT00783094|472103355|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
131130020|NCT00783094|472103356|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
131130021|NCT00783094|472103357|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
131130022|NCT00783094|472103355|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
131130023|NCT00783094|472103356|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
130972399|NCT01127178|471525009|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
131130024|NCT00783094|472103357|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
131130025|NCT00783094|472103355|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
131130026|NCT00783094|472103356|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
131130027|NCT00783094|472103357|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
131130028|NCT00783094|472103355|FG000|Open-Label Extension Period|Adverse Event|12|||
131130029|NCT00783094|472103356|FG001|Open-Label Extension Period|Adverse Event|7|||
131130030|NCT00783094|472103357|FG002|Open-Label Extension Period|Adverse Event|16|||
131130031|NCT00783094|472103355|FG000|Open-Label Extension Period|Death|0|||
131130032|NCT00783094|472103356|FG001|Open-Label Extension Period|Death|0|||
131130033|NCT00783094|472103357|FG002|Open-Label Extension Period|Death|1|||
131130034|NCT00783094|472103355|FG000|Open-Label Extension Period|Protocol Violation|4|||
131130035|NCT00783094|472103356|FG001|Open-Label Extension Period|Protocol Violation|5|||
131130036|NCT00783094|472103357|FG002|Open-Label Extension Period|Protocol Violation|7|||
131130037|NCT00783094|472103355|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
131130038|NCT00783094|472103356|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
131130039|NCT00783094|472103357|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
131130040|NCT00783094|472103355|FG000|Open-Label Extension Period|Physician Decision|4|||
131130041|NCT00783094|472103356|FG001|Open-Label Extension Period|Physician Decision|2|||
131130042|NCT00783094|472103357|FG002|Open-Label Extension Period|Physician Decision|3|||
131130043|NCT00783094|472103355|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
131130044|NCT00783094|472103356|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
131130045|NCT00783094|472103357|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
131130046|NCT02513329|472103358|FG000|Overall Study|Lost to Follow-up|5|||
131130047|NCT02513329|472103359|FG001|Overall Study|Lost to Follow-up|2|||
131130048|NCT01294670|472103360|FG000|Overall Study|Not treated|1|||
131130049|NCT01294670|472103361|FG001|Overall Study|Not treated|0|||
131130050|NCT01294670|472103362|FG002|Overall Study|Not treated|0|||
131130051|NCT01294670|472103363|FG003|Overall Study|Not treated|0|||
131130052|NCT01294670|472103364|FG004|Overall Study|Not treated|0|||
131130053|NCT02083380|472103368|FG000|Overall Study|Lack of Efficacy|68|||
131130054|NCT02083380|472103369|FG001|Overall Study|Lack of Efficacy|79|||
131130055|NCT02083380|472103370|FG002|Overall Study|Lack of Efficacy|64|||
131130056|NCT02083380|472103368|FG000|Overall Study|Withdrawal by Subject|9|||
131130057|NCT02083380|472103369|FG001|Overall Study|Withdrawal by Subject|3|||
131130058|NCT02083380|472103370|FG002|Overall Study|Withdrawal by Subject|7|||
131130059|NCT02083380|472103368|FG000|Overall Study|Physician Decision|1|||
131130060|NCT02083380|472103369|FG001|Overall Study|Physician Decision|6|||
131130061|NCT02083380|472103370|FG002|Overall Study|Physician Decision|3|||
131130062|NCT02083380|472103368|FG000|Overall Study|Adverse Event|0|||
131130063|NCT02083380|472103369|FG001|Overall Study|Adverse Event|0|||
131130064|NCT02083380|472103370|FG002|Overall Study|Adverse Event|1|||
131130065|NCT02083380|472103368|FG000|Overall Study|Lost to Follow-up|5|||
131130066|NCT02083380|472103369|FG001|Overall Study|Lost to Follow-up|3|||
131130067|NCT02083380|472103370|FG002|Overall Study|Lost to Follow-up|3|||
131130068|NCT02083380|472103368|FG000|Overall Study|Other|8|||
131130069|NCT02083380|472103369|FG001|Overall Study|Other|4|||
131130070|NCT02083380|472103370|FG002|Overall Study|Other|6|||
131130071|NCT00001379|472103371|FG000|Initial Treatment|Disease progression|21|||
131130072|NCT00001379|472103372|FG001|Initial Treatment|Disease progression|3|||
130716690|NCT03107026|470590899|FG002|Overall Study|Physician Decision|0|||
130716691|NCT02049450|470590900|FG000|Overall Study|Adverse Event|2|||
131130073|NCT00001379|472103373|FG002|Initial Treatment|Disease progression|0|||
131130074|NCT00001379|472103374|FG003|Initial Treatment|Disease progression|0|||
131130075|NCT00001379|472103371|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
131130076|NCT00001379|472103372|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
131130077|NCT00001379|472103373|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
131130078|NCT00001379|472103374|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
131130079|NCT00001379|472103371|FG000|Initial Treatment|Received alternative treatment|2|||
131130080|NCT00001379|472103372|FG001|Initial Treatment|Received alternative treatment|1|||
131130081|NCT00001379|472103373|FG002|Initial Treatment|Received alternative treatment|0|||
131130082|NCT00001379|472103374|FG003|Initial Treatment|Received alternative treatment|0|||
131130083|NCT00001379|472103371|FG000|Initial Treatment|Refused further treatment|2|||
131130084|NCT00001379|472103372|FG001|Initial Treatment|Refused further treatment|0|||
131130085|NCT00001379|472103373|FG002|Initial Treatment|Refused further treatment|0|||
131130086|NCT00001379|472103374|FG003|Initial Treatment|Refused further treatment|0|||
131130087|NCT00001379|472103371|FG000|Initial Treatment|Did not receive protocol treatment|0|||
131130088|NCT00001379|472103372|FG001|Initial Treatment|Did not receive protocol treatment|0|||
131130089|NCT00001379|472103373|FG002|Initial Treatment|Did not receive protocol treatment|5|||
131130090|NCT00001379|472103374|FG003|Initial Treatment|Did not receive protocol treatment|0|||
131130091|NCT00001379|472103371|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
131130092|NCT00001379|472103372|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
131130093|NCT00001379|472103373|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
131130094|NCT00001379|472103374|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
131130095|NCT00001379|472103371|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
131130096|NCT00001379|472103372|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
131130097|NCT00001379|472103373|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
130716692|NCT02049450|470590900|FG000|Overall Study|Withdrawal by Subject|1|||
131130098|NCT00001379|472103374|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
131130099|NCT00001379|472103371|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
130716693|NCT02049450|470590900|FG000|Overall Study|Patients/guardian decision|1|||
131130100|NCT00001379|472103372|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
131130101|NCT00001379|472103373|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
131130102|NCT00001379|472103374|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
130716694|NCT04711902|470590901|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
131227262|NCT01381900|472459669|FG002|Overall Study|Early withdraw|1|||
131130103|NCT00001379|472103371|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
131130104|NCT00001379|472103372|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
131130105|NCT00001379|472103373|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
131130106|NCT00001379|472103374|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
131130107|NCT00001379|472103371|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
131130108|NCT00001379|472103372|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
131130109|NCT00001379|472103373|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
131130110|NCT00001379|472103374|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
131130111|NCT01560780|472103378|FG000|Overall Study|Death|2|||
131130112|NCT01560780|472103379|FG001|Overall Study|Death|1|||
131130113|NCT01560780|472103378|FG000|Overall Study|Patient Preference|11|||
131130114|NCT01560780|472103379|FG001|Overall Study|Patient Preference|11|||
131130115|NCT03363321|472103380|FG000|Overall Study|Withdrawal by Subject|0|||
131130116|NCT03363321|472103381|FG001|Overall Study|Withdrawal by Subject|1|||
131130117|NCT03363321|472103382|FG002|Overall Study|Withdrawal by Subject|0|||
131130118|NCT03363321|472103383|FG003|Overall Study|Withdrawal by Subject|1|||
131130119|NCT03363321|472103384|FG004|Overall Study|Withdrawal by Subject|0|||
131130120|NCT01577186|472103385|FG000|Overall Study|Adverse Event|23|||
131130121|NCT01577186|472103385|FG000|Overall Study|Death|1|||
131130122|NCT01577186|472103385|FG000|Overall Study|Lost to Follow-up|28|||
131130123|NCT01577186|472103385|FG000|Overall Study|Withdrawal by Subject|35|||
131130124|NCT01577186|472103385|FG000|Overall Study|Insufficient Response|18|||
131130125|NCT01577186|472103385|FG000|Overall Study|Ineligible to Continue|15|||
131130126|NCT01577186|472103385|FG000|Overall Study|Non-Compliant|8|||
131130127|NCT01577186|472103385|FG000|Overall Study|Other|2|||
131130128|NCT01032915|472103386|FG000|Overall Study|Adverse Event|2|||
131130129|NCT01032915|472103387|FG001|Overall Study|Adverse Event|2|||
131130130|NCT01032915|472103388|FG002|Overall Study|Adverse Event|1|||
131130131|NCT01032915|472103389|FG003|Overall Study|Adverse Event|1|||
131130132|NCT01032915|472103386|FG000|Overall Study|Abnormal test procedure result|0|||
131130133|NCT01032915|472103387|FG001|Overall Study|Abnormal test procedure result|0|||
131130134|NCT01032915|472103388|FG002|Overall Study|Abnormal test procedure result|1|||
131130135|NCT01032915|472103389|FG003|Overall Study|Abnormal test procedure result|0|||
131130136|NCT01032915|472103386|FG000|Overall Study|Withdrawal by Subject|0|||
131130137|NCT01032915|472103387|FG001|Overall Study|Withdrawal by Subject|3|||
131130138|NCT01032915|472103388|FG002|Overall Study|Withdrawal by Subject|1|||
131130139|NCT01032915|472103389|FG003|Overall Study|Withdrawal by Subject|1|||
131130140|NCT01032915|472103386|FG000|Overall Study|Administrative reasons|5|||
131130141|NCT01032915|472103387|FG001|Overall Study|Administrative reasons|6|||
130972400|NCT01127178|471525008|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
130972401|NCT01127178|471525009|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
130972402|NCT01127178|471525008|FG000|Dose Escalation: Treatment Phase|Other|2|||
131130142|NCT01032915|472103388|FG002|Overall Study|Administrative reasons|4|||
131130143|NCT01032915|472103389|FG003|Overall Study|Administrative reasons|4|||
131130144|NCT01032915|472103386|FG000|Overall Study|Protocol Violation|1|||
131130145|NCT01032915|472103387|FG001|Overall Study|Protocol Violation|0|||
131130146|NCT01032915|472103388|FG002|Overall Study|Protocol Violation|0|||
131130147|NCT01032915|472103389|FG003|Overall Study|Protocol Violation|1|||
131130148|NCT02915523|472103393|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
131130149|NCT02915523|472103394|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
131130150|NCT02915523|472103395|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
131130151|NCT02915523|472103396|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
131130152|NCT02915523|472103393|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
131130153|NCT02915523|472103394|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
131130154|NCT02915523|472103395|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
131130155|NCT02915523|472103396|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
131130156|NCT02915523|472103393|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
131130157|NCT02915523|472103394|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
131130158|NCT02915523|472103395|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
131130159|NCT02915523|472103396|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
131130160|NCT02915523|472103393|FG000|Expansion Phase (Phase 2)|Death|0|||
131130161|NCT02915523|472103394|FG001|Expansion Phase (Phase 2)|Death|0|||
131130162|NCT02915523|472103395|FG002|Expansion Phase (Phase 2)|Death|26|||
131130163|NCT02915523|472103396|FG003|Expansion Phase (Phase 2)|Death|53|||
131130164|NCT02915523|472103393|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
131130165|NCT02915523|472103394|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
131130166|NCT02915523|472103395|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
131130167|NCT02915523|472103396|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
131130168|NCT02915523|472103393|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
131130169|NCT02915523|472103394|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
131130170|NCT02915523|472103395|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
131130171|NCT02915523|472103396|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
130972403|NCT01127178|471525009|FG001|Dose Escalation: Treatment Phase|Other|0|||
131227263|NCT01165684|472459672|FG000|Overall Study|Adverse Event|1|||
131227264|NCT01165684|472459673|FG001|Overall Study|Adverse Event|1|||
131227265|NCT01165684|472459672|FG000|Overall Study|Lack of Efficacy|2|||
131227266|NCT01165684|472459673|FG001|Overall Study|Lack of Efficacy|1|||
131227267|NCT01165684|472459672|FG000|Overall Study|Protocol Violation|7|||
131227268|NCT01165684|472459673|FG001|Overall Study|Protocol Violation|15|||
131227269|NCT01165684|472459672|FG000|Overall Study|Withdrawal Criteria|2|||
131227270|NCT01165684|472459673|FG001|Overall Study|Withdrawal Criteria|13|||
131227271|NCT01165684|472459672|FG000|Overall Study|Unclassified|16|||
131042845|NCT02497950|471789395|FG000|Overall Study|Death|209|||
131042846|NCT02497950|471789395|FG000|Overall Study|Transplanted|85|||
131042847|NCT02497950|471789395|FG000|Overall Study|Explanted|8|||
131042848|NCT02497950|471789395|FG000|Overall Study|Device Permanently Deactivated|4|||
131227272|NCT01165684|472459673|FG001|Overall Study|Unclassified|22|||
131227273|NCT00671879|472459676|FG000|Overall Study|Withdrawal by Subject|0|||
131227274|NCT00671879|472459677|FG001|Overall Study|Withdrawal by Subject|4|||
131227275|NCT00671879|472459678|FG002|Overall Study|Withdrawal by Subject|6|||
131227276|NCT04633837|472459679|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
131227277|NCT04633837|472459680|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
131227278|NCT00901628|472459681|FG000|Overall Study|disconnection of catheter|4|||
131227279|NCT00901628|472459682|FG001|Overall Study|disconnection of catheter|8|||
131227280|NCT00901628|472459681|FG000|Overall Study|disconnection of drain|0|||
131227281|NCT00901628|472459682|FG001|Overall Study|disconnection of drain|1|||
131227282|NCT00901628|472459681|FG000|Overall Study|peroneal nerve palsy|0|||
131227283|NCT00901628|472459682|FG001|Overall Study|peroneal nerve palsy|1|||
131227284|NCT01909466|472459690|FG000|Overall Study|Lost to Follow-up|5|||
131227285|NCT01909466|472459691|FG001|Overall Study|Lost to Follow-up|7|||
131227286|NCT01909466|472459690|FG000|Overall Study|Adverse Event|3|||
131227287|NCT01909466|472459691|FG001|Overall Study|Adverse Event|4|||
131227288|NCT01909466|472459690|FG000|Overall Study|Met Withdrawal Criteria|0|||
131227289|NCT01909466|472459691|FG001|Overall Study|Met Withdrawal Criteria|3|||
131227290|NCT01909466|472459690|FG000|Overall Study|Physician Decision|2|||
131227291|NCT01909466|472459691|FG001|Overall Study|Physician Decision|0|||
131227292|NCT01909466|472459690|FG000|Overall Study|Withdrawal by Subject|11|||
131227293|NCT01909466|472459691|FG001|Overall Study|Withdrawal by Subject|9|||
131227294|NCT01909466|472459690|FG000|Overall Study|Lack of Efficacy|1|||
131227295|NCT01909466|472459691|FG001|Overall Study|Lack of Efficacy|0|||
131227296|NCT01339910|472459692|FG000|Overall Study|Withdrawal by Subject|1|||
131227297|NCT01339910|472459693|FG001|Overall Study|Withdrawal by Subject|0|||
131227298|NCT01339910|472459692|FG000|Overall Study|Physician Decision|1|||
131227299|NCT01339910|472459693|FG001|Overall Study|Physician Decision|0|||
131227300|NCT01339910|472459692|FG000|Overall Study|Disease relapse|1|||
131227301|NCT01339910|472459693|FG001|Overall Study|Disease relapse|4|||
131227302|NCT01567306|472459694|FG000|Overall Study|Protocol Violation|2|||
131227303|NCT01567306|472459695|FG001|Overall Study|Protocol Violation|2|||
131227304|NCT01567306|472459696|FG002|Overall Study|Protocol Violation|0|||
130716695|NCT04711902|470590902|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
130716696|NCT04711902|470590903|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
130716697|NCT04711902|470590904|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
130716698|NCT04711902|470590905|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
131042849|NCT02497950|471789395|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
131042850|NCT02497950|471789395|FG000|Overall Study|Lost to Follow-up|6|||
131042851|NCT02497950|471789395|FG000|Overall Study|Withdrawal by Subject|2|||
131042852|NCT02497950|471789395|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
131042853|NCT02497950|471789395|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
131042854|NCT04308681|471789401|FG000|Pre-Treatment|Not reported|1|||
131042855|NCT04308681|471789402|FG001|Pre-Treatment|Not reported|1|||
131042856|NCT04308681|471789403|FG002|Pre-Treatment|Not reported|0|||
131042857|NCT04308681|471789404|FG003|Pre-Treatment|Not reported|0|||
131042858|NCT04308681|471789405|FG004|Pre-Treatment|Not reported|0|||
131042859|NCT04308681|471789406|FG005|Pre-Treatment|Not reported|2|||
131042860|NCT04308681|471789407|FG006|Pre-Treatment|Not reported|0|||
131042861|NCT04308681|471789408|FG007|Pre-Treatment|Not reported|0|||
131042862|NCT04308681|471789401|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
131042863|NCT04308681|471789402|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
131042864|NCT04308681|471789403|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
131042865|NCT04308681|471789404|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
131227305|NCT01567306|472459697|FG003|Overall Study|Protocol Violation|3|||
131227306|NCT01567306|472459698|FG004|Overall Study|Protocol Violation|1|||
131227307|NCT01567306|472459699|FG005|Overall Study|Protocol Violation|1|||
131227308|NCT01567306|472459694|FG000|Overall Study|Change site living|1|||
131227309|NCT01567306|472459695|FG001|Overall Study|Change site living|0|||
131227310|NCT01567306|472459696|FG002|Overall Study|Change site living|0|||
131227311|NCT01567306|472459697|FG003|Overall Study|Change site living|0|||
131227312|NCT01567306|472459698|FG004|Overall Study|Change site living|0|||
131227313|NCT01567306|472459699|FG005|Overall Study|Change site living|0|||
131227314|NCT01567306|472459694|FG000|Overall Study|Adverse Event|0|||
131130172|NCT02915523|472103393|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
131130173|NCT02915523|472103394|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
131130174|NCT02915523|472103395|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
131130175|NCT02915523|472103396|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
131130176|NCT00915681|472103397|FG000|Overall Study|Screening failures|46|||
131130177|NCT00811135|472103398|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
131130178|NCT00811135|472103398|FG000|Overall Study|Death|3|||
131130179|NCT00811135|472103398|FG000|Overall Study|Protocol Violation|2|||
131130180|NCT00811135|472103398|FG000|Overall Study|Violation of Selection Criteria|1|||
131130181|NCT00811135|472103398|FG000|Overall Study|Refused Treatment|1|||
131130182|NCT00811135|472103398|FG000|Overall Study|Withdrawal by Subject|3|||
131130183|NCT00811135|472103398|FG000|Overall Study|Administrative/Other Unspecified|11|||
131130184|NCT00811135|472103398|FG000|Overall Study|Ongoing|59|||
131130185|NCT00542269|472103406|FG000|Overall Study|Adverse Event|10|||
131130186|NCT00542269|472103407|FG001|Overall Study|Adverse Event|4|||
131130187|NCT00542269|472103408|FG002|Overall Study|Adverse Event|5|||
131130188|NCT00542269|472103406|FG000|Overall Study|Protocol Violation|1|||
131130189|NCT00542269|472103407|FG001|Overall Study|Protocol Violation|1|||
131130190|NCT00542269|472103408|FG002|Overall Study|Protocol Violation|0|||
131130191|NCT00542269|472103406|FG000|Overall Study|Withdrawal by Subject|1|||
131130192|NCT00542269|472103407|FG001|Overall Study|Withdrawal by Subject|0|||
131130193|NCT00542269|472103408|FG002|Overall Study|Withdrawal by Subject|0|||
131130194|NCT00542269|472103406|FG000|Overall Study|Administrative problems|1|||
131130195|NCT00542269|472103407|FG001|Overall Study|Administrative problems|1|||
131130196|NCT00542269|472103408|FG002|Overall Study|Administrative problems|1|||
131130197|NCT00845650|472103416|FG000|Overall Study|Withdrawal by Subject|0|||
131130198|NCT00845650|472103417|FG001|Overall Study|Withdrawal by Subject|0|||
131130199|NCT00845650|472103418|FG002|Overall Study|Withdrawal by Subject|0|||
131130200|NCT00845650|472103419|FG003|Overall Study|Withdrawal by Subject|0|||
131130201|NCT00845650|472103420|FG004|Overall Study|Withdrawal by Subject|2|||
131130202|NCT00845650|472103421|FG005|Overall Study|Withdrawal by Subject|0|||
131130203|NCT00845650|472103416|FG000|Overall Study|Lost to Follow-up|0|||
130716699|NCT04711902|470590906|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
130716700|NCT02238626|470590907|FG000|Overall Study|Adverse Event|3|||
131130204|NCT00845650|472103417|FG001|Overall Study|Lost to Follow-up|0|||
131130205|NCT00845650|472103418|FG002|Overall Study|Lost to Follow-up|3|||
131130206|NCT00845650|472103419|FG003|Overall Study|Lost to Follow-up|1|||
131130207|NCT00845650|472103420|FG004|Overall Study|Lost to Follow-up|0|||
131130208|NCT00845650|472103421|FG005|Overall Study|Lost to Follow-up|1|||
131130209|NCT00845650|472103416|FG000|Overall Study|Sponsor hold on dosing|0|||
131130210|NCT00845650|472103417|FG001|Overall Study|Sponsor hold on dosing|0|||
131130211|NCT00845650|472103418|FG002|Overall Study|Sponsor hold on dosing|0|||
131130212|NCT00845650|472103419|FG003|Overall Study|Sponsor hold on dosing|0|||
131130213|NCT00845650|472103420|FG004|Overall Study|Sponsor hold on dosing|1|||
131130214|NCT00845650|472103421|FG005|Overall Study|Sponsor hold on dosing|1|||
131130215|NCT00845650|472103416|FG000|Overall Study|Unable to access IV line|1|||
131130216|NCT00845650|472103417|FG001|Overall Study|Unable to access IV line|0|||
131130217|NCT00845650|472103418|FG002|Overall Study|Unable to access IV line|0|||
131130218|NCT00845650|472103419|FG003|Overall Study|Unable to access IV line|0|||
131130219|NCT00845650|472103420|FG004|Overall Study|Unable to access IV line|0|||
131130220|NCT00845650|472103421|FG005|Overall Study|Unable to access IV line|0|||
131130221|NCT00814892|472103422|FG000|Overall Study|Disease Progression|1|||
131130222|NCT00814892|472103422|FG000|Overall Study|Study Termination|1|||
131130223|NCT00401375|472103423|FG000|Overall Study|Protocol Violation|2|||
131130224|NCT00401375|472103424|FG001|Overall Study|Protocol Violation|2|||
131130225|NCT00401375|472103425|FG002|Overall Study|Protocol Violation|1|||
131130226|NCT00401375|472103423|FG000|Overall Study|Adverse Event|6|||
131130227|NCT00401375|472103424|FG001|Overall Study|Adverse Event|11|||
131130228|NCT00401375|472103425|FG002|Overall Study|Adverse Event|10|||
131227315|NCT01567306|472459695|FG001|Overall Study|Adverse Event|0|||
131227316|NCT01567306|472459696|FG002|Overall Study|Adverse Event|0|||
130716701|NCT02238626|470590908|FG001|Overall Study|Adverse Event|5|||
130716702|NCT02238626|470590909|FG002|Overall Study|Adverse Event|0|||
130716703|NCT02238626|470590910|FG003|Overall Study|Adverse Event|3|||
131130229|NCT00401375|472103423|FG000|Overall Study|Withdrawal by Subject|9|||
131130230|NCT00401375|472103424|FG001|Overall Study|Withdrawal by Subject|7|||
131130231|NCT00401375|472103425|FG002|Overall Study|Withdrawal by Subject|7|||
131130232|NCT00401375|472103423|FG000|Overall Study|Lost to Follow-up|0|||
131130233|NCT00401375|472103424|FG001|Overall Study|Lost to Follow-up|1|||
131130234|NCT00401375|472103425|FG002|Overall Study|Lost to Follow-up|1|||
131130235|NCT00401375|472103423|FG000|Overall Study|Other than specified|2|||
130716704|NCT02238626|470590907|FG000|Overall Study|Lost to Follow-up|2|||
130716705|NCT02238626|470590908|FG001|Overall Study|Lost to Follow-up|4|||
131130236|NCT00401375|472103424|FG001|Overall Study|Other than specified|1|||
131130237|NCT00401375|472103425|FG002|Overall Study|Other than specified|3|||
131130238|NCT00401375|472103423|FG000|Overall Study|Randomized but not treated|3|||
130716706|NCT02238626|470590909|FG002|Overall Study|Lost to Follow-up|2|||
131130239|NCT00401375|472103424|FG001|Overall Study|Randomized but not treated|3|||
131130240|NCT00401375|472103425|FG002|Overall Study|Randomized but not treated|3|||
131130241|NCT02821715|472103426|FG000|Overall Study|Protocol Violation|1|||
131130242|NCT02821715|472103427|FG001|Overall Study|Protocol Violation|0|||
131130243|NCT02821715|472103428|FG002|Overall Study|Protocol Violation|0|||
131130244|NCT02821715|472103429|FG003|Overall Study|Protocol Violation|0|||
131130245|NCT02821715|472103430|FG004|Overall Study|Protocol Violation|0|||
131130246|NCT02821715|472103431|FG005|Overall Study|Protocol Violation|0|||
131130247|NCT03152019|472103432|FG000|Overall Study|Adverse Event|0|||
131130248|NCT03152019|472103433|FG001|Overall Study|Adverse Event|1|||
131130249|NCT00254501|472103439|FG000|Overall Study|Lost to Follow-up|1|||
131130250|NCT00254501|472103440|FG001|Overall Study|Lost to Follow-up|1|||
131130251|NCT00923130|472103441|FG000|Overall Study|Stopped treatment due to progression|17|||
131130252|NCT00923130|472103441|FG000|Overall Study|Death|1|||
131130253|NCT00923130|472103441|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
131130254|NCT00923130|472103441|FG000|Overall Study|Switched to alternative treatment|2|||
131130255|NCT00923130|472103441|FG000|Overall Study|Refused further treatment|2|||
131130256|NCT00159861|472103443|FG000|Core Study - 16 Weeks|Death|3|||
131130257|NCT00159861|472103444|FG001|Core Study - 16 Weeks|Death|0|||
131130258|NCT00159861|472103443|FG000|Core Study - 16 Weeks|Adverse Event|12|||
131130259|NCT00159861|472103444|FG001|Core Study - 16 Weeks|Adverse Event|6|||
131130260|NCT00159861|472103443|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
131130261|NCT00159861|472103444|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
131130262|NCT00159861|472103443|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
131130263|NCT00159861|472103444|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
131130264|NCT00159861|472103443|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
131130265|NCT00159861|472103444|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
131130266|NCT00159861|472103443|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
131130267|NCT00159861|472103444|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
131130268|NCT00159861|472103443|FG000|Extension Study - up to 3 Years|Death|24|||
131130269|NCT00159861|472103444|FG001|Extension Study - up to 3 Years|Death|28|||
131130270|NCT00159861|472103443|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
131130271|NCT00159861|472103444|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
131130272|NCT00159861|472103443|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
131130273|NCT00159861|472103444|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
131130274|NCT00159861|472103443|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
131130275|NCT00159861|472103444|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
131130276|NCT00159861|472103443|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
131130277|NCT00159861|472103444|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
131130278|NCT04194528|472103449|FG000|Overall Study|Adverse Event|1|||
131130279|NCT03921424|472103452|FG000|Overall Study|Lost to Follow-up|0|||
131130280|NCT03921424|472103453|FG001|Overall Study|Lost to Follow-up|1|||
131130281|NCT03921424|472103452|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
131130282|NCT03921424|472103453|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
131130283|NCT00609791|472104937|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
131130284|NCT01394939|472104942|FG000|Overall Study|Adverse Event|1|||
131130285|NCT01394939|472104943|FG001|Overall Study|Adverse Event|3|||
131130286|NCT01394939|472104944|FG002|Overall Study|Adverse Event|0|||
131130287|NCT01394939|472104945|FG003|Overall Study|Adverse Event|2|||
131130288|NCT01394939|472104942|FG000|Overall Study|Death|0|||
131130289|NCT01394939|472104943|FG001|Overall Study|Death|2|||
131130290|NCT01394939|472104944|FG002|Overall Study|Death|0|||
131130291|NCT01394939|472104945|FG003|Overall Study|Death|0|||
131130292|NCT01394939|472104942|FG000|Overall Study|Physician Decision|0|||
131130293|NCT01394939|472104943|FG001|Overall Study|Physician Decision|1|||
131130294|NCT01394939|472104944|FG002|Overall Study|Physician Decision|0|||
130716707|NCT02238626|470590910|FG003|Overall Study|Lost to Follow-up|2|||
130716708|NCT02238626|470590907|FG000|Overall Study|Withdrawal by Subject|0|||
130716709|NCT02238626|470590908|FG001|Overall Study|Withdrawal by Subject|3|||
130716710|NCT02238626|470590909|FG002|Overall Study|Withdrawal by Subject|0|||
130716711|NCT02238626|470590910|FG003|Overall Study|Withdrawal by Subject|1|||
131130295|NCT01394939|472104945|FG003|Overall Study|Physician Decision|0|||
130716712|NCT02238626|470590907|FG000|Overall Study|Death|0|||
130716713|NCT02238626|470590908|FG001|Overall Study|Death|0|||
131130296|NCT01394939|472104942|FG000|Overall Study|Withdrawal by Subject|0|||
131130297|NCT01394939|472104943|FG001|Overall Study|Withdrawal by Subject|2|||
130716714|NCT02238626|470590909|FG002|Overall Study|Death|1|||
131130298|NCT01394939|472104944|FG002|Overall Study|Withdrawal by Subject|0|||
131130299|NCT01394939|472104945|FG003|Overall Study|Withdrawal by Subject|2|||
131130300|NCT01394939|472104942|FG000|Overall Study|Others|0|||
131130301|NCT01394939|472104943|FG001|Overall Study|Others|2|||
131130302|NCT01394939|472104944|FG002|Overall Study|Others|0|||
131130303|NCT01394939|472104945|FG003|Overall Study|Others|3|||
131130304|NCT00150592|472104948|FG000|Overall Study|Adverse Event|4|||
131130305|NCT00150592|472104949|FG001|Overall Study|Adverse Event|1|||
130716715|NCT02238626|470590910|FG003|Overall Study|Death|1|||
130716716|NCT02238626|470590907|FG000|Overall Study|Other|0|||
130972404|NCT01127178|471525008|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
130972405|NCT01127178|471525009|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
130972406|NCT01127178|471525008|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
130972407|NCT01127178|471525009|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
130972408|NCT01127178|471525008|FG000|Dose Escalation: Extension Phase|Other|1|||
130972409|NCT01127178|471525009|FG001|Dose Escalation: Extension Phase|Other|0|||
130972410|NCT04139317|471525010|FG000|Overall Study|Adverse Event|10|||
130972411|NCT04139317|471525011|FG001|Overall Study|Adverse Event|2|||
130972412|NCT04139317|471525010|FG000|Overall Study|Death|6|||
130972413|NCT04139317|471525011|FG001|Overall Study|Death|4|||
130972414|NCT04139317|471525010|FG000|Overall Study|Lost to Follow-up|1|||
130972415|NCT04139317|471525011|FG001|Overall Study|Lost to Follow-up|0|||
130972416|NCT04139317|471525010|FG000|Overall Study|Physician Decision|3|||
130972417|NCT04139317|471525011|FG001|Overall Study|Physician Decision|1|||
130972418|NCT04139317|471525010|FG000|Overall Study|Progressive Disease|19|||
130972419|NCT04139317|471525011|FG001|Overall Study|Progressive Disease|9|||
130972420|NCT04139317|471525010|FG000|Overall Study|Subject Decision|2|||
130972421|NCT04139317|471525011|FG001|Overall Study|Subject Decision|2|||
130972422|NCT03621696|471525012|FG000|Overall Study|Not eligible|0|||
130972423|NCT03621696|471525013|FG001|Overall Study|Not eligible|0|||
130972424|NCT03621696|471525014|FG002|Overall Study|Not eligible|0|||
130972425|NCT03621696|471525015|FG003|Overall Study|Not eligible|5|||
130972426|NCT03621696|471525012|FG000|Overall Study|Withdrawal by Subject|1|||
130972427|NCT03621696|471525013|FG001|Overall Study|Withdrawal by Subject|1|||
130972428|NCT03621696|471525014|FG002|Overall Study|Withdrawal by Subject|1|||
130972429|NCT03621696|471525015|FG003|Overall Study|Withdrawal by Subject|0|||
130972430|NCT03621696|471525012|FG000|Overall Study|Physician Decision|0|||
131042866|NCT04308681|471789405|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
131042867|NCT04308681|471789406|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
131042868|NCT04308681|471789407|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
131042869|NCT04308681|471789408|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
131042870|NCT04308681|471789401|FG000|Treatment up to Week 26|Other reasons|2|||
131042871|NCT04308681|471789402|FG001|Treatment up to Week 26|Other reasons|0|||
131042872|NCT04308681|471789403|FG002|Treatment up to Week 26|Other reasons|0|||
131042873|NCT04308681|471789404|FG003|Treatment up to Week 26|Other reasons|0|||
131042874|NCT04308681|471789405|FG004|Treatment up to Week 26|Other reasons|1|||
131042875|NCT04308681|471789406|FG005|Treatment up to Week 26|Other reasons|1|||
131042876|NCT04308681|471789407|FG006|Treatment up to Week 26|Other reasons|0|||
131042877|NCT04308681|471789408|FG007|Treatment up to Week 26|Other reasons|0|||
131042878|NCT04308681|471789401|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
131042879|NCT04308681|471789402|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
131042880|NCT04308681|471789403|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
131042881|NCT04308681|471789404|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
131042882|NCT04308681|471789405|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
131042883|NCT04308681|471789406|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
131042884|NCT04308681|471789407|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
131042885|NCT04308681|471789408|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
131042886|NCT04308681|471789401|FG000|Treatment up to Week 26|Adverse Event|6|||
130972431|NCT03621696|471525013|FG001|Overall Study|Physician Decision|0|||
131042887|NCT04308681|471789402|FG001|Treatment up to Week 26|Adverse Event|5|||
131042888|NCT04308681|471789403|FG002|Treatment up to Week 26|Adverse Event|5|||
131042889|NCT04308681|471789404|FG003|Treatment up to Week 26|Adverse Event|0|||
131042890|NCT04308681|471789405|FG004|Treatment up to Week 26|Adverse Event|6|||
131042891|NCT04308681|471789406|FG005|Treatment up to Week 26|Adverse Event|1|||
131042892|NCT04308681|471789407|FG006|Treatment up to Week 26|Adverse Event|0|||
131042893|NCT04308681|471789408|FG007|Treatment up to Week 26|Adverse Event|0|||
131042894|NCT04308681|471789401|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
131042895|NCT04308681|471789402|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
131042896|NCT04308681|471789403|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
131042897|NCT04308681|471789404|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
131042898|NCT04308681|471789405|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
131042899|NCT04308681|471789406|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
130972432|NCT03621696|471525014|FG002|Overall Study|Physician Decision|1|||
130972433|NCT03621696|471525015|FG003|Overall Study|Physician Decision|0|||
130972434|NCT04349553|471525016|FG000|Overall Study|Withdrawal by Subject|1|||
130972435|NCT04349553|471525017|FG001|Overall Study|Withdrawal by Subject|0|||
131042900|NCT04308681|471789407|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
130972436|NCT04349553|471525018|FG002|Overall Study|Withdrawal by Subject|1|||
130972437|NCT04349553|471525019|FG003|Overall Study|Withdrawal by Subject|0|||
131042901|NCT04308681|471789408|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
131130306|NCT00150592|472104948|FG000|Overall Study|Protocol Violation|1|||
130972438|NCT02372396|471525024|FG000|Overall Study|Lost to Follow-up|7|||
131130307|NCT00150592|472104949|FG001|Overall Study|Protocol Violation|0|||
131130308|NCT00150592|472104948|FG000|Overall Study|Withdrawal by Subject|1|||
131130309|NCT00150592|472104949|FG001|Overall Study|Withdrawal by Subject|2|||
131130310|NCT00150592|472104948|FG000|Overall Study|Non-compliance|1|||
131130311|NCT00150592|472104949|FG001|Overall Study|Non-compliance|0|||
131130312|NCT00874120|472104954|FG000|First Intervention|Adverse Event|0|||
131130313|NCT00874120|472104955|FG001|First Intervention|Adverse Event|1|||
131130314|NCT00874120|472104954|FG000|First Intervention|Withdrawal by Subject|2|||
131130315|NCT00874120|472104955|FG001|First Intervention|Withdrawal by Subject|0|||
131130316|NCT00874120|472104954|FG000|First Intervention|Lost to Follow-up|0|||
131130317|NCT00874120|472104955|FG001|First Intervention|Lost to Follow-up|1|||
131130318|NCT00874120|472104954|FG000|First Intervention|Protocol Violation|3|||
131130319|NCT00874120|472104955|FG001|First Intervention|Protocol Violation|0|||
131130320|NCT00874120|472104954|FG000|First Intervention|positive drug test|1|||
131130321|NCT00874120|472104955|FG001|First Intervention|positive drug test|0|||
131130322|NCT00874120|472104954|FG000|Second Intervention|Withdrawal by Subject|1|||
131130323|NCT00874120|472104955|FG001|Second Intervention|Withdrawal by Subject|0|||
131130324|NCT00874120|472104954|FG000|Second Intervention|Protocol Violation|1|||
131130325|NCT00874120|472104955|FG001|Second Intervention|Protocol Violation|0|||
131130326|NCT01823679|472104956|FG000|Overall Study|Death|1|||
131130327|NCT00522431|472104957|FG000|Overall Study|Adverse Event|5|||
131130328|NCT00522431|472104957|FG000|Overall Study|Protocol Violation|2|||
131130329|NCT00522431|472104957|FG000|Overall Study|Withdrawal by Subject|2|||
131130330|NCT00522431|472104957|FG000|Overall Study|Subject non-compliance|1|||
131130331|NCT00522431|472104957|FG000|Overall Study|Other/unknown|1|||
131130332|NCT00513409|472104963|FG000|Overall Study|Adverse Event|0|||
130972439|NCT02372396|471525025|FG001|Overall Study|Lost to Follow-up|9|||
130972440|NCT01272934|471525028|FG000|Overall Study|Adverse Event|0|||
130972441|NCT01272934|471525029|FG001|Overall Study|Adverse Event|1|||
130972442|NCT01272934|471525028|FG000|Overall Study|Abnormal Laboratory Value|0|||
130972443|NCT01272934|471525029|FG001|Overall Study|Abnormal Laboratory Value|1|||
130972444|NCT00214136|471525030|FG000|Overall Study|Death|5|||
130972445|NCT02310750|471525035|FG000|HP Period 1|Lost to Follow-up|0|||
130972446|NCT02310750|471525036|FG001|HP Period 1|Lost to Follow-up|0|||
130972447|NCT02310750|471525037|FG002|HP Period 1|Lost to Follow-up|0|||
130972448|NCT02310750|471525038|FG003|HP Period 1|Lost to Follow-up|0|||
130972449|NCT02310750|471525039|FG004|HP Period 1|Lost to Follow-up|0|||
130972450|NCT02310750|471525040|FG005|HP Period 1|Lost to Follow-up|0|||
130972451|NCT02310750|471525041|FG006|HP Period 1|Lost to Follow-up|1|||
130972452|NCT02310750|471525042|FG007|HP Period 1|Lost to Follow-up|0|||
130972453|NCT02310750|471525043|FG008|HP Period 1|Lost to Follow-up|0|||
130972454|NCT02310750|471525044|FG009|HP Period 1|Lost to Follow-up|0|||
130972455|NCT02310750|471525045|FG010|HP Period 1|Lost to Follow-up|0|||
130972456|NCT02310750|471525046|FG011|HP Period 1|Lost to Follow-up|0|||
130972457|NCT02310750|471525047|FG012|HP Period 1|Lost to Follow-up|0|||
131130333|NCT00513409|472104964|FG001|Overall Study|Adverse Event|1|||
131130334|NCT00513409|472104963|FG000|Overall Study|Withdrawal by Subject|0|||
131130335|NCT00513409|472104964|FG001|Overall Study|Withdrawal by Subject|2|||
131130336|NCT00513409|472104963|FG000|Overall Study|Lost to Follow-up|0|||
131130337|NCT00513409|472104964|FG001|Overall Study|Lost to Follow-up|1|||
131130338|NCT00513409|472104963|FG000|Overall Study|Physician Decision|1|||
131130339|NCT00513409|472104964|FG001|Overall Study|Physician Decision|0|||
130972458|NCT02310750|471525048|FG013|HP Period 1|Lost to Follow-up|0|||
130972459|NCT02310750|471525049|FG014|HP Period 1|Lost to Follow-up|0|||
130972460|NCT02310750|471525050|FG015|HP Period 1|Lost to Follow-up|0|||
130972461|NCT02310750|471525035|FG000|HP Period 1|Withdrawal by Subject|1|||
130972462|NCT02310750|471525036|FG001|HP Period 1|Withdrawal by Subject|0|||
130972463|NCT02310750|471525037|FG002|HP Period 1|Withdrawal by Subject|0|||
131130340|NCT00513409|472104963|FG000|Overall Study|Visit 3 not done|1|||
131130341|NCT00513409|472104964|FG001|Overall Study|Visit 3 not done|2|||
131130342|NCT01049035|472104965|FG000|Overall Study|Serious adverse event|0|||
131130343|NCT01049035|472104966|FG001|Overall Study|Serious adverse event|1|||
131130344|NCT01049035|472104967|FG002|Overall Study|Serious adverse event|1|||
131130345|NCT01049035|472104968|FG003|Overall Study|Serious adverse event|2|||
131130346|NCT01049035|472104969|FG004|Overall Study|Serious adverse event|0|||
131130347|NCT01049035|472104970|FG005|Overall Study|Serious adverse event|0|||
131130348|NCT01049035|472104971|FG006|Overall Study|Serious adverse event|0|||
131130349|NCT01049035|472104965|FG000|Overall Study|Other adverse event (AE)|0|||
131130350|NCT01049035|472104966|FG001|Overall Study|Other adverse event (AE)|0|||
131130351|NCT01049035|472104967|FG002|Overall Study|Other adverse event (AE)|0|||
131130352|NCT01049035|472104968|FG003|Overall Study|Other adverse event (AE)|1|||
131130353|NCT01049035|472104969|FG004|Overall Study|Other adverse event (AE)|0|||
131130354|NCT01049035|472104970|FG005|Overall Study|Other adverse event (AE)|0|||
131130355|NCT01049035|472104971|FG006|Overall Study|Other adverse event (AE)|0|||
131130356|NCT01049035|472104965|FG000|Overall Study|Non-compliance with the protocol|12|||
130972464|NCT02310750|471525038|FG003|HP Period 1|Withdrawal by Subject|1|||
130972465|NCT02310750|471525039|FG004|HP Period 1|Withdrawal by Subject|0|||
130972466|NCT02310750|471525040|FG005|HP Period 1|Withdrawal by Subject|0|||
130972467|NCT02310750|471525041|FG006|HP Period 1|Withdrawal by Subject|0|||
131130357|NCT01049035|472104966|FG001|Overall Study|Non-compliance with the protocol|6|||
131130358|NCT01049035|472104967|FG002|Overall Study|Non-compliance with the protocol|14|||
131130359|NCT01049035|472104968|FG003|Overall Study|Non-compliance with the protocol|5|||
131130360|NCT01049035|472104969|FG004|Overall Study|Non-compliance with the protocol|3|||
131130361|NCT01049035|472104970|FG005|Overall Study|Non-compliance with the protocol|4|||
131130362|NCT01049035|472104971|FG006|Overall Study|Non-compliance with the protocol|10|||
131130363|NCT01049035|472104965|FG000|Overall Study|Lost to Follow-up|5|||
131130364|NCT01049035|472104966|FG001|Overall Study|Lost to Follow-up|4|||
131130365|NCT01049035|472104967|FG002|Overall Study|Lost to Follow-up|4|||
131130366|NCT01049035|472104968|FG003|Overall Study|Lost to Follow-up|1|||
131130367|NCT01049035|472104969|FG004|Overall Study|Lost to Follow-up|0|||
131130368|NCT01049035|472104970|FG005|Overall Study|Lost to Follow-up|3|||
131130369|NCT01049035|472104971|FG006|Overall Study|Lost to Follow-up|3|||
131130370|NCT01049035|472104965|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
131130371|NCT01049035|472104966|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
131130372|NCT01049035|472104967|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
131130373|NCT01049035|472104968|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
131130374|NCT01049035|472104969|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
131130375|NCT01049035|472104970|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
131130376|NCT01049035|472104971|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
131130377|NCT03927105|472104972|FG000|Overall Study|Death|1|||
131130378|NCT03927105|472104972|FG000|Overall Study|In observation for potential re-treatment|2|||
131130379|NCT03927105|472104972|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
131130380|NCT03189446|472104976|FG000|Overall Study|Adverse Event|2|||
131130381|NCT03189446|472104976|FG000|Overall Study|Withdrawal by Subject|2|||
130716717|NCT02238626|470590908|FG001|Overall Study|Other|2|||
130972468|NCT02310750|471525042|FG007|HP Period 1|Withdrawal by Subject|0|||
131130382|NCT03189446|472104976|FG000|Overall Study|Physician Decision|1|||
131130383|NCT05634577|472104977|FG000|Overall Study|Lost to Follow-up|1|||
131130384|NCT05634577|472104977|FG000|Overall Study|Withdrawal by Subject|1|||
131130385|NCT04839978|472104978|FG000|Overall Study|Lost to Follow-up|135|||
131130386|NCT04839978|472104979|FG001|Overall Study|Lost to Follow-up|147|||
131130387|NCT03865706|472104980|FG000|Overall Study|Death|0|||
131130388|NCT03865706|472104981|FG001|Overall Study|Death|3|||
131130389|NCT03865706|472104982|FG002|Overall Study|Death|1|||
131130390|NCT02412787|472104986|FG000|Overall Study|Withdrawal by Subject|9|||
131130391|NCT02412787|472104986|FG000|Overall Study|Participation Terminated by Investigator|1|||
131130392|NCT02412787|472104986|FG000|Overall Study|Site Terminated by Sponsor|21|||
131130393|NCT02412787|472104986|FG000|Overall Study|Technical Problems|1|||
131130394|NCT02412787|472104986|FG000|Overall Study|Reason Not Specified|1|||
131130395|NCT02311153|472104987|FG000|Overall Study|Lost to Follow-up|5|||
131130396|NCT02311153|472104988|FG001|Overall Study|Lost to Follow-up|7|||
131130397|NCT00957008|472104993|FG000|Overall Study|Withdrawal by Subject|13|||
131130398|NCT00957008|472104994|FG001|Overall Study|Withdrawal by Subject|10|||
131130399|NCT00957008|472104995|FG002|Overall Study|Withdrawal by Subject|12|||
131130400|NCT00957008|472104996|FG003|Overall Study|Withdrawal by Subject|16|||
131130401|NCT00957008|472104993|FG000|Overall Study|Lost to Follow-up|3|||
131130402|NCT00957008|472104994|FG001|Overall Study|Lost to Follow-up|1|||
131130403|NCT00957008|472104995|FG002|Overall Study|Lost to Follow-up|3|||
131130404|NCT00957008|472104996|FG003|Overall Study|Lost to Follow-up|4|||
131130405|NCT00957008|472104993|FG000|Overall Study|Physician Decision|1|||
131130406|NCT00957008|472104994|FG001|Overall Study|Physician Decision|0|||
131130407|NCT00957008|472104995|FG002|Overall Study|Physician Decision|1|||
130716718|NCT02238626|470590909|FG002|Overall Study|Other|0|||
131130408|NCT00957008|472104996|FG003|Overall Study|Physician Decision|1|||
131130409|NCT00957008|472104993|FG000|Overall Study|Relocated; Family conflict|4|||
131130410|NCT00957008|472104994|FG001|Overall Study|Relocated; Family conflict|1|||
131130411|NCT00957008|472104995|FG002|Overall Study|Relocated; Family conflict|1|||
131130412|NCT00957008|472104996|FG003|Overall Study|Relocated; Family conflict|3|||
131130413|NCT01118351|472104997|FG000|Overall Study|Adverse Event|3|||
130972469|NCT02310750|471525043|FG008|HP Period 1|Withdrawal by Subject|0|||
130972470|NCT02310750|471525044|FG009|HP Period 1|Withdrawal by Subject|0|||
131130414|NCT01118351|472104997|FG000|Overall Study|Withdrawal by Subject|1|||
131130415|NCT00414453|472105011|FG000|Overall Study|Abnormal lab work|16|||
131130416|NCT00845728|472105012|FG000|Overall Study|Abnormal laboratory value (s)|2|||
131130417|NCT00845728|472105013|FG001|Overall Study|Abnormal laboratory value (s)|2|||
131130418|NCT00845728|472105012|FG000|Overall Study|Patient's inability to use the device|4|||
131130419|NCT00845728|472105013|FG001|Overall Study|Patient's inability to use the device|6|||
131130420|NCT00845728|472105012|FG000|Overall Study|Abnormal test procedure result (s)|7|||
131130421|NCT00845728|472105013|FG001|Overall Study|Abnormal test procedure result (s)|2|||
131130422|NCT00845728|472105012|FG000|Overall Study|Lost to Follow-up|22|||
130716719|NCT02238626|470590910|FG003|Overall Study|Other|0|||
130972471|NCT02310750|471525045|FG010|HP Period 1|Withdrawal by Subject|0|||
131130423|NCT00845728|472105013|FG001|Overall Study|Lost to Follow-up|13|||
130716720|NCT03347422|470590916|FG000|Part A (26 Weeks)|Adverse Event|3|||
131130424|NCT00845728|472105012|FG000|Overall Study|Death|24|||
131130425|NCT00845728|472105013|FG001|Overall Study|Death|26|||
131130426|NCT00845728|472105012|FG000|Overall Study|Administrative Problems|34|||
130972472|NCT02310750|471525046|FG011|HP Period 1|Withdrawal by Subject|0|||
130972473|NCT02310750|471525047|FG012|HP Period 1|Withdrawal by Subject|0|||
130972474|NCT02310750|471525048|FG013|HP Period 1|Withdrawal by Subject|0|||
130972475|NCT02310750|471525049|FG014|HP Period 1|Withdrawal by Subject|0|||
130972476|NCT02310750|471525050|FG015|HP Period 1|Withdrawal by Subject|0|||
130972477|NCT02310750|471525035|FG000|HP Washout 1|Lost to Follow-up|0|||
130972478|NCT02310750|471525036|FG001|HP Washout 1|Lost to Follow-up|0|||
130972479|NCT02310750|471525037|FG002|HP Washout 1|Lost to Follow-up|1|||
130972480|NCT02310750|471525038|FG003|HP Washout 1|Lost to Follow-up|1|||
130972481|NCT02310750|471525039|FG004|HP Washout 1|Lost to Follow-up|2|||
130972482|NCT02310750|471525040|FG005|HP Washout 1|Lost to Follow-up|2|||
130972483|NCT02310750|471525041|FG006|HP Washout 1|Lost to Follow-up|3|||
130972484|NCT02310750|471525042|FG007|HP Washout 1|Lost to Follow-up|0|||
130972485|NCT02310750|471525043|FG008|HP Washout 1|Lost to Follow-up|0|||
130972486|NCT02310750|471525044|FG009|HP Washout 1|Lost to Follow-up|0|||
130972487|NCT02310750|471525045|FG010|HP Washout 1|Lost to Follow-up|0|||
130972488|NCT02310750|471525046|FG011|HP Washout 1|Lost to Follow-up|0|||
130972489|NCT02310750|471525047|FG012|HP Washout 1|Lost to Follow-up|0|||
130972490|NCT02310750|471525048|FG013|HP Washout 1|Lost to Follow-up|0|||
130972491|NCT02310750|471525049|FG014|HP Washout 1|Lost to Follow-up|0|||
130972492|NCT02310750|471525050|FG015|HP Washout 1|Lost to Follow-up|0|||
130972493|NCT02310750|471525035|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972494|NCT02310750|471525036|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972495|NCT02310750|471525037|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972496|NCT02310750|471525038|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
130972497|NCT02310750|471525039|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972498|NCT02310750|471525040|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
130972499|NCT02310750|471525041|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972500|NCT02310750|471525042|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972501|NCT02310750|471525043|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
130972502|NCT02310750|471525044|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
130972503|NCT02310750|471525045|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972504|NCT02310750|471525046|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972505|NCT02310750|471525047|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972506|NCT02310750|471525048|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972507|NCT02310750|471525049|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972508|NCT02310750|471525050|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
130972509|NCT02310750|471525035|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972510|NCT02310750|471525036|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972511|NCT02310750|471525037|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972512|NCT02310750|471525038|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972513|NCT02310750|471525039|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972514|NCT02310750|471525040|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972515|NCT02310750|471525041|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972516|NCT02310750|471525042|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972517|NCT02310750|471525043|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972518|NCT02310750|471525044|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
130972519|NCT02310750|471525045|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972520|NCT02310750|471525046|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972521|NCT02310750|471525047|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972522|NCT02310750|471525048|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972523|NCT02310750|471525049|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972524|NCT02310750|471525050|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
130972525|NCT02310750|471525035|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972526|NCT02310750|471525036|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972527|NCT02310750|471525037|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972528|NCT02310750|471525038|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972529|NCT02310750|471525039|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972530|NCT02310750|471525040|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972531|NCT02310750|471525041|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972532|NCT02310750|471525042|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
130972533|NCT02310750|471525043|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
130972534|NCT02310750|471525044|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
130972535|NCT02310750|471525045|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972536|NCT02310750|471525046|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972537|NCT02310750|471525047|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972538|NCT02310750|471525048|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
131130427|NCT00845728|472105013|FG001|Overall Study|Administrative Problems|26|||
131130428|NCT00845728|472105012|FG000|Overall Study|Protocol Violation|36|||
131130429|NCT00845728|472105013|FG001|Overall Study|Protocol Violation|24|||
131130430|NCT00845728|472105012|FG000|Overall Study|Lack of Efficacy|51|||
131130431|NCT00845728|472105013|FG001|Overall Study|Lack of Efficacy|39|||
131130432|NCT00845728|472105012|FG000|Overall Study|Adverse Event|101|||
131130433|NCT00845728|472105013|FG001|Overall Study|Adverse Event|96|||
131130434|NCT00845728|472105012|FG000|Overall Study|Withdrawal by Subject|105|||
131130435|NCT00845728|472105013|FG001|Overall Study|Withdrawal by Subject|108|||
131130436|NCT04951037|472105016|FG000|Overall Study|Lost to Follow-up|16|||
131130437|NCT04951037|472105016|FG000|Overall Study|Withdrawal by Subject|5|||
130972539|NCT02310750|471525049|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972540|NCT02310750|471525050|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
130972541|NCT02310750|471525035|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972542|NCT02310750|471525036|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972543|NCT02310750|471525037|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
131130438|NCT04951037|472105016|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
131130439|NCT05630937|472105017|FG000|Overall Study|Study terminated by sponsor|1|||
131130440|NCT05630937|472105018|FG001|Overall Study|Study terminated by sponsor|1|||
130972544|NCT02310750|471525038|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972545|NCT02310750|471525039|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972546|NCT02310750|471525040|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972547|NCT02310750|471525041|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972548|NCT02310750|471525042|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
130972549|NCT02310750|471525043|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
130972550|NCT02310750|471525044|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972551|NCT02310750|471525045|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972552|NCT02310750|471525046|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972553|NCT02310750|471525047|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972554|NCT02310750|471525048|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972555|NCT02310750|471525049|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972556|NCT02310750|471525050|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
130972557|NCT02310750|471525035|FG000|HP Washout 2|Lost to Follow-up|0|||
130972558|NCT02310750|471525036|FG001|HP Washout 2|Lost to Follow-up|0|||
130972559|NCT02310750|471525037|FG002|HP Washout 2|Lost to Follow-up|0|||
130972560|NCT02310750|471525038|FG003|HP Washout 2|Lost to Follow-up|0|||
130972561|NCT02310750|471525039|FG004|HP Washout 2|Lost to Follow-up|1|||
130972562|NCT02310750|471525040|FG005|HP Washout 2|Lost to Follow-up|0|||
130972563|NCT02310750|471525041|FG006|HP Washout 2|Lost to Follow-up|7|||
131130441|NCT05630937|472105019|FG002|Overall Study|Study terminated by sponsor|8|||
131130442|NCT05630937|472105020|FG003|Overall Study|Study terminated by sponsor|0|||
131130443|NCT05630937|472105017|FG000|Overall Study|Lost to Follow-up|0|||
131130444|NCT05630937|472105018|FG001|Overall Study|Lost to Follow-up|0|||
131130445|NCT05630937|472105019|FG002|Overall Study|Lost to Follow-up|1|||
131130446|NCT05630937|472105020|FG003|Overall Study|Lost to Follow-up|0|||
131130447|NCT05630937|472105017|FG000|Overall Study|Enrolled but not treated|0|||
131130448|NCT05630937|472105018|FG001|Overall Study|Enrolled but not treated|0|||
131130449|NCT05630937|472105019|FG002|Overall Study|Enrolled but not treated|0|||
131130450|NCT05630937|472105020|FG003|Overall Study|Enrolled but not treated|1|||
131130451|NCT01604265|472105025|FG000|Overall Study|Adverse Event|1|||
131130452|NCT01604265|472105026|FG001|Overall Study|Adverse Event|0|||
131130453|NCT01604265|472105025|FG000|Overall Study|Withdrawal by Subject|1|||
131130454|NCT01604265|472105026|FG001|Overall Study|Withdrawal by Subject|0|||
131130455|NCT02706873|472105029|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
131130456|NCT02706873|472105030|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
131130457|NCT02706873|472105031|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
131130458|NCT02706873|472105032|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
131130459|NCT02706873|472105029|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
131130460|NCT02706873|472105030|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
131130461|NCT02706873|472105031|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
131130462|NCT02706873|472105032|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
131130463|NCT02706873|472105029|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
131130464|NCT02706873|472105030|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
131130465|NCT02706873|472105031|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
131130466|NCT02706873|472105032|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
131130467|NCT02706873|472105029|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
131130468|NCT02706873|472105030|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
131130469|NCT02706873|472105031|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
130716721|NCT03347422|470590917|FG001|Part A (26 Weeks)|Adverse Event|0|||
130716722|NCT03347422|470590916|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
130972564|NCT02310750|471525042|FG007|HP Washout 2|Lost to Follow-up|0|||
130972565|NCT02310750|471525043|FG008|HP Washout 2|Lost to Follow-up|0|||
130972566|NCT02310750|471525044|FG009|HP Washout 2|Lost to Follow-up|0|||
131130470|NCT02706873|472105032|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
130972567|NCT02310750|471525045|FG010|HP Washout 2|Lost to Follow-up|0|||
130972568|NCT02310750|471525046|FG011|HP Washout 2|Lost to Follow-up|0|||
130972569|NCT02310750|471525047|FG012|HP Washout 2|Lost to Follow-up|0|||
130972570|NCT02310750|471525048|FG013|HP Washout 2|Lost to Follow-up|0|||
130972571|NCT02310750|471525049|FG014|HP Washout 2|Lost to Follow-up|0|||
130972572|NCT02310750|471525050|FG015|HP Washout 2|Lost to Follow-up|0|||
130972573|NCT01226745|471525053|FG000|Overall Study|Did not complete schedule of assessments|8|||
130972574|NCT01226745|471525054|FG001|Overall Study|Did not complete schedule of assessments|3|||
130972575|NCT01226745|471525055|FG002|Overall Study|Did not complete schedule of assessments|6|||
130972576|NCT01226745|471525056|FG003|Overall Study|Did not complete schedule of assessments|0|||
130972577|NCT01226745|471525057|FG004|Overall Study|Did not complete schedule of assessments|0|||
130972578|NCT01226745|471525058|FG005|Overall Study|Did not complete schedule of assessments|1|||
130972579|NCT01226745|471525053|FG000|Overall Study|Lost to Follow-up|2|||
130972580|NCT01226745|471525054|FG001|Overall Study|Lost to Follow-up|6|||
130972581|NCT01226745|471525055|FG002|Overall Study|Lost to Follow-up|6|||
130972582|NCT01226745|471525056|FG003|Overall Study|Lost to Follow-up|1|||
130972583|NCT01226745|471525057|FG004|Overall Study|Lost to Follow-up|1|||
130972584|NCT01226745|471525058|FG005|Overall Study|Lost to Follow-up|2|||
130972585|NCT01226745|471525053|FG000|Overall Study|Death|1|||
130972586|NCT01226745|471525054|FG001|Overall Study|Death|0|||
130972587|NCT01226745|471525055|FG002|Overall Study|Death|0|||
130972588|NCT01226745|471525056|FG003|Overall Study|Death|0|||
130972589|NCT01226745|471525057|FG004|Overall Study|Death|0|||
130972590|NCT01226745|471525058|FG005|Overall Study|Death|1|||
130972591|NCT01226745|471525053|FG000|Overall Study|Other|6|||
130972592|NCT01226745|471525054|FG001|Overall Study|Other|7|||
130972593|NCT01226745|471525055|FG002|Overall Study|Other|8|||
130972594|NCT01226745|471525056|FG003|Overall Study|Other|4|||
130972595|NCT01226745|471525057|FG004|Overall Study|Other|3|||
130972596|NCT01226745|471525058|FG005|Overall Study|Other|1|||
130972597|NCT01435577|471525061|FG000|Overall Study|Adverse Event|10|||
130972598|NCT01435577|471525062|FG001|Overall Study|Adverse Event|0|||
130972599|NCT01435577|471525061|FG000|Overall Study|Lack of Efficacy|7|||
130972600|NCT01435577|471525062|FG001|Overall Study|Lack of Efficacy|51|||
130972601|NCT01435577|471525061|FG000|Overall Study|Alternative treatment started|0|||
130972602|NCT01435577|471525062|FG001|Overall Study|Alternative treatment started|1|||
130972603|NCT00718718|471525064|FG000|Prior to Week 12|Adverse Event|0|||
130972604|NCT00718718|471525065|FG001|Prior to Week 12|Adverse Event|0|||
130972605|NCT00718718|471525066|FG002|Prior to Week 12|Adverse Event|0|||
130972606|NCT00718718|471525067|FG003|Prior to Week 12|Adverse Event|0|||
130972607|NCT00718718|471525068|FG004|Prior to Week 12|Adverse Event|0|||
130972608|NCT00718718|471525069|FG005|Prior to Week 12|Adverse Event|0|||
130972609|NCT00718718|471525070|FG006|Prior to Week 12|Adverse Event|0|||
130972610|NCT00718718|471525071|FG007|Prior to Week 12|Adverse Event|1|||
130972611|NCT00718718|471525072|FG008|Prior to Week 12|Adverse Event|1|||
130972612|NCT00718718|471525073|FG009|Prior to Week 12|Adverse Event|0|||
130972613|NCT00718718|471525064|FG000|Prior to Week 12|Withdrawal by Subject|0|||
130972614|NCT00718718|471525065|FG001|Prior to Week 12|Withdrawal by Subject|0|||
130972615|NCT00718718|471525066|FG002|Prior to Week 12|Withdrawal by Subject|0|||
130972616|NCT00718718|471525067|FG003|Prior to Week 12|Withdrawal by Subject|0|||
130972617|NCT00718718|471525068|FG004|Prior to Week 12|Withdrawal by Subject|3|||
130972618|NCT00718718|471525069|FG005|Prior to Week 12|Withdrawal by Subject|0|||
130972619|NCT00718718|471525070|FG006|Prior to Week 12|Withdrawal by Subject|1|||
130972620|NCT00718718|471525071|FG007|Prior to Week 12|Withdrawal by Subject|1|||
130972621|NCT00718718|471525072|FG008|Prior to Week 12|Withdrawal by Subject|1|||
130972622|NCT00718718|471525073|FG009|Prior to Week 12|Withdrawal by Subject|0|||
130972623|NCT00718718|471525064|FG000|Prior to Week 12|Other|1|||
130972624|NCT00718718|471525065|FG001|Prior to Week 12|Other|0|||
130972625|NCT00718718|471525066|FG002|Prior to Week 12|Other|1|||
130972626|NCT00718718|471525067|FG003|Prior to Week 12|Other|0|||
130972627|NCT00718718|471525068|FG004|Prior to Week 12|Other|0|||
130972628|NCT00718718|471525069|FG005|Prior to Week 12|Other|0|||
130972629|NCT00718718|471525070|FG006|Prior to Week 12|Other|0|||
130972630|NCT00718718|471525071|FG007|Prior to Week 12|Other|0|||
130972631|NCT00718718|471525072|FG008|Prior to Week 12|Other|0|||
130972632|NCT00718718|471525073|FG009|Prior to Week 12|Other|0|||
130972633|NCT00718718|471525064|FG000|Week 12 to End of Study|Adverse Event|0|||
130972634|NCT00718718|471525065|FG001|Week 12 to End of Study|Adverse Event|0|||
130972635|NCT00718718|471525066|FG002|Week 12 to End of Study|Adverse Event|0|||
130972636|NCT00718718|471525067|FG003|Week 12 to End of Study|Adverse Event|0|||
130972637|NCT00718718|471525068|FG004|Week 12 to End of Study|Adverse Event|0|||
130972638|NCT00718718|471525069|FG005|Week 12 to End of Study|Adverse Event|0|||
130972639|NCT00718718|471525070|FG006|Week 12 to End of Study|Adverse Event|0|||
130972640|NCT00718718|471525071|FG007|Week 12 to End of Study|Adverse Event|1|||
130972641|NCT00718718|471525072|FG008|Week 12 to End of Study|Adverse Event|0|||
130972642|NCT00718718|471525073|FG009|Week 12 to End of Study|Adverse Event|0|||
130972643|NCT00718718|471525064|FG000|Week 12 to End of Study|Death|0|||
130972644|NCT00718718|471525065|FG001|Week 12 to End of Study|Death|0|||
130972645|NCT00718718|471525066|FG002|Week 12 to End of Study|Death|0|||
130972646|NCT00718718|471525067|FG003|Week 12 to End of Study|Death|0|||
130972647|NCT00718718|471525068|FG004|Week 12 to End of Study|Death|0|||
130972648|NCT00718718|471525069|FG005|Week 12 to End of Study|Death|1|||
130972649|NCT00718718|471525070|FG006|Week 12 to End of Study|Death|0|||
130972650|NCT00718718|471525071|FG007|Week 12 to End of Study|Death|0|||
130972651|NCT00718718|471525072|FG008|Week 12 to End of Study|Death|0|||
130972652|NCT00718718|471525073|FG009|Week 12 to End of Study|Death|0|||
130972653|NCT00718718|471525064|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
130972654|NCT00718718|471525065|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
130972655|NCT00718718|471525066|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
130972656|NCT00718718|471525067|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
130972657|NCT00718718|471525068|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
130972658|NCT00718718|471525069|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
130972659|NCT00718718|471525070|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
130972660|NCT00718718|471525071|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
130972661|NCT00718718|471525072|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
130972662|NCT00718718|471525073|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
130972663|NCT00718718|471525064|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
130972664|NCT00718718|471525065|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
131042902|NCT04308681|471789401|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
131042903|NCT04308681|471789402|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
131042904|NCT04308681|471789403|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
131042905|NCT04308681|471789404|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
131042906|NCT04308681|471789405|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
131042907|NCT04308681|471789406|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
131042908|NCT04308681|471789407|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
131042909|NCT04308681|471789408|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
131042910|NCT04308681|471789401|FG000|OTE - 26 Weeks|Death|0|||
131042911|NCT04308681|471789402|FG001|OTE - 26 Weeks|Death|1|||
131042912|NCT04308681|471789403|FG002|OTE - 26 Weeks|Death|0|||
131042913|NCT04308681|471789404|FG003|OTE - 26 Weeks|Death|0|||
131042914|NCT04308681|471789405|FG004|OTE - 26 Weeks|Death|0|||
131042915|NCT04308681|471789406|FG005|OTE - 26 Weeks|Death|0|||
131042916|NCT04308681|471789407|FG006|OTE - 26 Weeks|Death|1|||
131042917|NCT04308681|471789408|FG007|OTE - 26 Weeks|Death|0|||
131042918|NCT04308681|471789401|FG000|OTE - 26 Weeks|Adverse Event|0|||
131042919|NCT04308681|471789402|FG001|OTE - 26 Weeks|Adverse Event|2|||
131042920|NCT04308681|471789403|FG002|OTE - 26 Weeks|Adverse Event|8|||
131042921|NCT04308681|471789404|FG003|OTE - 26 Weeks|Adverse Event|3|||
131042922|NCT04308681|471789405|FG004|OTE - 26 Weeks|Adverse Event|0|||
131042923|NCT04308681|471789406|FG005|OTE - 26 Weeks|Adverse Event|1|||
131042924|NCT04308681|471789407|FG006|OTE - 26 Weeks|Adverse Event|2|||
131042925|NCT04308681|471789408|FG007|OTE - 26 Weeks|Adverse Event|0|||
131042926|NCT04308681|471789401|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
131042927|NCT04308681|471789402|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
131042928|NCT04308681|471789403|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
131042929|NCT04308681|471789404|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
131042930|NCT04308681|471789405|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
131042931|NCT04308681|471789406|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
131042932|NCT04308681|471789407|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
131042933|NCT04308681|471789408|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
131042934|NCT05565820|471789409|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
131042935|NCT05565820|471789410|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
131042936|NCT05565820|471789409|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
131042937|NCT05565820|471789410|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
131042938|NCT03295721|471789413|FG000|Overall Study|Adverse Event|1|||
131042939|NCT03295721|471789414|FG001|Overall Study|Adverse Event|0|||
131042940|NCT03295721|471789415|FG002|Overall Study|Adverse Event|0|||
131042941|NCT03295721|471789413|FG000|Overall Study|Lost to Follow-up|1|||
131042942|NCT03295721|471789414|FG001|Overall Study|Lost to Follow-up|1|||
131042943|NCT03295721|471789415|FG002|Overall Study|Lost to Follow-up|1|||
131042944|NCT03295721|471789413|FG000|Overall Study|Withdrawal by Subject|1|||
131042945|NCT03295721|471789414|FG001|Overall Study|Withdrawal by Subject|0|||
131042946|NCT03295721|471789415|FG002|Overall Study|Withdrawal by Subject|1|||
131042947|NCT03295721|471789413|FG000|Overall Study|Death|0|||
131042948|NCT03295721|471789414|FG001|Overall Study|Death|0|||
131130471|NCT02706873|472105029|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
130972665|NCT00718718|471525066|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
130972666|NCT00718718|471525067|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
130972667|NCT00718718|471525068|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
130972668|NCT00718718|471525069|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
131042949|NCT03295721|471789415|FG002|Overall Study|Death|1|||
130716723|NCT03347422|470590917|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
131042950|NCT04786119|471789419|FG000|Overall Study|Withdrawal by Subject|2|||
131042951|NCT03325985|471789420|FG000|Overall Study|Lost to Follow-up|122|||
131042952|NCT03325985|471789421|FG001|Overall Study|Lost to Follow-up|26|||
131042953|NCT03325985|471789422|FG002|Overall Study|Lost to Follow-up|141|||
131130472|NCT02706873|472105030|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
131130473|NCT02706873|472105031|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
131130474|NCT02706873|472105032|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
131130475|NCT02706873|472105029|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
131130476|NCT02706873|472105030|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
131130477|NCT02706873|472105031|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
131130478|NCT02706873|472105032|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
131130479|NCT02706873|472105029|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
131130480|NCT02706873|472105030|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
131130481|NCT02706873|472105031|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
131130482|NCT02706873|472105032|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
131130483|NCT02706873|472105029|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
131130484|NCT02706873|472105030|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
131130485|NCT02706873|472105031|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
131130486|NCT02706873|472105032|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
131130487|NCT02706873|472105029|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
131130488|NCT02706873|472105030|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
131130489|NCT02706873|472105031|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
131130490|NCT02706873|472105032|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
131130491|NCT02706873|472105029|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
131130492|NCT02706873|472105030|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
131130493|NCT02706873|472105031|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
131130494|NCT02706873|472105032|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
131130495|NCT02706873|472105029|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
131130496|NCT02706873|472105030|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
131130497|NCT02706873|472105031|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
131130498|NCT02706873|472105032|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
131130499|NCT02706873|472105029|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
131130500|NCT02706873|472105030|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
131130501|NCT02706873|472105031|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
131130502|NCT02706873|472105032|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
131130503|NCT02706873|472105029|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
131130504|NCT02706873|472105030|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
131130505|NCT02706873|472105031|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
131130506|NCT02706873|472105032|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
131130507|NCT00464334|472105038|FG000|Overall Study|Adverse Event|0|||
130972669|NCT00718718|471525070|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
130972670|NCT00718718|471525071|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
130972671|NCT00718718|471525072|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
130972672|NCT00718718|471525073|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
130972673|NCT00718718|471525064|FG000|Week 12 to End of Study|Other|0|||
130972674|NCT00718718|471525065|FG001|Week 12 to End of Study|Other|1|||
130972675|NCT00718718|471525066|FG002|Week 12 to End of Study|Other|0|||
130972676|NCT00718718|471525067|FG003|Week 12 to End of Study|Other|1|||
131130508|NCT00464334|472105039|FG001|Overall Study|Adverse Event|0|||
131130509|NCT00464334|472105040|FG002|Overall Study|Adverse Event|0|||
131130510|NCT00464334|472105041|FG003|Overall Study|Adverse Event|1|||
130972677|NCT00718718|471525068|FG004|Week 12 to End of Study|Other|0|||
130972678|NCT00718718|471525069|FG005|Week 12 to End of Study|Other|0|||
130972679|NCT00718718|471525070|FG006|Week 12 to End of Study|Other|1|||
130972680|NCT00718718|471525071|FG007|Week 12 to End of Study|Other|0|||
130972681|NCT00718718|471525072|FG008|Week 12 to End of Study|Other|0|||
130972682|NCT00718718|471525073|FG009|Week 12 to End of Study|Other|0|||
130972683|NCT04745169|471526351|FG000|Overall Study|Kidney transplantation|1|||
130972684|NCT04745169|471526351|FG000|Overall Study|Participant health problems|3|||
131130511|NCT00464334|472105042|FG004|Overall Study|Adverse Event|1|||
131130512|NCT00464334|472105043|FG005|Overall Study|Adverse Event|1|||
130972685|NCT04745169|471526351|FG000|Overall Study|Physician Decision|2|||
131130513|NCT00464334|472105044|FG006|Overall Study|Adverse Event|0|||
131130514|NCT00464334|472105045|FG007|Overall Study|Adverse Event|0|||
131130515|NCT00464334|472105046|FG008|Overall Study|Adverse Event|2|||
131130516|NCT00464334|472105047|FG009|Overall Study|Adverse Event|1|||
131130517|NCT00464334|472105048|FG010|Overall Study|Adverse Event|2|||
130972686|NCT02891187|471526352|FG000|Overall Study|Lost to Follow-up|1|||
131130518|NCT00464334|472105038|FG000|Overall Study|Lack of Efficacy|0|||
131130519|NCT00464334|472105039|FG001|Overall Study|Lack of Efficacy|1|||
131130520|NCT00464334|472105040|FG002|Overall Study|Lack of Efficacy|0|||
131130521|NCT00464334|472105041|FG003|Overall Study|Lack of Efficacy|0|||
131130522|NCT00464334|472105042|FG004|Overall Study|Lack of Efficacy|0|||
131130523|NCT00464334|472105043|FG005|Overall Study|Lack of Efficacy|0|||
130716724|NCT03347422|470590916|FG000|Part B (149 Weeks)|Adverse Event|0|||
130972687|NCT02891187|471526353|FG001|Overall Study|Lost to Follow-up|2|||
130972688|NCT02395120|471526356|FG000|Overall Study|Missed follow-up dental exam|57|||
130972689|NCT02395120|471526357|FG001|Overall Study|Missed follow-up dental exam|62|||
130972690|NCT02395120|471526358|FG002|Overall Study|Missed follow-up dental exam|6|||
131130524|NCT00464334|472105044|FG006|Overall Study|Lack of Efficacy|0|||
131130525|NCT00464334|472105045|FG007|Overall Study|Lack of Efficacy|0|||
131130526|NCT00464334|472105046|FG008|Overall Study|Lack of Efficacy|0|||
131130527|NCT00464334|472105047|FG009|Overall Study|Lack of Efficacy|0|||
131130528|NCT00464334|472105048|FG010|Overall Study|Lack of Efficacy|0|||
131130529|NCT00464334|472105038|FG000|Overall Study|Lost to Follow-up|0|||
131130530|NCT00464334|472105039|FG001|Overall Study|Lost to Follow-up|0|||
131130531|NCT00464334|472105040|FG002|Overall Study|Lost to Follow-up|1|||
131130532|NCT00464334|472105041|FG003|Overall Study|Lost to Follow-up|0|||
131130533|NCT00464334|472105042|FG004|Overall Study|Lost to Follow-up|1|||
131130534|NCT00464334|472105043|FG005|Overall Study|Lost to Follow-up|0|||
131130535|NCT00464334|472105044|FG006|Overall Study|Lost to Follow-up|1|||
131130536|NCT00464334|472105045|FG007|Overall Study|Lost to Follow-up|0|||
131130537|NCT00464334|472105046|FG008|Overall Study|Lost to Follow-up|0|||
131130538|NCT00464334|472105047|FG009|Overall Study|Lost to Follow-up|0|||
131130539|NCT00464334|472105048|FG010|Overall Study|Lost to Follow-up|2|||
131130540|NCT00464334|472105038|FG000|Overall Study|Progressive Disease|0|||
131130541|NCT00464334|472105039|FG001|Overall Study|Progressive Disease|0|||
131130542|NCT00464334|472105040|FG002|Overall Study|Progressive Disease|0|||
131130543|NCT00464334|472105041|FG003|Overall Study|Progressive Disease|0|||
130972691|NCT02395120|471526359|FG003|Overall Study|Missed follow-up dental exam|6|||
130972692|NCT02395120|471526360|FG004|Overall Study|Missed follow-up dental exam|51|||
130972693|NCT02526693|471526364|FG000|Overall Study|Physician Decision|3|||
130972694|NCT02526693|471526365|FG001|Overall Study|Physician Decision|1|||
130972695|NCT01983293|471526366|FG000|Overall Study|Withdrawal by Subject|29|||
130972696|NCT01983293|471526367|FG001|Overall Study|Withdrawal by Subject|15|||
130972697|NCT01983293|471526366|FG000|Overall Study|Missing 12-month visit|3|||
130972698|NCT01983293|471526367|FG001|Overall Study|Missing 12-month visit|3|||
130972699|NCT01983293|471526366|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
130972700|NCT01983293|471526367|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
130972701|NCT01275625|471526368|FG000|Overall Study|Death|1|||
130972702|NCT01275625|471526368|FG000|Overall Study|Lack of Efficacy|2|||
130972703|NCT01275625|471526368|FG000|Overall Study|Lost to Follow-up|1|||
130972704|NCT01275625|471526368|FG000|Overall Study|Withdrawal by Subject|3|||
130972705|NCT01275625|471526368|FG000|Overall Study|Protocol Violation|1|||
130972706|NCT01275625|471526368|FG000|Overall Study|Adverse Event|4|||
130972707|NCT01275625|471526368|FG000|Overall Study|Other|1|||
130972708|NCT03581305|471526369|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
130972709|NCT03581305|471526370|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
130972710|NCT03581305|471526369|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
130972711|NCT03581305|471526370|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
130972712|NCT03581305|471526369|FG000|Serotonergic Study|Withdrawal by Subject|5|||
130972713|NCT03581305|471526370|FG001|Serotonergic Study|Withdrawal by Subject|1|||
130972714|NCT01798927|471526373|FG000|Overall Study|Withdrawal by Subject|1|||
130972715|NCT03750552|471526374|FG000|Overall Study|Adverse Event|5|||
130972716|NCT03750552|471526375|FG001|Overall Study|Adverse Event|1|||
130972717|NCT03750552|471526374|FG000|Overall Study|Withdrawal by Subject|1|||
130972718|NCT03750552|471526375|FG001|Overall Study|Withdrawal by Subject|1|||
130972719|NCT03750552|471526374|FG000|Overall Study|Other|2|||
130972720|NCT03750552|471526375|FG001|Overall Study|Other|0|||
130972721|NCT01003899|471526376|FG000|Overall Study|Other Adverse Event|8|||
130972722|NCT01003899|471526376|FG000|Overall Study|Not entered|4|||
130972723|NCT01003899|471526376|FG000|Overall Study|Not treated|1|||
130972724|NCT01003899|471526376|FG000|Overall Study|Progressive disease|34|||
130972725|NCT01412944|471526378|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
130972726|NCT01412944|471526379|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
130972727|NCT01412944|471526380|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
130972728|NCT01412944|471526381|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
130972729|NCT01412944|471526382|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
130972730|NCT01412944|471526383|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
131130544|NCT00464334|472105042|FG004|Overall Study|Progressive Disease|0|||
130972731|NCT01412944|471526378|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
130972732|NCT01412944|471526379|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
130972733|NCT01412944|471526380|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
131130545|NCT00464334|472105043|FG005|Overall Study|Progressive Disease|1|||
131130546|NCT00464334|472105044|FG006|Overall Study|Progressive Disease|0|||
131130547|NCT00464334|472105045|FG007|Overall Study|Progressive Disease|0|||
130972734|NCT01412944|471526381|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
130972735|NCT01412944|471526382|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
130972736|NCT01412944|471526383|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
130972737|NCT01412944|471526378|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
130972738|NCT01412944|471526379|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
131130548|NCT00464334|472105046|FG008|Overall Study|Progressive Disease|1|||
131130549|NCT00464334|472105047|FG009|Overall Study|Progressive Disease|0|||
131130550|NCT00464334|472105048|FG010|Overall Study|Progressive Disease|0|||
130972739|NCT01412944|471526380|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
130972740|NCT01412944|471526381|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
130972741|NCT01412944|471526382|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
130972742|NCT01412944|471526383|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
131227317|NCT01567306|472459697|FG003|Overall Study|Adverse Event|2|||
131227318|NCT01567306|472459698|FG004|Overall Study|Adverse Event|4|||
131227319|NCT01567306|472459699|FG005|Overall Study|Adverse Event|1|||
131227320|NCT01567306|472459694|FG000|Overall Study|Lost to Follow-up|0|||
131227321|NCT01567306|472459695|FG001|Overall Study|Lost to Follow-up|0|||
131227322|NCT01567306|472459696|FG002|Overall Study|Lost to Follow-up|0|||
131227323|NCT01567306|472459697|FG003|Overall Study|Lost to Follow-up|0|||
130716725|NCT03347422|470590917|FG001|Part B (149 Weeks)|Adverse Event|1|||
130972743|NCT01412944|471526378|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
130972744|NCT01412944|471526379|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
130972745|NCT01412944|471526380|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
130972746|NCT01412944|471526381|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
130972747|NCT01412944|471526382|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
130972748|NCT01412944|471526383|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
130972749|NCT01412944|471526378|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
130972750|NCT01412944|471526379|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
130972751|NCT01412944|471526380|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
131042954|NCT03325985|471789423|FG003|Overall Study|Lost to Follow-up|28|||
131042955|NCT03325985|471789420|FG000|Overall Study|Death|99|||
131042956|NCT03325985|471789421|FG001|Overall Study|Death|36|||
131042957|NCT03325985|471789422|FG002|Overall Study|Death|94|||
131042958|NCT03325985|471789423|FG003|Overall Study|Death|32|||
131042959|NCT05828017|471789426|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
131042960|NCT02852655|471789427|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
131042961|NCT02852655|471789428|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
131042962|NCT02852655|471789429|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
131042963|NCT02852655|471789427|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
131042964|NCT02852655|471789428|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
131042965|NCT02852655|471789429|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
131042966|NCT02852655|471789427|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
131042967|NCT02852655|471789428|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
131042968|NCT02852655|471789429|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
131042969|NCT02852655|471789427|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
131042970|NCT02852655|471789428|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
131042971|NCT02852655|471789429|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
131042972|NCT02852655|471789427|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
131042973|NCT02852655|471789428|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
131042974|NCT02852655|471789429|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
131042975|NCT02852655|471789427|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
131042976|NCT02852655|471789428|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
131042977|NCT02852655|471789429|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
131042978|NCT02852655|471789427|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
131042979|NCT02852655|471789428|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
131042980|NCT02852655|471789429|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
131042981|NCT02852655|471789427|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
131042982|NCT02852655|471789428|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
131042983|NCT02852655|471789429|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
131042984|NCT02852655|471789427|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
131042985|NCT02852655|471789428|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
131042986|NCT02852655|471789429|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
131042987|NCT04230681|471789430|FG000|Overall Study|Physician Decision|2|||
131042988|NCT04230681|471789431|FG001|Overall Study|Physician Decision|3|||
130716726|NCT03347422|470590916|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
130716727|NCT03347422|470590917|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
130716728|NCT03347422|470590916|FG000|Part B (149 Weeks)|Other|1|||
130716729|NCT03347422|470590917|FG001|Part B (149 Weeks)|Other|0|||
130716730|NCT05183217|470590918|FG000|Overall Study|Withdrawal by Subject|1|||
130716731|NCT05183217|470590919|FG001|Overall Study|Withdrawal by Subject|1|||
130716732|NCT00969540|470590922|FG000|Overall Study|Lost to Follow-up|1|||
130972752|NCT01412944|471526381|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
130972753|NCT01412944|471526382|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
131227324|NCT01567306|472459698|FG004|Overall Study|Lost to Follow-up|2|||
131227325|NCT01567306|472459699|FG005|Overall Study|Lost to Follow-up|0|||
131227326|NCT01567306|472459694|FG000|Overall Study|Withdrawal by Subject|0|||
130716733|NCT00969540|470590923|FG001|Overall Study|Lost to Follow-up|1|||
130716734|NCT02397408|470590924|FG000|Overall Study|Physician Decision|4|||
131130551|NCT00464334|472105038|FG000|Overall Study|Study Terminated by Sponsor|0|||
131130552|NCT00464334|472105039|FG001|Overall Study|Study Terminated by Sponsor|0|||
131130553|NCT00464334|472105040|FG002|Overall Study|Study Terminated by Sponsor|0|||
131130554|NCT00464334|472105041|FG003|Overall Study|Study Terminated by Sponsor|1|||
131130555|NCT00464334|472105042|FG004|Overall Study|Study Terminated by Sponsor|0|||
131130556|NCT00464334|472105043|FG005|Overall Study|Study Terminated by Sponsor|0|||
131130557|NCT00464334|472105044|FG006|Overall Study|Study Terminated by Sponsor|0|||
131130558|NCT00464334|472105045|FG007|Overall Study|Study Terminated by Sponsor|0|||
131130559|NCT00464334|472105046|FG008|Overall Study|Study Terminated by Sponsor|0|||
131130560|NCT00464334|472105047|FG009|Overall Study|Study Terminated by Sponsor|0|||
131130561|NCT00464334|472105048|FG010|Overall Study|Study Terminated by Sponsor|0|||
131130562|NCT00464334|472105038|FG000|Overall Study|Withdrawal by Subject|1|||
131130563|NCT00464334|472105039|FG001|Overall Study|Withdrawal by Subject|7|||
131130564|NCT00464334|472105040|FG002|Overall Study|Withdrawal by Subject|4|||
131130565|NCT00464334|472105041|FG003|Overall Study|Withdrawal by Subject|2|||
131130566|NCT00464334|472105042|FG004|Overall Study|Withdrawal by Subject|2|||
131130567|NCT00464334|472105043|FG005|Overall Study|Withdrawal by Subject|2|||
131130568|NCT00464334|472105044|FG006|Overall Study|Withdrawal by Subject|2|||
131130569|NCT00464334|472105045|FG007|Overall Study|Withdrawal by Subject|1|||
131130570|NCT00464334|472105046|FG008|Overall Study|Withdrawal by Subject|3|||
131130571|NCT00464334|472105047|FG009|Overall Study|Withdrawal by Subject|0|||
131130572|NCT00464334|472105048|FG010|Overall Study|Withdrawal by Subject|0|||
131130573|NCT00794677|472105056|FG000|First Intervention|Withdrawal by Subject|2|||
131130574|NCT00794677|472105057|FG001|First Intervention|Withdrawal by Subject|0|||
131130575|NCT00796315|472105063|FG000|Overall Study|Protocol Violation|0|||
131130576|NCT00796315|472105064|FG001|Overall Study|Protocol Violation|1|||
131130577|NCT00796315|472105065|FG002|Overall Study|Protocol Violation|0|||
131130578|NCT00689871|472105072|FG000|Overall Study|Lost to Follow-up|123|||
131130579|NCT00689871|472105073|FG001|Overall Study|Lost to Follow-up|13|||
131130580|NCT00689871|472105074|FG002|Overall Study|Lost to Follow-up|37|||
131130581|NCT00689871|472105075|FG003|Overall Study|Lost to Follow-up|1|||
131130582|NCT00689871|472105072|FG000|Overall Study|Explanted of All Study Devices|36|||
131130583|NCT00689871|472105073|FG001|Overall Study|Explanted of All Study Devices|25|||
131130584|NCT00689871|472105074|FG002|Overall Study|Explanted of All Study Devices|29|||
131130585|NCT00689871|472105075|FG003|Overall Study|Explanted of All Study Devices|3|||
131130586|NCT00689871|472105072|FG000|Overall Study|Withdrawal by Subject|13|||
131130587|NCT00689871|472105073|FG001|Overall Study|Withdrawal by Subject|3|||
131130588|NCT00689871|472105074|FG002|Overall Study|Withdrawal by Subject|4|||
131130589|NCT00689871|472105075|FG003|Overall Study|Withdrawal by Subject|1|||
131130590|NCT00689871|472105072|FG000|Overall Study|Death|1|||
131130591|NCT00689871|472105073|FG001|Overall Study|Death|10|||
131130592|NCT00689871|472105074|FG002|Overall Study|Death|2|||
131130593|NCT00689871|472105075|FG003|Overall Study|Death|2|||
131130594|NCT00689871|472105072|FG000|Overall Study|Physician Decision|2|||
131130595|NCT00689871|472105073|FG001|Overall Study|Physician Decision|1|||
131130596|NCT00689871|472105074|FG002|Overall Study|Physician Decision|1|||
131130597|NCT00689871|472105075|FG003|Overall Study|Physician Decision|0|||
131130598|NCT00889265|472105078|FG000|Overall Study|Adverse Event|1|||
131130599|NCT00889265|472105078|FG000|Overall Study|Lost to Follow-up|5|||
131130600|NCT00889265|472105078|FG000|Overall Study|Protocol Violation|1|||
131130601|NCT00531752|472105079|FG000|First Double-blind Intervention Period|Adverse Event|2|||
131130602|NCT00531752|472105080|FG001|First Double-blind Intervention Period|Adverse Event|0|||
131130603|NCT00531752|472105081|FG002|First Double-blind Intervention Period|Adverse Event|1|||
131130604|NCT00531752|472105082|FG003|First Double-blind Intervention Period|Adverse Event|1|||
131130605|NCT00531752|472105079|FG000|First Double-blind Intervention Period|Other|1|||
131130606|NCT00531752|472105080|FG001|First Double-blind Intervention Period|Other|4|||
131130607|NCT00531752|472105081|FG002|First Double-blind Intervention Period|Other|4|||
131130608|NCT00531752|472105082|FG003|First Double-blind Intervention Period|Other|0|||
131130609|NCT00531752|472105079|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
131227327|NCT01567306|472459695|FG001|Overall Study|Withdrawal by Subject|0|||
131227328|NCT01567306|472459696|FG002|Overall Study|Withdrawal by Subject|0|||
131227329|NCT01567306|472459697|FG003|Overall Study|Withdrawal by Subject|0|||
131130610|NCT00531752|472105080|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
131227330|NCT01567306|472459698|FG004|Overall Study|Withdrawal by Subject|0|||
131130611|NCT00531752|472105081|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
131130612|NCT00531752|472105082|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
131130613|NCT00531752|472105079|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
131130614|NCT00531752|472105080|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
131130615|NCT00531752|472105081|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
131130616|NCT00531752|472105082|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
131130617|NCT00531752|472105079|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
131130618|NCT00531752|472105080|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
131130619|NCT00531752|472105081|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
130972754|NCT01412944|471526383|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
130972755|NCT01412944|471526378|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
130972756|NCT01412944|471526379|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
130972757|NCT01412944|471526380|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
130972758|NCT01412944|471526381|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
130972759|NCT01412944|471526382|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
130972760|NCT01412944|471526383|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
130972761|NCT01412944|471526378|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130972762|NCT01412944|471526379|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130972763|NCT01412944|471526380|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
130972764|NCT01412944|471526381|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
130972765|NCT01412944|471526382|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
130972766|NCT01412944|471526383|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130972767|NCT01412944|471526378|FG000|Entire: IV + Maintenance|Adverse Event|0|||
130972768|NCT01412944|471526379|FG001|Entire: IV + Maintenance|Adverse Event|0|||
131042989|NCT04230681|471789430|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
131042990|NCT04230681|471789431|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
131042991|NCT04230681|471789430|FG000|Overall Study|IV inadvertently removed|0|||
131042992|NCT04230681|471789431|FG001|Overall Study|IV inadvertently removed|1|||
131042993|NCT04294641|471790480|FG000|Overall Study|Screen failure|4|||
131042994|NCT05906784|471790482|FG000|Overall Study|Lost to Follow-up|2|||
131042995|NCT05906784|471790483|FG001|Overall Study|Lost to Follow-up|1|||
131042996|NCT05906784|471790484|FG002|Overall Study|Lost to Follow-up|1|||
131042997|NCT05906784|471790485|FG003|Overall Study|Lost to Follow-up|1|||
131042998|NCT02668692|471790486|FG000|Overall Study|Adverse Event|1|||
131042999|NCT02668692|471790487|FG001|Overall Study|Adverse Event|0|||
131043000|NCT01627574|471790491|FG000|Overall Study|Withdrawal by Subject|8|||
131043001|NCT01627574|471790492|FG001|Overall Study|Withdrawal by Subject|5|||
131043002|NCT01627574|471790491|FG000|Overall Study|Lost to Follow-up|13|||
131043003|NCT01627574|471790492|FG001|Overall Study|Lost to Follow-up|13|||
131043004|NCT04730739|471790493|FG000|Overall Study|Death|1|||
131043005|NCT01009788|471790497|FG000|Overall Study|Withdrawal by Subject|1|||
131043006|NCT01009788|471790498|FG001|Overall Study|Withdrawal by Subject|0|||
131043007|NCT02296684|471790499|FG000|Overall Study|Withdrawal by Subject|0|||
131043008|NCT02296684|471790500|FG001|Overall Study|Withdrawal by Subject|1|||
131043009|NCT02296684|471790501|FG002|Overall Study|Withdrawal by Subject|1|||
131043010|NCT02296684|471790499|FG000|Overall Study|Death|2|||
131043011|NCT02296684|471790500|FG001|Overall Study|Death|0|||
131043012|NCT02296684|471790501|FG002|Overall Study|Death|0|||
131043013|NCT05586490|471790502|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
131043014|NCT05586490|471790503|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
131043015|NCT05586490|471790504|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
131043016|NCT05586490|471790505|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
131043017|NCT05586490|471790506|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
131043018|NCT05586490|471790502|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
131043019|NCT05586490|471790503|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
131043020|NCT05586490|471790504|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
131043021|NCT05586490|471790505|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
131043022|NCT05586490|471790506|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
131043023|NCT05586490|471790502|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
131043024|NCT05586490|471790503|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
131043025|NCT05586490|471790504|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
131043026|NCT05586490|471790505|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
131043027|NCT05586490|471790506|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
131043028|NCT03556293|471790507|FG000|Overall Study|Ineligible for analysis|1904|||
131043029|NCT03556293|471790508|FG001|Overall Study|Ineligible for analysis|1471|||
131043030|NCT03556293|471790509|FG002|Overall Study|Ineligible for analysis|1091|||
131043031|NCT03556293|471790510|FG003|Overall Study|Ineligible for analysis|1269|||
131043032|NCT05012163|471790511|FG000|Overall Study|Protocol Violation|0|||
131043033|NCT05012163|471790512|FG001|Overall Study|Protocol Violation|0|||
131043034|NCT05012163|471790513|FG002|Overall Study|Protocol Violation|1|||
131043035|NCT05012163|471790514|FG003|Overall Study|Protocol Violation|1|||
131043036|NCT05076266|471790515|FG000|Overall Study|Survey not complete - Participant refusal|2|||
131043037|NCT05076266|471790516|FG001|Overall Study|Survey not complete - Participant refusal|0|||
131043038|NCT04003246|471790519|FG000|Overall Study|Death|9|||
131043039|NCT04132518|471790529|FG000|Overall Study|Prematurely withdrawn from the study|0|||
131043040|NCT04132518|471790530|FG001|Overall Study|Prematurely withdrawn from the study|9|||
131043041|NCT04132518|471790531|FG002|Overall Study|Prematurely withdrawn from the study|1|||
131043042|NCT05524402|471790533|FG000|Overall Study|Withdrawal by Subject|3|||
130972769|NCT01412944|471526380|FG002|Entire: IV + Maintenance|Adverse Event|0|||
131043043|NCT05524402|471790534|FG001|Overall Study|Withdrawal by Subject|1|||
130972770|NCT01412944|471526381|FG003|Entire: IV + Maintenance|Adverse Event|0|||
131130620|NCT00531752|472105082|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
131130621|NCT00531752|472105079|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
131130622|NCT00531752|472105080|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
131130623|NCT00531752|472105081|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
131130624|NCT00531752|472105082|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
131130625|NCT00531752|472105079|FG000|Second Double-blind Intervention Period|Other|1|||
131130626|NCT00531752|472105080|FG001|Second Double-blind Intervention Period|Other|1|||
131130627|NCT00531752|472105081|FG002|Second Double-blind Intervention Period|Other|0|||
131130628|NCT00531752|472105082|FG003|Second Double-blind Intervention Period|Other|0|||
131130629|NCT00531752|472105079|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
131130630|NCT00531752|472105080|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
131130631|NCT00531752|472105081|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
131130632|NCT00531752|472105082|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
131130633|NCT00531752|472105079|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
131130634|NCT00531752|472105080|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
131130635|NCT00531752|472105081|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
131130636|NCT00531752|472105082|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
131130637|NCT00950664|472105083|FG000|First Intervention|Lost to Follow-up|1|||
131130638|NCT00950664|472105084|FG001|First Intervention|Lost to Follow-up|3|||
131130639|NCT00950664|472105083|FG000|First Intervention|Withdrawal by Subject|2|||
131130640|NCT00950664|472105084|FG001|First Intervention|Withdrawal by Subject|2|||
131130641|NCT04489888|472105085|FG000|Overall Study|Death|75|||
131130642|NCT04489888|472105085|FG000|Overall Study|Sponsor Decision|26|||
131130643|NCT03349099|472105086|FG000|Overall Study|Physician Decision|3|||
131130644|NCT03349099|472105087|FG001|Overall Study|Physician Decision|4|||
131227331|NCT01567306|472459699|FG005|Overall Study|Withdrawal by Subject|1|||
131227332|NCT00738673|472459704|FG000|Overall Study|Adverse Event|1|||
131227333|NCT00738673|472459705|FG001|Overall Study|Adverse Event|0|||
131227334|NCT00738673|472459704|FG000|Overall Study|Lack of Efficacy|19|||
131227335|NCT00738673|472459705|FG001|Overall Study|Lack of Efficacy|8|||
131227336|NCT00738673|472459704|FG000|Overall Study|Protocol Violation|1|||
131227337|NCT00738673|472459705|FG001|Overall Study|Protocol Violation|2|||
131227338|NCT00738673|472459704|FG000|Overall Study|Withdrawal by Subject|3|||
131227339|NCT00738673|472459705|FG001|Overall Study|Withdrawal by Subject|1|||
131227340|NCT02736227|472459706|FG000|Overall Study|Withdrawal by Subject|0|||
131227341|NCT02736227|472459707|FG001|Overall Study|Withdrawal by Subject|0|||
131227342|NCT02736227|472459708|FG002|Overall Study|Withdrawal by Subject|1|||
131227343|NCT02736227|472459706|FG000|Overall Study|Physician Decision|0|||
131227344|NCT02736227|472459707|FG001|Overall Study|Physician Decision|0|||
131227345|NCT02736227|472459708|FG002|Overall Study|Physician Decision|5|||
131227346|NCT02736227|472459706|FG000|Overall Study|Non Compliant|0|||
131227347|NCT02736227|472459707|FG001|Overall Study|Non Compliant|0|||
131227348|NCT02736227|472459708|FG002|Overall Study|Non Compliant|2|||
131227349|NCT04120194|472459709|FG000|Overall Study|Lost to Follow-up|11|||
131227350|NCT04120194|472459710|FG001|Overall Study|Lost to Follow-up|8|||
131227351|NCT04120194|472459709|FG000|Overall Study|Adverse Event|4|||
131227352|NCT04120194|472459710|FG001|Overall Study|Adverse Event|5|||
131227353|NCT04120194|472459709|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
131227354|NCT04120194|472459710|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
131227355|NCT04120194|472459709|FG000|Overall Study|Miscellaneous|4|||
131227356|NCT04120194|472459710|FG001|Overall Study|Miscellaneous|5|||
131227357|NCT00827359|472459711|FG000|Overall Study|Progressive Diseas|19|||
131227358|NCT00827359|472459711|FG000|Overall Study|Unacceptable Toxicity|5|||
131227359|NCT00827359|472459711|FG000|Overall Study|Ineligible|1|||
131227360|NCT03840135|472459712|FG000|Overall Study|Protocol Violation|6|||
131227361|NCT03840135|472459713|FG001|Overall Study|Protocol Violation|1|||
131227362|NCT03840135|472459712|FG000|Overall Study|Withdrawal by Subject|1|||
131227363|NCT03840135|472459713|FG001|Overall Study|Withdrawal by Subject|0|||
131227364|NCT01159769|472459714|FG000|Overall Study|Adverse Event|1|||
131227365|NCT02555618|472459715|FG000|Overall Study|Sponsor's Circumstances|1|||
131130645|NCT03349099|472105086|FG000|Overall Study|Stone migrated from the kidney|1|||
131130646|NCT03349099|472105087|FG001|Overall Study|Stone migrated from the kidney|0|||
131130647|NCT00278993|472105088|FG000|Overall Study|Adverse Event|24|||
131130648|NCT00278993|472105088|FG000|Overall Study|Withdrawal by Subject|5|||
131227366|NCT02555618|472459716|FG001|Overall Study|Sponsor's Circumstances|0|||
131227367|NCT01401478|472459721|FG000|Overall Study|Study drug not available|6|||
131227368|NCT01401478|472459721|FG000|Overall Study|Adverse Event|5|||
131227369|NCT01401478|472459721|FG000|Overall Study|Hyperphosphatemia|5|||
131227370|NCT01401478|472459721|FG000|Overall Study|Lost to Follow-up|5|||
131130649|NCT00278993|472105088|FG000|Overall Study|Progressive Disease|65|||
131130650|NCT00278993|472105088|FG000|Overall Study|Physician Decision|9|||
131130651|NCT00278993|472105088|FG000|Overall Study|Not Otherwise Specified|4|||
131130652|NCT03829657|472105091|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
131227371|NCT01401478|472459721|FG000|Overall Study|Kidney transplantation|3|||
131130653|NCT03829657|472105092|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
131130654|NCT03829657|472105093|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
131130655|NCT03829657|472105094|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
131130656|NCT03829657|472105095|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
131130657|NCT03829657|472105091|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
131130658|NCT03829657|472105092|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
131130659|NCT03829657|472105093|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
131130660|NCT03829657|472105094|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
131130661|NCT03829657|472105095|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
131130662|NCT03829657|472105091|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
131130663|NCT03829657|472105092|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
131130664|NCT03829657|472105093|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
131130665|NCT03829657|472105094|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
131130666|NCT03829657|472105095|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
131130667|NCT03829657|472105091|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
131130668|NCT03829657|472105092|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
131130669|NCT03829657|472105093|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
131130670|NCT03829657|472105094|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
131130671|NCT03829657|472105095|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
131130672|NCT03829657|472105091|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
131130673|NCT03829657|472105092|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
131130674|NCT03829657|472105093|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
131130675|NCT03829657|472105094|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
131130676|NCT03829657|472105095|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
131130677|NCT03829657|472105091|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
131130678|NCT03829657|472105092|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
131130679|NCT03829657|472105093|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
131130680|NCT03829657|472105094|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
131130681|NCT03829657|472105095|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
131130682|NCT03829657|472105091|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
131130683|NCT03829657|472105092|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
131130684|NCT03829657|472105093|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
131130685|NCT03829657|472105094|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
131130686|NCT03829657|472105095|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
131130687|NCT03829657|472105091|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
131130688|NCT03829657|472105092|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
131130689|NCT03829657|472105093|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
131130690|NCT03829657|472105094|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
131130691|NCT03829657|472105095|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
131130692|NCT03829657|472105091|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
131130693|NCT03829657|472105092|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
131130694|NCT03829657|472105093|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
131130695|NCT03829657|472105094|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
131130696|NCT03829657|472105095|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
131130697|NCT03829657|472105091|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
131130698|NCT03829657|472105092|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
131130699|NCT03829657|472105093|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
131130700|NCT03829657|472105094|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
131130701|NCT03829657|472105095|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
131130702|NCT01014689|472105096|FG000|Overall Study|Lack of Efficacy|0|||
131130703|NCT01014689|472105097|FG001|Overall Study|Lack of Efficacy|1|||
131130704|NCT01014689|472105096|FG000|Overall Study|Adverse Event|3|||
131130705|NCT01014689|472105097|FG001|Overall Study|Adverse Event|0|||
131130706|NCT01014689|472105096|FG000|Overall Study|Withdrawal by Subject|5|||
131130707|NCT01014689|472105097|FG001|Overall Study|Withdrawal by Subject|4|||
130716735|NCT02397408|470590924|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
130716736|NCT01646138|470590925|FG000|Overall Study|Lost to Follow-up|0|||
130716737|NCT01646138|470590926|FG001|Overall Study|Lost to Follow-up|0|||
130716738|NCT01646138|470590927|FG002|Overall Study|Lost to Follow-up|0|||
130716739|NCT01646138|470590928|FG003|Overall Study|Lost to Follow-up|0|||
131130708|NCT01014689|472105096|FG000|Overall Study|Protocol Violation|1|||
131130709|NCT01014689|472105097|FG001|Overall Study|Protocol Violation|1|||
131130710|NCT01014689|472105096|FG000|Overall Study|Lost to Follow-up|3|||
130716740|NCT01646138|470590929|FG004|Overall Study|Lost to Follow-up|2|||
131130711|NCT01014689|472105097|FG001|Overall Study|Lost to Follow-up|7|||
131130712|NCT01014689|472105096|FG000|Overall Study|Pregnancy|1|||
131130713|NCT01014689|472105097|FG001|Overall Study|Pregnancy|0|||
131130714|NCT00647556|472106463|FG000|Overall Study|Adverse Event|0|||
131130715|NCT00647556|472106464|FG001|Overall Study|Adverse Event|1|||
131130716|NCT00647556|472106463|FG000|Overall Study|Lost to Follow-up|1|||
131130717|NCT00647556|472106464|FG001|Overall Study|Lost to Follow-up|0|||
131130718|NCT00647556|472106463|FG000|Overall Study|Protocol Violation|0|||
131130719|NCT00647556|472106464|FG001|Overall Study|Protocol Violation|1|||
131130720|NCT00647556|472106463|FG000|Overall Study|Withdrawal by Subject|1|||
131130721|NCT00647556|472106464|FG001|Overall Study|Withdrawal by Subject|0|||
131130722|NCT00647556|472106463|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
131130723|NCT00647556|472106464|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
131130724|NCT05594173|472106465|FG000|Overall Study|Adverse Event|1|||
131130725|NCT05594173|472106465|FG000|Overall Study|COVID-19 Pandemic|2|||
131130726|NCT01877187|472106466|FG000|Overall Study|Death|2|||
131130727|NCT01877187|472106466|FG000|Overall Study|Withdrawal by Subject|4|||
131130728|NCT01877187|472106466|FG000|Overall Study|Lost to Follow-up|3|||
131130729|NCT01877187|472106466|FG000|Overall Study|Declining clinical status|11|||
131130730|NCT01877187|472106466|FG000|Overall Study|Liver transplant|2|||
131130731|NCT03776175|472106468|FG000|Treatment Period (42 Days)|Adverse Event|0|||
131130732|NCT03776175|472106469|FG001|Treatment Period (42 Days)|Adverse Event|1|||
131130733|NCT03776175|472106470|FG002|Treatment Period (42 Days)|Adverse Event|1|||
131130734|NCT03776175|472106471|FG003|Treatment Period (42 Days)|Adverse Event|0|||
131130735|NCT03776175|472106468|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
131130736|NCT03776175|472106469|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
131130737|NCT03776175|472106470|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
131130738|NCT03776175|472106471|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
131130739|NCT03776175|472106468|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
131130740|NCT03776175|472106469|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
131130741|NCT03776175|472106470|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
131130742|NCT03776175|472106471|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
131130743|NCT03776175|472106468|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
131130744|NCT03776175|472106469|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
131130745|NCT03776175|472106470|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
131130746|NCT03776175|472106471|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
131130747|NCT03776175|472106468|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
131130748|NCT03776175|472106469|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
131130749|NCT03776175|472106470|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
131130750|NCT03776175|472106471|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
131130751|NCT03776175|472106468|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
131130752|NCT03776175|472106469|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
131130753|NCT03776175|472106470|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
131130754|NCT03776175|472106471|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
131130755|NCT01780831|472106481|FG000|Overall Study|Withdrawal by Subject|0|||
131130756|NCT01780831|472106482|FG001|Overall Study|Withdrawal by Subject|0|||
131130757|NCT01780831|472106483|FG002|Overall Study|Withdrawal by Subject|4|||
131130758|NCT01780831|472106484|FG003|Overall Study|Withdrawal by Subject|0|||
131130759|NCT01780831|472106481|FG000|Overall Study|Lost to Follow-up|0|||
131130760|NCT01780831|472106482|FG001|Overall Study|Lost to Follow-up|0|||
131130761|NCT01780831|472106483|FG002|Overall Study|Lost to Follow-up|0|||
131130762|NCT01780831|472106484|FG003|Overall Study|Lost to Follow-up|1|||
131130763|NCT02599961|472106485|FG000|Overall Study|Withdrawal by Subject|1|||
131130764|NCT02599961|472106485|FG000|Overall Study|Subject Non-Compliance|2|||
131130765|NCT02599961|472106485|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
131130766|NCT02599961|472106485|FG000|Overall Study|Other, Not Specified|3|||
131130767|NCT00143312|472106486|FG000|Overall Study|Death|11|||
131130768|NCT00143312|472106486|FG000|Overall Study|Adverse Event|2|||
131130769|NCT00143312|472106486|FG000|Overall Study|Lost to Follow-up|1|||
131130770|NCT00143312|472106486|FG000|Overall Study|Other|1|||
131130771|NCT00143312|472106486|FG000|Overall Study|Withdrawal by Subject|1|||
130972771|NCT01412944|471526382|FG004|Entire: IV + Maintenance|Adverse Event|1|||
130972772|NCT01412944|471526383|FG005|Entire: IV + Maintenance|Adverse Event|0|||
130972773|NCT01412944|471526378|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
131130772|NCT01029366|472106487|FG000|Overall Study|Withdrawal by Subject|1|||
131130773|NCT01029366|472106488|FG001|Overall Study|Withdrawal by Subject|0|||
131130774|NCT01029366|472106487|FG000|Overall Study|Death|1|||
131130775|NCT01029366|472106488|FG001|Overall Study|Death|1|||
131130776|NCT01029366|472106487|FG000|Overall Study|disease progression|2|||
130972774|NCT01412944|471526379|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
131130777|NCT01029366|472106488|FG001|Overall Study|disease progression|0|||
131130778|NCT01029366|472106487|FG000|Overall Study|manufacturing failure|0|||
131130779|NCT01029366|472106488|FG001|Overall Study|manufacturing failure|1|||
131130780|NCT00906087|472106494|FG000|Initial Washout|Withdrawal by Subject|1|||
131130781|NCT00906087|472106494|FG000|Initial Washout|Physician Decision|1|||
130972775|NCT01412944|471526380|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
130972776|NCT01412944|471526381|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
130972777|NCT01412944|471526382|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
131130782|NCT02898259|472106495|FG000|Overall Study|Adverse Event|0|||
130972778|NCT01412944|471526383|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
130972779|NCT01412944|471526378|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
130972780|NCT01412944|471526379|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
130972781|NCT01412944|471526380|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
130972782|NCT01412944|471526381|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
130972783|NCT01412944|471526382|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
130972784|NCT01412944|471526383|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
130972785|NCT01412944|471526378|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
130972786|NCT01412944|471526379|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
130972787|NCT01412944|471526380|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
130972788|NCT01412944|471526381|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
130972789|NCT01412944|471526382|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
130972790|NCT01412944|471526383|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
131130783|NCT02898259|472106496|FG001|Overall Study|Adverse Event|0|||
131130784|NCT02898259|472106497|FG002|Overall Study|Adverse Event|1|||
131130785|NCT02898259|472106498|FG003|Overall Study|Adverse Event|0|||
131130786|NCT02898259|472106499|FG004|Overall Study|Adverse Event|0|||
131130787|NCT02898259|472106495|FG000|Overall Study|Lack of Efficacy|1|||
131130788|NCT02898259|472106496|FG001|Overall Study|Lack of Efficacy|1|||
131130789|NCT02898259|472106497|FG002|Overall Study|Lack of Efficacy|3|||
131130790|NCT02898259|472106498|FG003|Overall Study|Lack of Efficacy|0|||
131130791|NCT02898259|472106499|FG004|Overall Study|Lack of Efficacy|0|||
131130792|NCT02898259|472106495|FG000|Overall Study|Lost to Follow-up|0|||
131130793|NCT02898259|472106496|FG001|Overall Study|Lost to Follow-up|0|||
131130794|NCT02898259|472106497|FG002|Overall Study|Lost to Follow-up|1|||
131130795|NCT02898259|472106498|FG003|Overall Study|Lost to Follow-up|0|||
131130796|NCT02898259|472106499|FG004|Overall Study|Lost to Follow-up|0|||
131130797|NCT02898259|472106495|FG000|Overall Study|Transformation before study began|0|||
131130798|NCT02898259|472106496|FG001|Overall Study|Transformation before study began|0|||
131130799|NCT02898259|472106497|FG002|Overall Study|Transformation before study began|0|||
131130800|NCT02898259|472106498|FG003|Overall Study|Transformation before study began|1|||
131130801|NCT02898259|472106499|FG004|Overall Study|Transformation before study began|0|||
131130802|NCT01046877|472106508|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
131130803|NCT01046877|472106508|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
131130804|NCT03016325|472106511|FG000|Treatment Period|Participant withdrew consent|0|||
131130805|NCT03016325|472106512|FG001|Treatment Period|Participant withdrew consent|1|||
131130806|NCT03016325|472106513|FG002|Treatment Period|Participant withdrew consent|0|||
131130807|NCT03016325|472106514|FG003|Treatment Period|Participant withdrew consent|0|||
131130808|NCT03016325|472106515|FG004|Treatment Period|Participant withdrew consent|0|||
131130809|NCT03016325|472106516|FG005|Treatment Period|Participant withdrew consent|0|||
131130810|NCT03016325|472106517|FG006|Treatment Period|Participant withdrew consent|0|||
131130811|NCT03016325|472106518|FG007|Treatment Period|Participant withdrew consent|0|||
131130812|NCT03016325|472106511|FG000|Treatment Period|Death|0|||
131130813|NCT03016325|472106512|FG001|Treatment Period|Death|0|||
131130814|NCT03016325|472106513|FG002|Treatment Period|Death|0|||
131130815|NCT03016325|472106514|FG003|Treatment Period|Death|0|||
131130816|NCT03016325|472106515|FG004|Treatment Period|Death|2|||
131130817|NCT03016325|472106516|FG005|Treatment Period|Death|0|||
131130818|NCT03016325|472106517|FG006|Treatment Period|Death|0|||
131130819|NCT03016325|472106518|FG007|Treatment Period|Death|0|||
131130820|NCT03016325|472106511|FG000|Treatment Period|Participant refuses assessments|0|||
131130821|NCT03016325|472106512|FG001|Treatment Period|Participant refuses assessments|0|||
131130822|NCT03016325|472106513|FG002|Treatment Period|Participant refuses assessments|1|||
131130823|NCT03016325|472106514|FG003|Treatment Period|Participant refuses assessments|0|||
130972791|NCT01412944|471526378|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
130972792|NCT01412944|471526379|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
131130824|NCT03016325|472106515|FG004|Treatment Period|Participant refuses assessments|0|||
131130825|NCT03016325|472106516|FG005|Treatment Period|Participant refuses assessments|0|||
131130826|NCT03016325|472106517|FG006|Treatment Period|Participant refuses assessments|0|||
131130827|NCT03016325|472106518|FG007|Treatment Period|Participant refuses assessments|0|||
131130828|NCT03016325|472106511|FG000|32-Day Follow-Up Period|Death|2|||
130972793|NCT01412944|471526380|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130972794|NCT01412944|471526381|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130972795|NCT01412944|471526382|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
131130829|NCT03016325|472106512|FG001|32-Day Follow-Up Period|Death|0|||
131130830|NCT03016325|472106513|FG002|32-Day Follow-Up Period|Death|5|||
131130831|NCT03016325|472106514|FG003|32-Day Follow-Up Period|Death|6|||
131130832|NCT03016325|472106515|FG004|32-Day Follow-Up Period|Death|3|||
131130833|NCT03016325|472106516|FG005|32-Day Follow-Up Period|Death|0|||
131130834|NCT03016325|472106517|FG006|32-Day Follow-Up Period|Death|0|||
131130835|NCT03016325|472106518|FG007|32-Day Follow-Up Period|Death|0|||
130972796|NCT01412944|471526383|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
130972797|NCT01412944|471526378|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
130716741|NCT01683838|470590930|FG000|Overall Study|Adverse Event|12|||
130716742|NCT01683838|470590931|FG001|Overall Study|Adverse Event|2|||
130716743|NCT01683838|470590930|FG000|Overall Study|Protocol Violation|3|||
130716744|NCT01683838|470590931|FG001|Overall Study|Protocol Violation|1|||
130716745|NCT01683838|470590930|FG000|Overall Study|Withdrawal by Subject|6|||
130716746|NCT01683838|470590931|FG001|Overall Study|Withdrawal by Subject|5|||
130716747|NCT01683838|470590930|FG000|Overall Study|Lost to Follow-up|1|||
130716748|NCT01683838|470590931|FG001|Overall Study|Lost to Follow-up|1|||
130716749|NCT01683838|470590930|FG000|Overall Study|Other|4|||
130716750|NCT01683838|470590931|FG001|Overall Study|Other|3|||
130716751|NCT01524679|470590932|FG000|Overall Study|Lost to Follow-up|1|||
130716752|NCT01524679|470590933|FG001|Overall Study|Lost to Follow-up|4|||
130716753|NCT01524679|470590932|FG000|Overall Study|Withdrawal by Subject|4|||
130716754|NCT01524679|470590933|FG001|Overall Study|Withdrawal by Subject|4|||
130716755|NCT01524679|470590932|FG000|Overall Study|Adverse Event|9|||
130716756|NCT01524679|470590933|FG001|Overall Study|Adverse Event|0|||
130716757|NCT01524679|470590932|FG000|Overall Study|Protocol Violation|1|||
130716758|NCT01524679|470590933|FG001|Overall Study|Protocol Violation|0|||
130716759|NCT01524679|470590932|FG000|Overall Study|Lack of Efficacy|2|||
130716760|NCT01524679|470590933|FG001|Overall Study|Lack of Efficacy|0|||
130716761|NCT01524679|470590932|FG000|Overall Study|e.g.wish for children, relocation|6|||
130716762|NCT01524679|470590933|FG001|Overall Study|e.g.wish for children, relocation|1|||
130716763|NCT00801099|470590934|FG000|Overall Study|Lost to Follow-up|101|||
130972798|NCT01412944|471526379|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
130972799|NCT01412944|471526380|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
130972800|NCT01412944|471526381|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
130972801|NCT01412944|471526382|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
130972802|NCT01412944|471526383|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
130972803|NCT01412944|471526378|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
130972804|NCT01412944|471526379|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
130972805|NCT01412944|471526380|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
130972806|NCT01412944|471526381|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
130972807|NCT01412944|471526382|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
130972808|NCT01412944|471526383|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
130972809|NCT01412944|471526378|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
130972810|NCT01412944|471526379|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
130972811|NCT01412944|471526380|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
130972812|NCT01412944|471526381|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
130972813|NCT01412944|471526382|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
130972814|NCT01412944|471526383|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
130972815|NCT01412944|471526378|FG000|Entire: IV + Maintenance|Adverse Event|0|||
130972816|NCT01412944|471526379|FG001|Entire: IV + Maintenance|Adverse Event|1|||
130972817|NCT01412944|471526380|FG002|Entire: IV + Maintenance|Adverse Event|0|||
130972818|NCT01412944|471526381|FG003|Entire: IV + Maintenance|Adverse Event|0|||
130972819|NCT01412944|471526382|FG004|Entire: IV + Maintenance|Adverse Event|0|||
130972820|NCT01412944|471526383|FG005|Entire: IV + Maintenance|Adverse Event|0|||
130972821|NCT01990950|471526384|FG000|Overall Study|Death|3|||
130972822|NCT01990950|471526384|FG000|Overall Study|Lost to Follow-up|2|||
130972823|NCT01990950|471526384|FG000|Overall Study|Withdrawal by Subject|6|||
130972824|NCT01259713|471526386|FG000|Overall Study|Adverse Event|54|||
130972825|NCT01259713|471526387|FG001|Overall Study|Adverse Event|23|||
130972826|NCT01259713|471526386|FG000|Overall Study|Death Not Related to IFI|8|||
130972827|NCT01259713|471526387|FG001|Overall Study|Death Not Related to IFI|1|||
130972828|NCT01259713|471526386|FG000|Overall Study|Investigators Discretion|14|||
130972829|NCT01259713|471526387|FG001|Overall Study|Investigators Discretion|6|||
130972830|NCT01259713|471526386|FG000|Overall Study|Lack of Efficacy|2|||
130972831|NCT01259713|471526387|FG001|Overall Study|Lack of Efficacy|0|||
130972832|NCT01259713|471526386|FG000|Overall Study|Protocol Violation|5|||
130972833|NCT01259713|471526387|FG001|Overall Study|Protocol Violation|4|||
131130836|NCT03016325|472106511|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
131130837|NCT03016325|472106512|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
131130838|NCT03016325|472106513|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
130716764|NCT03321630|470590942|FG000|Overall Study|Adverse Event|1|||
130716765|NCT03321630|470590942|FG000|Overall Study|Investigator Discretion|2|||
130716766|NCT03321630|470590942|FG000|Overall Study|Withdrawal by Subject|1|||
130716767|NCT02455050|470590943|FG000|Treatment Period 1|Lost to Follow-up|1|||
130716768|NCT02455050|470590944|FG001|Treatment Period 1|Lost to Follow-up|1|||
130716769|NCT02455050|470590945|FG002|Treatment Period 1|Lost to Follow-up|1|||
130716770|NCT02455050|470590946|FG003|Treatment Period 1|Lost to Follow-up|2|||
130972834|NCT01259713|471526386|FG000|Overall Study|Subject Withdrew Consent|12|||
130972835|NCT01259713|471526387|FG001|Overall Study|Subject Withdrew Consent|7|||
130972836|NCT06111742|471526388|FG000|Overall Study|Did not receive intervention|1|||
130972837|NCT06111742|471526389|FG001|Overall Study|Did not receive intervention|0|||
130972838|NCT06111742|471526390|FG002|Overall Study|Did not receive intervention|0|||
131130839|NCT03016325|472106514|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
131130840|NCT03016325|472106515|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
131130841|NCT03016325|472106516|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
131130842|NCT03016325|472106517|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
131130843|NCT03016325|472106518|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
131130844|NCT03016325|472106511|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
131130845|NCT03016325|472106512|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
131130846|NCT03016325|472106513|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
131130847|NCT03016325|472106514|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
131130848|NCT03016325|472106515|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
131130849|NCT03016325|472106516|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
131130850|NCT03016325|472106517|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
131130851|NCT03016325|472106518|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
131130852|NCT03016325|472106511|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
131130853|NCT03016325|472106512|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
131130854|NCT03016325|472106513|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
131130855|NCT03016325|472106514|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
131130856|NCT03016325|472106515|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
131130857|NCT03016325|472106516|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
131130858|NCT03016325|472106517|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
131130859|NCT03016325|472106518|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
131130860|NCT03016325|472106511|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
131130861|NCT03016325|472106512|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
131130862|NCT03016325|472106513|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
131130863|NCT03016325|472106514|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
131130864|NCT03016325|472106515|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
131130865|NCT03016325|472106516|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
131130866|NCT03016325|472106517|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
131130867|NCT03016325|472106518|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
131130868|NCT03016325|472106511|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131130869|NCT03016325|472106512|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131130870|NCT03016325|472106513|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
131130871|NCT03016325|472106514|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131130872|NCT03016325|472106515|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131130873|NCT03016325|472106516|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131130874|NCT03016325|472106517|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131130875|NCT03016325|472106518|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
131130876|NCT03016325|472106511|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131130877|NCT03016325|472106512|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
131130878|NCT03016325|472106513|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131130879|NCT03016325|472106514|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131130880|NCT03016325|472106515|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131130881|NCT03016325|472106516|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131130882|NCT03016325|472106517|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131130883|NCT03016325|472106518|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
131130884|NCT03016325|472106511|FG000|182-Day Follow-Up Period|Death|3|||
131130885|NCT03016325|472106512|FG001|182-Day Follow-Up Period|Death|3|||
131130886|NCT03016325|472106513|FG002|182-Day Follow-Up Period|Death|11|||
131130887|NCT03016325|472106514|FG003|182-Day Follow-Up Period|Death|12|||
131130888|NCT03016325|472106515|FG004|182-Day Follow-Up Period|Death|9|||
131130889|NCT03016325|472106516|FG005|182-Day Follow-Up Period|Death|0|||
131130890|NCT03016325|472106517|FG006|182-Day Follow-Up Period|Death|0|||
131130891|NCT03016325|472106518|FG007|182-Day Follow-Up Period|Death|1|||
131130892|NCT03016325|472106511|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
131130893|NCT03016325|472106512|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131130894|NCT03016325|472106513|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130972839|NCT06111742|471526388|FG000|Overall Study|Withdrawal by Subject|2|||
130972840|NCT06111742|471526389|FG001|Overall Study|Withdrawal by Subject|0|||
130972841|NCT06111742|471526390|FG002|Overall Study|Withdrawal by Subject|0|||
131130895|NCT03016325|472106514|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131130896|NCT03016325|472106515|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130972842|NCT00922428|471526395|FG000|Overall Study|retrospective/extremely implausible data|2|||
130972843|NCT00922428|471526395|FG000|Overall Study|no medication use or questionable use|13|||
130972844|NCT00448539|471526396|FG000|Overall Study|Medication non-compliance|4|||
131130897|NCT03016325|472106516|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130972845|NCT00448539|471526397|FG001|Overall Study|Medication non-compliance|1|||
130972846|NCT00448539|471526396|FG000|Overall Study|Protocol Violation|1|||
131130898|NCT03016325|472106517|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131130899|NCT03016325|472106518|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
131130900|NCT03016325|472106511|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
131130901|NCT03016325|472106512|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
131130902|NCT03016325|472106513|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
131130903|NCT03016325|472106514|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
131130904|NCT03016325|472106515|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
131130905|NCT03016325|472106516|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
131130906|NCT03016325|472106517|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
131130907|NCT03016325|472106518|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
131130908|NCT03016325|472106511|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131130909|NCT03016325|472106512|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131130910|NCT03016325|472106513|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131130911|NCT03016325|472106514|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131130912|NCT03016325|472106515|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
131130913|NCT03016325|472106516|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131130914|NCT03016325|472106517|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130775780|NCT01000974|470806585|FG000|Primary Vaccination Phase|Protocol Violation|40|||
130775781|NCT01000974|470806586|FG001|Primary Vaccination Phase|Protocol Violation|3|||
130775782|NCT01000974|470806587|FG002|Primary Vaccination Phase|Protocol Violation|2|||
130775783|NCT01000974|470806585|FG000|Primary Vaccination Phase|Adverse Event|14|||
130775784|NCT01000974|470806586|FG001|Primary Vaccination Phase|Adverse Event|2|||
130775785|NCT01000974|470806587|FG002|Primary Vaccination Phase|Adverse Event|2|||
130775786|NCT01000974|470806585|FG000|Primary Vaccination Phase|Other|4|||
130775787|NCT01000974|470806586|FG001|Primary Vaccination Phase|Other|9|||
130775788|NCT01000974|470806587|FG002|Primary Vaccination Phase|Other|12|||
130775789|NCT01000974|470806585|FG000|Booster Vaccination Phase|Protocol Violation|0|||
130775790|NCT01000974|470806586|FG001|Booster Vaccination Phase|Protocol Violation|0|||
130775791|NCT01000974|470806587|FG002|Booster Vaccination Phase|Protocol Violation|2|||
130775792|NCT01000974|470806585|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
130775793|NCT01000974|470806586|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
130775794|NCT01000974|470806587|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
130775795|NCT01000974|470806585|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
130775796|NCT01000974|470806586|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
130775797|NCT01000974|470806587|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
130775798|NCT01000974|470806585|FG000|Booster Vaccination Phase|Other|24|||
130775799|NCT01000974|470806586|FG001|Booster Vaccination Phase|Other|6|||
130775800|NCT01000974|470806587|FG002|Booster Vaccination Phase|Other|4|||
130775801|NCT02750332|470806590|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130775802|NCT02750332|470806591|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130775803|NCT02485483|470806596|FG000|Overall Study|Depression at baseline|15|||
130775804|NCT02485483|470806597|FG001|Overall Study|Depression at baseline|0|||
130775805|NCT02485483|470806596|FG000|Overall Study|Discontinued after baseline|39|||
130775806|NCT02485483|470806597|FG001|Overall Study|Discontinued after baseline|0|||
130775807|NCT01724177|470806599|FG000|Overall Study|Adverse Event|8|||
130775808|NCT01724177|470806599|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
130775809|NCT01724177|470806599|FG000|Overall Study|Nervous participant|1|||
130775810|NCT01724177|470806599|FG000|Overall Study|Serious Adverse Event Related|1|||
130775811|NCT02982863|470806604|FG000|Overall Study|Not eligible patients|809|||
130775812|NCT02982863|470806605|FG001|Overall Study|Not eligible patients|4261|||
130775813|NCT02982863|470806606|FG002|Overall Study|Not eligible patients|1852|||
130775814|NCT02982863|470806607|FG003|Overall Study|Not eligible patients|1400|||
130972847|NCT00448539|471526397|FG001|Overall Study|Protocol Violation|0|||
130972848|NCT00448539|471526396|FG000|Overall Study|Request of the investigator or sponsor|67|||
130972849|NCT00448539|471526397|FG001|Overall Study|Request of the investigator or sponsor|54|||
131130915|NCT03016325|472106518|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
131130916|NCT03016325|472106511|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
131130917|NCT03016325|472106512|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
131130918|NCT03016325|472106513|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
131130919|NCT03016325|472106514|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
131130920|NCT03016325|472106515|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
131130921|NCT03016325|472106516|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
131130922|NCT03016325|472106517|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
131227372|NCT01401478|472459721|FG000|Overall Study|Withdrawal by Subject|3|||
131227373|NCT01401478|472459721|FG000|Overall Study|Blood samples not available|1|||
130972850|NCT00448539|471526396|FG000|Overall Study|Withdrawal by Subject|20|||
130972851|NCT00448539|471526397|FG001|Overall Study|Withdrawal by Subject|24|||
131130923|NCT03016325|472106518|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
130775815|NCT02982863|470806608|FG004|Overall Study|Not eligible patients|492|||
130775816|NCT02457195|470806609|FG000|Overall Study|Adverse Event|3|||
130775817|NCT02457195|470806609|FG000|Overall Study|Protocol Violation|2|||
130775818|NCT02457195|470806609|FG000|Overall Study|Withdrawal by Subject|4|||
130716771|NCT02455050|470590943|FG000|Treatment Period 2|Lost to Follow-up|1|||
130716772|NCT02455050|470590944|FG001|Treatment Period 2|Lost to Follow-up|0|||
130716773|NCT02455050|470590945|FG002|Treatment Period 2|Lost to Follow-up|2|||
130716774|NCT02455050|470590946|FG003|Treatment Period 2|Lost to Follow-up|1|||
130972852|NCT00448539|471526396|FG000|Overall Study|Diary non-compliance|1|||
130972853|NCT00448539|471526397|FG001|Overall Study|Diary non-compliance|0|||
130972854|NCT00448539|471526396|FG000|Overall Study|Adverse Event|9|||
130972855|NCT00448539|471526397|FG001|Overall Study|Adverse Event|26|||
130972856|NCT00448539|471526396|FG000|Overall Study|Lack of Efficacy|27|||
130972857|NCT00448539|471526397|FG001|Overall Study|Lack of Efficacy|40|||
130972858|NCT00448539|471526396|FG000|Overall Study|Miscellaneous|2|||
130972859|NCT00448539|471526397|FG001|Overall Study|Miscellaneous|1|||
130972860|NCT00448539|471526396|FG000|Overall Study|Change of meds|2|||
131043044|NCT05524402|471790533|FG000|Overall Study|Lost to Follow-up|2|||
131043045|NCT05524402|471790534|FG001|Overall Study|Lost to Follow-up|1|||
131043046|NCT04056611|471790538|FG000|Overall Study|Physician Decision|1|||
131043047|NCT03733925|471790539|FG000|Overall Study|Lost to Follow-up|1|||
131043048|NCT03733925|471790539|FG000|Overall Study|Withdrawal by Subject|2|||
131043049|NCT03733925|471790539|FG000|Overall Study|Adverse Event|2|||
131043050|NCT03733925|471790539|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131043051|NCT03213873|471790540|FG000|Overall Study|Withdrawal by Subject|8|||
131043052|NCT03213873|471790541|FG001|Overall Study|Withdrawal by Subject|9|||
131043053|NCT03213873|471790540|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
131043054|NCT03213873|471790541|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
131043055|NCT03213873|471790540|FG000|Overall Study|Lost to Follow-up|0|||
131043056|NCT03213873|471790541|FG001|Overall Study|Lost to Follow-up|2|||
131043057|NCT02631746|471790547|FG000|Overall Study|Lack of Efficacy|3|||
131043058|NCT02361216|471790548|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
131043059|NCT02361216|471790549|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
131043060|NCT02361216|471790548|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
131043061|NCT02361216|471790549|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
131043062|NCT02361216|471790548|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
131043063|NCT02361216|471790549|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
131043064|NCT02361216|471790548|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
131043065|NCT02361216|471790549|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
131043066|NCT02361216|471790548|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
131043067|NCT02361216|471790549|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
131043068|NCT02361216|471790548|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
131043069|NCT02361216|471790549|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
131043070|NCT02224144|471790550|FG000|Overall Study|Lost to Follow-up|3|||
131043071|NCT02224144|471790551|FG001|Overall Study|Lost to Follow-up|1|||
131043072|NCT02224144|471790550|FG000|Overall Study|Death|2|||
131043073|NCT02224144|471790551|FG001|Overall Study|Death|0|||
131043074|NCT02224144|471790550|FG000|Overall Study|Withdrawal by Subject|0|||
131043075|NCT02224144|471790551|FG001|Overall Study|Withdrawal by Subject|1|||
131043076|NCT04544007|471790560|FG000|Overall Study|Withdrawal by Subject|1|||
131043077|NCT04544007|471790560|FG000|Overall Study|Confirmed Progressive Disease|1|||
131043078|NCT02988661|471790561|FG000|Overall Study|Death|2|||
131043079|NCT02988661|471790562|FG001|Overall Study|Death|18|||
131043080|NCT02988661|471790561|FG000|Overall Study|Lost to Follow-up|0|||
131043081|NCT02988661|471790562|FG001|Overall Study|Lost to Follow-up|33|||
131043082|NCT02988661|471790561|FG000|Overall Study|Withdrawal by Subject|0|||
131043083|NCT02988661|471790562|FG001|Overall Study|Withdrawal by Subject|6|||
131043084|NCT02988661|471790561|FG000|Overall Study|Unable to complete the 18-month survey|1|||
131043085|NCT02988661|471790562|FG001|Overall Study|Unable to complete the 18-month survey|27|||
131043086|NCT05660434|471790565|FG000|Overall Study|Never obtained study materials|2|||
131043087|NCT05660434|471790566|FG001|Overall Study|Never obtained study materials|1|||
131043088|NCT02413489|471790582|FG000|Overall Study|Death|11|||
131043089|NCT02413489|471790583|FG001|Overall Study|Death|3|||
131043090|NCT02413489|471790584|FG002|Overall Study|Death|4|||
131043091|NCT02413489|471790582|FG000|Overall Study|Withdrawal by Subject|2|||
131043092|NCT02413489|471790583|FG001|Overall Study|Withdrawal by Subject|0|||
131043093|NCT02413489|471790584|FG002|Overall Study|Withdrawal by Subject|0|||
131043094|NCT02413489|471790582|FG000|Overall Study|Study Terminated By Sponsor|2|||
131043095|NCT02413489|471790583|FG001|Overall Study|Study Terminated By Sponsor|13|||
131043096|NCT02413489|471790584|FG002|Overall Study|Study Terminated By Sponsor|1|||
131043097|NCT02575950|471790585|FG000|Overall Study|Withdrawal by Subject|0|||
131043098|NCT02575950|471790586|FG001|Overall Study|Withdrawal by Subject|0|||
131043099|NCT02575950|471790587|FG002|Overall Study|Withdrawal by Subject|0|||
130716775|NCT02981303|470590947|FG000|Overall Study|Progressive Disease|17|||
130716776|NCT02981303|470590948|FG001|Overall Study|Progressive Disease|37|||
130716777|NCT02981303|470590947|FG000|Overall Study|Adverse Event|1|||
130716778|NCT02981303|470590948|FG001|Overall Study|Adverse Event|4|||
130972861|NCT00448539|471526397|FG001|Overall Study|Change of meds|3|||
131043100|NCT02575950|471790588|FG003|Overall Study|Withdrawal by Subject|2|||
130972862|NCT00448539|471526396|FG000|Overall Study|Lost to Follow-up|1|||
130716779|NCT02981303|470590947|FG000|Overall Study|Withdrawal by Subject|0|||
130716780|NCT02981303|470590948|FG001|Overall Study|Withdrawal by Subject|1|||
130716781|NCT02325518|470590949|FG000|Overall Study|Adverse Event|4|||
130716782|NCT02325518|470590950|FG001|Overall Study|Adverse Event|1|||
130716783|NCT02325518|470590949|FG000|Overall Study|Physician Decision|0|||
130716784|NCT02325518|470590950|FG001|Overall Study|Physician Decision|1|||
130716785|NCT02325518|470590949|FG000|Overall Study|Withdrawal by Subject|0|||
130716786|NCT02325518|470590950|FG001|Overall Study|Withdrawal by Subject|1|||
130716787|NCT03393806|470590953|FG000|Overall Study|Physician Decision|1|||
130716788|NCT03393806|470590954|FG001|Overall Study|Physician Decision|0|||
130972863|NCT00448539|471526397|FG001|Overall Study|Lost to Follow-up|3|||
130972864|NCT02103439|471526398|FG000|Overall Study|Adverse Event|0|||
130972865|NCT02103439|471526399|FG001|Overall Study|Adverse Event|2|||
130972866|NCT02103439|471526398|FG000|Overall Study|Withdrawal by Subject|3|||
130972867|NCT02103439|471526399|FG001|Overall Study|Withdrawal by Subject|1|||
130972868|NCT00695903|471526400|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
130972869|NCT00695903|471526401|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
130972870|NCT00695903|471526400|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
130972871|NCT00695903|471526401|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
130972872|NCT00695903|471526400|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
130972873|NCT00695903|471526401|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
130972874|NCT00695903|471526400|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
130972875|NCT00695903|471526401|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
130972876|NCT00695903|471526400|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
130972877|NCT00695903|471526401|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
131043101|NCT02575950|471790585|FG000|Overall Study|Lost to Follow-up|0|||
131043102|NCT02575950|471790586|FG001|Overall Study|Lost to Follow-up|1|||
131043103|NCT02575950|471790587|FG002|Overall Study|Lost to Follow-up|0|||
131043104|NCT02575950|471790588|FG003|Overall Study|Lost to Follow-up|3|||
131043105|NCT04271046|471790589|FG000|Overall Study|Death|0|||
131043106|NCT04271046|471790590|FG001|Overall Study|Death|2|||
131043107|NCT04271046|471790591|FG002|Overall Study|Death|0|||
131043108|NCT04271046|471790592|FG003|Overall Study|Death|2|||
131043109|NCT04271046|471790589|FG000|Overall Study|Lost to Follow-up|12|||
131043110|NCT04271046|471790590|FG001|Overall Study|Lost to Follow-up|12|||
131043111|NCT04271046|471790591|FG002|Overall Study|Lost to Follow-up|11|||
131043112|NCT04271046|471790592|FG003|Overall Study|Lost to Follow-up|11|||
131043113|NCT04271046|471790589|FG000|Overall Study|Patient with Dementia Died|2|||
131043114|NCT04271046|471790590|FG001|Overall Study|Patient with Dementia Died|0|||
131043115|NCT04271046|471790591|FG002|Overall Study|Patient with Dementia Died|2|||
131043116|NCT04271046|471790592|FG003|Overall Study|Patient with Dementia Died|0|||
131043117|NCT04271046|471790589|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
131043118|NCT04271046|471790590|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
131043119|NCT04271046|471790591|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
131043120|NCT04271046|471790592|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
131043121|NCT03308877|471792952|FG000|Overall Study|Lost to Follow-up|32|||
131043122|NCT03308877|471792953|FG001|Overall Study|Lost to Follow-up|28|||
131043125|NCT04707469|471792967|FG000|Overall Study|Site closure|0|||
131043126|NCT04707469|471792968|FG001|Overall Study|Site closure|2|||
131043127|NCT04707469|471792969|FG002|Overall Study|Site closure|0|||
131043128|NCT04707469|471792967|FG000|Overall Study|Physician Decision|2|||
131043129|NCT04707469|471792968|FG001|Overall Study|Physician Decision|2|||
131043130|NCT04707469|471792969|FG002|Overall Study|Physician Decision|2|||
131043131|NCT04707469|471792967|FG000|Overall Study|Death|1|||
131043132|NCT04707469|471792968|FG001|Overall Study|Death|6|||
131043133|NCT04707469|471792969|FG002|Overall Study|Death|2|||
131043134|NCT04707469|471792967|FG000|Overall Study|Lost to Follow-up|9|||
131043135|NCT04707469|471792968|FG001|Overall Study|Lost to Follow-up|19|||
131043136|NCT04707469|471792969|FG002|Overall Study|Lost to Follow-up|14|||
131043137|NCT04707469|471792967|FG000|Overall Study|Withdrawal by Subject|17|||
131043138|NCT04707469|471792968|FG001|Overall Study|Withdrawal by Subject|16|||
131043139|NCT04707469|471792969|FG002|Overall Study|Withdrawal by Subject|12|||
131043140|NCT05218096|471792980|FG000|Primary Evaluation|Withdrawal by Subject|0|||
131043141|NCT05218096|471792981|FG001|Primary Evaluation|Withdrawal by Subject|0|||
130716789|NCT00886288|470590955|FG000|Overall Study|no respect of the 12 weeks period|657|||
130972878|NCT00695903|471526400|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
131043142|NCT05218096|471792982|FG002|Primary Evaluation|Withdrawal by Subject|2|||
131043143|NCT05218096|471792983|FG003|Primary Evaluation|Withdrawal by Subject|0|||
131043144|NCT05218096|471792984|FG004|Primary Evaluation|Withdrawal by Subject|0|||
131043145|NCT05218096|471792980|FG000|Primary Evaluation|Physician Decision|1|||
131043146|NCT05218096|471792981|FG001|Primary Evaluation|Physician Decision|0|||
131043147|NCT05218096|471792982|FG002|Primary Evaluation|Physician Decision|0|||
130716790|NCT00886288|470590956|FG001|Overall Study|no respect of the 12 weeks period|227|||
131227374|NCT01401478|472459721|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
131227375|NCT01401478|472459721|FG000|Overall Study|Low intact parathyroid hormone|1|||
131227376|NCT01401478|472459721|FG000|Overall Study|Serious adverse event|1|||
131227377|NCT01809314|472459722|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
131227378|NCT01809314|472459722|FG000|Overall Study|Adverse Event|6|||
130716791|NCT00886288|470590955|FG000|Overall Study|Lost to Follow-up|86|||
130716792|NCT00886288|470590956|FG001|Overall Study|Lost to Follow-up|0|||
130716793|NCT01259115|470590957|FG000|Period 1|Adverse Event|1|||
130716794|NCT01259115|470590958|FG001|Period 1|Adverse Event|0|||
130716795|NCT01259115|470590957|FG000|Period 1|Protocol Violation|2|||
130716796|NCT01259115|470590958|FG001|Period 1|Protocol Violation|0|||
130716797|NCT01259115|470590957|FG000|Period 1|Lost to Follow-up|0|||
130716798|NCT01259115|470590958|FG001|Period 1|Lost to Follow-up|1|||
130716799|NCT01259115|470590957|FG000|Period 2|Adverse Event|1|||
130716800|NCT01259115|470590958|FG001|Period 2|Adverse Event|0|||
130716801|NCT01675661|470590959|FG000|Overall Study|Lost to Follow-up|22|||
130716802|NCT01675661|470590960|FG001|Overall Study|Lost to Follow-up|23|||
130716803|NCT01675661|470590959|FG000|Overall Study|Practical problems|9|||
130972879|NCT00695903|471526401|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
130972880|NCT00695903|471526400|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
130972881|NCT00695903|471526401|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
130972882|NCT00695903|471526400|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
130972883|NCT00695903|471526401|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
130972884|NCT00695903|471526400|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
130972885|NCT00695903|471526401|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
130972886|NCT03966157|471526402|FG000|Overall Study|Physician Decision|1|||
130972887|NCT03966157|471526403|FG001|Overall Study|Physician Decision|0|||
130972888|NCT02384759|471526405|FG000|Overall Study|Patients not treated|3|||
131043148|NCT05218096|471792983|FG003|Primary Evaluation|Physician Decision|0|||
130972889|NCT02384759|471526406|FG001|Overall Study|Patients not treated|2|||
130972890|NCT03732209|471526408|FG000|Overall Study|Lost to Follow-up|4|||
130972891|NCT03732209|471526409|FG001|Overall Study|Lost to Follow-up|4|||
130972892|NCT03732209|471526408|FG000|Overall Study|Withdrawal by Subject|8|||
130972893|NCT03732209|471526409|FG001|Overall Study|Withdrawal by Subject|9|||
130972894|NCT02063724|471526410|FG000|Overall Study|Disease progression|1|||
130972895|NCT01715805|471526411|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
130972896|NCT01715805|471526412|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
130972897|NCT01715805|471526413|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
130972898|NCT01715805|471526414|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
130972899|NCT01715805|471526411|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
130972900|NCT01715805|471526412|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
130972901|NCT01715805|471526413|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
130972902|NCT01715805|471526414|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
130972903|NCT01715805|471526411|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
130972904|NCT01715805|471526412|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
130972905|NCT01715805|471526413|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
130972906|NCT01715805|471526414|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
130972907|NCT01715805|471526411|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
130972908|NCT01715805|471526412|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
130972909|NCT01715805|471526413|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
130972910|NCT01715805|471526414|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
130972911|NCT01715805|471526411|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
130972912|NCT01715805|471526412|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
130972913|NCT01715805|471526413|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
130972914|NCT01715805|471526414|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
130972915|NCT01715805|471526411|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
130972916|NCT01715805|471526412|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
130972917|NCT01715805|471526413|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
130972918|NCT01715805|471526414|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
130972919|NCT01715805|471526411|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
130972920|NCT01715805|471526412|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
130972921|NCT01715805|471526413|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
130972922|NCT01715805|471526414|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
130972923|NCT01715805|471526411|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
130972924|NCT01715805|471526412|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
130972925|NCT01715805|471526413|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
130972926|NCT01715805|471526414|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
131043149|NCT05218096|471792984|FG004|Primary Evaluation|Physician Decision|0|||
130716804|NCT01675661|470590960|FG001|Overall Study|Practical problems|5|||
130716805|NCT01675661|470590959|FG000|Overall Study|Moved away|5|||
130716806|NCT01675661|470590960|FG001|Overall Study|Moved away|6|||
130972927|NCT01715805|471526411|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
130972928|NCT01715805|471526412|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
130972929|NCT01715805|471526413|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
130972930|NCT01715805|471526414|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
130972931|NCT01715805|471526411|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
130972932|NCT01715805|471526412|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
130972933|NCT01715805|471526413|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
130972934|NCT01715805|471526414|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
130972935|NCT01715805|471526411|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
130972936|NCT01715805|471526412|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
130972937|NCT01715805|471526413|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
130972938|NCT01715805|471526414|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
130972939|NCT01715805|471526411|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
130972940|NCT01715805|471526412|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
130972941|NCT01715805|471526413|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
130972942|NCT01715805|471526414|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
130972943|NCT01715805|471526411|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
130972944|NCT01715805|471526412|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
130972945|NCT01715805|471526413|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
130972946|NCT01715805|471526414|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
130972947|NCT01715805|471526411|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
130972948|NCT01715805|471526412|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
130972949|NCT01715805|471526413|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
130972950|NCT01715805|471526414|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
130972951|NCT01618864|471526417|FG000|Overall Study|Withdrawal by Subject|2|||
130972952|NCT01618864|471526417|FG000|Overall Study|Lost to Follow-up|2|||
130972953|NCT05177770|471526418|FG000|Overall Study|Death|4|||
130972954|NCT05177770|471526418|FG000|Overall Study|Withdrawal by Subject|1|||
130972955|NCT05177770|471526418|FG000|Overall Study|Adverse Event prior to dosing|1|||
130972956|NCT00709722|471526423|FG000|Overall Study|Adverse Event|1|||
130972957|NCT04667117|471526424|FG000|Investigational Period|Lost to Follow-up|0|||
130972958|NCT04667117|471526425|FG001|Investigational Period|Lost to Follow-up|0|||
130972959|NCT04667117|471526426|FG002|Investigational Period|Lost to Follow-up|1|||
130972960|NCT04667117|471526424|FG000|Investigational Period|Protocol Deviation|0|||
130972961|NCT04667117|471526425|FG001|Investigational Period|Protocol Deviation|1|||
130972962|NCT04667117|471526426|FG002|Investigational Period|Protocol Deviation|0|||
130716807|NCT01675661|470590959|FG000|Overall Study|Withdrawal by Subject|3|||
130716808|NCT01675661|470590960|FG001|Overall Study|Withdrawal by Subject|7|||
130716809|NCT01675661|470590959|FG000|Overall Study|Physician Decision|0|||
130716810|NCT01675661|470590960|FG001|Overall Study|Physician Decision|2|||
130716811|NCT01675661|470590959|FG000|Overall Study|Death|0|||
130972963|NCT04667117|471526424|FG000|Extension Period|Lost to Follow-up|1|||
130972964|NCT04667117|471526425|FG001|Extension Period|Lost to Follow-up|0|||
130972965|NCT04667117|471526426|FG002|Extension Period|Lost to Follow-up|0|||
130972966|NCT01650259|471526440|FG000|Overall Study|Improvement|105|||
131043150|NCT05218096|471792980|FG000|Extended Treatment|Clinical Deterioration|1|||
131043151|NCT05218096|471792981|FG001|Extended Treatment|Clinical Deterioration|1|||
131043152|NCT05218096|471792982|FG002|Extended Treatment|Clinical Deterioration|0|||
131043153|NCT05218096|471792983|FG003|Extended Treatment|Clinical Deterioration|0|||
131043154|NCT05218096|471792984|FG004|Extended Treatment|Clinical Deterioration|0|||
131043155|NCT05218096|471792980|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
131043156|NCT05218096|471792981|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
131043157|NCT05218096|471792982|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
131043158|NCT05218096|471792983|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
131043159|NCT05218096|471792984|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
131043160|NCT05218096|471792980|FG000|Extended Treatment|Withdrawal by Subject|1|||
131043161|NCT05218096|471792981|FG001|Extended Treatment|Withdrawal by Subject|3|||
131043162|NCT05218096|471792982|FG002|Extended Treatment|Withdrawal by Subject|0|||
131043163|NCT05218096|471792983|FG003|Extended Treatment|Withdrawal by Subject|2|||
131043164|NCT05218096|471792984|FG004|Extended Treatment|Withdrawal by Subject|2|||
131043165|NCT05218096|471792980|FG000|Extended Treatment|Lack of Efficacy|3|||
131043166|NCT05218096|471792981|FG001|Extended Treatment|Lack of Efficacy|0|||
131043167|NCT05218096|471792982|FG002|Extended Treatment|Lack of Efficacy|0|||
131043168|NCT05218096|471792983|FG003|Extended Treatment|Lack of Efficacy|0|||
131043169|NCT05218096|471792984|FG004|Extended Treatment|Lack of Efficacy|0|||
131043170|NCT05218096|471792980|FG000|Extended Treatment|Physician Decision|0|||
131043171|NCT05218096|471792981|FG001|Extended Treatment|Physician Decision|1|||
131043172|NCT05218096|471792982|FG002|Extended Treatment|Physician Decision|0|||
131043173|NCT05218096|471792983|FG003|Extended Treatment|Physician Decision|0|||
131043174|NCT05218096|471792984|FG004|Extended Treatment|Physician Decision|0|||
130716812|NCT01675661|470590960|FG001|Overall Study|Death|1|||
130972967|NCT01650259|471526441|FG001|Overall Study|Improvement|0|||
130972968|NCT01650259|471526440|FG000|Overall Study|Adverse Event|127|||
130972969|NCT01650259|471526441|FG001|Overall Study|Adverse Event|0|||
130972970|NCT01650259|471526440|FG000|Overall Study|Lack of Efficacy|143|||
130972971|NCT01650259|471526441|FG001|Overall Study|Lack of Efficacy|0|||
130972972|NCT01650259|471526440|FG000|Overall Study|Lost to Follow-up|435|||
130972973|NCT01650259|471526441|FG001|Overall Study|Lost to Follow-up|0|||
130972974|NCT01650259|471526440|FG000|Overall Study|Patients had no visit after entry|70|||
130972975|NCT01650259|471526441|FG001|Overall Study|Patients had no visit after entry|0|||
130972976|NCT01650259|471526440|FG000|Overall Study|CRF not collected|98|||
130972977|NCT01650259|471526441|FG001|Overall Study|CRF not collected|82|||
130972978|NCT01650259|471526440|FG000|Overall Study|Not treated|1|||
130972979|NCT01650259|471526441|FG001|Overall Study|Not treated|7|||
130972980|NCT01650259|471526440|FG000|Overall Study|Other than listed|64|||
130972981|NCT01650259|471526441|FG001|Overall Study|Other than listed|146|||
130972982|NCT02663128|471526448|FG000|Period 2|Physician Decision|0|||
130972983|NCT02663128|471526449|FG001|Period 2|Physician Decision|0|||
130972984|NCT02663128|471526450|FG002|Period 2|Physician Decision|0|||
130972985|NCT02663128|471526451|FG003|Period 2|Physician Decision|0|||
130972986|NCT02663128|471526452|FG004|Period 2|Physician Decision|1|||
130972987|NCT02663128|471526453|FG005|Period 2|Physician Decision|0|||
130972988|NCT01358526|471526454|FG000|Open-label Titration Period|Adverse Event|95|||
130972989|NCT01358526|471526455|FG001|Open-label Titration Period|Adverse Event|0|||
130972990|NCT01358526|471526456|FG002|Open-label Titration Period|Adverse Event|0|||
130972991|NCT01358526|471526454|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
130972992|NCT01358526|471526455|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
130972993|NCT01358526|471526456|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
130972994|NCT01358526|471526454|FG000|Open-label Titration Period|Lost to Follow-up|25|||
130972995|NCT01358526|471526455|FG001|Open-label Titration Period|Lost to Follow-up|0|||
130972996|NCT01358526|471526456|FG002|Open-label Titration Period|Lost to Follow-up|0|||
130972997|NCT01358526|471526454|FG000|Open-label Titration Period|Lack of Efficacy|107|||
130972998|NCT01358526|471526455|FG001|Open-label Titration Period|Lack of Efficacy|0|||
130972999|NCT01358526|471526456|FG002|Open-label Titration Period|Lack of Efficacy|0|||
130973000|NCT01358526|471526454|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
130973001|NCT01358526|471526455|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
130973002|NCT01358526|471526456|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
130973003|NCT01358526|471526454|FG000|Open-label Titration Period|Administrative|8|||
130973004|NCT01358526|471526455|FG001|Open-label Titration Period|Administrative|0|||
130973005|NCT01358526|471526456|FG002|Open-label Titration Period|Administrative|0|||
130973006|NCT01358526|471526454|FG000|Open-label Titration Period|Did not qualify|178|||
130973007|NCT01358526|471526455|FG001|Open-label Titration Period|Did not qualify|0|||
130973008|NCT01358526|471526456|FG002|Open-label Titration Period|Did not qualify|0|||
130973009|NCT01358526|471526454|FG000|Double-blind Phase|Adverse Event|0|||
130973010|NCT01358526|471526455|FG001|Double-blind Phase|Adverse Event|24|||
130973011|NCT01358526|471526456|FG002|Double-blind Phase|Adverse Event|23|||
130973012|NCT01358526|471526454|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130973013|NCT01358526|471526455|FG001|Double-blind Phase|Withdrawal by Subject|10|||
130973014|NCT01358526|471526456|FG002|Double-blind Phase|Withdrawal by Subject|8|||
130973015|NCT01358526|471526454|FG000|Double-blind Phase|Lost to Follow-up|0|||
130973016|NCT01358526|471526455|FG001|Double-blind Phase|Lost to Follow-up|4|||
130973017|NCT01358526|471526456|FG002|Double-blind Phase|Lost to Follow-up|1|||
130973018|NCT01358526|471526454|FG000|Double-blind Phase|Lack of Efficacy|0|||
130973019|NCT01358526|471526455|FG001|Double-blind Phase|Lack of Efficacy|31|||
130973020|NCT01358526|471526456|FG002|Double-blind Phase|Lack of Efficacy|73|||
130973021|NCT01358526|471526454|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
130973022|NCT01358526|471526455|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
130973023|NCT01358526|471526456|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
130973024|NCT01358526|471526454|FG000|Double-blind Phase|Administrative|0|||
130973025|NCT01358526|471526455|FG001|Double-blind Phase|Administrative|6|||
130973026|NCT01358526|471526456|FG002|Double-blind Phase|Administrative|10|||
130973027|NCT03277313|471526474|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
130973028|NCT03277313|471526475|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
130973029|NCT03277313|471526474|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
131130924|NCT03016325|472106511|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130973030|NCT03277313|471526475|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
130973031|NCT03277313|471526474|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
130973032|NCT03277313|471526475|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
130973033|NCT03277313|471526474|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
130973034|NCT03277313|471526475|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
130973035|NCT03277313|471526474|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
130973036|NCT03277313|471526475|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
130973037|NCT02132611|471526478|FG000|Overall Study|Death|2|||
130973038|NCT02194621|471526487|FG000|Overall Study|6 withdrew prior to randomization|2|||
131130925|NCT03016325|472106512|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131130926|NCT03016325|472106513|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131130927|NCT03016325|472106514|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
131130928|NCT03016325|472106515|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130775819|NCT00158262|470806612|FG000|Overall Study|Lost to Follow-up|1|||
130973039|NCT02194621|471526488|FG001|Overall Study|6 withdrew prior to randomization|2|||
130973040|NCT02194621|471526489|FG002|Overall Study|6 withdrew prior to randomization|2|||
130973041|NCT02194621|471526487|FG000|Overall Study|Withdrawal by Subject|4|||
130973042|NCT02194621|471526488|FG001|Overall Study|Withdrawal by Subject|4|||
130973043|NCT02194621|471526489|FG002|Overall Study|Withdrawal by Subject|7|||
130973044|NCT02493127|471526490|FG000|Overall Study|Lost to Follow-up|1|||
130973045|NCT02493127|471526491|FG001|Overall Study|Lost to Follow-up|1|||
130973046|NCT02763384|471526492|FG000|Overall Study|Physician Decision|1|||
130973047|NCT02763384|471526492|FG000|Overall Study|Rapid decline - went on hospice|1|||
130973048|NCT02075593|471526501|FG000|Overall Study|Withdrawal by Subject|1|||
130973049|NCT00660010|471526502|FG000|Overall Study|Withdrawal by Subject|2|||
130973050|NCT00660010|471526502|FG000|Overall Study|Lost to Follow-up|3|||
130973051|NCT00660010|471526502|FG000|Overall Study|Adverse Event|1|||
130973052|NCT00660010|471526502|FG000|Overall Study|Noncompliance with visit schedule|3|||
130973053|NCT06167031|471526503|FG000|Overall Study|Lost to Follow-up|5|||
130973054|NCT06167031|471526504|FG001|Overall Study|Lost to Follow-up|1|||
130973055|NCT00920426|471528555|FG000|ITZ111451|Adverse Event|1|||
130973056|NCT00920426|471528556|FG001|ITZ111451|Adverse Event|0|||
130973057|NCT00920426|471528557|FG002|ITZ111451|Adverse Event|0|||
130973058|NCT00920426|471528558|FG003|ITZ111451|Adverse Event|0|||
130973059|NCT01432366|471528559|FG000|Overall Study|Non-Responder|7|||
130973060|NCT01432366|471528559|FG000|Overall Study|Adverse Event|8|||
130973061|NCT01432366|471528559|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
130973062|NCT01432366|471528559|FG000|Overall Study|Pregnancy|1|||
130973063|NCT01432366|471528559|FG000|Overall Study|Lost to Follow-up|13|||
130973064|NCT01432366|471528559|FG000|Overall Study|Lack of Efficacy|1|||
130973065|NCT01432366|471528559|FG000|Overall Study|Site Closed|20|||
130973066|NCT01432366|471528559|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
130973067|NCT01432366|471528559|FG000|Overall Study|Other|14|||
131043175|NCT05218096|471792980|FG000|Open-label Extension|Adverse Event|1|||
131043176|NCT05218096|471792981|FG001|Open-label Extension|Adverse Event|0|||
131043177|NCT05218096|471792982|FG002|Open-label Extension|Adverse Event|0|||
131043178|NCT05218096|471792983|FG003|Open-label Extension|Adverse Event|0|||
131043179|NCT05218096|471792984|FG004|Open-label Extension|Adverse Event|1|||
131043180|NCT05218096|471792980|FG000|Open-label Extension|Pregnancy|0|||
131043181|NCT05218096|471792981|FG001|Open-label Extension|Pregnancy|0|||
131043182|NCT05218096|471792982|FG002|Open-label Extension|Pregnancy|0|||
131043183|NCT05218096|471792983|FG003|Open-label Extension|Pregnancy|0|||
131043184|NCT05218096|471792984|FG004|Open-label Extension|Pregnancy|1|||
131043185|NCT05218096|471792980|FG000|Open-label Extension|Lack of Efficacy|1|||
131043186|NCT05218096|471792981|FG001|Open-label Extension|Lack of Efficacy|2|||
131043187|NCT05218096|471792982|FG002|Open-label Extension|Lack of Efficacy|0|||
131043188|NCT05218096|471792983|FG003|Open-label Extension|Lack of Efficacy|0|||
131043189|NCT05218096|471792984|FG004|Open-label Extension|Lack of Efficacy|0|||
131043190|NCT05218096|471792980|FG000|Open-label Extension|Lost to Follow-up|1|||
131043191|NCT05218096|471792981|FG001|Open-label Extension|Lost to Follow-up|0|||
131043192|NCT05218096|471792982|FG002|Open-label Extension|Lost to Follow-up|0|||
131043193|NCT05218096|471792983|FG003|Open-label Extension|Lost to Follow-up|0|||
131043194|NCT05218096|471792984|FG004|Open-label Extension|Lost to Follow-up|0|||
131043195|NCT05218096|471792980|FG000|Open-label Extension|Death|0|||
131043196|NCT05218096|471792981|FG001|Open-label Extension|Death|0|||
131043197|NCT05218096|471792982|FG002|Open-label Extension|Death|0|||
131043198|NCT05218096|471792983|FG003|Open-label Extension|Death|1|||
131043199|NCT05218096|471792984|FG004|Open-label Extension|Death|0|||
131043200|NCT05218096|471792980|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
131043201|NCT05218096|471792981|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
131043202|NCT05218096|471792982|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
131043203|NCT05218096|471792983|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
131043204|NCT05218096|471792984|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
131043205|NCT05269966|471792987|FG000|Overall Study|Adverse Event|4|||
131043206|NCT05269966|471792987|FG000|Overall Study|Withdrawal by Subject|1|||
131043207|NCT05269966|471792987|FG000|Overall Study|Lost to Follow-up|4|||
131043208|NCT05269966|471792987|FG000|Overall Study|Physician Decision|1|||
131043209|NCT05863156|471792996|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
131043210|NCT05863156|471792997|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
131043211|NCT05863156|471792998|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
131043212|NCT04660539|471793001|FG000|Overall Study|Adverse Event|10|||
131043213|NCT04660539|471793001|FG000|Overall Study|Lack of Efficacy|4|||
131043214|NCT04660539|471793001|FG000|Overall Study|Lost to Follow-up|5|||
130973068|NCT01808690|471528560|FG000|Overall Study|Withdrawal by Subject|1|||
131130929|NCT03016325|472106516|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131130930|NCT03016325|472106517|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131130931|NCT03016325|472106518|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
131130932|NCT03016325|472106511|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131130933|NCT03016325|472106512|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
131130934|NCT03016325|472106513|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131130935|NCT03016325|472106514|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131130936|NCT03016325|472106515|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131130937|NCT03016325|472106516|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131130938|NCT03016325|472106517|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131130939|NCT03016325|472106518|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
131130940|NCT03016325|472106511|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
131130941|NCT03016325|472106512|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
131130942|NCT03016325|472106513|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
131130943|NCT03016325|472106514|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
131130944|NCT03016325|472106515|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
131130945|NCT03016325|472106516|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
131130946|NCT03016325|472106517|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
131130947|NCT03016325|472106518|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
131130948|NCT02970292|472106519|FG000|Overall Study|Physician Decision|1|||
131130949|NCT02970292|472106520|FG001|Overall Study|Physician Decision|1|||
131130950|NCT02970292|472106519|FG000|Overall Study|Withdrawal by Subject|11|||
131130951|NCT02970292|472106520|FG001|Overall Study|Withdrawal by Subject|5|||
131130952|NCT02970292|472106519|FG000|Overall Study|Noncompliance with study drug|2|||
131130953|NCT02970292|472106520|FG001|Overall Study|Noncompliance with study drug|2|||
131130954|NCT02970292|472106519|FG000|Overall Study|Adverse Event|5|||
131130955|NCT02970292|472106520|FG001|Overall Study|Adverse Event|0|||
131130956|NCT02970292|472106519|FG000|Overall Study|Lack of Efficacy|1|||
131130957|NCT02970292|472106520|FG001|Overall Study|Lack of Efficacy|0|||
131130958|NCT02970292|472106519|FG000|Overall Study|Lost to Follow-up|1|||
131130959|NCT02970292|472106520|FG001|Overall Study|Lost to Follow-up|0|||
131130960|NCT02970292|472106519|FG000|Overall Study|Protocol Violation|2|||
131130961|NCT02970292|472106520|FG001|Overall Study|Protocol Violation|0|||
131130962|NCT02970292|472106519|FG000|Overall Study|Other|1|||
131130963|NCT02970292|472106520|FG001|Overall Study|Other|0|||
131130964|NCT00513500|472106526|FG000|Overall Study|Lost to Follow-up|35|||
131130965|NCT00513500|472106527|FG001|Overall Study|Lost to Follow-up|39|||
131130966|NCT00513500|472106526|FG000|Overall Study|Death|2|||
131130967|NCT00513500|472106527|FG001|Overall Study|Death|1|||
131130968|NCT00513500|472106526|FG000|Overall Study|Hospitalized|4|||
131130969|NCT00513500|472106527|FG001|Overall Study|Hospitalized|14|||
131130970|NCT00749996|472106530|FG000|Overall Study|Lost to Follow-up|7|||
130775820|NCT00158262|470806613|FG001|Overall Study|Lost to Follow-up|1|||
130775821|NCT02959918|470806614|FG000|Overall Study|Adverse Event|1|||
130973069|NCT01808690|471528561|FG001|Overall Study|Withdrawal by Subject|2|||
131130971|NCT00749996|472106531|FG001|Overall Study|Lost to Follow-up|4|||
131130972|NCT00749996|472106530|FG000|Overall Study|Withdrawal by Subject|5|||
131130973|NCT00749996|472106531|FG001|Overall Study|Withdrawal by Subject|4|||
131130974|NCT00749996|472106530|FG000|Overall Study|Protocol Violation|2|||
131130975|NCT00749996|472106531|FG001|Overall Study|Protocol Violation|3|||
131130976|NCT00749996|472106530|FG000|Overall Study|Physician Decision|2|||
131130977|NCT00749996|472106531|FG001|Overall Study|Physician Decision|0|||
131130978|NCT00749996|472106530|FG000|Overall Study|Pregnancy|0|||
131130979|NCT00749996|472106531|FG001|Overall Study|Pregnancy|2|||
130973070|NCT00377234|471528565|FG000|Overall Study|Adverse Event|14|||
130973071|NCT00377234|471528566|FG001|Overall Study|Adverse Event|17|||
130973072|NCT00377234|471528565|FG000|Overall Study|Withdrawal by Subject|11|||
130973073|NCT00377234|471528566|FG001|Overall Study|Withdrawal by Subject|9|||
130973074|NCT00377234|471528565|FG000|Overall Study|Lost to Follow-up|4|||
130973075|NCT00377234|471528566|FG001|Overall Study|Lost to Follow-up|2|||
130973076|NCT00377234|471528565|FG000|Overall Study|Administrative|2|||
130973077|NCT00377234|471528566|FG001|Overall Study|Administrative|1|||
130973078|NCT00377234|471528565|FG000|Overall Study|Not assigned|3|||
131130980|NCT00749996|472106530|FG000|Overall Study|Adverse Event|1|||
130973079|NCT00377234|471528566|FG001|Overall Study|Not assigned|2|||
130973080|NCT01880424|471528567|FG000|Overall Study|Adverse Event|7|||
130973081|NCT01880424|471528568|FG001|Overall Study|Adverse Event|6|||
131227379|NCT01809314|472459722|FG000|Overall Study|Insufficient Therapeutic Response|14|||
130973082|NCT01880424|471528567|FG000|Overall Study|Lack of Efficacy|1|||
130973083|NCT01880424|471528568|FG001|Overall Study|Lack of Efficacy|4|||
131130981|NCT00749996|472106531|FG001|Overall Study|Adverse Event|0|||
130973084|NCT01880424|471528567|FG000|Overall Study|Lost to Follow-up|3|||
130973085|NCT01880424|471528568|FG001|Overall Study|Lost to Follow-up|2|||
130973086|NCT01880424|471528567|FG000|Overall Study|Protocol Violation|11|||
130775822|NCT02959918|470806615|FG001|Overall Study|Adverse Event|1|||
130973087|NCT01880424|471528568|FG001|Overall Study|Protocol Violation|13|||
131130982|NCT00749996|472106530|FG000|Overall Study|Death|1|||
131130983|NCT00749996|472106531|FG001|Overall Study|Death|0|||
131130984|NCT01902290|472106532|FG000|Overall Study|Withdrawal by Subject|19|||
131130985|NCT01902290|472106533|FG001|Overall Study|Withdrawal by Subject|27|||
131130986|NCT01902290|472106532|FG000|Overall Study|Lost to Follow-up|2|||
131130987|NCT01902290|472106533|FG001|Overall Study|Lost to Follow-up|2|||
131130988|NCT01902290|472106532|FG000|Overall Study|Death|1|||
131130989|NCT01902290|472106533|FG001|Overall Study|Death|0|||
131130990|NCT01902290|472106532|FG000|Overall Study|Sponsor Decision|26|||
131130991|NCT01902290|472106533|FG001|Overall Study|Sponsor Decision|24|||
131130992|NCT00517829|472106534|FG000|Overall Study|Adverse Event|22|||
131130993|NCT00517829|472106535|FG001|Overall Study|Adverse Event|34|||
131130994|NCT00517829|472106534|FG000|Overall Study|Disease Progression|39|||
131130995|NCT00517829|472106535|FG001|Overall Study|Disease Progression|32|||
131130996|NCT00517829|472106534|FG000|Overall Study|Patient Request|6|||
131130997|NCT00517829|472106535|FG001|Overall Study|Patient Request|5|||
131130998|NCT00517829|472106534|FG000|Overall Study|Investigator Request|5|||
131130999|NCT00517829|472106535|FG001|Overall Study|Investigator Request|3|||
131131000|NCT00517829|472106534|FG000|Overall Study|Other|3|||
131131001|NCT00517829|472106535|FG001|Overall Study|Other|1|||
131131002|NCT03436862|472106537|FG000|Overall Study|Adverse Event|4|||
131131003|NCT03436862|472106537|FG000|Overall Study|Progressive Disease|2|||
131131004|NCT00606086|472106538|FG000|Overall Study|Adverse Event|1|||
131131005|NCT00606086|472106539|FG001|Overall Study|Adverse Event|1|||
131131006|NCT00606086|472106538|FG000|Overall Study|Lost to Follow-up|4|||
131131007|NCT00606086|472106539|FG001|Overall Study|Lost to Follow-up|8|||
131131008|NCT00606086|472106538|FG000|Overall Study|Protocol Violation|1|||
131131009|NCT00606086|472106539|FG001|Overall Study|Protocol Violation|0|||
131131010|NCT00606086|472106538|FG000|Overall Study|Withdrawal by Subject|5|||
131131011|NCT00606086|472106539|FG001|Overall Study|Withdrawal by Subject|3|||
131131012|NCT00606086|472106538|FG000|Overall Study|Non-compliance|0|||
131131013|NCT00606086|472106539|FG001|Overall Study|Non-compliance|1|||
131131014|NCT00606086|472106538|FG000|Overall Study|Randomized, not treated|1|||
131131015|NCT00606086|472106539|FG001|Overall Study|Randomized, not treated|2|||
131131016|NCT00391222|472106542|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
131131017|NCT00391222|472106543|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
131131018|NCT00391222|472106544|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
131131019|NCT00391222|472106545|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
131131020|NCT00391222|472106542|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
131131021|NCT00391222|472106543|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
131131022|NCT00391222|472106544|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
131131023|NCT00391222|472106545|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
131131024|NCT00391222|472106542|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
131131025|NCT00391222|472106543|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
131131026|NCT00391222|472106544|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
131131027|NCT00391222|472106545|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
131131028|NCT00391222|472106542|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
131131029|NCT00391222|472106543|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
131131030|NCT00391222|472106544|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
131131031|NCT00391222|472106545|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
131131032|NCT00391222|472106542|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
131131033|NCT00391222|472106543|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
131131034|NCT00391222|472106544|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
131131035|NCT00391222|472106545|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
131131036|NCT00391222|472106542|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
131131037|NCT00391222|472106543|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
131131038|NCT00391222|472106544|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
131131039|NCT00391222|472106545|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
131131040|NCT00391222|472106542|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
131131041|NCT00391222|472106543|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
131131042|NCT00391222|472106544|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
130973088|NCT01880424|471528567|FG000|Overall Study|Withdrawal by Subject|10|||
131131043|NCT00391222|472106545|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
130973089|NCT01880424|471528568|FG001|Overall Study|Withdrawal by Subject|30|||
130973090|NCT01880424|471528567|FG000|Overall Study|Other|1|||
131131044|NCT00391222|472106542|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
131131045|NCT00391222|472106543|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
131131046|NCT00391222|472106544|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
131131047|NCT00391222|472106545|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
131131048|NCT00391222|472106542|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
131131049|NCT00391222|472106543|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
130973091|NCT01880424|471528568|FG001|Overall Study|Other|0|||
130973092|NCT02062632|471528571|FG000|Overall Study|No treatment data|1|||
130973093|NCT01490632|471528573|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
130973094|NCT01490632|471528574|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
130973095|NCT01490632|471528575|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
130973096|NCT01490632|471528576|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
131131050|NCT00391222|472106544|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
131131051|NCT00391222|472106545|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
131131052|NCT00391222|472106542|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
131131053|NCT00391222|472106543|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
130973097|NCT01490632|471528577|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
130973098|NCT01490632|471528578|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
130973099|NCT01490632|471528579|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
130973100|NCT01490632|471528580|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
130973101|NCT01490632|471528581|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
130973102|NCT01490632|471528582|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
130973103|NCT01490632|471528583|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
130973104|NCT01490632|471528584|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
131131054|NCT00391222|472106544|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
131131055|NCT00391222|472106545|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
131131056|NCT00391222|472106542|FG000|Period III (Double-Blind Treatment)|Other|6|||
131131057|NCT00391222|472106543|FG001|Period III (Double-Blind Treatment)|Other|1|||
130973105|NCT01490632|471528585|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
130973106|NCT01490632|471528586|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
130973107|NCT01490632|471528587|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
130973108|NCT01490632|471528588|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
130973109|NCT01490632|471528589|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
130973110|NCT01490632|471528590|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
130973111|NCT01490632|471528591|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
130973112|NCT01490632|471528592|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
130973113|NCT01490632|471528573|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
130973114|NCT01490632|471528574|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
130973115|NCT01490632|471528575|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
130973116|NCT01490632|471528576|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
131131058|NCT00391222|472106544|FG002|Period III (Double-Blind Treatment)|Other|6|||
131131059|NCT00391222|472106545|FG003|Period III (Double-Blind Treatment)|Other|0|||
131131060|NCT03215771|472106546|FG000|Overall Study|Withdrawal by Subject|2|||
131131061|NCT03215771|472106546|FG000|Overall Study|Physician Decision|1|||
131131062|NCT02039375|472106547|FG000|Overall Study|Lost to Follow-up|2|||
130973117|NCT01490632|471528577|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130973118|NCT01490632|471528578|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130973119|NCT01490632|471528579|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130973120|NCT01490632|471528580|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130973121|NCT01490632|471528581|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131131063|NCT04770389|472106548|FG000|Overall Study|Adverse Event|1|||
131131064|NCT04770389|472106549|FG001|Overall Study|Adverse Event|2|||
131131065|NCT04770389|472106550|FG002|Overall Study|Adverse Event|0|||
131131066|NCT04770389|472106551|FG003|Overall Study|Adverse Event|1|||
131131067|NCT04770389|472106548|FG000|Overall Study|Withdrawal by Subject|0|||
131131068|NCT04770389|472106549|FG001|Overall Study|Withdrawal by Subject|2|||
131131069|NCT04770389|472106550|FG002|Overall Study|Withdrawal by Subject|1|||
131131070|NCT04770389|472106551|FG003|Overall Study|Withdrawal by Subject|0|||
131131071|NCT04770389|472106548|FG000|Overall Study|Failed attempt to draw blood|1|||
131131072|NCT04770389|472106549|FG001|Overall Study|Failed attempt to draw blood|0|||
131131073|NCT04770389|472106550|FG002|Overall Study|Failed attempt to draw blood|0|||
131131074|NCT04770389|472106551|FG003|Overall Study|Failed attempt to draw blood|0|||
131131075|NCT04770389|472106548|FG000|Overall Study|Left the country|0|||
131131076|NCT04770389|472106549|FG001|Overall Study|Left the country|0|||
130973122|NCT01490632|471528582|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131131077|NCT04770389|472106550|FG002|Overall Study|Left the country|1|||
131131078|NCT04770389|472106551|FG003|Overall Study|Left the country|2|||
131131079|NCT04770389|472106548|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
131131080|NCT04770389|472106549|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
131131081|NCT04770389|472106550|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
131131082|NCT04770389|472106551|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
131131083|NCT04770389|472106548|FG000|Overall Study|Lost to Follow-up|0|||
131131084|NCT04770389|472106549|FG001|Overall Study|Lost to Follow-up|0|||
131131085|NCT04770389|472106550|FG002|Overall Study|Lost to Follow-up|0|||
131131086|NCT04770389|472106551|FG003|Overall Study|Lost to Follow-up|1|||
130973123|NCT01490632|471528583|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130973124|NCT01490632|471528584|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130973125|NCT01490632|471528585|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131131087|NCT04770389|472106548|FG000|Overall Study|Moved away from study site|0|||
131131088|NCT04770389|472106549|FG001|Overall Study|Moved away from study site|1|||
131131089|NCT04770389|472106550|FG002|Overall Study|Moved away from study site|0|||
131131090|NCT04770389|472106551|FG003|Overall Study|Moved away from study site|0|||
131131091|NCT00550680|472106559|FG000|Overall Study|Administrative Reasons|1|||
131131092|NCT00550680|472106559|FG000|Overall Study|Adverse Event|5|||
131131093|NCT00550680|472106559|FG000|Overall Study|Death|3|||
131131094|NCT00550680|472106559|FG000|Overall Study|Early Improvement|1|||
131131095|NCT00550680|472106559|FG000|Overall Study|Lost to Follow-up|3|||
131131096|NCT00550680|472106559|FG000|Overall Study|Lack of Efficacy|1|||
131131097|NCT00550680|472106559|FG000|Overall Study|Other|10|||
131131098|NCT00550680|472106559|FG000|Overall Study|Protocol Violation|7|||
131131099|NCT00550680|472106559|FG000|Overall Study|Refused Treatment|19|||
131131100|NCT00550680|472106559|FG000|Overall Study|Screen Failure|6|||
131131101|NCT03693625|472106560|FG000|Overall Study|Adverse Event|2|||
131131102|NCT03693625|472106561|FG001|Overall Study|Adverse Event|0|||
131131103|NCT03693625|472106560|FG000|Overall Study|Study Terminated By Sponsor|20|||
131131104|NCT03693625|472106561|FG001|Overall Study|Study Terminated By Sponsor|7|||
131131105|NCT03693625|472106560|FG000|Overall Study|Withdrawal by Subject|1|||
131131106|NCT03693625|472106561|FG001|Overall Study|Withdrawal by Subject|1|||
131131107|NCT01508702|472106562|FG000|Overall Study|Adverse Event|7|||
131131108|NCT01508702|472106563|FG001|Overall Study|Adverse Event|3|||
131131109|NCT01508702|472106562|FG000|Overall Study|Gout flare|2|||
131131110|NCT01508702|472106563|FG001|Overall Study|Gout flare|0|||
131131111|NCT01508702|472106562|FG000|Overall Study|Protocol Violation|2|||
131131112|NCT01508702|472106563|FG001|Overall Study|Protocol Violation|1|||
131131113|NCT01508702|472106562|FG000|Overall Study|Lost to Follow-up|1|||
131131114|NCT01508702|472106563|FG001|Overall Study|Lost to Follow-up|2|||
131131115|NCT01508702|472106562|FG000|Overall Study|Withdrawal by Subject|11|||
131131116|NCT01508702|472106563|FG001|Overall Study|Withdrawal by Subject|7|||
131131117|NCT00250835|472106565|FG000|Overall Study|Withdrawal by Subject|1|||
131131118|NCT01187953|472106566|FG000|Overall Study|Death|11|||
131131119|NCT01187953|472106567|FG001|Overall Study|Death|13|||
131131120|NCT01187953|472106566|FG000|Overall Study|Adverse Event|1|||
131131121|NCT01187953|472106567|FG001|Overall Study|Adverse Event|2|||
131131122|NCT01187953|472106566|FG000|Overall Study|Lost to Follow-up|0|||
131131123|NCT01187953|472106567|FG001|Overall Study|Lost to Follow-up|3|||
131131124|NCT01187953|472106566|FG000|Overall Study|Withdrawal by Subject|3|||
131131125|NCT01187953|472106567|FG001|Overall Study|Withdrawal by Subject|3|||
131131126|NCT01464307|472106571|FG000|Main Period|Death|0|||
131131127|NCT01464307|472106572|FG001|Main Period|Death|1|||
131131128|NCT01464307|472106571|FG000|Main Period|Adverse Event|6|||
130716813|NCT01675661|470590959|FG000|Overall Study|Other reason|1|||
130716814|NCT01675661|470590960|FG001|Overall Study|Other reason|2|||
130716815|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716816|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
130973126|NCT01490632|471528586|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130973127|NCT01490632|471528587|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131131129|NCT01464307|472106572|FG001|Main Period|Adverse Event|1|||
131131130|NCT01464307|472106571|FG000|Main Period|Lack of Efficacy|2|||
131131131|NCT01464307|472106572|FG001|Main Period|Lack of Efficacy|0|||
131131132|NCT01464307|472106571|FG000|Main Period|Withdrawal by Subject|5|||
131131133|NCT01464307|472106572|FG001|Main Period|Withdrawal by Subject|2|||
131131134|NCT01464307|472106571|FG000|Main Period|Predefined discontinuation criteria|2|||
131131135|NCT01464307|472106572|FG001|Main Period|Predefined discontinuation criteria|1|||
131131136|NCT01464307|472106571|FG000|Open-Label Extension Period|Adverse Event|15|||
131131137|NCT01464307|472106572|FG001|Open-Label Extension Period|Adverse Event|0|||
131131138|NCT01464307|472106571|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
131131139|NCT01464307|472106572|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
131131140|NCT01464307|472106571|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
131131141|NCT01464307|472106572|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
131131142|NCT01464307|472106571|FG000|Open-Label Extension Period|Death|1|||
131131143|NCT01464307|472106572|FG001|Open-Label Extension Period|Death|0|||
131131144|NCT01464307|472106571|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
131131145|NCT01464307|472106572|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
131131146|NCT01464307|472106571|FG000|Open-Label Extension Period|Non-compliance|9|||
131131147|NCT01464307|472106572|FG001|Open-Label Extension Period|Non-compliance|0|||
131131148|NCT01464307|472106571|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
130716817|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
131131149|NCT01464307|472106572|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
131131150|NCT02457637|472106575|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
131131151|NCT04942925|472106578|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
131131152|NCT04942925|472106579|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
131131153|NCT04942925|472106578|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
130973128|NCT01490632|471528588|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131131154|NCT04942925|472106579|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
130775823|NCT02959918|470806616|FG002|Overall Study|Adverse Event|2|||
130775824|NCT02959918|470806617|FG003|Overall Study|Adverse Event|0|||
130775825|NCT02959918|470806618|FG004|Overall Study|Adverse Event|0|||
130775826|NCT02959918|470806619|FG005|Overall Study|Adverse Event|2|||
130775827|NCT02959918|470806620|FG006|Overall Study|Adverse Event|2|||
130775828|NCT02959918|470806621|FG007|Overall Study|Adverse Event|1|||
130775829|NCT02959918|470806622|FG008|Overall Study|Adverse Event|2|||
130775830|NCT02959918|470806623|FG009|Overall Study|Adverse Event|1|||
130775831|NCT02959918|470806624|FG010|Overall Study|Adverse Event|1|||
130775832|NCT02959918|470806625|FG011|Overall Study|Adverse Event|3|||
130775833|NCT02959918|470806626|FG012|Overall Study|Adverse Event|2|||
130775834|NCT02959918|470806627|FG013|Overall Study|Adverse Event|4|||
130775835|NCT02959918|470806614|FG000|Overall Study|Lost to Follow-up|0|||
130775836|NCT02959918|470806615|FG001|Overall Study|Lost to Follow-up|0|||
130775837|NCT02959918|470806616|FG002|Overall Study|Lost to Follow-up|0|||
130775838|NCT02959918|470806617|FG003|Overall Study|Lost to Follow-up|0|||
130775839|NCT02959918|470806618|FG004|Overall Study|Lost to Follow-up|0|||
130775840|NCT02959918|470806619|FG005|Overall Study|Lost to Follow-up|0|||
130775841|NCT02959918|470806620|FG006|Overall Study|Lost to Follow-up|0|||
130775842|NCT02959918|470806621|FG007|Overall Study|Lost to Follow-up|0|||
130775843|NCT02959918|470806622|FG008|Overall Study|Lost to Follow-up|0|||
130775844|NCT02959918|470806623|FG009|Overall Study|Lost to Follow-up|1|||
130775845|NCT02959918|470806624|FG010|Overall Study|Lost to Follow-up|0|||
130775846|NCT02959918|470806625|FG011|Overall Study|Lost to Follow-up|0|||
130775847|NCT02959918|470806626|FG012|Overall Study|Lost to Follow-up|1|||
130775848|NCT02959918|470806627|FG013|Overall Study|Lost to Follow-up|0|||
130775849|NCT02959918|470806614|FG000|Overall Study|Withdrawal by Subject|0|||
130775850|NCT02959918|470806615|FG001|Overall Study|Withdrawal by Subject|0|||
131131155|NCT01273883|472106580|FG000|First Intervention|Adverse Event|2|||
131131156|NCT01273883|472106581|FG001|First Intervention|Adverse Event|1|||
131131157|NCT01273883|472106580|FG000|Second Intervention|Lost to Follow-up|1|||
131131158|NCT01273883|472106581|FG001|Second Intervention|Lost to Follow-up|1|||
131131159|NCT01273883|472106580|FG000|Second Intervention|Lack of Efficacy|1|||
131131160|NCT01273883|472106581|FG001|Second Intervention|Lack of Efficacy|0|||
131131161|NCT01430455|472106585|FG000|Overall Study|Withdrawal by Subject|1|||
131131162|NCT01430455|472106585|FG000|Overall Study|Switched to follow-up phase|1|||
131131163|NCT00333359|472106587|FG000|Overall Study|Adverse Event|29|||
131131164|NCT00333359|472106588|FG001|Overall Study|Adverse Event|35|||
131131165|NCT00333359|472106587|FG000|Overall Study|Withdrawal by Subject|19|||
131131166|NCT00333359|472106588|FG001|Overall Study|Withdrawal by Subject|37|||
131131167|NCT00333359|472106587|FG000|Overall Study|Physician Decision|2|||
131131168|NCT00333359|472106588|FG001|Overall Study|Physician Decision|2|||
131131169|NCT00333359|472106587|FG000|Overall Study|Protocol Non-compliance|2|||
131131170|NCT00333359|472106588|FG001|Overall Study|Protocol Non-compliance|8|||
131131171|NCT00333359|472106587|FG000|Overall Study|Lost to Follow-up|15|||
131131172|NCT00333359|472106588|FG001|Overall Study|Lost to Follow-up|25|||
131131173|NCT00333359|472106587|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
131131174|NCT00333359|472106588|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
131131175|NCT00333359|472106587|FG000|Overall Study|Treatment Failure|3|||
131131176|NCT00333359|472106588|FG001|Overall Study|Treatment Failure|8|||
131131177|NCT00333359|472106587|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
131131178|NCT00333359|472106588|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
131131179|NCT02867995|472106590|FG000|Overall Study|Withdrawal by Subject|0|||
131131180|NCT02867995|472106591|FG001|Overall Study|Withdrawal by Subject|1|||
131131181|NCT02867995|472106590|FG000|Overall Study|Lost to Follow-up|0|||
131131182|NCT02867995|472106591|FG001|Overall Study|Lost to Follow-up|2|||
130775851|NCT02959918|470806616|FG002|Overall Study|Withdrawal by Subject|1|||
131131183|NCT01339559|472108283|FG000|Overall Study|Adverse Event|92|||
131131184|NCT01339559|472108283|FG000|Overall Study|Death|5|||
131131185|NCT01339559|472108283|FG000|Overall Study|Lack of Efficacy|164|||
130775852|NCT02959918|470806617|FG003|Overall Study|Withdrawal by Subject|2|||
130775853|NCT02959918|470806618|FG004|Overall Study|Withdrawal by Subject|0|||
130775854|NCT02959918|470806619|FG005|Overall Study|Withdrawal by Subject|0|||
130775855|NCT02959918|470806620|FG006|Overall Study|Withdrawal by Subject|1|||
130775856|NCT02959918|470806621|FG007|Overall Study|Withdrawal by Subject|0|||
130775857|NCT02959918|470806622|FG008|Overall Study|Withdrawal by Subject|1|||
130775858|NCT02959918|470806623|FG009|Overall Study|Withdrawal by Subject|1|||
130775859|NCT02959918|470806624|FG010|Overall Study|Withdrawal by Subject|2|||
131131186|NCT01339559|472108283|FG000|Overall Study|Lost to Follow-up|22|||
131131187|NCT01339559|472108283|FG000|Overall Study|Subject choice|89|||
131131188|NCT01339559|472108283|FG000|Overall Study|Protocol Violation|15|||
131131189|NCT01339559|472108283|FG000|Overall Study|Study closure at site|1|||
131131190|NCT01339559|472108283|FG000|Overall Study|Incarcerated|2|||
131131191|NCT01339559|472108283|FG000|Overall Study|Epilepsy surgery|1|||
131131192|NCT01339559|472108283|FG000|Overall Study|Pregnancy planned|2|||
131131193|NCT01339559|472108283|FG000|Overall Study|Left the country|1|||
131131194|NCT01339559|472108283|FG000|Overall Study|Investigator decision|2|||
131131195|NCT01339559|472108283|FG000|Overall Study|Patient didn't wish to continue|1|||
131131196|NCT01339559|472108283|FG000|Overall Study|PI decision|1|||
131131197|NCT01137773|472108284|FG000|Overall Study|Death|3|||
131131198|NCT01137773|472108285|FG001|Overall Study|Death|3|||
131131199|NCT01137773|472108284|FG000|Overall Study|Lost to Follow-up|6|||
131131200|NCT01137773|472108285|FG001|Overall Study|Lost to Follow-up|0|||
131131201|NCT03548051|472108286|FG000|Overall Study|Death|1|||
131131202|NCT03548051|472108287|FG001|Overall Study|Death|1|||
131131203|NCT03548051|472108286|FG000|Overall Study|Withdrawal by Subject|1|||
131131204|NCT03548051|472108287|FG001|Overall Study|Withdrawal by Subject|0|||
131131205|NCT02684981|472108288|FG000|Overall Study|Permanently discontinued the treatment|157|||
131131206|NCT02684981|472108289|FG001|Overall Study|Permanently discontinued the treatment|161|||
131131207|NCT02684981|472108290|FG002|Overall Study|Permanently discontinued the treatment|110|||
131131208|NCT02684981|472108288|FG000|Overall Study|Other|83|||
131131209|NCT02684981|472108289|FG001|Overall Study|Other|49|||
131131210|NCT02684981|472108290|FG002|Overall Study|Other|17|||
131131211|NCT03605680|472108292|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
131131212|NCT03605680|472108293|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
131131213|NCT03605680|472108294|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
131131214|NCT03605680|472108295|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
131131215|NCT03605680|472108292|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
131131216|NCT03605680|472108293|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
131131217|NCT03605680|472108294|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
131131218|NCT03605680|472108295|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
131131219|NCT03605680|472108292|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
131131220|NCT03605680|472108293|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
131131221|NCT03605680|472108294|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
131131222|NCT03605680|472108295|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
131131223|NCT03605680|472108292|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
131131224|NCT03605680|472108293|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
131131225|NCT03605680|472108294|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
131131226|NCT03605680|472108295|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
131131227|NCT03605680|472108292|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
131131228|NCT03605680|472108293|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
131131229|NCT03605680|472108294|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
131131230|NCT03605680|472108295|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
131131231|NCT03605680|472108292|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
131131232|NCT03605680|472108293|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
131131233|NCT03605680|472108294|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
131131234|NCT03605680|472108295|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
131131235|NCT03605680|472108292|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
131131236|NCT03605680|472108293|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
131131237|NCT03605680|472108294|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
131131238|NCT03605680|472108295|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
131131239|NCT03605680|472108292|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
131131240|NCT03605680|472108293|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
131131241|NCT03605680|472108294|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
131131242|NCT03605680|472108295|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
131131243|NCT03605680|472108292|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
131131244|NCT03605680|472108293|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
131131245|NCT03605680|472108294|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
131131246|NCT03605680|472108295|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
130716818|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130973129|NCT01490632|471528589|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130973130|NCT01490632|471528590|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130973131|NCT01490632|471528591|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
131131247|NCT03605680|472108292|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
131131248|NCT03605680|472108293|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
131131249|NCT03605680|472108294|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
131131250|NCT03605680|472108295|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
131131251|NCT03605680|472108292|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
131131252|NCT03605680|472108293|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
131131253|NCT03605680|472108294|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
131131254|NCT03605680|472108295|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
131131255|NCT03605680|472108292|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131131256|NCT03605680|472108293|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131131257|NCT03605680|472108294|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131227380|NCT01809314|472459722|FG000|Overall Study|Lost to Follow-up|724|||
130973132|NCT01490632|471528592|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
130973133|NCT01490632|471528573|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973134|NCT01490632|471528574|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973135|NCT01490632|471528575|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
130973136|NCT01490632|471528576|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
130973137|NCT01490632|471528577|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
131131258|NCT03605680|472108295|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
131131259|NCT03605680|472108292|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
131131260|NCT03605680|472108293|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
131131261|NCT03605680|472108294|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
131131262|NCT03605680|472108295|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
131131263|NCT03605680|472108292|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
131131264|NCT03605680|472108293|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
131131265|NCT03605680|472108294|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
131131266|NCT03605680|472108295|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
131131267|NCT03605680|472108292|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
131131268|NCT03605680|472108293|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
131131269|NCT03605680|472108294|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
131131270|NCT03605680|472108295|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
131131271|NCT03605680|472108292|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
131131272|NCT03605680|472108293|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
131131273|NCT03605680|472108294|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
131131274|NCT03605680|472108295|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
131131275|NCT03605680|472108292|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
131131276|NCT03605680|472108293|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
131131277|NCT03605680|472108294|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
131131278|NCT03605680|472108295|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
131131279|NCT03605680|472108292|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
131131280|NCT03605680|472108293|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
131131281|NCT03605680|472108294|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
131131282|NCT03605680|472108295|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
131131283|NCT03605680|472108292|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
131131284|NCT03605680|472108293|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
131131285|NCT03605680|472108294|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
131131286|NCT03605680|472108295|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
131131287|NCT00290433|472108297|FG000|Overall Study|Disease Progression|13|||
131131288|NCT00290433|472108297|FG000|Overall Study|Adverse Event|14|||
131131289|NCT00290433|472108297|FG000|Overall Study|Withdrawal by Subject|1|||
131131290|NCT00290433|472108297|FG000|Overall Study|Non-Compliance|1|||
131131291|NCT00290433|472108297|FG000|Overall Study|Congestive Heart Failure|1|||
131131292|NCT00290433|472108297|FG000|Overall Study|Transplant in CR|5|||
131131293|NCT00290433|472108297|FG000|Overall Study|Unrelated Infection/Death|1|||
131131294|NCT02559687|472108298|FG000|Overall Study|Death|112|||
131131295|NCT02559687|472108298|FG000|Overall Study|Sponsor Decision|5|||
131131296|NCT02559687|472108298|FG000|Overall Study|Withdrawal by Subject|4|||
130973138|NCT01490632|471528578|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973139|NCT01490632|471528579|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973140|NCT01490632|471528580|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973141|NCT01490632|471528581|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973142|NCT01490632|471528582|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973143|NCT01490632|471528583|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973144|NCT01490632|471528584|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973145|NCT01490632|471528585|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973146|NCT01490632|471528586|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973147|NCT01490632|471528587|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973148|NCT01490632|471528588|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973149|NCT01490632|471528589|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973150|NCT01490632|471528590|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973151|NCT01490632|471528591|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973152|NCT01490632|471528592|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
130973153|NCT01490632|471528573|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
130973154|NCT01490632|471528574|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
130973155|NCT01490632|471528575|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
131131297|NCT03031301|472108303|FG000|Overall Study|Protocol Violation|4|||
130775860|NCT02959918|470806625|FG011|Overall Study|Withdrawal by Subject|3|||
130775861|NCT02959918|470806626|FG012|Overall Study|Withdrawal by Subject|1|||
130973156|NCT01490632|471528576|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
130973157|NCT01490632|471528577|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
130973158|NCT01490632|471528578|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
130973159|NCT01490632|471528579|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
130973160|NCT01490632|471528580|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
130973161|NCT01490632|471528581|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
130973162|NCT01490632|471528582|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
130973163|NCT01490632|471528583|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
130973164|NCT01490632|471528584|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
130973165|NCT01490632|471528585|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
130973166|NCT01490632|471528586|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
130973167|NCT01490632|471528587|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
130973168|NCT01490632|471528588|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
130973169|NCT01490632|471528589|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
130973170|NCT01490632|471528590|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
130973171|NCT01490632|471528591|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
130973172|NCT01490632|471528592|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
130973173|NCT01490632|471528573|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
130973174|NCT01490632|471528574|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973175|NCT01490632|471528575|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973176|NCT01490632|471528576|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973177|NCT01490632|471528577|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973178|NCT01490632|471528578|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973179|NCT01490632|471528579|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973180|NCT01490632|471528580|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973181|NCT01490632|471528581|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973182|NCT01490632|471528582|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973183|NCT01490632|471528583|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973184|NCT01490632|471528584|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973185|NCT01490632|471528585|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973186|NCT01490632|471528586|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973187|NCT01490632|471528587|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973188|NCT01490632|471528588|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973189|NCT01490632|471528589|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973190|NCT01490632|471528590|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973191|NCT01490632|471528591|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973192|NCT01490632|471528592|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
130973193|NCT01490632|471528573|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
130973194|NCT01490632|471528574|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
130973195|NCT01490632|471528575|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973196|NCT01490632|471528576|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
130973197|NCT01490632|471528577|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
130973198|NCT01490632|471528578|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973199|NCT01490632|471528579|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973200|NCT01490632|471528580|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973201|NCT01490632|471528581|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973202|NCT01490632|471528582|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973203|NCT01490632|471528583|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973204|NCT01490632|471528584|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973205|NCT01490632|471528585|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973206|NCT01490632|471528586|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973207|NCT01490632|471528587|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973208|NCT01490632|471528588|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973209|NCT01490632|471528589|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973210|NCT01490632|471528590|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973211|NCT01490632|471528591|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973212|NCT01490632|471528592|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
130973213|NCT01490632|471528573|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973214|NCT01490632|471528574|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973215|NCT01490632|471528575|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973216|NCT01490632|471528576|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973217|NCT01490632|471528577|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
130973218|NCT01490632|471528578|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973219|NCT01490632|471528579|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130985717|NCT03642938|471574964|FG002|Overall Study|Withdrawal by Subject|0|||
130985718|NCT03642938|471574965|FG003|Overall Study|Withdrawal by Subject|1|||
130973220|NCT01490632|471528580|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973221|NCT01490632|471528581|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973222|NCT01490632|471528582|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973223|NCT01490632|471528583|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973224|NCT01490632|471528584|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973225|NCT01490632|471528585|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973226|NCT01490632|471528586|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973227|NCT01490632|471528587|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973228|NCT01490632|471528588|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973229|NCT01490632|471528589|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973230|NCT01490632|471528590|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973231|NCT01490632|471528591|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973232|NCT01490632|471528592|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
130973233|NCT01490632|471528573|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973234|NCT01490632|471528574|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973235|NCT01490632|471528575|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973236|NCT01490632|471528576|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973237|NCT01490632|471528577|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973238|NCT01490632|471528578|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
130973239|NCT01490632|471528579|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
130973240|NCT01490632|471528580|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973241|NCT01490632|471528581|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973242|NCT01490632|471528582|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
130973243|NCT01490632|471528583|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
130973244|NCT01490632|471528584|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
130973245|NCT01490632|471528585|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973246|NCT01490632|471528586|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973247|NCT01490632|471528587|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973248|NCT01490632|471528588|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973249|NCT01490632|471528589|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973250|NCT01490632|471528590|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973251|NCT01490632|471528591|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973252|NCT01490632|471528592|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
130973253|NCT01490632|471528573|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973254|NCT01490632|471528574|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973255|NCT01490632|471528575|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973256|NCT01490632|471528576|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973257|NCT01490632|471528577|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973258|NCT01490632|471528578|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973259|NCT01490632|471528579|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
130973260|NCT01490632|471528580|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973261|NCT01490632|471528581|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
130973262|NCT01490632|471528582|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
130973263|NCT01490632|471528583|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
130973264|NCT01490632|471528584|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973265|NCT01490632|471528585|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973266|NCT01490632|471528586|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973267|NCT01490632|471528587|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973268|NCT01490632|471528588|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973269|NCT01490632|471528589|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973270|NCT01490632|471528590|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973271|NCT01490632|471528591|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973272|NCT01490632|471528592|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
130973273|NCT01490632|471528573|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973274|NCT01490632|471528574|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973275|NCT01490632|471528575|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973276|NCT01490632|471528576|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973277|NCT01490632|471528577|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973278|NCT01490632|471528578|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973279|NCT01490632|471528579|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
130973280|NCT01490632|471528580|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973281|NCT01490632|471528581|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
131227381|NCT01684722|472459723|FG000|Overall Study|Lost to Follow-up|78|||
131227382|NCT01684722|472459724|FG001|Overall Study|Lost to Follow-up|56|||
131227383|NCT01684722|472459725|FG002|Overall Study|Lost to Follow-up|75|||
131227384|NCT01684722|472459726|FG003|Overall Study|Lost to Follow-up|89|||
130973282|NCT01490632|471528582|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
130973283|NCT01490632|471528583|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973284|NCT01490632|471528584|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973285|NCT01490632|471528585|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973286|NCT01490632|471528586|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973287|NCT01490632|471528587|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973288|NCT01490632|471528588|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973289|NCT01490632|471528589|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973290|NCT01490632|471528590|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973291|NCT01490632|471528591|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973292|NCT01490632|471528592|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
130973293|NCT01490632|471528573|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973294|NCT01490632|471528574|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973295|NCT01490632|471528575|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973296|NCT01490632|471528576|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973297|NCT01490632|471528577|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973298|NCT01490632|471528578|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973299|NCT01490632|471528579|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
130973300|NCT01490632|471528580|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973301|NCT01490632|471528581|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973302|NCT01490632|471528582|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973303|NCT01490632|471528583|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973304|NCT01490632|471528584|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973305|NCT01490632|471528585|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973306|NCT01490632|471528586|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973307|NCT01490632|471528587|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973308|NCT01490632|471528588|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973309|NCT01490632|471528589|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973310|NCT01490632|471528590|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973311|NCT01490632|471528591|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973312|NCT01490632|471528592|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
130973313|NCT01490632|471528573|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973314|NCT01490632|471528574|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973315|NCT01490632|471528575|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973316|NCT01490632|471528576|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973317|NCT01490632|471528577|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973318|NCT01490632|471528578|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
130973319|NCT01490632|471528579|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973320|NCT01490632|471528580|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973321|NCT01490632|471528581|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973322|NCT01490632|471528582|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973323|NCT01490632|471528583|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973324|NCT01490632|471528584|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973325|NCT01490632|471528585|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973326|NCT01490632|471528586|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973327|NCT01490632|471528587|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973328|NCT01490632|471528588|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973329|NCT01490632|471528589|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973330|NCT01490632|471528590|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973331|NCT01490632|471528591|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973332|NCT01490632|471528592|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
130973333|NCT01490632|471528573|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973334|NCT01490632|471528574|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973335|NCT01490632|471528575|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973336|NCT01490632|471528576|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973337|NCT01490632|471528577|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973338|NCT01490632|471528578|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973339|NCT01490632|471528579|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
130973340|NCT01490632|471528580|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973341|NCT01490632|471528581|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
130973342|NCT01490632|471528582|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973343|NCT01490632|471528583|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
130973344|NCT01490632|471528584|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
130973345|NCT01490632|471528585|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
131131298|NCT03031301|472108304|FG001|Overall Study|Protocol Violation|8|||
131131299|NCT03031301|472108303|FG000|Overall Study|Withdrawal by Subject|7|||
130973346|NCT01490632|471528586|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973347|NCT01490632|471528587|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973348|NCT01490632|471528588|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973349|NCT01490632|471528589|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973350|NCT01490632|471528590|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973351|NCT01490632|471528591|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973352|NCT01490632|471528592|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
130973353|NCT01490632|471528573|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973354|NCT01490632|471528574|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973355|NCT01490632|471528575|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973356|NCT01490632|471528576|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973357|NCT01490632|471528577|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973358|NCT01490632|471528578|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
130973359|NCT01490632|471528579|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
130973360|NCT01490632|471528580|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
130973361|NCT01490632|471528581|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
130973362|NCT01490632|471528582|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
130973363|NCT01490632|471528583|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
130973364|NCT01490632|471528584|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
130973365|NCT01490632|471528585|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973366|NCT01490632|471528586|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973367|NCT01490632|471528587|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973368|NCT01490632|471528588|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973369|NCT01490632|471528589|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973370|NCT01490632|471528590|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973371|NCT01490632|471528591|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973372|NCT01490632|471528592|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
130973373|NCT01490632|471528573|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973374|NCT01490632|471528574|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973375|NCT01490632|471528575|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973376|NCT01490632|471528576|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973377|NCT01490632|471528577|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973378|NCT01490632|471528578|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973379|NCT01490632|471528579|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973380|NCT01490632|471528580|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973381|NCT01490632|471528581|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973382|NCT01490632|471528582|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973383|NCT01490632|471528583|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973384|NCT01490632|471528584|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973385|NCT01490632|471528585|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973386|NCT01490632|471528586|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973387|NCT01490632|471528587|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
130973388|NCT01490632|471528588|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
130973389|NCT01490632|471528589|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973390|NCT01490632|471528590|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973391|NCT01490632|471528591|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973392|NCT01490632|471528592|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
130973393|NCT01490632|471528573|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973394|NCT01490632|471528574|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973395|NCT01490632|471528575|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973396|NCT01490632|471528576|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973397|NCT01490632|471528577|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973398|NCT01490632|471528578|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973399|NCT01490632|471528579|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973400|NCT01490632|471528580|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973401|NCT01490632|471528581|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973402|NCT01490632|471528582|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973403|NCT01490632|471528583|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973404|NCT01490632|471528584|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973405|NCT01490632|471528585|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973406|NCT01490632|471528586|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
130973407|NCT01490632|471528587|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973408|NCT01490632|471528588|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973409|NCT01490632|471528589|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973410|NCT01490632|471528590|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973411|NCT01490632|471528591|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973412|NCT01490632|471528592|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130973413|NCT01490632|471528573|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973414|NCT01490632|471528574|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973415|NCT01490632|471528575|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973416|NCT01490632|471528576|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130775862|NCT02959918|470806627|FG013|Overall Study|Withdrawal by Subject|1|||
130775863|NCT02959918|470806614|FG000|Overall Study|Protocol Violation|0|||
130775864|NCT02959918|470806615|FG001|Overall Study|Protocol Violation|0|||
130775865|NCT02959918|470806616|FG002|Overall Study|Protocol Violation|1|||
130775866|NCT02959918|470806617|FG003|Overall Study|Protocol Violation|0|||
130775867|NCT02959918|470806618|FG004|Overall Study|Protocol Violation|0|||
130775868|NCT02959918|470806619|FG005|Overall Study|Protocol Violation|1|||
130775869|NCT02959918|470806620|FG006|Overall Study|Protocol Violation|0|||
130973417|NCT01490632|471528577|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973418|NCT01490632|471528578|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973419|NCT01490632|471528579|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973420|NCT01490632|471528580|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973421|NCT01490632|471528581|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973422|NCT01490632|471528582|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130775870|NCT02959918|470806621|FG007|Overall Study|Protocol Violation|0|||
130775871|NCT02959918|470806622|FG008|Overall Study|Protocol Violation|2|||
130775872|NCT02959918|470806623|FG009|Overall Study|Protocol Violation|1|||
130775873|NCT02959918|470806624|FG010|Overall Study|Protocol Violation|0|||
130775874|NCT02959918|470806625|FG011|Overall Study|Protocol Violation|1|||
130973423|NCT01490632|471528583|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973424|NCT01490632|471528584|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973425|NCT01490632|471528585|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973426|NCT01490632|471528586|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973427|NCT01490632|471528587|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
130973428|NCT01490632|471528588|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
130973429|NCT01490632|471528589|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973430|NCT01490632|471528590|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973431|NCT01490632|471528591|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973432|NCT01490632|471528592|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
130973433|NCT01490632|471528573|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973434|NCT01490632|471528574|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973435|NCT01490632|471528575|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973436|NCT01490632|471528576|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973437|NCT01490632|471528577|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973438|NCT01490632|471528578|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973439|NCT01490632|471528579|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973440|NCT01490632|471528580|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973441|NCT01490632|471528581|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973442|NCT01490632|471528582|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973443|NCT01490632|471528583|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973444|NCT01490632|471528584|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973445|NCT01490632|471528585|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
130973446|NCT01490632|471528586|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
130973447|NCT01490632|471528587|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
130973448|NCT01490632|471528588|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
130973449|NCT01490632|471528589|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973450|NCT01490632|471528590|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973451|NCT01490632|471528591|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973452|NCT01490632|471528592|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
130973453|NCT01490632|471528573|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
130985719|NCT00105235|471574966|FG000|Overall Study|Death|4|||
130775875|NCT02959918|470806626|FG012|Overall Study|Protocol Violation|1|||
130775876|NCT02959918|470806627|FG013|Overall Study|Protocol Violation|0|||
130775877|NCT02959918|470806614|FG000|Overall Study|Stopping Rule Met|1|||
130775878|NCT02959918|470806615|FG001|Overall Study|Stopping Rule Met|0|||
130775879|NCT02959918|470806616|FG002|Overall Study|Stopping Rule Met|3|||
130775880|NCT02959918|470806617|FG003|Overall Study|Stopping Rule Met|4|||
130775881|NCT02959918|470806618|FG004|Overall Study|Stopping Rule Met|5|||
130973454|NCT01490632|471528574|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
130973455|NCT01490632|471528575|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
130973456|NCT01490632|471528576|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
130973457|NCT01490632|471528577|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
130973458|NCT01490632|471528578|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
130973459|NCT01490632|471528579|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
130973460|NCT01490632|471528580|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
130973461|NCT01490632|471528581|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
130973462|NCT01490632|471528582|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
130973463|NCT01490632|471528583|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
130973464|NCT01490632|471528584|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
130973465|NCT01490632|471528585|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
130973466|NCT01490632|471528586|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
130973467|NCT01490632|471528587|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
130973468|NCT01490632|471528588|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
130973469|NCT01490632|471528589|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
130973470|NCT01490632|471528590|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
130973471|NCT01490632|471528591|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
130973472|NCT01490632|471528592|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
130973473|NCT01490632|471528573|FG000|Part D: Re-Treatment Period|Death|0|||
130973474|NCT01490632|471528574|FG001|Part D: Re-Treatment Period|Death|0|||
130973475|NCT01490632|471528575|FG002|Part D: Re-Treatment Period|Death|0|||
130973476|NCT01490632|471528576|FG003|Part D: Re-Treatment Period|Death|0|||
130973477|NCT01490632|471528577|FG004|Part D: Re-Treatment Period|Death|0|||
130973478|NCT01490632|471528578|FG005|Part D: Re-Treatment Period|Death|0|||
130973479|NCT01490632|471528579|FG006|Part D: Re-Treatment Period|Death|0|||
130973480|NCT01490632|471528580|FG007|Part D: Re-Treatment Period|Death|0|||
130973481|NCT01490632|471528581|FG008|Part D: Re-Treatment Period|Death|0|||
130973482|NCT01490632|471528582|FG009|Part D: Re-Treatment Period|Death|0|||
130973483|NCT01490632|471528583|FG010|Part D: Re-Treatment Period|Death|0|||
130973484|NCT01490632|471528584|FG011|Part D: Re-Treatment Period|Death|0|||
130973485|NCT01490632|471528585|FG012|Part D: Re-Treatment Period|Death|0|||
130973486|NCT01490632|471528586|FG013|Part D: Re-Treatment Period|Death|0|||
130973487|NCT01490632|471528587|FG014|Part D: Re-Treatment Period|Death|0|||
130973488|NCT01490632|471528588|FG015|Part D: Re-Treatment Period|Death|0|||
130973489|NCT01490632|471528589|FG016|Part D: Re-Treatment Period|Death|0|||
130973490|NCT01490632|471528590|FG017|Part D: Re-Treatment Period|Death|0|||
130973491|NCT01490632|471528591|FG018|Part D: Re-Treatment Period|Death|1|||
130973492|NCT01490632|471528592|FG019|Part D: Re-Treatment Period|Death|0|||
130973493|NCT01490632|471528573|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973494|NCT01490632|471528574|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973495|NCT01490632|471528575|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973496|NCT01490632|471528576|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973497|NCT01490632|471528577|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973498|NCT01490632|471528578|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973499|NCT01490632|471528579|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973500|NCT01490632|471528580|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973501|NCT01490632|471528581|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973502|NCT01490632|471528582|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973503|NCT01490632|471528583|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973504|NCT01490632|471528584|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973505|NCT01490632|471528585|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973506|NCT01490632|471528586|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973507|NCT01490632|471528587|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130716819|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130973508|NCT01490632|471528588|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973509|NCT01490632|471528589|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
130973510|NCT01490632|471528590|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
130973511|NCT01490632|471528591|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
130973512|NCT01490632|471528592|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
130973513|NCT01490632|471528573|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973514|NCT01490632|471528574|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973515|NCT01490632|471528575|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973516|NCT01490632|471528576|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130716820|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
130973517|NCT01490632|471528577|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973518|NCT01490632|471528578|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130716821|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
130973519|NCT01490632|471528579|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973520|NCT01490632|471528580|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973521|NCT01490632|471528581|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973522|NCT01490632|471528582|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973523|NCT01490632|471528583|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130775882|NCT02959918|470806619|FG005|Overall Study|Stopping Rule Met|3|||
131043215|NCT04660539|471793001|FG000|Overall Study|Non-Compliance With Study Drug|3|||
131043216|NCT04660539|471793001|FG000|Overall Study|Reason not Specified|12|||
131043217|NCT04660539|471793001|FG000|Overall Study|Pregnancy|2|||
131043218|NCT04660539|471793001|FG000|Overall Study|Protocol Violation|2|||
131043219|NCT04660539|471793001|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
131043220|NCT04660539|471793001|FG000|Overall Study|Withdrawal by Subject|21|||
131043221|NCT03655028|471793004|FG000|12-weeks Follow up|Death|1|||
131043222|NCT03655028|471793005|FG001|12-weeks Follow up|Death|0|||
131043223|NCT03655028|471793004|FG000|12-weeks Follow up|Physician Decision|3|||
131043224|NCT03655028|471793005|FG001|12-weeks Follow up|Physician Decision|3|||
131043225|NCT03655028|471793004|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
131043226|NCT03655028|471793005|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
131043227|NCT03655028|471793004|FG000|12-weeks Follow up|Lost to Follow-up|4|||
131043228|NCT03655028|471793005|FG001|12-weeks Follow up|Lost to Follow-up|4|||
131043229|NCT03655028|471793004|FG000|24-weeks|Lost to Follow-up|1|||
131043230|NCT03655028|471793005|FG001|24-weeks|Lost to Follow-up|1|||
131043231|NCT03655028|471793004|FG000|24-weeks|Death|0|||
131043232|NCT03655028|471793005|FG001|24-weeks|Death|1|||
131043233|NCT03513302|471793006|FG000|First Intervention (14 Days)|Screen failure|15|||
131043234|NCT03513302|471793007|FG001|First Intervention (14 Days)|Screen failure|16|||
131043235|NCT05618587|471793008|FG000|Overall Study|Lost to Follow-up|2|||
131043236|NCT05618587|471793009|FG001|Overall Study|Lost to Follow-up|0|||
131043237|NCT05167864|471793012|FG000|Overall Study|Lost to Follow-up|7|||
131043238|NCT05167864|471793013|FG001|Overall Study|Lost to Follow-up|6|||
130716822|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716823|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716824|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130973524|NCT01490632|471528584|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973525|NCT01490632|471528585|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973526|NCT01490632|471528586|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973527|NCT01490632|471528587|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973528|NCT01490632|471528588|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973529|NCT01490632|471528589|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973530|NCT01490632|471528590|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973531|NCT01490632|471528591|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
130973532|NCT01490632|471528592|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130973533|NCT01490632|471528573|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
130973534|NCT01490632|471528574|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
130973535|NCT01490632|471528575|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
130973536|NCT01490632|471528576|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
130973537|NCT01490632|471528577|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
130716825|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716826|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716827|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716828|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716829|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716830|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716831|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716832|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716833|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716834|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716835|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716836|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716837|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716838|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716839|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130716840|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716841|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
130775883|NCT02959918|470806620|FG006|Overall Study|Stopping Rule Met|2|||
130775884|NCT02959918|470806621|FG007|Overall Study|Stopping Rule Met|4|||
130775885|NCT02959918|470806622|FG008|Overall Study|Stopping Rule Met|1|||
130775886|NCT02959918|470806623|FG009|Overall Study|Stopping Rule Met|1|||
130775887|NCT02959918|470806624|FG010|Overall Study|Stopping Rule Met|3|||
131043239|NCT05167864|471793014|FG002|Overall Study|Lost to Follow-up|7|||
131043240|NCT05167864|471793015|FG003|Overall Study|Lost to Follow-up|9|||
131043241|NCT03442309|471793016|FG000|Overall Study|Lost to Follow-up|1676|||
130775888|NCT02959918|470806625|FG011|Overall Study|Stopping Rule Met|5|||
130775889|NCT02959918|470806626|FG012|Overall Study|Stopping Rule Met|2|||
131043242|NCT03442309|471793017|FG001|Overall Study|Lost to Follow-up|1642|||
131043243|NCT04862416|471793018|FG000|Overall Study|Withdrawal by Subject|0|||
131043244|NCT04862416|471793019|FG001|Overall Study|Withdrawal by Subject|1|||
131043245|NCT04862416|471793020|FG002|Overall Study|Withdrawal by Subject|0|||
131043246|NCT04862416|471793021|FG003|Overall Study|Withdrawal by Subject|1|||
131043247|NCT04862416|471793022|FG004|Overall Study|Withdrawal by Subject|0|||
131043248|NCT04862416|471793023|FG005|Overall Study|Withdrawal by Subject|0|||
131043249|NCT04862416|471793024|FG006|Overall Study|Withdrawal by Subject|0|||
131043250|NCT04862416|471793025|FG007|Overall Study|Withdrawal by Subject|0|||
131043251|NCT03852550|471793026|FG000|Overall Study|Lost to Follow-up|4|||
131043252|NCT03852550|471793027|FG001|Overall Study|Lost to Follow-up|3|||
131043253|NCT03852550|471793026|FG000|Overall Study|Only parent outcomes completed|0|||
131043254|NCT03852550|471793027|FG001|Overall Study|Only parent outcomes completed|1|||
131043255|NCT03852550|471793026|FG000|Overall Study|Withdrawal by Subject|1|||
131043256|NCT03852550|471793027|FG001|Overall Study|Withdrawal by Subject|0|||
131043257|NCT05204654|471793028|FG000|Overall Study|Study terminated due to time restraint|2|||
131043258|NCT05204654|471793029|FG001|Overall Study|Study terminated due to time restraint|2|||
131043259|NCT05207956|471793049|FG000|Overall Study|Lost to follow up|1|||
131043260|NCT05207956|471793050|FG001|Overall Study|Lost to follow up|2|||
131043261|NCT01254864|471793053|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
131043262|NCT01254864|471793054|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
131043263|NCT01254864|471793055|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
131043264|NCT01254864|471793053|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
131043265|NCT01254864|471793054|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
131043266|NCT01254864|471793055|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
131043267|NCT01254864|471793053|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
131043268|NCT01254864|471793054|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
131043269|NCT01254864|471793055|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
131043270|NCT01254864|471793053|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
131043271|NCT01254864|471793054|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
131043272|NCT01254864|471793055|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
131043273|NCT01254864|471793053|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
131043274|NCT01254864|471793054|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
131043275|NCT01254864|471793055|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
131043276|NCT01254864|471793053|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
131043277|NCT01254864|471793054|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
131043278|NCT01254864|471793055|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
131043279|NCT01254864|471793053|FG000|Randomization Phase|Adverse Event|0|||
131043280|NCT01254864|471793054|FG001|Randomization Phase|Adverse Event|5|||
131043281|NCT01254864|471793055|FG002|Randomization Phase|Adverse Event|17|||
131043282|NCT01254864|471793053|FG000|Randomization Phase|Death|0|||
131043283|NCT01254864|471793054|FG001|Randomization Phase|Death|1|||
131043284|NCT01254864|471793055|FG002|Randomization Phase|Death|0|||
131043285|NCT01254864|471793053|FG000|Randomization Phase|Lost to Follow-up|0|||
131043286|NCT01254864|471793054|FG001|Randomization Phase|Lost to Follow-up|0|||
131043287|NCT01254864|471793055|FG002|Randomization Phase|Lost to Follow-up|1|||
131043288|NCT01254864|471793053|FG000|Randomization Phase|Physician Decision|0|||
131043289|NCT01254864|471793054|FG001|Randomization Phase|Physician Decision|20|||
131131300|NCT03031301|472108304|FG001|Overall Study|Withdrawal by Subject|4|||
131131301|NCT03031301|472108303|FG000|Overall Study|Lost to Follow-up|4|||
130973538|NCT01490632|471528578|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
130973539|NCT01490632|471528579|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
130973540|NCT01490632|471528580|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
130973541|NCT01490632|471528581|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
130973542|NCT01490632|471528582|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
130973543|NCT01490632|471528583|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
130973544|NCT01490632|471528584|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
130973545|NCT01490632|471528585|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
130973546|NCT01490632|471528586|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
130973547|NCT01490632|471528587|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
130973548|NCT01490632|471528588|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
130973549|NCT01490632|471528589|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
130973550|NCT01490632|471528590|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
130973551|NCT01490632|471528591|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
130973552|NCT01490632|471528592|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
130973553|NCT01490632|471528573|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
130973554|NCT01490632|471528574|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
131131302|NCT03031301|472108304|FG001|Overall Study|Lost to Follow-up|12|||
131043290|NCT01254864|471793055|FG002|Randomization Phase|Physician Decision|25|||
131043291|NCT01254864|471793053|FG000|Randomization Phase|Withdrawal by Subject|0|||
131043292|NCT01254864|471793054|FG001|Randomization Phase|Withdrawal by Subject|4|||
131043293|NCT01254864|471793055|FG002|Randomization Phase|Withdrawal by Subject|2|||
131043294|NCT01254864|471793053|FG000|Randomization Phase|Non-Compliance|0|||
131131303|NCT03031301|472108303|FG000|Overall Study|Noncompliance|1|||
130973555|NCT01490632|471528575|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
130973556|NCT01490632|471528576|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
130973557|NCT01490632|471528577|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
130973558|NCT01490632|471528578|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
130973559|NCT01490632|471528579|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
130973560|NCT01490632|471528580|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
130973561|NCT01490632|471528581|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
130973562|NCT01490632|471528582|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
130973563|NCT01490632|471528583|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
130973564|NCT01490632|471528584|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
130973565|NCT01490632|471528585|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
130973566|NCT01490632|471528586|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
130973567|NCT01490632|471528587|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
130973568|NCT01490632|471528588|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
130973569|NCT01490632|471528589|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
130973570|NCT01490632|471528590|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
130973571|NCT01490632|471528591|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
130973572|NCT01490632|471528592|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
130973573|NCT01490632|471528573|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130716842|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716843|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130973574|NCT01490632|471528574|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973575|NCT01490632|471528575|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973576|NCT01490632|471528576|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973577|NCT01490632|471528577|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973578|NCT01490632|471528578|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973579|NCT01490632|471528579|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973580|NCT01490632|471528580|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973581|NCT01490632|471528581|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973582|NCT01490632|471528582|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973583|NCT01490632|471528583|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973584|NCT01490632|471528584|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973585|NCT01490632|471528585|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973586|NCT01490632|471528586|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973587|NCT01490632|471528587|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973588|NCT01490632|471528588|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973589|NCT01490632|471528589|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130973590|NCT01490632|471528590|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
130973591|NCT01490632|471528591|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
130973592|NCT01490632|471528592|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
130973593|NCT00856856|471528598|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
130973594|NCT00856856|471528598|FG000|4-year Clinical Follow-up|Missed visit|1|||
130973595|NCT02696317|471528602|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
130973596|NCT02696317|471528603|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
130973597|NCT02696317|471528602|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
130973598|NCT02696317|471528603|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
130973599|NCT01343368|471528604|FG000|Overall Study|Death|1|||
130973600|NCT01343368|471528605|FG001|Overall Study|Death|0|||
130973601|NCT01343368|471528604|FG000|Overall Study|Lost to Follow-up|1|||
130973602|NCT01343368|471528605|FG001|Overall Study|Lost to Follow-up|0|||
130973603|NCT04955639|471528606|FG000|Overall Study|Withdrawal by Subject|2|||
130973604|NCT04955639|471528607|FG001|Overall Study|Withdrawal by Subject|2|||
130973605|NCT04955639|471528606|FG000|Overall Study|Week 26 survey not completed|2|||
130973606|NCT04955639|471528607|FG001|Overall Study|Week 26 survey not completed|2|||
130973607|NCT04447404|471528608|FG000|Overall Study|Death|2|||
130973608|NCT04447404|471528609|FG001|Overall Study|Death|0|||
130973609|NCT00321854|471528610|FG000|Overall Study|Adverse Event|41|||
130973610|NCT00321854|471528611|FG001|Overall Study|Adverse Event|43|||
130973611|NCT00321854|471528610|FG000|Overall Study|Lack of Efficacy|9|||
130973612|NCT00321854|471528611|FG001|Overall Study|Lack of Efficacy|14|||
130973613|NCT00321854|471528610|FG000|Overall Study|Protocol Violation|6|||
130973614|NCT00321854|471528611|FG001|Overall Study|Protocol Violation|5|||
130973615|NCT00321854|471528610|FG000|Overall Study|Lost to Follow-up|0|||
130973616|NCT00321854|471528611|FG001|Overall Study|Lost to Follow-up|2|||
130973617|NCT00321854|471528610|FG000|Overall Study|Withdrawal by Subject|6|||
130716844|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716845|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130973618|NCT00321854|471528611|FG001|Overall Study|Withdrawal by Subject|17|||
130973619|NCT00321854|471528610|FG000|Overall Study|Other|1|||
130973620|NCT00321854|471528611|FG001|Overall Study|Other|1|||
130973621|NCT01369342|471528612|FG000|Overall Study|Withdrawal by Subject|7|||
130973622|NCT01369342|471528613|FG001|Overall Study|Withdrawal by Subject|7|||
130973623|NCT01369342|471528614|FG002|Overall Study|Withdrawal by Subject|2|||
130973624|NCT01369342|471528612|FG000|Overall Study|Lost to Follow-up|5|||
130716846|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130973625|NCT01369342|471528613|FG001|Overall Study|Lost to Follow-up|2|||
130973626|NCT01369342|471528614|FG002|Overall Study|Lost to Follow-up|1|||
130973627|NCT01369342|471528612|FG000|Overall Study|Not Treated|1|||
130973628|NCT01369342|471528613|FG001|Overall Study|Not Treated|0|||
130973629|NCT01369342|471528614|FG002|Overall Study|Not Treated|0|||
130973630|NCT04723576|471528615|FG000|Overall Study|Withdrawal by Subject|2133|||
130973631|NCT04723576|471528616|FG001|Overall Study|Withdrawal by Subject|3234|||
130973632|NCT00413153|471528617|FG000|Overall Study|Withdrawal by Subject|1|||
130973633|NCT00413153|471528618|FG001|Overall Study|Withdrawal by Subject|1|||
130973634|NCT00413153|471528617|FG000|Overall Study|Adverse Event|1|||
130973635|NCT00413153|471528618|FG001|Overall Study|Adverse Event|0|||
130973636|NCT03204279|471528619|FG000|Overall Study|Withdrawal by Subject|0|||
130973637|NCT03204279|471528620|FG001|Overall Study|Withdrawal by Subject|1|||
130973638|NCT04969250|471528621|FG000|Overall Study|Protocol Violation|0|||
130973639|NCT04969250|471528622|FG001|Overall Study|Protocol Violation|2|||
130973640|NCT04969250|471528623|FG002|Overall Study|Protocol Violation|3|||
130973641|NCT04969250|471528624|FG003|Overall Study|Protocol Violation|8|||
130973642|NCT04969250|471528621|FG000|Overall Study|Withdrawal by Subject|0|||
130973643|NCT04969250|471528622|FG001|Overall Study|Withdrawal by Subject|1|||
130973644|NCT04969250|471528623|FG002|Overall Study|Withdrawal by Subject|0|||
130973645|NCT04969250|471528624|FG003|Overall Study|Withdrawal by Subject|0|||
130973646|NCT02278328|471528625|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
130973647|NCT02278328|471528626|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
130973648|NCT02278328|471528627|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
130973649|NCT02278328|471528625|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
130973650|NCT02278328|471528626|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
130973651|NCT02278328|471528627|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
130973652|NCT02278328|471528625|FG000|Neuropsych Screening|incomplete consent|0|||
130973653|NCT02278328|471528626|FG001|Neuropsych Screening|incomplete consent|0|||
130973654|NCT02278328|471528627|FG002|Neuropsych Screening|incomplete consent|2|||
130973655|NCT03834779|471528633|FG000|Overall Study|Death|1|||
130973656|NCT03834779|471528634|FG001|Overall Study|Death|2|||
130973657|NCT03834779|471528633|FG000|Overall Study|Lost to Follow-up|6|||
130973658|NCT03834779|471528634|FG001|Overall Study|Lost to Follow-up|4|||
130973659|NCT01292928|471528636|FG000|Overall Study|Death|8|||
130973660|NCT01292928|471528636|FG000|Overall Study|Withdrawal by Subject|8|||
130973661|NCT01292928|471528636|FG000|Overall Study|Lost to Follow-up|6|||
130973662|NCT01292928|471528636|FG000|Overall Study|Physician Decision|2|||
130973663|NCT00130533|471528641|FG000|Overall Study|Withdrawal by Subject|33|||
130973664|NCT00130533|471528642|FG001|Overall Study|Withdrawal by Subject|6|||
130973665|NCT00130533|471528641|FG000|Overall Study|Adverse Event|34|||
130973666|NCT00130533|471528642|FG001|Overall Study|Adverse Event|1|||
130973667|NCT00130533|471528641|FG000|Overall Study|Disease relapse|9|||
130973668|NCT00130533|471528642|FG001|Overall Study|Disease relapse|13|||
130973669|NCT00130533|471528641|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
130973670|NCT00130533|471528642|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
130973671|NCT00130533|471528641|FG000|Overall Study|Death|4|||
130973672|NCT00130533|471528642|FG001|Overall Study|Death|2|||
130973673|NCT00130533|471528641|FG000|Overall Study|Protocol Violation|5|||
130973674|NCT00130533|471528642|FG001|Overall Study|Protocol Violation|1|||
130716847|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716848|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716849|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716850|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716851|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716852|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130973675|NCT00130533|471528641|FG000|Overall Study|Lost to Follow-up|1|||
130973676|NCT00130533|471528642|FG001|Overall Study|Lost to Follow-up|1|||
130973677|NCT00130533|471528641|FG000|Overall Study|Sponsor´s decision|2|||
130973678|NCT00130533|471528642|FG001|Overall Study|Sponsor´s decision|0|||
130973679|NCT00130533|471528641|FG000|Overall Study|Second Primary Malignancy|0|||
130973680|NCT00130533|471528642|FG001|Overall Study|Second Primary Malignancy|1|||
130973681|NCT00130533|471528641|FG000|Overall Study|Other|12|||
130973682|NCT00130533|471528642|FG001|Overall Study|Other|5|||
130973683|NCT01059565|471528643|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
130973684|NCT01059565|471528644|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
130973685|NCT01059565|471528643|FG000|24-Week Randomized Phase|Adverse Event|5|||
130973686|NCT01059565|471528644|FG001|24-Week Randomized Phase|Adverse Event|0|||
130973687|NCT01059565|471528643|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
130973688|NCT01059565|471528644|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
130973689|NCT01059565|471528643|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
130973690|NCT01059565|471528644|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
130973691|NCT01059565|471528643|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
130775890|NCT02959918|470806627|FG013|Overall Study|Stopping Rule Met|1|||
130985720|NCT00105235|471574966|FG000|Overall Study|Physician Decision|1|||
130985721|NCT00105235|471574966|FG000|Overall Study|Withdrawal by Subject|2|||
130973692|NCT01059565|471528644|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
130973693|NCT01059565|471528643|FG000|24-Week Open-Label Phase|Adverse Event|2|||
130973694|NCT01059565|471528644|FG001|24-Week Open-Label Phase|Adverse Event|0|||
130973695|NCT01059565|471528643|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
130973696|NCT01059565|471528644|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
130973697|NCT01059565|471528643|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
130973698|NCT01059565|471528644|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
130973699|NCT01059565|471528643|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
130973700|NCT01059565|471528644|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
130973701|NCT01059565|471528643|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
130973702|NCT01059565|471528644|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
130973703|NCT01059565|471528643|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
130973704|NCT01059565|471528644|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
130973705|NCT03263429|471528649|FG000|Overall Study|Withdrawal by Subject|0|||
130973706|NCT03263429|471528650|FG001|Overall Study|Withdrawal by Subject|1|||
130973707|NCT03263429|471528651|FG002|Overall Study|Withdrawal by Subject|0|||
130973708|NCT03263429|471528649|FG000|Overall Study|Follow-Up Period Completed|0|||
130973709|NCT03263429|471528650|FG001|Overall Study|Follow-Up Period Completed|2|||
130973710|NCT03263429|471528651|FG002|Overall Study|Follow-Up Period Completed|0|||
130973711|NCT03263429|471528649|FG000|Overall Study|Death|3|||
130973712|NCT03263429|471528650|FG001|Overall Study|Death|5|||
130973713|NCT03263429|471528651|FG002|Overall Study|Death|16|||
130973714|NCT03263429|471528649|FG000|Overall Study|Participant unable to return|0|||
130973715|NCT03263429|471528650|FG001|Overall Study|Participant unable to return|0|||
130973716|NCT03263429|471528651|FG002|Overall Study|Participant unable to return|1|||
130973717|NCT03263429|471528649|FG000|Overall Study|Study Closed|0|||
130973718|NCT03263429|471528650|FG001|Overall Study|Study Closed|0|||
130973719|NCT03263429|471528651|FG002|Overall Study|Study Closed|1|||
130973720|NCT01605617|471528652|FG000|First Intervention|Adverse Event|0|||
130973721|NCT01605617|471528653|FG001|First Intervention|Adverse Event|1|||
130973722|NCT01605617|471528652|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
130973723|NCT01605617|471528653|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
130973724|NCT03759873|471528658|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
130973725|NCT03759873|471528659|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
130973726|NCT03759873|471528660|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
130973727|NCT03759873|471528661|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
130973728|NCT03759873|471528658|FG000|Overall Study|Moved outside eligible area|0|||
130973729|NCT03759873|471528659|FG001|Overall Study|Moved outside eligible area|2|||
130973730|NCT03759873|471528660|FG002|Overall Study|Moved outside eligible area|0|||
130973731|NCT03759873|471528661|FG003|Overall Study|Moved outside eligible area|0|||
130973732|NCT03759873|471528658|FG000|Overall Study|Withdrawal by Subject|0|||
130973733|NCT03759873|471528659|FG001|Overall Study|Withdrawal by Subject|0|||
130973734|NCT03759873|471528660|FG002|Overall Study|Withdrawal by Subject|1|||
130973735|NCT03759873|471528661|FG003|Overall Study|Withdrawal by Subject|0|||
130973736|NCT03579563|471528662|FG000|Overall Study|Lost to Follow-up|0|||
130973737|NCT03579563|471528663|FG001|Overall Study|Lost to Follow-up|0|||
130973738|NCT03579563|471528664|FG002|Overall Study|Lost to Follow-up|0|||
130973739|NCT03579563|471528665|FG003|Overall Study|Lost to Follow-up|0|||
130973740|NCT03579563|471528666|FG004|Overall Study|Lost to Follow-up|1|||
130973741|NCT03579563|471528667|FG005|Overall Study|Lost to Follow-up|0|||
130973742|NCT03579563|471528662|FG000|Overall Study|Lack of Efficacy|1|||
130973743|NCT03579563|471528663|FG001|Overall Study|Lack of Efficacy|1|||
130973744|NCT03579563|471528664|FG002|Overall Study|Lack of Efficacy|4|||
130973745|NCT03579563|471528665|FG003|Overall Study|Lack of Efficacy|1|||
130973746|NCT03579563|471528666|FG004|Overall Study|Lack of Efficacy|2|||
130973747|NCT03579563|471528667|FG005|Overall Study|Lack of Efficacy|3|||
130973748|NCT03579563|471528662|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
130973749|NCT03579563|471528663|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
130973750|NCT03579563|471528664|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
130973751|NCT03579563|471528665|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
130973752|NCT03579563|471528666|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
130973753|NCT03579563|471528667|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
130973754|NCT03579563|471528662|FG000|Overall Study|Time/distance concern|0|||
130973755|NCT03579563|471528663|FG001|Overall Study|Time/distance concern|0|||
130973756|NCT03579563|471528664|FG002|Overall Study|Time/distance concern|1|||
130973757|NCT03579563|471528665|FG003|Overall Study|Time/distance concern|0|||
130973758|NCT03579563|471528666|FG004|Overall Study|Time/distance concern|0|||
130973759|NCT03579563|471528667|FG005|Overall Study|Time/distance concern|1|||
130973760|NCT03579563|471528662|FG000|Overall Study|COVID shutdown|2|||
131043295|NCT01254864|471793054|FG001|Randomization Phase|Non-Compliance|1|||
130973761|NCT03579563|471528663|FG001|Overall Study|COVID shutdown|3|||
130973762|NCT03579563|471528664|FG002|Overall Study|COVID shutdown|4|||
130973763|NCT03579563|471528665|FG003|Overall Study|COVID shutdown|3|||
130973764|NCT03579563|471528666|FG004|Overall Study|COVID shutdown|1|||
130973765|NCT03579563|471528667|FG005|Overall Study|COVID shutdown|2|||
130973766|NCT03579563|471528662|FG000|Overall Study|Protocol administration error|1|||
130973767|NCT03579563|471528663|FG001|Overall Study|Protocol administration error|0|||
130973768|NCT03579563|471528664|FG002|Overall Study|Protocol administration error|1|||
130973769|NCT03579563|471528665|FG003|Overall Study|Protocol administration error|0|||
130973770|NCT03579563|471528666|FG004|Overall Study|Protocol administration error|1|||
130973771|NCT03579563|471528667|FG005|Overall Study|Protocol administration error|5|||
130973772|NCT03526250|471528668|FG000|Overall Study|Adverse Event|4|||
130973773|NCT03526250|471528668|FG000|Overall Study|Progressive Disease|16|||
130973774|NCT03526250|471528668|FG000|Overall Study|No Treatment|3|||
130973775|NCT02647359|471528669|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
130973776|NCT02647359|471528670|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
130973777|NCT02647359|471528669|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
130973778|NCT02647359|471528670|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
130973779|NCT02647359|471528669|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
130973780|NCT02647359|471528670|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
130973781|NCT02647359|471528669|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
130973782|NCT02647359|471528670|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
130973783|NCT02647359|471528669|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
130973784|NCT02647359|471528670|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
130973785|NCT02647359|471528669|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
130973786|NCT02647359|471528670|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
130973787|NCT00511004|471528671|FG000|Overall Study|Lost to Follow-up|0|||
130973788|NCT00511004|471528672|FG001|Overall Study|Lost to Follow-up|0|||
130973789|NCT00511004|471528673|FG002|Overall Study|Lost to Follow-up|4|||
130973790|NCT02096900|471528675|FG000|Overall Study|Did not receive medication|3|||
130973791|NCT02096900|471528676|FG001|Overall Study|Did not receive medication|1|||
130973792|NCT02096900|471528675|FG000|Overall Study|Surgery cancelled- medication received|1|||
130973793|NCT02096900|471528676|FG001|Overall Study|Surgery cancelled- medication received|1|||
130973794|NCT03034577|471528677|FG000|Overall Study|Withdrawal by Subject|6|||
130973795|NCT03034577|471528678|FG001|Overall Study|Withdrawal by Subject|9|||
130973796|NCT03034577|471528677|FG000|Overall Study|Lost to Follow-up|25|||
130973797|NCT03034577|471528678|FG001|Overall Study|Lost to Follow-up|26|||
130973798|NCT03230916|471528682|FG000|Overall Study|Withdrawal by Subject|0|||
130973799|NCT03230916|471528683|FG001|Overall Study|Withdrawal by Subject|0|||
130973800|NCT03230916|471528684|FG002|Overall Study|Withdrawal by Subject|0|||
130973801|NCT03230916|471528685|FG003|Overall Study|Withdrawal by Subject|0|||
130973802|NCT03230916|471528686|FG004|Overall Study|Withdrawal by Subject|0|||
130973803|NCT03230916|471528687|FG005|Overall Study|Withdrawal by Subject|1|||
130973804|NCT03230916|471528688|FG006|Overall Study|Withdrawal by Subject|0|||
130973805|NCT03230916|471528689|FG007|Overall Study|Withdrawal by Subject|0|||
130973806|NCT03230916|471528690|FG008|Overall Study|Withdrawal by Subject|0|||
130973807|NCT03230916|471528691|FG009|Overall Study|Withdrawal by Subject|0|||
130973808|NCT03230916|471528692|FG010|Overall Study|Withdrawal by Subject|0|||
130973809|NCT01128413|471528693|FG000|Overall Study|Withdrawal by Subject|1|||
130973810|NCT01128413|471528694|FG001|Overall Study|Withdrawal by Subject|0|||
130973811|NCT01128413|471528693|FG000|Overall Study|NICOM Monitor Problems|2|||
130973812|NCT01128413|471528694|FG001|Overall Study|NICOM Monitor Problems|1|||
130973813|NCT01128413|471528693|FG000|Overall Study|Pt made DNR|1|||
130973814|NCT01128413|471528694|FG001|Overall Study|Pt made DNR|0|||
130973815|NCT02010060|471528698|FG000|Overall Study|Lost to Follow-up|1|||
130973816|NCT02010060|471528699|FG001|Overall Study|Lost to Follow-up|2|||
130973817|NCT02010060|471528700|FG002|Overall Study|Lost to Follow-up|2|||
130973818|NCT02010060|471528698|FG000|Overall Study|Injury|0|||
130973819|NCT02010060|471528699|FG001|Overall Study|Injury|1|||
130973820|NCT02010060|471528700|FG002|Overall Study|Injury|0|||
130973821|NCT00680407|471528703|FG000|Overall Study|Lost to Follow-up|3|||
130973822|NCT00680407|471528704|FG001|Overall Study|Lost to Follow-up|3|||
130973823|NCT00680407|471528705|FG002|Overall Study|Lost to Follow-up|1|||
130973824|NCT00680407|471528703|FG000|Overall Study|Withdrawal by Subject|5|||
130973825|NCT00680407|471528704|FG001|Overall Study|Withdrawal by Subject|2|||
130973826|NCT00680407|471528705|FG002|Overall Study|Withdrawal by Subject|2|||
130973827|NCT03069482|471530050|FG000|Overall Study|Lost to Follow-up|0|||
130973828|NCT03069482|471530051|FG001|Overall Study|Lost to Follow-up|1|||
130973829|NCT03069482|471530050|FG000|Overall Study|Physician Decision|1|||
130973830|NCT03069482|471530051|FG001|Overall Study|Physician Decision|0|||
130973831|NCT00791765|471530052|FG000|Weeks 1 to 12|Adverse Event|0|||
130973832|NCT00791765|471530053|FG001|Weeks 1 to 12|Adverse Event|1|||
130973833|NCT00791765|471530052|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
130973834|NCT00791765|471530053|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
130973835|NCT00791765|471530052|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
130973836|NCT00791765|471530053|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
130973837|NCT00791765|471530052|FG000|Weeks 1 to 12|Physician Decision|1|||
130973838|NCT00791765|471530053|FG001|Weeks 1 to 12|Physician Decision|0|||
130973839|NCT00791765|471530052|FG000|Weeks 1 to 12|Disease progression|3|||
130973840|NCT00791765|471530053|FG001|Weeks 1 to 12|Disease progression|0|||
130973841|NCT00791765|471530052|FG000|Weeks 1 to 12|Ineligibility determined|0|||
130973842|NCT00791765|471530053|FG001|Weeks 1 to 12|Ineligibility determined|3|||
130973843|NCT00791765|471530052|FG000|Weeks 13 to 24|Protocol deviation|2|||
130973844|NCT00791765|471530053|FG001|Weeks 13 to 24|Protocol deviation|0|||
130973845|NCT00791765|471530052|FG000|Weeks 13 to 24|Adverse Event|0|||
130973846|NCT00791765|471530053|FG001|Weeks 13 to 24|Adverse Event|3|||
130973847|NCT00791765|471530052|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
130973848|NCT00791765|471530053|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
130973849|NCT00791765|471530052|FG000|Weeks 13 to 24|Disease progression|0|||
130973850|NCT00791765|471530053|FG001|Weeks 13 to 24|Disease progression|1|||
130973851|NCT00791765|471530052|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
130973852|NCT00791765|471530053|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
130973853|NCT00791765|471530052|FG000|Weeks 13 to 24|Other|0|||
130973854|NCT00791765|471530053|FG001|Weeks 13 to 24|Other|1|||
130973855|NCT01877408|471530064|FG000|Overall Study|Lost to Follow-up|0|||
130973856|NCT01877408|471530065|FG001|Overall Study|Lost to Follow-up|2|||
130973857|NCT00156065|471530066|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
130973858|NCT00156065|471530067|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
130973859|NCT00156065|471530068|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
130973860|NCT00156065|471530066|FG000|Overall Study|Adverse Event|8|||
130973861|NCT00156065|471530067|FG001|Overall Study|Adverse Event|11|||
130973862|NCT00156065|471530068|FG002|Overall Study|Adverse Event|4|||
130973863|NCT00156065|471530066|FG000|Overall Study|Lack of Efficacy|2|||
130973864|NCT00156065|471530067|FG001|Overall Study|Lack of Efficacy|9|||
130973865|NCT00156065|471530068|FG002|Overall Study|Lack of Efficacy|3|||
130973866|NCT00156065|471530066|FG000|Overall Study|Withdrawal by Subject|13|||
130973867|NCT00156065|471530067|FG001|Overall Study|Withdrawal by Subject|26|||
130973868|NCT00156065|471530068|FG002|Overall Study|Withdrawal by Subject|16|||
130973869|NCT00156065|471530066|FG000|Overall Study|Lost to Follow-up|5|||
130973870|NCT00156065|471530067|FG001|Overall Study|Lost to Follow-up|7|||
130973871|NCT00156065|471530068|FG002|Overall Study|Lost to Follow-up|1|||
130973872|NCT00156065|471530066|FG000|Overall Study|Other|2|||
130973873|NCT00156065|471530067|FG001|Overall Study|Other|9|||
130973874|NCT00156065|471530068|FG002|Overall Study|Other|3|||
130973875|NCT01292603|471530069|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
130973876|NCT01292603|471530070|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
130973877|NCT01292603|471530071|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
130973878|NCT01292603|471530072|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
130973879|NCT01292603|471530073|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
130973880|NCT01292603|471530074|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
130973881|NCT01292603|471530069|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
130973882|NCT01292603|471530070|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
130973883|NCT01292603|471530071|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
130973884|NCT01292603|471530072|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
130973885|NCT01292603|471530073|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
130973886|NCT01292603|471530074|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
130973887|NCT01292603|471530069|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
130973888|NCT01292603|471530070|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
130973889|NCT01292603|471530071|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
130973890|NCT01292603|471530072|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
131043296|NCT01254864|471793055|FG002|Randomization Phase|Non-Compliance|0|||
131043297|NCT01254864|471793053|FG000|Randomization Phase|Comorbidities|0|||
131043298|NCT01254864|471793054|FG001|Randomization Phase|Comorbidities|2|||
131043299|NCT01254864|471793055|FG002|Randomization Phase|Comorbidities|1|||
130973891|NCT01292603|471530073|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
130973892|NCT01292603|471530074|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
130973893|NCT01292603|471530069|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
130973894|NCT01292603|471530070|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
130973895|NCT01292603|471530071|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
130973896|NCT01292603|471530072|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
131043300|NCT01828112|471793058|FG000|Treatment Phase|Adverse Event|7|||
131043301|NCT01828112|471793059|FG001|Treatment Phase|Adverse Event|8|||
131043302|NCT01828112|471793060|FG002|Treatment Phase|Adverse Event|0|||
131043303|NCT01828112|471793058|FG000|Treatment Phase|Death|9|||
131043304|NCT01828112|471793059|FG001|Treatment Phase|Death|5|||
130973897|NCT01292603|471530073|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
131043305|NCT01828112|471793060|FG002|Treatment Phase|Death|0|||
130973898|NCT01292603|471530074|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
130973899|NCT01292603|471530069|FG000|Part 1: Regular Follow-Up Period|Death|3|||
130973900|NCT01292603|471530070|FG001|Part 1: Regular Follow-Up Period|Death|1|||
130973901|NCT01292603|471530071|FG002|Part 1: Regular Follow-Up Period|Death|3|||
130973902|NCT01292603|471530072|FG003|Part 1: Regular Follow-Up Period|Death|1|||
131043306|NCT01828112|471793058|FG000|Treatment Phase|No longer required treatment|0|||
131131304|NCT03031301|472108304|FG001|Overall Study|Noncompliance|3|||
130973903|NCT01292603|471530073|FG004|Part 1: Regular Follow-Up Period|Death|0|||
130973904|NCT01292603|471530074|FG005|Part 1: Regular Follow-Up Period|Death|0|||
130973905|NCT01292603|471530069|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
130973906|NCT01292603|471530070|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
130973907|NCT01292603|471530071|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
130973908|NCT01292603|471530072|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
130973909|NCT01292603|471530073|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
130973910|NCT01292603|471530074|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
130973911|NCT01292603|471530069|FG000|Part 2: Dose Confirmation Period|Death|0|||
130973912|NCT01292603|471530070|FG001|Part 2: Dose Confirmation Period|Death|0|||
130973913|NCT01292603|471530071|FG002|Part 2: Dose Confirmation Period|Death|0|||
130973914|NCT01292603|471530072|FG003|Part 2: Dose Confirmation Period|Death|0|||
130973915|NCT01292603|471530073|FG004|Part 2: Dose Confirmation Period|Death|1|||
130973916|NCT01292603|471530074|FG005|Part 2: Dose Confirmation Period|Death|0|||
130973917|NCT01292603|471530069|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
130973918|NCT01292603|471530070|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
130973919|NCT01292603|471530071|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
130973920|NCT01292603|471530072|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
130973921|NCT01292603|471530073|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
130973922|NCT01292603|471530074|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
130973923|NCT01292603|471530069|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
130973924|NCT01292603|471530070|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
130973925|NCT01292603|471530071|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
130973926|NCT01292603|471530072|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
130973927|NCT01292603|471530073|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
130973928|NCT01292603|471530074|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
130973929|NCT01292603|471530069|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
130973930|NCT01292603|471530070|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
130973931|NCT01292603|471530071|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
130973932|NCT01292603|471530072|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
130973933|NCT01292603|471530073|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
130973934|NCT01292603|471530074|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
130973935|NCT01292603|471530069|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
130973936|NCT01292603|471530070|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
130973937|NCT01292603|471530071|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
130973938|NCT01292603|471530072|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
130973939|NCT01292603|471530073|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
130973940|NCT01292603|471530074|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
130973941|NCT01292603|471530069|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
130973942|NCT01292603|471530070|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
130973943|NCT01292603|471530071|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
130973944|NCT01292603|471530072|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
130973945|NCT01292603|471530073|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
130973946|NCT01292603|471530074|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
130973947|NCT01292603|471530069|FG000|Part 2: Regular Follow-Up|Death|0|||
130973948|NCT01292603|471530070|FG001|Part 2: Regular Follow-Up|Death|0|||
130973949|NCT01292603|471530071|FG002|Part 2: Regular Follow-Up|Death|0|||
130973950|NCT01292603|471530072|FG003|Part 2: Regular Follow-Up|Death|0|||
130973951|NCT01292603|471530073|FG004|Part 2: Regular Follow-Up|Death|6|||
130973952|NCT01292603|471530074|FG005|Part 2: Regular Follow-Up|Death|3|||
130973953|NCT01292603|471530069|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
130973954|NCT01292603|471530070|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
130973955|NCT01292603|471530071|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
130973956|NCT01292603|471530072|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
130973957|NCT01292603|471530073|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
130973958|NCT01292603|471530074|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
130973959|NCT01292603|471530069|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
130973960|NCT01292603|471530070|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
130973961|NCT01292603|471530071|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
130973962|NCT01292603|471530072|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
130973963|NCT01292603|471530073|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
130973964|NCT01292603|471530074|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
130973965|NCT01292603|471530069|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
130973966|NCT01292603|471530070|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
130973967|NCT01292603|471530071|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
130973968|NCT01292603|471530072|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
130973969|NCT01292603|471530073|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
130973970|NCT01292603|471530074|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
131043307|NCT01828112|471793059|FG001|Treatment Phase|No longer required treatment|1|||
131043308|NCT01828112|471793060|FG002|Treatment Phase|No longer required treatment|0|||
131043309|NCT01828112|471793058|FG000|Treatment Phase|Physician Decision|6|||
131043310|NCT01828112|471793059|FG001|Treatment Phase|Physician Decision|7|||
131043311|NCT01828112|471793060|FG002|Treatment Phase|Physician Decision|0|||
131043312|NCT01828112|471793058|FG000|Treatment Phase|Pregnancy|1|||
131043313|NCT01828112|471793059|FG001|Treatment Phase|Pregnancy|0|||
131043314|NCT01828112|471793060|FG002|Treatment Phase|Pregnancy|0|||
131043315|NCT01828112|471793058|FG000|Treatment Phase|Progressive disease|79|||
130973971|NCT01292603|471530069|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
130973972|NCT01292603|471530070|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
130973973|NCT01292603|471530071|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
130973974|NCT01292603|471530072|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
130973975|NCT01292603|471530073|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
130973976|NCT01292603|471530074|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
130973977|NCT01292603|471530069|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
130973978|NCT01292603|471530070|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
130973979|NCT01292603|471530071|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
130973980|NCT01292603|471530072|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
130973981|NCT01292603|471530073|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
131043316|NCT01828112|471793059|FG001|Treatment Phase|Progressive disease|87|||
130973982|NCT01292603|471530074|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
130973983|NCT01292603|471530069|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
130973984|NCT01292603|471530070|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
130973985|NCT01292603|471530071|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
130973986|NCT01292603|471530072|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
130973987|NCT01292603|471530073|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
130973988|NCT01292603|471530074|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
130973989|NCT01292603|471530069|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
130973990|NCT01292603|471530070|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
130973991|NCT01292603|471530071|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
130973992|NCT01292603|471530072|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
130973993|NCT01292603|471530073|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
130973994|NCT01292603|471530074|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
131043317|NCT01828112|471793060|FG002|Treatment Phase|Progressive disease|0|||
131043318|NCT01828112|471793058|FG000|Treatment Phase|Study terminated by sponsor|1|||
131043319|NCT01828112|471793059|FG001|Treatment Phase|Study terminated by sponsor|0|||
131043320|NCT01828112|471793060|FG002|Treatment Phase|Study terminated by sponsor|0|||
131043321|NCT01828112|471793058|FG000|Treatment Phase|Subject/guardian decision|12|||
131043322|NCT01828112|471793059|FG001|Treatment Phase|Subject/guardian decision|8|||
131043323|NCT01828112|471793060|FG002|Treatment Phase|Subject/guardian decision|0|||
131043324|NCT01828112|471793058|FG000|Extension Treatment Phase|Adverse Event|0|||
131043325|NCT01828112|471793059|FG001|Extension Treatment Phase|Adverse Event|0|||
131043326|NCT01828112|471793060|FG002|Extension Treatment Phase|Adverse Event|6|||
131043327|NCT01828112|471793058|FG000|Extension Treatment Phase|Death|0|||
131227385|NCT01684722|472459723|FG000|Overall Study|Death|19|||
131227386|NCT01684722|472459724|FG001|Overall Study|Death|21|||
130716853|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130973995|NCT01292603|471530069|FG000|Overall Survival Status|Death|3|||
130973996|NCT01292603|471530070|FG001|Overall Survival Status|Death|1|||
130973997|NCT01292603|471530071|FG002|Overall Survival Status|Death|3|||
130973998|NCT01292603|471530072|FG003|Overall Survival Status|Death|1|||
130973999|NCT01292603|471530073|FG004|Overall Survival Status|Death|16|||
130974000|NCT01292603|471530074|FG005|Overall Survival Status|Death|10|||
130974001|NCT03870763|471530077|FG000|Overall Study|Study terminated by sponsor|0|||
130974002|NCT03870763|471530078|FG001|Overall Study|Study terminated by sponsor|2|||
130974003|NCT03870763|471530079|FG002|Overall Study|Study terminated by sponsor|0|||
130974004|NCT03870763|471530077|FG000|Overall Study|Withdrawal by Subject|0|||
130974005|NCT03870763|471530078|FG001|Overall Study|Withdrawal by Subject|1|||
130974006|NCT03870763|471530079|FG002|Overall Study|Withdrawal by Subject|0|||
131043328|NCT01828112|471793059|FG001|Extension Treatment Phase|Death|0|||
131043329|NCT01828112|471793060|FG002|Extension Treatment Phase|Death|17|||
130716854|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716855|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
131043330|NCT01828112|471793058|FG000|Extension Treatment Phase|Physician Decision|0|||
131043331|NCT01828112|471793059|FG001|Extension Treatment Phase|Physician Decision|0|||
131227387|NCT01684722|472459725|FG002|Overall Study|Death|19|||
130974007|NCT03870763|471530077|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
131227388|NCT01684722|472459726|FG003|Overall Study|Death|21|||
131227389|NCT01814137|472459727|FG000|Overall Study|Adverse Event|0|||
131227390|NCT01814137|472459728|FG001|Overall Study|Adverse Event|1|||
130974008|NCT03870763|471530078|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
130974009|NCT03870763|471530079|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
130974010|NCT03586648|471530082|FG000|Period 1|Withdrawal by Subject|0|||
130974011|NCT03586648|471530083|FG001|Period 1|Withdrawal by Subject|1|||
130974012|NCT03586648|471530082|FG000|Period 1|Lost to Follow-up|1|||
130974013|NCT03586648|471530083|FG001|Period 1|Lost to Follow-up|1|||
130974014|NCT03586648|471530082|FG000|Period 1|Adverse Event|1|||
130974015|NCT03586648|471530083|FG001|Period 1|Adverse Event|0|||
130974016|NCT03586648|471530082|FG000|Period 1|Study related symptoms or complaints|2|||
130974017|NCT03586648|471530083|FG001|Period 1|Study related symptoms or complaints|1|||
130974018|NCT03586648|471530082|FG000|Period 1|Physician Decision|0|||
130974019|NCT03586648|471530083|FG001|Period 1|Physician Decision|1|||
130974020|NCT03586648|471530082|FG000|Period 2|Adverse Event|1|||
130974021|NCT03586648|471530083|FG001|Period 2|Adverse Event|0|||
130974022|NCT00907153|471530087|FG000|Overall Study|Lost to Follow-up|1|||
130974023|NCT00907153|471530088|FG001|Overall Study|Lost to Follow-up|1|||
130974024|NCT00907153|471530087|FG000|Overall Study|Withdrawal by Subject|1|||
130974025|NCT00907153|471530088|FG001|Overall Study|Withdrawal by Subject|3|||
130974026|NCT03147248|471530089|FG000|Overall Study|Adverse Event|0|||
130974027|NCT03147248|471530090|FG001|Overall Study|Adverse Event|2|||
130974028|NCT03147248|471530091|FG002|Overall Study|Adverse Event|2|||
130974029|NCT03147248|471530092|FG003|Overall Study|Adverse Event|2|||
130974030|NCT03147248|471530093|FG004|Overall Study|Adverse Event|6|||
130974031|NCT03147248|471530094|FG005|Overall Study|Adverse Event|11|||
130974032|NCT03147248|471530089|FG000|Overall Study|Disease progression|1|||
130974033|NCT03147248|471530090|FG001|Overall Study|Disease progression|0|||
130974034|NCT03147248|471530091|FG002|Overall Study|Disease progression|0|||
130974035|NCT03147248|471530092|FG003|Overall Study|Disease progression|0|||
130974036|NCT03147248|471530093|FG004|Overall Study|Disease progression|0|||
130974037|NCT03147248|471530094|FG005|Overall Study|Disease progression|2|||
130974038|NCT03147248|471530089|FG000|Overall Study|Withdrawal by Subject|0|||
130974039|NCT03147248|471530090|FG001|Overall Study|Withdrawal by Subject|0|||
130974040|NCT03147248|471530091|FG002|Overall Study|Withdrawal by Subject|0|||
130974041|NCT03147248|471530092|FG003|Overall Study|Withdrawal by Subject|0|||
130974042|NCT03147248|471530093|FG004|Overall Study|Withdrawal by Subject|12|||
130974043|NCT03147248|471530094|FG005|Overall Study|Withdrawal by Subject|9|||
130974044|NCT03147248|471530089|FG000|Overall Study|Protocol Violation|0|||
130974045|NCT03147248|471530090|FG001|Overall Study|Protocol Violation|0|||
130974046|NCT03147248|471530091|FG002|Overall Study|Protocol Violation|0|||
130974047|NCT03147248|471530092|FG003|Overall Study|Protocol Violation|0|||
130974048|NCT03147248|471530093|FG004|Overall Study|Protocol Violation|2|||
130974049|NCT03147248|471530094|FG005|Overall Study|Protocol Violation|0|||
130974050|NCT03147248|471530089|FG000|Overall Study|Lost to Follow-up|0|||
130974051|NCT03147248|471530090|FG001|Overall Study|Lost to Follow-up|0|||
130974052|NCT03147248|471530091|FG002|Overall Study|Lost to Follow-up|0|||
130974053|NCT03147248|471530092|FG003|Overall Study|Lost to Follow-up|0|||
130974054|NCT03147248|471530093|FG004|Overall Study|Lost to Follow-up|2|||
130974055|NCT03147248|471530094|FG005|Overall Study|Lost to Follow-up|0|||
130974056|NCT03147248|471530089|FG000|Overall Study|Pregnancy|0|||
130974057|NCT03147248|471530090|FG001|Overall Study|Pregnancy|0|||
130974058|NCT03147248|471530091|FG002|Overall Study|Pregnancy|0|||
130974059|NCT03147248|471530092|FG003|Overall Study|Pregnancy|0|||
130974060|NCT03147248|471530093|FG004|Overall Study|Pregnancy|1|||
130974061|NCT03147248|471530094|FG005|Overall Study|Pregnancy|0|||
130974062|NCT03147248|471530089|FG000|Overall Study|Death|0|||
130974063|NCT03147248|471530090|FG001|Overall Study|Death|0|||
130974064|NCT03147248|471530091|FG002|Overall Study|Death|0|||
130974065|NCT03147248|471530092|FG003|Overall Study|Death|0|||
130974066|NCT03147248|471530093|FG004|Overall Study|Death|0|||
130974067|NCT03147248|471530094|FG005|Overall Study|Death|4|||
130974068|NCT03147248|471530089|FG000|Overall Study|Physician Decision|0|||
130974069|NCT03147248|471530090|FG001|Overall Study|Physician Decision|0|||
130974070|NCT03147248|471530091|FG002|Overall Study|Physician Decision|0|||
130974071|NCT03147248|471530092|FG003|Overall Study|Physician Decision|0|||
130974072|NCT03147248|471530093|FG004|Overall Study|Physician Decision|2|||
130974073|NCT03147248|471530094|FG005|Overall Study|Physician Decision|4|||
130974074|NCT03147248|471530089|FG000|Overall Study|Prolonged Dosing Interval|0|||
130974075|NCT03147248|471530090|FG001|Overall Study|Prolonged Dosing Interval|0|||
130974076|NCT03147248|471530091|FG002|Overall Study|Prolonged Dosing Interval|0|||
130974077|NCT03147248|471530092|FG003|Overall Study|Prolonged Dosing Interval|0|||
131043332|NCT01828112|471793060|FG002|Extension Treatment Phase|Physician Decision|5|||
131043333|NCT01828112|471793058|FG000|Extension Treatment Phase|Progressive disease|0|||
131043334|NCT01828112|471793059|FG001|Extension Treatment Phase|Progressive disease|0|||
130974078|NCT03147248|471530093|FG004|Overall Study|Prolonged Dosing Interval|1|||
130974079|NCT03147248|471530094|FG005|Overall Study|Prolonged Dosing Interval|1|||
130974080|NCT02388724|471530098|FG000|Overall Study|Reason not Specified|0|||
130974081|NCT02388724|471530099|FG001|Overall Study|Reason not Specified|1|||
130974082|NCT02388724|471530098|FG000|Overall Study|Major Protocol Deviation|3|||
130974083|NCT02388724|471530099|FG001|Overall Study|Major Protocol Deviation|3|||
130974084|NCT02388724|471530098|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
130974085|NCT02388724|471530099|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
130974086|NCT02388724|471530098|FG000|Overall Study|Voluntary Withdrawal|6|||
130974087|NCT02388724|471530099|FG001|Overall Study|Voluntary Withdrawal|5|||
130974088|NCT02388724|471530098|FG000|Overall Study|Randomized but not Treated|0|||
130974089|NCT02388724|471530099|FG001|Overall Study|Randomized but not Treated|2|||
130775891|NCT02959918|470806614|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
130775892|NCT02959918|470806615|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
130775893|NCT02959918|470806616|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
130974090|NCT02605954|471530100|FG000|Overall Study|Adverse Event|5|||
130974091|NCT02605954|471530101|FG001|Overall Study|Adverse Event|1|||
130974092|NCT02605954|471530100|FG000|Overall Study|Investigator's Discretion|1|||
130974093|NCT02605954|471530101|FG001|Overall Study|Investigator's Discretion|0|||
130974094|NCT02605954|471530100|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130974095|NCT02605954|471530101|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130974096|NCT02605954|471530100|FG000|Overall Study|Withdrew Consent|2|||
130974097|NCT02605954|471530101|FG001|Overall Study|Withdrew Consent|2|||
130974098|NCT02605954|471530100|FG000|Overall Study|Lost to Follow-up|3|||
130974099|NCT02605954|471530101|FG001|Overall Study|Lost to Follow-up|0|||
130974100|NCT02605954|471530100|FG000|Overall Study|Randomized but not treated|0|||
130974101|NCT02605954|471530101|FG001|Overall Study|Randomized but not treated|1|||
130974102|NCT03555396|471530102|FG000|Overall Study|Death|3|||
130974103|NCT03555396|471530103|FG001|Overall Study|Death|1|||
130974104|NCT03555396|471530102|FG000|Overall Study|Lost to Follow-up|0|||
130974105|NCT03555396|471530103|FG001|Overall Study|Lost to Follow-up|2|||
130974106|NCT03638141|471530112|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
130974107|NCT02513563|471530113|FG000|Overall Study|Death|4|||
130974108|NCT02513563|471530113|FG000|Overall Study|Withdrawal by Subject|4|||
130974109|NCT02513563|471530113|FG000|Overall Study|Physician Decision|1|||
130974110|NCT04818346|471530118|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
130974111|NCT04818346|471530119|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
130974112|NCT04818346|471530120|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
130974113|NCT04818346|471530121|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
130974114|NCT04818346|471530118|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
130974115|NCT04818346|471530119|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
130974116|NCT04818346|471530120|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
130974117|NCT04818346|471530121|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
130974118|NCT04818346|471530118|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
130974119|NCT04818346|471530119|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
130974120|NCT04818346|471530120|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
130974121|NCT04818346|471530121|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
130974122|NCT04818346|471530118|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
130974123|NCT04818346|471530119|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
130974124|NCT04818346|471530120|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
130974125|NCT04818346|471530121|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
130974126|NCT04818346|471530118|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
130974127|NCT04818346|471530119|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
130974128|NCT04818346|471530120|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
130974129|NCT04818346|471530121|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
130974130|NCT04818346|471530118|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
130974131|NCT04818346|471530119|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
130974132|NCT04818346|471530120|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
130974133|NCT04818346|471530121|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
130974134|NCT04818346|471530118|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
130974135|NCT04818346|471530119|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
130974136|NCT04818346|471530120|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
130974137|NCT04818346|471530121|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
130974138|NCT04818346|471530118|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
130974139|NCT04818346|471530119|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
130974140|NCT04818346|471530120|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
130974141|NCT04818346|471530121|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
130974142|NCT04818346|471530118|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
130974143|NCT04818346|471530119|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
130974144|NCT04818346|471530120|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
130974145|NCT04818346|471530121|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
130974146|NCT04818346|471530118|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
130974147|NCT04818346|471530119|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
130974148|NCT04818346|471530120|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
130974149|NCT04818346|471530121|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
130775894|NCT02959918|470806617|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
130974150|NCT04818346|471530118|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
130974151|NCT04818346|471530119|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
130974152|NCT04818346|471530120|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
130974153|NCT04818346|471530121|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
130974154|NCT04818346|471530118|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
130974155|NCT04818346|471530119|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
130974156|NCT04818346|471530120|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
130974157|NCT04818346|471530121|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
130974158|NCT04818346|471530118|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
130974159|NCT04818346|471530119|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
130974160|NCT04818346|471530120|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
130974161|NCT04818346|471530121|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
130974162|NCT04818346|471530118|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
130974163|NCT04818346|471530119|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
130974164|NCT04818346|471530120|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
130974165|NCT04818346|471530121|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
130974166|NCT04818346|471530118|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
130974167|NCT04818346|471530119|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
130974168|NCT04818346|471530120|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
130974169|NCT04818346|471530121|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
130974170|NCT01672801|471530122|FG000|Overall Study|Screen Failure|0|||
130974171|NCT01672801|471530123|FG001|Overall Study|Screen Failure|1|||
130974172|NCT01362140|471530124|FG000|Overall Study|Noncompliance|1|||
130974173|NCT01362140|471530125|FG001|Overall Study|Noncompliance|0|||
130974174|NCT01362140|471530124|FG000|Overall Study|Adverse Event|2|||
130974175|NCT01362140|471530125|FG001|Overall Study|Adverse Event|2|||
130974176|NCT01362140|471530124|FG000|Overall Study|Withdrawal by Subject|3|||
130974177|NCT01362140|471530125|FG001|Overall Study|Withdrawal by Subject|3|||
130974178|NCT01362140|471530124|FG000|Overall Study|Administrative Decision|0|||
130974179|NCT01362140|471530125|FG001|Overall Study|Administrative Decision|1|||
130974180|NCT01362140|471530124|FG000|Overall Study|Death|2|||
130974181|NCT01362140|471530125|FG001|Overall Study|Death|1|||
130974182|NCT01362140|471530124|FG000|Overall Study|Other|1|||
130974183|NCT01362140|471530125|FG001|Overall Study|Other|1|||
130974184|NCT01362140|471530124|FG000|Overall Study|Protocol-specified Criteria|1|||
130974185|NCT01362140|471530125|FG001|Overall Study|Protocol-specified Criteria|2|||
130974186|NCT01362140|471530124|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
130974187|NCT01362140|471530125|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
130974188|NCT00492284|471530127|FG000|Overall Study|Adverse Event|0|||
130974189|NCT00492284|471530128|FG001|Overall Study|Adverse Event|1|||
130974190|NCT00492284|471530129|FG002|Overall Study|Adverse Event|1|||
130974191|NCT00492284|471530130|FG003|Overall Study|Adverse Event|2|||
130974192|NCT00492284|471530127|FG000|Overall Study|Lost to Follow-up|0|||
130974193|NCT00492284|471530128|FG001|Overall Study|Lost to Follow-up|0|||
130974194|NCT00492284|471530129|FG002|Overall Study|Lost to Follow-up|3|||
130974195|NCT00492284|471530130|FG003|Overall Study|Lost to Follow-up|1|||
130974196|NCT00492284|471530127|FG000|Overall Study|Death|0|||
130974197|NCT00492284|471530128|FG001|Overall Study|Death|3|||
130974198|NCT00492284|471530129|FG002|Overall Study|Death|2|||
130974199|NCT00492284|471530130|FG003|Overall Study|Death|5|||
130974200|NCT00492284|471530127|FG000|Overall Study|Withdrawal by Subject|1|||
130974201|NCT00492284|471530128|FG001|Overall Study|Withdrawal by Subject|0|||
130974202|NCT00492284|471530129|FG002|Overall Study|Withdrawal by Subject|0|||
130974203|NCT00492284|471530130|FG003|Overall Study|Withdrawal by Subject|2|||
130974204|NCT06476366|471530131|FG000|Overall Study|Lost to Follow-up|1|||
130974205|NCT06476366|471530132|FG001|Overall Study|Lost to Follow-up|3|||
130974206|NCT06476366|471530131|FG000|Overall Study|Adverse Event|1|||
130974207|NCT06476366|471530132|FG001|Overall Study|Adverse Event|0|||
130974208|NCT02384954|471530136|FG000|Phase 1|Progressive Disease|2|||
130974209|NCT02384954|471530137|FG001|Phase 1|Progressive Disease|0|||
130974210|NCT02384954|471530138|FG002|Phase 1|Progressive Disease|1|||
130974211|NCT02384954|471530139|FG003|Phase 1|Progressive Disease|1|||
130974212|NCT02384954|471530140|FG004|Phase 1|Progressive Disease|0|||
130974213|NCT02384954|471530141|FG005|Phase 1|Progressive Disease|0|||
130974214|NCT02384954|471530142|FG006|Phase 1|Progressive Disease|0|||
130974215|NCT02384954|471530143|FG007|Phase 1|Progressive Disease|0|||
130974216|NCT02384954|471530144|FG008|Phase 1|Progressive Disease|0|||
130974217|NCT02384954|471530136|FG000|Phase 1|Adverse Event|0|||
130974218|NCT02384954|471530137|FG001|Phase 1|Adverse Event|0|||
130974219|NCT02384954|471530138|FG002|Phase 1|Adverse Event|1|||
130974220|NCT02384954|471530139|FG003|Phase 1|Adverse Event|0|||
130974221|NCT02384954|471530140|FG004|Phase 1|Adverse Event|0|||
130974222|NCT02384954|471530141|FG005|Phase 1|Adverse Event|0|||
130974223|NCT02384954|471530142|FG006|Phase 1|Adverse Event|0|||
131043335|NCT01828112|471793060|FG002|Extension Treatment Phase|Progressive disease|46|||
130974224|NCT02384954|471530143|FG007|Phase 1|Adverse Event|0|||
130974225|NCT02384954|471530144|FG008|Phase 1|Adverse Event|0|||
130974226|NCT02384954|471530136|FG000|Phase 2|Progressive Disease|0|||
130974227|NCT02384954|471530137|FG001|Phase 2|Progressive Disease|0|||
130974228|NCT02384954|471530138|FG002|Phase 2|Progressive Disease|0|||
130974229|NCT02384954|471530139|FG003|Phase 2|Progressive Disease|0|||
130974230|NCT02384954|471530140|FG004|Phase 2|Progressive Disease|0|||
130974231|NCT02384954|471530141|FG005|Phase 2|Progressive Disease|0|||
130974232|NCT02384954|471530142|FG006|Phase 2|Progressive Disease|0|||
130974233|NCT02384954|471530143|FG007|Phase 2|Progressive Disease|1|||
130974234|NCT02384954|471530144|FG008|Phase 2|Progressive Disease|2|||
130974235|NCT02384954|471530136|FG000|Phase 2|Adverse Event|0|||
130974236|NCT02384954|471530137|FG001|Phase 2|Adverse Event|0|||
130974237|NCT02384954|471530138|FG002|Phase 2|Adverse Event|0|||
130974238|NCT02384954|471530139|FG003|Phase 2|Adverse Event|0|||
130974239|NCT02384954|471530140|FG004|Phase 2|Adverse Event|0|||
130974240|NCT02384954|471530141|FG005|Phase 2|Adverse Event|0|||
130974241|NCT02384954|471530142|FG006|Phase 2|Adverse Event|0|||
130974242|NCT02384954|471530143|FG007|Phase 2|Adverse Event|1|||
130974243|NCT02384954|471530144|FG008|Phase 2|Adverse Event|1|||
130974244|NCT02384954|471530136|FG000|Phase 2|Failure to meet continuation criteria|0|||
130974245|NCT02384954|471530137|FG001|Phase 2|Failure to meet continuation criteria|0|||
130974246|NCT02384954|471530138|FG002|Phase 2|Failure to meet continuation criteria|0|||
130974247|NCT02384954|471530139|FG003|Phase 2|Failure to meet continuation criteria|0|||
130974248|NCT02384954|471530140|FG004|Phase 2|Failure to meet continuation criteria|0|||
130974249|NCT02384954|471530141|FG005|Phase 2|Failure to meet continuation criteria|0|||
130974250|NCT02384954|471530142|FG006|Phase 2|Failure to meet continuation criteria|0|||
130974251|NCT02384954|471530143|FG007|Phase 2|Failure to meet continuation criteria|1|||
130974252|NCT02384954|471530144|FG008|Phase 2|Failure to meet continuation criteria|0|||
130974253|NCT01910129|471530151|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
130974254|NCT01910129|471530152|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
130974255|NCT01910129|471530153|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
130974256|NCT01910129|471530151|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
130974257|NCT01910129|471530152|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
130974258|NCT01910129|471530153|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
130974259|NCT03150056|471530155|FG000|Overall Study|Withdrawal by Subject|0|||
130974260|NCT03150056|471530156|FG001|Overall Study|Withdrawal by Subject|0|||
130974261|NCT03150056|471530157|FG002|Overall Study|Withdrawal by Subject|0|||
130974262|NCT03150056|471530158|FG003|Overall Study|Withdrawal by Subject|0|||
130974263|NCT03150056|471530159|FG004|Overall Study|Withdrawal by Subject|0|||
130974264|NCT03150056|471530160|FG005|Overall Study|Withdrawal by Subject|2|||
130974265|NCT03150056|471530155|FG000|Overall Study|Study terminated by Sponsor|1|||
130974266|NCT03150056|471530156|FG001|Overall Study|Study terminated by Sponsor|3|||
130974267|NCT03150056|471530157|FG002|Overall Study|Study terminated by Sponsor|1|||
130974268|NCT03150056|471530158|FG003|Overall Study|Study terminated by Sponsor|1|||
130974269|NCT03150056|471530159|FG004|Overall Study|Study terminated by Sponsor|5|||
130974270|NCT03150056|471530160|FG005|Overall Study|Study terminated by Sponsor|6|||
130974271|NCT03150056|471530155|FG000|Overall Study|Death|9|||
130974272|NCT03150056|471530156|FG001|Overall Study|Death|2|||
130974273|NCT03150056|471530157|FG002|Overall Study|Death|2|||
130974274|NCT03150056|471530158|FG003|Overall Study|Death|7|||
130974275|NCT03150056|471530159|FG004|Overall Study|Death|8|||
130974276|NCT03150056|471530160|FG005|Overall Study|Death|10|||
130974277|NCT03595904|471530161|FG000|Overall Study|Protocol Violation|3|||
130974278|NCT03595904|471530162|FG001|Overall Study|Protocol Violation|1|||
130974279|NCT03595904|471530161|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
130974280|NCT03595904|471530162|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
130974281|NCT03595904|471530161|FG000|Overall Study|Insurance complications|1|||
130974282|NCT03595904|471530162|FG001|Overall Study|Insurance complications|0|||
130974283|NCT03595904|471530161|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
130974284|NCT03595904|471530162|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
130716856|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716857|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130974285|NCT01581281|471530163|FG000|Overall Study|Early Study Closure|15|||
130974286|NCT01581281|471530164|FG001|Overall Study|Early Study Closure|6|||
130974287|NCT01581281|471530165|FG002|Overall Study|Early Study Closure|12|||
130974288|NCT02187991|471530166|FG000|Overall Study|Adverse Event|13|||
130716858|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716859|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130974289|NCT02187991|471530167|FG001|Overall Study|Adverse Event|14|||
130974290|NCT02187991|471530168|FG002|Overall Study|Adverse Event|3|||
130974291|NCT02187991|471530169|FG003|Overall Study|Adverse Event|2|||
130974292|NCT02187991|471530166|FG000|Overall Study|Withdrawal by Subject|9|||
130974293|NCT02187991|471530167|FG001|Overall Study|Withdrawal by Subject|6|||
130974294|NCT02187991|471530168|FG002|Overall Study|Withdrawal by Subject|3|||
130974295|NCT02187991|471530169|FG003|Overall Study|Withdrawal by Subject|2|||
130974296|NCT02187991|471530166|FG000|Overall Study|Physician Decision|4|||
130974297|NCT02187991|471530167|FG001|Overall Study|Physician Decision|4|||
130974298|NCT02187991|471530168|FG002|Overall Study|Physician Decision|0|||
130974299|NCT02187991|471530169|FG003|Overall Study|Physician Decision|2|||
130974300|NCT02187991|471530166|FG000|Overall Study|Other, unrelated complication|7|||
130974301|NCT02187991|471530167|FG001|Overall Study|Other, unrelated complication|1|||
130974302|NCT02187991|471530168|FG002|Overall Study|Other, unrelated complication|1|||
130974303|NCT02187991|471530169|FG003|Overall Study|Other, unrelated complication|2|||
130974304|NCT02187991|471530166|FG000|Overall Study|Death|1|||
130974305|NCT02187991|471530167|FG001|Overall Study|Death|3|||
130974306|NCT02187991|471530168|FG002|Overall Study|Death|0|||
131227391|NCT01814137|472459727|FG000|Overall Study|Withdrawal by Subject|2|||
130974307|NCT02187991|471530169|FG003|Overall Study|Death|0|||
130974308|NCT01392560|471530172|FG000|Overall Study|Adverse Event|2|||
130974309|NCT01392560|471530172|FG000|Overall Study|not entered|8|||
130974310|NCT01392560|471530172|FG000|Overall Study|discontinued during placebo run-in|2|||
130974311|NCT00700401|471530179|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
130974312|NCT00700401|471530179|FG000|Overall Study|Adverse Event|5|||
130974313|NCT00700401|471530179|FG000|Overall Study|Refused Treatment|2|||
130974314|NCT00700401|471530179|FG000|Overall Study|Lost to Follow-up|1|||
130974315|NCT00700401|471530179|FG000|Overall Study|Treatment never started|1|||
130974316|NCT00700401|471530179|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
130974317|NCT00700401|471530179|FG000|Overall Study|Withdrawal by Subject|2|||
130974318|NCT03273946|471530180|FG000|Overall Study|Withdrawal by Subject|5|||
130974319|NCT03273946|471530180|FG000|Overall Study|Unwillingness of the guardian|1|||
130974320|NCT03273946|471530180|FG000|Overall Study|Participant refused to use the drug|2|||
130974321|NCT03273946|471530180|FG000|Overall Study|Participant relative refused to use drug|1|||
130974322|NCT00295750|471530183|FG000|Overall Study|Adverse Event|19|||
130974323|NCT00295750|471530184|FG001|Overall Study|Adverse Event|15|||
130974324|NCT00295750|471530185|FG002|Overall Study|Adverse Event|12|||
130974325|NCT00295750|471530183|FG000|Overall Study|Lack of Efficacy|1|||
130974326|NCT00295750|471530184|FG001|Overall Study|Lack of Efficacy|1|||
130974327|NCT00295750|471530185|FG002|Overall Study|Lack of Efficacy|0|||
130974328|NCT00295750|471530183|FG000|Overall Study|Lost to Follow-up|1|||
130974329|NCT00295750|471530184|FG001|Overall Study|Lost to Follow-up|4|||
130974330|NCT00295750|471530185|FG002|Overall Study|Lost to Follow-up|1|||
130974331|NCT00295750|471530183|FG000|Overall Study|Taking prohibited therapy|2|||
130974332|NCT00295750|471530184|FG001|Overall Study|Taking prohibited therapy|3|||
130974333|NCT00295750|471530185|FG002|Overall Study|Taking prohibited therapy|2|||
130974334|NCT00295750|471530183|FG000|Overall Study|Administrative errors|2|||
130974335|NCT00295750|471530184|FG001|Overall Study|Administrative errors|4|||
130974336|NCT00295750|471530185|FG002|Overall Study|Administrative errors|5|||
130974337|NCT00295750|471530183|FG000|Overall Study|Trial drug errors|1|||
130974338|NCT00295750|471530184|FG001|Overall Study|Trial drug errors|1|||
130974339|NCT00295750|471530185|FG002|Overall Study|Trial drug errors|0|||
130974340|NCT00295750|471530183|FG000|Overall Study|Disease progression|2|||
130974341|NCT00295750|471530184|FG001|Overall Study|Disease progression|1|||
130974342|NCT00295750|471530185|FG002|Overall Study|Disease progression|0|||
130974343|NCT00295750|471530183|FG000|Overall Study|Personal reasons|0|||
130974344|NCT00295750|471530184|FG001|Overall Study|Personal reasons|1|||
130974345|NCT00295750|471530185|FG002|Overall Study|Personal reasons|0|||
130974346|NCT00295750|471530183|FG000|Overall Study|Randomized but never received trial drug|4|||
130974347|NCT00295750|471530184|FG001|Overall Study|Randomized but never received trial drug|3|||
130974348|NCT00295750|471530185|FG002|Overall Study|Randomized but never received trial drug|3|||
130716860|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130716861|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130974349|NCT00295750|471530183|FG000|Overall Study|Withdrawal by Subject|9|||
130974350|NCT00295750|471530184|FG001|Overall Study|Withdrawal by Subject|4|||
130974351|NCT00295750|471530185|FG002|Overall Study|Withdrawal by Subject|7|||
130974352|NCT00295750|471530183|FG000|Overall Study|Protocol Violation|2|||
130974353|NCT00295750|471530184|FG001|Overall Study|Protocol Violation|4|||
130974354|NCT00295750|471530185|FG002|Overall Study|Protocol Violation|2|||
130974355|NCT02199028|471530191|FG000|Week 1|Adverse Event|1|||
130974356|NCT02199028|471530192|FG001|Week 1|Adverse Event|0|||
130974357|NCT02199028|471530191|FG000|Week 3|Adverse Event|1|||
130974358|NCT02199028|471530192|FG001|Week 3|Adverse Event|0|||
131227392|NCT01814137|472459728|FG001|Overall Study|Withdrawal by Subject|2|||
130716862|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130974359|NCT00355082|471530193|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
130974360|NCT00355082|471530194|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
130974361|NCT00355082|471530195|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
130974362|NCT00355082|471530193|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
130974363|NCT00355082|471530194|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
130974364|NCT00355082|471530195|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
131043336|NCT01828112|471793058|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
131227393|NCT01814137|472459727|FG000|Overall Study|Physician Decision|1|||
130974365|NCT00355082|471530193|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
130974366|NCT00355082|471530194|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
130974367|NCT00355082|471530195|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
130974368|NCT00355082|471530193|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
130974369|NCT00355082|471530194|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
130974370|NCT00355082|471530195|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
130974371|NCT00355082|471530193|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
130974372|NCT00355082|471530194|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
130974373|NCT00355082|471530195|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
130974374|NCT00355082|471530193|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
130974375|NCT00355082|471530194|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
130974376|NCT00355082|471530195|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
130974377|NCT00355082|471530193|FG000|Continuation Phase|Adverse Event|2|||
130974378|NCT00355082|471530194|FG001|Continuation Phase|Adverse Event|0|||
130974379|NCT00355082|471530195|FG002|Continuation Phase|Adverse Event|1|||
130974380|NCT00355082|471530193|FG000|Continuation Phase|Lost to Follow-up|2|||
130974381|NCT00355082|471530194|FG001|Continuation Phase|Lost to Follow-up|0|||
130974382|NCT00355082|471530195|FG002|Continuation Phase|Lost to Follow-up|1|||
130974383|NCT00355082|471530193|FG000|Continuation Phase|Protocol Violation|1|||
130974384|NCT00355082|471530194|FG001|Continuation Phase|Protocol Violation|0|||
130974385|NCT00355082|471530195|FG002|Continuation Phase|Protocol Violation|1|||
130974386|NCT00355082|471530193|FG000|Continuation Phase|Withdrawal by Subject|4|||
130974387|NCT00355082|471530194|FG001|Continuation Phase|Withdrawal by Subject|0|||
130974388|NCT00355082|471530195|FG002|Continuation Phase|Withdrawal by Subject|0|||
130974389|NCT00355082|471530193|FG000|Continuation Phase|Lack of Efficacy|5|||
130974390|NCT00355082|471530194|FG001|Continuation Phase|Lack of Efficacy|0|||
130974391|NCT00355082|471530195|FG002|Continuation Phase|Lack of Efficacy|0|||
130974392|NCT00355082|471530193|FG000|Continuation Phase|Site Closed by Sponsor|8|||
130974393|NCT00355082|471530194|FG001|Continuation Phase|Site Closed by Sponsor|0|||
130775895|NCT02959918|470806618|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130775896|NCT02959918|470806619|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130974394|NCT00355082|471530195|FG002|Continuation Phase|Site Closed by Sponsor|0|||
130974395|NCT00355082|471530193|FG000|Continuation Phase|Scheduling Error|1|||
130974396|NCT00355082|471530194|FG001|Continuation Phase|Scheduling Error|0|||
130974397|NCT00355082|471530195|FG002|Continuation Phase|Scheduling Error|0|||
130974398|NCT00355082|471530193|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
130974399|NCT00355082|471530194|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
130974400|NCT00355082|471530195|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
130974401|NCT04598152|471530199|FG000|Overall Study|Lost to Follow-up|0|||
130974402|NCT04598152|471530200|FG001|Overall Study|Lost to Follow-up|1|||
130974403|NCT03346759|471530201|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
130974404|NCT03346759|471530202|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
130974405|NCT03346759|471530201|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
130974406|NCT03346759|471530202|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
130974407|NCT03346759|471530201|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
130974408|NCT03346759|471530202|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
130974409|NCT04370054|471530203|FG000|Treatment Phase|Lost to Follow-up|1|||
130974410|NCT04370054|471530203|FG000|Treatment Phase|Withdrawal by Subject|1|||
130974411|NCT04370054|471530203|FG000|Follow-Up Phase|Ongoing|75|||
130974412|NCT00722761|471530204|FG000|Overall Study|Lost to Follow-up|1|||
130974413|NCT00722761|471530205|FG001|Overall Study|Lost to Follow-up|4|||
130974414|NCT00722761|471530204|FG000|Overall Study|Withdrawal by Subject|5|||
130974415|NCT00722761|471530205|FG001|Overall Study|Withdrawal by Subject|2|||
130974416|NCT05819749|471530207|FG000|Overall Study|Lost to Follow-up|1|||
130974417|NCT03214367|471532339|FG000|Lead-in Period|Withdrawal by Subject|50|||
130974418|NCT03214367|471532340|FG001|Lead-in Period|Withdrawal by Subject|0|||
130974419|NCT03214367|471532341|FG002|Lead-in Period|Withdrawal by Subject|0|||
130974420|NCT03214367|471532342|FG003|Lead-in Period|Withdrawal by Subject|0|||
130974421|NCT03214367|471532343|FG004|Lead-in Period|Withdrawal by Subject|2|||
130974422|NCT03214367|471532344|FG005|Lead-in Period|Withdrawal by Subject|0|||
130974423|NCT03214367|471532345|FG006|Lead-in Period|Withdrawal by Subject|0|||
130974424|NCT03214367|471532346|FG007|Lead-in Period|Withdrawal by Subject|0|||
130974425|NCT03214367|471532339|FG000|Lead-in Period|Adverse Event|3|||
130974426|NCT03214367|471532340|FG001|Lead-in Period|Adverse Event|0|||
131043337|NCT01828112|471793059|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
131043338|NCT01828112|471793060|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
130974427|NCT03214367|471532341|FG002|Lead-in Period|Adverse Event|0|||
130974428|NCT03214367|471532342|FG003|Lead-in Period|Adverse Event|0|||
130974429|NCT03214367|471532343|FG004|Lead-in Period|Adverse Event|0|||
130974430|NCT03214367|471532344|FG005|Lead-in Period|Adverse Event|0|||
130974431|NCT03214367|471532345|FG006|Lead-in Period|Adverse Event|0|||
130974432|NCT03214367|471532346|FG007|Lead-in Period|Adverse Event|0|||
130974433|NCT03214367|471532339|FG000|Lead-in Period|Lost to Follow-up|12|||
131043339|NCT01828112|471793058|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
130974434|NCT03214367|471532340|FG001|Lead-in Period|Lost to Follow-up|0|||
130974435|NCT03214367|471532341|FG002|Lead-in Period|Lost to Follow-up|0|||
130974436|NCT03214367|471532342|FG003|Lead-in Period|Lost to Follow-up|0|||
130974437|NCT03214367|471532343|FG004|Lead-in Period|Lost to Follow-up|0|||
130974438|NCT03214367|471532344|FG005|Lead-in Period|Lost to Follow-up|0|||
130974439|NCT03214367|471532345|FG006|Lead-in Period|Lost to Follow-up|0|||
130974440|NCT03214367|471532346|FG007|Lead-in Period|Lost to Follow-up|0|||
130974441|NCT03214367|471532339|FG000|Lead-in Period|Sponsor Decision|11|||
130974442|NCT03214367|471532340|FG001|Lead-in Period|Sponsor Decision|0|||
130974443|NCT03214367|471532341|FG002|Lead-in Period|Sponsor Decision|0|||
130974444|NCT03214367|471532342|FG003|Lead-in Period|Sponsor Decision|0|||
130974445|NCT03214367|471532343|FG004|Lead-in Period|Sponsor Decision|0|||
130974446|NCT03214367|471532344|FG005|Lead-in Period|Sponsor Decision|0|||
130974447|NCT03214367|471532345|FG006|Lead-in Period|Sponsor Decision|0|||
130974448|NCT03214367|471532346|FG007|Lead-in Period|Sponsor Decision|0|||
130974449|NCT03214367|471532339|FG000|Lead-in Period|Physician Decision|12|||
130974450|NCT03214367|471532340|FG001|Lead-in Period|Physician Decision|0|||
130974451|NCT03214367|471532341|FG002|Lead-in Period|Physician Decision|0|||
130974452|NCT03214367|471532342|FG003|Lead-in Period|Physician Decision|0|||
130974453|NCT03214367|471532343|FG004|Lead-in Period|Physician Decision|0|||
130974454|NCT03214367|471532344|FG005|Lead-in Period|Physician Decision|0|||
130974455|NCT03214367|471532345|FG006|Lead-in Period|Physician Decision|0|||
130974456|NCT03214367|471532346|FG007|Lead-in Period|Physician Decision|0|||
130974457|NCT03214367|471532339|FG000|Lead-in Period|Protocol Violation|5|||
130974458|NCT03214367|471532340|FG001|Lead-in Period|Protocol Violation|0|||
130974459|NCT03214367|471532341|FG002|Lead-in Period|Protocol Violation|0|||
130974460|NCT03214367|471532342|FG003|Lead-in Period|Protocol Violation|0|||
130974461|NCT03214367|471532343|FG004|Lead-in Period|Protocol Violation|0|||
130974462|NCT03214367|471532344|FG005|Lead-in Period|Protocol Violation|0|||
130974463|NCT03214367|471532345|FG006|Lead-in Period|Protocol Violation|0|||
130974464|NCT03214367|471532346|FG007|Lead-in Period|Protocol Violation|0|||
130974465|NCT03214367|471532339|FG000|Lead-in Period|Treatment Interruption|1|||
130974466|NCT03214367|471532340|FG001|Lead-in Period|Treatment Interruption|0|||
130974467|NCT03214367|471532341|FG002|Lead-in Period|Treatment Interruption|0|||
130974468|NCT03214367|471532342|FG003|Lead-in Period|Treatment Interruption|0|||
130974469|NCT03214367|471532343|FG004|Lead-in Period|Treatment Interruption|0|||
130974470|NCT03214367|471532344|FG005|Lead-in Period|Treatment Interruption|0|||
130974471|NCT03214367|471532345|FG006|Lead-in Period|Treatment Interruption|0|||
130974472|NCT03214367|471532346|FG007|Lead-in Period|Treatment Interruption|0|||
130974473|NCT03214367|471532339|FG000|Treatment Period|Adverse Event|0|||
130974474|NCT03214367|471532340|FG001|Treatment Period|Adverse Event|1|||
130974475|NCT03214367|471532341|FG002|Treatment Period|Adverse Event|4|||
130974476|NCT03214367|471532342|FG003|Treatment Period|Adverse Event|2|||
130974477|NCT03214367|471532343|FG004|Treatment Period|Adverse Event|0|||
130974478|NCT03214367|471532344|FG005|Treatment Period|Adverse Event|0|||
130974479|NCT03214367|471532345|FG006|Treatment Period|Adverse Event|0|||
130974480|NCT03214367|471532346|FG007|Treatment Period|Adverse Event|0|||
130974481|NCT03214367|471532339|FG000|Treatment Period|Death|0|||
131043340|NCT01828112|471793059|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
131043341|NCT01828112|471793060|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
131043342|NCT02446236|471793070|FG000|Overall Study|Screen Failure|1|||
131043343|NCT02446236|471793071|FG001|Overall Study|Screen Failure|0|||
130974482|NCT03214367|471532340|FG001|Treatment Period|Death|1|||
130974483|NCT03214367|471532341|FG002|Treatment Period|Death|1|||
130974484|NCT03214367|471532342|FG003|Treatment Period|Death|1|||
130974485|NCT03214367|471532343|FG004|Treatment Period|Death|0|||
131043344|NCT02446236|471793072|FG002|Overall Study|Screen Failure|1|||
131043345|NCT02446236|471793070|FG000|Overall Study|Actively Receiving Therapy|0|||
131043346|NCT02446236|471793071|FG001|Overall Study|Actively Receiving Therapy|0|||
131043347|NCT02446236|471793072|FG002|Overall Study|Actively Receiving Therapy|1|||
131043348|NCT00429364|471793073|FG000|Overall Study|Withdrawal by Subject|11|||
131227394|NCT01814137|472459728|FG001|Overall Study|Physician Decision|1|||
130716863|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130974486|NCT03214367|471532344|FG005|Treatment Period|Death|0|||
131043349|NCT00429364|471793074|FG001|Overall Study|Withdrawal by Subject|5|||
131043350|NCT00429364|471793073|FG000|Overall Study|Physician Decision|4|||
130974487|NCT03214367|471532345|FG006|Treatment Period|Death|0|||
131043351|NCT00429364|471793074|FG001|Overall Study|Physician Decision|2|||
130716864|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130974488|NCT03214367|471532346|FG007|Treatment Period|Death|0|||
130974489|NCT03214367|471532339|FG000|Treatment Period|Lost to Follow-up|0|||
131043352|NCT00429364|471793073|FG000|Overall Study|Lost to Follow-up|7|||
131043353|NCT00429364|471793074|FG001|Overall Study|Lost to Follow-up|6|||
130974490|NCT03214367|471532340|FG001|Treatment Period|Lost to Follow-up|5|||
130974491|NCT03214367|471532341|FG002|Treatment Period|Lost to Follow-up|3|||
130974492|NCT03214367|471532342|FG003|Treatment Period|Lost to Follow-up|2|||
130974493|NCT03214367|471532343|FG004|Treatment Period|Lost to Follow-up|0|||
130974494|NCT03214367|471532344|FG005|Treatment Period|Lost to Follow-up|2|||
130974495|NCT03214367|471532345|FG006|Treatment Period|Lost to Follow-up|1|||
130974496|NCT03214367|471532346|FG007|Treatment Period|Lost to Follow-up|0|||
130775897|NCT02959918|470806620|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130775898|NCT02959918|470806621|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130775899|NCT02959918|470806622|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130775900|NCT02959918|470806623|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130775901|NCT02959918|470806624|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130775902|NCT02959918|470806625|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130775903|NCT02959918|470806626|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130775904|NCT02959918|470806627|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130775905|NCT02959918|470806614|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775906|NCT02959918|470806615|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775907|NCT02959918|470806616|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130974497|NCT03214367|471532339|FG000|Treatment Period|Sponsor Decision|0|||
130974498|NCT03214367|471532340|FG001|Treatment Period|Sponsor Decision|3|||
130775908|NCT02959918|470806617|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775909|NCT02959918|470806618|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775910|NCT02959918|470806619|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775911|NCT02959918|470806620|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775912|NCT02959918|470806621|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
130974499|NCT03214367|471532341|FG002|Treatment Period|Sponsor Decision|0|||
130974500|NCT03214367|471532342|FG003|Treatment Period|Sponsor Decision|0|||
130974501|NCT03214367|471532343|FG004|Treatment Period|Sponsor Decision|0|||
130974502|NCT03214367|471532344|FG005|Treatment Period|Sponsor Decision|0|||
130974503|NCT03214367|471532345|FG006|Treatment Period|Sponsor Decision|0|||
130974504|NCT03214367|471532346|FG007|Treatment Period|Sponsor Decision|0|||
130974505|NCT03214367|471532339|FG000|Treatment Period|Physician Decision|0|||
130974506|NCT03214367|471532340|FG001|Treatment Period|Physician Decision|1|||
130974507|NCT03214367|471532341|FG002|Treatment Period|Physician Decision|2|||
130775913|NCT02959918|470806622|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775914|NCT02959918|470806623|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775915|NCT02959918|470806624|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775916|NCT02959918|470806625|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775917|NCT02959918|470806626|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775918|NCT02959918|470806627|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130775919|NCT02959918|470806614|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775920|NCT02959918|470806615|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775921|NCT02959918|470806616|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775922|NCT02959918|470806617|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775923|NCT02959918|470806618|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775924|NCT02959918|470806619|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775925|NCT02959918|470806620|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775926|NCT02959918|470806621|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775927|NCT02959918|470806622|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
130775928|NCT02959918|470806623|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775929|NCT02959918|470806624|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775930|NCT02959918|470806625|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130974508|NCT03214367|471532342|FG003|Treatment Period|Physician Decision|0|||
130974509|NCT03214367|471532343|FG004|Treatment Period|Physician Decision|0|||
130974510|NCT03214367|471532344|FG005|Treatment Period|Physician Decision|0|||
130974511|NCT03214367|471532345|FG006|Treatment Period|Physician Decision|0|||
130974512|NCT03214367|471532346|FG007|Treatment Period|Physician Decision|0|||
130974513|NCT03214367|471532339|FG000|Treatment Period|Protocol Violation|0|||
130974514|NCT03214367|471532340|FG001|Treatment Period|Protocol Violation|3|||
130974515|NCT03214367|471532341|FG002|Treatment Period|Protocol Violation|0|||
130974516|NCT03214367|471532342|FG003|Treatment Period|Protocol Violation|0|||
130974517|NCT03214367|471532343|FG004|Treatment Period|Protocol Violation|0|||
130974518|NCT03214367|471532344|FG005|Treatment Period|Protocol Violation|0|||
130974519|NCT03214367|471532345|FG006|Treatment Period|Protocol Violation|0|||
130775931|NCT02959918|470806626|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775932|NCT02959918|470806627|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130775933|NCT02959918|470806614|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775934|NCT02959918|470806615|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130974520|NCT03214367|471532346|FG007|Treatment Period|Protocol Violation|0|||
130974521|NCT03214367|471532339|FG000|Treatment Period|Withdrawal by Subject|0|||
131043354|NCT00429364|471793073|FG000|Overall Study|Death|0|||
131043355|NCT00429364|471793074|FG001|Overall Study|Death|1|||
131043356|NCT00429364|471793073|FG000|Overall Study|Underwent aortic root surgery|10|||
131043357|NCT00429364|471793074|FG001|Overall Study|Underwent aortic root surgery|18|||
130974522|NCT03214367|471532340|FG001|Treatment Period|Withdrawal by Subject|20|||
130974523|NCT03214367|471532341|FG002|Treatment Period|Withdrawal by Subject|23|||
130974524|NCT03214367|471532342|FG003|Treatment Period|Withdrawal by Subject|14|||
130974525|NCT03214367|471532343|FG004|Treatment Period|Withdrawal by Subject|0|||
130974526|NCT03214367|471532344|FG005|Treatment Period|Withdrawal by Subject|1|||
130974527|NCT03214367|471532345|FG006|Treatment Period|Withdrawal by Subject|1|||
130974528|NCT03214367|471532346|FG007|Treatment Period|Withdrawal by Subject|1|||
130974529|NCT03508843|471532347|FG000|Overall Study|Withdrawal by Subject|1|||
130974530|NCT03508843|471532347|FG000|Overall Study|technical difficulties|2|||
130974531|NCT01816594|471532355|FG000|Overall Study|Local Progress|0|||
130974532|NCT01816594|471532356|FG001|Overall Study|Local Progress|2|||
130974533|NCT01816594|471532355|FG000|Overall Study|Adverse Event|9|||
130974534|NCT01816594|471532356|FG001|Overall Study|Adverse Event|0|||
130974535|NCT01816594|471532355|FG000|Overall Study|Withdrawal by Subject|1|||
130974536|NCT01816594|471532356|FG001|Overall Study|Withdrawal by Subject|0|||
130974537|NCT01816594|471532355|FG000|Overall Study|Physician Decision|1|||
130974538|NCT01816594|471532356|FG001|Overall Study|Physician Decision|0|||
130974539|NCT03905655|471532357|FG000|Overall Study|Adverse Event|1|||
130974540|NCT03905655|471532358|FG001|Overall Study|Adverse Event|0|||
130974541|NCT03905655|471532359|FG002|Overall Study|Adverse Event|1|||
130974542|NCT03905655|471532360|FG003|Overall Study|Adverse Event|1|||
130974543|NCT02566031|471532361|FG000|Overall Study|Patient/guardian decision|14|||
130974544|NCT02566031|471532362|FG001|Overall Study|Patient/guardian decision|7|||
130974545|NCT02566031|471532361|FG000|Overall Study|Protocol deviation|2|||
130974546|NCT02566031|471532362|FG001|Overall Study|Protocol deviation|3|||
130974547|NCT02566031|471532361|FG000|Overall Study|Adverse Event|3|||
130974548|NCT02566031|471532362|FG001|Overall Study|Adverse Event|1|||
130974549|NCT02566031|471532361|FG000|Overall Study|Lost to Follow-up|1|||
130974550|NCT02566031|471532362|FG001|Overall Study|Lost to Follow-up|1|||
130974551|NCT00121238|471532363|FG000|Overall Study|disease progression before intervention|1|||
130974552|NCT00121238|471532363|FG000|Overall Study|Protocol Violation|2|||
130974553|NCT01026974|471532372|FG000|Overall Study|Withdrawal by Subject|0|||
130974554|NCT01026974|471532373|FG001|Overall Study|Withdrawal by Subject|1|||
130974555|NCT01026974|471532374|FG002|Overall Study|Withdrawal by Subject|7|||
130974556|NCT01026974|471532375|FG003|Overall Study|Withdrawal by Subject|2|||
130974557|NCT01026974|471532372|FG000|Overall Study|Lost to Follow-up|1|||
130974558|NCT01026974|471532373|FG001|Overall Study|Lost to Follow-up|1|||
130974559|NCT01026974|471532374|FG002|Overall Study|Lost to Follow-up|4|||
130974560|NCT01026974|471532375|FG003|Overall Study|Lost to Follow-up|0|||
130974561|NCT01026974|471532372|FG000|Overall Study|Adverse Event|0|||
130974562|NCT01026974|471532373|FG001|Overall Study|Adverse Event|0|||
130974563|NCT01026974|471532374|FG002|Overall Study|Adverse Event|0|||
130974564|NCT01026974|471532375|FG003|Overall Study|Adverse Event|1|||
130974565|NCT01026974|471532372|FG000|Overall Study|Inappropriate enrollment|0|||
130974566|NCT01026974|471532373|FG001|Overall Study|Inappropriate enrollment|0|||
130974567|NCT01026974|471532374|FG002|Overall Study|Inappropriate enrollment|1|||
130974568|NCT01026974|471532375|FG003|Overall Study|Inappropriate enrollment|0|||
130974569|NCT00325468|471532377|FG000|Overall Study|Adverse Event|1|||
130974570|NCT00325468|471532378|FG001|Overall Study|Adverse Event|1|||
131043358|NCT00429364|471793073|FG000|Overall Study|Pregnancy|0|||
131043359|NCT00429364|471793074|FG001|Overall Study|Pregnancy|1|||
131043360|NCT04871529|471793075|FG000|Overall Study|Withdrawal by Subject|0|||
131043361|NCT04871529|471793076|FG001|Overall Study|Withdrawal by Subject|1|||
130716865|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
130716866|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
130716867|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
131043362|NCT04871529|471793075|FG000|Overall Study|Death|0|||
130716868|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
130974571|NCT00325468|471532379|FG002|Overall Study|Adverse Event|0|||
130974572|NCT00325468|471532380|FG003|Overall Study|Adverse Event|5|||
130974573|NCT00325468|471532381|FG004|Overall Study|Adverse Event|1|||
130974574|NCT00325468|471532377|FG000|Overall Study|Death|2|||
130974575|NCT00325468|471532378|FG001|Overall Study|Death|0|||
130974576|NCT00325468|471532379|FG002|Overall Study|Death|2|||
130974577|NCT00325468|471532380|FG003|Overall Study|Death|4|||
130974578|NCT00325468|471532381|FG004|Overall Study|Death|0|||
130974579|NCT00325468|471532377|FG000|Overall Study|Lost to Follow-up|0|||
130974580|NCT00325468|471532378|FG001|Overall Study|Lost to Follow-up|0|||
130974581|NCT00325468|471532379|FG002|Overall Study|Lost to Follow-up|1|||
130974582|NCT00325468|471532380|FG003|Overall Study|Lost to Follow-up|2|||
130974583|NCT00325468|471532381|FG004|Overall Study|Lost to Follow-up|2|||
130974584|NCT00325468|471532377|FG000|Overall Study|Physician Decision|1|||
130974585|NCT00325468|471532378|FG001|Overall Study|Physician Decision|1|||
130974586|NCT00325468|471532379|FG002|Overall Study|Physician Decision|0|||
130974587|NCT00325468|471532380|FG003|Overall Study|Physician Decision|1|||
130974588|NCT00325468|471532381|FG004|Overall Study|Physician Decision|0|||
131043363|NCT04871529|471793076|FG001|Overall Study|Death|1|||
130716869|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
130716870|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
130974589|NCT00325468|471532377|FG000|Overall Study|Withdrawal by Subject|3|||
130974590|NCT00325468|471532378|FG001|Overall Study|Withdrawal by Subject|1|||
130974591|NCT00325468|471532379|FG002|Overall Study|Withdrawal by Subject|0|||
130974592|NCT00325468|471532380|FG003|Overall Study|Withdrawal by Subject|14|||
130974593|NCT00325468|471532381|FG004|Overall Study|Withdrawal by Subject|4|||
130974594|NCT00325468|471532377|FG000|Overall Study|site closure etc|4|||
130974595|NCT00325468|471532378|FG001|Overall Study|site closure etc|2|||
130974596|NCT00325468|471532379|FG002|Overall Study|site closure etc|1|||
130974597|NCT00325468|471532380|FG003|Overall Study|site closure etc|8|||
130974598|NCT00325468|471532381|FG004|Overall Study|site closure etc|1|||
130974599|NCT03280121|471532382|FG000|Overall Study|Physician Decision|1|||
130974600|NCT03280121|471532382|FG000|Overall Study|Lost to Follow-up|1|||
130974601|NCT03280121|471532382|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
130974602|NCT01314118|471532383|FG000|Overall Study|Adverse Event|9|||
130974603|NCT01314118|471532383|FG000|Overall Study|Progressive disease|27|||
130974604|NCT01314118|471532383|FG000|Overall Study|Physician Decision|11|||
130974605|NCT01314118|471532383|FG000|Overall Study|Death|4|||
130974606|NCT01314118|471532383|FG000|Overall Study|Protocol Violation|5|||
130974607|NCT01314118|471532383|FG000|Overall Study|Withdrawal by Subject|11|||
130974608|NCT01314118|471532383|FG000|Overall Study|Other|2|||
130974609|NCT01314118|471532383|FG000|Overall Study|Ongoing|62|||
130974610|NCT05585307|471532384|FG000|Overall Study|Lost to Follow-up|0|||
130974611|NCT05585307|471532385|FG001|Overall Study|Lost to Follow-up|0|||
130974612|NCT05585307|471532386|FG002|Overall Study|Lost to Follow-up|0|||
130974613|NCT05585307|471532387|FG003|Overall Study|Lost to Follow-up|0|||
130974614|NCT05585307|471532388|FG004|Overall Study|Lost to Follow-up|0|||
130974615|NCT05585307|471532389|FG005|Overall Study|Lost to Follow-up|0|||
130974616|NCT05585307|471532390|FG006|Overall Study|Lost to Follow-up|1|||
130974617|NCT05585307|471532391|FG007|Overall Study|Lost to Follow-up|0|||
130974618|NCT04420221|471532395|FG000|Overall Study|Withdrawal by Subject|0|||
130974619|NCT04420221|471532396|FG001|Overall Study|Withdrawal by Subject|0|||
130974620|NCT04420221|471532397|FG002|Overall Study|Withdrawal by Subject|0|||
130974621|NCT04420221|471532398|FG003|Overall Study|Withdrawal by Subject|0|||
130974622|NCT04420221|471532399|FG004|Overall Study|Withdrawal by Subject|0|||
130974623|NCT04420221|471532400|FG005|Overall Study|Withdrawal by Subject|20|||
130974624|NCT04420221|471532401|FG006|Overall Study|Withdrawal by Subject|5|||
130974625|NCT04420221|471532395|FG000|Overall Study|Other|0|||
130974626|NCT04420221|471532396|FG001|Overall Study|Other|0|||
130974627|NCT04420221|471532397|FG002|Overall Study|Other|0|||
130974628|NCT04420221|471532398|FG003|Overall Study|Other|0|||
130974629|NCT04420221|471532399|FG004|Overall Study|Other|0|||
130974630|NCT04420221|471532400|FG005|Overall Study|Other|1|||
130974631|NCT04420221|471532401|FG006|Overall Study|Other|1|||
130974632|NCT04420221|471532395|FG000|Overall Study|Lost to Follow-up|0|||
130974633|NCT04420221|471532396|FG001|Overall Study|Lost to Follow-up|0|||
130974634|NCT04420221|471532397|FG002|Overall Study|Lost to Follow-up|0|||
130974635|NCT04420221|471532398|FG003|Overall Study|Lost to Follow-up|0|||
130974636|NCT04420221|471532399|FG004|Overall Study|Lost to Follow-up|0|||
130974637|NCT04420221|471532400|FG005|Overall Study|Lost to Follow-up|3|||
130974638|NCT04420221|471532401|FG006|Overall Study|Lost to Follow-up|2|||
130974639|NCT04420221|471532395|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
130974640|NCT04420221|471532396|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
130974641|NCT04420221|471532397|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
130974642|NCT04420221|471532398|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
130974643|NCT04420221|471532399|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
130974644|NCT04420221|471532400|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
130974645|NCT04420221|471532401|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
130974646|NCT01556438|471532404|FG000|Overall Study|Adverse Event|4|||
130974647|NCT01556438|471532405|FG001|Overall Study|Adverse Event|2|||
130974648|NCT01556438|471532404|FG000|Overall Study|Sponsor Decision|0|||
131043364|NCT04871529|471793075|FG000|Overall Study|Not protocol specified|0|||
131043365|NCT04871529|471793076|FG001|Overall Study|Not protocol specified|1|||
131043366|NCT05184452|471793077|FG000|Overall Study|Lost to Follow-up|0|||
131227395|NCT01814137|472459727|FG000|Overall Study|Unclassified|2|||
130716871|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
130974649|NCT01556438|471532405|FG001|Overall Study|Sponsor Decision|2|||
130974650|NCT01556438|471532404|FG000|Overall Study|Progressive Disease|0|||
130974651|NCT01556438|471532405|FG001|Overall Study|Progressive Disease|6|||
130974652|NCT01556438|471532404|FG000|Overall Study|Death|0|||
130974653|NCT01556438|471532405|FG001|Overall Study|Death|1|||
130974654|NCT03695172|471532406|FG000|Overall Study|Withdrawal by Subject|1|||
130974655|NCT03695172|471532407|FG001|Overall Study|Withdrawal by Subject|1|||
130974656|NCT03695172|471532408|FG002|Overall Study|Withdrawal by Subject|0|||
130974657|NCT02734212|471532412|FG000|Overall Study|Lost to Follow-up|5|||
130974658|NCT02734212|471532413|FG001|Overall Study|Lost to Follow-up|10|||
130974659|NCT00688636|471532416|FG000|Overall Study|Adverse Event|2|||
130974660|NCT00688636|471532417|FG001|Overall Study|Adverse Event|1|||
131043367|NCT05184452|471793078|FG001|Overall Study|Lost to Follow-up|0|||
131227396|NCT01814137|472459728|FG001|Overall Study|Unclassified|1|||
130974661|NCT04053764|471532418|FG000|Overall Study|Withdrawal by Subject|6|||
130974662|NCT04053764|471532419|FG001|Overall Study|Withdrawal by Subject|2|||
130974663|NCT04053764|471532418|FG000|Overall Study|Physician Decision|2|||
130974664|NCT04053764|471532419|FG001|Overall Study|Physician Decision|1|||
130974665|NCT04053764|471532418|FG000|Overall Study|Adverse Event|1|||
130974666|NCT04053764|471532419|FG001|Overall Study|Adverse Event|0|||
130974667|NCT04053764|471532418|FG000|Overall Study|Pregnancy|1|||
130974668|NCT04053764|471532419|FG001|Overall Study|Pregnancy|0|||
130974669|NCT00965523|471532420|FG000|Study 221|Progressive Disease|4|||
130974670|NCT00965523|471532420|FG000|Study 221|Physician Decision|3|||
130974671|NCT00965523|471532420|FG000|Study 224|Progressive Disease|5|||
130974672|NCT00965523|471532420|FG000|Study 224|Physician Decision|1|||
130974673|NCT01939028|471532422|FG000|Overall Study|Withdrawal by Subject|5|||
130974674|NCT01939028|471532422|FG000|Overall Study|Physician Decision|7|||
130974675|NCT01881126|471532444|FG000|Overall Study|Non-compliance|1|||
130974676|NCT01881126|471532445|FG001|Overall Study|Non-compliance|1|||
130974677|NCT01881126|471532444|FG000|Overall Study|Adverse Event|0|||
130974678|NCT01881126|471532445|FG001|Overall Study|Adverse Event|1|||
130974679|NCT01090453|471532450|FG000|Overall Study|Withdrawal by Subject|1|||
130974680|NCT01090453|471532451|FG001|Overall Study|Withdrawal by Subject|2|||
130974681|NCT01090453|471532450|FG000|Overall Study|Lost to Follow-up|7|||
130974682|NCT01090453|471532451|FG001|Overall Study|Lost to Follow-up|7|||
130974683|NCT01090453|471532450|FG000|Overall Study|Non serious AEs|1|||
130974684|NCT01090453|471532451|FG001|Overall Study|Non serious AEs|0|||
130974685|NCT01090453|471532450|FG000|Overall Study|Protocol Violation|2|||
130974686|NCT01090453|471532451|FG001|Overall Study|Protocol Violation|0|||
130974687|NCT01090453|471532450|FG000|Overall Study|Other|2|||
130974688|NCT01090453|471532451|FG001|Overall Study|Other|4|||
130974689|NCT01090453|471532450|FG000|Overall Study|Eligibility Criteria|0|||
130974690|NCT01090453|471532451|FG001|Overall Study|Eligibility Criteria|1|||
130974691|NCT04072159|471532452|FG000|Overall Study|Lost to Follow-up|6|||
130974692|NCT04072159|471532453|FG001|Overall Study|Lost to Follow-up|6|||
130974693|NCT04072159|471532452|FG000|Overall Study|Withdrawal by Subject|2|||
130974694|NCT04072159|471532453|FG001|Overall Study|Withdrawal by Subject|0|||
130974695|NCT00522275|471532458|FG000|Overall Study|Adverse Event|35|||
130974696|NCT00522275|471532458|FG000|Overall Study|Lack of Efficacy|80|||
130974697|NCT00522275|471532458|FG000|Overall Study|Subject withdrew consent|16|||
130974698|NCT00522275|471532458|FG000|Overall Study|Protocol deviation|1|||
130974699|NCT00522275|471532458|FG000|Overall Study|Unsatisfactory compliance|11|||
130974700|NCT00522275|471532458|FG000|Overall Study|Lost to Follow-up|8|||
130974701|NCT00522275|471532458|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
130974702|NCT00522275|471532458|FG000|Overall Study|Other: Subject is pregnant|2|||
130974703|NCT00522275|471532458|FG000|Overall Study|Other: Subject relocated|2|||
130974704|NCT00522275|471532458|FG000|Overall Study|Other: Subject arrested|1|||
130974705|NCT00522275|471532458|FG000|Overall Study|Other: Site / clinic closed|4|||
130974706|NCT00522275|471532458|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
130974707|NCT00522275|471532458|FG000|Overall Study|Other: Sponsor request|2|||
130974708|NCT00522275|471532458|FG000|Overall Study|Other: Subject ran out of medication|1|||
130974709|NCT00522275|471532458|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
130974710|NCT00695669|471532460|FG000|Overall Study|Adverse Event|0|||
130974711|NCT00695669|471532461|FG001|Overall Study|Adverse Event|0|||
130974712|NCT00695669|471532462|FG002|Overall Study|Adverse Event|2|||
130974713|NCT00695669|471532463|FG003|Overall Study|Adverse Event|0|||
130974714|NCT00695669|471532460|FG000|Overall Study|Lost to Follow-up|4|||
130974715|NCT00695669|471532461|FG001|Overall Study|Lost to Follow-up|4|||
130974716|NCT00695669|471532462|FG002|Overall Study|Lost to Follow-up|1|||
130974717|NCT00695669|471532463|FG003|Overall Study|Lost to Follow-up|4|||
130974718|NCT05045625|471532464|FG000|Overall Study|Lost to Follow-up|3|||
130716872|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
130716873|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
130716874|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
130716875|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
130716876|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
130716877|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
130974719|NCT00092131|471532465|FG000|Treatment Period I|Adverse Event|1|||
130974720|NCT00092131|471532466|FG001|Treatment Period I|Adverse Event|0|||
130974721|NCT00092131|471532465|FG000|Treatment Period II|Adverse Event|0|||
130974722|NCT00092131|471532466|FG001|Treatment Period II|Adverse Event|1|||
130974723|NCT02341417|471532467|FG000|Overall Study|Withdrawal by Subject|0|||
130974724|NCT02341417|471532468|FG001|Overall Study|Withdrawal by Subject|2|||
130974725|NCT02341417|471532469|FG002|Overall Study|Withdrawal by Subject|0|||
130974726|NCT02341417|471532467|FG000|Overall Study|Decision by sponsor|2|||
130974727|NCT02341417|471532468|FG001|Overall Study|Decision by sponsor|0|||
130974728|NCT02341417|471532469|FG002|Overall Study|Decision by sponsor|0|||
130974729|NCT02341417|471532467|FG000|Overall Study|Death|0|||
130974730|NCT02341417|471532468|FG001|Overall Study|Death|0|||
130974731|NCT02341417|471532469|FG002|Overall Study|Death|1|||
130974732|NCT01857531|471532483|FG000|Overall Study|Withdrawal by Subject|4|||
130716878|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
130974733|NCT02576067|471532484|FG000|Overall Study|Death|0|||
130974734|NCT02576067|471532485|FG001|Overall Study|Death|1|||
130974735|NCT02576067|471532484|FG000|Overall Study|Lack of Efficacy|1|||
130974736|NCT02576067|471532485|FG001|Overall Study|Lack of Efficacy|0|||
130974737|NCT02576067|471532484|FG000|Overall Study|Lost to Follow-up|11|||
130974738|NCT02576067|471532485|FG001|Overall Study|Lost to Follow-up|0|||
130974739|NCT02576067|471532484|FG000|Overall Study|Withdrawal by Subject|11|||
130974740|NCT02576067|471532485|FG001|Overall Study|Withdrawal by Subject|2|||
130974741|NCT02576067|471532484|FG000|Overall Study|study closure of main CIRT trial)|0|||
130974742|NCT02576067|471532485|FG001|Overall Study|study closure of main CIRT trial)|8|||
130974743|NCT02576067|471532484|FG000|Overall Study|not randomized, failed run-in|7|||
130775935|NCT02959918|470806616|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775936|NCT02959918|470806617|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775937|NCT02959918|470806618|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775938|NCT02959918|470806619|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775939|NCT02959918|470806620|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775940|NCT02959918|470806621|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130974744|NCT02576067|471532485|FG001|Overall Study|not randomized, failed run-in|0|||
130974745|NCT02576067|471532484|FG000|Overall Study|screen failure/ re-enrolled|0|||
130974746|NCT02576067|471532485|FG001|Overall Study|screen failure/ re-enrolled|25|||
130974747|NCT02576067|471532484|FG000|Overall Study|Physician Decision|4|||
130974748|NCT02576067|471532485|FG001|Overall Study|Physician Decision|0|||
130974749|NCT04773587|471532488|FG000|Overall Study|Lost to Follow-up|11|||
130974750|NCT04773587|471532489|FG001|Overall Study|Lost to Follow-up|3|||
130974751|NCT04773587|471532488|FG000|Overall Study|Adverse Event|6|||
130974752|NCT04773587|471532489|FG001|Overall Study|Adverse Event|3|||
130974753|NCT04773587|471532488|FG000|Overall Study|Lack of Efficacy|5|||
130775941|NCT02959918|470806622|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775942|NCT02959918|470806623|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
130775943|NCT02959918|470806624|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775944|NCT02959918|470806625|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775945|NCT02959918|470806626|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775946|NCT02959918|470806627|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130775947|NCT02585713|470806631|FG000|Overall Study|Withdrew prior to treatment|2|||
130775948|NCT02585713|470806632|FG001|Overall Study|Withdrew prior to treatment|7|||
130775949|NCT02585713|470806631|FG000|Overall Study|Other|3|||
130775950|NCT02585713|470806632|FG001|Overall Study|Other|1|||
130775951|NCT03173456|470806635|FG000|Baseline|Medication dispensing system malfunction'|0|||
130775952|NCT03173456|470806636|FG001|Baseline|Medication dispensing system malfunction'|1|||
130775953|NCT03173456|470806637|FG002|Baseline|Medication dispensing system malfunction'|0|||
130775954|NCT03173456|470806638|FG003|Baseline|Medication dispensing system malfunction'|0|||
130775955|NCT03173456|470806639|FG004|Baseline|Medication dispensing system malfunction'|2|||
130775956|NCT03173456|470806635|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
130775957|NCT03173456|470806636|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
130775958|NCT03173456|470806637|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
130775959|NCT03173456|470806638|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
130775960|NCT03173456|470806639|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
130775961|NCT01733121|470806640|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
130775962|NCT01733121|470806641|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
130775963|NCT01733121|470806640|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
130775964|NCT01733121|470806641|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
130775965|NCT01733121|470806640|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
130775966|NCT01733121|470806641|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
130775967|NCT01733121|470806640|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
130775968|NCT01733121|470806641|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
130775969|NCT04501952|470806650|FG000|Overall Study|Adverse Event|0|||
130775970|NCT04501952|470806651|FG001|Overall Study|Adverse Event|3|||
130775971|NCT04501952|470806650|FG000|Overall Study|Investigator's Discretion|0|||
130775972|NCT04501952|470806651|FG001|Overall Study|Investigator's Discretion|1|||
130775973|NCT04501952|470806650|FG000|Overall Study|Protocol Violation|1|||
130775974|NCT04501952|470806651|FG001|Overall Study|Protocol Violation|1|||
130775975|NCT04501952|470806650|FG000|Overall Study|Withdrew Consent|5|||
130775976|NCT04501952|470806651|FG001|Overall Study|Withdrew Consent|4|||
130775977|NCT04501952|470806650|FG000|Overall Study|Lost to Follow-up|7|||
130775978|NCT04501952|470806651|FG001|Overall Study|Lost to Follow-up|2|||
130775979|NCT04501952|470806650|FG000|Overall Study|Randomized and Never Treated|13|||
130775980|NCT04501952|470806651|FG001|Overall Study|Randomized and Never Treated|9|||
130974754|NCT04773587|471532489|FG001|Overall Study|Lack of Efficacy|2|||
130974755|NCT04773587|471532488|FG000|Overall Study|Withdrawal by Subject|4|||
130974756|NCT04773587|471532489|FG001|Overall Study|Withdrawal by Subject|5|||
130974757|NCT04773587|471532488|FG000|Overall Study|Noncompliance|1|||
130974758|NCT04773587|471532489|FG001|Overall Study|Noncompliance|0|||
130974759|NCT04773587|471532488|FG000|Overall Study|Protocol Violation|1|||
130974760|NCT04773587|471532489|FG001|Overall Study|Protocol Violation|0|||
130974761|NCT04773587|471532488|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
130974762|NCT04773587|471532489|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
130974763|NCT02372409|471532490|FG000|Overall Study|Lost to Follow-up|1|||
130974764|NCT02372409|471532491|FG001|Overall Study|Lost to Follow-up|0|||
130974765|NCT02372409|471532490|FG000|Overall Study|Disease progression|1|||
130974766|NCT02372409|471532491|FG001|Overall Study|Disease progression|1|||
130974767|NCT01808313|471532492|FG000|Overall Study|Adverse Event|5|||
130974768|NCT01808313|471532492|FG000|Overall Study|Protocol Violation|2|||
130974769|NCT01808313|471532492|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130974770|NCT01808313|471532492|FG000|Overall Study|Lost to Follow-up|1|||
130974771|NCT01808313|471532492|FG000|Overall Study|Physician Decision|1|||
130974772|NCT04656847|471532495|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
130974773|NCT03301051|471532496|FG000|Overall Study|Adverse Event|0|||
130974774|NCT03301051|471532497|FG001|Overall Study|Adverse Event|4|||
130974775|NCT03301051|471532496|FG000|Overall Study|Withdrawal by Subject|59|||
130974776|NCT03301051|471532497|FG001|Overall Study|Withdrawal by Subject|65|||
130974777|NCT03301051|471532496|FG000|Overall Study|Lost to Follow-up|263|||
130974778|NCT03301051|471532497|FG001|Overall Study|Lost to Follow-up|282|||
130974779|NCT03301051|471532496|FG000|Overall Study|Protocol Violation|1|||
130974780|NCT03301051|471532497|FG001|Overall Study|Protocol Violation|3|||
130974781|NCT03301051|471532496|FG000|Overall Study|Physician Decision|1|||
130974782|NCT03301051|471532497|FG001|Overall Study|Physician Decision|3|||
130974783|NCT03301051|471532496|FG000|Overall Study|Death|1|||
130974784|NCT03301051|471532497|FG001|Overall Study|Death|1|||
130974785|NCT03301051|471532496|FG000|Overall Study|Miscellaneous|8|||
130974786|NCT03301051|471532497|FG001|Overall Study|Miscellaneous|4|||
130974787|NCT03301051|471532496|FG000|Overall Study|Randomized, not vaccinated|13|||
130974788|NCT03301051|471532497|FG001|Overall Study|Randomized, not vaccinated|10|||
130974789|NCT00047879|471532498|FG000|Overall Study|Progressive disease|4|||
130716879|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
130716880|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
130716881|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
130716882|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
130716883|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
130716884|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
130716885|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
130716886|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
130716887|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
130716888|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
130716889|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
130716890|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
130716891|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716892|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716893|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716894|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716895|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716896|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716897|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716898|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716899|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716900|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716901|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716902|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716903|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716904|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716905|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716906|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716907|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716908|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716909|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716910|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716911|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130974790|NCT00047879|471532499|FG001|Overall Study|Progressive disease|3|||
130974791|NCT00622167|471532500|FG000|Overall Study|Did not meet angiographic criteria|20|||
130974792|NCT01954017|471532503|FG000|Overall Study|Adverse Event|0|||
130974793|NCT01954017|471532504|FG001|Overall Study|Adverse Event|0|||
130974794|NCT01954017|471532505|FG002|Overall Study|Adverse Event|1|||
130974795|NCT01954017|471532503|FG000|Overall Study|Death|2|||
130974796|NCT01954017|471532504|FG001|Overall Study|Death|1|||
130974797|NCT01954017|471532505|FG002|Overall Study|Death|1|||
130974798|NCT01954017|471532503|FG000|Overall Study|Withdrawal by Subject|0|||
130974799|NCT01954017|471532504|FG001|Overall Study|Withdrawal by Subject|1|||
130974800|NCT01954017|471532505|FG002|Overall Study|Withdrawal by Subject|0|||
130974801|NCT01954017|471532503|FG000|Overall Study|Protocol Violation|0|||
130974802|NCT01954017|471532504|FG001|Overall Study|Protocol Violation|3|||
130974803|NCT01954017|471532505|FG002|Overall Study|Protocol Violation|2|||
130974804|NCT01954017|471532503|FG000|Overall Study|Necrotizing enterocolitis|1|||
130974805|NCT01954017|471532504|FG001|Overall Study|Necrotizing enterocolitis|0|||
130974806|NCT01954017|471532505|FG002|Overall Study|Necrotizing enterocolitis|1|||
130974807|NCT01954017|471532503|FG000|Overall Study|Enteral intake stopped >7 days|0|||
130974808|NCT01954017|471532504|FG001|Overall Study|Enteral intake stopped >7 days|1|||
130974809|NCT01954017|471532505|FG002|Overall Study|Enteral intake stopped >7 days|1|||
130974810|NCT01954017|471532503|FG000|Overall Study|All other reasons|2|||
130716912|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716913|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716914|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130716915|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716916|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716917|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716918|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716919|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716920|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
130716921|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
130716922|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716923|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716924|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
130716925|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716926|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716927|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716928|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716929|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716930|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716931|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716932|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716933|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716934|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716935|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716936|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716937|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716938|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716939|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130716940|NCT02393248|470590961|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716941|NCT02393248|470590962|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716942|NCT02393248|470590963|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716943|NCT02393248|470590964|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716944|NCT02393248|470590965|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716945|NCT02393248|470590966|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716946|NCT02393248|470590967|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
130716947|NCT02393248|470590968|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716948|NCT02393248|470590969|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716949|NCT02393248|470590970|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716950|NCT02393248|470590971|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716951|NCT02393248|470590972|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716952|NCT02393248|470590973|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716953|NCT02393248|470590974|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716954|NCT02393248|470590975|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716955|NCT02393248|470590976|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716956|NCT02393248|470590977|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716957|NCT02393248|470590978|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130974811|NCT01954017|471532504|FG001|Overall Study|All other reasons|2|||
130974812|NCT01954017|471532505|FG002|Overall Study|All other reasons|7|||
130974813|NCT00435370|471532510|FG000|Overall Study|Adverse Event|8|||
130974814|NCT00435370|471532511|FG001|Overall Study|Adverse Event|8|||
130974815|NCT00435370|471532510|FG000|Overall Study|Withdrawal by Subject|10|||
130974816|NCT00435370|471532511|FG001|Overall Study|Withdrawal by Subject|10|||
130974817|NCT00435370|471532510|FG000|Overall Study|Antipsychotic medication changed|4|||
130974818|NCT00435370|471532511|FG001|Overall Study|Antipsychotic medication changed|2|||
130974819|NCT03674177|471532515|FG000|Overall Study|Lost to Follow-up|2|||
130974820|NCT03674177|471532516|FG001|Overall Study|Lost to Follow-up|1|||
130974821|NCT03674177|471532517|FG002|Overall Study|Lost to Follow-up|0|||
130974822|NCT03674177|471532518|FG003|Overall Study|Lost to Follow-up|2|||
130974823|NCT00714168|471532519|FG000|Overall Study|Pregnancy|5|||
130974824|NCT00714168|471532520|FG001|Overall Study|Pregnancy|4|||
130974825|NCT00714168|471532519|FG000|Overall Study|Lost to Follow-up|32|||
130974826|NCT00714168|471532520|FG001|Overall Study|Lost to Follow-up|50|||
130974827|NCT00714168|471532519|FG000|Overall Study|Relocation|4|||
130974828|NCT00714168|471532520|FG001|Overall Study|Relocation|3|||
130974829|NCT00714168|471532519|FG000|Overall Study|Non-study medical condition|3|||
130974830|NCT00714168|471532520|FG001|Overall Study|Non-study medical condition|2|||
130974831|NCT02298192|471532524|FG000|Overall Study|Unclassified|3|||
131043368|NCT05184452|471793079|FG002|Overall Study|Lost to Follow-up|0|||
131043369|NCT05184452|471793080|FG003|Overall Study|Lost to Follow-up|0|||
131043370|NCT05184452|471793081|FG004|Overall Study|Lost to Follow-up|0|||
131043371|NCT05184452|471793082|FG005|Overall Study|Lost to Follow-up|2|||
130716958|NCT02393248|470590979|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716959|NCT02393248|470590980|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716960|NCT02393248|470590981|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716961|NCT02393248|470590982|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716962|NCT02393248|470590983|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716963|NCT02393248|470590984|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716964|NCT02393248|470590985|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130716965|NCT02393248|470590961|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716966|NCT02393248|470590962|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716967|NCT02393248|470590963|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716968|NCT02393248|470590964|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716969|NCT02393248|470590965|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716970|NCT02393248|470590966|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716971|NCT02393248|470590967|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716972|NCT02393248|470590968|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716973|NCT02393248|470590969|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716974|NCT02393248|470590970|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716975|NCT02393248|470590971|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716976|NCT02393248|470590972|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
130716977|NCT02393248|470590973|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
130716978|NCT02393248|470590974|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
130716979|NCT02393248|470590975|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
130716980|NCT02393248|470590976|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716981|NCT02393248|470590977|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716982|NCT02393248|470590978|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716983|NCT02393248|470590979|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716984|NCT02393248|470590980|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716985|NCT02393248|470590981|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716986|NCT02393248|470590982|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716987|NCT02393248|470590983|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716988|NCT02393248|470590984|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716989|NCT02393248|470590985|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130716990|NCT02393248|470590961|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716991|NCT02393248|470590962|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716992|NCT02393248|470590963|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716993|NCT02393248|470590964|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716994|NCT02393248|470590965|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716995|NCT02393248|470590966|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716996|NCT02393248|470590967|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716997|NCT02393248|470590968|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716998|NCT02393248|470590969|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130716999|NCT02393248|470590970|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717000|NCT02393248|470590971|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
130717001|NCT02393248|470590972|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
130717002|NCT02393248|470590973|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130974832|NCT02298192|471532525|FG001|Overall Study|Unclassified|2|||
130974833|NCT02298192|471532524|FG000|Overall Study|Withdrawal criteria|2|||
131043372|NCT05184452|471793083|FG006|Overall Study|Lost to Follow-up|0|||
130974834|NCT02298192|471532525|FG001|Overall Study|Withdrawal criteria|0|||
130974835|NCT02298192|471532524|FG000|Overall Study|Withdrawal by Subject|6|||
130974836|NCT02298192|471532525|FG001|Overall Study|Withdrawal by Subject|1|||
130974837|NCT02298192|471532524|FG000|Overall Study|Lost to Follow-up|2|||
130974838|NCT02298192|471532525|FG001|Overall Study|Lost to Follow-up|1|||
130974839|NCT02298192|471532524|FG000|Overall Study|Adverse Event|6|||
130974840|NCT02298192|471532525|FG001|Overall Study|Adverse Event|2|||
130974841|NCT04764396|471532529|FG000|Overall Study|Physician Decision|1|||
130974842|NCT04764396|471532530|FG001|Overall Study|Physician Decision|0|||
130974843|NCT02653482|471532532|FG000|Overall Study|Death|1|||
130974844|NCT02653482|471532533|FG001|Overall Study|Death|1|||
130974845|NCT01864564|471532536|FG000|Overall Study|Lost to Follow-up|17|||
130974846|NCT01864564|471532537|FG001|Overall Study|Lost to Follow-up|23|||
130974847|NCT01864564|471532536|FG000|Overall Study|Withdrawal by Subject|20|||
130974848|NCT01864564|471532537|FG001|Overall Study|Withdrawal by Subject|11|||
130974849|NCT01864564|471532536|FG000|Overall Study|Protocol Violation|0|||
130974850|NCT01864564|471532537|FG001|Overall Study|Protocol Violation|27|||
130974851|NCT01864564|471532536|FG000|Overall Study|not reported|0|||
130974852|NCT01864564|471532537|FG001|Overall Study|not reported|34|||
130974853|NCT03077724|471532538|FG000|Overall Study|Lost to Follow-up|5|||
130974854|NCT03077724|471532539|FG001|Overall Study|Lost to Follow-up|1|||
130974855|NCT03077724|471532538|FG000|Overall Study|Withdrawal by Subject|3|||
130974856|NCT03077724|471532539|FG001|Overall Study|Withdrawal by Subject|1|||
130974857|NCT06273774|471532542|FG000|Overall Study|Participant was out of state.|0|||
130974858|NCT06273774|471532543|FG001|Overall Study|Participant was out of state.|0|||
130974859|NCT06273774|471532544|FG002|Overall Study|Participant was out of state.|0|||
130974860|NCT06273774|471532545|FG003|Overall Study|Participant was out of state.|0|||
130974861|NCT06273774|471532546|FG004|Overall Study|Participant was out of state.|0|||
130974862|NCT06273774|471532547|FG005|Overall Study|Participant was out of state.|1|||
130974863|NCT06273774|471532542|FG000|Overall Study|Lost to Follow-up|0|||
130974864|NCT06273774|471532543|FG001|Overall Study|Lost to Follow-up|0|||
130974865|NCT06273774|471532544|FG002|Overall Study|Lost to Follow-up|0|||
130974866|NCT06273774|471532545|FG003|Overall Study|Lost to Follow-up|0|||
130974867|NCT06273774|471532546|FG004|Overall Study|Lost to Follow-up|1|||
130974868|NCT06273774|471532547|FG005|Overall Study|Lost to Follow-up|0|||
130974869|NCT04414696|471532552|FG000|3-month Follow up|Withdrawal by Subject|1|||
130974870|NCT04414696|471532553|FG001|3-month Follow up|Withdrawal by Subject|0|||
130974871|NCT04414696|471532552|FG000|3-month Follow up|Lost to Follow-up|22|||
130974872|NCT04414696|471532553|FG001|3-month Follow up|Lost to Follow-up|23|||
130974873|NCT04414696|471532552|FG000|6-month Follow up|Withdrawal by Subject|1|||
130974874|NCT04414696|471532553|FG001|6-month Follow up|Withdrawal by Subject|2|||
130974875|NCT04414696|471532552|FG000|6-month Follow up|Lost to Follow-up|5|||
130974876|NCT04414696|471532553|FG001|6-month Follow up|Lost to Follow-up|2|||
130974877|NCT00924287|471535460|FG000|Overall Study|Death|1|||
130974878|NCT01625897|471535461|FG000|Overall Study|Adverse Event|27|||
131043373|NCT05184452|471793084|FG007|Overall Study|Lost to Follow-up|0|||
131043374|NCT05184452|471793085|FG008|Overall Study|Lost to Follow-up|0|||
130717003|NCT02393248|470590974|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717004|NCT02393248|470590975|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717005|NCT02393248|470590976|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130775981|NCT00941304|470806652|FG000|Overall Study|Lost to Follow-up|1|||
130775982|NCT00941304|470806653|FG001|Overall Study|Lost to Follow-up|0|||
130717006|NCT02393248|470590977|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717007|NCT02393248|470590978|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717008|NCT02393248|470590979|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717009|NCT02393248|470590980|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717010|NCT02393248|470590981|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717011|NCT02393248|470590982|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717012|NCT02393248|470590983|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717013|NCT02393248|470590984|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130717014|NCT02393248|470590985|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130775983|NCT00941304|470806654|FG002|Overall Study|Lost to Follow-up|0|||
130775984|NCT00941304|470806655|FG003|Overall Study|Lost to Follow-up|0|||
130974879|NCT01625897|471535462|FG001|Overall Study|Adverse Event|10|||
130974880|NCT01625897|471535461|FG000|Overall Study|Physician Decision|0|||
130974881|NCT01625897|471535462|FG001|Overall Study|Physician Decision|1|||
130974882|NCT01625897|471535461|FG000|Overall Study|Withdrawal by Subject|25|||
130974883|NCT01625897|471535462|FG001|Overall Study|Withdrawal by Subject|3|||
130974884|NCT01912612|471535465|FG000|Overall Study|Adverse Event|4|||
131043375|NCT05184452|471793086|FG009|Overall Study|Lost to Follow-up|1|||
130974885|NCT01912612|471535466|FG001|Overall Study|Adverse Event|0|||
130974886|NCT01912612|471535467|FG002|Overall Study|Adverse Event|0|||
130974887|NCT01912612|471535465|FG000|Overall Study|Withdrew consent|1|||
130974888|NCT01912612|471535466|FG001|Overall Study|Withdrew consent|0|||
130974889|NCT01912612|471535467|FG002|Overall Study|Withdrew consent|0|||
131043376|NCT05184452|471793077|FG000|Overall Study|Withdrawal by Subject|0|||
130974890|NCT01912612|471535465|FG000|Overall Study|Study design change|0|||
130974891|NCT01912612|471535466|FG001|Overall Study|Study design change|0|||
130974892|NCT01912612|471535467|FG002|Overall Study|Study design change|3|||
130974893|NCT01588184|471535468|FG000|Overall Study|Death|1|||
130974894|NCT01588184|471535469|FG001|Overall Study|Death|0|||
130974895|NCT01588184|471535470|FG002|Overall Study|Death|0|||
130974896|NCT01588184|471535471|FG003|Overall Study|Death|1|||
130974897|NCT01588184|471535472|FG004|Overall Study|Death|1|||
130974898|NCT01588184|471535473|FG005|Overall Study|Death|1|||
130974899|NCT01588184|471535468|FG000|Overall Study|Withdrawal by Subject|2|||
130775985|NCT00941304|470806656|FG004|Overall Study|Lost to Follow-up|0|||
130775986|NCT00784719|470806657|FG000|Overall Study|Adverse Event|0|||
130775987|NCT00784719|470806658|FG001|Overall Study|Adverse Event|2|||
130775988|NCT00784719|470806659|FG002|Overall Study|Adverse Event|0|||
130775989|NCT00784719|470806660|FG003|Overall Study|Adverse Event|0|||
130775990|NCT00784719|470806661|FG004|Overall Study|Adverse Event|1|||
130775991|NCT00784719|470806662|FG005|Overall Study|Adverse Event|1|||
130775992|NCT00784719|470806663|FG006|Overall Study|Adverse Event|1|||
130775993|NCT00784719|470806657|FG000|Overall Study|Lost to Follow-up|0|||
130775994|NCT00784719|470806658|FG001|Overall Study|Lost to Follow-up|0|||
130775995|NCT00784719|470806659|FG002|Overall Study|Lost to Follow-up|0|||
130775996|NCT00784719|470806660|FG003|Overall Study|Lost to Follow-up|0|||
130775997|NCT00784719|470806661|FG004|Overall Study|Lost to Follow-up|1|||
130775998|NCT00784719|470806662|FG005|Overall Study|Lost to Follow-up|1|||
130775999|NCT00784719|470806663|FG006|Overall Study|Lost to Follow-up|0|||
130776000|NCT00784719|470806657|FG000|Overall Study|Other|2|||
130776001|NCT00784719|470806658|FG001|Overall Study|Other|1|||
130776002|NCT00784719|470806659|FG002|Overall Study|Other|1|||
130776003|NCT00784719|470806660|FG003|Overall Study|Other|0|||
130776004|NCT00784719|470806661|FG004|Overall Study|Other|2|||
130776005|NCT00784719|470806662|FG005|Overall Study|Other|1|||
130776006|NCT00784719|470806663|FG006|Overall Study|Other|3|||
130776007|NCT00784719|470806657|FG000|Overall Study|Withdrawal by Subject|1|||
130776008|NCT00784719|470806658|FG001|Overall Study|Withdrawal by Subject|0|||
130776009|NCT00784719|470806659|FG002|Overall Study|Withdrawal by Subject|0|||
130776010|NCT00784719|470806660|FG003|Overall Study|Withdrawal by Subject|0|||
130776011|NCT00784719|470806661|FG004|Overall Study|Withdrawal by Subject|2|||
130776012|NCT00784719|470806662|FG005|Overall Study|Withdrawal by Subject|0|||
130776013|NCT00784719|470806663|FG006|Overall Study|Withdrawal by Subject|1|||
130776014|NCT01408901|470806666|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
130776015|NCT01408901|470806667|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
130776016|NCT01408901|470806668|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
130776017|NCT01408901|470806669|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
130776018|NCT01408901|470806666|FG000|6-Week Follow-Up|Death|1|||
130776019|NCT01408901|470806667|FG001|6-Week Follow-Up|Death|0|||
130776020|NCT01408901|470806668|FG002|6-Week Follow-Up|Death|0|||
130776021|NCT01408901|470806669|FG003|6-Week Follow-Up|Death|0|||
130776022|NCT01408901|470806666|FG000|6-Week Follow-Up|Cancelled visit|0|||
130776023|NCT01408901|470806667|FG001|6-Week Follow-Up|Cancelled visit|1|||
130776024|NCT01408901|470806668|FG002|6-Week Follow-Up|Cancelled visit|0|||
130776025|NCT01408901|470806669|FG003|6-Week Follow-Up|Cancelled visit|2|||
130776026|NCT01408901|470806666|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
130776027|NCT01408901|470806667|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
130776028|NCT01408901|470806668|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
130776029|NCT01408901|470806669|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
130776030|NCT01408901|470806666|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
130776031|NCT01408901|470806667|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
130776032|NCT01408901|470806668|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
130776033|NCT01408901|470806669|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
130776034|NCT01408901|470806666|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
130776035|NCT01408901|470806667|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
130776036|NCT01408901|470806668|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
130776037|NCT01408901|470806669|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
130776038|NCT01408901|470806666|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
130776039|NCT01408901|470806667|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
130776040|NCT01408901|470806668|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
130776041|NCT01408901|470806669|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
130776042|NCT01408901|470806666|FG000|26-Week Follow-Up|Death|0|||
130776043|NCT01408901|470806667|FG001|26-Week Follow-Up|Death|1|||
130974900|NCT01588184|471535469|FG001|Overall Study|Withdrawal by Subject|4|||
130974901|NCT01588184|471535470|FG002|Overall Study|Withdrawal by Subject|0|||
130776044|NCT01408901|470806668|FG002|26-Week Follow-Up|Death|0|||
130974902|NCT01588184|471535471|FG003|Overall Study|Withdrawal by Subject|1|||
130776045|NCT01408901|470806669|FG003|26-Week Follow-Up|Death|0|||
130776046|NCT04004260|470806674|FG000|Overall Study|Withdrawal by Subject|7|||
130776047|NCT04004260|470806675|FG001|Overall Study|Withdrawal by Subject|3|||
130974903|NCT01588184|471535472|FG004|Overall Study|Withdrawal by Subject|0|||
130985722|NCT01964326|471574967|FG000|Overall Study|Adverse Event|48|||
130776048|NCT04004260|470806674|FG000|Overall Study|Lost to Follow-up|22|||
130776049|NCT04004260|470806675|FG001|Overall Study|Lost to Follow-up|12|||
130776050|NCT04004260|470806674|FG000|Overall Study|Did not engage in intervention|13|||
130776051|NCT04004260|470806675|FG001|Overall Study|Did not engage in intervention|17|||
130776052|NCT03414229|470806676|FG000|Overall Study|Adverse Event|1|||
130776053|NCT03414229|470806677|FG001|Overall Study|Adverse Event|0|||
130776054|NCT03414229|470806678|FG002|Overall Study|Adverse Event|2|||
130776055|NCT03414229|470806679|FG003|Overall Study|Adverse Event|1|||
130776056|NCT03414229|470806676|FG000|Overall Study|Lack of Efficacy|7|||
130776057|NCT03414229|470806677|FG001|Overall Study|Lack of Efficacy|4|||
130776058|NCT03414229|470806678|FG002|Overall Study|Lack of Efficacy|1|||
130776059|NCT03414229|470806679|FG003|Overall Study|Lack of Efficacy|9|||
130776060|NCT03414229|470806676|FG000|Overall Study|Change in therapy|1|||
130776061|NCT03414229|470806677|FG001|Overall Study|Change in therapy|0|||
130776062|NCT03414229|470806678|FG002|Overall Study|Change in therapy|0|||
130776063|NCT03414229|470806679|FG003|Overall Study|Change in therapy|0|||
130776064|NCT03414229|470806676|FG000|Overall Study|Pregnancy|0|||
130776065|NCT03414229|470806677|FG001|Overall Study|Pregnancy|0|||
130776066|NCT03414229|470806678|FG002|Overall Study|Pregnancy|1|||
130776067|NCT03414229|470806679|FG003|Overall Study|Pregnancy|0|||
130776068|NCT03414229|470806676|FG000|Overall Study|Withdrawal by Subject|0|||
130776069|NCT03414229|470806677|FG001|Overall Study|Withdrawal by Subject|1|||
130776070|NCT03414229|470806678|FG002|Overall Study|Withdrawal by Subject|1|||
130776071|NCT03414229|470806679|FG003|Overall Study|Withdrawal by Subject|0|||
130776072|NCT02716584|470806684|FG000|Overall Study|Lost to Follow-up|8|||
130776073|NCT02716584|470806685|FG001|Overall Study|Lost to Follow-up|5|||
130776074|NCT01903993|470806686|FG000|Overall Study|Death|118|||
130776075|NCT01903993|470806687|FG001|Overall Study|Death|121|||
130776076|NCT01903993|470806686|FG000|Overall Study|Withdrawal by Subject|15|||
130776077|NCT01903993|470806687|FG001|Overall Study|Withdrawal by Subject|4|||
130776078|NCT01903993|470806686|FG000|Overall Study|Lost to Follow-up|2|||
130776079|NCT01903993|470806687|FG001|Overall Study|Lost to Follow-up|3|||
130776080|NCT01903993|470806686|FG000|Overall Study|Study Terminated by Sponsor|8|||
130776081|NCT01903993|470806687|FG001|Overall Study|Study Terminated by Sponsor|14|||
130776082|NCT01903993|470806686|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
130776083|NCT01903993|470806687|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
130776084|NCT01243177|470806690|FG000|Overall Study|Lack of Efficacy|47|||
130776085|NCT01243177|470806691|FG001|Overall Study|Lack of Efficacy|31|||
130776086|NCT01243177|470806690|FG000|Overall Study|Protocol Violation|11|||
130776087|NCT01243177|470806691|FG001|Overall Study|Protocol Violation|10|||
130776088|NCT01243177|470806690|FG000|Overall Study|Lost to Follow-up|15|||
130776089|NCT01243177|470806691|FG001|Overall Study|Lost to Follow-up|18|||
130776090|NCT01243177|470806690|FG000|Overall Study|Withdrawal by Subject|46|||
130776091|NCT01243177|470806691|FG001|Overall Study|Withdrawal by Subject|38|||
130776092|NCT01243177|470806690|FG000|Overall Study|AE, serious fatal|0|||
130776093|NCT01243177|470806691|FG001|Overall Study|AE, serious fatal|1|||
130776094|NCT01243177|470806690|FG000|Overall Study|SAE, non-fatal|7|||
130776095|NCT01243177|470806691|FG001|Overall Study|SAE, non-fatal|9|||
130776096|NCT01243177|470806690|FG000|Overall Study|AE, non-serious non-fatal|40|||
130776097|NCT01243177|470806691|FG001|Overall Study|AE, non-serious non-fatal|58|||
130776098|NCT01243177|470806690|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
130776099|NCT01243177|470806691|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
130776100|NCT01243177|470806690|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130776101|NCT01243177|470806691|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
130776102|NCT01243177|470806690|FG000|Overall Study|Other Reason|11|||
130776103|NCT01243177|470806691|FG001|Overall Study|Other Reason|12|||
130776104|NCT05251233|470808288|FG000|Overall Study|Disease progression - did not start treatment|0|||
130776105|NCT05251233|470808289|FG001|Overall Study|Disease progression - did not start treatment|0|||
130776106|NCT05251233|470808290|FG002|Overall Study|Disease progression - did not start treatment|5|||
130776107|NCT05251233|470808288|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
130776108|NCT05251233|470808289|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
130776109|NCT05251233|470808290|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
130776110|NCT05251233|470808288|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
130776111|NCT05251233|470808289|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
130776112|NCT05251233|470808290|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
130776113|NCT05251233|470808288|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
130776114|NCT05251233|470808289|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
130776115|NCT05251233|470808290|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
130776116|NCT05251233|470808288|FG000|Overall Study|Death - did not start treatment|3|||
130776117|NCT05251233|470808289|FG001|Overall Study|Death - did not start treatment|0|||
130776118|NCT05251233|470808290|FG002|Overall Study|Death - did not start treatment|0|||
130776119|NCT05251233|470808288|FG000|Overall Study|Withdrawal by Subject|2|||
130776120|NCT05251233|470808289|FG001|Overall Study|Withdrawal by Subject|2|||
130776121|NCT05251233|470808290|FG002|Overall Study|Withdrawal by Subject|0|||
130776122|NCT05251233|470808288|FG000|Overall Study|Other complicating disease|2|||
130776123|NCT05251233|470808289|FG001|Overall Study|Other complicating disease|1|||
130776124|NCT05251233|470808290|FG002|Overall Study|Other complicating disease|0|||
130776125|NCT05251233|470808288|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
130776126|NCT05251233|470808289|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
130776127|NCT05251233|470808290|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
130776128|NCT05251233|470808288|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
130776129|NCT05251233|470808289|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
130776130|NCT05251233|470808290|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
130776131|NCT03272347|470808295|FG000|Overall Study|Death|0|||
130776132|NCT03272347|470808296|FG001|Overall Study|Death|0|||
130776133|NCT03272347|470808297|FG002|Overall Study|Death|0|||
130776134|NCT03272347|470808298|FG003|Overall Study|Death|1|||
130776135|NCT03272347|470808295|FG000|Overall Study|Lost to Follow-up|1|||
130776136|NCT03272347|470808296|FG001|Overall Study|Lost to Follow-up|3|||
130776137|NCT03272347|470808297|FG002|Overall Study|Lost to Follow-up|5|||
130776138|NCT03272347|470808298|FG003|Overall Study|Lost to Follow-up|1|||
130776139|NCT03272347|470808295|FG000|Overall Study|Physician Decision|4|||
130776140|NCT03272347|470808296|FG001|Overall Study|Physician Decision|2|||
130776141|NCT03272347|470808297|FG002|Overall Study|Physician Decision|5|||
130776142|NCT03272347|470808298|FG003|Overall Study|Physician Decision|4|||
130776143|NCT03272347|470808295|FG000|Overall Study|Screen Failure|1|||
130776144|NCT03272347|470808296|FG001|Overall Study|Screen Failure|0|||
130776145|NCT03272347|470808297|FG002|Overall Study|Screen Failure|0|||
130776146|NCT03272347|470808298|FG003|Overall Study|Screen Failure|0|||
130776147|NCT03272347|470808295|FG000|Overall Study|Withdrawal by Subject|5|||
130776148|NCT03272347|470808296|FG001|Overall Study|Withdrawal by Subject|1|||
130776149|NCT03272347|470808297|FG002|Overall Study|Withdrawal by Subject|2|||
130776150|NCT03272347|470808298|FG003|Overall Study|Withdrawal by Subject|1|||
130776151|NCT02861664|470808302|FG000|Overall Study|Withdrawal of Consent|0|||
130776152|NCT02861664|470808303|FG001|Overall Study|Withdrawal of Consent|1|||
130776153|NCT01239394|470808304|FG000|Overall Study|Adverse Event|1|||
130776154|NCT02781818|470808306|FG000|Overall Study|Lost to Follow-up|4|||
130776155|NCT02781818|470808307|FG001|Overall Study|Lost to Follow-up|2|||
130776156|NCT02781818|470808308|FG002|Overall Study|Lost to Follow-up|1|||
130776157|NCT01223404|470808309|FG000|First Intervention (1 Day)|Adverse Event|0|||
130776158|NCT01223404|470808310|FG001|First Intervention (1 Day)|Adverse Event|0|||
130776159|NCT01223404|470808311|FG002|First Intervention (1 Day)|Adverse Event|0|||
130776160|NCT01223404|470808312|FG003|First Intervention (1 Day)|Adverse Event|1|||
130776161|NCT01223404|470808313|FG004|First Intervention (1 Day)|Adverse Event|0|||
130776162|NCT01223404|470808314|FG005|First Intervention (1 Day)|Adverse Event|0|||
130776163|NCT01223404|470808309|FG000|Second Intervention (1 Day)|Adverse Event|1|||
130776164|NCT01223404|470808310|FG001|Second Intervention (1 Day)|Adverse Event|0|||
130776165|NCT01223404|470808311|FG002|Second Intervention (1 Day)|Adverse Event|0|||
130776166|NCT01223404|470808312|FG003|Second Intervention (1 Day)|Adverse Event|0|||
130776167|NCT01223404|470808313|FG004|Second Intervention (1 Day)|Adverse Event|0|||
130776168|NCT01223404|470808314|FG005|Second Intervention (1 Day)|Adverse Event|0|||
130776169|NCT01223404|470808309|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130776170|NCT01223404|470808310|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130776171|NCT01223404|470808311|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130776172|NCT01223404|470808312|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
130776173|NCT01223404|470808313|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130776174|NCT01223404|470808314|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130776175|NCT00707057|470808315|FG000|Overall Study|Withdrawal by Subject|8|||
130776176|NCT00707057|470808316|FG001|Overall Study|Withdrawal by Subject|3|||
130776177|NCT00707057|470808315|FG000|Overall Study|Dosed incorrectly|0|||
130776178|NCT00707057|470808316|FG001|Overall Study|Dosed incorrectly|1|||
130776179|NCT00577772|470808322|FG000|Overall Study|Lost to Follow-up|0|||
130776180|NCT00577772|470808323|FG001|Overall Study|Lost to Follow-up|1|||
130776181|NCT00572455|470808324|FG000|Stage I (14 Days)|Adverse Event|0|||
131043377|NCT05184452|471793078|FG001|Overall Study|Withdrawal by Subject|0|||
130776182|NCT00572455|470808325|FG001|Stage I (14 Days)|Adverse Event|0|||
130776183|NCT00572455|470808326|FG002|Stage I (14 Days)|Adverse Event|0|||
131043378|NCT05184452|471793079|FG002|Overall Study|Withdrawal by Subject|0|||
130776184|NCT00572455|470808327|FG003|Stage I (14 Days)|Adverse Event|0|||
130776185|NCT00572455|470808328|FG004|Stage I (14 Days)|Adverse Event|0|||
130776186|NCT00572455|470808329|FG005|Stage I (14 Days)|Adverse Event|3|||
130776187|NCT00572455|470808330|FG006|Stage I (14 Days)|Adverse Event|0|||
130776188|NCT00572455|470808331|FG007|Stage I (14 Days)|Adverse Event|0|||
130776189|NCT00572455|470808332|FG008|Stage I (14 Days)|Adverse Event|0|||
130776190|NCT00572455|470808333|FG009|Stage I (14 Days)|Adverse Event|0|||
130776191|NCT00572455|470808334|FG010|Stage I (14 Days)|Adverse Event|0|||
130776192|NCT00572455|470808335|FG011|Stage I (14 Days)|Adverse Event|0|||
130776193|NCT00572455|470808336|FG012|Stage I (14 Days)|Adverse Event|0|||
130776194|NCT00572455|470808337|FG013|Stage I (14 Days)|Adverse Event|0|||
131043379|NCT05184452|471793080|FG003|Overall Study|Withdrawal by Subject|0|||
130717015|NCT02393248|470590961|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
130717016|NCT02393248|470590962|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
130717017|NCT02393248|470590963|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
130717018|NCT02393248|470590964|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
130717019|NCT02393248|470590965|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
130717020|NCT02393248|470590966|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
130717021|NCT02393248|470590967|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
130717022|NCT02393248|470590968|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
130717023|NCT02393248|470590969|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
130717024|NCT02393248|470590970|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
130717025|NCT02393248|470590971|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
130717026|NCT02393248|470590972|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
130717027|NCT02393248|470590973|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
130717028|NCT02393248|470590974|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
130717029|NCT02393248|470590975|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
130717030|NCT02393248|470590976|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
130717031|NCT02393248|470590977|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
130717032|NCT02393248|470590978|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
130717033|NCT02393248|470590979|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
130717034|NCT02393248|470590980|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
130717035|NCT02393248|470590981|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
130717036|NCT02393248|470590982|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
130717037|NCT02393248|470590983|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
130717038|NCT02393248|470590984|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
130717039|NCT02393248|470590985|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
130717040|NCT02393248|470590961|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717041|NCT02393248|470590962|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717042|NCT02393248|470590963|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717043|NCT02393248|470590964|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717044|NCT02393248|470590965|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717045|NCT02393248|470590966|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717046|NCT02393248|470590967|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717047|NCT02393248|470590968|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717048|NCT02393248|470590969|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717049|NCT02393248|470590970|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717050|NCT02393248|470590971|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717051|NCT02393248|470590972|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
130717052|NCT02393248|470590973|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717053|NCT02393248|470590974|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
130717054|NCT02393248|470590975|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717055|NCT02393248|470590976|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717056|NCT02393248|470590977|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717057|NCT02393248|470590978|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717058|NCT02393248|470590979|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717059|NCT02393248|470590980|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717060|NCT02393248|470590981|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717061|NCT02393248|470590982|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717062|NCT02393248|470590983|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717063|NCT02393248|470590984|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717064|NCT02393248|470590985|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130717065|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717066|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717067|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717068|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717069|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717070|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717071|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717072|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717073|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717074|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717075|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717076|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717077|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717078|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130974904|NCT01588184|471535473|FG005|Overall Study|Withdrawal by Subject|0|||
130974905|NCT01588184|471535468|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
130974906|NCT01588184|471535469|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
130974907|NCT01588184|471535470|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
130776195|NCT00572455|470808324|FG000|Stage I (14 Days)|Other|0|||
130776196|NCT00572455|470808325|FG001|Stage I (14 Days)|Other|0|||
130776197|NCT00572455|470808326|FG002|Stage I (14 Days)|Other|0|||
130776198|NCT00572455|470808327|FG003|Stage I (14 Days)|Other|0|||
130776199|NCT00572455|470808328|FG004|Stage I (14 Days)|Other|1|||
130776200|NCT00572455|470808329|FG005|Stage I (14 Days)|Other|0|||
130776201|NCT00572455|470808330|FG006|Stage I (14 Days)|Other|0|||
130974908|NCT01588184|471535471|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
130974909|NCT01588184|471535472|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
130974910|NCT01588184|471535473|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
130974911|NCT01588184|471535468|FG000|Overall Study|multiple reasons|0|||
130974912|NCT01588184|471535469|FG001|Overall Study|multiple reasons|3|||
130974913|NCT01588184|471535470|FG002|Overall Study|multiple reasons|0|||
130974914|NCT01588184|471535471|FG003|Overall Study|multiple reasons|1|||
130974915|NCT01588184|471535472|FG004|Overall Study|multiple reasons|0|||
130974916|NCT01588184|471535473|FG005|Overall Study|multiple reasons|0|||
130974917|NCT02008890|471535475|FG000|Period 1|Withdrawal by Subject|7|||
130974918|NCT02008890|471535476|FG001|Period 1|Withdrawal by Subject|7|||
130776202|NCT00572455|470808331|FG007|Stage I (14 Days)|Other|0|||
130776203|NCT00572455|470808332|FG008|Stage I (14 Days)|Other|0|||
130776204|NCT00572455|470808333|FG009|Stage I (14 Days)|Other|0|||
130776205|NCT00572455|470808334|FG010|Stage I (14 Days)|Other|0|||
130776206|NCT00572455|470808335|FG011|Stage I (14 Days)|Other|0|||
130776207|NCT00572455|470808336|FG012|Stage I (14 Days)|Other|0|||
130776208|NCT00572455|470808337|FG013|Stage I (14 Days)|Other|0|||
130776209|NCT00572455|470808324|FG000|Stage II (28 Days)|Adverse Event|0|||
130776210|NCT00572455|470808325|FG001|Stage II (28 Days)|Adverse Event|0|||
130776211|NCT00572455|470808326|FG002|Stage II (28 Days)|Adverse Event|0|||
130776212|NCT00572455|470808327|FG003|Stage II (28 Days)|Adverse Event|0|||
130776213|NCT00572455|470808328|FG004|Stage II (28 Days)|Adverse Event|0|||
130776214|NCT00572455|470808329|FG005|Stage II (28 Days)|Adverse Event|0|||
130776215|NCT00572455|470808330|FG006|Stage II (28 Days)|Adverse Event|0|||
130776216|NCT00572455|470808331|FG007|Stage II (28 Days)|Adverse Event|0|||
130776217|NCT00572455|470808332|FG008|Stage II (28 Days)|Adverse Event|1|||
130776218|NCT00572455|470808333|FG009|Stage II (28 Days)|Adverse Event|3|||
130776219|NCT00572455|470808334|FG010|Stage II (28 Days)|Adverse Event|3|||
130776220|NCT00572455|470808335|FG011|Stage II (28 Days)|Adverse Event|4|||
130776221|NCT00572455|470808336|FG012|Stage II (28 Days)|Adverse Event|5|||
130776222|NCT00572455|470808337|FG013|Stage II (28 Days)|Adverse Event|1|||
130776223|NCT00572455|470808324|FG000|Stage II (28 Days)|Death|0|||
130776224|NCT00572455|470808325|FG001|Stage II (28 Days)|Death|0|||
130776225|NCT00572455|470808326|FG002|Stage II (28 Days)|Death|0|||
130776226|NCT00572455|470808327|FG003|Stage II (28 Days)|Death|0|||
130776227|NCT00572455|470808328|FG004|Stage II (28 Days)|Death|0|||
130776228|NCT00572455|470808329|FG005|Stage II (28 Days)|Death|0|||
130776229|NCT00572455|470808330|FG006|Stage II (28 Days)|Death|0|||
130776230|NCT00572455|470808331|FG007|Stage II (28 Days)|Death|0|||
130776231|NCT00572455|470808332|FG008|Stage II (28 Days)|Death|1|||
130776232|NCT00572455|470808333|FG009|Stage II (28 Days)|Death|0|||
130776233|NCT00572455|470808334|FG010|Stage II (28 Days)|Death|0|||
130776234|NCT00572455|470808335|FG011|Stage II (28 Days)|Death|0|||
130776235|NCT00572455|470808336|FG012|Stage II (28 Days)|Death|0|||
130776236|NCT00572455|470808337|FG013|Stage II (28 Days)|Death|0|||
130776237|NCT00572455|470808324|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
130776238|NCT00572455|470808325|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
130776239|NCT00572455|470808326|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
130776240|NCT00572455|470808327|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
130776241|NCT00572455|470808328|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
130776242|NCT00572455|470808329|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
130776243|NCT00572455|470808330|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
130776244|NCT00572455|470808331|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
130776245|NCT00572455|470808332|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
130776246|NCT00572455|470808333|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
130776247|NCT00572455|470808334|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
130776248|NCT00572455|470808335|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
130776249|NCT00572455|470808336|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
130776250|NCT00572455|470808337|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
130776251|NCT00572455|470808324|FG000|Stage II (28 Days)|Other|0|||
130776252|NCT00572455|470808325|FG001|Stage II (28 Days)|Other|0|||
130776253|NCT00572455|470808326|FG002|Stage II (28 Days)|Other|0|||
130776254|NCT00572455|470808327|FG003|Stage II (28 Days)|Other|0|||
130776255|NCT00572455|470808328|FG004|Stage II (28 Days)|Other|0|||
130776256|NCT00572455|470808329|FG005|Stage II (28 Days)|Other|0|||
130776257|NCT00572455|470808330|FG006|Stage II (28 Days)|Other|0|||
130776258|NCT00572455|470808331|FG007|Stage II (28 Days)|Other|0|||
130776259|NCT00572455|470808332|FG008|Stage II (28 Days)|Other|1|||
130776260|NCT00572455|470808333|FG009|Stage II (28 Days)|Other|0|||
130974919|NCT02008890|471535477|FG002|Period 1|Withdrawal by Subject|5|||
131131305|NCT03031301|472108303|FG000|Overall Study|Technical issue|1|||
130776261|NCT00572455|470808334|FG010|Stage II (28 Days)|Other|0|||
130776262|NCT00572455|470808335|FG011|Stage II (28 Days)|Other|0|||
130776263|NCT00572455|470808336|FG012|Stage II (28 Days)|Other|0|||
130974920|NCT02008890|471535478|FG003|Period 1|Withdrawal by Subject|0|||
130776264|NCT00572455|470808337|FG013|Stage II (28 Days)|Other|0|||
130776265|NCT00572455|470808324|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
130776266|NCT00572455|470808325|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
130776267|NCT00572455|470808326|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
130776268|NCT00572455|470808327|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
130776269|NCT00572455|470808328|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
130776270|NCT00572455|470808329|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
130776271|NCT00572455|470808330|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
130776272|NCT00572455|470808331|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
130776273|NCT00572455|470808332|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
130776274|NCT00572455|470808333|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
130776275|NCT00572455|470808334|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
130776276|NCT00572455|470808335|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
130776277|NCT00572455|470808336|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
130776278|NCT00572455|470808337|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
130776279|NCT02821416|470808340|FG000|Overall Study|Adverse Event|0|||
130776280|NCT02821416|470808341|FG001|Overall Study|Adverse Event|1|||
130776281|NCT02821416|470808340|FG000|Overall Study|Withdrawal by Subject|2|||
130776282|NCT02821416|470808341|FG001|Overall Study|Withdrawal by Subject|0|||
130776283|NCT02821416|470808340|FG000|Overall Study|Lost to Follow-up|1|||
130776284|NCT02821416|470808341|FG001|Overall Study|Lost to Follow-up|0|||
130776285|NCT04152083|470808342|FG000|Overall Study|Lost to Follow-up|2|||
130776286|NCT04152083|470808343|FG001|Overall Study|Lost to Follow-up|1|||
130776287|NCT04152083|470808342|FG000|Overall Study|Adverse Event|1|||
130776288|NCT04152083|470808343|FG001|Overall Study|Adverse Event|0|||
130776289|NCT04152083|470808342|FG000|Overall Study|Randomized but not treated|3|||
130776290|NCT04152083|470808343|FG001|Overall Study|Randomized but not treated|2|||
130776291|NCT00856999|470808344|FG000|Overall Study|Withdrawal by Subject|5|||
130776292|NCT00872521|470808345|FG000|Completed PAD Induction|Patient choice|0|||
130776293|NCT00872521|470808346|FG001|Completed PAD Induction|Patient choice|1|||
130776294|NCT00872521|470808347|FG002|Completed PAD Induction|Patient choice|0|||
130776295|NCT00872521|470808345|FG000|Completed PAD Induction|Disease progression|0|||
130776296|NCT00872521|470808346|FG001|Completed PAD Induction|Disease progression|2|||
130776297|NCT00872521|470808347|FG002|Completed PAD Induction|Disease progression|0|||
130776298|NCT00872521|470808345|FG000|Completed PAD Induction|Adverse Event|4|||
130776299|NCT00872521|470808346|FG001|Completed PAD Induction|Adverse Event|0|||
130776300|NCT00872521|470808347|FG002|Completed PAD Induction|Adverse Event|0|||
130776301|NCT00872521|470808345|FG000|Completed PAD Induction|Death|1|||
130776302|NCT00872521|470808346|FG001|Completed PAD Induction|Death|1|||
130776303|NCT00872521|470808347|FG002|Completed PAD Induction|Death|0|||
130776304|NCT00872521|470808345|FG000|Primary Endpoint Analysis|Other|1|||
130776305|NCT00872521|470808346|FG001|Primary Endpoint Analysis|Other|2|||
130776306|NCT00872521|470808347|FG002|Primary Endpoint Analysis|Other|0|||
130776307|NCT00872521|470808345|FG000|Primary Endpoint Analysis|Patient choice|0|||
130776308|NCT00872521|470808346|FG001|Primary Endpoint Analysis|Patient choice|1|||
130776309|NCT00872521|470808347|FG002|Primary Endpoint Analysis|Patient choice|0|||
130776310|NCT00872521|470808345|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
130776311|NCT00872521|470808346|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
130776312|NCT00872521|470808347|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
130974921|NCT02008890|471535479|FG004|Period 1|Withdrawal by Subject|0|||
130974922|NCT02008890|471535475|FG000|Period 1|Pregnancy|1|||
130974923|NCT02008890|471535476|FG001|Period 1|Pregnancy|0|||
130974924|NCT02008890|471535477|FG002|Period 1|Pregnancy|0|||
130776313|NCT00872521|470808345|FG000|Primary Endpoint Analysis|Patient response missing|0|||
130776314|NCT00872521|470808346|FG001|Primary Endpoint Analysis|Patient response missing|0|||
130776315|NCT00872521|470808347|FG002|Primary Endpoint Analysis|Patient response missing|1|||
130776316|NCT00872521|470808345|FG000|Completed 3-month Follow up|Other|0|||
130776317|NCT00872521|470808346|FG001|Completed 3-month Follow up|Other|2|||
130776318|NCT00872521|470808347|FG002|Completed 3-month Follow up|Other|0|||
130776319|NCT00872521|470808345|FG000|Completed 3-month Follow up|Physician Decision|0|||
130776320|NCT00872521|470808346|FG001|Completed 3-month Follow up|Physician Decision|1|||
130776321|NCT00872521|470808347|FG002|Completed 3-month Follow up|Physician Decision|0|||
130776322|NCT00872521|470808345|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
130776323|NCT00872521|470808346|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
130776324|NCT00872521|470808347|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
130776325|NCT04819438|470808348|FG000|Overall Study|Withdrawal by Subject|1|||
130776326|NCT04819438|470808349|FG001|Overall Study|Withdrawal by Subject|0|||
130776327|NCT04819438|470808348|FG000|Overall Study|Adverse Event|0|||
130974925|NCT02008890|471535478|FG003|Period 1|Pregnancy|0|||
130974926|NCT02008890|471535479|FG004|Period 1|Pregnancy|0|||
130776328|NCT04819438|470808349|FG001|Overall Study|Adverse Event|1|||
130776329|NCT04819438|470808348|FG000|Overall Study|Protocol Violation|0|||
130776330|NCT04819438|470808349|FG001|Overall Study|Protocol Violation|1|||
130974927|NCT02008890|471535475|FG000|Period 1|Physician Decision|1|||
130974928|NCT02008890|471535476|FG001|Period 1|Physician Decision|0|||
130717079|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717080|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717081|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717082|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717083|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
130717084|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717085|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
130717086|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
130717087|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717088|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
130717089|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130717090|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Death|0|||
130717091|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Death|0|||
130717092|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Death|0|||
130717093|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Death|0|||
130717094|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Death|0|||
130717095|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Death|0|||
130717096|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Death|0|||
130717097|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Death|0|||
130717098|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Death|0|||
130717099|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Death|0|||
130717100|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Death|0|||
130717101|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Death|0|||
130717102|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Death|0|||
130717103|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Death|0|||
130717104|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Death|0|||
130717105|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Death|1|||
130717106|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Death|7|||
130717107|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Death|5|||
130717108|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Death|5|||
130717109|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Death|3|||
130717110|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Death|7|||
130717111|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Death|5|||
130717112|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Death|6|||
130717113|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Death|3|||
130717114|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Death|0|||
130717115|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717116|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717117|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717118|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717119|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717120|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717121|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717122|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717123|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717124|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717125|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717126|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717127|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717128|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717129|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717130|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717131|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717132|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717133|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717134|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130717135|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717136|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717137|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717138|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
130717139|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130717140|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Disease Progression|0|||
130717141|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Disease Progression|0|||
130717142|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Disease Progression|0|||
130717143|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Disease Progression|0|||
130717144|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Disease Progression|0|||
130717145|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Disease Progression|0|||
130717146|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Disease Progression|0|||
130717147|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Disease Progression|0|||
130717148|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Disease Progression|0|||
130717149|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Disease Progression|0|||
130717150|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Disease Progression|0|||
130776331|NCT03465709|470808350|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
130776332|NCT03465709|470808350|FG000|Overall Study|Withdrawal by Subject|3|||
130776333|NCT03060291|470808351|FG000|3-month Follow-up|Declined to respond|8|||
130776334|NCT03060291|470808352|FG001|3-month Follow-up|Declined to respond|10|||
130776335|NCT03060291|470808353|FG002|3-month Follow-up|Declined to respond|2|||
130776336|NCT03060291|470808351|FG000|6-month Follow-up|Declined to respond|7|||
130776337|NCT03060291|470808352|FG001|6-month Follow-up|Declined to respond|13|||
130776338|NCT03060291|470808353|FG002|6-month Follow-up|Declined to respond|4|||
130776339|NCT03060291|470808351|FG000|12-month Follow-up|Declined to respond|7|||
130776340|NCT03060291|470808352|FG001|12-month Follow-up|Declined to respond|16|||
130776341|NCT03060291|470808353|FG002|12-month Follow-up|Declined to respond|6|||
130776342|NCT01720524|470808355|FG000|Part A|Insufficient Clinical Response|2|||
130776343|NCT01720524|470808356|FG001|Part A|Insufficient Clinical Response|4|||
130776344|NCT01720524|470808355|FG000|Part A|Adverse Event|2|||
130776345|NCT01720524|470808356|FG001|Part A|Adverse Event|2|||
130776346|NCT01720524|470808355|FG000|Part A|Death|2|||
130776347|NCT01720524|470808356|FG001|Part A|Death|1|||
130776348|NCT01720524|470808355|FG000|Part A|Lost to Follow-up|0|||
130776349|NCT01720524|470808356|FG001|Part A|Lost to Follow-up|1|||
130776350|NCT01720524|470808355|FG000|Part A|Missed 28 day follow-up visit|1|||
130776351|NCT01720524|470808356|FG001|Part A|Missed 28 day follow-up visit|1|||
130776352|NCT01720524|470808355|FG000|Part A|Withdrawal by Subject|0|||
130776353|NCT01720524|470808356|FG001|Part A|Withdrawal by Subject|1|||
130776354|NCT01720524|470808355|FG000|Part A|Other|0|||
130776355|NCT01720524|470808356|FG001|Part A|Other|1|||
130776356|NCT01720524|470808355|FG000|Part A|Lost to Follow-up|0|||
130776357|NCT01720524|470808356|FG001|Part A|Lost to Follow-up|1|||
130776358|NCT01720524|470808355|FG000|Part B|No longer willing to participate in study|1|||
130776359|NCT01720524|470808356|FG001|Part B|No longer willing to participate in study|4|||
131131306|NCT03031301|472108304|FG001|Overall Study|Technical issue|1|||
130776360|NCT01720524|470808355|FG000|Part B|Other|2|||
130776361|NCT01720524|470808356|FG001|Part B|Other|0|||
130776362|NCT01720524|470808355|FG000|Part B|Lost to Follow-up|2|||
130776363|NCT01720524|470808356|FG001|Part B|Lost to Follow-up|3|||
130776364|NCT01720524|470808355|FG000|Part B|Death|0|||
131131307|NCT03031301|472108303|FG000|Overall Study|Adverse Event|1|||
131131308|NCT03031301|472108304|FG001|Overall Study|Adverse Event|0|||
131131309|NCT02429414|472108305|FG000|Overall Study|Physician Decision|0|||
131131310|NCT02429414|472108306|FG001|Overall Study|Physician Decision|1|||
131131311|NCT03245450|472108307|FG000|Overall Study|Radiological disease progression|3|||
131131312|NCT03245450|472108308|FG001|Overall Study|Radiological disease progression|3|||
131131313|NCT03245450|472108309|FG002|Overall Study|Radiological disease progression|2|||
131131314|NCT03245450|472108310|FG003|Overall Study|Radiological disease progression|2|||
131131315|NCT03245450|472108311|FG004|Overall Study|Radiological disease progression|7|||
131131316|NCT03245450|472108312|FG005|Overall Study|Radiological disease progression|6|||
131131317|NCT03245450|472108313|FG006|Overall Study|Radiological disease progression|6|||
131131318|NCT03245450|472108307|FG000|Overall Study|Clinical disease progression|0|||
131131319|NCT03245450|472108308|FG001|Overall Study|Clinical disease progression|0|||
131131320|NCT03245450|472108309|FG002|Overall Study|Clinical disease progression|1|||
131131321|NCT03245450|472108310|FG003|Overall Study|Clinical disease progression|0|||
131131322|NCT03245450|472108311|FG004|Overall Study|Clinical disease progression|0|||
131131323|NCT03245450|472108312|FG005|Overall Study|Clinical disease progression|2|||
131131324|NCT03245450|472108313|FG006|Overall Study|Clinical disease progression|0|||
131131325|NCT03245450|472108307|FG000|Overall Study|Other|0|||
131131326|NCT03245450|472108308|FG001|Overall Study|Other|0|||
131131327|NCT03245450|472108309|FG002|Overall Study|Other|0|||
131131328|NCT03245450|472108310|FG003|Overall Study|Other|1|||
131131329|NCT03245450|472108311|FG004|Overall Study|Other|1|||
131131330|NCT03245450|472108312|FG005|Overall Study|Other|1|||
131131331|NCT03245450|472108313|FG006|Overall Study|Other|1|||
131131332|NCT03245450|472108307|FG000|Overall Study|Withdrawal by Subject|0|||
131131333|NCT03245450|472108308|FG001|Overall Study|Withdrawal by Subject|1|||
131131334|NCT03245450|472108309|FG002|Overall Study|Withdrawal by Subject|0|||
131131335|NCT03245450|472108310|FG003|Overall Study|Withdrawal by Subject|0|||
131131336|NCT03245450|472108311|FG004|Overall Study|Withdrawal by Subject|0|||
131131337|NCT03245450|472108312|FG005|Overall Study|Withdrawal by Subject|0|||
130974929|NCT02008890|471535477|FG002|Period 1|Physician Decision|1|||
131131338|NCT03245450|472108313|FG006|Overall Study|Withdrawal by Subject|0|||
131131339|NCT03245450|472108307|FG000|Overall Study|Adverse Event|0|||
131131340|NCT03245450|472108308|FG001|Overall Study|Adverse Event|0|||
130776365|NCT01720524|470808356|FG001|Part B|Death|2|||
130776366|NCT02105285|470808362|FG000|Overall Study|Adverse Event|1|||
130776367|NCT02105285|470808363|FG001|Overall Study|Adverse Event|1|||
130776368|NCT02105285|470808364|FG002|Overall Study|Adverse Event|0|||
131131341|NCT03245450|472108309|FG002|Overall Study|Adverse Event|0|||
131131342|NCT03245450|472108310|FG003|Overall Study|Adverse Event|0|||
130776369|NCT02105285|470808362|FG000|Overall Study|Protocol Violation|0|||
130776370|NCT02105285|470808363|FG001|Overall Study|Protocol Violation|1|||
130776371|NCT02105285|470808364|FG002|Overall Study|Protocol Violation|0|||
130776372|NCT02105285|470808362|FG000|Overall Study|Withdrawal by Subject|1|||
130776373|NCT02105285|470808363|FG001|Overall Study|Withdrawal by Subject|0|||
130776374|NCT02105285|470808364|FG002|Overall Study|Withdrawal by Subject|0|||
130776375|NCT01421641|470808365|FG000|Overall Study|Protocol Violation|2|||
130776376|NCT01421641|470808366|FG001|Overall Study|Protocol Violation|2|||
130776377|NCT03061188|470808368|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
130776378|NCT03061188|470808369|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
130776379|NCT03061188|470808370|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
130776380|NCT03061188|470808371|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
130776381|NCT03061188|470808368|FG000|On Follow-up for 3 Years|Death|0|||
130776382|NCT03061188|470808369|FG001|On Follow-up for 3 Years|Death|3|||
130776383|NCT03061188|470808370|FG002|On Follow-up for 3 Years|Death|5|||
130776384|NCT03061188|470808371|FG003|On Follow-up for 3 Years|Death|4|||
130776385|NCT03061188|470808368|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
130776386|NCT03061188|470808369|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
130776387|NCT03061188|470808370|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
130776388|NCT03061188|470808371|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
130776389|NCT02609984|470808372|FG000|Overall Study|Death|29|||
130776390|NCT02609984|470808373|FG001|Overall Study|Death|26|||
130776391|NCT02609984|470808372|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
130776392|NCT02609984|470808373|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
130776393|NCT02609984|470808372|FG000|Overall Study|Lost to Follow-up|1|||
130776394|NCT02609984|470808373|FG001|Overall Study|Lost to Follow-up|2|||
130776395|NCT02609984|470808372|FG000|Overall Study|Withdrawal by Subject|0|||
130776396|NCT02609984|470808373|FG001|Overall Study|Withdrawal by Subject|1|||
130776397|NCT02609984|470808372|FG000|Overall Study|Disease Progression|2|||
130776398|NCT02609984|470808373|FG001|Overall Study|Disease Progression|0|||
130776399|NCT02504320|470808374|FG000|Treatment Period 1|Positive Drug Screen|0|||
130776400|NCT02504320|470808375|FG001|Treatment Period 1|Positive Drug Screen|0|||
130776401|NCT02504320|470808376|FG002|Treatment Period 1|Positive Drug Screen|1|||
130776402|NCT02504320|470808377|FG003|Treatment Period 1|Positive Drug Screen|0|||
130776403|NCT02504320|470808374|FG000|Treatment Period 2|Positive Drug Screen|0|||
130776404|NCT02504320|470808375|FG001|Treatment Period 2|Positive Drug Screen|1|||
130776405|NCT02504320|470808376|FG002|Treatment Period 2|Positive Drug Screen|0|||
130776406|NCT02504320|470808377|FG003|Treatment Period 2|Positive Drug Screen|0|||
130776407|NCT02504320|470808374|FG000|Treatment Period 3|Positive Drug Screen|0|||
130776408|NCT02504320|470808375|FG001|Treatment Period 3|Positive Drug Screen|0|||
130776409|NCT02504320|470808376|FG002|Treatment Period 3|Positive Drug Screen|0|||
130776410|NCT02504320|470808377|FG003|Treatment Period 3|Positive Drug Screen|1|||
130776411|NCT02504320|470808374|FG000|Treatment Period 3|Adverse Event|0|||
130776412|NCT02504320|470808375|FG001|Treatment Period 3|Adverse Event|0|||
130776413|NCT02504320|470808376|FG002|Treatment Period 3|Adverse Event|1|||
130776414|NCT02504320|470808377|FG003|Treatment Period 3|Adverse Event|0|||
130776415|NCT01210222|470808378|FG000|Overall Study|Ineligible|2|||
130776416|NCT01210222|470808378|FG000|Overall Study|Never treated|1|||
130776417|NCT03293394|470808379|FG000|Follow-up (6 Months)|Adverse Event|4|||
130776418|NCT03293394|470808380|FG001|Follow-up (6 Months)|Adverse Event|2|||
130776419|NCT00436826|470808383|FG000|Double Blind Period (DBP)|Adverse Event|2|||
130776420|NCT00436826|470808384|FG001|Double Blind Period (DBP)|Adverse Event|0|||
130776421|NCT00436826|470808385|FG002|Double Blind Period (DBP)|Adverse Event|0|||
130776422|NCT00436826|470808386|FG003|Double Blind Period (DBP)|Adverse Event|0|||
130776423|NCT00436826|470808387|FG004|Double Blind Period (DBP)|Adverse Event|0|||
130776424|NCT00436826|470808388|FG005|Double Blind Period (DBP)|Adverse Event|0|||
130776425|NCT00436826|470808383|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
130776426|NCT00436826|470808384|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
130776427|NCT00436826|470808385|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
130776428|NCT00436826|470808386|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
130776429|NCT00436826|470808387|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
130776430|NCT00436826|470808388|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
130776431|NCT00436826|470808383|FG000|Double Blind Period (DBP)|Other|10|||
130776432|NCT00436826|470808384|FG001|Double Blind Period (DBP)|Other|11|||
130776433|NCT00436826|470808385|FG002|Double Blind Period (DBP)|Other|0|||
130776434|NCT00436826|470808386|FG003|Double Blind Period (DBP)|Other|0|||
130776435|NCT00436826|470808387|FG004|Double Blind Period (DBP)|Other|0|||
130776436|NCT00436826|470808388|FG005|Double Blind Period (DBP)|Other|0|||
130776437|NCT00436826|470808383|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130974930|NCT02008890|471535478|FG003|Period 1|Physician Decision|0|||
130776438|NCT00436826|470808384|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130776439|NCT00436826|470808385|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130776440|NCT00436826|470808386|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
130776441|NCT00436826|470808387|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130776442|NCT00436826|470808388|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130776443|NCT00436826|470808383|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130776444|NCT00436826|470808384|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130974931|NCT02008890|471535479|FG004|Period 1|Physician Decision|0|||
130776445|NCT00436826|470808385|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
130776446|NCT00436826|470808386|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
130776447|NCT00436826|470808387|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130776448|NCT00436826|470808388|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130776449|NCT00436826|470808383|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130776450|NCT00436826|470808384|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130776451|NCT00436826|470808385|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130776452|NCT00436826|470808386|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130776453|NCT00436826|470808387|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
130776454|NCT00436826|470808388|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
130776455|NCT04978337|470808389|FG000|Overall Study|Withdrawal by Subject|0|||
130776456|NCT04978337|470808390|FG001|Overall Study|Withdrawal by Subject|1|||
130776457|NCT01436227|470808392|FG000|Overall Study|Adverse Event|7|||
130776458|NCT01436227|470808392|FG000|Overall Study|Death|1|||
130776459|NCT01436227|470808392|FG000|Overall Study|Lack of Efficacy|1|||
130776460|NCT01436227|470808392|FG000|Overall Study|Lost to Follow-up|3|||
130776461|NCT01436227|470808392|FG000|Overall Study|Physician Decision|1|||
130776462|NCT01436227|470808392|FG000|Overall Study|Withdrawal by Subject|7|||
130776463|NCT01436227|470808392|FG000|Overall Study|Disease progression, relapse|6|||
130776464|NCT05568797|470808394|FG000|Overall Study|Adverse Event|0|||
130776465|NCT05568797|470808395|FG001|Overall Study|Adverse Event|8|||
130776466|NCT05568797|470808394|FG000|Overall Study|Lost to Follow-up|2|||
130776467|NCT05568797|470808395|FG001|Overall Study|Lost to Follow-up|3|||
130776468|NCT05568797|470808394|FG000|Overall Study|Withdrawal by Subject|1|||
130776469|NCT05568797|470808395|FG001|Overall Study|Withdrawal by Subject|10|||
130776470|NCT05568797|470808394|FG000|Overall Study|Other|2|||
130776471|NCT05568797|470808395|FG001|Overall Study|Other|2|||
130776472|NCT03131687|470808396|FG000|Overall Study|Adverse Event|0|||
130776473|NCT03131687|470808397|FG001|Overall Study|Adverse Event|1|||
130776474|NCT03131687|470808398|FG002|Overall Study|Adverse Event|0|||
130776475|NCT03131687|470808399|FG003|Overall Study|Adverse Event|1|||
130776476|NCT03131687|470808400|FG004|Overall Study|Adverse Event|2|||
130776477|NCT03131687|470808401|FG005|Overall Study|Adverse Event|2|||
130974932|NCT02008890|471535475|FG000|Period 1|Adverse Event|6|||
130974933|NCT02008890|471535476|FG001|Period 1|Adverse Event|8|||
130974934|NCT02008890|471535477|FG002|Period 1|Adverse Event|6|||
130974935|NCT02008890|471535478|FG003|Period 1|Adverse Event|0|||
130974936|NCT02008890|471535479|FG004|Period 1|Adverse Event|0|||
130974937|NCT02008890|471535475|FG000|Period 2|Adverse Event|12|||
130974938|NCT02008890|471535476|FG001|Period 2|Adverse Event|7|||
130974939|NCT02008890|471535477|FG002|Period 2|Adverse Event|0|||
130974940|NCT02008890|471535478|FG003|Period 2|Adverse Event|5|||
130974941|NCT02008890|471535479|FG004|Period 2|Adverse Event|5|||
130974942|NCT02008890|471535475|FG000|Period 2|Withdrawal by Subject|11|||
130974943|NCT02008890|471535476|FG001|Period 2|Withdrawal by Subject|8|||
130974944|NCT02008890|471535477|FG002|Period 2|Withdrawal by Subject|0|||
130974945|NCT02008890|471535478|FG003|Period 2|Withdrawal by Subject|7|||
130974946|NCT02008890|471535479|FG004|Period 2|Withdrawal by Subject|2|||
130974947|NCT02008890|471535475|FG000|Period 2|Physician Decision|4|||
130974948|NCT02008890|471535476|FG001|Period 2|Physician Decision|0|||
130974949|NCT02008890|471535477|FG002|Period 2|Physician Decision|0|||
130974950|NCT02008890|471535478|FG003|Period 2|Physician Decision|2|||
130974951|NCT02008890|471535479|FG004|Period 2|Physician Decision|1|||
130974952|NCT02008890|471535475|FG000|Period 2|Lost to Follow-up|0|||
130974953|NCT02008890|471535476|FG001|Period 2|Lost to Follow-up|0|||
130974954|NCT02008890|471535477|FG002|Period 2|Lost to Follow-up|1|||
130974955|NCT02008890|471535478|FG003|Period 2|Lost to Follow-up|0|||
130974956|NCT02008890|471535479|FG004|Period 2|Lost to Follow-up|0|||
130974957|NCT02008890|471535475|FG000|Extension Period|Withdrawal by Subject|3|||
130776478|NCT03131687|470808396|FG000|Overall Study|Death|1|||
130776479|NCT03131687|470808397|FG001|Overall Study|Death|0|||
130776480|NCT03131687|470808398|FG002|Overall Study|Death|0|||
130776481|NCT03131687|470808399|FG003|Overall Study|Death|0|||
130776482|NCT03131687|470808400|FG004|Overall Study|Death|0|||
130776483|NCT03131687|470808401|FG005|Overall Study|Death|0|||
130776484|NCT03131687|470808396|FG000|Overall Study|Withdrawal by Subject|3|||
130776485|NCT03131687|470808397|FG001|Overall Study|Withdrawal by Subject|3|||
130776486|NCT03131687|470808398|FG002|Overall Study|Withdrawal by Subject|3|||
130776487|NCT03131687|470808399|FG003|Overall Study|Withdrawal by Subject|1|||
130776488|NCT03131687|470808400|FG004|Overall Study|Withdrawal by Subject|2|||
130974958|NCT02008890|471535476|FG001|Extension Period|Withdrawal by Subject|2|||
130776489|NCT03131687|470808401|FG005|Overall Study|Withdrawal by Subject|1|||
130776490|NCT03131687|470808396|FG000|Overall Study|Lost to Follow-up|1|||
130776491|NCT03131687|470808397|FG001|Overall Study|Lost to Follow-up|4|||
130776492|NCT03131687|470808398|FG002|Overall Study|Lost to Follow-up|0|||
130776493|NCT03131687|470808399|FG003|Overall Study|Lost to Follow-up|1|||
130974959|NCT02008890|471535477|FG002|Extension Period|Withdrawal by Subject|0|||
130776494|NCT03131687|470808400|FG004|Overall Study|Lost to Follow-up|4|||
130776495|NCT03131687|470808401|FG005|Overall Study|Lost to Follow-up|2|||
130776496|NCT03131687|470808396|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
130776497|NCT03131687|470808397|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
130776498|NCT03131687|470808398|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
130776499|NCT03131687|470808399|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
130776500|NCT03131687|470808400|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
130776501|NCT03131687|470808401|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
130776502|NCT03131687|470808396|FG000|Overall Study|Principle Investigator Decision|0|||
130776503|NCT03131687|470808397|FG001|Overall Study|Principle Investigator Decision|1|||
130776504|NCT03131687|470808398|FG002|Overall Study|Principle Investigator Decision|0|||
130776505|NCT03131687|470808399|FG003|Overall Study|Principle Investigator Decision|0|||
130776506|NCT03131687|470808400|FG004|Overall Study|Principle Investigator Decision|0|||
130776507|NCT03131687|470808401|FG005|Overall Study|Principle Investigator Decision|0|||
130776508|NCT03131687|470808396|FG000|Overall Study|Inadvertent Enrollment|0|||
130776509|NCT03131687|470808397|FG001|Overall Study|Inadvertent Enrollment|0|||
130776510|NCT03131687|470808398|FG002|Overall Study|Inadvertent Enrollment|0|||
130776511|NCT03131687|470808399|FG003|Overall Study|Inadvertent Enrollment|1|||
130776512|NCT03131687|470808400|FG004|Overall Study|Inadvertent Enrollment|0|||
130776513|NCT03131687|470808401|FG005|Overall Study|Inadvertent Enrollment|0|||
130776514|NCT00869128|470808406|FG000|Overall Study|lack of Compliance|6|||
130776515|NCT00869128|470808407|FG001|Overall Study|lack of Compliance|6|||
130776516|NCT01118663|470808413|FG000|Overall Study|Adverse Event|2|||
130776517|NCT01118663|470808414|FG001|Overall Study|Adverse Event|1|||
130776518|NCT01118663|470808413|FG000|Overall Study|Withdrawal by Subject|0|||
130776519|NCT01118663|470808414|FG001|Overall Study|Withdrawal by Subject|1|||
130776520|NCT05279131|470808415|FG000|Overall Study|Lost to Follow-up|1|||
130776521|NCT05279131|470808415|FG000|Overall Study|Death|1|||
130776522|NCT05279131|470808415|FG000|Overall Study|Physician Decision|1|||
130776523|NCT02282163|470808422|FG000|Overall Study|Protocol Violation|1|||
130776524|NCT01603407|470808423|FG000|Overall Study|Adverse Event|1|||
130776525|NCT01603407|470808424|FG001|Overall Study|Adverse Event|1|||
130776526|NCT01603407|470808425|FG002|Overall Study|Adverse Event|1|||
130776527|NCT01603407|470808423|FG000|Overall Study|Protocol Violation|2|||
130776528|NCT01603407|470808424|FG001|Overall Study|Protocol Violation|2|||
130776529|NCT01603407|470808425|FG002|Overall Study|Protocol Violation|0|||
130776530|NCT01603407|470808423|FG000|Overall Study|Withdrawal by Subject|8|||
130776531|NCT01603407|470808424|FG001|Overall Study|Withdrawal by Subject|5|||
130776532|NCT01603407|470808425|FG002|Overall Study|Withdrawal by Subject|7|||
130776533|NCT01603407|470808423|FG000|Overall Study|Lost to Follow-up|0|||
130776534|NCT01603407|470808424|FG001|Overall Study|Lost to Follow-up|3|||
130776535|NCT01603407|470808425|FG002|Overall Study|Lost to Follow-up|2|||
130974960|NCT02008890|471535478|FG003|Extension Period|Withdrawal by Subject|4|||
130974961|NCT02008890|471535479|FG004|Extension Period|Withdrawal by Subject|2|||
130974962|NCT02008890|471535475|FG000|Extension Period|Lost to Follow-up|1|||
130974963|NCT02008890|471535476|FG001|Extension Period|Lost to Follow-up|0|||
130974964|NCT02008890|471535477|FG002|Extension Period|Lost to Follow-up|0|||
130974965|NCT02008890|471535478|FG003|Extension Period|Lost to Follow-up|0|||
130974966|NCT02008890|471535479|FG004|Extension Period|Lost to Follow-up|0|||
130974967|NCT02008890|471535475|FG000|Extension Period|Adverse Event|1|||
130974968|NCT02008890|471535476|FG001|Extension Period|Adverse Event|3|||
130974969|NCT02008890|471535477|FG002|Extension Period|Adverse Event|0|||
130974970|NCT02008890|471535478|FG003|Extension Period|Adverse Event|0|||
130974971|NCT02008890|471535479|FG004|Extension Period|Adverse Event|2|||
130974972|NCT02207816|471535480|FG000|Overall Study|Serious Adverse Event|0|||
130974973|NCT02207816|471535481|FG001|Overall Study|Serious Adverse Event|5|||
130974974|NCT02207816|471535482|FG002|Overall Study|Serious Adverse Event|2|||
130974975|NCT02207816|471535480|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
130974976|NCT02207816|471535481|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
130974977|NCT02207816|471535482|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
130974978|NCT02207816|471535480|FG000|Overall Study|Withdrawal by Subject|4|||
130974979|NCT02207816|471535481|FG001|Overall Study|Withdrawal by Subject|9|||
130974980|NCT02207816|471535482|FG002|Overall Study|Withdrawal by Subject|7|||
130974981|NCT02207816|471535480|FG000|Overall Study|Migrated/Moved From Study Area|41|||
130974982|NCT02207816|471535481|FG001|Overall Study|Migrated/Moved From Study Area|60|||
130974983|NCT02207816|471535482|FG002|Overall Study|Migrated/Moved From Study Area|51|||
130974984|NCT02207816|471535480|FG000|Overall Study|Lost to Follow-up|3|||
130974985|NCT02207816|471535481|FG001|Overall Study|Lost to Follow-up|9|||
130974986|NCT02207816|471535482|FG002|Overall Study|Lost to Follow-up|1|||
130974987|NCT02207816|471535480|FG000|Overall Study|Other|1|||
130974988|NCT02207816|471535481|FG001|Overall Study|Other|2|||
130776536|NCT02500719|470808426|FG000|Overall Study|Lost to Follow-up|2|||
130776537|NCT02500719|470808427|FG001|Overall Study|Lost to Follow-up|3|||
130776538|NCT02500719|470808426|FG000|Overall Study|Trauma history|1|||
130776539|NCT02500719|470808427|FG001|Overall Study|Trauma history|0|||
130776540|NCT02500719|470808426|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
130974989|NCT02207816|471535482|FG002|Overall Study|Other|4|||
130974990|NCT05912400|471535483|FG000|Overall Study|Lost to Follow-up|1|||
130974991|NCT05912400|471535484|FG001|Overall Study|Lost to Follow-up|0|||
130974992|NCT05912400|471535483|FG000|Overall Study|Physician Decision|6|||
130974993|NCT05912400|471535484|FG001|Overall Study|Physician Decision|0|||
130974994|NCT05912400|471535483|FG000|Overall Study|Withdrawal by Subject|1|||
130974995|NCT05912400|471535484|FG001|Overall Study|Withdrawal by Subject|0|||
130974996|NCT02522494|471535487|FG000|Overall Study|Lost to Follow-up|6|||
130974997|NCT02522494|471535488|FG001|Overall Study|Lost to Follow-up|2|||
130974998|NCT02522494|471535487|FG000|Overall Study|Withdrawal by Subject|1|||
130974999|NCT02522494|471535488|FG001|Overall Study|Withdrawal by Subject|0|||
130975000|NCT02522494|471535487|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
130975001|NCT02522494|471535488|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
130975002|NCT02522494|471535487|FG000|Overall Study|Participant did not watch the video|1|||
130975003|NCT02522494|471535488|FG001|Overall Study|Participant did not watch the video|0|||
130975004|NCT02522494|471535487|FG000|Overall Study|Death|0|||
130975005|NCT02522494|471535488|FG001|Overall Study|Death|1|||
130975006|NCT02811861|471535489|FG000|Overall Study|Radiological Disease Progression|123|||
130975007|NCT02811861|471535490|FG001|Overall Study|Radiological Disease Progression|97|||
130975008|NCT02811861|471535491|FG002|Overall Study|Radiological Disease Progression|174|||
130975009|NCT02811861|471535489|FG000|Overall Study|Clinical Disease Progression|20|||
130975010|NCT02811861|471535490|FG001|Overall Study|Clinical Disease Progression|19|||
130975011|NCT02811861|471535491|FG002|Overall Study|Clinical Disease Progression|22|||
130975012|NCT02811861|471535489|FG000|Overall Study|Adverse Event|63|||
131227397|NCT00219557|472459729|FG000|Phase 1|Lack of Efficacy|3|||
130776541|NCT02500719|470808427|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
130776542|NCT02500719|470808426|FG000|Overall Study|Did not meet criteria for PTSD|0|||
130776543|NCT02500719|470808427|FG001|Overall Study|Did not meet criteria for PTSD|1|||
130776544|NCT02500719|470808426|FG000|Overall Study|Claustrophobia|0|||
130776545|NCT02500719|470808427|FG001|Overall Study|Claustrophobia|1|||
130776546|NCT02500719|470808426|FG000|Overall Study|History of head trauma|0|||
130776547|NCT02500719|470808427|FG001|Overall Study|History of head trauma|1|||
130776548|NCT01990768|470808428|FG000|Intervention Started|Found to be ineligible|14|||
130776549|NCT01990768|470808429|FG001|Intervention Started|Found to be ineligible|13|||
130776550|NCT01990768|470808430|FG002|Intervention Started|Found to be ineligible|11|||
130776551|NCT01990768|470808428|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
130776552|NCT01990768|470808429|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
130776553|NCT01990768|470808430|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
130776554|NCT01990768|470808428|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
130776555|NCT01990768|470808429|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
130776556|NCT01990768|470808430|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
130776557|NCT01990768|470808428|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
130776558|NCT01990768|470808429|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
130776559|NCT01990768|470808430|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
130776560|NCT01990768|470808428|FG000|Intervention Started|Patient care priority|1|||
130776561|NCT01990768|470808429|FG001|Intervention Started|Patient care priority|2|||
130776562|NCT01990768|470808430|FG002|Intervention Started|Patient care priority|3|||
130776563|NCT01990768|470808428|FG000|Intervention Started|IV lost|2|||
130776564|NCT01990768|470808429|FG001|Intervention Started|IV lost|2|||
130776565|NCT01990768|470808430|FG002|Intervention Started|IV lost|2|||
130776566|NCT01990768|470808428|FG000|Intervention Started|Required CPR|1|||
130776567|NCT01990768|470808429|FG001|Intervention Started|Required CPR|1|||
130776568|NCT01990768|470808430|FG002|Intervention Started|Required CPR|0|||
130776569|NCT01990768|470808428|FG000|Intervention Started|Seizure or hx of seizure|0|||
130776570|NCT01990768|470808429|FG001|Intervention Started|Seizure or hx of seizure|0|||
130776571|NCT01990768|470808430|FG002|Intervention Started|Seizure or hx of seizure|2|||
130776572|NCT01990768|470808428|FG000|Intervention Started|Discovered to be pregnant|0|||
130776573|NCT01990768|470808429|FG001|Intervention Started|Discovered to be pregnant|1|||
130776574|NCT01990768|470808430|FG002|Intervention Started|Discovered to be pregnant|0|||
130776575|NCT01990768|470808428|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
130776576|NCT01990768|470808429|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
130776577|NCT01990768|470808430|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
130776578|NCT01990768|470808428|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
130776579|NCT01990768|470808429|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
130776580|NCT01990768|470808430|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
130776581|NCT01990768|470808428|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
130975013|NCT02811861|471535490|FG001|Overall Study|Adverse Event|60|||
130975014|NCT02811861|471535491|FG002|Overall Study|Adverse Event|41|||
130975015|NCT02811861|471535489|FG000|Overall Study|Lost to Follow-up|0|||
130975016|NCT02811861|471535490|FG001|Overall Study|Lost to Follow-up|0|||
130975017|NCT02811861|471535491|FG002|Overall Study|Lost to Follow-up|1|||
130975018|NCT02811861|471535489|FG000|Overall Study|Subject Choice|29|||
130975019|NCT02811861|471535490|FG001|Overall Study|Subject Choice|17|||
130975020|NCT02811861|471535491|FG002|Overall Study|Subject Choice|23|||
130975021|NCT02811861|471535489|FG000|Overall Study|Withdrawal by Subject|4|||
130975022|NCT02811861|471535490|FG001|Overall Study|Withdrawal by Subject|4|||
130975023|NCT02811861|471535491|FG002|Overall Study|Withdrawal by Subject|9|||
130975024|NCT02811861|471535489|FG000|Overall Study|Other|4|||
130975025|NCT02811861|471535490|FG001|Overall Study|Other|13|||
130975026|NCT02811861|471535491|FG002|Overall Study|Other|3|||
130975027|NCT02811861|471535489|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
130776582|NCT01990768|470808429|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
130776583|NCT01990768|470808430|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
130776584|NCT01990768|470808428|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
130776585|NCT01990768|470808429|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
130776586|NCT01990768|470808430|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
130776587|NCT01990768|470808428|FG000|Prehospital Study Drug Infusion|Death|3|||
130776588|NCT01990768|470808429|FG001|Prehospital Study Drug Infusion|Death|1|||
130776589|NCT01990768|470808430|FG002|Prehospital Study Drug Infusion|Death|1|||
130776590|NCT01990768|470808428|FG000|Prehospital Study Drug Infusion|Discharged|2|||
130776591|NCT01990768|470808429|FG001|Prehospital Study Drug Infusion|Discharged|1|||
130776592|NCT01990768|470808430|FG002|Prehospital Study Drug Infusion|Discharged|0|||
130776593|NCT01990768|470808428|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
130776594|NCT01990768|470808429|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
130776595|NCT01990768|470808430|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
130776596|NCT01990768|470808428|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
130776597|NCT01990768|470808429|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
130776598|NCT01990768|470808430|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
130776599|NCT01990768|470808428|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
130776600|NCT01990768|470808429|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
130776601|NCT01990768|470808430|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
130776602|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
130975028|NCT02811861|471535490|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
130975029|NCT02811861|471535491|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
130975030|NCT02811861|471535489|FG000|Overall Study|Randomized but not treated|2|||
130776603|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
130776604|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
130776605|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
130776606|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
130776607|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
130776608|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
130776609|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
130776610|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
130776611|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
130776612|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
130776613|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
130776614|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
130776615|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
130776616|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
130776617|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
130776618|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
130776619|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
130776620|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
130776621|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
130776622|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
130776623|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
130776624|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
130776625|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
130776626|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
130776627|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
130776628|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
130776629|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
130776630|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
130776631|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
130776632|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
130776633|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
130776634|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
130975031|NCT02811861|471535490|FG001|Overall Study|Randomized but not treated|3|||
130975032|NCT02811861|471535491|FG002|Overall Study|Randomized but not treated|17|||
130975033|NCT00360308|471535492|FG000|Overall Study|Adverse Event|15|||
130776635|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
130776636|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
130776637|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
130776638|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
130776639|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
130776640|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
130776641|NCT01990768|470808428|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
130776642|NCT01990768|470808429|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
130776643|NCT01990768|470808430|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
130776644|NCT01990768|470808428|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
130776645|NCT01990768|470808429|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
130776646|NCT01990768|470808430|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
130776647|NCT01990768|470808428|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
130776648|NCT01990768|470808429|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
130975034|NCT00360308|471535493|FG001|Overall Study|Adverse Event|14|||
130975035|NCT00360308|471535494|FG002|Overall Study|Adverse Event|25|||
130975036|NCT00360308|471535492|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
130975037|NCT00360308|471535493|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
130975038|NCT00360308|471535494|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
130975039|NCT00360308|471535492|FG000|Overall Study|Protocol Violation|2|||
130975040|NCT00360308|471535493|FG001|Overall Study|Protocol Violation|1|||
130975041|NCT00360308|471535494|FG002|Overall Study|Protocol Violation|2|||
130975042|NCT00360308|471535492|FG000|Overall Study|Withdrawal by Subject|11|||
130975043|NCT00360308|471535493|FG001|Overall Study|Withdrawal by Subject|7|||
130975044|NCT00360308|471535494|FG002|Overall Study|Withdrawal by Subject|14|||
130975045|NCT00360308|471535492|FG000|Overall Study|Lack of Efficacy|3|||
130975046|NCT00360308|471535493|FG001|Overall Study|Lack of Efficacy|0|||
130975047|NCT00360308|471535494|FG002|Overall Study|Lack of Efficacy|2|||
130975048|NCT00360308|471535492|FG000|Overall Study|Other|2|||
130975049|NCT00360308|471535493|FG001|Overall Study|Other|1|||
130975050|NCT00360308|471535494|FG002|Overall Study|Other|1|||
130975051|NCT00360308|471535492|FG000|Overall Study|Study termination by sponsor|43|||
130975052|NCT00360308|471535493|FG001|Overall Study|Study termination by sponsor|55|||
130975053|NCT00360308|471535494|FG002|Overall Study|Study termination by sponsor|44|||
130975054|NCT03461003|471535495|FG000|Overall Study|Lost to Follow-up|2|||
131131343|NCT03245450|472108311|FG004|Overall Study|Adverse Event|1|||
131131344|NCT03245450|472108312|FG005|Overall Study|Adverse Event|0|||
131131345|NCT03245450|472108313|FG006|Overall Study|Adverse Event|2|||
131131346|NCT01784861|472108318|FG000|Overall Study|Adverse Event|0|||
131131347|NCT01784861|472108319|FG001|Overall Study|Adverse Event|0|||
131131348|NCT01784861|472108320|FG002|Overall Study|Adverse Event|1|||
131131349|NCT01784861|472108321|FG003|Overall Study|Adverse Event|2|||
131131350|NCT01784861|472108322|FG004|Overall Study|Adverse Event|1|||
131131351|NCT01784861|472108323|FG005|Overall Study|Adverse Event|0|||
131131352|NCT01784861|472108318|FG000|Overall Study|Withdrawal by Subject|0|||
131131353|NCT01784861|472108319|FG001|Overall Study|Withdrawal by Subject|0|||
131131354|NCT01784861|472108320|FG002|Overall Study|Withdrawal by Subject|0|||
131131355|NCT01784861|472108321|FG003|Overall Study|Withdrawal by Subject|1|||
131131356|NCT01784861|472108322|FG004|Overall Study|Withdrawal by Subject|0|||
131131357|NCT01784861|472108323|FG005|Overall Study|Withdrawal by Subject|0|||
131131358|NCT01784861|472108318|FG000|Overall Study|Physician Decision|0|||
131131359|NCT01784861|472108319|FG001|Overall Study|Physician Decision|0|||
131131360|NCT01784861|472108320|FG002|Overall Study|Physician Decision|0|||
131131361|NCT01784861|472108321|FG003|Overall Study|Physician Decision|2|||
131131362|NCT01784861|472108322|FG004|Overall Study|Physician Decision|0|||
131131363|NCT01784861|472108323|FG005|Overall Study|Physician Decision|1|||
131131364|NCT03948178|472108326|FG000|Overall Study|Protocol Violation|1|||
131131365|NCT03948178|472108326|FG000|Overall Study|Lost to Follow-up|2|||
131131366|NCT03948178|472108326|FG000|Overall Study|Withdrawal by Subject|2|||
131131367|NCT03948178|472108326|FG000|Overall Study|Reason not known|2|||
131131368|NCT03948178|472108326|FG000|Overall Study|Personal reason|14|||
131131369|NCT03948178|472108326|FG000|Overall Study|Disease progression|30|||
131131370|NCT03948178|472108326|FG000|Overall Study|Adverse Event|12|||
130975055|NCT03461003|471535496|FG001|Overall Study|Lost to Follow-up|2|||
130975056|NCT03461003|471535495|FG000|Overall Study|Withdrawal by Subject|3|||
130975057|NCT03461003|471535496|FG001|Overall Study|Withdrawal by Subject|1|||
131131371|NCT03948178|472108326|FG000|Overall Study|Sponsor terminated study|164|||
131131372|NCT02432235|472108327|FG000|Overall Study|Death|1|||
131131373|NCT02432235|472108328|FG001|Overall Study|Death|1|||
131131374|NCT02432235|472108329|FG002|Overall Study|Death|2|||
131131375|NCT02432235|472108330|FG003|Overall Study|Death|2|||
131131376|NCT02432235|472108331|FG004|Overall Study|Death|1|||
130975058|NCT03489304|471535497|FG000|Overall Study|Lost to Follow-up|4|||
131131377|NCT02432235|472108332|FG005|Overall Study|Death|3|||
131131378|NCT02432235|472108333|FG006|Overall Study|Death|11|||
131131379|NCT02432235|472108334|FG007|Overall Study|Death|15|||
131131380|NCT02432235|472108335|FG008|Overall Study|Death|15|||
130975059|NCT02239679|471535501|FG000|Overall Study|Lost to Follow-up|1|||
130975060|NCT02239679|471535502|FG001|Overall Study|Lost to Follow-up|0|||
130975061|NCT02239679|471535503|FG002|Overall Study|Lost to Follow-up|0|||
130975062|NCT02239679|471535501|FG000|Overall Study|Withdrawal by Subject|2|||
130975063|NCT02239679|471535502|FG001|Overall Study|Withdrawal by Subject|3|||
130975064|NCT02239679|471535503|FG002|Overall Study|Withdrawal by Subject|1|||
130975065|NCT01217073|471535504|FG000|Base Period|Adverse Event|1|||
130975066|NCT01217073|471535505|FG001|Base Period|Adverse Event|0|||
130975067|NCT01217073|471535506|FG002|Base Period|Adverse Event|1|||
130975068|NCT01217073|471535507|FG003|Base Period|Adverse Event|0|||
130975069|NCT01217073|471535508|FG004|Base Period|Adverse Event|4|||
130975070|NCT01217073|471535509|FG005|Base Period|Adverse Event|1|||
130975071|NCT01217073|471535510|FG006|Base Period|Adverse Event|0|||
130975072|NCT01217073|471535511|FG007|Base Period|Adverse Event|0|||
130776649|NCT01990768|470808430|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
130776650|NCT01990768|470808428|FG000|6-Month Follow-up|No contact information|5|||
130776651|NCT01990768|470808429|FG001|6-Month Follow-up|No contact information|6|||
130776652|NCT01990768|470808430|FG002|6-Month Follow-up|No contact information|5|||
130776653|NCT01990768|470808428|FG000|6-Month Follow-up|Homeless|4|||
130776654|NCT01990768|470808429|FG001|6-Month Follow-up|Homeless|3|||
130776655|NCT01990768|470808430|FG002|6-Month Follow-up|Homeless|6|||
130776656|NCT01990768|470808428|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
130776657|NCT01990768|470808429|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
130776658|NCT01990768|470808430|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
130776659|NCT01990768|470808428|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
130776660|NCT01990768|470808429|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
130776661|NCT01990768|470808430|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
130776662|NCT01990768|470808428|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
130776663|NCT01990768|470808429|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
130776664|NCT01990768|470808430|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
130776665|NCT03538691|470808431|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
130776666|NCT03538691|470808432|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
130776667|NCT03538691|470808433|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
130776668|NCT03538691|470808434|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
130776669|NCT03538691|470808431|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
130776670|NCT03538691|470808432|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
130776671|NCT03538691|470808433|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
130776672|NCT03538691|470808434|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
130776673|NCT03538691|470808431|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
130776674|NCT03538691|470808432|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
130776675|NCT03538691|470808433|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
130776676|NCT03538691|470808434|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
130776677|NCT03538691|470808431|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
130776678|NCT03538691|470808432|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
130776679|NCT03538691|470808433|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
130776680|NCT03538691|470808434|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
130776681|NCT03538691|470808431|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
130776682|NCT03538691|470808432|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
130776683|NCT03538691|470808433|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
130975073|NCT01217073|471535504|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
130975074|NCT01217073|471535505|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130975075|NCT01217073|471535506|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130975076|NCT01217073|471535507|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130975077|NCT01217073|471535508|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130975078|NCT01217073|471535509|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130975079|NCT01217073|471535510|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130776684|NCT03538691|470808434|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
130975080|NCT01217073|471535511|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
130975081|NCT01217073|471535504|FG000|Base Period|Excluded medication|0|||
130975082|NCT01217073|471535505|FG001|Base Period|Excluded medication|0|||
130975083|NCT01217073|471535506|FG002|Base Period|Excluded medication|0|||
130975084|NCT01217073|471535507|FG003|Base Period|Excluded medication|0|||
131131381|NCT02432235|472108336|FG009|Overall Study|Death|3|||
130975085|NCT01217073|471535508|FG004|Base Period|Excluded medication|1|||
130975086|NCT01217073|471535509|FG005|Base Period|Excluded medication|0|||
130975087|NCT01217073|471535510|FG006|Base Period|Excluded medication|0|||
130975088|NCT01217073|471535511|FG007|Base Period|Excluded medication|0|||
130776685|NCT03538691|470808431|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
130776686|NCT03538691|470808432|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
130975089|NCT01217073|471535504|FG000|Base Period|Lack of Efficacy|0|||
130975090|NCT01217073|471535505|FG001|Base Period|Lack of Efficacy|0|||
130975091|NCT01217073|471535506|FG002|Base Period|Lack of Efficacy|0|||
130975092|NCT01217073|471535507|FG003|Base Period|Lack of Efficacy|0|||
130975093|NCT01217073|471535508|FG004|Base Period|Lack of Efficacy|0|||
130975094|NCT01217073|471535509|FG005|Base Period|Lack of Efficacy|1|||
130975095|NCT01217073|471535510|FG006|Base Period|Lack of Efficacy|0|||
130975096|NCT01217073|471535511|FG007|Base Period|Lack of Efficacy|0|||
130975097|NCT01217073|471535504|FG000|Base Period|Lost to Follow-up|0|||
130975098|NCT01217073|471535505|FG001|Base Period|Lost to Follow-up|0|||
130975099|NCT01217073|471535506|FG002|Base Period|Lost to Follow-up|1|||
131227398|NCT00219557|472459730|FG001|Phase 1|Lack of Efficacy|0|||
131227399|NCT00219557|472459731|FG002|Phase 1|Lack of Efficacy|0|||
130717151|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Disease Progression|0|||
130717152|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Disease Progression|0|||
130717153|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Disease Progression|0|||
130717154|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Disease Progression|0|||
130717155|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Disease Progression|0|||
130717156|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Disease Progression|0|||
130717157|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Disease Progression|0|||
130717158|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Disease Progression|0|||
130717159|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Disease Progression|0|||
130717160|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Disease Progression|2|||
130717161|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Disease Progression|1|||
130717162|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Disease Progression|0|||
130717163|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Disease Progression|0|||
130717164|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Disease Progression|0|||
130717165|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717166|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717167|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717168|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717169|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717170|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717171|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717172|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717173|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717174|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717175|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717176|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717177|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717178|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717179|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717180|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717181|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717182|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717183|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717184|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717185|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
130717186|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
130717187|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717188|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717189|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
130717190|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717191|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717192|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717193|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717194|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717195|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717196|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717197|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717198|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717199|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717200|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717201|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130720904|NCT01341782|470601557|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
130776687|NCT03538691|470808433|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
130975100|NCT01217073|471535507|FG003|Base Period|Lost to Follow-up|1|||
130975101|NCT01217073|471535508|FG004|Base Period|Lost to Follow-up|3|||
131227400|NCT00219557|472459729|FG000|Phase 1|Adverse Event|2|||
131227401|NCT00219557|472459730|FG001|Phase 1|Adverse Event|0|||
130776688|NCT03538691|470808434|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
130776689|NCT03538691|470808431|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
130776690|NCT03538691|470808432|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
130776691|NCT03538691|470808433|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
130975102|NCT01217073|471535509|FG005|Base Period|Lost to Follow-up|0|||
130776692|NCT03538691|470808434|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
130776693|NCT03538691|470808431|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
130776694|NCT03538691|470808432|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
130776695|NCT03538691|470808433|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
130776696|NCT03538691|470808434|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
130776697|NCT03538691|470808431|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
130975103|NCT01217073|471535510|FG006|Base Period|Lost to Follow-up|0|||
130975104|NCT01217073|471535511|FG007|Base Period|Lost to Follow-up|0|||
130975105|NCT01217073|471535504|FG000|Base Period|Physician Decision|0|||
130975106|NCT01217073|471535505|FG001|Base Period|Physician Decision|0|||
130975107|NCT01217073|471535506|FG002|Base Period|Physician Decision|0|||
130975108|NCT01217073|471535507|FG003|Base Period|Physician Decision|0|||
130975109|NCT01217073|471535508|FG004|Base Period|Physician Decision|1|||
130975110|NCT01217073|471535509|FG005|Base Period|Physician Decision|0|||
130975111|NCT01217073|471535510|FG006|Base Period|Physician Decision|0|||
130975112|NCT01217073|471535511|FG007|Base Period|Physician Decision|0|||
130975113|NCT01217073|471535504|FG000|Base Period|Protocol Violation|1|||
130975114|NCT01217073|471535505|FG001|Base Period|Protocol Violation|0|||
130975115|NCT01217073|471535506|FG002|Base Period|Protocol Violation|0|||
130975116|NCT01217073|471535507|FG003|Base Period|Protocol Violation|0|||
130975117|NCT01217073|471535508|FG004|Base Period|Protocol Violation|1|||
130975118|NCT01217073|471535509|FG005|Base Period|Protocol Violation|2|||
130975119|NCT01217073|471535510|FG006|Base Period|Protocol Violation|0|||
130975120|NCT01217073|471535511|FG007|Base Period|Protocol Violation|0|||
130776698|NCT03538691|470808432|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
130776699|NCT03538691|470808433|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
130776700|NCT03538691|470808434|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
130776701|NCT03538691|470808431|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
130776702|NCT03538691|470808432|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
130776703|NCT03538691|470808433|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
130776704|NCT03538691|470808434|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
130776705|NCT03538691|470808431|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
130776706|NCT03538691|470808432|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
130776707|NCT03538691|470808433|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
130776708|NCT03538691|470808434|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
130776709|NCT03538691|470808431|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
130776710|NCT03538691|470808432|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
130776711|NCT03538691|470808433|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
130776712|NCT03538691|470808434|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
130776713|NCT03538691|470808431|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
130776714|NCT03538691|470808432|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
130776715|NCT03538691|470808433|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
130776716|NCT03538691|470808434|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
130776717|NCT03538691|470808431|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
130776718|NCT03538691|470808432|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
130776719|NCT03538691|470808433|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
130776720|NCT03538691|470808434|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
130776721|NCT03538691|470808431|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
130776722|NCT03538691|470808432|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
130776723|NCT03538691|470808433|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
130776724|NCT03538691|470808434|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
130776725|NCT03538691|470808431|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
130776726|NCT03538691|470808432|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
130776727|NCT03538691|470808433|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
130776728|NCT03538691|470808434|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
130776729|NCT03538691|470808431|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
130776730|NCT03538691|470808432|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
130975121|NCT01217073|471535504|FG000|Base Period|Withdrawal by Subject|4|||
130975122|NCT01217073|471535505|FG001|Base Period|Withdrawal by Subject|5|||
130975123|NCT01217073|471535506|FG002|Base Period|Withdrawal by Subject|5|||
131043380|NCT05184452|471793081|FG004|Overall Study|Withdrawal by Subject|0|||
131043381|NCT05184452|471793082|FG005|Overall Study|Withdrawal by Subject|1|||
130776731|NCT03538691|470808433|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
130776732|NCT03538691|470808434|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
130776733|NCT03538691|470808431|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
130776734|NCT03538691|470808432|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
130776735|NCT03538691|470808433|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
130776736|NCT03538691|470808434|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
130776737|NCT03538691|470808431|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130776738|NCT03538691|470808432|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
130975124|NCT01217073|471535507|FG003|Base Period|Withdrawal by Subject|1|||
130975125|NCT01217073|471535508|FG004|Base Period|Withdrawal by Subject|5|||
130975126|NCT01217073|471535509|FG005|Base Period|Withdrawal by Subject|5|||
130975127|NCT01217073|471535510|FG006|Base Period|Withdrawal by Subject|0|||
130975128|NCT01217073|471535511|FG007|Base Period|Withdrawal by Subject|0|||
130975129|NCT01217073|471535504|FG000|Extension Period|Adverse Event|0|||
130975130|NCT01217073|471535505|FG001|Extension Period|Adverse Event|0|||
130975131|NCT01217073|471535506|FG002|Extension Period|Adverse Event|0|||
130975132|NCT01217073|471535507|FG003|Extension Period|Adverse Event|0|||
130776739|NCT03538691|470808433|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130776740|NCT03538691|470808434|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130776741|NCT03538691|470808431|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
130776742|NCT03538691|470808432|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
130776743|NCT03538691|470808433|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
130776744|NCT03538691|470808434|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
130776745|NCT03538691|470808431|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
130776746|NCT03538691|470808432|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
130776747|NCT03538691|470808433|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
130975133|NCT01217073|471535508|FG004|Extension Period|Adverse Event|0|||
130975134|NCT01217073|471535509|FG005|Extension Period|Adverse Event|0|||
130975135|NCT01217073|471535510|FG006|Extension Period|Adverse Event|19|||
130975136|NCT01217073|471535511|FG007|Extension Period|Adverse Event|5|||
130975137|NCT01217073|471535504|FG000|Extension Period|ALT/AST|0|||
130975138|NCT01217073|471535505|FG001|Extension Period|ALT/AST|0|||
130975139|NCT01217073|471535506|FG002|Extension Period|ALT/AST|0|||
130975140|NCT01217073|471535507|FG003|Extension Period|ALT/AST|0|||
130975141|NCT01217073|471535508|FG004|Extension Period|ALT/AST|0|||
130975142|NCT01217073|471535509|FG005|Extension Period|ALT/AST|0|||
130975143|NCT01217073|471535510|FG006|Extension Period|ALT/AST|2|||
130975144|NCT01217073|471535511|FG007|Extension Period|ALT/AST|0|||
130975145|NCT01217073|471535504|FG000|Extension Period|Contraindication to study medication|0|||
130975146|NCT01217073|471535505|FG001|Extension Period|Contraindication to study medication|0|||
130975147|NCT01217073|471535506|FG002|Extension Period|Contraindication to study medication|0|||
130975148|NCT01217073|471535507|FG003|Extension Period|Contraindication to study medication|0|||
130975149|NCT01217073|471535508|FG004|Extension Period|Contraindication to study medication|0|||
130975150|NCT01217073|471535509|FG005|Extension Period|Contraindication to study medication|0|||
130975151|NCT01217073|471535510|FG006|Extension Period|Contraindication to study medication|1|||
130975152|NCT01217073|471535511|FG007|Extension Period|Contraindication to study medication|0|||
130975153|NCT01217073|471535504|FG000|Extension Period|Creatinine/eGFR|0|||
130975154|NCT01217073|471535505|FG001|Extension Period|Creatinine/eGFR|0|||
130975155|NCT01217073|471535506|FG002|Extension Period|Creatinine/eGFR|0|||
130975156|NCT01217073|471535507|FG003|Extension Period|Creatinine/eGFR|0|||
130975157|NCT01217073|471535508|FG004|Extension Period|Creatinine/eGFR|0|||
130975158|NCT01217073|471535509|FG005|Extension Period|Creatinine/eGFR|0|||
130975159|NCT01217073|471535510|FG006|Extension Period|Creatinine/eGFR|11|||
130975160|NCT01217073|471535511|FG007|Extension Period|Creatinine/eGFR|1|||
130975161|NCT01217073|471535504|FG000|Extension Period|Death|0|||
130776748|NCT03538691|470808434|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
130776749|NCT03538691|470808431|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
130776750|NCT03538691|470808432|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
130776751|NCT03538691|470808433|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
130776752|NCT03538691|470808434|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
130776753|NCT03538691|470808431|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
130975162|NCT01217073|471535505|FG001|Extension Period|Death|0|||
130975163|NCT01217073|471535506|FG002|Extension Period|Death|0|||
130975164|NCT01217073|471535507|FG003|Extension Period|Death|0|||
130975165|NCT01217073|471535508|FG004|Extension Period|Death|0|||
130975166|NCT01217073|471535509|FG005|Extension Period|Death|0|||
130975167|NCT01217073|471535510|FG006|Extension Period|Death|1|||
130975168|NCT01217073|471535511|FG007|Extension Period|Death|0|||
130975169|NCT01217073|471535504|FG000|Extension Period|Excluded medication|0|||
130975170|NCT01217073|471535505|FG001|Extension Period|Excluded medication|0|||
130975171|NCT01217073|471535506|FG002|Extension Period|Excluded medication|0|||
130975172|NCT01217073|471535507|FG003|Extension Period|Excluded medication|0|||
130776754|NCT03538691|470808432|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
130776755|NCT03538691|470808433|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
130975173|NCT01217073|471535508|FG004|Extension Period|Excluded medication|0|||
130975174|NCT01217073|471535509|FG005|Extension Period|Excluded medication|0|||
130975175|NCT01217073|471535510|FG006|Extension Period|Excluded medication|2|||
130975176|NCT01217073|471535511|FG007|Extension Period|Excluded medication|0|||
130975177|NCT01217073|471535504|FG000|Extension Period|Lack of Efficacy|0|||
130975178|NCT01217073|471535505|FG001|Extension Period|Lack of Efficacy|0|||
130975179|NCT01217073|471535506|FG002|Extension Period|Lack of Efficacy|0|||
130975180|NCT01217073|471535507|FG003|Extension Period|Lack of Efficacy|0|||
130975181|NCT01217073|471535508|FG004|Extension Period|Lack of Efficacy|0|||
130975182|NCT01217073|471535509|FG005|Extension Period|Lack of Efficacy|0|||
130975183|NCT01217073|471535510|FG006|Extension Period|Lack of Efficacy|3|||
130975184|NCT01217073|471535511|FG007|Extension Period|Lack of Efficacy|0|||
130975185|NCT01217073|471535504|FG000|Extension Period|Lost to Follow-up|0|||
130975186|NCT01217073|471535505|FG001|Extension Period|Lost to Follow-up|0|||
130975187|NCT01217073|471535506|FG002|Extension Period|Lost to Follow-up|0|||
130975188|NCT01217073|471535507|FG003|Extension Period|Lost to Follow-up|0|||
130776756|NCT03538691|470808434|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
130776757|NCT03538691|470808431|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
130776758|NCT03538691|470808432|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
130776759|NCT03538691|470808433|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
130776760|NCT03538691|470808434|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
130776761|NCT03538691|470808431|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
130776762|NCT03538691|470808432|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
130776763|NCT03538691|470808433|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
130776764|NCT03538691|470808434|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
130776765|NCT03538691|470808431|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
130776766|NCT03538691|470808432|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
130776767|NCT03538691|470808433|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
130776768|NCT03538691|470808434|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
130776769|NCT03538691|470808431|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
130975189|NCT01217073|471535508|FG004|Extension Period|Lost to Follow-up|0|||
130975190|NCT01217073|471535509|FG005|Extension Period|Lost to Follow-up|0|||
130975191|NCT01217073|471535510|FG006|Extension Period|Lost to Follow-up|9|||
130975192|NCT01217073|471535511|FG007|Extension Period|Lost to Follow-up|1|||
130975193|NCT01217073|471535504|FG000|Extension Period|Non-compliance with study drug|0|||
130975194|NCT01217073|471535505|FG001|Extension Period|Non-compliance with study drug|0|||
130975195|NCT01217073|471535506|FG002|Extension Period|Non-compliance with study drug|0|||
130975196|NCT01217073|471535507|FG003|Extension Period|Non-compliance with study drug|0|||
130975197|NCT01217073|471535508|FG004|Extension Period|Non-compliance with study drug|0|||
130975198|NCT01217073|471535509|FG005|Extension Period|Non-compliance with study drug|0|||
130975199|NCT01217073|471535510|FG006|Extension Period|Non-compliance with study drug|0|||
130975200|NCT01217073|471535511|FG007|Extension Period|Non-compliance with study drug|1|||
130975201|NCT01217073|471535504|FG000|Extension Period|Physician Decision|0|||
130975202|NCT01217073|471535505|FG001|Extension Period|Physician Decision|0|||
130975203|NCT01217073|471535506|FG002|Extension Period|Physician Decision|0|||
130975204|NCT01217073|471535507|FG003|Extension Period|Physician Decision|0|||
130975205|NCT01217073|471535508|FG004|Extension Period|Physician Decision|0|||
130975206|NCT01217073|471535509|FG005|Extension Period|Physician Decision|0|||
130975207|NCT01217073|471535510|FG006|Extension Period|Physician Decision|4|||
130975208|NCT01217073|471535511|FG007|Extension Period|Physician Decision|1|||
130975209|NCT01217073|471535504|FG000|Extension Period|Protocol Violation|0|||
130975210|NCT01217073|471535505|FG001|Extension Period|Protocol Violation|0|||
130975211|NCT01217073|471535506|FG002|Extension Period|Protocol Violation|0|||
130975212|NCT01217073|471535507|FG003|Extension Period|Protocol Violation|0|||
130975213|NCT01217073|471535508|FG004|Extension Period|Protocol Violation|0|||
130975214|NCT01217073|471535509|FG005|Extension Period|Protocol Violation|0|||
130975215|NCT01217073|471535510|FG006|Extension Period|Protocol Violation|2|||
130975216|NCT01217073|471535511|FG007|Extension Period|Protocol Violation|1|||
130975217|NCT01217073|471535504|FG000|Extension Period|Site discontinued study participation|0|||
130776770|NCT03538691|470808432|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
130776771|NCT03538691|470808433|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
130776772|NCT03538691|470808434|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
130776773|NCT03538691|470808431|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130975218|NCT01217073|471535505|FG001|Extension Period|Site discontinued study participation|0|||
130975219|NCT01217073|471535506|FG002|Extension Period|Site discontinued study participation|0|||
130975220|NCT01217073|471535507|FG003|Extension Period|Site discontinued study participation|0|||
131043382|NCT05184452|471793083|FG006|Overall Study|Withdrawal by Subject|0|||
130776774|NCT03538691|470808432|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130776775|NCT03538691|470808433|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
130776776|NCT03538691|470808434|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
130776777|NCT06597084|470808435|FG000|Overall Study|Withdrawal by Subject|4|||
130776778|NCT06597084|470808436|FG001|Overall Study|Withdrawal by Subject|9|||
130776779|NCT06597084|470808435|FG000|Overall Study|Consent was not given by the patient until V2|0|||
130776780|NCT06597084|470808436|FG001|Overall Study|Consent was not given by the patient until V2|3|||
130776781|NCT06597084|470808435|FG000|Overall Study|Physician Decision|1|||
130776782|NCT06597084|470808436|FG001|Overall Study|Physician Decision|0|||
130776783|NCT06597084|470808435|FG000|Overall Study|Adverse Event|3|||
130776784|NCT06597084|470808436|FG001|Overall Study|Adverse Event|2|||
130776785|NCT06597084|470808435|FG000|Overall Study|Death|4|||
130776786|NCT06597084|470808436|FG001|Overall Study|Death|0|||
130776787|NCT06597084|470808435|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
130776788|NCT06597084|470808436|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
130776789|NCT06597084|470808435|FG000|Overall Study|Lost to Follow-up|4|||
130776790|NCT06597084|470808436|FG001|Overall Study|Lost to Follow-up|2|||
130776791|NCT06597084|470808435|FG000|Overall Study|Other. Not specified|1|||
130776792|NCT06597084|470808436|FG001|Overall Study|Other. Not specified|0|||
130776793|NCT02029274|470808442|FG000|Overall Study|Adverse Event|1|||
130776794|NCT02029274|470808443|FG001|Overall Study|Adverse Event|0|||
130776795|NCT02029274|470808444|FG002|Overall Study|Adverse Event|2|||
130776796|NCT02029274|470808445|FG003|Overall Study|Adverse Event|2|||
130776797|NCT00391872|470810276|FG000|Overall Study|Protocol Violation|7|||
130776798|NCT00391872|470810277|FG001|Overall Study|Protocol Violation|2|||
130776799|NCT00391872|470810276|FG000|Overall Study|Withdrawal by Subject|296|||
130776800|NCT00391872|470810277|FG001|Overall Study|Withdrawal by Subject|249|||
130776801|NCT00391872|470810276|FG000|Overall Study|Reason unknown|2|||
130776802|NCT00391872|470810277|FG001|Overall Study|Reason unknown|4|||
130776803|NCT00391872|470810276|FG000|Overall Study|Lost to Follow-up|2|||
130776804|NCT00391872|470810277|FG001|Overall Study|Lost to Follow-up|0|||
130776805|NCT00905632|470810279|FG000|Overall Study|Adverse Event|0|||
130776806|NCT00905632|470810280|FG001|Overall Study|Adverse Event|0|||
130776807|NCT00905632|470810281|FG002|Overall Study|Adverse Event|0|||
130776808|NCT00905632|470810282|FG003|Overall Study|Adverse Event|0|||
130776809|NCT00905632|470810283|FG004|Overall Study|Adverse Event|0|||
130776810|NCT00905632|470810284|FG005|Overall Study|Adverse Event|1|||
130776811|NCT00905632|470810285|FG006|Overall Study|Adverse Event|4|||
130776812|NCT01307891|470810288|FG000|Overall Study|Progressive Disease|3|||
130776813|NCT01307891|470810289|FG001|Overall Study|Progressive Disease|1|||
130776814|NCT03365934|470810290|FG000|Overall Study|Adverse Event|1|||
130776815|NCT03365934|470810290|FG000|Overall Study|Withdrawal by Subject|1|||
130776816|NCT02937740|470810291|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
130776817|NCT02937740|470810292|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
130776818|NCT02937740|470810291|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
130776819|NCT02937740|470810292|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
130776820|NCT02937740|470810291|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
130776821|NCT02937740|470810292|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
130776822|NCT02937740|470810291|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
130776823|NCT02937740|470810292|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
130776824|NCT02937740|470810291|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
130776825|NCT02937740|470810292|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
130776826|NCT02937740|470810291|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
130776827|NCT02937740|470810292|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
130776828|NCT00305227|470810295|FG000|Overall Study|Lost to Follow-up|7|||
130776829|NCT00305227|470810296|FG001|Overall Study|Lost to Follow-up|6|||
130776830|NCT04085601|470810297|FG000|Overall Study|Lost to Follow-up|1|||
130776831|NCT04085601|470810298|FG001|Overall Study|Lost to Follow-up|0|||
130776832|NCT04085601|470810297|FG000|Overall Study|Death|1|||
130776833|NCT04085601|470810298|FG001|Overall Study|Death|1|||
130776834|NCT03492437|470810299|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130776835|NCT03492437|470810300|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130776836|NCT02915159|470810301|FG000|Overall Study|Participant no longer meets criteria|2|||
130776837|NCT02915159|470810302|FG001|Overall Study|Participant no longer meets criteria|0|||
130776838|NCT02915159|470810301|FG000|Overall Study|poor/non-compliance|1|||
130776839|NCT02915159|470810302|FG001|Overall Study|poor/non-compliance|0|||
130776840|NCT02915159|470810301|FG000|Overall Study|Participant withdrew consent|5|||
130776841|NCT02915159|470810302|FG001|Overall Study|Participant withdrew consent|1|||
130776842|NCT02915159|470810301|FG000|Overall Study|Request to discontinue treatment|1|||
130776843|NCT02915159|470810302|FG001|Overall Study|Request to discontinue treatment|2|||
130776844|NCT02915159|470810301|FG000|Overall Study|Adverse Event|2|||
130776845|NCT02915159|470810302|FG001|Overall Study|Adverse Event|2|||
130776846|NCT02915159|470810301|FG000|Overall Study|Lack of Efficacy|0|||
130776847|NCT02915159|470810302|FG001|Overall Study|Lack of Efficacy|3|||
130776848|NCT04534517|470810304|FG000|Overall Study|Adverse Event|1|||
130776849|NCT04534517|470810304|FG000|Overall Study|Withdrawal by Subject|1|||
130776850|NCT04534517|470810304|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130776851|NCT04534517|470810304|FG000|Overall Study|COVID-19 Related|1|||
130776852|NCT03872843|470810305|FG000|Overall Study|Lost to Follow-up|5|||
130776853|NCT03872843|470810306|FG001|Overall Study|Lost to Follow-up|7|||
130975221|NCT01217073|471535508|FG004|Extension Period|Site discontinued study participation|0|||
130975222|NCT01217073|471535509|FG005|Extension Period|Site discontinued study participation|0|||
130776854|NCT00823264|470810307|FG000|Overall Study|Protocol Violation|2|||
130776855|NCT00823264|470810308|FG001|Overall Study|Protocol Violation|0|||
130776856|NCT05133323|470810309|FG000|Overall Study|Lack of Efficacy|0|||
130776857|NCT05133323|470810310|FG001|Overall Study|Lack of Efficacy|0|||
130776858|NCT05133323|470810311|FG002|Overall Study|Lack of Efficacy|1|||
130776859|NCT05133323|470810309|FG000|Overall Study|Withdrawal by Subject|2|||
130975223|NCT01217073|471535510|FG006|Extension Period|Site discontinued study participation|7|||
130975224|NCT01217073|471535511|FG007|Extension Period|Site discontinued study participation|2|||
130975225|NCT01217073|471535504|FG000|Extension Period|Withdrawal by Subject|0|||
130975226|NCT01217073|471535505|FG001|Extension Period|Withdrawal by Subject|0|||
130975227|NCT01217073|471535506|FG002|Extension Period|Withdrawal by Subject|0|||
130975228|NCT01217073|471535507|FG003|Extension Period|Withdrawal by Subject|0|||
130975229|NCT01217073|471535508|FG004|Extension Period|Withdrawal by Subject|0|||
130975230|NCT01217073|471535509|FG005|Extension Period|Withdrawal by Subject|0|||
130975231|NCT01217073|471535510|FG006|Extension Period|Withdrawal by Subject|30|||
130975232|NCT01217073|471535511|FG007|Extension Period|Withdrawal by Subject|8|||
130975233|NCT02047045|471535512|FG000|Baseline|Withdrawal by Subject|3|||
130975234|NCT02047045|471535513|FG001|Baseline|Withdrawal by Subject|2|||
130975235|NCT02047045|471535512|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
130975236|NCT02047045|471535513|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
130975237|NCT02047045|471535512|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
130975238|NCT02047045|471535513|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
130975239|NCT02047045|471535512|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
130975240|NCT02047045|471535513|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
130975241|NCT02047045|471535512|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
130975242|NCT02047045|471535513|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
130975243|NCT02047045|471535512|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
130975244|NCT02047045|471535513|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
130975245|NCT02047045|471535512|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
130975246|NCT02047045|471535513|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
130975247|NCT02047045|471535512|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
130975248|NCT02047045|471535513|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
130975249|NCT02047045|471535512|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
130975250|NCT02047045|471535513|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
130975251|NCT00765843|471535514|FG000|Overall Study|Lost to Follow-up|1|||
130975252|NCT00765843|471535515|FG001|Overall Study|Lost to Follow-up|3|||
130975253|NCT00765843|471535516|FG002|Overall Study|Lost to Follow-up|2|||
130975254|NCT00765843|471535514|FG000|Overall Study|did not return to receive intervention|0|||
130975255|NCT00765843|471535515|FG001|Overall Study|did not return to receive intervention|1|||
130975256|NCT00765843|471535516|FG002|Overall Study|did not return to receive intervention|0|||
130975257|NCT00765843|471535514|FG000|Overall Study|Adverse Event|0|||
130975258|NCT00765843|471535515|FG001|Overall Study|Adverse Event|0|||
130975259|NCT00765843|471535516|FG002|Overall Study|Adverse Event|1|||
130975260|NCT04066114|471535517|FG000|Overall Study|Adverse Event|1|||
130975261|NCT04066114|471535518|FG001|Overall Study|Adverse Event|0|||
130975262|NCT04066114|471535519|FG002|Overall Study|Adverse Event|0|||
130975263|NCT04066114|471535517|FG000|Overall Study|Withdrawal by Subject|1|||
130975264|NCT04066114|471535518|FG001|Overall Study|Withdrawal by Subject|0|||
130975265|NCT04066114|471535519|FG002|Overall Study|Withdrawal by Subject|0|||
130975266|NCT04066114|471535517|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
130975267|NCT04066114|471535518|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
130975268|NCT04066114|471535519|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
131131382|NCT02432235|472108337|FG010|Overall Study|Death|1|||
130776860|NCT05133323|470810310|FG001|Overall Study|Withdrawal by Subject|1|||
130776861|NCT05133323|470810311|FG002|Overall Study|Withdrawal by Subject|0|||
130776862|NCT00113295|470810312|FG000|Overall Study|Adverse Event|4|||
130776863|NCT00113295|470810313|FG001|Overall Study|Adverse Event|1|||
130975269|NCT02564523|471535522|FG000|Overall Study|Withdrawal by Subject|3|||
130975270|NCT02564523|471535523|FG001|Overall Study|Withdrawal by Subject|0|||
130975271|NCT02564523|471535524|FG002|Overall Study|Withdrawal by Subject|1|||
130776864|NCT00113295|470810312|FG000|Overall Study|Unrelated Medical Illness|1|||
130776865|NCT00113295|470810313|FG001|Overall Study|Unrelated Medical Illness|0|||
130975272|NCT02564523|471535525|FG003|Overall Study|Withdrawal by Subject|0|||
130975273|NCT02564523|471535526|FG004|Overall Study|Withdrawal by Subject|1|||
130776866|NCT01714544|470810314|FG000|Overall Study|Lost to Follow-up|1|||
130975274|NCT02564523|471535527|FG005|Overall Study|Withdrawal by Subject|0|||
130776867|NCT01714544|470810314|FG000|Overall Study|Physician Decision|1|||
130776868|NCT01714544|470810314|FG000|Overall Study|Withdrawal by Subject|1|||
130975275|NCT02564523|471535528|FG006|Overall Study|Withdrawal by Subject|1|||
130975276|NCT02564523|471535529|FG007|Overall Study|Withdrawal by Subject|0|||
130975277|NCT02564523|471535530|FG008|Overall Study|Withdrawal by Subject|0|||
130975278|NCT02564523|471535531|FG009|Overall Study|Withdrawal by Subject|0|||
130975279|NCT02564523|471535532|FG010|Overall Study|Withdrawal by Subject|1|||
130975280|NCT02564523|471535533|FG011|Overall Study|Withdrawal by Subject|0|||
130975281|NCT02564523|471535534|FG012|Overall Study|Withdrawal by Subject|1|||
130717202|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717203|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717204|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130776869|NCT02824224|470810323|FG000|Overall Study|Discontinued, IUS expulsion|0|||
130776870|NCT02824224|470810324|FG001|Overall Study|Discontinued, IUS expulsion|1|||
130776871|NCT02824224|470810323|FG000|Overall Study|Did not show up for allocation visit|2|||
130776872|NCT02824224|470810324|FG001|Overall Study|Did not show up for allocation visit|0|||
130776873|NCT02465437|470810331|FG000|Overall Study|Physician Decision|0|||
130776874|NCT02465437|470810332|FG001|Overall Study|Physician Decision|0|||
130776875|NCT02465437|470810333|FG002|Overall Study|Physician Decision|1|||
130776876|NCT02465437|470810334|FG003|Overall Study|Physician Decision|0|||
130776877|NCT02465437|470810331|FG000|Overall Study|Withdrawal by Subject|1|||
130776878|NCT02465437|470810332|FG001|Overall Study|Withdrawal by Subject|0|||
130776879|NCT02465437|470810333|FG002|Overall Study|Withdrawal by Subject|0|||
130776880|NCT02465437|470810334|FG003|Overall Study|Withdrawal by Subject|1|||
130776881|NCT02465437|470810331|FG000|Overall Study|Adverse Event|0|||
130776882|NCT02465437|470810332|FG001|Overall Study|Adverse Event|1|||
130776883|NCT02465437|470810333|FG002|Overall Study|Adverse Event|0|||
130776884|NCT02465437|470810334|FG003|Overall Study|Adverse Event|0|||
130776885|NCT00003483|470810335|FG000|Overall Study|Not evaluable|1|||
130776886|NCT02609386|470810338|FG000|Overall Study|Withdrawal by Subject|6|||
130776887|NCT02609386|470810339|FG001|Overall Study|Withdrawal by Subject|1|||
130776888|NCT02609386|470810338|FG000|Overall Study|Lost to Follow-up|3|||
130776889|NCT02609386|470810339|FG001|Overall Study|Lost to Follow-up|5|||
130776890|NCT02609386|470810338|FG000|Overall Study|Death|19|||
130717205|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717206|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717207|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717208|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717209|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717210|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
130717211|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717212|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717213|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717214|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130717215|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Adverse Event|0|||
130717216|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Adverse Event|0|||
130717217|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Adverse Event|0|||
130717218|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Adverse Event|0|||
130717219|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Adverse Event|0|||
130717220|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Adverse Event|0|||
130717221|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Adverse Event|0|||
130717222|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Adverse Event|0|||
130717223|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Adverse Event|0|||
130717224|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Adverse Event|0|||
130717225|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Adverse Event|0|||
130717226|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Adverse Event|0|||
130717227|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Adverse Event|0|||
130717228|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Adverse Event|0|||
130717229|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Adverse Event|0|||
130717230|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Adverse Event|0|||
130717231|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Adverse Event|0|||
130776891|NCT02609386|470810339|FG001|Overall Study|Death|9|||
130776892|NCT02609386|470810338|FG000|Overall Study|Physician Decision|0|||
130776893|NCT02609386|470810339|FG001|Overall Study|Physician Decision|2|||
130975282|NCT02564523|471535535|FG013|Overall Study|Withdrawal by Subject|0|||
130975283|NCT02564523|471535536|FG014|Overall Study|Withdrawal by Subject|0|||
130975284|NCT02564523|471535537|FG015|Overall Study|Withdrawal by Subject|0|||
130776894|NCT00105989|470810349|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
130776895|NCT00105989|470810350|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
130776896|NCT00105989|470810349|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
130776897|NCT00105989|470810350|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
130776898|NCT00105989|470810349|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
130776899|NCT00105989|470810350|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
130776900|NCT00105989|470810349|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
130776901|NCT00105989|470810350|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
130776902|NCT00105989|470810349|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
130776903|NCT00105989|470810350|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
130776904|NCT00105989|470810349|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
130776905|NCT00105989|470810350|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
130776906|NCT00105989|470810349|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
130776907|NCT00105989|470810350|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
130776908|NCT00105989|470810349|FG000|Acute - Open Label: Week 0-10|Death|1|||
130776909|NCT00105989|470810350|FG001|Acute - Open Label: Week 0-10|Death|0|||
130776910|NCT00105989|470810349|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
130776911|NCT00105989|470810350|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
130776912|NCT00105989|470810349|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
130776913|NCT00105989|470810350|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
130776914|NCT00105989|470810349|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
130776915|NCT00105989|470810350|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
130776916|NCT00105989|470810349|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
130776917|NCT00105989|470810350|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
130776918|NCT00105989|470810349|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
130776919|NCT00105989|470810350|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
130776920|NCT00105989|470810349|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
130776921|NCT00105989|470810350|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
130776922|NCT00105989|470810349|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
130776923|NCT00105989|470810350|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
130776924|NCT00105989|470810349|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
130776925|NCT00105989|470810350|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
130776926|NCT00105989|470810349|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
130776927|NCT00105989|470810350|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
130776928|NCT00105989|470810349|FG000|Continuation - Open Label:Week 10-34|Death|0|||
130776929|NCT00105989|470810350|FG001|Continuation - Open Label:Week 10-34|Death|0|||
130776930|NCT00105989|470810349|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
130776931|NCT00105989|470810350|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
130776932|NCT00105989|470810349|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
130776933|NCT00105989|470810350|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
130776934|NCT00105989|470810349|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
130776935|NCT00105989|470810350|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
130776936|NCT00105989|470810349|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
130776937|NCT00105989|470810350|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
130776938|NCT00105989|470810349|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
130776939|NCT00105989|470810350|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
130776940|NCT00105989|470810349|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
130776941|NCT00105989|470810350|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
130776942|NCT00105989|470810349|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
130776943|NCT00105989|470810350|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
130776944|NCT00105989|470810349|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
130776945|NCT00105989|470810350|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
130776946|NCT00105989|470810349|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
130776947|NCT00105989|470810350|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
130776948|NCT00105989|470810349|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
130776949|NCT00105989|470810350|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
130776950|NCT00105989|470810349|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
130776951|NCT00105989|470810350|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
130776952|NCT00105989|470810349|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
130776953|NCT00105989|470810350|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
130776954|NCT03442088|470810351|FG000|Overall Study|Adverse Event|1|||
131227402|NCT00219557|472459731|FG002|Phase 1|Adverse Event|0|||
131227403|NCT00219557|472459729|FG000|Phase 1|Withdrawal by Subject|1|||
131227404|NCT00219557|472459730|FG001|Phase 1|Withdrawal by Subject|0|||
130776955|NCT03442088|470810351|FG000|Overall Study|Lack of Efficacy|2|||
130776956|NCT03442088|470810351|FG000|Overall Study|Lost to Follow-up|2|||
130776957|NCT01001520|470810352|FG000|Medication Period 1|Withdrawal by Subject|2|||
131227405|NCT00219557|472459731|FG002|Phase 1|Withdrawal by Subject|0|||
130776958|NCT01001520|470810353|FG001|Medication Period 1|Withdrawal by Subject|2|||
130776959|NCT01001520|470810352|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
130776960|NCT01001520|470810353|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
130776961|NCT01001520|470810352|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
130776962|NCT01001520|470810353|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
130776963|NCT01001520|470810352|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
130776964|NCT01001520|470810353|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
130776965|NCT01001520|470810352|FG000|Washout Period|Withdrawal by Subject|2|||
130776966|NCT01001520|470810353|FG001|Washout Period|Withdrawal by Subject|1|||
130776967|NCT01001520|470810352|FG000|Medication Period 2|Withdrawal by Subject|0|||
130776968|NCT01001520|470810353|FG001|Medication Period 2|Withdrawal by Subject|3|||
130776969|NCT01869777|470810365|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
130776970|NCT00878800|470810376|FG000|Overall Study|Adverse Event|0|||
130776971|NCT00878800|470810377|FG001|Overall Study|Adverse Event|0|||
130717232|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Adverse Event|0|||
130717233|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Adverse Event|0|||
130717234|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Adverse Event|0|||
130717235|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Adverse Event|0|||
130717236|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Adverse Event|0|||
130717237|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Adverse Event|0|||
130717238|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Adverse Event|1|||
130717239|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Adverse Event|0|||
130717240|NCT02393248|470590961|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717241|NCT02393248|470590962|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717242|NCT02393248|470590963|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717243|NCT02393248|470590964|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717244|NCT02393248|470590965|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717245|NCT02393248|470590966|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717246|NCT02393248|470590967|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717247|NCT02393248|470590968|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717248|NCT02393248|470590969|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717249|NCT02393248|470590970|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717250|NCT02393248|470590971|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717251|NCT02393248|470590972|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717252|NCT02393248|470590973|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717253|NCT02393248|470590974|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717254|NCT02393248|470590975|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717255|NCT02393248|470590976|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717256|NCT02393248|470590977|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717257|NCT02393248|470590978|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717258|NCT02393248|470590979|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717259|NCT02393248|470590980|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717260|NCT02393248|470590981|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717261|NCT02393248|470590982|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717262|NCT02393248|470590983|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717263|NCT02393248|470590984|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
130717264|NCT02393248|470590985|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130717265|NCT01006135|470590986|FG000|Overall Study|Adverse Event|22|||
130717266|NCT01006135|470590986|FG000|Overall Study|Protocol Violation|14|||
130717267|NCT01006135|470590986|FG000|Overall Study|Lost to Follow-up|32|||
130717268|NCT01006135|470590986|FG000|Overall Study|Other|72|||
130717269|NCT00117325|470590987|FG000|Overall Study|Adverse Event|3|||
130717270|NCT00117325|470590988|FG001|Overall Study|Adverse Event|3|||
130717271|NCT00117325|470590987|FG000|Overall Study|Lost to Follow-up|1|||
130717272|NCT00117325|470590988|FG001|Overall Study|Lost to Follow-up|1|||
130717273|NCT00117325|470590987|FG000|Overall Study|Protocol Violation|2|||
130717274|NCT00117325|470590988|FG001|Overall Study|Protocol Violation|3|||
130776972|NCT00878800|470810378|FG002|Overall Study|Adverse Event|2|||
130776973|NCT00878800|470810379|FG003|Overall Study|Adverse Event|0|||
130776974|NCT00878800|470810380|FG004|Overall Study|Adverse Event|1|||
130776975|NCT00878800|470810376|FG000|Overall Study|Progressive disease|1|||
130975285|NCT02564523|471535538|FG016|Overall Study|Withdrawal by Subject|0|||
130975286|NCT02564523|471535539|FG017|Overall Study|Withdrawal by Subject|0|||
130717275|NCT00117325|470590987|FG000|Overall Study|Withdrawal by Subject|3|||
130717276|NCT00117325|470590988|FG001|Overall Study|Withdrawal by Subject|2|||
130717277|NCT00117325|470590987|FG000|Overall Study|Lack of Efficacy|1|||
130776976|NCT00878800|470810377|FG001|Overall Study|Progressive disease|5|||
130975287|NCT02564523|471535522|FG000|Overall Study|Adverse Event|0|||
131227406|NCT00219557|472459729|FG000|Phase 1|Started chemotherapy at other institute|1|||
131227407|NCT00219557|472459730|FG001|Phase 1|Started chemotherapy at other institute|0|||
131227408|NCT00219557|472459731|FG002|Phase 1|Started chemotherapy at other institute|0|||
131227409|NCT00219557|472459729|FG000|Phase 2|Lack of Efficacy|0|||
131227410|NCT00219557|472459730|FG001|Phase 2|Lack of Efficacy|21|||
131227411|NCT00219557|472459731|FG002|Phase 2|Lack of Efficacy|15|||
131227412|NCT00219557|472459729|FG000|Phase 2|Adverse Event|0|||
131227413|NCT00219557|472459730|FG001|Phase 2|Adverse Event|22|||
131227414|NCT00219557|472459731|FG002|Phase 2|Adverse Event|2|||
131227415|NCT00219557|472459729|FG000|Phase 2|Death|0|||
131227416|NCT00219557|472459730|FG001|Phase 2|Death|8|||
131227417|NCT00219557|472459731|FG002|Phase 2|Death|2|||
131227418|NCT00219557|472459729|FG000|Phase 2|Other|0|||
131227419|NCT00219557|472459730|FG001|Phase 2|Other|8|||
131227420|NCT00219557|472459731|FG002|Phase 2|Other|6|||
131227421|NCT00219557|472459729|FG000|Phase 2|Withdrawal by Subject|0|||
131227422|NCT00219557|472459730|FG001|Phase 2|Withdrawal by Subject|9|||
131227423|NCT00219557|472459731|FG002|Phase 2|Withdrawal by Subject|5|||
131227424|NCT00219557|472459729|FG000|Phase 2|Treatment not received|0|||
131227425|NCT00219557|472459730|FG001|Phase 2|Treatment not received|1|||
131227426|NCT00219557|472459731|FG002|Phase 2|Treatment not received|3|||
131227427|NCT00863057|472459734|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
131227428|NCT00863057|472459735|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
131227429|NCT00863057|472459736|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
131227430|NCT00863057|472459737|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
131227431|NCT00863057|472459734|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
131227432|NCT00863057|472459735|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
131227433|NCT00863057|472459736|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
131227434|NCT00863057|472459737|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
131227435|NCT00863057|472459734|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
131227436|NCT00863057|472459735|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
131227437|NCT00863057|472459736|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
131227438|NCT00863057|472459737|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
131227439|NCT00863057|472459734|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
131227440|NCT00863057|472459735|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
131227441|NCT00863057|472459736|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
131227442|NCT00863057|472459737|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
131227443|NCT02741271|472459744|FG000|Overall Study|Lost to Follow-up|2|||
131227444|NCT02741271|472459745|FG001|Overall Study|Lost to Follow-up|0|||
131227445|NCT02741271|472459744|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131227446|NCT02741271|472459745|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
131227447|NCT03652961|472459746|FG000|Overall Study|Lost to Follow-up|3|||
130717278|NCT00117325|470590988|FG001|Overall Study|Lack of Efficacy|0|||
130717279|NCT00117325|470590987|FG000|Overall Study|Use of prohibited medicine|1|||
130717280|NCT00117325|470590988|FG001|Overall Study|Use of prohibited medicine|2|||
130717281|NCT00117325|470590987|FG000|Overall Study|Early termination|1|||
130717282|NCT00117325|470590988|FG001|Overall Study|Early termination|1|||
130717283|NCT00117325|470590987|FG000|Overall Study|Admisnitrative|1|||
130717284|NCT00117325|470590988|FG001|Overall Study|Admisnitrative|0|||
130717285|NCT00338455|470590996|FG000|Overall Study|Death|2|||
130717286|NCT00338455|470590997|FG001|Overall Study|Death|1|||
130717287|NCT00338455|470590996|FG000|Overall Study|Physician Decision|1|||
130717288|NCT00338455|470590997|FG001|Overall Study|Physician Decision|0|||
130717289|NCT05084963|470591002|FG000|Overall Study|Withdrawal by Subject|0|||
130717290|NCT05084963|470591003|FG001|Overall Study|Withdrawal by Subject|0|||
130717291|NCT05084963|470591004|FG002|Overall Study|Withdrawal by Subject|1|||
130717292|NCT05442866|470591005|FG000|Overall Study|Death|1|||
130717293|NCT05442866|470591005|FG000|Overall Study|Lost to Follow-up|9|||
130717294|NCT05442866|470591005|FG000|Overall Study|Protocol Violation|1|||
130717295|NCT03819049|470591006|FG000|Overall Study|Lost to Follow-up|1|||
130717296|NCT03819049|470591007|FG001|Overall Study|Lost to Follow-up|2|||
130717297|NCT03819049|470591008|FG002|Overall Study|Lost to Follow-up|9|||
130717298|NCT03819049|470591009|FG003|Overall Study|Lost to Follow-up|0|||
130717299|NCT03819049|470591010|FG004|Overall Study|Lost to Follow-up|3|||
130717300|NCT03819049|470591011|FG005|Overall Study|Lost to Follow-up|1|||
130717301|NCT03819049|470591012|FG006|Overall Study|Lost to Follow-up|0|||
130717302|NCT03819049|470591006|FG000|Overall Study|Withdrawal by Subject|0|||
131227448|NCT03652961|472459746|FG000|Overall Study|Screen Failure|1|||
130717303|NCT03819049|470591007|FG001|Overall Study|Withdrawal by Subject|0|||
130717304|NCT03819049|470591008|FG002|Overall Study|Withdrawal by Subject|18|||
130717305|NCT03819049|470591009|FG003|Overall Study|Withdrawal by Subject|0|||
130717306|NCT03819049|470591010|FG004|Overall Study|Withdrawal by Subject|10|||
131227449|NCT01612156|472459747|FG000|Overall Study|Protocol Violation|2|||
131227450|NCT01612156|472459748|FG001|Overall Study|Protocol Violation|0|||
131227451|NCT00410410|472459749|FG000|Induction Period (IP)|Death|1|||
131227452|NCT00410410|472459750|FG001|Induction Period (IP)|Death|0|||
131227453|NCT00410410|472459751|FG002|Induction Period (IP)|Death|0|||
131227454|NCT00410410|472459752|FG003|Induction Period (IP)|Death|0|||
131227455|NCT00410410|472459753|FG004|Induction Period (IP)|Death|0|||
130975288|NCT02564523|471535523|FG001|Overall Study|Adverse Event|0|||
130975289|NCT02564523|471535524|FG002|Overall Study|Adverse Event|0|||
130975290|NCT02564523|471535525|FG003|Overall Study|Adverse Event|0|||
130975291|NCT02564523|471535526|FG004|Overall Study|Adverse Event|0|||
130975292|NCT02564523|471535527|FG005|Overall Study|Adverse Event|0|||
130975293|NCT02564523|471535528|FG006|Overall Study|Adverse Event|0|||
130975294|NCT02564523|471535529|FG007|Overall Study|Adverse Event|0|||
130975295|NCT02564523|471535530|FG008|Overall Study|Adverse Event|0|||
130975296|NCT02564523|471535531|FG009|Overall Study|Adverse Event|0|||
130975297|NCT02564523|471535532|FG010|Overall Study|Adverse Event|0|||
130975298|NCT02564523|471535533|FG011|Overall Study|Adverse Event|0|||
130975299|NCT02564523|471535534|FG012|Overall Study|Adverse Event|0|||
130975300|NCT02564523|471535535|FG013|Overall Study|Adverse Event|0|||
130975301|NCT02564523|471535536|FG014|Overall Study|Adverse Event|0|||
130975302|NCT02564523|471535537|FG015|Overall Study|Adverse Event|0|||
130975303|NCT02564523|471535538|FG016|Overall Study|Adverse Event|0|||
130975304|NCT02564523|471535539|FG017|Overall Study|Adverse Event|1|||
130975305|NCT02564523|471535522|FG000|Overall Study|Death|0|||
130975306|NCT02564523|471535523|FG001|Overall Study|Death|0|||
130975307|NCT02564523|471535524|FG002|Overall Study|Death|0|||
130975308|NCT02564523|471535525|FG003|Overall Study|Death|0|||
130975309|NCT02564523|471535526|FG004|Overall Study|Death|0|||
130975310|NCT02564523|471535527|FG005|Overall Study|Death|0|||
130975311|NCT02564523|471535528|FG006|Overall Study|Death|1|||
130975312|NCT02564523|471535529|FG007|Overall Study|Death|0|||
130975313|NCT02564523|471535530|FG008|Overall Study|Death|0|||
130975314|NCT02564523|471535531|FG009|Overall Study|Death|0|||
130975315|NCT02564523|471535532|FG010|Overall Study|Death|1|||
130975316|NCT02564523|471535533|FG011|Overall Study|Death|0|||
130975317|NCT02564523|471535534|FG012|Overall Study|Death|0|||
130975318|NCT02564523|471535535|FG013|Overall Study|Death|0|||
130975319|NCT02564523|471535536|FG014|Overall Study|Death|0|||
130975320|NCT02564523|471535537|FG015|Overall Study|Death|0|||
130975321|NCT02564523|471535538|FG016|Overall Study|Death|0|||
130975322|NCT02564523|471535539|FG017|Overall Study|Death|0|||
130975323|NCT02564523|471535522|FG000|Overall Study|Lost to Follow-up|2|||
130975324|NCT02564523|471535523|FG001|Overall Study|Lost to Follow-up|1|||
130975325|NCT02564523|471535524|FG002|Overall Study|Lost to Follow-up|4|||
130975326|NCT02564523|471535525|FG003|Overall Study|Lost to Follow-up|0|||
130975327|NCT02564523|471535526|FG004|Overall Study|Lost to Follow-up|1|||
130975328|NCT02564523|471535527|FG005|Overall Study|Lost to Follow-up|0|||
130975329|NCT02564523|471535528|FG006|Overall Study|Lost to Follow-up|1|||
130975330|NCT02564523|471535529|FG007|Overall Study|Lost to Follow-up|0|||
130975331|NCT02564523|471535530|FG008|Overall Study|Lost to Follow-up|0|||
130975332|NCT02564523|471535531|FG009|Overall Study|Lost to Follow-up|0|||
130975333|NCT02564523|471535532|FG010|Overall Study|Lost to Follow-up|0|||
130975334|NCT02564523|471535533|FG011|Overall Study|Lost to Follow-up|1|||
130975335|NCT02564523|471535534|FG012|Overall Study|Lost to Follow-up|1|||
130975336|NCT02564523|471535535|FG013|Overall Study|Lost to Follow-up|0|||
130975337|NCT02564523|471535536|FG014|Overall Study|Lost to Follow-up|0|||
130975338|NCT02564523|471535537|FG015|Overall Study|Lost to Follow-up|0|||
131227456|NCT00410410|472459754|FG005|Induction Period (IP)|Death|0|||
131227457|NCT00410410|472459755|FG006|Induction Period (IP)|Death|0|||
131227458|NCT00410410|472459756|FG007|Induction Period (IP)|Death|0|||
130975339|NCT02564523|471535538|FG016|Overall Study|Lost to Follow-up|0|||
130975340|NCT02564523|471535539|FG017|Overall Study|Lost to Follow-up|0|||
130975341|NCT02564523|471535522|FG000|Overall Study|Physician Decision|0|||
131227459|NCT00410410|472459757|FG008|Induction Period (IP)|Death|0|||
130717307|NCT03819049|470591011|FG005|Overall Study|Withdrawal by Subject|9|||
130717308|NCT03819049|470591012|FG006|Overall Study|Withdrawal by Subject|1|||
130717309|NCT03819049|470591006|FG000|Overall Study|Ongoing|0|||
130717310|NCT03819049|470591007|FG001|Overall Study|Ongoing|0|||
130717311|NCT03819049|470591008|FG002|Overall Study|Ongoing|75|||
130717312|NCT03819049|470591009|FG003|Overall Study|Ongoing|0|||
130717313|NCT03819049|470591010|FG004|Overall Study|Ongoing|41|||
130717314|NCT03819049|470591011|FG005|Overall Study|Ongoing|0|||
130717315|NCT03819049|470591012|FG006|Overall Study|Ongoing|0|||
130717316|NCT03819049|470591006|FG000|Overall Study|Other|0|||
130717317|NCT03819049|470591007|FG001|Overall Study|Other|0|||
130717318|NCT03819049|470591008|FG002|Overall Study|Other|2|||
130717319|NCT03819049|470591009|FG003|Overall Study|Other|0|||
130717320|NCT03819049|470591010|FG004|Overall Study|Other|0|||
130717321|NCT03819049|470591011|FG005|Overall Study|Other|0|||
130975342|NCT02564523|471535523|FG001|Overall Study|Physician Decision|0|||
130975343|NCT02564523|471535524|FG002|Overall Study|Physician Decision|0|||
130975344|NCT02564523|471535525|FG003|Overall Study|Physician Decision|0|||
130975345|NCT02564523|471535526|FG004|Overall Study|Physician Decision|1|||
130975346|NCT02564523|471535527|FG005|Overall Study|Physician Decision|0|||
130975347|NCT02564523|471535528|FG006|Overall Study|Physician Decision|0|||
130975348|NCT02564523|471535529|FG007|Overall Study|Physician Decision|0|||
130975349|NCT02564523|471535530|FG008|Overall Study|Physician Decision|0|||
130975350|NCT02564523|471535531|FG009|Overall Study|Physician Decision|0|||
130975351|NCT02564523|471535532|FG010|Overall Study|Physician Decision|1|||
131227460|NCT00410410|472459749|FG000|Induction Period (IP)|Adverse Event|3|||
131227461|NCT00410410|472459750|FG001|Induction Period (IP)|Adverse Event|4|||
131227462|NCT00410410|472459751|FG002|Induction Period (IP)|Adverse Event|2|||
131227463|NCT00410410|472459752|FG003|Induction Period (IP)|Adverse Event|4|||
131227464|NCT00410410|472459753|FG004|Induction Period (IP)|Adverse Event|1|||
130975352|NCT02564523|471535533|FG011|Overall Study|Physician Decision|0|||
130975353|NCT02564523|471535534|FG012|Overall Study|Physician Decision|0|||
130975354|NCT02564523|471535535|FG013|Overall Study|Physician Decision|0|||
130975355|NCT02564523|471535536|FG014|Overall Study|Physician Decision|0|||
130975356|NCT02564523|471535537|FG015|Overall Study|Physician Decision|0|||
130975357|NCT02564523|471535538|FG016|Overall Study|Physician Decision|0|||
130975358|NCT02564523|471535539|FG017|Overall Study|Physician Decision|0|||
130975359|NCT02564523|471535522|FG000|Overall Study|Protocol Violation|2|||
130975360|NCT02564523|471535523|FG001|Overall Study|Protocol Violation|2|||
130975361|NCT02564523|471535524|FG002|Overall Study|Protocol Violation|5|||
130975362|NCT02564523|471535525|FG003|Overall Study|Protocol Violation|0|||
130975363|NCT02564523|471535526|FG004|Overall Study|Protocol Violation|1|||
130975364|NCT02564523|471535527|FG005|Overall Study|Protocol Violation|0|||
130975365|NCT02564523|471535528|FG006|Overall Study|Protocol Violation|0|||
130975366|NCT02564523|471535529|FG007|Overall Study|Protocol Violation|0|||
131227465|NCT00410410|472459754|FG005|Induction Period (IP)|Adverse Event|0|||
131227466|NCT00410410|472459755|FG006|Induction Period (IP)|Adverse Event|0|||
131227467|NCT00410410|472459756|FG007|Induction Period (IP)|Adverse Event|0|||
131227468|NCT00410410|472459757|FG008|Induction Period (IP)|Adverse Event|0|||
131227469|NCT00410410|472459749|FG000|Induction Period (IP)|Lack of Efficacy|26|||
131227470|NCT00410410|472459750|FG001|Induction Period (IP)|Lack of Efficacy|24|||
131227471|NCT00410410|472459751|FG002|Induction Period (IP)|Lack of Efficacy|8|||
131227472|NCT00410410|472459752|FG003|Induction Period (IP)|Lack of Efficacy|8|||
131227473|NCT00410410|472459753|FG004|Induction Period (IP)|Lack of Efficacy|7|||
131227474|NCT00410410|472459754|FG005|Induction Period (IP)|Lack of Efficacy|7|||
131227475|NCT00410410|472459755|FG006|Induction Period (IP)|Lack of Efficacy|0|||
131227476|NCT00410410|472459756|FG007|Induction Period (IP)|Lack of Efficacy|0|||
131227477|NCT00410410|472459757|FG008|Induction Period (IP)|Lack of Efficacy|0|||
131227478|NCT00410410|472459749|FG000|Induction Period (IP)|Lost to Follow-up|2|||
131227479|NCT00410410|472459750|FG001|Induction Period (IP)|Lost to Follow-up|2|||
131227480|NCT00410410|472459751|FG002|Induction Period (IP)|Lost to Follow-up|2|||
131227481|NCT00410410|472459752|FG003|Induction Period (IP)|Lost to Follow-up|3|||
131227482|NCT00410410|472459753|FG004|Induction Period (IP)|Lost to Follow-up|0|||
131227483|NCT00410410|472459754|FG005|Induction Period (IP)|Lost to Follow-up|1|||
131227484|NCT00410410|472459755|FG006|Induction Period (IP)|Lost to Follow-up|0|||
131227485|NCT00410410|472459756|FG007|Induction Period (IP)|Lost to Follow-up|0|||
131227486|NCT00410410|472459757|FG008|Induction Period (IP)|Lost to Follow-up|0|||
131227487|NCT00410410|472459749|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
131227488|NCT00410410|472459750|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
131227489|NCT00410410|472459751|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
131227490|NCT00410410|472459752|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
131227491|NCT00410410|472459753|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
131227492|NCT00410410|472459754|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
131227493|NCT00410410|472459755|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
131227494|NCT00410410|472459756|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
131227495|NCT00410410|472459757|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
130717322|NCT03819049|470591012|FG006|Overall Study|Other|0|||
130717323|NCT03819049|470591006|FG000|Overall Study|Randomized but not vaccinated|0|||
130717324|NCT03819049|470591007|FG001|Overall Study|Randomized but not vaccinated|0|||
130717325|NCT03819049|470591008|FG002|Overall Study|Randomized but not vaccinated|0|||
130717326|NCT03819049|470591009|FG003|Overall Study|Randomized but not vaccinated|1|||
130717327|NCT03819049|470591010|FG004|Overall Study|Randomized but not vaccinated|0|||
130717328|NCT03819049|470591011|FG005|Overall Study|Randomized but not vaccinated|2|||
130717329|NCT03819049|470591012|FG006|Overall Study|Randomized but not vaccinated|1|||
130717330|NCT03819049|470591006|FG000|Overall Study|Physician Decision|0|||
130717331|NCT03819049|470591007|FG001|Overall Study|Physician Decision|0|||
130717332|NCT03819049|470591008|FG002|Overall Study|Physician Decision|0|||
130717333|NCT03819049|470591009|FG003|Overall Study|Physician Decision|0|||
130717334|NCT03819049|470591010|FG004|Overall Study|Physician Decision|0|||
130717335|NCT03819049|470591011|FG005|Overall Study|Physician Decision|0|||
130717336|NCT03819049|470591012|FG006|Overall Study|Physician Decision|1|||
130717337|NCT01568320|470591013|FG000|Overall Study|Death|20|||
130975367|NCT02564523|471535530|FG008|Overall Study|Protocol Violation|0|||
130975368|NCT02564523|471535531|FG009|Overall Study|Protocol Violation|0|||
130975369|NCT02564523|471535532|FG010|Overall Study|Protocol Violation|0|||
130975370|NCT02564523|471535533|FG011|Overall Study|Protocol Violation|0|||
131227496|NCT00410410|472459749|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131227497|NCT00410410|472459750|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131227498|NCT00410410|472459751|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
131227499|NCT00410410|472459752|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130975371|NCT02564523|471535534|FG012|Overall Study|Protocol Violation|0|||
130975372|NCT02564523|471535535|FG013|Overall Study|Protocol Violation|0|||
130975373|NCT02564523|471535536|FG014|Overall Study|Protocol Violation|0|||
130975374|NCT02564523|471535537|FG015|Overall Study|Protocol Violation|0|||
130975375|NCT02564523|471535538|FG016|Overall Study|Protocol Violation|0|||
130975376|NCT02564523|471535539|FG017|Overall Study|Protocol Violation|0|||
130975377|NCT02564523|471535522|FG000|Overall Study|Other|3|||
130975378|NCT02564523|471535523|FG001|Overall Study|Other|0|||
130975379|NCT02564523|471535524|FG002|Overall Study|Other|0|||
130975380|NCT02564523|471535525|FG003|Overall Study|Other|1|||
130975381|NCT02564523|471535526|FG004|Overall Study|Other|0|||
130975382|NCT02564523|471535527|FG005|Overall Study|Other|0|||
130975383|NCT02564523|471535528|FG006|Overall Study|Other|0|||
130975384|NCT02564523|471535529|FG007|Overall Study|Other|0|||
130975385|NCT02564523|471535530|FG008|Overall Study|Other|0|||
130975386|NCT02564523|471535531|FG009|Overall Study|Other|0|||
130975387|NCT02564523|471535532|FG010|Overall Study|Other|0|||
130975388|NCT02564523|471535533|FG011|Overall Study|Other|0|||
130975389|NCT02564523|471535534|FG012|Overall Study|Other|0|||
130975390|NCT02564523|471535535|FG013|Overall Study|Other|0|||
130975391|NCT02564523|471535536|FG014|Overall Study|Other|0|||
130975392|NCT02564523|471535537|FG015|Overall Study|Other|0|||
130975393|NCT02564523|471535538|FG016|Overall Study|Other|0|||
130975394|NCT02564523|471535539|FG017|Overall Study|Other|0|||
130975395|NCT04862143|471535554|FG000|Overall Study|Adverse Event|1|||
130975396|NCT04862143|471535554|FG000|Overall Study|Study terminated by sponsor|1|||
130975397|NCT02277106|471535555|FG000|Stage 2|Adverse Event|0|||
130975398|NCT02277106|471535556|FG001|Stage 2|Adverse Event|0|||
130975399|NCT02277106|471535557|FG002|Stage 2|Adverse Event|1|||
130975400|NCT01064739|471535558|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
130975401|NCT03031938|471535559|FG000|Overall Study|Death|1|||
130975402|NCT03031938|471535560|FG001|Overall Study|Death|0|||
130975403|NCT02479412|471535565|FG000|Overall Study|Adverse Event|0|||
130975404|NCT02479412|471535566|FG001|Overall Study|Adverse Event|0|||
130975405|NCT02479412|471535567|FG002|Overall Study|Adverse Event|1|||
130975406|NCT02479412|471535568|FG003|Overall Study|Adverse Event|0|||
130975407|NCT02479412|471535569|FG004|Overall Study|Adverse Event|0|||
130975408|NCT02479412|471535570|FG005|Overall Study|Adverse Event|0|||
130975409|NCT02479412|471535571|FG006|Overall Study|Adverse Event|0|||
130975410|NCT02479412|471535572|FG007|Overall Study|Adverse Event|0|||
130975411|NCT02479412|471535573|FG008|Overall Study|Adverse Event|0|||
130975412|NCT02479412|471535565|FG000|Overall Study|Study-specific withdrawal criteria|0|||
130975413|NCT02479412|471535566|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130975414|NCT02479412|471535567|FG002|Overall Study|Study-specific withdrawal criteria|1|||
130975415|NCT02479412|471535568|FG003|Overall Study|Study-specific withdrawal criteria|1|||
130975416|NCT02479412|471535569|FG004|Overall Study|Study-specific withdrawal criteria|0|||
130975417|NCT02479412|471535570|FG005|Overall Study|Study-specific withdrawal criteria|0|||
130975418|NCT02479412|471535571|FG006|Overall Study|Study-specific withdrawal criteria|0|||
130975419|NCT02479412|471535572|FG007|Overall Study|Study-specific withdrawal criteria|1|||
130975420|NCT02479412|471535573|FG008|Overall Study|Study-specific withdrawal criteria|1|||
130975421|NCT02479412|471535565|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
130975422|NCT02479412|471535566|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
130975423|NCT02479412|471535567|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
130975424|NCT02479412|471535568|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
130975425|NCT02479412|471535569|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
130975426|NCT02479412|471535570|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
130975427|NCT02479412|471535571|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
130975428|NCT02479412|471535572|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
130975429|NCT02479412|471535573|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
130975430|NCT00454051|471535574|FG000|Overall Study|Adverse Event|1|||
130975431|NCT00454051|471535575|FG001|Overall Study|Adverse Event|2|||
130975432|NCT00454051|471535574|FG000|Overall Study|Withdrawal by Subject|1|||
130975433|NCT00454051|471535575|FG001|Overall Study|Withdrawal by Subject|0|||
130975434|NCT00454051|471535574|FG000|Overall Study|Protocol Violation|1|||
130975435|NCT00454051|471535575|FG001|Overall Study|Protocol Violation|1|||
130975436|NCT01571362|471535576|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
130975437|NCT01571362|471535577|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
130975438|NCT01571362|471535578|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
130975439|NCT01571362|471535576|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
130975440|NCT01571362|471535577|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
130975441|NCT01571362|471535578|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
130975442|NCT01571362|471535576|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
130975443|NCT01571362|471535577|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
130975444|NCT01571362|471535578|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
130975445|NCT01571362|471535576|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
130975446|NCT01571362|471535577|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
130975447|NCT01571362|471535578|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
130975448|NCT01571362|471535576|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
130975449|NCT01571362|471535577|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
130975450|NCT01571362|471535578|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
130975451|NCT01571362|471535576|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
130975452|NCT01571362|471535577|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
130975453|NCT01571362|471535578|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
130975454|NCT01571362|471535576|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130975455|NCT01571362|471535577|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
130975456|NCT01571362|471535578|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
130975457|NCT01571362|471535576|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130975458|NCT01571362|471535577|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
130975459|NCT01571362|471535578|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
130975460|NCT01571362|471535576|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130975461|NCT01571362|471535577|FG001|Double-Blind Treatment Period|Adverse Event|9|||
130975462|NCT01571362|471535578|FG002|Double-Blind Treatment Period|Adverse Event|14|||
130975463|NCT01571362|471535576|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130975464|NCT01571362|471535577|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
130975465|NCT01571362|471535578|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
130975466|NCT01571362|471535576|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
130975467|NCT01571362|471535577|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
130975468|NCT01571362|471535578|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
130975469|NCT01571362|471535576|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
130975470|NCT01571362|471535577|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
130975471|NCT01571362|471535578|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
130975472|NCT03117738|471535579|FG000|Overall Study|Withdrawal by Subject|3|||
130975473|NCT03117738|471535580|FG001|Overall Study|Withdrawal by Subject|1|||
130975474|NCT03117738|471535579|FG000|Overall Study|Lost to Follow-up|1|||
130975475|NCT03117738|471535580|FG001|Overall Study|Lost to Follow-up|4|||
130975476|NCT01669629|471535582|FG000|Period 1|protocol deviation|1|||
130975477|NCT01669629|471535583|FG001|Period 1|protocol deviation|2|||
130975478|NCT01221597|471535584|FG000|Overall Study|Adverse Event|4|||
130975479|NCT01221597|471535585|FG001|Overall Study|Adverse Event|1|||
130975480|NCT01221597|471535584|FG000|Overall Study|Withdrawal by Subject|20|||
130975481|NCT01221597|471535585|FG001|Overall Study|Withdrawal by Subject|6|||
130975482|NCT01221597|471535584|FG000|Overall Study|Lost to Follow-up|6|||
130975483|NCT01221597|471535585|FG001|Overall Study|Lost to Follow-up|5|||
130975484|NCT01221597|471535584|FG000|Overall Study|Protocol Violation|1|||
130717338|NCT01568320|470591013|FG000|Overall Study|Lost to Follow-up|9|||
130717339|NCT01568320|470591013|FG000|Overall Study|Withdrawal by Subject|10|||
130717340|NCT01568320|470591013|FG000|Overall Study|Conversion to open repair|1|||
130717341|NCT01568320|470591013|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
130717342|NCT01616953|470591014|FG000|Overall Study|Lost to Follow-up|1|||
130717343|NCT01616953|470591015|FG001|Overall Study|Lost to Follow-up|0|||
130717344|NCT01616953|470591014|FG000|Overall Study|lack of bone and soft tissue|1|||
130717345|NCT01616953|470591015|FG001|Overall Study|lack of bone and soft tissue|0|||
130717346|NCT01394952|470591016|FG000|Overall Study|Lost to Follow-up|0|||
130717347|NCT01394952|470591017|FG001|Overall Study|Lost to Follow-up|5|||
130717348|NCT01394952|470591016|FG000|Overall Study|Withdrawal by Subject|10|||
130717349|NCT01394952|470591017|FG001|Overall Study|Withdrawal by Subject|5|||
130717350|NCT01394952|470591016|FG000|Overall Study|Physician Decision|2|||
130717351|NCT01394952|470591017|FG001|Overall Study|Physician Decision|0|||
130717352|NCT01394952|470591016|FG000|Overall Study|Sponsor Decision|5|||
130717353|NCT01394952|470591017|FG001|Overall Study|Sponsor Decision|7|||
130717354|NCT01986010|470591018|FG000|Overall Study|Adverse Event|0|||
130975485|NCT01221597|471535585|FG001|Overall Study|Protocol Violation|0|||
130975486|NCT01221597|471535584|FG000|Overall Study|Other|3|||
130975487|NCT01221597|471535585|FG001|Overall Study|Other|4|||
130975488|NCT01221597|471535584|FG000|Overall Study|Death|2|||
130975489|NCT01221597|471535585|FG001|Overall Study|Death|0|||
130975490|NCT03667053|471535587|FG000|Overall Study|Withdrawal by Subject|1|||
130975491|NCT03667053|471535588|FG001|Overall Study|Withdrawal by Subject|0|||
130975492|NCT03667053|471535589|FG002|Overall Study|Withdrawal by Subject|0|||
130975493|NCT03927950|471535590|FG000|Overall Study|Adverse Event|9|||
130975494|NCT04642638|471535593|FG000|Overall Study|Withdrawal by Subject|23|||
130717355|NCT01986010|470591019|FG001|Overall Study|Adverse Event|1|||
130717356|NCT01986010|470591020|FG002|Overall Study|Adverse Event|0|||
130975495|NCT04642638|471535594|FG001|Overall Study|Withdrawal by Subject|29|||
130975496|NCT04642638|471535595|FG002|Overall Study|Withdrawal by Subject|9|||
130975497|NCT04642638|471535596|FG003|Overall Study|Withdrawal by Subject|7|||
130975498|NCT04642638|471535597|FG004|Overall Study|Withdrawal by Subject|61|||
130717357|NCT01986010|470591021|FG003|Overall Study|Adverse Event|0|||
130717358|NCT01986010|470591022|FG004|Overall Study|Adverse Event|0|||
130975499|NCT04642638|471535598|FG005|Overall Study|Withdrawal by Subject|27|||
130975500|NCT04642638|471535593|FG000|Overall Study|Lost to Follow-up|17|||
130975501|NCT04642638|471535594|FG001|Overall Study|Lost to Follow-up|18|||
130975502|NCT04642638|471535595|FG002|Overall Study|Lost to Follow-up|5|||
130975503|NCT04642638|471535596|FG003|Overall Study|Lost to Follow-up|5|||
130975504|NCT04642638|471535597|FG004|Overall Study|Lost to Follow-up|6|||
130975505|NCT04642638|471535598|FG005|Overall Study|Lost to Follow-up|3|||
130975506|NCT04642638|471535593|FG000|Overall Study|Adverse Event|0|||
130975507|NCT04642638|471535594|FG001|Overall Study|Adverse Event|0|||
130975508|NCT04642638|471535595|FG002|Overall Study|Adverse Event|1|||
130975509|NCT04642638|471535596|FG003|Overall Study|Adverse Event|0|||
130975510|NCT04642638|471535597|FG004|Overall Study|Adverse Event|10|||
130975511|NCT04642638|471535598|FG005|Overall Study|Adverse Event|3|||
130975512|NCT04642638|471535593|FG000|Overall Study|Reason Not Specified|1|||
130975513|NCT04642638|471535594|FG001|Overall Study|Reason Not Specified|4|||
130975514|NCT04642638|471535595|FG002|Overall Study|Reason Not Specified|0|||
130975515|NCT04642638|471535596|FG003|Overall Study|Reason Not Specified|0|||
130975516|NCT04642638|471535597|FG004|Overall Study|Reason Not Specified|38|||
130975517|NCT04642638|471535598|FG005|Overall Study|Reason Not Specified|16|||
130975518|NCT04642638|471535593|FG000|Overall Study|Physician Decision|0|||
130975519|NCT04642638|471535594|FG001|Overall Study|Physician Decision|0|||
130776977|NCT00878800|470810378|FG002|Overall Study|Progressive disease|6|||
130776978|NCT00878800|470810379|FG003|Overall Study|Progressive disease|5|||
130776979|NCT00878800|470810380|FG004|Overall Study|Progressive disease|13|||
130776980|NCT00878800|470810376|FG000|Overall Study|Withdrew consent|1|||
130776981|NCT00878800|470810377|FG001|Overall Study|Withdrew consent|1|||
130776982|NCT00878800|470810378|FG002|Overall Study|Withdrew consent|0|||
130776983|NCT00878800|470810379|FG003|Overall Study|Withdrew consent|1|||
130776984|NCT00878800|470810380|FG004|Overall Study|Withdrew consent|1|||
130975520|NCT04642638|471535595|FG002|Overall Study|Physician Decision|0|||
131227500|NCT00410410|472459753|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
131227501|NCT00410410|472459754|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130776985|NCT00878800|470810376|FG000|Overall Study|Death|0|||
130776986|NCT00878800|470810377|FG001|Overall Study|Death|0|||
130776987|NCT00878800|470810378|FG002|Overall Study|Death|1|||
130776988|NCT00878800|470810379|FG003|Overall Study|Death|0|||
130776989|NCT00878800|470810380|FG004|Overall Study|Death|0|||
130776990|NCT00878800|470810376|FG000|Overall Study|Other|1|||
130776991|NCT00878800|470810377|FG001|Overall Study|Other|1|||
130776992|NCT00878800|470810378|FG002|Overall Study|Other|0|||
130776993|NCT00878800|470810379|FG003|Overall Study|Other|0|||
130776994|NCT00878800|470810380|FG004|Overall Study|Other|1|||
130776995|NCT00613821|470810381|FG000|Overall Study|Withdrawal by Subject|1|||
130776996|NCT00613821|470810382|FG001|Overall Study|Withdrawal by Subject|0|||
130776997|NCT00613821|470810381|FG000|Overall Study|Physician Decision|1|||
130776998|NCT00613821|470810382|FG001|Overall Study|Physician Decision|1|||
130776999|NCT03318003|470810383|FG000|Overall Study|Withdrawal by Subject|1|||
130777000|NCT03318003|470810384|FG001|Overall Study|Withdrawal by Subject|1|||
130777001|NCT03318003|470810383|FG000|Overall Study|fetal loss|0|||
130777002|NCT03318003|470810384|FG001|Overall Study|fetal loss|1|||
130777003|NCT02302846|470810386|FG000|Overall Study|Withdrawal by Subject|1|||
130777004|NCT01468454|470810387|FG000|Overall Study|Did not have surgery after PET|9|||
130777005|NCT04435808|470810388|FG000|Overall Study|Study stopped by DSMB|0|||
130777006|NCT04435808|470810389|FG001|Overall Study|Study stopped by DSMB|1|||
130777007|NCT02620787|470810390|FG000|Overall Study|Adverse Event|1|||
130777008|NCT02620787|470810391|FG001|Overall Study|Adverse Event|0|||
130975521|NCT04642638|471535596|FG003|Overall Study|Physician Decision|0|||
130975522|NCT04642638|471535597|FG004|Overall Study|Physician Decision|2|||
130975523|NCT04642638|471535598|FG005|Overall Study|Physician Decision|1|||
130975524|NCT04642638|471535593|FG000|Overall Study|Protocol Deviation|0|||
130975525|NCT04642638|471535594|FG001|Overall Study|Protocol Deviation|0|||
130975526|NCT04642638|471535595|FG002|Overall Study|Protocol Deviation|0|||
130975527|NCT04642638|471535596|FG003|Overall Study|Protocol Deviation|0|||
130975528|NCT04642638|471535597|FG004|Overall Study|Protocol Deviation|1|||
130975529|NCT04642638|471535598|FG005|Overall Study|Protocol Deviation|3|||
130975530|NCT04642638|471535593|FG000|Overall Study|Study Terminated|0|||
130975531|NCT04642638|471535594|FG001|Overall Study|Study Terminated|0|||
130975532|NCT04642638|471535595|FG002|Overall Study|Study Terminated|0|||
131227502|NCT00410410|472459755|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130777009|NCT02620787|470810390|FG000|Overall Study|Eligibility Criteria Not Met|1|||
130975533|NCT04642638|471535596|FG003|Overall Study|Study Terminated|0|||
130975534|NCT04642638|471535597|FG004|Overall Study|Study Terminated|484|||
131043383|NCT05184452|471793084|FG007|Overall Study|Withdrawal by Subject|0|||
130777010|NCT02620787|470810391|FG001|Overall Study|Eligibility Criteria Not Met|0|||
130777011|NCT00807612|470810396|FG000|Overall Study|Death|8|||
130777012|NCT00807612|470810396|FG000|Overall Study|Study early termination|5|||
130777013|NCT00807612|470810396|FG000|Overall Study|Withdrawal by Subject|1|||
130975535|NCT04642638|471535598|FG005|Overall Study|Study Terminated|250|||
130975536|NCT04642638|471535593|FG000|Overall Study|Pregnancy|0|||
130975537|NCT04642638|471535594|FG001|Overall Study|Pregnancy|0|||
130777014|NCT02028507|470810398|FG000|Overall Study|Progressive Disease|122|||
130777015|NCT02028507|470810399|FG001|Overall Study|Progressive Disease|90|||
130777016|NCT02028507|470810400|FG002|Overall Study|Progressive Disease|102|||
130975538|NCT04642638|471535595|FG002|Overall Study|Pregnancy|0|||
130975539|NCT04642638|471535596|FG003|Overall Study|Pregnancy|0|||
130975540|NCT04642638|471535597|FG004|Overall Study|Pregnancy|1|||
130975541|NCT04642638|471535598|FG005|Overall Study|Pregnancy|0|||
130975542|NCT00990652|471535599|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
130975543|NCT00990652|471535599|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
130975544|NCT02085408|471535601|FG000|Step 1: Induction|Disease Progression|19|||
130975545|NCT02085408|471535602|FG001|Step 1: Induction|Disease Progression|19|||
130777017|NCT02028507|470810401|FG003|Overall Study|Progressive Disease|89|||
130777018|NCT02028507|470810398|FG000|Overall Study|Adverse Event|8|||
130777019|NCT02028507|470810399|FG001|Overall Study|Adverse Event|25|||
130777020|NCT02028507|470810400|FG002|Overall Study|Adverse Event|3|||
130777021|NCT02028507|470810401|FG003|Overall Study|Adverse Event|16|||
130777022|NCT02028507|470810398|FG000|Overall Study|Withdrawal by Subject|6|||
130975546|NCT02085408|471535601|FG000|Step 1: Induction|Adverse Event|18|||
130975547|NCT02085408|471535602|FG001|Step 1: Induction|Adverse Event|17|||
130975548|NCT02085408|471535601|FG000|Step 1: Induction|Death|33|||
130975549|NCT02085408|471535602|FG001|Step 1: Induction|Death|30|||
130975550|NCT02085408|471535601|FG000|Step 1: Induction|Withdrawal by Subject|16|||
130975551|NCT02085408|471535602|FG001|Step 1: Induction|Withdrawal by Subject|8|||
130975552|NCT02085408|471535601|FG000|Step 1: Induction|Alternative Therapy|15|||
130975553|NCT02085408|471535602|FG001|Step 1: Induction|Alternative Therapy|19|||
130975554|NCT02085408|471535601|FG000|Step 1: Induction|Complicating Disease|2|||
130975555|NCT02085408|471535602|FG001|Step 1: Induction|Complicating Disease|3|||
130975556|NCT02085408|471535601|FG000|Step 1: Induction|Other|27|||
130975557|NCT02085408|471535602|FG001|Step 1: Induction|Other|39|||
130975558|NCT02085408|471535601|FG000|Step 1: Induction|Never started treatment|6|||
130975559|NCT02085408|471535602|FG001|Step 1: Induction|Never started treatment|4|||
130975560|NCT02085408|471535601|FG000|Step 2: Consolidation|Disease Progression|5|||
130975561|NCT02085408|471535602|FG001|Step 2: Consolidation|Disease Progression|20|||
130975562|NCT02085408|471535601|FG000|Step 2: Consolidation|Adverse Event|9|||
130777023|NCT02028507|470810399|FG001|Overall Study|Withdrawal by Subject|8|||
130777024|NCT02028507|470810400|FG002|Overall Study|Withdrawal by Subject|5|||
130777025|NCT02028507|470810401|FG003|Overall Study|Withdrawal by Subject|9|||
130777026|NCT02028507|470810398|FG000|Overall Study|Protocol Violation|2|||
130777027|NCT02028507|470810399|FG001|Overall Study|Protocol Violation|4|||
130777028|NCT02028507|470810400|FG002|Overall Study|Protocol Violation|1|||
130777029|NCT02028507|470810401|FG003|Overall Study|Protocol Violation|3|||
130777030|NCT02028507|470810398|FG000|Overall Study|Physician Decision|0|||
130777031|NCT02028507|470810399|FG001|Overall Study|Physician Decision|4|||
130777032|NCT02028507|470810400|FG002|Overall Study|Physician Decision|0|||
130777033|NCT02028507|470810401|FG003|Overall Study|Physician Decision|0|||
130777034|NCT02028507|470810398|FG000|Overall Study|Death|1|||
130777035|NCT02028507|470810399|FG001|Overall Study|Death|0|||
130777036|NCT02028507|470810400|FG002|Overall Study|Death|1|||
130975563|NCT02085408|471535602|FG001|Step 2: Consolidation|Adverse Event|8|||
130975564|NCT02085408|471535601|FG000|Step 2: Consolidation|Death|4|||
130975565|NCT02085408|471535602|FG001|Step 2: Consolidation|Death|3|||
130975566|NCT02085408|471535601|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
130975567|NCT02085408|471535602|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
130975568|NCT02085408|471535601|FG000|Step 2: Consolidation|Alternative Therapy|9|||
130975569|NCT02085408|471535602|FG001|Step 2: Consolidation|Alternative Therapy|3|||
130975570|NCT02085408|471535601|FG000|Step 2: Consolidation|Complicating Disease|0|||
130975571|NCT02085408|471535602|FG001|Step 2: Consolidation|Complicating Disease|2|||
130975572|NCT02085408|471535601|FG000|Step 2: Consolidation|Other|6|||
130975573|NCT02085408|471535602|FG001|Step 2: Consolidation|Other|6|||
131131383|NCT02432235|472108338|FG011|Overall Study|Death|0|||
131131384|NCT02432235|472108327|FG000|Overall Study|Withdrawal by Subject|0|||
131131385|NCT02432235|472108328|FG001|Overall Study|Withdrawal by Subject|1|||
131131386|NCT02432235|472108329|FG002|Overall Study|Withdrawal by Subject|0|||
131131387|NCT02432235|472108330|FG003|Overall Study|Withdrawal by Subject|0|||
131131388|NCT02432235|472108331|FG004|Overall Study|Withdrawal by Subject|0|||
131131389|NCT02432235|472108332|FG005|Overall Study|Withdrawal by Subject|2|||
131131390|NCT02432235|472108333|FG006|Overall Study|Withdrawal by Subject|5|||
131131391|NCT02432235|472108334|FG007|Overall Study|Withdrawal by Subject|3|||
131131392|NCT02432235|472108335|FG008|Overall Study|Withdrawal by Subject|1|||
131131393|NCT02432235|472108336|FG009|Overall Study|Withdrawal by Subject|0|||
131131394|NCT02432235|472108337|FG010|Overall Study|Withdrawal by Subject|0|||
130777037|NCT02028507|470810401|FG003|Overall Study|Death|3|||
130777038|NCT02028507|470810398|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
130777039|NCT02028507|470810399|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
130777040|NCT02028507|470810400|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
130975574|NCT02085408|471535601|FG000|Step 2: Consolidation|Never started treatment|4|||
130975575|NCT02085408|471535602|FG001|Step 2: Consolidation|Never started treatment|3|||
130777041|NCT02028507|470810401|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
130777042|NCT02028507|470810398|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
130777043|NCT02028507|470810399|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
130777044|NCT02028507|470810400|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
130777045|NCT02028507|470810401|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
130777046|NCT02028507|470810398|FG000|Overall Study|Randomized But Not Treated|3|||
130777047|NCT02028507|470810399|FG001|Overall Study|Randomized But Not Treated|6|||
130777048|NCT02028507|470810400|FG002|Overall Study|Randomized But Not Treated|0|||
130777049|NCT02028507|470810401|FG003|Overall Study|Randomized But Not Treated|4|||
130777050|NCT02028507|470810398|FG000|Overall Study|Enzyme defect|0|||
130777051|NCT02028507|470810399|FG001|Overall Study|Enzyme defect|0|||
130777052|NCT02028507|470810400|FG002|Overall Study|Enzyme defect|0|||
130777053|NCT02028507|470810401|FG003|Overall Study|Enzyme defect|1|||
130777054|NCT02028507|470810398|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
130777055|NCT02028507|470810399|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
130777056|NCT02028507|470810400|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
130777057|NCT02028507|470810401|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
130777058|NCT02028507|470810398|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
130777059|NCT02028507|470810399|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
130975576|NCT02085408|471535601|FG000|Step 3: Maintenance|Disease Progression|13|||
130975577|NCT02085408|471535602|FG001|Step 3: Maintenance|Disease Progression|11|||
130975578|NCT02085408|471535601|FG000|Step 3: Maintenance|Adverse Event|2|||
130975579|NCT02085408|471535602|FG001|Step 3: Maintenance|Adverse Event|4|||
131227503|NCT00410410|472459756|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130777060|NCT02028507|470810400|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
130777061|NCT02028507|470810401|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
130777062|NCT02258659|470810402|FG000|Overall Study|Withdrawal by Subject|1|||
130777063|NCT04892446|470810403|FG000|Overall Study|Death|4|||
130777064|NCT04892446|470810404|FG001|Overall Study|Death|4|||
130777065|NCT04892446|470810405|FG002|Overall Study|Death|0|||
130777066|NCT04892446|470810403|FG000|Overall Study|Withdrew consent|3|||
130777067|NCT04892446|470810404|FG001|Overall Study|Withdrew consent|0|||
130777068|NCT04892446|470810405|FG002|Overall Study|Withdrew consent|1|||
130777069|NCT04892446|470810403|FG000|Overall Study|Investigator's discretion|1|||
130777070|NCT04892446|470810404|FG001|Overall Study|Investigator's discretion|1|||
130777071|NCT04892446|470810405|FG002|Overall Study|Investigator's discretion|0|||
130777072|NCT04892446|470810403|FG000|Overall Study|Study terminated by sponsor|0|||
130777073|NCT04892446|470810404|FG001|Overall Study|Study terminated by sponsor|0|||
130777074|NCT04892446|470810405|FG002|Overall Study|Study terminated by sponsor|2|||
130777075|NCT00272844|470810406|FG000|Overall Study|Withdrawal by Subject|5|||
130777076|NCT00705341|470810409|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
130777077|NCT00705341|470810410|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
130777078|NCT00705341|470810411|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
130777079|NCT00705341|470810412|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
130777080|NCT00705341|470810409|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
130777081|NCT00705341|470810410|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
130777082|NCT00705341|470810411|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
130777083|NCT00705341|470810412|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
130777084|NCT00791700|470810413|FG000|Overall Study|Insufficient clinical response|1|||
130777085|NCT00791700|470810414|FG001|Overall Study|Insufficient clinical response|4|||
130777086|NCT00791700|470810415|FG002|Overall Study|Insufficient clinical response|1|||
130777087|NCT00791700|470810416|FG003|Overall Study|Insufficient clinical response|8|||
130777088|NCT00791700|470810413|FG000|Overall Study|No longer willing to participate|1|||
130777089|NCT00791700|470810414|FG001|Overall Study|No longer willing to participate|1|||
130777090|NCT00791700|470810415|FG002|Overall Study|No longer willing to participate|0|||
130777091|NCT00791700|470810416|FG003|Overall Study|No longer willing to participate|8|||
130777092|NCT00791700|470810413|FG000|Overall Study|Non-compliance with study treatment|0|||
130777093|NCT00791700|470810414|FG001|Overall Study|Non-compliance with study treatment|2|||
130777094|NCT00791700|470810415|FG002|Overall Study|Non-compliance with study treatment|0|||
130777095|NCT00791700|470810416|FG003|Overall Study|Non-compliance with study treatment|4|||
130777096|NCT00791700|470810413|FG000|Overall Study|Withdrawn due to pregnancy|0|||
130777097|NCT00791700|470810414|FG001|Overall Study|Withdrawn due to pregnancy|0|||
130777098|NCT00791700|470810415|FG002|Overall Study|Withdrawn due to pregnancy|0|||
130777099|NCT00791700|470810416|FG003|Overall Study|Withdrawn due to pregnancy|1|||
130777100|NCT00791700|470810413|FG000|Overall Study|Other|0|||
130777101|NCT00791700|470810414|FG001|Overall Study|Other|1|||
130777102|NCT00791700|470810415|FG002|Overall Study|Other|0|||
130777103|NCT00791700|470810416|FG003|Overall Study|Other|1|||
130777104|NCT00791700|470810413|FG000|Overall Study|Death|0|||
130777105|NCT00791700|470810414|FG001|Overall Study|Death|0|||
130777106|NCT00791700|470810415|FG002|Overall Study|Death|0|||
130975580|NCT02085408|471535601|FG000|Step 3: Maintenance|Death|1|||
130975581|NCT02085408|471535602|FG001|Step 3: Maintenance|Death|2|||
130975582|NCT02085408|471535601|FG000|Step 3: Maintenance|Alternative Therapy|1|||
130975583|NCT02085408|471535602|FG001|Step 3: Maintenance|Alternative Therapy|1|||
130975584|NCT02085408|471535601|FG000|Step 3: Maintenance|Complicating Disease|0|||
130975585|NCT02085408|471535602|FG001|Step 3: Maintenance|Complicating Disease|1|||
130975586|NCT02085408|471535601|FG000|Step 3: Maintenance|Other|3|||
130975587|NCT02085408|471535602|FG001|Step 3: Maintenance|Other|2|||
130975588|NCT02085408|471535601|FG000|Step 3: Maintenance|Never started treatment|5|||
130975589|NCT02085408|471535602|FG001|Step 3: Maintenance|Never started treatment|1|||
130975590|NCT01572727|471535605|FG000|Overall Study|Adverse Event|43|||
130975591|NCT01572727|471535606|FG001|Overall Study|Adverse Event|15|||
130975592|NCT01572727|471535605|FG000|Overall Study|Lost to Follow-up|1|||
130975593|NCT01572727|471535606|FG001|Overall Study|Lost to Follow-up|1|||
130975594|NCT01572727|471535605|FG000|Overall Study|Physician Decision|23|||
130975595|NCT01572727|471535606|FG001|Overall Study|Physician Decision|9|||
130975596|NCT01572727|471535605|FG000|Overall Study|Progressive disease|59|||
131043384|NCT05184452|471793085|FG008|Overall Study|Withdrawal by Subject|0|||
131227504|NCT00410410|472459757|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130717359|NCT01986010|470591023|FG005|Overall Study|Adverse Event|0|||
130717360|NCT01986010|470591024|FG006|Overall Study|Adverse Event|0|||
130717361|NCT01986010|470591025|FG007|Overall Study|Adverse Event|0|||
130717362|NCT01986010|470591026|FG008|Overall Study|Adverse Event|0|||
130717363|NCT01986010|470591027|FG009|Overall Study|Adverse Event|0|||
130717364|NCT01986010|470591028|FG010|Overall Study|Adverse Event|0|||
130717365|NCT01986010|470591029|FG011|Overall Study|Adverse Event|0|||
130717366|NCT01986010|470591030|FG012|Overall Study|Adverse Event|0|||
130717367|NCT01986010|470591031|FG013|Overall Study|Adverse Event|0|||
130717368|NCT01986010|470591032|FG014|Overall Study|Adverse Event|0|||
130717369|NCT01986010|470591033|FG015|Overall Study|Adverse Event|1|||
130717370|NCT01986010|470591034|FG016|Overall Study|Adverse Event|0|||
130717371|NCT01986010|470591018|FG000|Overall Study|Lost to Follow-up|2|||
130717372|NCT01986010|470591019|FG001|Overall Study|Lost to Follow-up|1|||
130717373|NCT01986010|470591020|FG002|Overall Study|Lost to Follow-up|2|||
130717374|NCT01986010|470591021|FG003|Overall Study|Lost to Follow-up|2|||
130717375|NCT01986010|470591022|FG004|Overall Study|Lost to Follow-up|2|||
130717376|NCT01986010|470591023|FG005|Overall Study|Lost to Follow-up|2|||
130717377|NCT01986010|470591024|FG006|Overall Study|Lost to Follow-up|0|||
130717378|NCT01986010|470591025|FG007|Overall Study|Lost to Follow-up|0|||
130717379|NCT01986010|470591026|FG008|Overall Study|Lost to Follow-up|4|||
130717380|NCT01986010|470591027|FG009|Overall Study|Lost to Follow-up|2|||
130717381|NCT01986010|470591028|FG010|Overall Study|Lost to Follow-up|0|||
130717382|NCT01986010|470591029|FG011|Overall Study|Lost to Follow-up|1|||
130717383|NCT01986010|470591030|FG012|Overall Study|Lost to Follow-up|1|||
130717384|NCT01986010|470591031|FG013|Overall Study|Lost to Follow-up|1|||
130717385|NCT01986010|470591032|FG014|Overall Study|Lost to Follow-up|2|||
130717386|NCT01986010|470591033|FG015|Overall Study|Lost to Follow-up|0|||
130717387|NCT01986010|470591034|FG016|Overall Study|Lost to Follow-up|0|||
130717388|NCT01986010|470591018|FG000|Overall Study|Physician Decision|0|||
130717389|NCT01986010|470591019|FG001|Overall Study|Physician Decision|0|||
130717390|NCT01986010|470591020|FG002|Overall Study|Physician Decision|0|||
130717391|NCT01986010|470591021|FG003|Overall Study|Physician Decision|0|||
130717392|NCT01986010|470591022|FG004|Overall Study|Physician Decision|0|||
130717393|NCT01986010|470591023|FG005|Overall Study|Physician Decision|0|||
130717394|NCT01986010|470591024|FG006|Overall Study|Physician Decision|0|||
130717395|NCT01986010|470591025|FG007|Overall Study|Physician Decision|0|||
130717396|NCT01986010|470591026|FG008|Overall Study|Physician Decision|0|||
130717397|NCT01986010|470591027|FG009|Overall Study|Physician Decision|0|||
130717398|NCT01986010|470591028|FG010|Overall Study|Physician Decision|0|||
130717399|NCT01986010|470591029|FG011|Overall Study|Physician Decision|0|||
130717400|NCT01986010|470591030|FG012|Overall Study|Physician Decision|0|||
130717401|NCT01986010|470591031|FG013|Overall Study|Physician Decision|0|||
130717402|NCT01986010|470591032|FG014|Overall Study|Physician Decision|1|||
130717403|NCT01986010|470591033|FG015|Overall Study|Physician Decision|0|||
130717404|NCT01986010|470591034|FG016|Overall Study|Physician Decision|0|||
130717405|NCT01986010|470591018|FG000|Overall Study|Withdrawal by Subject|2|||
130717406|NCT01986010|470591019|FG001|Overall Study|Withdrawal by Subject|2|||
130717407|NCT01986010|470591020|FG002|Overall Study|Withdrawal by Subject|3|||
130717408|NCT01986010|470591021|FG003|Overall Study|Withdrawal by Subject|0|||
130717409|NCT01986010|470591022|FG004|Overall Study|Withdrawal by Subject|2|||
130717410|NCT01986010|470591023|FG005|Overall Study|Withdrawal by Subject|4|||
130717411|NCT01986010|470591024|FG006|Overall Study|Withdrawal by Subject|0|||
130717412|NCT01986010|470591025|FG007|Overall Study|Withdrawal by Subject|0|||
130717413|NCT01986010|470591026|FG008|Overall Study|Withdrawal by Subject|0|||
130717414|NCT01986010|470591027|FG009|Overall Study|Withdrawal by Subject|0|||
130717415|NCT01986010|470591028|FG010|Overall Study|Withdrawal by Subject|0|||
130717416|NCT01986010|470591029|FG011|Overall Study|Withdrawal by Subject|2|||
130717417|NCT01986010|470591030|FG012|Overall Study|Withdrawal by Subject|0|||
130717418|NCT01986010|470591031|FG013|Overall Study|Withdrawal by Subject|1|||
130717419|NCT01986010|470591032|FG014|Overall Study|Withdrawal by Subject|2|||
130717420|NCT01986010|470591033|FG015|Overall Study|Withdrawal by Subject|0|||
130975597|NCT01572727|471535606|FG001|Overall Study|Progressive disease|82|||
130777107|NCT00791700|470810416|FG003|Overall Study|Death|1|||
130777108|NCT00791700|470810413|FG000|Overall Study|Lost to Follow-up|4|||
130777109|NCT00791700|470810414|FG001|Overall Study|Lost to Follow-up|3|||
130777110|NCT00791700|470810415|FG002|Overall Study|Lost to Follow-up|4|||
130777111|NCT00791700|470810416|FG003|Overall Study|Lost to Follow-up|6|||
130777112|NCT00791700|470810413|FG000|Overall Study|Adverse Event|0|||
130777113|NCT00791700|470810414|FG001|Overall Study|Adverse Event|0|||
130777114|NCT00791700|470810415|FG002|Overall Study|Adverse Event|1|||
130777115|NCT00791700|470810416|FG003|Overall Study|Adverse Event|1|||
130777116|NCT00527826|470810419|FG000|Overall Study|Adverse Event|10|||
130777117|NCT00527826|470810420|FG001|Overall Study|Adverse Event|10|||
130777118|NCT00527826|470810419|FG000|Overall Study|Lost to Follow-up|3|||
130777119|NCT00527826|470810420|FG001|Overall Study|Lost to Follow-up|2|||
130777120|NCT00527826|470810419|FG000|Overall Study|Withdrawal by Subject|5|||
130777121|NCT00527826|470810420|FG001|Overall Study|Withdrawal by Subject|8|||
130777122|NCT00527826|470810419|FG000|Overall Study|Inclusion Criteria Not Met|3|||
130777123|NCT00527826|470810420|FG001|Overall Study|Inclusion Criteria Not Met|3|||
130777124|NCT00527826|470810419|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
131227505|NCT00410410|472459749|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131227506|NCT00410410|472459750|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131227507|NCT00410410|472459751|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131227508|NCT00410410|472459752|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131227509|NCT00410410|472459753|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
131227510|NCT00410410|472459754|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
130717421|NCT01986010|470591034|FG016|Overall Study|Withdrawal by Subject|0|||
130717422|NCT01986010|470591018|FG000|Overall Study|Status Not Recorded|2|||
130717423|NCT01986010|470591019|FG001|Overall Study|Status Not Recorded|4|||
130717424|NCT01986010|470591020|FG002|Overall Study|Status Not Recorded|2|||
130717425|NCT01986010|470591021|FG003|Overall Study|Status Not Recorded|0|||
130717426|NCT01986010|470591022|FG004|Overall Study|Status Not Recorded|1|||
130717427|NCT01986010|470591023|FG005|Overall Study|Status Not Recorded|2|||
130717428|NCT01986010|470591024|FG006|Overall Study|Status Not Recorded|0|||
130717429|NCT01986010|470591025|FG007|Overall Study|Status Not Recorded|0|||
130717430|NCT01986010|470591026|FG008|Overall Study|Status Not Recorded|2|||
130717431|NCT01986010|470591027|FG009|Overall Study|Status Not Recorded|1|||
130717432|NCT01986010|470591028|FG010|Overall Study|Status Not Recorded|7|||
130717433|NCT01986010|470591029|FG011|Overall Study|Status Not Recorded|7|||
130717434|NCT01986010|470591030|FG012|Overall Study|Status Not Recorded|9|||
130717435|NCT01986010|470591031|FG013|Overall Study|Status Not Recorded|9|||
130717436|NCT01986010|470591032|FG014|Overall Study|Status Not Recorded|5|||
130717437|NCT01986010|470591033|FG015|Overall Study|Status Not Recorded|10|||
130717438|NCT01986010|470591034|FG016|Overall Study|Status Not Recorded|4|||
130717439|NCT01335997|470591035|FG000|Period I and II|Adverse Event|63|||
130717440|NCT01335997|470591036|FG001|Period I and II|Adverse Event|43|||
130717441|NCT01335997|470591035|FG000|Period I and II|Noncompliance with Study Drug|1|||
130717442|NCT01335997|470591036|FG001|Period I and II|Noncompliance with Study Drug|1|||
130717443|NCT01335997|470591035|FG000|Period I and II|Lost to Follow-up|3|||
130717444|NCT01335997|470591036|FG001|Period I and II|Lost to Follow-up|5|||
130717445|NCT01335997|470591035|FG000|Period I and II|Withdrawal by Subject|9|||
130717446|NCT01335997|470591036|FG001|Period I and II|Withdrawal by Subject|4|||
130717447|NCT01335997|470591035|FG000|Period I and II|Study Terminated by Sponsor|406|||
130717448|NCT01335997|470591036|FG001|Period I and II|Study Terminated by Sponsor|415|||
130717449|NCT01335997|470591035|FG000|Period I and II|Protocol Violation|9|||
130717450|NCT01335997|470591036|FG001|Period I and II|Protocol Violation|10|||
130717451|NCT01335997|470591035|FG000|Period I and II|Physician Decision|2|||
130717452|NCT01335997|470591036|FG001|Period I and II|Physician Decision|1|||
130717453|NCT01335997|470591035|FG000|Period III|Adverse Event|0|||
130717454|NCT01335997|470591036|FG001|Period III|Adverse Event|2|||
130717455|NCT01335997|470591035|FG000|Period III|Study Terminated by Sponsor|77|||
130717456|NCT01335997|470591036|FG001|Period III|Study Terminated by Sponsor|76|||
130717457|NCT01335997|470591035|FG000|Period III|Protocol Violation|0|||
130717458|NCT01335997|470591036|FG001|Period III|Protocol Violation|1|||
130717459|NCT01335997|470591035|FG000|Period III|Lost to Follow-up|1|||
130717460|NCT01335997|470591036|FG001|Period III|Lost to Follow-up|0|||
130717461|NCT01103466|470591039|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
130717462|NCT01103466|470591040|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
130717463|NCT01103466|470591041|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
130717464|NCT01103466|470591039|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
130717465|NCT01103466|470591040|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
130717466|NCT01103466|470591041|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
130777125|NCT00527826|470810420|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
130777126|NCT00527826|470810419|FG000|Overall Study|Additional Intake of Viani forte|0|||
130777127|NCT00527826|470810420|FG001|Overall Study|Additional Intake of Viani forte|1|||
130777128|NCT00527826|470810419|FG000|Overall Study|Participant moved away|0|||
130777129|NCT00527826|470810420|FG001|Overall Study|Participant moved away|1|||
130777130|NCT01808261|470810421|FG000|Overall Study|Physician Decision|0|||
130777131|NCT01808261|470810422|FG001|Overall Study|Physician Decision|2|||
130777132|NCT01808261|470810421|FG000|Overall Study|Study Closed/Terminated|25|||
130777133|NCT01808261|470810422|FG001|Overall Study|Study Closed/Terminated|23|||
130975598|NCT01572727|471535605|FG000|Overall Study|Protocol Violation|0|||
130975599|NCT01572727|471535606|FG001|Overall Study|Protocol Violation|1|||
130975600|NCT01572727|471535605|FG000|Overall Study|Study terminated by sponsor|61|||
130975601|NCT01572727|471535606|FG001|Overall Study|Study terminated by sponsor|83|||
130975602|NCT01572727|471535605|FG000|Overall Study|Parent/guardian decision|14|||
130975603|NCT01572727|471535606|FG001|Overall Study|Parent/guardian decision|9|||
130975604|NCT01572727|471535605|FG000|Overall Study|Death|2|||
130975605|NCT01572727|471535606|FG001|Overall Study|Death|2|||
130975606|NCT01572727|471535605|FG000|Overall Study|Untreated|4|||
130975607|NCT01572727|471535606|FG001|Overall Study|Untreated|7|||
130975608|NCT04732286|471535607|FG000|Overall Study|Progressive Disease|2|||
130975609|NCT04732286|471535607|FG000|Overall Study|Physician Decision|1|||
130975610|NCT04732286|471535607|FG000|Overall Study|Study Terminated by Sponsor|31|||
130975611|NCT04732286|471535607|FG000|Overall Study|Withdrawal by Subject|10|||
130975612|NCT04732286|471535607|FG000|Overall Study|Non-compliance With Study Drug|1|||
130975613|NCT04732286|471535607|FG000|Overall Study|Lost to Follow-up|4|||
130975614|NCT04732286|471535607|FG000|Overall Study|Death|51|||
130975615|NCT00319098|471535608|FG000|Overall Study|Serious adverse event|3|||
130975616|NCT00319098|471535609|FG001|Overall Study|Serious adverse event|0|||
130975617|NCT00319098|471535608|FG000|Overall Study|Adverse Event|20|||
130975618|NCT00319098|471535609|FG001|Overall Study|Adverse Event|1|||
130975619|NCT00319098|471535608|FG000|Overall Study|Withdrawal by Subject|37|||
130975620|NCT00319098|471535609|FG001|Overall Study|Withdrawal by Subject|8|||
130975621|NCT00319098|471535608|FG000|Overall Study|Migrated/moved from study area|2|||
130975622|NCT00319098|471535609|FG001|Overall Study|Migrated/moved from study area|1|||
130975623|NCT00319098|471535608|FG000|Overall Study|Lost to Follow-up|37|||
130975624|NCT00319098|471535609|FG001|Overall Study|Lost to Follow-up|13|||
130975625|NCT00319098|471535608|FG000|Overall Study|Others|33|||
130975626|NCT00319098|471535609|FG001|Overall Study|Others|8|||
130975627|NCT00319098|471535608|FG000|Overall Study|Protocol Violation|3|||
130975628|NCT00319098|471535609|FG001|Overall Study|Protocol Violation|1|||
130975629|NCT03449030|471535610|FG000|Overall Study|Withdrawal by Subject|0|||
130975630|NCT03449030|471535611|FG001|Overall Study|Withdrawal by Subject|0|||
130975631|NCT03449030|471535612|FG002|Overall Study|Withdrawal by Subject|0|||
130975632|NCT03449030|471535613|FG003|Overall Study|Withdrawal by Subject|1|||
130975633|NCT03449030|471535614|FG004|Overall Study|Withdrawal by Subject|1|||
130975634|NCT03449030|471535615|FG005|Overall Study|Withdrawal by Subject|1|||
130975635|NCT03449030|471535616|FG006|Overall Study|Withdrawal by Subject|1|||
130975636|NCT03449030|471535617|FG007|Overall Study|Withdrawal by Subject|2|||
130975637|NCT03449030|471535618|FG008|Overall Study|Withdrawal by Subject|0|||
130975638|NCT03449030|471535619|FG009|Overall Study|Withdrawal by Subject|0|||
130975639|NCT03449030|471535610|FG000|Overall Study|Symptomatic Deterioration|0|||
130975640|NCT03449030|471535611|FG001|Overall Study|Symptomatic Deterioration|1|||
131131395|NCT02432235|472108338|FG011|Overall Study|Withdrawal by Subject|0|||
131131396|NCT02432235|472108327|FG000|Overall Study|Lost to Follow-up|0|||
130777134|NCT01808261|470810421|FG000|Overall Study|Adverse event, non-fatal|2|||
130777135|NCT01808261|470810422|FG001|Overall Study|Adverse event, non-fatal|0|||
130777136|NCT01808261|470810421|FG000|Overall Study|Consent withdrawn by subject|6|||
130777137|NCT01808261|470810422|FG001|Overall Study|Consent withdrawn by subject|7|||
130777138|NCT01808261|470810421|FG000|Overall Study|Lost to Follow-up|3|||
130777139|NCT01808261|470810422|FG001|Overall Study|Lost to Follow-up|1|||
130777140|NCT01737879|470810427|FG000|Overall Study|Death|1|||
130777141|NCT01737879|470810427|FG000|Overall Study|Sponsor decision|40|||
130777142|NCT02497404|470810428|FG000|Overall Study|Adverse Event|1|||
130777143|NCT02998996|470810435|FG000|Overall Study|Lost to Follow-up|0|||
130975641|NCT03449030|471535612|FG002|Overall Study|Symptomatic Deterioration|0|||
130975642|NCT03449030|471535613|FG003|Overall Study|Symptomatic Deterioration|0|||
130975643|NCT03449030|471535614|FG004|Overall Study|Symptomatic Deterioration|0|||
130975644|NCT03449030|471535615|FG005|Overall Study|Symptomatic Deterioration|1|||
130975645|NCT03449030|471535616|FG006|Overall Study|Symptomatic Deterioration|1|||
130975646|NCT03449030|471535617|FG007|Overall Study|Symptomatic Deterioration|0|||
130975647|NCT03449030|471535618|FG008|Overall Study|Symptomatic Deterioration|2|||
130975648|NCT03449030|471535619|FG009|Overall Study|Symptomatic Deterioration|0|||
130975649|NCT03449030|471535610|FG000|Overall Study|Progressive Disease|1|||
130777144|NCT02998996|470810436|FG001|Overall Study|Lost to Follow-up|0|||
130975650|NCT03449030|471535611|FG001|Overall Study|Progressive Disease|0|||
130975651|NCT03449030|471535612|FG002|Overall Study|Progressive Disease|1|||
130975652|NCT03449030|471535613|FG003|Overall Study|Progressive Disease|4|||
130975653|NCT03449030|471535614|FG004|Overall Study|Progressive Disease|5|||
130975654|NCT03449030|471535615|FG005|Overall Study|Progressive Disease|3|||
130975655|NCT03449030|471535616|FG006|Overall Study|Progressive Disease|0|||
130975656|NCT03449030|471535617|FG007|Overall Study|Progressive Disease|1|||
130777145|NCT02998996|470810437|FG002|Overall Study|Lost to Follow-up|1|||
130777146|NCT02998996|470810438|FG003|Overall Study|Lost to Follow-up|0|||
130777147|NCT02998996|470810439|FG004|Overall Study|Lost to Follow-up|0|||
130975657|NCT03449030|471535618|FG008|Overall Study|Progressive Disease|1|||
130777148|NCT02998996|470810440|FG005|Overall Study|Lost to Follow-up|0|||
130777149|NCT02998996|470810435|FG000|Overall Study|Pregnancy|0|||
130777150|NCT02998996|470810436|FG001|Overall Study|Pregnancy|1|||
130777151|NCT02998996|470810437|FG002|Overall Study|Pregnancy|0|||
130777152|NCT02998996|470810438|FG003|Overall Study|Pregnancy|0|||
130777153|NCT02998996|470810439|FG004|Overall Study|Pregnancy|0|||
130777154|NCT02998996|470810440|FG005|Overall Study|Pregnancy|0|||
130777155|NCT02998996|470810435|FG000|Overall Study|Family reasons|0|||
130777156|NCT02998996|470810436|FG001|Overall Study|Family reasons|0|||
130777157|NCT02998996|470810437|FG002|Overall Study|Family reasons|0|||
130777158|NCT02998996|470810438|FG003|Overall Study|Family reasons|0|||
130777159|NCT02998996|470810439|FG004|Overall Study|Family reasons|1|||
130777160|NCT02998996|470810440|FG005|Overall Study|Family reasons|0|||
130777161|NCT01066871|470810443|FG000|Overall Study|Lost to Follow-up|0|||
130777162|NCT01066871|470810444|FG001|Overall Study|Lost to Follow-up|2|||
130777163|NCT01066871|470810445|FG002|Overall Study|Lost to Follow-up|2|||
130777164|NCT01066871|470810446|FG003|Overall Study|Lost to Follow-up|0|||
130777165|NCT01066871|470810443|FG000|Overall Study|Protocol Violation|1|||
130777166|NCT01066871|470810444|FG001|Overall Study|Protocol Violation|0|||
130777167|NCT01066871|470810445|FG002|Overall Study|Protocol Violation|3|||
130777168|NCT01066871|470810446|FG003|Overall Study|Protocol Violation|2|||
130777169|NCT01066871|470810443|FG000|Overall Study|Lack of Efficacy|0|||
130777170|NCT01066871|470810444|FG001|Overall Study|Lack of Efficacy|0|||
130777171|NCT01066871|470810445|FG002|Overall Study|Lack of Efficacy|0|||
130777172|NCT01066871|470810446|FG003|Overall Study|Lack of Efficacy|1|||
130777173|NCT01066871|470810443|FG000|Overall Study|Withdrawal by Subject|3|||
130777174|NCT01066871|470810444|FG001|Overall Study|Withdrawal by Subject|1|||
130777175|NCT01066871|470810445|FG002|Overall Study|Withdrawal by Subject|0|||
130777176|NCT01066871|470810446|FG003|Overall Study|Withdrawal by Subject|0|||
130777177|NCT01066871|470810443|FG000|Overall Study|Other|0|||
130777178|NCT01066871|470810444|FG001|Overall Study|Other|2|||
130777179|NCT01066871|470810445|FG002|Overall Study|Other|1|||
130777180|NCT01066871|470810446|FG003|Overall Study|Other|2|||
130777181|NCT00954122|470811723|FG000|Overall Study|Withdrawal by Subject|5|||
130777182|NCT00954122|470811723|FG000|Overall Study|Adverse Event|1|||
130777183|NCT00954122|470811723|FG000|Overall Study|Safety Reason|1|||
130777184|NCT02121795|470811732|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
130777185|NCT02121795|470811733|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
130777186|NCT02121795|470811732|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
130777187|NCT02121795|470811733|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
130777188|NCT02121795|470811732|FG000|Double-Blind Phase|Lost to Follow-up|7|||
130777189|NCT02121795|470811733|FG001|Double-Blind Phase|Lost to Follow-up|4|||
130777190|NCT02121795|470811732|FG000|Double-Blind Phase|Physician Decision|2|||
130777191|NCT02121795|470811733|FG001|Double-Blind Phase|Physician Decision|5|||
130777192|NCT02121795|470811732|FG000|Double-Blind Phase|Adverse Event|5|||
130777193|NCT02121795|470811733|FG001|Double-Blind Phase|Adverse Event|0|||
130777194|NCT02121795|470811732|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
130777195|NCT02121795|470811733|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
130777196|NCT02121795|470811732|FG000|Double-Blind Phase|Protocol Violation|0|||
130777197|NCT02121795|470811733|FG001|Double-Blind Phase|Protocol Violation|3|||
130777198|NCT02121795|470811732|FG000|Double-Blind Phase|Death|1|||
130777199|NCT02121795|470811733|FG001|Double-Blind Phase|Death|1|||
130777200|NCT02121795|470811732|FG000|Open-Label Phase|Physician Decision|8|||
130777201|NCT02121795|470811733|FG001|Open-Label Phase|Physician Decision|8|||
130777202|NCT02121795|470811732|FG000|Open-Label Phase|Withdrawal by Subject|3|||
130777203|NCT02121795|470811733|FG001|Open-Label Phase|Withdrawal by Subject|2|||
130777204|NCT02121795|470811732|FG000|Open-Label Phase|Lost to Follow-up|1|||
130777205|NCT02121795|470811733|FG001|Open-Label Phase|Lost to Follow-up|0|||
130777206|NCT00666211|470811734|FG000|Overall Study|Withdrawal by Subject|10|||
130777207|NCT00666211|470811735|FG001|Overall Study|Withdrawal by Subject|13|||
130777208|NCT00666211|470811734|FG000|Overall Study|went off medication, no more pain|1|||
130777209|NCT00666211|470811735|FG001|Overall Study|went off medication, no more pain|0|||
130777210|NCT00666211|470811734|FG000|Overall Study|patient non-compliant|6|||
130777211|NCT00666211|470811735|FG001|Overall Study|patient non-compliant|6|||
130777212|NCT00666211|470811734|FG000|Overall Study|disease progression|1|||
130777213|NCT00666211|470811735|FG001|Overall Study|disease progression|8|||
130777214|NCT00666211|470811734|FG000|Overall Study|Lost to Follow-up|2|||
130777215|NCT00666211|470811735|FG001|Overall Study|Lost to Follow-up|0|||
130777216|NCT00666211|470811734|FG000|Overall Study|toxicity|0|||
130777217|NCT00666211|470811735|FG001|Overall Study|toxicity|2|||
130777218|NCT00666211|470811734|FG000|Overall Study|hospital admission|0|||
130777219|NCT00666211|470811735|FG001|Overall Study|hospital admission|5|||
130777220|NCT00666211|470811734|FG000|Overall Study|Death|0|||
130777221|NCT00666211|470811735|FG001|Overall Study|Death|2|||
130777222|NCT00666211|470811734|FG000|Overall Study|off tx for other complicating disease|0|||
130777223|NCT00666211|470811735|FG001|Overall Study|off tx for other complicating disease|1|||
130777224|NCT00666211|470811734|FG000|Overall Study|Physician Decision|0|||
130777225|NCT00666211|470811735|FG001|Overall Study|Physician Decision|1|||
130777226|NCT02299388|470811736|FG000|Overall Study|Withdrawal by Subject|0|||
130777227|NCT02299388|470811737|FG001|Overall Study|Withdrawal by Subject|1|||
130777228|NCT00103662|470811738|FG000|Overall Study|Entered Rescue Procedure|0|||
130777229|NCT00103662|470811739|FG001|Overall Study|Entered Rescue Procedure|7|||
130777230|NCT00103662|470811738|FG000|Overall Study|Death|7|||
130777231|NCT00103662|470811739|FG001|Overall Study|Death|7|||
130777232|NCT00103662|470811738|FG000|Overall Study|Elective Withdrawal|5|||
130777233|NCT00103662|470811739|FG001|Overall Study|Elective Withdrawal|5|||
130777234|NCT00103662|470811738|FG000|Overall Study|Lost to Follow-up|0|||
130777235|NCT00103662|470811739|FG001|Overall Study|Lost to Follow-up|1|||
130777236|NCT00103662|470811738|FG000|Overall Study|Other|6|||
130777237|NCT00103662|470811739|FG001|Overall Study|Other|9|||
130777238|NCT00103662|470811738|FG000|Overall Study|Failed mobilization|0|||
130777239|NCT00103662|470811739|FG001|Overall Study|Failed mobilization|4|||
130777240|NCT00103662|470811738|FG000|Overall Study|Intercurrent illness|1|||
130777241|NCT00103662|470811739|FG001|Overall Study|Intercurrent illness|0|||
130777242|NCT03334188|470811742|FG000|Overall Study|Withdrawal by Subject|0|||
130777243|NCT03334188|470811743|FG001|Overall Study|Withdrawal by Subject|1|||
130777244|NCT03334188|470811742|FG000|Overall Study|Death|1|||
130777245|NCT03334188|470811743|FG001|Overall Study|Death|0|||
130777246|NCT03334188|470811742|FG000|Overall Study|Never had qualifying clinic visit|7|||
130777247|NCT03334188|470811743|FG001|Overall Study|Never had qualifying clinic visit|7|||
130777248|NCT03373760|470811746|FG000|Overall Study|Adverse Event|8|||
130777249|NCT03373760|470811746|FG000|Overall Study|Disease Progression|46|||
130777250|NCT03373760|470811746|FG000|Overall Study|Death|4|||
130777251|NCT01093586|470811747|FG000|Overall Study|Failed to engraft|3|||
130777252|NCT00357877|470811748|FG000|Overall Study|Death|2|||
130777253|NCT00357877|470811749|FG001|Overall Study|Death|1|||
130975658|NCT03449030|471535619|FG009|Overall Study|Progressive Disease|1|||
130975659|NCT03449030|471535610|FG000|Overall Study|Adverse Event|0|||
130975660|NCT03449030|471535611|FG001|Overall Study|Adverse Event|0|||
130975661|NCT03449030|471535612|FG002|Overall Study|Adverse Event|0|||
130975662|NCT03449030|471535613|FG003|Overall Study|Adverse Event|0|||
130975663|NCT03449030|471535614|FG004|Overall Study|Adverse Event|0|||
130975664|NCT03449030|471535615|FG005|Overall Study|Adverse Event|2|||
130975665|NCT03449030|471535616|FG006|Overall Study|Adverse Event|0|||
130717467|NCT01103466|470591039|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
130717468|NCT01103466|470591040|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
130717469|NCT01103466|470591041|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
130717470|NCT01103466|470591039|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
130717471|NCT01103466|470591040|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
130717472|NCT01103466|470591041|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
130717473|NCT01103466|470591039|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
130717474|NCT01103466|470591040|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
130717475|NCT01103466|470591041|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
130717476|NCT01103466|470591039|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
130717477|NCT01103466|470591040|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
130717478|NCT01103466|470591041|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
130717479|NCT02283983|470591050|FG000|Overall Study|Inclusion criteria not met|0|||
130717480|NCT02283983|470591051|FG001|Overall Study|Inclusion criteria not met|1|||
130717481|NCT02283983|470591050|FG000|Overall Study|Withdrawal by Subject|4|||
130717482|NCT02283983|470591051|FG001|Overall Study|Withdrawal by Subject|2|||
130717483|NCT02283983|470591050|FG000|Overall Study|Protocol Violation|0|||
130717484|NCT02283983|470591051|FG001|Overall Study|Protocol Violation|4|||
130717485|NCT02283983|470591050|FG000|Overall Study|Physician Decision|2|||
130717486|NCT02283983|470591051|FG001|Overall Study|Physician Decision|4|||
130717487|NCT02283983|470591050|FG000|Overall Study|Death|1|||
130717488|NCT02283983|470591051|FG001|Overall Study|Death|0|||
130717489|NCT02283983|470591050|FG000|Overall Study|Adverse Event|1|||
130717490|NCT02283983|470591051|FG001|Overall Study|Adverse Event|0|||
130717491|NCT02283983|470591050|FG000|Overall Study|Lost to Follow-up|9|||
130717492|NCT02283983|470591051|FG001|Overall Study|Lost to Follow-up|8|||
130717493|NCT02283983|470591050|FG000|Overall Study|Relapse|1|||
130717494|NCT02283983|470591051|FG001|Overall Study|Relapse|0|||
130717495|NCT04453202|470591053|FG000|Overall Study|Adverse Event|0|||
130777254|NCT00357877|470811748|FG000|Overall Study|Lost to Follow-up|20|||
130777255|NCT00357877|470811749|FG001|Overall Study|Lost to Follow-up|23|||
130777256|NCT00357877|470811748|FG000|Overall Study|Withdrawal by Subject|3|||
131131397|NCT02432235|472108328|FG001|Overall Study|Lost to Follow-up|0|||
130717496|NCT04453202|470591054|FG001|Overall Study|Adverse Event|0|||
130717497|NCT04453202|470591055|FG002|Overall Study|Adverse Event|0|||
130717498|NCT04453202|470591056|FG003|Overall Study|Adverse Event|0|||
130717499|NCT04453202|470591057|FG004|Overall Study|Adverse Event|0|||
130777257|NCT00357877|470811749|FG001|Overall Study|Withdrawal by Subject|3|||
130975666|NCT03449030|471535617|FG007|Overall Study|Adverse Event|0|||
130717500|NCT04453202|470591058|FG005|Overall Study|Adverse Event|0|||
130777258|NCT00357877|470811748|FG000|Overall Study|Administrative withdrawal|1|||
130777259|NCT00357877|470811749|FG001|Overall Study|Administrative withdrawal|1|||
130777260|NCT00357877|470811748|FG000|Overall Study|Other|0|||
130975667|NCT03449030|471535618|FG008|Overall Study|Adverse Event|0|||
130777261|NCT00357877|470811749|FG001|Overall Study|Other|2|||
130777262|NCT04668209|470811750|FG000|Overall Study|Withdrawal by Subject|2|||
130777263|NCT04668209|470811751|FG001|Overall Study|Withdrawal by Subject|2|||
130777264|NCT04668209|470811750|FG000|Overall Study|Lost to Follow-up|3|||
130777265|NCT04668209|470811751|FG001|Overall Study|Lost to Follow-up|4|||
130777266|NCT04668209|470811750|FG000|Overall Study|Subject Expired|2|||
130777267|NCT04668209|470811751|FG001|Overall Study|Subject Expired|0|||
130777268|NCT04668209|470811750|FG000|Overall Study|Withdrawn from study|0|||
130777269|NCT04668209|470811751|FG001|Overall Study|Withdrawn from study|1|||
130777270|NCT04668209|470811750|FG000|Overall Study|Adverse Event|0|||
130777271|NCT04668209|470811751|FG001|Overall Study|Adverse Event|1|||
130777272|NCT00613366|470811754|FG000|Overall Study|Withdrawal by Subject|3|||
130777273|NCT00613366|470811755|FG001|Overall Study|Withdrawal by Subject|2|||
130777274|NCT00766597|470811756|FG000|Overall Study|Unexpected closure of study|4|||
130777275|NCT00766597|470811756|FG000|Overall Study|Without CCR5-tropic virus|5|||
130975668|NCT03449030|471535619|FG009|Overall Study|Adverse Event|0|||
130717501|NCT04453202|470591059|FG006|Overall Study|Adverse Event|1|||
130777276|NCT01135524|470811757|FG000|Overall Study|Withdrawal by Subject|14|||
130777277|NCT01135524|470811757|FG000|Overall Study|Adverse Event|20|||
130975669|NCT03449030|471535610|FG000|Overall Study|Death|0|||
130975670|NCT03449030|471535611|FG001|Overall Study|Death|0|||
130975671|NCT03449030|471535612|FG002|Overall Study|Death|0|||
130975672|NCT03449030|471535613|FG003|Overall Study|Death|0|||
130975673|NCT03449030|471535614|FG004|Overall Study|Death|1|||
130975674|NCT03449030|471535615|FG005|Overall Study|Death|0|||
130975675|NCT03449030|471535616|FG006|Overall Study|Death|0|||
130975676|NCT03449030|471535617|FG007|Overall Study|Death|0|||
131131398|NCT02432235|472108329|FG002|Overall Study|Lost to Follow-up|0|||
130717502|NCT04453202|470591060|FG007|Overall Study|Adverse Event|0|||
130717503|NCT04453202|470591061|FG008|Overall Study|Adverse Event|0|||
130717504|NCT04453202|470591062|FG009|Overall Study|Adverse Event|0|||
130717505|NCT04453202|470591063|FG010|Overall Study|Adverse Event|0|||
130717506|NCT04453202|470591053|FG000|Overall Study|Death|0|||
130717507|NCT04453202|470591054|FG001|Overall Study|Death|0|||
130717508|NCT04453202|470591055|FG002|Overall Study|Death|0|||
130717509|NCT04453202|470591056|FG003|Overall Study|Death|0|||
130717510|NCT04453202|470591057|FG004|Overall Study|Death|0|||
130717511|NCT04453202|470591058|FG005|Overall Study|Death|0|||
130717512|NCT04453202|470591059|FG006|Overall Study|Death|0|||
130717513|NCT04453202|470591060|FG007|Overall Study|Death|0|||
130717514|NCT04453202|470591061|FG008|Overall Study|Death|0|||
130717515|NCT04453202|470591062|FG009|Overall Study|Death|1|||
130717516|NCT04453202|470591063|FG010|Overall Study|Death|0|||
130717517|NCT04453202|470591053|FG000|Overall Study|Lost to Follow-up|0|||
130717518|NCT04453202|470591054|FG001|Overall Study|Lost to Follow-up|1|||
130717519|NCT04453202|470591055|FG002|Overall Study|Lost to Follow-up|0|||
130717520|NCT04453202|470591056|FG003|Overall Study|Lost to Follow-up|1|||
130717521|NCT04453202|470591057|FG004|Overall Study|Lost to Follow-up|0|||
130717522|NCT04453202|470591058|FG005|Overall Study|Lost to Follow-up|0|||
130717523|NCT04453202|470591059|FG006|Overall Study|Lost to Follow-up|0|||
130717524|NCT04453202|470591060|FG007|Overall Study|Lost to Follow-up|0|||
130717525|NCT04453202|470591061|FG008|Overall Study|Lost to Follow-up|0|||
130717526|NCT04453202|470591062|FG009|Overall Study|Lost to Follow-up|1|||
130717527|NCT04453202|470591063|FG010|Overall Study|Lost to Follow-up|1|||
130717528|NCT04453202|470591053|FG000|Overall Study|Withdrawal by Subject|1|||
130717529|NCT04453202|470591054|FG001|Overall Study|Withdrawal by Subject|2|||
130717530|NCT04453202|470591055|FG002|Overall Study|Withdrawal by Subject|1|||
130717531|NCT04453202|470591056|FG003|Overall Study|Withdrawal by Subject|2|||
130717532|NCT04453202|470591057|FG004|Overall Study|Withdrawal by Subject|1|||
130717533|NCT04453202|470591058|FG005|Overall Study|Withdrawal by Subject|1|||
131131399|NCT02432235|472108330|FG003|Overall Study|Lost to Follow-up|0|||
130717534|NCT04453202|470591059|FG006|Overall Study|Withdrawal by Subject|0|||
130777278|NCT01135524|470811757|FG000|Overall Study|Lost to Follow-up|3|||
130777279|NCT01135524|470811757|FG000|Overall Study|Administrative|151|||
130777280|NCT01135524|470811757|FG000|Overall Study|Lack of Efficacy|8|||
130975677|NCT03449030|471535618|FG008|Overall Study|Death|0|||
130975678|NCT03449030|471535619|FG009|Overall Study|Death|0|||
130717535|NCT04453202|470591060|FG007|Overall Study|Withdrawal by Subject|0|||
130717536|NCT04453202|470591061|FG008|Overall Study|Withdrawal by Subject|0|||
130717537|NCT04453202|470591062|FG009|Overall Study|Withdrawal by Subject|1|||
130717538|NCT04453202|470591063|FG010|Overall Study|Withdrawal by Subject|0|||
130717539|NCT04453202|470591053|FG000|Overall Study|Adverse Event|0|||
130717540|NCT04453202|470591054|FG001|Overall Study|Adverse Event|0|||
130717541|NCT04453202|470591055|FG002|Overall Study|Adverse Event|0|||
130717542|NCT04453202|470591056|FG003|Overall Study|Adverse Event|0|||
130717543|NCT04453202|470591057|FG004|Overall Study|Adverse Event|0|||
130717544|NCT04453202|470591058|FG005|Overall Study|Adverse Event|1|||
130777281|NCT00943397|470811758|FG000|Overall Study|Adverse Event|0|||
130777282|NCT00943397|470811759|FG001|Overall Study|Adverse Event|6|||
130777283|NCT00943397|470811758|FG000|Overall Study|Lost to Follow-up|0|||
130777284|NCT00943397|470811759|FG001|Overall Study|Lost to Follow-up|4|||
130975679|NCT03943095|471535620|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
130777285|NCT00943397|470811758|FG000|Overall Study|Protocol Violation|2|||
130777286|NCT00943397|470811759|FG001|Overall Study|Protocol Violation|5|||
130777287|NCT00943397|470811758|FG000|Overall Study|Withdrawal by Subject|1|||
130777288|NCT00943397|470811759|FG001|Overall Study|Withdrawal by Subject|1|||
130777289|NCT00943397|470811758|FG000|Overall Study|Site terminated and other|12|||
130777290|NCT00943397|470811759|FG001|Overall Study|Site terminated and other|56|||
130975680|NCT03943095|471535621|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
130975681|NCT03943095|471535620|FG000|Overall Study|Withdrawal by Subject|1|||
130975682|NCT03943095|471535621|FG001|Overall Study|Withdrawal by Subject|0|||
130975683|NCT00679939|471535623|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
130975684|NCT00679939|471535624|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
130975685|NCT00679939|471535623|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
130975686|NCT00679939|471535624|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
130975687|NCT00679939|471535623|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
130975688|NCT00679939|471535624|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
130975689|NCT00679939|471535623|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
130975690|NCT00679939|471535624|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
130975691|NCT00679939|471535623|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
130975692|NCT00679939|471535624|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
130975693|NCT00679939|471535623|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
130975694|NCT00679939|471535624|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
130975695|NCT00679939|471535623|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
130975696|NCT00679939|471535624|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
130975697|NCT00679939|471535623|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
130975698|NCT00679939|471535624|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
130975699|NCT00679939|471535623|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
130975700|NCT00679939|471535624|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
130975701|NCT00679939|471535623|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
130975702|NCT00679939|471535624|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
130975703|NCT02269670|471535629|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
130975704|NCT04657211|471535632|FG000|Overall Study|Withdrawal by Subject|21|||
130975705|NCT04657211|471535632|FG000|Overall Study|Lost to Follow-up|113|||
130975706|NCT04657211|471535632|FG000|Overall Study|Death|47|||
130777291|NCT02907463|470811760|FG000|Overall Study|Lost to Follow-up|17|||
130777292|NCT02907463|470811760|FG000|Overall Study|Death|10|||
130777293|NCT02907463|470811760|FG000|Overall Study|Withdrawal by Subject|4|||
130777294|NCT02907463|470811760|FG000|Overall Study|MIS Approach was not used|2|||
130777295|NCT02907463|470811760|FG000|Overall Study|Not Implanted with Study Device|2|||
130777296|NCT02907463|470811760|FG000|Overall Study|Device Explanted|1|||
130777297|NCT02907463|470811760|FG000|Overall Study|Missing Exit Form|1|||
130777298|NCT01266824|470811761|FG000|Overall Study|Study terminated prior to completion|2|||
130777299|NCT01266824|470811762|FG001|Overall Study|Study terminated prior to completion|3|||
130777300|NCT00411450|470811763|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
130975707|NCT04657211|471535632|FG000|Overall Study|Transfer to another institution|21|||
130975708|NCT04657211|471535632|FG000|Overall Study|Other|29|||
130777301|NCT01716663|470811764|FG000|Overall Study|Withdrawn prior to procedure|4|||
130777302|NCT01716663|470811764|FG000|Overall Study|Treated with non-study catheter|2|||
130975709|NCT02693665|471535633|FG000|Overall Study|Death|3|||
130777303|NCT02254772|470811771|FG000|Overall Study|Ineligible|1|||
130777304|NCT02254772|470811771|FG000|Overall Study|Withdrawal by Subject|1|||
130777305|NCT05225558|470811772|FG000|Overall Study|Withdrawal by Subject|4|||
130777306|NCT05225558|470811773|FG001|Overall Study|Withdrawal by Subject|3|||
130777307|NCT05225558|470811772|FG000|Overall Study|Adverse Event|1|||
130777308|NCT05225558|470811773|FG001|Overall Study|Adverse Event|0|||
130777309|NCT05225558|470811772|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
130777310|NCT05225558|470811773|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
130777311|NCT05225558|470811772|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
130777312|NCT05225558|470811773|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
130777313|NCT01001910|470811774|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
130777314|NCT00614874|470811775|FG000|Overall Study|Protocol Violation|1|||
130777315|NCT00614874|470811775|FG000|Overall Study|Withdrawal by Subject|1|||
130777316|NCT03006562|470811776|FG000|Overall Study|Lost to Follow-up|0|||
130777317|NCT03006562|470811777|FG001|Overall Study|Lost to Follow-up|1|||
130777318|NCT01089127|470811782|FG000|Overall Study|Adverse Event|5|||
130777319|NCT01089127|470811783|FG001|Overall Study|Adverse Event|1|||
130975710|NCT02693665|471535634|FG001|Overall Study|Death|2|||
130975711|NCT02693665|471535633|FG000|Overall Study|Lost to Follow-up|7|||
130975712|NCT02693665|471535634|FG001|Overall Study|Lost to Follow-up|3|||
130975713|NCT02693665|471535633|FG000|Overall Study|Protocol Violation|1|||
131131400|NCT02432235|472108331|FG004|Overall Study|Lost to Follow-up|0|||
130975714|NCT02693665|471535634|FG001|Overall Study|Protocol Violation|0|||
130975715|NCT02693665|471535633|FG000|Overall Study|Withdrawal by Subject|2|||
130975716|NCT02693665|471535634|FG001|Overall Study|Withdrawal by Subject|0|||
130975717|NCT02693665|471535633|FG000|Overall Study|patient wanted to leave it behind|1|||
130975718|NCT02693665|471535634|FG001|Overall Study|patient wanted to leave it behind|0|||
130777320|NCT01089127|470811784|FG002|Overall Study|Adverse Event|1|||
130777321|NCT01089127|470811785|FG003|Overall Study|Adverse Event|0|||
130777322|NCT01089127|470811786|FG004|Overall Study|Adverse Event|0|||
130777323|NCT01089127|470811787|FG005|Overall Study|Adverse Event|1|||
130777324|NCT01089127|470811782|FG000|Overall Study|Subject withdrew consent|0|||
130777325|NCT01089127|470811783|FG001|Overall Study|Subject withdrew consent|1|||
130777326|NCT01089127|470811784|FG002|Overall Study|Subject withdrew consent|1|||
130777327|NCT01089127|470811785|FG003|Overall Study|Subject withdrew consent|1|||
130777328|NCT01089127|470811786|FG004|Overall Study|Subject withdrew consent|0|||
130777329|NCT01089127|470811787|FG005|Overall Study|Subject withdrew consent|2|||
130777330|NCT01089127|470811782|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130777331|NCT01089127|470811783|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130777332|NCT01089127|470811784|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130975719|NCT02693665|471535633|FG000|Overall Study|anxiety|1|||
130777333|NCT01089127|470811785|FG003|Overall Study|Abnormal test procedure result(s)|0|||
130777334|NCT01089127|470811786|FG004|Overall Study|Abnormal test procedure result(s)|0|||
130777335|NCT01089127|470811787|FG005|Overall Study|Abnormal test procedure result(s)|0|||
130777336|NCT01089127|470811782|FG000|Overall Study|Lost to Follow-up|1|||
130777337|NCT01089127|470811783|FG001|Overall Study|Lost to Follow-up|1|||
130777338|NCT01089127|470811784|FG002|Overall Study|Lost to Follow-up|0|||
130777339|NCT01089127|470811785|FG003|Overall Study|Lost to Follow-up|0|||
130777340|NCT01089127|470811786|FG004|Overall Study|Lost to Follow-up|1|||
130777341|NCT01089127|470811787|FG005|Overall Study|Lost to Follow-up|0|||
130777342|NCT01089127|470811782|FG000|Overall Study|Protocol deviation|0|||
130777343|NCT01089127|470811783|FG001|Overall Study|Protocol deviation|1|||
130777344|NCT01089127|470811784|FG002|Overall Study|Protocol deviation|0|||
130777345|NCT01089127|470811785|FG003|Overall Study|Protocol deviation|0|||
130777346|NCT01089127|470811786|FG004|Overall Study|Protocol deviation|1|||
130777347|NCT01089127|470811787|FG005|Overall Study|Protocol deviation|0|||
130777348|NCT00511810|470811789|FG000|Overall Study|Lost to Follow-up|1|||
130777349|NCT00511810|470811790|FG001|Overall Study|Lost to Follow-up|2|||
130777350|NCT00511810|470811789|FG000|Overall Study|Lack of Efficacy|0|||
130777351|NCT00511810|470811790|FG001|Overall Study|Lack of Efficacy|2|||
130777352|NCT00511810|470811789|FG000|Overall Study|Refused second scn|0|||
130777353|NCT00511810|470811790|FG001|Overall Study|Refused second scn|1|||
130777354|NCT02427841|470811791|FG000|Overall Study|Lack of Efficacy|5|||
130777355|NCT02427841|470811791|FG000|Overall Study|Physician Decision|2|||
130777356|NCT02427841|470811791|FG000|Overall Study|Withdrawal by Subject|1|||
130777357|NCT01048541|470811792|FG000|Overall Study|Withdrawal by Subject|1|||
130777358|NCT01048541|470811793|FG001|Overall Study|Withdrawal by Subject|0|||
130777359|NCT00627497|470811794|FG000|Overall Study|Lost to Follow-up|1|||
130777360|NCT00627497|470811795|FG001|Overall Study|Lost to Follow-up|1|||
130777361|NCT00627497|470811796|FG002|Overall Study|Lost to Follow-up|0|||
130777362|NCT00627497|470811797|FG003|Overall Study|Lost to Follow-up|0|||
130777363|NCT01502033|470811798|FG000|Overall Study|1 participant had scalp discomfort|1|||
130777364|NCT01502033|470811798|FG000|Overall Study|1 participant had worsening depression|1|||
130777365|NCT01502033|470811798|FG000|Overall Study|1 participant went back to school|1|||
130777366|NCT05285787|470811800|FG000|Overall Study|Withdrawal by Subject|1|||
130777367|NCT02360280|470811804|FG000|Overall Study|Withdrawal by Subject|2|||
130777368|NCT02360280|470811805|FG001|Overall Study|Withdrawal by Subject|0|||
130777369|NCT02360280|470811804|FG000|Overall Study|Adverse Event|0|||
130777370|NCT02360280|470811805|FG001|Overall Study|Adverse Event|1|||
130777371|NCT02360280|470811804|FG000|Overall Study|Lost to Follow-up|1|||
130777372|NCT02360280|470811805|FG001|Overall Study|Lost to Follow-up|0|||
130777373|NCT02472886|470811806|FG000|Overall Study|Lack of Efficacy|0|||
130777374|NCT02472886|470811807|FG001|Overall Study|Lack of Efficacy|2|||
130777375|NCT02472886|470811808|FG002|Overall Study|Lack of Efficacy|1|||
130777376|NCT00320788|470811809|FG000|Overall Study|Adverse Event|0|||
130777377|NCT00320788|470811810|FG001|Overall Study|Adverse Event|0|||
130777378|NCT00320788|470811811|FG002|Overall Study|Adverse Event|0|||
130777379|NCT00320788|470811812|FG003|Overall Study|Adverse Event|1|||
130777380|NCT00320788|470811813|FG004|Overall Study|Adverse Event|0|||
130975720|NCT02693665|471535634|FG001|Overall Study|anxiety|0|||
130975721|NCT02693665|471535633|FG000|Overall Study|family issues|1|||
130975722|NCT02693665|471535634|FG001|Overall Study|family issues|0|||
130777381|NCT00320788|470811809|FG000|Overall Study|Death|0|||
130777382|NCT00320788|470811810|FG001|Overall Study|Death|0|||
130777383|NCT00320788|470811811|FG002|Overall Study|Death|1|||
130777384|NCT00320788|470811812|FG003|Overall Study|Death|0|||
130777385|NCT00320788|470811813|FG004|Overall Study|Death|1|||
130777386|NCT00320788|470811809|FG000|Overall Study|Lost to Follow-up|0|||
130777387|NCT00320788|470811810|FG001|Overall Study|Lost to Follow-up|2|||
130777388|NCT00320788|470811811|FG002|Overall Study|Lost to Follow-up|1|||
130975723|NCT02693665|471535633|FG000|Overall Study|no reason given|1|||
130777389|NCT00320788|470811812|FG003|Overall Study|Lost to Follow-up|0|||
130777390|NCT00320788|470811813|FG004|Overall Study|Lost to Follow-up|0|||
130777391|NCT00320788|470811809|FG000|Overall Study|Decision by the Sponsor|1|||
130777392|NCT00320788|470811810|FG001|Overall Study|Decision by the Sponsor|1|||
130777393|NCT00320788|470811811|FG002|Overall Study|Decision by the Sponsor|0|||
130777394|NCT00320788|470811812|FG003|Overall Study|Decision by the Sponsor|0|||
130777395|NCT00320788|470811813|FG004|Overall Study|Decision by the Sponsor|1|||
130777396|NCT00320788|470811809|FG000|Overall Study|Other|1|||
130777397|NCT00320788|470811810|FG001|Overall Study|Other|2|||
130777398|NCT00320788|470811811|FG002|Overall Study|Other|1|||
130777399|NCT00320788|470811812|FG003|Overall Study|Other|1|||
130777400|NCT00320788|470811813|FG004|Overall Study|Other|1|||
130777401|NCT00320788|470811809|FG000|Overall Study|Physician Decision|1|||
130777402|NCT00320788|470811810|FG001|Overall Study|Physician Decision|1|||
130777403|NCT00320788|470811811|FG002|Overall Study|Physician Decision|0|||
130777404|NCT00320788|470811812|FG003|Overall Study|Physician Decision|0|||
130777405|NCT00320788|470811813|FG004|Overall Study|Physician Decision|0|||
130777406|NCT00320788|470811809|FG000|Overall Study|Protocol Violation|0|||
130777407|NCT00320788|470811810|FG001|Overall Study|Protocol Violation|0|||
130777408|NCT00320788|470811811|FG002|Overall Study|Protocol Violation|0|||
130777409|NCT00320788|470811812|FG003|Overall Study|Protocol Violation|0|||
130777410|NCT00320788|470811813|FG004|Overall Study|Protocol Violation|1|||
130777411|NCT00320788|470811809|FG000|Overall Study|Withdrawal by Subject|3|||
130777412|NCT00320788|470811810|FG001|Overall Study|Withdrawal by Subject|0|||
130777413|NCT00320788|470811811|FG002|Overall Study|Withdrawal by Subject|0|||
130777414|NCT00320788|470811812|FG003|Overall Study|Withdrawal by Subject|3|||
130777415|NCT00320788|470811813|FG004|Overall Study|Withdrawal by Subject|1|||
130777416|NCT02797678|470811834|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
130777417|NCT02797678|470811835|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
130777418|NCT02797678|470811836|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
130777419|NCT02797678|470811837|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
130777420|NCT02797678|470811834|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
130777421|NCT02797678|470811835|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
130777422|NCT02797678|470811836|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
130777423|NCT02797678|470811837|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
130777424|NCT02797678|470811834|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
130777425|NCT02797678|470811835|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
130777426|NCT02797678|470811836|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
130777427|NCT02797678|470811837|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
130777428|NCT02401035|470811838|FG000|Overall Study|Withdrawal by Subject|1|||
130777429|NCT02401035|470811839|FG001|Overall Study|Withdrawal by Subject|0|||
130777430|NCT03046953|470811841|FG000|Overall Study|Relapse/progressive disease|21|||
130777431|NCT03046953|470811841|FG000|Overall Study|Death|2|||
130777432|NCT03046953|470811841|FG000|Overall Study|Withdrawal by Subject|3|||
130777433|NCT04039204|470811842|FG000|Overall Study|Withdrawal by Subject|0|||
130777434|NCT04039204|470811843|FG001|Overall Study|Withdrawal by Subject|2|||
130777435|NCT01189461|470811844|FG000|Overall Study|Lack of Efficacy|13|||
130777436|NCT01189461|470811844|FG000|Overall Study|Lost to Follow-up|1|||
130777437|NCT01189461|470811844|FG000|Overall Study|Withdrawal by Subject|6|||
130777438|NCT01189461|470811844|FG000|Overall Study|Protocol Violation|1|||
130777439|NCT01189461|470811844|FG000|Overall Study|Adverse Event|2|||
130777440|NCT01189461|470811844|FG000|Overall Study|Did not meet entrance criteria|3|||
130777441|NCT01189461|470811844|FG000|Overall Study|Other|8|||
130777442|NCT00656175|470811846|FG000|Overall Study|Adverse Event|1|||
130777443|NCT00656175|470811847|FG001|Overall Study|Adverse Event|0|||
130777444|NCT00656175|470811846|FG000|Overall Study|Transportation issues|0|||
130777445|NCT00656175|470811847|FG001|Overall Study|Transportation issues|1|||
130777446|NCT00534638|470811856|FG000|Overall Study|Withdrawal by Subject|3|||
130777447|NCT00534638|470811857|FG001|Overall Study|Withdrawal by Subject|4|||
130777448|NCT00534638|470811856|FG000|Overall Study|Migrated/moved from study area|13|||
130777449|NCT00534638|470811857|FG001|Overall Study|Migrated/moved from study area|11|||
130777450|NCT00534638|470811856|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
130777451|NCT00534638|470811857|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
130777452|NCT00534638|470811856|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
130975724|NCT02693665|471535634|FG001|Overall Study|no reason given|0|||
130975725|NCT00710424|471535637|FG000|Overall Study|Adverse Event|30|||
130777453|NCT00534638|470811857|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
130777454|NCT00534638|470811856|FG000|Overall Study|Other|1685|||
130777455|NCT00534638|470811857|FG001|Overall Study|Other|902|||
130777456|NCT04162795|470811860|FG000|Overall Study|Other|16|||
130777457|NCT04162795|470811860|FG000|Overall Study|Screen failures|10|||
130777458|NCT05259163|470813239|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
130777459|NCT05259163|470813240|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
130975726|NCT00710424|471535638|FG001|Overall Study|Adverse Event|12|||
130777460|NCT01381926|470813243|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
130777461|NCT01381926|470813244|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
130777462|NCT01381926|470813243|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
130777463|NCT01381926|470813244|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
130777464|NCT02624947|470813245|FG000|Maternal Participants|Adverse Event|5|||
130777465|NCT02624947|470813246|FG001|Maternal Participants|Adverse Event|0|||
130777466|NCT02624947|470813245|FG000|Maternal Participants|Investigator Decision|5|||
130777467|NCT02624947|470813246|FG001|Maternal Participants|Investigator Decision|3|||
130777468|NCT02624947|470813245|FG000|Maternal Participants|Lost to Follow-up|54|||
130777469|NCT02624947|470813246|FG001|Maternal Participants|Lost to Follow-up|24|||
130777470|NCT02624947|470813245|FG000|Maternal Participants|Non Compliance|8|||
130777471|NCT02624947|470813246|FG001|Maternal Participants|Non Compliance|5|||
130777472|NCT02624947|470813245|FG000|Maternal Participants|Sponsor Request|1|||
130777473|NCT02624947|470813246|FG001|Maternal Participants|Sponsor Request|1|||
130777474|NCT02624947|470813245|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
130777475|NCT02624947|470813246|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
130777476|NCT02624947|470813245|FG000|Maternal Participants|Miscellaneous|23|||
130777477|NCT02624947|470813246|FG001|Maternal Participants|Miscellaneous|15|||
130777478|NCT02624947|470813245|FG000|Infant Participants|Adverse Event|18|||
130777479|NCT02624947|470813246|FG001|Infant Participants|Adverse Event|11|||
130777480|NCT02624947|470813245|FG000|Infant Participants|Investigator Decision|5|||
130777481|NCT02624947|470813246|FG001|Infant Participants|Investigator Decision|4|||
130777482|NCT02624947|470813245|FG000|Infant Participants|Lost to Follow-up|93|||
130777483|NCT02624947|470813246|FG001|Infant Participants|Lost to Follow-up|58|||
130777484|NCT02624947|470813245|FG000|Infant Participants|Non Compliance|17|||
130777485|NCT02624947|470813246|FG001|Infant Participants|Non Compliance|7|||
130777486|NCT02624947|470813245|FG000|Infant Participants|Sponsor Request|0|||
130777487|NCT02624947|470813246|FG001|Infant Participants|Sponsor Request|1|||
130777488|NCT02624947|470813245|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
130975727|NCT00710424|471535637|FG000|Overall Study|Lack of Efficacy|4|||
130975728|NCT00710424|471535638|FG001|Overall Study|Lack of Efficacy|5|||
130975729|NCT00710424|471535637|FG000|Overall Study|Withdrawal by Subject|5|||
130975730|NCT00710424|471535638|FG001|Overall Study|Withdrawal by Subject|3|||
130777489|NCT02624947|470813246|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
130777490|NCT02624947|470813245|FG000|Infant Participants|Miscellaneous|50|||
130777491|NCT02624947|470813246|FG001|Infant Participants|Miscellaneous|26|||
130777492|NCT01971567|470813260|FG000|Overall Study|Withdrawal by Subject|3|||
130777493|NCT01971567|470813261|FG001|Overall Study|Withdrawal by Subject|2|||
130777494|NCT01971567|470813260|FG000|Overall Study|Lost to Follow-up|1|||
130777495|NCT01971567|470813261|FG001|Overall Study|Lost to Follow-up|0|||
130777496|NCT01409915|470813262|FG000|Overall Study|Adverse Event|0|||
130777497|NCT01409915|470813263|FG001|Overall Study|Adverse Event|2|||
130777498|NCT01409915|470813262|FG000|Overall Study|Withdrawal by Subject|0|||
130777499|NCT01409915|470813263|FG001|Overall Study|Withdrawal by Subject|1|||
130777500|NCT01409915|470813262|FG000|Overall Study|Protocol Violation|1|||
130777501|NCT01409915|470813263|FG001|Overall Study|Protocol Violation|0|||
130777502|NCT04826484|470813265|FG000|Overall Study|Lost to Follow-up|2|||
130777503|NCT04826484|470813266|FG001|Overall Study|Lost to Follow-up|0|||
130777504|NCT00215644|470813267|FG000|Overall Study|Disease Progression|28|||
130777505|NCT00215644|470813268|FG001|Overall Study|Disease Progression|10|||
130777506|NCT00215644|470813267|FG000|Overall Study|Adverse Event|2|||
130777507|NCT00215644|470813268|FG001|Overall Study|Adverse Event|9|||
130777508|NCT00215644|470813267|FG000|Overall Study|Death|1|||
130777509|NCT00215644|470813268|FG001|Overall Study|Death|2|||
130777510|NCT00215644|470813267|FG000|Overall Study|Withdrawal by Subject|1|||
130777511|NCT00215644|470813268|FG001|Overall Study|Withdrawal by Subject|0|||
130777512|NCT00215644|470813267|FG000|Overall Study|Other|3|||
130777513|NCT00215644|470813268|FG001|Overall Study|Other|15|||
130777514|NCT00215644|470813267|FG000|Overall Study|Randomized but Not Treated|1|||
130777515|NCT00215644|470813268|FG001|Overall Study|Randomized but Not Treated|0|||
130777516|NCT02250300|470813269|FG000|Expansion Phase|Death|6|||
130777517|NCT02250300|470813270|FG001|Expansion Phase|Death|7|||
130777518|NCT02250300|470813271|FG002|Expansion Phase|Death|0|||
130777519|NCT02250300|470813272|FG003|Expansion Phase|Death|0|||
130777520|NCT03569098|470813275|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
130777521|NCT03569098|470813276|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
130777522|NCT03569098|470813277|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
130777523|NCT03569098|470813275|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
130777524|NCT03569098|470813276|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
130777525|NCT03569098|470813277|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
130777526|NCT03569098|470813275|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
130777527|NCT03569098|470813276|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
130777528|NCT03569098|470813277|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
130975731|NCT00710424|471535637|FG000|Overall Study|Lost to Follow-up|0|||
130975732|NCT00710424|471535638|FG001|Overall Study|Lost to Follow-up|1|||
130777529|NCT03569098|470813275|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
130777530|NCT03569098|470813276|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
130777531|NCT03569098|470813277|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
130777532|NCT03569098|470813275|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
130777533|NCT03569098|470813276|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
130777534|NCT03569098|470813277|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
130777535|NCT03569098|470813275|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
130777536|NCT03569098|470813276|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
130777537|NCT03569098|470813277|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
130777538|NCT03569098|470813275|FG000|Double-Blind Treatment Cycle 1|Other|1|||
130777539|NCT03569098|470813276|FG001|Double-Blind Treatment Cycle 1|Other|0|||
130777540|NCT03569098|470813277|FG002|Double-Blind Treatment Cycle 1|Other|1|||
130777541|NCT03569098|470813275|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
130777542|NCT03569098|470813276|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
130777543|NCT03569098|470813277|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
130777544|NCT03569098|470813275|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
130777545|NCT03569098|470813276|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
130777546|NCT03569098|470813277|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
130777547|NCT03569098|470813275|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
130777548|NCT03569098|470813276|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
130777549|NCT03569098|470813277|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
130777550|NCT03569098|470813275|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
130777551|NCT03569098|470813276|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
130777552|NCT03569098|470813277|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
130777553|NCT03569098|470813275|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
130777554|NCT03569098|470813276|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
130777555|NCT03569098|470813277|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
130777556|NCT03569098|470813275|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
130777557|NCT03569098|470813276|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
130777558|NCT03569098|470813277|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
130777559|NCT00758498|470813278|FG000|Overall Study|Adverse Event|2|||
130777560|NCT00758498|470813279|FG001|Overall Study|Adverse Event|2|||
130777561|NCT00758498|470813280|FG002|Overall Study|Adverse Event|3|||
130777562|NCT00758498|470813278|FG000|Overall Study|Subject legally detained out of state|1|||
130777563|NCT00758498|470813279|FG001|Overall Study|Subject legally detained out of state|0|||
130777564|NCT00758498|470813280|FG002|Overall Study|Subject legally detained out of state|0|||
130777565|NCT00758498|470813278|FG000|Overall Study|Withdrawal by Subject|0|||
130777566|NCT00758498|470813279|FG001|Overall Study|Withdrawal by Subject|0|||
130777567|NCT00758498|470813280|FG002|Overall Study|Withdrawal by Subject|1|||
130777568|NCT00758498|470813278|FG000|Overall Study|Noncompliance to study procedures|0|||
130777569|NCT00758498|470813279|FG001|Overall Study|Noncompliance to study procedures|0|||
130777570|NCT00758498|470813280|FG002|Overall Study|Noncompliance to study procedures|1|||
130777571|NCT01516736|470813285|FG000|Overall Study|Withdrawal by Subject|10|||
130777572|NCT01516736|470813286|FG001|Overall Study|Withdrawal by Subject|4|||
130777573|NCT01516736|470813285|FG000|Overall Study|Adverse Event|4|||
130777574|NCT01516736|470813286|FG001|Overall Study|Adverse Event|5|||
130777575|NCT01516736|470813285|FG000|Overall Study|Death|3|||
130777576|NCT01516736|470813286|FG001|Overall Study|Death|1|||
130777577|NCT01516736|470813285|FG000|Overall Study|Physician Decision|2|||
130777578|NCT01516736|470813286|FG001|Overall Study|Physician Decision|1|||
130777579|NCT01516736|470813285|FG000|Overall Study|Lack of Efficacy|1|||
130777580|NCT01516736|470813286|FG001|Overall Study|Lack of Efficacy|0|||
130777581|NCT01516736|470813285|FG000|Overall Study|Protocol Violation|0|||
130777582|NCT01516736|470813286|FG001|Overall Study|Protocol Violation|1|||
130777583|NCT01516736|470813285|FG000|Overall Study|Other (not specified)|0|||
130777584|NCT01516736|470813286|FG001|Overall Study|Other (not specified)|1|||
130777585|NCT01697800|470813287|FG000|Overall Study|Death|0|||
130777586|NCT01697800|470813288|FG001|Overall Study|Death|1|||
130777587|NCT04194489|470813294|FG000|Overall Study|Withdrawal by Subject|5|||
130777588|NCT04194489|470813294|FG000|Overall Study|Lost to Follow-up|48|||
130777589|NCT00522548|470813295|FG000|Overall Study|Adverse Event|2|||
130777590|NCT00522548|470813296|FG001|Overall Study|Adverse Event|2|||
130777591|NCT00522548|470813295|FG000|Overall Study|Withdrawal by Subject|0|||
130777592|NCT00522548|470813296|FG001|Overall Study|Withdrawal by Subject|2|||
130777593|NCT04147247|470813297|FG000|Overall Study|Progressive disease|3|||
130777594|NCT04147247|470813298|FG001|Overall Study|Progressive disease|3|||
130777595|NCT04147247|470813299|FG002|Overall Study|Progressive disease|4|||
130777596|NCT04147247|470813300|FG003|Overall Study|Progressive disease|4|||
130777597|NCT04147247|470813301|FG004|Overall Study|Progressive disease|3|||
130777598|NCT04147247|470813297|FG000|Overall Study|Physician Decision|0|||
130777599|NCT04147247|470813298|FG001|Overall Study|Physician Decision|1|||
130975733|NCT00710424|471535637|FG000|Overall Study|Refused medication, no side effects|1|||
130777600|NCT04147247|470813299|FG002|Overall Study|Physician Decision|0|||
130777601|NCT04147247|470813300|FG003|Overall Study|Physician Decision|0|||
130777602|NCT04147247|470813301|FG004|Overall Study|Physician Decision|0|||
130777603|NCT04147247|470813297|FG000|Overall Study|Clinical Disease Progression|0|||
130777604|NCT04147247|470813298|FG001|Overall Study|Clinical Disease Progression|0|||
130777605|NCT04147247|470813299|FG002|Overall Study|Clinical Disease Progression|0|||
130777606|NCT04147247|470813300|FG003|Overall Study|Clinical Disease Progression|0|||
130777607|NCT04147247|470813301|FG004|Overall Study|Clinical Disease Progression|1|||
130777608|NCT04147247|470813297|FG000|Overall Study|Adverse Event|0|||
130777609|NCT04147247|470813298|FG001|Overall Study|Adverse Event|0|||
130777610|NCT04147247|470813299|FG002|Overall Study|Adverse Event|1|||
130777611|NCT04147247|470813300|FG003|Overall Study|Adverse Event|0|||
130777612|NCT04147247|470813301|FG004|Overall Study|Adverse Event|1|||
130777613|NCT01111565|470813302|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
130777614|NCT01111565|470813303|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130777615|NCT01111565|470813304|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130777616|NCT01111565|470813305|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130777617|NCT01111565|470813306|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130777618|NCT01111565|470813302|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
130777619|NCT01111565|470813303|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130777620|NCT01111565|470813304|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130777621|NCT01111565|470813305|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130777622|NCT01111565|470813306|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130777623|NCT01111565|470813302|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
130777624|NCT01111565|470813303|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130777625|NCT01111565|470813304|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130777626|NCT01111565|470813305|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130777627|NCT01111565|470813306|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130777628|NCT01111565|470813302|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
130777629|NCT01111565|470813303|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130777630|NCT01111565|470813304|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130777631|NCT01111565|470813305|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130777632|NCT01111565|470813306|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130777633|NCT01111565|470813302|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
130777634|NCT01111565|470813303|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130777635|NCT01111565|470813304|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130777636|NCT01111565|470813305|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130777637|NCT01111565|470813306|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130777638|NCT01111565|470813302|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
130777639|NCT01111565|470813303|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130777640|NCT01111565|470813304|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130777641|NCT01111565|470813305|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130777642|NCT01111565|470813306|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130777643|NCT01111565|470813302|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
130777644|NCT01111565|470813303|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130777645|NCT01111565|470813304|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130777646|NCT01111565|470813305|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130777647|NCT01111565|470813306|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130777648|NCT01111565|470813302|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130777649|NCT01111565|470813303|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130777650|NCT01111565|470813304|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130777651|NCT01111565|470813305|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
130777652|NCT01111565|470813306|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130777653|NCT01111565|470813302|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130777654|NCT01111565|470813303|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130777655|NCT01111565|470813304|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
130777656|NCT01111565|470813305|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130777657|NCT01111565|470813306|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130777658|NCT01111565|470813302|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
130777659|NCT01111565|470813303|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
130777660|NCT01111565|470813304|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
130777661|NCT01111565|470813305|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
130777662|NCT01111565|470813306|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
130777663|NCT01111565|470813302|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130777664|NCT01111565|470813303|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130777665|NCT01111565|470813304|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130777666|NCT01111565|470813305|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
130777667|NCT01111565|470813306|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130777668|NCT01111565|470813302|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130777669|NCT01111565|470813303|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130777670|NCT01111565|470813304|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130777671|NCT01111565|470813305|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130777672|NCT01111565|470813306|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
130777673|NCT02683239|470813307|FG000|Overall Study|Protocol Violation|35|||
130975734|NCT00710424|471535638|FG001|Overall Study|Refused medication, no side effects|0|||
130975735|NCT00710424|471535637|FG000|Overall Study|Non-compliance with stable analgesia|1|||
130975736|NCT00710424|471535638|FG001|Overall Study|Non-compliance with stable analgesia|0|||
130975737|NCT00710424|471535637|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
130975738|NCT00710424|471535638|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
130975739|NCT00710424|471535637|FG000|Overall Study|Subject thought medication changed|1|||
130975740|NCT00710424|471535638|FG001|Overall Study|Subject thought medication changed|0|||
130975741|NCT00710424|471535637|FG000|Overall Study|Ceased treatment due to travel|1|||
130975742|NCT00710424|471535638|FG001|Overall Study|Ceased treatment due to travel|0|||
130975743|NCT00710424|471535637|FG000|Overall Study|Subject preferred paracetamol|0|||
130975744|NCT00710424|471535638|FG001|Overall Study|Subject preferred paracetamol|1|||
130975745|NCT00710424|471535637|FG000|Overall Study|Felt good so stopped treatment|0|||
130975746|NCT00710424|471535638|FG001|Overall Study|Felt good so stopped treatment|1|||
130975747|NCT01962493|471535639|FG000|Overall Study|Adverse Event|1|||
130975748|NCT01962493|471535640|FG001|Overall Study|Adverse Event|2|||
130975749|NCT01962493|471535639|FG000|Overall Study|Protocol Violation|0|||
130975750|NCT01962493|471535640|FG001|Overall Study|Protocol Violation|1|||
130975751|NCT01962493|471535639|FG000|Overall Study|Withdrawal by Subject|4|||
130975752|NCT01962493|471535640|FG001|Overall Study|Withdrawal by Subject|2|||
130975753|NCT03776136|471535641|FG000|Overall Study|Death|85|||
130975754|NCT03776136|471535641|FG000|Overall Study|Withdrawal by Subject|3|||
130975755|NCT03776136|471535641|FG000|Overall Study|Sponsor Decision|15|||
130975756|NCT02621931|471537478|FG000|Overall Study|Death|0|||
130975757|NCT02621931|471537479|FG001|Overall Study|Death|1|||
130975758|NCT02621931|471537480|FG002|Overall Study|Death|0|||
130975759|NCT02621931|471537478|FG000|Overall Study|Adverse Event|8|||
130975760|NCT02621931|471537479|FG001|Overall Study|Adverse Event|5|||
131131401|NCT02432235|472108332|FG005|Overall Study|Lost to Follow-up|1|||
130717545|NCT04453202|470591059|FG006|Overall Study|Adverse Event|0|||
130717546|NCT04453202|470591060|FG007|Overall Study|Adverse Event|0|||
130717547|NCT04453202|470591061|FG008|Overall Study|Adverse Event|0|||
130717548|NCT04453202|470591062|FG009|Overall Study|Adverse Event|0|||
130717549|NCT04453202|470591063|FG010|Overall Study|Adverse Event|0|||
130717550|NCT02912650|470591064|FG000|Overall Study|Withdrawal by Subject|1|||
130717551|NCT02912650|470591065|FG001|Overall Study|Withdrawal by Subject|0|||
130717552|NCT02912650|470591066|FG002|Overall Study|Withdrawal by Subject|1|||
130717553|NCT02912650|470591067|FG003|Overall Study|Withdrawal by Subject|5|||
130717554|NCT02912650|470591064|FG000|Overall Study|Adverse Event|0|||
130717555|NCT02912650|470591065|FG001|Overall Study|Adverse Event|0|||
130717556|NCT02912650|470591066|FG002|Overall Study|Adverse Event|1|||
130717557|NCT02912650|470591067|FG003|Overall Study|Adverse Event|0|||
130717558|NCT02562482|470591069|FG000|Overall Study|Enrolled, but did not receive product|4|||
130717559|NCT02562482|470591070|FG001|Overall Study|Enrolled, but did not receive product|0|||
130717560|NCT02562482|470591069|FG000|Overall Study|Lost to Follow-up|9|||
130777674|NCT02683239|470813308|FG001|Overall Study|Protocol Violation|23|||
130777675|NCT02683239|470813309|FG002|Overall Study|Protocol Violation|26|||
130777676|NCT02683239|470813310|FG003|Overall Study|Protocol Violation|4|||
130777677|NCT02683239|470813311|FG004|Overall Study|Protocol Violation|35|||
130777678|NCT02683239|470813312|FG005|Overall Study|Protocol Violation|4|||
130777679|NCT02683239|470813313|FG006|Overall Study|Protocol Violation|5|||
130777680|NCT02683239|470813307|FG000|Overall Study|Adverse Event|64|||
130777681|NCT02683239|470813308|FG001|Overall Study|Adverse Event|39|||
130777682|NCT02683239|470813309|FG002|Overall Study|Adverse Event|42|||
130777683|NCT02683239|470813310|FG003|Overall Study|Adverse Event|16|||
130777684|NCT02683239|470813311|FG004|Overall Study|Adverse Event|189|||
130975761|NCT02621931|471537480|FG002|Overall Study|Adverse Event|7|||
130975762|NCT02621931|471537478|FG000|Overall Study|Withdrawal by Subject|12|||
130975763|NCT02621931|471537479|FG001|Overall Study|Withdrawal by Subject|10|||
130975764|NCT02621931|471537480|FG002|Overall Study|Withdrawal by Subject|11|||
130975765|NCT02621931|471537478|FG000|Overall Study|Protocol Violation|2|||
130975766|NCT02621931|471537479|FG001|Overall Study|Protocol Violation|2|||
130975767|NCT02621931|471537480|FG002|Overall Study|Protocol Violation|2|||
130975768|NCT02621931|471537478|FG000|Overall Study|Pregnancy|2|||
130717561|NCT02562482|470591070|FG001|Overall Study|Lost to Follow-up|6|||
130975769|NCT02621931|471537479|FG001|Overall Study|Pregnancy|0|||
131131402|NCT02432235|472108333|FG006|Overall Study|Lost to Follow-up|0|||
130717562|NCT02562482|470591069|FG000|Overall Study|Moved from area|2|||
130777685|NCT02683239|470813312|FG005|Overall Study|Adverse Event|9|||
130975770|NCT02621931|471537480|FG002|Overall Study|Pregnancy|0|||
130975771|NCT02621931|471537478|FG000|Overall Study|Noncompliance to study procedures|0|||
130717563|NCT02562482|470591070|FG001|Overall Study|Moved from area|3|||
130717564|NCT02562482|470591069|FG000|Overall Study|Withdrawal by Subject|5|||
130717565|NCT02562482|470591070|FG001|Overall Study|Withdrawal by Subject|3|||
130975772|NCT02621931|471537479|FG001|Overall Study|Noncompliance to study procedures|1|||
130975773|NCT02621931|471537480|FG002|Overall Study|Noncompliance to study procedures|2|||
130975774|NCT02621931|471537478|FG000|Overall Study|Lost to Follow-up|8|||
130975775|NCT02621931|471537479|FG001|Overall Study|Lost to Follow-up|7|||
130975776|NCT02621931|471537480|FG002|Overall Study|Lost to Follow-up|10|||
130975777|NCT02621931|471537478|FG000|Overall Study|Lack of Efficacy|0|||
130975778|NCT02621931|471537479|FG001|Overall Study|Lack of Efficacy|0|||
130777686|NCT02683239|470813313|FG006|Overall Study|Adverse Event|9|||
130777687|NCT02683239|470813307|FG000|Overall Study|Physician Decision|38|||
130777688|NCT02683239|470813308|FG001|Overall Study|Physician Decision|19|||
130777689|NCT02683239|470813309|FG002|Overall Study|Physician Decision|14|||
130777690|NCT02683239|470813310|FG003|Overall Study|Physician Decision|73|||
130777691|NCT02683239|470813311|FG004|Overall Study|Physician Decision|143|||
130777692|NCT02683239|470813312|FG005|Overall Study|Physician Decision|14|||
130777693|NCT02683239|470813313|FG006|Overall Study|Physician Decision|15|||
130777694|NCT02683239|470813307|FG000|Overall Study|Withdrawal by Subject|187|||
130777695|NCT02683239|470813308|FG001|Overall Study|Withdrawal by Subject|99|||
130777696|NCT02683239|470813309|FG002|Overall Study|Withdrawal by Subject|91|||
130777697|NCT02683239|470813310|FG003|Overall Study|Withdrawal by Subject|18|||
130777698|NCT02683239|470813311|FG004|Overall Study|Withdrawal by Subject|248|||
130777699|NCT02683239|470813312|FG005|Overall Study|Withdrawal by Subject|22|||
130777700|NCT02683239|470813313|FG006|Overall Study|Withdrawal by Subject|28|||
130777701|NCT02683239|470813307|FG000|Overall Study|Lost to Follow-up|77|||
130777702|NCT02683239|470813308|FG001|Overall Study|Lost to Follow-up|24|||
130777703|NCT02683239|470813309|FG002|Overall Study|Lost to Follow-up|25|||
130777704|NCT02683239|470813310|FG003|Overall Study|Lost to Follow-up|7|||
130777705|NCT02683239|470813311|FG004|Overall Study|Lost to Follow-up|88|||
130777706|NCT02683239|470813312|FG005|Overall Study|Lost to Follow-up|8|||
130777707|NCT02683239|470813313|FG006|Overall Study|Lost to Follow-up|11|||
130777708|NCT02683239|470813307|FG000|Overall Study|Death|9|||
130777709|NCT02683239|470813308|FG001|Overall Study|Death|5|||
130777710|NCT02683239|470813309|FG002|Overall Study|Death|8|||
130777711|NCT02683239|470813310|FG003|Overall Study|Death|0|||
130777712|NCT02683239|470813311|FG004|Overall Study|Death|12|||
130777713|NCT02683239|470813312|FG005|Overall Study|Death|1|||
130777714|NCT02683239|470813313|FG006|Overall Study|Death|0|||
130777715|NCT02683239|470813307|FG000|Overall Study|Lack of Efficacy|50|||
130777716|NCT02683239|470813308|FG001|Overall Study|Lack of Efficacy|23|||
130777717|NCT02683239|470813309|FG002|Overall Study|Lack of Efficacy|12|||
130777718|NCT02683239|470813310|FG003|Overall Study|Lack of Efficacy|2|||
130777719|NCT02683239|470813311|FG004|Overall Study|Lack of Efficacy|29|||
130777720|NCT02683239|470813312|FG005|Overall Study|Lack of Efficacy|2|||
130777721|NCT02683239|470813313|FG006|Overall Study|Lack of Efficacy|3|||
130777722|NCT02683239|470813307|FG000|Overall Study|Missing data|0|||
130777723|NCT02683239|470813308|FG001|Overall Study|Missing data|1|||
130777724|NCT02683239|470813309|FG002|Overall Study|Missing data|1|||
130777725|NCT02683239|470813310|FG003|Overall Study|Missing data|0|||
130777726|NCT02683239|470813311|FG004|Overall Study|Missing data|1|||
130777727|NCT02683239|470813312|FG005|Overall Study|Missing data|0|||
130777728|NCT02683239|470813313|FG006|Overall Study|Missing data|0|||
130777729|NCT04131712|470813316|FG000|Overall Study|COVID related|0|||
130777730|NCT04131712|470813317|FG001|Overall Study|COVID related|0|||
130777731|NCT04131712|470813318|FG002|Overall Study|COVID related|2|||
130777732|NCT04131712|470813319|FG003|Overall Study|COVID related|0|||
130777733|NCT04131712|470813316|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
130777734|NCT04131712|470813317|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
130777735|NCT04131712|470813318|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
130777736|NCT04131712|470813319|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
130777737|NCT00873730|470813320|FG000|Overall Study|Protocol Deviation|5|||
130777738|NCT00873730|470813321|FG001|Overall Study|Protocol Deviation|2|||
130777739|NCT00873730|470813320|FG000|Overall Study|Adverse Event|0|||
130777740|NCT00873730|470813321|FG001|Overall Study|Adverse Event|2|||
130975779|NCT02621931|471537480|FG002|Overall Study|Lack of Efficacy|1|||
130975780|NCT02621931|471537478|FG000|Overall Study|Other|1|||
130975781|NCT02621931|471537479|FG001|Overall Study|Other|1|||
130777741|NCT00873730|470813320|FG000|Overall Study|Withdrawal by Subject|0|||
130777742|NCT00873730|470813321|FG001|Overall Study|Withdrawal by Subject|1|||
130777743|NCT00873730|470813320|FG000|Overall Study|Sponsor decision|1|||
130777744|NCT00873730|470813321|FG001|Overall Study|Sponsor decision|0|||
130777745|NCT04878055|470813322|FG000|Overall Study|Patient transferred in another department|0|||
130777746|NCT04878055|470813323|FG001|Overall Study|Patient transferred in another department|2|||
130777747|NCT04878055|470813322|FG000|Overall Study|Physician Decision|1|||
130975782|NCT02621931|471537480|FG002|Overall Study|Other|3|||
130975783|NCT02925455|471537481|FG000|Overall Study|Withdrawal by Subject|2|||
130975784|NCT02925455|471537482|FG001|Overall Study|Withdrawal by Subject|0|||
130975785|NCT04004611|471537485|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130777748|NCT04878055|470813323|FG001|Overall Study|Physician Decision|1|||
130777749|NCT04878055|470813322|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
130975786|NCT04004611|471537486|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130975787|NCT04004611|471537487|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130975788|NCT04004611|471537488|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130975789|NCT04004611|471537489|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130975790|NCT04004611|471537490|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130975791|NCT04004611|471537491|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130975792|NCT04004611|471537492|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
130975793|NCT04004611|471537493|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
130975794|NCT04004611|471537485|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130975795|NCT04004611|471537486|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130975796|NCT04004611|471537487|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130975797|NCT04004611|471537488|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130975798|NCT04004611|471537489|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130975799|NCT04004611|471537490|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
130975800|NCT04004611|471537491|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
130975801|NCT04004611|471537492|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
130975802|NCT04004611|471537493|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
130975803|NCT04004611|471537485|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130975804|NCT04004611|471537486|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130975805|NCT04004611|471537487|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130975806|NCT04004611|471537488|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130975807|NCT04004611|471537489|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
130975808|NCT04004611|471537490|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130975809|NCT04004611|471537491|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130975810|NCT04004611|471537492|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130975811|NCT04004611|471537493|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
131043385|NCT05184452|471793086|FG009|Overall Study|Withdrawal by Subject|1|||
130717566|NCT02562482|470591069|FG000|Overall Study|Physician Decision|1|||
130717567|NCT02562482|470591070|FG001|Overall Study|Physician Decision|3|||
130717568|NCT02562482|470591069|FG000|Overall Study|Illness/Injury unrelated to product|0|||
130717569|NCT02562482|470591070|FG001|Overall Study|Illness/Injury unrelated to product|1|||
130717570|NCT01674647|470591071|FG000|Treatment Period|Death|4|||
130717571|NCT01674647|470591072|FG001|Treatment Period|Death|1|||
130717572|NCT01674647|470591071|FG000|Treatment Period|Efficacy outcome reached|0|||
130717573|NCT01674647|470591072|FG001|Treatment Period|Efficacy outcome reached|1|||
130717574|NCT01674647|470591071|FG000|Treatment Period|Physician Decision|3|||
130717575|NCT01674647|470591072|FG001|Treatment Period|Physician Decision|1|||
130717576|NCT01674647|470591071|FG000|Treatment Period|Adverse Event|60|||
130717577|NCT01674647|470591072|FG001|Treatment Period|Adverse Event|22|||
130717578|NCT01674647|470591071|FG000|Treatment Period|Non-compliance with study drug|3|||
130717579|NCT01674647|470591072|FG001|Treatment Period|Non-compliance with study drug|0|||
130717580|NCT01674647|470591071|FG000|Treatment Period|Lost to Follow-up|1|||
130717581|NCT01674647|470591072|FG001|Treatment Period|Lost to Follow-up|1|||
130717582|NCT01674647|470591071|FG000|Treatment Period|Withdrawal by Subject|19|||
130717583|NCT01674647|470591072|FG001|Treatment Period|Withdrawal by Subject|16|||
130717584|NCT01674647|470591071|FG000|Treatment Period|Switching to other therapy|5|||
130717585|NCT01674647|470591072|FG001|Treatment Period|Switching to other therapy|2|||
130717586|NCT01674647|470591071|FG000|Treatment Period|Logistical difficulties|5|||
130717587|NCT01674647|470591072|FG001|Treatment Period|Logistical difficulties|8|||
130717588|NCT01674647|470591071|FG000|Treatment Period|Treatment failure|0|||
130717589|NCT01674647|470591072|FG001|Treatment Period|Treatment failure|14|||
130717590|NCT01674647|470591071|FG000|Treatment Period|Protocol Violation|56|||
130717591|NCT01674647|470591072|FG001|Treatment Period|Protocol Violation|36|||
130717592|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Death|3|||
130717593|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Death|2|||
130717594|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
130717595|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
130717596|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
130717597|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
130717598|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
130717599|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
130717600|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
130717601|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
130717602|NCT01674647|470591071|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
130717603|NCT01674647|470591072|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
130717604|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
130717605|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
130717606|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
130717607|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
130717608|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
130975812|NCT04004611|471537485|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
130975813|NCT04004611|471537486|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
130975814|NCT04004611|471537487|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
130717609|NCT01490866|470591073|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
130717610|NCT01490866|470591073|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
130717611|NCT01490866|470591073|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
130717612|NCT01490866|470591073|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
130717613|NCT01490866|470591073|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
130717614|NCT01490866|470591073|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
130717615|NCT02980874|470591074|FG000|Overall Study|Adverse Event|2|||
130717616|NCT02980874|470591075|FG001|Overall Study|Adverse Event|7|||
130717617|NCT02980874|470591074|FG000|Overall Study|Withdrawal by Subject|7|||
130717618|NCT02980874|470591075|FG001|Overall Study|Withdrawal by Subject|2|||
130717619|NCT02980874|470591074|FG000|Overall Study|Lost to Follow-up|5|||
130717620|NCT02980874|470591075|FG001|Overall Study|Lost to Follow-up|5|||
130717621|NCT02980874|470591074|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
130717622|NCT02980874|470591075|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
130717623|NCT02980874|470591074|FG000|Overall Study|Unknown study completion status|1|||
130717624|NCT02980874|470591075|FG001|Overall Study|Unknown study completion status|0|||
130717625|NCT00914459|470591076|FG000|Overall Study|Protocol Violation|0|||
130717626|NCT00914459|470591077|FG001|Overall Study|Protocol Violation|1|||
130717627|NCT00914459|470591076|FG000|Overall Study|Parent/Legal guardian request|1|||
130717628|NCT00914459|470591077|FG001|Overall Study|Parent/Legal guardian request|0|||
130717629|NCT01661179|470591078|FG000|Overall Study|Death|1|||
130717630|NCT01661179|470591078|FG000|Overall Study|Withdrawal by Subject|1|||
130717631|NCT01661179|470591078|FG000|Overall Study|Other Eligibility criteria|4|||
130717632|NCT04188301|470591079|FG000|Month 3|Lost to Follow-up|0|||
130717633|NCT04188301|470591080|FG001|Month 3|Lost to Follow-up|0|||
130717634|NCT04188301|470591081|FG002|Month 3|Lost to Follow-up|1|||
130717635|NCT04188301|470591079|FG000|Month 12|Lost to Follow-up|0|||
130717636|NCT04188301|470591080|FG001|Month 12|Lost to Follow-up|0|||
130717637|NCT04188301|470591081|FG002|Month 12|Lost to Follow-up|2|||
130717638|NCT04188301|470591079|FG000|Month 12|Death|1|||
130717639|NCT04188301|470591080|FG001|Month 12|Death|1|||
130717640|NCT04188301|470591081|FG002|Month 12|Death|0|||
130717641|NCT04188301|470591079|FG000|Month 18|Lost to Follow-up|6|||
130717642|NCT04188301|470591080|FG001|Month 18|Lost to Follow-up|0|||
130717643|NCT04188301|470591081|FG002|Month 18|Lost to Follow-up|0|||
130717644|NCT04221789|470593108|FG000|Overall Study|deviation from protoco|22|||
130717645|NCT04221789|470593109|FG001|Overall Study|deviation from protoco|8|||
130717646|NCT03747601|470593110|FG000|Overall Study|COVID halt to visits|4|||
130717647|NCT03303625|470593111|FG000|Overall Study|Withdrawal by Subject|2|||
130717648|NCT03303625|470593112|FG001|Overall Study|Withdrawal by Subject|0|||
130717649|NCT03303625|470593113|FG002|Overall Study|Withdrawal by Subject|0|||
130717650|NCT03303625|470593114|FG003|Overall Study|Withdrawal by Subject|0|||
130717651|NCT01367665|470593115|FG000|Overall Study|Death|102|||
130717652|NCT01367665|470593116|FG001|Overall Study|Death|19|||
130717653|NCT01367665|470593115|FG000|Overall Study|Lost to Follow-up|222|||
130717654|NCT01367665|470593116|FG001|Overall Study|Lost to Follow-up|22|||
130717655|NCT01367665|470593115|FG000|Overall Study|Not Done|118|||
130717656|NCT01367665|470593116|FG001|Overall Study|Not Done|14|||
130717657|NCT02906930|470593117|FG000|Overall Study|Withdrawal by Subject|0|||
130717658|NCT02906930|470593118|FG001|Overall Study|Withdrawal by Subject|5|||
130717659|NCT02906930|470593119|FG002|Overall Study|Withdrawal by Subject|5|||
130717660|NCT02906930|470593120|FG003|Overall Study|Withdrawal by Subject|4|||
130717661|NCT02906930|470593117|FG000|Overall Study|Lost to Follow-up|5|||
130717662|NCT02906930|470593118|FG001|Overall Study|Lost to Follow-up|7|||
130717663|NCT02906930|470593119|FG002|Overall Study|Lost to Follow-up|5|||
130717664|NCT02906930|470593120|FG003|Overall Study|Lost to Follow-up|2|||
130717665|NCT02906930|470593117|FG000|Overall Study|Death|0|||
130717666|NCT02906930|470593118|FG001|Overall Study|Death|0|||
130717667|NCT02906930|470593119|FG002|Overall Study|Death|1|||
130717668|NCT02906930|470593120|FG003|Overall Study|Death|0|||
130717669|NCT02906930|470593117|FG000|Overall Study|Other|1|||
130717670|NCT02906930|470593118|FG001|Overall Study|Other|2|||
130717671|NCT02906930|470593119|FG002|Overall Study|Other|1|||
130717672|NCT02906930|470593120|FG003|Overall Study|Other|2|||
130717673|NCT02564211|470593121|FG000|Overall Study|Adverse Event|4|||
130975815|NCT04004611|471537488|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
130717674|NCT01155024|470593122|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
130717675|NCT01155024|470593123|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
130717676|NCT01155024|470593122|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
130717677|NCT01155024|470593123|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
130717678|NCT01155024|470593122|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
130717679|NCT01155024|470593123|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
130975816|NCT04004611|471537489|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
130975817|NCT04004611|471537490|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
130975818|NCT04004611|471537491|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
130975819|NCT04004611|471537492|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
130975820|NCT04004611|471537493|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
130777750|NCT04878055|470813323|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
130777751|NCT04878055|470813322|FG000|Overall Study|Adverse Event|12|||
130777752|NCT04878055|470813323|FG001|Overall Study|Adverse Event|7|||
130777753|NCT04878055|470813322|FG000|Overall Study|Other|5|||
130777754|NCT04878055|470813323|FG001|Overall Study|Other|0|||
130777755|NCT04878055|470813322|FG000|Overall Study|Withdrawal by Subject|7|||
130975821|NCT04004611|471537485|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
130975822|NCT04004611|471537486|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130975823|NCT04004611|471537487|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
130975824|NCT04004611|471537488|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130975825|NCT04004611|471537489|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130975826|NCT04004611|471537490|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130975827|NCT04004611|471537491|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130975828|NCT04004611|471537492|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130975829|NCT04004611|471537493|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
130975830|NCT04004611|471537485|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130975831|NCT04004611|471537486|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
130975832|NCT04004611|471537487|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130975833|NCT04004611|471537488|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130975834|NCT04004611|471537489|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130975835|NCT04004611|471537490|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130975836|NCT04004611|471537491|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130975837|NCT04004611|471537492|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130975838|NCT04004611|471537493|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
130975839|NCT04420689|471537494|FG000|Overall Study|COVID-19 related hospitalization|0|||
130975840|NCT04420689|471537495|FG001|Overall Study|COVID-19 related hospitalization|0|||
130975841|NCT04420689|471537496|FG002|Overall Study|COVID-19 related hospitalization|0|||
130975842|NCT04420689|471537497|FG003|Overall Study|COVID-19 related hospitalization|0|||
130975843|NCT04420689|471537498|FG004|Overall Study|COVID-19 related hospitalization|1|||
130975844|NCT04420689|471537499|FG005|Overall Study|COVID-19 related hospitalization|0|||
130975845|NCT04420689|471537500|FG006|Overall Study|COVID-19 related hospitalization|0|||
130975846|NCT04420689|471537494|FG000|Overall Study|Physician Decision|0|||
130975847|NCT04420689|471537495|FG001|Overall Study|Physician Decision|0|||
130975848|NCT04420689|471537496|FG002|Overall Study|Physician Decision|0|||
130975849|NCT04420689|471537497|FG003|Overall Study|Physician Decision|0|||
130975850|NCT04420689|471537498|FG004|Overall Study|Physician Decision|0|||
130975851|NCT04420689|471537499|FG005|Overall Study|Physician Decision|1|||
130975852|NCT04420689|471537500|FG006|Overall Study|Physician Decision|0|||
130777756|NCT04878055|470813323|FG001|Overall Study|Withdrawal by Subject|3|||
130777757|NCT04878055|470813322|FG000|Overall Study|Lost to Follow-up|10|||
130777758|NCT04878055|470813323|FG001|Overall Study|Lost to Follow-up|1|||
130777759|NCT01968811|470813324|FG000|Overall Study|Protocol Violation|4|||
130777760|NCT01968811|470813324|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
130777761|NCT03904420|470813325|FG000|Overall Study|Study terminated|2|||
130777762|NCT03904420|470813326|FG001|Overall Study|Study terminated|2|||
130777763|NCT00716456|470813327|FG000|Overall Study|Adverse Event|0|||
130777764|NCT00716456|470813328|FG001|Overall Study|Adverse Event|2|||
130777765|NCT00716456|470813329|FG002|Overall Study|Adverse Event|0|||
130777766|NCT00447772|470813330|FG000|Overall Study|Lack of Efficacy|3|||
130777767|NCT00447772|470813330|FG000|Overall Study|Insufficient compliance|6|||
130777768|NCT00447772|470813330|FG000|Overall Study|Discontinuation of drug therapy|1|||
130777769|NCT00447772|470813330|FG000|Overall Study|Lost to Follow-up|9|||
130777770|NCT00447772|470813330|FG000|Overall Study|Withdrawal by Subject|1|||
130777771|NCT00447772|470813330|FG000|Overall Study|Unable to attend all study visits|2|||
130777772|NCT00447772|470813330|FG000|Overall Study|Adverse Event|1|||
130777773|NCT00447772|470813330|FG000|Overall Study|Patient relocated|1|||
130777774|NCT00447772|470813330|FG000|Overall Study|Incomplete documentation at visit 1|1|||
130975853|NCT00487162|471537506|FG000|Overall Study|Adverse Event|0|||
130975854|NCT00487162|471537507|FG001|Overall Study|Adverse Event|1|||
130777775|NCT00447772|470813330|FG000|Overall Study|Chemotherapy for lung cancer|1|||
130777776|NCT00447772|470813330|FG000|Overall Study|Premature re-injection required|1|||
130777777|NCT00875563|470813331|FG000|Overall Study|Death|4|||
130777778|NCT00875563|470813331|FG000|Overall Study|Withdrawal by Subject|7|||
130777779|NCT00875563|470813331|FG000|Overall Study|No long-term (3-5 year) consent|6|||
130975855|NCT00487162|471537506|FG000|Overall Study|Physician Decision|0|||
130975856|NCT00487162|471537507|FG001|Overall Study|Physician Decision|1|||
130777780|NCT00875563|470813331|FG000|Overall Study|Still be eligible for follow-up|7|||
130777781|NCT02896569|470813334|FG000|Overall Study|Lost to Follow-up|2|||
130975857|NCT00487162|471537506|FG000|Overall Study|Withdrawal by Subject|2|||
130975858|NCT00487162|471537507|FG001|Overall Study|Withdrawal by Subject|3|||
130975859|NCT00515502|471537509|FG000|Treatment Period 1|Adverse Event|0|||
130975860|NCT00515502|471537510|FG001|Treatment Period 1|Adverse Event|0|||
130975861|NCT00515502|471537511|FG002|Treatment Period 1|Adverse Event|0|||
130975862|NCT00515502|471537512|FG003|Treatment Period 1|Adverse Event|0|||
130717680|NCT04585789|470593124|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
130717681|NCT04585789|470593125|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
130717682|NCT04585789|470593126|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
130717683|NCT04585789|470593124|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
130717684|NCT04585789|470593125|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
130717685|NCT04585789|470593126|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
130717686|NCT01383135|470593133|FG000|Overall Study|Not Scanned / Imaged|1|||
130717687|NCT01383135|470593134|FG001|Overall Study|Not Scanned / Imaged|0|||
130717688|NCT01383135|470593135|FG002|Overall Study|Not Scanned / Imaged|1|||
130717689|NCT01383135|470593136|FG003|Overall Study|Not Scanned / Imaged|0|||
130717690|NCT01154816|470593138|FG000|Overall Study|Withdrawal by Subject|1|||
130717691|NCT01154816|470593139|FG001|Overall Study|Withdrawal by Subject|0|||
130717692|NCT01154816|470593140|FG002|Overall Study|Withdrawal by Subject|0|||
130717693|NCT01154816|470593141|FG003|Overall Study|Withdrawal by Subject|1|||
130717694|NCT01154816|470593142|FG004|Overall Study|Withdrawal by Subject|0|||
130717695|NCT01154816|470593143|FG005|Overall Study|Withdrawal by Subject|0|||
130717696|NCT01154816|470593144|FG006|Overall Study|Withdrawal by Subject|0|||
130717697|NCT01154816|470593145|FG007|Overall Study|Withdrawal by Subject|0|||
130717698|NCT01154816|470593146|FG008|Overall Study|Withdrawal by Subject|1|||
130717699|NCT01154816|470593147|FG009|Overall Study|Withdrawal by Subject|3|||
130717700|NCT01154816|470593148|FG010|Overall Study|Withdrawal by Subject|0|||
130717701|NCT01154816|470593149|FG011|Overall Study|Withdrawal by Subject|0|||
130717702|NCT01154816|470593138|FG000|Overall Study|Progressive Disease|13|||
130717703|NCT01154816|470593139|FG001|Overall Study|Progressive Disease|8|||
130717704|NCT01154816|470593140|FG002|Overall Study|Progressive Disease|9|||
130717705|NCT01154816|470593141|FG003|Overall Study|Progressive Disease|9|||
130717706|NCT01154816|470593142|FG004|Overall Study|Progressive Disease|8|||
130717707|NCT01154816|470593143|FG005|Overall Study|Progressive Disease|8|||
130717708|NCT01154816|470593144|FG006|Overall Study|Progressive Disease|5|||
130717709|NCT01154816|470593145|FG007|Overall Study|Progressive Disease|6|||
130717710|NCT01154816|470593146|FG008|Overall Study|Progressive Disease|8|||
130717711|NCT01154816|470593147|FG009|Overall Study|Progressive Disease|6|||
130717712|NCT01154816|470593148|FG010|Overall Study|Progressive Disease|10|||
130717713|NCT01154816|470593149|FG011|Overall Study|Progressive Disease|3|||
130717714|NCT01154816|470593138|FG000|Overall Study|Physician Decision|1|||
130717715|NCT01154816|470593139|FG001|Overall Study|Physician Decision|0|||
130717716|NCT01154816|470593140|FG002|Overall Study|Physician Decision|1|||
130717717|NCT01154816|470593141|FG003|Overall Study|Physician Decision|0|||
130717718|NCT01154816|470593142|FG004|Overall Study|Physician Decision|2|||
130717719|NCT01154816|470593143|FG005|Overall Study|Physician Decision|0|||
130717720|NCT01154816|470593144|FG006|Overall Study|Physician Decision|0|||
130717721|NCT01154816|470593145|FG007|Overall Study|Physician Decision|0|||
130717722|NCT01154816|470593146|FG008|Overall Study|Physician Decision|0|||
130717723|NCT01154816|470593147|FG009|Overall Study|Physician Decision|1|||
130717724|NCT01154816|470593148|FG010|Overall Study|Physician Decision|1|||
130717725|NCT01154816|470593149|FG011|Overall Study|Physician Decision|1|||
130717726|NCT01154816|470593138|FG000|Overall Study|Adverse Event|5|||
130717727|NCT01154816|470593139|FG001|Overall Study|Adverse Event|2|||
130717728|NCT01154816|470593140|FG002|Overall Study|Adverse Event|0|||
130717729|NCT01154816|470593141|FG003|Overall Study|Adverse Event|0|||
130717730|NCT01154816|470593142|FG004|Overall Study|Adverse Event|0|||
130717731|NCT01154816|470593143|FG005|Overall Study|Adverse Event|0|||
130717732|NCT01154816|470593144|FG006|Overall Study|Adverse Event|1|||
130717733|NCT01154816|470593145|FG007|Overall Study|Adverse Event|1|||
130717734|NCT01154816|470593146|FG008|Overall Study|Adverse Event|0|||
130717735|NCT01154816|470593147|FG009|Overall Study|Adverse Event|0|||
130717736|NCT01154816|470593148|FG010|Overall Study|Adverse Event|0|||
130717737|NCT01154816|470593149|FG011|Overall Study|Adverse Event|0|||
130717738|NCT03397771|470593150|FG000|Overall Study|2 erroneously randomized, never treated|3|||
130717739|NCT03397771|470593151|FG001|Overall Study|2 erroneously randomized, never treated|1|||
130717740|NCT03397771|470593150|FG000|Overall Study|Withdrawal by Subject|1|||
130717741|NCT03397771|470593151|FG001|Overall Study|Withdrawal by Subject|3|||
130717742|NCT03397771|470593150|FG000|Overall Study|Protocol Violation|2|||
130717743|NCT03397771|470593151|FG001|Overall Study|Protocol Violation|2|||
130975863|NCT00515502|471537513|FG004|Treatment Period 1|Adverse Event|0|||
130717744|NCT03397771|470593150|FG000|Overall Study|Adverse Event|2|||
130717745|NCT03397771|470593151|FG001|Overall Study|Adverse Event|1|||
130717746|NCT04078126|470593152|FG000|Washout|Study put on hold due to COVID-19|0|||
130717747|NCT04078126|470593153|FG001|Washout|Study put on hold due to COVID-19|2|||
130717748|NCT04078126|470593152|FG000|Period 2|Study put on hold due to COVID-19|1|||
130777782|NCT02896569|470813335|FG001|Overall Study|Lost to Follow-up|1|||
130975864|NCT00515502|471537514|FG005|Treatment Period 1|Adverse Event|0|||
130777783|NCT02896569|470813334|FG000|Overall Study|Physician Decision|1|||
130777784|NCT02896569|470813335|FG001|Overall Study|Physician Decision|3|||
130777785|NCT02896569|470813334|FG000|Overall Study|Adverse Event|0|||
130777786|NCT02896569|470813335|FG001|Overall Study|Adverse Event|1|||
130777787|NCT02896569|470813334|FG000|Overall Study|Withdrawal by Subject|1|||
130777788|NCT02896569|470813335|FG001|Overall Study|Withdrawal by Subject|0|||
130777789|NCT01462630|470813336|FG000|Overall Study|Did not initiate therapy|3|||
130777790|NCT01462630|470813336|FG000|Overall Study|Death|1|||
130777791|NCT01462630|470813336|FG000|Overall Study|Protocol Violation|2|||
130777792|NCT01462630|470813336|FG000|Overall Study|Adverse Event|1|||
130777793|NCT00970489|470813339|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
130777794|NCT00970489|470813340|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
130777795|NCT02592447|470813343|FG000|Overall Study|Lost to Follow-up|1|||
130777796|NCT02592447|470813344|FG001|Overall Study|Lost to Follow-up|0|||
130777797|NCT02592447|470813343|FG000|Overall Study|Ineligible after randomization|1|||
130777798|NCT02592447|470813344|FG001|Overall Study|Ineligible after randomization|0|||
130777799|NCT02592447|470813343|FG000|Overall Study|Withdrawal by Subject|0|||
130777800|NCT02592447|470813344|FG001|Overall Study|Withdrawal by Subject|1|||
130777801|NCT01841970|470813345|FG000|Overall Study|Withdrawal by Subject|1|||
130777802|NCT01841970|470813345|FG000|Overall Study|Physician Decision|2|||
130777803|NCT01841970|470813345|FG000|Overall Study|Lost to Follow-up|8|||
130777804|NCT00618826|470813354|FG000|Overall Study|Adverse Event|1|||
130777805|NCT02364388|470813359|FG000|Overall Study|Protocol Violation|1|||
130777806|NCT02364388|470813359|FG000|Overall Study|Technical Failure|3|||
130777807|NCT02364388|470813359|FG000|Overall Study|No OA/US data|2|||
130777808|NCT02364388|470813359|FG000|Overall Study|No Biopsy|2|||
130777809|NCT00327717|470813360|FG000|Overall Study|Adverse Event|6|||
130777810|NCT00327717|470813361|FG001|Overall Study|Adverse Event|6|||
130777811|NCT00327717|470813360|FG000|Overall Study|Lack of Efficacy|0|||
130777812|NCT00327717|470813361|FG001|Overall Study|Lack of Efficacy|1|||
130777813|NCT00327717|470813360|FG000|Overall Study|Withdrawal by Subject|3|||
130777814|NCT00327717|470813361|FG001|Overall Study|Withdrawal by Subject|7|||
130777815|NCT02080364|470813364|FG000|Baseline Period|Protocol Violation|2|||
130777816|NCT02080364|470813365|FG001|Baseline Period|Protocol Violation|1|||
130777817|NCT02080364|470813366|FG002|Baseline Period|Protocol Violation|0|||
130777818|NCT02080364|470813367|FG003|Baseline Period|Protocol Violation|0|||
130777819|NCT02080364|470813364|FG000|Baseline Period|Other|0|||
130777820|NCT02080364|470813365|FG001|Baseline Period|Other|1|||
130777821|NCT02080364|470813366|FG002|Baseline Period|Other|1|||
130975865|NCT00515502|471537515|FG006|Treatment Period 1|Adverse Event|1|||
130975866|NCT00515502|471537516|FG007|Treatment Period 1|Adverse Event|0|||
130975867|NCT00515502|471537517|FG008|Treatment Period 1|Adverse Event|1|||
130975868|NCT00515502|471537518|FG009|Treatment Period 1|Adverse Event|0|||
130975869|NCT00515502|471537519|FG010|Treatment Period 1|Adverse Event|0|||
130975870|NCT00515502|471537520|FG011|Treatment Period 1|Adverse Event|1|||
130975871|NCT00515502|471537509|FG000|Treatment Period 2|Adverse Event|0|||
130975872|NCT00515502|471537510|FG001|Treatment Period 2|Adverse Event|1|||
130975873|NCT00515502|471537511|FG002|Treatment Period 2|Adverse Event|0|||
130975874|NCT00515502|471537512|FG003|Treatment Period 2|Adverse Event|0|||
130975875|NCT00515502|471537513|FG004|Treatment Period 2|Adverse Event|0|||
130975876|NCT00515502|471537514|FG005|Treatment Period 2|Adverse Event|0|||
130975877|NCT00515502|471537515|FG006|Treatment Period 2|Adverse Event|0|||
130975878|NCT00515502|471537516|FG007|Treatment Period 2|Adverse Event|0|||
130975879|NCT00515502|471537517|FG008|Treatment Period 2|Adverse Event|0|||
130975880|NCT00515502|471537518|FG009|Treatment Period 2|Adverse Event|0|||
130975881|NCT00515502|471537519|FG010|Treatment Period 2|Adverse Event|0|||
130975882|NCT00515502|471537520|FG011|Treatment Period 2|Adverse Event|0|||
130975883|NCT02732938|471537524|FG000|Overall Study|Death|0|||
130975884|NCT02732938|471537525|FG001|Overall Study|Death|11|||
130975885|NCT02732938|471537526|FG002|Overall Study|Death|0|||
130975886|NCT02732938|471537524|FG000|Overall Study|Randomized but did not receive treatment|0|||
130975887|NCT02732938|471537525|FG001|Overall Study|Randomized but did not receive treatment|1|||
130777822|NCT02080364|470813367|FG003|Baseline Period|Other|0|||
130975888|NCT02732938|471537526|FG002|Overall Study|Randomized but did not receive treatment|0|||
130975889|NCT02732938|471537524|FG000|Overall Study|Refused further follow-up|1|||
130777823|NCT02080364|470813364|FG000|Treatment Period|Adverse Event|10|||
130777824|NCT02080364|470813365|FG001|Treatment Period|Adverse Event|15|||
130777825|NCT02080364|470813366|FG002|Treatment Period|Adverse Event|11|||
130777826|NCT02080364|470813367|FG003|Treatment Period|Adverse Event|14|||
130777827|NCT02080364|470813364|FG000|Treatment Period|Lost to Follow-up|2|||
130777828|NCT02080364|470813365|FG001|Treatment Period|Lost to Follow-up|3|||
130975890|NCT02732938|471537525|FG001|Overall Study|Refused further follow-up|0|||
130975891|NCT02732938|471537526|FG002|Overall Study|Refused further follow-up|0|||
130975892|NCT02732938|471537524|FG000|Overall Study|Study terminated by sponsor|3|||
130975893|NCT02732938|471537525|FG001|Overall Study|Study terminated by sponsor|6|||
130975894|NCT02732938|471537526|FG002|Overall Study|Study terminated by sponsor|0|||
130975895|NCT03647501|471537527|FG000|Overall Study|Lost to Follow-up|1|||
130777829|NCT02080364|470813366|FG002|Treatment Period|Lost to Follow-up|5|||
130975896|NCT03647501|471537528|FG001|Overall Study|Lost to Follow-up|1|||
130975897|NCT03647501|471537527|FG000|Overall Study|Withdrawal by Subject|0|||
130975898|NCT03647501|471537528|FG001|Overall Study|Withdrawal by Subject|1|||
130975899|NCT04530448|471537529|FG000|Overall Study|Physician Decision|3|||
130975900|NCT04530448|471537530|FG001|Overall Study|Physician Decision|0|||
130975901|NCT01491854|471537532|FG000|Overall Study|mainly due to premature termination|93|||
130975902|NCT01491854|471537532|FG000|Overall Study|Death|1|||
130975903|NCT01491854|471537532|FG000|Overall Study|Withdrawal by Subject|3|||
130975904|NCT01491854|471537532|FG000|Overall Study|Lost to Follow-up|33|||
130975905|NCT01433354|471537534|FG000|Overall Study|Adverse Event|6|||
130975906|NCT01433354|471537534|FG000|Overall Study|Lost to Follow-up|1|||
130975907|NCT01433354|471537534|FG000|Overall Study|Administrative problems|90|||
130975908|NCT01433354|471537534|FG000|Overall Study|Protocol Violation|2|||
130975909|NCT01433354|471537534|FG000|Overall Study|Lack of Efficacy|17|||
130975910|NCT01433354|471537534|FG000|Overall Study|Subject Withdrew Consent|3|||
130975911|NCT01540851|471537538|FG000|Overall Study|Lost to Follow-up|14|||
130975912|NCT01540851|471537539|FG001|Overall Study|Lost to Follow-up|15|||
130975913|NCT01540851|471537538|FG000|Overall Study|Withdrawal by Subject|7|||
130975914|NCT01540851|471537539|FG001|Overall Study|Withdrawal by Subject|3|||
130975915|NCT02013622|471537540|FG000|Overall Study|Lost to Follow-up|10|||
130975916|NCT02013622|471537540|FG000|Overall Study|Adverse Event|3|||
130777830|NCT02080364|470813367|FG003|Treatment Period|Lost to Follow-up|0|||
130975917|NCT02013622|471537540|FG000|Overall Study|Met Withdrawal Criteria|3|||
130975918|NCT02013622|471537540|FG000|Overall Study|Withdrawal by Subject|6|||
130975919|NCT02013622|471537540|FG000|Overall Study|Protocol Deviation|1|||
130975920|NCT02013622|471537540|FG000|Overall Study|Lack of Efficacy|1|||
130975921|NCT04307004|471537553|FG000|Randomization 1|Withdrawal by Subject|25|||
130975922|NCT04307004|471537554|FG001|Randomization 1|Withdrawal by Subject|26|||
130975923|NCT04307004|471537555|FG002|Randomization 1|Withdrawal by Subject|0|||
130975924|NCT04307004|471537556|FG003|Randomization 1|Withdrawal by Subject|0|||
130975925|NCT04307004|471537553|FG000|Randomization 2|Withdrawal by Subject|0|||
130975926|NCT04307004|471537554|FG001|Randomization 2|Withdrawal by Subject|0|||
130975927|NCT04307004|471537555|FG002|Randomization 2|Withdrawal by Subject|28|||
130975928|NCT04307004|471537556|FG003|Randomization 2|Withdrawal by Subject|23|||
130975929|NCT05545072|471537557|FG000|Overall Study|Lost to Follow-up|1|||
130975930|NCT05545072|471537558|FG001|Overall Study|Lost to Follow-up|0|||
130975931|NCT05545072|471537557|FG000|Overall Study|Study ended prematurely due to funding|2|||
130975932|NCT05545072|471537558|FG001|Overall Study|Study ended prematurely due to funding|2|||
130975933|NCT01324271|471537559|FG000|Overall Study|Lost to Follow-up|3|||
130975934|NCT01324271|471537560|FG001|Overall Study|Lost to Follow-up|0|||
130975935|NCT01324271|471537559|FG000|Overall Study|Physician Decision|1|||
130975936|NCT01324271|471537560|FG001|Overall Study|Physician Decision|0|||
130975937|NCT05130970|471537561|FG000|Overall Study|Adverse Event|1|||
130975938|NCT05130970|471537562|FG001|Overall Study|Adverse Event|1|||
130975939|NCT05130970|471537561|FG000|Overall Study|Death|0|||
130975940|NCT05130970|471537562|FG001|Overall Study|Death|1|||
130975941|NCT05130970|471537561|FG000|Overall Study|Lost to Follow-up|0|||
130975942|NCT05130970|471537562|FG001|Overall Study|Lost to Follow-up|1|||
130975943|NCT05130970|471537561|FG000|Overall Study|Physician Decision|0|||
130975944|NCT05130970|471537562|FG001|Overall Study|Physician Decision|1|||
130975945|NCT05130970|471537561|FG000|Overall Study|Withdrawal by Subject|1|||
130975946|NCT05130970|471537562|FG001|Overall Study|Withdrawal by Subject|1|||
130777831|NCT02080364|470813364|FG000|Treatment Period|Protocol Violation|5|||
130777832|NCT02080364|470813365|FG001|Treatment Period|Protocol Violation|3|||
130777833|NCT02080364|470813366|FG002|Treatment Period|Protocol Violation|5|||
130975947|NCT03996473|471537563|FG000|Treatment Assignment|Withdrawal by Subject|1|||
130975948|NCT03996473|471537563|FG000|Treatment Assignment|Progressive disease|6|||
130975949|NCT03996473|471537563|FG000|Treatment Assignment|Study drug never administered|1|||
130975950|NCT03996473|471537563|FG000|Active Follow-up|Death|1|||
130975951|NCT03996473|471537563|FG000|Long-term Follow-up|Death|5|||
130975952|NCT06116591|471537564|FG000|Overall Study|No longer met eligibility criteria|0|||
130975953|NCT06116591|471537565|FG001|Overall Study|No longer met eligibility criteria|1|||
130975954|NCT06116591|471537564|FG000|Overall Study|Other: Change in life situation|0|||
130975955|NCT06116591|471537565|FG001|Overall Study|Other: Change in life situation|1|||
130975956|NCT01381692|471537568|FG000|Overall Study|Adverse Event|1|||
130975957|NCT01381692|471537569|FG001|Overall Study|Adverse Event|0|||
130975958|NCT01381692|471537570|FG002|Overall Study|Adverse Event|0|||
130975959|NCT01381692|471537571|FG003|Overall Study|Adverse Event|0|||
130975960|NCT01381692|471537572|FG004|Overall Study|Adverse Event|0|||
130975961|NCT01381692|471537573|FG005|Overall Study|Adverse Event|0|||
130975962|NCT01270347|471537574|FG000|Core Phase|Adverse Event|1|||
130975963|NCT01270347|471537575|FG001|Core Phase|Adverse Event|6|||
130975964|NCT01270347|471537574|FG000|Core Phase|Withdrawal by Subject|1|||
130975965|NCT01270347|471537575|FG001|Core Phase|Withdrawal by Subject|2|||
130975966|NCT01270347|471537574|FG000|Core Phase|Lost to Follow-up|0|||
130975967|NCT01270347|471537575|FG001|Core Phase|Lost to Follow-up|1|||
130975968|NCT01270347|471537574|FG000|Core Phase|Miscellaneous|8|||
130975969|NCT01270347|471537575|FG001|Core Phase|Miscellaneous|14|||
130975970|NCT01270347|471537574|FG000|Extension Phase|Adverse Event|1|||
130777834|NCT02080364|470813367|FG003|Treatment Period|Protocol Violation|1|||
130777835|NCT02080364|470813364|FG000|Treatment Period|Withdrawal by Subject|16|||
130777836|NCT02080364|470813365|FG001|Treatment Period|Withdrawal by Subject|16|||
130777837|NCT02080364|470813366|FG002|Treatment Period|Withdrawal by Subject|15|||
130777838|NCT02080364|470813367|FG003|Treatment Period|Withdrawal by Subject|10|||
130777839|NCT02080364|470813364|FG000|Treatment Period|Study Terminated by Sponsor|0|||
130777840|NCT02080364|470813365|FG001|Treatment Period|Study Terminated by Sponsor|0|||
130777841|NCT02080364|470813366|FG002|Treatment Period|Study Terminated by Sponsor|180|||
130777842|NCT02080364|470813367|FG003|Treatment Period|Study Terminated by Sponsor|183|||
130777843|NCT02080364|470813364|FG000|Treatment Period|Other|14|||
130777844|NCT02080364|470813365|FG001|Treatment Period|Other|12|||
130777845|NCT02080364|470813366|FG002|Treatment Period|Other|21|||
130777846|NCT02080364|470813367|FG003|Treatment Period|Other|16|||
130777847|NCT00905424|470813368|FG000|Overall Study|Lost to Follow-up|3|||
130777848|NCT00905424|470813369|FG001|Overall Study|Lost to Follow-up|3|||
130777849|NCT00905424|470813368|FG000|Overall Study|Withdrawal by Subject|1|||
130777850|NCT00905424|470813369|FG001|Overall Study|Withdrawal by Subject|2|||
130777851|NCT00905424|470813368|FG000|Overall Study|Adverse Event|4|||
130777852|NCT00905424|470813369|FG001|Overall Study|Adverse Event|2|||
130777853|NCT00905424|470813368|FG000|Overall Study|Non-compliance with study medication|2|||
130777854|NCT00905424|470813369|FG001|Overall Study|Non-compliance with study medication|0|||
130777855|NCT00905424|470813368|FG000|Overall Study|Sponsor decision|1|||
130777856|NCT00905424|470813369|FG001|Overall Study|Sponsor decision|0|||
130777857|NCT00905424|470813368|FG000|Overall Study|Positive urine drug screen|0|||
130777858|NCT00905424|470813369|FG001|Overall Study|Positive urine drug screen|1|||
130777859|NCT00905424|470813368|FG000|Overall Study|Non-adherence to visit schedule|0|||
130777860|NCT00905424|470813369|FG001|Overall Study|Non-adherence to visit schedule|1|||
130777861|NCT00627926|470813371|FG000|Overall Study|Adverse Event|26|||
130777862|NCT00627926|470813372|FG001|Overall Study|Adverse Event|37|||
130975971|NCT01270347|471537575|FG001|Extension Phase|Adverse Event|3|||
130975972|NCT01270347|471537574|FG000|Extension Phase|Withdrawal by Subject|3|||
130975973|NCT01270347|471537575|FG001|Extension Phase|Withdrawal by Subject|4|||
130975974|NCT01270347|471537574|FG000|Extension Phase|Miscellaneous|2|||
130975975|NCT01270347|471537575|FG001|Extension Phase|Miscellaneous|2|||
130975976|NCT02189798|471537576|FG000|Extended Use Phase|Withdrawal by Subject|0|||
130975977|NCT02189798|471537577|FG001|Extended Use Phase|Withdrawal by Subject|4|||
130975978|NCT02189798|471537576|FG000|Extended Use Phase|Physician Decision|1|||
130975979|NCT02189798|471537577|FG001|Extended Use Phase|Physician Decision|0|||
130975980|NCT02189798|471537576|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
130975981|NCT02189798|471537577|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
130975982|NCT02189798|471537576|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
130975983|NCT02189798|471537577|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
130975984|NCT02189798|471537576|FG000|Extended Use Phase|Travel Issues|2|||
130975985|NCT02189798|471537577|FG001|Extended Use Phase|Travel Issues|1|||
130975986|NCT02189798|471537576|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
130975987|NCT02189798|471537577|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
130975988|NCT02273141|471537578|FG000|Overall Study|Adverse Event|0|||
130975989|NCT02273141|471537579|FG001|Overall Study|Adverse Event|1|||
130975990|NCT02273141|471537578|FG000|Overall Study|Lost to Follow-up|1|||
130975991|NCT02273141|471537579|FG001|Overall Study|Lost to Follow-up|3|||
130975992|NCT02273141|471537578|FG000|Overall Study|Withdrawal by Subject|10|||
130975993|NCT02273141|471537579|FG001|Overall Study|Withdrawal by Subject|15|||
130975994|NCT02273141|471537578|FG000|Overall Study|Various|6|||
130975995|NCT02273141|471537579|FG001|Overall Study|Various|6|||
130975996|NCT00529399|471537580|FG000|Overall Study|Lost to Follow-up|1|||
130975997|NCT00529399|471537581|FG001|Overall Study|Lost to Follow-up|0|||
130975998|NCT00529399|471537582|FG002|Overall Study|Lost to Follow-up|1|||
130975999|NCT00529399|471537580|FG000|Overall Study|Withdrawal by Subject|1|||
130976000|NCT00529399|471537581|FG001|Overall Study|Withdrawal by Subject|0|||
130976001|NCT00529399|471537582|FG002|Overall Study|Withdrawal by Subject|1|||
130976002|NCT00529399|471537580|FG000|Overall Study|Non-compliant|0|||
130976003|NCT00529399|471537581|FG001|Overall Study|Non-compliant|1|||
130976004|NCT00529399|471537582|FG002|Overall Study|Non-compliant|0|||
130976005|NCT04313881|471537594|FG000|Overall Study|Death|138|||
131227511|NCT00410410|472459755|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
131227512|NCT00410410|472459756|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130777863|NCT00627926|470813373|FG002|Overall Study|Adverse Event|36|||
130777864|NCT00627926|470813371|FG000|Overall Study|Death|1|||
130777865|NCT00627926|470813372|FG001|Overall Study|Death|0|||
130777866|NCT00627926|470813373|FG002|Overall Study|Death|0|||
130777867|NCT00627926|470813371|FG000|Overall Study|Lost to Follow-up|4|||
130777868|NCT00627926|470813372|FG001|Overall Study|Lost to Follow-up|3|||
130976006|NCT04313881|471537595|FG001|Overall Study|Death|126|||
130976007|NCT04313881|471537594|FG000|Overall Study|Study terminated by sponsor|108|||
130777869|NCT00627926|470813373|FG002|Overall Study|Lost to Follow-up|4|||
130976008|NCT04313881|471537595|FG001|Overall Study|Study terminated by sponsor|129|||
130976009|NCT04313881|471537594|FG000|Overall Study|Consent withdrawn|19|||
130976010|NCT04313881|471537595|FG001|Overall Study|Consent withdrawn|15|||
130976011|NCT04313881|471537594|FG000|Overall Study|Reason not Specified|3|||
130976012|NCT04313881|471537595|FG001|Overall Study|Reason not Specified|1|||
130976013|NCT00727272|471537596|FG000|Washout Period A|Adverse Event|0|||
130976014|NCT00727272|471537597|FG001|Washout Period A|Adverse Event|0|||
130976015|NCT00727272|471537598|FG002|Washout Period A|Adverse Event|1|||
130976016|NCT00727272|471537596|FG000|Washout Period B|Withdrawal by Subject|0|||
130976017|NCT00727272|471537597|FG001|Washout Period B|Withdrawal by Subject|0|||
130976018|NCT00727272|471537598|FG002|Washout Period B|Withdrawal by Subject|1|||
130976019|NCT00651664|471537599|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
130976020|NCT00651664|471537600|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
130976021|NCT00651664|471537601|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
130976022|NCT00651664|471537602|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
130976023|NCT00651664|471537603|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
130976024|NCT00651664|471537604|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
130976025|NCT00651664|471537605|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
130976026|NCT00651664|471537606|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
130976027|NCT00651664|471537607|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
130976028|NCT00651664|471537608|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
130976029|NCT00651664|471537599|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
130976030|NCT00651664|471537600|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
130976031|NCT00651664|471537601|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130976032|NCT00651664|471537602|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
130976033|NCT00651664|471537603|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
130976034|NCT00651664|471537604|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
130976035|NCT00651664|471537605|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
130976036|NCT00651664|471537606|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
130976037|NCT00651664|471537607|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
130976038|NCT00651664|471537608|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
130976039|NCT00651664|471537599|FG000|Overall Study|Progressive Disease|3|||
130976040|NCT00651664|471537600|FG001|Overall Study|Progressive Disease|3|||
130976041|NCT00651664|471537601|FG002|Overall Study|Progressive Disease|3|||
130976042|NCT00651664|471537602|FG003|Overall Study|Progressive Disease|12|||
130976043|NCT00651664|471537603|FG004|Overall Study|Progressive Disease|4|||
130976044|NCT00651664|471537604|FG005|Overall Study|Progressive Disease|1|||
130976045|NCT00651664|471537605|FG006|Overall Study|Progressive Disease|3|||
130976046|NCT00651664|471537606|FG007|Overall Study|Progressive Disease|6|||
130976047|NCT00651664|471537607|FG008|Overall Study|Progressive Disease|5|||
130976048|NCT00651664|471537608|FG009|Overall Study|Progressive Disease|5|||
130976049|NCT00651664|471537599|FG000|Overall Study|Patient Declined Further Treatment|0|||
130976050|NCT00651664|471537600|FG001|Overall Study|Patient Declined Further Treatment|0|||
130976051|NCT00651664|471537601|FG002|Overall Study|Patient Declined Further Treatment|0|||
130976052|NCT00651664|471537602|FG003|Overall Study|Patient Declined Further Treatment|1|||
130976053|NCT00651664|471537603|FG004|Overall Study|Patient Declined Further Treatment|1|||
130976054|NCT00651664|471537604|FG005|Overall Study|Patient Declined Further Treatment|1|||
130976055|NCT00651664|471537605|FG006|Overall Study|Patient Declined Further Treatment|0|||
130976056|NCT00651664|471537606|FG007|Overall Study|Patient Declined Further Treatment|0|||
130976057|NCT00651664|471537607|FG008|Overall Study|Patient Declined Further Treatment|0|||
130976058|NCT00651664|471537608|FG009|Overall Study|Patient Declined Further Treatment|1|||
130976059|NCT00651664|471537599|FG000|Overall Study|Symptomatic Deterioration|0|||
130976060|NCT00651664|471537600|FG001|Overall Study|Symptomatic Deterioration|0|||
130976061|NCT00651664|471537601|FG002|Overall Study|Symptomatic Deterioration|0|||
130976062|NCT00651664|471537602|FG003|Overall Study|Symptomatic Deterioration|1|||
130976063|NCT00651664|471537603|FG004|Overall Study|Symptomatic Deterioration|0|||
130976064|NCT00651664|471537604|FG005|Overall Study|Symptomatic Deterioration|0|||
130976065|NCT00651664|471537605|FG006|Overall Study|Symptomatic Deterioration|1|||
130976066|NCT00651664|471537606|FG007|Overall Study|Symptomatic Deterioration|0|||
130976067|NCT00651664|471537607|FG008|Overall Study|Symptomatic Deterioration|1|||
130976068|NCT00651664|471537608|FG009|Overall Study|Symptomatic Deterioration|0|||
130976069|NCT00651664|471537599|FG000|Overall Study|Reason not Specified|0|||
130976070|NCT00651664|471537600|FG001|Overall Study|Reason not Specified|0|||
130976071|NCT00651664|471537601|FG002|Overall Study|Reason not Specified|0|||
130976072|NCT00651664|471537602|FG003|Overall Study|Reason not Specified|0|||
130976073|NCT00651664|471537603|FG004|Overall Study|Reason not Specified|0|||
130976074|NCT00651664|471537604|FG005|Overall Study|Reason not Specified|0|||
130976075|NCT00651664|471537605|FG006|Overall Study|Reason not Specified|1|||
130976076|NCT00651664|471537606|FG007|Overall Study|Reason not Specified|0|||
130976077|NCT00651664|471537607|FG008|Overall Study|Reason not Specified|0|||
130976078|NCT00651664|471537608|FG009|Overall Study|Reason not Specified|0|||
130976079|NCT01474681|471537609|FG000|Overall Study|Death|0|||
130976080|NCT01474681|471537610|FG001|Overall Study|Death|3|||
130976081|NCT01474681|471537611|FG002|Overall Study|Death|2|||
130976082|NCT01474681|471537612|FG003|Overall Study|Death|6|||
130976083|NCT03998618|471537615|FG000|Overall Study|Death|7|||
130976084|NCT03998618|471537616|FG001|Overall Study|Death|11|||
130976085|NCT03998618|471537615|FG000|Overall Study|hospice enrollment|3|||
130976086|NCT03998618|471537616|FG001|Overall Study|hospice enrollment|3|||
130976087|NCT03998618|471537615|FG000|Overall Study|Not feeling well/health problems|3|||
130976088|NCT03998618|471537616|FG001|Overall Study|Not feeling well/health problems|5|||
130976089|NCT03998618|471537615|FG000|Overall Study|Lost to Follow-up|6|||
130976090|NCT03998618|471537616|FG001|Overall Study|Lost to Follow-up|6|||
130976091|NCT03998618|471537615|FG000|Overall Study|Withdrawal by Subject|0|||
130976092|NCT03998618|471537616|FG001|Overall Study|Withdrawal by Subject|4|||
130976093|NCT02195986|471537617|FG000|Overall Study|Adverse Event|3|||
130976094|NCT02195986|471537618|FG001|Overall Study|Adverse Event|0|||
130976095|NCT02195986|471537619|FG002|Overall Study|Adverse Event|0|||
130976096|NCT02195986|471537617|FG000|Overall Study|Withdrawal by Subject|0|||
130976097|NCT02195986|471537618|FG001|Overall Study|Withdrawal by Subject|3|||
130976098|NCT02195986|471537619|FG002|Overall Study|Withdrawal by Subject|0|||
130976099|NCT02195986|471537617|FG000|Overall Study|Family Emergency|0|||
130976100|NCT02195986|471537618|FG001|Overall Study|Family Emergency|0|||
130976101|NCT02195986|471537619|FG002|Overall Study|Family Emergency|1|||
130976102|NCT02195986|471537617|FG000|Overall Study|Protocol Violation|0|||
130976103|NCT02195986|471537618|FG001|Overall Study|Protocol Violation|1|||
130976104|NCT02195986|471537619|FG002|Overall Study|Protocol Violation|1|||
130976105|NCT02195986|471537617|FG000|Overall Study|Non-compliance|0|||
130976106|NCT02195986|471537618|FG001|Overall Study|Non-compliance|1|||
130976107|NCT02195986|471537619|FG002|Overall Study|Non-compliance|0|||
130976108|NCT02834780|471537622|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
130976109|NCT02834780|471537623|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
130976110|NCT02834780|471537624|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
130976111|NCT02834780|471537625|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
130976112|NCT02834780|471537626|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
130976113|NCT02834780|471537627|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
130976114|NCT02834780|471537628|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
130976115|NCT02834780|471537629|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
130976116|NCT02834780|471537630|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
130976117|NCT02834780|471537631|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
130976118|NCT02834780|471537632|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
130976119|NCT02834780|471537633|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
130976120|NCT02834780|471537634|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
130976121|NCT02834780|471537622|FG000|Overall Study|Withdrawal by Subject|0|||
130976122|NCT02834780|471537623|FG001|Overall Study|Withdrawal by Subject|0|||
130976123|NCT02834780|471537624|FG002|Overall Study|Withdrawal by Subject|1|||
130976124|NCT02834780|471537625|FG003|Overall Study|Withdrawal by Subject|0|||
130976125|NCT02834780|471537626|FG004|Overall Study|Withdrawal by Subject|0|||
130777870|NCT00627926|470813371|FG000|Overall Study|Withdrawal by Subject|2|||
130777871|NCT00627926|470813372|FG001|Overall Study|Withdrawal by Subject|1|||
130777872|NCT00627926|470813373|FG002|Overall Study|Withdrawal by Subject|0|||
130777873|NCT00627926|470813371|FG000|Overall Study|Lack of Efficacy|118|||
130777874|NCT00627926|470813372|FG001|Overall Study|Lack of Efficacy|40|||
130777875|NCT00627926|470813373|FG002|Overall Study|Lack of Efficacy|38|||
130777876|NCT00627926|470813371|FG000|Overall Study|Noncompliance/unspecified|8|||
130777877|NCT00627926|470813372|FG001|Overall Study|Noncompliance/unspecified|23|||
130777878|NCT00627926|470813373|FG002|Overall Study|Noncompliance/unspecified|17|||
130777879|NCT00571662|470813376|FG000|Overall Study|Withdrawal by Subject|2|||
130777880|NCT00571662|470813376|FG000|Overall Study|psychiatric instability|1|||
130777881|NCT00571662|470813376|FG000|Overall Study|Adverse Event|5|||
130777882|NCT00964028|470813377|FG000|Overall Study|Withdrawal by Subject|0|||
130976126|NCT02834780|471537627|FG005|Overall Study|Withdrawal by Subject|0|||
130976127|NCT02834780|471537628|FG006|Overall Study|Withdrawal by Subject|0|||
130976128|NCT02834780|471537629|FG007|Overall Study|Withdrawal by Subject|0|||
130976129|NCT02834780|471537630|FG008|Overall Study|Withdrawal by Subject|0|||
130976130|NCT02834780|471537631|FG009|Overall Study|Withdrawal by Subject|0|||
130976131|NCT02834780|471537632|FG010|Overall Study|Withdrawal by Subject|1|||
130976132|NCT02834780|471537633|FG011|Overall Study|Withdrawal by Subject|0|||
130976133|NCT02834780|471537634|FG012|Overall Study|Withdrawal by Subject|0|||
130976134|NCT02834780|471537622|FG000|Overall Study|Adverse Event|0|||
130976135|NCT02834780|471537623|FG001|Overall Study|Adverse Event|0|||
130976136|NCT02834780|471537624|FG002|Overall Study|Adverse Event|0|||
130976137|NCT02834780|471537625|FG003|Overall Study|Adverse Event|0|||
130976138|NCT02834780|471537626|FG004|Overall Study|Adverse Event|1|||
130976139|NCT02834780|471537627|FG005|Overall Study|Adverse Event|0|||
130777883|NCT00964028|470813378|FG001|Overall Study|Withdrawal by Subject|1|||
130777884|NCT02385110|470813379|FG000|Overall Study|Early Death|1|||
130777885|NCT02385110|470813380|FG001|Overall Study|Early Death|0|||
130976140|NCT02834780|471537628|FG006|Overall Study|Adverse Event|1|||
130976141|NCT02834780|471537629|FG007|Overall Study|Adverse Event|1|||
130976142|NCT02834780|471537630|FG008|Overall Study|Adverse Event|0|||
130777886|NCT03472521|470813381|FG000|Overall Study|Lost to Follow-up|3|||
130777887|NCT03472521|470813382|FG001|Overall Study|Lost to Follow-up|2|||
130777888|NCT03472521|470813381|FG000|Overall Study|Discontinued intervention|3|||
130777889|NCT03472521|470813382|FG001|Overall Study|Discontinued intervention|1|||
130777890|NCT00181883|470813387|FG000|Overall Study|Lack of Efficacy|2|||
130777891|NCT00181883|470813387|FG000|Overall Study|Treatment Limiting AEs|3|||
130777892|NCT00181883|470813387|FG000|Overall Study|Withdrawal by Subject|4|||
130777893|NCT00181883|470813387|FG000|Overall Study|Lost to Follow-up|1|||
130777894|NCT00765817|470813388|FG000|Overall Study|Adverse Event|13|||
130777895|NCT00765817|470813389|FG001|Overall Study|Adverse Event|1|||
130976143|NCT02834780|471537631|FG009|Overall Study|Adverse Event|2|||
130976144|NCT02834780|471537632|FG010|Overall Study|Adverse Event|0|||
130976145|NCT02834780|471537633|FG011|Overall Study|Adverse Event|3|||
130976146|NCT02834780|471537634|FG012|Overall Study|Adverse Event|2|||
130976147|NCT02834780|471537622|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
130976148|NCT02834780|471537623|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
130976149|NCT02834780|471537624|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
130976150|NCT02834780|471537625|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
130976151|NCT02834780|471537626|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
130976152|NCT02834780|471537627|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
130777896|NCT00765817|470813388|FG000|Overall Study|Death|0|||
130777897|NCT00765817|470813389|FG001|Overall Study|Death|1|||
130777898|NCT00765817|470813388|FG000|Overall Study|Entry criteria not met|2|||
130777899|NCT00765817|470813389|FG001|Overall Study|Entry criteria not met|2|||
130777900|NCT00765817|470813388|FG000|Overall Study|Loss of glucose control|0|||
130777901|NCT00765817|470813389|FG001|Overall Study|Loss of glucose control|2|||
130777902|NCT00765817|470813388|FG000|Overall Study|Lost to Follow-up|1|||
130777903|NCT00765817|470813389|FG001|Overall Study|Lost to Follow-up|3|||
130777904|NCT00765817|470813388|FG000|Overall Study|Physician Decision|2|||
130777905|NCT00765817|470813389|FG001|Overall Study|Physician Decision|1|||
130777906|NCT00765817|470813388|FG000|Overall Study|Protocol Violation|1|||
130777907|NCT00765817|470813389|FG001|Overall Study|Protocol Violation|1|||
130777908|NCT00765817|470813388|FG000|Overall Study|Subject decision|7|||
130777909|NCT00765817|470813389|FG001|Overall Study|Subject decision|11|||
130777910|NCT00103285|470815299|FG000|Induction|Adverse Event|14|||
130777911|NCT00103285|470815300|FG001|Induction|Adverse Event|0|||
130777912|NCT00103285|470815301|FG002|Induction|Adverse Event|0|||
130777913|NCT00103285|470815302|FG003|Induction|Adverse Event|0|||
130777914|NCT00103285|470815303|FG004|Induction|Adverse Event|0|||
130777915|NCT00103285|470815304|FG005|Induction|Adverse Event|0|||
130777916|NCT00103285|470815305|FG006|Induction|Adverse Event|0|||
130777917|NCT00103285|470815306|FG007|Induction|Adverse Event|0|||
130777918|NCT00103285|470815299|FG000|Induction|Death|24|||
130777919|NCT00103285|470815300|FG001|Induction|Death|0|||
130777920|NCT00103285|470815301|FG002|Induction|Death|0|||
130777921|NCT00103285|470815302|FG003|Induction|Death|0|||
130777922|NCT00103285|470815303|FG004|Induction|Death|0|||
130777923|NCT00103285|470815304|FG005|Induction|Death|0|||
130777924|NCT00103285|470815305|FG006|Induction|Death|0|||
130777925|NCT00103285|470815306|FG007|Induction|Death|0|||
130777926|NCT00103285|470815299|FG000|Induction|Physician Decision|103|||
130777927|NCT00103285|470815300|FG001|Induction|Physician Decision|0|||
130777928|NCT00103285|470815301|FG002|Induction|Physician Decision|0|||
130777929|NCT00103285|470815302|FG003|Induction|Physician Decision|0|||
130777930|NCT00103285|470815303|FG004|Induction|Physician Decision|0|||
130777931|NCT00103285|470815304|FG005|Induction|Physician Decision|0|||
130777932|NCT00103285|470815305|FG006|Induction|Physician Decision|0|||
130777933|NCT00103285|470815306|FG007|Induction|Physician Decision|0|||
130777934|NCT00103285|470815299|FG000|Induction|Withdrawal by Subject|1|||
130777935|NCT00103285|470815300|FG001|Induction|Withdrawal by Subject|0|||
130777936|NCT00103285|470815301|FG002|Induction|Withdrawal by Subject|0|||
130777937|NCT00103285|470815302|FG003|Induction|Withdrawal by Subject|0|||
130777938|NCT00103285|470815303|FG004|Induction|Withdrawal by Subject|0|||
130777939|NCT00103285|470815304|FG005|Induction|Withdrawal by Subject|0|||
130976153|NCT02834780|471537628|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
130976154|NCT02834780|471537629|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
130777940|NCT00103285|470815305|FG006|Induction|Withdrawal by Subject|0|||
130777941|NCT00103285|470815306|FG007|Induction|Withdrawal by Subject|0|||
130777942|NCT00103285|470815299|FG000|Induction|Ineligible|43|||
130777943|NCT00103285|470815300|FG001|Induction|Ineligible|0|||
130777944|NCT00103285|470815301|FG002|Induction|Ineligible|0|||
130777945|NCT00103285|470815302|FG003|Induction|Ineligible|0|||
130777946|NCT00103285|470815303|FG004|Induction|Ineligible|0|||
130777947|NCT00103285|470815304|FG005|Induction|Ineligible|0|||
130777948|NCT00103285|470815305|FG006|Induction|Ineligible|0|||
130777949|NCT00103285|470815306|FG007|Induction|Ineligible|0|||
130777950|NCT00103285|470815299|FG000|Induction|Refusal|906|||
130777951|NCT00103285|470815300|FG001|Induction|Refusal|0|||
130777952|NCT00103285|470815301|FG002|Induction|Refusal|0|||
130985723|NCT01964326|471574967|FG000|Overall Study|Death|2|||
130985724|NCT01964326|471574967|FG000|Overall Study|Protocol Violation|4|||
130985725|NCT01964326|471574967|FG000|Overall Study|Lost to Follow-up|88|||
130976155|NCT02834780|471537630|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
130976156|NCT02834780|471537631|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
130976157|NCT02834780|471537632|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
130976158|NCT02834780|471537633|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
130976159|NCT02834780|471537634|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
130976160|NCT02834780|471537622|FG000|Overall Study|Other|1|||
130976161|NCT02834780|471537623|FG001|Overall Study|Other|0|||
130976162|NCT02834780|471537624|FG002|Overall Study|Other|1|||
130976163|NCT02834780|471537625|FG003|Overall Study|Other|2|||
130976164|NCT02834780|471537626|FG004|Overall Study|Other|0|||
130976165|NCT02834780|471537627|FG005|Overall Study|Other|0|||
130976166|NCT02834780|471537628|FG006|Overall Study|Other|0|||
130976167|NCT02834780|471537629|FG007|Overall Study|Other|0|||
130976168|NCT02834780|471537630|FG008|Overall Study|Other|0|||
130976169|NCT02834780|471537631|FG009|Overall Study|Other|0|||
130976170|NCT02834780|471537632|FG010|Overall Study|Other|0|||
130976171|NCT02834780|471537633|FG011|Overall Study|Other|0|||
130976172|NCT02834780|471537634|FG012|Overall Study|Other|1|||
130777953|NCT00103285|470815302|FG003|Induction|Refusal|0|||
130976173|NCT02415400|471537635|FG000|Overall Study|Adverse Event|0|||
130976174|NCT02415400|471537636|FG001|Overall Study|Adverse Event|1|||
130976175|NCT02415400|471537637|FG002|Overall Study|Adverse Event|1|||
130976176|NCT02415400|471537638|FG003|Overall Study|Adverse Event|2|||
130976177|NCT02415400|471537635|FG000|Overall Study|Participant request to stop therapy|4|||
130976178|NCT02415400|471537636|FG001|Overall Study|Participant request to stop therapy|3|||
130777954|NCT00103285|470815303|FG004|Induction|Refusal|0|||
130777955|NCT00103285|470815304|FG005|Induction|Refusal|0|||
130777956|NCT00103285|470815305|FG006|Induction|Refusal|0|||
130976179|NCT02415400|471537637|FG002|Overall Study|Participant request to stop therapy|8|||
130976180|NCT02415400|471537638|FG003|Overall Study|Participant request to stop therapy|6|||
130976181|NCT02415400|471537635|FG000|Overall Study|Participant withdrew consent|14|||
130976182|NCT02415400|471537636|FG001|Overall Study|Participant withdrew consent|12|||
130976183|NCT02415400|471537637|FG002|Overall Study|Participant withdrew consent|30|||
130976184|NCT02415400|471537638|FG003|Overall Study|Participant withdrew consent|21|||
130976185|NCT02415400|471537635|FG000|Overall Study|Death|39|||
130976186|NCT02415400|471537636|FG001|Overall Study|Death|41|||
130976187|NCT02415400|471537637|FG002|Overall Study|Death|35|||
130976188|NCT02415400|471537638|FG003|Overall Study|Death|42|||
130976189|NCT02415400|471537635|FG000|Overall Study|Lost to Follow-up|3|||
130976190|NCT02415400|471537636|FG001|Overall Study|Lost to Follow-up|3|||
130976191|NCT02415400|471537637|FG002|Overall Study|Lost to Follow-up|2|||
130976192|NCT02415400|471537638|FG003|Overall Study|Lost to Follow-up|5|||
130976193|NCT02415400|471537635|FG000|Overall Study|Poor/Non-Compliance|0|||
130976194|NCT02415400|471537636|FG001|Overall Study|Poor/Non-Compliance|1|||
130976195|NCT02415400|471537637|FG002|Overall Study|Poor/Non-Compliance|3|||
130976196|NCT02415400|471537638|FG003|Overall Study|Poor/Non-Compliance|4|||
130976197|NCT02415400|471537635|FG000|Overall Study|Participant no longer meets criteria|2|||
130976198|NCT02415400|471537636|FG001|Overall Study|Participant no longer meets criteria|0|||
130976199|NCT02415400|471537637|FG002|Overall Study|Participant no longer meets criteria|0|||
130976200|NCT02415400|471537638|FG003|Overall Study|Participant no longer meets criteria|1|||
130976201|NCT02415400|471537635|FG000|Overall Study|Participant doesn't answer phone|1|||
130976202|NCT02415400|471537636|FG001|Overall Study|Participant doesn't answer phone|0|||
130976203|NCT02415400|471537637|FG002|Overall Study|Participant doesn't answer phone|0|||
130976204|NCT02415400|471537638|FG003|Overall Study|Participant doesn't answer phone|0|||
130976205|NCT02415400|471537635|FG000|Overall Study|Participant wanted home visits|1|||
130777957|NCT00103285|470815306|FG007|Induction|Refusal|0|||
130777958|NCT00103285|470815299|FG000|Induction|Other|258|||
130777959|NCT00103285|470815300|FG001|Induction|Other|0|||
130777960|NCT00103285|470815301|FG002|Induction|Other|0|||
130976206|NCT02415400|471537636|FG001|Overall Study|Participant wanted home visits|0|||
130976207|NCT02415400|471537637|FG002|Overall Study|Participant wanted home visits|0|||
130976208|NCT02415400|471537638|FG003|Overall Study|Participant wanted home visits|0|||
130976209|NCT02415400|471537635|FG000|Overall Study|Randomized in error|2|||
130976210|NCT02415400|471537636|FG001|Overall Study|Randomized in error|0|||
130976211|NCT02415400|471537637|FG002|Overall Study|Randomized in error|0|||
130976212|NCT02415400|471537638|FG003|Overall Study|Randomized in error|0|||
130976213|NCT02415400|471537635|FG000|Overall Study|No study drug on site|0|||
130976214|NCT02415400|471537636|FG001|Overall Study|No study drug on site|1|||
130976215|NCT02415400|471537637|FG002|Overall Study|No study drug on site|0|||
130777961|NCT00103285|470815302|FG003|Induction|Other|0|||
130777962|NCT00103285|470815303|FG004|Induction|Other|0|||
130777963|NCT00103285|470815304|FG005|Induction|Other|0|||
130777964|NCT00103285|470815305|FG006|Induction|Other|0|||
130976216|NCT02415400|471537638|FG003|Overall Study|No study drug on site|0|||
130976217|NCT02415400|471537635|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
130976218|NCT02415400|471537636|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
130976219|NCT02415400|471537637|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
130976220|NCT02415400|471537638|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
130976221|NCT02415400|471537635|FG000|Overall Study|Coagulation values cannot be set|0|||
130976222|NCT02415400|471537636|FG001|Overall Study|Coagulation values cannot be set|0|||
130976223|NCT02415400|471537637|FG002|Overall Study|Coagulation values cannot be set|1|||
130976224|NCT02415400|471537638|FG003|Overall Study|Coagulation values cannot be set|0|||
130976225|NCT02415400|471537635|FG000|Overall Study|State regulations prevent participation|0|||
130976226|NCT02415400|471537636|FG001|Overall Study|State regulations prevent participation|0|||
130976227|NCT02415400|471537637|FG002|Overall Study|State regulations prevent participation|1|||
130976228|NCT02415400|471537638|FG003|Overall Study|State regulations prevent participation|0|||
130976229|NCT02415400|471537635|FG000|Overall Study|Poor treatment monitoring|0|||
130976230|NCT02415400|471537636|FG001|Overall Study|Poor treatment monitoring|0|||
130976231|NCT02415400|471537637|FG002|Overall Study|Poor treatment monitoring|1|||
130976232|NCT02415400|471537638|FG003|Overall Study|Poor treatment monitoring|0|||
130976233|NCT02415400|471537635|FG000|Overall Study|Participant in jail|0|||
130976234|NCT02415400|471537636|FG001|Overall Study|Participant in jail|0|||
130976235|NCT02415400|471537637|FG002|Overall Study|Participant in jail|1|||
130976236|NCT02415400|471537638|FG003|Overall Study|Participant in jail|0|||
130976237|NCT02415400|471537635|FG000|Overall Study|Investigator decision|0|||
130976238|NCT02415400|471537636|FG001|Overall Study|Investigator decision|0|||
130976239|NCT02415400|471537637|FG002|Overall Study|Investigator decision|1|||
130976240|NCT02415400|471537638|FG003|Overall Study|Investigator decision|1|||
130976241|NCT02415400|471537635|FG000|Overall Study|Site closure; participant won't transfer|0|||
130976242|NCT02415400|471537636|FG001|Overall Study|Site closure; participant won't transfer|0|||
130976243|NCT02415400|471537637|FG002|Overall Study|Site closure; participant won't transfer|0|||
130976244|NCT02415400|471537638|FG003|Overall Study|Site closure; participant won't transfer|1|||
130976245|NCT02270450|471537639|FG000|Overall Study|Refusal unrelated to adverse event|3|||
130976246|NCT02270450|471537640|FG001|Overall Study|Refusal unrelated to adverse event|1|||
130976247|NCT02270450|471537641|FG002|Overall Study|Refusal unrelated to adverse event|5|||
130976248|NCT02270450|471537642|FG003|Overall Study|Refusal unrelated to adverse event|14|||
130976249|NCT02270450|471537639|FG000|Overall Study|Progression/relapse|1|||
130976250|NCT02270450|471537640|FG001|Overall Study|Progression/relapse|2|||
130976251|NCT02270450|471537641|FG002|Overall Study|Progression/relapse|4|||
130976252|NCT02270450|471537642|FG003|Overall Study|Progression/relapse|9|||
130976253|NCT02270450|471537639|FG000|Overall Study|Death|19|||
130976254|NCT02270450|471537640|FG001|Overall Study|Death|19|||
130976255|NCT02270450|471537641|FG002|Overall Study|Death|31|||
130976256|NCT02270450|471537642|FG003|Overall Study|Death|59|||
130976257|NCT02363738|471537643|FG000|Overall Study|Adverse Event|5|||
130976258|NCT02363738|471537644|FG001|Overall Study|Adverse Event|2|||
130976259|NCT02363738|471537643|FG000|Overall Study|Lack of Efficacy|1|||
130976260|NCT02363738|471537644|FG001|Overall Study|Lack of Efficacy|2|||
130976261|NCT02363738|471537643|FG000|Overall Study|Lost to Follow-up|2|||
130976262|NCT02363738|471537644|FG001|Overall Study|Lost to Follow-up|1|||
130976263|NCT02081846|471537650|FG000|Overall Study|Withdrawal by Subject|1|||
130976264|NCT02081846|471537651|FG001|Overall Study|Withdrawal by Subject|0|||
130976265|NCT02081846|471537650|FG000|Overall Study|invalid consent|1|||
130976266|NCT02081846|471537651|FG001|Overall Study|invalid consent|0|||
130976267|NCT03282227|471537652|FG000|Overall Study|Exposure Goals Achieved|60|||
130976268|NCT03282227|471537652|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
130976269|NCT03282227|471537652|FG000|Overall Study|Adverse Event|15|||
130976270|NCT03282227|471537652|FG000|Overall Study|Lost to Follow-up|21|||
130976271|NCT03282227|471537652|FG000|Overall Study|Withdrawal by Subject|20|||
130976272|NCT03282227|471537652|FG000|Overall Study|Lack of Efficacy|12|||
130976273|NCT03282227|471537652|FG000|Overall Study|Sponsor decision|3|||
130976274|NCT03282227|471537652|FG000|Overall Study|Physician Decision|2|||
130976275|NCT03282227|471537652|FG000|Overall Study|Pregnancy|2|||
130976276|NCT03282227|471537652|FG000|Overall Study|Other|1|||
130976277|NCT02576678|471537653|FG000|Overall Study|Adverse Event|0|||
130976278|NCT02576678|471537654|FG001|Overall Study|Adverse Event|0|||
130976279|NCT02576678|471537655|FG002|Overall Study|Adverse Event|2|||
130976280|NCT02576678|471537653|FG000|Overall Study|Withdrawal by Subject|3|||
130976281|NCT02576678|471537654|FG001|Overall Study|Withdrawal by Subject|1|||
130976282|NCT02576678|471537655|FG002|Overall Study|Withdrawal by Subject|2|||
130976283|NCT02576678|471537653|FG000|Overall Study|Lost to Follow-up|0|||
130976284|NCT02576678|471537654|FG001|Overall Study|Lost to Follow-up|0|||
130976285|NCT02576678|471537655|FG002|Overall Study|Lost to Follow-up|1|||
130976286|NCT02576678|471537653|FG000|Overall Study|Miscellaneous|2|||
130976287|NCT02576678|471537654|FG001|Overall Study|Miscellaneous|0|||
130976288|NCT02576678|471537655|FG002|Overall Study|Miscellaneous|0|||
130976289|NCT02491671|471537659|FG000|Overall Study|Adverse Event|6|||
130976290|NCT02491671|471537660|FG001|Overall Study|Adverse Event|8|||
130976291|NCT02491671|471537659|FG000|Overall Study|Death|0|||
130976292|NCT02491671|471537660|FG001|Overall Study|Death|2|||
130976293|NCT02491671|471537659|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
130976294|NCT02491671|471537660|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
130976295|NCT02251990|471537664|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
130976296|NCT02251990|471537665|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
130976297|NCT02251990|471537664|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
130976298|NCT02251990|471537665|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
130976299|NCT02251990|471537664|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
130976300|NCT02251990|471537665|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
130976301|NCT02251990|471537664|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
130976302|NCT02251990|471537665|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
130976303|NCT02251990|471537664|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
130976304|NCT02251990|471537665|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
130976305|NCT02251990|471537664|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
130976306|NCT02251990|471537665|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
130976307|NCT03265600|471537666|FG000|Overall Study|Lost to Follow-up|17|||
130976308|NCT03265600|471537667|FG001|Overall Study|Lost to Follow-up|5|||
130976309|NCT03265600|471537666|FG000|Overall Study|Withdrawal by Subject|4|||
130976310|NCT03265600|471537667|FG001|Overall Study|Withdrawal by Subject|2|||
130976311|NCT03265600|471537666|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
130976312|NCT03265600|471537667|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
130976313|NCT00535730|471537668|FG000|Overall Study|Adverse Event|1|||
130976314|NCT00535730|471537669|FG001|Overall Study|Adverse Event|1|||
130976315|NCT00535730|471537668|FG000|Overall Study|Lost to Follow-up|0|||
130976316|NCT00535730|471537669|FG001|Overall Study|Lost to Follow-up|1|||
130976317|NCT00535730|471537668|FG000|Overall Study|Physician Decision|0|||
130976318|NCT00535730|471537669|FG001|Overall Study|Physician Decision|1|||
130976319|NCT00535730|471537668|FG000|Overall Study|Protocol Violation|1|||
130976320|NCT00535730|471537669|FG001|Overall Study|Protocol Violation|0|||
130976321|NCT00535730|471537668|FG000|Overall Study|Withdrawal by Subject|0|||
130976322|NCT00535730|471537669|FG001|Overall Study|Withdrawal by Subject|4|||
130976323|NCT04330638|471537670|FG000|Overall Study|Adverse Event|9|||
130976324|NCT04330638|471537671|FG001|Overall Study|Adverse Event|10|||
130976325|NCT04330638|471537672|FG002|Overall Study|Adverse Event|15|||
131227513|NCT00410410|472459757|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130976326|NCT04330638|471537673|FG003|Overall Study|Adverse Event|6|||
130976327|NCT04330638|471537674|FG004|Overall Study|Adverse Event|10|||
130976328|NCT04330638|471537675|FG005|Overall Study|Adverse Event|5|||
130976329|NCT04330638|471537670|FG000|Overall Study|Other|2|||
130976330|NCT04330638|471537671|FG001|Overall Study|Other|2|||
130976331|NCT04330638|471537672|FG002|Overall Study|Other|5|||
131227514|NCT00410410|472459749|FG000|Induction Period (IP)|Other|0|||
130976332|NCT04330638|471537673|FG003|Overall Study|Other|1|||
130717749|NCT04078126|470593153|FG001|Period 2|Study put on hold due to COVID-19|1|||
130717750|NCT02669758|470593156|FG000|Overall Study|Withdrawal by Subject|43|||
130717751|NCT02669758|470593156|FG000|Overall Study|Lost to Follow-up|19|||
130717752|NCT02669758|470593156|FG000|Overall Study|Adverse Event|16|||
130717753|NCT02669758|470593156|FG000|Overall Study|Non-Compliance with Study Drug|8|||
130717754|NCT02669758|470593156|FG000|Overall Study|Lack of Efficacy|5|||
130717755|NCT02669758|470593156|FG000|Overall Study|Pregnancy|1|||
130717756|NCT02669758|470593156|FG000|Overall Study|Study noncompliance|1|||
130717757|NCT02669758|470593156|FG000|Overall Study|Protocol Violation|1|||
130717758|NCT02605993|470593159|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
130717759|NCT02605993|470593160|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
130717760|NCT02605993|470593161|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
130717761|NCT02605993|470593162|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
130717762|NCT02603393|470593163|FG000|Overall Study|Patient/guardian decision|32|||
130717763|NCT02603393|470593164|FG001|Overall Study|Patient/guardian decision|18|||
130717764|NCT02603393|470593163|FG000|Overall Study|Adverse Event|17|||
130717765|NCT02603393|470593164|FG001|Overall Study|Adverse Event|15|||
130717766|NCT02603393|470593163|FG000|Overall Study|Technical problems|4|||
130717767|NCT02603393|470593164|FG001|Overall Study|Technical problems|7|||
130717768|NCT02603393|470593163|FG000|Overall Study|Lack of Efficacy|7|||
130717769|NCT02603393|470593164|FG001|Overall Study|Lack of Efficacy|2|||
130717770|NCT02603393|470593163|FG000|Overall Study|Death|3|||
130717771|NCT02603393|470593164|FG001|Overall Study|Death|4|||
130717772|NCT02603393|470593163|FG000|Overall Study|Physician Decision|3|||
130717773|NCT02603393|470593164|FG001|Overall Study|Physician Decision|3|||
130717774|NCT02603393|470593163|FG000|Overall Study|Protocol deviation|2|||
130717775|NCT02603393|470593164|FG001|Overall Study|Protocol deviation|3|||
130717776|NCT02603393|470593163|FG000|Overall Study|Lost to Follow-up|1|||
130717777|NCT02603393|470593164|FG001|Overall Study|Lost to Follow-up|2|||
130717778|NCT02603393|470593163|FG000|Overall Study|Non-compliance with study treatment|1|||
130976333|NCT04330638|471537674|FG004|Overall Study|Other|3|||
130976334|NCT04330638|471537675|FG005|Overall Study|Other|2|||
130976335|NCT04330638|471537670|FG000|Overall Study|Withdrawal by Subject|4|||
130717779|NCT02603393|470593164|FG001|Overall Study|Non-compliance with study treatment|0|||
130976336|NCT04330638|471537671|FG001|Overall Study|Withdrawal by Subject|0|||
130976337|NCT04330638|471537672|FG002|Overall Study|Withdrawal by Subject|0|||
130717780|NCT02603393|470593163|FG000|Overall Study|Sponsor decision|1|||
130717781|NCT02603393|470593164|FG001|Overall Study|Sponsor decision|0|||
130976338|NCT04330638|471537673|FG003|Overall Study|Withdrawal by Subject|0|||
130976339|NCT04330638|471537674|FG004|Overall Study|Withdrawal by Subject|0|||
130976340|NCT04330638|471537675|FG005|Overall Study|Withdrawal by Subject|0|||
130976341|NCT04330638|471537670|FG000|Overall Study|Lost to Follow-up|3|||
130976342|NCT04330638|471537671|FG001|Overall Study|Lost to Follow-up|2|||
130976343|NCT04330638|471537672|FG002|Overall Study|Lost to Follow-up|3|||
130976344|NCT04330638|471537673|FG003|Overall Study|Lost to Follow-up|2|||
130976345|NCT04330638|471537674|FG004|Overall Study|Lost to Follow-up|3|||
130976346|NCT04330638|471537675|FG005|Overall Study|Lost to Follow-up|0|||
130976347|NCT02293538|471537676|FG000|Overall Study|Adverse Event|0|||
130976348|NCT02293538|471537677|FG001|Overall Study|Adverse Event|1|||
130976349|NCT02293538|471537676|FG000|Overall Study|Lost to Follow-up|1|||
130976350|NCT02293538|471537677|FG001|Overall Study|Lost to Follow-up|0|||
130976351|NCT02293538|471537676|FG000|Overall Study|Withdrawal by Subject|0|||
130976352|NCT02293538|471537677|FG001|Overall Study|Withdrawal by Subject|1|||
130976353|NCT00322348|471537678|FG000|Overall Study|Adverse Event|0|||
130976354|NCT00322348|471537679|FG001|Overall Study|Adverse Event|1|||
130717782|NCT01868893|470593167|FG000|Overall Study|Adverse Event|2|||
130717783|NCT01868893|470593167|FG000|Overall Study|Commercial availability of study drug|17|||
130717784|NCT01868893|470593167|FG000|Overall Study|Neutropenia|1|||
130717785|NCT01783548|470593168|FG000|Overall Study|Adverse Event|8|||
130717786|NCT01783548|470593169|FG001|Overall Study|Adverse Event|4|||
130717787|NCT01783548|470593168|FG000|Overall Study|Withdrawal by Subject|11|||
130717788|NCT01783548|470593169|FG001|Overall Study|Withdrawal by Subject|8|||
130717789|NCT01783548|470593168|FG000|Overall Study|Non-compliance|4|||
130717790|NCT01783548|470593169|FG001|Overall Study|Non-compliance|0|||
130717791|NCT01783548|470593168|FG000|Overall Study|Protocol Violation|2|||
130717792|NCT01783548|470593169|FG001|Overall Study|Protocol Violation|2|||
130717793|NCT01783548|470593168|FG000|Overall Study|Lost to Follow-up|8|||
130717794|NCT01783548|470593169|FG001|Overall Study|Lost to Follow-up|3|||
130717795|NCT01783548|470593168|FG000|Overall Study|Lack of Efficacy|1|||
130717796|NCT01783548|470593169|FG001|Overall Study|Lack of Efficacy|1|||
130717797|NCT00988442|470593170|FG000|Overall Study|Death|1|||
130717798|NCT00988442|470593171|FG001|Overall Study|Death|2|||
130717799|NCT00988442|470593170|FG000|Overall Study|Lost to Follow-up|0|||
130717800|NCT00988442|470593171|FG001|Overall Study|Lost to Follow-up|1|||
130717801|NCT00988442|470593170|FG000|Overall Study|Early Study Closure|29|||
130717802|NCT00988442|470593171|FG001|Overall Study|Early Study Closure|25|||
130717803|NCT01735955|470593175|FG000|Overall Study|Administrative problems|1|||
130717804|NCT01735955|470593175|FG000|Overall Study|Patient/guardian decision|1|||
130717805|NCT01735955|470593175|FG000|Overall Study|Patient withdrew consent|2|||
130717806|NCT01735955|470593175|FG000|Overall Study|Physician Decision|4|||
130717807|NCT01735955|470593175|FG000|Overall Study|Disease progression|24|||
130717808|NCT01735955|470593175|FG000|Overall Study|Adverse Event|5|||
130717809|NCT03317834|470593178|FG000|Overall Study|Death|2|||
130717810|NCT03317834|470593178|FG000|Overall Study|Device Revision|5|||
130717811|NCT03317834|470593178|FG000|Overall Study|Withdrawal by Subject|13|||
130717812|NCT03317834|470593178|FG000|Overall Study|Lost to Follow-up|13|||
130717813|NCT00123474|470593184|FG000|Randomized to Treatment|Randomized, never treated|1|||
130717814|NCT00123474|470593185|FG001|Randomized to Treatment|Randomized, never treated|4|||
130717815|NCT00123474|470593186|FG002|Randomized to Treatment|Randomized, never treated|2|||
130717816|NCT00123474|470593187|FG003|Randomized to Treatment|Randomized, never treated|1|||
130717817|NCT00123474|470593184|FG000|As Treated at Study Closure|not reported when site closed|1|||
130717818|NCT00123474|470593185|FG001|As Treated at Study Closure|not reported when site closed|0|||
130717819|NCT00123474|470593186|FG002|As Treated at Study Closure|not reported when site closed|1|||
130717820|NCT00123474|470593187|FG003|As Treated at Study Closure|not reported when site closed|0|||
130717821|NCT00123474|470593184|FG000|As Treated at Study Closure|Adverse Event|10|||
130717822|NCT00123474|470593185|FG001|As Treated at Study Closure|Adverse Event|4|||
130717823|NCT00123474|470593186|FG002|As Treated at Study Closure|Adverse Event|10|||
130717824|NCT00123474|470593187|FG003|As Treated at Study Closure|Adverse Event|8|||
130717825|NCT00123474|470593184|FG000|As Treated at Study Closure|Disease Progression|35|||
130717826|NCT00123474|470593185|FG001|As Treated at Study Closure|Disease Progression|42|||
130717827|NCT00123474|470593186|FG002|As Treated at Study Closure|Disease Progression|29|||
130717828|NCT00123474|470593187|FG003|As Treated at Study Closure|Disease Progression|27|||
130717829|NCT00123474|470593184|FG000|As Treated at Study Closure|Investigator Request|12|||
130777965|NCT00103285|470815306|FG007|Induction|Other|0|||
130976355|NCT00322348|471537678|FG000|Overall Study|Withdrawal by Subject|1|||
130976356|NCT00322348|471537679|FG001|Overall Study|Withdrawal by Subject|4|||
130976357|NCT00322348|471537678|FG000|Overall Study|Lost to Follow-up|1|||
130976358|NCT00322348|471537679|FG001|Overall Study|Lost to Follow-up|0|||
130717830|NCT00123474|470593185|FG001|As Treated at Study Closure|Investigator Request|6|||
130717831|NCT00123474|470593186|FG002|As Treated at Study Closure|Investigator Request|7|||
130717832|NCT00123474|470593187|FG003|As Treated at Study Closure|Investigator Request|5|||
130717833|NCT00123474|470593184|FG000|As Treated at Study Closure|non-specified|54|||
130717834|NCT00123474|470593185|FG001|As Treated at Study Closure|non-specified|47|||
130717835|NCT00123474|470593186|FG002|As Treated at Study Closure|non-specified|57|||
130717836|NCT00123474|470593187|FG003|As Treated at Study Closure|non-specified|60|||
130976359|NCT00322348|471537678|FG000|Overall Study|Death|0|||
130976360|NCT00322348|471537679|FG001|Overall Study|Death|2|||
130976361|NCT00322348|471537678|FG000|Overall Study|Disease Progression|30|||
130976362|NCT00322348|471537679|FG001|Overall Study|Disease Progression|25|||
130976363|NCT00322348|471537678|FG000|Overall Study|Reasons not specified|5|||
130976364|NCT00322348|471537679|FG001|Overall Study|Reasons not specified|1|||
130976365|NCT00936858|471537680|FG000|Overall Study|Death|3|||
130976366|NCT00936858|471537680|FG000|Overall Study|Progression|29|||
130976367|NCT00936858|471537680|FG000|Overall Study|Withdrawal by Subject|5|||
130976368|NCT00936858|471537680|FG000|Overall Study|Adverse Event|1|||
130976369|NCT00936858|471537680|FG000|Overall Study|Physician Decision|7|||
130976370|NCT00936858|471537680|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
130976371|NCT00936858|471537680|FG000|Overall Study|Lost to Follow-up|1|||
130976372|NCT02985866|471539208|FG000|Overall Study|Poor CGM data|1|||
130976373|NCT02985866|471539209|FG001|Overall Study|Poor CGM data|1|||
130976374|NCT00686166|471539214|FG000|Overall Study|Adverse Event|7|||
130976375|NCT00686166|471539214|FG000|Overall Study|Withdrawal by Subject|1|||
130976376|NCT00686166|471539214|FG000|Overall Study|Progression/Relapse|1|||
130976377|NCT00686166|471539214|FG000|Overall Study|Death|1|||
130976378|NCT00686166|471539214|FG000|Overall Study|Not Protocol Specified|1|||
130976379|NCT00686166|471539214|FG000|Overall Study|Ineligible|5|||
130976380|NCT00686166|471539214|FG000|Overall Study|Did not begin protocol therapy|4|||
130976381|NCT01549613|471539217|FG000|Overall Study|Lost to Follow-up|11|||
130976382|NCT01549613|471539218|FG001|Overall Study|Lost to Follow-up|11|||
130976383|NCT02216123|471539219|FG000|Overall Study|Lost to Follow-up|4|||
130976384|NCT02216123|471539220|FG001|Overall Study|Lost to Follow-up|2|||
130976385|NCT02216123|471539219|FG000|Overall Study|Withdrawal by Subject|2|||
130777966|NCT00103285|470815299|FG000|Response Assignment|Adverse Event|0|||
130777967|NCT00103285|470815300|FG001|Response Assignment|Adverse Event|8|||
130777968|NCT00103285|470815301|FG002|Response Assignment|Adverse Event|3|||
130777969|NCT00103285|470815302|FG003|Response Assignment|Adverse Event|2|||
130777970|NCT00103285|470815303|FG004|Response Assignment|Adverse Event|3|||
130777971|NCT00103285|470815304|FG005|Response Assignment|Adverse Event|1|||
130777972|NCT00103285|470815305|FG006|Response Assignment|Adverse Event|1|||
130777973|NCT00103285|470815306|FG007|Response Assignment|Adverse Event|2|||
130777974|NCT00103285|470815299|FG000|Response Assignment|Death|0|||
130976386|NCT02216123|471539220|FG001|Overall Study|Withdrawal by Subject|0|||
130976387|NCT04477187|471539223|FG000|Overall Study|Lost to Follow-up|2|||
130976388|NCT00464815|471539225|FG000|Overall Study|Withdrawal by Subject|6|||
130976389|NCT00464815|471539226|FG001|Overall Study|Withdrawal by Subject|3|||
130976390|NCT00254982|471539227|FG000|Overall Study|Other|2|||
130976391|NCT00254982|471539228|FG001|Overall Study|Other|1|||
130976392|NCT00254982|471539227|FG000|Overall Study|Lack of Efficacy|5|||
130976393|NCT00254982|471539228|FG001|Overall Study|Lack of Efficacy|3|||
130976394|NCT00254982|471539227|FG000|Overall Study|Lost to Follow-up|5|||
130976395|NCT00254982|471539228|FG001|Overall Study|Lost to Follow-up|3|||
130976396|NCT00254982|471539227|FG000|Overall Study|Adverse Event|18|||
130976397|NCT00254982|471539228|FG001|Overall Study|Adverse Event|16|||
130976398|NCT00254982|471539227|FG000|Overall Study|Withdrawal by Subject|1|||
130976399|NCT00254982|471539228|FG001|Overall Study|Withdrawal by Subject|1|||
130976400|NCT00254982|471539227|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
130976401|NCT00254982|471539228|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
130976402|NCT00254982|471539227|FG000|Overall Study|Protocol deviation|1|||
130976403|NCT00254982|471539228|FG001|Overall Study|Protocol deviation|1|||
130976404|NCT00254982|471539227|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
130976405|NCT00254982|471539228|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
130976406|NCT00254982|471539227|FG000|Overall Study|Malignancy|0|||
130976407|NCT00254982|471539228|FG001|Overall Study|Malignancy|2|||
130976408|NCT00254982|471539227|FG000|Overall Study|Opportunistic infection|1|||
130976409|NCT00254982|471539228|FG001|Overall Study|Opportunistic infection|0|||
130976410|NCT00254982|471539227|FG000|Overall Study|Abnormal liver function tests|2|||
130976411|NCT00254982|471539228|FG001|Overall Study|Abnormal liver function tests|1|||
130976412|NCT01613248|471539231|FG000|Overall Study|Adverse Event|0|||
130976413|NCT01613248|471539232|FG001|Overall Study|Adverse Event|0|||
130976414|NCT01613248|471539233|FG002|Overall Study|Adverse Event|0|||
130976415|NCT01613248|471539234|FG003|Overall Study|Adverse Event|1|||
130976416|NCT01613248|471539235|FG004|Overall Study|Adverse Event|0|||
130976417|NCT01613248|471539236|FG005|Overall Study|Adverse Event|0|||
130976418|NCT01613248|471539231|FG000|Overall Study|Withdrawal by Subject|3|||
130976419|NCT01613248|471539232|FG001|Overall Study|Withdrawal by Subject|2|||
130976420|NCT01613248|471539233|FG002|Overall Study|Withdrawal by Subject|2|||
130976421|NCT01613248|471539234|FG003|Overall Study|Withdrawal by Subject|5|||
131131403|NCT02432235|472108334|FG007|Overall Study|Lost to Follow-up|0|||
131131404|NCT02432235|472108335|FG008|Overall Study|Lost to Follow-up|1|||
131131405|NCT02432235|472108336|FG009|Overall Study|Lost to Follow-up|0|||
130777975|NCT00103285|470815300|FG001|Response Assignment|Death|5|||
130777976|NCT00103285|470815301|FG002|Response Assignment|Death|2|||
130777977|NCT00103285|470815302|FG003|Response Assignment|Death|2|||
130976422|NCT01613248|471539235|FG004|Overall Study|Withdrawal by Subject|0|||
130976423|NCT01613248|471539236|FG005|Overall Study|Withdrawal by Subject|1|||
130976424|NCT01613248|471539231|FG000|Overall Study|Lost to Follow-up|5|||
130976425|NCT01613248|471539232|FG001|Overall Study|Lost to Follow-up|7|||
130976426|NCT01613248|471539233|FG002|Overall Study|Lost to Follow-up|4|||
130976427|NCT01613248|471539234|FG003|Overall Study|Lost to Follow-up|8|||
130976428|NCT01613248|471539235|FG004|Overall Study|Lost to Follow-up|4|||
130976429|NCT01613248|471539236|FG005|Overall Study|Lost to Follow-up|2|||
130976430|NCT01613248|471539231|FG000|Overall Study|Study Terminated by Sponsor|4|||
130976431|NCT01613248|471539232|FG001|Overall Study|Study Terminated by Sponsor|6|||
130976432|NCT01613248|471539233|FG002|Overall Study|Study Terminated by Sponsor|8|||
130976433|NCT01613248|471539234|FG003|Overall Study|Study Terminated by Sponsor|8|||
130976434|NCT01613248|471539235|FG004|Overall Study|Study Terminated by Sponsor|9|||
130976435|NCT01613248|471539236|FG005|Overall Study|Study Terminated by Sponsor|11|||
130976436|NCT01613248|471539231|FG000|Overall Study|Physician Decision|8|||
130976437|NCT01613248|471539232|FG001|Overall Study|Physician Decision|8|||
130976438|NCT01613248|471539233|FG002|Overall Study|Physician Decision|9|||
130976439|NCT01613248|471539234|FG003|Overall Study|Physician Decision|4|||
130976440|NCT01613248|471539235|FG004|Overall Study|Physician Decision|7|||
130976441|NCT01613248|471539236|FG005|Overall Study|Physician Decision|6|||
130976442|NCT01613248|471539231|FG000|Overall Study|Lack of Qualifying Event|9|||
130976443|NCT01613248|471539232|FG001|Overall Study|Lack of Qualifying Event|11|||
130976444|NCT01613248|471539233|FG002|Overall Study|Lack of Qualifying Event|10|||
130976445|NCT01613248|471539234|FG003|Overall Study|Lack of Qualifying Event|11|||
130976446|NCT01613248|471539235|FG004|Overall Study|Lack of Qualifying Event|15|||
130976447|NCT01613248|471539236|FG005|Overall Study|Lack of Qualifying Event|18|||
130976448|NCT01613248|471539231|FG000|Overall Study|Pregnancy|0|||
130976449|NCT01613248|471539232|FG001|Overall Study|Pregnancy|0|||
130976450|NCT01613248|471539233|FG002|Overall Study|Pregnancy|0|||
130976451|NCT01613248|471539234|FG003|Overall Study|Pregnancy|1|||
130976452|NCT01613248|471539235|FG004|Overall Study|Pregnancy|0|||
130976453|NCT01613248|471539236|FG005|Overall Study|Pregnancy|0|||
130976454|NCT02015676|471539245|FG000|Overall Study|Adverse Event|2|||
130976455|NCT02015676|471539246|FG001|Overall Study|Adverse Event|18|||
130976456|NCT02015676|471539247|FG002|Overall Study|Adverse Event|0|||
130976457|NCT02015676|471539245|FG000|Overall Study|Lack of Efficacy|2|||
130976458|NCT02015676|471539246|FG001|Overall Study|Lack of Efficacy|4|||
130976459|NCT02015676|471539247|FG002|Overall Study|Lack of Efficacy|0|||
130976460|NCT02015676|471539245|FG000|Overall Study|Protocol Violation|1|||
130976461|NCT02015676|471539246|FG001|Overall Study|Protocol Violation|0|||
130976462|NCT02015676|471539247|FG002|Overall Study|Protocol Violation|0|||
130976463|NCT02015676|471539245|FG000|Overall Study|Withdrawal by Subject|1|||
130976464|NCT02015676|471539246|FG001|Overall Study|Withdrawal by Subject|7|||
130976465|NCT02015676|471539247|FG002|Overall Study|Withdrawal by Subject|1|||
130976466|NCT02015676|471539245|FG000|Overall Study|Administrative reasons|0|||
130976467|NCT02015676|471539246|FG001|Overall Study|Administrative reasons|3|||
130976468|NCT02015676|471539247|FG002|Overall Study|Administrative reasons|1|||
130976469|NCT02015676|471539245|FG000|Overall Study|Death|0|||
130976470|NCT02015676|471539246|FG001|Overall Study|Death|1|||
130976471|NCT02015676|471539247|FG002|Overall Study|Death|0|||
130976472|NCT02015676|471539245|FG000|Overall Study|Disease progression|3|||
130976473|NCT02015676|471539246|FG001|Overall Study|Disease progression|1|||
130976474|NCT02015676|471539247|FG002|Overall Study|Disease progression|1|||
130976475|NCT00971048|471539248|FG000|Overall Study|Protocol Violation|1|||
130976476|NCT00971048|471539249|FG001|Overall Study|Protocol Violation|2|||
130976477|NCT00971048|471539250|FG002|Overall Study|Protocol Violation|0|||
130976478|NCT00971048|471539251|FG003|Overall Study|Protocol Violation|1|||
130976479|NCT00971048|471539248|FG000|Overall Study|Adverse Event|0|||
130976480|NCT00971048|471539249|FG001|Overall Study|Adverse Event|0|||
130976481|NCT00971048|471539250|FG002|Overall Study|Adverse Event|1|||
130976482|NCT00971048|471539251|FG003|Overall Study|Adverse Event|0|||
130976483|NCT00971048|471539248|FG000|Overall Study|Physician Decision|0|||
130976484|NCT00971048|471539249|FG001|Overall Study|Physician Decision|0|||
130976485|NCT00971048|471539250|FG002|Overall Study|Physician Decision|0|||
130976486|NCT00971048|471539251|FG003|Overall Study|Physician Decision|1|||
130976487|NCT03321396|471539252|FG000|Overall Study|Physician Decision|1|||
130976488|NCT01654549|471539253|FG000|Overall Study|H.pylori eradication not successful|0|||
130976489|NCT01654549|471539254|FG001|Overall Study|H.pylori eradication not successful|1|||
130976490|NCT01869491|471539255|FG000|Overall Study|Adverse Event|3|||
130976491|NCT01869491|471539256|FG001|Overall Study|Adverse Event|5|||
130976492|NCT01869491|471539255|FG000|Overall Study|Lack of Efficacy|0|||
130976493|NCT01869491|471539256|FG001|Overall Study|Lack of Efficacy|3|||
130976494|NCT01869491|471539255|FG000|Overall Study|Withdrawal by Subject|6|||
130976495|NCT01869491|471539256|FG001|Overall Study|Withdrawal by Subject|7|||
130976496|NCT01869491|471539255|FG000|Overall Study|Lost to Follow-up|11|||
130976497|NCT01869491|471539256|FG001|Overall Study|Lost to Follow-up|9|||
130976498|NCT01869491|471539255|FG000|Overall Study|No further need of investigational product|1|||
130976499|NCT01869491|471539256|FG001|Overall Study|No further need of investigational product|0|||
130976500|NCT04009291|471539257|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
131131406|NCT02432235|472108337|FG010|Overall Study|Lost to Follow-up|0|||
130777978|NCT00103285|470815303|FG004|Response Assignment|Death|3|||
130777979|NCT00103285|470815304|FG005|Response Assignment|Death|1|||
130777980|NCT00103285|470815305|FG006|Response Assignment|Death|0|||
130777981|NCT00103285|470815306|FG007|Response Assignment|Death|8|||
130777982|NCT00103285|470815299|FG000|Response Assignment|Lost to Follow-up|0|||
130777983|NCT00103285|470815300|FG001|Response Assignment|Lost to Follow-up|9|||
130777984|NCT00103285|470815301|FG002|Response Assignment|Lost to Follow-up|5|||
130976501|NCT04009291|471539258|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
130777985|NCT00103285|470815302|FG003|Response Assignment|Lost to Follow-up|5|||
130777986|NCT00103285|470815303|FG004|Response Assignment|Lost to Follow-up|1|||
130777987|NCT00103285|470815304|FG005|Response Assignment|Lost to Follow-up|2|||
130777988|NCT00103285|470815305|FG006|Response Assignment|Lost to Follow-up|2|||
130976502|NCT04009291|471539259|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
130976503|NCT04009291|471539260|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
130976504|NCT04009291|471539261|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
130976505|NCT04009291|471539257|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
130976506|NCT04009291|471539258|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
130976507|NCT04009291|471539259|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
130976508|NCT04009291|471539260|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
130976509|NCT04009291|471539261|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
130976510|NCT05553808|471539264|FG000|Overall Study|Death|25|||
130976511|NCT05553808|471539265|FG001|Overall Study|Death|62|||
130976512|NCT05553808|471539264|FG000|Overall Study|Site Closed|6|||
130976513|NCT05553808|471539265|FG001|Overall Study|Site Closed|6|||
130976514|NCT05553808|471539264|FG000|Overall Study|Lost to Follow-up|1|||
130976515|NCT05553808|471539265|FG001|Overall Study|Lost to Follow-up|0|||
130976516|NCT05553808|471539264|FG000|Overall Study|Withdrawal by Subject|3|||
130976517|NCT05553808|471539265|FG001|Overall Study|Withdrawal by Subject|2|||
130976518|NCT00989287|471539268|FG000|Overall Study|Adverse Event|1|||
130976519|NCT00989287|471539269|FG001|Overall Study|Adverse Event|0|||
130976520|NCT00989287|471539268|FG000|Overall Study|Lost to Follow-up|0|||
130976521|NCT00989287|471539269|FG001|Overall Study|Lost to Follow-up|1|||
130976522|NCT00729833|471539270|FG000|Overall Study|Death|5|||
130976523|NCT00729833|471539271|FG001|Overall Study|Death|1|||
130976524|NCT00729833|471539272|FG002|Overall Study|Death|3|||
130976525|NCT00729833|471539273|FG003|Overall Study|Death|5|||
130976526|NCT00729833|471539270|FG000|Overall Study|Study Terminated by Sponsor|0|||
130976527|NCT00729833|471539271|FG001|Overall Study|Study Terminated by Sponsor|0|||
130976528|NCT00729833|471539272|FG002|Overall Study|Study Terminated by Sponsor|1|||
130976529|NCT00729833|471539273|FG003|Overall Study|Study Terminated by Sponsor|0|||
130976530|NCT00729833|471539270|FG000|Overall Study|Lost to Follow-up|1|||
130976531|NCT00729833|471539271|FG001|Overall Study|Lost to Follow-up|0|||
130976532|NCT00729833|471539272|FG002|Overall Study|Lost to Follow-up|0|||
130976533|NCT00729833|471539273|FG003|Overall Study|Lost to Follow-up|0|||
130976534|NCT00729833|471539270|FG000|Overall Study|Withdrawal by Subject|3|||
130976535|NCT00729833|471539271|FG001|Overall Study|Withdrawal by Subject|1|||
130976536|NCT00729833|471539272|FG002|Overall Study|Withdrawal by Subject|3|||
130976537|NCT00729833|471539273|FG003|Overall Study|Withdrawal by Subject|0|||
130976538|NCT00729833|471539270|FG000|Overall Study|Unspecified Reasons|11|||
130976539|NCT00729833|471539271|FG001|Overall Study|Unspecified Reasons|5|||
130976540|NCT00729833|471539272|FG002|Overall Study|Unspecified Reasons|5|||
130976541|NCT00729833|471539273|FG003|Overall Study|Unspecified Reasons|1|||
130976542|NCT01041638|471539274|FG000|Overall Study|Adverse Event|4|||
130976543|NCT01041638|471539274|FG000|Overall Study|Death|1|||
130976544|NCT01041638|471539274|FG000|Overall Study|Lack of Efficacy|7|||
130976545|NCT01041638|471539274|FG000|Overall Study|Physician Decision|4|||
130976546|NCT01041638|471539274|FG000|Overall Study|Withdrawal by Subject|11|||
130976547|NCT00417079|471539275|FG000|Overall Study|Disease progression|267|||
130976548|NCT00417079|471539276|FG001|Overall Study|Disease progression|180|||
130976549|NCT00417079|471539275|FG000|Overall Study|Adverse Event|32|||
130976550|NCT00417079|471539276|FG001|Overall Study|Adverse Event|67|||
130976551|NCT00417079|471539275|FG000|Overall Study|Non-compliance to protocol|0|||
130976552|NCT00417079|471539276|FG001|Overall Study|Non-compliance to protocol|1|||
131131407|NCT02432235|472108338|FG011|Overall Study|Lost to Follow-up|0|||
131131408|NCT02432235|472108327|FG000|Overall Study|Miscellaneous|0|||
130976553|NCT00417079|471539275|FG000|Overall Study|Lost to Follow-up|2|||
130976554|NCT00417079|471539276|FG001|Overall Study|Lost to Follow-up|0|||
130976555|NCT00417079|471539275|FG000|Overall Study|Withdrawal by Subject|17|||
130976556|NCT00417079|471539276|FG001|Overall Study|Withdrawal by Subject|8|||
131131409|NCT02432235|472108328|FG001|Overall Study|Miscellaneous|0|||
130777989|NCT00103285|470815306|FG007|Response Assignment|Lost to Follow-up|5|||
130976557|NCT00417079|471539275|FG000|Overall Study|Not treated|6|||
130976558|NCT00417079|471539276|FG001|Overall Study|Not treated|7|||
130976559|NCT00417079|471539275|FG000|Overall Study|Screened failure|2|||
130976560|NCT00417079|471539276|FG001|Overall Study|Screened failure|1|||
130976561|NCT00417079|471539275|FG000|Overall Study|Investigator's decision|1|||
130976562|NCT00417079|471539276|FG001|Overall Study|Investigator's decision|4|||
130976563|NCT00417079|471539275|FG000|Overall Study|Non-confirmed Disease progression|1|||
130976564|NCT00417079|471539276|FG001|Overall Study|Non-confirmed Disease progression|1|||
130976565|NCT00417079|471539275|FG000|Overall Study|Clinical deterioration|1|||
130976566|NCT00417079|471539276|FG001|Overall Study|Clinical deterioration|0|||
130976567|NCT00417079|471539275|FG000|Overall Study|Screening error|2|||
130976568|NCT00417079|471539276|FG001|Overall Study|Screening error|1|||
130976569|NCT00417079|471539275|FG000|Overall Study|Withdrawal by subject's family|0|||
131131410|NCT02432235|472108329|FG002|Overall Study|Miscellaneous|0|||
131131411|NCT02432235|472108330|FG003|Overall Study|Miscellaneous|0|||
131131412|NCT02432235|472108331|FG004|Overall Study|Miscellaneous|1|||
131131413|NCT02432235|472108332|FG005|Overall Study|Miscellaneous|6|||
131131414|NCT02432235|472108333|FG006|Overall Study|Miscellaneous|2|||
131131415|NCT02432235|472108334|FG007|Overall Study|Miscellaneous|2|||
131131416|NCT02432235|472108335|FG008|Overall Study|Miscellaneous|4|||
131131417|NCT02432235|472108336|FG009|Overall Study|Miscellaneous|0|||
131131418|NCT02432235|472108337|FG010|Overall Study|Miscellaneous|0|||
131131419|NCT02432235|472108338|FG011|Overall Study|Miscellaneous|1|||
131131420|NCT00382993|472108339|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
131131421|NCT00382993|472108340|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
131131422|NCT00382993|472108339|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
130976570|NCT00417079|471539276|FG001|Overall Study|Withdrawal by subject's family|1|||
130976571|NCT00417079|471539275|FG000|Overall Study|Patient unable to come to the clinic|0|||
130976572|NCT00417079|471539276|FG001|Overall Study|Patient unable to come to the clinic|1|||
130976573|NCT00417079|471539275|FG000|Overall Study|abnormal liver function tests|0|||
130976574|NCT00417079|471539276|FG001|Overall Study|abnormal liver function tests|1|||
130976575|NCT01687257|471539279|FG000|Overall Study|Efficacy Failure|6|||
130976576|NCT01687257|471539280|FG001|Overall Study|Efficacy Failure|0|||
130976577|NCT01687257|471539281|FG002|Overall Study|Efficacy Failure|5|||
130976578|NCT01687257|471539279|FG000|Overall Study|Subject Withdrew Consent|1|||
130976579|NCT01687257|471539280|FG001|Overall Study|Subject Withdrew Consent|1|||
130976580|NCT01687257|471539281|FG002|Overall Study|Subject Withdrew Consent|1|||
130976581|NCT01687257|471539279|FG000|Overall Study|Adverse Event|1|||
130976582|NCT01687257|471539280|FG001|Overall Study|Adverse Event|0|||
130976583|NCT01687257|471539281|FG002|Overall Study|Adverse Event|0|||
130976584|NCT01687257|471539279|FG000|Overall Study|Investigator's Discretion|0|||
130976585|NCT01687257|471539280|FG001|Overall Study|Investigator's Discretion|3|||
130976586|NCT01687257|471539281|FG002|Overall Study|Investigator's Discretion|0|||
130976587|NCT04403698|471539282|FG000|Overall Study|Adverse Event|1|||
130976588|NCT04403698|471539283|FG001|Overall Study|Adverse Event|1|||
130976589|NCT04403698|471539282|FG000|Overall Study|Lost to Follow-up|1|||
130976590|NCT04403698|471539283|FG001|Overall Study|Lost to Follow-up|0|||
130976591|NCT04403698|471539282|FG000|Overall Study|Protocol Violation|0|||
130976592|NCT04403698|471539283|FG001|Overall Study|Protocol Violation|1|||
130976593|NCT03152552|471539284|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
130976594|NCT03152552|471539285|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
130976595|NCT03152552|471539286|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
130976596|NCT03152552|471539287|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
130976597|NCT03152552|471539288|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
130976598|NCT03152552|471539284|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
130976599|NCT03152552|471539285|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
130976600|NCT03152552|471539286|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
130976601|NCT03152552|471539287|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
130976602|NCT03152552|471539288|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
130976603|NCT03152552|471539284|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
130976604|NCT03152552|471539285|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
130976605|NCT03152552|471539286|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
130976606|NCT03152552|471539287|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
130976607|NCT03152552|471539288|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
130976608|NCT03152552|471539284|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131131423|NCT00382993|472108340|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
131131424|NCT00382993|472108339|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
130976609|NCT03152552|471539285|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130976610|NCT03152552|471539286|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130976611|NCT03152552|471539287|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131131425|NCT00382993|472108340|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
130717837|NCT00123474|470593184|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
130976612|NCT03152552|471539288|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130976613|NCT03152552|471539284|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
130976614|NCT03152552|471539285|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
130976615|NCT03152552|471539286|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
130976616|NCT03152552|471539287|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
130976617|NCT03152552|471539288|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
131131426|NCT00382993|472108339|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
131131427|NCT00382993|472108340|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
130777990|NCT00103285|470815299|FG000|Response Assignment|Physician Decision|0|||
130777991|NCT00103285|470815300|FG001|Response Assignment|Physician Decision|13|||
130777992|NCT00103285|470815301|FG002|Response Assignment|Physician Decision|14|||
130777993|NCT00103285|470815302|FG003|Response Assignment|Physician Decision|9|||
130777994|NCT00103285|470815303|FG004|Response Assignment|Physician Decision|13|||
130777995|NCT00103285|470815304|FG005|Response Assignment|Physician Decision|7|||
130777996|NCT00103285|470815305|FG006|Response Assignment|Physician Decision|4|||
130777997|NCT00103285|470815306|FG007|Response Assignment|Physician Decision|35|||
130777998|NCT00103285|470815299|FG000|Response Assignment|Protocol Violation|0|||
130777999|NCT00103285|470815300|FG001|Response Assignment|Protocol Violation|2|||
130778000|NCT00103285|470815301|FG002|Response Assignment|Protocol Violation|0|||
130778001|NCT00103285|470815302|FG003|Response Assignment|Protocol Violation|0|||
130778002|NCT00103285|470815303|FG004|Response Assignment|Protocol Violation|0|||
130778003|NCT00103285|470815304|FG005|Response Assignment|Protocol Violation|0|||
130778004|NCT00103285|470815305|FG006|Response Assignment|Protocol Violation|0|||
130778005|NCT00103285|470815306|FG007|Response Assignment|Protocol Violation|0|||
130778006|NCT00103285|470815299|FG000|Response Assignment|Withdrawal by Subject|0|||
130778007|NCT00103285|470815300|FG001|Response Assignment|Withdrawal by Subject|4|||
130778008|NCT00103285|470815301|FG002|Response Assignment|Withdrawal by Subject|1|||
130778009|NCT00103285|470815302|FG003|Response Assignment|Withdrawal by Subject|1|||
130778010|NCT00103285|470815303|FG004|Response Assignment|Withdrawal by Subject|2|||
130778011|NCT00103285|470815304|FG005|Response Assignment|Withdrawal by Subject|2|||
130778012|NCT00103285|470815305|FG006|Response Assignment|Withdrawal by Subject|0|||
130778013|NCT00103285|470815306|FG007|Response Assignment|Withdrawal by Subject|2|||
130778014|NCT00103285|470815299|FG000|Response Assignment|Ineligible|0|||
130778015|NCT00103285|470815300|FG001|Response Assignment|Ineligible|8|||
130778016|NCT00103285|470815301|FG002|Response Assignment|Ineligible|6|||
130778017|NCT00103285|470815302|FG003|Response Assignment|Ineligible|2|||
130778018|NCT00103285|470815303|FG004|Response Assignment|Ineligible|0|||
130778019|NCT00103285|470815304|FG005|Response Assignment|Ineligible|3|||
130778020|NCT00103285|470815305|FG006|Response Assignment|Ineligible|1|||
130778021|NCT00103285|470815306|FG007|Response Assignment|Ineligible|5|||
130778022|NCT00103285|470815299|FG000|Response Assignment|Refusal|0|||
130778023|NCT00103285|470815300|FG001|Response Assignment|Refusal|53|||
130778024|NCT00103285|470815301|FG002|Response Assignment|Refusal|5|||
130778025|NCT00103285|470815302|FG003|Response Assignment|Refusal|3|||
130778026|NCT00103285|470815303|FG004|Response Assignment|Refusal|25|||
130778027|NCT00103285|470815304|FG005|Response Assignment|Refusal|15|||
130778028|NCT00103285|470815305|FG006|Response Assignment|Refusal|30|||
130778029|NCT00103285|470815306|FG007|Response Assignment|Refusal|10|||
130778030|NCT00103285|470815299|FG000|Response Assignment|Other|0|||
130778031|NCT00103285|470815300|FG001|Response Assignment|Other|30|||
130778032|NCT00103285|470815301|FG002|Response Assignment|Other|48|||
130778033|NCT00103285|470815302|FG003|Response Assignment|Other|38|||
130778034|NCT00103285|470815303|FG004|Response Assignment|Other|37|||
130778035|NCT00103285|470815304|FG005|Response Assignment|Other|17|||
130778036|NCT00103285|470815305|FG006|Response Assignment|Other|11|||
130778037|NCT00103285|470815306|FG007|Response Assignment|Other|53|||
130778038|NCT00452439|470815308|FG000|Overall Study|Lost to Follow-up|1|||
130778039|NCT00452439|470815309|FG001|Overall Study|Lost to Follow-up|1|||
130778040|NCT00452439|470815308|FG000|Overall Study|Refused Treatment|4|||
130778041|NCT00452439|470815309|FG001|Overall Study|Refused Treatment|3|||
130778042|NCT00452439|470815308|FG000|Overall Study|Death|3|||
130778043|NCT00452439|470815309|FG001|Overall Study|Death|1|||
130778044|NCT00452439|470815308|FG000|Overall Study|Bone Marrow Transplant|0|||
130778045|NCT00452439|470815309|FG001|Overall Study|Bone Marrow Transplant|1|||
130778046|NCT00452439|470815308|FG000|Overall Study|Too Ill to Continue|0|||
130976618|NCT03152552|471539284|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
130976619|NCT03152552|471539285|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
130976620|NCT03152552|471539286|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
130976621|NCT03152552|471539287|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
130976622|NCT03152552|471539288|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
130976623|NCT03152552|471539284|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
130976624|NCT03152552|471539285|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
130976625|NCT03152552|471539286|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
131043386|NCT04428203|471793100|FG000|Overall Study|Adverse Event|1|||
131043387|NCT04428203|471793101|FG001|Overall Study|Adverse Event|0|||
131043388|NCT04428203|471793102|FG002|Overall Study|Adverse Event|0|||
131043389|NCT04428203|471793100|FG000|Overall Study|Withdrawal by Subject|1|||
131043390|NCT04428203|471793101|FG001|Overall Study|Withdrawal by Subject|0|||
131043391|NCT04428203|471793102|FG002|Overall Study|Withdrawal by Subject|1|||
131043392|NCT05280574|471793103|FG000|Overall Study|Withdrawal by Subject|0|||
131043393|NCT05280574|471793104|FG001|Overall Study|Withdrawal by Subject|2|||
131043394|NCT05280574|471793105|FG002|Overall Study|Withdrawal by Subject|0|||
131043395|NCT05237284|471793110|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
131043396|NCT05237284|471793111|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
131043397|NCT05237284|471793112|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
131131428|NCT00382993|472108339|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
131131429|NCT00382993|472108340|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
130976626|NCT03152552|471539287|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
130976627|NCT03152552|471539288|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
130976628|NCT04899349|471539291|FG000|Overall Study|Study terminated by Sponsor|2|||
130976629|NCT04899349|471539292|FG001|Overall Study|Study terminated by Sponsor|0|||
130976630|NCT01022762|471539294|FG000|Overall Study|Adverse Event|3|||
130976631|NCT01022762|471539295|FG001|Overall Study|Adverse Event|1|||
130976632|NCT01022762|471539294|FG000|Overall Study|Lack of Efficacy|0|||
130976633|NCT01022762|471539295|FG001|Overall Study|Lack of Efficacy|1|||
130976634|NCT01022762|471539294|FG000|Overall Study|Protocol Violation|7|||
130976635|NCT01022762|471539295|FG001|Overall Study|Protocol Violation|6|||
130976636|NCT01022762|471539294|FG000|Overall Study|Unclassified|12|||
130976637|NCT01022762|471539295|FG001|Overall Study|Unclassified|20|||
130976638|NCT01302119|471539296|FG000|Overall Study|Withdrawal by Subject|30|||
130976639|NCT01302119|471539297|FG001|Overall Study|Withdrawal by Subject|20|||
130976640|NCT01302119|471539296|FG000|Overall Study|Lost to Follow-up|10|||
130976641|NCT01302119|471539297|FG001|Overall Study|Lost to Follow-up|4|||
130976642|NCT01302119|471539296|FG000|Overall Study|Adverse Event|2|||
130976643|NCT01302119|471539297|FG001|Overall Study|Adverse Event|1|||
130976644|NCT01302119|471539296|FG000|Overall Study|Non-compliance|4|||
130976645|NCT01302119|471539297|FG001|Overall Study|Non-compliance|2|||
130976646|NCT01302119|471539296|FG000|Overall Study|Non-specific|4|||
130976647|NCT01302119|471539297|FG001|Overall Study|Non-specific|1|||
130976648|NCT04084314|471539301|FG000|Overall Study|Subject/guardian decision|91|||
130976649|NCT04084314|471539301|FG000|Overall Study|Adverse Event|24|||
130976650|NCT04084314|471539301|FG000|Overall Study|Lost to Follow-up|19|||
130976651|NCT04084314|471539301|FG000|Overall Study|New therapy for study indication|9|||
130976652|NCT04084314|471539301|FG000|Overall Study|Pregnancy|9|||
130976653|NCT04084314|471539301|FG000|Overall Study|Withdrawal of informed consent|8|||
130976654|NCT04084314|471539301|FG000|Overall Study|Physician Decision|4|||
130976655|NCT04084314|471539301|FG000|Overall Study|Protocol Deviation|3|||
130976656|NCT00802074|471539302|FG000|Overall Study|Adverse Event|1|||
130976657|NCT00802074|471539303|FG001|Overall Study|Adverse Event|1|||
130976658|NCT00802074|471539304|FG002|Overall Study|Adverse Event|1|||
130976659|NCT00802074|471539305|FG003|Overall Study|Adverse Event|0|||
130976660|NCT00802074|471539306|FG004|Overall Study|Adverse Event|0|||
130976661|NCT00802074|471539307|FG005|Overall Study|Adverse Event|0|||
130976662|NCT00802074|471539302|FG000|Overall Study|Withdrawal by Subject|1|||
130976663|NCT00802074|471539303|FG001|Overall Study|Withdrawal by Subject|0|||
130976664|NCT00802074|471539304|FG002|Overall Study|Withdrawal by Subject|0|||
130976665|NCT00802074|471539305|FG003|Overall Study|Withdrawal by Subject|0|||
130976666|NCT00802074|471539306|FG004|Overall Study|Withdrawal by Subject|0|||
130976667|NCT00802074|471539307|FG005|Overall Study|Withdrawal by Subject|0|||
130976668|NCT03336619|471539308|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
130976669|NCT03336619|471539309|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
130976670|NCT03336619|471539308|FG000|Overall Study|Withdrawal by Subject|17|||
130976671|NCT03336619|471539309|FG001|Overall Study|Withdrawal by Subject|16|||
130976672|NCT03336619|471539308|FG000|Overall Study|Adverse Event|2|||
130976673|NCT03336619|471539309|FG001|Overall Study|Adverse Event|5|||
130976674|NCT03336619|471539308|FG000|Overall Study|Physician Decision|3|||
131131430|NCT00382993|472108339|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
130976675|NCT03336619|471539309|FG001|Overall Study|Physician Decision|0|||
130976676|NCT03743038|471539310|FG000|Overall Study|Physician Decision|1|||
130976677|NCT01300546|471539311|FG000|Overall Study|Withdrawal by Subject|1|||
130976678|NCT01300546|471539312|FG001|Overall Study|Withdrawal by Subject|0|||
130976679|NCT01300546|471539311|FG000|Overall Study|Lost to Follow-up|0|||
130976680|NCT01300546|471539312|FG001|Overall Study|Lost to Follow-up|2|||
130976681|NCT01300546|471539311|FG000|Overall Study|Lack of Efficacy|0|||
130976682|NCT01300546|471539312|FG001|Overall Study|Lack of Efficacy|3|||
130976683|NCT01300546|471539311|FG000|Overall Study|Adverse Event|0|||
130976684|NCT01300546|471539312|FG001|Overall Study|Adverse Event|1|||
130976685|NCT02820623|471539313|FG000|Overall Study|Withdrawal by Subject|1|||
130976686|NCT02820623|471539314|FG001|Overall Study|Withdrawal by Subject|3|||
130976687|NCT02820623|471539315|FG002|Overall Study|Withdrawal by Subject|3|||
130976688|NCT02820623|471539313|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
130976689|NCT02820623|471539314|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
130976690|NCT02820623|471539315|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
130976691|NCT02820623|471539313|FG000|Overall Study|Therapist unable to enroll clients|1|||
130976692|NCT02820623|471539314|FG001|Overall Study|Therapist unable to enroll clients|1|||
130976693|NCT02820623|471539315|FG002|Overall Study|Therapist unable to enroll clients|3|||
130976694|NCT02820623|471539313|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
130976695|NCT02820623|471539314|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
130976696|NCT02820623|471539315|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
131131431|NCT00382993|472108340|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
131131432|NCT00382993|472108339|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
131131433|NCT00382993|472108340|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
131131434|NCT00382993|472108339|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
131131435|NCT00382993|472108340|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
131131436|NCT00382993|472108339|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
131131437|NCT00382993|472108340|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
131131438|NCT00382993|472108339|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
131131439|NCT00382993|472108340|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
131131440|NCT01965262|472108347|FG000|Second Intervention (7 Days)|Discontinued|0|||
131131441|NCT01965262|472108348|FG001|Second Intervention (7 Days)|Discontinued|1|||
131131442|NCT01965262|472108347|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
131131443|NCT01965262|472108348|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
131131444|NCT01965262|472108347|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
131131445|NCT01965262|472108348|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
131131446|NCT01827670|472108357|FG000|Overall Study|Withdrawal of Consent|3|||
131131447|NCT01827670|472108358|FG001|Overall Study|Withdrawal of Consent|2|||
131131448|NCT01827670|472108357|FG000|Overall Study|Lost to Follow-up|0|||
131131449|NCT01827670|472108358|FG001|Overall Study|Lost to Follow-up|1|||
131131450|NCT00790907|472108363|FG000|Overall Study|Adverse Event|9|||
131131451|NCT00790907|472108364|FG001|Overall Study|Adverse Event|7|||
131131452|NCT00790907|472108365|FG002|Overall Study|Adverse Event|6|||
131131453|NCT00790907|472108363|FG000|Overall Study|Physician Decision|304|||
131131454|NCT00790907|472108364|FG001|Overall Study|Physician Decision|271|||
131131455|NCT00790907|472108365|FG002|Overall Study|Physician Decision|255|||
131131456|NCT00790907|472108363|FG000|Overall Study|Withdrawal by Subject|1|||
131131457|NCT00790907|472108364|FG001|Overall Study|Withdrawal by Subject|7|||
131131458|NCT00790907|472108365|FG002|Overall Study|Withdrawal by Subject|5|||
131131459|NCT00790907|472108363|FG000|Overall Study|Bleeding Event|11|||
131131460|NCT00790907|472108364|FG001|Overall Study|Bleeding Event|16|||
131131461|NCT00790907|472108365|FG002|Overall Study|Bleeding Event|21|||
131131462|NCT00790907|472108363|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
131131463|NCT00790907|472108364|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
131131464|NCT00790907|472108365|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
131131465|NCT00790907|472108363|FG000|Overall Study|Qualifying Condition Not Present|29|||
131131466|NCT00790907|472108364|FG001|Overall Study|Qualifying Condition Not Present|14|||
131131467|NCT00790907|472108365|FG002|Overall Study|Qualifying Condition Not Present|16|||
131131468|NCT00790907|472108363|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
131131469|NCT00790907|472108364|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
130778047|NCT00452439|470815309|FG001|Overall Study|Too Ill to Continue|1|||
130778048|NCT00452439|470815308|FG000|Overall Study|Failed to achieve complete response|2|||
130976697|NCT01965834|471539316|FG000|Overall Study|Lack of Efficacy|4|||
130976698|NCT04988308|471539317|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
130976699|NCT04988308|471539318|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
130976700|NCT04988308|471539319|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
130976701|NCT04988308|471539320|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130976702|NCT04988308|471539321|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130976703|NCT04988308|471539322|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
130976704|NCT04988308|471539317|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130976705|NCT04988308|471539318|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130976706|NCT04988308|471539319|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
130976707|NCT04988308|471539320|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130976708|NCT04988308|471539321|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130976709|NCT04988308|471539322|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130976710|NCT04988308|471539317|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
130976711|NCT04988308|471539318|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
130976712|NCT04988308|471539319|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
130976713|NCT04988308|471539320|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
130976714|NCT04988308|471539321|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
131131470|NCT00790907|472108365|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
131227515|NCT00410410|472459750|FG001|Induction Period (IP)|Other|0|||
131227516|NCT00410410|472459751|FG002|Induction Period (IP)|Other|1|||
130976715|NCT04988308|471539322|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
131131471|NCT00790907|472108363|FG000|Overall Study|Did Not Receive Study Drug|10|||
131131472|NCT00790907|472108364|FG001|Overall Study|Did Not Receive Study Drug|0|||
131227517|NCT00410410|472459752|FG003|Induction Period (IP)|Other|0|||
131131473|NCT00790907|472108365|FG002|Overall Study|Did Not Receive Study Drug|0|||
131131474|NCT00109707|472108367|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
131227518|NCT00410410|472459753|FG004|Induction Period (IP)|Other|0|||
130976716|NCT04988308|471539317|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
130976717|NCT04988308|471539318|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
130976718|NCT04988308|471539319|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
130976719|NCT04988308|471539320|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130976720|NCT04988308|471539321|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130976721|NCT04988308|471539322|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
130976722|NCT04988308|471539317|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
130976723|NCT04988308|471539318|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
130976724|NCT04988308|471539319|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
130976725|NCT04988308|471539320|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
130976726|NCT04988308|471539321|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
130976727|NCT04988308|471539322|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
130976728|NCT04988308|471539317|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130976729|NCT04988308|471539318|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130976730|NCT04988308|471539319|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
130976731|NCT04988308|471539320|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
130976732|NCT04988308|471539321|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
130976733|NCT04988308|471539322|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
130976734|NCT04988308|471539317|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130976735|NCT04988308|471539318|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130976736|NCT04988308|471539319|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
130976737|NCT04988308|471539320|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
130976738|NCT04988308|471539321|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
130976739|NCT04988308|471539322|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
130976740|NCT04988308|471539317|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130976741|NCT04988308|471539318|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130976742|NCT04988308|471539319|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
130976743|NCT04988308|471539320|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
130976744|NCT04988308|471539321|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
130976745|NCT04988308|471539322|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
130976746|NCT04988308|471539317|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
130976747|NCT04988308|471539318|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
130976748|NCT04988308|471539319|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
130976749|NCT04988308|471539320|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
130976750|NCT04988308|471539321|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
130976751|NCT04988308|471539322|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
130976752|NCT02625623|471539331|FG000|Overall Study|Participants randomized but not treated|9|||
130976753|NCT02625623|471539332|FG001|Overall Study|Participants randomized but not treated|1|||
130976754|NCT00744653|471539333|FG000|Overall Study|antineoplastic treatment|11|||
130976755|NCT00744653|471539333|FG000|Overall Study|Death|1|||
130976756|NCT00744653|471539333|FG000|Overall Study|Lost to Follow-up|1|||
130976757|NCT00744653|471539333|FG000|Overall Study|Physician Decision|3|||
130976758|NCT03826667|471539336|FG000|Overall Study|Protocol deviation|21|||
130976759|NCT00808808|471539337|FG000|Overall Study|Vaccinated; survey not completed|131|||
130976760|NCT00808808|471539338|FG001|Overall Study|Vaccinated; survey not completed|169|||
130976761|NCT00808808|471539339|FG002|Overall Study|Vaccinated; survey not completed|302|||
130976762|NCT00808808|471539337|FG000|Overall Study|Employee was not vaccinated.|2686|||
130976763|NCT00808808|471539338|FG001|Overall Study|Employee was not vaccinated.|2268|||
130976764|NCT00808808|471539339|FG002|Overall Study|Employee was not vaccinated.|2255|||
130976765|NCT00617344|471539340|FG000|Overall Study|Serious adverse event|1|||
130976766|NCT00617344|471539341|FG001|Overall Study|Serious adverse event|0|||
130976767|NCT00617344|471539342|FG002|Overall Study|Serious adverse event|0|||
130976768|NCT00617344|471539340|FG000|Overall Study|Other Adverse Event|1|||
130976769|NCT00617344|471539341|FG001|Overall Study|Other Adverse Event|1|||
130976770|NCT00617344|471539342|FG002|Overall Study|Other Adverse Event|0|||
130976771|NCT00617344|471539340|FG000|Overall Study|Protocol Violation|10|||
130976772|NCT00617344|471539341|FG001|Overall Study|Protocol Violation|8|||
130976773|NCT00617344|471539342|FG002|Overall Study|Protocol Violation|5|||
131131475|NCT00109707|472108368|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
131131476|NCT00109707|472108369|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
131131477|NCT00109707|472108367|FG000|Overall Study|Abnormal laboratory values|1|||
130976774|NCT00617344|471539340|FG000|Overall Study|Lost to Follow-up|5|||
130976775|NCT00617344|471539341|FG001|Overall Study|Lost to Follow-up|4|||
130976776|NCT00617344|471539342|FG002|Overall Study|Lost to Follow-up|1|||
130976777|NCT00617344|471539340|FG000|Overall Study|Withdrawal by Subject|8|||
130976778|NCT00617344|471539341|FG001|Overall Study|Withdrawal by Subject|9|||
130976779|NCT00617344|471539342|FG002|Overall Study|Withdrawal by Subject|2|||
130976780|NCT02352948|471539344|FG000|Overall Study|Death|47|||
131131478|NCT00109707|472108368|FG001|Overall Study|Abnormal laboratory values|0|||
131131479|NCT00109707|472108369|FG002|Overall Study|Abnormal laboratory values|0|||
131131480|NCT00109707|472108367|FG000|Overall Study|Administrative problems|2|||
131131481|NCT00109707|472108368|FG001|Overall Study|Administrative problems|0|||
131131482|NCT00109707|472108369|FG002|Overall Study|Administrative problems|1|||
131131483|NCT00109707|472108367|FG000|Overall Study|Adverse Event|10|||
131131484|NCT00109707|472108368|FG001|Overall Study|Adverse Event|2|||
131131485|NCT00109707|472108369|FG002|Overall Study|Adverse Event|3|||
131131486|NCT00109707|472108367|FG000|Overall Study|Death|4|||
131131487|NCT00109707|472108368|FG001|Overall Study|Death|0|||
131131488|NCT00109707|472108369|FG002|Overall Study|Death|0|||
131131489|NCT00109707|472108367|FG000|Overall Study|Disease progression|12|||
131131490|NCT00109707|472108368|FG001|Overall Study|Disease progression|4|||
131131491|NCT00109707|472108369|FG002|Overall Study|Disease progression|3|||
131131492|NCT00109707|472108367|FG000|Overall Study|Lost to Follow-up|3|||
131131493|NCT00109707|472108368|FG001|Overall Study|Lost to Follow-up|0|||
131131494|NCT00109707|472108369|FG002|Overall Study|Lost to Follow-up|0|||
131131495|NCT00109707|472108367|FG000|Overall Study|Protocol Violation|1|||
131131496|NCT00109707|472108368|FG001|Overall Study|Protocol Violation|0|||
131131497|NCT00109707|472108369|FG002|Overall Study|Protocol Violation|0|||
131131498|NCT00109707|472108367|FG000|Overall Study|Patient withdrew consent|6|||
131131499|NCT00109707|472108368|FG001|Overall Study|Patient withdrew consent|1|||
131131500|NCT00109707|472108369|FG002|Overall Study|Patient withdrew consent|0|||
131131501|NCT02250274|472108370|FG000|Overall Study|Insufficient blood draw amount|7|||
131131502|NCT02250274|472108371|FG001|Overall Study|Insufficient blood draw amount|6|||
131131503|NCT00446511|472108374|FG000|Overall Study|Adverse Event|7|||
131131504|NCT00446511|472108375|FG001|Overall Study|Adverse Event|2|||
131131505|NCT00446511|472108376|FG002|Overall Study|Adverse Event|3|||
131131506|NCT00446511|472108377|FG003|Overall Study|Adverse Event|1|||
131131507|NCT00446511|472108374|FG000|Overall Study|Protocol Violation|0|||
131131508|NCT00446511|472108375|FG001|Overall Study|Protocol Violation|0|||
131131509|NCT00446511|472108376|FG002|Overall Study|Protocol Violation|0|||
131227519|NCT00410410|472459754|FG005|Induction Period (IP)|Other|0|||
131227520|NCT00410410|472459755|FG006|Induction Period (IP)|Other|0|||
130717838|NCT00123474|470593185|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
130976781|NCT02352948|471539345|FG001|Overall Study|Death|48|||
130976782|NCT02352948|471539346|FG002|Overall Study|Death|114|||
130976783|NCT02352948|471539347|FG003|Overall Study|Death|74|||
130976784|NCT02352948|471539348|FG004|Overall Study|Death|77|||
130976785|NCT02352948|471539349|FG005|Overall Study|Death|44|||
130976786|NCT02352948|471539344|FG000|Overall Study|Lost to Follow-up|1|||
130976787|NCT02352948|471539345|FG001|Overall Study|Lost to Follow-up|0|||
130976788|NCT02352948|471539346|FG002|Overall Study|Lost to Follow-up|2|||
130976789|NCT02352948|471539347|FG003|Overall Study|Lost to Follow-up|1|||
130976790|NCT02352948|471539348|FG004|Overall Study|Lost to Follow-up|2|||
130976791|NCT02352948|471539349|FG005|Overall Study|Lost to Follow-up|1|||
130976792|NCT02352948|471539344|FG000|Overall Study|Withdrawal by Subject|1|||
130976793|NCT02352948|471539345|FG001|Overall Study|Withdrawal by Subject|10|||
130976794|NCT02352948|471539346|FG002|Overall Study|Withdrawal by Subject|11|||
130976795|NCT02352948|471539347|FG003|Overall Study|Withdrawal by Subject|23|||
130976796|NCT02352948|471539348|FG004|Overall Study|Withdrawal by Subject|9|||
130976797|NCT02352948|471539349|FG005|Overall Study|Withdrawal by Subject|4|||
130976798|NCT02352948|471539344|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130976799|NCT02352948|471539345|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130976800|NCT02352948|471539346|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130976801|NCT02352948|471539347|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130976802|NCT02352948|471539348|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130976803|NCT02352948|471539349|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
130976804|NCT02352948|471539344|FG000|Overall Study|Other|0|||
130976805|NCT02352948|471539345|FG001|Overall Study|Other|0|||
130976806|NCT02352948|471539346|FG002|Overall Study|Other|2|||
130976807|NCT02352948|471539347|FG003|Overall Study|Other|0|||
130976808|NCT02352948|471539348|FG004|Overall Study|Other|0|||
130976809|NCT02352948|471539349|FG005|Overall Study|Other|0|||
130976810|NCT01453595|471539351|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130976811|NCT01453595|471539352|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130976812|NCT01453595|471539353|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130976813|NCT00941330|471539354|FG000|Overall Study|Other|1|||
130976814|NCT00941330|471539355|FG001|Overall Study|Other|0|||
131227521|NCT00410410|472459756|FG007|Induction Period (IP)|Other|0|||
131131510|NCT00446511|472108377|FG003|Overall Study|Protocol Violation|1|||
131131511|NCT00446511|472108374|FG000|Overall Study|Withdrawal by Subject|0|||
131131512|NCT00446511|472108375|FG001|Overall Study|Withdrawal by Subject|0|||
131131513|NCT00446511|472108376|FG002|Overall Study|Withdrawal by Subject|0|||
131131514|NCT00446511|472108377|FG003|Overall Study|Withdrawal by Subject|3|||
131131515|NCT00446511|472108374|FG000|Overall Study|Administrative Problems|3|||
131131516|NCT00446511|472108375|FG001|Overall Study|Administrative Problems|0|||
131131517|NCT00446511|472108376|FG002|Overall Study|Administrative Problems|4|||
131227522|NCT00410410|472459757|FG008|Induction Period (IP)|Other|0|||
130976815|NCT00941330|471539354|FG000|Overall Study|Physician Decision|0|||
131131518|NCT00446511|472108377|FG003|Overall Study|Administrative Problems|1|||
131131519|NCT01618214|472108378|FG000|Overall Study|Adverse Event|3|||
131131520|NCT01618214|472108379|FG001|Overall Study|Adverse Event|1|||
131131521|NCT01618214|472108378|FG000|Overall Study|Lack of Efficacy|1|||
131131522|NCT01618214|472108379|FG001|Overall Study|Lack of Efficacy|1|||
131131523|NCT01618214|472108378|FG000|Overall Study|Protocol Violation|1|||
130976816|NCT00941330|471539355|FG001|Overall Study|Physician Decision|2|||
130976817|NCT00506493|471539358|FG000|Overall Study|Death|6|||
130976818|NCT00506493|471539358|FG000|Overall Study|Withdrawal by Subject|5|||
130976819|NCT02943408|471541108|FG000|Overall Study|Lost to Follow-up|7|||
130976820|NCT02943408|471541109|FG001|Overall Study|Lost to Follow-up|1|||
130976821|NCT02943408|471541108|FG000|Overall Study|Withdrawal by Subject|0|||
130976822|NCT02943408|471541109|FG001|Overall Study|Withdrawal by Subject|1|||
130976823|NCT01621126|471541112|FG000|Overall Study|Physician Decision|6|||
130976824|NCT00886340|471541113|FG000|Overall Study|Withdrawal by Subject|0|||
130976825|NCT00886340|471541114|FG001|Overall Study|Withdrawal by Subject|7|||
130976826|NCT01949311|471541116|FG000|Overall Study|Lost to Follow-up|73|||
130976827|NCT01949311|471541116|FG000|Overall Study|Terminated by Sponsor|708|||
130976828|NCT01949311|471541116|FG000|Overall Study|Withdrawal by Subject|375|||
130976829|NCT01949311|471541116|FG000|Overall Study|Lack of Efficacy|50|||
130976830|NCT01949311|471541116|FG000|Overall Study|Protocol Deviation|34|||
130976831|NCT01949311|471541116|FG000|Overall Study|Pregnancy|20|||
130976832|NCT01949311|471541116|FG000|Overall Study|Physician Decision|9|||
130976833|NCT01949311|471541116|FG000|Overall Study|Other|4|||
130976834|NCT01949311|471541116|FG000|Overall Study|Adverse Event|107|||
130976835|NCT02338154|471541117|FG000|Overall Study|Death|46|||
130976836|NCT02338154|471541117|FG000|Overall Study|Valve Implant Failure|17|||
130976837|NCT02338154|471541117|FG000|Overall Study|Valve Explant|11|||
130976838|NCT02338154|471541117|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
130976839|NCT02338154|471541117|FG000|Overall Study|Lost to Follow-up|8|||
130976840|NCT02338154|471541117|FG000|Overall Study|Other Reason|3|||
130976841|NCT02338154|471541117|FG000|Overall Study|Patients Without Exit Form|47|||
130976842|NCT02338154|471541117|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
130976843|NCT02120027|471541120|FG000|Overall Study|Adverse Event|4|||
130976844|NCT02120027|471541121|FG001|Overall Study|Adverse Event|5|||
130976845|NCT02120027|471541120|FG000|Overall Study|Lack of Efficacy|3|||
130976846|NCT02120027|471541121|FG001|Overall Study|Lack of Efficacy|5|||
130976847|NCT02120027|471541120|FG000|Overall Study|Lost to Follow-up|5|||
130976848|NCT02120027|471541121|FG001|Overall Study|Lost to Follow-up|13|||
130976849|NCT02120027|471541120|FG000|Overall Study|Other|4|||
130976850|NCT02120027|471541121|FG001|Overall Study|Other|0|||
130976851|NCT02120027|471541120|FG000|Overall Study|Physician Decision|4|||
130976852|NCT02120027|471541121|FG001|Overall Study|Physician Decision|3|||
130976853|NCT02120027|471541120|FG000|Overall Study|Protocol Violation|18|||
130976854|NCT02120027|471541121|FG001|Overall Study|Protocol Violation|21|||
130976855|NCT02120027|471541120|FG000|Overall Study|Study terminated by Sponsor|45|||
130976856|NCT02120027|471541121|FG001|Overall Study|Study terminated by Sponsor|47|||
130976857|NCT02120027|471541120|FG000|Overall Study|Withdrawal by Subject|33|||
130976858|NCT02120027|471541121|FG001|Overall Study|Withdrawal by Subject|25|||
130976859|NCT01925950|471541127|FG000|Part 2|Withdrawal by Subject|1|||
130976860|NCT01925950|471541128|FG001|Part 2|Withdrawal by Subject|0|||
130976861|NCT00381940|471541129|FG000|Overall Study|Lack of Efficacy|3|||
130976862|NCT00381940|471541129|FG000|Overall Study|Protocol Violation|1|||
130976863|NCT00381940|471541129|FG000|Overall Study|Ineligible|1|||
130976864|NCT03162224|471541130|FG000|Overall Study|Death|4|||
130976865|NCT03162224|471541131|FG001|Overall Study|Death|5|||
130976866|NCT03162224|471541132|FG002|Overall Study|Death|8|||
130976867|NCT03162224|471541130|FG000|Overall Study|Withdrawal by Subject|1|||
130976868|NCT03162224|471541131|FG001|Overall Study|Withdrawal by Subject|0|||
130976869|NCT03162224|471541132|FG002|Overall Study|Withdrawal by Subject|1|||
130976870|NCT03162224|471541130|FG000|Overall Study|Lost to Follow-up|0|||
130976871|NCT03162224|471541131|FG001|Overall Study|Lost to Follow-up|1|||
130976872|NCT03162224|471541132|FG002|Overall Study|Lost to Follow-up|0|||
130976873|NCT03162224|471541130|FG000|Overall Study|Other|6|||
130976874|NCT03162224|471541131|FG001|Overall Study|Other|2|||
130976875|NCT03162224|471541132|FG002|Overall Study|Other|1|||
130976876|NCT04162769|471541133|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
131131524|NCT01618214|472108379|FG001|Overall Study|Protocol Violation|4|||
131131525|NCT01618214|472108378|FG000|Overall Study|Withdrawal Criteria|1|||
130976877|NCT04162769|471541134|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
130976878|NCT04162769|471541135|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
130976879|NCT04162769|471541136|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
130976880|NCT04162769|471541133|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
130976881|NCT04162769|471541134|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
131131526|NCT01618214|472108379|FG001|Overall Study|Withdrawal Criteria|2|||
131131527|NCT01618214|472108378|FG000|Overall Study|Unclassified|4|||
130976882|NCT04162769|471541135|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
130976883|NCT04162769|471541136|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
130976884|NCT04162769|471541133|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
130778049|NCT00452439|470815309|FG001|Overall Study|Failed to achieve complete response|0|||
130778050|NCT00452439|470815308|FG000|Overall Study|Relapse|3|||
130778051|NCT00452439|470815309|FG001|Overall Study|Relapse|0|||
130778052|NCT00452439|470815308|FG000|Overall Study|Fracture|1|||
130778053|NCT00452439|470815309|FG001|Overall Study|Fracture|0|||
130778054|NCT03512353|470815311|FG000|Overall Study|Sponsor Decision|3|||
131131528|NCT01618214|472108379|FG001|Overall Study|Unclassified|5|||
130778055|NCT03512353|470815311|FG000|Overall Study|Death|1|||
130778056|NCT01302418|470815312|FG000|Overall Study|Protocol Violation|9|||
130778057|NCT01302418|470815312|FG000|Overall Study|Non-evaluable|9|||
130778058|NCT00377637|470815313|FG000|Induction Phase|Adverse Event|12|||
130778059|NCT00377637|470815314|FG001|Induction Phase|Adverse Event|21|||
130778060|NCT00377637|470815315|FG002|Induction Phase|Adverse Event|0|||
130778061|NCT00377637|470815316|FG003|Induction Phase|Adverse Event|0|||
130778062|NCT00377637|470815313|FG000|Induction Phase|Deterioration/serum creatinine|2|||
130778063|NCT00377637|470815314|FG001|Induction Phase|Deterioration/serum creatinine|0|||
130778064|NCT00377637|470815315|FG002|Induction Phase|Deterioration/serum creatinine|0|||
130778065|NCT00377637|470815316|FG003|Induction Phase|Deterioration/serum creatinine|0|||
130778066|NCT00377637|470815313|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
130778067|NCT00377637|470815314|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
130778068|NCT00377637|470815315|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
130778069|NCT00377637|470815316|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
130778070|NCT00377637|470815313|FG000|Induction Phase|Lost to Follow-up|2|||
130778071|NCT00377637|470815314|FG001|Induction Phase|Lost to Follow-up|1|||
130778072|NCT00377637|470815315|FG002|Induction Phase|Lost to Follow-up|0|||
130778073|NCT00377637|470815316|FG003|Induction Phase|Lost to Follow-up|0|||
130778074|NCT00377637|470815313|FG000|Induction Phase|Death|1|||
130778075|NCT00377637|470815314|FG001|Induction Phase|Death|3|||
130778076|NCT00377637|470815315|FG002|Induction Phase|Death|0|||
130778077|NCT00377637|470815316|FG003|Induction Phase|Death|0|||
130778078|NCT00377637|470815313|FG000|Induction Phase|Withdrawal by Subject|5|||
130778079|NCT00377637|470815314|FG001|Induction Phase|Withdrawal by Subject|6|||
130778080|NCT00377637|470815315|FG002|Induction Phase|Withdrawal by Subject|0|||
130778081|NCT00377637|470815316|FG003|Induction Phase|Withdrawal by Subject|0|||
130778082|NCT00377637|470815313|FG000|Induction Phase|Physician Decision|3|||
130778083|NCT00377637|470815314|FG001|Induction Phase|Physician Decision|1|||
130778084|NCT00377637|470815315|FG002|Induction Phase|Physician Decision|0|||
131131529|NCT02228590|472108381|FG000|Overall Study|Withdrawal by Subject|1|||
131131530|NCT00574275|472108382|FG000|Overall Study|Randomized but not treated|2|||
131131531|NCT00574275|472108383|FG001|Overall Study|Randomized but not treated|3|||
131131532|NCT00574275|472108382|FG000|Overall Study|Adverse Event|32|||
131131533|NCT00574275|472108383|FG001|Overall Study|Adverse Event|76|||
131131534|NCT00574275|472108382|FG000|Overall Study|Disease progression|160|||
131131535|NCT00574275|472108383|FG001|Overall Study|Disease progression|146|||
131131536|NCT00574275|472108382|FG000|Overall Study|Lost to Follow-up|2|||
131131537|NCT00574275|472108383|FG001|Overall Study|Lost to Follow-up|1|||
131131538|NCT00574275|472108382|FG000|Overall Study|Study stopped based on DMC decision|62|||
131131539|NCT00574275|472108383|FG001|Overall Study|Study stopped based on DMC decision|23|||
131131540|NCT00574275|472108382|FG000|Overall Study|Withdrawal by Subject|15|||
131131541|NCT00574275|472108383|FG001|Overall Study|Withdrawal by Subject|17|||
131131542|NCT00574275|472108382|FG000|Overall Study|Error calculating tumor measurement|1|||
131131543|NCT00574275|472108383|FG001|Overall Study|Error calculating tumor measurement|0|||
131131544|NCT00574275|472108382|FG000|Overall Study|Physician Decision|1|||
131131545|NCT00574275|472108383|FG001|Overall Study|Physician Decision|1|||
131131546|NCT00574275|472108382|FG000|Overall Study|Protocol Violation|0|||
131131547|NCT00574275|472108383|FG001|Overall Study|Protocol Violation|1|||
131131548|NCT00574275|472108382|FG000|Overall Study|Patient and Investigator decision|0|||
131131549|NCT00574275|472108383|FG001|Overall Study|Patient and Investigator decision|1|||
131131550|NCT00574275|472108382|FG000|Overall Study|Insurance change|0|||
131131551|NCT00574275|472108383|FG001|Overall Study|Insurance change|1|||
131131552|NCT00574275|472108382|FG000|Overall Study|Operation for curative intent|0|||
130778085|NCT00377637|470815316|FG003|Induction Phase|Physician Decision|0|||
130778086|NCT00377637|470815313|FG000|Induction Phase|Sponsor decision|1|||
131131553|NCT00574275|472108383|FG001|Overall Study|Operation for curative intent|1|||
131131554|NCT00960843|472108385|FG000|Overall Study|Lost to Follow-up|2|||
130778087|NCT00377637|470815314|FG001|Induction Phase|Sponsor decision|2|||
130778088|NCT00377637|470815315|FG002|Induction Phase|Sponsor decision|0|||
131131555|NCT00960843|472108386|FG001|Overall Study|Lost to Follow-up|0|||
131131556|NCT00960843|472108385|FG000|Overall Study|Protocol Violation|0|||
131131557|NCT00960843|472108386|FG001|Overall Study|Protocol Violation|4|||
131131558|NCT00960843|472108385|FG000|Overall Study|Repeated needle dislodgment|0|||
131131559|NCT00960843|472108386|FG001|Overall Study|Repeated needle dislodgment|1|||
130778089|NCT00377637|470815316|FG003|Induction Phase|Sponsor decision|0|||
130778090|NCT00377637|470815313|FG000|Induction Phase|Non-Compliance|1|||
130778091|NCT00377637|470815314|FG001|Induction Phase|Non-Compliance|0|||
130778092|NCT00377637|470815315|FG002|Induction Phase|Non-Compliance|0|||
130778093|NCT00377637|470815316|FG003|Induction Phase|Non-Compliance|0|||
131227523|NCT00410410|472459749|FG000|Maintenance Period (MP)|Death|0|||
131131560|NCT03873714|472108387|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
131131561|NCT03028870|472108388|FG000|Overall Study|Adverse Event|7|||
131131562|NCT03028870|472108389|FG001|Overall Study|Adverse Event|4|||
131131563|NCT03028870|472108390|FG002|Overall Study|Adverse Event|3|||
131131564|NCT03028870|472108391|FG003|Overall Study|Adverse Event|3|||
131131565|NCT03028870|472108388|FG000|Overall Study|Withdrawal by Subject|1|||
131131566|NCT03028870|472108389|FG001|Overall Study|Withdrawal by Subject|1|||
131131567|NCT03028870|472108390|FG002|Overall Study|Withdrawal by Subject|1|||
131131568|NCT03028870|472108391|FG003|Overall Study|Withdrawal by Subject|2|||
131131569|NCT03028870|472108388|FG000|Overall Study|Lost to Follow-up|1|||
131131570|NCT03028870|472108389|FG001|Overall Study|Lost to Follow-up|0|||
131131571|NCT03028870|472108390|FG002|Overall Study|Lost to Follow-up|0|||
131131572|NCT03028870|472108391|FG003|Overall Study|Lost to Follow-up|0|||
131131573|NCT03028870|472108388|FG000|Overall Study|Lack of Efficacy|3|||
131131574|NCT03028870|472108389|FG001|Overall Study|Lack of Efficacy|0|||
131131575|NCT03028870|472108390|FG002|Overall Study|Lack of Efficacy|0|||
131131576|NCT03028870|472108391|FG003|Overall Study|Lack of Efficacy|0|||
131131577|NCT03028870|472108388|FG000|Overall Study|Administrative|5|||
131131578|NCT03028870|472108389|FG001|Overall Study|Administrative|5|||
131131579|NCT03028870|472108390|FG002|Overall Study|Administrative|12|||
131131580|NCT03028870|472108391|FG003|Overall Study|Administrative|4|||
131131581|NCT00708123|472108392|FG000|Period 1|Protocol Violation|0|||
131131582|NCT00708123|472108393|FG001|Period 1|Protocol Violation|1|||
131131583|NCT00708123|472108394|FG002|Period 1|Protocol Violation|0|||
131131584|NCT00708123|472108395|FG003|Period 1|Protocol Violation|1|||
131131585|NCT00708123|472108396|FG004|Period 1|Protocol Violation|0|||
131131586|NCT00708123|472108392|FG000|Period 1|Adverse Event|0|||
131131587|NCT00708123|472108393|FG001|Period 1|Adverse Event|0|||
131131588|NCT00708123|472108394|FG002|Period 1|Adverse Event|1|||
131131589|NCT00708123|472108395|FG003|Period 1|Adverse Event|0|||
131131590|NCT00708123|472108396|FG004|Period 1|Adverse Event|0|||
131131591|NCT00708123|472108392|FG000|Period 2|Protocol Violation|0|||
131131592|NCT00708123|472108393|FG001|Period 2|Protocol Violation|0|||
131131593|NCT00708123|472108394|FG002|Period 2|Protocol Violation|0|||
131131594|NCT00708123|472108395|FG003|Period 2|Protocol Violation|1|||
131131595|NCT00708123|472108396|FG004|Period 2|Protocol Violation|0|||
131131596|NCT00708123|472108392|FG000|Period 2|Other Reason|1|||
131131597|NCT00708123|472108393|FG001|Period 2|Other Reason|0|||
131131598|NCT00708123|472108394|FG002|Period 2|Other Reason|0|||
131131599|NCT00708123|472108395|FG003|Period 2|Other Reason|0|||
131131600|NCT00708123|472108396|FG004|Period 2|Other Reason|0|||
131131601|NCT00708123|472108392|FG000|Period 3|Lost to Follow-up|0|||
131131602|NCT00708123|472108393|FG001|Period 3|Lost to Follow-up|0|||
131131603|NCT00708123|472108394|FG002|Period 3|Lost to Follow-up|1|||
131131604|NCT00708123|472108395|FG003|Period 3|Lost to Follow-up|1|||
131131605|NCT00708123|472108396|FG004|Period 3|Lost to Follow-up|0|||
131131606|NCT00708123|472108392|FG000|Period 4|Protocol Violation|0|||
131131607|NCT00708123|472108393|FG001|Period 4|Protocol Violation|1|||
131131608|NCT00708123|472108394|FG002|Period 4|Protocol Violation|0|||
131131609|NCT00708123|472108395|FG003|Period 4|Protocol Violation|0|||
131131610|NCT00708123|472108396|FG004|Period 4|Protocol Violation|0|||
131131611|NCT04486950|472108397|FG000|Overall Study|Lost to Follow-up|0|||
131131612|NCT04486950|472108398|FG001|Overall Study|Lost to Follow-up|0|||
131131613|NCT04486950|472108399|FG002|Overall Study|Lost to Follow-up|0|||
131131614|NCT04486950|472108400|FG003|Overall Study|Lost to Follow-up|0|||
130976885|NCT04162769|471541134|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
130976886|NCT04162769|471541135|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
130976887|NCT04162769|471541136|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
130976888|NCT04162769|471541133|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
130976889|NCT04162769|471541134|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
130976890|NCT04162769|471541135|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
130976891|NCT04162769|471541136|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
130976892|NCT04162769|471541133|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
130976893|NCT04162769|471541134|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
130976894|NCT04162769|471541135|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
131131615|NCT04486950|472108401|FG004|Overall Study|Lost to Follow-up|0|||
131131616|NCT04486950|472108402|FG005|Overall Study|Lost to Follow-up|1|||
131131617|NCT04486950|472108403|FG006|Overall Study|Lost to Follow-up|0|||
131131618|NCT04703075|472108404|FG000|Overall Study|Adverse Event|11|||
131131619|NCT04703075|472108405|FG001|Overall Study|Adverse Event|7|||
131131620|NCT04703075|472108404|FG000|Overall Study|Lost to Follow-up|6|||
131131621|NCT04703075|472108405|FG001|Overall Study|Lost to Follow-up|12|||
131131622|NCT04703075|472108404|FG000|Overall Study|Physician Decision|3|||
131131623|NCT04703075|472108405|FG001|Overall Study|Physician Decision|0|||
131131624|NCT04703075|472108404|FG000|Overall Study|Moved|0|||
131131625|NCT04703075|472108405|FG001|Overall Study|Moved|2|||
131131626|NCT04703075|472108404|FG000|Overall Study|Index INH Resistant|0|||
131131627|NCT04703075|472108405|FG001|Overall Study|Index INH Resistant|1|||
131131628|NCT04703075|472108404|FG000|Overall Study|Lack of Efficacy|6|||
130976895|NCT04162769|471541136|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
130976896|NCT04162769|471541133|FG000|Double-blind Treatment (12-Week)|Other|0|||
130976897|NCT04162769|471541134|FG001|Double-blind Treatment (12-Week)|Other|1|||
131131629|NCT04703075|472108405|FG001|Overall Study|Lack of Efficacy|18|||
131131630|NCT01119248|472108406|FG000|Overall Study|Physician Decision|5|||
131131631|NCT01967550|472108407|FG000|Overall Study|Withdrawal by Subject|1|||
131131632|NCT01967550|472108408|FG001|Overall Study|Withdrawal by Subject|0|||
131131633|NCT01967550|472108407|FG000|Overall Study|Adverse Event|2|||
131131634|NCT01967550|472108408|FG001|Overall Study|Adverse Event|0|||
131131635|NCT01967550|472108407|FG000|Overall Study|Protocol Violation|2|||
131131636|NCT01967550|472108408|FG001|Overall Study|Protocol Violation|1|||
131131637|NCT01967550|472108407|FG000|Overall Study|Non Compliance|0|||
131131638|NCT01967550|472108408|FG001|Overall Study|Non Compliance|1|||
131131639|NCT00562354|472108409|FG000|Overall Study|Physician Decision|0|||
131131640|NCT00562354|472108410|FG001|Overall Study|Physician Decision|1|||
131131641|NCT00562354|472108409|FG000|Overall Study|Lost to Follow-up|0|||
131131642|NCT00562354|472108410|FG001|Overall Study|Lost to Follow-up|1|||
131131643|NCT00317109|472108411|FG000|Overall Study|Withdrawal by Subject|2|||
131131644|NCT00317109|472108412|FG001|Overall Study|Withdrawal by Subject|0|||
131131645|NCT00317109|472108411|FG000|Overall Study|Migated/moved from study area|1|||
131131646|NCT00317109|472108412|FG001|Overall Study|Migated/moved from study area|0|||
131131647|NCT01883635|472108416|FG000|Overall Study|Withdrawal by Subject|4|||
131131648|NCT01883635|472108417|FG001|Overall Study|Withdrawal by Subject|0|||
131131649|NCT00761514|472108418|FG000|Overall Study|Adverse Event|1|||
131131650|NCT00761514|472108418|FG000|Overall Study|Withdrawal by Subject|2|||
131131651|NCT00761514|472108418|FG000|Overall Study|Lost to Follow-up|1|||
131131652|NCT00761514|472108418|FG000|Overall Study|Health insurance didn't cover study drug|1|||
131131653|NCT00761514|472108418|FG000|Overall Study|Problem complying with study visit|1|||
131131654|NCT00761514|472108418|FG000|Overall Study|Unable to pay for medications|1|||
131131655|NCT03885089|472108421|FG000|Overall Study|No informed consent for publication of study results|2|||
131131656|NCT01425008|472108430|FG000|Dose Escalation Phase|Progressive Disease|2|||
131131657|NCT01425008|472108431|FG001|Dose Escalation Phase|Progressive Disease|3|||
131131658|NCT01425008|472108432|FG002|Dose Escalation Phase|Progressive Disease|2|||
131131659|NCT01425008|472108433|FG003|Dose Escalation Phase|Progressive Disease|3|||
131131660|NCT01425008|472108434|FG004|Dose Escalation Phase|Progressive Disease|5|||
131131661|NCT01425008|472108435|FG005|Dose Escalation Phase|Progressive Disease|4|||
131131662|NCT01425008|472108436|FG006|Dose Escalation Phase|Progressive Disease|0|||
131131663|NCT01425008|472108437|FG007|Dose Escalation Phase|Progressive Disease|2|||
131131664|NCT01425008|472108438|FG008|Dose Escalation Phase|Progressive Disease|6|||
131131665|NCT01425008|472108439|FG009|Dose Escalation Phase|Progressive Disease|2|||
131227524|NCT00410410|472459750|FG001|Maintenance Period (MP)|Death|0|||
131227525|NCT00410410|472459751|FG002|Maintenance Period (MP)|Death|0|||
130717839|NCT00123474|470593186|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
130717840|NCT00123474|470593187|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
130717841|NCT00123474|470593184|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
130717842|NCT00123474|470593185|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
130717843|NCT00123474|470593186|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
130717844|NCT00123474|470593187|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
130717845|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
130717846|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
130717847|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717848|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717849|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
130717850|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717851|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717852|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717853|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
130717854|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717855|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
130717856|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717857|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717858|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
131227526|NCT00410410|472459752|FG003|Maintenance Period (MP)|Death|0|||
130717859|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717860|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717861|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
131131666|NCT01425008|472108440|FG010|Dose Escalation Phase|Progressive Disease|0|||
131131667|NCT01425008|472108441|FG011|Dose Escalation Phase|Progressive Disease|0|||
131131668|NCT01425008|472108442|FG012|Dose Escalation Phase|Progressive Disease|0|||
131131669|NCT01425008|472108443|FG013|Dose Escalation Phase|Progressive Disease|0|||
131131670|NCT01425008|472108444|FG014|Dose Escalation Phase|Progressive Disease|0|||
131131671|NCT01425008|472108445|FG015|Dose Escalation Phase|Progressive Disease|0|||
131227527|NCT00410410|472459753|FG004|Maintenance Period (MP)|Death|0|||
131043398|NCT05237284|471793113|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
131043399|NCT05237284|471793110|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
131043400|NCT05237284|471793111|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
131043401|NCT05237284|471793112|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
131043402|NCT05237284|471793113|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
131043403|NCT05237284|471793110|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
131043404|NCT05237284|471793111|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
131043405|NCT05237284|471793112|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
131043406|NCT05237284|471793113|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
131043407|NCT05237284|471793110|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
131043408|NCT05237284|471793111|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
131043409|NCT05237284|471793112|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
131043410|NCT05237284|471793113|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
131043411|NCT05237284|471793110|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
131043412|NCT05237284|471793111|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
131227528|NCT00410410|472459754|FG005|Maintenance Period (MP)|Death|0|||
130717862|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130717863|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717864|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
130717865|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717866|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
130717867|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717868|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717869|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717870|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717871|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717872|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717873|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
130717874|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717875|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
130717876|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717877|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717878|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717879|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717880|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130717881|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
130717882|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
130717883|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
130717884|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717885|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
130717886|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717887|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717888|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717889|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717890|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717891|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
130717892|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717893|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717894|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717895|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130778094|NCT00377637|470815313|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
130778095|NCT00377637|470815314|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
131043413|NCT05237284|471793112|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
131043414|NCT05237284|471793113|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
131043415|NCT05237284|471793110|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
131043416|NCT05237284|471793111|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
131043417|NCT05237284|471793112|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
131043418|NCT05237284|471793113|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
131043419|NCT05237284|471793110|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
131043420|NCT05237284|471793111|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
131043421|NCT05237284|471793112|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
131227529|NCT00410410|472459755|FG006|Maintenance Period (MP)|Death|1|||
130717896|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717897|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717898|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130717899|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717900|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717901|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
131043422|NCT05237284|471793113|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
130717902|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
130717903|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717904|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717905|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717906|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717907|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717908|NCT03893565|470593192|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717909|NCT03893565|470593193|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
130717910|NCT03893565|470593194|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
130717911|NCT03893565|470593195|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
130717912|NCT03893565|470593196|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717913|NCT03893565|470593197|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717914|NCT03893565|470593198|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717915|NCT03893565|470593199|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717916|NCT03893565|470593200|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130717917|NCT03893565|470593192|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
130717918|NCT03893565|470593193|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
130717919|NCT03893565|470593194|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
130717920|NCT03893565|470593195|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
130717921|NCT03893565|470593196|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
131043423|NCT05237284|471793110|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
131043424|NCT05237284|471793111|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
131043425|NCT05237284|471793112|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
131043426|NCT05237284|471793113|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
131043427|NCT05237284|471793110|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
131043428|NCT05237284|471793111|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
131043429|NCT05237284|471793112|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
131043430|NCT05237284|471793113|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
131043431|NCT04571619|471793117|FG000|Phase 1|Death|22|||
131043432|NCT04571619|471793118|FG001|Phase 1|Death|18|||
131043433|NCT04571619|471793117|FG000|Phase 1|Withdrawal by Subject|7|||
131043434|NCT04571619|471793118|FG001|Phase 1|Withdrawal by Subject|2|||
131043435|NCT04571619|471793117|FG000|Phase 2|Death|13|||
131043436|NCT04571619|471793118|FG001|Phase 2|Death|16|||
131043437|NCT04571619|471793117|FG000|Phase 2|Withdrawal by Subject|6|||
131043438|NCT04571619|471793118|FG001|Phase 2|Withdrawal by Subject|4|||
131043439|NCT02780700|471793128|FG000|Overall Study|Progressive disease|1|||
131043440|NCT04218851|471793137|FG000|Overall Study|Death|1|||
131043441|NCT04218851|471793138|FG001|Overall Study|Death|3|||
131043442|NCT05285137|471793139|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
131043443|NCT05285137|471793140|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
131043444|NCT05285137|471793141|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
131043445|NCT05285137|471793142|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
131043446|NCT05285137|471793143|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
131043447|NCT05285137|471793144|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
131043448|NCT05285137|471793145|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
131043449|NCT05285137|471793146|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
131043450|NCT05285137|471793147|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
131043451|NCT05285137|471793139|FG000|Overall Study|Lost to Follow-up|0|||
131043452|NCT05285137|471793140|FG001|Overall Study|Lost to Follow-up|0|||
131043453|NCT05285137|471793141|FG002|Overall Study|Lost to Follow-up|1|||
131043454|NCT05285137|471793142|FG003|Overall Study|Lost to Follow-up|3|||
131043455|NCT05285137|471793143|FG004|Overall Study|Lost to Follow-up|0|||
131043456|NCT05285137|471793144|FG005|Overall Study|Lost to Follow-up|0|||
131043457|NCT05285137|471793145|FG006|Overall Study|Lost to Follow-up|1|||
131043458|NCT05285137|471793146|FG007|Overall Study|Lost to Follow-up|0|||
131043459|NCT05285137|471793147|FG008|Overall Study|Lost to Follow-up|0|||
131043460|NCT05285137|471793139|FG000|Overall Study|Physician Decision|0|||
131043461|NCT05285137|471793140|FG001|Overall Study|Physician Decision|1|||
131043462|NCT05285137|471793141|FG002|Overall Study|Physician Decision|0|||
131043463|NCT05285137|471793142|FG003|Overall Study|Physician Decision|0|||
131043464|NCT05285137|471793143|FG004|Overall Study|Physician Decision|0|||
131043465|NCT05285137|471793144|FG005|Overall Study|Physician Decision|0|||
130778096|NCT00377637|470815315|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
130778097|NCT00377637|470815316|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
130778098|NCT00377637|470815313|FG000|Maintenance Phase|Adverse Event|0|||
130778099|NCT00377637|470815314|FG001|Maintenance Phase|Adverse Event|0|||
130778100|NCT00377637|470815315|FG002|Maintenance Phase|Adverse Event|29|||
130778101|NCT00377637|470815316|FG003|Maintenance Phase|Adverse Event|43|||
130778102|NCT00377637|470815313|FG000|Maintenance Phase|Physician Decision|0|||
130778103|NCT00377637|470815314|FG001|Maintenance Phase|Physician Decision|0|||
130778104|NCT00377637|470815315|FG002|Maintenance Phase|Physician Decision|5|||
130778105|NCT00377637|470815316|FG003|Maintenance Phase|Physician Decision|4|||
130778106|NCT00377637|470815313|FG000|Maintenance Phase|Lost to Follow-up|0|||
130778107|NCT00377637|470815314|FG001|Maintenance Phase|Lost to Follow-up|0|||
130778108|NCT00377637|470815315|FG002|Maintenance Phase|Lost to Follow-up|3|||
130778109|NCT00377637|470815316|FG003|Maintenance Phase|Lost to Follow-up|1|||
130778110|NCT00377637|470815313|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130778111|NCT00377637|470815314|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130778112|NCT00377637|470815315|FG002|Maintenance Phase|Withdrawal by Subject|3|||
130778113|NCT00377637|470815316|FG003|Maintenance Phase|Withdrawal by Subject|3|||
130778114|NCT00377637|470815313|FG000|Maintenance Phase|Sponsor decision|0|||
130778115|NCT00377637|470815314|FG001|Maintenance Phase|Sponsor decision|0|||
130778116|NCT00377637|470815315|FG002|Maintenance Phase|Sponsor decision|2|||
130778117|NCT00377637|470815316|FG003|Maintenance Phase|Sponsor decision|3|||
130778118|NCT00377637|470815313|FG000|Maintenance Phase|Non-compliance|0|||
130778119|NCT00377637|470815314|FG001|Maintenance Phase|Non-compliance|0|||
130778120|NCT00377637|470815315|FG002|Maintenance Phase|Non-compliance|1|||
130778121|NCT00377637|470815316|FG003|Maintenance Phase|Non-compliance|1|||
130778122|NCT00377637|470815313|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
130778123|NCT00377637|470815314|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
130778124|NCT00377637|470815315|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
130778125|NCT00377637|470815316|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
130778126|NCT00377637|470815313|FG000|Maintenance Phase|Death|0|||
130778127|NCT00377637|470815314|FG001|Maintenance Phase|Death|0|||
130778128|NCT00377637|470815315|FG002|Maintenance Phase|Death|0|||
130778129|NCT00377637|470815316|FG003|Maintenance Phase|Death|1|||
130778130|NCT00994110|470815318|FG000|Overall Study|Withdrawal by Subject|9|||
130778131|NCT00994110|470815319|FG001|Overall Study|Withdrawal by Subject|9|||
130778132|NCT00994110|470815318|FG000|Overall Study|Not Treated|4|||
130778133|NCT00994110|470815319|FG001|Overall Study|Not Treated|8|||
130778134|NCT00994110|470815318|FG000|Overall Study|Adverse Event|1|||
130778135|NCT00994110|470815319|FG001|Overall Study|Adverse Event|0|||
130778136|NCT00994110|470815318|FG000|Overall Study|Patient not resected|41|||
130778137|NCT00994110|470815319|FG001|Overall Study|Patient not resected|52|||
130778138|NCT00994110|470815318|FG000|Overall Study|Pt not eligible|10|||
130778139|NCT00994110|470815319|FG001|Overall Study|Pt not eligible|5|||
130778140|NCT00368108|470815320|FG000|Overall Study|Adverse Event|38|||
130778141|NCT00368108|470815321|FG001|Overall Study|Adverse Event|26|||
130778142|NCT00368108|470815322|FG002|Overall Study|Adverse Event|44|||
130778143|NCT00368108|470815320|FG000|Overall Study|Abnormal Laboratory Value|0|||
130778144|NCT00368108|470815321|FG001|Overall Study|Abnormal Laboratory Value|0|||
130778145|NCT00368108|470815322|FG002|Overall Study|Abnormal Laboratory Value|3|||
130778146|NCT00368108|470815320|FG000|Overall Study|Protocol Violation|5|||
130778147|NCT00368108|470815321|FG001|Overall Study|Protocol Violation|9|||
130778148|NCT00368108|470815322|FG002|Overall Study|Protocol Violation|9|||
131043466|NCT05285137|471793145|FG006|Overall Study|Physician Decision|0|||
130778149|NCT00368108|470815320|FG000|Overall Study|Withdrawal by Subject|9|||
130778150|NCT00368108|470815321|FG001|Overall Study|Withdrawal by Subject|3|||
130778151|NCT00368108|470815322|FG002|Overall Study|Withdrawal by Subject|5|||
130778152|NCT00368108|470815320|FG000|Overall Study|Lack of Efficacy|7|||
130778153|NCT00368108|470815321|FG001|Overall Study|Lack of Efficacy|8|||
130778154|NCT00368108|470815322|FG002|Overall Study|Lack of Efficacy|5|||
130778155|NCT00368108|470815320|FG000|Overall Study|Physician Decision|2|||
130778156|NCT00368108|470815321|FG001|Overall Study|Physician Decision|0|||
130778157|NCT00368108|470815322|FG002|Overall Study|Physician Decision|1|||
130778158|NCT00368108|470815320|FG000|Overall Study|Other|3|||
130778159|NCT00368108|470815321|FG001|Overall Study|Other|7|||
130778160|NCT00368108|470815322|FG002|Overall Study|Other|1|||
130778161|NCT00130689|470815323|FG000|Overall Study|Progressive Disease|29|||
130778162|NCT00130689|470815323|FG000|Overall Study|Death|1|||
130778163|NCT00130689|470815323|FG000|Overall Study|Clinical Deterioration|4|||
130778164|NCT00130689|470815323|FG000|Overall Study|Withdrawal by Subject|3|||
130778165|NCT00130689|470815323|FG000|Overall Study|Ineligible|6|||
130778166|NCT01254656|470815324|FG000|Overall Study|Discontinued due to termination of study|40|||
130778167|NCT01254656|470815325|FG001|Overall Study|Discontinued due to termination of study|39|||
130778168|NCT01254656|470815326|FG002|Overall Study|Discontinued due to termination of study|13|||
130778169|NCT01254656|470815324|FG000|Overall Study|Lack of Efficacy|3|||
130778170|NCT01254656|470815325|FG001|Overall Study|Lack of Efficacy|0|||
130778171|NCT01254656|470815326|FG002|Overall Study|Lack of Efficacy|0|||
130778172|NCT01254656|470815324|FG000|Overall Study|Lost to Follow-up|1|||
131131672|NCT01425008|472108446|FG016|Dose Escalation Phase|Progressive Disease|0|||
131131673|NCT01425008|472108447|FG017|Dose Escalation Phase|Progressive Disease|0|||
131131674|NCT01425008|472108448|FG018|Dose Escalation Phase|Progressive Disease|0|||
131131675|NCT01425008|472108430|FG000|Dose Escalation Phase|Adverse Event|2|||
131131676|NCT01425008|472108431|FG001|Dose Escalation Phase|Adverse Event|0|||
131131677|NCT01425008|472108432|FG002|Dose Escalation Phase|Adverse Event|0|||
131131678|NCT01425008|472108433|FG003|Dose Escalation Phase|Adverse Event|0|||
131131679|NCT01425008|472108434|FG004|Dose Escalation Phase|Adverse Event|0|||
131131680|NCT01425008|472108435|FG005|Dose Escalation Phase|Adverse Event|2|||
131131681|NCT01425008|472108436|FG006|Dose Escalation Phase|Adverse Event|0|||
131131682|NCT01425008|472108437|FG007|Dose Escalation Phase|Adverse Event|0|||
130778173|NCT01254656|470815325|FG001|Overall Study|Lost to Follow-up|0|||
130778174|NCT01254656|470815326|FG002|Overall Study|Lost to Follow-up|2|||
130778175|NCT01254656|470815324|FG000|Overall Study|Withdrawal by Subject|2|||
130778176|NCT01254656|470815325|FG001|Overall Study|Withdrawal by Subject|2|||
130778177|NCT01254656|470815326|FG002|Overall Study|Withdrawal by Subject|1|||
130778178|NCT01254656|470815324|FG000|Overall Study|Pregnancy|0|||
131131683|NCT01425008|472108438|FG008|Dose Escalation Phase|Adverse Event|2|||
131131684|NCT01425008|472108439|FG009|Dose Escalation Phase|Adverse Event|0|||
131131685|NCT01425008|472108440|FG010|Dose Escalation Phase|Adverse Event|0|||
131131686|NCT01425008|472108441|FG011|Dose Escalation Phase|Adverse Event|0|||
130778179|NCT01254656|470815325|FG001|Overall Study|Pregnancy|0|||
130976898|NCT04162769|471541135|FG002|Double-blind Treatment (12-Week)|Other|1|||
131131687|NCT01425008|472108442|FG012|Dose Escalation Phase|Adverse Event|0|||
131131688|NCT01425008|472108443|FG013|Dose Escalation Phase|Adverse Event|0|||
131131689|NCT01425008|472108444|FG014|Dose Escalation Phase|Adverse Event|0|||
131131690|NCT01425008|472108445|FG015|Dose Escalation Phase|Adverse Event|0|||
131131691|NCT01425008|472108446|FG016|Dose Escalation Phase|Adverse Event|0|||
131131692|NCT01425008|472108447|FG017|Dose Escalation Phase|Adverse Event|0|||
131131693|NCT01425008|472108448|FG018|Dose Escalation Phase|Adverse Event|0|||
131131694|NCT01425008|472108430|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131695|NCT01425008|472108431|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131696|NCT01425008|472108432|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131697|NCT01425008|472108433|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131698|NCT01425008|472108434|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
131131699|NCT01425008|472108435|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131700|NCT01425008|472108436|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
131131701|NCT01425008|472108437|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
131131702|NCT01425008|472108438|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
131131703|NCT01425008|472108439|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131704|NCT01425008|472108440|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131227530|NCT00410410|472459756|FG007|Maintenance Period (MP)|Death|0|||
131227531|NCT00410410|472459757|FG008|Maintenance Period (MP)|Death|0|||
130976899|NCT04162769|471541136|FG003|Double-blind Treatment (12-Week)|Other|0|||
130976900|NCT04162769|471541133|FG000|OLE Period (52-Week)|Adverse Event|0|||
130976901|NCT04162769|471541134|FG001|OLE Period (52-Week)|Adverse Event|0|||
130976902|NCT04162769|471541135|FG002|OLE Period (52-Week)|Adverse Event|0|||
130976903|NCT04162769|471541136|FG003|OLE Period (52-Week)|Adverse Event|5|||
130976904|NCT04162769|471541133|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
130976905|NCT04162769|471541134|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
130976906|NCT04162769|471541135|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
130976907|NCT04162769|471541136|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
130976908|NCT04162769|471541133|FG000|OLE Period (52-Week)|Physician Decision|0|||
130976909|NCT04162769|471541134|FG001|OLE Period (52-Week)|Physician Decision|0|||
130976910|NCT04162769|471541135|FG002|OLE Period (52-Week)|Physician Decision|0|||
130976911|NCT04162769|471541136|FG003|OLE Period (52-Week)|Physician Decision|1|||
130976912|NCT04162769|471541133|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
130976913|NCT04162769|471541134|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
130976914|NCT04162769|471541135|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
130976915|NCT04162769|471541136|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
130976916|NCT04162769|471541133|FG000|OLE Period (52-Week)|Protocol deviation|0|||
130976917|NCT04162769|471541134|FG001|OLE Period (52-Week)|Protocol deviation|0|||
130976918|NCT04162769|471541135|FG002|OLE Period (52-Week)|Protocol deviation|0|||
130976919|NCT04162769|471541136|FG003|OLE Period (52-Week)|Protocol deviation|2|||
131131705|NCT01425008|472108441|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131706|NCT01425008|472108442|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131227532|NCT00410410|472459749|FG000|Maintenance Period (MP)|Adverse Event|0|||
131131707|NCT01425008|472108443|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131708|NCT01425008|472108444|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130778180|NCT01254656|470815326|FG002|Overall Study|Pregnancy|2|||
130778181|NCT01254656|470815324|FG000|Overall Study|Adverse Event|1|||
130976920|NCT00725452|471541140|FG000|Overall Study|Adverse Event|3|||
130976921|NCT00725452|471541140|FG000|Overall Study|Lack of Efficacy|2|||
131131709|NCT01425008|472108445|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131710|NCT01425008|472108446|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131711|NCT01425008|472108447|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131712|NCT01425008|472108448|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131131713|NCT01425008|472108430|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
131131714|NCT01425008|472108431|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
131131715|NCT01425008|472108432|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
131131716|NCT01425008|472108433|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131131717|NCT01425008|472108434|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
131131718|NCT01425008|472108435|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
131131719|NCT01425008|472108436|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
131131720|NCT01425008|472108437|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
131131721|NCT01425008|472108438|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
131131722|NCT01425008|472108439|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
131131723|NCT01425008|472108440|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
131131724|NCT01425008|472108441|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
131131725|NCT01425008|472108442|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
131131726|NCT01425008|472108443|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
131131727|NCT01425008|472108444|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
130717922|NCT03893565|470593197|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
130717923|NCT03893565|470593198|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
130717924|NCT03893565|470593199|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
130717925|NCT03893565|470593200|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
130717926|NCT03893565|470593192|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717927|NCT03893565|470593193|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717928|NCT03893565|470593194|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717929|NCT03893565|470593195|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717930|NCT03893565|470593196|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717931|NCT03893565|470593197|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717932|NCT03893565|470593198|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
130717933|NCT03893565|470593199|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130717934|NCT03893565|470593200|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130976922|NCT00725452|471541140|FG000|Overall Study|Reason not specified|1|||
130976923|NCT00725452|471541140|FG000|Overall Study|Physician Decision|1|||
130976924|NCT00725452|471541140|FG000|Overall Study|Withdrawal by Subject|3|||
130976925|NCT00725452|471541140|FG000|Overall Study|Lost to Follow-up|1|||
130976926|NCT00620750|471541141|FG000|Overall Study|Lost to Follow-up|25|||
130976927|NCT00746590|471541142|FG000|Overall Study|Death|1|||
130976928|NCT04402866|471541144|FG000|Overall Study|Discontinued Prior to Treatment|0|||
130976929|NCT04402866|471541145|FG001|Overall Study|Discontinued Prior to Treatment|0|||
130976930|NCT04402866|471541146|FG002|Overall Study|Discontinued Prior to Treatment|0|||
130976931|NCT04402866|471541147|FG003|Overall Study|Discontinued Prior to Treatment|0|||
130976932|NCT04402866|471541148|FG004|Overall Study|Discontinued Prior to Treatment|2|||
130976933|NCT04402866|471541149|FG005|Overall Study|Discontinued Prior to Treatment|3|||
130976934|NCT04402866|471541144|FG000|Overall Study|Adverse Event|2|||
130976935|NCT04402866|471541145|FG001|Overall Study|Adverse Event|1|||
130976936|NCT04402866|471541146|FG002|Overall Study|Adverse Event|0|||
130976937|NCT04402866|471541147|FG003|Overall Study|Adverse Event|0|||
130976938|NCT04402866|471541148|FG004|Overall Study|Adverse Event|13|||
130976939|NCT04402866|471541149|FG005|Overall Study|Adverse Event|8|||
130976940|NCT04402866|471541144|FG000|Overall Study|Miscellaneous|0|||
130976941|NCT04402866|471541145|FG001|Overall Study|Miscellaneous|0|||
130976942|NCT04402866|471541146|FG002|Overall Study|Miscellaneous|1|||
130976943|NCT04402866|471541147|FG003|Overall Study|Miscellaneous|0|||
130976944|NCT04402866|471541148|FG004|Overall Study|Miscellaneous|0|||
130976945|NCT04402866|471541149|FG005|Overall Study|Miscellaneous|0|||
130976946|NCT04402866|471541144|FG000|Overall Study|Lost to Follow-up|0|||
130976947|NCT04402866|471541145|FG001|Overall Study|Lost to Follow-up|0|||
130976948|NCT04402866|471541146|FG002|Overall Study|Lost to Follow-up|0|||
130976949|NCT04402866|471541147|FG003|Overall Study|Lost to Follow-up|0|||
130976950|NCT04402866|471541148|FG004|Overall Study|Lost to Follow-up|0|||
130976951|NCT04402866|471541149|FG005|Overall Study|Lost to Follow-up|1|||
130976952|NCT04402866|471541144|FG000|Overall Study|Withdrawal by Subject|0|||
130976953|NCT04402866|471541145|FG001|Overall Study|Withdrawal by Subject|0|||
130976954|NCT04402866|471541146|FG002|Overall Study|Withdrawal by Subject|0|||
131131728|NCT01425008|472108445|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
131131729|NCT01425008|472108446|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
131227533|NCT00410410|472459750|FG001|Maintenance Period (MP)|Adverse Event|0|||
130976955|NCT04402866|471541147|FG003|Overall Study|Withdrawal by Subject|0|||
130976956|NCT04402866|471541148|FG004|Overall Study|Withdrawal by Subject|0|||
130976957|NCT04402866|471541149|FG005|Overall Study|Withdrawal by Subject|2|||
130976958|NCT00476476|471541156|FG000|Overall Study|Adverse Event|2|||
130720905|NCT01341782|470601558|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
130976959|NCT00476476|471541157|FG001|Overall Study|Adverse Event|7|||
130976960|NCT00476476|471541156|FG000|Overall Study|Progressive Disease|0|||
130976961|NCT00476476|471541157|FG001|Overall Study|Progressive Disease|17|||
130976962|NCT02633137|471541165|FG000|Overall Study|Adverse Event|1|||
130976963|NCT02633137|471541165|FG000|Overall Study|Lack of Efficacy|2|||
130976964|NCT02633137|471541165|FG000|Overall Study|Withdrawal by Subject|1|||
130976965|NCT01972841|471541168|FG000|Overall Study|Randomized but Never Received Treatment|2|||
130976966|NCT01972841|471541169|FG001|Overall Study|Randomized but Never Received Treatment|5|||
130976967|NCT01972841|471541170|FG002|Overall Study|Randomized but Never Received Treatment|4|||
130976968|NCT01972841|471541171|FG003|Overall Study|Randomized but Never Received Treatment|2|||
130976969|NCT01972841|471541172|FG004|Overall Study|Randomized but Never Received Treatment|6|||
130976970|NCT01972841|471541173|FG005|Overall Study|Randomized but Never Received Treatment|13|||
130976971|NCT01972841|471541168|FG000|Overall Study|Adverse Event|13|||
130976972|NCT01972841|471541169|FG001|Overall Study|Adverse Event|8|||
130976973|NCT01972841|471541170|FG002|Overall Study|Adverse Event|12|||
130976974|NCT01972841|471541171|FG003|Overall Study|Adverse Event|9|||
130976975|NCT01972841|471541172|FG004|Overall Study|Adverse Event|21|||
130976976|NCT01972841|471541173|FG005|Overall Study|Adverse Event|26|||
130976977|NCT01972841|471541168|FG000|Overall Study|Lack of Efficacy|1|||
130976978|NCT01972841|471541169|FG001|Overall Study|Lack of Efficacy|0|||
130976979|NCT01972841|471541170|FG002|Overall Study|Lack of Efficacy|0|||
130976980|NCT01972841|471541171|FG003|Overall Study|Lack of Efficacy|2|||
130976981|NCT01972841|471541172|FG004|Overall Study|Lack of Efficacy|4|||
130976982|NCT01972841|471541173|FG005|Overall Study|Lack of Efficacy|1|||
130976983|NCT01972841|471541168|FG000|Overall Study|Lost to Follow-up|4|||
130976984|NCT01972841|471541169|FG001|Overall Study|Lost to Follow-up|2|||
130976985|NCT01972841|471541170|FG002|Overall Study|Lost to Follow-up|4|||
130976986|NCT01972841|471541171|FG003|Overall Study|Lost to Follow-up|2|||
130976987|NCT01972841|471541172|FG004|Overall Study|Lost to Follow-up|9|||
130976988|NCT01972841|471541173|FG005|Overall Study|Lost to Follow-up|3|||
130976989|NCT01972841|471541168|FG000|Overall Study|Protocol Violation|2|||
130976990|NCT01972841|471541169|FG001|Overall Study|Protocol Violation|2|||
130976991|NCT01972841|471541170|FG002|Overall Study|Protocol Violation|3|||
130976992|NCT01972841|471541171|FG003|Overall Study|Protocol Violation|5|||
130976993|NCT01972841|471541172|FG004|Overall Study|Protocol Violation|9|||
130976994|NCT01972841|471541173|FG005|Overall Study|Protocol Violation|4|||
130976995|NCT01972841|471541168|FG000|Overall Study|Withdrawal by participants|21|||
130976996|NCT01972841|471541169|FG001|Overall Study|Withdrawal by participants|27|||
130976997|NCT01972841|471541170|FG002|Overall Study|Withdrawal by participants|23|||
130976998|NCT01972841|471541171|FG003|Overall Study|Withdrawal by participants|16|||
130976999|NCT01972841|471541172|FG004|Overall Study|Withdrawal by participants|33|||
130977000|NCT01972841|471541173|FG005|Overall Study|Withdrawal by participants|34|||
130977001|NCT01972841|471541168|FG000|Overall Study|Miscellaneous|0|||
130977002|NCT01972841|471541169|FG001|Overall Study|Miscellaneous|0|||
130977003|NCT01972841|471541170|FG002|Overall Study|Miscellaneous|4|||
130977004|NCT01972841|471541171|FG003|Overall Study|Miscellaneous|1|||
130977005|NCT01972841|471541172|FG004|Overall Study|Miscellaneous|0|||
130977006|NCT01972841|471541173|FG005|Overall Study|Miscellaneous|4|||
130977007|NCT01972841|471541168|FG000|Overall Study|Did not have end of treatment page|0|||
130977008|NCT01972841|471541169|FG001|Overall Study|Did not have end of treatment page|0|||
130977009|NCT01972841|471541170|FG002|Overall Study|Did not have end of treatment page|0|||
130977010|NCT01972841|471541171|FG003|Overall Study|Did not have end of treatment page|0|||
130977011|NCT01972841|471541172|FG004|Overall Study|Did not have end of treatment page|1|||
130977012|NCT01972841|471541173|FG005|Overall Study|Did not have end of treatment page|0|||
130977013|NCT03644186|471541174|FG000|Overall Study|Withdrawal by Subject|1|||
130977014|NCT03644186|471541175|FG001|Overall Study|Withdrawal by Subject|1|||
130977015|NCT04391023|471541179|FG000|Overall Study|Withdrawal by Subject|2|||
130977016|NCT04391023|471541180|FG001|Overall Study|Withdrawal by Subject|2|||
130977017|NCT02308748|471541183|FG000|Period 1|Withdrawal by Subject|0|||
130977018|NCT02308748|471541184|FG001|Period 1|Withdrawal by Subject|0|||
130977019|NCT02308748|471541185|FG002|Period 1|Withdrawal by Subject|1|||
130977020|NCT02308748|471541186|FG003|Period 1|Withdrawal by Subject|0|||
131131730|NCT01425008|472108447|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
131131731|NCT01425008|472108448|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
130977021|NCT02308748|471541187|FG004|Period 1|Withdrawal by Subject|0|||
130977022|NCT02308748|471541188|FG005|Period 1|Withdrawal by Subject|0|||
130977023|NCT02308748|471541189|FG006|Period 1|Withdrawal by Subject|0|||
130977024|NCT02308748|471541190|FG007|Period 1|Withdrawal by Subject|0|||
130977025|NCT02308748|471541191|FG008|Period 1|Withdrawal by Subject|0|||
130977026|NCT02308748|471541192|FG009|Period 1|Withdrawal by Subject|0|||
130977027|NCT02308748|471541183|FG000|Period 2|Adverse Event|0|||
130977028|NCT02308748|471541184|FG001|Period 2|Adverse Event|0|||
130977029|NCT02308748|471541185|FG002|Period 2|Adverse Event|0|||
131131732|NCT01425008|472108430|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
130977030|NCT02308748|471541186|FG003|Period 2|Adverse Event|0|||
130977031|NCT02308748|471541187|FG004|Period 2|Adverse Event|0|||
130977032|NCT02308748|471541188|FG005|Period 2|Adverse Event|0|||
130717935|NCT03893565|470593192|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130717936|NCT03893565|470593193|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130977033|NCT02308748|471541189|FG006|Period 2|Adverse Event|0|||
130977034|NCT02308748|471541190|FG007|Period 2|Adverse Event|1|||
130977035|NCT02308748|471541191|FG008|Period 2|Adverse Event|0|||
130977036|NCT02308748|471541192|FG009|Period 2|Adverse Event|0|||
130977037|NCT02308748|471541183|FG000|Period 3|Protocol Violation|0|||
130977038|NCT02308748|471541184|FG001|Period 3|Protocol Violation|0|||
130977039|NCT02308748|471541185|FG002|Period 3|Protocol Violation|0|||
130977040|NCT02308748|471541186|FG003|Period 3|Protocol Violation|0|||
130977041|NCT02308748|471541187|FG004|Period 3|Protocol Violation|0|||
130977042|NCT02308748|471541188|FG005|Period 3|Protocol Violation|0|||
130977043|NCT02308748|471541189|FG006|Period 3|Protocol Violation|0|||
130977044|NCT02308748|471541190|FG007|Period 3|Protocol Violation|0|||
130977045|NCT02308748|471541191|FG008|Period 3|Protocol Violation|0|||
130977046|NCT02308748|471541192|FG009|Period 3|Protocol Violation|1|||
130977047|NCT02308748|471541183|FG000|Period 5|Adverse Event|1|||
130977048|NCT02308748|471541184|FG001|Period 5|Adverse Event|0|||
130977049|NCT02308748|471541185|FG002|Period 5|Adverse Event|0|||
130977050|NCT02308748|471541186|FG003|Period 5|Adverse Event|0|||
130977051|NCT02308748|471541187|FG004|Period 5|Adverse Event|0|||
130977052|NCT02308748|471541188|FG005|Period 5|Adverse Event|0|||
130977053|NCT02308748|471541189|FG006|Period 5|Adverse Event|0|||
130977054|NCT02308748|471541190|FG007|Period 5|Adverse Event|0|||
130977055|NCT02308748|471541191|FG008|Period 5|Adverse Event|1|||
130977056|NCT02308748|471541192|FG009|Period 5|Adverse Event|0|||
130977057|NCT03570619|471541198|FG000|Overall Study|Adverse Event|2|||
130977058|NCT03570619|471541199|FG001|Overall Study|Adverse Event|0|||
130977059|NCT03570619|471541200|FG002|Overall Study|Adverse Event|1|||
130977060|NCT03570619|471541198|FG000|Overall Study|new diagnosis of new malignancy|1|||
130977061|NCT03570619|471541199|FG001|Overall Study|new diagnosis of new malignancy|0|||
130977062|NCT03570619|471541200|FG002|Overall Study|new diagnosis of new malignancy|0|||
130977063|NCT03570619|471541198|FG000|Overall Study|Physician Decision|1|||
130977064|NCT03570619|471541199|FG001|Overall Study|Physician Decision|1|||
130977065|NCT03570619|471541200|FG002|Overall Study|Physician Decision|0|||
130977066|NCT03570619|471541198|FG000|Overall Study|Withdrawal by Subject|0|||
130977067|NCT03570619|471541199|FG001|Overall Study|Withdrawal by Subject|2|||
131043467|NCT05285137|471793146|FG007|Overall Study|Physician Decision|0|||
131043468|NCT05285137|471793147|FG008|Overall Study|Physician Decision|0|||
131043469|NCT05285137|471793139|FG000|Overall Study|Pregnancy|0|||
131043470|NCT05285137|471793140|FG001|Overall Study|Pregnancy|0|||
131043471|NCT05285137|471793141|FG002|Overall Study|Pregnancy|0|||
131043472|NCT05285137|471793142|FG003|Overall Study|Pregnancy|0|||
131043473|NCT05285137|471793143|FG004|Overall Study|Pregnancy|0|||
131043474|NCT05285137|471793144|FG005|Overall Study|Pregnancy|0|||
131043475|NCT05285137|471793145|FG006|Overall Study|Pregnancy|1|||
131043476|NCT05285137|471793146|FG007|Overall Study|Pregnancy|0|||
131043477|NCT05285137|471793147|FG008|Overall Study|Pregnancy|0|||
131043478|NCT05285137|471793139|FG000|Overall Study|Withdrawal by Subject|0|||
131043479|NCT05285137|471793140|FG001|Overall Study|Withdrawal by Subject|1|||
131043480|NCT05285137|471793141|FG002|Overall Study|Withdrawal by Subject|2|||
131043481|NCT05285137|471793142|FG003|Overall Study|Withdrawal by Subject|1|||
131043482|NCT05285137|471793143|FG004|Overall Study|Withdrawal by Subject|0|||
131043483|NCT05285137|471793144|FG005|Overall Study|Withdrawal by Subject|0|||
131043484|NCT05285137|471793145|FG006|Overall Study|Withdrawal by Subject|0|||
131043485|NCT05285137|471793146|FG007|Overall Study|Withdrawal by Subject|0|||
131043486|NCT05285137|471793147|FG008|Overall Study|Withdrawal by Subject|1|||
131043487|NCT03484819|471793148|FG000|Overall Study|Death|2|||
131043488|NCT03484819|471793148|FG000|Overall Study|Adverse Event|2|||
131043489|NCT03484819|471793148|FG000|Overall Study|Physician Decision|1|||
131043490|NCT03484819|471793148|FG000|Overall Study|Withdrawal by Subject|2|||
131043491|NCT03484819|471793148|FG000|Overall Study|Disease Progression|4|||
131043492|NCT03484819|471793148|FG000|Overall Study|Complicating Condition|1|||
131045889|NCT03812614|471802294|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
131045890|NCT03812614|471802295|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
131045891|NCT03812614|471802292|FG000|6-month Follow-up|Lost to Follow-up|0|||
131045892|NCT03812614|471802293|FG001|6-month Follow-up|Lost to Follow-up|0|||
131045893|NCT03812614|471802294|FG002|6-month Follow-up|Lost to Follow-up|12|||
130977068|NCT03570619|471541200|FG002|Overall Study|Withdrawal by Subject|0|||
130977069|NCT01565707|471541203|FG000|Overall Study|Adverse Event|1|||
131045894|NCT03812614|471802295|FG003|6-month Follow-up|Lost to Follow-up|8|||
131045895|NCT03812614|471802292|FG000|12-month Follow-up|Lost to Follow-up|18|||
131045896|NCT03812614|471802293|FG001|12-month Follow-up|Lost to Follow-up|17|||
131045897|NCT03812614|471802294|FG002|12-month Follow-up|Lost to Follow-up|5|||
131045898|NCT03812614|471802295|FG003|12-month Follow-up|Lost to Follow-up|2|||
130977070|NCT01565707|471541204|FG001|Overall Study|Adverse Event|6|||
130977071|NCT01565707|471541205|FG002|Overall Study|Adverse Event|2|||
130977072|NCT01565707|471541206|FG003|Overall Study|Adverse Event|1|||
131227534|NCT00410410|472459751|FG002|Maintenance Period (MP)|Adverse Event|0|||
130720906|NCT01341782|470601557|FG000|Overall Study|Other|5|||
130977073|NCT01565707|471541203|FG000|Overall Study|Lost to Follow-up|1|||
130977074|NCT01565707|471541204|FG001|Overall Study|Lost to Follow-up|0|||
130977075|NCT01565707|471541205|FG002|Overall Study|Lost to Follow-up|0|||
130977076|NCT01565707|471541206|FG003|Overall Study|Lost to Follow-up|0|||
130977077|NCT01565707|471541203|FG000|Overall Study|Protocol Violation|1|||
130977078|NCT01565707|471541204|FG001|Overall Study|Protocol Violation|0|||
130977079|NCT01565707|471541205|FG002|Overall Study|Protocol Violation|0|||
130977080|NCT01565707|471541206|FG003|Overall Study|Protocol Violation|1|||
130977081|NCT01565707|471541203|FG000|Overall Study|Withdrawal by Subject|3|||
130977082|NCT01565707|471541204|FG001|Overall Study|Withdrawal by Subject|1|||
130977083|NCT01565707|471541205|FG002|Overall Study|Withdrawal by Subject|1|||
130977084|NCT01565707|471541206|FG003|Overall Study|Withdrawal by Subject|1|||
130977085|NCT01565707|471541203|FG000|Overall Study|Randomized but not evaluable|2|||
130977086|NCT01565707|471541204|FG001|Overall Study|Randomized but not evaluable|0|||
130977087|NCT01565707|471541205|FG002|Overall Study|Randomized but not evaluable|0|||
130977088|NCT01565707|471541206|FG003|Overall Study|Randomized but not evaluable|0|||
130977089|NCT01565707|471541203|FG000|Overall Study|Miscellaneous|1|||
130977090|NCT01565707|471541204|FG001|Overall Study|Miscellaneous|1|||
130977091|NCT01565707|471541205|FG002|Overall Study|Miscellaneous|0|||
130977092|NCT01565707|471541206|FG003|Overall Study|Miscellaneous|2|||
130977093|NCT00983073|471541211|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
130977094|NCT00983073|471541211|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
130977095|NCT00983073|471541211|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
130977096|NCT00983073|471541211|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
130977097|NCT00983073|471541211|FG000|Titration and Optimal Dose Period|Other reason|4|||
130977098|NCT00983073|471541211|FG000|Maintenance Period|Adverse Event|5|||
130977099|NCT00983073|471541211|FG000|Maintenance Period|Withdrawal by Subject|2|||
130977100|NCT00983073|471541211|FG000|Maintenance Period|Lack of Efficacy|2|||
130977101|NCT00983073|471541211|FG000|Maintenance Period|Other Reason|7|||
130977102|NCT05374421|471541212|FG000|Overall Study|Withdrawal by Subject|3|||
130977103|NCT05374421|471541213|FG001|Overall Study|Withdrawal by Subject|4|||
130977104|NCT05557942|471541214|FG000|Overall Study|Death|0|||
130977105|NCT05557942|471541215|FG001|Overall Study|Death|0|||
130977106|NCT05557942|471541216|FG002|Overall Study|Death|0|||
130977107|NCT05557942|471541217|FG003|Overall Study|Death|2|||
130977108|NCT05557942|471541218|FG004|Overall Study|Death|1|||
130977109|NCT05557942|471541219|FG005|Overall Study|Death|1|||
130977110|NCT05557942|471541214|FG000|Overall Study|Physician Decision|1|||
130977111|NCT05557942|471541215|FG001|Overall Study|Physician Decision|1|||
130977112|NCT05557942|471541216|FG002|Overall Study|Physician Decision|2|||
130977113|NCT05557942|471541217|FG003|Overall Study|Physician Decision|3|||
130977114|NCT05557942|471541218|FG004|Overall Study|Physician Decision|0|||
130977115|NCT05557942|471541219|FG005|Overall Study|Physician Decision|2|||
130977116|NCT05557942|471541214|FG000|Overall Study|Study terminated by sponsor|17|||
130977117|NCT05557942|471541215|FG001|Overall Study|Study terminated by sponsor|17|||
130977118|NCT05557942|471541216|FG002|Overall Study|Study terminated by sponsor|14|||
130977119|NCT05557942|471541217|FG003|Overall Study|Study terminated by sponsor|40|||
130977120|NCT05557942|471541218|FG004|Overall Study|Study terminated by sponsor|45|||
130977121|NCT05557942|471541219|FG005|Overall Study|Study terminated by sponsor|37|||
130977122|NCT05557942|471541214|FG000|Overall Study|Protocol Violation|0|||
130977123|NCT05557942|471541215|FG001|Overall Study|Protocol Violation|0|||
130977124|NCT05557942|471541216|FG002|Overall Study|Protocol Violation|0|||
130977125|NCT05557942|471541217|FG003|Overall Study|Protocol Violation|0|||
130977126|NCT05557942|471541218|FG004|Overall Study|Protocol Violation|0|||
130977127|NCT05557942|471541219|FG005|Overall Study|Protocol Violation|1|||
131043493|NCT03106740|471794648|FG000|Overall Study|Lost to Follow-up|2|||
131043494|NCT03106740|471794649|FG001|Overall Study|Lost to Follow-up|2|||
131043495|NCT03106740|471794648|FG000|Overall Study|Withdrawal by Subject|2|||
131043496|NCT03106740|471794649|FG001|Overall Study|Withdrawal by Subject|4|||
131043497|NCT03106740|471794648|FG000|Overall Study|Physician Decision|0|||
131043498|NCT03106740|471794649|FG001|Overall Study|Physician Decision|1|||
131043499|NCT03106740|471794648|FG000|Overall Study|Partial data|1|||
131043500|NCT03106740|471794649|FG001|Overall Study|Partial data|0|||
131043501|NCT04565990|471794650|FG000|Overall Study|Death|5|||
131043502|NCT04565990|471794650|FG000|Overall Study|Lost to Follow-up|1|||
131043503|NCT04565990|471794650|FG000|Overall Study|Withdrawal by Subject|1|||
131043504|NCT04797858|471794651|FG000|Overall Study|Withdrawal by Subject|0|||
131043505|NCT04797858|471794652|FG001|Overall Study|Withdrawal by Subject|1|||
131043506|NCT04797858|471794651|FG000|Overall Study|Excluded due to administrative error|7|||
131227535|NCT00410410|472459752|FG003|Maintenance Period (MP)|Adverse Event|0|||
130977128|NCT05557942|471541214|FG000|Overall Study|Withdrawal by Subject|0|||
130977129|NCT05557942|471541215|FG001|Overall Study|Withdrawal by Subject|0|||
130977130|NCT05557942|471541216|FG002|Overall Study|Withdrawal by Subject|0|||
130977131|NCT05557942|471541217|FG003|Overall Study|Withdrawal by Subject|0|||
130977132|NCT05557942|471541218|FG004|Overall Study|Withdrawal by Subject|2|||
130977133|NCT05557942|471541219|FG005|Overall Study|Withdrawal by Subject|0|||
130977134|NCT00613951|471541221|FG000|Overall Study|Adverse Event|1|||
130977135|NCT00613951|471541222|FG001|Overall Study|Adverse Event|0|||
130977136|NCT00613951|471541223|FG002|Overall Study|Adverse Event|1|||
130977137|NCT00613951|471541221|FG000|Overall Study|Lack of Efficacy|0|||
130977138|NCT00613951|471541222|FG001|Overall Study|Lack of Efficacy|1|||
130977139|NCT00613951|471541223|FG002|Overall Study|Lack of Efficacy|1|||
130977140|NCT00613951|471541221|FG000|Overall Study|Protocol Violation|1|||
130977141|NCT00613951|471541222|FG001|Overall Study|Protocol Violation|1|||
130977142|NCT00613951|471541223|FG002|Overall Study|Protocol Violation|1|||
130977143|NCT00613951|471541221|FG000|Overall Study|Unclassified|5|||
130977144|NCT00613951|471541222|FG001|Overall Study|Unclassified|3|||
130977145|NCT00613951|471541223|FG002|Overall Study|Unclassified|2|||
130977146|NCT00655980|471541227|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
130977147|NCT00655980|471541228|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
130977148|NCT00655980|471541229|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
130977149|NCT05540522|471541230|FG000|Overall Study|Adverse Event|1|||
130977150|NCT05540522|471541231|FG001|Overall Study|Adverse Event|0|||
130977151|NCT05540522|471541232|FG002|Overall Study|Adverse Event|2|||
130977152|NCT05540522|471541233|FG003|Overall Study|Adverse Event|5|||
130977153|NCT05540522|471541230|FG000|Overall Study|Lost to Follow-up|487|||
130977154|NCT05540522|471541231|FG001|Overall Study|Lost to Follow-up|427|||
130977155|NCT05540522|471541232|FG002|Overall Study|Lost to Follow-up|146|||
130977156|NCT05540522|471541233|FG003|Overall Study|Lost to Follow-up|166|||
130977157|NCT05540522|471541230|FG000|Overall Study|Physician Decision|11|||
130977158|NCT05540522|471541231|FG001|Overall Study|Physician Decision|19|||
130977159|NCT05540522|471541232|FG002|Overall Study|Physician Decision|8|||
130977160|NCT05540522|471541233|FG003|Overall Study|Physician Decision|13|||
130977161|NCT05540522|471541230|FG000|Overall Study|Pregnancy|1|||
130977162|NCT05540522|471541231|FG001|Overall Study|Pregnancy|0|||
130977163|NCT05540522|471541232|FG002|Overall Study|Pregnancy|0|||
130977164|NCT05540522|471541233|FG003|Overall Study|Pregnancy|0|||
130977165|NCT05540522|471541230|FG000|Overall Study|Protocol Violation|3|||
130977166|NCT05540522|471541231|FG001|Overall Study|Protocol Violation|1|||
130977167|NCT05540522|471541232|FG002|Overall Study|Protocol Violation|9|||
130977168|NCT05540522|471541233|FG003|Overall Study|Protocol Violation|7|||
130977169|NCT05540522|471541230|FG000|Overall Study|Withdrawal by Subject|168|||
130977170|NCT05540522|471541231|FG001|Overall Study|Withdrawal by Subject|134|||
130977171|NCT05540522|471541232|FG002|Overall Study|Withdrawal by Subject|331|||
130977172|NCT05540522|471541233|FG003|Overall Study|Withdrawal by Subject|322|||
130977173|NCT05540522|471541230|FG000|Overall Study|Death|7|||
130977174|NCT05540522|471541231|FG001|Overall Study|Death|9|||
130977175|NCT05540522|471541232|FG002|Overall Study|Death|49|||
130977176|NCT05540522|471541233|FG003|Overall Study|Death|46|||
130977177|NCT05540522|471541230|FG000|Overall Study|Not vaccinated|34|||
130977178|NCT05540522|471541231|FG001|Overall Study|Not vaccinated|53|||
130977179|NCT05540522|471541232|FG002|Overall Study|Not vaccinated|57|||
130977180|NCT05540522|471541233|FG003|Overall Study|Not vaccinated|50|||
130977181|NCT05540522|471541230|FG000|Overall Study|No longer meets eligibility criteria|0|||
130977182|NCT05540522|471541231|FG001|Overall Study|No longer meets eligibility criteria|0|||
130977183|NCT05540522|471541232|FG002|Overall Study|No longer meets eligibility criteria|3|||
130977184|NCT05540522|471541233|FG003|Overall Study|No longer meets eligibility criteria|2|||
130977185|NCT05540522|471541230|FG000|Overall Study|Other (Unspecified)|8|||
130977186|NCT05540522|471541231|FG001|Overall Study|Other (Unspecified)|10|||
130977187|NCT05540522|471541232|FG002|Overall Study|Other (Unspecified)|4|||
130977188|NCT05540522|471541233|FG003|Overall Study|Other (Unspecified)|2|||
130977189|NCT03754803|471541234|FG000|Overall Study|Withdrawal by Subject|2|||
130977192|NCT04439110|471541237|FG000|Overall Study|Ineligible|2|||
130977193|NCT04439110|471541237|FG000|Overall Study|Adverse Event|4|||
130977194|NCT04439110|471541237|FG000|Overall Study|Death|2|||
130977195|NCT04439110|471541237|FG000|Overall Study|Disease proression|25|||
130977196|NCT04439110|471541237|FG000|Overall Study|Withdrawal by Subject|1|||
130977197|NCT04439110|471541237|FG000|Overall Study|Alternative therapy|1|||
130977198|NCT04439110|471541237|FG000|Overall Study|Other complicating disease|1|||
130977199|NCT04439110|471541237|FG000|Overall Study|Personal reasons|1|||
130977200|NCT04439110|471541237|FG000|Overall Study|Still on treatment|1|||
131131733|NCT01425008|472108431|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
130977201|NCT04348604|471541238|FG000|Week 8|Withdrawal by Subject|1|||
130977202|NCT04348604|471541239|FG001|Week 8|Withdrawal by Subject|1|||
130977203|NCT04348604|471541238|FG000|Week 8|Lost to Follow-up|1|||
130977204|NCT04348604|471541239|FG001|Week 8|Lost to Follow-up|2|||
130977205|NCT04348604|471541238|FG000|Week 8|Suspended|0|||
130977206|NCT04348604|471541239|FG001|Week 8|Suspended|1|||
130977207|NCT04348604|471541238|FG000|Week 12|Lost to Follow-up|1|||
130977208|NCT04348604|471541239|FG001|Week 12|Lost to Follow-up|2|||
130977209|NCT04348604|471541238|FG000|Week 12|Withdrawal by Subject|1|||
130977210|NCT04348604|471541239|FG001|Week 12|Withdrawal by Subject|0|||
130977211|NCT04348604|471541238|FG000|Week 24|Lost to Follow-up|2|||
130977212|NCT04348604|471541239|FG001|Week 24|Lost to Follow-up|1|||
131131734|NCT01425008|472108432|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
131131735|NCT01425008|472108433|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
131131736|NCT01425008|472108434|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
131131737|NCT01425008|472108435|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
131131738|NCT01425008|472108436|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
131131739|NCT01425008|472108437|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
131131740|NCT01425008|472108438|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
131131741|NCT01425008|472108439|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
131131742|NCT01425008|472108440|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
130977213|NCT02097108|471541240|FG000|Overall Study|Adverse Event|1|||
130977214|NCT02097108|471541240|FG000|Overall Study|patient was abroad for 6 months|1|||
130977215|NCT00127608|471541241|FG000|Overall Study|VZV DNA negative|1|||
130977216|NCT05245864|471541242|FG000|Overall Study|Withdrawal by Subject|1|||
130977217|NCT05245864|471541243|FG001|Overall Study|Withdrawal by Subject|1|||
130977218|NCT01329029|471541244|FG000|Overall Study|Withdrawal by Subject|117|||
130977219|NCT01329029|471541245|FG001|Overall Study|Withdrawal by Subject|87|||
130977220|NCT01329029|471541244|FG000|Overall Study|Adverse Event|82|||
130977221|NCT01329029|471541245|FG001|Overall Study|Adverse Event|29|||
130977222|NCT01329029|471541244|FG000|Overall Study|Death|16|||
130977223|NCT01329029|471541245|FG001|Overall Study|Death|19|||
130977224|NCT01329029|471541244|FG000|Overall Study|Other|14|||
130977225|NCT01329029|471541245|FG001|Overall Study|Other|20|||
130977226|NCT01329029|471541244|FG000|Overall Study|COPD Exacerbation|11|||
130977227|NCT01329029|471541245|FG001|Overall Study|COPD Exacerbation|18|||
130977228|NCT01329029|471541244|FG000|Overall Study|Physician Decision|16|||
130977229|NCT01329029|471541245|FG001|Overall Study|Physician Decision|13|||
130977230|NCT01329029|471541244|FG000|Overall Study|Lost to Follow-up|8|||
130977231|NCT01329029|471541245|FG001|Overall Study|Lost to Follow-up|5|||
130977232|NCT01329029|471541244|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
130977233|NCT01329029|471541245|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
130977234|NCT01266642|471541251|FG000|Overall Study|Protocol Violation|0|||
130977235|NCT01266642|471541252|FG001|Overall Study|Protocol Violation|1|||
130977236|NCT02119260|471542772|FG000|Overall Study|Adverse Event|1|||
130977237|NCT02119260|471542773|FG001|Overall Study|Adverse Event|0|||
130977238|NCT02119260|471542774|FG002|Overall Study|Adverse Event|0|||
130977239|NCT02119260|471542775|FG003|Overall Study|Adverse Event|0|||
130977240|NCT02119260|471542776|FG004|Overall Study|Adverse Event|0|||
130977241|NCT02119260|471542777|FG005|Overall Study|Adverse Event|0|||
130977242|NCT02119260|471542778|FG006|Overall Study|Adverse Event|0|||
130977243|NCT02119260|471542772|FG000|Overall Study|Withdrew consent|0|||
130977244|NCT02119260|471542773|FG001|Overall Study|Withdrew consent|1|||
130977245|NCT02119260|471542774|FG002|Overall Study|Withdrew consent|1|||
130977246|NCT02119260|471542775|FG003|Overall Study|Withdrew consent|0|||
130977247|NCT02119260|471542776|FG004|Overall Study|Withdrew consent|0|||
130977248|NCT02119260|471542777|FG005|Overall Study|Withdrew consent|0|||
130977249|NCT02119260|471542778|FG006|Overall Study|Withdrew consent|0|||
130977250|NCT01738984|471542779|FG000|Overall Study|Pregnancy|4|||
130977251|NCT01738984|471542780|FG001|Overall Study|Pregnancy|0|||
130977252|NCT01738984|471542779|FG000|Overall Study|Withdrawal by Subject|1|||
130977253|NCT01738984|471542780|FG001|Overall Study|Withdrawal by Subject|0|||
130977254|NCT01738984|471542779|FG000|Overall Study|Lost to Follow-up|59|||
130977255|NCT01738984|471542780|FG001|Overall Study|Lost to Follow-up|39|||
130977256|NCT00857207|471542781|FG000|Overall Study|Withdrawal by Subject|13|||
130977257|NCT00857207|471542782|FG001|Overall Study|Withdrawal by Subject|0|||
130977258|NCT00857207|471542781|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
130977259|NCT00857207|471542782|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
130977260|NCT00857207|471542781|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
130977261|NCT00857207|471542782|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
130977262|NCT00955357|471542784|FG000|Titration Phase|Adverse Event|9|||
131131743|NCT01425008|472108441|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
130720907|NCT01341782|470601558|FG001|Overall Study|Other|0|||
130977263|NCT00955357|471542785|FG001|Titration Phase|Adverse Event|46|||
130977264|NCT00955357|471542784|FG000|Titration Phase|Lack of Efficacy|0|||
130977265|NCT00955357|471542785|FG001|Titration Phase|Lack of Efficacy|2|||
130977266|NCT00955357|471542784|FG000|Titration Phase|Protocol Violation|3|||
130977267|NCT00955357|471542785|FG001|Titration Phase|Protocol Violation|7|||
130977268|NCT00955357|471542784|FG000|Titration Phase|Lost to Follow-up|1|||
130977269|NCT00955357|471542785|FG001|Titration Phase|Lost to Follow-up|3|||
130977270|NCT00955357|471542784|FG000|Titration Phase|Withdrawal by Subject|3|||
130977271|NCT00955357|471542785|FG001|Titration Phase|Withdrawal by Subject|5|||
130977272|NCT00955357|471542784|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
130977273|NCT00955357|471542785|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
130977274|NCT00955357|471542784|FG000|Titration Phase|Study medication not tolerated|0|||
130977275|NCT00955357|471542785|FG001|Titration Phase|Study medication not tolerated|1|||
131131744|NCT01425008|472108442|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
130717937|NCT03893565|470593194|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130977276|NCT00955357|471542784|FG000|Titration Phase|Non compliance to study procedures|0|||
130977277|NCT00955357|471542785|FG001|Titration Phase|Non compliance to study procedures|1|||
130977278|NCT00955357|471542784|FG000|Maintenance Phase|Adverse Event|3|||
130977279|NCT00955357|471542785|FG001|Maintenance Phase|Adverse Event|23|||
130977280|NCT00955357|471542784|FG000|Maintenance Phase|Lack of Efficacy|0|||
130977281|NCT00955357|471542785|FG001|Maintenance Phase|Lack of Efficacy|4|||
130977282|NCT00955357|471542784|FG000|Maintenance Phase|Protocol Violation|2|||
130977283|NCT00955357|471542785|FG001|Maintenance Phase|Protocol Violation|6|||
130977284|NCT00955357|471542784|FG000|Maintenance Phase|Lost to Follow-up|2|||
130977285|NCT00955357|471542785|FG001|Maintenance Phase|Lost to Follow-up|7|||
130977286|NCT00955357|471542784|FG000|Maintenance Phase|Withdrawal by Subject|4|||
130977287|NCT00955357|471542785|FG001|Maintenance Phase|Withdrawal by Subject|4|||
130977288|NCT00955357|471542784|FG000|Maintenance Phase|Patient moving out of area|0|||
130977289|NCT00955357|471542785|FG001|Maintenance Phase|Patient moving out of area|1|||
130977290|NCT00955357|471542784|FG000|Maintenance Phase|Non compliance to study procedures|1|||
130977291|NCT00955357|471542785|FG001|Maintenance Phase|Non compliance to study procedures|0|||
130977292|NCT01258608|471542786|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
130977293|NCT01258608|471542787|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
130977294|NCT01258608|471542786|FG000|Overall Study|Clinical progression|1|||
130977295|NCT01258608|471542787|FG001|Overall Study|Clinical progression|0|||
130977296|NCT01258608|471542786|FG000|Overall Study|Sponsor decision|0|||
130977297|NCT01258608|471542787|FG001|Overall Study|Sponsor decision|1|||
130977298|NCT01258608|471542786|FG000|Overall Study|Physician Decision|6|||
130977299|NCT01258608|471542787|FG001|Overall Study|Physician Decision|1|||
130977300|NCT01258608|471542786|FG000|Overall Study|Lost to Follow-up|0|||
130977301|NCT01258608|471542787|FG001|Overall Study|Lost to Follow-up|1|||
130977302|NCT01258608|471542786|FG000|Overall Study|Lack of compliance|1|||
130977303|NCT01258608|471542787|FG001|Overall Study|Lack of compliance|0|||
130977304|NCT01258608|471542786|FG000|Overall Study|Lack of Efficacy|0|||
130977305|NCT01258608|471542787|FG001|Overall Study|Lack of Efficacy|1|||
130977306|NCT01258608|471542786|FG000|Overall Study|Adverse Event|6|||
130977307|NCT01258608|471542787|FG001|Overall Study|Adverse Event|10|||
130977308|NCT01258608|471542786|FG000|Overall Study|Withdrawal by Subject|6|||
130977309|NCT01258608|471542787|FG001|Overall Study|Withdrawal by Subject|5|||
130977310|NCT01471054|471542788|FG000|Overall Study|Study terminated prematurely|4|||
130977311|NCT01471054|471542789|FG001|Overall Study|Study terminated prematurely|0|||
130977312|NCT01843192|471542790|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
130977313|NCT01843192|471542791|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
130977314|NCT01843192|471542792|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
130977315|NCT02181803|471542793|FG000|Overall Study|Withdrawal by Subject|0|||
130977316|NCT02181803|471542794|FG001|Overall Study|Withdrawal by Subject|2|||
130977317|NCT02181803|471542795|FG002|Overall Study|Withdrawal by Subject|0|||
130977318|NCT02181803|471542796|FG003|Overall Study|Withdrawal by Subject|0|||
130977319|NCT02181803|471542797|FG004|Overall Study|Withdrawal by Subject|0|||
130977320|NCT02181803|471542798|FG005|Overall Study|Withdrawal by Subject|0|||
130977321|NCT02181803|471542799|FG006|Overall Study|Withdrawal by Subject|0|||
130977322|NCT02181803|471542800|FG007|Overall Study|Withdrawal by Subject|0|||
131043507|NCT04797858|471794652|FG001|Overall Study|Excluded due to administrative error|8|||
131043508|NCT04826471|471794653|FG000|Overall Study|Lost to Follow-up|2|||
131043509|NCT04826471|471794653|FG000|Overall Study|Protocol Violation|3|||
131043510|NCT04826471|471794653|FG000|Overall Study|Withdrawal by Subject|1|||
131043511|NCT04414722|471794654|FG000|Overall Study|Lost to Follow-up|3|||
131043512|NCT04414722|471794655|FG001|Overall Study|Lost to Follow-up|4|||
131043513|NCT04414722|471794656|FG002|Overall Study|Lost to Follow-up|3|||
131043514|NCT04414722|471794657|FG003|Overall Study|Lost to Follow-up|2|||
131043515|NCT04414722|471794658|FG004|Overall Study|Lost to Follow-up|3|||
131043516|NCT04414722|471794654|FG000|Overall Study|Withdrawal by Subject|6|||
131043517|NCT04414722|471794655|FG001|Overall Study|Withdrawal by Subject|3|||
131043518|NCT04414722|471794656|FG002|Overall Study|Withdrawal by Subject|1|||
131043519|NCT04414722|471794657|FG003|Overall Study|Withdrawal by Subject|5|||
131043520|NCT04414722|471794658|FG004|Overall Study|Withdrawal by Subject|1|||
131043521|NCT04414722|471794654|FG000|Overall Study|Physician Decision|0|||
131043522|NCT04414722|471794655|FG001|Overall Study|Physician Decision|1|||
130977323|NCT02181803|471542801|FG008|Overall Study|Withdrawal by Subject|0|||
131043523|NCT04414722|471794656|FG002|Overall Study|Physician Decision|2|||
131043524|NCT04414722|471794657|FG003|Overall Study|Physician Decision|0|||
130977324|NCT02181803|471542793|FG000|Overall Study|Physician Decision|0|||
130977325|NCT02181803|471542794|FG001|Overall Study|Physician Decision|0|||
130977326|NCT02181803|471542795|FG002|Overall Study|Physician Decision|0|||
130977327|NCT02181803|471542796|FG003|Overall Study|Physician Decision|1|||
130977328|NCT02181803|471542797|FG004|Overall Study|Physician Decision|0|||
130977329|NCT02181803|471542798|FG005|Overall Study|Physician Decision|0|||
130977330|NCT02181803|471542799|FG006|Overall Study|Physician Decision|0|||
131043525|NCT04414722|471794658|FG004|Overall Study|Physician Decision|0|||
131043526|NCT04414722|471794654|FG000|Overall Study|Non-participatory|0|||
130977331|NCT02181803|471542800|FG007|Overall Study|Physician Decision|1|||
130977332|NCT02181803|471542801|FG008|Overall Study|Physician Decision|0|||
130977333|NCT02181803|471542793|FG000|Overall Study|Adverse Event|0|||
130977334|NCT02181803|471542794|FG001|Overall Study|Adverse Event|2|||
130977335|NCT02181803|471542795|FG002|Overall Study|Adverse Event|0|||
130977336|NCT02181803|471542796|FG003|Overall Study|Adverse Event|1|||
130977337|NCT02181803|471542797|FG004|Overall Study|Adverse Event|0|||
130977338|NCT02181803|471542798|FG005|Overall Study|Adverse Event|0|||
130977339|NCT02181803|471542799|FG006|Overall Study|Adverse Event|1|||
130977340|NCT02181803|471542800|FG007|Overall Study|Adverse Event|0|||
130977341|NCT02181803|471542801|FG008|Overall Study|Adverse Event|0|||
130977342|NCT03912259|471542802|FG000|Overall Study|Adverse Event (AE)|2|||
130977343|NCT03912259|471542803|FG001|Overall Study|Adverse Event (AE)|4|||
130977344|NCT03912259|471542802|FG000|Overall Study|Lack of Efficacy|4|||
130977345|NCT03912259|471542803|FG001|Overall Study|Lack of Efficacy|1|||
130977346|NCT03912259|471542802|FG000|Overall Study|Withdrawal by Subject|11|||
130977347|NCT03912259|471542803|FG001|Overall Study|Withdrawal by Subject|1|||
130977348|NCT02131272|471542804|FG000|Overall Study|Withdrawal by parent|0|||
130977349|NCT02131272|471542805|FG001|Overall Study|Withdrawal by parent|1|||
130977350|NCT02131272|471542804|FG000|Overall Study|Withdrawal by Subject|0|||
130977351|NCT02131272|471542805|FG001|Overall Study|Withdrawal by Subject|1|||
130977352|NCT02131272|471542804|FG000|Overall Study|Withdrawal Criteria|1|||
130977353|NCT02131272|471542805|FG001|Overall Study|Withdrawal Criteria|0|||
130977354|NCT03166618|471542806|FG000|Overall Study|Study was Terminated|0|||
130977355|NCT03166618|471542807|FG001|Overall Study|Study was Terminated|1|||
130977356|NCT03561090|471542808|FG000|Overall Study|Adverse Event|11|||
130977357|NCT03561090|471542809|FG001|Overall Study|Adverse Event|7|||
130977358|NCT03561090|471542808|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130977359|NCT03561090|471542809|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130977360|NCT03561090|471542808|FG000|Overall Study|Protocol Violation|2|||
130977361|NCT03561090|471542809|FG001|Overall Study|Protocol Violation|2|||
130977362|NCT03561090|471542808|FG000|Overall Study|Withdrawal by Subject|7|||
130977363|NCT03561090|471542809|FG001|Overall Study|Withdrawal by Subject|7|||
130977364|NCT03561090|471542808|FG000|Overall Study|Lost to Follow-up|7|||
130977365|NCT03561090|471542809|FG001|Overall Study|Lost to Follow-up|2|||
130977366|NCT03561090|471542808|FG000|Overall Study|Study Terminated by Sponsor|10|||
130977367|NCT03561090|471542809|FG001|Overall Study|Study Terminated by Sponsor|15|||
130977368|NCT03561090|471542808|FG000|Overall Study|Randomized by Mistake|1|||
130977369|NCT03561090|471542809|FG001|Overall Study|Randomized by Mistake|1|||
130977370|NCT03561090|471542808|FG000|Overall Study|Other Not Specified|0|||
130977371|NCT03561090|471542809|FG001|Overall Study|Other Not Specified|2|||
130977372|NCT02163733|471542816|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
130977373|NCT02163733|471542817|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
130977374|NCT02163733|471542818|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
130977375|NCT02163733|471542816|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
130977376|NCT02163733|471542817|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
130977377|NCT02163733|471542818|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
130977378|NCT00713648|471542819|FG000|Overall Study|Adverse Event|1|||
130977379|NCT00713648|471542819|FG000|Overall Study|Unclassified|2|||
130977380|NCT00713648|471542819|FG000|Overall Study|According to Protocol|2|||
130977381|NCT00713648|471542819|FG000|Overall Study|Development of antibodies|3|||
130977382|NCT02633800|471542820|FG000|Overall Study|Death|3|||
130977383|NCT02633800|471542821|FG001|Overall Study|Death|3|||
130977384|NCT02633800|471542820|FG000|Overall Study|Reason not provided|1|||
130977385|NCT02633800|471542821|FG001|Overall Study|Reason not provided|0|||
130977386|NCT02633800|471542820|FG000|Overall Study|Radiologic(al) progression|23|||
130977387|NCT02633800|471542821|FG001|Overall Study|Radiologic(al) progression|23|||
130977388|NCT02633800|471542820|FG000|Overall Study|Clinical progression|3|||
130717938|NCT03893565|470593195|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130717939|NCT03893565|470593196|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130717940|NCT03893565|470593197|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
130977389|NCT02633800|471542821|FG001|Overall Study|Clinical progression|6|||
130977390|NCT02633800|471542820|FG000|Overall Study|Study terminated by sponsor|6|||
130977391|NCT02633800|471542821|FG001|Overall Study|Study terminated by sponsor|5|||
130977392|NCT02633800|471542820|FG000|Overall Study|Adverse event, non-fatal|7|||
130977393|NCT02633800|471542821|FG001|Overall Study|Adverse event, non-fatal|2|||
130977394|NCT02633800|471542820|FG000|Overall Study|Withdrawal by Subject|0|||
130977395|NCT02633800|471542821|FG001|Overall Study|Withdrawal by Subject|3|||
130977396|NCT02633800|471542820|FG000|Overall Study|Patient Request|1|||
130977397|NCT02633800|471542821|FG001|Overall Study|Patient Request|1|||
130977398|NCT00082173|471542822|FG000|Overall Study|Withdrawal by Subject|3|||
130977399|NCT00082173|471542823|FG001|Overall Study|Withdrawal by Subject|5|||
130977400|NCT00082173|471542822|FG000|Overall Study|Lost to Follow-up|1|||
130977401|NCT00082173|471542823|FG001|Overall Study|Lost to Follow-up|0|||
130977402|NCT00082173|471542822|FG000|Overall Study|Adverse Event|1|||
130977403|NCT00082173|471542823|FG001|Overall Study|Adverse Event|0|||
131131745|NCT01425008|472108443|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
131131746|NCT01425008|472108444|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
131131747|NCT01425008|472108445|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
130977404|NCT00082173|471542822|FG000|Overall Study|Culture negative or resistant at baselin|5|||
130977405|NCT00082173|471542823|FG001|Overall Study|Culture negative or resistant at baselin|6|||
130977406|NCT01733732|471542824|FG000|Overall Study|Adverse Event|1|||
130977407|NCT01733732|471542825|FG001|Overall Study|Adverse Event|0|||
130977408|NCT01733732|471542824|FG000|Overall Study|Did not attend all study visits|1|||
130977409|NCT01733732|471542825|FG001|Overall Study|Did not attend all study visits|0|||
130977410|NCT01260350|471542837|FG000|Overall Study|Lack of Efficacy|0|||
130977411|NCT01260350|471542838|FG001|Overall Study|Lack of Efficacy|0|||
130977412|NCT01260350|471542839|FG002|Overall Study|Lack of Efficacy|0|||
130977413|NCT01260350|471542840|FG003|Overall Study|Lack of Efficacy|0|||
130977414|NCT01260350|471542841|FG004|Overall Study|Lack of Efficacy|0|||
130977415|NCT01260350|471542842|FG005|Overall Study|Lack of Efficacy|0|||
130977416|NCT01260350|471542843|FG006|Overall Study|Lack of Efficacy|0|||
130977417|NCT01260350|471542844|FG007|Overall Study|Lack of Efficacy|0|||
130977418|NCT01260350|471542845|FG008|Overall Study|Lack of Efficacy|0|||
130977419|NCT01260350|471542846|FG009|Overall Study|Lack of Efficacy|0|||
130977420|NCT01260350|471542847|FG010|Overall Study|Lack of Efficacy|0|||
130977421|NCT01260350|471542848|FG011|Overall Study|Lack of Efficacy|0|||
130977422|NCT01260350|471542849|FG012|Overall Study|Lack of Efficacy|0|||
130977423|NCT01260350|471542850|FG013|Overall Study|Lack of Efficacy|0|||
130977424|NCT01260350|471542851|FG014|Overall Study|Lack of Efficacy|0|||
130977425|NCT01260350|471542852|FG015|Overall Study|Lack of Efficacy|0|||
130977426|NCT01260350|471542853|FG016|Overall Study|Lack of Efficacy|0|||
130977427|NCT01260350|471542854|FG017|Overall Study|Lack of Efficacy|1|||
130977428|NCT01260350|471542855|FG018|Overall Study|Lack of Efficacy|0|||
130977429|NCT01260350|471542856|FG019|Overall Study|Lack of Efficacy|0|||
130977430|NCT01260350|471542857|FG020|Overall Study|Lack of Efficacy|3|||
130977431|NCT01260350|471542858|FG021|Overall Study|Lack of Efficacy|0|||
130977432|NCT01260350|471542837|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977433|NCT01260350|471542838|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977434|NCT01260350|471542839|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977435|NCT01260350|471542840|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977436|NCT01260350|471542841|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977437|NCT01260350|471542842|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977438|NCT01260350|471542843|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977439|NCT01260350|471542844|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977440|NCT01260350|471542845|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
130977441|NCT01260350|471542846|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977442|NCT01260350|471542847|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977443|NCT01260350|471542848|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977444|NCT01260350|471542849|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977445|NCT01260350|471542850|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977446|NCT01260350|471542851|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977447|NCT01260350|471542852|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977448|NCT01260350|471542853|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977449|NCT01260350|471542854|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977450|NCT01260350|471542855|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977451|NCT01260350|471542856|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977452|NCT01260350|471542857|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977453|NCT01260350|471542858|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
130977454|NCT02794285|471542861|FG000|Overall Study|Adverse Event|11|||
130977455|NCT02794285|471542862|FG001|Overall Study|Adverse Event|4|||
130977456|NCT02794285|471542863|FG002|Overall Study|Adverse Event|5|||
130977457|NCT02794285|471542864|FG003|Overall Study|Adverse Event|8|||
130977458|NCT02794285|471542861|FG000|Overall Study|Condition Under Investigation Improved|1|||
130977459|NCT02794285|471542862|FG001|Overall Study|Condition Under Investigation Improved|0|||
130977460|NCT02794285|471542863|FG002|Overall Study|Condition Under Investigation Improved|0|||
130977461|NCT02794285|471542864|FG003|Overall Study|Condition Under Investigation Improved|0|||
130977462|NCT02794285|471542861|FG000|Overall Study|Condition Under Investigation Worsened|0|||
130977463|NCT02794285|471542862|FG001|Overall Study|Condition Under Investigation Worsened|2|||
130977464|NCT02794285|471542863|FG002|Overall Study|Condition Under Investigation Worsened|1|||
130977465|NCT02794285|471542864|FG003|Overall Study|Condition Under Investigation Worsened|0|||
130977466|NCT02794285|471542861|FG000|Overall Study|Death|2|||
130977467|NCT02794285|471542862|FG001|Overall Study|Death|1|||
130977468|NCT02794285|471542863|FG002|Overall Study|Death|2|||
130977469|NCT02794285|471542864|FG003|Overall Study|Death|0|||
131131748|NCT01425008|472108446|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
130977470|NCT02794285|471542861|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
130977471|NCT02794285|471542862|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
130977472|NCT02794285|471542863|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
130977473|NCT02794285|471542864|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
130977474|NCT02794285|471542861|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
130977475|NCT02794285|471542862|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
130977476|NCT02794285|471542863|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
130977477|NCT02794285|471542864|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
130977478|NCT02794285|471542861|FG000|Overall Study|Lack of Efficacy|10|||
130977479|NCT02794285|471542862|FG001|Overall Study|Lack of Efficacy|6|||
130977480|NCT02794285|471542863|FG002|Overall Study|Lack of Efficacy|3|||
130977481|NCT02794285|471542864|FG003|Overall Study|Lack of Efficacy|3|||
130977482|NCT02794285|471542861|FG000|Overall Study|Lost to Follow-up|5|||
130977483|NCT02794285|471542862|FG001|Overall Study|Lost to Follow-up|6|||
130977484|NCT02794285|471542863|FG002|Overall Study|Lost to Follow-up|3|||
130977485|NCT02794285|471542864|FG003|Overall Study|Lost to Follow-up|1|||
130977486|NCT02794285|471542861|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
130977487|NCT02794285|471542862|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
130977488|NCT02794285|471542863|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
130977489|NCT02794285|471542864|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
130977490|NCT02794285|471542861|FG000|Overall Study|Withdrawal by Subject|38|||
130977491|NCT02794285|471542862|FG001|Overall Study|Withdrawal by Subject|29|||
130977492|NCT02794285|471542863|FG002|Overall Study|Withdrawal by Subject|20|||
130977493|NCT02794285|471542864|FG003|Overall Study|Withdrawal by Subject|12|||
130977494|NCT02794285|471542861|FG000|Overall Study|Missing|1|||
130977495|NCT02794285|471542862|FG001|Overall Study|Missing|0|||
130977496|NCT02794285|471542863|FG002|Overall Study|Missing|0|||
130977497|NCT02794285|471542864|FG003|Overall Study|Missing|0|||
130977498|NCT02794285|471542861|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
130977499|NCT02794285|471542862|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
130977500|NCT02794285|471542863|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
130977501|NCT02794285|471542864|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
130977502|NCT02794285|471542861|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
130977503|NCT02794285|471542862|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
130977504|NCT02794285|471542863|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
130977505|NCT02794285|471542864|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
130977506|NCT00868439|471542865|FG000|Overall Study|Adverse Event|4|||
130977507|NCT00868439|471542866|FG001|Overall Study|Adverse Event|3|||
130977508|NCT00868439|471542865|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
130977509|NCT00868439|471542866|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
130977510|NCT00868439|471542865|FG000|Overall Study|Death|0|||
130977511|NCT00868439|471542866|FG001|Overall Study|Death|1|||
130977512|NCT00868439|471542865|FG000|Overall Study|Protocol Violation|1|||
130977513|NCT00868439|471542866|FG001|Overall Study|Protocol Violation|1|||
130977514|NCT00868439|471542865|FG000|Overall Study|Physician Decision|1|||
130977515|NCT00868439|471542866|FG001|Overall Study|Physician Decision|0|||
130977516|NCT00868439|471542865|FG000|Overall Study|Withdrawal by Subject|0|||
130977517|NCT00868439|471542866|FG001|Overall Study|Withdrawal by Subject|1|||
130977518|NCT00937924|471542877|FG000|Overall Study|Lost to Follow-up|44|||
130977519|NCT00937924|471542878|FG001|Overall Study|Lost to Follow-up|44|||
130977520|NCT00937924|471542879|FG002|Overall Study|Lost to Follow-up|41|||
130977521|NCT00224874|471542880|FG000|Overall Study|Withdrawal by Subject|0|||
130977522|NCT00224874|471542881|FG001|Overall Study|Withdrawal by Subject|0|||
130977523|NCT00224874|471542882|FG002|Overall Study|Withdrawal by Subject|1|||
130977524|NCT00224874|471542883|FG003|Overall Study|Withdrawal by Subject|0|||
130977525|NCT05072080|471542886|FG000|Overall Study|Death|0|||
130977526|NCT05072080|471542887|FG001|Overall Study|Death|0|||
130977527|NCT05072080|471542888|FG002|Overall Study|Death|1|||
130977528|NCT05072080|471542889|FG003|Overall Study|Death|0|||
130977529|NCT05072080|471542886|FG000|Overall Study|Lost to Follow-up|65|||
130977530|NCT05072080|471542887|FG001|Overall Study|Lost to Follow-up|70|||
131131749|NCT01425008|472108447|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
131131750|NCT01425008|472108448|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
131131751|NCT01425008|472108430|FG000|Dose Escalation Phase|Other|0|||
131131752|NCT01425008|472108431|FG001|Dose Escalation Phase|Other|0|||
131131753|NCT01425008|472108432|FG002|Dose Escalation Phase|Other|0|||
131131754|NCT01425008|472108433|FG003|Dose Escalation Phase|Other|0|||
130977531|NCT05072080|471542888|FG002|Overall Study|Lost to Follow-up|58|||
130977532|NCT05072080|471542889|FG003|Overall Study|Lost to Follow-up|23|||
131131755|NCT01425008|472108434|FG004|Dose Escalation Phase|Other|0|||
130720908|NCT00620555|470601559|FG000|Overall Study|Adverse Event|4|||
130977533|NCT05072080|471542886|FG000|Overall Study|Physician Decision|2|||
130977534|NCT05072080|471542887|FG001|Overall Study|Physician Decision|1|||
130977535|NCT05072080|471542888|FG002|Overall Study|Physician Decision|1|||
130977536|NCT05072080|471542889|FG003|Overall Study|Physician Decision|0|||
130977537|NCT05072080|471542886|FG000|Overall Study|Withdrawal by Subject|45|||
130977538|NCT05072080|471542887|FG001|Overall Study|Withdrawal by Subject|30|||
130977539|NCT05072080|471542888|FG002|Overall Study|Withdrawal by Subject|27|||
130977540|NCT05072080|471542889|FG003|Overall Study|Withdrawal by Subject|7|||
131131756|NCT01425008|472108435|FG005|Dose Escalation Phase|Other|0|||
131131757|NCT01425008|472108436|FG006|Dose Escalation Phase|Other|0|||
130717941|NCT03893565|470593198|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
130717942|NCT03893565|470593199|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130977541|NCT05072080|471542886|FG000|Overall Study|Sponsor Decision|0|||
130977542|NCT05072080|471542887|FG001|Overall Study|Sponsor Decision|1|||
130977543|NCT05072080|471542888|FG002|Overall Study|Sponsor Decision|0|||
130977544|NCT05072080|471542889|FG003|Overall Study|Sponsor Decision|0|||
130977545|NCT05072080|471542886|FG000|Overall Study|Subject moved|1|||
130977546|NCT05072080|471542887|FG001|Overall Study|Subject moved|3|||
130977547|NCT05072080|471542888|FG002|Overall Study|Subject moved|5|||
130977548|NCT05072080|471542889|FG003|Overall Study|Subject moved|2|||
130977549|NCT05072080|471542886|FG000|Overall Study|Withdrawal by parent|0|||
130977550|NCT05072080|471542887|FG001|Overall Study|Withdrawal by parent|0|||
130977551|NCT05072080|471542888|FG002|Overall Study|Withdrawal by parent|1|||
130977552|NCT05072080|471542889|FG003|Overall Study|Withdrawal by parent|0|||
130977553|NCT05072080|471542886|FG000|Overall Study|Subject was deployed|0|||
130977554|NCT05072080|471542887|FG001|Overall Study|Subject was deployed|1|||
130977555|NCT05072080|471542888|FG002|Overall Study|Subject was deployed|0|||
130977556|NCT05072080|471542889|FG003|Overall Study|Subject was deployed|0|||
130977557|NCT05072080|471542886|FG000|Overall Study|Subject left site without receiving dose|0|||
130977558|NCT05072080|471542887|FG001|Overall Study|Subject left site without receiving dose|1|||
130977559|NCT05072080|471542888|FG002|Overall Study|Subject left site without receiving dose|0|||
130977560|NCT05072080|471542889|FG003|Overall Study|Subject left site without receiving dose|0|||
130977561|NCT05072080|471542886|FG000|Overall Study|Subject incarcerated|0|||
130977562|NCT05072080|471542887|FG001|Overall Study|Subject incarcerated|1|||
130977563|NCT05072080|471542888|FG002|Overall Study|Subject incarcerated|0|||
130977564|NCT05072080|471542889|FG003|Overall Study|Subject incarcerated|1|||
130977565|NCT05072080|471542886|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
130977566|NCT05072080|471542887|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
130977567|NCT05072080|471542888|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
130977568|NCT05072080|471542889|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
130977569|NCT05072080|471542886|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
130977570|NCT05072080|471542887|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
130977571|NCT05072080|471542888|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
130977572|NCT05072080|471542889|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
130977573|NCT03152526|471542890|FG000|Overall Study|Withdrawal by Subject|0|||
130977574|NCT03152526|471542891|FG001|Overall Study|Withdrawal by Subject|1|||
130977575|NCT02395042|471542892|FG000|Treatment 1 Period|Adverse Event|1|||
130977576|NCT02395042|471542893|FG001|Treatment 1 Period|Adverse Event|3|||
130977577|NCT02395042|471542894|FG002|Treatment 1 Period|Adverse Event|1|||
130977578|NCT02395042|471542892|FG000|Treatment 1 Period|Lack of Efficacy|1|||
130977579|NCT02395042|471542893|FG001|Treatment 1 Period|Lack of Efficacy|1|||
130977580|NCT02395042|471542894|FG002|Treatment 1 Period|Lack of Efficacy|0|||
130977581|NCT02395042|471542892|FG000|Treatment 1 Period|Lost to Follow-up|1|||
130977582|NCT02395042|471542893|FG001|Treatment 1 Period|Lost to Follow-up|0|||
130977583|NCT02395042|471542894|FG002|Treatment 1 Period|Lost to Follow-up|0|||
130977584|NCT02395042|471542892|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
130977585|NCT02395042|471542893|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
130977586|NCT02395042|471542894|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
130977587|NCT02395042|471542892|FG000|Treatment 2 Period|Lack of Efficacy|1|||
130977588|NCT02395042|471542893|FG001|Treatment 2 Period|Lack of Efficacy|1|||
130977589|NCT02395042|471542894|FG002|Treatment 2 Period|Lack of Efficacy|0|||
130977590|NCT02807558|471542895|FG000|Overall Study|Consent withdrawn by participant|4|||
130977591|NCT02807558|471542896|FG001|Overall Study|Consent withdrawn by participant|0|||
130977592|NCT02807558|471542897|FG002|Overall Study|Consent withdrawn by participant|4|||
130977593|NCT02807558|471542898|FG003|Overall Study|Consent withdrawn by participant|2|||
130977594|NCT02807558|471542899|FG004|Overall Study|Consent withdrawn by participant|1|||
130977595|NCT02807558|471542900|FG005|Overall Study|Consent withdrawn by participant|0|||
130717943|NCT03893565|470593200|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130977596|NCT02807558|471542895|FG000|Overall Study|Non-compliance with Study Drug|0|||
130977597|NCT02807558|471542896|FG001|Overall Study|Non-compliance with Study Drug|0|||
130977598|NCT02807558|471542897|FG002|Overall Study|Non-compliance with Study Drug|1|||
130977599|NCT02807558|471542898|FG003|Overall Study|Non-compliance with Study Drug|0|||
130977600|NCT02807558|471542899|FG004|Overall Study|Non-compliance with Study Drug|0|||
130717944|NCT03893565|470593192|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
130977601|NCT02807558|471542900|FG005|Overall Study|Non-compliance with Study Drug|0|||
130977602|NCT02807558|471542895|FG000|Overall Study|Adverse Event|0|||
130977603|NCT02807558|471542896|FG001|Overall Study|Adverse Event|0|||
130977604|NCT02807558|471542897|FG002|Overall Study|Adverse Event|9|||
130977605|NCT02807558|471542898|FG003|Overall Study|Adverse Event|0|||
130977606|NCT02807558|471542899|FG004|Overall Study|Adverse Event|0|||
130977607|NCT02807558|471542900|FG005|Overall Study|Adverse Event|0|||
131043527|NCT04414722|471794655|FG001|Overall Study|Non-participatory|1|||
131043528|NCT04414722|471794656|FG002|Overall Study|Non-participatory|1|||
131043529|NCT04414722|471794657|FG003|Overall Study|Non-participatory|0|||
131043530|NCT04414722|471794658|FG004|Overall Study|Non-participatory|0|||
131043531|NCT04304144|471794659|FG000|DLT Observation Period|Physician Decision|0|||
131043532|NCT04304144|471794660|FG001|DLT Observation Period|Physician Decision|1|||
131043533|NCT04304144|471794661|FG002|DLT Observation Period|Physician Decision|0|||
131043534|NCT04304144|471794662|FG003|DLT Observation Period|Physician Decision|0|||
131043535|NCT04304144|471794659|FG000|Continued Treatment Period|Adverse Event|0|||
131043536|NCT04304144|471794660|FG001|Continued Treatment Period|Adverse Event|1|||
131043537|NCT04304144|471794661|FG002|Continued Treatment Period|Adverse Event|0|||
131043538|NCT04304144|471794662|FG003|Continued Treatment Period|Adverse Event|0|||
131043539|NCT04304144|471794659|FG000|Continued Treatment Period|Death|0|||
131043540|NCT04304144|471794660|FG001|Continued Treatment Period|Death|0|||
131043541|NCT04304144|471794661|FG002|Continued Treatment Period|Death|1|||
131043542|NCT04304144|471794662|FG003|Continued Treatment Period|Death|2|||
131043543|NCT04304144|471794659|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
131043544|NCT04304144|471794660|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
131043545|NCT04304144|471794661|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
131043546|NCT04304144|471794662|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
131043547|NCT04304144|471794659|FG000|Continued Treatment Period|Other than specified|2|||
131043548|NCT04304144|471794660|FG001|Continued Treatment Period|Other than specified|0|||
131043549|NCT04304144|471794661|FG002|Continued Treatment Period|Other than specified|1|||
131043550|NCT04304144|471794662|FG003|Continued Treatment Period|Other than specified|1|||
131043551|NCT05256654|471794663|FG000|Overall Study|Adverse Event|0|||
131043552|NCT05256654|471794664|FG001|Overall Study|Adverse Event|0|||
131043553|NCT05256654|471794665|FG002|Overall Study|Adverse Event|1|||
131043554|NCT05256654|471794666|FG003|Overall Study|Adverse Event|0|||
131043555|NCT05256654|471794663|FG000|Overall Study|Lost to Follow-up|0|||
131043556|NCT05256654|471794664|FG001|Overall Study|Lost to Follow-up|0|||
131043557|NCT05256654|471794665|FG002|Overall Study|Lost to Follow-up|0|||
131043558|NCT05256654|471794666|FG003|Overall Study|Lost to Follow-up|1|||
131043559|NCT05256654|471794663|FG000|Overall Study|Withdrawal by Subject|1|||
131043560|NCT05256654|471794664|FG001|Overall Study|Withdrawal by Subject|2|||
131043561|NCT05256654|471794665|FG002|Overall Study|Withdrawal by Subject|1|||
131043562|NCT05256654|471794666|FG003|Overall Study|Withdrawal by Subject|3|||
131043563|NCT05256654|471794663|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
131043564|NCT05256654|471794664|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
131043565|NCT05256654|471794665|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
131043566|NCT05256654|471794666|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
131043567|NCT05256654|471794663|FG000|Overall Study|Other|0|||
131043568|NCT05256654|471794664|FG001|Overall Study|Other|0|||
131043569|NCT05256654|471794665|FG002|Overall Study|Other|0|||
131043570|NCT05256654|471794666|FG003|Overall Study|Other|1|||
131043571|NCT04862234|471794671|FG000|Overall Study|Surgery cancellation|1|||
131043572|NCT04862234|471794672|FG001|Overall Study|Surgery cancellation|2|||
131043573|NCT04862234|471794671|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
131043574|NCT04862234|471794672|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
131043575|NCT04862234|471794671|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
131043576|NCT04862234|471794672|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
131043577|NCT03292484|471794673|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
131043578|NCT03292484|471794673|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
131043579|NCT03292484|471794673|FG000|Overall Study|Protocol Violation|2|||
131043580|NCT03292484|471794673|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
131043581|NCT03292484|471794673|FG000|Overall Study|Sponsor decision|349|||
131043582|NCT03292484|471794673|FG000|Overall Study|Lost to Follow-up|7|||
131043583|NCT03292484|471794673|FG000|Overall Study|Coronavirus Disease 2019|1|||
131043584|NCT03292484|471794673|FG000|Overall Study|Other|20|||
131043585|NCT05425420|471794676|FG000|Overall Study|Physician Decision|1|||
131043586|NCT05425420|471794676|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
131043587|NCT03714815|471794677|FG000|Overall Study|Physician Decision|2|||
131043588|NCT03714815|471794677|FG000|Overall Study|Withdrawal by Subject|2|||
131043589|NCT03714815|471794677|FG000|Overall Study|Death|11|||
131043590|NCT03505008|471794678|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
131043591|NCT03505008|471794679|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
131043592|NCT03505008|471794680|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
131043593|NCT03505008|471794681|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
131043594|NCT03505008|471794678|FG000|Before Week 24 Randomization|Adverse Event|10|||
131043595|NCT03505008|471794679|FG001|Before Week 24 Randomization|Adverse Event|0|||
131043596|NCT03505008|471794680|FG002|Before Week 24 Randomization|Adverse Event|0|||
131043597|NCT03505008|471794681|FG003|Before Week 24 Randomization|Adverse Event|0|||
131043598|NCT03505008|471794678|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
130720909|NCT00620555|470601559|FG000|Overall Study|Protocol Violation|2|||
131131758|NCT01425008|472108437|FG007|Dose Escalation Phase|Other|0|||
130977608|NCT02807558|471542895|FG000|Overall Study|Death|23|||
130977609|NCT02807558|471542896|FG001|Overall Study|Death|2|||
130977610|NCT02807558|471542897|FG002|Overall Study|Death|3|||
130977611|NCT02807558|471542898|FG003|Overall Study|Death|43|||
130977612|NCT02807558|471542899|FG004|Overall Study|Death|24|||
130977613|NCT02807558|471542900|FG005|Overall Study|Death|15|||
130977614|NCT02807558|471542895|FG000|Overall Study|Progressive Disease|0|||
130977615|NCT02807558|471542896|FG001|Overall Study|Progressive Disease|0|||
130977616|NCT02807558|471542897|FG002|Overall Study|Progressive Disease|1|||
130977617|NCT02807558|471542898|FG003|Overall Study|Progressive Disease|0|||
130977618|NCT02807558|471542899|FG004|Overall Study|Progressive Disease|0|||
130977619|NCT02807558|471542900|FG005|Overall Study|Progressive Disease|0|||
130977620|NCT02807558|471542895|FG000|Overall Study|Other than specified|1|||
130977621|NCT02807558|471542896|FG001|Overall Study|Other than specified|0|||
130977622|NCT02807558|471542897|FG002|Overall Study|Other than specified|2|||
130977623|NCT02807558|471542898|FG003|Overall Study|Other than specified|0|||
130977624|NCT02807558|471542899|FG004|Overall Study|Other than specified|1|||
130977625|NCT02807558|471542900|FG005|Overall Study|Other than specified|1|||
130977626|NCT02807558|471542895|FG000|Overall Study|Lack of Efficacy|0|||
130977627|NCT02807558|471542896|FG001|Overall Study|Lack of Efficacy|0|||
130977628|NCT02807558|471542897|FG002|Overall Study|Lack of Efficacy|9|||
130977629|NCT02807558|471542898|FG003|Overall Study|Lack of Efficacy|0|||
130977630|NCT02807558|471542899|FG004|Overall Study|Lack of Efficacy|0|||
130977631|NCT02807558|471542900|FG005|Overall Study|Lack of Efficacy|0|||
130977632|NCT04969198|471542901|FG000|Overall Study|Withdrawal by Subject|20|||
130977633|NCT04969198|471542901|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
130977634|NCT04969198|471542901|FG000|Overall Study|Lost to Follow-up|20|||
130977635|NCT02701985|471542902|FG000|Overall Study|Withdrawal by Subject|1|||
130977636|NCT02701985|471542903|FG001|Overall Study|Withdrawal by Subject|1|||
130977637|NCT02701985|471542902|FG000|Overall Study|Lost to Follow-up|1|||
130977638|NCT02701985|471542903|FG001|Overall Study|Lost to Follow-up|0|||
130977639|NCT02701985|471542902|FG000|Overall Study|Death|1|||
130977640|NCT02701985|471542903|FG001|Overall Study|Death|0|||
130977641|NCT02701985|471542902|FG000|Overall Study|Adverse Event|0|||
130977642|NCT02701985|471542903|FG001|Overall Study|Adverse Event|5|||
130977643|NCT01640808|471542904|FG000|Overall Study|Unable to continue dynamic CT|14|||
130977644|NCT01640808|471542905|FG001|Overall Study|Unable to continue dynamic CT|4|||
130977645|NCT01640808|471542904|FG000|Overall Study|Withdrawal by Subject|12|||
130977646|NCT01640808|471542905|FG001|Overall Study|Withdrawal by Subject|4|||
130977647|NCT01640808|471542904|FG000|Overall Study|Lost to Follow-up|4|||
130977648|NCT01640808|471542905|FG001|Overall Study|Lost to Follow-up|0|||
130977649|NCT01640808|471542904|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
130977650|NCT01640808|471542905|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
130977651|NCT01640808|471542904|FG000|Overall Study|Administration of anticancer drugs|2|||
130977652|NCT01640808|471542905|FG001|Overall Study|Administration of anticancer drugs|1|||
130977653|NCT01640808|471542904|FG000|Overall Study|Physician Decision|19|||
130977654|NCT01640808|471542905|FG001|Overall Study|Physician Decision|5|||
130977655|NCT01640808|471542904|FG000|Overall Study|Randomized but not treated|4|||
130977656|NCT01640808|471542905|FG001|Overall Study|Randomized but not treated|2|||
130977657|NCT05207813|471542909|FG000|Overall Study|Lost to Follow-up|2|||
130977658|NCT01371851|471542910|FG000|Overall Study|Lost to Follow-up|5|||
130977659|NCT01371851|471542911|FG001|Overall Study|Lost to Follow-up|8|||
130977660|NCT01371851|471542910|FG000|Overall Study|was arrested and put in jail|0|||
130977661|NCT01371851|471542911|FG001|Overall Study|was arrested and put in jail|1|||
130977662|NCT01371851|471542910|FG000|Overall Study|non study related adverse event|1|||
130977663|NCT01371851|471542911|FG001|Overall Study|non study related adverse event|0|||
130977664|NCT01371851|471542910|FG000|Overall Study|Blood Pressure outside study parameters|2|||
130977665|NCT01371851|471542911|FG001|Overall Study|Blood Pressure outside study parameters|0|||
130977666|NCT00833638|471542912|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
130977667|NCT00833638|471542913|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
130977668|NCT00833638|471542914|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
130977669|NCT00833638|471542912|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
130977670|NCT00833638|471542913|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
130977671|NCT00833638|471542914|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
130977672|NCT00833638|471542912|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
131131759|NCT01425008|472108438|FG008|Dose Escalation Phase|Other|1|||
130720910|NCT00620555|470601559|FG000|Overall Study|Lack of Efficacy|12|||
130977673|NCT00833638|471542913|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
130977674|NCT00833638|471542914|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
130977675|NCT00833638|471542912|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
130977676|NCT00833638|471542913|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
130977677|NCT00833638|471542914|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
130977678|NCT00833638|471542912|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
131131760|NCT01425008|472108439|FG009|Dose Escalation Phase|Other|0|||
131131761|NCT01425008|472108440|FG010|Dose Escalation Phase|Other|0|||
131131762|NCT01425008|472108441|FG011|Dose Escalation Phase|Other|0|||
131131763|NCT01425008|472108442|FG012|Dose Escalation Phase|Other|0|||
131131764|NCT01425008|472108443|FG013|Dose Escalation Phase|Other|0|||
131131765|NCT01425008|472108444|FG014|Dose Escalation Phase|Other|0|||
131131766|NCT01425008|472108445|FG015|Dose Escalation Phase|Other|0|||
131131767|NCT01425008|472108446|FG016|Dose Escalation Phase|Other|0|||
130717945|NCT03893565|470593193|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
130977679|NCT00833638|471542913|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
130977680|NCT00833638|471542914|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
130977681|NCT00833638|471542912|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
130977682|NCT00833638|471542913|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
130977683|NCT00833638|471542914|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
130977684|NCT00833638|471542912|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
130977685|NCT00833638|471542913|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
130977686|NCT00833638|471542914|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
130977687|NCT00833638|471542912|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
130977688|NCT00833638|471542913|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
130977689|NCT00833638|471542914|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
130977690|NCT00833638|471542912|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
130977691|NCT00833638|471542913|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
130977692|NCT00833638|471542914|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
130977693|NCT00490646|471542915|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
130977694|NCT00490646|471542916|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
130977695|NCT00490646|471542915|FG000|Overall Study|Never Treated (had an adverse event)|1|||
130977696|NCT00490646|471542916|FG001|Overall Study|Never Treated (had an adverse event)|0|||
130977697|NCT00490646|471542915|FG000|Overall Study|Never Treated (withdrew consent)|0|||
130977698|NCT00490646|471542916|FG001|Overall Study|Never Treated (withdrew consent)|1|||
130977699|NCT01178086|471542917|FG000|Overall Study|Participant refusal|7|||
130977700|NCT01178086|471542917|FG000|Overall Study|Physician Decision|44|||
130977701|NCT01178086|471542917|FG000|Overall Study|Switch to other CLL therapy|113|||
130977702|NCT01178086|471542917|FG000|Overall Study|Death|59|||
130977703|NCT01178086|471542917|FG000|Overall Study|Other unspecified|89|||
130977704|NCT01178086|471542917|FG000|Overall Study|Excluded from EAS|20|||
130977705|NCT05608629|471542918|FG000|Overall Study|Lost to Follow-up|2|||
130977706|NCT02962908|471542921|FG000|Overall Study|Lost to Follow-up|0|||
130977707|NCT02962908|471542922|FG001|Overall Study|Lost to Follow-up|3|||
130977708|NCT02962908|471542923|FG002|Overall Study|Lost to Follow-up|0|||
130977709|NCT02962908|471542924|FG003|Overall Study|Lost to Follow-up|1|||
130977710|NCT02962908|471542921|FG000|Overall Study|Withdrawal by Subject|0|||
130977711|NCT02962908|471542922|FG001|Overall Study|Withdrawal by Subject|3|||
130977712|NCT02962908|471542923|FG002|Overall Study|Withdrawal by Subject|0|||
130977713|NCT02962908|471542924|FG003|Overall Study|Withdrawal by Subject|2|||
130977714|NCT02962908|471542921|FG000|Overall Study|Protocol Violation|0|||
130977715|NCT02962908|471542922|FG001|Overall Study|Protocol Violation|1|||
130977716|NCT02962908|471542923|FG002|Overall Study|Protocol Violation|0|||
130977717|NCT02962908|471542924|FG003|Overall Study|Protocol Violation|0|||
130977718|NCT02962908|471542921|FG000|Overall Study|Physician Decision|0|||
130977719|NCT02962908|471542922|FG001|Overall Study|Physician Decision|1|||
130977720|NCT02962908|471542923|FG002|Overall Study|Physician Decision|0|||
130977721|NCT02962908|471542924|FG003|Overall Study|Physician Decision|0|||
130977722|NCT03543254|471542925|FG000|Overall Study|Lost to Follow-up|1|||
130977723|NCT01261338|471542926|FG000|Overall Study|Withdrawal by Subject|3|||
130977724|NCT01261338|471542927|FG001|Overall Study|Withdrawal by Subject|2|||
130977725|NCT00234065|471542928|FG000|Overall Study|Adverse Event|268|||
130977726|NCT00234065|471542929|FG001|Overall Study|Adverse Event|166|||
131131768|NCT01425008|472108447|FG017|Dose Escalation Phase|Other|0|||
131131769|NCT01425008|472108448|FG018|Dose Escalation Phase|Other|0|||
131131770|NCT01425008|472108430|FG000|Dose Expansion Phase|Progressive Disease|0|||
131131771|NCT01425008|472108431|FG001|Dose Expansion Phase|Progressive Disease|0|||
130717946|NCT03893565|470593194|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
130977727|NCT00234065|471542928|FG000|Overall Study|Withdrawal by Subject|73|||
131131772|NCT01425008|472108432|FG002|Dose Expansion Phase|Progressive Disease|0|||
131131773|NCT01425008|472108433|FG003|Dose Expansion Phase|Progressive Disease|0|||
131131774|NCT01425008|472108434|FG004|Dose Expansion Phase|Progressive Disease|0|||
130977728|NCT00234065|471542929|FG001|Overall Study|Withdrawal by Subject|56|||
130977729|NCT00234065|471542928|FG000|Overall Study|Physician Decision|23|||
130977730|NCT00234065|471542929|FG001|Overall Study|Physician Decision|22|||
130977731|NCT00234065|471542928|FG000|Overall Study|Not Classified|111|||
130977732|NCT00234065|471542929|FG001|Overall Study|Not Classified|112|||
130977733|NCT00126438|471542930|FG000|Overall Study|Withdrawal due to adverse event|1|||
131131775|NCT01425008|472108435|FG005|Dose Expansion Phase|Progressive Disease|0|||
130778182|NCT01254656|470815325|FG001|Overall Study|Adverse Event|1|||
131131776|NCT01425008|472108436|FG006|Dose Expansion Phase|Progressive Disease|0|||
131131777|NCT01425008|472108437|FG007|Dose Expansion Phase|Progressive Disease|0|||
131043599|NCT03505008|471794679|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
131043600|NCT03505008|471794680|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
131043601|NCT03505008|471794681|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
131043602|NCT03505008|471794678|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
131043603|NCT03505008|471794679|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
131043604|NCT03505008|471794680|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
131043605|NCT03505008|471794681|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
131043606|NCT03505008|471794678|FG000|Before Week 24 Randomization|Physician Decision|2|||
131043607|NCT03505008|471794679|FG001|Before Week 24 Randomization|Physician Decision|0|||
130778183|NCT01254656|470815326|FG002|Overall Study|Adverse Event|0|||
130778184|NCT01254656|470815324|FG000|Overall Study|Death|0|||
130778185|NCT01254656|470815325|FG001|Overall Study|Death|1|||
130778186|NCT01254656|470815326|FG002|Overall Study|Death|0|||
130778187|NCT03286218|470815327|FG000|Qualification Phase Period 1|Adverse Event|1|||
130778188|NCT03286218|470815328|FG001|Qualification Phase Period 1|Adverse Event|0|||
131043608|NCT03505008|471794680|FG002|Before Week 24 Randomization|Physician Decision|0|||
131043609|NCT03505008|471794681|FG003|Before Week 24 Randomization|Physician Decision|0|||
131043610|NCT03505008|471794678|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
130778189|NCT03286218|470815329|FG002|Qualification Phase Period 1|Adverse Event|0|||
130778190|NCT03286218|470815330|FG003|Qualification Phase Period 1|Adverse Event|0|||
130778191|NCT03286218|470815331|FG004|Qualification Phase Period 1|Adverse Event|0|||
130778192|NCT03286218|470815332|FG005|Qualification Phase Period 1|Adverse Event|0|||
130778193|NCT03286218|470815333|FG006|Qualification Phase Period 1|Adverse Event|0|||
130778194|NCT03286218|470815334|FG007|Qualification Phase Period 1|Adverse Event|0|||
130778195|NCT03286218|470815335|FG008|Qualification Phase Period 1|Adverse Event|0|||
130778196|NCT03286218|470815336|FG009|Qualification Phase Period 1|Adverse Event|0|||
130778197|NCT03286218|470815337|FG010|Qualification Phase Period 1|Adverse Event|0|||
130778198|NCT03286218|470815338|FG011|Qualification Phase Period 1|Adverse Event|0|||
130778199|NCT03286218|470815327|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778200|NCT03286218|470815328|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
130778201|NCT03286218|470815329|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778202|NCT03286218|470815330|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778203|NCT03286218|470815331|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778204|NCT03286218|470815332|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778205|NCT03286218|470815333|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778206|NCT03286218|470815334|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778207|NCT03286218|470815335|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778208|NCT03286218|470815336|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778209|NCT03286218|470815337|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778210|NCT03286218|470815338|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
130778211|NCT03286218|470815327|FG000|Qualification Phase Period 2|Adverse Event|0|||
131043611|NCT03505008|471794679|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
131043612|NCT03505008|471794680|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
131043613|NCT03505008|471794681|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
131043614|NCT03505008|471794678|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
131043615|NCT03505008|471794679|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
131043616|NCT03505008|471794680|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
131043617|NCT03505008|471794681|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
131043618|NCT03505008|471794678|FG000|Before Week 24 Randomization|Complication|1|||
131043619|NCT03505008|471794679|FG001|Before Week 24 Randomization|Complication|0|||
131043620|NCT03505008|471794680|FG002|Before Week 24 Randomization|Complication|0|||
131043621|NCT03505008|471794681|FG003|Before Week 24 Randomization|Complication|0|||
131043622|NCT03505008|471794678|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
130778212|NCT03286218|470815328|FG001|Qualification Phase Period 2|Adverse Event|1|||
130778213|NCT03286218|470815329|FG002|Qualification Phase Period 2|Adverse Event|0|||
130778214|NCT03286218|470815330|FG003|Qualification Phase Period 2|Adverse Event|0|||
130778215|NCT03286218|470815331|FG004|Qualification Phase Period 2|Adverse Event|0|||
130778216|NCT03286218|470815332|FG005|Qualification Phase Period 2|Adverse Event|0|||
130778217|NCT03286218|470815333|FG006|Qualification Phase Period 2|Adverse Event|0|||
130778218|NCT03286218|470815334|FG007|Qualification Phase Period 2|Adverse Event|0|||
130778219|NCT03286218|470815335|FG008|Qualification Phase Period 2|Adverse Event|0|||
130778220|NCT03286218|470815336|FG009|Qualification Phase Period 2|Adverse Event|0|||
130778221|NCT03286218|470815337|FG010|Qualification Phase Period 2|Adverse Event|0|||
130778222|NCT03286218|470815338|FG011|Qualification Phase Period 2|Adverse Event|0|||
130778223|NCT03286218|470815327|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
131043623|NCT03505008|471794679|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
131043624|NCT03505008|471794680|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
131043625|NCT03505008|471794681|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
131043626|NCT03505008|471794678|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
130977734|NCT00126438|471542931|FG001|Overall Study|Withdrawal due to adverse event|0|||
130977735|NCT00126438|471542930|FG000|Overall Study|Lost to Follow-up|22|||
130977736|NCT00126438|471542931|FG001|Overall Study|Lost to Follow-up|0|||
131227536|NCT00410410|472459753|FG004|Maintenance Period (MP)|Adverse Event|0|||
131227537|NCT00410410|472459754|FG005|Maintenance Period (MP)|Adverse Event|0|||
131227538|NCT00410410|472459755|FG006|Maintenance Period (MP)|Adverse Event|1|||
131227539|NCT00410410|472459756|FG007|Maintenance Period (MP)|Adverse Event|3|||
131227540|NCT00410410|472459757|FG008|Maintenance Period (MP)|Adverse Event|0|||
131227541|NCT00410410|472459749|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
130717947|NCT03893565|470593195|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
130717948|NCT03893565|470593196|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
130717949|NCT03893565|470593197|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
130717950|NCT03893565|470593198|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
130977737|NCT00126438|471542930|FG000|Overall Study|Protocol Violation|8|||
130977738|NCT00126438|471542931|FG001|Overall Study|Protocol Violation|8|||
130977739|NCT00126438|471542930|FG000|Overall Study|Withdrawal by Subject|3|||
130977740|NCT00126438|471542931|FG001|Overall Study|Withdrawal by Subject|2|||
130977741|NCT02313428|471542932|FG000|Overall Study|Lost to Follow-up|1|||
130977742|NCT02313428|471542933|FG001|Overall Study|Lost to Follow-up|1|||
130977743|NCT02899728|471542934|FG000|Overall Study|Withdrawal by Subject|1|||
130977744|NCT02899728|471542935|FG001|Overall Study|Withdrawal by Subject|1|||
130977745|NCT00593567|471544806|FG000|Overall Study|Adverse Event|2|||
130977746|NCT00593567|471544807|FG001|Overall Study|Adverse Event|0|||
130977747|NCT00593567|471544806|FG000|Overall Study|Physician Decision|2|||
130977748|NCT00593567|471544807|FG001|Overall Study|Physician Decision|0|||
130977749|NCT00593567|471544806|FG000|Overall Study|Protocol Violation|13|||
130977750|NCT00593567|471544807|FG001|Overall Study|Protocol Violation|7|||
130977751|NCT00593567|471544806|FG000|Overall Study|Lack of Efficacy|2|||
130977752|NCT00593567|471544807|FG001|Overall Study|Lack of Efficacy|1|||
130717951|NCT03893565|470593199|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
130717952|NCT03893565|470593200|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
130717953|NCT03893565|470593192|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717954|NCT03893565|470593193|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717955|NCT03893565|470593194|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717956|NCT03893565|470593195|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717957|NCT03893565|470593196|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717958|NCT03893565|470593197|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717959|NCT03893565|470593198|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717960|NCT03893565|470593199|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
130717961|NCT03893565|470593200|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130717962|NCT03893565|470593192|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717963|NCT03893565|470593193|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717964|NCT03893565|470593194|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717965|NCT03893565|470593195|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717966|NCT03893565|470593196|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717967|NCT03893565|470593197|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717968|NCT03893565|470593198|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717969|NCT03893565|470593199|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
130977753|NCT00593567|471544806|FG000|Overall Study|Withdrawal by Subject|1|||
130977754|NCT00593567|471544807|FG001|Overall Study|Withdrawal by Subject|2|||
130977755|NCT00844857|471544810|FG000|Overall Study|Adverse Event|24|||
130977756|NCT00844857|471544811|FG001|Overall Study|Adverse Event|5|||
130977757|NCT00844857|471544810|FG000|Overall Study|Sponsor Decision|1|||
131043627|NCT03505008|471794679|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
131043628|NCT03505008|471794680|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
131043629|NCT03505008|471794681|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
131043630|NCT03505008|471794678|FG000|After Week 24 Randomization|Adverse Event|0|||
131043631|NCT03505008|471794679|FG001|After Week 24 Randomization|Adverse Event|1|||
131043632|NCT03505008|471794680|FG002|After Week 24 Randomization|Adverse Event|2|||
131043633|NCT03505008|471794681|FG003|After Week 24 Randomization|Adverse Event|2|||
131043634|NCT03505008|471794678|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
131043635|NCT03505008|471794679|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
131043636|NCT03505008|471794680|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
131043637|NCT03505008|471794681|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
131043638|NCT03505008|471794678|FG000|After Week 24 Randomization|Protocol Violation|0|||
131043639|NCT03505008|471794679|FG001|After Week 24 Randomization|Protocol Violation|0|||
131043640|NCT03505008|471794680|FG002|After Week 24 Randomization|Protocol Violation|1|||
131227542|NCT00410410|472459750|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
131227543|NCT00410410|472459751|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
130977758|NCT00844857|471544811|FG001|Overall Study|Sponsor Decision|1|||
131227544|NCT00410410|472459752|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
130778224|NCT03286218|470815328|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
130778225|NCT03286218|470815329|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130778226|NCT03286218|470815330|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130778227|NCT03286218|470815331|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130778228|NCT03286218|470815332|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130778229|NCT03286218|470815333|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130778230|NCT03286218|470815334|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130778231|NCT03286218|470815335|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130778232|NCT03286218|470815336|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130778233|NCT03286218|470815337|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130778234|NCT03286218|470815338|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130778235|NCT03286218|470815327|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
130778236|NCT03286218|470815328|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
130778237|NCT03286218|470815329|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
130778238|NCT03286218|470815330|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
130778239|NCT03286218|470815331|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
130778240|NCT03286218|470815332|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
130778241|NCT03286218|470815333|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
130778242|NCT03286218|470815334|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
130778243|NCT03286218|470815335|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
130778244|NCT03286218|470815336|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
130778245|NCT03286218|470815337|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
130778246|NCT03286218|470815338|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
130778247|NCT03286218|470815327|FG000|Qualification Phase Period 2|Protocol Violation|2|||
131131778|NCT01425008|472108438|FG008|Dose Expansion Phase|Progressive Disease|0|||
131131779|NCT01425008|472108439|FG009|Dose Expansion Phase|Progressive Disease|0|||
130778248|NCT03286218|470815328|FG001|Qualification Phase Period 2|Protocol Violation|0|||
130778249|NCT03286218|470815329|FG002|Qualification Phase Period 2|Protocol Violation|0|||
130778250|NCT03286218|470815330|FG003|Qualification Phase Period 2|Protocol Violation|0|||
130778251|NCT03286218|470815331|FG004|Qualification Phase Period 2|Protocol Violation|0|||
131131780|NCT01425008|472108440|FG010|Dose Expansion Phase|Progressive Disease|10|||
130778252|NCT03286218|470815332|FG005|Qualification Phase Period 2|Protocol Violation|0|||
131131781|NCT01425008|472108441|FG011|Dose Expansion Phase|Progressive Disease|4|||
131131782|NCT01425008|472108442|FG012|Dose Expansion Phase|Progressive Disease|12|||
131043641|NCT03505008|471794681|FG003|After Week 24 Randomization|Protocol Violation|0|||
131043642|NCT03276676|471794685|FG000|Overall Study|Withdrawal by Subject|2|||
131043643|NCT03276676|471794686|FG001|Overall Study|Withdrawal by Subject|1|||
131043644|NCT04741776|471794688|FG000|Overall Study|Withdrawal by Subject|7|||
131043645|NCT04741776|471794689|FG001|Overall Study|Withdrawal by Subject|10|||
131043646|NCT04741776|471794690|FG002|Overall Study|Withdrawal by Subject|10|||
131043647|NCT04741776|471794691|FG003|Overall Study|Withdrawal by Subject|17|||
131043648|NCT04741776|471794688|FG000|Overall Study|Death|0|||
131043649|NCT04741776|471794689|FG001|Overall Study|Death|0|||
131043650|NCT04741776|471794690|FG002|Overall Study|Death|1|||
131043651|NCT04741776|471794691|FG003|Overall Study|Death|0|||
131043652|NCT04089865|471794692|FG000|Overall Study|Withdrawal by Subject|2|||
131043653|NCT04089865|471794693|FG001|Overall Study|Withdrawal by Subject|2|||
131043654|NCT04089865|471794694|FG002|Overall Study|Withdrawal by Subject|7|||
131043655|NCT04089865|471794695|FG003|Overall Study|Withdrawal by Subject|2|||
131043656|NCT03926130|471794696|FG000|Overall Study|Adverse Event|9|||
131043657|NCT03926130|471794697|FG001|Overall Study|Adverse Event|11|||
131043658|NCT03926130|471794698|FG002|Overall Study|Adverse Event|2|||
131043659|NCT03926130|471794699|FG003|Overall Study|Adverse Event|0|||
131043660|NCT03926130|471794696|FG000|Overall Study|Death|2|||
131043661|NCT03926130|471794697|FG001|Overall Study|Death|0|||
131043662|NCT03926130|471794698|FG002|Overall Study|Death|1|||
131043663|NCT03926130|471794699|FG003|Overall Study|Death|0|||
131043664|NCT03926130|471794696|FG000|Overall Study|Lack of Efficacy|14|||
131043665|NCT03926130|471794697|FG001|Overall Study|Lack of Efficacy|11|||
131043666|NCT03926130|471794698|FG002|Overall Study|Lack of Efficacy|7|||
131043667|NCT03926130|471794699|FG003|Overall Study|Lack of Efficacy|1|||
131043668|NCT03926130|471794696|FG000|Overall Study|Lost to Follow-up|0|||
131043669|NCT03926130|471794697|FG001|Overall Study|Lost to Follow-up|7|||
131043670|NCT03926130|471794698|FG002|Overall Study|Lost to Follow-up|1|||
131131783|NCT01425008|472108443|FG013|Dose Expansion Phase|Progressive Disease|1|||
131043671|NCT03926130|471794699|FG003|Overall Study|Lost to Follow-up|0|||
131043672|NCT03926130|471794696|FG000|Overall Study|As Reported by Investigator|2|||
131043673|NCT03926130|471794697|FG001|Overall Study|As Reported by Investigator|6|||
131043674|NCT03926130|471794698|FG002|Overall Study|As Reported by Investigator|6|||
131131784|NCT01425008|472108444|FG014|Dose Expansion Phase|Progressive Disease|5|||
131043675|NCT03926130|471794699|FG003|Overall Study|As Reported by Investigator|0|||
131043676|NCT03926130|471794696|FG000|Overall Study|Physician Decision|3|||
131043677|NCT03926130|471794697|FG001|Overall Study|Physician Decision|2|||
131131785|NCT01425008|472108445|FG015|Dose Expansion Phase|Progressive Disease|8|||
131131786|NCT01425008|472108446|FG016|Dose Expansion Phase|Progressive Disease|9|||
131131787|NCT01425008|472108447|FG017|Dose Expansion Phase|Progressive Disease|2|||
131131788|NCT01425008|472108448|FG018|Dose Expansion Phase|Progressive Disease|10|||
131131789|NCT01425008|472108430|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
131131790|NCT01425008|472108431|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
131131791|NCT01425008|472108432|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
131131792|NCT01425008|472108433|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
131131793|NCT01425008|472108434|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
131131794|NCT01425008|472108435|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
131131795|NCT01425008|472108436|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
131131796|NCT01425008|472108437|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
131131797|NCT01425008|472108438|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
131131798|NCT01425008|472108439|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
131131799|NCT01425008|472108440|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
131131800|NCT01425008|472108441|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
131131801|NCT01425008|472108442|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
131131802|NCT01425008|472108443|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
131131803|NCT01425008|472108444|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
131131804|NCT01425008|472108445|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
131131805|NCT01425008|472108446|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
131131806|NCT01425008|472108447|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
131131807|NCT01425008|472108448|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
131131808|NCT01425008|472108430|FG000|Dose Expansion Phase|Other|0|||
131131809|NCT01425008|472108431|FG001|Dose Expansion Phase|Other|0|||
131131810|NCT01425008|472108432|FG002|Dose Expansion Phase|Other|0|||
131131811|NCT01425008|472108433|FG003|Dose Expansion Phase|Other|0|||
131131812|NCT01425008|472108434|FG004|Dose Expansion Phase|Other|0|||
131131813|NCT01425008|472108435|FG005|Dose Expansion Phase|Other|0|||
131131814|NCT01425008|472108436|FG006|Dose Expansion Phase|Other|0|||
131131815|NCT01425008|472108437|FG007|Dose Expansion Phase|Other|0|||
131131816|NCT01425008|472108438|FG008|Dose Expansion Phase|Other|0|||
131131817|NCT01425008|472108439|FG009|Dose Expansion Phase|Other|0|||
131131818|NCT01425008|472108440|FG010|Dose Expansion Phase|Other|0|||
131131819|NCT01425008|472108441|FG011|Dose Expansion Phase|Other|0|||
131131820|NCT01425008|472108442|FG012|Dose Expansion Phase|Other|1|||
131131821|NCT01425008|472108443|FG013|Dose Expansion Phase|Other|0|||
131131822|NCT01425008|472108444|FG014|Dose Expansion Phase|Other|0|||
131131823|NCT01425008|472108445|FG015|Dose Expansion Phase|Other|0|||
131131824|NCT01425008|472108446|FG016|Dose Expansion Phase|Other|2|||
130717970|NCT03893565|470593200|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130717971|NCT03893565|470593192|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717972|NCT03893565|470593193|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717973|NCT03893565|470593194|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130977759|NCT00844857|471544810|FG000|Overall Study|Physician Decision|2|||
130977760|NCT00844857|471544811|FG001|Overall Study|Physician Decision|0|||
130977761|NCT00844857|471544810|FG000|Overall Study|Parent/Caregiver Decision|6|||
130977762|NCT00844857|471544811|FG001|Overall Study|Parent/Caregiver Decision|2|||
130977763|NCT00844857|471544810|FG000|Overall Study|Withdrawal by Subject|8|||
130977764|NCT00844857|471544811|FG001|Overall Study|Withdrawal by Subject|7|||
130977765|NCT00844857|471544810|FG000|Overall Study|Protocol Violation|6|||
130977766|NCT00844857|471544811|FG001|Overall Study|Protocol Violation|0|||
130977767|NCT00844857|471544810|FG000|Overall Study|Lack of Efficacy|5|||
130977768|NCT00844857|471544811|FG001|Overall Study|Lack of Efficacy|5|||
130977769|NCT00844857|471544810|FG000|Overall Study|Clinical Relapse|0|||
130977770|NCT00844857|471544811|FG001|Overall Study|Clinical Relapse|1|||
130977771|NCT00844857|471544810|FG000|Overall Study|Entry Criteria Not Met|0|||
130977772|NCT00844857|471544811|FG001|Overall Study|Entry Criteria Not Met|1|||
130977773|NCT00844857|471544810|FG000|Overall Study|Lost to Follow-up|2|||
130977774|NCT00844857|471544811|FG001|Overall Study|Lost to Follow-up|3|||
130977775|NCT00844857|471544810|FG000|Overall Study|Did Not Take Study Drug|3|||
130977776|NCT00844857|471544811|FG001|Overall Study|Did Not Take Study Drug|1|||
130977777|NCT00844857|471544810|FG000|Overall Study|Good Clinical Practice Violations|21|||
130977778|NCT00844857|471544811|FG001|Overall Study|Good Clinical Practice Violations|11|||
130977779|NCT02057874|471544812|FG000|Overall Study|participant did not return for scan|1|||
131131825|NCT01425008|472108447|FG017|Dose Expansion Phase|Other|0|||
131131826|NCT01425008|472108448|FG018|Dose Expansion Phase|Other|4|||
131131827|NCT01425008|472108430|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
131131828|NCT01425008|472108431|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
131131829|NCT01425008|472108432|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
131131830|NCT01425008|472108433|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
131131831|NCT01425008|472108434|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
131131832|NCT01425008|472108435|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
131131833|NCT01425008|472108436|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
130977780|NCT00440531|471544818|FG000|Overall Study|Adverse Event|1|||
130977781|NCT00440531|471544819|FG001|Overall Study|Adverse Event|0|||
130977782|NCT00440531|471544820|FG002|Overall Study|Adverse Event|2|||
130977783|NCT00440531|471544818|FG000|Overall Study|Withdrawal by Subject|2|||
130977784|NCT00440531|471544819|FG001|Overall Study|Withdrawal by Subject|0|||
130977785|NCT00440531|471544820|FG002|Overall Study|Withdrawal by Subject|0|||
130977786|NCT00440531|471544818|FG000|Overall Study|Protocol Violation|1|||
130977787|NCT00440531|471544819|FG001|Overall Study|Protocol Violation|2|||
130977788|NCT00440531|471544820|FG002|Overall Study|Protocol Violation|0|||
130977789|NCT00440531|471544818|FG000|Overall Study|Lost to Follow-up|4|||
130977790|NCT00440531|471544819|FG001|Overall Study|Lost to Follow-up|3|||
130977791|NCT00440531|471544820|FG002|Overall Study|Lost to Follow-up|5|||
130977792|NCT00440531|471544818|FG000|Overall Study|see pre-assignment details|2|||
130977793|NCT00440531|471544819|FG001|Overall Study|see pre-assignment details|0|||
130977794|NCT00440531|471544820|FG002|Overall Study|see pre-assignment details|0|||
130977795|NCT00447057|471544821|FG000|Overall Study|Adverse Event|4|||
130977796|NCT00447057|471544822|FG001|Overall Study|Adverse Event|10|||
130977797|NCT00447057|471544823|FG002|Overall Study|Adverse Event|0|||
130977798|NCT00447057|471544824|FG003|Overall Study|Adverse Event|3|||
130977799|NCT00447057|471544821|FG000|Overall Study|Death due to study disease|6|||
130977800|NCT00447057|471544822|FG001|Overall Study|Death due to study disease|4|||
130977801|NCT00447057|471544823|FG002|Overall Study|Death due to study disease|1|||
130977802|NCT00447057|471544824|FG003|Overall Study|Death due to study disease|1|||
130977803|NCT00447057|471544821|FG000|Overall Study|Lost to Follow-up|0|||
130977804|NCT00447057|471544822|FG001|Overall Study|Lost to Follow-up|1|||
130977805|NCT00447057|471544823|FG002|Overall Study|Lost to Follow-up|0|||
130977806|NCT00447057|471544824|FG003|Overall Study|Lost to Follow-up|0|||
130977807|NCT00447057|471544821|FG000|Overall Study|Entry criteria not met|1|||
130977808|NCT00447057|471544822|FG001|Overall Study|Entry criteria not met|1|||
130977809|NCT00447057|471544823|FG002|Overall Study|Entry criteria not met|0|||
130977810|NCT00447057|471544824|FG003|Overall Study|Entry criteria not met|0|||
130977811|NCT00447057|471544821|FG000|Overall Study|Protocol Violation|0|||
130977812|NCT00447057|471544822|FG001|Overall Study|Protocol Violation|1|||
130977813|NCT00447057|471544823|FG002|Overall Study|Protocol Violation|0|||
130977814|NCT00447057|471544824|FG003|Overall Study|Protocol Violation|0|||
130977815|NCT00447057|471544821|FG000|Overall Study|Withdrawal by Subject|4|||
130977816|NCT00447057|471544822|FG001|Overall Study|Withdrawal by Subject|5|||
130977817|NCT00447057|471544823|FG002|Overall Study|Withdrawal by Subject|1|||
130977818|NCT00447057|471544824|FG003|Overall Study|Withdrawal by Subject|1|||
130977819|NCT00447057|471544821|FG000|Overall Study|Physician Decision|9|||
130977820|NCT00447057|471544822|FG001|Overall Study|Physician Decision|6|||
130977821|NCT00447057|471544823|FG002|Overall Study|Physician Decision|3|||
130977822|NCT00447057|471544824|FG003|Overall Study|Physician Decision|1|||
130977823|NCT00447057|471544821|FG000|Overall Study|Sponsor decision|1|||
130977824|NCT00447057|471544822|FG001|Overall Study|Sponsor decision|1|||
130977825|NCT00447057|471544823|FG002|Overall Study|Sponsor decision|0|||
130977826|NCT00447057|471544824|FG003|Overall Study|Sponsor decision|0|||
130977827|NCT00447057|471544821|FG000|Overall Study|Progressive disease|58|||
130977828|NCT00447057|471544822|FG001|Overall Study|Progressive disease|43|||
130977829|NCT00447057|471544823|FG002|Overall Study|Progressive disease|13|||
130977830|NCT00447057|471544824|FG003|Overall Study|Progressive disease|18|||
130977831|NCT00447057|471544821|FG000|Overall Study|Death due to adverse event|0|||
130977832|NCT00447057|471544822|FG001|Overall Study|Death due to adverse event|0|||
131043678|NCT03926130|471794698|FG002|Overall Study|Physician Decision|1|||
130977833|NCT00447057|471544823|FG002|Overall Study|Death due to adverse event|1|||
130977834|NCT00447057|471544824|FG003|Overall Study|Death due to adverse event|2|||
130977835|NCT00447057|471544821|FG000|Overall Study|Death, study drug related|0|||
131043679|NCT03926130|471794699|FG003|Overall Study|Physician Decision|0|||
131043680|NCT03926130|471794696|FG000|Overall Study|Pregnancy|2|||
131043681|NCT03926130|471794697|FG001|Overall Study|Pregnancy|2|||
131043682|NCT03926130|471794698|FG002|Overall Study|Pregnancy|1|||
131043683|NCT03926130|471794699|FG003|Overall Study|Pregnancy|0|||
131043684|NCT03926130|471794696|FG000|Overall Study|Withdrawal by Subject|20|||
131043685|NCT03926130|471794697|FG001|Overall Study|Withdrawal by Subject|28|||
131043686|NCT03926130|471794698|FG002|Overall Study|Withdrawal by Subject|18|||
131043687|NCT03926130|471794699|FG003|Overall Study|Withdrawal by Subject|1|||
131043688|NCT03926130|471794696|FG000|Overall Study|Non-Compliance|1|||
131043689|NCT03926130|471794697|FG001|Overall Study|Non-Compliance|1|||
131043690|NCT03926130|471794698|FG002|Overall Study|Non-Compliance|0|||
130977836|NCT00447057|471544822|FG001|Overall Study|Death, study drug related|1|||
131043691|NCT03926130|471794699|FG003|Overall Study|Non-Compliance|0|||
131043692|NCT03926130|471794696|FG000|Overall Study|Disposition Not Captured|0|||
131227545|NCT00410410|472459753|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
131043693|NCT03926130|471794697|FG001|Overall Study|Disposition Not Captured|2|||
130977837|NCT00447057|471544823|FG002|Overall Study|Death, study drug related|0|||
130977838|NCT00447057|471544824|FG003|Overall Study|Death, study drug related|0|||
130977839|NCT03393000|471544828|FG000|Overall Study|Death|11|||
130977840|NCT03393000|471544828|FG000|Overall Study|Withdrawal by Subject|2|||
131043694|NCT03926130|471794698|FG002|Overall Study|Disposition Not Captured|1|||
130717974|NCT03893565|470593195|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130977841|NCT03393000|471544828|FG000|Overall Study|Physician Decision|1|||
130977842|NCT04493216|471544829|FG000|Overall Study|Study terminated by sponsor|30|||
130977843|NCT04493216|471544830|FG001|Overall Study|Study terminated by sponsor|33|||
130977844|NCT04493216|471544831|FG002|Overall Study|Study terminated by sponsor|28|||
130977845|NCT04493216|471544832|FG003|Overall Study|Study terminated by sponsor|27|||
130977846|NCT04493216|471544829|FG000|Overall Study|Withdrawal by Subject|2|||
130977847|NCT04493216|471544830|FG001|Overall Study|Withdrawal by Subject|1|||
130977848|NCT04493216|471544831|FG002|Overall Study|Withdrawal by Subject|1|||
130977849|NCT04493216|471544832|FG003|Overall Study|Withdrawal by Subject|2|||
130977850|NCT04493216|471544829|FG000|Overall Study|Protocol Violation|1|||
130977851|NCT04493216|471544830|FG001|Overall Study|Protocol Violation|2|||
130977852|NCT04493216|471544831|FG002|Overall Study|Protocol Violation|0|||
130977853|NCT04493216|471544832|FG003|Overall Study|Protocol Violation|2|||
130977854|NCT04493216|471544829|FG000|Overall Study|Physician Decision|0|||
130977855|NCT04493216|471544830|FG001|Overall Study|Physician Decision|0|||
130977856|NCT04493216|471544831|FG002|Overall Study|Physician Decision|1|||
130977857|NCT04493216|471544832|FG003|Overall Study|Physician Decision|0|||
130977858|NCT04493216|471544829|FG000|Overall Study|Lost to Follow-up|2|||
130977859|NCT04493216|471544830|FG001|Overall Study|Lost to Follow-up|1|||
130977860|NCT04493216|471544831|FG002|Overall Study|Lost to Follow-up|0|||
130977861|NCT04493216|471544832|FG003|Overall Study|Lost to Follow-up|1|||
130977862|NCT04493216|471544829|FG000|Overall Study|Adverse Event|1|||
130977863|NCT04493216|471544830|FG001|Overall Study|Adverse Event|4|||
130977864|NCT04493216|471544831|FG002|Overall Study|Adverse Event|5|||
130977865|NCT04493216|471544832|FG003|Overall Study|Adverse Event|2|||
130977866|NCT04493216|471544829|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
130977867|NCT04493216|471544830|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
130977868|NCT04493216|471544831|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
130977869|NCT04493216|471544832|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
130977870|NCT01559844|471544833|FG000|Overall Study|Consent Withdrawn|7|||
130977871|NCT01559844|471544833|FG000|Overall Study|Death|5|||
130977872|NCT01559844|471544833|FG000|Overall Study|Efficacy Failure|10|||
130977873|NCT01559844|471544833|FG000|Overall Study|No Longer A Transplant Candidate|3|||
130977874|NCT00951041|471544836|FG000|Overall Study|Withdrawal by Subject|1|||
130977875|NCT00951041|471544837|FG001|Overall Study|Withdrawal by Subject|1|||
130977876|NCT00951041|471544836|FG000|Overall Study|Lost to Follow-up|1|||
130977877|NCT00951041|471544837|FG001|Overall Study|Lost to Follow-up|0|||
130977878|NCT00951041|471544836|FG000|Overall Study|Other|3|||
130977879|NCT00951041|471544837|FG001|Overall Study|Other|0|||
130977880|NCT01514448|471544838|FG000|Overall Study|Death|7|||
130977881|NCT01514448|471544839|FG001|Overall Study|Death|8|||
130977882|NCT01514448|471544838|FG000|Overall Study|Withdrawal by Subject|2|||
130977883|NCT01514448|471544839|FG001|Overall Study|Withdrawal by Subject|0|||
130977884|NCT01514448|471544838|FG000|Overall Study|Lost to Follow-up|2|||
130977885|NCT01514448|471544839|FG001|Overall Study|Lost to Follow-up|0|||
130977886|NCT01514448|471544838|FG000|Overall Study|New Cancer Therapy|1|||
130977887|NCT01514448|471544839|FG001|Overall Study|New Cancer Therapy|0|||
130977888|NCT02314624|471544840|FG000|Overall Study|No participating patient|16|||
130977889|NCT02314624|471544841|FG001|Overall Study|No participating patient|13|||
130977890|NCT02314624|471544840|FG000|Overall Study|Participant withdrew|7|||
130977891|NCT02314624|471544841|FG001|Overall Study|Participant withdrew|2|||
130977892|NCT02314624|471544840|FG000|Overall Study|Lost to Follow-up|2|||
130977893|NCT02314624|471544841|FG001|Overall Study|Lost to Follow-up|5|||
130977894|NCT02314624|471544840|FG000|Overall Study|Dropped/Excluded by PI|6|||
130977895|NCT02314624|471544841|FG001|Overall Study|Dropped/Excluded by PI|6|||
130977896|NCT03151005|471544844|FG000|Overall Study|Lost to Follow-up|5|||
130977897|NCT03151005|471544845|FG001|Overall Study|Lost to Follow-up|5|||
130977898|NCT04786444|471544846|FG000|Overall Study|Withdrawal by Subject|4|||
130977899|NCT04786444|471544847|FG001|Overall Study|Withdrawal by Subject|7|||
130977900|NCT04786444|471544848|FG002|Overall Study|Withdrawal by Subject|2|||
130977901|NCT04786444|471544846|FG000|Overall Study|Lost to Follow-up|11|||
130977902|NCT04786444|471544847|FG001|Overall Study|Lost to Follow-up|9|||
130977903|NCT04786444|471544848|FG002|Overall Study|Lost to Follow-up|10|||
130977904|NCT04786444|471544846|FG000|Overall Study|Subject would like to become pregnant|0|||
130977905|NCT04786444|471544847|FG001|Overall Study|Subject would like to become pregnant|1|||
130977906|NCT04786444|471544848|FG002|Overall Study|Subject would like to become pregnant|0|||
131043695|NCT03926130|471794699|FG003|Overall Study|Disposition Not Captured|0|||
131043696|NCT03583333|471794700|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
131043697|NCT03583333|471794701|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
130977907|NCT02462876|471544849|FG000|Overall Study|Death|3|||
130977908|NCT02462876|471544849|FG000|Overall Study|Lost to Follow-up|7|||
130977909|NCT02462876|471544849|FG000|Overall Study|Surgical Bypass|9|||
130977910|NCT02462876|471544849|FG000|Overall Study|Amputation Above the Metatarsals|1|||
130977911|NCT02462876|471544849|FG000|Overall Study|36 months follow-up visit missed|1|||
130977912|NCT02462876|471544849|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
131131834|NCT01425008|472108437|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
131131835|NCT01425008|472108438|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
131131836|NCT01425008|472108439|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
130778253|NCT03286218|470815333|FG006|Qualification Phase Period 2|Protocol Violation|0|||
130778254|NCT03286218|470815334|FG007|Qualification Phase Period 2|Protocol Violation|0|||
130778255|NCT03286218|470815335|FG008|Qualification Phase Period 2|Protocol Violation|0|||
130977913|NCT02462876|471544849|FG000|Overall Study|Patient did not come back to the vascular department|1|||
130977914|NCT02462876|471544849|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
131131837|NCT01425008|472108440|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
131131838|NCT01425008|472108441|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
130977915|NCT02462876|471544849|FG000|Overall Study|Patient refused to come back|1|||
130977916|NCT02462876|471544849|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
130977917|NCT02462876|471544849|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
130977918|NCT01786512|471544854|FG000|Overall Study|Lost to Follow-up|0|||
130778256|NCT03286218|470815336|FG009|Qualification Phase Period 2|Protocol Violation|0|||
130778257|NCT03286218|470815337|FG010|Qualification Phase Period 2|Protocol Violation|0|||
130778258|NCT03286218|470815338|FG011|Qualification Phase Period 2|Protocol Violation|0|||
130778259|NCT03286218|470815327|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
130778260|NCT03286218|470815328|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
130778261|NCT03286218|470815329|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
130778262|NCT03286218|470815330|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
130778263|NCT03286218|470815331|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
130778264|NCT03286218|470815332|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
130778265|NCT03286218|470815333|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
130778266|NCT03286218|470815334|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
130778267|NCT03286218|470815335|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
130778268|NCT03286218|470815336|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
130778269|NCT03286218|470815337|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
130778270|NCT03286218|470815338|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
130778271|NCT03286218|470815327|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
130778272|NCT03286218|470815328|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
130778273|NCT03286218|470815329|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
130778274|NCT03286218|470815330|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
130778275|NCT03286218|470815331|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
130778276|NCT03286218|470815332|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
130778277|NCT03286218|470815333|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
130778278|NCT03286218|470815334|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
130778279|NCT03286218|470815335|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
130778280|NCT03286218|470815336|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
130778281|NCT03286218|470815337|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
130778282|NCT03286218|470815338|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
130778283|NCT03286218|470815327|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
130778284|NCT03286218|470815328|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
130778285|NCT03286218|470815329|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
130778286|NCT03286218|470815330|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
130778287|NCT03286218|470815331|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
130977919|NCT01786512|471544855|FG001|Overall Study|Lost to Follow-up|0|||
130977920|NCT01786512|471544856|FG002|Overall Study|Lost to Follow-up|0|||
130977921|NCT01786512|471544857|FG003|Overall Study|Lost to Follow-up|0|||
130977922|NCT01786512|471544858|FG004|Overall Study|Lost to Follow-up|0|||
130977923|NCT01786512|471544859|FG005|Overall Study|Lost to Follow-up|0|||
130977924|NCT01786512|471544860|FG006|Overall Study|Lost to Follow-up|0|||
130977925|NCT01786512|471544861|FG007|Overall Study|Lost to Follow-up|0|||
130977926|NCT01786512|471544862|FG008|Overall Study|Lost to Follow-up|0|||
130977927|NCT01786512|471544863|FG009|Overall Study|Lost to Follow-up|1|||
130977928|NCT01786512|471544864|FG010|Overall Study|Lost to Follow-up|0|||
130977929|NCT01786512|471544854|FG000|Overall Study|Decision by sponsor|0|||
130977930|NCT01786512|471544855|FG001|Overall Study|Decision by sponsor|0|||
130977931|NCT01786512|471544856|FG002|Overall Study|Decision by sponsor|0|||
130977932|NCT01786512|471544857|FG003|Overall Study|Decision by sponsor|0|||
130977933|NCT01786512|471544858|FG004|Overall Study|Decision by sponsor|0|||
131131839|NCT01425008|472108442|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
131131840|NCT01425008|472108443|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
130977934|NCT01786512|471544859|FG005|Overall Study|Decision by sponsor|0|||
131131841|NCT01425008|472108444|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
130778288|NCT03286218|470815332|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
130778289|NCT03286218|470815333|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
130778290|NCT03286218|470815334|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
130977935|NCT01786512|471544860|FG006|Overall Study|Decision by sponsor|0|||
130977936|NCT01786512|471544861|FG007|Overall Study|Decision by sponsor|0|||
130977937|NCT01786512|471544862|FG008|Overall Study|Decision by sponsor|0|||
131131842|NCT01425008|472108445|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
131131843|NCT01425008|472108446|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
131131844|NCT01425008|472108447|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
131131845|NCT01425008|472108448|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
131131846|NCT01425008|472108430|FG000|Dose Expansion Phase|Adverse Event|0|||
130977938|NCT01786512|471544863|FG009|Overall Study|Decision by sponsor|0|||
130977939|NCT01786512|471544864|FG010|Overall Study|Decision by sponsor|2|||
130977940|NCT01786512|471544854|FG000|Overall Study|Withdrawal by Subject|0|||
130977941|NCT01786512|471544855|FG001|Overall Study|Withdrawal by Subject|1|||
130977942|NCT01786512|471544856|FG002|Overall Study|Withdrawal by Subject|0|||
131131847|NCT01425008|472108431|FG001|Dose Expansion Phase|Adverse Event|0|||
131131848|NCT01425008|472108432|FG002|Dose Expansion Phase|Adverse Event|0|||
131131849|NCT01425008|472108433|FG003|Dose Expansion Phase|Adverse Event|0|||
131131850|NCT01425008|472108434|FG004|Dose Expansion Phase|Adverse Event|0|||
131131851|NCT01425008|472108435|FG005|Dose Expansion Phase|Adverse Event|0|||
131131852|NCT01425008|472108436|FG006|Dose Expansion Phase|Adverse Event|0|||
130717975|NCT03893565|470593196|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717976|NCT03893565|470593197|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717977|NCT03893565|470593198|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717978|NCT03893565|470593199|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
130717979|NCT03893565|470593200|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130717980|NCT03893565|470593192|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717981|NCT03893565|470593193|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717982|NCT03893565|470593194|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717983|NCT03893565|470593195|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717984|NCT03893565|470593196|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717985|NCT03893565|470593197|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717986|NCT03893565|470593198|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717987|NCT03893565|470593199|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130717988|NCT03893565|470593200|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
130717989|NCT02387983|470593204|FG000|Overall Study|Adverse Event|4|||
130717990|NCT02387983|470593204|FG000|Overall Study|Protocol Violation|1|||
130717991|NCT02387983|470593204|FG000|Overall Study|Withdrawal by Subject|2|||
130717992|NCT02440568|470593205|FG000|Overall Study|Death|1|||
130717993|NCT02440568|470593206|FG001|Overall Study|Death|3|||
130717994|NCT02440568|470593207|FG002|Overall Study|Death|4|||
130717995|NCT02440568|470593208|FG003|Overall Study|Death|2|||
130717996|NCT02440568|470593205|FG000|Overall Study|Lack of Efficacy|2|||
130717997|NCT02440568|470593206|FG001|Overall Study|Lack of Efficacy|0|||
130717998|NCT02440568|470593207|FG002|Overall Study|Lack of Efficacy|1|||
130717999|NCT02440568|470593208|FG003|Overall Study|Lack of Efficacy|0|||
130718000|NCT02440568|470593205|FG000|Overall Study|Lost to Follow-up|1|||
130718001|NCT02440568|470593206|FG001|Overall Study|Lost to Follow-up|0|||
130718002|NCT02440568|470593207|FG002|Overall Study|Lost to Follow-up|0|||
130718003|NCT02440568|470593208|FG003|Overall Study|Lost to Follow-up|0|||
130718004|NCT02302859|470593211|FG000|Overall Study|Lost Phone|1|||
130718005|NCT02302859|470593212|FG001|Overall Study|Lost Phone|1|||
130718006|NCT02302859|470593211|FG000|Overall Study|Withdrawal by Subject|0|||
130718007|NCT02302859|470593212|FG001|Overall Study|Withdrawal by Subject|1|||
130718008|NCT01157897|470593222|FG000|Overall Study|Lost to Follow-up|2|||
130718009|NCT01157897|470593223|FG001|Overall Study|Lost to Follow-up|0|||
130718010|NCT01157897|470593224|FG002|Overall Study|Lost to Follow-up|0|||
130718011|NCT01157897|470593225|FG003|Overall Study|Lost to Follow-up|1|||
130718012|NCT01157897|470593222|FG000|Overall Study|Relocated|0|||
130718013|NCT01157897|470593223|FG001|Overall Study|Relocated|2|||
130718014|NCT01157897|470593224|FG002|Overall Study|Relocated|0|||
130778291|NCT03286218|470815335|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
130977943|NCT01786512|471544857|FG003|Overall Study|Withdrawal by Subject|0|||
130977944|NCT01786512|471544858|FG004|Overall Study|Withdrawal by Subject|0|||
130977945|NCT01786512|471544859|FG005|Overall Study|Withdrawal by Subject|0|||
131131853|NCT01425008|472108437|FG007|Dose Expansion Phase|Adverse Event|0|||
131131854|NCT01425008|472108438|FG008|Dose Expansion Phase|Adverse Event|0|||
131131855|NCT01425008|472108439|FG009|Dose Expansion Phase|Adverse Event|0|||
131131856|NCT01425008|472108440|FG010|Dose Expansion Phase|Adverse Event|2|||
130718015|NCT01157897|470593225|FG003|Overall Study|Relocated|0|||
130718016|NCT03734666|470593226|FG000|Overall Study|Other|7|||
130718017|NCT03734666|470593227|FG001|Overall Study|Other|4|||
130718018|NCT03734666|470593226|FG000|Overall Study|Lost to Follow-up|12|||
130718019|NCT03734666|470593227|FG001|Overall Study|Lost to Follow-up|12|||
130718020|NCT03276221|470593228|FG000|Overall Study|Lost to Follow-up|6|||
130718021|NCT03276221|470593229|FG001|Overall Study|Lost to Follow-up|2|||
130778292|NCT03286218|470815336|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
130977946|NCT01786512|471544860|FG006|Overall Study|Withdrawal by Subject|1|||
130977947|NCT01786512|471544861|FG007|Overall Study|Withdrawal by Subject|0|||
131131857|NCT01425008|472108441|FG011|Dose Expansion Phase|Adverse Event|3|||
130977948|NCT01786512|471544862|FG008|Overall Study|Withdrawal by Subject|0|||
130977949|NCT01786512|471544863|FG009|Overall Study|Withdrawal by Subject|3|||
130977950|NCT01786512|471544864|FG010|Overall Study|Withdrawal by Subject|7|||
130977951|NCT01786512|471544854|FG000|Overall Study|Death|0|||
130977952|NCT01786512|471544855|FG001|Overall Study|Death|0|||
130977953|NCT01786512|471544856|FG002|Overall Study|Death|0|||
130977954|NCT01786512|471544857|FG003|Overall Study|Death|0|||
130977955|NCT01786512|471544858|FG004|Overall Study|Death|0|||
130977956|NCT01786512|471544859|FG005|Overall Study|Death|0|||
130977957|NCT01786512|471544860|FG006|Overall Study|Death|0|||
130977958|NCT01786512|471544861|FG007|Overall Study|Death|0|||
130977959|NCT01786512|471544862|FG008|Overall Study|Death|4|||
130977960|NCT01786512|471544863|FG009|Overall Study|Death|1|||
130977961|NCT01786512|471544864|FG010|Overall Study|Death|3|||
130977962|NCT00605293|471544865|FG000|Overall Study|Death|2|||
130977963|NCT00605293|471544866|FG001|Overall Study|Death|1|||
130977964|NCT00605293|471544865|FG000|Overall Study|Insufficient Therapeutic Response|2|||
130977965|NCT00605293|471544866|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130977966|NCT00605293|471544865|FG000|Overall Study|Adverse Event|1|||
130977967|NCT00605293|471544866|FG001|Overall Study|Adverse Event|0|||
130977968|NCT00605293|471544865|FG000|Overall Study|Holidays Dialysis Out|1|||
130977969|NCT00605293|471544866|FG001|Overall Study|Holidays Dialysis Out|0|||
130977970|NCT00605293|471544865|FG000|Overall Study|Blood Transfusion|7|||
130977971|NCT00605293|471544866|FG001|Overall Study|Blood Transfusion|1|||
130977972|NCT00605293|471544865|FG000|Overall Study|Renal Transplantation|3|||
130977973|NCT00605293|471544866|FG001|Overall Study|Renal Transplantation|1|||
130977974|NCT00605293|471544865|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
130977975|NCT00605293|471544866|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
130977976|NCT00605293|471544865|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
130977977|NCT00605293|471544866|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
130977978|NCT00605293|471544865|FG000|Overall Study|Principal Investigator Decision|0|||
130977979|NCT00605293|471544866|FG001|Overall Study|Principal Investigator Decision|1|||
130977980|NCT03137303|471544868|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
130977981|NCT03137303|471544869|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
130977982|NCT03137303|471544868|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
130977983|NCT03137303|471544869|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
130977984|NCT03137303|471544868|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
130977985|NCT03137303|471544869|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
130977986|NCT03137303|471544868|FG000|T3: 9-month Follow-up|Death|1|||
130977987|NCT03137303|471544869|FG001|T3: 9-month Follow-up|Death|0|||
130977988|NCT03137303|471544868|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
130977989|NCT03137303|471544869|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
130977990|NCT03137303|471544868|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
130977991|NCT03137303|471544869|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
130977992|NCT03137303|471544868|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
130977993|NCT03137303|471544869|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
130977994|NCT02723864|471544872|FG000|Overall Study|Refused further treatment|1|||
130977995|NCT02723864|471544873|FG001|Overall Study|Refused further treatment|0|||
130977996|NCT02723864|471544874|FG002|Overall Study|Refused further treatment|0|||
130977997|NCT02723864|471544875|FG003|Overall Study|Refused further treatment|0|||
130977998|NCT02723864|471544876|FG004|Overall Study|Refused further treatment|1|||
130977999|NCT02723864|471544877|FG005|Overall Study|Refused further treatment|2|||
130978000|NCT02723864|471544878|FG006|Overall Study|Refused further treatment|0|||
130978001|NCT02723864|471544872|FG000|Overall Study|Exceed treatment hold time|0|||
130978002|NCT02723864|471544873|FG001|Overall Study|Exceed treatment hold time|1|||
130978003|NCT02723864|471544874|FG002|Overall Study|Exceed treatment hold time|0|||
130978004|NCT02723864|471544875|FG003|Overall Study|Exceed treatment hold time|0|||
130978005|NCT02723864|471544876|FG004|Overall Study|Exceed treatment hold time|0|||
130978006|NCT02723864|471544877|FG005|Overall Study|Exceed treatment hold time|0|||
130978007|NCT02723864|471544878|FG006|Overall Study|Exceed treatment hold time|0|||
130978008|NCT02723864|471544872|FG000|Overall Study|Clinical progression|0|||
130978009|NCT02723864|471544873|FG001|Overall Study|Clinical progression|0|||
130978010|NCT02723864|471544874|FG002|Overall Study|Clinical progression|1|||
131131858|NCT01425008|472108442|FG012|Dose Expansion Phase|Adverse Event|3|||
131131859|NCT01425008|472108443|FG013|Dose Expansion Phase|Adverse Event|0|||
131131860|NCT01425008|472108444|FG014|Dose Expansion Phase|Adverse Event|1|||
130978011|NCT02723864|471544875|FG003|Overall Study|Clinical progression|0|||
130978012|NCT02723864|471544876|FG004|Overall Study|Clinical progression|0|||
130978013|NCT02723864|471544877|FG005|Overall Study|Clinical progression|3|||
131131861|NCT01425008|472108445|FG015|Dose Expansion Phase|Adverse Event|1|||
131131862|NCT01425008|472108446|FG016|Dose Expansion Phase|Adverse Event|5|||
130978014|NCT02723864|471544878|FG006|Overall Study|Clinical progression|1|||
130978015|NCT02723864|471544872|FG000|Overall Study|Physician Decision|0|||
130978016|NCT02723864|471544873|FG001|Overall Study|Physician Decision|0|||
130978017|NCT02723864|471544874|FG002|Overall Study|Physician Decision|0|||
130978018|NCT02723864|471544875|FG003|Overall Study|Physician Decision|0|||
131131863|NCT01425008|472108447|FG017|Dose Expansion Phase|Adverse Event|0|||
130978019|NCT02723864|471544876|FG004|Overall Study|Physician Decision|0|||
130978020|NCT02723864|471544877|FG005|Overall Study|Physician Decision|0|||
130978021|NCT02723864|471544878|FG006|Overall Study|Physician Decision|1|||
130978022|NCT02723864|471544872|FG000|Overall Study|Changes in patient condition|0|||
130978023|NCT02723864|471544873|FG001|Overall Study|Changes in patient condition|0|||
130978024|NCT02723864|471544874|FG002|Overall Study|Changes in patient condition|0|||
130978025|NCT02723864|471544875|FG003|Overall Study|Changes in patient condition|0|||
130978026|NCT02723864|471544876|FG004|Overall Study|Changes in patient condition|0|||
130978027|NCT02723864|471544877|FG005|Overall Study|Changes in patient condition|1|||
130978028|NCT02723864|471544878|FG006|Overall Study|Changes in patient condition|0|||
130978029|NCT02723864|471544872|FG000|Overall Study|Patient choice|0|||
130978030|NCT02723864|471544873|FG001|Overall Study|Patient choice|0|||
130978031|NCT02723864|471544874|FG002|Overall Study|Patient choice|0|||
130978032|NCT02723864|471544875|FG003|Overall Study|Patient choice|0|||
130978033|NCT02723864|471544876|FG004|Overall Study|Patient choice|0|||
130978034|NCT02723864|471544877|FG005|Overall Study|Patient choice|1|||
130978035|NCT02723864|471544878|FG006|Overall Study|Patient choice|0|||
130978036|NCT02723864|471544872|FG000|Overall Study|Adverse Event|0|||
130978037|NCT02723864|471544873|FG001|Overall Study|Adverse Event|0|||
130978038|NCT02723864|471544874|FG002|Overall Study|Adverse Event|0|||
130978039|NCT02723864|471544875|FG003|Overall Study|Adverse Event|0|||
130978040|NCT02723864|471544876|FG004|Overall Study|Adverse Event|0|||
130978041|NCT02723864|471544877|FG005|Overall Study|Adverse Event|1|||
130978042|NCT02723864|471544878|FG006|Overall Study|Adverse Event|0|||
130978043|NCT02723864|471544872|FG000|Overall Study|Started new treatment|0|||
130978044|NCT02723864|471544873|FG001|Overall Study|Started new treatment|0|||
130978045|NCT02723864|471544874|FG002|Overall Study|Started new treatment|0|||
130978046|NCT02723864|471544875|FG003|Overall Study|Started new treatment|0|||
130978047|NCT02723864|471544876|FG004|Overall Study|Started new treatment|0|||
130978048|NCT02723864|471544877|FG005|Overall Study|Started new treatment|1|||
130978049|NCT02723864|471544878|FG006|Overall Study|Started new treatment|0|||
130978050|NCT02723864|471544872|FG000|Overall Study|Switched to alternative treatment|0|||
130978051|NCT02723864|471544873|FG001|Overall Study|Switched to alternative treatment|0|||
130978052|NCT02723864|471544874|FG002|Overall Study|Switched to alternative treatment|0|||
130978053|NCT02723864|471544875|FG003|Overall Study|Switched to alternative treatment|0|||
130978054|NCT02723864|471544876|FG004|Overall Study|Switched to alternative treatment|0|||
130978055|NCT02723864|471544877|FG005|Overall Study|Switched to alternative treatment|1|||
130978056|NCT02723864|471544878|FG006|Overall Study|Switched to alternative treatment|0|||
130978057|NCT02723864|471544872|FG000|Overall Study|Late determination of ineligibility|0|||
130978058|NCT02723864|471544873|FG001|Overall Study|Late determination of ineligibility|0|||
130978059|NCT02723864|471544874|FG002|Overall Study|Late determination of ineligibility|0|||
130978060|NCT02723864|471544875|FG003|Overall Study|Late determination of ineligibility|0|||
130978061|NCT02723864|471544876|FG004|Overall Study|Late determination of ineligibility|0|||
130978062|NCT02723864|471544877|FG005|Overall Study|Late determination of ineligibility|1|||
130978063|NCT02723864|471544878|FG006|Overall Study|Late determination of ineligibility|0|||
130978064|NCT00815295|471544886|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
130978065|NCT00815295|471544887|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
130978066|NCT00815295|471544888|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
130978067|NCT00530855|471544889|FG000|Overall Study|Lack of Efficacy|20|||
130978068|NCT00530855|471544889|FG000|Overall Study|Withdrawal by Subject|30|||
130978069|NCT00530855|471544889|FG000|Overall Study|Fatal Serious AE|3|||
130978070|NCT00530855|471544889|FG000|Overall Study|Non Fatal Serious AE|7|||
130978071|NCT00530855|471544889|FG000|Overall Study|Non Fatal Non Serious AE|12|||
130978072|NCT00530855|471544889|FG000|Overall Study|Protocol Violation|3|||
130978073|NCT00530855|471544889|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
130978074|NCT00530855|471544889|FG000|Overall Study|Lost to Follow-up|9|||
130978075|NCT00530855|471544889|FG000|Overall Study|Other reason for premature termination|17|||
130978076|NCT01292876|471544890|FG000|Overall Study|Physician Decision|4|||
130978077|NCT01328574|471544906|FG000|Overall Study|Refused further treatment|1|||
130978078|NCT00003298|471544907|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
130978079|NCT00003298|471544907|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
130978080|NCT00003298|471544907|FG000|Surgery|Unresectable at surgery|3|||
130978081|NCT00003298|471544907|FG000|Surgery|Progression before surgery|2|||
130978082|NCT00003298|471544907|FG000|Surgery|Unevaluable and off study|2|||
130978083|NCT00003298|471544907|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
130978084|NCT00003298|471544907|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
130978085|NCT00003298|471544907|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
130978086|NCT00003298|471544907|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
130978087|NCT00003298|471544907|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
130978088|NCT00003298|471544907|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
130978089|NCT00003298|471544907|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
130978090|NCT00003298|471544907|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
130978091|NCT00003298|471544907|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
131131864|NCT01425008|472108448|FG018|Dose Expansion Phase|Adverse Event|3|||
131131865|NCT01425008|472108430|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
131131866|NCT01425008|472108431|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
130778293|NCT03286218|470815337|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
130778294|NCT03286218|470815338|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
130778295|NCT02532374|470815341|FG000|Overall Study|Withdrawal by Subject|1|||
130778296|NCT02532374|470815341|FG000|Overall Study|Physician Decision|1|||
130778297|NCT02762084|470815342|FG000|Overall Study|Withdrawal by Subject|1|||
130978092|NCT00003298|471544907|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
130978093|NCT01994954|471544912|FG000|Overall Study|Death|1|||
130978094|NCT01994954|471544913|FG001|Overall Study|Death|0|||
130978095|NCT01994954|471544912|FG000|Overall Study|Withdrawal by Subject|9|||
130978096|NCT01994954|471544913|FG001|Overall Study|Withdrawal by Subject|14|||
130978097|NCT01994954|471544912|FG000|Overall Study|Physician Decision|2|||
130978098|NCT01994954|471544913|FG001|Overall Study|Physician Decision|2|||
130978099|NCT01994954|471544912|FG000|Overall Study|Lost to Follow-up|8|||
130978100|NCT01994954|471544913|FG001|Overall Study|Lost to Follow-up|10|||
130978101|NCT01994954|471544912|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
130978102|NCT01994954|471544913|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
130978103|NCT01454583|471544918|FG000|1st Year|Lost to Follow-up|1057|||
130978104|NCT01454583|471544919|FG001|1st Year|Lost to Follow-up|318|||
130978105|NCT01454583|471544920|FG002|1st Year|Lost to Follow-up|180|||
130978106|NCT01454583|471544918|FG000|2nd Year|Lost to Follow-up|3965|||
130978107|NCT01454583|471544919|FG001|2nd Year|Lost to Follow-up|1049|||
130978108|NCT01454583|471544920|FG002|2nd Year|Lost to Follow-up|737|||
130978109|NCT01454583|471544918|FG000|3rd Year|Lost to Follow-up|1959|||
130978110|NCT01454583|471544919|FG001|3rd Year|Lost to Follow-up|512|||
130978111|NCT01454583|471544920|FG002|3rd Year|Lost to Follow-up|297|||
130978112|NCT02677116|471544923|FG000|Overall Study|Adverse Event|0|||
130978113|NCT02677116|471544924|FG001|Overall Study|Adverse Event|1|||
130978114|NCT02677116|471544925|FG002|Overall Study|Adverse Event|0|||
130978115|NCT02677116|471544926|FG003|Overall Study|Adverse Event|0|||
130978116|NCT02677116|471544927|FG004|Overall Study|Adverse Event|0|||
130978117|NCT02677116|471544928|FG005|Overall Study|Adverse Event|1|||
130978118|NCT02677116|471544929|FG006|Overall Study|Adverse Event|1|||
130978119|NCT02677116|471544930|FG007|Overall Study|Adverse Event|0|||
130978120|NCT02677116|471544931|FG008|Overall Study|Adverse Event|0|||
130978121|NCT02677116|471544923|FG000|Overall Study|Physician Decision|0|||
130978122|NCT02677116|471544924|FG001|Overall Study|Physician Decision|2|||
130978123|NCT02677116|471544925|FG002|Overall Study|Physician Decision|3|||
130978124|NCT02677116|471544926|FG003|Overall Study|Physician Decision|2|||
130978125|NCT02677116|471544927|FG004|Overall Study|Physician Decision|1|||
130978126|NCT02677116|471544928|FG005|Overall Study|Physician Decision|3|||
131043698|NCT03583333|471794700|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
131043699|NCT03583333|471794701|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
131043700|NCT03583333|471794700|FG000|Overall Study|Withdrawal by Subject|9|||
131043701|NCT03583333|471794701|FG001|Overall Study|Withdrawal by Subject|5|||
131043702|NCT03583333|471794700|FG000|Overall Study|Physician Decision|3|||
131043703|NCT03583333|471794701|FG001|Overall Study|Physician Decision|2|||
131043704|NCT03583333|471794700|FG000|Overall Study|Death|12|||
131043705|NCT03583333|471794701|FG001|Overall Study|Death|7|||
131043706|NCT03824366|471794709|FG000|Overall Study|Death|1|||
131043707|NCT03824366|471794709|FG000|Overall Study|Previously unidentified metal artifact|1|||
131043708|NCT03824366|471794709|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
131043709|NCT03824366|471794709|FG000|Overall Study|Withdrawal by Subject|1|||
131043710|NCT05069896|471794710|FG000|Overall Study|Adverse Event|0|||
131043711|NCT05069896|471794711|FG001|Overall Study|Adverse Event|1|||
131043712|NCT05069896|471794712|FG002|Overall Study|Adverse Event|1|||
131043713|NCT05069896|471794713|FG003|Overall Study|Adverse Event|0|||
131043714|NCT05069896|471794714|FG004|Overall Study|Adverse Event|0|||
131043715|NCT05069896|471794715|FG005|Overall Study|Adverse Event|0|||
131043716|NCT05069896|471794710|FG000|Overall Study|Lost to Follow-up|0|||
131043717|NCT05069896|471794711|FG001|Overall Study|Lost to Follow-up|0|||
131043718|NCT05069896|471794712|FG002|Overall Study|Lost to Follow-up|1|||
131043719|NCT05069896|471794713|FG003|Overall Study|Lost to Follow-up|0|||
131043720|NCT05069896|471794714|FG004|Overall Study|Lost to Follow-up|1|||
131043721|NCT05069896|471794715|FG005|Overall Study|Lost to Follow-up|2|||
131043722|NCT04068831|471794716|FG000|Overall Study|Disease Progression|10|||
130978127|NCT02677116|471544929|FG006|Overall Study|Physician Decision|1|||
130978128|NCT02677116|471544930|FG007|Overall Study|Physician Decision|1|||
130978129|NCT02677116|471544931|FG008|Overall Study|Physician Decision|2|||
130978130|NCT02677116|471544923|FG000|Overall Study|Withdrawal by parent or guardian|2|||
130978131|NCT02677116|471544924|FG001|Overall Study|Withdrawal by parent or guardian|1|||
131043723|NCT04068831|471794717|FG001|Overall Study|Disease Progression|8|||
131043724|NCT04820322|471794718|FG000|Overall Study|Adverse Event|1|||
131043725|NCT04820322|471794719|FG001|Overall Study|Adverse Event|0|||
131043726|NCT00323856|471794723|FG000|Overall Study|Withdrawal by Subject|1|||
131043727|NCT00323856|471794723|FG000|Overall Study|Was uncooperative and noncompliant|1|||
131131867|NCT01425008|472108432|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
131131868|NCT01425008|472108433|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
131131869|NCT01425008|472108434|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
130978132|NCT02677116|471544925|FG002|Overall Study|Withdrawal by parent or guardian|0|||
130978133|NCT02677116|471544926|FG003|Overall Study|Withdrawal by parent or guardian|1|||
130978134|NCT02677116|471544927|FG004|Overall Study|Withdrawal by parent or guardian|0|||
130978135|NCT02677116|471544928|FG005|Overall Study|Withdrawal by parent or guardian|0|||
130978136|NCT02677116|471544929|FG006|Overall Study|Withdrawal by parent or guardian|2|||
130978137|NCT02677116|471544930|FG007|Overall Study|Withdrawal by parent or guardian|1|||
130978138|NCT02677116|471544931|FG008|Overall Study|Withdrawal by parent or guardian|0|||
130978139|NCT02677116|471544923|FG000|Overall Study|Withdrawal by Subject|1|||
130978140|NCT02677116|471544924|FG001|Overall Study|Withdrawal by Subject|0|||
130978141|NCT02677116|471544925|FG002|Overall Study|Withdrawal by Subject|0|||
130978142|NCT02677116|471544926|FG003|Overall Study|Withdrawal by Subject|0|||
130978143|NCT02677116|471544927|FG004|Overall Study|Withdrawal by Subject|0|||
130978144|NCT02677116|471544928|FG005|Overall Study|Withdrawal by Subject|0|||
130978145|NCT02677116|471544929|FG006|Overall Study|Withdrawal by Subject|0|||
130978146|NCT02677116|471544930|FG007|Overall Study|Withdrawal by Subject|0|||
130978147|NCT02677116|471544931|FG008|Overall Study|Withdrawal by Subject|0|||
130978148|NCT02363946|471544932|FG000|Overall Study|Lost to Follow-up|0|||
130978149|NCT02363946|471544933|FG001|Overall Study|Lost to Follow-up|0|||
130978150|NCT02363946|471544934|FG002|Overall Study|Lost to Follow-up|0|||
130978151|NCT02363946|471544935|FG003|Overall Study|Lost to Follow-up|0|||
130978152|NCT02363946|471544936|FG004|Overall Study|Lost to Follow-up|0|||
130978153|NCT02363946|471544937|FG005|Overall Study|Lost to Follow-up|0|||
130978154|NCT02363946|471544938|FG006|Overall Study|Lost to Follow-up|0|||
130978155|NCT02363946|471544939|FG007|Overall Study|Lost to Follow-up|1|||
130978156|NCT02363946|471544940|FG008|Overall Study|Lost to Follow-up|0|||
130978157|NCT02363946|471544941|FG009|Overall Study|Lost to Follow-up|0|||
130978158|NCT02363946|471544942|FG010|Overall Study|Lost to Follow-up|0|||
130978159|NCT02363946|471544943|FG011|Overall Study|Lost to Follow-up|0|||
130978160|NCT02363946|471544944|FG012|Overall Study|Lost to Follow-up|0|||
130978161|NCT01967732|471544945|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
130978162|NCT01967732|471544946|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
130978163|NCT01967732|471544947|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
130978164|NCT01967732|471544948|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
130978165|NCT01967732|471544945|FG000|First Intervention (Day 1)|Poor venous access|0|||
130978166|NCT01967732|471544946|FG001|First Intervention (Day 1)|Poor venous access|1|||
130978167|NCT01967732|471544947|FG002|First Intervention (Day 1)|Poor venous access|0|||
130978168|NCT01967732|471544948|FG003|First Intervention (Day 1)|Poor venous access|0|||
130978169|NCT03342638|471544949|FG000|Overall Study|Withdrawal by Subject|1|||
130978170|NCT03342638|471544950|FG001|Overall Study|Withdrawal by Subject|0|||
130978171|NCT03342638|471544949|FG000|Overall Study|Physician Decision|0|||
130978172|NCT03342638|471544950|FG001|Overall Study|Physician Decision|1|||
130978173|NCT01292239|471544966|FG000|Overall Study|Other|1|||
130978174|NCT01292239|471544967|FG001|Overall Study|Other|1|||
130978175|NCT01292239|471544966|FG000|Overall Study|Withdrawal by Subject|3|||
130978176|NCT01292239|471544967|FG001|Overall Study|Withdrawal by Subject|6|||
130978177|NCT00113568|471544968|FG000|Overall Study|Adverse Event|97|||
130978178|NCT00113568|471544968|FG000|Overall Study|Death|1|||
130978179|NCT00113568|471544968|FG000|Overall Study|Lack of Efficacy|30|||
130978180|NCT00113568|471544968|FG000|Overall Study|Lost to Follow-up|156|||
130978181|NCT00113568|471544968|FG000|Overall Study|Protocol Violation|32|||
131131870|NCT01425008|472108435|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
131131871|NCT01425008|472108436|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
131131872|NCT01425008|472108437|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
131131873|NCT01425008|472108438|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
131131874|NCT01425008|472108439|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
131131875|NCT01425008|472108440|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
131131876|NCT01425008|472108441|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
131131877|NCT01425008|472108442|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
130718022|NCT03276221|470593230|FG002|Overall Study|Lost to Follow-up|0|||
130718023|NCT03276221|470593228|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
130718024|NCT03276221|470593229|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
130718025|NCT03276221|470593230|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
130718026|NCT00681590|470593231|FG000|Overall Study|Withdrawal by Subject|2|||
130718027|NCT00681590|470593232|FG001|Overall Study|Withdrawal by Subject|12|||
131131878|NCT01425008|472108443|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
130718028|NCT00424775|470593233|FG000|Overall Study|Adverse Event|2|||
130978182|NCT00113568|471544968|FG000|Overall Study|Withdrawal by Subject|117|||
130978183|NCT00113568|471544968|FG000|Overall Study|Other|112|||
131131879|NCT01425008|472108444|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
131131880|NCT01425008|472108445|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
130978184|NCT00262821|471544969|FG000|Overall Study|Ineligible - wrong stage|0|||
130978185|NCT00262821|471544970|FG001|Overall Study|Ineligible - wrong stage|3|||
130978186|NCT00262821|471544969|FG000|Overall Study|Ineligible - wrong cell type|2|||
131043728|NCT00323856|471794723|FG000|Overall Study|Reason not specified|1|||
131043729|NCT00323856|471794723|FG000|Overall Study|Missing|2|||
131043730|NCT03156465|471794724|FG000|Overall Study|Withdrawal by Subject|2|||
131043731|NCT04086121|471794734|FG000|Overall Study|Other than listed|8|||
131043732|NCT04086121|471794734|FG000|Overall Study|Withdrawal by Subject|3|||
131043733|NCT04086121|471794734|FG000|Overall Study|Lost to Follow-up|2|||
131043734|NCT04086121|471794734|FG000|Overall Study|Adverse Event|1|||
131043735|NCT04580914|471794737|FG000|Overall Study|Withdrawal by Subject|6|||
131043736|NCT04580914|471794737|FG000|Overall Study|Lost to Follow-up|2|||
131043737|NCT03580356|471794738|FG000|Treatment Period|Withdrawal by Subject|13|||
131043738|NCT03580356|471794739|FG001|Treatment Period|Withdrawal by Subject|0|||
131043739|NCT03580356|471794740|FG002|Treatment Period|Withdrawal by Subject|13|||
131043740|NCT03580356|471794741|FG003|Treatment Period|Withdrawal by Subject|1|||
131043741|NCT03580356|471794742|FG004|Treatment Period|Withdrawal by Subject|17|||
131043742|NCT03580356|471794743|FG005|Treatment Period|Withdrawal by Subject|0|||
131043743|NCT03580356|471794744|FG006|Treatment Period|Withdrawal by Subject|5|||
131043744|NCT03580356|471794745|FG007|Treatment Period|Withdrawal by Subject|0|||
131043745|NCT03580356|471794738|FG000|Treatment Period|Adverse Event|10|||
131043746|NCT03580356|471794739|FG001|Treatment Period|Adverse Event|0|||
131043747|NCT03580356|471794740|FG002|Treatment Period|Adverse Event|13|||
131043748|NCT03580356|471794741|FG003|Treatment Period|Adverse Event|0|||
131043749|NCT03580356|471794742|FG004|Treatment Period|Adverse Event|5|||
131043750|NCT03580356|471794743|FG005|Treatment Period|Adverse Event|0|||
131043751|NCT03580356|471794744|FG006|Treatment Period|Adverse Event|8|||
131043752|NCT03580356|471794745|FG007|Treatment Period|Adverse Event|0|||
131043753|NCT03580356|471794738|FG000|Treatment Period|Protocol Violation|5|||
131043754|NCT03580356|471794739|FG001|Treatment Period|Protocol Violation|0|||
131043755|NCT03580356|471794740|FG002|Treatment Period|Protocol Violation|6|||
131043756|NCT03580356|471794741|FG003|Treatment Period|Protocol Violation|1|||
131043757|NCT03580356|471794742|FG004|Treatment Period|Protocol Violation|9|||
131043758|NCT03580356|471794743|FG005|Treatment Period|Protocol Violation|1|||
131043759|NCT03580356|471794744|FG006|Treatment Period|Protocol Violation|1|||
131043760|NCT03580356|471794745|FG007|Treatment Period|Protocol Violation|0|||
131043761|NCT03580356|471794738|FG000|Treatment Period|Lack of Efficacy|6|||
131043762|NCT03580356|471794739|FG001|Treatment Period|Lack of Efficacy|0|||
131043763|NCT03580356|471794740|FG002|Treatment Period|Lack of Efficacy|2|||
131043764|NCT03580356|471794741|FG003|Treatment Period|Lack of Efficacy|0|||
131043765|NCT03580356|471794742|FG004|Treatment Period|Lack of Efficacy|3|||
131043766|NCT03580356|471794743|FG005|Treatment Period|Lack of Efficacy|0|||
131043767|NCT03580356|471794744|FG006|Treatment Period|Lack of Efficacy|3|||
131043768|NCT03580356|471794745|FG007|Treatment Period|Lack of Efficacy|0|||
131043769|NCT03580356|471794738|FG000|Treatment Period|Pregnancy|1|||
131043770|NCT03580356|471794739|FG001|Treatment Period|Pregnancy|0|||
131043771|NCT03580356|471794740|FG002|Treatment Period|Pregnancy|7|||
131043772|NCT03580356|471794741|FG003|Treatment Period|Pregnancy|0|||
131043773|NCT03580356|471794742|FG004|Treatment Period|Pregnancy|2|||
131043774|NCT03580356|471794743|FG005|Treatment Period|Pregnancy|0|||
131043775|NCT03580356|471794744|FG006|Treatment Period|Pregnancy|1|||
131043776|NCT03580356|471794745|FG007|Treatment Period|Pregnancy|0|||
131043777|NCT03580356|471794738|FG000|Treatment Period|Physician Decision|2|||
131043778|NCT03580356|471794739|FG001|Treatment Period|Physician Decision|0|||
131043779|NCT03580356|471794740|FG002|Treatment Period|Physician Decision|1|||
131043780|NCT03580356|471794741|FG003|Treatment Period|Physician Decision|0|||
131043781|NCT03580356|471794742|FG004|Treatment Period|Physician Decision|4|||
131043782|NCT03580356|471794743|FG005|Treatment Period|Physician Decision|0|||
131043783|NCT03580356|471794744|FG006|Treatment Period|Physician Decision|2|||
131043784|NCT03580356|471794745|FG007|Treatment Period|Physician Decision|0|||
131043785|NCT03580356|471794738|FG000|Treatment Period|Lost to Follow-up|1|||
131043786|NCT03580356|471794739|FG001|Treatment Period|Lost to Follow-up|1|||
131043787|NCT03580356|471794740|FG002|Treatment Period|Lost to Follow-up|1|||
131043788|NCT03580356|471794741|FG003|Treatment Period|Lost to Follow-up|0|||
131043789|NCT03580356|471794742|FG004|Treatment Period|Lost to Follow-up|3|||
131043790|NCT03580356|471794743|FG005|Treatment Period|Lost to Follow-up|0|||
131043791|NCT03580356|471794744|FG006|Treatment Period|Lost to Follow-up|1|||
131043792|NCT03580356|471794745|FG007|Treatment Period|Lost to Follow-up|0|||
131043793|NCT03580356|471794738|FG000|Treatment Period|Death|0|||
131043794|NCT03580356|471794739|FG001|Treatment Period|Death|0|||
131043795|NCT03580356|471794740|FG002|Treatment Period|Death|1|||
131043796|NCT03580356|471794741|FG003|Treatment Period|Death|0|||
131043797|NCT03580356|471794742|FG004|Treatment Period|Death|0|||
131043798|NCT03580356|471794743|FG005|Treatment Period|Death|0|||
131043799|NCT03580356|471794744|FG006|Treatment Period|Death|0|||
131043800|NCT03580356|471794745|FG007|Treatment Period|Death|0|||
131043801|NCT03580356|471794738|FG000|Treatment Period|Technical problems|0|||
131043802|NCT03580356|471794739|FG001|Treatment Period|Technical problems|0|||
131043803|NCT03580356|471794740|FG002|Treatment Period|Technical problems|0|||
131043804|NCT03580356|471794741|FG003|Treatment Period|Technical problems|0|||
131043805|NCT03580356|471794742|FG004|Treatment Period|Technical problems|1|||
131043806|NCT03580356|471794743|FG005|Treatment Period|Technical problems|0|||
131227546|NCT00410410|472459754|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
130718029|NCT00424775|470593234|FG001|Overall Study|Adverse Event|0|||
130718030|NCT00424775|470593233|FG000|Overall Study|Lack of Efficacy|1|||
130718031|NCT00424775|470593234|FG001|Overall Study|Lack of Efficacy|0|||
130718032|NCT01791153|470593235|FG000|Part 1: Blinded Period|Adverse Event|7|||
130718033|NCT01791153|470593236|FG001|Part 1: Blinded Period|Adverse Event|3|||
130718034|NCT01791153|470593237|FG002|Part 1: Blinded Period|Adverse Event|2|||
130718035|NCT01791153|470593238|FG003|Part 1: Blinded Period|Adverse Event|0|||
130718036|NCT01791153|470593239|FG004|Part 1: Blinded Period|Adverse Event|0|||
130718037|NCT01791153|470593240|FG005|Part 1: Blinded Period|Adverse Event|0|||
130718038|NCT01791153|470593241|FG006|Part 1: Blinded Period|Adverse Event|0|||
130718039|NCT01791153|470593242|FG007|Part 1: Blinded Period|Adverse Event|0|||
130718040|NCT01791153|470593235|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
130718041|NCT01791153|470593236|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
130718042|NCT01791153|470593237|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
130718043|NCT01791153|470593238|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
130718044|NCT01791153|470593239|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
130718045|NCT01791153|470593240|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
130718046|NCT01791153|470593241|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
130718047|NCT01791153|470593242|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
130718048|NCT01791153|470593235|FG000|Part 1: Blinded Period|Non-Compliance|1|||
130718049|NCT01791153|470593236|FG001|Part 1: Blinded Period|Non-Compliance|0|||
130718050|NCT01791153|470593237|FG002|Part 1: Blinded Period|Non-Compliance|0|||
130718051|NCT01791153|470593238|FG003|Part 1: Blinded Period|Non-Compliance|0|||
130718052|NCT01791153|470593239|FG004|Part 1: Blinded Period|Non-Compliance|0|||
130718053|NCT01791153|470593240|FG005|Part 1: Blinded Period|Non-Compliance|0|||
130718054|NCT01791153|470593241|FG006|Part 1: Blinded Period|Non-Compliance|0|||
130718055|NCT01791153|470593242|FG007|Part 1: Blinded Period|Non-Compliance|0|||
130718056|NCT01791153|470593235|FG000|Part 1: Blinded Period|Physician Decision|0|||
130718057|NCT01791153|470593236|FG001|Part 1: Blinded Period|Physician Decision|0|||
130718058|NCT01791153|470593237|FG002|Part 1: Blinded Period|Physician Decision|0|||
130718059|NCT01791153|470593238|FG003|Part 1: Blinded Period|Physician Decision|1|||
130718060|NCT01791153|470593239|FG004|Part 1: Blinded Period|Physician Decision|0|||
130718061|NCT01791153|470593240|FG005|Part 1: Blinded Period|Physician Decision|0|||
130718062|NCT01791153|470593241|FG006|Part 1: Blinded Period|Physician Decision|0|||
130718063|NCT01791153|470593242|FG007|Part 1: Blinded Period|Physician Decision|0|||
130718064|NCT01791153|470593235|FG000|Part 1: Blinded Period|Protocol Violation|0|||
130718065|NCT01791153|470593236|FG001|Part 1: Blinded Period|Protocol Violation|0|||
130718066|NCT01791153|470593237|FG002|Part 1: Blinded Period|Protocol Violation|0|||
130718067|NCT01791153|470593238|FG003|Part 1: Blinded Period|Protocol Violation|1|||
130718068|NCT01791153|470593239|FG004|Part 1: Blinded Period|Protocol Violation|0|||
130718069|NCT01791153|470593240|FG005|Part 1: Blinded Period|Protocol Violation|0|||
130718070|NCT01791153|470593241|FG006|Part 1: Blinded Period|Protocol Violation|0|||
130718071|NCT01791153|470593242|FG007|Part 1: Blinded Period|Protocol Violation|0|||
130718072|NCT01791153|470593235|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
130718073|NCT01791153|470593236|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
130718074|NCT01791153|470593237|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
130718075|NCT01791153|470593238|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
130718076|NCT01791153|470593239|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
130718077|NCT01791153|470593240|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
130718078|NCT01791153|470593241|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
130718079|NCT01791153|470593242|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
130718080|NCT01791153|470593235|FG000|Part 2: Open-label Period|Adverse Event|0|||
130718081|NCT01791153|470593236|FG001|Part 2: Open-label Period|Adverse Event|0|||
130978187|NCT00262821|471544970|FG001|Overall Study|Ineligible - wrong cell type|2|||
130978188|NCT00262821|471544969|FG000|Overall Study|Ineligible - wrong primary|0|||
130978189|NCT00262821|471544970|FG001|Overall Study|Ineligible - wrong primary|1|||
130978190|NCT00262821|471544969|FG000|Overall Study|Ineligible - inadequate pathology|1|||
130978191|NCT00262821|471544970|FG001|Overall Study|Ineligible - inadequate pathology|3|||
130978192|NCT00262821|471544969|FG000|Overall Study|Ineligible - elevated creatinine|0|||
130978193|NCT00262821|471544970|FG001|Overall Study|Ineligible - elevated creatinine|2|||
130978194|NCT00262821|471544969|FG000|Overall Study|Ineligible - required test not done|1|||
130978195|NCT00262821|471544970|FG001|Overall Study|Ineligible - required test not done|4|||
130978196|NCT00262821|471544969|FG000|Overall Study|Inevaluable - inadequate data|0|||
130978197|NCT00262821|471544970|FG001|Overall Study|Inevaluable - inadequate data|4|||
130978198|NCT01988779|471544972|FG000|Overall Study|Withdrawal by Subject|2|||
130978199|NCT01988779|471544973|FG001|Overall Study|Withdrawal by Subject|2|||
130978200|NCT01988779|471544972|FG000|Overall Study|Protocol Violation|1|||
130978201|NCT01988779|471544973|FG001|Overall Study|Protocol Violation|0|||
130978202|NCT00584727|471544974|FG000|First Intervention|Discontinuation|0|||
130978203|NCT00584727|471544975|FG001|First Intervention|Discontinuation|0|||
130978204|NCT00584727|471544976|FG002|First Intervention|Discontinuation|1|||
130978205|NCT00584727|471544977|FG003|First Intervention|Discontinuation|0|||
130978206|NCT00584727|471544978|FG004|First Intervention|Discontinuation|0|||
130778298|NCT02762084|470815343|FG001|Overall Study|Withdrawal by Subject|0|||
130778299|NCT02762084|470815344|FG002|Overall Study|Withdrawal by Subject|0|||
130778300|NCT02762084|470815342|FG000|Overall Study|Adverse Event|0|||
130778301|NCT02762084|470815343|FG001|Overall Study|Adverse Event|0|||
130778302|NCT02762084|470815344|FG002|Overall Study|Adverse Event|1|||
130778303|NCT01781962|470815351|FG000|Overall Study|Other Miscellaneous Reasons|5|||
130778304|NCT03200548|470815352|FG000|Overall Study|Withdrawal by Subject|5|||
130778305|NCT03200548|470815353|FG001|Overall Study|Withdrawal by Subject|11|||
130778306|NCT03200548|470815354|FG002|Overall Study|Withdrawal by Subject|7|||
130778307|NCT03200548|470815355|FG003|Overall Study|Withdrawal by Subject|6|||
130778308|NCT01765296|470815360|FG000|Overall Study|Protocol Violation|0|||
130778309|NCT01765296|470815361|FG001|Overall Study|Protocol Violation|5|||
130778310|NCT01765296|470815362|FG002|Overall Study|Protocol Violation|4|||
130778311|NCT01765296|470815360|FG000|Overall Study|Withdrawal by Subject|4|||
130778312|NCT01765296|470815361|FG001|Overall Study|Withdrawal by Subject|2|||
130778313|NCT01765296|470815362|FG002|Overall Study|Withdrawal by Subject|2|||
130778314|NCT01765296|470815360|FG000|Overall Study|Adverse Event|1|||
130778315|NCT01765296|470815361|FG001|Overall Study|Adverse Event|13|||
130778316|NCT01765296|470815362|FG002|Overall Study|Adverse Event|5|||
130778317|NCT01765296|470815360|FG000|Overall Study|Lack of Efficacy|0|||
130778318|NCT01765296|470815361|FG001|Overall Study|Lack of Efficacy|0|||
130778319|NCT01765296|470815362|FG002|Overall Study|Lack of Efficacy|2|||
130778320|NCT03257436|470815363|FG000|Overall Study|Withdrawal by Subject|76|||
130778321|NCT03257436|470815363|FG000|Overall Study|Death|19|||
130778322|NCT05417412|470815364|FG000|Overall Study|Lost to Follow-up|2|||
130778323|NCT03478371|470815367|FG000|Overall Study|non-compliance|1|||
130778324|NCT03478371|470815367|FG000|Overall Study|Lost to Follow-up|4|||
130778325|NCT02849743|470815368|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
130778326|NCT02849743|470815369|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
130778327|NCT02849743|470815368|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
130778328|NCT02849743|470815369|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130778329|NCT03874013|470815374|FG000|Overall Study|Adverse Event|0|||
130778330|NCT03874013|470815375|FG001|Overall Study|Adverse Event|1|||
130778331|NCT01096160|470815377|FG000|Overall Study|Adverse Event|0|||
130778332|NCT01096160|470815378|FG001|Overall Study|Adverse Event|0|||
130778333|NCT01096160|470815379|FG002|Overall Study|Adverse Event|1|||
130778334|NCT01096160|470815380|FG003|Overall Study|Adverse Event|0|||
130778335|NCT01096160|470815381|FG004|Overall Study|Adverse Event|0|||
130778336|NCT01096160|470815382|FG005|Overall Study|Adverse Event|0|||
130778337|NCT01096160|470815383|FG006|Overall Study|Adverse Event|0|||
130778338|NCT01096160|470815384|FG007|Overall Study|Adverse Event|0|||
130778339|NCT01096160|470815385|FG008|Overall Study|Adverse Event|0|||
130778340|NCT01096160|470815386|FG009|Overall Study|Adverse Event|1|||
130778341|NCT01096160|470815377|FG000|Overall Study|Met stopping criteria per protocol|0|||
130778342|NCT01096160|470815378|FG001|Overall Study|Met stopping criteria per protocol|0|||
130778343|NCT01096160|470815379|FG002|Overall Study|Met stopping criteria per protocol|0|||
130778344|NCT01096160|470815380|FG003|Overall Study|Met stopping criteria per protocol|0|||
130778345|NCT01096160|470815381|FG004|Overall Study|Met stopping criteria per protocol|1|||
130778346|NCT01096160|470815382|FG005|Overall Study|Met stopping criteria per protocol|0|||
130978207|NCT00584727|471544979|FG005|First Intervention|Discontinuation|0|||
130978208|NCT00584727|471544974|FG000|Third Intervention|Protocol Violation|0|||
130978209|NCT00584727|471544975|FG001|Third Intervention|Protocol Violation|0|||
130978210|NCT00584727|471544976|FG002|Third Intervention|Protocol Violation|1|||
130978211|NCT00584727|471544977|FG003|Third Intervention|Protocol Violation|0|||
130978212|NCT00584727|471544978|FG004|Third Intervention|Protocol Violation|4|||
130978213|NCT00584727|471544979|FG005|Third Intervention|Protocol Violation|2|||
130778347|NCT01096160|470815383|FG006|Overall Study|Met stopping criteria per protocol|2|||
130778348|NCT01096160|470815384|FG007|Overall Study|Met stopping criteria per protocol|0|||
130778349|NCT01096160|470815385|FG008|Overall Study|Met stopping criteria per protocol|2|||
130778350|NCT01096160|470815386|FG009|Overall Study|Met stopping criteria per protocol|0|||
130778351|NCT00922116|470815388|FG000|Overall Study|Adverse Event|4|||
130778352|NCT00922116|470815388|FG000|Overall Study|Death|1|||
130778353|NCT00922116|470815388|FG000|Overall Study|Lost to Follow-up|1|||
130778354|NCT00922116|470815388|FG000|Overall Study|Withdrawal by Subject|4|||
130778355|NCT00922116|470815388|FG000|Overall Study|Other|5|||
130778356|NCT04607135|470815389|FG000|Overall Study|Physician Decision|1|||
130778357|NCT04607135|470815389|FG000|Overall Study|Withdrawal by Subject|1|||
130778358|NCT04607135|470815389|FG000|Overall Study|Equipment not working|3|||
130778359|NCT06060496|470815390|FG000|Overall Study|Withdrawal by Subject|2|||
130778360|NCT06060496|470815390|FG000|Overall Study|Lost to Follow-up|2|||
130778361|NCT03990051|470815391|FG000|Masked Period|Lost to Follow-up|1|||
130778362|NCT03990051|470815392|FG001|Masked Period|Lost to Follow-up|0|||
130778363|NCT03990051|470815391|FG000|Long Term Period|Death|1|||
130778364|NCT03990051|470815392|FG001|Long Term Period|Death|1|||
130978214|NCT00377403|471544981|FG000|Overall Study|Unable to contact for telephone intervie|4|||
130978215|NCT00377403|471544982|FG001|Overall Study|Unable to contact for telephone intervie|7|||
130978216|NCT01922076|471544983|FG000|Overall Study|Adverse Event|0|||
130978217|NCT01922076|471544984|FG001|Overall Study|Adverse Event|0|||
130978218|NCT01922076|471544985|FG002|Overall Study|Adverse Event|0|||
130978219|NCT01922076|471544986|FG003|Overall Study|Adverse Event|0|||
130978220|NCT01922076|471544987|FG004|Overall Study|Adverse Event|1|||
130978221|NCT01922076|471544988|FG005|Overall Study|Adverse Event|0|||
130978222|NCT01922076|471544989|FG006|Overall Study|Adverse Event|0|||
130978223|NCT01922076|471544983|FG000|Overall Study|Physician Decision|0|||
130978224|NCT01922076|471544984|FG001|Overall Study|Physician Decision|0|||
130978225|NCT01922076|471544985|FG002|Overall Study|Physician Decision|1|||
130978226|NCT01922076|471544986|FG003|Overall Study|Physician Decision|0|||
130978227|NCT01922076|471544987|FG004|Overall Study|Physician Decision|0|||
130978228|NCT01922076|471544988|FG005|Overall Study|Physician Decision|0|||
130978229|NCT01922076|471544989|FG006|Overall Study|Physician Decision|0|||
130978230|NCT01922076|471544983|FG000|Overall Study|Withdrawal by Subject|0|||
130978231|NCT01922076|471544984|FG001|Overall Study|Withdrawal by Subject|0|||
130978232|NCT01922076|471544985|FG002|Overall Study|Withdrawal by Subject|0|||
130978233|NCT01922076|471544986|FG003|Overall Study|Withdrawal by Subject|1|||
130978234|NCT01922076|471544987|FG004|Overall Study|Withdrawal by Subject|0|||
130978235|NCT01922076|471544988|FG005|Overall Study|Withdrawal by Subject|1|||
130978236|NCT01922076|471544989|FG006|Overall Study|Withdrawal by Subject|1|||
130978237|NCT01018394|471544990|FG000|Overall Study|Withdrawal by Subject|5|||
130978238|NCT01018394|471544991|FG001|Overall Study|Withdrawal by Subject|5|||
130978239|NCT01018394|471544990|FG000|Overall Study|Lost to Follow-up|4|||
130978240|NCT01018394|471544991|FG001|Overall Study|Lost to Follow-up|3|||
130978241|NCT00683644|471544992|FG000|Overall Study|Withdrawal by Subject|4|||
130978242|NCT00683644|471544993|FG001|Overall Study|Withdrawal by Subject|2|||
130978243|NCT00683644|471544992|FG000|Overall Study|Lost to Follow-up|1|||
130978244|NCT00683644|471544993|FG001|Overall Study|Lost to Follow-up|4|||
130978245|NCT00683644|471544992|FG000|Overall Study|Adverse Event|1|||
130978246|NCT00683644|471544993|FG001|Overall Study|Adverse Event|2|||
130978247|NCT00683644|471544992|FG000|Overall Study|Low copper, other health problems,|7|||
130978248|NCT00683644|471544993|FG001|Overall Study|Low copper, other health problems,|6|||
130978249|NCT01669122|471544994|FG000|Period I|Lost to Follow-up|1|||
130978250|NCT01669122|471544994|FG000|Washout Period II|Protocol Violation|2|||
130978251|NCT03762473|471544995|FG000|Overall Study|Death|1|||
130978252|NCT03762473|471544996|FG001|Overall Study|Death|0|||
130978253|NCT05132699|471544997|FG000|Overall Study|Withdrawal by Subject|3|||
130978254|NCT05132699|471544998|FG001|Overall Study|Withdrawal by Subject|0|||
130978255|NCT02858895|471545001|FG000|Overall Study|Disease progression|31|||
130778365|NCT03990051|470815391|FG000|Long Term Period|Lost to Follow-up|7|||
130778366|NCT03990051|470815392|FG001|Long Term Period|Lost to Follow-up|2|||
130778367|NCT03193047|470815394|FG000|Overall Study|Physician Decision|1|||
130778368|NCT03193047|470815395|FG001|Overall Study|Physician Decision|0|||
130778369|NCT03193047|470815394|FG000|Overall Study|Participant Left State|1|||
130778370|NCT03193047|470815395|FG001|Overall Study|Participant Left State|0|||
130778371|NCT01509664|470815396|FG000|Overall Study|Lost to Follow-up|15|||
130778372|NCT01509664|470815397|FG001|Overall Study|Lost to Follow-up|21|||
130778373|NCT00149396|470815402|FG000|Overall Study|Death|15|||
130778374|NCT00149396|470815402|FG000|Overall Study|Withdrawal by Subject|1|||
130778375|NCT00149396|470815402|FG000|Overall Study|Subject noncompliance|2|||
130778376|NCT00149396|470815402|FG000|Overall Study|other treatment|5|||
130778377|NCT00186485|470815403|FG000|Overall Study|Lost to Follow-up|3|||
130778378|NCT00379899|470815404|FG000|Overall Study|Adverse Event|7|||
130778379|NCT00379899|470815405|FG001|Overall Study|Adverse Event|3|||
130778380|NCT00379899|470815404|FG000|Overall Study|Death|10|||
130778381|NCT00379899|470815405|FG001|Overall Study|Death|10|||
130778382|NCT00379899|470815404|FG000|Overall Study|Lost to Follow-up|2|||
130778383|NCT00379899|470815405|FG001|Overall Study|Lost to Follow-up|4|||
130778384|NCT00379899|470815404|FG000|Overall Study|Physician Decision|3|||
130778385|NCT00379899|470815405|FG001|Overall Study|Physician Decision|4|||
130778386|NCT00379899|470815404|FG000|Overall Study|Withdrawal by Subject|5|||
130978256|NCT02858895|471545001|FG000|Overall Study|Death|2|||
131227547|NCT00410410|472459755|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
130778387|NCT00379899|470815405|FG001|Overall Study|Withdrawal by Subject|5|||
130978257|NCT02858895|471545001|FG000|Overall Study|Adverse Event|1|||
130978258|NCT02858895|471545001|FG000|Overall Study|Withdrawal by Subject|3|||
130978259|NCT02858895|471545001|FG000|Overall Study|hospice,|1|||
130978260|NCT02858895|471545001|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
130978261|NCT00785291|471547414|FG000|Overall Study|Never began treatment|8|||
130778388|NCT00379899|470815404|FG000|Overall Study|Ineligibility determined|0|||
130778389|NCT00379899|470815405|FG001|Overall Study|Ineligibility determined|1|||
130778390|NCT00379899|470815404|FG000|Overall Study|Noncompliance|1|||
130978262|NCT00785291|471547415|FG001|Overall Study|Never began treatment|4|||
130978263|NCT00785291|471547416|FG002|Overall Study|Never began treatment|4|||
130978264|NCT00785291|471547414|FG000|Overall Study|Adverse Event|39|||
130978265|NCT00785291|471547415|FG001|Overall Study|Adverse Event|70|||
130978266|NCT00785291|471547416|FG002|Overall Study|Adverse Event|56|||
130978267|NCT00785291|471547414|FG000|Overall Study|Death|7|||
131227548|NCT00410410|472459756|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
130718082|NCT01791153|470593237|FG002|Part 2: Open-label Period|Adverse Event|0|||
130718083|NCT01791153|470593238|FG003|Part 2: Open-label Period|Adverse Event|0|||
130718084|NCT01791153|470593239|FG004|Part 2: Open-label Period|Adverse Event|0|||
130718085|NCT01791153|470593240|FG005|Part 2: Open-label Period|Adverse Event|1|||
130718086|NCT01791153|470593241|FG006|Part 2: Open-label Period|Adverse Event|1|||
130718087|NCT01791153|470593242|FG007|Part 2: Open-label Period|Adverse Event|2|||
130718088|NCT01791153|470593235|FG000|Part 2: Open-label Period|Death|0|||
130718089|NCT01791153|470593236|FG001|Part 2: Open-label Period|Death|0|||
130718090|NCT01791153|470593237|FG002|Part 2: Open-label Period|Death|0|||
130718091|NCT01791153|470593238|FG003|Part 2: Open-label Period|Death|0|||
130718092|NCT01791153|470593239|FG004|Part 2: Open-label Period|Death|0|||
130718093|NCT01791153|470593240|FG005|Part 2: Open-label Period|Death|1|||
130718094|NCT01791153|470593241|FG006|Part 2: Open-label Period|Death|1|||
130718095|NCT01791153|470593242|FG007|Part 2: Open-label Period|Death|1|||
130718096|NCT01791153|470593235|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
130718097|NCT01791153|470593236|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
130718098|NCT01791153|470593237|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
130718099|NCT01791153|470593238|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
130718100|NCT01791153|470593239|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
130718101|NCT01791153|470593240|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
130718102|NCT01791153|470593241|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
130718103|NCT01791153|470593242|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
130718104|NCT01791153|470593235|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
130718105|NCT01791153|470593236|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
130718106|NCT01791153|470593237|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
130718107|NCT01791153|470593238|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
130718108|NCT01791153|470593239|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
130718109|NCT01791153|470593240|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
130718110|NCT01791153|470593241|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
130718111|NCT01791153|470593242|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
130718112|NCT01791153|470593235|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
130718113|NCT01791153|470593236|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
130718114|NCT01791153|470593237|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
130718115|NCT01791153|470593238|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
130718116|NCT01791153|470593239|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
130718117|NCT01791153|470593240|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
130718118|NCT01791153|470593241|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
130718119|NCT01791153|470593242|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
130718120|NCT01791153|470593235|FG000|Part 2: Open-label Period|Physician Decision|0|||
130718121|NCT01791153|470593236|FG001|Part 2: Open-label Period|Physician Decision|0|||
130718122|NCT01791153|470593237|FG002|Part 2: Open-label Period|Physician Decision|0|||
130718123|NCT01791153|470593238|FG003|Part 2: Open-label Period|Physician Decision|0|||
130718124|NCT01791153|470593239|FG004|Part 2: Open-label Period|Physician Decision|1|||
130718125|NCT01791153|470593240|FG005|Part 2: Open-label Period|Physician Decision|1|||
130718126|NCT01791153|470593241|FG006|Part 2: Open-label Period|Physician Decision|0|||
130718127|NCT01791153|470593242|FG007|Part 2: Open-label Period|Physician Decision|0|||
130718128|NCT00975286|470593243|FG000|Overall Study|Adverse Event|9|||
130718129|NCT00975286|470593244|FG001|Overall Study|Adverse Event|19|||
130718130|NCT00975286|470593243|FG000|Overall Study|Protocol Violation|1|||
130718131|NCT00975286|470593244|FG001|Overall Study|Protocol Violation|2|||
130718132|NCT00975286|470593243|FG000|Overall Study|Withdrawal by Subject|0|||
130718133|NCT00975286|470593244|FG001|Overall Study|Withdrawal by Subject|2|||
130718134|NCT00975286|470593243|FG000|Overall Study|Familial and Personal Reasons|2|||
130718135|NCT00975286|470593244|FG001|Overall Study|Familial and Personal Reasons|2|||
130718136|NCT00975286|470593243|FG000|Overall Study|Poor Compliance to Protocol|0|||
130718137|NCT00975286|470593244|FG001|Overall Study|Poor Compliance to Protocol|2|||
130718138|NCT00975286|470593243|FG000|Overall Study|Sponsor Decision|0|||
130718139|NCT00975286|470593244|FG001|Overall Study|Sponsor Decision|2|||
130718140|NCT02357342|470593245|FG000|First 6 Months|Death|2|||
130718141|NCT02357342|470593246|FG001|First 6 Months|Death|0|||
130718142|NCT04156620|470593248|FG000|Overall Study|Adverse event - TP 1|5|||
130718143|NCT04156620|470593249|FG001|Overall Study|Adverse event - TP 1|2|||
130718144|NCT04156620|470593248|FG000|Overall Study|Lost to follow-up TP 1|1|||
130718145|NCT04156620|470593249|FG001|Overall Study|Lost to follow-up TP 1|1|||
130718146|NCT04156620|470593248|FG000|Overall Study|Progressive disease - TP 1|0|||
130718147|NCT04156620|470593249|FG001|Overall Study|Progressive disease - TP 1|1|||
130718148|NCT04156620|470593248|FG000|Overall Study|Subject decision - TP 1|3|||
130718149|NCT04156620|470593249|FG001|Overall Study|Subject decision - TP 1|5|||
130718150|NCT04156620|470593248|FG000|Overall Study|Adverse event - TP 2|5|||
130718151|NCT04156620|470593249|FG001|Overall Study|Adverse event - TP 2|6|||
130718152|NCT04156620|470593248|FG000|Overall Study|Death - TP 2|1|||
130718153|NCT04156620|470593249|FG001|Overall Study|Death - TP 2|0|||
130718154|NCT04156620|470593248|FG000|Overall Study|Lost to follow-up - TP 2|5|||
130778391|NCT00379899|470815405|FG001|Overall Study|Noncompliance|1|||
130778392|NCT00379899|470815404|FG000|Overall Study|Parathyroidectomy|0|||
130778393|NCT00379899|470815405|FG001|Overall Study|Parathyroidectomy|2|||
130778394|NCT00379899|470815404|FG000|Overall Study|Renal transplantation|5|||
130778395|NCT00379899|470815405|FG001|Overall Study|Renal transplantation|4|||
130778396|NCT00379899|470815404|FG000|Overall Study|Coronary artery bypass graft|1|||
130778397|NCT00379899|470815405|FG001|Overall Study|Coronary artery bypass graft|1|||
130778398|NCT00379899|470815404|FG000|Overall Study|Other protocol-specified criteria|3|||
130778399|NCT00379899|470815405|FG001|Overall Study|Other protocol-specified criteria|4|||
130778400|NCT00379899|470815404|FG000|Overall Study|Other|3|||
130778401|NCT00379899|470815405|FG001|Overall Study|Other|1|||
130778402|NCT05225389|470815406|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
130778403|NCT03311841|470815407|FG000|14-day Wash-out|Adverse Event|0|||
130778404|NCT03311841|470815408|FG001|14-day Wash-out|Adverse Event|1|||
130778405|NCT03311841|470815409|FG002|14-day Wash-out|Adverse Event|0|||
130778406|NCT03311841|470815410|FG003|14-day Wash-out|Adverse Event|0|||
130778407|NCT03311841|470815411|FG004|14-day Wash-out|Adverse Event|0|||
130778408|NCT03311841|470815407|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
130778409|NCT03311841|470815408|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
130778410|NCT03311841|470815409|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
130778411|NCT03311841|470815410|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
130778412|NCT03311841|470815411|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
130778413|NCT01026948|470815412|FG000|Overall Study|Physician Decision|8|||
130778414|NCT03360019|470815418|FG000|Overall Study|Withdrawal by Subject|2|||
130778415|NCT03360019|470815419|FG001|Overall Study|Withdrawal by Subject|0|||
130778416|NCT03360019|470815420|FG002|Overall Study|Withdrawal by Subject|0|||
130778417|NCT03360019|470815418|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
130778418|NCT03360019|470815419|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
130778419|NCT03360019|470815420|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
130778420|NCT00753675|470815421|FG000|Overall Study|other reason|11|||
130778421|NCT00753675|470815422|FG001|Overall Study|other reason|12|||
130778422|NCT00753675|470815423|FG002|Overall Study|other reason|13|||
130778423|NCT00753675|470815421|FG000|Overall Study|Death|1|||
130778424|NCT00753675|470815422|FG001|Overall Study|Death|2|||
130778425|NCT00753675|470815423|FG002|Overall Study|Death|4|||
130778426|NCT00753675|470815421|FG000|Overall Study|Adverse Event|11|||
130778427|NCT00753675|470815422|FG001|Overall Study|Adverse Event|9|||
130778428|NCT00753675|470815423|FG002|Overall Study|Adverse Event|4|||
130778429|NCT00753675|470815421|FG000|Overall Study|Objective progression of disease|35|||
130778430|NCT00753675|470815422|FG001|Overall Study|Objective progression of disease|35|||
130778431|NCT00753675|470815423|FG002|Overall Study|Objective progression of disease|35|||
130778432|NCT00753675|470815421|FG000|Overall Study|Withdrawal by Subject|0|||
130778433|NCT00753675|470815422|FG001|Overall Study|Withdrawal by Subject|1|||
130778434|NCT00753675|470815423|FG002|Overall Study|Withdrawal by Subject|0|||
130778435|NCT00753675|470815421|FG000|Overall Study|Lost to Follow-up|1|||
131131881|NCT01425008|472108446|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
131131882|NCT01425008|472108447|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
131131883|NCT01425008|472108448|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
131131884|NCT01425008|472108430|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131885|NCT01425008|472108431|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130778436|NCT00753675|470815422|FG001|Overall Study|Lost to Follow-up|0|||
130778437|NCT00753675|470815423|FG002|Overall Study|Lost to Follow-up|0|||
130778438|NCT01462110|470815424|FG000|Overall Study|Adverse Event|1|||
131131886|NCT01425008|472108432|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131887|NCT01425008|472108433|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131888|NCT01425008|472108434|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131889|NCT01425008|472108435|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131890|NCT01425008|472108436|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131891|NCT01425008|472108437|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131892|NCT01425008|472108438|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131893|NCT01425008|472108439|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131894|NCT01425008|472108440|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130778439|NCT01462110|470815425|FG001|Overall Study|Adverse Event|0|||
131131895|NCT01425008|472108441|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131896|NCT01425008|472108442|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131897|NCT01425008|472108443|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130778440|NCT02149264|470815431|FG000|Overall Study|Withdrawal by Subject|9|||
130778441|NCT02149264|470815431|FG000|Overall Study|Adverse Event|7|||
130778442|NCT02149264|470815431|FG000|Overall Study|Physician Decision|3|||
130778443|NCT02149264|470815431|FG000|Overall Study|Protocol Violation|1|||
130778444|NCT03283930|470815432|FG000|Overall Study|Scheduling conflict|8|||
130778445|NCT03283930|470815433|FG001|Overall Study|Scheduling conflict|10|||
130978268|NCT00785291|471547415|FG001|Overall Study|Death|4|||
131131898|NCT01425008|472108444|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131899|NCT01425008|472108445|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131900|NCT01425008|472108446|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131901|NCT01425008|472108447|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131131902|NCT01425008|472108448|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
131131903|NCT00805480|472108451|FG000|Overall Study|Withdrawal by Subject|13|||
131131904|NCT00805480|472108452|FG001|Overall Study|Withdrawal by Subject|5|||
131131905|NCT00805480|472108453|FG002|Overall Study|Withdrawal by Subject|11|||
131131906|NCT00805480|472108454|FG003|Overall Study|Withdrawal by Subject|5|||
131131907|NCT00805480|472108451|FG000|Overall Study|Lost to Follow-up|1|||
131131908|NCT00805480|472108452|FG001|Overall Study|Lost to Follow-up|2|||
131131909|NCT00805480|472108453|FG002|Overall Study|Lost to Follow-up|0|||
131131910|NCT00805480|472108454|FG003|Overall Study|Lost to Follow-up|0|||
131131911|NCT00805480|472108451|FG000|Overall Study|Adverse Event|0|||
131131912|NCT00805480|472108452|FG001|Overall Study|Adverse Event|0|||
131131913|NCT00805480|472108453|FG002|Overall Study|Adverse Event|1|||
130778446|NCT03283930|470815432|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
130778447|NCT03283930|470815433|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
130778448|NCT03283930|470815432|FG000|Overall Study|Technical software issue|2|||
130778449|NCT03283930|470815433|FG001|Overall Study|Technical software issue|2|||
131131914|NCT00805480|472108454|FG003|Overall Study|Adverse Event|0|||
131131915|NCT00562588|472108455|FG000|Overall Study|Adverse Event|40|||
130778450|NCT00805129|470815434|FG000|Overall Study|Not treated|1|||
130778451|NCT02499120|470815438|FG000|Overall Study|Death|52|||
130778452|NCT02499120|470815439|FG001|Overall Study|Death|43|||
130778453|NCT02499120|470815438|FG000|Overall Study|Lost to Follow-up|1|||
130778454|NCT02499120|470815439|FG001|Overall Study|Lost to Follow-up|2|||
130778455|NCT02499120|470815438|FG000|Overall Study|Participant refused further follow-up|1|||
130778456|NCT02499120|470815439|FG001|Overall Study|Participant refused further follow-up|0|||
130778457|NCT02499120|470815438|FG000|Overall Study|Withdrawal by Subject|2|||
130778458|NCT02499120|470815439|FG001|Overall Study|Withdrawal by Subject|5|||
130778459|NCT02499120|470815438|FG000|Overall Study|Other|9|||
130778460|NCT02499120|470815439|FG001|Overall Study|Other|10|||
130778461|NCT01839916|470815448|FG000|Overall Study|Death|9|||
130778462|NCT01839916|470815448|FG000|Overall Study|Physician Decision|17|||
130778463|NCT01839916|470815448|FG000|Overall Study|Relapse|12|||
130778464|NCT01839916|470815448|FG000|Overall Study|GVHD|2|||
130778465|NCT01839916|470815448|FG000|Overall Study|Graft Failure|1|||
130778466|NCT04235504|470815453|FG000|Study Phase|Withdrawal by Subject|5|||
130778467|NCT04235504|470815454|FG001|Study Phase|Withdrawal by Subject|2|||
130778468|NCT04235504|470815455|FG002|Study Phase|Withdrawal by Subject|0|||
130778469|NCT04235504|470815456|FG003|Study Phase|Withdrawal by Subject|0|||
130778470|NCT04235504|470815453|FG000|Continuation Phase|Withdrawal by Subject|0|||
130778471|NCT04235504|470815454|FG001|Continuation Phase|Withdrawal by Subject|4|||
130978269|NCT00785291|471547416|FG002|Overall Study|Death|3|||
131131916|NCT00562588|472108456|FG001|Overall Study|Adverse Event|58|||
131131917|NCT00562588|472108455|FG000|Overall Study|Protocol Violation|30|||
131131918|NCT00562588|472108456|FG001|Overall Study|Protocol Violation|26|||
131131919|NCT00562588|472108455|FG000|Overall Study|Lost to Follow-up|12|||
131131920|NCT00562588|472108456|FG001|Overall Study|Lost to Follow-up|4|||
131131921|NCT00562588|472108455|FG000|Overall Study|Withdrawal by Subject|10|||
131131922|NCT00562588|472108456|FG001|Overall Study|Withdrawal by Subject|9|||
131131923|NCT00562588|472108455|FG000|Overall Study|Other|0|||
131131924|NCT00562588|472108456|FG001|Overall Study|Other|2|||
131131925|NCT03315871|472108460|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
131131926|NCT03315871|472108461|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
130778472|NCT04235504|470815455|FG002|Continuation Phase|Withdrawal by Subject|0|||
130978270|NCT00785291|471547414|FG000|Overall Study|Withdrawal by Subject|35|||
130978271|NCT00785291|471547415|FG001|Overall Study|Withdrawal by Subject|36|||
130978272|NCT00785291|471547416|FG002|Overall Study|Withdrawal by Subject|17|||
130978273|NCT00785291|471547414|FG000|Overall Study|Alternative Therapy|12|||
130978274|NCT00785291|471547415|FG001|Overall Study|Alternative Therapy|6|||
130978275|NCT00785291|471547416|FG002|Overall Study|Alternative Therapy|7|||
130978276|NCT00785291|471547414|FG000|Overall Study|Complicating illness|6|||
130978277|NCT00785291|471547415|FG001|Overall Study|Complicating illness|4|||
130978278|NCT00785291|471547416|FG002|Overall Study|Complicating illness|4|||
130978279|NCT00785291|471547414|FG000|Overall Study|Other Medical Reasons|29|||
131131927|NCT03315871|472108462|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
130778473|NCT04235504|470815456|FG003|Continuation Phase|Withdrawal by Subject|0|||
130778474|NCT04235504|470815453|FG000|Continuation Phase|Adverse Event|0|||
131131928|NCT03315871|472108460|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
130778475|NCT04235504|470815454|FG001|Continuation Phase|Adverse Event|1|||
131131929|NCT03315871|472108461|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
130978280|NCT00785291|471547415|FG001|Overall Study|Other Medical Reasons|25|||
130978281|NCT00785291|471547416|FG002|Overall Study|Other Medical Reasons|15|||
130978282|NCT00570674|471547417|FG000|Overall Study|Withdrawal by Subject|0|||
131131930|NCT03315871|472108462|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
130778476|NCT04235504|470815455|FG002|Continuation Phase|Adverse Event|0|||
130978283|NCT00570674|471547418|FG001|Overall Study|Withdrawal by Subject|0|||
130778477|NCT04235504|470815456|FG003|Continuation Phase|Adverse Event|0|||
130978284|NCT00570674|471547419|FG002|Overall Study|Withdrawal by Subject|1|||
130978285|NCT00570674|471547420|FG003|Overall Study|Withdrawal by Subject|0|||
130978286|NCT00570674|471547421|FG004|Overall Study|Withdrawal by Subject|0|||
130978287|NCT00570674|471547422|FG005|Overall Study|Withdrawal by Subject|0|||
130978288|NCT00570674|471547423|FG006|Overall Study|Withdrawal by Subject|0|||
130978289|NCT02979639|471547424|FG000|Overall Study|Withdrawal based on medical judgement|1|||
130978290|NCT02979639|471547424|FG000|Overall Study|Lost to Follow-up|8|||
130978291|NCT02979639|471547424|FG000|Overall Study|Withdrawal by Subject|3|||
130978292|NCT02979639|471547424|FG000|Overall Study|Adverse Event|2|||
130978293|NCT00160680|471547439|FG000|Overall Study|Adverse Event|0|||
130978294|NCT00160680|471547440|FG001|Overall Study|Adverse Event|1|||
130978295|NCT00160680|471547439|FG000|Overall Study|Lack of Efficacy|2|||
130978296|NCT00160680|471547440|FG001|Overall Study|Lack of Efficacy|1|||
130978297|NCT00160680|471547439|FG000|Overall Study|Lost to Follow-up|3|||
130978298|NCT00160680|471547440|FG001|Overall Study|Lost to Follow-up|2|||
130978299|NCT00160680|471547439|FG000|Overall Study|Withdrawal by Subject|4|||
130978300|NCT00160680|471547440|FG001|Overall Study|Withdrawal by Subject|9|||
130978301|NCT01773070|471547441|FG000|Overall Study|Withdrawal by Subject|24|||
130978302|NCT01773070|471547441|FG000|Overall Study|Lost to Follow-up|39|||
130978303|NCT01773070|471547441|FG000|Overall Study|Other|15|||
130978304|NCT01773070|471547441|FG000|Overall Study|Death (unrelated to study procedures)|3|||
130978305|NCT02450331|471547442|FG000|Overall Study|Death|162|||
130978306|NCT02450331|471547443|FG001|Overall Study|Death|171|||
130978307|NCT02450331|471547442|FG000|Overall Study|Lost to Follow-up|14|||
130978308|NCT02450331|471547443|FG001|Overall Study|Lost to Follow-up|12|||
130978309|NCT02450331|471547442|FG000|Overall Study|Withdrawal by Subject|55|||
130978310|NCT02450331|471547443|FG001|Overall Study|Withdrawal by Subject|44|||
130978311|NCT02450331|471547442|FG000|Overall Study|Non-specified other|1|||
130978312|NCT02450331|471547443|FG001|Overall Study|Non-specified other|1|||
130978313|NCT03232983|471547444|FG000|Period 1|Physician Decision|0|||
130978314|NCT03232983|471547445|FG001|Period 1|Physician Decision|0|||
130978315|NCT03232983|471547446|FG002|Period 1|Physician Decision|1|||
130978316|NCT03232983|471547447|FG003|Period 1|Physician Decision|0|||
130978317|NCT03232983|471547444|FG000|Washout Period 2|Physician Decision|0|||
130978318|NCT03232983|471547445|FG001|Washout Period 2|Physician Decision|0|||
130978319|NCT03232983|471547446|FG002|Washout Period 2|Physician Decision|1|||
130978320|NCT03232983|471547447|FG003|Washout Period 2|Physician Decision|0|||
130978321|NCT03232983|471547444|FG000|Washout Period 2|Withdrawal by Subject|0|||
130978322|NCT03232983|471547445|FG001|Washout Period 2|Withdrawal by Subject|0|||
130978323|NCT03232983|471547446|FG002|Washout Period 2|Withdrawal by Subject|0|||
130978324|NCT03232983|471547447|FG003|Washout Period 2|Withdrawal by Subject|1|||
130978325|NCT03232983|471547444|FG000|Period 4|Withdrawal by Subject|1|||
130978326|NCT03232983|471547445|FG001|Period 4|Withdrawal by Subject|0|||
130978327|NCT03232983|471547446|FG002|Period 4|Withdrawal by Subject|0|||
130978328|NCT03232983|471547447|FG003|Period 4|Withdrawal by Subject|0|||
130978329|NCT03643952|471547448|FG000|Overall Study|Lack of Efficacy|1|||
130978330|NCT01358968|471547449|FG000|Period 2|Adverse Event|0|||
130978331|NCT01358968|471547450|FG001|Period 2|Adverse Event|1|||
130978332|NCT01358968|471547451|FG002|Period 2|Adverse Event|0|||
130978333|NCT01358968|471547452|FG003|Period 2|Adverse Event|0|||
130978334|NCT01358968|471547449|FG000|Continued Access Phase|Progression of Disease|0|||
130978335|NCT01358968|471547450|FG001|Continued Access Phase|Progression of Disease|0|||
130978336|NCT01358968|471547451|FG002|Continued Access Phase|Progression of Disease|8|||
130978337|NCT01358968|471547452|FG003|Continued Access Phase|Progression of Disease|4|||
130978338|NCT01358968|471547449|FG000|Continued Access Phase|Protocol Violation|0|||
130978339|NCT01358968|471547450|FG001|Continued Access Phase|Protocol Violation|0|||
130978340|NCT01358968|471547451|FG002|Continued Access Phase|Protocol Violation|0|||
130978341|NCT01358968|471547452|FG003|Continued Access Phase|Protocol Violation|2|||
130978342|NCT01358968|471547449|FG000|Continued Access Phase|Withdrawal by Subject|0|||
130978343|NCT01358968|471547450|FG001|Continued Access Phase|Withdrawal by Subject|0|||
130978344|NCT01358968|471547451|FG002|Continued Access Phase|Withdrawal by Subject|3|||
130978345|NCT01358968|471547452|FG003|Continued Access Phase|Withdrawal by Subject|0|||
130978346|NCT01358968|471547449|FG000|Continued Access Phase|Death|0|||
130978347|NCT01358968|471547450|FG001|Continued Access Phase|Death|0|||
130978348|NCT01358968|471547451|FG002|Continued Access Phase|Death|1|||
130978349|NCT01358968|471547452|FG003|Continued Access Phase|Death|1|||
130978350|NCT01627327|471547453|FG000|Overall Study|Adverse Event|6|||
130978351|NCT01627327|471547454|FG001|Overall Study|Adverse Event|12|||
130778478|NCT04235504|470815453|FG000|Continuation Phase|Physician Decision|1|||
130978352|NCT01627327|471547453|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
130978353|NCT01627327|471547454|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
130978354|NCT01627327|471547453|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
130978355|NCT01627327|471547454|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
130978356|NCT01627327|471547453|FG000|Overall Study|Protocol Violation|4|||
130778479|NCT04235504|470815454|FG001|Continuation Phase|Physician Decision|2|||
130978357|NCT01627327|471547454|FG001|Overall Study|Protocol Violation|10|||
130978358|NCT01627327|471547453|FG000|Overall Study|Lost to Follow-up|1|||
130978359|NCT01627327|471547454|FG001|Overall Study|Lost to Follow-up|3|||
130978360|NCT01627327|471547453|FG000|Overall Study|Physician Decision|1|||
130978361|NCT01627327|471547454|FG001|Overall Study|Physician Decision|0|||
130978362|NCT01627327|471547453|FG000|Overall Study|Withdrawal by Subject|3|||
130978363|NCT01627327|471547454|FG001|Overall Study|Withdrawal by Subject|3|||
130978364|NCT04528069|471547458|FG000|Overall Study|Adverse Event|1|||
130978365|NCT04528069|471547458|FG000|Overall Study|Lost to Follow-up|1|||
130978366|NCT04528069|471547458|FG000|Overall Study|Patient Unable to Come|1|||
130978367|NCT04528069|471547458|FG000|Overall Study|Patient Unable to Attend|1|||
130978368|NCT02525874|471547459|FG000|Overall Study|Other|1|||
130978369|NCT02525874|471547459|FG000|Overall Study|Investigator Decision|1|||
130978370|NCT02525874|471547459|FG000|Overall Study|Consent withdrawn|22|||
130978371|NCT02525874|471547459|FG000|Overall Study|Non-compliance with study drug|3|||
130978372|NCT02525874|471547459|FG000|Overall Study|Adverse Event|17|||
130978373|NCT02525874|471547459|FG000|Overall Study|Lost to Follow-up|7|||
130978374|NCT02525874|471547459|FG000|Overall Study|Disease progression, defined by protocol|2|||
130978375|NCT02525874|471547459|FG000|Overall Study|Disease relapse|4|||
130978376|NCT02525874|471547459|FG000|Overall Study|Alternative Treatment for MS|2|||
130978377|NCT02525874|471547459|FG000|Overall Study|New lesions in Brain|1|||
130978378|NCT01814371|471547460|FG000|Overall Study|Lost to Follow-up|30|||
130978379|NCT01814371|471547461|FG001|Overall Study|Lost to Follow-up|27|||
130978380|NCT01692782|471547462|FG000|Overall Study|Adverse Event|12|||
130978381|NCT01692782|471547463|FG001|Overall Study|Adverse Event|32|||
130978382|NCT01692782|471547464|FG002|Overall Study|Adverse Event|2|||
130978383|NCT01692782|471547462|FG000|Overall Study|Lack of Efficacy|1|||
130978384|NCT01692782|471547463|FG001|Overall Study|Lack of Efficacy|2|||
130978385|NCT01692782|471547464|FG002|Overall Study|Lack of Efficacy|0|||
130978386|NCT01692782|471547462|FG000|Overall Study|Lost to Follow-up|2|||
130978387|NCT01692782|471547463|FG001|Overall Study|Lost to Follow-up|7|||
130978388|NCT01692782|471547464|FG002|Overall Study|Lost to Follow-up|1|||
130978389|NCT01692782|471547462|FG000|Overall Study|Pregnancy|1|||
130978390|NCT01692782|471547463|FG001|Overall Study|Pregnancy|0|||
130978391|NCT01692782|471547464|FG002|Overall Study|Pregnancy|0|||
130978392|NCT01692782|471547462|FG000|Overall Study|Protocol Violation|1|||
130978393|NCT01692782|471547463|FG001|Overall Study|Protocol Violation|0|||
130978394|NCT01692782|471547464|FG002|Overall Study|Protocol Violation|2|||
130978395|NCT01692782|471547462|FG000|Overall Study|Non-complance with study drug|0|||
130978396|NCT01692782|471547463|FG001|Overall Study|Non-complance with study drug|4|||
130978397|NCT01692782|471547464|FG002|Overall Study|Non-complance with study drug|1|||
130978398|NCT01692782|471547462|FG000|Overall Study|Non-compliant with study visits|0|||
130978399|NCT01692782|471547463|FG001|Overall Study|Non-compliant with study visits|0|||
130978400|NCT01692782|471547464|FG002|Overall Study|Non-compliant with study visits|1|||
130978401|NCT01692782|471547462|FG000|Overall Study|SAE not related to study drug|0|||
130978402|NCT01692782|471547463|FG001|Overall Study|SAE not related to study drug|1|||
130978403|NCT01692782|471547464|FG002|Overall Study|SAE not related to study drug|0|||
130978404|NCT01692782|471547462|FG000|Overall Study|Withdrawal by Subject|3|||
130978405|NCT01692782|471547463|FG001|Overall Study|Withdrawal by Subject|10|||
130978406|NCT01692782|471547464|FG002|Overall Study|Withdrawal by Subject|3|||
130978407|NCT03252587|471547465|FG000|Overall Study|Adverse Event|3|||
130978408|NCT03252587|471547466|FG001|Overall Study|Adverse Event|8|||
130978409|NCT03252587|471547467|FG002|Overall Study|Adverse Event|6|||
130978410|NCT03252587|471547468|FG003|Overall Study|Adverse Event|12|||
130978411|NCT03252587|471547465|FG000|Overall Study|Lack of Efficacy|7|||
130978412|NCT03252587|471547466|FG001|Overall Study|Lack of Efficacy|2|||
130978413|NCT03252587|471547467|FG002|Overall Study|Lack of Efficacy|2|||
131043807|NCT03580356|471794744|FG006|Treatment Period|Technical problems|0|||
131043808|NCT03580356|471794745|FG007|Treatment Period|Technical problems|0|||
131043809|NCT03580356|471794738|FG000|Treatment Period|Misrandomized, no treatment|0|||
131043810|NCT03580356|471794739|FG001|Treatment Period|Misrandomized, no treatment|0|||
131043811|NCT03580356|471794740|FG002|Treatment Period|Misrandomized, no treatment|1|||
131043812|NCT03580356|471794741|FG003|Treatment Period|Misrandomized, no treatment|0|||
131043813|NCT03580356|471794742|FG004|Treatment Period|Misrandomized, no treatment|2|||
131043814|NCT03580356|471794743|FG005|Treatment Period|Misrandomized, no treatment|0|||
131043815|NCT03580356|471794744|FG006|Treatment Period|Misrandomized, no treatment|0|||
131043816|NCT03580356|471794745|FG007|Treatment Period|Misrandomized, no treatment|0|||
131043817|NCT03580356|471794738|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
131043818|NCT03580356|471794739|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
131043819|NCT03580356|471794740|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
131043820|NCT03580356|471794741|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
130978414|NCT03252587|471547468|FG003|Overall Study|Lack of Efficacy|4|||
130978415|NCT03252587|471547465|FG000|Overall Study|Lost to Follow-up|2|||
130978416|NCT03252587|471547466|FG001|Overall Study|Lost to Follow-up|0|||
130978417|NCT03252587|471547467|FG002|Overall Study|Lost to Follow-up|0|||
130978418|NCT03252587|471547468|FG003|Overall Study|Lost to Follow-up|2|||
130978419|NCT03252587|471547465|FG000|Overall Study|Pregnancy|2|||
130978420|NCT03252587|471547466|FG001|Overall Study|Pregnancy|1|||
130978421|NCT03252587|471547467|FG002|Overall Study|Pregnancy|0|||
130978422|NCT03252587|471547468|FG003|Overall Study|Pregnancy|1|||
130978423|NCT03252587|471547465|FG000|Overall Study|Withdrawal by Subject|8|||
130978424|NCT03252587|471547466|FG001|Overall Study|Withdrawal by Subject|4|||
130978425|NCT03252587|471547467|FG002|Overall Study|Withdrawal by Subject|4|||
130978426|NCT03252587|471547468|FG003|Overall Study|Withdrawal by Subject|4|||
130978427|NCT03252587|471547465|FG000|Overall Study|Other Reasons|2|||
130978428|NCT03252587|471547466|FG001|Overall Study|Other Reasons|5|||
130978429|NCT03252587|471547467|FG002|Overall Study|Other Reasons|5|||
130978430|NCT03252587|471547468|FG003|Overall Study|Other Reasons|4|||
130978431|NCT04052204|471547469|FG000|Overall Study|Death|1|||
130978432|NCT04052204|471547470|FG001|Overall Study|Death|0|||
130978433|NCT04052204|471547471|FG002|Overall Study|Death|0|||
130978434|NCT04052204|471547469|FG000|Overall Study|Progressive disease|1|||
130978435|NCT04052204|471547470|FG001|Overall Study|Progressive disease|0|||
130978436|NCT04052204|471547471|FG002|Overall Study|Progressive disease|0|||
130978437|NCT04052204|471547469|FG000|Overall Study|Other|1|||
130718155|NCT04156620|470593249|FG001|Overall Study|Lost to follow-up - TP 2|2|||
130718156|NCT04156620|470593248|FG000|Overall Study|Physician decision - TP 2|4|||
130718157|NCT04156620|470593249|FG001|Overall Study|Physician decision - TP 2|2|||
130718158|NCT04156620|470593248|FG000|Overall Study|Pregnancy - TP 2|1|||
130718159|NCT04156620|470593249|FG001|Overall Study|Pregnancy - TP 2|1|||
130978438|NCT04052204|471547470|FG001|Overall Study|Other|0|||
130978439|NCT04052204|471547471|FG002|Overall Study|Other|0|||
130978440|NCT03945188|471547477|FG000|Overall Study|Protocol Violation|1|||
130978441|NCT03945188|471547478|FG001|Overall Study|Protocol Violation|0|||
130978442|NCT03945188|471547477|FG000|Overall Study|Disease worsening|79|||
130978443|NCT03945188|471547478|FG001|Overall Study|Disease worsening|73|||
130718160|NCT04156620|470593248|FG000|Overall Study|Subject decision - TP 2|11|||
130978444|NCT03945188|471547477|FG000|Overall Study|Physician Decision|2|||
130718161|NCT04156620|470593249|FG001|Overall Study|Subject decision - TP 2|9|||
130718162|NCT04156620|470593248|FG000|Overall Study|New therapy for study indication - TP 2|1|||
130718163|NCT04156620|470593249|FG001|Overall Study|New therapy for study indication - TP 2|0|||
130718164|NCT02722148|470593250|FG000|Overall Study|Lost to Follow-up|2|||
130718165|NCT02722148|470593250|FG000|Overall Study|Non compliant with treatment regimen|3|||
130718166|NCT01753336|470593252|FG000|Overall Study|Patient decision|12|||
130718167|NCT01753336|470593252|FG000|Overall Study|Lost to Follow-up|3|||
130718168|NCT01753336|470593252|FG000|Overall Study|Physician Decision|2|||
130718169|NCT01753336|470593252|FG000|Overall Study|Sponsor's decision|2|||
130718170|NCT01753336|470593252|FG000|Overall Study|Withdrawal by Subject|1|||
130718171|NCT01946191|470593256|FG000|Allocation|Did not complete orientation|1|||
130718172|NCT01946191|470593257|FG001|Allocation|Did not complete orientation|1|||
130718173|NCT01946191|470593256|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
130718174|NCT01946191|470593257|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
130718175|NCT01946191|470593256|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
130718176|NCT01946191|470593257|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
130718177|NCT01946191|470593256|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
130718178|NCT01946191|470593257|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
130718179|NCT01629966|470593258|FG000|Overall Study|Pregnancy|0|||
130718180|NCT01629966|470593259|FG001|Overall Study|Pregnancy|1|||
130718181|NCT01629966|470593260|FG002|Overall Study|Pregnancy|0|||
130718182|NCT01629966|470593258|FG000|Overall Study|Lost to Follow-up|10|||
130718183|NCT01629966|470593259|FG001|Overall Study|Lost to Follow-up|13|||
130718184|NCT01629966|470593260|FG002|Overall Study|Lost to Follow-up|9|||
130718185|NCT01629966|470593258|FG000|Overall Study|Withdrawal by Subject|8|||
130718186|NCT01629966|470593259|FG001|Overall Study|Withdrawal by Subject|9|||
130978445|NCT03945188|471547478|FG001|Overall Study|Physician Decision|2|||
130978446|NCT03945188|471547477|FG000|Overall Study|Lack of Efficacy|7|||
130978447|NCT03945188|471547478|FG001|Overall Study|Lack of Efficacy|4|||
130978448|NCT03945188|471547477|FG000|Overall Study|Pregnancy|2|||
130978449|NCT03945188|471547478|FG001|Overall Study|Pregnancy|0|||
130978450|NCT03945188|471547477|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
130978451|NCT03945188|471547478|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
130978452|NCT03945188|471547477|FG000|Overall Study|Adverse Event|10|||
130978453|NCT03945188|471547478|FG001|Overall Study|Adverse Event|5|||
130978454|NCT03945188|471547477|FG000|Overall Study|Other|2|||
131043821|NCT03580356|471794742|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
131043822|NCT03580356|471794743|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
131043823|NCT03580356|471794744|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
131043824|NCT03580356|471794745|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
131043825|NCT03580356|471794738|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
131043826|NCT03580356|471794739|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
131043827|NCT03580356|471794740|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
131043828|NCT03580356|471794741|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
131227549|NCT00410410|472459757|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
131227550|NCT00410410|472459749|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
130718187|NCT01629966|470593260|FG002|Overall Study|Withdrawal by Subject|16|||
130718188|NCT01629966|470593258|FG000|Overall Study|Protocol Violation|7|||
130978455|NCT03945188|471547478|FG001|Overall Study|Other|2|||
130978456|NCT03945188|471547477|FG000|Overall Study|Lost to Follow-up|1|||
130978457|NCT03945188|471547478|FG001|Overall Study|Lost to Follow-up|2|||
130978458|NCT01618162|471547506|FG000|Overall Study|Protocol Violation|13|||
130978459|NCT01618162|471547507|FG001|Overall Study|Protocol Violation|10|||
130978460|NCT01618162|471547506|FG000|Overall Study|Adverse Event|9|||
130978461|NCT01618162|471547507|FG001|Overall Study|Adverse Event|2|||
130978462|NCT01618162|471547506|FG000|Overall Study|Withdrawal Criteria|2|||
130978463|NCT01618162|471547507|FG001|Overall Study|Withdrawal Criteria|10|||
130978464|NCT01618162|471547506|FG000|Overall Study|Unclassified|14|||
130978465|NCT01618162|471547507|FG001|Overall Study|Unclassified|13|||
130978466|NCT04794803|471547508|FG000|Overall Study|Death|1|||
130978467|NCT04794803|471547509|FG001|Overall Study|Death|3|||
130978468|NCT04794803|471547508|FG000|Overall Study|Lost to Follow-up|2|||
130978469|NCT04794803|471547509|FG001|Overall Study|Lost to Follow-up|2|||
130978470|NCT04794803|471547508|FG000|Overall Study|Withdrawal by Subject|1|||
130978471|NCT04794803|471547509|FG001|Overall Study|Withdrawal by Subject|0|||
130978472|NCT04794803|471547508|FG000|Overall Study|Physician Decision|1|||
130978473|NCT04794803|471547509|FG001|Overall Study|Physician Decision|1|||
130978474|NCT04794803|471547508|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
130978475|NCT04794803|471547509|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
130978476|NCT04794803|471547508|FG000|Overall Study|Refused to continue the treatment|1|||
130978477|NCT04794803|471547509|FG001|Overall Study|Refused to continue the treatment|0|||
130978478|NCT04794803|471547508|FG000|Overall Study|Patient admitted to ICU|0|||
130978479|NCT04794803|471547509|FG001|Overall Study|Patient admitted to ICU|1|||
130978480|NCT04124926|471547510|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
130978481|NCT04124926|471547511|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
130978482|NCT04124926|471547512|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
130978483|NCT04124926|471547513|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
131043829|NCT03580356|471794742|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
131043830|NCT03580356|471794743|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
131043831|NCT03580356|471794744|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
131043832|NCT03580356|471794745|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
131043833|NCT03580356|471794738|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
131043834|NCT03580356|471794739|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
131043835|NCT03580356|471794740|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
131043836|NCT03580356|471794741|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
131043837|NCT03580356|471794742|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
131043838|NCT03580356|471794743|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
131043839|NCT03580356|471794744|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
131043840|NCT03580356|471794745|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
131043841|NCT03580356|471794738|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131043842|NCT03580356|471794739|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131043843|NCT03580356|471794740|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
131043844|NCT03580356|471794741|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131043845|NCT03580356|471794742|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
131043846|NCT03580356|471794743|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131043847|NCT03580356|471794744|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131043848|NCT03580356|471794745|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
131043849|NCT03580356|471794738|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
131043850|NCT03580356|471794739|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
131043851|NCT03580356|471794740|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
131043852|NCT03580356|471794741|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
131043853|NCT03580356|471794742|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
131043854|NCT03580356|471794743|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
131043855|NCT03580356|471794744|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
131043856|NCT03580356|471794745|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
131043857|NCT03580356|471794738|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
131043858|NCT03580356|471794739|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
131043859|NCT03580356|471794740|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
131043860|NCT03580356|471794741|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
131043861|NCT03580356|471794742|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
130978484|NCT04124926|471547514|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
130978485|NCT04124926|471547510|FG000|Healing Phase|Protocol Violation|0|||
130978486|NCT04124926|471547511|FG001|Healing Phase|Protocol Violation|1|||
130978487|NCT04124926|471547512|FG002|Healing Phase|Protocol Violation|0|||
130978488|NCT04124926|471547513|FG003|Healing Phase|Protocol Violation|0|||
130778480|NCT04235504|470815455|FG002|Continuation Phase|Physician Decision|1|||
130778481|NCT04235504|470815456|FG003|Continuation Phase|Physician Decision|0|||
130778482|NCT00101868|470815463|FG000|Overall Study|Death|10|||
130778483|NCT00101868|470815464|FG001|Overall Study|Death|10|||
130778484|NCT00101868|470815463|FG000|Overall Study|Withdrawal by Subject|8|||
130778485|NCT00101868|470815464|FG001|Overall Study|Withdrawal by Subject|9|||
130778486|NCT00101868|470815463|FG000|Overall Study|Protocol Violation|3|||
130778487|NCT00101868|470815464|FG001|Overall Study|Protocol Violation|0|||
130778488|NCT00101868|470815463|FG000|Overall Study|Lost to Follow-up|8|||
130778489|NCT00101868|470815464|FG001|Overall Study|Lost to Follow-up|13|||
130778490|NCT02106351|470815465|FG000|Treatment Cycle 1|Adverse Event|2|||
130778491|NCT02106351|470815466|FG001|Treatment Cycle 1|Adverse Event|0|||
130778492|NCT02106351|470815467|FG002|Treatment Cycle 1|Adverse Event|0|||
130778493|NCT02106351|470815465|FG000|Treatment Cycle 1|Consent withdrawn|1|||
130778494|NCT02106351|470815466|FG001|Treatment Cycle 1|Consent withdrawn|0|||
130778495|NCT02106351|470815467|FG002|Treatment Cycle 1|Consent withdrawn|2|||
130778496|NCT02106351|470815465|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
130778497|NCT02106351|470815466|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
130778498|NCT02106351|470815467|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
130778499|NCT02106351|470815465|FG000|Treatment Cycle 1|Other|0|||
130778500|NCT02106351|470815466|FG001|Treatment Cycle 1|Other|3|||
130778501|NCT02106351|470815467|FG002|Treatment Cycle 1|Other|1|||
130778502|NCT02106351|470815465|FG000|Treatment Cycle 1|Randomised but not treated|1|||
130778503|NCT02106351|470815466|FG001|Treatment Cycle 1|Randomised but not treated|0|||
130778504|NCT02106351|470815467|FG002|Treatment Cycle 1|Randomised but not treated|1|||
130778505|NCT02106351|470815465|FG000|Treatment Cycle 2|Adverse Event|0|||
130778506|NCT02106351|470815466|FG001|Treatment Cycle 2|Adverse Event|2|||
130778507|NCT02106351|470815467|FG002|Treatment Cycle 2|Adverse Event|0|||
130778508|NCT02106351|470815465|FG000|Treatment Cycle 2|Consent withdrawn|0|||
130778509|NCT02106351|470815466|FG001|Treatment Cycle 2|Consent withdrawn|1|||
130778510|NCT02106351|470815467|FG002|Treatment Cycle 2|Consent withdrawn|1|||
130778511|NCT02106351|470815465|FG000|Treatment Cycle 2|Other|0|||
130778512|NCT02106351|470815466|FG001|Treatment Cycle 2|Other|2|||
130778513|NCT02106351|470815467|FG002|Treatment Cycle 2|Other|2|||
130778514|NCT02106351|470815465|FG000|Treatment Cycle 3|Adverse Event|0|||
130778515|NCT02106351|470815466|FG001|Treatment Cycle 3|Adverse Event|1|||
130778516|NCT02106351|470815467|FG002|Treatment Cycle 3|Adverse Event|0|||
130778517|NCT02106351|470815465|FG000|Treatment Cycle 3|Consent withdrawn|0|||
130778518|NCT02106351|470815466|FG001|Treatment Cycle 3|Consent withdrawn|0|||
130778519|NCT02106351|470815467|FG002|Treatment Cycle 3|Consent withdrawn|2|||
130778520|NCT02106351|470815465|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
130778521|NCT02106351|470815466|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
130778522|NCT02106351|470815467|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
130778523|NCT02106351|470815465|FG000|Treatment Cycle 3|Other|0|||
130778524|NCT02106351|470815466|FG001|Treatment Cycle 3|Other|2|||
130778525|NCT02106351|470815467|FG002|Treatment Cycle 3|Other|3|||
130778526|NCT02106351|470815465|FG000|Treatment Cycle 4|Consent withdrawn|0|||
130778527|NCT02106351|470815466|FG001|Treatment Cycle 4|Consent withdrawn|0|||
130778528|NCT02106351|470815467|FG002|Treatment Cycle 4|Consent withdrawn|2|||
130778529|NCT02106351|470815465|FG000|Treatment Cycle 4|Other|0|||
130778530|NCT02106351|470815466|FG001|Treatment Cycle 4|Other|1|||
130778531|NCT02106351|470815467|FG002|Treatment Cycle 4|Other|0|||
130718189|NCT01629966|470593259|FG001|Overall Study|Protocol Violation|9|||
130718190|NCT01629966|470593260|FG002|Overall Study|Protocol Violation|7|||
130718191|NCT01629966|470593258|FG000|Overall Study|Lack of Efficacy|5|||
130718192|NCT01629966|470593259|FG001|Overall Study|Lack of Efficacy|2|||
130718193|NCT01629966|470593260|FG002|Overall Study|Lack of Efficacy|4|||
130718194|NCT01629966|470593258|FG000|Overall Study|Adverse Event|11|||
130718195|NCT01629966|470593259|FG001|Overall Study|Adverse Event|18|||
130718196|NCT01629966|470593260|FG002|Overall Study|Adverse Event|30|||
130718197|NCT04568031|470593261|FG000|Overall Study|Lost to Follow-up|1|||
130718198|NCT04568031|470593262|FG001|Overall Study|Lost to Follow-up|0|||
130718199|NCT04568031|470593263|FG002|Overall Study|Lost to Follow-up|0|||
130718200|NCT04568031|470593264|FG003|Overall Study|Lost to Follow-up|0|||
130778532|NCT00069823|470815468|FG000|Overall Study|Did not have follow-up diary cards|6|||
130778533|NCT00069823|470815469|FG001|Overall Study|Did not have follow-up diary cards|3|||
130778534|NCT00520039|470815470|FG000|Overall Study|Exclusion criteria met at first visit|7|||
130718201|NCT04568031|470593261|FG000|Overall Study|Physician Decision|1|||
130718202|NCT04568031|470593262|FG001|Overall Study|Physician Decision|0|||
130778535|NCT00520039|470815471|FG001|Overall Study|Exclusion criteria met at first visit|5|||
130778536|NCT02329327|470815472|FG000|Overall Study|Death|78|||
130778537|NCT02329327|470815473|FG001|Overall Study|Death|0|||
130778538|NCT02329327|470815472|FG000|Overall Study|Withdrawal by Subject|3|||
130778539|NCT02329327|470815473|FG001|Overall Study|Withdrawal by Subject|0|||
130778540|NCT02329327|470815472|FG000|Overall Study|Lost to Follow-up|4|||
130778541|NCT02329327|470815473|FG001|Overall Study|Lost to Follow-up|0|||
130778542|NCT03560869|470815474|FG000|Overall Study|Withdrawal by Subject|3|||
130778543|NCT03560869|470815475|FG001|Overall Study|Withdrawal by Subject|4|||
130718203|NCT04568031|470593263|FG002|Overall Study|Physician Decision|1|||
131131931|NCT03315871|472108460|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
131131932|NCT03315871|472108461|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
131131933|NCT03315871|472108462|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
131131934|NCT03315871|472108460|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
131131935|NCT03315871|472108461|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
131131936|NCT03315871|472108462|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
131131937|NCT03315871|472108460|FG000|PROSTVAC + CV301|Progressive disease|0|||
130718204|NCT04568031|470593264|FG003|Overall Study|Physician Decision|0|||
130718205|NCT04568031|470593261|FG000|Overall Study|Withdrawal by Subject|1|||
130718206|NCT04568031|470593262|FG001|Overall Study|Withdrawal by Subject|0|||
130718207|NCT04568031|470593263|FG002|Overall Study|Withdrawal by Subject|4|||
130718208|NCT04568031|470593264|FG003|Overall Study|Withdrawal by Subject|1|||
130718209|NCT03753763|470593281|FG000|Overall Study|Adverse Event|2|||
130718210|NCT03753763|470593282|FG001|Overall Study|Adverse Event|0|||
130718211|NCT03753763|470593281|FG000|Overall Study|Withdrawal by Subject|3|||
130718212|NCT03753763|470593282|FG001|Overall Study|Withdrawal by Subject|1|||
130718213|NCT03753763|470593281|FG000|Overall Study|clinical deterioration|1|||
130718214|NCT03753763|470593282|FG001|Overall Study|clinical deterioration|0|||
130718215|NCT01104779|470593283|FG000|Overall Study|Protocol Violation|1|||
130718216|NCT01104779|470593284|FG001|Overall Study|Protocol Violation|2|||
130718217|NCT01104779|470593285|FG002|Overall Study|Protocol Violation|2|||
130718218|NCT01104779|470593283|FG000|Overall Study|Lack of Efficacy|26|||
130718219|NCT01104779|470593284|FG001|Overall Study|Lack of Efficacy|12|||
130718220|NCT01104779|470593285|FG002|Overall Study|Lack of Efficacy|13|||
130718221|NCT01104779|470593283|FG000|Overall Study|Adverse Event|13|||
130718222|NCT01104779|470593284|FG001|Overall Study|Adverse Event|14|||
130718223|NCT01104779|470593285|FG002|Overall Study|Adverse Event|13|||
130718224|NCT01104779|470593283|FG000|Overall Study|Did not meet inc/exc criteria|1|||
130718225|NCT01104779|470593284|FG001|Overall Study|Did not meet inc/exc criteria|1|||
130718226|NCT01104779|470593285|FG002|Overall Study|Did not meet inc/exc criteria|1|||
130718227|NCT01104779|470593283|FG000|Overall Study|Other reasons|0|||
130718228|NCT01104779|470593284|FG001|Overall Study|Other reasons|1|||
130718229|NCT01104779|470593285|FG002|Overall Study|Other reasons|0|||
130718230|NCT01104779|470593283|FG000|Overall Study|Lost to Follow-up|2|||
130718231|NCT01104779|470593284|FG001|Overall Study|Lost to Follow-up|0|||
130718232|NCT01104779|470593285|FG002|Overall Study|Lost to Follow-up|1|||
130718233|NCT01104779|470593283|FG000|Overall Study|Withdrawal by Subject|16|||
130718234|NCT01104779|470593284|FG001|Overall Study|Withdrawal by Subject|25|||
130718235|NCT01104779|470593285|FG002|Overall Study|Withdrawal by Subject|32|||
130718236|NCT00389831|470593286|FG000|Overall Study|Lack of Efficacy|0|||
130718237|NCT00389831|470593287|FG001|Overall Study|Lack of Efficacy|2|||
130718238|NCT00389831|470593286|FG000|Overall Study|Did not receive treatment.|0|||
130718239|NCT00389831|470593287|FG001|Overall Study|Did not receive treatment.|2|||
130718240|NCT00389831|470593286|FG000|Overall Study|Other reasons|0|||
130718241|NCT00389831|470593287|FG001|Overall Study|Other reasons|2|||
130718242|NCT00389831|470593286|FG000|Overall Study|Lost to Follow-up|0|||
130718243|NCT00389831|470593287|FG001|Overall Study|Lost to Follow-up|1|||
130718244|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
130718245|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
130718246|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718247|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718248|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718249|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718250|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718251|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718252|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718253|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718254|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718255|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718256|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718257|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130718258|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
130718259|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
130718260|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718261|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718262|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718263|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718264|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718265|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718266|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718267|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
131131938|NCT03315871|472108461|FG001|PROSTVAC + CV301|Progressive disease|0|||
131131939|NCT03315871|472108462|FG002|PROSTVAC + CV301|Progressive disease|1|||
131131940|NCT03315871|472108460|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
131131941|NCT03315871|472108461|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
131131942|NCT03315871|472108462|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
131131943|NCT04099251|472111710|FG000|Pre-Treatment|Other reasons|1|||
131131944|NCT04099251|472111711|FG001|Pre-Treatment|Other reasons|0|||
131131945|NCT04099251|472111710|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
131131946|NCT04099251|472111711|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
131131947|NCT04099251|472111710|FG000|Blinded Treatment Phase|Other reasons|16|||
131131948|NCT04099251|472111711|FG001|Blinded Treatment Phase|Other reasons|7|||
131131949|NCT04099251|472111710|FG000|Blinded Treatment Phase|Disease recurrence|26|||
131131950|NCT04099251|472111711|FG001|Blinded Treatment Phase|Disease recurrence|41|||
131131951|NCT04099251|472111710|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
131131952|NCT04099251|472111711|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
131131953|NCT04099251|472111710|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
131131954|NCT04099251|472111711|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
131131955|NCT04099251|472111710|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
131131956|NCT04099251|472111711|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
131131957|NCT04099251|472111710|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
131131958|NCT04099251|472111711|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
131131959|NCT04099251|472111710|FG000|Blinded Treatment Phase|Death|6|||
131131960|NCT04099251|472111711|FG001|Blinded Treatment Phase|Death|2|||
131131961|NCT04099251|472111710|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
131131962|NCT04099251|472111711|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
130978489|NCT04124926|471547514|FG004|Healing Phase|Protocol Violation|0|||
130978490|NCT04124926|471547510|FG000|Healing Phase|Lost to Follow-up|5|||
130978491|NCT04124926|471547511|FG001|Healing Phase|Lost to Follow-up|4|||
130978492|NCT04124926|471547512|FG002|Healing Phase|Lost to Follow-up|0|||
130978493|NCT04124926|471547513|FG003|Healing Phase|Lost to Follow-up|0|||
130978494|NCT04124926|471547514|FG004|Healing Phase|Lost to Follow-up|0|||
130978495|NCT04124926|471547510|FG000|Healing Phase|Voluntary Withdrawal|10|||
130978496|NCT04124926|471547511|FG001|Healing Phase|Voluntary Withdrawal|7|||
130978497|NCT04124926|471547512|FG002|Healing Phase|Voluntary Withdrawal|0|||
130978498|NCT04124926|471547513|FG003|Healing Phase|Voluntary Withdrawal|0|||
130978499|NCT04124926|471547514|FG004|Healing Phase|Voluntary Withdrawal|0|||
130978500|NCT04124926|471547510|FG000|Healing Phase|Withdrawal of Consent|5|||
130978501|NCT04124926|471547511|FG001|Healing Phase|Withdrawal of Consent|3|||
130978502|NCT04124926|471547512|FG002|Healing Phase|Withdrawal of Consent|0|||
130978503|NCT04124926|471547513|FG003|Healing Phase|Withdrawal of Consent|0|||
130978504|NCT04124926|471547514|FG004|Healing Phase|Withdrawal of Consent|0|||
130978505|NCT04124926|471547510|FG000|Healing Phase|Miscellaneous|8|||
130978506|NCT04124926|471547511|FG001|Healing Phase|Miscellaneous|7|||
130978507|NCT04124926|471547512|FG002|Healing Phase|Miscellaneous|0|||
130978508|NCT04124926|471547513|FG003|Healing Phase|Miscellaneous|0|||
130978509|NCT04124926|471547514|FG004|Healing Phase|Miscellaneous|0|||
130978510|NCT04124926|471547510|FG000|Healing Phase|Randomized but not Treated|0|||
130978511|NCT04124926|471547511|FG001|Healing Phase|Randomized but not Treated|3|||
130978512|NCT04124926|471547512|FG002|Healing Phase|Randomized but not Treated|0|||
130978513|NCT04124926|471547513|FG003|Healing Phase|Randomized but not Treated|0|||
130978514|NCT04124926|471547514|FG004|Healing Phase|Randomized but not Treated|0|||
130978515|NCT04124926|471547510|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
130978516|NCT04124926|471547511|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
130978517|NCT04124926|471547512|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
130978518|NCT04124926|471547513|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
130978519|NCT04124926|471547514|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
130978520|NCT04124926|471547510|FG000|Maintenance Phase|Protocol Violation|0|||
130978521|NCT04124926|471547511|FG001|Maintenance Phase|Protocol Violation|0|||
130978522|NCT04124926|471547512|FG002|Maintenance Phase|Protocol Violation|3|||
130978523|NCT04124926|471547513|FG003|Maintenance Phase|Protocol Violation|0|||
130978524|NCT04124926|471547514|FG004|Maintenance Phase|Protocol Violation|0|||
131227551|NCT00410410|472459750|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
131227552|NCT00410410|472459751|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
131227553|NCT00410410|472459752|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
130978525|NCT04124926|471547510|FG000|Maintenance Phase|Lost to Follow-up|0|||
130978526|NCT04124926|471547511|FG001|Maintenance Phase|Lost to Follow-up|0|||
130978527|NCT04124926|471547512|FG002|Maintenance Phase|Lost to Follow-up|7|||
131227554|NCT00410410|472459753|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
131227555|NCT00410410|472459754|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
130978528|NCT04124926|471547513|FG003|Maintenance Phase|Lost to Follow-up|8|||
130978529|NCT04124926|471547514|FG004|Maintenance Phase|Lost to Follow-up|9|||
130978530|NCT04124926|471547510|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
130978531|NCT04124926|471547511|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
130978532|NCT04124926|471547512|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
131131963|NCT04099251|472111710|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
131131964|NCT04099251|472111711|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
131131965|NCT04099251|472111710|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
131131966|NCT04099251|472111711|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
131131967|NCT04099251|472111710|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
131131968|NCT04099251|472111711|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
131131969|NCT04099251|472111710|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
131131970|NCT04099251|472111711|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
131131971|NCT04099251|472111710|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
131131972|NCT04099251|472111711|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
131131973|NCT04099251|472111710|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
131131974|NCT04099251|472111711|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
131131975|NCT04099251|472111710|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
131131976|NCT04099251|472111711|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
131131977|NCT04099251|472111710|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
131131978|NCT04099251|472111711|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
131131979|NCT05032157|472111712|FG000|Overall Study|Adverse Event|12|||
130978533|NCT04124926|471547513|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
130978534|NCT04124926|471547514|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
130978535|NCT04124926|471547510|FG000|Maintenance Phase|Pregnancy|0|||
130978536|NCT04124926|471547511|FG001|Maintenance Phase|Pregnancy|0|||
130978537|NCT04124926|471547512|FG002|Maintenance Phase|Pregnancy|0|||
130978538|NCT04124926|471547513|FG003|Maintenance Phase|Pregnancy|1|||
130978539|NCT04124926|471547514|FG004|Maintenance Phase|Pregnancy|0|||
130978540|NCT04124926|471547510|FG000|Maintenance Phase|Lack of Efficacy|0|||
130978541|NCT04124926|471547511|FG001|Maintenance Phase|Lack of Efficacy|0|||
130978542|NCT04124926|471547512|FG002|Maintenance Phase|Lack of Efficacy|0|||
130978543|NCT04124926|471547513|FG003|Maintenance Phase|Lack of Efficacy|0|||
130978544|NCT04124926|471547514|FG004|Maintenance Phase|Lack of Efficacy|1|||
130978545|NCT04124926|471547510|FG000|Maintenance Phase|Withdrawal of Consent|0|||
130978546|NCT04124926|471547511|FG001|Maintenance Phase|Withdrawal of Consent|0|||
130978547|NCT04124926|471547512|FG002|Maintenance Phase|Withdrawal of Consent|5|||
130978548|NCT04124926|471547513|FG003|Maintenance Phase|Withdrawal of Consent|5|||
130978549|NCT04124926|471547514|FG004|Maintenance Phase|Withdrawal of Consent|5|||
130978550|NCT04124926|471547510|FG000|Maintenance Phase|Miscellaneous|0|||
130978551|NCT04124926|471547511|FG001|Maintenance Phase|Miscellaneous|0|||
130978552|NCT04124926|471547512|FG002|Maintenance Phase|Miscellaneous|1|||
130978553|NCT04124926|471547513|FG003|Maintenance Phase|Miscellaneous|2|||
130978554|NCT04124926|471547514|FG004|Maintenance Phase|Miscellaneous|4|||
130978555|NCT04124926|471547510|FG000|Maintenance Phase|Randomized but not Treated|0|||
130978556|NCT04124926|471547511|FG001|Maintenance Phase|Randomized but not Treated|0|||
130978557|NCT04124926|471547512|FG002|Maintenance Phase|Randomized but not Treated|2|||
130978558|NCT04124926|471547513|FG003|Maintenance Phase|Randomized but not Treated|2|||
130978559|NCT04124926|471547514|FG004|Maintenance Phase|Randomized but not Treated|0|||
130978560|NCT00423176|471547518|FG000|Overall Study|Adverse Event|4|||
130978561|NCT00423176|471547519|FG001|Overall Study|Adverse Event|6|||
130978562|NCT00423176|471547518|FG000|Overall Study|Treatment Failure|1|||
130978563|NCT00423176|471547519|FG001|Overall Study|Treatment Failure|6|||
130978564|NCT00423176|471547518|FG000|Overall Study|Lost to Follow-up|4|||
130978565|NCT00423176|471547519|FG001|Overall Study|Lost to Follow-up|7|||
130978566|NCT00423176|471547518|FG000|Overall Study|Withdrawal by Subject|4|||
130978567|NCT00423176|471547519|FG001|Overall Study|Withdrawal by Subject|3|||
130978568|NCT00423176|471547518|FG000|Overall Study|Protocol Violation|1|||
130978569|NCT00423176|471547519|FG001|Overall Study|Protocol Violation|3|||
130978570|NCT00423176|471547518|FG000|Overall Study|Did not meet protocol eligibility|2|||
130978571|NCT00423176|471547519|FG001|Overall Study|Did not meet protocol eligibility|4|||
130978572|NCT04867369|471547522|FG000|Overall Study|Withdrawal by Subject|1|||
130978573|NCT04867369|471547523|FG001|Overall Study|Withdrawal by Subject|0|||
130978574|NCT05554237|471547524|FG000|Part 2 (7 Days)|Adverse Event|0|||
130978575|NCT05554237|471547525|FG001|Part 2 (7 Days)|Adverse Event|0|||
130978576|NCT05554237|471547526|FG002|Part 2 (7 Days)|Adverse Event|0|||
130978577|NCT05554237|471547527|FG003|Part 2 (7 Days)|Adverse Event|0|||
130978578|NCT05554237|471547528|FG004|Part 2 (7 Days)|Adverse Event|2|||
130978579|NCT05554237|471547529|FG005|Part 2 (7 Days)|Adverse Event|0|||
130978580|NCT05554237|471547530|FG006|Part 2 (7 Days)|Adverse Event|0|||
130978581|NCT05554237|471547531|FG007|Part 2 (7 Days)|Adverse Event|0|||
130978582|NCT05554237|471547532|FG008|Part 2 (7 Days)|Adverse Event|0|||
130978583|NCT05554237|471547533|FG009|Part 2 (7 Days)|Adverse Event|1|||
130978584|NCT05554237|471547534|FG010|Part 2 (7 Days)|Adverse Event|0|||
130978585|NCT05554237|471547535|FG011|Part 2 (7 Days)|Adverse Event|0|||
130978586|NCT05554237|471547536|FG012|Part 2 (7 Days)|Adverse Event|1|||
130978587|NCT05554237|471547537|FG013|Part 2 (7 Days)|Adverse Event|0|||
130978588|NCT04435366|471547538|FG000|Year 1 (12 Months)|Adverse Event|3|||
131131980|NCT05032157|472111713|FG001|Overall Study|Adverse Event|7|||
131131981|NCT05032157|472111712|FG000|Overall Study|Pregnancy|0|||
131131982|NCT05032157|472111713|FG001|Overall Study|Pregnancy|2|||
130718268|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718269|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718270|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718271|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130718272|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
130718273|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
130718274|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718275|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718276|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718277|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718278|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718279|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718280|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718281|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718282|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718283|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718284|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718285|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130718286|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
130718287|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
130718288|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718289|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718290|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718291|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718292|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718293|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718294|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718295|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718296|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718297|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718298|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718299|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130718300|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
130718301|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
130718302|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718303|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718304|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718305|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718306|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718307|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718308|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718309|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718310|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718311|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718312|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718313|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130718314|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
130718315|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
130718316|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718317|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718318|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718319|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718320|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718321|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718322|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718323|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718324|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718325|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718326|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718327|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130718328|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
130718329|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
130718330|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718331|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718332|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130778544|NCT03560869|470815474|FG000|Overall Study|Screening failure|4|||
130778545|NCT03560869|470815475|FG001|Overall Study|Screening failure|4|||
130778546|NCT03560869|470815474|FG000|Overall Study|Withdrawal by PI|0|||
130778547|NCT03560869|470815475|FG001|Overall Study|Withdrawal by PI|1|||
130778548|NCT01801111|470815476|FG000|Overall Study|Adverse Event|12|||
130778549|NCT01801111|470815476|FG000|Overall Study|Death|8|||
130778550|NCT01801111|470815476|FG000|Overall Study|Physician Decision|5|||
130778551|NCT01801111|470815476|FG000|Overall Study|Other|1|||
130778552|NCT01801111|470815476|FG000|Overall Study|Withdrawal by Subject|4|||
130778553|NCT01801111|470815476|FG000|Overall Study|Study Terminated by Sponsor|27|||
130778554|NCT01801111|470815476|FG000|Overall Study|Progressive Disease|81|||
130778555|NCT01210482|470815477|FG000|Overall Study|Protocol Violation|1|||
130778556|NCT01210482|470815477|FG000|Overall Study|Case Report Forms were not collected|18|||
130778557|NCT01210482|470815477|FG000|Overall Study|Duplicated|2|||
130778558|NCT01210482|470815477|FG000|Overall Study|No Drug Administration|28|||
130778559|NCT01223937|470815478|FG000|Overall Study|Withdrawal by Subject|3|||
130778560|NCT01223937|470815479|FG001|Overall Study|Withdrawal by Subject|2|||
130778561|NCT01223937|470815478|FG000|Overall Study|Lost to Follow-up|1|||
130778562|NCT01223937|470815479|FG001|Overall Study|Lost to Follow-up|4|||
130778563|NCT01223937|470815478|FG000|Overall Study|Adverse Event|1|||
130778564|NCT01223937|470815479|FG001|Overall Study|Adverse Event|4|||
130778565|NCT01223937|470815478|FG000|Overall Study|Protocol Violation|8|||
130778566|NCT01223937|470815479|FG001|Overall Study|Protocol Violation|7|||
131043862|NCT03580356|471794743|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
131043863|NCT03580356|471794744|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
131227556|NCT00410410|472459755|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
130778567|NCT01223937|470815478|FG000|Overall Study|Other|4|||
130778568|NCT01223937|470815479|FG001|Overall Study|Other|1|||
130778569|NCT03284853|470815481|FG000|Overall Study|Adverse Event|40|||
130778570|NCT03284853|470815482|FG001|Overall Study|Adverse Event|4|||
130778571|NCT03284853|470815481|FG000|Overall Study|Withdrawal by Subject|5|||
130778572|NCT03284853|470815482|FG001|Overall Study|Withdrawal by Subject|1|||
130778573|NCT03284853|470815481|FG000|Overall Study|Lost to Follow-up|1|||
130778574|NCT03284853|470815482|FG001|Overall Study|Lost to Follow-up|0|||
130778575|NCT03284853|470815481|FG000|Overall Study|Lack of Efficacy|1|||
130778576|NCT03284853|470815482|FG001|Overall Study|Lack of Efficacy|0|||
130778577|NCT03284853|470815481|FG000|Overall Study|Disallowed Concurrent Medication|1|||
130778578|NCT03284853|470815482|FG001|Overall Study|Disallowed Concurrent Medication|1|||
130778579|NCT03284853|470815481|FG000|Overall Study|Protocol Violation|3|||
130778580|NCT03284853|470815482|FG001|Overall Study|Protocol Violation|3|||
130778581|NCT03284853|470815481|FG000|Overall Study|Death|0|||
130778582|NCT03284853|470815482|FG001|Overall Study|Death|1|||
130778583|NCT03284853|470815481|FG000|Overall Study|Other - Reason not reported in CSR|4|||
130778584|NCT03284853|470815482|FG001|Overall Study|Other - Reason not reported in CSR|3|||
130778585|NCT05176717|470815483|FG000|Overall Study|Sponsor Decision|1|||
130778586|NCT05176717|470815484|FG001|Overall Study|Sponsor Decision|2|||
130778587|NCT05176717|470815485|FG002|Overall Study|Sponsor Decision|2|||
130778588|NCT02308228|470815487|FG000|Overall Study|Adverse Event|3|||
130778589|NCT02308228|470815488|FG001|Overall Study|Adverse Event|4|||
130778590|NCT02308228|470815487|FG000|Overall Study|Withdrawal by Subject|5|||
130778591|NCT02308228|470815488|FG001|Overall Study|Withdrawal by Subject|3|||
130778592|NCT03999749|470815491|FG000|Overall Study|Toxicity|16|||
130778593|NCT03999749|470815491|FG000|Overall Study|Withdrawal by Subject|3|||
130778594|NCT03999749|470815491|FG000|Overall Study|Disease progression|26|||
130778595|NCT03999749|470815491|FG000|Overall Study|Physician Decision|4|||
130778596|NCT03999749|470815491|FG000|Overall Study|Death|5|||
131043864|NCT03580356|471794745|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
131043865|NCT03580356|471794738|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
131043866|NCT03580356|471794739|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
131043867|NCT03580356|471794740|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
131043868|NCT03580356|471794741|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
131043869|NCT03580356|471794742|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
131043870|NCT03580356|471794743|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
131043871|NCT03580356|471794744|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
131043872|NCT03580356|471794745|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
131043873|NCT05715528|471794747|FG000|Overall Study|Randomized but never treated|11|||
130778597|NCT03999749|470815491|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
130778598|NCT00255164|470815492|FG000|Overall Study|Adverse Event|10|||
130778599|NCT00255164|470815493|FG001|Overall Study|Adverse Event|6|||
130778600|NCT00255164|470815494|FG002|Overall Study|Adverse Event|9|||
130778601|NCT00255164|470815492|FG000|Overall Study|Lost to Follow-up|4|||
130778602|NCT00255164|470815493|FG001|Overall Study|Lost to Follow-up|3|||
130778603|NCT00255164|470815494|FG002|Overall Study|Lost to Follow-up|4|||
130778604|NCT00255164|470815492|FG000|Overall Study|Withdrawal by Subject|18|||
130778605|NCT00255164|470815493|FG001|Overall Study|Withdrawal by Subject|17|||
130778606|NCT00255164|470815494|FG002|Overall Study|Withdrawal by Subject|8|||
130778607|NCT00255164|470815492|FG000|Overall Study|Noncompliance|0|||
130778608|NCT00255164|470815493|FG001|Overall Study|Noncompliance|1|||
131043874|NCT05715528|471794748|FG001|Overall Study|Randomized but never treated|13|||
130978589|NCT04435366|471547539|FG001|Year 1 (12 Months)|Adverse Event|0|||
130978590|NCT04435366|471547540|FG002|Year 1 (12 Months)|Adverse Event|2|||
130978591|NCT04435366|471547538|FG000|Year 1 (12 Months)|Death|2|||
130978592|NCT04435366|471547539|FG001|Year 1 (12 Months)|Death|0|||
130978593|NCT04435366|471547540|FG002|Year 1 (12 Months)|Death|1|||
130978594|NCT04435366|471547538|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
130978595|NCT04435366|471547539|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
130718333|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718334|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718335|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718336|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718337|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718338|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718339|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718340|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718341|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130718342|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
130718343|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
130718344|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718345|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718346|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718347|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718348|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718349|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718350|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718351|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718352|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718353|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718354|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718355|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130718356|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
130718357|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
130718358|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718359|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718360|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718361|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718362|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718363|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718364|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718365|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718366|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718367|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718368|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718369|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130718370|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
130718371|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
130718372|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718373|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718374|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718375|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718376|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718377|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718378|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718379|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718380|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718381|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718382|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718383|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130718384|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
130718385|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
130978596|NCT04435366|471547540|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
130978597|NCT04435366|471547538|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
130978598|NCT04435366|471547539|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
130978599|NCT04435366|471547540|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
130978600|NCT04435366|471547538|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
130718386|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718387|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
131227557|NCT00410410|472459756|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
131227558|NCT00410410|472459757|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
131227559|NCT00410410|472459749|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
131227560|NCT00410410|472459750|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
131227561|NCT00410410|472459751|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
131227562|NCT00410410|472459752|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
130778609|NCT00255164|470815494|FG002|Overall Study|Noncompliance|2|||
130778610|NCT00255164|470815492|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
130778611|NCT00255164|470815493|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
130978601|NCT04435366|471547539|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
130978602|NCT04435366|471547540|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
130978603|NCT04435366|471547538|FG000|Year 1 (12 Months)|Not treated|0|||
130978604|NCT04435366|471547539|FG001|Year 1 (12 Months)|Not treated|0|||
130978605|NCT04435366|471547540|FG002|Year 1 (12 Months)|Not treated|1|||
130978606|NCT04435366|471547538|FG000|Year 2 (12 Months)|Death|1|||
130978607|NCT04435366|471547539|FG001|Year 2 (12 Months)|Death|4|||
130978608|NCT04435366|471547540|FG002|Year 2 (12 Months)|Death|6|||
130978609|NCT04435366|471547538|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
130978610|NCT04435366|471547539|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
130978611|NCT04435366|471547540|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
130978612|NCT04435366|471547538|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
130978613|NCT04435366|471547539|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
130978614|NCT04435366|471547540|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
130778612|NCT00255164|470815494|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
130778613|NCT00255164|470815492|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
130778614|NCT00255164|470815493|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
130778615|NCT00255164|470815494|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
130778616|NCT00255164|470815492|FG000|Overall Study|Possible Barrett's Esophagus|1|||
130778617|NCT00255164|470815493|FG001|Overall Study|Possible Barrett's Esophagus|3|||
130778618|NCT00255164|470815494|FG002|Overall Study|Possible Barrett's Esophagus|8|||
130778619|NCT00255164|470815492|FG000|Overall Study|Esophageal Stricture|0|||
130778620|NCT00255164|470815493|FG001|Overall Study|Esophageal Stricture|0|||
130778621|NCT00255164|470815494|FG002|Overall Study|Esophageal Stricture|1|||
130978615|NCT04435366|471547538|FG000|Year 2 (12 Months)|Adverse Event|2|||
130978616|NCT04435366|471547539|FG001|Year 2 (12 Months)|Adverse Event|1|||
130978617|NCT04435366|471547540|FG002|Year 2 (12 Months)|Adverse Event|6|||
130978618|NCT02477111|471547541|FG000|Overall Study|Death|28|||
130978619|NCT02477111|471547541|FG000|Overall Study|Withdrawal by Subject|19|||
130978620|NCT02477111|471547541|FG000|Overall Study|Lost to Follow-up|4|||
130978621|NCT02192502|471547542|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
130978622|NCT02192502|471547543|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
130978623|NCT02192502|471547542|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
130978624|NCT02192502|471547543|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
130978625|NCT02192502|471547542|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
130978626|NCT02192502|471547543|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
130978627|NCT03896035|471547547|FG000|Overall Study|Lost to Follow-up|2|||
130978628|NCT03896035|471547548|FG001|Overall Study|Lost to Follow-up|6|||
130978629|NCT03896035|471547547|FG000|Overall Study|Withdrawal by Subject|0|||
130978630|NCT03896035|471547548|FG001|Overall Study|Withdrawal by Subject|1|||
131043875|NCT05715528|471794747|FG000|Overall Study|Withdrew consent|7|||
131043876|NCT05715528|471794748|FG001|Overall Study|Withdrew consent|15|||
131043877|NCT05715528|471794747|FG000|Overall Study|Lost to Follow-up|5|||
131043878|NCT05715528|471794748|FG001|Overall Study|Lost to Follow-up|13|||
131043879|NCT05715528|471794747|FG000|Overall Study|Investigator's discretion|3|||
131043880|NCT05715528|471794748|FG001|Overall Study|Investigator's discretion|1|||
131043881|NCT05715528|471794747|FG000|Overall Study|Protocol Violation|2|||
131043882|NCT05715528|471794748|FG001|Overall Study|Protocol Violation|0|||
131043883|NCT05715528|471794747|FG000|Overall Study|Non-compliance with study drug|0|||
131043884|NCT05715528|471794748|FG001|Overall Study|Non-compliance with study drug|1|||
131043885|NCT03118518|471794749|FG000|Overall Study|Early Exit after treatment|2|||
131043886|NCT03118518|471794750|FG001|Overall Study|Early Exit after treatment|8|||
131043887|NCT03118518|471794749|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
131043888|NCT03118518|471794750|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
131043889|NCT02834390|471794751|FG000|Induction Phase|Progressive disease|0|||
131043890|NCT02834390|471794752|FG001|Induction Phase|Progressive disease|1|||
131043891|NCT02834390|471794751|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
131043892|NCT02834390|471794752|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
131043893|NCT02834390|471794751|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
131043894|NCT02834390|471794752|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
131043895|NCT02834390|471794751|FG000|Consolidation Phase|Physician Decision|1|||
131043896|NCT02834390|471794752|FG001|Consolidation Phase|Physician Decision|1|||
131043897|NCT02998528|471794758|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
131227563|NCT00410410|472459753|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
131227564|NCT00410410|472459754|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
131227565|NCT00410410|472459755|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
131227566|NCT00410410|472459756|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
131227567|NCT00410410|472459757|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
131227568|NCT00410410|472459749|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131227569|NCT00410410|472459750|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130778622|NCT00255164|470815492|FG000|Overall Study|Therapeutic Failure|11|||
130778623|NCT00255164|470815493|FG001|Overall Study|Therapeutic Failure|2|||
130778624|NCT00255164|470815494|FG002|Overall Study|Therapeutic Failure|3|||
130778625|NCT05219968|470815495|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
130778626|NCT05219968|470815496|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130778627|NCT05219968|470815497|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130778628|NCT05219968|470815498|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130978631|NCT03896035|471547547|FG000|Overall Study|Health/family health issues during COVID|0|||
130978632|NCT03896035|471547548|FG001|Overall Study|Health/family health issues during COVID|4|||
130978633|NCT03492281|471547549|FG000|Overall Study|Withdrawal by Subject|21|||
130978634|NCT03492281|471547550|FG001|Overall Study|Withdrawal by Subject|14|||
130978635|NCT03492281|471547551|FG002|Overall Study|Withdrawal by Subject|13|||
130978636|NCT03492281|471547549|FG000|Overall Study|Lost to Follow-up|14|||
130978637|NCT03492281|471547550|FG001|Overall Study|Lost to Follow-up|15|||
130978638|NCT03492281|471547551|FG002|Overall Study|Lost to Follow-up|10|||
130978639|NCT03492281|471547549|FG000|Overall Study|Adverse Event|6|||
130978640|NCT03492281|471547550|FG001|Overall Study|Adverse Event|8|||
130978641|NCT03492281|471547551|FG002|Overall Study|Adverse Event|13|||
130978642|NCT03492281|471547549|FG000|Overall Study|Lack of Efficacy|3|||
130978643|NCT03492281|471547550|FG001|Overall Study|Lack of Efficacy|0|||
130978644|NCT03492281|471547551|FG002|Overall Study|Lack of Efficacy|1|||
130978645|NCT03492281|471547549|FG000|Overall Study|Physician Decision|1|||
130978646|NCT03492281|471547550|FG001|Overall Study|Physician Decision|0|||
130978647|NCT03492281|471547551|FG002|Overall Study|Physician Decision|3|||
130978648|NCT03492281|471547549|FG000|Overall Study|Protocol Violation|0|||
130978649|NCT03492281|471547550|FG001|Overall Study|Protocol Violation|2|||
130978650|NCT03492281|471547551|FG002|Overall Study|Protocol Violation|1|||
130978651|NCT03492281|471547549|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
130978652|NCT03492281|471547550|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
130978653|NCT03492281|471547551|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
130978654|NCT03492281|471547549|FG000|Overall Study|Death|0|||
130978655|NCT03492281|471547550|FG001|Overall Study|Death|0|||
130978656|NCT03492281|471547551|FG002|Overall Study|Death|1|||
130978657|NCT03492281|471547549|FG000|Overall Study|Captured as Other in Database|8|||
130978658|NCT03492281|471547550|FG001|Overall Study|Captured as Other in Database|6|||
130978659|NCT03492281|471547551|FG002|Overall Study|Captured as Other in Database|3|||
130978660|NCT01506193|471547552|FG000|Overall Study|Protocol Violation|1|||
130978661|NCT01506193|471547553|FG001|Overall Study|Protocol Violation|0|||
130978662|NCT01506193|471547554|FG002|Overall Study|Protocol Violation|1|||
130978663|NCT01506193|471547552|FG000|Overall Study|Migrated/moved from study area|0|||
130978664|NCT01506193|471547553|FG001|Overall Study|Migrated/moved from study area|0|||
130978665|NCT01506193|471547554|FG002|Overall Study|Migrated/moved from study area|1|||
130978666|NCT01506193|471547552|FG000|Overall Study|Adverse event, non-fatal|0|||
130978667|NCT01506193|471547553|FG001|Overall Study|Adverse event, non-fatal|0|||
130978668|NCT01506193|471547554|FG002|Overall Study|Adverse event, non-fatal|1|||
130978669|NCT01506193|471547552|FG000|Overall Study|Withdrawal by Subject|5|||
130978670|NCT01506193|471547553|FG001|Overall Study|Withdrawal by Subject|1|||
130978671|NCT01506193|471547554|FG002|Overall Study|Withdrawal by Subject|8|||
130978672|NCT01506193|471547552|FG000|Overall Study|Lost to Follow-up|8|||
130978673|NCT01506193|471547553|FG001|Overall Study|Lost to Follow-up|3|||
130978674|NCT01506193|471547554|FG002|Overall Study|Lost to Follow-up|3|||
130978675|NCT04575467|471547557|FG000|Overall Study|Adverse Event|0|||
130978676|NCT04575467|471547558|FG001|Overall Study|Adverse Event|1|||
130978677|NCT04575467|471547559|FG002|Overall Study|Adverse Event|0|||
130978678|NCT04575467|471547560|FG003|Overall Study|Adverse Event|0|||
130778629|NCT05219968|470815499|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130978679|NCT00743366|471547561|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
130978680|NCT00743366|471547562|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
130978681|NCT03206203|471547563|FG000|Treatment|Death|38|||
130978682|NCT03206203|471547564|FG001|Treatment|Death|26|||
130978683|NCT03206203|471547565|FG002|Treatment|Death|0|||
130978684|NCT03206203|471547563|FG000|Treatment|Withdrawal by Subject|1|||
130978685|NCT03206203|471547564|FG001|Treatment|Withdrawal by Subject|0|||
130978686|NCT03206203|471547565|FG002|Treatment|Withdrawal by Subject|0|||
130978687|NCT03206203|471547563|FG000|Treatment|Lost to Follow-up|4|||
130978688|NCT03206203|471547564|FG001|Treatment|Lost to Follow-up|0|||
130978689|NCT03206203|471547565|FG002|Treatment|Lost to Follow-up|0|||
130978690|NCT03206203|471547563|FG000|Treatment|N/A in Follow-Up|8|||
130978691|NCT03206203|471547564|FG001|Treatment|N/A in Follow-Up|1|||
130978692|NCT03206203|471547565|FG002|Treatment|N/A in Follow-Up|0|||
130978693|NCT03206203|471547563|FG000|Treatment|Disease progression|0|||
130978694|NCT03206203|471547564|FG001|Treatment|Disease progression|1|||
130978695|NCT03206203|471547565|FG002|Treatment|Disease progression|0|||
130978696|NCT03206203|471547563|FG000|Treatment|Refused follow-up|0|||
130978697|NCT03206203|471547564|FG001|Treatment|Refused follow-up|1|||
130978698|NCT03206203|471547565|FG002|Treatment|Refused follow-up|0|||
130978699|NCT03206203|471547563|FG000|Treatment|Cross over to Arm 1|0|||
130978700|NCT03206203|471547564|FG001|Treatment|Cross over to Arm 1|19|||
130978701|NCT03206203|471547565|FG002|Treatment|Cross over to Arm 1|0|||
130978702|NCT03206203|471547563|FG000|Optional Cross-Over|Death|0|||
130978703|NCT03206203|471547564|FG001|Optional Cross-Over|Death|0|||
130978704|NCT03206203|471547565|FG002|Optional Cross-Over|Death|14|||
130978705|NCT03206203|471547563|FG000|Optional Cross-Over|Refused follow-up|0|||
130978706|NCT03206203|471547564|FG001|Optional Cross-Over|Refused follow-up|0|||
130978707|NCT03206203|471547565|FG002|Optional Cross-Over|Refused follow-up|2|||
130978708|NCT01483924|471547566|FG000|Overall Study|Withdrawal by Subject|2|||
131043898|NCT02998528|471794759|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
131043899|NCT02998528|471794760|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
131043900|NCT02998528|471794758|FG000|Randomization Period|Participant withdrew consent|0|||
131043901|NCT02998528|471794759|FG001|Randomization Period|Participant withdrew consent|3|||
131043902|NCT02998528|471794760|FG002|Randomization Period|Participant withdrew consent|0|||
131043903|NCT02998528|471794758|FG000|Randomization Period|Participant no longer meets study criteria|1|||
131043904|NCT02998528|471794759|FG001|Randomization Period|Participant no longer meets study criteria|3|||
131043905|NCT02998528|471794760|FG002|Randomization Period|Participant no longer meets study criteria|2|||
131043906|NCT02998528|471794758|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
131043907|NCT02998528|471794759|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
131043908|NCT02998528|471794760|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
131043909|NCT02998528|471794758|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
131043910|NCT02998528|471794759|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
131043911|NCT02998528|471794760|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
131043912|NCT02998528|471794758|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
131043913|NCT02998528|471794759|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
131043914|NCT02998528|471794760|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
131043915|NCT02998528|471794758|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
131043916|NCT02998528|471794759|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
131043917|NCT02998528|471794760|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
131227570|NCT00410410|472459751|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131227571|NCT00410410|472459752|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131227572|NCT00410410|472459753|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131227573|NCT00410410|472459754|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131227574|NCT00410410|472459755|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
131227575|NCT00410410|472459756|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
131227576|NCT00410410|472459757|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
131227577|NCT00410410|472459749|FG000|Open-Label Period (OL)|Death|0|||
131227578|NCT00410410|472459750|FG001|Open-Label Period (OL)|Death|0|||
131227579|NCT00410410|472459751|FG002|Open-Label Period (OL)|Death|0|||
131227580|NCT00410410|472459752|FG003|Open-Label Period (OL)|Death|0|||
131227581|NCT00410410|472459753|FG004|Open-Label Period (OL)|Death|0|||
131227582|NCT00410410|472459754|FG005|Open-Label Period (OL)|Death|0|||
131227583|NCT00410410|472459755|FG006|Open-Label Period (OL)|Death|0|||
131227584|NCT00410410|472459756|FG007|Open-Label Period (OL)|Death|0|||
131227585|NCT00410410|472459757|FG008|Open-Label Period (OL)|Death|1|||
131227586|NCT00410410|472459749|FG000|Open-Label Period (OL)|Adverse Event|0|||
131227587|NCT00410410|472459750|FG001|Open-Label Period (OL)|Adverse Event|0|||
131227588|NCT00410410|472459751|FG002|Open-Label Period (OL)|Adverse Event|0|||
131227589|NCT00410410|472459752|FG003|Open-Label Period (OL)|Adverse Event|0|||
131227590|NCT00410410|472459753|FG004|Open-Label Period (OL)|Adverse Event|0|||
131227591|NCT00410410|472459754|FG005|Open-Label Period (OL)|Adverse Event|0|||
131227592|NCT00410410|472459755|FG006|Open-Label Period (OL)|Adverse Event|0|||
131227593|NCT00410410|472459756|FG007|Open-Label Period (OL)|Adverse Event|0|||
131227594|NCT00410410|472459757|FG008|Open-Label Period (OL)|Adverse Event|10|||
131227595|NCT00410410|472459749|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
131227596|NCT00410410|472459750|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
130978709|NCT01483924|471547567|FG001|Overall Study|Withdrawal by Subject|0|||
130978710|NCT01483924|471547568|FG002|Overall Study|Withdrawal by Subject|0|||
130978711|NCT01483924|471547569|FG003|Overall Study|Withdrawal by Subject|1|||
130978712|NCT01483924|471547570|FG004|Overall Study|Withdrawal by Subject|1|||
130978713|NCT01483924|471547566|FG000|Overall Study|Adverse Event|0|||
130978714|NCT01483924|471547567|FG001|Overall Study|Adverse Event|0|||
130978715|NCT01483924|471547568|FG002|Overall Study|Adverse Event|1|||
131227597|NCT00410410|472459751|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
131131983|NCT05032157|472111712|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131131984|NCT05032157|472111713|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
130978716|NCT01483924|471547569|FG003|Overall Study|Adverse Event|1|||
130978717|NCT01483924|471547570|FG004|Overall Study|Adverse Event|0|||
130978718|NCT01483924|471547566|FG000|Overall Study|Non-compliance|0|||
130978719|NCT01483924|471547567|FG001|Overall Study|Non-compliance|0|||
130978720|NCT01483924|471547568|FG002|Overall Study|Non-compliance|0|||
130978721|NCT01483924|471547569|FG003|Overall Study|Non-compliance|1|||
130978722|NCT01483924|471547570|FG004|Overall Study|Non-compliance|1|||
130978723|NCT01483924|471547566|FG000|Overall Study|Sponsor concern over ECG result|0|||
130978724|NCT01483924|471547567|FG001|Overall Study|Sponsor concern over ECG result|0|||
130978725|NCT01483924|471547568|FG002|Overall Study|Sponsor concern over ECG result|0|||
130978726|NCT01483924|471547569|FG003|Overall Study|Sponsor concern over ECG result|1|||
130978727|NCT01483924|471547570|FG004|Overall Study|Sponsor concern over ECG result|0|||
130978728|NCT03565887|471547576|FG000|Overall Study|Adverse Event|1|||
130978729|NCT03565887|471547577|FG001|Overall Study|Adverse Event|0|||
130978730|NCT03565887|471547576|FG000|Overall Study|Withdrawal by Subject|0|||
130978731|NCT03565887|471547577|FG001|Overall Study|Withdrawal by Subject|2|||
130978732|NCT01152580|471547578|FG000|Overall Study|Withdrawal by Subject|0|||
130978733|NCT01152580|471547579|FG001|Overall Study|Withdrawal by Subject|1|||
131131985|NCT05032157|472111712|FG000|Overall Study|Protocol Deviation|8|||
131131986|NCT05032157|472111713|FG001|Overall Study|Protocol Deviation|4|||
131131987|NCT05032157|472111712|FG000|Overall Study|Lost to Follow-up|1|||
131131988|NCT05032157|472111713|FG001|Overall Study|Lost to Follow-up|3|||
131131989|NCT05032157|472111712|FG000|Overall Study|Physician Decision|7|||
131131990|NCT05032157|472111713|FG001|Overall Study|Physician Decision|2|||
131131991|NCT05032157|472111712|FG000|Overall Study|Patient Decision|38|||
131131992|NCT05032157|472111713|FG001|Overall Study|Patient Decision|19|||
131131993|NCT03047980|472111714|FG000|Overall Study|Adverse Event|1|||
131131994|NCT00880893|472111715|FG000|Overall Study|Protocol Violation|13|||
131131995|NCT00880893|472111716|FG001|Overall Study|Protocol Violation|1|||
131131996|NCT00880893|472111715|FG000|Overall Study|Withdrawal by Subject|15|||
131131997|NCT00880893|472111716|FG001|Overall Study|Withdrawal by Subject|11|||
131131998|NCT00880893|472111715|FG000|Overall Study|Lost to Follow-up|76|||
131131999|NCT00880893|472111716|FG001|Overall Study|Lost to Follow-up|33|||
131132000|NCT00880893|472111715|FG000|Overall Study|Serious adverse event|3|||
131132001|NCT00880893|472111716|FG001|Overall Study|Serious adverse event|0|||
131132002|NCT02164981|472111717|FG000|Started|Withdrawal by Subject|2|||
131132003|NCT02164981|472111718|FG001|Started|Withdrawal by Subject|1|||
131132004|NCT02164981|472111719|FG002|Started|Withdrawal by Subject|0|||
131132005|NCT02164981|472111717|FG000|Started|Protocol Violation|2|||
131132006|NCT02164981|472111718|FG001|Started|Protocol Violation|0|||
130978734|NCT00449176|471547581|FG000|Overall Study|Withdrawal by Subject|39|||
131132007|NCT02164981|472111719|FG002|Started|Protocol Violation|0|||
131132008|NCT02164981|472111717|FG000|Started|Adverse Event|1|||
131132009|NCT02164981|472111718|FG001|Started|Adverse Event|2|||
131132010|NCT02164981|472111719|FG002|Started|Adverse Event|0|||
131132011|NCT02164981|472111717|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
131132012|NCT02164981|472111718|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
130978735|NCT00449176|471547582|FG001|Overall Study|Withdrawal by Subject|43|||
130978736|NCT00449176|471547583|FG002|Overall Study|Withdrawal by Subject|59|||
131132013|NCT02164981|472111719|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
131132014|NCT02164981|472111717|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
131132015|NCT02164981|472111718|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
131132016|NCT02164981|472111719|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
131132017|NCT02164981|472111717|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
131132018|NCT02164981|472111718|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
131132019|NCT02164981|472111719|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
131132020|NCT01783678|472111720|FG000|Overall Study|Randomized but Not Treated|0|||
131132021|NCT01783678|472111721|FG001|Overall Study|Randomized but Not Treated|0|||
131132022|NCT01783678|472111722|FG002|Overall Study|Randomized but Not Treated|0|||
131132023|NCT01783678|472111723|FG003|Overall Study|Randomized but Not Treated|1|||
131132024|NCT01783678|472111724|FG004|Overall Study|Randomized but Not Treated|0|||
131132025|NCT01783678|472111725|FG005|Overall Study|Randomized but Not Treated|0|||
131132026|NCT01783678|472111720|FG000|Overall Study|Lack of Efficacy|1|||
131132027|NCT01783678|472111721|FG001|Overall Study|Lack of Efficacy|13|||
131132028|NCT01783678|472111722|FG002|Overall Study|Lack of Efficacy|1|||
131132029|NCT01783678|472111723|FG003|Overall Study|Lack of Efficacy|3|||
131132030|NCT01783678|472111724|FG004|Overall Study|Lack of Efficacy|6|||
131132031|NCT01783678|472111725|FG005|Overall Study|Lack of Efficacy|5|||
131132032|NCT01783678|472111720|FG000|Overall Study|Lost to Follow-up|0|||
131132033|NCT01783678|472111721|FG001|Overall Study|Lost to Follow-up|4|||
131132034|NCT01783678|472111722|FG002|Overall Study|Lost to Follow-up|0|||
131132035|NCT01783678|472111723|FG003|Overall Study|Lost to Follow-up|2|||
130978737|NCT00449176|471547581|FG000|Overall Study|Lost to Follow-up|13|||
130978738|NCT00449176|471547582|FG001|Overall Study|Lost to Follow-up|8|||
130978739|NCT00449176|471547583|FG002|Overall Study|Lost to Follow-up|12|||
130978740|NCT00449176|471547581|FG000|Overall Study|Adverse Event|51|||
130978741|NCT00449176|471547582|FG001|Overall Study|Adverse Event|107|||
130978742|NCT00449176|471547583|FG002|Overall Study|Adverse Event|15|||
130978743|NCT00449176|471547581|FG000|Overall Study|Lack of Efficacy|13|||
130978744|NCT00449176|471547582|FG001|Overall Study|Lack of Efficacy|7|||
130978745|NCT00449176|471547583|FG002|Overall Study|Lack of Efficacy|50|||
130978746|NCT00449176|471547581|FG000|Overall Study|Study drug non-compliant|14|||
130978747|NCT00449176|471547582|FG001|Overall Study|Study drug non-compliant|11|||
130978748|NCT00449176|471547583|FG002|Overall Study|Study drug non-compliant|11|||
130978749|NCT00449176|471547581|FG000|Overall Study|all other|22|||
130978750|NCT00449176|471547582|FG001|Overall Study|all other|19|||
130978751|NCT00449176|471547583|FG002|Overall Study|all other|20|||
130978752|NCT00675766|471547584|FG000|Overall Study|Lost to Follow-up|6|||
130978753|NCT00675766|471547585|FG001|Overall Study|Lost to Follow-up|5|||
130978754|NCT00675766|471547586|FG002|Overall Study|Lost to Follow-up|21|||
130978755|NCT00675766|471547587|FG003|Overall Study|Lost to Follow-up|26|||
130978756|NCT03182868|471547590|FG000|Overall Study|Protocol Violation|3|||
130978757|NCT03182868|471547591|FG001|Overall Study|Protocol Violation|0|||
130978758|NCT03182868|471547592|FG002|Overall Study|Protocol Violation|4|||
130978759|NCT03182868|471547593|FG003|Overall Study|Protocol Violation|1|||
130978760|NCT03182868|471547594|FG004|Overall Study|Protocol Violation|8|||
130978761|NCT03015402|471547597|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130978762|NCT03015402|471547598|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
130978763|NCT03015402|471547597|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
130978764|NCT03015402|471547598|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
130978765|NCT03213158|471547599|FG000|Overall Study|Withdrawal by Subject|1|||
130978766|NCT03213158|471547599|FG000|Overall Study|Physician Decision|2|||
130978767|NCT01995461|471547600|FG000|Overall Study|Death|1|||
130978768|NCT01995461|471547600|FG000|Overall Study|Lost to Follow-up|2|||
130978769|NCT01995461|471547600|FG000|Overall Study|Withdrawal by Subject|2|||
130978770|NCT00736645|471547603|FG000|Overall Study|Adverse Event|0|||
130978771|NCT00736645|471547604|FG001|Overall Study|Adverse Event|2|||
130978772|NCT00736645|471547605|FG002|Overall Study|Adverse Event|0|||
130978773|NCT00736645|471547606|FG003|Overall Study|Adverse Event|0|||
130978774|NCT00295022|471547609|FG000|Overall Study|Adverse Event|1|||
130978775|NCT00295022|471547610|FG001|Overall Study|Adverse Event|1|||
130978776|NCT00295022|471547611|FG002|Overall Study|Adverse Event|2|||
130978777|NCT00295022|471547609|FG000|Overall Study|Lost to Follow-up|0|||
130978778|NCT00295022|471547610|FG001|Overall Study|Lost to Follow-up|0|||
130978779|NCT00295022|471547611|FG002|Overall Study|Lost to Follow-up|1|||
130978780|NCT00295022|471547609|FG000|Overall Study|Withdrawal by Subject|0|||
130978781|NCT00295022|471547610|FG001|Overall Study|Withdrawal by Subject|0|||
130978782|NCT00295022|471547611|FG002|Overall Study|Withdrawal by Subject|2|||
130978783|NCT00734630|471547612|FG000|Overall Study|Lack of Efficacy|4|||
130978784|NCT00734630|471547613|FG001|Overall Study|Lack of Efficacy|4|||
130978785|NCT00734630|471547612|FG000|Overall Study|Withdrawal by Subject|7|||
130978786|NCT00734630|471547613|FG001|Overall Study|Withdrawal by Subject|9|||
130978787|NCT00734630|471547612|FG000|Overall Study|Lost to Follow-up|13|||
130978788|NCT00734630|471547613|FG001|Overall Study|Lost to Follow-up|7|||
130978789|NCT00734630|471547612|FG000|Overall Study|Protocol Violation|0|||
130978790|NCT00734630|471547613|FG001|Overall Study|Protocol Violation|3|||
130978791|NCT00734630|471547612|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
130978792|NCT00734630|471547613|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
130978793|NCT00734630|471547612|FG000|Overall Study|Adverse Event|3|||
130978794|NCT00734630|471547613|FG001|Overall Study|Adverse Event|6|||
130978795|NCT00734630|471547612|FG000|Overall Study|Randomized in Error|0|||
130978796|NCT00734630|471547613|FG001|Overall Study|Randomized in Error|1|||
130718388|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718389|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718390|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718391|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718392|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718393|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718394|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718395|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718396|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718397|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130718398|NCT03982199|470593288|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
130718399|NCT03982199|470593289|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
130718400|NCT03982199|470593290|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718401|NCT03982199|470593291|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130978797|NCT00734630|471547612|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
131132036|NCT01783678|472111724|FG004|Overall Study|Lost to Follow-up|1|||
131132037|NCT01783678|472111725|FG005|Overall Study|Lost to Follow-up|0|||
131132038|NCT01783678|472111720|FG000|Overall Study|Withdrew Consent|1|||
131132039|NCT01783678|472111721|FG001|Overall Study|Withdrew Consent|1|||
130978798|NCT00734630|471547613|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
130978799|NCT00734630|471547612|FG000|Overall Study|Poor Compliance|1|||
130978800|NCT00734630|471547613|FG001|Overall Study|Poor Compliance|1|||
130718402|NCT03982199|470593292|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718403|NCT03982199|470593293|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130978801|NCT03085485|471547623|FG000|Overall Study|Death|1|||
130978802|NCT03085485|471547624|FG001|Overall Study|Death|0|||
130978803|NCT03085485|471547623|FG000|Overall Study|Lost to Follow-up|1|||
130978804|NCT03085485|471547624|FG001|Overall Study|Lost to Follow-up|0|||
130978805|NCT00450411|471547628|FG000|Overall Study|Protocol Violation|6|||
130978806|NCT00450411|471547628|FG000|Overall Study|No protocol treatment|2|||
130978807|NCT02130193|471547632|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
130978808|NCT02130193|471547633|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
130978809|NCT02130193|471547634|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
130978810|NCT02130193|471547632|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
130978811|NCT02130193|471547633|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
130978812|NCT02130193|471547634|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
130978813|NCT02130193|471547632|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
130978814|NCT02130193|471547633|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
130978815|NCT02130193|471547634|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
130978816|NCT02130193|471547632|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
130718404|NCT03982199|470593294|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718405|NCT03982199|470593295|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718406|NCT03982199|470593296|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718407|NCT03982199|470593297|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718408|NCT03982199|470593298|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718409|NCT03982199|470593299|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718410|NCT03982199|470593300|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718411|NCT03982199|470593301|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130718412|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718413|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718414|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718415|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
130718416|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718417|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718418|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718419|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718420|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718421|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718422|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718423|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718424|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718425|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130718426|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718427|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718428|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
130718429|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718430|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718431|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718432|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718433|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718434|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718435|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718436|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718437|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718438|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130718439|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130778630|NCT05219968|470815495|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
130778631|NCT05219968|470815496|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
130978817|NCT02130193|471547633|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
131132040|NCT01783678|472111722|FG002|Overall Study|Withdrew Consent|0|||
131132041|NCT01783678|472111723|FG003|Overall Study|Withdrew Consent|2|||
130978818|NCT02130193|471547634|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
130978819|NCT02077166|471547635|FG000|Overall Study|Death|6|||
130978820|NCT02077166|471547636|FG001|Overall Study|Death|7|||
130978821|NCT02077166|471547637|FG002|Overall Study|Death|5|||
131132042|NCT01783678|472111724|FG004|Overall Study|Withdrew Consent|0|||
130778632|NCT05219968|470815497|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
130778633|NCT05219968|470815498|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
130778634|NCT05219968|470815499|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
130778635|NCT05219968|470815495|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
130778636|NCT05219968|470815496|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
130778637|NCT05219968|470815497|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
130778638|NCT05219968|470815498|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
130778639|NCT05219968|470815499|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
130778640|NCT05219968|470815495|FG000|Week 24 Treatment Period|Adverse Event|3|||
130778641|NCT05219968|470815496|FG001|Week 24 Treatment Period|Adverse Event|0|||
130778642|NCT05219968|470815497|FG002|Week 24 Treatment Period|Adverse Event|0|||
130778643|NCT05219968|470815498|FG003|Week 24 Treatment Period|Adverse Event|0|||
130778644|NCT05219968|470815499|FG004|Week 24 Treatment Period|Adverse Event|0|||
130778645|NCT05219968|470815495|FG000|Week 24 Treatment Period|Physician Decision|0|||
130778646|NCT05219968|470815496|FG001|Week 24 Treatment Period|Physician Decision|1|||
130778647|NCT05219968|470815497|FG002|Week 24 Treatment Period|Physician Decision|0|||
130778648|NCT05219968|470815498|FG003|Week 24 Treatment Period|Physician Decision|0|||
130778649|NCT05219968|470815499|FG004|Week 24 Treatment Period|Physician Decision|0|||
130778650|NCT05219968|470815495|FG000|Week 24 Treatment Period|Other, not specified|3|||
130778651|NCT05219968|470815496|FG001|Week 24 Treatment Period|Other, not specified|0|||
130778652|NCT05219968|470815497|FG002|Week 24 Treatment Period|Other, not specified|0|||
130778653|NCT05219968|470815498|FG003|Week 24 Treatment Period|Other, not specified|0|||
130778654|NCT05219968|470815499|FG004|Week 24 Treatment Period|Other, not specified|0|||
130778655|NCT05219968|470815495|FG000|Safety Extension Period|Treatment administration failure|0|||
130778656|NCT05219968|470815496|FG001|Safety Extension Period|Treatment administration failure|0|||
130778657|NCT05219968|470815497|FG002|Safety Extension Period|Treatment administration failure|0|||
130778658|NCT05219968|470815498|FG003|Safety Extension Period|Treatment administration failure|1|||
130778659|NCT05219968|470815499|FG004|Safety Extension Period|Treatment administration failure|4|||
130778660|NCT05219968|470815495|FG000|Safety Extension Period|Bilateral dislodgement|0|||
130778661|NCT05219968|470815496|FG001|Safety Extension Period|Bilateral dislodgement|0|||
130778662|NCT05219968|470815497|FG002|Safety Extension Period|Bilateral dislodgement|4|||
130778663|NCT05219968|470815498|FG003|Safety Extension Period|Bilateral dislodgement|0|||
130778664|NCT05219968|470815499|FG004|Safety Extension Period|Bilateral dislodgement|1|||
130778665|NCT05219968|470815495|FG000|Safety Extension Period|Withdrawal by Subject|0|||
130778666|NCT05219968|470815496|FG001|Safety Extension Period|Withdrawal by Subject|0|||
130778667|NCT05219968|470815497|FG002|Safety Extension Period|Withdrawal by Subject|2|||
130778668|NCT05219968|470815498|FG003|Safety Extension Period|Withdrawal by Subject|0|||
130778669|NCT05219968|470815499|FG004|Safety Extension Period|Withdrawal by Subject|4|||
130778670|NCT05219968|470815495|FG000|Safety Extension Period|Adverse Event|0|||
130778671|NCT05219968|470815496|FG001|Safety Extension Period|Adverse Event|0|||
130778672|NCT05219968|470815497|FG002|Safety Extension Period|Adverse Event|2|||
130778673|NCT05219968|470815498|FG003|Safety Extension Period|Adverse Event|1|||
130778674|NCT05219968|470815499|FG004|Safety Extension Period|Adverse Event|1|||
130778675|NCT05219968|470815495|FG000|Safety Extension Period|Lost to Follow-up|0|||
130778676|NCT05219968|470815496|FG001|Safety Extension Period|Lost to Follow-up|0|||
130778677|NCT05219968|470815497|FG002|Safety Extension Period|Lost to Follow-up|0|||
130778678|NCT05219968|470815498|FG003|Safety Extension Period|Lost to Follow-up|1|||
130778679|NCT05219968|470815499|FG004|Safety Extension Period|Lost to Follow-up|0|||
130778680|NCT04587336|470815500|FG000|Overall Study|Lost to Follow-up|1|||
130778681|NCT04587336|470815501|FG001|Overall Study|Lost to Follow-up|0|||
130778682|NCT01845597|470817378|FG000|Overall Study|Death|8|||
130778683|NCT01845597|470817378|FG000|Overall Study|Lost to Follow-up|22|||
130778684|NCT02581488|470817382|FG000|Overall Study|Adverse Event|6|||
131132043|NCT01783678|472111725|FG005|Overall Study|Withdrew Consent|0|||
130778685|NCT02581488|470817383|FG001|Overall Study|Adverse Event|7|||
130778686|NCT02581488|470817382|FG000|Overall Study|Lost to Follow-up|1|||
130778687|NCT02581488|470817383|FG001|Overall Study|Lost to Follow-up|0|||
130778688|NCT02581488|470817382|FG000|Overall Study|Withdrawal by Subject|1|||
130778689|NCT02581488|470817383|FG001|Overall Study|Withdrawal by Subject|0|||
130778690|NCT02581488|470817382|FG000|Overall Study|Non-Compliance|1|||
130778691|NCT02581488|470817383|FG001|Overall Study|Non-Compliance|0|||
130778692|NCT02581488|470817382|FG000|Overall Study|Protocol Violation|0|||
130778693|NCT02581488|470817383|FG001|Overall Study|Protocol Violation|4|||
130778694|NCT01877668|470817384|FG000|Overall Study|Death|0|||
131132044|NCT01995071|472111726|FG000|Overall Study|Adverse Event|0|||
130778695|NCT01877668|470817385|FG001|Overall Study|Death|0|||
130778696|NCT01877668|470817386|FG002|Overall Study|Death|0|||
130778697|NCT01877668|470817387|FG003|Overall Study|Death|1|||
130778698|NCT01877668|470817388|FG004|Overall Study|Death|0|||
130778699|NCT01877668|470817384|FG000|Overall Study|No longer met study criteria|1|||
130778700|NCT01877668|470817385|FG001|Overall Study|No longer met study criteria|0|||
130778701|NCT01877668|470817386|FG002|Overall Study|No longer met study criteria|1|||
130778702|NCT01877668|470817387|FG003|Overall Study|No longer met study criteria|0|||
130778703|NCT01877668|470817388|FG004|Overall Study|No longer met study criteria|0|||
130778704|NCT01877668|470817384|FG000|Overall Study|Insufficient clinical response|0|||
130778705|NCT01877668|470817385|FG001|Overall Study|Insufficient clinical response|1|||
130778706|NCT01877668|470817386|FG002|Overall Study|Insufficient clinical response|2|||
130778707|NCT01877668|470817387|FG003|Overall Study|Insufficient clinical response|2|||
130778708|NCT01877668|470817388|FG004|Overall Study|Insufficient clinical response|0|||
130778709|NCT01877668|470817384|FG000|Overall Study|Lost to Follow-up|0|||
130778710|NCT01877668|470817385|FG001|Overall Study|Lost to Follow-up|2|||
130778711|NCT01877668|470817386|FG002|Overall Study|Lost to Follow-up|1|||
130778712|NCT01877668|470817387|FG003|Overall Study|Lost to Follow-up|0|||
130778713|NCT01877668|470817388|FG004|Overall Study|Lost to Follow-up|0|||
130778714|NCT01877668|470817384|FG000|Overall Study|Withdrawal by Subject|2|||
130778715|NCT01877668|470817385|FG001|Overall Study|Withdrawal by Subject|0|||
130778716|NCT01877668|470817386|FG002|Overall Study|Withdrawal by Subject|3|||
130778717|NCT01877668|470817387|FG003|Overall Study|Withdrawal by Subject|2|||
130778718|NCT01877668|470817388|FG004|Overall Study|Withdrawal by Subject|2|||
130778719|NCT01877668|470817384|FG000|Overall Study|Other|1|||
130778720|NCT01877668|470817385|FG001|Overall Study|Other|1|||
130778721|NCT01877668|470817386|FG002|Overall Study|Other|1|||
130778722|NCT01877668|470817387|FG003|Overall Study|Other|1|||
130778723|NCT01877668|470817388|FG004|Overall Study|Other|3|||
130778724|NCT01877668|470817384|FG000|Overall Study|Protocol Violation|1|||
130778725|NCT01877668|470817385|FG001|Overall Study|Protocol Violation|1|||
130778726|NCT01877668|470817386|FG002|Overall Study|Protocol Violation|0|||
130778727|NCT01877668|470817387|FG003|Overall Study|Protocol Violation|0|||
131227598|NCT00410410|472459752|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
131227599|NCT00410410|472459753|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
131227600|NCT00410410|472459754|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
131227601|NCT00410410|472459755|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
131227602|NCT00410410|472459756|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
131227603|NCT00410410|472459757|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
131227604|NCT00410410|472459749|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
131227605|NCT00410410|472459750|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
131227606|NCT00410410|472459751|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
131227607|NCT00410410|472459752|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
131227608|NCT00410410|472459753|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
131227609|NCT00410410|472459754|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
131227610|NCT00410410|472459755|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
131227611|NCT00410410|472459756|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
131227612|NCT00410410|472459757|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
131227613|NCT00410410|472459749|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
131227614|NCT00410410|472459750|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
131227615|NCT00410410|472459751|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
131227616|NCT00410410|472459752|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
131227617|NCT00410410|472459753|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
131227618|NCT00410410|472459754|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
131227619|NCT00410410|472459755|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
131227620|NCT00410410|472459756|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
131227621|NCT00410410|472459757|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
131227622|NCT00410410|472459749|FG000|Open-Label Period (OL)|Pregnancy|0|||
131227623|NCT00410410|472459750|FG001|Open-Label Period (OL)|Pregnancy|0|||
130718440|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718441|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718442|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
130718443|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718444|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718445|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718446|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718447|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718448|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130978822|NCT02077166|471547638|FG003|Overall Study|Death|6|||
130978823|NCT02077166|471547639|FG004|Overall Study|Death|4|||
131227624|NCT00410410|472459751|FG002|Open-Label Period (OL)|Pregnancy|0|||
131227625|NCT00410410|472459752|FG003|Open-Label Period (OL)|Pregnancy|0|||
130718449|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130778728|NCT01877668|470817388|FG004|Overall Study|Protocol Violation|3|||
130778729|NCT01877668|470817384|FG000|Overall Study|Adverse event related to study drug|2|||
130778730|NCT01877668|470817385|FG001|Overall Study|Adverse event related to study drug|2|||
130778731|NCT01877668|470817386|FG002|Overall Study|Adverse event related to study drug|2|||
130778732|NCT01877668|470817387|FG003|Overall Study|Adverse event related to study drug|2|||
130778733|NCT01877668|470817388|FG004|Overall Study|Adverse event related to study drug|1|||
130978824|NCT02077166|471547640|FG005|Overall Study|Death|32|||
131227626|NCT00410410|472459753|FG004|Open-Label Period (OL)|Pregnancy|0|||
131227627|NCT00410410|472459754|FG005|Open-Label Period (OL)|Pregnancy|0|||
131227628|NCT00410410|472459755|FG006|Open-Label Period (OL)|Pregnancy|0|||
130718450|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130978825|NCT02077166|471547641|FG006|Overall Study|Death|22|||
130978826|NCT02077166|471547635|FG000|Overall Study|Study Closure by Sponsor|3|||
130978827|NCT02077166|471547636|FG001|Overall Study|Study Closure by Sponsor|0|||
130978828|NCT02077166|471547637|FG002|Overall Study|Study Closure by Sponsor|2|||
130978829|NCT02077166|471547638|FG003|Overall Study|Study Closure by Sponsor|2|||
130978830|NCT02077166|471547639|FG004|Overall Study|Study Closure by Sponsor|2|||
130978831|NCT02077166|471547640|FG005|Overall Study|Study Closure by Sponsor|12|||
130978832|NCT02077166|471547641|FG006|Overall Study|Study Closure by Sponsor|4|||
130978833|NCT02077166|471547635|FG000|Overall Study|Lost to Follow-up|0|||
130978834|NCT02077166|471547636|FG001|Overall Study|Lost to Follow-up|0|||
130978835|NCT02077166|471547637|FG002|Overall Study|Lost to Follow-up|0|||
130978836|NCT02077166|471547638|FG003|Overall Study|Lost to Follow-up|0|||
130978837|NCT02077166|471547639|FG004|Overall Study|Lost to Follow-up|0|||
130978838|NCT02077166|471547640|FG005|Overall Study|Lost to Follow-up|1|||
130978839|NCT02077166|471547641|FG006|Overall Study|Lost to Follow-up|0|||
130978840|NCT02077166|471547635|FG000|Overall Study|Withdrawal by Subject|3|||
130978841|NCT02077166|471547636|FG001|Overall Study|Withdrawal by Subject|0|||
130978842|NCT02077166|471547637|FG002|Overall Study|Withdrawal by Subject|1|||
130978843|NCT02077166|471547638|FG003|Overall Study|Withdrawal by Subject|1|||
130978844|NCT02077166|471547639|FG004|Overall Study|Withdrawal by Subject|1|||
130978845|NCT02077166|471547640|FG005|Overall Study|Withdrawal by Subject|3|||
130978846|NCT02077166|471547641|FG006|Overall Study|Withdrawal by Subject|0|||
130978847|NCT02077166|471547635|FG000|Overall Study|Other, Not Specified|0|||
130978848|NCT02077166|471547636|FG001|Overall Study|Other, Not Specified|0|||
131227629|NCT00410410|472459756|FG007|Open-Label Period (OL)|Pregnancy|0|||
130718451|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718452|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718453|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130718454|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718455|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718456|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
130718457|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
130718458|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718459|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718460|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718461|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718462|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718463|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718464|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718465|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718466|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718467|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130718468|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718469|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718470|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718471|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
130718472|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718473|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718474|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718475|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718476|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718477|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718478|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718479|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718480|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718481|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130718482|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718483|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718484|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
130718485|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
130718486|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718487|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130978849|NCT02077166|471547637|FG002|Overall Study|Other, Not Specified|1|||
130978850|NCT02077166|471547638|FG003|Overall Study|Other, Not Specified|0|||
130978851|NCT02077166|471547639|FG004|Overall Study|Other, Not Specified|1|||
131227630|NCT00410410|472459757|FG008|Open-Label Period (OL)|Pregnancy|1|||
130978852|NCT02077166|471547640|FG005|Overall Study|Other, Not Specified|7|||
130778734|NCT01877668|470817384|FG000|Overall Study|Adverse event unrelated to study drug|4|||
130778735|NCT01877668|470817385|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130778736|NCT01877668|470817386|FG002|Overall Study|Adverse event unrelated to study drug|2|||
130978853|NCT02077166|471547641|FG006|Overall Study|Other, Not Specified|8|||
130978854|NCT02277444|471547649|FG000|Overall Study|Adverse Event|10|||
130978855|NCT02277444|471547649|FG000|Overall Study|Withdrawal by Subject|3|||
130978856|NCT02277444|471547649|FG000|Overall Study|Other|1|||
130978857|NCT02277444|471547649|FG000|Overall Study|Enrolled and not Treated|3|||
130978858|NCT02277444|471547649|FG000|Overall Study|Ongoing|113|||
130978859|NCT03576768|471549586|FG000|Overall Study|Lost to Follow-up|3|||
130978860|NCT03576768|471549587|FG001|Overall Study|Lost to Follow-up|3|||
130978861|NCT03576768|471549588|FG002|Overall Study|Lost to Follow-up|0|||
130978862|NCT03576768|471549589|FG003|Overall Study|Lost to Follow-up|0|||
130978863|NCT04050865|471549590|FG000|Overall Study|Adverse Event|1|||
130978864|NCT04050865|471549591|FG001|Overall Study|Adverse Event|0|||
130978865|NCT04050865|471549590|FG000|Overall Study|no insert|1|||
130978866|NCT04050865|471549591|FG001|Overall Study|no insert|0|||
130978867|NCT04050865|471549590|FG000|Overall Study|Only 1 insert|2|||
130978868|NCT04050865|471549591|FG001|Overall Study|Only 1 insert|3|||
130978869|NCT04050865|471549590|FG000|Overall Study|Physician Decision|0|||
130978870|NCT04050865|471549591|FG001|Overall Study|Physician Decision|1|||
130978871|NCT04050865|471549590|FG000|Overall Study|Withdrawal by Subject|0|||
130978872|NCT04050865|471549591|FG001|Overall Study|Withdrawal by Subject|1|||
130978873|NCT04205630|471549592|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
130978874|NCT04205630|471549592|FG000|Overall Study|Disease clinical progression|7|||
130978875|NCT04205630|471549592|FG000|Overall Study|Withdrawal by Subject|2|||
130978876|NCT04205630|471549592|FG000|Overall Study|Adverse Event|17|||
130978877|NCT04205630|471549592|FG000|Overall Study|Other|1|||
130978878|NCT04279314|471549597|FG000|Overall Study|Adverse Event|55|||
130978879|NCT04279314|471549597|FG000|Overall Study|Withdrawal by Subject|5|||
130978880|NCT04279314|471549597|FG000|Overall Study|Lack of Efficacy|5|||
130978881|NCT04279314|471549597|FG000|Overall Study|Protocol Violation|3|||
130978882|NCT04279314|471549597|FG000|Overall Study|Other (not COVID-19 related)|2|||
130978883|NCT02481310|471549598|FG000|Follow up|Still in follow up|0|||
130978884|NCT02481310|471549599|FG001|Follow up|Still in follow up|3|||
130978885|NCT02481310|471549600|FG002|Follow up|Still in follow up|0|||
130978886|NCT02583425|471549609|FG000|Screening|Did not meet entry criteria|12|||
130978887|NCT02583425|471549609|FG000|Baseline|Did not meet continued criteria|5|||
130978888|NCT02583425|471549609|FG000|Treatment Period|Adverse Event|1|||
130978889|NCT01597050|471549612|FG000|Overall Study|Withdrawal by Subject|1|||
130978890|NCT01597050|471549613|FG001|Overall Study|Withdrawal by Subject|0|||
130978891|NCT00483184|471549614|FG000|Overall Study|Withdrawal by Subject|2|||
130978892|NCT00483184|471549615|FG001|Overall Study|Withdrawal by Subject|2|||
130978893|NCT00483184|471549616|FG002|Overall Study|Withdrawal by Subject|0|||
130978894|NCT00483184|471549614|FG000|Overall Study|Lost to Follow-up|1|||
130978895|NCT00483184|471549615|FG001|Overall Study|Lost to Follow-up|0|||
130978896|NCT00483184|471549616|FG002|Overall Study|Lost to Follow-up|0|||
130978897|NCT00483184|471549614|FG000|Overall Study|Adverse Event|1|||
130978898|NCT00483184|471549615|FG001|Overall Study|Adverse Event|2|||
130978899|NCT00483184|471549616|FG002|Overall Study|Adverse Event|2|||
130978900|NCT00483184|471549614|FG000|Overall Study|Protocol Violation|1|||
130978901|NCT00483184|471549615|FG001|Overall Study|Protocol Violation|0|||
130978902|NCT00483184|471549616|FG002|Overall Study|Protocol Violation|1|||
130978903|NCT00558428|471549617|FG000|Overall Study|Adverse Event|6|||
130978904|NCT00558428|471549618|FG001|Overall Study|Adverse Event|22|||
130978905|NCT00558428|471549619|FG002|Overall Study|Adverse Event|3|||
130978906|NCT00558428|471549620|FG003|Overall Study|Adverse Event|4|||
130778737|NCT01877668|470817387|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130778738|NCT01877668|470817388|FG004|Overall Study|Adverse event unrelated to study drug|1|||
130778739|NCT01348139|470817419|FG000|Period 1|Adverse Event|1|||
130778740|NCT01348139|470817420|FG001|Period 1|Adverse Event|0|||
130778741|NCT01348139|470817421|FG002|Period 1|Adverse Event|0|||
130978907|NCT00558428|471549617|FG000|Overall Study|Lost to Follow-up|0|||
130978908|NCT00558428|471549618|FG001|Overall Study|Lost to Follow-up|1|||
130978909|NCT00558428|471549619|FG002|Overall Study|Lost to Follow-up|0|||
130978910|NCT00558428|471549620|FG003|Overall Study|Lost to Follow-up|0|||
130978911|NCT00558428|471549617|FG000|Overall Study|Lack of Efficacy|0|||
130978912|NCT00558428|471549618|FG001|Overall Study|Lack of Efficacy|0|||
130978913|NCT00558428|471549619|FG002|Overall Study|Lack of Efficacy|1|||
130978914|NCT00558428|471549620|FG003|Overall Study|Lack of Efficacy|2|||
130978915|NCT00558428|471549617|FG000|Overall Study|Non compliant with protocol|1|||
130978916|NCT00558428|471549618|FG001|Overall Study|Non compliant with protocol|0|||
130978917|NCT00558428|471549619|FG002|Overall Study|Non compliant with protocol|0|||
130778742|NCT01348139|470817422|FG003|Period 1|Adverse Event|0|||
130978918|NCT00558428|471549620|FG003|Overall Study|Non compliant with protocol|3|||
130978919|NCT00558428|471549617|FG000|Overall Study|Consent withdrawn|2|||
130978920|NCT00558428|471549618|FG001|Overall Study|Consent withdrawn|1|||
130978921|NCT00558428|471549619|FG002|Overall Study|Consent withdrawn|0|||
130978922|NCT00558428|471549620|FG003|Overall Study|Consent withdrawn|1|||
130778743|NCT01348139|470817423|FG004|Period 1|Adverse Event|0|||
130778744|NCT01348139|470817424|FG005|Period 1|Adverse Event|0|||
130778745|NCT01619852|470817427|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
130778746|NCT01619852|470817428|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
130778747|NCT01619852|470817427|FG000|3 Month Follow up|Lost to Follow-up|31|||
130778748|NCT01619852|470817428|FG001|3 Month Follow up|Lost to Follow-up|34|||
130778749|NCT03933449|470817429|FG000|Overall Study|Adverse Event|6|||
130778750|NCT03933449|470817430|FG001|Overall Study|Adverse Event|4|||
130778751|NCT03933449|470817429|FG000|Overall Study|Death|55|||
130778752|NCT03933449|470817430|FG001|Overall Study|Death|57|||
131227631|NCT00410410|472459749|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130778753|NCT03933449|470817429|FG000|Overall Study|Sponsor Decision|1|||
130778754|NCT03933449|470817430|FG001|Overall Study|Sponsor Decision|0|||
130778755|NCT02659943|470817431|FG000|Overall Study|Switched to alternative treatment|1|||
130778756|NCT02659943|470817432|FG001|Overall Study|Switched to alternative treatment|1|||
130778757|NCT02659943|470817433|FG002|Overall Study|Switched to alternative treatment|0|||
130778758|NCT02659943|470817434|FG003|Overall Study|Switched to alternative treatment|2|||
130778759|NCT02659943|470817435|FG004|Overall Study|Switched to alternative treatment|1|||
130778760|NCT02659943|470817436|FG005|Overall Study|Switched to alternative treatment|0|||
131227632|NCT00410410|472459750|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131227633|NCT00410410|472459751|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131227634|NCT00410410|472459752|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131227635|NCT00410410|472459753|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131227636|NCT00410410|472459754|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130718488|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718489|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718490|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718491|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718492|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718493|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718494|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718495|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130718496|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718497|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718498|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718499|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718500|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718501|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718502|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718503|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718504|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
130718505|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718506|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718507|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718508|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718509|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130718510|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718511|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718512|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718513|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718514|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718515|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718516|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718517|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718518|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
130718519|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718520|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718521|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130718522|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130778761|NCT02659943|470817437|FG006|Overall Study|Switched to alternative treatment|1|||
130778762|NCT02659943|470817431|FG000|Overall Study|Disease progression on study|0|||
130778763|NCT02659943|470817432|FG001|Overall Study|Disease progression on study|1|||
130778764|NCT02659943|470817433|FG002|Overall Study|Disease progression on study|1|||
131227637|NCT00410410|472459755|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130778765|NCT02659943|470817434|FG003|Overall Study|Disease progression on study|1|||
130718523|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130778766|NCT02659943|470817435|FG004|Overall Study|Disease progression on study|1|||
130778767|NCT02659943|470817436|FG005|Overall Study|Disease progression on study|4|||
130778768|NCT02659943|470817437|FG006|Overall Study|Disease progression on study|0|||
130778769|NCT02659943|470817431|FG000|Overall Study|Patient's condition per principal investigator|0|||
130778770|NCT02659943|470817432|FG001|Overall Study|Patient's condition per principal investigator|0|||
130778771|NCT02659943|470817433|FG002|Overall Study|Patient's condition per principal investigator|0|||
130778772|NCT02659943|470817434|FG003|Overall Study|Patient's condition per principal investigator|0|||
130778773|NCT02659943|470817435|FG004|Overall Study|Patient's condition per principal investigator|0|||
130778774|NCT02659943|470817436|FG005|Overall Study|Patient's condition per principal investigator|1|||
130778775|NCT02659943|470817437|FG006|Overall Study|Patient's condition per principal investigator|0|||
130778776|NCT02659943|470817431|FG000|Overall Study|Ineligible|0|||
130778777|NCT02659943|470817432|FG001|Overall Study|Ineligible|0|||
130778778|NCT02659943|470817433|FG002|Overall Study|Ineligible|0|||
130778779|NCT02659943|470817434|FG003|Overall Study|Ineligible|0|||
130778780|NCT02659943|470817435|FG004|Overall Study|Ineligible|0|||
130778781|NCT02659943|470817436|FG005|Overall Study|Ineligible|0|||
130778782|NCT02659943|470817437|FG006|Overall Study|Ineligible|1|||
130778783|NCT02659943|470817431|FG000|Overall Study|No longer meets eligibility|0|||
130778784|NCT02659943|470817432|FG001|Overall Study|No longer meets eligibility|0|||
130778785|NCT02659943|470817433|FG002|Overall Study|No longer meets eligibility|0|||
130778786|NCT02659943|470817434|FG003|Overall Study|No longer meets eligibility|0|||
130778787|NCT02659943|470817435|FG004|Overall Study|No longer meets eligibility|0|||
130778788|NCT02659943|470817436|FG005|Overall Study|No longer meets eligibility|0|||
130778789|NCT02659943|470817437|FG006|Overall Study|No longer meets eligibility|1|||
130778790|NCT02659943|470817431|FG000|Overall Study|No treatment, per protocol|0|||
130778791|NCT02659943|470817432|FG001|Overall Study|No treatment, per protocol|0|||
130778792|NCT02659943|470817433|FG002|Overall Study|No treatment, per protocol|0|||
130778793|NCT02659943|470817434|FG003|Overall Study|No treatment, per protocol|0|||
130778794|NCT02659943|470817435|FG004|Overall Study|No treatment, per protocol|0|||
130778795|NCT02659943|470817436|FG005|Overall Study|No treatment, per protocol|0|||
130778796|NCT02659943|470817437|FG006|Overall Study|No treatment, per protocol|3|||
130778797|NCT01576575|470817438|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
130778798|NCT01576575|470817438|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
130778799|NCT01576575|470817438|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
130778800|NCT01723072|470817439|FG000|Overall Study|Withdrawal by Subject|7|||
130718524|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718525|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718526|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718527|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718528|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718529|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718530|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718531|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718532|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
130718533|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718534|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718535|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718536|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718537|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130718538|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718539|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718540|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718541|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718542|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718543|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718544|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718545|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718546|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
130718547|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718548|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718549|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718550|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718551|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130718552|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718553|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130778801|NCT01723072|470817440|FG001|Overall Study|Withdrawal by Subject|13|||
130778802|NCT01723072|470817439|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
130778803|NCT01723072|470817440|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
130778804|NCT01723072|470817439|FG000|Overall Study|Other|4|||
130718554|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130778805|NCT01723072|470817440|FG001|Overall Study|Other|3|||
130778806|NCT03428100|470817441|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
130778807|NCT03428100|470817442|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130778808|NCT03428100|470817443|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
130778809|NCT03428100|470817444|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
130778810|NCT03428100|470817445|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130778811|NCT03428100|470817446|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130778812|NCT03428100|470817447|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130778813|NCT03428100|470817448|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130778814|NCT03428100|470817449|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130778815|NCT03428100|470817450|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130778816|NCT03428100|470817451|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130778817|NCT03428100|470817452|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130778818|NCT03428100|470817453|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
131132045|NCT01995071|472111727|FG001|Overall Study|Adverse Event|0|||
131132046|NCT01995071|472111728|FG002|Overall Study|Adverse Event|0|||
130718555|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718556|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718557|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718558|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718559|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718560|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
130718561|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718562|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718563|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718564|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718565|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130718566|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718567|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718568|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718569|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718570|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718571|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
130718572|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718573|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
130718574|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
130718575|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718576|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718577|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718578|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718579|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130718580|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718581|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718582|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718583|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718584|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718585|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718586|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718587|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718588|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
130718589|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718590|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718591|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718592|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718593|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130718594|NCT03982199|470593288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718595|NCT03982199|470593289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718596|NCT03982199|470593290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131132047|NCT01995071|472111729|FG003|Overall Study|Adverse Event|0|||
131132048|NCT01995071|472111730|FG004|Overall Study|Adverse Event|0|||
131132049|NCT01995071|472111731|FG005|Overall Study|Adverse Event|0|||
131132050|NCT01995071|472111732|FG006|Overall Study|Adverse Event|1|||
131132051|NCT01995071|472111733|FG007|Overall Study|Adverse Event|0|||
131132052|NCT01995071|472111734|FG008|Overall Study|Adverse Event|0|||
131132053|NCT01995071|472111735|FG009|Overall Study|Adverse Event|0|||
131132054|NCT01995071|472111736|FG010|Overall Study|Adverse Event|0|||
131132055|NCT01995071|472111737|FG011|Overall Study|Adverse Event|0|||
130978923|NCT00558428|471549617|FG000|Overall Study|Other|3|||
130978924|NCT00558428|471549618|FG001|Overall Study|Other|0|||
130978925|NCT00558428|471549619|FG002|Overall Study|Other|0|||
130978926|NCT00558428|471549620|FG003|Overall Study|Other|1|||
130978927|NCT05224050|471549621|FG000|Overall Study|Withdrawal by Subject|9|||
130978928|NCT05224050|471549621|FG000|Overall Study|Lost to Follow-up|3|||
130978929|NCT01137474|471549622|FG000|Overall Study|Adverse Event|3|||
130978930|NCT01137474|471549623|FG001|Overall Study|Adverse Event|5|||
130978931|NCT01137474|471549624|FG002|Overall Study|Adverse Event|1|||
130978932|NCT01137474|471549625|FG003|Overall Study|Adverse Event|3|||
130978933|NCT01137474|471549622|FG000|Overall Study|Withdrawal by Subject|7|||
130978934|NCT01137474|471549623|FG001|Overall Study|Withdrawal by Subject|2|||
130978935|NCT01137474|471549624|FG002|Overall Study|Withdrawal by Subject|6|||
130978936|NCT01137474|471549625|FG003|Overall Study|Withdrawal by Subject|9|||
130978937|NCT01137474|471549622|FG000|Overall Study|No longer met study criteria|6|||
130978938|NCT01137474|471549623|FG001|Overall Study|No longer met study criteria|1|||
130978939|NCT01137474|471549624|FG002|Overall Study|No longer met study criteria|0|||
130978940|NCT01137474|471549625|FG003|Overall Study|No longer met study criteria|5|||
130978941|NCT01137474|471549622|FG000|Overall Study|Lost to Follow-up|5|||
130978942|NCT01137474|471549623|FG001|Overall Study|Lost to Follow-up|1|||
130978943|NCT01137474|471549624|FG002|Overall Study|Lost to Follow-up|0|||
130978944|NCT01137474|471549625|FG003|Overall Study|Lost to Follow-up|2|||
130978945|NCT01137474|471549622|FG000|Overall Study|Lack of Efficacy|0|||
130978946|NCT01137474|471549623|FG001|Overall Study|Lack of Efficacy|0|||
130978947|NCT01137474|471549624|FG002|Overall Study|Lack of Efficacy|0|||
130978948|NCT01137474|471549625|FG003|Overall Study|Lack of Efficacy|2|||
130978949|NCT01137474|471549622|FG000|Overall Study|Other|3|||
130978950|NCT01137474|471549623|FG001|Overall Study|Other|1|||
130978951|NCT01137474|471549624|FG002|Overall Study|Other|0|||
130978952|NCT01137474|471549625|FG003|Overall Study|Other|0|||
130978953|NCT01137474|471549622|FG000|Overall Study|Pregnancy|0|||
130978954|NCT01137474|471549623|FG001|Overall Study|Pregnancy|1|||
130978955|NCT01137474|471549624|FG002|Overall Study|Pregnancy|0|||
130978956|NCT01137474|471549625|FG003|Overall Study|Pregnancy|0|||
130978957|NCT01137474|471549622|FG000|Overall Study|Administrative reason by sponsor|0|||
130978958|NCT01137474|471549623|FG001|Overall Study|Administrative reason by sponsor|1|||
130978959|NCT01137474|471549624|FG002|Overall Study|Administrative reason by sponsor|0|||
130978960|NCT01137474|471549625|FG003|Overall Study|Administrative reason by sponsor|0|||
130978961|NCT02219048|471549626|FG000|Overall Study|Adverse Event|2|||
130978962|NCT02219048|471549627|FG001|Overall Study|Adverse Event|5|||
130978963|NCT02219048|471549626|FG000|Overall Study|No longer meets eligibility criteria|1|||
131132056|NCT01995071|472111726|FG000|Overall Study|Moved|0|||
131132057|NCT01995071|472111727|FG001|Overall Study|Moved|0|||
131132058|NCT01995071|472111728|FG002|Overall Study|Moved|1|||
131132059|NCT01995071|472111729|FG003|Overall Study|Moved|0|||
131132060|NCT01995071|472111730|FG004|Overall Study|Moved|1|||
131132061|NCT01995071|472111731|FG005|Overall Study|Moved|0|||
131132062|NCT01995071|472111732|FG006|Overall Study|Moved|0|||
131132063|NCT01995071|472111733|FG007|Overall Study|Moved|0|||
131132064|NCT01995071|472111734|FG008|Overall Study|Moved|0|||
131132065|NCT01995071|472111735|FG009|Overall Study|Moved|0|||
131132066|NCT01995071|472111736|FG010|Overall Study|Moved|1|||
131132067|NCT01995071|472111737|FG011|Overall Study|Moved|0|||
131132068|NCT01995071|472111726|FG000|Overall Study|Lost to Follow-up|1|||
131132069|NCT01995071|472111727|FG001|Overall Study|Lost to Follow-up|0|||
131132070|NCT01995071|472111728|FG002|Overall Study|Lost to Follow-up|0|||
131132071|NCT01995071|472111729|FG003|Overall Study|Lost to Follow-up|0|||
131132072|NCT01995071|472111730|FG004|Overall Study|Lost to Follow-up|0|||
131132073|NCT01995071|472111731|FG005|Overall Study|Lost to Follow-up|0|||
131132074|NCT01995071|472111732|FG006|Overall Study|Lost to Follow-up|0|||
131132075|NCT01995071|472111733|FG007|Overall Study|Lost to Follow-up|1|||
131132076|NCT01995071|472111734|FG008|Overall Study|Lost to Follow-up|1|||
131132077|NCT01995071|472111735|FG009|Overall Study|Lost to Follow-up|0|||
131132078|NCT01995071|472111736|FG010|Overall Study|Lost to Follow-up|0|||
131132079|NCT01995071|472111737|FG011|Overall Study|Lost to Follow-up|0|||
130978964|NCT02219048|471549627|FG001|Overall Study|No longer meets eligibility criteria|0|||
130978965|NCT02219048|471549626|FG000|Overall Study|Study terminated by sponsor|16|||
130978966|NCT02219048|471549627|FG001|Overall Study|Study terminated by sponsor|15|||
131132080|NCT01995071|472111726|FG000|Overall Study|Incarcerated|0|||
130978967|NCT02219048|471549626|FG000|Overall Study|Withdrawal by Subject|2|||
130978968|NCT02219048|471549627|FG001|Overall Study|Withdrawal by Subject|0|||
130978969|NCT02219048|471549626|FG000|Overall Study|Other|0|||
130978970|NCT02219048|471549627|FG001|Overall Study|Other|1|||
130978971|NCT00911534|471549628|FG000|Overall Study|Adverse Event|4|||
130978972|NCT00911534|471549629|FG001|Overall Study|Adverse Event|4|||
130978973|NCT00911534|471549628|FG000|Overall Study|Lost to Follow-up|2|||
130978974|NCT00911534|471549629|FG001|Overall Study|Lost to Follow-up|4|||
130978975|NCT00911534|471549628|FG000|Overall Study|Withdrawal by Subject|2|||
131132081|NCT01995071|472111727|FG001|Overall Study|Incarcerated|0|||
131132082|NCT01995071|472111728|FG002|Overall Study|Incarcerated|0|||
131132083|NCT01995071|472111729|FG003|Overall Study|Incarcerated|0|||
131132084|NCT01995071|472111730|FG004|Overall Study|Incarcerated|0|||
131132085|NCT01995071|472111731|FG005|Overall Study|Incarcerated|0|||
130978976|NCT00911534|471549629|FG001|Overall Study|Withdrawal by Subject|1|||
130978977|NCT00911534|471549628|FG000|Overall Study|Lack of Efficacy|4|||
130978978|NCT00911534|471549629|FG001|Overall Study|Lack of Efficacy|1|||
130978979|NCT00911534|471549628|FG000|Overall Study|Withdrawal of consent|1|||
130978980|NCT00911534|471549629|FG001|Overall Study|Withdrawal of consent|4|||
130978981|NCT00911534|471549628|FG000|Overall Study|Other|2|||
130978982|NCT00911534|471549629|FG001|Overall Study|Other|2|||
130978983|NCT01388816|471549630|FG000|Overall Study|Adverse Event|0|||
130978984|NCT01388816|471549631|FG001|Overall Study|Adverse Event|2|||
130978985|NCT01388816|471549632|FG002|Overall Study|Adverse Event|0|||
130978986|NCT01388816|471549633|FG003|Overall Study|Adverse Event|0|||
130978987|NCT01388816|471549630|FG000|Overall Study|Lost to Follow-up|0|||
130978988|NCT01388816|471549631|FG001|Overall Study|Lost to Follow-up|1|||
130978989|NCT01388816|471549632|FG002|Overall Study|Lost to Follow-up|0|||
130978990|NCT01388816|471549633|FG003|Overall Study|Lost to Follow-up|0|||
130978991|NCT01388816|471549630|FG000|Overall Study|Withdrawal by Subject|2|||
130978992|NCT01388816|471549631|FG001|Overall Study|Withdrawal by Subject|1|||
130978993|NCT01388816|471549632|FG002|Overall Study|Withdrawal by Subject|1|||
130978994|NCT01388816|471549633|FG003|Overall Study|Withdrawal by Subject|0|||
130978995|NCT01388816|471549630|FG000|Overall Study|Protocol Violation|0|||
130978996|NCT01388816|471549631|FG001|Overall Study|Protocol Violation|0|||
130978997|NCT01388816|471549632|FG002|Overall Study|Protocol Violation|2|||
130978998|NCT01388816|471549633|FG003|Overall Study|Protocol Violation|0|||
130978999|NCT03792126|471549634|FG000|Overall Study|Adverse Event|1|||
130979000|NCT03792126|471549635|FG001|Overall Study|Adverse Event|2|||
130979001|NCT03792126|471549634|FG000|Overall Study|Death|0|||
130979002|NCT03792126|471549635|FG001|Overall Study|Death|1|||
130979003|NCT03792126|471549634|FG000|Overall Study|Lost to Follow-up|1|||
130979004|NCT03792126|471549635|FG001|Overall Study|Lost to Follow-up|0|||
130979005|NCT03792126|471549634|FG000|Overall Study|Withdrawal by Subject|0|||
130979006|NCT03792126|471549635|FG001|Overall Study|Withdrawal by Subject|1|||
130979007|NCT03792126|471549634|FG000|Overall Study|COVID-19 Restrictions|1|||
130979008|NCT03792126|471549635|FG001|Overall Study|COVID-19 Restrictions|3|||
130979009|NCT03792126|471549634|FG000|Overall Study|Symptoms resolved|0|||
130979010|NCT03792126|471549635|FG001|Overall Study|Symptoms resolved|3|||
130979011|NCT03240692|471549636|FG000|Overall Study|Physician Decision|1|||
130979012|NCT03240692|471549636|FG000|Overall Study|Withdrawal by Subject|1|||
130979013|NCT02300220|471549637|FG000|Overall Study|Lost to Follow-up|1|||
130979014|NCT02300220|471549638|FG001|Overall Study|Lost to Follow-up|2|||
130979015|NCT02300220|471549637|FG000|Overall Study|Death|1|||
130979016|NCT02300220|471549638|FG001|Overall Study|Death|1|||
130979017|NCT02300220|471549637|FG000|Overall Study|Adverse Event|1|||
130979018|NCT02300220|471549638|FG001|Overall Study|Adverse Event|1|||
130979019|NCT02300220|471549637|FG000|Overall Study|Protocol Violation|1|||
130979020|NCT02300220|471549638|FG001|Overall Study|Protocol Violation|0|||
130979021|NCT02300220|471549637|FG000|Overall Study|Withdrawal by Subject|0|||
130979022|NCT02300220|471549638|FG001|Overall Study|Withdrawal by Subject|2|||
130979023|NCT02300220|471549637|FG000|Overall Study|Did not tolerate IMP|0|||
130979024|NCT02300220|471549638|FG001|Overall Study|Did not tolerate IMP|1|||
130979025|NCT04322682|471549639|FG000|Overall Study|Withdrawal by Subject|33|||
130979026|NCT04322682|471549640|FG001|Overall Study|Withdrawal by Subject|47|||
130979027|NCT04322682|471549639|FG000|Overall Study|Death|5|||
130979028|NCT04322682|471549640|FG001|Overall Study|Death|9|||
130979029|NCT04322682|471549639|FG000|Overall Study|Lost to Follow-up|4|||
130979030|NCT04322682|471549640|FG001|Overall Study|Lost to Follow-up|8|||
130979031|NCT04322682|471549639|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
130979032|NCT04322682|471549640|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
131132086|NCT01995071|472111732|FG006|Overall Study|Incarcerated|0|||
130979033|NCT02238379|471549642|FG000|Overall Study|Lost to Follow-up|1|||
130979034|NCT02238379|471549643|FG001|Overall Study|Lost to Follow-up|0|||
130979035|NCT04123067|471549644|FG000|Overall Study|Lost to Follow-up|0|||
130979036|NCT04123067|471549645|FG001|Overall Study|Lost to Follow-up|1|||
130979037|NCT00441090|471549646|FG000|Overall Study|Adverse Event|0|||
130979038|NCT00441090|471549647|FG001|Overall Study|Adverse Event|1|||
130979039|NCT00441090|471549648|FG002|Overall Study|Adverse Event|1|||
131132087|NCT01995071|472111733|FG007|Overall Study|Incarcerated|1|||
131132088|NCT01995071|472111734|FG008|Overall Study|Incarcerated|0|||
130979040|NCT00441090|471549649|FG003|Overall Study|Adverse Event|0|||
130979041|NCT00441090|471549650|FG004|Overall Study|Adverse Event|0|||
130979042|NCT00441090|471549646|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
130979043|NCT00441090|471549647|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
130979044|NCT00441090|471549648|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
130979045|NCT00441090|471549649|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
130979046|NCT00441090|471549650|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
130979047|NCT00441090|471549646|FG000|Overall Study|Withdrawal by Subject|1|||
130979048|NCT00441090|471549647|FG001|Overall Study|Withdrawal by Subject|0|||
130979049|NCT00441090|471549648|FG002|Overall Study|Withdrawal by Subject|1|||
130979050|NCT00441090|471549649|FG003|Overall Study|Withdrawal by Subject|0|||
130979051|NCT00441090|471549650|FG004|Overall Study|Withdrawal by Subject|0|||
130979052|NCT00441090|471549646|FG000|Overall Study|Lack of Efficacy|1|||
130979053|NCT00441090|471549647|FG001|Overall Study|Lack of Efficacy|0|||
130979054|NCT00441090|471549648|FG002|Overall Study|Lack of Efficacy|0|||
130979055|NCT00441090|471549649|FG003|Overall Study|Lack of Efficacy|0|||
130979056|NCT00441090|471549650|FG004|Overall Study|Lack of Efficacy|0|||
130979057|NCT01441102|471549651|FG000|Overall Study|Adverse Event|1|||
130979058|NCT01441102|471549651|FG000|Overall Study|Withdrawal by Subject|2|||
130979059|NCT00605280|471549652|FG000|Year 1|Protocol Violation|0|||
130979060|NCT00605280|471549653|FG001|Year 1|Protocol Violation|0|||
130979061|NCT00605280|471549654|FG002|Year 1|Protocol Violation|0|||
130979062|NCT00605280|471549655|FG003|Year 1|Protocol Violation|1|||
130979063|NCT00605280|471549652|FG000|Year 1|Adverse Event|3|||
130979064|NCT00605280|471549653|FG001|Year 1|Adverse Event|1|||
130979065|NCT00605280|471549654|FG002|Year 1|Adverse Event|1|||
130979066|NCT00605280|471549655|FG003|Year 1|Adverse Event|5|||
130979067|NCT00605280|471549652|FG000|Year 1|Physician Decision|7|||
130979068|NCT00605280|471549653|FG001|Year 1|Physician Decision|4|||
130979069|NCT00605280|471549654|FG002|Year 1|Physician Decision|0|||
130979070|NCT00605280|471549655|FG003|Year 1|Physician Decision|6|||
130979071|NCT00605280|471549652|FG000|Year 1|Withdrawal by Subject|2|||
130979072|NCT00605280|471549653|FG001|Year 1|Withdrawal by Subject|4|||
130979073|NCT00605280|471549654|FG002|Year 1|Withdrawal by Subject|0|||
130979074|NCT00605280|471549655|FG003|Year 1|Withdrawal by Subject|4|||
130979075|NCT00605280|471549652|FG000|Year 1|Other|2|||
130979076|NCT00605280|471549653|FG001|Year 1|Other|1|||
130979077|NCT00605280|471549654|FG002|Year 1|Other|0|||
130979078|NCT00605280|471549655|FG003|Year 1|Other|1|||
130979079|NCT00605280|471549652|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
130979080|NCT00605280|471549653|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
130979081|NCT00605280|471549654|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
130979082|NCT00605280|471549655|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
130979083|NCT00605280|471549652|FG000|Year 2|Adverse Event|4|||
130979084|NCT00605280|471549653|FG001|Year 2|Adverse Event|0|||
130979085|NCT00605280|471549654|FG002|Year 2|Adverse Event|2|||
130979086|NCT00605280|471549655|FG003|Year 2|Adverse Event|4|||
130979087|NCT00605280|471549652|FG000|Year 2|Physician Decision|11|||
130979088|NCT00605280|471549653|FG001|Year 2|Physician Decision|6|||
130979089|NCT00605280|471549654|FG002|Year 2|Physician Decision|4|||
130979090|NCT00605280|471549655|FG003|Year 2|Physician Decision|11|||
130979091|NCT00605280|471549652|FG000|Year 2|Withdrawal by Subject|4|||
130979092|NCT00605280|471549653|FG001|Year 2|Withdrawal by Subject|0|||
130979093|NCT00605280|471549654|FG002|Year 2|Withdrawal by Subject|0|||
130979094|NCT00605280|471549655|FG003|Year 2|Withdrawal by Subject|4|||
130979095|NCT00605280|471549652|FG000|Year 2|Other|1|||
130979096|NCT00605280|471549653|FG001|Year 2|Other|0|||
130979097|NCT00605280|471549654|FG002|Year 2|Other|0|||
130979098|NCT00605280|471549655|FG003|Year 2|Other|1|||
130979099|NCT00605280|471549652|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
130979100|NCT00605280|471549653|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
130979101|NCT00605280|471549654|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
130979102|NCT00605280|471549655|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
130979103|NCT00605280|471549652|FG000|Year 3 Extension|Adverse Event|2|||
130979104|NCT00605280|471549653|FG001|Year 3 Extension|Adverse Event|0|||
130979105|NCT00605280|471549654|FG002|Year 3 Extension|Adverse Event|0|||
130979106|NCT00605280|471549655|FG003|Year 3 Extension|Adverse Event|2|||
130979107|NCT00605280|471549652|FG000|Year 3 Extension|Physician Decision|0|||
130979108|NCT00605280|471549653|FG001|Year 3 Extension|Physician Decision|0|||
130979109|NCT00605280|471549654|FG002|Year 3 Extension|Physician Decision|0|||
130979110|NCT00605280|471549655|FG003|Year 3 Extension|Physician Decision|2|||
130979111|NCT00605280|471549652|FG000|Year 3 Extension|Withdrawal by Subject|2|||
130979112|NCT00605280|471549653|FG001|Year 3 Extension|Withdrawal by Subject|0|||
130979113|NCT00605280|471549654|FG002|Year 3 Extension|Withdrawal by Subject|0|||
130979114|NCT00605280|471549655|FG003|Year 3 Extension|Withdrawal by Subject|5|||
130979115|NCT00605280|471549652|FG000|Year 3 Extension|Other|2|||
130979116|NCT00605280|471549653|FG001|Year 3 Extension|Other|0|||
130979117|NCT00605280|471549654|FG002|Year 3 Extension|Other|0|||
130979118|NCT00605280|471549655|FG003|Year 3 Extension|Other|0|||
130979119|NCT00605280|471549652|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
130979120|NCT00605280|471549653|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
130979121|NCT00605280|471549654|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
130979122|NCT00605280|471549655|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
130979123|NCT01775904|471549659|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
130979124|NCT01775904|471549659|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
130979125|NCT00518115|471549660|FG000|Overall Study|Adverse Event|6|||
130979126|NCT00518115|471549661|FG001|Overall Study|Adverse Event|1|||
130979127|NCT00518115|471549662|FG002|Overall Study|Adverse Event|5|||
130979128|NCT00518115|471549663|FG003|Overall Study|Adverse Event|6|||
130979129|NCT00518115|471549664|FG004|Overall Study|Adverse Event|5|||
131227638|NCT00410410|472459756|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
131227639|NCT00410410|472459757|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
131227640|NCT00410410|472459749|FG000|Open-Label Period (OL)|Other|0|||
131227641|NCT00410410|472459750|FG001|Open-Label Period (OL)|Other|0|||
131227642|NCT00410410|472459751|FG002|Open-Label Period (OL)|Other|0|||
131227643|NCT00410410|472459752|FG003|Open-Label Period (OL)|Other|0|||
131227644|NCT00410410|472459753|FG004|Open-Label Period (OL)|Other|0|||
131227645|NCT00410410|472459754|FG005|Open-Label Period (OL)|Other|0|||
131227646|NCT00410410|472459755|FG006|Open-Label Period (OL)|Other|0|||
131227647|NCT00410410|472459756|FG007|Open-Label Period (OL)|Other|0|||
131227648|NCT00410410|472459757|FG008|Open-Label Period (OL)|Other|7|||
131227649|NCT01783496|472459758|FG000|Overall Study|Lost to Follow-up|0|||
131227650|NCT01783496|472459759|FG001|Overall Study|Lost to Follow-up|0|||
131227651|NCT01783496|472459760|FG002|Overall Study|Lost to Follow-up|0|||
131227652|NCT01783496|472459761|FG003|Overall Study|Lost to Follow-up|2|||
131227653|NCT01783496|472459762|FG004|Overall Study|Lost to Follow-up|0|||
131227654|NCT01783496|472459763|FG005|Overall Study|Lost to Follow-up|1|||
131227655|NCT01783496|472459758|FG000|Overall Study|Withdrawal by Subject|1|||
131227656|NCT01783496|472459759|FG001|Overall Study|Withdrawal by Subject|0|||
131227657|NCT01783496|472459760|FG002|Overall Study|Withdrawal by Subject|0|||
131227658|NCT01783496|472459761|FG003|Overall Study|Withdrawal by Subject|0|||
131227659|NCT01783496|472459762|FG004|Overall Study|Withdrawal by Subject|0|||
131227660|NCT01783496|472459763|FG005|Overall Study|Withdrawal by Subject|0|||
131227661|NCT01023269|472459764|FG000|Overall Study|early termination of the study|2|||
131227662|NCT01023269|472459765|FG001|Overall Study|early termination of the study|0|||
131227663|NCT00947011|472459768|FG000|Overall Study|Study was terminated,PI left institution|12|||
131227664|NCT00814658|472459769|FG000|Overall Study|Lost to Follow-up|0|||
131227665|NCT00814658|472459770|FG001|Overall Study|Lost to Follow-up|1|||
131227666|NCT00814658|472459769|FG000|Overall Study|Physician Decision|1|||
131227667|NCT00814658|472459770|FG001|Overall Study|Physician Decision|0|||
131227668|NCT00814658|472459769|FG000|Overall Study|Adverse Event|3|||
131227669|NCT00814658|472459770|FG001|Overall Study|Adverse Event|3|||
131227670|NCT05266456|472459771|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
131227671|NCT05266456|472459772|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
131227672|NCT05266456|472459773|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
131227673|NCT05266456|472459774|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
131227674|NCT05266456|472459771|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
131227675|NCT05266456|472459772|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
131227676|NCT05266456|472459773|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
131227677|NCT05266456|472459774|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
131227678|NCT05266456|472459771|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
131227679|NCT05266456|472459772|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
131227680|NCT05266456|472459773|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
131227681|NCT05266456|472459774|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
131227682|NCT05266456|472459771|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
131227683|NCT05266456|472459772|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
131227684|NCT05266456|472459773|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
130718597|NCT03982199|470593291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131227685|NCT05266456|472459774|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
131227686|NCT05266456|472459771|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
131227687|NCT05266456|472459772|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
131227688|NCT05266456|472459773|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
131227689|NCT05266456|472459774|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
131227690|NCT01141283|472459775|FG000|Overall Study|Adverse Event|56|||
131227691|NCT01141283|472459775|FG000|Overall Study|Lost to Follow-up|4|||
131227692|NCT01141283|472459775|FG000|Overall Study|Withdrawal by Subject|14|||
131227693|NCT01141283|472459775|FG000|Overall Study|Administrative|4|||
130718598|NCT03982199|470593292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718599|NCT03982199|470593293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
130718600|NCT03982199|470593294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718601|NCT03982199|470593295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
130718602|NCT03982199|470593296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
130718603|NCT03982199|470593297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718604|NCT03982199|470593298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718605|NCT03982199|470593299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130718606|NCT03982199|470593300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131227694|NCT01141283|472459775|FG000|Overall Study|Lack of Efficacy|10|||
131227695|NCT02868281|472459777|FG000|Overall Study|Adverse Event|2|||
131227696|NCT02868281|472459778|FG001|Overall Study|Adverse Event|2|||
131227697|NCT02868281|472459777|FG000|Overall Study|Protocol Violation|13|||
131227698|NCT02868281|472459778|FG001|Overall Study|Protocol Violation|10|||
131227699|NCT02868281|472459777|FG000|Overall Study|Lost to Follow-up|3|||
131227700|NCT02868281|472459778|FG001|Overall Study|Lost to Follow-up|6|||
131227701|NCT02868281|472459777|FG000|Overall Study|Withdrawal by Subject|11|||
131227702|NCT02868281|472459778|FG001|Overall Study|Withdrawal by Subject|15|||
131227703|NCT02868281|472459777|FG000|Overall Study|Physician Decision|2|||
130718607|NCT03982199|470593301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
131227704|NCT02868281|472459778|FG001|Overall Study|Physician Decision|0|||
131227705|NCT02868281|472459777|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
131227706|NCT02868281|472459778|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
131227707|NCT02868281|472459777|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
131227708|NCT02868281|472459778|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
131227709|NCT02868281|472459777|FG000|Overall Study|Long journey/moving away|1|||
131227710|NCT02868281|472459778|FG001|Overall Study|Long journey/moving away|1|||
131227711|NCT01722266|472459779|FG000|Overall Study|Withdrawal by Subject|1|||
131227712|NCT01722266|472459780|FG001|Overall Study|Withdrawal by Subject|2|||
131227713|NCT01722266|472459781|FG002|Overall Study|Withdrawal by Subject|0|||
131227714|NCT01722266|472459782|FG003|Overall Study|Withdrawal by Subject|0|||
131227715|NCT01722266|472459779|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
131227716|NCT01722266|472459780|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
131227717|NCT01722266|472459781|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
131132089|NCT01995071|472111735|FG009|Overall Study|Incarcerated|0|||
131132090|NCT01995071|472111736|FG010|Overall Study|Incarcerated|0|||
131132091|NCT01995071|472111737|FG011|Overall Study|Incarcerated|0|||
131132092|NCT02404103|472111738|FG000|Overall Study|Adverse Event|1|||
131132093|NCT02404103|472111739|FG001|Overall Study|Adverse Event|0|||
131132094|NCT02404103|472111738|FG000|Overall Study|Lost to Follow-up|3|||
131132095|NCT02404103|472111739|FG001|Overall Study|Lost to Follow-up|3|||
131132096|NCT00328627|472111740|FG000|Overall Study|Hyperglycemic Rescue|41|||
131132097|NCT00328627|472111741|FG001|Overall Study|Hyperglycemic Rescue|18|||
131132098|NCT00328627|472111742|FG002|Overall Study|Hyperglycemic Rescue|16|||
131132099|NCT00328627|472111743|FG003|Overall Study|Hyperglycemic Rescue|13|||
131132100|NCT00328627|472111744|FG004|Overall Study|Hyperglycemic Rescue|6|||
131132101|NCT00328627|472111745|FG005|Overall Study|Hyperglycemic Rescue|5|||
131227718|NCT01722266|472459782|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
131227719|NCT01722266|472459779|FG000|Overall Study|Dropped out due to Nausea|0|||
131227720|NCT01722266|472459780|FG001|Overall Study|Dropped out due to Nausea|0|||
130718608|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718609|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718610|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718611|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718612|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718613|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718614|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718615|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718616|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130718617|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
130718618|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
130718619|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
130718620|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
130718621|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
130718622|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718623|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718624|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718625|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718626|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718627|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718628|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718629|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718630|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718631|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
130718632|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130979130|NCT00518115|471549665|FG005|Overall Study|Adverse Event|5|||
130979131|NCT00518115|471549666|FG006|Overall Study|Adverse Event|5|||
130979132|NCT00518115|471549667|FG007|Overall Study|Adverse Event|10|||
131132102|NCT00328627|472111746|FG006|Overall Study|Hyperglycemic Rescue|19|||
131132103|NCT00328627|472111747|FG007|Overall Study|Hyperglycemic Rescue|6|||
131132104|NCT00328627|472111748|FG008|Overall Study|Hyperglycemic Rescue|6|||
131227721|NCT01722266|472459781|FG002|Overall Study|Dropped out due to Nausea|2|||
131227722|NCT01722266|472459782|FG003|Overall Study|Dropped out due to Nausea|0|||
131227723|NCT03811249|472459785|FG000|Overall Study|Withdrawal by Subject|44|||
131227724|NCT03811249|472459785|FG000|Overall Study|Missed Visit|24|||
131227725|NCT03124381|472459786|FG000|Overall Study|Lost to Follow-up|1|||
131227726|NCT03124381|472459787|FG001|Overall Study|Lost to Follow-up|1|||
131227727|NCT03124381|472459786|FG000|Overall Study|Withdrawal by Subject|6|||
131227728|NCT03124381|472459787|FG001|Overall Study|Withdrawal by Subject|3|||
131227729|NCT03124381|472459786|FG000|Overall Study|Protocol Violation|0|||
131227730|NCT03124381|472459787|FG001|Overall Study|Protocol Violation|1|||
131227731|NCT03124381|472459786|FG000|Overall Study|Adverse Event|1|||
131227732|NCT03124381|472459787|FG001|Overall Study|Adverse Event|1|||
131227733|NCT03124381|472459786|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
131227734|NCT03124381|472459787|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
131227735|NCT01783730|472459789|FG000|Overall Study|Failed to meet inclusion criteria|6|||
130979133|NCT00518115|471549668|FG008|Overall Study|Adverse Event|2|||
131132105|NCT00328627|472111749|FG009|Overall Study|Hyperglycemic Rescue|11|||
131132106|NCT00328627|472111750|FG010|Overall Study|Hyperglycemic Rescue|3|||
131132107|NCT00328627|472111751|FG011|Overall Study|Hyperglycemic Rescue|2|||
131132108|NCT00328627|472111740|FG000|Overall Study|Adverse Event|3|||
131132109|NCT00328627|472111741|FG001|Overall Study|Adverse Event|1|||
131132110|NCT00328627|472111742|FG002|Overall Study|Adverse Event|2|||
131132111|NCT00328627|472111743|FG003|Overall Study|Adverse Event|3|||
131132112|NCT00328627|472111744|FG004|Overall Study|Adverse Event|1|||
131132113|NCT00328627|472111745|FG005|Overall Study|Adverse Event|2|||
131132114|NCT00328627|472111746|FG006|Overall Study|Adverse Event|1|||
131132115|NCT00328627|472111747|FG007|Overall Study|Adverse Event|2|||
131132116|NCT00328627|472111748|FG008|Overall Study|Adverse Event|0|||
131132117|NCT00328627|472111749|FG009|Overall Study|Adverse Event|7|||
131132118|NCT00328627|472111750|FG010|Overall Study|Adverse Event|5|||
131132119|NCT00328627|472111751|FG011|Overall Study|Adverse Event|4|||
131132120|NCT00328627|472111740|FG000|Overall Study|Protocol Violation|2|||
131132121|NCT00328627|472111741|FG001|Overall Study|Protocol Violation|2|||
131132122|NCT00328627|472111742|FG002|Overall Study|Protocol Violation|2|||
131132123|NCT00328627|472111743|FG003|Overall Study|Protocol Violation|8|||
131132124|NCT00328627|472111744|FG004|Overall Study|Protocol Violation|5|||
131132125|NCT00328627|472111745|FG005|Overall Study|Protocol Violation|5|||
131132126|NCT00328627|472111746|FG006|Overall Study|Protocol Violation|6|||
131132127|NCT00328627|472111747|FG007|Overall Study|Protocol Violation|2|||
131132128|NCT00328627|472111748|FG008|Overall Study|Protocol Violation|1|||
131132129|NCT00328627|472111749|FG009|Overall Study|Protocol Violation|4|||
131132130|NCT00328627|472111750|FG010|Overall Study|Protocol Violation|6|||
131132131|NCT00328627|472111751|FG011|Overall Study|Protocol Violation|2|||
131132132|NCT00328627|472111740|FG000|Overall Study|Lost to Follow-up|4|||
131132133|NCT00328627|472111741|FG001|Overall Study|Lost to Follow-up|2|||
131132134|NCT00328627|472111742|FG002|Overall Study|Lost to Follow-up|2|||
131132135|NCT00328627|472111743|FG003|Overall Study|Lost to Follow-up|4|||
131132136|NCT00328627|472111744|FG004|Overall Study|Lost to Follow-up|0|||
131132137|NCT00328627|472111745|FG005|Overall Study|Lost to Follow-up|2|||
131132138|NCT00328627|472111746|FG006|Overall Study|Lost to Follow-up|3|||
131132139|NCT00328627|472111747|FG007|Overall Study|Lost to Follow-up|0|||
131132140|NCT00328627|472111748|FG008|Overall Study|Lost to Follow-up|3|||
131132141|NCT00328627|472111749|FG009|Overall Study|Lost to Follow-up|2|||
131132142|NCT00328627|472111750|FG010|Overall Study|Lost to Follow-up|0|||
131132143|NCT00328627|472111751|FG011|Overall Study|Lost to Follow-up|1|||
131132144|NCT00328627|472111740|FG000|Overall Study|Withdrawal by Subject|5|||
131132145|NCT00328627|472111741|FG001|Overall Study|Withdrawal by Subject|4|||
131132146|NCT00328627|472111742|FG002|Overall Study|Withdrawal by Subject|5|||
131132147|NCT00328627|472111743|FG003|Overall Study|Withdrawal by Subject|6|||
131132148|NCT00328627|472111744|FG004|Overall Study|Withdrawal by Subject|2|||
131132149|NCT00328627|472111745|FG005|Overall Study|Withdrawal by Subject|5|||
131132150|NCT00328627|472111746|FG006|Overall Study|Withdrawal by Subject|4|||
131132151|NCT00328627|472111747|FG007|Overall Study|Withdrawal by Subject|4|||
131132152|NCT00328627|472111748|FG008|Overall Study|Withdrawal by Subject|4|||
131132153|NCT00328627|472111749|FG009|Overall Study|Withdrawal by Subject|5|||
131132154|NCT00328627|472111750|FG010|Overall Study|Withdrawal by Subject|2|||
131132155|NCT00328627|472111751|FG011|Overall Study|Withdrawal by Subject|7|||
131132156|NCT00328627|472111740|FG000|Overall Study|Pregnancy|0|||
131132157|NCT00328627|472111741|FG001|Overall Study|Pregnancy|1|||
131132158|NCT00328627|472111742|FG002|Overall Study|Pregnancy|0|||
131132159|NCT00328627|472111743|FG003|Overall Study|Pregnancy|0|||
131132160|NCT00328627|472111744|FG004|Overall Study|Pregnancy|0|||
131132161|NCT00328627|472111745|FG005|Overall Study|Pregnancy|0|||
131132162|NCT00328627|472111746|FG006|Overall Study|Pregnancy|0|||
131132163|NCT00328627|472111747|FG007|Overall Study|Pregnancy|0|||
131132164|NCT00328627|472111748|FG008|Overall Study|Pregnancy|0|||
131132165|NCT00328627|472111749|FG009|Overall Study|Pregnancy|0|||
131132166|NCT00328627|472111750|FG010|Overall Study|Pregnancy|0|||
131132167|NCT00328627|472111751|FG011|Overall Study|Pregnancy|0|||
131227736|NCT01841359|472459790|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
131227737|NCT01841359|472459790|FG000|Overall Study|Concommitant medical issues|2|||
131227738|NCT01841359|472459790|FG000|Overall Study|Adverse Event|3|||
130979134|NCT00518115|471549669|FG009|Overall Study|Adverse Event|9|||
130979135|NCT00518115|471549660|FG000|Overall Study|Lost to Follow-up|0|||
130979136|NCT00518115|471549661|FG001|Overall Study|Lost to Follow-up|0|||
130979137|NCT00518115|471549662|FG002|Overall Study|Lost to Follow-up|2|||
130979138|NCT00518115|471549663|FG003|Overall Study|Lost to Follow-up|3|||
130979139|NCT00518115|471549664|FG004|Overall Study|Lost to Follow-up|1|||
130979140|NCT00518115|471549665|FG005|Overall Study|Lost to Follow-up|3|||
130979141|NCT00518115|471549666|FG006|Overall Study|Lost to Follow-up|0|||
130979142|NCT00518115|471549667|FG007|Overall Study|Lost to Follow-up|1|||
130979143|NCT00518115|471549668|FG008|Overall Study|Lost to Follow-up|1|||
130979144|NCT00518115|471549669|FG009|Overall Study|Lost to Follow-up|1|||
130979145|NCT00518115|471549660|FG000|Overall Study|Protocol Violation|1|||
130979146|NCT00518115|471549661|FG001|Overall Study|Protocol Violation|3|||
130979147|NCT00518115|471549662|FG002|Overall Study|Protocol Violation|1|||
130979148|NCT00518115|471549663|FG003|Overall Study|Protocol Violation|0|||
130979149|NCT00518115|471549664|FG004|Overall Study|Protocol Violation|0|||
130979150|NCT00518115|471549665|FG005|Overall Study|Protocol Violation|0|||
130979151|NCT00518115|471549666|FG006|Overall Study|Protocol Violation|0|||
130979152|NCT00518115|471549667|FG007|Overall Study|Protocol Violation|0|||
130979153|NCT00518115|471549668|FG008|Overall Study|Protocol Violation|0|||
130979154|NCT00518115|471549669|FG009|Overall Study|Protocol Violation|0|||
130979155|NCT00518115|471549660|FG000|Overall Study|Withdrawal by Subject|1|||
130979156|NCT00518115|471549661|FG001|Overall Study|Withdrawal by Subject|1|||
130979157|NCT00518115|471549662|FG002|Overall Study|Withdrawal by Subject|5|||
130979158|NCT00518115|471549663|FG003|Overall Study|Withdrawal by Subject|0|||
130979159|NCT00518115|471549664|FG004|Overall Study|Withdrawal by Subject|2|||
130979160|NCT00518115|471549665|FG005|Overall Study|Withdrawal by Subject|1|||
130979161|NCT00518115|471549666|FG006|Overall Study|Withdrawal by Subject|0|||
130979162|NCT00518115|471549667|FG007|Overall Study|Withdrawal by Subject|2|||
130979163|NCT00518115|471549668|FG008|Overall Study|Withdrawal by Subject|1|||
130979164|NCT00518115|471549669|FG009|Overall Study|Withdrawal by Subject|3|||
130979165|NCT00518115|471549660|FG000|Overall Study|Lack of Efficacy|1|||
130979166|NCT00518115|471549661|FG001|Overall Study|Lack of Efficacy|0|||
130979167|NCT00518115|471549662|FG002|Overall Study|Lack of Efficacy|1|||
130979168|NCT00518115|471549663|FG003|Overall Study|Lack of Efficacy|1|||
130979169|NCT00518115|471549664|FG004|Overall Study|Lack of Efficacy|0|||
130979170|NCT00518115|471549665|FG005|Overall Study|Lack of Efficacy|0|||
130979171|NCT00518115|471549666|FG006|Overall Study|Lack of Efficacy|0|||
130979172|NCT00518115|471549667|FG007|Overall Study|Lack of Efficacy|1|||
130979173|NCT00518115|471549668|FG008|Overall Study|Lack of Efficacy|0|||
130979174|NCT00518115|471549669|FG009|Overall Study|Lack of Efficacy|0|||
130979175|NCT00518115|471549660|FG000|Overall Study|Non-Compliance|1|||
130979176|NCT00518115|471549661|FG001|Overall Study|Non-Compliance|0|||
130979177|NCT00518115|471549662|FG002|Overall Study|Non-Compliance|1|||
130979178|NCT00518115|471549663|FG003|Overall Study|Non-Compliance|0|||
130979179|NCT00518115|471549664|FG004|Overall Study|Non-Compliance|1|||
130979180|NCT00518115|471549665|FG005|Overall Study|Non-Compliance|1|||
130979181|NCT00518115|471549666|FG006|Overall Study|Non-Compliance|1|||
130979182|NCT00518115|471549667|FG007|Overall Study|Non-Compliance|1|||
130979183|NCT00518115|471549668|FG008|Overall Study|Non-Compliance|0|||
130979184|NCT00518115|471549669|FG009|Overall Study|Non-Compliance|1|||
130979185|NCT00518115|471549660|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
130979186|NCT00518115|471549661|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
130979187|NCT00518115|471549662|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130979188|NCT00518115|471549663|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130979189|NCT00518115|471549664|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
131227739|NCT01841359|472459790|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
131227740|NCT02151461|472459791|FG000|Overall Study|Adverse Event|5|||
131227741|NCT02151461|472459792|FG001|Overall Study|Adverse Event|1|||
131227742|NCT02151461|472459793|FG002|Overall Study|Adverse Event|0|||
131227743|NCT02151461|472459794|FG003|Overall Study|Adverse Event|2|||
130979190|NCT00518115|471549665|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
130979191|NCT00518115|471549666|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130979192|NCT00518115|471549667|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130979193|NCT00518115|471549668|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130979194|NCT00518115|471549669|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130979195|NCT00518115|471549660|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
130979196|NCT00518115|471549661|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130979197|NCT00518115|471549662|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130979198|NCT00518115|471549663|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130979199|NCT00518115|471549664|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130979200|NCT00518115|471549665|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130979201|NCT00518115|471549666|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130979202|NCT00518115|471549667|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130979203|NCT00518115|471549668|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130718633|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718634|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718635|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130718636|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718637|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718638|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718639|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718640|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718641|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718642|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718643|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718644|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718645|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718646|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718647|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718648|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130718649|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
130718650|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718651|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718652|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718653|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718654|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718655|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718656|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718657|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718658|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718659|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130718660|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
130718661|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
130979204|NCT00518115|471549669|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
130979205|NCT00518115|471549660|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
130979206|NCT00518115|471549661|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
130979207|NCT00518115|471549662|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
130979208|NCT00518115|471549663|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
130979209|NCT00518115|471549664|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
130979210|NCT00518115|471549665|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
130979211|NCT00518115|471549666|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
130979212|NCT00518115|471549667|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
130979213|NCT00518115|471549668|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
130979214|NCT00518115|471549669|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
130979215|NCT00518115|471549660|FG000|Overall Study|Wrong Monotherapy Administered|0|||
130979216|NCT00518115|471549661|FG001|Overall Study|Wrong Monotherapy Administered|0|||
130979217|NCT00518115|471549662|FG002|Overall Study|Wrong Monotherapy Administered|1|||
130979218|NCT00518115|471549663|FG003|Overall Study|Wrong Monotherapy Administered|0|||
130979219|NCT00518115|471549664|FG004|Overall Study|Wrong Monotherapy Administered|0|||
130979220|NCT00518115|471549665|FG005|Overall Study|Wrong Monotherapy Administered|0|||
130979221|NCT00518115|471549666|FG006|Overall Study|Wrong Monotherapy Administered|1|||
130979222|NCT00518115|471549667|FG007|Overall Study|Wrong Monotherapy Administered|0|||
130979223|NCT00518115|471549668|FG008|Overall Study|Wrong Monotherapy Administered|0|||
130979224|NCT00518115|471549669|FG009|Overall Study|Wrong Monotherapy Administered|0|||
130979225|NCT00518115|471549660|FG000|Overall Study|Violation of Exclusion Criteria|0|||
130979226|NCT00518115|471549661|FG001|Overall Study|Violation of Exclusion Criteria|0|||
130979227|NCT00518115|471549662|FG002|Overall Study|Violation of Exclusion Criteria|0|||
130979228|NCT00518115|471549663|FG003|Overall Study|Violation of Exclusion Criteria|1|||
130979229|NCT00518115|471549664|FG004|Overall Study|Violation of Exclusion Criteria|0|||
130979230|NCT00518115|471549665|FG005|Overall Study|Violation of Exclusion Criteria|0|||
130979231|NCT00518115|471549666|FG006|Overall Study|Violation of Exclusion Criteria|1|||
130979232|NCT00518115|471549667|FG007|Overall Study|Violation of Exclusion Criteria|0|||
130979233|NCT00518115|471549668|FG008|Overall Study|Violation of Exclusion Criteria|0|||
130979234|NCT00518115|471549669|FG009|Overall Study|Violation of Exclusion Criteria|0|||
130979235|NCT00518115|471549660|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
130979236|NCT00518115|471549661|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
130979237|NCT00518115|471549662|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
130979238|NCT00518115|471549663|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
130718662|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
130979239|NCT00518115|471549664|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
130979240|NCT00518115|471549665|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
131227744|NCT02151461|472459791|FG000|Overall Study|Lost to Follow-up|0|||
131227745|NCT02151461|472459792|FG001|Overall Study|Lost to Follow-up|0|||
131227746|NCT02151461|472459793|FG002|Overall Study|Lost to Follow-up|1|||
131227747|NCT02151461|472459794|FG003|Overall Study|Lost to Follow-up|1|||
131227748|NCT02151461|472459791|FG000|Overall Study|Withdrawal by Subject|1|||
131227749|NCT02151461|472459792|FG001|Overall Study|Withdrawal by Subject|0|||
131227750|NCT02151461|472459793|FG002|Overall Study|Withdrawal by Subject|1|||
131227751|NCT02151461|472459794|FG003|Overall Study|Withdrawal by Subject|1|||
131227752|NCT02151461|472459791|FG000|Overall Study|Treatment discontinuation|0|||
131227753|NCT02151461|472459792|FG001|Overall Study|Treatment discontinuation|0|||
131227754|NCT02151461|472459793|FG002|Overall Study|Treatment discontinuation|1|||
131227755|NCT02151461|472459794|FG003|Overall Study|Treatment discontinuation|0|||
131227756|NCT02168270|472459795|FG000|Overall Study|Lack of Efficacy|4|||
130979241|NCT00518115|471549666|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
130979242|NCT00518115|471549667|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
130979243|NCT00518115|471549668|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
130979244|NCT00518115|471549669|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
130979245|NCT00518115|471549660|FG000|Overall Study|Withdrew Consent|0|||
130979246|NCT00518115|471549661|FG001|Overall Study|Withdrew Consent|0|||
130979247|NCT00518115|471549662|FG002|Overall Study|Withdrew Consent|0|||
130979248|NCT00518115|471549663|FG003|Overall Study|Withdrew Consent|0|||
130979249|NCT00518115|471549664|FG004|Overall Study|Withdrew Consent|0|||
130979250|NCT00518115|471549665|FG005|Overall Study|Withdrew Consent|1|||
130979251|NCT00518115|471549666|FG006|Overall Study|Withdrew Consent|0|||
130979252|NCT00518115|471549667|FG007|Overall Study|Withdrew Consent|0|||
130979253|NCT00518115|471549668|FG008|Overall Study|Withdrew Consent|0|||
130979254|NCT00518115|471549669|FG009|Overall Study|Withdrew Consent|0|||
130979255|NCT00518115|471549660|FG000|Overall Study|Moved Out of State|0|||
130979256|NCT00518115|471549661|FG001|Overall Study|Moved Out of State|0|||
130979257|NCT00518115|471549662|FG002|Overall Study|Moved Out of State|0|||
130979258|NCT00518115|471549663|FG003|Overall Study|Moved Out of State|0|||
130979259|NCT00518115|471549664|FG004|Overall Study|Moved Out of State|0|||
130979260|NCT00518115|471549665|FG005|Overall Study|Moved Out of State|0|||
130979261|NCT00518115|471549666|FG006|Overall Study|Moved Out of State|0|||
130979262|NCT00518115|471549667|FG007|Overall Study|Moved Out of State|0|||
130979263|NCT00518115|471549668|FG008|Overall Study|Moved Out of State|0|||
130979264|NCT00518115|471549669|FG009|Overall Study|Moved Out of State|1|||
130979265|NCT04891419|471549670|FG000|Overall Study|Withdrawal by Subject|4|||
130979266|NCT04891419|471549671|FG001|Overall Study|Withdrawal by Subject|0|||
130979267|NCT04891419|471549670|FG000|Overall Study|Lost to Follow-up|1|||
130979268|NCT04891419|471549671|FG001|Overall Study|Lost to Follow-up|3|||
130979269|NCT00843167|471549672|FG000|Treatment Period|Adverse Event|1|||
130979270|NCT00843167|471549673|FG001|Treatment Period|Adverse Event|5|||
130979271|NCT00843167|471549672|FG000|Treatment Period|Withdrawal by Subject|2|||
130979272|NCT00843167|471549673|FG001|Treatment Period|Withdrawal by Subject|3|||
130979273|NCT00127101|471549674|FG000|Base Protocol|Adverse Event|0|||
130979274|NCT00127101|471549675|FG001|Base Protocol|Adverse Event|2|||
130979275|NCT00127101|471549676|FG002|Base Protocol|Adverse Event|1|||
130979276|NCT00127101|471549677|FG003|Base Protocol|Adverse Event|0|||
130979277|NCT00127101|471549678|FG004|Base Protocol|Adverse Event|0|||
130979278|NCT00127101|471549679|FG005|Base Protocol|Adverse Event|0|||
130979279|NCT00127101|471549674|FG000|Base Protocol|Lack of Efficacy|1|||
130979280|NCT00127101|471549675|FG001|Base Protocol|Lack of Efficacy|0|||
130979281|NCT00127101|471549676|FG002|Base Protocol|Lack of Efficacy|0|||
130979282|NCT00127101|471549677|FG003|Base Protocol|Lack of Efficacy|0|||
130979283|NCT00127101|471549678|FG004|Base Protocol|Lack of Efficacy|2|||
130979284|NCT00127101|471549679|FG005|Base Protocol|Lack of Efficacy|0|||
130979285|NCT00127101|471549674|FG000|Base Protocol|Withdrawal by Subject|1|||
130979286|NCT00127101|471549675|FG001|Base Protocol|Withdrawal by Subject|2|||
130979287|NCT00127101|471549676|FG002|Base Protocol|Withdrawal by Subject|1|||
130979288|NCT00127101|471549677|FG003|Base Protocol|Withdrawal by Subject|0|||
131227757|NCT02533999|472459798|FG000|Overall Study|Lost to Follow-up|3|||
131227758|NCT02533999|472459799|FG001|Overall Study|Lost to Follow-up|5|||
131227759|NCT02533999|472459798|FG000|Overall Study|Protocol Violation|3|||
130979289|NCT00127101|471549678|FG004|Base Protocol|Withdrawal by Subject|0|||
131227760|NCT02533999|472459799|FG001|Overall Study|Protocol Violation|0|||
131043918|NCT02998528|471794758|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
130979290|NCT00127101|471549679|FG005|Base Protocol|Withdrawal by Subject|1|||
130979291|NCT00127101|471549674|FG000|Continuation Phase|Adverse Event|0|||
130979292|NCT00127101|471549675|FG001|Continuation Phase|Adverse Event|0|||
130979293|NCT00127101|471549676|FG002|Continuation Phase|Adverse Event|0|||
130979294|NCT00127101|471549677|FG003|Continuation Phase|Adverse Event|0|||
130979295|NCT00127101|471549678|FG004|Continuation Phase|Adverse Event|1|||
131227761|NCT02533999|472459798|FG000|Overall Study|Adverse Event|0|||
131227762|NCT02533999|472459799|FG001|Overall Study|Adverse Event|1|||
131227763|NCT02533999|472459798|FG000|Overall Study|Randomized but intervention not received|0|||
130979296|NCT00127101|471549679|FG005|Continuation Phase|Adverse Event|1|||
130979297|NCT00127101|471549674|FG000|Continuation Phase|Lack of Efficacy|0|||
130979298|NCT00127101|471549675|FG001|Continuation Phase|Lack of Efficacy|0|||
130979299|NCT00127101|471549676|FG002|Continuation Phase|Lack of Efficacy|0|||
130979300|NCT00127101|471549677|FG003|Continuation Phase|Lack of Efficacy|0|||
130979301|NCT00127101|471549678|FG004|Continuation Phase|Lack of Efficacy|0|||
130979302|NCT00127101|471549679|FG005|Continuation Phase|Lack of Efficacy|1|||
130979303|NCT00127101|471549674|FG000|Continuation Phase|Withdrawal by Subject|0|||
130979304|NCT00127101|471549675|FG001|Continuation Phase|Withdrawal by Subject|0|||
130979305|NCT00127101|471549676|FG002|Continuation Phase|Withdrawal by Subject|1|||
130979306|NCT00127101|471549677|FG003|Continuation Phase|Withdrawal by Subject|0|||
130979307|NCT00127101|471549678|FG004|Continuation Phase|Withdrawal by Subject|2|||
130979308|NCT00127101|471549679|FG005|Continuation Phase|Withdrawal by Subject|1|||
130979309|NCT02291614|471549682|FG000|Overall Study|Lost to Follow-up|0|||
130979310|NCT02291614|471549683|FG001|Overall Study|Lost to Follow-up|0|||
130979311|NCT02291614|471549684|FG002|Overall Study|Lost to Follow-up|0|||
130979312|NCT02291614|471549685|FG003|Overall Study|Lost to Follow-up|0|||
130979313|NCT02291614|471549686|FG004|Overall Study|Lost to Follow-up|0|||
130979314|NCT02291614|471549687|FG005|Overall Study|Lost to Follow-up|0|||
130979315|NCT02291614|471549688|FG006|Overall Study|Lost to Follow-up|0|||
130979316|NCT02291614|471549689|FG007|Overall Study|Lost to Follow-up|1|||
130979317|NCT02291614|471549690|FG008|Overall Study|Lost to Follow-up|0|||
130979318|NCT02291614|471549691|FG009|Overall Study|Lost to Follow-up|0|||
130979319|NCT02291614|471549692|FG010|Overall Study|Lost to Follow-up|0|||
130979320|NCT02291614|471549682|FG000|Overall Study|Withdrawal by Subject|0|||
130979321|NCT02291614|471549683|FG001|Overall Study|Withdrawal by Subject|1|||
130979322|NCT02291614|471549684|FG002|Overall Study|Withdrawal by Subject|0|||
130979323|NCT02291614|471549685|FG003|Overall Study|Withdrawal by Subject|0|||
130979324|NCT02291614|471549686|FG004|Overall Study|Withdrawal by Subject|0|||
130979325|NCT02291614|471549687|FG005|Overall Study|Withdrawal by Subject|0|||
130979326|NCT02291614|471549688|FG006|Overall Study|Withdrawal by Subject|0|||
130979327|NCT02291614|471549689|FG007|Overall Study|Withdrawal by Subject|0|||
130979328|NCT02291614|471549690|FG008|Overall Study|Withdrawal by Subject|0|||
130979329|NCT02291614|471549691|FG009|Overall Study|Withdrawal by Subject|2|||
130979330|NCT02291614|471549692|FG010|Overall Study|Withdrawal by Subject|2|||
130979331|NCT02291614|471549682|FG000|Overall Study|Decision by sponsor|0|||
130979332|NCT02291614|471549683|FG001|Overall Study|Decision by sponsor|0|||
130979333|NCT02291614|471549684|FG002|Overall Study|Decision by sponsor|0|||
130979334|NCT02291614|471549685|FG003|Overall Study|Decision by sponsor|1|||
130979335|NCT02291614|471549686|FG004|Overall Study|Decision by sponsor|0|||
130979336|NCT02291614|471549687|FG005|Overall Study|Decision by sponsor|0|||
130979337|NCT02291614|471549688|FG006|Overall Study|Decision by sponsor|0|||
130979338|NCT02291614|471549689|FG007|Overall Study|Decision by sponsor|0|||
130979339|NCT02291614|471549690|FG008|Overall Study|Decision by sponsor|0|||
130979340|NCT02291614|471549691|FG009|Overall Study|Decision by sponsor|0|||
130979341|NCT02291614|471549692|FG010|Overall Study|Decision by sponsor|0|||
130979342|NCT02291614|471549682|FG000|Overall Study|Death|0|||
130979343|NCT02291614|471549683|FG001|Overall Study|Death|0|||
130979344|NCT02291614|471549684|FG002|Overall Study|Death|1|||
130979345|NCT02291614|471549685|FG003|Overall Study|Death|0|||
130979346|NCT02291614|471549686|FG004|Overall Study|Death|1|||
130979347|NCT02291614|471549687|FG005|Overall Study|Death|1|||
130979348|NCT02291614|471549688|FG006|Overall Study|Death|1|||
130979349|NCT02291614|471549689|FG007|Overall Study|Death|0|||
130979350|NCT02291614|471549690|FG008|Overall Study|Death|0|||
130979351|NCT02291614|471549691|FG009|Overall Study|Death|0|||
130979352|NCT02291614|471549692|FG010|Overall Study|Death|0|||
130979353|NCT01662310|471549693|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
130979354|NCT01662310|471549694|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
130979355|NCT01662310|471549695|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
130979356|NCT01662310|471549696|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
130979357|NCT01662310|471549697|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
130979358|NCT01662310|471549693|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
130979359|NCT01662310|471549694|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
130979360|NCT01662310|471549695|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
130979361|NCT01662310|471549696|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
130979362|NCT01662310|471549697|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
130979363|NCT01662310|471549693|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
130979364|NCT01662310|471549694|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
130979365|NCT01662310|471549695|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
130979366|NCT01662310|471549696|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
130979367|NCT01662310|471549697|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
130979368|NCT01662310|471549693|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
130979369|NCT01662310|471549694|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
130979370|NCT01662310|471549695|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
130979371|NCT01662310|471549696|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
130979372|NCT01662310|471549697|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
130979373|NCT01662310|471549693|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
130979374|NCT01662310|471549694|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
130979375|NCT01662310|471549695|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
130979376|NCT01662310|471549696|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
130979377|NCT01662310|471549697|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
130979378|NCT01662310|471549693|FG000|Run-In or Stabilization Phase|Other|1|||
130979379|NCT01662310|471549694|FG001|Run-In or Stabilization Phase|Other|0|||
130979380|NCT01662310|471549695|FG002|Run-In or Stabilization Phase|Other|0|||
130979381|NCT01662310|471549696|FG003|Run-In or Stabilization Phase|Other|0|||
130979382|NCT01662310|471549697|FG004|Run-In or Stabilization Phase|Other|0|||
130979383|NCT01662310|471549693|FG000|Double-Blind Phase|Adverse Event|0|||
130979384|NCT01662310|471549694|FG001|Double-Blind Phase|Adverse Event|0|||
130979385|NCT01662310|471549695|FG002|Double-Blind Phase|Adverse Event|1|||
130979386|NCT01662310|471549696|FG003|Double-Blind Phase|Adverse Event|0|||
130979387|NCT01662310|471549697|FG004|Double-Blind Phase|Adverse Event|0|||
130979388|NCT01662310|471549693|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130979389|NCT01662310|471549694|FG001|Double-Blind Phase|Lost to Follow-up|3|||
130979390|NCT01662310|471549695|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130979391|NCT01662310|471549696|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130979392|NCT01662310|471549697|FG004|Double-Blind Phase|Lost to Follow-up|0|||
130979393|NCT01662310|471549693|FG000|Double-Blind Phase|Pregnancy|0|||
130979394|NCT01662310|471549694|FG001|Double-Blind Phase|Pregnancy|2|||
130979395|NCT01662310|471549695|FG002|Double-Blind Phase|Pregnancy|0|||
130979396|NCT01662310|471549696|FG003|Double-Blind Phase|Pregnancy|0|||
130979397|NCT01662310|471549697|FG004|Double-Blind Phase|Pregnancy|0|||
130979398|NCT01662310|471549693|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130979399|NCT01662310|471549694|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
130979400|NCT01662310|471549695|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
130979401|NCT01662310|471549696|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130979402|NCT01662310|471549697|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130979403|NCT01662310|471549693|FG000|Double-Blind Phase|Other|0|||
130979404|NCT01662310|471549694|FG001|Double-Blind Phase|Other|0|||
130979405|NCT01662310|471549695|FG002|Double-Blind Phase|Other|1|||
130979406|NCT01662310|471549696|FG003|Double-Blind Phase|Other|0|||
130979407|NCT01662310|471549697|FG004|Double-Blind Phase|Other|0|||
130979408|NCT01662310|471549693|FG000|Double-Blind Phase|Randomized but not treated|0|||
130979409|NCT01662310|471549694|FG001|Double-Blind Phase|Randomized but not treated|1|||
130979410|NCT01662310|471549695|FG002|Double-Blind Phase|Randomized but not treated|0|||
130979411|NCT01662310|471549696|FG003|Double-Blind Phase|Randomized but not treated|0|||
130979412|NCT01662310|471549697|FG004|Double-Blind Phase|Randomized but not treated|0|||
130979413|NCT01662310|471549693|FG000|Open-Label Extension Phase|Adverse Event|0|||
130979414|NCT01662310|471549694|FG001|Open-Label Extension Phase|Adverse Event|0|||
130979415|NCT01662310|471549695|FG002|Open-Label Extension Phase|Adverse Event|0|||
130979416|NCT01662310|471549696|FG003|Open-Label Extension Phase|Adverse Event|3|||
130979417|NCT01662310|471549697|FG004|Open-Label Extension Phase|Adverse Event|0|||
130979418|NCT01662310|471549693|FG000|Open-Label Extension Phase|Death|0|||
130979419|NCT01662310|471549694|FG001|Open-Label Extension Phase|Death|0|||
130979420|NCT01662310|471549695|FG002|Open-Label Extension Phase|Death|0|||
130979421|NCT01662310|471549696|FG003|Open-Label Extension Phase|Death|1|||
130979422|NCT01662310|471549697|FG004|Open-Label Extension Phase|Death|0|||
130979423|NCT01662310|471549693|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
130979424|NCT01662310|471549694|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
130979425|NCT01662310|471549695|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
130979426|NCT01662310|471549696|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
130979427|NCT01662310|471549697|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
130979428|NCT01662310|471549693|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130979429|NCT01662310|471549694|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130979430|NCT01662310|471549695|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130979431|NCT01662310|471549696|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
130979432|NCT01662310|471549697|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
130979433|NCT01662310|471549693|FG000|Open-Label Extension Phase|Pregnancy|0|||
131227764|NCT02533999|472459799|FG001|Overall Study|Randomized but intervention not received|1|||
131227765|NCT01102777|472459800|FG000|Overall Study|Death|2|||
131227766|NCT01102777|472459801|FG001|Overall Study|Death|6|||
131227767|NCT01102777|472459800|FG000|Overall Study|Lost to Follow-up|7|||
131227768|NCT01102777|472459801|FG001|Overall Study|Lost to Follow-up|10|||
130718663|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
131227769|NCT05017493|472459802|FG000|Overall Study|Withdrawal by Subject|26|||
130979434|NCT01662310|471549694|FG001|Open-Label Extension Phase|Pregnancy|0|||
130979435|NCT01662310|471549695|FG002|Open-Label Extension Phase|Pregnancy|0|||
130979436|NCT01662310|471549696|FG003|Open-Label Extension Phase|Pregnancy|1|||
130979437|NCT01662310|471549697|FG004|Open-Label Extension Phase|Pregnancy|0|||
130979438|NCT01662310|471549693|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
130979439|NCT01662310|471549694|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
130979440|NCT01662310|471549695|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
131043919|NCT02998528|471794759|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
131227770|NCT05017493|472459803|FG001|Overall Study|Withdrawal by Subject|0|||
130979441|NCT01662310|471549696|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
130979442|NCT01662310|471549697|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
130979443|NCT04302350|471549702|FG000|Overall Study|Physician Decision|1|||
130979444|NCT04302350|471549703|FG001|Overall Study|Physician Decision|1|||
130979445|NCT04302350|471549704|FG002|Overall Study|Physician Decision|2|||
130979446|NCT04302350|471549702|FG000|Overall Study|Lack of Efficacy|1|||
130979447|NCT04302350|471549703|FG001|Overall Study|Lack of Efficacy|1|||
130979448|NCT04302350|471549704|FG002|Overall Study|Lack of Efficacy|4|||
130979449|NCT04302350|471549702|FG000|Overall Study|Adverse Event|0|||
130979450|NCT04302350|471549703|FG001|Overall Study|Adverse Event|1|||
130979451|NCT04302350|471549704|FG002|Overall Study|Adverse Event|2|||
130979452|NCT02012491|471549705|FG000|Overall Study|Lost to Follow-up|1|||
130979453|NCT02012491|471549706|FG001|Overall Study|Lost to Follow-up|0|||
130979454|NCT02012491|471549705|FG000|Overall Study|Protocol Violation|0|||
130979455|NCT02012491|471549706|FG001|Overall Study|Protocol Violation|1|||
130979456|NCT02012491|471549705|FG000|Overall Study|Withdrawal by Subject|1|||
130979457|NCT02012491|471549706|FG001|Overall Study|Withdrawal by Subject|0|||
130979458|NCT02137369|471549717|FG000|Overall Study|Withdrawal by Subject|3|||
130979459|NCT02137369|471549718|FG001|Overall Study|Withdrawal by Subject|2|||
130979460|NCT02137369|471549717|FG000|Overall Study|Adverse Event|2|||
130979461|NCT02137369|471549718|FG001|Overall Study|Adverse Event|0|||
130979462|NCT02137369|471549717|FG000|Overall Study|Lost to Follow-up|1|||
130979463|NCT02137369|471549718|FG001|Overall Study|Lost to Follow-up|0|||
130979464|NCT02137369|471549717|FG000|Overall Study|Moved away|2|||
130979465|NCT02137369|471549718|FG001|Overall Study|Moved away|0|||
130979466|NCT03969719|471549719|FG000|Overall Study|Other reasons not specified|1|||
130979467|NCT03969719|471549720|FG001|Overall Study|Other reasons not specified|1|||
130979468|NCT03969719|471549721|FG002|Overall Study|Other reasons not specified|3|||
130979469|NCT03969719|471549719|FG000|Overall Study|Withdrawal by Subject|2|||
130979470|NCT03969719|471549720|FG001|Overall Study|Withdrawal by Subject|3|||
130979471|NCT03969719|471549721|FG002|Overall Study|Withdrawal by Subject|2|||
130979472|NCT03969719|471549719|FG000|Overall Study|Protocol Violation|1|||
130979473|NCT03969719|471549720|FG001|Overall Study|Protocol Violation|2|||
130979474|NCT03969719|471549721|FG002|Overall Study|Protocol Violation|0|||
130979475|NCT03969719|471549719|FG000|Overall Study|Adverse Event|0|||
130979476|NCT03969719|471549720|FG001|Overall Study|Adverse Event|2|||
130979477|NCT03969719|471549721|FG002|Overall Study|Adverse Event|0|||
130979478|NCT03969719|471549719|FG000|Overall Study|Lost to Follow-up|0|||
130979479|NCT03969719|471549720|FG001|Overall Study|Lost to Follow-up|1|||
130979480|NCT03969719|471549721|FG002|Overall Study|Lost to Follow-up|0|||
130979481|NCT01297959|471549722|FG000|Overall Study|Adverse Event|0|||
130979482|NCT01297959|471549723|FG001|Overall Study|Adverse Event|1|||
130979483|NCT01297959|471549722|FG000|Overall Study|Protocol Violation|2|||
130979484|NCT01297959|471549723|FG001|Overall Study|Protocol Violation|1|||
130979485|NCT01297959|471549722|FG000|Overall Study|Withdrawal by Subject|5|||
130979486|NCT01297959|471549723|FG001|Overall Study|Withdrawal by Subject|4|||
130979487|NCT01297959|471549722|FG000|Overall Study|Physician Decision|0|||
130979488|NCT01297959|471549723|FG001|Overall Study|Physician Decision|1|||
130979489|NCT01297959|471549722|FG000|Overall Study|Unrelated medical illness / complication|0|||
130979490|NCT01297959|471549723|FG001|Overall Study|Unrelated medical illness / complication|2|||
130979491|NCT01297959|471549722|FG000|Overall Study|Other|13|||
130979492|NCT01297959|471549723|FG001|Overall Study|Other|7|||
130979493|NCT01667432|471549724|FG000|Overall Study|Premature Study Termination|26|||
130979494|NCT01667432|471549724|FG000|Overall Study|Failure to Return|10|||
130979495|NCT01667432|471549724|FG000|Overall Study|Moved to Another Center|3|||
130718664|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130979496|NCT01667432|471549724|FG000|Overall Study|Lost to Follow-up|3|||
131132168|NCT00328627|472111740|FG000|Overall Study|Physician Decision|4|||
131132169|NCT00328627|472111741|FG001|Overall Study|Physician Decision|3|||
131132170|NCT00328627|472111742|FG002|Overall Study|Physician Decision|1|||
131132171|NCT00328627|472111743|FG003|Overall Study|Physician Decision|2|||
130718665|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718666|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718667|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718668|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718669|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130979497|NCT01667432|471549724|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
130979498|NCT01667432|471549724|FG000|Overall Study|Insufficient Therapeutic Response|4|||
130979499|NCT01667432|471549724|FG000|Overall Study|Adverse Event|1|||
131132172|NCT00328627|472111744|FG004|Overall Study|Physician Decision|1|||
130979500|NCT01667432|471549724|FG000|Overall Study|Protocol Deviation|2|||
130979501|NCT01667432|471549724|FG000|Overall Study|Principal Investigator Decision|1|||
130979502|NCT01667432|471549724|FG000|Overall Study|Reason Not Specified|2|||
130979503|NCT01667432|471549724|FG000|Overall Study|Missing Information|4|||
130979504|NCT00829387|471549725|FG000|Overall Study|Withdrawal by Subject|2|||
130979505|NCT00829387|471549726|FG001|Overall Study|Withdrawal by Subject|3|||
130979506|NCT00829387|471549725|FG000|Overall Study|Disqualified by PI|1|||
130718670|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718671|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718672|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718673|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718674|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718675|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718676|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130718677|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
130979507|NCT00829387|471549726|FG001|Overall Study|Disqualified by PI|0|||
130979508|NCT03519854|471549727|FG000|Overall Study|Technical Error|0|||
130979509|NCT03519854|471549728|FG001|Overall Study|Technical Error|0|||
130979510|NCT03519854|471549729|FG002|Overall Study|Technical Error|1|||
130979511|NCT03519854|471549730|FG003|Overall Study|Technical Error|0|||
130979512|NCT03519854|471549731|FG004|Overall Study|Technical Error|0|||
130979513|NCT03519854|471549732|FG005|Overall Study|Technical Error|0|||
130979514|NCT03519854|471549733|FG006|Overall Study|Technical Error|0|||
130979515|NCT03519854|471549734|FG007|Overall Study|Technical Error|0|||
130979516|NCT03519854|471549735|FG008|Overall Study|Technical Error|0|||
130979517|NCT03519854|471549736|FG009|Overall Study|Technical Error|0|||
131132173|NCT00328627|472111745|FG005|Overall Study|Physician Decision|1|||
131132174|NCT00328627|472111746|FG006|Overall Study|Physician Decision|1|||
131132175|NCT00328627|472111747|FG007|Overall Study|Physician Decision|0|||
131132176|NCT00328627|472111748|FG008|Overall Study|Physician Decision|3|||
131132177|NCT00328627|472111749|FG009|Overall Study|Physician Decision|2|||
130979518|NCT03519854|471549737|FG010|Overall Study|Technical Error|0|||
130979519|NCT03519854|471549738|FG011|Overall Study|Technical Error|0|||
130979520|NCT03519854|471549739|FG012|Overall Study|Technical Error|0|||
130979521|NCT03519854|471549740|FG013|Overall Study|Technical Error|0|||
130979522|NCT03519854|471549741|FG014|Overall Study|Technical Error|0|||
130979523|NCT03519854|471549742|FG015|Overall Study|Technical Error|0|||
130979524|NCT03519854|471549743|FG016|Overall Study|Technical Error|0|||
130979525|NCT03519854|471549744|FG017|Overall Study|Technical Error|0|||
130979526|NCT00707031|471549745|FG000|Overall Study|Adverse Event|45|||
130979527|NCT00707031|471549746|FG001|Overall Study|Adverse Event|45|||
130979528|NCT00707031|471549745|FG000|Overall Study|Lack of Efficacy|19|||
130979529|NCT00707031|471549746|FG001|Overall Study|Lack of Efficacy|6|||
130979530|NCT00707031|471549745|FG000|Overall Study|Lost to Follow-up|2|||
130979531|NCT00707031|471549746|FG001|Overall Study|Lost to Follow-up|1|||
130979532|NCT00707031|471549745|FG000|Overall Study|Protocol Violation|1|||
130979533|NCT00707031|471549746|FG001|Overall Study|Protocol Violation|0|||
130979534|NCT00707031|471549745|FG000|Overall Study|Withdrawal by Subject|7|||
130979535|NCT00707031|471549746|FG001|Overall Study|Withdrawal by Subject|8|||
130979536|NCT00707031|471549745|FG000|Overall Study|Poor Compliance to Protocol|7|||
130979537|NCT00707031|471549746|FG001|Overall Study|Poor Compliance to Protocol|13|||
130979538|NCT00707031|471549745|FG000|Overall Study|Familial or Personal Reasons|12|||
130979539|NCT00707031|471549746|FG001|Overall Study|Familial or Personal Reasons|15|||
130979540|NCT00707031|471549745|FG000|Overall Study|Serious Noncompliance|2|||
130979541|NCT00707031|471549746|FG001|Overall Study|Serious Noncompliance|3|||
130979542|NCT00707031|471549745|FG000|Overall Study|Sponsor Decision|9|||
130979543|NCT00707031|471549746|FG001|Overall Study|Sponsor Decision|8|||
131132178|NCT00328627|472111750|FG010|Overall Study|Physician Decision|1|||
131132179|NCT00328627|472111751|FG011|Overall Study|Physician Decision|0|||
131132180|NCT00328627|472111740|FG000|Overall Study|Other|0|||
131132181|NCT00328627|472111741|FG001|Overall Study|Other|0|||
131132182|NCT00328627|472111742|FG002|Overall Study|Other|0|||
131132183|NCT00328627|472111743|FG003|Overall Study|Other|1|||
130718678|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718679|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718680|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130979544|NCT02747238|471549747|FG000|Overall Study|Lack of Efficacy|0|||
130979545|NCT02747238|471549748|FG001|Overall Study|Lack of Efficacy|1|||
131132184|NCT00328627|472111744|FG004|Overall Study|Other|0|||
131132185|NCT00328627|472111745|FG005|Overall Study|Other|0|||
131132186|NCT00328627|472111746|FG006|Overall Study|Other|1|||
131132187|NCT00328627|472111747|FG007|Overall Study|Other|0|||
131132188|NCT00328627|472111748|FG008|Overall Study|Other|0|||
131227771|NCT05017493|472459802|FG000|Overall Study|Physician Decision|15|||
130979546|NCT02747238|471549747|FG000|Overall Study|Data lost|3|||
131132189|NCT00328627|472111749|FG009|Overall Study|Other|1|||
131132190|NCT00328627|472111750|FG010|Overall Study|Other|1|||
131132191|NCT00328627|472111751|FG011|Overall Study|Other|0|||
130979547|NCT02747238|471549748|FG001|Overall Study|Data lost|5|||
130979548|NCT00951275|471549749|FG000|Overall Study|Administrative Reason|1|||
130979549|NCT00951275|471549749|FG000|Overall Study|Adverse Event|7|||
130979550|NCT00951275|471549749|FG000|Overall Study|Withdrawal by Subject|4|||
130979551|NCT00951275|471549749|FG000|Overall Study|Protocol Violation|1|||
130979552|NCT01389973|471549758|FG000|Overall Study|Lost to Follow-up|1|||
131132192|NCT00112905|472111752|FG000|Overall Study|Adverse Event|4|||
130979553|NCT01389973|471549758|FG000|Overall Study|Trial Stopped by Sponsor|9|||
130979554|NCT01389973|471549758|FG000|Overall Study|Other|10|||
130979555|NCT02626780|471549759|FG000|Overall Study|Withdrawal by Subject|3|||
130979556|NCT04304833|471549760|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
130979557|NCT04304833|471549761|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
130979558|NCT03456700|471549762|FG000|Overall Study|Withdrawal by Subject|1|||
130979559|NCT04154787|471549763|FG000|Overall Study|Adverse Event|0|||
130979560|NCT04154787|471549764|FG001|Overall Study|Adverse Event|1|||
130979561|NCT04154787|471549765|FG002|Overall Study|Adverse Event|0|||
130979562|NCT04154787|471549763|FG000|Overall Study|Patient Requires Other Treatment|0|||
130979563|NCT04154787|471549764|FG001|Overall Study|Patient Requires Other Treatment|1|||
130979564|NCT04154787|471549765|FG002|Overall Study|Patient Requires Other Treatment|0|||
130979565|NCT04154787|471549763|FG000|Overall Study|Study Terminated By Sponsor|0|||
130979566|NCT04154787|471549764|FG001|Overall Study|Study Terminated By Sponsor|6|||
130979567|NCT04154787|471549765|FG002|Overall Study|Study Terminated By Sponsor|1|||
130979568|NCT04154787|471549763|FG000|Overall Study|Subject Decision|0|||
130979569|NCT04154787|471549764|FG001|Overall Study|Subject Decision|1|||
130979570|NCT04154787|471549765|FG002|Overall Study|Subject Decision|0|||
130979571|NCT04154787|471549763|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
130979572|NCT04154787|471549764|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
130979573|NCT04154787|471549765|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
130979574|NCT01951625|471549766|FG000|Treatment Period|Protocol Violation|2|||
130979575|NCT01951625|471549767|FG001|Treatment Period|Protocol Violation|0|||
130979576|NCT01951625|471549768|FG002|Treatment Period|Protocol Violation|1|||
130979577|NCT01951625|471549769|FG003|Treatment Period|Protocol Violation|3|||
130979578|NCT01951625|471549770|FG004|Treatment Period|Protocol Violation|2|||
130979579|NCT01951625|471549766|FG000|Treatment Period|Physician Decision|0|||
130979580|NCT01951625|471549767|FG001|Treatment Period|Physician Decision|0|||
130979581|NCT01951625|471549768|FG002|Treatment Period|Physician Decision|0|||
130979582|NCT01951625|471549769|FG003|Treatment Period|Physician Decision|0|||
130979583|NCT01951625|471549770|FG004|Treatment Period|Physician Decision|1|||
130979584|NCT01951625|471549766|FG000|Treatment Period|Protocol driven decision point|0|||
130979585|NCT01951625|471549767|FG001|Treatment Period|Protocol driven decision point|5|||
130979586|NCT01951625|471549768|FG002|Treatment Period|Protocol driven decision point|0|||
130979587|NCT01951625|471549769|FG003|Treatment Period|Protocol driven decision point|2|||
130979588|NCT01951625|471549770|FG004|Treatment Period|Protocol driven decision point|1|||
130979589|NCT01951625|471549766|FG000|Treatment Period|Non compliance with study drug|1|||
130979590|NCT01951625|471549767|FG001|Treatment Period|Non compliance with study drug|2|||
130979591|NCT01951625|471549768|FG002|Treatment Period|Non compliance with study drug|2|||
130979592|NCT01951625|471549769|FG003|Treatment Period|Non compliance with study drug|0|||
130979593|NCT01951625|471549770|FG004|Treatment Period|Non compliance with study drug|0|||
130979594|NCT01951625|471549766|FG000|Treatment Period|Death|3|||
130979595|NCT01951625|471549767|FG001|Treatment Period|Death|2|||
130979596|NCT01951625|471549768|FG002|Treatment Period|Death|2|||
130979597|NCT01951625|471549769|FG003|Treatment Period|Death|1|||
130979598|NCT01951625|471549770|FG004|Treatment Period|Death|2|||
130979599|NCT01951625|471549766|FG000|Treatment Period|Adverse Event|7|||
130979600|NCT01951625|471549767|FG001|Treatment Period|Adverse Event|10|||
130979601|NCT01951625|471549768|FG002|Treatment Period|Adverse Event|9|||
130979602|NCT01951625|471549769|FG003|Treatment Period|Adverse Event|8|||
130979603|NCT01951625|471549770|FG004|Treatment Period|Adverse Event|8|||
130979604|NCT01951625|471549766|FG000|Treatment Period|Withdrawal by Subject|5|||
130979605|NCT01951625|471549767|FG001|Treatment Period|Withdrawal by Subject|2|||
130979606|NCT01951625|471549768|FG002|Treatment Period|Withdrawal by Subject|1|||
130979607|NCT01951625|471549769|FG003|Treatment Period|Withdrawal by Subject|7|||
130979608|NCT01951625|471549770|FG004|Treatment Period|Withdrawal by Subject|3|||
130979609|NCT01951625|471549766|FG000|Treatment Period|Lost to Follow-up|1|||
130979610|NCT01951625|471549767|FG001|Treatment Period|Lost to Follow-up|0|||
130979611|NCT01951625|471549768|FG002|Treatment Period|Lost to Follow-up|0|||
130979612|NCT01951625|471549769|FG003|Treatment Period|Lost to Follow-up|1|||
130979613|NCT01951625|471549770|FG004|Treatment Period|Lost to Follow-up|0|||
130979614|NCT01951625|471549766|FG000|Follow Up Period|Non-compliance with study drug|1|||
130979615|NCT01951625|471549767|FG001|Follow Up Period|Non-compliance with study drug|0|||
130979616|NCT01951625|471549768|FG002|Follow Up Period|Non-compliance with study drug|0|||
130979617|NCT01951625|471549769|FG003|Follow Up Period|Non-compliance with study drug|0|||
130979618|NCT01951625|471549770|FG004|Follow Up Period|Non-compliance with study drug|0|||
130979619|NCT01951625|471549766|FG000|Follow Up Period|Death|1|||
130979620|NCT01951625|471549767|FG001|Follow Up Period|Death|3|||
130979621|NCT01951625|471549768|FG002|Follow Up Period|Death|2|||
131132193|NCT00112905|472111752|FG000|Overall Study|Death|1|||
131132194|NCT00112905|472111752|FG000|Overall Study|Ineligibility|5|||
131132195|NCT00112905|472111752|FG000|Overall Study|Alternative treatment|1|||
131132196|NCT00112905|472111752|FG000|Overall Study|performance status was deteiorating|1|||
131132197|NCT02600507|472111753|FG000|Overall Study|Adverse Event|3|||
130979622|NCT01951625|471549769|FG003|Follow Up Period|Death|2|||
130979623|NCT01951625|471549770|FG004|Follow Up Period|Death|1|||
130979624|NCT01951625|471549766|FG000|Follow Up Period|Logistical difficulties|1|||
130979625|NCT01951625|471549767|FG001|Follow Up Period|Logistical difficulties|2|||
130979626|NCT01951625|471549768|FG002|Follow Up Period|Logistical difficulties|0|||
130979627|NCT01951625|471549769|FG003|Follow Up Period|Logistical difficulties|0|||
130979628|NCT01951625|471549770|FG004|Follow Up Period|Logistical difficulties|0|||
130979629|NCT01951625|471549766|FG000|Follow Up Period|Adverse Event|0|||
130979630|NCT01951625|471549767|FG001|Follow Up Period|Adverse Event|3|||
130979631|NCT01951625|471549768|FG002|Follow Up Period|Adverse Event|2|||
130979632|NCT01951625|471549769|FG003|Follow Up Period|Adverse Event|3|||
130979633|NCT01951625|471549770|FG004|Follow Up Period|Adverse Event|5|||
130979634|NCT01951625|471549766|FG000|Follow Up Period|Withdrawal by Subject|4|||
130979635|NCT01951625|471549767|FG001|Follow Up Period|Withdrawal by Subject|1|||
130979636|NCT01951625|471549768|FG002|Follow Up Period|Withdrawal by Subject|0|||
130979637|NCT01951625|471549769|FG003|Follow Up Period|Withdrawal by Subject|5|||
130979638|NCT01951625|471549770|FG004|Follow Up Period|Withdrawal by Subject|3|||
130979639|NCT01951625|471549766|FG000|Follow Up Period|Lost to Follow-up|1|||
130979640|NCT01951625|471549767|FG001|Follow Up Period|Lost to Follow-up|0|||
130979641|NCT01951625|471549768|FG002|Follow Up Period|Lost to Follow-up|0|||
130979642|NCT01951625|471549769|FG003|Follow Up Period|Lost to Follow-up|1|||
130979643|NCT01951625|471549770|FG004|Follow Up Period|Lost to Follow-up|1|||
130979644|NCT03053050|471549773|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
130979645|NCT03053050|471549774|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
130979646|NCT03053050|471549775|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
130979647|NCT03053050|471549776|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
130979648|NCT03053050|471549773|FG000|Randomized Phase|Withdrew Consent|16|||
130979649|NCT03053050|471549774|FG001|Randomized Phase|Withdrew Consent|8|||
130979650|NCT03053050|471549775|FG002|Randomized Phase|Withdrew Consent|9|||
131132198|NCT02600507|472111754|FG001|Overall Study|Adverse Event|15|||
131132199|NCT02600507|472111755|FG002|Overall Study|Adverse Event|5|||
131132200|NCT02600507|472111753|FG000|Overall Study|Lack of Efficacy|3|||
131132201|NCT02600507|472111754|FG001|Overall Study|Lack of Efficacy|8|||
131132202|NCT02600507|472111755|FG002|Overall Study|Lack of Efficacy|5|||
131132203|NCT02600507|472111753|FG000|Overall Study|Lost to Follow-up|3|||
131132204|NCT02600507|472111754|FG001|Overall Study|Lost to Follow-up|5|||
131132205|NCT02600507|472111755|FG002|Overall Study|Lost to Follow-up|2|||
131132206|NCT02600507|472111753|FG000|Overall Study|Protocol Violation|12|||
131132207|NCT02600507|472111754|FG001|Overall Study|Protocol Violation|4|||
131132208|NCT02600507|472111755|FG002|Overall Study|Protocol Violation|4|||
131132209|NCT02600507|472111753|FG000|Overall Study|Physician Decision|1|||
131132210|NCT02600507|472111754|FG001|Overall Study|Physician Decision|0|||
131132211|NCT02600507|472111755|FG002|Overall Study|Physician Decision|1|||
131132212|NCT02600507|472111753|FG000|Overall Study|Withdrawal by Subject|7|||
131132213|NCT02600507|472111754|FG001|Overall Study|Withdrawal by Subject|11|||
131132214|NCT02600507|472111755|FG002|Overall Study|Withdrawal by Subject|7|||
131132215|NCT02600507|472111753|FG000|Overall Study|Other|0|||
131132216|NCT02600507|472111754|FG001|Overall Study|Other|1|||
131132217|NCT02600507|472111755|FG002|Overall Study|Other|1|||
131132218|NCT00605085|472111761|FG000|Overall Study|Withdrawal by Subject|8|||
131132219|NCT00605085|472111762|FG001|Overall Study|Withdrawal by Subject|5|||
131132220|NCT00605085|472111761|FG000|Overall Study|Adverse Event|9|||
131132221|NCT00605085|472111762|FG001|Overall Study|Adverse Event|5|||
131132222|NCT00605085|472111761|FG000|Overall Study|Pregnancy|2|||
131132223|NCT00605085|472111762|FG001|Overall Study|Pregnancy|0|||
131132224|NCT00605085|472111761|FG000|Overall Study|Protocol Violation|3|||
131132225|NCT00605085|472111762|FG001|Overall Study|Protocol Violation|2|||
131132226|NCT00605085|472111761|FG000|Overall Study|Lost to Follow-up|10|||
131132227|NCT00605085|472111762|FG001|Overall Study|Lost to Follow-up|5|||
131132228|NCT00605085|472111761|FG000|Overall Study|administrative reasons|18|||
131132229|NCT00605085|472111762|FG001|Overall Study|administrative reasons|8|||
131132230|NCT00621504|472111763|FG000|Overall Study|Adverse Event|1|||
131132231|NCT00621504|472111764|FG001|Overall Study|Adverse Event|3|||
131132232|NCT00621504|472111763|FG000|Overall Study|At the request of sponsor/investigator|1|||
131132233|NCT00621504|472111764|FG001|Overall Study|At the request of sponsor/investigator|0|||
131132234|NCT00621504|472111763|FG000|Overall Study|Withdrew consent|9|||
131132235|NCT00621504|472111764|FG001|Overall Study|Withdrew consent|6|||
131132236|NCT00621504|472111763|FG000|Overall Study|Lost to Follow-up|8|||
131132237|NCT00621504|472111764|FG001|Overall Study|Lost to Follow-up|10|||
131132238|NCT00621504|472111763|FG000|Overall Study|Other|1|||
131132239|NCT00621504|472111764|FG001|Overall Study|Other|0|||
131132240|NCT00621504|472111763|FG000|Overall Study|Death|6|||
131132241|NCT00621504|472111764|FG001|Overall Study|Death|6|||
131132242|NCT03311711|472111769|FG000|Overall Study|Death|1|||
131132243|NCT03311711|472111770|FG001|Overall Study|Death|0|||
131132244|NCT03311711|472111771|FG002|Overall Study|Death|0|||
131132245|NCT03311711|472111772|FG003|Overall Study|Death|0|||
131132246|NCT03311711|472111773|FG004|Overall Study|Death|0|||
130979651|NCT03053050|471549776|FG003|Randomized Phase|Withdrew Consent|0|||
131132247|NCT03311711|472111774|FG005|Overall Study|Death|0|||
131132248|NCT03311711|472111775|FG006|Overall Study|Death|1|||
131132249|NCT03311711|472111776|FG007|Overall Study|Death|0|||
131132250|NCT03311711|472111777|FG008|Overall Study|Death|1|||
131132251|NCT03311711|472111778|FG009|Overall Study|Death|0|||
131132252|NCT03311711|472111769|FG000|Overall Study|Death of dyad partner|0|||
131132253|NCT03311711|472111770|FG001|Overall Study|Death of dyad partner|1|||
130979652|NCT03053050|471549773|FG000|Randomized Phase|Investigator's Discretion|6|||
130979653|NCT03053050|471549774|FG001|Randomized Phase|Investigator's Discretion|6|||
130979654|NCT03053050|471549775|FG002|Randomized Phase|Investigator's Discretion|3|||
130979655|NCT03053050|471549776|FG003|Randomized Phase|Investigator's Discretion|0|||
130979656|NCT03053050|471549773|FG000|Randomized Phase|Lost to Follow-up|5|||
130979657|NCT03053050|471549774|FG001|Randomized Phase|Lost to Follow-up|1|||
130979658|NCT03053050|471549775|FG002|Randomized Phase|Lost to Follow-up|1|||
130979659|NCT03053050|471549776|FG003|Randomized Phase|Lost to Follow-up|0|||
130979660|NCT03053050|471549773|FG000|Randomized Phase|Adverse Event|0|||
130979661|NCT03053050|471549774|FG001|Randomized Phase|Adverse Event|1|||
130979662|NCT03053050|471549775|FG002|Randomized Phase|Adverse Event|0|||
130979663|NCT03053050|471549776|FG003|Randomized Phase|Adverse Event|0|||
130979664|NCT03053050|471549773|FG000|Randomized Phase|Randomized but Never Treated|2|||
130979665|NCT03053050|471549774|FG001|Randomized Phase|Randomized but Never Treated|2|||
130979666|NCT03053050|471549775|FG002|Randomized Phase|Randomized but Never Treated|2|||
130979667|NCT03053050|471549776|FG003|Randomized Phase|Randomized but Never Treated|0|||
130979668|NCT03053050|471549773|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
130979669|NCT03053050|471549774|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
130979670|NCT03053050|471549775|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
130979671|NCT03053050|471549776|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
130979672|NCT03053050|471549773|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
130979673|NCT03053050|471549774|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
130979674|NCT03053050|471549775|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
130979675|NCT03053050|471549776|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
130979676|NCT03053050|471549773|FG000|Open-label Phase|Withdrew Consent|0|||
130979677|NCT03053050|471549774|FG001|Open-label Phase|Withdrew Consent|0|||
130979678|NCT03053050|471549775|FG002|Open-label Phase|Withdrew Consent|0|||
130979679|NCT03053050|471549776|FG003|Open-label Phase|Withdrew Consent|6|||
130979680|NCT03053050|471549773|FG000|Open-label Phase|Investigator's Discretion|0|||
130979681|NCT03053050|471549774|FG001|Open-label Phase|Investigator's Discretion|0|||
130979682|NCT03053050|471549775|FG002|Open-label Phase|Investigator's Discretion|0|||
130979683|NCT03053050|471549776|FG003|Open-label Phase|Investigator's Discretion|4|||
130979684|NCT05338333|471549777|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
130979685|NCT05338333|471549778|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
130979686|NCT02459574|471549782|FG000|Overall Study|Withdrawal by Subject|6|||
130979687|NCT02459574|471549783|FG001|Overall Study|Withdrawal by Subject|6|||
130979688|NCT02459574|471549784|FG002|Overall Study|Withdrawal by Subject|2|||
130979689|NCT02459574|471549782|FG000|Overall Study|Lost to Follow-up|1|||
130979690|NCT02459574|471549783|FG001|Overall Study|Lost to Follow-up|1|||
130979691|NCT02459574|471549784|FG002|Overall Study|Lost to Follow-up|0|||
130979692|NCT02459574|471549782|FG000|Overall Study|Death|0|||
130979693|NCT02459574|471549783|FG001|Overall Study|Death|1|||
130979694|NCT02459574|471549784|FG002|Overall Study|Death|0|||
130979695|NCT00251745|471549785|FG000|Overall Study|Adverse Event|7|||
130979696|NCT00251745|471549786|FG001|Overall Study|Adverse Event|9|||
130979697|NCT00251745|471549787|FG002|Overall Study|Adverse Event|11|||
130979698|NCT00251745|471549785|FG000|Overall Study|Lost to Follow-up|4|||
130979699|NCT00251745|471549786|FG001|Overall Study|Lost to Follow-up|2|||
130979700|NCT00251745|471549787|FG002|Overall Study|Lost to Follow-up|5|||
130979701|NCT00251745|471549785|FG000|Overall Study|Withdrawal by Subject|13|||
130979702|NCT00251745|471549786|FG001|Overall Study|Withdrawal by Subject|7|||
130979703|NCT00251745|471549787|FG002|Overall Study|Withdrawal by Subject|3|||
130979704|NCT00251745|471549785|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130979705|NCT00251745|471549786|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
130979706|NCT00251745|471549787|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
130979707|NCT00251745|471549785|FG000|Overall Study|Lack of Efficacy|3|||
130979708|NCT00251745|471549786|FG001|Overall Study|Lack of Efficacy|0|||
130979709|NCT00251745|471549787|FG002|Overall Study|Lack of Efficacy|0|||
131132254|NCT03311711|472111771|FG002|Overall Study|Death of dyad partner|0|||
131132255|NCT03311711|472111772|FG003|Overall Study|Death of dyad partner|0|||
131132256|NCT03311711|472111773|FG004|Overall Study|Death of dyad partner|0|||
130979710|NCT00251745|471549785|FG000|Overall Study|Noncompliant|0|||
130979711|NCT00251745|471549786|FG001|Overall Study|Noncompliant|2|||
130979712|NCT00251745|471549787|FG002|Overall Study|Noncompliant|2|||
130979713|NCT00251745|471549785|FG000|Overall Study|Pregnancy|0|||
130979714|NCT00251745|471549786|FG001|Overall Study|Pregnancy|1|||
130979715|NCT00251745|471549787|FG002|Overall Study|Pregnancy|0|||
130979716|NCT00251745|471549785|FG000|Overall Study|Per Subject Request|0|||
130979717|NCT00251745|471549786|FG001|Overall Study|Per Subject Request|0|||
130979718|NCT00251745|471549787|FG002|Overall Study|Per Subject Request|1|||
130979719|NCT00251745|471549785|FG000|Overall Study|Per Investigator Request|1|||
131132257|NCT03311711|472111774|FG005|Overall Study|Death of dyad partner|0|||
131227772|NCT05017493|472459803|FG001|Overall Study|Physician Decision|0|||
131227773|NCT05017493|472459802|FG000|Overall Study|Protocol Violation|81|||
131227774|NCT05017493|472459803|FG001|Overall Study|Protocol Violation|0|||
131227775|NCT02862535|472459808|FG000|Overall Study|Death|7|||
131227776|NCT02862535|472459809|FG001|Overall Study|Death|3|||
131227777|NCT02862535|472459810|FG002|Overall Study|Death|2|||
131227778|NCT02862535|472459811|FG003|Overall Study|Death|5|||
131227779|NCT02862535|472459808|FG000|Overall Study|Study Terminated by Sponsor|1|||
131227780|NCT02862535|472459809|FG001|Overall Study|Study Terminated by Sponsor|3|||
131227781|NCT02862535|472459810|FG002|Overall Study|Study Terminated by Sponsor|8|||
131227782|NCT02862535|472459811|FG003|Overall Study|Study Terminated by Sponsor|5|||
131227783|NCT02862535|472459808|FG000|Overall Study|Enrolled, not Treated|1|||
131227784|NCT02862535|472459809|FG001|Overall Study|Enrolled, not Treated|0|||
131227785|NCT02862535|472459810|FG002|Overall Study|Enrolled, not Treated|0|||
131227786|NCT02862535|472459811|FG003|Overall Study|Enrolled, not Treated|1|||
131227787|NCT02472977|472459817|FG000|Overall Study|Disease progression|4|||
131227788|NCT02472977|472459818|FG001|Overall Study|Disease progression|25|||
131227789|NCT02472977|472459819|FG002|Overall Study|Disease progression|6|||
131227790|NCT02472977|472459817|FG000|Overall Study|Withdrawal by Subject|0|||
131227791|NCT02472977|472459818|FG001|Overall Study|Withdrawal by Subject|1|||
131227792|NCT02472977|472459819|FG002|Overall Study|Withdrawal by Subject|0|||
131227793|NCT02472977|472459817|FG000|Overall Study|Study drug toxicity|2|||
131227794|NCT02472977|472459818|FG001|Overall Study|Study drug toxicity|0|||
131227795|NCT02472977|472459819|FG002|Overall Study|Study drug toxicity|2|||
131227796|NCT02472977|472459817|FG000|Overall Study|Subject request to discontinue treatment|0|||
131227797|NCT02472977|472459818|FG001|Overall Study|Subject request to discontinue treatment|1|||
131227798|NCT02472977|472459819|FG002|Overall Study|Subject request to discontinue treatment|0|||
131132258|NCT03311711|472111775|FG006|Overall Study|Death of dyad partner|0|||
131132259|NCT03311711|472111776|FG007|Overall Study|Death of dyad partner|1|||
131132260|NCT03311711|472111777|FG008|Overall Study|Death of dyad partner|0|||
131132261|NCT03311711|472111778|FG009|Overall Study|Death of dyad partner|1|||
131132262|NCT03311711|472111769|FG000|Overall Study|Lost to Follow-up|2|||
131132263|NCT03311711|472111770|FG001|Overall Study|Lost to Follow-up|2|||
131132264|NCT03311711|472111771|FG002|Overall Study|Lost to Follow-up|0|||
131132265|NCT03311711|472111772|FG003|Overall Study|Lost to Follow-up|0|||
131132266|NCT03311711|472111773|FG004|Overall Study|Lost to Follow-up|0|||
131132267|NCT03311711|472111774|FG005|Overall Study|Lost to Follow-up|0|||
131227799|NCT00738920|472459820|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
131227800|NCT00738920|472459821|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
131227801|NCT00738920|472459822|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
131227802|NCT00738920|472459820|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
131227803|NCT00738920|472459821|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
131227804|NCT00738920|472459822|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
131227805|NCT00738920|472459820|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
131227806|NCT00738920|472459821|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
131227807|NCT00738920|472459822|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
131227808|NCT00738920|472459820|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
131227809|NCT00738920|472459821|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
131227810|NCT00738920|472459822|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
131227811|NCT00738920|472459820|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
131227812|NCT00738920|472459821|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
131227813|NCT00738920|472459822|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
131227814|NCT00738920|472459820|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
131227815|NCT00738920|472459821|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
130778819|NCT03428100|470817454|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130979720|NCT00251745|471549786|FG001|Overall Study|Per Investigator Request|0|||
130979721|NCT00251745|471549787|FG002|Overall Study|Per Investigator Request|0|||
130979722|NCT04866017|471549790|FG000|Overall Study|Study Terminated by Sponsor|13|||
130979723|NCT04866017|471549791|FG001|Overall Study|Study Terminated by Sponsor|14|||
131132268|NCT03311711|472111775|FG006|Overall Study|Lost to Follow-up|1|||
130979724|NCT04866017|471549792|FG002|Overall Study|Study Terminated by Sponsor|13|||
130979725|NCT04866017|471549790|FG000|Overall Study|Death|8|||
130979726|NCT04866017|471549791|FG001|Overall Study|Death|4|||
130979727|NCT04866017|471549792|FG002|Overall Study|Death|8|||
130979728|NCT04866017|471549790|FG000|Overall Study|Withdrawal by Subject|1|||
131227816|NCT00738920|472459822|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
131227817|NCT00738920|472459820|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
131227818|NCT00738920|472459821|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
131227819|NCT00738920|472459822|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
131227820|NCT00738920|472459820|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
131132269|NCT03311711|472111776|FG007|Overall Study|Lost to Follow-up|1|||
131132270|NCT03311711|472111777|FG008|Overall Study|Lost to Follow-up|0|||
131132271|NCT03311711|472111778|FG009|Overall Study|Lost to Follow-up|0|||
130979729|NCT04866017|471549791|FG001|Overall Study|Withdrawal by Subject|0|||
130979730|NCT04866017|471549792|FG002|Overall Study|Withdrawal by Subject|1|||
130979731|NCT04866017|471549790|FG000|Overall Study|Physician Decision|0|||
130979732|NCT04866017|471549791|FG001|Overall Study|Physician Decision|1|||
130979733|NCT04866017|471549792|FG002|Overall Study|Physician Decision|0|||
130979734|NCT01475136|471549793|FG000|Overall Study|Sponsor Decision|0|||
130979735|NCT01475136|471549794|FG001|Overall Study|Sponsor Decision|1|||
130979736|NCT01475136|471549795|FG002|Overall Study|Sponsor Decision|0|||
130979737|NCT01475136|471549796|FG003|Overall Study|Sponsor Decision|0|||
130979738|NCT01475136|471549793|FG000|Overall Study|Entry Criteria Not Met|0|||
130979739|NCT01475136|471549794|FG001|Overall Study|Entry Criteria Not Met|2|||
130979740|NCT01475136|471549795|FG002|Overall Study|Entry Criteria Not Met|3|||
130979741|NCT01475136|471549796|FG003|Overall Study|Entry Criteria Not Met|1|||
130979742|NCT01475136|471549793|FG000|Overall Study|Withdrawal by Subject|0|||
130979743|NCT01475136|471549794|FG001|Overall Study|Withdrawal by Subject|0|||
130979744|NCT01475136|471549795|FG002|Overall Study|Withdrawal by Subject|0|||
130979745|NCT01475136|471549796|FG003|Overall Study|Withdrawal by Subject|2|||
130979746|NCT01475136|471549793|FG000|Overall Study|Adverse Event|1|||
130979747|NCT01475136|471549794|FG001|Overall Study|Adverse Event|0|||
130979748|NCT01475136|471549795|FG002|Overall Study|Adverse Event|0|||
130979749|NCT01475136|471549796|FG003|Overall Study|Adverse Event|1|||
130979750|NCT01475136|471549793|FG000|Overall Study|Death|0|||
130979751|NCT01475136|471549794|FG001|Overall Study|Death|0|||
130979752|NCT01475136|471549795|FG002|Overall Study|Death|0|||
130979753|NCT01475136|471549796|FG003|Overall Study|Death|1|||
130979754|NCT00003508|471551973|FG000|Overall Study|Not evaluable|5|||
130979755|NCT01712009|471551974|FG000|Overall Study|Withdrawal by Subject|24|||
130979756|NCT01712009|471551975|FG001|Overall Study|Withdrawal by Subject|15|||
130979757|NCT01712009|471551976|FG002|Overall Study|Withdrawal by Subject|8|||
130979758|NCT01712009|471551974|FG000|Overall Study|Lost to Follow-up|2|||
130979759|NCT01712009|471551975|FG001|Overall Study|Lost to Follow-up|0|||
130979760|NCT01712009|471551976|FG002|Overall Study|Lost to Follow-up|1|||
130979761|NCT01712009|471551974|FG000|Overall Study|Decision by Sponsor|12|||
130979762|NCT01712009|471551975|FG001|Overall Study|Decision by Sponsor|14|||
130979763|NCT01712009|471551976|FG002|Overall Study|Decision by Sponsor|12|||
130979764|NCT02160314|471551977|FG000|Overall Study|Adverse Event|0|||
130979765|NCT02160314|471551978|FG001|Overall Study|Adverse Event|6|||
130979766|NCT02160314|471551977|FG000|Overall Study|Protocol Violation|0|||
130979767|NCT02160314|471551978|FG001|Overall Study|Protocol Violation|4|||
130979768|NCT02160314|471551977|FG000|Overall Study|Withdrawal by Subject|1|||
130979769|NCT02160314|471551978|FG001|Overall Study|Withdrawal by Subject|2|||
130979770|NCT02160314|471551977|FG000|Overall Study|Lost to Follow-up|0|||
130979771|NCT02160314|471551978|FG001|Overall Study|Lost to Follow-up|1|||
130979772|NCT01377480|471551982|FG000|Overall Study|Protocol Violation|0|||
130979773|NCT01377480|471551983|FG001|Overall Study|Protocol Violation|0|||
130979774|NCT01377480|471551984|FG002|Overall Study|Protocol Violation|0|||
130979775|NCT01377480|471551985|FG003|Overall Study|Protocol Violation|4|||
130979776|NCT01377480|471551982|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
130979777|NCT01377480|471551983|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
130979778|NCT01377480|471551984|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
130979779|NCT01377480|471551985|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
130979780|NCT01377480|471551982|FG000|Overall Study|Withdrawal by Subject|0|||
130979781|NCT01377480|471551983|FG001|Overall Study|Withdrawal by Subject|0|||
130979782|NCT01377480|471551984|FG002|Overall Study|Withdrawal by Subject|1|||
130979783|NCT01377480|471551985|FG003|Overall Study|Withdrawal by Subject|0|||
130979784|NCT01377480|471551982|FG000|Overall Study|Serious adverse event|0|||
130979785|NCT01377480|471551983|FG001|Overall Study|Serious adverse event|0|||
130979786|NCT01377480|471551984|FG002|Overall Study|Serious adverse event|1|||
130979787|NCT01377480|471551985|FG003|Overall Study|Serious adverse event|1|||
130979788|NCT01377480|471551982|FG000|Overall Study|Other|0|||
130979789|NCT01377480|471551983|FG001|Overall Study|Other|0|||
130979790|NCT01377480|471551984|FG002|Overall Study|Other|7|||
130979791|NCT01377480|471551985|FG003|Overall Study|Other|6|||
130979792|NCT00590902|471551989|FG000|Overall Study|Death|1|||
130979793|NCT01986881|471551990|FG000|Overall Study|Death|228|||
130979794|NCT01986881|471551991|FG001|Overall Study|Death|233|||
130979795|NCT01986881|471551992|FG002|Overall Study|Death|247|||
130979796|NCT01986881|471551990|FG000|Overall Study|Lost to Follow-up|51|||
130979797|NCT01986881|471551991|FG001|Overall Study|Lost to Follow-up|44|||
130979798|NCT01986881|471551992|FG002|Overall Study|Lost to Follow-up|55|||
130979799|NCT01986881|471551990|FG000|Overall Study|Physician Decision|7|||
130979800|NCT01986881|471551991|FG001|Overall Study|Physician Decision|4|||
130979801|NCT01986881|471551992|FG002|Overall Study|Physician Decision|6|||
130979802|NCT01986881|471551990|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
130979803|NCT01986881|471551991|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
130979804|NCT01986881|471551992|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
130979805|NCT01986881|471551990|FG000|Overall Study|Withdrawal by Subject|41|||
130979806|NCT01986881|471551991|FG001|Overall Study|Withdrawal by Subject|60|||
130979807|NCT01986881|471551992|FG002|Overall Study|Withdrawal by Subject|45|||
130718681|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130979808|NCT01986881|471551990|FG000|Overall Study|Subject Moved|0|||
130979809|NCT01986881|471551991|FG001|Overall Study|Subject Moved|1|||
130979810|NCT01986881|471551992|FG002|Overall Study|Subject Moved|0|||
130979811|NCT01986881|471551990|FG000|Overall Study|Other|1|||
130979812|NCT01986881|471551991|FG001|Overall Study|Other|2|||
130979813|NCT01986881|471551992|FG002|Overall Study|Other|2|||
130979814|NCT03224182|471551998|FG000|Overall Study|Study Drug Not Instilled|6|||
130979815|NCT03224182|471551999|FG001|Overall Study|Study Drug Not Instilled|1|||
130979816|NCT03224182|471551998|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
130979817|NCT03224182|471551999|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
130979818|NCT03224182|471551998|FG000|Overall Study|Withdrew of Consent|4|||
130979819|NCT03224182|471551999|FG001|Overall Study|Withdrew of Consent|2|||
130979820|NCT03224182|471551998|FG000|Overall Study|Investigator Decision|3|||
130979821|NCT03224182|471551999|FG001|Overall Study|Investigator Decision|1|||
130979822|NCT03224182|471551998|FG000|Overall Study|Sponsor Decision|26|||
130979823|NCT03224182|471551999|FG001|Overall Study|Sponsor Decision|12|||
130979824|NCT03224182|471551998|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
130979825|NCT03224182|471551999|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
130979826|NCT03224182|471551998|FG000|Overall Study|Lost to Follow-up|1|||
130979827|NCT03224182|471551999|FG001|Overall Study|Lost to Follow-up|0|||
130979828|NCT03224182|471551998|FG000|Overall Study|Participant Had Recurrence|11|||
130979829|NCT03224182|471551999|FG001|Overall Study|Participant Had Recurrence|5|||
130979830|NCT03224182|471551998|FG000|Overall Study|Death|0|||
130979831|NCT03224182|471551999|FG001|Overall Study|Death|1|||
130979832|NCT03224182|471551998|FG000|Overall Study|Reason not Specified|3|||
130979833|NCT03224182|471551999|FG001|Overall Study|Reason not Specified|3|||
130979834|NCT03224182|471551998|FG000|Overall Study|Other|1|||
130979835|NCT03224182|471551999|FG001|Overall Study|Other|0|||
130979836|NCT02822222|471552000|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
130979837|NCT02822222|471552001|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
130979838|NCT00643916|471552002|FG000|Overall Study|Protocol Violation|0|||
130979839|NCT00643916|471552003|FG001|Overall Study|Protocol Violation|1|||
130979840|NCT00643916|471552004|FG002|Overall Study|Protocol Violation|1|||
130979841|NCT00643916|471552005|FG003|Overall Study|Protocol Violation|1|||
130979842|NCT00643916|471552006|FG004|Overall Study|Protocol Violation|0|||
130979843|NCT00643916|471552007|FG005|Overall Study|Protocol Violation|0|||
130979844|NCT00643916|471552002|FG000|Overall Study|Lost to Follow-up|0|||
130979845|NCT00643916|471552003|FG001|Overall Study|Lost to Follow-up|1|||
130979846|NCT00643916|471552004|FG002|Overall Study|Lost to Follow-up|0|||
130979847|NCT00643916|471552005|FG003|Overall Study|Lost to Follow-up|0|||
130979848|NCT00643916|471552006|FG004|Overall Study|Lost to Follow-up|0|||
130979849|NCT00643916|471552007|FG005|Overall Study|Lost to Follow-up|0|||
130979850|NCT00643916|471552002|FG000|Overall Study|Withdrawal by Subject|2|||
130979851|NCT00643916|471552003|FG001|Overall Study|Withdrawal by Subject|2|||
130979852|NCT00643916|471552004|FG002|Overall Study|Withdrawal by Subject|2|||
130979853|NCT00643916|471552005|FG003|Overall Study|Withdrawal by Subject|1|||
130979854|NCT00643916|471552006|FG004|Overall Study|Withdrawal by Subject|0|||
130979855|NCT00643916|471552007|FG005|Overall Study|Withdrawal by Subject|1|||
130979856|NCT00643916|471552002|FG000|Overall Study|Not Vaccinated|2|||
130979857|NCT00643916|471552003|FG001|Overall Study|Not Vaccinated|2|||
131043920|NCT02998528|471794760|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
131043921|NCT02998528|471794758|FG000|Neoadjuvant Treatment Period|Death|1|||
131043922|NCT02998528|471794759|FG001|Neoadjuvant Treatment Period|Death|0|||
131043923|NCT02998528|471794760|FG002|Neoadjuvant Treatment Period|Death|0|||
131043924|NCT02998528|471794758|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
131043925|NCT02998528|471794759|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
131043926|NCT02998528|471794760|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
131043927|NCT02998528|471794758|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
131043928|NCT02998528|471794759|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
131043929|NCT02998528|471794760|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
131043930|NCT02998528|471794758|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
131043931|NCT02998528|471794759|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
131043932|NCT02998528|471794760|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
131043933|NCT02998528|471794758|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
131043934|NCT02998528|471794759|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
131043935|NCT02998528|471794760|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
131043936|NCT02998528|471794758|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
131043937|NCT02998528|471794759|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
131043938|NCT02998528|471794760|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
130718682|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130979858|NCT00643916|471552004|FG002|Overall Study|Not Vaccinated|3|||
131227821|NCT00738920|472459821|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
131227822|NCT00738920|472459822|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
131227823|NCT00738920|472459820|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
131227824|NCT00738920|472459821|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
131227825|NCT00738920|472459822|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
131227826|NCT00738920|472459820|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
131227827|NCT00738920|472459821|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
131227828|NCT00738920|472459822|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
131227829|NCT00720798|472461501|FG000|Overall Study|Adverse Event|304|||
131227830|NCT00720798|472461501|FG000|Overall Study|Death|39|||
131227831|NCT00720798|472461501|FG000|Overall Study|Insufficient Therapeutic Response|129|||
131227832|NCT00720798|472461501|FG000|Overall Study|Protocol Violation|4|||
131227833|NCT00720798|472461501|FG000|Overall Study|Refused Treatment|151|||
131227834|NCT00720798|472461501|FG000|Overall Study|Failure to Return|46|||
131227835|NCT00720798|472461501|FG000|Overall Study|Reason not Specified|83|||
131227836|NCT00433381|472461502|FG000|Overall Study|Ineligible / no protocol treatment|3|||
131227837|NCT00433381|472461503|FG001|Overall Study|Ineligible / no protocol treatment|3|||
131227838|NCT00598559|472461505|FG000|Overall Study|Adverse Event|11|||
131227839|NCT00598559|472461506|FG001|Overall Study|Adverse Event|7|||
131227840|NCT00598559|472461507|FG002|Overall Study|Adverse Event|0|||
131227841|NCT00598559|472461505|FG000|Overall Study|Withdrawal by Subject|2|||
131227842|NCT00598559|472461506|FG001|Overall Study|Withdrawal by Subject|2|||
131227843|NCT00598559|472461507|FG002|Overall Study|Withdrawal by Subject|0|||
131227844|NCT00598559|472461505|FG000|Overall Study|Protocol Non-compliance|1|||
131227845|NCT00598559|472461506|FG001|Overall Study|Protocol Non-compliance|0|||
131227846|NCT00598559|472461507|FG002|Overall Study|Protocol Non-compliance|0|||
131227847|NCT00598559|472461505|FG000|Overall Study|Early discharge from hospital|9|||
131227848|NCT00598559|472461506|FG001|Overall Study|Early discharge from hospital|12|||
131227849|NCT00598559|472461507|FG002|Overall Study|Early discharge from hospital|3|||
131227850|NCT00598559|472461505|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
131227851|NCT00598559|472461506|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
131227852|NCT00598559|472461507|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
131227853|NCT01059071|472461508|FG000|Overall Study|Lack of Efficacy|1|||
131227854|NCT01059071|472461509|FG001|Overall Study|Lack of Efficacy|4|||
131227855|NCT01059071|472461510|FG002|Overall Study|Lack of Efficacy|2|||
131227856|NCT01059071|472461511|FG003|Overall Study|Lack of Efficacy|3|||
131227857|NCT01059071|472461508|FG000|Overall Study|Withdrawal by Subject|1|||
131227858|NCT01059071|472461509|FG001|Overall Study|Withdrawal by Subject|0|||
131227859|NCT01059071|472461510|FG002|Overall Study|Withdrawal by Subject|0|||
131227860|NCT01059071|472461511|FG003|Overall Study|Withdrawal by Subject|2|||
131227861|NCT01059071|472461508|FG000|Overall Study|Physician Decision|0|||
131227862|NCT01059071|472461509|FG001|Overall Study|Physician Decision|0|||
131227863|NCT01059071|472461510|FG002|Overall Study|Physician Decision|0|||
131227864|NCT01059071|472461511|FG003|Overall Study|Physician Decision|1|||
131227865|NCT00936884|472461516|FG000|Double-blind|Withdrawal by Subject|6|||
131227866|NCT00936884|472461517|FG001|Double-blind|Withdrawal by Subject|4|||
131227867|NCT00936884|472461518|FG002|Double-blind|Withdrawal by Subject|0|||
131227868|NCT00936884|472461516|FG000|Double-blind|Death|2|||
131227869|NCT00936884|472461517|FG001|Double-blind|Death|1|||
131227870|NCT00936884|472461518|FG002|Double-blind|Death|0|||
131227871|NCT00936884|472461516|FG000|Double-blind|Lack of Efficacy|1|||
131227872|NCT00936884|472461517|FG001|Double-blind|Lack of Efficacy|1|||
131227873|NCT00936884|472461518|FG002|Double-blind|Lack of Efficacy|0|||
131227874|NCT00936884|472461516|FG000|Double-blind|Adverse Event|1|||
131227875|NCT00936884|472461517|FG001|Double-blind|Adverse Event|0|||
131227876|NCT00936884|472461518|FG002|Double-blind|Adverse Event|0|||
131227877|NCT00936884|472461516|FG000|Double-blind|Physician Decision|1|||
131227878|NCT00936884|472461517|FG001|Double-blind|Physician Decision|0|||
131132272|NCT03311711|472111769|FG000|Overall Study|Withdrawal by Subject|1|||
131132273|NCT03311711|472111770|FG001|Overall Study|Withdrawal by Subject|1|||
131132274|NCT03311711|472111771|FG002|Overall Study|Withdrawal by Subject|0|||
131132275|NCT03311711|472111772|FG003|Overall Study|Withdrawal by Subject|0|||
131132276|NCT03311711|472111773|FG004|Overall Study|Withdrawal by Subject|0|||
131132277|NCT03311711|472111774|FG005|Overall Study|Withdrawal by Subject|0|||
131132278|NCT03311711|472111775|FG006|Overall Study|Withdrawal by Subject|3|||
131132279|NCT03311711|472111776|FG007|Overall Study|Withdrawal by Subject|3|||
131132280|NCT03311711|472111777|FG008|Overall Study|Withdrawal by Subject|0|||
131227879|NCT00936884|472461518|FG002|Double-blind|Physician Decision|0|||
131132281|NCT03311711|472111778|FG009|Overall Study|Withdrawal by Subject|0|||
131132282|NCT01623271|472111783|FG000|Overall Study|Withdrawal by Subject|2|||
131227880|NCT00936884|472461516|FG000|Double-blind|No post baseline diary entry|1|||
131227881|NCT00936884|472461517|FG001|Double-blind|No post baseline diary entry|0|||
131227882|NCT00936884|472461518|FG002|Double-blind|No post baseline diary entry|0|||
131227883|NCT00936884|472461516|FG000|Double-blind|Did not receive study drug|0|||
131227884|NCT00936884|472461517|FG001|Double-blind|Did not receive study drug|1|||
131227885|NCT00936884|472461518|FG002|Double-blind|Did not receive study drug|0|||
131227886|NCT01034137|472461523|FG000|Overall Study|Adverse Event|9|||
131227887|NCT01034137|472461524|FG001|Overall Study|Adverse Event|10|||
131227888|NCT01034137|472461525|FG002|Overall Study|Adverse Event|8|||
131227889|NCT01034137|472461523|FG000|Overall Study|Withdrawal by Subject|4|||
131227890|NCT01034137|472461524|FG001|Overall Study|Withdrawal by Subject|3|||
131227891|NCT01034137|472461525|FG002|Overall Study|Withdrawal by Subject|3|||
131227892|NCT01034137|472461523|FG000|Overall Study|Lack of Efficacy|9|||
131227893|NCT01034137|472461524|FG001|Overall Study|Lack of Efficacy|4|||
131227894|NCT01034137|472461525|FG002|Overall Study|Lack of Efficacy|13|||
131227895|NCT01034137|472461523|FG000|Overall Study|Protocol Violation|2|||
131227896|NCT01034137|472461524|FG001|Overall Study|Protocol Violation|2|||
131227897|NCT01034137|472461525|FG002|Overall Study|Protocol Violation|1|||
131227898|NCT01034137|472461523|FG000|Overall Study|Refused treatment or did not cooperate|2|||
131227899|NCT01034137|472461524|FG001|Overall Study|Refused treatment or did not cooperate|0|||
131227900|NCT01034137|472461525|FG002|Overall Study|Refused treatment or did not cooperate|1|||
131227901|NCT01034137|472461523|FG000|Overall Study|Administrative or other|2|||
131227902|NCT01034137|472461524|FG001|Overall Study|Administrative or other|3|||
131227903|NCT01034137|472461525|FG002|Overall Study|Administrative or other|4|||
131227904|NCT01764854|472461529|FG000|Overall Study|Adverse Event|0|||
131227905|NCT01764854|472461530|FG001|Overall Study|Adverse Event|0|||
131227906|NCT01764854|472461531|FG002|Overall Study|Adverse Event|2|||
131227907|NCT01764854|472461532|FG003|Overall Study|Adverse Event|0|||
131227908|NCT01764854|472461529|FG000|Overall Study|Withdrawal by Subject|0|||
131227909|NCT01764854|472461530|FG001|Overall Study|Withdrawal by Subject|0|||
131227910|NCT01764854|472461531|FG002|Overall Study|Withdrawal by Subject|1|||
131227911|NCT01764854|472461532|FG003|Overall Study|Withdrawal by Subject|0|||
131227912|NCT01764854|472461529|FG000|Overall Study|relocation|0|||
131227913|NCT01764854|472461530|FG001|Overall Study|relocation|0|||
131227914|NCT01764854|472461531|FG002|Overall Study|relocation|2|||
131227915|NCT01764854|472461532|FG003|Overall Study|relocation|0|||
131227916|NCT01764854|472461529|FG000|Overall Study|Protocol Violation|0|||
131227917|NCT01764854|472461530|FG001|Overall Study|Protocol Violation|0|||
131227918|NCT01764854|472461531|FG002|Overall Study|Protocol Violation|1|||
131227919|NCT01764854|472461532|FG003|Overall Study|Protocol Violation|2|||
131227920|NCT03377556|472461541|FG000|Overall Study|Adverse Event|5|||
131227921|NCT03377556|472461541|FG000|Overall Study|Refusal unrelated to adverse events|1|||
131227922|NCT03377556|472461541|FG000|Overall Study|Progression/relapse|38|||
131227923|NCT03377556|472461541|FG000|Overall Study|Death|3|||
131227924|NCT00472446|472461542|FG000|Overall Study|Protocol Violation|0|||
131227925|NCT00472446|472461543|FG001|Overall Study|Protocol Violation|0|||
131227926|NCT00472446|472461544|FG002|Overall Study|Protocol Violation|0|||
131227927|NCT00472446|472461545|FG003|Overall Study|Protocol Violation|1|||
131227928|NCT00472446|472461542|FG000|Overall Study|Reintervention|0|||
131227929|NCT00472446|472461543|FG001|Overall Study|Reintervention|0|||
131227930|NCT00472446|472461544|FG002|Overall Study|Reintervention|1|||
131227931|NCT00472446|472461545|FG003|Overall Study|Reintervention|1|||
131227932|NCT00472446|472461542|FG000|Overall Study|Questionnaires not returned|5|||
131227933|NCT00472446|472461543|FG001|Overall Study|Questionnaires not returned|6|||
131227934|NCT00472446|472461544|FG002|Overall Study|Questionnaires not returned|6|||
131227935|NCT00472446|472461545|FG003|Overall Study|Questionnaires not returned|4|||
131227936|NCT00827827|472461546|FG000|Overall Study|Lost to Follow-up|3|||
130718683|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
131043939|NCT02998528|471794758|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
131043940|NCT02998528|471794759|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
131043941|NCT02998528|471794760|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
131043942|NCT03213678|471794763|FG000|Overall Study|Death|1|||
131043943|NCT03213678|471794763|FG000|Overall Study|Physician Decision|1|||
131043944|NCT03213678|471794763|FG000|Overall Study|Progressive disease|16|||
131043945|NCT03174275|471794764|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
131043946|NCT03174275|471794764|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
131043947|NCT03174275|471794764|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
131043948|NCT03174275|471794764|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
131043949|NCT03174275|471794764|FG000|Adjuvant Chemotherapy|Progression|1|||
131043950|NCT03174275|471794764|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
131043951|NCT03174275|471794764|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
131043952|NCT03174275|471794764|FG000|Adjuvant Durvalumab|Progression|1|||
131043953|NCT03174275|471794764|FG000|Adjuvant Durvalumab|Adverse Event|3|||
131043954|NCT03174275|471794764|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
131043955|NCT03174275|471794764|FG000|Adjuvant Radiotherapy|Progression|1|||
131043956|NCT03174275|471794764|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
131043957|NCT01820611|471794765|FG000|Overall Study|Death|8|||
131043958|NCT01820611|471794765|FG000|Overall Study|Adverse Event|1|||
131043959|NCT01820611|471794765|FG000|Overall Study|Withdrawal by Subject|9|||
131043960|NCT04456296|471794766|FG000|Overall Study|Withdrawal by Subject|14|||
131043961|NCT04456296|471794767|FG001|Overall Study|Withdrawal by Subject|21|||
131227937|NCT00827827|472461547|FG001|Overall Study|Lost to Follow-up|0|||
130979859|NCT00643916|471552005|FG003|Overall Study|Not Vaccinated|0|||
130979860|NCT00643916|471552006|FG004|Overall Study|Not Vaccinated|2|||
130979861|NCT00643916|471552007|FG005|Overall Study|Not Vaccinated|0|||
130979862|NCT00499031|471552008|FG000|Overall Study|Improper pre-protocol treatment|1|||
130979863|NCT00499031|471552008|FG000|Overall Study|Required test not done|1|||
130979864|NCT00499031|471552008|FG000|Overall Study|Never treated|1|||
130979865|NCT02606279|471552010|FG000|Overall Study|Lost to Follow-up|0|||
130979866|NCT02606279|471552011|FG001|Overall Study|Lost to Follow-up|1|||
130979867|NCT02184611|471552012|FG000|Overall Study|Lack of Efficacy|11|||
130979868|NCT02184611|471552013|FG001|Overall Study|Lack of Efficacy|15|||
130979869|NCT02184611|471552012|FG000|Overall Study|Withdrawal by Subject|5|||
130979870|NCT02184611|471552013|FG001|Overall Study|Withdrawal by Subject|6|||
130979871|NCT02184611|471552012|FG000|Overall Study|Adverse Event|4|||
130979872|NCT02184611|471552013|FG001|Overall Study|Adverse Event|5|||
130979873|NCT02184611|471552012|FG000|Overall Study|Protocol Violation|1|||
130979874|NCT02184611|471552013|FG001|Overall Study|Protocol Violation|1|||
130979875|NCT02184611|471552012|FG000|Overall Study|Protocol defined stopping criteria|0|||
130979876|NCT02184611|471552013|FG001|Overall Study|Protocol defined stopping criteria|1|||
130979877|NCT00985725|471552019|FG000|Overall Study|Adverse Event|4|||
130979878|NCT00985725|471552020|FG001|Overall Study|Adverse Event|1|||
130979879|NCT00985725|471552019|FG000|Overall Study|Protocol Violation|1|||
130979880|NCT00985725|471552020|FG001|Overall Study|Protocol Violation|3|||
130979881|NCT00985725|471552019|FG000|Overall Study|Withdrawal by Subject|4|||
130979882|NCT00985725|471552020|FG001|Overall Study|Withdrawal by Subject|4|||
130979883|NCT00985725|471552019|FG000|Overall Study|Lost to Follow-up|1|||
130979884|NCT00985725|471552020|FG001|Overall Study|Lost to Follow-up|1|||
130979885|NCT00985725|471552019|FG000|Overall Study|Lack of Efficacy|0|||
130979886|NCT00985725|471552020|FG001|Overall Study|Lack of Efficacy|1|||
130979887|NCT00985725|471552019|FG000|Overall Study|Non-compliance|1|||
130979888|NCT00985725|471552020|FG001|Overall Study|Non-compliance|2|||
130979889|NCT00985725|471552019|FG000|Overall Study|Out-of-window visits|0|||
130979890|NCT00985725|471552020|FG001|Overall Study|Out-of-window visits|1|||
130979891|NCT03563716|471552021|FG000|Overall Study|Death|20|||
130979892|NCT03563716|471552022|FG001|Overall Study|Death|14|||
130979893|NCT03563716|471552021|FG000|Overall Study|Withdrawal by Subject|3|||
130979894|NCT03563716|471552022|FG001|Overall Study|Withdrawal by Subject|3|||
130979895|NCT03563716|471552021|FG000|Overall Study|Still on Study|45|||
130979896|NCT03563716|471552022|FG001|Overall Study|Still on Study|50|||
130979897|NCT02080871|471552025|FG000|Overall Study|Death|1|||
130979898|NCT02080871|471552025|FG000|Overall Study|Lost to Follow-up|1|||
130979899|NCT00234052|471552026|FG000|Treatment|Withdrawal by Subject|3|||
130979900|NCT00234052|471552026|FG000|Treatment|Adverse Event|5|||
130979901|NCT00234052|471552026|FG000|Treatment|Death|2|||
130979902|NCT00234052|471552026|FG000|Treatment|Progressive Disease|11|||
130979903|NCT00234052|471552026|FG000|Follow-up for 5 Years|Death|41|||
130979904|NCT00234052|471552026|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
130979905|NCT00234052|471552026|FG000|Follow-up for 5 Years|Other|7|||
130979906|NCT02428296|471552027|FG000|Overall Study|Adverse Event|7|||
130979907|NCT02428296|471552027|FG000|Overall Study|Withdrawal by Subject|2|||
130979908|NCT01615328|471552028|FG000|Overall Study|Lost to Follow-up|3|||
130979909|NCT01615328|471552029|FG001|Overall Study|Lost to Follow-up|5|||
130979910|NCT02548455|471552032|FG000|Overall Study|Withdrawal by Subject|27|||
130979911|NCT02548455|471552032|FG000|Overall Study|Death|26|||
130979912|NCT02548455|471552032|FG000|Overall Study|Lost to Follow-up|14|||
130979913|NCT02548455|471552032|FG000|Overall Study|Visit not completed|173|||
130979914|NCT02261493|471552036|FG000|Overall Study|Noncompliance|0|||
130979915|NCT02261493|471552037|FG001|Overall Study|Noncompliance|0|||
130979916|NCT02261493|471552038|FG002|Overall Study|Noncompliance|2|||
130979917|NCT02261493|471552036|FG000|Overall Study|Physician Decision|0|||
130979918|NCT02261493|471552037|FG001|Overall Study|Physician Decision|1|||
130979919|NCT02261493|471552038|FG002|Overall Study|Physician Decision|0|||
130979920|NCT02261493|471552036|FG000|Overall Study|Undisclosed alcohol abuse|0|||
130979921|NCT02261493|471552037|FG001|Overall Study|Undisclosed alcohol abuse|1|||
131227938|NCT00827827|472461546|FG000|Overall Study|Fall at home- hospitalization|1|||
131227939|NCT00827827|472461547|FG001|Overall Study|Fall at home- hospitalization|0|||
131227940|NCT00827827|472461546|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
130979922|NCT02261493|471552038|FG002|Overall Study|Undisclosed alcohol abuse|0|||
130979923|NCT02261493|471552036|FG000|Overall Study|Protocol Violation|1|||
130979924|NCT02261493|471552037|FG001|Overall Study|Protocol Violation|0|||
130979925|NCT02261493|471552038|FG002|Overall Study|Protocol Violation|0|||
130979926|NCT02261493|471552036|FG000|Overall Study|Personal Reasons|14|||
130979927|NCT02261493|471552037|FG001|Overall Study|Personal Reasons|14|||
130979928|NCT02261493|471552038|FG002|Overall Study|Personal Reasons|16|||
130979929|NCT02261493|471552036|FG000|Overall Study|Lost to Follow-up|14|||
130979930|NCT02261493|471552037|FG001|Overall Study|Lost to Follow-up|27|||
130979931|NCT02261493|471552038|FG002|Overall Study|Lost to Follow-up|8|||
130979932|NCT02261493|471552036|FG000|Overall Study|Pregnancy|1|||
130979933|NCT02261493|471552037|FG001|Overall Study|Pregnancy|2|||
130979934|NCT02261493|471552038|FG002|Overall Study|Pregnancy|0|||
130979935|NCT02261493|471552036|FG000|Overall Study|Lack of Efficacy|0|||
130979936|NCT02261493|471552037|FG001|Overall Study|Lack of Efficacy|1|||
130979937|NCT02261493|471552038|FG002|Overall Study|Lack of Efficacy|0|||
130979938|NCT02261493|471552036|FG000|Overall Study|Adverse Event|0|||
130979939|NCT02261493|471552037|FG001|Overall Study|Adverse Event|1|||
130979940|NCT02261493|471552038|FG002|Overall Study|Adverse Event|0|||
130979941|NCT02230956|471552039|FG000|Overall Study|Adverse Event|1|||
130979942|NCT02230956|471552040|FG001|Overall Study|Adverse Event|1|||
130979943|NCT02230956|471552041|FG002|Overall Study|Adverse Event|0|||
130979944|NCT02230956|471552039|FG000|Overall Study|Lack of Efficacy|1|||
130979945|NCT02230956|471552040|FG001|Overall Study|Lack of Efficacy|1|||
130979946|NCT02230956|471552041|FG002|Overall Study|Lack of Efficacy|1|||
130979947|NCT02230956|471552039|FG000|Overall Study|Lost to Follow-up|1|||
130979948|NCT02230956|471552040|FG001|Overall Study|Lost to Follow-up|1|||
130979949|NCT02230956|471552041|FG002|Overall Study|Lost to Follow-up|2|||
130979950|NCT02230956|471552039|FG000|Overall Study|Personal Reasons|2|||
130979951|NCT02230956|471552040|FG001|Overall Study|Personal Reasons|1|||
130979952|NCT02230956|471552041|FG002|Overall Study|Personal Reasons|1|||
130979953|NCT02230956|471552039|FG000|Overall Study|Protocol Violation|0|||
130979954|NCT02230956|471552040|FG001|Overall Study|Protocol Violation|1|||
130979955|NCT02230956|471552041|FG002|Overall Study|Protocol Violation|1|||
130979956|NCT02230956|471552039|FG000|Overall Study|Other Miscellaneous Reason|0|||
130979957|NCT02230956|471552040|FG001|Overall Study|Other Miscellaneous Reason|1|||
130979958|NCT02230956|471552041|FG002|Overall Study|Other Miscellaneous Reason|2|||
130979959|NCT00338884|471552042|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
130979960|NCT00338884|471552042|FG000|Overall Study|Adverse Event|14|||
130979961|NCT00338884|471552042|FG000|Overall Study|Death|8|||
130979962|NCT00338884|471552042|FG000|Overall Study|Other|4|||
130979963|NCT00338884|471552042|FG000|Overall Study|Global Deterioration of Health Status|3|||
130979964|NCT00338884|471552042|FG000|Overall Study|Withdrawal by Subject|3|||
130979965|NCT00338884|471552042|FG000|Overall Study|Lost to Follow-up|1|||
130979966|NCT00338884|471552042|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
130979967|NCT01970982|471552044|FG000|Overall Study|Withdrawal by Subject|0|||
130979968|NCT01970982|471552045|FG001|Overall Study|Withdrawal by Subject|0|||
130979969|NCT01970982|471552046|FG002|Overall Study|Withdrawal by Subject|2|||
130979970|NCT01984684|471552051|FG000|Overall Study|Lost to Follow-up|25|||
130979971|NCT01984684|471552052|FG001|Overall Study|Lost to Follow-up|24|||
130979972|NCT01984684|471552051|FG000|Overall Study|Adverse Event|8|||
130979973|NCT01984684|471552052|FG001|Overall Study|Adverse Event|12|||
130979974|NCT01984684|471552051|FG000|Overall Study|Withdrawal by Subject|9|||
130979975|NCT01984684|471552052|FG001|Overall Study|Withdrawal by Subject|9|||
130979976|NCT01984684|471552051|FG000|Overall Study|Lack of Efficacy|3|||
130979977|NCT01984684|471552052|FG001|Overall Study|Lack of Efficacy|6|||
130979978|NCT01984684|471552051|FG000|Overall Study|Physician Decision|4|||
130979979|NCT01984684|471552052|FG001|Overall Study|Physician Decision|2|||
130979980|NCT01984684|471552051|FG000|Overall Study|Protocol Violation|4|||
130979981|NCT01984684|471552052|FG001|Overall Study|Protocol Violation|2|||
130979982|NCT01984684|471552051|FG000|Overall Study|Death|0|||
130979983|NCT01984684|471552052|FG001|Overall Study|Death|1|||
130979984|NCT01984684|471552051|FG000|Overall Study|Noncompliance with study drug|2|||
130979985|NCT01984684|471552052|FG001|Overall Study|Noncompliance with study drug|1|||
130979986|NCT01984684|471552051|FG000|Overall Study|Subject incarcerated|1|||
130979987|NCT01984684|471552052|FG001|Overall Study|Subject incarcerated|0|||
130979988|NCT01984684|471552051|FG000|Overall Study|Study drug not available at site|1|||
130979989|NCT01984684|471552052|FG001|Overall Study|Study drug not available at site|1|||
130979990|NCT01984684|471552051|FG000|Overall Study|Subject had inadequate IV access|0|||
130979991|NCT01984684|471552052|FG001|Overall Study|Subject had inadequate IV access|1|||
130979992|NCT05711641|471552057|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
131227941|NCT00827827|472461547|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
131227942|NCT00827827|472461546|FG000|Overall Study|Gout|1|||
131227943|NCT00827827|472461547|FG001|Overall Study|Gout|0|||
131227944|NCT00827827|472461546|FG000|Overall Study|Transportation issues|1|||
131227945|NCT00827827|472461547|FG001|Overall Study|Transportation issues|0|||
130979993|NCT05711641|471552058|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
130979994|NCT05711641|471552057|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
130979995|NCT05711641|471552058|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
130979996|NCT04575051|471552059|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
130979997|NCT04575051|471552060|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
130979998|NCT04575051|471552061|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
130979999|NCT04575051|471552062|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
130980000|NCT04575051|471552063|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
130980001|NCT04575051|471552059|FG000|Time Period 1|Missing follow up|1|||
130980002|NCT04575051|471552060|FG001|Time Period 1|Missing follow up|3|||
130980003|NCT04575051|471552061|FG002|Time Period 1|Missing follow up|1|||
130980004|NCT04575051|471552062|FG003|Time Period 1|Missing follow up|3|||
130980005|NCT04575051|471552063|FG004|Time Period 1|Missing follow up|2|||
131227946|NCT00827827|472461546|FG000|Overall Study|Burned with water at home|1|||
131227947|NCT00827827|472461547|FG001|Overall Study|Burned with water at home|0|||
131227948|NCT02063698|472461551|FG000|Overall Study|did not complete booklet for days 2-8|1|||
131227949|NCT02063698|472461552|FG001|Overall Study|did not complete booklet for days 2-8|2|||
131227950|NCT01953783|472461553|FG000|Overall Study|Progressive disease|2|||
131227951|NCT00686920|472461554|FG000|Overall Study|Death|45|||
131227952|NCT00686920|472461555|FG001|Overall Study|Death|14|||
131227953|NCT00686920|472461554|FG000|Overall Study|Liver Transplant|23|||
131227954|NCT00686920|472461555|FG001|Overall Study|Liver Transplant|8|||
131227955|NCT00686920|472461554|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
131227956|NCT00686920|472461555|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
131227957|NCT00686920|472461554|FG000|Overall Study|Withdrawal by Subject|23|||
131227958|NCT00686920|472461555|FG001|Overall Study|Withdrawal by Subject|5|||
130980006|NCT04575051|471552059|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
130980007|NCT04575051|471552060|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
130980008|NCT04575051|471552061|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
130980009|NCT04575051|471552062|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
130980010|NCT04575051|471552063|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
130980011|NCT04575051|471552059|FG000|Time Period 2|Missing follow up|1|||
130980012|NCT04575051|471552060|FG001|Time Period 2|Missing follow up|8|||
130980013|NCT04575051|471552061|FG002|Time Period 2|Missing follow up|7|||
130980014|NCT04575051|471552062|FG003|Time Period 2|Missing follow up|0|||
130980015|NCT04575051|471552063|FG004|Time Period 2|Missing follow up|1|||
130980016|NCT04575051|471552059|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
130980017|NCT04575051|471552060|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
130980018|NCT04575051|471552061|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
130980019|NCT04575051|471552062|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
130980020|NCT04575051|471552063|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
130980021|NCT04575051|471552059|FG000|Time Period 3|Missing follow up|8|||
130980022|NCT04575051|471552060|FG001|Time Period 3|Missing follow up|6|||
130980023|NCT04575051|471552061|FG002|Time Period 3|Missing follow up|4|||
130980024|NCT04575051|471552062|FG003|Time Period 3|Missing follow up|3|||
130980025|NCT04575051|471552063|FG004|Time Period 3|Missing follow up|0|||
130980026|NCT04575051|471552059|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
130980027|NCT04575051|471552060|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
130980028|NCT04575051|471552061|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
130980029|NCT04575051|471552062|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
130980030|NCT04575051|471552063|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
130980031|NCT04575051|471552059|FG000|Time Period 4|Missing follow up|17|||
130980032|NCT04575051|471552060|FG001|Time Period 4|Missing follow up|3|||
130980033|NCT04575051|471552061|FG002|Time Period 4|Missing follow up|4|||
130980034|NCT04575051|471552062|FG003|Time Period 4|Missing follow up|2|||
130980035|NCT04575051|471552063|FG004|Time Period 4|Missing follow up|1|||
130980036|NCT04575051|471552059|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
130980037|NCT04575051|471552060|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
130980038|NCT04575051|471552061|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
130980039|NCT04575051|471552062|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
130980040|NCT04575051|471552063|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
130980041|NCT04575051|471552059|FG000|Time Period 5|Missing follow up|11|||
130980042|NCT04575051|471552060|FG001|Time Period 5|Missing follow up|8|||
130980043|NCT04575051|471552061|FG002|Time Period 5|Missing follow up|12|||
130980044|NCT04575051|471552062|FG003|Time Period 5|Missing follow up|3|||
130980045|NCT04575051|471552063|FG004|Time Period 5|Missing follow up|11|||
130980046|NCT03624504|471552064|FG000|Overall Study|Unsuccessful Implant|1|||
130980047|NCT02862457|471552065|FG000|Overall Study|Death|1|||
130980048|NCT02862457|471552066|FG001|Overall Study|Death|3|||
130980049|NCT02862457|471552067|FG002|Overall Study|Death|2|||
130980050|NCT02862457|471552068|FG003|Overall Study|Death|3|||
130980051|NCT02862457|471552069|FG004|Overall Study|Death|0|||
130980052|NCT02862457|471552070|FG005|Overall Study|Death|2|||
130980053|NCT02862457|471552071|FG006|Overall Study|Death|1|||
131227959|NCT00686920|472461554|FG000|Overall Study|Protocol Violation|2|||
131227960|NCT00686920|472461555|FG001|Overall Study|Protocol Violation|1|||
131227961|NCT00686920|472461554|FG000|Overall Study|Adverse Event|10|||
130980054|NCT02862457|471552065|FG000|Overall Study|Lost to Follow-up|1|||
130980055|NCT02862457|471552066|FG001|Overall Study|Lost to Follow-up|0|||
131227962|NCT00686920|472461555|FG001|Overall Study|Adverse Event|2|||
130980056|NCT02862457|471552067|FG002|Overall Study|Lost to Follow-up|0|||
130980057|NCT02862457|471552068|FG003|Overall Study|Lost to Follow-up|1|||
130980058|NCT02862457|471552069|FG004|Overall Study|Lost to Follow-up|0|||
130980059|NCT02862457|471552070|FG005|Overall Study|Lost to Follow-up|0|||
130980060|NCT02862457|471552071|FG006|Overall Study|Lost to Follow-up|0|||
130980061|NCT02862457|471552065|FG000|Overall Study|Withdrawal by Subject|0|||
130980062|NCT02862457|471552066|FG001|Overall Study|Withdrawal by Subject|0|||
130980063|NCT02862457|471552067|FG002|Overall Study|Withdrawal by Subject|1|||
130980064|NCT02862457|471552068|FG003|Overall Study|Withdrawal by Subject|0|||
130980065|NCT02862457|471552069|FG004|Overall Study|Withdrawal by Subject|0|||
130980066|NCT02862457|471552070|FG005|Overall Study|Withdrawal by Subject|1|||
130980067|NCT02862457|471552071|FG006|Overall Study|Withdrawal by Subject|0|||
130980068|NCT00951483|471552074|FG000|Overall Study|Physician Decision|4|||
130980069|NCT00951483|471552075|FG001|Overall Study|Physician Decision|0|||
130980070|NCT00951483|471552074|FG000|Overall Study|Withdrawal by Subject|15|||
130980071|NCT00951483|471552075|FG001|Overall Study|Withdrawal by Subject|0|||
130980072|NCT00335322|471552076|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
130980073|NCT00335322|471552077|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
130980074|NCT00335322|471552078|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
130980075|NCT03364751|471552081|FG000|Overall Study|Withdrawal by Subject|1|||
130980076|NCT03364751|471552082|FG001|Overall Study|Withdrawal by Subject|0|||
130980077|NCT03364751|471552083|FG002|Overall Study|Withdrawal by Subject|0|||
130980078|NCT03364751|471552084|FG003|Overall Study|Withdrawal by Subject|0|||
130980079|NCT03364751|471552081|FG000|Overall Study|Lost to Follow-up|0|||
130980080|NCT03364751|471552082|FG001|Overall Study|Lost to Follow-up|1|||
130980081|NCT03364751|471552083|FG002|Overall Study|Lost to Follow-up|0|||
130980082|NCT03364751|471552084|FG003|Overall Study|Lost to Follow-up|0|||
130980083|NCT03583554|471552085|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
130980084|NCT03583554|471552086|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
130980085|NCT03583554|471552087|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
130980086|NCT03178266|471552088|FG000|Overall Study|Death|0|||
130980087|NCT03178266|471552089|FG001|Overall Study|Death|1|||
130980088|NCT03178266|471552088|FG000|Overall Study|Disont. Early|0|||
130980089|NCT03178266|471552089|FG001|Overall Study|Disont. Early|1|||
130980090|NCT03178266|471552088|FG000|Overall Study|Withdrawal by Subject|0|||
130980091|NCT03178266|471552089|FG001|Overall Study|Withdrawal by Subject|2|||
130980092|NCT02342886|471552090|FG000|Overall Study|Treatment non-compliance|1|||
130980093|NCT02342886|471552091|FG001|Overall Study|Treatment non-compliance|0|||
130980094|NCT02342886|471552092|FG002|Overall Study|Treatment non-compliance|0|||
130980095|NCT02342886|471552093|FG003|Overall Study|Treatment non-compliance|1|||
130980096|NCT02342886|471552094|FG004|Overall Study|Treatment non-compliance|0|||
130980097|NCT02342886|471552090|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
130980098|NCT02342886|471552091|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
130980099|NCT02342886|471552092|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
130980100|NCT02342886|471552093|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
130980101|NCT02342886|471552094|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
130980102|NCT02342886|471552090|FG000|Overall Study|Adverse event/specific toxicity|4|||
130980103|NCT02342886|471552091|FG001|Overall Study|Adverse event/specific toxicity|3|||
130980104|NCT02342886|471552092|FG002|Overall Study|Adverse event/specific toxicity|11|||
130980105|NCT02342886|471552093|FG003|Overall Study|Adverse event/specific toxicity|2|||
130980106|NCT02342886|471552094|FG004|Overall Study|Adverse event/specific toxicity|1|||
130980107|NCT02342886|471552090|FG000|Overall Study|Lost to Follow-up|1|||
130980108|NCT02342886|471552091|FG001|Overall Study|Lost to Follow-up|0|||
130980109|NCT02342886|471552092|FG002|Overall Study|Lost to Follow-up|0|||
130980110|NCT02342886|471552093|FG003|Overall Study|Lost to Follow-up|0|||
130980111|NCT02342886|471552094|FG004|Overall Study|Lost to Follow-up|0|||
130980112|NCT02342886|471552090|FG000|Overall Study|Death|1|||
130980113|NCT02342886|471552091|FG001|Overall Study|Death|2|||
130980114|NCT02342886|471552092|FG002|Overall Study|Death|1|||
130980115|NCT02342886|471552093|FG003|Overall Study|Death|0|||
130980116|NCT02342886|471552094|FG004|Overall Study|Death|1|||
130980117|NCT02342886|471552090|FG000|Overall Study|Withdrawal by Subject|0|||
130980118|NCT02342886|471552091|FG001|Overall Study|Withdrawal by Subject|1|||
130980119|NCT02342886|471552092|FG002|Overall Study|Withdrawal by Subject|0|||
130980120|NCT02342886|471552093|FG003|Overall Study|Withdrawal by Subject|1|||
130980121|NCT02342886|471552094|FG004|Overall Study|Withdrawal by Subject|0|||
130980122|NCT02342886|471552090|FG000|Overall Study|Investigator/sponsor decision|0|||
130980123|NCT02342886|471552091|FG001|Overall Study|Investigator/sponsor decision|2|||
130980124|NCT02342886|471552092|FG002|Overall Study|Investigator/sponsor decision|0|||
130980125|NCT02342886|471552093|FG003|Overall Study|Investigator/sponsor decision|3|||
131227963|NCT00686920|472461554|FG000|Overall Study|Personal Reason|0|||
131227964|NCT00686920|472461555|FG001|Overall Study|Personal Reason|1|||
130980126|NCT02342886|471552094|FG004|Overall Study|Investigator/sponsor decision|1|||
130980127|NCT02342886|471552090|FG000|Overall Study|Pregnancy|0|||
130980128|NCT02342886|471552091|FG001|Overall Study|Pregnancy|0|||
130980129|NCT02342886|471552092|FG002|Overall Study|Pregnancy|2|||
130980130|NCT02342886|471552093|FG003|Overall Study|Pregnancy|0|||
130980131|NCT02342886|471552094|FG004|Overall Study|Pregnancy|0|||
130980132|NCT02342886|471552090|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
130980133|NCT02342886|471552091|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
130980134|NCT02342886|471552092|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
130980135|NCT02342886|471552093|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
130980136|NCT02342886|471552094|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
130980137|NCT02342886|471552090|FG000|Overall Study|Protocol Violation|0|||
130980138|NCT02342886|471552091|FG001|Overall Study|Protocol Violation|0|||
130980139|NCT02342886|471552092|FG002|Overall Study|Protocol Violation|0|||
130980140|NCT02342886|471552093|FG003|Overall Study|Protocol Violation|2|||
130980141|NCT02342886|471552094|FG004|Overall Study|Protocol Violation|0|||
130980142|NCT02275065|471552095|FG000|Overall Study|Randomized but not treated|1|||
130980143|NCT02275065|471552096|FG001|Overall Study|Randomized but not treated|0|||
130980144|NCT02275065|471552097|FG002|Overall Study|Randomized but not treated|1|||
130980145|NCT02275065|471552098|FG003|Overall Study|Randomized but not treated|1|||
131132283|NCT01745146|472111787|FG000|Overall Study|Withdrawal by Subject|1|||
131132284|NCT01745146|472111788|FG001|Overall Study|Withdrawal by Subject|3|||
131132285|NCT01745146|472111787|FG000|Overall Study|Lost to Follow-up|2|||
131132286|NCT01745146|472111788|FG001|Overall Study|Lost to Follow-up|0|||
131132287|NCT00488982|472111789|FG000|Course 1|Physician Decision|0|||
131132288|NCT00488982|472111790|FG001|Course 1|Physician Decision|2|||
131132289|NCT00488982|472111791|FG002|Course 1|Physician Decision|4|||
131132290|NCT00488982|472111789|FG000|Course 1|Withdrawal by Subject|0|||
131132291|NCT00488982|472111790|FG001|Course 1|Withdrawal by Subject|8|||
131132292|NCT00488982|472111791|FG002|Course 1|Withdrawal by Subject|2|||
131132293|NCT00488982|472111789|FG000|Course 1|nonprotocol therapy|0|||
131132294|NCT00488982|472111790|FG001|Course 1|nonprotocol therapy|2|||
131132295|NCT00488982|472111791|FG002|Course 1|nonprotocol therapy|2|||
131132296|NCT00488982|472111789|FG000|Course 1|Adverse Event|0|||
131132297|NCT00488982|472111790|FG001|Course 1|Adverse Event|0|||
131132298|NCT00488982|472111791|FG002|Course 1|Adverse Event|6|||
131132299|NCT03548558|472111792|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
131132300|NCT03548558|472111793|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
131132301|NCT03548558|472111794|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
131132302|NCT03548558|472111795|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
131132303|NCT03548558|472111796|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
131132304|NCT03548558|472111797|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
131132305|NCT03548558|472111798|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
131227965|NCT00686920|472461554|FG000|Overall Study|Lost to Follow-up|15|||
131227966|NCT00686920|472461555|FG001|Overall Study|Lost to Follow-up|3|||
130718684|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718685|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718686|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718687|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718688|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718689|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130718690|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
130718691|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
130980146|NCT02275065|471552099|FG004|Overall Study|Randomized but not treated|0|||
130980147|NCT01328080|471552100|FG000|Overall Study|Lost to Follow-up|5|||
130980148|NCT00862134|471552101|FG000|Overall Study|Death|1|||
131227967|NCT00686920|472461554|FG000|Overall Study|Moved to Another State|1|||
131227968|NCT00686920|472461555|FG001|Overall Study|Moved to Another State|0|||
131227969|NCT00686920|472461554|FG000|Overall Study|Transferred to Nursing Home|1|||
131227970|NCT00686920|472461555|FG001|Overall Study|Transferred to Nursing Home|0|||
131227971|NCT00686920|472461554|FG000|Overall Study|Noncompliance|9|||
131227972|NCT00686920|472461555|FG001|Overall Study|Noncompliance|0|||
131227973|NCT00686920|472461554|FG000|Overall Study|Principal Investigator Decision|2|||
131227974|NCT00686920|472461555|FG001|Overall Study|Principal Investigator Decision|0|||
131227975|NCT00591253|472461556|FG000|Overall Study|Adverse Event|3|||
131227976|NCT00591253|472461557|FG001|Overall Study|Adverse Event|3|||
130718692|NCT03982199|470593288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718693|NCT03982199|470593289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718694|NCT03982199|470593290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718695|NCT03982199|470593291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718696|NCT03982199|470593292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718697|NCT03982199|470593293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718698|NCT03982199|470593294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130778820|NCT03428100|470817455|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130980149|NCT00862134|471552102|FG001|Overall Study|Death|0|||
130980150|NCT00862134|471552101|FG000|Overall Study|Physician Decision|0|||
130980151|NCT00862134|471552102|FG001|Overall Study|Physician Decision|1|||
131132306|NCT03548558|472111792|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
131132307|NCT03548558|472111793|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
130980152|NCT00862134|471552101|FG000|Overall Study|Withdrawal by Subject|1|||
131132308|NCT03548558|472111794|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
131227977|NCT00591253|472461558|FG002|Overall Study|Adverse Event|1|||
130980153|NCT00862134|471552102|FG001|Overall Study|Withdrawal by Subject|2|||
130980154|NCT00862134|471552101|FG000|Overall Study|Sponsor terminated study|5|||
130980155|NCT00862134|471552102|FG001|Overall Study|Sponsor terminated study|7|||
130980156|NCT00862134|471552101|FG000|Overall Study|Adverse Event|2|||
130980157|NCT00862134|471552102|FG001|Overall Study|Adverse Event|2|||
130980158|NCT00862134|471552101|FG000|Overall Study|Withdrew prior to dosing|2|||
130980159|NCT00862134|471552102|FG001|Overall Study|Withdrew prior to dosing|0|||
130980160|NCT02191267|471552103|FG000|Overall Study|Withdrawal by Subject|1|||
130980161|NCT02191267|471552104|FG001|Overall Study|Withdrawal by Subject|0|||
130980162|NCT02191267|471552105|FG002|Overall Study|Withdrawal by Subject|0|||
130980163|NCT00765674|471552106|FG000|Overall Study|Adverse Event|7|||
130980164|NCT00765674|471552107|FG001|Overall Study|Adverse Event|2|||
130980165|NCT00765674|471552108|FG002|Overall Study|Adverse Event|8|||
130980166|NCT00765674|471552109|FG003|Overall Study|Adverse Event|11|||
130980167|NCT00765674|471552106|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
130980168|NCT00765674|471552107|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
130980169|NCT00765674|471552108|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
130980170|NCT00765674|471552109|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
130980171|NCT00765674|471552106|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130980172|NCT00765674|471552107|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
130980173|NCT00765674|471552108|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
130980174|NCT00765674|471552109|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
130980175|NCT00765674|471552106|FG000|Overall Study|Lack of Efficacy|2|||
130980176|NCT00765674|471552107|FG001|Overall Study|Lack of Efficacy|3|||
130980177|NCT00765674|471552108|FG002|Overall Study|Lack of Efficacy|1|||
130980178|NCT00765674|471552109|FG003|Overall Study|Lack of Efficacy|2|||
130980179|NCT00765674|471552106|FG000|Overall Study|Protocol Violation|2|||
130980180|NCT00765674|471552107|FG001|Overall Study|Protocol Violation|0|||
130980181|NCT00765674|471552108|FG002|Overall Study|Protocol Violation|1|||
130980182|NCT00765674|471552109|FG003|Overall Study|Protocol Violation|0|||
130980183|NCT00765674|471552106|FG000|Overall Study|Withdrawal by Subject|5|||
130980184|NCT00765674|471552107|FG001|Overall Study|Withdrawal by Subject|7|||
130980185|NCT00765674|471552108|FG002|Overall Study|Withdrawal by Subject|3|||
130980186|NCT00765674|471552109|FG003|Overall Study|Withdrawal by Subject|8|||
130980187|NCT00765674|471552106|FG000|Overall Study|Lost to Follow-up|4|||
130980188|NCT00765674|471552107|FG001|Overall Study|Lost to Follow-up|6|||
130980189|NCT00765674|471552108|FG002|Overall Study|Lost to Follow-up|2|||
130980190|NCT00765674|471552109|FG003|Overall Study|Lost to Follow-up|1|||
130980191|NCT00765674|471552106|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
130980192|NCT00765674|471552107|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
130980193|NCT00765674|471552108|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
130980194|NCT00765674|471552109|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
130980195|NCT01813474|471552110|FG000|Overall Study|Withdrawal by Subject|0|||
130980196|NCT01813474|471552111|FG001|Overall Study|Withdrawal by Subject|0|||
130980197|NCT01813474|471552112|FG002|Overall Study|Withdrawal by Subject|1|||
130980198|NCT01813474|471552110|FG000|Overall Study|Adverse Event|1|||
130980199|NCT01813474|471552111|FG001|Overall Study|Adverse Event|1|||
130980200|NCT01813474|471552112|FG002|Overall Study|Adverse Event|0|||
130980201|NCT01813474|471552110|FG000|Overall Study|Lack of Efficacy|2|||
130980202|NCT01813474|471552111|FG001|Overall Study|Lack of Efficacy|6|||
130980203|NCT01813474|471552112|FG002|Overall Study|Lack of Efficacy|9|||
130980204|NCT01813474|471552110|FG000|Overall Study|Death|0|||
131227978|NCT00591253|472461556|FG000|Overall Study|Protocol Violation|2|||
131227979|NCT00591253|472461557|FG001|Overall Study|Protocol Violation|2|||
131227980|NCT00591253|472461558|FG002|Overall Study|Protocol Violation|2|||
130980205|NCT01813474|471552111|FG001|Overall Study|Death|0|||
130980206|NCT01813474|471552112|FG002|Overall Study|Death|1|||
130980207|NCT00316082|471552113|FG000|Overall Study|Lack of Efficacy|2|||
130980208|NCT00316082|471552114|FG001|Overall Study|Lack of Efficacy|3|||
130980209|NCT00316082|471552115|FG002|Overall Study|Lack of Efficacy|3|||
130980210|NCT00316082|471552116|FG003|Overall Study|Lack of Efficacy|4|||
130980211|NCT00316082|471552117|FG004|Overall Study|Lack of Efficacy|6|||
130980212|NCT00316082|471552113|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
130980213|NCT00316082|471552114|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
131227981|NCT00591253|472461556|FG000|Overall Study|Lost to Follow-up|2|||
130980214|NCT00316082|471552115|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
130980215|NCT00316082|471552116|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
130980216|NCT00316082|471552117|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
130980217|NCT00316082|471552113|FG000|Overall Study|Lost to Follow-up|7|||
130980218|NCT00316082|471552114|FG001|Overall Study|Lost to Follow-up|6|||
130980219|NCT00316082|471552115|FG002|Overall Study|Lost to Follow-up|7|||
130980220|NCT00316082|471552116|FG003|Overall Study|Lost to Follow-up|8|||
130980221|NCT00316082|471552117|FG004|Overall Study|Lost to Follow-up|6|||
130980222|NCT00316082|471552113|FG000|Overall Study|Poor/noncompliance|6|||
130980223|NCT00316082|471552114|FG001|Overall Study|Poor/noncompliance|1|||
130980224|NCT00316082|471552115|FG002|Overall Study|Poor/noncompliance|4|||
130980225|NCT00316082|471552116|FG003|Overall Study|Poor/noncompliance|1|||
130980226|NCT00316082|471552117|FG004|Overall Study|Poor/noncompliance|4|||
130980227|NCT00316082|471552113|FG000|Overall Study|Adverse Event|4|||
130980228|NCT00316082|471552114|FG001|Overall Study|Adverse Event|2|||
130980229|NCT00316082|471552115|FG002|Overall Study|Adverse Event|5|||
130980230|NCT00316082|471552116|FG003|Overall Study|Adverse Event|1|||
130980231|NCT00316082|471552117|FG004|Overall Study|Adverse Event|3|||
130980232|NCT00316082|471552113|FG000|Overall Study|Subject no longer meets study criteria|3|||
130980233|NCT00316082|471552114|FG001|Overall Study|Subject no longer meets study criteria|1|||
130980234|NCT00316082|471552115|FG002|Overall Study|Subject no longer meets study criteria|2|||
130980235|NCT00316082|471552116|FG003|Overall Study|Subject no longer meets study criteria|2|||
130980236|NCT00316082|471552117|FG004|Overall Study|Subject no longer meets study criteria|1|||
131132309|NCT03548558|472111795|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
131132310|NCT03548558|472111796|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
131132311|NCT03548558|472111797|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
131132312|NCT03548558|472111798|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
131132313|NCT03548558|472111792|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
131132314|NCT03548558|472111793|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
131132315|NCT03548558|472111794|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
131132316|NCT03548558|472111795|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
131132317|NCT03548558|472111796|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
131132318|NCT03548558|472111797|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
131132319|NCT03548558|472111798|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
131132320|NCT03548558|472111792|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
131132321|NCT03548558|472111793|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
131132322|NCT03548558|472111794|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
131132323|NCT03548558|472111795|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
131132324|NCT03548558|472111796|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
131132325|NCT03548558|472111797|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
131132326|NCT03548558|472111798|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
131132327|NCT03548558|472111792|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
131132328|NCT03548558|472111793|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
131132329|NCT03548558|472111794|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
131132330|NCT03548558|472111795|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
131132331|NCT03548558|472111796|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
131132332|NCT03548558|472111797|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
131132333|NCT03548558|472111798|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
131132334|NCT03548558|472111792|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
131132335|NCT03548558|472111793|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
131132336|NCT03548558|472111794|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
131132337|NCT03548558|472111795|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
131132338|NCT03548558|472111796|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
131132339|NCT03548558|472111797|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
131132340|NCT03548558|472111798|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
131132341|NCT03273166|472111804|FG000|Overall Study|Withdrawn prior to Completion|31|||
131132342|NCT02669017|472111805|FG000|Overall Study|Death|1|||
131132343|NCT02669017|472111806|FG001|Overall Study|Death|2|||
131132344|NCT02669017|472111807|FG002|Overall Study|Death|2|||
131132345|NCT02669017|472111808|FG003|Overall Study|Death|3|||
131132346|NCT02669017|472111809|FG004|Overall Study|Death|8|||
131132347|NCT02669017|472111810|FG005|Overall Study|Death|18|||
131132348|NCT02669017|472111811|FG006|Overall Study|Death|10|||
131132349|NCT02669017|472111812|FG007|Overall Study|Death|47|||
131132350|NCT02669017|472111813|FG008|Overall Study|Death|20|||
131132351|NCT02669017|472111805|FG000|Overall Study|Withdrawal by Subject|0|||
131132352|NCT02669017|472111806|FG001|Overall Study|Withdrawal by Subject|0|||
131132353|NCT02669017|472111807|FG002|Overall Study|Withdrawal by Subject|0|||
131132354|NCT02669017|472111808|FG003|Overall Study|Withdrawal by Subject|1|||
131132355|NCT02669017|472111809|FG004|Overall Study|Withdrawal by Subject|2|||
131132356|NCT02669017|472111810|FG005|Overall Study|Withdrawal by Subject|0|||
131132357|NCT02669017|472111811|FG006|Overall Study|Withdrawal by Subject|0|||
131132358|NCT02669017|472111812|FG007|Overall Study|Withdrawal by Subject|2|||
131132359|NCT02669017|472111813|FG008|Overall Study|Withdrawal by Subject|2|||
131132360|NCT02669017|472111805|FG000|Overall Study|Lost to Follow-up|0|||
131132361|NCT02669017|472111806|FG001|Overall Study|Lost to Follow-up|0|||
131132362|NCT02669017|472111807|FG002|Overall Study|Lost to Follow-up|0|||
130980237|NCT00316082|471552113|FG000|Overall Study|Physician Decision|1|||
130980238|NCT00316082|471552114|FG001|Overall Study|Physician Decision|1|||
130980239|NCT00316082|471552115|FG002|Overall Study|Physician Decision|2|||
130980240|NCT00316082|471552116|FG003|Overall Study|Physician Decision|1|||
131132363|NCT02669017|472111808|FG003|Overall Study|Lost to Follow-up|0|||
131132364|NCT02669017|472111809|FG004|Overall Study|Lost to Follow-up|0|||
131227982|NCT00591253|472461557|FG001|Overall Study|Lost to Follow-up|4|||
131227983|NCT00591253|472461558|FG002|Overall Study|Lost to Follow-up|0|||
131227984|NCT00591253|472461556|FG000|Overall Study|Withdrawal by Subject|1|||
131227985|NCT00591253|472461557|FG001|Overall Study|Withdrawal by Subject|7|||
131227986|NCT00591253|472461558|FG002|Overall Study|Withdrawal by Subject|6|||
131227987|NCT00591253|472461556|FG000|Overall Study|Lack of Efficacy|1|||
131227988|NCT00591253|472461557|FG001|Overall Study|Lack of Efficacy|0|||
131227989|NCT00591253|472461558|FG002|Overall Study|Lack of Efficacy|3|||
131227990|NCT00591253|472461556|FG000|Overall Study|Other|5|||
131227991|NCT00591253|472461557|FG001|Overall Study|Other|5|||
131227992|NCT00591253|472461558|FG002|Overall Study|Other|3|||
131227993|NCT01504867|472461559|FG000|Overall Study|Inclusion criteria not met|2|||
131227994|NCT01504867|472461560|FG001|Overall Study|Inclusion criteria not met|2|||
131227995|NCT01504867|472461559|FG000|Overall Study|Consent revoked|5|||
131227996|NCT01504867|472461560|FG001|Overall Study|Consent revoked|1|||
130718699|NCT03982199|470593295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718700|NCT03982199|470593296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718701|NCT03982199|470593297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718702|NCT03982199|470593298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718703|NCT03982199|470593299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718704|NCT03982199|470593300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
130718705|NCT03982199|470593301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130718706|NCT00594646|470593302|FG000|Overall Study|Withdrawal by Subject|1|||
130718707|NCT00594646|470593302|FG000|Overall Study|Lost to Follow-up|15|||
130718708|NCT03907462|470593305|FG000|Overall Study|Physician Decision|1|||
130718709|NCT03907462|470593306|FG001|Overall Study|Physician Decision|3|||
130718710|NCT03907462|470593307|FG002|Overall Study|Physician Decision|1|||
130718711|NCT03907462|470593305|FG000|Overall Study|Withdrawal by Subject|6|||
130718712|NCT03907462|470593306|FG001|Overall Study|Withdrawal by Subject|3|||
130718713|NCT03907462|470593307|FG002|Overall Study|Withdrawal by Subject|3|||
130718714|NCT03907462|470593305|FG000|Overall Study|Pregnancy|4|||
130718715|NCT03907462|470593306|FG001|Overall Study|Pregnancy|2|||
130718716|NCT03907462|470593307|FG002|Overall Study|Pregnancy|6|||
130718717|NCT03907462|470593305|FG000|Overall Study|Lost to Follow-up|16|||
130718718|NCT03907462|470593306|FG001|Overall Study|Lost to Follow-up|18|||
130718719|NCT03907462|470593307|FG002|Overall Study|Lost to Follow-up|22|||
130718720|NCT03548064|470597202|FG000|Overall Study|Withdrawal by Subject|0|||
130718721|NCT03548064|470597203|FG001|Overall Study|Withdrawal by Subject|0|||
130718722|NCT03548064|470597204|FG002|Overall Study|Withdrawal by Subject|0|||
130718723|NCT03548064|470597205|FG003|Overall Study|Withdrawal by Subject|1|||
130718724|NCT03548064|470597206|FG004|Overall Study|Withdrawal by Subject|0|||
130718725|NCT03548064|470597207|FG005|Overall Study|Withdrawal by Subject|0|||
130718726|NCT03548064|470597208|FG006|Overall Study|Withdrawal by Subject|0|||
130718727|NCT03548064|470597209|FG007|Overall Study|Withdrawal by Subject|0|||
130718728|NCT03548064|470597202|FG000|Overall Study|Lost to Follow-up|0|||
130718729|NCT03548064|470597203|FG001|Overall Study|Lost to Follow-up|0|||
130718730|NCT03548064|470597204|FG002|Overall Study|Lost to Follow-up|0|||
130718731|NCT03548064|470597205|FG003|Overall Study|Lost to Follow-up|0|||
130718732|NCT03548064|470597206|FG004|Overall Study|Lost to Follow-up|2|||
130718733|NCT03548064|470597207|FG005|Overall Study|Lost to Follow-up|0|||
130718734|NCT03548064|470597208|FG006|Overall Study|Lost to Follow-up|0|||
130718735|NCT03548064|470597209|FG007|Overall Study|Lost to Follow-up|0|||
130718736|NCT03548064|470597202|FG000|Overall Study|Covid-19 Pandemic|0|||
130718737|NCT03548064|470597203|FG001|Overall Study|Covid-19 Pandemic|0|||
130718738|NCT03548064|470597204|FG002|Overall Study|Covid-19 Pandemic|0|||
130718739|NCT03548064|470597205|FG003|Overall Study|Covid-19 Pandemic|0|||
130718740|NCT03548064|470597206|FG004|Overall Study|Covid-19 Pandemic|10|||
130718741|NCT03548064|470597207|FG005|Overall Study|Covid-19 Pandemic|3|||
130718742|NCT03548064|470597208|FG006|Overall Study|Covid-19 Pandemic|0|||
130718743|NCT03548064|470597209|FG007|Overall Study|Covid-19 Pandemic|0|||
130718744|NCT05011123|470597210|FG000|Overall Study|Withdrawal by Subject|4|||
130718745|NCT05011123|470597211|FG001|Overall Study|Withdrawal by Subject|2|||
131043962|NCT04456296|471794768|FG002|Overall Study|Withdrawal by Subject|21|||
131043963|NCT04456296|471794766|FG000|Overall Study|Adverse Event|2|||
131227997|NCT00871169|472461561|FG000|Overall Study|Protocol Violation|1|||
130718746|NCT05011123|470597210|FG000|Overall Study|Lost to Follow-up|7|||
130718747|NCT05011123|470597211|FG001|Overall Study|Lost to Follow-up|6|||
130718748|NCT05011123|470597210|FG000|Overall Study|Ongoing at the time of DBL date|36|||
130718749|NCT05011123|470597211|FG001|Overall Study|Ongoing at the time of DBL date|10|||
130718750|NCT05011123|470597210|FG000|Overall Study|Randomized but did not receive vaccination|1|||
130718751|NCT05011123|470597211|FG001|Overall Study|Randomized but did not receive vaccination|0|||
130718752|NCT00006721|470597212|FG000|Overall Study|Adverse Event|0|||
130718753|NCT00006721|470597213|FG001|Overall Study|Adverse Event|4|||
130718754|NCT00006721|470597214|FG002|Overall Study|Adverse Event|4|||
131227998|NCT00871169|472461561|FG000|Overall Study|Patient did not receive study treatment|2|||
130718755|NCT00006721|470597212|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
130718756|NCT00006721|470597213|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
131227999|NCT03210259|472461565|FG000|12-Week Run-in Period|Adverse Event|1|||
131043964|NCT04456296|471794767|FG001|Overall Study|Adverse Event|2|||
131043965|NCT04456296|471794768|FG002|Overall Study|Adverse Event|2|||
131043966|NCT04456296|471794766|FG000|Overall Study|Death|1|||
131043967|NCT04456296|471794767|FG001|Overall Study|Death|0|||
131043968|NCT04456296|471794768|FG002|Overall Study|Death|0|||
131043969|NCT04456296|471794766|FG000|Overall Study|Lost to Follow-up|3|||
131043970|NCT04456296|471794767|FG001|Overall Study|Lost to Follow-up|5|||
131043971|NCT04456296|471794768|FG002|Overall Study|Lost to Follow-up|6|||
131043972|NCT04456296|471794766|FG000|Overall Study|Other than specified|0|||
131043973|NCT04456296|471794767|FG001|Overall Study|Other than specified|1|||
131043974|NCT04456296|471794768|FG002|Overall Study|Other than specified|4|||
131043975|NCT04456296|471794766|FG000|Overall Study|Randomized, not treated|2|||
131043976|NCT04456296|471794767|FG001|Overall Study|Randomized, not treated|1|||
131043977|NCT04456296|471794768|FG002|Overall Study|Randomized, not treated|0|||
131043978|NCT04247802|471794769|FG000|Overall Study|Withdrawal by Subject|1|||
131043979|NCT04247802|471794770|FG001|Overall Study|Withdrawal by Subject|3|||
131043980|NCT04247802|471794769|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
131132365|NCT02669017|472111810|FG005|Overall Study|Lost to Follow-up|0|||
131132366|NCT02669017|472111811|FG006|Overall Study|Lost to Follow-up|0|||
131132367|NCT02669017|472111812|FG007|Overall Study|Lost to Follow-up|0|||
131132368|NCT02669017|472111813|FG008|Overall Study|Lost to Follow-up|1|||
131132369|NCT02669017|472111805|FG000|Overall Study|Miscellaneous|0|||
130718757|NCT00006721|470597214|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
130718758|NCT00006721|470597212|FG000|Overall Study|Progression/Relapse|0|||
130718759|NCT00006721|470597213|FG001|Overall Study|Progression/Relapse|1|||
130718760|NCT00006721|470597214|FG002|Overall Study|Progression/Relapse|2|||
130718761|NCT00006721|470597212|FG000|Overall Study|Death|0|||
130718762|NCT00006721|470597213|FG001|Overall Study|Death|1|||
130718763|NCT00006721|470597214|FG002|Overall Study|Death|2|||
130718764|NCT00006721|470597212|FG000|Overall Study|Other - Not Protocol Specified|0|||
130718765|NCT00006721|470597213|FG001|Overall Study|Other - Not Protocol Specified|7|||
130718766|NCT00006721|470597214|FG002|Overall Study|Other - Not Protocol Specified|7|||
130718767|NCT00006721|470597212|FG000|Overall Study|Ineligible|2|||
130718768|NCT00006721|470597213|FG001|Overall Study|Ineligible|12|||
130718769|NCT00006721|470597214|FG002|Overall Study|Ineligible|10|||
130718770|NCT00006721|470597212|FG000|Overall Study|Eligible but no Treatment Received|1|||
130718771|NCT00006721|470597213|FG001|Overall Study|Eligible but no Treatment Received|0|||
130718772|NCT00006721|470597214|FG002|Overall Study|Eligible but no Treatment Received|0|||
130718773|NCT04732221|470597215|FG000|Base Period|Death|2|||
130718774|NCT04732221|470597216|FG001|Base Period|Death|0|||
130718775|NCT04732221|470597217|FG002|Base Period|Death|0|||
130718776|NCT04732221|470597218|FG003|Base Period|Death|0|||
130718777|NCT04732221|470597219|FG004|Base Period|Death|0|||
130718778|NCT04732221|470597220|FG005|Base Period|Death|0|||
130718779|NCT04732221|470597221|FG006|Base Period|Death|0|||
130718780|NCT04732221|470597215|FG000|Base Period|Withdrawal by Subject|0|||
130718781|NCT04732221|470597216|FG001|Base Period|Withdrawal by Subject|1|||
130718782|NCT04732221|470597217|FG002|Base Period|Withdrawal by Subject|1|||
130718783|NCT04732221|470597218|FG003|Base Period|Withdrawal by Subject|0|||
130718784|NCT04732221|470597219|FG004|Base Period|Withdrawal by Subject|0|||
130718785|NCT04732221|470597220|FG005|Base Period|Withdrawal by Subject|0|||
130718786|NCT04732221|470597221|FG006|Base Period|Withdrawal by Subject|0|||
130718787|NCT04732221|470597215|FG000|Extension Period|Adverse Event|0|||
130718788|NCT04732221|470597216|FG001|Extension Period|Adverse Event|0|||
130718789|NCT04732221|470597217|FG002|Extension Period|Adverse Event|0|||
130718790|NCT04732221|470597218|FG003|Extension Period|Adverse Event|0|||
130718791|NCT04732221|470597219|FG004|Extension Period|Adverse Event|0|||
130718792|NCT04732221|470597220|FG005|Extension Period|Adverse Event|1|||
130718793|NCT04732221|470597221|FG006|Extension Period|Adverse Event|0|||
130718794|NCT04732221|470597215|FG000|Extension Period|Death|0|||
130718795|NCT04732221|470597216|FG001|Extension Period|Death|0|||
130718796|NCT04732221|470597217|FG002|Extension Period|Death|0|||
130718797|NCT04732221|470597218|FG003|Extension Period|Death|0|||
130718798|NCT04732221|470597219|FG004|Extension Period|Death|1|||
130718799|NCT04732221|470597220|FG005|Extension Period|Death|0|||
130718800|NCT04732221|470597221|FG006|Extension Period|Death|2|||
130718801|NCT04732221|470597215|FG000|Extension Period|Pregnancy|0|||
130718802|NCT04732221|470597216|FG001|Extension Period|Pregnancy|0|||
130718803|NCT04732221|470597217|FG002|Extension Period|Pregnancy|0|||
130718804|NCT04732221|470597218|FG003|Extension Period|Pregnancy|0|||
130718805|NCT04732221|470597219|FG004|Extension Period|Pregnancy|1|||
131043981|NCT04247802|471794770|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
131132370|NCT02669017|472111806|FG001|Overall Study|Miscellaneous|0|||
130718806|NCT04732221|470597220|FG005|Extension Period|Pregnancy|0|||
130718807|NCT04732221|470597221|FG006|Extension Period|Pregnancy|0|||
130718808|NCT04732221|470597215|FG000|Extension Period|Sponsors Decision|0|||
130718809|NCT04732221|470597216|FG001|Extension Period|Sponsors Decision|0|||
130718810|NCT04732221|470597217|FG002|Extension Period|Sponsors Decision|0|||
130718811|NCT04732221|470597218|FG003|Extension Period|Sponsors Decision|0|||
130718812|NCT04732221|470597219|FG004|Extension Period|Sponsors Decision|41|||
131043982|NCT05962814|471794774|FG000|Overall Study|failed eligibility|1|||
130980241|NCT00316082|471552117|FG004|Overall Study|Physician Decision|1|||
130980242|NCT00316082|471552113|FG000|Overall Study|Death|0|||
130980243|NCT00316082|471552114|FG001|Overall Study|Death|0|||
130980244|NCT00316082|471552115|FG002|Overall Study|Death|1|||
130980245|NCT00316082|471552116|FG003|Overall Study|Death|0|||
130980246|NCT00316082|471552117|FG004|Overall Study|Death|0|||
130980247|NCT00316082|471552113|FG000|Overall Study|Administrative reason by sponsor|0|||
130980248|NCT00316082|471552114|FG001|Overall Study|Administrative reason by sponsor|0|||
130980249|NCT00316082|471552115|FG002|Overall Study|Administrative reason by sponsor|1|||
130980250|NCT00316082|471552116|FG003|Overall Study|Administrative reason by sponsor|0|||
130980251|NCT00316082|471552117|FG004|Overall Study|Administrative reason by sponsor|0|||
130980252|NCT00528775|471552122|FG000|Overall Study|Other not specified|1|||
130980253|NCT01569438|471552127|FG000|Overall Study|Lack of Efficacy|1|||
130980254|NCT01569438|471552128|FG001|Overall Study|Lack of Efficacy|2|||
130980255|NCT01569438|471552127|FG000|Overall Study|Withdrawal by Subject|0|||
130980256|NCT01569438|471552128|FG001|Overall Study|Withdrawal by Subject|3|||
130980257|NCT01569438|471552127|FG000|Overall Study|Adverse Event|2|||
130980258|NCT01569438|471552128|FG001|Overall Study|Adverse Event|15|||
130980259|NCT01569438|471552127|FG000|Overall Study|Protocol Violation|2|||
130980260|NCT01569438|471552128|FG001|Overall Study|Protocol Violation|0|||
130980261|NCT01569438|471552127|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
130980262|NCT01569438|471552128|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
130980263|NCT01569438|471552127|FG000|Overall Study|Sponsor/Physician decision|1|||
130980264|NCT01569438|471552128|FG001|Overall Study|Sponsor/Physician decision|1|||
130980265|NCT01569438|471552127|FG000|Overall Study|Unable to adhere to study schedule|0|||
130980266|NCT01569438|471552128|FG001|Overall Study|Unable to adhere to study schedule|1|||
130980267|NCT00827918|471552132|FG000|Overall Study|Adverse Event|4|||
130980268|NCT00827918|471552133|FG001|Overall Study|Adverse Event|0|||
130980269|NCT00827918|471552134|FG002|Overall Study|Adverse Event|0|||
130980270|NCT00827918|471552132|FG000|Overall Study|Lack of Efficacy|16|||
130980271|NCT00827918|471552133|FG001|Overall Study|Lack of Efficacy|4|||
130980272|NCT00827918|471552134|FG002|Overall Study|Lack of Efficacy|15|||
130980273|NCT00827918|471552132|FG000|Overall Study|Physician Decision|1|||
130980274|NCT00827918|471552133|FG001|Overall Study|Physician Decision|0|||
130980275|NCT00827918|471552134|FG002|Overall Study|Physician Decision|0|||
130980276|NCT00827918|471552132|FG000|Overall Study|Pregnancy|0|||
130980277|NCT00827918|471552133|FG001|Overall Study|Pregnancy|1|||
130980278|NCT00827918|471552134|FG002|Overall Study|Pregnancy|0|||
130980279|NCT00827918|471552132|FG000|Overall Study|Progressive Disease|1|||
130980280|NCT00827918|471552133|FG001|Overall Study|Progressive Disease|1|||
130980281|NCT00827918|471552134|FG002|Overall Study|Progressive Disease|0|||
130980282|NCT00827918|471552132|FG000|Overall Study|Protocol Violation|0|||
130980283|NCT00827918|471552133|FG001|Overall Study|Protocol Violation|1|||
130980284|NCT00827918|471552134|FG002|Overall Study|Protocol Violation|0|||
130980285|NCT00827918|471552132|FG000|Overall Study|Withdrawal by Subject|6|||
130980286|NCT00827918|471552133|FG001|Overall Study|Withdrawal by Subject|2|||
130980287|NCT00827918|471552134|FG002|Overall Study|Withdrawal by Subject|6|||
130980288|NCT02432105|471552136|FG000|Overall Study|Lost to Follow-up|1|||
130980289|NCT02432105|471552137|FG001|Overall Study|Lost to Follow-up|1|||
130980290|NCT02432105|471552138|FG002|Overall Study|Lost to Follow-up|0|||
130980291|NCT02432105|471552136|FG000|Overall Study|Withdrawal by Subject|1|||
130980292|NCT02432105|471552137|FG001|Overall Study|Withdrawal by Subject|0|||
130980293|NCT02432105|471552138|FG002|Overall Study|Withdrawal by Subject|1|||
130980294|NCT02432105|471552136|FG000|Overall Study|Culture positive for yeast|0|||
130980295|NCT02432105|471552137|FG001|Overall Study|Culture positive for yeast|1|||
130980296|NCT02432105|471552138|FG002|Overall Study|Culture positive for yeast|0|||
130980297|NCT02432105|471552136|FG000|Overall Study|Randomized in error|0|||
130980298|NCT02432105|471552137|FG001|Overall Study|Randomized in error|0|||
130980299|NCT02432105|471552138|FG002|Overall Study|Randomized in error|2|||
130980300|NCT01302847|471552139|FG000|Overall Study|Death|0|||
130980301|NCT01302847|471552140|FG001|Overall Study|Death|1|||
130980302|NCT01302847|471552141|FG002|Overall Study|Death|0|||
130980303|NCT01302847|471552142|FG003|Overall Study|Death|0|||
130980304|NCT01302847|471552143|FG004|Overall Study|Death|0|||
130980305|NCT01302847|471552144|FG005|Overall Study|Death|1|||
130980306|NCT01302847|471552145|FG006|Overall Study|Death|1|||
130980307|NCT01302847|471552146|FG007|Overall Study|Death|0|||
130980308|NCT01302847|471552139|FG000|Overall Study|Pregnancy|2|||
130980309|NCT01302847|471552140|FG001|Overall Study|Pregnancy|0|||
130980310|NCT01302847|471552141|FG002|Overall Study|Pregnancy|0|||
130980311|NCT01302847|471552142|FG003|Overall Study|Pregnancy|0|||
130980312|NCT01302847|471552143|FG004|Overall Study|Pregnancy|0|||
130980313|NCT01302847|471552144|FG005|Overall Study|Pregnancy|0|||
130980314|NCT01302847|471552145|FG006|Overall Study|Pregnancy|0|||
130980315|NCT01302847|471552146|FG007|Overall Study|Pregnancy|0|||
130980316|NCT01302847|471552139|FG000|Overall Study|Virologic failure|0|||
130980317|NCT01302847|471552140|FG001|Overall Study|Virologic failure|2|||
130980318|NCT01302847|471552141|FG002|Overall Study|Virologic failure|0|||
130980319|NCT01302847|471552142|FG003|Overall Study|Virologic failure|2|||
130980320|NCT01302847|471552143|FG004|Overall Study|Virologic failure|1|||
131228000|NCT03210259|472461566|FG001|12-Week Run-in Period|Adverse Event|0|||
131228001|NCT03210259|472461567|FG002|12-Week Run-in Period|Adverse Event|0|||
131228002|NCT03210259|472461565|FG000|12-Week Run-in Period|Death|1|||
131228003|NCT03210259|472461566|FG001|12-Week Run-in Period|Death|0|||
131228004|NCT03210259|472461567|FG002|12-Week Run-in Period|Death|0|||
131228005|NCT03210259|472461565|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
131228006|NCT03210259|472461566|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
131228007|NCT03210259|472461567|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
131228008|NCT03210259|472461565|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
131228009|NCT03210259|472461566|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
131228010|NCT03210259|472461567|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
131228011|NCT03210259|472461565|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
131228012|NCT03210259|472461566|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
131228013|NCT03210259|472461567|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
131228014|NCT03210259|472461565|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
131228015|NCT03210259|472461566|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
131228016|NCT03210259|472461567|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
131228017|NCT03210259|472461565|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
131228018|NCT03210259|472461566|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
131228019|NCT03210259|472461567|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
131228020|NCT03210259|472461565|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
131228021|NCT03210259|472461566|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
131228022|NCT03210259|472461567|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
131228023|NCT03210259|472461565|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
131228024|NCT03210259|472461566|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
130980321|NCT01302847|471552144|FG005|Overall Study|Virologic failure|3|||
130980322|NCT01302847|471552145|FG006|Overall Study|Virologic failure|1|||
130980323|NCT01302847|471552146|FG007|Overall Study|Virologic failure|2|||
130980324|NCT01302847|471552139|FG000|Overall Study|Severe debilitation, unable to continue|0|||
130980325|NCT01302847|471552140|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130980326|NCT01302847|471552141|FG002|Overall Study|Severe debilitation, unable to continue|0|||
130980327|NCT01302847|471552142|FG003|Overall Study|Severe debilitation, unable to continue|0|||
130980328|NCT01302847|471552143|FG004|Overall Study|Severe debilitation, unable to continue|0|||
130980329|NCT01302847|471552144|FG005|Overall Study|Severe debilitation, unable to continue|1|||
130980330|NCT01302847|471552145|FG006|Overall Study|Severe debilitation, unable to continue|1|||
130980331|NCT01302847|471552146|FG007|Overall Study|Severe debilitation, unable to continue|0|||
130980332|NCT01302847|471552139|FG000|Overall Study|Not able to get to clinic|1|||
130980333|NCT01302847|471552140|FG001|Overall Study|Not able to get to clinic|1|||
130980334|NCT01302847|471552141|FG002|Overall Study|Not able to get to clinic|0|||
130980335|NCT01302847|471552142|FG003|Overall Study|Not able to get to clinic|0|||
130980336|NCT01302847|471552143|FG004|Overall Study|Not able to get to clinic|0|||
130980337|NCT01302847|471552144|FG005|Overall Study|Not able to get to clinic|0|||
130980338|NCT01302847|471552145|FG006|Overall Study|Not able to get to clinic|0|||
130980339|NCT01302847|471552146|FG007|Overall Study|Not able to get to clinic|0|||
130980340|NCT01302847|471552139|FG000|Overall Study|Site closing|2|||
130980341|NCT01302847|471552140|FG001|Overall Study|Site closing|2|||
130980342|NCT01302847|471552141|FG002|Overall Study|Site closing|0|||
130980343|NCT01302847|471552142|FG003|Overall Study|Site closing|0|||
130980344|NCT01302847|471552143|FG004|Overall Study|Site closing|0|||
130980345|NCT01302847|471552144|FG005|Overall Study|Site closing|0|||
130980346|NCT01302847|471552145|FG006|Overall Study|Site closing|0|||
130980347|NCT01302847|471552146|FG007|Overall Study|Site closing|0|||
130980348|NCT01302847|471552139|FG000|Overall Study|Withdrawal by Subject|1|||
130980349|NCT01302847|471552140|FG001|Overall Study|Withdrawal by Subject|0|||
130980350|NCT01302847|471552141|FG002|Overall Study|Withdrawal by Subject|0|||
130980351|NCT01302847|471552142|FG003|Overall Study|Withdrawal by Subject|0|||
130980352|NCT01302847|471552143|FG004|Overall Study|Withdrawal by Subject|1|||
130980353|NCT01302847|471552144|FG005|Overall Study|Withdrawal by Subject|0|||
130980354|NCT01302847|471552145|FG006|Overall Study|Withdrawal by Subject|0|||
130980355|NCT01302847|471552146|FG007|Overall Study|Withdrawal by Subject|1|||
130980356|NCT01302847|471552139|FG000|Overall Study|Not willing to adhere to requirements|5|||
130980357|NCT01302847|471552140|FG001|Overall Study|Not willing to adhere to requirements|0|||
131228025|NCT03210259|472461567|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
130718813|NCT04732221|470597220|FG005|Extension Period|Sponsors Decision|40|||
130980358|NCT01302847|471552141|FG002|Overall Study|Not willing to adhere to requirements|1|||
130980359|NCT01302847|471552142|FG003|Overall Study|Not willing to adhere to requirements|0|||
130980360|NCT01302847|471552143|FG004|Overall Study|Not willing to adhere to requirements|0|||
130980361|NCT01302847|471552144|FG005|Overall Study|Not willing to adhere to requirements|0|||
131228026|NCT03210259|472461565|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
131228027|NCT03210259|472461566|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
131228028|NCT03210259|472461567|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
131228029|NCT03210259|472461565|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
131132371|NCT02669017|472111807|FG002|Overall Study|Miscellaneous|0|||
131132372|NCT02669017|472111808|FG003|Overall Study|Miscellaneous|0|||
131132373|NCT02669017|472111809|FG004|Overall Study|Miscellaneous|2|||
131132374|NCT02669017|472111810|FG005|Overall Study|Miscellaneous|1|||
131132375|NCT02669017|472111811|FG006|Overall Study|Miscellaneous|1|||
131132376|NCT02669017|472111812|FG007|Overall Study|Miscellaneous|13|||
131132377|NCT02669017|472111813|FG008|Overall Study|Miscellaneous|2|||
131132378|NCT02192827|472111815|FG000|Overall Study|Lost to Follow-up|25|||
131132379|NCT02192827|472111816|FG001|Overall Study|Lost to Follow-up|27|||
131132380|NCT02192827|472111815|FG000|Overall Study|Given additional steroids with admission|13|||
131132381|NCT02192827|472111816|FG001|Overall Study|Given additional steroids with admission|11|||
130718814|NCT04732221|470597221|FG006|Extension Period|Sponsors Decision|40|||
130980362|NCT01302847|471552145|FG006|Overall Study|Not willing to adhere to requirements|0|||
130980363|NCT01302847|471552146|FG007|Overall Study|Not willing to adhere to requirements|2|||
130980364|NCT01302847|471552139|FG000|Overall Study|Site unable to contact participant|2|||
130980365|NCT01302847|471552140|FG001|Overall Study|Site unable to contact participant|1|||
130980366|NCT01302847|471552141|FG002|Overall Study|Site unable to contact participant|0|||
130980367|NCT01302847|471552142|FG003|Overall Study|Site unable to contact participant|0|||
130980368|NCT01302847|471552143|FG004|Overall Study|Site unable to contact participant|0|||
130980369|NCT01302847|471552144|FG005|Overall Study|Site unable to contact participant|0|||
130980370|NCT01302847|471552145|FG006|Overall Study|Site unable to contact participant|2|||
130980371|NCT01302847|471552146|FG007|Overall Study|Site unable to contact participant|0|||
130980372|NCT00374322|471552147|FG000|Overall Study|Lost to Follow-up|92|||
130980373|NCT00374322|471552148|FG001|Overall Study|Lost to Follow-up|90|||
130980374|NCT00374322|471552147|FG000|Overall Study|Protocol Violation|8|||
130980375|NCT00374322|471552148|FG001|Overall Study|Protocol Violation|3|||
130980376|NCT00374322|471552147|FG000|Overall Study|Withdrawal by Subject|235|||
130980377|NCT00374322|471552148|FG001|Overall Study|Withdrawal by Subject|167|||
130980378|NCT00374322|471552147|FG000|Overall Study|Sponsor Terminated Study|866|||
130980379|NCT00374322|471552148|FG001|Overall Study|Sponsor Terminated Study|990|||
130980380|NCT00374322|471552147|FG000|Overall Study|Physician Decision|36|||
130980381|NCT00374322|471552148|FG001|Overall Study|Physician Decision|32|||
130980382|NCT00374322|471552147|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
130980383|NCT00374322|471552148|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
130980384|NCT00374322|471552147|FG000|Overall Study|Sponsor Decision|2|||
130980385|NCT00374322|471552148|FG001|Overall Study|Sponsor Decision|3|||
130980386|NCT00374322|471552147|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
130980387|NCT00374322|471552148|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
130980388|NCT00374322|471552147|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
130980389|NCT00374322|471552148|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
130980390|NCT00374322|471552147|FG000|Overall Study|Severe Toxicity|1|||
130980391|NCT00374322|471552148|FG001|Overall Study|Severe Toxicity|0|||
130980392|NCT00374322|471552147|FG000|Overall Study|Site Closed|2|||
130980393|NCT00374322|471552148|FG001|Overall Study|Site Closed|2|||
130980394|NCT00374322|471552147|FG000|Overall Study|Participant Changed Physician|1|||
130980395|NCT00374322|471552148|FG001|Overall Study|Participant Changed Physician|0|||
130980396|NCT00374322|471552147|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
130980397|NCT00374322|471552148|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
130980398|NCT00374322|471552147|FG000|Overall Study|Noncompliance with Study Requirements|0|||
130980399|NCT00374322|471552148|FG001|Overall Study|Noncompliance with Study Requirements|1|||
130980400|NCT00374322|471552147|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
130980401|NCT00374322|471552148|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
130980402|NCT00374322|471552147|FG000|Overall Study|Did Not Receive Study Medication|8|||
130980403|NCT00374322|471552148|FG001|Overall Study|Did Not Receive Study Medication|6|||
130980404|NCT01112579|471552153|FG000|Overall Study|Missed Visit|1|||
130980405|NCT01112579|471552154|FG001|Overall Study|Missed Visit|1|||
130980406|NCT01112579|471552153|FG000|Overall Study|Death|0|||
130980407|NCT01112579|471552154|FG001|Overall Study|Death|2|||
130980408|NCT00818753|471552155|FG000|Overall Study|Protocol Violation|1|||
130980409|NCT00818753|471552156|FG001|Overall Study|Protocol Violation|0|||
130980410|NCT00818753|471552157|FG002|Overall Study|Protocol Violation|0|||
130980411|NCT00818753|471552155|FG000|Overall Study|Other reason (not specified)|0|||
130980412|NCT00818753|471552156|FG001|Overall Study|Other reason (not specified)|0|||
130980413|NCT00818753|471552157|FG002|Overall Study|Other reason (not specified)|1|||
130718815|NCT04732221|470597215|FG000|Extension Period|Withdrawal by Subject|0|||
130980414|NCT00818753|471552155|FG000|Overall Study|Randomised and not treated|2|||
130980415|NCT00818753|471552156|FG001|Overall Study|Randomised and not treated|0|||
130980416|NCT00818753|471552157|FG002|Overall Study|Randomised and not treated|0|||
130980417|NCT03703466|471552158|FG000|Overall Study|Death|2|||
130980418|NCT03703466|471552159|FG001|Overall Study|Death|1|||
130980419|NCT03703466|471552160|FG002|Overall Study|Death|0|||
131132382|NCT03509350|472111817|FG000|Overall Study|Withdrawal by Subject|0|||
131132383|NCT03509350|472111818|FG001|Overall Study|Withdrawal by Subject|2|||
131132384|NCT01425203|472111819|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
130980420|NCT03703466|471552158|FG000|Overall Study|Withdrawal by Subject|0|||
130980421|NCT03703466|471552159|FG001|Overall Study|Withdrawal by Subject|3|||
130980422|NCT03703466|471552160|FG002|Overall Study|Withdrawal by Subject|0|||
130980423|NCT03703466|471552158|FG000|Overall Study|Completed < 3 Cycles|2|||
130980424|NCT03703466|471552159|FG001|Overall Study|Completed < 3 Cycles|2|||
130980425|NCT03703466|471552160|FG002|Overall Study|Completed < 3 Cycles|2|||
130980426|NCT04508699|471552162|FG000|Overall Study|Lack of Efficacy|2|||
130980427|NCT04508699|471552163|FG001|Overall Study|Lack of Efficacy|15|||
130980428|NCT04508699|471552162|FG000|Overall Study|Withdrawal by Subject|0|||
130980429|NCT04508699|471552163|FG001|Overall Study|Withdrawal by Subject|2|||
130980430|NCT03355326|471552164|FG000|Overall Study|Protocol Violation|3|||
130980431|NCT03355326|471552165|FG001|Overall Study|Protocol Violation|3|||
130980432|NCT04918784|471553968|FG000|Overall Study|Amputation - no longer eligible|1|||
130980433|NCT04918784|471553969|FG001|Overall Study|Amputation - no longer eligible|2|||
130980434|NCT04918784|471553968|FG000|Overall Study|Death|1|||
130980435|NCT04918784|471553969|FG001|Overall Study|Death|0|||
130980436|NCT04918784|471553968|FG000|Overall Study|patient non-compliance|3|||
130980437|NCT04918784|471553969|FG001|Overall Study|patient non-compliance|1|||
130980438|NCT04918784|471553968|FG000|Overall Study|Adverse Event|1|||
130980439|NCT04918784|471553969|FG001|Overall Study|Adverse Event|0|||
130980440|NCT04179175|471553973|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
130980441|NCT04179175|471553974|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
130980442|NCT04179175|471553975|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
130980443|NCT04179175|471553976|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
130980444|NCT04179175|471553977|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
130980445|NCT04179175|471553978|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
130980446|NCT04179175|471553973|FG000|Overall Study|Adverse Event|5|||
130980447|NCT04179175|471553974|FG001|Overall Study|Adverse Event|3|||
130980448|NCT04179175|471553975|FG002|Overall Study|Adverse Event|3|||
130980449|NCT04179175|471553976|FG003|Overall Study|Adverse Event|4|||
130980450|NCT04179175|471553977|FG004|Overall Study|Adverse Event|6|||
130980451|NCT04179175|471553978|FG005|Overall Study|Adverse Event|6|||
130980452|NCT04179175|471553973|FG000|Overall Study|Lack of Efficacy|5|||
130980453|NCT04179175|471553974|FG001|Overall Study|Lack of Efficacy|1|||
130980454|NCT04179175|471553975|FG002|Overall Study|Lack of Efficacy|3|||
130980455|NCT04179175|471553976|FG003|Overall Study|Lack of Efficacy|2|||
130980456|NCT04179175|471553977|FG004|Overall Study|Lack of Efficacy|18|||
130980457|NCT04179175|471553978|FG005|Overall Study|Lack of Efficacy|7|||
130980458|NCT04179175|471553973|FG000|Overall Study|Lost to Follow-up|5|||
130980459|NCT04179175|471553974|FG001|Overall Study|Lost to Follow-up|3|||
130980460|NCT04179175|471553975|FG002|Overall Study|Lost to Follow-up|2|||
131043983|NCT02865538|471794776|FG000|Overall Study|Withdrawal by Subject|0|||
131043984|NCT02865538|471794777|FG001|Overall Study|Withdrawal by Subject|0|||
131043985|NCT02865538|471794778|FG002|Overall Study|Withdrawal by Subject|1|||
131043986|NCT02865538|471794779|FG003|Overall Study|Withdrawal by Subject|0|||
131043987|NCT02865538|471794780|FG004|Overall Study|Withdrawal by Subject|0|||
131043988|NCT02865538|471794776|FG000|Overall Study|Lost to Follow-up|1|||
131043989|NCT02865538|471794777|FG001|Overall Study|Lost to Follow-up|0|||
131043990|NCT02865538|471794778|FG002|Overall Study|Lost to Follow-up|0|||
131043991|NCT02865538|471794779|FG003|Overall Study|Lost to Follow-up|0|||
131043992|NCT02865538|471794780|FG004|Overall Study|Lost to Follow-up|0|||
131043993|NCT05290493|471796132|FG000|Overall Study|Withdrawal by Subject|2|||
131043994|NCT05290493|471796133|FG001|Overall Study|Withdrawal by Subject|2|||
131043995|NCT05290493|471796132|FG000|Overall Study|Adverse Event|1|||
131043996|NCT05290493|471796133|FG001|Overall Study|Adverse Event|0|||
131043997|NCT04615273|471796137|FG000|Overall Study|Withdrawal by Subject|3|||
131043998|NCT04615273|471796138|FG001|Overall Study|Withdrawal by Subject|1|||
131043999|NCT04615273|471796139|FG002|Overall Study|Withdrawal by Subject|2|||
131044000|NCT04615273|471796137|FG000|Overall Study|Adverse Event|1|||
131044001|NCT04615273|471796138|FG001|Overall Study|Adverse Event|0|||
131044002|NCT04615273|471796139|FG002|Overall Study|Adverse Event|1|||
131044003|NCT04615273|471796137|FG000|Overall Study|Lost to Follow-up|0|||
131044004|NCT04615273|471796138|FG001|Overall Study|Lost to Follow-up|1|||
131044005|NCT04615273|471796139|FG002|Overall Study|Lost to Follow-up|0|||
131044006|NCT04615273|471796137|FG000|Overall Study|Physician Decision|0|||
131044007|NCT04615273|471796138|FG001|Overall Study|Physician Decision|0|||
130980461|NCT04179175|471553976|FG003|Overall Study|Lost to Follow-up|2|||
130980462|NCT04179175|471553977|FG004|Overall Study|Lost to Follow-up|4|||
130980463|NCT04179175|471553978|FG005|Overall Study|Lost to Follow-up|5|||
130980464|NCT04179175|471553973|FG000|Overall Study|Physician Decision|2|||
130980465|NCT04179175|471553974|FG001|Overall Study|Physician Decision|0|||
130980466|NCT04179175|471553975|FG002|Overall Study|Physician Decision|2|||
130980467|NCT04179175|471553976|FG003|Overall Study|Physician Decision|3|||
131044008|NCT04615273|471796139|FG002|Overall Study|Physician Decision|1|||
131044009|NCT04615273|471796137|FG000|Overall Study|Other|0|||
131044010|NCT04615273|471796138|FG001|Overall Study|Other|1|||
131044011|NCT04615273|471796139|FG002|Overall Study|Other|0|||
131044012|NCT04615273|471796137|FG000|Overall Study|Randomized but not treated|1|||
131228030|NCT03210259|472461566|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
131228031|NCT03210259|472461567|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
131228032|NCT00252187|472461568|FG000|Overall Study|Adverse Event|3|||
131228033|NCT00252187|472461569|FG001|Overall Study|Adverse Event|1|||
131228034|NCT00252187|472461568|FG000|Overall Study|Withdrawal by Subject|1|||
131228035|NCT00252187|472461569|FG001|Overall Study|Withdrawal by Subject|0|||
131228036|NCT01875445|472461572|FG000|Overall Study|Lost to Follow-up|5|||
131228037|NCT01875445|472461573|FG001|Overall Study|Lost to Follow-up|0|||
131228038|NCT01875445|472461572|FG000|Overall Study|Withdrawal by Subject|2|||
131228039|NCT01875445|472461573|FG001|Overall Study|Withdrawal by Subject|0|||
131228040|NCT00706706|472461574|FG000|Overall Study|Death|53|||
131228041|NCT00706706|472461574|FG000|Overall Study|Lost to Follow-up|7|||
131228042|NCT00706706|472461574|FG000|Overall Study|Study endpoint had reached|45|||
131228043|NCT01154153|472461577|FG000|Overall Study|Poor compliance to protocol|2|||
131228044|NCT01154153|472461578|FG001|Overall Study|Poor compliance to protocol|0|||
131228045|NCT01154153|472461577|FG000|Overall Study|Unable to use labs|2|||
131228046|NCT01154153|472461578|FG001|Overall Study|Unable to use labs|3|||
131228047|NCT01154153|472461577|FG000|Overall Study|Withdrew consent|1|||
131228048|NCT01154153|472461578|FG001|Overall Study|Withdrew consent|0|||
131228049|NCT00210626|472461583|FG000|Overall Study|Adverse Event|1|||
131228050|NCT00210626|472461584|FG001|Overall Study|Adverse Event|2|||
131228051|NCT00210626|472461583|FG000|Overall Study|Protocol Violation|1|||
131228052|NCT00210626|472461584|FG001|Overall Study|Protocol Violation|5|||
131228053|NCT00210626|472461583|FG000|Overall Study|Lost to Follow-up|11|||
131228054|NCT00210626|472461584|FG001|Overall Study|Lost to Follow-up|11|||
131228055|NCT00210626|472461583|FG000|Overall Study|Death|1|||
131228056|NCT00210626|472461584|FG001|Overall Study|Death|0|||
131228057|NCT00210626|472461583|FG000|Overall Study|Withdrawal by Subject|29|||
131228058|NCT00210626|472461584|FG001|Overall Study|Withdrawal by Subject|20|||
131228059|NCT00210626|472461583|FG000|Overall Study|Physician Decision|0|||
131228060|NCT00210626|472461584|FG001|Overall Study|Physician Decision|2|||
130980468|NCT04179175|471553977|FG004|Overall Study|Physician Decision|1|||
130980469|NCT04179175|471553978|FG005|Overall Study|Physician Decision|1|||
130980470|NCT04179175|471553973|FG000|Overall Study|Pregnancy|3|||
130980471|NCT04179175|471553974|FG001|Overall Study|Pregnancy|0|||
130980472|NCT04179175|471553975|FG002|Overall Study|Pregnancy|3|||
130980473|NCT04179175|471553976|FG003|Overall Study|Pregnancy|0|||
130980474|NCT04179175|471553977|FG004|Overall Study|Pregnancy|1|||
130980475|NCT04179175|471553978|FG005|Overall Study|Pregnancy|2|||
130980476|NCT04179175|471553973|FG000|Overall Study|Withdrawal by Subject|22|||
130980477|NCT04179175|471553974|FG001|Overall Study|Withdrawal by Subject|10|||
130980478|NCT04179175|471553975|FG002|Overall Study|Withdrawal by Subject|12|||
130980479|NCT04179175|471553976|FG003|Overall Study|Withdrawal by Subject|8|||
130980480|NCT04179175|471553977|FG004|Overall Study|Withdrawal by Subject|23|||
130980481|NCT04179175|471553978|FG005|Overall Study|Withdrawal by Subject|31|||
130980482|NCT04179175|471553973|FG000|Overall Study|Technical problems|0|||
130980483|NCT04179175|471553974|FG001|Overall Study|Technical problems|0|||
130980484|NCT04179175|471553975|FG002|Overall Study|Technical problems|1|||
130980485|NCT04179175|471553976|FG003|Overall Study|Technical problems|1|||
130980486|NCT04179175|471553977|FG004|Overall Study|Technical problems|0|||
130980487|NCT04179175|471553978|FG005|Overall Study|Technical problems|0|||
130980488|NCT02586025|471553988|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
130980489|NCT02586025|471553989|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
130980490|NCT02586025|471553988|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
130980491|NCT02586025|471553989|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
130980492|NCT02586025|471553988|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
130980493|NCT02586025|471553989|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
130980494|NCT02586025|471553988|FG000|Neoadjuvant Treatment|Death|1|||
130980495|NCT02586025|471553989|FG001|Neoadjuvant Treatment|Death|0|||
130980496|NCT02586025|471553988|FG000|Neoadjuvant Treatment|Adverse Event|1|||
130980497|NCT02586025|471553989|FG001|Neoadjuvant Treatment|Adverse Event|0|||
130980498|NCT02586025|471553988|FG000|Neoadjuvant Treatment|Physician Decision|2|||
130980499|NCT02586025|471553989|FG001|Neoadjuvant Treatment|Physician Decision|1|||
130980500|NCT02586025|471553988|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
130980501|NCT02586025|471553989|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
130980502|NCT02586025|471553988|FG000|Adjuvant Treatment|Recurrent Disease|4|||
130980503|NCT02586025|471553989|FG001|Adjuvant Treatment|Recurrent Disease|5|||
130980504|NCT02586025|471553988|FG000|Adjuvant Treatment|Physician Decision|0|||
130980505|NCT02586025|471553989|FG001|Adjuvant Treatment|Physician Decision|1|||
130980506|NCT02586025|471553988|FG000|Adjuvant Treatment|Pregnancy|1|||
130980507|NCT02586025|471553989|FG001|Adjuvant Treatment|Pregnancy|0|||
130980508|NCT02586025|471553988|FG000|Treatment-Free Follow-Up|Death|11|||
130980509|NCT02586025|471553989|FG001|Treatment-Free Follow-Up|Death|11|||
130980510|NCT02586025|471553988|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
130980511|NCT02586025|471553989|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
130980512|NCT02586025|471553988|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
130980513|NCT02586025|471553989|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
130980514|NCT02586025|471553988|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
130980515|NCT02586025|471553989|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
130980516|NCT02586025|471553988|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
130980517|NCT02586025|471553989|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
130980518|NCT00175825|471553990|FG000|Overall Study|Adverse Event|3|||
130980519|NCT00175825|471553991|FG001|Overall Study|Adverse Event|2|||
130980520|NCT00175825|471553992|FG002|Overall Study|Adverse Event|1|||
130980521|NCT00175825|471553993|FG003|Overall Study|Adverse Event|1|||
130980522|NCT00175825|471553990|FG000|Overall Study|Lost to Follow-up|1|||
130980523|NCT00175825|471553991|FG001|Overall Study|Lost to Follow-up|2|||
130980524|NCT00175825|471553992|FG002|Overall Study|Lost to Follow-up|0|||
130980525|NCT00175825|471553993|FG003|Overall Study|Lost to Follow-up|0|||
130980526|NCT00175825|471553990|FG000|Overall Study|Withdrawal by Subject|1|||
130980527|NCT00175825|471553991|FG001|Overall Study|Withdrawal by Subject|0|||
130980528|NCT00175825|471553992|FG002|Overall Study|Withdrawal by Subject|0|||
130980529|NCT00175825|471553993|FG003|Overall Study|Withdrawal by Subject|0|||
130980530|NCT02030015|471553994|FG000|Overall Study|Withdrawal by Subject|3|||
130980531|NCT02030015|471553994|FG000|Overall Study|Death|13|||
130980532|NCT03014674|471553996|FG000|Overall Study|Withdrawal by Subject|1|||
130980533|NCT03014674|471553997|FG001|Overall Study|Withdrawal by Subject|0|||
130980534|NCT03014674|471553998|FG002|Overall Study|Withdrawal by Subject|0|||
130980535|NCT00833560|471553999|FG000|Overall Study|Toxicity|13|||
130980536|NCT00833560|471553999|FG000|Overall Study|Adverse Event|11|||
130980537|NCT00833560|471553999|FG000|Overall Study|Protocol Violation|6|||
130980538|NCT00833560|471553999|FG000|Overall Study|Lack of Efficacy|4|||
130980539|NCT00833560|471553999|FG000|Overall Study|Death|2|||
130980540|NCT00833560|471553999|FG000|Overall Study|Pregression of other disease|1|||
130980541|NCT00833560|471553999|FG000|Overall Study|Other|5|||
130980542|NCT04605978|471554008|FG000|Overall Study|Adverse Event|2|||
130980543|NCT04605978|471554009|FG001|Overall Study|Adverse Event|1|||
130980544|NCT04605978|471554008|FG000|Overall Study|Withdrawal nonmedical reason|1|||
130980545|NCT04605978|471554009|FG001|Overall Study|Withdrawal nonmedical reason|1|||
130980546|NCT03104699|471554010|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
130980547|NCT03104699|471554011|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
130980548|NCT03104699|471554012|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
130980549|NCT03104699|471554013|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
130980550|NCT03104699|471554014|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
130980551|NCT03104699|471554015|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
130980552|NCT03104699|471554010|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
130980553|NCT03104699|471554011|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
130980554|NCT03104699|471554012|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
130980555|NCT03104699|471554013|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
130980556|NCT03104699|471554014|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
130980557|NCT03104699|471554015|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
130980558|NCT03104699|471554010|FG000|Phase 1: Dose Escalation|Death|6|||
130980559|NCT03104699|471554011|FG001|Phase 1: Dose Escalation|Death|3|||
130980560|NCT03104699|471554012|FG002|Phase 1: Dose Escalation|Death|0|||
130980561|NCT03104699|471554013|FG003|Phase 1: Dose Escalation|Death|1|||
130980562|NCT03104699|471554014|FG004|Phase 1: Dose Escalation|Death|1|||
130980563|NCT03104699|471554015|FG005|Phase 1: Dose Escalation|Death|0|||
130980564|NCT03104699|471554010|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
130980565|NCT03104699|471554011|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
130980566|NCT03104699|471554012|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
130980567|NCT03104699|471554013|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
130980568|NCT03104699|471554014|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
130980569|NCT03104699|471554015|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
130980570|NCT03104699|471554010|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
130980571|NCT03104699|471554011|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
130980572|NCT03104699|471554012|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
130980573|NCT03104699|471554013|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
130980574|NCT03104699|471554014|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
130980575|NCT03104699|471554015|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
130980576|NCT03104699|471554010|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
131132385|NCT01425203|472111820|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
130778821|NCT03428100|470817456|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130980577|NCT03104699|471554011|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
130980578|NCT03104699|471554012|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
130980579|NCT03104699|471554013|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
130980580|NCT03104699|471554014|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
130980581|NCT03104699|471554015|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
130980582|NCT03104699|471554010|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
130980583|NCT03104699|471554011|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
130980584|NCT03104699|471554012|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
130718816|NCT04732221|470597216|FG001|Extension Period|Withdrawal by Subject|0|||
130718817|NCT04732221|470597217|FG002|Extension Period|Withdrawal by Subject|0|||
131044013|NCT04615273|471796138|FG001|Overall Study|Randomized but not treated|3|||
131044014|NCT04615273|471796139|FG002|Overall Study|Randomized but not treated|1|||
131044015|NCT03677141|471796143|FG000|Overall Study|Death|2|||
131044016|NCT03677141|471796144|FG001|Overall Study|Death|1|||
131044017|NCT03677141|471796145|FG002|Overall Study|Death|6|||
131044018|NCT03677141|471796146|FG003|Overall Study|Death|9|||
130718818|NCT04732221|470597218|FG003|Extension Period|Withdrawal by Subject|0|||
131044019|NCT03677141|471796147|FG004|Overall Study|Death|5|||
131044020|NCT03677141|471796148|FG005|Overall Study|Death|3|||
131044021|NCT03677141|471796143|FG000|Overall Study|Lost to Follow-up|0|||
131044022|NCT03677141|471796144|FG001|Overall Study|Lost to Follow-up|0|||
131044023|NCT03677141|471796145|FG002|Overall Study|Lost to Follow-up|0|||
131044024|NCT03677141|471796146|FG003|Overall Study|Lost to Follow-up|2|||
131044025|NCT03677141|471796147|FG004|Overall Study|Lost to Follow-up|0|||
131044026|NCT03677141|471796148|FG005|Overall Study|Lost to Follow-up|0|||
131044027|NCT03677141|471796143|FG000|Overall Study|Screen failure or enrolled in error|0|||
131044028|NCT03677141|471796144|FG001|Overall Study|Screen failure or enrolled in error|0|||
130718819|NCT04732221|470597219|FG004|Extension Period|Withdrawal by Subject|1|||
130718820|NCT04732221|470597220|FG005|Extension Period|Withdrawal by Subject|5|||
130718821|NCT04732221|470597221|FG006|Extension Period|Withdrawal by Subject|2|||
130718822|NCT04347122|470597222|FG000|Overall Study|Physician Decision|0|||
130718823|NCT04347122|470597223|FG001|Overall Study|Physician Decision|3|||
130718824|NCT04347122|470597224|FG002|Overall Study|Physician Decision|3|||
130718825|NCT04347122|470597225|FG003|Overall Study|Physician Decision|6|||
130718826|NCT05327816|470597226|FG000|Overall Study|Lost to Follow-up|1|||
130718827|NCT05327816|470597227|FG001|Overall Study|Lost to Follow-up|0|||
130718828|NCT05327816|470597228|FG002|Overall Study|Lost to Follow-up|0|||
130718829|NCT05327816|470597229|FG003|Overall Study|Lost to Follow-up|0|||
130718830|NCT05327816|470597230|FG004|Overall Study|Lost to Follow-up|0|||
130718831|NCT05327816|470597231|FG005|Overall Study|Lost to Follow-up|0|||
130718832|NCT05327816|470597232|FG006|Overall Study|Lost to Follow-up|0|||
130718833|NCT05327816|470597233|FG007|Overall Study|Lost to Follow-up|0|||
130718834|NCT05327816|470597234|FG008|Overall Study|Lost to Follow-up|0|||
130718835|NCT05327816|470597235|FG009|Overall Study|Lost to Follow-up|1|||
130718836|NCT05327816|470597236|FG010|Overall Study|Lost to Follow-up|0|||
130718837|NCT05327816|470597226|FG000|Overall Study|Withdrawal by Subject|0|||
130718838|NCT05327816|470597227|FG001|Overall Study|Withdrawal by Subject|0|||
130718839|NCT05327816|470597228|FG002|Overall Study|Withdrawal by Subject|0|||
130718840|NCT05327816|470597229|FG003|Overall Study|Withdrawal by Subject|0|||
130718841|NCT05327816|470597230|FG004|Overall Study|Withdrawal by Subject|1|||
130718842|NCT05327816|470597231|FG005|Overall Study|Withdrawal by Subject|1|||
130718843|NCT05327816|470597232|FG006|Overall Study|Withdrawal by Subject|0|||
130718844|NCT05327816|470597233|FG007|Overall Study|Withdrawal by Subject|0|||
130718845|NCT05327816|470597234|FG008|Overall Study|Withdrawal by Subject|0|||
130718846|NCT05327816|470597235|FG009|Overall Study|Withdrawal by Subject|0|||
130718847|NCT05327816|470597236|FG010|Overall Study|Withdrawal by Subject|0|||
130718848|NCT05327816|470597226|FG000|Overall Study|Study Terminated by Sponsor|11|||
130718849|NCT05327816|470597227|FG001|Overall Study|Study Terminated by Sponsor|12|||
130718850|NCT05327816|470597228|FG002|Overall Study|Study Terminated by Sponsor|12|||
130718851|NCT05327816|470597229|FG003|Overall Study|Study Terminated by Sponsor|12|||
130718852|NCT05327816|470597230|FG004|Overall Study|Study Terminated by Sponsor|11|||
130718853|NCT05327816|470597231|FG005|Overall Study|Study Terminated by Sponsor|11|||
130718854|NCT05327816|470597232|FG006|Overall Study|Study Terminated by Sponsor|11|||
130718855|NCT05327816|470597233|FG007|Overall Study|Study Terminated by Sponsor|11|||
130718856|NCT05327816|470597234|FG008|Overall Study|Study Terminated by Sponsor|11|||
130718857|NCT05327816|470597235|FG009|Overall Study|Study Terminated by Sponsor|11|||
130718858|NCT05327816|470597236|FG010|Overall Study|Study Terminated by Sponsor|12|||
130718859|NCT05327816|470597226|FG000|Overall Study|Randomized but not treated|0|||
130718860|NCT05327816|470597227|FG001|Overall Study|Randomized but not treated|0|||
130718861|NCT05327816|470597228|FG002|Overall Study|Randomized but not treated|0|||
130718862|NCT05327816|470597229|FG003|Overall Study|Randomized but not treated|0|||
130718863|NCT05327816|470597230|FG004|Overall Study|Randomized but not treated|0|||
130718864|NCT05327816|470597231|FG005|Overall Study|Randomized but not treated|0|||
130718865|NCT05327816|470597232|FG006|Overall Study|Randomized but not treated|1|||
130718866|NCT05327816|470597233|FG007|Overall Study|Randomized but not treated|1|||
130718867|NCT05327816|470597234|FG008|Overall Study|Randomized but not treated|1|||
130718868|NCT05327816|470597235|FG009|Overall Study|Randomized but not treated|0|||
130718869|NCT05327816|470597236|FG010|Overall Study|Randomized but not treated|0|||
130718870|NCT01167257|470597238|FG000|Overall Study|Lost to Follow-up|2|||
130718871|NCT01167257|470597239|FG001|Overall Study|Lost to Follow-up|2|||
130718872|NCT01167257|470597238|FG000|Overall Study|Withdrew consent|1|||
131044029|NCT03677141|471796145|FG002|Overall Study|Screen failure or enrolled in error|0|||
131044030|NCT03677141|471796146|FG003|Overall Study|Screen failure or enrolled in error|0|||
131044031|NCT03677141|471796147|FG004|Overall Study|Screen failure or enrolled in error|2|||
131044032|NCT03677141|471796148|FG005|Overall Study|Screen failure or enrolled in error|0|||
131228061|NCT00210626|472461583|FG000|Overall Study|Sponser Request|1|||
131228062|NCT00210626|472461584|FG001|Overall Study|Sponser Request|0|||
131228063|NCT00210626|472461583|FG000|Overall Study|Other|4|||
131228064|NCT00210626|472461584|FG001|Overall Study|Other|5|||
131228065|NCT02473510|472461585|FG000|Overall Study|Lost to Follow-up|1|||
131228066|NCT02473510|472461586|FG001|Overall Study|Lost to Follow-up|2|||
131228067|NCT00771901|472461587|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
131228068|NCT00771901|472461588|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
131228069|NCT00771901|472461589|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
131228070|NCT02280356|472461592|FG000|Overall Study|Not Treated|2|||
131228071|NCT02280356|472461592|FG000|Overall Study|Withdrawal by Subject|1|||
131228072|NCT02280356|472461592|FG000|Overall Study|Not evaluable|2|||
131228073|NCT01086215|472461593|FG000|Overall Study|Death|14|||
131228074|NCT01086215|472461594|FG001|Overall Study|Death|8|||
131228075|NCT01086215|472461595|FG002|Overall Study|Death|8|||
131228076|NCT01086215|472461596|FG003|Overall Study|Death|1|||
131228077|NCT01086215|472461593|FG000|Overall Study|Lost to Follow-up|22|||
131228078|NCT01086215|472461594|FG001|Overall Study|Lost to Follow-up|39|||
131228079|NCT01086215|472461595|FG002|Overall Study|Lost to Follow-up|18|||
131228080|NCT01086215|472461596|FG003|Overall Study|Lost to Follow-up|2|||
131228081|NCT01965652|472461597|FG000|Overall Study|Adverse Event|40|||
131228082|NCT01965652|472461598|FG001|Overall Study|Adverse Event|37|||
131228083|NCT01965652|472461597|FG000|Overall Study|Withdrawal by Subject|62|||
131228084|NCT01965652|472461598|FG001|Overall Study|Withdrawal by Subject|69|||
131228085|NCT01965652|472461597|FG000|Overall Study|Lost to Follow-up|53|||
131228086|NCT01965652|472461598|FG001|Overall Study|Lost to Follow-up|40|||
131228087|NCT01965652|472461597|FG000|Overall Study|Protocol Violation|34|||
131228088|NCT01965652|472461598|FG001|Overall Study|Protocol Violation|38|||
131228089|NCT01965652|472461597|FG000|Overall Study|Death|3|||
131228090|NCT01965652|472461598|FG001|Overall Study|Death|4|||
131228091|NCT01965652|472461597|FG000|Overall Study|Other - Miscellaneous|18|||
131228092|NCT01965652|472461598|FG001|Overall Study|Other - Miscellaneous|21|||
131228093|NCT01965652|472461597|FG000|Overall Study|Pregnancy|0|||
131228094|NCT01965652|472461598|FG001|Overall Study|Pregnancy|1|||
131228095|NCT01121900|472461601|FG000|First Intervention Period|Adverse Event|1|||
131228096|NCT01121900|472461602|FG001|First Intervention Period|Adverse Event|1|||
131228097|NCT01121900|472461601|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
131132386|NCT01425203|472111821|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
131132387|NCT01425203|472111819|FG000|Treatment Phase|Failure at futility timepoint|8|||
131132388|NCT01425203|472111820|FG001|Treatment Phase|Failure at futility timepoint|27|||
131132389|NCT01425203|472111821|FG002|Treatment Phase|Failure at futility timepoint|0|||
131132390|NCT01425203|472111819|FG000|Treatment Phase|Other virologic failure criteria|5|||
131132391|NCT01425203|472111820|FG001|Treatment Phase|Other virologic failure criteria|3|||
131132392|NCT01425203|472111821|FG002|Treatment Phase|Other virologic failure criteria|0|||
131132393|NCT01425203|472111819|FG000|Treatment Phase|Unidentified reasons|11|||
131132394|NCT01425203|472111820|FG001|Treatment Phase|Unidentified reasons|5|||
130718873|NCT01167257|470597239|FG001|Overall Study|Withdrew consent|1|||
130718874|NCT04305587|470597240|FG000|Overall Study|Withdrawal by Subject|0|||
130718875|NCT04305587|470597241|FG001|Overall Study|Withdrawal by Subject|0|||
130718876|NCT04305587|470597242|FG002|Overall Study|Withdrawal by Subject|0|||
131132395|NCT01425203|472111821|FG002|Treatment Phase|Unidentified reasons|0|||
130718877|NCT04305587|470597243|FG003|Overall Study|Withdrawal by Subject|1|||
130718878|NCT04305587|470597244|FG004|Overall Study|Withdrawal by Subject|0|||
130718879|NCT04305587|470597245|FG005|Overall Study|Withdrawal by Subject|0|||
130718880|NCT04305587|470597246|FG006|Overall Study|Withdrawal by Subject|0|||
130718881|NCT04305587|470597247|FG007|Overall Study|Withdrawal by Subject|0|||
130718882|NCT04305587|470597248|FG008|Overall Study|Withdrawal by Subject|0|||
130718883|NCT02752906|470597249|FG000|Overall Study|Protocol Violation|2|||
131132396|NCT01425203|472111819|FG000|Treatment Phase|Did not receive treatment|0|||
131132397|NCT01425203|472111820|FG001|Treatment Phase|Did not receive treatment|1|||
131228098|NCT01121900|472461602|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131228099|NCT03469271|472461603|FG000|Overall Study|Withdrawal by Subject|2|||
131228100|NCT03469271|472461604|FG001|Overall Study|Withdrawal by Subject|0|||
131132398|NCT01425203|472111821|FG002|Treatment Phase|Did not receive treatment|0|||
131228101|NCT03469271|472461605|FG002|Overall Study|Withdrawal by Subject|0|||
131228102|NCT03469271|472461606|FG003|Overall Study|Withdrawal by Subject|1|||
131228103|NCT01328054|472461607|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
131228104|NCT01328054|472461608|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
131228105|NCT01328054|472461607|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
131132399|NCT01425203|472111819|FG000|Crossover Phase|Failure at futility timepoint|0|||
131228106|NCT01328054|472461608|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
131228107|NCT01328054|472461607|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
131228108|NCT01328054|472461608|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
131132400|NCT01425203|472111820|FG001|Crossover Phase|Failure at futility timepoint|0|||
131132401|NCT01425203|472111821|FG002|Crossover Phase|Failure at futility timepoint|3|||
131228109|NCT03493698|472461609|FG000|Treatment Period C|Adverse Event|1|||
130980585|NCT03104699|471554013|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
130980586|NCT03104699|471554014|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
130980587|NCT03104699|471554015|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
130980588|NCT03104699|471554010|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
130980589|NCT03104699|471554011|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
130980590|NCT03104699|471554012|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
130980591|NCT03104699|471554013|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
130980592|NCT03104699|471554014|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
130980593|NCT03104699|471554015|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
130980594|NCT03104699|471554010|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130980595|NCT03104699|471554011|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130980596|NCT03104699|471554012|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130980597|NCT03104699|471554013|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130980598|NCT03104699|471554014|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
130980599|NCT03104699|471554015|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
130980600|NCT03104699|471554010|FG000|Phase 2: Dose Expansion|Death|0|||
130980601|NCT03104699|471554011|FG001|Phase 2: Dose Expansion|Death|0|||
130980602|NCT03104699|471554012|FG002|Phase 2: Dose Expansion|Death|0|||
130980603|NCT03104699|471554013|FG003|Phase 2: Dose Expansion|Death|0|||
130980604|NCT03104699|471554014|FG004|Phase 2: Dose Expansion|Death|0|||
130980605|NCT03104699|471554015|FG005|Phase 2: Dose Expansion|Death|107|||
130980606|NCT03104699|471554010|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
130980607|NCT03104699|471554011|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
130980608|NCT03104699|471554012|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
130980609|NCT03104699|471554013|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
130980610|NCT03104699|471554014|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
130980611|NCT03104699|471554015|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
130980612|NCT03104699|471554010|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
130980613|NCT03104699|471554011|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
130980614|NCT03104699|471554012|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
130980615|NCT03104699|471554013|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
130980616|NCT03104699|471554014|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
130980617|NCT03104699|471554015|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
130980618|NCT03104699|471554010|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130980619|NCT03104699|471554011|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130980620|NCT03104699|471554012|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130980621|NCT03104699|471554013|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130980622|NCT03104699|471554014|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
130980623|NCT03104699|471554015|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
130980624|NCT03104699|471554010|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
130980625|NCT03104699|471554011|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
130980626|NCT03104699|471554012|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
130980627|NCT03104699|471554013|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
130980628|NCT03104699|471554014|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
130980629|NCT03104699|471554015|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
130980630|NCT01690130|471554016|FG000|Overall Study|Subject have cancelled visit.|1|||
130980631|NCT01690130|471554017|FG001|Overall Study|Subject have cancelled visit.|0|||
130980632|NCT01644734|471554018|FG000|Overall Study|Adverse Event|4|||
130980633|NCT01644734|471554018|FG000|Overall Study|Lost to Follow-up|17|||
130980634|NCT01644734|471554018|FG000|Overall Study|Reasons other than stated above|7|||
130980635|NCT01644734|471554018|FG000|Overall Study|Missing documentation|238|||
130980636|NCT05159622|471554019|FG000|Overall Study|Lost to Follow-up|4|||
130980637|NCT05159622|471554020|FG001|Overall Study|Lost to Follow-up|5|||
130778822|NCT03428100|470817457|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130980638|NCT03318523|471554021|FG000|PC Period: Up to Year 1|Adverse Event|1|||
130980639|NCT03318523|471554022|FG001|PC Period: Up to Year 1|Adverse Event|0|||
130980640|NCT03318523|471554023|FG002|PC Period: Up to Year 1|Adverse Event|2|||
130980641|NCT03318523|471554024|FG003|PC Period: Up to Year 1|Adverse Event|0|||
130980642|NCT03318523|471554025|FG004|PC Period: Up to Year 1|Adverse Event|0|||
130980643|NCT03318523|471554026|FG005|PC Period: Up to Year 1|Adverse Event|0|||
130980644|NCT03318523|471554027|FG006|PC Period: Up to Year 1|Adverse Event|0|||
130980645|NCT03318523|471554028|FG007|PC Period: Up to Year 1|Adverse Event|0|||
130980646|NCT03318523|471554029|FG008|PC Period: Up to Year 1|Adverse Event|0|||
130980647|NCT03318523|471554030|FG009|PC Period: Up to Year 1|Adverse Event|0|||
130980648|NCT03318523|471554021|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
130980649|NCT03318523|471554022|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
130980650|NCT03318523|471554023|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
130980651|NCT03318523|471554024|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
130980652|NCT03318523|471554025|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
130980653|NCT03318523|471554026|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
130980654|NCT03318523|471554027|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
130980655|NCT03318523|471554028|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
130980656|NCT03318523|471554029|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
130980657|NCT03318523|471554030|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
130980658|NCT03318523|471554021|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130980659|NCT03318523|471554022|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130980660|NCT03318523|471554023|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130980661|NCT03318523|471554024|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130980662|NCT03318523|471554025|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
130980663|NCT03318523|471554026|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130980664|NCT03318523|471554027|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130980665|NCT03318523|471554028|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
130980666|NCT03318523|471554029|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130980667|NCT03318523|471554030|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
130980668|NCT03318523|471554021|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130980669|NCT03318523|471554022|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130980670|NCT03318523|471554023|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130980671|NCT03318523|471554024|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130980672|NCT03318523|471554025|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
130980673|NCT03318523|471554026|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130980674|NCT03318523|471554027|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
130980675|NCT03318523|471554028|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
130980676|NCT03318523|471554029|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
130980677|NCT03318523|471554030|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
130980678|NCT03318523|471554021|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130980679|NCT03318523|471554022|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130980680|NCT03318523|471554023|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130980681|NCT03318523|471554024|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130980682|NCT03318523|471554025|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130980683|NCT03318523|471554026|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
130980684|NCT03318523|471554027|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130980685|NCT03318523|471554028|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130980686|NCT03318523|471554029|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130980687|NCT03318523|471554030|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
130980688|NCT03318523|471554021|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130980689|NCT03318523|471554022|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130980690|NCT03318523|471554023|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130980691|NCT03318523|471554024|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130980692|NCT03318523|471554025|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130980693|NCT03318523|471554026|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130980694|NCT03318523|471554027|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130980695|NCT03318523|471554028|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130980696|NCT03318523|471554029|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
130980697|NCT03318523|471554030|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
130980698|NCT03318523|471554021|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
130980699|NCT03318523|471554022|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
130980700|NCT03318523|471554023|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
130980701|NCT03318523|471554024|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
130980702|NCT03318523|471554025|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
130980703|NCT03318523|471554026|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
130980704|NCT03318523|471554027|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
130980705|NCT03318523|471554028|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
130980706|NCT03318523|471554029|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
130980707|NCT03318523|471554030|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
130980708|NCT03318523|471554021|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130980709|NCT03318523|471554022|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130980710|NCT03318523|471554023|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130980711|NCT03318523|471554024|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
131044033|NCT03677141|471796143|FG000|Overall Study|Physician Decision|0|||
131044034|NCT03677141|471796144|FG001|Overall Study|Physician Decision|0|||
131044035|NCT03677141|471796145|FG002|Overall Study|Physician Decision|0|||
131044036|NCT03677141|471796146|FG003|Overall Study|Physician Decision|0|||
131044037|NCT03677141|471796147|FG004|Overall Study|Physician Decision|1|||
131044038|NCT03677141|471796148|FG005|Overall Study|Physician Decision|0|||
131044039|NCT03677141|471796143|FG000|Overall Study|Withdrawal by Subject|0|||
131044040|NCT03677141|471796144|FG001|Overall Study|Withdrawal by Subject|0|||
131044041|NCT03677141|471796145|FG002|Overall Study|Withdrawal by Subject|1|||
130980712|NCT03318523|471554025|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
130980713|NCT03318523|471554026|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130980714|NCT03318523|471554027|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130980715|NCT03318523|471554028|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
130980716|NCT03318523|471554029|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
130980717|NCT03318523|471554030|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
130980718|NCT03581981|471554034|FG000|Overall Study|Withdrawal by Subject|12|||
130980719|NCT03581981|471554035|FG001|Overall Study|Withdrawal by Subject|13|||
130980720|NCT03581981|471554034|FG000|Overall Study|Physician Decision|1|||
130980721|NCT03581981|471554035|FG001|Overall Study|Physician Decision|2|||
130980722|NCT03581981|471554034|FG000|Overall Study|Lost to Follow-up|0|||
130980723|NCT03581981|471554035|FG001|Overall Study|Lost to Follow-up|4|||
130980724|NCT01410474|471554036|FG000|Overall Study|Withdrawal by Subject|0|||
130980725|NCT01410474|471554037|FG001|Overall Study|Withdrawal by Subject|1|||
130980726|NCT00828984|471554039|FG000|Overall Study|Adverse Event|2|||
130980727|NCT00828984|471554040|FG001|Overall Study|Adverse Event|3|||
130980728|NCT00828984|471554041|FG002|Overall Study|Adverse Event|0|||
130980729|NCT00828984|471554039|FG000|Overall Study|Lost to Follow-up|5|||
130980730|NCT00828984|471554040|FG001|Overall Study|Lost to Follow-up|3|||
130980731|NCT00828984|471554041|FG002|Overall Study|Lost to Follow-up|1|||
130980732|NCT00828984|471554039|FG000|Overall Study|Withdrawal by Subject|4|||
130980733|NCT00828984|471554040|FG001|Overall Study|Withdrawal by Subject|4|||
130980734|NCT00828984|471554041|FG002|Overall Study|Withdrawal by Subject|4|||
130980735|NCT00828984|471554039|FG000|Overall Study|Ineligable|1|||
130980736|NCT00828984|471554040|FG001|Overall Study|Ineligable|2|||
130980737|NCT00828984|471554041|FG002|Overall Study|Ineligable|0|||
130980738|NCT00828984|471554039|FG000|Overall Study|Medical Contraindication|0|||
130980739|NCT00828984|471554040|FG001|Overall Study|Medical Contraindication|1|||
130980740|NCT00828984|471554041|FG002|Overall Study|Medical Contraindication|0|||
130980741|NCT00828984|471554039|FG000|Overall Study|Noncompliant|1|||
130980742|NCT00828984|471554040|FG001|Overall Study|Noncompliant|2|||
130980743|NCT00828984|471554041|FG002|Overall Study|Noncompliant|3|||
130980744|NCT00828984|471554039|FG000|Overall Study|ConMed|1|||
130980745|NCT00828984|471554040|FG001|Overall Study|ConMed|1|||
130980746|NCT00828984|471554041|FG002|Overall Study|ConMed|1|||
130980747|NCT00863655|471554045|FG000|Overall Study|Protocol Violation|4|||
130980748|NCT00863655|471554046|FG001|Overall Study|Protocol Violation|0|||
130980749|NCT00863655|471554045|FG000|Overall Study|Adverse Event|52|||
130980750|NCT00863655|471554046|FG001|Overall Study|Adverse Event|8|||
130980751|NCT00863655|471554045|FG000|Overall Study|Withdrawal by Subject|47|||
130980752|NCT00863655|471554046|FG001|Overall Study|Withdrawal by Subject|7|||
130980753|NCT00863655|471554045|FG000|Overall Study|Administrative problems|1|||
130980754|NCT00863655|471554046|FG001|Overall Study|Administrative problems|0|||
130980755|NCT00863655|471554045|FG000|Overall Study|Death|7|||
130980756|NCT00863655|471554046|FG001|Overall Study|Death|1|||
130980757|NCT00863655|471554045|FG000|Overall Study|New cancer therapy|5|||
130980758|NCT00863655|471554046|FG001|Overall Study|New cancer therapy|1|||
130980759|NCT00863655|471554045|FG000|Overall Study|Disease progression|364|||
130980760|NCT00863655|471554046|FG001|Overall Study|Disease progression|221|||
130980761|NCT00863655|471554045|FG000|Overall Study|Treatment completed as per protocol|5|||
130980762|NCT00863655|471554046|FG001|Overall Study|Treatment completed as per protocol|1|||
130980763|NCT02157779|471554049|FG000|Overall Study|Logistical|9|||
130980764|NCT02157779|471554050|FG001|Overall Study|Logistical|3|||
130980765|NCT02157779|471554049|FG000|Overall Study|Stopped attending, reason unknown|11|||
130980766|NCT02157779|471554050|FG001|Overall Study|Stopped attending, reason unknown|7|||
130980767|NCT02157779|471554049|FG000|Overall Study|No response to outreach after Baseline|1|||
130980768|NCT02157779|471554050|FG001|Overall Study|No response to outreach after Baseline|1|||
130980769|NCT02157779|471554049|FG000|Overall Study|Moved|1|||
130980770|NCT02157779|471554050|FG001|Overall Study|Moved|0|||
130980771|NCT02157779|471554049|FG000|Overall Study|Medical|1|||
130980772|NCT02157779|471554050|FG001|Overall Study|Medical|0|||
130980773|NCT02157779|471554049|FG000|Overall Study|Legal issue|1|||
130980774|NCT02157779|471554050|FG001|Overall Study|Legal issue|0|||
130980775|NCT00002558|471554054|FG000|Overall Study|Withdrawal by Subject|0|||
130980776|NCT00002558|471554055|FG001|Overall Study|Withdrawal by Subject|1|||
130980777|NCT02065336|471554056|FG000|Extension Phase|Study Terminated by Sponsor|0|||
130980778|NCT02065336|471554057|FG001|Extension Phase|Study Terminated by Sponsor|0|||
130778823|NCT03428100|470817458|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130980779|NCT02065336|471554058|FG002|Extension Phase|Study Terminated by Sponsor|0|||
130980780|NCT02065336|471554059|FG003|Extension Phase|Study Terminated by Sponsor|0|||
130980781|NCT02065336|471554060|FG004|Extension Phase|Study Terminated by Sponsor|0|||
130980782|NCT02065336|471554061|FG005|Extension Phase|Study Terminated by Sponsor|0|||
130980783|NCT02065336|471554062|FG006|Extension Phase|Study Terminated by Sponsor|0|||
130980784|NCT02065336|471554063|FG007|Extension Phase|Study Terminated by Sponsor|0|||
130980785|NCT02065336|471554064|FG008|Extension Phase|Study Terminated by Sponsor|2|||
130778824|NCT03428100|470817459|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130980786|NCT02065336|471554065|FG009|Extension Phase|Study Terminated by Sponsor|8|||
130980787|NCT00626028|471554066|FG000|Overall Study|Adverse Event|1|||
130980788|NCT00626028|471554067|FG001|Overall Study|Adverse Event|1|||
130980789|NCT00626028|471554066|FG000|Overall Study|Device Failure|0|||
130980790|NCT00626028|471554067|FG001|Overall Study|Device Failure|1|||
130980791|NCT00626028|471554066|FG000|Overall Study|Physician Decision|2|||
130980792|NCT00626028|471554067|FG001|Overall Study|Physician Decision|1|||
130980793|NCT00626028|471554066|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
130980794|NCT00626028|471554067|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
130980795|NCT00831779|471554069|FG000|Overall Study|Lost to Follow-up|1|||
130980796|NCT00831779|471554070|FG001|Overall Study|Lost to Follow-up|0|||
130980797|NCT00831779|471554069|FG000|Overall Study|No longer met criteria|0|||
130980798|NCT00831779|471554070|FG001|Overall Study|No longer met criteria|1|||
130980799|NCT02436330|471554071|FG000|Cohort 1|Lost to Follow-up|5|||
130980800|NCT02436330|471554072|FG001|Cohort 1|Lost to Follow-up|2|||
130980801|NCT02436330|471554071|FG000|Cohort 1|Withdrawal by Subject|0|||
130980802|NCT02436330|471554072|FG001|Cohort 1|Withdrawal by Subject|1|||
130980803|NCT02436330|471554071|FG000|Cohort 2|Lost to Follow-up|2|||
130980804|NCT02436330|471554072|FG001|Cohort 2|Lost to Follow-up|0|||
130980805|NCT02436330|471554071|FG000|Cohort 2|Withdrawal by Subject|2|||
130980806|NCT02436330|471554072|FG001|Cohort 2|Withdrawal by Subject|3|||
130980807|NCT02436330|471554071|FG000|Cohort 3|Lost to Follow-up|1|||
130980808|NCT02436330|471554072|FG001|Cohort 3|Lost to Follow-up|0|||
130980809|NCT02436330|471554071|FG000|Cohort 3|Withdrawal by Subject|4|||
130980810|NCT02436330|471554072|FG001|Cohort 3|Withdrawal by Subject|0|||
130980811|NCT02436330|471554071|FG000|Cohort 4|Lost to Follow-up|1|||
130980812|NCT02436330|471554072|FG001|Cohort 4|Lost to Follow-up|0|||
130980813|NCT02436330|471554071|FG000|Cohort 4|Withdrawal by Subject|1|||
130980814|NCT02436330|471554072|FG001|Cohort 4|Withdrawal by Subject|0|||
130980815|NCT02436330|471554071|FG000|Cohort 5|Lost to Follow-up|3|||
130980816|NCT02436330|471554072|FG001|Cohort 5|Lost to Follow-up|2|||
130980817|NCT02436330|471554071|FG000|Cohort 5|Withdrawal by Subject|3|||
130980818|NCT02436330|471554072|FG001|Cohort 5|Withdrawal by Subject|2|||
130980819|NCT02436330|471554071|FG000|Cohort 6|Lost to Follow-up|2|||
130980820|NCT02436330|471554072|FG001|Cohort 6|Lost to Follow-up|0|||
130980821|NCT02436330|471554071|FG000|Cohort 6|Withdrawal by Subject|1|||
130980822|NCT02436330|471554072|FG001|Cohort 6|Withdrawal by Subject|1|||
130980823|NCT01375114|471554074|FG000|Overall Study|Lost to Follow-up|1|||
130980824|NCT01375114|471554075|FG001|Overall Study|Lost to Follow-up|0|||
130980825|NCT01375114|471554076|FG002|Overall Study|Lost to Follow-up|1|||
130980826|NCT01375114|471554074|FG000|Overall Study|Disease Progression|3|||
130980827|NCT01375114|471554075|FG001|Overall Study|Disease Progression|2|||
130980828|NCT01375114|471554076|FG002|Overall Study|Disease Progression|2|||
130980829|NCT01375114|471554074|FG000|Overall Study|Patient Changed Mind|0|||
130980830|NCT01375114|471554075|FG001|Overall Study|Patient Changed Mind|0|||
130980831|NCT01375114|471554076|FG002|Overall Study|Patient Changed Mind|2|||
130980832|NCT01375114|471554074|FG000|Overall Study|Pruritus|0|||
130980833|NCT01375114|471554075|FG001|Overall Study|Pruritus|0|||
130980834|NCT01375114|471554076|FG002|Overall Study|Pruritus|1|||
130980835|NCT01375114|471554074|FG000|Overall Study|Restlessness|0|||
130980836|NCT01375114|471554075|FG001|Overall Study|Restlessness|0|||
130980837|NCT01375114|471554076|FG002|Overall Study|Restlessness|1|||
130980838|NCT01375114|471554074|FG000|Overall Study|Diarrhea|0|||
130980839|NCT01375114|471554075|FG001|Overall Study|Diarrhea|0|||
130980840|NCT01375114|471554076|FG002|Overall Study|Diarrhea|1|||
130980841|NCT01375114|471554074|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
130980842|NCT01375114|471554075|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
130980843|NCT01375114|471554076|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
130980844|NCT01375114|471554074|FG000|Overall Study|Nausea|0|||
130980845|NCT01375114|471554075|FG001|Overall Study|Nausea|1|||
130980846|NCT01375114|471554076|FG002|Overall Study|Nausea|0|||
130980847|NCT01375114|471554074|FG000|Overall Study|Increased AST/ALT|0|||
130980848|NCT01375114|471554075|FG001|Overall Study|Increased AST/ALT|1|||
130980849|NCT01375114|471554076|FG002|Overall Study|Increased AST/ALT|0|||
130980850|NCT01375114|471554074|FG000|Overall Study|Vaginal Hemorrhage|0|||
130980851|NCT01375114|471554075|FG001|Overall Study|Vaginal Hemorrhage|1|||
130980852|NCT01375114|471554076|FG002|Overall Study|Vaginal Hemorrhage|0|||
130980853|NCT01375114|471554074|FG000|Overall Study|Family problem|0|||
130980854|NCT01375114|471554075|FG001|Overall Study|Family problem|1|||
130980855|NCT01375114|471554076|FG002|Overall Study|Family problem|0|||
130980856|NCT01375114|471554074|FG000|Overall Study|Protocol Violation|2|||
130980857|NCT01375114|471554075|FG001|Overall Study|Protocol Violation|0|||
130980858|NCT01375114|471554076|FG002|Overall Study|Protocol Violation|0|||
130980859|NCT03575325|471554077|FG000|Overall Study|Death|1|||
130980860|NCT00162370|471554078|FG000|Efficacy Population|Lost to Follow-up|51|||
130980861|NCT04040751|471554079|FG000|Overall Study|Withdrawal by Subject|2|||
130980862|NCT04040751|471554080|FG001|Overall Study|Withdrawal by Subject|0|||
130980863|NCT04040751|471554081|FG002|Overall Study|Withdrawal by Subject|2|||
130980864|NCT04040751|471554082|FG003|Overall Study|Withdrawal by Subject|0|||
131132402|NCT01425203|472111819|FG000|Crossover Phase|Other virologic failure criteria|0|||
130980865|NCT02472964|471554083|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
131228110|NCT03493698|472461609|FG000|Treatment Period C|Withdrawal by Subject|1|||
131228111|NCT03760510|472461610|FG000|Overall Study|Not ventilated for 24 hours|105|||
131228112|NCT03760510|472461611|FG001|Overall Study|Not ventilated for 24 hours|97|||
131228113|NCT03361956|472461612|FG000|Overall Study|Adverse Event|1|||
131228114|NCT03361956|472461613|FG001|Overall Study|Adverse Event|0|||
131228115|NCT03361956|472461614|FG002|Overall Study|Adverse Event|1|||
131228116|NCT03361956|472461615|FG003|Overall Study|Adverse Event|1|||
131228117|NCT03361956|472461616|FG004|Overall Study|Adverse Event|0|||
131228118|NCT03361956|472461612|FG000|Overall Study|Other|0|||
131228119|NCT03361956|472461613|FG001|Overall Study|Other|0|||
130718884|NCT02752906|470597250|FG001|Overall Study|Protocol Violation|1|||
130718885|NCT02752906|470597249|FG000|Overall Study|Withdrawal by Subject|2|||
131044042|NCT03677141|471796146|FG003|Overall Study|Withdrawal by Subject|1|||
131044043|NCT03677141|471796147|FG004|Overall Study|Withdrawal by Subject|1|||
131044044|NCT03677141|471796148|FG005|Overall Study|Withdrawal by Subject|0|||
131044045|NCT03673501|471796156|FG000|Overall Study|Participants ongoing.|36|||
131044046|NCT03673501|471796157|FG001|Overall Study|Participants ongoing.|24|||
131044047|NCT05838027|471796158|FG000|Overall Study|Lost to Follow-up|5|||
131044048|NCT05838027|471796159|FG001|Overall Study|Lost to Follow-up|1|||
130718886|NCT02752906|470597250|FG001|Overall Study|Withdrawal by Subject|2|||
130718887|NCT02752906|470597249|FG000|Overall Study|Lost to Follow-up|3|||
130980866|NCT02472964|471554084|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
130980867|NCT02472964|471554083|FG000|Part 1 (up to Week 24)|disease progression|58|||
130980868|NCT02472964|471554084|FG001|Part 1 (up to Week 24)|disease progression|47|||
130980869|NCT02472964|471554083|FG000|Part 1 (up to Week 24)|Death|3|||
130980870|NCT02472964|471554084|FG001|Part 1 (up to Week 24)|Death|6|||
130980871|NCT02472964|471554083|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
130980872|NCT02472964|471554084|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
130980873|NCT02472964|471554083|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
130980874|NCT02472964|471554084|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
130980875|NCT02472964|471554083|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
130980876|NCT02472964|471554084|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
130980877|NCT02472964|471554083|FG000|Part 1 (up to Week 24)|Other|2|||
130980878|NCT02472964|471554084|FG001|Part 1 (up to Week 24)|Other|1|||
130980879|NCT02472964|471554083|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
130980880|NCT02472964|471554084|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
130980881|NCT02472964|471554083|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
130980882|NCT02472964|471554084|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
130980883|NCT02472964|471554083|FG000|Part 2 (Week 24-week 48)|Death|0|||
130980884|NCT02472964|471554084|FG001|Part 2 (Week 24-week 48)|Death|1|||
130980885|NCT02472964|471554083|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
130980886|NCT02472964|471554084|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
130980887|NCT02472964|471554083|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
131044049|NCT05838027|471796158|FG000|Overall Study|Withdrawal by Subject|1|||
131044050|NCT05838027|471796159|FG001|Overall Study|Withdrawal by Subject|0|||
131044051|NCT04599634|471796160|FG000|Overall Study|Dose limiting toxicity|0|||
131044052|NCT04599634|471796161|FG001|Overall Study|Dose limiting toxicity|0|||
130718888|NCT02752906|470597250|FG001|Overall Study|Lost to Follow-up|2|||
130718889|NCT02492880|470597252|FG000|Overall Study|Lost to Follow-up|1|||
130718890|NCT02492880|470597252|FG000|Overall Study|Protocol Violation|1|||
130718891|NCT00554190|470597253|FG000|Overall Study|Termination forms not completed|10|||
130718892|NCT04241315|470597260|FG000|Overall Study|Withdrawal by Subject|0|||
130718893|NCT04241315|470597261|FG001|Overall Study|Withdrawal by Subject|1|||
130718894|NCT00699283|470597262|FG000|Overall Study|Lack of Efficacy|15|||
130718895|NCT00699283|470597263|FG001|Overall Study|Lack of Efficacy|5|||
130718896|NCT00699283|470597262|FG000|Overall Study|Lost to Follow-up|2|||
130718897|NCT00699283|470597263|FG001|Overall Study|Lost to Follow-up|0|||
130718898|NCT00699283|470597262|FG000|Overall Study|Withdrawal by Subject|1|||
130718899|NCT00699283|470597263|FG001|Overall Study|Withdrawal by Subject|0|||
130718900|NCT00699283|470597262|FG000|Overall Study|Other Reason|5|||
130718901|NCT00699283|470597263|FG001|Overall Study|Other Reason|1|||
130718902|NCT00699283|470597262|FG000|Overall Study|SAE, non-fatal|1|||
130718903|NCT00699283|470597263|FG001|Overall Study|SAE, non-fatal|1|||
130980888|NCT02472964|471554084|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
130980889|NCT02472964|471554083|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
131044053|NCT04599634|471796162|FG002|Overall Study|Dose limiting toxicity|2|||
130718904|NCT00699283|470597262|FG000|Overall Study|AE, non-serious non-fatal|8|||
130718905|NCT00699283|470597263|FG001|Overall Study|AE, non-serious non-fatal|1|||
130980890|NCT02472964|471554084|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
130980891|NCT02472964|471554083|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
131044054|NCT04599634|471796163|FG003|Overall Study|Dose limiting toxicity|0|||
130718906|NCT00699283|470597262|FG000|Overall Study|AE of unknown type|1|||
130718907|NCT00699283|470597263|FG001|Overall Study|AE of unknown type|0|||
130718908|NCT00394524|470597264|FG000|Overall Study|Protocol Violation|2|||
131228120|NCT03361956|472461614|FG002|Overall Study|Other|0|||
131228121|NCT03361956|472461615|FG003|Overall Study|Other|1|||
131228122|NCT03361956|472461616|FG004|Overall Study|Other|0|||
130718909|NCT00394524|470597265|FG001|Overall Study|Protocol Violation|3|||
130718910|NCT00394524|470597264|FG000|Overall Study|Death|1|||
130718911|NCT00394524|470597265|FG001|Overall Study|Death|0|||
131132403|NCT01425203|472111820|FG001|Crossover Phase|Other virologic failure criteria|0|||
131132404|NCT01425203|472111821|FG002|Crossover Phase|Other virologic failure criteria|3|||
131132405|NCT00535132|472111824|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
131132406|NCT00535132|472111825|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
130980892|NCT02472964|471554084|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
130980893|NCT01749982|471554085|FG000|Overall Study|Physician Decision|0|||
130980894|NCT01749982|471554086|FG001|Overall Study|Physician Decision|0|||
130980895|NCT01749982|471554087|FG002|Overall Study|Physician Decision|0|||
130980896|NCT01749982|471554088|FG003|Overall Study|Physician Decision|1|||
130980897|NCT01749982|471554085|FG000|Overall Study|Lost to Follow-up|0|||
130980898|NCT01749982|471554086|FG001|Overall Study|Lost to Follow-up|0|||
130980899|NCT01749982|471554087|FG002|Overall Study|Lost to Follow-up|0|||
130980900|NCT01749982|471554088|FG003|Overall Study|Lost to Follow-up|1|||
130980901|NCT01749982|471554085|FG000|Overall Study|Withdrawal by Subject|0|||
130980902|NCT01749982|471554086|FG001|Overall Study|Withdrawal by Subject|0|||
130980903|NCT01749982|471554087|FG002|Overall Study|Withdrawal by Subject|0|||
130980904|NCT01749982|471554088|FG003|Overall Study|Withdrawal by Subject|1|||
130980905|NCT01596582|471554089|FG000|Overall Study|Deemed ineligible after study visit|3|||
130980906|NCT01596582|471554090|FG001|Overall Study|Deemed ineligible after study visit|6|||
130980907|NCT01596582|471554089|FG000|Overall Study|Missing all outcome data|1|||
130980908|NCT01596582|471554090|FG001|Overall Study|Missing all outcome data|1|||
130980909|NCT03923933|471554095|FG000|Overall Study|Lost to Follow-up|1|||
130980910|NCT03923933|471554096|FG001|Overall Study|Lost to Follow-up|0|||
130980911|NCT03923933|471554095|FG000|Overall Study|Withdrawal by Subject|0|||
130980912|NCT03923933|471554096|FG001|Overall Study|Withdrawal by Subject|1|||
130980913|NCT00419263|471554097|FG000|Overall Study|Lost to Follow-up|2|||
130980914|NCT00419263|471554098|FG001|Overall Study|Lost to Follow-up|1|||
130980915|NCT00419263|471554099|FG002|Overall Study|Lost to Follow-up|1|||
130980916|NCT00419263|471554097|FG000|Overall Study|Randomized in Error, Not Treated|1|||
130980917|NCT00419263|471554098|FG001|Overall Study|Randomized in Error, Not Treated|1|||
130980918|NCT00419263|471554099|FG002|Overall Study|Randomized in Error, Not Treated|0|||
130980919|NCT00419263|471554097|FG000|Overall Study|Adverse Event|0|||
130980920|NCT00419263|471554098|FG001|Overall Study|Adverse Event|0|||
130980921|NCT00419263|471554099|FG002|Overall Study|Adverse Event|1|||
130980922|NCT00419263|471554097|FG000|Overall Study|Withdrawal by Subject|0|||
130980923|NCT00419263|471554098|FG001|Overall Study|Withdrawal by Subject|0|||
130980924|NCT00419263|471554099|FG002|Overall Study|Withdrawal by Subject|1|||
130980925|NCT00587964|471554100|FG000|Overall Study|Withdrawal by Subject|1|||
130980926|NCT00587964|471554100|FG000|Overall Study|Lost to Follow-up|1|||
130980927|NCT00587964|471554100|FG000|Overall Study|Patient found to be ineligible|1|||
130980928|NCT00587964|471554100|FG000|Overall Study|Patient did not receive intervention|5|||
130980929|NCT00587964|471554100|FG000|Overall Study|Progression of Disease|4|||
130980930|NCT00540124|471554101|FG000|Overall Study|Adverse Event|0|||
130980931|NCT00540124|471554102|FG001|Overall Study|Adverse Event|2|||
130980932|NCT00540124|471554103|FG002|Overall Study|Adverse Event|1|||
130980933|NCT00540124|471554101|FG000|Overall Study|Entry Criteria Not Met|2|||
130980934|NCT00540124|471554102|FG001|Overall Study|Entry Criteria Not Met|0|||
130980935|NCT00540124|471554103|FG002|Overall Study|Entry Criteria Not Met|0|||
131132407|NCT00535132|472111824|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
131132408|NCT00535132|472111825|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
131132409|NCT00267748|472111828|FG000|Non-randomized Period|Progressive disease|10|||
131132410|NCT00267748|472111829|FG001|Non-randomized Period|Progressive disease|0|||
130980936|NCT00540124|471554101|FG000|Overall Study|Lack of Efficacy|1|||
130980937|NCT00540124|471554102|FG001|Overall Study|Lack of Efficacy|0|||
130980938|NCT00540124|471554103|FG002|Overall Study|Lack of Efficacy|0|||
130980939|NCT00540124|471554101|FG000|Overall Study|Withdrawal by Subject|1|||
130980940|NCT00540124|471554102|FG001|Overall Study|Withdrawal by Subject|1|||
130980941|NCT00540124|471554103|FG002|Overall Study|Withdrawal by Subject|0|||
130980942|NCT01207102|471554110|FG000|Overall Study|Withdrawal by Subject|5|||
130980943|NCT01207102|471554110|FG000|Overall Study|Adverse Event|2|||
130980944|NCT01207102|471554110|FG000|Overall Study|progression|2|||
130980945|NCT01207102|471554110|FG000|Overall Study|Withdrawal by Treating Physician|1|||
130980946|NCT01777854|471554113|FG000|Overall Study|Physician Decision|3|||
130980947|NCT01777854|471554114|FG001|Overall Study|Physician Decision|3|||
130980948|NCT03649230|471554115|FG000|Overall Study|Adverse Event|12|||
130980949|NCT03649230|471554115|FG000|Overall Study|Death|8|||
130980950|NCT03649230|471554115|FG000|Overall Study|Withdrawal by Subject|6|||
130980951|NCT03649230|471554115|FG000|Overall Study|Physician Decision|5|||
130980952|NCT03649230|471554115|FG000|Overall Study|Disease progression|5|||
131132411|NCT00267748|472111830|FG002|Non-randomized Period|Progressive disease|0|||
130718912|NCT00394524|470597264|FG000|Overall Study|Withdrawal by Subject|0|||
130718913|NCT00394524|470597265|FG001|Overall Study|Withdrawal by Subject|1|||
130980953|NCT03649230|471554115|FG000|Overall Study|Switched to non-HEC|5|||
130980954|NCT03649230|471554115|FG000|Overall Study|Chemotherapy discontinued|4|||
130980955|NCT03649230|471554115|FG000|Overall Study|Received only 3 HEC cycles|4|||
130980956|NCT03649230|471554115|FG000|Overall Study|Screen Failure|3|||
130980957|NCT03649230|471554115|FG000|Overall Study|Patient stopped treatment|2|||
130980958|NCT03649230|471554115|FG000|Overall Study|Protocol Violation|1|||
130980959|NCT03649230|471554115|FG000|Overall Study|Non-compliance|1|||
130980960|NCT03649230|471554115|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
130980961|NCT01693068|471554121|FG000|Randomization Period|On-study|2|||
130980962|NCT01693068|471554122|FG001|Randomization Period|On-study|5|||
130980963|NCT01693068|471554123|FG002|Randomization Period|On-study|0|||
130980964|NCT01693068|471554121|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
130980965|NCT01693068|471554122|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
130980966|NCT01693068|471554123|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
130980967|NCT03311373|471554126|FG000|Overall Study|Adverse Event|1|||
130980968|NCT03311373|471554126|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
130980969|NCT03311373|471554126|FG000|Overall Study|Lost to Follow-up|1|||
130980970|NCT03311373|471554126|FG000|Overall Study|Physician Decision|1|||
130980971|NCT03311373|471554126|FG000|Overall Study|Withdrawal by Subject|3|||
130980972|NCT01400503|471554130|FG000|Overall Study|Withdrawal by Subject|1|||
130980973|NCT01400503|471554130|FG000|Overall Study|Study Terminated by Sponsor|58|||
130980974|NCT01400503|471554130|FG000|Overall Study|Other|1|||
130980975|NCT00058123|471554131|FG000|Overall Study|Wrong histology|9|||
130980976|NCT00058123|471554131|FG000|Overall Study|Received >3 prior treatments|1|||
130980977|NCT01212770|471554132|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
130980978|NCT01212770|471554133|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
130980979|NCT01212770|471554134|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
130980980|NCT01212770|471554135|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130980981|NCT01212770|471554136|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130980982|NCT01212770|471554137|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130980983|NCT01212770|471554138|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130980984|NCT01212770|471554139|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130980985|NCT01212770|471554140|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130980986|NCT01212770|471554132|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
130980987|NCT01212770|471554133|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
130980988|NCT01212770|471554134|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
130980989|NCT01212770|471554135|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130980990|NCT01212770|471554136|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130980991|NCT01212770|471554137|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130980992|NCT01212770|471554138|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130980993|NCT01212770|471554139|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130980994|NCT01212770|471554140|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130980995|NCT01212770|471554132|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
130980996|NCT01212770|471554133|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
130980997|NCT01212770|471554134|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
130980998|NCT01212770|471554135|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130980999|NCT01212770|471554136|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130981000|NCT01212770|471554137|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130981001|NCT01212770|471554138|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130981002|NCT01212770|471554139|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130981003|NCT01212770|471554140|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130981004|NCT01212770|471554132|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
130981005|NCT01212770|471554133|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130981006|NCT01212770|471554134|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
130981007|NCT01212770|471554135|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130981008|NCT01212770|471554136|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130981009|NCT01212770|471554137|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130981010|NCT01212770|471554138|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130981011|NCT01212770|471554139|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130981012|NCT01212770|471554140|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130981013|NCT01212770|471554132|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130981014|NCT01212770|471554133|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130981015|NCT01212770|471554134|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
130981016|NCT01212770|471554135|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130981017|NCT01212770|471554136|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131132412|NCT00267748|472111828|FG000|Non-randomized Period|Adverse Event|8|||
131132413|NCT00267748|472111829|FG001|Non-randomized Period|Adverse Event|0|||
130981018|NCT01212770|471554137|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130778825|NCT03428100|470817441|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
130981019|NCT01212770|471554138|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130981020|NCT01212770|471554139|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130981021|NCT01212770|471554140|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130981022|NCT01212770|471554132|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
130981023|NCT01212770|471554133|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
130981024|NCT01212770|471554134|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
130981025|NCT01212770|471554135|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130981026|NCT01212770|471554136|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130981027|NCT01212770|471554137|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130981028|NCT01212770|471554138|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130981029|NCT01212770|471554139|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130981030|NCT01212770|471554140|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
130981031|NCT01212770|471554132|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130981032|NCT01212770|471554133|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
130981033|NCT01212770|471554134|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
130981034|NCT01212770|471554135|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
130981035|NCT01212770|471554136|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130981036|NCT01212770|471554137|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130981037|NCT01212770|471554138|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
130981038|NCT01212770|471554139|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130981039|NCT01212770|471554140|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130981040|NCT01212770|471554132|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
130981041|NCT01212770|471554133|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
130981042|NCT01212770|471554134|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
130981043|NCT01212770|471554135|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
130981044|NCT01212770|471554136|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
130981045|NCT01212770|471554137|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
130981046|NCT01212770|471554138|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
130981047|NCT01212770|471554139|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
130981048|NCT01212770|471554140|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
130981049|NCT01212770|471554132|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
130981050|NCT01212770|471554133|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
130981051|NCT01212770|471554134|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
130981052|NCT01212770|471554135|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
130981053|NCT01212770|471554136|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
130981054|NCT01212770|471554137|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
130981055|NCT01212770|471554138|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
130981056|NCT01212770|471554139|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
130981057|NCT01212770|471554140|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
130981058|NCT01212770|471554132|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130981059|NCT01212770|471554133|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130981060|NCT01212770|471554134|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
130981061|NCT01212770|471554135|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130981062|NCT01212770|471554136|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130981063|NCT01212770|471554137|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130981064|NCT01212770|471554138|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130981065|NCT01212770|471554139|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130981066|NCT01212770|471554140|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
130981067|NCT01212770|471554132|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130981068|NCT01212770|471554133|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130981069|NCT01212770|471554134|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130981070|NCT01212770|471554135|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
130981071|NCT01212770|471554136|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130981072|NCT01212770|471554137|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
131044055|NCT02962076|471796166|FG000|Overall Study|MHED tracer not available|5|||
131044056|NCT02962076|471796166|FG000|Overall Study|Protocol Violation|1|||
131044057|NCT02962076|471796166|FG000|Overall Study|Physician Decision|1|||
131044058|NCT03536884|471796167|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
131044059|NCT03536884|471796168|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
131044060|NCT03536884|471796169|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131044061|NCT03536884|471796170|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131044062|NCT03536884|471796171|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131044063|NCT03536884|471796172|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131132414|NCT00267748|472111830|FG002|Non-randomized Period|Adverse Event|0|||
131132415|NCT00267748|472111828|FG000|Non-randomized Period|Death|1|||
130718914|NCT01398514|470597266|FG000|Overall Study|Adverse Event|1|||
130981073|NCT01212770|471554138|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130981074|NCT01212770|471554139|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130981075|NCT01212770|471554140|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
130981076|NCT01212770|471554132|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130981077|NCT01212770|471554133|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130981078|NCT01212770|471554134|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
130981079|NCT01212770|471554135|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
130981080|NCT01212770|471554136|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130981081|NCT01212770|471554137|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130981082|NCT01212770|471554138|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130981083|NCT01212770|471554139|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130981084|NCT01212770|471554140|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
130981085|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130981086|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
130981087|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
130981088|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130981089|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130981090|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130981091|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130981092|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130981093|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
130981094|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130981095|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
130981096|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
130981097|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130981098|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130981099|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130981100|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130981101|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
130981102|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
130981103|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130981104|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
130981105|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130981106|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130981107|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130981108|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130981109|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130981110|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130981111|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
130981112|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130981113|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
130981114|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
130981115|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130981116|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130981117|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130981118|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130981119|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
130981120|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
130981121|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
130981122|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
130981123|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
130981124|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
130981125|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
130981126|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
130981127|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
130981128|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
130981129|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
130981130|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130981131|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
130981132|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
130981133|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130981134|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130981135|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130981136|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130981137|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130981138|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
130981139|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130981140|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
130981141|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
130981142|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130981143|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130981144|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130981145|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130981146|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
130981147|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
130981148|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130981149|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
130981150|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
130981151|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130981152|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130981153|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130981154|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130981155|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
130981156|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
130981157|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130981158|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
130981159|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
130981160|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130981161|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130981162|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130981163|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130981164|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
130981165|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
130981166|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130981167|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
130981168|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130981169|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130981170|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130981171|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130981172|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130981173|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130981174|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130981175|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130981176|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130981177|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130981178|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130981179|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130981180|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130981181|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130981182|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
130981183|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
130981184|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130981185|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
130981186|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
130981187|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130981188|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130981189|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130981190|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130981191|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
130981192|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
130981193|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130981194|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
130981195|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
130981196|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130981197|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131044064|NCT03536884|471796173|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131044065|NCT03536884|471796174|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131044066|NCT03536884|471796175|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131044067|NCT03536884|471796176|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131044068|NCT03536884|471796177|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131044069|NCT03536884|471796178|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
131044070|NCT03536884|471796167|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131044071|NCT03536884|471796168|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
131044072|NCT03536884|471796169|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131132416|NCT00267748|472111829|FG001|Non-randomized Period|Death|0|||
130778826|NCT03428100|470817442|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
130981198|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130981199|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130981200|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130981201|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
130981202|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130981203|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
130981204|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
130981205|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130981206|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130981207|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130981208|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130981209|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
130981210|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130981211|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130981212|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
130981213|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
130981214|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130981215|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130981216|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130981217|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130981218|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
130981219|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
130981220|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130981221|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
130981222|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
130981223|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130981224|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130981225|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130981226|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130981227|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130981228|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130981229|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130981230|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130981231|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
130981232|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130981233|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130981234|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130981235|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130981236|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130981237|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130981238|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130981239|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
130981240|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130981241|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130981242|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130981243|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130981244|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130981245|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130981246|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
130981247|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
130981248|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
130981249|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
130981250|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
130981251|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
130981252|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
130981253|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
130981254|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
131044073|NCT03536884|471796170|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131044074|NCT03536884|471796171|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131044075|NCT03536884|471796172|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131044076|NCT03536884|471796173|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131044077|NCT03536884|471796174|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131044078|NCT03536884|471796175|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131044079|NCT03536884|471796176|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131044080|NCT03536884|471796177|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131044081|NCT03536884|471796178|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
131044082|NCT03536884|471796167|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
130718915|NCT01398514|470597267|FG001|Overall Study|Adverse Event|0|||
130981255|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
130981256|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130981257|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130981258|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
130981259|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130981260|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130981261|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130981262|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130981263|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130981264|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130981265|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130981266|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130981267|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
130981268|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130981269|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130981270|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130981271|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130981272|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130981273|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
130981274|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130981275|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130981276|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
130981277|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130981278|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130981279|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130981280|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130981281|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130981282|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130981283|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130981284|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
130981285|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
130981286|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130981287|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130981288|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130981289|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130981290|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
130981291|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130981292|NCT01212770|471554132|FG000|Long-term Safety Phase (Year 5)|Death|0|||
130981293|NCT01212770|471554133|FG001|Long-term Safety Phase (Year 5)|Death|0|||
130981294|NCT01212770|471554134|FG002|Long-term Safety Phase (Year 5)|Death|0|||
130981295|NCT01212770|471554135|FG003|Long-term Safety Phase (Year 5)|Death|0|||
130981296|NCT01212770|471554136|FG004|Long-term Safety Phase (Year 5)|Death|0|||
130981297|NCT01212770|471554137|FG005|Long-term Safety Phase (Year 5)|Death|0|||
130981298|NCT01212770|471554138|FG006|Long-term Safety Phase (Year 5)|Death|0|||
130981299|NCT01212770|471554139|FG007|Long-term Safety Phase (Year 5)|Death|1|||
130981300|NCT01212770|471554140|FG008|Long-term Safety Phase (Year 5)|Death|0|||
130981301|NCT00608582|471554143|FG000|Overall Study|Lost to Follow-up|2|||
130981302|NCT00608582|471554144|FG001|Overall Study|Lost to Follow-up|0|||
130981303|NCT00608582|471554143|FG000|Overall Study|No Best Response in Phase 1 located|1|||
130981304|NCT00608582|471554144|FG001|Overall Study|No Best Response in Phase 1 located|1|||
130981305|NCT00608582|471554143|FG000|Overall Study|Illicit Drug Use|1|||
130981306|NCT00608582|471554144|FG001|Overall Study|Illicit Drug Use|0|||
130981307|NCT00608582|471554143|FG000|Overall Study|Early stage Design Change|0|||
130981308|NCT00608582|471554144|FG001|Overall Study|Early stage Design Change|3|||
130981309|NCT00289887|471555426|FG000|Overall Study|Adverse Event|3|||
130981310|NCT00289887|471555427|FG001|Overall Study|Adverse Event|3|||
130981311|NCT00289887|471555426|FG000|Overall Study|Lack of Efficacy|3|||
130981312|NCT00289887|471555427|FG001|Overall Study|Lack of Efficacy|11|||
130981313|NCT00289887|471555426|FG000|Overall Study|Lost to Follow-up|3|||
130718916|NCT01398514|470597266|FG000|Overall Study|Non-compliance with study procedures|2|||
130981314|NCT00289887|471555427|FG001|Overall Study|Lost to Follow-up|3|||
130981315|NCT00289887|471555426|FG000|Overall Study|Protocol Violation|3|||
130981316|NCT00289887|471555427|FG001|Overall Study|Protocol Violation|1|||
130981317|NCT00289887|471555426|FG000|Overall Study|Withdrawal by Subject|3|||
130981318|NCT00289887|471555427|FG001|Overall Study|Withdrawal by Subject|8|||
130981319|NCT00289887|471555426|FG000|Overall Study|Other|7|||
130981320|NCT00289887|471555427|FG001|Overall Study|Other|3|||
130981321|NCT00428090|471555436|FG000|Overall Study|Adverse Event|10|||
130981322|NCT00428090|471555437|FG001|Overall Study|Adverse Event|8|||
130981323|NCT00428090|471555438|FG002|Overall Study|Adverse Event|10|||
130981324|NCT00428090|471555439|FG003|Overall Study|Adverse Event|11|||
130981325|NCT00428090|471555436|FG000|Overall Study|Lost to Follow-up|3|||
130981326|NCT00428090|471555437|FG001|Overall Study|Lost to Follow-up|6|||
130981327|NCT00428090|471555438|FG002|Overall Study|Lost to Follow-up|1|||
130981328|NCT00428090|471555439|FG003|Overall Study|Lost to Follow-up|4|||
130981329|NCT00428090|471555436|FG000|Overall Study|Protocol Violation|3|||
130981330|NCT00428090|471555437|FG001|Overall Study|Protocol Violation|1|||
130981331|NCT00428090|471555438|FG002|Overall Study|Protocol Violation|3|||
130981332|NCT00428090|471555439|FG003|Overall Study|Protocol Violation|3|||
130981333|NCT00428090|471555436|FG000|Overall Study|Withdrawal by Subject|10|||
130981334|NCT00428090|471555437|FG001|Overall Study|Withdrawal by Subject|12|||
130981335|NCT00428090|471555438|FG002|Overall Study|Withdrawal by Subject|15|||
130981336|NCT00428090|471555439|FG003|Overall Study|Withdrawal by Subject|5|||
130981337|NCT00428090|471555436|FG000|Overall Study|Sponsor terminated study|0|||
130981338|NCT00428090|471555437|FG001|Overall Study|Sponsor terminated study|1|||
130981339|NCT00428090|471555438|FG002|Overall Study|Sponsor terminated study|0|||
130981340|NCT00428090|471555439|FG003|Overall Study|Sponsor terminated study|0|||
130981341|NCT00428090|471555436|FG000|Overall Study|Non-compliance|4|||
130981342|NCT00428090|471555437|FG001|Overall Study|Non-compliance|0|||
130981343|NCT00428090|471555438|FG002|Overall Study|Non-compliance|1|||
130981344|NCT00428090|471555439|FG003|Overall Study|Non-compliance|3|||
130981345|NCT00428090|471555436|FG000|Overall Study|Par. did not returned to visit|1|||
130981346|NCT00428090|471555437|FG001|Overall Study|Par. did not returned to visit|0|||
130981347|NCT00428090|471555438|FG002|Overall Study|Par. did not returned to visit|0|||
130981348|NCT00428090|471555439|FG003|Overall Study|Par. did not returned to visit|1|||
130981349|NCT00428090|471555436|FG000|Overall Study|Follow-Up visit not possible|1|||
130981350|NCT00428090|471555437|FG001|Overall Study|Follow-Up visit not possible|0|||
130981351|NCT00428090|471555438|FG002|Overall Study|Follow-Up visit not possible|0|||
130981352|NCT00428090|471555439|FG003|Overall Study|Follow-Up visit not possible|0|||
130981353|NCT00428090|471555436|FG000|Overall Study|Prohibited medication used for SAE|1|||
130981354|NCT00428090|471555437|FG001|Overall Study|Prohibited medication used for SAE|0|||
130981355|NCT00428090|471555438|FG002|Overall Study|Prohibited medication used for SAE|0|||
130981356|NCT00428090|471555439|FG003|Overall Study|Prohibited medication used for SAE|0|||
130981357|NCT00428090|471555436|FG000|Overall Study|Death of par.|1|||
130981358|NCT00428090|471555437|FG001|Overall Study|Death of par.|0|||
130981359|NCT00428090|471555438|FG002|Overall Study|Death of par.|1|||
130981360|NCT00428090|471555439|FG003|Overall Study|Death of par.|0|||
130981361|NCT00428090|471555436|FG000|Overall Study|Visit 7 exceed the visit window|0|||
130981362|NCT00428090|471555437|FG001|Overall Study|Visit 7 exceed the visit window|1|||
130981363|NCT00428090|471555438|FG002|Overall Study|Visit 7 exceed the visit window|0|||
130981364|NCT00428090|471555439|FG003|Overall Study|Visit 7 exceed the visit window|0|||
130981365|NCT00428090|471555436|FG000|Overall Study|Medical monitor terminated par.|0|||
130981366|NCT00428090|471555437|FG001|Overall Study|Medical monitor terminated par.|1|||
130981367|NCT00428090|471555438|FG002|Overall Study|Medical monitor terminated par.|0|||
130981368|NCT00428090|471555439|FG003|Overall Study|Medical monitor terminated par.|0|||
130981369|NCT00428090|471555436|FG000|Overall Study|Mental status of par. was|0|||
130981370|NCT00428090|471555437|FG001|Overall Study|Mental status of par. was|1|||
130981371|NCT00428090|471555438|FG002|Overall Study|Mental status of par. was|0|||
130981372|NCT00428090|471555439|FG003|Overall Study|Mental status of par. was|0|||
130981373|NCT00428090|471555436|FG000|Overall Study|Worsening of AD|0|||
130981374|NCT00428090|471555437|FG001|Overall Study|Worsening of AD|0|||
130981375|NCT00428090|471555438|FG002|Overall Study|Worsening of AD|1|||
130981376|NCT00428090|471555439|FG003|Overall Study|Worsening of AD|0|||
130981377|NCT00428090|471555436|FG000|Overall Study|Excluded for concerning QTc value|0|||
130981378|NCT00428090|471555437|FG001|Overall Study|Excluded for concerning QTc value|0|||
130981379|NCT00428090|471555438|FG002|Overall Study|Excluded for concerning QTc value|1|||
130981380|NCT00428090|471555439|FG003|Overall Study|Excluded for concerning QTc value|0|||
130981381|NCT00428090|471555436|FG000|Overall Study|Insufficient AD documentation|0|||
130981382|NCT00428090|471555437|FG001|Overall Study|Insufficient AD documentation|0|||
130981383|NCT00428090|471555438|FG002|Overall Study|Insufficient AD documentation|1|||
130981384|NCT00428090|471555439|FG003|Overall Study|Insufficient AD documentation|0|||
130981385|NCT00428090|471555436|FG000|Overall Study|High MMSE scores|0|||
130981386|NCT00428090|471555437|FG001|Overall Study|High MMSE scores|0|||
130981387|NCT00428090|471555438|FG002|Overall Study|High MMSE scores|1|||
130981388|NCT00428090|471555439|FG003|Overall Study|High MMSE scores|0|||
131044083|NCT03536884|471796168|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
131044084|NCT03536884|471796169|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131044085|NCT03536884|471796170|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131044086|NCT03536884|471796171|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131044087|NCT03536884|471796172|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131044088|NCT03536884|471796173|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131044089|NCT03536884|471796174|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131044090|NCT03536884|471796175|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131044091|NCT03536884|471796176|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131044092|NCT03536884|471796177|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
130981389|NCT00428090|471555436|FG000|Overall Study|Deterioration of cognitive status|0|||
130981390|NCT00428090|471555437|FG001|Overall Study|Deterioration of cognitive status|0|||
130981391|NCT00428090|471555438|FG002|Overall Study|Deterioration of cognitive status|1|||
130981392|NCT00428090|471555439|FG003|Overall Study|Deterioration of cognitive status|0|||
130981393|NCT00428090|471555436|FG000|Overall Study|Serious adverse event|0|||
130981394|NCT00428090|471555437|FG001|Overall Study|Serious adverse event|0|||
130981395|NCT00428090|471555438|FG002|Overall Study|Serious adverse event|1|||
130981396|NCT00428090|471555439|FG003|Overall Study|Serious adverse event|0|||
130981397|NCT00428090|471555436|FG000|Overall Study|Excluded for heart insufficiency|0|||
130981398|NCT00428090|471555437|FG001|Overall Study|Excluded for heart insufficiency|0|||
130981399|NCT00428090|471555438|FG002|Overall Study|Excluded for heart insufficiency|1|||
130981400|NCT00428090|471555439|FG003|Overall Study|Excluded for heart insufficiency|0|||
130981401|NCT00428090|471555436|FG000|Overall Study|Raised Creatinine Value|0|||
130981402|NCT00428090|471555437|FG001|Overall Study|Raised Creatinine Value|0|||
130981403|NCT00428090|471555438|FG002|Overall Study|Raised Creatinine Value|0|||
130981404|NCT00428090|471555439|FG003|Overall Study|Raised Creatinine Value|1|||
130981405|NCT03409666|471555440|FG000|Overall Study|Physician Decision|0|||
130981406|NCT03409666|471555441|FG001|Overall Study|Physician Decision|1|||
130981407|NCT03409666|471555440|FG000|Overall Study|Protocol Violation|0|||
130981408|NCT03409666|471555441|FG001|Overall Study|Protocol Violation|3|||
130981409|NCT00512148|471555445|FG000|Primay Study Period|Withdrawal by Subject|1|||
130981410|NCT00677833|471555446|FG000|Overall Study|Withdrawal by Subject|4|||
130981411|NCT00677833|471555447|FG001|Overall Study|Withdrawal by Subject|0|||
130981412|NCT00677833|471555448|FG002|Overall Study|Withdrawal by Subject|1|||
130981413|NCT00677833|471555449|FG003|Overall Study|Withdrawal by Subject|3|||
130981414|NCT00677833|471555446|FG000|Overall Study|Lost to Follow-up|0|||
130981415|NCT00677833|471555447|FG001|Overall Study|Lost to Follow-up|0|||
130981416|NCT00677833|471555448|FG002|Overall Study|Lost to Follow-up|1|||
130981417|NCT00677833|471555449|FG003|Overall Study|Lost to Follow-up|0|||
130981418|NCT02690974|471555452|FG000|Overall Study|Adverse Event|16|||
130981419|NCT02690974|471555452|FG000|Overall Study|Death|9|||
130981420|NCT02690974|471555452|FG000|Overall Study|Subject/guardian decision|4|||
130981421|NCT02690974|471555452|FG000|Overall Study|Lost to Follow-up|3|||
130981422|NCT02690974|471555452|FG000|Overall Study|Withdrawal of Informed Consent|3|||
130981423|NCT02690974|471555452|FG000|Overall Study|Physician Decision|2|||
130981424|NCT02690974|471555452|FG000|Overall Study|Non-compliance with study treatment|1|||
130981425|NCT02690974|471555452|FG000|Overall Study|Protocol-defined stopping criteria|1|||
130981426|NCT02690974|471555452|FG000|Overall Study|Protocol Deviation|1|||
130981427|NCT01666951|471555457|FG000|Overall Study|Not dosed|1|||
130981428|NCT01666951|471555458|FG001|Overall Study|Not dosed|1|||
130981429|NCT00522301|471555459|FG000|Overall Study|Withdrawal by Subject|1|||
130981430|NCT00522301|471555459|FG000|Overall Study|Adverse Event|5|||
130981431|NCT00337272|471555460|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
130981432|NCT00337272|471555461|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
130981433|NCT00337272|471555460|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
130981434|NCT00337272|471555461|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
130981435|NCT00337272|471555460|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
130981436|NCT00337272|471555461|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
130981437|NCT00337272|471555460|FG000|Treatment Period|Non-compliance|1|||
130981438|NCT00337272|471555461|FG001|Treatment Period|Non-compliance|1|||
130981439|NCT00337272|471555460|FG000|Treatment Period|Withdrawal by Subject|0|||
130981440|NCT00337272|471555461|FG001|Treatment Period|Withdrawal by Subject|1|||
130981441|NCT00337272|471555460|FG000|Withdrawal Period|Non-compliance|0|||
130981442|NCT00337272|471555461|FG001|Withdrawal Period|Non-compliance|1|||
130981443|NCT02366910|471555465|FG000|Overall Study|Withdrawal by Subject|2|||
130981444|NCT02366910|471555465|FG000|Overall Study|Screen Failure|3|||
130981445|NCT02623322|471555469|FG000|Overall Study|Lost to Follow-up|2|||
130981446|NCT02623322|471555470|FG001|Overall Study|Lost to Follow-up|1|||
130981447|NCT02623322|471555471|FG002|Overall Study|Lost to Follow-up|0|||
130981448|NCT03284788|471555472|FG000|Overall Study|Withdrawal by Subject|2|||
130981449|NCT03813238|471555479|FG000|Overall Study|Adverse Event|0|||
130981450|NCT03813238|471555480|FG001|Overall Study|Adverse Event|6|||
130981451|NCT03813238|471555479|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130981452|NCT03813238|471555480|FG001|Overall Study|Withdrawal by parent/guardian|2|||
130981453|NCT03813238|471555479|FG000|Overall Study|Lost to Follow-up|0|||
130981454|NCT03813238|471555480|FG001|Overall Study|Lost to Follow-up|1|||
130981455|NCT03813238|471555479|FG000|Overall Study|Other than specified|1|||
130981456|NCT03813238|471555480|FG001|Overall Study|Other than specified|2|||
130981457|NCT03338894|471555481|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
130981458|NCT04465357|471555482|FG000|Overall Study|Adverse Event|2|||
130981459|NCT04465357|471555482|FG000|Overall Study|Lack of Efficacy|1|||
130981460|NCT04465357|471555482|FG000|Overall Study|Lost to Follow-up|2|||
130981461|NCT04465357|471555482|FG000|Overall Study|Withdrawal by Subject|6|||
130981462|NCT04465357|471555482|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
130981463|NCT00420199|471555483|FG000|Overall Study|Participant no longer met study criteria|1|||
130981464|NCT00420199|471555484|FG001|Overall Study|Participant no longer met study criteria|0|||
130981465|NCT01239030|471555491|FG000|Double Blind|Adverse Event|0|||
130981466|NCT01239030|471555492|FG001|Double Blind|Adverse Event|1|||
130981467|NCT01239030|471555493|FG002|Double Blind|Adverse Event|0|||
130981468|NCT01239030|471555494|FG003|Double Blind|Adverse Event|2|||
130981469|NCT01239030|471555495|FG004|Double Blind|Adverse Event|0|||
130981470|NCT01239030|471555491|FG000|Double Blind|Withdrawal by Subject|0|||
130981471|NCT01239030|471555492|FG001|Double Blind|Withdrawal by Subject|1|||
130981472|NCT01239030|471555493|FG002|Double Blind|Withdrawal by Subject|1|||
130981473|NCT01239030|471555494|FG003|Double Blind|Withdrawal by Subject|0|||
130981474|NCT01239030|471555495|FG004|Double Blind|Withdrawal by Subject|1|||
130981475|NCT01239030|471555491|FG000|Double Blind|Lost to Follow-up|1|||
130981476|NCT01239030|471555492|FG001|Double Blind|Lost to Follow-up|1|||
130981477|NCT01239030|471555493|FG002|Double Blind|Lost to Follow-up|0|||
130981478|NCT01239030|471555494|FG003|Double Blind|Lost to Follow-up|0|||
130981479|NCT01239030|471555495|FG004|Double Blind|Lost to Follow-up|0|||
130981480|NCT01239030|471555491|FG000|Double Blind|Physician Decision|0|||
130981481|NCT01239030|471555492|FG001|Double Blind|Physician Decision|1|||
130981482|NCT01239030|471555493|FG002|Double Blind|Physician Decision|0|||
130981483|NCT01239030|471555494|FG003|Double Blind|Physician Decision|0|||
130981484|NCT01239030|471555495|FG004|Double Blind|Physician Decision|0|||
130981485|NCT01239030|471555491|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
130981486|NCT01239030|471555492|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
130981487|NCT01239030|471555493|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
130981488|NCT01239030|471555494|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
130981489|NCT01239030|471555495|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
130981490|NCT01239030|471555491|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
130981491|NCT01239030|471555492|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
130981492|NCT01239030|471555493|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
130981493|NCT01239030|471555494|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
130981494|NCT01239030|471555495|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
130981495|NCT01239030|471555491|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
130981496|NCT01239030|471555492|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
130981497|NCT01239030|471555493|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
130981498|NCT01239030|471555494|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
130981499|NCT01239030|471555495|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
130981500|NCT01239030|471555491|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
130981501|NCT01239030|471555492|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
130981502|NCT01239030|471555493|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
130981503|NCT01239030|471555494|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
130981504|NCT01239030|471555495|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
130981505|NCT00977665|471555496|FG000|Overall Study|Withdrawal by Subject|1|||
130981506|NCT00977665|471555497|FG001|Overall Study|Withdrawal by Subject|3|||
130981507|NCT00977665|471555496|FG000|Overall Study|Physician Decision|2|||
130981508|NCT00977665|471555497|FG001|Overall Study|Physician Decision|1|||
130981509|NCT00977665|471555496|FG000|Overall Study|Sponsor requested withdrawal|0|||
130981510|NCT00977665|471555497|FG001|Overall Study|Sponsor requested withdrawal|1|||
130981511|NCT00977665|471555496|FG000|Overall Study|Lost to Follow-up|1|||
130981512|NCT00977665|471555497|FG001|Overall Study|Lost to Follow-up|0|||
130981513|NCT00977665|471555496|FG000|Overall Study|Death|3|||
130981514|NCT00977665|471555497|FG001|Overall Study|Death|2|||
130981515|NCT00977665|471555496|FG000|Overall Study|Adverse Event|14|||
130981516|NCT00977665|471555497|FG001|Overall Study|Adverse Event|7|||
130981517|NCT00977665|471555496|FG000|Overall Study|Treatment failure|0|||
130981518|NCT00977665|471555497|FG001|Overall Study|Treatment failure|1|||
130981519|NCT02085252|471555516|FG000|Overall Study|Withdrawal of Consent|1|||
131044093|NCT03536884|471796178|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
131044094|NCT03536884|471796167|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044095|NCT03536884|471796168|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
131044096|NCT03536884|471796169|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044097|NCT03536884|471796170|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044098|NCT03536884|471796171|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044099|NCT03536884|471796172|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044100|NCT03536884|471796173|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044101|NCT03536884|471796174|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044102|NCT03536884|471796175|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044103|NCT03536884|471796176|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044104|NCT03536884|471796177|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044105|NCT03536884|471796178|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
131044106|NCT03536884|471796167|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131045899|NCT05205161|471802296|FG000|Overall Study|Study terminated by sponsor|3|||
130981520|NCT02085252|471555517|FG001|Overall Study|Withdrawal of Consent|0|||
130981521|NCT02085252|471555516|FG000|Overall Study|Adverse Event|0|||
130981522|NCT02085252|471555517|FG001|Overall Study|Adverse Event|1|||
130981523|NCT02085252|471555516|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
130981524|NCT02085252|471555517|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
130981525|NCT02085252|471555516|FG000|Overall Study|Reason Not Specified|0|||
130981526|NCT02085252|471555517|FG001|Overall Study|Reason Not Specified|1|||
130981527|NCT02085252|471555516|FG000|Overall Study|Reason Unknown|0|||
130981528|NCT02085252|471555517|FG001|Overall Study|Reason Unknown|1|||
130981529|NCT02925676|471555519|FG000|Overall Study|Withdrawal by Subject|1|||
130981530|NCT03260868|471555520|FG000|Overall Study|Poor Compliance to Protocol|0|||
130981531|NCT03260868|471555521|FG001|Overall Study|Poor Compliance to Protocol|2|||
130981532|NCT03260868|471555520|FG000|Overall Study|Study Terminated By Sponsor|2|||
130981533|NCT03260868|471555521|FG001|Overall Study|Study Terminated By Sponsor|1|||
130981534|NCT03260868|471555520|FG000|Overall Study|Other than specified above|1|||
130981535|NCT03260868|471555521|FG001|Overall Study|Other than specified above|0|||
130981536|NCT01298999|471555525|FG000|Overall Study|Physician Decision|0|||
130981537|NCT01298999|471555526|FG001|Overall Study|Physician Decision|1|||
130981538|NCT01298999|471555525|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
130981539|NCT01298999|471555526|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
130981540|NCT00541450|471555527|FG000|Phase A|Adverse Event|3|||
130981541|NCT00541450|471555528|FG001|Phase A|Adverse Event|0|||
130981542|NCT00541450|471555527|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
130981543|NCT00541450|471555528|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
130981544|NCT00541450|471555527|FG000|Phase A|Hyperglycemia|0|||
130981545|NCT00541450|471555528|FG001|Phase A|Hyperglycemia|1|||
130981546|NCT00541450|471555527|FG000|Phase A|Lost to Follow-up|6|||
130981547|NCT00541450|471555528|FG001|Phase A|Lost to Follow-up|4|||
130981548|NCT00541450|471555527|FG000|Phase A|Physician Decision|2|||
130981549|NCT00541450|471555528|FG001|Phase A|Physician Decision|0|||
130981550|NCT00541450|471555527|FG000|Phase A|Protocol Violation|2|||
130981551|NCT00541450|471555528|FG001|Phase A|Protocol Violation|3|||
130981552|NCT00541450|471555527|FG000|Phase A|Withdrawal by Subject|7|||
130981553|NCT00541450|471555528|FG001|Phase A|Withdrawal by Subject|7|||
130981554|NCT00541450|471555527|FG000|Phase B|Adverse Event|6|||
130981555|NCT00541450|471555528|FG001|Phase B|Adverse Event|6|||
130981556|NCT00541450|471555527|FG000|Phase B|Hyperglycemia|10|||
130981557|NCT00541450|471555528|FG001|Phase B|Hyperglycemia|9|||
130981558|NCT00541450|471555527|FG000|Phase B|Lost to Follow-up|6|||
130981559|NCT00541450|471555528|FG001|Phase B|Lost to Follow-up|4|||
130981560|NCT00541450|471555527|FG000|Phase B|Physician Decision|4|||
130981561|NCT00541450|471555528|FG001|Phase B|Physician Decision|2|||
130981562|NCT00541450|471555527|FG000|Phase B|Pregnancy|0|||
130981563|NCT00541450|471555528|FG001|Phase B|Pregnancy|1|||
130981564|NCT00541450|471555527|FG000|Phase B|Protocol Violation|3|||
130981565|NCT00541450|471555528|FG001|Phase B|Protocol Violation|3|||
130981566|NCT00541450|471555527|FG000|Phase B|Withdrawal by Subject|8|||
130981567|NCT00541450|471555528|FG001|Phase B|Withdrawal by Subject|6|||
130981568|NCT02151266|471555529|FG000|Overall Study|Lost to Follow-up|1|||
130981569|NCT02151266|471555530|FG001|Overall Study|Lost to Follow-up|4|||
130981570|NCT02151266|471555531|FG002|Overall Study|Lost to Follow-up|1|||
130981571|NCT02151266|471555529|FG000|Overall Study|Did NOT receive intervention|3|||
130981572|NCT02151266|471555530|FG001|Overall Study|Did NOT receive intervention|6|||
130981573|NCT02151266|471555531|FG002|Overall Study|Did NOT receive intervention|2|||
130981574|NCT02151266|471555529|FG000|Overall Study|Not able to exercise|4|||
130981575|NCT02151266|471555530|FG001|Overall Study|Not able to exercise|5|||
130981576|NCT02151266|471555531|FG002|Overall Study|Not able to exercise|4|||
130981577|NCT00803452|471555532|FG000|Overall Study|Adverse Event|0|||
130981578|NCT00803452|471555533|FG001|Overall Study|Adverse Event|2|||
130981579|NCT00803452|471555532|FG000|Overall Study|Lost to Follow-up|0|||
130981580|NCT00803452|471555533|FG001|Overall Study|Lost to Follow-up|3|||
130981581|NCT02816138|471555537|FG000|Overall Study|Adverse Event|1|||
130981582|NCT00981084|471555538|FG000|Post Intervention (Data Analysis)|poor effort|1|||
130981583|NCT00981084|471555539|FG001|Post Intervention (Data Analysis)|poor effort|1|||
130981584|NCT00981084|471555538|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
130981585|NCT00981084|471555539|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
130981586|NCT02291679|471555540|FG000|Overall Study|Adverse Event|2|||
131228123|NCT03361956|472461612|FG000|Overall Study|Withdrawal by Subject|2|||
130981587|NCT02291679|471555541|FG001|Overall Study|Adverse Event|12|||
130981588|NCT02291679|471555542|FG002|Overall Study|Adverse Event|19|||
130981589|NCT02291679|471555540|FG000|Overall Study|Protocol Violation|5|||
131228124|NCT03361956|472461613|FG001|Overall Study|Withdrawal by Subject|2|||
130981590|NCT02291679|471555541|FG001|Overall Study|Protocol Violation|1|||
130981591|NCT02291679|471555542|FG002|Overall Study|Protocol Violation|7|||
130981592|NCT02291679|471555540|FG000|Overall Study|Withdrew Consent|18|||
130981593|NCT02291679|471555541|FG001|Overall Study|Withdrew Consent|10|||
130981594|NCT02291679|471555542|FG002|Overall Study|Withdrew Consent|15|||
130981595|NCT02291679|471555540|FG000|Overall Study|Lost to Follow-up|12|||
130981596|NCT02291679|471555541|FG001|Overall Study|Lost to Follow-up|10|||
130981597|NCT02291679|471555542|FG002|Overall Study|Lost to Follow-up|9|||
130981598|NCT02291679|471555540|FG000|Overall Study|Insufficient Therapeutic Response|5|||
130981599|NCT02291679|471555541|FG001|Overall Study|Insufficient Therapeutic Response|5|||
130981600|NCT02291679|471555542|FG002|Overall Study|Insufficient Therapeutic Response|7|||
130981601|NCT02291679|471555540|FG000|Overall Study|Other|2|||
130981602|NCT02291679|471555541|FG001|Overall Study|Other|4|||
130981603|NCT02291679|471555542|FG002|Overall Study|Other|2|||
130981604|NCT00725296|471555543|FG000|Overall Study|Adverse Event|11|||
130981605|NCT00725296|471555543|FG000|Overall Study|Lack of Efficacy|7|||
130981606|NCT00725296|471555543|FG000|Overall Study|Withdrawal by Subject|3|||
130981607|NCT00725296|471555543|FG000|Overall Study|Non-Compliance|2|||
130981608|NCT00725296|471555543|FG000|Overall Study|Lost to Follow-up|1|||
130981609|NCT00725296|471555543|FG000|Overall Study|Other|38|||
130981610|NCT03360942|471555544|FG000|Overall Study|Device explanted|2|||
130981611|NCT03360942|471555544|FG000|Overall Study|Study closure|1|||
130981612|NCT03360942|471555544|FG000|Overall Study|Withdrawal by Subject|2|||
130981613|NCT05073133|471555545|FG000|Overall Study|Death|2|||
130981614|NCT01266850|471557044|FG000|Overall Study|Lost to Follow-up|19|||
130981615|NCT01266850|471557045|FG001|Overall Study|Lost to Follow-up|19|||
130981616|NCT01266850|471557046|FG002|Overall Study|Lost to Follow-up|13|||
130981617|NCT01266850|471557047|FG003|Overall Study|Lost to Follow-up|13|||
130981618|NCT01266850|471557048|FG004|Overall Study|Lost to Follow-up|12|||
130981619|NCT01266850|471557044|FG000|Overall Study|Withdrawal by Subject|8|||
130981620|NCT01266850|471557045|FG001|Overall Study|Withdrawal by Subject|9|||
130981621|NCT01266850|471557046|FG002|Overall Study|Withdrawal by Subject|6|||
130981622|NCT01266850|471557047|FG003|Overall Study|Withdrawal by Subject|9|||
130981623|NCT01266850|471557048|FG004|Overall Study|Withdrawal by Subject|12|||
130981624|NCT01266850|471557044|FG000|Overall Study|Physician Decision|3|||
130981625|NCT01266850|471557045|FG001|Overall Study|Physician Decision|6|||
130981626|NCT01266850|471557046|FG002|Overall Study|Physician Decision|4|||
130981627|NCT01266850|471557047|FG003|Overall Study|Physician Decision|4|||
130981628|NCT01266850|471557048|FG004|Overall Study|Physician Decision|3|||
130981629|NCT01266850|471557044|FG000|Overall Study|Protocol Violation|0|||
130981630|NCT01266850|471557045|FG001|Overall Study|Protocol Violation|1|||
130981631|NCT01266850|471557046|FG002|Overall Study|Protocol Violation|0|||
130981632|NCT01266850|471557047|FG003|Overall Study|Protocol Violation|1|||
130981633|NCT01266850|471557048|FG004|Overall Study|Protocol Violation|2|||
130981634|NCT01266850|471557044|FG000|Overall Study|Adverse Event|0|||
130981635|NCT01266850|471557045|FG001|Overall Study|Adverse Event|0|||
130981636|NCT01266850|471557046|FG002|Overall Study|Adverse Event|0|||
130981637|NCT01266850|471557047|FG003|Overall Study|Adverse Event|0|||
130981638|NCT01266850|471557048|FG004|Overall Study|Adverse Event|1|||
130981639|NCT01266850|471557044|FG000|Overall Study|Site Closure|0|||
130981640|NCT01266850|471557045|FG001|Overall Study|Site Closure|1|||
130981641|NCT01266850|471557046|FG002|Overall Study|Site Closure|1|||
130981642|NCT01266850|471557047|FG003|Overall Study|Site Closure|1|||
130981643|NCT01266850|471557048|FG004|Overall Study|Site Closure|0|||
130981644|NCT00437645|471557049|FG000|Overall Study|Adverse Event|15|||
130981645|NCT00437645|471557050|FG001|Overall Study|Adverse Event|84|||
130981646|NCT00437645|471557049|FG000|Overall Study|Withdrawal by Subject|10|||
130981647|NCT00437645|471557050|FG001|Overall Study|Withdrawal by Subject|22|||
130981648|NCT00437645|471557049|FG000|Overall Study|Protocol Violation|3|||
130981649|NCT00437645|471557050|FG001|Overall Study|Protocol Violation|3|||
130981650|NCT00437645|471557049|FG000|Overall Study|Lost to Follow-up|2|||
130981651|NCT00437645|471557050|FG001|Overall Study|Lost to Follow-up|3|||
130981652|NCT00437645|471557049|FG000|Overall Study|Administrative problems|2|||
130981653|NCT00437645|471557050|FG001|Overall Study|Administrative problems|1|||
130981654|NCT00437645|471557049|FG000|Overall Study|Lack of Efficacy|2|||
130981655|NCT00437645|471557050|FG001|Overall Study|Lack of Efficacy|1|||
130981656|NCT00437645|471557049|FG000|Overall Study|Condition no longer requires study drug|1|||
130981657|NCT00437645|471557050|FG001|Overall Study|Condition no longer requires study drug|1|||
130981658|NCT03751631|471557054|FG000|Overall Study|Withdrawal by Subject|0|||
130981659|NCT03751631|471557055|FG001|Overall Study|Withdrawal by Subject|0|||
130981660|NCT03751631|471557056|FG002|Overall Study|Withdrawal by Subject|1|||
130981661|NCT03751631|471557057|FG003|Overall Study|Withdrawal by Subject|1|||
130981662|NCT03751631|471557058|FG004|Overall Study|Withdrawal by Subject|0|||
130981663|NCT03751631|471557059|FG005|Overall Study|Withdrawal by Subject|0|||
130981664|NCT03382782|471557061|FG000|Cohort 1|Withdrawal by Subject|11|||
130718917|NCT01398514|470597267|FG001|Overall Study|Non-compliance with study procedures|0|||
130718918|NCT01398514|470597266|FG000|Overall Study|Physiologic non-responsiveness|1|||
130981665|NCT03382782|471557062|FG001|Cohort 1|Withdrawal by Subject|5|||
131132417|NCT00267748|472111830|FG002|Non-randomized Period|Death|0|||
131132418|NCT00267748|472111828|FG000|Non-randomized Period|Participant not willing to participate|1|||
131132419|NCT00267748|472111829|FG001|Non-randomized Period|Participant not willing to participate|0|||
130981666|NCT03382782|471557063|FG002|Cohort 1|Withdrawal by Subject|0|||
130981667|NCT03382782|471557061|FG000|Cohort 2|Withdrawal by Subject|1|||
130981668|NCT03382782|471557062|FG001|Cohort 2|Withdrawal by Subject|1|||
131228125|NCT03361956|472461614|FG002|Overall Study|Withdrawal by Subject|2|||
131228126|NCT03361956|472461615|FG003|Overall Study|Withdrawal by Subject|0|||
131228127|NCT03361956|472461616|FG004|Overall Study|Withdrawal by Subject|3|||
131228128|NCT03361956|472461612|FG000|Overall Study|Disease Relapse|0|||
131228129|NCT03361956|472461613|FG001|Overall Study|Disease Relapse|0|||
131228130|NCT03361956|472461614|FG002|Overall Study|Disease Relapse|1|||
131228131|NCT03361956|472461615|FG003|Overall Study|Disease Relapse|0|||
131228132|NCT03361956|472461616|FG004|Overall Study|Disease Relapse|0|||
131228133|NCT03361956|472461612|FG000|Overall Study|Physician Decision|0|||
131228134|NCT03361956|472461613|FG001|Overall Study|Physician Decision|2|||
131228135|NCT03361956|472461614|FG002|Overall Study|Physician Decision|0|||
131228136|NCT03361956|472461615|FG003|Overall Study|Physician Decision|1|||
131228137|NCT03361956|472461616|FG004|Overall Study|Physician Decision|0|||
131228138|NCT03361956|472461612|FG000|Overall Study|Lost to Follow-up|0|||
131228139|NCT03361956|472461613|FG001|Overall Study|Lost to Follow-up|0|||
131228140|NCT03361956|472461614|FG002|Overall Study|Lost to Follow-up|1|||
131228141|NCT03361956|472461615|FG003|Overall Study|Lost to Follow-up|1|||
131228142|NCT03361956|472461616|FG004|Overall Study|Lost to Follow-up|2|||
131228143|NCT00408876|472461617|FG000|Overall Study|Adverse Event|9|||
131228144|NCT00408876|472461618|FG001|Overall Study|Adverse Event|17|||
131228145|NCT00408876|472461619|FG002|Overall Study|Adverse Event|27|||
131228146|NCT00408876|472461620|FG003|Overall Study|Adverse Event|10|||
131228147|NCT00408876|472461617|FG000|Overall Study|Withdrawal by Subject|3|||
131228148|NCT00408876|472461618|FG001|Overall Study|Withdrawal by Subject|6|||
131228149|NCT00408876|472461619|FG002|Overall Study|Withdrawal by Subject|6|||
131228150|NCT00408876|472461620|FG003|Overall Study|Withdrawal by Subject|14|||
131228151|NCT00408876|472461617|FG000|Overall Study|Lack of Efficacy|2|||
131228152|NCT00408876|472461618|FG001|Overall Study|Lack of Efficacy|4|||
131228153|NCT00408876|472461619|FG002|Overall Study|Lack of Efficacy|5|||
131228154|NCT00408876|472461620|FG003|Overall Study|Lack of Efficacy|6|||
131228155|NCT00408876|472461617|FG000|Overall Study|Lost to Follow-up|1|||
131228156|NCT00408876|472461618|FG001|Overall Study|Lost to Follow-up|6|||
131228157|NCT00408876|472461619|FG002|Overall Study|Lost to Follow-up|5|||
131228158|NCT00408876|472461620|FG003|Overall Study|Lost to Follow-up|2|||
131228159|NCT00408876|472461617|FG000|Overall Study|Protocol Violation|0|||
131228160|NCT00408876|472461618|FG001|Overall Study|Protocol Violation|3|||
131228161|NCT00408876|472461619|FG002|Overall Study|Protocol Violation|4|||
131228162|NCT00408876|472461620|FG003|Overall Study|Protocol Violation|3|||
131228163|NCT00408876|472461617|FG000|Overall Study|Physician Decision|1|||
131228164|NCT00408876|472461618|FG001|Overall Study|Physician Decision|0|||
131228165|NCT00408876|472461619|FG002|Overall Study|Physician Decision|3|||
131228166|NCT00408876|472461620|FG003|Overall Study|Physician Decision|0|||
131228167|NCT02006147|472461621|FG000|Overall Study|Protocol Violation|1|||
131228168|NCT02006147|472461622|FG001|Overall Study|Protocol Violation|1|||
131228169|NCT02006147|472461623|FG002|Overall Study|Protocol Violation|0|||
131228170|NCT02006147|472461624|FG003|Overall Study|Protocol Violation|0|||
131228171|NCT02006147|472461621|FG000|Overall Study|Withdrawal by Subject|0|||
131228172|NCT02006147|472461622|FG001|Overall Study|Withdrawal by Subject|1|||
131228173|NCT02006147|472461623|FG002|Overall Study|Withdrawal by Subject|0|||
131228174|NCT02006147|472461624|FG003|Overall Study|Withdrawal by Subject|0|||
131228175|NCT02006147|472461621|FG000|Overall Study|Withdrawal by Sponsor|1|||
131228176|NCT02006147|472461622|FG001|Overall Study|Withdrawal by Sponsor|0|||
130718919|NCT01398514|470597267|FG001|Overall Study|Physiologic non-responsiveness|3|||
131044107|NCT03536884|471796168|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
131044108|NCT03536884|471796169|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131044109|NCT03536884|471796170|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131044110|NCT03536884|471796171|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131044111|NCT03536884|471796172|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131044112|NCT03536884|471796173|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131228177|NCT02006147|472461623|FG002|Overall Study|Withdrawal by Sponsor|0|||
131228178|NCT02006147|472461624|FG003|Overall Study|Withdrawal by Sponsor|0|||
130718920|NCT01398514|470597266|FG000|Overall Study|Failure to show a conditioned response|4|||
130718921|NCT01398514|470597267|FG001|Overall Study|Failure to show a conditioned response|3|||
131228179|NCT05478603|472461630|FG000|Overall Study|Withdrawal by Subject|0|||
131228180|NCT05478603|472461631|FG001|Overall Study|Withdrawal by Subject|1|||
131228181|NCT05478603|472461632|FG002|Overall Study|Withdrawal by Subject|0|||
131228182|NCT05478603|472461633|FG003|Overall Study|Withdrawal by Subject|0|||
131228183|NCT00291330|472461636|FG000|Overall Study|Adverse Event|47|||
131228184|NCT00291330|472461637|FG001|Overall Study|Adverse Event|40|||
131228185|NCT00291330|472461636|FG000|Overall Study|Protocol Violation|13|||
131228186|NCT00291330|472461637|FG001|Overall Study|Protocol Violation|20|||
131228187|NCT00291330|472461636|FG000|Overall Study|Lost to Follow-up|16|||
131228188|NCT00291330|472461637|FG001|Overall Study|Lost to Follow-up|11|||
131228189|NCT00291330|472461636|FG000|Overall Study|Withdrawal by Subject|22|||
131228190|NCT00291330|472461637|FG001|Overall Study|Withdrawal by Subject|25|||
131228191|NCT00291330|472461636|FG000|Overall Study|Other|3|||
131044113|NCT03536884|471796174|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131044114|NCT03536884|471796175|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131044115|NCT03536884|471796176|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131228192|NCT00291330|472461637|FG001|Overall Study|Other|1|||
131228193|NCT00566709|472461640|FG000|Overall Study|Protocol Violation|5|||
131228194|NCT00566709|472461641|FG001|Overall Study|Protocol Violation|0|||
131228195|NCT03443869|472461644|FG000|Overall Study|Death|3|||
131228196|NCT03443869|472461645|FG001|Overall Study|Death|3|||
131044116|NCT03536884|471796177|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131044117|NCT03536884|471796178|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
131044118|NCT03536884|471796167|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131044119|NCT03536884|471796168|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
131044120|NCT03536884|471796169|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131044121|NCT03536884|471796170|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131044122|NCT03536884|471796171|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131044123|NCT03536884|471796172|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131132420|NCT00267748|472111830|FG002|Non-randomized Period|Participant not willing to participate|0|||
131132421|NCT00267748|472111828|FG000|Non-randomized Period|Other|3|||
131132422|NCT00267748|472111829|FG001|Non-randomized Period|Other|0|||
131132423|NCT00267748|472111830|FG002|Non-randomized Period|Other|0|||
131132424|NCT00267748|472111828|FG000|Randomized Period|Death|0|||
131132425|NCT00267748|472111829|FG001|Randomized Period|Death|2|||
131132426|NCT00267748|472111830|FG002|Randomized Period|Death|3|||
131132427|NCT00267748|472111828|FG000|Randomized Period|Adverse Event|0|||
131132428|NCT00267748|472111829|FG001|Randomized Period|Adverse Event|23|||
131132429|NCT00267748|472111830|FG002|Randomized Period|Adverse Event|25|||
131132430|NCT00267748|472111828|FG000|Randomized Period|Global deterioration of health status|0|||
131132431|NCT00267748|472111829|FG001|Randomized Period|Global deterioration of health status|6|||
131132432|NCT00267748|472111830|FG002|Randomized Period|Global deterioration of health status|7|||
131132433|NCT00267748|472111828|FG000|Randomized Period|Lost to Follow-up|0|||
131132434|NCT00267748|472111829|FG001|Randomized Period|Lost to Follow-up|1|||
131132435|NCT00267748|472111830|FG002|Randomized Period|Lost to Follow-up|0|||
131132436|NCT00267748|472111828|FG000|Randomized Period|Objective progression or relapse|0|||
131132437|NCT00267748|472111829|FG001|Randomized Period|Objective progression or relapse|77|||
131132438|NCT00267748|472111830|FG002|Randomized Period|Objective progression or relapse|86|||
131132439|NCT00267748|472111828|FG000|Randomized Period|Withdrawal by Subject|0|||
131132440|NCT00267748|472111829|FG001|Randomized Period|Withdrawal by Subject|9|||
131132441|NCT00267748|472111830|FG002|Randomized Period|Withdrawal by Subject|2|||
131132442|NCT00267748|472111828|FG000|Randomized Period|Other|0|||
131132443|NCT00267748|472111829|FG001|Randomized Period|Other|9|||
131132444|NCT00267748|472111830|FG002|Randomized Period|Other|6|||
131132445|NCT00267748|472111828|FG000|Randomized Period|randomized but not treated|0|||
131132446|NCT00267748|472111829|FG001|Randomized Period|randomized but not treated|0|||
131132447|NCT00267748|472111830|FG002|Randomized Period|randomized but not treated|3|||
131132448|NCT01294800|472111831|FG000|Overall Study|Adverse Event|7|||
131132449|NCT01294800|472111832|FG001|Overall Study|Adverse Event|6|||
131132450|NCT01294800|472111833|FG002|Overall Study|Adverse Event|12|||
131132451|NCT01294800|472111834|FG003|Overall Study|Adverse Event|5|||
131132452|NCT01294800|472111831|FG000|Overall Study|Subject Withdrew Consent|2|||
131132453|NCT01294800|472111832|FG001|Overall Study|Subject Withdrew Consent|2|||
131132454|NCT01294800|472111833|FG002|Overall Study|Subject Withdrew Consent|2|||
131132455|NCT01294800|472111834|FG003|Overall Study|Subject Withdrew Consent|11|||
131132456|NCT01294800|472111831|FG000|Overall Study|Lost to Follow-up|0|||
131132457|NCT01294800|472111832|FG001|Overall Study|Lost to Follow-up|0|||
131132458|NCT01294800|472111833|FG002|Overall Study|Lost to Follow-up|1|||
131132459|NCT01294800|472111834|FG003|Overall Study|Lost to Follow-up|0|||
131132460|NCT01294800|472111831|FG000|Overall Study|Non-compliance With Protocol|0|||
131132461|NCT01294800|472111832|FG001|Overall Study|Non-compliance With Protocol|1|||
131132462|NCT01294800|472111833|FG002|Overall Study|Non-compliance With Protocol|1|||
131132463|NCT01294800|472111834|FG003|Overall Study|Non-compliance With Protocol|0|||
131132464|NCT01294800|472111831|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
131132465|NCT01294800|472111832|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
131132466|NCT01294800|472111833|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
131132467|NCT01294800|472111834|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
131228197|NCT03443869|472461644|FG000|Overall Study|Withdrawal by Subject|34|||
130778827|NCT03428100|470817443|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
131132468|NCT00797732|472111838|FG000|Overall Study|Withdrawal by Subject|3|||
131132469|NCT00797732|472111839|FG001|Overall Study|Withdrawal by Subject|3|||
131132470|NCT00797732|472111840|FG002|Overall Study|Withdrawal by Subject|0|||
131132471|NCT00797732|472111838|FG000|Overall Study|Lost to Follow-up|1|||
131132472|NCT00797732|472111839|FG001|Overall Study|Lost to Follow-up|0|||
131228198|NCT03443869|472461645|FG001|Overall Study|Withdrawal by Subject|22|||
131044124|NCT03536884|471796173|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131044125|NCT03536884|471796174|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131228199|NCT03443869|472461644|FG000|Overall Study|Lost to Follow-up|1|||
131228200|NCT03443869|472461645|FG001|Overall Study|Lost to Follow-up|2|||
131228201|NCT03443869|472461644|FG000|Overall Study|Physician Decision|3|||
131228202|NCT03443869|472461645|FG001|Overall Study|Physician Decision|3|||
131228203|NCT03443869|472461644|FG000|Overall Study|Other|4|||
131228204|NCT03443869|472461645|FG001|Overall Study|Other|4|||
131228205|NCT00299728|472461646|FG000|Overall Study|Lost to Follow-up|0|||
131228206|NCT00299728|472461647|FG001|Overall Study|Lost to Follow-up|1|||
131228207|NCT00299728|472461646|FG000|Overall Study|Withdrawal by Subject|0|||
131228208|NCT00299728|472461647|FG001|Overall Study|Withdrawal by Subject|1|||
131228209|NCT00299728|472461646|FG000|Overall Study|Progressive disease|0|||
131228210|NCT00299728|472461647|FG001|Overall Study|Progressive disease|1|||
131228211|NCT02378506|472461648|FG000|Overall Study|Lack of Efficacy|3|||
131228212|NCT02378506|472461648|FG000|Overall Study|Withdrawal by Subject|4|||
131228213|NCT02378506|472461648|FG000|Overall Study|Protocol Violation|2|||
131228214|NCT02378506|472461648|FG000|Overall Study|Death|1|||
131228215|NCT02378506|472461648|FG000|Overall Study|Adverse Event|14|||
131228216|NCT02378506|472461648|FG000|Overall Study|Randomized But Not Treated|1|||
131228217|NCT01606137|472461649|FG000|Overall Study|Adverse Event|85|||
131228218|NCT01606137|472461649|FG000|Overall Study|Withdrawal by Subject|74|||
131228219|NCT01606137|472461649|FG000|Overall Study|Lack of Efficacy|56|||
131228220|NCT01606137|472461649|FG000|Overall Study|Lost to Follow-up|15|||
131228221|NCT01606137|472461649|FG000|Overall Study|Protocol Violation|1|||
131228222|NCT01606137|472461649|FG000|Overall Study|Patient non-compliance|9|||
131228223|NCT01606137|472461649|FG000|Overall Study|Death|1|||
131228224|NCT01606137|472461649|FG000|Overall Study|Decreased/no pain|4|||
131228225|NCT01606137|472461649|FG000|Overall Study|Issues with driving|4|||
131228226|NCT01606137|472461649|FG000|Overall Study|multiple sclerosis less stable|1|||
131228227|NCT01606137|472461649|FG000|Overall Study|Increased bilirubin|1|||
131228228|NCT01606137|472461649|FG000|Overall Study|Spray causes nausea|1|||
131228229|NCT01606137|472461649|FG000|Overall Study|Not enough improvement|4|||
131228230|NCT01606137|472461649|FG000|Overall Study|Wanted to try another treatment|1|||
131228231|NCT01606137|472461649|FG000|Overall Study|Patient leaving country|1|||
131228232|NCT01606137|472461649|FG000|Overall Study|Personal reasons|1|||
131228233|NCT01606137|472461649|FG000|Overall Study|Unable to tolerate study med. taste|1|||
131228234|NCT01606137|472461649|FG000|Overall Study|Patient moving|1|||
131228235|NCT01606137|472461649|FG000|Overall Study|Unable to collect consistent data|1|||
131228236|NCT03572933|472463150|FG000|Overall Study|Adverse Event|4|||
131228237|NCT03572933|472463151|FG001|Overall Study|Adverse Event|1|||
131228238|NCT03572933|472463150|FG000|Overall Study|Withdrawal by Subject|0|||
131228239|NCT03572933|472463151|FG001|Overall Study|Withdrawal by Subject|1|||
131228240|NCT01405950|472463152|FG000|Overall Study|Withdrawal by Subject|1|||
131228241|NCT01405950|472463153|FG001|Overall Study|Withdrawal by Subject|0|||
131228242|NCT01405950|472463154|FG002|Overall Study|Withdrawal by Subject|0|||
131228243|NCT01405950|472463155|FG003|Overall Study|Withdrawal by Subject|0|||
131228244|NCT02410252|472463156|FG000|Overall Study|Withdrawal by Subject|4|||
131228245|NCT02410252|472463156|FG000|Overall Study|Physician Decision|2|||
131228246|NCT00387712|472463159|FG000|Overall Study|Physician Decision|6|||
131228247|NCT00387712|472463160|FG001|Overall Study|Physician Decision|4|||
131228248|NCT00387712|472463159|FG000|Overall Study|Lost to Follow-up|17|||
131228249|NCT00387712|472463160|FG001|Overall Study|Lost to Follow-up|20|||
131228250|NCT00387712|472463159|FG000|Overall Study|Withdrawal by Subject|6|||
131228251|NCT00387712|472463160|FG001|Overall Study|Withdrawal by Subject|12|||
131228252|NCT01907737|472463167|FG000|Overall Study|Withdrawal by Subject|1|||
131228253|NCT01772368|472463169|FG000|Overall Study|Adverse Event|1|||
131228254|NCT01772368|472463169|FG000|Overall Study|Withdrawal by Subject|3|||
131228255|NCT01772368|472463169|FG000|Overall Study|Protocol Violation|2|||
131044126|NCT03536884|471796175|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131044127|NCT03536884|471796176|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131044128|NCT03536884|471796177|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131044129|NCT03536884|471796178|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
131044130|NCT03536884|471796167|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
131044131|NCT03536884|471796168|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
131044132|NCT03536884|471796169|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
131228256|NCT01772368|472463169|FG000|Overall Study|Other|1|||
131228257|NCT01452529|472463173|FG000|Run-in Period|Adverse Event|96|||
131228258|NCT01452529|472463174|FG001|Run-in Period|Adverse Event|0|||
131228259|NCT01452529|472463175|FG002|Run-in Period|Adverse Event|0|||
131228260|NCT01452529|472463173|FG000|Run-in Period|Withdrawal by Subject|49|||
131228261|NCT01452529|472463174|FG001|Run-in Period|Withdrawal by Subject|0|||
131228262|NCT01452529|472463175|FG002|Run-in Period|Withdrawal by Subject|0|||
131228263|NCT01452529|472463173|FG000|Run-in Period|Lost to Follow-up|19|||
131228264|NCT01452529|472463174|FG001|Run-in Period|Lost to Follow-up|0|||
131228265|NCT01452529|472463175|FG002|Run-in Period|Lost to Follow-up|0|||
131228266|NCT01452529|472463173|FG000|Run-in Period|Lack of Efficacy|46|||
130981669|NCT03382782|471557063|FG002|Cohort 2|Withdrawal by Subject|0|||
130981670|NCT03382782|471557061|FG000|Cohort 3|Withdrawal by Subject|1|||
130981671|NCT03382782|471557062|FG001|Cohort 3|Withdrawal by Subject|2|||
130981672|NCT03382782|471557063|FG002|Cohort 3|Withdrawal by Subject|0|||
130981673|NCT01791725|471557064|FG000|Overall Study|Withdrawal by Subject|0|||
130981674|NCT01791725|471557065|FG001|Overall Study|Withdrawal by Subject|1|||
130981675|NCT01791725|471557066|FG002|Overall Study|Withdrawal by Subject|0|||
130981676|NCT03255824|471557067|FG000|Overall Study|Under-sedation|2|||
130981677|NCT03255824|471557068|FG001|Overall Study|Under-sedation|1|||
130981678|NCT02001194|471557070|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
130981679|NCT02001194|471557071|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
130981680|NCT02001194|471557072|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
130981681|NCT02001194|471557073|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
130981682|NCT02001194|471557070|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
130981683|NCT02001194|471557071|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
130981684|NCT02001194|471557072|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
130981685|NCT02001194|471557073|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
130981686|NCT03320018|471557077|FG000|Treatment Period|Withdrawal by Subject|1|||
130981687|NCT03320018|471557078|FG001|Treatment Period|Withdrawal by Subject|0|||
130981688|NCT03320018|471557077|FG000|Day 90 Follow up|Death|0|||
130981689|NCT03320018|471557078|FG001|Day 90 Follow up|Death|1|||
130981690|NCT03205371|471557086|FG000|Overall Study|Withdrawal by Subject|4|||
130981691|NCT03205371|471557087|FG001|Overall Study|Withdrawal by Subject|1|||
130981692|NCT03205371|471557088|FG002|Overall Study|Withdrawal by Subject|0|||
130981693|NCT03205371|471557089|FG003|Overall Study|Withdrawal by Subject|0|||
130981694|NCT03205371|471557090|FG004|Overall Study|Withdrawal by Subject|0|||
130981695|NCT03205371|471557091|FG005|Overall Study|Withdrawal by Subject|0|||
130981696|NCT03205371|471557092|FG006|Overall Study|Withdrawal by Subject|4|||
130981697|NCT03205371|471557093|FG007|Overall Study|Withdrawal by Subject|0|||
130981698|NCT03205371|471557094|FG008|Overall Study|Withdrawal by Subject|2|||
130981699|NCT03205371|471557095|FG009|Overall Study|Withdrawal by Subject|0|||
130981700|NCT03205371|471557096|FG010|Overall Study|Withdrawal by Subject|0|||
130981701|NCT03205371|471557097|FG011|Overall Study|Withdrawal by Subject|1|||
130981702|NCT03205371|471557086|FG000|Overall Study|Lost to Follow-up|0|||
130981703|NCT03205371|471557087|FG001|Overall Study|Lost to Follow-up|0|||
130981704|NCT03205371|471557088|FG002|Overall Study|Lost to Follow-up|0|||
130981705|NCT03205371|471557089|FG003|Overall Study|Lost to Follow-up|0|||
130981706|NCT03205371|471557090|FG004|Overall Study|Lost to Follow-up|0|||
130981707|NCT03205371|471557091|FG005|Overall Study|Lost to Follow-up|0|||
130981708|NCT03205371|471557092|FG006|Overall Study|Lost to Follow-up|5|||
130981709|NCT03205371|471557093|FG007|Overall Study|Lost to Follow-up|2|||
130981710|NCT03205371|471557094|FG008|Overall Study|Lost to Follow-up|3|||
130981711|NCT03205371|471557095|FG009|Overall Study|Lost to Follow-up|0|||
130981712|NCT03205371|471557096|FG010|Overall Study|Lost to Follow-up|0|||
130981713|NCT03205371|471557097|FG011|Overall Study|Lost to Follow-up|0|||
130981714|NCT03205371|471557086|FG000|Overall Study|Protocol Violation|0|||
130981715|NCT03205371|471557087|FG001|Overall Study|Protocol Violation|0|||
130981716|NCT03205371|471557088|FG002|Overall Study|Protocol Violation|0|||
130981717|NCT03205371|471557089|FG003|Overall Study|Protocol Violation|0|||
130981718|NCT03205371|471557090|FG004|Overall Study|Protocol Violation|0|||
130981719|NCT03205371|471557091|FG005|Overall Study|Protocol Violation|0|||
130981720|NCT03205371|471557092|FG006|Overall Study|Protocol Violation|1|||
130981721|NCT03205371|471557093|FG007|Overall Study|Protocol Violation|0|||
130981722|NCT03205371|471557094|FG008|Overall Study|Protocol Violation|0|||
130981723|NCT03205371|471557095|FG009|Overall Study|Protocol Violation|0|||
130981724|NCT03205371|471557096|FG010|Overall Study|Protocol Violation|0|||
130981725|NCT03205371|471557097|FG011|Overall Study|Protocol Violation|0|||
130981726|NCT03205371|471557086|FG000|Overall Study|Adverse Event|0|||
130981727|NCT03205371|471557087|FG001|Overall Study|Adverse Event|0|||
130981728|NCT03205371|471557088|FG002|Overall Study|Adverse Event|0|||
130981729|NCT03205371|471557089|FG003|Overall Study|Adverse Event|0|||
130981730|NCT03205371|471557090|FG004|Overall Study|Adverse Event|0|||
130981731|NCT03205371|471557091|FG005|Overall Study|Adverse Event|0|||
130981732|NCT03205371|471557092|FG006|Overall Study|Adverse Event|0|||
130981733|NCT03205371|471557093|FG007|Overall Study|Adverse Event|1|||
130981734|NCT03205371|471557094|FG008|Overall Study|Adverse Event|0|||
130981735|NCT03205371|471557095|FG009|Overall Study|Adverse Event|0|||
131044133|NCT03536884|471796170|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
131044134|NCT03536884|471796171|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
130981736|NCT03205371|471557096|FG010|Overall Study|Adverse Event|0|||
130981737|NCT03205371|471557097|FG011|Overall Study|Adverse Event|0|||
131132473|NCT00797732|472111840|FG002|Overall Study|Lost to Follow-up|0|||
131132474|NCT00797732|472111838|FG000|Overall Study|Death|1|||
131132475|NCT00797732|472111839|FG001|Overall Study|Death|0|||
131132476|NCT00797732|472111840|FG002|Overall Study|Death|0|||
131132477|NCT00797732|472111838|FG000|Overall Study|Not meet inclusion criteria|0|||
131132478|NCT00797732|472111839|FG001|Overall Study|Not meet inclusion criteria|0|||
131132479|NCT00797732|472111840|FG002|Overall Study|Not meet inclusion criteria|7|||
131132480|NCT00797732|472111838|FG000|Overall Study|Excluded due to time constraints|0|||
131132481|NCT00797732|472111839|FG001|Overall Study|Excluded due to time constraints|0|||
131132482|NCT00797732|472111840|FG002|Overall Study|Excluded due to time constraints|24|||
131132483|NCT00797732|472111838|FG000|Overall Study|Refused to Participate|0|||
131132484|NCT00797732|472111839|FG001|Overall Study|Refused to Participate|0|||
131132485|NCT00797732|472111840|FG002|Overall Study|Refused to Participate|123|||
130981752|NCT02618967|471557101|FG000|Overall Study|Lost to Follow-up|0|||
130981753|NCT02618967|471557102|FG001|Overall Study|Lost to Follow-up|0|||
130981754|NCT02618967|471557103|FG002|Overall Study|Lost to Follow-up|1|||
130981755|NCT02618967|471557104|FG003|Overall Study|Lost to Follow-up|0|||
130981756|NCT02618967|471557105|FG004|Overall Study|Lost to Follow-up|2|||
130981757|NCT02618967|471557106|FG005|Overall Study|Lost to Follow-up|0|||
130981758|NCT02618967|471557107|FG006|Overall Study|Lost to Follow-up|0|||
130981759|NCT02618967|471557108|FG007|Overall Study|Lost to Follow-up|0|||
130981760|NCT02618967|471557101|FG000|Overall Study|Withdrawal by Subject|1|||
130981761|NCT02618967|471557102|FG001|Overall Study|Withdrawal by Subject|0|||
130981762|NCT02618967|471557103|FG002|Overall Study|Withdrawal by Subject|0|||
130718922|NCT02771795|470597268|FG000|Overall Study|Withdrawal by Subject|47|||
130718923|NCT02771795|470597269|FG001|Overall Study|Withdrawal by Subject|37|||
130718924|NCT02771795|470597268|FG000|Overall Study|Termination by premature discontinuation of study|168|||
130718925|NCT02771795|470597269|FG001|Overall Study|Termination by premature discontinuation of study|185|||
130981763|NCT02618967|471557104|FG003|Overall Study|Withdrawal by Subject|0|||
130981764|NCT02618967|471557105|FG004|Overall Study|Withdrawal by Subject|0|||
130981765|NCT02618967|471557106|FG005|Overall Study|Withdrawal by Subject|0|||
130981766|NCT02618967|471557107|FG006|Overall Study|Withdrawal by Subject|0|||
130981767|NCT02618967|471557108|FG007|Overall Study|Withdrawal by Subject|0|||
130981768|NCT02612311|471557109|FG000|Overall Study|Adverse Event|16|||
130981769|NCT02612311|471557110|FG001|Overall Study|Adverse Event|12|||
130981770|NCT02612311|471557111|FG002|Overall Study|Adverse Event|7|||
130981771|NCT02612311|471557112|FG003|Overall Study|Adverse Event|13|||
130981772|NCT02612311|471557109|FG000|Overall Study|Death|29|||
130981773|NCT02612311|471557110|FG001|Overall Study|Death|10|||
130981774|NCT02612311|471557111|FG002|Overall Study|Death|11|||
130981775|NCT02612311|471557112|FG003|Overall Study|Death|11|||
130981776|NCT02612311|471557109|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
130981777|NCT02612311|471557110|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
130981778|NCT02612311|471557111|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
130718926|NCT01345175|470597274|FG000|Overall Study|Physician Decision|0|||
130718927|NCT01345175|470597275|FG001|Overall Study|Physician Decision|1|||
130718928|NCT01345175|470597274|FG000|Overall Study|Withdrawal by Subject|1|||
130718929|NCT01345175|470597275|FG001|Overall Study|Withdrawal by Subject|1|||
130718930|NCT01345175|470597274|FG000|Overall Study|Failed to complete BFI|3|||
130718931|NCT01345175|470597275|FG001|Overall Study|Failed to complete BFI|2|||
130718932|NCT01345175|470597274|FG000|Overall Study|Stopped taking medication|2|||
130718933|NCT01345175|470597275|FG001|Overall Study|Stopped taking medication|2|||
130718934|NCT04112173|470597276|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
130718935|NCT02570113|470597286|FG000|Overall Study|Withdrawal by Subject|3|||
130718936|NCT00910091|470597287|FG000|Pre-assignment|Withdrawal by Subject|0|||
130718937|NCT00910091|470597288|FG001|Pre-assignment|Withdrawal by Subject|2|||
130718938|NCT00910091|470597287|FG000|Treatment and Survival|Withdrawal by Subject|3|||
130718939|NCT00910091|470597288|FG001|Treatment and Survival|Withdrawal by Subject|4|||
130718940|NCT00910091|470597287|FG000|Treatment and Survival|Adverse Event|1|||
130718941|NCT00910091|470597288|FG001|Treatment and Survival|Adverse Event|0|||
130718942|NCT00622466|470597289|FG000|Overall Study|Death|1|||
130718943|NCT00622466|470597289|FG000|Overall Study|Adverse Event|1|||
130718944|NCT00622466|470597289|FG000|Overall Study|Withdrawal by Subject|2|||
130718945|NCT01908816|470597292|FG000|Overall Study|Subject's no longer requires study drug|0|||
130718946|NCT01908816|470597293|FG001|Overall Study|Subject's no longer requires study drug|0|||
130718947|NCT01908816|470597294|FG002|Overall Study|Subject's no longer requires study drug|0|||
130718948|NCT01908816|470597295|FG003|Overall Study|Subject's no longer requires study drug|1|||
130718949|NCT01908816|470597292|FG000|Overall Study|Protocol deviation|1|||
130718950|NCT01908816|470597293|FG001|Overall Study|Protocol deviation|2|||
130718951|NCT01908816|470597294|FG002|Overall Study|Protocol deviation|1|||
130718952|NCT01908816|470597295|FG003|Overall Study|Protocol deviation|1|||
130718953|NCT01908816|470597292|FG000|Overall Study|Withdrawal by Subject|0|||
130718954|NCT01908816|470597293|FG001|Overall Study|Withdrawal by Subject|4|||
130718955|NCT01908816|470597294|FG002|Overall Study|Withdrawal by Subject|2|||
130778828|NCT03428100|470817444|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
130981779|NCT02612311|471557112|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
130981780|NCT02612311|471557109|FG000|Overall Study|Investigator's Decision|11|||
130981781|NCT02612311|471557110|FG001|Overall Study|Investigator's Decision|15|||
130981782|NCT02612311|471557111|FG002|Overall Study|Investigator's Decision|6|||
130981783|NCT02612311|471557112|FG003|Overall Study|Investigator's Decision|6|||
130981784|NCT02612311|471557109|FG000|Overall Study|Lack of Efficacy|0|||
130981785|NCT02612311|471557110|FG001|Overall Study|Lack of Efficacy|0|||
130981786|NCT02612311|471557111|FG002|Overall Study|Lack of Efficacy|1|||
130981787|NCT02612311|471557112|FG003|Overall Study|Lack of Efficacy|1|||
130981788|NCT02612311|471557109|FG000|Overall Study|Lost to Follow-up|2|||
130981789|NCT02612311|471557110|FG001|Overall Study|Lost to Follow-up|2|||
130981790|NCT02612311|471557111|FG002|Overall Study|Lost to Follow-up|1|||
130981791|NCT02612311|471557112|FG003|Overall Study|Lost to Follow-up|2|||
130981792|NCT02612311|471557109|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
130981793|NCT02612311|471557110|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
130981794|NCT02612311|471557111|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
130981795|NCT02612311|471557112|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
130981796|NCT02612311|471557109|FG000|Overall Study|Site Terminated by Sponsor|29|||
130981797|NCT02612311|471557110|FG001|Overall Study|Site Terminated by Sponsor|12|||
130981798|NCT02612311|471557111|FG002|Overall Study|Site Terminated by Sponsor|13|||
130981799|NCT02612311|471557112|FG003|Overall Study|Site Terminated by Sponsor|5|||
130981800|NCT02612311|471557109|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
130981801|NCT02612311|471557110|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
130981802|NCT02612311|471557111|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
130981803|NCT02612311|471557112|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
130981804|NCT02612311|471557109|FG000|Overall Study|Reason Not Specified|3|||
130981805|NCT02612311|471557110|FG001|Overall Study|Reason Not Specified|7|||
130981806|NCT02612311|471557111|FG002|Overall Study|Reason Not Specified|4|||
130981807|NCT02612311|471557112|FG003|Overall Study|Reason Not Specified|5|||
130981808|NCT02612311|471557109|FG000|Overall Study|Unknown/Missing|10|||
130981809|NCT02612311|471557110|FG001|Overall Study|Unknown/Missing|13|||
130981810|NCT02612311|471557111|FG002|Overall Study|Unknown/Missing|4|||
130981811|NCT02612311|471557112|FG003|Overall Study|Unknown/Missing|0|||
130981812|NCT02612311|471557109|FG000|Overall Study|Non-Compliance with Study|1|||
130981813|NCT02612311|471557110|FG001|Overall Study|Non-Compliance with Study|0|||
130981814|NCT02612311|471557111|FG002|Overall Study|Non-Compliance with Study|0|||
130981815|NCT02612311|471557112|FG003|Overall Study|Non-Compliance with Study|0|||
130981816|NCT04393441|471557113|FG000|Overall Study|Adverse Event|0|||
130981817|NCT04393441|471557114|FG001|Overall Study|Adverse Event|3|||
130981818|NCT04393441|471557113|FG000|Overall Study|Withdrawal by Subject|5|||
130981819|NCT04393441|471557114|FG001|Overall Study|Withdrawal by Subject|7|||
130981820|NCT04393441|471557113|FG000|Overall Study|Lost to Follow-up|0|||
130981821|NCT04393441|471557114|FG001|Overall Study|Lost to Follow-up|2|||
130981822|NCT04393441|471557113|FG000|Overall Study|Protocol Deviation|2|||
130981823|NCT04393441|471557114|FG001|Overall Study|Protocol Deviation|1|||
130981824|NCT04393441|471557113|FG000|Overall Study|Reason not Specified|1|||
130981825|NCT04393441|471557114|FG001|Overall Study|Reason not Specified|1|||
130981826|NCT04542018|471557118|FG000|Overall Study|Withdrawal by Subject|0|||
130981827|NCT04542018|471557119|FG001|Overall Study|Withdrawal by Subject|0|||
130981828|NCT04542018|471557120|FG002|Overall Study|Withdrawal by Subject|4|||
130981829|NCT04542018|471557118|FG000|Overall Study|Protocol Violation|0|||
130981830|NCT04542018|471557119|FG001|Overall Study|Protocol Violation|0|||
130981831|NCT04542018|471557120|FG002|Overall Study|Protocol Violation|2|||
130981832|NCT00689221|471557121|FG000|Overall Study|Ongoing at cut-off date|39|||
130981833|NCT00689221|471557122|FG001|Overall Study|Ongoing at cut-off date|36|||
130981834|NCT01812655|471557123|FG000|Overall Study|Protocol Violation|1|||
130981835|NCT01812655|471557124|FG001|Overall Study|Protocol Violation|1|||
130981836|NCT01812655|471557125|FG002|Overall Study|Protocol Violation|0|||
130981837|NCT04672941|471557127|FG000|Overall Study|Investigator decision|1|||
130981838|NCT04672941|471557127|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
130981839|NCT04672941|471557127|FG000|Overall Study|COVID-19 related but no adverse event|1|||
130981840|NCT04672941|471557127|FG000|Overall Study|Adverse Event|2|||
130981841|NCT04672941|471557127|FG000|Overall Study|Lost to Follow-up|2|||
130981842|NCT04435665|471557128|FG000|Overall Study|Lost to Follow-up|0|||
130981843|NCT04435665|471557129|FG001|Overall Study|Lost to Follow-up|0|||
130981844|NCT04435665|471557130|FG002|Overall Study|Lost to Follow-up|0|||
130981845|NCT04435665|471557131|FG003|Overall Study|Lost to Follow-up|1|||
130981846|NCT00765388|471557132|FG000|Period 1|Lack of Efficacy|1|||
130981847|NCT00765388|471557133|FG001|Period 1|Lack of Efficacy|2|||
130981848|NCT00765388|471557132|FG000|Period 1|Lost to Follow-up|0|||
130981849|NCT00765388|471557133|FG001|Period 1|Lost to Follow-up|1|||
130981850|NCT00765388|471557132|FG000|Period 1|Herpes Zoster|0|||
130981851|NCT00765388|471557133|FG001|Period 1|Herpes Zoster|1|||
130981852|NCT00765388|471557132|FG000|Period 1|Hip operation|0|||
130981853|NCT00765388|471557133|FG001|Period 1|Hip operation|1|||
130981854|NCT01563536|471557137|FG000|Overall Study|Withdrawal by Subject|0|||
130981855|NCT01563536|471557138|FG001|Overall Study|Withdrawal by Subject|2|||
130981856|NCT01563536|471557137|FG000|Overall Study|Lost to Follow-up|1|||
130981857|NCT01563536|471557138|FG001|Overall Study|Lost to Follow-up|0|||
130981858|NCT00538590|471557146|FG000|Overall Study|Death|1|||
130981859|NCT00538590|471557147|FG001|Overall Study|Death|0|||
130981860|NCT01256567|471557148|FG000|Overall Study|Withdrawal by Subject|1|||
130981861|NCT00344461|471557163|FG000|Overall Study|Adverse Event|6|||
131228267|NCT01452529|472463174|FG001|Run-in Period|Lack of Efficacy|0|||
131228268|NCT01452529|472463175|FG002|Run-in Period|Lack of Efficacy|0|||
131228269|NCT01452529|472463173|FG000|Run-in Period|Confirmed or suspected diversion|23|||
131228270|NCT01452529|472463174|FG001|Run-in Period|Confirmed or suspected diversion|0|||
131228271|NCT01452529|472463175|FG002|Run-in Period|Confirmed or suspected diversion|0|||
131228272|NCT01452529|472463173|FG000|Run-in Period|Administrative|21|||
131228273|NCT01452529|472463174|FG001|Run-in Period|Administrative|0|||
131228274|NCT01452529|472463175|FG002|Run-in Period|Administrative|0|||
131228275|NCT01452529|472463173|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
131228276|NCT01452529|472463174|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
131228277|NCT01452529|472463175|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
131228278|NCT01452529|472463173|FG000|Double-blind (DB) Period|Adverse Event|0|||
131044135|NCT03536884|471796172|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
131044136|NCT03536884|471796173|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
131044137|NCT03536884|471796174|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
131044138|NCT03536884|471796175|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
131044139|NCT03536884|471796176|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
131044140|NCT03536884|471796177|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
131044141|NCT03536884|471796178|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
131044142|NCT03536884|471796167|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131044143|NCT03536884|471796168|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131044144|NCT03536884|471796169|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
131044145|NCT03536884|471796170|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
131044146|NCT03536884|471796171|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
131044147|NCT03536884|471796172|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131044148|NCT03536884|471796173|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131044149|NCT03536884|471796174|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131044150|NCT03536884|471796175|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131228279|NCT01452529|472463174|FG001|Double-blind (DB) Period|Adverse Event|18|||
131228280|NCT01452529|472463175|FG002|Double-blind (DB) Period|Adverse Event|11|||
131228281|NCT01452529|472463173|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
131228282|NCT01452529|472463174|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
131228283|NCT01452529|472463175|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
131044151|NCT03536884|471796176|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131044152|NCT03536884|471796177|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131228284|NCT01452529|472463173|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
131228285|NCT01452529|472463174|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
131228286|NCT01452529|472463175|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
131228287|NCT01452529|472463173|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
131044153|NCT03536884|471796178|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
131044154|NCT03536884|471796167|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131044155|NCT03536884|471796168|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131228288|NCT01452529|472463174|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
131228289|NCT01452529|472463175|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
131228290|NCT01452529|472463173|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
131228291|NCT01452529|472463174|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
131228292|NCT01452529|472463175|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
131228293|NCT01452529|472463173|FG000|Double-blind (DB) Period|Administrative|0|||
131228294|NCT01452529|472463174|FG001|Double-blind (DB) Period|Administrative|11|||
131228295|NCT01452529|472463175|FG002|Double-blind (DB) Period|Administrative|7|||
131228296|NCT03347695|472463179|FG000|Overall Study|Death|0|||
131228297|NCT03347695|472463180|FG001|Overall Study|Death|4|||
131228298|NCT03347695|472463179|FG000|Overall Study|Lost to Follow-up|0|||
131228299|NCT03347695|472463180|FG001|Overall Study|Lost to Follow-up|1|||
131228300|NCT00909727|472463201|FG000|Overall Study|Adverse Event|1|||
131228301|NCT00909727|472463202|FG001|Overall Study|Adverse Event|0|||
131228302|NCT00909727|472463201|FG000|Overall Study|Wrong Genotype|1|||
131228303|NCT00909727|472463202|FG001|Overall Study|Wrong Genotype|0|||
131228304|NCT00909727|472463201|FG000|Overall Study|Withdrawal of Consent|1|||
131228305|NCT00909727|472463202|FG001|Overall Study|Withdrawal of Consent|0|||
131228306|NCT00909727|472463201|FG000|Overall Study|Prohibited Medication|1|||
131228307|NCT00909727|472463202|FG001|Overall Study|Prohibited Medication|0|||
131044156|NCT03536884|471796169|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131044157|NCT03536884|471796170|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
131228308|NCT00295854|472463207|FG000|Overall Study|Adverse Event|7|||
131228309|NCT00295854|472463208|FG001|Overall Study|Adverse Event|7|||
131228310|NCT00295854|472463209|FG002|Overall Study|Adverse Event|6|||
131228311|NCT00295854|472463207|FG000|Overall Study|Protocol Violation|1|||
131228312|NCT00295854|472463208|FG001|Overall Study|Protocol Violation|1|||
131228313|NCT00295854|472463209|FG002|Overall Study|Protocol Violation|1|||
131228314|NCT00295854|472463207|FG000|Overall Study|Lost to Follow-up|2|||
131228315|NCT00295854|472463208|FG001|Overall Study|Lost to Follow-up|0|||
131228316|NCT00295854|472463209|FG002|Overall Study|Lost to Follow-up|1|||
131228317|NCT00295854|472463207|FG000|Overall Study|Withdrawal by Subject|3|||
131228318|NCT00295854|472463208|FG001|Overall Study|Withdrawal by Subject|7|||
131228319|NCT00295854|472463209|FG002|Overall Study|Withdrawal by Subject|4|||
131228320|NCT00295854|472463207|FG000|Overall Study|did not continue to meet criteria|1|||
131228321|NCT00295854|472463208|FG001|Overall Study|did not continue to meet criteria|1|||
131228322|NCT00295854|472463209|FG002|Overall Study|did not continue to meet criteria|2|||
131228323|NCT00295854|472463207|FG000|Overall Study|required a prohibited medication|1|||
131228324|NCT00295854|472463208|FG001|Overall Study|required a prohibited medication|0|||
131228325|NCT00295854|472463209|FG002|Overall Study|required a prohibited medication|0|||
131228326|NCT00295854|472463207|FG000|Overall Study|Other|3|||
131228327|NCT00295854|472463208|FG001|Overall Study|Other|5|||
131228328|NCT00295854|472463209|FG002|Overall Study|Other|1|||
131228329|NCT00672620|472463210|FG000|Overall Study|Adverse Event|7|||
131228330|NCT00672620|472463211|FG001|Overall Study|Adverse Event|7|||
131228331|NCT00672620|472463212|FG002|Overall Study|Adverse Event|12|||
131228332|NCT00672620|472463213|FG003|Overall Study|Adverse Event|17|||
131228333|NCT00672620|472463210|FG000|Overall Study|Lack of Efficacy|1|||
131228334|NCT00672620|472463211|FG001|Overall Study|Lack of Efficacy|2|||
131228335|NCT00672620|472463212|FG002|Overall Study|Lack of Efficacy|2|||
131228336|NCT00672620|472463213|FG003|Overall Study|Lack of Efficacy|0|||
131228337|NCT00672620|472463210|FG000|Overall Study|Noncompliance with Study Drug|3|||
131228338|NCT00672620|472463211|FG001|Overall Study|Noncompliance with Study Drug|4|||
131228339|NCT00672620|472463212|FG002|Overall Study|Noncompliance with Study Drug|0|||
131228340|NCT00672620|472463213|FG003|Overall Study|Noncompliance with Study Drug|2|||
131228341|NCT00672620|472463210|FG000|Overall Study|Protocol Deviations|5|||
131228342|NCT00672620|472463211|FG001|Overall Study|Protocol Deviations|7|||
131228343|NCT00672620|472463212|FG002|Overall Study|Protocol Deviations|2|||
131228344|NCT00672620|472463213|FG003|Overall Study|Protocol Deviations|5|||
131132486|NCT00401752|472111841|FG000|Overall Study|Adverse Event|2|||
131132487|NCT00401752|472111842|FG001|Overall Study|Adverse Event|5|||
131132488|NCT00401752|472111841|FG000|Overall Study|Withdrawal by Subject|2|||
131132489|NCT00401752|472111842|FG001|Overall Study|Withdrawal by Subject|6|||
131132490|NCT00401752|472111841|FG000|Overall Study|Lost to Follow-up|1|||
130981862|NCT00344461|471557163|FG000|Overall Study|Death|1|||
130981863|NCT00344461|471557163|FG000|Overall Study|Lack of Efficacy|2|||
130981864|NCT00344461|471557163|FG000|Overall Study|Lost to Follow-up|2|||
130981865|NCT00344461|471557163|FG000|Overall Study|Physician Decision|2|||
130981866|NCT00344461|471557163|FG000|Overall Study|Protocol Violation|6|||
131132491|NCT00401752|472111842|FG001|Overall Study|Lost to Follow-up|4|||
131132492|NCT00401752|472111841|FG000|Overall Study|Development of any exclusion criteria|4|||
131132493|NCT00401752|472111842|FG001|Overall Study|Development of any exclusion criteria|2|||
131132494|NCT00401752|472111841|FG000|Overall Study|Physician Decision|1|||
131132495|NCT00401752|472111842|FG001|Overall Study|Physician Decision|1|||
131132496|NCT01895322|472111843|FG000|Overall Study|Adverse Event|1|||
131132497|NCT01895322|472111843|FG000|Overall Study|Withdrawal by Subject|2|||
131132498|NCT01895322|472111843|FG000|Overall Study|Protocol Violation|10|||
131132499|NCT02275338|472111844|FG000|Overall Study|Adverse Event|15|||
131132500|NCT02275338|472111844|FG000|Overall Study|Lack of Efficacy|3|||
131132501|NCT02275338|472111844|FG000|Overall Study|Withdrawal by Subject|4|||
131132502|NCT02275338|472111844|FG000|Overall Study|Disease progression (death)|1|||
131132503|NCT02275338|472111844|FG000|Overall Study|Ineligible to start Phase 2|4|||
131132504|NCT02275338|472111844|FG000|Overall Study|Reason not specified|5|||
131132505|NCT02275338|472111844|FG000|Overall Study|Does not meet entry criteria|1|||
131132506|NCT02941627|472111845|FG000|Overall Study|Death|1|||
131132507|NCT02941627|472111845|FG000|Overall Study|Surgical failure|1|||
131132508|NCT02941627|472111845|FG000|Overall Study|cholesteatoma prevented implantation|1|||
131132509|NCT03594227|472111846|FG000|Overall Study|Adverse Event|2|||
131132510|NCT03594227|472111847|FG001|Overall Study|Adverse Event|1|||
131132511|NCT03594227|472111848|FG002|Overall Study|Adverse Event|0|||
131132512|NCT03594227|472111849|FG003|Overall Study|Adverse Event|2|||
131132513|NCT03594227|472111846|FG000|Overall Study|Lost to Follow-up|1|||
131132514|NCT03594227|472111847|FG001|Overall Study|Lost to Follow-up|1|||
131132515|NCT03594227|472111848|FG002|Overall Study|Lost to Follow-up|1|||
131132516|NCT03594227|472111849|FG003|Overall Study|Lost to Follow-up|0|||
131132517|NCT03594227|472111846|FG000|Overall Study|Withdrawal by Subject|1|||
130718956|NCT01908816|470597295|FG003|Overall Study|Withdrawal by Subject|2|||
130981867|NCT00344461|471557163|FG000|Overall Study|Withdrawal by Subject|2|||
130981868|NCT00636610|471557164|FG000|Overall Study|Adverse Event|4|||
131132518|NCT03594227|472111847|FG001|Overall Study|Withdrawal by Subject|1|||
131132519|NCT03594227|472111848|FG002|Overall Study|Withdrawal by Subject|1|||
131132520|NCT03594227|472111849|FG003|Overall Study|Withdrawal by Subject|1|||
131132521|NCT03594227|472111846|FG000|Overall Study|Pregnancy|0|||
131228345|NCT00672620|472463210|FG000|Overall Study|Withdrawal of Consent|6|||
131228346|NCT00672620|472463211|FG001|Overall Study|Withdrawal of Consent|12|||
131228347|NCT00672620|472463212|FG002|Overall Study|Withdrawal of Consent|5|||
131228348|NCT00672620|472463213|FG003|Overall Study|Withdrawal of Consent|6|||
131228349|NCT00672620|472463210|FG000|Overall Study|Lost to Follow-up|8|||
131228350|NCT00672620|472463211|FG001|Overall Study|Lost to Follow-up|19|||
131228351|NCT00672620|472463212|FG002|Overall Study|Lost to Follow-up|8|||
131044158|NCT03536884|471796171|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
131044159|NCT03536884|471796172|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131044160|NCT03536884|471796173|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131044161|NCT03536884|471796174|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131044162|NCT03536884|471796175|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131044163|NCT03536884|471796176|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131044164|NCT03536884|471796177|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131044165|NCT03536884|471796178|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
131044166|NCT03536884|471796167|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131044167|NCT03536884|471796168|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131044168|NCT03536884|471796169|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
131044169|NCT03536884|471796170|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
131044170|NCT03536884|471796171|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
131044171|NCT03536884|471796172|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131044172|NCT03536884|471796173|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131044173|NCT03536884|471796174|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131044174|NCT03536884|471796175|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131044175|NCT03536884|471796176|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131044176|NCT03536884|471796177|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131044177|NCT03536884|471796178|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
131044178|NCT03536884|471796167|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131044179|NCT03536884|471796168|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131044180|NCT03536884|471796169|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
131044181|NCT03536884|471796170|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
131132522|NCT03594227|472111847|FG001|Overall Study|Pregnancy|1|||
131132523|NCT03594227|472111848|FG002|Overall Study|Pregnancy|0|||
131132524|NCT03594227|472111849|FG003|Overall Study|Pregnancy|0|||
131132525|NCT03594227|472111846|FG000|Overall Study|Sponsor Decision|0|||
131132526|NCT03594227|472111847|FG001|Overall Study|Sponsor Decision|0|||
131132527|NCT03594227|472111848|FG002|Overall Study|Sponsor Decision|0|||
131132528|NCT03594227|472111849|FG003|Overall Study|Sponsor Decision|1|||
131132529|NCT03594227|472111846|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
131132530|NCT03594227|472111847|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
131132531|NCT03594227|472111848|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
131132532|NCT03594227|472111849|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
131132533|NCT01888640|472111850|FG000|Overall Study|Lost to Follow-up|1|||
131132534|NCT01888640|472111851|FG001|Overall Study|Lost to Follow-up|2|||
131132535|NCT01888640|472111852|FG002|Overall Study|Lost to Follow-up|0|||
131132536|NCT01888640|472111850|FG000|Overall Study|Withdrawal by Subject|15|||
131132537|NCT01888640|472111851|FG001|Overall Study|Withdrawal by Subject|11|||
131132538|NCT01888640|472111852|FG002|Overall Study|Withdrawal by Subject|4|||
131132539|NCT01888640|472111850|FG000|Overall Study|Minimum dose not met|10|||
131132540|NCT01888640|472111851|FG001|Overall Study|Minimum dose not met|16|||
131132541|NCT01888640|472111852|FG002|Overall Study|Minimum dose not met|0|||
131132542|NCT01888640|472111850|FG000|Overall Study|Given wrong unit (placebo)|1|||
131132543|NCT01888640|472111851|FG001|Overall Study|Given wrong unit (placebo)|0|||
131132544|NCT01888640|472111852|FG002|Overall Study|Given wrong unit (placebo)|0|||
131132545|NCT01888640|472111850|FG000|Overall Study|Excluded for prior TENS|0|||
131132546|NCT01888640|472111851|FG001|Overall Study|Excluded for prior TENS|1|||
131132547|NCT01888640|472111852|FG002|Overall Study|Excluded for prior TENS|0|||
131132548|NCT01888640|472111850|FG000|Overall Study|Researcher Termination of Participant|0|||
131132549|NCT01888640|472111851|FG001|Overall Study|Researcher Termination of Participant|1|||
131132550|NCT01888640|472111852|FG002|Overall Study|Researcher Termination of Participant|1|||
131132551|NCT02199080|472111859|FG000|Overall Study|Protocol Violation|12|||
131132552|NCT01277549|472111860|FG000|Overall Study|Failed to meet eligibility criteria|13|||
131132553|NCT01277549|472111861|FG001|Overall Study|Failed to meet eligibility criteria|9|||
131132554|NCT01277549|472111860|FG000|Overall Study|Withdrawal by Subject|1|||
131132555|NCT01277549|472111861|FG001|Overall Study|Withdrawal by Subject|3|||
131132556|NCT01277549|472111860|FG000|Overall Study|Protocol Violation|10|||
131132557|NCT01277549|472111861|FG001|Overall Study|Protocol Violation|1|||
131132558|NCT01277549|472111860|FG000|Overall Study|Physician Decision|2|||
131132559|NCT01277549|472111861|FG001|Overall Study|Physician Decision|1|||
131132560|NCT01097863|472111864|FG000|Overall Study|Discomfort|1|||
131132561|NCT01097863|472111865|FG001|Overall Study|Discomfort|0|||
131132562|NCT01097863|472111866|FG002|Overall Study|Discomfort|1|||
131132563|NCT01097863|472111864|FG000|Overall Study|Did not return for final visit|0|||
131132564|NCT01097863|472111865|FG001|Overall Study|Did not return for final visit|0|||
131132565|NCT01097863|472111866|FG002|Overall Study|Did not return for final visit|1|||
131132566|NCT02703311|472111867|FG000|Overall Study|Death|5|||
131132567|NCT02703311|472111867|FG000|Overall Study|Withdrawal by Subject|3|||
131132568|NCT00652366|472111868|FG000|Overall Study|Adverse Event|8|||
131132569|NCT00652366|472111869|FG001|Overall Study|Adverse Event|4|||
131132570|NCT00652366|472111870|FG002|Overall Study|Adverse Event|7|||
131132571|NCT00652366|472111871|FG003|Overall Study|Adverse Event|17|||
131132572|NCT00652366|472111872|FG004|Overall Study|Adverse Event|13|||
131132573|NCT00652366|472111868|FG000|Overall Study|Death|5|||
131132574|NCT00652366|472111869|FG001|Overall Study|Death|4|||
131132575|NCT00652366|472111870|FG002|Overall Study|Death|1|||
131132576|NCT00652366|472111871|FG003|Overall Study|Death|8|||
131132577|NCT00652366|472111872|FG004|Overall Study|Death|5|||
131132578|NCT00652366|472111868|FG000|Overall Study|Lack of Efficacy|84|||
131132579|NCT00652366|472111869|FG001|Overall Study|Lack of Efficacy|58|||
131132580|NCT00652366|472111870|FG002|Overall Study|Lack of Efficacy|53|||
131132581|NCT00652366|472111871|FG003|Overall Study|Lack of Efficacy|133|||
130718957|NCT01908816|470597292|FG000|Overall Study|Lost to Follow-up|3|||
130718958|NCT01908816|470597293|FG001|Overall Study|Lost to Follow-up|5|||
130718959|NCT01908816|470597294|FG002|Overall Study|Lost to Follow-up|4|||
130981869|NCT00636610|471557165|FG001|Overall Study|Adverse Event|4|||
130981870|NCT00636610|471557164|FG000|Overall Study|Death|6|||
130981871|NCT00636610|471557165|FG001|Overall Study|Death|3|||
130981872|NCT00636610|471557164|FG000|Overall Study|Physician decision to withdraw patient|15|||
130981873|NCT00636610|471557165|FG001|Overall Study|Physician decision to withdraw patient|9|||
130981874|NCT00636610|471557164|FG000|Overall Study|Subject decision to withdraw|15|||
130981875|NCT00636610|471557165|FG001|Overall Study|Subject decision to withdraw|11|||
130981876|NCT00636610|471557164|FG000|Overall Study|Disease progression - radiographic|41|||
130981877|NCT00636610|471557165|FG001|Overall Study|Disease progression - radiographic|51|||
130981878|NCT00636610|471557164|FG000|Overall Study|Disease progression - clinical|8|||
130981879|NCT00636610|471557165|FG001|Overall Study|Disease progression - clinical|3|||
130981880|NCT00636610|471557164|FG000|Overall Study|Reason for discontinuation not available|3|||
130981881|NCT00636610|471557165|FG001|Overall Study|Reason for discontinuation not available|2|||
130981882|NCT00671931|471557166|FG000|Overall Study|Physician Decision|1|||
130981883|NCT00671931|471557167|FG001|Overall Study|Physician Decision|0|||
130981884|NCT00671931|471557168|FG002|Overall Study|Physician Decision|0|||
130981885|NCT00671931|471557169|FG003|Overall Study|Physician Decision|2|||
130981886|NCT00671931|471557170|FG004|Overall Study|Physician Decision|1|||
130981887|NCT01169675|471557173|FG000|Overall Study|Progressive disease|13|||
130981888|NCT01169675|471557174|FG001|Overall Study|Progressive disease|2|||
130981889|NCT01169675|471557175|FG002|Overall Study|Progressive disease|5|||
130981890|NCT01169675|471557176|FG003|Overall Study|Progressive disease|15|||
130981891|NCT01169675|471557177|FG004|Overall Study|Progressive disease|1|||
130981892|NCT01169675|471557173|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130981893|NCT01169675|471557174|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130981894|NCT01169675|471557175|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130981895|NCT01169675|471557176|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130981896|NCT01169675|471557177|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130981897|NCT01169675|471557173|FG000|Overall Study|Adverse Event|5|||
130981898|NCT01169675|471557174|FG001|Overall Study|Adverse Event|1|||
130981899|NCT01169675|471557175|FG002|Overall Study|Adverse Event|2|||
130981900|NCT01169675|471557176|FG003|Overall Study|Adverse Event|0|||
130981901|NCT01169675|471557177|FG004|Overall Study|Adverse Event|0|||
130981902|NCT01169675|471557173|FG000|Overall Study|Withdrawal by Subject|1|||
130981903|NCT01169675|471557174|FG001|Overall Study|Withdrawal by Subject|0|||
130981904|NCT01169675|471557175|FG002|Overall Study|Withdrawal by Subject|0|||
131132582|NCT00652366|472111872|FG004|Overall Study|Lack of Efficacy|13|||
131132583|NCT00652366|472111868|FG000|Overall Study|Violation of Selection Criteria|0|||
131132584|NCT00652366|472111869|FG001|Overall Study|Violation of Selection Criteria|0|||
131132585|NCT00652366|472111870|FG002|Overall Study|Violation of Selection Criteria|1|||
130981905|NCT01169675|471557176|FG003|Overall Study|Withdrawal by Subject|1|||
130981906|NCT01169675|471557177|FG004|Overall Study|Withdrawal by Subject|2|||
130981907|NCT01169675|471557173|FG000|Overall Study|Other Reason Not Defined Above|0|||
130981908|NCT01169675|471557174|FG001|Overall Study|Other Reason Not Defined Above|0|||
130981909|NCT01169675|471557175|FG002|Overall Study|Other Reason Not Defined Above|0|||
130981910|NCT01169675|471557176|FG003|Overall Study|Other Reason Not Defined Above|1|||
130981911|NCT01169675|471557177|FG004|Overall Study|Other Reason Not Defined Above|1|||
130981912|NCT01971723|471557178|FG000|Overall Study|Withdrawal by Subject|1|||
130981913|NCT01971723|471557179|FG001|Overall Study|Withdrawal by Subject|1|||
130981914|NCT01971723|471557178|FG000|Overall Study|Protocol Violation|1|||
130981915|NCT01971723|471557179|FG001|Overall Study|Protocol Violation|2|||
130981916|NCT01648270|471557180|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
130981917|NCT04969263|471557181|FG000|Overall Study|Death|1|||
131132586|NCT00652366|472111871|FG003|Overall Study|Violation of Selection Criteria|0|||
130981918|NCT04969263|471557181|FG000|Overall Study|Lost to Follow-up|2|||
130981919|NCT04969263|471557181|FG000|Overall Study|Withdrawal by Subject|5|||
130981920|NCT04969263|471557181|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
131132587|NCT00652366|472111872|FG004|Overall Study|Violation of Selection Criteria|0|||
131132588|NCT00652366|472111868|FG000|Overall Study|Protocol Violation|1|||
130718960|NCT01908816|470597295|FG003|Overall Study|Lost to Follow-up|2|||
131044182|NCT03536884|471796171|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
131044183|NCT03536884|471796172|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131044184|NCT03536884|471796173|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131044185|NCT03536884|471796174|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131044186|NCT03536884|471796175|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131044187|NCT03536884|471796176|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131044188|NCT03536884|471796177|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131044189|NCT03536884|471796178|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
131044190|NCT03536884|471796167|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
131044191|NCT03536884|471796168|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
131044192|NCT03536884|471796169|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
131044193|NCT03536884|471796170|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
131044194|NCT03536884|471796171|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
131044195|NCT03536884|471796172|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
131044196|NCT03536884|471796173|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
131044197|NCT03536884|471796174|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
131044198|NCT03536884|471796175|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
131044199|NCT03536884|471796176|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
131044200|NCT03536884|471796177|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
131044201|NCT03536884|471796178|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
131044202|NCT03536884|471796167|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131044203|NCT03536884|471796168|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131044204|NCT03536884|471796169|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131044205|NCT03536884|471796170|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131044206|NCT03536884|471796171|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131044207|NCT03536884|471796172|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
131044208|NCT03536884|471796173|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
131044209|NCT03536884|471796174|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
131044210|NCT03536884|471796175|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
131044211|NCT03536884|471796176|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131044212|NCT03536884|471796177|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131228352|NCT00672620|472463213|FG003|Overall Study|Lost to Follow-up|11|||
131228353|NCT00672620|472463210|FG000|Overall Study|Reason not Specified|3|||
131228354|NCT00672620|472463211|FG001|Overall Study|Reason not Specified|3|||
131044213|NCT03536884|471796178|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
131044214|NCT03536884|471796167|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131044215|NCT03536884|471796168|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131044216|NCT03536884|471796169|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131044217|NCT03536884|471796170|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131044218|NCT03536884|471796171|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131044219|NCT03536884|471796172|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
131044220|NCT03536884|471796173|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131044221|NCT03536884|471796174|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
131044222|NCT03536884|471796175|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131044223|NCT03536884|471796176|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131044224|NCT03536884|471796177|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131044225|NCT03536884|471796178|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
131044226|NCT03536884|471796167|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131044227|NCT03536884|471796168|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131044228|NCT03536884|471796169|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131044229|NCT03536884|471796170|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131044230|NCT03536884|471796171|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131044231|NCT03536884|471796172|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
131044232|NCT03536884|471796173|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131044233|NCT03536884|471796174|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
131044234|NCT03536884|471796175|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
131044235|NCT03536884|471796176|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131044236|NCT03536884|471796177|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131044237|NCT03536884|471796178|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
131044238|NCT03536884|471796167|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131044239|NCT03536884|471796168|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131044240|NCT03536884|471796169|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131044241|NCT03536884|471796170|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131044242|NCT03536884|471796171|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131228355|NCT00672620|472463212|FG002|Overall Study|Reason not Specified|2|||
131228356|NCT00672620|472463213|FG003|Overall Study|Reason not Specified|1|||
130778829|NCT03428100|470817445|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131044243|NCT03536884|471796172|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
131044244|NCT03536884|471796173|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
131044245|NCT03536884|471796174|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
131044246|NCT03536884|471796175|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
131044247|NCT03536884|471796176|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131044248|NCT03536884|471796177|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
130981921|NCT02693743|471557183|FG000|Overall Study|Physician Decision|1|||
130981922|NCT02693743|471557184|FG001|Overall Study|Physician Decision|0|||
130981923|NCT01024608|471557186|FG000|Overall Study|Adverse Event|1|||
130981924|NCT01024608|471557187|FG001|Overall Study|Adverse Event|0|||
130981925|NCT01024608|471557186|FG000|Overall Study|Withdrawal by Subject|1|||
130981926|NCT01024608|471557187|FG001|Overall Study|Withdrawal by Subject|0|||
130981927|NCT01024608|471557186|FG000|Overall Study|Lost to Follow-up|0|||
130981928|NCT01024608|471557187|FG001|Overall Study|Lost to Follow-up|1|||
130981929|NCT01024608|471557186|FG000|Overall Study|Protocol Violation|0|||
130981930|NCT01024608|471557187|FG001|Overall Study|Protocol Violation|3|||
130981931|NCT01024608|471557186|FG000|Overall Study|Never received study treatment|2|||
130981932|NCT01024608|471557187|FG001|Overall Study|Never received study treatment|0|||
130981933|NCT02412137|471557205|FG000|Overall Study|Withdrawal by Subject|2|||
130981934|NCT02412137|471557206|FG001|Overall Study|Withdrawal by Subject|0|||
130981935|NCT02412137|471557205|FG000|Overall Study|Lost to Follow-up|21|||
130981936|NCT02412137|471557206|FG001|Overall Study|Lost to Follow-up|14|||
130981937|NCT02412137|471557205|FG000|Overall Study|Physician Decision|28|||
130981938|NCT02412137|471557206|FG001|Overall Study|Physician Decision|9|||
130981939|NCT01323530|471559309|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
130981940|NCT01323530|471559310|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130981941|NCT01323530|471559311|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130981942|NCT01323530|471559312|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130981943|NCT01323530|471559313|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130981944|NCT01323530|471559314|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
130981945|NCT01323530|471559315|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130981946|NCT01323530|471559309|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
130981947|NCT01323530|471559310|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
130981948|NCT01323530|471559311|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
130981949|NCT01323530|471559312|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130981950|NCT01323530|471559313|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
130981951|NCT01323530|471559314|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130981952|NCT01323530|471559315|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
131132589|NCT00652366|472111869|FG001|Overall Study|Protocol Violation|0|||
131132590|NCT00652366|472111870|FG002|Overall Study|Protocol Violation|0|||
131132591|NCT00652366|472111871|FG003|Overall Study|Protocol Violation|0|||
131132592|NCT00652366|472111872|FG004|Overall Study|Protocol Violation|0|||
131132593|NCT00652366|472111868|FG000|Overall Study|Refused treatment|3|||
131132594|NCT00652366|472111869|FG001|Overall Study|Refused treatment|7|||
131132595|NCT00652366|472111870|FG002|Overall Study|Refused treatment|6|||
131132596|NCT00652366|472111871|FG003|Overall Study|Refused treatment|17|||
131132597|NCT00652366|472111872|FG004|Overall Study|Refused treatment|5|||
131132598|NCT00652366|472111868|FG000|Overall Study|Other|5|||
131132599|NCT00652366|472111869|FG001|Overall Study|Other|2|||
131132600|NCT00652366|472111870|FG002|Overall Study|Other|3|||
131132601|NCT00652366|472111871|FG003|Overall Study|Other|4|||
131132602|NCT00652366|472111872|FG004|Overall Study|Other|0|||
131132603|NCT02069899|472111877|FG000|Overall Study|Adverse Event|6|||
131132604|NCT02069899|472111878|FG001|Overall Study|Adverse Event|0|||
131132605|NCT02069899|472111879|FG002|Overall Study|Adverse Event|1|||
131132606|NCT02069899|472111877|FG000|Overall Study|Withdrawal by Participant|2|||
131132607|NCT02069899|472111878|FG001|Overall Study|Withdrawal by Participant|0|||
131132608|NCT02069899|472111879|FG002|Overall Study|Withdrawal by Participant|0|||
131132609|NCT02069899|472111877|FG000|Overall Study|Lost to Follow-up|1|||
131132610|NCT02069899|472111878|FG001|Overall Study|Lost to Follow-up|0|||
131132611|NCT02069899|472111879|FG002|Overall Study|Lost to Follow-up|1|||
131132612|NCT02069899|472111877|FG000|Overall Study|Other|4|||
131132613|NCT02069899|472111878|FG001|Overall Study|Other|0|||
131132614|NCT02069899|472111879|FG002|Overall Study|Other|0|||
131132615|NCT02069899|472111877|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
131132616|NCT02069899|472111878|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
131132617|NCT02069899|472111879|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
131132618|NCT02069899|472111877|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
131132619|NCT02069899|472111878|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
131132620|NCT02069899|472111879|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
131132621|NCT00490451|472111882|FG000|Overall Study|Adverse Event|3|||
131132622|NCT00490451|472111883|FG001|Overall Study|Adverse Event|3|||
131132623|NCT00490451|472111882|FG000|Overall Study|Death|3|||
131132624|NCT00490451|472111883|FG001|Overall Study|Death|1|||
131132625|NCT00490451|472111882|FG000|Overall Study|Withdrawal by Subject|2|||
131132626|NCT00490451|472111883|FG001|Overall Study|Withdrawal by Subject|0|||
131132627|NCT00490451|472111882|FG000|Overall Study|Investigator Decision|1|||
131228357|NCT00772577|472463214|FG000|Overall Study|Adverse Event|6|||
130981953|NCT01323530|471559309|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
130981954|NCT01323530|471559310|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
131132628|NCT00490451|472111883|FG001|Overall Study|Investigator Decision|0|||
131132629|NCT00490451|472111882|FG000|Overall Study|Protocol Violation|1|||
130981955|NCT01323530|471559311|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
130981956|NCT01323530|471559312|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
130981957|NCT01323530|471559313|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
130718961|NCT01908816|470597292|FG000|Overall Study|Death|1|||
130718962|NCT01908816|470597293|FG001|Overall Study|Death|0|||
130718963|NCT01908816|470597294|FG002|Overall Study|Death|7|||
130718964|NCT01908816|470597295|FG003|Overall Study|Death|1|||
130718965|NCT01908816|470597292|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130718966|NCT01908816|470597293|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
130718967|NCT01908816|470597294|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
130718968|NCT01908816|470597295|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130718969|NCT01908816|470597292|FG000|Overall Study|Early termination|87|||
130718970|NCT01908816|470597293|FG001|Overall Study|Early termination|60|||
130718971|NCT01908816|470597294|FG002|Overall Study|Early termination|43|||
130718972|NCT01908816|470597295|FG003|Overall Study|Early termination|28|||
130718973|NCT02628743|470597297|FG000|Overall Study|Other|3|||
130718974|NCT02628743|470597297|FG000|Overall Study|Withdrawal by Subject|50|||
130718975|NCT02628743|470597297|FG000|Overall Study|Study Terminated by Sponsor|76|||
130718976|NCT02628743|470597297|FG000|Overall Study|Physician Decision|2|||
130718977|NCT02534844|470597298|FG000|Part B|Withdrawal by Subject|0|||
130718978|NCT02534844|470597299|FG001|Part B|Withdrawal by Subject|0|||
130718979|NCT02534844|470597300|FG002|Part B|Withdrawal by Subject|0|||
130718980|NCT02534844|470597301|FG003|Part B|Withdrawal by Subject|0|||
130718981|NCT02534844|470597302|FG004|Part B|Withdrawal by Subject|2|||
130718982|NCT02534844|470597303|FG005|Part B|Withdrawal by Subject|1|||
130718983|NCT03560986|470597304|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
130718984|NCT03560986|470597305|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
130718985|NCT03560986|470597304|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
130718986|NCT03560986|470597305|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
130718987|NCT03560986|470597304|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
130981958|NCT01323530|471559314|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
130981959|NCT01323530|471559315|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
130981960|NCT01323530|471559309|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130981961|NCT01323530|471559310|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130981962|NCT01323530|471559311|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130981963|NCT01323530|471559312|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130981964|NCT01323530|471559313|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130981965|NCT01323530|471559314|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
130981966|NCT01323530|471559315|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
130981967|NCT01323530|471559309|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130981968|NCT01323530|471559310|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130981969|NCT01323530|471559311|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130981970|NCT01323530|471559312|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130981971|NCT01323530|471559313|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130981972|NCT01323530|471559314|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
130981973|NCT01323530|471559315|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
130981974|NCT01323530|471559309|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130981975|NCT01323530|471559310|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130981976|NCT01323530|471559311|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130981977|NCT01323530|471559312|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130981978|NCT01323530|471559313|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130981979|NCT01323530|471559314|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
130981980|NCT01323530|471559315|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
130981981|NCT01323530|471559309|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130981982|NCT01323530|471559310|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130981983|NCT01323530|471559311|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130981984|NCT01323530|471559312|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130981985|NCT01323530|471559313|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130981986|NCT01323530|471559314|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
130981987|NCT01323530|471559315|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
130981988|NCT01323530|471559309|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
131132630|NCT00490451|472111883|FG001|Overall Study|Protocol Violation|0|||
131132631|NCT00490451|472111882|FG000|Overall Study|Progressive Disease|53|||
131132632|NCT00490451|472111883|FG001|Overall Study|Progressive Disease|34|||
131132633|NCT01181011|472111884|FG000|Overall Study|Adverse Event|2|||
131132634|NCT01181011|472111884|FG000|Overall Study|Lost to Follow-up|1|||
131132635|NCT00137111|472111885|FG000|Total Therapy|Death|35|||
130718988|NCT03560986|470597305|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
130720911|NCT00620555|470601559|FG000|Overall Study|Withdrawal by Subject|1|||
130981989|NCT01323530|471559310|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130981990|NCT01323530|471559311|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130981991|NCT01323530|471559312|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130981992|NCT01323530|471559313|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130981993|NCT01323530|471559314|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
130981994|NCT01323530|471559315|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
130981995|NCT02532179|471559316|FG000|Overall Study|Lost to Follow-up|1|||
130981996|NCT02532179|471559316|FG000|Overall Study|Pregnancy|1|||
130981997|NCT02532179|471559316|FG000|Overall Study|Subject received depot steroid injection|1|||
130981998|NCT01735201|471559321|FG000|Overall Study|Adverse Event|1|||
130981999|NCT01735201|471559322|FG001|Overall Study|Adverse Event|1|||
130982000|NCT01735201|471559323|FG002|Overall Study|Adverse Event|0|||
130982001|NCT01735201|471559324|FG003|Overall Study|Adverse Event|1|||
130982002|NCT01735201|471559325|FG004|Overall Study|Adverse Event|1|||
130982003|NCT01735201|471559326|FG005|Overall Study|Adverse Event|3|||
130982004|NCT01735201|471559327|FG006|Overall Study|Adverse Event|2|||
130982005|NCT01735201|471559328|FG007|Overall Study|Adverse Event|1|||
130982006|NCT01735201|471559321|FG000|Overall Study|Personal Reasons|1|||
130982007|NCT01735201|471559322|FG001|Overall Study|Personal Reasons|0|||
130982008|NCT01735201|471559323|FG002|Overall Study|Personal Reasons|0|||
130982009|NCT01735201|471559324|FG003|Overall Study|Personal Reasons|0|||
130982010|NCT01735201|471559325|FG004|Overall Study|Personal Reasons|0|||
130982011|NCT01735201|471559326|FG005|Overall Study|Personal Reasons|0|||
130982012|NCT01735201|471559327|FG006|Overall Study|Personal Reasons|0|||
130982013|NCT01735201|471559328|FG007|Overall Study|Personal Reasons|0|||
130982014|NCT01735201|471559321|FG000|Overall Study|Protocol Violation|1|||
130982015|NCT01735201|471559322|FG001|Overall Study|Protocol Violation|0|||
130982016|NCT01735201|471559323|FG002|Overall Study|Protocol Violation|0|||
130982017|NCT01735201|471559324|FG003|Overall Study|Protocol Violation|0|||
130982018|NCT01735201|471559325|FG004|Overall Study|Protocol Violation|0|||
130982019|NCT01735201|471559326|FG005|Overall Study|Protocol Violation|0|||
130982020|NCT01735201|471559327|FG006|Overall Study|Protocol Violation|0|||
130982021|NCT01735201|471559328|FG007|Overall Study|Protocol Violation|0|||
130982022|NCT01735201|471559321|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130982023|NCT01735201|471559322|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130982024|NCT01735201|471559323|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130982025|NCT01735201|471559324|FG003|Overall Study|Other Miscellaneous Reasons|1|||
130982026|NCT01735201|471559325|FG004|Overall Study|Other Miscellaneous Reasons|0|||
130982027|NCT01735201|471559326|FG005|Overall Study|Other Miscellaneous Reasons|2|||
130982028|NCT01735201|471559327|FG006|Overall Study|Other Miscellaneous Reasons|1|||
130982029|NCT01735201|471559328|FG007|Overall Study|Other Miscellaneous Reasons|1|||
130982030|NCT01553318|471559329|FG000|Overall Study|Protocol Violation|3|||
130982031|NCT01553318|471559330|FG001|Overall Study|Protocol Violation|2|||
130982032|NCT04128293|471559333|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
130982033|NCT04128293|471559334|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
130982034|NCT04128293|471559335|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
130982035|NCT04128293|471559336|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
130982036|NCT02127372|471559337|FG000|Overall Study|Withdrawal by Subject|1|||
130982037|NCT02127372|471559338|FG001|Overall Study|Withdrawal by Subject|0|||
130982038|NCT03432364|471559340|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
130982039|NCT04493931|471559342|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
130982040|NCT04493931|471559343|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130982041|NCT04493931|471559344|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130982042|NCT04493931|471559345|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130982043|NCT04493931|471559346|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130982044|NCT04493931|471559347|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130982045|NCT04493931|471559348|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130982046|NCT04493931|471559342|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
131132636|NCT00137111|472111886|FG001|Total Therapy|Death|0|||
131132637|NCT00137111|472111887|FG002|Total Therapy|Death|0|||
131132638|NCT00137111|472111888|FG003|Total Therapy|Death|0|||
131132639|NCT00137111|472111885|FG000|Total Therapy|Non Compliance|5|||
131132640|NCT00137111|472111886|FG001|Total Therapy|Non Compliance|0|||
131132641|NCT00137111|472111887|FG002|Total Therapy|Non Compliance|0|||
131132642|NCT00137111|472111888|FG003|Total Therapy|Non Compliance|0|||
131132643|NCT02425826|472111891|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
131132644|NCT02425826|472111892|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
131132645|NCT02425826|472111893|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
131132646|NCT02425826|472111891|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
130778830|NCT03428100|470817446|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130982047|NCT04493931|471559343|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
130982048|NCT04493931|471559344|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
131132647|NCT02425826|472111892|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
131044249|NCT03536884|471796178|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
131044250|NCT03536884|471796167|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044251|NCT03536884|471796168|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044252|NCT03536884|471796169|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044253|NCT03536884|471796170|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044254|NCT03536884|471796171|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044255|NCT03536884|471796172|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
131044256|NCT03536884|471796173|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044257|NCT03536884|471796174|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044258|NCT03536884|471796175|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044259|NCT03536884|471796176|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044260|NCT03536884|471796177|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044261|NCT03536884|471796178|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
131044262|NCT03536884|471796167|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131044263|NCT03536884|471796168|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131044264|NCT03536884|471796169|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131044265|NCT03536884|471796170|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131044266|NCT03536884|471796171|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131044267|NCT03536884|471796172|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131044268|NCT03536884|471796173|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
131044269|NCT03536884|471796174|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131044270|NCT03536884|471796175|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131044271|NCT03536884|471796176|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131044272|NCT03536884|471796177|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
131044273|NCT03536884|471796178|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
130718989|NCT03560986|470597304|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
130718990|NCT03560986|470597305|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
130718991|NCT03560986|470597304|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
130982049|NCT04493931|471559345|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
130982050|NCT04493931|471559346|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
130982051|NCT04493931|471559347|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
130982052|NCT04493931|471559348|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
130982053|NCT04493931|471559342|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130982054|NCT04493931|471559343|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
130982055|NCT04493931|471559344|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130982056|NCT04493931|471559345|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130982057|NCT04493931|471559346|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130982058|NCT04493931|471559347|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130982059|NCT04493931|471559348|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
130982060|NCT04493931|471559342|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130982061|NCT04493931|471559343|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130982062|NCT04493931|471559344|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
130982063|NCT04493931|471559345|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130982064|NCT04493931|471559346|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130982065|NCT04493931|471559347|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130982066|NCT04493931|471559348|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
130982067|NCT00430248|471559350|FG000|Overall Study|Adverse Event|49|||
130982068|NCT00430248|471559351|FG001|Overall Study|Adverse Event|61|||
130982069|NCT00430248|471559352|FG002|Overall Study|Adverse Event|64|||
130982070|NCT00430248|471559350|FG000|Overall Study|Protocol Violation|10|||
130982071|NCT00430248|471559351|FG001|Overall Study|Protocol Violation|2|||
130982072|NCT00430248|471559352|FG002|Overall Study|Protocol Violation|4|||
130982073|NCT00430248|471559350|FG000|Overall Study|Personal Reasons|12|||
130982074|NCT00430248|471559351|FG001|Overall Study|Personal Reasons|24|||
130982075|NCT00430248|471559352|FG002|Overall Study|Personal Reasons|9|||
130982076|NCT00430248|471559350|FG000|Overall Study|Lost to Follow-up|28|||
130982077|NCT00430248|471559351|FG001|Overall Study|Lost to Follow-up|33|||
130982078|NCT00430248|471559352|FG002|Overall Study|Lost to Follow-up|28|||
131044274|NCT03536884|471796167|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130718992|NCT03560986|470597305|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
130718993|NCT03560986|470597304|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
130982079|NCT00430248|471559350|FG000|Overall Study|Therapeutic Failure|1|||
130982080|NCT00430248|471559351|FG001|Overall Study|Therapeutic Failure|1|||
130982081|NCT00430248|471559352|FG002|Overall Study|Therapeutic Failure|1|||
130982082|NCT00430248|471559350|FG000|Overall Study|Withdrawal by Subject|14|||
130982083|NCT00430248|471559351|FG001|Overall Study|Withdrawal by Subject|20|||
130982084|NCT00430248|471559352|FG002|Overall Study|Withdrawal by Subject|16|||
130982085|NCT00430248|471559350|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130982086|NCT00430248|471559351|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
130982087|NCT00430248|471559352|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130982088|NCT00430248|471559350|FG000|Overall Study|Gout Flare|3|||
130982089|NCT00430248|471559351|FG001|Overall Study|Gout Flare|7|||
130982090|NCT00430248|471559352|FG002|Overall Study|Gout Flare|2|||
130982091|NCT00430248|471559350|FG000|Overall Study|Reason Not Specified|8|||
130982092|NCT00430248|471559351|FG001|Overall Study|Reason Not Specified|8|||
130982093|NCT00430248|471559352|FG002|Overall Study|Reason Not Specified|11|||
130982094|NCT01754467|471559356|FG000|Overall Study|Lost to Follow-up|1|||
130982095|NCT01970462|471559357|FG000|Overall Study|Lost to Follow-up|0|||
130982096|NCT01970462|471559358|FG001|Overall Study|Lost to Follow-up|2|||
130982097|NCT00754338|471559359|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
130982098|NCT00754338|471559360|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
130982099|NCT00754338|471559361|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
130982100|NCT00754338|471559362|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
130982101|NCT00754338|471559359|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
130982102|NCT00754338|471559360|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
130982103|NCT00754338|471559361|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
130982104|NCT00754338|471559362|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
130982105|NCT04020341|471559365|FG000|Overall Study|Adverse Event|8|||
130982106|NCT04020341|471559366|FG001|Overall Study|Adverse Event|6|||
130982107|NCT04020341|471559365|FG000|Overall Study|Lost to Follow-up|8|||
130982108|NCT04020341|471559366|FG001|Overall Study|Lost to Follow-up|2|||
130982109|NCT04020341|471559365|FG000|Overall Study|Withdrawal by Subject|16|||
130982110|NCT04020341|471559366|FG001|Overall Study|Withdrawal by Subject|16|||
130982111|NCT04020341|471559365|FG000|Overall Study|Participant not able to swallow the tablet|1|||
130982112|NCT04020341|471559366|FG001|Overall Study|Participant not able to swallow the tablet|0|||
130982113|NCT04020341|471559365|FG000|Overall Study|Physician Decision|0|||
130982114|NCT04020341|471559366|FG001|Overall Study|Physician Decision|2|||
130982115|NCT04020341|471559365|FG000|Overall Study|Protocol Deviation|0|||
130982116|NCT04020341|471559366|FG001|Overall Study|Protocol Deviation|2|||
130982117|NCT05763628|471559367|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
130982118|NCT05763628|471559368|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
130982119|NCT05763628|471559367|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
130982120|NCT05763628|471559368|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
130982121|NCT05763628|471559367|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
130982122|NCT05763628|471559368|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
130982123|NCT04683926|471559369|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
130982124|NCT04683926|471559370|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
130982125|NCT04683926|471559371|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
130982126|NCT04683926|471559372|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
130982127|NCT04385368|471559373|FG000|Overall Study|Death|5|||
130982128|NCT04385368|471559374|FG001|Overall Study|Death|5|||
130982129|NCT04385368|471559373|FG000|Overall Study|Physician Decision|3|||
130982130|NCT04385368|471559374|FG001|Overall Study|Physician Decision|0|||
130982131|NCT04385368|471559373|FG000|Overall Study|Withdrawal by Subject|4|||
130982132|NCT04385368|471559374|FG001|Overall Study|Withdrawal by Subject|3|||
130982133|NCT02123108|471559377|FG000|Overall Study|Death|2|||
130982134|NCT02123108|471559378|FG001|Overall Study|Death|3|||
130982135|NCT00716092|471559379|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
130982136|NCT00716092|471559380|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
130982137|NCT00716092|471559381|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
130982138|NCT02054806|471559382|FG000|Overall Study|Sponsor Decision|31|||
131044275|NCT03536884|471796168|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131044276|NCT03536884|471796169|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131044277|NCT03536884|471796170|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131228358|NCT00772577|472463215|FG001|Overall Study|Adverse Event|3|||
130982139|NCT02054806|471559382|FG000|Overall Study|Withdrawal by Subject|43|||
130982140|NCT02054806|471559382|FG000|Overall Study|Protocol Violation|2|||
130982141|NCT02054806|471559382|FG000|Overall Study|Lost to Follow-up|10|||
130982142|NCT02054806|471559382|FG000|Overall Study|Death|391|||
130982143|NCT04721925|471559383|FG000|2-Month Assessment|Lost to Follow-up|5|||
130982144|NCT04721925|471559384|FG001|2-Month Assessment|Lost to Follow-up|3|||
130982145|NCT04721925|471559383|FG000|4-Month Assessment|Lost to Follow-up|3|||
130982146|NCT04721925|471559384|FG001|4-Month Assessment|Lost to Follow-up|6|||
130982147|NCT01132326|471559385|FG000|Overall Study|Lack of Efficacy|25|||
130982148|NCT01132326|471559385|FG000|Overall Study|Adverse Event|37|||
130982149|NCT01132326|471559385|FG000|Overall Study|Protocol Violation|1|||
130982150|NCT01132326|471559385|FG000|Overall Study|Lost to Follow-up|16|||
130982151|NCT01132326|471559385|FG000|Overall Study|Withdrawal by Subject|40|||
130982152|NCT01132326|471559385|FG000|Overall Study|Physician Decision|10|||
130982153|NCT01132326|471559385|FG000|Overall Study|Study Termination|80|||
130982154|NCT01132326|471559385|FG000|Overall Study|Declining Health|1|||
130982155|NCT01132326|471559385|FG000|Overall Study|Pregnancy|1|||
130982156|NCT01132326|471559385|FG000|Overall Study|Caregiver Withdrew Consent|1|||
130982157|NCT01132326|471559385|FG000|Overall Study|Death|5|||
130982158|NCT01132326|471559385|FG000|Overall Study|Subject Unable to Come To Visits|1|||
130982159|NCT00677235|471559386|FG000|Overall Study|Withdrawal by Subject|1|||
130982160|NCT00677235|471559387|FG001|Overall Study|Withdrawal by Subject|1|||
130982161|NCT00677235|471559386|FG000|Overall Study|Lost to Follow-up|2|||
130982162|NCT00677235|471559387|FG001|Overall Study|Lost to Follow-up|1|||
130982163|NCT00677235|471559386|FG000|Overall Study|Death|37|||
130982164|NCT00677235|471559387|FG001|Overall Study|Death|36|||
130982165|NCT00677235|471559386|FG000|Overall Study|Adverse Experience|1|||
130982166|NCT00677235|471559387|FG001|Overall Study|Adverse Experience|0|||
130982167|NCT00952367|471559388|FG000|Overall Study|Withdrawal by Subject|2|||
130982168|NCT00952367|471559388|FG000|Overall Study|Noncoordination|1|||
130982169|NCT00952367|471559388|FG000|Overall Study|Protocol Violation|3|||
130982170|NCT01040260|471559389|FG000|Overall Study|Withdrawal by Subject|12|||
130982171|NCT01040260|471559390|FG001|Overall Study|Withdrawal by Subject|6|||
130982172|NCT01040260|471559389|FG000|Overall Study|Lost to Follow-up|3|||
130982173|NCT01040260|471559390|FG001|Overall Study|Lost to Follow-up|5|||
130982174|NCT01113502|471559395|FG000|Overall Study|Withdrawal by Subject|1|||
130982175|NCT01113502|471559396|FG001|Overall Study|Withdrawal by Subject|0|||
130982176|NCT01113502|471559397|FG002|Overall Study|Withdrawal by Subject|1|||
130982177|NCT01113502|471559398|FG003|Overall Study|Withdrawal by Subject|1|||
130982178|NCT01113502|471559399|FG004|Overall Study|Withdrawal by Subject|0|||
130982179|NCT01113502|471559395|FG000|Overall Study|Adverse Event|0|||
130982180|NCT01113502|471559396|FG001|Overall Study|Adverse Event|0|||
130982181|NCT01113502|471559397|FG002|Overall Study|Adverse Event|3|||
130982182|NCT01113502|471559398|FG003|Overall Study|Adverse Event|2|||
130982183|NCT01113502|471559399|FG004|Overall Study|Adverse Event|0|||
130982185|NCT04570436|471559403|FG000|Overall Study|Adverse Event|0|||
130982186|NCT04570436|471559404|FG001|Overall Study|Adverse Event|0|||
130982187|NCT04570436|471559405|FG002|Overall Study|Adverse Event|1|||
130982188|NCT04570436|471559406|FG003|Overall Study|Adverse Event|0|||
130982189|NCT04570436|471559407|FG004|Overall Study|Adverse Event|0|||
130982190|NCT04570436|471559408|FG005|Overall Study|Adverse Event|0|||
130982191|NCT04570436|471559409|FG006|Overall Study|Adverse Event|0|||
130982192|NCT04570436|471559410|FG007|Overall Study|Adverse Event|0|||
130982193|NCT04570436|471559411|FG008|Overall Study|Adverse Event|0|||
130982194|NCT04570436|471559412|FG009|Overall Study|Adverse Event|0|||
130982195|NCT04570436|471559403|FG000|Overall Study|Physician Decision|1|||
130982196|NCT04570436|471559404|FG001|Overall Study|Physician Decision|0|||
130982197|NCT04570436|471559405|FG002|Overall Study|Physician Decision|0|||
130982198|NCT04570436|471559406|FG003|Overall Study|Physician Decision|0|||
130982199|NCT04570436|471559407|FG004|Overall Study|Physician Decision|0|||
130982200|NCT04570436|471559408|FG005|Overall Study|Physician Decision|0|||
130982201|NCT04570436|471559409|FG006|Overall Study|Physician Decision|0|||
130982202|NCT04570436|471559410|FG007|Overall Study|Physician Decision|0|||
130982203|NCT04570436|471559411|FG008|Overall Study|Physician Decision|0|||
130982204|NCT04570436|471559412|FG009|Overall Study|Physician Decision|0|||
130982205|NCT00781391|471559413|FG000|Overall Study|never received study drug|24|||
131044278|NCT03536884|471796171|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131044279|NCT03536884|471796172|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131044280|NCT03536884|471796173|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
131044281|NCT03536884|471796174|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130982206|NCT00781391|471559414|FG001|Overall Study|never received study drug|23|||
130982207|NCT00781391|471559415|FG002|Overall Study|never received study drug|32|||
130982208|NCT00781391|471559413|FG000|Overall Study|Protocol Violation|19|||
131044282|NCT03536884|471796175|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
130718994|NCT03560986|470597305|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
130982209|NCT00781391|471559414|FG001|Overall Study|Protocol Violation|17|||
130982210|NCT00781391|471559415|FG002|Overall Study|Protocol Violation|20|||
130982211|NCT00781391|471559413|FG000|Overall Study|Death|789|||
130982212|NCT00781391|471559414|FG001|Overall Study|Death|730|||
130982213|NCT00781391|471559415|FG002|Overall Study|Death|706|||
130982214|NCT00781391|471559413|FG000|Overall Study|Withdrawal by Subject|47|||
130982215|NCT00781391|471559414|FG001|Overall Study|Withdrawal by Subject|37|||
130982216|NCT00781391|471559415|FG002|Overall Study|Withdrawal by Subject|25|||
130982217|NCT00781391|471559413|FG000|Overall Study|Lost to Follow-up|0|||
130982218|NCT00781391|471559414|FG001|Overall Study|Lost to Follow-up|0|||
130982219|NCT00781391|471559415|FG002|Overall Study|Lost to Follow-up|1|||
130982220|NCT00929162|471559416|FG000|Overall Study|Adverse Event|8|||
130982221|NCT00929162|471559417|FG001|Overall Study|Adverse Event|5|||
131044283|NCT03536884|471796176|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131044284|NCT03536884|471796177|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131044285|NCT03536884|471796178|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
131044286|NCT03536884|471796167|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044287|NCT03536884|471796168|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044288|NCT03536884|471796169|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044289|NCT03536884|471796170|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044290|NCT03536884|471796171|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044291|NCT03536884|471796172|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
131044292|NCT03536884|471796173|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044293|NCT03536884|471796174|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044294|NCT03536884|471796175|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044295|NCT03536884|471796176|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044296|NCT03536884|471796177|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044297|NCT03536884|471796178|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
131044298|NCT03536884|471796167|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044299|NCT03536884|471796168|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044300|NCT03536884|471796169|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044301|NCT03536884|471796170|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044302|NCT03536884|471796171|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044303|NCT03536884|471796172|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044304|NCT03536884|471796173|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044305|NCT03536884|471796174|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044306|NCT03536884|471796175|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
131044307|NCT03536884|471796176|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044308|NCT03536884|471796177|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044309|NCT03536884|471796178|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
131044310|NCT03536884|471796167|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131044311|NCT03536884|471796168|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131044312|NCT03536884|471796169|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131044313|NCT03536884|471796170|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131044314|NCT03536884|471796171|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131044315|NCT03536884|471796172|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131044316|NCT03536884|471796173|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131044317|NCT03536884|471796174|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131044318|NCT03536884|471796175|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
131044319|NCT03536884|471796176|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
131044320|NCT03536884|471796177|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
131044321|NCT03536884|471796178|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
131044322|NCT03536884|471796167|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131044323|NCT03536884|471796168|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131044324|NCT03536884|471796169|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131044325|NCT03536884|471796170|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131044326|NCT03536884|471796171|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131044327|NCT03536884|471796172|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131044328|NCT03536884|471796173|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131044329|NCT03536884|471796174|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131044330|NCT03536884|471796175|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
131044331|NCT03536884|471796176|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
131044332|NCT03536884|471796177|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
131044333|NCT03536884|471796178|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
131044334|NCT03536884|471796167|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044335|NCT03536884|471796168|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044336|NCT03536884|471796169|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044337|NCT03536884|471796170|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044338|NCT03536884|471796171|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044339|NCT03536884|471796172|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044340|NCT03536884|471796173|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044341|NCT03536884|471796174|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044342|NCT03536884|471796175|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044343|NCT03536884|471796176|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044344|NCT03536884|471796177|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
131044345|NCT03536884|471796178|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
131044346|NCT03536884|471796167|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
130982222|NCT00929162|471559416|FG000|Overall Study|Withdrawal by Subject|3|||
130982223|NCT00929162|471559417|FG001|Overall Study|Withdrawal by Subject|1|||
130982224|NCT00929162|471559416|FG000|Overall Study|Protocol Violation|32|||
130982225|NCT00929162|471559417|FG001|Overall Study|Protocol Violation|30|||
130982226|NCT00929162|471559416|FG000|Overall Study|Other termination reason|5|||
130982227|NCT00929162|471559417|FG001|Overall Study|Other termination reason|6|||
130982228|NCT02355002|471559418|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
130982229|NCT02355002|471559419|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
130982230|NCT02355002|471559418|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
130982231|NCT02355002|471559419|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
130982232|NCT02355002|471559418|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
130982233|NCT02355002|471559419|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
130982234|NCT02355002|471559418|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
130982235|NCT02355002|471559419|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
130982236|NCT02355002|471559418|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
130982237|NCT02355002|471559419|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
130982238|NCT02355002|471559418|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
130982239|NCT02355002|471559419|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
130982240|NCT02355002|471559418|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
130982241|NCT02355002|471559419|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
130982242|NCT00708916|471559420|FG000|Overall Study|Subject Noncompliance|2|||
130982243|NCT00708916|471559420|FG000|Overall Study|Adverse Event|2|||
130982244|NCT02835339|471559426|FG000|Overall Study|Did not receive allocated intervention|13|||
130982245|NCT02835339|471559427|FG001|Overall Study|Did not receive allocated intervention|16|||
130982246|NCT01077544|471559428|FG000|Overall Study|New Cancer Therapy|3|||
130982247|NCT01077544|471559429|FG001|Overall Study|New Cancer Therapy|3|||
130982248|NCT01077544|471559428|FG000|Overall Study|Adverse Event|0|||
130982249|NCT01077544|471559429|FG001|Overall Study|Adverse Event|1|||
130982250|NCT01077544|471559428|FG000|Overall Study|Disease Progression|0|||
130982251|NCT01077544|471559429|FG001|Overall Study|Disease Progression|1|||
130982252|NCT04918147|471559430|FG000|Overall Study|Disease flare as defined in protocol|0|||
130982253|NCT04918147|471559431|FG001|Overall Study|Disease flare as defined in protocol|2|||
130982254|NCT03804710|471559433|FG000|Overall Study|Adverse Event|0|||
130982255|NCT03804710|471559434|FG001|Overall Study|Adverse Event|3|||
130982256|NCT03804710|471559433|FG000|Overall Study|Withdrawal by Subject|2|||
130982257|NCT03804710|471559434|FG001|Overall Study|Withdrawal by Subject|1|||
130982258|NCT03804710|471559433|FG000|Overall Study|Other|0|||
130982259|NCT03804710|471559434|FG001|Overall Study|Other|1|||
130982260|NCT04198805|471559435|FG000|Overall Study|Death|0|||
130982261|NCT04198805|471559436|FG001|Overall Study|Death|0|||
130982262|NCT04198805|471559437|FG002|Overall Study|Death|0|||
130982263|NCT04198805|471559438|FG003|Overall Study|Death|1|||
130982264|NCT04198805|471559435|FG000|Overall Study|Early Termination|8|||
130982265|NCT04198805|471559436|FG001|Overall Study|Early Termination|4|||
130982266|NCT04198805|471559437|FG002|Overall Study|Early Termination|6|||
130982267|NCT04198805|471559438|FG003|Overall Study|Early Termination|9|||
130982268|NCT01330433|471559439|FG000|Overall Study|Death|1|||
130982269|NCT01330433|471559440|FG001|Overall Study|Death|3|||
130982270|NCT01330433|471559439|FG000|Overall Study|Lost to Follow-up|1|||
130982271|NCT01330433|471559440|FG001|Overall Study|Lost to Follow-up|0|||
130982272|NCT03599349|471559441|FG000|Overall Study|Lost to Follow-up|1|||
130982273|NCT01830127|471559447|FG000|Overall Study|Adverse Event|1|||
130982274|NCT01830127|471559448|FG001|Overall Study|Adverse Event|6|||
130982275|NCT01830127|471559447|FG000|Overall Study|Lack of Efficacy|3|||
130982276|NCT01830127|471559448|FG001|Overall Study|Lack of Efficacy|0|||
130982277|NCT01830127|471559447|FG000|Overall Study|Withdrawal by Subject|1|||
130982278|NCT01830127|471559448|FG001|Overall Study|Withdrawal by Subject|1|||
130982279|NCT01830127|471559447|FG000|Overall Study|Other reason not defined above|0|||
130982280|NCT01830127|471559448|FG001|Overall Study|Other reason not defined above|2|||
130982281|NCT00567190|471559449|FG000|Overall Study|Death|235|||
130982282|NCT00567190|471559450|FG001|Overall Study|Death|280|||
130778831|NCT03428100|470817447|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130778832|NCT03428100|470817448|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130982283|NCT00567190|471559449|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
130982284|NCT00567190|471559450|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
130982285|NCT00553696|471559454|FG000|Overall Study|Adverse Event|2|||
130982286|NCT00553696|471559455|FG001|Overall Study|Adverse Event|4|||
130982287|NCT00553696|471559456|FG002|Overall Study|Adverse Event|0|||
130982288|NCT00553696|471559457|FG003|Overall Study|Adverse Event|1|||
130982289|NCT00553696|471559454|FG000|Overall Study|Global deterioration of health status|0|||
130982290|NCT00553696|471559455|FG001|Overall Study|Global deterioration of health status|2|||
130982291|NCT00553696|471559456|FG002|Overall Study|Global deterioration of health status|0|||
130982292|NCT00553696|471559457|FG003|Overall Study|Global deterioration of health status|0|||
130982293|NCT00553696|471559454|FG000|Overall Study|Objective progression or relapse|2|||
130982294|NCT00553696|471559455|FG001|Overall Study|Objective progression or relapse|9|||
130982295|NCT00553696|471559456|FG002|Overall Study|Objective progression or relapse|6|||
130982296|NCT00553696|471559457|FG003|Overall Study|Objective progression or relapse|0|||
130982297|NCT00553696|471559454|FG000|Overall Study|Withdrawal by Subject|0|||
130982298|NCT00553696|471559455|FG001|Overall Study|Withdrawal by Subject|1|||
130982299|NCT00553696|471559456|FG002|Overall Study|Withdrawal by Subject|0|||
130982300|NCT00553696|471559457|FG003|Overall Study|Withdrawal by Subject|0|||
130982301|NCT04839965|471559458|FG000|Overall Study|Death|6|||
130982302|NCT04839965|471559459|FG001|Overall Study|Death|6|||
130982303|NCT04839965|471559458|FG000|Overall Study|Lost to Follow-up|1|||
130982304|NCT04839965|471559459|FG001|Overall Study|Lost to Follow-up|0|||
130982305|NCT02365519|471559460|FG000|Randomized and Treated|Adverse Event|0|||
130982306|NCT02365519|471559461|FG001|Randomized and Treated|Adverse Event|1|||
130982307|NCT02365519|471559462|FG002|Randomized and Treated|Adverse Event|0|||
130982308|NCT02365519|471559460|FG000|Randomized and Treated|Withdrawal by Subject|0|||
130982309|NCT02365519|471559461|FG001|Randomized and Treated|Withdrawal by Subject|1|||
130982310|NCT02365519|471559462|FG002|Randomized and Treated|Withdrawal by Subject|1|||
130982311|NCT02048072|471559463|FG000|Overall Study|Adverse Event|3|||
130982312|NCT02048072|471559463|FG000|Overall Study|Lost to Follow-up|1|||
130982313|NCT02355028|471559464|FG000|Overall Study|Adverse Event|2|||
130982314|NCT02355028|471559465|FG001|Overall Study|Adverse Event|0|||
130982315|NCT02355028|471559464|FG000|Overall Study|Withdrawal by Subject|1|||
130982316|NCT02355028|471559465|FG001|Overall Study|Withdrawal by Subject|1|||
130982317|NCT02355028|471559464|FG000|Overall Study|Deemed ineligible after randomization|8|||
130982318|NCT02355028|471559465|FG001|Overall Study|Deemed ineligible after randomization|4|||
130982319|NCT02276222|471559466|FG000|Overall Study|Adverse Event|62|||
130982320|NCT02276222|471559467|FG001|Overall Study|Adverse Event|11|||
130982321|NCT02276222|471559466|FG000|Overall Study|Death|3|||
130982322|NCT02276222|471559467|FG001|Overall Study|Death|4|||
130982323|NCT02276222|471559466|FG000|Overall Study|Lack of Efficacy|13|||
130982324|NCT02276222|471559467|FG001|Overall Study|Lack of Efficacy|3|||
130982325|NCT02276222|471559466|FG000|Overall Study|Protocol Violation|3|||
130982326|NCT02276222|471559467|FG001|Overall Study|Protocol Violation|2|||
130982327|NCT02276222|471559466|FG000|Overall Study|Withdrawal by Subject|79|||
130982328|NCT02276222|471559467|FG001|Overall Study|Withdrawal by Subject|33|||
130982329|NCT02276222|471559466|FG000|Overall Study|non compliance with study medication|6|||
130982330|NCT02276222|471559467|FG001|Overall Study|non compliance with study medication|2|||
130982331|NCT02276222|471559466|FG000|Overall Study|sponsor decision|0|||
130982332|NCT02276222|471559467|FG001|Overall Study|sponsor decision|3|||
130982333|NCT02276222|471559466|FG000|Overall Study|Lost to Follow-up|15|||
130982334|NCT02276222|471559467|FG001|Overall Study|Lost to Follow-up|5|||
130982335|NCT02276222|471559466|FG000|Overall Study|Physician Decision|2|||
130982336|NCT02276222|471559467|FG001|Overall Study|Physician Decision|1|||
130982337|NCT02276222|471559466|FG000|Overall Study|sheduling conflict|1|||
130982338|NCT02276222|471559467|FG001|Overall Study|sheduling conflict|0|||
130982339|NCT02276222|471559466|FG000|Overall Study|subject withdrew after randomization|1|||
130982340|NCT02276222|471559467|FG001|Overall Study|subject withdrew after randomization|0|||
130982341|NCT03645759|471559468|FG000|Overall Study|Lost to Follow-up|3|||
130982342|NCT03645759|471559469|FG001|Overall Study|Lost to Follow-up|2|||
130982343|NCT00902694|471559470|FG000|Overall Study|Death|1|||
130982344|NCT00902694|471559471|FG001|Overall Study|Death|3|||
130982345|NCT00902694|471559470|FG000|Overall Study|Lost to Follow-up|1|||
130982346|NCT00902694|471559471|FG001|Overall Study|Lost to Follow-up|0|||
131044347|NCT03536884|471796168|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131044348|NCT03536884|471796169|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131044349|NCT03536884|471796170|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131044350|NCT03536884|471796171|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131044351|NCT03536884|471796172|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131044352|NCT03536884|471796173|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131044353|NCT03536884|471796174|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131044354|NCT03536884|471796175|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131044355|NCT03536884|471796176|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131132648|NCT02425826|472111893|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
130982347|NCT00902694|471559470|FG000|Overall Study|Censored per protocol|3|||
130982348|NCT00902694|471559471|FG001|Overall Study|Censored per protocol|1|||
130982349|NCT00902694|471559470|FG000|Overall Study|Pregnancy|1|||
130982350|NCT00902694|471559471|FG001|Overall Study|Pregnancy|1|||
130982351|NCT00902694|471559470|FG000|Overall Study|Incarceration|1|||
130982352|NCT00902694|471559471|FG001|Overall Study|Incarceration|0|||
130982353|NCT01592370|471559474|FG000|Overall Study|Disease Progression|62|||
130982354|NCT01592370|471559475|FG001|Overall Study|Disease Progression|16|||
130982355|NCT01592370|471559476|FG002|Overall Study|Disease Progression|52|||
130982356|NCT01592370|471559477|FG003|Overall Study|Disease Progression|3|||
130982357|NCT01592370|471559478|FG004|Overall Study|Disease Progression|3|||
130982358|NCT01592370|471559479|FG005|Overall Study|Disease Progression|31|||
130982359|NCT01592370|471559480|FG006|Overall Study|Disease Progression|14|||
130982360|NCT01592370|471559474|FG000|Overall Study|Study Drug Toxicity|14|||
130982361|NCT01592370|471559475|FG001|Overall Study|Study Drug Toxicity|3|||
130982362|NCT01592370|471559476|FG002|Overall Study|Study Drug Toxicity|0|||
130982363|NCT01592370|471559477|FG003|Overall Study|Study Drug Toxicity|0|||
130982364|NCT01592370|471559478|FG004|Overall Study|Study Drug Toxicity|0|||
130982365|NCT01592370|471559479|FG005|Overall Study|Study Drug Toxicity|0|||
130982366|NCT01592370|471559480|FG006|Overall Study|Study Drug Toxicity|1|||
130982367|NCT01592370|471559474|FG000|Overall Study|AE unrelated to study drug|4|||
130982368|NCT01592370|471559475|FG001|Overall Study|AE unrelated to study drug|3|||
130982369|NCT01592370|471559476|FG002|Overall Study|AE unrelated to study drug|0|||
130982370|NCT01592370|471559477|FG003|Overall Study|AE unrelated to study drug|0|||
130982371|NCT01592370|471559478|FG004|Overall Study|AE unrelated to study drug|0|||
130982372|NCT01592370|471559479|FG005|Overall Study|AE unrelated to study drug|0|||
130982373|NCT01592370|471559480|FG006|Overall Study|AE unrelated to study drug|1|||
130982374|NCT01592370|471559474|FG000|Overall Study|Request to discontinue study treatment|5|||
130982375|NCT01592370|471559475|FG001|Overall Study|Request to discontinue study treatment|0|||
130982376|NCT01592370|471559476|FG002|Overall Study|Request to discontinue study treatment|2|||
130982377|NCT01592370|471559477|FG003|Overall Study|Request to discontinue study treatment|0|||
130982378|NCT01592370|471559478|FG004|Overall Study|Request to discontinue study treatment|1|||
130982379|NCT01592370|471559479|FG005|Overall Study|Request to discontinue study treatment|2|||
130982380|NCT01592370|471559480|FG006|Overall Study|Request to discontinue study treatment|0|||
130982381|NCT01592370|471559474|FG000|Overall Study|Withdrew consent|1|||
130982382|NCT01592370|471559475|FG001|Overall Study|Withdrew consent|2|||
130982383|NCT01592370|471559476|FG002|Overall Study|Withdrew consent|1|||
130982384|NCT01592370|471559477|FG003|Overall Study|Withdrew consent|1|||
130982385|NCT01592370|471559478|FG004|Overall Study|Withdrew consent|0|||
130982386|NCT01592370|471559479|FG005|Overall Study|Withdrew consent|0|||
130982387|NCT01592370|471559480|FG006|Overall Study|Withdrew consent|0|||
130982388|NCT01592370|471559474|FG000|Overall Study|Maximum clinical benefit|11|||
130982389|NCT01592370|471559475|FG001|Overall Study|Maximum clinical benefit|1|||
130982390|NCT01592370|471559476|FG002|Overall Study|Maximum clinical benefit|7|||
130982391|NCT01592370|471559477|FG003|Overall Study|Maximum clinical benefit|1|||
130982392|NCT01592370|471559478|FG004|Overall Study|Maximum clinical benefit|0|||
130982393|NCT01592370|471559479|FG005|Overall Study|Maximum clinical benefit|0|||
130982394|NCT01592370|471559480|FG006|Overall Study|Maximum clinical benefit|0|||
130982395|NCT01592370|471559474|FG000|Overall Study|No longer meets study criteria|1|||
130982396|NCT01592370|471559475|FG001|Overall Study|No longer meets study criteria|0|||
130982397|NCT01592370|471559476|FG002|Overall Study|No longer meets study criteria|0|||
130982398|NCT01592370|471559477|FG003|Overall Study|No longer meets study criteria|0|||
130982399|NCT01592370|471559478|FG004|Overall Study|No longer meets study criteria|0|||
130982400|NCT01592370|471559479|FG005|Overall Study|No longer meets study criteria|0|||
130982401|NCT01592370|471559480|FG006|Overall Study|No longer meets study criteria|0|||
130982402|NCT01592370|471559474|FG000|Overall Study|Other Reasons|6|||
130982403|NCT01592370|471559475|FG001|Overall Study|Other Reasons|0|||
130982404|NCT01592370|471559476|FG002|Overall Study|Other Reasons|10|||
130982405|NCT01592370|471559477|FG003|Overall Study|Other Reasons|0|||
130982406|NCT01592370|471559478|FG004|Overall Study|Other Reasons|0|||
130982407|NCT01592370|471559479|FG005|Overall Study|Other Reasons|1|||
130982408|NCT01592370|471559480|FG006|Overall Study|Other Reasons|0|||
130982409|NCT04922554|471559481|FG000|Overall Study|Adverse Event|4|||
130982410|NCT04922554|471559482|FG001|Overall Study|Adverse Event|0|||
130982411|NCT04922554|471559481|FG000|Overall Study|Withdrawal by Subject|1|||
130982412|NCT04922554|471559482|FG001|Overall Study|Withdrawal by Subject|0|||
130720912|NCT00620555|470601559|FG000|Overall Study|Choice of other treatment|1|||
130982413|NCT01111123|471561282|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
130982414|NCT01111123|471561283|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
130982415|NCT01111123|471561282|FG000|Maintenance Phase|Lost to Follow-up|0|||
130982416|NCT01111123|471561283|FG001|Maintenance Phase|Lost to Follow-up|2|||
130982417|NCT00119405|471561284|FG000|Overall Study|Withdrawal by Subject|1|||
130982418|NCT03597568|471561304|FG000|Overall Study|Withdrawal by Subject|1|||
130982419|NCT03597568|471561305|FG001|Overall Study|Withdrawal by Subject|1|||
130982420|NCT03597568|471561304|FG000|Overall Study|Unable to analyze vascular data|1|||
130982421|NCT03597568|471561305|FG001|Overall Study|Unable to analyze vascular data|1|||
130982422|NCT01357616|471561306|FG000|Overall Study|Adverse Event|1|||
130982423|NCT01357616|471561307|FG001|Overall Study|Adverse Event|1|||
130982424|NCT01357616|471561306|FG000|Overall Study|Lost to Follow-up|4|||
130982425|NCT01357616|471561307|FG001|Overall Study|Lost to Follow-up|3|||
130982426|NCT01357616|471561306|FG000|Overall Study|Protocol Violation|0|||
130982427|NCT01357616|471561307|FG001|Overall Study|Protocol Violation|2|||
130982428|NCT01357616|471561306|FG000|Overall Study|Inadequate Control of IOP|1|||
130982429|NCT01357616|471561307|FG001|Overall Study|Inadequate Control of IOP|2|||
130982430|NCT01357616|471561306|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
130982431|NCT01357616|471561307|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
130982432|NCT01357616|471561306|FG000|Overall Study|Withdrawal by Subject|1|||
130982433|NCT01357616|471561307|FG001|Overall Study|Withdrawal by Subject|0|||
130982434|NCT01699022|471561312|FG000|Overall Study|Early discontinuation from the study|3|||
130982435|NCT02052310|471561313|FG000|Overall Study|Death|64|||
130982436|NCT02052310|471561314|FG001|Overall Study|Death|54|||
130982437|NCT02052310|471561313|FG000|Overall Study|Withdrawal by Subject|37|||
130982438|NCT02052310|471561314|FG001|Overall Study|Withdrawal by Subject|49|||
130982439|NCT02052310|471561313|FG000|Overall Study|Other than specified|32|||
130982440|NCT02052310|471561314|FG001|Overall Study|Other than specified|29|||
130982441|NCT02052310|471561313|FG000|Overall Study|Adverse Event|29|||
130982442|NCT02052310|471561314|FG001|Overall Study|Adverse Event|22|||
130982443|NCT02052310|471561313|FG000|Overall Study|Kidney Transplant|23|||
130982444|NCT02052310|471561314|FG001|Overall Study|Kidney Transplant|29|||
130982445|NCT02052310|471561313|FG000|Overall Study|Physician Decision|14|||
130982446|NCT02052310|471561314|FG001|Overall Study|Physician Decision|7|||
130982447|NCT02052310|471561313|FG000|Overall Study|Lack of Efficacy|6|||
130982448|NCT02052310|471561314|FG001|Overall Study|Lack of Efficacy|1|||
130982449|NCT02052310|471561313|FG000|Overall Study|Site Terminated by Sponsor|5|||
130982450|NCT02052310|471561314|FG001|Overall Study|Site Terminated by Sponsor|13|||
130982451|NCT02052310|471561313|FG000|Overall Study|Lost to Follow-up|4|||
130982452|NCT02052310|471561314|FG001|Overall Study|Lost to Follow-up|2|||
130982453|NCT02052310|471561313|FG000|Overall Study|Protocol Violation|1|||
130982454|NCT02052310|471561314|FG001|Overall Study|Protocol Violation|6|||
130982455|NCT02066402|471561319|FG000|Overall Study|Adverse Event|1|||
130982456|NCT02066402|471561320|FG001|Overall Study|Adverse Event|2|||
130982457|NCT02066402|471561319|FG000|Overall Study|Lost to Follow-up|11|||
130982458|NCT02066402|471561320|FG001|Overall Study|Lost to Follow-up|8|||
130982459|NCT02066402|471561319|FG000|Overall Study|Withdrawal by Subject|14|||
130982460|NCT02066402|471561320|FG001|Overall Study|Withdrawal by Subject|11|||
130982461|NCT02066402|471561319|FG000|Overall Study|Progressive disease-clinical progression|0|||
130982462|NCT02066402|471561320|FG001|Overall Study|Progressive disease-clinical progression|1|||
130982463|NCT02066402|471561319|FG000|Overall Study|Protocol driven decision point|0|||
130982464|NCT02066402|471561320|FG001|Overall Study|Protocol driven decision point|1|||
130982465|NCT00152464|471561321|FG000|Overall Study|Adverse Event|3|||
130982466|NCT00152464|471561322|FG001|Overall Study|Adverse Event|6|||
130982467|NCT00152464|471561321|FG000|Overall Study|Lost to Follow-up|8|||
130982468|NCT00152464|471561322|FG001|Overall Study|Lost to Follow-up|4|||
130982469|NCT00152464|471561321|FG000|Overall Study|Protocol Violation|3|||
130982470|NCT00152464|471561322|FG001|Overall Study|Protocol Violation|1|||
130982471|NCT00152464|471561321|FG000|Overall Study|Withdrawal by Subject|21|||
130982472|NCT00152464|471561322|FG001|Overall Study|Withdrawal by Subject|22|||
130982473|NCT00152464|471561321|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
130982474|NCT00152464|471561322|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
130982475|NCT00152464|471561321|FG000|Overall Study|Eczema deterioration|0|||
130982476|NCT00152464|471561322|FG001|Overall Study|Eczema deterioration|1|||
130982477|NCT00152464|471561321|FG000|Overall Study|Parent decision|1|||
130982478|NCT00152464|471561322|FG001|Overall Study|Parent decision|1|||
130982479|NCT00152464|471561321|FG000|Overall Study|Investigator decision|1|||
130982480|NCT00152464|471561322|FG001|Overall Study|Investigator decision|0|||
130982481|NCT00152464|471561321|FG000|Overall Study|Lack of Efficacy|1|||
130982482|NCT00152464|471561322|FG001|Overall Study|Lack of Efficacy|0|||
130982483|NCT00152464|471561321|FG000|Overall Study|Eczema poorly controlled|1|||
130982484|NCT00152464|471561322|FG001|Overall Study|Eczema poorly controlled|0|||
130982485|NCT00152464|471561321|FG000|Overall Study|Patient relocated|1|||
130982486|NCT00152464|471561322|FG001|Overall Study|Patient relocated|0|||
130982487|NCT02565914|471561323|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
130982488|NCT02565914|471561323|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
130982489|NCT02565914|471561323|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
131228359|NCT00772577|472463214|FG000|Overall Study|Abnormal laboratory values|0|||
131228360|NCT00772577|472463215|FG001|Overall Study|Abnormal laboratory values|1|||
131228361|NCT00772577|472463214|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131228362|NCT00772577|472463215|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
131228363|NCT00772577|472463214|FG000|Overall Study|Patient withdrew consent|8|||
131228364|NCT00772577|472463215|FG001|Overall Study|Patient withdrew consent|5|||
130718995|NCT03560986|470597304|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
130982490|NCT02565914|471561323|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
130982491|NCT02565914|471561323|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
130982492|NCT02565914|471561323|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
130982493|NCT02565914|471561323|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
130982494|NCT02565914|471561323|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
130982495|NCT02565914|471561323|FG000|Part A (Up to 96 Weeks)|Other|18|||
130982496|NCT02565914|471561323|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
130982497|NCT02565914|471561323|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
130982498|NCT02565914|471561323|FG000|Part B (Up to 96 Weeks)|Other|1|||
130982499|NCT02565914|471561323|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
130982500|NCT02565914|471561323|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
130982501|NCT02565914|471561323|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
130982502|NCT02565914|471561323|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
130982503|NCT02565914|471561323|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
130982504|NCT02565914|471561323|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
130982505|NCT02565914|471561323|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
130982506|NCT02565914|471561323|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
130982507|NCT02565914|471561323|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
130982508|NCT02565914|471561323|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
130982509|NCT02565914|471561323|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
130982510|NCT02565914|471561323|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
130982511|NCT01505387|471561324|FG000|Overall Study|Protocol Violation|1|||
130982512|NCT01505387|471561325|FG001|Overall Study|Protocol Violation|0|||
130982513|NCT01505387|471561324|FG000|Overall Study|Withdrawal by Subject|1|||
130982514|NCT01505387|471561325|FG001|Overall Study|Withdrawal by Subject|1|||
130982515|NCT01197508|471561332|FG000|Overall Study|Withdrawal by Subject|8|||
130982516|NCT01197508|471561333|FG001|Overall Study|Withdrawal by Subject|7|||
130982517|NCT01197508|471561334|FG002|Overall Study|Withdrawal by Subject|15|||
130982518|NCT01197508|471561335|FG003|Overall Study|Withdrawal by Subject|4|||
130982519|NCT01197508|471561332|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
130982520|NCT01197508|471561333|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
130982521|NCT01197508|471561334|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
130982522|NCT01197508|471561335|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
130982523|NCT01197508|471561332|FG000|Overall Study|Adverse Event|10|||
130982524|NCT01197508|471561333|FG001|Overall Study|Adverse Event|13|||
130982525|NCT01197508|471561334|FG002|Overall Study|Adverse Event|23|||
130982526|NCT01197508|471561335|FG003|Overall Study|Adverse Event|3|||
130982527|NCT01197508|471561332|FG000|Overall Study|Severe non-compliance to protocol|0|||
130982528|NCT01197508|471561333|FG001|Overall Study|Severe non-compliance to protocol|3|||
130982529|NCT01197508|471561334|FG002|Overall Study|Severe non-compliance to protocol|1|||
130982530|NCT01197508|471561335|FG003|Overall Study|Severe non-compliance to protocol|3|||
130982531|NCT01197508|471561332|FG000|Overall Study|Condition under investigation worsened|1|||
130982532|NCT01197508|471561333|FG001|Overall Study|Condition under investigation worsened|1|||
130982533|NCT01197508|471561334|FG002|Overall Study|Condition under investigation worsened|1|||
131132649|NCT02425826|472111891|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
130718996|NCT03560986|470597305|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
130718997|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
130718998|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
130718999|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
130719000|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
130719001|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
130719002|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
130719003|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
130719004|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
130719005|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
130719006|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
130719007|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
130719008|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
130719009|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
130719010|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
130719011|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
130719012|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
130719013|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
130719014|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
130719015|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
130719016|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
130719017|NCT00593736|470597317|FG000|Screening Period and Placebo Run-in|Various|0|||
130719018|NCT00593736|470597318|FG001|Screening Period and Placebo Run-in|Various|0|||
130719019|NCT00593736|470597319|FG002|Screening Period and Placebo Run-in|Various|0|||
130719020|NCT00593736|470597320|FG003|Screening Period and Placebo Run-in|Various|25|||
130719021|NCT00593736|470597317|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
130719022|NCT00593736|470597318|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
130719023|NCT00593736|470597319|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
130719024|NCT00593736|470597320|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
130719025|NCT00593736|470597317|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
130719026|NCT00593736|470597318|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
131132650|NCT02425826|472111892|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
131044356|NCT03536884|471796177|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
131044357|NCT03536884|471796178|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
131044358|NCT03536884|471796167|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131044359|NCT03536884|471796168|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131044360|NCT03536884|471796169|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131044361|NCT03536884|471796170|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131044362|NCT03536884|471796171|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131044363|NCT03536884|471796172|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131132651|NCT02425826|472111893|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
131132652|NCT02425826|472111891|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
131132653|NCT02425826|472111892|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
131132654|NCT02425826|472111893|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
131132655|NCT02425826|472111891|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
131132656|NCT02425826|472111892|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
131132657|NCT02425826|472111893|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
131132658|NCT02425826|472111891|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
131132659|NCT02425826|472111892|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
131132660|NCT02425826|472111893|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
131132661|NCT02425826|472111891|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
130982534|NCT01197508|471561335|FG003|Overall Study|Condition under investigation worsened|1|||
130982535|NCT01197508|471561332|FG000|Overall Study|Lack of Efficacy|1|||
130982536|NCT01197508|471561333|FG001|Overall Study|Lack of Efficacy|2|||
130982537|NCT01197508|471561334|FG002|Overall Study|Lack of Efficacy|2|||
130982538|NCT01197508|471561335|FG003|Overall Study|Lack of Efficacy|1|||
130982539|NCT01197508|471561332|FG000|Overall Study|Study-specific withdrawal criteria|0|||
130982540|NCT01197508|471561333|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130982541|NCT01197508|471561334|FG002|Overall Study|Study-specific withdrawal criteria|1|||
130982542|NCT01197508|471561335|FG003|Overall Study|Study-specific withdrawal criteria|2|||
130982543|NCT01197508|471561332|FG000|Overall Study|Lost to Follow-up|1|||
130982544|NCT01197508|471561333|FG001|Overall Study|Lost to Follow-up|1|||
130982545|NCT01197508|471561334|FG002|Overall Study|Lost to Follow-up|2|||
130982546|NCT01197508|471561335|FG003|Overall Study|Lost to Follow-up|0|||
130982547|NCT01197508|471561332|FG000|Overall Study|Other|2|||
130982548|NCT01197508|471561333|FG001|Overall Study|Other|3|||
130982549|NCT01197508|471561334|FG002|Overall Study|Other|2|||
130982550|NCT01197508|471561335|FG003|Overall Study|Other|2|||
130982551|NCT00266825|471561336|FG000|Completed Follow-Up|Lost to Follow-up|14|||
130982552|NCT00266825|471561337|FG001|Completed Follow-Up|Lost to Follow-up|19|||
130982553|NCT00266825|471561336|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
130982554|NCT00266825|471561337|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
130982555|NCT01301391|471561340|FG000|Overall Study|Death|13|||
130982556|NCT01301391|471561340|FG000|Overall Study|Lost to Follow-up|3|||
130982557|NCT01301391|471561340|FG000|Overall Study|Physician Decision|2|||
130982558|NCT01301391|471561340|FG000|Overall Study|Sponsor's decision|8|||
130982559|NCT02799784|471561344|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
130982560|NCT02799784|471561345|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
130982561|NCT02799784|471561344|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
130982562|NCT02799784|471561345|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
130982563|NCT02799784|471561344|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
130982564|NCT02799784|471561345|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
130982565|NCT02799784|471561344|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
130982566|NCT02799784|471561345|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
130982567|NCT02799784|471561344|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
130982568|NCT02799784|471561345|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
130982569|NCT02799784|471561344|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
130982570|NCT02799784|471561345|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
131132662|NCT02425826|472111892|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
131132663|NCT02425826|472111893|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
131132664|NCT02425826|472111891|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
130982571|NCT02570126|471561352|FG000|Overall Study|Lost to Follow-up|2|||
130982572|NCT02570126|471561353|FG001|Overall Study|Lost to Follow-up|0|||
130982573|NCT02570126|471561352|FG000|Overall Study|Unable To Arrange Visit 3|1|||
130982574|NCT02570126|471561353|FG001|Overall Study|Unable To Arrange Visit 3|0|||
130982575|NCT02570126|471561352|FG000|Overall Study|Violation Of Procedures GSK|0|||
130982576|NCT02570126|471561353|FG001|Overall Study|Violation Of Procedures GSK|1|||
130982577|NCT02570126|471561352|FG000|Overall Study|Protocol Violation|0|||
130982578|NCT02570126|471561353|FG001|Overall Study|Protocol Violation|1|||
130982579|NCT02570126|471561352|FG000|Overall Study|Withdrawal by Subject|3|||
130982580|NCT02570126|471561353|FG001|Overall Study|Withdrawal by Subject|7|||
130982581|NCT00917579|471561354|FG000|Washout >= 2 Weeks|Adverse Event|1|||
130982582|NCT00917579|471561355|FG001|Washout >= 2 Weeks|Adverse Event|0|||
130982583|NCT00917579|471561354|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
130982584|NCT00917579|471561355|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
130982585|NCT01235546|471561364|FG000|Overall Study|Staff error, medication not administered|1|||
130982586|NCT01235546|471561365|FG001|Overall Study|Staff error, medication not administered|0|||
130982587|NCT01235546|471561364|FG000|Overall Study|Protocol Violation|1|||
130982588|NCT01235546|471561365|FG001|Overall Study|Protocol Violation|1|||
130982589|NCT02740049|471561367|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
130982590|NCT01256411|471561368|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
130982591|NCT01256411|471561369|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
130982592|NCT01256411|471561370|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
130982593|NCT01256411|471561371|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
130982594|NCT01256411|471561372|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
130982595|NCT01256411|471561373|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
130982596|NCT01256411|471561368|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
130982597|NCT01256411|471561369|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
130982598|NCT01256411|471561370|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
130982599|NCT01256411|471561371|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
130982600|NCT01256411|471561372|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
130982601|NCT01256411|471561373|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
130982602|NCT01256411|471561368|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
130982603|NCT01256411|471561369|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
130982604|NCT01256411|471561370|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
130982605|NCT01256411|471561371|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
130982606|NCT01256411|471561372|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
130982607|NCT01256411|471561373|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
130982608|NCT01256411|471561368|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
130982609|NCT01256411|471561369|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
130982610|NCT01256411|471561370|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
130982611|NCT01256411|471561371|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
130982612|NCT01256411|471561372|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
130982613|NCT01256411|471561373|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
130982614|NCT01256411|471561368|FG000|Extension by Maximum Treatment|Adverse Event|4|||
130982615|NCT01256411|471561369|FG001|Extension by Maximum Treatment|Adverse Event|2|||
130982616|NCT01256411|471561370|FG002|Extension by Maximum Treatment|Adverse Event|1|||
130982617|NCT01256411|471561371|FG003|Extension by Maximum Treatment|Adverse Event|0|||
130982618|NCT01256411|471561372|FG004|Extension by Maximum Treatment|Adverse Event|0|||
130982619|NCT01256411|471561373|FG005|Extension by Maximum Treatment|Adverse Event|0|||
130982620|NCT01256411|471561368|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
130982621|NCT01256411|471561369|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
130982622|NCT01256411|471561370|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
130982623|NCT01256411|471561371|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
130982624|NCT01256411|471561372|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
130982625|NCT01256411|471561373|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
130982626|NCT01256411|471561368|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
130982627|NCT01256411|471561369|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
130982628|NCT01256411|471561370|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
130982629|NCT01256411|471561371|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
130982630|NCT01256411|471561372|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
130982631|NCT01256411|471561373|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
130982632|NCT01256411|471561368|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
130982633|NCT01256411|471561369|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
130982634|NCT01256411|471561370|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
130982635|NCT01256411|471561371|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
130982636|NCT01256411|471561372|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
130982637|NCT01256411|471561373|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
130982638|NCT01256411|471561368|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
130982639|NCT01256411|471561369|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
130982640|NCT01256411|471561370|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
130982641|NCT01256411|471561371|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
130982642|NCT01256411|471561372|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
130982643|NCT01256411|471561373|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
131044364|NCT03536884|471796173|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131044365|NCT03536884|471796174|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
130982644|NCT01256411|471561368|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
131044366|NCT03536884|471796175|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131044367|NCT03536884|471796176|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131044368|NCT03536884|471796177|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
131044369|NCT03536884|471796178|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
131044370|NCT03485729|471796193|FG000|Overall Study|Withdrawal by Subject|0|||
131044371|NCT03485729|471796194|FG001|Overall Study|Withdrawal by Subject|0|||
131044372|NCT03485729|471796195|FG002|Overall Study|Withdrawal by Subject|1|||
131044373|NCT03485729|471796193|FG000|Overall Study|Disease progression|8|||
131044374|NCT03485729|471796194|FG001|Overall Study|Disease progression|13|||
131044375|NCT03485729|471796195|FG002|Overall Study|Disease progression|1|||
131044376|NCT03485729|471796193|FG000|Overall Study|Hospice care|1|||
131044377|NCT03485729|471796194|FG001|Overall Study|Hospice care|0|||
131044378|NCT03485729|471796195|FG002|Overall Study|Hospice care|0|||
131044379|NCT03485729|471796193|FG000|Overall Study|Poor performance status|1|||
131044380|NCT03485729|471796194|FG001|Overall Study|Poor performance status|0|||
131044381|NCT03485729|471796195|FG002|Overall Study|Poor performance status|0|||
131044382|NCT03485729|471796193|FG000|Overall Study|Illness|0|||
131044383|NCT03485729|471796194|FG001|Overall Study|Illness|1|||
131044384|NCT03485729|471796195|FG002|Overall Study|Illness|0|||
131044385|NCT05035654|471796197|FG000|Overall Study|Physician Decision|0|||
131044386|NCT05035654|471796198|FG001|Overall Study|Physician Decision|1|||
131044387|NCT05035654|471796199|FG002|Overall Study|Physician Decision|0|||
131044388|NCT05035654|471796197|FG000|Overall Study|Adverse Event|0|||
131044389|NCT05035654|471796198|FG001|Overall Study|Adverse Event|1|||
131044390|NCT05035654|471796199|FG002|Overall Study|Adverse Event|0|||
131044391|NCT05035654|471796197|FG000|Overall Study|Withdrawal by Subject|0|||
131044392|NCT05035654|471796198|FG001|Overall Study|Withdrawal by Subject|0|||
131044393|NCT05035654|471796199|FG002|Overall Study|Withdrawal by Subject|4|||
131044394|NCT05035654|471796197|FG000|Overall Study|Bilateral Dislodgement|1|||
131044395|NCT05035654|471796198|FG001|Overall Study|Bilateral Dislodgement|0|||
131044396|NCT05035654|471796199|FG002|Overall Study|Bilateral Dislodgement|0|||
131044397|NCT02839265|471796204|FG000|Overall Study|Screen Failure|2|||
131044398|NCT02839265|471796204|FG000|Overall Study|Death|1|||
131044399|NCT02839265|471796204|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
131044400|NCT03635424|471796205|FG000|Overall Study|Adverse Event|1|||
131044401|NCT03635424|471796205|FG000|Overall Study|Death|1|||
131044402|NCT03635424|471796205|FG000|Overall Study|Device not implanted|1|||
131044403|NCT05533190|471796208|FG000|Overall Study|Lost to Follow-up|19|||
131044404|NCT05533190|471796209|FG001|Overall Study|Lost to Follow-up|7|||
131044405|NCT05533190|471796208|FG000|Overall Study|Failed to download app|1|||
131044406|NCT05533190|471796209|FG001|Overall Study|Failed to download app|0|||
131044407|NCT05533190|471796208|FG000|Overall Study|Thought app was a scam|1|||
131044408|NCT05533190|471796209|FG001|Overall Study|Thought app was a scam|0|||
131044409|NCT05533190|471796208|FG000|Overall Study|Withdrawal by Subject|2|||
131044410|NCT05533190|471796209|FG001|Overall Study|Withdrawal by Subject|0|||
131044411|NCT05856435|471796227|FG000|Overall Study|Lost to Follow-up|6|||
131044412|NCT02323880|471796228|FG000|Overall Study|Adverse Event|2|||
131044413|NCT02323880|471796229|FG001|Overall Study|Adverse Event|0|||
131044414|NCT02323880|471796230|FG002|Overall Study|Adverse Event|1|||
131044415|NCT02323880|471796231|FG003|Overall Study|Adverse Event|1|||
131228365|NCT00772577|472463214|FG000|Overall Study|Lost to Follow-up|4|||
131044416|NCT02323880|471796232|FG004|Overall Study|Adverse Event|1|||
131044417|NCT02323880|471796233|FG005|Overall Study|Adverse Event|0|||
131044418|NCT02323880|471796234|FG006|Overall Study|Adverse Event|1|||
131044419|NCT02323880|471796235|FG007|Overall Study|Adverse Event|0|||
131044420|NCT02323880|471796228|FG000|Overall Study|Death|0|||
131044421|NCT02323880|471796229|FG001|Overall Study|Death|0|||
131044422|NCT02323880|471796230|FG002|Overall Study|Death|0|||
131044423|NCT02323880|471796231|FG003|Overall Study|Death|0|||
131044424|NCT02323880|471796232|FG004|Overall Study|Death|0|||
131044425|NCT02323880|471796233|FG005|Overall Study|Death|1|||
131044426|NCT02323880|471796234|FG006|Overall Study|Death|0|||
131044427|NCT02323880|471796235|FG007|Overall Study|Death|0|||
131044428|NCT02323880|471796228|FG000|Overall Study|Lack of Efficacy|4|||
131044429|NCT02323880|471796229|FG001|Overall Study|Lack of Efficacy|11|||
131044430|NCT02323880|471796230|FG002|Overall Study|Lack of Efficacy|5|||
131044431|NCT02323880|471796231|FG003|Overall Study|Lack of Efficacy|5|||
131044432|NCT02323880|471796232|FG004|Overall Study|Lack of Efficacy|4|||
131044433|NCT02323880|471796233|FG005|Overall Study|Lack of Efficacy|8|||
131044434|NCT02323880|471796234|FG006|Overall Study|Lack of Efficacy|4|||
131044435|NCT02323880|471796235|FG007|Overall Study|Lack of Efficacy|6|||
131044436|NCT02323880|471796228|FG000|Overall Study|Physician Decision|0|||
131228366|NCT00772577|472463215|FG001|Overall Study|Lost to Follow-up|3|||
131044437|NCT02323880|471796229|FG001|Overall Study|Physician Decision|0|||
131044438|NCT02323880|471796230|FG002|Overall Study|Physician Decision|0|||
131044439|NCT02323880|471796231|FG003|Overall Study|Physician Decision|0|||
131044440|NCT02323880|471796232|FG004|Overall Study|Physician Decision|1|||
131044441|NCT02323880|471796233|FG005|Overall Study|Physician Decision|1|||
131132665|NCT02425826|472111892|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
131132666|NCT02425826|472111893|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
131132667|NCT02425826|472111891|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
131132668|NCT02425826|472111892|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
130982645|NCT01256411|471561369|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
130982646|NCT01256411|471561370|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
130982647|NCT01256411|471561371|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
130982648|NCT01256411|471561372|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
130982649|NCT01256411|471561373|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
130982650|NCT02316769|471561374|FG000|Overall Study|Physician Decision|1|||
130982651|NCT02316769|471561375|FG001|Overall Study|Physician Decision|0|||
130982652|NCT02316769|471561374|FG000|Overall Study|Withdrawal by Subject|1|||
130982653|NCT02316769|471561375|FG001|Overall Study|Withdrawal by Subject|0|||
130982654|NCT04535947|471561378|FG000|Overall Study|Adverse Event|1|||
130982655|NCT04535947|471561379|FG001|Overall Study|Adverse Event|4|||
130982656|NCT04535947|471561378|FG000|Overall Study|Other reasons not specified|2|||
130982657|NCT04535947|471561379|FG001|Overall Study|Other reasons not specified|0|||
130982658|NCT04535947|471561378|FG000|Overall Study|Withdrawal by Subject|1|||
130982659|NCT04535947|471561379|FG001|Overall Study|Withdrawal by Subject|1|||
130982660|NCT03002610|471561388|FG000|Overall Study|Withdrawal by Subject|6|||
130982661|NCT03002610|471561389|FG001|Overall Study|Withdrawal by Subject|25|||
130982662|NCT03002610|471561390|FG002|Overall Study|Withdrawal by Subject|13|||
130982663|NCT03802123|471561391|FG000|Overall Study|Withdrawal by Subject|3|||
130982664|NCT03802123|471561391|FG000|Overall Study|Physician Decision|1|||
130982665|NCT03802123|471561391|FG000|Overall Study|Subject moved to hospice care|1|||
130982666|NCT03802123|471561391|FG000|Overall Study|technician error|1|||
130982667|NCT03802123|471561391|FG000|Overall Study|Death|3|||
130982668|NCT01822587|471561392|FG000|Overall Study|Lost to Follow-up|7|||
130982669|NCT01822587|471561393|FG001|Overall Study|Lost to Follow-up|9|||
130982670|NCT01822587|471561394|FG002|Overall Study|Lost to Follow-up|12|||
130982671|NCT01822587|471561392|FG000|Overall Study|Physician Decision|9|||
130982672|NCT01822587|471561393|FG001|Overall Study|Physician Decision|6|||
130982673|NCT01822587|471561394|FG002|Overall Study|Physician Decision|6|||
130982674|NCT01274182|471561395|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130982675|NCT01274182|471561396|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130982676|NCT01274182|471561397|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
130982677|NCT01274182|471561395|FG000|Overall Study|Adverse Event|4|||
130982678|NCT01274182|471561396|FG001|Overall Study|Adverse Event|5|||
130982679|NCT01274182|471561397|FG002|Overall Study|Adverse Event|3|||
130982680|NCT01274182|471561395|FG000|Overall Study|Withdrawal by Subject|5|||
130982681|NCT01274182|471561396|FG001|Overall Study|Withdrawal by Subject|5|||
130982682|NCT01274182|471561397|FG002|Overall Study|Withdrawal by Subject|3|||
130982683|NCT01274182|471561395|FG000|Overall Study|Lost to Follow-up|2|||
130982684|NCT01274182|471561396|FG001|Overall Study|Lost to Follow-up|3|||
130982685|NCT01274182|471561397|FG002|Overall Study|Lost to Follow-up|1|||
130982686|NCT01274182|471561395|FG000|Overall Study|Protocol Violation|3|||
130982687|NCT01274182|471561396|FG001|Overall Study|Protocol Violation|2|||
131132669|NCT02425826|472111893|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
131132670|NCT02425826|472111891|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
131132671|NCT02425826|472111892|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
131132672|NCT02425826|472111893|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
131132673|NCT02124564|472111899|FG000|Treatment Period|Adverse Event|2|||
131132674|NCT02124564|472111899|FG000|Treatment Period|Lack of Efficacy|3|||
131132675|NCT02124564|472111899|FG000|Treatment Period|Withdrawal by Subject|2|||
131132676|NCT02043548|472111902|FG000|Overall Study|Lack of Efficacy|1|||
131132677|NCT02043548|472111903|FG001|Overall Study|Lack of Efficacy|0|||
131132678|NCT02043548|472111902|FG000|Overall Study|Adverse Event|0|||
131132679|NCT02043548|472111903|FG001|Overall Study|Adverse Event|1|||
130982688|NCT01274182|471561397|FG002|Overall Study|Protocol Violation|0|||
130982689|NCT01274182|471561395|FG000|Overall Study|Death|1|||
130982690|NCT01274182|471561396|FG001|Overall Study|Death|0|||
130982691|NCT01274182|471561397|FG002|Overall Study|Death|1|||
130982692|NCT01362439|471561401|FG000|Overall Study|Adverse Event|1|||
130982693|NCT01362439|471561401|FG000|Overall Study|Lack of Efficacy|3|||
131228367|NCT00772577|472463214|FG000|Overall Study|Administrative problems|2|||
130778833|NCT03428100|470817449|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130982694|NCT01362439|471561401|FG000|Overall Study|Lost to Follow-up|2|||
130982695|NCT01362439|471561401|FG000|Overall Study|Study medication non-compliant|1|||
130982696|NCT01362439|471561401|FG000|Overall Study|Participant who withdrew consent|8|||
130982697|NCT00658567|471561402|FG000|Overall Study|Adverse Event|5|||
130982698|NCT00658567|471561403|FG001|Overall Study|Adverse Event|2|||
130982699|NCT00658567|471561404|FG002|Overall Study|Adverse Event|3|||
130982700|NCT00658567|471561402|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
130982701|NCT00658567|471561403|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
130982702|NCT00658567|471561404|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
130982703|NCT00658567|471561402|FG000|Overall Study|Physician Decision|0|||
130982704|NCT00658567|471561403|FG001|Overall Study|Physician Decision|1|||
130982705|NCT00658567|471561404|FG002|Overall Study|Physician Decision|0|||
130982706|NCT00658567|471561402|FG000|Overall Study|At Discretion of Sponsor|1|||
130982707|NCT00658567|471561403|FG001|Overall Study|At Discretion of Sponsor|1|||
130982708|NCT00658567|471561404|FG002|Overall Study|At Discretion of Sponsor|1|||
130982709|NCT01281644|471561405|FG000|Overall Study|Lost to Follow-up|3|||
130982710|NCT01281644|471561405|FG000|Overall Study|Withdrawal by Subject|2|||
130982711|NCT01755702|471561406|FG000|Wash Out Period I|Other Reason|3|||
130982712|NCT01755702|471561406|FG000|Washout Period II|Other Reason|5|||
130982713|NCT03172702|471561409|FG000|Overall Study|Adverse Event|9|||
130982714|NCT03172702|471561409|FG000|Overall Study|Death|2|||
130982715|NCT03172702|471561409|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
130982716|NCT03172702|471561409|FG000|Overall Study|Withdrawal by Subject|5|||
130982717|NCT03172702|471561409|FG000|Overall Study|Other|2|||
130982718|NCT03923959|471561410|FG000|Overall Study|Death|16|||
130982719|NCT03923959|471561411|FG001|Overall Study|Death|12|||
130982720|NCT03923959|471561410|FG000|Overall Study|Lost to Follow-up|56|||
130982721|NCT03923959|471561411|FG001|Overall Study|Lost to Follow-up|56|||
130982722|NCT03923959|471561410|FG000|Overall Study|Withdrawal by Subject|1|||
130982723|NCT03923959|471561411|FG001|Overall Study|Withdrawal by Subject|1|||
130982724|NCT03923959|471561410|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
130982725|NCT03923959|471561411|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
130982726|NCT02954354|471561412|FG000|Overall Study|Adverse Event|2|||
130982727|NCT02954354|471561413|FG001|Overall Study|Adverse Event|2|||
130982728|NCT02954354|471561414|FG002|Overall Study|Adverse Event|4|||
130982729|NCT02954354|471561412|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
130982730|NCT02954354|471561413|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
130982731|NCT02954354|471561414|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
130982732|NCT02954354|471561412|FG000|Overall Study|Lack of Efficacy|0|||
130982733|NCT02954354|471561413|FG001|Overall Study|Lack of Efficacy|2|||
131132680|NCT01314716|472111907|FG000|Double-Blind Phase|Randomized but not treated|1|||
131132681|NCT01314716|472111908|FG001|Double-Blind Phase|Randomized but not treated|1|||
131132682|NCT01314716|472111907|FG000|Double-Blind Phase|Adverse Event|10|||
131132683|NCT01314716|472111908|FG001|Double-Blind Phase|Adverse Event|4|||
131132684|NCT01314716|472111907|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
131132685|NCT01314716|472111908|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
131132686|NCT01314716|472111907|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131132687|NCT01314716|472111908|FG001|Double-Blind Phase|Lost to Follow-up|1|||
131132688|NCT01314716|472111907|FG000|Double-Blind Phase|Sponsor request|1|||
131132689|NCT01314716|472111908|FG001|Double-Blind Phase|Sponsor request|2|||
131132690|NCT01314716|472111907|FG000|Double-Blind Phase|Physician Decision|0|||
131132691|NCT01314716|472111908|FG001|Double-Blind Phase|Physician Decision|1|||
131132692|NCT01314716|472111907|FG000|Open-Label Phase|Adverse Event|4|||
131132693|NCT01314716|472111908|FG001|Open-Label Phase|Adverse Event|6|||
131132694|NCT01314716|472111907|FG000|Open-Label Phase|Withdrawal by Subject|1|||
131132695|NCT01314716|472111908|FG001|Open-Label Phase|Withdrawal by Subject|2|||
131132696|NCT01314716|472111907|FG000|Open-Label Phase|Physician Decision|5|||
131132697|NCT01314716|472111908|FG001|Open-Label Phase|Physician Decision|4|||
131132698|NCT04311502|472113768|FG000|Overall Study|Death|1|||
131132699|NCT04311502|472113769|FG001|Overall Study|Death|1|||
131132700|NCT04311502|472113770|FG002|Overall Study|Death|1|||
131132701|NCT04311502|472113768|FG000|Overall Study|Lost to Follow-up|2|||
131132702|NCT04311502|472113769|FG001|Overall Study|Lost to Follow-up|3|||
131132703|NCT04311502|472113770|FG002|Overall Study|Lost to Follow-up|0|||
131132704|NCT04311502|472113768|FG000|Overall Study|Participant is in prison|1|||
131132705|NCT04311502|472113769|FG001|Overall Study|Participant is in prison|0|||
131132706|NCT04311502|472113770|FG002|Overall Study|Participant is in prison|0|||
131132707|NCT04311502|472113768|FG000|Overall Study|Participant moved out of country|1|||
131132708|NCT04311502|472113769|FG001|Overall Study|Participant moved out of country|0|||
131132709|NCT04311502|472113770|FG002|Overall Study|Participant moved out of country|0|||
131132710|NCT04311502|472113768|FG000|Overall Study|Withdrawal by Subject|2|||
130982734|NCT02954354|471561414|FG002|Overall Study|Lack of Efficacy|0|||
130982735|NCT02954354|471561412|FG000|Overall Study|Withdrawal by Subject|17|||
130982736|NCT02954354|471561413|FG001|Overall Study|Withdrawal by Subject|9|||
130982737|NCT02954354|471561414|FG002|Overall Study|Withdrawal by Subject|11|||
130982738|NCT02954354|471561412|FG000|Overall Study|Lost to Follow-up|12|||
130982739|NCT02954354|471561413|FG001|Overall Study|Lost to Follow-up|5|||
130982740|NCT02954354|471561414|FG002|Overall Study|Lost to Follow-up|0|||
130982741|NCT02954354|471561412|FG000|Overall Study|Miscellaneous|2|||
130982742|NCT02954354|471561413|FG001|Overall Study|Miscellaneous|2|||
130982743|NCT02954354|471561414|FG002|Overall Study|Miscellaneous|1|||
130982744|NCT04495179|471561415|FG000|Overall Study|Lost to Follow-up|0|||
130982745|NCT04495179|471561416|FG001|Overall Study|Lost to Follow-up|1|||
130982746|NCT04495179|471561415|FG000|Overall Study|Withdrawal by Subject|2|||
131132711|NCT04311502|472113769|FG001|Overall Study|Withdrawal by Subject|0|||
131044442|NCT02323880|471796234|FG006|Overall Study|Physician Decision|1|||
131044443|NCT02323880|471796235|FG007|Overall Study|Physician Decision|0|||
131044444|NCT02323880|471796228|FG000|Overall Study|Withdrawal by Subject|0|||
131044445|NCT02323880|471796229|FG001|Overall Study|Withdrawal by Subject|2|||
131044446|NCT02323880|471796230|FG002|Overall Study|Withdrawal by Subject|0|||
131044447|NCT02323880|471796231|FG003|Overall Study|Withdrawal by Subject|0|||
131044448|NCT02323880|471796232|FG004|Overall Study|Withdrawal by Subject|0|||
131044449|NCT02323880|471796233|FG005|Overall Study|Withdrawal by Subject|0|||
131044450|NCT02323880|471796234|FG006|Overall Study|Withdrawal by Subject|0|||
131044451|NCT02323880|471796235|FG007|Overall Study|Withdrawal by Subject|0|||
131044452|NCT04167553|471796236|FG000|Overall Study|Withdrawal by Subject|1|||
131044453|NCT04167553|471796237|FG001|Overall Study|Withdrawal by Subject|0|||
131044454|NCT04167553|471796238|FG002|Overall Study|Withdrawal by Subject|1|||
131044455|NCT04167553|471796239|FG003|Overall Study|Withdrawal by Subject|2|||
131044456|NCT04167553|471796240|FG004|Overall Study|Withdrawal by Subject|1|||
131044457|NCT04167553|471796241|FG005|Overall Study|Withdrawal by Subject|0|||
131044458|NCT04167553|471796242|FG006|Overall Study|Withdrawal by Subject|0|||
131044459|NCT04167553|471796236|FG000|Overall Study|Physician Decision|0|||
131044460|NCT04167553|471796237|FG001|Overall Study|Physician Decision|0|||
131044461|NCT04167553|471796238|FG002|Overall Study|Physician Decision|0|||
131044462|NCT04167553|471796239|FG003|Overall Study|Physician Decision|0|||
131044463|NCT04167553|471796240|FG004|Overall Study|Physician Decision|2|||
131044464|NCT04167553|471796241|FG005|Overall Study|Physician Decision|2|||
131044465|NCT04167553|471796242|FG006|Overall Study|Physician Decision|0|||
131044466|NCT04167553|471796236|FG000|Overall Study|Lost to Follow-up|0|||
131044467|NCT04167553|471796237|FG001|Overall Study|Lost to Follow-up|0|||
131044468|NCT04167553|471796238|FG002|Overall Study|Lost to Follow-up|2|||
131044469|NCT04167553|471796239|FG003|Overall Study|Lost to Follow-up|0|||
131044470|NCT04167553|471796240|FG004|Overall Study|Lost to Follow-up|0|||
131044471|NCT04167553|471796241|FG005|Overall Study|Lost to Follow-up|0|||
131044472|NCT04167553|471796242|FG006|Overall Study|Lost to Follow-up|0|||
131044473|NCT04934072|471796244|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
131044474|NCT04934072|471796245|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
131044475|NCT04934072|471796246|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
131044476|NCT04934072|471796247|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
131044477|NCT04934072|471796248|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
131044478|NCT04934072|471796244|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
131044479|NCT04934072|471796245|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
131044480|NCT04934072|471796246|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
131044481|NCT04934072|471796247|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
131044482|NCT04934072|471796248|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
131044483|NCT04934072|471796244|FG000|Day 0 to Week 52|Other|3|||
131044484|NCT04934072|471796245|FG001|Day 0 to Week 52|Other|1|||
131044485|NCT04934072|471796246|FG002|Day 0 to Week 52|Other|0|||
131044486|NCT04934072|471796247|FG003|Day 0 to Week 52|Other|0|||
131044487|NCT04934072|471796248|FG004|Day 0 to Week 52|Other|0|||
131044488|NCT04934072|471796244|FG000|Day 0 to Week 52|Adverse Event|1|||
131044489|NCT04934072|471796245|FG001|Day 0 to Week 52|Adverse Event|3|||
131044490|NCT04934072|471796246|FG002|Day 0 to Week 52|Adverse Event|0|||
131044491|NCT04934072|471796247|FG003|Day 0 to Week 52|Adverse Event|0|||
131044492|NCT04934072|471796248|FG004|Day 0 to Week 52|Adverse Event|0|||
131044493|NCT04934072|471796244|FG000|Week 52 to Week 78|Adverse Event|0|||
131044494|NCT04934072|471796245|FG001|Week 52 to Week 78|Adverse Event|0|||
131044495|NCT04934072|471796246|FG002|Week 52 to Week 78|Adverse Event|0|||
131044496|NCT04934072|471796247|FG003|Week 52 to Week 78|Adverse Event|1|||
131044497|NCT04934072|471796248|FG004|Week 52 to Week 78|Adverse Event|1|||
131044498|NCT04934072|471796244|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
131044499|NCT04934072|471796245|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
131044500|NCT04934072|471796246|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
131044501|NCT04934072|471796247|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
131044502|NCT04934072|471796248|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
131044503|NCT04934072|471796244|FG000|Week 52 to Week 78|Other|0|||
131044504|NCT04934072|471796245|FG001|Week 52 to Week 78|Other|0|||
131044505|NCT04934072|471796246|FG002|Week 52 to Week 78|Other|1|||
131044506|NCT04934072|471796247|FG003|Week 52 to Week 78|Other|0|||
131044507|NCT04934072|471796248|FG004|Week 52 to Week 78|Other|0|||
131044508|NCT05736458|471796254|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
131044509|NCT05736458|471796255|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
131044510|NCT05736458|471796256|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
131044511|NCT05736458|471796254|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
131044512|NCT05736458|471796255|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
131044513|NCT05736458|471796256|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
131044514|NCT05736458|471796254|FG000|TMS/fMRI #1|Physician Decision|0|||
131044515|NCT05736458|471796255|FG001|TMS/fMRI #1|Physician Decision|0|||
131044516|NCT05736458|471796256|FG002|TMS/fMRI #1|Physician Decision|2|||
131044517|NCT05736458|471796254|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
131044518|NCT05736458|471796255|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
131132712|NCT04311502|472113770|FG002|Overall Study|Withdrawal by Subject|0|||
131132713|NCT04311502|472113768|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
131132714|NCT04311502|472113769|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
131132715|NCT04311502|472113770|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
131132716|NCT03040999|472113771|FG000|Overall Study|Lost to Follow-up|2|||
131132717|NCT03040999|472113772|FG001|Overall Study|Lost to Follow-up|2|||
131132718|NCT03040999|472113771|FG000|Overall Study|Withdrawal by Subject|12|||
131132719|NCT03040999|472113772|FG001|Overall Study|Withdrawal by Subject|13|||
131132720|NCT03040999|472113771|FG000|Overall Study|Death|155|||
131132721|NCT03040999|472113772|FG001|Overall Study|Death|171|||
131132722|NCT03040999|472113771|FG000|Overall Study|Physician Decision|0|||
131132723|NCT03040999|472113772|FG001|Overall Study|Physician Decision|3|||
131132724|NCT03657043|472113773|FG000|Overall Study|Withdrawal by Subject|1|||
131132725|NCT03657043|472113774|FG001|Overall Study|Withdrawal by Subject|1|||
131132726|NCT03657043|472113775|FG002|Overall Study|Withdrawal by Subject|0|||
131132727|NCT03657043|472113776|FG003|Overall Study|Withdrawal by Subject|0|||
131132728|NCT03657043|472113777|FG004|Overall Study|Withdrawal by Subject|4|||
131132729|NCT03657043|472113773|FG000|Overall Study|Study closure by Sponsor|0|||
131132730|NCT03657043|472113774|FG001|Overall Study|Study closure by Sponsor|2|||
131132731|NCT03657043|472113775|FG002|Overall Study|Study closure by Sponsor|0|||
131132732|NCT03657043|472113776|FG003|Overall Study|Study closure by Sponsor|0|||
131132733|NCT03657043|472113777|FG004|Overall Study|Study closure by Sponsor|17|||
131132734|NCT03657043|472113773|FG000|Overall Study|Lost to Follow-up|0|||
131132735|NCT03657043|472113774|FG001|Overall Study|Lost to Follow-up|0|||
131132736|NCT03657043|472113775|FG002|Overall Study|Lost to Follow-up|0|||
131132737|NCT03657043|472113776|FG003|Overall Study|Lost to Follow-up|0|||
131132738|NCT03657043|472113777|FG004|Overall Study|Lost to Follow-up|4|||
131132739|NCT03657043|472113773|FG000|Overall Study|Death|6|||
131132740|NCT03657043|472113774|FG001|Overall Study|Death|5|||
131132741|NCT03657043|472113775|FG002|Overall Study|Death|0|||
131132742|NCT03657043|472113776|FG003|Overall Study|Death|0|||
131132743|NCT03657043|472113777|FG004|Overall Study|Death|53|||
131132744|NCT03657043|472113773|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
131132745|NCT03657043|472113774|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
131132746|NCT03657043|472113775|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
131132747|NCT03657043|472113776|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
131132748|NCT03657043|472113777|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
131132749|NCT03657043|472113773|FG000|Overall Study|Adverse Event|0|||
131132750|NCT03657043|472113774|FG001|Overall Study|Adverse Event|0|||
131132751|NCT03657043|472113775|FG002|Overall Study|Adverse Event|0|||
131132752|NCT03657043|472113776|FG003|Overall Study|Adverse Event|0|||
131132753|NCT03657043|472113777|FG004|Overall Study|Adverse Event|2|||
131132754|NCT03657043|472113773|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
131132755|NCT03657043|472113774|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
131132756|NCT03657043|472113775|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
131132757|NCT03657043|472113776|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
131132758|NCT03657043|472113777|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
131132759|NCT03657043|472113773|FG000|Overall Study|Withdrawal - declined follow-up|0|||
131132760|NCT03657043|472113774|FG001|Overall Study|Withdrawal - declined follow-up|0|||
131132761|NCT03657043|472113775|FG002|Overall Study|Withdrawal - declined follow-up|0|||
131132762|NCT03657043|472113776|FG003|Overall Study|Withdrawal - declined follow-up|0|||
131132763|NCT03657043|472113777|FG004|Overall Study|Withdrawal - declined follow-up|1|||
131132764|NCT02627495|472113780|FG000|Overall Study|Withdrawal by Subject|4|||
131132765|NCT03257267|472113781|FG000|Overall Study|Adverse Event|17|||
131132766|NCT03257267|472113782|FG001|Overall Study|Adverse Event|7|||
131132767|NCT03257267|472113781|FG000|Overall Study|Death|96|||
131132768|NCT03257267|472113782|FG001|Overall Study|Death|98|||
131132769|NCT03257267|472113781|FG000|Overall Study|Lost to Follow-up|2|||
131132770|NCT03257267|472113782|FG001|Overall Study|Lost to Follow-up|2|||
131132771|NCT03257267|472113781|FG000|Overall Study|Non-compliance with Study Drug|0|||
131132772|NCT03257267|472113782|FG001|Overall Study|Non-compliance with Study Drug|2|||
131132773|NCT03257267|472113781|FG000|Overall Study|Participant Decision|35|||
131132774|NCT03257267|472113782|FG001|Overall Study|Participant Decision|43|||
131132775|NCT03257267|472113781|FG000|Overall Study|Sponsor Decision|1|||
131132776|NCT03257267|472113782|FG001|Overall Study|Sponsor Decision|0|||
131132777|NCT03257267|472113781|FG000|Overall Study|Physician Decision|1|||
131132778|NCT03257267|472113782|FG001|Overall Study|Physician Decision|3|||
131132779|NCT03257267|472113781|FG000|Overall Study|Disease Progression|109|||
131132780|NCT03257267|472113782|FG001|Overall Study|Disease Progression|121|||
131132781|NCT03257267|472113781|FG000|Overall Study|Withdrawal by Subject|8|||
131132782|NCT03257267|472113782|FG001|Overall Study|Withdrawal by Subject|26|||
131132783|NCT03257267|472113781|FG000|Overall Study|Other|0|||
131132784|NCT03257267|472113782|FG001|Overall Study|Other|2|||
131132785|NCT01979523|472113783|FG000|Overall Study|Withdrawal by Subject|1|||
131132786|NCT01979523|472113784|FG001|Overall Study|Withdrawal by Subject|0|||
131132787|NCT00706134|472113785|FG000|Overall Study|Adverse Event|8|||
131132788|NCT00706134|472113786|FG001|Overall Study|Adverse Event|7|||
130982747|NCT04495179|471561416|FG001|Overall Study|Withdrawal by Subject|4|||
130982748|NCT04495179|471561415|FG000|Overall Study|Study terminated by sponsor|0|||
130982749|NCT04495179|471561416|FG001|Overall Study|Study terminated by sponsor|18|||
130982750|NCT04495179|471561415|FG000|Overall Study|Death|0|||
130719027|NCT00593736|470597319|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
130719028|NCT00593736|470597320|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
130719029|NCT00593736|470597317|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
130719030|NCT00593736|470597318|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
130719031|NCT00593736|470597319|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
130719032|NCT00593736|470597320|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
130719033|NCT00593736|470597317|FG000|Treatment Period and Placebo Run-out|Various|1|||
130719034|NCT00593736|470597318|FG001|Treatment Period and Placebo Run-out|Various|1|||
130719035|NCT00593736|470597319|FG002|Treatment Period and Placebo Run-out|Various|1|||
130719036|NCT00593736|470597320|FG003|Treatment Period and Placebo Run-out|Various|0|||
130719037|NCT01857271|470597321|FG000|Overall Study|Lost to Follow-up|1|||
130719038|NCT03493386|470597322|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130719039|NCT03493386|470597323|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
130719040|NCT03493386|470597324|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130719041|NCT03493386|470597325|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130719042|NCT04645966|470597326|FG000|Vaccination Phase|Adverse Event|1|||
130719043|NCT04645966|470597327|FG001|Vaccination Phase|Adverse Event|0|||
130719044|NCT04645966|470597328|FG002|Vaccination Phase|Adverse Event|0|||
130719045|NCT04645966|470597329|FG003|Vaccination Phase|Adverse Event|0|||
130719046|NCT04645966|470597330|FG004|Vaccination Phase|Adverse Event|0|||
130719047|NCT04645966|470597331|FG005|Vaccination Phase|Adverse Event|0|||
130719048|NCT04645966|470597332|FG006|Vaccination Phase|Adverse Event|1|||
130719049|NCT04645966|470597333|FG007|Vaccination Phase|Adverse Event|0|||
130719050|NCT04645966|470597334|FG008|Vaccination Phase|Adverse Event|0|||
130719051|NCT04645966|470597326|FG000|Vaccination Phase|Death|0|||
130719052|NCT04645966|470597327|FG001|Vaccination Phase|Death|0|||
130719053|NCT04645966|470597328|FG002|Vaccination Phase|Death|0|||
130719054|NCT04645966|470597329|FG003|Vaccination Phase|Death|0|||
130719055|NCT04645966|470597330|FG004|Vaccination Phase|Death|0|||
130982751|NCT04495179|471561416|FG001|Overall Study|Death|4|||
130982752|NCT04495179|471561415|FG000|Overall Study|Adverse Event|0|||
130982753|NCT04495179|471561416|FG001|Overall Study|Adverse Event|1|||
130982754|NCT04212091|471561417|FG000|Overall Study|Lost to Follow-up|0|||
130982755|NCT04212091|471561418|FG001|Overall Study|Lost to Follow-up|0|||
130982756|NCT04212091|471561419|FG002|Overall Study|Lost to Follow-up|0|||
130982757|NCT04212091|471561420|FG003|Overall Study|Lost to Follow-up|0|||
130982758|NCT04212091|471561421|FG004|Overall Study|Lost to Follow-up|1|||
130982759|NCT04212091|471561422|FG005|Overall Study|Lost to Follow-up|1|||
130982760|NCT04212091|471561417|FG000|Overall Study|Participant unable to adhere to visit|0|||
130982761|NCT04212091|471561418|FG001|Overall Study|Participant unable to adhere to visit|0|||
130982762|NCT04212091|471561419|FG002|Overall Study|Participant unable to adhere to visit|0|||
130982763|NCT04212091|471561420|FG003|Overall Study|Participant unable to adhere to visit|0|||
130982764|NCT04212091|471561421|FG004|Overall Study|Participant unable to adhere to visit|1|||
130982765|NCT04212091|471561422|FG005|Overall Study|Participant unable to adhere to visit|0|||
130982766|NCT01428076|471561431|FG000|Overall Study|Adverse Event|0|||
130982767|NCT01428076|471561432|FG001|Overall Study|Adverse Event|1|||
130982768|NCT02454101|471561433|FG000|Overall Study|Adverse Event|2|||
130982769|NCT02454101|471561434|FG001|Overall Study|Adverse Event|3|||
130982770|NCT02454101|471561433|FG000|Overall Study|Lost to Follow-up|3|||
130982771|NCT02454101|471561434|FG001|Overall Study|Lost to Follow-up|4|||
130982772|NCT02216773|471561435|FG000|Overall Study|Disease progression|4|||
130982773|NCT02216773|471561436|FG001|Overall Study|Disease progression|2|||
130982774|NCT02216773|471561435|FG000|Overall Study|Insufficient FLRV|4|||
130982775|NCT02216773|471561436|FG001|Overall Study|Insufficient FLRV|0|||
130982776|NCT02216773|471561435|FG000|Overall Study|Abandoned|4|||
130982777|NCT02216773|471561436|FG001|Overall Study|Abandoned|3|||
130982778|NCT04274894|471561437|FG000|Overall Study|Adverse Event|7|||
130982779|NCT04274894|471561437|FG000|Overall Study|Withdrew consent|5|||
130982780|NCT04274894|471561437|FG000|Overall Study|Lost to Follow-up|9|||
130982781|NCT04274894|471561437|FG000|Overall Study|COVID-19 infection|1|||
130982782|NCT04274894|471561437|FG000|Overall Study|Other, not specified|20|||
130982783|NCT04510675|471561438|FG000|Overall Study|Withdrawal by Subject|5|||
130982784|NCT01494584|471561439|FG000|Overall Study|Study Closed/Terminated|1|||
130982785|NCT01666808|471561440|FG000|Overall Study|Lost to Follow-up|9|||
130982786|NCT01666808|471561441|FG001|Overall Study|Lost to Follow-up|15|||
130982787|NCT01666808|471561440|FG000|Overall Study|Withdrawal by Subject|3|||
130982788|NCT01666808|471561441|FG001|Overall Study|Withdrawal by Subject|1|||
130982789|NCT01666808|471561440|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
130982790|NCT01666808|471561441|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
130982791|NCT01499082|471561442|FG000|Overall Study|Randomized but not Treated|0|||
130982792|NCT01499082|471561443|FG001|Overall Study|Randomized but not Treated|1|||
131132789|NCT00706134|472113787|FG002|Overall Study|Adverse Event|2|||
131132790|NCT00706134|472113788|FG003|Overall Study|Adverse Event|3|||
131132791|NCT00706134|472113785|FG000|Overall Study|Lost to Follow-up|0|||
131132792|NCT00706134|472113786|FG001|Overall Study|Lost to Follow-up|1|||
131132793|NCT00706134|472113787|FG002|Overall Study|Lost to Follow-up|0|||
131132794|NCT00706134|472113788|FG003|Overall Study|Lost to Follow-up|0|||
131132795|NCT00706134|472113785|FG000|Overall Study|Protocol Violation|0|||
131132796|NCT00706134|472113786|FG001|Overall Study|Protocol Violation|6|||
131132797|NCT00706134|472113787|FG002|Overall Study|Protocol Violation|0|||
131132798|NCT00706134|472113788|FG003|Overall Study|Protocol Violation|3|||
131132799|NCT00706134|472113785|FG000|Overall Study|Withdrawal by Subject|1|||
131132800|NCT00706134|472113786|FG001|Overall Study|Withdrawal by Subject|2|||
131132801|NCT00706134|472113787|FG002|Overall Study|Withdrawal by Subject|1|||
131132802|NCT00706134|472113788|FG003|Overall Study|Withdrawal by Subject|0|||
131132803|NCT00706134|472113785|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
131132804|NCT00706134|472113786|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131132805|NCT00706134|472113787|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
131132806|NCT00706134|472113788|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
131132807|NCT00706134|472113785|FG000|Overall Study|Did not meet study criteria|2|||
131132808|NCT00706134|472113786|FG001|Overall Study|Did not meet study criteria|0|||
131132809|NCT00706134|472113787|FG002|Overall Study|Did not meet study criteria|0|||
131132810|NCT00706134|472113788|FG003|Overall Study|Did not meet study criteria|0|||
131132811|NCT01982292|472113789|FG000|Overall Study|Adverse Event|2|||
131132812|NCT01982292|472113790|FG001|Overall Study|Adverse Event|0|||
131132813|NCT01982292|472113789|FG000|Overall Study|Death|1|||
131132814|NCT01982292|472113790|FG001|Overall Study|Death|0|||
131132815|NCT01982292|472113789|FG000|Overall Study|Lost to Follow-up|2|||
131132816|NCT01982292|472113790|FG001|Overall Study|Lost to Follow-up|0|||
131132817|NCT01982292|472113789|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
131132818|NCT01982292|472113790|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
131132819|NCT01982292|472113789|FG000|Overall Study|Protocol Deviation|1|||
131132820|NCT01982292|472113790|FG001|Overall Study|Protocol Deviation|0|||
131132821|NCT01982292|472113789|FG000|Overall Study|Patient/Guardian Decision|3|||
131132822|NCT01982292|472113790|FG001|Overall Study|Patient/Guardian Decision|1|||
131132823|NCT01982292|472113789|FG000|Overall Study|Technical Problems|2|||
131132824|NCT01982292|472113790|FG001|Overall Study|Technical Problems|0|||
131132825|NCT00746252|472113791|FG000|Overall Study|weight gain >7.5 %|1|||
131132826|NCT00746252|472113792|FG001|Overall Study|weight gain >7.5 %|2|||
131132827|NCT00082888|472113793|FG000|Overall Study|Ineligible|1|||
131132828|NCT00082888|472113794|FG001|Overall Study|Ineligible|0|||
131132829|NCT00082888|472113795|FG002|Overall Study|Ineligible|0|||
131132830|NCT02239939|472113797|FG000|Overall Study|Adverse Event|1|||
131132831|NCT02239939|472113798|FG001|Overall Study|Adverse Event|0|||
131132832|NCT02239939|472113797|FG000|Overall Study|Withdrawal by Subject|1|||
131132833|NCT02239939|472113798|FG001|Overall Study|Withdrawal by Subject|1|||
131132834|NCT02239939|472113797|FG000|Overall Study|Lost to Follow-up|0|||
131132835|NCT02239939|472113798|FG001|Overall Study|Lost to Follow-up|1|||
131132836|NCT03325673|472113808|FG000|Overall Study|Adverse Event|4|||
131132837|NCT03325673|472113809|FG001|Overall Study|Adverse Event|0|||
131132838|NCT01659320|472113810|FG000|Overall Study|Withdrawal by Subject|2|||
131132839|NCT01659320|472113810|FG000|Overall Study|Physician Decision|1|||
131132840|NCT01514682|472113811|FG000|Overall Study|Withdrawal by Subject|2|||
131132841|NCT01514682|472113812|FG001|Overall Study|Withdrawal by Subject|3|||
131132842|NCT01514682|472113811|FG000|Overall Study|Physician Decision|4|||
131132843|NCT01514682|472113812|FG001|Overall Study|Physician Decision|3|||
131132844|NCT00590590|472113813|FG000|Overall Study|Lack of Efficacy|1|||
131132845|NCT00590590|472113814|FG001|Overall Study|Lack of Efficacy|2|||
131132846|NCT00590590|472113815|FG002|Overall Study|Lack of Efficacy|0|||
131132847|NCT00590590|472113813|FG000|Overall Study|Adverse Event|1|||
130982793|NCT01499082|471561442|FG000|Overall Study|Adverse Event|12|||
130982794|NCT01499082|471561443|FG001|Overall Study|Adverse Event|16|||
130982795|NCT01499082|471561442|FG000|Overall Study|Lack of Efficacy|1|||
131132848|NCT00590590|472113814|FG001|Overall Study|Adverse Event|0|||
131132849|NCT00590590|472113815|FG002|Overall Study|Adverse Event|0|||
130982796|NCT01499082|471561443|FG001|Overall Study|Lack of Efficacy|1|||
130982797|NCT01499082|471561442|FG000|Overall Study|Protocol Violation|6|||
131132850|NCT00590590|472113813|FG000|Overall Study|Protocol Violation|0|||
131132851|NCT00590590|472113814|FG001|Overall Study|Protocol Violation|0|||
131132852|NCT00590590|472113815|FG002|Overall Study|Protocol Violation|2|||
131132853|NCT00590590|472113813|FG000|Overall Study|Lost to Follow-up|4|||
131132854|NCT00590590|472113814|FG001|Overall Study|Lost to Follow-up|1|||
131132855|NCT00590590|472113815|FG002|Overall Study|Lost to Follow-up|2|||
131132856|NCT00590590|472113813|FG000|Overall Study|Withdrawal by Subject|0|||
131132857|NCT00590590|472113814|FG001|Overall Study|Withdrawal by Subject|1|||
131132858|NCT00590590|472113815|FG002|Overall Study|Withdrawal by Subject|1|||
131132859|NCT00590590|472113813|FG000|Overall Study|Did not complete due to study closure|1|||
131132860|NCT00590590|472113814|FG001|Overall Study|Did not complete due to study closure|1|||
131132861|NCT00590590|472113815|FG002|Overall Study|Did not complete due to study closure|1|||
131132862|NCT00590590|472113813|FG000|Overall Study|Did not complete study|0|||
131132863|NCT00590590|472113814|FG001|Overall Study|Did not complete study|1|||
131132864|NCT00590590|472113815|FG002|Overall Study|Did not complete study|0|||
131132865|NCT00132132|472113818|FG000|Overall Study|Lost to Follow-up|7|||
131132866|NCT00132132|472113819|FG001|Overall Study|Lost to Follow-up|2|||
131132867|NCT01870401|472113820|FG000|Overall Study|Death|48|||
131132868|NCT01870401|472113821|FG001|Overall Study|Death|24|||
131132869|NCT01870401|472113820|FG000|Overall Study|Withdrawal by Subject|39|||
131132870|NCT01870401|472113821|FG001|Overall Study|Withdrawal by Subject|26|||
131132871|NCT01870401|472113820|FG000|Overall Study|Lost to Follow-up|19|||
131132872|NCT01870401|472113821|FG001|Overall Study|Lost to Follow-up|14|||
131132873|NCT01870401|472113820|FG000|Overall Study|Other|9|||
131132874|NCT01870401|472113821|FG001|Overall Study|Other|7|||
131132875|NCT01870401|472113820|FG000|Overall Study|On-going in the Study|35|||
131132876|NCT01870401|472113821|FG001|Overall Study|On-going in the Study|25|||
131132877|NCT04623242|472113822|FG000|Overall Study|Withdrawal by Subject|7|||
131132878|NCT04623242|472113823|FG001|Overall Study|Withdrawal by Subject|12|||
131132879|NCT04623242|472113824|FG002|Overall Study|Withdrawal by Subject|5|||
131132880|NCT04623242|472113825|FG003|Overall Study|Withdrawal by Subject|7|||
131132881|NCT04623242|472113826|FG004|Overall Study|Withdrawal by Subject|0|||
131132882|NCT04623242|472113822|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
131132883|NCT04623242|472113823|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
131132884|NCT04623242|472113824|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
131132885|NCT04623242|472113825|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
131132886|NCT04623242|472113826|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
131132887|NCT04623242|472113822|FG000|Overall Study|Subject unblinded to mutation status|0|||
131132888|NCT04623242|472113823|FG001|Overall Study|Subject unblinded to mutation status|0|||
131132889|NCT04623242|472113824|FG002|Overall Study|Subject unblinded to mutation status|0|||
131132890|NCT04623242|472113825|FG003|Overall Study|Subject unblinded to mutation status|13|||
131132891|NCT04623242|472113826|FG004|Overall Study|Subject unblinded to mutation status|0|||
131132892|NCT00820898|472113827|FG000|Overall Study|Inelgible - wrong primary site|1|||
131132893|NCT00272038|472113830|FG000|Overall Study|withdrew before they received 2 cycles|7|||
131132894|NCT00493870|472113831|FG000|Overall Study|Lost to Follow-up|12|||
131132895|NCT00493870|472113832|FG001|Overall Study|Lost to Follow-up|15|||
131132896|NCT01289015|472113837|FG000|Overall Study|Protocol Violation|12|||
131132897|NCT01289015|472113838|FG001|Overall Study|Protocol Violation|9|||
131132898|NCT01289015|472113837|FG000|Overall Study|Adverse Event|3|||
131132899|NCT01289015|472113838|FG001|Overall Study|Adverse Event|0|||
131132900|NCT01289015|472113837|FG000|Overall Study|Lost to Follow-up|33|||
131132901|NCT01289015|472113838|FG001|Overall Study|Lost to Follow-up|17|||
131132902|NCT01289015|472113837|FG000|Overall Study|Withdrawal by Subject|17|||
131132903|NCT01289015|472113838|FG001|Overall Study|Withdrawal by Subject|8|||
131132904|NCT01289015|472113837|FG000|Overall Study|Disease progression|1|||
131132905|NCT01289015|472113838|FG001|Overall Study|Disease progression|0|||
131132906|NCT01289015|472113837|FG000|Overall Study|Negative baseline culture and others|33|||
131132907|NCT01289015|472113838|FG001|Overall Study|Negative baseline culture and others|20|||
131132908|NCT01709149|472113842|FG000|Open-label Lead-in Phase|Adverse Event|109|||
131132909|NCT01709149|472113843|FG001|Open-label Lead-in Phase|Adverse Event|0|||
131132910|NCT01709149|472113844|FG002|Open-label Lead-in Phase|Adverse Event|0|||
131132911|NCT01709149|472113842|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
131132912|NCT01709149|472113843|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
131132913|NCT01709149|472113844|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
131132914|NCT01709149|472113842|FG000|Open-label Lead-in Phase|Death|1|||
131132915|NCT01709149|472113843|FG001|Open-label Lead-in Phase|Death|0|||
131132916|NCT01709149|472113844|FG002|Open-label Lead-in Phase|Death|0|||
131132917|NCT01709149|472113842|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
131132918|NCT01709149|472113843|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
131132919|NCT01709149|472113844|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
131132920|NCT01709149|472113842|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
131132921|NCT01709149|472113843|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
131132922|NCT01709149|472113844|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
131132923|NCT01709149|472113842|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
131132924|NCT01709149|472113843|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
131132925|NCT01709149|472113844|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
131132926|NCT01709149|472113842|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
131132927|NCT01709149|472113843|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
131132928|NCT01709149|472113844|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
131132929|NCT01709149|472113842|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
131132930|NCT01709149|472113843|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
130719056|NCT04645966|470597331|FG005|Vaccination Phase|Death|1|||
131132931|NCT01709149|472113844|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
130719057|NCT04645966|470597332|FG006|Vaccination Phase|Death|0|||
131132932|NCT01709149|472113842|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
131132933|NCT01709149|472113843|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
131132934|NCT01709149|472113844|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
131132935|NCT01709149|472113842|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131132936|NCT01709149|472113843|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
131132937|NCT01709149|472113844|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
131132938|NCT02797808|472113849|FG000|Overall Study|Withdrawal by Subject|1|||
131132939|NCT02797808|472113850|FG001|Overall Study|Withdrawal by Subject|1|||
131132940|NCT02797808|472113849|FG000|Overall Study|Physician Decision|6|||
131132941|NCT02797808|472113850|FG001|Overall Study|Physician Decision|2|||
131132942|NCT02590588|472113851|FG000|Overall Study|Adverse Event|1|||
131132943|NCT05098041|472113855|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
131132944|NCT01857869|472113861|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
131132945|NCT01857869|472113862|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
131132946|NCT01857869|472113863|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
131132947|NCT01857869|472113864|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
131132948|NCT01857869|472113865|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
131132949|NCT01857869|472113866|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
131132950|NCT01857869|472113867|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
131132951|NCT01857869|472113868|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
131132952|NCT01857869|472113869|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
131132953|NCT01857869|472113870|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
131132954|NCT01857869|472113861|FG000|Primary/Challenge Phase|Pregnancy|1|||
131132955|NCT01857869|472113862|FG001|Primary/Challenge Phase|Pregnancy|0|||
131132956|NCT01857869|472113863|FG002|Primary/Challenge Phase|Pregnancy|0|||
131132957|NCT01857869|472113864|FG003|Primary/Challenge Phase|Pregnancy|0|||
131132958|NCT01857869|472113865|FG004|Primary/Challenge Phase|Pregnancy|0|||
131132959|NCT01857869|472113866|FG005|Primary/Challenge Phase|Pregnancy|0|||
131132960|NCT01857869|472113867|FG006|Primary/Challenge Phase|Pregnancy|0|||
131132961|NCT01857869|472113868|FG007|Primary/Challenge Phase|Pregnancy|0|||
131132962|NCT01857869|472113869|FG008|Primary/Challenge Phase|Pregnancy|0|||
131132963|NCT01857869|472113870|FG009|Primary/Challenge Phase|Pregnancy|0|||
131132964|NCT01857869|472113861|FG000|Primary/Challenge Phase|Protocol Violation|1|||
131132965|NCT01857869|472113862|FG001|Primary/Challenge Phase|Protocol Violation|0|||
131132966|NCT01857869|472113863|FG002|Primary/Challenge Phase|Protocol Violation|0|||
131132967|NCT01857869|472113864|FG003|Primary/Challenge Phase|Protocol Violation|0|||
131132968|NCT01857869|472113865|FG004|Primary/Challenge Phase|Protocol Violation|0|||
131132969|NCT01857869|472113866|FG005|Primary/Challenge Phase|Protocol Violation|0|||
131132970|NCT01857869|472113867|FG006|Primary/Challenge Phase|Protocol Violation|0|||
131132971|NCT01857869|472113868|FG007|Primary/Challenge Phase|Protocol Violation|0|||
131132972|NCT01857869|472113869|FG008|Primary/Challenge Phase|Protocol Violation|0|||
131132973|NCT01857869|472113870|FG009|Primary/Challenge Phase|Protocol Violation|0|||
131132974|NCT01857869|472113861|FG000|Primary/Challenge Phase|Other|1|||
131132975|NCT01857869|472113862|FG001|Primary/Challenge Phase|Other|1|||
131132976|NCT01857869|472113863|FG002|Primary/Challenge Phase|Other|0|||
131132977|NCT01857869|472113864|FG003|Primary/Challenge Phase|Other|0|||
131132978|NCT01857869|472113865|FG004|Primary/Challenge Phase|Other|0|||
131132979|NCT01857869|472113866|FG005|Primary/Challenge Phase|Other|0|||
131132980|NCT01857869|472113867|FG006|Primary/Challenge Phase|Other|0|||
131132981|NCT01857869|472113868|FG007|Primary/Challenge Phase|Other|0|||
131132982|NCT01857869|472113869|FG008|Primary/Challenge Phase|Other|0|||
131132983|NCT01857869|472113870|FG009|Primary/Challenge Phase|Other|0|||
131132984|NCT01857869|472113861|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131132985|NCT01857869|472113862|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131132986|NCT01857869|472113863|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131132987|NCT01857869|472113864|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
131132988|NCT01857869|472113865|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131132989|NCT01857869|472113866|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131132990|NCT01857869|472113867|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131132991|NCT01857869|472113868|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131132992|NCT01857869|472113869|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131132993|NCT01857869|472113870|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
131132994|NCT01857869|472113861|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131132995|NCT01857869|472113862|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131132996|NCT01857869|472113863|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131132997|NCT01857869|472113864|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
131132998|NCT01857869|472113865|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131132999|NCT01857869|472113866|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131133000|NCT01857869|472113867|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131133001|NCT01857869|472113868|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131133002|NCT01857869|472113869|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131133003|NCT01857869|472113870|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
131133004|NCT03603496|472113880|FG000|Overall Study|Death|19|||
131133005|NCT03603496|472113881|FG001|Overall Study|Death|24|||
131133006|NCT03603496|472113880|FG000|Overall Study|Lost to Follow-up|141|||
131133007|NCT03603496|472113881|FG001|Overall Study|Lost to Follow-up|141|||
131133008|NCT03603496|472113880|FG000|Overall Study|Withdrawal by Subject|26|||
131133009|NCT03603496|472113881|FG001|Overall Study|Withdrawal by Subject|20|||
131133010|NCT00774345|472113882|FG000|Pre-treatment|Other reasons|2|||
131133011|NCT00774345|472113883|FG001|Pre-treatment|Other reasons|0|||
131133012|NCT00774345|472113882|FG000|Treatment|Adverse Event|61|||
131133013|NCT00774345|472113883|FG001|Treatment|Adverse Event|15|||
131133014|NCT00774345|472113882|FG000|Treatment|Progressive Disease without histologic transformation|51|||
131133015|NCT00774345|472113883|FG001|Treatment|Progressive Disease without histologic transformation|111|||
131133016|NCT00774345|472113882|FG000|Treatment|Progressive Disease with histologic transformation|4|||
131133017|NCT00774345|472113883|FG001|Treatment|Progressive Disease with histologic transformation|2|||
131133018|NCT00774345|472113882|FG000|Treatment|Withdrawal by Subject|5|||
131133019|NCT00774345|472113883|FG001|Treatment|Withdrawal by Subject|2|||
131133020|NCT00774345|472113882|FG000|Treatment|Lost to Follow-up|1|||
131133021|NCT00774345|472113883|FG001|Treatment|Lost to Follow-up|1|||
131133022|NCT00774345|472113882|FG000|Treatment|Death|4|||
131133023|NCT00774345|472113883|FG001|Treatment|Death|0|||
131133024|NCT00774345|472113882|FG000|Treatment|Other Reasons|32|||
131133025|NCT00774345|472113883|FG001|Treatment|Other Reasons|26|||
131133026|NCT00835237|472113884|FG000|Overall Study|Lost to Follow-up|4|||
131133027|NCT00835237|472113885|FG001|Overall Study|Lost to Follow-up|0|||
131133028|NCT00835237|472113884|FG000|Overall Study|Withdrawal by Subject|2|||
131133029|NCT00835237|472113885|FG001|Overall Study|Withdrawal by Subject|0|||
131133030|NCT01265550|472113888|FG000|Pre Randomization|Withdrawal by Subject|0|||
131133031|NCT01265550|472113889|FG001|Pre Randomization|Withdrawal by Subject|0|||
131133032|NCT01265550|472113890|FG002|Pre Randomization|Withdrawal by Subject|0|||
131133033|NCT01265550|472113891|FG003|Pre Randomization|Withdrawal by Subject|70|||
131133034|NCT01265550|472113888|FG000|Pre Randomization|Technical Exclusions|0|||
131133035|NCT01265550|472113889|FG001|Pre Randomization|Technical Exclusions|0|||
131133036|NCT01265550|472113890|FG002|Pre Randomization|Technical Exclusions|0|||
131133037|NCT01265550|472113891|FG003|Pre Randomization|Technical Exclusions|54|||
131133038|NCT01265550|472113888|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
131133039|NCT01265550|472113889|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
131133040|NCT01265550|472113890|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
131133041|NCT01265550|472113891|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
131133042|NCT01265550|472113888|FG000|Pre Randomization|Non-GERD organic disorders|0|||
131133043|NCT01265550|472113889|FG001|Pre Randomization|Non-GERD organic disorders|0|||
131133044|NCT01265550|472113890|FG002|Pre Randomization|Non-GERD organic disorders|0|||
131133045|NCT01265550|472113891|FG003|Pre Randomization|Non-GERD organic disorders|23|||
131133046|NCT01265550|472113888|FG000|Pre Randomization|Functional heartburn|0|||
131133047|NCT01265550|472113889|FG001|Pre Randomization|Functional heartburn|0|||
131133048|NCT01265550|472113890|FG002|Pre Randomization|Functional heartburn|0|||
131133049|NCT01265550|472113891|FG003|Pre Randomization|Functional heartburn|99|||
130719058|NCT04645966|470597333|FG007|Vaccination Phase|Death|0|||
130719059|NCT04645966|470597334|FG008|Vaccination Phase|Death|0|||
130719060|NCT04645966|470597326|FG000|Vaccination Phase|Protocol Violation|0|||
130719061|NCT04645966|470597327|FG001|Vaccination Phase|Protocol Violation|0|||
130982798|NCT01499082|471561443|FG001|Overall Study|Protocol Violation|8|||
130982799|NCT01499082|471561442|FG000|Overall Study|Diverse Reasons|18|||
130982800|NCT01499082|471561443|FG001|Overall Study|Diverse Reasons|14|||
130982801|NCT01499082|471561442|FG000|Overall Study|Site Closure for Noncompliance|5|||
130982802|NCT01499082|471561443|FG001|Overall Study|Site Closure for Noncompliance|2|||
130982803|NCT01499082|471561442|FG000|Overall Study|Hypoglycemia|2|||
130982804|NCT01499082|471561443|FG001|Overall Study|Hypoglycemia|3|||
130982805|NCT01499082|471561442|FG000|Overall Study|Lost to Follow-up|1|||
130982806|NCT01499082|471561443|FG001|Overall Study|Lost to Follow-up|3|||
130982807|NCT00686881|471561449|FG000|Overall Study|Withdrawal by Subject|11|||
130982808|NCT00686881|471561450|FG001|Overall Study|Withdrawal by Subject|18|||
130982809|NCT00686881|471561449|FG000|Overall Study|Lost to Follow-up|0|||
130982810|NCT00686881|471561450|FG001|Overall Study|Lost to Follow-up|1|||
130982811|NCT00686881|471561449|FG000|Overall Study|Treatment-related adverse event|10|||
130982812|NCT00686881|471561450|FG001|Overall Study|Treatment-related adverse event|9|||
130982813|NCT00686881|471561449|FG000|Overall Study|Met discontinuation criteria|5|||
130982814|NCT00686881|471561450|FG001|Overall Study|Met discontinuation criteria|0|||
130982815|NCT00686881|471561449|FG000|Overall Study|Onset of malignant tumor|11|||
130982816|NCT00686881|471561450|FG001|Overall Study|Onset of malignant tumor|11|||
130982817|NCT00686881|471561449|FG000|Overall Study|Lack of Efficacy|4|||
130982818|NCT00686881|471561450|FG001|Overall Study|Lack of Efficacy|3|||
130982819|NCT00686881|471561449|FG000|Overall Study|Physician Decision|1|||
131133050|NCT00623428|472113892|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
130719062|NCT04645966|470597328|FG002|Vaccination Phase|Protocol Violation|0|||
130982820|NCT00686881|471561450|FG001|Overall Study|Physician Decision|0|||
130982821|NCT00686881|471561449|FG000|Overall Study|Circumstances of site|1|||
131133051|NCT00623428|472113893|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
131133052|NCT00623428|472113892|FG000|Treatment Period|Death|0|||
131133053|NCT00623428|472113893|FG001|Treatment Period|Death|1|||
131133054|NCT00623428|472113892|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
131133055|NCT00623428|472113893|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
131133056|NCT00623428|472113892|FG000|Treatment Period|Insufficient therapeutic response|0|||
131133057|NCT00623428|472113893|FG001|Treatment Period|Insufficient therapeutic response|2|||
131133058|NCT00623428|472113892|FG000|Treatment Period|Other|0|||
131133059|NCT00623428|472113893|FG001|Treatment Period|Other|1|||
131133060|NCT00623428|472113892|FG000|Treatment Period|Withdrawal by Subject|0|||
131133061|NCT00623428|472113893|FG001|Treatment Period|Withdrawal by Subject|1|||
131133062|NCT00623428|472113892|FG000|Follow-up Period|Relapse post-treatment|11|||
131133063|NCT00623428|472113893|FG001|Follow-up Period|Relapse post-treatment|3|||
131133064|NCT00623428|472113892|FG000|Follow-up Period|Failure to return|10|||
131133065|NCT00623428|472113893|FG001|Follow-up Period|Failure to return|2|||
131133066|NCT00623428|472113892|FG000|Follow-up Period|Patient withdrew consent|5|||
131133067|NCT00623428|472113893|FG001|Follow-up Period|Patient withdrew consent|4|||
131133068|NCT00623428|472113892|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
131133069|NCT00623428|472113893|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
131133070|NCT00623428|472113892|FG000|Follow-up Period|Did not cooperate|0|||
131133071|NCT00623428|472113893|FG001|Follow-up Period|Did not cooperate|3|||
130719063|NCT04645966|470597329|FG003|Vaccination Phase|Protocol Violation|0|||
130719064|NCT04645966|470597330|FG004|Vaccination Phase|Protocol Violation|1|||
130719065|NCT04645966|470597331|FG005|Vaccination Phase|Protocol Violation|0|||
130719066|NCT04645966|470597332|FG006|Vaccination Phase|Protocol Violation|0|||
130719067|NCT04645966|470597333|FG007|Vaccination Phase|Protocol Violation|0|||
130719068|NCT04645966|470597334|FG008|Vaccination Phase|Protocol Violation|0|||
130719069|NCT04645966|470597326|FG000|Vaccination Phase|Study terminated by sponsor|0|||
130719070|NCT04645966|470597327|FG001|Vaccination Phase|Study terminated by sponsor|0|||
130719071|NCT04645966|470597328|FG002|Vaccination Phase|Study terminated by sponsor|14|||
130719072|NCT04645966|470597329|FG003|Vaccination Phase|Study terminated by sponsor|15|||
130719073|NCT04645966|470597330|FG004|Vaccination Phase|Study terminated by sponsor|47|||
130719074|NCT04645966|470597331|FG005|Vaccination Phase|Study terminated by sponsor|43|||
130719075|NCT04645966|470597332|FG006|Vaccination Phase|Study terminated by sponsor|29|||
130719076|NCT04645966|470597333|FG007|Vaccination Phase|Study terminated by sponsor|29|||
130719077|NCT04645966|470597334|FG008|Vaccination Phase|Study terminated by sponsor|12|||
130719078|NCT04645966|470597326|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
130719079|NCT04645966|470597327|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
130719080|NCT04645966|470597328|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
130719081|NCT04645966|470597329|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
130719082|NCT04645966|470597330|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
130719083|NCT04645966|470597331|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
130719084|NCT04645966|470597332|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
130719085|NCT04645966|470597333|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
130719086|NCT04645966|470597334|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
130719087|NCT04645966|470597326|FG000|Vaccination Phase|Other|0|||
130719088|NCT04645966|470597327|FG001|Vaccination Phase|Other|0|||
130719089|NCT04645966|470597328|FG002|Vaccination Phase|Other|0|||
130719090|NCT04645966|470597329|FG003|Vaccination Phase|Other|0|||
130719091|NCT04645966|470597330|FG004|Vaccination Phase|Other|0|||
130719092|NCT04645966|470597331|FG005|Vaccination Phase|Other|2|||
130719093|NCT04645966|470597332|FG006|Vaccination Phase|Other|0|||
130719094|NCT04645966|470597333|FG007|Vaccination Phase|Other|0|||
130719095|NCT04645966|470597334|FG008|Vaccination Phase|Other|0|||
130719096|NCT04645966|470597326|FG000|Vaccination Phase|Lost to Follow-up|0|||
130719097|NCT04645966|470597327|FG001|Vaccination Phase|Lost to Follow-up|0|||
130719098|NCT04645966|470597328|FG002|Vaccination Phase|Lost to Follow-up|0|||
130719099|NCT04645966|470597329|FG003|Vaccination Phase|Lost to Follow-up|0|||
130719100|NCT04645966|470597330|FG004|Vaccination Phase|Lost to Follow-up|0|||
130719101|NCT04645966|470597331|FG005|Vaccination Phase|Lost to Follow-up|0|||
130719102|NCT04645966|470597332|FG006|Vaccination Phase|Lost to Follow-up|0|||
130719103|NCT04645966|470597333|FG007|Vaccination Phase|Lost to Follow-up|1|||
130719104|NCT04645966|470597334|FG008|Vaccination Phase|Lost to Follow-up|0|||
130719105|NCT04645966|470597326|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
130719106|NCT04645966|470597327|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
130719107|NCT04645966|470597328|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
130719108|NCT04645966|470597329|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
130719109|NCT04645966|470597330|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
130719110|NCT04645966|470597331|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
131133072|NCT00623428|472113892|FG000|Follow-up Period|Reason not specified|1|||
131133073|NCT00623428|472113893|FG001|Follow-up Period|Reason not specified|1|||
131133074|NCT00623428|472113892|FG000|Follow-up Period|Death|0|||
131133075|NCT00623428|472113893|FG001|Follow-up Period|Death|1|||
130719111|NCT04645966|470597332|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
130719112|NCT04645966|470597333|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
131133076|NCT01929408|472113896|FG000|Overall Study|received HCT as initial treatment|8|||
131133077|NCT02788747|472113897|FG000|Overall Study|Adverse Event|1|||
131133078|NCT02788747|472113898|FG001|Overall Study|Adverse Event|0|||
131133079|NCT02788747|472113899|FG002|Overall Study|Adverse Event|0|||
131133080|NCT02500121|472113900|FG000|Overall Study|Lost to Follow-up|0|||
131133081|NCT02500121|472113901|FG001|Overall Study|Lost to Follow-up|1|||
130982822|NCT00686881|471561450|FG001|Overall Study|Circumstances of site|1|||
130982823|NCT00686881|471561449|FG000|Overall Study|Did not meet protocol eligibility|1|||
130982824|NCT00686881|471561450|FG001|Overall Study|Did not meet protocol eligibility|0|||
130982825|NCT00686881|471561449|FG000|Overall Study|Irregular visits|1|||
130982826|NCT00686881|471561450|FG001|Overall Study|Irregular visits|0|||
130982827|NCT00686881|471561449|FG000|Overall Study|Study discontinuation|35|||
130982828|NCT00686881|471561450|FG001|Overall Study|Study discontinuation|32|||
130982829|NCT00686881|471561449|FG000|Overall Study|Never received study drug|2|||
130982830|NCT00686881|471561450|FG001|Overall Study|Never received study drug|6|||
130982831|NCT05899686|471561451|FG000|Overall Study|Protocol Violation|1|||
130982832|NCT02170025|471561452|FG000|Overall Study|Adverse Event|2|||
130982833|NCT02170025|471561453|FG001|Overall Study|Adverse Event|0|||
130982834|NCT00572195|471561454|FG000|Overall Study|Withdrawal by Subject|50|||
130982835|NCT00572195|471561454|FG000|Overall Study|Death|9|||
130982836|NCT00572195|471561454|FG000|Overall Study|Adverse Event|4|||
130982837|NCT00572195|471561454|FG000|Overall Study|Lost to Follow-up|5|||
130982838|NCT01525602|471561455|FG000|Overall Study|Adverse Event|1|||
131133082|NCT02500121|472113900|FG000|Overall Study|Withdrawal by Subject|1|||
131133083|NCT02500121|472113901|FG001|Overall Study|Withdrawal by Subject|1|||
131133084|NCT02500121|472113900|FG000|Overall Study|Death|26|||
131133085|NCT02500121|472113901|FG001|Overall Study|Death|24|||
131133086|NCT00852995|472113903|FG000|Overall Study|Adverse Event|1|||
131133087|NCT00852995|472113904|FG001|Overall Study|Adverse Event|0|||
131133088|NCT00852995|472113905|FG002|Overall Study|Adverse Event|4|||
131133089|NCT00852995|472113906|FG003|Overall Study|Adverse Event|0|||
131133090|NCT00852995|472113907|FG004|Overall Study|Adverse Event|0|||
131133091|NCT00852995|472113903|FG000|Overall Study|Lost to Follow-up|0|||
131133092|NCT00852995|472113904|FG001|Overall Study|Lost to Follow-up|1|||
131133093|NCT00852995|472113905|FG002|Overall Study|Lost to Follow-up|1|||
131133094|NCT00852995|472113906|FG003|Overall Study|Lost to Follow-up|0|||
131133095|NCT00852995|472113907|FG004|Overall Study|Lost to Follow-up|0|||
131133096|NCT00852995|472113903|FG000|Overall Study|Withdrawal by Subject|4|||
131133097|NCT00852995|472113904|FG001|Overall Study|Withdrawal by Subject|0|||
131133098|NCT00852995|472113905|FG002|Overall Study|Withdrawal by Subject|0|||
131133099|NCT00852995|472113906|FG003|Overall Study|Withdrawal by Subject|1|||
131133100|NCT00852995|472113907|FG004|Overall Study|Withdrawal by Subject|2|||
131133101|NCT00852995|472113903|FG000|Overall Study|Non-Compliance|0|||
131133102|NCT00852995|472113904|FG001|Overall Study|Non-Compliance|0|||
131133103|NCT00852995|472113905|FG002|Overall Study|Non-Compliance|0|||
131133104|NCT00852995|472113906|FG003|Overall Study|Non-Compliance|2|||
131133105|NCT00852995|472113907|FG004|Overall Study|Non-Compliance|0|||
131133106|NCT00852995|472113903|FG000|Overall Study|Progressive Disease|1|||
131133107|NCT00852995|472113904|FG001|Overall Study|Progressive Disease|0|||
131133108|NCT00852995|472113905|FG002|Overall Study|Progressive Disease|0|||
131133109|NCT00852995|472113906|FG003|Overall Study|Progressive Disease|2|||
131133110|NCT00852995|472113907|FG004|Overall Study|Progressive Disease|1|||
131228368|NCT00772577|472463215|FG001|Overall Study|Administrative problems|1|||
131228369|NCT00772577|472463214|FG000|Overall Study|Protocol Deviation|3|||
131228370|NCT00772577|472463215|FG001|Overall Study|Protocol Deviation|2|||
131228371|NCT03211156|472463216|FG000|Overall Study|Withdrawal by Subject|0|||
131228372|NCT03211156|472463217|FG001|Overall Study|Withdrawal by Subject|2|||
131228373|NCT03211156|472463216|FG000|Overall Study|Lost to Follow-up|1|||
131228374|NCT03211156|472463217|FG001|Overall Study|Lost to Follow-up|1|||
131228375|NCT03211156|472463216|FG000|Overall Study|Adverse Event|1|||
130982839|NCT01525602|471561456|FG001|Overall Study|Adverse Event|0|||
130982840|NCT01525602|471561457|FG002|Overall Study|Adverse Event|1|||
130982841|NCT01525602|471561458|FG003|Overall Study|Adverse Event|1|||
131133111|NCT00852995|472113903|FG000|Overall Study|Physician Decision|1|||
131133112|NCT00852995|472113904|FG001|Overall Study|Physician Decision|0|||
131133113|NCT00852995|472113905|FG002|Overall Study|Physician Decision|0|||
131133114|NCT00852995|472113906|FG003|Overall Study|Physician Decision|0|||
131228376|NCT03211156|472463217|FG001|Overall Study|Adverse Event|0|||
131228377|NCT04272775|472463218|FG000|Overall Study|Study Terminated by Sponsor|1|||
131228378|NCT04272775|472463219|FG001|Overall Study|Study Terminated by Sponsor|0|||
130982842|NCT01525602|471561459|FG004|Overall Study|Adverse Event|3|||
130982843|NCT01525602|471561460|FG005|Overall Study|Adverse Event|3|||
130982844|NCT01525602|471561461|FG006|Overall Study|Adverse Event|0|||
131133115|NCT00852995|472113907|FG004|Overall Study|Physician Decision|0|||
131133116|NCT00852995|472113903|FG000|Overall Study|Protocol Violation|0|||
131133117|NCT00852995|472113904|FG001|Overall Study|Protocol Violation|0|||
130982845|NCT01525602|471561462|FG007|Overall Study|Adverse Event|1|||
131133118|NCT00852995|472113905|FG002|Overall Study|Protocol Violation|0|||
131133119|NCT00852995|472113906|FG003|Overall Study|Protocol Violation|0|||
131228379|NCT04272775|472463218|FG000|Overall Study|Protocol Violation|0|||
131133120|NCT00852995|472113907|FG004|Overall Study|Protocol Violation|1|||
131133121|NCT00852995|472113903|FG000|Overall Study|Moved Out of Area|1|||
130982846|NCT01525602|471561455|FG000|Overall Study|Disease progression|6|||
130982847|NCT01525602|471561456|FG001|Overall Study|Disease progression|3|||
130982848|NCT01525602|471561457|FG002|Overall Study|Disease progression|2|||
130982849|NCT01525602|471561458|FG003|Overall Study|Disease progression|5|||
131133122|NCT00852995|472113904|FG001|Overall Study|Moved Out of Area|0|||
131133123|NCT00852995|472113905|FG002|Overall Study|Moved Out of Area|0|||
131133124|NCT00852995|472113906|FG003|Overall Study|Moved Out of Area|0|||
131133125|NCT00852995|472113907|FG004|Overall Study|Moved Out of Area|0|||
131133126|NCT01836783|472113908|FG000|Overall Study|Withdrawal by Subject|0|||
131133127|NCT01836783|472113909|FG001|Overall Study|Withdrawal by Subject|2|||
131133128|NCT04518462|472113910|FG000|Overall Study|Withdrawal by Subject|0|||
131133129|NCT04518462|472113911|FG001|Overall Study|Withdrawal by Subject|0|||
131133130|NCT04518462|472113912|FG002|Overall Study|Withdrawal by Subject|1|||
131133131|NCT04518462|472113910|FG000|Overall Study|Physician Decision|1|||
131133132|NCT04518462|472113911|FG001|Overall Study|Physician Decision|1|||
131133133|NCT04518462|472113912|FG002|Overall Study|Physician Decision|0|||
131133134|NCT04418076|472113916|FG000|Overall Study|Death|1|||
131133135|NCT04418076|472113917|FG001|Overall Study|Death|0|||
131133136|NCT04418076|472113918|FG002|Overall Study|Death|0|||
131133137|NCT04418076|472113919|FG003|Overall Study|Death|0|||
131133138|NCT04418076|472113916|FG000|Overall Study|Lost to Follow-up|2|||
131133139|NCT04418076|472113917|FG001|Overall Study|Lost to Follow-up|5|||
131133140|NCT04418076|472113918|FG002|Overall Study|Lost to Follow-up|1|||
131133141|NCT04418076|472113919|FG003|Overall Study|Lost to Follow-up|2|||
131133142|NCT04418076|472113916|FG000|Overall Study|Withdrawal by Subject|1|||
131133143|NCT04418076|472113917|FG001|Overall Study|Withdrawal by Subject|0|||
131133144|NCT04418076|472113918|FG002|Overall Study|Withdrawal by Subject|1|||
130982850|NCT01525602|471561459|FG004|Overall Study|Disease progression|22|||
130982851|NCT01525602|471561460|FG005|Overall Study|Disease progression|2|||
130982852|NCT01525602|471561461|FG006|Overall Study|Disease progression|3|||
130982853|NCT01525602|471561462|FG007|Overall Study|Disease progression|3|||
130982854|NCT01525602|471561455|FG000|Overall Study|Clinical progression|2|||
130982855|NCT01525602|471561456|FG001|Overall Study|Clinical progression|0|||
130982856|NCT01525602|471561457|FG002|Overall Study|Clinical progression|0|||
130982857|NCT01525602|471561458|FG003|Overall Study|Clinical progression|0|||
130982858|NCT01525602|471561459|FG004|Overall Study|Clinical progression|0|||
130982859|NCT01525602|471561460|FG005|Overall Study|Clinical progression|0|||
130982860|NCT01525602|471561461|FG006|Overall Study|Clinical progression|1|||
130982861|NCT01525602|471561462|FG007|Overall Study|Clinical progression|1|||
130982862|NCT01525602|471561455|FG000|Overall Study|Non-compliance|0|||
130982863|NCT01525602|471561456|FG001|Overall Study|Non-compliance|0|||
130982864|NCT01525602|471561457|FG002|Overall Study|Non-compliance|0|||
130982865|NCT01525602|471561458|FG003|Overall Study|Non-compliance|0|||
130982866|NCT01525602|471561459|FG004|Overall Study|Non-compliance|1|||
130982867|NCT01525602|471561460|FG005|Overall Study|Non-compliance|0|||
130982868|NCT01525602|471561461|FG006|Overall Study|Non-compliance|0|||
130982869|NCT01525602|471561462|FG007|Overall Study|Non-compliance|0|||
130982870|NCT01525602|471561455|FG000|Overall Study|Withdrawal by Subject|0|||
130982871|NCT01525602|471561456|FG001|Overall Study|Withdrawal by Subject|0|||
130982872|NCT01525602|471561457|FG002|Overall Study|Withdrawal by Subject|0|||
130982873|NCT01525602|471561458|FG003|Overall Study|Withdrawal by Subject|0|||
130982874|NCT01525602|471561459|FG004|Overall Study|Withdrawal by Subject|3|||
130982875|NCT01525602|471561460|FG005|Overall Study|Withdrawal by Subject|1|||
131133145|NCT04418076|472113919|FG003|Overall Study|Withdrawal by Subject|1|||
130778834|NCT03428100|470817450|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130982876|NCT01525602|471561461|FG006|Overall Study|Withdrawal by Subject|0|||
130982877|NCT01525602|471561462|FG007|Overall Study|Withdrawal by Subject|1|||
130982878|NCT01525602|471561455|FG000|Overall Study|Physician Decision|0|||
130982879|NCT01525602|471561456|FG001|Overall Study|Physician Decision|0|||
130982880|NCT01525602|471561457|FG002|Overall Study|Physician Decision|0|||
130982881|NCT01525602|471561458|FG003|Overall Study|Physician Decision|0|||
130982882|NCT01525602|471561459|FG004|Overall Study|Physician Decision|3|||
130982883|NCT01525602|471561460|FG005|Overall Study|Physician Decision|0|||
130982884|NCT01525602|471561461|FG006|Overall Study|Physician Decision|1|||
130982885|NCT01525602|471561462|FG007|Overall Study|Physician Decision|0|||
130982886|NCT01525602|471561455|FG000|Overall Study|Death|0|||
130982887|NCT01525602|471561456|FG001|Overall Study|Death|0|||
130982888|NCT01525602|471561457|FG002|Overall Study|Death|0|||
130982889|NCT01525602|471561458|FG003|Overall Study|Death|0|||
131133146|NCT04418076|472113916|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
131133147|NCT04418076|472113917|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
131133148|NCT04418076|472113918|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
131133149|NCT04418076|472113919|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
131133150|NCT01471782|472113920|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
131133151|NCT01471782|472113921|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
131133152|NCT01471782|472113922|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
130982890|NCT01525602|471561459|FG004|Overall Study|Death|1|||
130982891|NCT01525602|471561460|FG005|Overall Study|Death|1|||
130982892|NCT01525602|471561461|FG006|Overall Study|Death|0|||
130982893|NCT01525602|471561462|FG007|Overall Study|Death|0|||
130982894|NCT01525602|471561455|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
130982895|NCT01525602|471561456|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
130982896|NCT01525602|471561457|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
130982897|NCT01525602|471561458|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
130982898|NCT01525602|471561459|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
130982899|NCT01525602|471561460|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
130982900|NCT01525602|471561461|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
130982901|NCT01525602|471561462|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
130982902|NCT03657277|471561463|FG000|Overall Study|Physician Decision|2|||
130982903|NCT03657277|471561463|FG000|Overall Study|Lost to Follow-up|1|||
130982904|NCT03657277|471561463|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
130982905|NCT04349280|471561464|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
130982906|NCT04349280|471561465|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
130982907|NCT04349280|471561464|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
130982908|NCT04349280|471561465|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
130982909|NCT04349280|471561464|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
130982910|NCT04349280|471561465|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
130982911|NCT00657618|471561466|FG000|Overall Study|Adverse Event|32|||
130982912|NCT00657618|471561466|FG000|Overall Study|Withdrawal by Subject|8|||
130982913|NCT00657618|471561466|FG000|Overall Study|negative for leishmaniasis|2|||
130982914|NCT00657618|471561466|FG000|Overall Study|didn't start due to schedule conflicts|1|||
130982915|NCT04981678|471561467|FG000|Overall Study|Lost to Follow-up|0|||
130982916|NCT04981678|471561468|FG001|Overall Study|Lost to Follow-up|1|||
130982917|NCT01194570|471563368|FG000|Overall Study|Adverse Event|22|||
130982918|NCT01194570|471563369|FG001|Overall Study|Adverse Event|40|||
130982919|NCT01194570|471563368|FG000|Overall Study|Death|6|||
130982920|NCT01194570|471563369|FG001|Overall Study|Death|20|||
130982921|NCT01194570|471563368|FG000|Overall Study|Lack of Efficacy|32|||
130982922|NCT01194570|471563369|FG001|Overall Study|Lack of Efficacy|33|||
130982923|NCT01194570|471563368|FG000|Overall Study|Lost to Follow-up|4|||
130982924|NCT01194570|471563369|FG001|Overall Study|Lost to Follow-up|15|||
130982925|NCT01194570|471563368|FG000|Overall Study|Non-Compliance|2|||
130982926|NCT01194570|471563369|FG001|Overall Study|Non-Compliance|2|||
130982927|NCT01194570|471563368|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130982928|NCT01194570|471563369|FG001|Overall Study|Non-Compliance With Study Drug|2|||
130982929|NCT01194570|471563368|FG000|Overall Study|Other|18|||
130982930|NCT01194570|471563369|FG001|Overall Study|Other|47|||
130982931|NCT01194570|471563368|FG000|Overall Study|Physician Decision|10|||
130982932|NCT01194570|471563369|FG001|Overall Study|Physician Decision|25|||
130982933|NCT01194570|471563368|FG000|Overall Study|Protocol Violation|1|||
130982934|NCT01194570|471563369|FG001|Overall Study|Protocol Violation|2|||
130982935|NCT01194570|471563368|FG000|Overall Study|Study Terminated By Sponsor|0|||
130982936|NCT01194570|471563369|FG001|Overall Study|Study Terminated By Sponsor|1|||
130982937|NCT01194570|471563368|FG000|Overall Study|Withdrawal by Subject|57|||
130982938|NCT01194570|471563369|FG001|Overall Study|Withdrawal by Subject|82|||
130982939|NCT01194570|471563368|FG000|Overall Study|Pregnancy|1|||
130982940|NCT01194570|471563369|FG001|Overall Study|Pregnancy|1|||
130982941|NCT03076970|471563373|FG000|Washout Period 2|Adverse Event|0|||
130982942|NCT03076970|471563374|FG001|Washout Period 2|Adverse Event|0|||
130982943|NCT03076970|471563375|FG002|Washout Period 2|Adverse Event|0|||
130982944|NCT03076970|471563376|FG003|Washout Period 2|Adverse Event|0|||
130982945|NCT03076970|471563377|FG004|Washout Period 2|Adverse Event|1|||
130982946|NCT03076970|471563378|FG005|Washout Period 2|Adverse Event|0|||
130982947|NCT03076970|471563373|FG000|Period 3|Withdrawal by Subject|0|||
130982948|NCT03076970|471563374|FG001|Period 3|Withdrawal by Subject|0|||
130982949|NCT03076970|471563375|FG002|Period 3|Withdrawal by Subject|0|||
130982950|NCT03076970|471563376|FG003|Period 3|Withdrawal by Subject|0|||
130982951|NCT03076970|471563377|FG004|Period 3|Withdrawal by Subject|0|||
130982952|NCT03076970|471563378|FG005|Period 3|Withdrawal by Subject|1|||
130982953|NCT03076970|471563373|FG000|Period 3|Failure to meet I/E criteria|0|||
130982954|NCT03076970|471563374|FG001|Period 3|Failure to meet I/E criteria|0|||
130982955|NCT03076970|471563375|FG002|Period 3|Failure to meet I/E criteria|0|||
130982956|NCT03076970|471563376|FG003|Period 3|Failure to meet I/E criteria|0|||
130982957|NCT03076970|471563377|FG004|Period 3|Failure to meet I/E criteria|1|||
130982958|NCT03076970|471563378|FG005|Period 3|Failure to meet I/E criteria|0|||
130982959|NCT02543658|471563379|FG000|Overall Study|Lack of Efficacy|0|||
130982960|NCT02543658|471563380|FG001|Overall Study|Lack of Efficacy|4|||
130982961|NCT00789815|471563381|FG000|Overall Study|Protocol Violation|6|||
130982962|NCT00789815|471563382|FG001|Overall Study|Protocol Violation|1|||
130982963|NCT00789815|471563381|FG000|Overall Study|Intubation due to massive bleeding|1|||
130982964|NCT00789815|471563382|FG001|Overall Study|Intubation due to massive bleeding|0|||
130982965|NCT02035332|471563383|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
130982966|NCT00662857|471563384|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
130982967|NCT00662857|471563385|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
130982968|NCT00662857|471563384|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
130982969|NCT00662857|471563385|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
130982970|NCT00662857|471563384|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
130982971|NCT00662857|471563385|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
130982972|NCT03966053|471563386|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
130982973|NCT01332227|471563388|FG000|Overall Study|Adverse Event|4|||
130982974|NCT01332227|471563389|FG001|Overall Study|Adverse Event|1|||
130982975|NCT01332227|471563388|FG000|Overall Study|Withdrawal by Subject|5|||
130982976|NCT01332227|471563389|FG001|Overall Study|Withdrawal by Subject|1|||
130982977|NCT01332227|471563388|FG000|Overall Study|Lost to Follow-up|2|||
130982978|NCT01332227|471563389|FG001|Overall Study|Lost to Follow-up|0|||
130982979|NCT01332227|471563388|FG000|Overall Study|Lack of Efficacy|3|||
130982980|NCT01332227|471563389|FG001|Overall Study|Lack of Efficacy|1|||
130982981|NCT01332227|471563388|FG000|Overall Study|Poor compliance/noncompliance|1|||
130982982|NCT01332227|471563389|FG001|Overall Study|Poor compliance/noncompliance|1|||
130982983|NCT01332227|471563388|FG000|Overall Study|Patient moved from area|1|||
130982984|NCT01332227|471563389|FG001|Overall Study|Patient moved from area|0|||
130982985|NCT01332227|471563388|FG000|Overall Study|Patient began prohibited medication|0|||
130982986|NCT01332227|471563389|FG001|Overall Study|Patient began prohibited medication|1|||
130982987|NCT00514943|471563390|FG000|Stage 1|Progressive disease|4|||
130982988|NCT00514943|471563391|FG001|Stage 1|Progressive disease|8|||
130982989|NCT00514943|471563390|FG000|Stage 1|Other Adverse Event|16|||
130982990|NCT00514943|471563391|FG001|Stage 1|Other Adverse Event|6|||
130982991|NCT00514943|471563390|FG000|Stage 1|Not treated|1|||
130982992|NCT00514943|471563391|FG001|Stage 1|Not treated|2|||
130982993|NCT00514943|471563390|FG000|Stage 1|Patient refused to continue study meds|8|||
130982994|NCT00514943|471563391|FG001|Stage 1|Patient refused to continue study meds|3|||
130982995|NCT00514943|471563390|FG000|Stage 1|Other than stated above|1|||
130982996|NCT00514943|471563391|FG001|Stage 1|Other than stated above|7|||
130982997|NCT00514943|471563390|FG000|Stage 2|Progressive disease|27|||
130982998|NCT00514943|471563391|FG001|Stage 2|Progressive disease|24|||
130982999|NCT00514943|471563390|FG000|Stage 2|Other Adverse Event|3|||
130983000|NCT00514943|471563391|FG001|Stage 2|Other Adverse Event|10|||
131044519|NCT05736458|471796256|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
131044520|NCT05013385|471796261|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
131044521|NCT01447719|471796266|FG000|Overall Study|Image acquisition failure|2|||
131044522|NCT01447719|471796266|FG000|Overall Study|Invalid image or not imaged|3|||
131044523|NCT01447719|471796266|FG000|Overall Study|Subject still living at end of study|79|||
131044524|NCT01447719|471796266|FG000|Overall Study|Withdrawal by Subject|2|||
131044525|NCT01447719|471796266|FG000|Overall Study|Family withdrew autopsy consent|7|||
131044526|NCT05100628|471796267|FG000|Overall Study|Progressive Disease|1|||
131044527|NCT05100628|471796268|FG001|Overall Study|Progressive Disease|0|||
131044528|NCT05100628|471796269|FG002|Overall Study|Progressive Disease|0|||
131044529|NCT05100628|471796270|FG003|Overall Study|Progressive Disease|0|||
131044530|NCT05100628|471796267|FG000|Overall Study|Study Terminated by Sponsor|0|||
131044531|NCT05100628|471796268|FG001|Overall Study|Study Terminated by Sponsor|0|||
131044532|NCT05100628|471796269|FG002|Overall Study|Study Terminated by Sponsor|3|||
131044533|NCT05100628|471796270|FG003|Overall Study|Study Terminated by Sponsor|0|||
131044534|NCT05100628|471796267|FG000|Overall Study|unkown|0|||
131044535|NCT05100628|471796268|FG001|Overall Study|unkown|1|||
131044536|NCT05100628|471796269|FG002|Overall Study|unkown|0|||
131044537|NCT05100628|471796270|FG003|Overall Study|unkown|0|||
131044538|NCT05900154|471796276|FG000|Follow-Up Period|Lost to Follow-up|1|||
131044539|NCT05900154|471796277|FG001|Follow-Up Period|Lost to Follow-up|2|||
131044540|NCT05900154|471796278|FG002|Follow-Up Period|Lost to Follow-up|1|||
131044541|NCT05900154|471796279|FG003|Follow-Up Period|Lost to Follow-up|0|||
131044542|NCT05900154|471796280|FG004|Follow-Up Period|Lost to Follow-up|1|||
131044543|NCT05900154|471796281|FG005|Follow-Up Period|Lost to Follow-up|1|||
131044544|NCT03993392|471796286|FG000|Overall Study|Withdrawal by Subject|3|||
131044545|NCT03993392|471796286|FG000|Overall Study|Lost to Follow-up|2|||
131044546|NCT03993392|471796286|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
131044547|NCT02518048|471796289|FG000|Overall Study|Withdrawal by Subject|1|||
130983001|NCT00514943|471563390|FG000|Stage 2|Patient refused to continue study meds|2|||
130983002|NCT00514943|471563391|FG001|Stage 2|Patient refused to continue study meds|0|||
130983003|NCT00514943|471563390|FG000|Stage 2|Other than stated above|0|||
130983004|NCT00514943|471563391|FG001|Stage 2|Other than stated above|2|||
130983005|NCT01783418|471563396|FG000|Overall Study|Withdrawal by Subject|1|||
130983006|NCT01783418|471563397|FG001|Overall Study|Withdrawal by Subject|0|||
130983007|NCT03548207|471563398|FG000|Overall Study|Death|10|||
130983008|NCT03548207|471563399|FG001|Overall Study|Death|23|||
131044548|NCT04451772|471797554|FG000|Overall Study|Adverse Event|1|||
131044549|NCT04451772|471797555|FG001|Overall Study|Adverse Event|0|||
131044550|NCT04451772|471797556|FG002|Overall Study|Adverse Event|1|||
131044551|NCT04451772|471797557|FG003|Overall Study|Adverse Event|1|||
131044552|NCT04451772|471797558|FG004|Overall Study|Adverse Event|0|||
131044553|NCT04451772|471797559|FG005|Overall Study|Adverse Event|3|||
130983009|NCT03548207|471563400|FG002|Overall Study|Death|3|||
130983010|NCT03548207|471563398|FG000|Overall Study|Lost to Follow-up|0|||
130983011|NCT03548207|471563399|FG001|Overall Study|Lost to Follow-up|2|||
130983012|NCT03548207|471563400|FG002|Overall Study|Lost to Follow-up|0|||
130983013|NCT03548207|471563398|FG000|Overall Study|Withdrawal by Subject|0|||
130983014|NCT03548207|471563399|FG001|Overall Study|Withdrawal by Subject|3|||
130983015|NCT03548207|471563400|FG002|Overall Study|Withdrawal by Subject|0|||
130983016|NCT03548207|471563398|FG000|Overall Study|Sponsor decision|19|||
131133153|NCT01471782|472113923|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
131133154|NCT01471782|472113924|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
131133155|NCT01471782|472113925|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
131133156|NCT01471782|472113920|FG000|Overall Study|Lack of Efficacy|1|||
131133157|NCT01471782|472113921|FG001|Overall Study|Lack of Efficacy|2|||
131133158|NCT01471782|472113922|FG002|Overall Study|Lack of Efficacy|1|||
131133159|NCT01471782|472113923|FG003|Overall Study|Lack of Efficacy|1|||
131133160|NCT01471782|472113924|FG004|Overall Study|Lack of Efficacy|5|||
131133161|NCT01471782|472113925|FG005|Overall Study|Lack of Efficacy|18|||
131133162|NCT01471782|472113920|FG000|Overall Study|Adverse Event|1|||
131133163|NCT01471782|472113921|FG001|Overall Study|Adverse Event|1|||
131133164|NCT01471782|472113922|FG002|Overall Study|Adverse Event|2|||
131133165|NCT01471782|472113923|FG003|Overall Study|Adverse Event|2|||
131133166|NCT01471782|472113924|FG004|Overall Study|Adverse Event|3|||
131133167|NCT01471782|472113925|FG005|Overall Study|Adverse Event|1|||
130983017|NCT03548207|471563399|FG001|Overall Study|Sponsor decision|40|||
130983018|NCT03548207|471563400|FG002|Overall Study|Sponsor decision|6|||
130983019|NCT03548207|471563398|FG000|Overall Study|Randomized but not treated|6|||
130983020|NCT03548207|471563399|FG001|Overall Study|Randomized but not treated|10|||
130983021|NCT03548207|471563400|FG002|Overall Study|Randomized but not treated|4|||
130983022|NCT00999466|471563401|FG000|Main Part|Withdrawal by Subject|0|||
130983023|NCT00999466|471563402|FG001|Main Part|Withdrawal by Subject|0|||
130983024|NCT00999466|471563403|FG002|Main Part|Withdrawal by Subject|2|||
130983025|NCT00999466|471563401|FG000|Main Part|Adverse Event|0|||
130983026|NCT00999466|471563402|FG001|Main Part|Adverse Event|4|||
130983027|NCT00999466|471563403|FG002|Main Part|Adverse Event|2|||
130983028|NCT03040713|471563404|FG000|Overall Study|Positive amyloid scan|3|||
130983029|NCT02563002|471563405|FG000|Overall Study|Death|72|||
130983030|NCT02563002|471563406|FG001|Overall Study|Death|87|||
130983031|NCT02563002|471563405|FG000|Overall Study|Lost to Follow-up|5|||
130983032|NCT02563002|471563406|FG001|Overall Study|Lost to Follow-up|0|||
130983033|NCT02563002|471563405|FG000|Overall Study|Physician Decision|0|||
130983034|NCT02563002|471563406|FG001|Overall Study|Physician Decision|2|||
130983035|NCT02563002|471563405|FG000|Overall Study|Withdrawal by Subject|2|||
130983036|NCT02563002|471563406|FG001|Overall Study|Withdrawal by Subject|10|||
130983037|NCT02563002|471563405|FG000|Overall Study|Sponsor decision|74|||
130983038|NCT02563002|471563406|FG001|Overall Study|Sponsor decision|55|||
130983039|NCT03466086|471563407|FG000|Period 1|Sponsor decision due to study timeline|1|||
130983040|NCT03466086|471563408|FG001|Period 1|Sponsor decision due to study timeline|0|||
130983041|NCT03466086|471563407|FG000|Period 1|Withdrawal by Subject|1|||
131228380|NCT04272775|472463219|FG001|Overall Study|Protocol Violation|1|||
131228381|NCT04272775|472463218|FG000|Overall Study|Symptomatic Deterioration|1|||
131228382|NCT04272775|472463219|FG001|Overall Study|Symptomatic Deterioration|1|||
131228383|NCT04272775|472463218|FG000|Overall Study|Withdrawal by Subject|1|||
131228384|NCT04272775|472463219|FG001|Overall Study|Withdrawal by Subject|2|||
131228385|NCT04272775|472463218|FG000|Overall Study|Adverse Event|1|||
131228386|NCT04272775|472463219|FG001|Overall Study|Adverse Event|2|||
131228387|NCT04272775|472463218|FG000|Overall Study|Progressive Disease|3|||
131228388|NCT04272775|472463219|FG001|Overall Study|Progressive Disease|1|||
131228389|NCT00678392|472463220|FG000|Overall Study|Adverse Event|0|||
131228390|NCT00678392|472463221|FG001|Overall Study|Adverse Event|6|||
131228391|NCT00678392|472463220|FG000|Overall Study|Death|280|||
131228392|NCT00678392|472463221|FG001|Overall Study|Death|269|||
130983042|NCT03466086|471563408|FG001|Period 1|Withdrawal by Subject|0|||
130983043|NCT00595504|471563409|FG000|Overall Study|Withdrawal by Subject|1|||
131133168|NCT01471782|472113920|FG000|Overall Study|Other|0|||
131133169|NCT01471782|472113921|FG001|Overall Study|Other|0|||
131133170|NCT01471782|472113922|FG002|Overall Study|Other|1|||
131228393|NCT00678392|472463220|FG000|Overall Study|Lost to Follow-up|15|||
130983044|NCT00595504|471563410|FG001|Overall Study|Withdrawal by Subject|3|||
130983045|NCT00595504|471563409|FG000|Overall Study|Physician Decision|1|||
130983046|NCT00595504|471563410|FG001|Overall Study|Physician Decision|0|||
130983047|NCT01949870|471563411|FG000|Overall Study|Lack of Efficacy|2|||
130983048|NCT01949870|471563411|FG000|Overall Study|Adverse Event|1|||
130983049|NCT01949870|471563411|FG000|Overall Study|Study termination|1|||
130983050|NCT01949870|471563411|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
131133171|NCT01471782|472113923|FG003|Overall Study|Other|1|||
131133172|NCT01471782|472113924|FG004|Overall Study|Other|6|||
131133173|NCT01471782|472113925|FG005|Overall Study|Other|5|||
131133174|NCT01471782|472113920|FG000|Overall Study|Change of Chemotherapy|1|||
131228394|NCT00678392|472463221|FG001|Overall Study|Lost to Follow-up|13|||
131228395|NCT00678392|472463220|FG000|Overall Study|Objective Progression or Relapse|3|||
130983051|NCT00677352|471563412|FG000|Treatment Phase|Adverse Event|14|||
130983052|NCT00677352|471563413|FG001|Treatment Phase|Adverse Event|22|||
130983053|NCT00677352|471563412|FG000|Treatment Phase|Lack of Efficacy|2|||
130983054|NCT00677352|471563413|FG001|Treatment Phase|Lack of Efficacy|3|||
130983055|NCT00677352|471563412|FG000|Treatment Phase|Lost to Follow-up|0|||
130983056|NCT00677352|471563413|FG001|Treatment Phase|Lost to Follow-up|1|||
130983057|NCT00677352|471563412|FG000|Treatment Phase|Withdrawal by Subject|7|||
130983058|NCT00677352|471563413|FG001|Treatment Phase|Withdrawal by Subject|7|||
130983059|NCT00677352|471563412|FG000|Treatment Phase|Physician Decision|1|||
130983060|NCT00677352|471563413|FG001|Treatment Phase|Physician Decision|0|||
130983061|NCT00677352|471563412|FG000|Treatment Phase|Pregnancy|0|||
130983062|NCT00677352|471563413|FG001|Treatment Phase|Pregnancy|1|||
130983063|NCT00677352|471563412|FG000|Treatment Phase|Protocol Violation|1|||
131228396|NCT00678392|472463221|FG001|Overall Study|Objective Progression or Relapse|8|||
131228397|NCT00678392|472463220|FG000|Overall Study|Sponsor's Decision|1|||
131228398|NCT00678392|472463221|FG001|Overall Study|Sponsor's Decision|2|||
131228399|NCT00678392|472463220|FG000|Overall Study|Withdrawal by Subject|4|||
131228400|NCT00678392|472463221|FG001|Overall Study|Withdrawal by Subject|4|||
131228401|NCT00678392|472463220|FG000|Overall Study|Randomized But Not Treated|2|||
131228402|NCT00678392|472463221|FG001|Overall Study|Randomized But Not Treated|7|||
131228403|NCT00678392|472463220|FG000|Overall Study|Other|56|||
131228404|NCT00678392|472463221|FG001|Overall Study|Other|53|||
131228405|NCT01405820|472463224|FG000|Randomized Treatment Period|Adverse Event|3|||
130983064|NCT00677352|471563413|FG001|Treatment Phase|Protocol Violation|1|||
130983065|NCT00677352|471563412|FG000|Treatment Phase|Transference or work related matter|0|||
130983066|NCT00677352|471563413|FG001|Treatment Phase|Transference or work related matter|5|||
130983067|NCT00677352|471563412|FG000|Treatment Phase|Not treated|0|||
130983068|NCT00677352|471563413|FG001|Treatment Phase|Not treated|2|||
130983069|NCT00677352|471563412|FG000|Tapering Phase|Adverse Event|1|||
130983070|NCT00677352|471563413|FG001|Tapering Phase|Adverse Event|5|||
130983071|NCT00677352|471563412|FG000|Tapering Phase|Withdrawal by Subject|5|||
130983072|NCT00677352|471563413|FG001|Tapering Phase|Withdrawal by Subject|3|||
130983073|NCT00677352|471563412|FG000|Tapering Phase|Pregnancy|0|||
130983074|NCT00677352|471563413|FG001|Tapering Phase|Pregnancy|1|||
130983075|NCT00677352|471563412|FG000|Tapering Phase|Job transfer|0|||
130983076|NCT00677352|471563413|FG001|Tapering Phase|Job transfer|1|||
130983077|NCT02182973|471563414|FG000|Overall Study|Withdrawal by Subject|3|||
130983078|NCT02182973|471563415|FG001|Overall Study|Withdrawal by Subject|0|||
130983079|NCT01123382|471563416|FG000|Overall Study|Withdrawal by Subject|1|||
130983080|NCT01123382|471563417|FG001|Overall Study|Withdrawal by Subject|4|||
130983081|NCT01123382|471563416|FG000|Overall Study|Lost to Follow-up|1|||
130983082|NCT01123382|471563417|FG001|Overall Study|Lost to Follow-up|2|||
130983083|NCT00594854|471563418|FG000|Overall Study|Study terminated|7|||
130983084|NCT00594854|471563419|FG001|Overall Study|Study terminated|10|||
131044554|NCT04451772|471797554|FG000|Overall Study|Withdrawal by Subject|2|||
131228406|NCT01405820|472463225|FG001|Randomized Treatment Period|Adverse Event|3|||
131228407|NCT01405820|472463226|FG002|Randomized Treatment Period|Adverse Event|3|||
131228408|NCT01405820|472463227|FG003|Randomized Treatment Period|Adverse Event|0|||
131228409|NCT01405820|472463228|FG004|Randomized Treatment Period|Adverse Event|2|||
130778835|NCT03428100|470817451|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
131044555|NCT04451772|471797555|FG001|Overall Study|Withdrawal by Subject|7|||
131044556|NCT04451772|471797556|FG002|Overall Study|Withdrawal by Subject|2|||
131044557|NCT04451772|471797557|FG003|Overall Study|Withdrawal by Subject|1|||
131044558|NCT04451772|471797558|FG004|Overall Study|Withdrawal by Subject|1|||
131044559|NCT04451772|471797559|FG005|Overall Study|Withdrawal by Subject|0|||
131044560|NCT04451772|471797554|FG000|Overall Study|Other, not specified|1|||
131044561|NCT04451772|471797555|FG001|Overall Study|Other, not specified|2|||
131044562|NCT04451772|471797556|FG002|Overall Study|Other, not specified|1|||
131044563|NCT04451772|471797557|FG003|Overall Study|Other, not specified|0|||
131044564|NCT04451772|471797558|FG004|Overall Study|Other, not specified|0|||
131044565|NCT04451772|471797559|FG005|Overall Study|Other, not specified|1|||
131044566|NCT04451772|471797554|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
131044567|NCT04451772|471797555|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
131044568|NCT04451772|471797556|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
131044569|NCT04451772|471797557|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
131044570|NCT04451772|471797558|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
131044571|NCT04451772|471797559|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
131228410|NCT01405820|472463229|FG005|Randomized Treatment Period|Adverse Event|1|||
131228411|NCT01405820|472463224|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
130983085|NCT06134180|471563430|FG000|Overall Study|Lost to Follow-up|4|||
130983090|NCT03338829|471563433|FG000|Overall Study|Lost to Follow-up|4|||
130983091|NCT03338829|471563434|FG001|Overall Study|Lost to Follow-up|2|||
130983092|NCT03338829|471563435|FG002|Overall Study|Lost to Follow-up|4|||
130983093|NCT03338829|471563433|FG000|Overall Study|Pregnancy loss|1|||
130983094|NCT03338829|471563434|FG001|Overall Study|Pregnancy loss|1|||
130983095|NCT03338829|471563435|FG002|Overall Study|Pregnancy loss|0|||
130983096|NCT03338829|471563433|FG000|Overall Study|Protocol Violation|0|||
130983097|NCT03338829|471563434|FG001|Overall Study|Protocol Violation|1|||
130983098|NCT03338829|471563435|FG002|Overall Study|Protocol Violation|0|||
130983099|NCT02684006|471563436|FG000|Overall Study|Other|18|||
130983100|NCT02684006|471563437|FG001|Overall Study|Other|6|||
130983101|NCT02684006|471563436|FG000|Overall Study|Protocol Violation|2|||
130983102|NCT02684006|471563437|FG001|Overall Study|Protocol Violation|1|||
130983103|NCT02684006|471563436|FG000|Overall Study|Non-compliance with study drug|1|||
130983104|NCT02684006|471563437|FG001|Overall Study|Non-compliance with study drug|1|||
130983105|NCT02684006|471563436|FG000|Overall Study|No longer met eligibility criteria|6|||
130983106|NCT02684006|471563437|FG001|Overall Study|No longer met eligibility criteria|2|||
130983107|NCT02684006|471563436|FG000|Overall Study|Lost to Follow-up|0|||
130983108|NCT02684006|471563437|FG001|Overall Study|Lost to Follow-up|1|||
130983109|NCT02684006|471563436|FG000|Overall Study|Death|25|||
130983110|NCT02684006|471563437|FG001|Overall Study|Death|22|||
130983111|NCT02684006|471563436|FG000|Overall Study|Global deterioration of health status|18|||
130983112|NCT02684006|471563437|FG001|Overall Study|Global deterioration of health status|20|||
130983113|NCT02684006|471563436|FG000|Overall Study|Physician Decision|15|||
130983114|NCT02684006|471563437|FG001|Overall Study|Physician Decision|8|||
130983115|NCT02684006|471563436|FG000|Overall Study|Adverse Event|86|||
130983116|NCT02684006|471563437|FG001|Overall Study|Adverse Event|65|||
130983117|NCT02684006|471563436|FG000|Overall Study|Withdrawal by Subject|29|||
130983118|NCT02684006|471563437|FG001|Overall Study|Withdrawal by Subject|43|||
130983119|NCT02684006|471563436|FG000|Overall Study|Progressive disease|236|||
130983120|NCT02684006|471563437|FG001|Overall Study|Progressive disease|266|||
130983121|NCT02684006|471563436|FG000|Overall Study|Participation terminated by sponsor|6|||
130983122|NCT02684006|471563437|FG001|Overall Study|Participation terminated by sponsor|9|||
130983123|NCT01368965|471563441|FG000|Overall Study|Lost to Follow-up|12|||
130983124|NCT00569582|471563455|FG000|Overall Study|Withdrawal by Subject|5|||
130983125|NCT00569582|471563455|FG000|Overall Study|Death|2|||
130983126|NCT00569582|471563455|FG000|Overall Study|Adverse Event|7|||
130983127|NCT00569582|471563455|FG000|Overall Study|Subject was too ill to travel.|1|||
130983128|NCT00569582|471563455|FG000|Overall Study|Subject was non-compliant.|1|||
130983129|NCT02355743|471563456|FG000|Overall Study|Withdrawal by Subject|1|||
130983130|NCT02355743|471563456|FG000|Overall Study|Lost to Follow-up|1|||
130983131|NCT00715429|471563462|FG000|Overall Study|Did not complete the study diary|0|||
130983132|NCT00715429|471563463|FG001|Overall Study|Did not complete the study diary|1|||
130983133|NCT04085328|471563464|FG000|Overall Study|Witihdrew Consent|16|||
130983134|NCT04085328|471563465|FG001|Overall Study|Witihdrew Consent|16|||
130983135|NCT04085328|471563464|FG000|Overall Study|Adverse Event|8|||
130983136|NCT04085328|471563465|FG001|Overall Study|Adverse Event|7|||
130983137|NCT04085328|471563464|FG000|Overall Study|Lost to Follow-up|7|||
130983138|NCT04085328|471563465|FG001|Overall Study|Lost to Follow-up|2|||
130983139|NCT04085328|471563464|FG000|Overall Study|Physician Decision|0|||
130983140|NCT04085328|471563465|FG001|Overall Study|Physician Decision|1|||
130983141|NCT04085328|471563464|FG000|Overall Study|Pregnancy|0|||
130983142|NCT04085328|471563465|FG001|Overall Study|Pregnancy|1|||
130983143|NCT04085328|471563464|FG000|Overall Study|Reasons Related to COVID-19|5|||
130983144|NCT04085328|471563465|FG001|Overall Study|Reasons Related to COVID-19|8|||
130983145|NCT04085328|471563464|FG000|Overall Study|Did not meet inclusion criteria|1|||
130983146|NCT04085328|471563465|FG001|Overall Study|Did not meet inclusion criteria|1|||
130983147|NCT04085328|471563464|FG000|Overall Study|Early termination|1|||
130983148|NCT04085328|471563465|FG001|Overall Study|Early termination|0|||
130983149|NCT00514735|471563466|FG000|Overall Study|Withdrawal by Subject|13|||
130983150|NCT00514735|471563467|FG001|Overall Study|Withdrawal by Subject|5|||
130983151|NCT00514735|471563466|FG000|Overall Study|Death|1|||
131044572|NCT03858517|471797561|FG000|Overall Study|Adverse Event|1|||
131044573|NCT03858517|471797561|FG000|Overall Study|Lost to Follow-up|1|||
131044574|NCT03858517|471797561|FG000|Overall Study|removed for being incarcerated|1|||
131044575|NCT03858517|471797561|FG000|Overall Study|Sponsor Closure|48|||
131044576|NCT02828358|471797566|FG000|Overall Study|Physician Decision|7|||
131044577|NCT02828358|471797567|FG001|Overall Study|Physician Decision|1|||
131044578|NCT02828358|471797566|FG000|Overall Study|Treatment Failure|6|||
131044579|NCT02828358|471797567|FG001|Overall Study|Treatment Failure|0|||
131044580|NCT02828358|471797566|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
131044581|NCT02828358|471797567|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
130778836|NCT03428100|470817452|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130983152|NCT00514735|471563467|FG001|Overall Study|Death|0|||
130983153|NCT00514735|471563466|FG000|Overall Study|Lost to Follow-up|0|||
130983154|NCT00514735|471563467|FG001|Overall Study|Lost to Follow-up|1|||
130983155|NCT02782169|471563468|FG000|Overall Study|Lost to Follow-up|1|||
131044582|NCT02828358|471797566|FG000|Overall Study|Refusal of further protocol therapy|2|||
130983156|NCT02782169|471563469|FG001|Overall Study|Lost to Follow-up|2|||
130983157|NCT02975973|471563470|FG000|Overall Study|Adverse Event|1|||
130983158|NCT02975973|471563471|FG001|Overall Study|Adverse Event|1|||
130983159|NCT02975973|471563472|FG002|Overall Study|Adverse Event|1|||
130983160|NCT02975973|471563473|FG003|Overall Study|Adverse Event|0|||
130983161|NCT00771810|471563474|FG000|Overall Study|Adverse Event|3|||
130983162|NCT00771810|471563475|FG001|Overall Study|Adverse Event|0|||
130983163|NCT00771810|471563476|FG002|Overall Study|Adverse Event|2|||
130983164|NCT00771810|471563474|FG000|Overall Study|Lost to Follow-up|0|||
130983165|NCT00771810|471563475|FG001|Overall Study|Lost to Follow-up|0|||
130983166|NCT00771810|471563476|FG002|Overall Study|Lost to Follow-up|1|||
130983167|NCT00771810|471563474|FG000|Overall Study|Physician Decision|1|||
130983168|NCT00771810|471563475|FG001|Overall Study|Physician Decision|2|||
130983169|NCT00771810|471563476|FG002|Overall Study|Physician Decision|2|||
130983170|NCT00771810|471563474|FG000|Overall Study|Protocol Violation|0|||
130983171|NCT00771810|471563475|FG001|Overall Study|Protocol Violation|1|||
130983172|NCT00771810|471563476|FG002|Overall Study|Protocol Violation|1|||
130983173|NCT00771810|471563474|FG000|Overall Study|Withdrawal by Subject|1|||
130983174|NCT00771810|471563475|FG001|Overall Study|Withdrawal by Subject|2|||
130983175|NCT00771810|471563476|FG002|Overall Study|Withdrawal by Subject|0|||
130983176|NCT00771810|471563474|FG000|Overall Study|Other|0|||
130983177|NCT00771810|471563475|FG001|Overall Study|Other|0|||
130983178|NCT00771810|471563476|FG002|Overall Study|Other|1|||
130983179|NCT00045305|471563482|FG000|Overall Study|Lack of Efficacy|6|||
130983180|NCT00045305|471563482|FG000|Overall Study|Adverse Event|3|||
130983181|NCT00045305|471563482|FG000|Overall Study|Death|3|||
130983182|NCT00045305|471563482|FG000|Overall Study|site error|2|||
130983183|NCT01936857|471563488|FG000|Overall Study|Sent to prison or 06 center|11|||
130983184|NCT01936857|471563489|FG001|Overall Study|Sent to prison or 06 center|12|||
130983185|NCT01936857|471563488|FG000|Overall Study|Lost to Follow-up|10|||
130983186|NCT01936857|471563489|FG001|Overall Study|Lost to Follow-up|7|||
130983187|NCT01936857|471563488|FG000|Overall Study|Death|7|||
130983188|NCT01936857|471563489|FG001|Overall Study|Death|3|||
130983189|NCT01936857|471563488|FG000|Overall Study|Moved|2|||
130983190|NCT01936857|471563489|FG001|Overall Study|Moved|1|||
130983191|NCT01936857|471563488|FG000|Overall Study|Withdrawal by Subject|1|||
130983192|NCT01936857|471563489|FG001|Overall Study|Withdrawal by Subject|0|||
130983193|NCT01936857|471563488|FG000|Overall Study|Side effect of medication|1|||
130983194|NCT01936857|471563489|FG001|Overall Study|Side effect of medication|0|||
130983195|NCT01936857|471563488|FG000|Overall Study|Other|2|||
130983196|NCT01936857|471563489|FG001|Overall Study|Other|2|||
130983197|NCT03848403|471563490|FG000|Period 2 (Day 8)|Adverse Event|1|||
130983198|NCT03848403|471563491|FG001|Period 2 (Day 8)|Adverse Event|2|||
130983199|NCT03848403|471563492|FG002|Period 2 (Day 8)|Adverse Event|2|||
130983200|NCT03848403|471563490|FG000|Period 2 (Day 8)|Physician Decision|0|||
130983201|NCT03848403|471563491|FG001|Period 2 (Day 8)|Physician Decision|1|||
130983202|NCT03848403|471563492|FG002|Period 2 (Day 8)|Physician Decision|0|||
130983203|NCT03848403|471563490|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
130983204|NCT03848403|471563491|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
130983205|NCT03848403|471563492|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
130983206|NCT02279043|471563493|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
130983207|NCT02279043|471563494|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
130983208|NCT02279043|471563495|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
130983209|NCT02279043|471563493|FG000|Overall Study|Lost to Follow-up|46|||
131133175|NCT01471782|472113921|FG001|Overall Study|Change of Chemotherapy|1|||
131133176|NCT01471782|472113922|FG002|Overall Study|Change of Chemotherapy|0|||
131133177|NCT01471782|472113923|FG003|Overall Study|Change of Chemotherapy|0|||
131133178|NCT01471782|472113924|FG004|Overall Study|Change of Chemotherapy|1|||
131133179|NCT01471782|472113925|FG005|Overall Study|Change of Chemotherapy|4|||
131133180|NCT01471782|472113920|FG000|Overall Study|Disease Relapse|0|||
131133181|NCT01471782|472113921|FG001|Overall Study|Disease Relapse|0|||
130719113|NCT04645966|470597334|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
130719114|NCT04645966|470597326|FG000|Follow-up Phase|Lost to Follow-up|0|||
130719115|NCT04645966|470597327|FG001|Follow-up Phase|Lost to Follow-up|0|||
130983210|NCT02279043|471563494|FG001|Overall Study|Lost to Follow-up|88|||
130983211|NCT02279043|471563495|FG002|Overall Study|Lost to Follow-up|0|||
130983212|NCT01939548|471563496|FG000|Overall Study|Non compliance|0|||
130983213|NCT01939548|471563497|FG001|Overall Study|Non compliance|2|||
130983214|NCT01939548|471563498|FG002|Overall Study|Non compliance|0|||
130983215|NCT01939548|471563496|FG000|Overall Study|Study Terminated by Sponsor|17|||
131133182|NCT01471782|472113922|FG002|Overall Study|Disease Relapse|0|||
130719116|NCT04645966|470597328|FG002|Follow-up Phase|Lost to Follow-up|0|||
130719117|NCT04645966|470597329|FG003|Follow-up Phase|Lost to Follow-up|0|||
130983216|NCT01939548|471563497|FG001|Overall Study|Study Terminated by Sponsor|19|||
130983217|NCT01939548|471563498|FG002|Overall Study|Study Terminated by Sponsor|12|||
130983218|NCT01939548|471563496|FG000|Overall Study|Insufficient Clinical Response|1|||
130983219|NCT01939548|471563497|FG001|Overall Study|Insufficient Clinical Response|0|||
130983220|NCT01939548|471563498|FG002|Overall Study|Insufficient Clinical Response|0|||
131133183|NCT01471782|472113923|FG003|Overall Study|Disease Relapse|1|||
131133184|NCT01471782|472113924|FG004|Overall Study|Disease Relapse|2|||
130983221|NCT01939548|471563496|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
130983222|NCT01939548|471563497|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
130983223|NCT01939548|471563498|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
130983224|NCT01939548|471563496|FG000|Overall Study|Withdrawal by Subject|4|||
130983225|NCT01939548|471563497|FG001|Overall Study|Withdrawal by Subject|4|||
130983226|NCT01939548|471563498|FG002|Overall Study|Withdrawal by Subject|1|||
130983227|NCT01939548|471563496|FG000|Overall Study|Protocol Violation|7|||
130983228|NCT01939548|471563497|FG001|Overall Study|Protocol Violation|6|||
130983229|NCT01939548|471563498|FG002|Overall Study|Protocol Violation|5|||
130983230|NCT01939548|471563496|FG000|Overall Study|Lost to Follow-up|5|||
130983231|NCT01939548|471563497|FG001|Overall Study|Lost to Follow-up|5|||
130983232|NCT01939548|471563498|FG002|Overall Study|Lost to Follow-up|3|||
130983233|NCT01939548|471563496|FG000|Overall Study|Adverse Event|2|||
130983234|NCT01939548|471563497|FG001|Overall Study|Adverse Event|9|||
130983235|NCT01939548|471563498|FG002|Overall Study|Adverse Event|7|||
130983236|NCT01939548|471563496|FG000|Overall Study|Death|0|||
130983237|NCT01939548|471563497|FG001|Overall Study|Death|0|||
130983238|NCT01939548|471563498|FG002|Overall Study|Death|1|||
130983239|NCT01939548|471563496|FG000|Overall Study|Participant dropped|0|||
130983240|NCT01939548|471563497|FG001|Overall Study|Participant dropped|0|||
130983241|NCT01939548|471563498|FG002|Overall Study|Participant dropped|1|||
130983242|NCT01939548|471563496|FG000|Overall Study|Participant unwilling to continue|0|||
130983243|NCT01939548|471563497|FG001|Overall Study|Participant unwilling to continue|1|||
130983244|NCT01939548|471563498|FG002|Overall Study|Participant unwilling to continue|0|||
130983245|NCT01939548|471563496|FG000|Overall Study|Participant withdrew consent|0|||
130983246|NCT01939548|471563497|FG001|Overall Study|Participant withdrew consent|2|||
130983247|NCT01939548|471563498|FG002|Overall Study|Participant withdrew consent|0|||
130983248|NCT01939548|471563496|FG000|Overall Study|Did not complete follow-up|0|||
130983249|NCT01939548|471563497|FG001|Overall Study|Did not complete follow-up|1|||
130983250|NCT01939548|471563498|FG002|Overall Study|Did not complete follow-up|0|||
130983251|NCT02124265|471563499|FG000|Overall Study|Adverse Event|1|||
130983252|NCT00490282|471563500|FG000|Overall Study|Withdrawal by Subject|3|||
130983253|NCT02114151|471563508|FG000|Overall Study|Death|1|||
130983254|NCT02114151|471563508|FG000|Overall Study|Lost to Follow-up|1|||
130983255|NCT02114151|471563508|FG000|Overall Study|Withdrawal by Subject|5|||
130983256|NCT01337674|471564868|FG000|Treatment Period 1|Adverse Event|0|||
130983257|NCT01337674|471564869|FG001|Treatment Period 1|Adverse Event|1|||
130983258|NCT01337674|471564870|FG002|Treatment Period 1|Adverse Event|0|||
130983259|NCT01337674|471564871|FG003|Treatment Period 1|Adverse Event|0|||
130983260|NCT01337674|471564868|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
130983261|NCT01337674|471564869|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
130983262|NCT01337674|471564870|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
130983263|NCT01337674|471564871|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
130983264|NCT01337674|471564868|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130983265|NCT01337674|471564869|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130983266|NCT01337674|471564870|FG002|Treatment Period 2|Withdrawal by Subject|1|||
130983267|NCT01337674|471564871|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130983268|NCT01203930|471564872|FG000|Overall Study|Disease Progression|0|||
130983269|NCT01203930|471564873|FG001|Overall Study|Disease Progression|4|||
130983270|NCT01203930|471564872|FG000|Overall Study|Death|3|||
130983271|NCT01203930|471564873|FG001|Overall Study|Death|1|||
130983272|NCT01203930|471564872|FG000|Overall Study|Withdrew Consent|1|||
130983273|NCT01203930|471564873|FG001|Overall Study|Withdrew Consent|10|||
130983274|NCT01203930|471564872|FG000|Overall Study|Investigator Request|0|||
130983275|NCT01203930|471564873|FG001|Overall Study|Investigator Request|8|||
130983276|NCT01203930|471564872|FG000|Overall Study|Study Terminated by Sponsor|0|||
130983277|NCT01203930|471564873|FG001|Overall Study|Study Terminated by Sponsor|12|||
130983278|NCT01203930|471564872|FG000|Overall Study|Poor tolerance of study drug|0|||
130983279|NCT01203930|471564873|FG001|Overall Study|Poor tolerance of study drug|1|||
130983280|NCT01203930|471564872|FG000|Overall Study|Adverse Event|17|||
130983281|NCT01203930|471564873|FG001|Overall Study|Adverse Event|5|||
130983282|NCT02178059|471564874|FG000|Washout|Physician Decision|1|||
130983283|NCT02178059|471564875|FG001|Washout|Physician Decision|0|||
130983284|NCT05178121|471564876|FG000|Overall Study|Other|4|||
130983285|NCT05178121|471564876|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
130983286|NCT00838682|471564880|FG000|Overall Study|Lost to Follow-up|21|||
130983287|NCT00838682|471564881|FG001|Overall Study|Lost to Follow-up|14|||
130983288|NCT00838682|471564880|FG000|Overall Study|detection of exclusion criteria|4|||
130983289|NCT00838682|471564881|FG001|Overall Study|detection of exclusion criteria|3|||
130983290|NCT00838682|471564880|FG000|Overall Study|Protocol Violation|0|||
130983291|NCT00838682|471564881|FG001|Overall Study|Protocol Violation|1|||
130983292|NCT00838682|471564880|FG000|Overall Study|Withdrawal by Subject|0|||
131044583|NCT02828358|471797567|FG001|Overall Study|Refusal of further protocol therapy|0|||
130983293|NCT00838682|471564881|FG001|Overall Study|Withdrawal by Subject|1|||
130983294|NCT00989092|471564884|FG000|Overall Study|Physician Decision|9|||
130983295|NCT00989092|471564885|FG001|Overall Study|Physician Decision|6|||
130983296|NCT00989092|471564884|FG000|Overall Study|Adverse Event|20|||
131228412|NCT01405820|472463225|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
131228413|NCT01405820|472463226|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
131228414|NCT01405820|472463227|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
131228415|NCT01405820|472463228|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
131228416|NCT01405820|472463229|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
131228417|NCT01405820|472463224|FG000|Randomized Treatment Period|Other|2|||
131228418|NCT01405820|472463225|FG001|Randomized Treatment Period|Other|2|||
131228419|NCT01405820|472463226|FG002|Randomized Treatment Period|Other|1|||
131228420|NCT01405820|472463227|FG003|Randomized Treatment Period|Other|1|||
131228421|NCT01405820|472463228|FG004|Randomized Treatment Period|Other|0|||
131228422|NCT01405820|472463229|FG005|Randomized Treatment Period|Other|0|||
131228423|NCT01405820|472463224|FG000|Randomized Treatment Period|Physician Decision|0|||
131228424|NCT01405820|472463225|FG001|Randomized Treatment Period|Physician Decision|2|||
131228425|NCT01405820|472463226|FG002|Randomized Treatment Period|Physician Decision|1|||
131228426|NCT01405820|472463227|FG003|Randomized Treatment Period|Physician Decision|0|||
131228427|NCT01405820|472463228|FG004|Randomized Treatment Period|Physician Decision|0|||
131228428|NCT01405820|472463229|FG005|Randomized Treatment Period|Physician Decision|0|||
131228429|NCT01405820|472463224|FG000|Randomized Treatment Period|Rescue|0|||
131228430|NCT01405820|472463225|FG001|Randomized Treatment Period|Rescue|1|||
131228431|NCT01405820|472463226|FG002|Randomized Treatment Period|Rescue|13|||
131228432|NCT01405820|472463227|FG003|Randomized Treatment Period|Rescue|10|||
131228433|NCT01405820|472463228|FG004|Randomized Treatment Period|Rescue|8|||
131228434|NCT01405820|472463229|FG005|Randomized Treatment Period|Rescue|8|||
131228435|NCT01405820|472463224|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
131228436|NCT01405820|472463225|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
131228437|NCT01405820|472463226|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
131228438|NCT01405820|472463227|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
131228439|NCT01405820|472463228|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
131228440|NCT01405820|472463229|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
131228441|NCT01405820|472463224|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
131228442|NCT01405820|472463225|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
131228443|NCT01405820|472463226|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
131228444|NCT01405820|472463227|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
131228445|NCT01405820|472463228|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
131228446|NCT01405820|472463229|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
131228447|NCT01405820|472463224|FG000|Randomized Treatment Period|Death|0|||
131228448|NCT01405820|472463225|FG001|Randomized Treatment Period|Death|0|||
131228449|NCT01405820|472463226|FG002|Randomized Treatment Period|Death|0|||
131228450|NCT01405820|472463227|FG003|Randomized Treatment Period|Death|1|||
131228451|NCT01405820|472463228|FG004|Randomized Treatment Period|Death|0|||
131228452|NCT01405820|472463229|FG005|Randomized Treatment Period|Death|0|||
131228453|NCT01405820|472463224|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130983297|NCT00989092|471564885|FG001|Overall Study|Adverse Event|1|||
130983298|NCT00989092|471564884|FG000|Overall Study|Chemotherapy initiated|12|||
130983299|NCT00989092|471564885|FG001|Overall Study|Chemotherapy initiated|4|||
130983300|NCT00989092|471564884|FG000|Overall Study|Withdrawal by Subject|17|||
130983301|NCT00989092|471564885|FG001|Overall Study|Withdrawal by Subject|9|||
130983302|NCT00989092|471564884|FG000|Overall Study|Death|14|||
130983303|NCT00989092|471564885|FG001|Overall Study|Death|2|||
130983304|NCT00989092|471564884|FG000|Overall Study|Ineligibility determined|3|||
130983305|NCT00989092|471564885|FG001|Overall Study|Ineligibility determined|3|||
130983306|NCT00989092|471564884|FG000|Overall Study|Lost to Follow-up|6|||
130983307|NCT00989092|471564885|FG001|Overall Study|Lost to Follow-up|2|||
130983308|NCT00989092|471564884|FG000|Overall Study|Other|3|||
131228454|NCT01405820|472463225|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130983309|NCT00989092|471564885|FG001|Overall Study|Other|1|||
131228455|NCT01405820|472463226|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
131228456|NCT01405820|472463227|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
131228457|NCT01405820|472463228|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
131228458|NCT01405820|472463229|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
131228459|NCT01405820|472463224|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
131228460|NCT01405820|472463225|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
131228461|NCT01405820|472463226|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
131228462|NCT01405820|472463227|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
130983310|NCT00989092|471564884|FG000|Overall Study|Protocol deviation|2|||
131228463|NCT01405820|472463228|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
131228464|NCT01405820|472463229|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
131228465|NCT01405820|472463224|FG000|Open-Label Treatment Period|Other|1|||
131228466|NCT01405820|472463225|FG001|Open-Label Treatment Period|Other|1|||
131228467|NCT01405820|472463226|FG002|Open-Label Treatment Period|Other|1|||
131228468|NCT01405820|472463227|FG003|Open-Label Treatment Period|Other|1|||
130983311|NCT00989092|471564885|FG001|Overall Study|Protocol deviation|0|||
130983312|NCT00989092|471564884|FG000|Overall Study|Erythropoietin therapy initiated|2|||
130983313|NCT00989092|471564885|FG001|Overall Study|Erythropoietin therapy initiated|0|||
130983314|NCT00989092|471564884|FG000|Overall Study|Did not receive study drug|2|||
130983315|NCT00989092|471564885|FG001|Overall Study|Did not receive study drug|0|||
130983316|NCT04098406|471564888|FG000|Overall Study|Adverse Event|2|||
130983317|NCT04098406|471564889|FG001|Overall Study|Adverse Event|1|||
130983318|NCT04098406|471564888|FG000|Overall Study|Withdrawal by Subject|1|||
130983319|NCT04098406|471564889|FG001|Overall Study|Withdrawal by Subject|0|||
130983320|NCT02173548|471564890|FG000|Overall Study|Lost to Follow-up|0|||
130983321|NCT02173548|471564891|FG001|Overall Study|Lost to Follow-up|2|||
130983322|NCT02173548|471564890|FG000|Overall Study|Withdrawal by Subject|1|||
130983323|NCT02173548|471564891|FG001|Overall Study|Withdrawal by Subject|0|||
130983324|NCT00415610|471564895|FG000|Overall Study|Death|3|||
130983325|NCT00415610|471564896|FG001|Overall Study|Death|2|||
130983326|NCT00415610|471564897|FG002|Overall Study|Death|5|||
130983327|NCT04539821|471564900|FG000|Overall Study|Withdrawal by Subject|2|||
130983328|NCT04539821|471564900|FG000|Overall Study|continued care with their physician|20|||
130983329|NCT04539821|471564900|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
130983330|NCT02691182|471564901|FG000|Overall Study|Withdrawal by Subject|4|||
131044584|NCT02828358|471797566|FG000|Overall Study|Relapse|25|||
131044585|NCT02828358|471797567|FG001|Overall Study|Relapse|0|||
131044586|NCT02828358|471797566|FG000|Overall Study|Still on therapy|5|||
131044587|NCT02828358|471797567|FG001|Overall Study|Still on therapy|0|||
131044588|NCT03717935|471797568|FG000|Overall Study|Withdrawal by Subject|0|||
130719118|NCT04645966|470597330|FG004|Follow-up Phase|Lost to Follow-up|0|||
130719119|NCT04645966|470597331|FG005|Follow-up Phase|Lost to Follow-up|0|||
130719120|NCT04645966|470597332|FG006|Follow-up Phase|Lost to Follow-up|0|||
130719121|NCT04645966|470597333|FG007|Follow-up Phase|Lost to Follow-up|1|||
130719122|NCT04645966|470597334|FG008|Follow-up Phase|Lost to Follow-up|0|||
130719123|NCT02116608|470597336|FG000|Overall Study|Lost to Follow-up|0|||
130719124|NCT02116608|470597337|FG001|Overall Study|Lost to Follow-up|0|||
130719125|NCT02116608|470597338|FG002|Overall Study|Lost to Follow-up|1|||
130719126|NCT02116608|470597336|FG000|Overall Study|Physician Decision|0|||
130719127|NCT02116608|470597337|FG001|Overall Study|Physician Decision|1|||
130719128|NCT02116608|470597338|FG002|Overall Study|Physician Decision|0|||
130719129|NCT02116608|470597336|FG000|Overall Study|Death|0|||
130719130|NCT02116608|470597337|FG001|Overall Study|Death|1|||
130719131|NCT02116608|470597338|FG002|Overall Study|Death|0|||
130719132|NCT01468818|470597342|FG000|Overall Study|Death during treatment|2|||
130719133|NCT01212588|470597343|FG000|Overall Study|Physician Decision|0|||
130719134|NCT01212588|470597344|FG001|Overall Study|Physician Decision|1|||
130719135|NCT01212588|470597343|FG000|Overall Study|Protocol Violation|1|||
130719136|NCT01212588|470597344|FG001|Overall Study|Protocol Violation|1|||
130719137|NCT01059344|470597345|FG000|Overall Study|Adverse Event|12|||
130983331|NCT02691182|471564902|FG001|Overall Study|Withdrawal by Subject|7|||
130983332|NCT02691182|471564903|FG002|Overall Study|Withdrawal by Subject|6|||
130983333|NCT02691182|471564904|FG003|Overall Study|Withdrawal by Subject|8|||
131044589|NCT03717935|471797569|FG001|Overall Study|Withdrawal by Subject|2|||
131044590|NCT02990338|471797574|FG000|Overall Study|Randomized and not treated|4|||
131044591|NCT02990338|471797575|FG001|Overall Study|Randomized and not treated|2|||
131044592|NCT02990338|471797574|FG000|Overall Study|Adverse Event|23|||
131044593|NCT02990338|471797575|FG001|Overall Study|Adverse Event|22|||
131044594|NCT02990338|471797574|FG000|Overall Study|Progressive disease|118|||
131044595|NCT02990338|471797575|FG001|Overall Study|Progressive disease|107|||
131044596|NCT02990338|471797574|FG000|Overall Study|Poor compliance to protocol|0|||
131044597|NCT02990338|471797575|FG001|Overall Study|Poor compliance to protocol|1|||
131044598|NCT02990338|471797574|FG000|Overall Study|Withdrawal by Subject|6|||
131044599|NCT02990338|471797575|FG001|Overall Study|Withdrawal by Subject|8|||
131044600|NCT02990338|471797574|FG000|Overall Study|Physician's decision|2|||
131044601|NCT02990338|471797575|FG001|Overall Study|Physician's decision|6|||
131044602|NCT02990338|471797574|FG000|Overall Study|Treatment extension study|0|||
131044603|NCT02990338|471797575|FG001|Overall Study|Treatment extension study|6|||
131044604|NCT02990338|471797574|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
131044605|NCT02990338|471797575|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
131044606|NCT02990338|471797574|FG000|Overall Study|Continue with therapy available commercially|0|||
131044607|NCT02990338|471797575|FG001|Overall Study|Continue with therapy available commercially|1|||
131044608|NCT04479761|471797577|FG000|Overall Study|could not perform the balance tasks|1|||
131133185|NCT01471782|472113925|FG005|Overall Study|Disease Relapse|1|||
130719138|NCT01059344|470597346|FG001|Overall Study|Adverse Event|30|||
130983334|NCT02691182|471564901|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
130983335|NCT02691182|471564902|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
130983336|NCT02691182|471564903|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
131044609|NCT04479761|471797578|FG001|Overall Study|could not perform the balance tasks|0|||
131044610|NCT04479761|471797579|FG002|Overall Study|could not perform the balance tasks|0|||
131044611|NCT04479761|471797577|FG000|Overall Study|Adverse Event|1|||
130719139|NCT01059344|470597345|FG000|Overall Study|Withdrawal by Subject|6|||
130719140|NCT01059344|470597346|FG001|Overall Study|Withdrawal by Subject|9|||
130719141|NCT01059344|470597345|FG000|Overall Study|Lost to Follow-up|1|||
130719142|NCT01059344|470597346|FG001|Overall Study|Lost to Follow-up|1|||
130983337|NCT02691182|471564904|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
130983338|NCT02691182|471564901|FG000|Overall Study|Lost to Follow-up|8|||
130983339|NCT02691182|471564902|FG001|Overall Study|Lost to Follow-up|33|||
130983340|NCT02691182|471564903|FG002|Overall Study|Lost to Follow-up|19|||
130983341|NCT02691182|471564904|FG003|Overall Study|Lost to Follow-up|22|||
130983342|NCT02691182|471564901|FG000|Overall Study|Adverse Event|3|||
130983343|NCT02691182|471564902|FG001|Overall Study|Adverse Event|10|||
130983344|NCT02691182|471564903|FG002|Overall Study|Adverse Event|10|||
130983345|NCT02691182|471564904|FG003|Overall Study|Adverse Event|11|||
130983346|NCT02691182|471564901|FG000|Overall Study|Physician Decision|3|||
130983347|NCT02691182|471564902|FG001|Overall Study|Physician Decision|7|||
130983348|NCT02691182|471564903|FG002|Overall Study|Physician Decision|14|||
130983349|NCT02691182|471564904|FG003|Overall Study|Physician Decision|8|||
130983350|NCT02691182|471564901|FG000|Overall Study|Lack of Efficacy|0|||
130983351|NCT02691182|471564902|FG001|Overall Study|Lack of Efficacy|0|||
130983352|NCT02691182|471564903|FG002|Overall Study|Lack of Efficacy|0|||
130983353|NCT02691182|471564904|FG003|Overall Study|Lack of Efficacy|4|||
130983354|NCT02691182|471564901|FG000|Overall Study|Protocol Violation|2|||
130983355|NCT02691182|471564902|FG001|Overall Study|Protocol Violation|6|||
130983356|NCT02691182|471564903|FG002|Overall Study|Protocol Violation|6|||
130983357|NCT02691182|471564904|FG003|Overall Study|Protocol Violation|8|||
130983358|NCT02691182|471564901|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
130719143|NCT01059344|470597345|FG000|Overall Study|Other|3|||
130719144|NCT01059344|470597346|FG001|Overall Study|Other|6|||
130719145|NCT01739348|470597347|FG000|Part I (Base Study)|Adverse Event|41|||
130983359|NCT02691182|471564902|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
130983360|NCT02691182|471564903|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
130983361|NCT02691182|471564904|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
130983362|NCT02691182|471564901|FG000|Overall Study|Missing|0|||
130983363|NCT02691182|471564902|FG001|Overall Study|Missing|5|||
130983364|NCT02691182|471564903|FG002|Overall Study|Missing|1|||
130983365|NCT02691182|471564904|FG003|Overall Study|Missing|5|||
130983366|NCT00645164|471564905|FG000|Overall Study|Lost to Follow-up|2|||
130983367|NCT00645164|471564905|FG000|Overall Study|Withdrawal by Subject|4|||
130719146|NCT01739348|470597348|FG001|Part I (Base Study)|Adverse Event|52|||
130719147|NCT01739348|470597349|FG002|Part I (Base Study)|Adverse Event|8|||
130719148|NCT01739348|470597350|FG003|Part I (Base Study)|Adverse Event|33|||
130719149|NCT01739348|470597347|FG000|Part I (Base Study)|Death|10|||
130719150|NCT01739348|470597348|FG001|Part I (Base Study)|Death|7|||
130719151|NCT01739348|470597349|FG002|Part I (Base Study)|Death|2|||
130719152|NCT01739348|470597350|FG003|Part I (Base Study)|Death|8|||
130719153|NCT01739348|470597347|FG000|Part I (Base Study)|Lack of Efficacy|3|||
130719154|NCT01739348|470597348|FG001|Part I (Base Study)|Lack of Efficacy|8|||
130719155|NCT01739348|470597349|FG002|Part I (Base Study)|Lack of Efficacy|0|||
130719156|NCT01739348|470597350|FG003|Part I (Base Study)|Lack of Efficacy|7|||
130719157|NCT01739348|470597347|FG000|Part I (Base Study)|Lost to Follow-up|4|||
130719158|NCT01739348|470597348|FG001|Part I (Base Study)|Lost to Follow-up|2|||
130719159|NCT01739348|470597349|FG002|Part I (Base Study)|Lost to Follow-up|4|||
130719160|NCT01739348|470597350|FG003|Part I (Base Study)|Lost to Follow-up|4|||
130719161|NCT01739348|470597347|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
130719162|NCT01739348|470597348|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
130719163|NCT01739348|470597349|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
130983368|NCT00645164|471564905|FG000|Overall Study|Protocol Violation|1|||
130983369|NCT00117676|471564906|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
130983370|NCT00117676|471564907|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
131044612|NCT04479761|471797578|FG001|Overall Study|Adverse Event|0|||
131044613|NCT04479761|471797579|FG002|Overall Study|Adverse Event|0|||
131044614|NCT04479761|471797577|FG000|Overall Study|one control did not meet screening criteria|0|||
130719164|NCT01739348|470597350|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
130719165|NCT01739348|470597347|FG000|Part I (Base Study)|Physician Decision|10|||
130719166|NCT01739348|470597348|FG001|Part I (Base Study)|Physician Decision|7|||
131044615|NCT04479761|471797578|FG001|Overall Study|one control did not meet screening criteria|0|||
131044616|NCT04479761|471797579|FG002|Overall Study|one control did not meet screening criteria|1|||
131044617|NCT04479761|471797577|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
131044618|NCT04479761|471797578|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
131044619|NCT04479761|471797579|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
131044620|NCT04186819|471797580|FG000|Overall Study|Adverse Event|1|||
131044621|NCT04186819|471797580|FG000|Overall Study|Lost to Follow-up|1|||
131044622|NCT04186819|471797580|FG000|Overall Study|Opted for EBRT|1|||
131044623|NCT04186819|471797580|FG000|Overall Study|Opted SBRT|1|||
131044624|NCT04186819|471797580|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
131044625|NCT04186819|471797580|FG000|Overall Study|Physician Decision|1|||
131228469|NCT01405820|472463228|FG004|Open-Label Treatment Period|Other|1|||
131228470|NCT01405820|472463229|FG005|Open-Label Treatment Period|Other|1|||
131228471|NCT01405820|472463224|FG000|Open-Label Treatment Period|Physician Decision|0|||
131228472|NCT01405820|472463225|FG001|Open-Label Treatment Period|Physician Decision|0|||
131228473|NCT01405820|472463226|FG002|Open-Label Treatment Period|Physician Decision|1|||
130983371|NCT00117676|471564906|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
130983372|NCT00117676|471564907|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
130983373|NCT00117676|471564906|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
130983374|NCT00117676|471564907|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
130983375|NCT00117676|471564906|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
130983376|NCT00117676|471564907|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
130983377|NCT00117676|471564906|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
130983378|NCT00117676|471564907|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
131228474|NCT01405820|472463227|FG003|Open-Label Treatment Period|Physician Decision|2|||
131228475|NCT01405820|472463228|FG004|Open-Label Treatment Period|Physician Decision|1|||
131228476|NCT01405820|472463229|FG005|Open-Label Treatment Period|Physician Decision|0|||
131228477|NCT01405820|472463224|FG000|Open-Label Treatment Period|Adverse Event|0|||
131228478|NCT01405820|472463225|FG001|Open-Label Treatment Period|Adverse Event|0|||
131228479|NCT01405820|472463226|FG002|Open-Label Treatment Period|Adverse Event|0|||
131228480|NCT01405820|472463227|FG003|Open-Label Treatment Period|Adverse Event|1|||
131228481|NCT01405820|472463228|FG004|Open-Label Treatment Period|Adverse Event|0|||
131228482|NCT01405820|472463229|FG005|Open-Label Treatment Period|Adverse Event|0|||
131228483|NCT01418352|472463236|FG000|Overall Study|Lost to Follow-up|2|||
131228484|NCT01418352|472463237|FG001|Overall Study|Lost to Follow-up|0|||
131228485|NCT01418352|472463238|FG002|Overall Study|Lost to Follow-up|0|||
131228486|NCT01418352|472463239|FG003|Overall Study|Lost to Follow-up|0|||
131228487|NCT01418352|472463236|FG000|Overall Study|Adverse Event|0|||
131228488|NCT01418352|472463237|FG001|Overall Study|Adverse Event|1|||
131228489|NCT01418352|472463238|FG002|Overall Study|Adverse Event|0|||
131228490|NCT01418352|472463239|FG003|Overall Study|Adverse Event|0|||
131228491|NCT01418352|472463236|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
131228492|NCT01418352|472463237|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
131228493|NCT01418352|472463238|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
130983379|NCT00117676|471564906|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
130983380|NCT00117676|471564907|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
131228494|NCT01418352|472463239|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
131228495|NCT01418352|472463236|FG000|Overall Study|Subject Withdrew Consent|0|||
131228496|NCT01418352|472463237|FG001|Overall Study|Subject Withdrew Consent|1|||
131228497|NCT01418352|472463238|FG002|Overall Study|Subject Withdrew Consent|2|||
131228498|NCT01418352|472463239|FG003|Overall Study|Subject Withdrew Consent|1|||
131228499|NCT01418352|472463236|FG000|Overall Study|Protocol Deviation|0|||
131228500|NCT01418352|472463237|FG001|Overall Study|Protocol Deviation|0|||
131228501|NCT01418352|472463238|FG002|Overall Study|Protocol Deviation|1|||
131228502|NCT01418352|472463239|FG003|Overall Study|Protocol Deviation|0|||
131228503|NCT01418352|472463236|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
131228504|NCT01418352|472463237|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
131228505|NCT01418352|472463238|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
131228506|NCT01418352|472463239|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
131228507|NCT00619619|472463240|FG000|Overall Study|Physician Decision|0|||
131228508|NCT00619619|472463241|FG001|Overall Study|Physician Decision|0|||
131228509|NCT00619619|472463242|FG002|Overall Study|Physician Decision|1|||
131228510|NCT00619619|472463243|FG003|Overall Study|Physician Decision|0|||
131228511|NCT00619619|472463244|FG004|Overall Study|Physician Decision|0|||
131228512|NCT00619619|472463245|FG005|Overall Study|Physician Decision|0|||
131228513|NCT00619619|472463246|FG006|Overall Study|Physician Decision|0|||
131228514|NCT00619619|472463247|FG007|Overall Study|Physician Decision|0|||
131228515|NCT00619619|472463240|FG000|Overall Study|Protocol Violation|0|||
131228516|NCT00619619|472463241|FG001|Overall Study|Protocol Violation|0|||
131228517|NCT00619619|472463242|FG002|Overall Study|Protocol Violation|0|||
130983381|NCT00117676|471564906|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
130983382|NCT00117676|471564907|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
130983383|NCT00117676|471564906|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
131228518|NCT00619619|472463243|FG003|Overall Study|Protocol Violation|1|||
130983384|NCT00117676|471564907|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
130983385|NCT00117676|471564906|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
130983386|NCT00117676|471564907|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
130983387|NCT00117676|471564906|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
130983388|NCT00117676|471564907|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
130983389|NCT00117676|471564906|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
131228519|NCT00619619|472463244|FG004|Overall Study|Protocol Violation|0|||
131228520|NCT00619619|472463245|FG005|Overall Study|Protocol Violation|0|||
131228521|NCT00619619|472463246|FG006|Overall Study|Protocol Violation|1|||
131228522|NCT00619619|472463247|FG007|Overall Study|Protocol Violation|1|||
131228523|NCT00619619|472463240|FG000|Overall Study|Adverse Event|0|||
131228524|NCT00619619|472463241|FG001|Overall Study|Adverse Event|0|||
131228525|NCT00619619|472463242|FG002|Overall Study|Adverse Event|0|||
131228526|NCT00619619|472463243|FG003|Overall Study|Adverse Event|0|||
131228527|NCT00619619|472463244|FG004|Overall Study|Adverse Event|2|||
131228528|NCT00619619|472463245|FG005|Overall Study|Adverse Event|0|||
131228529|NCT00619619|472463246|FG006|Overall Study|Adverse Event|0|||
131228530|NCT00619619|472463247|FG007|Overall Study|Adverse Event|2|||
131228531|NCT01092702|472463248|FG000|Overall Study|Withdrawal by Subject|7|||
131228532|NCT01092702|472463248|FG000|Overall Study|Lost to Follow-up|2|||
131228533|NCT03263819|472463249|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
131228534|NCT03263819|472463250|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
131228535|NCT01271933|472463262|FG000|Single-Blind Phase|Lack of Efficacy|37|||
130719167|NCT01739348|470597349|FG002|Part I (Base Study)|Physician Decision|1|||
130719168|NCT01739348|470597350|FG003|Part I (Base Study)|Physician Decision|4|||
130719169|NCT01739348|470597347|FG000|Part I (Base Study)|Protocol Violation|2|||
130719170|NCT01739348|470597348|FG001|Part I (Base Study)|Protocol Violation|0|||
130719171|NCT01739348|470597349|FG002|Part I (Base Study)|Protocol Violation|1|||
130719172|NCT01739348|470597350|FG003|Part I (Base Study)|Protocol Violation|2|||
130719173|NCT01739348|470597347|FG000|Part I (Base Study)|Screen Failure|2|||
130719174|NCT01739348|470597348|FG001|Part I (Base Study)|Screen Failure|0|||
130719175|NCT01739348|470597349|FG002|Part I (Base Study)|Screen Failure|0|||
130719176|NCT01739348|470597350|FG003|Part I (Base Study)|Screen Failure|0|||
130719177|NCT01739348|470597347|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
130719178|NCT01739348|470597348|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
130719179|NCT01739348|470597349|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
130719180|NCT01739348|470597350|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
130719181|NCT01739348|470597347|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
130719182|NCT01739348|470597348|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
130719183|NCT01739348|470597349|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
130719184|NCT01739348|470597350|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
130719185|NCT01739348|470597347|FG000|Part I (Base Study)|Participant Moved|4|||
130719186|NCT01739348|470597348|FG001|Part I (Base Study)|Participant Moved|3|||
130719187|NCT01739348|470597349|FG002|Part I (Base Study)|Participant Moved|1|||
130719188|NCT01739348|470597350|FG003|Part I (Base Study)|Participant Moved|7|||
130719189|NCT01739348|470597347|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
130719190|NCT01739348|470597348|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
130719191|NCT01739348|470597349|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
130719192|NCT01739348|470597350|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
130719193|NCT01739348|470597347|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
130719194|NCT01739348|470597348|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
130719195|NCT01739348|470597349|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
130719196|NCT01739348|470597350|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
130719197|NCT01739348|470597347|FG000|Part II (Extension Study)|Adverse Event|10|||
130719198|NCT01739348|470597348|FG001|Part II (Extension Study)|Adverse Event|11|||
130719199|NCT01739348|470597349|FG002|Part II (Extension Study)|Adverse Event|7|||
130719200|NCT01739348|470597350|FG003|Part II (Extension Study)|Adverse Event|26|||
130719201|NCT01739348|470597347|FG000|Part II (Extension Study)|Death|3|||
130719202|NCT01739348|470597348|FG001|Part II (Extension Study)|Death|3|||
130719203|NCT01739348|470597349|FG002|Part II (Extension Study)|Death|2|||
130719204|NCT01739348|470597350|FG003|Part II (Extension Study)|Death|6|||
130719205|NCT01739348|470597347|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
130719206|NCT01739348|470597348|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
130719207|NCT01739348|470597349|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
130719208|NCT01739348|470597350|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
130719209|NCT01739348|470597347|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
130719210|NCT01739348|470597348|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
130719211|NCT01739348|470597349|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
130719212|NCT01739348|470597350|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
130719213|NCT01739348|470597347|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
131228536|NCT01271933|472463263|FG001|Single-Blind Phase|Lack of Efficacy|0|||
131228537|NCT01271933|472463264|FG002|Single-Blind Phase|Lack of Efficacy|0|||
131228538|NCT01271933|472463262|FG000|Single-Blind Phase|Lost to Follow-up|10|||
130719214|NCT01739348|470597348|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
130719215|NCT01739348|470597349|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
130719216|NCT01739348|470597350|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
130719217|NCT01739348|470597347|FG000|Part II (Extension Study)|Physician Decision|7|||
130719218|NCT01739348|470597348|FG001|Part II (Extension Study)|Physician Decision|11|||
130719219|NCT01739348|470597349|FG002|Part II (Extension Study)|Physician Decision|6|||
131228539|NCT01271933|472463263|FG001|Single-Blind Phase|Lost to Follow-up|0|||
131228540|NCT01271933|472463264|FG002|Single-Blind Phase|Lost to Follow-up|0|||
130983390|NCT00117676|471564907|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
130983391|NCT00117676|471564906|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
130983392|NCT00117676|471564907|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
130983393|NCT00117676|471564906|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
130983394|NCT00117676|471564907|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
130983395|NCT00117676|471564906|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
130719220|NCT01739348|470597350|FG003|Part II (Extension Study)|Physician Decision|12|||
130719221|NCT01739348|470597347|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
130719222|NCT01739348|470597348|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
130719223|NCT01739348|470597349|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
130719224|NCT01739348|470597350|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
130719225|NCT01739348|470597347|FG000|Part II (Extension Study)|Participant Moved|3|||
130719226|NCT01739348|470597348|FG001|Part II (Extension Study)|Participant Moved|3|||
130719227|NCT01739348|470597349|FG002|Part II (Extension Study)|Participant Moved|0|||
130719228|NCT01739348|470597350|FG003|Part II (Extension Study)|Participant Moved|3|||
130719229|NCT01739348|470597347|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
130719230|NCT01739348|470597348|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
130719231|NCT01739348|470597349|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
130719232|NCT01739348|470597350|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
130719233|NCT01739348|470597347|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
130719234|NCT01739348|470597348|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
130719235|NCT01739348|470597349|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
130719236|NCT01739348|470597350|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
130719237|NCT01447420|470597354|FG000|Overall Study|Adverse Event|2|||
130719238|NCT01447420|470597355|FG001|Overall Study|Adverse Event|4|||
130719239|NCT01447420|470597356|FG002|Overall Study|Adverse Event|2|||
130719240|NCT01447420|470597354|FG000|Overall Study|Protocol Violation|3|||
130719241|NCT01447420|470597355|FG001|Overall Study|Protocol Violation|3|||
130719242|NCT01447420|470597356|FG002|Overall Study|Protocol Violation|0|||
130719243|NCT01447420|470597354|FG000|Overall Study|Withdrawal by Subject|4|||
130719244|NCT01447420|470597355|FG001|Overall Study|Withdrawal by Subject|1|||
130719245|NCT01447420|470597356|FG002|Overall Study|Withdrawal by Subject|0|||
130719246|NCT01447420|470597354|FG000|Overall Study|Lack of Efficacy|1|||
130719247|NCT01447420|470597355|FG001|Overall Study|Lack of Efficacy|19|||
130719248|NCT01447420|470597356|FG002|Overall Study|Lack of Efficacy|8|||
130719249|NCT05788289|470597363|FG000|Overall Study|Death|3|||
130719250|NCT01974440|470597364|FG000|Overall Study|Lost to Follow-up|7|||
130719251|NCT01974440|470597365|FG001|Overall Study|Lost to Follow-up|7|||
130719252|NCT01974440|470597364|FG000|Overall Study|Withdrawal by Subject|24|||
130719253|NCT01974440|470597365|FG001|Overall Study|Withdrawal by Subject|20|||
130719254|NCT01974440|470597364|FG000|Overall Study|Sponsor decision|109|||
130719255|NCT01974440|470597365|FG001|Overall Study|Sponsor decision|110|||
130719256|NCT00762437|470597366|FG000|Overall Study|Lost to Follow-up|7|||
130719257|NCT00762437|470597366|FG000|Overall Study|Missed final study visit|11|||
130719258|NCT00762437|470597366|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
130719259|NCT03569228|470597367|FG000|Overall Study|Withdrawal by PI|0|||
130719260|NCT03569228|470597368|FG001|Overall Study|Withdrawal by PI|0|||
130719261|NCT03569228|470597369|FG002|Overall Study|Withdrawal by PI|2|||
130719262|NCT03569228|470597370|FG003|Overall Study|Withdrawal by PI|2|||
130719263|NCT03569228|470597371|FG004|Overall Study|Withdrawal by PI|1|||
130719264|NCT03569228|470597372|FG005|Overall Study|Withdrawal by PI|0|||
130719265|NCT03569228|470597373|FG006|Overall Study|Withdrawal by PI|0|||
130719266|NCT03569228|470597374|FG007|Overall Study|Withdrawal by PI|0|||
130719267|NCT03569228|470597375|FG008|Overall Study|Withdrawal by PI|0|||
130719268|NCT03569228|470597367|FG000|Overall Study|Lost to Follow-up|0|||
130719269|NCT03569228|470597368|FG001|Overall Study|Lost to Follow-up|0|||
130719270|NCT03569228|470597369|FG002|Overall Study|Lost to Follow-up|0|||
130719271|NCT03569228|470597370|FG003|Overall Study|Lost to Follow-up|0|||
130719272|NCT03569228|470597371|FG004|Overall Study|Lost to Follow-up|0|||
130719273|NCT03569228|470597372|FG005|Overall Study|Lost to Follow-up|0|||
130719274|NCT03569228|470597373|FG006|Overall Study|Lost to Follow-up|0|||
130719275|NCT03569228|470597374|FG007|Overall Study|Lost to Follow-up|0|||
130719276|NCT03569228|470597375|FG008|Overall Study|Lost to Follow-up|1|||
130719277|NCT03569228|470597367|FG000|Overall Study|Screen Fail|2|||
130719278|NCT03569228|470597368|FG001|Overall Study|Screen Fail|2|||
130983396|NCT00117676|471564907|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
130983397|NCT00117676|471564906|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
130719279|NCT03569228|470597369|FG002|Overall Study|Screen Fail|1|||
130719280|NCT03569228|470597370|FG003|Overall Study|Screen Fail|1|||
130719281|NCT03569228|470597371|FG004|Overall Study|Screen Fail|1|||
130719282|NCT03569228|470597372|FG005|Overall Study|Screen Fail|3|||
130719283|NCT03569228|470597373|FG006|Overall Study|Screen Fail|1|||
130719284|NCT03569228|470597374|FG007|Overall Study|Screen Fail|5|||
130719285|NCT03569228|470597375|FG008|Overall Study|Screen Fail|2|||
130719286|NCT00085423|470597380|FG000|Overall Study|Withdrawal by Subject|1|||
131228541|NCT01271933|472463262|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
131228542|NCT01271933|472463263|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
131228543|NCT01271933|472463264|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
131228544|NCT01271933|472463262|FG000|Single-Blind Phase|Protocol Violation|3|||
131228545|NCT01271933|472463263|FG001|Single-Blind Phase|Protocol Violation|0|||
131228546|NCT01271933|472463264|FG002|Single-Blind Phase|Protocol Violation|0|||
131228547|NCT01271933|472463262|FG000|Single-Blind Phase|Adverse Event|52|||
131228548|NCT01271933|472463263|FG001|Single-Blind Phase|Adverse Event|0|||
131228549|NCT01271933|472463264|FG002|Single-Blind Phase|Adverse Event|0|||
131228550|NCT01271933|472463262|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
131228551|NCT01271933|472463263|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
131228552|NCT01271933|472463264|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
131228553|NCT01271933|472463262|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
131228554|NCT01271933|472463263|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
130983398|NCT00117676|471564907|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
130983399|NCT00117676|471564906|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
130983400|NCT00117676|471564907|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
130983401|NCT00117676|471564906|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
131228555|NCT01271933|472463264|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
131228556|NCT01271933|472463262|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
131228557|NCT01271933|472463263|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
131228558|NCT01271933|472463264|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
131228559|NCT01271933|472463262|FG000|Double-Blind Phase|Randomized but not treated|0|||
131228560|NCT01271933|472463263|FG001|Double-Blind Phase|Randomized but not treated|0|||
130719287|NCT00085423|470597380|FG000|Overall Study|screen failure|1|||
130983402|NCT00117676|471564907|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
130983403|NCT00117676|471564906|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
130983404|NCT00117676|471564907|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
130983405|NCT00117676|471564906|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
130983406|NCT00117676|471564907|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
131044626|NCT04186819|471797580|FG000|Overall Study|RP Delayed|1|||
131044627|NCT04186819|471797580|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
131044628|NCT04186819|471797580|FG000|Overall Study|Subject declined for financial reasons|1|||
131044629|NCT04186819|471797580|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
131044630|NCT04186819|471797580|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
131044631|NCT04186819|471797580|FG000|Overall Study|The subject opted for other treatment option|2|||
131044632|NCT04186819|471797580|FG000|Overall Study|The subject opted for other treatment options|1|||
131044633|NCT04186819|471797580|FG000|Overall Study|Withdrawal by Subject|3|||
131044634|NCT04186819|471797580|FG000|Overall Study|Reason not specified|1|||
131044635|NCT01199133|471797582|FG000|Year 1|Adverse Event|16|||
131044636|NCT01199133|471797583|FG001|Year 1|Adverse Event|4|||
131044637|NCT01199133|471797582|FG000|Year 1|Withdrawal by Subject|8|||
131044638|NCT01199133|471797583|FG001|Year 1|Withdrawal by Subject|4|||
131044639|NCT01199133|471797582|FG000|Year 1|Any other reason not above-mentioned|6|||
131044640|NCT01199133|471797583|FG001|Year 1|Any other reason not above-mentioned|7|||
131044641|NCT01199133|471797582|FG000|Year 2|Adverse Event|1|||
131044642|NCT01199133|471797583|FG001|Year 2|Adverse Event|0|||
131044643|NCT01199133|471797582|FG000|Year 2|Withdrawal by Subject|1|||
131044644|NCT01199133|471797583|FG001|Year 2|Withdrawal by Subject|1|||
131044645|NCT01199133|471797582|FG000|Year 2|Any other reason not above-mentioned|1|||
131044646|NCT01199133|471797583|FG001|Year 2|Any other reason not above-mentioned|2|||
131044647|NCT02997202|471797584|FG000|Overall Study|Miscellaneous|2|||
131044648|NCT02997202|471797585|FG001|Overall Study|Miscellaneous|2|||
131044649|NCT02997202|471797584|FG000|Overall Study|Withdrawal by Subject|8|||
131044650|NCT02997202|471797585|FG001|Overall Study|Withdrawal by Subject|12|||
131044651|NCT02997202|471797584|FG000|Overall Study|Lost to Follow-up|5|||
131044652|NCT02997202|471797585|FG001|Overall Study|Lost to Follow-up|3|||
131044653|NCT02997202|471797584|FG000|Overall Study|Death|41|||
131044654|NCT02997202|471797585|FG001|Overall Study|Death|45|||
131044655|NCT03252288|471797588|FG000|Overall Study|Death|1|||
131044656|NCT03252288|471797589|FG001|Overall Study|Death|0|||
131044657|NCT03252288|471797590|FG002|Overall Study|Death|0|||
131044658|NCT03252288|471797588|FG000|Overall Study|Death|11|||
131044659|NCT03252288|471797589|FG001|Overall Study|Death|0|||
131044660|NCT03252288|471797590|FG002|Overall Study|Death|0|||
131044661|NCT03252288|471797588|FG000|Overall Study|Withdrawal by Subject|2|||
131228561|NCT01271933|472463264|FG002|Double-Blind Phase|Randomized but not treated|1|||
131228562|NCT01271933|472463262|FG000|Double-Blind Phase|Lack of Efficacy|0|||
130719288|NCT00536263|470597386|FG000|Overall Study|Adverse Event|5|||
131044662|NCT03252288|471797589|FG001|Overall Study|Withdrawal by Subject|0|||
131044663|NCT03252288|471797590|FG002|Overall Study|Withdrawal by Subject|0|||
131044664|NCT03252288|471797588|FG000|Overall Study|Lost to Follow-up|79|||
131044665|NCT03252288|471797589|FG001|Overall Study|Lost to Follow-up|0|||
131044666|NCT03252288|471797590|FG002|Overall Study|Lost to Follow-up|0|||
131044667|NCT03252288|471797588|FG000|Overall Study|Loss of baseline data on tablets|6|||
131044668|NCT03252288|471797589|FG001|Overall Study|Loss of baseline data on tablets|0|||
131044669|NCT03252288|471797590|FG002|Overall Study|Loss of baseline data on tablets|0|||
131044670|NCT02542631|471797598|FG000|Overall Study|Adverse Event|1|||
131044671|NCT02542631|471797599|FG001|Overall Study|Adverse Event|1|||
131133186|NCT01471782|472113920|FG000|Overall Study|Physician Decision|0|||
131133187|NCT01471782|472113921|FG001|Overall Study|Physician Decision|0|||
131133188|NCT01471782|472113922|FG002|Overall Study|Physician Decision|0|||
131133189|NCT01471782|472113923|FG003|Overall Study|Physician Decision|0|||
131133190|NCT01471782|472113924|FG004|Overall Study|Physician Decision|3|||
131133191|NCT01471782|472113925|FG005|Overall Study|Physician Decision|8|||
131133192|NCT01471782|472113920|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131133193|NCT01471782|472113921|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131133194|NCT01471782|472113922|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131133195|NCT01471782|472113923|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131133196|NCT01471782|472113924|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
131133197|NCT01471782|472113925|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
131133198|NCT01471782|472113920|FG000|Overall Study|Death|0|||
131133199|NCT01471782|472113921|FG001|Overall Study|Death|0|||
131133200|NCT01471782|472113922|FG002|Overall Study|Death|0|||
131133201|NCT01471782|472113923|FG003|Overall Study|Death|0|||
131133202|NCT01471782|472113924|FG004|Overall Study|Death|0|||
131133203|NCT01471782|472113925|FG005|Overall Study|Death|1|||
131133204|NCT01452152|472113926|FG000|Overall Study|Study termination by sponsor|5|||
131133205|NCT01452152|472113927|FG001|Overall Study|Study termination by sponsor|0|||
131133206|NCT01452152|472113928|FG002|Overall Study|Study termination by sponsor|4|||
131133207|NCT02068547|472115208|FG000|Overall Study|Lost to Follow-up|3|||
131133208|NCT02068547|472115209|FG001|Overall Study|Lost to Follow-up|3|||
131133209|NCT02068547|472115208|FG000|Overall Study|Physician Decision|1|||
131133210|NCT02068547|472115209|FG001|Overall Study|Physician Decision|0|||
131133211|NCT01736579|472115210|FG000|Overall Study|Termination of Study by Sponsor|2|||
131133212|NCT01736579|472115211|FG001|Overall Study|Termination of Study by Sponsor|2|||
131133213|NCT02543528|472115219|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
131133214|NCT02543528|472115220|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
131133215|NCT02543528|472115221|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
131133216|NCT02543528|472115222|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
131133217|NCT02543528|472115223|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
131133218|NCT02543528|472115219|FG000|Adaptation Period|Lens Handling Difficultes|0|||
131133219|NCT02543528|472115220|FG001|Adaptation Period|Lens Handling Difficultes|0|||
131133220|NCT02543528|472115221|FG002|Adaptation Period|Lens Handling Difficultes|0|||
131133221|NCT02543528|472115222|FG003|Adaptation Period|Lens Handling Difficultes|0|||
131133222|NCT02543528|472115223|FG004|Adaptation Period|Lens Handling Difficultes|8|||
131133223|NCT02543528|472115219|FG000|Adaptation Period|Lost to Follow-up|0|||
131133224|NCT02543528|472115220|FG001|Adaptation Period|Lost to Follow-up|0|||
131133225|NCT02543528|472115221|FG002|Adaptation Period|Lost to Follow-up|0|||
131133226|NCT02543528|472115222|FG003|Adaptation Period|Lost to Follow-up|0|||
131133227|NCT02543528|472115223|FG004|Adaptation Period|Lost to Follow-up|14|||
131133228|NCT02543528|472115219|FG000|Adaptation Period|Adverse Event|0|||
131133229|NCT02543528|472115220|FG001|Adaptation Period|Adverse Event|0|||
131133230|NCT02543528|472115221|FG002|Adaptation Period|Adverse Event|0|||
131133231|NCT02543528|472115222|FG003|Adaptation Period|Adverse Event|0|||
131133232|NCT02543528|472115223|FG004|Adaptation Period|Adverse Event|2|||
131133233|NCT02543528|472115219|FG000|Extended Wear Period|Adverse Event|17|||
131133234|NCT02543528|472115220|FG001|Extended Wear Period|Adverse Event|11|||
131133235|NCT02543528|472115221|FG002|Extended Wear Period|Adverse Event|16|||
131133236|NCT02543528|472115222|FG003|Extended Wear Period|Adverse Event|3|||
131133237|NCT02543528|472115223|FG004|Extended Wear Period|Adverse Event|0|||
131133238|NCT02543528|472115219|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
131133239|NCT02543528|472115220|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
131133240|NCT02543528|472115221|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
131133241|NCT02543528|472115222|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
131044672|NCT02542631|471797598|FG000|Overall Study|Sponsor Termination|1|||
131044673|NCT02542631|471797599|FG001|Overall Study|Sponsor Termination|0|||
131044674|NCT02542631|471797598|FG000|Overall Study|Withdrawal by Subject|11|||
131044675|NCT02542631|471797599|FG001|Overall Study|Withdrawal by Subject|16|||
131044676|NCT02542631|471797598|FG000|Overall Study|Protocol Violation|1|||
131133242|NCT02543528|472115223|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
131133243|NCT02543528|472115219|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
131133244|NCT02543528|472115220|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
131133245|NCT02543528|472115221|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
131133246|NCT02543528|472115222|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
131133247|NCT02543528|472115223|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
131133248|NCT02543528|472115219|FG000|Extended Wear Period|Lost to Follow-up|0|||
131133249|NCT02543528|472115220|FG001|Extended Wear Period|Lost to Follow-up|1|||
131228563|NCT01271933|472463263|FG001|Double-Blind Phase|Lack of Efficacy|6|||
131228564|NCT01271933|472463264|FG002|Double-Blind Phase|Lack of Efficacy|9|||
131228565|NCT01271933|472463262|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131228566|NCT01271933|472463263|FG001|Double-Blind Phase|Lost to Follow-up|1|||
131228567|NCT01271933|472463264|FG002|Double-Blind Phase|Lost to Follow-up|1|||
131228568|NCT01271933|472463262|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
131228569|NCT01271933|472463263|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
131228570|NCT01271933|472463264|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
131228571|NCT01271933|472463262|FG000|Double-Blind Phase|Adverse Event|0|||
131228572|NCT01271933|472463263|FG001|Double-Blind Phase|Adverse Event|3|||
131228573|NCT01271933|472463264|FG002|Double-Blind Phase|Adverse Event|0|||
131228574|NCT01271933|472463262|FG000|Double-Blind Phase|Participant request-personal reason|0|||
131228575|NCT01271933|472463263|FG001|Double-Blind Phase|Participant request-personal reason|1|||
131228576|NCT01271933|472463264|FG002|Double-Blind Phase|Participant request-personal reason|0|||
131228577|NCT01138150|472463265|FG000|Overall Study|blood unable to be processed|0|||
131228578|NCT01138150|472463266|FG001|Overall Study|blood unable to be processed|1|||
131228579|NCT01138150|472463265|FG000|Overall Study|Physician Decision|1|||
131228580|NCT01138150|472463266|FG001|Overall Study|Physician Decision|0|||
131228581|NCT01620983|472463267|FG000|Overall Study|Lost to Follow-up|8|||
131228582|NCT01620983|472463268|FG001|Overall Study|Lost to Follow-up|4|||
131228583|NCT01620983|472463269|FG002|Overall Study|Lost to Follow-up|9|||
131228584|NCT01620983|472463267|FG000|Overall Study|Withdrawal by Subject|6|||
131228585|NCT01620983|472463268|FG001|Overall Study|Withdrawal by Subject|8|||
130983407|NCT00117676|471564906|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
130983408|NCT00117676|471564907|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
130983409|NCT00117676|471564906|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
131228586|NCT01620983|472463269|FG002|Overall Study|Withdrawal by Subject|1|||
131228587|NCT01620983|472463267|FG000|Overall Study|Death|2|||
131228588|NCT01620983|472463268|FG001|Overall Study|Death|0|||
130983410|NCT00117676|471564907|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
130983411|NCT00117676|471564906|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
130983412|NCT00117676|471564907|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
130983413|NCT00117676|471564906|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
130983414|NCT00117676|471564907|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
130983415|NCT00117676|471564906|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
130983416|NCT00117676|471564907|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
130983417|NCT00117676|471564906|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
130983418|NCT00117676|471564907|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
130983419|NCT00117676|471564906|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
130983420|NCT00117676|471564907|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
130983421|NCT00117676|471564906|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
130983422|NCT00117676|471564907|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
130983423|NCT00117676|471564906|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
130983424|NCT00117676|471564907|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
130983425|NCT00117676|471564906|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
130983426|NCT00117676|471564907|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
130983427|NCT00117676|471564906|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
130983428|NCT00117676|471564907|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
130983429|NCT00117676|471564906|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
130983430|NCT00117676|471564907|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
130983431|NCT00117676|471564906|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
130983432|NCT00117676|471564907|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
130983433|NCT00117676|471564906|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
130983434|NCT00117676|471564907|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
130983435|NCT00117676|471564906|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
130983436|NCT00117676|471564907|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
130983437|NCT00117676|471564906|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
130983438|NCT00117676|471564907|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
130983439|NCT00952822|471564908|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
130983440|NCT00952822|471564909|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
131228589|NCT01620983|472463269|FG002|Overall Study|Death|0|||
131228590|NCT01620983|472463267|FG000|Overall Study|Physician Decision|3|||
131228591|NCT01620983|472463268|FG001|Overall Study|Physician Decision|10|||
131228592|NCT01620983|472463269|FG002|Overall Study|Physician Decision|5|||
131228593|NCT05085964|472463271|FG000|Overall Study|Premature termination of study|21|||
131228594|NCT05085964|472463272|FG001|Overall Study|Premature termination of study|0|||
131228595|NCT00545233|472463273|FG000|Overall Study|Adverse Event|10|||
131228596|NCT00545233|472463274|FG001|Overall Study|Adverse Event|5|||
131228597|NCT00545233|472463273|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
130983441|NCT00952822|471564910|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
130983442|NCT00952822|471564911|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
130983443|NCT00952822|471564908|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
130983444|NCT00952822|471564909|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
130983445|NCT00952822|471564910|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
130983446|NCT00952822|471564911|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
130983447|NCT00691938|471564915|FG000|Overall Study|QTc prolongation|1|||
130983448|NCT00691938|471564916|FG001|Overall Study|QTc prolongation|0|||
131133250|NCT02543528|472115221|FG002|Extended Wear Period|Lost to Follow-up|2|||
131133251|NCT02543528|472115222|FG003|Extended Wear Period|Lost to Follow-up|1|||
131133252|NCT02543528|472115223|FG004|Extended Wear Period|Lost to Follow-up|0|||
131133253|NCT02543528|472115219|FG000|Extended Wear Period|Withdrawal by Subject|10|||
131133254|NCT02543528|472115220|FG001|Extended Wear Period|Withdrawal by Subject|9|||
131133255|NCT02543528|472115221|FG002|Extended Wear Period|Withdrawal by Subject|4|||
131133256|NCT02543528|472115222|FG003|Extended Wear Period|Withdrawal by Subject|5|||
131133257|NCT02543528|472115223|FG004|Extended Wear Period|Withdrawal by Subject|0|||
131133258|NCT02049944|472115224|FG000|Overall Study|Protocol Violation|2|||
131133259|NCT01408147|472115225|FG000|Overall Study|Withdrawal by Subject|0|||
131133260|NCT01408147|472115226|FG001|Overall Study|Withdrawal by Subject|1|||
131133261|NCT01765673|472115227|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
131133262|NCT01042600|472115228|FG000|Overall Study|Ineligible|1|||
131133263|NCT01042600|472115229|FG001|Overall Study|Ineligible|0|||
131133264|NCT05048719|472115230|FG000|Overall Study|Withdrawal by Subject|2|||
131133265|NCT05048719|472115231|FG001|Overall Study|Withdrawal by Subject|1|||
130983449|NCT00691938|471564917|FG002|Overall Study|QTc prolongation|0|||
130983450|NCT00691938|471564918|FG003|Overall Study|QTc prolongation|0|||
130983451|NCT00691938|471564919|FG004|Overall Study|QTc prolongation|0|||
130983452|NCT00691938|471564920|FG005|Overall Study|QTc prolongation|0|||
130983453|NCT00691938|471564921|FG006|Overall Study|QTc prolongation|0|||
131044677|NCT02542631|471797599|FG001|Overall Study|Protocol Violation|1|||
131044678|NCT02542631|471797598|FG000|Overall Study|Physician Decision|6|||
131044679|NCT02542631|471797599|FG001|Overall Study|Physician Decision|4|||
131044680|NCT02542631|471797598|FG000|Overall Study|Lost to Follow-up|6|||
131044681|NCT02542631|471797599|FG001|Overall Study|Lost to Follow-up|5|||
131044682|NCT02542631|471797598|FG000|Overall Study|Death|1|||
131044683|NCT02542631|471797599|FG001|Overall Study|Death|2|||
131044684|NCT02542631|471797598|FG000|Overall Study|Other|2|||
131044685|NCT02542631|471797599|FG001|Overall Study|Other|1|||
131044686|NCT02542631|471797598|FG000|Overall Study|Used Prohibited Medication|2|||
131044687|NCT02542631|471797599|FG001|Overall Study|Used Prohibited Medication|1|||
131044688|NCT02938923|471797600|FG000|Overall Study|Death|1|||
131044689|NCT02938923|471797601|FG001|Overall Study|Death|0|||
131044690|NCT02938923|471797602|FG002|Overall Study|Death|0|||
131044691|NCT02938923|471797600|FG000|Overall Study|Physician Decision|0|||
131044692|NCT02938923|471797601|FG001|Overall Study|Physician Decision|2|||
131044693|NCT02938923|471797602|FG002|Overall Study|Physician Decision|0|||
131044694|NCT02938923|471797600|FG000|Overall Study|Withdrawal by Subject|0|||
131044695|NCT02938923|471797601|FG001|Overall Study|Withdrawal by Subject|1|||
131044696|NCT02938923|471797602|FG002|Overall Study|Withdrawal by Subject|1|||
131044697|NCT04583280|471797607|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
131044698|NCT04583280|471797608|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
131044699|NCT00631475|471797609|FG000|Overall Study|Death|18|||
131044700|NCT00631475|471797609|FG000|Overall Study|Adverse Event|14|||
131044701|NCT00631475|471797609|FG000|Overall Study|Withdrew consent|5|||
131044702|NCT00631475|471797609|FG000|Overall Study|Preparation for lung transplant|8|||
131044703|NCT00303459|471797610|FG000|Overall Study|Death|33|||
131044704|NCT00303459|471797611|FG001|Overall Study|Death|44|||
131044705|NCT00303459|471797610|FG000|Overall Study|Withdrawal of consent|32|||
131044706|NCT00303459|471797611|FG001|Overall Study|Withdrawal of consent|26|||
131044707|NCT00303459|471797610|FG000|Overall Study|Lost to Follow-up|5|||
131044708|NCT00303459|471797611|FG001|Overall Study|Lost to Follow-up|4|||
131044709|NCT00303459|471797610|FG000|Overall Study|Administrative reason|7|||
131044710|NCT00303459|471797611|FG001|Overall Study|Administrative reason|7|||
131044711|NCT00303459|471797610|FG000|Overall Study|Decision by the investigator|5|||
131044712|NCT00303459|471797611|FG001|Overall Study|Decision by the investigator|7|||
131044713|NCT00303459|471797610|FG000|Overall Study|Lung transplantation|1|||
131044714|NCT00303459|471797611|FG001|Overall Study|Lung transplantation|1|||
131044715|NCT04129554|471797612|FG000|Overall Study|Withdrawal by Subject|4|||
131044716|NCT04129554|471797613|FG001|Overall Study|Withdrawal by Subject|3|||
131044717|NCT04129554|471797612|FG000|Overall Study|Other|0|||
131044718|NCT04129554|471797613|FG001|Overall Study|Other|2|||
131044719|NCT01570361|471797614|FG000|Overall Study|Subject discontinued|1|||
131044720|NCT01570361|471797615|FG001|Overall Study|Subject discontinued|2|||
131044721|NCT01570361|471797614|FG000|Overall Study|Sponsor closing the study|51|||
131044722|NCT01570361|471797615|FG001|Overall Study|Sponsor closing the study|50|||
130983454|NCT04860518|471564924|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
131228598|NCT00545233|472463274|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
131228599|NCT00545233|472463273|FG000|Overall Study|Protocol Violation|2|||
131228600|NCT00545233|472463274|FG001|Overall Study|Protocol Violation|0|||
131228601|NCT00545233|472463273|FG000|Overall Study|Refused Treatment|9|||
131228602|NCT00545233|472463274|FG001|Overall Study|Refused Treatment|7|||
131228603|NCT00545233|472463273|FG000|Overall Study|Failure to Return|4|||
131228604|NCT00545233|472463274|FG001|Overall Study|Failure to Return|6|||
131228605|NCT00545233|472463273|FG000|Overall Study|Insufficient response|14|||
131228606|NCT00545233|472463274|FG001|Overall Study|Insufficient response|15|||
131228607|NCT00545233|472463273|FG000|Overall Study|Physician Decision|2|||
131228608|NCT00545233|472463274|FG001|Overall Study|Physician Decision|1|||
131228609|NCT01208402|472463278|FG000|Overall Study|Withdrawal by Subject|1|||
131228610|NCT01208402|472463279|FG001|Overall Study|Withdrawal by Subject|0|||
131228611|NCT01335464|472463281|FG000|Overall Study|Adverse Event|15|||
131228612|NCT01335464|472463282|FG001|Overall Study|Adverse Event|25|||
131228613|NCT01335464|472463281|FG000|Overall Study|Non compliant with protocol|2|||
131228614|NCT01335464|472463282|FG001|Overall Study|Non compliant with protocol|0|||
131228615|NCT01335464|472463281|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
131228616|NCT01335464|472463282|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
131228617|NCT01335464|472463281|FG000|Overall Study|Not treated|2|||
131228618|NCT01335464|472463282|FG001|Overall Study|Not treated|0|||
131228619|NCT01335464|472463281|FG000|Overall Study|Reason other than those stated above|1|||
131228620|NCT01335464|472463282|FG001|Overall Study|Reason other than those stated above|1|||
131228621|NCT03156270|472463283|FG000|Overall Study|Failed pre-treatment screening|1|||
131228622|NCT03156270|472463283|FG000|Overall Study|Lost to Follow-up|1|||
131228623|NCT00446654|472463284|FG000|Overall Study|Withdrawal by Subject|1|||
131228624|NCT00446654|472463285|FG001|Overall Study|Withdrawal by Subject|0|||
131228625|NCT00446654|472463284|FG000|Overall Study|Adverse Event|1|||
131228626|NCT00446654|472463285|FG001|Overall Study|Adverse Event|0|||
131228627|NCT02110706|472463289|FG000|Overall Study|Adverse Event|2|||
131228628|NCT02110706|472463290|FG001|Overall Study|Adverse Event|3|||
131228629|NCT02110706|472463289|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
131228630|NCT02110706|472463290|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
131228631|NCT02087059|472463291|FG000|Overall Study|Disease Progression|1|||
131228632|NCT02087059|472463291|FG000|Overall Study|Adverse Event|5|||
131228633|NCT02087059|472463291|FG000|Overall Study|Lost to Follow-up|1|||
131228634|NCT02175966|472463292|FG000|Follow-up Period|Lack of Efficacy|10|||
131228635|NCT02175966|472463293|FG001|Follow-up Period|Lack of Efficacy|6|||
131228636|NCT01306253|472463294|FG000|Overall Study|Lost to Follow-up|1|||
131228637|NCT01306253|472463295|FG001|Overall Study|Lost to Follow-up|1|||
131228638|NCT01261325|472463296|FG000|Overall Study|Lack of Efficacy|1|||
131228639|NCT01261325|472463297|FG001|Overall Study|Lack of Efficacy|1|||
131228640|NCT01261325|472463298|FG002|Overall Study|Lack of Efficacy|0|||
131228641|NCT01261325|472463296|FG000|Overall Study|Withdrawal by Subject|2|||
130983455|NCT04860518|471564925|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
130983456|NCT04555096|471564930|FG000|Overall Study|Death|4|||
131228642|NCT01261325|472463297|FG001|Overall Study|Withdrawal by Subject|2|||
131228643|NCT01261325|472463298|FG002|Overall Study|Withdrawal by Subject|4|||
131228644|NCT01261325|472463296|FG000|Overall Study|SAE, non-fatal|1|||
131228645|NCT01261325|472463297|FG001|Overall Study|SAE, non-fatal|5|||
131228646|NCT01261325|472463298|FG002|Overall Study|SAE, non-fatal|1|||
131228647|NCT01261325|472463296|FG000|Overall Study|AE, non-serious non-fatal|9|||
131228648|NCT01261325|472463297|FG001|Overall Study|AE, non-serious non-fatal|15|||
130778837|NCT03428100|470817453|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130983457|NCT04555096|471564931|FG001|Overall Study|Death|4|||
130983458|NCT04555096|471564930|FG000|Overall Study|Withdrawal by Subject|1|||
130983459|NCT04555096|471564931|FG001|Overall Study|Withdrawal by Subject|0|||
130983460|NCT04555096|471564930|FG000|Overall Study|Other|0|||
130983461|NCT04555096|471564931|FG001|Overall Study|Other|1|||
130983462|NCT04642898|471564934|FG000|Overall Study|Withdrawal by Subject|2|||
130983463|NCT04642898|471564935|FG001|Overall Study|Withdrawal by Subject|4|||
130983464|NCT04642898|471564936|FG002|Overall Study|Withdrawal by Subject|4|||
130983465|NCT04642898|471564937|FG003|Overall Study|Withdrawal by Subject|6|||
130983466|NCT04642898|471564938|FG004|Overall Study|Withdrawal by Subject|2|||
130983467|NCT04642898|471564939|FG005|Overall Study|Withdrawal by Subject|6|||
130983468|NCT04642898|471564934|FG000|Overall Study|Lost to Follow-up|0|||
130983469|NCT04642898|471564935|FG001|Overall Study|Lost to Follow-up|0|||
130983470|NCT04642898|471564936|FG002|Overall Study|Lost to Follow-up|0|||
130983471|NCT04642898|471564937|FG003|Overall Study|Lost to Follow-up|2|||
130983472|NCT04642898|471564938|FG004|Overall Study|Lost to Follow-up|0|||
130983473|NCT04642898|471564939|FG005|Overall Study|Lost to Follow-up|1|||
130983474|NCT04642898|471564934|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
130983475|NCT04642898|471564935|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
130983476|NCT04642898|471564936|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
130983477|NCT04642898|471564937|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
131228649|NCT01261325|472463298|FG002|Overall Study|AE, non-serious non-fatal|13|||
131228650|NCT01261325|472463296|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
131228651|NCT01261325|472463297|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131228652|NCT01261325|472463298|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
131228653|NCT01261325|472463296|FG000|Overall Study|Non Compliance|2|||
131228654|NCT01261325|472463297|FG001|Overall Study|Non Compliance|0|||
131228655|NCT01261325|472463298|FG002|Overall Study|Non Compliance|0|||
131228656|NCT01261325|472463296|FG000|Overall Study|Patient Randomized by Mistake|0|||
131228657|NCT01261325|472463297|FG001|Overall Study|Patient Randomized by Mistake|1|||
131228658|NCT01261325|472463298|FG002|Overall Study|Patient Randomized by Mistake|0|||
131228659|NCT01261325|472463296|FG000|Overall Study|Erroneously Randomized|1|||
131228660|NCT01261325|472463297|FG001|Overall Study|Erroneously Randomized|0|||
131228661|NCT01261325|472463298|FG002|Overall Study|Erroneously Randomized|0|||
131228662|NCT01261325|472463296|FG000|Overall Study|Screen Failure|1|||
131228663|NCT01261325|472463297|FG001|Overall Study|Screen Failure|0|||
131228664|NCT01261325|472463298|FG002|Overall Study|Screen Failure|0|||
131228665|NCT01261325|472463296|FG000|Overall Study|Randomized in Error|0|||
131228666|NCT01261325|472463297|FG001|Overall Study|Randomized in Error|0|||
131228667|NCT01261325|472463298|FG002|Overall Study|Randomized in Error|1|||
131228668|NCT01261325|472463296|FG000|Overall Study|Protocol Violation|0|||
131228669|NCT01261325|472463297|FG001|Overall Study|Protocol Violation|3|||
131228670|NCT01261325|472463298|FG002|Overall Study|Protocol Violation|1|||
131228671|NCT01261325|472463296|FG000|Overall Study|Lost to Follow-up|0|||
131228672|NCT01261325|472463297|FG001|Overall Study|Lost to Follow-up|1|||
131228673|NCT01261325|472463298|FG002|Overall Study|Lost to Follow-up|3|||
131228674|NCT01261325|472463296|FG000|Overall Study|AE, serious fatal|0|||
131228675|NCT01261325|472463297|FG001|Overall Study|AE, serious fatal|0|||
131228676|NCT01261325|472463298|FG002|Overall Study|AE, serious fatal|2|||
131228677|NCT00871728|472463302|FG000|Overall Study|Adverse Event|1|||
131228678|NCT00871728|472463302|FG000|Overall Study|Protocol Violation|7|||
131228679|NCT00871728|472463302|FG000|Overall Study|Lost to Follow-up|2|||
131228680|NCT00871728|472463302|FG000|Overall Study|Failed to Visit Hospital|4|||
131228681|NCT00871728|472463302|FG000|Overall Study|Participant Non-compliance|1|||
131228682|NCT00871728|472463302|FG000|Overall Study|Withdrawal of Informed Consent|5|||
131228683|NCT01829295|472463305|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
131228684|NCT01829295|472463306|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
131228685|NCT01829295|472463307|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
131228686|NCT01829295|472463308|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
131228687|NCT01829295|472463305|FG000|6-12 Months|Adverse Event|0|||
131228688|NCT01829295|472463306|FG001|6-12 Months|Adverse Event|0|||
131228689|NCT01829295|472463307|FG002|6-12 Months|Adverse Event|3|||
131228690|NCT01829295|472463308|FG003|6-12 Months|Adverse Event|2|||
131228691|NCT01829295|472463305|FG000|6-12 Months|Lost to Follow-up|2|||
131228692|NCT01829295|472463306|FG001|6-12 Months|Lost to Follow-up|0|||
131228693|NCT01829295|472463307|FG002|6-12 Months|Lost to Follow-up|0|||
131228694|NCT01829295|472463308|FG003|6-12 Months|Lost to Follow-up|0|||
131228695|NCT01829295|472463305|FG000|6-12 Months|Withdrawal by Subject|2|||
131228696|NCT01829295|472463306|FG001|6-12 Months|Withdrawal by Subject|2|||
131228697|NCT01829295|472463307|FG002|6-12 Months|Withdrawal by Subject|0|||
131228698|NCT01829295|472463308|FG003|6-12 Months|Withdrawal by Subject|0|||
131228699|NCT03558997|472463309|FG000|Overall Study|Adverse Event|0|||
131228700|NCT03558997|472463310|FG001|Overall Study|Adverse Event|2|||
131228701|NCT03558997|472463311|FG002|Overall Study|Adverse Event|5|||
131228702|NCT03558997|472463312|FG003|Overall Study|Adverse Event|1|||
131228703|NCT03558997|472463309|FG000|Overall Study|Physician Decision|0|||
131228704|NCT03558997|472463310|FG001|Overall Study|Physician Decision|0|||
131228705|NCT03558997|472463311|FG002|Overall Study|Physician Decision|1|||
131228706|NCT03558997|472463312|FG003|Overall Study|Physician Decision|0|||
131228707|NCT03558997|472463309|FG000|Overall Study|Withdrawal by Subject|1|||
131228708|NCT03558997|472463310|FG001|Overall Study|Withdrawal by Subject|0|||
131228709|NCT03558997|472463311|FG002|Overall Study|Withdrawal by Subject|1|||
131228710|NCT03558997|472463312|FG003|Overall Study|Withdrawal by Subject|1|||
131228711|NCT03558997|472463309|FG000|Overall Study|Lost to Follow-up|0|||
131228712|NCT03558997|472463310|FG001|Overall Study|Lost to Follow-up|0|||
131228713|NCT03558997|472463311|FG002|Overall Study|Lost to Follow-up|1|||
131228714|NCT03558997|472463312|FG003|Overall Study|Lost to Follow-up|0|||
131228715|NCT02230085|472463315|FG000|Overall Study|Physician Decision|1|||
131228716|NCT02230085|472463315|FG000|Overall Study|Withdrawal by Subject|3|||
131228717|NCT02884206|472465705|FG000|Valsartan Run-in Period|Death|1|||
131228718|NCT02884206|472465706|FG001|Valsartan Run-in Period|Death|0|||
131228719|NCT02884206|472465707|FG002|Valsartan Run-in Period|Death|0|||
131228720|NCT02884206|472465705|FG000|Valsartan Run-in Period|Adverse Event|31|||
131228721|NCT02884206|472465706|FG001|Valsartan Run-in Period|Adverse Event|0|||
131228722|NCT02884206|472465707|FG002|Valsartan Run-in Period|Adverse Event|0|||
131228723|NCT02884206|472465705|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
131228724|NCT02884206|472465706|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
131228725|NCT02884206|472465707|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
131133266|NCT05048719|472115232|FG002|Overall Study|Withdrawal by Subject|3|||
131133267|NCT05048719|472115233|FG003|Overall Study|Withdrawal by Subject|1|||
131133268|NCT05048719|472115234|FG004|Overall Study|Withdrawal by Subject|0|||
131133269|NCT05048719|472115235|FG005|Overall Study|Withdrawal by Subject|2|||
131133270|NCT05048719|472115236|FG006|Overall Study|Withdrawal by Subject|1|||
131133271|NCT05048719|472115237|FG007|Overall Study|Withdrawal by Subject|1|||
131133272|NCT05048719|472115238|FG008|Overall Study|Withdrawal by Subject|0|||
131133273|NCT05048719|472115230|FG000|Overall Study|Death|1|||
131133274|NCT05048719|472115231|FG001|Overall Study|Death|0|||
131133275|NCT05048719|472115232|FG002|Overall Study|Death|0|||
131133276|NCT05048719|472115233|FG003|Overall Study|Death|0|||
131133277|NCT05048719|472115234|FG004|Overall Study|Death|0|||
131133278|NCT05048719|472115235|FG005|Overall Study|Death|0|||
131133279|NCT05048719|472115236|FG006|Overall Study|Death|0|||
131133280|NCT05048719|472115237|FG007|Overall Study|Death|0|||
131133281|NCT05048719|472115238|FG008|Overall Study|Death|0|||
131133282|NCT05048719|472115230|FG000|Overall Study|Adverse Event|0|||
131133283|NCT05048719|472115231|FG001|Overall Study|Adverse Event|1|||
131133284|NCT05048719|472115232|FG002|Overall Study|Adverse Event|2|||
131133285|NCT05048719|472115233|FG003|Overall Study|Adverse Event|0|||
131133286|NCT05048719|472115234|FG004|Overall Study|Adverse Event|1|||
131133287|NCT05048719|472115235|FG005|Overall Study|Adverse Event|0|||
131133288|NCT05048719|472115236|FG006|Overall Study|Adverse Event|0|||
131133289|NCT05048719|472115237|FG007|Overall Study|Adverse Event|0|||
131133290|NCT05048719|472115238|FG008|Overall Study|Adverse Event|0|||
131133291|NCT05048719|472115230|FG000|Overall Study|Lost to Follow-up|0|||
131133292|NCT05048719|472115231|FG001|Overall Study|Lost to Follow-up|0|||
131133293|NCT05048719|472115232|FG002|Overall Study|Lost to Follow-up|1|||
131133294|NCT05048719|472115233|FG003|Overall Study|Lost to Follow-up|3|||
131133295|NCT05048719|472115234|FG004|Overall Study|Lost to Follow-up|1|||
131133296|NCT05048719|472115235|FG005|Overall Study|Lost to Follow-up|1|||
131133297|NCT05048719|472115236|FG006|Overall Study|Lost to Follow-up|1|||
131133298|NCT05048719|472115237|FG007|Overall Study|Lost to Follow-up|1|||
131133299|NCT05048719|472115238|FG008|Overall Study|Lost to Follow-up|0|||
131133300|NCT05048719|472115230|FG000|Overall Study|Physician Decision|0|||
131133301|NCT05048719|472115231|FG001|Overall Study|Physician Decision|0|||
131133302|NCT05048719|472115232|FG002|Overall Study|Physician Decision|0|||
131133303|NCT05048719|472115233|FG003|Overall Study|Physician Decision|0|||
131133304|NCT05048719|472115234|FG004|Overall Study|Physician Decision|0|||
131133305|NCT05048719|472115235|FG005|Overall Study|Physician Decision|0|||
131133306|NCT05048719|472115236|FG006|Overall Study|Physician Decision|0|||
131133307|NCT05048719|472115237|FG007|Overall Study|Physician Decision|1|||
131133308|NCT05048719|472115238|FG008|Overall Study|Physician Decision|1|||
131133309|NCT05048719|472115230|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
131133310|NCT05048719|472115231|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131133311|NCT05048719|472115232|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131133312|NCT05048719|472115233|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131133313|NCT05048719|472115234|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131133314|NCT05048719|472115235|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131133315|NCT05048719|472115236|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131133316|NCT05048719|472115237|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131133317|NCT05048719|472115238|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
131133318|NCT05048719|472115230|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131133319|NCT05048719|472115231|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
131133320|NCT05048719|472115232|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131133321|NCT05048719|472115233|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131133322|NCT05048719|472115234|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131133323|NCT05048719|472115235|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131133324|NCT05048719|472115236|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131133325|NCT05048719|472115237|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131133326|NCT05048719|472115238|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
131133327|NCT05048719|472115230|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131133328|NCT05048719|472115231|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
131133329|NCT05048719|472115232|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130719289|NCT00536263|470597387|FG001|Overall Study|Adverse Event|5|||
131133330|NCT05048719|472115233|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131133331|NCT05048719|472115234|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131133332|NCT05048719|472115235|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131133333|NCT05048719|472115236|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131133334|NCT05048719|472115237|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
131133335|NCT05048719|472115238|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130983478|NCT04642898|471564938|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
130983479|NCT04642898|471564939|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
130983480|NCT04642898|471564934|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
130983481|NCT04642898|471564935|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
130983482|NCT04642898|471564936|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
130983483|NCT04642898|471564937|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
130983484|NCT04642898|471564938|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
130983485|NCT04642898|471564939|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
130983486|NCT03574597|471564940|FG000|Overall Study|Withdrawal by Subject|67|||
130983487|NCT03574597|471564941|FG001|Overall Study|Withdrawal by Subject|96|||
130983488|NCT03574597|471564940|FG000|Overall Study|Lost to Follow-up|192|||
130983489|NCT03574597|471564941|FG001|Overall Study|Lost to Follow-up|188|||
130983490|NCT03434678|471564942|FG000|Overall Study|Withdrawal by Subject|13|||
130983491|NCT03434678|471564943|FG001|Overall Study|Withdrawal by Subject|13|||
130983492|NCT03434678|471564942|FG000|Overall Study|Found to be ineligible post randomization|2|||
130983493|NCT03434678|471564943|FG001|Overall Study|Found to be ineligible post randomization|1|||
130983494|NCT06060457|471564946|FG000|Overall Study|Adverse Event|1|||
130983495|NCT06060457|471564947|FG001|Overall Study|Adverse Event|1|||
130983496|NCT06060457|471564946|FG000|Overall Study|Death|2|||
130983497|NCT06060457|471564947|FG001|Overall Study|Death|2|||
130983498|NCT06060457|471564946|FG000|Overall Study|Lost to Follow-up|17|||
130983499|NCT06060457|471564947|FG001|Overall Study|Lost to Follow-up|19|||
130983500|NCT06060457|471564946|FG000|Overall Study|Physician Decision|0|||
130983501|NCT06060457|471564947|FG001|Overall Study|Physician Decision|1|||
130983502|NCT06060457|471564946|FG000|Overall Study|Protocol Violation|1|||
130983503|NCT06060457|471564947|FG001|Overall Study|Protocol Violation|1|||
130983504|NCT06060457|471564946|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
130983505|NCT06060457|471564947|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
130983506|NCT06060457|471564946|FG000|Overall Study|Withdrawal by Subject|12|||
130983507|NCT06060457|471564947|FG001|Overall Study|Withdrawal by Subject|15|||
130983508|NCT06060457|471564946|FG000|Overall Study|Other Than Specified|2|||
130983509|NCT06060457|471564947|FG001|Overall Study|Other Than Specified|1|||
130983510|NCT02061202|471564948|FG000|Overall Study|Lost to Follow-up|1|||
130983511|NCT02061202|471564949|FG001|Overall Study|Lost to Follow-up|1|||
130983512|NCT01533493|471564950|FG000|Overall Study|Adverse Event|2|||
130983513|NCT01533493|471564951|FG001|Overall Study|Adverse Event|1|||
130983514|NCT01533493|471564950|FG000|Overall Study|Withdrawal by Subject|1|||
130983515|NCT01533493|471564951|FG001|Overall Study|Withdrawal by Subject|2|||
130983516|NCT01533493|471564950|FG000|Overall Study|Lost to Follow-up|2|||
130983517|NCT01533493|471564951|FG001|Overall Study|Lost to Follow-up|0|||
130983518|NCT05163522|471564952|FG000|Overall Study|Withdrawal by Subject|0|||
130983519|NCT05163522|471564953|FG001|Overall Study|Withdrawal by Subject|0|||
130983520|NCT05163522|471564954|FG002|Overall Study|Withdrawal by Subject|1|||
130983521|NCT05163522|471564955|FG003|Overall Study|Withdrawal by Subject|0|||
130983522|NCT05163522|471564956|FG004|Overall Study|Withdrawal by Subject|0|||
130983523|NCT05163522|471564957|FG005|Overall Study|Withdrawal by Subject|0|||
130983524|NCT05163522|471564958|FG006|Overall Study|Withdrawal by Subject|0|||
130983525|NCT05163522|471564959|FG007|Overall Study|Withdrawal by Subject|0|||
130983526|NCT05163522|471564960|FG008|Overall Study|Withdrawal by Subject|0|||
130983527|NCT05163522|471564961|FG009|Overall Study|Withdrawal by Subject|0|||
130983528|NCT05163522|471564962|FG010|Overall Study|Withdrawal by Subject|0|||
130983529|NCT02660827|471564963|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
130983530|NCT02660827|471564963|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
130983531|NCT02660827|471564963|FG000|From Study to End of Continued Access|Adverse Event|3|||
130983532|NCT02660827|471564963|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
130983533|NCT02660827|471564963|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
130983534|NCT02660827|471564963|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
130719290|NCT00536263|470597388|FG002|Overall Study|Adverse Event|7|||
130983535|NCT02660827|471564963|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
130983536|NCT02660827|471564963|FG000|Period 2: Continued Access Period|Adverse Event|3|||
130983537|NCT02638948|471564969|FG000|Overall Study|Withdrawal by Subject|4|||
130983538|NCT02638948|471564970|FG001|Overall Study|Withdrawal by Subject|5|||
130983539|NCT02638948|471564971|FG002|Overall Study|Withdrawal by Subject|3|||
130983540|NCT02638948|471564972|FG003|Overall Study|Withdrawal by Subject|1|||
130983541|NCT02638948|471564969|FG000|Overall Study|Administrative Reason by Sponsor|0|||
130983542|NCT02638948|471564970|FG001|Overall Study|Administrative Reason by Sponsor|1|||
130983543|NCT02638948|471564971|FG002|Overall Study|Administrative Reason by Sponsor|0|||
130983544|NCT02638948|471564972|FG003|Overall Study|Administrative Reason by Sponsor|4|||
130983545|NCT02638948|471564969|FG000|Overall Study|Adverse Event|0|||
130983546|NCT02638948|471564970|FG001|Overall Study|Adverse Event|0|||
131044723|NCT01570361|471797614|FG000|Overall Study|Subject excluded|5|||
131044724|NCT01570361|471797615|FG001|Overall Study|Subject excluded|3|||
131133336|NCT05048719|472115230|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131133337|NCT05048719|472115231|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131133338|NCT05048719|472115232|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131133339|NCT05048719|472115233|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
130719291|NCT00536263|470597386|FG000|Overall Study|Lost to Follow-up|3|||
130719292|NCT00536263|470597387|FG001|Overall Study|Lost to Follow-up|4|||
130719293|NCT00536263|470597388|FG002|Overall Study|Lost to Follow-up|4|||
130719294|NCT00536263|470597386|FG000|Overall Study|Subject withdrew - not treatment related|2|||
130719295|NCT00536263|470597387|FG001|Overall Study|Subject withdrew - not treatment related|0|||
130719296|NCT00536263|470597388|FG002|Overall Study|Subject withdrew - not treatment related|5|||
130719297|NCT00536263|470597386|FG000|Overall Study|Subject withdrew - treatment related|0|||
130719298|NCT00536263|470597387|FG001|Overall Study|Subject withdrew - treatment related|3|||
130719299|NCT00536263|470597388|FG002|Overall Study|Subject withdrew - treatment related|2|||
130719300|NCT00536263|470597386|FG000|Overall Study|Noncompliance with protocol|0|||
130719301|NCT00536263|470597387|FG001|Overall Study|Noncompliance with protocol|0|||
130719302|NCT00536263|470597388|FG002|Overall Study|Noncompliance with protocol|1|||
130719303|NCT00536263|470597386|FG000|Overall Study|Did not meet protocol eligibility|1|||
130983547|NCT02638948|471564971|FG002|Overall Study|Adverse Event|1|||
130983548|NCT02638948|471564972|FG003|Overall Study|Adverse Event|1|||
130983549|NCT02638948|471564969|FG000|Overall Study|Lack of Efficacy|1|||
130983550|NCT02638948|471564970|FG001|Overall Study|Lack of Efficacy|1|||
130719304|NCT00536263|470597387|FG001|Overall Study|Did not meet protocol eligibility|2|||
130719305|NCT00536263|470597388|FG002|Overall Study|Did not meet protocol eligibility|2|||
130778838|NCT03428100|470817454|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130983551|NCT02638948|471564971|FG002|Overall Study|Lack of Efficacy|0|||
130983552|NCT02638948|471564972|FG003|Overall Study|Lack of Efficacy|0|||
130983553|NCT02638948|471564969|FG000|Overall Study|Lost to Follow-up|0|||
130983554|NCT02638948|471564970|FG001|Overall Study|Lost to Follow-up|0|||
130983555|NCT02638948|471564971|FG002|Overall Study|Lost to Follow-up|1|||
130983556|NCT02638948|471564972|FG003|Overall Study|Lost to Follow-up|1|||
130983557|NCT02638948|471564969|FG000|Overall Study|Poor/Non-Compliance|0|||
130983558|NCT02638948|471564970|FG001|Overall Study|Poor/Non-Compliance|2|||
130983559|NCT02638948|471564971|FG002|Overall Study|Poor/Non-Compliance|1|||
130983560|NCT02638948|471564972|FG003|Overall Study|Poor/Non-Compliance|0|||
130983561|NCT02638948|471564969|FG000|Overall Study|Participant no longer met study criteria|0|||
130983562|NCT02638948|471564970|FG001|Overall Study|Participant no longer met study criteria|1|||
130983563|NCT02638948|471564971|FG002|Overall Study|Participant no longer met study criteria|0|||
130983564|NCT02638948|471564972|FG003|Overall Study|Participant no longer met study criteria|0|||
130983565|NCT02638948|471564969|FG000|Overall Study|Other than specified above|4|||
130983566|NCT02638948|471564970|FG001|Overall Study|Other than specified above|1|||
131133340|NCT05048719|472115234|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131133341|NCT05048719|472115235|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131133342|NCT05048719|472115236|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131133343|NCT05048719|472115237|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131133344|NCT05048719|472115238|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
131133345|NCT05048719|472115230|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131133346|NCT05048719|472115231|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131133347|NCT05048719|472115232|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131133348|NCT05048719|472115233|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131133349|NCT05048719|472115234|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131133350|NCT05048719|472115235|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
131133351|NCT05048719|472115236|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131133352|NCT05048719|472115237|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131133353|NCT05048719|472115238|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
131133354|NCT04541004|472115239|FG000|Overall Study|Adverse Event|2|||
131133355|NCT00817531|472115241|FG000|Overall Study|Adverse Event|1|||
131133356|NCT00817531|472115241|FG000|Overall Study|Lack of Efficacy|1|||
131133357|NCT02105454|472115246|FG000|Overall Study|Withdrawal by Subject|1|||
131133358|NCT02721355|472115247|FG000|Overall Study|Lost to Follow-up|6|||
131133359|NCT02721355|472115248|FG001|Overall Study|Lost to Follow-up|1|||
131133360|NCT00356278|472115249|FG000|Overall Study|Withdrawal by Subject|25|||
131133361|NCT00356278|472115250|FG001|Overall Study|Withdrawal by Subject|15|||
131133362|NCT00356278|472115251|FG002|Overall Study|Withdrawal by Subject|19|||
131133363|NCT01652287|472115252|FG000|Overall Study|Withdrawal by Subject|2|||
130719306|NCT03285308|470597391|FG000|Overall Study|Adverse Event|3|||
130719307|NCT03285308|470597392|FG001|Overall Study|Adverse Event|7|||
130719308|NCT03285308|470597391|FG000|Overall Study|Withdrawal by Subject|8|||
130983567|NCT02638948|471564971|FG002|Overall Study|Other than specified above|1|||
130983568|NCT02638948|471564972|FG003|Overall Study|Other than specified above|1|||
130983569|NCT00810264|471564976|FG000|Overall Study|Lost to Follow-up|191|||
130983570|NCT00810264|471564976|FG000|Overall Study|Withdrawal by subject or physician|721|||
130983571|NCT00810264|471564976|FG000|Overall Study|Death|641|||
130983572|NCT06213701|471564977|FG000|Overall Study|Withdrawal by Subject|2|||
130983573|NCT06213701|471564978|FG001|Overall Study|Withdrawal by Subject|1|||
131133364|NCT01652287|472115253|FG001|Overall Study|Withdrawal by Subject|0|||
130719309|NCT03285308|470597392|FG001|Overall Study|Withdrawal by Subject|9|||
130719310|NCT03285308|470597391|FG000|Overall Study|Lost to Follow-up|3|||
130719311|NCT03285308|470597392|FG001|Overall Study|Lost to Follow-up|1|||
130719312|NCT03285308|470597391|FG000|Overall Study|Protocol Deviation|6|||
130719313|NCT03285308|470597392|FG001|Overall Study|Protocol Deviation|5|||
130719314|NCT03285308|470597391|FG000|Overall Study|Reason not Specified|0|||
130719315|NCT03285308|470597392|FG001|Overall Study|Reason not Specified|1|||
130719316|NCT01181271|470597394|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
130719317|NCT01181271|470597394|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
130719318|NCT01181271|470597394|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
130719319|NCT01181271|470597394|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
130719320|NCT04135196|470597395|FG000|Overall Study|Lost to Follow-up|8|||
130719321|NCT04135196|470597396|FG001|Overall Study|Lost to Follow-up|7|||
130719322|NCT04135196|470597397|FG002|Overall Study|Lost to Follow-up|8|||
130719323|NCT04135196|470597398|FG003|Overall Study|Lost to Follow-up|9|||
130719324|NCT04135196|470597399|FG004|Overall Study|Lost to Follow-up|1|||
130719325|NCT04135196|470597395|FG000|Overall Study|Pregnancy|0|||
130719326|NCT04135196|470597396|FG001|Overall Study|Pregnancy|0|||
130719327|NCT04135196|470597397|FG002|Overall Study|Pregnancy|1|||
130719328|NCT04135196|470597398|FG003|Overall Study|Pregnancy|0|||
130719329|NCT04135196|470597399|FG004|Overall Study|Pregnancy|0|||
130719330|NCT04135196|470597395|FG000|Overall Study|Withdrawal by Subject|0|||
130719331|NCT04135196|470597396|FG001|Overall Study|Withdrawal by Subject|0|||
130719332|NCT04135196|470597397|FG002|Overall Study|Withdrawal by Subject|0|||
130719333|NCT04135196|470597398|FG003|Overall Study|Withdrawal by Subject|0|||
130719334|NCT04135196|470597399|FG004|Overall Study|Withdrawal by Subject|1|||
130719335|NCT00809159|470597400|FG000|Part 1|Adverse Event|1|||
130719336|NCT00809159|470597401|FG001|Part 1|Adverse Event|1|||
130719337|NCT00809159|470597402|FG002|Part 1|Adverse Event|0|||
130719338|NCT00809159|470597403|FG003|Part 1|Adverse Event|0|||
130719339|NCT00809159|470597404|FG004|Part 1|Adverse Event|0|||
130719340|NCT00809159|470597405|FG005|Part 1|Adverse Event|0|||
130719341|NCT00809159|470597400|FG000|Part 1|Lost to Follow-up|1|||
130719342|NCT00809159|470597401|FG001|Part 1|Lost to Follow-up|0|||
130719343|NCT00809159|470597402|FG002|Part 1|Lost to Follow-up|0|||
130719344|NCT00809159|470597403|FG003|Part 1|Lost to Follow-up|0|||
130719345|NCT00809159|470597404|FG004|Part 1|Lost to Follow-up|0|||
130719346|NCT00809159|470597405|FG005|Part 1|Lost to Follow-up|0|||
130719347|NCT00809159|470597400|FG000|Part 1|Withdrawal by Subject|3|||
130719348|NCT00809159|470597401|FG001|Part 1|Withdrawal by Subject|1|||
130719349|NCT00809159|470597402|FG002|Part 1|Withdrawal by Subject|0|||
130719350|NCT00809159|470597403|FG003|Part 1|Withdrawal by Subject|0|||
130719351|NCT00809159|470597404|FG004|Part 1|Withdrawal by Subject|0|||
130719352|NCT00809159|470597405|FG005|Part 1|Withdrawal by Subject|0|||
130719353|NCT00809159|470597400|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
130719354|NCT00809159|470597401|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
130719355|NCT00809159|470597402|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
130719356|NCT00809159|470597403|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
130719357|NCT00809159|470597404|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
130719358|NCT00809159|470597405|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
130719359|NCT00809159|470597400|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
130719360|NCT00809159|470597401|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
130983574|NCT06213701|471564979|FG002|Overall Study|Withdrawal by Subject|0|||
130983575|NCT02495025|471564986|FG000|Overall Study|Lost to Follow-up|21|||
130719361|NCT00809159|470597402|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
130719362|NCT00809159|470597403|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
130719363|NCT00809159|470597404|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
130719364|NCT00809159|470597405|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
130719365|NCT00809159|470597400|FG000|Part 1 and 2|Administrative problems|0|||
130719366|NCT00809159|470597401|FG001|Part 1 and 2|Administrative problems|0|||
130719367|NCT00809159|470597402|FG002|Part 1 and 2|Administrative problems|0|||
130719368|NCT00809159|470597403|FG003|Part 1 and 2|Administrative problems|1|||
130983576|NCT02495025|471564987|FG001|Overall Study|Lost to Follow-up|14|||
130719369|NCT00809159|470597404|FG004|Part 1 and 2|Administrative problems|0|||
130719370|NCT00809159|470597405|FG005|Part 1 and 2|Administrative problems|0|||
130719371|NCT00809159|470597400|FG000|Part 1 and 2|Adverse Event|0|||
130719372|NCT00809159|470597401|FG001|Part 1 and 2|Adverse Event|0|||
130719373|NCT00809159|470597402|FG002|Part 1 and 2|Adverse Event|1|||
130719374|NCT00809159|470597403|FG003|Part 1 and 2|Adverse Event|0|||
130719375|NCT00809159|470597404|FG004|Part 1 and 2|Adverse Event|1|||
130719376|NCT00809159|470597405|FG005|Part 1 and 2|Adverse Event|1|||
130719377|NCT00809159|470597400|FG000|Part 1 and 2|Lost to Follow-up|0|||
130719378|NCT00809159|470597401|FG001|Part 1 and 2|Lost to Follow-up|0|||
130719379|NCT00809159|470597402|FG002|Part 1 and 2|Lost to Follow-up|1|||
130719380|NCT00809159|470597403|FG003|Part 1 and 2|Lost to Follow-up|1|||
130719381|NCT00809159|470597404|FG004|Part 1 and 2|Lost to Follow-up|0|||
130719382|NCT00809159|470597405|FG005|Part 1 and 2|Lost to Follow-up|0|||
130719383|NCT00809159|470597400|FG000|Part 1 and 2|Withdrawal by Subject|0|||
130719384|NCT00809159|470597401|FG001|Part 1 and 2|Withdrawal by Subject|0|||
130719385|NCT00809159|470597402|FG002|Part 1 and 2|Withdrawal by Subject|4|||
130719386|NCT00809159|470597403|FG003|Part 1 and 2|Withdrawal by Subject|0|||
130719387|NCT00809159|470597404|FG004|Part 1 and 2|Withdrawal by Subject|0|||
130719388|NCT00809159|470597405|FG005|Part 1 and 2|Withdrawal by Subject|1|||
130719389|NCT03201211|470597406|FG000|Overall Study|Adverse Event|1|||
130719390|NCT03201211|470597407|FG001|Overall Study|Adverse Event|0|||
130719391|NCT03201211|470597408|FG002|Overall Study|Adverse Event|0|||
130719392|NCT03201211|470597406|FG000|Overall Study|Protocol Violation|1|||
130719393|NCT03201211|470597407|FG001|Overall Study|Protocol Violation|0|||
130719394|NCT03201211|470597408|FG002|Overall Study|Protocol Violation|0|||
130719395|NCT03201211|470597406|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131133365|NCT00527605|472115254|FG000|Overall Study|Adverse Event|3|||
131133366|NCT00527605|472115255|FG001|Overall Study|Adverse Event|0|||
131133367|NCT00527605|472115254|FG000|Overall Study|Withdrawal by Subject|3|||
131133368|NCT00527605|472115255|FG001|Overall Study|Withdrawal by Subject|7|||
131133369|NCT00527605|472115254|FG000|Overall Study|Lost to Follow-up|6|||
131133370|NCT00527605|472115255|FG001|Overall Study|Lost to Follow-up|2|||
130719396|NCT03201211|470597407|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130719397|NCT03201211|470597408|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
130719398|NCT03201211|470597406|FG000|Overall Study|OTHER unknown reasons|0|||
130719399|NCT03201211|470597407|FG001|Overall Study|OTHER unknown reasons|1|||
131133371|NCT00527605|472115254|FG000|Overall Study|Protocol Violation|1|||
131133372|NCT00527605|472115255|FG001|Overall Study|Protocol Violation|2|||
131133373|NCT00763139|472115256|FG000|Overall Study|Adverse Event|4|||
131133374|NCT00763139|472115257|FG001|Overall Study|Adverse Event|2|||
131133375|NCT00763139|472115256|FG000|Overall Study|Withdrawal by Subject|0|||
131133376|NCT00763139|472115257|FG001|Overall Study|Withdrawal by Subject|1|||
131133377|NCT00763139|472115256|FG000|Overall Study|med change not allowed by protocol|1|||
131133378|NCT00763139|472115257|FG001|Overall Study|med change not allowed by protocol|0|||
131133379|NCT01592760|472115258|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
131228726|NCT02884206|472465705|FG000|Valsartan Run-in Period|Protocol deviation|4|||
130719400|NCT03201211|470597408|FG002|Overall Study|OTHER unknown reasons|0|||
130719401|NCT01083810|470597409|FG000|Overall Study|Lost to Follow-up|23|||
131228727|NCT02884206|472465706|FG001|Valsartan Run-in Period|Protocol deviation|0|||
131228728|NCT02884206|472465707|FG002|Valsartan Run-in Period|Protocol deviation|0|||
131228729|NCT02884206|472465705|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
130719402|NCT01083810|470597410|FG001|Overall Study|Lost to Follow-up|11|||
130719403|NCT01083810|470597411|FG002|Overall Study|Lost to Follow-up|4|||
130719404|NCT01083810|470597409|FG000|Overall Study|Adverse Event|15|||
130719405|NCT01083810|470597410|FG001|Overall Study|Adverse Event|11|||
130719406|NCT01083810|470597411|FG002|Overall Study|Adverse Event|4|||
130719407|NCT01083810|470597409|FG000|Overall Study|Withdrawal by Subject|7|||
130719408|NCT01083810|470597410|FG001|Overall Study|Withdrawal by Subject|2|||
130719409|NCT01083810|470597411|FG002|Overall Study|Withdrawal by Subject|4|||
130719410|NCT01083810|470597409|FG000|Overall Study|Reason not reported|6|||
130719411|NCT01083810|470597410|FG001|Overall Study|Reason not reported|1|||
130719412|NCT01083810|470597411|FG002|Overall Study|Reason not reported|1|||
130719413|NCT01083810|470597409|FG000|Overall Study|Non-compliance|4|||
130719414|NCT01083810|470597410|FG001|Overall Study|Non-compliance|7|||
130719415|NCT01083810|470597411|FG002|Overall Study|Non-compliance|2|||
130719416|NCT01083810|470597409|FG000|Overall Study|Simplification|4|||
130719417|NCT01083810|470597410|FG001|Overall Study|Simplification|1|||
130719418|NCT01083810|470597411|FG002|Overall Study|Simplification|0|||
130719419|NCT01083810|470597409|FG000|Overall Study|Death|2|||
130719420|NCT01083810|470597410|FG001|Overall Study|Death|2|||
130719421|NCT01083810|470597411|FG002|Overall Study|Death|3|||
130719422|NCT01083810|470597409|FG000|Overall Study|Co-morbidities|1|||
130719423|NCT01083810|470597410|FG001|Overall Study|Co-morbidities|0|||
130719424|NCT01083810|470597411|FG002|Overall Study|Co-morbidities|0|||
130719425|NCT01083810|470597409|FG000|Overall Study|Participation in study|1|||
130719426|NCT01083810|470597410|FG001|Overall Study|Participation in study|0|||
130719427|NCT01083810|470597411|FG002|Overall Study|Participation in study|0|||
130719428|NCT01083810|470597409|FG000|Overall Study|Therapy break|1|||
130719429|NCT01083810|470597410|FG001|Overall Study|Therapy break|2|||
131133380|NCT01592760|472115259|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
131133381|NCT01592760|472115260|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
131133382|NCT04312009|472115261|FG000|Overall Study|Withdrawal by Subject|2|||
131133383|NCT04312009|472115262|FG001|Overall Study|Withdrawal by Subject|1|||
130719430|NCT01083810|470597411|FG002|Overall Study|Therapy break|2|||
130719431|NCT01083810|470597409|FG000|Overall Study|Virologic failure|1|||
130719432|NCT01083810|470597410|FG001|Overall Study|Virologic failure|8|||
130719433|NCT01083810|470597411|FG002|Overall Study|Virologic failure|0|||
130719434|NCT02991430|470597414|FG000|Treatment Period 1|Adverse Event|1|||
130719435|NCT02991430|470597415|FG001|Treatment Period 1|Adverse Event|0|||
130719436|NCT02991430|470597416|FG002|Treatment Period 1|Adverse Event|2|||
130719437|NCT02991430|470597414|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130719438|NCT02991430|470597415|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130719439|NCT02991430|470597416|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130719440|NCT02991430|470597414|FG000|Treatment Period 2|Study Termination|6|||
130719441|NCT02991430|470597415|FG001|Treatment Period 2|Study Termination|3|||
130719442|NCT02991430|470597416|FG002|Treatment Period 2|Study Termination|3|||
130719443|NCT02991430|470597414|FG000|Treatment Period 2|Lost to Follow-up|0|||
130719444|NCT02991430|470597415|FG001|Treatment Period 2|Lost to Follow-up|0|||
130719445|NCT02991430|470597416|FG002|Treatment Period 2|Lost to Follow-up|1|||
130719446|NCT02991430|470597414|FG000|Post-treatment Observation Period|Study Termination|3|||
130719447|NCT02991430|470597415|FG001|Post-treatment Observation Period|Study Termination|6|||
130719448|NCT02991430|470597416|FG002|Post-treatment Observation Period|Study Termination|5|||
130719449|NCT03118570|470597417|FG000|Overall Study|Adverse Event|2|||
130719450|NCT03118570|470597418|FG001|Overall Study|Adverse Event|0|||
130719451|NCT03118570|470597419|FG002|Overall Study|Adverse Event|0|||
130719452|NCT03118570|470597420|FG003|Overall Study|Adverse Event|0|||
130719453|NCT03118570|470597421|FG004|Overall Study|Adverse Event|3|||
130719454|NCT03118570|470597417|FG000|Overall Study|Withdrawal by Subject|0|||
130719455|NCT03118570|470597418|FG001|Overall Study|Withdrawal by Subject|1|||
130719456|NCT03118570|470597419|FG002|Overall Study|Withdrawal by Subject|4|||
130719457|NCT03118570|470597420|FG003|Overall Study|Withdrawal by Subject|0|||
130719458|NCT03118570|470597421|FG004|Overall Study|Withdrawal by Subject|1|||
130719459|NCT03118570|470597417|FG000|Overall Study|Lost to Follow-up|2|||
130719460|NCT03118570|470597418|FG001|Overall Study|Lost to Follow-up|3|||
130719461|NCT03118570|470597419|FG002|Overall Study|Lost to Follow-up|1|||
130983577|NCT02495025|471564986|FG000|Overall Study|Withdrawal by Subject|5|||
130983578|NCT02495025|471564987|FG001|Overall Study|Withdrawal by Subject|0|||
130983579|NCT00313820|471564989|FG000|Assigned to Treatment|Other|1|||
130983580|NCT00313820|471564990|FG001|Assigned to Treatment|Other|0|||
130983581|NCT00313820|471564989|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
130983582|NCT00313820|471564990|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
130719462|NCT03118570|470597420|FG003|Overall Study|Lost to Follow-up|0|||
130719463|NCT03118570|470597421|FG004|Overall Study|Lost to Follow-up|1|||
130719464|NCT03118570|470597417|FG000|Overall Study|Other, Not Specified|1|||
130719465|NCT03118570|470597418|FG001|Overall Study|Other, Not Specified|3|||
130778839|NCT03428100|470817455|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130983583|NCT00313820|471564989|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
130983584|NCT00313820|471564990|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
130983585|NCT00313820|471564989|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
130983586|NCT00313820|471564990|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
130983587|NCT00313820|471564989|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
130983588|NCT00313820|471564990|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
130983589|NCT00313820|471564989|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
130983590|NCT00313820|471564990|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
130983591|NCT00265889|471564993|FG000|Overall Study|Physician Decision|1|||
130983592|NCT00265889|471564993|FG000|Overall Study|Protocol Violation|1|||
130983593|NCT00265889|471564993|FG000|Overall Study|Insurance denied the request|3|||
130983594|NCT02134587|471564994|FG000|Overall Study|Did not completed all meetings|30|||
130983595|NCT01515748|471564998|FG000|Overall Study|Withdrawal by Subject|32|||
130983596|NCT01515748|471564999|FG001|Overall Study|Withdrawal by Subject|41|||
130983597|NCT01515748|471564998|FG000|Overall Study|Lost to Follow-up|2|||
130983598|NCT01515748|471564999|FG001|Overall Study|Lost to Follow-up|4|||
130983599|NCT01515748|471564998|FG000|Overall Study|Other than specified above|5|||
130983600|NCT01515748|471564999|FG001|Overall Study|Other than specified above|10|||
130983601|NCT03221387|471565002|FG000|Overall Study|Lost to Follow-up|1|||
130983602|NCT03221387|471565002|FG000|Overall Study|Lung transplant|1|||
130983603|NCT00522626|471565003|FG000|Overall Study|Lost to Follow-up|7|||
130983604|NCT04102579|471565009|FG000|Overall Study|Withdrawal by Subject|3|||
130983605|NCT04102579|471565010|FG001|Overall Study|Withdrawal by Subject|4|||
130983606|NCT04102579|471565009|FG000|Overall Study|Lost to Follow-up|0|||
130983607|NCT04102579|471565010|FG001|Overall Study|Lost to Follow-up|1|||
130983608|NCT04102579|471565009|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
130983609|NCT04102579|471565010|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
130983610|NCT04102579|471565009|FG000|Overall Study|Other than Specified|1|||
130983611|NCT04102579|471565010|FG001|Overall Study|Other than Specified|0|||
130983612|NCT04102579|471565009|FG000|Overall Study|Not Dosed with Study Drug|0|||
131133384|NCT00179309|472115273|FG000|Treatment|Toxicity|2|||
130719466|NCT03118570|470597419|FG002|Overall Study|Other, Not Specified|0|||
130983613|NCT04102579|471565010|FG001|Overall Study|Not Dosed with Study Drug|1|||
130983614|NCT03419364|471565011|FG000|Overall Study|Delivery due to maternal condition|2|||
130983615|NCT03419364|471565012|FG001|Overall Study|Delivery due to maternal condition|0|||
130719467|NCT03118570|470597420|FG003|Overall Study|Other, Not Specified|0|||
130719468|NCT03118570|470597421|FG004|Overall Study|Other, Not Specified|0|||
130719469|NCT03970837|470597422|FG000|Overall Study|Adverse Event|23|||
130719470|NCT03970837|470597423|FG001|Overall Study|Adverse Event|20|||
130719471|NCT03970837|470597424|FG002|Overall Study|Adverse Event|16|||
130719472|NCT03970837|470597425|FG003|Overall Study|Adverse Event|6|||
130719473|NCT03970837|470597426|FG004|Overall Study|Adverse Event|4|||
130719474|NCT03970837|470597427|FG005|Overall Study|Adverse Event|5|||
130719475|NCT03970837|470597428|FG006|Overall Study|Adverse Event|1|||
130719476|NCT03970837|470597429|FG007|Overall Study|Adverse Event|5|||
130719477|NCT03970837|470597430|FG008|Overall Study|Adverse Event|0|||
130719478|NCT03970837|470597431|FG009|Overall Study|Adverse Event|0|||
130719479|NCT03970837|470597432|FG010|Overall Study|Adverse Event|1|||
130719480|NCT03970837|470597433|FG011|Overall Study|Adverse Event|1|||
130719481|NCT03970837|470597422|FG000|Overall Study|Lack of Efficacy|14|||
130719482|NCT03970837|470597423|FG001|Overall Study|Lack of Efficacy|12|||
130719483|NCT03970837|470597424|FG002|Overall Study|Lack of Efficacy|1|||
130719484|NCT03970837|470597425|FG003|Overall Study|Lack of Efficacy|2|||
130719485|NCT03970837|470597426|FG004|Overall Study|Lack of Efficacy|3|||
130719486|NCT03970837|470597427|FG005|Overall Study|Lack of Efficacy|4|||
130719487|NCT03970837|470597428|FG006|Overall Study|Lack of Efficacy|6|||
130983616|NCT03419364|471565013|FG002|Overall Study|Delivery due to maternal condition|0|||
130983617|NCT00939484|471566355|FG000|Overall Study|Progression/Relapse|8|||
130983618|NCT00939484|471566356|FG001|Overall Study|Progression/Relapse|20|||
130983619|NCT00939484|471566357|FG002|Overall Study|Progression/Relapse|3|||
130983620|NCT01224925|471566358|FG000|Overall Study|Lost to Follow-up|3|||
130983621|NCT01224925|471566359|FG001|Overall Study|Lost to Follow-up|2|||
130983622|NCT00245102|471566361|FG000|Overall Study|Not Treated|1|||
130983623|NCT00245102|471566362|FG001|Overall Study|Not Treated|0|||
130983624|NCT00245102|471566363|FG002|Overall Study|Not Treated|1|||
130983625|NCT00245102|471566364|FG003|Overall Study|Not Treated|0|||
130983626|NCT00245102|471566365|FG004|Overall Study|Not Treated|0|||
130983627|NCT00245102|471566366|FG005|Overall Study|Not Treated|0|||
130983628|NCT00245102|471566361|FG000|Overall Study|Protocol Violation|1|||
130983629|NCT00245102|471566362|FG001|Overall Study|Protocol Violation|0|||
130983630|NCT00245102|471566363|FG002|Overall Study|Protocol Violation|0|||
130983631|NCT00245102|471566364|FG003|Overall Study|Protocol Violation|0|||
130983632|NCT00245102|471566365|FG004|Overall Study|Protocol Violation|0|||
130983633|NCT00245102|471566366|FG005|Overall Study|Protocol Violation|0|||
130983634|NCT00245102|471566361|FG000|Overall Study|Death|0|||
130983635|NCT00245102|471566362|FG001|Overall Study|Death|0|||
130983636|NCT00245102|471566363|FG002|Overall Study|Death|0|||
130983637|NCT00245102|471566364|FG003|Overall Study|Death|1|||
130983638|NCT00245102|471566365|FG004|Overall Study|Death|0|||
130983639|NCT00245102|471566366|FG005|Overall Study|Death|0|||
130983640|NCT00245102|471566361|FG000|Overall Study|Adverse Event|4|||
130983641|NCT00245102|471566362|FG001|Overall Study|Adverse Event|2|||
130983642|NCT00245102|471566363|FG002|Overall Study|Adverse Event|5|||
130983643|NCT00245102|471566364|FG003|Overall Study|Adverse Event|1|||
130983644|NCT00245102|471566365|FG004|Overall Study|Adverse Event|0|||
130983645|NCT00245102|471566366|FG005|Overall Study|Adverse Event|2|||
130983646|NCT00245102|471566361|FG000|Overall Study|Decline in performance|0|||
130983647|NCT00245102|471566362|FG001|Overall Study|Decline in performance|2|||
130983648|NCT00245102|471566363|FG002|Overall Study|Decline in performance|0|||
130983649|NCT00245102|471566364|FG003|Overall Study|Decline in performance|1|||
130983650|NCT00245102|471566365|FG004|Overall Study|Decline in performance|0|||
130983651|NCT00245102|471566366|FG005|Overall Study|Decline in performance|2|||
130983652|NCT00245102|471566361|FG000|Overall Study|Participant needed surgery|0|||
130983653|NCT00245102|471566362|FG001|Overall Study|Participant needed surgery|0|||
130983654|NCT00245102|471566363|FG002|Overall Study|Participant needed surgery|1|||
130983655|NCT00245102|471566364|FG003|Overall Study|Participant needed surgery|0|||
130983656|NCT00245102|471566365|FG004|Overall Study|Participant needed surgery|0|||
130983657|NCT00245102|471566366|FG005|Overall Study|Participant needed surgery|0|||
131044725|NCT01570361|471797614|FG000|Overall Study|Subject withdrew consent|14|||
131044726|NCT01570361|471797615|FG001|Overall Study|Subject withdrew consent|9|||
130719488|NCT03970837|470597429|FG007|Overall Study|Lack of Efficacy|1|||
130719489|NCT03970837|470597430|FG008|Overall Study|Lack of Efficacy|1|||
130719490|NCT03970837|470597431|FG009|Overall Study|Lack of Efficacy|0|||
130983658|NCT00245102|471566361|FG000|Overall Study|Clinical progression|1|||
130983659|NCT00245102|471566362|FG001|Overall Study|Clinical progression|0|||
130983660|NCT00245102|471566363|FG002|Overall Study|Clinical progression|0|||
130983661|NCT00245102|471566364|FG003|Overall Study|Clinical progression|0|||
130983662|NCT00245102|471566365|FG004|Overall Study|Clinical progression|0|||
130983663|NCT00245102|471566366|FG005|Overall Study|Clinical progression|0|||
130983664|NCT01756352|471566369|FG000|Overall Study|moved away and lost to followup|1|||
130719491|NCT03970837|470597432|FG010|Overall Study|Lack of Efficacy|0|||
130719492|NCT03970837|470597433|FG011|Overall Study|Lack of Efficacy|0|||
130983665|NCT03315143|471566370|FG000|Overall Study|Death|240|||
130983666|NCT03315143|471566371|FG001|Overall Study|Death|246|||
130983667|NCT03315143|471566370|FG000|Overall Study|Withdrawal by Subject|57|||
130983668|NCT03315143|471566371|FG001|Overall Study|Withdrawal by Subject|68|||
130983669|NCT03315143|471566370|FG000|Overall Study|Site Terminated by Sponsor|256|||
130983670|NCT03315143|471566371|FG001|Overall Study|Site Terminated by Sponsor|282|||
130983671|NCT03315143|471566370|FG000|Overall Study|Study Terminated by Sponsor|4723|||
130983672|NCT03315143|471566371|FG001|Overall Study|Study Terminated by Sponsor|4664|||
130983673|NCT03315143|471566370|FG000|Overall Study|Reason not Specified|16|||
130719493|NCT03970837|470597422|FG000|Overall Study|Lost to Follow-up|6|||
130719494|NCT03970837|470597423|FG001|Overall Study|Lost to Follow-up|5|||
130719495|NCT03970837|470597424|FG002|Overall Study|Lost to Follow-up|5|||
130719496|NCT03970837|470597425|FG003|Overall Study|Lost to Follow-up|1|||
130719497|NCT03970837|470597426|FG004|Overall Study|Lost to Follow-up|0|||
130719498|NCT03970837|470597427|FG005|Overall Study|Lost to Follow-up|2|||
130719499|NCT03970837|470597428|FG006|Overall Study|Lost to Follow-up|0|||
130719500|NCT03970837|470597429|FG007|Overall Study|Lost to Follow-up|0|||
130719501|NCT03970837|470597430|FG008|Overall Study|Lost to Follow-up|0|||
130719502|NCT03970837|470597431|FG009|Overall Study|Lost to Follow-up|0|||
130719503|NCT03970837|470597432|FG010|Overall Study|Lost to Follow-up|0|||
130719504|NCT03970837|470597433|FG011|Overall Study|Lost to Follow-up|0|||
130719505|NCT03970837|470597422|FG000|Overall Study|Protocol Violation|1|||
130719506|NCT03970837|470597423|FG001|Overall Study|Protocol Violation|0|||
130719507|NCT03970837|470597424|FG002|Overall Study|Protocol Violation|0|||
130719508|NCT03970837|470597425|FG003|Overall Study|Protocol Violation|0|||
130719509|NCT03970837|470597426|FG004|Overall Study|Protocol Violation|0|||
130719510|NCT03970837|470597427|FG005|Overall Study|Protocol Violation|0|||
130719511|NCT03970837|470597428|FG006|Overall Study|Protocol Violation|0|||
130719512|NCT03970837|470597429|FG007|Overall Study|Protocol Violation|0|||
130719513|NCT03970837|470597430|FG008|Overall Study|Protocol Violation|0|||
130719514|NCT03970837|470597431|FG009|Overall Study|Protocol Violation|0|||
130719515|NCT03970837|470597432|FG010|Overall Study|Protocol Violation|0|||
130719516|NCT03970837|470597433|FG011|Overall Study|Protocol Violation|0|||
130719517|NCT03970837|470597422|FG000|Overall Study|Physician Decision|5|||
130719518|NCT03970837|470597423|FG001|Overall Study|Physician Decision|8|||
130719519|NCT03970837|470597424|FG002|Overall Study|Physician Decision|4|||
130719520|NCT03970837|470597425|FG003|Overall Study|Physician Decision|1|||
130719521|NCT03970837|470597426|FG004|Overall Study|Physician Decision|5|||
130719522|NCT03970837|470597427|FG005|Overall Study|Physician Decision|2|||
130719523|NCT03970837|470597428|FG006|Overall Study|Physician Decision|4|||
130719524|NCT03970837|470597429|FG007|Overall Study|Physician Decision|5|||
130719525|NCT03970837|470597430|FG008|Overall Study|Physician Decision|0|||
130719526|NCT03970837|470597431|FG009|Overall Study|Physician Decision|1|||
130719527|NCT03970837|470597432|FG010|Overall Study|Physician Decision|0|||
130719528|NCT03970837|470597433|FG011|Overall Study|Physician Decision|0|||
130719529|NCT03970837|470597422|FG000|Overall Study|Withdrawal by Subject|32|||
130719530|NCT03970837|470597423|FG001|Overall Study|Withdrawal by Subject|35|||
130719531|NCT03970837|470597424|FG002|Overall Study|Withdrawal by Subject|12|||
130719532|NCT03970837|470597425|FG003|Overall Study|Withdrawal by Subject|8|||
130719533|NCT03970837|470597426|FG004|Overall Study|Withdrawal by Subject|6|||
130719534|NCT03970837|470597427|FG005|Overall Study|Withdrawal by Subject|8|||
130719535|NCT03970837|470597428|FG006|Overall Study|Withdrawal by Subject|2|||
130719536|NCT03970837|470597429|FG007|Overall Study|Withdrawal by Subject|3|||
130719537|NCT03970837|470597430|FG008|Overall Study|Withdrawal by Subject|0|||
130719538|NCT03970837|470597431|FG009|Overall Study|Withdrawal by Subject|0|||
130719539|NCT03970837|470597432|FG010|Overall Study|Withdrawal by Subject|0|||
130719540|NCT03970837|470597433|FG011|Overall Study|Withdrawal by Subject|1|||
130719541|NCT03970837|470597422|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
130719542|NCT03970837|470597423|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
130719543|NCT03970837|470597424|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
130719544|NCT03970837|470597425|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130719545|NCT03970837|470597426|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
130719546|NCT03970837|470597427|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130719547|NCT03970837|470597428|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130983674|NCT03315143|471566371|FG001|Overall Study|Reason not Specified|32|||
130719548|NCT03970837|470597429|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130719549|NCT03970837|470597430|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130719550|NCT03970837|470597431|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130719551|NCT03970837|470597432|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130719552|NCT03970837|470597433|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130719553|NCT03970837|470597422|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130719554|NCT03970837|470597423|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130983675|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
130719555|NCT03970837|470597424|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130983676|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
130719556|NCT03970837|470597425|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130983677|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
130983678|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
130983679|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
130983680|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
130983681|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
130983682|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
130983683|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
130983684|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
130983685|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
130983686|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
130983687|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
130983688|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
130983689|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
130983690|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
130983691|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
130983692|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
130983693|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
130983694|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
130983695|NCT00549757|471566372|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
130983696|NCT00549757|471566373|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
130983697|NCT00549757|471566372|FG000|Extension Period (in Average 9 Months)|Death|143|||
130983698|NCT00549757|471566373|FG001|Extension Period (in Average 9 Months)|Death|136|||
131133385|NCT00179309|472115274|FG001|Treatment|Toxicity|3|||
131133386|NCT00179309|472115273|FG000|Treatment|Withdrawal by Subject|1|||
131133387|NCT00179309|472115274|FG001|Treatment|Withdrawal by Subject|2|||
131133388|NCT00179309|472115273|FG000|Treatment|Allergy|1|||
131133389|NCT00179309|472115274|FG001|Treatment|Allergy|0|||
131133390|NCT01678144|472115277|FG000|Stage 1: MAR Classic|Adverse Event|1|||
131133391|NCT02363686|472115280|FG000|Overall Study|Withdrawal by Subject|22|||
131133392|NCT02363686|472115280|FG000|Overall Study|incomplete FEES examinations|13|||
130719557|NCT03970837|470597426|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130719558|NCT03970837|470597427|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130719559|NCT03970837|470597428|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
130719560|NCT03970837|470597429|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
130719561|NCT03970837|470597430|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
130719562|NCT03970837|470597431|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
130719563|NCT03970837|470597432|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
130983699|NCT00549757|471566372|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
130983700|NCT00549757|471566373|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
130983701|NCT00549757|471566372|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
130983702|NCT00549757|471566373|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
130983703|NCT00549757|471566372|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
130983704|NCT00549757|471566373|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
130983705|NCT02641392|471566374|FG000|Overall Study|Lost to Follow-up|0|||
130983706|NCT02641392|471566375|FG001|Overall Study|Lost to Follow-up|0|||
130983707|NCT02641392|471566376|FG002|Overall Study|Lost to Follow-up|2|||
130983708|NCT02641392|471566374|FG000|Overall Study|Withdrawal by Subject|0|||
130983709|NCT02641392|471566375|FG001|Overall Study|Withdrawal by Subject|0|||
130983710|NCT02641392|471566376|FG002|Overall Study|Withdrawal by Subject|17|||
130983711|NCT02641392|471566374|FG000|Overall Study|Adverse Event|0|||
130983712|NCT02641392|471566375|FG001|Overall Study|Adverse Event|1|||
130983713|NCT02641392|471566376|FG002|Overall Study|Adverse Event|25|||
130983714|NCT02641392|471566374|FG000|Overall Study|Study Terminated by Sponsor|4|||
130983715|NCT02641392|471566375|FG001|Overall Study|Study Terminated by Sponsor|12|||
130983716|NCT02641392|471566376|FG002|Overall Study|Study Terminated by Sponsor|144|||
130983717|NCT02641392|471566374|FG000|Overall Study|Lack of Efficacy|0|||
130983718|NCT02641392|471566375|FG001|Overall Study|Lack of Efficacy|0|||
130983719|NCT02641392|471566376|FG002|Overall Study|Lack of Efficacy|101|||
130983720|NCT02641392|471566374|FG000|Overall Study|Miscellaneous|0|||
130983721|NCT02641392|471566375|FG001|Overall Study|Miscellaneous|0|||
131133393|NCT01496885|472115284|FG000|Overall Study|Lost to Follow-up|13|||
131133394|NCT01496885|472115284|FG000|Overall Study|Withdrawal by Subject|7|||
130983722|NCT02641392|471566376|FG002|Overall Study|Miscellaneous|3|||
130983723|NCT02641392|471566374|FG000|Overall Study|Death|0|||
130983724|NCT02641392|471566375|FG001|Overall Study|Death|0|||
130983725|NCT02641392|471566376|FG002|Overall Study|Death|1|||
130983726|NCT01127646|471566377|FG000|Overall Study|Entry Criteria Not Met|1|||
130983727|NCT01127646|471566378|FG001|Overall Study|Entry Criteria Not Met|0|||
130983728|NCT01127646|471566377|FG000|Overall Study|Protocol Violation|0|||
131133728|NCT01661140|472117173|FG000|Double-Blind Period|Refused Treatment|0|||
130719564|NCT03970837|470597433|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
130719565|NCT02132754|470597434|FG000|Overall Study|Adverse Event|0|||
130719566|NCT02132754|470597435|FG001|Overall Study|Adverse Event|0|||
130719567|NCT02132754|470597436|FG002|Overall Study|Adverse Event|0|||
130719568|NCT02132754|470597437|FG003|Overall Study|Adverse Event|0|||
130719569|NCT02132754|470597438|FG004|Overall Study|Adverse Event|0|||
130719570|NCT02132754|470597439|FG005|Overall Study|Adverse Event|0|||
130719571|NCT02132754|470597440|FG006|Overall Study|Adverse Event|0|||
130719572|NCT02132754|470597441|FG007|Overall Study|Adverse Event|0|||
130719573|NCT02132754|470597442|FG008|Overall Study|Adverse Event|0|||
130719574|NCT02132754|470597443|FG009|Overall Study|Adverse Event|0|||
130719575|NCT02132754|470597444|FG010|Overall Study|Adverse Event|0|||
130719576|NCT02132754|470597445|FG011|Overall Study|Adverse Event|0|||
130719577|NCT02132754|470597446|FG012|Overall Study|Adverse Event|0|||
130719578|NCT02132754|470597447|FG013|Overall Study|Adverse Event|0|||
130719579|NCT02132754|470597448|FG014|Overall Study|Adverse Event|0|||
130719580|NCT02132754|470597449|FG015|Overall Study|Adverse Event|0|||
130719581|NCT02132754|470597450|FG016|Overall Study|Adverse Event|0|||
130719582|NCT02132754|470597451|FG017|Overall Study|Adverse Event|1|||
130719583|NCT02132754|470597452|FG018|Overall Study|Adverse Event|0|||
130719584|NCT02132754|470597453|FG019|Overall Study|Adverse Event|0|||
130719585|NCT02132754|470597454|FG020|Overall Study|Adverse Event|0|||
130719586|NCT02132754|470597455|FG021|Overall Study|Adverse Event|0|||
130983729|NCT01127646|471566378|FG001|Overall Study|Protocol Violation|1|||
130983730|NCT01662063|471566379|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
130983731|NCT01662063|471566380|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
130983732|NCT01662063|471566381|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
130983733|NCT01662063|471566379|FG000|Overall Study|Lack of Efficacy|1|||
130983734|NCT01662063|471566380|FG001|Overall Study|Lack of Efficacy|6|||
130983735|NCT01662063|471566381|FG002|Overall Study|Lack of Efficacy|0|||
130983736|NCT01662063|471566379|FG000|Overall Study|Lost to Follow-up|0|||
130983737|NCT01662063|471566380|FG001|Overall Study|Lost to Follow-up|4|||
130983738|NCT01662063|471566381|FG002|Overall Study|Lost to Follow-up|0|||
130983739|NCT01662063|471566379|FG000|Overall Study|Protocol Violation|1|||
130983740|NCT01662063|471566380|FG001|Overall Study|Protocol Violation|0|||
130983741|NCT01662063|471566381|FG002|Overall Study|Protocol Violation|0|||
130983742|NCT01662063|471566379|FG000|Overall Study|Withdrawal by Subject|2|||
130983743|NCT01662063|471566380|FG001|Overall Study|Withdrawal by Subject|4|||
130983744|NCT01662063|471566381|FG002|Overall Study|Withdrawal by Subject|1|||
130983745|NCT01662063|471566379|FG000|Overall Study|Physician Decision|0|||
130983746|NCT01662063|471566380|FG001|Overall Study|Physician Decision|2|||
130983747|NCT01662063|471566381|FG002|Overall Study|Physician Decision|0|||
130983748|NCT01662063|471566379|FG000|Overall Study|Other|0|||
130983749|NCT01662063|471566380|FG001|Overall Study|Other|1|||
130983750|NCT01662063|471566381|FG002|Overall Study|Other|0|||
130983751|NCT00293267|471566382|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
130983752|NCT00293267|471566383|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
130983753|NCT00293267|471566382|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
130983754|NCT00293267|471566383|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
130983755|NCT00293267|471566382|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
130983756|NCT00293267|471566383|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
130983757|NCT00293267|471566382|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
130983758|NCT00293267|471566383|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
130983759|NCT00293267|471566382|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
131044727|NCT01570361|471797614|FG000|Overall Study|Adverse Event|2|||
131044728|NCT01570361|471797615|FG001|Overall Study|Adverse Event|1|||
131044729|NCT01570361|471797614|FG000|Overall Study|Lost to Follow-up|4|||
131044730|NCT01570361|471797615|FG001|Overall Study|Lost to Follow-up|4|||
131044731|NCT01570361|471797614|FG000|Overall Study|Death|5|||
131044732|NCT01570361|471797615|FG001|Overall Study|Death|4|||
131044733|NCT01570361|471797614|FG000|Overall Study|Other|0|||
131044734|NCT01570361|471797615|FG001|Overall Study|Other|2|||
131044735|NCT05158504|471797618|FG000|Overall Study|Lost to Follow-up|2|||
131044736|NCT05158504|471797619|FG001|Overall Study|Lost to Follow-up|3|||
131044737|NCT03606512|471797620|FG000|Overall Study|Lost to Follow-up|0|||
131044738|NCT03606512|471797621|FG001|Overall Study|Lost to Follow-up|1|||
131044739|NCT03606512|471797620|FG000|Overall Study|'moved from study area|0|||
131044740|NCT03606512|471797621|FG001|Overall Study|'moved from study area|1|||
130719587|NCT02132754|470597456|FG022|Overall Study|Adverse Event|0|||
130719588|NCT02132754|470597457|FG023|Overall Study|Adverse Event|0|||
130719589|NCT02132754|470597458|FG024|Overall Study|Adverse Event|0|||
130719590|NCT02132754|470597459|FG025|Overall Study|Adverse Event|1|||
131044741|NCT05513937|471797622|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
131044742|NCT05513937|471797623|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
131133729|NCT01661140|472117174|FG001|Double-Blind Period|Refused Treatment|0|||
130719591|NCT02132754|470597460|FG026|Overall Study|Adverse Event|1|||
130719592|NCT02132754|470597461|FG027|Overall Study|Adverse Event|0|||
130719593|NCT02132754|470597462|FG028|Overall Study|Adverse Event|0|||
130719594|NCT02132754|470597463|FG029|Overall Study|Adverse Event|0|||
130983760|NCT00293267|471566383|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
130983761|NCT00293267|471566382|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
130983762|NCT00293267|471566383|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
130983763|NCT00293267|471566382|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
130983764|NCT00293267|471566383|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
130983765|NCT00293267|471566382|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
130983766|NCT00293267|471566383|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
130983767|NCT00293267|471566382|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
130983768|NCT00293267|471566383|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
130983769|NCT00293267|471566382|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
130983770|NCT00293267|471566383|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
130983771|NCT00293267|471566382|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
130983772|NCT00293267|471566383|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
130983773|NCT00293267|471566382|FG000|Extension - Double-Blind Week 49-156|Death|3|||
130983774|NCT00293267|471566383|FG001|Extension - Double-Blind Week 49-156|Death|0|||
130983775|NCT00293267|471566382|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
130983776|NCT00293267|471566383|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
130983777|NCT00293267|471566382|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
130983778|NCT00293267|471566383|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
130983779|NCT00293267|471566382|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
130983780|NCT00293267|471566383|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
130983781|NCT00293267|471566382|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
130983782|NCT00293267|471566383|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
130983783|NCT00293267|471566382|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
130983784|NCT00293267|471566383|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
130983785|NCT00293267|471566382|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
130983786|NCT00293267|471566383|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
130983787|NCT00293267|471566382|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
130983788|NCT00293267|471566383|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
130983789|NCT00293267|471566382|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
130985726|NCT01964326|471574967|FG000|Overall Study|Withdrawal by Subject|87|||
131133395|NCT01496885|472115284|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
131133396|NCT01496885|472115284|FG000|Overall Study|Death|1|||
131133397|NCT04607733|472115293|FG000|Overall Study|Lost to Follow-up|1|||
131133398|NCT04607733|472115294|FG001|Overall Study|Lost to Follow-up|0|||
131133399|NCT04607733|472115295|FG002|Overall Study|Lost to Follow-up|0|||
131133400|NCT04607733|472115296|FG003|Overall Study|Lost to Follow-up|1|||
131133401|NCT04607733|472115297|FG004|Overall Study|Lost to Follow-up|1|||
131133402|NCT04607733|472115298|FG005|Overall Study|Lost to Follow-up|0|||
131133403|NCT04607733|472115293|FG000|Overall Study|Withdrawal by Subject|0|||
131133404|NCT04607733|472115294|FG001|Overall Study|Withdrawal by Subject|0|||
131133405|NCT04607733|472115295|FG002|Overall Study|Withdrawal by Subject|0|||
131133406|NCT04607733|472115296|FG003|Overall Study|Withdrawal by Subject|0|||
131133407|NCT04607733|472115297|FG004|Overall Study|Withdrawal by Subject|1|||
131133408|NCT04607733|472115298|FG005|Overall Study|Withdrawal by Subject|0|||
131133409|NCT01665807|472115299|FG000|Overall Study|Withdrawal by Subject|2|||
131133410|NCT01665807|472115300|FG001|Overall Study|Withdrawal by Subject|0|||
131133411|NCT01665807|472115301|FG002|Overall Study|Withdrawal by Subject|1|||
131133412|NCT00075504|472115334|FG000|Overall Study|Withdrawal by Subject|9|||
131133413|NCT00075504|472115335|FG001|Overall Study|Withdrawal by Subject|7|||
131133414|NCT01692301|472115337|FG000|Overall Study|Adverse Event|15|||
131133415|NCT01692301|472115338|FG001|Overall Study|Adverse Event|12|||
131133416|NCT01692301|472115337|FG000|Overall Study|Death|1|||
131133417|NCT01692301|472115338|FG001|Overall Study|Death|2|||
131133418|NCT01692301|472115337|FG000|Overall Study|Lack of Efficacy|0|||
131133419|NCT01692301|472115338|FG001|Overall Study|Lack of Efficacy|5|||
131133420|NCT01692301|472115337|FG000|Overall Study|Non-compliance with study treatment|1|||
131133421|NCT01692301|472115338|FG001|Overall Study|Non-compliance with study treatment|2|||
131133422|NCT01692301|472115337|FG000|Overall Study|Protocol deviation|9|||
131133423|NCT01692301|472115338|FG001|Overall Study|Protocol deviation|2|||
131133424|NCT01692301|472115337|FG000|Overall Study|Patient/guardian decision|16|||
131133425|NCT01692301|472115338|FG001|Overall Study|Patient/guardian decision|15|||
131133426|NCT01692301|472115337|FG000|Overall Study|Technical problems|0|||
131133427|NCT01692301|472115338|FG001|Overall Study|Technical problems|1|||
131133428|NCT01692301|472115337|FG000|Overall Study|Physician Decision|2|||
131133429|NCT01692301|472115338|FG001|Overall Study|Physician Decision|2|||
131133430|NCT01692301|472115337|FG000|Overall Study|Lost to Follow-up|1|||
131133431|NCT01692301|472115338|FG001|Overall Study|Lost to Follow-up|1|||
131133432|NCT01568593|472115339|FG000|Overall Study|Lack of Efficacy|4|||
131133433|NCT01568593|472115340|FG001|Overall Study|Lack of Efficacy|1|||
131133434|NCT01568593|472115339|FG000|Overall Study|Adverse Event|3|||
130719595|NCT02132754|470597464|FG030|Overall Study|Adverse Event|1|||
130719596|NCT02132754|470597465|FG031|Overall Study|Adverse Event|0|||
130719597|NCT02132754|470597466|FG032|Overall Study|Adverse Event|1|||
130719598|NCT02132754|470597467|FG033|Overall Study|Adverse Event|1|||
130719599|NCT02132754|470597434|FG000|Overall Study|Clinical Progression|0|||
130719600|NCT02132754|470597435|FG001|Overall Study|Clinical Progression|0|||
130719601|NCT02132754|470597436|FG002|Overall Study|Clinical Progression|0|||
130719602|NCT02132754|470597437|FG003|Overall Study|Clinical Progression|0|||
130719603|NCT02132754|470597438|FG004|Overall Study|Clinical Progression|0|||
130719604|NCT02132754|470597439|FG005|Overall Study|Clinical Progression|0|||
130719605|NCT02132754|470597440|FG006|Overall Study|Clinical Progression|0|||
130719606|NCT02132754|470597441|FG007|Overall Study|Clinical Progression|0|||
130719607|NCT02132754|470597442|FG008|Overall Study|Clinical Progression|0|||
130719608|NCT02132754|470597443|FG009|Overall Study|Clinical Progression|1|||
130719609|NCT02132754|470597444|FG010|Overall Study|Clinical Progression|0|||
130719610|NCT02132754|470597445|FG011|Overall Study|Clinical Progression|0|||
130719611|NCT02132754|470597446|FG012|Overall Study|Clinical Progression|0|||
130719612|NCT02132754|470597447|FG013|Overall Study|Clinical Progression|0|||
130719613|NCT02132754|470597448|FG014|Overall Study|Clinical Progression|0|||
130719614|NCT02132754|470597449|FG015|Overall Study|Clinical Progression|0|||
130983790|NCT00293267|471566383|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
130983791|NCT00293267|471566382|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
130983792|NCT00293267|471566383|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
130983793|NCT00293267|471566382|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
130983794|NCT00293267|471566383|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
130983795|NCT00293267|471566382|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
130983796|NCT00293267|471566383|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
130983797|NCT00293267|471566382|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
130983798|NCT00293267|471566383|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
130983799|NCT00293267|471566382|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
130983800|NCT00293267|471566383|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
130983801|NCT00293267|471566382|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
130983802|NCT00293267|471566383|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
130983803|NCT00293267|471566382|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
130985727|NCT01964326|471574967|FG000|Overall Study|Pregnancy|1|||
130985728|NCT01964326|471574967|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
130985729|NCT01964326|471574967|FG000|Overall Study|Physician Decision|55|||
130719615|NCT02132754|470597450|FG016|Overall Study|Clinical Progression|1|||
130719616|NCT02132754|470597451|FG017|Overall Study|Clinical Progression|1|||
130719617|NCT02132754|470597452|FG018|Overall Study|Clinical Progression|0|||
130719618|NCT02132754|470597453|FG019|Overall Study|Clinical Progression|1|||
130719619|NCT02132754|470597454|FG020|Overall Study|Clinical Progression|0|||
130985730|NCT01964326|471574967|FG000|Overall Study|Investigator Discretion|1|||
130985731|NCT01964326|471574967|FG000|Overall Study|Other|9|||
130985732|NCT01964326|471574967|FG000|Overall Study|Did not meet eligibility criteria|1|||
130985733|NCT02347657|471574968|FG000|Overall Study|Physician Decision|0|||
130985734|NCT02347657|471574969|FG001|Overall Study|Physician Decision|1|||
130985735|NCT02347657|471574968|FG000|Overall Study|Adverse Event|8|||
130985736|NCT02347657|471574969|FG001|Overall Study|Adverse Event|4|||
130985737|NCT02347657|471574968|FG000|Overall Study|Withdrawal by Subject|6|||
130985738|NCT02347657|471574969|FG001|Overall Study|Withdrawal by Subject|7|||
130985739|NCT02347657|471574968|FG000|Overall Study|Randomized but not treated|1|||
130985740|NCT02347657|471574969|FG001|Overall Study|Randomized but not treated|0|||
130985741|NCT02347657|471574968|FG000|Overall Study|Other|3|||
130985742|NCT02347657|471574969|FG001|Overall Study|Other|3|||
130985743|NCT00261495|471574970|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
130985744|NCT00261495|471574971|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
130985745|NCT00261495|471574970|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
130985746|NCT00261495|471574971|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
130985747|NCT00261495|471574970|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
130985748|NCT00261495|471574971|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
130985749|NCT00261495|471574970|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
130985750|NCT00261495|471574971|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
130985751|NCT00261495|471574970|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
130985752|NCT00261495|471574971|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
130985753|NCT00261495|471574970|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
130985754|NCT00261495|471574971|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
130985755|NCT00261495|471574970|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
130985756|NCT00261495|471574971|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
130985757|NCT00261495|471574970|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
130985758|NCT00261495|471574971|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
130983804|NCT00293267|471566383|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
130983805|NCT00293267|471566382|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
130983806|NCT00293267|471566383|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
130719620|NCT02132754|470597455|FG021|Overall Study|Clinical Progression|0|||
130719621|NCT02132754|470597456|FG022|Overall Study|Clinical Progression|1|||
130719622|NCT02132754|470597457|FG023|Overall Study|Clinical Progression|0|||
130719623|NCT02132754|470597458|FG024|Overall Study|Clinical Progression|1|||
130719624|NCT02132754|470597459|FG025|Overall Study|Clinical Progression|1|||
130719625|NCT02132754|470597460|FG026|Overall Study|Clinical Progression|0|||
130719626|NCT02132754|470597461|FG027|Overall Study|Clinical Progression|1|||
130719627|NCT02132754|470597462|FG028|Overall Study|Clinical Progression|1|||
130719628|NCT02132754|470597463|FG029|Overall Study|Clinical Progression|0|||
130719629|NCT02132754|470597464|FG030|Overall Study|Clinical Progression|1|||
130719630|NCT02132754|470597465|FG031|Overall Study|Clinical Progression|0|||
130719631|NCT02132754|470597466|FG032|Overall Study|Clinical Progression|0|||
130719632|NCT02132754|470597467|FG033|Overall Study|Clinical Progression|2|||
130719633|NCT02132754|470597434|FG000|Overall Study|Death|0|||
130719634|NCT02132754|470597435|FG001|Overall Study|Death|0|||
130719635|NCT02132754|470597436|FG002|Overall Study|Death|0|||
130719636|NCT02132754|470597437|FG003|Overall Study|Death|0|||
130719637|NCT02132754|470597438|FG004|Overall Study|Death|0|||
130719638|NCT02132754|470597439|FG005|Overall Study|Death|0|||
130719639|NCT02132754|470597440|FG006|Overall Study|Death|0|||
130719640|NCT02132754|470597441|FG007|Overall Study|Death|0|||
130719641|NCT02132754|470597442|FG008|Overall Study|Death|0|||
130719642|NCT02132754|470597443|FG009|Overall Study|Death|0|||
130719643|NCT02132754|470597444|FG010|Overall Study|Death|0|||
130719644|NCT02132754|470597445|FG011|Overall Study|Death|0|||
130719645|NCT02132754|470597446|FG012|Overall Study|Death|0|||
130719646|NCT02132754|470597447|FG013|Overall Study|Death|0|||
130719647|NCT02132754|470597448|FG014|Overall Study|Death|0|||
130719648|NCT02132754|470597449|FG015|Overall Study|Death|1|||
130719649|NCT02132754|470597450|FG016|Overall Study|Death|0|||
130719650|NCT02132754|470597451|FG017|Overall Study|Death|0|||
130719651|NCT02132754|470597452|FG018|Overall Study|Death|0|||
130719652|NCT02132754|470597453|FG019|Overall Study|Death|1|||
130719653|NCT02132754|470597454|FG020|Overall Study|Death|0|||
130719654|NCT02132754|470597455|FG021|Overall Study|Death|1|||
130719655|NCT02132754|470597456|FG022|Overall Study|Death|0|||
130719656|NCT02132754|470597457|FG023|Overall Study|Death|0|||
130719657|NCT02132754|470597458|FG024|Overall Study|Death|0|||
130719658|NCT02132754|470597459|FG025|Overall Study|Death|0|||
130719659|NCT02132754|470597460|FG026|Overall Study|Death|1|||
130719660|NCT02132754|470597461|FG027|Overall Study|Death|0|||
130719661|NCT02132754|470597462|FG028|Overall Study|Death|0|||
130719662|NCT02132754|470597463|FG029|Overall Study|Death|0|||
130719663|NCT02132754|470597464|FG030|Overall Study|Death|0|||
130719664|NCT02132754|470597465|FG031|Overall Study|Death|0|||
130719665|NCT02132754|470597466|FG032|Overall Study|Death|0|||
130719666|NCT02132754|470597467|FG033|Overall Study|Death|2|||
130719667|NCT02132754|470597434|FG000|Overall Study|Excluded Medication|0|||
130719668|NCT02132754|470597435|FG001|Overall Study|Excluded Medication|0|||
130719669|NCT02132754|470597436|FG002|Overall Study|Excluded Medication|0|||
130719670|NCT02132754|470597437|FG003|Overall Study|Excluded Medication|0|||
130719671|NCT02132754|470597438|FG004|Overall Study|Excluded Medication|0|||
130719672|NCT02132754|470597439|FG005|Overall Study|Excluded Medication|0|||
130719673|NCT02132754|470597440|FG006|Overall Study|Excluded Medication|0|||
130719674|NCT02132754|470597441|FG007|Overall Study|Excluded Medication|0|||
130719675|NCT02132754|470597442|FG008|Overall Study|Excluded Medication|0|||
130719676|NCT02132754|470597443|FG009|Overall Study|Excluded Medication|0|||
130719677|NCT02132754|470597444|FG010|Overall Study|Excluded Medication|0|||
130719678|NCT02132754|470597445|FG011|Overall Study|Excluded Medication|0|||
130983807|NCT01814748|471566386|FG000|Overall Study|Lost to Follow-up|1|||
130983808|NCT01814748|471566387|FG001|Overall Study|Lost to Follow-up|2|||
130983809|NCT01814748|471566386|FG000|Overall Study|Study site terminated by sponsor|1|||
130719679|NCT02132754|470597446|FG012|Overall Study|Excluded Medication|0|||
130719680|NCT02132754|470597447|FG013|Overall Study|Excluded Medication|0|||
130778840|NCT03428100|470817456|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130778841|NCT03428100|470817457|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130778842|NCT03428100|470817458|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130983810|NCT01814748|471566387|FG001|Overall Study|Study site terminated by sponsor|1|||
130983811|NCT01814748|471566386|FG000|Overall Study|Withdrawal by Subject|6|||
131133435|NCT01568593|472115340|FG001|Overall Study|Adverse Event|2|||
130719681|NCT02132754|470597448|FG014|Overall Study|Excluded Medication|0|||
130719682|NCT02132754|470597449|FG015|Overall Study|Excluded Medication|0|||
130719683|NCT02132754|470597450|FG016|Overall Study|Excluded Medication|0|||
130719684|NCT02132754|470597451|FG017|Overall Study|Excluded Medication|0|||
130719685|NCT02132754|470597452|FG018|Overall Study|Excluded Medication|0|||
130719686|NCT02132754|470597453|FG019|Overall Study|Excluded Medication|0|||
130719687|NCT02132754|470597454|FG020|Overall Study|Excluded Medication|1|||
130719688|NCT02132754|470597455|FG021|Overall Study|Excluded Medication|0|||
131228730|NCT02884206|472465706|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
131228731|NCT02884206|472465707|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
131228732|NCT02884206|472465705|FG000|Valsartan Run-in Period|Physician Decision|1|||
131228733|NCT02884206|472465706|FG001|Valsartan Run-in Period|Physician Decision|0|||
131228734|NCT02884206|472465707|FG002|Valsartan Run-in Period|Physician Decision|0|||
131228735|NCT02884206|472465705|FG000|LCZ696 Run-in Period|Adverse Event|38|||
131228736|NCT02884206|472465706|FG001|LCZ696 Run-in Period|Adverse Event|0|||
131228737|NCT02884206|472465707|FG002|LCZ696 Run-in Period|Adverse Event|0|||
131228738|NCT02884206|472465705|FG000|LCZ696 Run-in Period|Death|2|||
131228739|NCT02884206|472465706|FG001|LCZ696 Run-in Period|Death|0|||
131228740|NCT02884206|472465707|FG002|LCZ696 Run-in Period|Death|0|||
131228741|NCT02884206|472465705|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
131228742|NCT02884206|472465706|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
131228743|NCT02884206|472465707|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
131228744|NCT02884206|472465705|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
131228745|NCT02884206|472465706|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
131228746|NCT02884206|472465707|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
131228747|NCT02884206|472465705|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
131228748|NCT02884206|472465706|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
131228749|NCT02884206|472465707|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
131228750|NCT02884206|472465705|FG000|LCZ696 Run-in Period|Physician Decision|1|||
131228751|NCT02884206|472465706|FG001|LCZ696 Run-in Period|Physician Decision|0|||
131228752|NCT02884206|472465707|FG002|LCZ696 Run-in Period|Physician Decision|0|||
131228753|NCT02884206|472465705|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
131228754|NCT02884206|472465706|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
131228755|NCT02884206|472465707|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
131228756|NCT02884206|472465705|FG000|Double-Blind Period|Death|0|||
131228757|NCT02884206|472465706|FG001|Double-Blind Period|Death|28|||
131228758|NCT02884206|472465707|FG002|Double-Blind Period|Death|39|||
131228759|NCT02884206|472465705|FG000|Double-Blind Period|Patient/guardian decision|0|||
130983812|NCT01814748|471566387|FG001|Overall Study|Withdrawal by Subject|4|||
130983813|NCT04044456|471566388|FG000|Overall Study|Lost to Follow-up|4|||
130983814|NCT04044456|471566389|FG001|Overall Study|Lost to Follow-up|1|||
130778843|NCT03428100|470817459|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130778844|NCT03428100|470817441|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778845|NCT03428100|470817442|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
130778846|NCT03428100|470817443|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
130778847|NCT03428100|470817444|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778848|NCT03428100|470817445|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778849|NCT03428100|470817446|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778850|NCT03428100|470817447|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778851|NCT03428100|470817448|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778852|NCT03428100|470817449|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778853|NCT03428100|470817450|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778854|NCT03428100|470817451|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130983815|NCT04044456|471566388|FG000|Overall Study|Withdrawal by Subject|1|||
130983816|NCT04044456|471566389|FG001|Overall Study|Withdrawal by Subject|0|||
130983817|NCT00330174|471566392|FG000|Overall Study|Withdrawal by Subject|7|||
130719689|NCT02132754|470597456|FG022|Overall Study|Excluded Medication|0|||
130719690|NCT02132754|470597457|FG023|Overall Study|Excluded Medication|0|||
130719691|NCT02132754|470597458|FG024|Overall Study|Excluded Medication|0|||
130719692|NCT02132754|470597459|FG025|Overall Study|Excluded Medication|0|||
130719693|NCT02132754|470597460|FG026|Overall Study|Excluded Medication|0|||
130719694|NCT02132754|470597461|FG027|Overall Study|Excluded Medication|0|||
130719695|NCT02132754|470597462|FG028|Overall Study|Excluded Medication|0|||
130719696|NCT02132754|470597463|FG029|Overall Study|Excluded Medication|0|||
130719697|NCT02132754|470597464|FG030|Overall Study|Excluded Medication|0|||
130719698|NCT02132754|470597465|FG031|Overall Study|Excluded Medication|0|||
130719699|NCT02132754|470597466|FG032|Overall Study|Excluded Medication|0|||
130719700|NCT02132754|470597467|FG033|Overall Study|Excluded Medication|1|||
130719701|NCT02132754|470597434|FG000|Overall Study|Physician Decision|0|||
131228760|NCT02884206|472465706|FG001|Double-Blind Period|Patient/guardian decision|10|||
131228761|NCT02884206|472465707|FG002|Double-Blind Period|Patient/guardian decision|13|||
130719702|NCT02132754|470597435|FG001|Overall Study|Physician Decision|0|||
130719703|NCT02132754|470597436|FG002|Overall Study|Physician Decision|0|||
130719704|NCT02132754|470597437|FG003|Overall Study|Physician Decision|0|||
131228762|NCT02884206|472465705|FG000|Double-Blind Period|Lost to Follow-up|0|||
131228763|NCT02884206|472465706|FG001|Double-Blind Period|Lost to Follow-up|4|||
130719705|NCT02132754|470597438|FG004|Overall Study|Physician Decision|0|||
131228764|NCT02884206|472465707|FG002|Double-Blind Period|Lost to Follow-up|4|||
130719706|NCT02132754|470597439|FG005|Overall Study|Physician Decision|0|||
130719707|NCT02132754|470597440|FG006|Overall Study|Physician Decision|0|||
130719708|NCT02132754|470597441|FG007|Overall Study|Physician Decision|0|||
131228765|NCT02884206|472465705|FG000|Double-Blind Period|Physician Decision|0|||
131228766|NCT02884206|472465706|FG001|Double-Blind Period|Physician Decision|2|||
131228767|NCT02884206|472465707|FG002|Double-Blind Period|Physician Decision|0|||
131228768|NCT02884206|472465705|FG000|Double-Blind Period|Adverse Event|0|||
131228769|NCT02884206|472465706|FG001|Double-Blind Period|Adverse Event|0|||
131228770|NCT02884206|472465707|FG002|Double-Blind Period|Adverse Event|3|||
131228771|NCT02884206|472465705|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
131228772|NCT02884206|472465706|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
131228773|NCT02884206|472465707|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
131228774|NCT04467697|472465708|FG000|Overall Study|Adverse Event|2|||
131228775|NCT04467697|472465708|FG000|Overall Study|Lost to Follow-up|6|||
131228776|NCT04467697|472465708|FG000|Overall Study|Withdrawal by Subject|9|||
131228777|NCT04467697|472465708|FG000|Overall Study|Protocol Violation|3|||
131228778|NCT02231710|472465711|FG000|Overall Study|Physician Decision|1|||
131228779|NCT00829413|472465714|FG000|Overall Study|No study drug admimnistered|13|||
131228780|NCT00829413|472465714|FG000|Overall Study|Training Patients|67|||
131228781|NCT00829413|472465714|FG000|Overall Study|No truth standard procedure available|9|||
131228782|NCT00829413|472465714|FG000|Overall Study|Technically inadequate truth standard|2|||
131228783|NCT00829413|472465714|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
131228784|NCT03487796|472465716|FG000|Overall Study|Lost to Follow-up|18|||
131228785|NCT03487796|472465717|FG001|Overall Study|Lost to Follow-up|6|||
131228786|NCT00124020|472465720|FG000|Overall Study|Death|67|||
131228787|NCT00124020|472465721|FG001|Overall Study|Death|71|||
131228788|NCT00124020|472465720|FG000|Overall Study|Withdrawal by Subject|13|||
131228789|NCT00124020|472465721|FG001|Overall Study|Withdrawal by Subject|11|||
131228790|NCT00124020|472465720|FG000|Overall Study|Lost to Follow-up|5|||
131228791|NCT00124020|472465721|FG001|Overall Study|Lost to Follow-up|8|||
131228792|NCT00124020|472465720|FG000|Overall Study|Other|1|||
131228793|NCT00124020|472465721|FG001|Overall Study|Other|1|||
131228794|NCT00124020|472465720|FG000|Overall Study|Transfer to another hospital|2|||
131228795|NCT00124020|472465721|FG001|Overall Study|Transfer to another hospital|0|||
131228796|NCT02043366|472465722|FG000|Overall Study|Lost to Follow-up|2|||
131228797|NCT02043366|472465723|FG001|Overall Study|Lost to Follow-up|2|||
131228798|NCT02043366|472465724|FG002|Overall Study|Lost to Follow-up|2|||
131228799|NCT02043366|472465725|FG003|Overall Study|Lost to Follow-up|2|||
131228800|NCT02043366|472465726|FG004|Overall Study|Lost to Follow-up|2|||
131228801|NCT02043366|472465727|FG005|Overall Study|Lost to Follow-up|2|||
131228802|NCT00891774|472465730|FG000|Overall Study|Lost to Follow-up|5|||
131228803|NCT00891774|472465730|FG000|Overall Study|Illness (Self/Mother)|3|||
131228804|NCT00891774|472465730|FG000|Overall Study|Withdrawal by Subject|2|||
131228805|NCT00891774|472465730|FG000|Overall Study|Protocol Violation|4|||
131228806|NCT03175120|472465734|FG000|Overall Study|Adverse Event|2|||
131228807|NCT03175120|472465735|FG001|Overall Study|Adverse Event|2|||
130983818|NCT00330174|471566393|FG001|Overall Study|Withdrawal by Subject|7|||
130983819|NCT00330174|471566392|FG000|Overall Study|Lost to Follow-up|4|||
130983820|NCT00330174|471566393|FG001|Overall Study|Lost to Follow-up|1|||
131228808|NCT03175120|472465734|FG000|Overall Study|Protocol Violation|5|||
131228809|NCT03175120|472465735|FG001|Overall Study|Protocol Violation|2|||
131228810|NCT03175120|472465734|FG000|Overall Study|Lost to Follow-up|1|||
130719709|NCT02132754|470597442|FG008|Overall Study|Physician Decision|0|||
130719710|NCT02132754|470597443|FG009|Overall Study|Physician Decision|1|||
130719711|NCT02132754|470597444|FG010|Overall Study|Physician Decision|0|||
130719712|NCT02132754|470597445|FG011|Overall Study|Physician Decision|1|||
130719713|NCT02132754|470597446|FG012|Overall Study|Physician Decision|1|||
130719714|NCT02132754|470597447|FG013|Overall Study|Physician Decision|0|||
130719715|NCT02132754|470597448|FG014|Overall Study|Physician Decision|0|||
130719716|NCT02132754|470597449|FG015|Overall Study|Physician Decision|1|||
130719717|NCT02132754|470597450|FG016|Overall Study|Physician Decision|0|||
130719718|NCT02132754|470597451|FG017|Overall Study|Physician Decision|0|||
130719719|NCT02132754|470597452|FG018|Overall Study|Physician Decision|0|||
130719720|NCT02132754|470597453|FG019|Overall Study|Physician Decision|0|||
130719721|NCT02132754|470597454|FG020|Overall Study|Physician Decision|0|||
130719722|NCT02132754|470597455|FG021|Overall Study|Physician Decision|0|||
130719723|NCT02132754|470597456|FG022|Overall Study|Physician Decision|0|||
130719724|NCT02132754|470597457|FG023|Overall Study|Physician Decision|0|||
130719725|NCT02132754|470597458|FG024|Overall Study|Physician Decision|1|||
130719726|NCT02132754|470597459|FG025|Overall Study|Physician Decision|0|||
130983821|NCT00330174|471566392|FG000|Overall Study|Clinical deterioration|1|||
130983822|NCT00330174|471566393|FG001|Overall Study|Clinical deterioration|2|||
130719727|NCT02132754|470597460|FG026|Overall Study|Physician Decision|0|||
130719728|NCT02132754|470597461|FG027|Overall Study|Physician Decision|0|||
130719729|NCT02132754|470597462|FG028|Overall Study|Physician Decision|0|||
131228811|NCT03175120|472465735|FG001|Overall Study|Lost to Follow-up|0|||
131228812|NCT03175120|472465734|FG000|Overall Study|Withdrawal by Subject|2|||
131228813|NCT03175120|472465735|FG001|Overall Study|Withdrawal by Subject|5|||
131228814|NCT03175120|472465734|FG000|Overall Study|Other|2|||
131228815|NCT03175120|472465735|FG001|Overall Study|Other|3|||
131228816|NCT01977092|472465736|FG000|Overall Study|Death|3|||
130983823|NCT00330174|471566392|FG000|Overall Study|Excessive missed visits|3|||
130719730|NCT02132754|470597463|FG029|Overall Study|Physician Decision|0|||
130719731|NCT02132754|470597464|FG030|Overall Study|Physician Decision|0|||
130719732|NCT02132754|470597465|FG031|Overall Study|Physician Decision|1|||
130719733|NCT02132754|470597466|FG032|Overall Study|Physician Decision|0|||
130719734|NCT02132754|470597467|FG033|Overall Study|Physician Decision|3|||
130719735|NCT02132754|470597434|FG000|Overall Study|Progressive Disease|1|||
130719736|NCT02132754|470597435|FG001|Overall Study|Progressive Disease|1|||
130719737|NCT02132754|470597436|FG002|Overall Study|Progressive Disease|1|||
130719738|NCT02132754|470597437|FG003|Overall Study|Progressive Disease|1|||
131044743|NCT05513937|471797624|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
131044744|NCT05513937|471797625|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
131044745|NCT05513937|471797622|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
131044746|NCT05513937|471797623|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
131044747|NCT05513937|471797624|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
131044748|NCT05513937|471797625|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
131044749|NCT05513937|471797622|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
131044750|NCT05513937|471797623|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
131044751|NCT05513937|471797624|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
131044752|NCT05513937|471797625|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
131044753|NCT05513937|471797622|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
131044754|NCT05513937|471797623|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
131044755|NCT05513937|471797624|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
131044756|NCT05513937|471797625|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
131044757|NCT05513937|471797622|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
131044758|NCT05513937|471797623|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
131044759|NCT05513937|471797624|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
131044760|NCT05513937|471797625|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
131044761|NCT05513937|471797622|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
131044762|NCT05513937|471797623|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
131044763|NCT05513937|471797624|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
131044764|NCT05513937|471797625|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
131044765|NCT02846545|471797626|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
131044766|NCT02846545|471797627|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
131044767|NCT02846545|471797626|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
131044768|NCT02846545|471797627|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
131044769|NCT02846545|471797626|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
131044770|NCT02846545|471797627|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
131044771|NCT02846545|471797626|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
131044772|NCT02846545|471797627|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
131044773|NCT02846545|471797626|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
131044774|NCT02846545|471797627|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
131044775|NCT03691298|471797630|FG000|Overall Study|Lost to Follow-up|8|||
131044776|NCT03691298|471797630|FG000|Overall Study|Sponsor terminated study|2|||
131044777|NCT02492711|471797634|FG000|Overall Study|Adverse Event|9|||
131044778|NCT02492711|471797635|FG001|Overall Study|Adverse Event|9|||
131044779|NCT02492711|471797636|FG002|Overall Study|Adverse Event|2|||
131044780|NCT02492711|471797634|FG000|Overall Study|Death|3|||
131044781|NCT02492711|471797635|FG001|Overall Study|Death|3|||
131044782|NCT02492711|471797636|FG002|Overall Study|Death|0|||
131044783|NCT02492711|471797634|FG000|Overall Study|Withdrawal by Subject|10|||
131044784|NCT02492711|471797635|FG001|Overall Study|Withdrawal by Subject|16|||
131044785|NCT02492711|471797636|FG002|Overall Study|Withdrawal by Subject|5|||
131044786|NCT02492711|471797634|FG000|Overall Study|Physician Decision|10|||
131044787|NCT02492711|471797635|FG001|Overall Study|Physician Decision|6|||
131044788|NCT02492711|471797636|FG002|Overall Study|Physician Decision|4|||
131044789|NCT02492711|471797634|FG000|Overall Study|Lost to Follow-up|0|||
131044790|NCT02492711|471797635|FG001|Overall Study|Lost to Follow-up|0|||
131044791|NCT02492711|471797636|FG002|Overall Study|Lost to Follow-up|1|||
131044792|NCT02492711|471797634|FG000|Overall Study|study treatment delay|2|||
131044793|NCT02492711|471797635|FG001|Overall Study|study treatment delay|1|||
131044794|NCT02492711|471797636|FG002|Overall Study|study treatment delay|0|||
131133436|NCT02109484|472115341|FG000|Overall Study|Lost to Follow-up|0|||
130719739|NCT02132754|470597438|FG004|Overall Study|Progressive Disease|1|||
131044795|NCT02492711|471797634|FG000|Overall Study|change in chemotherapy|0|||
131044796|NCT02492711|471797635|FG001|Overall Study|change in chemotherapy|1|||
131044797|NCT02492711|471797636|FG002|Overall Study|change in chemotherapy|0|||
131044798|NCT02492711|471797634|FG000|Overall Study|never treated|2|||
131044799|NCT02492711|471797635|FG001|Overall Study|never treated|4|||
131133437|NCT02109484|472115342|FG001|Overall Study|Lost to Follow-up|0|||
130719740|NCT02132754|470597439|FG005|Overall Study|Progressive Disease|1|||
130719741|NCT02132754|470597440|FG006|Overall Study|Progressive Disease|1|||
131228817|NCT01977092|472465737|FG001|Overall Study|Death|4|||
131228818|NCT01977092|472465736|FG000|Overall Study|Lost to Follow-up|23|||
131228819|NCT01977092|472465737|FG001|Overall Study|Lost to Follow-up|14|||
131228820|NCT01977092|472465736|FG000|Overall Study|Withdrawal by Subject|2|||
131228821|NCT01977092|472465737|FG001|Overall Study|Withdrawal by Subject|1|||
131228822|NCT01977092|472465736|FG000|Overall Study|In prison|3|||
131228823|NCT01977092|472465737|FG001|Overall Study|In prison|11|||
131228824|NCT03038113|472465738|FG000|Overall Study|Withdrawal by Subject|0|||
131228825|NCT03038113|472465739|FG001|Overall Study|Withdrawal by Subject|0|||
131228826|NCT03038113|472465740|FG002|Overall Study|Withdrawal by Subject|1|||
131228827|NCT03038113|472465741|FG003|Overall Study|Withdrawal by Subject|0|||
131228828|NCT03038113|472465742|FG004|Overall Study|Withdrawal by Subject|0|||
131228829|NCT03038113|472465743|FG005|Overall Study|Withdrawal by Subject|0|||
131228830|NCT03038113|472465744|FG006|Overall Study|Withdrawal by Subject|0|||
131228831|NCT03038113|472465745|FG007|Overall Study|Withdrawal by Subject|0|||
131228832|NCT03038113|472465746|FG008|Overall Study|Withdrawal by Subject|0|||
131228833|NCT03038113|472465747|FG009|Overall Study|Withdrawal by Subject|0|||
131228834|NCT03038113|472465748|FG010|Overall Study|Withdrawal by Subject|0|||
131228835|NCT03038113|472465749|FG011|Overall Study|Withdrawal by Subject|0|||
131228836|NCT03038113|472465750|FG012|Overall Study|Withdrawal by Subject|0|||
131228837|NCT03038113|472465751|FG013|Overall Study|Withdrawal by Subject|1|||
131228838|NCT03038113|472465738|FG000|Overall Study|Lost to Follow-up|0|||
131228839|NCT03038113|472465739|FG001|Overall Study|Lost to Follow-up|0|||
131228840|NCT03038113|472465740|FG002|Overall Study|Lost to Follow-up|0|||
131228841|NCT03038113|472465741|FG003|Overall Study|Lost to Follow-up|0|||
131228842|NCT03038113|472465742|FG004|Overall Study|Lost to Follow-up|0|||
131228843|NCT03038113|472465743|FG005|Overall Study|Lost to Follow-up|0|||
131228844|NCT03038113|472465744|FG006|Overall Study|Lost to Follow-up|1|||
131228845|NCT03038113|472465745|FG007|Overall Study|Lost to Follow-up|0|||
131228846|NCT03038113|472465746|FG008|Overall Study|Lost to Follow-up|0|||
131228847|NCT03038113|472465747|FG009|Overall Study|Lost to Follow-up|0|||
131228848|NCT03038113|472465748|FG010|Overall Study|Lost to Follow-up|0|||
131228849|NCT03038113|472465749|FG011|Overall Study|Lost to Follow-up|0|||
131228850|NCT03038113|472465750|FG012|Overall Study|Lost to Follow-up|0|||
131228851|NCT03038113|472465751|FG013|Overall Study|Lost to Follow-up|0|||
131228852|NCT00723554|472465753|FG000|Overall Study|Adverse Event|12|||
131228853|NCT00723554|472465753|FG000|Overall Study|Investigator's judgement|5|||
131228854|NCT00723554|472465753|FG000|Overall Study|Inhaled medication other than iloprost|4|||
131228855|NCT00723554|472465753|FG000|Overall Study|Withdrawal of consent|3|||
131228856|NCT00723554|472465753|FG000|Overall Study|Other|3|||
131228857|NCT00723554|472465753|FG000|Overall Study|Lost to Follow-up|1|||
131228858|NCT00723554|472465753|FG000|Overall Study|Non-compliance|1|||
131228859|NCT03255031|472465754|FG000|Overall Study|Adverse Event|5|||
131228860|NCT03255031|472465755|FG001|Overall Study|Adverse Event|3|||
131228861|NCT03255031|472465754|FG000|Overall Study|Physician Decision|2|||
131228862|NCT03255031|472465755|FG001|Overall Study|Physician Decision|1|||
131228863|NCT03255031|472465754|FG000|Overall Study|Withdrawal by Subject|9|||
131228864|NCT03255031|472465755|FG001|Overall Study|Withdrawal by Subject|3|||
131228865|NCT01689974|472465757|FG000|Overall Study|Termination of Study|5|||
131228866|NCT01689974|472465758|FG001|Overall Study|Termination of Study|5|||
131228867|NCT00415532|472465762|FG000|Treatment Period|Adverse Event|2|||
130719742|NCT02132754|470597441|FG007|Overall Study|Progressive Disease|1|||
130719743|NCT02132754|470597442|FG008|Overall Study|Progressive Disease|1|||
130719744|NCT02132754|470597443|FG009|Overall Study|Progressive Disease|3|||
131133438|NCT02109484|472115343|FG002|Overall Study|Lost to Follow-up|0|||
131133439|NCT02109484|472115344|FG003|Overall Study|Lost to Follow-up|1|||
131133440|NCT02109484|472115345|FG004|Overall Study|Lost to Follow-up|1|||
131133441|NCT02109484|472115346|FG005|Overall Study|Lost to Follow-up|0|||
131133442|NCT02109484|472115347|FG006|Overall Study|Lost to Follow-up|1|||
131133443|NCT02109484|472115348|FG007|Overall Study|Lost to Follow-up|0|||
131133444|NCT02109484|472115341|FG000|Overall Study|Withdrawal by Subject|0|||
130719745|NCT02132754|470597444|FG010|Overall Study|Progressive Disease|3|||
130719746|NCT02132754|470597445|FG011|Overall Study|Progressive Disease|2|||
130719747|NCT02132754|470597446|FG012|Overall Study|Progressive Disease|2|||
130719748|NCT02132754|470597447|FG013|Overall Study|Progressive Disease|3|||
130719749|NCT02132754|470597448|FG014|Overall Study|Progressive Disease|2|||
130719750|NCT02132754|470597449|FG015|Overall Study|Progressive Disease|1|||
130719751|NCT02132754|470597450|FG016|Overall Study|Progressive Disease|2|||
130719752|NCT02132754|470597451|FG017|Overall Study|Progressive Disease|1|||
131228868|NCT00415532|472465763|FG001|Treatment Period|Adverse Event|3|||
130719753|NCT02132754|470597452|FG018|Overall Study|Progressive Disease|3|||
130719754|NCT02132754|470597453|FG019|Overall Study|Progressive Disease|1|||
131133445|NCT02109484|472115342|FG001|Overall Study|Withdrawal by Subject|0|||
131228869|NCT00415532|472465762|FG000|Treatment Period|Death|2|||
131228870|NCT00415532|472465763|FG001|Treatment Period|Death|1|||
131228871|NCT00415532|472465762|FG000|Treatment Period|Lost to Follow-up|1|||
131228872|NCT00415532|472465763|FG001|Treatment Period|Lost to Follow-up|1|||
131228873|NCT00415532|472465762|FG000|Treatment Period|Protocol Violation|1|||
131228874|NCT00415532|472465763|FG001|Treatment Period|Protocol Violation|0|||
130719755|NCT02132754|470597454|FG020|Overall Study|Progressive Disease|1|||
130719756|NCT02132754|470597455|FG021|Overall Study|Progressive Disease|3|||
130719757|NCT02132754|470597456|FG022|Overall Study|Progressive Disease|2|||
130719758|NCT02132754|470597457|FG023|Overall Study|Progressive Disease|3|||
130719759|NCT02132754|470597458|FG024|Overall Study|Progressive Disease|0|||
130719760|NCT02132754|470597459|FG025|Overall Study|Progressive Disease|1|||
130719761|NCT02132754|470597460|FG026|Overall Study|Progressive Disease|2|||
130719762|NCT02132754|470597461|FG027|Overall Study|Progressive Disease|1|||
130719763|NCT02132754|470597462|FG028|Overall Study|Progressive Disease|2|||
130719764|NCT02132754|470597463|FG029|Overall Study|Progressive Disease|3|||
130719765|NCT02132754|470597464|FG030|Overall Study|Progressive Disease|1|||
130719766|NCT02132754|470597465|FG031|Overall Study|Progressive Disease|1|||
130719767|NCT02132754|470597466|FG032|Overall Study|Progressive Disease|3|||
130719768|NCT02132754|470597467|FG033|Overall Study|Progressive Disease|6|||
130719769|NCT02132754|470597434|FG000|Overall Study|Screen Failure|0|||
130719770|NCT02132754|470597435|FG001|Overall Study|Screen Failure|0|||
130719771|NCT02132754|470597436|FG002|Overall Study|Screen Failure|0|||
130719772|NCT02132754|470597437|FG003|Overall Study|Screen Failure|0|||
130719773|NCT02132754|470597438|FG004|Overall Study|Screen Failure|0|||
130719774|NCT02132754|470597439|FG005|Overall Study|Screen Failure|0|||
130719775|NCT02132754|470597440|FG006|Overall Study|Screen Failure|0|||
130719776|NCT02132754|470597441|FG007|Overall Study|Screen Failure|0|||
130719777|NCT02132754|470597442|FG008|Overall Study|Screen Failure|0|||
130719778|NCT02132754|470597443|FG009|Overall Study|Screen Failure|0|||
130719779|NCT02132754|470597444|FG010|Overall Study|Screen Failure|0|||
130719780|NCT02132754|470597445|FG011|Overall Study|Screen Failure|0|||
130719781|NCT02132754|470597446|FG012|Overall Study|Screen Failure|0|||
130719782|NCT02132754|470597447|FG013|Overall Study|Screen Failure|0|||
130719783|NCT02132754|470597448|FG014|Overall Study|Screen Failure|0|||
130719784|NCT02132754|470597449|FG015|Overall Study|Screen Failure|0|||
130719785|NCT02132754|470597450|FG016|Overall Study|Screen Failure|0|||
130719786|NCT02132754|470597451|FG017|Overall Study|Screen Failure|0|||
130719787|NCT02132754|470597452|FG018|Overall Study|Screen Failure|0|||
130719788|NCT02132754|470597453|FG019|Overall Study|Screen Failure|1|||
130719789|NCT02132754|470597454|FG020|Overall Study|Screen Failure|0|||
130719790|NCT02132754|470597455|FG021|Overall Study|Screen Failure|1|||
130719791|NCT02132754|470597456|FG022|Overall Study|Screen Failure|0|||
130719792|NCT02132754|470597457|FG023|Overall Study|Screen Failure|0|||
130719793|NCT02132754|470597458|FG024|Overall Study|Screen Failure|0|||
130719794|NCT02132754|470597459|FG025|Overall Study|Screen Failure|0|||
130719795|NCT02132754|470597460|FG026|Overall Study|Screen Failure|0|||
130719796|NCT02132754|470597461|FG027|Overall Study|Screen Failure|0|||
130719797|NCT02132754|470597462|FG028|Overall Study|Screen Failure|0|||
130719798|NCT02132754|470597463|FG029|Overall Study|Screen Failure|0|||
130719799|NCT02132754|470597464|FG030|Overall Study|Screen Failure|0|||
130719800|NCT02132754|470597465|FG031|Overall Study|Screen Failure|0|||
130719801|NCT02132754|470597466|FG032|Overall Study|Screen Failure|0|||
130719802|NCT02132754|470597467|FG033|Overall Study|Screen Failure|0|||
130719803|NCT02132754|470597434|FG000|Overall Study|Transferred to Extension Study|0|||
130719804|NCT02132754|470597435|FG001|Overall Study|Transferred to Extension Study|0|||
130719805|NCT02132754|470597436|FG002|Overall Study|Transferred to Extension Study|0|||
130719806|NCT02132754|470597437|FG003|Overall Study|Transferred to Extension Study|0|||
130719807|NCT02132754|470597438|FG004|Overall Study|Transferred to Extension Study|0|||
130719808|NCT02132754|470597439|FG005|Overall Study|Transferred to Extension Study|0|||
130719809|NCT02132754|470597440|FG006|Overall Study|Transferred to Extension Study|0|||
130719810|NCT02132754|470597441|FG007|Overall Study|Transferred to Extension Study|0|||
130719811|NCT02132754|470597442|FG008|Overall Study|Transferred to Extension Study|0|||
130719812|NCT02132754|470597443|FG009|Overall Study|Transferred to Extension Study|0|||
130719813|NCT02132754|470597444|FG010|Overall Study|Transferred to Extension Study|0|||
130719814|NCT02132754|470597445|FG011|Overall Study|Transferred to Extension Study|0|||
130719815|NCT02132754|470597446|FG012|Overall Study|Transferred to Extension Study|0|||
130719816|NCT02132754|470597447|FG013|Overall Study|Transferred to Extension Study|0|||
130719817|NCT02132754|470597448|FG014|Overall Study|Transferred to Extension Study|0|||
130719818|NCT02132754|470597449|FG015|Overall Study|Transferred to Extension Study|0|||
130719819|NCT02132754|470597450|FG016|Overall Study|Transferred to Extension Study|0|||
130719820|NCT02132754|470597451|FG017|Overall Study|Transferred to Extension Study|0|||
130719821|NCT02132754|470597452|FG018|Overall Study|Transferred to Extension Study|0|||
130719822|NCT02132754|470597453|FG019|Overall Study|Transferred to Extension Study|0|||
130719823|NCT02132754|470597454|FG020|Overall Study|Transferred to Extension Study|0|||
130719824|NCT02132754|470597455|FG021|Overall Study|Transferred to Extension Study|0|||
130719825|NCT02132754|470597456|FG022|Overall Study|Transferred to Extension Study|0|||
130719826|NCT02132754|470597457|FG023|Overall Study|Transferred to Extension Study|0|||
130719827|NCT02132754|470597458|FG024|Overall Study|Transferred to Extension Study|0|||
130719828|NCT02132754|470597459|FG025|Overall Study|Transferred to Extension Study|0|||
130719829|NCT02132754|470597460|FG026|Overall Study|Transferred to Extension Study|0|||
130719830|NCT02132754|470597461|FG027|Overall Study|Transferred to Extension Study|0|||
130719831|NCT02132754|470597462|FG028|Overall Study|Transferred to Extension Study|0|||
131228875|NCT00415532|472465762|FG000|Treatment Period|Withdrawal by Subject|6|||
131228876|NCT00415532|472465763|FG001|Treatment Period|Withdrawal by Subject|6|||
131228877|NCT00415532|472465762|FG000|Treatment Period|Other|2|||
131228878|NCT00415532|472465763|FG001|Treatment Period|Other|2|||
131228879|NCT00415532|472465762|FG000|Treatment Period|Ineligibility determined|1|||
131228880|NCT00415532|472465763|FG001|Treatment Period|Ineligibility determined|1|||
131228881|NCT00415532|472465762|FG000|Treatment Period|Noncompliance|1|||
131228882|NCT00415532|472465763|FG001|Treatment Period|Noncompliance|1|||
131228883|NCT00415532|472465762|FG000|Treatment Period|Requirement for alternative therapy|1|||
130983824|NCT00330174|471566393|FG001|Overall Study|Excessive missed visits|8|||
130983825|NCT00330174|471566392|FG000|Overall Study|Miscellaneous reasons|7|||
130983826|NCT00330174|471566393|FG001|Overall Study|Miscellaneous reasons|1|||
130983827|NCT01844284|471566394|FG000|Overall Study|Lost to Follow-up|12|||
130983828|NCT01844284|471566395|FG001|Overall Study|Lost to Follow-up|7|||
130719832|NCT02132754|470597463|FG029|Overall Study|Transferred to Extension Study|0|||
130719833|NCT02132754|470597464|FG030|Overall Study|Transferred to Extension Study|0|||
130719834|NCT02132754|470597465|FG031|Overall Study|Transferred to Extension Study|0|||
130719835|NCT02132754|470597466|FG032|Overall Study|Transferred to Extension Study|0|||
130719836|NCT02132754|470597467|FG033|Overall Study|Transferred to Extension Study|6|||
130719837|NCT02132754|470597434|FG000|Overall Study|Withdrawal by Subject|0|||
130719838|NCT02132754|470597435|FG001|Overall Study|Withdrawal by Subject|0|||
130719839|NCT02132754|470597436|FG002|Overall Study|Withdrawal by Subject|0|||
130719840|NCT02132754|470597437|FG003|Overall Study|Withdrawal by Subject|0|||
130719841|NCT02132754|470597438|FG004|Overall Study|Withdrawal by Subject|0|||
130719842|NCT02132754|470597439|FG005|Overall Study|Withdrawal by Subject|0|||
130719843|NCT02132754|470597440|FG006|Overall Study|Withdrawal by Subject|0|||
130719844|NCT02132754|470597441|FG007|Overall Study|Withdrawal by Subject|0|||
130719845|NCT02132754|470597442|FG008|Overall Study|Withdrawal by Subject|0|||
130719846|NCT02132754|470597443|FG009|Overall Study|Withdrawal by Subject|1|||
130719847|NCT02132754|470597444|FG010|Overall Study|Withdrawal by Subject|0|||
130719848|NCT02132754|470597445|FG011|Overall Study|Withdrawal by Subject|0|||
130719849|NCT02132754|470597446|FG012|Overall Study|Withdrawal by Subject|1|||
130719850|NCT02132754|470597447|FG013|Overall Study|Withdrawal by Subject|0|||
130719851|NCT02132754|470597448|FG014|Overall Study|Withdrawal by Subject|1|||
130719852|NCT02132754|470597449|FG015|Overall Study|Withdrawal by Subject|2|||
130719853|NCT02132754|470597450|FG016|Overall Study|Withdrawal by Subject|1|||
130719854|NCT02132754|470597451|FG017|Overall Study|Withdrawal by Subject|0|||
130719855|NCT02132754|470597452|FG018|Overall Study|Withdrawal by Subject|0|||
130719856|NCT02132754|470597453|FG019|Overall Study|Withdrawal by Subject|0|||
130719857|NCT02132754|470597454|FG020|Overall Study|Withdrawal by Subject|1|||
130719858|NCT02132754|470597455|FG021|Overall Study|Withdrawal by Subject|0|||
130719859|NCT02132754|470597456|FG022|Overall Study|Withdrawal by Subject|0|||
130719860|NCT02132754|470597457|FG023|Overall Study|Withdrawal by Subject|0|||
130719861|NCT02132754|470597458|FG024|Overall Study|Withdrawal by Subject|1|||
130719862|NCT02132754|470597459|FG025|Overall Study|Withdrawal by Subject|0|||
130719863|NCT02132754|470597460|FG026|Overall Study|Withdrawal by Subject|0|||
130719864|NCT02132754|470597461|FG027|Overall Study|Withdrawal by Subject|1|||
130719865|NCT02132754|470597462|FG028|Overall Study|Withdrawal by Subject|0|||
130719866|NCT02132754|470597463|FG029|Overall Study|Withdrawal by Subject|0|||
130719867|NCT02132754|470597464|FG030|Overall Study|Withdrawal by Subject|0|||
130719868|NCT02132754|470597465|FG031|Overall Study|Withdrawal by Subject|1|||
130719869|NCT02132754|470597466|FG032|Overall Study|Withdrawal by Subject|0|||
130719870|NCT02132754|470597467|FG033|Overall Study|Withdrawal by Subject|2|||
130719871|NCT00477295|470597472|FG000|Overall Study|Adverse Event|31|||
130983829|NCT02755597|471566396|FG000|Overall Study|Withdrew consent|27|||
130983830|NCT02755597|471566397|FG001|Overall Study|Withdrew consent|11|||
130983831|NCT02755597|471566396|FG000|Overall Study|Lost to Follow-up|1|||
131044800|NCT02492711|471797636|FG002|Overall Study|never treated|0|||
131044801|NCT02492711|471797634|FG000|Overall Study|Other|0|||
131044802|NCT02492711|471797635|FG001|Overall Study|Other|0|||
131044803|NCT02492711|471797636|FG002|Overall Study|Other|1|||
131044804|NCT03245840|471797642|FG000|Overall Study|Adverse Event|6|||
131044805|NCT03245840|471797643|FG001|Overall Study|Adverse Event|0|||
131044806|NCT03245840|471797642|FG000|Overall Study|Death|2|||
131044807|NCT03245840|471797643|FG001|Overall Study|Death|0|||
131044808|NCT03245840|471797642|FG000|Overall Study|Withdrawal by Subject|31|||
131044809|NCT03245840|471797643|FG001|Overall Study|Withdrawal by Subject|1|||
131044810|NCT03245840|471797642|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
131044811|NCT03245840|471797643|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131044812|NCT03245840|471797642|FG000|Overall Study|Physician Decision|4|||
131044813|NCT03245840|471797643|FG001|Overall Study|Physician Decision|1|||
131044814|NCT03245840|471797642|FG000|Overall Study|Study Terminated by Sponsor|56|||
131044815|NCT03245840|471797643|FG001|Overall Study|Study Terminated by Sponsor|6|||
131044816|NCT03245840|471797642|FG000|Overall Study|Site Terminated by Sponsor|4|||
131044817|NCT03245840|471797643|FG001|Overall Study|Site Terminated by Sponsor|0|||
131228884|NCT00415532|472465763|FG001|Treatment Period|Requirement for alternative therapy|0|||
131228885|NCT00415532|472465762|FG000|Safety Follow Up Period|Adverse Event|1|||
131228886|NCT00415532|472465763|FG001|Safety Follow Up Period|Adverse Event|3|||
131228887|NCT00415532|472465762|FG000|Safety Follow Up Period|Death|3|||
131228888|NCT00415532|472465763|FG001|Safety Follow Up Period|Death|0|||
131228889|NCT00415532|472465762|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
131228890|NCT00415532|472465763|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
131228891|NCT00415532|472465762|FG000|Safety Follow Up Period|Other|1|||
131228892|NCT00415532|472465763|FG001|Safety Follow Up Period|Other|4|||
131228893|NCT00415532|472465762|FG000|Safety Follow Up Period|Ineligibility determined|1|||
131228894|NCT00415532|472465763|FG001|Safety Follow Up Period|Ineligibility determined|1|||
131228895|NCT00415532|472465762|FG000|Safety Follow Up Period|Noncompliance|1|||
131228896|NCT00415532|472465763|FG001|Safety Follow Up Period|Noncompliance|0|||
131228897|NCT00415532|472465762|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
131228898|NCT00415532|472465763|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
131228899|NCT01698320|472465764|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
131228900|NCT01698320|472465765|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
131228901|NCT01698320|472465766|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
131228902|NCT01698320|472465764|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
131228903|NCT01698320|472465765|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
131228904|NCT01698320|472465766|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
131228905|NCT01698320|472465764|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
131228906|NCT01698320|472465765|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
131228907|NCT01698320|472465766|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
131228908|NCT01698320|472465764|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
131228909|NCT01698320|472465765|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
131228910|NCT01698320|472465766|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
131228911|NCT01698320|472465764|FG000|12-Week Double-Blind Period|Adverse Event|0|||
131228912|NCT01698320|472465765|FG001|12-Week Double-Blind Period|Adverse Event|1|||
131228913|NCT01698320|472465766|FG002|12-Week Double-Blind Period|Adverse Event|1|||
130719872|NCT00477295|470597473|FG001|Overall Study|Adverse Event|35|||
130719873|NCT00477295|470597472|FG000|Overall Study|Withdrawal by Subject|35|||
130719874|NCT00477295|470597473|FG001|Overall Study|Withdrawal by Subject|24|||
130719875|NCT00477295|470597472|FG000|Overall Study|Lack of Efficacy|23|||
130719876|NCT00477295|470597473|FG001|Overall Study|Lack of Efficacy|23|||
130719877|NCT00477295|470597472|FG000|Overall Study|Protocol Violation|3|||
130719878|NCT00477295|470597473|FG001|Overall Study|Protocol Violation|8|||
130719879|NCT00477295|470597472|FG000|Overall Study|Physician Decision|4|||
130719880|NCT00477295|470597473|FG001|Overall Study|Physician Decision|5|||
130719881|NCT00477295|470597472|FG000|Overall Study|Lost to Follow-up|21|||
130719882|NCT00477295|470597473|FG001|Overall Study|Lost to Follow-up|11|||
130719883|NCT00477295|470597472|FG000|Overall Study|Other|4|||
130719884|NCT00477295|470597473|FG001|Overall Study|Other|3|||
130719885|NCT00228423|470597476|FG000|Overall Study|Adverse Event|2|||
130719886|NCT00228423|470597477|FG001|Overall Study|Adverse Event|5|||
130719887|NCT00228423|470597476|FG000|Overall Study|Withdrawal by Subject|7|||
130719888|NCT00228423|470597477|FG001|Overall Study|Withdrawal by Subject|3|||
130719889|NCT00228423|470597476|FG000|Overall Study|Protocol Violation|1|||
130719890|NCT00228423|470597477|FG001|Overall Study|Protocol Violation|3|||
130719891|NCT00228423|470597476|FG000|Overall Study|Physician Decision|0|||
130719892|NCT00228423|470597477|FG001|Overall Study|Physician Decision|1|||
130719893|NCT01709838|470597491|FG000|Overall Study|Withdrawal by Subject|21|||
130719894|NCT01709838|470597491|FG000|Overall Study|Lost to Follow-up|16|||
130719895|NCT01709838|470597491|FG000|Overall Study|Pregnancy|10|||
130719896|NCT01709838|470597491|FG000|Overall Study|Subject/guardian decision|8|||
130719897|NCT01709838|470597491|FG000|Overall Study|Adverse Event|4|||
130719898|NCT01709838|470597491|FG000|Overall Study|Physician Decision|4|||
130719899|NCT01709838|470597491|FG000|Overall Study|Death|3|||
130719900|NCT01709838|470597491|FG000|Overall Study|Protocol Violation|1|||
130719901|NCT03190330|470599630|FG000|Overall Study|Adverse Event|2|||
130719902|NCT03190330|470599630|FG000|Overall Study|Death|10|||
130719903|NCT03190330|470599630|FG000|Overall Study|Lost to Follow-up|1|||
130719904|NCT03190330|470599630|FG000|Overall Study|Withdrawal by Subject|6|||
130719905|NCT03190330|470599630|FG000|Overall Study|Progressive Disease|1|||
130719906|NCT03845296|470599639|FG000|Overall Study|On Treatment|2|||
130719907|NCT03845296|470599640|FG001|Overall Study|On Treatment|1|||
131228914|NCT01698320|472465764|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
130719908|NCT03845296|470599639|FG000|Overall Study|Adverse Event|4|||
130719909|NCT03845296|470599640|FG001|Overall Study|Adverse Event|11|||
130719910|NCT03845296|470599639|FG000|Overall Study|Refusal unrelated to adverse event|0|||
131228915|NCT01698320|472465765|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
131228916|NCT01698320|472465766|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
131228917|NCT01698320|472465764|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
131228918|NCT01698320|472465765|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
130719911|NCT03845296|470599640|FG001|Overall Study|Refusal unrelated to adverse event|1|||
130719912|NCT03845296|470599639|FG000|Overall Study|Progression/relapse|14|||
131228919|NCT01698320|472465766|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
131228920|NCT01698320|472465764|FG000|12-Week Double-Blind Period|Pregnancy|0|||
131228921|NCT01698320|472465765|FG001|12-Week Double-Blind Period|Pregnancy|1|||
131228922|NCT01698320|472465766|FG002|12-Week Double-Blind Period|Pregnancy|1|||
131228923|NCT01698320|472465764|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
131228924|NCT01698320|472465765|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
131228925|NCT01698320|472465766|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
131228926|NCT01698320|472465764|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
131228927|NCT01698320|472465765|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
131228928|NCT01698320|472465766|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
131228929|NCT01698320|472465764|FG000|40-Week Open-Label Period|Adverse Event|0|||
131228930|NCT01698320|472465765|FG001|40-Week Open-Label Period|Adverse Event|3|||
131228931|NCT01698320|472465766|FG002|40-Week Open-Label Period|Adverse Event|2|||
131228932|NCT01698320|472465764|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
131228933|NCT01698320|472465765|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
131228934|NCT01698320|472465766|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
131228935|NCT01698320|472465764|FG000|40-Week Open-Label Period|Pregnancy|0|||
131228936|NCT01698320|472465765|FG001|40-Week Open-Label Period|Pregnancy|2|||
131228937|NCT01698320|472465766|FG002|40-Week Open-Label Period|Pregnancy|1|||
131228938|NCT01698320|472465764|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
131228939|NCT01698320|472465765|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
131228940|NCT01698320|472465766|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
131228941|NCT01698320|472465764|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
131228942|NCT01698320|472465765|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
131228943|NCT01698320|472465766|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
131228944|NCT01952574|472465767|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
131228945|NCT01952574|472465768|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
131228946|NCT01952574|472465769|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
131228947|NCT01952574|472465770|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
131228948|NCT01952574|472465771|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131228949|NCT01952574|472465772|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131228950|NCT01952574|472465773|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
131228951|NCT01952574|472465767|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
131228952|NCT01952574|472465768|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
131228953|NCT01952574|472465769|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
131228954|NCT01952574|472465770|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
131228955|NCT01952574|472465771|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
131228956|NCT01952574|472465772|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
131228957|NCT01952574|472465773|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
131228958|NCT01952574|472465767|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
131228959|NCT01952574|472465768|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
131228960|NCT01952574|472465769|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
131228961|NCT01952574|472465770|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
131228962|NCT01952574|472465771|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
131228963|NCT01952574|472465772|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
131228964|NCT01952574|472465773|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
131228965|NCT01952574|472465767|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
131228966|NCT01952574|472465768|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
131228967|NCT01952574|472465769|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
131228968|NCT01952574|472465770|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
131228969|NCT01952574|472465771|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
131228970|NCT01952574|472465772|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
131228971|NCT01952574|472465773|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
131228972|NCT01952574|472465767|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
131228973|NCT01952574|472465768|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
131228974|NCT01952574|472465769|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
131228975|NCT01952574|472465770|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
131228976|NCT01952574|472465771|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
131228977|NCT01952574|472465772|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
131228978|NCT01952574|472465773|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
131228979|NCT01952574|472465767|FG000|Open-label Treatment Phase|Missing|0|||
131228980|NCT01952574|472465768|FG001|Open-label Treatment Phase|Missing|0|||
130983832|NCT02755597|471566397|FG001|Overall Study|Lost to Follow-up|0|||
130983833|NCT02755597|471566396|FG000|Overall Study|Death|78|||
131228981|NCT01952574|472465769|FG002|Open-label Treatment Phase|Missing|0|||
131228982|NCT01952574|472465770|FG003|Open-label Treatment Phase|Missing|0|||
131228983|NCT01952574|472465771|FG004|Open-label Treatment Phase|Missing|4|||
131228984|NCT01952574|472465772|FG005|Open-label Treatment Phase|Missing|0|||
130983834|NCT02755597|471566397|FG001|Overall Study|Death|36|||
130983835|NCT02755597|471566396|FG000|Overall Study|Study terminated by Sponsor|67|||
130719913|NCT03845296|470599640|FG001|Overall Study|Progression/relapse|18|||
130719914|NCT03845296|470599639|FG000|Overall Study|Death|4|||
130719915|NCT03845296|470599640|FG001|Overall Study|Death|0|||
130719916|NCT03845296|470599639|FG000|Overall Study|Other - not protocol specified|1|||
130719917|NCT03845296|470599640|FG001|Overall Study|Other - not protocol specified|3|||
130719918|NCT05091307|470599641|FG000|Overall Study|Death|0|||
130719919|NCT05091307|470599642|FG001|Overall Study|Death|0|||
130719920|NCT05091307|470599643|FG002|Overall Study|Death|1|||
130719921|NCT05091307|470599644|FG003|Overall Study|Death|0|||
130719922|NCT05091307|470599641|FG000|Overall Study|Lost to Follow-up|33|||
130719923|NCT05091307|470599642|FG001|Overall Study|Lost to Follow-up|33|||
130719924|NCT05091307|470599643|FG002|Overall Study|Lost to Follow-up|2|||
130719925|NCT05091307|470599644|FG003|Overall Study|Lost to Follow-up|0|||
130719926|NCT05091307|470599641|FG000|Overall Study|Physician Decision|1|||
130719927|NCT05091307|470599642|FG001|Overall Study|Physician Decision|0|||
130719928|NCT05091307|470599643|FG002|Overall Study|Physician Decision|0|||
130719929|NCT05091307|470599644|FG003|Overall Study|Physician Decision|0|||
130719930|NCT05091307|470599641|FG000|Overall Study|Protocol Violation|1|||
130719931|NCT05091307|470599642|FG001|Overall Study|Protocol Violation|0|||
130719932|NCT05091307|470599643|FG002|Overall Study|Protocol Violation|0|||
130719933|NCT05091307|470599644|FG003|Overall Study|Protocol Violation|0|||
130719934|NCT05091307|470599641|FG000|Overall Study|Withdrawal by Subject|16|||
130719935|NCT05091307|470599642|FG001|Overall Study|Withdrawal by Subject|16|||
130719936|NCT05091307|470599643|FG002|Overall Study|Withdrawal by Subject|0|||
130719937|NCT05091307|470599644|FG003|Overall Study|Withdrawal by Subject|1|||
130719938|NCT05091307|470599641|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
130719939|NCT05091307|470599642|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
130719940|NCT05091307|470599643|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
130719941|NCT05091307|470599644|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
130719942|NCT05091307|470599641|FG000|Overall Study|Initiated Prohibited Medication|1|||
130719943|NCT05091307|470599642|FG001|Overall Study|Initiated Prohibited Medication|0|||
130719944|NCT05091307|470599643|FG002|Overall Study|Initiated Prohibited Medication|0|||
130719945|NCT05091307|470599644|FG003|Overall Study|Initiated Prohibited Medication|0|||
130719946|NCT05091307|470599641|FG000|Overall Study|Other|4|||
130719947|NCT05091307|470599642|FG001|Overall Study|Other|4|||
130719948|NCT05091307|470599643|FG002|Overall Study|Other|0|||
130719949|NCT05091307|470599644|FG003|Overall Study|Other|0|||
130719950|NCT05091307|470599641|FG000|Overall Study|Randomized but not vaccinated|0|||
130719951|NCT05091307|470599642|FG001|Overall Study|Randomized but not vaccinated|2|||
130719952|NCT05091307|470599643|FG002|Overall Study|Randomized but not vaccinated|0|||
130719953|NCT05091307|470599644|FG003|Overall Study|Randomized but not vaccinated|0|||
130719954|NCT03611543|470599647|FG000|Overall Study|Withdrawal by Subject|4|||
130719955|NCT03611543|470599648|FG001|Overall Study|Withdrawal by Subject|4|||
130719956|NCT03611543|470599647|FG000|Overall Study|Physician Decision|1|||
130719957|NCT03611543|470599648|FG001|Overall Study|Physician Decision|1|||
130719958|NCT03611543|470599647|FG000|Overall Study|Protocol Violation|2|||
130719959|NCT03611543|470599648|FG001|Overall Study|Protocol Violation|2|||
130719960|NCT03611543|470599647|FG000|Overall Study|Device failure|2|||
130719961|NCT03611543|470599648|FG001|Overall Study|Device failure|2|||
130719962|NCT03611543|470599647|FG000|Overall Study|Missing information|5|||
130719963|NCT03611543|470599648|FG001|Overall Study|Missing information|5|||
130719964|NCT02081209|470599649|FG000|Overall Study|Withdrawal by Subject|1|||
130719965|NCT02799095|470599657|FG000|Part A|Adverse Event|1|||
130719966|NCT02799095|470599658|FG001|Part A|Adverse Event|0|||
130719967|NCT02799095|470599659|FG002|Part A|Adverse Event|1|||
130719968|NCT02799095|470599660|FG003|Part A|Adverse Event|4|||
130719969|NCT02799095|470599661|FG004|Part A|Adverse Event|1|||
130719970|NCT02799095|470599662|FG005|Part A|Adverse Event|0|||
130719971|NCT02799095|470599663|FG006|Part A|Adverse Event|0|||
130719972|NCT02799095|470599664|FG007|Part A|Adverse Event|0|||
130719973|NCT02799095|470599665|FG008|Part A|Adverse Event|0|||
130719974|NCT02799095|470599666|FG009|Part A|Adverse Event|0|||
130719975|NCT02799095|470599667|FG010|Part A|Adverse Event|0|||
130719976|NCT02799095|470599668|FG011|Part A|Adverse Event|0|||
130719977|NCT02799095|470599669|FG012|Part A|Adverse Event|0|||
130719978|NCT02799095|470599670|FG013|Part A|Adverse Event|0|||
130719979|NCT02799095|470599671|FG014|Part A|Adverse Event|0|||
130778855|NCT03428100|470817452|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130778856|NCT03428100|470817453|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130719980|NCT02799095|470599672|FG015|Part A|Adverse Event|0|||
130719981|NCT02799095|470599673|FG016|Part A|Adverse Event|0|||
130719982|NCT02799095|470599657|FG000|Part A|Death|0|||
130719983|NCT02799095|470599658|FG001|Part A|Death|0|||
130719984|NCT02799095|470599659|FG002|Part A|Death|0|||
130719985|NCT02799095|470599660|FG003|Part A|Death|0|||
130719986|NCT02799095|470599661|FG004|Part A|Death|0|||
130719987|NCT02799095|470599662|FG005|Part A|Death|0|||
130719988|NCT02799095|470599663|FG006|Part A|Death|3|||
130719989|NCT02799095|470599664|FG007|Part A|Death|0|||
130719990|NCT02799095|470599665|FG008|Part A|Death|0|||
130719991|NCT02799095|470599666|FG009|Part A|Death|0|||
130719992|NCT02799095|470599667|FG010|Part A|Death|0|||
130719993|NCT02799095|470599668|FG011|Part A|Death|0|||
130719994|NCT02799095|470599669|FG012|Part A|Death|0|||
130719995|NCT02799095|470599670|FG013|Part A|Death|0|||
130719996|NCT02799095|470599671|FG014|Part A|Death|0|||
130719997|NCT02799095|470599672|FG015|Part A|Death|0|||
130719998|NCT02799095|470599673|FG016|Part A|Death|0|||
130719999|NCT02799095|470599657|FG000|Part A|Lost to Follow-up|0|||
130720000|NCT02799095|470599658|FG001|Part A|Lost to Follow-up|1|||
130720001|NCT02799095|470599659|FG002|Part A|Lost to Follow-up|0|||
130720002|NCT02799095|470599660|FG003|Part A|Lost to Follow-up|0|||
130720003|NCT02799095|470599661|FG004|Part A|Lost to Follow-up|0|||
130720004|NCT02799095|470599662|FG005|Part A|Lost to Follow-up|0|||
130720005|NCT02799095|470599663|FG006|Part A|Lost to Follow-up|1|||
130720006|NCT02799095|470599664|FG007|Part A|Lost to Follow-up|0|||
130720007|NCT02799095|470599665|FG008|Part A|Lost to Follow-up|0|||
130720008|NCT02799095|470599666|FG009|Part A|Lost to Follow-up|0|||
130720009|NCT02799095|470599667|FG010|Part A|Lost to Follow-up|0|||
130720010|NCT02799095|470599668|FG011|Part A|Lost to Follow-up|0|||
130720011|NCT02799095|470599669|FG012|Part A|Lost to Follow-up|0|||
130720012|NCT02799095|470599670|FG013|Part A|Lost to Follow-up|0|||
130720013|NCT02799095|470599671|FG014|Part A|Lost to Follow-up|0|||
130720014|NCT02799095|470599672|FG015|Part A|Lost to Follow-up|0|||
130720015|NCT02799095|470599673|FG016|Part A|Lost to Follow-up|0|||
130720016|NCT02799095|470599657|FG000|Part A|Progressive Disease|3|||
130720017|NCT02799095|470599658|FG001|Part A|Progressive Disease|3|||
130720018|NCT02799095|470599659|FG002|Part A|Progressive Disease|3|||
130720019|NCT02799095|470599660|FG003|Part A|Progressive Disease|2|||
130720020|NCT02799095|470599661|FG004|Part A|Progressive Disease|2|||
130720021|NCT02799095|470599662|FG005|Part A|Progressive Disease|0|||
130720022|NCT02799095|470599663|FG006|Part A|Progressive Disease|0|||
130720023|NCT02799095|470599664|FG007|Part A|Progressive Disease|0|||
130720024|NCT02799095|470599665|FG008|Part A|Progressive Disease|0|||
130720025|NCT02799095|470599666|FG009|Part A|Progressive Disease|0|||
130720026|NCT02799095|470599667|FG010|Part A|Progressive Disease|0|||
130720027|NCT02799095|470599668|FG011|Part A|Progressive Disease|0|||
130720028|NCT02799095|470599669|FG012|Part A|Progressive Disease|0|||
130720029|NCT02799095|470599670|FG013|Part A|Progressive Disease|0|||
130720030|NCT02799095|470599671|FG014|Part A|Progressive Disease|0|||
130720031|NCT02799095|470599672|FG015|Part A|Progressive Disease|0|||
130720032|NCT02799095|470599673|FG016|Part A|Progressive Disease|0|||
130720033|NCT02799095|470599657|FG000|Part A|Clinical Progression|1|||
130720034|NCT02799095|470599658|FG001|Part A|Clinical Progression|0|||
130720035|NCT02799095|470599659|FG002|Part A|Clinical Progression|2|||
130720036|NCT02799095|470599660|FG003|Part A|Clinical Progression|1|||
130720037|NCT02799095|470599661|FG004|Part A|Clinical Progression|5|||
130720038|NCT02799095|470599662|FG005|Part A|Clinical Progression|0|||
130720039|NCT02799095|470599663|FG006|Part A|Clinical Progression|0|||
130720040|NCT02799095|470599664|FG007|Part A|Clinical Progression|0|||
130720041|NCT02799095|470599665|FG008|Part A|Clinical Progression|0|||
130720042|NCT02799095|470599666|FG009|Part A|Clinical Progression|0|||
130720043|NCT02799095|470599667|FG010|Part A|Clinical Progression|0|||
130720044|NCT02799095|470599668|FG011|Part A|Clinical Progression|0|||
130720045|NCT02799095|470599669|FG012|Part A|Clinical Progression|0|||
130720046|NCT02799095|470599670|FG013|Part A|Clinical Progression|0|||
130720047|NCT02799095|470599671|FG014|Part A|Clinical Progression|0|||
130720048|NCT02799095|470599672|FG015|Part A|Clinical Progression|0|||
130720049|NCT02799095|470599673|FG016|Part A|Clinical Progression|0|||
130720050|NCT02799095|470599657|FG000|Part A|Protocol Deviation|0|||
130720051|NCT02799095|470599658|FG001|Part A|Protocol Deviation|0|||
130720052|NCT02799095|470599659|FG002|Part A|Protocol Deviation|1|||
130720053|NCT02799095|470599660|FG003|Part A|Protocol Deviation|0|||
130720054|NCT02799095|470599661|FG004|Part A|Protocol Deviation|0|||
130720055|NCT02799095|470599662|FG005|Part A|Protocol Deviation|0|||
130720056|NCT02799095|470599663|FG006|Part A|Protocol Deviation|0|||
131133446|NCT02109484|472115343|FG002|Overall Study|Withdrawal by Subject|0|||
131133447|NCT02109484|472115344|FG003|Overall Study|Withdrawal by Subject|0|||
131133448|NCT02109484|472115345|FG004|Overall Study|Withdrawal by Subject|1|||
130720057|NCT02799095|470599664|FG007|Part A|Protocol Deviation|0|||
130720058|NCT02799095|470599665|FG008|Part A|Protocol Deviation|0|||
130720059|NCT02799095|470599666|FG009|Part A|Protocol Deviation|0|||
130720060|NCT02799095|470599667|FG010|Part A|Protocol Deviation|0|||
130720061|NCT02799095|470599668|FG011|Part A|Protocol Deviation|0|||
130720062|NCT02799095|470599669|FG012|Part A|Protocol Deviation|0|||
130720063|NCT02799095|470599670|FG013|Part A|Protocol Deviation|0|||
130720064|NCT02799095|470599671|FG014|Part A|Protocol Deviation|0|||
130720065|NCT02799095|470599672|FG015|Part A|Protocol Deviation|0|||
130720066|NCT02799095|470599673|FG016|Part A|Protocol Deviation|0|||
130720067|NCT02799095|470599657|FG000|Part A|Withdrawal by Subject|0|||
130720068|NCT02799095|470599658|FG001|Part A|Withdrawal by Subject|0|||
130720069|NCT02799095|470599659|FG002|Part A|Withdrawal by Subject|0|||
130720070|NCT02799095|470599660|FG003|Part A|Withdrawal by Subject|1|||
130720071|NCT02799095|470599661|FG004|Part A|Withdrawal by Subject|3|||
130720072|NCT02799095|470599662|FG005|Part A|Withdrawal by Subject|1|||
130720073|NCT02799095|470599663|FG006|Part A|Withdrawal by Subject|1|||
130720074|NCT02799095|470599664|FG007|Part A|Withdrawal by Subject|0|||
130720075|NCT02799095|470599665|FG008|Part A|Withdrawal by Subject|0|||
130720076|NCT02799095|470599666|FG009|Part A|Withdrawal by Subject|0|||
130983836|NCT02755597|471566397|FG001|Overall Study|Study terminated by Sponsor|47|||
130983837|NCT02755597|471566396|FG000|Overall Study|Other, not specified|20|||
130983838|NCT02755597|471566397|FG001|Overall Study|Other, not specified|3|||
130983839|NCT02755597|471566396|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
130983840|NCT02755597|471566397|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
130720077|NCT02799095|470599667|FG010|Part A|Withdrawal by Subject|0|||
130720078|NCT02799095|470599668|FG011|Part A|Withdrawal by Subject|0|||
130720079|NCT02799095|470599669|FG012|Part A|Withdrawal by Subject|0|||
130720080|NCT02799095|470599670|FG013|Part A|Withdrawal by Subject|0|||
130720081|NCT02799095|470599671|FG014|Part A|Withdrawal by Subject|0|||
130720082|NCT02799095|470599672|FG015|Part A|Withdrawal by Subject|0|||
130720083|NCT02799095|470599673|FG016|Part A|Withdrawal by Subject|0|||
130720084|NCT02799095|470599657|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
130720085|NCT02799095|470599658|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
130720086|NCT02799095|470599659|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
130720087|NCT02799095|470599660|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
130720088|NCT02799095|470599661|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
130720089|NCT02799095|470599662|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
130720090|NCT02799095|470599663|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
130720091|NCT02799095|470599664|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
130720092|NCT02799095|470599665|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
130720093|NCT02799095|470599666|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
130720094|NCT02799095|470599667|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
130720095|NCT02799095|470599668|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
130720096|NCT02799095|470599669|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
130720097|NCT02799095|470599670|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
130720098|NCT02799095|470599671|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
130720099|NCT02799095|470599672|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
130720100|NCT02799095|470599673|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
130720101|NCT02799095|470599657|FG000|Part B|Death|0|||
130720102|NCT02799095|470599658|FG001|Part B|Death|0|||
130720103|NCT02799095|470599659|FG002|Part B|Death|0|||
130720104|NCT02799095|470599660|FG003|Part B|Death|0|||
130720105|NCT02799095|470599661|FG004|Part B|Death|0|||
130720106|NCT02799095|470599662|FG005|Part B|Death|0|||
130720107|NCT02799095|470599663|FG006|Part B|Death|0|||
130720108|NCT02799095|470599664|FG007|Part B|Death|7|||
130720109|NCT02799095|470599665|FG008|Part B|Death|7|||
130720110|NCT02799095|470599666|FG009|Part B|Death|0|||
130720111|NCT02799095|470599667|FG010|Part B|Death|0|||
130720112|NCT02799095|470599668|FG011|Part B|Death|0|||
130720113|NCT02799095|470599669|FG012|Part B|Death|0|||
130720114|NCT02799095|470599670|FG013|Part B|Death|0|||
130720115|NCT02799095|470599671|FG014|Part B|Death|0|||
130720116|NCT02799095|470599672|FG015|Part B|Death|0|||
130720117|NCT02799095|470599673|FG016|Part B|Death|0|||
130720118|NCT02799095|470599657|FG000|Part B|Progressive Disease|0|||
130720119|NCT02799095|470599658|FG001|Part B|Progressive Disease|0|||
130720120|NCT02799095|470599659|FG002|Part B|Progressive Disease|0|||
130720121|NCT02799095|470599660|FG003|Part B|Progressive Disease|0|||
130720122|NCT02799095|470599661|FG004|Part B|Progressive Disease|0|||
130720123|NCT02799095|470599662|FG005|Part B|Progressive Disease|0|||
130720124|NCT02799095|470599663|FG006|Part B|Progressive Disease|0|||
130720125|NCT02799095|470599664|FG007|Part B|Progressive Disease|1|||
130720126|NCT02799095|470599665|FG008|Part B|Progressive Disease|0|||
130720127|NCT02799095|470599666|FG009|Part B|Progressive Disease|0|||
130720128|NCT02799095|470599667|FG010|Part B|Progressive Disease|0|||
130720129|NCT02799095|470599668|FG011|Part B|Progressive Disease|0|||
130720130|NCT02799095|470599669|FG012|Part B|Progressive Disease|0|||
130720131|NCT02799095|470599670|FG013|Part B|Progressive Disease|0|||
130983841|NCT03641313|471566401|FG000|Overall Study|Death|1|||
130983842|NCT03641313|471566401|FG000|Overall Study|Withdrawal by Subject|2|||
131133449|NCT02109484|472115346|FG005|Overall Study|Withdrawal by Subject|1|||
130720132|NCT02799095|470599671|FG014|Part B|Progressive Disease|0|||
130720133|NCT02799095|470599672|FG015|Part B|Progressive Disease|0|||
130720134|NCT02799095|470599673|FG016|Part B|Progressive Disease|0|||
130720135|NCT02799095|470599657|FG000|Part B|Withdrawal by Subject|0|||
130720136|NCT02799095|470599658|FG001|Part B|Withdrawal by Subject|0|||
130720137|NCT02799095|470599659|FG002|Part B|Withdrawal by Subject|0|||
130720138|NCT02799095|470599660|FG003|Part B|Withdrawal by Subject|0|||
130720139|NCT02799095|470599661|FG004|Part B|Withdrawal by Subject|0|||
130720140|NCT02799095|470599662|FG005|Part B|Withdrawal by Subject|0|||
130720141|NCT02799095|470599663|FG006|Part B|Withdrawal by Subject|0|||
130720142|NCT02799095|470599664|FG007|Part B|Withdrawal by Subject|10|||
130720143|NCT02799095|470599665|FG008|Part B|Withdrawal by Subject|7|||
130720144|NCT02799095|470599666|FG009|Part B|Withdrawal by Subject|0|||
130720145|NCT02799095|470599667|FG010|Part B|Withdrawal by Subject|0|||
130720146|NCT02799095|470599668|FG011|Part B|Withdrawal by Subject|0|||
130983843|NCT03641313|471566401|FG000|Overall Study|Declining health|1|||
130983844|NCT03641313|471566401|FG000|Overall Study|Adverse Event|1|||
130983845|NCT02753595|471566406|FG000|Overall Study|Sponsor termination|2|||
130983846|NCT02753595|471566407|FG001|Overall Study|Sponsor termination|2|||
130983847|NCT01570868|471566408|FG000|Overall Study|Adverse Event|8|||
130983848|NCT01570868|471566409|FG001|Overall Study|Adverse Event|1|||
130983849|NCT01570868|471566408|FG000|Overall Study|FDA Recommendation|23|||
130983850|NCT01570868|471566409|FG001|Overall Study|FDA Recommendation|3|||
130983851|NCT01570868|471566408|FG000|Overall Study|Physician Decision|10|||
130983852|NCT01570868|471566409|FG001|Overall Study|Physician Decision|4|||
130983853|NCT01570868|471566408|FG000|Overall Study|Lost to Follow-up|1|||
130983854|NCT01570868|471566409|FG001|Overall Study|Lost to Follow-up|0|||
130983855|NCT01570868|471566408|FG000|Overall Study|Withdrawal by Subject|1|||
130983856|NCT01570868|471566409|FG001|Overall Study|Withdrawal by Subject|0|||
130983857|NCT01422408|471566418|FG000|Overall Study|Adverse Event|1|||
130983858|NCT01422408|471566418|FG000|Overall Study|Withdrawal by Subject|3|||
130983859|NCT02953938|471566419|FG000|Overall Study|Adverse Event|0|||
130983860|NCT02953938|471566420|FG001|Overall Study|Adverse Event|1|||
130983861|NCT02953938|471566419|FG000|Overall Study|Withdrawal by Subject|1|||
130983862|NCT02953938|471566420|FG001|Overall Study|Withdrawal by Subject|1|||
130983863|NCT05007392|471566421|FG000|Overall Study|Randomized but not treated|1|||
130983864|NCT05007392|471566422|FG001|Overall Study|Randomized but not treated|2|||
130983865|NCT05007392|471566421|FG000|Overall Study|Other|5|||
130983866|NCT05007392|471566422|FG001|Overall Study|Other|4|||
130983867|NCT05007392|471566421|FG000|Overall Study|Lost to Follow-up|1|||
130983868|NCT05007392|471566422|FG001|Overall Study|Lost to Follow-up|2|||
130983869|NCT05007392|471566421|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
131044818|NCT03245840|471797642|FG000|Overall Study|Lost to Follow-up|12|||
131044819|NCT03245840|471797643|FG001|Overall Study|Lost to Follow-up|2|||
130720147|NCT02799095|470599669|FG012|Part B|Withdrawal by Subject|0|||
130720148|NCT02799095|470599670|FG013|Part B|Withdrawal by Subject|0|||
130720149|NCT02799095|470599671|FG014|Part B|Withdrawal by Subject|0|||
130720150|NCT02799095|470599672|FG015|Part B|Withdrawal by Subject|0|||
130720151|NCT02799095|470599673|FG016|Part B|Withdrawal by Subject|0|||
130720152|NCT02799095|470599657|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
130720153|NCT02799095|470599658|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
130720154|NCT02799095|470599659|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
130720155|NCT02799095|470599660|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
130720156|NCT02799095|470599661|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
130720157|NCT02799095|470599662|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
130720158|NCT02799095|470599663|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
130720159|NCT02799095|470599664|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
130720160|NCT02799095|470599665|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
130720161|NCT02799095|470599666|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
130720162|NCT02799095|470599667|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
130720163|NCT02799095|470599668|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
130720164|NCT02799095|470599669|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
130720165|NCT02799095|470599670|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
130720166|NCT02799095|470599671|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
130720167|NCT02799095|470599672|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
130720168|NCT02799095|470599673|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
130720169|NCT02799095|470599657|FG000|Part C|Adverse Event|0|||
130720170|NCT02799095|470599658|FG001|Part C|Adverse Event|0|||
130720171|NCT02799095|470599659|FG002|Part C|Adverse Event|0|||
130720172|NCT02799095|470599660|FG003|Part C|Adverse Event|0|||
130720173|NCT02799095|470599661|FG004|Part C|Adverse Event|0|||
130983870|NCT05007392|471566422|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
131044820|NCT03245840|471797642|FG000|Overall Study|Pregnancy|2|||
131044821|NCT03245840|471797643|FG001|Overall Study|Pregnancy|0|||
131044822|NCT03245840|471797642|FG000|Overall Study|Non-Compliance with Study Drug|2|||
131044823|NCT03245840|471797643|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131044824|NCT03245840|471797642|FG000|Overall Study|Not treated|1|||
131044825|NCT03245840|471797643|FG001|Overall Study|Not treated|1|||
131044826|NCT04109066|471797648|FG000|Pre-treatment|Participant withdrew consent|2|||
131044827|NCT04109066|471797649|FG001|Pre-treatment|Participant withdrew consent|0|||
130983871|NCT05007392|471566421|FG000|Overall Study|Use of prohibited concomitant drug|1|||
130983872|NCT05007392|471566422|FG001|Overall Study|Use of prohibited concomitant drug|1|||
130983873|NCT05007392|471566421|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
130983874|NCT05007392|471566422|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
130983875|NCT05007392|471566421|FG000|Overall Study|Adverse Event|10|||
131044828|NCT04109066|471797648|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
130720174|NCT02799095|470599662|FG005|Part C|Adverse Event|0|||
130720175|NCT02799095|470599663|FG006|Part C|Adverse Event|0|||
130720176|NCT02799095|470599664|FG007|Part C|Adverse Event|0|||
130720177|NCT02799095|470599665|FG008|Part C|Adverse Event|0|||
130720178|NCT02799095|470599666|FG009|Part C|Adverse Event|0|||
130720179|NCT02799095|470599667|FG010|Part C|Adverse Event|3|||
130720180|NCT02799095|470599668|FG011|Part C|Adverse Event|1|||
131044829|NCT04109066|471797649|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
130720181|NCT02799095|470599669|FG012|Part C|Adverse Event|0|||
130720182|NCT02799095|470599670|FG013|Part C|Adverse Event|1|||
130720183|NCT02799095|470599671|FG014|Part C|Adverse Event|0|||
130720184|NCT02799095|470599672|FG015|Part C|Adverse Event|0|||
130720185|NCT02799095|470599673|FG016|Part C|Adverse Event|0|||
130720186|NCT02799095|470599657|FG000|Part C|Death|0|||
130720187|NCT02799095|470599658|FG001|Part C|Death|0|||
130720188|NCT02799095|470599659|FG002|Part C|Death|0|||
130720189|NCT02799095|470599660|FG003|Part C|Death|0|||
130720190|NCT02799095|470599661|FG004|Part C|Death|0|||
130720191|NCT02799095|470599662|FG005|Part C|Death|0|||
130720192|NCT02799095|470599663|FG006|Part C|Death|0|||
130720193|NCT02799095|470599664|FG007|Part C|Death|0|||
130720194|NCT02799095|470599665|FG008|Part C|Death|0|||
130720195|NCT02799095|470599666|FG009|Part C|Death|0|||
130720196|NCT02799095|470599667|FG010|Part C|Death|7|||
130720197|NCT02799095|470599668|FG011|Part C|Death|5|||
130720198|NCT02799095|470599669|FG012|Part C|Death|6|||
130720199|NCT02799095|470599670|FG013|Part C|Death|8|||
130720200|NCT02799095|470599671|FG014|Part C|Death|1|||
130720201|NCT02799095|470599672|FG015|Part C|Death|8|||
130720202|NCT02799095|470599673|FG016|Part C|Death|1|||
130720203|NCT02799095|470599657|FG000|Part C|Lost to Follow-up|0|||
130720204|NCT02799095|470599658|FG001|Part C|Lost to Follow-up|0|||
130720205|NCT02799095|470599659|FG002|Part C|Lost to Follow-up|0|||
130720206|NCT02799095|470599660|FG003|Part C|Lost to Follow-up|0|||
131044830|NCT04109066|471797648|FG000|Treatment|Lack of Efficacy|2|||
130720207|NCT02799095|470599661|FG004|Part C|Lost to Follow-up|0|||
131044831|NCT04109066|471797649|FG001|Treatment|Lack of Efficacy|4|||
131044832|NCT04109066|471797648|FG000|Treatment|Adverse Event|23|||
131044833|NCT04109066|471797649|FG001|Treatment|Adverse Event|7|||
131044834|NCT04109066|471797648|FG000|Treatment|Participant request to discontinue Study treatment|15|||
131044835|NCT04109066|471797649|FG001|Treatment|Participant request to discontinue Study treatment|14|||
131044836|NCT04109066|471797648|FG000|Treatment|Withdrawal by Subject|8|||
131044837|NCT04109066|471797649|FG001|Treatment|Withdrawal by Subject|8|||
131044838|NCT04109066|471797648|FG000|Treatment|Death|3|||
131044839|NCT04109066|471797649|FG001|Treatment|Death|0|||
131044840|NCT04109066|471797648|FG000|Treatment|Participant no longer meets study criteria|2|||
131044841|NCT04109066|471797649|FG001|Treatment|Participant no longer meets study criteria|2|||
131044842|NCT04109066|471797648|FG000|Treatment|Administrative reasons by sponsor|2|||
131044843|NCT04109066|471797649|FG001|Treatment|Administrative reasons by sponsor|3|||
131044844|NCT04109066|471797648|FG000|Treatment|Other reasons|17|||
131044845|NCT04109066|471797649|FG001|Treatment|Other reasons|23|||
131044846|NCT04109066|471797648|FG000|Treatment|Disease Progression|4|||
131044847|NCT04109066|471797649|FG001|Treatment|Disease Progression|7|||
131044848|NCT04109066|471797648|FG000|Treatment|Study drug toxicity|12|||
131044849|NCT04109066|471797649|FG001|Treatment|Study drug toxicity|5|||
131044850|NCT04109066|471797648|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
131044851|NCT04109066|471797649|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
131044852|NCT04109066|471797648|FG000|Treatment|Disease Recurrence|0|||
131044853|NCT04109066|471797649|FG001|Treatment|Disease Recurrence|2|||
131044854|NCT04109066|471797648|FG000|Treatment|Not reported|4|||
131044855|NCT04109066|471797649|FG001|Treatment|Not reported|8|||
131044856|NCT05890105|471797651|FG000|Overall Study|Adverse Event|1|||
131044857|NCT05890105|471797652|FG001|Overall Study|Adverse Event|0|||
131044858|NCT05890105|471797653|FG002|Overall Study|Adverse Event|0|||
131044859|NCT05890105|471797651|FG000|Overall Study|Other|1|||
131044860|NCT05890105|471797652|FG001|Overall Study|Other|2|||
131044861|NCT05890105|471797653|FG002|Overall Study|Other|0|||
131044862|NCT04505410|471797654|FG000|Overall Study|Adverse Event|2|||
131044863|NCT04505410|471797655|FG001|Overall Study|Adverse Event|0|||
131044864|NCT04505410|471797654|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
131044865|NCT04505410|471797655|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
131044866|NCT04505410|471797654|FG000|Overall Study|did not want to follow diet|1|||
131044867|NCT04505410|471797655|FG001|Overall Study|did not want to follow diet|0|||
131044868|NCT04505410|471797654|FG000|Overall Study|flare up of ulcerative colitis|0|||
131044869|NCT04505410|471797655|FG001|Overall Study|flare up of ulcerative colitis|1|||
131044870|NCT04505410|471797654|FG000|Overall Study|Lost to Follow-up|0|||
130720208|NCT02799095|470599662|FG005|Part C|Lost to Follow-up|0|||
131044871|NCT04505410|471797655|FG001|Overall Study|Lost to Follow-up|2|||
131044872|NCT04505410|471797654|FG000|Overall Study|Lost to Follow-up|1|||
131044873|NCT04505410|471797655|FG001|Overall Study|Lost to Follow-up|0|||
130720209|NCT02799095|470599663|FG006|Part C|Lost to Follow-up|0|||
130720210|NCT02799095|470599664|FG007|Part C|Lost to Follow-up|0|||
130720211|NCT02799095|470599665|FG008|Part C|Lost to Follow-up|0|||
130720212|NCT02799095|470599666|FG009|Part C|Lost to Follow-up|0|||
130720213|NCT02799095|470599667|FG010|Part C|Lost to Follow-up|1|||
130720214|NCT02799095|470599668|FG011|Part C|Lost to Follow-up|1|||
130720215|NCT02799095|470599669|FG012|Part C|Lost to Follow-up|1|||
130720216|NCT02799095|470599670|FG013|Part C|Lost to Follow-up|3|||
130720217|NCT02799095|470599671|FG014|Part C|Lost to Follow-up|0|||
130720218|NCT02799095|470599672|FG015|Part C|Lost to Follow-up|0|||
130720219|NCT02799095|470599673|FG016|Part C|Lost to Follow-up|0|||
130720220|NCT02799095|470599657|FG000|Part C|Progressive Disease|0|||
130720221|NCT02799095|470599658|FG001|Part C|Progressive Disease|0|||
130720222|NCT02799095|470599659|FG002|Part C|Progressive Disease|0|||
130720223|NCT02799095|470599660|FG003|Part C|Progressive Disease|0|||
130720224|NCT02799095|470599661|FG004|Part C|Progressive Disease|0|||
130720225|NCT02799095|470599662|FG005|Part C|Progressive Disease|0|||
130720226|NCT02799095|470599663|FG006|Part C|Progressive Disease|0|||
130720227|NCT02799095|470599664|FG007|Part C|Progressive Disease|0|||
130720228|NCT02799095|470599665|FG008|Part C|Progressive Disease|0|||
130720229|NCT02799095|470599666|FG009|Part C|Progressive Disease|2|||
130720230|NCT02799095|470599667|FG010|Part C|Progressive Disease|13|||
130720231|NCT02799095|470599668|FG011|Part C|Progressive Disease|2|||
130720232|NCT02799095|470599669|FG012|Part C|Progressive Disease|0|||
130720233|NCT02799095|470599670|FG013|Part C|Progressive Disease|1|||
130720234|NCT02799095|470599671|FG014|Part C|Progressive Disease|0|||
130720235|NCT02799095|470599672|FG015|Part C|Progressive Disease|0|||
130720236|NCT02799095|470599673|FG016|Part C|Progressive Disease|0|||
130720237|NCT02799095|470599657|FG000|Part C|Clinical Progression|0|||
130720238|NCT02799095|470599658|FG001|Part C|Clinical Progression|0|||
130720239|NCT02799095|470599659|FG002|Part C|Clinical Progression|0|||
130720240|NCT02799095|470599660|FG003|Part C|Clinical Progression|0|||
130720241|NCT02799095|470599661|FG004|Part C|Clinical Progression|0|||
130720242|NCT02799095|470599662|FG005|Part C|Clinical Progression|0|||
130720243|NCT02799095|470599663|FG006|Part C|Clinical Progression|0|||
130720244|NCT02799095|470599664|FG007|Part C|Clinical Progression|0|||
130720245|NCT02799095|470599665|FG008|Part C|Clinical Progression|0|||
130720246|NCT02799095|470599666|FG009|Part C|Clinical Progression|1|||
130720247|NCT02799095|470599667|FG010|Part C|Clinical Progression|3|||
130720248|NCT02799095|470599668|FG011|Part C|Clinical Progression|0|||
130720249|NCT02799095|470599669|FG012|Part C|Clinical Progression|0|||
130720250|NCT02799095|470599670|FG013|Part C|Clinical Progression|1|||
130720251|NCT02799095|470599671|FG014|Part C|Clinical Progression|0|||
130720252|NCT02799095|470599672|FG015|Part C|Clinical Progression|0|||
130720253|NCT02799095|470599673|FG016|Part C|Clinical Progression|0|||
130720254|NCT02799095|470599657|FG000|Part C|Withdrawal by Subject|0|||
130720255|NCT02799095|470599658|FG001|Part C|Withdrawal by Subject|0|||
130720256|NCT02799095|470599659|FG002|Part C|Withdrawal by Subject|0|||
130720257|NCT02799095|470599660|FG003|Part C|Withdrawal by Subject|0|||
130720258|NCT02799095|470599661|FG004|Part C|Withdrawal by Subject|0|||
130720259|NCT02799095|470599662|FG005|Part C|Withdrawal by Subject|0|||
130720260|NCT02799095|470599663|FG006|Part C|Withdrawal by Subject|0|||
130720261|NCT02799095|470599664|FG007|Part C|Withdrawal by Subject|0|||
130720262|NCT02799095|470599665|FG008|Part C|Withdrawal by Subject|0|||
131044874|NCT04505410|471797654|FG000|Overall Study|initiated another diet on their own|0|||
131044875|NCT04505410|471797655|FG001|Overall Study|initiated another diet on their own|2|||
131044876|NCT06262477|471799025|FG000|Overall Study|Withdrawal by Subject|1|||
131044877|NCT06262477|471799026|FG001|Overall Study|Withdrawal by Subject|0|||
131044878|NCT06262477|471799025|FG000|Overall Study|Adverse Event|0|||
131044879|NCT06262477|471799026|FG001|Overall Study|Adverse Event|1|||
131044880|NCT06262477|471799025|FG000|Overall Study|Lost to Follow-up|0|||
131044881|NCT06262477|471799026|FG001|Overall Study|Lost to Follow-up|1|||
131044882|NCT04183283|471799036|FG000|Period 1|Withdrawal by Subject|0|||
131044883|NCT04183283|471799037|FG001|Period 1|Withdrawal by Subject|1|||
131044884|NCT04183283|471799038|FG002|Period 1|Withdrawal by Subject|0|||
131044885|NCT04183283|471799039|FG003|Period 1|Withdrawal by Subject|0|||
131044886|NCT04183283|471799036|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
131044887|NCT04183283|471799037|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
131133450|NCT02109484|472115347|FG006|Overall Study|Withdrawal by Subject|1|||
131133451|NCT02109484|472115348|FG007|Overall Study|Withdrawal by Subject|0|||
131133452|NCT02109484|472115341|FG000|Overall Study|Physician Decision|0|||
131133453|NCT02109484|472115342|FG001|Overall Study|Physician Decision|0|||
131133454|NCT02109484|472115343|FG002|Overall Study|Physician Decision|0|||
131133455|NCT02109484|472115344|FG003|Overall Study|Physician Decision|0|||
131133456|NCT02109484|472115345|FG004|Overall Study|Physician Decision|2|||
131133457|NCT02109484|472115346|FG005|Overall Study|Physician Decision|0|||
131133458|NCT02109484|472115347|FG006|Overall Study|Physician Decision|0|||
131044888|NCT04183283|471799038|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
130720263|NCT02799095|470599666|FG009|Part C|Withdrawal by Subject|0|||
130720264|NCT02799095|470599667|FG010|Part C|Withdrawal by Subject|13|||
130720265|NCT02799095|470599668|FG011|Part C|Withdrawal by Subject|15|||
130720266|NCT02799095|470599669|FG012|Part C|Withdrawal by Subject|13|||
130720267|NCT02799095|470599670|FG013|Part C|Withdrawal by Subject|21|||
130720268|NCT02799095|470599671|FG014|Part C|Withdrawal by Subject|0|||
130720269|NCT02799095|470599672|FG015|Part C|Withdrawal by Subject|12|||
131044889|NCT04183283|471799039|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
131133459|NCT02109484|472115348|FG007|Overall Study|Physician Decision|0|||
130720270|NCT02799095|470599673|FG016|Part C|Withdrawal by Subject|1|||
130720271|NCT02799095|470599657|FG000|Part C|Physician Decision|0|||
130720272|NCT02799095|470599658|FG001|Part C|Physician Decision|0|||
130720273|NCT02799095|470599659|FG002|Part C|Physician Decision|0|||
131133460|NCT02109484|472115341|FG000|Overall Study|Death|0|||
131044890|NCT05363163|471799043|FG000|Overall Study|Withdrawal by Subject|13|||
131044891|NCT04999111|471799049|FG000|Overall Study|Lost to Follow-up|21|||
131044892|NCT04999111|471799050|FG001|Overall Study|Lost to Follow-up|16|||
131044893|NCT04999111|471799051|FG002|Overall Study|Lost to Follow-up|2|||
131044894|NCT04999111|471799052|FG003|Overall Study|Lost to Follow-up|26|||
131044895|NCT04999111|471799053|FG004|Overall Study|Lost to Follow-up|30|||
131044896|NCT04999111|471799054|FG005|Overall Study|Lost to Follow-up|6|||
131044897|NCT04999111|471799049|FG000|Overall Study|Physician Decision|1|||
131044898|NCT04999111|471799050|FG001|Overall Study|Physician Decision|3|||
131044899|NCT04999111|471799051|FG002|Overall Study|Physician Decision|0|||
131044900|NCT04999111|471799052|FG003|Overall Study|Physician Decision|1|||
131228985|NCT01952574|472465773|FG006|Open-label Treatment Phase|Missing|0|||
131228986|NCT01952574|472465767|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
131228987|NCT01952574|472465768|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
131228988|NCT01952574|472465769|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
131228989|NCT01952574|472465770|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
131228990|NCT01952574|472465771|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
131228991|NCT01952574|472465772|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
131228992|NCT01952574|472465773|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
131228993|NCT01952574|472465767|FG000|Open-label Treatment Phase|Death|0|||
131228994|NCT01952574|472465768|FG001|Open-label Treatment Phase|Death|0|||
131228995|NCT01952574|472465769|FG002|Open-label Treatment Phase|Death|0|||
131228996|NCT01952574|472465770|FG003|Open-label Treatment Phase|Death|0|||
131228997|NCT01952574|472465771|FG004|Open-label Treatment Phase|Death|1|||
131228998|NCT01952574|472465772|FG005|Open-label Treatment Phase|Death|0|||
131228999|NCT01952574|472465773|FG006|Open-label Treatment Phase|Death|0|||
131229000|NCT01952574|472465767|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131229001|NCT01952574|472465768|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131229002|NCT01952574|472465769|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131229003|NCT01952574|472465770|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131229004|NCT01952574|472465771|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131044901|NCT04999111|471799053|FG004|Overall Study|Physician Decision|2|||
131044902|NCT04999111|471799054|FG005|Overall Study|Physician Decision|0|||
131044903|NCT04999111|471799049|FG000|Overall Study|Withdrawal by Subject|23|||
131044904|NCT04999111|471799050|FG001|Overall Study|Withdrawal by Subject|29|||
131044905|NCT04999111|471799051|FG002|Overall Study|Withdrawal by Subject|15|||
131044906|NCT04999111|471799052|FG003|Overall Study|Withdrawal by Subject|30|||
131044907|NCT04999111|471799053|FG004|Overall Study|Withdrawal by Subject|35|||
131044908|NCT04999111|471799054|FG005|Overall Study|Withdrawal by Subject|10|||
131133461|NCT02109484|472115342|FG001|Overall Study|Death|0|||
131133462|NCT02109484|472115343|FG002|Overall Study|Death|0|||
131133463|NCT02109484|472115344|FG003|Overall Study|Death|0|||
131133464|NCT02109484|472115345|FG004|Overall Study|Death|0|||
131133465|NCT02109484|472115346|FG005|Overall Study|Death|0|||
131133466|NCT02109484|472115347|FG006|Overall Study|Death|0|||
131133467|NCT02109484|472115348|FG007|Overall Study|Death|2|||
131133468|NCT02109484|472115341|FG000|Overall Study|Moved away from study area|0|||
131133469|NCT02109484|472115342|FG001|Overall Study|Moved away from study area|0|||
131133470|NCT02109484|472115343|FG002|Overall Study|Moved away from study area|0|||
131133471|NCT02109484|472115344|FG003|Overall Study|Moved away from study area|0|||
131133472|NCT02109484|472115345|FG004|Overall Study|Moved away from study area|0|||
131133473|NCT02109484|472115346|FG005|Overall Study|Moved away from study area|0|||
131133474|NCT02109484|472115347|FG006|Overall Study|Moved away from study area|1|||
131133475|NCT02109484|472115348|FG007|Overall Study|Moved away from study area|1|||
131133476|NCT02111993|472115353|FG000|Overall Study|Physician Decision|5|||
131133477|NCT02111993|472115354|FG001|Overall Study|Physician Decision|4|||
131133478|NCT00293579|472115355|FG000|Overall Study|Withdrawal by Subject|1|||
131133479|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
131044909|NCT04999111|471799049|FG000|Overall Study|Other|6|||
131044910|NCT04999111|471799050|FG001|Overall Study|Other|6|||
131044911|NCT04999111|471799051|FG002|Overall Study|Other|3|||
131044912|NCT04999111|471799052|FG003|Overall Study|Other|8|||
131044913|NCT04999111|471799053|FG004|Overall Study|Other|8|||
131133480|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
131133481|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
131133482|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
131133483|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
131044914|NCT04999111|471799054|FG005|Overall Study|Other|5|||
131044915|NCT04999111|471799049|FG000|Overall Study|Non-compliance with study schedule|1|||
131044916|NCT04999111|471799050|FG001|Overall Study|Non-compliance with study schedule|0|||
131044917|NCT04999111|471799051|FG002|Overall Study|Non-compliance with study schedule|0|||
131229005|NCT01952574|472465772|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
131229006|NCT01952574|472465773|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
131229007|NCT01952574|472465767|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
131044918|NCT04999111|471799052|FG003|Overall Study|Non-compliance with study schedule|1|||
131133484|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
130983876|NCT05007392|471566422|FG001|Overall Study|Adverse Event|6|||
131044919|NCT04999111|471799053|FG004|Overall Study|Non-compliance with study schedule|1|||
130983877|NCT05007392|471566421|FG000|Overall Study|Participant choice|5|||
130983878|NCT05007392|471566422|FG001|Overall Study|Participant choice|10|||
130983879|NCT05007392|471566421|FG000|Overall Study|Withdrawal of consent|5|||
130983880|NCT05007392|471566422|FG001|Overall Study|Withdrawal of consent|4|||
130983881|NCT01218126|471566423|FG000|Overall Study|Adverse Event|8|||
130983882|NCT01218126|471566424|FG001|Overall Study|Adverse Event|10|||
130983883|NCT01218126|471566425|FG002|Overall Study|Adverse Event|12|||
130983884|NCT01218126|471566426|FG003|Overall Study|Adverse Event|16|||
130983885|NCT01218126|471566423|FG000|Overall Study|Lack of Efficacy|7|||
130983886|NCT01218126|471566424|FG001|Overall Study|Lack of Efficacy|2|||
130983887|NCT01218126|471566425|FG002|Overall Study|Lack of Efficacy|2|||
130983888|NCT01218126|471566426|FG003|Overall Study|Lack of Efficacy|6|||
130983889|NCT01218126|471566423|FG000|Overall Study|Protocol Violation|5|||
130983890|NCT01218126|471566424|FG001|Overall Study|Protocol Violation|2|||
130983891|NCT01218126|471566425|FG002|Overall Study|Protocol Violation|2|||
130983892|NCT01218126|471566426|FG003|Overall Study|Protocol Violation|3|||
130983893|NCT01218126|471566423|FG000|Overall Study|Protocol-defined stopping criteria|1|||
130983894|NCT01218126|471566424|FG001|Overall Study|Protocol-defined stopping criteria|1|||
130983895|NCT01218126|471566425|FG002|Overall Study|Protocol-defined stopping criteria|0|||
130983896|NCT01218126|471566426|FG003|Overall Study|Protocol-defined stopping criteria|0|||
130983897|NCT01218126|471566423|FG000|Overall Study|Lost to Follow-up|0|||
130983898|NCT01218126|471566424|FG001|Overall Study|Lost to Follow-up|0|||
130983899|NCT01218126|471566425|FG002|Overall Study|Lost to Follow-up|0|||
130983900|NCT01218126|471566426|FG003|Overall Study|Lost to Follow-up|2|||
130983901|NCT01218126|471566423|FG000|Overall Study|Physician Decision|1|||
130983902|NCT01218126|471566424|FG001|Overall Study|Physician Decision|2|||
130983903|NCT01218126|471566425|FG002|Overall Study|Physician Decision|4|||
130983904|NCT01218126|471566426|FG003|Overall Study|Physician Decision|2|||
130983905|NCT01218126|471566423|FG000|Overall Study|Withdrawal by Subject|2|||
130983906|NCT01218126|471566424|FG001|Overall Study|Withdrawal by Subject|5|||
130983907|NCT01218126|471566425|FG002|Overall Study|Withdrawal by Subject|4|||
130983908|NCT01218126|471566426|FG003|Overall Study|Withdrawal by Subject|6|||
130983909|NCT01860703|471566427|FG000|Overall Study|Adverse Event|1|||
130983910|NCT01860703|471566428|FG001|Overall Study|Adverse Event|4|||
130983911|NCT01860703|471566429|FG002|Overall Study|Adverse Event|0|||
130983912|NCT01860703|471566430|FG003|Overall Study|Adverse Event|2|||
130983913|NCT01860703|471566427|FG000|Overall Study|Withdrawal by Subject|0|||
130983914|NCT01860703|471566428|FG001|Overall Study|Withdrawal by Subject|1|||
130983915|NCT01860703|471566429|FG002|Overall Study|Withdrawal by Subject|0|||
130983916|NCT01860703|471566430|FG003|Overall Study|Withdrawal by Subject|0|||
130983917|NCT01860703|471566427|FG000|Overall Study|Personal reason|1|||
130983918|NCT01860703|471566428|FG001|Overall Study|Personal reason|0|||
130983919|NCT01860703|471566429|FG002|Overall Study|Personal reason|1|||
130983920|NCT01860703|471566430|FG003|Overall Study|Personal reason|0|||
130983921|NCT02453685|471566435|FG000|Overall Study|Adverse Event|0|||
130983922|NCT02453685|471566436|FG001|Overall Study|Adverse Event|1|||
130983923|NCT02453685|471566435|FG000|Overall Study|Protocol Violation|7|||
130983924|NCT02453685|471566436|FG001|Overall Study|Protocol Violation|4|||
130983925|NCT02453685|471566435|FG000|Overall Study|Lost to Follow-up|0|||
130983926|NCT02453685|471566436|FG001|Overall Study|Lost to Follow-up|1|||
130983927|NCT02453685|471566435|FG000|Overall Study|Withdrawal by Subject|8|||
130983928|NCT02453685|471566436|FG001|Overall Study|Withdrawal by Subject|4|||
130983929|NCT02453685|471566435|FG000|Overall Study|Unclassified|4|||
130983930|NCT02453685|471566436|FG001|Overall Study|Unclassified|2|||
130983931|NCT00453986|471566437|FG000|Overall Study|Lost to Follow-up|6|||
130983932|NCT00453986|471566438|FG001|Overall Study|Lost to Follow-up|5|||
130983933|NCT00453986|471566439|FG002|Overall Study|Lost to Follow-up|6|||
130983934|NCT00453986|471566440|FG003|Overall Study|Lost to Follow-up|2|||
130983935|NCT00453986|471566441|FG004|Overall Study|Lost to Follow-up|0|||
130983936|NCT02778100|471566444|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
130983937|NCT02778100|471566445|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
130983938|NCT01338025|471566453|FG000|Overall Study|Unexpected closure of study|10|||
130983939|NCT01338025|471566454|FG001|Overall Study|Unexpected closure of study|9|||
130983940|NCT01338025|471566453|FG000|Overall Study|Withdrawal by Subject|0|||
131044920|NCT04999111|471799054|FG005|Overall Study|Non-compliance with study schedule|1|||
131044921|NCT04999111|471799049|FG000|Overall Study|Randomized but not vaccinated|1|||
131044922|NCT04999111|471799050|FG001|Overall Study|Randomized but not vaccinated|2|||
131044923|NCT04999111|471799051|FG002|Overall Study|Randomized but not vaccinated|0|||
131044924|NCT04999111|471799052|FG003|Overall Study|Randomized but not vaccinated|3|||
131044925|NCT04999111|471799053|FG004|Overall Study|Randomized but not vaccinated|3|||
131044926|NCT04999111|471799054|FG005|Overall Study|Randomized but not vaccinated|0|||
131044927|NCT04999111|471799049|FG000|Overall Study|Adverse Event|1|||
131044928|NCT04999111|471799050|FG001|Overall Study|Adverse Event|1|||
131044929|NCT04999111|471799051|FG002|Overall Study|Adverse Event|0|||
131044930|NCT04999111|471799052|FG003|Overall Study|Adverse Event|0|||
131044931|NCT04999111|471799053|FG004|Overall Study|Adverse Event|0|||
130720274|NCT02799095|470599660|FG003|Part C|Physician Decision|0|||
130983941|NCT01338025|471566454|FG001|Overall Study|Withdrawal by Subject|2|||
130983942|NCT01338025|471566453|FG000|Overall Study|Found ineligible after starting|1|||
130983943|NCT01338025|471566454|FG001|Overall Study|Found ineligible after starting|0|||
130983944|NCT04120233|471566457|FG000|Overall Study|Adverse Event|0|||
131044932|NCT04999111|471799054|FG005|Overall Study|Adverse Event|0|||
130720275|NCT02799095|470599661|FG004|Part C|Physician Decision|0|||
130983945|NCT04120233|471566458|FG001|Overall Study|Adverse Event|0|||
130983946|NCT04120233|471566459|FG002|Overall Study|Adverse Event|0|||
130983947|NCT04120233|471566460|FG003|Overall Study|Adverse Event|0|||
130983948|NCT04120233|471566461|FG004|Overall Study|Adverse Event|1|||
130983949|NCT04120233|471566462|FG005|Overall Study|Adverse Event|0|||
130983950|NCT03779906|471566463|FG000|Overall Study|Lost to Follow-up|7|||
130983951|NCT03779906|471566463|FG000|Overall Study|COVID pandemic|1|||
130983952|NCT02553460|471566466|FG000|Overall Study|Death|3|||
130983953|NCT02553460|471566466|FG000|Overall Study|Withdrawal by Subject|1|||
130983954|NCT02553460|471566466|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
130983955|NCT02553460|471566466|FG000|Overall Study|Relapse or Transplant|14|||
130983956|NCT02553460|471566466|FG000|Overall Study|No response to treatment|2|||
130983957|NCT02553460|471566466|FG000|Overall Study|CAR T cells|2|||
130983958|NCT04814368|471566467|FG000|Overall Study|Study Terminated by Sponsor|0|||
130983959|NCT04814368|471566468|FG001|Overall Study|Study Terminated by Sponsor|3|||
130983960|NCT04814368|471566469|FG002|Overall Study|Study Terminated by Sponsor|0|||
130983961|NCT04814368|471566470|FG003|Overall Study|Study Terminated by Sponsor|2|||
130983962|NCT04814368|471566467|FG000|Overall Study|Subject Decision|1|||
130983963|NCT04814368|471566468|FG001|Overall Study|Subject Decision|2|||
130983964|NCT04814368|471566469|FG002|Overall Study|Subject Decision|0|||
130983965|NCT04814368|471566470|FG003|Overall Study|Subject Decision|0|||
130983966|NCT00949884|471568330|FG000|Overall Study|Adverse Event|14|||
130983967|NCT00949884|471568331|FG001|Overall Study|Adverse Event|3|||
130983968|NCT00949884|471568332|FG002|Overall Study|Adverse Event|12|||
130983969|NCT00949884|471568330|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
130983970|NCT00949884|471568331|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
130983971|NCT00949884|471568332|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
130983972|NCT00949884|471568330|FG000|Overall Study|Lost to Follow-up|7|||
130983973|NCT00949884|471568331|FG001|Overall Study|Lost to Follow-up|5|||
130983974|NCT00949884|471568332|FG002|Overall Study|Lost to Follow-up|5|||
130983975|NCT00949884|471568330|FG000|Overall Study|Physician Decision|5|||
130983976|NCT00949884|471568331|FG001|Overall Study|Physician Decision|0|||
130983977|NCT00949884|471568332|FG002|Overall Study|Physician Decision|6|||
130983978|NCT00949884|471568330|FG000|Overall Study|Treatment non-compliance|5|||
130983979|NCT00949884|471568331|FG001|Overall Study|Treatment non-compliance|0|||
130983980|NCT00949884|471568332|FG002|Overall Study|Treatment non-compliance|8|||
130983981|NCT00949884|471568330|FG000|Overall Study|Withdrawal by Subject|13|||
130983982|NCT00949884|471568331|FG001|Overall Study|Withdrawal by Subject|4|||
130983983|NCT00949884|471568332|FG002|Overall Study|Withdrawal by Subject|16|||
130983984|NCT00949884|471568330|FG000|Overall Study|Lack of Efficacy|4|||
130983985|NCT00949884|471568331|FG001|Overall Study|Lack of Efficacy|2|||
130983986|NCT00949884|471568332|FG002|Overall Study|Lack of Efficacy|7|||
130983987|NCT00949884|471568330|FG000|Overall Study|Study terminated by sponsor|0|||
130983988|NCT00949884|471568331|FG001|Overall Study|Study terminated by sponsor|0|||
130983989|NCT00949884|471568332|FG002|Overall Study|Study terminated by sponsor|1|||
130983990|NCT01953003|471568333|FG000|Overall Study|Not treated|0|||
130983991|NCT01953003|471568334|FG001|Overall Study|Not treated|1|||
130983992|NCT01953003|471568333|FG000|Overall Study|Progressive disease|35|||
130983993|NCT01953003|471568334|FG001|Overall Study|Progressive disease|45|||
130983994|NCT01953003|471568333|FG000|Overall Study|Related Adverse events|7|||
130983995|NCT01953003|471568334|FG001|Overall Study|Related Adverse events|2|||
131044933|NCT04999111|471799049|FG000|Overall Study|Initiated prohibited medication|0|||
131044934|NCT04999111|471799050|FG001|Overall Study|Initiated prohibited medication|0|||
131044935|NCT04999111|471799051|FG002|Overall Study|Initiated prohibited medication|0|||
131044936|NCT04999111|471799052|FG003|Overall Study|Initiated prohibited medication|0|||
131044937|NCT04999111|471799053|FG004|Overall Study|Initiated prohibited medication|1|||
131044938|NCT04999111|471799054|FG005|Overall Study|Initiated prohibited medication|0|||
131044939|NCT04709419|471799055|FG000|Overall Study|Physician Decision|1|||
131044940|NCT04709419|471799056|FG001|Overall Study|Physician Decision|0|||
131044941|NCT05683340|471799057|FG000|Overall Study|Adverse Event|1|||
131044942|NCT05683340|471799058|FG001|Overall Study|Adverse Event|1|||
131044943|NCT05683340|471799057|FG000|Overall Study|Protocol Violation|1|||
131044944|NCT05683340|471799058|FG001|Overall Study|Protocol Violation|0|||
131044945|NCT05683340|471799057|FG000|Overall Study|Withdrawal by Subject|0|||
130720276|NCT02799095|470599662|FG005|Part C|Physician Decision|0|||
130720277|NCT02799095|470599663|FG006|Part C|Physician Decision|0|||
130983996|NCT01953003|471568333|FG000|Overall Study|Non-related adverse events|0|||
130983997|NCT01953003|471568334|FG001|Overall Study|Non-related adverse events|2|||
130983998|NCT01953003|471568333|FG000|Overall Study|Protocol Violation|0|||
130983999|NCT01953003|471568334|FG001|Overall Study|Protocol Violation|1|||
130984000|NCT01953003|471568333|FG000|Overall Study|Withdrawal by Subject|14|||
130720278|NCT02799095|470599664|FG007|Part C|Physician Decision|0|||
130720279|NCT02799095|470599665|FG008|Part C|Physician Decision|0|||
130720280|NCT02799095|470599666|FG009|Part C|Physician Decision|0|||
130720281|NCT02799095|470599667|FG010|Part C|Physician Decision|1|||
130720282|NCT02799095|470599668|FG011|Part C|Physician Decision|0|||
130720283|NCT02799095|470599669|FG012|Part C|Physician Decision|0|||
130720284|NCT02799095|470599670|FG013|Part C|Physician Decision|0|||
130720285|NCT02799095|470599671|FG014|Part C|Physician Decision|0|||
130720286|NCT02799095|470599672|FG015|Part C|Physician Decision|0|||
130720287|NCT02799095|470599673|FG016|Part C|Physician Decision|0|||
130720288|NCT02799095|470599657|FG000|Part C|Other|0|||
130720289|NCT02799095|470599658|FG001|Part C|Other|0|||
130720290|NCT02799095|470599659|FG002|Part C|Other|0|||
130984001|NCT01953003|471568334|FG001|Overall Study|Withdrawal by Subject|4|||
130720291|NCT02799095|470599660|FG003|Part C|Other|0|||
130720292|NCT02799095|470599661|FG004|Part C|Other|0|||
130720293|NCT02799095|470599662|FG005|Part C|Other|0|||
130720294|NCT02799095|470599663|FG006|Part C|Other|0|||
130720295|NCT02799095|470599664|FG007|Part C|Other|0|||
130720296|NCT02799095|470599665|FG008|Part C|Other|0|||
130720297|NCT02799095|470599666|FG009|Part C|Other|0|||
130720298|NCT02799095|470599667|FG010|Part C|Other|0|||
130720299|NCT02799095|470599668|FG011|Part C|Other|2|||
130720300|NCT02799095|470599669|FG012|Part C|Other|2|||
130720301|NCT02799095|470599670|FG013|Part C|Other|0|||
130720302|NCT02799095|470599671|FG014|Part C|Other|0|||
130720303|NCT02799095|470599672|FG015|Part C|Other|0|||
130720304|NCT02799095|470599673|FG016|Part C|Other|0|||
130720305|NCT03589768|470599681|FG000|Overall Study|Death|1|||
130720306|NCT03589768|470599682|FG001|Overall Study|Death|0|||
130720307|NCT03589768|470599683|FG002|Overall Study|Death|8|||
130720308|NCT03589768|470599684|FG003|Overall Study|Death|3|||
130720309|NCT03589768|470599681|FG000|Overall Study|Withdrawal by Subject|2|||
130720310|NCT03589768|470599682|FG001|Overall Study|Withdrawal by Subject|0|||
130720311|NCT03589768|470599683|FG002|Overall Study|Withdrawal by Subject|0|||
130720312|NCT03589768|470599684|FG003|Overall Study|Withdrawal by Subject|0|||
130720313|NCT03589768|470599681|FG000|Overall Study|Protocol Violation|1|||
130720314|NCT03589768|470599682|FG001|Overall Study|Protocol Violation|0|||
130720315|NCT03589768|470599683|FG002|Overall Study|Protocol Violation|0|||
130720316|NCT03589768|470599684|FG003|Overall Study|Protocol Violation|0|||
130720317|NCT00112866|470599685|FG000|Overall Study|Protocol Violation|1|||
130720318|NCT00112866|470599686|FG001|Overall Study|Protocol Violation|0|||
130720319|NCT00112866|470599685|FG000|Overall Study|did not start treatment post-op|1|||
130720320|NCT00112866|470599686|FG001|Overall Study|did not start treatment post-op|2|||
130720321|NCT02213510|470599689|FG000|Overall Study|Death|0|||
130720322|NCT02213510|470599690|FG001|Overall Study|Death|1|||
130720323|NCT02213510|470599689|FG000|Overall Study|Lost to Follow-up|1|||
130720324|NCT02213510|470599690|FG001|Overall Study|Lost to Follow-up|0|||
130720325|NCT01502410|470599693|FG000|Overall Study|Adverse Event|1|||
130720326|NCT01502410|470599694|FG001|Overall Study|Adverse Event|2|||
130720327|NCT01502410|470599695|FG002|Overall Study|Adverse Event|0|||
130720328|NCT01502410|470599696|FG003|Overall Study|Adverse Event|0|||
130720329|NCT01502410|470599693|FG000|Overall Study|Lack of Efficacy|7|||
130720330|NCT01502410|470599694|FG001|Overall Study|Lack of Efficacy|7|||
130720331|NCT01502410|470599695|FG002|Overall Study|Lack of Efficacy|0|||
130720332|NCT01502410|470599696|FG003|Overall Study|Lack of Efficacy|0|||
130720333|NCT01502410|470599693|FG000|Overall Study|Physician Decision|0|||
130720334|NCT01502410|470599694|FG001|Overall Study|Physician Decision|1|||
130720335|NCT01502410|470599695|FG002|Overall Study|Physician Decision|0|||
130720336|NCT01502410|470599696|FG003|Overall Study|Physician Decision|0|||
130720337|NCT01502410|470599693|FG000|Overall Study|Withdrawal by Subject|2|||
130720338|NCT01502410|470599694|FG001|Overall Study|Withdrawal by Subject|0|||
130720339|NCT01502410|470599695|FG002|Overall Study|Withdrawal by Subject|0|||
130778857|NCT03428100|470817454|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130720340|NCT01502410|470599696|FG003|Overall Study|Withdrawal by Subject|0|||
130720341|NCT02903030|470599697|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130984002|NCT03092375|471568335|FG000|Overall Study|Lack of Efficacy|0|||
130984003|NCT03092375|471568336|FG001|Overall Study|Lack of Efficacy|1|||
130984004|NCT03092375|471568337|FG002|Overall Study|Lack of Efficacy|1|||
130984005|NCT03092375|471568338|FG003|Overall Study|Lack of Efficacy|0|||
130720342|NCT02903030|470599698|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130720343|NCT03786718|470599702|FG000|Overall Study|Lost to Follow-up|3|||
130720344|NCT03786718|470599702|FG000|Overall Study|Withdrawal by Subject|1|||
130720345|NCT03786718|470599702|FG000|Overall Study|Did not use the intervention|2|||
130720346|NCT03786718|470599702|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
130720347|NCT00754650|470599716|FG000|Overall Study|Disease Progression|2|||
130720348|NCT00805675|470599717|FG000|Overall Study|Adverse Event|0|||
130720349|NCT00805675|470599718|FG001|Overall Study|Adverse Event|0|||
130720350|NCT00805675|470599719|FG002|Overall Study|Adverse Event|1|||
130720351|NCT03537599|470599723|FG000|Overall Study|Disease Progression|2|||
130720352|NCT03537599|470599724|FG001|Overall Study|Disease Progression|1|||
130720353|NCT03537599|470599723|FG000|Overall Study|Death|0|||
130720354|NCT03537599|470599724|FG001|Overall Study|Death|1|||
130720355|NCT01007942|470599725|FG000|Overall Study|Adverse Event|29|||
130720356|NCT01007942|470599726|FG001|Overall Study|Adverse Event|14|||
130720357|NCT01007942|470599725|FG000|Overall Study|Abnormal test procedure|0|||
130720358|NCT01007942|470599726|FG001|Overall Study|Abnormal test procedure|1|||
130720359|NCT01007942|470599725|FG000|Overall Study|Disease progression|217|||
130720360|NCT01007942|470599726|FG001|Overall Study|Disease progression|242|||
130720361|NCT01007942|470599725|FG000|Overall Study|New cancer therapy|5|||
130720362|NCT01007942|470599726|FG001|Overall Study|New cancer therapy|1|||
130720363|NCT01007942|470599725|FG000|Overall Study|Protocol Violation|1|||
130720364|NCT01007942|470599726|FG001|Overall Study|Protocol Violation|1|||
130720365|NCT01007942|470599725|FG000|Overall Study|Withdrawal by Subject|19|||
130720366|NCT01007942|470599726|FG001|Overall Study|Withdrawal by Subject|14|||
130720367|NCT01007942|470599725|FG000|Overall Study|Lost to Follow-up|1|||
130720368|NCT01007942|470599726|FG001|Overall Study|Lost to Follow-up|0|||
130720369|NCT01007942|470599725|FG000|Overall Study|Administrative problems|2|||
130720370|NCT01007942|470599726|FG001|Overall Study|Administrative problems|0|||
130720371|NCT01007942|470599725|FG000|Overall Study|Death|3|||
130720372|NCT01007942|470599726|FG001|Overall Study|Death|2|||
130720373|NCT01007942|470599725|FG000|Overall Study|Patients untreated|4|||
130720374|NCT01007942|470599726|FG001|Overall Study|Patients untreated|3|||
130720375|NCT05083585|470599727|FG000|Overall Study|Death|1|||
130720376|NCT05083585|470599728|FG001|Overall Study|Death|1|||
130720377|NCT05083585|470599727|FG000|Overall Study|Lost to Follow-up|1|||
130720378|NCT05083585|470599728|FG001|Overall Study|Lost to Follow-up|1|||
130720379|NCT05083585|470599727|FG000|Overall Study|Withdrawal by Subject|2|||
130720380|NCT05083585|470599728|FG001|Overall Study|Withdrawal by Subject|0|||
130720381|NCT05083585|470599727|FG000|Overall Study|Randomized but not vaccinated|2|||
130720382|NCT05083585|470599728|FG001|Overall Study|Randomized but not vaccinated|0|||
130720383|NCT03929757|470599729|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
130720384|NCT03929757|470599730|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
130720385|NCT03929757|470599731|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
130720386|NCT03929757|470599729|FG000|Main Study: Up to Day 365|Other|1|||
130720387|NCT03929757|470599730|FG001|Main Study: Up to Day 365|Other|0|||
130720388|NCT03929757|470599731|FG002|Main Study: Up to Day 365|Other|0|||
130720389|NCT03929757|470599729|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
130720390|NCT03929757|470599730|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
130720391|NCT03929757|470599731|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
130720392|NCT00114166|470599732|FG000|Overall Study|Wrong primary|0|||
130720393|NCT00114166|470599733|FG001|Overall Study|Wrong primary|1|||
130720394|NCT00806286|470599734|FG000|Overall Study|Adverse Event|5|||
130720395|NCT00806286|470599735|FG001|Overall Study|Adverse Event|2|||
130984006|NCT00224770|471568347|FG000|Overall Study|Lost to Follow-up|4|||
130984007|NCT00224770|471568348|FG001|Overall Study|Lost to Follow-up|2|||
130984008|NCT00224770|471568349|FG002|Overall Study|Lost to Follow-up|0|||
130984009|NCT01106430|471568350|FG000|Overall Study|Adverse Event|8|||
130984010|NCT01106430|471568351|FG001|Overall Study|Adverse Event|10|||
130984011|NCT01106430|471568350|FG000|Overall Study|Lack of Efficacy|2|||
130984012|NCT01106430|471568351|FG001|Overall Study|Lack of Efficacy|13|||
130984013|NCT01106430|471568350|FG000|Overall Study|Lost to Follow-up|5|||
130984014|NCT01106430|471568351|FG001|Overall Study|Lost to Follow-up|1|||
130984015|NCT01106430|471568350|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
130984016|NCT01106430|471568351|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
130984017|NCT01106430|471568350|FG000|Overall Study|Moved Out Of State|0|||
130984018|NCT01106430|471568351|FG001|Overall Study|Moved Out Of State|1|||
130984019|NCT01106430|471568350|FG000|Overall Study|Refused To Take Medication|0|||
130984020|NCT01106430|471568351|FG001|Overall Study|Refused To Take Medication|1|||
130984021|NCT01106430|471568350|FG000|Overall Study|Noncompliance|0|||
130984022|NCT01106430|471568351|FG001|Overall Study|Noncompliance|1|||
130984023|NCT01106430|471568350|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
130984024|NCT01106430|471568351|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
130984025|NCT01106430|471568350|FG000|Overall Study|Previous Use Of Marijuana|1|||
130984026|NCT01106430|471568351|FG001|Overall Study|Previous Use Of Marijuana|0|||
130720396|NCT00806286|470599736|FG002|Overall Study|Adverse Event|0|||
130720397|NCT00806286|470599734|FG000|Overall Study|Disease progression|31|||
130720398|NCT00806286|470599735|FG001|Overall Study|Disease progression|38|||
130720399|NCT00806286|470599736|FG002|Overall Study|Disease progression|1|||
130720400|NCT00806286|470599734|FG000|Overall Study|Death|1|||
130720401|NCT00806286|470599735|FG001|Overall Study|Death|6|||
130720402|NCT00806286|470599736|FG002|Overall Study|Death|0|||
130720403|NCT00806286|470599734|FG000|Overall Study|Lost to Follow-up|0|||
130720404|NCT00806286|470599735|FG001|Overall Study|Lost to Follow-up|1|||
130720405|NCT00806286|470599736|FG002|Overall Study|Lost to Follow-up|0|||
130720406|NCT00806286|470599734|FG000|Overall Study|Withdrawal by Subject|8|||
130984027|NCT01106430|471568350|FG000|Overall Study|Protocol Violation|7|||
130984028|NCT01106430|471568351|FG001|Overall Study|Protocol Violation|2|||
130984029|NCT01106430|471568350|FG000|Overall Study|Withdrawal by Subject|8|||
130984030|NCT01106430|471568351|FG001|Overall Study|Withdrawal by Subject|4|||
130984031|NCT01255592|471568354|FG000|Overall Study|Adverse Event|5|||
131044946|NCT05683340|471799058|FG001|Overall Study|Withdrawal by Subject|2|||
131044947|NCT01314105|471799062|FG000|Overall Study|Progressive Disease|6|||
131044948|NCT01314105|471799063|FG001|Overall Study|Progressive Disease|10|||
131044949|NCT01314105|471799062|FG000|Overall Study|Refused to continue taking medication|0|||
131044950|NCT01314105|471799063|FG001|Overall Study|Refused to continue taking medication|1|||
131044951|NCT01314105|471799062|FG000|Overall Study|Other Adverse Event|1|||
131044952|NCT01314105|471799063|FG001|Overall Study|Other Adverse Event|1|||
131044953|NCT02056834|471799064|FG000|Overall Study|Lost to Follow-up|7|||
131044954|NCT06106022|471799068|FG000|Overall Study|Lost to Follow-up|1|||
131044955|NCT06106022|471799069|FG001|Overall Study|Lost to Follow-up|0|||
131044956|NCT06106022|471799068|FG000|Overall Study|Voluntary Withdrawal|0|||
131044957|NCT06106022|471799069|FG001|Overall Study|Voluntary Withdrawal|2|||
131044958|NCT03640286|471799072|FG000|Overall Study|Adverse Event|6|||
131044959|NCT03640286|471799073|FG001|Overall Study|Adverse Event|6|||
131044960|NCT03640286|471799072|FG000|Overall Study|Lost to Follow-up|3|||
131044961|NCT03640286|471799073|FG001|Overall Study|Lost to Follow-up|6|||
131044962|NCT03640286|471799072|FG000|Overall Study|Pregnancy|1|||
131044963|NCT03640286|471799073|FG001|Overall Study|Pregnancy|0|||
131044964|NCT03640286|471799072|FG000|Overall Study|Withdrawal by Subject|10|||
131044965|NCT03640286|471799073|FG001|Overall Study|Withdrawal by Subject|10|||
131044966|NCT03640286|471799072|FG000|Overall Study|Non-compliance|4|||
131044967|NCT03640286|471799073|FG001|Overall Study|Non-compliance|10|||
131044968|NCT03640286|471799072|FG000|Overall Study|Medication change|1|||
131044969|NCT03640286|471799073|FG001|Overall Study|Medication change|0|||
131044970|NCT03640286|471799072|FG000|Overall Study|Other|1|||
131044971|NCT03640286|471799073|FG001|Overall Study|Other|2|||
131044972|NCT03640286|471799072|FG000|Overall Study|Joined another lifestyle program|0|||
131044973|NCT03640286|471799073|FG001|Overall Study|Joined another lifestyle program|1|||
131044974|NCT03181516|471799074|FG000|Overall Study|Withdrawal by Subject|14|||
131044975|NCT03181516|471799075|FG001|Overall Study|Withdrawal by Subject|7|||
131044976|NCT03181516|471799074|FG000|Overall Study|Lost to Follow-up|2|||
131044977|NCT03181516|471799075|FG001|Overall Study|Lost to Follow-up|2|||
131044978|NCT04880733|471799076|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
131044979|NCT04880733|471799077|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
131044980|NCT04880733|471799078|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
131044981|NCT04880733|471799076|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
131044982|NCT04880733|471799077|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
131044983|NCT04880733|471799078|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
131044984|NCT04880733|471799076|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
131044985|NCT04880733|471799077|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
131044986|NCT04880733|471799078|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
131044987|NCT04880733|471799076|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
131044988|NCT04880733|471799077|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
131044989|NCT04880733|471799078|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
131044990|NCT04880733|471799076|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
131044991|NCT04880733|471799077|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
131044992|NCT04880733|471799078|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
130984032|NCT01255592|471568355|FG001|Overall Study|Adverse Event|0|||
130984033|NCT01255592|471568354|FG000|Overall Study|Withdrawal by Subject|1|||
130984034|NCT01255592|471568355|FG001|Overall Study|Withdrawal by Subject|0|||
130984035|NCT01255592|471568354|FG000|Overall Study|Other|0|||
130984036|NCT01255592|471568355|FG001|Overall Study|Other|1|||
131133485|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
130720407|NCT00806286|470599735|FG001|Overall Study|Withdrawal by Subject|3|||
130720408|NCT00806286|470599736|FG002|Overall Study|Withdrawal by Subject|1|||
130720409|NCT00806286|470599734|FG000|Overall Study|Physician Decision|2|||
130720410|NCT00806286|470599735|FG001|Overall Study|Physician Decision|2|||
130720411|NCT00806286|470599736|FG002|Overall Study|Physician Decision|0|||
130720412|NCT00806286|470599734|FG000|Overall Study|Due to a variety of reasons|7|||
130720413|NCT00806286|470599735|FG001|Overall Study|Due to a variety of reasons|2|||
130720414|NCT00806286|470599736|FG002|Overall Study|Due to a variety of reasons|1|||
130984037|NCT03704584|471568357|FG000|Overall Study|Withdrawal by Subject|1|||
130720415|NCT03402750|470599737|FG000|Overall Study|Lost to Follow-up|2|||
130984038|NCT03704584|471568358|FG001|Overall Study|Withdrawal by Subject|0|||
130984039|NCT03439189|471568359|FG000|Overall Study|Protocol Violation|19|||
131044993|NCT05552508|471799079|FG000|Overall Study|Adverse Event|3|||
131044994|NCT05424380|471799080|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
131044995|NCT05424380|471799081|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
131044996|NCT05424380|471799082|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
130720416|NCT03402750|470599738|FG001|Overall Study|Lost to Follow-up|1|||
130720417|NCT03469336|470599739|FG000|Overall Study|Adverse Event|1|||
130984040|NCT03439189|471568359|FG000|Overall Study|Lack of Efficacy|63|||
130984041|NCT01777321|471568360|FG000|Overall Study|Withdrawal by Subject|0|||
131044997|NCT05424380|471799083|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
131044998|NCT05424380|471799084|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
131044999|NCT05424380|471799085|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
131045000|NCT05424380|471799080|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
131045001|NCT05424380|471799081|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
131045002|NCT05424380|471799082|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
131045003|NCT05424380|471799083|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
131045004|NCT05424380|471799084|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
131045005|NCT05424380|471799085|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
131045006|NCT05424380|471799080|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
131045007|NCT05424380|471799081|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
131045008|NCT05424380|471799082|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
131045009|NCT05424380|471799083|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
131045010|NCT05424380|471799084|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
131045011|NCT05424380|471799085|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
131045012|NCT05424380|471799080|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
131045013|NCT05424380|471799081|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
131045014|NCT05424380|471799082|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
131045015|NCT05424380|471799083|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
131045016|NCT05424380|471799084|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
131045017|NCT05424380|471799085|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
131045018|NCT05424380|471799080|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
131045019|NCT05424380|471799081|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
131045020|NCT05424380|471799082|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
131045021|NCT05424380|471799083|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
131045022|NCT05424380|471799084|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
131045023|NCT05424380|471799085|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
131045024|NCT05424380|471799080|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
131045025|NCT05424380|471799081|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
131045026|NCT05424380|471799082|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
131045027|NCT05424380|471799083|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
131045028|NCT05424380|471799084|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
131045029|NCT05424380|471799085|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
131045030|NCT05424380|471799080|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
131045031|NCT05424380|471799081|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
131045032|NCT05424380|471799082|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
131045033|NCT05424380|471799083|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
131045034|NCT05424380|471799084|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
131045035|NCT05424380|471799085|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
131045036|NCT05424380|471799080|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
131045037|NCT05424380|471799081|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
131045038|NCT05424380|471799082|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
131045039|NCT05424380|471799083|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
131045040|NCT05424380|471799084|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
131045041|NCT05424380|471799085|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
131045042|NCT05424380|471799080|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131045043|NCT05424380|471799081|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131045044|NCT05424380|471799082|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131045045|NCT05424380|471799083|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
131045046|NCT05424380|471799084|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131045047|NCT05424380|471799085|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131045048|NCT05424380|471799080|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
131045049|NCT05424380|471799081|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
131045050|NCT05424380|471799082|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
131045051|NCT05424380|471799083|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
131045052|NCT05424380|471799084|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
131045053|NCT05424380|471799085|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
131045054|NCT05424380|471799080|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
131045055|NCT05424380|471799081|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
131045056|NCT05424380|471799082|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
131045057|NCT05424380|471799083|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
131045058|NCT05424380|471799084|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
131045059|NCT05424380|471799085|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
131045060|NCT05424380|471799080|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
131045061|NCT05424380|471799081|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
131045062|NCT05424380|471799082|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
131045063|NCT05424380|471799083|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
131045064|NCT05424380|471799084|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
131045065|NCT05424380|471799085|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
131045066|NCT05424380|471799080|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131045067|NCT05424380|471799081|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131045068|NCT05424380|471799082|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131045069|NCT05424380|471799083|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131045070|NCT05424380|471799084|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
131045071|NCT05424380|471799085|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
131045072|NCT05424380|471799080|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
131045073|NCT05424380|471799081|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
131045074|NCT05424380|471799082|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
131045075|NCT05424380|471799083|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
131045076|NCT05424380|471799084|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
131045077|NCT05424380|471799085|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
131045078|NCT02909686|471799090|FG000|Overall Study|Physician Decision|3|||
131045079|NCT02909686|471799090|FG000|Overall Study|Withdrawal by Subject|2|||
131045080|NCT06037668|471799093|FG000|Overall Study|Lost to Follow-up|1|||
131045081|NCT06037668|471799094|FG001|Overall Study|Lost to Follow-up|1|||
131045082|NCT06037668|471799093|FG000|Overall Study|Protocol Violation|1|||
130720418|NCT03825341|470599740|FG000|Overall Study|Withdrawal by Subject|0|||
130720419|NCT03825341|470599741|FG001|Overall Study|Withdrawal by Subject|1|||
130720420|NCT00289536|470599743|FG000|Period 3|Lost to Follow-up|0|||
130720421|NCT00289536|470599744|FG001|Period 3|Lost to Follow-up|0|||
130720422|NCT00289536|470599745|FG002|Period 3|Lost to Follow-up|1|||
130720423|NCT04283500|470599749|FG000|Overall Study|Lost to Follow-up|8|||
130720424|NCT04283500|470599749|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
131045083|NCT06037668|471799094|FG001|Overall Study|Protocol Violation|0|||
131045084|NCT06037668|471799093|FG000|Overall Study|Withdrawal by Subject|1|||
131045085|NCT06037668|471799094|FG001|Overall Study|Withdrawal by Subject|0|||
131045086|NCT06037668|471799093|FG000|Overall Study|Other Study Discontinuation Reason|1|||
131045087|NCT06037668|471799094|FG001|Overall Study|Other Study Discontinuation Reason|0|||
131045088|NCT05224544|471799095|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
131045089|NCT05224544|471799096|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
131045090|NCT04804540|471799097|FG000|Overall Study|Adverse Event|26|||
131045091|NCT04804540|471799098|FG001|Overall Study|Adverse Event|13|||
131045092|NCT05172232|471799099|FG000|Overall Study|Lost to Follow-up|3|||
131045093|NCT01828021|471799100|FG000|Overall Study|Adverse Event|5|||
131045094|NCT01828021|471799100|FG000|Overall Study|Lack of Efficacy|17|||
131045095|NCT01828021|471799100|FG000|Overall Study|Withdrawal by Subject|2|||
131045096|NCT01828021|471799100|FG000|Overall Study|Ileal obstruction, unrelated|1|||
131045097|NCT00844415|471799101|FG000|Overall Study|Withdrawal by Subject|1|||
131045098|NCT02473445|471799103|FG000|Overall Study|Withdrawal by Subject|2|||
131045099|NCT02473445|471799103|FG000|Overall Study|Sponsor Decision|20|||
131045100|NCT03988621|471799104|FG000|Overall Study|Lost to Follow-up|16|||
131045101|NCT03988621|471799105|FG001|Overall Study|Lost to Follow-up|17|||
131045102|NCT03988621|471799104|FG000|Overall Study|Withdrawal by Subject|14|||
131045103|NCT03988621|471799105|FG001|Overall Study|Withdrawal by Subject|7|||
131045104|NCT03988621|471799104|FG000|Overall Study|Patient Lost to Follow Up|15|||
131045105|NCT03988621|471799105|FG001|Overall Study|Patient Lost to Follow Up|15|||
131045106|NCT03988621|471799104|FG000|Overall Study|Patient death|1|||
131045107|NCT03988621|471799105|FG001|Overall Study|Patient death|5|||
131045108|NCT04629339|471799106|FG000|Overall Study|Death|1|||
131045109|NCT04629339|471799107|FG001|Overall Study|Death|0|||
131045110|NCT04629339|471799108|FG002|Overall Study|Death|2|||
131045111|NCT04629339|471799109|FG003|Overall Study|Death|2|||
131045112|NCT04629339|471799110|FG004|Overall Study|Death|0|||
131045113|NCT04629339|471799106|FG000|Overall Study|Disease Progression|0|||
131133486|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
131133487|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
131133488|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
131133489|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
131133490|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
131133491|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
131133492|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
131133493|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
131133494|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
131133495|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
131133496|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
131133497|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
131133498|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
131133499|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
131133500|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
131045114|NCT04629339|471799107|FG001|Overall Study|Disease Progression|0|||
131045115|NCT04629339|471799108|FG002|Overall Study|Disease Progression|1|||
131045116|NCT04629339|471799109|FG003|Overall Study|Disease Progression|1|||
131045117|NCT04629339|471799110|FG004|Overall Study|Disease Progression|0|||
131045118|NCT04629339|471799106|FG000|Overall Study|Lost to Follow-up|0|||
131045119|NCT04629339|471799107|FG001|Overall Study|Lost to Follow-up|0|||
131045120|NCT04629339|471799108|FG002|Overall Study|Lost to Follow-up|0|||
131045121|NCT04629339|471799109|FG003|Overall Study|Lost to Follow-up|1|||
131045122|NCT04629339|471799110|FG004|Overall Study|Lost to Follow-up|0|||
131045123|NCT04629339|471799106|FG000|Overall Study|Physician Decision|0|||
131045124|NCT04629339|471799107|FG001|Overall Study|Physician Decision|1|||
131045125|NCT04629339|471799108|FG002|Overall Study|Physician Decision|0|||
131045126|NCT04629339|471799109|FG003|Overall Study|Physician Decision|0|||
131045127|NCT04629339|471799110|FG004|Overall Study|Physician Decision|0|||
131045128|NCT04629339|471799106|FG000|Overall Study|Study Terminated by Sponsor|0|||
131045129|NCT04629339|471799107|FG001|Overall Study|Study Terminated by Sponsor|0|||
131045130|NCT04629339|471799108|FG002|Overall Study|Study Terminated by Sponsor|0|||
131045131|NCT04629339|471799109|FG003|Overall Study|Study Terminated by Sponsor|1|||
131045132|NCT04629339|471799110|FG004|Overall Study|Study Terminated by Sponsor|0|||
131045133|NCT04629339|471799106|FG000|Overall Study|Withdrawal by Subject|0|||
131045134|NCT04629339|471799107|FG001|Overall Study|Withdrawal by Subject|0|||
131045135|NCT04629339|471799108|FG002|Overall Study|Withdrawal by Subject|2|||
131045136|NCT04629339|471799109|FG003|Overall Study|Withdrawal by Subject|2|||
131045137|NCT04629339|471799110|FG004|Overall Study|Withdrawal by Subject|0|||
131045138|NCT04158739|471799113|FG000|Overall Study|Adverse Event|1|||
131045139|NCT04158739|471799114|FG001|Overall Study|Adverse Event|0|||
131045140|NCT04158739|471799113|FG000|Overall Study|Death|0|||
131045141|NCT04158739|471799114|FG001|Overall Study|Death|1|||
131045142|NCT04158739|471799113|FG000|Overall Study|Lack of Efficacy|3|||
131045143|NCT04158739|471799114|FG001|Overall Study|Lack of Efficacy|7|||
131045144|NCT04158739|471799113|FG000|Overall Study|Physician Decision|0|||
131045145|NCT04158739|471799114|FG001|Overall Study|Physician Decision|1|||
131045146|NCT04158739|471799113|FG000|Overall Study|Withdrawal by Subject|3|||
131045147|NCT04158739|471799114|FG001|Overall Study|Withdrawal by Subject|0|||
131045148|NCT03914469|471799115|FG000|Overall Study|Lost to Follow-up|1|||
131045149|NCT03914469|471799116|FG001|Overall Study|Lost to Follow-up|4|||
131045150|NCT04778410|471799117|FG000|Safety Run-in Period|Death|5|||
131045151|NCT04778410|471799118|FG001|Safety Run-in Period|Death|6|||
131045152|NCT04778410|471799119|FG002|Safety Run-in Period|Death|0|||
131045153|NCT04778410|471799120|FG003|Safety Run-in Period|Death|0|||
131045154|NCT04778410|471799121|FG004|Safety Run-in Period|Death|0|||
131045155|NCT04778410|471799122|FG005|Safety Run-in Period|Death|0|||
131045156|NCT04778410|471799117|FG000|Phase 2 Period|Death|0|||
131045157|NCT04778410|471799118|FG001|Phase 2 Period|Death|0|||
131045158|NCT04778410|471799119|FG002|Phase 2 Period|Death|0|||
131045159|NCT04778410|471799120|FG003|Phase 2 Period|Death|5|||
131045160|NCT04778410|471799121|FG004|Phase 2 Period|Death|18|||
131045161|NCT04778410|471799122|FG005|Phase 2 Period|Death|0|||
131045162|NCT04778410|471799117|FG000|Phase 2 Period|Lost to Follow-up|0|||
131045163|NCT04778410|471799118|FG001|Phase 2 Period|Lost to Follow-up|0|||
131045164|NCT04778410|471799119|FG002|Phase 2 Period|Lost to Follow-up|0|||
131045165|NCT04778410|471799120|FG003|Phase 2 Period|Lost to Follow-up|1|||
131045166|NCT04778410|471799121|FG004|Phase 2 Period|Lost to Follow-up|1|||
131045167|NCT04778410|471799122|FG005|Phase 2 Period|Lost to Follow-up|0|||
131045168|NCT04778410|471799117|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
131045169|NCT04778410|471799118|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
131045170|NCT04778410|471799119|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
131045171|NCT04778410|471799120|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
131045172|NCT04778410|471799121|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
131045173|NCT04778410|471799122|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
131229008|NCT01952574|472465768|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
131045174|NCT04778410|471799117|FG000|Phase 2 Period|Withdrew Consent|0|||
131045175|NCT04778410|471799118|FG001|Phase 2 Period|Withdrew Consent|0|||
131045176|NCT04778410|471799119|FG002|Phase 2 Period|Withdrew Consent|0|||
131045177|NCT04778410|471799120|FG003|Phase 2 Period|Withdrew Consent|0|||
131229009|NCT01952574|472465769|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
131229010|NCT01952574|472465770|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
131045178|NCT04778410|471799121|FG004|Phase 2 Period|Withdrew Consent|2|||
131045179|NCT04778410|471799122|FG005|Phase 2 Period|Withdrew Consent|0|||
131045180|NCT00677365|471799125|FG000|Overall Study|Adverse Event|2|||
131045181|NCT00677365|471799126|FG001|Overall Study|Adverse Event|1|||
131045182|NCT00677365|471799127|FG002|Overall Study|Adverse Event|1|||
131045183|NCT00677365|471799128|FG003|Overall Study|Adverse Event|2|||
131045184|NCT00677365|471799125|FG000|Overall Study|Withdrawal by Subject|0|||
131045185|NCT00677365|471799126|FG001|Overall Study|Withdrawal by Subject|0|||
131045186|NCT00677365|471799127|FG002|Overall Study|Withdrawal by Subject|1|||
131045187|NCT00677365|471799128|FG003|Overall Study|Withdrawal by Subject|0|||
131045188|NCT00677365|471799125|FG000|Overall Study|Other reason|0|||
131045189|NCT00677365|471799126|FG001|Overall Study|Other reason|0|||
131045190|NCT00677365|471799127|FG002|Overall Study|Other reason|0|||
131045191|NCT00677365|471799128|FG003|Overall Study|Other reason|1|||
130720425|NCT02006693|470599752|FG000|Overall Study|No Reason Specified|6|||
130720426|NCT02006693|470599753|FG001|Overall Study|No Reason Specified|8|||
130720427|NCT02006693|470599752|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
130720428|NCT02006693|470599753|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
130720429|NCT02006693|470599752|FG000|Overall Study|XEN Implant Explantation|0|||
130720430|NCT02006693|470599753|FG001|Overall Study|XEN Implant Explantation|1|||
131045192|NCT01121588|471799129|FG000|Overall Study|Death|5|||
131045193|NCT01121588|471799130|FG001|Overall Study|Death|3|||
131045194|NCT01121588|471799131|FG002|Overall Study|Death|13|||
131045195|NCT01121588|471799129|FG000|Overall Study|Study Terminated by Sponsor|1|||
131045196|NCT01121588|471799130|FG001|Overall Study|Study Terminated by Sponsor|1|||
131045197|NCT01121588|471799131|FG002|Overall Study|Study Terminated by Sponsor|0|||
131045198|NCT01121588|471799129|FG000|Overall Study|Participant Refused Further Followup|2|||
131045199|NCT01121588|471799130|FG001|Overall Study|Participant Refused Further Followup|0|||
131045200|NCT01121588|471799131|FG002|Overall Study|Participant Refused Further Followup|2|||
131045201|NCT01121588|471799129|FG000|Overall Study|Lost to Follow-up|0|||
131045202|NCT01121588|471799130|FG001|Overall Study|Lost to Follow-up|1|||
131045203|NCT01121588|471799131|FG002|Overall Study|Lost to Follow-up|1|||
131045204|NCT01121588|471799129|FG000|Overall Study|Non-Specified Reasons|9|||
131045205|NCT01121588|471799130|FG001|Overall Study|Non-Specified Reasons|4|||
131045206|NCT01121588|471799131|FG002|Overall Study|Non-Specified Reasons|2|||
131045207|NCT00721149|471799133|FG000|Overall Study|Physician Decision|1|||
131045208|NCT02585323|471800021|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
131045209|NCT02585323|471800022|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
131045210|NCT02585323|471800021|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
131045211|NCT02585323|471800022|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
131045212|NCT02585323|471800021|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
131045213|NCT02585323|471800022|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
131045214|NCT02585323|471800021|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
131045215|NCT02585323|471800022|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
131045216|NCT01130883|471800023|FG000|Overall Study|Patient Noncompliance|6|||
131045217|NCT01130883|471800023|FG000|Overall Study|Reason Unknown|1|||
131045218|NCT01130883|471800023|FG000|Overall Study|Adverse Event|3|||
131045219|NCT03981926|471800027|FG000|Overall Study|Lost to Follow-up|5|||
131045220|NCT03981926|471800028|FG001|Overall Study|Lost to Follow-up|9|||
131045221|NCT05464069|471800029|FG000|Overall Study|Protocol Violation|3|||
131045222|NCT05464069|471800030|FG001|Overall Study|Protocol Violation|2|||
131133501|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
131133502|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
131133503|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
131133504|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
131133505|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
131133506|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
131133507|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
131133508|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
131229011|NCT01952574|472465771|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
131229012|NCT01952574|472465772|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
131229013|NCT01952574|472465773|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
130720431|NCT02006693|470599752|FG000|Overall Study|Death|2|||
130720432|NCT02006693|470599753|FG001|Overall Study|Death|2|||
130720433|NCT02006693|470599752|FG000|Overall Study|Lost to Follow-up|4|||
131045223|NCT04136912|471800031|FG000|Overall Study|Operational reasons|0|||
131045224|NCT04136912|471800032|FG001|Overall Study|Operational reasons|0|||
131045225|NCT04136912|471800033|FG002|Overall Study|Operational reasons|2|||
131045226|NCT05976334|471800034|FG000|Part B|Death|0|||
131045227|NCT05976334|471800035|FG001|Part B|Death|1|||
131045228|NCT05976334|471800034|FG000|Part B|Study Terminated by Sponsor|0|||
131045229|NCT05976334|471800035|FG001|Part B|Study Terminated by Sponsor|1|||
130720434|NCT02006693|470599753|FG001|Overall Study|Lost to Follow-up|1|||
130720435|NCT02006693|470599752|FG000|Overall Study|Patient Decision|4|||
131045230|NCT05976334|471800034|FG000|Part B|Reason Not Specified|0|||
131045231|NCT05976334|471800035|FG001|Part B|Reason Not Specified|1|||
131045232|NCT02437136|471800038|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
131045233|NCT02437136|471800039|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131045234|NCT02437136|471800040|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131045235|NCT02437136|471800041|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131045236|NCT02437136|471800042|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131045237|NCT02437136|471800043|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131045238|NCT02437136|471800044|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
131045239|NCT02437136|471800038|FG000|Expansion (Phase 2)|Death|0|||
130720436|NCT02006693|470599753|FG001|Overall Study|Patient Decision|0|||
131229014|NCT00770991|472465778|FG000|Overall Study|Physician Decision|2|||
131229015|NCT00770991|472465779|FG001|Overall Study|Physician Decision|0|||
131229016|NCT00770991|472465778|FG000|Overall Study|Withdrawal by Subject|1|||
131229017|NCT00770991|472465779|FG001|Overall Study|Withdrawal by Subject|0|||
131229018|NCT00770991|472465778|FG000|Overall Study|Adverse Event|1|||
131229019|NCT00770991|472465779|FG001|Overall Study|Adverse Event|5|||
131229020|NCT00770991|472465778|FG000|Overall Study|Pregnancy|1|||
131229021|NCT00770991|472465779|FG001|Overall Study|Pregnancy|0|||
131229022|NCT02040766|472465780|FG000|Overall Study|Adverse Event|1|||
131229023|NCT02040766|472465781|FG001|Overall Study|Adverse Event|1|||
131229024|NCT02040766|472465782|FG002|Overall Study|Adverse Event|1|||
131229025|NCT02040766|472465783|FG003|Overall Study|Adverse Event|0|||
131229026|NCT02040766|472465784|FG004|Overall Study|Adverse Event|2|||
131229027|NCT02040766|472465780|FG000|Overall Study|Withdrawal by Subject|4|||
131229028|NCT02040766|472465781|FG001|Overall Study|Withdrawal by Subject|3|||
131229029|NCT02040766|472465782|FG002|Overall Study|Withdrawal by Subject|2|||
131229030|NCT02040766|472465783|FG003|Overall Study|Withdrawal by Subject|3|||
131229031|NCT02040766|472465784|FG004|Overall Study|Withdrawal by Subject|2|||
131229032|NCT02040766|472465780|FG000|Overall Study|Non-compliance|0|||
131045240|NCT02437136|471800039|FG001|Expansion (Phase 2)|Death|0|||
131045241|NCT02437136|471800040|FG002|Expansion (Phase 2)|Death|0|||
131045242|NCT02437136|471800041|FG003|Expansion (Phase 2)|Death|6|||
131045243|NCT02437136|471800042|FG004|Expansion (Phase 2)|Death|37|||
131045244|NCT02437136|471800043|FG005|Expansion (Phase 2)|Death|29|||
131045245|NCT02437136|471800044|FG006|Expansion (Phase 2)|Death|24|||
131045246|NCT02437136|471800038|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
131045247|NCT02437136|471800039|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
131229033|NCT02040766|472465781|FG001|Overall Study|Non-compliance|1|||
131229034|NCT02040766|472465782|FG002|Overall Study|Non-compliance|0|||
131229035|NCT02040766|472465783|FG003|Overall Study|Non-compliance|0|||
131229036|NCT02040766|472465784|FG004|Overall Study|Non-compliance|0|||
131229037|NCT02040766|472465780|FG000|Overall Study|Protocol Violation|2|||
131229038|NCT02040766|472465781|FG001|Overall Study|Protocol Violation|1|||
131229039|NCT02040766|472465782|FG002|Overall Study|Protocol Violation|2|||
131229040|NCT02040766|472465783|FG003|Overall Study|Protocol Violation|3|||
131229041|NCT02040766|472465784|FG004|Overall Study|Protocol Violation|0|||
131229042|NCT02040766|472465780|FG000|Overall Study|Lost to Follow-up|4|||
131229043|NCT02040766|472465781|FG001|Overall Study|Lost to Follow-up|1|||
131229044|NCT02040766|472465782|FG002|Overall Study|Lost to Follow-up|3|||
131229045|NCT02040766|472465783|FG003|Overall Study|Lost to Follow-up|1|||
131229046|NCT02040766|472465784|FG004|Overall Study|Lost to Follow-up|4|||
131229047|NCT02040766|472465780|FG000|Overall Study|Not reported|1|||
131229048|NCT02040766|472465781|FG001|Overall Study|Not reported|0|||
131229049|NCT02040766|472465782|FG002|Overall Study|Not reported|0|||
131229050|NCT02040766|472465783|FG003|Overall Study|Not reported|0|||
131229051|NCT02040766|472465784|FG004|Overall Study|Not reported|0|||
131229052|NCT02040766|472465780|FG000|Overall Study|Lack of Efficacy|6|||
131229053|NCT02040766|472465781|FG001|Overall Study|Lack of Efficacy|3|||
131229054|NCT02040766|472465782|FG002|Overall Study|Lack of Efficacy|4|||
131229055|NCT02040766|472465783|FG003|Overall Study|Lack of Efficacy|6|||
131229056|NCT02040766|472465784|FG004|Overall Study|Lack of Efficacy|5|||
131229057|NCT02974114|472465785|FG000|Overall Study|Other (Not specified)|0|||
131229058|NCT02974114|472465786|FG001|Overall Study|Other (Not specified)|1|||
131229059|NCT02974114|472465787|FG002|Overall Study|Other (Not specified)|2|||
131045248|NCT02437136|471800040|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
131045249|NCT02437136|471800041|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
131045250|NCT02437136|471800042|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
131045251|NCT02437136|471800043|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
131045252|NCT02437136|471800044|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
131045253|NCT02437136|471800038|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
131045254|NCT02437136|471800039|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
131045255|NCT02437136|471800040|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
131045256|NCT02437136|471800041|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
131045257|NCT02437136|471800042|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
131045258|NCT02437136|471800043|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
131045259|NCT02437136|471800044|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
131045260|NCT04526886|471800045|FG000|Overall Study|Physician Decision|4|||
131045261|NCT05524116|471800050|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
131045262|NCT05524116|471800051|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
131045263|NCT05524116|471800050|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
131045264|NCT05524116|471800051|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
131045265|NCT05524116|471800050|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
131045266|NCT05524116|471800051|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
131229060|NCT04147715|472465797|FG000|Overall Study|Adverse Event|0|||
131229061|NCT04147715|472465798|FG001|Overall Study|Adverse Event|0|||
131229062|NCT04147715|472465799|FG002|Overall Study|Adverse Event|0|||
131229063|NCT04147715|472465800|FG003|Overall Study|Adverse Event|0|||
131229064|NCT04147715|472465801|FG004|Overall Study|Adverse Event|0|||
131045267|NCT05524116|471800050|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
131045268|NCT05524116|471800051|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
131045269|NCT05524116|471800050|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
131045270|NCT05524116|471800051|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
131045271|NCT05405985|471800055|FG000|Overall Study|Withdrawal by Subject|1|||
131045272|NCT05405985|471800056|FG001|Overall Study|Withdrawal by Subject|0|||
131045273|NCT04282980|471800058|FG000|Overall Study|Remained on treatment|6|||
131045274|NCT04282980|471800058|FG000|Overall Study|Survival follow-up|11|||
131045275|NCT04282980|471800058|FG000|Overall Study|Withdrawal of informed consent|1|||
131045276|NCT04282980|471800058|FG000|Overall Study|Lost to Follow-up|1|||
131045277|NCT01917084|471800059|FG000|Overall Study|Withdrawal by Subject|1|||
131045278|NCT03571386|471800060|FG000|Overall Study|scheduling conflict|4|||
131045279|NCT03571386|471800061|FG001|Overall Study|scheduling conflict|0|||
131045280|NCT03571386|471800060|FG000|Overall Study|Withdrawal by Subject|15|||
131045281|NCT03571386|471800061|FG001|Overall Study|Withdrawal by Subject|5|||
131045282|NCT04311632|471800068|FG000|Overall Study|Withdrawal by Subject|0|||
131045283|NCT04311632|471800069|FG001|Overall Study|Withdrawal by Subject|0|||
131045284|NCT04311632|471800070|FG002|Overall Study|Withdrawal by Subject|1|||
131045285|NCT04632225|471800071|FG000|Overall Study|Withdrawal by Subject|2|||
131045286|NCT04632225|471800072|FG001|Overall Study|Withdrawal by Subject|2|||
131045287|NCT04605159|471800073|FG000|Overall Study|Adverse Event|6|||
131045288|NCT04605159|471800074|FG001|Overall Study|Adverse Event|3|||
131045289|NCT04605159|471800075|FG002|Overall Study|Adverse Event|21|||
131045290|NCT04605159|471800076|FG003|Overall Study|Adverse Event|4|||
131045291|NCT04605159|471800073|FG000|Overall Study|Lost to Follow-up|74|||
131045292|NCT04605159|471800074|FG001|Overall Study|Lost to Follow-up|45|||
131045293|NCT04605159|471800075|FG002|Overall Study|Lost to Follow-up|119|||
131045294|NCT04605159|471800076|FG003|Overall Study|Lost to Follow-up|80|||
131045295|NCT04605159|471800073|FG000|Overall Study|Protocol Violation|4|||
131045296|NCT04605159|471800074|FG001|Overall Study|Protocol Violation|5|||
131045297|NCT04605159|471800075|FG002|Overall Study|Protocol Violation|2|||
131045298|NCT04605159|471800076|FG003|Overall Study|Protocol Violation|0|||
131045299|NCT04605159|471800073|FG000|Overall Study|Withdrawal by Subject|66|||
131045300|NCT04605159|471800074|FG001|Overall Study|Withdrawal by Subject|37|||
131045301|NCT04605159|471800075|FG002|Overall Study|Withdrawal by Subject|68|||
131045302|NCT04605159|471800076|FG003|Overall Study|Withdrawal by Subject|50|||
131045303|NCT04605159|471800073|FG000|Overall Study|Migrated / moved from the study area|32|||
131045304|NCT04605159|471800074|FG001|Overall Study|Migrated / moved from the study area|22|||
131045305|NCT04605159|471800075|FG002|Overall Study|Migrated / moved from the study area|41|||
131045306|NCT04605159|471800076|FG003|Overall Study|Migrated / moved from the study area|21|||
131045307|NCT04605159|471800073|FG000|Overall Study|Other|1|||
131045308|NCT04605159|471800074|FG001|Overall Study|Other|2|||
131045309|NCT04605159|471800075|FG002|Overall Study|Other|7|||
131045310|NCT04605159|471800076|FG003|Overall Study|Other|3|||
131045311|NCT02278211|471800077|FG000|Overall Study|Unable to analyse PET scan|2|||
131045312|NCT03015532|471800079|FG000|Overall Study|Adverse Event|0|||
131045313|NCT03015532|471800080|FG001|Overall Study|Adverse Event|0|||
131045314|NCT03015532|471800081|FG002|Overall Study|Adverse Event|0|||
131045315|NCT03015532|471800082|FG003|Overall Study|Adverse Event|0|||
131045316|NCT03015532|471800083|FG004|Overall Study|Adverse Event|0|||
131045317|NCT03015532|471800084|FG005|Overall Study|Adverse Event|2|||
131045318|NCT03015532|471800085|FG006|Overall Study|Adverse Event|1|||
131045319|NCT03015532|471800086|FG007|Overall Study|Adverse Event|0|||
131045320|NCT03015532|471800079|FG000|Overall Study|Withdrawal by Subject|0|||
131045321|NCT03015532|471800080|FG001|Overall Study|Withdrawal by Subject|0|||
131045322|NCT03015532|471800081|FG002|Overall Study|Withdrawal by Subject|0|||
131045323|NCT03015532|471800082|FG003|Overall Study|Withdrawal by Subject|0|||
131045324|NCT03015532|471800083|FG004|Overall Study|Withdrawal by Subject|0|||
131045325|NCT03015532|471800084|FG005|Overall Study|Withdrawal by Subject|0|||
131045326|NCT03015532|471800085|FG006|Overall Study|Withdrawal by Subject|1|||
131133509|NCT00784654|472115362|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
131133510|NCT00784654|472115363|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
131133511|NCT00784654|472115364|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
131133512|NCT00784654|472115362|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
131045327|NCT03015532|471800086|FG007|Overall Study|Withdrawal by Subject|0|||
131045328|NCT05970861|471800087|FG000|Overall Study|Physician Decision|4|||
131045329|NCT05970861|471800088|FG001|Overall Study|Physician Decision|4|||
131045330|NCT05970861|471800087|FG000|Overall Study|Lost to Follow-up|4|||
131045331|NCT05970861|471800088|FG001|Overall Study|Lost to Follow-up|3|||
131045332|NCT03663205|471800094|FG000|Overall Study|Death|144|||
131045333|NCT03663205|471800095|FG001|Overall Study|Death|69|||
131045334|NCT03663205|471800094|FG000|Overall Study|Sponsor decision|53|||
131045335|NCT03663205|471800095|FG001|Overall Study|Sponsor decision|19|||
131045336|NCT03663205|471800094|FG000|Overall Study|Withdrawal by Subject|8|||
131045337|NCT03663205|471800095|FG001|Overall Study|Withdrawal by Subject|11|||
131045338|NCT03663205|471800094|FG000|Overall Study|Lost to Follow-up|7|||
130720437|NCT01119508|470599756|FG000|Overall Study|Adverse Event|56|||
130720438|NCT01119508|470599756|FG000|Overall Study|Withdrawal by Subject|2|||
130720439|NCT01119508|470599756|FG000|Overall Study|Died before tumor response evaluation|1|||
130720440|NCT00265395|470599757|FG000|Overall Study|Adverse Event|3|||
130720441|NCT00265395|470599758|FG001|Overall Study|Adverse Event|6|||
130720442|NCT00265395|470599757|FG000|Overall Study|Lost to Follow-up|2|||
130720443|NCT00265395|470599758|FG001|Overall Study|Lost to Follow-up|1|||
130720444|NCT00265395|470599757|FG000|Overall Study|Withdrawal by Subject|1|||
130720445|NCT00265395|470599758|FG001|Overall Study|Withdrawal by Subject|6|||
130720446|NCT00265395|470599757|FG000|Overall Study|Protocol Violation|2|||
130720447|NCT00265395|470599758|FG001|Overall Study|Protocol Violation|2|||
130720448|NCT00265395|470599757|FG000|Overall Study|Lack of Efficacy|0|||
130720449|NCT00265395|470599758|FG001|Overall Study|Lack of Efficacy|1|||
130720450|NCT00265395|470599757|FG000|Overall Study|Administrative|0|||
130720451|NCT00265395|470599758|FG001|Overall Study|Administrative|1|||
130720452|NCT00552578|470599764|FG000|Overall Study|Lost to Follow-up|1|||
130720453|NCT00552578|470599765|FG001|Overall Study|Lost to Follow-up|1|||
130720454|NCT04053465|470599766|FG000|Overall Study|Withdrawal by Subject|4|||
130720455|NCT04053465|470599767|FG001|Overall Study|Withdrawal by Subject|4|||
130720456|NCT02338193|470599769|FG000|Overall Study|Withdrawal by Subject|0|||
130720457|NCT02338193|470599770|FG001|Overall Study|Withdrawal by Subject|0|||
130720458|NCT02338193|470599771|FG002|Overall Study|Withdrawal by Subject|2|||
130720459|NCT02338193|470599769|FG000|Overall Study|Pregnancy|0|||
130720460|NCT02338193|470599770|FG001|Overall Study|Pregnancy|1|||
130720461|NCT02338193|470599771|FG002|Overall Study|Pregnancy|1|||
130720462|NCT02338193|470599769|FG000|Overall Study|Noncompliant with visits|2|||
130720463|NCT02338193|470599770|FG001|Overall Study|Noncompliant with visits|2|||
130720464|NCT02338193|470599771|FG002|Overall Study|Noncompliant with visits|7|||
130720465|NCT02338193|470599769|FG000|Overall Study|moved out of state|0|||
130720466|NCT02338193|470599770|FG001|Overall Study|moved out of state|1|||
130720467|NCT02338193|470599771|FG002|Overall Study|moved out of state|0|||
130720468|NCT02338193|470599769|FG000|Overall Study|intolerant of side effects|1|||
130720469|NCT02338193|470599770|FG001|Overall Study|intolerant of side effects|0|||
130720470|NCT02338193|470599771|FG002|Overall Study|intolerant of side effects|0|||
130720471|NCT00742924|470599772|FG000|Overall Study|Adverse Event|0|||
130720472|NCT00742924|470599773|FG001|Overall Study|Adverse Event|0|||
130720473|NCT00742924|470599774|FG002|Overall Study|Adverse Event|1|||
130720474|NCT00742924|470599775|FG003|Overall Study|Adverse Event|1|||
130720475|NCT00742924|470599772|FG000|Overall Study|Lack of Efficacy|5|||
130720476|NCT00742924|470599773|FG001|Overall Study|Lack of Efficacy|1|||
130720477|NCT00742924|470599774|FG002|Overall Study|Lack of Efficacy|2|||
130720478|NCT00742924|470599775|FG003|Overall Study|Lack of Efficacy|4|||
130720479|NCT00742924|470599772|FG000|Overall Study|Physician Decision|0|||
130720480|NCT00742924|470599773|FG001|Overall Study|Physician Decision|0|||
130720481|NCT00742924|470599774|FG002|Overall Study|Physician Decision|0|||
130720482|NCT00742924|470599775|FG003|Overall Study|Physician Decision|1|||
130720483|NCT00742924|470599772|FG000|Overall Study|Withdrawal by Subject|0|||
130720484|NCT00742924|470599773|FG001|Overall Study|Withdrawal by Subject|1|||
130984042|NCT01777321|471568361|FG001|Overall Study|Withdrawal by Subject|1|||
130984043|NCT04791761|471568365|FG000|Overall Study|Lost to Follow-up|8|||
130984044|NCT04791761|471568366|FG001|Overall Study|Lost to Follow-up|6|||
130984045|NCT04791761|471568367|FG002|Overall Study|Lost to Follow-up|10|||
130984046|NCT04791761|471568365|FG000|Overall Study|Withdrawal by Subject|0|||
130984047|NCT04791761|471568366|FG001|Overall Study|Withdrawal by Subject|1|||
130984048|NCT04791761|471568367|FG002|Overall Study|Withdrawal by Subject|1|||
131045339|NCT03663205|471800095|FG001|Overall Study|Lost to Follow-up|9|||
130720485|NCT00742924|470599774|FG002|Overall Study|Withdrawal by Subject|1|||
130720486|NCT00742924|470599775|FG003|Overall Study|Withdrawal by Subject|0|||
130720487|NCT00660400|470599776|FG000|Overall Study|Lack of insurance approval|1|||
130720488|NCT00660400|470599776|FG000|Overall Study|Suboptimal organ function|1|||
130720489|NCT00660400|470599776|FG000|Overall Study|Intracranial hemorrhage|1|||
130720490|NCT00660400|470599776|FG000|Overall Study|Withdrawal by Subject|1|||
130720491|NCT02643355|470599777|FG000|Overall Study|Withdrawal by Subject|1|||
130720492|NCT02643355|470599778|FG001|Overall Study|Withdrawal by Subject|3|||
130720493|NCT02643355|470599777|FG000|Overall Study|Protocol Violation|0|||
130720494|NCT02643355|470599778|FG001|Overall Study|Protocol Violation|2|||
130984049|NCT04791761|471568365|FG000|Overall Study|Protocol Violation|0|||
131045340|NCT03663205|471800094|FG000|Overall Study|Transferred to long term extension study|11|||
130984050|NCT04791761|471568366|FG001|Overall Study|Protocol Violation|1|||
131045341|NCT03663205|471800095|FG001|Overall Study|Transferred to long term extension study|3|||
131045342|NCT04206787|471800096|FG000|Overall Study|Other than listed|2|||
131045343|NCT04206787|471800096|FG000|Overall Study|Investigator decision|1|||
131045344|NCT04206787|471800096|FG000|Overall Study|Death|25|||
131045345|NCT04206787|471800096|FG000|Overall Study|Lost to Follow-up|9|||
131045346|NCT04206787|471800096|FG000|Overall Study|Withdrawal of consent|9|||
131045347|NCT02039401|471800098|FG000|Overall Study|Adverse Event|0|||
131045348|NCT02039401|471800099|FG001|Overall Study|Adverse Event|1|||
131045349|NCT03057054|471800100|FG000|Overall Study|Death|4|||
131045350|NCT03057054|471800101|FG001|Overall Study|Death|4|||
131045351|NCT03057054|471800100|FG000|Overall Study|Withdrawal by Subject|6|||
131045352|NCT03057054|471800101|FG001|Overall Study|Withdrawal by Subject|3|||
130720495|NCT06354998|470599779|FG000|Overall Study|Withdrawal by Subject|3|||
130984051|NCT04791761|471568367|FG002|Overall Study|Protocol Violation|1|||
130984052|NCT00089141|471568368|FG000|Overall Study|Termination of trial|18|||
130984053|NCT00089141|471568369|FG001|Overall Study|Termination of trial|24|||
130984054|NCT00508261|471568372|FG000|Overall Study|Other|0|||
130984055|NCT00508261|471568373|FG001|Overall Study|Other|1|||
130984056|NCT00508261|471568374|FG002|Overall Study|Other|1|||
130984057|NCT00508261|471568375|FG003|Overall Study|Other|0|||
130984058|NCT00508261|471568372|FG000|Overall Study|Serious Adverse Event|0|||
130984059|NCT00508261|471568373|FG001|Overall Study|Serious Adverse Event|1|||
130984060|NCT00508261|471568374|FG002|Overall Study|Serious Adverse Event|0|||
130984061|NCT00508261|471568375|FG003|Overall Study|Serious Adverse Event|0|||
130984062|NCT00508261|471568372|FG000|Overall Study|Withdrawal by Subject|3|||
130984063|NCT00508261|471568373|FG001|Overall Study|Withdrawal by Subject|4|||
130984064|NCT00508261|471568374|FG002|Overall Study|Withdrawal by Subject|4|||
130984065|NCT00508261|471568375|FG003|Overall Study|Withdrawal by Subject|0|||
130984066|NCT00508261|471568372|FG000|Overall Study|Migrated/ moved from study area|0|||
130984067|NCT00508261|471568373|FG001|Overall Study|Migrated/ moved from study area|1|||
130984068|NCT00508261|471568374|FG002|Overall Study|Migrated/ moved from study area|0|||
130984069|NCT00508261|471568375|FG003|Overall Study|Migrated/ moved from study area|0|||
130984070|NCT00508261|471568372|FG000|Overall Study|Lost to Follow-up|0|||
130984071|NCT00508261|471568373|FG001|Overall Study|Lost to Follow-up|1|||
130984072|NCT00508261|471568374|FG002|Overall Study|Lost to Follow-up|1|||
130984073|NCT00508261|471568375|FG003|Overall Study|Lost to Follow-up|1|||
130984074|NCT00180479|471568376|FG000|Overall Study|Death|4|||
130984075|NCT00180479|471568377|FG001|Overall Study|Death|2|||
130984076|NCT00180479|471568376|FG000|Overall Study|Lost to Follow-up|9|||
130984077|NCT00180479|471568377|FG001|Overall Study|Lost to Follow-up|7|||
130984078|NCT00180479|471568376|FG000|Overall Study|Withdrawal by Subject|3|||
130984079|NCT00180479|471568377|FG001|Overall Study|Withdrawal by Subject|3|||
130984080|NCT00180479|471568376|FG000|Overall Study|Informed consent not signed|0|||
130984081|NCT00180479|471568377|FG001|Overall Study|Informed consent not signed|1|||
130984082|NCT05131165|471568378|FG000|Overall Study|Death|1|||
130984083|NCT05131165|471568379|FG001|Overall Study|Death|1|||
130984084|NCT05131165|471568380|FG002|Overall Study|Death|0|||
130984085|NCT05131165|471568378|FG000|Overall Study|Lost to Follow-up|2|||
130984086|NCT05131165|471568379|FG001|Overall Study|Lost to Follow-up|2|||
130984087|NCT05131165|471568380|FG002|Overall Study|Lost to Follow-up|5|||
130984088|NCT05131165|471568378|FG000|Overall Study|Transferred out of clinic|1|||
130984089|NCT05131165|471568379|FG001|Overall Study|Transferred out of clinic|0|||
130984090|NCT05131165|471568380|FG002|Overall Study|Transferred out of clinic|3|||
130984091|NCT05131165|471568378|FG000|Overall Study|Dropped out|1|||
130984092|NCT05131165|471568379|FG001|Overall Study|Dropped out|2|||
130984093|NCT05131165|471568380|FG002|Overall Study|Dropped out|0|||
130984094|NCT00526630|471568394|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
130984095|NCT00526630|471568395|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
130984096|NCT00526630|471568394|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
130984097|NCT00526630|471568395|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
130720496|NCT06354998|470599780|FG001|Overall Study|Withdrawal by Subject|0|||
130984098|NCT02459262|471568396|FG000|Overall Study|Withdrawal by Subject|0|||
131045353|NCT03057054|471800100|FG000|Overall Study|Ineligible|1|||
131045354|NCT03057054|471800101|FG001|Overall Study|Ineligible|1|||
131045355|NCT03734029|471800106|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
131045356|NCT03734029|471800107|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
131045357|NCT03734029|471800106|FG000|Overall Study|Adverse Event|60|||
131045358|NCT03734029|471800107|FG001|Overall Study|Adverse Event|14|||
131045359|NCT03734029|471800106|FG000|Overall Study|Withdrawal by Subject|12|||
131045360|NCT03734029|471800107|FG001|Overall Study|Withdrawal by Subject|11|||
131045361|NCT03734029|471800106|FG000|Overall Study|Clinical progression by investigator|10|||
131045362|NCT03734029|471800107|FG001|Overall Study|Clinical progression by investigator|8|||
131045363|NCT03734029|471800106|FG000|Overall Study|Death|5|||
131045364|NCT03734029|471800107|FG001|Overall Study|Death|2|||
131045365|NCT03734029|471800106|FG000|Overall Study|Physician Decision|4|||
131045366|NCT03734029|471800107|FG001|Overall Study|Physician Decision|3|||
131045367|NCT03734029|471800106|FG000|Overall Study|Other|2|||
131045368|NCT03734029|471800107|FG001|Overall Study|Other|0|||
130984099|NCT02459262|471568397|FG001|Overall Study|Withdrawal by Subject|0|||
130984100|NCT02459262|471568398|FG002|Overall Study|Withdrawal by Subject|0|||
130984101|NCT02459262|471568399|FG003|Overall Study|Withdrawal by Subject|0|||
130984102|NCT02459262|471568400|FG004|Overall Study|Withdrawal by Subject|0|||
130984103|NCT02459262|471568401|FG005|Overall Study|Withdrawal by Subject|0|||
130984104|NCT02459262|471568402|FG006|Overall Study|Withdrawal by Subject|0|||
130984105|NCT02459262|471568403|FG007|Overall Study|Withdrawal by Subject|0|||
130984106|NCT02459262|471568404|FG008|Overall Study|Withdrawal by Subject|0|||
130984107|NCT02459262|471568405|FG009|Overall Study|Withdrawal by Subject|1|||
130984108|NCT02459262|471568406|FG010|Overall Study|Withdrawal by Subject|0|||
131045369|NCT03734029|471800106|FG000|Overall Study|Lost to Follow-up|0|||
131045370|NCT03734029|471800107|FG001|Overall Study|Lost to Follow-up|1|||
131045371|NCT03734029|471800106|FG000|Overall Study|Randomized, but not treated|2|||
131045372|NCT03734029|471800107|FG001|Overall Study|Randomized, but not treated|12|||
131045373|NCT01586910|471800807|FG000|Overall Study|Death|4|||
131045374|NCT01586910|471800808|FG001|Overall Study|Death|4|||
131045375|NCT01586910|471800807|FG000|Overall Study|Withdrawal by Subject|6|||
131045376|NCT01586910|471800808|FG001|Overall Study|Withdrawal by Subject|43|||
131045377|NCT01586910|471800807|FG000|Overall Study|Physician withdrew Subject|5|||
131045378|NCT01586910|471800808|FG001|Overall Study|Physician withdrew Subject|24|||
131045379|NCT01064440|471800809|FG000|Overall Study|Lost to Follow-up|1|||
131045380|NCT01064440|471800810|FG001|Overall Study|Lost to Follow-up|1|||
131045381|NCT01064440|471800811|FG002|Overall Study|Lost to Follow-up|1|||
131045382|NCT01064440|471800809|FG000|Overall Study|Non-compliance|0|||
131045383|NCT01064440|471800810|FG001|Overall Study|Non-compliance|1|||
131045384|NCT01064440|471800811|FG002|Overall Study|Non-compliance|0|||
131045385|NCT01064440|471800809|FG000|Overall Study|Death|1|||
131045386|NCT01064440|471800810|FG001|Overall Study|Death|0|||
131045387|NCT01064440|471800811|FG002|Overall Study|Death|1|||
131045388|NCT01064440|471800809|FG000|Overall Study|Withdrawal by Subject|0|||
131045389|NCT01064440|471800810|FG001|Overall Study|Withdrawal by Subject|1|||
131045390|NCT01064440|471800811|FG002|Overall Study|Withdrawal by Subject|1|||
131045391|NCT01064440|471800809|FG000|Overall Study|Other: amputation|1|||
131045392|NCT01064440|471800810|FG001|Overall Study|Other: amputation|0|||
131045393|NCT01064440|471800811|FG002|Overall Study|Other: amputation|0|||
131045394|NCT04108130|471800812|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
131045395|NCT04108130|471800813|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
131045396|NCT04108130|471800812|FG000|Overall Study|Consent Withdrawn|9|||
131045397|NCT04108130|471800813|FG001|Overall Study|Consent Withdrawn|6|||
131045398|NCT04108130|471800812|FG000|Overall Study|Surgery Cancelled|4|||
131045399|NCT04108130|471800813|FG001|Overall Study|Surgery Cancelled|4|||
131045400|NCT04108130|471800812|FG000|Overall Study|Found Ineligible for Study|4|||
131045401|NCT04108130|471800813|FG001|Overall Study|Found Ineligible for Study|3|||
131045402|NCT04108130|471800812|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
131045403|NCT04108130|471800813|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
131045404|NCT04108130|471800812|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
131045405|NCT04108130|471800813|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
131045406|NCT05507333|471800814|FG000|Overall Study|Protocol Violation|1|||
131045407|NCT03972150|471800815|FG000|Overall Study|Adverse Event|0|||
131045408|NCT03972150|471800816|FG001|Overall Study|Adverse Event|1|||
131045409|NCT03972150|471800817|FG002|Overall Study|Adverse Event|1|||
131045410|NCT03972150|471800818|FG003|Overall Study|Adverse Event|0|||
131045411|NCT03972150|471800819|FG004|Overall Study|Adverse Event|0|||
131045412|NCT03972150|471800815|FG000|Overall Study|Progressive disease|3|||
131045413|NCT03972150|471800816|FG001|Overall Study|Progressive disease|5|||
131045414|NCT03972150|471800817|FG002|Overall Study|Progressive disease|2|||
131045415|NCT03972150|471800818|FG003|Overall Study|Progressive disease|2|||
131045416|NCT03972150|471800819|FG004|Overall Study|Progressive disease|3|||
131045417|NCT04881461|471800829|FG000|Overall Study|Adverse Event|2|||
131045418|NCT04881461|471800830|FG001|Overall Study|Adverse Event|4|||
131045419|NCT04881461|471800829|FG000|Overall Study|Withdrawal by Subject|19|||
131045420|NCT04881461|471800830|FG001|Overall Study|Withdrawal by Subject|19|||
131045421|NCT04881461|471800829|FG000|Overall Study|Lost to Follow-up|4|||
131045422|NCT04881461|471800830|FG001|Overall Study|Lost to Follow-up|4|||
131045423|NCT04881461|471800829|FG000|Overall Study|Lack of Efficacy|1|||
131045424|NCT04881461|471800830|FG001|Overall Study|Lack of Efficacy|0|||
131045425|NCT04881461|471800829|FG000|Overall Study|"Reason stated as other in CRF"|1|||
131045426|NCT04881461|471800830|FG001|Overall Study|"Reason stated as other in CRF"|2|||
131045427|NCT05422885|471800837|FG000|Overall Study|Lost to Follow-up|1|||
131045428|NCT05422885|471800837|FG000|Overall Study|Withdrawal by Subject|2|||
131045429|NCT04084574|471800838|FG000|Overall Study|Lost to Follow-up|1|||
131045430|NCT04084574|471800839|FG001|Overall Study|Lost to Follow-up|0|||
131045431|NCT04084574|471800838|FG000|Overall Study|Physician Decision|1|||
131045432|NCT04084574|471800839|FG001|Overall Study|Physician Decision|0|||
131045433|NCT04084574|471800838|FG000|Overall Study|Relocated out of state|1|||
131045434|NCT04084574|471800839|FG001|Overall Study|Relocated out of state|0|||
131045435|NCT02944968|471800842|FG000|Overall Study|Subject excluded before study procedure|1|||
131045436|NCT02944968|471800842|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
131045437|NCT02905331|471800843|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
131045438|NCT02905331|471800844|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
131045439|NCT02905331|471800845|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
131045440|NCT02905331|471800843|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
131045441|NCT02905331|471800844|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
131045442|NCT02905331|471800845|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
131229065|NCT04147715|472465802|FG005|Overall Study|Adverse Event|0|||
131045443|NCT02905331|471800843|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
131229066|NCT04147715|472465803|FG006|Overall Study|Adverse Event|0|||
130720497|NCT00826449|470599783|FG000|Overall Study|Disease Progression|4|||
130720498|NCT00826449|470599783|FG000|Overall Study|Withdrawal by Subject|1|||
130720499|NCT02994940|470599784|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
130720500|NCT02994940|470599785|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
130720501|NCT02994940|470599784|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
130720502|NCT02994940|470599785|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
130720503|NCT02994940|470599784|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
130720504|NCT02994940|470599785|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
130720505|NCT03233230|470599786|FG000|Overall Study|Adverse Event|6|||
130720506|NCT03233230|470599787|FG001|Overall Study|Adverse Event|3|||
130720507|NCT03233230|470599788|FG002|Overall Study|Adverse Event|6|||
130720508|NCT03233230|470599789|FG003|Overall Study|Adverse Event|3|||
130720509|NCT03233230|470599786|FG000|Overall Study|Protocol Violation|1|||
130720510|NCT03233230|470599787|FG001|Overall Study|Protocol Violation|2|||
130720511|NCT03233230|470599788|FG002|Overall Study|Protocol Violation|1|||
130720512|NCT03233230|470599789|FG003|Overall Study|Protocol Violation|1|||
130720513|NCT03233230|470599786|FG000|Overall Study|Lack of Efficacy|1|||
130720514|NCT03233230|470599787|FG001|Overall Study|Lack of Efficacy|0|||
130720515|NCT03233230|470599788|FG002|Overall Study|Lack of Efficacy|0|||
130720516|NCT03233230|470599789|FG003|Overall Study|Lack of Efficacy|0|||
130720517|NCT03233230|470599786|FG000|Overall Study|Other|5|||
130720518|NCT03233230|470599787|FG001|Overall Study|Other|5|||
130720519|NCT03233230|470599788|FG002|Overall Study|Other|5|||
130720520|NCT03233230|470599789|FG003|Overall Study|Other|3|||
130720521|NCT03233230|470599786|FG000|Overall Study|Withdrawal by Subject|2|||
130720522|NCT03233230|470599787|FG001|Overall Study|Withdrawal by Subject|2|||
130720523|NCT03233230|470599788|FG002|Overall Study|Withdrawal by Subject|0|||
130720524|NCT03233230|470599789|FG003|Overall Study|Withdrawal by Subject|1|||
130720525|NCT03233230|470599786|FG000|Overall Study|Lost to Follow-up|0|||
130720526|NCT03233230|470599787|FG001|Overall Study|Lost to Follow-up|3|||
130720527|NCT03233230|470599788|FG002|Overall Study|Lost to Follow-up|0|||
130984109|NCT00840801|471568407|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
130984110|NCT00840801|471568408|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
130984111|NCT00840801|471568409|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
130984112|NCT00840801|471568407|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
130984113|NCT00840801|471568408|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
130984114|NCT00840801|471568409|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
130984115|NCT00840801|471568407|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
130984116|NCT00840801|471568408|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
130984117|NCT00840801|471568409|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
130984118|NCT00840801|471568407|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
130984119|NCT00840801|471568408|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
130984120|NCT00840801|471568409|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
130984121|NCT01242748|471568410|FG000|Overall Study|Adverse Event|10|||
130984122|NCT01242748|471568411|FG001|Overall Study|Adverse Event|5|||
130984123|NCT01242748|471568410|FG000|Overall Study|Lost to Follow-up|6|||
130984124|NCT01242748|471568411|FG001|Overall Study|Lost to Follow-up|2|||
130984125|NCT01242748|471568410|FG000|Overall Study|Physician Decision|3|||
130984126|NCT01242748|471568411|FG001|Overall Study|Physician Decision|2|||
130984127|NCT01242748|471568410|FG000|Overall Study|Protocol Violation|1|||
131045444|NCT02905331|471800844|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
131045445|NCT02905331|471800845|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
131045446|NCT02905331|471800843|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
131045447|NCT02905331|471800844|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
131045448|NCT02905331|471800845|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
131045449|NCT02905331|471800843|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
131045450|NCT02905331|471800844|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
131045451|NCT02905331|471800845|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
131045452|NCT01385202|471800846|FG000|Overall Study|Lost to Follow-up|6|||
131045453|NCT01385202|471800846|FG000|Overall Study|Not Eligible|11|||
131045454|NCT01385202|471800846|FG000|Overall Study|Withdrawn|1|||
131045455|NCT03681262|471800847|FG000|Overall Study|Continuing on study|3|||
131045456|NCT03681262|471800848|FG001|Overall Study|Continuing on study|3|||
131045457|NCT03681262|471800847|FG000|Overall Study|Lost to Follow-up|1|||
131045458|NCT03681262|471800848|FG001|Overall Study|Lost to Follow-up|0|||
131045459|NCT04102111|471800849|FG000|Overall Study|Withdrawal by Subject|2|||
131045460|NCT04102111|471800850|FG001|Overall Study|Withdrawal by Subject|3|||
131045461|NCT04102111|471800849|FG000|Overall Study|Adverse Event|1|||
130720528|NCT03233230|470599789|FG003|Overall Study|Lost to Follow-up|0|||
130720529|NCT02987959|470599790|FG000|Overall Study|Grantor stopped supply of drugs|6|||
130984128|NCT01242748|471568411|FG001|Overall Study|Protocol Violation|0|||
130984129|NCT01242748|471568410|FG000|Overall Study|Withdrawal by Subject|10|||
131045462|NCT04102111|471800850|FG001|Overall Study|Adverse Event|1|||
131045463|NCT04102111|471800849|FG000|Overall Study|Study terminated by sponsor|1|||
131045464|NCT04102111|471800850|FG001|Overall Study|Study terminated by sponsor|3|||
131045465|NCT02577354|471800851|FG000|Overall Study|Lack of Efficacy|4|||
131045466|NCT02577354|471800852|FG001|Overall Study|Lack of Efficacy|4|||
131045467|NCT02577354|471800851|FG000|Overall Study|Lost to Follow-up|3|||
131045468|NCT02577354|471800852|FG001|Overall Study|Lost to Follow-up|1|||
131229067|NCT04147715|472465804|FG007|Overall Study|Adverse Event|2|||
131229068|NCT04147715|472465805|FG008|Overall Study|Adverse Event|1|||
131229069|NCT04147715|472465806|FG009|Overall Study|Adverse Event|0|||
131229070|NCT04147715|472465807|FG010|Overall Study|Adverse Event|0|||
131229071|NCT04147715|472465808|FG011|Overall Study|Adverse Event|0|||
131229072|NCT03404206|472465809|FG000|Overall Study|Withdrawal by Subject|1|||
131229073|NCT03404206|472465810|FG001|Overall Study|Withdrawal by Subject|1|||
131229074|NCT03404206|472465811|FG002|Overall Study|Withdrawal by Subject|0|||
131229075|NCT03404206|472465809|FG000|Overall Study|Lost to Follow-up|3|||
131229076|NCT03404206|472465810|FG001|Overall Study|Lost to Follow-up|1|||
131229077|NCT03404206|472465811|FG002|Overall Study|Lost to Follow-up|0|||
131229078|NCT01626859|472465820|FG000|Overall Study|Adverse Event|1|||
131229079|NCT01626859|472465821|FG001|Overall Study|Adverse Event|3|||
130720530|NCT01898650|470599796|FG000|Overall Study|the subject would not lie still for imaging|1|||
130720531|NCT00911807|470599797|FG000|Overall Study|Adverse Event|2|||
130720532|NCT00911807|470599798|FG001|Overall Study|Adverse Event|1|||
130720533|NCT00911807|470599799|FG002|Overall Study|Adverse Event|5|||
130720534|NCT00911807|470599797|FG000|Overall Study|Death|0|||
130720535|NCT00911807|470599798|FG001|Overall Study|Death|0|||
130984130|NCT01242748|471568411|FG001|Overall Study|Withdrawal by Subject|2|||
130984131|NCT01242748|471568410|FG000|Overall Study|Miscellaneous reasons|8|||
130984132|NCT01242748|471568411|FG001|Overall Study|Miscellaneous reasons|3|||
130984133|NCT01750879|471568418|FG000|Overall Study|Adverse Event|8|||
130984134|NCT01750879|471568419|FG001|Overall Study|Adverse Event|0|||
130984135|NCT01750879|471568418|FG000|Overall Study|Lack of Efficacy|1|||
130984136|NCT01750879|471568419|FG001|Overall Study|Lack of Efficacy|0|||
130984137|NCT01750879|471568418|FG000|Overall Study|Withdrawal by Subject|1|||
130984138|NCT01750879|471568419|FG001|Overall Study|Withdrawal by Subject|0|||
130984139|NCT01750879|471568418|FG000|Overall Study|Did not complete per protocol|0|||
130984140|NCT01750879|471568419|FG001|Overall Study|Did not complete per protocol|3|||
130984141|NCT03518125|471568426|FG000|Overall Study|Lost to Follow-up|0|||
130984142|NCT03518125|471568427|FG001|Overall Study|Lost to Follow-up|2|||
130984143|NCT03518125|471568428|FG002|Overall Study|Lost to Follow-up|0|||
130984144|NCT03518125|471568429|FG003|Overall Study|Lost to Follow-up|0|||
130984145|NCT03518125|471568430|FG004|Overall Study|Lost to Follow-up|3|||
130984146|NCT03518125|471568431|FG005|Overall Study|Lost to Follow-up|5|||
130984147|NCT03518125|471568426|FG000|Overall Study|Physician Decision|0|||
130984148|NCT03518125|471568427|FG001|Overall Study|Physician Decision|1|||
130984149|NCT03518125|471568428|FG002|Overall Study|Physician Decision|0|||
130984150|NCT03518125|471568429|FG003|Overall Study|Physician Decision|0|||
130984151|NCT03518125|471568430|FG004|Overall Study|Physician Decision|0|||
130984152|NCT03518125|471568431|FG005|Overall Study|Physician Decision|0|||
130984153|NCT03518125|471568426|FG000|Overall Study|Withdrawal by Subject|1|||
130984154|NCT03518125|471568427|FG001|Overall Study|Withdrawal by Subject|1|||
130984155|NCT03518125|471568428|FG002|Overall Study|Withdrawal by Subject|0|||
130984156|NCT03518125|471568429|FG003|Overall Study|Withdrawal by Subject|1|||
130984157|NCT03518125|471568430|FG004|Overall Study|Withdrawal by Subject|1|||
130984158|NCT03518125|471568431|FG005|Overall Study|Withdrawal by Subject|3|||
130984159|NCT03518125|471568426|FG000|Overall Study|Missed Day 394 Visit|1|||
130984160|NCT03518125|471568427|FG001|Overall Study|Missed Day 394 Visit|0|||
130984161|NCT03518125|471568428|FG002|Overall Study|Missed Day 394 Visit|0|||
130984162|NCT03518125|471568429|FG003|Overall Study|Missed Day 394 Visit|0|||
130984163|NCT03518125|471568430|FG004|Overall Study|Missed Day 394 Visit|0|||
130984164|NCT03518125|471568431|FG005|Overall Study|Missed Day 394 Visit|0|||
130984165|NCT02093663|471568436|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
130984166|NCT02093663|471568437|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
130984167|NCT02093663|471568438|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
130984168|NCT02093663|471568439|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
130984169|NCT02093663|471568440|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
131045469|NCT02577354|471800851|FG000|Overall Study|Missed Visit|4|||
131045470|NCT02577354|471800852|FG001|Overall Study|Missed Visit|3|||
131229080|NCT01626859|472465822|FG002|Overall Study|Adverse Event|2|||
131229081|NCT01626859|472465820|FG000|Overall Study|Physician Decision|0|||
131229082|NCT01626859|472465821|FG001|Overall Study|Physician Decision|1|||
130984170|NCT02093663|471568436|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
130984171|NCT02093663|471568437|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130984172|NCT02093663|471568438|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130984173|NCT02093663|471568439|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130984174|NCT02093663|471568440|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
131045471|NCT02577354|471800851|FG000|Overall Study|Adverse Event|4|||
131229083|NCT01626859|472465822|FG002|Overall Study|Physician Decision|0|||
131133513|NCT00784654|472115363|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
131133514|NCT00784654|472115364|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
131133515|NCT00784654|472115362|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
131133516|NCT00784654|472115363|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
131133517|NCT00784654|472115364|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
131133518|NCT00784654|472115362|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131133519|NCT00784654|472115363|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
131133520|NCT00784654|472115364|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
131133521|NCT00784654|472115362|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
131133522|NCT00784654|472115363|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
131133523|NCT00784654|472115364|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
130720536|NCT00911807|470599799|FG002|Overall Study|Death|1|||
130720537|NCT00911807|470599797|FG000|Overall Study|Protocol Violation|6|||
130720538|NCT00911807|470599798|FG001|Overall Study|Protocol Violation|4|||
130984175|NCT02093663|471568436|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
130984176|NCT02093663|471568437|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
130984177|NCT02093663|471568438|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
130984178|NCT02093663|471568439|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
130984179|NCT02093663|471568440|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
130984180|NCT02093663|471568436|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
130984181|NCT02093663|471568437|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
130984182|NCT02093663|471568438|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
130984183|NCT02093663|471568439|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
130984184|NCT02093663|471568440|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
130984185|NCT02093663|471568436|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130984186|NCT02093663|471568437|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130984187|NCT02093663|471568438|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
130984188|NCT02093663|471568439|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130984189|NCT02093663|471568440|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130984190|NCT02093663|471568436|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
130984191|NCT02093663|471568437|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
130984192|NCT02093663|471568438|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
130984193|NCT02093663|471568439|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
130984194|NCT02093663|471568440|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
130984195|NCT02093663|471568436|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
130984196|NCT02093663|471568437|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
130984197|NCT02093663|471568438|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
130984198|NCT02093663|471568439|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
130984199|NCT02093663|471568440|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
130984200|NCT02093663|471568436|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
130984201|NCT02093663|471568437|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
130984202|NCT02093663|471568438|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
130984203|NCT02093663|471568439|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
130984204|NCT02093663|471568440|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
130984205|NCT02093663|471568436|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
130984206|NCT02093663|471568437|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
130984207|NCT02093663|471568438|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
130984208|NCT02093663|471568439|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
130984209|NCT02093663|471568440|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
130984210|NCT00508404|471568443|FG000|Overall Study|Ongoing at Data Cut-off|12|||
131045472|NCT02577354|471800852|FG001|Overall Study|Adverse Event|5|||
131045473|NCT04707768|471800859|FG000|Overall Study|Adverse Event|9|||
131045474|NCT04707768|471800860|FG001|Overall Study|Adverse Event|18|||
131045475|NCT04707768|471800861|FG002|Overall Study|Adverse Event|3|||
131045476|NCT04707768|471800859|FG000|Overall Study|Investigator's Discretion|8|||
131045477|NCT04707768|471800860|FG001|Overall Study|Investigator's Discretion|4|||
131045478|NCT04707768|471800861|FG002|Overall Study|Investigator's Discretion|3|||
131133524|NCT00784654|472115362|FG000|Randomized Withdrawal Period|Adverse Event|0|||
131133525|NCT00784654|472115363|FG001|Randomized Withdrawal Period|Adverse Event|1|||
131133526|NCT00784654|472115364|FG002|Randomized Withdrawal Period|Adverse Event|1|||
131133527|NCT00784654|472115362|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
131133528|NCT00784654|472115363|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
131133529|NCT00784654|472115364|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
131133530|NCT00784654|472115362|FG000|Randomized Withdrawal Period|Family reasons|0|||
131133531|NCT00784654|472115363|FG001|Randomized Withdrawal Period|Family reasons|0|||
131133532|NCT00784654|472115364|FG002|Randomized Withdrawal Period|Family reasons|1|||
131133533|NCT00262873|472115365|FG000|Overall Study|Adverse Event|3|||
131045479|NCT04707768|471800859|FG000|Overall Study|Withdrawal by Subject|6|||
131045480|NCT04707768|471800860|FG001|Overall Study|Withdrawal by Subject|8|||
131045481|NCT04707768|471800861|FG002|Overall Study|Withdrawal by Subject|2|||
131045482|NCT04707768|471800859|FG000|Overall Study|Lack of Efficacy|1|||
131045483|NCT04707768|471800860|FG001|Overall Study|Lack of Efficacy|3|||
131045484|NCT04707768|471800861|FG002|Overall Study|Lack of Efficacy|0|||
131045485|NCT04707768|471800859|FG000|Overall Study|Lost to Follow-up|0|||
131045486|NCT04707768|471800860|FG001|Overall Study|Lost to Follow-up|0|||
131045487|NCT04707768|471800861|FG002|Overall Study|Lost to Follow-up|3|||
131045488|NCT04707768|471800859|FG000|Overall Study|Death|13|||
131045489|NCT04707768|471800860|FG001|Overall Study|Death|11|||
131045490|NCT04707768|471800861|FG002|Overall Study|Death|13|||
131045491|NCT04707768|471800859|FG000|Overall Study|Protocol Violation|2|||
131045492|NCT04707768|471800860|FG001|Overall Study|Protocol Violation|1|||
131045493|NCT04707768|471800861|FG002|Overall Study|Protocol Violation|0|||
131045494|NCT04707768|471800859|FG000|Overall Study|Non Compliance with Study Drug|1|||
131045495|NCT04707768|471800860|FG001|Overall Study|Non Compliance with Study Drug|0|||
131045496|NCT04707768|471800861|FG002|Overall Study|Non Compliance with Study Drug|0|||
131045497|NCT04707768|471800859|FG000|Overall Study|Transplant|4|||
130984211|NCT00508404|471568443|FG000|Overall Study|Adverse Event|2|||
130984212|NCT00508404|471568443|FG000|Overall Study|Death|16|||
130984213|NCT00508404|471568443|FG000|Overall Study|Physician Decision|2|||
130984214|NCT00508404|471568443|FG000|Overall Study|Withdrawal by Subject|3|||
130984215|NCT00508404|471568443|FG000|Overall Study|Protocol-specified Criteria|2|||
130984216|NCT00508404|471568443|FG000|Overall Study|Lost to Follow-up|2|||
130984217|NCT00508404|471568443|FG000|Overall Study|Other - Not Specified|3|||
130984218|NCT01078155|471568445|FG000|Overall Study|Adverse Event|7|||
130984219|NCT01078155|471568445|FG000|Overall Study|Lack of Efficacy|16|||
130984220|NCT01078155|471568445|FG000|Overall Study|Participant's Decision|6|||
130984221|NCT01078155|471568445|FG000|Overall Study|Lost to Follow-up|15|||
130984222|NCT03286751|471568446|FG000|Washout Period 1|Withdrawal by Subject|0|||
130984223|NCT03286751|471568447|FG001|Washout Period 1|Withdrawal by Subject|0|||
130984224|NCT03286751|471568448|FG002|Washout Period 1|Withdrawal by Subject|0|||
130984225|NCT03286751|471568449|FG003|Washout Period 1|Withdrawal by Subject|0|||
130984226|NCT03286751|471568450|FG004|Washout Period 1|Withdrawal by Subject|1|||
130984227|NCT03286751|471568451|FG005|Washout Period 1|Withdrawal by Subject|0|||
130984228|NCT03286751|471568446|FG000|Washout Period 2|Personal Reasons|0|||
130984229|NCT03286751|471568447|FG001|Washout Period 2|Personal Reasons|1|||
130984230|NCT03286751|471568448|FG002|Washout Period 2|Personal Reasons|0|||
130984231|NCT03286751|471568449|FG003|Washout Period 2|Personal Reasons|0|||
130984232|NCT03286751|471568450|FG004|Washout Period 2|Personal Reasons|0|||
130984233|NCT03286751|471568451|FG005|Washout Period 2|Personal Reasons|0|||
130984234|NCT03286751|471568446|FG000|Washout Period 5|Adverse Event|0|||
130984235|NCT03286751|471568447|FG001|Washout Period 5|Adverse Event|0|||
130984236|NCT03286751|471568448|FG002|Washout Period 5|Adverse Event|0|||
130984237|NCT03286751|471568449|FG003|Washout Period 5|Adverse Event|0|||
130984238|NCT03286751|471568450|FG004|Washout Period 5|Adverse Event|1|||
130984239|NCT03286751|471568451|FG005|Washout Period 5|Adverse Event|0|||
130984240|NCT04067401|471568452|FG000|Overall Study|Withdrawal by Subject|7|||
130984241|NCT04067401|471568453|FG001|Overall Study|Withdrawal by Subject|0|||
130984242|NCT04067401|471568452|FG000|Overall Study|no data provided|1|||
130984243|NCT04067401|471568453|FG001|Overall Study|no data provided|0|||
130984244|NCT01477853|471568456|FG000|Phase A|Adverse Event|1|||
130984245|NCT01477853|471568457|FG001|Phase A|Adverse Event|2|||
130984246|NCT01477853|471568458|FG002|Phase A|Adverse Event|2|||
130984247|NCT01477853|471568456|FG000|Phase A|Lost to Follow-up|4|||
131045498|NCT04707768|471800860|FG001|Overall Study|Transplant|4|||
131045499|NCT04707768|471800861|FG002|Overall Study|Transplant|8|||
131045500|NCT04707768|471800859|FG000|Overall Study|Other|9|||
131045501|NCT04707768|471800860|FG001|Overall Study|Other|5|||
131045502|NCT04707768|471800861|FG002|Overall Study|Other|2|||
131045503|NCT04078152|471800862|FG000|Overall Study|Other|83|||
131045504|NCT04078152|471800863|FG001|Overall Study|Other|22|||
131045505|NCT04078152|471800864|FG002|Overall Study|Other|25|||
131045506|NCT04078152|471800862|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
131045507|NCT04078152|471800863|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
131045508|NCT04078152|471800864|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
131133534|NCT00262873|472115365|FG000|Overall Study|Withdrawal by Subject|5|||
131133535|NCT00844753|472115366|FG000|Overall Study|Lack of Efficacy|1|||
131133536|NCT00844753|472115367|FG001|Overall Study|Lack of Efficacy|0|||
130720539|NCT00911807|470599799|FG002|Overall Study|Protocol Violation|9|||
130984248|NCT01477853|471568457|FG001|Phase A|Lost to Follow-up|3|||
130984249|NCT01477853|471568458|FG002|Phase A|Lost to Follow-up|2|||
130984250|NCT01477853|471568456|FG000|Phase A|Physician Decision|1|||
130984251|NCT01477853|471568457|FG001|Phase A|Physician Decision|0|||
130984252|NCT01477853|471568458|FG002|Phase A|Physician Decision|1|||
130984253|NCT01477853|471568456|FG000|Phase A|Study terminated by sponsor|37|||
131045509|NCT04078152|471800862|FG000|Overall Study|Withdrawal by Subject|5|||
131045510|NCT04078152|471800863|FG001|Overall Study|Withdrawal by Subject|0|||
131045511|NCT04078152|471800864|FG002|Overall Study|Withdrawal by Subject|1|||
131045512|NCT04078152|471800862|FG000|Overall Study|Death|10|||
131045513|NCT04078152|471800863|FG001|Overall Study|Death|2|||
130984254|NCT01477853|471568457|FG001|Phase A|Study terminated by sponsor|40|||
130984255|NCT01477853|471568458|FG002|Phase A|Study terminated by sponsor|39|||
130984256|NCT01477853|471568456|FG000|Phase B|Lost to Follow-up|0|||
130984257|NCT01477853|471568457|FG001|Phase B|Lost to Follow-up|1|||
130984258|NCT01477853|471568458|FG002|Phase B|Lost to Follow-up|0|||
130984259|NCT01477853|471568456|FG000|Phase B|Study terminated by sponsor|12|||
130984260|NCT01477853|471568457|FG001|Phase B|Study terminated by sponsor|10|||
130984261|NCT01477853|471568458|FG002|Phase B|Study terminated by sponsor|11|||
130984262|NCT01050816|471568459|FG000|Overall Study|Lost to Follow-up|2|||
130984263|NCT01050816|471568459|FG000|Overall Study|patient's refusal|2|||
130984264|NCT03086330|471568460|FG000|Overall Study|Withdrawal by Subject|3|||
130984265|NCT03086330|471568461|FG001|Overall Study|Withdrawal by Subject|2|||
130984266|NCT03086330|471568460|FG000|Overall Study|Lost to Follow-up|1|||
130984267|NCT03086330|471568461|FG001|Overall Study|Lost to Follow-up|2|||
130984268|NCT00238433|471568467|FG000|Overall Study|Screen failure|1|||
130984269|NCT00238433|471568467|FG000|Overall Study|Lost to Follow-up|1|||
130984270|NCT00238433|471568467|FG000|Overall Study|Death|1|||
130984271|NCT01972529|471568470|FG000|Overall Study|Adverse Event|0|||
130984272|NCT01972529|471568471|FG001|Overall Study|Adverse Event|1|||
130984273|NCT01972529|471568472|FG002|Overall Study|Adverse Event|0|||
130984274|NCT01972529|471568473|FG003|Overall Study|Adverse Event|0|||
130984275|NCT01972529|471568470|FG000|Overall Study|Lost to Follow-up|1|||
130984276|NCT01972529|471568471|FG001|Overall Study|Lost to Follow-up|0|||
130984277|NCT01972529|471568472|FG002|Overall Study|Lost to Follow-up|0|||
130984278|NCT01972529|471568473|FG003|Overall Study|Lost to Follow-up|0|||
130984279|NCT01972529|471568470|FG000|Overall Study|Participant Choice|0|||
130984280|NCT01972529|471568471|FG001|Overall Study|Participant Choice|1|||
130984281|NCT01972529|471568472|FG002|Overall Study|Participant Choice|0|||
130984282|NCT01972529|471568473|FG003|Overall Study|Participant Choice|0|||
130984283|NCT01972529|471568470|FG000|Overall Study|Withdrawl of Consent|1|||
130984284|NCT01972529|471568471|FG001|Overall Study|Withdrawl of Consent|2|||
130984285|NCT01972529|471568472|FG002|Overall Study|Withdrawl of Consent|0|||
130984286|NCT01972529|471568473|FG003|Overall Study|Withdrawl of Consent|1|||
130984287|NCT01972529|471568470|FG000|Overall Study|Other|0|||
130984288|NCT01972529|471568471|FG001|Overall Study|Other|0|||
130984289|NCT01972529|471568472|FG002|Overall Study|Other|0|||
130984290|NCT01972529|471568473|FG003|Overall Study|Other|2|||
130984291|NCT01972529|471568470|FG000|Overall Study|Not treated|0|||
130984292|NCT01972529|471568471|FG001|Overall Study|Not treated|1|||
130984293|NCT01972529|471568472|FG002|Overall Study|Not treated|2|||
130984294|NCT01972529|471568473|FG003|Overall Study|Not treated|1|||
130984295|NCT02274857|471568474|FG000|Overall Study|Adverse Event|1|||
130984296|NCT02274857|471568475|FG001|Overall Study|Adverse Event|0|||
130984297|NCT02274857|471568474|FG000|Overall Study|Death|1|||
130984298|NCT02274857|471568475|FG001|Overall Study|Death|2|||
130984299|NCT02274857|471568474|FG000|Overall Study|Lost to Follow-up|3|||
130984300|NCT02274857|471568475|FG001|Overall Study|Lost to Follow-up|0|||
130984301|NCT02274857|471568474|FG000|Overall Study|Physician Decision|2|||
130984302|NCT02274857|471568475|FG001|Overall Study|Physician Decision|0|||
130984303|NCT02274857|471568474|FG000|Overall Study|Trial screen failure|0|||
130984304|NCT02274857|471568475|FG001|Overall Study|Trial screen failure|2|||
130984305|NCT02274857|471568474|FG000|Overall Study|Withdrawal by Subject|11|||
130984306|NCT02274857|471568475|FG001|Overall Study|Withdrawal by Subject|2|||
130984307|NCT02274857|471568474|FG000|Overall Study|Other|2|||
130984308|NCT02274857|471568475|FG001|Overall Study|Other|0|||
130984309|NCT02403180|471568479|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
130984310|NCT02403180|471568480|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
130984311|NCT02403180|471568479|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
130984312|NCT02403180|471568480|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
130984313|NCT01445652|471568484|FG000|Overall Study|Not comfortable in lenses|5|||
130984314|NCT01445652|471568485|FG001|Overall Study|Not comfortable in lenses|0|||
130984315|NCT01445652|471568484|FG000|Overall Study|Failed to attend scheduled visit|2|||
130984316|NCT01445652|471568485|FG001|Overall Study|Failed to attend scheduled visit|3|||
130984317|NCT01445652|471568484|FG000|Overall Study|Failed teach session|2|||
130984318|NCT01445652|471568485|FG001|Overall Study|Failed teach session|0|||
130984319|NCT01445652|471568484|FG000|Overall Study|Adverse Event|1|||
130984320|NCT01445652|471568485|FG001|Overall Study|Adverse Event|0|||
130720540|NCT00911807|470599797|FG000|Overall Study|Withdrawal by Subject|8|||
130984321|NCT03595332|471568488|FG000|Overall Study|Lost to Follow-up|16|||
130984322|NCT03595332|471568489|FG001|Overall Study|Lost to Follow-up|22|||
130984323|NCT03595332|471568488|FG000|Overall Study|Unable to retrieve ID from school|0|||
130984324|NCT03595332|471568489|FG001|Overall Study|Unable to retrieve ID from school|2|||
130984325|NCT00611858|471568490|FG000|Overall Study|Adverse Event|2|||
130984326|NCT00611858|471568490|FG000|Overall Study|Withdrawal by Subject|2|||
130984327|NCT01058304|471568491|FG000|Overall Study|Withdrawal by Subject|8|||
130984328|NCT01058304|471568492|FG001|Overall Study|Withdrawal by Subject|5|||
130984329|NCT01058304|471568491|FG000|Overall Study|Lost to Follow-up|13|||
130984330|NCT01058304|471568492|FG001|Overall Study|Lost to Follow-up|16|||
130720541|NCT00911807|470599798|FG001|Overall Study|Withdrawal by Subject|10|||
130720542|NCT00911807|470599799|FG002|Overall Study|Withdrawal by Subject|7|||
130720543|NCT00911807|470599797|FG000|Overall Study|Organizational reasons|1|||
130720544|NCT00911807|470599798|FG001|Overall Study|Organizational reasons|3|||
130720545|NCT00911807|470599799|FG002|Overall Study|Organizational reasons|1|||
130720546|NCT04430855|470599802|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
130720547|NCT04430855|470599803|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
130984331|NCT01058304|471568491|FG000|Overall Study|Developed exclusion criterion|6|||
130984332|NCT01058304|471568492|FG001|Overall Study|Developed exclusion criterion|12|||
130984333|NCT01820559|471568493|FG000|Overall Study|Adverse Event|4|||
130984334|NCT01820559|471568494|FG001|Overall Study|Adverse Event|6|||
130984335|NCT01820559|471568495|FG002|Overall Study|Adverse Event|13|||
130984336|NCT01820559|471568493|FG000|Overall Study|Withdrawal by Subject|1|||
130984337|NCT01820559|471568494|FG001|Overall Study|Withdrawal by Subject|2|||
130984338|NCT01820559|471568495|FG002|Overall Study|Withdrawal by Subject|5|||
130984339|NCT01820559|471568493|FG000|Overall Study|Protocol Violation|2|||
130984340|NCT01820559|471568494|FG001|Overall Study|Protocol Violation|1|||
130984341|NCT01820559|471568495|FG002|Overall Study|Protocol Violation|3|||
130984342|NCT01820559|471568493|FG000|Overall Study|Subject's non-compliance|1|||
130984343|NCT01820559|471568494|FG001|Overall Study|Subject's non-compliance|0|||
130984344|NCT01820559|471568495|FG002|Overall Study|Subject's non-compliance|2|||
130984345|NCT01820559|471568493|FG000|Overall Study|Lost to Follow-up|3|||
130984346|NCT01820559|471568494|FG001|Overall Study|Lost to Follow-up|2|||
130984347|NCT01820559|471568495|FG002|Overall Study|Lost to Follow-up|2|||
130984348|NCT01820559|471568493|FG000|Overall Study|At sponsor request|0|||
130984349|NCT01820559|471568494|FG001|Overall Study|At sponsor request|0|||
130984350|NCT01820559|471568495|FG002|Overall Study|At sponsor request|1|||
130984351|NCT01820559|471568493|FG000|Overall Study|Lack of Efficacy|3|||
130984352|NCT01820559|471568494|FG001|Overall Study|Lack of Efficacy|2|||
130984353|NCT01820559|471568495|FG002|Overall Study|Lack of Efficacy|3|||
130984354|NCT02515279|471568503|FG000|Overall Study|Adverse Event|7|||
130984355|NCT02515279|471568503|FG000|Overall Study|Lack of Efficacy|31|||
130984356|NCT02515279|471568503|FG000|Overall Study|Lost to Follow-up|9|||
130984357|NCT02515279|471568503|FG000|Overall Study|Withdrawal by Subject|18|||
130984358|NCT02515279|471568503|FG000|Overall Study|End-of-treatment visit not attended|17|||
130984359|NCT02515279|471568503|FG000|Overall Study|Other|22|||
130984360|NCT01800968|471568504|FG000|Overall Study|Death|23|||
130984361|NCT01800968|471568505|FG001|Overall Study|Death|16|||
130984362|NCT01800968|471568504|FG000|Overall Study|Lost to Follow-up|5|||
130984363|NCT01800968|471568505|FG001|Overall Study|Lost to Follow-up|7|||
130984364|NCT01800968|471568504|FG000|Overall Study|Withdrawal by Subject|7|||
130984365|NCT01800968|471568505|FG001|Overall Study|Withdrawal by Subject|9|||
130984366|NCT01800968|471568504|FG000|Overall Study|Physician Decision|1|||
130984367|NCT01800968|471568505|FG001|Overall Study|Physician Decision|0|||
130984368|NCT03185481|471568507|FG000|Overall Study|Adverse Event|1|||
130984369|NCT03185481|471568507|FG000|Overall Study|Study Terminated by Sponsor|4|||
130984370|NCT03266770|471568512|FG000|Overall Study|Physician Decision|3|||
130984371|NCT03266770|471568512|FG000|Overall Study|Insufficient study supplies|1|||
130984372|NCT03266770|471568512|FG000|Overall Study|Adverse Event|1|||
130984373|NCT02657031|471568513|FG000|Overall Study|Adverse Event|1|||
130984374|NCT02657031|471568514|FG001|Overall Study|Adverse Event|2|||
130984375|NCT05168579|471569728|FG000|Overall Study|Lack of Consent|1|||
130984376|NCT05168579|471569729|FG001|Overall Study|Lack of Consent|0|||
130984377|NCT05168579|471569728|FG000|Overall Study|Conflicts with time|2|||
130984378|NCT05168579|471569729|FG001|Overall Study|Conflicts with time|0|||
130984379|NCT05168579|471569728|FG000|Overall Study|Time slots were full|3|||
130984380|NCT05168579|471569729|FG001|Overall Study|Time slots were full|0|||
130984381|NCT05168579|471569728|FG000|Overall Study|Lost to Follow-up|0|||
130984382|NCT05168579|471569729|FG001|Overall Study|Lost to Follow-up|15|||
130984383|NCT01424930|471569730|FG000|Overall Study|Adverse Event|0|||
130984384|NCT01424930|471569731|FG001|Overall Study|Adverse Event|1|||
130984385|NCT01424930|471569730|FG000|Overall Study|Death|1|||
130984386|NCT01424930|471569731|FG001|Overall Study|Death|0|||
130984387|NCT01424930|471569730|FG000|Overall Study|Progressive Disease|3|||
130984388|NCT01424930|471569731|FG001|Overall Study|Progressive Disease|6|||
130984389|NCT01424930|471569730|FG000|Overall Study|Screen Failure|0|||
130984390|NCT01424930|471569731|FG001|Overall Study|Screen Failure|1|||
130984391|NCT01424930|471569730|FG000|Overall Study|Reason not specified|0|||
130984392|NCT01424930|471569731|FG001|Overall Study|Reason not specified|6|||
130984393|NCT01621880|471569732|FG000|Overall Study|Adverse Event|5|||
130984394|NCT01621880|471569733|FG001|Overall Study|Adverse Event|1|||
130984395|NCT01621880|471569732|FG000|Overall Study|Withdrawal by Subject|5|||
130984396|NCT01621880|471569733|FG001|Overall Study|Withdrawal by Subject|4|||
130984397|NCT00948974|471569734|FG000|Overall Study|Lost to Follow-up|23|||
130984398|NCT00948974|471569735|FG001|Overall Study|Lost to Follow-up|20|||
130984399|NCT00118716|471569739|FG000|Overall Study|Adverse Event|2|||
130984400|NCT00118716|471569740|FG001|Overall Study|Adverse Event|7|||
130984401|NCT00118716|471569739|FG000|Overall Study|Protocol Violation|5|||
130984402|NCT00118716|471569740|FG001|Overall Study|Protocol Violation|4|||
130984403|NCT00118716|471569739|FG000|Overall Study|Withdrawal by Subject|0|||
130984404|NCT00118716|471569740|FG001|Overall Study|Withdrawal by Subject|1|||
130984405|NCT00118716|471569739|FG000|Overall Study|Exacerbation|2|||
130984406|NCT00118716|471569740|FG001|Overall Study|Exacerbation|2|||
130984407|NCT00118716|471569739|FG000|Overall Study|Discontinued by sponsor|1|||
130984408|NCT00118716|471569740|FG001|Overall Study|Discontinued by sponsor|1|||
130984409|NCT00118716|471569739|FG000|Overall Study|Non-compliance|1|||
130984410|NCT00118716|471569740|FG001|Overall Study|Non-compliance|3|||
130984411|NCT00118716|471569739|FG000|Overall Study|misrandomized|1|||
130984412|NCT00118716|471569740|FG001|Overall Study|misrandomized|1|||
130984413|NCT00118716|471569739|FG000|Overall Study|Expired drug use|1|||
130984414|NCT00118716|471569740|FG001|Overall Study|Expired drug use|2|||
130984415|NCT00118716|471569739|FG000|Overall Study|Investigator discretion|0|||
130984416|NCT00118716|471569740|FG001|Overall Study|Investigator discretion|1|||
130984417|NCT00454571|471569741|FG000|Overall Study|Adverse Event|2|||
130984418|NCT00454571|471569742|FG001|Overall Study|Adverse Event|0|||
130984419|NCT00454571|471569741|FG000|Overall Study|Physician Decision|0|||
130984420|NCT00454571|471569742|FG001|Overall Study|Physician Decision|1|||
130984421|NCT00454571|471569741|FG000|Overall Study|Protocol Violation|1|||
130984422|NCT00454571|471569742|FG001|Overall Study|Protocol Violation|0|||
130984423|NCT00454571|471569741|FG000|Overall Study|Withdrawal by Subject|10|||
130984424|NCT00454571|471569742|FG001|Overall Study|Withdrawal by Subject|5|||
130984425|NCT02436811|471569743|FG000|Overall Study|Lost to Follow-up|2|||
130984426|NCT02436811|471569744|FG001|Overall Study|Lost to Follow-up|9|||
130984427|NCT02436811|471569745|FG002|Overall Study|Lost to Follow-up|7|||
130984428|NCT02227875|471569746|FG000|Overall Study|Protocol Violation|10|||
130984429|NCT02227875|471569747|FG001|Overall Study|Protocol Violation|7|||
130984430|NCT02227875|471569746|FG000|Overall Study|Other|1|||
130984431|NCT02227875|471569747|FG001|Overall Study|Other|3|||
130984432|NCT02227875|471569746|FG000|Overall Study|Physician Decision|1|||
130984433|NCT02227875|471569747|FG001|Overall Study|Physician Decision|0|||
130984434|NCT02227875|471569746|FG000|Overall Study|Adverse Event|3|||
130984435|NCT02227875|471569747|FG001|Overall Study|Adverse Event|0|||
130984436|NCT02227875|471569746|FG000|Overall Study|Withdrawal by Subject|12|||
130984437|NCT02227875|471569747|FG001|Overall Study|Withdrawal by Subject|13|||
130984438|NCT02227875|471569746|FG000|Overall Study|Lost to Follow-up|10|||
130984439|NCT02227875|471569747|FG001|Overall Study|Lost to Follow-up|10|||
130984440|NCT04209725|471569750|FG000|Overall Study|Adverse Event|1|||
130984441|NCT02657317|471569751|FG000|Overall Study|Withdrawal by Subject|2|||
130984442|NCT02657317|471569752|FG001|Overall Study|Withdrawal by Subject|0|||
130984443|NCT02657317|471569751|FG000|Overall Study|Lost to Follow-up|3|||
130984444|NCT02657317|471569752|FG001|Overall Study|Lost to Follow-up|3|||
130984445|NCT01089374|471569753|FG000|Overall Study|Lost to Follow-up|3|||
130984446|NCT01089374|471569754|FG001|Overall Study|Lost to Follow-up|0|||
130984447|NCT01089374|471569753|FG000|Overall Study|Withdrawal by Subject|1|||
130984448|NCT01089374|471569754|FG001|Overall Study|Withdrawal by Subject|0|||
130984449|NCT01089374|471569753|FG000|Overall Study|Study closed early - low accrual|6|||
130984450|NCT01089374|471569754|FG001|Overall Study|Study closed early - low accrual|0|||
130984451|NCT01201811|471569755|FG000|Overall Study|Adverse Event|6|||
130984452|NCT01201811|471569755|FG000|Overall Study|Disease progression|3|||
130984453|NCT01201811|471569755|FG000|Overall Study|Withdrawal by Subject|3|||
130984454|NCT01201811|471569755|FG000|Overall Study|Death|4|||
130984455|NCT01201811|471569755|FG000|Overall Study|Treatment Failure|2|||
130984456|NCT01201811|471569755|FG000|Overall Study|Physician Decision|1|||
130984457|NCT02856113|471569756|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130984458|NCT02856113|471569757|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
130984459|NCT02856113|471569756|FG000|Overall Study|Significant Protocol Deviation|1|||
130984460|NCT02856113|471569757|FG001|Overall Study|Significant Protocol Deviation|0|||
130984461|NCT02856113|471569756|FG000|Overall Study|Lost to Follow-up|3|||
130984462|NCT02856113|471569757|FG001|Overall Study|Lost to Follow-up|5|||
130984463|NCT02856113|471569756|FG000|Overall Study|Voluntary Withdrawal|3|||
130984464|NCT02856113|471569757|FG001|Overall Study|Voluntary Withdrawal|5|||
130984465|NCT02856113|471569756|FG000|Overall Study|Pregnancy|0|||
130984466|NCT02856113|471569757|FG001|Overall Study|Pregnancy|1|||
130984467|NCT02856113|471569756|FG000|Overall Study|Principal Investigator Discretion|2|||
130984468|NCT02856113|471569757|FG001|Overall Study|Principal Investigator Discretion|1|||
130984469|NCT02856113|471569756|FG000|Overall Study|Randomized but not Treated|1|||
130984470|NCT02856113|471569757|FG001|Overall Study|Randomized but not Treated|0|||
130984471|NCT02856113|471569756|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
130984472|NCT02856113|471569757|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
130984473|NCT02857426|471569758|FG000|Overall Study|Disease progression|34|||
130984474|NCT02857426|471569759|FG001|Overall Study|Disease progression|13|||
130984475|NCT02857426|471569758|FG000|Overall Study|Study drug toxicity|4|||
130984476|NCT02857426|471569759|FG001|Overall Study|Study drug toxicity|1|||
130984477|NCT02857426|471569758|FG000|Overall Study|Death|1|||
130984478|NCT02857426|471569759|FG001|Overall Study|Death|0|||
130984479|NCT02857426|471569758|FG000|Overall Study|Adverse event unrelated to study drug|6|||
130984480|NCT02857426|471569759|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130984481|NCT02857426|471569758|FG000|Overall Study|Participant withdrew consent|1|||
130984482|NCT02857426|471569759|FG001|Overall Study|Participant withdrew consent|1|||
130984483|NCT02857426|471569758|FG000|Overall Study|Maximum clinical benefit|1|||
130984484|NCT02857426|471569759|FG001|Overall Study|Maximum clinical benefit|0|||
130984485|NCT02857426|471569758|FG000|Overall Study|Completed treatment|0|||
130984486|NCT02857426|471569759|FG001|Overall Study|Completed treatment|2|||
130984487|NCT01780935|471569763|FG000|Overall Study|Admin problems due to early termination|321|||
130984488|NCT01780935|471569764|FG001|Overall Study|Admin problems due to early termination|309|||
130984489|NCT01780935|471569763|FG000|Overall Study|Adverse Event|2|||
130984490|NCT01780935|471569764|FG001|Overall Study|Adverse Event|4|||
130984491|NCT01780935|471569763|FG000|Overall Study|Death|1|||
130984492|NCT01780935|471569764|FG001|Overall Study|Death|6|||
130984493|NCT01780935|471569763|FG000|Overall Study|Lost to Follow-up|2|||
130984494|NCT01780935|471569764|FG001|Overall Study|Lost to Follow-up|6|||
130984495|NCT01780935|471569763|FG000|Overall Study|Physician Decision|1|||
130984496|NCT01780935|471569764|FG001|Overall Study|Physician Decision|1|||
130984497|NCT01780935|471569763|FG000|Overall Study|Protocol deviation|0|||
130984498|NCT01780935|471569764|FG001|Overall Study|Protocol deviation|1|||
130984499|NCT01780935|471569763|FG000|Overall Study|Patient withdrew consent|8|||
130984500|NCT01780935|471569764|FG001|Overall Study|Patient withdrew consent|9|||
130984501|NCT02831257|471569765|FG000|Overall Study|Lack of Efficacy|3|||
130984502|NCT02831257|471569765|FG000|Overall Study|Adverse Event|2|||
130984503|NCT02831257|471569765|FG000|Overall Study|Physician Decision|1|||
130984504|NCT02831257|471569765|FG000|Overall Study|Withdrawal by Subject|6|||
130984505|NCT00855595|471569766|FG000|Overall Study|Withdrawal by Subject|1|||
130984506|NCT00855595|471569767|FG001|Overall Study|Withdrawal by Subject|2|||
130984507|NCT00855595|471569766|FG000|Overall Study|Lost to Follow-up|3|||
130984508|NCT00855595|471569767|FG001|Overall Study|Lost to Follow-up|3|||
130984509|NCT00855595|471569766|FG000|Overall Study|Adverse Event|1|||
130984510|NCT00855595|471569767|FG001|Overall Study|Adverse Event|1|||
130984511|NCT00855595|471569766|FG000|Overall Study|patient moved out of state|1|||
130984512|NCT00855595|471569767|FG001|Overall Study|patient moved out of state|0|||
130984513|NCT00855595|471569766|FG000|Overall Study|patient left country|0|||
130984514|NCT00855595|471569767|FG001|Overall Study|patient left country|1|||
130984515|NCT00166296|471569768|FG000|Overall Study|Withdrawal by Subject|1|||
130984516|NCT00166296|471569769|FG001|Overall Study|Withdrawal by Subject|3|||
130984517|NCT00166296|471569768|FG000|Overall Study|Adverse Event|2|||
130984518|NCT00166296|471569769|FG001|Overall Study|Adverse Event|4|||
130984519|NCT00166296|471569768|FG000|Overall Study|Lost to Follow-up|4|||
130984520|NCT00166296|471569769|FG001|Overall Study|Lost to Follow-up|2|||
130984521|NCT04035200|471569775|FG000|Overall Study|Lost to Follow-up|0|||
130984522|NCT04035200|471569776|FG001|Overall Study|Lost to Follow-up|1|||
130984523|NCT04035200|471569777|FG002|Overall Study|Lost to Follow-up|0|||
130984524|NCT04035200|471569775|FG000|Overall Study|Withdrawal by Subject|1|||
130984525|NCT04035200|471569776|FG001|Overall Study|Withdrawal by Subject|4|||
130984526|NCT04035200|471569777|FG002|Overall Study|Withdrawal by Subject|4|||
130984527|NCT04035200|471569775|FG000|Overall Study|COVID-19|1|||
130984528|NCT04035200|471569776|FG001|Overall Study|COVID-19|0|||
130984529|NCT04035200|471569777|FG002|Overall Study|COVID-19|0|||
130984530|NCT04035200|471569775|FG000|Overall Study|Early Termination|0|||
130984531|NCT04035200|471569776|FG001|Overall Study|Early Termination|1|||
130984532|NCT04035200|471569777|FG002|Overall Study|Early Termination|0|||
130984533|NCT04035200|471569775|FG000|Overall Study|Non-compliance|0|||
130984534|NCT04035200|471569776|FG001|Overall Study|Non-compliance|1|||
130984535|NCT04035200|471569777|FG002|Overall Study|Non-compliance|0|||
130984536|NCT03033225|471569778|FG000|Overall Study|Withdrawal by Subject|5|||
130984537|NCT03412396|471569782|FG000|Overall Study|Withdrawal by Subject|2|||
131045514|NCT04078152|471800864|FG002|Overall Study|Death|12|||
131045515|NCT04078152|471800862|FG000|Overall Study|Adverse Event|1|||
131045516|NCT04078152|471800863|FG001|Overall Study|Adverse Event|0|||
131045517|NCT04078152|471800864|FG002|Overall Study|Adverse Event|0|||
130984538|NCT03412396|471569782|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
131045518|NCT02510235|471800865|FG000|Overall Study|Withdrawal by Subject|1|||
130984539|NCT03412396|471569782|FG000|Overall Study|Did not undergo RP|2|||
130984540|NCT04899245|471569791|FG000|Overall Study|Withdrawal by Subject|3|||
130984541|NCT04899245|471569792|FG001|Overall Study|Withdrawal by Subject|5|||
130984542|NCT04899245|471569793|FG002|Overall Study|Withdrawal by Subject|2|||
130984543|NCT04899245|471569791|FG000|Overall Study|No longer eligible - Left staff position|0|||
130984544|NCT04899245|471569792|FG001|Overall Study|No longer eligible - Left staff position|0|||
130984545|NCT04899245|471569793|FG002|Overall Study|No longer eligible - Left staff position|1|||
130984546|NCT04899245|471569791|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
130984547|NCT04899245|471569792|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
130984548|NCT04899245|471569793|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
130984549|NCT04899245|471569791|FG000|Overall Study|No longer eligible - Moved away from area|2|||
130984550|NCT04899245|471569792|FG001|Overall Study|No longer eligible - Moved away from area|2|||
130984551|NCT04899245|471569793|FG002|Overall Study|No longer eligible - Moved away from area|0|||
131133537|NCT00844753|472115368|FG002|Overall Study|Lack of Efficacy|2|||
131133538|NCT00844753|472115369|FG003|Overall Study|Lack of Efficacy|2|||
131133539|NCT00844753|472115366|FG000|Overall Study|Adverse Event|3|||
131133540|NCT00844753|472115367|FG001|Overall Study|Adverse Event|2|||
131133541|NCT00844753|472115368|FG002|Overall Study|Adverse Event|5|||
131133542|NCT00844753|472115369|FG003|Overall Study|Adverse Event|5|||
131133543|NCT00844753|472115366|FG000|Overall Study|Lost to Follow-up|1|||
130984552|NCT03371940|471569803|FG000|Overall Study|Withdrawal by Subject|8|||
130984553|NCT03371940|471569804|FG001|Overall Study|Withdrawal by Subject|1|||
130984554|NCT03371940|471569805|FG002|Overall Study|Withdrawal by Subject|3|||
130984555|NCT03371940|471569806|FG003|Overall Study|Withdrawal by Subject|4|||
130984556|NCT05099926|471569812|FG000|Overall Study|Lost to Follow-up|1|||
130984557|NCT00724152|471569816|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
130984558|NCT00724152|471569817|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
130984559|NCT00724152|471569818|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
130984560|NCT00724152|471569816|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
130984561|NCT00724152|471569817|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
130984562|NCT00724152|471569818|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
130984563|NCT00386022|471569819|FG000|Plus Estrogen|Lost to Follow-up|2|||
130984564|NCT00386022|471569820|FG001|Plus Estrogen|Lost to Follow-up|0|||
130984565|NCT00386022|471569819|FG000|Plus Estrogen|Adverse Event|0|||
130984566|NCT00386022|471569820|FG001|Plus Estrogen|Adverse Event|1|||
130984567|NCT00031486|471569830|FG000|Overall Study|Adverse Event|1|||
130984568|NCT00031486|471569831|FG001|Overall Study|Adverse Event|0|||
130984569|NCT00031486|471569830|FG000|Overall Study|Lost to Follow-up|0|||
130984570|NCT00031486|471569831|FG001|Overall Study|Lost to Follow-up|1|||
130984571|NCT00031486|471569830|FG000|Overall Study|Withdrawal by Subject|3|||
130984572|NCT00031486|471569831|FG001|Overall Study|Withdrawal by Subject|2|||
130984573|NCT00031486|471569830|FG000|Overall Study|Death|0|||
130984574|NCT00031486|471569831|FG001|Overall Study|Death|3|||
130984575|NCT00031486|471569830|FG000|Overall Study|Non-compliant|0|||
130984576|NCT00031486|471569831|FG001|Overall Study|Non-compliant|4|||
130984577|NCT00031486|471569830|FG000|Overall Study|Did not meet eligibility requirement|2|||
130984578|NCT00031486|471569831|FG001|Overall Study|Did not meet eligibility requirement|1|||
130984579|NCT00031486|471569830|FG000|Overall Study|Other|1|||
130984580|NCT00031486|471569831|FG001|Overall Study|Other|1|||
130984581|NCT03685591|471569832|FG000|Overall Study|Global Deterioration of Health Status|0|||
130984582|NCT03685591|471569833|FG001|Overall Study|Global Deterioration of Health Status|0|||
130984583|NCT03685591|471569834|FG002|Overall Study|Global Deterioration of Health Status|0|||
130984584|NCT03685591|471569835|FG003|Overall Study|Global Deterioration of Health Status|1|||
130984585|NCT03685591|471569836|FG004|Overall Study|Global Deterioration of Health Status|2|||
130984586|NCT03685591|471569837|FG005|Overall Study|Global Deterioration of Health Status|4|||
130984587|NCT03685591|471569838|FG006|Overall Study|Global Deterioration of Health Status|1|||
130984588|NCT03685591|471569839|FG007|Overall Study|Global Deterioration of Health Status|1|||
130984589|NCT03685591|471569840|FG008|Overall Study|Global Deterioration of Health Status|0|||
130984590|NCT03685591|471569832|FG000|Overall Study|Progressive Disease|1|||
130984591|NCT03685591|471569833|FG001|Overall Study|Progressive Disease|1|||
130984592|NCT03685591|471569834|FG002|Overall Study|Progressive Disease|0|||
130984593|NCT03685591|471569835|FG003|Overall Study|Progressive Disease|3|||
130984594|NCT03685591|471569836|FG004|Overall Study|Progressive Disease|5|||
130984595|NCT03685591|471569837|FG005|Overall Study|Progressive Disease|4|||
130984596|NCT03685591|471569838|FG006|Overall Study|Progressive Disease|3|||
130984597|NCT03685591|471569839|FG007|Overall Study|Progressive Disease|2|||
130984598|NCT03685591|471569840|FG008|Overall Study|Progressive Disease|1|||
130984599|NCT03685591|471569832|FG000|Overall Study|Other|0|||
130984600|NCT03685591|471569833|FG001|Overall Study|Other|0|||
130984601|NCT03685591|471569834|FG002|Overall Study|Other|1|||
130984602|NCT03685591|471569835|FG003|Overall Study|Other|0|||
130984603|NCT03685591|471569836|FG004|Overall Study|Other|2|||
130984604|NCT03685591|471569837|FG005|Overall Study|Other|3|||
130984605|NCT03685591|471569838|FG006|Overall Study|Other|0|||
130984606|NCT03685591|471569839|FG007|Overall Study|Other|0|||
130984607|NCT03685591|471569840|FG008|Overall Study|Other|0|||
130984608|NCT03685591|471569832|FG000|Overall Study|Withdrawal by Subject|0|||
130984609|NCT03685591|471569833|FG001|Overall Study|Withdrawal by Subject|0|||
130984610|NCT03685591|471569834|FG002|Overall Study|Withdrawal by Subject|0|||
130984611|NCT03685591|471569835|FG003|Overall Study|Withdrawal by Subject|0|||
130984612|NCT03685591|471569836|FG004|Overall Study|Withdrawal by Subject|3|||
130984613|NCT03685591|471569837|FG005|Overall Study|Withdrawal by Subject|2|||
130984614|NCT03685591|471569838|FG006|Overall Study|Withdrawal by Subject|0|||
131133544|NCT00844753|472115367|FG001|Overall Study|Lost to Follow-up|1|||
130984615|NCT03685591|471569839|FG007|Overall Study|Withdrawal by Subject|0|||
130984616|NCT03685591|471569840|FG008|Overall Study|Withdrawal by Subject|1|||
130984617|NCT03685591|471569832|FG000|Overall Study|Adverse Event|0|||
130984618|NCT03685591|471569833|FG001|Overall Study|Adverse Event|0|||
130984619|NCT03685591|471569834|FG002|Overall Study|Adverse Event|0|||
131133545|NCT00844753|472115368|FG002|Overall Study|Lost to Follow-up|0|||
130984620|NCT03685591|471569835|FG003|Overall Study|Adverse Event|1|||
130984621|NCT03685591|471569836|FG004|Overall Study|Adverse Event|1|||
130984622|NCT03685591|471569837|FG005|Overall Study|Adverse Event|4|||
130984623|NCT03685591|471569838|FG006|Overall Study|Adverse Event|0|||
130984624|NCT03685591|471569839|FG007|Overall Study|Adverse Event|1|||
130984625|NCT03685591|471569840|FG008|Overall Study|Adverse Event|1|||
130984626|NCT00168038|471569841|FG000|Overall Study|Adverse Event|1|||
130984627|NCT00168038|471569841|FG000|Overall Study|Therapy failure|1|||
130984628|NCT01685138|471569842|FG000|Overall Study|Lost to Follow-up|1|||
130984629|NCT01685138|471569842|FG000|Overall Study|Protocol Violation|1|||
130984630|NCT01685138|471569842|FG000|Overall Study|No longer requires treatment|1|||
130984631|NCT01685138|471569842|FG000|Overall Study|Subject/guardian decision|2|||
130984632|NCT01685138|471569842|FG000|Overall Study|Physician Decision|6|||
130984633|NCT01685138|471569842|FG000|Overall Study|Death|10|||
130984634|NCT01685138|471569842|FG000|Overall Study|Adverse Event|18|||
130984635|NCT01685138|471569842|FG000|Overall Study|Progressive disease|53|||
130984636|NCT03078816|471569847|FG000|Overall Study|Withdrawal by Subject|1|||
130984637|NCT01648348|471569854|FG000|Overall Study|Cancel|1|||
130984638|NCT01648348|471569855|FG001|Overall Study|Cancel|0|||
130984639|NCT01648348|471569856|FG002|Overall Study|Cancel|0|||
130984640|NCT01648348|471569857|FG003|Overall Study|Cancel|0|||
130984641|NCT01648348|471569858|FG004|Overall Study|Cancel|3|||
130984642|NCT01648348|471569859|FG005|Overall Study|Cancel|6|||
130984643|NCT01648348|471569854|FG000|Overall Study|Replaced for MTD analysis|1|||
130984644|NCT01648348|471569855|FG001|Overall Study|Replaced for MTD analysis|0|||
130984645|NCT01648348|471569856|FG002|Overall Study|Replaced for MTD analysis|1|||
130984646|NCT01648348|471569857|FG003|Overall Study|Replaced for MTD analysis|0|||
130984647|NCT01648348|471569858|FG004|Overall Study|Replaced for MTD analysis|0|||
130984648|NCT01648348|471569859|FG005|Overall Study|Replaced for MTD analysis|0|||
130984649|NCT01951638|471569863|FG000|Treatment Period|Protocol Violation|0|||
130984650|NCT01951638|471569864|FG001|Treatment Period|Protocol Violation|0|||
130984651|NCT01951638|471569865|FG002|Treatment Period|Protocol Violation|0|||
130984652|NCT01951638|471569866|FG003|Treatment Period|Protocol Violation|2|||
130984653|NCT01951638|471569867|FG004|Treatment Period|Protocol Violation|0|||
130984654|NCT01951638|471569863|FG000|Treatment Period|Protocol-driven decision point|1|||
130984655|NCT01951638|471569864|FG001|Treatment Period|Protocol-driven decision point|3|||
130984656|NCT01951638|471569865|FG002|Treatment Period|Protocol-driven decision point|0|||
130984657|NCT01951638|471569866|FG003|Treatment Period|Protocol-driven decision point|0|||
130984658|NCT01951638|471569867|FG004|Treatment Period|Protocol-driven decision point|0|||
130984659|NCT01951638|471569863|FG000|Treatment Period|Logistical difficulties|0|||
130984660|NCT01951638|471569864|FG001|Treatment Period|Logistical difficulties|1|||
130984661|NCT01951638|471569865|FG002|Treatment Period|Logistical difficulties|1|||
130984662|NCT01951638|471569866|FG003|Treatment Period|Logistical difficulties|0|||
130984663|NCT01951638|471569867|FG004|Treatment Period|Logistical difficulties|0|||
130984664|NCT01951638|471569863|FG000|Treatment Period|Withdrawal by Subject|9|||
130984665|NCT01951638|471569864|FG001|Treatment Period|Withdrawal by Subject|6|||
130984666|NCT01951638|471569865|FG002|Treatment Period|Withdrawal by Subject|4|||
130984667|NCT01951638|471569866|FG003|Treatment Period|Withdrawal by Subject|5|||
130984668|NCT01951638|471569867|FG004|Treatment Period|Withdrawal by Subject|4|||
130984669|NCT01951638|471569863|FG000|Treatment Period|Death|0|||
130984670|NCT01951638|471569864|FG001|Treatment Period|Death|0|||
130984671|NCT01951638|471569865|FG002|Treatment Period|Death|0|||
130984672|NCT01951638|471569866|FG003|Treatment Period|Death|3|||
130984673|NCT01951638|471569867|FG004|Treatment Period|Death|1|||
130984674|NCT01951638|471569863|FG000|Treatment Period|Adverse Event|3|||
130984675|NCT01951638|471569864|FG001|Treatment Period|Adverse Event|4|||
130984676|NCT01951638|471569865|FG002|Treatment Period|Adverse Event|8|||
130984677|NCT01951638|471569866|FG003|Treatment Period|Adverse Event|6|||
131045519|NCT02510235|471800866|FG001|Overall Study|Withdrawal by Subject|0|||
131045520|NCT00450216|471800867|FG000|Overall Study|Adverse Event|38|||
131045521|NCT00450216|471800868|FG001|Overall Study|Adverse Event|23|||
131045522|NCT00450216|471800867|FG000|Overall Study|Withdrawal by Subject|48|||
131045523|NCT00450216|471800868|FG001|Overall Study|Withdrawal by Subject|26|||
130984678|NCT01951638|471569867|FG004|Treatment Period|Adverse Event|5|||
130984679|NCT01951638|471569863|FG000|Follow-up Period|Protocol Violation|0|||
130984680|NCT01951638|471569864|FG001|Follow-up Period|Protocol Violation|0|||
130984681|NCT01951638|471569865|FG002|Follow-up Period|Protocol Violation|0|||
130984682|NCT01951638|471569866|FG003|Follow-up Period|Protocol Violation|1|||
130984683|NCT01951638|471569867|FG004|Follow-up Period|Protocol Violation|0|||
130984684|NCT01951638|471569863|FG000|Follow-up Period|Logistical difficulties|0|||
130984685|NCT01951638|471569864|FG001|Follow-up Period|Logistical difficulties|2|||
130984686|NCT01951638|471569865|FG002|Follow-up Period|Logistical difficulties|0|||
131045524|NCT00450216|471800867|FG000|Overall Study|Lost to Follow-up|16|||
130984687|NCT01951638|471569866|FG003|Follow-up Period|Logistical difficulties|0|||
130984688|NCT01951638|471569867|FG004|Follow-up Period|Logistical difficulties|1|||
130984689|NCT01951638|471569863|FG000|Follow-up Period|Withdrawal by Subject|1|||
130984690|NCT01951638|471569864|FG001|Follow-up Period|Withdrawal by Subject|5|||
131045525|NCT00450216|471800868|FG001|Overall Study|Lost to Follow-up|9|||
130720548|NCT04430855|470599802|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
130720549|NCT04430855|470599803|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
130720550|NCT04430855|470599802|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
130720551|NCT04430855|470599803|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
130984691|NCT01951638|471569865|FG002|Follow-up Period|Withdrawal by Subject|2|||
130984692|NCT01951638|471569866|FG003|Follow-up Period|Withdrawal by Subject|1|||
130984693|NCT01951638|471569867|FG004|Follow-up Period|Withdrawal by Subject|2|||
130984694|NCT01951638|471569863|FG000|Follow-up Period|Lost to Follow-up|0|||
130984695|NCT01951638|471569864|FG001|Follow-up Period|Lost to Follow-up|1|||
130984696|NCT01951638|471569865|FG002|Follow-up Period|Lost to Follow-up|0|||
130984697|NCT01951638|471569866|FG003|Follow-up Period|Lost to Follow-up|1|||
130984698|NCT01951638|471569867|FG004|Follow-up Period|Lost to Follow-up|0|||
130984699|NCT01951638|471569863|FG000|Follow-up Period|Death|1|||
130984700|NCT01951638|471569864|FG001|Follow-up Period|Death|0|||
130720552|NCT04430855|470599802|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
130720553|NCT04430855|470599803|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
130720554|NCT04430855|470599802|FG000|Period 1 (Weeks 1-12)|Other|0|||
130720555|NCT04430855|470599803|FG001|Period 1 (Weeks 1-12)|Other|1|||
130720556|NCT04430855|470599802|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
130720557|NCT04430855|470599803|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
130720558|NCT04430855|470599802|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
130720559|NCT04430855|470599803|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
131045526|NCT00450216|471800867|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
131045527|NCT00450216|471800868|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
130984701|NCT01951638|471569865|FG002|Follow-up Period|Death|1|||
130984702|NCT01951638|471569866|FG003|Follow-up Period|Death|4|||
130984703|NCT01951638|471569867|FG004|Follow-up Period|Death|1|||
130984704|NCT01951638|471569863|FG000|Follow-up Period|Adverse Event|0|||
130984705|NCT01951638|471569864|FG001|Follow-up Period|Adverse Event|1|||
130984706|NCT01951638|471569865|FG002|Follow-up Period|Adverse Event|2|||
130984707|NCT01951638|471569866|FG003|Follow-up Period|Adverse Event|1|||
130984708|NCT01951638|471569867|FG004|Follow-up Period|Adverse Event|1|||
130984709|NCT00459342|471569869|FG000|Overall Study|Not eligible|1|||
130984710|NCT00552084|471569870|FG000|Overall Study|Adverse Event|2|||
130984711|NCT00552084|471569871|FG001|Overall Study|Adverse Event|3|||
130984712|NCT00552084|471569870|FG000|Overall Study|Withdrawal by Subject|4|||
130984713|NCT00552084|471569871|FG001|Overall Study|Withdrawal by Subject|5|||
130984714|NCT00552084|471569870|FG000|Overall Study|Protocol Violation|1|||
130984715|NCT00552084|471569871|FG001|Overall Study|Protocol Violation|0|||
130984716|NCT00552084|471569870|FG000|Overall Study|change in anti-arrythmic drug|1|||
130984717|NCT00552084|471569871|FG001|Overall Study|change in anti-arrythmic drug|1|||
130984718|NCT03017079|471569872|FG000|Overall Study|Physician Decision|1|||
130984719|NCT03017079|471569873|FG001|Overall Study|Physician Decision|1|||
130984720|NCT03017079|471569872|FG000|Overall Study|Death|3|||
130984721|NCT03017079|471569873|FG001|Overall Study|Death|2|||
130984722|NCT03017079|471569872|FG000|Overall Study|Lack of Efficacy|2|||
130984723|NCT03017079|471569873|FG001|Overall Study|Lack of Efficacy|2|||
130984724|NCT03017079|471569872|FG000|Overall Study|Protocol Violation|0|||
130984725|NCT03017079|471569873|FG001|Overall Study|Protocol Violation|1|||
130984726|NCT02240108|471571352|FG000|Overall Study|Other than specified|8|||
130984727|NCT02240108|471571353|FG001|Overall Study|Other than specified|6|||
130984728|NCT02240108|471571352|FG000|Overall Study|Adverse Event|1|||
130984729|NCT02240108|471571353|FG001|Overall Study|Adverse Event|9|||
130984730|NCT02240108|471571352|FG000|Overall Study|Pregnancy|1|||
130984731|NCT02240108|471571353|FG001|Overall Study|Pregnancy|0|||
130984732|NCT02240108|471571352|FG000|Overall Study|Withdrawal by Subject|4|||
130984733|NCT02240108|471571353|FG001|Overall Study|Withdrawal by Subject|9|||
130984734|NCT02240108|471571352|FG000|Overall Study|StudyTerminated by Sponsor|0|||
130984735|NCT02240108|471571353|FG001|Overall Study|StudyTerminated by Sponsor|1|||
130984736|NCT01345630|471571354|FG000|Overall Study|Adverse Event|22|||
130720560|NCT04430855|470599802|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
130720561|NCT04430855|470599803|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
130720562|NCT01425723|470599804|FG000|Overall Study|Lack of Efficacy|0|||
130720563|NCT01425723|470599805|FG001|Overall Study|Lack of Efficacy|1|||
130720564|NCT01425723|470599804|FG000|Overall Study|Withdrawal by Subject|1|||
130720565|NCT01425723|470599805|FG001|Overall Study|Withdrawal by Subject|4|||
130984737|NCT01345630|471571355|FG001|Overall Study|Adverse Event|23|||
131045528|NCT00450216|471800867|FG000|Overall Study|misc|21|||
131045529|NCT00450216|471800868|FG001|Overall Study|misc|20|||
130720566|NCT01425723|470599804|FG000|Overall Study|Lost to Follow-up|0|||
130720567|NCT01425723|470599805|FG001|Overall Study|Lost to Follow-up|3|||
130984738|NCT01345630|471571354|FG000|Overall Study|Lost to Follow-up|17|||
130984739|NCT01345630|471571355|FG001|Overall Study|Lost to Follow-up|16|||
130984740|NCT01345630|471571354|FG000|Overall Study|Protocol Violation|4|||
130984741|NCT01345630|471571355|FG001|Overall Study|Protocol Violation|1|||
130984742|NCT01345630|471571354|FG000|Overall Study|Medication error without associated AE|0|||
130984743|NCT01345630|471571355|FG001|Overall Study|Medication error without associated AE|1|||
130720568|NCT01425723|470599804|FG000|Overall Study|Physician Decision|2|||
131045530|NCT03367156|471802222|FG000|Overall Study|Lack of interest|3|||
131045531|NCT03367156|471802223|FG001|Overall Study|Lack of interest|1|||
131045532|NCT03367156|471802222|FG000|Overall Study|Death|2|||
131045533|NCT03367156|471802223|FG001|Overall Study|Death|0|||
131045534|NCT03367156|471802222|FG000|Overall Study|Lost to Follow-up|2|||
131045535|NCT03367156|471802223|FG001|Overall Study|Lost to Follow-up|1|||
131045536|NCT03367156|471802222|FG000|Overall Study|Became ineligible|1|||
131045537|NCT03367156|471802223|FG001|Overall Study|Became ineligible|2|||
131045538|NCT03367156|471802222|FG000|Overall Study|Hospitalization|1|||
131045539|NCT03367156|471802223|FG001|Overall Study|Hospitalization|0|||
131045540|NCT03367156|471802222|FG000|Overall Study|Concerned about Treatment|11|||
131045541|NCT03367156|471802223|FG001|Overall Study|Concerned about Treatment|3|||
131133546|NCT00844753|472115369|FG003|Overall Study|Lost to Follow-up|1|||
130984744|NCT01345630|471571354|FG000|Overall Study|Study terminated by sponsor|254|||
130984745|NCT01345630|471571355|FG001|Overall Study|Study terminated by sponsor|285|||
130984746|NCT01345630|471571354|FG000|Overall Study|Other reasons|6|||
130984747|NCT01345630|471571355|FG001|Overall Study|Other reasons|8|||
130984748|NCT01345630|471571354|FG000|Overall Study|Withdrawn due to pregnancy|1|||
130984749|NCT01345630|471571355|FG001|Overall Study|Withdrawn due to pregnancy|2|||
130984750|NCT01345630|471571354|FG000|Overall Study|No longer willing to participate|9|||
130984751|NCT01345630|471571355|FG001|Overall Study|No longer willing to participate|12|||
130984752|NCT01345630|471571354|FG000|Overall Study|Insufficient clinical response|48|||
130984753|NCT01345630|471571355|FG001|Overall Study|Insufficient clinical response|11|||
130984754|NCT04233372|471571356|FG000|Overall Study|Lost to Follow-up|104|||
130984755|NCT04233372|471571356|FG000|Overall Study|Adverse Event|8|||
130984756|NCT04233372|471571356|FG000|Overall Study|Withdrawal by Subject|2|||
130984757|NCT03938454|471571357|FG000|Overall Study|Protocol Violation|1|||
130984758|NCT03938454|471571357|FG000|Overall Study|Withdrawal by Subject|2|||
130984759|NCT03938454|471571357|FG000|Overall Study|Lost to Follow-up|3|||
130984760|NCT01090310|471571358|FG000|Core Study|Adverse Event|2|||
130984761|NCT01090310|471571359|FG001|Core Study|Adverse Event|2|||
130984762|NCT01090310|471571360|FG002|Core Study|Adverse Event|1|||
130984763|NCT01090310|471571361|FG003|Core Study|Adverse Event|1|||
130984764|NCT01090310|471571358|FG000|Core Study|Subject withdrew consent|0|||
130984765|NCT01090310|471571359|FG001|Core Study|Subject withdrew consent|3|||
130984766|NCT01090310|471571360|FG002|Core Study|Subject withdrew consent|1|||
130984767|NCT01090310|471571361|FG003|Core Study|Subject withdrew consent|1|||
130984768|NCT01090310|471571358|FG000|Core Study|Abnormal test procedure result|0|||
130984769|NCT01090310|471571359|FG001|Core Study|Abnormal test procedure result|0|||
130984770|NCT01090310|471571360|FG002|Core Study|Abnormal test procedure result|1|||
130984771|NCT01090310|471571361|FG003|Core Study|Abnormal test procedure result|0|||
130984772|NCT01090310|471571358|FG000|Core Study|Administrative reasons|5|||
130984773|NCT01090310|471571359|FG001|Core Study|Administrative reasons|6|||
130984774|NCT01090310|471571360|FG002|Core Study|Administrative reasons|4|||
130984775|NCT01090310|471571361|FG003|Core Study|Administrative reasons|4|||
130984776|NCT01090310|471571358|FG000|Core Study|Protocol deviation|1|||
130984777|NCT01090310|471571359|FG001|Core Study|Protocol deviation|0|||
130984778|NCT01090310|471571360|FG002|Core Study|Protocol deviation|0|||
130984779|NCT01090310|471571361|FG003|Core Study|Protocol deviation|1|||
130984780|NCT01090310|471571358|FG000|Extension Study|Aministrative problems|13|||
130984781|NCT01090310|471571359|FG001|Extension Study|Aministrative problems|15|||
130984782|NCT01090310|471571360|FG002|Extension Study|Aministrative problems|14|||
130984783|NCT01090310|471571361|FG003|Extension Study|Aministrative problems|18|||
130984784|NCT01090310|471571358|FG000|Extension Study|Adverse Event|0|||
130984785|NCT01090310|471571359|FG001|Extension Study|Adverse Event|0|||
130984786|NCT01090310|471571360|FG002|Extension Study|Adverse Event|0|||
130984787|NCT01090310|471571361|FG003|Extension Study|Adverse Event|1|||
130984788|NCT01090310|471571358|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
130984789|NCT01090310|471571359|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
130984790|NCT01090310|471571360|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
130984791|NCT01090310|471571361|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
130984792|NCT01090310|471571358|FG000|Extension Study|Subject withdrew consent|0|||
130984793|NCT01090310|471571359|FG001|Extension Study|Subject withdrew consent|1|||
130984794|NCT01090310|471571360|FG002|Extension Study|Subject withdrew consent|0|||
130984795|NCT01090310|471571361|FG003|Extension Study|Subject withdrew consent|0|||
130984796|NCT01142388|471571362|FG000|Overall Study|Lack of Efficacy|21|||
130984797|NCT01142388|471571363|FG001|Overall Study|Lack of Efficacy|31|||
130984798|NCT01142388|471571362|FG000|Overall Study|Adverse Event|9|||
130984799|NCT01142388|471571363|FG001|Overall Study|Adverse Event|5|||
130984800|NCT01142388|471571362|FG000|Overall Study|Death|3|||
131045542|NCT03367156|471802222|FG000|Overall Study|Started new treatment|4|||
130984801|NCT01142388|471571363|FG001|Overall Study|Death|2|||
130984802|NCT01142388|471571362|FG000|Overall Study|Withdrawal by Subject|5|||
130984803|NCT01142388|471571363|FG001|Overall Study|Withdrawal by Subject|3|||
130984804|NCT01142388|471571362|FG000|Overall Study|Alternative therapy|1|||
130984805|NCT01142388|471571363|FG001|Overall Study|Alternative therapy|0|||
131045543|NCT03367156|471802223|FG001|Overall Study|Started new treatment|1|||
131133547|NCT00844753|472115366|FG000|Overall Study|could not swallow medication|2|||
130720569|NCT01425723|470599805|FG001|Overall Study|Physician Decision|0|||
130720570|NCT01425723|470599804|FG000|Overall Study|Other|1|||
130720571|NCT01425723|470599805|FG001|Overall Study|Other|10|||
130720572|NCT00186043|470599806|FG000|Overall Study|Lack of Efficacy|1|||
130720573|NCT00186043|470599807|FG001|Overall Study|Lack of Efficacy|3|||
130720574|NCT00186043|470599806|FG000|Overall Study|Lost to Follow-up|4|||
130720575|NCT00186043|470599807|FG001|Overall Study|Lost to Follow-up|6|||
130720576|NCT00186043|470599806|FG000|Overall Study|Withdrawal by Subject|1|||
130720577|NCT00186043|470599807|FG001|Overall Study|Withdrawal by Subject|0|||
130720578|NCT00186043|470599806|FG000|Overall Study|Adverse Event|7|||
130720579|NCT00186043|470599807|FG001|Overall Study|Adverse Event|3|||
130720580|NCT00186043|470599806|FG000|Overall Study|Protocol Violation|2|||
130720581|NCT00186043|470599807|FG001|Overall Study|Protocol Violation|1|||
130720582|NCT04874636|470599808|FG000|Overall Study|Adverse Event|17|||
130720583|NCT04874636|470599809|FG001|Overall Study|Adverse Event|7|||
130720584|NCT04874636|470599808|FG000|Overall Study|Lost to Follow-up|1|||
130720585|NCT04874636|470599809|FG001|Overall Study|Lost to Follow-up|0|||
130720586|NCT04874636|470599808|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130720587|NCT04874636|470599809|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130720588|NCT04874636|470599808|FG000|Overall Study|Physician Decision|1|||
130720589|NCT04874636|470599809|FG001|Overall Study|Physician Decision|0|||
130720590|NCT04874636|470599808|FG000|Overall Study|Withdrawal by Subject|6|||
130720591|NCT04874636|470599809|FG001|Overall Study|Withdrawal by Subject|5|||
130720592|NCT01770392|470599810|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
130720593|NCT04639713|470599811|FG000|Overall Study|Protocol Noncompliance|2|||
130720594|NCT04639713|470599811|FG000|Overall Study|Withdrawal by Subject|1|||
130720595|NCT03870477|470599820|FG000|Overall Study|Early Study Termination|1|||
130720596|NCT03258853|470599821|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
130720597|NCT03258853|470599822|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
130720598|NCT00871741|470599827|FG000|Overall Study|Premature study termination|9|||
130720599|NCT00871741|470599828|FG001|Overall Study|Premature study termination|7|||
130720600|NCT03433755|470599833|FG000|Overall Study|Lost to Follow-up|1|||
130720601|NCT03433755|470599834|FG001|Overall Study|Lost to Follow-up|0|||
130984806|NCT01142388|471571362|FG000|Overall Study|Other complications|0|||
130984807|NCT01142388|471571363|FG001|Overall Study|Other complications|2|||
130984808|NCT01142388|471571362|FG000|Overall Study|Other|1|||
130984809|NCT01142388|471571363|FG001|Overall Study|Other|1|||
130984810|NCT01142388|471571362|FG000|Overall Study|Never started therapy|7|||
130984811|NCT01142388|471571363|FG001|Overall Study|Never started therapy|3|||
130984812|NCT00695786|471571364|FG000|Overall Study|Adverse Event|0|||
130984813|NCT00695786|471571365|FG001|Overall Study|Adverse Event|3|||
130984814|NCT00695786|471571366|FG002|Overall Study|Adverse Event|4|||
130984815|NCT00695786|471571367|FG003|Overall Study|Adverse Event|2|||
130984816|NCT00695786|471571364|FG000|Overall Study|Lost to Follow-up|0|||
130984817|NCT00695786|471571365|FG001|Overall Study|Lost to Follow-up|5|||
130984818|NCT00695786|471571366|FG002|Overall Study|Lost to Follow-up|1|||
130984819|NCT00695786|471571367|FG003|Overall Study|Lost to Follow-up|1|||
130984820|NCT00695786|471571364|FG000|Overall Study|Withdrawal by Subject|0|||
130984821|NCT00695786|471571365|FG001|Overall Study|Withdrawal by Subject|4|||
130984822|NCT00695786|471571366|FG002|Overall Study|Withdrawal by Subject|3|||
130984823|NCT00695786|471571367|FG003|Overall Study|Withdrawal by Subject|1|||
130984824|NCT00695786|471571364|FG000|Overall Study|Deemed Ineligible|1|||
130984825|NCT00695786|471571365|FG001|Overall Study|Deemed Ineligible|0|||
130984826|NCT00695786|471571366|FG002|Overall Study|Deemed Ineligible|0|||
130984827|NCT00695786|471571367|FG003|Overall Study|Deemed Ineligible|0|||
130984828|NCT00695786|471571364|FG000|Overall Study|Lack of Efficacy|0|||
130984829|NCT00695786|471571365|FG001|Overall Study|Lack of Efficacy|0|||
131133548|NCT00844753|472115367|FG001|Overall Study|could not swallow medication|0|||
130720602|NCT03433755|470599835|FG002|Overall Study|Lost to Follow-up|0|||
130720603|NCT03433755|470599836|FG003|Overall Study|Lost to Follow-up|0|||
130720604|NCT03433755|470599833|FG000|Overall Study|Decision by Sponsor|1|||
130984830|NCT00695786|471571366|FG002|Overall Study|Lack of Efficacy|0|||
130984831|NCT00695786|471571367|FG003|Overall Study|Lack of Efficacy|4|||
130720605|NCT03433755|470599834|FG001|Overall Study|Decision by Sponsor|0|||
130720606|NCT03433755|470599835|FG002|Overall Study|Decision by Sponsor|0|||
130720607|NCT03433755|470599836|FG003|Overall Study|Decision by Sponsor|0|||
130778858|NCT03428100|470817455|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130984832|NCT01364922|471571371|FG000|Open-label (OL) Period|Adverse Event|7|||
130984833|NCT01364922|471571372|FG001|Open-label (OL) Period|Adverse Event|0|||
130984834|NCT01364922|471571373|FG002|Open-label (OL) Period|Adverse Event|0|||
130984835|NCT01364922|471571371|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
130720608|NCT01565850|470599837|FG000|Overall Study|Adverse Event|0|||
130720609|NCT01565850|470599838|FG001|Overall Study|Adverse Event|1|||
130984836|NCT01364922|471571372|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
130720610|NCT01565850|470599837|FG000|Overall Study|Lost to Follow-up|12|||
130720611|NCT01565850|470599838|FG001|Overall Study|Lost to Follow-up|4|||
130984837|NCT01364922|471571373|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
131045544|NCT05507437|471802224|FG000|Overall Study|Withdrawal by Subject|1|||
131045545|NCT05507437|471802225|FG001|Overall Study|Withdrawal by Subject|1|||
131045546|NCT05507437|471802224|FG000|Overall Study|Death|3|||
131045547|NCT05507437|471802225|FG001|Overall Study|Death|0|||
131045548|NCT05247034|471802228|FG000|Overall Study|Lost to Follow-up|3|||
131045549|NCT05247034|471802229|FG001|Overall Study|Lost to Follow-up|2|||
131045550|NCT05247034|471802228|FG000|Overall Study|Organizational problems when attending appointments|1|||
131045551|NCT05247034|471802229|FG001|Overall Study|Organizational problems when attending appointments|0|||
131045552|NCT04464564|471802230|FG000|Period A (Placebo lead-in)|Other|5|||
131045553|NCT04464564|471802231|FG001|Period A (Placebo lead-in)|Other|0|||
131045554|NCT04464564|471802232|FG002|Period A (Placebo lead-in)|Other|0|||
131045555|NCT04464564|471802233|FG003|Period A (Placebo lead-in)|Other|0|||
131045556|NCT04464564|471802230|FG000|Period B (Randomization Period)|Adverse Event|0|||
131045557|NCT04464564|471802231|FG001|Period B (Randomization Period)|Adverse Event|1|||
131045558|NCT04464564|471802232|FG002|Period B (Randomization Period)|Adverse Event|2|||
131045559|NCT04464564|471802233|FG003|Period B (Randomization Period)|Adverse Event|8|||
131045560|NCT04464564|471802230|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
131045561|NCT04464564|471802231|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
131045562|NCT04464564|471802232|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
131045563|NCT04464564|471802233|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
131045564|NCT04464564|471802230|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
131045565|NCT04464564|471802231|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
131045566|NCT04464564|471802232|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
131045567|NCT04464564|471802233|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
131045568|NCT04464564|471802230|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
131045569|NCT04464564|471802231|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
131045570|NCT04464564|471802232|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
131045571|NCT04464564|471802233|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
131045572|NCT04464564|471802230|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
131045573|NCT04464564|471802231|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
131045574|NCT04464564|471802232|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
131045575|NCT04464564|471802233|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
131045576|NCT04464564|471802230|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
131045577|NCT04464564|471802231|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
131045578|NCT04464564|471802232|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
131045579|NCT04464564|471802233|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
131045580|NCT04464564|471802230|FG000|Period B (Randomization Period)|Reason not Specified|0|||
131045581|NCT04464564|471802231|FG001|Period B (Randomization Period)|Reason not Specified|3|||
131045582|NCT04464564|471802232|FG002|Period B (Randomization Period)|Reason not Specified|3|||
131045583|NCT04464564|471802233|FG003|Period B (Randomization Period)|Reason not Specified|3|||
131045584|NCT03505710|471802234|FG000|Overall Study|Progressive Disease|24|||
131045585|NCT03505710|471802235|FG001|Overall Study|Progressive Disease|17|||
131045586|NCT03505710|471802236|FG002|Overall Study|Progressive Disease|43|||
130984838|NCT01364922|471571371|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
130984839|NCT01364922|471571372|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
130984840|NCT01364922|471571373|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
130984841|NCT01364922|471571371|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
130984842|NCT01364922|471571372|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
130984843|NCT01364922|471571373|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
130984844|NCT01364922|471571371|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
130984845|NCT01364922|471571372|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
130984846|NCT01364922|471571373|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
130984847|NCT01364922|471571371|FG000|Open-label (OL) Period|Other, Unspecified|1|||
130984848|NCT01364922|471571372|FG001|Open-label (OL) Period|Other, Unspecified|0|||
130984849|NCT01364922|471571373|FG002|Open-label (OL) Period|Other, Unspecified|0|||
130984850|NCT01364922|471571371|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
130984851|NCT01364922|471571372|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
130984852|NCT01364922|471571373|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
130984853|NCT01364922|471571371|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
130984854|NCT01364922|471571372|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
130984855|NCT01364922|471571373|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
130984856|NCT01364922|471571371|FG000|Double-Blind (DB) Period|Adverse Event|0|||
130984857|NCT01364922|471571372|FG001|Double-Blind (DB) Period|Adverse Event|0|||
130984858|NCT01364922|471571373|FG002|Double-Blind (DB) Period|Adverse Event|1|||
130984859|NCT01364922|471571371|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
130984860|NCT01364922|471571372|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
130984861|NCT01364922|471571373|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
130984862|NCT04244396|471571374|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
130984863|NCT04244396|471571374|FG000|Overall Study|Withdrawal by Subject|2|||
131045587|NCT03505710|471802234|FG000|Overall Study|Clinical Progression|6|||
130720612|NCT01565850|470599837|FG000|Overall Study|Investigator's Discretion|2|||
130720613|NCT01565850|470599838|FG001|Overall Study|Investigator's Discretion|1|||
130720614|NCT01565850|470599837|FG000|Overall Study|Participant noncompliance|2|||
130720615|NCT01565850|470599838|FG001|Overall Study|Participant noncompliance|0|||
130720616|NCT01565850|470599837|FG000|Overall Study|Withdrew Consent|4|||
130720617|NCT01565850|470599838|FG001|Overall Study|Withdrew Consent|2|||
130720618|NCT04941729|470601476|FG000|Overall Study|Death|0|||
130720619|NCT04941729|470601477|FG001|Overall Study|Death|1|||
130720620|NCT04941729|470601476|FG000|Overall Study|Study terminated by sponsor|11|||
130720621|NCT04941729|470601477|FG001|Overall Study|Study terminated by sponsor|10|||
130720622|NCT04994483|470601478|FG000|Overall Study|Adverse Event|26|||
130720623|NCT04994483|470601479|FG001|Overall Study|Adverse Event|17|||
130720624|NCT04994483|470601478|FG000|Overall Study|Lost to Follow-up|6|||
130720625|NCT04994483|470601479|FG001|Overall Study|Lost to Follow-up|10|||
130720626|NCT04994483|470601478|FG000|Overall Study|Noncompliance with study drug|8|||
130720627|NCT04994483|470601479|FG001|Overall Study|Noncompliance with study drug|5|||
130720628|NCT04994483|470601478|FG000|Overall Study|Physician Decision|5|||
130720629|NCT04994483|470601479|FG001|Overall Study|Physician Decision|0|||
130720630|NCT04994483|470601478|FG000|Overall Study|Withdrawal by Subject|41|||
130720631|NCT04994483|470601479|FG001|Overall Study|Withdrawal by Subject|38|||
130720632|NCT04994483|470601478|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
130720633|NCT04994483|470601479|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
130720634|NCT04994483|470601478|FG000|Overall Study|Met stopping criteria|1|||
130720635|NCT04994483|470601479|FG001|Overall Study|Met stopping criteria|0|||
130720636|NCT04994483|470601478|FG000|Overall Study|Randomized in error, not treated|4|||
130720637|NCT04994483|470601479|FG001|Overall Study|Randomized in error, not treated|3|||
130984864|NCT04244396|471571374|FG000|Overall Study|Study termination|37|||
130984865|NCT01787097|471571375|FG000|Overall Study|Withdrawal by Subject|1|||
130984866|NCT01787097|471571376|FG001|Overall Study|Withdrawal by Subject|0|||
130984867|NCT01787097|471571377|FG002|Overall Study|Withdrawal by Subject|0|||
130984868|NCT01787097|471571378|FG003|Overall Study|Withdrawal by Subject|0|||
130984869|NCT00553501|471571385|FG000|Overall Study|Adverse Event|2|||
130984870|NCT00553501|471571385|FG000|Overall Study|Death|1|||
130984871|NCT00553501|471571385|FG000|Overall Study|Progression|1|||
130984872|NCT02293395|471571386|FG000|Overall Study|Lost to Follow-up|1|||
130984873|NCT02293395|471571387|FG001|Overall Study|Lost to Follow-up|0|||
130984874|NCT02293395|471571386|FG000|Overall Study|Withdrawal by Subject|8|||
130984875|NCT02293395|471571387|FG001|Overall Study|Withdrawal by Subject|7|||
130984876|NCT01464021|471571390|FG000|Overall Study|Withdrawal by Subject|13|||
130984877|NCT01464021|471571390|FG000|Overall Study|Lost to Follow-up|1|||
130984878|NCT01464021|471571390|FG000|Overall Study|Lack of Efficacy|1|||
130984879|NCT01464021|471571390|FG000|Overall Study|various|11|||
130984880|NCT00861614|471571391|FG000|Overall Study|Disease Progression|182|||
130984881|NCT00861614|471571392|FG001|Overall Study|Disease Progression|263|||
130984882|NCT00861614|471571391|FG000|Overall Study|Study Drug Toxicity|79|||
130984883|NCT00861614|471571392|FG001|Overall Study|Study Drug Toxicity|6|||
130984884|NCT00861614|471571391|FG000|Overall Study|Death|32|||
130984885|NCT00861614|471571392|FG001|Overall Study|Death|19|||
130984886|NCT00861614|471571391|FG000|Overall Study|Adverse Event|27|||
130984887|NCT00861614|471571392|FG001|Overall Study|Adverse Event|23|||
130984888|NCT00861614|471571391|FG000|Overall Study|Withdrawal by Subject|34|||
130984889|NCT00861614|471571392|FG001|Overall Study|Withdrawal by Subject|35|||
130984890|NCT00861614|471571391|FG000|Overall Study|Other|17|||
130984891|NCT00861614|471571392|FG001|Overall Study|Other|22|||
130984892|NCT03391765|471571393|FG000|Overall Study|Adverse Event|2|||
130984893|NCT03391765|471571394|FG001|Overall Study|Adverse Event|0|||
130984894|NCT03391765|471571395|FG002|Overall Study|Adverse Event|0|||
130984895|NCT03391765|471571396|FG003|Overall Study|Adverse Event|2|||
130984896|NCT03391765|471571393|FG000|Overall Study|Withdrew consent|5|||
130984897|NCT03391765|471571394|FG001|Overall Study|Withdrew consent|7|||
130984898|NCT03391765|471571395|FG002|Overall Study|Withdrew consent|2|||
130984899|NCT03391765|471571396|FG003|Overall Study|Withdrew consent|5|||
130984900|NCT03391765|471571393|FG000|Overall Study|Other, not specified|44|||
130984901|NCT03391765|471571394|FG001|Overall Study|Other, not specified|38|||
130984902|NCT03391765|471571395|FG002|Overall Study|Other, not specified|21|||
130984903|NCT03391765|471571396|FG003|Overall Study|Other, not specified|16|||
130984904|NCT00944658|471571397|FG000|Treatment 12 Weeks|Adverse Event|0|||
130984905|NCT00944658|471571398|FG001|Treatment 12 Weeks|Adverse Event|2|||
130984906|NCT01289418|471571402|FG000|Day 8 Survey|email address invalid|283|||
130984907|NCT01289418|471571402|FG000|Day 8 Survey|participants did not complete the survey|1935|||
130984908|NCT01289418|471571402|FG000|Day 29 Survey|email address invalid|283|||
130984909|NCT01289418|471571402|FG000|Day 29 Survey|participants did not complete the survey|2185|||
130984910|NCT02832622|471571408|FG000|Overall Study|MPP not programmed|1259|||
130984911|NCT02832622|471571408|FG000|Overall Study|Withdrawal by Subject|123|||
130984912|NCT02832622|471571408|FG000|Overall Study|Death|119|||
130984913|NCT02832622|471571408|FG000|Overall Study|Unsuccessful CRT implant|93|||
131133549|NCT00844753|472115368|FG002|Overall Study|could not swallow medication|0|||
130984914|NCT02832622|471571408|FG000|Overall Study|Lost to Follow-up|45|||
130984915|NCT02832622|471571408|FG000|Overall Study|Patient non-compliance|42|||
130984916|NCT02832622|471571408|FG000|Overall Study|Withdrawal by other reasons|25|||
130984917|NCT02832622|471571408|FG000|Overall Study|System explant|24|||
130984918|NCT02832622|471571408|FG000|Overall Study|Physician Decision|6|||
130984919|NCT02472652|471571409|FG000|Overall Study|Lost to Follow-up|1|||
130984920|NCT00998400|471571414|FG000|Overall Study|Lack of interest/motivation|1|||
130984921|NCT00998400|471571415|FG001|Overall Study|Lack of interest/motivation|2|||
130984922|NCT00998400|471571414|FG000|Overall Study|Logistical problems|1|||
130984923|NCT00998400|471571415|FG001|Overall Study|Logistical problems|0|||
130984924|NCT03185832|471571416|FG000|Overall Study|Death|9|||
130984925|NCT03185832|471571417|FG001|Overall Study|Death|14|||
130984926|NCT03185832|471571418|FG002|Overall Study|Death|9|||
130984927|NCT03185832|471571419|FG003|Overall Study|Death|7|||
130984928|NCT03185832|471571416|FG000|Overall Study|Withdrawn - vital status available|0|||
130984929|NCT03185832|471571417|FG001|Overall Study|Withdrawn - vital status available|1|||
130984930|NCT03185832|471571418|FG002|Overall Study|Withdrawn - vital status available|1|||
130984931|NCT03185832|471571419|FG003|Overall Study|Withdrawn - vital status available|4|||
130984932|NCT01083641|471571420|FG000|Overall Study|Withdrawal by Subject|2|||
130984933|NCT03386032|471571421|FG000|Overall Study|Lack of Efficacy|6|||
130984934|NCT03386032|471571422|FG001|Overall Study|Lack of Efficacy|2|||
130984935|NCT03386032|471571423|FG002|Overall Study|Lack of Efficacy|0|||
130984936|NCT03386032|471571421|FG000|Overall Study|Adverse Event|2|||
130984937|NCT03386032|471571422|FG001|Overall Study|Adverse Event|2|||
130984938|NCT03386032|471571423|FG002|Overall Study|Adverse Event|0|||
130984939|NCT03386032|471571421|FG000|Overall Study|Withdrawal by Subject|1|||
130984940|NCT03386032|471571422|FG001|Overall Study|Withdrawal by Subject|0|||
130984941|NCT03386032|471571423|FG002|Overall Study|Withdrawal by Subject|0|||
130984942|NCT03386032|471571421|FG000|Overall Study|Lost to Follow-up|9|||
130984943|NCT03386032|471571422|FG001|Overall Study|Lost to Follow-up|3|||
130984944|NCT03386032|471571423|FG002|Overall Study|Lost to Follow-up|0|||
130984945|NCT01807156|471571424|FG000|Overall Study|Physician Decision|1|||
130984946|NCT01493687|471571431|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
130984947|NCT01493687|471571432|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
130984948|NCT01493687|471571431|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
130984949|NCT01493687|471571432|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
130984950|NCT01493687|471571431|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
130984951|NCT01493687|471571432|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
130984952|NCT01493687|471571431|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
130984953|NCT01493687|471571432|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
130984954|NCT01493687|471571431|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
130984955|NCT01493687|471571432|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
130984956|NCT01493687|471571431|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
130984957|NCT01493687|471571432|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
130984958|NCT01493687|471571431|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
130984959|NCT01493687|471571432|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
130984960|NCT01493687|471571431|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
130984961|NCT01493687|471571432|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
130984962|NCT01493687|471571431|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
130984963|NCT01493687|471571432|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
130984964|NCT01493687|471571431|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
130984965|NCT01493687|471571432|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
130984966|NCT01493687|471571431|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
130984967|NCT01493687|471571432|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
130984968|NCT01493687|471571431|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
130984969|NCT01493687|471571432|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
130984970|NCT01493687|471571431|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
130984971|NCT01493687|471571432|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
130984972|NCT01493687|471571431|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
130984973|NCT01493687|471571432|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
130984974|NCT01493687|471571431|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
130984975|NCT01493687|471571432|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
130984976|NCT02364180|471571436|FG000|Overall Study|Screen Fail|1|||
130984977|NCT02323646|471571437|FG000|Treatment Course 1|Adverse Event|1|||
130984978|NCT02323646|471571438|FG001|Treatment Course 1|Adverse Event|0|||
130984979|NCT02323646|471571439|FG002|Treatment Course 1|Adverse Event|1|||
130984980|NCT02323646|471571437|FG000|Treatment Course 1|Heavy Bleeding|1|||
130984981|NCT02323646|471571438|FG001|Treatment Course 1|Heavy Bleeding|1|||
130984982|NCT02323646|471571439|FG002|Treatment Course 1|Heavy Bleeding|0|||
130984983|NCT02323646|471571437|FG000|Treatment Course 1|Lost to Follow-up|1|||
130984984|NCT02323646|471571438|FG001|Treatment Course 1|Lost to Follow-up|0|||
130984985|NCT02323646|471571439|FG002|Treatment Course 1|Lost to Follow-up|2|||
130984986|NCT02323646|471571437|FG000|Treatment Course 1|Withdrawal by Subject|0|||
130984987|NCT02323646|471571438|FG001|Treatment Course 1|Withdrawal by Subject|2|||
130984988|NCT02323646|471571439|FG002|Treatment Course 1|Withdrawal by Subject|0|||
130984989|NCT02323646|471571437|FG000|Treatment Course 2|Adverse Event|1|||
130984990|NCT02323646|471571438|FG001|Treatment Course 2|Adverse Event|0|||
130984991|NCT02323646|471571439|FG002|Treatment Course 2|Adverse Event|1|||
130984992|NCT02323646|471571437|FG000|Treatment Course 2|Lost to Follow-up|0|||
130984993|NCT02323646|471571438|FG001|Treatment Course 2|Lost to Follow-up|0|||
130984994|NCT02323646|471571439|FG002|Treatment Course 2|Lost to Follow-up|1|||
130984995|NCT02323646|471571437|FG000|Treatment Course 2|Non-compliance|0|||
130984996|NCT02323646|471571438|FG001|Treatment Course 2|Non-compliance|1|||
130984997|NCT02323646|471571439|FG002|Treatment Course 2|Non-compliance|1|||
130984998|NCT00521144|471571440|FG000|Overall Study|Not Treated|0|||
130984999|NCT00521144|471571441|FG001|Overall Study|Not Treated|0|||
130985000|NCT00521144|471571442|FG002|Overall Study|Not Treated|0|||
130985001|NCT00521144|471571443|FG003|Overall Study|Not Treated|1|||
130985002|NCT00521144|471571444|FG004|Overall Study|Not Treated|0|||
130985003|NCT00521144|471571440|FG000|Overall Study|Adverse Event|0|||
130985004|NCT00521144|471571441|FG001|Overall Study|Adverse Event|1|||
130985005|NCT00521144|471571442|FG002|Overall Study|Adverse Event|0|||
130985006|NCT00521144|471571443|FG003|Overall Study|Adverse Event|0|||
130985007|NCT00521144|471571444|FG004|Overall Study|Adverse Event|1|||
130985008|NCT00521144|471571440|FG000|Overall Study|Progressive Disease|4|||
130985009|NCT00521144|471571441|FG001|Overall Study|Progressive Disease|2|||
130985010|NCT00521144|471571442|FG002|Overall Study|Progressive Disease|2|||
130985011|NCT00521144|471571443|FG003|Overall Study|Progressive Disease|0|||
130985012|NCT00521144|471571444|FG004|Overall Study|Progressive Disease|6|||
130985013|NCT01370525|471571445|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
130985014|NCT01370525|471571446|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
130985015|NCT01370525|471571445|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130985016|NCT01370525|471571446|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130985017|NCT01370525|471571445|FG000|Overall Study|Adverse Event|0|||
130985018|NCT01370525|471571446|FG001|Overall Study|Adverse Event|1|||
130985019|NCT01370525|471571445|FG000|Overall Study|Protocol Violation|2|||
130985020|NCT01370525|471571446|FG001|Overall Study|Protocol Violation|1|||
130985021|NCT01370525|471571445|FG000|Overall Study|Lost to follow up|2|||
130985022|NCT01370525|471571446|FG001|Overall Study|Lost to follow up|6|||
130985023|NCT01059643|471571455|FG000|Overall Study|Adverse Event|3|||
130985024|NCT01059643|471571455|FG000|Overall Study|Withdrawal by Subject|2|||
130985025|NCT01059643|471571455|FG000|Overall Study|Physician Decision|1|||
130985026|NCT00106184|471571457|FG000|Overall Study|Withdrawal by Subject|3|||
130985027|NCT00106184|471571458|FG001|Overall Study|Withdrawal by Subject|2|||
130985028|NCT02313909|471571459|FG000|Overall Study|Consent withdrawn by participant|33|||
130985029|NCT02313909|471571460|FG001|Overall Study|Consent withdrawn by participant|33|||
130985030|NCT02313909|471571459|FG000|Overall Study|Lost to Follow-up|24|||
130985031|NCT02313909|471571460|FG001|Overall Study|Lost to Follow-up|17|||
130985032|NCT02923739|471571466|FG000|Overall Study|Withdrawal by Subject|2|||
130985033|NCT02923739|471571467|FG001|Overall Study|Withdrawal by Subject|0|||
130985034|NCT02923739|471571468|FG002|Overall Study|Withdrawal by Subject|0|||
130985035|NCT02923739|471571469|FG003|Overall Study|Withdrawal by Subject|0|||
130985036|NCT02923739|471571466|FG000|Overall Study|Failed Screening|3|||
130985037|NCT02923739|471571467|FG001|Overall Study|Failed Screening|0|||
130985038|NCT02923739|471571468|FG002|Overall Study|Failed Screening|0|||
130985039|NCT02923739|471571469|FG003|Overall Study|Failed Screening|0|||
130985040|NCT00409682|471571477|FG000|Open-label Induction Period|Adverse Event|1|||
130985041|NCT00409682|471571478|FG001|Open-label Induction Period|Adverse Event|0|||
130985042|NCT00409682|471571479|FG002|Open-label Induction Period|Adverse Event|0|||
131045588|NCT03505710|471802235|FG001|Overall Study|Clinical Progression|8|||
131045589|NCT03505710|471802236|FG002|Overall Study|Clinical Progression|3|||
131045590|NCT03505710|471802234|FG000|Overall Study|Adverse Event|12|||
131045591|NCT03505710|471802235|FG001|Overall Study|Adverse Event|6|||
131045592|NCT03505710|471802236|FG002|Overall Study|Adverse Event|28|||
131045593|NCT03505710|471802234|FG000|Overall Study|Withdrawal by Subject|1|||
131045594|NCT03505710|471802235|FG001|Overall Study|Withdrawal by Subject|3|||
131045595|NCT03505710|471802236|FG002|Overall Study|Withdrawal by Subject|7|||
130985043|NCT00409682|471571477|FG000|Open-label Induction Period|Lack of Efficacy|1|||
130985044|NCT00409682|471571478|FG001|Open-label Induction Period|Lack of Efficacy|0|||
130985045|NCT00409682|471571479|FG002|Open-label Induction Period|Lack of Efficacy|0|||
130985046|NCT00409682|471571477|FG000|Open-label Induction Period|Protocol Violation|1|||
130985047|NCT00409682|471571478|FG001|Open-label Induction Period|Protocol Violation|0|||
130985048|NCT00409682|471571479|FG002|Open-label Induction Period|Protocol Violation|0|||
130985049|NCT00409682|471571477|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
130985050|NCT00409682|471571478|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
131045596|NCT03505710|471802234|FG000|Overall Study|Physician Decision|1|||
130985051|NCT00409682|471571479|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
131045597|NCT03505710|471802235|FG001|Overall Study|Physician Decision|1|||
130985052|NCT00409682|471571477|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
130985053|NCT00409682|471571478|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
130985054|NCT00409682|471571479|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
130985055|NCT00409682|471571477|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
130985056|NCT00409682|471571478|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
130985057|NCT00409682|471571479|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
130985058|NCT00409682|471571477|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
130985059|NCT00409682|471571478|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
130985060|NCT00409682|471571479|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
130985061|NCT00409682|471571477|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
130985062|NCT00409682|471571478|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
130985063|NCT00409682|471571479|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
130985064|NCT00409682|471571477|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
130985065|NCT00409682|471571478|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
130985066|NCT00409682|471571479|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
130985067|NCT00409682|471571477|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
130985068|NCT00409682|471571478|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
130985069|NCT00409682|471571479|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
130985070|NCT01896869|471571482|FG000|Overall Study|Withdrawal by Subject|0|||
130985071|NCT01896869|471571483|FG001|Overall Study|Withdrawal by Subject|6|||
130985072|NCT01896869|471571482|FG000|Overall Study|Lost to Follow-up|1|||
130985073|NCT01896869|471571483|FG001|Overall Study|Lost to Follow-up|0|||
130985074|NCT03494166|471571491|FG000|Overall Study|Death|0|||
130985075|NCT03494166|471571492|FG001|Overall Study|Death|0|||
130985076|NCT03494166|471571493|FG002|Overall Study|Death|0|||
130985077|NCT03494166|471571494|FG003|Overall Study|Death|1|||
130985078|NCT03494166|471571495|FG004|Overall Study|Death|3|||
130985079|NCT03494166|471571496|FG005|Overall Study|Death|0|||
130985080|NCT03494166|471571491|FG000|Overall Study|Lost to Follow-up|2|||
130985081|NCT03494166|471571492|FG001|Overall Study|Lost to Follow-up|2|||
130985082|NCT03494166|471571493|FG002|Overall Study|Lost to Follow-up|2|||
130985083|NCT03494166|471571494|FG003|Overall Study|Lost to Follow-up|2|||
130985084|NCT03494166|471571495|FG004|Overall Study|Lost to Follow-up|14|||
130985085|NCT03494166|471571496|FG005|Overall Study|Lost to Follow-up|0|||
130985086|NCT03494166|471571491|FG000|Overall Study|Withdrawal by Subject|10|||
130985087|NCT03494166|471571492|FG001|Overall Study|Withdrawal by Subject|7|||
130985088|NCT03494166|471571493|FG002|Overall Study|Withdrawal by Subject|0|||
130985089|NCT03494166|471571494|FG003|Overall Study|Withdrawal by Subject|5|||
130985090|NCT03494166|471571495|FG004|Overall Study|Withdrawal by Subject|3|||
130985091|NCT03494166|471571496|FG005|Overall Study|Withdrawal by Subject|17|||
130985092|NCT03494166|471571491|FG000|Overall Study|Screen failure|1|||
130985093|NCT03494166|471571492|FG001|Overall Study|Screen failure|0|||
130985094|NCT03494166|471571493|FG002|Overall Study|Screen failure|0|||
130985095|NCT03494166|471571494|FG003|Overall Study|Screen failure|0|||
130985096|NCT03494166|471571495|FG004|Overall Study|Screen failure|1|||
130985097|NCT03494166|471571496|FG005|Overall Study|Screen failure|0|||
130985098|NCT03138733|471571497|FG000|Overall Study|Death|17|||
130985099|NCT03138733|471571498|FG001|Overall Study|Death|18|||
130985100|NCT03138733|471571497|FG000|Overall Study|Withdrawal by Subject|11|||
130985101|NCT03138733|471571498|FG001|Overall Study|Withdrawal by Subject|6|||
130985102|NCT03138733|471571497|FG000|Overall Study|Lost to Follow-up|3|||
130985103|NCT03138733|471571498|FG001|Overall Study|Lost to Follow-up|2|||
130985104|NCT03138733|471571497|FG000|Overall Study|Adverse Event|1|||
130985105|NCT03138733|471571498|FG001|Overall Study|Adverse Event|0|||
130985106|NCT03138733|471571497|FG000|Overall Study|Protocol Violation|1|||
130985107|NCT03138733|471571498|FG001|Overall Study|Protocol Violation|3|||
130985108|NCT03138733|471571497|FG000|Overall Study|Administrative or logistical reason|1|||
130985109|NCT03138733|471571498|FG001|Overall Study|Administrative or logistical reason|0|||
130985110|NCT03138733|471571497|FG000|Overall Study|The patient was transferred to another hospital|1|||
130985111|NCT03138733|471571498|FG001|Overall Study|The patient was transferred to another hospital|0|||
130985112|NCT04252742|471571501|FG000|Overall Study|Decision by sponsor|0|||
130985113|NCT04252742|471571502|FG001|Overall Study|Decision by sponsor|2|||
130985114|NCT04252742|471571501|FG000|Overall Study|Withdrawal by Subject|15|||
130985115|NCT04252742|471571502|FG001|Overall Study|Withdrawal by Subject|9|||
130985116|NCT04252742|471571501|FG000|Overall Study|Lost to Follow-up|0|||
130985117|NCT04252742|471571502|FG001|Overall Study|Lost to Follow-up|1|||
130985118|NCT02220894|471571503|FG000|Overall Study|Adverse Event|127|||
131133550|NCT00844753|472115369|FG003|Overall Study|could not swallow medication|0|||
131133551|NCT00844753|472115366|FG000|Overall Study|Withdrawal by Subject|1|||
130985119|NCT02220894|471571504|FG001|Overall Study|Adverse Event|74|||
130985120|NCT02220894|471571503|FG000|Overall Study|Death|418|||
130985121|NCT02220894|471571504|FG001|Overall Study|Death|508|||
130985122|NCT02220894|471571503|FG000|Overall Study|Lost to Follow-up|0|||
130985123|NCT02220894|471571504|FG001|Overall Study|Lost to Follow-up|4|||
130985124|NCT02220894|471571503|FG000|Overall Study|Site Terminated by Sponsor|2|||
130985125|NCT02220894|471571504|FG001|Overall Study|Site Terminated by Sponsor|0|||
130985126|NCT02220894|471571503|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
130985127|NCT02220894|471571504|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
130985128|NCT02220894|471571503|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130985129|NCT02220894|471571504|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130985130|NCT02220894|471571503|FG000|Overall Study|Withdrawal by Subject|10|||
130985131|NCT02220894|471571504|FG001|Overall Study|Withdrawal by Subject|9|||
130985132|NCT00500903|471571507|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
130985133|NCT00500903|471571508|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
130985134|NCT00500903|471571509|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
130985135|NCT00500903|471571507|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
130985136|NCT00500903|471571508|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
130985137|NCT00500903|471571509|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130985138|NCT00500903|471571507|FG000|Overall Study|Progressive Disease|41|||
130985139|NCT00500903|471571508|FG001|Overall Study|Progressive Disease|2|||
130985140|NCT00500903|471571509|FG002|Overall Study|Progressive Disease|15|||
130985141|NCT00500903|471571507|FG000|Overall Study|Patient Declined Further Treatment|0|||
130985142|NCT00500903|471571508|FG001|Overall Study|Patient Declined Further Treatment|0|||
130985143|NCT00500903|471571509|FG002|Overall Study|Patient Declined Further Treatment|3|||
130985144|NCT00500903|471571507|FG000|Overall Study|Symptomatic Deterioration|2|||
130985145|NCT00500903|471571508|FG001|Overall Study|Symptomatic Deterioration|0|||
130985146|NCT00500903|471571509|FG002|Overall Study|Symptomatic Deterioration|0|||
130985147|NCT00500903|471571507|FG000|Overall Study|Reason Not Specified|10|||
130985148|NCT00500903|471571508|FG001|Overall Study|Reason Not Specified|0|||
130985149|NCT00500903|471571509|FG002|Overall Study|Reason Not Specified|2|||
130985150|NCT00696410|471571510|FG000|Overall Study|Lost to Follow-up|2|||
130985151|NCT00696410|471571511|FG001|Overall Study|Lost to Follow-up|0|||
130985152|NCT00696410|471571510|FG000|Overall Study|Withdrawal by Subject|8|||
130985153|NCT00696410|471571511|FG001|Overall Study|Withdrawal by Subject|0|||
130985154|NCT00696410|471571510|FG000|Overall Study|Physician Decision|3|||
130985155|NCT00696410|471571511|FG001|Overall Study|Physician Decision|0|||
130985156|NCT02618616|471571512|FG000|Overall Study|Lack of Efficacy|4|||
130985157|NCT02618616|471571513|FG001|Overall Study|Lack of Efficacy|0|||
130985158|NCT02618616|471571512|FG000|Overall Study|Pregnancy|0|||
130985159|NCT02618616|471571513|FG001|Overall Study|Pregnancy|1|||
130985160|NCT02618616|471571512|FG000|Overall Study|Adverse Event|8|||
130985161|NCT02618616|471571513|FG001|Overall Study|Adverse Event|0|||
130985162|NCT02618616|471571512|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
130985163|NCT02618616|471571513|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
130985164|NCT02618616|471571512|FG000|Overall Study|Consent withdrawn by subject|8|||
130985165|NCT02618616|471571513|FG001|Overall Study|Consent withdrawn by subject|5|||
130985166|NCT02618616|471571512|FG000|Overall Study|Lost to Follow-up|0|||
130985167|NCT02618616|471571513|FG001|Overall Study|Lost to Follow-up|1|||
130985168|NCT02686034|471571515|FG000|Run-In Period 1|Eligibility|12|||
130985169|NCT02686034|471571516|FG001|Run-In Period 1|Eligibility|10|||
130985170|NCT02686034|471571515|FG000|Run-In Period 1|Withdrawal by Subject|4|||
130985171|NCT02686034|471571516|FG001|Run-In Period 1|Withdrawal by Subject|3|||
130985172|NCT02686034|471571515|FG000|Run-In Period 1|Lost to Follow-up|4|||
130985173|NCT02686034|471571516|FG001|Run-In Period 1|Lost to Follow-up|4|||
130985174|NCT02686034|471571515|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
130985175|NCT02686034|471571516|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
130985176|NCT02686034|471571515|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
130985177|NCT02686034|471571516|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
130985178|NCT02686034|471571515|FG000|Randomized Controlled Period 2|Adverse Event|0|||
130985179|NCT02686034|471571516|FG001|Randomized Controlled Period 2|Adverse Event|2|||
130985180|NCT02686034|471571515|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
130985181|NCT02686034|471571516|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
130985182|NCT02686034|471571515|FG000|Open Label Period 3|Lost to Follow-up|0|||
130985183|NCT02686034|471571516|FG001|Open Label Period 3|Lost to Follow-up|1|||
130985184|NCT03538951|471571517|FG000|Overall Study|Withdrawal by Subject|1|||
130985185|NCT03538951|471571518|FG001|Overall Study|Withdrawal by Subject|2|||
130985186|NCT00949715|471572809|FG000|Overall Study|Physician Decision|1|||
130985187|NCT00949715|471572810|FG001|Overall Study|Physician Decision|0|||
130985188|NCT00949715|471572809|FG000|Overall Study|Lost to Follow-up|1|||
130985189|NCT00949715|471572810|FG001|Overall Study|Lost to Follow-up|0|||
130985190|NCT00949715|471572809|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
130985191|NCT00949715|471572810|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
130985192|NCT01352585|471572811|FG000|Overall Study|Adverse Event|2|||
130985193|NCT01352585|471572812|FG001|Overall Study|Adverse Event|1|||
130985194|NCT01352585|471572811|FG000|Overall Study|Lost to Follow-up|1|||
130985195|NCT01352585|471572812|FG001|Overall Study|Lost to Follow-up|0|||
131133552|NCT00844753|472115367|FG001|Overall Study|Withdrawal by Subject|0|||
131133553|NCT00844753|472115368|FG002|Overall Study|Withdrawal by Subject|0|||
131133554|NCT00844753|472115369|FG003|Overall Study|Withdrawal by Subject|3|||
131133555|NCT03595553|472115371|FG000|Overall Study|Withdrawal by Subject|20|||
130720638|NCT04994483|470601478|FG000|Overall Study|Lack of a reliable study partner|0|||
130720639|NCT04994483|470601479|FG001|Overall Study|Lack of a reliable study partner|1|||
130720640|NCT04994483|470601478|FG000|Overall Study|Met MRI exclusion criteria|0|||
130720641|NCT04994483|470601479|FG001|Overall Study|Met MRI exclusion criteria|1|||
130720642|NCT01200992|470601480|FG000|Overall Study|Study terminated early|35|||
130720643|NCT01200992|470601481|FG001|Overall Study|Study terminated early|41|||
130720644|NCT01200992|470601480|FG000|Overall Study|Randomized but not treated|2|||
130720645|NCT01200992|470601481|FG001|Overall Study|Randomized but not treated|0|||
130720646|NCT00191113|470601490|FG000|Core Study|Withdrawal by Subject|25|||
130720647|NCT00191113|470601491|FG001|Core Study|Withdrawal by Subject|9|||
130720648|NCT00191113|470601490|FG000|Core Study|Protocol Violation|6|||
130720649|NCT00191113|470601491|FG001|Core Study|Protocol Violation|2|||
130720650|NCT00191113|470601490|FG000|Core Study|Lost to Follow-up|3|||
130720651|NCT00191113|470601491|FG001|Core Study|Lost to Follow-up|0|||
130720652|NCT00191113|470601490|FG000|Core Study|Adverse Event|0|||
130720653|NCT00191113|470601491|FG001|Core Study|Adverse Event|2|||
130720654|NCT00191113|470601490|FG000|Core Study|Lack of Efficacy|0|||
130720655|NCT00191113|470601491|FG001|Core Study|Lack of Efficacy|2|||
130720656|NCT00191113|470601490|FG000|Core Study|Death|1|||
130985196|NCT01352585|471572811|FG000|Overall Study|Other|5|||
130985197|NCT01352585|471572812|FG001|Overall Study|Other|2|||
130985198|NCT05050578|471572815|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
130985199|NCT05050578|471572816|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
130985200|NCT05050578|471572815|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
130985201|NCT05050578|471572816|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
130985202|NCT05050578|471572815|FG000|Period 2, 30 Days|Protocol Violation|0|||
130985203|NCT05050578|471572816|FG001|Period 2, 30 Days|Protocol Violation|1|||
130985204|NCT02243280|471572817|FG000|Treated|Adverse Event|1|||
130720657|NCT00191113|470601491|FG001|Core Study|Death|0|||
130720658|NCT00368979|470601497|FG000|Overall Study|Adverse Event|9|||
130720659|NCT00368979|470601498|FG001|Overall Study|Adverse Event|16|||
130720660|NCT00368979|470601497|FG000|Overall Study|Lack of Efficacy|5|||
130720661|NCT00368979|470601498|FG001|Overall Study|Lack of Efficacy|3|||
130720662|NCT00368979|470601497|FG000|Overall Study|Other|3|||
130720663|NCT00368979|470601498|FG001|Overall Study|Other|1|||
130720664|NCT00368979|470601497|FG000|Overall Study|Lost to Follow-up|1|||
130720665|NCT00368979|470601498|FG001|Overall Study|Lost to Follow-up|0|||
130720666|NCT00368979|470601497|FG000|Overall Study|Protocol Violation|2|||
130720667|NCT00368979|470601498|FG001|Overall Study|Protocol Violation|1|||
130720668|NCT00368979|470601497|FG000|Overall Study|Withdrawal by Subject|5|||
130720669|NCT00368979|470601498|FG001|Overall Study|Withdrawal by Subject|9|||
130720670|NCT00631657|470601501|FG000|6-Month Treatment Period|Adverse Event|47|||
130720671|NCT00631657|470601502|FG001|6-Month Treatment Period|Adverse Event|0|||
130720672|NCT00631657|470601503|FG002|6-Month Treatment Period|Adverse Event|7|||
130720673|NCT00631657|470601501|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
130720674|NCT00631657|470601502|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
130720675|NCT00631657|470601503|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
130720676|NCT00631657|470601501|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
130720677|NCT00631657|470601502|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
130720678|NCT00631657|470601503|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
130720679|NCT00631657|470601501|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
130720680|NCT00631657|470601502|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
130720681|NCT00631657|470601503|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
130720682|NCT00631657|470601501|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
130720683|NCT00631657|470601502|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
130720684|NCT00631657|470601503|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
130720685|NCT00631657|470601501|FG000|6-Month Treatment Period|Other|16|||
130985205|NCT02243280|471572818|FG001|Treated|Adverse Event|0|||
130985206|NCT02243280|471572819|FG002|Treated|Adverse Event|0|||
130985207|NCT02243280|471572820|FG003|Treated|Adverse Event|0|||
130720686|NCT00631657|470601502|FG001|6-Month Treatment Period|Other|0|||
131045598|NCT03505710|471802236|FG002|Overall Study|Physician Decision|2|||
130720687|NCT00631657|470601503|FG002|6-Month Treatment Period|Other|4|||
131045599|NCT03505710|471802234|FG000|Overall Study|Death|4|||
130720688|NCT00631657|470601501|FG000|6-Month Treatment Period|Not Treated|2|||
130720689|NCT00631657|470601502|FG001|6-Month Treatment Period|Not Treated|0|||
130720690|NCT00631657|470601503|FG002|6-Month Treatment Period|Not Treated|1|||
130720691|NCT00631657|470601501|FG000|7-Day Discontinuation Period|Not Treated|1|||
130720692|NCT00631657|470601502|FG001|7-Day Discontinuation Period|Not Treated|1|||
130720693|NCT00631657|470601503|FG002|7-Day Discontinuation Period|Not Treated|1|||
130985208|NCT02243280|471572821|FG004|Treated|Adverse Event|0|||
131045600|NCT03505710|471802235|FG001|Overall Study|Death|5|||
130720694|NCT00631657|470601501|FG000|7-Day Discontinuation Period|Other|1|||
130720695|NCT00631657|470601502|FG001|7-Day Discontinuation Period|Other|0|||
130720696|NCT00631657|470601503|FG002|7-Day Discontinuation Period|Other|0|||
130720697|NCT00325195|470601504|FG000|Randomized|Not dosed|5|||
130985209|NCT02243280|471572822|FG005|Treated|Adverse Event|0|||
130985210|NCT02243280|471572823|FG006|Treated|Adverse Event|0|||
131045601|NCT03505710|471802236|FG002|Overall Study|Death|6|||
130985211|NCT02243280|471572824|FG007|Treated|Adverse Event|0|||
130985212|NCT02243280|471572825|FG008|Treated|Adverse Event|0|||
130985213|NCT02243280|471572826|FG009|Treated|Adverse Event|0|||
130985214|NCT02243280|471572827|FG010|Treated|Adverse Event|1|||
130985215|NCT02243280|471572817|FG000|Treated|Lost to Follow-up|0|||
130985216|NCT02243280|471572818|FG001|Treated|Lost to Follow-up|0|||
130985217|NCT02243280|471572819|FG002|Treated|Lost to Follow-up|0|||
130985218|NCT02243280|471572820|FG003|Treated|Lost to Follow-up|0|||
130985219|NCT02243280|471572821|FG004|Treated|Lost to Follow-up|0|||
130985220|NCT02243280|471572822|FG005|Treated|Lost to Follow-up|0|||
130985221|NCT02243280|471572823|FG006|Treated|Lost to Follow-up|0|||
130985222|NCT02243280|471572824|FG007|Treated|Lost to Follow-up|0|||
130985223|NCT02243280|471572825|FG008|Treated|Lost to Follow-up|1|||
130985224|NCT02243280|471572826|FG009|Treated|Lost to Follow-up|0|||
130985225|NCT02243280|471572827|FG010|Treated|Lost to Follow-up|2|||
130985226|NCT03928028|471572828|FG000|Overall Study|Physician Decision|9|||
130985227|NCT03928028|471572829|FG001|Overall Study|Physician Decision|6|||
130985228|NCT03928028|471572830|FG002|Overall Study|Physician Decision|3|||
130985229|NCT03928028|471572828|FG000|Overall Study|Withdrawal by Subject|12|||
130985230|NCT03928028|471572829|FG001|Overall Study|Withdrawal by Subject|3|||
130985231|NCT03928028|471572830|FG002|Overall Study|Withdrawal by Subject|3|||
130985232|NCT04525547|471572831|FG000|Overall Study|Not treated with Ofev|2|||
130985233|NCT04525547|471572831|FG000|Overall Study|Off-label use|2|||
130985234|NCT04525547|471572831|FG000|Overall Study|Lost to Follow-up|1|||
130985235|NCT03122119|471572832|FG000|Overall Study|Did not meet eligibility critria|1|||
130985236|NCT00800202|471572833|FG000|Overall Study|Adverse Event|7|||
130985237|NCT00800202|471572834|FG001|Overall Study|Adverse Event|6|||
130985238|NCT00800202|471572833|FG000|Overall Study|Death|1|||
130985239|NCT00800202|471572834|FG001|Overall Study|Death|0|||
130985240|NCT00800202|471572833|FG000|Overall Study|Other|5|||
130985241|NCT00800202|471572834|FG001|Overall Study|Other|0|||
130985242|NCT00800202|471572833|FG000|Overall Study|Disease Progression|54|||
130985243|NCT00800202|471572834|FG001|Overall Study|Disease Progression|18|||
130985244|NCT04425902|471572835|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
130985245|NCT02940574|471572841|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
130985246|NCT02940574|471572842|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
130985247|NCT02940574|471572841|FG000|1-year Follow-up|Lost to Follow-up|3|||
130985248|NCT02940574|471572842|FG001|1-year Follow-up|Lost to Follow-up|4|||
130985249|NCT00387894|471572843|FG000|Overall Study|Withdrawal by Subject|1|||
130985250|NCT02421666|471572844|FG000|6-month Follow-up|Lost to Follow-up|8|||
130985251|NCT02421666|471572845|FG001|6-month Follow-up|Lost to Follow-up|7|||
130985252|NCT02421666|471572844|FG000|6-month Follow-up|Withdrawal by Subject|5|||
130985253|NCT02421666|471572845|FG001|6-month Follow-up|Withdrawal by Subject|6|||
130985254|NCT02421666|471572844|FG000|12-month Follow-up|Lost to Follow-up|5|||
130985255|NCT02421666|471572845|FG001|12-month Follow-up|Lost to Follow-up|5|||
130985256|NCT02421666|471572844|FG000|12-month Follow-up|Withdrawal by Subject|6|||
130985257|NCT02421666|471572845|FG001|12-month Follow-up|Withdrawal by Subject|11|||
130985258|NCT01119768|471572850|FG000|Treatment Period|Lack of Efficacy|18|||
130985259|NCT01119768|471572851|FG001|Treatment Period|Lack of Efficacy|25|||
130985260|NCT00643123|471572867|FG000|Overall Study|Lost to Follow-up|4|||
130985261|NCT00643123|471572868|FG001|Overall Study|Lost to Follow-up|0|||
130985262|NCT00643123|471572867|FG000|Overall Study|Withdrawal by Subject|1|||
130985263|NCT00643123|471572868|FG001|Overall Study|Withdrawal by Subject|1|||
131045602|NCT03505710|471802234|FG000|Overall Study|Other Reasons|1|||
131045603|NCT03505710|471802235|FG001|Overall Study|Other Reasons|1|||
131045604|NCT03505710|471802236|FG002|Overall Study|Other Reasons|1|||
131045605|NCT03505710|471802234|FG000|Overall Study|Study Terminated by Sponsor|0|||
131045606|NCT03505710|471802235|FG001|Overall Study|Study Terminated by Sponsor|0|||
131045607|NCT03505710|471802236|FG002|Overall Study|Study Terminated by Sponsor|1|||
131045608|NCT00942877|471802240|FG000|Overall Study|Refused further treatment|1|||
131045609|NCT00942877|471802241|FG001|Overall Study|Refused further treatment|1|||
131045610|NCT00942877|471802240|FG000|Overall Study|Patient was not treated|1|||
131045611|NCT00942877|471802241|FG001|Overall Study|Patient was not treated|0|||
131045612|NCT00942877|471802240|FG000|Overall Study|Adverse Event|1|||
131045613|NCT00942877|471802241|FG001|Overall Study|Adverse Event|0|||
131045614|NCT00942877|471802240|FG000|Overall Study|Progressive disease|42|||
131045615|NCT00942877|471802241|FG001|Overall Study|Progressive disease|3|||
131045616|NCT02782676|471802243|FG000|Overall Study|Lost to Follow-up|0|||
131045617|NCT02782676|471802244|FG001|Overall Study|Lost to Follow-up|1|||
130985264|NCT01591382|471572873|FG000|Overall Study|Discharged Prior to Study Completion|2|||
130985265|NCT01591382|471572874|FG001|Overall Study|Discharged Prior to Study Completion|1|||
130985266|NCT01591382|471572873|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
130985267|NCT01591382|471572874|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
130985268|NCT00855062|471572875|FG000|Step1|Early Study Closure|5|||
130985269|NCT00855062|471572876|FG001|Step1|Early Study Closure|7|||
131045618|NCT03334695|471802245|FG000|Overall Study|Lost to Follow-up|3|||
131045619|NCT03334695|471802246|FG001|Overall Study|Lost to Follow-up|3|||
131045620|NCT03334695|471802245|FG000|Overall Study|Physician Decision|1|||
130985270|NCT00855062|471572875|FG000|Step1|Adverse Event|1|||
130985271|NCT00855062|471572876|FG001|Step1|Adverse Event|1|||
130985272|NCT00855062|471572875|FG000|Step1|Protocol Violation|1|||
130985273|NCT00855062|471572876|FG001|Step1|Protocol Violation|0|||
130985274|NCT00855062|471572875|FG000|Step1|Pregnancy|1|||
130985275|NCT00855062|471572876|FG001|Step1|Pregnancy|0|||
130985276|NCT00855062|471572875|FG000|Step1|Withdrawal by Subject|2|||
130985277|NCT00855062|471572876|FG001|Step1|Withdrawal by Subject|3|||
130985278|NCT00855062|471572875|FG000|Step2|Early Study Closure|6|||
130985279|NCT00855062|471572876|FG001|Step2|Early Study Closure|2|||
130985280|NCT00855062|471572875|FG000|Step2|Adverse Event|0|||
130985281|NCT00855062|471572876|FG001|Step2|Adverse Event|3|||
130985282|NCT00855062|471572875|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
130985283|NCT00855062|471572876|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
130985284|NCT01960725|471572877|FG000|Overall Study|Lost to Follow-up|4|||
130985285|NCT01960725|471572878|FG001|Overall Study|Lost to Follow-up|3|||
130985286|NCT01960725|471572877|FG000|Overall Study|Withdrawal by Subject|1|||
130985287|NCT01960725|471572878|FG001|Overall Study|Withdrawal by Subject|0|||
130985288|NCT01960725|471572877|FG000|Overall Study|unable to obtain blood sample|1|||
130985289|NCT01960725|471572878|FG001|Overall Study|unable to obtain blood sample|2|||
130985290|NCT02110901|471572879|FG000|Overall Study|Death|6|||
130985291|NCT02110901|471572880|FG001|Overall Study|Death|3|||
130985292|NCT02110901|471572879|FG000|Overall Study|Lost to Follow-up|12|||
130985293|NCT02110901|471572880|FG001|Overall Study|Lost to Follow-up|8|||
130985294|NCT02110901|471572879|FG000|Overall Study|Withdrawal by Subject|7|||
130985295|NCT02110901|471572880|FG001|Overall Study|Withdrawal by Subject|3|||
130985296|NCT02110901|471572879|FG000|Overall Study|received a kidney transplant|5|||
130985297|NCT02110901|471572880|FG001|Overall Study|received a kidney transplant|0|||
130985298|NCT02634788|471572881|FG000|Overall Study|Adverse Event|0|||
130985299|NCT02634788|471572882|FG001|Overall Study|Adverse Event|8|||
130985300|NCT02634788|471572883|FG002|Overall Study|Adverse Event|3|||
130985301|NCT02634788|471572884|FG003|Overall Study|Adverse Event|1|||
130985302|NCT02634788|471572881|FG000|Overall Study|Lack of Efficacy|4|||
130985303|NCT02634788|471572882|FG001|Overall Study|Lack of Efficacy|0|||
130985304|NCT02634788|471572883|FG002|Overall Study|Lack of Efficacy|1|||
130985305|NCT02634788|471572884|FG003|Overall Study|Lack of Efficacy|4|||
130985306|NCT02634788|471572881|FG000|Overall Study|Lost to Follow-up|0|||
130985307|NCT02634788|471572882|FG001|Overall Study|Lost to Follow-up|1|||
130985308|NCT02634788|471572883|FG002|Overall Study|Lost to Follow-up|0|||
130985309|NCT02634788|471572884|FG003|Overall Study|Lost to Follow-up|0|||
130985310|NCT02634788|471572881|FG000|Overall Study|Withdrawal by Subject|0|||
130985311|NCT02634788|471572882|FG001|Overall Study|Withdrawal by Subject|1|||
130985312|NCT02634788|471572883|FG002|Overall Study|Withdrawal by Subject|1|||
130985313|NCT02634788|471572884|FG003|Overall Study|Withdrawal by Subject|0|||
130985314|NCT00758459|471572885|FG000|Overall Study|Adverse Event|3|||
130985315|NCT00758459|471572886|FG001|Overall Study|Adverse Event|2|||
130985316|NCT00758459|471572885|FG000|Overall Study|Protocol Violation|0|||
130985317|NCT00758459|471572886|FG001|Overall Study|Protocol Violation|1|||
130985318|NCT00758459|471572885|FG000|Overall Study|Withdrawal by Subject|0|||
130985319|NCT00758459|471572886|FG001|Overall Study|Withdrawal by Subject|1|||
130985320|NCT02496767|471572901|FG000|Open-label Lead-in Phase|Adverse Event|176|||
130985321|NCT02496767|471572902|FG001|Open-label Lead-in Phase|Adverse Event|0|||
130985322|NCT02496767|471572903|FG002|Open-label Lead-in Phase|Adverse Event|0|||
130985323|NCT02496767|471572904|FG003|Open-label Lead-in Phase|Adverse Event|0|||
130985324|NCT02496767|471572905|FG004|Open-label Lead-in Phase|Adverse Event|0|||
130985325|NCT02496767|471572906|FG005|Open-label Lead-in Phase|Adverse Event|0|||
130985326|NCT02496767|471572907|FG006|Open-label Lead-in Phase|Adverse Event|0|||
130985327|NCT02496767|471572908|FG007|Open-label Lead-in Phase|Adverse Event|0|||
130985328|NCT02496767|471572901|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
130985329|NCT02496767|471572902|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
130985330|NCT02496767|471572903|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
130985331|NCT02496767|471572904|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
130985332|NCT02496767|471572905|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
130985333|NCT02496767|471572906|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
130985334|NCT02496767|471572907|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
131045621|NCT03334695|471802246|FG001|Overall Study|Physician Decision|2|||
131045622|NCT03334695|471802245|FG000|Overall Study|Protocol Violation|0|||
131045623|NCT03334695|471802246|FG001|Overall Study|Protocol Violation|1|||
131045624|NCT02641730|471802247|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
131045625|NCT02641730|471802248|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131045626|NCT02641730|471802249|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
131045627|NCT02641730|471802250|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
131045628|NCT02641730|471802251|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
131045629|NCT02641730|471802247|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
130985335|NCT02496767|471572908|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
130985336|NCT02496767|471572901|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
131045630|NCT02641730|471802248|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
131045631|NCT02641730|471802249|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
131045632|NCT02641730|471802250|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
131045633|NCT02641730|471802251|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
131045634|NCT02641730|471802247|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
131045635|NCT02641730|471802248|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
131045636|NCT02641730|471802249|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
131045637|NCT02641730|471802250|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
131045638|NCT02641730|471802251|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
131045639|NCT02641730|471802247|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131045640|NCT02641730|471802248|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131045641|NCT02641730|471802249|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
131045642|NCT02641730|471802250|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
131045643|NCT02641730|471802251|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
131045644|NCT02641730|471802247|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
131045645|NCT02641730|471802248|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
131045646|NCT02641730|471802249|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
131045647|NCT02641730|471802250|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
131045648|NCT02641730|471802251|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
131045649|NCT02641730|471802247|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
131045650|NCT02641730|471802248|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
131045651|NCT02641730|471802249|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
131045652|NCT02641730|471802250|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
131045653|NCT02641730|471802251|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
131045654|NCT02874742|471802252|FG000|Overall Study|Death|0|||
131045655|NCT02874742|471802253|FG001|Overall Study|Death|1|||
131045656|NCT02874742|471802254|FG002|Overall Study|Death|0|||
131045657|NCT02874742|471802252|FG000|Overall Study|Lost to Follow-up|5|||
131045658|NCT02874742|471802253|FG001|Overall Study|Lost to Follow-up|4|||
131045659|NCT02874742|471802254|FG002|Overall Study|Lost to Follow-up|1|||
131045660|NCT02874742|471802252|FG000|Overall Study|Withdrawal by Subject|17|||
131045661|NCT02874742|471802253|FG001|Overall Study|Withdrawal by Subject|8|||
131045662|NCT02874742|471802254|FG002|Overall Study|Withdrawal by Subject|0|||
131045663|NCT02874742|471802252|FG000|Overall Study|Other|4|||
131045664|NCT02874742|471802253|FG001|Overall Study|Other|1|||
131045665|NCT02874742|471802254|FG002|Overall Study|Other|0|||
131045666|NCT02874742|471802252|FG000|Overall Study|Progressive Disease|1|||
131045667|NCT02874742|471802253|FG001|Overall Study|Progressive Disease|0|||
131045668|NCT02874742|471802254|FG002|Overall Study|Progressive Disease|0|||
131045669|NCT02874742|471802252|FG000|Overall Study|Screen Failure|0|||
131045670|NCT02874742|471802253|FG001|Overall Study|Screen Failure|2|||
131045671|NCT02874742|471802254|FG002|Overall Study|Screen Failure|0|||
131045672|NCT02326974|471802259|FG000|Overall Study|Withdrawal by Subject|2|||
131045673|NCT02326974|471802259|FG000|Overall Study|failed heterogenity evaluation|5|||
131045674|NCT04173247|471802260|FG000|Overall Study|Withdrawal by Subject|0|||
131045675|NCT04173247|471802261|FG001|Overall Study|Withdrawal by Subject|2|||
131045676|NCT04173247|471802260|FG000|Overall Study|Death|1|||
131045677|NCT04173247|471802261|FG001|Overall Study|Death|0|||
131045678|NCT04173247|471802260|FG000|Overall Study|Physician Decision|1|||
131045679|NCT04173247|471802261|FG001|Overall Study|Physician Decision|0|||
131045680|NCT04924400|471802269|FG000|Overall Study|Lost to Follow-up|3|||
131045681|NCT04924400|471802270|FG001|Overall Study|Lost to Follow-up|0|||
131045682|NCT04424316|471802271|FG000|Overall Study|Adverse Event|0|||
131045683|NCT04424316|471802272|FG001|Overall Study|Adverse Event|1|||
131045684|NCT04424316|471802273|FG002|Overall Study|Adverse Event|0|||
131045685|NCT04424316|471802274|FG003|Overall Study|Adverse Event|0|||
131045686|NCT04424316|471802271|FG000|Overall Study|Death|1|||
131045687|NCT04424316|471802272|FG001|Overall Study|Death|0|||
131045688|NCT04424316|471802273|FG002|Overall Study|Death|8|||
131045689|NCT04424316|471802274|FG003|Overall Study|Death|14|||
131045690|NCT04424316|471802271|FG000|Overall Study|Lost to Follow-up|93|||
131045691|NCT04424316|471802272|FG001|Overall Study|Lost to Follow-up|88|||
131045692|NCT04424316|471802273|FG002|Overall Study|Lost to Follow-up|224|||
131045693|NCT04424316|471802274|FG003|Overall Study|Lost to Follow-up|211|||
131045694|NCT04424316|471802271|FG000|Overall Study|No longer met eligibility criteria|1|||
131045695|NCT04424316|471802272|FG001|Overall Study|No longer met eligibility criteria|0|||
131045696|NCT04424316|471802273|FG002|Overall Study|No longer met eligibility criteria|0|||
131045697|NCT04424316|471802274|FG003|Overall Study|No longer met eligibility criteria|0|||
131045698|NCT04424316|471802271|FG000|Overall Study|Other|15|||
131045699|NCT04424316|471802272|FG001|Overall Study|Other|11|||
131045700|NCT04424316|471802273|FG002|Overall Study|Other|34|||
131045701|NCT04424316|471802274|FG003|Overall Study|Other|45|||
131045702|NCT04424316|471802271|FG000|Overall Study|Physician Decision|1|||
131045703|NCT04424316|471802272|FG001|Overall Study|Physician Decision|0|||
131045704|NCT04424316|471802273|FG002|Overall Study|Physician Decision|1|||
131045705|NCT04424316|471802274|FG003|Overall Study|Physician Decision|1|||
131045706|NCT04424316|471802271|FG000|Overall Study|Protocol Violation|0|||
131045707|NCT04424316|471802272|FG001|Overall Study|Protocol Violation|1|||
130720698|NCT00325195|470601505|FG001|Randomized|Not dosed|5|||
130720699|NCT00325195|470601506|FG002|Randomized|Not dosed|3|||
130720700|NCT00325195|470601504|FG000|Received Intervention: ITT Population|Adverse Event|15|||
130720701|NCT00325195|470601505|FG001|Received Intervention: ITT Population|Adverse Event|17|||
130720702|NCT00325195|470601506|FG002|Received Intervention: ITT Population|Adverse Event|1|||
130720703|NCT00325195|470601504|FG000|Received Intervention: ITT Population|Death|3|||
130985337|NCT02496767|471572902|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
130985338|NCT02496767|471572903|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
130985339|NCT02496767|471572904|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
130985340|NCT02496767|471572905|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
130985341|NCT02496767|471572906|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
130985342|NCT02496767|471572907|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
130985343|NCT02496767|471572908|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
130985344|NCT02496767|471572901|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
130985345|NCT02496767|471572902|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
130985346|NCT02496767|471572903|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
130985347|NCT02496767|471572904|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
130985348|NCT02496767|471572905|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
130985349|NCT02496767|471572906|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
130985350|NCT02496767|471572907|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
130985351|NCT02496767|471572908|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
130985352|NCT02496767|471572901|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
130985353|NCT02496767|471572902|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
130985354|NCT02496767|471572903|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
130985355|NCT02496767|471572904|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
130985356|NCT02496767|471572905|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
130985357|NCT02496767|471572906|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
130985358|NCT02496767|471572907|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
130985359|NCT02496767|471572908|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
130985360|NCT02496767|471572901|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
130985361|NCT02496767|471572902|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
130985362|NCT02496767|471572903|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
130985363|NCT02496767|471572904|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
130985364|NCT02496767|471572905|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
130985365|NCT02496767|471572906|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
130985366|NCT02496767|471572907|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
130985367|NCT02496767|471572908|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
131045708|NCT04424316|471802273|FG002|Overall Study|Protocol Violation|0|||
131045709|NCT04424316|471802274|FG003|Overall Study|Protocol Violation|0|||
131045710|NCT04424316|471802271|FG000|Overall Study|Withdrawal by Subject|71|||
131045711|NCT04424316|471802272|FG001|Overall Study|Withdrawal by Subject|77|||
130720704|NCT00325195|470601505|FG001|Received Intervention: ITT Population|Death|1|||
130720705|NCT00325195|470601506|FG002|Received Intervention: ITT Population|Death|0|||
130720706|NCT00325195|470601504|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
130720707|NCT00325195|470601505|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
130720708|NCT00325195|470601506|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
130720709|NCT00325195|470601504|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
130720710|NCT00325195|470601505|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
130720711|NCT00325195|470601506|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
130720712|NCT00325195|470601504|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
130720713|NCT00325195|470601505|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
130720714|NCT00325195|470601506|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
130720715|NCT01716715|470601507|FG000|Overall Study|Never Treated|2|||
130720716|NCT01716715|470601508|FG001|Overall Study|Never Treated|4|||
130720717|NCT04228783|470601509|FG000|Overall Study|Adverse Event|1|||
130720718|NCT04228783|470601510|FG001|Overall Study|Adverse Event|0|||
130720719|NCT04228783|470601511|FG002|Overall Study|Adverse Event|2|||
130720720|NCT04228783|470601512|FG003|Overall Study|Adverse Event|0|||
131045712|NCT04424316|471802273|FG002|Overall Study|Withdrawal by Subject|0|||
131045713|NCT04424316|471802274|FG003|Overall Study|Withdrawal by Subject|0|||
131045714|NCT04424316|471802271|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130985368|NCT02496767|471572901|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
130985369|NCT02496767|471572902|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
131045715|NCT04424316|471802272|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130720721|NCT04228783|470601513|FG004|Overall Study|Adverse Event|0|||
130720722|NCT04228783|470601514|FG005|Overall Study|Adverse Event|1|||
130720723|NCT04228783|470601509|FG000|Overall Study|Death|0|||
130720724|NCT04228783|470601510|FG001|Overall Study|Death|0|||
130720725|NCT04228783|470601511|FG002|Overall Study|Death|0|||
131133556|NCT03595553|472115372|FG001|Overall Study|Withdrawal by Subject|8|||
131133557|NCT03595553|472115371|FG000|Overall Study|Physician Decision|3|||
131133558|NCT03595553|472115372|FG001|Overall Study|Physician Decision|2|||
131133559|NCT03595553|472115371|FG000|Overall Study|Adverse Event|2|||
131133560|NCT03595553|472115372|FG001|Overall Study|Adverse Event|5|||
131133561|NCT03595553|472115371|FG000|Overall Study|Death|24|||
131133562|NCT03595553|472115372|FG001|Overall Study|Death|22|||
131133563|NCT03595553|472115371|FG000|Overall Study|Lost to Follow-up|6|||
131133564|NCT03595553|472115372|FG001|Overall Study|Lost to Follow-up|7|||
131133565|NCT03595553|472115371|FG000|Overall Study|Other as indicated in CSR|3|||
131133566|NCT03595553|472115372|FG001|Overall Study|Other as indicated in CSR|3|||
131133567|NCT03595553|472115371|FG000|Overall Study|Sponsor Decision|0|||
131133568|NCT03595553|472115372|FG001|Overall Study|Sponsor Decision|1|||
131133569|NCT01437397|472115373|FG000|Overall Study|Lost to Follow-up|9|||
131133570|NCT01437397|472115374|FG001|Overall Study|Lost to Follow-up|4|||
131133571|NCT01437397|472115375|FG002|Overall Study|Lost to Follow-up|2|||
131133572|NCT01437397|472115376|FG003|Overall Study|Lost to Follow-up|4|||
131133573|NCT01437397|472115377|FG004|Overall Study|Lost to Follow-up|5|||
131133574|NCT01437397|472115373|FG000|Overall Study|Withdrawal by Subject|11|||
131133575|NCT01437397|472115374|FG001|Overall Study|Withdrawal by Subject|12|||
131133576|NCT01437397|472115375|FG002|Overall Study|Withdrawal by Subject|24|||
131133577|NCT01437397|472115376|FG003|Overall Study|Withdrawal by Subject|11|||
131133578|NCT01437397|472115377|FG004|Overall Study|Withdrawal by Subject|22|||
131133579|NCT01437397|472115373|FG000|Overall Study|Protocol Violation|10|||
131133580|NCT01437397|472115374|FG001|Overall Study|Protocol Violation|12|||
131133581|NCT01437397|472115375|FG002|Overall Study|Protocol Violation|13|||
131133582|NCT01437397|472115376|FG003|Overall Study|Protocol Violation|21|||
131133583|NCT01437397|472115377|FG004|Overall Study|Protocol Violation|19|||
131133584|NCT01437397|472115373|FG000|Overall Study|Lack of Efficacy|5|||
131133585|NCT01437397|472115374|FG001|Overall Study|Lack of Efficacy|4|||
131133586|NCT01437397|472115375|FG002|Overall Study|Lack of Efficacy|8|||
131133587|NCT01437397|472115376|FG003|Overall Study|Lack of Efficacy|10|||
131133588|NCT01437397|472115377|FG004|Overall Study|Lack of Efficacy|20|||
131133589|NCT01437397|472115373|FG000|Overall Study|Adverse Event|21|||
131133590|NCT01437397|472115374|FG001|Overall Study|Adverse Event|22|||
131133591|NCT01437397|472115375|FG002|Overall Study|Adverse Event|16|||
131133592|NCT01437397|472115376|FG003|Overall Study|Adverse Event|14|||
131133593|NCT01437397|472115377|FG004|Overall Study|Adverse Event|21|||
131133594|NCT01437397|472115373|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
131133595|NCT01437397|472115374|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
130720726|NCT04228783|470601512|FG003|Overall Study|Death|0|||
130720727|NCT04228783|470601513|FG004|Overall Study|Death|1|||
130720728|NCT04228783|470601514|FG005|Overall Study|Death|0|||
130720729|NCT04228783|470601509|FG000|Overall Study|Lost to Follow-up|36|||
130720730|NCT04228783|470601510|FG001|Overall Study|Lost to Follow-up|36|||
130720731|NCT04228783|470601511|FG002|Overall Study|Lost to Follow-up|28|||
130720732|NCT04228783|470601512|FG003|Overall Study|Lost to Follow-up|6|||
130985370|NCT02496767|471572903|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
130985371|NCT02496767|471572904|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
130985372|NCT02496767|471572905|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
130985373|NCT02496767|471572906|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
130985374|NCT02496767|471572907|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
130985375|NCT02496767|471572908|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
130985376|NCT02496767|471572901|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130985377|NCT02496767|471572902|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
130985378|NCT02496767|471572903|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
130985379|NCT02496767|471572904|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
130985380|NCT02496767|471572905|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
130985381|NCT02496767|471572906|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130985382|NCT02496767|471572907|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130985383|NCT02496767|471572908|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130985384|NCT02496767|471572901|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
131133596|NCT01437397|472115375|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
131133597|NCT01437397|472115376|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
131133598|NCT01437397|472115377|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
131133599|NCT01687712|472115380|FG000|Cycle 1|Not Biochemically Pregnant|386|||
131133600|NCT01687712|472115381|FG001|Cycle 1|Not Biochemically Pregnant|348|||
131133601|NCT01687712|472115380|FG000|Cycle 1|Early Pregnancy Loss|43|||
131133602|NCT01687712|472115381|FG001|Cycle 1|Early Pregnancy Loss|60|||
131133603|NCT01687712|472115380|FG000|Cycle 1|Ectopic Pregnancy|5|||
131133604|NCT01687712|472115381|FG001|Cycle 1|Ectopic Pregnancy|5|||
131133605|NCT01687712|472115380|FG000|Cycle 1|Heterotropic Pregnancy|1|||
131133606|NCT01687712|472115381|FG001|Cycle 1|Heterotropic Pregnancy|0|||
131133607|NCT01687712|472115380|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
130720733|NCT04228783|470601513|FG004|Overall Study|Lost to Follow-up|14|||
130720734|NCT04228783|470601514|FG005|Overall Study|Lost to Follow-up|3|||
131045716|NCT04424316|471802273|FG002|Overall Study|Withdrawal by parent/guardian|74|||
131045717|NCT04424316|471802274|FG003|Overall Study|Withdrawal by parent/guardian|81|||
131045718|NCT04424316|471802271|FG000|Overall Study|Randomized but not vaccinated|13|||
131045719|NCT04424316|471802272|FG001|Overall Study|Randomized but not vaccinated|21|||
131045720|NCT04424316|471802273|FG002|Overall Study|Randomized but not vaccinated|0|||
131045721|NCT04424316|471802274|FG003|Overall Study|Randomized but not vaccinated|0|||
131045722|NCT04424316|471802271|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
131045723|NCT04424316|471802272|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
131045724|NCT04424316|471802273|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
131045725|NCT04424316|471802274|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
131045726|NCT00412607|471802275|FG000|Overall Study|Withdrawal by Subject|9|||
131045727|NCT00412607|471802275|FG000|Overall Study|Lost to Follow-up|19|||
131045728|NCT00412607|471802275|FG000|Overall Study|Death|61|||
131045729|NCT00412607|471802275|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
131045730|NCT05070741|471802276|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
131045731|NCT03582033|471802278|FG000|Part A|Other|0|||
131045732|NCT03582033|471802279|FG001|Part A|Other|0|||
131045733|NCT03582033|471802280|FG002|Part A|Other|0|||
131045734|NCT03582033|471802281|FG003|Part A|Other|0|||
131045735|NCT03582033|471802282|FG004|Part A|Other|2|||
131045736|NCT03582033|471802283|FG005|Part A|Other|0|||
131045737|NCT03582033|471802284|FG006|Part A|Other|0|||
131045738|NCT03582033|471802285|FG007|Part A|Other|0|||
131045739|NCT03582033|471802286|FG008|Part A|Other|0|||
131045740|NCT03582033|471802287|FG009|Part A|Other|0|||
131045741|NCT03582033|471802278|FG000|Part A|Death|1|||
131045742|NCT03582033|471802279|FG001|Part A|Death|1|||
131045743|NCT03582033|471802280|FG002|Part A|Death|2|||
131045744|NCT03582033|471802281|FG003|Part A|Death|4|||
131045745|NCT03582033|471802282|FG004|Part A|Death|11|||
131045746|NCT03582033|471802283|FG005|Part A|Death|0|||
131045747|NCT03582033|471802284|FG006|Part A|Death|0|||
131045748|NCT03582033|471802285|FG007|Part A|Death|0|||
131045749|NCT03582033|471802286|FG008|Part A|Death|0|||
131045750|NCT03582033|471802287|FG009|Part A|Death|0|||
131045751|NCT03582033|471802278|FG000|Part A|Lost to Follow-up|0|||
131045752|NCT03582033|471802279|FG001|Part A|Lost to Follow-up|0|||
131045753|NCT03582033|471802280|FG002|Part A|Lost to Follow-up|0|||
131045754|NCT03582033|471802281|FG003|Part A|Lost to Follow-up|0|||
131045755|NCT03582033|471802282|FG004|Part A|Lost to Follow-up|1|||
131045756|NCT03582033|471802283|FG005|Part A|Lost to Follow-up|0|||
131045757|NCT03582033|471802284|FG006|Part A|Lost to Follow-up|0|||
131045758|NCT03582033|471802285|FG007|Part A|Lost to Follow-up|0|||
131045759|NCT03582033|471802286|FG008|Part A|Lost to Follow-up|0|||
131045760|NCT03582033|471802287|FG009|Part A|Lost to Follow-up|0|||
131045761|NCT03582033|471802278|FG000|Part A|Study terminated by sponsor|0|||
131045762|NCT03582033|471802279|FG001|Part A|Study terminated by sponsor|0|||
131045763|NCT03582033|471802280|FG002|Part A|Study terminated by sponsor|0|||
131045764|NCT03582033|471802281|FG003|Part A|Study terminated by sponsor|2|||
131045765|NCT03582033|471802282|FG004|Part A|Study terminated by sponsor|1|||
131045766|NCT03582033|471802283|FG005|Part A|Study terminated by sponsor|0|||
131045767|NCT03582033|471802284|FG006|Part A|Study terminated by sponsor|0|||
131045768|NCT03582033|471802285|FG007|Part A|Study terminated by sponsor|0|||
131045769|NCT03582033|471802286|FG008|Part A|Study terminated by sponsor|0|||
131045770|NCT03582033|471802287|FG009|Part A|Study terminated by sponsor|0|||
131045771|NCT03582033|471802278|FG000|Part A|Withdrawal by Subject|1|||
131045772|NCT03582033|471802279|FG001|Part A|Withdrawal by Subject|1|||
131045773|NCT03582033|471802280|FG002|Part A|Withdrawal by Subject|0|||
131133608|NCT01687712|472115381|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
131133609|NCT01687712|472115380|FG000|Cycle 1|Abortion|3|||
131133610|NCT01687712|472115381|FG001|Cycle 1|Abortion|0|||
131133611|NCT01687712|472115380|FG000|Cycle 1|Intrauterine Fetal Death|0|||
131045774|NCT03582033|471802281|FG003|Part A|Withdrawal by Subject|1|||
131045775|NCT03582033|471802282|FG004|Part A|Withdrawal by Subject|7|||
131045776|NCT03582033|471802283|FG005|Part A|Withdrawal by Subject|0|||
131045777|NCT03582033|471802284|FG006|Part A|Withdrawal by Subject|0|||
131045778|NCT03582033|471802285|FG007|Part A|Withdrawal by Subject|0|||
131045779|NCT03582033|471802286|FG008|Part A|Withdrawal by Subject|0|||
131133612|NCT01687712|472115381|FG001|Cycle 1|Intrauterine Fetal Death|1|||
131045780|NCT03582033|471802287|FG009|Part A|Withdrawal by Subject|0|||
131045781|NCT03582033|471802278|FG000|Part B|Death|0|||
131045782|NCT03582033|471802279|FG001|Part B|Death|0|||
131045783|NCT03582033|471802280|FG002|Part B|Death|0|||
131045784|NCT03582033|471802281|FG003|Part B|Death|0|||
131045785|NCT03582033|471802282|FG004|Part B|Death|0|||
131045786|NCT03582033|471802283|FG005|Part B|Death|2|||
131045787|NCT03582033|471802284|FG006|Part B|Death|0|||
131045788|NCT03582033|471802285|FG007|Part B|Death|0|||
131045789|NCT03582033|471802286|FG008|Part B|Death|0|||
131045790|NCT03582033|471802287|FG009|Part B|Death|0|||
131045791|NCT03582033|471802278|FG000|Part B|Study terminated by sponsor|0|||
131045792|NCT03582033|471802279|FG001|Part B|Study terminated by sponsor|0|||
131045793|NCT03582033|471802280|FG002|Part B|Study terminated by sponsor|0|||
130985385|NCT02496767|471572902|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
130985386|NCT02496767|471572903|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
130985387|NCT02496767|471572904|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130985388|NCT02496767|471572905|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130985389|NCT02496767|471572906|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130985390|NCT02496767|471572907|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130985391|NCT02496767|471572908|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130985392|NCT02496767|471572901|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130985393|NCT02496767|471572902|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
131133613|NCT01687712|472115380|FG000|Cycle 1|Lost to Follow-up|1|||
130720735|NCT04228783|470601509|FG000|Overall Study|Physician Decision|1|||
130720736|NCT04228783|470601510|FG001|Overall Study|Physician Decision|2|||
130720737|NCT04228783|470601511|FG002|Overall Study|Physician Decision|0|||
130720738|NCT04228783|470601512|FG003|Overall Study|Physician Decision|0|||
130720739|NCT04228783|470601513|FG004|Overall Study|Physician Decision|0|||
130720740|NCT04228783|470601514|FG005|Overall Study|Physician Decision|0|||
130720741|NCT04228783|470601509|FG000|Overall Study|Protocol Violation|0|||
130720742|NCT04228783|470601510|FG001|Overall Study|Protocol Violation|0|||
130720743|NCT04228783|470601511|FG002|Overall Study|Protocol Violation|0|||
130720744|NCT04228783|470601512|FG003|Overall Study|Protocol Violation|1|||
130720745|NCT04228783|470601513|FG004|Overall Study|Protocol Violation|0|||
130720746|NCT04228783|470601514|FG005|Overall Study|Protocol Violation|0|||
130720747|NCT04228783|470601509|FG000|Overall Study|Withdrawal by Subject|6|||
130720748|NCT04228783|470601510|FG001|Overall Study|Withdrawal by Subject|10|||
130720749|NCT04228783|470601511|FG002|Overall Study|Withdrawal by Subject|19|||
130720750|NCT04228783|470601512|FG003|Overall Study|Withdrawal by Subject|1|||
130720751|NCT04228783|470601513|FG004|Overall Study|Withdrawal by Subject|2|||
130720752|NCT04228783|470601514|FG005|Overall Study|Withdrawal by Subject|0|||
130720753|NCT04228783|470601509|FG000|Overall Study|Other|4|||
130720754|NCT04228783|470601510|FG001|Overall Study|Other|3|||
130720755|NCT04228783|470601511|FG002|Overall Study|Other|2|||
130720756|NCT04228783|470601512|FG003|Overall Study|Other|1|||
130720757|NCT04228783|470601513|FG004|Overall Study|Other|0|||
130720758|NCT04228783|470601514|FG005|Overall Study|Other|0|||
130720759|NCT03327792|470601515|FG000|Overall Study|Adverse Event|4|||
130720760|NCT03327792|470601516|FG001|Overall Study|Adverse Event|0|||
130720761|NCT03327792|470601515|FG000|Overall Study|Family/Personal issues|3|||
130720762|NCT03327792|470601516|FG001|Overall Study|Family/Personal issues|2|||
130720763|NCT03327792|470601515|FG000|Overall Study|Lost to Follow-up|0|||
130720764|NCT03327792|470601516|FG001|Overall Study|Lost to Follow-up|1|||
130720765|NCT00626392|470601517|FG000|Run-in Period|Adverse Event|0|||
130720766|NCT00626392|470601518|FG001|Run-in Period|Adverse Event|0|||
130720767|NCT00626392|470601519|FG002|Run-in Period|Adverse Event|1|||
130720768|NCT00626392|470601520|FG003|Run-in Period|Adverse Event|0|||
130720769|NCT00626392|470601521|FG004|Run-in Period|Adverse Event|1|||
130720770|NCT00626392|470601522|FG005|Run-in Period|Adverse Event|0|||
130720771|NCT00626392|470601517|FG000|Run-in Period|Withdrawal by Subject|0|||
130720772|NCT00626392|470601518|FG001|Run-in Period|Withdrawal by Subject|1|||
130720773|NCT00626392|470601519|FG002|Run-in Period|Withdrawal by Subject|1|||
130720774|NCT00626392|470601520|FG003|Run-in Period|Withdrawal by Subject|1|||
130720775|NCT00626392|470601521|FG004|Run-in Period|Withdrawal by Subject|3|||
130720776|NCT00626392|470601522|FG005|Run-in Period|Withdrawal by Subject|1|||
130720777|NCT00626392|470601517|FG000|Run-in Period|Noncompliance|1|||
130720778|NCT00626392|470601518|FG001|Run-in Period|Noncompliance|0|||
130720779|NCT00626392|470601519|FG002|Run-in Period|Noncompliance|1|||
130720780|NCT00626392|470601520|FG003|Run-in Period|Noncompliance|0|||
130720781|NCT00626392|470601521|FG004|Run-in Period|Noncompliance|0|||
130720782|NCT00626392|470601522|FG005|Run-in Period|Noncompliance|0|||
130720783|NCT00626392|470601517|FG000|Coadministration Period|Adverse Event|3|||
131133614|NCT01687712|472115381|FG001|Cycle 1|Lost to Follow-up|1|||
131133615|NCT01687712|472115380|FG000|Cycle 2|Not Biochemically Pregnant|74|||
130720784|NCT00626392|470601518|FG001|Coadministration Period|Adverse Event|1|||
130720785|NCT00626392|470601519|FG002|Coadministration Period|Adverse Event|7|||
130778859|NCT03428100|470817456|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130720786|NCT00626392|470601520|FG003|Coadministration Period|Adverse Event|4|||
130720787|NCT00626392|470601521|FG004|Coadministration Period|Adverse Event|3|||
130720788|NCT00626392|470601522|FG005|Coadministration Period|Adverse Event|4|||
130720789|NCT00626392|470601517|FG000|Coadministration Period|Withdrawal by Subject|1|||
130720790|NCT00626392|470601518|FG001|Coadministration Period|Withdrawal by Subject|1|||
130720791|NCT00626392|470601519|FG002|Coadministration Period|Withdrawal by Subject|0|||
130720792|NCT00626392|470601520|FG003|Coadministration Period|Withdrawal by Subject|1|||
130720793|NCT00626392|470601521|FG004|Coadministration Period|Withdrawal by Subject|0|||
130720794|NCT00626392|470601522|FG005|Coadministration Period|Withdrawal by Subject|1|||
130720795|NCT00626392|470601517|FG000|Coadministration Period|Protocol Violation|0|||
130720796|NCT00626392|470601518|FG001|Coadministration Period|Protocol Violation|1|||
130720797|NCT00626392|470601519|FG002|Coadministration Period|Protocol Violation|0|||
131045919|NCT03248479|471802304|FG004|Overall Study|Study terminated by sponsor|0|||
131045920|NCT03248479|471802305|FG005|Overall Study|Study terminated by sponsor|0|||
131045921|NCT03248479|471802306|FG006|Overall Study|Study terminated by sponsor|0|||
131045922|NCT03248479|471802307|FG007|Overall Study|Study terminated by sponsor|1|||
131045923|NCT03248479|471802308|FG008|Overall Study|Study terminated by sponsor|1|||
131045924|NCT03248479|471802309|FG009|Overall Study|Study terminated by sponsor|0|||
131045925|NCT03248479|471802310|FG010|Overall Study|Study terminated by sponsor|5|||
131045926|NCT03248479|471802311|FG011|Overall Study|Study terminated by sponsor|4|||
131045927|NCT03248479|471802312|FG012|Overall Study|Study terminated by sponsor|0|||
131045928|NCT03248479|471802300|FG000|Overall Study|Consent withdrawn|6|||
131045929|NCT03248479|471802301|FG001|Overall Study|Consent withdrawn|3|||
131045930|NCT03248479|471802302|FG002|Overall Study|Consent withdrawn|0|||
131045931|NCT03248479|471802303|FG003|Overall Study|Consent withdrawn|9|||
131045932|NCT03248479|471802304|FG004|Overall Study|Consent withdrawn|1|||
131045933|NCT03248479|471802305|FG005|Overall Study|Consent withdrawn|0|||
131045934|NCT03248479|471802306|FG006|Overall Study|Consent withdrawn|0|||
131045935|NCT03248479|471802307|FG007|Overall Study|Consent withdrawn|1|||
131045936|NCT03248479|471802308|FG008|Overall Study|Consent withdrawn|0|||
131045937|NCT03248479|471802309|FG009|Overall Study|Consent withdrawn|3|||
131045938|NCT03248479|471802310|FG010|Overall Study|Consent withdrawn|1|||
131045939|NCT03248479|471802311|FG011|Overall Study|Consent withdrawn|0|||
131045940|NCT03248479|471802312|FG012|Overall Study|Consent withdrawn|1|||
131045941|NCT03248479|471802300|FG000|Overall Study|Lost to Follow-up|2|||
131045942|NCT03248479|471802301|FG001|Overall Study|Lost to Follow-up|1|||
131045943|NCT03248479|471802302|FG002|Overall Study|Lost to Follow-up|0|||
131045944|NCT03248479|471802303|FG003|Overall Study|Lost to Follow-up|0|||
130985759|NCT00261495|471574970|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
130985760|NCT00261495|471574971|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
130985761|NCT00261495|471574970|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
130985762|NCT00261495|471574971|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
130985763|NCT00261495|471574970|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
130985764|NCT00261495|471574971|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
130985765|NCT00261495|471574970|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
130985766|NCT00261495|471574971|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
130985767|NCT00261495|471574970|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
130985768|NCT00261495|471574971|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
130985769|NCT00261495|471574970|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
130985770|NCT00261495|471574971|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
130985771|NCT00261495|471574970|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
130985772|NCT00261495|471574971|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
130985773|NCT00261495|471574970|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
130985774|NCT00261495|471574971|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
130985775|NCT00261495|471574970|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
130985776|NCT00261495|471574971|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
130985777|NCT00261495|471574970|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
130985778|NCT00261495|471574971|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
130985779|NCT00261495|471574970|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130985780|NCT00261495|471574971|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
130985781|NCT00261495|471574970|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
130985782|NCT00261495|471574971|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
130985783|NCT00261495|471574970|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
130985784|NCT00261495|471574971|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130985785|NCT01059630|471574977|FG000|Overall Study|Death|100|||
130985786|NCT01059630|471574978|FG001|Overall Study|Death|84|||
130985787|NCT01059630|471574977|FG000|Overall Study|Lost to Follow-up|4|||
130985788|NCT01059630|471574978|FG001|Overall Study|Lost to Follow-up|1|||
130985789|NCT01059630|471574977|FG000|Overall Study|Physician Decision|2|||
130985790|NCT01059630|471574978|FG001|Overall Study|Physician Decision|4|||
130985791|NCT01059630|471574977|FG000|Overall Study|Withdrawal by Subject|21|||
130985792|NCT01059630|471574978|FG001|Overall Study|Withdrawal by Subject|14|||
130985793|NCT01281202|471574979|FG000|Overall Study|Adverse Event|2|||
130985794|NCT01281202|471574980|FG001|Overall Study|Adverse Event|0|||
130985795|NCT01281202|471574979|FG000|Overall Study|Withdrawal by Subject|2|||
130985796|NCT01281202|471574980|FG001|Overall Study|Withdrawal by Subject|2|||
130985797|NCT01281202|471574979|FG000|Overall Study|Protocol Violation|11|||
130985798|NCT01281202|471574980|FG001|Overall Study|Protocol Violation|10|||
131045945|NCT03248479|471802304|FG004|Overall Study|Lost to Follow-up|0|||
131045946|NCT03248479|471802305|FG005|Overall Study|Lost to Follow-up|0|||
131045947|NCT03248479|471802306|FG006|Overall Study|Lost to Follow-up|0|||
131045948|NCT03248479|471802307|FG007|Overall Study|Lost to Follow-up|0|||
131045949|NCT03248479|471802308|FG008|Overall Study|Lost to Follow-up|0|||
131045950|NCT03248479|471802309|FG009|Overall Study|Lost to Follow-up|0|||
131045951|NCT03248479|471802310|FG010|Overall Study|Lost to Follow-up|0|||
130985799|NCT01281202|471574979|FG000|Overall Study|Administrative|2|||
130985800|NCT01281202|471574980|FG001|Overall Study|Administrative|8|||
131045952|NCT03248479|471802311|FG011|Overall Study|Lost to Follow-up|0|||
131045953|NCT03248479|471802312|FG012|Overall Study|Lost to Follow-up|1|||
131045954|NCT03248479|471802300|FG000|Overall Study|Not reported|0|||
131045955|NCT03248479|471802301|FG001|Overall Study|Not reported|0|||
131045956|NCT03248479|471802302|FG002|Overall Study|Not reported|0|||
131045957|NCT03248479|471802303|FG003|Overall Study|Not reported|1|||
131045958|NCT03248479|471802304|FG004|Overall Study|Not reported|1|||
131045959|NCT03248479|471802305|FG005|Overall Study|Not reported|0|||
131045960|NCT03248479|471802306|FG006|Overall Study|Not reported|0|||
131045961|NCT03248479|471802307|FG007|Overall Study|Not reported|1|||
131045962|NCT03248479|471802308|FG008|Overall Study|Not reported|1|||
131045963|NCT03248479|471802309|FG009|Overall Study|Not reported|0|||
131045964|NCT03248479|471802310|FG010|Overall Study|Not reported|0|||
131045965|NCT03248479|471802311|FG011|Overall Study|Not reported|0|||
131045966|NCT03248479|471802312|FG012|Overall Study|Not reported|0|||
131045967|NCT05123027|471802318|FG000|Overall Study|Lost to Follow-up|17|||
131045968|NCT05123027|471802319|FG001|Overall Study|Lost to Follow-up|22|||
131045969|NCT05123027|471802318|FG000|Overall Study|Incarceration|3|||
131045970|NCT05123027|471802319|FG001|Overall Study|Incarceration|4|||
131045971|NCT05123027|471802318|FG000|Overall Study|Death|2|||
131045972|NCT05123027|471802319|FG001|Overall Study|Death|2|||
131045973|NCT05123027|471802318|FG000|Overall Study|Other|2|||
131045974|NCT05123027|471802319|FG001|Overall Study|Other|0|||
131045975|NCT03735979|471802320|FG000|Overall Study|Lost to Follow-up|1|||
131045976|NCT03735979|471802321|FG001|Overall Study|Lost to Follow-up|12|||
131045977|NCT03735979|471802322|FG002|Overall Study|Lost to Follow-up|14|||
131045978|NCT03735979|471802320|FG000|Overall Study|Withdrawal by Subject|1|||
131045979|NCT03735979|471802321|FG001|Overall Study|Withdrawal by Subject|5|||
131045980|NCT03735979|471802322|FG002|Overall Study|Withdrawal by Subject|2|||
131045981|NCT03735979|471802320|FG000|Overall Study|Not due to the above reasons|1|||
131045982|NCT03735979|471802321|FG001|Overall Study|Not due to the above reasons|0|||
131045983|NCT03735979|471802322|FG002|Overall Study|Not due to the above reasons|0|||
131045984|NCT05112900|471802323|FG000|Overall Study|Withdrawal by Subject|960|||
131045985|NCT05112900|471802324|FG001|Overall Study|Withdrawal by Subject|921|||
131045986|NCT05112900|471802325|FG002|Overall Study|Withdrawal by Subject|968|||
131045987|NCT01475786|471802330|FG000|Overall Study|Adverse Event|0|||
131045988|NCT01475786|471802331|FG001|Overall Study|Adverse Event|1|||
131045989|NCT01475786|471802332|FG002|Overall Study|Adverse Event|0|||
131045990|NCT01475786|471802330|FG000|Overall Study|Lost to Follow-up|1|||
131045991|NCT01475786|471802331|FG001|Overall Study|Lost to Follow-up|2|||
130720925|NCT00724048|470601563|FG002|Overall Study|Withdrawal by Subject|1|||
130720926|NCT00724048|470601564|FG003|Overall Study|Withdrawal by Subject|2|||
130720927|NCT00724048|470601561|FG000|Overall Study|Investigator decision|0|||
130720928|NCT00724048|470601562|FG001|Overall Study|Investigator decision|0|||
130720929|NCT00724048|470601563|FG002|Overall Study|Investigator decision|1|||
130720930|NCT00724048|470601564|FG003|Overall Study|Investigator decision|0|||
131045992|NCT01475786|471802332|FG002|Overall Study|Lost to Follow-up|1|||
131045993|NCT01475786|471802330|FG000|Overall Study|Withdrawal by Subject|0|||
131045994|NCT01475786|471802331|FG001|Overall Study|Withdrawal by Subject|1|||
131045995|NCT01475786|471802332|FG002|Overall Study|Withdrawal by Subject|1|||
131045996|NCT01475786|471802330|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
131045997|NCT01475786|471802331|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
130720931|NCT00724048|470601561|FG000|Overall Study|Did not tolerate study drug|0|||
130720932|NCT00724048|470601562|FG001|Overall Study|Did not tolerate study drug|0|||
130720933|NCT00724048|470601563|FG002|Overall Study|Did not tolerate study drug|0|||
131045998|NCT01475786|471802332|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
131045999|NCT05654662|471802333|FG000|Overall Study|Withdrawal by Subject|1|||
131046000|NCT05654662|471802334|FG001|Overall Study|Withdrawal by Subject|0|||
131046001|NCT05654662|471802333|FG000|Overall Study|A death in the family|1|||
131046002|NCT05654662|471802334|FG001|Overall Study|A death in the family|0|||
130720934|NCT00724048|470601564|FG003|Overall Study|Did not tolerate study drug|1|||
130720935|NCT00724048|470601561|FG000|Overall Study|Other than specified|1|||
130720936|NCT00724048|470601562|FG001|Overall Study|Other than specified|1|||
130720937|NCT00724048|470601563|FG002|Overall Study|Other than specified|0|||
131046003|NCT03165955|471802335|FG000|Treatment|Withdrawal by Subject|3|||
131046004|NCT03165955|471802335|FG000|Treatment|Death|1|||
131046005|NCT03165955|471802335|FG000|Treatment|Adverse Event|1|||
131046006|NCT03165955|471802335|FG000|Treatment|Progressive disease|3|||
131046007|NCT04499521|471802338|FG000|Overall Study|Disease Progression|1|||
131046008|NCT04499521|471802339|FG001|Overall Study|Disease Progression|0|||
131046009|NCT05525104|471802340|FG000|Overall Study|Failed caudal analgesia|1|||
131046010|NCT05525104|471802341|FG001|Overall Study|Failed caudal analgesia|3|||
131046011|NCT05525104|471802340|FG000|Overall Study|Premedication needed|0|||
131046012|NCT05525104|471802341|FG001|Overall Study|Premedication needed|1|||
131046013|NCT05525104|471802340|FG000|Overall Study|Protocol Violation|10|||
131046014|NCT05525104|471802341|FG001|Overall Study|Protocol Violation|0|||
130720938|NCT00724048|470601564|FG003|Overall Study|Other than specified|0|||
130720939|NCT00407758|470601565|FG000|Overall Study|ineligible -improper prior treatment|1|||
131046015|NCT05525104|471802340|FG000|Overall Study|Cancelled operation|1|||
131046016|NCT05525104|471802341|FG001|Overall Study|Cancelled operation|0|||
131046017|NCT04678856|471802342|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
131046018|NCT04678856|471802343|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
131046019|NCT04678856|471802342|FG000|Overall Study|Withdrawal by Subject|5|||
131046020|NCT04678856|471802343|FG001|Overall Study|Withdrawal by Subject|1|||
131046021|NCT04389957|471803746|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
131046022|NCT04389957|471803747|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
131046023|NCT04389957|471803748|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
131046024|NCT04389957|471803749|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
131046025|NCT04389957|471803750|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
131046026|NCT05460871|471803754|FG000|Overall Study|Withdrawal by Subject|1|||
131046027|NCT05460871|471803755|FG001|Overall Study|Withdrawal by Subject|2|||
131046028|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
131046029|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
131046030|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
131046031|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
131046032|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
131046033|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
131046034|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
131046035|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
131046036|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
131046037|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
131046038|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
131046039|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
131046040|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
131046041|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
131046042|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
131046043|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
131046044|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
131046045|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
131046046|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
131046047|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
131046048|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
131046049|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
131046050|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
131046051|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
131046052|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
131046053|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
131046054|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
131046055|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
131046056|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
131046057|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
131046058|NCT04614948|471803756|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
131046059|NCT04614948|471803757|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
131046060|NCT04614948|471803758|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
131046061|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
131046062|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
130720940|NCT01822275|470601566|FG000|Overall Study|Withdrawal by Subject|3|||
131046063|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
131046064|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
131046065|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
131046066|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
131046067|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
131046068|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
131046069|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
131046070|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
131046071|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
131046072|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
131046073|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
131046074|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
131046075|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
131046076|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
131046077|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
131046078|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
131046079|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
130985801|NCT01281202|471574979|FG000|Overall Study|Lost to Follow-up|11|||
130985802|NCT01281202|471574980|FG001|Overall Study|Lost to Follow-up|13|||
130985803|NCT01281202|471574979|FG000|Overall Study|Incarceration|0|||
130985804|NCT01281202|471574980|FG001|Overall Study|Incarceration|3|||
130985805|NCT04270747|471574987|FG000|Through Week 16|Adverse Event|1|||
130985806|NCT04270747|471574988|FG001|Through Week 16|Adverse Event|2|||
130985807|NCT04270747|471574989|FG002|Through Week 16|Adverse Event|0|||
130985808|NCT04270747|471574987|FG000|Through Week 16|Death|0|||
131046080|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
131046081|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
130985809|NCT04270747|471574988|FG001|Through Week 16|Death|2|||
130985810|NCT04270747|471574989|FG002|Through Week 16|Death|0|||
130985811|NCT04270747|471574987|FG000|Through Week 16|Consent Withdrawn|3|||
130985812|NCT04270747|471574988|FG001|Through Week 16|Consent Withdrawn|3|||
130985813|NCT04270747|471574989|FG002|Through Week 16|Consent Withdrawn|0|||
130985814|NCT04270747|471574987|FG000|Through Week 16|Physician Decision|1|||
130985815|NCT04270747|471574988|FG001|Through Week 16|Physician Decision|1|||
130985816|NCT04270747|471574989|FG002|Through Week 16|Physician Decision|0|||
130985817|NCT04270747|471574987|FG000|Through Week 16|Lost to Follow-up|2|||
130985818|NCT04270747|471574988|FG001|Through Week 16|Lost to Follow-up|0|||
130985819|NCT04270747|471574989|FG002|Through Week 16|Lost to Follow-up|0|||
130985820|NCT04270747|471574987|FG000|Through Week 16|Protocol Violation|1|||
130985821|NCT04270747|471574988|FG001|Through Week 16|Protocol Violation|2|||
130985822|NCT04270747|471574989|FG002|Through Week 16|Protocol Violation|0|||
130985823|NCT04270747|471574987|FG000|Through Week 16|Protocol Specified Criteria|6|||
130985824|NCT04270747|471574988|FG001|Through Week 16|Protocol Specified Criteria|7|||
130985825|NCT04270747|471574989|FG002|Through Week 16|Protocol Specified Criteria|0|||
130985826|NCT04270747|471574987|FG000|Through Week 16|Miscellaneous|1|||
130985827|NCT04270747|471574988|FG001|Through Week 16|Miscellaneous|1|||
130985828|NCT04270747|471574989|FG002|Through Week 16|Miscellaneous|0|||
130985829|NCT04270747|471574987|FG000|Post Week 16|Adverse Event|7|||
130985830|NCT04270747|471574988|FG001|Post Week 16|Adverse Event|5|||
130985831|NCT04270747|471574989|FG002|Post Week 16|Adverse Event|1|||
130985832|NCT04270747|471574987|FG000|Post Week 16|Death|2|||
130985833|NCT04270747|471574988|FG001|Post Week 16|Death|0|||
130985834|NCT04270747|471574989|FG002|Post Week 16|Death|2|||
130985835|NCT04270747|471574987|FG000|Post Week 16|Consent Withdrawn|4|||
130985836|NCT04270747|471574988|FG001|Post Week 16|Consent Withdrawn|3|||
130985837|NCT04270747|471574989|FG002|Post Week 16|Consent Withdrawn|6|||
130985838|NCT04270747|471574987|FG000|Post Week 16|Physician Decision|3|||
130985839|NCT04270747|471574988|FG001|Post Week 16|Physician Decision|1|||
130985840|NCT04270747|471574989|FG002|Post Week 16|Physician Decision|1|||
130985841|NCT04270747|471574987|FG000|Post Week 16|Lost to Follow-up|2|||
130985842|NCT04270747|471574988|FG001|Post Week 16|Lost to Follow-up|1|||
130985843|NCT04270747|471574989|FG002|Post Week 16|Lost to Follow-up|0|||
130985844|NCT04270747|471574987|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
130985845|NCT04270747|471574988|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
130985846|NCT04270747|471574989|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
130985847|NCT04270747|471574987|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
130985848|NCT04270747|471574988|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
130985849|NCT04270747|471574989|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
130985850|NCT04270747|471574987|FG000|Post Week 16|Miscellaneous|1|||
130985851|NCT04270747|471574988|FG001|Post Week 16|Miscellaneous|0|||
130985852|NCT04270747|471574989|FG002|Post Week 16|Miscellaneous|1|||
130985853|NCT01784068|471574993|FG000|NTCS Phase|Adverse Event|5|||
130985854|NCT01784068|471574994|FG001|NTCS Phase|Adverse Event|0|||
130985855|NCT01784068|471574993|FG000|NTCS Phase|Physician Decision|2|||
130985856|NCT01784068|471574994|FG001|NTCS Phase|Physician Decision|0|||
130985857|NCT01784068|471574993|FG000|NTCS Phase|Patient/guardian decision|3|||
130985858|NCT01784068|471574994|FG001|NTCS Phase|Patient/guardian decision|0|||
130985859|NCT01784068|471574993|FG000|NTCS Phase|Death|2|||
130985860|NCT01784068|471574994|FG001|NTCS Phase|Death|0|||
130985861|NCT01784068|471574993|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
130985862|NCT01784068|471574994|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
130985863|NCT01784068|471574993|FG000|TFR Phase|Physician Decision|0|||
130985864|NCT01784068|471574994|FG001|TFR Phase|Physician Decision|1|||
130985865|NCT01784068|471574993|FG000|TFR Phase|Patient/guardian decision|0|||
130985866|NCT01784068|471574994|FG001|TFR Phase|Patient/guardian decision|3|||
131046082|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
131046083|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
131046084|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
131046085|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
131046086|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
131046087|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
131046088|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
131046089|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
131046090|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
131046091|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
131046092|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
131046093|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
131046094|NCT04614948|471803756|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
131046095|NCT04614948|471803757|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
131046096|NCT04614948|471803758|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
131046097|NCT00964392|471803759|FG000|Overall Study|Withdrawal by Subject|4|||
131046098|NCT00964392|471803760|FG001|Overall Study|Withdrawal by Subject|6|||
131046099|NCT00964392|471803759|FG000|Overall Study|Lost to Follow-up|4|||
131046100|NCT00964392|471803760|FG001|Overall Study|Lost to Follow-up|10|||
131046101|NCT00964392|471803759|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
131046102|NCT00964392|471803760|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
131046103|NCT00964392|471803759|FG000|Overall Study|Not completed|44|||
131046104|NCT00964392|471803760|FG001|Overall Study|Not completed|168|||
131046105|NCT03498521|471803761|FG000|Overall Study|Death|191|||
131046106|NCT03498521|471803762|FG001|Overall Study|Death|64|||
131046107|NCT03498521|471803763|FG002|Overall Study|Death|72|||
131046108|NCT03498521|471803761|FG000|Overall Study|Exclusion criteria|1|||
131046109|NCT03498521|471803762|FG001|Overall Study|Exclusion criteria|0|||
131046110|NCT03498521|471803763|FG002|Overall Study|Exclusion criteria|0|||
131046111|NCT03498521|471803761|FG000|Overall Study|Lost to Follow-up|3|||
131046112|NCT03498521|471803762|FG001|Overall Study|Lost to Follow-up|3|||
131046113|NCT03498521|471803763|FG002|Overall Study|Lost to Follow-up|3|||
131046114|NCT03498521|471803761|FG000|Overall Study|No profile due to technical failure|1|||
131046115|NCT03498521|471803762|FG001|Overall Study|No profile due to technical failure|0|||
131046116|NCT03498521|471803763|FG002|Overall Study|No profile due to technical failure|0|||
131046117|NCT03498521|471803761|FG000|Overall Study|Physician Decision|0|||
131046118|NCT03498521|471803762|FG001|Overall Study|Physician Decision|1|||
131046119|NCT03498521|471803763|FG002|Overall Study|Physician Decision|0|||
131046120|NCT03498521|471803761|FG000|Overall Study|Withdrawal by Subject|9|||
131046121|NCT03498521|471803762|FG001|Overall Study|Withdrawal by Subject|6|||
131046122|NCT03498521|471803763|FG002|Overall Study|Withdrawal by Subject|2|||
131046123|NCT03498521|471803761|FG000|Overall Study|Study ongoing|121|||
131046124|NCT03498521|471803762|FG001|Overall Study|Study ongoing|36|||
131046125|NCT03498521|471803763|FG002|Overall Study|Study ongoing|15|||
131046126|NCT04055012|471803764|FG000|Overall Study|Withdrawal by Subject|1|||
131046127|NCT04055012|471803765|FG001|Overall Study|Withdrawal by Subject|3|||
131046128|NCT04055012|471803766|FG002|Overall Study|Withdrawal by Subject|1|||
131046129|NCT04055012|471803767|FG003|Overall Study|Withdrawal by Subject|0|||
131046130|NCT04055012|471803764|FG000|Overall Study|Metformin Recall|1|||
131133730|NCT01661140|472117175|FG002|Double-Blind Period|Refused Treatment|1|||
131133731|NCT01661140|472117173|FG000|Double-Blind Period|Adverse Event|0|||
131133732|NCT01661140|472117174|FG001|Double-Blind Period|Adverse Event|16|||
131133733|NCT01661140|472117175|FG002|Double-Blind Period|Adverse Event|18|||
131133734|NCT01661140|472117173|FG000|Double-Blind Period|Protocol Violation|0|||
131133735|NCT01661140|472117174|FG001|Double-Blind Period|Protocol Violation|2|||
131133736|NCT01661140|472117175|FG002|Double-Blind Period|Protocol Violation|3|||
131133737|NCT01661140|472117173|FG000|Double-Blind Period|Withdrawal by Subject|0|||
131133738|NCT01661140|472117174|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131133739|NCT01661140|472117175|FG002|Double-Blind Period|Withdrawal by Subject|3|||
131133740|NCT01661140|472117173|FG000|Double-Blind Period|Investigator's Decision|0|||
131133741|NCT01661140|472117174|FG001|Double-Blind Period|Investigator's Decision|1|||
131133742|NCT01661140|472117175|FG002|Double-Blind Period|Investigator's Decision|2|||
131133743|NCT01661140|472117173|FG000|Double-Blind Period|Sponsor Termination|0|||
131133744|NCT01661140|472117174|FG001|Double-Blind Period|Sponsor Termination|14|||
131133745|NCT01661140|472117175|FG002|Double-Blind Period|Sponsor Termination|17|||
131133746|NCT01661140|472117173|FG000|Double-Blind Period|Administrative/Other|0|||
131133747|NCT01661140|472117174|FG001|Double-Blind Period|Administrative/Other|7|||
131133748|NCT01661140|472117175|FG002|Double-Blind Period|Administrative/Other|6|||
131133749|NCT01391000|472117176|FG000|Overall Study|Lost to Follow-up|2|||
131133750|NCT01391000|472117177|FG001|Overall Study|Lost to Follow-up|0|||
131133751|NCT00494091|472117180|FG000|Overall Study|Death|5|||
131133752|NCT00494091|472117181|FG001|Overall Study|Death|54|||
131133753|NCT00494091|472117180|FG000|Overall Study|Lost to Follow-up|0|||
131046131|NCT04055012|471803765|FG001|Overall Study|Metformin Recall|1|||
131046132|NCT04055012|471803766|FG002|Overall Study|Metformin Recall|1|||
131133754|NCT00494091|472117181|FG001|Overall Study|Lost to Follow-up|4|||
131133755|NCT00494091|472117180|FG000|Overall Study|Other|1|||
131133756|NCT00494091|472117181|FG001|Overall Study|Other|11|||
131046133|NCT04055012|471803767|FG003|Overall Study|Metformin Recall|0|||
131046134|NCT05830799|471803773|FG000|Overall Study|Withdrawal by Subject|1|||
131046135|NCT03652272|471803774|FG000|3 Month|Withdrawal by Subject|1|||
131046136|NCT03652272|471803775|FG001|3 Month|Withdrawal by Subject|1|||
131046137|NCT03652272|471803774|FG000|3 Month|Lost to Follow-up|16|||
131046138|NCT03652272|471803775|FG001|3 Month|Lost to Follow-up|14|||
131229466|NCT04136626|472465930|FG001|Treatment Phase|Withdrawal by Subject|9|||
131229467|NCT04136626|472465929|FG000|Treatment Phase|Adverse Event|1|||
131046139|NCT04633538|471803778|FG000|Overall Study|Death|1|||
131046140|NCT04633538|471803778|FG000|Overall Study|Lost to Follow-up|3|||
131046141|NCT04633538|471803778|FG000|Overall Study|Withdrawal by Subject|1|||
131046142|NCT02938520|471803779|FG000|Overall Study|On-going at the time of analysis|258|||
131046143|NCT02938520|471803780|FG001|Overall Study|On-going at the time of analysis|261|||
131046144|NCT02938520|471803779|FG000|Overall Study|Physician Decision|2|||
131046145|NCT02938520|471803780|FG001|Overall Study|Physician Decision|5|||
131046146|NCT02938520|471803779|FG000|Overall Study|Lost to Follow-up|2|||
131046147|NCT02938520|471803780|FG001|Overall Study|Lost to Follow-up|2|||
131046148|NCT02938520|471803779|FG000|Overall Study|Withdrawal by Subject|7|||
131046149|NCT02938520|471803780|FG001|Overall Study|Withdrawal by Subject|7|||
131046150|NCT02938520|471803779|FG000|Overall Study|Protocol Violation|0|||
131046151|NCT02938520|471803780|FG001|Overall Study|Protocol Violation|1|||
131046152|NCT02938520|471803779|FG000|Overall Study|Lack of Efficacy|5|||
131046153|NCT02938520|471803780|FG001|Overall Study|Lack of Efficacy|3|||
131046154|NCT02938520|471803779|FG000|Overall Study|Adverse Event|9|||
131046155|NCT02938520|471803780|FG001|Overall Study|Adverse Event|4|||
131046156|NCT05652010|471803784|FG000|First Intervention|Withdrawal by Subject|0|||
131046157|NCT05652010|471803785|FG001|First Intervention|Withdrawal by Subject|1|||
131046158|NCT05652010|471803784|FG000|Second Intervention|Withdrawal by Subject|1|||
131046159|NCT05652010|471803785|FG001|Second Intervention|Withdrawal by Subject|0|||
131046160|NCT05741294|471803786|FG000|Overall Study|Lost to Follow-up|3|||
131046161|NCT05741294|471803786|FG000|Overall Study|Protocol deviation|3|||
131046162|NCT05741294|471803786|FG000|Overall Study|Withdrawal by Subject|1|||
131046163|NCT04163991|471803787|FG000|Overall Study|Adverse Event|0|||
131046164|NCT04163991|471803788|FG001|Overall Study|Adverse Event|0|||
131046165|NCT04163991|471803789|FG002|Overall Study|Adverse Event|0|||
131046166|NCT04163991|471803790|FG003|Overall Study|Adverse Event|1|||
131046167|NCT04163991|471803791|FG004|Overall Study|Adverse Event|0|||
131046168|NCT04163991|471803787|FG000|Overall Study|Death|0|||
131046169|NCT04163991|471803788|FG001|Overall Study|Death|0|||
131046170|NCT04163991|471803789|FG002|Overall Study|Death|1|||
131046171|NCT04163991|471803790|FG003|Overall Study|Death|0|||
131046172|NCT04163991|471803791|FG004|Overall Study|Death|0|||
131046173|NCT04163991|471803787|FG000|Overall Study|Lost to Follow-up|0|||
131046174|NCT04163991|471803788|FG001|Overall Study|Lost to Follow-up|1|||
131229468|NCT04136626|472465930|FG001|Treatment Phase|Adverse Event|0|||
131229469|NCT04136626|472465929|FG000|Treatment Phase|Lost to Follow-up|1|||
131046175|NCT04163991|471803789|FG002|Overall Study|Lost to Follow-up|0|||
131046176|NCT04163991|471803790|FG003|Overall Study|Lost to Follow-up|0|||
131046177|NCT04163991|471803791|FG004|Overall Study|Lost to Follow-up|0|||
131046178|NCT04163991|471803787|FG000|Overall Study|Withdrawal by Subject|1|||
131133757|NCT00494091|472117180|FG000|Overall Study|Withdrawal by Subject|0|||
131133758|NCT00494091|472117181|FG001|Overall Study|Withdrawal by Subject|7|||
131133759|NCT00883337|472117186|FG000|Core Treatment Period|Adverse Event|9|||
131133760|NCT00883337|472117187|FG001|Core Treatment Period|Adverse Event|12|||
131133761|NCT00883337|472117188|FG002|Core Treatment Period|Adverse Event|22|||
131133762|NCT00883337|472117186|FG000|Core Treatment Period|Lack of Efficacy|7|||
131133763|NCT00883337|472117187|FG001|Core Treatment Period|Lack of Efficacy|4|||
131133764|NCT00883337|472117188|FG002|Core Treatment Period|Lack of Efficacy|2|||
131133765|NCT00883337|472117186|FG000|Core Treatment Period|Lost to Follow-up|1|||
131133766|NCT00883337|472117187|FG001|Core Treatment Period|Lost to Follow-up|1|||
131133767|NCT00883337|472117188|FG002|Core Treatment Period|Lost to Follow-up|0|||
131133768|NCT00883337|472117186|FG000|Core Treatment Period|Withdrawal by Subject|2|||
131133769|NCT00883337|472117187|FG001|Core Treatment Period|Withdrawal by Subject|2|||
131133770|NCT00883337|472117188|FG002|Core Treatment Period|Withdrawal by Subject|6|||
131133771|NCT00883337|472117186|FG000|Core Treatment Period|Wish to be pregnant|1|||
131133772|NCT00883337|472117187|FG001|Core Treatment Period|Wish to be pregnant|2|||
131133773|NCT00883337|472117188|FG002|Core Treatment Period|Wish to be pregnant|1|||
131133774|NCT00883337|472117186|FG000|Core Treatment Period|Poor compliance to protocol|0|||
131133775|NCT00883337|472117187|FG001|Core Treatment Period|Poor compliance to protocol|0|||
131046179|NCT04163991|471803788|FG001|Overall Study|Withdrawal by Subject|1|||
131046180|NCT04163991|471803789|FG002|Overall Study|Withdrawal by Subject|3|||
131133776|NCT00883337|472117188|FG002|Core Treatment Period|Poor compliance to protocol|1|||
131133777|NCT00883337|472117186|FG000|Core Treatment Period|Other than above|0|||
131133778|NCT00883337|472117187|FG001|Core Treatment Period|Other than above|1|||
131046181|NCT04163991|471803790|FG003|Overall Study|Withdrawal by Subject|1|||
131046182|NCT04163991|471803791|FG004|Overall Study|Withdrawal by Subject|1|||
131046183|NCT04163991|471803787|FG000|Overall Study|Other, Not Specified|0|||
131046184|NCT04163991|471803788|FG001|Overall Study|Other, Not Specified|1|||
131046185|NCT04163991|471803789|FG002|Overall Study|Other, Not Specified|1|||
131046186|NCT04163991|471803790|FG003|Overall Study|Other, Not Specified|1|||
131046187|NCT04163991|471803791|FG004|Overall Study|Other, Not Specified|0|||
131046188|NCT03372057|471803792|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
131046189|NCT03372057|471803793|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
130720941|NCT01822275|470601566|FG000|Overall Study|Adverse Event|3|||
130720942|NCT01822275|470601566|FG000|Overall Study|Progression|14|||
130720943|NCT01822275|470601566|FG000|Overall Study|Physician Decision|2|||
130720944|NCT00073021|470601567|FG000|Overall Study|Protocol Violation|2|||
130720945|NCT00073021|470601568|FG001|Overall Study|Protocol Violation|1|||
130720946|NCT00073021|470601567|FG000|Overall Study|Adverse Event|4|||
130720947|NCT00073021|470601568|FG001|Overall Study|Adverse Event|4|||
130720948|NCT00073021|470601567|FG000|Overall Study|Withdrawal by Subject|6|||
130720949|NCT00073021|470601568|FG001|Overall Study|Withdrawal by Subject|5|||
130720950|NCT00073021|470601567|FG000|Overall Study|Physician Decision|3|||
130720951|NCT00073021|470601568|FG001|Overall Study|Physician Decision|1|||
130985867|NCT01784068|471574993|FG000|TFR Phase|Death|0|||
130985868|NCT01784068|471574994|FG001|TFR Phase|Death|1|||
130985869|NCT01784068|471574993|FG000|TFR Phase|Lack of Efficacy|0|||
130985870|NCT01784068|471574994|FG001|TFR Phase|Lack of Efficacy|88|||
130985871|NCT00701038|471575005|FG000|Overall Study|study amended pilot group of patients|4|||
130985872|NCT00701038|471575006|FG001|Overall Study|study amended pilot group of patients|4|||
130985873|NCT04992546|471575011|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
130985874|NCT04992546|471575011|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
130985875|NCT04992546|471575011|FG000|Open-Label Treatment Period|Adverse Event|3|||
130985876|NCT04992546|471575011|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
130985877|NCT00717860|471575013|FG000|Overall Study|Clinical adverse experience|5|||
130985878|NCT00717860|471575014|FG001|Overall Study|Clinical adverse experience|9|||
130985879|NCT00717860|471575013|FG000|Overall Study|Laboratory adverse experience|2|||
130985880|NCT00717860|471575014|FG001|Overall Study|Laboratory adverse experience|2|||
130985881|NCT00717860|471575013|FG000|Overall Study|Lack of Efficacy|7|||
130985882|NCT00717860|471575014|FG001|Overall Study|Lack of Efficacy|13|||
130985883|NCT00717860|471575013|FG000|Overall Study|Discontinued for other reason|6|||
130985884|NCT00717860|471575014|FG001|Overall Study|Discontinued for other reason|1|||
130985885|NCT00717860|471575013|FG000|Overall Study|Withdrew consent|7|||
130985886|NCT00717860|471575014|FG001|Overall Study|Withdrew consent|3|||
130985887|NCT04058353|471575018|FG000|Overall Study|Adverse Event|2|||
130985888|NCT04058353|471575019|FG001|Overall Study|Adverse Event|1|||
130985889|NCT04058353|471575018|FG000|Overall Study|Physician Decision|1|||
130985890|NCT04058353|471575019|FG001|Overall Study|Physician Decision|0|||
130985891|NCT04058353|471575018|FG000|Overall Study|Other|1|||
130985892|NCT04058353|471575019|FG001|Overall Study|Other|0|||
130985893|NCT00698646|471575020|FG000|Overall Study|Adverse Event|8|||
130985894|NCT00698646|471575021|FG001|Overall Study|Adverse Event|7|||
130985895|NCT00698646|471575022|FG002|Overall Study|Adverse Event|8|||
130985896|NCT00698646|471575020|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
130985897|NCT00698646|471575021|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
130985898|NCT00698646|471575022|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
130985899|NCT00698646|471575020|FG000|Overall Study|Protocol Deviation|6|||
130985900|NCT00698646|471575021|FG001|Overall Study|Protocol Deviation|2|||
130985901|NCT00698646|471575022|FG002|Overall Study|Protocol Deviation|3|||
130985902|NCT00698646|471575020|FG000|Overall Study|Withdrawal by Subject|10|||
130985903|NCT00698646|471575021|FG001|Overall Study|Withdrawal by Subject|11|||
130985904|NCT00698646|471575022|FG002|Overall Study|Withdrawal by Subject|8|||
130985905|NCT00698646|471575020|FG000|Overall Study|Lost to Follow-up|0|||
130985906|NCT00698646|471575021|FG001|Overall Study|Lost to Follow-up|0|||
130985907|NCT00698646|471575022|FG002|Overall Study|Lost to Follow-up|2|||
130985908|NCT00698646|471575020|FG000|Overall Study|Administrative problems|1|||
130985909|NCT00698646|471575021|FG001|Overall Study|Administrative problems|0|||
130985910|NCT00698646|471575022|FG002|Overall Study|Administrative problems|1|||
130985911|NCT00279201|471575023|FG000|Initiation|Death|1|||
130985912|NCT00279201|471575024|FG001|Initiation|Death|5|||
130985913|NCT00279201|471575025|FG002|Initiation|Death|0|||
130985914|NCT00279201|471575026|FG003|Initiation|Death|0|||
130985915|NCT00279201|471575027|FG004|Initiation|Death|0|||
130985916|NCT00279201|471575028|FG005|Initiation|Death|0|||
130985917|NCT00279201|471575023|FG000|Initiation|Adverse Event|6|||
130985918|NCT00279201|471575024|FG001|Initiation|Adverse Event|15|||
130985919|NCT00279201|471575025|FG002|Initiation|Adverse Event|0|||
130985920|NCT00279201|471575026|FG003|Initiation|Adverse Event|0|||
130985921|NCT00279201|471575027|FG004|Initiation|Adverse Event|0|||
130985922|NCT00279201|471575028|FG005|Initiation|Adverse Event|0|||
130985923|NCT00279201|471575023|FG000|Initiation|Lost to Follow-up|42|||
130985924|NCT00279201|471575024|FG001|Initiation|Lost to Follow-up|41|||
130985925|NCT00279201|471575025|FG002|Initiation|Lost to Follow-up|0|||
130985926|NCT00279201|471575026|FG003|Initiation|Lost to Follow-up|0|||
130985927|NCT00279201|471575027|FG004|Initiation|Lost to Follow-up|0|||
130985928|NCT00279201|471575028|FG005|Initiation|Lost to Follow-up|0|||
130985929|NCT00279201|471575023|FG000|Initiation|Entry Criteria Exclusion|7|||
130985930|NCT00279201|471575024|FG001|Initiation|Entry Criteria Exclusion|9|||
130985931|NCT00279201|471575025|FG002|Initiation|Entry Criteria Exclusion|0|||
130985932|NCT00279201|471575026|FG003|Initiation|Entry Criteria Exclusion|0|||
130985933|NCT00279201|471575027|FG004|Initiation|Entry Criteria Exclusion|0|||
130985934|NCT00279201|471575028|FG005|Initiation|Entry Criteria Exclusion|0|||
130985935|NCT00279201|471575023|FG000|Initiation|Protocol Violation|9|||
130985936|NCT00279201|471575024|FG001|Initiation|Protocol Violation|10|||
130985937|NCT00279201|471575025|FG002|Initiation|Protocol Violation|0|||
130985938|NCT00279201|471575026|FG003|Initiation|Protocol Violation|0|||
130985939|NCT00279201|471575027|FG004|Initiation|Protocol Violation|0|||
130985940|NCT00279201|471575028|FG005|Initiation|Protocol Violation|0|||
130985941|NCT00279201|471575023|FG000|Initiation|Withdrawal by Subject|35|||
130985942|NCT00279201|471575024|FG001|Initiation|Withdrawal by Subject|41|||
130985943|NCT00279201|471575025|FG002|Initiation|Withdrawal by Subject|0|||
130985944|NCT00279201|471575026|FG003|Initiation|Withdrawal by Subject|0|||
130985945|NCT00279201|471575027|FG004|Initiation|Withdrawal by Subject|0|||
130985946|NCT00279201|471575028|FG005|Initiation|Withdrawal by Subject|0|||
130985947|NCT00279201|471575023|FG000|Initiation|Physician Decision|15|||
130985948|NCT00279201|471575024|FG001|Initiation|Physician Decision|18|||
130985949|NCT00279201|471575025|FG002|Initiation|Physician Decision|0|||
130985950|NCT00279201|471575026|FG003|Initiation|Physician Decision|0|||
130985951|NCT00279201|471575027|FG004|Initiation|Physician Decision|0|||
130985952|NCT00279201|471575028|FG005|Initiation|Physician Decision|0|||
130985953|NCT00279201|471575023|FG000|Initiation|Sponsor Decision|13|||
130985954|NCT00279201|471575024|FG001|Initiation|Sponsor Decision|5|||
130985955|NCT00279201|471575025|FG002|Initiation|Sponsor Decision|0|||
130985956|NCT00279201|471575026|FG003|Initiation|Sponsor Decision|0|||
130985957|NCT00279201|471575027|FG004|Initiation|Sponsor Decision|0|||
130985958|NCT00279201|471575028|FG005|Initiation|Sponsor Decision|0|||
130985959|NCT00279201|471575023|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
130985960|NCT00279201|471575024|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
130985961|NCT00279201|471575025|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
130985962|NCT00279201|471575026|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
130985963|NCT00279201|471575027|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
130985964|NCT00279201|471575028|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
130985965|NCT00279201|471575023|FG000|Maintenance|Lack of Efficacy|32|||
130985966|NCT00279201|471575024|FG001|Maintenance|Lack of Efficacy|30|||
130985967|NCT00279201|471575025|FG002|Maintenance|Lack of Efficacy|0|||
130985968|NCT00279201|471575026|FG003|Maintenance|Lack of Efficacy|0|||
130985969|NCT00279201|471575027|FG004|Maintenance|Lack of Efficacy|0|||
130985970|NCT00279201|471575028|FG005|Maintenance|Lack of Efficacy|0|||
130985971|NCT00279201|471575023|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
130985972|NCT00279201|471575024|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
130985973|NCT00279201|471575025|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
130985974|NCT00279201|471575026|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
130985975|NCT00279201|471575027|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
130985976|NCT00279201|471575028|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
130985977|NCT00279201|471575023|FG000|Maintenance|Adverse Event|4|||
130985978|NCT00279201|471575024|FG001|Maintenance|Adverse Event|4|||
130985979|NCT00279201|471575025|FG002|Maintenance|Adverse Event|0|||
130985980|NCT00279201|471575026|FG003|Maintenance|Adverse Event|0|||
130985981|NCT00279201|471575027|FG004|Maintenance|Adverse Event|0|||
130985982|NCT00279201|471575028|FG005|Maintenance|Adverse Event|0|||
130985983|NCT00279201|471575023|FG000|Maintenance|Death|4|||
130985984|NCT00279201|471575024|FG001|Maintenance|Death|4|||
130985985|NCT00279201|471575025|FG002|Maintenance|Death|0|||
131046190|NCT03372057|471803794|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
131046191|NCT03372057|471803792|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
131046192|NCT03372057|471803793|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
131046193|NCT03372057|471803794|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
131046194|NCT03372057|471803792|FG000|Dose Optimization Phase|Death|16|||
131046195|NCT03372057|471803793|FG001|Dose Optimization Phase|Death|11|||
131046196|NCT03372057|471803794|FG002|Dose Optimization Phase|Death|0|||
131046197|NCT03372057|471803792|FG000|Expansion Phase|Withdrawal by Subject|0|||
131046198|NCT03372057|471803793|FG001|Expansion Phase|Withdrawal by Subject|0|||
131046199|NCT03372057|471803794|FG002|Expansion Phase|Withdrawal by Subject|4|||
131229470|NCT04136626|472465930|FG001|Treatment Phase|Lost to Follow-up|5|||
131229471|NCT04136626|472465929|FG000|12-month Follow-up|Lost to Follow-up|8|||
131229472|NCT04136626|472465930|FG001|12-month Follow-up|Lost to Follow-up|7|||
130985986|NCT00279201|471575026|FG003|Maintenance|Death|0|||
130985987|NCT00279201|471575027|FG004|Maintenance|Death|0|||
130985988|NCT00279201|471575028|FG005|Maintenance|Death|0|||
130985989|NCT00279201|471575023|FG000|Maintenance|Lost to Follow-up|17|||
131229473|NCT00628745|472465931|FG000|Overall Study|Withdrawal by Subject|63|||
130985990|NCT00279201|471575024|FG001|Maintenance|Lost to Follow-up|13|||
130985991|NCT00279201|471575025|FG002|Maintenance|Lost to Follow-up|0|||
130985992|NCT00279201|471575026|FG003|Maintenance|Lost to Follow-up|0|||
130985993|NCT00279201|471575027|FG004|Maintenance|Lost to Follow-up|0|||
130985994|NCT00279201|471575028|FG005|Maintenance|Lost to Follow-up|0|||
130985995|NCT00279201|471575023|FG000|Maintenance|Entry Criteria Exclusion|1|||
130985996|NCT00279201|471575024|FG001|Maintenance|Entry Criteria Exclusion|4|||
130985997|NCT00279201|471575025|FG002|Maintenance|Entry Criteria Exclusion|0|||
130985998|NCT00279201|471575026|FG003|Maintenance|Entry Criteria Exclusion|0|||
131229474|NCT00628745|472465932|FG001|Overall Study|Withdrawal by Subject|3|||
131229475|NCT00628745|472465933|FG002|Overall Study|Withdrawal by Subject|9|||
131046200|NCT03372057|471803792|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
131046201|NCT03372057|471803793|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
131046202|NCT03372057|471803794|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
130985999|NCT00279201|471575027|FG004|Maintenance|Entry Criteria Exclusion|0|||
130986000|NCT00279201|471575028|FG005|Maintenance|Entry Criteria Exclusion|0|||
130986001|NCT00279201|471575023|FG000|Maintenance|Protocol Violation|16|||
130986002|NCT00279201|471575024|FG001|Maintenance|Protocol Violation|24|||
130986003|NCT00279201|471575025|FG002|Maintenance|Protocol Violation|0|||
130986004|NCT00279201|471575026|FG003|Maintenance|Protocol Violation|0|||
130986005|NCT00279201|471575027|FG004|Maintenance|Protocol Violation|0|||
130986006|NCT00279201|471575028|FG005|Maintenance|Protocol Violation|0|||
130986007|NCT00279201|471575023|FG000|Maintenance|Withdrawal by Subject|18|||
130986008|NCT00279201|471575024|FG001|Maintenance|Withdrawal by Subject|18|||
130986009|NCT00279201|471575025|FG002|Maintenance|Withdrawal by Subject|0|||
130986010|NCT00279201|471575026|FG003|Maintenance|Withdrawal by Subject|0|||
130986011|NCT00279201|471575027|FG004|Maintenance|Withdrawal by Subject|0|||
130986012|NCT00279201|471575028|FG005|Maintenance|Withdrawal by Subject|0|||
130986013|NCT00279201|471575023|FG000|Maintenance|Physician Decision|9|||
130986014|NCT00279201|471575024|FG001|Maintenance|Physician Decision|9|||
130986015|NCT00279201|471575025|FG002|Maintenance|Physician Decision|0|||
130986016|NCT00279201|471575026|FG003|Maintenance|Physician Decision|0|||
130986017|NCT00279201|471575027|FG004|Maintenance|Physician Decision|0|||
130986018|NCT00279201|471575028|FG005|Maintenance|Physician Decision|0|||
130986019|NCT00279201|471575023|FG000|Maintenance|Sponsor Decision|4|||
130986020|NCT00279201|471575024|FG001|Maintenance|Sponsor Decision|0|||
130986021|NCT00279201|471575025|FG002|Maintenance|Sponsor Decision|0|||
130986022|NCT00279201|471575026|FG003|Maintenance|Sponsor Decision|0|||
130986023|NCT00279201|471575027|FG004|Maintenance|Sponsor Decision|0|||
130986024|NCT00279201|471575028|FG005|Maintenance|Sponsor Decision|0|||
130986025|NCT00279201|471575023|FG000|Maintenance|HbA1c>7.5%|123|||
130986026|NCT00279201|471575024|FG001|Maintenance|HbA1c>7.5%|126|||
130986027|NCT00279201|471575025|FG002|Maintenance|HbA1c>7.5%|0|||
130986028|NCT00279201|471575026|FG003|Maintenance|HbA1c>7.5%|0|||
130986029|NCT00279201|471575027|FG004|Maintenance|HbA1c>7.5%|0|||
130986030|NCT00279201|471575028|FG005|Maintenance|HbA1c>7.5%|0|||
130986031|NCT00279201|471575023|FG000|Intensification Addendum|Withdrawal by Subject|0|||
130986032|NCT00279201|471575024|FG001|Intensification Addendum|Withdrawal by Subject|0|||
130986033|NCT00279201|471575025|FG002|Intensification Addendum|Withdrawal by Subject|12|||
130986034|NCT00279201|471575026|FG003|Intensification Addendum|Withdrawal by Subject|14|||
130986035|NCT00279201|471575027|FG004|Intensification Addendum|Withdrawal by Subject|9|||
130986036|NCT00279201|471575028|FG005|Intensification Addendum|Withdrawal by Subject|18|||
130986037|NCT00279201|471575023|FG000|Intensification Addendum|Lost to Follow-up|0|||
130986038|NCT00279201|471575024|FG001|Intensification Addendum|Lost to Follow-up|0|||
130986039|NCT00279201|471575025|FG002|Intensification Addendum|Lost to Follow-up|4|||
130986040|NCT00279201|471575026|FG003|Intensification Addendum|Lost to Follow-up|6|||
130986041|NCT00279201|471575027|FG004|Intensification Addendum|Lost to Follow-up|7|||
130986042|NCT00279201|471575028|FG005|Intensification Addendum|Lost to Follow-up|7|||
130986043|NCT00279201|471575023|FG000|Intensification Addendum|Protocol Violation|0|||
130986044|NCT00279201|471575024|FG001|Intensification Addendum|Protocol Violation|0|||
130986045|NCT00279201|471575025|FG002|Intensification Addendum|Protocol Violation|2|||
130986046|NCT00279201|471575026|FG003|Intensification Addendum|Protocol Violation|2|||
130986047|NCT00279201|471575027|FG004|Intensification Addendum|Protocol Violation|6|||
130986048|NCT00279201|471575028|FG005|Intensification Addendum|Protocol Violation|6|||
130986049|NCT00279201|471575023|FG000|Intensification Addendum|Adverse Event|0|||
130986050|NCT00279201|471575024|FG001|Intensification Addendum|Adverse Event|0|||
130986051|NCT00279201|471575025|FG002|Intensification Addendum|Adverse Event|0|||
130986052|NCT00279201|471575026|FG003|Intensification Addendum|Adverse Event|4|||
130986053|NCT00279201|471575027|FG004|Intensification Addendum|Adverse Event|1|||
130986054|NCT00279201|471575028|FG005|Intensification Addendum|Adverse Event|3|||
130986055|NCT00279201|471575023|FG000|Intensification Addendum|Physician Decision|0|||
130986056|NCT00279201|471575024|FG001|Intensification Addendum|Physician Decision|0|||
130986057|NCT00279201|471575025|FG002|Intensification Addendum|Physician Decision|4|||
130986058|NCT00279201|471575026|FG003|Intensification Addendum|Physician Decision|1|||
130986059|NCT00279201|471575027|FG004|Intensification Addendum|Physician Decision|3|||
130986060|NCT00279201|471575028|FG005|Intensification Addendum|Physician Decision|2|||
130986061|NCT00279201|471575023|FG000|Intensification Addendum|Sponsor Decision|0|||
130986062|NCT00279201|471575024|FG001|Intensification Addendum|Sponsor Decision|0|||
130986063|NCT00279201|471575025|FG002|Intensification Addendum|Sponsor Decision|0|||
130986064|NCT00279201|471575026|FG003|Intensification Addendum|Sponsor Decision|0|||
130986065|NCT00279201|471575027|FG004|Intensification Addendum|Sponsor Decision|1|||
130986066|NCT00279201|471575028|FG005|Intensification Addendum|Sponsor Decision|1|||
130986067|NCT00279201|471575023|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
130986068|NCT00279201|471575024|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
131046203|NCT03372057|471803792|FG000|Expansion Phase|Death|0|||
131046204|NCT03372057|471803793|FG001|Expansion Phase|Death|0|||
131046205|NCT03372057|471803794|FG002|Expansion Phase|Death|78|||
130986069|NCT00279201|471575025|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
130986070|NCT00279201|471575026|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
130986071|NCT00279201|471575027|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
130986072|NCT00279201|471575028|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
130986073|NCT00279201|471575023|FG000|Intensification Addendum|Lack of Efficacy|0|||
130986074|NCT00279201|471575024|FG001|Intensification Addendum|Lack of Efficacy|0|||
130986075|NCT00279201|471575025|FG002|Intensification Addendum|Lack of Efficacy|0|||
130986076|NCT00279201|471575026|FG003|Intensification Addendum|Lack of Efficacy|1|||
130986077|NCT00279201|471575027|FG004|Intensification Addendum|Lack of Efficacy|1|||
130986078|NCT00279201|471575028|FG005|Intensification Addendum|Lack of Efficacy|0|||
130986079|NCT00279201|471575023|FG000|Intensification Addendum|Death|0|||
130986080|NCT00279201|471575024|FG001|Intensification Addendum|Death|0|||
130986081|NCT00279201|471575025|FG002|Intensification Addendum|Death|0|||
130986082|NCT00279201|471575026|FG003|Intensification Addendum|Death|0|||
130986083|NCT00279201|471575027|FG004|Intensification Addendum|Death|1|||
130986084|NCT00279201|471575028|FG005|Intensification Addendum|Death|0|||
130986085|NCT02390531|471575031|FG000|Overall Study|Death|0|||
130986086|NCT02390531|471575032|FG001|Overall Study|Death|2|||
130986087|NCT02390531|471575033|FG002|Overall Study|Death|0|||
130986088|NCT02390531|471575034|FG003|Overall Study|Death|1|||
130986089|NCT02390531|471575035|FG004|Overall Study|Death|0|||
130986090|NCT02390531|471575036|FG005|Overall Study|Death|0|||
130986091|NCT02390531|471575037|FG006|Overall Study|Death|0|||
130986092|NCT02390531|471575038|FG007|Overall Study|Death|1|||
130986093|NCT02390531|471575031|FG000|Overall Study|Protocol Violation|0|||
130986094|NCT02390531|471575032|FG001|Overall Study|Protocol Violation|0|||
130986095|NCT02390531|471575033|FG002|Overall Study|Protocol Violation|0|||
130986096|NCT02390531|471575034|FG003|Overall Study|Protocol Violation|0|||
130986097|NCT02390531|471575035|FG004|Overall Study|Protocol Violation|1|||
130986098|NCT02390531|471575036|FG005|Overall Study|Protocol Violation|0|||
130986099|NCT02390531|471575037|FG006|Overall Study|Protocol Violation|2|||
130986100|NCT02390531|471575038|FG007|Overall Study|Protocol Violation|0|||
131046206|NCT03372057|471803792|FG000|Expansion Phase|Progressive Disease|0|||
131046207|NCT03372057|471803793|FG001|Expansion Phase|Progressive Disease|0|||
131046208|NCT03372057|471803794|FG002|Expansion Phase|Progressive Disease|1|||
131046209|NCT03372057|471803792|FG000|Expansion Phase|Adverse Event|0|||
131046210|NCT03372057|471803793|FG001|Expansion Phase|Adverse Event|0|||
131046211|NCT03372057|471803794|FG002|Expansion Phase|Adverse Event|1|||
131046212|NCT05953740|471803795|FG000|Period 1|Physician Decision|0|||
131046213|NCT05953740|471803796|FG001|Period 1|Physician Decision|1|||
131046214|NCT05953740|471803797|FG002|Period 1|Physician Decision|0|||
131046215|NCT05953740|471803798|FG003|Period 1|Physician Decision|0|||
131046216|NCT05953740|471803799|FG004|Period 1|Physician Decision|0|||
131046217|NCT05953740|471803800|FG005|Period 1|Physician Decision|0|||
131046218|NCT05953740|471803801|FG006|Period 1|Physician Decision|0|||
131046219|NCT05953740|471803802|FG007|Period 1|Physician Decision|0|||
131046220|NCT05953740|471803795|FG000|Period 2|Withdrawal by Subject|0|||
131046221|NCT05953740|471803796|FG001|Period 2|Withdrawal by Subject|1|||
131046222|NCT05953740|471803797|FG002|Period 2|Withdrawal by Subject|1|||
131046223|NCT05953740|471803798|FG003|Period 2|Withdrawal by Subject|0|||
131229476|NCT00628745|472465934|FG003|Overall Study|Withdrawal by Subject|2|||
131229477|NCT00628745|472465935|FG004|Overall Study|Withdrawal by Subject|69|||
131229478|NCT00628745|472465931|FG000|Overall Study|Does not meet inclusion criteria|0|||
131229479|NCT00628745|472465932|FG001|Overall Study|Does not meet inclusion criteria|12|||
131229480|NCT00628745|472465933|FG002|Overall Study|Does not meet inclusion criteria|0|||
131229481|NCT00628745|472465934|FG003|Overall Study|Does not meet inclusion criteria|0|||
131229482|NCT00628745|472465935|FG004|Overall Study|Does not meet inclusion criteria|18|||
131229483|NCT00628745|472465931|FG000|Overall Study|Participation in an interventional clinical trial|81|||
131229484|NCT00628745|472465932|FG001|Overall Study|Participation in an interventional clinical trial|4|||
131229485|NCT00628745|472465933|FG002|Overall Study|Participation in an interventional clinical trial|7|||
130986101|NCT00511875|471575039|FG000|Overall Study|Lost to Follow-up|4|||
130986102|NCT00511875|471575040|FG001|Overall Study|Lost to Follow-up|0|||
130986103|NCT00511875|471575039|FG000|Overall Study|Missing variables|1|||
131046224|NCT05953740|471803799|FG004|Period 2|Withdrawal by Subject|0|||
131046225|NCT05953740|471803800|FG005|Period 2|Withdrawal by Subject|0|||
130986104|NCT00511875|471575040|FG001|Overall Study|Missing variables|0|||
131046226|NCT05953740|471803801|FG006|Period 2|Withdrawal by Subject|0|||
131046227|NCT05953740|471803802|FG007|Period 2|Withdrawal by Subject|0|||
131046228|NCT03880955|471803803|FG000|Overall Study|Adverse Event|1|||
130720952|NCT00073021|470601567|FG000|Overall Study|Lack of Efficacy|11|||
130986105|NCT00542880|471575041|FG000|Period 1|Eligibility criteria not fulfilled|2|||
130986106|NCT00542880|471575042|FG001|Period 1|Eligibility criteria not fulfilled|6|||
130986107|NCT00542880|471575041|FG000|Period 1|Adverse Event|2|||
130986108|NCT00542880|471575042|FG001|Period 1|Adverse Event|2|||
131046229|NCT03880955|471803803|FG000|Overall Study|Death|1|||
131046230|NCT03880955|471803803|FG000|Overall Study|Lost to Follow-up|12|||
131046231|NCT03880955|471803803|FG000|Overall Study|Withdrawal by Subject|4|||
131046232|NCT03880955|471803803|FG000|Overall Study|Missing- Study Site Closed|27|||
131046233|NCT04214418|471803806|FG000|Overall Study|Withdrawal by Subject|1|||
131046234|NCT04214418|471803807|FG001|Overall Study|Withdrawal by Subject|0|||
131046235|NCT04214418|471803808|FG002|Overall Study|Withdrawal by Subject|0|||
130720953|NCT00073021|470601568|FG001|Overall Study|Lack of Efficacy|5|||
130720954|NCT01672970|470601570|FG000|Overall Study|Lack of Efficacy|12|||
130720955|NCT01672970|470601570|FG000|Overall Study|Adverse Event|18|||
130720956|NCT01672970|470601570|FG000|Overall Study|Withdrawal by Subject|2|||
130720957|NCT01672970|470601570|FG000|Overall Study|Lost to Follow-up|5|||
130720958|NCT01672970|470601570|FG000|Overall Study|Other|9|||
130720959|NCT01672970|470601570|FG000|Overall Study|Enrolled but not treated|1|||
130720960|NCT03276780|470601571|FG000|Overall Study|Withdrawal by Subject|5|||
130720961|NCT03276780|470601572|FG001|Overall Study|Withdrawal by Subject|3|||
130720962|NCT03276780|470601571|FG000|Overall Study|Lost to Follow-up|3|||
130720963|NCT03276780|470601572|FG001|Overall Study|Lost to Follow-up|5|||
130720964|NCT03276780|470601571|FG000|Overall Study|Moved out of state|1|||
130720965|NCT03276780|470601572|FG001|Overall Study|Moved out of state|1|||
130720966|NCT03276780|470601571|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
130720967|NCT03276780|470601572|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
130720968|NCT03276780|470601571|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
130720969|NCT03276780|470601572|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
130720970|NCT03835221|470601573|FG000|Methafilcon A|Withdrawal by Subject|1|||
130720971|NCT00390221|470601575|FG000|Overall Study|Lost to Follow-up|0|||
130720972|NCT00390221|470601576|FG001|Overall Study|Lost to Follow-up|3|||
131229486|NCT00628745|472465934|FG003|Overall Study|Participation in an interventional clinical trial|0|||
130720973|NCT00390221|470601577|FG002|Overall Study|Lost to Follow-up|0|||
131046236|NCT04214418|471803809|FG003|Overall Study|Withdrawal by Subject|0|||
131046237|NCT04214418|471803810|FG004|Overall Study|Withdrawal by Subject|0|||
131046238|NCT04214418|471803811|FG005|Overall Study|Withdrawal by Subject|0|||
131046239|NCT04214418|471803806|FG000|Overall Study|Adverse Event|0|||
131046240|NCT04214418|471803807|FG001|Overall Study|Adverse Event|2|||
131046241|NCT04214418|471803808|FG002|Overall Study|Adverse Event|0|||
131046242|NCT04214418|471803809|FG003|Overall Study|Adverse Event|0|||
131046243|NCT04214418|471803810|FG004|Overall Study|Adverse Event|0|||
131046244|NCT04214418|471803811|FG005|Overall Study|Adverse Event|0|||
131046245|NCT04214418|471803806|FG000|Overall Study|Death|1|||
131046246|NCT04214418|471803807|FG001|Overall Study|Death|0|||
131046247|NCT04214418|471803808|FG002|Overall Study|Death|0|||
131046248|NCT04214418|471803809|FG003|Overall Study|Death|0|||
131046249|NCT04214418|471803810|FG004|Overall Study|Death|0|||
131046250|NCT04214418|471803811|FG005|Overall Study|Death|0|||
131046251|NCT04635059|471803813|FG000|Overall Study|Study terminated early.|4|||
131046252|NCT03011034|471803817|FG000|Overall Study|Adverse Event|1|||
131046253|NCT03011034|471803818|FG001|Overall Study|Adverse Event|0|||
131046254|NCT00319111|471803821|FG000|Overall Study|Adverse Event|20|||
131046255|NCT00319111|471803821|FG000|Overall Study|Withdrawal of consent|11|||
131046256|NCT00319111|471803821|FG000|Overall Study|Death|9|||
131046257|NCT00319111|471803821|FG000|Overall Study|Lack of clinical improvement|4|||
131046258|NCT00319111|471803821|FG000|Overall Study|Administrative|2|||
131046259|NCT00319111|471803821|FG000|Overall Study|Treatment failure|1|||
131046260|NCT01438853|471803824|FG000|Overall Study|Death|0|||
131046261|NCT01438853|471803825|FG001|Overall Study|Death|0|||
131046262|NCT01438853|471803826|FG002|Overall Study|Death|0|||
131046263|NCT01438853|471803827|FG003|Overall Study|Death|1|||
131046264|NCT01438853|471803824|FG000|Overall Study|Withdrawal by Subject|0|||
131046265|NCT01438853|471803825|FG001|Overall Study|Withdrawal by Subject|0|||
131046266|NCT01438853|471803826|FG002|Overall Study|Withdrawal by Subject|1|||
131046267|NCT01438853|471803827|FG003|Overall Study|Withdrawal by Subject|0|||
131046268|NCT02624050|471803828|FG000|Overall Study|Physician Decision|4|||
130720974|NCT00390221|470601575|FG000|Overall Study|Adverse Event|1|||
131046269|NCT02624050|471803829|FG001|Overall Study|Physician Decision|0|||
131046270|NCT02624050|471803828|FG000|Overall Study|Protocol Violation|2|||
130720975|NCT00390221|470601576|FG001|Overall Study|Adverse Event|4|||
131046271|NCT02624050|471803829|FG001|Overall Study|Protocol Violation|0|||
131046272|NCT03904576|471803830|FG000|Washout Period|Protocol Violation|1|||
131046273|NCT03904576|471803831|FG001|Washout Period|Protocol Violation|1|||
131046274|NCT04743973|471803833|FG000|Overall Study|Withdrawal by Subject|5|||
131046275|NCT03279978|471803834|FG000|Overall Study|Withdrawal by Subject|0|||
131046276|NCT03279978|471803835|FG001|Overall Study|Withdrawal by Subject|1|||
130720976|NCT00390221|470601577|FG002|Overall Study|Adverse Event|3|||
130720977|NCT00390221|470601575|FG000|Overall Study|Investigator Decision|0|||
131046277|NCT03279978|471803836|FG002|Overall Study|Withdrawal by Subject|0|||
131046278|NCT03279978|471803837|FG003|Overall Study|Withdrawal by Subject|0|||
131046279|NCT03279978|471803838|FG004|Overall Study|Withdrawal by Subject|0|||
131046280|NCT03279978|471803839|FG005|Overall Study|Withdrawal by Subject|0|||
131046281|NCT03279978|471803840|FG006|Overall Study|Withdrawal by Subject|0|||
131046282|NCT03279978|471803841|FG007|Overall Study|Withdrawal by Subject|0|||
131046283|NCT03279978|471803842|FG008|Overall Study|Withdrawal by Subject|0|||
131046284|NCT03279978|471803843|FG009|Overall Study|Withdrawal by Subject|1|||
131046285|NCT03279978|471803834|FG000|Overall Study|Lost to Follow-up|1|||
131046286|NCT03279978|471803835|FG001|Overall Study|Lost to Follow-up|0|||
131046287|NCT03279978|471803836|FG002|Overall Study|Lost to Follow-up|1|||
131046288|NCT03279978|471803837|FG003|Overall Study|Lost to Follow-up|0|||
131046289|NCT03279978|471803838|FG004|Overall Study|Lost to Follow-up|0|||
131046290|NCT03279978|471803839|FG005|Overall Study|Lost to Follow-up|0|||
131046291|NCT03279978|471803840|FG006|Overall Study|Lost to Follow-up|0|||
131046292|NCT03279978|471803841|FG007|Overall Study|Lost to Follow-up|0|||
131046293|NCT03279978|471803842|FG008|Overall Study|Lost to Follow-up|0|||
131046294|NCT03279978|471803843|FG009|Overall Study|Lost to Follow-up|0|||
131046295|NCT03279978|471803834|FG000|Overall Study|Other than stated above|0|||
131046296|NCT03279978|471803835|FG001|Overall Study|Other than stated above|0|||
131046297|NCT03279978|471803836|FG002|Overall Study|Other than stated above|0|||
131046298|NCT03279978|471803837|FG003|Overall Study|Other than stated above|0|||
131046299|NCT03279978|471803838|FG004|Overall Study|Other than stated above|0|||
131046300|NCT03279978|471803839|FG005|Overall Study|Other than stated above|0|||
131046301|NCT03279978|471803840|FG006|Overall Study|Other than stated above|1|||
131046302|NCT03279978|471803841|FG007|Overall Study|Other than stated above|0|||
131046303|NCT03279978|471803842|FG008|Overall Study|Other than stated above|0|||
131046304|NCT03279978|471803843|FG009|Overall Study|Other than stated above|0|||
131046305|NCT04330040|471803844|FG000|Overall Study|Other: Adverse event|5|||
131046306|NCT04330040|471803845|FG001|Overall Study|Other: Adverse event|0|||
131046307|NCT04330040|471803846|FG002|Overall Study|Other: Adverse event|0|||
131046308|NCT04330040|471803844|FG000|Overall Study|Disease progression|38|||
131046309|NCT04330040|471803845|FG001|Overall Study|Disease progression|10|||
131046310|NCT04330040|471803846|FG002|Overall Study|Disease progression|0|||
131046311|NCT04330040|471803844|FG000|Overall Study|Physician Decision|5|||
131046312|NCT04330040|471803845|FG001|Overall Study|Physician Decision|3|||
131046313|NCT04330040|471803846|FG002|Overall Study|Physician Decision|0|||
131046314|NCT04330040|471803844|FG000|Overall Study|Lost to Follow-up|1|||
131046315|NCT04330040|471803845|FG001|Overall Study|Lost to Follow-up|1|||
131046316|NCT04330040|471803846|FG002|Overall Study|Lost to Follow-up|0|||
131046317|NCT04330040|471803844|FG000|Overall Study|Death|2|||
131046318|NCT04330040|471803845|FG001|Overall Study|Death|1|||
131046319|NCT04330040|471803846|FG002|Overall Study|Death|0|||
131046320|NCT04330040|471803844|FG000|Overall Study|Withdrawal by Subject|3|||
131046321|NCT04330040|471803845|FG001|Overall Study|Withdrawal by Subject|3|||
131046322|NCT04330040|471803846|FG002|Overall Study|Withdrawal by Subject|0|||
131046323|NCT04330040|471803844|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
131046324|NCT04330040|471803845|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
131046325|NCT04330040|471803846|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
131046326|NCT04330040|471803844|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
131046327|NCT04330040|471803845|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
131046328|NCT04330040|471803846|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
131046329|NCT04330040|471803844|FG000|Overall Study|Other: Disease progression|1|||
131046330|NCT04330040|471803845|FG001|Overall Study|Other: Disease progression|0|||
131046331|NCT04330040|471803846|FG002|Overall Study|Other: Disease progression|0|||
131046332|NCT04330040|471803844|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
131046333|NCT04330040|471803845|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
131046334|NCT04330040|471803846|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
131046335|NCT04330040|471803844|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
130720978|NCT00390221|470601576|FG001|Overall Study|Investigator Decision|0|||
131046336|NCT04330040|471803845|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
131046337|NCT04330040|471803846|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
131046338|NCT04330040|471803844|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
131046339|NCT04330040|471803845|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
131046340|NCT04330040|471803846|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
131046341|NCT00626795|471803849|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
131133779|NCT00883337|472117188|FG002|Core Treatment Period|Other than above|1|||
131133780|NCT00883337|472117186|FG000|Extension Treatment Period|Adverse Event|8|||
131133781|NCT00883337|472117187|FG001|Extension Treatment Period|Adverse Event|5|||
131133782|NCT00883337|472117188|FG002|Extension Treatment Period|Adverse Event|5|||
131133783|NCT00883337|472117186|FG000|Extension Treatment Period|Lack of Efficacy|8|||
131133784|NCT00883337|472117187|FG001|Extension Treatment Period|Lack of Efficacy|8|||
131133785|NCT00883337|472117188|FG002|Extension Treatment Period|Lack of Efficacy|8|||
130720979|NCT00390221|470601577|FG002|Overall Study|Investigator Decision|1|||
130986109|NCT00542880|471575041|FG000|Period 1|Development of study-specific criteria|1|||
130986110|NCT00542880|471575042|FG001|Period 1|Development of study-specific criteria|2|||
130986111|NCT00542880|471575041|FG000|Period 1|Withdrawal by Subject|1|||
131046342|NCT00626795|471803850|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
131046343|NCT00626795|471803851|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
131046344|NCT00626795|471803849|FG000|Blinded Treatment|Lack of Efficacy|2|||
131046345|NCT00626795|471803850|FG001|Blinded Treatment|Lack of Efficacy|0|||
131046346|NCT00626795|471803851|FG002|Blinded Treatment|Lack of Efficacy|0|||
131046347|NCT00626795|471803849|FG000|Blinded Treatment|Unacceptable adverse event|0|||
131046348|NCT00626795|471803850|FG001|Blinded Treatment|Unacceptable adverse event|0|||
131046349|NCT00626795|471803851|FG002|Blinded Treatment|Unacceptable adverse event|1|||
131046350|NCT00626795|471803849|FG000|Blinded Treatment|Protocol Violation|0|||
131046351|NCT00626795|471803850|FG001|Blinded Treatment|Protocol Violation|1|||
131046352|NCT00626795|471803851|FG002|Blinded Treatment|Protocol Violation|1|||
131046353|NCT00626795|471803849|FG000|Blinded Treatment|Withdrawal by Subject|1|||
131046354|NCT00626795|471803850|FG001|Blinded Treatment|Withdrawal by Subject|1|||
131046355|NCT00626795|471803851|FG002|Blinded Treatment|Withdrawal by Subject|0|||
131046356|NCT00626795|471803849|FG000|Blinded Treatment|Other reasons|2|||
131046357|NCT00626795|471803850|FG001|Blinded Treatment|Other reasons|0|||
131046358|NCT00626795|471803851|FG002|Blinded Treatment|Other reasons|2|||
131046359|NCT00626795|471803849|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
131046360|NCT00626795|471803850|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
131046361|NCT00626795|471803851|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
131046362|NCT01756300|471803857|FG000|Overall Study|Death|1|||
131046363|NCT01756300|471803857|FG000|Overall Study|Withdrawal by Subject|1|||
131046364|NCT03990883|471803858|FG000|Blinded Treatment Phase|Adverse Event|1|||
131046365|NCT03990883|471803859|FG001|Blinded Treatment Phase|Adverse Event|1|||
131046366|NCT03990883|471803860|FG002|Blinded Treatment Phase|Adverse Event|0|||
130986112|NCT00542880|471575042|FG001|Period 1|Withdrawal by Subject|1|||
130986113|NCT00542880|471575041|FG000|Period 1|Protocol Violation|0|||
130986114|NCT00542880|471575042|FG001|Period 1|Protocol Violation|1|||
130986115|NCT00542880|471575041|FG000|Period 2|Adverse Event|5|||
130986116|NCT00542880|471575042|FG001|Period 2|Adverse Event|7|||
130986117|NCT00542880|471575041|FG000|Period 2|Eligibility not fulfilled|0|||
130986118|NCT00542880|471575042|FG001|Period 2|Eligibility not fulfilled|1|||
130986119|NCT00542880|471575041|FG000|Period 2|Discontinuation criteria|2|||
130986120|NCT00542880|471575042|FG001|Period 2|Discontinuation criteria|0|||
130986121|NCT00542880|471575041|FG000|Period 2|Severe non-compliance|0|||
130986122|NCT00542880|471575042|FG001|Period 2|Severe non-compliance|1|||
130986123|NCT00542880|471575041|FG000|Period 2|Other|0|||
130986124|NCT00542880|471575042|FG001|Period 2|Other|1|||
130986125|NCT00542880|471575041|FG000|Period 3|Adverse Event|0|||
130986126|NCT00542880|471575042|FG001|Period 3|Adverse Event|2|||
130986127|NCT00696384|471575043|FG000|Open Label Phase|Adverse Event|27|||
130986128|NCT00696384|471575044|FG001|Open Label Phase|Adverse Event|0|||
130986129|NCT00696384|471575045|FG002|Open Label Phase|Adverse Event|0|||
130986130|NCT00696384|471575043|FG000|Open Label Phase|Protocol Violation|18|||
130986131|NCT00696384|471575044|FG001|Open Label Phase|Protocol Violation|0|||
130986132|NCT00696384|471575045|FG002|Open Label Phase|Protocol Violation|0|||
130986133|NCT00696384|471575043|FG000|Open Label Phase|Lost to Follow-up|24|||
130986134|NCT00696384|471575044|FG001|Open Label Phase|Lost to Follow-up|0|||
130986135|NCT00696384|471575045|FG002|Open Label Phase|Lost to Follow-up|0|||
130986136|NCT00696384|471575043|FG000|Open Label Phase|Withdrawal by Subject|37|||
130986137|NCT00696384|471575044|FG001|Open Label Phase|Withdrawal by Subject|0|||
130986138|NCT00696384|471575045|FG002|Open Label Phase|Withdrawal by Subject|0|||
130986139|NCT00696384|471575043|FG000|Open Label Phase|Other|6|||
130986140|NCT00696384|471575044|FG001|Open Label Phase|Other|0|||
130986141|NCT00696384|471575045|FG002|Open Label Phase|Other|0|||
130986142|NCT00696384|471575043|FG000|Open Label Phase|Lack of Efficacy|3|||
130986143|NCT00696384|471575044|FG001|Open Label Phase|Lack of Efficacy|0|||
131046367|NCT03990883|471803858|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
130986144|NCT00696384|471575045|FG002|Open Label Phase|Lack of Efficacy|0|||
130986145|NCT00696384|471575043|FG000|Open Label Phase|Physician Decision|4|||
130986146|NCT00696384|471575044|FG001|Open Label Phase|Physician Decision|0|||
131046368|NCT03990883|471803859|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
131046369|NCT03990883|471803860|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
131046370|NCT03990883|471803858|FG000|Blinded Treatment Phase|Physician Decision|1|||
130986147|NCT00696384|471575045|FG002|Open Label Phase|Physician Decision|0|||
131046371|NCT03990883|471803859|FG001|Blinded Treatment Phase|Physician Decision|0|||
131046372|NCT03990883|471803860|FG002|Blinded Treatment Phase|Physician Decision|0|||
131046373|NCT03990883|471803858|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
131133786|NCT00883337|472117186|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
131133787|NCT00883337|472117187|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
131133788|NCT00883337|472117188|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
130986148|NCT00696384|471575043|FG000|Double Blind Phase|Adverse Event|0|||
131133789|NCT00883337|472117186|FG000|Extension Treatment Period|Lost to Follow-up|1|||
131133790|NCT00883337|472117187|FG001|Extension Treatment Period|Lost to Follow-up|0|||
131133791|NCT00883337|472117188|FG002|Extension Treatment Period|Lost to Follow-up|0|||
131133792|NCT00883337|472117186|FG000|Extension Treatment Period|Other than above|10|||
131133793|NCT00883337|472117187|FG001|Extension Treatment Period|Other than above|9|||
131133794|NCT00883337|472117188|FG002|Extension Treatment Period|Other than above|5|||
131133795|NCT03468309|472117192|FG000|Overall Study|Lost to Follow-up|4|||
130720980|NCT00390221|470601575|FG000|Overall Study|Withdrawal by Subject|13|||
130986149|NCT00696384|471575044|FG001|Double Blind Phase|Adverse Event|2|||
130986150|NCT00696384|471575045|FG002|Double Blind Phase|Adverse Event|2|||
130986151|NCT00696384|471575043|FG000|Double Blind Phase|Lost to Follow-up|0|||
130986152|NCT00696384|471575044|FG001|Double Blind Phase|Lost to Follow-up|2|||
130986153|NCT00696384|471575045|FG002|Double Blind Phase|Lost to Follow-up|1|||
130986154|NCT00696384|471575043|FG000|Double Blind Phase|Withdrawal by Subject|0|||
130986155|NCT00696384|471575044|FG001|Double Blind Phase|Withdrawal by Subject|4|||
130986156|NCT00696384|471575045|FG002|Double Blind Phase|Withdrawal by Subject|3|||
130986157|NCT00696384|471575043|FG000|Double Blind Phase|Lack of Efficacy|0|||
130986158|NCT00696384|471575044|FG001|Double Blind Phase|Lack of Efficacy|1|||
130986159|NCT00696384|471575045|FG002|Double Blind Phase|Lack of Efficacy|0|||
130986160|NCT00696384|471575043|FG000|Double Blind Phase|Physician Decision|0|||
130986161|NCT00696384|471575044|FG001|Double Blind Phase|Physician Decision|2|||
130986162|NCT00696384|471575045|FG002|Double Blind Phase|Physician Decision|0|||
130986163|NCT01678131|471575046|FG000|Overall Study|Adverse Event|0|||
130986164|NCT01678131|471575047|FG001|Overall Study|Adverse Event|1|||
130986165|NCT01678131|471575048|FG002|Overall Study|Adverse Event|0|||
130986166|NCT01678131|471575046|FG000|Overall Study|Withdrawal by Subject|0|||
130986167|NCT01678131|471575047|FG001|Overall Study|Withdrawal by Subject|0|||
130986168|NCT01678131|471575048|FG002|Overall Study|Withdrawal by Subject|2|||
130986169|NCT02027402|471575050|FG000|Overall Study|Withdrawal by Subject|4|||
130986170|NCT02027402|471575051|FG001|Overall Study|Withdrawal by Subject|1|||
130986171|NCT00941798|471575055|FG000|Overall Study|Withdrawal by Subject|72|||
130986172|NCT00941798|471575056|FG001|Overall Study|Withdrawal by Subject|74|||
130986173|NCT00941798|471575055|FG000|Overall Study|Adverse Event|43|||
130986174|NCT00941798|471575056|FG001|Overall Study|Adverse Event|23|||
130986175|NCT00941798|471575055|FG000|Overall Study|Lost to Follow-up|29|||
130986176|NCT00941798|471575056|FG001|Overall Study|Lost to Follow-up|23|||
130986177|NCT00941798|471575055|FG000|Overall Study|Protocol Violation|17|||
130986178|NCT00941798|471575056|FG001|Overall Study|Protocol Violation|20|||
130986179|NCT00941798|471575055|FG000|Overall Study|Administrative problems|13|||
130986180|NCT00941798|471575056|FG001|Overall Study|Administrative problems|23|||
130986181|NCT00941798|471575055|FG000|Overall Study|Lack of Efficacy|10|||
130986182|NCT00941798|471575056|FG001|Overall Study|Lack of Efficacy|17|||
130986183|NCT00941798|471575055|FG000|Overall Study|Patient's inability to use device|6|||
130986184|NCT00941798|471575056|FG001|Overall Study|Patient's inability to use device|1|||
130986185|NCT00941798|471575055|FG000|Overall Study|Abnormal test procedure results|3|||
130986186|NCT00941798|471575056|FG001|Overall Study|Abnormal test procedure results|1|||
130986187|NCT00941798|471575055|FG000|Overall Study|Abnormal laboratory values|1|||
130986188|NCT00941798|471575056|FG001|Overall Study|Abnormal laboratory values|2|||
130986189|NCT00941798|471575055|FG000|Overall Study|Death|0|||
130986190|NCT00941798|471575056|FG001|Overall Study|Death|1|||
130986191|NCT03444376|471575061|FG000|Part A|Disease relapse or Progression|1|||
130986192|NCT03444376|471575061|FG000|Part A|Withdrawal by Subject|2|||
130986193|NCT03444376|471575061|FG000|Part A|Adverse Event|1|||
130986194|NCT03444376|471575061|FG000|Part B|Disease relapse or Progression|18|||
130986195|NCT03444376|471575061|FG000|Part B|Withdrawal by Subject|2|||
130986196|NCT03444376|471575061|FG000|Part B|Adverse Event|2|||
130986197|NCT03444376|471575061|FG000|Part B|Physician Decision|1|||
130986198|NCT03444376|471575061|FG000|Part C|Disease relapse or Progression|43|||
130986199|NCT03444376|471575061|FG000|Part C|Withdrawal by Subject|5|||
130986200|NCT03444376|471575061|FG000|Part C|Adverse Event|2|||
130986201|NCT03444376|471575061|FG000|Part C|Physician Decision|2|||
130986202|NCT03444376|471575061|FG000|Part C|Death|1|||
130986203|NCT00766675|471576246|FG000|Overall Study|Adverse Event|16|||
130986204|NCT00766675|471576246|FG000|Overall Study|Lost to Follow-up|2|||
130986205|NCT00766675|471576246|FG000|Overall Study|Withdrawal by Subject|11|||
130986206|NCT00766675|471576246|FG000|Overall Study|Protocol Violation|8|||
130986207|NCT00766675|471576246|FG000|Overall Study|Participant took prohibited medication|1|||
130986208|NCT00766675|471576246|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
130986209|NCT00766675|471576246|FG000|Overall Study|Insufficient therapy|1|||
130986210|NCT03308825|471576247|FG000|Overall Study|Lost to Follow-up|2|||
130986211|NCT03308825|471576248|FG001|Overall Study|Lost to Follow-up|2|||
130986212|NCT03308825|471576249|FG002|Overall Study|Lost to Follow-up|1|||
130986213|NCT03308825|471576250|FG003|Overall Study|Lost to Follow-up|0|||
130986214|NCT03308825|471576247|FG000|Overall Study|Protocol Violation|0|||
130986215|NCT03308825|471576248|FG001|Overall Study|Protocol Violation|2|||
130986216|NCT03308825|471576249|FG002|Overall Study|Protocol Violation|0|||
130720981|NCT00390221|470601576|FG001|Overall Study|Withdrawal by Subject|9|||
130720982|NCT00390221|470601577|FG002|Overall Study|Withdrawal by Subject|7|||
130720983|NCT00390221|470601575|FG000|Overall Study|Subject Non-compliance|1|||
131046374|NCT03990883|471803859|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
131046375|NCT03990883|471803860|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
131046376|NCT03990883|471803858|FG000|Blinded Treatment Phase|COVID-19|3|||
131046377|NCT03990883|471803859|FG001|Blinded Treatment Phase|COVID-19|2|||
131046378|NCT03990883|471803860|FG002|Blinded Treatment Phase|COVID-19|0|||
131046379|NCT03990883|471803858|FG000|Blinded Treatment Phase|Personal Reasons|6|||
131046380|NCT03990883|471803859|FG001|Blinded Treatment Phase|Personal Reasons|3|||
131046381|NCT03990883|471803860|FG002|Blinded Treatment Phase|Personal Reasons|0|||
131046382|NCT03990883|471803858|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
131046383|NCT03990883|471803859|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
131046384|NCT03990883|471803860|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
130720984|NCT00390221|470601576|FG001|Overall Study|Subject Non-compliance|0|||
131046385|NCT03990883|471803858|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
131046386|NCT03990883|471803859|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
131046387|NCT03990883|471803860|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
131046388|NCT03990883|471803858|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
131046389|NCT03990883|471803859|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
131046390|NCT03990883|471803860|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
131046391|NCT04427007|471804750|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
131046392|NCT04427007|471804751|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
131046393|NCT06262347|471804756|FG000|Overall Study|Lost to Follow-up|4|||
131046394|NCT06262347|471804757|FG001|Overall Study|Lost to Follow-up|3|||
131046395|NCT06262347|471804756|FG000|Overall Study|Withdrawal by Subject|0|||
131046396|NCT06262347|471804757|FG001|Overall Study|Withdrawal by Subject|1|||
131046397|NCT02095691|471804766|FG000|Overall Study|Physician Decision|1|||
131046398|NCT00887198|471804767|FG000|Randomized Period|Ongoing|42|||
131046399|NCT00887198|471804768|FG001|Randomized Period|Ongoing|0|||
131046400|NCT00887198|471804769|FG002|Randomized Period|Ongoing|0|||
131046401|NCT00887198|471804767|FG000|Randomized Period|Adverse Event|50|||
131046402|NCT00887198|471804768|FG001|Randomized Period|Adverse Event|33|||
131046403|NCT00887198|471804769|FG002|Randomized Period|Adverse Event|0|||
131046404|NCT00887198|471804767|FG000|Randomized Period|Lost to Follow-up|1|||
131046405|NCT00887198|471804768|FG001|Randomized Period|Lost to Follow-up|0|||
131046406|NCT00887198|471804769|FG002|Randomized Period|Lost to Follow-up|0|||
131046407|NCT00887198|471804767|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
131046408|NCT00887198|471804768|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
131046409|NCT00887198|471804769|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
131046410|NCT00887198|471804767|FG000|Randomized Period|Withdrawal by Subject|41|||
131046411|NCT00887198|471804768|FG001|Randomized Period|Withdrawal by Subject|56|||
131046412|NCT00887198|471804769|FG002|Randomized Period|Withdrawal by Subject|0|||
131046413|NCT00887198|471804767|FG000|Randomized Period|Progressive disease|366|||
131046414|NCT00887198|471804768|FG001|Randomized Period|Progressive disease|370|||
131046415|NCT00887198|471804769|FG002|Randomized Period|Progressive disease|0|||
131046416|NCT00887198|471804767|FG000|Randomized Period|Other|42|||
131046417|NCT00887198|471804768|FG001|Randomized Period|Other|30|||
131046418|NCT00887198|471804769|FG002|Randomized Period|Other|0|||
131046419|NCT00887198|471804767|FG000|Randomized Period|Randomized, Not treated|4|||
131046420|NCT00887198|471804768|FG001|Randomized Period|Randomized, Not treated|2|||
131046421|NCT00887198|471804769|FG002|Randomized Period|Randomized, Not treated|0|||
131046422|NCT00887198|471804767|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
131046423|NCT00887198|471804768|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
131046424|NCT00887198|471804769|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
131046425|NCT00887198|471804767|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
131046426|NCT00887198|471804768|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
131046427|NCT00887198|471804769|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
131046428|NCT00887198|471804767|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
131046429|NCT00887198|471804768|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
131046430|NCT00887198|471804769|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
131046431|NCT00887198|471804767|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
131133796|NCT03468309|472117192|FG000|Overall Study|Withdrawal by Subject|2|||
131133797|NCT05131204|472117200|FG000|Overall Study|Sponsor request|2|||
130720985|NCT00390221|470601577|FG002|Overall Study|Subject Non-compliance|2|||
130720986|NCT00390221|470601575|FG000|Overall Study|Other|3|||
131046432|NCT00887198|471804768|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
131046433|NCT00887198|471804769|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
131046434|NCT00887198|471804767|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
130720987|NCT00390221|470601576|FG001|Overall Study|Other|4|||
130720988|NCT00390221|470601577|FG002|Overall Study|Other|2|||
130720989|NCT02533375|470601578|FG000|Overall Study|Lack of Efficacy|3|||
130720990|NCT02533375|470601578|FG000|Overall Study|Adverse Event|2|||
131046435|NCT00887198|471804768|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
131046436|NCT00887198|471804769|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
131046437|NCT00887198|471804767|FG000|Cross Over (Placebo to AA)|Other|0|||
131046438|NCT00887198|471804768|FG001|Cross Over (Placebo to AA)|Other|0|||
131229487|NCT00628745|472465935|FG004|Overall Study|Participation in an interventional clinical trial|63|||
131229488|NCT00628745|472465931|FG000|Overall Study|Physician Decision|8|||
131229489|NCT00628745|472465932|FG001|Overall Study|Physician Decision|4|||
131229490|NCT00628745|472465933|FG002|Overall Study|Physician Decision|3|||
131229491|NCT00628745|472465934|FG003|Overall Study|Physician Decision|0|||
131229492|NCT00628745|472465935|FG004|Overall Study|Physician Decision|30|||
131229493|NCT00628745|472465931|FG000|Overall Study|Lost to Follow-up|109|||
131229494|NCT00628745|472465932|FG001|Overall Study|Lost to Follow-up|7|||
131229495|NCT00628745|472465933|FG002|Overall Study|Lost to Follow-up|7|||
131229496|NCT00628745|472465934|FG003|Overall Study|Lost to Follow-up|0|||
131229497|NCT00628745|472465935|FG004|Overall Study|Lost to Follow-up|498|||
131229498|NCT00628745|472465931|FG000|Overall Study|Death|197|||
131229499|NCT00628745|472465932|FG001|Overall Study|Death|81|||
131229500|NCT00628745|472465933|FG002|Overall Study|Death|12|||
131229501|NCT00628745|472465934|FG003|Overall Study|Death|4|||
131229502|NCT00628745|472465935|FG004|Overall Study|Death|939|||
131229503|NCT00628745|472465931|FG000|Overall Study|Participant transferred to another THAOS site|6|||
131229504|NCT00628745|472465932|FG001|Overall Study|Participant transferred to another THAOS site|0|||
131229505|NCT00628745|472465933|FG002|Overall Study|Participant transferred to another THAOS site|0|||
131229506|NCT00628745|472465934|FG003|Overall Study|Participant transferred to another THAOS site|0|||
131229507|NCT00628745|472465935|FG004|Overall Study|Participant transferred to another THAOS site|7|||
131229508|NCT00628745|472465931|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
131229509|NCT00628745|472465932|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
131229510|NCT00628745|472465933|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
131229511|NCT00628745|472465934|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
131229512|NCT00628745|472465935|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
131229513|NCT00628745|472465931|FG000|Overall Study|Site closure|152|||
131229514|NCT00628745|472465932|FG001|Overall Study|Site closure|146|||
131229515|NCT00628745|472465933|FG002|Overall Study|Site closure|6|||
131229516|NCT00628745|472465934|FG003|Overall Study|Site closure|8|||
131229517|NCT00628745|472465935|FG004|Overall Study|Site closure|691|||
131229518|NCT00628745|472465931|FG000|Overall Study|Duplicate participant|0|||
131229519|NCT00628745|472465932|FG001|Overall Study|Duplicate participant|0|||
131229520|NCT00628745|472465933|FG002|Overall Study|Duplicate participant|0|||
131229521|NCT00628745|472465934|FG003|Overall Study|Duplicate participant|0|||
131229522|NCT00628745|472465935|FG004|Overall Study|Duplicate participant|1|||
131229523|NCT00628745|472465931|FG000|Overall Study|Missing|4|||
130986217|NCT03308825|471576250|FG003|Overall Study|Protocol Violation|0|||
130986218|NCT00685945|471576251|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
130986219|NCT01728792|471576252|FG000|Overall Study|Withdrawal of Consent|1|||
130986220|NCT01728792|471576253|FG001|Overall Study|Withdrawal of Consent|1|||
130986221|NCT01728792|471576254|FG002|Overall Study|Withdrawal of Consent|0|||
130986222|NCT01728792|471576255|FG003|Overall Study|Withdrawal of Consent|1|||
130986223|NCT01728792|471576256|FG004|Overall Study|Withdrawal of Consent|0|||
130986224|NCT01728792|471576252|FG000|Overall Study|Lost to Follow-up|2|||
130986225|NCT01728792|471576253|FG001|Overall Study|Lost to Follow-up|1|||
130986226|NCT01728792|471576254|FG002|Overall Study|Lost to Follow-up|4|||
130986227|NCT01728792|471576255|FG003|Overall Study|Lost to Follow-up|2|||
130986228|NCT01728792|471576256|FG004|Overall Study|Lost to Follow-up|0|||
130986229|NCT04277455|471576259|FG000|Overall Study|Lost to Follow-up|1|||
130986230|NCT04737109|471576260|FG000|Study Treatment|Disease Progression|5|||
130986231|NCT04737109|471576261|FG001|Study Treatment|Disease Progression|0|||
130986232|NCT04737109|471576262|FG002|Study Treatment|Disease Progression|0|||
130986233|NCT04737109|471576263|FG003|Study Treatment|Disease Progression|0|||
130986234|NCT04737109|471576260|FG000|Study Treatment|Death on study|1|||
130986235|NCT04737109|471576261|FG001|Study Treatment|Death on study|0|||
130986236|NCT04737109|471576262|FG002|Study Treatment|Death on study|0|||
130986237|NCT04737109|471576263|FG003|Study Treatment|Death on study|0|||
130986238|NCT01582789|471576268|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
130986239|NCT01582789|471576269|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
130986240|NCT02259517|471576270|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
131229524|NCT00628745|472465932|FG001|Overall Study|Missing|3|||
131229525|NCT00628745|472465933|FG002|Overall Study|Missing|0|||
131229526|NCT00628745|472465934|FG003|Overall Study|Missing|0|||
131229527|NCT00628745|472465935|FG004|Overall Study|Missing|10|||
131229528|NCT00628745|472465931|FG000|Overall Study|Othe reasons|987|||
131229529|NCT00628745|472465932|FG001|Overall Study|Othe reasons|373|||
131229530|NCT00628745|472465933|FG002|Overall Study|Othe reasons|105|||
130986241|NCT02259517|471576271|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
130986242|NCT02259517|471576272|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
130720991|NCT02823652|470601586|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
130720992|NCT02823652|470601587|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
130986243|NCT02259517|471576270|FG000|Overall Study|Withdrawal by Subject|0|||
130986244|NCT02259517|471576271|FG001|Overall Study|Withdrawal by Subject|0|||
130986245|NCT02259517|471576272|FG002|Overall Study|Withdrawal by Subject|3|||
130986246|NCT02276066|471576273|FG000|Overall Study|Lost to Follow-up|21|||
130986247|NCT02276066|471576274|FG001|Overall Study|Lost to Follow-up|11|||
130986248|NCT02710292|471576282|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
130986249|NCT02710292|471576283|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
130986250|NCT02710292|471576282|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
130986251|NCT02710292|471576283|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
130986252|NCT01191840|471576284|FG000|Overall Study|withdrew consent|2|||
130986253|NCT01191840|471576285|FG001|Overall Study|withdrew consent|1|||
130986254|NCT01191840|471576284|FG000|Overall Study|Subject discontinued treatment|1|||
130986255|NCT01191840|471576285|FG001|Overall Study|Subject discontinued treatment|2|||
130986256|NCT01191840|471576284|FG000|Overall Study|Lost to Follow-up|4|||
130986257|NCT01191840|471576285|FG001|Overall Study|Lost to Follow-up|6|||
130986258|NCT01191840|471576284|FG000|Overall Study|Non Staph Infection|4|||
130986259|NCT01191840|471576285|FG001|Overall Study|Non Staph Infection|3|||
130986260|NCT01191840|471576284|FG000|Overall Study|ineligible at enrollment|1|||
130986261|NCT01191840|471576285|FG001|Overall Study|ineligible at enrollment|0|||
130986262|NCT01191840|471576284|FG000|Overall Study|IRB approval lapse|0|||
130986263|NCT01191840|471576285|FG001|Overall Study|IRB approval lapse|2|||
130986264|NCT01191840|471576284|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
130986265|NCT01191840|471576285|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
130986266|NCT01191840|471576284|FG000|Overall Study|Withdrawal by Subject|2|||
130986267|NCT01191840|471576285|FG001|Overall Study|Withdrawal by Subject|0|||
130986268|NCT02736825|471576286|FG000|Overall Study|Lost to Follow-up|10|||
130986269|NCT02736825|471576287|FG001|Overall Study|Lost to Follow-up|11|||
130986270|NCT02736825|471576286|FG000|Overall Study|Early Termination|0|||
130986271|NCT02736825|471576287|FG001|Overall Study|Early Termination|1|||
130986272|NCT00790452|471576288|FG000|Overall Study|Drug supply issue|1|||
130986273|NCT00790452|471576289|FG001|Overall Study|Drug supply issue|0|||
130986274|NCT01564368|471576296|FG000|Overall Study|Ineligible|18|||
130986275|NCT01564368|471576296|FG000|Overall Study|Not Randomized in Parent study|116|||
130986276|NCT01564368|471576296|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
130986277|NCT01564368|471576296|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
130986278|NCT01802437|471576297|FG000|Overall Study|Lost to Follow-up|1|||
130986279|NCT01802437|471576298|FG001|Overall Study|Lost to Follow-up|0|||
130986280|NCT01802437|471576297|FG000|Overall Study|Withdrawal by Subject|3|||
130986281|NCT01802437|471576298|FG001|Overall Study|Withdrawal by Subject|4|||
130986282|NCT04082884|471576299|FG000|Overall Study|Withdrawal by Subject|1|||
130986283|NCT00331344|471576300|FG000|Phase I|Adverse Event|0|||
130986284|NCT00331344|471576301|FG001|Phase I|Adverse Event|0|||
130986285|NCT00331344|471576302|FG002|Phase I|Adverse Event|0|||
130986286|NCT00331344|471576303|FG003|Phase I|Adverse Event|1|||
130986287|NCT00331344|471576304|FG004|Phase I|Adverse Event|2|||
130986288|NCT00331344|471576305|FG005|Phase I|Adverse Event|2|||
130986289|NCT00331344|471576306|FG006|Phase I|Adverse Event|0|||
130986290|NCT00331344|471576307|FG007|Phase I|Adverse Event|1|||
130986291|NCT00331344|471576308|FG008|Phase I|Adverse Event|0|||
130986292|NCT00331344|471576300|FG000|Phase II|Death|0|||
130986293|NCT00331344|471576301|FG001|Phase II|Death|0|||
130986294|NCT00331344|471576302|FG002|Phase II|Death|0|||
130986295|NCT00331344|471576303|FG003|Phase II|Death|0|||
130986296|NCT00331344|471576304|FG004|Phase II|Death|0|||
130720993|NCT02823652|470601588|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
130986297|NCT00331344|471576305|FG005|Phase II|Death|0|||
130986298|NCT00331344|471576306|FG006|Phase II|Death|0|||
130986299|NCT00331344|471576307|FG007|Phase II|Death|0|||
130986300|NCT00331344|471576308|FG008|Phase II|Death|4|||
130986301|NCT00659490|471576314|FG000|Overall Study|Lost to Follow-up|2|||
130986302|NCT00659490|471576315|FG001|Overall Study|Lost to Follow-up|0|||
130986303|NCT00659490|471576316|FG002|Overall Study|Lost to Follow-up|1|||
130986304|NCT02228967|471576317|FG000|Overall Study|Lost to Follow-up|146|||
130986305|NCT02228967|471576318|FG001|Overall Study|Lost to Follow-up|142|||
130986306|NCT02228967|471576317|FG000|Overall Study|Withdrawal by Subject|13|||
130986307|NCT02228967|471576318|FG001|Overall Study|Withdrawal by Subject|18|||
130986308|NCT00520975|471576319|FG000|Overall Study|Disease progression|31|||
131046439|NCT00887198|471804769|FG002|Cross Over (Placebo to AA)|Other|19|||
130986309|NCT00520975|471576320|FG001|Overall Study|Disease progression|23|||
130986310|NCT00520975|471576319|FG000|Overall Study|Adverse Event|7|||
130986311|NCT00520975|471576320|FG001|Overall Study|Adverse Event|10|||
130986312|NCT00520975|471576319|FG000|Overall Study|Death|0|||
130986313|NCT00520975|471576320|FG001|Overall Study|Death|2|||
130986314|NCT00520975|471576319|FG000|Overall Study|Withdrawal by Subject|3|||
130986315|NCT00520975|471576320|FG001|Overall Study|Withdrawal by Subject|5|||
130986316|NCT00520975|471576319|FG000|Overall Study|Other therapy|2|||
130986317|NCT00520975|471576320|FG001|Overall Study|Other therapy|4|||
131229531|NCT00628745|472465934|FG003|Overall Study|Othe reasons|1|||
131229532|NCT00628745|472465935|FG004|Overall Study|Othe reasons|1772|||
131229533|NCT00982410|472467603|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
131229534|NCT00982410|472467604|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
131229535|NCT00982410|472467603|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
131229536|NCT00982410|472467604|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
131229537|NCT00982410|472467603|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
130778873|NCT03428100|470817451|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131046440|NCT05007080|471804770|FG000|Overall Study|Lost to Follow-up|0|||
131046441|NCT05007080|471804771|FG001|Overall Study|Lost to Follow-up|1|||
130986318|NCT00520975|471576319|FG000|Overall Study|Other reasons|4|||
130986319|NCT00520975|471576320|FG001|Overall Study|Other reasons|2|||
130986320|NCT00520975|471576319|FG000|Overall Study|Not start protocol therapy|1|||
130986321|NCT00520975|471576320|FG001|Overall Study|Not start protocol therapy|2|||
130986322|NCT01995539|471576321|FG000|Overall Study|Screening Failure|1|||
130986323|NCT01995539|471576321|FG000|Overall Study|Withdrawal by Investigator|15|||
131046442|NCT05007080|471804772|FG002|Overall Study|Lost to Follow-up|0|||
131046443|NCT05007080|471804773|FG003|Overall Study|Lost to Follow-up|1|||
131046444|NCT05007080|471804774|FG004|Overall Study|Lost to Follow-up|1|||
131046445|NCT05007080|471804775|FG005|Overall Study|Lost to Follow-up|1|||
131046446|NCT05007080|471804770|FG000|Overall Study|Death|0|||
131046447|NCT05007080|471804771|FG001|Overall Study|Death|1|||
130778874|NCT03428100|470817452|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778875|NCT03428100|470817453|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130986324|NCT01995539|471576321|FG000|Overall Study|Withdrawal by Subject|11|||
130986325|NCT01995539|471576321|FG000|Overall Study|Lost to Follow-up|5|||
130986326|NCT01995539|471576321|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
130986327|NCT01376323|471576323|FG000|Overall Study|Adverse Event|1|||
130986328|NCT01376323|471576324|FG001|Overall Study|Adverse Event|0|||
130986329|NCT01376323|471576325|FG002|Overall Study|Adverse Event|0|||
130986330|NCT01376323|471576326|FG003|Overall Study|Adverse Event|2|||
130986331|NCT01376323|471576327|FG004|Overall Study|Adverse Event|0|||
130986332|NCT01376323|471576323|FG000|Overall Study|Lost to Follow-up|0|||
130986333|NCT01376323|471576324|FG001|Overall Study|Lost to Follow-up|0|||
130986334|NCT01376323|471576325|FG002|Overall Study|Lost to Follow-up|0|||
130986335|NCT01376323|471576326|FG003|Overall Study|Lost to Follow-up|2|||
130986336|NCT01376323|471576327|FG004|Overall Study|Lost to Follow-up|0|||
130986337|NCT01376323|471576323|FG000|Overall Study|Physician Decision|1|||
130986338|NCT01376323|471576324|FG001|Overall Study|Physician Decision|0|||
130986339|NCT01376323|471576325|FG002|Overall Study|Physician Decision|2|||
130986340|NCT01376323|471576326|FG003|Overall Study|Physician Decision|1|||
130986341|NCT01376323|471576327|FG004|Overall Study|Physician Decision|1|||
130986342|NCT01376323|471576323|FG000|Overall Study|Withdrawal by Subject|0|||
130986343|NCT01376323|471576324|FG001|Overall Study|Withdrawal by Subject|1|||
130986344|NCT01376323|471576325|FG002|Overall Study|Withdrawal by Subject|1|||
130986345|NCT01376323|471576326|FG003|Overall Study|Withdrawal by Subject|0|||
130986346|NCT01376323|471576327|FG004|Overall Study|Withdrawal by Subject|0|||
131046448|NCT05007080|471804772|FG002|Overall Study|Death|0|||
131046449|NCT05007080|471804773|FG003|Overall Study|Death|0|||
131046450|NCT05007080|471804774|FG004|Overall Study|Death|0|||
131046451|NCT05007080|471804775|FG005|Overall Study|Death|0|||
131046452|NCT05007080|471804770|FG000|Overall Study|Withdrawal by Subject|1|||
131046453|NCT05007080|471804771|FG001|Overall Study|Withdrawal by Subject|2|||
131046454|NCT05007080|471804772|FG002|Overall Study|Withdrawal by Subject|0|||
131046455|NCT05007080|471804773|FG003|Overall Study|Withdrawal by Subject|2|||
131046456|NCT05007080|471804774|FG004|Overall Study|Withdrawal by Subject|1|||
131046457|NCT05007080|471804775|FG005|Overall Study|Withdrawal by Subject|1|||
131046458|NCT05007080|471804770|FG000|Overall Study|Other|1|||
131046459|NCT05007080|471804771|FG001|Overall Study|Other|0|||
131046460|NCT05007080|471804772|FG002|Overall Study|Other|1|||
131046461|NCT05007080|471804773|FG003|Overall Study|Other|1|||
131046462|NCT05007080|471804774|FG004|Overall Study|Other|0|||
131046463|NCT05007080|471804775|FG005|Overall Study|Other|2|||
131046464|NCT05007080|471804770|FG000|Overall Study|Randomized not vaccinated|0|||
131046465|NCT05007080|471804771|FG001|Overall Study|Randomized not vaccinated|0|||
131046466|NCT05007080|471804772|FG002|Overall Study|Randomized not vaccinated|0|||
131046467|NCT05007080|471804773|FG003|Overall Study|Randomized not vaccinated|0|||
131046468|NCT05007080|471804774|FG004|Overall Study|Randomized not vaccinated|0|||
131046469|NCT05007080|471804775|FG005|Overall Study|Randomized not vaccinated|1|||
131046470|NCT00319046|471804776|FG000|Overall Study|withdrawal of subject's consent|7|||
131046471|NCT00319046|471804776|FG000|Overall Study|administrative reason|1|||
131046472|NCT05147584|471804777|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
130986347|NCT04681729|471576328|FG000|Overall Study|Lack of Efficacy|2|||
130986348|NCT04681729|471576329|FG001|Overall Study|Lack of Efficacy|2|||
130986349|NCT04681729|471576328|FG000|Overall Study|Withdrawal by Subject|8|||
130986350|NCT04681729|471576329|FG001|Overall Study|Withdrawal by Subject|9|||
130986351|NCT00499863|471576331|FG000|Overall Study|Lack of Efficacy|21|||
130986352|NCT00499863|471576332|FG001|Overall Study|Lack of Efficacy|27|||
130986353|NCT00499863|471576331|FG000|Overall Study|Protocol Violation|12|||
130986354|NCT00499863|471576332|FG001|Overall Study|Protocol Violation|7|||
130986355|NCT00499863|471576331|FG000|Overall Study|Withdrawal by Subject|6|||
130986356|NCT00499863|471576332|FG001|Overall Study|Withdrawal by Subject|4|||
130986357|NCT00499863|471576331|FG000|Overall Study|Adverse Event|8|||
130986358|NCT00499863|471576332|FG001|Overall Study|Adverse Event|2|||
130986359|NCT00499863|471576331|FG000|Overall Study|Sponsor decision|2|||
130986360|NCT00499863|471576332|FG001|Overall Study|Sponsor decision|2|||
130986361|NCT00499863|471576331|FG000|Overall Study|Lost to Follow-up|1|||
130986362|NCT00499863|471576332|FG001|Overall Study|Lost to Follow-up|1|||
130986363|NCT03351738|471576333|FG000|Overall Study|Withdrawal by Subject|0|||
130986364|NCT03351738|471576334|FG001|Overall Study|Withdrawal by Subject|1|||
130986365|NCT03351738|471576335|FG002|Overall Study|Withdrawal by Subject|0|||
130986366|NCT03351738|471576336|FG003|Overall Study|Withdrawal by Subject|1|||
130986367|NCT03351738|471576337|FG004|Overall Study|Withdrawal by Subject|0|||
130986368|NCT03351738|471576338|FG005|Overall Study|Withdrawal by Subject|0|||
130986369|NCT01375205|471576339|FG000|Overall Study|Lost to Follow-up|15|||
130986370|NCT01375205|471576340|FG001|Overall Study|Lost to Follow-up|12|||
130986371|NCT01375205|471576339|FG000|Overall Study|Withdrawal by Subject|6|||
130986372|NCT01375205|471576340|FG001|Overall Study|Withdrawal by Subject|1|||
130986373|NCT05687032|471576341|FG000|Treatment Phase|Adverse Event|13|||
130986374|NCT05687032|471576341|FG000|Treatment Phase|Death|1|||
130986375|NCT05687032|471576341|FG000|Treatment Phase|Physician Decision|3|||
130986376|NCT05687032|471576341|FG000|Treatment Phase|Progressive disease|9|||
130986377|NCT05687032|471576341|FG000|Treatment Phase|Withdrawal by Subject|5|||
130986378|NCT05687032|471576341|FG000|Follow-Up Phase|Death|16|||
130986379|NCT05687032|471576341|FG000|Follow-Up Phase|Ongoing|26|||
130986380|NCT05614089|471576342|FG000|Overall Study|Pregnancy|5|||
130986381|NCT05614089|471576343|FG001|Overall Study|Pregnancy|2|||
130986382|NCT05614089|471576342|FG000|Overall Study|Lost to Follow-up|5|||
130986383|NCT05614089|471576343|FG001|Overall Study|Lost to Follow-up|1|||
130986384|NCT05614089|471576342|FG000|Overall Study|Death|0|||
130986385|NCT05614089|471576343|FG001|Overall Study|Death|1|||
130986386|NCT05614089|471576342|FG000|Overall Study|Adverse Event|1|||
130986387|NCT05614089|471576343|FG001|Overall Study|Adverse Event|0|||
130986388|NCT03759834|471576344|FG000|Overall Study|Withdrawal by Subject|1|||
130986389|NCT05701995|471576345|FG000|Pre-Treatment|Randomization Error|1|||
130986390|NCT05701995|471576346|FG001|Pre-Treatment|Randomization Error|1|||
130986391|NCT05701995|471576345|FG000|Treatment|Withdrawal by Subject|8|||
130986392|NCT05701995|471576346|FG001|Treatment|Withdrawal by Subject|4|||
130986393|NCT05701995|471576345|FG000|Treatment|Lost to Follow-up|2|||
130986394|NCT05701995|471576346|FG001|Treatment|Lost to Follow-up|3|||
130986395|NCT05701995|471576345|FG000|Treatment|Adverse Event|3|||
130986396|NCT05701995|471576346|FG001|Treatment|Adverse Event|1|||
130986397|NCT05701995|471576345|FG000|Treatment|Other Reason|1|||
130986398|NCT05701995|471576346|FG001|Treatment|Other Reason|1|||
130986399|NCT05701995|471576345|FG000|Treatment|Death|1|||
130986400|NCT05701995|471576346|FG001|Treatment|Death|0|||
130986401|NCT05701995|471576345|FG000|Treatment|Physician Decision|0|||
130986402|NCT05701995|471576346|FG001|Treatment|Physician Decision|1|||
130986403|NCT01064297|471576350|FG000|Overall Study|Lost to Follow-up|791|||
130986404|NCT01064297|471576351|FG001|Overall Study|Lost to Follow-up|48|||
130986405|NCT01064297|471576352|FG002|Overall Study|Lost to Follow-up|133|||
130986406|NCT04179721|471576357|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
130986407|NCT04179721|471576358|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
130986408|NCT04179721|471576357|FG000|Overall Study|Lost to Follow-up|0|||
130986409|NCT04179721|471576358|FG001|Overall Study|Lost to Follow-up|1|||
130986410|NCT00112580|471576359|FG000|Overall Study|Adverse Event|1|||
130720994|NCT02823652|470601586|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
130720995|NCT02823652|470601587|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
130720996|NCT02823652|470601588|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
130720997|NCT02823652|470601586|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
130720998|NCT02823652|470601587|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
130986411|NCT00112580|471576360|FG001|Overall Study|Adverse Event|2|||
130720999|NCT02823652|470601588|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
130986412|NCT00112580|471576359|FG000|Overall Study|Disease progression|5|||
130986413|NCT00112580|471576360|FG001|Overall Study|Disease progression|16|||
130986414|NCT00112580|471576359|FG000|Overall Study|Participant withdrew consent|2|||
130986415|NCT00112580|471576360|FG001|Overall Study|Participant withdrew consent|1|||
130986416|NCT05619003|471576361|FG000|Overall Study|Adverse Event|1|||
130986417|NCT03183388|471577513|FG000|Overall Study|Lost to Follow-up|3|||
130986418|NCT03183388|471577514|FG001|Overall Study|Lost to Follow-up|5|||
130986419|NCT03183388|471577513|FG000|Overall Study|Physician Decision|1|||
130986420|NCT03183388|471577514|FG001|Overall Study|Physician Decision|4|||
130721000|NCT02823652|470601586|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
130721001|NCT02823652|470601587|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
131133798|NCT05131204|472117201|FG001|Overall Study|Sponsor request|1|||
131133799|NCT03446885|472117202|FG000|Overall Study|Lost to Follow-up|1|||
131133800|NCT03446885|472117203|FG001|Overall Study|Lost to Follow-up|0|||
131133801|NCT03446885|472117202|FG000|Overall Study|Did not complete entire visit|1|||
131133802|NCT03446885|472117203|FG001|Overall Study|Did not complete entire visit|0|||
131133803|NCT01485627|472117206|FG000|Overall Study|Patient withdrew|6|||
131133804|NCT01485627|472117207|FG001|Overall Study|Patient withdrew|5|||
131133805|NCT01485627|472117206|FG000|Overall Study|Patient died|3|||
131133806|NCT01485627|472117207|FG001|Overall Study|Patient died|1|||
131133807|NCT01485627|472117206|FG000|Overall Study|Patient lost to followup|0|||
131133808|NCT01485627|472117207|FG001|Overall Study|Patient lost to followup|1|||
131133809|NCT01485627|472117206|FG000|Overall Study|Caregiver withdrew|3|||
131133810|NCT01485627|472117207|FG001|Overall Study|Caregiver withdrew|3|||
131133811|NCT01485627|472117206|FG000|Overall Study|Caregiver lost to follow up|11|||
131133812|NCT01485627|472117207|FG001|Overall Study|Caregiver lost to follow up|12|||
131133813|NCT01485627|472117206|FG000|Overall Study|Caregiver died|1|||
131133814|NCT01485627|472117207|FG001|Overall Study|Caregiver died|0|||
131133815|NCT01485627|472117206|FG000|Overall Study|caregiver was not bereaved|42|||
131133816|NCT01485627|472117207|FG001|Overall Study|caregiver was not bereaved|35|||
131133817|NCT02264990|472117210|FG000|Overall Study|Death|255|||
131133818|NCT02264990|472117211|FG001|Overall Study|Death|250|||
131133819|NCT02264990|472117210|FG000|Overall Study|Withdrawal by Subject|4|||
131133820|NCT02264990|472117211|FG001|Overall Study|Withdrawal by Subject|5|||
131133821|NCT02264990|472117210|FG000|Overall Study|Lost to Follow-up|1|||
131133822|NCT02264990|472117211|FG001|Overall Study|Lost to Follow-up|3|||
131133823|NCT02264990|472117210|FG000|Overall Study|Other|0|||
131133824|NCT02264990|472117211|FG001|Overall Study|Other|1|||
131133825|NCT01098071|472117220|FG000|Overall Study|Surgery (adenoidectomy)|2|||
131133826|NCT01098071|472117220|FG000|Overall Study|Lost to Follow-up|13|||
131133827|NCT01662895|472117222|FG000|Overall Study|Lost to Follow-up|0|||
131133828|NCT01662895|472117223|FG001|Overall Study|Lost to Follow-up|1|||
130721002|NCT02823652|470601588|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
130721003|NCT03567382|470601591|FG000|Overall Study|Lost to Follow-up|1|||
130721004|NCT03567382|470601592|FG001|Overall Study|Lost to Follow-up|21|||
130721005|NCT03567382|470601593|FG002|Overall Study|Lost to Follow-up|1|||
130721006|NCT03567382|470601594|FG003|Overall Study|Lost to Follow-up|21|||
130721007|NCT03567382|470601591|FG000|Overall Study|Withdrawal by Subject|2|||
131133829|NCT02728830|472117229|FG000|Overall Study|Exclusionary Surgery|9|||
131133830|NCT02728830|472117229|FG000|Overall Study|Exclusionary Pathology|6|||
131133831|NCT02728830|472117229|FG000|Overall Study|Physician Decision|3|||
130721008|NCT03567382|470601592|FG001|Overall Study|Withdrawal by Subject|14|||
130721009|NCT03567382|470601593|FG002|Overall Study|Withdrawal by Subject|1|||
131133832|NCT02728830|472117229|FG000|Overall Study|Withdrawal by Subject|2|||
131133833|NCT02728830|472117229|FG000|Overall Study|Lost to Follow-up|1|||
131133834|NCT02728830|472117229|FG000|Overall Study|Exclusionary Lab Values|1|||
131046529|NCT04214834|471804785|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
131046530|NCT04214834|471804786|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
131046531|NCT03884101|471804789|FG000|Overall Study|Participant Ongoing in Study|202|||
131046532|NCT03884101|471804790|FG001|Overall Study|Participant Ongoing in Study|186|||
131046533|NCT03884101|471804789|FG000|Overall Study|Death|212|||
131046534|NCT03884101|471804790|FG001|Overall Study|Death|224|||
131046535|NCT03884101|471804789|FG000|Overall Study|Lost to Follow-up|0|||
131133835|NCT02728830|472117229|FG000|Overall Study|Contraindicated Illness|1|||
131133836|NCT02728830|472117229|FG000|Overall Study|Language Barrier|1|||
131133837|NCT01081795|472117230|FG000|Overall Study|Adverse Event|18|||
130721010|NCT03567382|470601594|FG003|Overall Study|Withdrawal by Subject|12|||
130721011|NCT00620659|470601595|FG000|Treatment Period 1|Adverse Event|1|||
131046536|NCT03884101|471804790|FG001|Overall Study|Lost to Follow-up|1|||
131133838|NCT01081795|472117231|FG001|Overall Study|Adverse Event|23|||
131133839|NCT01081795|472117232|FG002|Overall Study|Adverse Event|6|||
131133840|NCT01081795|472117230|FG000|Overall Study|Lack of Efficacy|7|||
131133841|NCT01081795|472117231|FG001|Overall Study|Lack of Efficacy|5|||
131133842|NCT01081795|472117232|FG002|Overall Study|Lack of Efficacy|19|||
131133843|NCT01081795|472117230|FG000|Overall Study|Subject's schedule|1|||
131133844|NCT01081795|472117231|FG001|Overall Study|Subject's schedule|1|||
131133845|NCT01081795|472117232|FG002|Overall Study|Subject's schedule|2|||
131133846|NCT01081795|472117230|FG000|Overall Study|Revocation of informed consent|2|||
131133847|NCT01081795|472117231|FG001|Overall Study|Revocation of informed consent|0|||
131133848|NCT01081795|472117232|FG002|Overall Study|Revocation of informed consent|0|||
131133849|NCT01081795|472117230|FG000|Overall Study|Ineligible for participation|1|||
131133850|NCT01081795|472117231|FG001|Overall Study|Ineligible for participation|0|||
131133851|NCT01081795|472117232|FG002|Overall Study|Ineligible for participation|0|||
131133852|NCT01081795|472117230|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
131133853|NCT01081795|472117231|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
131133854|NCT01081795|472117232|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
131133855|NCT01081795|472117230|FG000|Overall Study|Using drug with restricted days of use|2|||
131133856|NCT01081795|472117231|FG001|Overall Study|Using drug with restricted days of use|3|||
131133857|NCT01081795|472117232|FG002|Overall Study|Using drug with restricted days of use|2|||
131133858|NCT01081795|472117230|FG000|Overall Study|Other|1|||
131133859|NCT01081795|472117231|FG001|Overall Study|Other|2|||
131133860|NCT01081795|472117232|FG002|Overall Study|Other|0|||
131133861|NCT01142726|472117233|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
131133862|NCT01142726|472117234|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
131133863|NCT01142726|472117235|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
131133864|NCT01142726|472117233|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
131133865|NCT01142726|472117234|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
131133866|NCT01142726|472117235|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
131133867|NCT01142726|472117233|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
130721012|NCT00620659|470601596|FG001|Treatment Period 1|Adverse Event|0|||
131046537|NCT03884101|471804789|FG000|Overall Study|Withdrawal by Subject|6|||
130721013|NCT00620659|470601597|FG002|Treatment Period 1|Adverse Event|0|||
131133868|NCT01142726|472117234|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
131133869|NCT01142726|472117235|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
131133870|NCT01142726|472117233|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
130721014|NCT00620659|470601598|FG003|Treatment Period 1|Adverse Event|3|||
130986421|NCT03183388|471577513|FG000|Overall Study|Withdrawal by Subject|4|||
130986422|NCT03183388|471577514|FG001|Overall Study|Withdrawal by Subject|1|||
130986423|NCT03183388|471577513|FG000|Overall Study|Moved|1|||
130986424|NCT03183388|471577514|FG001|Overall Study|Moved|0|||
130986425|NCT03183388|471577513|FG000|Overall Study|Met Exclusion Criteria|2|||
130986426|NCT03183388|471577514|FG001|Overall Study|Met Exclusion Criteria|2|||
130986427|NCT03183388|471577513|FG000|Overall Study|COVID Pandemic Related|2|||
130986428|NCT03183388|471577514|FG001|Overall Study|COVID Pandemic Related|4|||
130986429|NCT01264380|471577517|FG000|Period C|Disease Progression|0|||
130986430|NCT01264380|471577518|FG001|Period C|Disease Progression|0|||
130986431|NCT01264380|471577519|FG002|Period C|Disease Progression|4|||
130986432|NCT01264380|471577517|FG000|Period C|Death|0|||
130986433|NCT01264380|471577518|FG001|Period C|Death|0|||
130986434|NCT01264380|471577519|FG002|Period C|Death|2|||
130986435|NCT01264380|471577517|FG000|Period C|Follow-up for survival status|0|||
130986436|NCT01264380|471577518|FG001|Period C|Follow-up for survival status|0|||
130986437|NCT01264380|471577519|FG002|Period C|Follow-up for survival status|6|||
130986438|NCT01264380|471577517|FG000|Period C|Withdrawal by Subject|0|||
130986439|NCT01264380|471577518|FG001|Period C|Withdrawal by Subject|0|||
130986440|NCT01264380|471577519|FG002|Period C|Withdrawal by Subject|1|||
130986441|NCT01264380|471577517|FG000|Period C|Adverse Event|0|||
130986442|NCT01264380|471577518|FG001|Period C|Adverse Event|0|||
130986443|NCT01264380|471577519|FG002|Period C|Adverse Event|1|||
130986444|NCT01147822|471577520|FG000|Overall Study|Lost to Follow-up|14|||
130986445|NCT01147822|471577521|FG001|Overall Study|Lost to Follow-up|6|||
130986446|NCT01147822|471577520|FG000|Overall Study|Withdrawal by Subject|10|||
130986447|NCT01147822|471577521|FG001|Overall Study|Withdrawal by Subject|16|||
130986448|NCT01147822|471577520|FG000|Overall Study|Physician Decision|9|||
130986449|NCT01147822|471577521|FG001|Overall Study|Physician Decision|8|||
130986450|NCT01147822|471577520|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
130986451|NCT01147822|471577521|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
130986452|NCT01147822|471577520|FG000|Overall Study|Protocol Violation|1|||
130986453|NCT01147822|471577521|FG001|Overall Study|Protocol Violation|1|||
130986454|NCT00642902|471577524|FG000|Overall Study|Adverse Event|0|||
130986455|NCT00642902|471577525|FG001|Overall Study|Adverse Event|1|||
130986456|NCT00642902|471577526|FG002|Overall Study|Adverse Event|3|||
130986457|NCT00642902|471577527|FG003|Overall Study|Adverse Event|1|||
130986458|NCT00642902|471577524|FG000|Overall Study|Lost to Follow-up|1|||
130986459|NCT00642902|471577525|FG001|Overall Study|Lost to Follow-up|1|||
130986460|NCT00642902|471577526|FG002|Overall Study|Lost to Follow-up|0|||
130986461|NCT00642902|471577527|FG003|Overall Study|Lost to Follow-up|0|||
130986462|NCT00642902|471577524|FG000|Overall Study|Lack of Efficacy|0|||
130986463|NCT00642902|471577525|FG001|Overall Study|Lack of Efficacy|3|||
130986464|NCT00642902|471577526|FG002|Overall Study|Lack of Efficacy|3|||
130986465|NCT00642902|471577527|FG003|Overall Study|Lack of Efficacy|0|||
130986466|NCT00642902|471577524|FG000|Overall Study|Death|1|||
130986467|NCT00642902|471577525|FG001|Overall Study|Death|0|||
130986468|NCT00642902|471577526|FG002|Overall Study|Death|0|||
130986469|NCT00642902|471577527|FG003|Overall Study|Death|0|||
130986470|NCT00642902|471577524|FG000|Overall Study|Premature termination of clinical trial|37|||
130986471|NCT00642902|471577525|FG001|Overall Study|Premature termination of clinical trial|32|||
130986472|NCT00642902|471577526|FG002|Overall Study|Premature termination of clinical trial|35|||
130986473|NCT00642902|471577527|FG003|Overall Study|Premature termination of clinical trial|35|||
130986474|NCT00642902|471577524|FG000|Overall Study|Randomized, but not treated|0|||
130986475|NCT00642902|471577525|FG001|Overall Study|Randomized, but not treated|0|||
130986476|NCT00642902|471577526|FG002|Overall Study|Randomized, but not treated|1|||
130986477|NCT00642902|471577527|FG003|Overall Study|Randomized, but not treated|0|||
130986478|NCT00642902|471577524|FG000|Overall Study|Other|1|||
130986479|NCT00642902|471577525|FG001|Overall Study|Other|5|||
131046538|NCT03884101|471804790|FG001|Overall Study|Withdrawal by Subject|11|||
131046539|NCT03370913|471804791|FG000|Overall Study|Death|1|||
131046540|NCT03370913|471804791|FG000|Overall Study|Lost to Follow-up|1|||
131046541|NCT04369911|471804794|FG000|Overall Study|Lost to Follow-up|3|||
131046542|NCT04369911|471804795|FG001|Overall Study|Lost to Follow-up|3|||
131046543|NCT04369911|471804794|FG000|Overall Study|Withdrawal by Subject|1|||
130986480|NCT00642902|471577526|FG002|Overall Study|Other|1|||
130986481|NCT00642902|471577527|FG003|Overall Study|Other|4|||
130986482|NCT00429663|471577528|FG000|Overall Study|Lost to Follow-up|24|||
130986483|NCT00429663|471577529|FG001|Overall Study|Lost to Follow-up|31|||
130986484|NCT00429663|471577528|FG000|Overall Study|Physician Decision|6|||
130986485|NCT00429663|471577529|FG001|Overall Study|Physician Decision|3|||
131046544|NCT04369911|471804795|FG001|Overall Study|Withdrawal by Subject|2|||
131046545|NCT05451693|471804796|FG000|Overall Study|Withdrawal by Subject|1|||
130986486|NCT00429663|471577528|FG000|Overall Study|Withdrawal by Subject|2|||
131046546|NCT05451693|471804797|FG001|Overall Study|Withdrawal by Subject|1|||
130986487|NCT00429663|471577529|FG001|Overall Study|Withdrawal by Subject|5|||
130986488|NCT00429663|471577528|FG000|Overall Study|Death|4|||
130986489|NCT00429663|471577529|FG001|Overall Study|Death|0|||
130986490|NCT03953898|471577535|FG000|Overall Study|Lack of Efficacy|8|||
130986491|NCT03953898|471577535|FG000|Overall Study|Death|3|||
130986492|NCT03953898|471577535|FG000|Overall Study|Withdrawal by Subject|2|||
130986493|NCT03953898|471577535|FG000|Overall Study|Adverse Event|1|||
130986494|NCT03261271|471577536|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
130986495|NCT03261271|471577537|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
130986496|NCT01932697|471577538|FG000|Overall Study|Received a different amount of tx|1|||
130986497|NCT01932697|471577539|FG001|Overall Study|Received a different amount of tx|0|||
130986498|NCT01932697|471577538|FG000|Overall Study|Ineligible|1|||
130986499|NCT01932697|471577539|FG001|Overall Study|Ineligible|0|||
130986500|NCT03420781|471577540|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
130986501|NCT03420781|471577541|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
130986502|NCT03420781|471577542|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
130986503|NCT03420781|471577543|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
130986504|NCT03420781|471577544|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
130986505|NCT03420781|471577540|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
130986506|NCT03420781|471577541|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
130986507|NCT03420781|471577542|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
130986508|NCT03420781|471577543|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
130986509|NCT03420781|471577544|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
130986510|NCT03420781|471577540|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
130986511|NCT03420781|471577541|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
130986512|NCT03420781|471577542|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
130986513|NCT03420781|471577543|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
130986514|NCT03420781|471577544|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
130986515|NCT03420781|471577540|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
130986516|NCT03420781|471577541|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
130986517|NCT03420781|471577542|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130986518|NCT03420781|471577543|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130986519|NCT03420781|471577544|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130986520|NCT03420781|471577540|FG000|Treatment Period (40 Weeks)|Death|2|||
130986521|NCT03420781|471577541|FG001|Treatment Period (40 Weeks)|Death|2|||
130986522|NCT03420781|471577542|FG002|Treatment Period (40 Weeks)|Death|0|||
130986523|NCT03420781|471577543|FG003|Treatment Period (40 Weeks)|Death|0|||
130986524|NCT03420781|471577544|FG004|Treatment Period (40 Weeks)|Death|0|||
130986525|NCT03420781|471577540|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
130986526|NCT03420781|471577541|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
130986527|NCT03420781|471577542|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
130986528|NCT03420781|471577543|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
130986529|NCT03420781|471577544|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
130986530|NCT03420781|471577540|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
130986531|NCT03420781|471577541|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
130986532|NCT03420781|471577542|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
130986533|NCT03420781|471577543|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
130986534|NCT03420781|471577544|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
130986535|NCT03420781|471577540|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
130986536|NCT03420781|471577541|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
130986537|NCT03420781|471577542|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
130986538|NCT03420781|471577543|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
130986539|NCT03420781|471577544|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
130986540|NCT03420781|471577540|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
130986541|NCT03420781|471577541|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
130986542|NCT03420781|471577542|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
130986543|NCT03420781|471577543|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
130986544|NCT03420781|471577544|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
130986545|NCT03420781|471577540|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
130986546|NCT03420781|471577541|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
130986547|NCT03420781|471577542|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
130986548|NCT03420781|471577543|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
130986549|NCT03420781|471577544|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
130986550|NCT03420781|471577540|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
130986551|NCT03420781|471577541|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
130986552|NCT03420781|471577542|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
130986553|NCT03420781|471577543|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
130986554|NCT03420781|471577544|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
130986555|NCT03420781|471577540|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
130986556|NCT03420781|471577541|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
130986557|NCT03420781|471577542|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
131229538|NCT00982410|472467604|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
131046547|NCT04675034|471804798|FG000|Overall Study|Lost to Follow-up|1|||
131046548|NCT04675034|471804799|FG001|Overall Study|Lost to Follow-up|1|||
131046549|NCT04675034|471804800|FG002|Overall Study|Lost to Follow-up|0|||
131046550|NCT04675034|471804801|FG003|Overall Study|Lost to Follow-up|2|||
131046551|NCT04675034|471804802|FG004|Overall Study|Lost to Follow-up|0|||
131046552|NCT04675034|471804798|FG000|Overall Study|Protocol Violation|1|||
131046553|NCT04675034|471804799|FG001|Overall Study|Protocol Violation|0|||
131046554|NCT04675034|471804800|FG002|Overall Study|Protocol Violation|0|||
131046555|NCT04675034|471804801|FG003|Overall Study|Protocol Violation|1|||
131046556|NCT04675034|471804802|FG004|Overall Study|Protocol Violation|3|||
131046557|NCT04675034|471804798|FG000|Overall Study|Withdrawal by Subject|9|||
131046558|NCT04675034|471804799|FG001|Overall Study|Withdrawal by Subject|3|||
131046559|NCT04675034|471804800|FG002|Overall Study|Withdrawal by Subject|4|||
131046560|NCT04675034|471804801|FG003|Overall Study|Withdrawal by Subject|8|||
131046561|NCT04675034|471804802|FG004|Overall Study|Withdrawal by Subject|6|||
131046562|NCT05008055|471804807|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
131046563|NCT05008055|471804808|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
131046564|NCT05008055|471804809|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
131046565|NCT04679389|471804810|FG000|Overall Study|Adverse Event|1|||
131046566|NCT04679389|471804811|FG001|Overall Study|Adverse Event|0|||
131046567|NCT04679389|471804810|FG000|Overall Study|Protocol Violation|2|||
131046568|NCT04679389|471804811|FG001|Overall Study|Protocol Violation|0|||
131046569|NCT04679389|471804810|FG000|Overall Study|Physician Decision|3|||
131046570|NCT04679389|471804811|FG001|Overall Study|Physician Decision|5|||
131046571|NCT04679389|471804810|FG000|Overall Study|Withdrawal by Subject|5|||
131046572|NCT04679389|471804811|FG001|Overall Study|Withdrawal by Subject|7|||
131046573|NCT02919917|471804820|FG000|Overall Study|Withdrawal by Subject|4|||
131046574|NCT02919917|471804821|FG001|Overall Study|Withdrawal by Subject|8|||
131046575|NCT05215054|471804822|FG000|Overall Study|Lost to Follow-up|1|||
131046576|NCT05215054|471804823|FG001|Overall Study|Lost to Follow-up|1|||
131046577|NCT05215054|471804822|FG000|Overall Study|Protocol Violation|1|||
131046578|NCT05215054|471804823|FG001|Overall Study|Protocol Violation|1|||
131046579|NCT05215054|471804822|FG000|Overall Study|Withdrawal by Subject|4|||
131046580|NCT05215054|471804823|FG001|Overall Study|Withdrawal by Subject|4|||
131046581|NCT01651000|471804824|FG000|Overall Study|Adverse Event|2|||
131046582|NCT01651000|471804825|FG001|Overall Study|Adverse Event|8|||
131046583|NCT01651000|471804824|FG000|Overall Study|Lost to Follow-up|3|||
131046584|NCT01651000|471804825|FG001|Overall Study|Lost to Follow-up|2|||
131046585|NCT01651000|471804824|FG000|Overall Study|Protocol Violation|0|||
131046586|NCT01651000|471804825|FG001|Overall Study|Protocol Violation|3|||
131046587|NCT01651000|471804824|FG000|Overall Study|Withdrawal by Subject|2|||
131046588|NCT01651000|471804825|FG001|Overall Study|Withdrawal by Subject|10|||
131046589|NCT01651000|471804824|FG000|Overall Study|Subject noncompliance|0|||
131046590|NCT01651000|471804825|FG001|Overall Study|Subject noncompliance|3|||
131046591|NCT01651000|471804824|FG000|Overall Study|Lack of Efficacy|1|||
131046592|NCT01651000|471804825|FG001|Overall Study|Lack of Efficacy|1|||
131046593|NCT01651000|471804824|FG000|Overall Study|Physician Decision|1|||
131046594|NCT01651000|471804825|FG001|Overall Study|Physician Decision|0|||
131046595|NCT01651000|471804824|FG000|Overall Study|Administrative reason|1|||
131046596|NCT01651000|471804825|FG001|Overall Study|Administrative reason|0|||
131046597|NCT01651000|471804824|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
131046598|NCT01651000|471804825|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
131046599|NCT04633278|471805770|FG000|Overall Study|Adverse Event|1|||
130721015|NCT00620659|470601599|FG004|Treatment Period 1|Adverse Event|0|||
130721016|NCT00620659|470601600|FG005|Treatment Period 1|Adverse Event|0|||
130721017|NCT00620659|470601595|FG000|Treatment Period 1|Protocol Violation|1|||
130721018|NCT00620659|470601596|FG001|Treatment Period 1|Protocol Violation|0|||
130721019|NCT00620659|470601597|FG002|Treatment Period 1|Protocol Violation|0|||
130721020|NCT00620659|470601598|FG003|Treatment Period 1|Protocol Violation|0|||
130721021|NCT00620659|470601599|FG004|Treatment Period 1|Protocol Violation|0|||
130721022|NCT00620659|470601600|FG005|Treatment Period 1|Protocol Violation|0|||
130721023|NCT00620659|470601595|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130721024|NCT00620659|470601596|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130721025|NCT00620659|470601597|FG002|Treatment Period 1|Withdrawal by Subject|1|||
131046600|NCT04633278|471805771|FG001|Overall Study|Adverse Event|0|||
131046601|NCT04633278|471805770|FG000|Overall Study|Withdrawal by Subject|1|||
131046602|NCT04633278|471805771|FG001|Overall Study|Withdrawal by Subject|0|||
131046603|NCT04633278|471805770|FG000|Overall Study|Death|11|||
131046604|NCT04633278|471805771|FG001|Overall Study|Death|7|||
131046605|NCT04633278|471805770|FG000|Overall Study|Sponsor Decision|3|||
131046606|NCT04633278|471805771|FG001|Overall Study|Sponsor Decision|0|||
131046607|NCT04633278|471805770|FG000|Overall Study|Not Listed|1|||
130721026|NCT00620659|470601598|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130721027|NCT00620659|470601599|FG004|Treatment Period 1|Withdrawal by Subject|1|||
131046608|NCT04633278|471805771|FG001|Overall Study|Not Listed|0|||
131046609|NCT03636490|471805772|FG000|Overall Study|Dropped out or incomplete data|141|||
131046610|NCT02246127|471805773|FG000|First Course Treatment|Adverse Event|9|||
131133871|NCT01142726|472117234|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
131133872|NCT01142726|472117235|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
131133873|NCT01142726|472117233|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
131133874|NCT01142726|472117234|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
131133875|NCT01142726|472117235|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
131133876|NCT01142726|472117233|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
131133877|NCT01142726|472117234|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
131133878|NCT01142726|472117235|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
131133879|NCT01142726|472117233|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
131133880|NCT01142726|472117234|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
131133881|NCT01142726|472117235|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
131133882|NCT01142726|472117233|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
131133883|NCT01142726|472117234|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
131133884|NCT01142726|472117235|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
131133885|NCT01142726|472117233|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
131133886|NCT01142726|472117234|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
131133887|NCT01142726|472117235|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
131133888|NCT01142726|472117233|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
131133889|NCT01142726|472117234|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
131133890|NCT01142726|472117235|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
131133891|NCT01142726|472117233|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
131133892|NCT01142726|472117234|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
131133893|NCT01142726|472117235|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
131133894|NCT01142726|472117233|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
131133895|NCT01142726|472117234|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
131133896|NCT01142726|472117235|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
131133897|NCT01142726|472117233|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
131133898|NCT01142726|472117234|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
131133899|NCT01142726|472117235|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
131133900|NCT01142726|472117233|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
131133901|NCT01142726|472117234|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
131133902|NCT01142726|472117235|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
131133903|NCT01142726|472117233|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
131133904|NCT01142726|472117234|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
131133905|NCT01142726|472117235|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
131133906|NCT01142726|472117233|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
131133907|NCT01142726|472117234|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
131046611|NCT02246127|471805774|FG001|First Course Treatment|Adverse Event|7|||
131046612|NCT02246127|471805773|FG000|First Course Treatment|Withdrawal by Subject|6|||
131046613|NCT02246127|471805774|FG001|First Course Treatment|Withdrawal by Subject|7|||
131046614|NCT02246127|471805773|FG000|First Course Treatment|Physician Decision|9|||
131046615|NCT02246127|471805774|FG001|First Course Treatment|Physician Decision|9|||
131046616|NCT02246127|471805773|FG000|First Course Treatment|Death|3|||
131046617|NCT02246127|471805774|FG001|First Course Treatment|Death|3|||
131046618|NCT02246127|471805773|FG000|First Course Treatment|Not reported reasons|6|||
131046619|NCT02246127|471805774|FG001|First Course Treatment|Not reported reasons|7|||
131046620|NCT02246127|471805773|FG000|First Course Treatment|Not treated|3|||
131046621|NCT02246127|471805774|FG001|First Course Treatment|Not treated|3|||
131046622|NCT04560179|471805794|FG000|Overall Study|Physician Decision|1|||
131046623|NCT04560179|471805795|FG001|Overall Study|Physician Decision|0|||
131046624|NCT04560179|471805796|FG002|Overall Study|Physician Decision|0|||
130721028|NCT00620659|470601600|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130721029|NCT00620659|470601595|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
130721030|NCT00620659|470601596|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
130721031|NCT00620659|470601597|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
130721032|NCT00620659|470601598|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
130721033|NCT00620659|470601599|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
130721034|NCT00620659|470601600|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
130721035|NCT00620659|470601595|FG000|Treatment Period 2|Adverse Event|0|||
130721036|NCT00620659|470601596|FG001|Treatment Period 2|Adverse Event|3|||
130721037|NCT00620659|470601597|FG002|Treatment Period 2|Adverse Event|0|||
130721038|NCT00620659|470601598|FG003|Treatment Period 2|Adverse Event|0|||
130721039|NCT00620659|470601599|FG004|Treatment Period 2|Adverse Event|2|||
130778876|NCT03428100|470817454|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
131046625|NCT04560179|471805797|FG003|Overall Study|Physician Decision|0|||
131046626|NCT04560179|471805798|FG004|Overall Study|Physician Decision|0|||
131046627|NCT04560179|471805794|FG000|Overall Study|Adverse Event|0|||
131046628|NCT04560179|471805795|FG001|Overall Study|Adverse Event|0|||
131046629|NCT04560179|471805796|FG002|Overall Study|Adverse Event|0|||
131046630|NCT04560179|471805797|FG003|Overall Study|Adverse Event|1|||
131046631|NCT04560179|471805798|FG004|Overall Study|Adverse Event|0|||
131046632|NCT04524689|471805803|FG000|Overall Study|Withdrawal by Subject|1|||
131046633|NCT04524689|471805804|FG001|Overall Study|Withdrawal by Subject|1|||
131046634|NCT04524689|471805805|FG002|Overall Study|Withdrawal by Subject|0|||
131046635|NCT04524689|471805806|FG003|Overall Study|Withdrawal by Subject|0|||
131046636|NCT04524689|471805807|FG004|Overall Study|Withdrawal by Subject|1|||
131046637|NCT04524689|471805808|FG005|Overall Study|Withdrawal by Subject|0|||
131046638|NCT04524689|471805803|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
131046639|NCT04524689|471805804|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
131046640|NCT04524689|471805805|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
131046641|NCT04524689|471805806|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
131046642|NCT04524689|471805807|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
131046643|NCT04524689|471805808|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
131046644|NCT04524689|471805803|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
131046645|NCT04524689|471805804|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
131046646|NCT04524689|471805805|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
131046647|NCT04524689|471805806|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
131046648|NCT04524689|471805807|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
131046649|NCT04524689|471805808|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
131046650|NCT04967599|471805809|FG000|Overall Study|Lost to Follow-up|35|||
131046651|NCT04967599|471805810|FG001|Overall Study|Lost to Follow-up|19|||
131046652|NCT04967599|471805811|FG002|Overall Study|Lost to Follow-up|23|||
131046653|NCT03662022|471805814|FG000|Year 1 2019|prevalent case|83|||
131046654|NCT03662022|471805815|FG001|Year 1 2019|prevalent case|116|||
131046655|NCT03662022|471805816|FG002|Year 1 2019|prevalent case|158|||
131046656|NCT03662022|471805817|FG003|Year 1 2019|prevalent case|99|||
131046657|NCT03662022|471805814|FG000|Year 2 2020|incident case|18|||
131046658|NCT03662022|471805815|FG001|Year 2 2020|incident case|18|||
131046659|NCT03662022|471805816|FG002|Year 2 2020|incident case|16|||
131046660|NCT03662022|471805817|FG003|Year 2 2020|incident case|26|||
131046661|NCT03662022|471805814|FG000|Year 2 2020|other case|18|||
131046662|NCT03662022|471805815|FG001|Year 2 2020|other case|16|||
131046663|NCT03662022|471805816|FG002|Year 2 2020|other case|16|||
131046664|NCT03662022|471805817|FG003|Year 2 2020|other case|24|||
131046665|NCT03662022|471805814|FG000|Year 2 2020|Lost to Follow-up|1633|||
131046666|NCT03662022|471805815|FG001|Year 2 2020|Lost to Follow-up|1183|||
131046667|NCT03662022|471805816|FG002|Year 2 2020|Lost to Follow-up|1381|||
131046668|NCT03662022|471805817|FG003|Year 2 2020|Lost to Follow-up|2858|||
131046669|NCT03662022|471805814|FG000|Year 3 2021|incident case|24|||
131046670|NCT03662022|471805815|FG001|Year 3 2021|incident case|27|||
131046671|NCT03662022|471805816|FG002|Year 3 2021|incident case|24|||
131046672|NCT03662022|471805817|FG003|Year 3 2021|incident case|11|||
131046673|NCT03662022|471805814|FG000|Year 3 2021|other case|4|||
131046674|NCT03662022|471805815|FG001|Year 3 2021|other case|15|||
131046675|NCT03662022|471805816|FG002|Year 3 2021|other case|10|||
131046676|NCT03662022|471805817|FG003|Year 3 2021|other case|14|||
131046677|NCT03662022|471805814|FG000|Year 3 2021|Lost to Follow-up|179|||
131046678|NCT03662022|471805815|FG001|Year 3 2021|Lost to Follow-up|244|||
131046679|NCT03662022|471805816|FG002|Year 3 2021|Lost to Follow-up|480|||
131046680|NCT03662022|471805817|FG003|Year 3 2021|Lost to Follow-up|477|||
130721040|NCT00620659|470601600|FG005|Treatment Period 2|Adverse Event|0|||
130721041|NCT00620659|470601595|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130721042|NCT00620659|470601596|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131046681|NCT03662022|471805814|FG000|Year 4 2022|incident case|25|||
131046682|NCT03662022|471805815|FG001|Year 4 2022|incident case|41|||
131046683|NCT03662022|471805816|FG002|Year 4 2022|incident case|28|||
131046684|NCT03662022|471805817|FG003|Year 4 2022|incident case|7|||
131046685|NCT03662022|471805814|FG000|Year 4 2022|other case|8|||
131046686|NCT03662022|471805815|FG001|Year 4 2022|other case|19|||
131046687|NCT03662022|471805816|FG002|Year 4 2022|other case|13|||
131046688|NCT03662022|471805817|FG003|Year 4 2022|other case|7|||
131046689|NCT03662022|471805814|FG000|Year 4 2022|Lost to Follow-up|986|||
131046690|NCT03662022|471805815|FG001|Year 4 2022|Lost to Follow-up|1079|||
131046691|NCT03662022|471805816|FG002|Year 4 2022|Lost to Follow-up|1236|||
131046692|NCT03662022|471805817|FG003|Year 4 2022|Lost to Follow-up|1826|||
130721043|NCT00620659|470601597|FG002|Treatment Period 2|Withdrawal by Subject|1|||
131046693|NCT04490109|471805828|FG000|Overall Study|Lost to Follow-up|3|||
131046694|NCT04490109|471805829|FG001|Overall Study|Lost to Follow-up|10|||
131046695|NCT04490109|471805830|FG002|Overall Study|Lost to Follow-up|4|||
131046696|NCT04490109|471805828|FG000|Overall Study|Withdrawal by Subject|8|||
131046697|NCT04490109|471805829|FG001|Overall Study|Withdrawal by Subject|6|||
131046698|NCT04490109|471805830|FG002|Overall Study|Withdrawal by Subject|9|||
131046699|NCT04490109|471805828|FG000|Overall Study|Physician Decision|0|||
131133908|NCT01142726|472117235|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
131133909|NCT00419380|472117238|FG000|Overall Study|Lack of Efficacy|1|||
131046700|NCT04490109|471805829|FG001|Overall Study|Physician Decision|2|||
131046701|NCT04490109|471805830|FG002|Overall Study|Physician Decision|3|||
130986558|NCT03420781|471577543|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
130986559|NCT03420781|471577544|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
130986560|NCT03420781|471577540|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
130986561|NCT03420781|471577541|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
130986562|NCT03420781|471577542|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
130986563|NCT03420781|471577543|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
130986564|NCT03420781|471577544|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
130986565|NCT00246337|471577545|FG000|Overall Study|Lost to Follow-up|3|||
130986566|NCT00246337|471577546|FG001|Overall Study|Lost to Follow-up|0|||
130986567|NCT00246337|471577547|FG002|Overall Study|Lost to Follow-up|0|||
130986568|NCT00246337|471577548|FG003|Overall Study|Lost to Follow-up|0|||
130986569|NCT00246337|471577549|FG004|Overall Study|Lost to Follow-up|2|||
130986570|NCT00246337|471577550|FG005|Overall Study|Lost to Follow-up|2|||
130986571|NCT00246337|471577551|FG006|Overall Study|Lost to Follow-up|1|||
130986572|NCT00246337|471577552|FG007|Overall Study|Lost to Follow-up|2|||
130986573|NCT00246337|471577553|FG008|Overall Study|Lost to Follow-up|0|||
130986574|NCT00246337|471577545|FG000|Overall Study|Protocol Violation|1|||
130986575|NCT00246337|471577546|FG001|Overall Study|Protocol Violation|0|||
130986576|NCT00246337|471577547|FG002|Overall Study|Protocol Violation|0|||
130986577|NCT00246337|471577548|FG003|Overall Study|Protocol Violation|0|||
130986578|NCT00246337|471577549|FG004|Overall Study|Protocol Violation|1|||
130986579|NCT00246337|471577550|FG005|Overall Study|Protocol Violation|0|||
130986580|NCT00246337|471577551|FG006|Overall Study|Protocol Violation|1|||
130986581|NCT00246337|471577552|FG007|Overall Study|Protocol Violation|1|||
130986582|NCT00246337|471577553|FG008|Overall Study|Protocol Violation|0|||
130986583|NCT00246337|471577545|FG000|Overall Study|Withdrawal by Subject|2|||
130986584|NCT00246337|471577546|FG001|Overall Study|Withdrawal by Subject|0|||
130986585|NCT00246337|471577547|FG002|Overall Study|Withdrawal by Subject|0|||
130986586|NCT00246337|471577548|FG003|Overall Study|Withdrawal by Subject|0|||
130986587|NCT00246337|471577549|FG004|Overall Study|Withdrawal by Subject|0|||
130986588|NCT00246337|471577550|FG005|Overall Study|Withdrawal by Subject|0|||
130986589|NCT00246337|471577551|FG006|Overall Study|Withdrawal by Subject|1|||
130986590|NCT00246337|471577552|FG007|Overall Study|Withdrawal by Subject|1|||
130986591|NCT00246337|471577553|FG008|Overall Study|Withdrawal by Subject|0|||
130986592|NCT00246337|471577545|FG000|Overall Study|Lack of Qualifying Event|8|||
130986593|NCT00246337|471577546|FG001|Overall Study|Lack of Qualifying Event|2|||
130986594|NCT00246337|471577547|FG002|Overall Study|Lack of Qualifying Event|1|||
130986595|NCT00246337|471577548|FG003|Overall Study|Lack of Qualifying Event|1|||
130986596|NCT00246337|471577549|FG004|Overall Study|Lack of Qualifying Event|1|||
130986597|NCT00246337|471577550|FG005|Overall Study|Lack of Qualifying Event|3|||
130986598|NCT00246337|471577551|FG006|Overall Study|Lack of Qualifying Event|3|||
130986599|NCT00246337|471577552|FG007|Overall Study|Lack of Qualifying Event|2|||
130986600|NCT00246337|471577553|FG008|Overall Study|Lack of Qualifying Event|5|||
130986601|NCT00246337|471577545|FG000|Overall Study|Site Terminated|10|||
130986602|NCT00246337|471577546|FG001|Overall Study|Site Terminated|0|||
130986603|NCT00246337|471577547|FG002|Overall Study|Site Terminated|0|||
130986604|NCT00246337|471577548|FG003|Overall Study|Site Terminated|0|||
130986605|NCT00246337|471577549|FG004|Overall Study|Site Terminated|0|||
130986606|NCT00246337|471577550|FG005|Overall Study|Site Terminated|7|||
130986607|NCT00246337|471577551|FG006|Overall Study|Site Terminated|1|||
130986608|NCT00246337|471577552|FG007|Overall Study|Site Terminated|6|||
130986609|NCT00246337|471577553|FG008|Overall Study|Site Terminated|2|||
130986610|NCT00246337|471577545|FG000|Overall Study|Abnormal baseline lab values|7|||
130986611|NCT00246337|471577546|FG001|Overall Study|Abnormal baseline lab values|0|||
130986612|NCT00246337|471577547|FG002|Overall Study|Abnormal baseline lab values|2|||
130986613|NCT00246337|471577548|FG003|Overall Study|Abnormal baseline lab values|0|||
130986614|NCT00246337|471577549|FG004|Overall Study|Abnormal baseline lab values|0|||
130986615|NCT00246337|471577550|FG005|Overall Study|Abnormal baseline lab values|2|||
130986616|NCT00246337|471577551|FG006|Overall Study|Abnormal baseline lab values|2|||
130986617|NCT00246337|471577552|FG007|Overall Study|Abnormal baseline lab values|0|||
130986618|NCT00246337|471577553|FG008|Overall Study|Abnormal baseline lab values|4|||
130986619|NCT00246337|471577545|FG000|Overall Study|Overwhelmed|0|||
130986620|NCT00246337|471577546|FG001|Overall Study|Overwhelmed|0|||
130986621|NCT00246337|471577547|FG002|Overall Study|Overwhelmed|0|||
130986622|NCT00246337|471577548|FG003|Overall Study|Overwhelmed|0|||
130986623|NCT00246337|471577549|FG004|Overall Study|Overwhelmed|0|||
131046702|NCT04490109|471805828|FG000|Overall Study|Adverse Event|2|||
131046703|NCT04490109|471805829|FG001|Overall Study|Adverse Event|1|||
131046704|NCT04490109|471805830|FG002|Overall Study|Adverse Event|0|||
130986624|NCT00246337|471577550|FG005|Overall Study|Overwhelmed|1|||
130986625|NCT00246337|471577551|FG006|Overall Study|Overwhelmed|0|||
130986626|NCT00246337|471577552|FG007|Overall Study|Overwhelmed|0|||
130986627|NCT00246337|471577553|FG008|Overall Study|Overwhelmed|0|||
130986628|NCT00246337|471577545|FG000|Overall Study|Protocol Violator|1|||
130986629|NCT00246337|471577546|FG001|Overall Study|Protocol Violator|0|||
130986630|NCT00246337|471577547|FG002|Overall Study|Protocol Violator|0|||
131046705|NCT04490109|471805828|FG000|Overall Study|Significant Non-Compliance|2|||
131046706|NCT04490109|471805829|FG001|Overall Study|Significant Non-Compliance|4|||
131046707|NCT04490109|471805830|FG002|Overall Study|Significant Non-Compliance|4|||
131046708|NCT04490109|471805828|FG000|Overall Study|Significant Clinical Event|0|||
131046709|NCT04490109|471805829|FG001|Overall Study|Significant Clinical Event|1|||
131046710|NCT04490109|471805830|FG002|Overall Study|Significant Clinical Event|0|||
131046711|NCT04490109|471805828|FG000|Overall Study|Other Reason|4|||
131046712|NCT04490109|471805829|FG001|Overall Study|Other Reason|1|||
131046713|NCT04490109|471805830|FG002|Overall Study|Other Reason|1|||
131046714|NCT03817983|471805833|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
131046715|NCT03817983|471805834|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
131046716|NCT03817983|471805835|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
131046717|NCT03744676|471805836|FG000|Pre-Treatment Phase|Disease related complications|2|||
131046718|NCT03744676|471805836|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
131046719|NCT03744676|471805836|FG000|Pre-Treatment Phase|Death|7|||
131046720|NCT03744676|471805836|FG000|Pre-Treatment Phase|Other Reasons|7|||
131046721|NCT03744676|471805836|FG000|Treatment Phase|Participant withdrew consent|8|||
131046722|NCT03744676|471805836|FG000|Treatment Phase|Death|33|||
131046723|NCT03744676|471805836|FG000|Treatment Phase|other reasons|6|||
131046724|NCT05541484|471805848|FG000|Overall Study|Withdrawal by Subject|1|||
131046725|NCT05541484|471805849|FG001|Overall Study|Withdrawal by Subject|0|||
131046726|NCT03884439|471805855|FG000|Overall Study|No informed consent for publication of study results|38|||
131046727|NCT03884439|471805855|FG000|Overall Study|Contract violation/deficiency|7|||
131046728|NCT03547271|471805856|FG000|Overall Study|Adverse Event|1|||
131046729|NCT03547271|471805857|FG001|Overall Study|Adverse Event|1|||
131046730|NCT03547271|471805858|FG002|Overall Study|Adverse Event|0|||
131046731|NCT03547271|471805859|FG003|Overall Study|Adverse Event|0|||
131046732|NCT03547271|471805856|FG000|Overall Study|Protocol deviation|5|||
131046733|NCT03547271|471805857|FG001|Overall Study|Protocol deviation|7|||
131046734|NCT03547271|471805858|FG002|Overall Study|Protocol deviation|3|||
131046735|NCT03547271|471805859|FG003|Overall Study|Protocol deviation|0|||
131046736|NCT03547271|471805856|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
131046737|NCT03547271|471805857|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
131046738|NCT03547271|471805858|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
131046739|NCT03547271|471805859|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
131046740|NCT03547271|471805856|FG000|Overall Study|Lost to Follow-up|3|||
131046741|NCT03547271|471805857|FG001|Overall Study|Lost to Follow-up|3|||
131046742|NCT03547271|471805858|FG002|Overall Study|Lost to Follow-up|1|||
131046743|NCT03547271|471805859|FG003|Overall Study|Lost to Follow-up|0|||
131046744|NCT04159519|471805868|FG000|Overall Study|Adverse Event|1|||
131046745|NCT04159519|471805869|FG001|Overall Study|Adverse Event|1|||
131046746|NCT04159519|471805868|FG000|Overall Study|Lack of Efficacy|1|||
131046747|NCT04159519|471805869|FG001|Overall Study|Lack of Efficacy|0|||
131046748|NCT04159519|471805868|FG000|Overall Study|Discontinued from study|1|||
131046749|NCT04159519|471805869|FG001|Overall Study|Discontinued from study|0|||
131046750|NCT04159519|471805868|FG000|Overall Study|Protocol Violation|1|||
131046751|NCT04159519|471805869|FG001|Overall Study|Protocol Violation|1|||
131046752|NCT04159519|471805868|FG000|Overall Study|Withdrawal by Subject|4|||
131046753|NCT04159519|471805869|FG001|Overall Study|Withdrawal by Subject|4|||
131046754|NCT02765412|471805870|FG000|Overall Study|Death|482|||
131046755|NCT02765412|471805871|FG001|Overall Study|Death|855|||
131046756|NCT05267639|471806665|FG000|Overall Study|Withdrawal by Subject|1|||
131046757|NCT05267639|471806666|FG001|Overall Study|Withdrawal by Subject|0|||
131046758|NCT04244175|471806670|FG000|Overall Study|Adverse Event|3|||
131046759|NCT04244175|471806671|FG001|Overall Study|Adverse Event|2|||
131046760|NCT04244175|471806672|FG002|Overall Study|Adverse Event|5|||
131133910|NCT00419380|472117239|FG001|Overall Study|Lack of Efficacy|7|||
130721044|NCT00620659|470601598|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130721045|NCT00620659|470601599|FG004|Treatment Period 2|Withdrawal by Subject|3|||
130721046|NCT00620659|470601600|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130721047|NCT00620659|470601595|FG000|Placebo Washout Period 2|Adverse Event|2|||
131046761|NCT04244175|471806670|FG000|Overall Study|Lack of Efficacy|1|||
131046762|NCT04244175|471806671|FG001|Overall Study|Lack of Efficacy|0|||
131046763|NCT04244175|471806672|FG002|Overall Study|Lack of Efficacy|1|||
131046764|NCT04244175|471806670|FG000|Overall Study|Lost to Follow-up|1|||
131046765|NCT04244175|471806671|FG001|Overall Study|Lost to Follow-up|0|||
131046766|NCT04244175|471806672|FG002|Overall Study|Lost to Follow-up|0|||
131133911|NCT00419380|472117238|FG000|Overall Study|Physician Decision|0|||
131133912|NCT00419380|472117239|FG001|Overall Study|Physician Decision|1|||
131046767|NCT04244175|471806670|FG000|Overall Study|Non-compliance with study drug|1|||
131046768|NCT04244175|471806671|FG001|Overall Study|Non-compliance with study drug|0|||
131046769|NCT04244175|471806672|FG002|Overall Study|Non-compliance with study drug|1|||
131046770|NCT04244175|471806670|FG000|Overall Study|Protocol deviation|0|||
131133913|NCT00419380|472117238|FG000|Overall Study|Lost to Follow-up|0|||
131046771|NCT04244175|471806671|FG001|Overall Study|Protocol deviation|1|||
131046772|NCT04244175|471806672|FG002|Overall Study|Protocol deviation|0|||
131046773|NCT04244175|471806670|FG000|Overall Study|Withdrawal by Subject|1|||
131133914|NCT00419380|472117239|FG001|Overall Study|Lost to Follow-up|1|||
130986631|NCT00246337|471577548|FG003|Overall Study|Protocol Violator|0|||
130986632|NCT00246337|471577549|FG004|Overall Study|Protocol Violator|0|||
130986633|NCT00246337|471577550|FG005|Overall Study|Protocol Violator|0|||
130986634|NCT00246337|471577551|FG006|Overall Study|Protocol Violator|0|||
130986635|NCT00246337|471577552|FG007|Overall Study|Protocol Violator|0|||
130986636|NCT00246337|471577553|FG008|Overall Study|Protocol Violator|0|||
130986637|NCT00246337|471577545|FG000|Overall Study|Reported as completing trial in error|0|||
130986638|NCT00246337|471577546|FG001|Overall Study|Reported as completing trial in error|0|||
130986639|NCT00246337|471577547|FG002|Overall Study|Reported as completing trial in error|0|||
130986640|NCT00246337|471577548|FG003|Overall Study|Reported as completing trial in error|0|||
130986641|NCT00246337|471577549|FG004|Overall Study|Reported as completing trial in error|0|||
130986642|NCT00246337|471577550|FG005|Overall Study|Reported as completing trial in error|0|||
130986643|NCT00246337|471577551|FG006|Overall Study|Reported as completing trial in error|0|||
130986644|NCT00246337|471577552|FG007|Overall Study|Reported as completing trial in error|1|||
130986645|NCT00246337|471577553|FG008|Overall Study|Reported as completing trial in error|0|||
130986646|NCT01226511|471577558|FG000|Acute Treatment Period|Adverse Event|7|||
130986647|NCT01226511|471577559|FG001|Acute Treatment Period|Adverse Event|6|||
130986648|NCT01226511|471577558|FG000|Acute Treatment Period|Lack of Efficacy|2|||
130986649|NCT01226511|471577559|FG001|Acute Treatment Period|Lack of Efficacy|1|||
130986650|NCT01226511|471577558|FG000|Acute Treatment Period|Lost to Follow-up|3|||
130986651|NCT01226511|471577559|FG001|Acute Treatment Period|Lost to Follow-up|6|||
130986652|NCT01226511|471577558|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
130986653|NCT01226511|471577559|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
130986654|NCT01226511|471577558|FG000|Acute Treatment Period|Protocol Violation|5|||
130986655|NCT01226511|471577559|FG001|Acute Treatment Period|Protocol Violation|5|||
130986656|NCT01226511|471577558|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
130986657|NCT01226511|471577559|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
130986658|NCT01226511|471577558|FG000|Extension Treatment Period|Adverse Event|8|||
130986659|NCT01226511|471577559|FG001|Extension Treatment Period|Adverse Event|8|||
130986660|NCT01226511|471577558|FG000|Extension Treatment Period|Lack of Efficacy|3|||
130986661|NCT01226511|471577559|FG001|Extension Treatment Period|Lack of Efficacy|2|||
130986662|NCT01226511|471577558|FG000|Extension Treatment Period|Lost to Follow-up|4|||
130986663|NCT01226511|471577559|FG001|Extension Treatment Period|Lost to Follow-up|3|||
130986664|NCT01226511|471577558|FG000|Extension Treatment Period|Protocol Violation|2|||
130986665|NCT01226511|471577559|FG001|Extension Treatment Period|Protocol Violation|2|||
130986666|NCT01226511|471577558|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
130986667|NCT01226511|471577559|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
130986668|NCT01226511|471577558|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
130986669|NCT01226511|471577559|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
130986670|NCT01226511|471577558|FG000|Extension Treatment Period|Sponsor Decision|1|||
130986671|NCT01226511|471577559|FG001|Extension Treatment Period|Sponsor Decision|1|||
130986672|NCT01226511|471577558|FG000|Taper Period|Adverse Event|1|||
130986673|NCT01226511|471577559|FG001|Taper Period|Adverse Event|0|||
130986674|NCT01226511|471577558|FG000|Taper Period|Lost to Follow-up|2|||
130986675|NCT01226511|471577559|FG001|Taper Period|Lost to Follow-up|2|||
130986676|NCT01226511|471577558|FG000|Taper Period|Protocol Violation|1|||
130986677|NCT01226511|471577559|FG001|Taper Period|Protocol Violation|0|||
130986678|NCT01226511|471577558|FG000|Taper Period|Parent/Caregiver Decision|1|||
130986679|NCT01226511|471577559|FG001|Taper Period|Parent/Caregiver Decision|1|||
130986680|NCT02696564|471577561|FG000|Overall Study|Death|1|||
130986681|NCT02696564|471577562|FG001|Overall Study|Death|2|||
130986682|NCT02696564|471577561|FG000|Overall Study|Withdrawal by Subject|3|||
130986683|NCT02696564|471577562|FG001|Overall Study|Withdrawal by Subject|2|||
130986684|NCT02696564|471577561|FG000|Overall Study|Lost to Follow-up|3|||
130986685|NCT02696564|471577562|FG001|Overall Study|Lost to Follow-up|3|||
130986686|NCT02696564|471577561|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
130986687|NCT02696564|471577562|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
130986688|NCT02696564|471577561|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
130986689|NCT02696564|471577562|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
130986690|NCT02696564|471577561|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
130986691|NCT02696564|471577562|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
130986692|NCT02696564|471577561|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
131046774|NCT04244175|471806671|FG001|Overall Study|Withdrawal by Subject|3|||
131229539|NCT00982410|472467603|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
131229540|NCT00982410|472467604|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
131229541|NCT00982410|472467603|FG000|6-month Follow-up Assessment|participant no transportation|1|||
131229542|NCT00982410|472467604|FG001|6-month Follow-up Assessment|participant no transportation|0|||
131229543|NCT00982410|472467603|FG000|6-month Follow-up Assessment|incarceration|0|||
131229544|NCT00982410|472467604|FG001|6-month Follow-up Assessment|incarceration|2|||
131229545|NCT00982410|472467603|FG000|6-month Follow-up Assessment|patent surgery|0|||
130986693|NCT02696564|471577562|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
130986694|NCT02696564|471577561|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
130986695|NCT02696564|471577562|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
130986696|NCT01337986|471577563|FG000|Overall Study|Adverse Event|2|||
130986697|NCT01337986|471577564|FG001|Overall Study|Adverse Event|2|||
130986698|NCT01337986|471577563|FG000|Overall Study|Lost to Follow-up|1|||
130986699|NCT01337986|471577564|FG001|Overall Study|Lost to Follow-up|0|||
130986700|NCT01337986|471577563|FG000|Overall Study|Protocol Violation|0|||
130986701|NCT01337986|471577564|FG001|Overall Study|Protocol Violation|3|||
130986702|NCT01520402|471577565|FG000|Overall Study|Withdrawal by Subject|2|||
130986703|NCT01520402|471577565|FG000|Overall Study|Physician Decision|3|||
130778877|NCT03428100|470817455|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778878|NCT03428100|470817456|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778879|NCT03428100|470817457|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130986704|NCT01722162|471577567|FG000|Overall Study|Withdrawal by Subject|1|||
131046775|NCT04244175|471806672|FG002|Overall Study|Withdrawal by Subject|1|||
130778880|NCT03428100|470817458|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130778881|NCT03428100|470817459|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130986705|NCT01722162|471577568|FG001|Overall Study|Withdrawal by Subject|1|||
130986706|NCT01722162|471577567|FG000|Overall Study|Found ineligible|1|||
131046776|NCT04244175|471806670|FG000|Overall Study|Other, not specified|0|||
131046777|NCT04244175|471806671|FG001|Overall Study|Other, not specified|1|||
131046778|NCT04244175|471806672|FG002|Overall Study|Other, not specified|2|||
131046779|NCT04595331|471806673|FG000|Overall Study|Withdrawal by Subject|0|||
131046780|NCT04595331|471806674|FG001|Overall Study|Withdrawal by Subject|1|||
131046781|NCT04595331|471806673|FG000|Overall Study|Lost to Follow-up|0|||
131046782|NCT04595331|471806674|FG001|Overall Study|Lost to Follow-up|5|||
131046783|NCT04595331|471806673|FG000|Overall Study|Medical reason|0|||
131046784|NCT04595331|471806674|FG001|Overall Study|Medical reason|1|||
131046785|NCT06655818|471806681|FG000|Overall Study|Withdrawal by Subject|1|||
131046786|NCT02163694|471806682|FG000|Overall Study|Adverse event- related to progression|4|||
131046787|NCT02163694|471806683|FG001|Overall Study|Adverse event- related to progression|10|||
131046788|NCT02163694|471806682|FG000|Overall Study|Adverse event- not related to progression|7|||
131046789|NCT02163694|471806683|FG001|Overall Study|Adverse event- not related to progression|22|||
131046790|NCT02163694|471806682|FG000|Overall Study|Withdrew consent|13|||
131046791|NCT02163694|471806683|FG001|Overall Study|Withdrew consent|28|||
131046792|NCT02163694|471806682|FG000|Overall Study|Lost to Follow-up|2|||
131046793|NCT02163694|471806683|FG001|Overall Study|Lost to Follow-up|2|||
131046794|NCT02163694|471806682|FG000|Overall Study|Sponsor discontinued study|3|||
131046795|NCT02163694|471806683|FG001|Overall Study|Sponsor discontinued study|29|||
131046796|NCT02163694|471806682|FG000|Overall Study|Progressive disease per protocol|125|||
131046797|NCT02163694|471806683|FG001|Overall Study|Progressive disease per protocol|224|||
131229546|NCT00982410|472467604|FG001|6-month Follow-up Assessment|patent surgery|1|||
131229547|NCT00982410|472467603|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
131229548|NCT00982410|472467604|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
131229549|NCT00982410|472467603|FG000|12-month Follow-up Assessment|Death|0|||
131229550|NCT00982410|472467604|FG001|12-month Follow-up Assessment|Death|2|||
131229551|NCT00982410|472467603|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
131229552|NCT00982410|472467604|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
131229553|NCT00982410|472467603|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
131229554|NCT00982410|472467604|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
131229555|NCT00982410|472467603|FG000|12-month Follow-up Assessment|incarceration|2|||
131229556|NCT00982410|472467604|FG001|12-month Follow-up Assessment|incarceration|1|||
131229557|NCT00982410|472467603|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
131229558|NCT00982410|472467604|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
131229559|NCT03322462|472467605|FG000|Overall Study|Technical difficulties|2|||
131229560|NCT03322462|472467605|FG000|Overall Study|Other|1|||
131229561|NCT02004847|472467606|FG000|Overall Study|Protocol Violation|1|||
131229562|NCT02004847|472467607|FG001|Overall Study|Protocol Violation|1|||
131229563|NCT02034799|472467608|FG000|Overall Study|Withdrawal by Subject|0|||
131229564|NCT02034799|472467609|FG001|Overall Study|Withdrawal by Subject|2|||
131229565|NCT02034799|472467608|FG000|Overall Study|Lost to Follow-up|0|||
131229566|NCT02034799|472467609|FG001|Overall Study|Lost to Follow-up|1|||
131229567|NCT02034799|472467608|FG000|Overall Study|Death|2|||
131229568|NCT02034799|472467609|FG001|Overall Study|Death|1|||
131229569|NCT00434161|472467618|FG000|Overall Study|Adverse Event|5|||
131229570|NCT00434161|472467619|FG001|Overall Study|Adverse Event|1|||
131229571|NCT00434161|472467620|FG002|Overall Study|Adverse Event|4|||
131229572|NCT00434161|472467618|FG000|Overall Study|Lost to Follow-up|0|||
131229573|NCT00434161|472467619|FG001|Overall Study|Lost to Follow-up|1|||
131229574|NCT00434161|472467620|FG002|Overall Study|Lost to Follow-up|0|||
131229575|NCT00434161|472467618|FG000|Overall Study|Death|1|||
131229576|NCT00434161|472467619|FG001|Overall Study|Death|0|||
131229577|NCT00434161|472467620|FG002|Overall Study|Death|1|||
130986707|NCT01722162|471577568|FG001|Overall Study|Found ineligible|0|||
130986708|NCT01722162|471577567|FG000|Overall Study|Unrelated to study adverse event|2|||
130986709|NCT01722162|471577568|FG001|Overall Study|Unrelated to study adverse event|2|||
130778882|NCT03428100|470817441|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778883|NCT03428100|470817442|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
130778884|NCT03428100|470817443|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778885|NCT03428100|470817444|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
131046798|NCT02163694|471806682|FG000|Overall Study|Other, not specified|17|||
131046799|NCT02163694|471806683|FG001|Overall Study|Other, not specified|22|||
131046800|NCT02163694|471806682|FG000|Overall Study|Randomized but Not Treated|1|||
131046801|NCT02163694|471806683|FG001|Overall Study|Randomized but Not Treated|0|||
131046802|NCT02163694|471806682|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
131046803|NCT02163694|471806683|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
131046804|NCT06010836|471806692|FG000|Overall Study|Lost to Follow-up|2|||
131046805|NCT06010836|471806693|FG001|Overall Study|Lost to Follow-up|2|||
131046806|NCT06010836|471806692|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
131046807|NCT06010836|471806693|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
131046808|NCT06010836|471806692|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
131046809|NCT06010836|471806693|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
131046810|NCT06010836|471806692|FG000|Overall Study|Did not receive intervention discussion|0|||
131046811|NCT06010836|471806693|FG001|Overall Study|Did not receive intervention discussion|4|||
131046812|NCT04496752|471806694|FG000|Second Assessment|Lost to Follow-up|3|||
131046813|NCT04496752|471806695|FG001|Second Assessment|Lost to Follow-up|3|||
131046814|NCT04496752|471806694|FG000|Second Assessment|Adverse Event|2|||
131046815|NCT04496752|471806695|FG001|Second Assessment|Adverse Event|0|||
131046816|NCT02461134|471806699|FG000|Overall Study|Adverse Event|1|||
130778886|NCT03428100|470817445|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130986710|NCT01722162|471577567|FG000|Overall Study|Adverse Event|1|||
130986711|NCT01722162|471577568|FG001|Overall Study|Adverse Event|1|||
130986712|NCT01722162|471577567|FG000|Overall Study|Insurance denial post enrollment|0|||
130986713|NCT01722162|471577568|FG001|Overall Study|Insurance denial post enrollment|1|||
130986714|NCT01722162|471577567|FG000|Overall Study|Noncompliance|0|||
130986715|NCT01722162|471577568|FG001|Overall Study|Noncompliance|1|||
130986716|NCT03124199|471577569|FG000|Overall Study|Lost to Follow-up|4|||
130986717|NCT01538472|471577570|FG000|Overall Study|Disease Progression|3|||
130986718|NCT01538472|471577570|FG000|Overall Study|Death|1|||
130986719|NCT02309112|471577571|FG000|Overall Study|Withdrawal by Subject|1|||
130986720|NCT02309112|471577572|FG001|Overall Study|Withdrawal by Subject|0|||
130986721|NCT02309112|471577573|FG002|Overall Study|Withdrawal by Subject|1|||
130986722|NCT02309112|471577571|FG000|Overall Study|Lost to Follow-up|0|||
130986723|NCT02309112|471577572|FG001|Overall Study|Lost to Follow-up|1|||
130986724|NCT02309112|471577573|FG002|Overall Study|Lost to Follow-up|0|||
130986725|NCT03170375|471577574|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
130986726|NCT03170375|471577575|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
130986727|NCT03170375|471577576|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
130986728|NCT03170375|471577574|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
130986729|NCT03170375|471577575|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
130986730|NCT03170375|471577576|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
130986731|NCT00763958|471577579|FG000|Overall Study|did not meet final criteria|4|||
130986732|NCT00763958|471577580|FG001|Overall Study|did not meet final criteria|4|||
130986733|NCT00763958|471577579|FG000|Overall Study|Lost to Follow-up|10|||
130986734|NCT00763958|471577580|FG001|Overall Study|Lost to Follow-up|2|||
130986735|NCT00763958|471577579|FG000|Overall Study|Believed they were receiving placebo|0|||
130986736|NCT00763958|471577580|FG001|Overall Study|Believed they were receiving placebo|5|||
130986737|NCT02535364|471577588|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
130986738|NCT02535364|471577588|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
130986739|NCT02535364|471577588|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
130986740|NCT02535364|471577588|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
130986741|NCT02535364|471577588|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
130986742|NCT02535364|471577588|FG000|Part B Screening|Death|2|||
130986743|NCT02535364|471577588|FG000|Part B Screening|Physician Decision|1|||
130986744|NCT02535364|471577588|FG000|Part B Screening|Withdrawal by Subject|1|||
130986745|NCT02535364|471577588|FG000|Part B Screening|Adverse Event|1|||
130986746|NCT02535364|471577588|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
130986747|NCT02535364|471577588|FG000|Study Treatment|Death|1|||
130986748|NCT02535364|471577588|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
130986749|NCT02535364|471577588|FG000|12-Month Follow-up Period|Disease progression|22|||
130986750|NCT02535364|471577588|FG000|12-Month Follow-up Period|Death|5|||
130986751|NCT02535364|471577588|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
131046817|NCT04761198|471806700|FG000|Overall Study|Progressive Disease|1|||
131046818|NCT04761198|471806701|FG001|Overall Study|Progressive Disease|0|||
131046819|NCT04761198|471806702|FG002|Overall Study|Progressive Disease|0|||
131046820|NCT04761198|471806703|FG003|Overall Study|Progressive Disease|1|||
131046821|NCT04761198|471806704|FG004|Overall Study|Progressive Disease|4|||
131046822|NCT04761198|471806705|FG005|Overall Study|Progressive Disease|1|||
131046823|NCT04761198|471806706|FG006|Overall Study|Progressive Disease|2|||
131046824|NCT04761198|471806700|FG000|Overall Study|Protocol Violation|0|||
131046825|NCT04761198|471806701|FG001|Overall Study|Protocol Violation|0|||
131046826|NCT04761198|471806702|FG002|Overall Study|Protocol Violation|0|||
131046827|NCT04761198|471806703|FG003|Overall Study|Protocol Violation|0|||
131046828|NCT04761198|471806704|FG004|Overall Study|Protocol Violation|1|||
131046829|NCT04761198|471806705|FG005|Overall Study|Protocol Violation|0|||
131046830|NCT04761198|471806706|FG006|Overall Study|Protocol Violation|0|||
131229578|NCT00434161|472467618|FG000|Overall Study|Non-Compliance|1|||
131229579|NCT00434161|472467619|FG001|Overall Study|Non-Compliance|1|||
131229580|NCT00434161|472467620|FG002|Overall Study|Non-Compliance|0|||
131229581|NCT00434161|472467618|FG000|Overall Study|Withdrawal by Subject|2|||
131229582|NCT00434161|472467619|FG001|Overall Study|Withdrawal by Subject|0|||
131229583|NCT00434161|472467620|FG002|Overall Study|Withdrawal by Subject|3|||
131046831|NCT04761198|471806700|FG000|Overall Study|Death|2|||
131046832|NCT04761198|471806701|FG001|Overall Study|Death|1|||
131046833|NCT04761198|471806702|FG002|Overall Study|Death|2|||
131046834|NCT04761198|471806703|FG003|Overall Study|Death|5|||
131046835|NCT04761198|471806704|FG004|Overall Study|Death|14|||
131046836|NCT04761198|471806705|FG005|Overall Study|Death|2|||
131046837|NCT04761198|471806706|FG006|Overall Study|Death|5|||
131046838|NCT04761198|471806700|FG000|Overall Study|Lost to Follow-up|0|||
131046839|NCT04761198|471806701|FG001|Overall Study|Lost to Follow-up|0|||
131046840|NCT04761198|471806702|FG002|Overall Study|Lost to Follow-up|0|||
131046841|NCT04761198|471806703|FG003|Overall Study|Lost to Follow-up|0|||
131046842|NCT04761198|471806704|FG004|Overall Study|Lost to Follow-up|1|||
131046843|NCT04761198|471806705|FG005|Overall Study|Lost to Follow-up|0|||
131046844|NCT04761198|471806706|FG006|Overall Study|Lost to Follow-up|0|||
131046845|NCT04761198|471806700|FG000|Overall Study|Withdrawal by Subject|2|||
131046846|NCT04761198|471806701|FG001|Overall Study|Withdrawal by Subject|0|||
131046847|NCT04761198|471806702|FG002|Overall Study|Withdrawal by Subject|1|||
131046848|NCT04761198|471806703|FG003|Overall Study|Withdrawal by Subject|0|||
131046849|NCT04761198|471806704|FG004|Overall Study|Withdrawal by Subject|2|||
131046850|NCT04761198|471806705|FG005|Overall Study|Withdrawal by Subject|0|||
131046851|NCT04761198|471806706|FG006|Overall Study|Withdrawal by Subject|1|||
131046852|NCT04761198|471806700|FG000|Overall Study|Study Terminated by Sponsor|6|||
131046853|NCT04761198|471806701|FG001|Overall Study|Study Terminated by Sponsor|0|||
131046854|NCT04761198|471806702|FG002|Overall Study|Study Terminated by Sponsor|5|||
131046855|NCT04761198|471806703|FG003|Overall Study|Study Terminated by Sponsor|3|||
131046856|NCT04761198|471806704|FG004|Overall Study|Study Terminated by Sponsor|10|||
131046857|NCT04761198|471806705|FG005|Overall Study|Study Terminated by Sponsor|1|||
131046858|NCT04761198|471806706|FG006|Overall Study|Study Terminated by Sponsor|2|||
131046859|NCT02994927|471806707|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131046860|NCT02994927|471806708|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131046861|NCT02994927|471806707|FG000|Overall Study|Did not meet eligibility criteria|0|||
131046862|NCT02994927|471806708|FG001|Overall Study|Did not meet eligibility criteria|1|||
131046863|NCT02994927|471806707|FG000|Overall Study|Physician Decision|4|||
131046864|NCT02994927|471806708|FG001|Overall Study|Physician Decision|3|||
131046865|NCT02994927|471806707|FG000|Overall Study|Death|4|||
131046866|NCT02994927|471806708|FG001|Overall Study|Death|2|||
131046867|NCT02994927|471806707|FG000|Overall Study|Adverse Event|2|||
131046868|NCT02994927|471806708|FG001|Overall Study|Adverse Event|1|||
131046869|NCT02994927|471806707|FG000|Overall Study|Withdrawal by Subject|3|||
131046870|NCT02994927|471806708|FG001|Overall Study|Withdrawal by Subject|6|||
131046871|NCT02994927|471806707|FG000|Overall Study|Lost to Follow-up|2|||
131046872|NCT02994927|471806708|FG001|Overall Study|Lost to Follow-up|1|||
131046873|NCT03533257|471806716|FG000|Overall Study|Adverse Event|4|||
131229584|NCT00434161|472467618|FG000|Overall Study|Logistical error study assessments|1|||
131046874|NCT03533257|471806717|FG001|Overall Study|Adverse Event|2|||
131046875|NCT03533257|471806716|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
131046876|NCT03533257|471806717|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
131046877|NCT03493542|471806718|FG000|Base Study|Withdrawal by Subject|0|||
131046878|NCT03493542|471806719|FG001|Base Study|Withdrawal by Subject|4|||
131046879|NCT03493542|471806720|FG002|Base Study|Withdrawal by Subject|0|||
131046880|NCT03493542|471806718|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
131046881|NCT03493542|471806719|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
131046882|NCT03493542|471806720|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
131046883|NCT03493542|471806718|FG000|Extension Study|Withdrawal by Subject|0|||
131046884|NCT03493542|471806719|FG001|Extension Study|Withdrawal by Subject|0|||
131046885|NCT03493542|471806720|FG002|Extension Study|Withdrawal by Subject|25|||
131046886|NCT04093869|471806721|FG000|Overall Study|Death|0|||
131046887|NCT04093869|471806722|FG001|Overall Study|Death|1|||
131046888|NCT04093869|471806721|FG000|Overall Study|Withdrawal by Subject|1|||
131046889|NCT04093869|471806722|FG001|Overall Study|Withdrawal by Subject|0|||
131046890|NCT03250676|471806723|FG000|Overall Study|Adverse Event|0|||
131046891|NCT03250676|471806724|FG001|Overall Study|Adverse Event|0|||
131046892|NCT03250676|471806725|FG002|Overall Study|Adverse Event|0|||
131046893|NCT03250676|471806726|FG003|Overall Study|Adverse Event|1|||
131133915|NCT00419380|472117238|FG000|Overall Study|Withdrawal by Subject|0|||
131133916|NCT00419380|472117239|FG001|Overall Study|Withdrawal by Subject|1|||
131133917|NCT01026831|472117242|FG000|Overall Study|Adverse Event|4|||
131133918|NCT01026831|472117243|FG001|Overall Study|Adverse Event|3|||
131133919|NCT01026831|472117242|FG000|Overall Study|Lost to Follow-up|2|||
131133920|NCT01026831|472117243|FG001|Overall Study|Lost to Follow-up|0|||
130721048|NCT00620659|470601596|FG001|Placebo Washout Period 2|Adverse Event|0|||
130721049|NCT00620659|470601597|FG002|Placebo Washout Period 2|Adverse Event|0|||
130721050|NCT00620659|470601598|FG003|Placebo Washout Period 2|Adverse Event|0|||
130721051|NCT00620659|470601599|FG004|Placebo Washout Period 2|Adverse Event|0|||
130721052|NCT00620659|470601600|FG005|Placebo Washout Period 2|Adverse Event|0|||
130721053|NCT00620659|470601595|FG000|Treatment Period 3|Adverse Event|0|||
130721054|NCT00620659|470601596|FG001|Treatment Period 3|Adverse Event|2|||
130721055|NCT00620659|470601597|FG002|Treatment Period 3|Adverse Event|0|||
130721056|NCT00620659|470601598|FG003|Treatment Period 3|Adverse Event|0|||
130721057|NCT00620659|470601599|FG004|Treatment Period 3|Adverse Event|0|||
130721058|NCT00620659|470601600|FG005|Treatment Period 3|Adverse Event|0|||
130721059|NCT00620659|470601595|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130721060|NCT00620659|470601596|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130721061|NCT00620659|470601597|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130721062|NCT00620659|470601598|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130721063|NCT00620659|470601599|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130721064|NCT00620659|470601600|FG005|Treatment Period 3|Withdrawal by Subject|0|||
130721065|NCT01193127|470601601|FG000|Randomized|Surgery Cancelled|0|||
130721066|NCT01193127|470601602|FG001|Randomized|Surgery Cancelled|0|||
130721067|NCT01193127|470601603|FG002|Randomized|Surgery Cancelled|0|||
130721068|NCT01193127|470601604|FG003|Randomized|Surgery Cancelled|1|||
130721069|NCT01193127|470601601|FG000|Treated|Withdrawal by Subject|0|||
130721070|NCT01193127|470601602|FG001|Treated|Withdrawal by Subject|0|||
130721071|NCT01193127|470601603|FG002|Treated|Withdrawal by Subject|0|||
130721072|NCT01193127|470601604|FG003|Treated|Withdrawal by Subject|1|||
130721073|NCT03246646|470601605|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
130721074|NCT03246646|470601606|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
130721075|NCT03246646|470601605|FG000|Overall Study|Withdrawal by Subject|3|||
130721076|NCT03246646|470601606|FG001|Overall Study|Withdrawal by Subject|0|||
130721077|NCT03246646|470601605|FG000|Overall Study|Lost to Follow-up|7|||
130721078|NCT03246646|470601606|FG001|Overall Study|Lost to Follow-up|0|||
130721079|NCT02352779|470601607|FG000|Overall Study|Personal Issues|1|||
130721080|NCT02352779|470601608|FG001|Overall Study|Personal Issues|1|||
130721081|NCT02352779|470601609|FG002|Overall Study|Personal Issues|0|||
130721082|NCT02352779|470601607|FG000|Overall Study|Too Many Forms|2|||
130721083|NCT02352779|470601608|FG001|Overall Study|Too Many Forms|0|||
130721084|NCT02352779|470601609|FG002|Overall Study|Too Many Forms|0|||
130721085|NCT02352779|470601607|FG000|Overall Study|Feeling Overwhelmed|1|||
130721086|NCT02352779|470601608|FG001|Overall Study|Feeling Overwhelmed|0|||
130721087|NCT02352779|470601609|FG002|Overall Study|Feeling Overwhelmed|0|||
130721088|NCT02352779|470601607|FG000|Overall Study|Disliked Intervention|1|||
130721089|NCT02352779|470601608|FG001|Overall Study|Disliked Intervention|0|||
130721090|NCT02352779|470601609|FG002|Overall Study|Disliked Intervention|0|||
130721091|NCT02352779|470601607|FG000|Overall Study|Changed Mind|1|||
130721092|NCT02352779|470601608|FG001|Overall Study|Changed Mind|0|||
130721093|NCT02352779|470601609|FG002|Overall Study|Changed Mind|0|||
130721094|NCT02352779|470601607|FG000|Overall Study|Study Related Symptoms|1|||
130721095|NCT02352779|470601608|FG001|Overall Study|Study Related Symptoms|0|||
130721096|NCT02352779|470601609|FG002|Overall Study|Study Related Symptoms|0|||
130721097|NCT02352779|470601607|FG000|Overall Study|Absence of Symptoms|1|||
130721098|NCT02352779|470601608|FG001|Overall Study|Absence of Symptoms|0|||
130721099|NCT02352779|470601609|FG002|Overall Study|Absence of Symptoms|0|||
130721100|NCT02352779|470601607|FG000|Overall Study|Other Medical Reason|0|||
130721101|NCT02352779|470601608|FG001|Overall Study|Other Medical Reason|0|||
130721102|NCT02352779|470601609|FG002|Overall Study|Other Medical Reason|1|||
131046894|NCT03250676|471806727|FG004|Overall Study|Adverse Event|2|||
131046895|NCT03250676|471806728|FG005|Overall Study|Adverse Event|9|||
131046896|NCT03250676|471806723|FG000|Overall Study|Withdrawal by Subject|1|||
131046897|NCT03250676|471806724|FG001|Overall Study|Withdrawal by Subject|0|||
131046898|NCT03250676|471806725|FG002|Overall Study|Withdrawal by Subject|0|||
131046899|NCT03250676|471806726|FG003|Overall Study|Withdrawal by Subject|1|||
130721103|NCT02352779|470601607|FG000|Overall Study|No Reason|0|||
130721104|NCT02352779|470601608|FG001|Overall Study|No Reason|0|||
130721105|NCT02352779|470601609|FG002|Overall Study|No Reason|1|||
130721106|NCT04555720|470601612|FG000|Overall Study|Lost to Follow-up|2|||
130721107|NCT04555720|470601613|FG001|Overall Study|Lost to Follow-up|0|||
131046900|NCT03250676|471806727|FG004|Overall Study|Withdrawal by Subject|1|||
131046901|NCT03250676|471806728|FG005|Overall Study|Withdrawal by Subject|2|||
131046902|NCT03250676|471806723|FG000|Overall Study|Physician Decision|0|||
131046903|NCT03250676|471806724|FG001|Overall Study|Physician Decision|0|||
131046904|NCT03250676|471806725|FG002|Overall Study|Physician Decision|0|||
131046905|NCT03250676|471806726|FG003|Overall Study|Physician Decision|2|||
131133921|NCT01026831|472117242|FG000|Overall Study|Physician Decision|1|||
131133922|NCT01026831|472117243|FG001|Overall Study|Physician Decision|1|||
131133923|NCT01026831|472117242|FG000|Overall Study|Protocol Violation|0|||
131133924|NCT01026831|472117243|FG001|Overall Study|Protocol Violation|2|||
131133925|NCT01026831|472117242|FG000|Overall Study|Withdrawal by Subject|7|||
131133926|NCT01026831|472117243|FG001|Overall Study|Withdrawal by Subject|5|||
131133927|NCT01180660|472117244|FG000|Overall Study|Changed to open surgery|1|||
131133928|NCT01180660|472117245|FG001|Overall Study|Changed to open surgery|0|||
131133929|NCT03861559|472117246|FG000|Overall Study|Adverse Event|0|||
131133930|NCT03861559|472117247|FG001|Overall Study|Adverse Event|2|||
131133931|NCT03861559|472117246|FG000|Overall Study|Treatment failure|0|||
131046906|NCT03250676|471806727|FG004|Overall Study|Physician Decision|0|||
131046907|NCT03250676|471806728|FG005|Overall Study|Physician Decision|3|||
131046908|NCT03250676|471806723|FG000|Overall Study|Withdrawal of consent|0|||
131046909|NCT03250676|471806724|FG001|Overall Study|Withdrawal of consent|0|||
131046910|NCT03250676|471806725|FG002|Overall Study|Withdrawal of consent|2|||
131046911|NCT03250676|471806726|FG003|Overall Study|Withdrawal of consent|0|||
131046912|NCT03250676|471806727|FG004|Overall Study|Withdrawal of consent|0|||
131046913|NCT03250676|471806728|FG005|Overall Study|Withdrawal of consent|2|||
131046914|NCT03250676|471806723|FG000|Overall Study|Other|1|||
131046915|NCT03250676|471806724|FG001|Overall Study|Other|0|||
131046916|NCT03250676|471806725|FG002|Overall Study|Other|0|||
131046917|NCT03250676|471806726|FG003|Overall Study|Other|0|||
131046918|NCT03250676|471806727|FG004|Overall Study|Other|0|||
131046919|NCT03250676|471806728|FG005|Overall Study|Other|0|||
131046920|NCT03250676|471806723|FG000|Overall Study|Disease progression|4|||
131046921|NCT03250676|471806724|FG001|Overall Study|Disease progression|12|||
131046922|NCT03250676|471806725|FG002|Overall Study|Disease progression|9|||
131046923|NCT03250676|471806726|FG003|Overall Study|Disease progression|7|||
131046924|NCT03250676|471806727|FG004|Overall Study|Disease progression|4|||
131046925|NCT03250676|471806728|FG005|Overall Study|Disease progression|88|||
131046926|NCT04780581|471806729|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
131046927|NCT04780581|471806730|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
131229585|NCT00434161|472467619|FG001|Overall Study|Logistical error study assessments|0|||
131229586|NCT00434161|472467620|FG002|Overall Study|Logistical error study assessments|3|||
131229587|NCT03342898|472467621|FG000|Overall Study|Adverse Event|3|||
131229588|NCT03342898|472467622|FG001|Overall Study|Adverse Event|1|||
131229589|NCT03342898|472467623|FG002|Overall Study|Adverse Event|0|||
131229590|NCT03342898|472467621|FG000|Overall Study|Lost to Follow-up|44|||
131229591|NCT03342898|472467622|FG001|Overall Study|Lost to Follow-up|40|||
131229592|NCT03342898|472467623|FG002|Overall Study|Lost to Follow-up|42|||
131229593|NCT03342898|472467621|FG000|Overall Study|Withdrawal of Consent|5|||
131229594|NCT03342898|472467622|FG001|Overall Study|Withdrawal of Consent|9|||
131229595|NCT03342898|472467623|FG002|Overall Study|Withdrawal of Consent|11|||
131229596|NCT03342898|472467621|FG000|Overall Study|Death|0|||
131229597|NCT03342898|472467622|FG001|Overall Study|Death|1|||
131229598|NCT03342898|472467623|FG002|Overall Study|Death|1|||
131229599|NCT03342898|472467621|FG000|Overall Study|Reason not Specified|2|||
131229600|NCT03342898|472467622|FG001|Overall Study|Reason not Specified|2|||
131229601|NCT03342898|472467623|FG002|Overall Study|Reason not Specified|0|||
131229602|NCT01267266|472467624|FG000|Enrollment Phase|Withdrawal by Subject|2|||
131229603|NCT01267266|472467625|FG001|Enrollment Phase|Withdrawal by Subject|0|||
131229604|NCT01267266|472467624|FG000|Lead-in Phase|Lack of Efficacy|20|||
131229605|NCT01267266|472467625|FG001|Lead-in Phase|Lack of Efficacy|0|||
131229606|NCT01267266|472467624|FG000|Lead-in Phase|Adverse Event|2|||
131229607|NCT01267266|472467625|FG001|Lead-in Phase|Adverse Event|0|||
131229608|NCT01267266|472467624|FG000|Lead-in Phase|Withdrawal by Subject|1|||
131229609|NCT01267266|472467625|FG001|Lead-in Phase|Withdrawal by Subject|0|||
131229610|NCT01466686|472467637|FG000|Overall Study|Withdrawal by Subject|1|||
131229611|NCT01907087|472467639|FG000|Overall Study|Withdrawal by Subject|1|||
131229612|NCT05216978|472467640|FG000|Overall Study|Withdrawal by Subject|3|||
131229613|NCT05216978|472467640|FG000|Overall Study|Lost to Follow-up|5|||
131229614|NCT00658320|472467642|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
131229615|NCT00658320|472467643|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
131229616|NCT00658320|472467642|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
131229617|NCT00658320|472467643|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
130721108|NCT04555720|470601614|FG002|Overall Study|Lost to Follow-up|0|||
131046928|NCT04780581|471806729|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
131133932|NCT03861559|472117247|FG001|Overall Study|Treatment failure|2|||
131133933|NCT03861559|472117246|FG000|Overall Study|Noncompliance|1|||
131133934|NCT03861559|472117247|FG001|Overall Study|Noncompliance|1|||
131133935|NCT03861559|472117246|FG000|Overall Study|Did not meet eligibility requirements|1|||
130778887|NCT03428100|470817446|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778888|NCT03428100|470817447|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778889|NCT03428100|470817448|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778890|NCT03428100|470817449|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778891|NCT03428100|470817450|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778892|NCT03428100|470817451|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778893|NCT03428100|470817452|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778894|NCT03428100|470817453|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778895|NCT03428100|470817454|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778896|NCT03428100|470817455|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778897|NCT03428100|470817456|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778898|NCT03428100|470817457|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778899|NCT03428100|470817458|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778900|NCT03428100|470817459|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130778901|NCT03428100|470817441|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130778902|NCT03428100|470817442|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130778903|NCT03428100|470817443|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130778904|NCT03428100|470817444|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131046929|NCT04780581|471806730|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
130778905|NCT03428100|470817445|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130778906|NCT03428100|470817446|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
130778907|NCT03428100|470817447|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130778908|NCT03428100|470817448|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
130778909|NCT03428100|470817449|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130778910|NCT03428100|470817450|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
131046930|NCT03781089|471807331|FG000|Overall Study|Constipation|1|||
131046931|NCT03781089|471807332|FG001|Overall Study|Constipation|0|||
131046932|NCT03781089|471807331|FG000|Overall Study|Positive pregnancy test|0|||
131046933|NCT03781089|471807332|FG001|Overall Study|Positive pregnancy test|1|||
131046934|NCT03417284|471807333|FG000|Overall Study|Inadequate supply on study drug|1|||
130778911|NCT03428100|470817451|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130778912|NCT03428100|470817452|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130778913|NCT03428100|470817453|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
130778914|NCT03428100|470817454|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130778915|NCT03428100|470817455|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130778916|NCT03428100|470817456|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130778917|NCT03428100|470817457|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
130778918|NCT03428100|470817458|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130778919|NCT03428100|470817459|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130778920|NCT03428100|470817441|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
130778921|NCT03428100|470817442|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
130778922|NCT03428100|470817443|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
130778923|NCT03428100|470817444|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
130778924|NCT03428100|470817445|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
130778925|NCT03428100|470817446|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
130778926|NCT03428100|470817447|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
130778927|NCT03428100|470817448|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
130778928|NCT03428100|470817449|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
130778929|NCT03428100|470817450|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
130778930|NCT03428100|470817451|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
130778931|NCT03428100|470817452|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
130778932|NCT03428100|470817453|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
130778933|NCT03428100|470817454|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
130778934|NCT03428100|470817455|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
130778935|NCT03428100|470817456|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
130778936|NCT03428100|470817457|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
130778937|NCT03428100|470817458|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
130778938|NCT03428100|470817459|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
130778939|NCT03428100|470817441|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130778940|NCT03428100|470817442|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130778941|NCT03428100|470817443|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130778942|NCT03428100|470817444|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130778943|NCT03428100|470817445|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
130778944|NCT03428100|470817446|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
130778945|NCT03428100|470817447|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
130778946|NCT03428100|470817448|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130778947|NCT03428100|470817449|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130778948|NCT03428100|470817450|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130778949|NCT03428100|470817451|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130778950|NCT03428100|470817452|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130778951|NCT03428100|470817453|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
130778952|NCT03428100|470817454|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
130778953|NCT03428100|470817455|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
130778954|NCT03428100|470817456|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
130778955|NCT03428100|470817457|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130778956|NCT03428100|470817458|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130778957|NCT03428100|470817459|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
130778958|NCT03428100|470817441|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778959|NCT03428100|470817442|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778960|NCT03428100|470817443|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130986752|NCT02535364|471577588|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
130986753|NCT02535364|471577588|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
130986754|NCT00571701|471577589|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
130986755|NCT00571701|471577590|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
130986756|NCT00571701|471577589|FG000|First Intervention 12 Months|Death|1|||
130986757|NCT00571701|471577590|FG001|First Intervention 12 Months|Death|0|||
130986758|NCT00571701|471577589|FG000|Second Intervention 12 Months|Adverse Event|0|||
130986759|NCT00571701|471577590|FG001|Second Intervention 12 Months|Adverse Event|1|||
130986760|NCT00571701|471577589|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
130986761|NCT00571701|471577590|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
130986762|NCT04766086|471577594|FG000|Overall Study|Lost to Follow-up|3|||
130986763|NCT04766086|471577595|FG001|Overall Study|Lost to Follow-up|5|||
130986764|NCT04766086|471577596|FG002|Overall Study|Lost to Follow-up|3|||
130986765|NCT04766086|471577594|FG000|Overall Study|Withdrawal by Subject|1|||
130986766|NCT04766086|471577595|FG001|Overall Study|Withdrawal by Subject|1|||
130986767|NCT04766086|471577596|FG002|Overall Study|Withdrawal by Subject|2|||
130986768|NCT04766086|471577594|FG000|Overall Study|Other|0|||
130986769|NCT04766086|471577595|FG001|Overall Study|Other|0|||
130986770|NCT04766086|471577596|FG002|Overall Study|Other|1|||
130986771|NCT03815019|471577597|FG000|Overall Study|Withdrawal by Subject|6|||
130986772|NCT03815019|471577598|FG001|Overall Study|Withdrawal by Subject|8|||
130986773|NCT01320943|471577599|FG000|Overall Study|Lost to Follow-up|1|||
130986774|NCT01320943|471577600|FG001|Overall Study|Lost to Follow-up|0|||
130986775|NCT01320943|471577599|FG000|Overall Study|Physician Decision|0|||
130986776|NCT01320943|471577600|FG001|Overall Study|Physician Decision|1|||
130986777|NCT01320943|471577599|FG000|Overall Study|Randomized but not Treated|0|||
130986778|NCT01320943|471577600|FG001|Overall Study|Randomized but not Treated|1|||
130986779|NCT03937219|471577601|FG000|Overall Study|Death|223|||
130986780|NCT03937219|471577602|FG001|Overall Study|Death|211|||
130986781|NCT03937219|471577601|FG000|Overall Study|Withdrawal by Subject|17|||
130986782|NCT03937219|471577602|FG001|Overall Study|Withdrawal by Subject|25|||
130986783|NCT03937219|471577601|FG000|Overall Study|Lost to Follow-up|3|||
130986784|NCT03937219|471577602|FG001|Overall Study|Lost to Follow-up|4|||
130986785|NCT00532155|471577603|FG000|Overall Study|Adverse Event|66|||
130986786|NCT00532155|471577604|FG001|Overall Study|Adverse Event|123|||
130986787|NCT00532155|471577603|FG000|Overall Study|Lack of Efficacy|332|||
130986788|NCT00532155|471577604|FG001|Overall Study|Lack of Efficacy|255|||
130986789|NCT00532155|471577603|FG000|Overall Study|Protocol Violation|1|||
130986790|NCT00532155|471577604|FG001|Overall Study|Protocol Violation|3|||
130986791|NCT00532155|471577603|FG000|Overall Study|Lost to Follow-up|2|||
130986792|NCT00532155|471577604|FG001|Overall Study|Lost to Follow-up|0|||
130986793|NCT00532155|471577603|FG000|Overall Study|Physician Decision|16|||
130986794|NCT00532155|471577604|FG001|Overall Study|Physician Decision|15|||
130986795|NCT00532155|471577603|FG000|Overall Study|Withdrawal by Subject|23|||
130986796|NCT00532155|471577604|FG001|Overall Study|Withdrawal by Subject|44|||
130986797|NCT00532155|471577603|FG000|Overall Study|Consent withdrawn|5|||
130986798|NCT00532155|471577604|FG001|Overall Study|Consent withdrawn|7|||
130986799|NCT00532155|471577603|FG000|Overall Study|Moved|1|||
130986800|NCT00532155|471577604|FG001|Overall Study|Moved|0|||
130986801|NCT00532155|471577603|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
130986802|NCT00532155|471577604|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
130778961|NCT03428100|470817444|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130986803|NCT00532155|471577603|FG000|Overall Study|Occurence of a second cancer|0|||
130986804|NCT00532155|471577604|FG001|Overall Study|Occurence of a second cancer|1|||
130986805|NCT00532155|471577603|FG000|Overall Study|Occurence of a secondary cancer|0|||
130986806|NCT00532155|471577604|FG001|Overall Study|Occurence of a secondary cancer|1|||
130986807|NCT00532155|471577603|FG000|Overall Study|Promotor ended study|1|||
130986808|NCT00532155|471577604|FG001|Overall Study|Promotor ended study|0|||
130986809|NCT00532155|471577603|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
130986810|NCT00532155|471577604|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
131046935|NCT03417284|471807334|FG001|Overall Study|Inadequate supply on study drug|0|||
131046936|NCT03417284|471807335|FG002|Overall Study|Inadequate supply on study drug|0|||
131046937|NCT03417284|471807336|FG003|Overall Study|Inadequate supply on study drug|0|||
131046938|NCT03417284|471807333|FG000|Overall Study|Disease Progression|0|||
131046939|NCT03417284|471807334|FG001|Overall Study|Disease Progression|0|||
131046940|NCT03417284|471807335|FG002|Overall Study|Disease Progression|1|||
131046941|NCT03417284|471807336|FG003|Overall Study|Disease Progression|0|||
131046942|NCT05132400|471807337|FG000|Overall Study|Withdrawal by Subject|14|||
131133936|NCT03861559|472117247|FG001|Overall Study|Did not meet eligibility requirements|0|||
130778962|NCT03428100|470817445|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778963|NCT03428100|470817446|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778964|NCT03428100|470817447|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778965|NCT03428100|470817448|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
130778966|NCT03428100|470817449|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778967|NCT03428100|470817450|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778968|NCT03428100|470817451|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778969|NCT03428100|470817452|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
130778970|NCT03428100|470817453|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
130778971|NCT03428100|470817454|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778972|NCT03428100|470817455|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
130778973|NCT03428100|470817456|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778974|NCT03428100|470817457|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
131046943|NCT05132400|471807338|FG001|Overall Study|Withdrawal by Subject|8|||
131046944|NCT05132400|471807337|FG000|Overall Study|Lost to Follow-up|132|||
131046945|NCT05132400|471807338|FG001|Overall Study|Lost to Follow-up|121|||
131133937|NCT02751502|472117248|FG000|Overall Study|Lack of funding|4|||
130778975|NCT03428100|470817458|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
130778976|NCT03428100|470817459|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130778977|NCT03428100|470817441|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
130778978|NCT03428100|470817442|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
130778979|NCT03428100|470817443|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
130778980|NCT03428100|470817444|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
130778981|NCT03428100|470817445|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
130778982|NCT03428100|470817446|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
130778983|NCT03428100|470817447|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
130778984|NCT03428100|470817448|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
130778985|NCT03428100|470817449|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
130778986|NCT03428100|470817450|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
130778987|NCT03428100|470817451|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
130778988|NCT03428100|470817452|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
130778989|NCT03428100|470817453|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
130778990|NCT03428100|470817454|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
130778991|NCT03428100|470817455|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
130778992|NCT03428100|470817456|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
130778993|NCT03428100|470817457|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
130778994|NCT03428100|470817458|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
131133938|NCT02678390|472117249|FG000|AE (1 Day)|Withdrawal by Subject|0|||
131133939|NCT02678390|472117250|FG001|AE (1 Day)|Withdrawal by Subject|1|||
131133940|NCT03499028|472117251|FG000|Overall Study|Lost to Follow-up|12|||
131133941|NCT03499028|472117252|FG001|Overall Study|Lost to Follow-up|9|||
131133942|NCT03499028|472117251|FG000|Overall Study|Withdrawal by Subject|5|||
131046952|NCT05311176|471807340|FG000|Overall Study|Death|6|||
131046953|NCT05311176|471807340|FG000|Overall Study|Sponsor discontinued the study|1|||
131046954|NCT05836012|471807362|FG000|Overall Study|Lost to Follow-up|1|||
131046955|NCT05836012|471807363|FG001|Overall Study|Lost to Follow-up|0|||
131046956|NCT05836012|471807362|FG000|Overall Study|Withdrawal by Subject|1|||
131046957|NCT05836012|471807363|FG001|Overall Study|Withdrawal by Subject|3|||
131046958|NCT05836012|471807362|FG000|Overall Study|Reason not included in pre-specified categories|2|||
131046959|NCT05836012|471807363|FG001|Overall Study|Reason not included in pre-specified categories|1|||
131046960|NCT05454514|471807364|FG000|Overall Study|Withdrawal by Subject|4|||
131046961|NCT05785130|471807365|FG000|Overall Study|Withdrawal by Subject|1|||
131046962|NCT05785130|471807366|FG001|Overall Study|Withdrawal by Subject|0|||
131046963|NCT05785130|471807365|FG000|Overall Study|Lack of Efficacy|0|||
131046964|NCT05785130|471807366|FG001|Overall Study|Lack of Efficacy|1|||
131046965|NCT06065735|471807367|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
131046966|NCT06065735|471807368|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
131046967|NCT06065735|471807369|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
131046968|NCT06065735|471807367|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
131046969|NCT06065735|471807368|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
131046970|NCT06065735|471807369|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
131133943|NCT03499028|472117252|FG001|Overall Study|Withdrawal by Subject|8|||
131133944|NCT03499028|472117251|FG000|Overall Study|Unplanned SNF discharge|5|||
131046971|NCT06065735|471807367|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
131046972|NCT06065735|471807368|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
131046973|NCT06065735|471807369|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
131046974|NCT06065735|471807367|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
131046975|NCT06065735|471807368|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
131046976|NCT06065735|471807369|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
131046977|NCT06065735|471807367|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
131046978|NCT06065735|471807368|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
131046979|NCT06065735|471807369|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
131046980|NCT02532621|471807370|FG000|Overall Study|Death|3|||
131046981|NCT02532621|471807370|FG000|Overall Study|Lost to Follow-up|3|||
131133945|NCT03499028|472117252|FG001|Overall Study|Unplanned SNF discharge|8|||
131133946|NCT00498173|472117253|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
130721109|NCT04555720|470601615|FG003|Overall Study|Lost to Follow-up|0|||
130721110|NCT04555720|470601612|FG000|Overall Study|Withdrawal by Subject|4|||
130721111|NCT04555720|470601613|FG001|Overall Study|Withdrawal by Subject|6|||
130721112|NCT04555720|470601614|FG002|Overall Study|Withdrawal by Subject|0|||
130721113|NCT04555720|470601615|FG003|Overall Study|Withdrawal by Subject|0|||
130721114|NCT00968799|470601616|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
130721115|NCT00719849|470601617|FG000|Overall Study|Death|0|||
130721116|NCT00719849|470601618|FG001|Overall Study|Death|1|||
130721117|NCT01372774|470601621|FG000|Overall Study|Withdrawal prior to treatment|4|||
130721118|NCT01372774|470601622|FG001|Overall Study|Withdrawal prior to treatment|5|||
130721119|NCT02201290|470601623|FG000|Overall Study|Withdrawal by Subject|2|||
130721120|NCT02201290|470601623|FG000|Overall Study|Lack of Efficacy|2|||
130721121|NCT02201290|470601623|FG000|Overall Study|Adverse Event|1|||
130721122|NCT03283319|470604205|FG000|Overall Study|Lost to Follow-up|5|||
130721123|NCT03283319|470604206|FG001|Overall Study|Lost to Follow-up|4|||
130721124|NCT03283319|470604207|FG002|Overall Study|Lost to Follow-up|5|||
130721125|NCT03283319|470604208|FG003|Overall Study|Lost to Follow-up|5|||
130721126|NCT03283319|470604209|FG004|Overall Study|Lost to Follow-up|4|||
130721127|NCT03283319|470604210|FG005|Overall Study|Lost to Follow-up|3|||
130721128|NCT03283319|470604205|FG000|Overall Study|Withdrawal by Subject|2|||
130721129|NCT03283319|470604206|FG001|Overall Study|Withdrawal by Subject|2|||
130721130|NCT03283319|470604207|FG002|Overall Study|Withdrawal by Subject|2|||
130721131|NCT03283319|470604208|FG003|Overall Study|Withdrawal by Subject|1|||
130721132|NCT03283319|470604209|FG004|Overall Study|Withdrawal by Subject|0|||
130721133|NCT03283319|470604210|FG005|Overall Study|Withdrawal by Subject|1|||
130721134|NCT03283319|470604205|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
130721135|NCT03283319|470604206|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
130721136|NCT03283319|470604207|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
130721137|NCT03283319|470604208|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
130721138|NCT03283319|470604209|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
130721139|NCT03283319|470604210|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
130721140|NCT00792935|470604211|FG000|Overall Study|Adverse Event|2|||
130721141|NCT00792935|470604212|FG001|Overall Study|Adverse Event|1|||
130721142|NCT00792935|470604211|FG000|Overall Study|Lost to Follow-up|0|||
130721143|NCT00792935|470604212|FG001|Overall Study|Lost to Follow-up|1|||
130721144|NCT00792935|470604211|FG000|Overall Study|Protocol Violation|2|||
130721145|NCT00792935|470604212|FG001|Overall Study|Protocol Violation|0|||
130721146|NCT00792935|470604211|FG000|Overall Study|Withdrawal by Subject|0|||
130721147|NCT00792935|470604212|FG001|Overall Study|Withdrawal by Subject|1|||
130721148|NCT03186781|470604213|FG000|Overall Study|Lost to Follow-up|0|||
130721149|NCT03186781|470604214|FG001|Overall Study|Lost to Follow-up|0|||
130721150|NCT03186781|470604215|FG002|Overall Study|Lost to Follow-up|1|||
130721151|NCT03186781|470604216|FG003|Overall Study|Lost to Follow-up|0|||
130721152|NCT03186781|470604217|FG004|Overall Study|Lost to Follow-up|1|||
130721153|NCT03186781|470604218|FG005|Overall Study|Lost to Follow-up|0|||
130721154|NCT03186781|470604213|FG000|Overall Study|Moved from Area|0|||
130721155|NCT03186781|470604214|FG001|Overall Study|Moved from Area|0|||
130721156|NCT03186781|470604215|FG002|Overall Study|Moved from Area|0|||
130721157|NCT03186781|470604216|FG003|Overall Study|Moved from Area|0|||
131046982|NCT02532621|471807370|FG000|Overall Study|Withdrawal by Subject|6|||
131046983|NCT02532621|471807370|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
131046984|NCT02532621|471807370|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
131046985|NCT04795245|471807373|FG000|Overall Study|Unkown reason|7|||
131046986|NCT04795245|471807373|FG000|Overall Study|Death|17|||
131133947|NCT00498173|472117254|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
130721158|NCT03186781|470604217|FG004|Overall Study|Moved from Area|1|||
130721159|NCT03186781|470604218|FG005|Overall Study|Moved from Area|0|||
130721160|NCT03186781|470604213|FG000|Overall Study|Withdrawal by Subject|0|||
130721161|NCT03186781|470604214|FG001|Overall Study|Withdrawal by Subject|0|||
130721162|NCT03186781|470604215|FG002|Overall Study|Withdrawal by Subject|0|||
130721163|NCT03186781|470604216|FG003|Overall Study|Withdrawal by Subject|0|||
130721164|NCT03186781|470604217|FG004|Overall Study|Withdrawal by Subject|1|||
130986811|NCT00532155|471577603|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
130986812|NCT00532155|471577604|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
130986813|NCT00532155|471577603|FG000|Overall Study|Study stopped|1|||
130986814|NCT00532155|471577604|FG001|Overall Study|Study stopped|0|||
130986815|NCT00532155|471577603|FG000|Overall Study|Study terminated by sponsor|1|||
130721165|NCT03186781|470604218|FG005|Overall Study|Withdrawal by Subject|0|||
130721166|NCT04663295|470604219|FG000|Run-in Period|Withdrawal by Subject|3|||
130721167|NCT04663295|470604219|FG000|Overall Study Period|Pregnancy|1|||
130721168|NCT04663295|470604219|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
130721169|NCT03665441|470604220|FG000|Overall Study|survival follow up ongoing|23|||
130721170|NCT03665441|470604221|FG001|Overall Study|survival follow up ongoing|0|||
130721171|NCT03665441|470604220|FG000|Overall Study|Patients ongoing on treatment|9|||
130721172|NCT03665441|470604221|FG001|Overall Study|Patients ongoing on treatment|6|||
130721173|NCT03665441|470604220|FG000|Overall Study|Randomized but not treated|7|||
130721174|NCT03665441|470604221|FG001|Overall Study|Randomized but not treated|11|||
130721175|NCT03954834|470604222|FG000|Overall Study|Adverse Event|1|||
130721176|NCT03954834|470604223|FG001|Overall Study|Adverse Event|3|||
130721177|NCT03954834|470604224|FG002|Overall Study|Adverse Event|1|||
130721178|NCT03954834|470604225|FG003|Overall Study|Adverse Event|1|||
130721179|NCT03954834|470604222|FG000|Overall Study|Death|0|||
130721180|NCT03954834|470604223|FG001|Overall Study|Death|0|||
130721181|NCT03954834|470604224|FG002|Overall Study|Death|0|||
130721182|NCT03954834|470604225|FG003|Overall Study|Death|1|||
130721183|NCT03954834|470604222|FG000|Overall Study|Physician Decision|0|||
130986816|NCT00532155|471577604|FG001|Overall Study|Study terminated by sponsor|0|||
130986817|NCT00532155|471577603|FG000|Overall Study|Study termination stop further treatment|4|||
130986818|NCT00532155|471577604|FG001|Overall Study|Study termination stop further treatment|0|||
130986819|NCT00532155|471577603|FG000|Overall Study|Did not receive study medication|2|||
130986820|NCT00532155|471577604|FG001|Overall Study|Did not receive study medication|6|||
130986821|NCT03483038|471577605|FG000|Overall Study|Subjects still in follow-up|18|||
130986822|NCT02134925|471577606|FG000|Overall Study|Withdrawal by Subject|1|||
130986823|NCT02134925|471577607|FG001|Overall Study|Withdrawal by Subject|0|||
130986824|NCT02134925|471577606|FG000|Overall Study|Cancel|1|||
130986825|NCT02134925|471577607|FG001|Overall Study|Cancel|6|||
130986826|NCT04987762|471577608|FG000|Overall Study|Study was Terminated by Sponsor|103|||
130986827|NCT02158884|471577613|FG000|Baseline Assessment|Missed performance assessment|3|||
130986828|NCT02158884|471577613|FG000|Baseline Assessment|Missed SMFA|1|||
130986829|NCT02158884|471577613|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
130986830|NCT02158884|471577613|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
130986831|NCT02158884|471577613|FG000|6 Month Assessment|Missed SMFA|20|||
130986832|NCT02158884|471577613|FG000|12 Month Assessment|Missed SMFA|17|||
130986833|NCT00504426|471577614|FG000|Overall Study|Adverse Event|0|||
130986834|NCT00504426|471577615|FG001|Overall Study|Adverse Event|0|||
130986835|NCT00504426|471577616|FG002|Overall Study|Adverse Event|2|||
130986836|NCT00504426|471577617|FG003|Overall Study|Adverse Event|0|||
130986837|NCT00504426|471577614|FG000|Overall Study|Protocol Violation|1|||
130986838|NCT00504426|471577615|FG001|Overall Study|Protocol Violation|1|||
130986839|NCT00504426|471577616|FG002|Overall Study|Protocol Violation|2|||
130986840|NCT00504426|471577617|FG003|Overall Study|Protocol Violation|0|||
130986841|NCT00504426|471577614|FG000|Overall Study|Withdrawal by Subject|2|||
130986842|NCT00504426|471577615|FG001|Overall Study|Withdrawal by Subject|0|||
130986843|NCT00504426|471577616|FG002|Overall Study|Withdrawal by Subject|0|||
130986844|NCT00504426|471577617|FG003|Overall Study|Withdrawal by Subject|0|||
130986845|NCT03988166|471577620|FG000|Overall Study|Lost to Follow-up|2|||
130986846|NCT03988166|471577620|FG000|Overall Study|Death|1|||
130986847|NCT03248375|471577621|FG000|Overall Study|Lost to Follow-up|5|||
130986848|NCT00633464|471577622|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
131046987|NCT04795245|471807373|FG000|Overall Study|Other than listed|19|||
130721184|NCT03954834|470604223|FG001|Overall Study|Physician Decision|1|||
130721185|NCT03954834|470604224|FG002|Overall Study|Physician Decision|0|||
130721186|NCT03954834|470604225|FG003|Overall Study|Physician Decision|2|||
130721187|NCT03954834|470604222|FG000|Overall Study|Protocol Violation|1|||
130721188|NCT03954834|470604223|FG001|Overall Study|Protocol Violation|0|||
130986849|NCT00633464|471577623|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
130986850|NCT00633464|471577622|FG000|Overall Study|Never Treated (Randomized in error)|0|||
131046988|NCT04795245|471807373|FG000|Overall Study|Adverse Event|143|||
130986851|NCT00633464|471577623|FG001|Overall Study|Never Treated (Randomized in error)|1|||
130986852|NCT02612064|471577624|FG000|Overall Study|Withdrawal by Subject|1|||
130986853|NCT02612064|471577625|FG001|Overall Study|Withdrawal by Subject|1|||
130986854|NCT02612064|471577624|FG000|Overall Study|Other|0|||
130986855|NCT02612064|471577625|FG001|Overall Study|Other|2|||
130721189|NCT03954834|470604224|FG002|Overall Study|Protocol Violation|0|||
130986856|NCT01669798|471577628|FG000|Overall Study|Physician Decision|5|||
131046989|NCT04795245|471807373|FG000|Overall Study|Progressive disease|512|||
130721190|NCT03954834|470604225|FG003|Overall Study|Protocol Violation|1|||
130986857|NCT00558064|471577630|FG000|Overall Study|Adverse Event|3|||
130986858|NCT00558064|471577631|FG001|Overall Study|Adverse Event|2|||
131133948|NCT00498173|472117255|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
130721191|NCT03954834|470604222|FG000|Overall Study|Withdrawal by Subject|2|||
130721192|NCT03954834|470604223|FG001|Overall Study|Withdrawal by Subject|3|||
130721193|NCT03954834|470604224|FG002|Overall Study|Withdrawal by Subject|13|||
130721194|NCT03954834|470604225|FG003|Overall Study|Withdrawal by Subject|6|||
130721195|NCT03954834|470604222|FG000|Overall Study|Participant left the country|0|||
130721196|NCT03954834|470604223|FG001|Overall Study|Participant left the country|0|||
130721197|NCT03954834|470604224|FG002|Overall Study|Participant left the country|1|||
130721198|NCT03954834|470604225|FG003|Overall Study|Participant left the country|0|||
130721199|NCT03954834|470604222|FG000|Overall Study|Lost to Follow-up|3|||
130721200|NCT03954834|470604223|FG001|Overall Study|Lost to Follow-up|2|||
130721201|NCT03954834|470604224|FG002|Overall Study|Lost to Follow-up|3|||
130721202|NCT03954834|470604225|FG003|Overall Study|Lost to Follow-up|5|||
130721203|NCT03047330|470604229|FG000|Sleep Block 1|Withdrawal by Subject|3|||
130721204|NCT00663026|470604230|FG000|Overall Study|Lost to Follow-up|1|||
130721205|NCT00663026|470604231|FG001|Overall Study|Lost to Follow-up|0|||
130721206|NCT00663026|470604232|FG002|Overall Study|Lost to Follow-up|0|||
130721207|NCT00663026|470604230|FG000|Overall Study|Other|1|||
130721208|NCT00663026|470604231|FG001|Overall Study|Other|2|||
130721209|NCT00663026|470604232|FG002|Overall Study|Other|0|||
130721210|NCT00663026|470604230|FG000|Overall Study|Adverse Event|0|||
130721211|NCT00663026|470604231|FG001|Overall Study|Adverse Event|2|||
130721212|NCT00663026|470604232|FG002|Overall Study|Adverse Event|3|||
130721213|NCT00663026|470604230|FG000|Overall Study|Caregiver Request|0|||
130721214|NCT00663026|470604231|FG001|Overall Study|Caregiver Request|2|||
130721215|NCT00663026|470604232|FG002|Overall Study|Caregiver Request|0|||
130721216|NCT00663026|470604230|FG000|Overall Study|Withdrawal by Subject|0|||
130721217|NCT00663026|470604231|FG001|Overall Study|Withdrawal by Subject|0|||
130721218|NCT00663026|470604232|FG002|Overall Study|Withdrawal by Subject|1|||
130721219|NCT01570686|470604233|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130721220|NCT01570686|470604234|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130721221|NCT01570686|470604233|FG000|Overall Study|Administrative problems|0|||
130721222|NCT01570686|470604234|FG001|Overall Study|Administrative problems|1|||
130721223|NCT01570686|470604233|FG000|Overall Study|Adverse Event|8|||
130721224|NCT01570686|470604234|FG001|Overall Study|Adverse Event|6|||
130721225|NCT01570686|470604233|FG000|Overall Study|Lost to Follow-up|4|||
130721226|NCT01570686|470604234|FG001|Overall Study|Lost to Follow-up|3|||
130721227|NCT01570686|470604233|FG000|Overall Study|Protocol Deviation|3|||
130721228|NCT01570686|470604234|FG001|Overall Study|Protocol Deviation|0|||
130721229|NCT01570686|470604233|FG000|Overall Study|Withdrawal by Subject|4|||
130721230|NCT01570686|470604234|FG001|Overall Study|Withdrawal by Subject|4|||
130721231|NCT01570686|470604233|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130721232|NCT01570686|470604234|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130721233|NCT00686075|470604236|FG000|Overall Study|Withdrawal by Subject|4|||
130721234|NCT00686075|470604237|FG001|Overall Study|Withdrawal by Subject|3|||
130721235|NCT00686075|470604238|FG002|Overall Study|Withdrawal by Subject|3|||
130721236|NCT00686075|470604239|FG003|Overall Study|Withdrawal by Subject|7|||
130721237|NCT00686075|470604240|FG004|Overall Study|Withdrawal by Subject|1|||
130721238|NCT00686075|470604241|FG005|Overall Study|Withdrawal by Subject|0|||
130721239|NCT00686075|470604242|FG006|Overall Study|Withdrawal by Subject|0|||
130721240|NCT00686075|470604243|FG007|Overall Study|Withdrawal by Subject|2|||
130721241|NCT00686075|470604244|FG008|Overall Study|Withdrawal by Subject|4|||
130721242|NCT00686075|470604245|FG009|Overall Study|Withdrawal by Subject|6|||
130721243|NCT00686075|470604236|FG000|Overall Study|Lost to Follow-up|3|||
130721244|NCT00686075|470604237|FG001|Overall Study|Lost to Follow-up|6|||
130721245|NCT00686075|470604238|FG002|Overall Study|Lost to Follow-up|3|||
130721246|NCT00686075|470604239|FG003|Overall Study|Lost to Follow-up|2|||
130721247|NCT00686075|470604240|FG004|Overall Study|Lost to Follow-up|3|||
130721248|NCT00686075|470604241|FG005|Overall Study|Lost to Follow-up|3|||
130721249|NCT00686075|470604242|FG006|Overall Study|Lost to Follow-up|0|||
130721250|NCT00686075|470604243|FG007|Overall Study|Lost to Follow-up|0|||
130721251|NCT00686075|470604244|FG008|Overall Study|Lost to Follow-up|2|||
130721252|NCT00686075|470604245|FG009|Overall Study|Lost to Follow-up|3|||
130721253|NCT00686075|470604236|FG000|Overall Study|Other|1|||
130721254|NCT00686075|470604237|FG001|Overall Study|Other|1|||
130721255|NCT00686075|470604238|FG002|Overall Study|Other|0|||
130721256|NCT00686075|470604239|FG003|Overall Study|Other|0|||
130721257|NCT00686075|470604240|FG004|Overall Study|Other|0|||
130721258|NCT00686075|470604241|FG005|Overall Study|Other|0|||
130721259|NCT00686075|470604242|FG006|Overall Study|Other|0|||
130721260|NCT00686075|470604243|FG007|Overall Study|Other|0|||
130721261|NCT00686075|470604244|FG008|Overall Study|Other|0|||
130721262|NCT00686075|470604245|FG009|Overall Study|Other|1|||
130721263|NCT04715932|470604246|FG000|Overall Study|Lost to Follow-up|1|||
130721264|NCT04715932|470604247|FG001|Overall Study|Lost to Follow-up|0|||
130721265|NCT03783039|470604260|FG000|Overall Study|Death|2|||
130721266|NCT03783039|470604261|FG001|Overall Study|Death|1|||
130721267|NCT01682863|470604262|FG000|Overall Study|Subject/guardian decision|19|||
130721268|NCT01682863|470604263|FG001|Overall Study|Subject/guardian decision|12|||
130778995|NCT03428100|470817459|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
130778996|NCT03428100|470817441|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130778997|NCT03428100|470817442|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130778998|NCT03428100|470817443|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130778999|NCT03428100|470817444|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779000|NCT03428100|470817445|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779001|NCT03428100|470817446|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779002|NCT03428100|470817447|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
130779003|NCT03428100|470817448|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779004|NCT03428100|470817449|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779005|NCT03428100|470817450|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779006|NCT03428100|470817451|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779007|NCT03428100|470817452|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779008|NCT03428100|470817453|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779009|NCT03428100|470817454|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779010|NCT03428100|470817455|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779011|NCT03428100|470817456|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779012|NCT03428100|470817457|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779013|NCT03428100|470817458|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130779014|NCT03428100|470817459|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
130779015|NCT03428100|470817441|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130779016|NCT03428100|470817442|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130779017|NCT03428100|470817443|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130779018|NCT03428100|470817444|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130779019|NCT03428100|470817445|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
130779020|NCT03428100|470817446|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
130779021|NCT03428100|470817447|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
130779022|NCT03428100|470817448|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
130779023|NCT03428100|470817449|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
130779024|NCT03428100|470817450|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
130779025|NCT03428100|470817451|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
130779026|NCT03428100|470817452|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
130779027|NCT03428100|470817453|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
130779028|NCT03428100|470817454|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
130779029|NCT03428100|470817455|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
130779030|NCT03428100|470817456|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
130779031|NCT03428100|470817457|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
130779032|NCT03428100|470817458|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
130779033|NCT03428100|470817459|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
130779034|NCT03428100|470817441|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130779035|NCT03428100|470817442|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130779036|NCT03428100|470817443|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130779037|NCT03428100|470817444|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130986859|NCT00558064|471577630|FG000|Overall Study|Lack of Efficacy|0|||
130986860|NCT00558064|471577631|FG001|Overall Study|Lack of Efficacy|1|||
130721269|NCT01682863|470604264|FG002|Overall Study|Subject/guardian decision|10|||
130721270|NCT01682863|470604262|FG000|Overall Study|Lost to Follow-up|5|||
130721271|NCT01682863|470604263|FG001|Overall Study|Lost to Follow-up|1|||
130721272|NCT01682863|470604264|FG002|Overall Study|Lost to Follow-up|6|||
130721273|NCT01682863|470604262|FG000|Overall Study|Death|1|||
130721274|NCT01682863|470604263|FG001|Overall Study|Death|3|||
130721275|NCT01682863|470604264|FG002|Overall Study|Death|4|||
130721276|NCT01682863|470604262|FG000|Overall Study|Protocol deviation|1|||
130721277|NCT01682863|470604263|FG001|Overall Study|Protocol deviation|0|||
130721278|NCT01682863|470604264|FG002|Overall Study|Protocol deviation|1|||
130721279|NCT01682863|470604262|FG000|Overall Study|Technical problems|1|||
130721280|NCT01682863|470604263|FG001|Overall Study|Technical problems|0|||
130721281|NCT01682863|470604264|FG002|Overall Study|Technical problems|0|||
130721282|NCT01682863|470604262|FG000|Overall Study|Adverse Event|0|||
130721283|NCT01682863|470604263|FG001|Overall Study|Adverse Event|1|||
130721284|NCT01682863|470604264|FG002|Overall Study|Adverse Event|2|||
130721285|NCT01682863|470604262|FG000|Overall Study|Physician Decision|0|||
130721286|NCT01682863|470604263|FG001|Overall Study|Physician Decision|0|||
130721287|NCT01682863|470604264|FG002|Overall Study|Physician Decision|1|||
130721288|NCT00918138|470604266|FG000|Overall Study|Subject withdrew consent|1|||
130721289|NCT00918138|470604267|FG001|Overall Study|Subject withdrew consent|1|||
130779038|NCT03428100|470817445|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130779039|NCT03428100|470817446|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130779040|NCT03428100|470817447|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
130779041|NCT03428100|470817448|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130779042|NCT03428100|470817449|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130779043|NCT03428100|470817450|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
130779044|NCT03428100|470817451|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
130779045|NCT03428100|470817452|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
130779046|NCT03428100|470817453|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130779047|NCT03428100|470817454|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
130779048|NCT03428100|470817455|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
130779049|NCT03428100|470817456|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130779050|NCT03428100|470817457|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
130779051|NCT03428100|470817458|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130779052|NCT03428100|470817459|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130779053|NCT04556760|470817460|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130779054|NCT04556760|470817461|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
130779055|NCT04556760|470817462|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130779056|NCT04556760|470817463|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130779057|NCT04556760|470817464|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130779058|NCT04556760|470817465|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130779059|NCT04556760|470817460|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130779060|NCT04556760|470817461|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130779061|NCT04556760|470817462|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130779062|NCT04556760|470817463|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
130779063|NCT04556760|470817464|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130779064|NCT04556760|470817465|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130779065|NCT02168491|470817467|FG000|Overall Study|Withdrawal by Subject|1|||
130779066|NCT01610037|470817469|FG000|All Patients|Adverse Event|27|||
130779067|NCT01610037|470817470|FG001|All Patients|Adverse Event|22|||
130779068|NCT01610037|470817471|FG002|All Patients|Adverse Event|26|||
130779069|NCT01610037|470817469|FG000|All Patients|Withdrawal by Subject|12|||
130779070|NCT01610037|470817470|FG001|All Patients|Withdrawal by Subject|10|||
130779071|NCT01610037|470817471|FG002|All Patients|Withdrawal by Subject|20|||
130779072|NCT01610037|470817469|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
130779073|NCT01610037|470817470|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
130779074|NCT01610037|470817471|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
130779075|NCT01610037|470817469|FG000|All Patients|Death|4|||
130779076|NCT01610037|470817470|FG001|All Patients|Death|2|||
130779077|NCT01610037|470817471|FG002|All Patients|Death|1|||
130779078|NCT01610037|470817469|FG000|All Patients|Protocol deviation|4|||
130779079|NCT01610037|470817470|FG001|All Patients|Protocol deviation|3|||
130779080|NCT01610037|470817471|FG002|All Patients|Protocol deviation|3|||
130779081|NCT01610037|470817469|FG000|All Patients|Abnormal laboratory value|1|||
130779082|NCT01610037|470817470|FG001|All Patients|Abnormal laboratory value|1|||
130779083|NCT01610037|470817471|FG002|All Patients|Abnormal laboratory value|0|||
130779084|NCT01610037|470817469|FG000|All Patients|Administrative problems|1|||
130779085|NCT01610037|470817470|FG001|All Patients|Administrative problems|4|||
130779086|NCT01610037|470817471|FG002|All Patients|Administrative problems|4|||
130779087|NCT01610037|470817469|FG000|All Patients|Lost to Follow-up|1|||
130779088|NCT01610037|470817470|FG001|All Patients|Lost to Follow-up|0|||
130779089|NCT01610037|470817471|FG002|All Patients|Lost to Follow-up|0|||
130779090|NCT01610037|470817469|FG000|All Patients|Abnormal test procedure result(s)|0|||
130779091|NCT01610037|470817470|FG001|All Patients|Abnormal test procedure result(s)|1|||
130779092|NCT01610037|470817471|FG002|All Patients|Abnormal test procedure result(s)|3|||
130779093|NCT01610037|470817469|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
130779094|NCT01610037|470817470|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
130779095|NCT01610037|470817471|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
130779096|NCT01610037|470817469|FG000|Treatment and Follow up Period|Death|10|||
130779097|NCT01610037|470817470|FG001|Treatment and Follow up Period|Death|5|||
130779098|NCT01610037|470817471|FG002|Treatment and Follow up Period|Death|4|||
130779099|NCT01610037|470817469|FG000|Treatment and Follow up Period|Administrative problems|1|||
130779100|NCT01610037|470817470|FG001|Treatment and Follow up Period|Administrative problems|3|||
130779101|NCT01610037|470817471|FG002|Treatment and Follow up Period|Administrative problems|2|||
130779102|NCT01610037|470817469|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
131133949|NCT01110200|472117256|FG000|Overall Study|Adverse Event|28|||
131133950|NCT01110200|472117257|FG001|Overall Study|Adverse Event|28|||
131133951|NCT01110200|472117256|FG000|Overall Study|Withdrawal by Subject|25|||
131133952|NCT01110200|472117257|FG001|Overall Study|Withdrawal by Subject|32|||
131133953|NCT01110200|472117256|FG000|Overall Study|Lack of Efficacy|16|||
131133954|NCT01110200|472117257|FG001|Overall Study|Lack of Efficacy|25|||
131133955|NCT01110200|472117256|FG000|Overall Study|Protocol Violation|14|||
131133956|NCT01110200|472117257|FG001|Overall Study|Protocol Violation|12|||
131133957|NCT01110200|472117256|FG000|Overall Study|Physician Decision|13|||
131133958|NCT01110200|472117257|FG001|Overall Study|Physician Decision|17|||
131133959|NCT01110200|472117256|FG000|Overall Study|Lost to Follow-up|10|||
131133960|NCT01110200|472117257|FG001|Overall Study|Lost to Follow-up|7|||
131133961|NCT00903175|472117258|FG000|Period 1 - First Line|Adverse Event|36|||
131133962|NCT00903175|472117259|FG001|Period 1 - First Line|Adverse Event|50|||
131133963|NCT00903175|472117258|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
131133964|NCT00903175|472117259|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
131133965|NCT00903175|472117258|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
131133966|NCT00903175|472117259|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
131133967|NCT00903175|472117258|FG000|Period 1 - First Line|Protocol Violation|3|||
131133968|NCT00903175|472117259|FG001|Period 1 - First Line|Protocol Violation|3|||
131133969|NCT00903175|472117258|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
131133970|NCT00903175|472117259|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
131133971|NCT00903175|472117258|FG000|Period 1 - First Line|Administrative problems|12|||
131133972|NCT00903175|472117259|FG001|Period 1 - First Line|Administrative problems|13|||
131133973|NCT00903175|472117258|FG000|Period 1 - First Line|Death|17|||
131133974|NCT00903175|472117259|FG001|Period 1 - First Line|Death|10|||
131133975|NCT00903175|472117258|FG000|Period 2 - Second Line|Missing|1|||
131133976|NCT00903175|472117259|FG001|Period 2 - Second Line|Missing|0|||
131133977|NCT00903175|472117258|FG000|Period 2 - Second Line|Adverse Event|16|||
131133978|NCT00903175|472117259|FG001|Period 2 - Second Line|Adverse Event|20|||
131133979|NCT00903175|472117258|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
131133980|NCT00903175|472117259|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
131133981|NCT00903175|472117258|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
131133982|NCT00903175|472117259|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
131133983|NCT00903175|472117258|FG000|Period 2 - Second Line|Administrative problems|19|||
131133984|NCT00903175|472117259|FG001|Period 2 - Second Line|Administrative problems|9|||
131133985|NCT00903175|472117258|FG000|Period 2 - Second Line|Death|5|||
131133986|NCT00903175|472117259|FG001|Period 2 - Second Line|Death|2|||
131133987|NCT01632566|472117262|FG000|Overall Study|Withdrawal by Subject|0|||
131133988|NCT01632566|472117263|FG001|Overall Study|Withdrawal by Subject|1|||
131133989|NCT01632566|472117264|FG002|Overall Study|Withdrawal by Subject|0|||
131133990|NCT01632566|472117265|FG003|Overall Study|Withdrawal by Subject|0|||
131133991|NCT01632566|472117266|FG004|Overall Study|Withdrawal by Subject|0|||
131133992|NCT01632566|472117262|FG000|Overall Study|Sponsor Decision|0|||
131133993|NCT01632566|472117263|FG001|Overall Study|Sponsor Decision|2|||
131133994|NCT01632566|472117264|FG002|Overall Study|Sponsor Decision|9|||
131133995|NCT01632566|472117265|FG003|Overall Study|Sponsor Decision|2|||
131133996|NCT01632566|472117266|FG004|Overall Study|Sponsor Decision|2|||
131133997|NCT02158091|472117268|FG000|Overall Study|DLT|2|||
131133998|NCT02158091|472117269|FG001|Overall Study|DLT|1|||
131133999|NCT02158091|472117270|FG002|Overall Study|DLT|0|||
131134000|NCT03977467|472117271|FG000|Overall Study|Disease Progression|1|||
131229618|NCT00658320|472467642|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
130721290|NCT00918138|470604266|FG000|Overall Study|Death|1|||
130721291|NCT00918138|470604267|FG001|Overall Study|Death|0|||
130721292|NCT00699374|470604268|FG000|Overall Study|Death|93|||
130721293|NCT00699374|470604269|FG001|Overall Study|Death|83|||
130721294|NCT00699374|470604268|FG000|Overall Study|Adverse Event|70|||
131134001|NCT03977467|472117272|FG001|Overall Study|Disease Progression|1|||
131134002|NCT03977467|472117273|FG002|Overall Study|Disease Progression|30|||
131134003|NCT03977467|472117274|FG003|Overall Study|Disease Progression|0|||
131134004|NCT03977467|472117271|FG000|Overall Study|Adverse Event|0|||
131134005|NCT03977467|472117272|FG001|Overall Study|Adverse Event|1|||
131134006|NCT03977467|472117273|FG002|Overall Study|Adverse Event|0|||
131134007|NCT03977467|472117274|FG003|Overall Study|Adverse Event|0|||
131134008|NCT03977467|472117271|FG000|Overall Study|Death|0|||
131134009|NCT03977467|472117272|FG001|Overall Study|Death|0|||
130721295|NCT00699374|470604269|FG001|Overall Study|Adverse Event|67|||
131134010|NCT03977467|472117273|FG002|Overall Study|Death|3|||
131134011|NCT03977467|472117274|FG003|Overall Study|Death|0|||
131134012|NCT03977467|472117271|FG000|Overall Study|Lack of Efficacy|0|||
131134013|NCT03977467|472117272|FG001|Overall Study|Lack of Efficacy|0|||
131134014|NCT03977467|472117273|FG002|Overall Study|Lack of Efficacy|1|||
131134015|NCT03977467|472117274|FG003|Overall Study|Lack of Efficacy|0|||
131134016|NCT03977467|472117271|FG000|Overall Study|Withdrawal by Subject|2|||
131134017|NCT03977467|472117272|FG001|Overall Study|Withdrawal by Subject|1|||
131134018|NCT03977467|472117273|FG002|Overall Study|Withdrawal by Subject|4|||
131134019|NCT03977467|472117274|FG003|Overall Study|Withdrawal by Subject|0|||
131134020|NCT03977467|472117271|FG000|Overall Study|Study Terminated|1|||
130721296|NCT00699374|470604268|FG000|Overall Study|Global deterioration of health status|7|||
130986861|NCT00558064|471577630|FG000|Overall Study|Protocol Violation|1|||
130721297|NCT00699374|470604269|FG001|Overall Study|Global deterioration of health status|8|||
130721298|NCT00699374|470604268|FG000|Overall Study|Lost to Follow-up|3|||
130721299|NCT00699374|470604269|FG001|Overall Study|Lost to Follow-up|5|||
130721300|NCT00699374|470604268|FG000|Overall Study|Withdrawal by Subject|34|||
130721301|NCT00699374|470604269|FG001|Overall Study|Withdrawal by Subject|44|||
130721302|NCT00699374|470604268|FG000|Overall Study|Objective progression or relapse|281|||
130721303|NCT00699374|470604269|FG001|Overall Study|Objective progression or relapse|277|||
130721304|NCT00699374|470604268|FG000|Overall Study|Other|18|||
130721305|NCT00699374|470604269|FG001|Overall Study|Other|15|||
130721306|NCT00699374|470604268|FG000|Overall Study|Protocol Violation|2|||
130721307|NCT00699374|470604269|FG001|Overall Study|Protocol Violation|6|||
130721308|NCT00699374|470604268|FG000|Overall Study|Study terminated by sponsor|13|||
130721309|NCT00699374|470604269|FG001|Overall Study|Study terminated by sponsor|28|||
130721310|NCT00699374|470604268|FG000|Overall Study|Randomized but not treated|4|||
130721311|NCT00699374|470604269|FG001|Overall Study|Randomized but not treated|2|||
130721312|NCT00699374|470604268|FG000|Overall Study|Died 28 days after last dose|5|||
130721313|NCT00699374|470604269|FG001|Overall Study|Died 28 days after last dose|9|||
130721314|NCT02885181|470604273|FG000|Overall Study|Investigator's Discretion|0|||
130721315|NCT02885181|470604274|FG001|Overall Study|Investigator's Discretion|1|||
130721316|NCT02885181|470604275|FG002|Overall Study|Investigator's Discretion|0|||
130721317|NCT02885181|470604276|FG003|Overall Study|Investigator's Discretion|1|||
130721318|NCT02885181|470604273|FG000|Overall Study|Adverse Event|0|||
130721319|NCT02885181|470604274|FG001|Overall Study|Adverse Event|0|||
130721320|NCT02885181|470604275|FG002|Overall Study|Adverse Event|0|||
130721321|NCT02885181|470604276|FG003|Overall Study|Adverse Event|1|||
130721322|NCT02885181|470604273|FG000|Overall Study|Withdrawal by Subject|0|||
130721323|NCT02885181|470604274|FG001|Overall Study|Withdrawal by Subject|0|||
130721324|NCT02885181|470604275|FG002|Overall Study|Withdrawal by Subject|0|||
130721325|NCT02885181|470604276|FG003|Overall Study|Withdrawal by Subject|1|||
130721326|NCT01517373|470604279|FG000|Run-in Period|Death|1|||
130721327|NCT01517373|470604280|FG001|Run-in Period|Death|0|||
130721328|NCT01517373|470604281|FG002|Run-in Period|Death|0|||
130721329|NCT01517373|470604282|FG003|Run-in Period|Death|0|||
130721330|NCT01517373|470604283|FG004|Run-in Period|Death|0|||
130721331|NCT01517373|470604284|FG005|Run-in Period|Death|0|||
130721332|NCT01517373|470604279|FG000|Run-in Period|Adverse Event|5|||
130721333|NCT01517373|470604280|FG001|Run-in Period|Adverse Event|0|||
130721334|NCT01517373|470604281|FG002|Run-in Period|Adverse Event|0|||
130721335|NCT01517373|470604282|FG003|Run-in Period|Adverse Event|0|||
130721336|NCT01517373|470604283|FG004|Run-in Period|Adverse Event|0|||
130721337|NCT01517373|470604284|FG005|Run-in Period|Adverse Event|0|||
130721338|NCT01517373|470604279|FG000|Run-in Period|Did not meet eligibility criteria|34|||
130721339|NCT01517373|470604280|FG001|Run-in Period|Did not meet eligibility criteria|0|||
130721340|NCT01517373|470604281|FG002|Run-in Period|Did not meet eligibility criteria|0|||
130721341|NCT01517373|470604282|FG003|Run-in Period|Did not meet eligibility criteria|0|||
130721342|NCT01517373|470604283|FG004|Run-in Period|Did not meet eligibility criteria|0|||
130721343|NCT01517373|470604284|FG005|Run-in Period|Did not meet eligibility criteria|0|||
130721344|NCT01517373|470604279|FG000|Run-in Period|Lost to Follow-up|1|||
130721345|NCT01517373|470604280|FG001|Run-in Period|Lost to Follow-up|0|||
130721346|NCT01517373|470604281|FG002|Run-in Period|Lost to Follow-up|0|||
130721347|NCT01517373|470604282|FG003|Run-in Period|Lost to Follow-up|0|||
130721348|NCT01517373|470604283|FG004|Run-in Period|Lost to Follow-up|0|||
130721349|NCT01517373|470604284|FG005|Run-in Period|Lost to Follow-up|0|||
130721350|NCT01517373|470604279|FG000|Run-in Period|Withdrawal by Subject|12|||
130721351|NCT01517373|470604280|FG001|Run-in Period|Withdrawal by Subject|0|||
130721352|NCT01517373|470604281|FG002|Run-in Period|Withdrawal by Subject|0|||
130779103|NCT01610037|470817470|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
130779104|NCT01610037|470817471|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
130779105|NCT00705757|470817472|FG000|Overall Study|Lack of Efficacy|5|||
130779106|NCT00705757|470817473|FG001|Overall Study|Lack of Efficacy|1|||
130779107|NCT00705757|470817474|FG002|Overall Study|Lack of Efficacy|3|||
130721353|NCT01517373|470604282|FG003|Run-in Period|Withdrawal by Subject|0|||
130721354|NCT01517373|470604283|FG004|Run-in Period|Withdrawal by Subject|0|||
130721355|NCT01517373|470604284|FG005|Run-in Period|Withdrawal by Subject|0|||
130721356|NCT01517373|470604279|FG000|Run-in Period|Sponsor Decision|3|||
130721357|NCT01517373|470604280|FG001|Run-in Period|Sponsor Decision|0|||
130721358|NCT01517373|470604281|FG002|Run-in Period|Sponsor Decision|0|||
130721359|NCT01517373|470604282|FG003|Run-in Period|Sponsor Decision|0|||
130779108|NCT00705757|470817472|FG000|Overall Study|Lost to Follow-up|7|||
130779109|NCT00705757|470817473|FG001|Overall Study|Lost to Follow-up|6|||
130779110|NCT00705757|470817474|FG002|Overall Study|Lost to Follow-up|6|||
130721360|NCT01517373|470604283|FG004|Run-in Period|Sponsor Decision|0|||
130721361|NCT01517373|470604284|FG005|Run-in Period|Sponsor Decision|0|||
130721362|NCT01517373|470604279|FG000|Run-in Period|Other|1|||
130721363|NCT01517373|470604280|FG001|Run-in Period|Other|0|||
130721364|NCT01517373|470604281|FG002|Run-in Period|Other|0|||
130721365|NCT01517373|470604282|FG003|Run-in Period|Other|0|||
130721366|NCT01517373|470604283|FG004|Run-in Period|Other|0|||
130986862|NCT00558064|471577631|FG001|Overall Study|Protocol Violation|0|||
130986863|NCT00558064|471577630|FG000|Overall Study|Lost to Follow-up|0|||
130986864|NCT00558064|471577631|FG001|Overall Study|Lost to Follow-up|1|||
130986865|NCT00558064|471577630|FG000|Overall Study|Withdrawal by Subject|0|||
130986866|NCT00558064|471577631|FG001|Overall Study|Withdrawal by Subject|1|||
130986867|NCT00558064|471577630|FG000|Overall Study|No visit within allowance period|1|||
130986868|NCT00558064|471577631|FG001|Overall Study|No visit within allowance period|0|||
130986869|NCT00982930|471577634|FG000|Overall Study|Adverse Event|1|||
130986870|NCT00982930|471577634|FG000|Overall Study|Withdrawal by Subject|1|||
130986871|NCT00982930|471577634|FG000|Overall Study|Administrative Problems|2|||
130986872|NCT01489189|471577635|FG000|Overall Study|Withdrawal by Subject|20|||
130986873|NCT01489189|471577636|FG001|Overall Study|Withdrawal by Subject|23|||
130986874|NCT01489189|471577635|FG000|Overall Study|Death|10|||
130986875|NCT01489189|471577636|FG001|Overall Study|Death|8|||
130986876|NCT01489189|471577635|FG000|Overall Study|Missed Visit|1|||
130986877|NCT01489189|471577636|FG001|Overall Study|Missed Visit|4|||
130986878|NCT05597722|471577637|FG000|Overall Study|Study was terminated|6|||
130986879|NCT05597722|471577638|FG001|Overall Study|Study was terminated|1|||
130986880|NCT00404495|471577639|FG000|Overall Study|Death|37|||
130986881|NCT00404495|471577640|FG001|Overall Study|Death|11|||
130986882|NCT00404495|471577639|FG000|Overall Study|Lost to Follow-up|5|||
130986883|NCT00404495|471577640|FG001|Overall Study|Lost to Follow-up|0|||
130986884|NCT00404495|471577639|FG000|Overall Study|Other|1|||
130986885|NCT00404495|471577640|FG001|Overall Study|Other|0|||
130986886|NCT00404495|471577639|FG000|Overall Study|Withdrawal by Subject|1|||
130986887|NCT00404495|471577640|FG001|Overall Study|Withdrawal by Subject|0|||
130986888|NCT04108000|471577641|FG000|Overall Study|Death of patient|1|||
130986889|NCT04108000|471577642|FG001|Overall Study|Death of patient|0|||
130986890|NCT04108000|471577643|FG002|Overall Study|Death of patient|1|||
130986891|NCT04108000|471577644|FG003|Overall Study|Death of patient|0|||
130986892|NCT04108000|471577641|FG000|Overall Study|Withdrawal by Subject|2|||
130986893|NCT04108000|471577642|FG001|Overall Study|Withdrawal by Subject|2|||
130986894|NCT04108000|471577643|FG002|Overall Study|Withdrawal by Subject|0|||
131134021|NCT03977467|472117272|FG001|Overall Study|Study Terminated|0|||
131134022|NCT03977467|472117273|FG002|Overall Study|Study Terminated|0|||
131134023|NCT03977467|472117274|FG003|Overall Study|Study Terminated|1|||
131134024|NCT05913232|472117275|FG000|Overall Study|Adverse Event|0|||
131134025|NCT05913232|472117276|FG001|Overall Study|Adverse Event|2|||
131134026|NCT05913232|472117277|FG002|Overall Study|Adverse Event|1|||
131134027|NCT05913232|472117278|FG003|Overall Study|Adverse Event|1|||
131134028|NCT01318109|472117279|FG000|Overall Study|Adverse Event|0|||
131134029|NCT01318109|472117280|FG001|Overall Study|Adverse Event|2|||
131134030|NCT01318109|472117281|FG002|Overall Study|Adverse Event|0|||
131134031|NCT01318109|472117279|FG000|Overall Study|Withdrawal by Subject|1|||
131134032|NCT01318109|472117280|FG001|Overall Study|Withdrawal by Subject|0|||
131134033|NCT01318109|472117281|FG002|Overall Study|Withdrawal by Subject|0|||
131134034|NCT01318109|472117279|FG000|Overall Study|Schedule Conflict|0|||
131134035|NCT01318109|472117280|FG001|Overall Study|Schedule Conflict|1|||
130986895|NCT04108000|471577644|FG003|Overall Study|Withdrawal by Subject|0|||
131134036|NCT01318109|472117281|FG002|Overall Study|Schedule Conflict|0|||
130986896|NCT04108000|471577641|FG000|Overall Study|Death of surrogate partner|0|||
130986897|NCT04108000|471577642|FG001|Overall Study|Death of surrogate partner|1|||
130986898|NCT04108000|471577643|FG002|Overall Study|Death of surrogate partner|0|||
130986899|NCT04108000|471577644|FG003|Overall Study|Death of surrogate partner|1|||
130986900|NCT02044848|471578979|FG000|Overall Study|Administrative Problems|2|||
130986901|NCT02044848|471578980|FG001|Overall Study|Administrative Problems|3|||
130986902|NCT01160484|471578989|FG000|Overall Study|Lack of Efficacy|9|||
131134037|NCT01328951|472117282|FG000|Overall Study|Disease Progression|17|||
131134038|NCT01328951|472117283|FG001|Overall Study|Disease Progression|14|||
130986903|NCT01160484|471578989|FG000|Overall Study|Adverse Event|6|||
130986904|NCT01160484|471578989|FG000|Overall Study|Withdrawal by Subject|2|||
130986905|NCT01160484|471578989|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
130986906|NCT01679301|471578990|FG000|Screening Period|screen failure|3|||
130986907|NCT01679301|471578991|FG001|Screening Period|screen failure|0|||
130986908|NCT01679301|471578992|FG002|Screening Period|screen failure|0|||
130986909|NCT01529008|471578995|FG000|Bone Marrow Harvesting|Physician Decision|1|||
130986910|NCT01529008|471578996|FG001|Bone Marrow Harvesting|Physician Decision|1|||
130986911|NCT01529008|471578995|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
131134039|NCT01328951|472117282|FG000|Overall Study|Adverse Event|2|||
131134040|NCT01328951|472117283|FG001|Overall Study|Adverse Event|0|||
131134041|NCT01328951|472117282|FG000|Overall Study|Death|243|||
131134042|NCT01328951|472117283|FG001|Overall Study|Death|258|||
131134043|NCT01328951|472117282|FG000|Overall Study|Lost to Follow-up|6|||
131134044|NCT01328951|472117283|FG001|Overall Study|Lost to Follow-up|7|||
131134045|NCT01328951|472117282|FG000|Overall Study|Withdrawal by Subject|6|||
131134046|NCT01328951|472117283|FG001|Overall Study|Withdrawal by Subject|6|||
131134047|NCT01328951|472117282|FG000|Overall Study|Study Closed by the Sponsor|36|||
131134048|NCT01328951|472117283|FG001|Overall Study|Study Closed by the Sponsor|31|||
131134049|NCT01328951|472117282|FG000|Overall Study|Other|11|||
131134050|NCT01328951|472117283|FG001|Overall Study|Other|6|||
131134051|NCT04042103|472117287|FG000|Overall Study|Lost to Follow-up|1|||
131134052|NCT04042103|472117287|FG000|Overall Study|Withdrawal by Subject|1|||
131134053|NCT01003210|472117288|FG000|Overall Study|Lost to Follow-up|1|||
131134054|NCT01003210|472117289|FG001|Overall Study|Lost to Follow-up|3|||
130721367|NCT01517373|470604284|FG005|Run-in Period|Other|0|||
130721368|NCT01517373|470604279|FG000|Treatment Period|Adverse Event|0|||
130721369|NCT01517373|470604280|FG001|Treatment Period|Adverse Event|0|||
130721370|NCT01517373|470604281|FG002|Treatment Period|Adverse Event|0|||
130721371|NCT01517373|470604282|FG003|Treatment Period|Adverse Event|0|||
130721372|NCT01517373|470604283|FG004|Treatment Period|Adverse Event|0|||
130721373|NCT01517373|470604284|FG005|Treatment Period|Adverse Event|2|||
130721374|NCT01517373|470604279|FG000|Treatment Period|Lost to Follow-up|0|||
130721375|NCT01517373|470604280|FG001|Treatment Period|Lost to Follow-up|0|||
130721376|NCT01517373|470604281|FG002|Treatment Period|Lost to Follow-up|1|||
130721377|NCT01517373|470604282|FG003|Treatment Period|Lost to Follow-up|1|||
130721378|NCT01517373|470604283|FG004|Treatment Period|Lost to Follow-up|0|||
130721379|NCT01517373|470604284|FG005|Treatment Period|Lost to Follow-up|0|||
130721380|NCT01517373|470604279|FG000|Treatment Period|Withdrawal by Subject|0|||
130721381|NCT01517373|470604280|FG001|Treatment Period|Withdrawal by Subject|3|||
130721382|NCT01517373|470604281|FG002|Treatment Period|Withdrawal by Subject|2|||
130721383|NCT01517373|470604282|FG003|Treatment Period|Withdrawal by Subject|2|||
130721384|NCT01517373|470604283|FG004|Treatment Period|Withdrawal by Subject|2|||
130721385|NCT01517373|470604284|FG005|Treatment Period|Withdrawal by Subject|3|||
130721386|NCT01517373|470604279|FG000|Treatment Period|Other|0|||
130721387|NCT01517373|470604280|FG001|Treatment Period|Other|0|||
130721388|NCT01517373|470604281|FG002|Treatment Period|Other|0|||
130721389|NCT01517373|470604282|FG003|Treatment Period|Other|0|||
130986912|NCT01529008|471578996|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
130986913|NCT01529008|471578995|FG000|Treatment|Adverse Event|6|||
130986914|NCT01529008|471578996|FG001|Treatment|Adverse Event|0|||
130986915|NCT01529008|471578995|FG000|Treatment|Other|3|||
130721390|NCT01517373|470604283|FG004|Treatment Period|Other|1|||
130986916|NCT01529008|471578996|FG001|Treatment|Other|1|||
130986917|NCT01529008|471578995|FG000|Efficacy Analysis|Protocol Violation|2|||
130721391|NCT01517373|470604284|FG005|Treatment Period|Other|0|||
130721392|NCT01517373|470604279|FG000|Treatment Period|Protocol Violation|0|||
130721393|NCT01517373|470604280|FG001|Treatment Period|Protocol Violation|0|||
130721394|NCT01517373|470604281|FG002|Treatment Period|Protocol Violation|0|||
130721395|NCT01517373|470604282|FG003|Treatment Period|Protocol Violation|0|||
130721396|NCT01517373|470604283|FG004|Treatment Period|Protocol Violation|1|||
130721397|NCT01517373|470604284|FG005|Treatment Period|Protocol Violation|0|||
130721398|NCT01517373|470604279|FG000|Treatment Period|Lack of Efficacy|0|||
130721399|NCT01517373|470604280|FG001|Treatment Period|Lack of Efficacy|1|||
130721400|NCT01517373|470604281|FG002|Treatment Period|Lack of Efficacy|1|||
130721401|NCT01517373|470604282|FG003|Treatment Period|Lack of Efficacy|3|||
130721402|NCT01517373|470604283|FG004|Treatment Period|Lack of Efficacy|2|||
130721403|NCT01517373|470604284|FG005|Treatment Period|Lack of Efficacy|0|||
130721404|NCT01517373|470604279|FG000|Treatment Period|Medication error without AEs|0|||
130721405|NCT01517373|470604280|FG001|Treatment Period|Medication error without AEs|0|||
130721406|NCT01517373|470604281|FG002|Treatment Period|Medication error without AEs|2|||
130721407|NCT01517373|470604282|FG003|Treatment Period|Medication error without AEs|1|||
130721408|NCT01517373|470604283|FG004|Treatment Period|Medication error without AEs|0|||
130721409|NCT01517373|470604284|FG005|Treatment Period|Medication error without AEs|2|||
130721410|NCT04562155|470604288|FG000|Overall Study|COVID-19 pandemic|0|||
130721411|NCT04562155|470604289|FG001|Overall Study|COVID-19 pandemic|0|||
130721412|NCT04562155|470604290|FG002|Overall Study|COVID-19 pandemic|0|||
130721413|NCT04562155|470604291|FG003|Overall Study|COVID-19 pandemic|1|||
130721414|NCT04562155|470604288|FG000|Overall Study|Adverse Event|7|||
130721415|NCT04562155|470604289|FG001|Overall Study|Adverse Event|3|||
130721416|NCT04562155|470604290|FG002|Overall Study|Adverse Event|8|||
130721417|NCT04562155|470604291|FG003|Overall Study|Adverse Event|1|||
130721418|NCT04562155|470604288|FG000|Overall Study|Withdrawal by Subject|3|||
130721419|NCT04562155|470604289|FG001|Overall Study|Withdrawal by Subject|6|||
130721420|NCT04562155|470604290|FG002|Overall Study|Withdrawal by Subject|3|||
130721421|NCT04562155|470604291|FG003|Overall Study|Withdrawal by Subject|3|||
130986918|NCT01529008|471578996|FG001|Efficacy Analysis|Protocol Violation|0|||
130721422|NCT04562155|470604288|FG000|Overall Study|Participant personal reason|1|||
130721423|NCT04562155|470604289|FG001|Overall Study|Participant personal reason|0|||
130721424|NCT04562155|470604290|FG002|Overall Study|Participant personal reason|2|||
130721425|NCT04562155|470604291|FG003|Overall Study|Participant personal reason|1|||
130986919|NCT01529008|471578995|FG000|Efficacy Analysis|Physician Decision|0|||
130986920|NCT01529008|471578996|FG001|Efficacy Analysis|Physician Decision|1|||
131134055|NCT00271817|472117290|FG000|Part 1|Adverse Event|68|||
131134056|NCT00271817|472117291|FG001|Part 1|Adverse Event|25|||
130721426|NCT01085201|470604294|FG000|Overall Study|Scheduling conflict|1|||
130721427|NCT01085201|470604295|FG001|Overall Study|Scheduling conflict|0|||
130721428|NCT01085201|470604296|FG002|Overall Study|Scheduling conflict|1|||
131134057|NCT00271817|472117292|FG002|Part 1|Adverse Event|156|||
130986921|NCT01529008|471578995|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
130986922|NCT01529008|471578996|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
130986923|NCT00332332|471578997|FG000|Overall Study|Adverse Event|13|||
130986924|NCT00332332|471578997|FG000|Overall Study|Death|1|||
130986925|NCT00332332|471578997|FG000|Overall Study|Withdrawal by Subject|8|||
130986926|NCT00332332|471578997|FG000|Overall Study|Physician Decision|1|||
130986927|NCT00332332|471578997|FG000|Overall Study|Lost to Follow-up|3|||
130986928|NCT00332332|471578997|FG000|Overall Study|Protocol deviation|4|||
131046990|NCT04795245|471807373|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
131046991|NCT03418740|471807374|FG000|Overall Study|Lost to Follow-up|13|||
131046992|NCT03418740|471807374|FG000|Overall Study|Scheduling Issues|7|||
131046993|NCT03418740|471807374|FG000|Overall Study|Withdrawal by Subject|2|||
131046994|NCT03418740|471807374|FG000|Overall Study|Unable to Continue Consent|1|||
131046995|NCT04157517|471807379|FG000|Overall Study|Death|1|||
131046996|NCT04157517|471807380|FG001|Overall Study|Death|2|||
131046997|NCT04157517|471807381|FG002|Overall Study|Death|2|||
131046998|NCT04157517|471807382|FG003|Overall Study|Death|3|||
131046999|NCT04157517|471807383|FG004|Overall Study|Death|3|||
131047000|NCT04157517|471807384|FG005|Overall Study|Death|4|||
131047001|NCT04157517|471807385|FG006|Overall Study|Death|1|||
131047002|NCT04157517|471807386|FG007|Overall Study|Death|2|||
131047003|NCT04157517|471807387|FG008|Overall Study|Death|4|||
131047004|NCT04157517|471807388|FG009|Overall Study|Death|0|||
131047005|NCT04157517|471807379|FG000|Overall Study|Withdrawal by Subject|1|||
131047006|NCT04157517|471807380|FG001|Overall Study|Withdrawal by Subject|1|||
131134058|NCT00271817|472117290|FG000|Part 1|Lost to Follow-up|6|||
131134059|NCT00271817|472117291|FG001|Part 1|Lost to Follow-up|8|||
131134060|NCT00271817|472117292|FG002|Part 1|Lost to Follow-up|24|||
131134061|NCT00271817|472117290|FG000|Part 1|Protocol Violation|5|||
131134062|NCT00271817|472117291|FG001|Part 1|Protocol Violation|4|||
131134063|NCT00271817|472117292|FG002|Part 1|Protocol Violation|7|||
131134064|NCT00271817|472117290|FG000|Part 1|Patient Moved|3|||
131134065|NCT00271817|472117291|FG001|Part 1|Patient Moved|1|||
131134066|NCT00271817|472117292|FG002|Part 1|Patient Moved|5|||
131134067|NCT00271817|472117290|FG000|Part 1|Withdrawal by Subject|23|||
131134068|NCT00271817|472117291|FG001|Part 1|Withdrawal by Subject|17|||
131134069|NCT00271817|472117292|FG002|Part 1|Withdrawal by Subject|45|||
131134070|NCT00271817|472117290|FG000|Part 1|LDL < 50 mg/dL|1|||
131134071|NCT00271817|472117291|FG001|Part 1|LDL < 50 mg/dL|4|||
130721429|NCT01085201|470604297|FG003|Overall Study|Scheduling conflict|0|||
130721430|NCT01085201|470604298|FG004|Overall Study|Scheduling conflict|0|||
130721431|NCT01085201|470604294|FG000|Overall Study|Unknown- no study drug|2|||
130721432|NCT01085201|470604295|FG001|Overall Study|Unknown- no study drug|0|||
130721433|NCT01085201|470604296|FG002|Overall Study|Unknown- no study drug|0|||
130721434|NCT01085201|470604297|FG003|Overall Study|Unknown- no study drug|0|||
130721435|NCT01085201|470604298|FG004|Overall Study|Unknown- no study drug|0|||
130721436|NCT01085201|470604294|FG000|Overall Study|Fond ineligible after consent|0|||
130721437|NCT01085201|470604295|FG001|Overall Study|Fond ineligible after consent|1|||
130721438|NCT01085201|470604296|FG002|Overall Study|Fond ineligible after consent|1|||
130721439|NCT01085201|470604297|FG003|Overall Study|Fond ineligible after consent|0|||
130721440|NCT01085201|470604298|FG004|Overall Study|Fond ineligible after consent|0|||
130721441|NCT04516759|470604301|FG000|Overall Study|Withdrawal by Subject|1|||
130721442|NCT04516759|470604302|FG001|Overall Study|Withdrawal by Subject|1|||
130721443|NCT04516759|470604301|FG000|Overall Study|Other|0|||
130721444|NCT04516759|470604302|FG001|Overall Study|Other|1|||
130721445|NCT00528411|470604303|FG000|Overall Study|Adverse Event|4|||
130721446|NCT00528411|470604304|FG001|Overall Study|Adverse Event|0|||
130721447|NCT00528411|470604305|FG002|Overall Study|Adverse Event|1|||
130721448|NCT00528411|470604303|FG000|Overall Study|Incorrect Enrolment|1|||
130721449|NCT00528411|470604304|FG001|Overall Study|Incorrect Enrolment|1|||
130721450|NCT00528411|470604305|FG002|Overall Study|Incorrect Enrolment|0|||
130721451|NCT00528411|470604303|FG000|Overall Study|Severe non-compliance to protocol|0|||
130721452|NCT00528411|470604304|FG001|Overall Study|Severe non-compliance to protocol|1|||
130721453|NCT00528411|470604305|FG002|Overall Study|Severe non-compliance to protocol|0|||
130721454|NCT00528411|470604303|FG000|Overall Study|Prior commitment medication|0|||
130721455|NCT00528411|470604304|FG001|Overall Study|Prior commitment medication|1|||
130721456|NCT00528411|470604305|FG002|Overall Study|Prior commitment medication|0|||
130721457|NCT01221363|470604309|FG000|Overall Study|Pregnancy|1|||
130721458|NCT01221363|470604310|FG001|Overall Study|Pregnancy|0|||
130721459|NCT01221363|470604309|FG000|Overall Study|Withdrawal by Subject|11|||
130721460|NCT01221363|470604310|FG001|Overall Study|Withdrawal by Subject|5|||
130721461|NCT02695537|470604311|FG000|Overall Study|Adverse Event|3|||
130721462|NCT02695537|470604311|FG000|Overall Study|Lack of Efficacy|28|||
130721463|NCT02695537|470604311|FG000|Overall Study|Withdrawal by Subject|4|||
130986929|NCT00332332|471578997|FG000|Overall Study|Noncompliance|2|||
131134072|NCT00271817|472117292|FG002|Part 1|LDL < 50 mg/dL|48|||
131134073|NCT00271817|472117290|FG000|Part 2|Adverse Event|0|||
131134074|NCT00271817|472117291|FG001|Part 2|Adverse Event|17|||
131134075|NCT00271817|472117292|FG002|Part 2|Adverse Event|33|||
131047007|NCT04157517|471807381|FG002|Overall Study|Withdrawal by Subject|1|||
131047008|NCT04157517|471807382|FG003|Overall Study|Withdrawal by Subject|0|||
131047009|NCT04157517|471807383|FG004|Overall Study|Withdrawal by Subject|0|||
130721464|NCT02695537|470604311|FG000|Overall Study|Protocol Violation|3|||
130721465|NCT03597529|470604312|FG000|Overall Study|Lost to Follow-up|10|||
130721466|NCT03597529|470604313|FG001|Overall Study|Lost to Follow-up|12|||
130721467|NCT03597529|470604312|FG000|Overall Study|Physician Decision|3|||
130721468|NCT03597529|470604313|FG001|Overall Study|Physician Decision|1|||
130721469|NCT03597529|470604312|FG000|Overall Study|Withdrawal by Subject|6|||
130721470|NCT03597529|470604313|FG001|Overall Study|Withdrawal by Subject|3|||
130721471|NCT03597529|470604312|FG000|Overall Study|Non-compliant with study activities|1|||
130721472|NCT03597529|470604313|FG001|Overall Study|Non-compliant with study activities|2|||
130721473|NCT02865460|470604320|FG000|Overall Study|Adverse Event|1|||
130721474|NCT02865460|470604321|FG001|Overall Study|Adverse Event|0|||
130721475|NCT02865460|470604320|FG000|Overall Study|Withdrawal by Subject|1|||
130721476|NCT02865460|470604321|FG001|Overall Study|Withdrawal by Subject|1|||
130721477|NCT02865460|470604320|FG000|Overall Study|Lost to Follow-up|7|||
130721478|NCT02865460|470604321|FG001|Overall Study|Lost to Follow-up|4|||
130721479|NCT02865460|470604320|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
130721480|NCT02865460|470604321|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
130721481|NCT02238795|470604328|FG000|Overall Study|Patient without purpura fulminans|1|||
130721482|NCT01292226|470604332|FG000|Overall Study|Adverse Event|5|||
130721483|NCT01292226|470604332|FG000|Overall Study|Death|1|||
130721484|NCT01292226|470604332|FG000|Overall Study|Graft loss|1|||
130721485|NCT01292226|470604332|FG000|Overall Study|Protocol Violation|3|||
130721486|NCT01292226|470604332|FG000|Overall Study|Withdrawal by Subject|1|||
130721487|NCT01292226|470604332|FG000|Overall Study|Other|2|||
130721488|NCT01584843|470604333|FG000|First Treatment Period|Adverse Event|0|||
130721489|NCT01584843|470604334|FG001|First Treatment Period|Adverse Event|0|||
130721490|NCT01584843|470604335|FG002|First Treatment Period|Adverse Event|1|||
130721491|NCT01584843|470604336|FG003|First Treatment Period|Adverse Event|0|||
130721492|NCT01584843|470604337|FG004|First Treatment Period|Adverse Event|0|||
130721493|NCT01584843|470604338|FG005|First Treatment Period|Adverse Event|0|||
130721494|NCT01584843|470604333|FG000|First Treatment Period|Protocol Violation|0|||
130721495|NCT01584843|470604334|FG001|First Treatment Period|Protocol Violation|0|||
130721496|NCT01584843|470604335|FG002|First Treatment Period|Protocol Violation|0|||
130721497|NCT01584843|470604336|FG003|First Treatment Period|Protocol Violation|0|||
130721498|NCT01584843|470604337|FG004|First Treatment Period|Protocol Violation|0|||
130721499|NCT01584843|470604338|FG005|First Treatment Period|Protocol Violation|1|||
131047010|NCT04157517|471807384|FG005|Overall Study|Withdrawal by Subject|1|||
131047011|NCT04157517|471807385|FG006|Overall Study|Withdrawal by Subject|0|||
131047012|NCT04157517|471807386|FG007|Overall Study|Withdrawal by Subject|0|||
131047013|NCT04157517|471807387|FG008|Overall Study|Withdrawal by Subject|1|||
131047014|NCT04157517|471807388|FG009|Overall Study|Withdrawal by Subject|0|||
131047015|NCT04157517|471807379|FG000|Overall Study|Other|1|||
131047016|NCT04157517|471807380|FG001|Overall Study|Other|0|||
131047017|NCT04157517|471807381|FG002|Overall Study|Other|0|||
131047018|NCT04157517|471807382|FG003|Overall Study|Other|0|||
131047019|NCT04157517|471807383|FG004|Overall Study|Other|0|||
131047020|NCT04157517|471807384|FG005|Overall Study|Other|1|||
131047021|NCT04157517|471807385|FG006|Overall Study|Other|2|||
131047022|NCT04157517|471807386|FG007|Overall Study|Other|7|||
131047023|NCT04157517|471807387|FG008|Overall Study|Other|7|||
131047024|NCT04157517|471807388|FG009|Overall Study|Other|0|||
131047025|NCT02933489|471807389|FG000|Overall Study|Ineligible|3|||
131047026|NCT02933489|471807390|FG001|Overall Study|Ineligible|3|||
131047027|NCT02933489|471807389|FG000|Overall Study|Withdrawal by Subject|27|||
131047028|NCT02933489|471807390|FG001|Overall Study|Withdrawal by Subject|18|||
131047029|NCT02933489|471807389|FG000|Overall Study|Unable to complete exams (other)|14|||
131047030|NCT02933489|471807390|FG001|Overall Study|Unable to complete exams (other)|7|||
131047031|NCT05020353|471808038|FG000|Overall Study|Protocol Violation|7|||
131047032|NCT05020353|471808038|FG000|Overall Study|Withdrawal by Subject|33|||
131047033|NCT05985395|471808042|FG000|Overall Study|Physician Decision|2|||
131047034|NCT05985395|471808043|FG001|Overall Study|Physician Decision|1|||
131047035|NCT05985395|471808042|FG000|Overall Study|Withdrawal by Subject|1|||
131047036|NCT05985395|471808043|FG001|Overall Study|Withdrawal by Subject|0|||
131047037|NCT03333915|471808044|FG000|Overall Study|Lost to Follow-up|0|||
131047038|NCT03333915|471808045|FG001|Overall Study|Lost to Follow-up|0|||
131047039|NCT03333915|471808046|FG002|Overall Study|Lost to Follow-up|1|||
131047040|NCT03333915|471808047|FG003|Overall Study|Lost to Follow-up|0|||
131047041|NCT03333915|471808048|FG004|Overall Study|Lost to Follow-up|0|||
131047042|NCT03333915|471808044|FG000|Overall Study|Disease Progression|0|||
131047043|NCT03333915|471808045|FG001|Overall Study|Disease Progression|1|||
130721500|NCT01584843|470604333|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130721501|NCT01584843|470604334|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
131047044|NCT03333915|471808046|FG002|Overall Study|Disease Progression|0|||
131047045|NCT03333915|471808047|FG003|Overall Study|Disease Progression|0|||
131047046|NCT03333915|471808048|FG004|Overall Study|Disease Progression|0|||
130721502|NCT01584843|470604335|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130721503|NCT01584843|470604336|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130721504|NCT01584843|470604337|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130721505|NCT01584843|470604338|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
130721506|NCT01584843|470604333|FG000|Second Treatment Period|Withdrawal by Subject|0|||
130721507|NCT01584843|470604334|FG001|Second Treatment Period|Withdrawal by Subject|0|||
130721508|NCT01584843|470604335|FG002|Second Treatment Period|Withdrawal by Subject|0|||
130721509|NCT01584843|470604336|FG003|Second Treatment Period|Withdrawal by Subject|0|||
130721510|NCT01584843|470604337|FG004|Second Treatment Period|Withdrawal by Subject|0|||
130721511|NCT01584843|470604338|FG005|Second Treatment Period|Withdrawal by Subject|1|||
130721512|NCT02196701|470604339|FG000|Overall Study|Adverse Event|1|||
130721513|NCT02196701|470604339|FG000|Overall Study|Lost to Follow-up|1|||
130721514|NCT02196701|470604339|FG000|Overall Study|Non-adherence to Protocol|1|||
130721515|NCT00311402|470604340|FG000|Overall Study|Adverse Event|118|||
130721516|NCT00311402|470604341|FG001|Overall Study|Adverse Event|105|||
130721517|NCT00311402|470604340|FG000|Overall Study|Lost to Follow-up|0|||
130721518|NCT00311402|470604341|FG001|Overall Study|Lost to Follow-up|3|||
130721519|NCT00311402|470604340|FG000|Overall Study|Withdrawal by Subject|17|||
130721520|NCT00311402|470604341|FG001|Overall Study|Withdrawal by Subject|18|||
130721521|NCT00311402|470604340|FG000|Overall Study|Lack of Efficacy|58|||
130721522|NCT00311402|470604341|FG001|Overall Study|Lack of Efficacy|42|||
130721523|NCT00311402|470604340|FG000|Overall Study|Protocol Violation|7|||
130721524|NCT00311402|470604341|FG001|Overall Study|Protocol Violation|6|||
130721525|NCT00311402|470604340|FG000|Overall Study|IRB's rejection etc.|10|||
130721526|NCT00311402|470604341|FG001|Overall Study|IRB's rejection etc.|3|||
130721527|NCT02640053|470604342|FG000|Overall Study|Withdrawal by Subject|2|||
130721528|NCT02640053|470604343|FG001|Overall Study|Withdrawal by Subject|1|||
130721529|NCT02640053|470604342|FG000|Overall Study|Adverse Event|1|||
130721530|NCT02640053|470604343|FG001|Overall Study|Adverse Event|1|||
130721531|NCT02640053|470604342|FG000|Overall Study|Alternative Therapy|1|||
130721532|NCT02640053|470604343|FG001|Overall Study|Alternative Therapy|1|||
130721533|NCT02640053|470604342|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
130721534|NCT02640053|470604343|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
130721535|NCT03283761|470604344|FG000|Study Treatment|Patient Non-Compliance|1|||
130721536|NCT03283761|470604344|FG000|Study Treatment|Alternative Cancer Therapy|7|||
130721537|NCT03283761|470604344|FG000|Study Treatment|Disease progression|21|||
130721538|NCT03283761|470604344|FG000|Study Treatment|Adverse Event|3|||
130721539|NCT03283761|470604344|FG000|Study Treatment|Withdrawal by Subject|4|||
130721540|NCT03283761|470604344|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
130986930|NCT00332332|471578997|FG000|Overall Study|Disease progression|2|||
130986931|NCT00332332|471578997|FG000|Overall Study|Other|18|||
130986932|NCT00332332|471578997|FG000|Overall Study|Did not receive study treatment|16|||
130986933|NCT01382602|471578998|FG000|Overall Study|Protocol Violation|0|||
130986934|NCT01382602|471578999|FG001|Overall Study|Protocol Violation|3|||
130986935|NCT01382602|471578998|FG000|Overall Study|Withdrawal by Subject|0|||
130986936|NCT01382602|471578999|FG001|Overall Study|Withdrawal by Subject|1|||
130986937|NCT01392300|471579006|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
130986938|NCT01392300|471579007|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
130986939|NCT01392300|471579008|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
130986940|NCT01392300|471579006|FG000|Main Period (MP)|Withdrawal by Subject|5|||
130986941|NCT01392300|471579007|FG001|Main Period (MP)|Withdrawal by Subject|1|||
130986942|NCT01392300|471579008|FG002|Main Period (MP)|Withdrawal by Subject|0|||
130986943|NCT01392300|471579006|FG000|Main Period (MP)|Lost to Follow-up|3|||
130986944|NCT01392300|471579007|FG001|Main Period (MP)|Lost to Follow-up|3|||
130986945|NCT01392300|471579008|FG002|Main Period (MP)|Lost to Follow-up|0|||
130986946|NCT01392300|471579006|FG000|Main Period (MP)|Non-compliance|1|||
130986947|NCT01392300|471579007|FG001|Main Period (MP)|Non-compliance|0|||
130986948|NCT01392300|471579008|FG002|Main Period (MP)|Non-compliance|0|||
130986949|NCT01392300|471579006|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
130986950|NCT01392300|471579007|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
130986951|NCT01392300|471579008|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
130986952|NCT01392300|471579006|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
130986953|NCT01392300|471579007|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
130986954|NCT01392300|471579008|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
130986955|NCT01392300|471579006|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
131047047|NCT03333915|471808044|FG000|Overall Study|Death|0|||
131047048|NCT03333915|471808045|FG001|Overall Study|Death|0|||
131047049|NCT03333915|471808046|FG002|Overall Study|Death|0|||
131047050|NCT03333915|471808047|FG003|Overall Study|Death|37|||
131047051|NCT03333915|471808048|FG004|Overall Study|Death|18|||
130721541|NCT03283761|470604344|FG000|Study Treatment|Symptomatic Deterioration|1|||
130721542|NCT03283761|470604344|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
130721543|NCT03283761|470604344|FG000|Follow up|Lost to Follow-up|1|||
130721544|NCT03283761|470604344|FG000|Follow up|Symptomatic Deterioration|1|||
130721545|NCT03283761|470604344|FG000|Follow up|Death|29|||
130721546|NCT03283761|470604344|FG000|Follow up|study terminated|4|||
130721547|NCT03283761|470604344|FG000|Follow up|Primary Investigator Withdrawal|1|||
130721548|NCT03283761|470604344|FG000|Follow up|Switched to alternative therapy|1|||
130721549|NCT03283761|470604344|FG000|Follow up|Subject is now in Hospice|1|||
130721550|NCT04159935|470604345|FG000|Overall Study|Study terminated due to COVID-19|1|||
130721551|NCT04159935|470604346|FG001|Overall Study|Study terminated due to COVID-19|3|||
130721552|NCT02036775|470604347|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130721553|NCT02036775|470604348|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130721554|NCT02036775|470604349|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130721555|NCT02036775|470604350|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130721556|NCT02036775|470604351|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130721557|NCT02036775|470604352|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
130721558|NCT03923530|470604353|FG000|Overall Study|Withdrawal by Subject|1|||
130721559|NCT03923530|470604353|FG000|Overall Study|screen failure|3|||
130721560|NCT01458106|470604362|FG000|Overall Study|Withdrawal by Subject|2|||
130721561|NCT01458106|470604363|FG001|Overall Study|Withdrawal by Subject|0|||
130721562|NCT01458106|470604362|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
130721563|NCT01458106|470604363|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
130721564|NCT01458106|470604362|FG000|Overall Study|Withdrawn Per Protocol|0|||
130721565|NCT01458106|470604363|FG001|Overall Study|Withdrawn Per Protocol|1|||
130721566|NCT00855803|470604364|FG000|Overall Study|Death|2|||
130721567|NCT00855803|470604364|FG000|Overall Study|Lost to Follow-up|2|||
130721568|NCT00855803|470604364|FG000|Overall Study|Technical inability to undergo procedure|2|||
130721569|NCT00855803|470604364|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
130721570|NCT00855803|470604364|FG000|Overall Study|Withdrawal by Subject|3|||
130721571|NCT00855803|470604364|FG000|Overall Study|Physician Decision|3|||
130721572|NCT03050060|470604369|FG000|Overall Study|Adverse Event|7|||
130721573|NCT03050060|470604369|FG000|Overall Study|Withdrawal by Subject|1|||
130721574|NCT03050060|470604369|FG000|Overall Study|Progression|7|||
130721575|NCT02288182|470604370|FG000|Overall Study|Adverse Event|0|||
130721576|NCT02288182|470604371|FG001|Overall Study|Adverse Event|1|||
130721577|NCT02288182|470604370|FG000|Overall Study|Lost to Follow-up|0|||
130721578|NCT02288182|470604371|FG001|Overall Study|Lost to Follow-up|1|||
130721579|NCT02582866|470604372|FG000|Overall Study|Death|1|||
130721580|NCT02582866|470604372|FG000|Overall Study|Lack of Efficacy|2|||
130721581|NCT02582866|470604372|FG000|Overall Study|Lost to Follow-up|2|||
130721582|NCT02582866|470604372|FG000|Overall Study|Withdrawal by Subject|7|||
130721583|NCT02582866|470604372|FG000|Overall Study|Investigator decision|5|||
130721584|NCT02582866|470604372|FG000|Overall Study|Participant wants to get pregnant|1|||
130721585|NCT02582866|470604372|FG000|Overall Study|Pregnancy|2|||
130721586|NCT02582866|470604372|FG000|Overall Study|Sponsor decision|1|||
130986956|NCT01392300|471579007|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
130986957|NCT01392300|471579008|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
130986958|NCT01392300|471579006|FG000|Open Label Extension (OLEX) Period|Death|0|||
130986959|NCT01392300|471579007|FG001|Open Label Extension (OLEX) Period|Death|0|||
130986960|NCT01392300|471579008|FG002|Open Label Extension (OLEX) Period|Death|4|||
130986961|NCT01392300|471579006|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
130986962|NCT01392300|471579007|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
130986963|NCT01392300|471579008|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
130986964|NCT01392300|471579006|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
130986965|NCT01392300|471579007|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
130986966|NCT01392300|471579008|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
130986967|NCT01392300|471579006|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
130986968|NCT01392300|471579007|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
130986969|NCT01392300|471579008|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
130986970|NCT05056870|471579013|FG000|Period 1|Site COVID-19 Related|3|||
130986971|NCT05056870|471579014|FG001|Period 1|Site COVID-19 Related|3|||
130986972|NCT05056870|471579013|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130986973|NCT05056870|471579014|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
130986974|NCT05056870|471579013|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
130986975|NCT05056870|471579014|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
131047052|NCT03333915|471808044|FG000|Overall Study|Sponsor's Decision|0|||
130721587|NCT02582866|470604372|FG000|Overall Study|Withdrawal due to personal reasons|1|||
130721588|NCT02056392|470604377|FG000|Overall Study|Lost to Follow-up|0|||
130721589|NCT02056392|470604378|FG001|Overall Study|Lost to Follow-up|1|||
130721590|NCT02056392|470604379|FG002|Overall Study|Lost to Follow-up|2|||
130721591|NCT02056392|470604380|FG003|Overall Study|Lost to Follow-up|0|||
130721592|NCT02056392|470604381|FG004|Overall Study|Lost to Follow-up|0|||
130721593|NCT02056392|470604382|FG005|Overall Study|Lost to Follow-up|0|||
130721594|NCT02056392|470604377|FG000|Overall Study|Protocol Violation|1|||
130721595|NCT02056392|470604378|FG001|Overall Study|Protocol Violation|0|||
130721596|NCT02056392|470604379|FG002|Overall Study|Protocol Violation|1|||
130721597|NCT02056392|470604380|FG003|Overall Study|Protocol Violation|0|||
130721598|NCT02056392|470604381|FG004|Overall Study|Protocol Violation|0|||
130721599|NCT02056392|470604382|FG005|Overall Study|Protocol Violation|0|||
130721600|NCT02056392|470604377|FG000|Overall Study|Withdrawal by Subject|1|||
130721601|NCT02056392|470604378|FG001|Overall Study|Withdrawal by Subject|0|||
130721602|NCT02056392|470604379|FG002|Overall Study|Withdrawal by Subject|0|||
130721603|NCT02056392|470604380|FG003|Overall Study|Withdrawal by Subject|0|||
130721604|NCT02056392|470604381|FG004|Overall Study|Withdrawal by Subject|1|||
130721605|NCT02056392|470604382|FG005|Overall Study|Withdrawal by Subject|0|||
130721606|NCT00633243|470606247|FG000|Overall Study|Withdrawal by Subject|0|||
130721607|NCT00633243|470606248|FG001|Overall Study|Withdrawal by Subject|1|||
130721608|NCT00633243|470606247|FG000|Overall Study|incarceration|0|||
130721609|NCT00633243|470606248|FG001|Overall Study|incarceration|2|||
130721610|NCT00633243|470606247|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
130721611|NCT00633243|470606248|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
130721612|NCT00633243|470606247|FG000|Overall Study|Not comfortable with self-injecting|0|||
130721613|NCT00633243|470606248|FG001|Overall Study|Not comfortable with self-injecting|1|||
130721614|NCT00633243|470606247|FG000|Overall Study|Mental Health--Depression|0|||
130721615|NCT00633243|470606248|FG001|Overall Study|Mental Health--Depression|1|||
130721616|NCT00633243|470606247|FG000|Overall Study|Couldn't tolerate side-effects|1|||
130721617|NCT00633243|470606248|FG001|Overall Study|Couldn't tolerate side-effects|1|||
130721618|NCT02022748|470606249|FG000|Overall Study|Adverse Event|1|||
130721619|NCT02022748|470606250|FG001|Overall Study|Adverse Event|1|||
130721620|NCT02022748|470606251|FG002|Overall Study|Adverse Event|0|||
130721621|NCT02022748|470606249|FG000|Overall Study|Withdrawal by Subject|0|||
130721622|NCT02022748|470606250|FG001|Overall Study|Withdrawal by Subject|1|||
130721623|NCT02022748|470606251|FG002|Overall Study|Withdrawal by Subject|0|||
130721624|NCT00461253|470606252|FG000|Overall Study|Death|985|||
130721625|NCT00461253|470606253|FG001|Overall Study|Death|0|||
130721626|NCT00461253|470606252|FG000|Overall Study|Protocol Violation|613|||
130721627|NCT00461253|470606253|FG001|Overall Study|Protocol Violation|236|||
130721628|NCT00461253|470606252|FG000|Overall Study|no response|2609|||
130721629|NCT00461253|470606253|FG001|Overall Study|no response|11789|||
130721630|NCT00461253|470606252|FG000|Overall Study|administrative|773|||
130721631|NCT00461253|470606253|FG001|Overall Study|administrative|7773|||
130721632|NCT04240392|470606254|FG000|Overall Study|Withdrawal by Subject|13|||
130721633|NCT04240392|470606255|FG001|Overall Study|Withdrawal by Subject|4|||
130721634|NCT04240392|470606254|FG000|Overall Study|Lost to Follow-up|11|||
130721635|NCT04240392|470606255|FG001|Overall Study|Lost to Follow-up|12|||
130721636|NCT01523457|470606256|FG000|Overall Study|Withdrawal by Subject|7|||
130721637|NCT01523457|470606257|FG001|Overall Study|Withdrawal by Subject|2|||
130721638|NCT00721630|470606258|FG000|Overall Study|Participant found to be ineligible|1|||
130721639|NCT03700385|470606261|FG000|Overall Study|Lost to Follow-up|1|||
130721640|NCT01555671|470606265|FG000|Overall Study|Physician Decision|20|||
130721641|NCT01555671|470606266|FG001|Overall Study|Physician Decision|25|||
130721642|NCT00372411|470606267|FG000|Overall Study|Withdrawal by Subject|3|||
130721643|NCT00372411|470606268|FG001|Overall Study|Withdrawal by Subject|4|||
130721644|NCT00372411|470606269|FG002|Overall Study|Withdrawal by Subject|1|||
130721645|NCT00372411|470606267|FG000|Overall Study|Death|0|||
130721646|NCT00372411|470606268|FG001|Overall Study|Death|2|||
130721647|NCT00372411|470606269|FG002|Overall Study|Death|1|||
130721648|NCT00372411|470606267|FG000|Overall Study|Lost to Follow-up|1|||
130721649|NCT00372411|470606268|FG001|Overall Study|Lost to Follow-up|1|||
130721650|NCT00372411|470606269|FG002|Overall Study|Lost to Follow-up|1|||
130721651|NCT00372411|470606267|FG000|Overall Study|Adverse Event|1|||
130721652|NCT00372411|470606268|FG001|Overall Study|Adverse Event|1|||
130986976|NCT05056870|471579013|FG000|Period 2|COVID-19 Related|1|||
130986977|NCT05056870|471579014|FG001|Period 2|COVID-19 Related|0|||
130986978|NCT05056870|471579013|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
130986979|NCT05056870|471579014|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
130986980|NCT00676130|471579015|FG000|Overall Study|Lost to Follow-up|0|||
130986981|NCT00676130|471579016|FG001|Overall Study|Lost to Follow-up|1|||
130986982|NCT00676130|471579015|FG000|Overall Study|Found ineligible|3|||
130986983|NCT00676130|471579016|FG001|Overall Study|Found ineligible|2|||
130986984|NCT00676130|471579015|FG000|Overall Study|Withdrawal by Subject|0|||
130986985|NCT00676130|471579016|FG001|Overall Study|Withdrawal by Subject|1|||
130986986|NCT01682213|471579019|FG000|Overall Study|Withdrawal by Subject|2|||
130986987|NCT00742079|471579020|FG000|Overall Study|Lost to Follow-up|0|||
130986988|NCT00742079|471579021|FG001|Overall Study|Lost to Follow-up|1|||
131047053|NCT03333915|471808045|FG001|Overall Study|Sponsor's Decision|0|||
130721653|NCT00372411|470606269|FG002|Overall Study|Adverse Event|0|||
130721654|NCT04590040|470606270|FG000|Treatment Period|Lost to Follow-up|2|||
130721655|NCT04590040|470606271|FG001|Treatment Period|Lost to Follow-up|5|||
130721656|NCT04590040|470606272|FG002|Treatment Period|Lost to Follow-up|0|||
130721657|NCT04590040|470606270|FG000|Treatment Period|Physician Decision|0|||
130721658|NCT04590040|470606271|FG001|Treatment Period|Physician Decision|0|||
130721659|NCT04590040|470606272|FG002|Treatment Period|Physician Decision|2|||
130986989|NCT01181726|471579022|FG000|First Intervention|Adverse Event|1|||
130986990|NCT01181726|471579023|FG001|First Intervention|Adverse Event|0|||
130986991|NCT01114204|471579025|FG000|Overall Study|Adverse Event|3|||
130986992|NCT01114204|471579026|FG001|Overall Study|Adverse Event|2|||
130986993|NCT01114204|471579025|FG000|Overall Study|Lost to Follow-up|1|||
130986994|NCT01114204|471579026|FG001|Overall Study|Lost to Follow-up|0|||
130986995|NCT01114204|471579025|FG000|Overall Study|Withdrawal by Subject|10|||
130986996|NCT01114204|471579026|FG001|Overall Study|Withdrawal by Subject|6|||
130986997|NCT01114204|471579025|FG000|Overall Study|Death|1|||
130986998|NCT01114204|471579026|FG001|Overall Study|Death|0|||
130986999|NCT01114204|471579025|FG000|Overall Study|Other-Personal reasons|2|||
131047054|NCT03333915|471808046|FG002|Overall Study|Sponsor's Decision|0|||
131047055|NCT03333915|471808047|FG003|Overall Study|Sponsor's Decision|48|||
131047056|NCT03333915|471808048|FG004|Overall Study|Sponsor's Decision|4|||
131047057|NCT03333915|471808044|FG000|Overall Study|Withdrawal by Subject|0|||
131047058|NCT03333915|471808045|FG001|Overall Study|Withdrawal by Subject|0|||
131047059|NCT03333915|471808046|FG002|Overall Study|Withdrawal by Subject|0|||
131047060|NCT03333915|471808047|FG003|Overall Study|Withdrawal by Subject|5|||
131047061|NCT03333915|471808048|FG004|Overall Study|Withdrawal by Subject|1|||
131047062|NCT03522298|471808055|FG000|Overall Study|Adverse Event|1|||
131047063|NCT03522298|471808056|FG001|Overall Study|Adverse Event|0|||
131047064|NCT03522298|471808057|FG002|Overall Study|Adverse Event|0|||
131047065|NCT03522298|471808058|FG003|Overall Study|Adverse Event|1|||
130721660|NCT01284361|470606275|FG000|Overall Study|Withdrawal by Subject|1|||
130721661|NCT01284361|470606275|FG000|Overall Study|Protocol Violation|5|||
130721662|NCT01284361|470606275|FG000|Overall Study|Adverse Event|1|||
130721663|NCT01284361|470606275|FG000|Overall Study|Lost to Follow-up|2|||
130721664|NCT04003896|470606276|FG000|Overall Study|Withdrawal by Subject|3|||
130721665|NCT04003896|470606276|FG000|Overall Study|Physician Decision|1|||
130721666|NCT01957397|470606279|FG000|Test Period 1|sudden leakage/small bag|1|||
131047066|NCT03522298|471808055|FG000|Overall Study|Death|2|||
131047067|NCT03522298|471808056|FG001|Overall Study|Death|4|||
130721667|NCT01957397|470606280|FG001|Test Period 1|sudden leakage/small bag|1|||
130721668|NCT01957397|470606279|FG000|Test Period 1|Withdrawal by Subject|1|||
130721669|NCT01957397|470606280|FG001|Test Period 1|Withdrawal by Subject|0|||
130721670|NCT01957397|470606279|FG000|Test Period 2|Adverse Event|0|||
130721671|NCT01957397|470606280|FG001|Test Period 2|Adverse Event|1|||
130721672|NCT01957397|470606279|FG000|Test Period 3|Adverse Event|1|||
130721673|NCT01957397|470606280|FG001|Test Period 3|Adverse Event|2|||
130721674|NCT01957397|470606279|FG000|Test Period 3|the adhesive did not work|1|||
130721675|NCT01957397|470606280|FG001|Test Period 3|the adhesive did not work|0|||
130721676|NCT00324649|470606281|FG000|Overall Study|Adverse Event|1|||
130721677|NCT00324649|470606282|FG001|Overall Study|Adverse Event|4|||
130721678|NCT00324649|470606281|FG000|Overall Study|Withdrawal by Subject|0|||
130721679|NCT00324649|470606282|FG001|Overall Study|Withdrawal by Subject|1|||
130721680|NCT00324649|470606281|FG000|Overall Study|Noncompliance|1|||
130721681|NCT00324649|470606282|FG001|Overall Study|Noncompliance|0|||
130721682|NCT00540293|470606283|FG000|Overall Study|Adverse event related to study drug|10|||
130721683|NCT00540293|470606283|FG000|Overall Study|Adverse event not related to study drug|7|||
130721684|NCT00540293|470606283|FG000|Overall Study|Withdrawal by Subject|6|||
130721685|NCT00540293|470606283|FG000|Overall Study|Protocol violation, & subject schedule|12|||
130721686|NCT02740699|470606286|FG000|Overall Study|Lost to Follow-up|5|||
130721687|NCT02740699|470606286|FG000|Overall Study|Withdrawal by Subject|14|||
130721688|NCT02740699|470606286|FG000|Overall Study|Physician Decision|5|||
130721689|NCT04713553|470606287|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
130721690|NCT04713553|470606288|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
130721691|NCT04713553|470606289|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
130721692|NCT04713553|470606290|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
130721693|NCT04713553|470606291|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
130721694|NCT04713553|470606292|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
130721695|NCT04713553|470606293|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
130721696|NCT04713553|470606287|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721697|NCT04713553|470606288|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721698|NCT04713553|470606289|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721699|NCT04713553|470606290|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
130721700|NCT04713553|470606291|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721701|NCT04713553|470606292|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721702|NCT04713553|470606293|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130721703|NCT04713553|470606287|FG000|Primary Study (2 Months)|Other|1|||
130721704|NCT04713553|470606288|FG001|Primary Study (2 Months)|Other|2|||
130721705|NCT04713553|470606289|FG002|Primary Study (2 Months)|Other|0|||
130721706|NCT04713553|470606290|FG003|Primary Study (2 Months)|Other|0|||
130721707|NCT04713553|470606291|FG004|Primary Study (2 Months)|Other|1|||
130987000|NCT01114204|471579026|FG001|Overall Study|Other-Personal reasons|0|||
130987001|NCT01114204|471579025|FG000|Overall Study|Other-Medical monitor request|1|||
130987002|NCT01114204|471579026|FG001|Overall Study|Other-Medical monitor request|0|||
131047068|NCT03522298|471808057|FG002|Overall Study|Death|8|||
131047069|NCT03522298|471808058|FG003|Overall Study|Death|8|||
130987003|NCT01114204|471579025|FG000|Overall Study|Other-Participant request|2|||
130987004|NCT01114204|471579026|FG001|Overall Study|Other-Participant request|0|||
130987005|NCT01114204|471579025|FG000|Overall Study|Other-Protocol Violation|1|||
130987006|NCT01114204|471579026|FG001|Overall Study|Other-Protocol Violation|0|||
130987007|NCT00674570|471579027|FG000|Overall Study|Withdrawal by Subject|0|||
130987008|NCT00674570|471579028|FG001|Overall Study|Withdrawal by Subject|2|||
130987009|NCT00674570|471579029|FG002|Overall Study|Withdrawal by Subject|0|||
130987010|NCT03633929|471579030|FG000|Overall Study|Lost to Follow-up|1|||
130987011|NCT03633929|471579030|FG000|Overall Study|Did not login to software. Did not participate|3|||
130987012|NCT04461795|471579031|FG000|Overall Study|Lost to Follow-up|2|||
130987013|NCT04461795|471579031|FG000|Overall Study|Withdrawal by Subject|2|||
130987014|NCT04461795|471579031|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
130987015|NCT02798211|471579035|FG000|Period 1|Adverse Event|1|||
130987016|NCT02798211|471579036|FG001|Period 1|Adverse Event|1|||
130987017|NCT02798211|471579037|FG002|Period 1|Adverse Event|0|||
130987018|NCT02798211|471579038|FG003|Period 1|Adverse Event|0|||
130987019|NCT02798211|471579039|FG004|Period 1|Adverse Event|0|||
130987020|NCT02798211|471579040|FG005|Period 1|Adverse Event|0|||
130987021|NCT02798211|471579035|FG000|Period 1|Lost to Follow-up|2|||
130987022|NCT02798211|471579036|FG001|Period 1|Lost to Follow-up|1|||
130987023|NCT02798211|471579037|FG002|Period 1|Lost to Follow-up|0|||
130987024|NCT02798211|471579038|FG003|Period 1|Lost to Follow-up|0|||
130987025|NCT02798211|471579039|FG004|Period 1|Lost to Follow-up|0|||
130987026|NCT02798211|471579040|FG005|Period 1|Lost to Follow-up|0|||
130987027|NCT02798211|471579035|FG000|Period 1|Protocol Violation|0|||
130987028|NCT02798211|471579036|FG001|Period 1|Protocol Violation|0|||
130987029|NCT02798211|471579037|FG002|Period 1|Protocol Violation|2|||
130987030|NCT02798211|471579038|FG003|Period 1|Protocol Violation|0|||
130987031|NCT02798211|471579039|FG004|Period 1|Protocol Violation|0|||
130987032|NCT02798211|471579040|FG005|Period 1|Protocol Violation|0|||
130721708|NCT04713553|470606292|FG005|Primary Study (2 Months)|Other|0|||
130721709|NCT04713553|470606293|FG006|Primary Study (2 Months)|Other|0|||
130987033|NCT02798211|471579035|FG000|Period 1|Withdrawal by Subject|1|||
130987034|NCT02798211|471579036|FG001|Period 1|Withdrawal by Subject|1|||
130721710|NCT04713553|470606287|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
130721711|NCT04713553|470606288|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
130721712|NCT04713553|470606289|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
130721713|NCT04713553|470606290|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
130721714|NCT04713553|470606291|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
130721715|NCT04713553|470606292|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
130721716|NCT04713553|470606293|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
130721717|NCT04713553|470606287|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721718|NCT04713553|470606288|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721719|NCT04713553|470606289|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
130721720|NCT04713553|470606290|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721721|NCT04713553|470606291|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721722|NCT04713553|470606292|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721723|NCT04713553|470606293|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
130721724|NCT02315196|470606300|FG000|Overall Study|Withdrew consent|9|||
130721725|NCT04729309|470606301|FG000|Period 1|Subject unable to return for Period 2|3|||
130721726|NCT04729309|470606302|FG001|Period 1|Subject unable to return for Period 2|0|||
130721727|NCT04729309|470606301|FG000|Period 1|Lost to Follow-up|1|||
130721728|NCT04729309|470606302|FG001|Period 1|Lost to Follow-up|0|||
130721729|NCT00537303|470606303|FG000|Overall Study|Adverse Event|1|||
130721730|NCT00537303|470606304|FG001|Overall Study|Adverse Event|4|||
130721731|NCT00537303|470606303|FG000|Overall Study|Lack of Efficacy|6|||
130721732|NCT00537303|470606304|FG001|Overall Study|Lack of Efficacy|7|||
130721733|NCT00537303|470606303|FG000|Overall Study|Protocol Violation|8|||
130721734|NCT00537303|470606304|FG001|Overall Study|Protocol Violation|4|||
130721735|NCT00537303|470606303|FG000|Overall Study|Withdrawal criteria|3|||
130721736|NCT00537303|470606304|FG001|Overall Study|Withdrawal criteria|3|||
130987035|NCT02798211|471579037|FG002|Period 1|Withdrawal by Subject|0|||
130987036|NCT02798211|471579038|FG003|Period 1|Withdrawal by Subject|0|||
130987037|NCT02798211|471579039|FG004|Period 1|Withdrawal by Subject|0|||
130987038|NCT02798211|471579040|FG005|Period 1|Withdrawal by Subject|0|||
130721737|NCT00537303|470606303|FG000|Overall Study|Unclassified|8|||
130987039|NCT02798211|471579035|FG000|Period 1|Death|0|||
130987040|NCT02798211|471579036|FG001|Period 1|Death|0|||
130987041|NCT02798211|471579037|FG002|Period 1|Death|1|||
130987042|NCT02798211|471579038|FG003|Period 1|Death|0|||
130987043|NCT02798211|471579039|FG004|Period 1|Death|0|||
130987044|NCT02798211|471579040|FG005|Period 1|Death|0|||
130987045|NCT02798211|471579035|FG000|Period 1|Withdrawal of Informed Consent|2|||
130987046|NCT02798211|471579036|FG001|Period 1|Withdrawal of Informed Consent|7|||
130987047|NCT02798211|471579037|FG002|Period 1|Withdrawal of Informed Consent|3|||
130987048|NCT02798211|471579038|FG003|Period 1|Withdrawal of Informed Consent|0|||
130987049|NCT02798211|471579039|FG004|Period 1|Withdrawal of Informed Consent|0|||
130987050|NCT02798211|471579040|FG005|Period 1|Withdrawal of Informed Consent|0|||
131047070|NCT03522298|471808055|FG000|Overall Study|Patient decision|0|||
131047071|NCT03522298|471808056|FG001|Overall Study|Patient decision|2|||
131047072|NCT03522298|471808057|FG002|Overall Study|Patient decision|2|||
131047073|NCT03522298|471808058|FG003|Overall Study|Patient decision|2|||
131047074|NCT01897441|471808059|FG000|Overall Study|Lost to Follow-up|0|||
131047075|NCT01897441|471808060|FG001|Overall Study|Lost to Follow-up|0|||
131047076|NCT01897441|471808061|FG002|Overall Study|Lost to Follow-up|1|||
131047077|NCT01897441|471808062|FG003|Overall Study|Lost to Follow-up|0|||
131047078|NCT01897441|471808063|FG004|Overall Study|Lost to Follow-up|0|||
131047079|NCT01897441|471808064|FG005|Overall Study|Lost to Follow-up|0|||
131047080|NCT01897441|471808059|FG000|Overall Study|Withdrawal by Subject|0|||
131047081|NCT01897441|471808060|FG001|Overall Study|Withdrawal by Subject|0|||
131047082|NCT01897441|471808061|FG002|Overall Study|Withdrawal by Subject|0|||
131047083|NCT01897441|471808062|FG003|Overall Study|Withdrawal by Subject|0|||
131047084|NCT01897441|471808063|FG004|Overall Study|Withdrawal by Subject|1|||
131047085|NCT01897441|471808064|FG005|Overall Study|Withdrawal by Subject|0|||
131047086|NCT01897441|471808059|FG000|Overall Study|Withdrawn by Provider|0|||
131047087|NCT01897441|471808060|FG001|Overall Study|Withdrawn by Provider|2|||
131047088|NCT01897441|471808061|FG002|Overall Study|Withdrawn by Provider|0|||
131047089|NCT01897441|471808062|FG003|Overall Study|Withdrawn by Provider|0|||
131047090|NCT01897441|471808063|FG004|Overall Study|Withdrawn by Provider|0|||
131047091|NCT01897441|471808064|FG005|Overall Study|Withdrawn by Provider|0|||
131047092|NCT02806726|471808065|FG000|Overall Study|Lost to Follow-up|1|||
130987051|NCT02798211|471579035|FG000|Period 2|Withdrawal by Subject|2|||
130987052|NCT02798211|471579036|FG001|Period 2|Withdrawal by Subject|0|||
130987053|NCT02798211|471579037|FG002|Period 2|Withdrawal by Subject|0|||
130987054|NCT02798211|471579038|FG003|Period 2|Withdrawal by Subject|0|||
130987055|NCT02798211|471579039|FG004|Period 2|Withdrawal by Subject|2|||
130987056|NCT02798211|471579040|FG005|Period 2|Withdrawal by Subject|2|||
130987057|NCT02798211|471579035|FG000|Period 2|Adverse Event|5|||
130987058|NCT02798211|471579036|FG001|Period 2|Adverse Event|0|||
130987059|NCT02798211|471579037|FG002|Period 2|Adverse Event|0|||
130987060|NCT02798211|471579038|FG003|Period 2|Adverse Event|0|||
130987061|NCT02798211|471579039|FG004|Period 2|Adverse Event|1|||
130987062|NCT02798211|471579040|FG005|Period 2|Adverse Event|0|||
130987063|NCT02798211|471579035|FG000|Period 2|Lack of Efficacy|1|||
130987064|NCT02798211|471579036|FG001|Period 2|Lack of Efficacy|0|||
130987065|NCT02798211|471579037|FG002|Period 2|Lack of Efficacy|0|||
130987066|NCT02798211|471579038|FG003|Period 2|Lack of Efficacy|1|||
130987067|NCT02798211|471579039|FG004|Period 2|Lack of Efficacy|0|||
130987068|NCT02798211|471579040|FG005|Period 2|Lack of Efficacy|1|||
130987069|NCT02798211|471579035|FG000|Period 2|Lost to Follow-up|3|||
130987070|NCT02798211|471579036|FG001|Period 2|Lost to Follow-up|0|||
130987071|NCT02798211|471579037|FG002|Period 2|Lost to Follow-up|0|||
130987072|NCT02798211|471579038|FG003|Period 2|Lost to Follow-up|0|||
130987073|NCT02798211|471579039|FG004|Period 2|Lost to Follow-up|2|||
130987074|NCT02798211|471579040|FG005|Period 2|Lost to Follow-up|0|||
130987075|NCT02798211|471579035|FG000|Period 2|Physician Decision|1|||
130987076|NCT02798211|471579036|FG001|Period 2|Physician Decision|0|||
130987077|NCT02798211|471579037|FG002|Period 2|Physician Decision|0|||
130987078|NCT02798211|471579038|FG003|Period 2|Physician Decision|1|||
130987079|NCT02798211|471579039|FG004|Period 2|Physician Decision|1|||
130987080|NCT02798211|471579040|FG005|Period 2|Physician Decision|0|||
130987081|NCT02798211|471579035|FG000|Period 2|Pregnancy|0|||
130987082|NCT02798211|471579036|FG001|Period 2|Pregnancy|0|||
130987083|NCT02798211|471579037|FG002|Period 2|Pregnancy|0|||
130987084|NCT02798211|471579038|FG003|Period 2|Pregnancy|2|||
130987085|NCT02798211|471579039|FG004|Period 2|Pregnancy|0|||
130987086|NCT02798211|471579040|FG005|Period 2|Pregnancy|0|||
131047093|NCT04281498|471808066|FG000|Overall Study|Progression of disease|1|||
131047094|NCT04281498|471808066|FG000|Overall Study|Planned SCT|1|||
130987087|NCT02798211|471579035|FG000|Period 2|Technical problems|1|||
130987088|NCT02798211|471579036|FG001|Period 2|Technical problems|0|||
130987089|NCT02798211|471579037|FG002|Period 2|Technical problems|0|||
130987090|NCT02798211|471579038|FG003|Period 2|Technical problems|1|||
131047095|NCT04281498|471808066|FG000|Overall Study|Alternative Treatment|1|||
131047096|NCT03587805|471808067|FG000|Overall Study|Adverse Event|72|||
131047097|NCT03587805|471808067|FG000|Overall Study|Death|1|||
131047098|NCT03587805|471808067|FG000|Overall Study|Lost to Follow-up|78|||
131047099|NCT03587805|471808067|FG000|Overall Study|Withdrawal by Subject|105|||
131047100|NCT03587805|471808067|FG000|Overall Study|Lack of Efficacy|119|||
131047101|NCT03587805|471808067|FG000|Overall Study|Reason unknown|26|||
131047102|NCT03587805|471808067|FG000|Overall Study|COVID_19 pandemic|4|||
131047103|NCT03587805|471808067|FG000|Overall Study|Various reasons|121|||
130987091|NCT02798211|471579039|FG004|Period 2|Technical problems|0|||
130987092|NCT02798211|471579040|FG005|Period 2|Technical problems|0|||
131047104|NCT03587805|471808067|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130987093|NCT02798211|471579035|FG000|Period 2|Withdrawal of Informed Consent|1|||
130987094|NCT02798211|471579036|FG001|Period 2|Withdrawal of Informed Consent|0|||
130987095|NCT02798211|471579037|FG002|Period 2|Withdrawal of Informed Consent|0|||
130987096|NCT02798211|471579038|FG003|Period 2|Withdrawal of Informed Consent|2|||
131047105|NCT01527188|471808068|FG000|Overall Study|Adverse Event|5|||
131047106|NCT01527188|471808069|FG001|Overall Study|Adverse Event|5|||
131047107|NCT01527188|471808070|FG002|Overall Study|Adverse Event|11|||
131047108|NCT01527188|471808071|FG003|Overall Study|Adverse Event|0|||
131047109|NCT01527188|471808068|FG000|Overall Study|Withdrawal by Subject|3|||
131047110|NCT01527188|471808069|FG001|Overall Study|Withdrawal by Subject|6|||
131047111|NCT01527188|471808070|FG002|Overall Study|Withdrawal by Subject|4|||
131047112|NCT01527188|471808071|FG003|Overall Study|Withdrawal by Subject|4|||
131047113|NCT01527188|471808068|FG000|Overall Study|Any other reason not above-mentioned|6|||
131047114|NCT01527188|471808069|FG001|Overall Study|Any other reason not above-mentioned|7|||
131047115|NCT01527188|471808070|FG002|Overall Study|Any other reason not above-mentioned|8|||
131047116|NCT01527188|471808071|FG003|Overall Study|Any other reason not above-mentioned|8|||
131047117|NCT04626427|471808072|FG000|Overall Study|Death|1|||
131047118|NCT04626427|471808072|FG000|Overall Study|Withdrawal by Subject|1|||
131047119|NCT04626427|471808072|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
131134076|NCT00271817|472117290|FG000|Part 2|Lack of Efficacy|0|||
131134077|NCT00271817|472117291|FG001|Part 2|Lack of Efficacy|1|||
131134078|NCT00271817|472117292|FG002|Part 2|Lack of Efficacy|6|||
131134079|NCT00271817|472117290|FG000|Part 2|Lost to Follow-up|0|||
131134080|NCT00271817|472117291|FG001|Part 2|Lost to Follow-up|6|||
131134081|NCT00271817|472117292|FG002|Part 2|Lost to Follow-up|18|||
131134082|NCT00271817|472117290|FG000|Part 2|Protocol Violation|0|||
131134083|NCT00271817|472117291|FG001|Part 2|Protocol Violation|3|||
131134084|NCT00271817|472117292|FG002|Part 2|Protocol Violation|5|||
131134085|NCT00271817|472117290|FG000|Part 2|Patient Moved|0|||
131134086|NCT00271817|472117291|FG001|Part 2|Patient Moved|0|||
131134087|NCT00271817|472117292|FG002|Part 2|Patient Moved|5|||
131134088|NCT00271817|472117290|FG000|Part 2|Withdrawal by Subject|0|||
131134089|NCT00271817|472117291|FG001|Part 2|Withdrawal by Subject|2|||
131134090|NCT00271817|472117292|FG002|Part 2|Withdrawal by Subject|13|||
131134091|NCT00271817|472117290|FG000|Part 2|LDL < 50 mg/dL|0|||
131134092|NCT00271817|472117291|FG001|Part 2|LDL < 50 mg/dL|3|||
131134093|NCT00271817|472117292|FG002|Part 2|LDL < 50 mg/dL|4|||
131134094|NCT00861744|472117296|FG000|Overall Study|Adverse Event|0|||
131134095|NCT00861744|472117297|FG001|Overall Study|Adverse Event|0|||
131134096|NCT00861744|472117298|FG002|Overall Study|Adverse Event|0|||
130987097|NCT02798211|471579039|FG004|Period 2|Withdrawal of Informed Consent|2|||
130987098|NCT02798211|471579040|FG005|Period 2|Withdrawal of Informed Consent|3|||
130987099|NCT05292534|471579041|FG000|Overall Study|Protocol Violation|3|||
131047120|NCT04626427|471808072|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
130987100|NCT05292534|471579042|FG001|Overall Study|Protocol Violation|4|||
130987101|NCT05292534|471579041|FG000|Overall Study|Withdrawal by Subject|0|||
130987102|NCT05292534|471579042|FG001|Overall Study|Withdrawal by Subject|1|||
130987103|NCT01982435|471579043|FG000|Overall Study|Adverse Event|1|||
130987104|NCT01982435|471579044|FG001|Overall Study|Adverse Event|0|||
130987105|NCT03086018|471579045|FG000|Final Testing for End of Trial|Adverse Event|1|||
130987106|NCT03086018|471579045|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
130987107|NCT01892345|471579046|FG000|Overall Study|Adverse Event|0|||
130987108|NCT01892345|471579047|FG001|Overall Study|Adverse Event|2|||
130987109|NCT01892345|471579046|FG000|Overall Study|Death|1|||
130987110|NCT01892345|471579047|FG001|Overall Study|Death|0|||
130987111|NCT01892345|471579046|FG000|Overall Study|Lost to Follow-up|3|||
130987112|NCT01892345|471579047|FG001|Overall Study|Lost to Follow-up|0|||
130987113|NCT01892345|471579046|FG000|Overall Study|Withdrawal by Subject|12|||
130987114|NCT01892345|471579047|FG001|Overall Study|Withdrawal by Subject|1|||
130987115|NCT02748694|471579048|FG000|Overall Study|Voluntary Withdrawal|0|||
130987116|NCT02748694|471579049|FG001|Overall Study|Voluntary Withdrawal|0|||
130987117|NCT02748694|471579050|FG002|Overall Study|Voluntary Withdrawal|0|||
130987118|NCT02748694|471579051|FG003|Overall Study|Voluntary Withdrawal|0|||
130987119|NCT02748694|471579052|FG004|Overall Study|Voluntary Withdrawal|0|||
130987120|NCT02748694|471579053|FG005|Overall Study|Voluntary Withdrawal|0|||
130987121|NCT02748694|471579054|FG006|Overall Study|Voluntary Withdrawal|0|||
130987122|NCT02748694|471579055|FG007|Overall Study|Voluntary Withdrawal|0|||
130987123|NCT02748694|471579056|FG008|Overall Study|Voluntary Withdrawal|0|||
130987124|NCT02748694|471579057|FG009|Overall Study|Voluntary Withdrawal|0|||
130987125|NCT02748694|471579058|FG010|Overall Study|Voluntary Withdrawal|0|||
130987126|NCT02748694|471579059|FG011|Overall Study|Voluntary Withdrawal|0|||
130987127|NCT02748694|471579060|FG012|Overall Study|Voluntary Withdrawal|0|||
130987128|NCT02748694|471579061|FG013|Overall Study|Voluntary Withdrawal|0|||
130987129|NCT02748694|471579062|FG014|Overall Study|Voluntary Withdrawal|2|||
130987130|NCT01473381|471579063|FG000|Overall Study|Adverse Event|8|||
131134097|NCT00861744|472117299|FG003|Overall Study|Adverse Event|1|||
131134098|NCT00861744|472117296|FG000|Overall Study|Lost to Follow-up|7|||
131134099|NCT00861744|472117297|FG001|Overall Study|Lost to Follow-up|19|||
131134100|NCT00861744|472117298|FG002|Overall Study|Lost to Follow-up|17|||
131134101|NCT00861744|472117299|FG003|Overall Study|Lost to Follow-up|12|||
131134102|NCT00861744|472117296|FG000|Overall Study|Withdrawal by Subject|10|||
131134103|NCT00861744|472117297|FG001|Overall Study|Withdrawal by Subject|6|||
130721738|NCT00537303|470606304|FG001|Overall Study|Unclassified|7|||
130721739|NCT02085135|470606306|FG000|Overall Study|Adverse Event|4|||
130721740|NCT02085135|470606307|FG001|Overall Study|Adverse Event|7|||
130721741|NCT02085135|470606306|FG000|Overall Study|Lost to Follow-up|2|||
130721742|NCT02085135|470606307|FG001|Overall Study|Lost to Follow-up|2|||
130721743|NCT02085135|470606306|FG000|Overall Study|Withdrawal by Subject|3|||
130721744|NCT02085135|470606307|FG001|Overall Study|Withdrawal by Subject|0|||
130987131|NCT01473381|471579064|FG001|Overall Study|Adverse Event|20|||
130987132|NCT01473381|471579065|FG002|Overall Study|Adverse Event|25|||
130987133|NCT01473381|471579066|FG003|Overall Study|Adverse Event|17|||
130987134|NCT01473381|471579063|FG000|Overall Study|Insufficient Therapeutic Response|10|||
130987135|NCT01473381|471579064|FG001|Overall Study|Insufficient Therapeutic Response|1|||
130987136|NCT01473381|471579065|FG002|Overall Study|Insufficient Therapeutic Response|2|||
130987137|NCT01473381|471579066|FG003|Overall Study|Insufficient Therapeutic Response|3|||
130987138|NCT01473381|471579063|FG000|Overall Study|Protocol Violation|17|||
130987139|NCT01473381|471579064|FG001|Overall Study|Protocol Violation|23|||
130987140|NCT01473381|471579065|FG002|Overall Study|Protocol Violation|19|||
130987141|NCT01473381|471579066|FG003|Overall Study|Protocol Violation|17|||
130987142|NCT01473381|471579063|FG000|Overall Study|Withdrawal of Consent|20|||
130987143|NCT01473381|471579064|FG001|Overall Study|Withdrawal of Consent|21|||
130987144|NCT01473381|471579065|FG002|Overall Study|Withdrawal of Consent|20|||
130987145|NCT01473381|471579066|FG003|Overall Study|Withdrawal of Consent|26|||
130987146|NCT01473381|471579063|FG000|Overall Study|Lost to Follow-up|25|||
130987147|NCT01473381|471579064|FG001|Overall Study|Lost to Follow-up|28|||
130987148|NCT01473381|471579065|FG002|Overall Study|Lost to Follow-up|35|||
130987149|NCT01473381|471579066|FG003|Overall Study|Lost to Follow-up|23|||
130987150|NCT01473381|471579063|FG000|Overall Study|Other Reasons|0|||
130987151|NCT01473381|471579064|FG001|Overall Study|Other Reasons|0|||
130987152|NCT01473381|471579065|FG002|Overall Study|Other Reasons|1|||
130987153|NCT01473381|471579066|FG003|Overall Study|Other Reasons|3|||
130987154|NCT02487810|471579067|FG000|Overall Study|Withdrawal by Subject|1|||
130987155|NCT02487810|471579068|FG001|Overall Study|Withdrawal by Subject|0|||
130987156|NCT01889186|471579069|FG000|Overall Study|Adverse event- not related to progression|18|||
130987157|NCT01889186|471579070|FG001|Overall Study|Adverse event- not related to progression|5|||
130987158|NCT01889186|471579069|FG000|Overall Study|Adverse event- related to progression|7|||
130987159|NCT01889186|471579070|FG001|Overall Study|Adverse event- related to progression|2|||
130987160|NCT01889186|471579069|FG000|Overall Study|COVID-19 logistical restrictions|1|||
130987161|NCT01889186|471579070|FG001|Overall Study|COVID-19 logistical restrictions|0|||
130987162|NCT01889186|471579069|FG000|Overall Study|Investigator request|1|||
130987163|NCT01889186|471579070|FG001|Overall Study|Investigator request|1|||
130987164|NCT01889186|471579069|FG000|Overall Study|Progressive disease- Richter's|12|||
130987165|NCT01889186|471579070|FG001|Overall Study|Progressive disease- Richter's|7|||
130987166|NCT01889186|471579069|FG000|Overall Study|Progressive disease per protocol|46|||
130987167|NCT01889186|471579070|FG001|Overall Study|Progressive disease per protocol|17|||
130987168|NCT01889186|471579069|FG000|Overall Study|Stem cell transplant|2|||
130987169|NCT01889186|471579070|FG001|Overall Study|Stem cell transplant|1|||
130987170|NCT01889186|471579069|FG000|Overall Study|Withdrew consent|2|||
130987171|NCT01889186|471579070|FG001|Overall Study|Withdrew consent|3|||
130987172|NCT01889186|471579069|FG000|Overall Study|Other, not specified|18|||
130987173|NCT01889186|471579070|FG001|Overall Study|Other, not specified|15|||
130987174|NCT03056534|471579076|FG000|Overall Study|Participant withdrew consent|8|||
130987175|NCT03056534|471579076|FG000|Overall Study|Participant not able to return|6|||
130987176|NCT03056534|471579076|FG000|Overall Study|Lost to Follow-up|37|||
130987177|NCT03056534|471579076|FG000|Overall Study|Investigator judgment|1|||
130987178|NCT03056534|471579076|FG000|Overall Study|Death|4|||
130987179|NCT03056534|471579076|FG000|Overall Study|Adverse Event|1|||
130987180|NCT03056534|471579076|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
130987181|NCT04241094|471579083|FG000|Overall Study|Dropped out of treatment|4|||
130987182|NCT04241094|471579083|FG000|Overall Study|Ineligible after clinical assessment|2|||
130987183|NCT04241094|471579083|FG000|Overall Study|Lost to Follow-up|2|||
131047121|NCT03982186|471808073|FG000|Overall Study|Lost to Follow-up|0|||
131047122|NCT03982186|471808074|FG001|Overall Study|Lost to Follow-up|1|||
131047123|NCT03982186|471808075|FG002|Overall Study|Lost to Follow-up|2|||
130721745|NCT02085135|470606306|FG000|Overall Study|Lack of Efficacy|2|||
131047124|NCT03982186|471808076|FG003|Overall Study|Lost to Follow-up|1|||
131047125|NCT03982186|471808077|FG004|Overall Study|Lost to Follow-up|1|||
130721746|NCT02085135|470606307|FG001|Overall Study|Lack of Efficacy|0|||
130987184|NCT00316173|471579084|FG000|Run-in Phase|Adverse Event|1|||
131047126|NCT03982186|471808078|FG005|Overall Study|Lost to Follow-up|0|||
130721747|NCT01136967|470606309|FG000|Overall Study|Adverse Event|9|||
130721748|NCT01136967|470606310|FG001|Overall Study|Adverse Event|12|||
130987185|NCT00316173|471579085|FG001|Run-in Phase|Adverse Event|0|||
130987186|NCT00316173|471579084|FG000|Run-in Phase|Protocol Violation|1|||
130987187|NCT00316173|471579085|FG001|Run-in Phase|Protocol Violation|0|||
131047127|NCT03982186|471808073|FG000|Overall Study|Physician Decision|0|||
130721749|NCT01136967|470606309|FG000|Overall Study|Participant Choice|8|||
130987188|NCT00316173|471579084|FG000|Run-in Phase|Study Follow-up Stopped|5|||
130987189|NCT00316173|471579085|FG001|Run-in Phase|Study Follow-up Stopped|0|||
130987190|NCT00316173|471579084|FG000|Treatment Phase|Adverse Event|0|||
130987191|NCT00316173|471579085|FG001|Treatment Phase|Adverse Event|1|||
130987192|NCT00316173|471579084|FG000|Treatment Phase|Lack of Efficacy|0|||
130987193|NCT00316173|471579085|FG001|Treatment Phase|Lack of Efficacy|3|||
131134104|NCT00861744|472117298|FG002|Overall Study|Withdrawal by Subject|6|||
131134105|NCT00861744|472117299|FG003|Overall Study|Withdrawal by Subject|19|||
131134106|NCT00861744|472117296|FG000|Overall Study|Protocol Violation|0|||
131134107|NCT00861744|472117297|FG001|Overall Study|Protocol Violation|1|||
131134108|NCT00861744|472117298|FG002|Overall Study|Protocol Violation|0|||
131134109|NCT00861744|472117299|FG003|Overall Study|Protocol Violation|0|||
131134110|NCT00861744|472117296|FG000|Overall Study|Migration from study area|0|||
131134111|NCT00861744|472117297|FG001|Overall Study|Migration from study area|3|||
131134112|NCT00861744|472117298|FG002|Overall Study|Migration from study area|1|||
131134113|NCT00861744|472117299|FG003|Overall Study|Migration from study area|0|||
131134114|NCT00861744|472117296|FG000|Overall Study|Blood draws|0|||
131134115|NCT00861744|472117297|FG001|Overall Study|Blood draws|0|||
131134116|NCT00861744|472117298|FG002|Overall Study|Blood draws|0|||
131134117|NCT00861744|472117299|FG003|Overall Study|Blood draws|1|||
131134118|NCT05107765|472117300|FG000|Overall Study|Lost to Follow-up|4|||
131134119|NCT05107765|472117301|FG001|Overall Study|Lost to Follow-up|1|||
131134120|NCT05107765|472117300|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
130721750|NCT01136967|470606310|FG001|Overall Study|Participant Choice|3|||
130721751|NCT01136967|470606309|FG000|Overall Study|Lost to Follow-up|0|||
130721752|NCT01136967|470606310|FG001|Overall Study|Lost to Follow-up|1|||
130721753|NCT01136967|470606309|FG000|Overall Study|Withdrawal by Subject|1|||
130721754|NCT01136967|470606310|FG001|Overall Study|Withdrawal by Subject|2|||
130721755|NCT01136967|470606309|FG000|Overall Study|Clinical Progression|3|||
130721756|NCT01136967|470606310|FG001|Overall Study|Clinical Progression|5|||
130721757|NCT01136967|470606309|FG000|Overall Study|Radiation|1|||
130721758|NCT01136967|470606310|FG001|Overall Study|Radiation|0|||
130721759|NCT01136967|470606309|FG000|Overall Study|Non-compliance|1|||
130721760|NCT01136967|470606310|FG001|Overall Study|Non-compliance|0|||
130721761|NCT01136967|470606309|FG000|Overall Study|Investigator's Choice|1|||
130721762|NCT01136967|470606310|FG001|Overall Study|Investigator's Choice|1|||
130721763|NCT01136967|470606309|FG000|Overall Study|Increase in Lesion Size|0|||
130721764|NCT01136967|470606310|FG001|Overall Study|Increase in Lesion Size|2|||
130721765|NCT01136967|470606309|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
130721766|NCT01136967|470606310|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
130721767|NCT03839823|470606311|FG000|Overall Study|Adverse Event|8|||
130721768|NCT03839823|470606312|FG001|Overall Study|Adverse Event|4|||
130721769|NCT03839823|470606311|FG000|Overall Study|Death|1|||
130721770|NCT03839823|470606312|FG001|Overall Study|Death|0|||
130721771|NCT03839823|470606311|FG000|Overall Study|Physician Decision|1|||
130721772|NCT03839823|470606312|FG001|Overall Study|Physician Decision|5|||
130721773|NCT03839823|470606311|FG000|Overall Study|Progressive Disease (PD)|65|||
130721774|NCT03839823|470606312|FG001|Overall Study|Progressive Disease (PD)|65|||
130721775|NCT03839823|470606311|FG000|Overall Study|Subject Decision|2|||
130721776|NCT03839823|470606312|FG001|Overall Study|Subject Decision|9|||
130721777|NCT03839823|470606311|FG000|Overall Study|Not Treated|0|||
130721778|NCT03839823|470606312|FG001|Overall Study|Not Treated|10|||
130721779|NCT03151811|470606316|FG000|Overall Study|Randomized But Not Treated|18|||
130721780|NCT03151811|470606317|FG001|Overall Study|Randomized But Not Treated|3|||
130721781|NCT03151811|470606316|FG000|Overall Study|Progressive Disease|130|||
130721782|NCT03151811|470606317|FG001|Overall Study|Progressive Disease|170|||
130721783|NCT03151811|470606316|FG000|Overall Study|Adverse Event|49|||
130721784|NCT03151811|470606317|FG001|Overall Study|Adverse Event|40|||
130721785|NCT03151811|470606316|FG000|Overall Study|Lack of Efficacy|6|||
130721786|NCT03151811|470606317|FG001|Overall Study|Lack of Efficacy|8|||
130721787|NCT03151811|470606316|FG000|Overall Study|Physician Decision|21|||
130721788|NCT03151811|470606317|FG001|Overall Study|Physician Decision|9|||
130721789|NCT03151811|470606316|FG000|Overall Study|Withdrawal by Subject|17|||
130721790|NCT03151811|470606317|FG001|Overall Study|Withdrawal by Subject|7|||
130721791|NCT03151811|470606316|FG000|Overall Study|Lost to Follow-up|0|||
130721792|NCT03151811|470606317|FG001|Overall Study|Lost to Follow-up|1|||
130721793|NCT03151811|470606316|FG000|Overall Study|Study Terminated by Sponsor|5|||
130721794|NCT03151811|470606317|FG001|Overall Study|Study Terminated by Sponsor|11|||
130987194|NCT00316173|471579084|FG000|Treatment Phase|Lost to Follow-up|0|||
130987195|NCT00316173|471579085|FG001|Treatment Phase|Lost to Follow-up|3|||
130987196|NCT00316173|471579084|FG000|Treatment Phase|Withdrawal by Subject|0|||
130987197|NCT00316173|471579085|FG001|Treatment Phase|Withdrawal by Subject|1|||
130987198|NCT00316173|471579084|FG000|Treatment Phase|Study Follow-up Stopped|0|||
131134121|NCT05107765|472117301|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
131134122|NCT05107765|472117300|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
131134123|NCT05107765|472117301|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
131134124|NCT01411085|472117304|FG000|Overall Study|Physician Decision|1|||
131134125|NCT01411085|472117304|FG000|Overall Study|Protocol Violation|1|||
131047128|NCT03982186|471808074|FG001|Overall Study|Physician Decision|1|||
131047129|NCT03982186|471808075|FG002|Overall Study|Physician Decision|0|||
131047130|NCT03982186|471808076|FG003|Overall Study|Physician Decision|0|||
131047131|NCT03982186|471808077|FG004|Overall Study|Physician Decision|0|||
131047132|NCT03982186|471808078|FG005|Overall Study|Physician Decision|0|||
131047133|NCT03982186|471808073|FG000|Overall Study|Withdrawal by Subject|3|||
131047134|NCT03982186|471808074|FG001|Overall Study|Withdrawal by Subject|4|||
131047135|NCT03982186|471808075|FG002|Overall Study|Withdrawal by Subject|1|||
131047136|NCT03982186|471808076|FG003|Overall Study|Withdrawal by Subject|7|||
131047137|NCT03982186|471808077|FG004|Overall Study|Withdrawal by Subject|2|||
131047138|NCT03982186|471808078|FG005|Overall Study|Withdrawal by Subject|0|||
131047139|NCT03982186|471808073|FG000|Overall Study|Randomized and not treated|0|||
131047140|NCT03982186|471808074|FG001|Overall Study|Randomized and not treated|0|||
131047141|NCT03982186|471808075|FG002|Overall Study|Randomized and not treated|0|||
131047142|NCT03982186|471808076|FG003|Overall Study|Randomized and not treated|1|||
131047143|NCT03982186|471808077|FG004|Overall Study|Randomized and not treated|0|||
131047144|NCT03982186|471808078|FG005|Overall Study|Randomized and not treated|0|||
131047145|NCT01265537|471808079|FG000|Overall Study|Adverse Event|2|||
131047146|NCT01265537|471808080|FG001|Overall Study|Adverse Event|1|||
131047147|NCT01265537|471808079|FG000|Overall Study|Physician Decision|0|||
131134126|NCT01411085|472117304|FG000|Overall Study|Adverse Event|1|||
131134127|NCT03110224|472117305|FG000|Overall Study|Death|3|||
130721795|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
130721796|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
130721797|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
130721798|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
130721799|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
130721800|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
130721801|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
130721802|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
130721803|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
130721804|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
130721805|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Death|1|||
130721806|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Death|0|||
130721807|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Death|0|||
130721808|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Death|0|||
130721809|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Death|0|||
130721810|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
130721811|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
130721812|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
130721813|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
130721814|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
130721815|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
130721816|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
130721817|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
130721818|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
130721819|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
130721820|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
130721821|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
130721822|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
130721823|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
130721824|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
130721825|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
130721826|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
130721827|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
130721828|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
130721829|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130721830|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
130721831|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130721832|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130721833|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130721834|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
131047148|NCT01265537|471808080|FG001|Overall Study|Physician Decision|1|||
131047149|NCT05866926|471808081|FG000|Overall Study|Death|16|||
131047150|NCT05866926|471808082|FG001|Overall Study|Death|9|||
131047151|NCT05866926|471808081|FG000|Overall Study|Lost to Follow-up|0|||
131047152|NCT05866926|471808082|FG001|Overall Study|Lost to Follow-up|1|||
131047153|NCT05866926|471808081|FG000|Overall Study|Adverse Event|1|||
131047154|NCT05866926|471808082|FG001|Overall Study|Adverse Event|0|||
131047155|NCT05866926|471808081|FG000|Overall Study|Withdrawal by Subject|5|||
131047156|NCT05866926|471808082|FG001|Overall Study|Withdrawal by Subject|1|||
131134128|NCT03110224|472117305|FG000|Overall Study|Lost to Follow-up|132|||
130779111|NCT00705757|470817472|FG000|Overall Study|Withdrawal by Subject|1|||
130779112|NCT00705757|470817473|FG001|Overall Study|Withdrawal by Subject|1|||
130779113|NCT00705757|470817474|FG002|Overall Study|Withdrawal by Subject|2|||
130779114|NCT01411852|470817475|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
130779115|NCT01411852|470817476|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
130779116|NCT01411852|470817475|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
130779117|NCT01411852|470817476|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
130779118|NCT01411852|470817475|FG000|Prehospital Intervention Phase|Found to be under age|0|||
130779119|NCT01411852|470817476|FG001|Prehospital Intervention Phase|Found to be under age|1|||
130779120|NCT01411852|470817475|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
130779121|NCT01411852|470817476|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
130779122|NCT01411852|470817475|FG000|Hospital Intervention Phase|Severe head injury|5|||
130779123|NCT01411852|470817476|FG001|Hospital Intervention Phase|Severe head injury|4|||
130779124|NCT01411852|470817475|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
130779125|NCT01411852|470817476|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
130779126|NCT01411852|470817475|FG000|Hospital Intervention Phase|Miscommunication error|1|||
130779127|NCT01411852|470817476|FG001|Hospital Intervention Phase|Miscommunication error|2|||
130779128|NCT01411852|470817475|FG000|Hospital Intervention Phase|CPR administered|3|||
130779129|NCT01411852|470817476|FG001|Hospital Intervention Phase|CPR administered|1|||
130779130|NCT01411852|470817475|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
130779131|NCT01411852|470817476|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
130779132|NCT01411852|470817475|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
130779133|NCT01411852|470817476|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
130779134|NCT01411852|470817475|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
130779135|NCT01411852|470817476|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
130779136|NCT01411852|470817475|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
130779137|NCT01411852|470817476|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
130779138|NCT01411852|470817475|FG000|Hospital Intervention Phase|Other ineligible|2|||
130779139|NCT01411852|470817476|FG001|Hospital Intervention Phase|Other ineligible|2|||
130779140|NCT01411852|470817475|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
130779141|NCT01411852|470817476|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
130779142|NCT01411852|470817475|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
130779143|NCT01411852|470817476|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
130779144|NCT01411852|470817475|FG000|Hospital Intervention Phase|Vascular access failed|1|||
130779145|NCT01411852|470817476|FG001|Hospital Intervention Phase|Vascular access failed|0|||
130779146|NCT03743025|470817477|FG000|Overall Study|Surgery was cancelled|2|||
130779147|NCT03743025|470817478|FG001|Overall Study|Surgery was cancelled|1|||
130779148|NCT02420119|470817479|FG000|Overall Study|insufficient laboratory data|5|||
130779149|NCT00807885|470817480|FG000|Overall Study|Lost to Follow-up|0|||
130779150|NCT00807885|470817481|FG001|Overall Study|Lost to Follow-up|0|||
130779151|NCT00807885|470817482|FG002|Overall Study|Lost to Follow-up|0|||
130779152|NCT00807885|470817483|FG003|Overall Study|Lost to Follow-up|0|||
130779153|NCT00807885|470817484|FG004|Overall Study|Lost to Follow-up|0|||
130779154|NCT00807885|470817485|FG005|Overall Study|Lost to Follow-up|1|||
130779155|NCT00807885|470817486|FG006|Overall Study|Lost to Follow-up|0|||
130779156|NCT00807885|470817487|FG007|Overall Study|Lost to Follow-up|0|||
130779157|NCT00807885|470817488|FG008|Overall Study|Lost to Follow-up|0|||
130779158|NCT03126786|470817489|FG000|Overall Study|Adverse Event|3|||
130779159|NCT03126786|470817490|FG001|Overall Study|Adverse Event|0|||
130779160|NCT03126786|470817489|FG000|Overall Study|Lost to Follow-up|0|||
130779161|NCT03126786|470817490|FG001|Overall Study|Lost to Follow-up|1|||
130779162|NCT03126786|470817489|FG000|Overall Study|Withdrawal by Subject|3|||
130779163|NCT03126786|470817490|FG001|Overall Study|Withdrawal by Subject|1|||
130779164|NCT00227539|470817491|FG000|Overall Study|Protocol Violation|1|||
130779165|NCT00991289|470817492|FG000|Overall Study|Adverse Event|1|||
130779166|NCT00991289|470817492|FG000|Overall Study|Physician Decision|2|||
130779167|NCT00991289|470817492|FG000|Overall Study|Withdrawal by Subject|3|||
130779168|NCT00991289|470817492|FG000|Overall Study|Lost to Follow-up|4|||
130779169|NCT00991289|470817492|FG000|Overall Study|Protocol Violation|2|||
130779170|NCT00426764|470817493|FG000|Overall Study|Protocol Violation|1|||
130987199|NCT00316173|471579085|FG001|Treatment Phase|Study Follow-up Stopped|34|||
130779171|NCT00426764|470817493|FG000|Overall Study|Withdrawal by Subject|4|||
130779172|NCT00426764|470817493|FG000|Overall Study|Physician Decision|6|||
130779173|NCT00426764|470817493|FG000|Overall Study|Compassionate Use|1|||
130987200|NCT03764072|471579086|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
130779174|NCT00426764|470817493|FG000|Overall Study|Progressive Disease|83|||
130779175|NCT00426764|470817493|FG000|Overall Study|Adverse Event|24|||
130779176|NCT00426764|470817493|FG000|Overall Study|Other|1|||
130779177|NCT00426764|470817493|FG000|Overall Study|Death|1|||
130779178|NCT00426764|470817493|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
130779179|NCT03804268|470817496|FG000|Overall Study|Adverse Event|2|||
130779180|NCT03804268|470817497|FG001|Overall Study|Adverse Event|2|||
131047157|NCT05866926|471808081|FG000|Overall Study|Disease progression|1|||
130721835|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Other|4|||
130721836|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Other|4|||
130721837|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Other|3|||
130721838|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Other|1|||
130987201|NCT03764072|471579087|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
130987202|NCT03764072|471579088|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
130987203|NCT03764072|471579089|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
130987204|NCT03764072|471579090|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
130987205|NCT03764072|471579091|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
130987206|NCT03764072|471579086|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
130987207|NCT03764072|471579087|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
130987208|NCT03764072|471579088|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
130987209|NCT03764072|471579089|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
130987210|NCT03764072|471579090|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
130987211|NCT03764072|471579091|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
130987212|NCT03764072|471579086|FG000|Overall Study|Lost to Follow-up|0|||
130987213|NCT03764072|471579087|FG001|Overall Study|Lost to Follow-up|0|||
130987214|NCT03764072|471579088|FG002|Overall Study|Lost to Follow-up|0|||
130987215|NCT03764072|471579089|FG003|Overall Study|Lost to Follow-up|0|||
130987216|NCT03764072|471579090|FG004|Overall Study|Lost to Follow-up|1|||
130987217|NCT03764072|471579091|FG005|Overall Study|Lost to Follow-up|0|||
130987218|NCT03750006|471579098|FG000|Overall Study|Withdrawal by Subject|8|||
130987219|NCT03750006|471579098|FG000|Overall Study|COVID PANDEMIC|11|||
130987220|NCT04739761|471579105|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
130987221|NCT04739761|471579106|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
130987222|NCT04739761|471579105|FG000|Overall Study|By complete response from the participant|1|||
130987223|NCT04739761|471579106|FG001|Overall Study|By complete response from the participant|0|||
130987224|NCT04739761|471579105|FG000|Overall Study|Lost to Follow-up|3|||
130987225|NCT04739761|471579106|FG001|Overall Study|Lost to Follow-up|3|||
130987226|NCT04739761|471579105|FG000|Overall Study|Death|13|||
130987227|NCT04739761|471579106|FG001|Overall Study|Death|13|||
130987228|NCT04739761|471579105|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
130987229|NCT04739761|471579106|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
130987230|NCT04739761|471579105|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
130987231|NCT04739761|471579106|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
130987232|NCT04739761|471579105|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
130987233|NCT04739761|471579106|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
130987234|NCT04739761|471579105|FG000|Overall Study|Adverse Event|0|||
130987235|NCT04739761|471579106|FG001|Overall Study|Adverse Event|3|||
130987236|NCT04739761|471579105|FG000|Overall Study|Participant decision|1|||
130987237|NCT04739761|471579106|FG001|Overall Study|Participant decision|0|||
130987238|NCT04739761|471579105|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
130987239|NCT04739761|471579106|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
130987240|NCT04739761|471579105|FG000|Overall Study|Participant immediately started next line of treatment|1|||
130987241|NCT04739761|471579106|FG001|Overall Study|Participant immediately started next line of treatment|0|||
130987242|NCT04739761|471579105|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
130987243|NCT04739761|471579106|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
130987244|NCT04739761|471579105|FG000|Overall Study|Lack of clinical benefit|1|||
130987245|NCT04739761|471579106|FG001|Overall Study|Lack of clinical benefit|0|||
130987246|NCT04739761|471579105|FG000|Overall Study|Disease progression|5|||
130987247|NCT04739761|471579106|FG001|Overall Study|Disease progression|5|||
130987248|NCT04739761|471579105|FG000|Overall Study|Withdrawal by Subject|14|||
130987249|NCT04739761|471579106|FG001|Overall Study|Withdrawal by Subject|13|||
130987250|NCT04739761|471579105|FG000|Overall Study|Protocol Violation|1|||
130987251|NCT04739761|471579106|FG001|Overall Study|Protocol Violation|0|||
130987252|NCT04739761|471579105|FG000|Overall Study|Physician Decision|2|||
130987253|NCT04739761|471579106|FG001|Overall Study|Physician Decision|0|||
130987254|NCT03881696|471579107|FG000|Overall Study|Adverse Event|2|||
130987255|NCT03881696|471579108|FG001|Overall Study|Adverse Event|0|||
131047158|NCT05866926|471808082|FG001|Overall Study|Disease progression|0|||
130721839|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Other|0|||
130721840|NCT01081834|470606321|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
130721841|NCT01081834|470606322|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
130987256|NCT03881696|471579107|FG000|Overall Study|Withdrawal by Subject|2|||
130987257|NCT03881696|471579108|FG001|Overall Study|Withdrawal by Subject|0|||
130987258|NCT03881696|471579107|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
131047159|NCT05866926|471808081|FG000|Overall Study|other causes|2|||
130721842|NCT01081834|470606323|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130987259|NCT03881696|471579108|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
130721843|NCT01081834|470606324|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130987260|NCT03881696|471579107|FG000|Overall Study|Failure to meet continuation criteria|1|||
130987261|NCT03881696|471579108|FG001|Overall Study|Failure to meet continuation criteria|0|||
130987262|NCT01061333|471579110|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
130987263|NCT01061333|471579111|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
131047160|NCT05866926|471808082|FG001|Overall Study|other causes|1|||
131047161|NCT03635567|471808551|FG000|Overall Study|Lost to Follow-up|4|||
131047162|NCT03635567|471808552|FG001|Overall Study|Lost to Follow-up|1|||
131047163|NCT03635567|471808551|FG000|Overall Study|Withdrawal by Subject|11|||
131047164|NCT03635567|471808552|FG001|Overall Study|Withdrawal by Subject|16|||
131047165|NCT03635567|471808551|FG000|Overall Study|Sponsor Decision|99|||
131047166|NCT03635567|471808552|FG001|Overall Study|Sponsor Decision|57|||
131047167|NCT03635567|471808551|FG000|Overall Study|Death|194|||
131047168|NCT03635567|471808552|FG001|Overall Study|Death|235|||
131047169|NCT01880515|471808554|FG000|Overall Study|Lost to Follow-up|3|||
131047170|NCT01880515|471808555|FG001|Overall Study|Lost to Follow-up|2|||
131047171|NCT01880515|471808554|FG000|Overall Study|Disease Progression|5|||
131047172|NCT01880515|471808555|FG001|Overall Study|Disease Progression|7|||
131047173|NCT02076009|471808556|FG000|Overall Study|Death|172|||
131047174|NCT02076009|471808557|FG001|Overall Study|Death|153|||
131047175|NCT02076009|471808556|FG000|Overall Study|Withdrawal by Subject|16|||
131047176|NCT02076009|471808557|FG001|Overall Study|Withdrawal by Subject|12|||
131047177|NCT02076009|471808556|FG000|Overall Study|Lost to Follow-up|4|||
131047178|NCT02076009|471808557|FG001|Overall Study|Lost to Follow-up|2|||
131047179|NCT02076009|471808556|FG000|Overall Study|Progressive Disease|1|||
131047180|NCT02076009|471808557|FG001|Overall Study|Progressive Disease|0|||
131047181|NCT02076009|471808556|FG000|Overall Study|Physician Decision|0|||
131047182|NCT02076009|471808557|FG001|Overall Study|Physician Decision|1|||
131047183|NCT02076009|471808556|FG000|Overall Study|End of data collection|90|||
131047184|NCT02076009|471808557|FG001|Overall Study|End of data collection|118|||
131047185|NCT04165213|471808558|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
131047186|NCT04165213|471808559|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
131047187|NCT04165213|471808558|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
131047188|NCT04165213|471808559|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
131047189|NCT04165213|471808558|FG000|Clinician Enrollment|Termination from site|0|||
131047190|NCT04165213|471808559|FG001|Clinician Enrollment|Termination from site|1|||
131047191|NCT04165213|471808558|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
131047192|NCT04165213|471808559|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
131047193|NCT04165213|471808558|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
131047194|NCT04165213|471808559|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
131047195|NCT04165213|471808558|FG000|Caregiver Enrollment|Physician Decision|1|||
131047196|NCT04165213|471808559|FG001|Caregiver Enrollment|Physician Decision|0|||
131047197|NCT04165213|471808558|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
131047198|NCT04165213|471808559|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
131047199|NCT04165213|471808558|FG000|Caregiver Enrollment|PLWD death|2|||
131047200|NCT04165213|471808559|FG001|Caregiver Enrollment|PLWD death|0|||
131047201|NCT04165213|471808558|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
131047202|NCT04165213|471808559|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
131047203|NCT04165213|471808558|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
131047204|NCT04165213|471808559|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
131047205|NCT04165213|471808558|FG000|PLWD Enrollment|Lost to Follow-up|1|||
131047206|NCT04165213|471808559|FG001|PLWD Enrollment|Lost to Follow-up|1|||
131047207|NCT04165213|471808558|FG000|PLWD Enrollment|Physician Decision|1|||
131047208|NCT04165213|471808559|FG001|PLWD Enrollment|Physician Decision|0|||
131047209|NCT04165213|471808558|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
131047210|NCT04165213|471808559|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
131047211|NCT04165213|471808558|FG000|PLWD Enrollment|Death|2|||
131047212|NCT04165213|471808559|FG001|PLWD Enrollment|Death|0|||
131047213|NCT04165213|471808558|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
131047214|NCT04165213|471808559|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
131047215|NCT04933474|471808560|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
131047216|NCT04933474|471808561|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
131047217|NCT04933474|471808560|FG000|Overall Study|Lost to Follow-up|19|||
131047218|NCT04933474|471808561|FG001|Overall Study|Lost to Follow-up|9|||
131047219|NCT04933474|471808560|FG000|Overall Study|Life Burden - unable to participate|6|||
131047220|NCT04933474|471808561|FG001|Overall Study|Life Burden - unable to participate|2|||
131047221|NCT04933474|471808560|FG000|Overall Study|Disease Burden - unable to participate|4|||
131047222|NCT04933474|471808561|FG001|Overall Study|Disease Burden - unable to participate|1|||
131047223|NCT04933474|471808560|FG000|Overall Study|Surgery/Hospitalization|1|||
131047224|NCT04933474|471808561|FG001|Overall Study|Surgery/Hospitalization|2|||
131047225|NCT04933474|471808560|FG000|Overall Study|Dissatisfied with Intervention|1|||
131047226|NCT04933474|471808561|FG001|Overall Study|Dissatisfied with Intervention|1|||
131047227|NCT04933474|471808560|FG000|Overall Study|Withdrew interest in participation|1|||
131047228|NCT04933474|471808561|FG001|Overall Study|Withdrew interest in participation|0|||
131047229|NCT04933474|471808560|FG000|Overall Study|Had previously enrolled in the study|0|||
130721844|NCT01081834|470606325|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130721845|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130721846|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130721847|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130721848|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
131047230|NCT04933474|471808561|FG001|Overall Study|Had previously enrolled in the study|1|||
131047231|NCT05988398|471808575|FG000|Overall Study|Lack of time|21|||
131047232|NCT05988398|471808576|FG001|Overall Study|Lack of time|0|||
131047233|NCT05988398|471808575|FG000|Overall Study|Absent from school|0|||
131047234|NCT05988398|471808576|FG001|Overall Study|Absent from school|38|||
131047235|NCT05988398|471808575|FG000|Overall Study|Chose not to participate|0|||
131047236|NCT05988398|471808576|FG001|Overall Study|Chose not to participate|42|||
131047237|NCT05988398|471808575|FG000|Overall Study|Other commitments (e.g., sports)|0|||
131047238|NCT05988398|471808576|FG001|Overall Study|Other commitments (e.g., sports)|25|||
131047239|NCT00942734|471808581|FG000|Overall Study|Adverse Event|2|||
131047240|NCT00942734|471808581|FG000|Overall Study|Protocol Violation|3|||
131047241|NCT00942734|471808581|FG000|Overall Study|Disease Progression|2|||
131047242|NCT00942734|471808581|FG000|Overall Study|Physician Decision|1|||
131047243|NCT03816397|471808582|FG000|Overall Study|Censored at interim analysis date.|13|||
131047244|NCT03816397|471808583|FG001|Overall Study|Censored at interim analysis date.|6|||
131047245|NCT03816397|471808582|FG000|Overall Study|Withdrawal by Subject|1|||
131047246|NCT03816397|471808583|FG001|Overall Study|Withdrawal by Subject|1|||
131047247|NCT02777593|471808595|FG000|Overall Study|Still in study|1|||
131047248|NCT02777593|471808596|FG001|Overall Study|Still in study|32|||
131047249|NCT02777593|471808597|FG002|Overall Study|Still in study|3|||
131047250|NCT02777593|471808598|FG003|Overall Study|Still in study|6|||
131047251|NCT02777593|471808599|FG004|Overall Study|Still in study|5|||
131047252|NCT02777593|471808595|FG000|Overall Study|Death|21|||
131047253|NCT02777593|471808596|FG001|Overall Study|Death|28|||
131047254|NCT02777593|471808597|FG002|Overall Study|Death|0|||
131047255|NCT02777593|471808598|FG003|Overall Study|Death|5|||
131047256|NCT02777593|471808599|FG004|Overall Study|Death|0|||
131047257|NCT02777593|471808595|FG000|Overall Study|Withdrawal by Subject|8|||
131047258|NCT02777593|471808596|FG001|Overall Study|Withdrawal by Subject|4|||
131047259|NCT02777593|471808597|FG002|Overall Study|Withdrawal by Subject|1|||
131047260|NCT02777593|471808598|FG003|Overall Study|Withdrawal by Subject|1|||
131047261|NCT02777593|471808599|FG004|Overall Study|Withdrawal by Subject|0|||
131047262|NCT02777593|471808595|FG000|Overall Study|Lost to Follow-up|8|||
131047263|NCT02777593|471808596|FG001|Overall Study|Lost to Follow-up|16|||
131047264|NCT02777593|471808597|FG002|Overall Study|Lost to Follow-up|5|||
131047265|NCT02777593|471808598|FG003|Overall Study|Lost to Follow-up|0|||
131047266|NCT02777593|471808599|FG004|Overall Study|Lost to Follow-up|1|||
131047267|NCT02777593|471808595|FG000|Overall Study|Physician Decision|2|||
131047268|NCT02777593|471808596|FG001|Overall Study|Physician Decision|2|||
131047269|NCT02777593|471808597|FG002|Overall Study|Physician Decision|0|||
130721849|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130721850|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Death|1|||
130721851|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Death|0|||
130721852|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Death|0|||
130721853|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Death|0|||
130721854|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Death|0|||
130721855|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
131047270|NCT02777593|471808598|FG003|Overall Study|Physician Decision|0|||
131047271|NCT02777593|471808599|FG004|Overall Study|Physician Decision|0|||
131047272|NCT02777593|471808595|FG000|Overall Study|Discontinued due to Other|1|||
131047273|NCT02777593|471808596|FG001|Overall Study|Discontinued due to Other|0|||
131047274|NCT02777593|471808597|FG002|Overall Study|Discontinued due to Other|0|||
131047275|NCT02777593|471808598|FG003|Overall Study|Discontinued due to Other|0|||
131047276|NCT02777593|471808599|FG004|Overall Study|Discontinued due to Other|0|||
131134129|NCT03110224|472117305|FG000|Overall Study|Physician Decision|2|||
131047277|NCT05485935|471808600|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
131047278|NCT05485935|471808601|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
131047279|NCT05485935|471808600|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
131047280|NCT05485935|471808601|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
131047281|NCT05485935|471808600|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
131047282|NCT05485935|471808601|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
131047283|NCT05485935|471808600|FG000|Period 2 (T2 and V3)|loss of contact|0|||
131047284|NCT05485935|471808601|FG001|Period 2 (T2 and V3)|loss of contact|1|||
131047285|NCT05129501|471808605|FG000|Overall Study|Lost to Follow-up|54|||
131134130|NCT03110224|472117305|FG000|Overall Study|Site Closed by Physician|35|||
131047286|NCT05129501|471808606|FG001|Overall Study|Lost to Follow-up|41|||
131047287|NCT01220531|471808609|FG000|Overall Study|Death|7|||
131134131|NCT03110224|472117305|FG000|Overall Study|Site Closed by Sponsor|202|||
131047288|NCT01220531|471808609|FG000|Overall Study|Lost to Follow-up|1|||
131047289|NCT02325154|471808610|FG000|Overall Study|Physician Decision|1|||
130779181|NCT03804268|470817496|FG000|Overall Study|Withdrawal by Subject|2|||
130779182|NCT03804268|470817497|FG001|Overall Study|Withdrawal by Subject|0|||
130779183|NCT03804268|470817496|FG000|Overall Study|Lost to Follow-up|1|||
130779184|NCT03804268|470817497|FG001|Overall Study|Lost to Follow-up|0|||
130779185|NCT03804268|470817496|FG000|Overall Study|Physician Decision|2|||
130779186|NCT03804268|470817497|FG001|Overall Study|Physician Decision|0|||
130779187|NCT02716779|470817498|FG000|Monotherapy|Adverse Event|0|||
130779188|NCT02716779|470817499|FG001|Monotherapy|Adverse Event|1|||
130779189|NCT02716779|470817500|FG002|Monotherapy|Adverse Event|1|||
130779190|NCT02716779|470817498|FG000|Combination Therapy|Adverse Event|0|||
130779191|NCT02716779|470817499|FG001|Combination Therapy|Adverse Event|2|||
130779192|NCT02716779|470817500|FG002|Combination Therapy|Adverse Event|1|||
130779193|NCT01843803|470817503|FG000|Overall Study|not a Veteran, did not see provider|1|||
130779194|NCT01843803|470817504|FG001|Overall Study|not a Veteran, did not see provider|3|||
130779195|NCT01051817|470817512|FG000|Overall Study|Adverse Event|0|||
130779196|NCT01051817|470817513|FG001|Overall Study|Adverse Event|2|||
130779197|NCT01051817|470817512|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
130779198|NCT01051817|470817513|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
130779199|NCT01051817|470817512|FG000|Overall Study|Withdrawal by Subject|3|||
130779200|NCT01051817|470817513|FG001|Overall Study|Withdrawal by Subject|5|||
130779201|NCT01051817|470817512|FG000|Overall Study|Protocol Violation|0|||
131047290|NCT02611687|471809253|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
131047291|NCT02611687|471809254|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
131047292|NCT00447980|471809258|FG000|Overall Study|Withdrawal by Subject|1|||
131047293|NCT00447980|471809259|FG001|Overall Study|Withdrawal by Subject|1|||
131047294|NCT00447980|471809260|FG002|Overall Study|Withdrawal by Subject|4|||
131047295|NCT00447980|471809261|FG003|Overall Study|Withdrawal by Subject|4|||
131047296|NCT00447980|471809258|FG000|Overall Study|Lost to Follow-up|1|||
131047297|NCT00447980|471809259|FG001|Overall Study|Lost to Follow-up|1|||
131047298|NCT00447980|471809260|FG002|Overall Study|Lost to Follow-up|0|||
131047299|NCT00447980|471809261|FG003|Overall Study|Lost to Follow-up|0|||
131047300|NCT00447980|471809258|FG000|Overall Study|Did not proceed with surgery|3|||
131047301|NCT00447980|471809259|FG001|Overall Study|Did not proceed with surgery|3|||
131047302|NCT00447980|471809260|FG002|Overall Study|Did not proceed with surgery|2|||
131047303|NCT00447980|471809261|FG003|Overall Study|Did not proceed with surgery|2|||
131047304|NCT05157841|471809262|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
131047305|NCT05157841|471809263|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
131047306|NCT05157841|471809264|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
131047307|NCT05157841|471809262|FG000|Part A (14 Days)|Adverse Event|1|||
131047308|NCT05157841|471809263|FG001|Part A (14 Days)|Adverse Event|0|||
131047309|NCT05157841|471809264|FG002|Part A (14 Days)|Adverse Event|0|||
131047310|NCT05157841|471809262|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
131047311|NCT05157841|471809263|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
131047312|NCT05157841|471809264|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
131047313|NCT03242915|471809271|FG000|Overall Study|Adverse Event|5|||
131047314|NCT03242915|471809272|FG001|Overall Study|Adverse Event|1|||
131047315|NCT03242915|471809271|FG000|Overall Study|Withdrawal by Subject|0|||
131047316|NCT03242915|471809272|FG001|Overall Study|Withdrawal by Subject|2|||
131047317|NCT03242915|471809271|FG000|Overall Study|Physician Decision|4|||
131047318|NCT03242915|471809272|FG001|Overall Study|Physician Decision|1|||
131047319|NCT04908930|471809281|FG000|Overall Study|Lost to Follow-up|1|||
131047320|NCT04908930|471809282|FG001|Overall Study|Lost to Follow-up|1|||
131047321|NCT04908930|471809283|FG002|Overall Study|Lost to Follow-up|0|||
131047322|NCT04908930|471809284|FG003|Overall Study|Lost to Follow-up|0|||
131047323|NCT04908930|471809285|FG004|Overall Study|Lost to Follow-up|0|||
131047324|NCT04908930|471809281|FG000|Overall Study|hardware in mouth|1|||
131047325|NCT04908930|471809282|FG001|Overall Study|hardware in mouth|1|||
131047326|NCT04908930|471809283|FG002|Overall Study|hardware in mouth|0|||
131047327|NCT04908930|471809284|FG003|Overall Study|hardware in mouth|0|||
131047328|NCT04908930|471809285|FG004|Overall Study|hardware in mouth|0|||
131047329|NCT04908930|471809281|FG000|Overall Study|wrong team|1|||
131047330|NCT04908930|471809282|FG001|Overall Study|wrong team|0|||
131047331|NCT04908930|471809283|FG002|Overall Study|wrong team|0|||
131047332|NCT04908930|471809284|FG003|Overall Study|wrong team|0|||
131047333|NCT04908930|471809285|FG004|Overall Study|wrong team|0|||
130779202|NCT01051817|470817513|FG001|Overall Study|Protocol Violation|1|||
130779203|NCT02989402|470817514|FG000|Overall Study|Adverse event, or serious adverse event|4|||
130779204|NCT02989402|470817514|FG000|Overall Study|Death|2|||
131047334|NCT04908930|471809281|FG000|Overall Study|quit team|2|||
131047335|NCT04908930|471809282|FG001|Overall Study|quit team|4|||
131047336|NCT04908930|471809283|FG002|Overall Study|quit team|0|||
131047337|NCT04908930|471809284|FG003|Overall Study|quit team|0|||
131047338|NCT04908930|471809285|FG004|Overall Study|quit team|0|||
131047339|NCT04908930|471809281|FG000|Overall Study|Withdrawal by Subject|1|||
131047340|NCT04908930|471809282|FG001|Overall Study|Withdrawal by Subject|2|||
131047341|NCT04908930|471809283|FG002|Overall Study|Withdrawal by Subject|0|||
131134132|NCT03110224|472117305|FG000|Overall Study|Withdrawal by Subject|9|||
131134133|NCT03809611|472117306|FG000|Overall Study|Withdrawal by Subject|1|||
131134134|NCT03809611|472117307|FG001|Overall Study|Withdrawal by Subject|1|||
131134135|NCT02193074|472117308|FG000|Overall Study|Withdrawal by Subject|1|||
131134136|NCT02193074|472117309|FG001|Overall Study|Withdrawal by Subject|2|||
131134137|NCT02193074|472117308|FG000|Overall Study|Adverse Event|16|||
131134138|NCT02193074|472117309|FG001|Overall Study|Adverse Event|13|||
131134139|NCT03124563|472117310|FG000|Overall Study|Lost to Follow-up|1|||
131134140|NCT03124563|472117311|FG001|Overall Study|Lost to Follow-up|1|||
131134141|NCT03124563|472117310|FG000|Overall Study|Withdrawal by Subject|1|||
131134142|NCT03124563|472117311|FG001|Overall Study|Withdrawal by Subject|1|||
131134143|NCT01534533|472117312|FG000|Overall Study|Lost to Follow-up|3|||
131134144|NCT01534533|472117313|FG001|Overall Study|Lost to Follow-up|0|||
131134145|NCT01534533|472117314|FG002|Overall Study|Lost to Follow-up|4|||
131134146|NCT01534533|472117315|FG003|Overall Study|Lost to Follow-up|3|||
131134147|NCT01534533|472117312|FG000|Overall Study|Withdrawal by Subject|5|||
131134148|NCT01534533|472117313|FG001|Overall Study|Withdrawal by Subject|3|||
131134149|NCT01534533|472117314|FG002|Overall Study|Withdrawal by Subject|4|||
131134150|NCT01534533|472117315|FG003|Overall Study|Withdrawal by Subject|1|||
131134151|NCT02028455|472117316|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
131134152|NCT02028455|472117317|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
131134153|NCT02028455|472117318|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
131134154|NCT02028455|472117319|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130721856|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
130721857|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130721858|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130721859|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130721860|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130721861|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130721862|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130721863|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130721864|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130721865|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130721866|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
130721867|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
131047342|NCT04908930|471809284|FG003|Overall Study|Withdrawal by Subject|0|||
131047343|NCT04908930|471809285|FG004|Overall Study|Withdrawal by Subject|0|||
131047344|NCT04908930|471809281|FG000|Overall Study|parent not liking program|0|||
131047345|NCT04908930|471809282|FG001|Overall Study|parent not liking program|1|||
131047346|NCT04908930|471809283|FG002|Overall Study|parent not liking program|0|||
131047347|NCT04908930|471809284|FG003|Overall Study|parent not liking program|0|||
131047348|NCT04908930|471809285|FG004|Overall Study|parent not liking program|0|||
131047349|NCT05718687|471809293|FG000|Overall Study|Withdrawal by Subject|3|||
131047350|NCT03092674|471809294|FG000|Overall Study|Adverse Event or Side Effects|1|||
131047351|NCT03092674|471809295|FG001|Overall Study|Adverse Event or Side Effects|4|||
131047352|NCT03092674|471809296|FG002|Overall Study|Adverse Event or Side Effects|4|||
131047353|NCT03092674|471809294|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
131047354|NCT03092674|471809295|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
131047355|NCT03092674|471809296|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
131047356|NCT03092674|471809294|FG000|Overall Study|Progression/Relapse|5|||
131047357|NCT03092674|471809295|FG001|Overall Study|Progression/Relapse|4|||
131047358|NCT03092674|471809296|FG002|Overall Study|Progression/Relapse|8|||
131047359|NCT03092674|471809294|FG000|Overall Study|Death|4|||
131047360|NCT03092674|471809295|FG001|Overall Study|Death|8|||
131047361|NCT03092674|471809296|FG002|Overall Study|Death|2|||
131047362|NCT03092674|471809294|FG000|Overall Study|Other - Not Protocol Specified|11|||
131047363|NCT03092674|471809295|FG001|Overall Study|Other - Not Protocol Specified|8|||
131047364|NCT03092674|471809296|FG002|Overall Study|Other - Not Protocol Specified|8|||
131047365|NCT00709956|471809297|FG000|Overall Study|Withdrawal by Subject|1|||
131134155|NCT02028455|472117320|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
131134156|NCT02028455|472117321|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130721868|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130721869|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
131047366|NCT00709956|471809298|FG001|Overall Study|Withdrawal by Subject|1|||
131047367|NCT00709956|471809297|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
131047368|NCT00709956|471809298|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
131047369|NCT03008382|471809299|FG000|Overall Study|Withdrawal by Subject|2|||
131047370|NCT03008382|471809300|FG001|Overall Study|Withdrawal by Subject|5|||
131047371|NCT03008382|471809301|FG002|Overall Study|Withdrawal by Subject|2|||
131047372|NCT03008382|471809302|FG003|Overall Study|Withdrawal by Subject|0|||
131047373|NCT03008382|471809299|FG000|Overall Study|Protocol Violation|1|||
131047374|NCT03008382|471809300|FG001|Overall Study|Protocol Violation|0|||
131047375|NCT03008382|471809301|FG002|Overall Study|Protocol Violation|0|||
131047376|NCT03008382|471809302|FG003|Overall Study|Protocol Violation|0|||
131047377|NCT03008382|471809299|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
131047378|NCT03008382|471809300|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
131047379|NCT03008382|471809301|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
131047380|NCT03008382|471809302|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
131047381|NCT03008382|471809299|FG000|Overall Study|Lost to Follow-up|0|||
131047382|NCT03008382|471809300|FG001|Overall Study|Lost to Follow-up|0|||
131047383|NCT03008382|471809301|FG002|Overall Study|Lost to Follow-up|1|||
131047384|NCT03008382|471809302|FG003|Overall Study|Lost to Follow-up|0|||
131047385|NCT03008382|471809299|FG000|Overall Study|Screenfail|0|||
131047386|NCT03008382|471809300|FG001|Overall Study|Screenfail|0|||
131047387|NCT03008382|471809301|FG002|Overall Study|Screenfail|2|||
131047388|NCT03008382|471809302|FG003|Overall Study|Screenfail|0|||
131047389|NCT03782116|471809303|FG000|Completed Intervetion|Lost to Follow-up|11|||
131047390|NCT03782116|471809304|FG001|Completed Intervetion|Lost to Follow-up|7|||
131047391|NCT03782116|471809303|FG000|Completed Intervetion|Withdrawal by Subject|6|||
131047392|NCT03782116|471809304|FG001|Completed Intervetion|Withdrawal by Subject|5|||
131047393|NCT03782116|471809303|FG000|Included in Analysis|Protocol Violation|5|||
131047394|NCT03782116|471809304|FG001|Included in Analysis|Protocol Violation|5|||
131047395|NCT03215706|471809305|FG000|Randomization|Adverse Event unrelated to study drug|1|||
131047396|NCT03215706|471809306|FG001|Randomization|Adverse Event unrelated to study drug|0|||
131047397|NCT03215706|471809305|FG000|Randomization|participant withdrew consent|1|||
131047398|NCT03215706|471809306|FG001|Randomization|participant withdrew consent|3|||
131047399|NCT03215706|471809305|FG000|Randomization|no longer meets study criteria|1|||
131047400|NCT03215706|471809306|FG001|Randomization|no longer meets study criteria|4|||
131047401|NCT03215706|471809305|FG000|Randomization|other reasons|0|||
131047402|NCT03215706|471809306|FG001|Randomization|other reasons|2|||
131047403|NCT03215706|471809305|FG000|Treatment Period|Disease Progression|150|||
131047404|NCT03215706|471809306|FG001|Treatment Period|Disease Progression|142|||
131047405|NCT03215706|471809305|FG000|Treatment Period|Study Drug Toxicity|53|||
131047406|NCT03215706|471809306|FG001|Treatment Period|Study Drug Toxicity|21|||
131047407|NCT03215706|471809305|FG000|Treatment Period|Death|2|||
131047408|NCT03215706|471809306|FG001|Treatment Period|Death|1|||
131047409|NCT03215706|471809305|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
131047410|NCT03215706|471809306|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
131047411|NCT03215706|471809305|FG000|Treatment Period|Request to D/C treatment|1|||
131047412|NCT03215706|471809306|FG001|Treatment Period|Request to D/C treatment|6|||
131047413|NCT03215706|471809305|FG000|Treatment Period|Participant withdrew consent|3|||
131047414|NCT03215706|471809306|FG001|Treatment Period|Participant withdrew consent|4|||
131047415|NCT03215706|471809305|FG000|Treatment Period|Lost to Follow-up|0|||
131047416|NCT03215706|471809306|FG001|Treatment Period|Lost to Follow-up|1|||
131047417|NCT03215706|471809305|FG000|Treatment Period|Other Reasons|4|||
131047418|NCT03215706|471809306|FG001|Treatment Period|Other Reasons|5|||
131047419|NCT03215706|471809305|FG000|Treatment Period|Ongoing in the treatment period|105|||
131047420|NCT03215706|471809306|FG001|Treatment Period|Ongoing in the treatment period|43|||
131047421|NCT03512301|471809938|FG000|Overall Study|Protocol Violation|2|||
131047422|NCT03512301|471809938|FG000|Overall Study|Did Not Qualify|3|||
131047423|NCT03512301|471809938|FG000|Overall Study|Age-ineligible|1|||
131047424|NCT03512301|471809938|FG000|Overall Study|Inadequate fluency with the English language|3|||
131047425|NCT03983382|471809939|FG000|Overall Study|Death|1|||
131047426|NCT03983382|471809939|FG000|Overall Study|Lost to Follow-up|3|||
131047427|NCT03983382|471809939|FG000|Overall Study|Physician Decision|2|||
131047428|NCT03983382|471809939|FG000|Overall Study|Withdrawal by Subject|10|||
131047429|NCT03983382|471809939|FG000|Overall Study|Change in cancer treatment|2|||
131047430|NCT04174170|471809940|FG000|Placebo Run-in Period|Not Randomized|38|||
131047431|NCT04174170|471809941|FG001|Placebo Run-in Period|Not Randomized|0|||
131047432|NCT04174170|471809942|FG002|Placebo Run-in Period|Not Randomized|0|||
131047433|NCT04174170|471809943|FG003|Placebo Run-in Period|Not Randomized|0|||
131047434|NCT04174170|471809940|FG000|Double Blind Treatment Period|Adverse Event|0|||
131047435|NCT04174170|471809941|FG001|Double Blind Treatment Period|Adverse Event|9|||
131047436|NCT04174170|471809942|FG002|Double Blind Treatment Period|Adverse Event|9|||
131047437|NCT04174170|471809943|FG003|Double Blind Treatment Period|Adverse Event|8|||
131047438|NCT04174170|471809940|FG000|Double Blind Treatment Period|Death|0|||
131134157|NCT02028455|472117322|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
131047439|NCT04174170|471809941|FG001|Double Blind Treatment Period|Death|1|||
131047440|NCT04174170|471809942|FG002|Double Blind Treatment Period|Death|0|||
131047441|NCT04174170|471809943|FG003|Double Blind Treatment Period|Death|0|||
131047442|NCT04174170|471809940|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
131047443|NCT04174170|471809941|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
131047444|NCT04174170|471809942|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
131047445|NCT04174170|471809943|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
131047446|NCT04174170|471809940|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
131047447|NCT04174170|471809941|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
131047448|NCT04174170|471809942|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
131047449|NCT04174170|471809943|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
131047450|NCT04174170|471809940|FG000|Double Blind Treatment Period|Physician Decision|0|||
131047451|NCT04174170|471809941|FG001|Double Blind Treatment Period|Physician Decision|1|||
131047452|NCT04174170|471809942|FG002|Double Blind Treatment Period|Physician Decision|0|||
131047453|NCT04174170|471809943|FG003|Double Blind Treatment Period|Physician Decision|1|||
131047454|NCT04174170|471809940|FG000|Double Blind Treatment Period|Pregnancy|0|||
131047455|NCT04174170|471809941|FG001|Double Blind Treatment Period|Pregnancy|1|||
131047456|NCT04174170|471809942|FG002|Double Blind Treatment Period|Pregnancy|0|||
131047457|NCT04174170|471809943|FG003|Double Blind Treatment Period|Pregnancy|1|||
131047458|NCT04174170|471809940|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
131047459|NCT04174170|471809941|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
131047460|NCT04174170|471809942|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
131047461|NCT04174170|471809943|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
131047462|NCT04174170|471809940|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
131047463|NCT04174170|471809941|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
131047464|NCT04174170|471809942|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
131047465|NCT04174170|471809943|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
131047466|NCT04174170|471809940|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
131047467|NCT04174170|471809941|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
131047468|NCT04174170|471809942|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
131047469|NCT04174170|471809943|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
131047470|NCT04772534|471809951|FG000|Overall Study|Physician Decision|1|||
131047471|NCT04772534|471809952|FG001|Overall Study|Physician Decision|0|||
131047472|NCT04772534|471809953|FG002|Overall Study|Physician Decision|0|||
131047473|NCT04772534|471809951|FG000|Overall Study|Withdrawal by Subject|3|||
131047474|NCT04772534|471809952|FG001|Overall Study|Withdrawal by Subject|0|||
131047475|NCT04772534|471809953|FG002|Overall Study|Withdrawal by Subject|1|||
131047476|NCT04194450|471809954|FG000|Overall Study|not eligible|1|||
131047477|NCT04194450|471809955|FG001|Overall Study|not eligible|0|||
131047478|NCT03786926|471809965|FG000|Overall Study|Adverse Event|0|||
131047479|NCT03786926|471809966|FG001|Overall Study|Adverse Event|0|||
131047480|NCT03786926|471809967|FG002|Overall Study|Adverse Event|0|||
131047481|NCT03786926|471809968|FG003|Overall Study|Adverse Event|0|||
131047482|NCT03786926|471809969|FG004|Overall Study|Adverse Event|0|||
131047483|NCT03786926|471809970|FG005|Overall Study|Adverse Event|0|||
131047484|NCT03786926|471809971|FG006|Overall Study|Adverse Event|0|||
131047485|NCT03786926|471809972|FG007|Overall Study|Adverse Event|1|||
131047486|NCT03786926|471809973|FG008|Overall Study|Adverse Event|1|||
131047487|NCT03786926|471809974|FG009|Overall Study|Adverse Event|0|||
131047488|NCT03786926|471809975|FG010|Overall Study|Adverse Event|1|||
131047489|NCT03786926|471809965|FG000|Overall Study|Progressive disease|3|||
131047490|NCT03786926|471809966|FG001|Overall Study|Progressive disease|0|||
131047491|NCT03786926|471809967|FG002|Overall Study|Progressive disease|3|||
131047492|NCT03786926|471809968|FG003|Overall Study|Progressive disease|1|||
131047493|NCT03786926|471809969|FG004|Overall Study|Progressive disease|2|||
131047494|NCT03786926|471809970|FG005|Overall Study|Progressive disease|2|||
131047495|NCT03786926|471809971|FG006|Overall Study|Progressive disease|1|||
131047496|NCT03786926|471809972|FG007|Overall Study|Progressive disease|6|||
131047497|NCT03786926|471809973|FG008|Overall Study|Progressive disease|1|||
131047498|NCT03786926|471809974|FG009|Overall Study|Progressive disease|1|||
131047499|NCT03786926|471809975|FG010|Overall Study|Progressive disease|1|||
131047500|NCT03786926|471809965|FG000|Overall Study|Death|0|||
131047501|NCT03786926|471809966|FG001|Overall Study|Death|1|||
131047502|NCT03786926|471809967|FG002|Overall Study|Death|1|||
131047503|NCT03786926|471809968|FG003|Overall Study|Death|0|||
131047504|NCT03786926|471809969|FG004|Overall Study|Death|0|||
131047505|NCT03786926|471809970|FG005|Overall Study|Death|0|||
131047506|NCT03786926|471809971|FG006|Overall Study|Death|0|||
131047507|NCT03786926|471809972|FG007|Overall Study|Death|0|||
131047508|NCT03786926|471809973|FG008|Overall Study|Death|0|||
131047509|NCT03786926|471809974|FG009|Overall Study|Death|1|||
131047510|NCT03786926|471809975|FG010|Overall Study|Death|2|||
131047511|NCT03786926|471809965|FG000|Overall Study|Physician Decision|0|||
131047512|NCT03786926|471809966|FG001|Overall Study|Physician Decision|1|||
131047513|NCT03786926|471809967|FG002|Overall Study|Physician Decision|0|||
131047514|NCT03786926|471809968|FG003|Overall Study|Physician Decision|1|||
131047515|NCT03786926|471809969|FG004|Overall Study|Physician Decision|2|||
131047516|NCT03786926|471809970|FG005|Overall Study|Physician Decision|0|||
131047517|NCT03786926|471809971|FG006|Overall Study|Physician Decision|0|||
131047518|NCT03786926|471809972|FG007|Overall Study|Physician Decision|2|||
131047519|NCT03786926|471809973|FG008|Overall Study|Physician Decision|1|||
131047520|NCT03786926|471809974|FG009|Overall Study|Physician Decision|1|||
131047521|NCT03786926|471809975|FG010|Overall Study|Physician Decision|0|||
130779205|NCT02989402|470817514|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
130779206|NCT02989402|470817514|FG000|Overall Study|Lost to Follow-up|8|||
130779207|NCT02989402|470817514|FG000|Overall Study|Patient no longer on monotherapy|1|||
130779208|NCT02989402|470817514|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
130779209|NCT02989402|470817514|FG000|Overall Study|Withdrawal by Subject|7|||
130779210|NCT02989402|470817514|FG000|Overall Study|Other|2|||
130779211|NCT02686164|470817523|FG000|Overall Study|Adverse Event|1|||
130779212|NCT02686164|470817523|FG000|Overall Study|Withdrawal of consent|1|||
130779213|NCT02686164|470817523|FG000|Overall Study|Clinical progression|1|||
130779214|NCT00672633|470817526|FG000|Overall Study|Withdrawal by Subject|0|||
130779215|NCT00672633|470817527|FG001|Overall Study|Withdrawal by Subject|1|||
130779216|NCT02824627|470817528|FG000|Overall Study|Adverse Event|1|||
130779217|NCT02824627|470817529|FG001|Overall Study|Adverse Event|2|||
130779218|NCT02824627|470817528|FG000|Overall Study|Lost to Follow-up|2|||
130779219|NCT02824627|470817529|FG001|Overall Study|Lost to Follow-up|1|||
130779220|NCT01938846|470817530|FG000|Overall Study|Progressive disease|26|||
130779221|NCT01938846|470817531|FG001|Overall Study|Progressive disease|18|||
130779222|NCT01938846|470817532|FG002|Overall Study|Progressive disease|16|||
130779223|NCT01938846|470817530|FG000|Overall Study|Adverse Event|8|||
130779224|NCT01938846|470817531|FG001|Overall Study|Adverse Event|4|||
130779225|NCT01938846|470817532|FG002|Overall Study|Adverse Event|3|||
130779226|NCT01938846|470817530|FG000|Overall Study|Withdrawal by Subject|2|||
130779227|NCT01938846|470817531|FG001|Overall Study|Withdrawal by Subject|2|||
130779228|NCT01938846|470817532|FG002|Overall Study|Withdrawal by Subject|1|||
130779229|NCT01938846|470817530|FG000|Overall Study|Other than listed|5|||
130779230|NCT01938846|470817531|FG001|Overall Study|Other than listed|1|||
130779231|NCT01938846|470817532|FG002|Overall Study|Other than listed|4|||
130779232|NCT02324361|470817535|FG000|Overall Study|Lost to Follow-up|5|||
130779233|NCT02324361|470817536|FG001|Overall Study|Lost to Follow-up|2|||
130779234|NCT00823134|470819440|FG000|Overall Study|Invalid measurement|1|||
130779235|NCT02291029|470819444|FG000|Overall Study|Withdrawal by Subject|0|||
130779236|NCT02291029|470819445|FG001|Overall Study|Withdrawal by Subject|0|||
130779237|NCT02291029|470819446|FG002|Overall Study|Withdrawal by Subject|1|||
130779238|NCT02291029|470819447|FG003|Overall Study|Withdrawal by Subject|0|||
130779239|NCT02291029|470819448|FG004|Overall Study|Withdrawal by Subject|0|||
130779240|NCT02291029|470819449|FG005|Overall Study|Withdrawal by Subject|0|||
130779241|NCT02291029|470819444|FG000|Overall Study|Adverse Event|0|||
130779242|NCT02291029|470819445|FG001|Overall Study|Adverse Event|1|||
130779243|NCT02291029|470819446|FG002|Overall Study|Adverse Event|0|||
130779244|NCT02291029|470819447|FG003|Overall Study|Adverse Event|0|||
130779245|NCT02291029|470819448|FG004|Overall Study|Adverse Event|0|||
130779246|NCT02291029|470819449|FG005|Overall Study|Adverse Event|0|||
130779247|NCT00493012|470819450|FG000|Overall Study|Lost to Follow-up|18|||
130779248|NCT00493012|470819451|FG001|Overall Study|Lost to Follow-up|17|||
130779249|NCT01519817|470819453|FG000|Overall Study|Withdrawal by Subject|1|||
130779250|NCT01519817|470819454|FG001|Overall Study|Withdrawal by Subject|0|||
130779251|NCT01519817|470819455|FG002|Overall Study|Withdrawal by Subject|0|||
130779252|NCT01519817|470819456|FG003|Overall Study|Withdrawal by Subject|0|||
131047522|NCT03786926|471809965|FG000|Overall Study|Withdrawal by Subject|0|||
131047523|NCT03786926|471809966|FG001|Overall Study|Withdrawal by Subject|1|||
131047524|NCT03786926|471809967|FG002|Overall Study|Withdrawal by Subject|1|||
131047525|NCT03786926|471809968|FG003|Overall Study|Withdrawal by Subject|0|||
131229619|NCT00658320|472467643|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
131229620|NCT00658320|472467642|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
131229621|NCT00658320|472467643|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
131229622|NCT02668783|472467644|FG000|Overall Study|Pregnancy|0|||
131229623|NCT02668783|472467645|FG001|Overall Study|Pregnancy|1|||
131229624|NCT02668783|472467644|FG000|Overall Study|Protocol Violation|2|||
131229625|NCT02668783|472467645|FG001|Overall Study|Protocol Violation|1|||
131229626|NCT02668783|472467644|FG000|Overall Study|Study terminated by sponsor|9|||
131229627|NCT02668783|472467645|FG001|Overall Study|Study terminated by sponsor|10|||
131229628|NCT02668783|472467644|FG000|Overall Study|Subject moved|1|||
130779253|NCT01519817|470819453|FG000|Overall Study|Off study due to infection|0|||
130779254|NCT01519817|470819454|FG001|Overall Study|Off study due to infection|0|||
131047526|NCT03786926|471809969|FG004|Overall Study|Withdrawal by Subject|0|||
131047527|NCT03786926|471809970|FG005|Overall Study|Withdrawal by Subject|0|||
131047528|NCT03786926|471809971|FG006|Overall Study|Withdrawal by Subject|1|||
130779255|NCT01519817|470819455|FG002|Overall Study|Off study due to infection|0|||
131047529|NCT03786926|471809972|FG007|Overall Study|Withdrawal by Subject|0|||
131047530|NCT03786926|471809973|FG008|Overall Study|Withdrawal by Subject|1|||
131047531|NCT03786926|471809974|FG009|Overall Study|Withdrawal by Subject|0|||
130779256|NCT01519817|470819456|FG003|Overall Study|Off study due to infection|1|||
130779257|NCT02922153|470819457|FG000|Overall Study|Death|8|||
130779258|NCT02922153|470819458|FG001|Overall Study|Death|1|||
130779259|NCT02922153|470819457|FG000|Overall Study|Lost to Follow-up|1|||
130779260|NCT02922153|470819458|FG001|Overall Study|Lost to Follow-up|0|||
130779261|NCT02922153|470819457|FG000|Overall Study|Physician Decision|1|||
131047532|NCT03786926|471809975|FG010|Overall Study|Withdrawal by Subject|1|||
131047533|NCT03786926|471809965|FG000|Overall Study|Study terminated by Sponsor|0|||
131047534|NCT03786926|471809966|FG001|Overall Study|Study terminated by Sponsor|0|||
131047535|NCT03786926|471809967|FG002|Overall Study|Study terminated by Sponsor|0|||
131047536|NCT03786926|471809968|FG003|Overall Study|Study terminated by Sponsor|0|||
131047537|NCT03786926|471809969|FG004|Overall Study|Study terminated by Sponsor|1|||
131047538|NCT03786926|471809970|FG005|Overall Study|Study terminated by Sponsor|0|||
131047539|NCT03786926|471809971|FG006|Overall Study|Study terminated by Sponsor|0|||
131047540|NCT03786926|471809972|FG007|Overall Study|Study terminated by Sponsor|4|||
131047541|NCT03786926|471809973|FG008|Overall Study|Study terminated by Sponsor|0|||
131047542|NCT03786926|471809974|FG009|Overall Study|Study terminated by Sponsor|0|||
131047543|NCT03786926|471809975|FG010|Overall Study|Study terminated by Sponsor|0|||
131047544|NCT03786926|471809965|FG000|Overall Study|Anti-neoplasm treatment|0|||
131047545|NCT03786926|471809966|FG001|Overall Study|Anti-neoplasm treatment|0|||
131047546|NCT03786926|471809967|FG002|Overall Study|Anti-neoplasm treatment|0|||
131047547|NCT03786926|471809968|FG003|Overall Study|Anti-neoplasm treatment|0|||
131047548|NCT03786926|471809969|FG004|Overall Study|Anti-neoplasm treatment|1|||
131047549|NCT03786926|471809970|FG005|Overall Study|Anti-neoplasm treatment|0|||
131047550|NCT03786926|471809971|FG006|Overall Study|Anti-neoplasm treatment|1|||
131047551|NCT03786926|471809972|FG007|Overall Study|Anti-neoplasm treatment|0|||
131047552|NCT03786926|471809973|FG008|Overall Study|Anti-neoplasm treatment|0|||
131047553|NCT03786926|471809974|FG009|Overall Study|Anti-neoplasm treatment|0|||
131047554|NCT03786926|471809975|FG010|Overall Study|Anti-neoplasm treatment|0|||
131047555|NCT03786926|471809965|FG000|Overall Study|Other|0|||
131047556|NCT03786926|471809966|FG001|Overall Study|Other|0|||
131047557|NCT03786926|471809967|FG002|Overall Study|Other|0|||
131047558|NCT03786926|471809968|FG003|Overall Study|Other|1|||
131047559|NCT03786926|471809969|FG004|Overall Study|Other|0|||
131047560|NCT03786926|471809970|FG005|Overall Study|Other|1|||
131047561|NCT03786926|471809971|FG006|Overall Study|Other|0|||
131047562|NCT03786926|471809972|FG007|Overall Study|Other|0|||
131047563|NCT03786926|471809973|FG008|Overall Study|Other|2|||
131047564|NCT03786926|471809974|FG009|Overall Study|Other|0|||
131047565|NCT03786926|471809975|FG010|Overall Study|Other|0|||
131047566|NCT05875701|471809981|FG000|Overall Study|Lost to Follow-up|2|||
131047567|NCT05875701|471809982|FG001|Overall Study|Lost to Follow-up|0|||
131047568|NCT05875701|471809981|FG000|Overall Study|Withdrawal by Subject|1|||
130721870|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130721871|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130721872|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130721873|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130721874|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130721875|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
130721876|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
130721877|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
130721878|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
130721879|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
130721880|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Other|4|||
130721881|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Other|5|||
130721882|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Other|4|||
131134158|NCT02028455|472117323|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
131134159|NCT02028455|472117316|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
131134160|NCT02028455|472117317|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
131134161|NCT02028455|472117318|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
131134162|NCT02028455|472117319|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
131134163|NCT02028455|472117320|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
131134164|NCT02028455|472117321|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
131134165|NCT02028455|472117322|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
131134166|NCT02028455|472117323|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
131134167|NCT02028455|472117316|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131134168|NCT02028455|472117317|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131134169|NCT02028455|472117318|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131229629|NCT02668783|472467645|FG001|Overall Study|Subject moved|0|||
131047569|NCT05875701|471809982|FG001|Overall Study|Withdrawal by Subject|1|||
131047570|NCT04408755|471809983|FG000|Period A (Placebo lead-in)|Other|11|||
131047571|NCT04408755|471809984|FG001|Period A (Placebo lead-in)|Other|0|||
131047572|NCT04408755|471809985|FG002|Period A (Placebo lead-in)|Other|0|||
131047573|NCT04408755|471809986|FG003|Period A (Placebo lead-in)|Other|0|||
131047574|NCT04408755|471809983|FG000|Period B (Randomization Period)|Adverse Event|0|||
131047575|NCT04408755|471809984|FG001|Period B (Randomization Period)|Adverse Event|3|||
131047576|NCT04408755|471809985|FG002|Period B (Randomization Period)|Adverse Event|0|||
131047577|NCT04408755|471809986|FG003|Period B (Randomization Period)|Adverse Event|1|||
131134170|NCT02028455|472117319|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131134171|NCT02028455|472117320|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131134172|NCT02028455|472117321|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
131134173|NCT02028455|472117322|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
131134174|NCT02028455|472117323|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
130721883|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Other|0|||
130721884|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Other|0|||
130721885|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
130721886|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
130721887|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
130721888|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
130721889|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
130721890|NCT01081834|470606321|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130721891|NCT01081834|470606322|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
130721892|NCT01081834|470606323|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130721893|NCT01081834|470606324|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130721894|NCT01081834|470606325|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130721895|NCT01475097|470606332|FG000|Overall Study|Protocol Violation|1|||
130721896|NCT01475097|470606333|FG001|Overall Study|Protocol Violation|1|||
130721897|NCT00851318|470606344|FG000|Overall Study|Withdrawal by Subject|7|||
130721898|NCT00851318|470606345|FG001|Overall Study|Withdrawal by Subject|1|||
130721899|NCT00851318|470606346|FG002|Overall Study|Withdrawal by Subject|5|||
130721900|NCT00851318|470606347|FG003|Overall Study|Withdrawal by Subject|3|||
130721901|NCT00851318|470606344|FG000|Overall Study|Adverse Event|13|||
130721902|NCT00851318|470606345|FG001|Overall Study|Adverse Event|2|||
130721903|NCT00851318|470606346|FG002|Overall Study|Adverse Event|9|||
130721904|NCT00851318|470606347|FG003|Overall Study|Adverse Event|12|||
130721905|NCT00851318|470606344|FG000|Overall Study|Pregnancy|0|||
130721906|NCT00851318|470606345|FG001|Overall Study|Pregnancy|0|||
130721907|NCT00851318|470606346|FG002|Overall Study|Pregnancy|1|||
130721908|NCT00851318|470606347|FG003|Overall Study|Pregnancy|1|||
130721909|NCT00851318|470606344|FG000|Overall Study|Lack of Efficacy|8|||
130721910|NCT00851318|470606345|FG001|Overall Study|Lack of Efficacy|2|||
130721911|NCT00851318|470606346|FG002|Overall Study|Lack of Efficacy|4|||
130721912|NCT00851318|470606347|FG003|Overall Study|Lack of Efficacy|2|||
130721913|NCT00851318|470606344|FG000|Overall Study|Non-compliance with Study Procedures|2|||
130721914|NCT00851318|470606345|FG001|Overall Study|Non-compliance with Study Procedures|0|||
130721915|NCT00851318|470606346|FG002|Overall Study|Non-compliance with Study Procedures|1|||
130721916|NCT00851318|470606347|FG003|Overall Study|Non-compliance with Study Procedures|0|||
130721917|NCT00851318|470606344|FG000|Overall Study|Physician Decision|0|||
130721918|NCT00851318|470606345|FG001|Overall Study|Physician Decision|0|||
130721919|NCT00851318|470606346|FG002|Overall Study|Physician Decision|1|||
130721920|NCT00851318|470606347|FG003|Overall Study|Physician Decision|1|||
130721921|NCT01844856|470606354|FG000|Overall Study|Lost to Follow-up|15|||
130721922|NCT01844856|470606355|FG001|Overall Study|Lost to Follow-up|3|||
130721923|NCT01844856|470606354|FG000|Overall Study|Adverse Event|3|||
130721924|NCT01844856|470606355|FG001|Overall Study|Adverse Event|6|||
130721925|NCT01844856|470606354|FG000|Overall Study|Withdrawal by Subject|3|||
130721926|NCT01844856|470606355|FG001|Overall Study|Withdrawal by Subject|2|||
130721927|NCT01844856|470606354|FG000|Overall Study|Noncompliance|2|||
130721928|NCT01844856|470606355|FG001|Overall Study|Noncompliance|3|||
130721929|NCT01844856|470606354|FG000|Overall Study|Enterococcus Resistant|0|||
130721930|NCT01844856|470606355|FG001|Overall Study|Enterococcus Resistant|1|||
130721931|NCT01844856|470606354|FG000|Overall Study|Inadvertently Not Scheduled|1|||
130721932|NCT01844856|470606355|FG001|Overall Study|Inadvertently Not Scheduled|0|||
130721933|NCT01844856|470606354|FG000|Overall Study|Randomized but was a Screen Failure|0|||
130721934|NCT01844856|470606355|FG001|Overall Study|Randomized but was a Screen Failure|1|||
130721935|NCT01001988|470606356|FG000|Overall Study|Protocol Violation|84|||
130721936|NCT01001988|470606356|FG000|Overall Study|Withdrawal by Subject|18|||
130779262|NCT02922153|470819458|FG001|Overall Study|Physician Decision|1|||
130779263|NCT02692586|470819463|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
130779264|NCT02692586|470819463|FG000|Overall Study|Received adjunctive thrombolytics|2|||
130721937|NCT01001988|470606356|FG000|Overall Study|Lost to Follow-up|15|||
130721938|NCT01442688|470606359|FG000|First Intervention|Withdrawal by Subject|1|||
130721939|NCT01442688|470606360|FG001|First Intervention|Withdrawal by Subject|0|||
130721940|NCT01442688|470606359|FG000|First Intervention|subject incarcerated|1|||
130721941|NCT01442688|470606360|FG001|First Intervention|subject incarcerated|0|||
130721942|NCT01442688|470606359|FG000|Second Intervention|Adverse Event|1|||
130721943|NCT01442688|470606360|FG001|Second Intervention|Adverse Event|0|||
130721944|NCT00927394|470606361|FG000|Overall Study|Adverse Event|14|||
130721945|NCT00927394|470606362|FG001|Overall Study|Adverse Event|9|||
130721946|NCT00927394|470606361|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
130721947|NCT00927394|470606362|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
131047578|NCT04408755|471809983|FG000|Period B (Randomization Period)|Death|0|||
131134175|NCT02028455|472117316|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
130721948|NCT00927394|470606361|FG000|Overall Study|Withdrawal by Subject|20|||
130721949|NCT00927394|470606362|FG001|Overall Study|Withdrawal by Subject|24|||
130721950|NCT00927394|470606361|FG000|Overall Study|Lost to Follow-up|8|||
130721951|NCT00927394|470606362|FG001|Overall Study|Lost to Follow-up|14|||
130721952|NCT00927394|470606361|FG000|Overall Study|Administrative Problem|1|||
130721953|NCT00927394|470606362|FG001|Overall Study|Administrative Problem|0|||
130721954|NCT00927394|470606361|FG000|Overall Study|Death|1|||
130721955|NCT00927394|470606362|FG001|Overall Study|Death|1|||
130721956|NCT00927394|470606361|FG000|Overall Study|Protocol deviation|16|||
130721957|NCT00927394|470606362|FG001|Overall Study|Protocol deviation|13|||
130721958|NCT00927394|470606361|FG000|Overall Study|Randomized in error|0|||
130721959|NCT00927394|470606362|FG001|Overall Study|Randomized in error|1|||
130721960|NCT01329549|470606369|FG000|Overall Study|Withdrawal by Subject|1|||
130721961|NCT01329549|470606369|FG000|Overall Study|Adverse Event|1|||
130721962|NCT00998309|470606380|FG000|Overall Study|Protocol Violation|4|||
130721963|NCT04480021|470606383|FG000|Overall Study|Lost to Follow-up|3|||
130721964|NCT04480021|470606384|FG001|Overall Study|Lost to Follow-up|4|||
130721965|NCT01844505|470606387|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
130721966|NCT01844505|470606388|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
131047579|NCT04408755|471809984|FG001|Period B (Randomization Period)|Death|0|||
131047580|NCT04408755|471809985|FG002|Period B (Randomization Period)|Death|1|||
131047581|NCT04408755|471809986|FG003|Period B (Randomization Period)|Death|0|||
131047582|NCT04408755|471809983|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
131134176|NCT02028455|472117317|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
131134177|NCT02028455|472117318|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
131134178|NCT02028455|472117319|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
130721967|NCT01844505|470606389|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
131047583|NCT04408755|471809984|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
131047584|NCT04408755|471809985|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
131047585|NCT04408755|471809986|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
131047586|NCT04408755|471809983|FG000|Period B (Randomization Period)|Physician Decision|0|||
131047587|NCT04408755|471809984|FG001|Period B (Randomization Period)|Physician Decision|0|||
131047588|NCT04408755|471809985|FG002|Period B (Randomization Period)|Physician Decision|1|||
131047589|NCT04408755|471809986|FG003|Period B (Randomization Period)|Physician Decision|0|||
131047590|NCT04408755|471809983|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
131047591|NCT04408755|471809984|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
131047592|NCT04408755|471809985|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
131047593|NCT04408755|471809986|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
131047594|NCT04408755|471809983|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
131047595|NCT04408755|471809984|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
131047596|NCT04408755|471809985|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
131047597|NCT04408755|471809986|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
131047598|NCT04408755|471809983|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
131047599|NCT04408755|471809984|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
131047600|NCT04408755|471809985|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
131047601|NCT04408755|471809986|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
131047602|NCT04408755|471809983|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
131047603|NCT04408755|471809984|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
131047604|NCT04408755|471809985|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
131047605|NCT04408755|471809986|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
131047606|NCT04408755|471809983|FG000|Period B (Randomization Period)|Reason not Specified|0|||
131047607|NCT04408755|471809984|FG001|Period B (Randomization Period)|Reason not Specified|1|||
131047608|NCT04408755|471809985|FG002|Period B (Randomization Period)|Reason not Specified|0|||
131047609|NCT04408755|471809986|FG003|Period B (Randomization Period)|Reason not Specified|2|||
131047610|NCT00308997|471809987|FG000|Overall Study|Subject feigned clinical data|0|||
131047611|NCT00308997|471809988|FG001|Overall Study|Subject feigned clinical data|1|||
131047612|NCT00308997|471809987|FG000|Overall Study|Unable to tolerate intervention|1|||
131134179|NCT02028455|472117320|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
131047613|NCT00308997|471809988|FG001|Overall Study|Unable to tolerate intervention|0|||
131047614|NCT04490356|471809989|FG000|Overall Study|Lost to Follow-up|1|||
130721968|NCT01844505|470606387|FG000|Treatment Period|Other Reasons|120|||
130721969|NCT01844505|470606388|FG001|Treatment Period|Other Reasons|136|||
130721970|NCT01844505|470606389|FG002|Treatment Period|Other Reasons|58|||
130721971|NCT01844505|470606387|FG000|Treatment Period|Lost to Follow-up|9|||
130721972|NCT01844505|470606388|FG001|Treatment Period|Lost to Follow-up|11|||
130721973|NCT01844505|470606389|FG002|Treatment Period|Lost to Follow-up|6|||
130721974|NCT01844505|470606387|FG000|Treatment Period|Death|175|||
131047615|NCT01499368|471809990|FG000|Overall Study|Did not meet I/E criteria|8|||
131047616|NCT01499368|471809991|FG001|Overall Study|Did not meet I/E criteria|4|||
131047617|NCT01499368|471809992|FG002|Overall Study|Did not meet I/E criteria|4|||
131047618|NCT01499368|471809990|FG000|Overall Study|Prohibited Concomitant medication|1|||
131047619|NCT01499368|471809991|FG001|Overall Study|Prohibited Concomitant medication|1|||
131047620|NCT01499368|471809992|FG002|Overall Study|Prohibited Concomitant medication|0|||
131047621|NCT01499368|471809990|FG000|Overall Study|Withdrawal by Subject|11|||
131047622|NCT01499368|471809991|FG001|Overall Study|Withdrawal by Subject|10|||
131047623|NCT01499368|471809992|FG002|Overall Study|Withdrawal by Subject|8|||
131047624|NCT01499368|471809990|FG000|Overall Study|Lost to Follow-up|3|||
131047625|NCT01499368|471809991|FG001|Overall Study|Lost to Follow-up|2|||
131047626|NCT01499368|471809992|FG002|Overall Study|Lost to Follow-up|5|||
131047627|NCT01499368|471809990|FG000|Overall Study|Adverse Event|4|||
131047628|NCT01499368|471809991|FG001|Overall Study|Adverse Event|0|||
131047629|NCT01499368|471809992|FG002|Overall Study|Adverse Event|2|||
131047630|NCT01499368|471809990|FG000|Overall Study|Physician Decision|0|||
131047631|NCT01499368|471809991|FG001|Overall Study|Physician Decision|1|||
131047632|NCT01499368|471809992|FG002|Overall Study|Physician Decision|0|||
131047633|NCT01499368|471809990|FG000|Overall Study|Deviation from visit window|0|||
131047634|NCT01499368|471809991|FG001|Overall Study|Deviation from visit window|0|||
131047635|NCT01499368|471809992|FG002|Overall Study|Deviation from visit window|1|||
131047636|NCT01499368|471809990|FG000|Overall Study|Error of Prescriptions|0|||
131047637|NCT01499368|471809991|FG001|Overall Study|Error of Prescriptions|0|||
131047638|NCT01499368|471809992|FG002|Overall Study|Error of Prescriptions|1|||
131047639|NCT06059443|471809993|FG000|Overall Study|Withdrawal by Subject|2|||
131047640|NCT06059443|471809994|FG001|Overall Study|Withdrawal by Subject|0|||
131047641|NCT06059443|471809993|FG000|Overall Study|Lost to Follow-up|2|||
131047642|NCT06059443|471809994|FG001|Overall Study|Lost to Follow-up|2|||
131047643|NCT05771467|471809996|FG000|Overall Study|Lost to Follow-up|6|||
131047644|NCT05771467|471809997|FG001|Overall Study|Lost to Follow-up|3|||
131047645|NCT01553149|471810000|FG000|Overall Study|Adverse Event|0|||
131047646|NCT01553149|471810001|FG001|Overall Study|Adverse Event|9|||
131047647|NCT01553149|471810000|FG000|Overall Study|Physician Decision|5|||
131047648|NCT01553149|471810001|FG001|Overall Study|Physician Decision|10|||
131047649|NCT01553149|471810000|FG000|Overall Study|Ineligible|0|||
131047650|NCT01553149|471810001|FG001|Overall Study|Ineligible|1|||
131047651|NCT01105091|471810003|FG000|Overall Study|Death|2|||
131047652|NCT01105091|471810004|FG001|Overall Study|Death|0|||
131047653|NCT00945724|471810005|FG000|Overall Study|Withdrawal by Subject|2|||
131047654|NCT00945724|471810005|FG000|Overall Study|Physician Decision|1|||
131047655|NCT00945724|471810005|FG000|Overall Study|Adverse Event|5|||
131047656|NCT00945724|471810005|FG000|Overall Study|Second malignancy|1|||
131047657|NCT03934931|471810456|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
131047658|NCT03934931|471810457|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
131047659|NCT03934931|471810458|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
131047660|NCT03733626|471810460|FG000|Overall Study|Physician Decision|4|||
131047661|NCT03733626|471810461|FG001|Overall Study|Physician Decision|4|||
131047662|NCT04586244|471810464|FG000|Overall Study|Lost to Follow-up|1|||
131047663|NCT04586244|471810465|FG001|Overall Study|Lost to Follow-up|0|||
131047664|NCT04586244|471810466|FG002|Overall Study|Lost to Follow-up|0|||
131047665|NCT04586244|471810467|FG003|Overall Study|Lost to Follow-up|1|||
131047666|NCT04586244|471810468|FG004|Overall Study|Lost to Follow-up|0|||
131047667|NCT04586244|471810464|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
131047668|NCT04586244|471810465|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
131047669|NCT04586244|471810466|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
131047670|NCT04586244|471810467|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
131047671|NCT04586244|471810468|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
131134180|NCT02028455|472117321|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
131134181|NCT02028455|472117322|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
131134182|NCT02028455|472117323|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
131134183|NCT02787850|472118843|FG000|Overall Study|Withdrawal by Subject|0|||
131134184|NCT02787850|472118844|FG001|Overall Study|Withdrawal by Subject|1|||
131134185|NCT00452699|472118845|FG000|Overall Study|Adverse Event|10|||
131047672|NCT04174560|471810473|FG000|Overall Study|Lost to Follow-up|1|||
131047673|NCT04174560|471810474|FG001|Overall Study|Lost to Follow-up|0|||
131047674|NCT04174560|471810475|FG002|Overall Study|Lost to Follow-up|0|||
131047675|NCT04174560|471810476|FG003|Overall Study|Lost to Follow-up|0|||
131134186|NCT00452699|472118846|FG001|Overall Study|Adverse Event|3|||
131047676|NCT04174560|471810473|FG000|Overall Study|Withdrawal by Subject|0|||
131047677|NCT04174560|471810474|FG001|Overall Study|Withdrawal by Subject|0|||
131047678|NCT04174560|471810475|FG002|Overall Study|Withdrawal by Subject|2|||
131047679|NCT04174560|471810476|FG003|Overall Study|Withdrawal by Subject|0|||
131047680|NCT05424718|471810478|FG000|Overall Study|Lost to Follow-up|5|||
131047681|NCT05424718|471810479|FG001|Overall Study|Lost to Follow-up|4|||
131047682|NCT04046549|471810481|FG000|Overall Study|Adverse Event|1|||
131047683|NCT04046549|471810481|FG000|Overall Study|Physician Decision|1|||
131047684|NCT04046549|471810481|FG000|Overall Study|Withdrawal by Subject|3|||
131047685|NCT04046549|471810481|FG000|Overall Study|Other, Not Specified|5|||
131047686|NCT03142009|471810482|FG000|Overall Study|Lost to Follow-up|45|||
131047687|NCT03142009|471810483|FG001|Overall Study|Lost to Follow-up|30|||
131047688|NCT03872466|471810484|FG000|Overall Study|Withdrawal by Subject|1|||
131047689|NCT03872466|471810485|FG001|Overall Study|Withdrawal by Subject|0|||
131047690|NCT03872466|471810484|FG000|Overall Study|Physician Decision|2|||
131047691|NCT03872466|471810485|FG001|Overall Study|Physician Decision|0|||
131047692|NCT01778686|471810486|FG000|Overall Study|Adverse Event|0|||
131047693|NCT01778686|471810487|FG001|Overall Study|Adverse Event|0|||
131047694|NCT01778686|471810488|FG002|Overall Study|Adverse Event|1|||
131047695|NCT00994643|471811080|FG000|Overall Study|Withdrawal by Subject|1|||
131047696|NCT04129164|471811084|FG000|Overall Study|Non-compliance with procedures|0|||
131047697|NCT04129164|471811085|FG001|Overall Study|Non-compliance with procedures|0|||
131047698|NCT04129164|471811086|FG002|Overall Study|Non-compliance with procedures|2|||
131047699|NCT04129164|471811087|FG003|Overall Study|Non-compliance with procedures|0|||
131047700|NCT04129164|471811084|FG000|Overall Study|Adverse Event|0|||
131047701|NCT04129164|471811085|FG001|Overall Study|Adverse Event|0|||
131047702|NCT04129164|471811086|FG002|Overall Study|Adverse Event|2|||
131047703|NCT04129164|471811087|FG003|Overall Study|Adverse Event|0|||
131047704|NCT04129164|471811084|FG000|Overall Study|Pregnancy|0|||
131047705|NCT04129164|471811085|FG001|Overall Study|Pregnancy|0|||
131047706|NCT04129164|471811086|FG002|Overall Study|Pregnancy|0|||
131047707|NCT04129164|471811087|FG003|Overall Study|Pregnancy|1|||
131047708|NCT04129164|471811084|FG000|Overall Study|Withdrawal by Subject|3|||
131047709|NCT04129164|471811085|FG001|Overall Study|Withdrawal by Subject|2|||
131047710|NCT04129164|471811086|FG002|Overall Study|Withdrawal by Subject|4|||
131047711|NCT04129164|471811087|FG003|Overall Study|Withdrawal by Subject|6|||
131047712|NCT04129164|471811084|FG000|Overall Study|Death|0|||
131047713|NCT04129164|471811085|FG001|Overall Study|Death|1|||
131047714|NCT04129164|471811086|FG002|Overall Study|Death|0|||
131047715|NCT04129164|471811087|FG003|Overall Study|Death|0|||
131047716|NCT04129164|471811084|FG000|Overall Study|Lost to Follow-up|0|||
131047717|NCT04129164|471811085|FG001|Overall Study|Lost to Follow-up|1|||
131047718|NCT04129164|471811086|FG002|Overall Study|Lost to Follow-up|0|||
131047719|NCT04129164|471811087|FG003|Overall Study|Lost to Follow-up|0|||
131047720|NCT02231749|471811090|FG000|Overall Study|Disease progression|229|||
131047721|NCT02231749|471811091|FG001|Overall Study|Disease progression|297|||
131047722|NCT02231749|471811090|FG000|Overall Study|Study Drug Toxicity|134|||
131047723|NCT02231749|471811091|FG001|Overall Study|Study Drug Toxicity|63|||
131047724|NCT02231749|471811090|FG000|Overall Study|Death|1|||
131047725|NCT02231749|471811091|FG001|Overall Study|Death|1|||
131047726|NCT02231749|471811090|FG000|Overall Study|AE unrelated to Study drug|32|||
131047727|NCT02231749|471811091|FG001|Overall Study|AE unrelated to Study drug|31|||
131047728|NCT02231749|471811090|FG000|Overall Study|Participant's request to discontinue|10|||
131047729|NCT02231749|471811091|FG001|Overall Study|Participant's request to discontinue|21|||
131047730|NCT02231749|471811090|FG000|Overall Study|Participant withdrew Consent|8|||
131047731|NCT02231749|471811091|FG001|Overall Study|Participant withdrew Consent|15|||
131047732|NCT02231749|471811090|FG000|Overall Study|Lost to Follow-up|1|||
131047733|NCT02231749|471811091|FG001|Overall Study|Lost to Follow-up|2|||
131047734|NCT02231749|471811090|FG000|Overall Study|Maximum Clinical Benefit|5|||
131047735|NCT02231749|471811091|FG001|Overall Study|Maximum Clinical Benefit|8|||
131047736|NCT02231749|471811090|FG000|Overall Study|Poor/Non-Compliance|0|||
131047737|NCT02231749|471811091|FG001|Overall Study|Poor/Non-Compliance|3|||
131047738|NCT02231749|471811090|FG000|Overall Study|Pregnancy|1|||
131047739|NCT02231749|471811091|FG001|Overall Study|Pregnancy|0|||
131047740|NCT02231749|471811090|FG000|Overall Study|other|0|||
131047741|NCT02231749|471811091|FG001|Overall Study|other|8|||
131047742|NCT02231749|471811090|FG000|Overall Study|No longer meets Study Criteria|1|||
131047743|NCT02231749|471811091|FG001|Overall Study|No longer meets Study Criteria|0|||
131047744|NCT02989662|471811097|FG000|Overall Study|Lost to Follow-up|0|||
131047745|NCT02989662|471811098|FG001|Overall Study|Lost to Follow-up|0|||
131047746|NCT02989662|471811099|FG002|Overall Study|Lost to Follow-up|0|||
131047747|NCT02989662|471811100|FG003|Overall Study|Lost to Follow-up|2|||
131047748|NCT02989662|471811097|FG000|Overall Study|Physician Decision|3|||
131047749|NCT02989662|471811098|FG001|Overall Study|Physician Decision|0|||
131047750|NCT02989662|471811099|FG002|Overall Study|Physician Decision|0|||
131047751|NCT02989662|471811100|FG003|Overall Study|Physician Decision|0|||
131047752|NCT02989662|471811097|FG000|Overall Study|Withdrawal by Subject|1|||
131047753|NCT02989662|471811098|FG001|Overall Study|Withdrawal by Subject|0|||
131047754|NCT02989662|471811099|FG002|Overall Study|Withdrawal by Subject|0|||
131047755|NCT02989662|471811100|FG003|Overall Study|Withdrawal by Subject|0|||
131047756|NCT02726386|471811103|FG000|Overall Study|Adverse Event|17|||
131047757|NCT02726386|471811104|FG001|Overall Study|Adverse Event|20|||
131047758|NCT02726386|471811103|FG000|Overall Study|Withdrawal by Subject|14|||
131047759|NCT02726386|471811104|FG001|Overall Study|Withdrawal by Subject|28|||
131047760|NCT02726386|471811103|FG000|Overall Study|Other reasons|7|||
131047761|NCT02726386|471811104|FG001|Overall Study|Other reasons|8|||
131047762|NCT03201939|471811108|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
131047763|NCT03201939|471811109|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
131047764|NCT05707351|471811112|FG000|Overall Study|Withdrawal by Subject|2|||
131047765|NCT05707351|471811112|FG000|Overall Study|Reason Not Specified|1|||
131047766|NCT02951052|471811123|FG000|Overall Study|Adverse Event|13|||
131047767|NCT02951052|471811124|FG001|Overall Study|Adverse Event|5|||
131047768|NCT02951052|471811123|FG000|Overall Study|Withdrawal by Subject|1|||
131047769|NCT02951052|471811124|FG001|Overall Study|Withdrawal by Subject|5|||
131047770|NCT02951052|471811123|FG000|Overall Study|Physician Decision|2|||
131047771|NCT02951052|471811124|FG001|Overall Study|Physician Decision|0|||
131047772|NCT02951052|471811123|FG000|Overall Study|Lost to Follow-up|1|||
131047773|NCT02951052|471811124|FG001|Overall Study|Lost to Follow-up|1|||
131047774|NCT02951052|471811123|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
131047775|NCT02951052|471811124|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
131047776|NCT02951052|471811123|FG000|Overall Study|Protocol Violation|5|||
131047777|NCT02951052|471811124|FG001|Overall Study|Protocol Violation|3|||
131047778|NCT02951052|471811123|FG000|Overall Study|Lack of Efficacy|3|||
131047779|NCT02951052|471811124|FG001|Overall Study|Lack of Efficacy|4|||
131047780|NCT02951052|471811123|FG000|Overall Study|Ongoing|1|||
131047781|NCT02951052|471811124|FG001|Overall Study|Ongoing|0|||
131047782|NCT02206828|471811133|FG000|Overall Study|Lost to Follow-up|7|||
131047783|NCT05412004|471812179|FG000|Overall Study|Adverse Event|0|||
131047784|NCT05412004|471812180|FG001|Overall Study|Adverse Event|2|||
131047785|NCT05412004|471812181|FG002|Overall Study|Adverse Event|1|||
131047786|NCT05412004|471812182|FG003|Overall Study|Adverse Event|5|||
131047787|NCT05412004|471812179|FG000|Overall Study|Assigned Treatment by Mistake|5|||
131047788|NCT05412004|471812180|FG001|Overall Study|Assigned Treatment by Mistake|10|||
131047789|NCT05412004|471812181|FG002|Overall Study|Assigned Treatment by Mistake|2|||
131047790|NCT05412004|471812182|FG003|Overall Study|Assigned Treatment by Mistake|5|||
131047791|NCT05412004|471812179|FG000|Overall Study|Lost to Follow-up|3|||
131047792|NCT05412004|471812180|FG001|Overall Study|Lost to Follow-up|0|||
131047793|NCT05412004|471812181|FG002|Overall Study|Lost to Follow-up|0|||
131047794|NCT05412004|471812182|FG003|Overall Study|Lost to Follow-up|0|||
131047795|NCT05412004|471812179|FG000|Overall Study|Patient could not travel to site|0|||
131047796|NCT05412004|471812180|FG001|Overall Study|Patient could not travel to site|1|||
131047797|NCT05412004|471812181|FG002|Overall Study|Patient could not travel to site|0|||
131047798|NCT05412004|471812182|FG003|Overall Study|Patient could not travel to site|0|||
131047799|NCT05412004|471812179|FG000|Overall Study|Physician Decision|0|||
131047800|NCT05412004|471812180|FG001|Overall Study|Physician Decision|1|||
131047801|NCT05412004|471812181|FG002|Overall Study|Physician Decision|0|||
131047802|NCT05412004|471812182|FG003|Overall Study|Physician Decision|0|||
131047803|NCT05412004|471812179|FG000|Overall Study|Pregnancy|0|||
131047804|NCT05412004|471812180|FG001|Overall Study|Pregnancy|1|||
131047805|NCT05412004|471812181|FG002|Overall Study|Pregnancy|0|||
131047806|NCT05412004|471812182|FG003|Overall Study|Pregnancy|0|||
131047807|NCT05412004|471812179|FG000|Overall Study|Protocol Violation|1|||
131047808|NCT05412004|471812180|FG001|Overall Study|Protocol Violation|0|||
131047809|NCT05412004|471812181|FG002|Overall Study|Protocol Violation|0|||
131047810|NCT05412004|471812182|FG003|Overall Study|Protocol Violation|0|||
131047811|NCT05412004|471812179|FG000|Overall Study|Withdrawal by Subject|4|||
131047812|NCT05412004|471812180|FG001|Overall Study|Withdrawal by Subject|19|||
131047813|NCT05412004|471812181|FG002|Overall Study|Withdrawal by Subject|4|||
131047814|NCT05412004|471812182|FG003|Overall Study|Withdrawal by Subject|14|||
131047815|NCT05412004|471812179|FG000|Overall Study|Screen Failure|0|||
131047816|NCT05412004|471812180|FG001|Overall Study|Screen Failure|0|||
131047817|NCT05412004|471812181|FG002|Overall Study|Screen Failure|0|||
131047818|NCT05412004|471812182|FG003|Overall Study|Screen Failure|1|||
131047819|NCT05412004|471812179|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
131047820|NCT05412004|471812180|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
130721975|NCT01844505|470606388|FG001|Treatment Period|Death|154|||
130721976|NCT01844505|470606389|FG002|Treatment Period|Death|228|||
130721977|NCT03384654|470606390|FG000|Overall Study|Withdrawal by Subject|0|||
131047821|NCT05412004|471812181|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
131047822|NCT05412004|471812182|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
131047823|NCT04644029|471812183|FG000|Overall Study|Death|1|||
131047824|NCT04644029|471812184|FG001|Overall Study|Death|0|||
131047825|NCT04644029|471812183|FG000|Overall Study|Physician Decision|1|||
131047826|NCT04644029|471812184|FG001|Overall Study|Physician Decision|2|||
130721978|NCT03384654|470606391|FG001|Overall Study|Withdrawal by Subject|0|||
131047827|NCT04644029|471812183|FG000|Overall Study|Withdrawal by Subject|21|||
131047828|NCT04644029|471812184|FG001|Overall Study|Withdrawal by Subject|19|||
131047829|NCT04644029|471812183|FG000|Overall Study|Lost to Follow-up|31|||
131047830|NCT04644029|471812184|FG001|Overall Study|Lost to Follow-up|34|||
131047831|NCT04644029|471812183|FG000|Overall Study|Study Terminated by Sponsor|308|||
131047832|NCT04644029|471812184|FG001|Overall Study|Study Terminated by Sponsor|309|||
131047833|NCT04644029|471812183|FG000|Overall Study|Randomized in Error|2|||
131047834|NCT04644029|471812184|FG001|Overall Study|Randomized in Error|1|||
131047835|NCT04644029|471812183|FG000|Overall Study|Other|0|||
131047836|NCT04644029|471812184|FG001|Overall Study|Other|1|||
131047837|NCT00968149|471812185|FG000|Overall Study|Adverse Event|5|||
131047838|NCT00968149|471812186|FG001|Overall Study|Adverse Event|1|||
131047839|NCT00968149|471812185|FG000|Overall Study|Lack of Efficacy|0|||
131047840|NCT00968149|471812186|FG001|Overall Study|Lack of Efficacy|4|||
131047841|NCT00968149|471812185|FG000|Overall Study|Lost to Follow-up|0|||
131047842|NCT00968149|471812186|FG001|Overall Study|Lost to Follow-up|1|||
131047843|NCT00968149|471812185|FG000|Overall Study|Protocol Violation|4|||
131047844|NCT00968149|471812186|FG001|Overall Study|Protocol Violation|0|||
131047845|NCT00968149|471812185|FG000|Overall Study|Withdrawal by Subject|2|||
131047846|NCT00968149|471812186|FG001|Overall Study|Withdrawal by Subject|0|||
131047847|NCT03705793|471812187|FG000|Overall Study|Lost to Follow-up|3|||
131047848|NCT03705793|471812188|FG001|Overall Study|Lost to Follow-up|4|||
131047849|NCT03705793|471812187|FG000|Overall Study|Withdrawal by Subject|2|||
131047850|NCT03705793|471812188|FG001|Overall Study|Withdrawal by Subject|1|||
131047851|NCT02719574|471812189|FG000|Phase 1 (Dose Escalation)|Other|0|||
131047852|NCT02719574|471812190|FG001|Phase 1 (Dose Escalation)|Other|2|||
131047853|NCT02719574|471812191|FG002|Phase 1 (Dose Escalation)|Other|1|||
131047854|NCT02719574|471812192|FG003|Phase 1 (Dose Escalation)|Other|2|||
131047855|NCT02719574|471812193|FG004|Phase 1 (Dose Escalation)|Other|2|||
131047856|NCT02719574|471812194|FG005|Phase 1 (Dose Escalation)|Other|0|||
131047857|NCT02719574|471812195|FG006|Phase 1 (Dose Escalation)|Other|0|||
131047858|NCT02719574|471812196|FG007|Phase 1 (Dose Escalation)|Other|0|||
131047859|NCT02719574|471812197|FG008|Phase 1 (Dose Escalation)|Other|0|||
131047860|NCT02719574|471812198|FG009|Phase 1 (Dose Escalation)|Other|0|||
131047861|NCT02719574|471812199|FG010|Phase 1 (Dose Escalation)|Other|0|||
131047862|NCT02719574|471812200|FG011|Phase 1 (Dose Escalation)|Other|0|||
131047863|NCT02719574|471812201|FG012|Phase 1 (Dose Escalation)|Other|0|||
131047864|NCT02719574|471812202|FG013|Phase 1 (Dose Escalation)|Other|0|||
131047865|NCT02719574|471812203|FG014|Phase 1 (Dose Escalation)|Other|0|||
131047866|NCT02719574|471812204|FG015|Phase 1 (Dose Escalation)|Other|0|||
131047867|NCT02719574|471812205|FG016|Phase 1 (Dose Escalation)|Other|0|||
131047868|NCT02719574|471812189|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
131047869|NCT02719574|471812190|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
131047870|NCT02719574|471812191|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
131047871|NCT02719574|471812192|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
131047872|NCT02719574|471812193|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
131047873|NCT02719574|471812194|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
131047874|NCT02719574|471812195|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047875|NCT02719574|471812196|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047876|NCT02719574|471812197|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047877|NCT02719574|471812198|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047878|NCT02719574|471812199|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047879|NCT02719574|471812200|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047880|NCT02719574|471812201|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047881|NCT02719574|471812202|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047882|NCT02719574|471812203|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047883|NCT02719574|471812204|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047884|NCT02719574|471812205|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
131047885|NCT02719574|471812189|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047886|NCT02719574|471812190|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
131047887|NCT02719574|471812191|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
131047888|NCT02719574|471812192|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047889|NCT02719574|471812193|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
131047890|NCT02719574|471812194|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
131047891|NCT02719574|471812195|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047892|NCT02719574|471812196|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047893|NCT02719574|471812197|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047894|NCT02719574|471812198|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131229630|NCT02668783|472467644|FG000|Overall Study|Withdrawal by Subject|1|||
131047895|NCT02719574|471812199|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047896|NCT02719574|471812200|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047897|NCT02719574|471812201|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047898|NCT02719574|471812202|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047899|NCT02719574|471812203|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047900|NCT02719574|471812204|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047901|NCT02719574|471812205|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
131047902|NCT02719574|471812189|FG000|Phase 1 (Dose Escalation)|Death|2|||
131047903|NCT02719574|471812190|FG001|Phase 1 (Dose Escalation)|Death|1|||
131047904|NCT02719574|471812191|FG002|Phase 1 (Dose Escalation)|Death|1|||
131047905|NCT02719574|471812192|FG003|Phase 1 (Dose Escalation)|Death|0|||
131047906|NCT02719574|471812193|FG004|Phase 1 (Dose Escalation)|Death|0|||
131047907|NCT02719574|471812194|FG005|Phase 1 (Dose Escalation)|Death|0|||
130721979|NCT03384654|470606392|FG002|Overall Study|Withdrawal by Subject|1|||
130721980|NCT03384654|470606393|FG003|Overall Study|Withdrawal by Subject|0|||
130721981|NCT00827632|470606394|FG000|Overall Study|Lost to Follow-up|8|||
130721982|NCT00827632|470606395|FG001|Overall Study|Lost to Follow-up|12|||
131047908|NCT02719574|471812195|FG006|Phase 1 (Dose Escalation)|Death|0|||
131047909|NCT02719574|471812196|FG007|Phase 1 (Dose Escalation)|Death|0|||
131047910|NCT02719574|471812197|FG008|Phase 1 (Dose Escalation)|Death|0|||
131047911|NCT02719574|471812198|FG009|Phase 1 (Dose Escalation)|Death|0|||
131047912|NCT02719574|471812199|FG010|Phase 1 (Dose Escalation)|Death|0|||
131047913|NCT02719574|471812200|FG011|Phase 1 (Dose Escalation)|Death|0|||
131047914|NCT02719574|471812201|FG012|Phase 1 (Dose Escalation)|Death|0|||
131047915|NCT02719574|471812202|FG013|Phase 1 (Dose Escalation)|Death|0|||
131047916|NCT02719574|471812203|FG014|Phase 1 (Dose Escalation)|Death|0|||
131047917|NCT02719574|471812204|FG015|Phase 1 (Dose Escalation)|Death|0|||
131047918|NCT02719574|471812205|FG016|Phase 1 (Dose Escalation)|Death|0|||
131047919|NCT02719574|471812189|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047920|NCT02719574|471812190|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
131047921|NCT02719574|471812191|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047922|NCT02719574|471812192|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047923|NCT02719574|471812193|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
131047924|NCT02719574|471812194|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
131047925|NCT02719574|471812195|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047926|NCT02719574|471812196|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047927|NCT02719574|471812197|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047928|NCT02719574|471812198|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047929|NCT02719574|471812199|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047930|NCT02719574|471812200|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047931|NCT02719574|471812201|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047932|NCT02719574|471812202|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047933|NCT02719574|471812203|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047934|NCT02719574|471812204|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047935|NCT02719574|471812205|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
131047936|NCT02719574|471812189|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047937|NCT02719574|471812190|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047938|NCT02719574|471812191|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047939|NCT02719574|471812192|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047940|NCT02719574|471812193|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
131047941|NCT02719574|471812194|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
131047942|NCT02719574|471812195|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047943|NCT02719574|471812196|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047944|NCT02719574|471812197|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047945|NCT02719574|471812198|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047946|NCT02719574|471812199|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047947|NCT02719574|471812200|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047948|NCT02719574|471812201|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047949|NCT02719574|471812202|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047950|NCT02719574|471812203|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047951|NCT02719574|471812204|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047952|NCT02719574|471812205|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
131047953|NCT02719574|471812189|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047954|NCT02719574|471812190|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047955|NCT02719574|471812191|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
131047956|NCT02719574|471812192|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047957|NCT02719574|471812193|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047958|NCT02719574|471812194|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131134187|NCT00452699|472118845|FG000|Overall Study|Lack of Efficacy|6|||
131134188|NCT00452699|472118846|FG001|Overall Study|Lack of Efficacy|4|||
131134189|NCT00452699|472118845|FG000|Overall Study|Lost to Follow-up|6|||
131134190|NCT00452699|472118846|FG001|Overall Study|Lost to Follow-up|9|||
131134191|NCT00452699|472118845|FG000|Overall Study|Protocol Violation|21|||
131134192|NCT00452699|472118846|FG001|Overall Study|Protocol Violation|25|||
131134193|NCT00452699|472118845|FG000|Overall Study|Withdrawal by Subject|26|||
131134194|NCT00452699|472118846|FG001|Overall Study|Withdrawal by Subject|25|||
131047959|NCT02719574|471812195|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047960|NCT02719574|471812196|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047961|NCT02719574|471812197|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047962|NCT02719574|471812198|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047963|NCT02719574|471812199|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047964|NCT02719574|471812200|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047965|NCT02719574|471812201|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047966|NCT02719574|471812202|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131134195|NCT00452699|472118845|FG000|Overall Study|Other|12|||
131134196|NCT00452699|472118846|FG001|Overall Study|Other|7|||
131134197|NCT02921971|472118847|FG000|Overall Study|Adverse Event|1|||
130721983|NCT00827632|470606394|FG000|Overall Study|Early withdrawal|14|||
131047967|NCT02719574|471812203|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047968|NCT02719574|471812204|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047969|NCT02719574|471812205|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
131047970|NCT02719574|471812189|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047971|NCT02719574|471812190|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047972|NCT02719574|471812191|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047973|NCT02719574|471812192|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047974|NCT02719574|471812193|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047975|NCT02719574|471812194|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047976|NCT02719574|471812195|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
131047977|NCT02719574|471812196|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
131047978|NCT02719574|471812197|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
131047979|NCT02719574|471812198|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047980|NCT02719574|471812199|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047981|NCT02719574|471812200|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047982|NCT02719574|471812201|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047983|NCT02719574|471812202|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047984|NCT02719574|471812203|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047985|NCT02719574|471812204|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047986|NCT02719574|471812205|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
131047987|NCT02719574|471812189|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131047988|NCT02719574|471812190|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131047989|NCT02719574|471812191|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131047990|NCT02719574|471812192|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131047991|NCT02719574|471812193|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131047992|NCT02719574|471812194|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131047993|NCT02719574|471812195|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
131047994|NCT02719574|471812196|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
131047995|NCT02719574|471812197|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131047996|NCT02719574|471812198|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131047997|NCT02719574|471812199|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131047998|NCT02719574|471812200|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131047999|NCT02719574|471812201|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131048000|NCT02719574|471812202|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131048001|NCT02719574|471812203|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131048002|NCT02719574|471812204|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131048003|NCT02719574|471812205|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
131048004|NCT02719574|471812189|FG000|Phase 1 (Dose Expansion)|Death|0|||
131048005|NCT02719574|471812190|FG001|Phase 1 (Dose Expansion)|Death|0|||
131048006|NCT02719574|471812191|FG002|Phase 1 (Dose Expansion)|Death|0|||
131048007|NCT02719574|471812192|FG003|Phase 1 (Dose Expansion)|Death|0|||
131048008|NCT02719574|471812193|FG004|Phase 1 (Dose Expansion)|Death|0|||
131048009|NCT02719574|471812194|FG005|Phase 1 (Dose Expansion)|Death|0|||
131048010|NCT02719574|471812195|FG006|Phase 1 (Dose Expansion)|Death|1|||
131048011|NCT02719574|471812196|FG007|Phase 1 (Dose Expansion)|Death|6|||
131048012|NCT02719574|471812197|FG008|Phase 1 (Dose Expansion)|Death|0|||
131048013|NCT02719574|471812198|FG009|Phase 1 (Dose Expansion)|Death|0|||
131048014|NCT02719574|471812199|FG010|Phase 1 (Dose Expansion)|Death|0|||
131048015|NCT02719574|471812200|FG011|Phase 1 (Dose Expansion)|Death|0|||
131048016|NCT02719574|471812201|FG012|Phase 1 (Dose Expansion)|Death|0|||
131048017|NCT02719574|471812202|FG013|Phase 1 (Dose Expansion)|Death|0|||
131048018|NCT02719574|471812203|FG014|Phase 1 (Dose Expansion)|Death|0|||
131048019|NCT02719574|471812204|FG015|Phase 1 (Dose Expansion)|Death|0|||
131048020|NCT02719574|471812205|FG016|Phase 1 (Dose Expansion)|Death|0|||
131048021|NCT02719574|471812189|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048022|NCT02719574|471812190|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048023|NCT02719574|471812191|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048024|NCT02719574|471812192|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048025|NCT02719574|471812193|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048026|NCT02719574|471812194|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048027|NCT02719574|471812195|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
131048028|NCT02719574|471812196|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
131048029|NCT02719574|471812197|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048030|NCT02719574|471812198|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048031|NCT02719574|471812199|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048032|NCT02719574|471812200|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
131134198|NCT02921971|472118848|FG001|Overall Study|Adverse Event|2|||
131134199|NCT02921971|472118847|FG000|Overall Study|Lack of Efficacy|3|||
131048033|NCT02719574|471812201|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048034|NCT02719574|471812202|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048035|NCT02719574|471812203|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048036|NCT02719574|471812204|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048037|NCT02719574|471812205|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
131048038|NCT02719574|471812189|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048039|NCT02719574|471812190|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
130779265|NCT04155463|470819465|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
131048040|NCT02719574|471812191|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048041|NCT02719574|471812192|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048042|NCT02719574|471812193|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048043|NCT02719574|471812194|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048044|NCT02719574|471812195|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
131048045|NCT02719574|471812196|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
131048046|NCT02719574|471812197|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048047|NCT02719574|471812198|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048048|NCT02719574|471812199|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048049|NCT02719574|471812200|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048050|NCT02719574|471812201|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048051|NCT02719574|471812202|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048052|NCT02719574|471812203|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048053|NCT02719574|471812204|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048054|NCT02719574|471812205|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
131048055|NCT02719574|471812189|FG000|Phase 1 (Dose Expansion)|Other|0|||
131048056|NCT02719574|471812190|FG001|Phase 1 (Dose Expansion)|Other|0|||
131048057|NCT02719574|471812191|FG002|Phase 1 (Dose Expansion)|Other|0|||
131048058|NCT02719574|471812192|FG003|Phase 1 (Dose Expansion)|Other|0|||
131048059|NCT02719574|471812193|FG004|Phase 1 (Dose Expansion)|Other|0|||
131048060|NCT02719574|471812194|FG005|Phase 1 (Dose Expansion)|Other|0|||
131048061|NCT02719574|471812195|FG006|Phase 1 (Dose Expansion)|Other|1|||
131048062|NCT02719574|471812196|FG007|Phase 1 (Dose Expansion)|Other|7|||
131048063|NCT02719574|471812197|FG008|Phase 1 (Dose Expansion)|Other|0|||
131048064|NCT02719574|471812198|FG009|Phase 1 (Dose Expansion)|Other|0|||
131048065|NCT02719574|471812199|FG010|Phase 1 (Dose Expansion)|Other|0|||
131048066|NCT02719574|471812200|FG011|Phase 1 (Dose Expansion)|Other|0|||
131048067|NCT02719574|471812201|FG012|Phase 1 (Dose Expansion)|Other|0|||
131048068|NCT02719574|471812202|FG013|Phase 1 (Dose Expansion)|Other|0|||
131048069|NCT02719574|471812203|FG014|Phase 1 (Dose Expansion)|Other|0|||
131048070|NCT02719574|471812204|FG015|Phase 1 (Dose Expansion)|Other|0|||
131048071|NCT02719574|471812205|FG016|Phase 1 (Dose Expansion)|Other|0|||
131048072|NCT02719574|471812189|FG000|Phase 2|Protocol Defined Disease Progression|0|||
131048073|NCT02719574|471812190|FG001|Phase 2|Protocol Defined Disease Progression|0|||
131048074|NCT02719574|471812191|FG002|Phase 2|Protocol Defined Disease Progression|0|||
131048075|NCT02719574|471812192|FG003|Phase 2|Protocol Defined Disease Progression|0|||
131048076|NCT02719574|471812193|FG004|Phase 2|Protocol Defined Disease Progression|0|||
131048077|NCT02719574|471812194|FG005|Phase 2|Protocol Defined Disease Progression|0|||
131048078|NCT02719574|471812195|FG006|Phase 2|Protocol Defined Disease Progression|0|||
131048079|NCT02719574|471812196|FG007|Phase 2|Protocol Defined Disease Progression|0|||
131048080|NCT02719574|471812197|FG008|Phase 2|Protocol Defined Disease Progression|0|||
131048081|NCT02719574|471812198|FG009|Phase 2|Protocol Defined Disease Progression|65|||
131048082|NCT02719574|471812199|FG010|Phase 2|Protocol Defined Disease Progression|8|||
131048083|NCT02719574|471812200|FG011|Phase 2|Protocol Defined Disease Progression|2|||
131048084|NCT02719574|471812201|FG012|Phase 2|Protocol Defined Disease Progression|4|||
131048085|NCT02719574|471812202|FG013|Phase 2|Protocol Defined Disease Progression|9|||
131048086|NCT02719574|471812203|FG014|Phase 2|Protocol Defined Disease Progression|11|||
131048087|NCT02719574|471812204|FG015|Phase 2|Protocol Defined Disease Progression|3|||
131048088|NCT02719574|471812205|FG016|Phase 2|Protocol Defined Disease Progression|4|||
131048089|NCT02719574|471812189|FG000|Phase 2|Adverse Event|0|||
131048090|NCT02719574|471812190|FG001|Phase 2|Adverse Event|0|||
131048091|NCT02719574|471812191|FG002|Phase 2|Adverse Event|0|||
131048092|NCT02719574|471812192|FG003|Phase 2|Adverse Event|0|||
131048093|NCT02719574|471812193|FG004|Phase 2|Adverse Event|0|||
131048094|NCT02719574|471812194|FG005|Phase 2|Adverse Event|0|||
131048095|NCT02719574|471812195|FG006|Phase 2|Adverse Event|0|||
131048096|NCT02719574|471812196|FG007|Phase 2|Adverse Event|0|||
131048097|NCT02719574|471812197|FG008|Phase 2|Adverse Event|0|||
131048098|NCT02719574|471812198|FG009|Phase 2|Adverse Event|27|||
131048099|NCT02719574|471812199|FG010|Phase 2|Adverse Event|0|||
131048100|NCT02719574|471812200|FG011|Phase 2|Adverse Event|1|||
131048101|NCT02719574|471812201|FG012|Phase 2|Adverse Event|1|||
131048102|NCT02719574|471812202|FG013|Phase 2|Adverse Event|1|||
131048103|NCT02719574|471812203|FG014|Phase 2|Adverse Event|2|||
131048104|NCT02719574|471812204|FG015|Phase 2|Adverse Event|2|||
131048105|NCT02719574|471812205|FG016|Phase 2|Adverse Event|3|||
131048106|NCT02719574|471812189|FG000|Phase 2|Other|0|||
131048107|NCT02719574|471812190|FG001|Phase 2|Other|0|||
131048108|NCT02719574|471812191|FG002|Phase 2|Other|0|||
131048109|NCT02719574|471812192|FG003|Phase 2|Other|0|||
131048110|NCT02719574|471812193|FG004|Phase 2|Other|0|||
131048111|NCT02719574|471812194|FG005|Phase 2|Other|0|||
131134200|NCT02921971|472118848|FG001|Overall Study|Lack of Efficacy|1|||
131048112|NCT02719574|471812195|FG006|Phase 2|Other|0|||
131048113|NCT02719574|471812196|FG007|Phase 2|Other|0|||
131048114|NCT02719574|471812197|FG008|Phase 2|Other|0|||
131048115|NCT02719574|471812198|FG009|Phase 2|Other|20|||
131048116|NCT02719574|471812199|FG010|Phase 2|Other|7|||
131048117|NCT02719574|471812200|FG011|Phase 2|Other|0|||
131048118|NCT02719574|471812201|FG012|Phase 2|Other|5|||
131048119|NCT02719574|471812202|FG013|Phase 2|Other|7|||
131048120|NCT02719574|471812203|FG014|Phase 2|Other|0|||
131048121|NCT02719574|471812204|FG015|Phase 2|Other|1|||
131048122|NCT02719574|471812205|FG016|Phase 2|Other|4|||
131048123|NCT02719574|471812189|FG000|Phase 2|Transplant|0|||
131048124|NCT02719574|471812190|FG001|Phase 2|Transplant|0|||
131048125|NCT02719574|471812191|FG002|Phase 2|Transplant|0|||
131048126|NCT02719574|471812192|FG003|Phase 2|Transplant|0|||
131048127|NCT02719574|471812193|FG004|Phase 2|Transplant|0|||
131048128|NCT02719574|471812194|FG005|Phase 2|Transplant|0|||
130721984|NCT00827632|470606395|FG001|Overall Study|Early withdrawal|11|||
130721985|NCT01910389|470606397|FG000|Overall Study|Withdrawal by Subject|2|||
130721986|NCT01910389|470606398|FG001|Overall Study|Withdrawal by Subject|0|||
130721987|NCT01910389|470606397|FG000|Overall Study|Study Closed|13|||
131048129|NCT02719574|471812195|FG006|Phase 2|Transplant|0|||
131048130|NCT02719574|471812196|FG007|Phase 2|Transplant|0|||
131048131|NCT02719574|471812197|FG008|Phase 2|Transplant|0|||
131048132|NCT02719574|471812198|FG009|Phase 2|Transplant|15|||
131048133|NCT02719574|471812199|FG010|Phase 2|Transplant|2|||
131048134|NCT02719574|471812200|FG011|Phase 2|Transplant|0|||
131048135|NCT02719574|471812201|FG012|Phase 2|Transplant|6|||
131048136|NCT02719574|471812202|FG013|Phase 2|Transplant|1|||
131048137|NCT02719574|471812203|FG014|Phase 2|Transplant|1|||
131048138|NCT02719574|471812204|FG015|Phase 2|Transplant|0|||
131048139|NCT02719574|471812205|FG016|Phase 2|Transplant|0|||
131048140|NCT02719574|471812189|FG000|Phase 2|Death|0|||
131048141|NCT02719574|471812190|FG001|Phase 2|Death|0|||
131048142|NCT02719574|471812191|FG002|Phase 2|Death|0|||
131048143|NCT02719574|471812192|FG003|Phase 2|Death|0|||
131048144|NCT02719574|471812193|FG004|Phase 2|Death|0|||
131048145|NCT02719574|471812194|FG005|Phase 2|Death|0|||
131048146|NCT02719574|471812195|FG006|Phase 2|Death|0|||
131048147|NCT02719574|471812196|FG007|Phase 2|Death|0|||
131048148|NCT02719574|471812197|FG008|Phase 2|Death|0|||
131048149|NCT02719574|471812198|FG009|Phase 2|Death|14|||
131048150|NCT02719574|471812199|FG010|Phase 2|Death|0|||
131048151|NCT02719574|471812200|FG011|Phase 2|Death|0|||
131048152|NCT02719574|471812201|FG012|Phase 2|Death|1|||
131048153|NCT02719574|471812202|FG013|Phase 2|Death|1|||
131048154|NCT02719574|471812203|FG014|Phase 2|Death|2|||
131048155|NCT02719574|471812204|FG015|Phase 2|Death|0|||
131048156|NCT02719574|471812205|FG016|Phase 2|Death|0|||
131048157|NCT02719574|471812189|FG000|Phase 2|Investigator Decision|0|||
131048158|NCT02719574|471812190|FG001|Phase 2|Investigator Decision|0|||
131048159|NCT02719574|471812191|FG002|Phase 2|Investigator Decision|0|||
131048160|NCT02719574|471812192|FG003|Phase 2|Investigator Decision|0|||
131048161|NCT02719574|471812193|FG004|Phase 2|Investigator Decision|0|||
131048162|NCT02719574|471812194|FG005|Phase 2|Investigator Decision|0|||
131048163|NCT02719574|471812195|FG006|Phase 2|Investigator Decision|0|||
131048164|NCT02719574|471812196|FG007|Phase 2|Investigator Decision|0|||
131048165|NCT02719574|471812197|FG008|Phase 2|Investigator Decision|0|||
131048166|NCT02719574|471812198|FG009|Phase 2|Investigator Decision|6|||
131048167|NCT02719574|471812199|FG010|Phase 2|Investigator Decision|1|||
131048168|NCT02719574|471812200|FG011|Phase 2|Investigator Decision|2|||
131048169|NCT02719574|471812201|FG012|Phase 2|Investigator Decision|3|||
131048170|NCT02719574|471812202|FG013|Phase 2|Investigator Decision|1|||
131048171|NCT02719574|471812203|FG014|Phase 2|Investigator Decision|3|||
131048172|NCT02719574|471812204|FG015|Phase 2|Investigator Decision|2|||
131048173|NCT02719574|471812205|FG016|Phase 2|Investigator Decision|0|||
131048174|NCT02719574|471812189|FG000|Phase 2|Withdrawal by Subject|0|||
131048175|NCT02719574|471812190|FG001|Phase 2|Withdrawal by Subject|0|||
131048176|NCT02719574|471812191|FG002|Phase 2|Withdrawal by Subject|0|||
131048177|NCT02719574|471812192|FG003|Phase 2|Withdrawal by Subject|0|||
131048178|NCT02719574|471812193|FG004|Phase 2|Withdrawal by Subject|0|||
131048179|NCT02719574|471812194|FG005|Phase 2|Withdrawal by Subject|0|||
131048180|NCT02719574|471812195|FG006|Phase 2|Withdrawal by Subject|0|||
131048181|NCT02719574|471812196|FG007|Phase 2|Withdrawal by Subject|0|||
131048182|NCT02719574|471812197|FG008|Phase 2|Withdrawal by Subject|0|||
131048183|NCT02719574|471812198|FG009|Phase 2|Withdrawal by Subject|5|||
131048184|NCT02719574|471812199|FG010|Phase 2|Withdrawal by Subject|0|||
131048185|NCT02719574|471812200|FG011|Phase 2|Withdrawal by Subject|0|||
131048186|NCT02719574|471812201|FG012|Phase 2|Withdrawal by Subject|0|||
131048187|NCT02719574|471812202|FG013|Phase 2|Withdrawal by Subject|1|||
131048188|NCT02719574|471812203|FG014|Phase 2|Withdrawal by Subject|1|||
131048189|NCT02719574|471812204|FG015|Phase 2|Withdrawal by Subject|2|||
131048190|NCT02719574|471812205|FG016|Phase 2|Withdrawal by Subject|0|||
131048191|NCT02719574|471812189|FG000|Phase 2|Protocol Violation|0|||
131048192|NCT02719574|471812190|FG001|Phase 2|Protocol Violation|0|||
131048193|NCT02719574|471812191|FG002|Phase 2|Protocol Violation|0|||
131048194|NCT02719574|471812192|FG003|Phase 2|Protocol Violation|0|||
131048195|NCT02719574|471812193|FG004|Phase 2|Protocol Violation|0|||
131048196|NCT02719574|471812194|FG005|Phase 2|Protocol Violation|0|||
131048197|NCT02719574|471812195|FG006|Phase 2|Protocol Violation|0|||
131048198|NCT02719574|471812196|FG007|Phase 2|Protocol Violation|0|||
131048199|NCT02719574|471812197|FG008|Phase 2|Protocol Violation|0|||
131048200|NCT02719574|471812198|FG009|Phase 2|Protocol Violation|1|||
131048201|NCT02719574|471812199|FG010|Phase 2|Protocol Violation|0|||
130721988|NCT01910389|470606398|FG001|Overall Study|Study Closed|8|||
131048202|NCT02719574|471812200|FG011|Phase 2|Protocol Violation|0|||
131048203|NCT02719574|471812201|FG012|Phase 2|Protocol Violation|0|||
131048204|NCT02719574|471812202|FG013|Phase 2|Protocol Violation|0|||
131048205|NCT02719574|471812203|FG014|Phase 2|Protocol Violation|0|||
131048206|NCT02719574|471812204|FG015|Phase 2|Protocol Violation|0|||
131048207|NCT02719574|471812205|FG016|Phase 2|Protocol Violation|0|||
131048208|NCT02720068|471812207|FG000|Overall Study|Adverse Event|0|||
131048209|NCT02720068|471812208|FG001|Overall Study|Adverse Event|0|||
131048210|NCT02720068|471812209|FG002|Overall Study|Adverse Event|0|||
131048211|NCT02720068|471812210|FG003|Overall Study|Adverse Event|0|||
131048212|NCT02720068|471812211|FG004|Overall Study|Adverse Event|0|||
131048213|NCT02720068|471812212|FG005|Overall Study|Adverse Event|0|||
131048214|NCT02720068|471812213|FG006|Overall Study|Adverse Event|0|||
131048215|NCT02720068|471812214|FG007|Overall Study|Adverse Event|0|||
131048216|NCT02720068|471812215|FG008|Overall Study|Adverse Event|0|||
131048217|NCT02720068|471812216|FG009|Overall Study|Adverse Event|0|||
131048218|NCT02720068|471812217|FG010|Overall Study|Adverse Event|0|||
131048219|NCT02720068|471812218|FG011|Overall Study|Adverse Event|1|||
131048220|NCT02720068|471812219|FG012|Overall Study|Adverse Event|0|||
131048221|NCT02720068|471812220|FG013|Overall Study|Adverse Event|0|||
131048222|NCT02720068|471812221|FG014|Overall Study|Adverse Event|0|||
131048223|NCT02720068|471812222|FG015|Overall Study|Adverse Event|0|||
131048224|NCT02720068|471812223|FG016|Overall Study|Adverse Event|0|||
131048225|NCT02720068|471812224|FG017|Overall Study|Adverse Event|0|||
131048226|NCT02720068|471812207|FG000|Overall Study|Death|1|||
131048227|NCT02720068|471812208|FG001|Overall Study|Death|3|||
131048228|NCT02720068|471812209|FG002|Overall Study|Death|2|||
131048229|NCT02720068|471812210|FG003|Overall Study|Death|1|||
131048230|NCT02720068|471812211|FG004|Overall Study|Death|2|||
131048231|NCT02720068|471812212|FG005|Overall Study|Death|1|||
131048232|NCT02720068|471812213|FG006|Overall Study|Death|2|||
131048233|NCT02720068|471812214|FG007|Overall Study|Death|2|||
131048234|NCT02720068|471812215|FG008|Overall Study|Death|3|||
131048235|NCT02720068|471812216|FG009|Overall Study|Death|1|||
131048236|NCT02720068|471812217|FG010|Overall Study|Death|20|||
131048237|NCT02720068|471812218|FG011|Overall Study|Death|166|||
131048238|NCT02720068|471812219|FG012|Overall Study|Death|34|||
131048239|NCT02720068|471812220|FG013|Overall Study|Death|30|||
131048240|NCT02720068|471812221|FG014|Overall Study|Death|45|||
131048241|NCT02720068|471812222|FG015|Overall Study|Death|16|||
131048242|NCT02720068|471812223|FG016|Overall Study|Death|20|||
131048243|NCT02720068|471812224|FG017|Overall Study|Death|28|||
131048244|NCT02720068|471812207|FG000|Overall Study|Lost to Follow-up|0|||
131048245|NCT02720068|471812208|FG001|Overall Study|Lost to Follow-up|0|||
131048246|NCT02720068|471812209|FG002|Overall Study|Lost to Follow-up|0|||
131048247|NCT02720068|471812210|FG003|Overall Study|Lost to Follow-up|0|||
131048248|NCT02720068|471812211|FG004|Overall Study|Lost to Follow-up|0|||
131048249|NCT02720068|471812212|FG005|Overall Study|Lost to Follow-up|0|||
130721989|NCT04669691|470606403|FG000|Overall Study|Death|0|||
130721990|NCT04669691|470606404|FG001|Overall Study|Death|1|||
130721991|NCT04669691|470606405|FG002|Overall Study|Death|0|||
130721992|NCT04669691|470606406|FG003|Overall Study|Death|0|||
130721993|NCT04669691|470606407|FG004|Overall Study|Death|0|||
130721994|NCT04669691|470606408|FG005|Overall Study|Death|0|||
131048250|NCT02720068|471812213|FG006|Overall Study|Lost to Follow-up|0|||
131048251|NCT02720068|471812214|FG007|Overall Study|Lost to Follow-up|0|||
131048252|NCT02720068|471812215|FG008|Overall Study|Lost to Follow-up|0|||
131048253|NCT02720068|471812216|FG009|Overall Study|Lost to Follow-up|0|||
130721995|NCT02304458|470606409|FG000|Overall Study|Adverse Event|0|||
130721996|NCT02304458|470606410|FG001|Overall Study|Adverse Event|0|||
130721997|NCT02304458|470606411|FG002|Overall Study|Adverse Event|7|||
131048254|NCT02720068|471812217|FG010|Overall Study|Lost to Follow-up|0|||
130721998|NCT02304458|470606412|FG003|Overall Study|Adverse Event|0|||
130721999|NCT02304458|470606413|FG004|Overall Study|Adverse Event|0|||
130722000|NCT02304458|470606414|FG005|Overall Study|Adverse Event|0|||
131048255|NCT02720068|471812218|FG011|Overall Study|Lost to Follow-up|1|||
131048256|NCT02720068|471812219|FG012|Overall Study|Lost to Follow-up|0|||
131048257|NCT02720068|471812220|FG013|Overall Study|Lost to Follow-up|1|||
131048258|NCT02720068|471812221|FG014|Overall Study|Lost to Follow-up|2|||
131048259|NCT02720068|471812222|FG015|Overall Study|Lost to Follow-up|0|||
131048260|NCT02720068|471812223|FG016|Overall Study|Lost to Follow-up|0|||
131048261|NCT02720068|471812224|FG017|Overall Study|Lost to Follow-up|1|||
131048262|NCT02720068|471812207|FG000|Overall Study|Physician Decision|0|||
131048263|NCT02720068|471812208|FG001|Overall Study|Physician Decision|0|||
130722001|NCT02304458|470606415|FG006|Overall Study|Adverse Event|3|||
131048264|NCT02720068|471812209|FG002|Overall Study|Physician Decision|0|||
131048265|NCT02720068|471812210|FG003|Overall Study|Physician Decision|1|||
131048266|NCT02720068|471812211|FG004|Overall Study|Physician Decision|0|||
131048267|NCT02720068|471812212|FG005|Overall Study|Physician Decision|0|||
131134201|NCT02921971|472118847|FG000|Overall Study|Other than specified above|2|||
130722002|NCT02304458|470606416|FG007|Overall Study|Adverse Event|4|||
131048268|NCT02720068|471812213|FG006|Overall Study|Physician Decision|0|||
131048269|NCT02720068|471812214|FG007|Overall Study|Physician Decision|0|||
131048270|NCT02720068|471812215|FG008|Overall Study|Physician Decision|0|||
131048271|NCT02720068|471812216|FG009|Overall Study|Physician Decision|0|||
131048272|NCT02720068|471812217|FG010|Overall Study|Physician Decision|0|||
131048273|NCT02720068|471812218|FG011|Overall Study|Physician Decision|1|||
131048274|NCT02720068|471812219|FG012|Overall Study|Physician Decision|0|||
131048275|NCT02720068|471812220|FG013|Overall Study|Physician Decision|0|||
131048276|NCT02720068|471812221|FG014|Overall Study|Physician Decision|0|||
131048277|NCT02720068|471812222|FG015|Overall Study|Physician Decision|0|||
131048278|NCT02720068|471812223|FG016|Overall Study|Physician Decision|0|||
131048279|NCT02720068|471812224|FG017|Overall Study|Physician Decision|1|||
131048280|NCT02720068|471812207|FG000|Overall Study|Progressive Disease|2|||
131048281|NCT02720068|471812208|FG001|Overall Study|Progressive Disease|3|||
131048282|NCT02720068|471812209|FG002|Overall Study|Progressive Disease|1|||
131048283|NCT02720068|471812210|FG003|Overall Study|Progressive Disease|1|||
131048284|NCT02720068|471812211|FG004|Overall Study|Progressive Disease|1|||
131048285|NCT02720068|471812212|FG005|Overall Study|Progressive Disease|2|||
131048286|NCT02720068|471812213|FG006|Overall Study|Progressive Disease|1|||
131048287|NCT02720068|471812214|FG007|Overall Study|Progressive Disease|1|||
131048288|NCT02720068|471812215|FG008|Overall Study|Progressive Disease|0|||
131048289|NCT02720068|471812216|FG009|Overall Study|Progressive Disease|1|||
131048290|NCT02720068|471812217|FG010|Overall Study|Progressive Disease|0|||
131048291|NCT02720068|471812218|FG011|Overall Study|Progressive Disease|4|||
131048292|NCT02720068|471812219|FG012|Overall Study|Progressive Disease|1|||
131048293|NCT02720068|471812220|FG013|Overall Study|Progressive Disease|0|||
131048294|NCT02720068|471812221|FG014|Overall Study|Progressive Disease|0|||
131048295|NCT02720068|471812222|FG015|Overall Study|Progressive Disease|0|||
131048296|NCT02720068|471812223|FG016|Overall Study|Progressive Disease|0|||
131048297|NCT02720068|471812224|FG017|Overall Study|Progressive Disease|0|||
131048298|NCT02720068|471812207|FG000|Overall Study|Sponsor Decision|0|||
131048299|NCT02720068|471812208|FG001|Overall Study|Sponsor Decision|0|||
131048300|NCT02720068|471812209|FG002|Overall Study|Sponsor Decision|0|||
131048301|NCT02720068|471812210|FG003|Overall Study|Sponsor Decision|0|||
131048302|NCT02720068|471812211|FG004|Overall Study|Sponsor Decision|0|||
131048303|NCT02720068|471812212|FG005|Overall Study|Sponsor Decision|0|||
131048304|NCT02720068|471812213|FG006|Overall Study|Sponsor Decision|0|||
131048305|NCT02720068|471812214|FG007|Overall Study|Sponsor Decision|0|||
131048306|NCT02720068|471812215|FG008|Overall Study|Sponsor Decision|0|||
131048307|NCT02720068|471812216|FG009|Overall Study|Sponsor Decision|0|||
131048308|NCT02720068|471812217|FG010|Overall Study|Sponsor Decision|0|||
131048309|NCT02720068|471812218|FG011|Overall Study|Sponsor Decision|6|||
131048310|NCT02720068|471812219|FG012|Overall Study|Sponsor Decision|3|||
131048311|NCT02720068|471812220|FG013|Overall Study|Sponsor Decision|2|||
131048312|NCT02720068|471812221|FG014|Overall Study|Sponsor Decision|4|||
131048313|NCT02720068|471812222|FG015|Overall Study|Sponsor Decision|4|||
131048314|NCT02720068|471812223|FG016|Overall Study|Sponsor Decision|0|||
131048315|NCT02720068|471812224|FG017|Overall Study|Sponsor Decision|8|||
131048316|NCT02720068|471812207|FG000|Overall Study|Withdrawal by Subject|0|||
131048317|NCT02720068|471812208|FG001|Overall Study|Withdrawal by Subject|0|||
131048318|NCT02720068|471812209|FG002|Overall Study|Withdrawal by Subject|0|||
131048319|NCT02720068|471812210|FG003|Overall Study|Withdrawal by Subject|0|||
131048320|NCT02720068|471812211|FG004|Overall Study|Withdrawal by Subject|0|||
131048321|NCT02720068|471812212|FG005|Overall Study|Withdrawal by Subject|0|||
131048322|NCT02720068|471812213|FG006|Overall Study|Withdrawal by Subject|0|||
131048323|NCT02720068|471812214|FG007|Overall Study|Withdrawal by Subject|0|||
131048324|NCT02720068|471812215|FG008|Overall Study|Withdrawal by Subject|0|||
131048325|NCT02720068|471812216|FG009|Overall Study|Withdrawal by Subject|1|||
131048326|NCT02720068|471812217|FG010|Overall Study|Withdrawal by Subject|0|||
131048327|NCT02720068|471812218|FG011|Overall Study|Withdrawal by Subject|27|||
131048328|NCT02720068|471812219|FG012|Overall Study|Withdrawal by Subject|2|||
131048329|NCT02720068|471812220|FG013|Overall Study|Withdrawal by Subject|8|||
131048330|NCT02720068|471812221|FG014|Overall Study|Withdrawal by Subject|7|||
131048331|NCT02720068|471812222|FG015|Overall Study|Withdrawal by Subject|0|||
131048332|NCT02720068|471812223|FG016|Overall Study|Withdrawal by Subject|0|||
131048333|NCT02720068|471812224|FG017|Overall Study|Withdrawal by Subject|2|||
131048334|NCT02720068|471812207|FG000|Overall Study|Protocol Violation|0|||
130722003|NCT02304458|470606409|FG000|Overall Study|Death|0|||
131048335|NCT02720068|471812208|FG001|Overall Study|Protocol Violation|0|||
131048336|NCT02720068|471812209|FG002|Overall Study|Protocol Violation|0|||
130722004|NCT02304458|470606410|FG001|Overall Study|Death|0|||
131048337|NCT02720068|471812210|FG003|Overall Study|Protocol Violation|0|||
131048338|NCT02720068|471812211|FG004|Overall Study|Protocol Violation|0|||
131048339|NCT02720068|471812212|FG005|Overall Study|Protocol Violation|0|||
131048340|NCT02720068|471812213|FG006|Overall Study|Protocol Violation|0|||
131048341|NCT02720068|471812214|FG007|Overall Study|Protocol Violation|0|||
130722005|NCT02304458|470606411|FG002|Overall Study|Death|2|||
131048342|NCT02720068|471812215|FG008|Overall Study|Protocol Violation|0|||
131134202|NCT02921971|472118848|FG001|Overall Study|Other than specified above|1|||
131134203|NCT00326898|472118849|FG000|Overall Study|Disease progression|52|||
131134204|NCT00326898|472118850|FG001|Overall Study|Disease progression|54|||
131134205|NCT00326898|472118851|FG002|Overall Study|Disease progression|102|||
131134206|NCT00326898|472118849|FG000|Overall Study|Adverse Event|124|||
131134207|NCT00326898|472118850|FG001|Overall Study|Adverse Event|128|||
130822725|NCT00887159|470980584|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
131048343|NCT02720068|471812216|FG009|Overall Study|Protocol Violation|0|||
131048344|NCT02720068|471812217|FG010|Overall Study|Protocol Violation|1|||
131048345|NCT02720068|471812218|FG011|Overall Study|Protocol Violation|0|||
131048346|NCT02720068|471812219|FG012|Overall Study|Protocol Violation|0|||
131048347|NCT02720068|471812220|FG013|Overall Study|Protocol Violation|0|||
131048348|NCT02720068|471812221|FG014|Overall Study|Protocol Violation|1|||
131048349|NCT02720068|471812222|FG015|Overall Study|Protocol Violation|0|||
131048350|NCT02720068|471812223|FG016|Overall Study|Protocol Violation|1|||
131048351|NCT02720068|471812224|FG017|Overall Study|Protocol Violation|0|||
131048352|NCT00113360|471812227|FG000|Overall Study|Adverse Event|3|||
131048353|NCT00113360|471812227|FG000|Overall Study|Subject required surgery|1|||
131048354|NCT00113360|471812227|FG000|Overall Study|Did not meet eligibility criteria|3|||
131048355|NCT02467270|471812242|FG000|Overall Study|Participants Never Treated|0|||
131048356|NCT02467270|471812243|FG001|Overall Study|Participants Never Treated|1|||
131048357|NCT02467270|471812244|FG002|Overall Study|Participants Never Treated|0|||
131048358|NCT02467270|471812242|FG000|Overall Study|Ongoing|50|||
131048359|NCT02467270|471812243|FG001|Overall Study|Ongoing|41|||
131048360|NCT02467270|471812244|FG002|Overall Study|Ongoing|43|||
131048361|NCT02467270|471812242|FG000|Overall Study|Adverse Event|16|||
131048362|NCT02467270|471812243|FG001|Overall Study|Adverse Event|15|||
131048363|NCT02467270|471812244|FG002|Overall Study|Adverse Event|14|||
131048364|NCT02467270|471812242|FG000|Overall Study|Progressive Disease|7|||
131048365|NCT02467270|471812243|FG001|Overall Study|Progressive Disease|7|||
131048366|NCT02467270|471812244|FG002|Overall Study|Progressive Disease|4|||
131048367|NCT02467270|471812242|FG000|Overall Study|Death|2|||
131048368|NCT02467270|471812243|FG001|Overall Study|Death|0|||
131048369|NCT02467270|471812244|FG002|Overall Study|Death|2|||
131048370|NCT02467270|471812242|FG000|Overall Study|Lack of Efficacy|12|||
131048371|NCT02467270|471812243|FG001|Overall Study|Lack of Efficacy|18|||
131048372|NCT02467270|471812244|FG002|Overall Study|Lack of Efficacy|23|||
131048373|NCT02467270|471812242|FG000|Overall Study|Non-compliance With Study Drug|0|||
131048374|NCT02467270|471812243|FG001|Overall Study|Non-compliance With Study Drug|2|||
131048375|NCT02467270|471812244|FG002|Overall Study|Non-compliance With Study Drug|1|||
131048376|NCT02467270|471812242|FG000|Overall Study|Lost to Follow-up|2|||
131048377|NCT02467270|471812243|FG001|Overall Study|Lost to Follow-up|1|||
131048378|NCT02467270|471812244|FG002|Overall Study|Lost to Follow-up|0|||
131048379|NCT02467270|471812242|FG000|Overall Study|Pregnancy|0|||
131048380|NCT02467270|471812243|FG001|Overall Study|Pregnancy|1|||
131048381|NCT02467270|471812244|FG002|Overall Study|Pregnancy|0|||
131048382|NCT02467270|471812242|FG000|Overall Study|Physician Decision|0|||
131048383|NCT02467270|471812243|FG001|Overall Study|Physician Decision|4|||
131048384|NCT02467270|471812244|FG002|Overall Study|Physician Decision|1|||
131048385|NCT02467270|471812242|FG000|Overall Study|Withdrawal by Subject|4|||
131048386|NCT02467270|471812243|FG001|Overall Study|Withdrawal by Subject|3|||
131048387|NCT02467270|471812244|FG002|Overall Study|Withdrawal by Subject|5|||
131048388|NCT02467270|471812242|FG000|Overall Study|Reason not Specified|1|||
131048389|NCT02467270|471812243|FG001|Overall Study|Reason not Specified|2|||
131048390|NCT02467270|471812244|FG002|Overall Study|Reason not Specified|1|||
131048391|NCT00739908|471812245|FG000|Overall Study|Adverse Event|5|||
131048392|NCT00739908|471812246|FG001|Overall Study|Adverse Event|6|||
131048393|NCT00739908|471812245|FG000|Overall Study|Withdrawal by Subject|4|||
131048394|NCT00739908|471812246|FG001|Overall Study|Withdrawal by Subject|2|||
131048395|NCT00739908|471812245|FG000|Overall Study|Lost to Follow-up|14|||
131048396|NCT00739908|471812246|FG001|Overall Study|Lost to Follow-up|9|||
131048397|NCT00739908|471812245|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
131048398|NCT00739908|471812246|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
131048399|NCT00739908|471812245|FG000|Overall Study|Non-Compliance With Study Medication|0|||
131048400|NCT00739908|471812246|FG001|Overall Study|Non-Compliance With Study Medication|3|||
131048401|NCT00739908|471812245|FG000|Overall Study|Lack of Efficacy|0|||
131048402|NCT00739908|471812246|FG001|Overall Study|Lack of Efficacy|1|||
131048403|NCT00739908|471812245|FG000|Overall Study|Relocation|0|||
131048404|NCT00739908|471812246|FG001|Overall Study|Relocation|1|||
131048405|NCT00495677|471812248|FG000|Stage 1 (25 Days)|Adverse Event|0|||
131048406|NCT00495677|471812249|FG001|Stage 1 (25 Days)|Adverse Event|0|||
131048407|NCT00495677|471812250|FG002|Stage 1 (25 Days)|Adverse Event|1|||
131048408|NCT00495677|471812251|FG003|Stage 1 (25 Days)|Adverse Event|0|||
131048409|NCT00495677|471812252|FG004|Stage 1 (25 Days)|Adverse Event|0|||
131134208|NCT00326898|472118851|FG002|Overall Study|Adverse Event|33|||
131048410|NCT00495677|471812253|FG005|Stage 1 (25 Days)|Adverse Event|0|||
131048411|NCT00495677|471812254|FG006|Stage 1 (25 Days)|Adverse Event|0|||
131048412|NCT03868930|471812258|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
131048413|NCT03868930|471812259|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
131048414|NCT03868930|471812258|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
131048415|NCT03868930|471812259|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
131048416|NCT03868930|471812258|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
131048417|NCT03868930|471812259|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
131048418|NCT03868930|471812258|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
131048419|NCT03868930|471812259|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
131048420|NCT03868930|471812258|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
131048421|NCT03868930|471812259|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
131048422|NCT01046825|471812260|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
131048423|NCT01046825|471812261|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
131048424|NCT01046825|471812262|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
131048425|NCT01046825|471812263|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
131048426|NCT01046825|471812264|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
131048427|NCT01046825|471812260|FG000|Overall Study|Physician Decision|0|||
131048428|NCT01046825|471812261|FG001|Overall Study|Physician Decision|1|||
131048429|NCT01046825|471812262|FG002|Overall Study|Physician Decision|2|||
131048430|NCT01046825|471812263|FG003|Overall Study|Physician Decision|0|||
131048431|NCT01046825|471812264|FG004|Overall Study|Physician Decision|0|||
131048432|NCT01046825|471812260|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
131048433|NCT01046825|471812261|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
131048434|NCT01046825|471812262|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
131048435|NCT01046825|471812263|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
131048436|NCT01046825|471812264|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
131048437|NCT01046825|471812260|FG000|Overall Study|Found to be ineligible|0|||
131048438|NCT01046825|471812261|FG001|Overall Study|Found to be ineligible|1|||
131048439|NCT01046825|471812262|FG002|Overall Study|Found to be ineligible|0|||
131048440|NCT01046825|471812263|FG003|Overall Study|Found to be ineligible|0|||
131048441|NCT01046825|471812264|FG004|Overall Study|Found to be ineligible|0|||
131048442|NCT01046825|471812260|FG000|Overall Study|Death|0|||
131048443|NCT01046825|471812261|FG001|Overall Study|Death|0|||
131048444|NCT01046825|471812262|FG002|Overall Study|Death|0|||
131048445|NCT01046825|471812263|FG003|Overall Study|Death|1|||
131048446|NCT01046825|471812264|FG004|Overall Study|Death|0|||
131048447|NCT01046825|471812260|FG000|Overall Study|Did not submit biology samples|0|||
131048448|NCT01046825|471812261|FG001|Overall Study|Did not submit biology samples|0|||
131048449|NCT01046825|471812262|FG002|Overall Study|Did not submit biology samples|0|||
131048450|NCT01046825|471812263|FG003|Overall Study|Did not submit biology samples|0|||
131048451|NCT01046825|471812264|FG004|Overall Study|Did not submit biology samples|13|||
131048452|NCT01773993|471812266|FG000|Overall Study|No Visit After Treatment|35|||
131048453|NCT04664881|471812267|FG000|Overall Study|Withdrawal by Subject|1|||
131048454|NCT04664881|471812268|FG001|Overall Study|Withdrawal by Subject|8|||
131048455|NCT04664881|471812267|FG000|Overall Study|Physician Decision|0|||
131229631|NCT02668783|472467645|FG001|Overall Study|Withdrawal by Subject|0|||
131229632|NCT00112489|472467648|FG000|Overall Study|Refused further treatment|8|||
131229633|NCT00112489|472467648|FG000|Overall Study|Adverse Event|12|||
130722006|NCT02304458|470606412|FG003|Overall Study|Death|0|||
131048456|NCT04664881|471812268|FG001|Overall Study|Physician Decision|5|||
131048457|NCT04664881|471812267|FG000|Overall Study|Lost to Follow-up|1|||
131048458|NCT04664881|471812268|FG001|Overall Study|Lost to Follow-up|0|||
131048459|NCT04757753|471812271|FG000|Overall Study|Lost to Follow-up|7|||
131048460|NCT04757753|471812272|FG001|Overall Study|Lost to Follow-up|7|||
131048461|NCT04757753|471812271|FG000|Overall Study|Withdrawal by Subject|0|||
131048462|NCT04757753|471812272|FG001|Overall Study|Withdrawal by Subject|3|||
131048463|NCT04757753|471812271|FG000|Overall Study|Endodontic treatment failure|1|||
131048464|NCT04757753|471812272|FG001|Overall Study|Endodontic treatment failure|2|||
131048465|NCT04757753|471812271|FG000|Overall Study|Tooth fracture/extraction|3|||
131048466|NCT04757753|471812272|FG001|Overall Study|Tooth fracture/extraction|0|||
131048467|NCT00328783|471812273|FG000|Overall Study|Could not tolerate ABC|21|||
131048468|NCT00328783|471812273|FG000|Overall Study|No heart in RT field|4|||
131048469|NCT00328783|471812273|FG000|Overall Study|Withdrawal by Subject|1|||
131048470|NCT00357682|471812274|FG000|Overall Study|Did not receive allocated Treatment|10|||
131048471|NCT00357682|471812275|FG001|Overall Study|Did not receive allocated Treatment|9|||
131048472|NCT00357682|471812276|FG002|Overall Study|Did not receive allocated Treatment|9|||
131048473|NCT00357682|471812277|FG003|Overall Study|Did not receive allocated Treatment|10|||
131048474|NCT00357682|471812274|FG000|Overall Study|Withdrew consent|6|||
131048475|NCT00357682|471812275|FG001|Overall Study|Withdrew consent|6|||
131048476|NCT00357682|471812276|FG002|Overall Study|Withdrew consent|5|||
131048477|NCT00357682|471812277|FG003|Overall Study|Withdrew consent|5|||
131048478|NCT00357682|471812274|FG000|Overall Study|Lost to Follow-up|39|||
131048479|NCT00357682|471812275|FG001|Overall Study|Lost to Follow-up|33|||
131048480|NCT00357682|471812276|FG002|Overall Study|Lost to Follow-up|26|||
131048481|NCT00357682|471812277|FG003|Overall Study|Lost to Follow-up|35|||
131229634|NCT00112489|472467648|FG000|Overall Study|Death|2|||
130722007|NCT02304458|470606413|FG004|Overall Study|Death|0|||
130722008|NCT02304458|470606414|FG005|Overall Study|Death|0|||
130722009|NCT02304458|470606415|FG006|Overall Study|Death|1|||
130722010|NCT02304458|470606416|FG007|Overall Study|Death|0|||
130722011|NCT02304458|470606409|FG000|Overall Study|Lack of Efficacy|4|||
130722012|NCT02304458|470606410|FG001|Overall Study|Lack of Efficacy|6|||
130722013|NCT02304458|470606411|FG002|Overall Study|Lack of Efficacy|38|||
130722014|NCT02304458|470606412|FG003|Overall Study|Lack of Efficacy|5|||
130722015|NCT02304458|470606413|FG004|Overall Study|Lack of Efficacy|6|||
130722016|NCT02304458|470606414|FG005|Overall Study|Lack of Efficacy|6|||
130722017|NCT02304458|470606415|FG006|Overall Study|Lack of Efficacy|21|||
130722018|NCT02304458|470606416|FG007|Overall Study|Lack of Efficacy|4|||
130722019|NCT02304458|470606409|FG000|Overall Study|Physician Decision|2|||
130722020|NCT02304458|470606410|FG001|Overall Study|Physician Decision|0|||
130722021|NCT02304458|470606411|FG002|Overall Study|Physician Decision|16|||
131048482|NCT00357682|471812274|FG000|Overall Study|Adverse Event|24|||
131048483|NCT00357682|471812275|FG001|Overall Study|Adverse Event|32|||
131048484|NCT00357682|471812276|FG002|Overall Study|Adverse Event|22|||
131048485|NCT00357682|471812277|FG003|Overall Study|Adverse Event|27|||
131048486|NCT00357682|471812274|FG000|Overall Study|Physician Decision|32|||
131048487|NCT00357682|471812275|FG001|Overall Study|Physician Decision|20|||
131048488|NCT00357682|471812276|FG002|Overall Study|Physician Decision|24|||
131048489|NCT00357682|471812277|FG003|Overall Study|Physician Decision|30|||
131048490|NCT00357682|471812274|FG000|Overall Study|Patient decision|73|||
131048491|NCT00357682|471812275|FG001|Overall Study|Patient decision|80|||
131048492|NCT00357682|471812276|FG002|Overall Study|Patient decision|51|||
131048493|NCT00357682|471812277|FG003|Overall Study|Patient decision|59|||
131048494|NCT00357682|471812274|FG000|Overall Study|Other reason|157|||
131048495|NCT00357682|471812275|FG001|Overall Study|Other reason|130|||
131048496|NCT00357682|471812276|FG002|Overall Study|Other reason|114|||
131048497|NCT00357682|471812277|FG003|Overall Study|Other reason|99|||
131048498|NCT02701283|471812284|FG000|Overall Study|Death|25|||
131048499|NCT02701283|471812285|FG001|Overall Study|Death|29|||
131048500|NCT02701283|471812286|FG002|Overall Study|Death|19|||
131134209|NCT00326898|472118849|FG000|Overall Study|Death|2|||
130722022|NCT02304458|470606412|FG003|Overall Study|Physician Decision|1|||
130722023|NCT02304458|470606413|FG004|Overall Study|Physician Decision|0|||
130722024|NCT02304458|470606414|FG005|Overall Study|Physician Decision|0|||
130722025|NCT02304458|470606415|FG006|Overall Study|Physician Decision|3|||
130722026|NCT02304458|470606416|FG007|Overall Study|Physician Decision|0|||
130722027|NCT02304458|470606409|FG000|Overall Study|Protocol Violation|0|||
130722028|NCT02304458|470606410|FG001|Overall Study|Protocol Violation|0|||
130722029|NCT02304458|470606411|FG002|Overall Study|Protocol Violation|1|||
131048501|NCT02701283|471812284|FG000|Overall Study|Lost to Follow-up|3|||
131048502|NCT02701283|471812285|FG001|Overall Study|Lost to Follow-up|8|||
131134210|NCT00326898|472118850|FG001|Overall Study|Death|0|||
131134211|NCT00326898|472118851|FG002|Overall Study|Death|0|||
131134212|NCT00326898|472118849|FG000|Overall Study|Withdrawal by Subject|134|||
131134213|NCT00326898|472118850|FG001|Overall Study|Withdrawal by Subject|128|||
131134214|NCT00326898|472118851|FG002|Overall Study|Withdrawal by Subject|32|||
131134215|NCT00326898|472118849|FG000|Overall Study|Alternative therapy|1|||
131134216|NCT00326898|472118850|FG001|Overall Study|Alternative therapy|0|||
131134217|NCT00326898|472118851|FG002|Overall Study|Alternative therapy|0|||
131134218|NCT00326898|472118849|FG000|Overall Study|Other complicating disease|5|||
131134219|NCT00326898|472118850|FG001|Overall Study|Other complicating disease|5|||
131134220|NCT00326898|472118851|FG002|Overall Study|Other complicating disease|4|||
131134221|NCT00326898|472118849|FG000|Overall Study|Other/Missing/Unknown|33|||
131134222|NCT00326898|472118850|FG001|Overall Study|Other/Missing/Unknown|28|||
131134223|NCT00326898|472118851|FG002|Overall Study|Other/Missing/Unknown|32|||
131134224|NCT03847987|472118852|FG000|Overall Study|Lost to Follow-up|1|||
131134225|NCT03847987|472118853|FG001|Overall Study|Lost to Follow-up|0|||
131134226|NCT03847987|472118852|FG000|Overall Study|Adverse Event|2|||
131134227|NCT03847987|472118853|FG001|Overall Study|Adverse Event|0|||
131134228|NCT01637142|472118859|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
131134229|NCT02111564|472118860|FG000|Overall Study|Death|109|||
131134230|NCT02111564|472118861|FG001|Overall Study|Death|120|||
131134231|NCT02111564|472118860|FG000|Overall Study|Lost to Follow-up|2|||
131134232|NCT02111564|472118861|FG001|Overall Study|Lost to Follow-up|3|||
130722030|NCT02304458|470606412|FG003|Overall Study|Protocol Violation|0|||
130722031|NCT02304458|470606413|FG004|Overall Study|Protocol Violation|0|||
130722032|NCT02304458|470606414|FG005|Overall Study|Protocol Violation|0|||
131048503|NCT02701283|471812286|FG002|Overall Study|Lost to Follow-up|1|||
131048504|NCT02701283|471812284|FG000|Overall Study|Withdrawal by Subject|12|||
130722033|NCT02304458|470606415|FG006|Overall Study|Protocol Violation|0|||
130722034|NCT02304458|470606416|FG007|Overall Study|Protocol Violation|0|||
130722035|NCT02304458|470606409|FG000|Overall Study|Withdrawal by Subject|1|||
130722036|NCT02304458|470606410|FG001|Overall Study|Withdrawal by Subject|0|||
131048505|NCT02701283|471812285|FG001|Overall Study|Withdrawal by Subject|41|||
131048506|NCT02701283|471812286|FG002|Overall Study|Withdrawal by Subject|1|||
131048507|NCT02701283|471812284|FG000|Overall Study|Missed 2-year visit|22|||
131048508|NCT02701283|471812285|FG001|Overall Study|Missed 2-year visit|27|||
130722037|NCT02304458|470606411|FG002|Overall Study|Withdrawal by Subject|7|||
131048509|NCT02701283|471812286|FG002|Overall Study|Missed 2-year visit|0|||
131048510|NCT02701283|471812284|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
131048511|NCT02701283|471812285|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
131048512|NCT02701283|471812286|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
131048513|NCT04012567|471812287|FG000|Overall Study|Lost to Follow-up|0|||
131048514|NCT04012567|471812288|FG001|Overall Study|Lost to Follow-up|1|||
131048515|NCT04012567|471812287|FG000|Overall Study|Withdrawal by Subject|1|||
131048516|NCT04012567|471812288|FG001|Overall Study|Withdrawal by Subject|0|||
131134233|NCT02111564|472118860|FG000|Overall Study|Withdrawal by Subject|20|||
131134234|NCT02111564|472118861|FG001|Overall Study|Withdrawal by Subject|20|||
131134235|NCT00687362|472118862|FG000|Overall Study|Protocol Violation|2|||
131134236|NCT00687362|472118862|FG000|Overall Study|Withdrawal by Subject|1|||
131048521|NCT05180539|471813157|FG000|Overall Study|Lost to Follow-up|27|||
131048522|NCT05180539|471813158|FG001|Overall Study|Lost to Follow-up|30|||
131048523|NCT02566889|471813159|FG000|Overall Study|Withdrawal by Subject|3|||
131048524|NCT02566889|471813160|FG001|Overall Study|Withdrawal by Subject|1|||
131048525|NCT02566889|471813159|FG000|Overall Study|Adverse Event|4|||
131048526|NCT02566889|471813160|FG001|Overall Study|Adverse Event|2|||
131048527|NCT02566889|471813159|FG000|Overall Study|Other|6|||
131048528|NCT02566889|471813160|FG001|Overall Study|Other|2|||
131048529|NCT04518943|471813161|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
131048530|NCT04518943|471813162|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
131048531|NCT04518943|471813163|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
131048532|NCT04518943|471813164|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
131048533|NCT04518943|471813165|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
131048534|NCT04518943|471813166|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
131048535|NCT04518943|471813167|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
131048536|NCT04518943|471813168|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
131048537|NCT04518943|471813169|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
131048538|NCT04518943|471813170|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
131048539|NCT04518943|471813171|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
131048540|NCT04518943|471813172|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
131048541|NCT04518943|471813173|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
131048542|NCT04518943|471813174|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
131048543|NCT04518943|471813175|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
131048544|NCT04518943|471813176|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
131048545|NCT03699163|471813177|FG000|Overall Study|Physician Decision|12|||
131048546|NCT03699163|471813178|FG001|Overall Study|Physician Decision|0|||
131048547|NCT03699163|471813177|FG000|Overall Study|failed QC measures|205|||
131048548|NCT03699163|471813178|FG001|Overall Study|failed QC measures|206|||
131048549|NCT03875313|471813182|FG000|Overall Study|Withdrawal by Subject|1|||
131048550|NCT03875313|471813183|FG001|Overall Study|Withdrawal by Subject|3|||
131048551|NCT03875313|471813184|FG002|Overall Study|Withdrawal by Subject|0|||
131048552|NCT03875313|471813185|FG003|Overall Study|Withdrawal by Subject|0|||
131048553|NCT03875313|471813186|FG004|Overall Study|Withdrawal by Subject|0|||
131048554|NCT03875313|471813182|FG000|Overall Study|Death|0|||
131048555|NCT03875313|471813183|FG001|Overall Study|Death|0|||
131048556|NCT03875313|471813184|FG002|Overall Study|Death|0|||
131048557|NCT03875313|471813185|FG003|Overall Study|Death|0|||
131048558|NCT03875313|471813186|FG004|Overall Study|Death|1|||
131048559|NCT03875313|471813182|FG000|Overall Study|Lost to Follow-up|0|||
131048560|NCT03875313|471813183|FG001|Overall Study|Lost to Follow-up|0|||
131048561|NCT03875313|471813184|FG002|Overall Study|Lost to Follow-up|0|||
131048562|NCT03875313|471813185|FG003|Overall Study|Lost to Follow-up|0|||
131048563|NCT03875313|471813186|FG004|Overall Study|Lost to Follow-up|1|||
131048564|NCT03875313|471813182|FG000|Overall Study|Study Termination by Sponsor|0|||
131048565|NCT03875313|471813183|FG001|Overall Study|Study Termination by Sponsor|1|||
131048566|NCT03875313|471813184|FG002|Overall Study|Study Termination by Sponsor|1|||
131048567|NCT03875313|471813185|FG003|Overall Study|Study Termination by Sponsor|0|||
131048568|NCT03875313|471813186|FG004|Overall Study|Study Termination by Sponsor|1|||
131048569|NCT03875313|471813182|FG000|Overall Study|New Anticancer Treatment|0|||
131048570|NCT03875313|471813183|FG001|Overall Study|New Anticancer Treatment|1|||
131048571|NCT03875313|471813184|FG002|Overall Study|New Anticancer Treatment|2|||
131048572|NCT03875313|471813185|FG003|Overall Study|New Anticancer Treatment|1|||
130722038|NCT02304458|470606412|FG003|Overall Study|Withdrawal by Subject|0|||
131048573|NCT03875313|471813186|FG004|Overall Study|New Anticancer Treatment|0|||
131134237|NCT00925015|472118865|FG000|Overall Study|Adverse Event|1|||
130722039|NCT02304458|470606413|FG004|Overall Study|Withdrawal by Subject|0|||
131048574|NCT03875313|471813182|FG000|Overall Study|Other, Not Specified|2|||
131048575|NCT03875313|471813183|FG001|Overall Study|Other, Not Specified|11|||
131048576|NCT03875313|471813184|FG002|Overall Study|Other, Not Specified|3|||
131048577|NCT03875313|471813185|FG003|Overall Study|Other, Not Specified|3|||
131048578|NCT03875313|471813186|FG004|Overall Study|Other, Not Specified|1|||
131048579|NCT04227899|471813190|FG000|Overall Study|Withdrawal by Subject|6|||
131048580|NCT04227899|471813191|FG001|Overall Study|Withdrawal by Subject|3|||
131048581|NCT04227899|471813190|FG000|Overall Study|Death|12|||
131048582|NCT04227899|471813191|FG001|Overall Study|Death|6|||
131048583|NCT04227899|471813190|FG000|Overall Study|Lost to Follow-up|2|||
131048584|NCT04227899|471813191|FG001|Overall Study|Lost to Follow-up|1|||
131048585|NCT03286114|471813195|FG000|Overall Study|Adverse Event|6|||
131048586|NCT03286114|471813195|FG000|Overall Study|Death|3|||
131048587|NCT02075554|471813197|FG000|Overall Study|Lost to Follow-up|7|||
131048588|NCT02075554|471813197|FG000|Overall Study|Withdrawal by Subject|5|||
131048589|NCT02075554|471813197|FG000|Overall Study|Physician Decision|3|||
131048590|NCT04993677|471813204|FG000|Overall Study|Lost to Follow-up|1|||
131048591|NCT04993677|471813205|FG001|Overall Study|Lost to Follow-up|0|||
131048592|NCT04993677|471813206|FG002|Overall Study|Lost to Follow-up|0|||
131048593|NCT04993677|471813207|FG003|Overall Study|Lost to Follow-up|0|||
131048594|NCT04993677|471813204|FG000|Overall Study|Death|11|||
131048595|NCT04993677|471813205|FG001|Overall Study|Death|8|||
131048596|NCT04993677|471813206|FG002|Overall Study|Death|3|||
131048597|NCT04993677|471813207|FG003|Overall Study|Death|1|||
131048598|NCT04993677|471813204|FG000|Overall Study|Subject withdrawal of consent|4|||
131048599|NCT04993677|471813205|FG001|Overall Study|Subject withdrawal of consent|3|||
131048600|NCT04993677|471813206|FG002|Overall Study|Subject withdrawal of consent|0|||
131048601|NCT04993677|471813207|FG003|Overall Study|Subject withdrawal of consent|2|||
131048602|NCT04993677|471813204|FG000|Overall Study|Study termination by sponsor|3|||
131048603|NCT04993677|471813205|FG001|Overall Study|Study termination by sponsor|25|||
131048604|NCT04993677|471813206|FG002|Overall Study|Study termination by sponsor|3|||
131048605|NCT04993677|471813207|FG003|Overall Study|Study termination by sponsor|3|||
131048606|NCT04993677|471813204|FG000|Overall Study|Other|2|||
131048607|NCT04993677|471813205|FG001|Overall Study|Other|3|||
131048608|NCT04993677|471813206|FG002|Overall Study|Other|3|||
131048609|NCT04993677|471813207|FG003|Overall Study|Other|2|||
131048610|NCT00003222|471813214|FG000|Overall Study|Physician Decision|0|||
131048611|NCT00003222|471813215|FG001|Overall Study|Physician Decision|1|||
131048612|NCT03767335|471813216|FG000|Overall Study|Physician Decision|1|||
131048613|NCT03767335|471813217|FG001|Overall Study|Physician Decision|1|||
131048614|NCT03767335|471813218|FG002|Overall Study|Physician Decision|0|||
131048615|NCT03767335|471813216|FG000|Overall Study|Withdrawal by Subject|0|||
131048616|NCT03767335|471813217|FG001|Overall Study|Withdrawal by Subject|0|||
131048617|NCT03767335|471813218|FG002|Overall Study|Withdrawal by Subject|6|||
131048618|NCT03767335|471813216|FG000|Overall Study|Participant excluded from efficacy population|0|||
131048619|NCT03767335|471813217|FG001|Overall Study|Participant excluded from efficacy population|0|||
131048620|NCT03767335|471813218|FG002|Overall Study|Participant excluded from efficacy population|1|||
131048621|NCT03767335|471813216|FG000|Overall Study|Death|0|||
131048622|NCT03767335|471813217|FG001|Overall Study|Death|0|||
131048623|NCT03767335|471813218|FG002|Overall Study|Death|2|||
131048624|NCT03767335|471813216|FG000|Overall Study|Progressive Disease|2|||
131048625|NCT03767335|471813217|FG001|Overall Study|Progressive Disease|2|||
131048626|NCT03767335|471813218|FG002|Overall Study|Progressive Disease|2|||
131048627|NCT03767335|471813216|FG000|Overall Study|Disease progression needing additional medication|0|||
131048628|NCT03767335|471813217|FG001|Overall Study|Disease progression needing additional medication|0|||
131048629|NCT03767335|471813218|FG002|Overall Study|Disease progression needing additional medication|17|||
131048630|NCT03767335|471813216|FG000|Overall Study|Sponsor decision|0|||
131048631|NCT03767335|471813217|FG001|Overall Study|Sponsor decision|0|||
131048632|NCT03767335|471813218|FG002|Overall Study|Sponsor decision|2|||
131048633|NCT03767335|471813216|FG000|Overall Study|Other Medical Reasons|0|||
131048634|NCT03767335|471813217|FG001|Overall Study|Other Medical Reasons|0|||
131048635|NCT03767335|471813218|FG002|Overall Study|Other Medical Reasons|3|||
131048636|NCT04495621|471813220|FG000|Overall Study|Withdrawal by Subject|0|||
131048637|NCT04495621|471813221|FG001|Overall Study|Withdrawal by Subject|3|||
131048638|NCT04495621|471813220|FG000|Overall Study|Death|7|||
131048639|NCT04495621|471813221|FG001|Overall Study|Death|11|||
131048640|NCT04495621|471813220|FG000|Overall Study|Investigator Decision|0|||
131048641|NCT04495621|471813221|FG001|Overall Study|Investigator Decision|7|||
131048642|NCT04495621|471813220|FG000|Overall Study|Lost to Follow-up|0|||
131048643|NCT04495621|471813221|FG001|Overall Study|Lost to Follow-up|1|||
131048644|NCT01313559|471813227|FG000|Overall Study|Withdrawal by Subject|1|||
131048645|NCT01313559|471813228|FG001|Overall Study|Withdrawal by Subject|2|||
131048646|NCT01313559|471813227|FG000|Overall Study|Disease progression|1|||
131048647|NCT01313559|471813228|FG001|Overall Study|Disease progression|0|||
131048648|NCT01313559|471813227|FG000|Overall Study|Rising PSA|2|||
131048649|NCT01313559|471813228|FG001|Overall Study|Rising PSA|0|||
131048650|NCT02656706|471813229|FG000|Overall Study|Insurance Denial|1|||
131048651|NCT03725332|471813230|FG000|Overall Study|Adverse Event|5|||
131048652|NCT03725332|471813231|FG001|Overall Study|Adverse Event|10|||
131048653|NCT03725332|471813230|FG000|Overall Study|Death|1|||
131048654|NCT03725332|471813231|FG001|Overall Study|Death|3|||
131048655|NCT03725332|471813230|FG000|Overall Study|Lost to Follow-up|43|||
131048656|NCT03725332|471813231|FG001|Overall Study|Lost to Follow-up|122|||
131048657|NCT03725332|471813230|FG000|Overall Study|Withdrawal by Subject|0|||
131048658|NCT03725332|471813231|FG001|Overall Study|Withdrawal by Subject|1|||
131048659|NCT03725332|471813230|FG000|Overall Study|Duplicate enrollment|0|||
131048660|NCT03725332|471813231|FG001|Overall Study|Duplicate enrollment|1|||
131048661|NCT03725332|471813230|FG000|Overall Study|Did not consent|0|||
131048662|NCT03725332|471813231|FG001|Overall Study|Did not consent|1|||
131048663|NCT04908514|471813243|FG000|Overall Study|Lost to Follow-up|2|||
131048664|NCT04908514|471813243|FG000|Overall Study|Withdrawal by Subject|1|||
131048665|NCT03248492|471813852|FG000|Overall Study|Progressive Disease|24|||
131048666|NCT03248492|471813853|FG001|Overall Study|Progressive Disease|23|||
131048667|NCT03248492|471813854|FG002|Overall Study|Progressive Disease|11|||
131048668|NCT03248492|471813855|FG003|Overall Study|Progressive Disease|66|||
131048669|NCT03248492|471813856|FG004|Overall Study|Progressive Disease|1|||
131048670|NCT03248492|471813852|FG000|Overall Study|Adverse Event|14|||
131048671|NCT03248492|471813853|FG001|Overall Study|Adverse Event|13|||
131048672|NCT03248492|471813854|FG002|Overall Study|Adverse Event|9|||
131048673|NCT03248492|471813855|FG003|Overall Study|Adverse Event|22|||
131048674|NCT03248492|471813856|FG004|Overall Study|Adverse Event|2|||
131048675|NCT03248492|471813852|FG000|Overall Study|Withdrawal by Subject|5|||
131048676|NCT03248492|471813853|FG001|Overall Study|Withdrawal by Subject|4|||
131048677|NCT03248492|471813854|FG002|Overall Study|Withdrawal by Subject|0|||
131048678|NCT03248492|471813855|FG003|Overall Study|Withdrawal by Subject|8|||
131048679|NCT03248492|471813856|FG004|Overall Study|Withdrawal by Subject|1|||
131048680|NCT03248492|471813852|FG000|Overall Study|Physician Decision|1|||
131048681|NCT03248492|471813853|FG001|Overall Study|Physician Decision|1|||
131048682|NCT03248492|471813854|FG002|Overall Study|Physician Decision|1|||
131048683|NCT03248492|471813855|FG003|Overall Study|Physician Decision|7|||
131048684|NCT03248492|471813856|FG004|Overall Study|Physician Decision|0|||
131048685|NCT03248492|471813852|FG000|Overall Study|Death|1|||
131048686|NCT03248492|471813853|FG001|Overall Study|Death|1|||
131048687|NCT03248492|471813854|FG002|Overall Study|Death|0|||
131048688|NCT03248492|471813855|FG003|Overall Study|Death|6|||
131048689|NCT03248492|471813856|FG004|Overall Study|Death|0|||
131048690|NCT03248492|471813852|FG000|Overall Study|Study Terminated by Sponsor|3|||
131048691|NCT03248492|471813853|FG001|Overall Study|Study Terminated by Sponsor|1|||
131048692|NCT03248492|471813854|FG002|Overall Study|Study Terminated by Sponsor|0|||
131048693|NCT03248492|471813855|FG003|Overall Study|Study Terminated by Sponsor|7|||
131048694|NCT03248492|471813856|FG004|Overall Study|Study Terminated by Sponsor|0|||
131048695|NCT03248492|471813852|FG000|Overall Study|Other|2|||
131048696|NCT03248492|471813853|FG001|Overall Study|Other|5|||
131048697|NCT03248492|471813854|FG002|Overall Study|Other|0|||
131048698|NCT03248492|471813855|FG003|Overall Study|Other|14|||
131048699|NCT03248492|471813856|FG004|Overall Study|Other|0|||
131048700|NCT03705390|471813857|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
131048701|NCT03705390|471813857|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
131048702|NCT04940624|471813859|FG000|Overall Study|Adverse Event|4|||
131048703|NCT04940624|471813860|FG001|Overall Study|Adverse Event|11|||
131048704|NCT04940624|471813859|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131048705|NCT04940624|471813860|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
131048706|NCT04940624|471813859|FG000|Overall Study|Physician Decision|1|||
131048707|NCT04940624|471813860|FG001|Overall Study|Physician Decision|0|||
131048708|NCT04940624|471813859|FG000|Overall Study|Lost to Follow-up|1|||
131048709|NCT04940624|471813860|FG001|Overall Study|Lost to Follow-up|0|||
131048710|NCT04940624|471813859|FG000|Overall Study|Reason Not Specified|1|||
131048711|NCT04940624|471813860|FG001|Overall Study|Reason Not Specified|0|||
131048712|NCT05116774|471813865|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
131048713|NCT05116774|471813866|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
131048714|NCT05116774|471813865|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
131048715|NCT05116774|471813866|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
130722040|NCT02304458|470606414|FG005|Overall Study|Withdrawal by Subject|0|||
130722041|NCT02304458|470606415|FG006|Overall Study|Withdrawal by Subject|1|||
131048716|NCT05116774|471813865|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
131048717|NCT05116774|471813866|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
131048718|NCT05116774|471813865|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
131048719|NCT05116774|471813866|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
131048720|NCT03150862|471813867|FG000|Overall Study|Death|2|||
131048721|NCT03150862|471813868|FG001|Overall Study|Death|7|||
130722042|NCT02304458|470606416|FG007|Overall Study|Withdrawal by Subject|0|||
131048722|NCT03150862|471813869|FG002|Overall Study|Death|8|||
131048723|NCT03150862|471813870|FG003|Overall Study|Death|27|||
131048724|NCT03150862|471813871|FG004|Overall Study|Death|4|||
131048725|NCT03150862|471813872|FG005|Overall Study|Death|8|||
131048726|NCT03150862|471813873|FG006|Overall Study|Death|6|||
131048727|NCT03150862|471813874|FG007|Overall Study|Death|21|||
131048728|NCT03150862|471813867|FG000|Overall Study|Withdrawal by Subject|1|||
131048729|NCT03150862|471813868|FG001|Overall Study|Withdrawal by Subject|1|||
131048730|NCT03150862|471813869|FG002|Overall Study|Withdrawal by Subject|0|||
130722043|NCT03401450|470606417|FG000|Overall Study|Lost to Follow-up|4|||
130722044|NCT03401450|470606418|FG001|Overall Study|Lost to Follow-up|6|||
130722045|NCT03401450|470606417|FG000|Overall Study|Anesthesia plan changed|2|||
131048731|NCT03150862|471813870|FG003|Overall Study|Withdrawal by Subject|3|||
131048732|NCT03150862|471813871|FG004|Overall Study|Withdrawal by Subject|1|||
131048733|NCT03150862|471813872|FG005|Overall Study|Withdrawal by Subject|1|||
131048734|NCT03150862|471813873|FG006|Overall Study|Withdrawal by Subject|1|||
131048735|NCT03150862|471813874|FG007|Overall Study|Withdrawal by Subject|3|||
131048736|NCT03150862|471813867|FG000|Overall Study|Lost to Follow-up|0|||
131048737|NCT03150862|471813868|FG001|Overall Study|Lost to Follow-up|0|||
131048738|NCT03150862|471813869|FG002|Overall Study|Lost to Follow-up|1|||
131048739|NCT03150862|471813870|FG003|Overall Study|Lost to Follow-up|0|||
131048740|NCT03150862|471813871|FG004|Overall Study|Lost to Follow-up|0|||
131048741|NCT03150862|471813872|FG005|Overall Study|Lost to Follow-up|0|||
131048742|NCT03150862|471813873|FG006|Overall Study|Lost to Follow-up|0|||
131048743|NCT03150862|471813874|FG007|Overall Study|Lost to Follow-up|2|||
131048744|NCT03150862|471813867|FG000|Overall Study|Sponsor's decision|0|||
131048745|NCT03150862|471813868|FG001|Overall Study|Sponsor's decision|0|||
131048746|NCT03150862|471813869|FG002|Overall Study|Sponsor's decision|0|||
131048747|NCT03150862|471813870|FG003|Overall Study|Sponsor's decision|10|||
131048748|NCT03150862|471813871|FG004|Overall Study|Sponsor's decision|3|||
131048749|NCT03150862|471813872|FG005|Overall Study|Sponsor's decision|0|||
131048750|NCT03150862|471813873|FG006|Overall Study|Sponsor's decision|1|||
131048751|NCT03150862|471813874|FG007|Overall Study|Sponsor's decision|1|||
131048752|NCT03150862|471813867|FG000|Overall Study|Change in Methylation status|0|||
131048753|NCT03150862|471813868|FG001|Overall Study|Change in Methylation status|0|||
131048754|NCT03150862|471813869|FG002|Overall Study|Change in Methylation status|0|||
131048755|NCT03150862|471813870|FG003|Overall Study|Change in Methylation status|0|||
131048756|NCT03150862|471813871|FG004|Overall Study|Change in Methylation status|1|||
131048757|NCT03150862|471813872|FG005|Overall Study|Change in Methylation status|0|||
131048758|NCT03150862|471813873|FG006|Overall Study|Change in Methylation status|0|||
131048759|NCT03150862|471813874|FG007|Overall Study|Change in Methylation status|0|||
131048760|NCT03150862|471813867|FG000|Overall Study|Roll over in to Long Term Extension|0|||
131048761|NCT03150862|471813868|FG001|Overall Study|Roll over in to Long Term Extension|0|||
131048762|NCT03150862|471813869|FG002|Overall Study|Roll over in to Long Term Extension|0|||
131048763|NCT03150862|471813870|FG003|Overall Study|Roll over in to Long Term Extension|0|||
131048764|NCT03150862|471813871|FG004|Overall Study|Roll over in to Long Term Extension|0|||
131048765|NCT03150862|471813872|FG005|Overall Study|Roll over in to Long Term Extension|0|||
131048766|NCT03150862|471813873|FG006|Overall Study|Roll over in to Long Term Extension|0|||
131048767|NCT03150862|471813874|FG007|Overall Study|Roll over in to Long Term Extension|1|||
131048768|NCT03150862|471813867|FG000|Overall Study|Progressive Disease|0|||
131048769|NCT03150862|471813868|FG001|Overall Study|Progressive Disease|0|||
131048770|NCT03150862|471813869|FG002|Overall Study|Progressive Disease|0|||
131048771|NCT03150862|471813870|FG003|Overall Study|Progressive Disease|0|||
131048772|NCT03150862|471813871|FG004|Overall Study|Progressive Disease|0|||
131048773|NCT03150862|471813872|FG005|Overall Study|Progressive Disease|0|||
131048774|NCT03150862|471813873|FG006|Overall Study|Progressive Disease|0|||
131048775|NCT03150862|471813874|FG007|Overall Study|Progressive Disease|2|||
131048776|NCT04505722|471813876|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
131048777|NCT04505722|471813877|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
131048778|NCT04505722|471813878|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
131048779|NCT04505722|471813876|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
131048780|NCT04505722|471813877|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
131048781|NCT04505722|471813878|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
131048782|NCT04505722|471813876|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
131048783|NCT04505722|471813877|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
131048784|NCT04505722|471813878|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
131048785|NCT04505722|471813876|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
131048786|NCT04505722|471813877|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
131048787|NCT04505722|471813878|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
131048788|NCT04505722|471813876|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
131048789|NCT04505722|471813877|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
131048790|NCT04505722|471813878|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
131048791|NCT04505722|471813876|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
131048792|NCT04505722|471813877|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
131048793|NCT04505722|471813878|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
131048794|NCT04505722|471813876|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
131048795|NCT04505722|471813877|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
131048796|NCT04505722|471813878|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
131048797|NCT04505722|471813876|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
131048798|NCT04505722|471813877|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
131048799|NCT04505722|471813878|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
131048800|NCT04505722|471813876|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
131048801|NCT04505722|471813877|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
131048802|NCT04505722|471813878|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
131048803|NCT04505722|471813876|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
131048804|NCT04505722|471813877|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
131048805|NCT04505722|471813878|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
131048806|NCT04505722|471813876|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
131048807|NCT04505722|471813877|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
131048808|NCT04505722|471813878|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
131048809|NCT04505722|471813876|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
131048810|NCT04505722|471813877|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
131048811|NCT04505722|471813878|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
131048812|NCT04505722|471813876|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
131048813|NCT04505722|471813877|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
131048814|NCT04505722|471813878|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
131048815|NCT04505722|471813876|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
131048816|NCT04505722|471813877|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
131048817|NCT04505722|471813878|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
131048818|NCT04505722|471813876|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
131048819|NCT04505722|471813877|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
131048820|NCT04505722|471813878|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
131048821|NCT04755595|471813879|FG000|Overall Study|Lost to Follow-up|1|||
131048822|NCT00319696|471813880|FG000|Overall Study|Adverse Event|36|||
131048823|NCT00319696|471813880|FG000|Overall Study|withdrawal of consent|14|||
131048824|NCT00319696|471813880|FG000|Overall Study|administrative|7|||
131048825|NCT00319696|471813880|FG000|Overall Study|Lost to Follow-up|3|||
131048826|NCT03891758|471813882|FG000|Overall Study|Adverse Event|2|||
131048827|NCT03891758|471813883|FG001|Overall Study|Adverse Event|0|||
131048828|NCT03891758|471813882|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131048829|NCT03891758|471813883|FG001|Overall Study|Withdrawal by parent/guardian|2|||
131048830|NCT04977583|471814316|FG000|Overall Study|Lost to Follow-up|8|||
131048831|NCT04977583|471814317|FG001|Overall Study|Lost to Follow-up|4|||
131048832|NCT04977583|471814318|FG002|Overall Study|Lost to Follow-up|13|||
131048833|NCT04977583|471814316|FG000|Overall Study|Withdrawal by Subject|3|||
131048834|NCT04977583|471814317|FG001|Overall Study|Withdrawal by Subject|2|||
131048835|NCT04977583|471814318|FG002|Overall Study|Withdrawal by Subject|1|||
131048836|NCT04121546|471814319|FG000|Overall Study|Lost to Follow-up|1|||
131048837|NCT04121546|471814320|FG001|Overall Study|Lost to Follow-up|3|||
131048838|NCT03653364|471814321|FG000|Overall Study|Withdrawal by Subject|1|||
131048839|NCT03653364|471814321|FG000|Overall Study|Enrolled in Error|1|||
131048840|NCT03653364|471814321|FG000|Overall Study|Death|1|||
131048841|NCT00686595|471814322|FG000|Overall Study|Adverse Event|3|||
131048842|NCT00686595|471814322|FG000|Overall Study|Protocol Violation|1|||
131048843|NCT00686595|471814322|FG000|Overall Study|Lost to Follow-up|1|||
131048844|NCT00686595|471814322|FG000|Overall Study|Lack of Efficacy|1|||
131048845|NCT00686595|471814322|FG000|Overall Study|Poor Compliance|1|||
131048846|NCT03213457|471814323|FG000|Screening Period|Withdrawal by Subject|0|||
131048847|NCT03213457|471814324|FG001|Screening Period|Withdrawal by Subject|1|||
131048848|NCT03213457|471814325|FG002|Screening Period|Withdrawal by Subject|0|||
131048849|NCT03213457|471814323|FG000|Screening Period|Other|1|||
131048850|NCT03213457|471814324|FG001|Screening Period|Other|0|||
131048851|NCT03213457|471814325|FG002|Screening Period|Other|0|||
131048852|NCT03213457|471814323|FG000|Double-Blind Period|Adverse Event|3|||
131048853|NCT03213457|471814324|FG001|Double-Blind Period|Adverse Event|2|||
131048854|NCT03213457|471814325|FG002|Double-Blind Period|Adverse Event|7|||
131048855|NCT03213457|471814323|FG000|Double-Blind Period|Withdrawal by Subject|14|||
131048856|NCT03213457|471814324|FG001|Double-Blind Period|Withdrawal by Subject|2|||
131134238|NCT00925015|472118866|FG001|Overall Study|Adverse Event|2|||
131134239|NCT00925015|472118867|FG002|Overall Study|Adverse Event|1|||
131134240|NCT00925015|472118865|FG000|Overall Study|Physician Decision|0|||
131134241|NCT00925015|472118866|FG001|Overall Study|Physician Decision|1|||
131134242|NCT00925015|472118867|FG002|Overall Study|Physician Decision|0|||
131134243|NCT00925015|472118865|FG000|Overall Study|Progressive Disease|7|||
131134244|NCT00925015|472118866|FG001|Overall Study|Progressive Disease|3|||
131134245|NCT00925015|472118867|FG002|Overall Study|Progressive Disease|4|||
131134246|NCT00925015|472118865|FG000|Overall Study|Withdrawal by Subject|0|||
131134247|NCT00925015|472118866|FG001|Overall Study|Withdrawal by Subject|0|||
131048857|NCT03213457|471814325|FG002|Double-Blind Period|Withdrawal by Subject|14|||
131048858|NCT03213457|471814323|FG000|Double-Blind Period|Lost to Follow-up|2|||
131048859|NCT03213457|471814324|FG001|Double-Blind Period|Lost to Follow-up|3|||
131048860|NCT03213457|471814325|FG002|Double-Blind Period|Lost to Follow-up|9|||
131048861|NCT03213457|471814323|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
131048862|NCT03213457|471814324|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
131048863|NCT03213457|471814325|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
131134248|NCT00925015|472118867|FG002|Overall Study|Withdrawal by Subject|1|||
131134249|NCT05499559|472118868|FG000|Overall Study|Lost to Follow-up|467|||
130779266|NCT04155463|470819466|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
131048864|NCT03213457|471814323|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
131048865|NCT03213457|471814324|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
131048866|NCT03213457|471814325|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
131048867|NCT03213457|471814323|FG000|Double-Blind Period|Pregnancy|5|||
131048868|NCT03213457|471814324|FG001|Double-Blind Period|Pregnancy|0|||
131048869|NCT03213457|471814325|FG002|Double-Blind Period|Pregnancy|0|||
131048870|NCT03213457|471814323|FG000|Double-Blind Period|Other|10|||
131048871|NCT03213457|471814324|FG001|Double-Blind Period|Other|3|||
131048872|NCT03213457|471814325|FG002|Double-Blind Period|Other|17|||
131048873|NCT03213457|471814323|FG000|Open-Label Period|Adverse Event|1|||
131048874|NCT03213457|471814324|FG001|Open-Label Period|Adverse Event|2|||
131048875|NCT03213457|471814325|FG002|Open-Label Period|Adverse Event|2|||
131048876|NCT03213457|471814323|FG000|Open-Label Period|Withdrawal by Subject|12|||
131048877|NCT03213457|471814324|FG001|Open-Label Period|Withdrawal by Subject|5|||
131048878|NCT03213457|471814325|FG002|Open-Label Period|Withdrawal by Subject|24|||
131048879|NCT03213457|471814323|FG000|Open-Label Period|Lost to Follow-up|1|||
131048880|NCT03213457|471814324|FG001|Open-Label Period|Lost to Follow-up|2|||
131048881|NCT03213457|471814325|FG002|Open-Label Period|Lost to Follow-up|8|||
131048882|NCT03213457|471814323|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
131048883|NCT03213457|471814324|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
131048884|NCT03213457|471814325|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
131048885|NCT03213457|471814323|FG000|Open-Label Period|Non-compliance with study procedures|1|||
131048886|NCT03213457|471814324|FG001|Open-Label Period|Non-compliance with study procedures|1|||
131048887|NCT03213457|471814325|FG002|Open-Label Period|Non-compliance with study procedures|2|||
131048888|NCT03213457|471814323|FG000|Open-Label Period|Exclusionary medications|0|||
131048889|NCT03213457|471814324|FG001|Open-Label Period|Exclusionary medications|0|||
131048890|NCT03213457|471814325|FG002|Open-Label Period|Exclusionary medications|1|||
131048891|NCT03213457|471814323|FG000|Open-Label Period|Other|1|||
131048892|NCT03213457|471814324|FG001|Open-Label Period|Other|1|||
131048893|NCT03213457|471814325|FG002|Open-Label Period|Other|6|||
131048894|NCT03213457|471814323|FG000|Follow-Up Period|Adverse Event|16|||
131048895|NCT03213457|471814324|FG001|Follow-Up Period|Adverse Event|8|||
131048896|NCT03213457|471814325|FG002|Follow-Up Period|Adverse Event|37|||
131048897|NCT03213457|471814323|FG000|Follow-Up Period|Withdrawal by Subject|18|||
131048898|NCT03213457|471814324|FG001|Follow-Up Period|Withdrawal by Subject|11|||
131048899|NCT03213457|471814325|FG002|Follow-Up Period|Withdrawal by Subject|55|||
131048900|NCT03213457|471814323|FG000|Follow-Up Period|Lost to Follow-up|28|||
131048901|NCT03213457|471814324|FG001|Follow-Up Period|Lost to Follow-up|15|||
131048902|NCT03213457|471814325|FG002|Follow-Up Period|Lost to Follow-up|50|||
131048903|NCT03213457|471814323|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
131048904|NCT03213457|471814324|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
131048905|NCT03213457|471814325|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
131048906|NCT03213457|471814323|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
131048907|NCT03213457|471814324|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
131048908|NCT03213457|471814325|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
131048909|NCT03213457|471814323|FG000|Follow-Up Period|Pregnancy|7|||
131048910|NCT03213457|471814324|FG001|Follow-Up Period|Pregnancy|0|||
131048911|NCT03213457|471814325|FG002|Follow-Up Period|Pregnancy|18|||
131048912|NCT03213457|471814323|FG000|Follow-Up Period|Exclusionary medications|1|||
131048913|NCT03213457|471814324|FG001|Follow-Up Period|Exclusionary medications|1|||
131048914|NCT03213457|471814325|FG002|Follow-Up Period|Exclusionary medications|5|||
131048915|NCT03213457|471814323|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
131048916|NCT03213457|471814324|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
131048917|NCT03213457|471814325|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
131048918|NCT03213457|471814323|FG000|Follow-Up Period|Other|14|||
131048919|NCT03213457|471814324|FG001|Follow-Up Period|Other|10|||
131048920|NCT03213457|471814325|FG002|Follow-Up Period|Other|31|||
131048921|NCT01830595|471814326|FG000|First Period|Withdrawal by Subject|1|||
131048922|NCT01830595|471814327|FG001|First Period|Withdrawal by Subject|3|||
131048923|NCT01830595|471814326|FG000|Washout|Withdrawal by Subject|2|||
131048924|NCT01830595|471814327|FG001|Washout|Withdrawal by Subject|2|||
131048925|NCT05934292|471814334|FG000|Overall Study|Lost to Follow-up|0|||
131048926|NCT05934292|471814335|FG001|Overall Study|Lost to Follow-up|0|||
131048927|NCT05934292|471814336|FG002|Overall Study|Lost to Follow-up|1|||
131048928|NCT05934292|471814337|FG003|Overall Study|Lost to Follow-up|0|||
131048929|NCT04479787|471814338|FG000|Through 6 Months|Withdrawal by Subject|16|||
131048930|NCT04479787|471814339|FG001|Through 6 Months|Withdrawal by Subject|14|||
131048931|NCT04479787|471814338|FG000|Through 6 Months|Unsuccessful Trial|17|||
131048932|NCT04479787|471814339|FG001|Through 6 Months|Unsuccessful Trial|0|||
131048933|NCT04479787|471814338|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
131048934|NCT04479787|471814339|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
131048935|NCT04479787|471814338|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
131048936|NCT04479787|471814339|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
131048937|NCT04479787|471814338|FG000|Through 6 Months|Lost to Follow-up|3|||
131048938|NCT04479787|471814339|FG001|Through 6 Months|Lost to Follow-up|2|||
131048939|NCT04479787|471814338|FG000|Through 6 Months|Death|3|||
131048940|NCT04479787|471814339|FG001|Through 6 Months|Death|0|||
131048941|NCT04479787|471814338|FG000|Through 6 Months|Inclusion/Exclusion|2|||
131048942|NCT04479787|471814339|FG001|Through 6 Months|Inclusion/Exclusion|1|||
131048943|NCT04479787|471814338|FG000|Through 6 Months|Subject Became Pregnant|1|||
131048944|NCT04479787|471814339|FG001|Through 6 Months|Subject Became Pregnant|1|||
131048945|NCT04479787|471814338|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
131048946|NCT04479787|471814339|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
131048947|NCT04479787|471814338|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
131048948|NCT04479787|471814339|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
131048949|NCT04479787|471814338|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
131048950|NCT04479787|471814339|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
131048951|NCT04479787|471814338|FG000|After 6 Months|Withdrawal by Subject|3|||
131048952|NCT04479787|471814339|FG001|After 6 Months|Withdrawal by Subject|13|||
131048953|NCT04479787|471814338|FG000|After 6 Months|Unsuccessful Trial|0|||
131048954|NCT04479787|471814339|FG001|After 6 Months|Unsuccessful Trial|7|||
131048955|NCT04479787|471814338|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
131048956|NCT04479787|471814339|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
131048957|NCT04479787|471814338|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
131048958|NCT04479787|471814339|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
131048959|NCT04479787|471814338|FG000|After 6 Months|Death|2|||
131048960|NCT04479787|471814339|FG001|After 6 Months|Death|0|||
131048961|NCT04479787|471814338|FG000|After 6 Months|Lost to Follow-up|1|||
131048962|NCT04479787|471814339|FG001|After 6 Months|Lost to Follow-up|1|||
131048963|NCT04479787|471814338|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
131048964|NCT04479787|471814339|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
131048965|NCT04479787|471814338|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
131048966|NCT04479787|471814339|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
131048967|NCT04479787|471814338|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
131048968|NCT04479787|471814339|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
131048969|NCT04479787|471814338|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
131048970|NCT04479787|471814339|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
131048971|NCT05714059|471814340|FG000|Overall Study|Withdrawal by Subject|2|||
131048972|NCT05714059|471814341|FG001|Overall Study|Withdrawal by Subject|2|||
131048973|NCT05714059|471814340|FG000|Overall Study|Adverse Event|0|||
131048974|NCT05714059|471814341|FG001|Overall Study|Adverse Event|1|||
131048975|NCT05714059|471814340|FG000|Overall Study|Lost to Follow-up|0|||
131048976|NCT05714059|471814341|FG001|Overall Study|Lost to Follow-up|1|||
131048977|NCT05714059|471814340|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
131048978|NCT05714059|471814341|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
131048979|NCT05714059|471814340|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
131048980|NCT05714059|471814341|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
131048981|NCT04899674|471814342|FG000|Test|Adverse Event|1|||
131048982|NCT03774472|471814343|FG000|Overall Study|Physician Decision|1|||
131048983|NCT03774472|471814344|FG001|Overall Study|Physician Decision|0|||
131048984|NCT03774472|471814345|FG002|Overall Study|Physician Decision|0|||
131048985|NCT03774472|471814343|FG000|Overall Study|Progression prior to 4 weeks|0|||
131048986|NCT03774472|471814344|FG001|Overall Study|Progression prior to 4 weeks|1|||
131048987|NCT03774472|471814345|FG002|Overall Study|Progression prior to 4 weeks|0|||
131048988|NCT03774472|471814343|FG000|Overall Study|Withdrawal by Subject|0|||
131048989|NCT03774472|471814344|FG001|Overall Study|Withdrawal by Subject|1|||
131048990|NCT03774472|471814345|FG002|Overall Study|Withdrawal by Subject|0|||
131048991|NCT04059406|471814347|FG000|Overall Study|Early Treatment Termination|5|||
131048992|NCT04059406|471814348|FG001|Overall Study|Early Treatment Termination|5|||
131048993|NCT04059406|471814349|FG002|Overall Study|Early Treatment Termination|15|||
130722046|NCT03401450|470606418|FG001|Overall Study|Anesthesia plan changed|2|||
130722047|NCT03401450|470606417|FG000|Overall Study|Did not complete medication diary|4|||
130722048|NCT03401450|470606418|FG001|Overall Study|Did not complete medication diary|2|||
130722049|NCT03401450|470606417|FG000|Overall Study|post surgery medication change|2|||
130722050|NCT03401450|470606418|FG001|Overall Study|post surgery medication change|1|||
130722051|NCT03401450|470606417|FG000|Overall Study|Cancelled surgery|0|||
131048994|NCT05155306|471814350|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
130722052|NCT03401450|470606418|FG001|Overall Study|Cancelled surgery|2|||
131048995|NCT05155306|471814351|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
131048996|NCT05155306|471814352|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
131048997|NCT05155306|471814353|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
131048998|NCT05155306|471814350|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
131048999|NCT05155306|471814351|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
131049000|NCT05155306|471814352|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
131049001|NCT05155306|471814353|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
131049002|NCT05039021|471814923|FG000|Overall Study|Death|1|||
131049003|NCT05039021|471814923|FG000|Overall Study|Lost to Follow-up|3|||
131049004|NCT02422615|471814924|FG000|Treatment Period|Progressive disease|314|||
131049005|NCT02422615|471814925|FG001|Treatment Period|Progressive disease|200|||
131049006|NCT02422615|471814924|FG000|Treatment Period|Adverse Event|51|||
131049007|NCT02422615|471814925|FG001|Treatment Period|Adverse Event|9|||
131049008|NCT02422615|471814924|FG000|Treatment Period|Physician Decision|32|||
131049009|NCT02422615|471814925|FG001|Treatment Period|Physician Decision|8|||
131049010|NCT02422615|471814924|FG000|Treatment Period|Subject/guardian decision|38|||
131049011|NCT02422615|471814925|FG001|Treatment Period|Subject/guardian decision|8|||
131049012|NCT02422615|471814924|FG000|Treatment Period|Death|2|||
131049013|NCT02422615|471814925|FG001|Treatment Period|Death|1|||
131049014|NCT02422615|471814924|FG000|Treatment Period|Technical problems|0|||
131049015|NCT02422615|471814925|FG001|Treatment Period|Technical problems|1|||
131049016|NCT02422615|471814924|FG000|Treatment Period|Protocol deviation|1|||
131049017|NCT02422615|471814925|FG001|Treatment Period|Protocol deviation|1|||
131049018|NCT02422615|471814924|FG000|Treatment Period|Study terminated as per protocol|46|||
131049019|NCT02422615|471814925|FG001|Treatment Period|Study terminated as per protocol|14|||
131049020|NCT02422615|471814924|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
131049021|NCT02422615|471814925|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131049022|NCT02422615|471814924|FG000|Post-treatment Efficacy Follow-up|Death|2|||
131049023|NCT02422615|471814925|FG001|Post-treatment Efficacy Follow-up|Death|1|||
131049024|NCT02422615|471814924|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
131049025|NCT02422615|471814925|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131049026|NCT02422615|471814924|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
131049027|NCT02422615|471814925|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
131049028|NCT02422615|471814924|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
131049029|NCT02422615|471814925|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
131049030|NCT02422615|471814924|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
131049031|NCT02422615|471814925|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
131049032|NCT01596972|471814926|FG000|Overall Study|Physician Decision|1|||
131049033|NCT01596972|471814927|FG001|Overall Study|Physician Decision|9|||
131049034|NCT01596972|471814926|FG000|Overall Study|Lost to Follow-up|0|||
131049035|NCT01596972|471814927|FG001|Overall Study|Lost to Follow-up|4|||
131049036|NCT01596972|471814926|FG000|Overall Study|Withdrawal by Subject|0|||
131049037|NCT01596972|471814927|FG001|Overall Study|Withdrawal by Subject|1|||
131049038|NCT01639131|471814928|FG000|Overall Study|Disease Progression|6|||
131049039|NCT01260896|471814941|FG000|First Intervention|Withdrawn Due to Emesis|2|||
131049040|NCT01260896|471814942|FG001|First Intervention|Withdrawn Due to Emesis|0|||
131049041|NCT00087685|471814947|FG000|Overall Study|Adverse Event|5|||
131049042|NCT00087685|471814947|FG000|Overall Study|Non-Compliance|1|||
131049043|NCT00087685|471814947|FG000|Overall Study|Progressive Disease|5|||
131049044|NCT00087685|471814947|FG000|Overall Study|Withdrawal by Subject|3|||
131049045|NCT05601882|471814948|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
131049046|NCT05601882|471814949|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
131049047|NCT05601882|471814950|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
131049048|NCT05601882|471814951|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
131049049|NCT05601882|471814948|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
131049050|NCT05601882|471814949|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
130722053|NCT01214915|470606420|FG000|Overall Study|Adverse Event|8|||
131049051|NCT05601882|471814950|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
131049052|NCT05601882|471814951|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
131049053|NCT05601882|471814948|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
131049054|NCT05601882|471814949|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
131049055|NCT05601882|471814950|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
131049056|NCT05601882|471814951|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
131049057|NCT05601882|471814948|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
131049058|NCT05601882|471814949|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
131049059|NCT05601882|471814950|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
131049060|NCT05601882|471814951|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
131049061|NCT05601882|471814948|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
131049062|NCT05601882|471814949|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
131049063|NCT05601882|471814950|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
131049064|NCT05601882|471814951|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
131049065|NCT05601882|471814948|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
131049066|NCT05601882|471814949|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
131049067|NCT05601882|471814950|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
131049068|NCT05601882|471814951|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
131049069|NCT04158141|471814952|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
131049070|NCT04158141|471814953|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
131049071|NCT04158141|471814954|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
131049072|NCT04158141|471814952|FG000|Step 1: Registration|Adverse Event|1|||
131049073|NCT04158141|471814953|FG001|Step 1: Registration|Adverse Event|0|||
131049074|NCT04158141|471814954|FG002|Step 1: Registration|Adverse Event|0|||
131049075|NCT04158141|471814952|FG000|Step 1: Registration|Withdrawal by Subject|1|||
131049076|NCT04158141|471814953|FG001|Step 1: Registration|Withdrawal by Subject|0|||
131049077|NCT04158141|471814954|FG002|Step 1: Registration|Withdrawal by Subject|0|||
131049078|NCT04158141|471814952|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
131049079|NCT04158141|471814953|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
131049080|NCT04158141|471814954|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
131049081|NCT04121741|471814958|FG000|Overall Study|Protocol Violation|1|||
131049082|NCT04121741|471814959|FG001|Overall Study|Protocol Violation|0|||
131049083|NCT04121741|471814960|FG002|Overall Study|Protocol Violation|0|||
131049084|NCT04121741|471814961|FG003|Overall Study|Protocol Violation|0|||
131049085|NCT04121741|471814962|FG004|Overall Study|Protocol Violation|0|||
131049086|NCT04121741|471814963|FG005|Overall Study|Protocol Violation|0|||
131049087|NCT03473223|471814964|FG000|Overall Study|Lost to Follow-up|1|||
131049088|NCT03473223|471814965|FG001|Overall Study|Lost to Follow-up|1|||
131049089|NCT03473223|471814964|FG000|Overall Study|Withdrawal by Subject|47|||
131049090|NCT03473223|471814965|FG001|Overall Study|Withdrawal by Subject|42|||
131049091|NCT03473223|471814964|FG000|Overall Study|Indirect contact|32|||
131049092|NCT03473223|471814965|FG001|Overall Study|Indirect contact|29|||
131049093|NCT03473223|471814964|FG000|Overall Study|Other (Not specified)|32|||
131049094|NCT03473223|471814965|FG001|Overall Study|Other (Not specified)|20|||
131049095|NCT00115934|471814968|FG000|Overall Study|Lost to Follow-up|1|||
131049096|NCT00115934|471814969|FG001|Overall Study|Lost to Follow-up|0|||
131049097|NCT00115934|471814968|FG000|Overall Study|Did not receive intervention|3|||
131049098|NCT00115934|471814969|FG001|Overall Study|Did not receive intervention|2|||
131049099|NCT05827068|471814975|FG000|Overall Study|Lost to Follow-up|1|||
131049100|NCT05827068|471814976|FG001|Overall Study|Lost to Follow-up|4|||
131049101|NCT05827068|471814977|FG002|Overall Study|Lost to Follow-up|1|||
131049102|NCT05827068|471814978|FG003|Overall Study|Lost to Follow-up|1|||
131049103|NCT05827068|471814979|FG004|Overall Study|Lost to Follow-up|2|||
131049104|NCT05827068|471814980|FG005|Overall Study|Lost to Follow-up|4|||
131049105|NCT05827068|471814981|FG006|Overall Study|Lost to Follow-up|1|||
131049106|NCT05827068|471814975|FG000|Overall Study|Withdrawal by Subject|4|||
131049107|NCT05827068|471814976|FG001|Overall Study|Withdrawal by Subject|0|||
131049108|NCT05827068|471814977|FG002|Overall Study|Withdrawal by Subject|1|||
131049109|NCT05827068|471814978|FG003|Overall Study|Withdrawal by Subject|2|||
131049110|NCT05827068|471814979|FG004|Overall Study|Withdrawal by Subject|3|||
131049111|NCT05827068|471814980|FG005|Overall Study|Withdrawal by Subject|0|||
131049112|NCT05827068|471814981|FG006|Overall Study|Withdrawal by Subject|1|||
131049113|NCT05827068|471814975|FG000|Overall Study|Physician Decision|0|||
131049114|NCT05827068|471814976|FG001|Overall Study|Physician Decision|0|||
131049115|NCT05827068|471814977|FG002|Overall Study|Physician Decision|0|||
131049116|NCT05827068|471814978|FG003|Overall Study|Physician Decision|0|||
131049117|NCT05827068|471814979|FG004|Overall Study|Physician Decision|1|||
131049118|NCT05827068|471814980|FG005|Overall Study|Physician Decision|0|||
131049119|NCT05827068|471814981|FG006|Overall Study|Physician Decision|1|||
131049120|NCT05827068|471814975|FG000|Overall Study|Other Than Specified|0|||
131049121|NCT05827068|471814976|FG001|Overall Study|Other Than Specified|1|||
131049122|NCT05827068|471814977|FG002|Overall Study|Other Than Specified|0|||
131049123|NCT05827068|471814978|FG003|Overall Study|Other Than Specified|0|||
131049124|NCT05827068|471814979|FG004|Overall Study|Other Than Specified|0|||
130722054|NCT01214915|470606420|FG000|Overall Study|Lack of Efficacy|3|||
130722055|NCT03155945|470606421|FG000|Overall Study|Lost to Follow-up|0|||
130722056|NCT03155945|470606422|FG001|Overall Study|Lost to Follow-up|1|||
131049125|NCT05827068|471814980|FG005|Overall Study|Other Than Specified|0|||
131049126|NCT05827068|471814981|FG006|Overall Study|Other Than Specified|0|||
131134250|NCT04681170|472118869|FG000|Stratified Enrolment & run-in|Death|1|||
131134251|NCT04681170|472118870|FG001|Stratified Enrolment & run-in|Death|0|||
131134252|NCT04681170|472118869|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
131134253|NCT04681170|472118870|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
131134254|NCT04681170|472118869|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
131134255|NCT04681170|472118870|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
130722057|NCT03155945|470606421|FG000|Overall Study|Withdrawal by Subject|0|||
131134256|NCT04681170|472118869|FG000|Open Label Efficacy Phase|Adverse Event|0|||
131134257|NCT04681170|472118870|FG001|Open Label Efficacy Phase|Adverse Event|2|||
131134258|NCT04681170|472118869|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
131134259|NCT04681170|472118870|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
130722058|NCT03155945|470606422|FG001|Overall Study|Withdrawal by Subject|1|||
130722059|NCT03155945|470606421|FG000|Overall Study|Other Reason|0|||
130722060|NCT03155945|470606422|FG001|Overall Study|Other Reason|1|||
131134260|NCT04681170|472118869|FG000|Open Label Safety Phase|AEs and none compliance|0|||
130722061|NCT03395405|470608145|FG000|Overall Study|Death|0|||
130722062|NCT03395405|470608146|FG001|Overall Study|Death|2|||
130722063|NCT03395405|470608145|FG000|Overall Study|Lost to Follow-up|0|||
130722064|NCT03395405|470608146|FG001|Overall Study|Lost to Follow-up|1|||
130722065|NCT03395405|470608145|FG000|Overall Study|Protocol Violation|0|||
130722066|NCT03395405|470608146|FG001|Overall Study|Protocol Violation|1|||
130722067|NCT03395405|470608145|FG000|Overall Study|Withdrawal by Subject|3|||
131134261|NCT04681170|472118870|FG001|Open Label Safety Phase|AEs and none compliance|1|||
131134262|NCT04986202|472118871|FG000|Overall Study|Death|10|||
131134263|NCT04986202|472118872|FG001|Overall Study|Death|3|||
131134264|NCT04986202|472118873|FG002|Overall Study|Death|10|||
131134265|NCT04986202|472118871|FG000|Overall Study|Physician Decision|3|||
131134266|NCT04986202|472118872|FG001|Overall Study|Physician Decision|1|||
131134267|NCT04986202|472118873|FG002|Overall Study|Physician Decision|2|||
131134268|NCT04986202|472118871|FG000|Overall Study|Withdrawal by Subject|4|||
131134269|NCT04986202|472118872|FG001|Overall Study|Withdrawal by Subject|2|||
131134270|NCT04986202|472118873|FG002|Overall Study|Withdrawal by Subject|4|||
131134271|NCT02468648|472118874|FG000|Overall Study|Death|1|||
131134272|NCT02118792|472118875|FG000|Overall Study|Withdrawal by Subject|6|||
131134273|NCT02118792|472118876|FG001|Overall Study|Withdrawal by Subject|3|||
131134274|NCT02118792|472118875|FG000|Overall Study|Lost to Follow-up|4|||
131134275|NCT02118792|472118876|FG001|Overall Study|Lost to Follow-up|4|||
131134276|NCT02118792|472118875|FG000|Overall Study|Adverse Event|5|||
131134277|NCT02118792|472118876|FG001|Overall Study|Adverse Event|4|||
131134278|NCT02118792|472118875|FG000|Overall Study|Withdrawal by parent/guardian|14|||
131134279|NCT02118792|472118876|FG001|Overall Study|Withdrawal by parent/guardian|20|||
131134280|NCT02118792|472118875|FG000|Overall Study|Other|1|||
131134281|NCT02118792|472118876|FG001|Overall Study|Other|6|||
131134282|NCT02118792|472118875|FG000|Overall Study|Randomised but not treated|1|||
131134283|NCT02118792|472118876|FG001|Overall Study|Randomised but not treated|0|||
131134284|NCT02787863|472118877|FG000|Overall Study|Death|1|||
131134285|NCT02787863|472118878|FG001|Overall Study|Death|0|||
131134286|NCT02787863|472118879|FG002|Overall Study|Death|1|||
131134287|NCT02787863|472118880|FG003|Overall Study|Death|0|||
131134288|NCT02787863|472118881|FG004|Overall Study|Death|0|||
131134289|NCT02787863|472118882|FG005|Overall Study|Death|0|||
131134290|NCT02787863|472118883|FG006|Overall Study|Death|0|||
131134291|NCT02787863|472118884|FG007|Overall Study|Death|0|||
131134292|NCT02787863|472118877|FG000|Overall Study|Withdrawal by Subject|0|||
131134293|NCT02787863|472118878|FG001|Overall Study|Withdrawal by Subject|1|||
131134294|NCT02787863|472118879|FG002|Overall Study|Withdrawal by Subject|1|||
131134295|NCT02787863|472118880|FG003|Overall Study|Withdrawal by Subject|0|||
131134296|NCT02787863|472118881|FG004|Overall Study|Withdrawal by Subject|0|||
131134297|NCT02787863|472118882|FG005|Overall Study|Withdrawal by Subject|0|||
131134298|NCT02787863|472118883|FG006|Overall Study|Withdrawal by Subject|0|||
131134299|NCT02787863|472118884|FG007|Overall Study|Withdrawal by Subject|0|||
131134300|NCT01368835|472118885|FG000|Overall Study|Inclusion criteria/photography quality|22|||
131134301|NCT01368835|472118885|FG000|Overall Study|Lost to Follow-up|11|||
131134302|NCT03118297|472118886|FG000|Overall Study|Lost to Follow-up|0|||
131134303|NCT03118297|472118887|FG001|Overall Study|Lost to Follow-up|2|||
131134304|NCT02754726|472118888|FG000|Overall Study|Progressive Disease by RECIST|13|||
131134305|NCT02754726|472118888|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
131134306|NCT02754726|472118888|FG000|Overall Study|Clinical Disease Progression|5|||
131134307|NCT02754726|472118888|FG000|Overall Study|Adverse Event|3|||
131134308|NCT02754726|472118888|FG000|Overall Study|Withdrawal by Subject|1|||
131134309|NCT02754726|472118888|FG000|Overall Study|Tolerability|1|||
131134310|NCT00252057|472118903|FG000|Overall Study|Withdrawal by Subject|2|||
131134311|NCT00252057|472118904|FG001|Overall Study|Withdrawal by Subject|5|||
131134312|NCT00252057|472118903|FG000|Overall Study|Death|1|||
131134313|NCT00252057|472118904|FG001|Overall Study|Death|2|||
131134314|NCT00252057|472118903|FG000|Overall Study|Participant previously enrolled|0|||
131134315|NCT00252057|472118904|FG001|Overall Study|Participant previously enrolled|1|||
131134316|NCT01903837|472118906|FG000|Part A|Withdrawal by Subject|4|||
131134317|NCT01903837|472118907|FG001|Part A|Withdrawal by Subject|9|||
130722068|NCT03395405|470608146|FG001|Overall Study|Withdrawal by Subject|1|||
130722069|NCT03395405|470608145|FG000|Overall Study|COVID-19 Pandemic|1|||
131134318|NCT01903837|472118908|FG002|Part A|Withdrawal by Subject|8|||
131134319|NCT01903837|472118909|FG003|Part A|Withdrawal by Subject|5|||
131134320|NCT01903837|472118906|FG000|Part A|Adverse Event|3|||
131134321|NCT01903837|472118907|FG001|Part A|Adverse Event|6|||
131134322|NCT01903837|472118908|FG002|Part A|Adverse Event|9|||
131134323|NCT01903837|472118909|FG003|Part A|Adverse Event|6|||
131134324|NCT01903837|472118906|FG000|Part A|Lost to Follow-up|9|||
131134325|NCT01903837|472118907|FG001|Part A|Lost to Follow-up|7|||
131134326|NCT01903837|472118908|FG002|Part A|Lost to Follow-up|7|||
131134327|NCT01903837|472118909|FG003|Part A|Lost to Follow-up|2|||
131134328|NCT01903837|472118906|FG000|Part A|Non-compliance with study drug|1|||
131134329|NCT01903837|472118907|FG001|Part A|Non-compliance with study drug|4|||
131134330|NCT01903837|472118908|FG002|Part A|Non-compliance with study drug|4|||
131049153|NCT04039113|471814986|FG000|Overall Study|Withdrawal by Subject|8|||
131049154|NCT04039113|471814987|FG001|Overall Study|Withdrawal by Subject|11|||
131049155|NCT04039113|471814986|FG000|Overall Study|Lost to Follow-up|1|||
131049156|NCT04039113|471814987|FG001|Overall Study|Lost to Follow-up|1|||
131049157|NCT04039113|471814986|FG000|Overall Study|Adverse Event|2|||
131049158|NCT04039113|471814987|FG001|Overall Study|Adverse Event|2|||
131049159|NCT04039113|471814986|FG000|Overall Study|Death|2|||
131049160|NCT04039113|471814987|FG001|Overall Study|Death|4|||
131049161|NCT04039113|471814986|FG000|Overall Study|Site Closure|6|||
131049162|NCT04039113|471814987|FG001|Overall Study|Site Closure|0|||
131049163|NCT04039113|471814986|FG000|Overall Study|Failure to meet randomisation criteria|4|||
131049164|NCT04039113|471814987|FG001|Overall Study|Failure to meet randomisation criteria|0|||
131049165|NCT00353496|471814988|FG000|Overall Study|Adverse Event|1|||
131049166|NCT00353496|471814989|FG001|Overall Study|Adverse Event|0|||
131049167|NCT00353496|471814988|FG000|Overall Study|Protocol Violation|2|||
131049168|NCT00353496|471814989|FG001|Overall Study|Protocol Violation|2|||
131049169|NCT00353496|471814988|FG000|Overall Study|Withdrawal by Subject|3|||
131049170|NCT00353496|471814989|FG001|Overall Study|Withdrawal by Subject|4|||
131049171|NCT00353496|471814988|FG000|Overall Study|Physician Decision|6|||
131049172|NCT00353496|471814989|FG001|Overall Study|Physician Decision|9|||
131049173|NCT00353496|471814988|FG000|Overall Study|Not otherwise specified|4|||
131049174|NCT00353496|471814989|FG001|Overall Study|Not otherwise specified|2|||
131049175|NCT00312208|471815639|FG000|Overall Study|Adverse Event|97|||
131049176|NCT00312208|471815640|FG001|Overall Study|Adverse Event|61|||
131049177|NCT00312208|471815639|FG000|Overall Study|Protocol Violation|5|||
131049178|NCT00312208|471815640|FG001|Overall Study|Protocol Violation|3|||
131049179|NCT00312208|471815639|FG000|Overall Study|Death|2|||
131049180|NCT00312208|471815640|FG001|Overall Study|Death|1|||
131049181|NCT00312208|471815639|FG000|Overall Study|Lack of Efficacy|7|||
131049182|NCT00312208|471815640|FG001|Overall Study|Lack of Efficacy|4|||
131049183|NCT00312208|471815639|FG000|Overall Study|Lost to Follow-up|3|||
131049184|NCT00312208|471815640|FG001|Overall Study|Lost to Follow-up|5|||
131049185|NCT00312208|471815639|FG000|Overall Study|Withdrawal by Subject|53|||
131049186|NCT00312208|471815640|FG001|Overall Study|Withdrawal by Subject|42|||
131049187|NCT00312208|471815639|FG000|Overall Study|Other|5|||
131049188|NCT00312208|471815640|FG001|Overall Study|Other|7|||
131049189|NCT02284113|471815641|FG000|Overall Study|Adverse Event|1|||
131049190|NCT02284113|471815642|FG001|Overall Study|Adverse Event|0|||
131049191|NCT02284113|471815641|FG000|Overall Study|non-compliance|0|||
131049192|NCT02284113|471815642|FG001|Overall Study|non-compliance|1|||
131049193|NCT02284113|471815641|FG000|Overall Study|Withdrawal by Subject|0|||
131049194|NCT02284113|471815642|FG001|Overall Study|Withdrawal by Subject|1|||
131049195|NCT02284113|471815641|FG000|Overall Study|not provided|0|||
131049196|NCT02284113|471815642|FG001|Overall Study|not provided|1|||
131049197|NCT02284113|471815641|FG000|Overall Study|surgery cancelled|2|||
131049198|NCT02284113|471815642|FG001|Overall Study|surgery cancelled|0|||
131049199|NCT03885232|471815645|FG000|Overall Study|Lost to Follow-up|74|||
131049200|NCT03885232|471815646|FG001|Overall Study|Lost to Follow-up|32|||
131049201|NCT03885232|471815645|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
131049202|NCT03885232|471815646|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
131049203|NCT01315132|471815649|FG000|Overall Study|not treated due to disease progression|1|||
131049204|NCT03660930|471815652|FG000|Overall Study|Adverse Event|0|||
131049205|NCT03660930|471815653|FG001|Overall Study|Adverse Event|0|||
131049206|NCT03660930|471815654|FG002|Overall Study|Adverse Event|0|||
131049207|NCT03660930|471815655|FG003|Overall Study|Adverse Event|2|||
131049208|NCT03660930|471815656|FG004|Overall Study|Adverse Event|0|||
131049209|NCT03660930|471815657|FG005|Overall Study|Adverse Event|1|||
131049210|NCT03660930|471815658|FG006|Overall Study|Adverse Event|0|||
131049211|NCT03660930|471815659|FG007|Overall Study|Adverse Event|0|||
131049212|NCT03660930|471815652|FG000|Overall Study|Withdrawal by Subject|0|||
131049213|NCT03660930|471815653|FG001|Overall Study|Withdrawal by Subject|0|||
131049214|NCT03660930|471815654|FG002|Overall Study|Withdrawal by Subject|0|||
131049215|NCT03660930|471815655|FG003|Overall Study|Withdrawal by Subject|0|||
131049216|NCT03660930|471815656|FG004|Overall Study|Withdrawal by Subject|0|||
131049217|NCT03660930|471815657|FG005|Overall Study|Withdrawal by Subject|1|||
131049218|NCT03660930|471815658|FG006|Overall Study|Withdrawal by Subject|0|||
131049219|NCT03660930|471815659|FG007|Overall Study|Withdrawal by Subject|0|||
131049220|NCT05018143|471815662|FG000|Overall Study|Lost to Follow-up|5|||
131049221|NCT05018143|471815663|FG001|Overall Study|Lost to Follow-up|4|||
131049222|NCT05018143|471815662|FG000|Overall Study|Withdrawal by Subject|0|||
131049223|NCT05018143|471815663|FG001|Overall Study|Withdrawal by Subject|1|||
131049224|NCT06688357|471815664|FG000|Overall Study|Adverse Event|0|||
131049225|NCT06688357|471815665|FG001|Overall Study|Adverse Event|1|||
131049226|NCT04018495|471815666|FG000|Overall Study|Physician Decision|1|||
131049227|NCT01084863|471815669|FG000|Main Study Treatment Period|Disease progression|11|||
131049228|NCT01084863|471815670|FG001|Main Study Treatment Period|Disease progression|7|||
131049229|NCT01084863|471815669|FG000|Main Study Treatment Period|Adverse Event|5|||
131049230|NCT01084863|471815670|FG001|Main Study Treatment Period|Adverse Event|3|||
131049231|NCT01084863|471815669|FG000|Main Study Treatment Period|Other Reason|0|||
131049232|NCT01084863|471815670|FG001|Main Study Treatment Period|Other Reason|1|||
131049233|NCT01084863|471815669|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
131049234|NCT01084863|471815670|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
131049235|NCT01084863|471815669|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
131049236|NCT01084863|471815670|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
131049237|NCT01084863|471815669|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
131049238|NCT01084863|471815670|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
131134331|NCT01903837|472118909|FG003|Part A|Non-compliance with study drug|0|||
131134332|NCT01903837|472118906|FG000|Part A|Physician Decision|1|||
131134333|NCT01903837|472118907|FG001|Part A|Physician Decision|1|||
131134334|NCT01903837|472118908|FG002|Part A|Physician Decision|0|||
131134335|NCT01903837|472118909|FG003|Part A|Physician Decision|0|||
131134336|NCT01903837|472118906|FG000|Part A|Protocol Violation|1|||
131134337|NCT01903837|472118907|FG001|Part A|Protocol Violation|1|||
131134338|NCT01903837|472118908|FG002|Part A|Protocol Violation|0|||
131134339|NCT01903837|472118909|FG003|Part A|Protocol Violation|0|||
131134340|NCT01903837|472118906|FG000|Part B|Lost to Follow-up|0|||
131134341|NCT01903837|472118907|FG001|Part B|Lost to Follow-up|3|||
131134342|NCT01903837|472118908|FG002|Part B|Lost to Follow-up|3|||
131134343|NCT01903837|472118909|FG003|Part B|Lost to Follow-up|4|||
131134344|NCT01903837|472118906|FG000|Part B|Withdrawal by Subject|1|||
131134345|NCT01903837|472118907|FG001|Part B|Withdrawal by Subject|2|||
131134346|NCT01903837|472118908|FG002|Part B|Withdrawal by Subject|0|||
131134347|NCT01903837|472118909|FG003|Part B|Withdrawal by Subject|3|||
131134348|NCT01903837|472118906|FG000|Part B|Adverse Event|3|||
131134349|NCT01903837|472118907|FG001|Part B|Adverse Event|0|||
131134350|NCT01903837|472118908|FG002|Part B|Adverse Event|2|||
131134351|NCT01903837|472118909|FG003|Part B|Adverse Event|0|||
131134352|NCT01903837|472118906|FG000|Part B|Non-compliance with study drug|2|||
131134353|NCT01903837|472118907|FG001|Part B|Non-compliance with study drug|0|||
131134354|NCT01903837|472118908|FG002|Part B|Non-compliance with study drug|0|||
131134355|NCT01903837|472118909|FG003|Part B|Non-compliance with study drug|1|||
131134356|NCT01903837|472118906|FG000|Part B|Incarceration|2|||
131134357|NCT01903837|472118907|FG001|Part B|Incarceration|0|||
131134358|NCT01903837|472118908|FG002|Part B|Incarceration|0|||
131134359|NCT01903837|472118909|FG003|Part B|Incarceration|1|||
131134360|NCT01903837|472118906|FG000|Part B|Physician Decision|1|||
131134361|NCT01903837|472118907|FG001|Part B|Physician Decision|0|||
131134362|NCT01903837|472118908|FG002|Part B|Physician Decision|0|||
131134363|NCT01903837|472118909|FG003|Part B|Physician Decision|2|||
131134364|NCT01903837|472118906|FG000|Part B|Lack of Efficacy|0|||
131134365|NCT01903837|472118907|FG001|Part B|Lack of Efficacy|1|||
131134366|NCT01903837|472118908|FG002|Part B|Lack of Efficacy|0|||
131134367|NCT01903837|472118909|FG003|Part B|Lack of Efficacy|0|||
131134368|NCT00705939|472118911|FG000|Overall Study|Protocol Violation|0|||
131134369|NCT00705939|472118912|FG001|Overall Study|Protocol Violation|0|||
131134370|NCT00705939|472118913|FG002|Overall Study|Protocol Violation|1|||
131134371|NCT00705939|472118911|FG000|Overall Study|Withdrawal by Subject|0|||
131134372|NCT00705939|472118912|FG001|Overall Study|Withdrawal by Subject|1|||
131134373|NCT00705939|472118913|FG002|Overall Study|Withdrawal by Subject|3|||
131134374|NCT00705939|472118911|FG000|Overall Study|Physician Decision|0|||
131134375|NCT00705939|472118912|FG001|Overall Study|Physician Decision|1|||
131134376|NCT00705939|472118913|FG002|Overall Study|Physician Decision|0|||
131134377|NCT05048342|472118914|FG000|Overall Study|Adverse Event|1|||
131134378|NCT05048342|472118914|FG000|Overall Study|Subject decision|2|||
131134379|NCT01441063|472118915|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
131134380|NCT01441063|472118915|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
131134381|NCT00143455|472118918|FG000|Cohort 1|Adverse Event|8|||
131134382|NCT00143455|472118919|FG001|Cohort 1|Adverse Event|4|||
131134383|NCT00143455|472118920|FG002|Cohort 1|Adverse Event|0|||
131134384|NCT00143455|472118921|FG003|Cohort 1|Adverse Event|0|||
131134385|NCT00143455|472118918|FG000|Cohort 1|Death|5|||
131134386|NCT00143455|472118919|FG001|Cohort 1|Death|2|||
131134387|NCT00143455|472118920|FG002|Cohort 1|Death|0|||
131134388|NCT00143455|472118921|FG003|Cohort 1|Death|0|||
131134389|NCT00143455|472118918|FG000|Cohort 1|Progressive Disease|0|||
131134390|NCT00143455|472118919|FG001|Cohort 1|Progressive Disease|6|||
131134391|NCT00143455|472118920|FG002|Cohort 1|Progressive Disease|0|||
131134392|NCT00143455|472118921|FG003|Cohort 1|Progressive Disease|0|||
131134393|NCT00143455|472118918|FG000|Cohort 1|Withdrawal by Subject|1|||
131134394|NCT00143455|472118919|FG001|Cohort 1|Withdrawal by Subject|4|||
131134395|NCT00143455|472118920|FG002|Cohort 1|Withdrawal by Subject|0|||
131134396|NCT00143455|472118921|FG003|Cohort 1|Withdrawal by Subject|0|||
131134397|NCT00143455|472118918|FG000|Cohort 1|Randomized But Not Treated|0|||
131134398|NCT00143455|472118919|FG001|Cohort 1|Randomized But Not Treated|1|||
131134399|NCT00143455|472118920|FG002|Cohort 1|Randomized But Not Treated|0|||
131134400|NCT00143455|472118921|FG003|Cohort 1|Randomized But Not Treated|0|||
131134401|NCT00143455|472118918|FG000|Cohort 2|Adverse Event|0|||
131134402|NCT00143455|472118919|FG001|Cohort 2|Adverse Event|0|||
131134403|NCT00143455|472118920|FG002|Cohort 2|Adverse Event|42|||
131134404|NCT00143455|472118921|FG003|Cohort 2|Adverse Event|30|||
131049239|NCT01084863|471815669|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
131049240|NCT01084863|471815670|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
131049241|NCT01084863|471815669|FG000|Treatment Period Beyond Cycle 8|Other|0|||
131049242|NCT01084863|471815670|FG001|Treatment Period Beyond Cycle 8|Other|1|||
131049243|NCT01084863|471815669|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
131049244|NCT01084863|471815670|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
131049245|NCT03834740|471815671|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
131049246|NCT03834740|471815672|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
131049247|NCT03834740|471815673|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
131049248|NCT03275285|471815674|FG000|Overall Study|Ongoing|45|||
131049249|NCT03275285|471815675|FG001|Overall Study|Ongoing|69|||
131049250|NCT03656718|471815676|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
131049251|NCT03656718|471815677|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
131049252|NCT03656718|471815678|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
131049253|NCT03656718|471815679|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
131049254|NCT03656718|471815680|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
131049255|NCT03656718|471815681|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
131049256|NCT03656718|471815682|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
131049257|NCT03656718|471815676|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
131049258|NCT03656718|471815677|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
131049259|NCT03656718|471815678|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
131049260|NCT03656718|471815679|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
131049261|NCT03656718|471815680|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
131049262|NCT03656718|471815681|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
131049263|NCT03656718|471815682|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
131049264|NCT03656718|471815676|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
131049265|NCT03656718|471815677|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
131049266|NCT03656718|471815678|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
131049267|NCT03656718|471815679|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
131049268|NCT03656718|471815680|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
131049269|NCT03656718|471815681|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
131049270|NCT03656718|471815682|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
131049271|NCT03656718|471815676|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131049272|NCT03656718|471815677|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131049273|NCT03656718|471815678|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131049274|NCT03656718|471815679|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131049275|NCT03656718|471815680|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131049276|NCT03656718|471815681|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
131049277|NCT03656718|471815682|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
131049278|NCT03656718|471815676|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
131049279|NCT03656718|471815677|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
131049280|NCT03656718|471815678|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
131049281|NCT03656718|471815679|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
131049282|NCT03656718|471815680|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
131049283|NCT03656718|471815681|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
131049284|NCT03656718|471815682|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
131049285|NCT03656718|471815676|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
131049286|NCT03656718|471815677|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
131049287|NCT03656718|471815678|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
131049288|NCT03656718|471815679|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
131049289|NCT03656718|471815680|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
131049290|NCT03656718|471815681|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
131049291|NCT03656718|471815682|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
131049292|NCT03656718|471815676|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131049293|NCT03656718|471815677|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131049294|NCT03656718|471815678|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131049295|NCT03656718|471815679|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131049296|NCT03656718|471815680|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131049297|NCT03656718|471815681|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
131049298|NCT03656718|471815682|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
131049299|NCT03656718|471815676|FG000|Treatment Period Part C|Disease progression|0|||
131049300|NCT03656718|471815677|FG001|Treatment Period Part C|Disease progression|0|||
131049301|NCT03656718|471815678|FG002|Treatment Period Part C|Disease progression|0|||
131049302|NCT03656718|471815679|FG003|Treatment Period Part C|Disease progression|0|||
131049303|NCT03656718|471815680|FG004|Treatment Period Part C|Disease progression|12|||
131049304|NCT03656718|471815681|FG005|Treatment Period Part C|Disease progression|0|||
131049305|NCT03656718|471815682|FG006|Treatment Period Part C|Disease progression|0|||
131049306|NCT03656718|471815676|FG000|Treatment Period Part C|Death|0|||
131049307|NCT03656718|471815677|FG001|Treatment Period Part C|Death|0|||
131049308|NCT03656718|471815678|FG002|Treatment Period Part C|Death|0|||
131049309|NCT03656718|471815679|FG003|Treatment Period Part C|Death|0|||
131049310|NCT03656718|471815680|FG004|Treatment Period Part C|Death|1|||
131049311|NCT03656718|471815681|FG005|Treatment Period Part C|Death|0|||
131049312|NCT03656718|471815682|FG006|Treatment Period Part C|Death|0|||
131049313|NCT03656718|471815676|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131049314|NCT03656718|471815677|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131049315|NCT03656718|471815678|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131049316|NCT03656718|471815679|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131049317|NCT03656718|471815680|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
131049318|NCT03656718|471815681|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131049319|NCT03656718|471815682|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
131049320|NCT03656718|471815676|FG000|Treatment Period Part C|Other reasons|0|||
131049321|NCT03656718|471815677|FG001|Treatment Period Part C|Other reasons|0|||
131049322|NCT03656718|471815678|FG002|Treatment Period Part C|Other reasons|0|||
131049323|NCT03656718|471815679|FG003|Treatment Period Part C|Other reasons|0|||
131049324|NCT03656718|471815680|FG004|Treatment Period Part C|Other reasons|1|||
131049325|NCT03656718|471815681|FG005|Treatment Period Part C|Other reasons|0|||
131049326|NCT03656718|471815682|FG006|Treatment Period Part C|Other reasons|0|||
131049327|NCT03656718|471815676|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
131049328|NCT03656718|471815677|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
131049329|NCT03656718|471815678|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
131049330|NCT03656718|471815679|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
131049331|NCT03656718|471815680|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
131049332|NCT03656718|471815681|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
131049333|NCT03656718|471815682|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
131049334|NCT06191679|471815683|FG000|Baseline|Lost to Follow-up|1|||
131049335|NCT06191679|471815684|FG001|Baseline|Lost to Follow-up|0|||
131049336|NCT06191679|471815685|FG002|Baseline|Lost to Follow-up|1|||
131049337|NCT06191679|471815686|FG003|Baseline|Lost to Follow-up|0|||
131049338|NCT06191679|471815683|FG000|Allocation to Group|Withdrawal by Subject|0|||
131049339|NCT06191679|471815684|FG001|Allocation to Group|Withdrawal by Subject|1|||
131049340|NCT06191679|471815685|FG002|Allocation to Group|Withdrawal by Subject|2|||
131049341|NCT06191679|471815686|FG003|Allocation to Group|Withdrawal by Subject|0|||
131049342|NCT06191679|471815683|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
131049343|NCT06191679|471815684|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
131049344|NCT06191679|471815685|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
131049345|NCT06191679|471815686|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
131049346|NCT06191679|471815683|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
131049347|NCT06191679|471815684|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
131049348|NCT06191679|471815685|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
131049349|NCT06191679|471815686|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
131049350|NCT06191679|471815683|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
131049351|NCT06191679|471815684|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
131049352|NCT06191679|471815685|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
131049353|NCT06191679|471815686|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
131049354|NCT02500576|471815687|FG000|Overall Study|Adverse Event|0|||
131049355|NCT02500576|471815688|FG001|Overall Study|Adverse Event|1|||
131049356|NCT02500576|471815687|FG000|Overall Study|Death|2|||
131049357|NCT02500576|471815688|FG001|Overall Study|Death|1|||
131049358|NCT02500576|471815687|FG000|Overall Study|Lack of Efficacy|5|||
131049359|NCT02500576|471815688|FG001|Overall Study|Lack of Efficacy|5|||
131049360|NCT02500576|471815687|FG000|Overall Study|Withdrawal by Subject|1|||
131049361|NCT02500576|471815688|FG001|Overall Study|Withdrawal by Subject|1|||
131049362|NCT04882917|471815691|FG000|Overall Study|Adverse Event|0|||
131049363|NCT04882917|471815692|FG001|Overall Study|Adverse Event|1|||
131049364|NCT04882917|471815693|FG002|Overall Study|Adverse Event|2|||
131049365|NCT04882917|471815694|FG003|Overall Study|Adverse Event|2|||
131049366|NCT04882917|471815691|FG000|Overall Study|Withdrawal by Subject|1|||
131049367|NCT04882917|471815692|FG001|Overall Study|Withdrawal by Subject|0|||
131049368|NCT04882917|471815693|FG002|Overall Study|Withdrawal by Subject|2|||
131049369|NCT04882917|471815694|FG003|Overall Study|Withdrawal by Subject|1|||
131049370|NCT04882917|471815691|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
131049371|NCT04882917|471815692|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
131049372|NCT04882917|471815693|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
131049373|NCT04882917|471815694|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
131049374|NCT00319020|471815696|FG000|Overall Study|Death|2|||
131049375|NCT00319020|471815697|FG001|Overall Study|Death|2|||
131049376|NCT00319020|471815696|FG000|Overall Study|Withdrawal by Subject|4|||
131049377|NCT00319020|471815697|FG001|Overall Study|Withdrawal by Subject|1|||
131049378|NCT00319020|471815696|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
131049379|NCT00319020|471815697|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
131049380|NCT00319020|471815696|FG000|Overall Study|Administrative reason|0|||
131049381|NCT00319020|471815697|FG001|Overall Study|Administrative reason|5|||
131049382|NCT00319020|471815696|FG000|Overall Study|Disease progression|0|||
131049383|NCT00319020|471815697|FG001|Overall Study|Disease progression|2|||
131049384|NCT00319020|471815696|FG000|Overall Study|Transplant|0|||
131049385|NCT00319020|471815697|FG001|Overall Study|Transplant|1|||
131049386|NCT00319020|471815696|FG000|Overall Study|Treatment failure|0|||
131049387|NCT00319020|471815697|FG001|Overall Study|Treatment failure|1|||
131049388|NCT00319020|471815696|FG000|Overall Study|Adverse Event|0|||
131049389|NCT00319020|471815697|FG001|Overall Study|Adverse Event|1|||
131049390|NCT03997474|471815701|FG000|Overall Study|Death|6|||
131049391|NCT03997474|471815702|FG001|Overall Study|Death|2|||
131049392|NCT03997474|471815703|FG002|Overall Study|Death|1|||
131049393|NCT03997474|471815701|FG000|Overall Study|Physician Decision|2|||
131049394|NCT03997474|471815702|FG001|Overall Study|Physician Decision|0|||
131049395|NCT03997474|471815703|FG002|Overall Study|Physician Decision|0|||
131049396|NCT03997474|471815701|FG000|Overall Study|study terminated by sponsor|1|||
131049397|NCT03997474|471815702|FG001|Overall Study|study terminated by sponsor|0|||
131049398|NCT03997474|471815703|FG002|Overall Study|study terminated by sponsor|1|||
131049399|NCT01470144|471815704|FG000|Overall Study|Adverse Event|2|||
131049400|NCT01470144|471815704|FG000|Overall Study|Death|1|||
131049401|NCT01470144|471815704|FG000|Overall Study|Lung transplant|6|||
131049402|NCT01470144|471815704|FG000|Overall Study|Patient's and investigator's decision|1|||
131049403|NCT03140670|471816540|FG000|Overall Study|Withdrawal by Subject|2|||
131049404|NCT03140670|471816540|FG000|Overall Study|Lost to Follow-up|1|||
131049405|NCT03140670|471816540|FG000|Overall Study|Physician Decision|1|||
131049406|NCT00220805|471816541|FG000|Overall Study|Adverse Event|1|||
131049407|NCT00220805|471816542|FG001|Overall Study|Adverse Event|3|||
131049408|NCT00220805|471816541|FG000|Overall Study|Withdrawal by Subject|3|||
131049409|NCT00220805|471816542|FG001|Overall Study|Withdrawal by Subject|0|||
131049410|NCT00220805|471816541|FG000|Overall Study|Lack of Efficacy|1|||
131049411|NCT00220805|471816542|FG001|Overall Study|Lack of Efficacy|0|||
131049412|NCT00220805|471816541|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
131049413|NCT00220805|471816542|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
131049414|NCT02325466|471816543|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
131049415|NCT02325466|471816544|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
131049416|NCT02325466|471816545|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
131049417|NCT02325466|471816543|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
131049418|NCT02325466|471816544|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
131049419|NCT02325466|471816545|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
131049420|NCT02325466|471816543|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
131049421|NCT02325466|471816544|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
131049422|NCT02325466|471816545|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
131049423|NCT02325466|471816543|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
131049424|NCT02325466|471816544|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
131049425|NCT02325466|471816545|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
131049426|NCT02325466|471816543|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
131049427|NCT02325466|471816544|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
131049428|NCT02325466|471816545|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
131134405|NCT00143455|472118918|FG000|Cohort 2|No Longer Required Study Treatment|0|||
131134406|NCT00143455|472118919|FG001|Cohort 2|No Longer Required Study Treatment|0|||
131134407|NCT00143455|472118920|FG002|Cohort 2|No Longer Required Study Treatment|1|||
131134408|NCT00143455|472118921|FG003|Cohort 2|No Longer Required Study Treatment|0|||
131134409|NCT00143455|472118918|FG000|Cohort 2|Protocol Violation|0|||
131134410|NCT00143455|472118919|FG001|Cohort 2|Protocol Violation|0|||
131134411|NCT00143455|472118920|FG002|Cohort 2|Protocol Violation|1|||
131134412|NCT00143455|472118921|FG003|Cohort 2|Protocol Violation|1|||
130722070|NCT03395405|470608146|FG001|Overall Study|COVID-19 Pandemic|0|||
131049429|NCT02325466|471816543|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
131049430|NCT02325466|471816544|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
131049431|NCT02325466|471816545|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
131049432|NCT02325466|471816543|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
131134413|NCT00143455|472118918|FG000|Cohort 2|Lost to Follow-up|0|||
131134414|NCT00143455|472118919|FG001|Cohort 2|Lost to Follow-up|0|||
131134415|NCT00143455|472118920|FG002|Cohort 2|Lost to Follow-up|1|||
130779267|NCT03234036|470819467|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
131049433|NCT02325466|471816544|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
131049434|NCT02325466|471816545|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
131049435|NCT02325466|471816543|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
131049436|NCT02325466|471816544|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
131049437|NCT02325466|471816545|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
131049438|NCT02325466|471816543|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
131049439|NCT02325466|471816544|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
131049440|NCT02325466|471816545|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
131049441|NCT01105975|471816549|FG000|Overall Study|Adverse Event|2|||
131049442|NCT01105975|471816550|FG001|Overall Study|Adverse Event|1|||
131049443|NCT01105975|471816551|FG002|Overall Study|Adverse Event|5|||
131049444|NCT01105975|471816552|FG003|Overall Study|Adverse Event|1|||
131049445|NCT01105975|471816553|FG004|Overall Study|Adverse Event|0|||
131049446|NCT01105975|471816554|FG005|Overall Study|Adverse Event|1|||
131049447|NCT01105975|471816555|FG006|Overall Study|Adverse Event|2|||
131049448|NCT01105975|471816556|FG007|Overall Study|Adverse Event|4|||
131049449|NCT01105975|471816557|FG008|Overall Study|Adverse Event|1|||
131049450|NCT01105975|471816558|FG009|Overall Study|Adverse Event|4|||
131049451|NCT01105975|471816549|FG000|Overall Study|Withdrawal by Subject|2|||
131049452|NCT01105975|471816550|FG001|Overall Study|Withdrawal by Subject|2|||
131049453|NCT01105975|471816551|FG002|Overall Study|Withdrawal by Subject|2|||
131049454|NCT01105975|471816552|FG003|Overall Study|Withdrawal by Subject|0|||
131049455|NCT01105975|471816553|FG004|Overall Study|Withdrawal by Subject|4|||
131049456|NCT01105975|471816554|FG005|Overall Study|Withdrawal by Subject|1|||
131049457|NCT01105975|471816555|FG006|Overall Study|Withdrawal by Subject|2|||
131049458|NCT01105975|471816556|FG007|Overall Study|Withdrawal by Subject|1|||
131049459|NCT01105975|471816557|FG008|Overall Study|Withdrawal by Subject|0|||
131049460|NCT01105975|471816558|FG009|Overall Study|Withdrawal by Subject|3|||
131049461|NCT01105975|471816549|FG000|Overall Study|Lost to Follow-up|1|||
131049462|NCT01105975|471816550|FG001|Overall Study|Lost to Follow-up|0|||
131049463|NCT01105975|471816551|FG002|Overall Study|Lost to Follow-up|0|||
131049464|NCT01105975|471816552|FG003|Overall Study|Lost to Follow-up|1|||
131049465|NCT01105975|471816553|FG004|Overall Study|Lost to Follow-up|1|||
131049466|NCT01105975|471816554|FG005|Overall Study|Lost to Follow-up|0|||
131049467|NCT01105975|471816555|FG006|Overall Study|Lost to Follow-up|0|||
131049468|NCT01105975|471816556|FG007|Overall Study|Lost to Follow-up|0|||
131049469|NCT01105975|471816557|FG008|Overall Study|Lost to Follow-up|1|||
131049470|NCT01105975|471816558|FG009|Overall Study|Lost to Follow-up|0|||
131049471|NCT01105975|471816549|FG000|Overall Study|Physician Decision|0|||
131049472|NCT01105975|471816550|FG001|Overall Study|Physician Decision|0|||
131049473|NCT01105975|471816551|FG002|Overall Study|Physician Decision|0|||
131049474|NCT01105975|471816552|FG003|Overall Study|Physician Decision|0|||
131049475|NCT01105975|471816553|FG004|Overall Study|Physician Decision|0|||
131049476|NCT01105975|471816554|FG005|Overall Study|Physician Decision|0|||
131049477|NCT01105975|471816555|FG006|Overall Study|Physician Decision|2|||
131049478|NCT01105975|471816556|FG007|Overall Study|Physician Decision|0|||
131049479|NCT01105975|471816557|FG008|Overall Study|Physician Decision|0|||
131049480|NCT01105975|471816558|FG009|Overall Study|Physician Decision|0|||
131049481|NCT01105975|471816549|FG000|Overall Study|Protocol Violation|0|||
131049482|NCT01105975|471816550|FG001|Overall Study|Protocol Violation|2|||
131049483|NCT01105975|471816551|FG002|Overall Study|Protocol Violation|2|||
131049484|NCT01105975|471816552|FG003|Overall Study|Protocol Violation|0|||
131049485|NCT01105975|471816553|FG004|Overall Study|Protocol Violation|1|||
131049486|NCT01105975|471816554|FG005|Overall Study|Protocol Violation|1|||
131049487|NCT01105975|471816555|FG006|Overall Study|Protocol Violation|1|||
131049488|NCT01105975|471816556|FG007|Overall Study|Protocol Violation|1|||
131049489|NCT01105975|471816557|FG008|Overall Study|Protocol Violation|2|||
131049490|NCT01105975|471816558|FG009|Overall Study|Protocol Violation|2|||
131049491|NCT01105975|471816549|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131049492|NCT01105975|471816550|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131049493|NCT01105975|471816551|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131049494|NCT01105975|471816552|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131049495|NCT01105975|471816553|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131049496|NCT01105975|471816554|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
131049497|NCT01105975|471816555|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131049498|NCT01105975|471816556|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
131134416|NCT00143455|472118921|FG003|Cohort 2|Lost to Follow-up|4|||
131134417|NCT00143455|472118918|FG000|Cohort 2|Death|0|||
131134418|NCT00143455|472118919|FG001|Cohort 2|Death|0|||
131049499|NCT01105975|471816557|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
131049500|NCT01105975|471816558|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
131049501|NCT00982644|471816559|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
131049502|NCT00982644|471816560|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
131134419|NCT00143455|472118920|FG002|Cohort 2|Death|20|||
131134420|NCT00143455|472118921|FG003|Cohort 2|Death|12|||
131049503|NCT00982644|471816559|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
131049504|NCT00982644|471816560|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
131049505|NCT00982644|471816559|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
131049506|NCT00982644|471816560|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
131049507|NCT00982644|471816559|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
131049508|NCT00982644|471816560|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
131049509|NCT00982644|471816559|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
131049510|NCT00982644|471816560|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
131049511|NCT00982644|471816559|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
131049512|NCT00982644|471816560|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
131049513|NCT00982644|471816559|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
131049514|NCT00982644|471816560|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
131049515|NCT00982644|471816559|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
131049516|NCT00982644|471816560|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
131049517|NCT00982644|471816559|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
131049518|NCT00982644|471816560|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
131049519|NCT00982644|471816559|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
131049520|NCT00982644|471816560|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
131049521|NCT00943917|471816563|FG000|Stage I|Adverse Event|1|||
131049522|NCT00943917|471816564|FG001|Stage I|Adverse Event|2|||
131049523|NCT00943917|471816565|FG002|Stage I|Adverse Event|2|||
131049524|NCT00943917|471816566|FG003|Stage I|Adverse Event|0|||
131049525|NCT00943917|471816567|FG004|Stage I|Adverse Event|0|||
131049526|NCT00943917|471816568|FG005|Stage I|Adverse Event|0|||
131049527|NCT00943917|471816569|FG006|Stage I|Adverse Event|0|||
131049528|NCT00943917|471816570|FG007|Stage I|Adverse Event|0|||
131049529|NCT00943917|471816571|FG008|Stage I|Adverse Event|0|||
131049530|NCT00943917|471816572|FG009|Stage I|Adverse Event|0|||
131049531|NCT00943917|471816573|FG010|Stage I|Adverse Event|0|||
131049532|NCT00943917|471816574|FG011|Stage I|Adverse Event|0|||
131049533|NCT00943917|471816575|FG012|Stage I|Adverse Event|0|||
131049534|NCT00943917|471816576|FG013|Stage I|Adverse Event|0|||
131049535|NCT00943917|471816577|FG014|Stage I|Adverse Event|0|||
131049536|NCT00943917|471816563|FG000|Stage I|Lost to Follow-up|0|||
131049537|NCT00943917|471816564|FG001|Stage I|Lost to Follow-up|0|||
131049538|NCT00943917|471816565|FG002|Stage I|Lost to Follow-up|1|||
131049539|NCT00943917|471816566|FG003|Stage I|Lost to Follow-up|0|||
131049540|NCT00943917|471816567|FG004|Stage I|Lost to Follow-up|0|||
131049541|NCT00943917|471816568|FG005|Stage I|Lost to Follow-up|0|||
131049542|NCT00943917|471816569|FG006|Stage I|Lost to Follow-up|0|||
131049543|NCT00943917|471816570|FG007|Stage I|Lost to Follow-up|0|||
131049544|NCT00943917|471816571|FG008|Stage I|Lost to Follow-up|0|||
131049545|NCT00943917|471816572|FG009|Stage I|Lost to Follow-up|0|||
131049546|NCT00943917|471816573|FG010|Stage I|Lost to Follow-up|0|||
131049547|NCT00943917|471816574|FG011|Stage I|Lost to Follow-up|0|||
131049548|NCT00943917|471816575|FG012|Stage I|Lost to Follow-up|0|||
131049549|NCT00943917|471816576|FG013|Stage I|Lost to Follow-up|0|||
131049550|NCT00943917|471816577|FG014|Stage I|Lost to Follow-up|0|||
131049551|NCT00943917|471816563|FG000|Stage I|hyperglycemia|0|||
131049552|NCT00943917|471816564|FG001|Stage I|hyperglycemia|0|||
131134421|NCT00143455|472118918|FG000|Cohort 2|Progressive Disease|0|||
131134422|NCT00143455|472118919|FG001|Cohort 2|Progressive Disease|0|||
131134423|NCT00143455|472118920|FG002|Cohort 2|Progressive Disease|20|||
131134424|NCT00143455|472118921|FG003|Cohort 2|Progressive Disease|27|||
131134425|NCT00143455|472118918|FG000|Cohort 2|Withdrawal by Subject|0|||
131134426|NCT00143455|472118919|FG001|Cohort 2|Withdrawal by Subject|0|||
131134427|NCT00143455|472118920|FG002|Cohort 2|Withdrawal by Subject|13|||
131134428|NCT00143455|472118921|FG003|Cohort 2|Withdrawal by Subject|12|||
131229635|NCT00112489|472467648|FG000|Overall Study|Other, Not Specified|9|||
130779268|NCT03234036|470819468|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
130779269|NCT03234036|470819469|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
130779270|NCT03234036|470819470|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
130779271|NCT02999789|470819473|FG000|Overall Study|Withdrawal by Subject|0|||
130779272|NCT02999789|470819474|FG001|Overall Study|Withdrawal by Subject|1|||
131049553|NCT00943917|471816565|FG002|Stage I|hyperglycemia|1|||
131049554|NCT00943917|471816566|FG003|Stage I|hyperglycemia|0|||
131049555|NCT00943917|471816567|FG004|Stage I|hyperglycemia|0|||
131049556|NCT00943917|471816568|FG005|Stage I|hyperglycemia|0|||
131049557|NCT00943917|471816569|FG006|Stage I|hyperglycemia|0|||
131049558|NCT00943917|471816570|FG007|Stage I|hyperglycemia|0|||
131049559|NCT00943917|471816571|FG008|Stage I|hyperglycemia|0|||
131049560|NCT00943917|471816572|FG009|Stage I|hyperglycemia|0|||
131049561|NCT00943917|471816573|FG010|Stage I|hyperglycemia|0|||
131049562|NCT00943917|471816574|FG011|Stage I|hyperglycemia|0|||
131049563|NCT00943917|471816575|FG012|Stage I|hyperglycemia|0|||
131134429|NCT00143455|472118918|FG000|Cohort 2|Other|0|||
131134430|NCT00143455|472118919|FG001|Cohort 2|Other|0|||
131134431|NCT00143455|472118920|FG002|Cohort 2|Other|7|||
131134432|NCT00143455|472118921|FG003|Cohort 2|Other|6|||
131134433|NCT00143455|472118918|FG000|Cohort 2|Randomized But Not Treated|0|||
131049564|NCT00943917|471816576|FG013|Stage I|hyperglycemia|0|||
130722071|NCT04345601|470608147|FG000|Overall Study|Death|0|||
130722072|NCT04345601|470608148|FG001|Overall Study|Death|3|||
130722073|NCT04345601|470608149|FG002|Overall Study|Death|2|||
130722074|NCT04345601|470608147|FG000|Overall Study|Lost to Follow-up|0|||
130722075|NCT04345601|470608148|FG001|Overall Study|Lost to Follow-up|0|||
131049565|NCT00943917|471816577|FG014|Stage I|hyperglycemia|0|||
131049566|NCT00943917|471816563|FG000|Stage I|A1C elevation|1|||
131049567|NCT00943917|471816564|FG001|Stage I|A1C elevation|0|||
131049568|NCT00943917|471816565|FG002|Stage I|A1C elevation|0|||
131049569|NCT00943917|471816566|FG003|Stage I|A1C elevation|0|||
131049570|NCT00943917|471816567|FG004|Stage I|A1C elevation|0|||
131049571|NCT00943917|471816568|FG005|Stage I|A1C elevation|0|||
131049572|NCT00943917|471816569|FG006|Stage I|A1C elevation|0|||
131049573|NCT00943917|471816570|FG007|Stage I|A1C elevation|0|||
131049574|NCT00943917|471816571|FG008|Stage I|A1C elevation|0|||
131049575|NCT00943917|471816572|FG009|Stage I|A1C elevation|0|||
131049576|NCT00943917|471816573|FG010|Stage I|A1C elevation|0|||
131049577|NCT00943917|471816574|FG011|Stage I|A1C elevation|0|||
131049578|NCT00943917|471816575|FG012|Stage I|A1C elevation|0|||
131049579|NCT00943917|471816576|FG013|Stage I|A1C elevation|0|||
131049580|NCT00943917|471816577|FG014|Stage I|A1C elevation|0|||
131049581|NCT00943917|471816563|FG000|Stage I|Withdrawal by Subject|2|||
131049582|NCT00943917|471816564|FG001|Stage I|Withdrawal by Subject|1|||
131049583|NCT00943917|471816565|FG002|Stage I|Withdrawal by Subject|2|||
131049584|NCT00943917|471816566|FG003|Stage I|Withdrawal by Subject|0|||
131049585|NCT00943917|471816567|FG004|Stage I|Withdrawal by Subject|0|||
131049586|NCT00943917|471816568|FG005|Stage I|Withdrawal by Subject|0|||
131049587|NCT00943917|471816569|FG006|Stage I|Withdrawal by Subject|0|||
131049588|NCT00943917|471816570|FG007|Stage I|Withdrawal by Subject|0|||
131049589|NCT00943917|471816571|FG008|Stage I|Withdrawal by Subject|0|||
131049590|NCT00943917|471816572|FG009|Stage I|Withdrawal by Subject|0|||
131049591|NCT00943917|471816573|FG010|Stage I|Withdrawal by Subject|0|||
131049592|NCT00943917|471816574|FG011|Stage I|Withdrawal by Subject|0|||
131049593|NCT00943917|471816575|FG012|Stage I|Withdrawal by Subject|0|||
131049594|NCT00943917|471816576|FG013|Stage I|Withdrawal by Subject|0|||
131049595|NCT00943917|471816577|FG014|Stage I|Withdrawal by Subject|0|||
131049596|NCT00943917|471816563|FG000|Stage II|Adverse Event|0|||
131049597|NCT00943917|471816564|FG001|Stage II|Adverse Event|0|||
131049598|NCT00943917|471816565|FG002|Stage II|Adverse Event|0|||
131049599|NCT00943917|471816566|FG003|Stage II|Adverse Event|0|||
131049600|NCT00943917|471816567|FG004|Stage II|Adverse Event|0|||
131049601|NCT00943917|471816568|FG005|Stage II|Adverse Event|1|||
131049602|NCT00943917|471816569|FG006|Stage II|Adverse Event|3|||
131049603|NCT00943917|471816570|FG007|Stage II|Adverse Event|0|||
131049604|NCT00943917|471816571|FG008|Stage II|Adverse Event|1|||
131049605|NCT00943917|471816572|FG009|Stage II|Adverse Event|0|||
131049606|NCT00943917|471816573|FG010|Stage II|Adverse Event|0|||
131049607|NCT00943917|471816574|FG011|Stage II|Adverse Event|0|||
131049608|NCT00943917|471816575|FG012|Stage II|Adverse Event|0|||
131049609|NCT00943917|471816576|FG013|Stage II|Adverse Event|0|||
131049610|NCT00943917|471816577|FG014|Stage II|Adverse Event|0|||
131049611|NCT00943917|471816563|FG000|Stage II|Withdrawal by Subject|0|||
131049612|NCT00943917|471816564|FG001|Stage II|Withdrawal by Subject|0|||
131049613|NCT00943917|471816565|FG002|Stage II|Withdrawal by Subject|0|||
131049614|NCT00943917|471816566|FG003|Stage II|Withdrawal by Subject|0|||
131049615|NCT00943917|471816567|FG004|Stage II|Withdrawal by Subject|0|||
131049616|NCT00943917|471816568|FG005|Stage II|Withdrawal by Subject|1|||
131049617|NCT00943917|471816569|FG006|Stage II|Withdrawal by Subject|0|||
131049618|NCT00943917|471816570|FG007|Stage II|Withdrawal by Subject|0|||
131049619|NCT00943917|471816571|FG008|Stage II|Withdrawal by Subject|0|||
131049620|NCT00943917|471816572|FG009|Stage II|Withdrawal by Subject|0|||
131049621|NCT00943917|471816573|FG010|Stage II|Withdrawal by Subject|0|||
131049622|NCT00943917|471816574|FG011|Stage II|Withdrawal by Subject|0|||
131049623|NCT00943917|471816575|FG012|Stage II|Withdrawal by Subject|0|||
131049624|NCT00943917|471816576|FG013|Stage II|Withdrawal by Subject|0|||
131049625|NCT00943917|471816577|FG014|Stage II|Withdrawal by Subject|0|||
131049626|NCT00943917|471816563|FG000|Stage II|Pregnancy|0|||
131049627|NCT00943917|471816564|FG001|Stage II|Pregnancy|0|||
131049628|NCT00943917|471816565|FG002|Stage II|Pregnancy|0|||
131049629|NCT00943917|471816566|FG003|Stage II|Pregnancy|0|||
130722076|NCT04345601|470608149|FG002|Overall Study|Lost to Follow-up|2|||
130722077|NCT00000378|470608150|FG000|Overall Study|Lack of Efficacy|16|||
131049630|NCT00943917|471816567|FG004|Stage II|Pregnancy|0|||
131049631|NCT00943917|471816568|FG005|Stage II|Pregnancy|1|||
131049632|NCT00943917|471816569|FG006|Stage II|Pregnancy|0|||
131049633|NCT00943917|471816570|FG007|Stage II|Pregnancy|0|||
130722078|NCT00000378|470608151|FG001|Overall Study|Lack of Efficacy|14|||
131049634|NCT00943917|471816571|FG008|Stage II|Pregnancy|0|||
131049635|NCT00943917|471816572|FG009|Stage II|Pregnancy|0|||
131049636|NCT00943917|471816573|FG010|Stage II|Pregnancy|0|||
131049637|NCT00943917|471816574|FG011|Stage II|Pregnancy|0|||
131049638|NCT00943917|471816575|FG012|Stage II|Pregnancy|0|||
131049639|NCT00943917|471816576|FG013|Stage II|Pregnancy|0|||
131049640|NCT00943917|471816577|FG014|Stage II|Pregnancy|0|||
131049641|NCT00943917|471816563|FG000|Stage II Continuation|Adverse Event|0|||
131049642|NCT00943917|471816564|FG001|Stage II Continuation|Adverse Event|0|||
131049643|NCT00943917|471816565|FG002|Stage II Continuation|Adverse Event|0|||
131049644|NCT00943917|471816566|FG003|Stage II Continuation|Adverse Event|0|||
131049645|NCT00943917|471816567|FG004|Stage II Continuation|Adverse Event|0|||
131049646|NCT00943917|471816568|FG005|Stage II Continuation|Adverse Event|0|||
131049647|NCT00943917|471816569|FG006|Stage II Continuation|Adverse Event|0|||
131049648|NCT00943917|471816570|FG007|Stage II Continuation|Adverse Event|0|||
131049649|NCT00943917|471816571|FG008|Stage II Continuation|Adverse Event|0|||
131049650|NCT00943917|471816572|FG009|Stage II Continuation|Adverse Event|0|||
131049651|NCT00943917|471816573|FG010|Stage II Continuation|Adverse Event|0|||
131049652|NCT00943917|471816574|FG011|Stage II Continuation|Adverse Event|1|||
131049653|NCT00943917|471816575|FG012|Stage II Continuation|Adverse Event|2|||
131049654|NCT00943917|471816576|FG013|Stage II Continuation|Adverse Event|1|||
131049655|NCT00943917|471816577|FG014|Stage II Continuation|Adverse Event|1|||
131049656|NCT00943917|471816563|FG000|Stage II Continuation|Withdrawal by Subject|0|||
131049657|NCT00943917|471816564|FG001|Stage II Continuation|Withdrawal by Subject|0|||
131049658|NCT00943917|471816565|FG002|Stage II Continuation|Withdrawal by Subject|0|||
131049659|NCT00943917|471816566|FG003|Stage II Continuation|Withdrawal by Subject|0|||
131049660|NCT00943917|471816567|FG004|Stage II Continuation|Withdrawal by Subject|0|||
131049661|NCT00943917|471816568|FG005|Stage II Continuation|Withdrawal by Subject|0|||
131049662|NCT00943917|471816569|FG006|Stage II Continuation|Withdrawal by Subject|0|||
131049663|NCT00943917|471816570|FG007|Stage II Continuation|Withdrawal by Subject|0|||
131049664|NCT00943917|471816571|FG008|Stage II Continuation|Withdrawal by Subject|0|||
131049665|NCT00943917|471816572|FG009|Stage II Continuation|Withdrawal by Subject|0|||
131049666|NCT00943917|471816573|FG010|Stage II Continuation|Withdrawal by Subject|0|||
131049667|NCT00943917|471816574|FG011|Stage II Continuation|Withdrawal by Subject|0|||
131049668|NCT00943917|471816575|FG012|Stage II Continuation|Withdrawal by Subject|0|||
131049669|NCT00943917|471816576|FG013|Stage II Continuation|Withdrawal by Subject|1|||
131049670|NCT00943917|471816577|FG014|Stage II Continuation|Withdrawal by Subject|3|||
131049671|NCT00943917|471816563|FG000|Stage II Continuation|Protocol Violation|0|||
131049672|NCT00943917|471816564|FG001|Stage II Continuation|Protocol Violation|0|||
131049673|NCT00943917|471816565|FG002|Stage II Continuation|Protocol Violation|0|||
131049674|NCT00943917|471816566|FG003|Stage II Continuation|Protocol Violation|0|||
131049675|NCT00943917|471816567|FG004|Stage II Continuation|Protocol Violation|0|||
131049676|NCT00943917|471816568|FG005|Stage II Continuation|Protocol Violation|0|||
131049677|NCT00943917|471816569|FG006|Stage II Continuation|Protocol Violation|0|||
131049678|NCT00943917|471816570|FG007|Stage II Continuation|Protocol Violation|0|||
131049679|NCT00943917|471816571|FG008|Stage II Continuation|Protocol Violation|0|||
131049680|NCT00943917|471816572|FG009|Stage II Continuation|Protocol Violation|1|||
131049681|NCT00943917|471816573|FG010|Stage II Continuation|Protocol Violation|0|||
131049682|NCT00943917|471816574|FG011|Stage II Continuation|Protocol Violation|1|||
131049683|NCT00943917|471816575|FG012|Stage II Continuation|Protocol Violation|0|||
131049684|NCT00943917|471816576|FG013|Stage II Continuation|Protocol Violation|0|||
131049685|NCT00943917|471816577|FG014|Stage II Continuation|Protocol Violation|0|||
131049686|NCT00943917|471816563|FG000|Stage II Continuation|hypoglycemia|0|||
131049687|NCT00943917|471816564|FG001|Stage II Continuation|hypoglycemia|0|||
131049688|NCT00943917|471816565|FG002|Stage II Continuation|hypoglycemia|0|||
131049689|NCT00943917|471816566|FG003|Stage II Continuation|hypoglycemia|0|||
131049690|NCT00943917|471816567|FG004|Stage II Continuation|hypoglycemia|0|||
131049691|NCT00943917|471816568|FG005|Stage II Continuation|hypoglycemia|0|||
131049692|NCT00943917|471816569|FG006|Stage II Continuation|hypoglycemia|0|||
131049693|NCT00943917|471816570|FG007|Stage II Continuation|hypoglycemia|0|||
131049694|NCT00943917|471816571|FG008|Stage II Continuation|hypoglycemia|0|||
131049695|NCT00943917|471816572|FG009|Stage II Continuation|hypoglycemia|0|||
131049696|NCT00943917|471816573|FG010|Stage II Continuation|hypoglycemia|0|||
131049697|NCT00943917|471816574|FG011|Stage II Continuation|hypoglycemia|0|||
131049698|NCT00943917|471816575|FG012|Stage II Continuation|hypoglycemia|1|||
131049699|NCT00943917|471816576|FG013|Stage II Continuation|hypoglycemia|0|||
131049700|NCT00943917|471816577|FG014|Stage II Continuation|hypoglycemia|0|||
131049701|NCT00943917|471816563|FG000|Stage II Continuation|A1C elevation|0|||
131049702|NCT00943917|471816564|FG001|Stage II Continuation|A1C elevation|0|||
131049703|NCT00943917|471816565|FG002|Stage II Continuation|A1C elevation|0|||
130722079|NCT02448706|470608156|FG000|Overall Study|Withdrawal by Subject|4|||
131049704|NCT00943917|471816566|FG003|Stage II Continuation|A1C elevation|0|||
131049705|NCT00943917|471816567|FG004|Stage II Continuation|A1C elevation|0|||
130722080|NCT02448706|470608157|FG001|Overall Study|Withdrawal by Subject|3|||
130722081|NCT02448706|470608156|FG000|Overall Study|Protocol Violation|1|||
130722082|NCT02448706|470608157|FG001|Overall Study|Protocol Violation|1|||
131049706|NCT00943917|471816568|FG005|Stage II Continuation|A1C elevation|0|||
131049707|NCT00943917|471816569|FG006|Stage II Continuation|A1C elevation|0|||
131049708|NCT00943917|471816570|FG007|Stage II Continuation|A1C elevation|0|||
131049709|NCT00943917|471816571|FG008|Stage II Continuation|A1C elevation|0|||
130779273|NCT02999789|470819473|FG000|Overall Study|Became ineligible|1|||
131049710|NCT00943917|471816572|FG009|Stage II Continuation|A1C elevation|0|||
131049711|NCT00943917|471816573|FG010|Stage II Continuation|A1C elevation|0|||
131049712|NCT00943917|471816574|FG011|Stage II Continuation|A1C elevation|0|||
131049713|NCT00943917|471816575|FG012|Stage II Continuation|A1C elevation|0|||
131049714|NCT00943917|471816576|FG013|Stage II Continuation|A1C elevation|1|||
131049715|NCT00943917|471816577|FG014|Stage II Continuation|A1C elevation|0|||
131049716|NCT01171976|471816578|FG000|Overall Study|Protocol Violation|0|||
131049717|NCT01171976|471816579|FG001|Overall Study|Protocol Violation|0|||
131049718|NCT01171976|471816580|FG002|Overall Study|Protocol Violation|1|||
131049719|NCT01171976|471816578|FG000|Overall Study|Death|2|||
131049720|NCT01171976|471816579|FG001|Overall Study|Death|4|||
131049721|NCT01171976|471816580|FG002|Overall Study|Death|1|||
131049722|NCT01171976|471816578|FG000|Overall Study|Lost to Follow-up|4|||
131049723|NCT01171976|471816579|FG001|Overall Study|Lost to Follow-up|0|||
131049724|NCT01171976|471816580|FG002|Overall Study|Lost to Follow-up|2|||
131049725|NCT01171976|471816578|FG000|Overall Study|Withdrawal by Subject|1|||
131049726|NCT01171976|471816579|FG001|Overall Study|Withdrawal by Subject|5|||
131049727|NCT01171976|471816580|FG002|Overall Study|Withdrawal by Subject|6|||
131049728|NCT01171976|471816578|FG000|Overall Study|Abnormal test result|1|||
131049729|NCT01171976|471816579|FG001|Overall Study|Abnormal test result|0|||
131049730|NCT01171976|471816580|FG002|Overall Study|Abnormal test result|0|||
131049731|NCT01171976|471816578|FG000|Overall Study|Adverse Event|6|||
131049732|NCT01171976|471816579|FG001|Overall Study|Adverse Event|2|||
131049733|NCT01171976|471816580|FG002|Overall Study|Adverse Event|5|||
131049734|NCT03840902|471816581|FG000|Overall Study|Randomized but not treated|1|||
131049735|NCT03840902|471816582|FG001|Overall Study|Randomized but not treated|1|||
131049736|NCT02754596|471816586|FG000|Overall Study|Withdrawal by Subject|3|||
131049737|NCT02754596|471816587|FG001|Overall Study|Withdrawal by Subject|4|||
131049738|NCT02754596|471816588|FG002|Overall Study|Withdrawal by Subject|0|||
131049739|NCT02754596|471816586|FG000|Overall Study|Physician Decision|1|||
131049740|NCT02754596|471816587|FG001|Overall Study|Physician Decision|1|||
131049741|NCT02754596|471816588|FG002|Overall Study|Physician Decision|1|||
131049742|NCT02754596|471816586|FG000|Overall Study|Lost to Follow-up|1|||
131049743|NCT02754596|471816587|FG001|Overall Study|Lost to Follow-up|1|||
131049744|NCT02754596|471816588|FG002|Overall Study|Lost to Follow-up|2|||
131049745|NCT02754596|471816586|FG000|Overall Study|Death|0|||
131049746|NCT02754596|471816587|FG001|Overall Study|Death|2|||
131049747|NCT02754596|471816588|FG002|Overall Study|Death|0|||
131049748|NCT02754596|471816586|FG000|Overall Study|Adverse Event|1|||
131049749|NCT02754596|471816587|FG001|Overall Study|Adverse Event|0|||
131049750|NCT02754596|471816588|FG002|Overall Study|Adverse Event|1|||
131049751|NCT02754596|471816586|FG000|Overall Study|Other|1|||
131049752|NCT02754596|471816587|FG001|Overall Study|Other|0|||
131049753|NCT02754596|471816588|FG002|Overall Study|Other|0|||
131049754|NCT03357952|471816589|FG000|Overall Study|Withdrawal by Subject|0|||
131049755|NCT03357952|471816590|FG001|Overall Study|Withdrawal by Subject|1|||
131049756|NCT03357952|471816589|FG000|Overall Study|Sponsor Decision|9|||
131049757|NCT03357952|471816590|FG001|Overall Study|Sponsor Decision|0|||
131049758|NCT01371994|471816591|FG000|Overall Study|Adverse Event|3|||
131049759|NCT01371994|471816592|FG001|Overall Study|Adverse Event|6|||
131049760|NCT01371994|471816591|FG000|Overall Study|Lack of Efficacy|3|||
131049761|NCT01371994|471816592|FG001|Overall Study|Lack of Efficacy|0|||
131049762|NCT01371994|471816591|FG000|Overall Study|Withdrawal by Subject|13|||
131049763|NCT01371994|471816592|FG001|Overall Study|Withdrawal by Subject|7|||
131049764|NCT01371994|471816591|FG000|Overall Study|Lost to Follow-up|1|||
131049765|NCT01371994|471816592|FG001|Overall Study|Lost to Follow-up|1|||
131049766|NCT01371994|471816591|FG000|Overall Study|Protocol Violation|24|||
131049767|NCT01371994|471816592|FG001|Overall Study|Protocol Violation|17|||
131049768|NCT01371994|471816591|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
131049769|NCT01371994|471816592|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
131049770|NCT01371994|471816591|FG000|Overall Study|Physician Decision|1|||
131049771|NCT01371994|471816592|FG001|Overall Study|Physician Decision|1|||
131049772|NCT01371994|471816591|FG000|Overall Study|Miscellaneous Reasons|6|||
131049773|NCT01371994|471816592|FG001|Overall Study|Miscellaneous Reasons|4|||
131049774|NCT03280030|471816593|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
131049775|NCT03280030|471816594|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
131049776|NCT03280030|471816595|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
131049777|NCT03280030|471816593|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
131049778|NCT03280030|471816594|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
131049779|NCT03280030|471816595|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
131049780|NCT03280030|471816593|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
131049781|NCT03280030|471816594|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
131049782|NCT03280030|471816595|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
131049783|NCT03280030|471816593|FG000|Part 2 - Efficacy|Adverse Event|0|||
131049784|NCT03280030|471816594|FG001|Part 2 - Efficacy|Adverse Event|4|||
131049785|NCT03280030|471816595|FG002|Part 2 - Efficacy|Adverse Event|6|||
131049786|NCT03280030|471816593|FG000|Part 2 - Efficacy|Death|0|||
131049787|NCT03280030|471816594|FG001|Part 2 - Efficacy|Death|3|||
131049788|NCT03280030|471816595|FG002|Part 2 - Efficacy|Death|0|||
131049789|NCT03280030|471816593|FG000|Part 2 - Efficacy|Physician Decision|0|||
131049790|NCT03280030|471816594|FG001|Part 2 - Efficacy|Physician Decision|10|||
131049791|NCT03280030|471816595|FG002|Part 2 - Efficacy|Physician Decision|16|||
131049792|NCT03280030|471816593|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
131049793|NCT03280030|471816594|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
131049794|NCT03280030|471816595|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
131049795|NCT03280030|471816593|FG000|Part 2 - Efficacy|Progressive disease|0|||
131049796|NCT03280030|471816594|FG001|Part 2 - Efficacy|Progressive disease|7|||
131049797|NCT03280030|471816595|FG002|Part 2 - Efficacy|Progressive disease|5|||
131049798|NCT01208974|471816598|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
131049799|NCT01208974|471816599|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
131049800|NCT01208974|471816600|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
131049801|NCT01208974|471816601|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
131049802|NCT01208974|471816598|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
131049803|NCT01208974|471816599|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
131049804|NCT01208974|471816600|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
131049805|NCT01208974|471816601|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
131049806|NCT01208974|471816598|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
131049807|NCT01208974|471816599|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
131049808|NCT01208974|471816600|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
131049809|NCT01208974|471816601|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
131049810|NCT03211247|471816602|FG000|Overall Study|Adverse Event|8|||
131049811|NCT03211247|471816603|FG001|Overall Study|Adverse Event|0|||
131049812|NCT03211247|471816604|FG002|Overall Study|Adverse Event|1|||
131049813|NCT03211247|471816605|FG003|Overall Study|Adverse Event|0|||
131049814|NCT03211247|471816606|FG004|Overall Study|Adverse Event|0|||
131049815|NCT03211247|471816602|FG000|Overall Study|Lost to Follow-up|2|||
131049816|NCT03211247|471816603|FG001|Overall Study|Lost to Follow-up|1|||
131049817|NCT03211247|471816604|FG002|Overall Study|Lost to Follow-up|0|||
131049818|NCT03211247|471816605|FG003|Overall Study|Lost to Follow-up|0|||
131049819|NCT03211247|471816606|FG004|Overall Study|Lost to Follow-up|0|||
131049820|NCT03211247|471816602|FG000|Overall Study|Physician Decision|1|||
131049821|NCT03211247|471816603|FG001|Overall Study|Physician Decision|2|||
131049822|NCT03211247|471816604|FG002|Overall Study|Physician Decision|0|||
131049823|NCT03211247|471816605|FG003|Overall Study|Physician Decision|0|||
131049824|NCT03211247|471816606|FG004|Overall Study|Physician Decision|0|||
131049825|NCT03211247|471816602|FG000|Overall Study|Non-compliance with study drug|2|||
131049826|NCT03211247|471816603|FG001|Overall Study|Non-compliance with study drug|0|||
131049827|NCT03211247|471816604|FG002|Overall Study|Non-compliance with study drug|0|||
131049828|NCT03211247|471816605|FG003|Overall Study|Non-compliance with study drug|0|||
131049829|NCT03211247|471816606|FG004|Overall Study|Non-compliance with study drug|0|||
131049830|NCT03211247|471816602|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
131049831|NCT03211247|471816603|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
131049832|NCT03211247|471816604|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
131134434|NCT00143455|472118919|FG001|Cohort 2|Randomized But Not Treated|0|||
131134435|NCT00143455|472118920|FG002|Cohort 2|Randomized But Not Treated|1|||
131134436|NCT00143455|472118921|FG003|Cohort 2|Randomized But Not Treated|1|||
131134437|NCT03713944|472118922|FG000|Study Treatment|Patient non-compliance|1|||
131134438|NCT03713944|472118922|FG000|Study Treatment|Alternative Cancer Therapy|3|||
131134439|NCT03713944|472118922|FG000|Study Treatment|Disease Progression|18|||
131134440|NCT03713944|472118922|FG000|Study Treatment|AE/Side Effects/Complications|2|||
131134441|NCT03713944|472118922|FG000|Study Treatment|Death|2|||
131134442|NCT03713944|472118922|FG000|Study Treatment|Withdrawal by Subject|1|||
131134443|NCT03713944|472118922|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
131134444|NCT03713944|472118922|FG000|Study Treatment|Symptomatic Deterioration|2|||
131134445|NCT03713944|472118922|FG000|Follow up|Withdrawal by Subject|2|||
131134446|NCT03713944|472118922|FG000|Follow up|Death|11|||
131134447|NCT03713944|472118922|FG000|Follow up|Study Terminated|3|||
131134448|NCT03847610|472118923|FG000|Overall Study|Withdrawal by Subject|1|||
131229636|NCT00112489|472467648|FG000|Overall Study|Patient never treated|2|||
131229637|NCT00112489|472467648|FG000|Overall Study|Ineligible|7|||
131229638|NCT01003886|472467649|FG000|Overall Study|Lack of Efficacy|5|||
131229639|NCT01003886|472467649|FG000|Overall Study|Lost to Follow-up|169|||
131229640|NCT01003886|472467649|FG000|Overall Study|Withdrawal by Subject|39|||
131134449|NCT01445769|472118924|FG000|Overall Study|Consent Withdrawn|2|||
131229641|NCT01003886|472467649|FG000|Overall Study|Other|14|||
131134450|NCT01445769|472118924|FG000|Overall Study|Disease Progression|1|||
131134451|NCT01445769|472118924|FG000|Overall Study|Lost to Follow-up|5|||
131134452|NCT03099707|472118925|FG000|Overall Study|Withdrawal by Subject|0|||
131134453|NCT03099707|472118926|FG001|Overall Study|Withdrawal by Subject|3|||
131134454|NCT03099707|472118925|FG000|Overall Study|Lost to Follow-up|0|||
131134455|NCT03099707|472118926|FG001|Overall Study|Lost to Follow-up|1|||
131134456|NCT03127384|472118936|FG000|Overall Study|Lost to Follow-up|4|||
131229642|NCT01003886|472467649|FG000|Overall Study|Adverse Event|3|||
131134457|NCT03127384|472118936|FG000|Overall Study|Subject request|2|||
131134458|NCT01967537|472118940|FG000|Overall Study|Withdrawal by Subject|52|||
131134459|NCT01967537|472118940|FG000|Overall Study|Refuse treatment|2|||
131134460|NCT01967537|472118940|FG000|Overall Study|Lost to Follow-up|6|||
131134461|NCT01079182|472118941|FG000|Overall Study|Lost to Follow-up|1634|||
131134462|NCT01079182|472118941|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
131134463|NCT01079182|472118941|FG000|Overall Study|Lack of Efficacy|514|||
131134464|NCT01079182|472118941|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
131134465|NCT01079182|472118941|FG000|Overall Study|Reasons not Evaluated|271|||
131134466|NCT04417894|472118942|FG000|Overall Study|Lost to Follow-up|3|||
131134467|NCT04417894|472118943|FG001|Overall Study|Lost to Follow-up|0|||
131134468|NCT04417894|472118942|FG000|Overall Study|Withdrawal by Subject|7|||
131134469|NCT04417894|472118943|FG001|Overall Study|Withdrawal by Subject|6|||
131134470|NCT04417894|472118942|FG000|Overall Study|Lack of Efficacy|3|||
131134471|NCT04417894|472118943|FG001|Overall Study|Lack of Efficacy|1|||
131134472|NCT05130463|472118944|FG000|Overall Study|Unspecified reasons|2|||
131134473|NCT05130463|472118944|FG000|Overall Study|off-label indication dose|435|||
131134474|NCT03461757|472118945|FG000|Overall Study|Adverse Event|1|||
131134475|NCT03461757|472118946|FG001|Overall Study|Adverse Event|0|||
131134476|NCT03461757|472118945|FG000|Overall Study|Lost to Follow-up|13|||
131134477|NCT03461757|472118946|FG001|Overall Study|Lost to Follow-up|7|||
131134478|NCT03461757|472118945|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
131134479|NCT03461757|472118946|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
131134480|NCT03461757|472118945|FG000|Overall Study|Non-compliance with study treatment|0|||
131134481|NCT03461757|472118946|FG001|Overall Study|Non-compliance with study treatment|1|||
131134482|NCT03461757|472118945|FG000|Overall Study|Pregnancy|2|||
131134483|NCT03461757|472118946|FG001|Overall Study|Pregnancy|0|||
131134484|NCT03461757|472118945|FG000|Overall Study|Protocol Violation|1|||
131134485|NCT03461757|472118946|FG001|Overall Study|Protocol Violation|1|||
131134486|NCT03461757|472118945|FG000|Overall Study|Withdrawal by Subject|7|||
131134487|NCT03461757|472118946|FG001|Overall Study|Withdrawal by Subject|7|||
131134488|NCT03461757|472118945|FG000|Overall Study|Other Reasons|1|||
131134489|NCT03461757|472118946|FG001|Overall Study|Other Reasons|4|||
131134490|NCT03652662|472118952|FG000|Overall Study|Withdrawal by Subject|2|||
131134491|NCT03652662|472118953|FG001|Overall Study|Withdrawal by Subject|1|||
131134492|NCT03652662|472118952|FG000|Overall Study|Lost to Follow-up|1|||
131134493|NCT03652662|472118953|FG001|Overall Study|Lost to Follow-up|0|||
131134494|NCT00487539|472118954|FG000|Overall Study|Adverse Event|3|||
131134495|NCT00487539|472118955|FG001|Overall Study|Adverse Event|2|||
131134496|NCT00487539|472118956|FG002|Overall Study|Adverse Event|1|||
131134497|NCT00487539|472118957|FG003|Overall Study|Adverse Event|1|||
131134498|NCT00487539|472118954|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131134499|NCT00487539|472118955|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131134500|NCT00487539|472118956|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131134501|NCT00487539|472118957|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
131134502|NCT00487539|472118954|FG000|Overall Study|Other|3|||
131134503|NCT00487539|472118955|FG001|Overall Study|Other|1|||
131134504|NCT00487539|472118956|FG002|Overall Study|Other|2|||
131134505|NCT00487539|472118957|FG003|Overall Study|Other|2|||
131134506|NCT03440814|472118958|FG000|Overall Study|Adverse Event|2|||
131134507|NCT03440814|472118959|FG001|Overall Study|Adverse Event|1|||
131134508|NCT03440814|472118958|FG000|Overall Study|Lost to Follow-up|2|||
131134509|NCT03440814|472118959|FG001|Overall Study|Lost to Follow-up|0|||
131134510|NCT03440814|472118958|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
131134511|NCT03440814|472118959|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
131134512|NCT00879697|472118960|FG000|Overall Study|Physician Decision|2|||
131134513|NCT00879697|472118961|FG001|Overall Study|Physician Decision|2|||
131134514|NCT00088374|472118962|FG000|Overall Study|patient did not receive any 17AAG|1|||
131134515|NCT00088374|472118962|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
130779274|NCT02999789|470819474|FG001|Overall Study|Became ineligible|2|||
130779275|NCT04613739|470819477|FG000|Overall Study|Lost to Follow-up|6|||
130779276|NCT04613739|470819478|FG001|Overall Study|Lost to Follow-up|9|||
130779277|NCT04613739|470819477|FG000|Overall Study|potentially duplicative/fraudulent|1|||
131134516|NCT00720109|472118963|FG000|Induction Period|Did not meet eligibility criteria|3|||
131134517|NCT00720109|472118964|FG001|Induction Period|Did not meet eligibility criteria|0|||
131134518|NCT00720109|472118965|FG002|Induction Period|Did not meet eligibility criteria|0|||
131134519|NCT00720109|472118963|FG000|Induction Period|Bone Marrow Transplant|2|||
131134520|NCT00720109|472118964|FG001|Induction Period|Bone Marrow Transplant|0|||
131134521|NCT00720109|472118965|FG002|Induction Period|Bone Marrow Transplant|0|||
131134522|NCT00720109|472118963|FG000|Induction Period|Physician Decision|1|||
131134523|NCT00720109|472118964|FG001|Induction Period|Physician Decision|0|||
131134524|NCT00720109|472118965|FG002|Induction Period|Physician Decision|0|||
131134525|NCT00720109|472118963|FG000|Risk Stratification Period|Adverse Event|0|||
131134526|NCT00720109|472118964|FG001|Risk Stratification Period|Adverse Event|1|||
131134527|NCT00720109|472118965|FG002|Risk Stratification Period|Adverse Event|0|||
131134528|NCT00720109|472118963|FG000|Risk Stratification Period|Physician Decision|0|||
131049833|NCT03211247|471816605|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
131049834|NCT03211247|471816606|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
131049835|NCT03211247|471816602|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
131049836|NCT03211247|471816603|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
131049837|NCT03211247|471816604|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
131049838|NCT03211247|471816605|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
131049839|NCT03211247|471816606|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
131049840|NCT03211247|471816602|FG000|Overall Study|Protocol Violation|0|||
131049841|NCT03211247|471816603|FG001|Overall Study|Protocol Violation|1|||
131049842|NCT03211247|471816604|FG002|Overall Study|Protocol Violation|0|||
131049843|NCT03211247|471816605|FG003|Overall Study|Protocol Violation|0|||
131049844|NCT03211247|471816606|FG004|Overall Study|Protocol Violation|0|||
131049845|NCT01983683|471816609|FG000|Overall Study|Withdrawal by Subject|14|||
131049846|NCT01983683|471816610|FG001|Overall Study|Withdrawal by Subject|18|||
131049847|NCT01983683|471816609|FG000|Overall Study|Death|11|||
131049848|NCT01983683|471816610|FG001|Overall Study|Death|15|||
131049849|NCT01983683|471816609|FG000|Overall Study|Physician Decision|8|||
131049850|NCT01983683|471816610|FG001|Overall Study|Physician Decision|9|||
131049851|NCT01983683|471816609|FG000|Overall Study|Lost to Follow-up|4|||
131049852|NCT01983683|471816610|FG001|Overall Study|Lost to Follow-up|8|||
131049853|NCT01983683|471816609|FG000|Overall Study|Sponsor Decision|1|||
131049854|NCT01983683|471816610|FG001|Overall Study|Sponsor Decision|1|||
131049855|NCT04153890|471816614|FG000|Overall Study|Lost to Follow-up|9|||
131049856|NCT04153890|471816615|FG001|Overall Study|Lost to Follow-up|0|||
131049857|NCT04153890|471816616|FG002|Overall Study|Lost to Follow-up|9|||
131049858|NCT04153890|471816617|FG003|Overall Study|Lost to Follow-up|0|||
131049859|NCT04153890|471816614|FG000|Overall Study|Death|0|||
131049860|NCT04153890|471816615|FG001|Overall Study|Death|2|||
131049861|NCT04153890|471816616|FG002|Overall Study|Death|0|||
131049862|NCT04153890|471816617|FG003|Overall Study|Death|0|||
131049863|NCT04153890|471816614|FG000|Overall Study|Withdrawal by Subject|0|||
131049864|NCT04153890|471816615|FG001|Overall Study|Withdrawal by Subject|0|||
131049865|NCT04153890|471816616|FG002|Overall Study|Withdrawal by Subject|0|||
131049866|NCT04153890|471816617|FG003|Overall Study|Withdrawal by Subject|2|||
131049867|NCT03959423|471816618|FG000|Overall Study|Withdrawal by Subject|2|||
131049868|NCT03959423|471816619|FG001|Overall Study|Withdrawal by Subject|3|||
131049869|NCT03959423|471816618|FG000|Overall Study|Physician Decision|0|||
131049870|NCT03959423|471816619|FG001|Overall Study|Physician Decision|1|||
131049871|NCT03959423|471816618|FG000|Overall Study|Lost to Follow-up|1|||
131049872|NCT03959423|471816619|FG001|Overall Study|Lost to Follow-up|0|||
131049873|NCT03959423|471816618|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
131049874|NCT03959423|471816619|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131049875|NCT05786612|471816621|FG000|Overall Study|Adverse Event|1|||
131049876|NCT05786612|471816622|FG001|Overall Study|Adverse Event|2|||
131049877|NCT05786612|471816621|FG000|Overall Study|one screening failure|0|||
131049878|NCT05786612|471816622|FG001|Overall Study|one screening failure|2|||
131049879|NCT04926740|471816623|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
131049880|NCT04926740|471816624|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
131049881|NCT04926740|471816623|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
131049882|NCT04926740|471816624|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
131049883|NCT02549352|471816625|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
131049884|NCT02549352|471816626|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
131049885|NCT02549352|471816625|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
131049886|NCT02549352|471816626|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
131049887|NCT02549352|471816625|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
131049888|NCT02549352|471816626|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
131049889|NCT02549352|471816625|FG000|12-month Follow-up|Withdrawal by Subject|4|||
131049890|NCT02549352|471816626|FG001|12-month Follow-up|Withdrawal by Subject|5|||
131049891|NCT02549352|471816625|FG000|12-month Follow-up|Lost to Follow-up|3|||
131049892|NCT02549352|471816626|FG001|12-month Follow-up|Lost to Follow-up|2|||
131049893|NCT02549352|471816625|FG000|12-month Follow-up|Death|0|||
131049894|NCT02549352|471816626|FG001|12-month Follow-up|Death|1|||
131049895|NCT02549352|471816625|FG000|12-month Follow-up|Protocol Violation|0|||
131134529|NCT00720109|472118964|FG001|Risk Stratification Period|Physician Decision|2|||
131134530|NCT00720109|472118965|FG002|Risk Stratification Period|Physician Decision|1|||
131049896|NCT02549352|471816626|FG001|12-month Follow-up|Protocol Violation|1|||
131049897|NCT02549352|471816625|FG000|12-month Follow-up|Other|1|||
131049898|NCT02549352|471816626|FG001|12-month Follow-up|Other|3|||
131049899|NCT04980300|471816629|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
131049900|NCT04980300|471816630|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
131049901|NCT04980300|471816629|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
131049902|NCT04980300|471816630|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
131049903|NCT04980300|471816629|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
131134531|NCT00720109|472118963|FG000|Risk Stratification Period|Bone marrow transplant|0|||
131049904|NCT04980300|471816630|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
131049905|NCT04980300|471816629|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
131049906|NCT04980300|471816630|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
131049907|NCT03459196|471818069|FG000|Overall Study|Subject didn't receive study catheter|2|||
131049908|NCT00146172|471818071|FG000|Overall Study|Adverse Event|0|||
131049909|NCT00146172|471818072|FG001|Overall Study|Adverse Event|0|||
131049910|NCT00146172|471818073|FG002|Overall Study|Adverse Event|1|||
131049911|NCT00146172|471818074|FG003|Overall Study|Adverse Event|1|||
131049912|NCT00146172|471818075|FG004|Overall Study|Adverse Event|0|||
131049913|NCT00146172|471818076|FG005|Overall Study|Adverse Event|2|||
131049914|NCT00146172|471818077|FG006|Overall Study|Adverse Event|3|||
131049915|NCT00146172|471818078|FG007|Overall Study|Adverse Event|10|||
131049916|NCT00146172|471818071|FG000|Overall Study|Lost to Follow-up|0|||
131049917|NCT00146172|471818072|FG001|Overall Study|Lost to Follow-up|0|||
131049918|NCT00146172|471818073|FG002|Overall Study|Lost to Follow-up|0|||
131049919|NCT00146172|471818074|FG003|Overall Study|Lost to Follow-up|0|||
131049920|NCT00146172|471818075|FG004|Overall Study|Lost to Follow-up|0|||
131049921|NCT00146172|471818076|FG005|Overall Study|Lost to Follow-up|0|||
131049922|NCT00146172|471818077|FG006|Overall Study|Lost to Follow-up|0|||
131049923|NCT00146172|471818078|FG007|Overall Study|Lost to Follow-up|1|||
131049924|NCT00146172|471818071|FG000|Overall Study|Disease Progression|2|||
131049925|NCT00146172|471818072|FG001|Overall Study|Disease Progression|4|||
131049926|NCT00146172|471818073|FG002|Overall Study|Disease Progression|2|||
131049927|NCT00146172|471818074|FG003|Overall Study|Disease Progression|5|||
131049928|NCT00146172|471818075|FG004|Overall Study|Disease Progression|2|||
131049929|NCT00146172|471818076|FG005|Overall Study|Disease Progression|2|||
131049930|NCT00146172|471818077|FG006|Overall Study|Disease Progression|1|||
131049931|NCT00146172|471818078|FG007|Overall Study|Disease Progression|22|||
131049932|NCT00146172|471818071|FG000|Overall Study|Death|0|||
131049933|NCT00146172|471818072|FG001|Overall Study|Death|0|||
131049934|NCT00146172|471818073|FG002|Overall Study|Death|0|||
131049935|NCT00146172|471818074|FG003|Overall Study|Death|0|||
131049936|NCT00146172|471818075|FG004|Overall Study|Death|0|||
131049937|NCT00146172|471818076|FG005|Overall Study|Death|0|||
131049938|NCT00146172|471818077|FG006|Overall Study|Death|1|||
131049939|NCT00146172|471818078|FG007|Overall Study|Death|0|||
131049940|NCT00146172|471818071|FG000|Overall Study|Physician Decision|0|||
131049941|NCT00146172|471818072|FG001|Overall Study|Physician Decision|0|||
131049942|NCT00146172|471818073|FG002|Overall Study|Physician Decision|0|||
131049943|NCT00146172|471818074|FG003|Overall Study|Physician Decision|0|||
131049944|NCT00146172|471818075|FG004|Overall Study|Physician Decision|0|||
131049945|NCT00146172|471818076|FG005|Overall Study|Physician Decision|0|||
131049946|NCT00146172|471818077|FG006|Overall Study|Physician Decision|0|||
131049947|NCT00146172|471818078|FG007|Overall Study|Physician Decision|1|||
131049948|NCT00146172|471818071|FG000|Overall Study|Withdrawal by Subject|0|||
131049949|NCT00146172|471818072|FG001|Overall Study|Withdrawal by Subject|0|||
131049950|NCT00146172|471818073|FG002|Overall Study|Withdrawal by Subject|0|||
131049951|NCT00146172|471818074|FG003|Overall Study|Withdrawal by Subject|0|||
131049952|NCT00146172|471818075|FG004|Overall Study|Withdrawal by Subject|0|||
131049953|NCT00146172|471818076|FG005|Overall Study|Withdrawal by Subject|1|||
131049954|NCT00146172|471818077|FG006|Overall Study|Withdrawal by Subject|1|||
131049955|NCT00146172|471818078|FG007|Overall Study|Withdrawal by Subject|4|||
131049956|NCT00146172|471818071|FG000|Overall Study|Symptomatic Deterioration|1|||
131049957|NCT00146172|471818072|FG001|Overall Study|Symptomatic Deterioration|0|||
131049958|NCT00146172|471818073|FG002|Overall Study|Symptomatic Deterioration|1|||
131049959|NCT00146172|471818074|FG003|Overall Study|Symptomatic Deterioration|0|||
131049960|NCT00146172|471818075|FG004|Overall Study|Symptomatic Deterioration|1|||
131049961|NCT00146172|471818076|FG005|Overall Study|Symptomatic Deterioration|2|||
131049962|NCT00146172|471818077|FG006|Overall Study|Symptomatic Deterioration|0|||
131049963|NCT00146172|471818078|FG007|Overall Study|Symptomatic Deterioration|2|||
131049964|NCT03876457|471818081|FG000|Overall Study|Lost to Follow-up|1|||
131049965|NCT03876457|471818082|FG001|Overall Study|Lost to Follow-up|3|||
131049966|NCT01184326|471818083|FG000|Overall Study|Adverse Event|1|||
131049967|NCT01184326|471818084|FG001|Overall Study|Adverse Event|2|||
131049968|NCT01184326|471818085|FG002|Overall Study|Adverse Event|0|||
131049969|NCT01184326|471818083|FG000|Overall Study|Death|0|||
131049970|NCT01184326|471818084|FG001|Overall Study|Death|0|||
131049971|NCT01184326|471818085|FG002|Overall Study|Death|1|||
131049972|NCT01184326|471818083|FG000|Overall Study|Withdrawal by Subject|0|||
131049973|NCT01184326|471818084|FG001|Overall Study|Withdrawal by Subject|0|||
131049974|NCT01184326|471818085|FG002|Overall Study|Withdrawal by Subject|1|||
131049975|NCT01184326|471818083|FG000|Overall Study|Physician Decision|1|||
131049976|NCT01184326|471818084|FG001|Overall Study|Physician Decision|1|||
131049977|NCT01184326|471818085|FG002|Overall Study|Physician Decision|0|||
131049978|NCT01184326|471818083|FG000|Overall Study|Disease Progression|1|||
131049979|NCT01184326|471818084|FG001|Overall Study|Disease Progression|3|||
131049980|NCT01184326|471818085|FG002|Overall Study|Disease Progression|12|||
131049981|NCT01288443|471818086|FG000|Overall Study|Adverse Event|0|||
131049982|NCT01288443|471818087|FG001|Overall Study|Adverse Event|0|||
131049983|NCT01288443|471818088|FG002|Overall Study|Adverse Event|1|||
131049984|NCT01288443|471818089|FG003|Overall Study|Adverse Event|1|||
131049985|NCT01288443|471818090|FG004|Overall Study|Adverse Event|3|||
131049986|NCT01288443|471818091|FG005|Overall Study|Adverse Event|1|||
131049987|NCT01288443|471818086|FG000|Overall Study|Poor compliance to protocol|0|||
131049988|NCT01288443|471818087|FG001|Overall Study|Poor compliance to protocol|0|||
131049989|NCT01288443|471818088|FG002|Overall Study|Poor compliance to protocol|0|||
131049990|NCT01288443|471818089|FG003|Overall Study|Poor compliance to protocol|0|||
131049991|NCT01288443|471818090|FG004|Overall Study|Poor compliance to protocol|0|||
131049992|NCT01288443|471818091|FG005|Overall Study|Poor compliance to protocol|1|||
131049993|NCT01288443|471818086|FG000|Overall Study|Participant Moved|0|||
131049994|NCT01288443|471818087|FG001|Overall Study|Participant Moved|0|||
131049995|NCT01288443|471818088|FG002|Overall Study|Participant Moved|0|||
131049996|NCT01288443|471818089|FG003|Overall Study|Participant Moved|1|||
131049997|NCT01288443|471818090|FG004|Overall Study|Participant Moved|2|||
131049998|NCT01288443|471818091|FG005|Overall Study|Participant Moved|1|||
131049999|NCT01288443|471818086|FG000|Overall Study|Consent withdrawn by Participant|0|||
131050000|NCT01288443|471818087|FG001|Overall Study|Consent withdrawn by Participant|0|||
131050001|NCT01288443|471818088|FG002|Overall Study|Consent withdrawn by Participant|0|||
131050002|NCT01288443|471818089|FG003|Overall Study|Consent withdrawn by Participant|0|||
131050003|NCT01288443|471818090|FG004|Overall Study|Consent withdrawn by Participant|0|||
131050004|NCT01288443|471818091|FG005|Overall Study|Consent withdrawn by Participant|1|||
131050005|NCT01288443|471818086|FG000|Overall Study|Lost to Follow-up|0|||
131050006|NCT01288443|471818087|FG001|Overall Study|Lost to Follow-up|1|||
131050007|NCT01288443|471818088|FG002|Overall Study|Lost to Follow-up|0|||
131050008|NCT01288443|471818089|FG003|Overall Study|Lost to Follow-up|0|||
131050009|NCT01288443|471818090|FG004|Overall Study|Lost to Follow-up|0|||
131050010|NCT01288443|471818091|FG005|Overall Study|Lost to Follow-up|0|||
131050011|NCT01288443|471818086|FG000|Overall Study|Study drug auto-injector administration|0|||
131050012|NCT01288443|471818087|FG001|Overall Study|Study drug auto-injector administration|0|||
131050013|NCT01288443|471818088|FG002|Overall Study|Study drug auto-injector administration|0|||
131050014|NCT01288443|471818089|FG003|Overall Study|Study drug auto-injector administration|0|||
131050015|NCT01288443|471818090|FG004|Overall Study|Study drug auto-injector administration|1|||
131050016|NCT01288443|471818091|FG005|Overall Study|Study drug auto-injector administration|1|||
131050017|NCT01288443|471818086|FG000|Overall Study|Other than above|0|||
131050018|NCT01288443|471818087|FG001|Overall Study|Other than above|0|||
131050019|NCT01288443|471818088|FG002|Overall Study|Other than above|0|||
131050020|NCT01288443|471818089|FG003|Overall Study|Other than above|2|||
131050021|NCT01288443|471818090|FG004|Overall Study|Other than above|1|||
131050022|NCT01288443|471818091|FG005|Overall Study|Other than above|0|||
131050023|NCT01964300|471818093|FG000|Overall Study|Ineligible after enrollment|0|||
131050024|NCT01964300|471818094|FG001|Overall Study|Ineligible after enrollment|1|||
131050025|NCT01964300|471818093|FG000|Overall Study|Adverse Event|1|||
131050026|NCT01964300|471818094|FG001|Overall Study|Adverse Event|1|||
131050027|NCT01964300|471818093|FG000|Overall Study|Lack of Efficacy|3|||
131050028|NCT01964300|471818094|FG001|Overall Study|Lack of Efficacy|5|||
131050029|NCT01964300|471818093|FG000|Overall Study|Withdrawal by Subject|0|||
131050030|NCT01964300|471818094|FG001|Overall Study|Withdrawal by Subject|1|||
131050031|NCT01964300|471818093|FG000|Overall Study|To receive alternative therapy|1|||
131050032|NCT01964300|471818094|FG001|Overall Study|To receive alternative therapy|2|||
131050033|NCT01964300|471818093|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
131050034|NCT01964300|471818094|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
131050035|NCT01964300|471818093|FG000|Overall Study|Weight criteria not met|0|||
131050036|NCT01964300|471818094|FG001|Overall Study|Weight criteria not met|1|||
131050037|NCT00557492|471818095|FG000|Overall Study|Change in health insurance|1|||
131050038|NCT01574716|471818096|FG000|Part 1|Death|3|||
131050039|NCT01574716|471818097|FG001|Part 1|Death|1|||
131050040|NCT01574716|471818098|FG002|Part 1|Death|8|||
131050041|NCT01574716|471818099|FG003|Part 1|Death|0|||
131050042|NCT01574716|471818100|FG004|Part 1|Death|0|||
131050043|NCT01574716|471818096|FG000|Part 1|Discontinuation of study by sponsor|0|||
131050044|NCT01574716|471818097|FG001|Part 1|Discontinuation of study by sponsor|0|||
131050045|NCT01574716|471818098|FG002|Part 1|Discontinuation of study by sponsor|1|||
131050046|NCT01574716|471818099|FG003|Part 1|Discontinuation of study by sponsor|0|||
131050047|NCT01574716|471818100|FG004|Part 1|Discontinuation of study by sponsor|0|||
131050048|NCT01574716|471818096|FG000|Part 1|Withdrawal by Subject|0|||
130722083|NCT01359969|470608161|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
130722084|NCT00470067|470608166|FG000|Overall Study|Death|1|||
130722085|NCT00470067|470608166|FG000|Overall Study|Disease Progression|6|||
131050049|NCT01574716|471818097|FG001|Part 1|Withdrawal by Subject|2|||
131050050|NCT01574716|471818098|FG002|Part 1|Withdrawal by Subject|0|||
131050051|NCT01574716|471818099|FG003|Part 1|Withdrawal by Subject|0|||
131050052|NCT01574716|471818100|FG004|Part 1|Withdrawal by Subject|0|||
131050053|NCT01574716|471818096|FG000|Part 1|Lost to Follow-up|0|||
131050054|NCT01574716|471818097|FG001|Part 1|Lost to Follow-up|1|||
131050055|NCT01574716|471818098|FG002|Part 1|Lost to Follow-up|0|||
131050056|NCT01574716|471818099|FG003|Part 1|Lost to Follow-up|0|||
131050057|NCT01574716|471818100|FG004|Part 1|Lost to Follow-up|0|||
131134532|NCT00720109|472118964|FG001|Risk Stratification Period|Bone marrow transplant|9|||
131134533|NCT00720109|472118965|FG002|Risk Stratification Period|Bone marrow transplant|7|||
131134534|NCT00720109|472118963|FG000|Risk Stratification Period|Disease progression or relapse|0|||
131134535|NCT00720109|472118964|FG001|Risk Stratification Period|Disease progression or relapse|2|||
131134536|NCT00720109|472118965|FG002|Risk Stratification Period|Disease progression or relapse|0|||
131134537|NCT00720109|472118963|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
131134538|NCT00720109|472118964|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
131134539|NCT00720109|472118965|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
131134540|NCT00371865|472118966|FG000|Overall Study|Lack of Efficacy|0|||
131134541|NCT00371865|472118967|FG001|Overall Study|Lack of Efficacy|2|||
131134542|NCT00371865|472118966|FG000|Overall Study|Protocol Violation|3|||
131134543|NCT00371865|472118967|FG001|Overall Study|Protocol Violation|2|||
131134544|NCT00371865|472118966|FG000|Overall Study|Withdrawal by Subject|12|||
131134545|NCT00371865|472118967|FG001|Overall Study|Withdrawal by Subject|10|||
131050058|NCT01574716|471818096|FG000|Part 2|Progressive disease|0|||
131050059|NCT01574716|471818097|FG001|Part 2|Progressive disease|0|||
131050060|NCT01574716|471818098|FG002|Part 2|Progressive disease|0|||
131050061|NCT01574716|471818099|FG003|Part 2|Progressive disease|1|||
131050062|NCT01574716|471818100|FG004|Part 2|Progressive disease|0|||
131050063|NCT01574716|471818096|FG000|Part 2|Death|0|||
131134546|NCT02508194|472118968|FG000|Overall Study|Death|5|||
131134547|NCT02508194|472118969|FG001|Overall Study|Death|3|||
131134548|NCT02508194|472118968|FG000|Overall Study|Lost to Follow-up|25|||
131134549|NCT02508194|472118969|FG001|Overall Study|Lost to Follow-up|18|||
131134550|NCT02508194|472118968|FG000|Overall Study|Withdrawal by Subject|20|||
131134551|NCT02508194|472118969|FG001|Overall Study|Withdrawal by Subject|18|||
131134552|NCT02508194|472118968|FG000|Overall Study|Error in Randomization|1|||
131134553|NCT02508194|472118969|FG001|Overall Study|Error in Randomization|3|||
131134554|NCT02508194|472118968|FG000|Overall Study|Principal Investigator Decision|1|||
131134555|NCT02508194|472118969|FG001|Overall Study|Principal Investigator Decision|2|||
131134556|NCT04153188|472118976|FG000|Overall Study|Lost to Follow-up|1|||
130722086|NCT03400943|470608167|FG000|Treatment Period 1|Adverse Event|0|||
130722087|NCT03400943|470608168|FG001|Treatment Period 1|Adverse Event|0|||
131050064|NCT01574716|471818097|FG001|Part 2|Death|0|||
131050065|NCT01574716|471818098|FG002|Part 2|Death|0|||
131050066|NCT01574716|471818099|FG003|Part 2|Death|76|||
131050067|NCT01574716|471818100|FG004|Part 2|Death|35|||
131050068|NCT01574716|471818096|FG000|Part 2|Discontinuation of study by sponsor|0|||
131050069|NCT01574716|471818097|FG001|Part 2|Discontinuation of study by sponsor|0|||
131050070|NCT01574716|471818098|FG002|Part 2|Discontinuation of study by sponsor|0|||
131050071|NCT01574716|471818099|FG003|Part 2|Discontinuation of study by sponsor|51|||
131050072|NCT01574716|471818100|FG004|Part 2|Discontinuation of study by sponsor|31|||
131050073|NCT01574716|471818096|FG000|Part 2|Withdrawal by Subject|0|||
131050074|NCT01574716|471818097|FG001|Part 2|Withdrawal by Subject|0|||
131050075|NCT01574716|471818098|FG002|Part 2|Withdrawal by Subject|0|||
131050076|NCT01574716|471818099|FG003|Part 2|Withdrawal by Subject|5|||
131050077|NCT01574716|471818100|FG004|Part 2|Withdrawal by Subject|4|||
131050078|NCT01574716|471818096|FG000|Part 2|Brain metastases|0|||
131050079|NCT01574716|471818097|FG001|Part 2|Brain metastases|0|||
131050080|NCT01574716|471818098|FG002|Part 2|Brain metastases|0|||
131050081|NCT01574716|471818099|FG003|Part 2|Brain metastases|1|||
131050082|NCT01574716|471818100|FG004|Part 2|Brain metastases|0|||
131050083|NCT01574716|471818096|FG000|Part 2|Lost to Follow-up|0|||
131050084|NCT01574716|471818097|FG001|Part 2|Lost to Follow-up|0|||
131050085|NCT01574716|471818098|FG002|Part 2|Lost to Follow-up|0|||
131050086|NCT01574716|471818099|FG003|Part 2|Lost to Follow-up|3|||
131050087|NCT01574716|471818100|FG004|Part 2|Lost to Follow-up|0|||
131050088|NCT02438137|471818101|FG000|Overall Study|Lost to Follow-up|3|||
131050089|NCT02438137|471818102|FG001|Overall Study|Lost to Follow-up|2|||
131050090|NCT02438137|471818101|FG000|Overall Study|Adverse Event|1|||
131050091|NCT02438137|471818102|FG001|Overall Study|Adverse Event|0|||
131050092|NCT02438137|471818101|FG000|Overall Study|Withdrawal by Subject|4|||
131050093|NCT02438137|471818102|FG001|Overall Study|Withdrawal by Subject|3|||
131050094|NCT02438137|471818101|FG000|Overall Study|Physician Decision|0|||
131050095|NCT02438137|471818102|FG001|Overall Study|Physician Decision|1|||
131134557|NCT04153188|472118977|FG001|Overall Study|Lost to Follow-up|1|||
131134558|NCT04153188|472118976|FG000|Overall Study|Withdrawal by Subject|2|||
131134559|NCT04153188|472118977|FG001|Overall Study|Withdrawal by Subject|0|||
131134560|NCT04153188|472118976|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
131050096|NCT02111096|471818103|FG000|Overall Study|Adverse Event|4|||
131050097|NCT02111096|471818104|FG001|Overall Study|Adverse Event|1|||
131050098|NCT02111096|471818105|FG002|Overall Study|Adverse Event|2|||
131050099|NCT02111096|471818103|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131050100|NCT02111096|471818104|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130722088|NCT03400943|470608169|FG002|Treatment Period 1|Adverse Event|0|||
131050101|NCT02111096|471818105|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131050102|NCT02111096|471818103|FG000|Overall Study|Lost to Follow Up|1|||
131050103|NCT02111096|471818104|FG001|Overall Study|Lost to Follow Up|1|||
131050104|NCT02111096|471818105|FG002|Overall Study|Lost to Follow Up|1|||
131050105|NCT02111096|471818103|FG000|Overall Study|Physician Decision|0|||
131050106|NCT02111096|471818104|FG001|Overall Study|Physician Decision|1|||
131050107|NCT02111096|471818105|FG002|Overall Study|Physician Decision|0|||
131050108|NCT02111096|471818103|FG000|Overall Study|Protocol Violation|1|||
131050109|NCT02111096|471818104|FG001|Overall Study|Protocol Violation|0|||
131050110|NCT02111096|471818105|FG002|Overall Study|Protocol Violation|1|||
131050111|NCT02111096|471818103|FG000|Overall Study|Terminated by Sponsor|53|||
131050112|NCT02111096|471818104|FG001|Overall Study|Terminated by Sponsor|35|||
131050113|NCT02111096|471818105|FG002|Overall Study|Terminated by Sponsor|54|||
131050114|NCT02111096|471818103|FG000|Overall Study|Withdrawal by Subject|4|||
131050115|NCT02111096|471818104|FG001|Overall Study|Withdrawal by Subject|2|||
131050116|NCT02111096|471818105|FG002|Overall Study|Withdrawal by Subject|8|||
131050117|NCT03621735|471818106|FG000|Overall Study|Withdrawal by Subject|13|||
131050118|NCT03621735|471818107|FG001|Overall Study|Withdrawal by Subject|13|||
131050119|NCT03709706|471818113|FG000|Overall Study|Adverse Event|0|||
131134561|NCT04153188|472118977|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
131134562|NCT00264238|472118978|FG000|Overall Study|Protocol Violation|1|||
131134563|NCT04899232|472118979|FG000|Screening Period|Physician Decision|1|||
131134564|NCT04899232|472118980|FG001|Screening Period|Physician Decision|0|||
131134565|NCT04899232|472118981|FG002|Screening Period|Physician Decision|0|||
131134566|NCT04899232|472118979|FG000|Screening Period|Withdrawal by Subject|1|||
131134567|NCT04899232|472118980|FG001|Screening Period|Withdrawal by Subject|0|||
131134568|NCT04899232|472118981|FG002|Screening Period|Withdrawal by Subject|0|||
131134569|NCT04899232|472118979|FG000|Screening Period|Participant discharged before receiving intervention|3|||
131134570|NCT04899232|472118980|FG001|Screening Period|Participant discharged before receiving intervention|0|||
131134571|NCT04899232|472118981|FG002|Screening Period|Participant discharged before receiving intervention|0|||
131134572|NCT00700271|472118982|FG000|Overall Study|Adverse Event|4|||
131134573|NCT00700271|472118983|FG001|Overall Study|Adverse Event|6|||
131134574|NCT00700271|472118982|FG000|Overall Study|Protocol Violation|1|||
131134575|NCT00700271|472118983|FG001|Overall Study|Protocol Violation|0|||
131134576|NCT00700271|472118982|FG000|Overall Study|Administrative Reasons|1|||
131134577|NCT00700271|472118983|FG001|Overall Study|Administrative Reasons|0|||
131134578|NCT00700271|472118982|FG000|Overall Study|Withdrawal by Subject|6|||
131134579|NCT00700271|472118983|FG001|Overall Study|Withdrawal by Subject|4|||
131134580|NCT00700271|472118982|FG000|Overall Study|Lost to Follow-up|2|||
131134581|NCT00700271|472118983|FG001|Overall Study|Lost to Follow-up|2|||
131134582|NCT01564862|472118984|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
131134583|NCT01564862|472118985|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
131134584|NCT01564862|472118986|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
131134585|NCT01564862|472118984|FG000|Overall Study|Major Protocol Deviation|3|||
131134586|NCT01564862|472118985|FG001|Overall Study|Major Protocol Deviation|3|||
131134587|NCT01564862|472118986|FG002|Overall Study|Major Protocol Deviation|4|||
131134588|NCT01564862|472118984|FG000|Overall Study|Lost to Follow-up|10|||
131134589|NCT01564862|472118985|FG001|Overall Study|Lost to Follow-up|8|||
131134590|NCT01564862|472118986|FG002|Overall Study|Lost to Follow-up|6|||
131134591|NCT01564862|472118984|FG000|Overall Study|Voluntary Withdrawal|9|||
131134592|NCT01564862|472118985|FG001|Overall Study|Voluntary Withdrawal|6|||
131134593|NCT01564862|472118986|FG002|Overall Study|Voluntary Withdrawal|8|||
131134594|NCT01564862|472118984|FG000|Overall Study|Lack of Efficacy|1|||
131134595|NCT01564862|472118985|FG001|Overall Study|Lack of Efficacy|5|||
131134596|NCT01564862|472118986|FG002|Overall Study|Lack of Efficacy|6|||
131050120|NCT03709706|471818114|FG001|Overall Study|Adverse Event|1|||
131050121|NCT03709706|471818113|FG000|Overall Study|Physician Decision|14|||
131050122|NCT03709706|471818114|FG001|Overall Study|Physician Decision|8|||
131050123|NCT03709706|471818113|FG000|Overall Study|Withdrawal by Subject|2|||
131050124|NCT03709706|471818114|FG001|Overall Study|Withdrawal by Subject|1|||
130722089|NCT03400943|470608170|FG003|Treatment Period 1|Adverse Event|1|||
131050125|NCT03709706|471818113|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
130722090|NCT03400943|470608167|FG000|Treatment Period 1|Lost to Follow-up|1|||
131050126|NCT03709706|471818114|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
131050127|NCT04868617|471818115|FG000|Overall Study|Death|1|||
131050128|NCT04868617|471818116|FG001|Overall Study|Death|0|||
131050129|NCT04868617|471818115|FG000|Overall Study|Adverse Event|1|||
131050130|NCT04868617|471818116|FG001|Overall Study|Adverse Event|0|||
131050131|NCT04868617|471818115|FG000|Overall Study|Withdrawal by Subject|1|||
131050132|NCT04868617|471818116|FG001|Overall Study|Withdrawal by Subject|0|||
131050133|NCT04868617|471818115|FG000|Overall Study|Device deficiency|1|||
131050134|NCT04868617|471818116|FG001|Overall Study|Device deficiency|0|||
131050135|NCT03183050|471818117|FG000|Overall Study|Lost to Follow-up|23|||
131050136|NCT02797132|471818118|FG000|Part A (15 Days)|Adverse Event|1|||
131050137|NCT02797132|471818118|FG000|Part B (24 Weeks)|Adverse Event|3|||
131050138|NCT00754065|471818121|FG000|Overall Study|Never received treatment|12|||
131050139|NCT00754065|471818122|FG001|Overall Study|Never received treatment|2|||
130722091|NCT03400943|470608168|FG001|Treatment Period 1|Lost to Follow-up|0|||
131050140|NCT00754065|471818121|FG000|Overall Study|Adverse Event|19|||
131050141|NCT00754065|471818122|FG001|Overall Study|Adverse Event|25|||
131050142|NCT00754065|471818121|FG000|Overall Study|Lost to Follow-up|7|||
131050143|NCT00754065|471818122|FG001|Overall Study|Lost to Follow-up|11|||
131050144|NCT00754065|471818121|FG000|Overall Study|Protocol Violation|12|||
131050145|NCT00754065|471818122|FG001|Overall Study|Protocol Violation|10|||
131050146|NCT00754065|471818121|FG000|Overall Study|Withdrawal by Subject|4|||
131050147|NCT00754065|471818122|FG001|Overall Study|Withdrawal by Subject|5|||
131050148|NCT00754065|471818121|FG000|Overall Study|Pregnancy|6|||
131050149|NCT00754065|471818122|FG001|Overall Study|Pregnancy|0|||
131050150|NCT00754065|471818121|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
131050151|NCT00754065|471818122|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
131050152|NCT01074294|471818123|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
131050153|NCT01074294|471818124|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
131050154|NCT01074294|471818125|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
131050155|NCT01074294|471818126|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
131050156|NCT01074294|471818123|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
131050157|NCT01074294|471818124|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
131050158|NCT01074294|471818125|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
131050159|NCT01074294|471818126|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
131050160|NCT01074294|471818123|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
131050161|NCT01074294|471818124|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
131050162|NCT01074294|471818125|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
131050163|NCT01074294|471818126|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
131050164|NCT01074294|471818123|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
131050165|NCT01074294|471818124|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
131050166|NCT01074294|471818125|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
131050167|NCT01074294|471818126|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
131050168|NCT01074294|471818123|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
131050169|NCT01074294|471818124|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
131050170|NCT01074294|471818125|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
131050171|NCT01074294|471818126|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
131050172|NCT01074294|471818123|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
131050173|NCT01074294|471818124|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
131050174|NCT01074294|471818125|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
131050175|NCT01074294|471818126|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
131050176|NCT01074294|471818123|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
131050177|NCT01074294|471818124|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
131050178|NCT01074294|471818125|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
131050179|NCT01074294|471818126|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
131050180|NCT01074294|471818123|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
131050181|NCT01074294|471818124|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
131050182|NCT01074294|471818125|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
131050183|NCT01074294|471818126|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
131050184|NCT01074294|471818123|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
131050185|NCT01074294|471818124|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
131050186|NCT01074294|471818125|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
131050187|NCT01074294|471818126|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
131050188|NCT01074294|471818123|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
131050189|NCT01074294|471818124|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
131134597|NCT01564862|472118984|FG000|Overall Study|Other reason(s)|1|||
131134598|NCT01564862|472118985|FG001|Overall Study|Other reason(s)|0|||
131134599|NCT01564862|472118986|FG002|Overall Study|Other reason(s)|0|||
131134600|NCT02396589|472118987|FG000|Intervention|Lost to Follow-up|1|||
131134601|NCT02396589|472118988|FG001|Intervention|Lost to Follow-up|0|||
131134602|NCT02396589|472118987|FG000|6 Month Follow-up|change in health status|0|||
131134603|NCT02396589|472118988|FG001|6 Month Follow-up|change in health status|1|||
131134604|NCT02396589|472118987|FG000|9 Month Follow-up|Death|0|||
131134605|NCT02396589|472118988|FG001|9 Month Follow-up|Death|1|||
131134606|NCT02396589|472118987|FG000|12 Month Follow up|Lost to Follow-up|0|||
131134607|NCT02396589|472118988|FG001|12 Month Follow up|Lost to Follow-up|2|||
131134608|NCT04341948|472118989|FG000|Overall Study|Adverse Event|0|||
131134609|NCT04341948|472118990|FG001|Overall Study|Adverse Event|1|||
131134610|NCT04341948|472118989|FG000|Overall Study|Lost to Follow-up|6|||
131134611|NCT04341948|472118990|FG001|Overall Study|Lost to Follow-up|1|||
131134612|NCT04341948|472118989|FG000|Overall Study|Physician Decision|1|||
131134613|NCT04341948|472118990|FG001|Overall Study|Physician Decision|2|||
131134614|NCT04341948|472118989|FG000|Overall Study|Withdrawal by Participant|6|||
131134615|NCT04341948|472118990|FG001|Overall Study|Withdrawal by Participant|3|||
131134616|NCT04341948|472118989|FG000|Overall Study|Lack of compliance by Participant|1|||
131134617|NCT04341948|472118990|FG001|Overall Study|Lack of compliance by Participant|0|||
131050190|NCT01074294|471818125|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
131050191|NCT01074294|471818126|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
131050192|NCT01074294|471818123|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
131050193|NCT01074294|471818124|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
131050194|NCT01074294|471818125|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
131050195|NCT01074294|471818126|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
131050196|NCT01074294|471818123|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
131050197|NCT01074294|471818124|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
131050198|NCT01074294|471818125|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
131050199|NCT01074294|471818126|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
131050200|NCT01074294|471818123|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
131050201|NCT01074294|471818124|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
131050202|NCT01074294|471818125|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
131050203|NCT01074294|471818126|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
131050204|NCT00112359|471818127|FG000|Overall Study|Unrelated adverse event|16|||
131050205|NCT00112359|471818128|FG001|Overall Study|Unrelated adverse event|8|||
131050206|NCT00112359|471818127|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
131050207|NCT00112359|471818128|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
131050208|NCT00112359|471818127|FG000|Overall Study|Related adverse event|5|||
131050209|NCT00112359|471818128|FG001|Overall Study|Related adverse event|3|||
131050210|NCT00112359|471818127|FG000|Overall Study|Lost to Follow-up|0|||
131050211|NCT00112359|471818128|FG001|Overall Study|Lost to Follow-up|1|||
131050212|NCT00112359|471818127|FG000|Overall Study|Personal/administrative|1|||
131050213|NCT00112359|471818128|FG001|Overall Study|Personal/administrative|1|||
131050214|NCT00112359|471818127|FG000|Overall Study|Other|3|||
131050215|NCT00112359|471818128|FG001|Overall Study|Other|0|||
131050216|NCT00623194|471818129|FG000|Overall Study|Lack of Efficacy|1|||
131050217|NCT00623194|471818129|FG000|Overall Study|Protocol Violation|3|||
131050218|NCT00623194|471818129|FG000|Overall Study|Unclassified|1|||
131050219|NCT01988402|471818130|FG000|Overall Study|Adverse Event|1|||
131050220|NCT01988402|471818131|FG001|Overall Study|Adverse Event|2|||
131050221|NCT01988402|471818130|FG000|Overall Study|Withdrawal by Subject|1|||
131050222|NCT01988402|471818131|FG001|Overall Study|Withdrawal by Subject|0|||
131050223|NCT01961609|471818132|FG000|Initiation|Missing|3|||
131050224|NCT01961609|471818133|FG001|Initiation|Missing|2|||
131050225|NCT01961609|471818134|FG002|Initiation|Missing|0|||
131050226|NCT01961609|471818135|FG003|Initiation|Missing|0|||
131050227|NCT01961609|471818132|FG000|Initiation|Protocol deviation|1|||
131050228|NCT01961609|471818133|FG001|Initiation|Protocol deviation|0|||
131050229|NCT01961609|471818134|FG002|Initiation|Protocol deviation|0|||
131050230|NCT01961609|471818135|FG003|Initiation|Protocol deviation|0|||
131050231|NCT01961609|471818132|FG000|Initiation|Death|0|||
131050232|NCT01961609|471818133|FG001|Initiation|Death|1|||
131050233|NCT01961609|471818134|FG002|Initiation|Death|0|||
131050234|NCT01961609|471818135|FG003|Initiation|Death|0|||
131050235|NCT01961609|471818132|FG000|Initiation|Administrative problems|1|||
131050236|NCT01961609|471818133|FG001|Initiation|Administrative problems|0|||
131050237|NCT01961609|471818134|FG002|Initiation|Administrative problems|0|||
131050238|NCT01961609|471818135|FG003|Initiation|Administrative problems|0|||
131050239|NCT01961609|471818132|FG000|Initiation|Withdrawal by Subject|1|||
131050240|NCT01961609|471818133|FG001|Initiation|Withdrawal by Subject|2|||
131050241|NCT01961609|471818134|FG002|Initiation|Withdrawal by Subject|0|||
131050242|NCT01961609|471818135|FG003|Initiation|Withdrawal by Subject|0|||
131050243|NCT01961609|471818132|FG000|Initiation|Lack of Efficacy|2|||
131050244|NCT01961609|471818133|FG001|Initiation|Lack of Efficacy|1|||
130722092|NCT03400943|470608169|FG002|Treatment Period 1|Lost to Follow-up|0|||
130722093|NCT03400943|470608170|FG003|Treatment Period 1|Lost to Follow-up|0|||
131050245|NCT01961609|471818134|FG002|Initiation|Lack of Efficacy|0|||
131050246|NCT01961609|471818135|FG003|Initiation|Lack of Efficacy|0|||
131050247|NCT01961609|471818132|FG000|Initiation|Abnormal lab values|0|||
131050248|NCT01961609|471818133|FG001|Initiation|Abnormal lab values|1|||
131050249|NCT01961609|471818134|FG002|Initiation|Abnormal lab values|0|||
131050250|NCT01961609|471818135|FG003|Initiation|Abnormal lab values|0|||
131050251|NCT01961609|471818132|FG000|Initiation|Adverse Event|3|||
131050252|NCT01961609|471818133|FG001|Initiation|Adverse Event|5|||
131050253|NCT01961609|471818134|FG002|Initiation|Adverse Event|0|||
131050254|NCT01961609|471818135|FG003|Initiation|Adverse Event|0|||
131050255|NCT01961609|471818132|FG000|Initiation|Randomized but not treated|1|||
131050256|NCT01961609|471818133|FG001|Initiation|Randomized but not treated|1|||
131050257|NCT01961609|471818134|FG002|Initiation|Randomized but not treated|0|||
131050258|NCT01961609|471818135|FG003|Initiation|Randomized but not treated|0|||
131050259|NCT01961609|471818132|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
131050260|NCT01961609|471818133|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
131050261|NCT01961609|471818134|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
131134618|NCT04705051|472120595|FG000|Overall Study|Enrolled but not treated|1|||
130779278|NCT04613739|470819478|FG001|Overall Study|potentially duplicative/fraudulent|3|||
131050262|NCT01961609|471818135|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
131050263|NCT01961609|471818132|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
131050264|NCT01961609|471818133|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
131050265|NCT01961609|471818134|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
131050266|NCT01961609|471818135|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
131050267|NCT01961609|471818132|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
131050268|NCT01961609|471818133|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
131050269|NCT01961609|471818134|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
131050270|NCT01961609|471818135|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
131050271|NCT01961609|471818132|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
131050272|NCT01961609|471818133|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
131050273|NCT01961609|471818134|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
131050274|NCT01961609|471818135|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
131050275|NCT01961609|471818132|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
131050276|NCT01961609|471818133|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
131050277|NCT01961609|471818134|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
131050278|NCT01961609|471818135|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
131050279|NCT01961609|471818132|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
131050280|NCT01961609|471818133|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
131134619|NCT04705051|472120595|FG000|Overall Study|Study terminated by sponsor|23|||
131134620|NCT01761266|472120599|FG000|Overall Study|Death|415|||
131134621|NCT01761266|472120600|FG001|Overall Study|Death|402|||
131134622|NCT01761266|472120599|FG000|Overall Study|Lost to Follow-up|8|||
131134623|NCT01761266|472120600|FG001|Overall Study|Lost to Follow-up|12|||
131134624|NCT01761266|472120599|FG000|Overall Study|Withdrawal by Subject|14|||
131134625|NCT01761266|472120600|FG001|Overall Study|Withdrawal by Subject|10|||
131134626|NCT01761266|472120599|FG000|Overall Study|Sponsor Decision|41|||
131134627|NCT01761266|472120600|FG001|Overall Study|Sponsor Decision|52|||
131134628|NCT01284114|472120601|FG000|Overall Study|viral infection|1|||
131050281|NCT01961609|471818134|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
131050282|NCT01961609|471818135|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
131050283|NCT01961609|471818132|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
131050284|NCT01961609|471818133|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
131050285|NCT01961609|471818134|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
131050286|NCT01961609|471818135|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
131050287|NCT01961609|471818132|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
131050288|NCT01961609|471818133|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
131050289|NCT01961609|471818134|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
131050290|NCT01961609|471818135|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
131050291|NCT01961609|471818132|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
131050292|NCT01961609|471818133|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
131050293|NCT01961609|471818134|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
131050294|NCT01961609|471818135|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
131050295|NCT01961609|471818132|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
131050296|NCT01961609|471818133|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
131050297|NCT01961609|471818134|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
131134629|NCT01284114|472120601|FG000|Overall Study|From the results of ALLTITUDE study|1|||
131134630|NCT01284114|472120601|FG000|Overall Study|Symptomatic hypotension|1|||
131134631|NCT01284114|472120601|FG000|Overall Study|dizziness|1|||
131134632|NCT03445000|472120603|FG000|Overall Study|Disease progression|8|||
131134633|NCT03445000|472120603|FG000|Overall Study|Adverse Event|3|||
131134634|NCT03445000|472120603|FG000|Overall Study|Death|2|||
131134635|NCT03445000|472120603|FG000|Overall Study|Physician Decision|1|||
131134636|NCT03409744|472120604|FG000|Overall Study|Death|2|||
131134637|NCT03409744|472120604|FG000|Overall Study|Physician Decision|5|||
131134638|NCT03409744|472120604|FG000|Overall Study|Pregnancy|1|||
131134639|NCT03409744|472120604|FG000|Overall Study|Lost to Follow-up|1|||
131134640|NCT03409744|472120604|FG000|Overall Study|Protocol Violation|1|||
131134641|NCT00264004|472120606|FG000|Overall Study|Adverse Event|2|||
131134642|NCT00264004|472120607|FG001|Overall Study|Adverse Event|3|||
131134643|NCT00264004|472120608|FG002|Overall Study|Adverse Event|6|||
131134644|NCT00264004|472120609|FG003|Overall Study|Adverse Event|4|||
131134645|NCT00264004|472120606|FG000|Overall Study|Withdrawal by Subject|0|||
131134646|NCT00264004|472120607|FG001|Overall Study|Withdrawal by Subject|1|||
131134647|NCT00264004|472120608|FG002|Overall Study|Withdrawal by Subject|2|||
131134648|NCT00264004|472120609|FG003|Overall Study|Withdrawal by Subject|2|||
131134649|NCT00264004|472120606|FG000|Overall Study|Other|2|||
131134650|NCT00264004|472120607|FG001|Overall Study|Other|2|||
131134651|NCT00264004|472120608|FG002|Overall Study|Other|0|||
131134652|NCT00264004|472120609|FG003|Overall Study|Other|3|||
131134653|NCT00264004|472120606|FG000|Overall Study|Development study specific disc. crit.|1|||
131134654|NCT00264004|472120607|FG001|Overall Study|Development study specific disc. crit.|0|||
130779279|NCT01178125|470819483|FG000|Overall Study|Lost to Follow-up|397|||
131050298|NCT01961609|471818135|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
131050299|NCT01961609|471818132|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
131050300|NCT01961609|471818133|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
131050301|NCT01961609|471818134|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
131050302|NCT01961609|471818135|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
131050303|NCT01961609|471818132|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
131050304|NCT01961609|471818133|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
131050305|NCT01961609|471818134|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
131050306|NCT01961609|471818135|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
131050307|NCT04060212|471818138|FG000|Overall Study|Withdrawal by Subject|7|||
131050308|NCT03500549|471818139|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
131050309|NCT03500549|471818140|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
131050310|NCT03500549|471818139|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
131050311|NCT03500549|471818140|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
131050312|NCT02107261|471818141|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
131050313|NCT02107261|471818142|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
131050314|NCT02107261|471818141|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
131050315|NCT02107261|471818142|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
131050316|NCT03222609|471818143|FG000|Overall Study|Withdrew consent|2|||
131050317|NCT03222609|471818144|FG001|Overall Study|Withdrew consent|3|||
131050318|NCT03222609|471818145|FG002|Overall Study|Withdrew consent|4|||
131050319|NCT03222609|471818146|FG003|Overall Study|Withdrew consent|2|||
131050320|NCT03222609|471818143|FG000|Overall Study|Lost to Follow-up|1|||
131050321|NCT03222609|471818144|FG001|Overall Study|Lost to Follow-up|0|||
131134655|NCT00264004|472120608|FG002|Overall Study|Development study specific disc. crit.|1|||
131134656|NCT00264004|472120609|FG003|Overall Study|Development study specific disc. crit.|0|||
131134657|NCT00264004|472120606|FG000|Overall Study|Cond. under inv. worsened|9|||
131134658|NCT00264004|472120607|FG001|Overall Study|Cond. under inv. worsened|5|||
131134659|NCT00264004|472120608|FG002|Overall Study|Cond. under inv. worsened|3|||
131134660|NCT00264004|472120609|FG003|Overall Study|Cond. under inv. worsened|4|||
131134661|NCT00264004|472120606|FG000|Overall Study|Not treated|3|||
131134662|NCT00264004|472120607|FG001|Overall Study|Not treated|0|||
131134663|NCT00264004|472120608|FG002|Overall Study|Not treated|2|||
131134664|NCT00264004|472120609|FG003|Overall Study|Not treated|2|||
131134665|NCT00691483|472120610|FG000|Overall Study|Adverse Event|14|||
131134666|NCT00691483|472120611|FG001|Overall Study|Adverse Event|6|||
131134667|NCT00691483|472120610|FG000|Overall Study|Lost to Follow-up|17|||
131134668|NCT00691483|472120611|FG001|Overall Study|Lost to Follow-up|10|||
131134669|NCT00691483|472120610|FG000|Overall Study|Withdrawal by Subject|24|||
131134670|NCT00691483|472120611|FG001|Overall Study|Withdrawal by Subject|7|||
131134671|NCT00691483|472120610|FG000|Overall Study|Other known cause|6|||
131134672|NCT00691483|472120611|FG001|Overall Study|Other known cause|1|||
131134673|NCT00691483|472120610|FG000|Overall Study|Randomized by not treated|7|||
131134674|NCT00691483|472120611|FG001|Overall Study|Randomized by not treated|1|||
131134675|NCT01535729|472120613|FG000|Overall Study|Withdrawal by Subject|2|||
131134676|NCT01535729|472120613|FG000|Overall Study|Disease progression|230|||
131134677|NCT01535729|472120613|FG000|Overall Study|Discontinued treatment|25|||
131134678|NCT01535729|472120613|FG000|Overall Study|Lost to Follow-up|8|||
131134679|NCT01535729|472120613|FG000|Overall Study|Death|52|||
131134680|NCT01535729|472120613|FG000|Overall Study|Other|19|||
131134681|NCT01535729|472120613|FG000|Overall Study|Did not sign informed consent|1|||
131134682|NCT01535729|472120613|FG000|Overall Study|No previous chemotherapy|33|||
131134683|NCT01535729|472120613|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
131134684|NCT01535729|472120613|FG000|Overall Study|Protocol Violation|11|||
131134685|NCT01535729|472120613|FG000|Overall Study|Screening failure|1|||
131134686|NCT01535729|472120613|FG000|Overall Study|Not treated|9|||
131134687|NCT01535729|472120613|FG000|Overall Study|No participant record available|5|||
130779280|NCT01178125|470819483|FG000|Overall Study|Adverse Event|244|||
130779281|NCT01178125|470819483|FG000|Overall Study|Withdrawal by Subject|209|||
130779282|NCT01178125|470819483|FG000|Overall Study|Noncompliance|184|||
130779283|NCT01178125|470819483|FG000|Overall Study|Pregnancy|55|||
131050322|NCT03222609|471818145|FG002|Overall Study|Lost to Follow-up|0|||
131050323|NCT03222609|471818146|FG003|Overall Study|Lost to Follow-up|0|||
131050324|NCT03222609|471818143|FG000|Overall Study|Death|16|||
131050325|NCT03222609|471818144|FG001|Overall Study|Death|13|||
131134688|NCT02740478|472120614|FG000|Overall Study|Withdrawal by Subject|1|||
131050326|NCT03222609|471818145|FG002|Overall Study|Death|9|||
131050327|NCT03222609|471818146|FG003|Overall Study|Death|6|||
131050328|NCT03222609|471818143|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
131134689|NCT02615990|472120617|FG000|Overall Study|study terminated|1|||
131134690|NCT02615990|472120618|FG001|Overall Study|study terminated|1|||
131134691|NCT01363986|472120619|FG000|Overall Study|Disease progression|1|||
131134692|NCT00130832|472120620|FG000|Overall Study|Adverse Event|1|||
131134693|NCT00130832|472120621|FG001|Overall Study|Adverse Event|1|||
131134694|NCT00130832|472120620|FG000|Overall Study|Lost to Follow-up|1|||
131134695|NCT00130832|472120621|FG001|Overall Study|Lost to Follow-up|2|||
131050329|NCT03222609|471818144|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
131050330|NCT03222609|471818145|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
131050331|NCT03222609|471818146|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
131050332|NCT05521516|471818147|FG000|Overall Study|Withdrawal by Subject|1|||
131050333|NCT05521516|471818148|FG001|Overall Study|Withdrawal by Subject|1|||
131050334|NCT00747565|471818149|FG000|Overall Study|Withdrawal by Subject|10|||
131050335|NCT00747565|471818150|FG001|Overall Study|Withdrawal by Subject|6|||
131050336|NCT00747565|471818149|FG000|Overall Study|Lost to Follow-up|4|||
131050337|NCT00747565|471818150|FG001|Overall Study|Lost to Follow-up|1|||
131050338|NCT03777657|471818151|FG000|Overall Study|Death|397|||
131050339|NCT03777657|471818152|FG001|Overall Study|Death|431|||
131050340|NCT03777657|471818151|FG000|Overall Study|Study Closed by Sponsor|77|||
131050341|NCT03777657|471818152|FG001|Overall Study|Study Closed by Sponsor|38|||
131050342|NCT03777657|471818151|FG000|Overall Study|Withdrawal by Subject|20|||
131050343|NCT03777657|471818152|FG001|Overall Study|Withdrawal by Subject|17|||
131050344|NCT03777657|471818151|FG000|Overall Study|Lost to Follow-up|6|||
131050345|NCT03777657|471818152|FG001|Overall Study|Lost to Follow-up|10|||
131050346|NCT00545545|471818153|FG000|Overall Study|Progressive Neoplastic Disease|1|||
131050347|NCT00545545|471818154|FG001|Overall Study|Progressive Neoplastic Disease|5|||
131050348|NCT00545545|471818155|FG002|Overall Study|Progressive Neoplastic Disease|0|||
131050349|NCT00545545|471818156|FG003|Overall Study|Progressive Neoplastic Disease|4|||
131050350|NCT00545545|471818157|FG004|Overall Study|Progressive Neoplastic Disease|8|||
131050351|NCT00545545|471818158|FG005|Overall Study|Progressive Neoplastic Disease|7|||
131050352|NCT00545545|471818153|FG000|Overall Study|Withdrawal by Subject|0|||
131050353|NCT00545545|471818154|FG001|Overall Study|Withdrawal by Subject|1|||
131050354|NCT00545545|471818155|FG002|Overall Study|Withdrawal by Subject|0|||
131050355|NCT00545545|471818156|FG003|Overall Study|Withdrawal by Subject|0|||
131050356|NCT00545545|471818157|FG004|Overall Study|Withdrawal by Subject|0|||
131050357|NCT00545545|471818158|FG005|Overall Study|Withdrawal by Subject|0|||
131050358|NCT00545545|471818153|FG000|Overall Study|Physician Decision|1|||
131050359|NCT00545545|471818154|FG001|Overall Study|Physician Decision|0|||
131050360|NCT00545545|471818155|FG002|Overall Study|Physician Decision|0|||
131050361|NCT00545545|471818156|FG003|Overall Study|Physician Decision|0|||
131050362|NCT00545545|471818157|FG004|Overall Study|Physician Decision|0|||
131050363|NCT00545545|471818158|FG005|Overall Study|Physician Decision|1|||
131050364|NCT00545545|471818153|FG000|Overall Study|Irinotecan intolerance|1|||
131050365|NCT00545545|471818154|FG001|Overall Study|Irinotecan intolerance|1|||
131050366|NCT00545545|471818155|FG002|Overall Study|Irinotecan intolerance|0|||
131050367|NCT00545545|471818156|FG003|Overall Study|Irinotecan intolerance|0|||
131050368|NCT00545545|471818157|FG004|Overall Study|Irinotecan intolerance|0|||
131050369|NCT00545545|471818158|FG005|Overall Study|Irinotecan intolerance|0|||
131050370|NCT00545545|471818153|FG000|Overall Study|No target lesions to track post surgery|0|||
131050371|NCT00545545|471818154|FG001|Overall Study|No target lesions to track post surgery|0|||
131050372|NCT00545545|471818155|FG002|Overall Study|No target lesions to track post surgery|0|||
131050373|NCT00545545|471818156|FG003|Overall Study|No target lesions to track post surgery|0|||
131050374|NCT00545545|471818157|FG004|Overall Study|No target lesions to track post surgery|1|||
131050375|NCT00545545|471818158|FG005|Overall Study|No target lesions to track post surgery|1|||
131050376|NCT03691493|471818159|FG000|Overall Study|Withdrawal by Subject|1|||
131050377|NCT00227266|471818171|FG000|Overall Study|Withdrawal by Subject|0|||
131050378|NCT00227266|471818172|FG001|Overall Study|Withdrawal by Subject|0|||
131050379|NCT00227266|471818173|FG002|Overall Study|Withdrawal by Subject|1|||
131050380|NCT00227266|471818171|FG000|Overall Study|Protocol Violation|1|||
131050381|NCT00227266|471818172|FG001|Overall Study|Protocol Violation|0|||
131050382|NCT00227266|471818173|FG002|Overall Study|Protocol Violation|1|||
131134696|NCT00130832|472120620|FG000|Overall Study|Protocol Violation|6|||
131134697|NCT00130832|472120621|FG001|Overall Study|Protocol Violation|8|||
131134698|NCT00130832|472120620|FG000|Overall Study|Withdrawal by Subject|6|||
131050383|NCT00227266|471818171|FG000|Overall Study|Excessive weight gain|0|||
131050384|NCT00227266|471818172|FG001|Overall Study|Excessive weight gain|0|||
131050385|NCT00227266|471818173|FG002|Overall Study|Excessive weight gain|2|||
131050386|NCT02678689|471818174|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
131050387|NCT02678689|471818175|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
131134699|NCT00130832|472120621|FG001|Overall Study|Withdrawal by Subject|1|||
131134700|NCT00130832|472120620|FG000|Overall Study|Moved|2|||
131134701|NCT00130832|472120621|FG001|Overall Study|Moved|2|||
131134702|NCT00130832|472120620|FG000|Overall Study|Other|0|||
131134703|NCT00130832|472120621|FG001|Overall Study|Other|3|||
131134704|NCT03905863|472120622|FG000|Overall Study|Adverse Event|2|||
131134705|NCT03905863|472120623|FG001|Overall Study|Adverse Event|4|||
131134706|NCT03905863|472120622|FG000|Overall Study|Withdrawal by Subject|2|||
131134707|NCT03905863|472120623|FG001|Overall Study|Withdrawal by Subject|2|||
131134708|NCT03905863|472120622|FG000|Overall Study|Physician Decision|0|||
131134709|NCT03905863|472120623|FG001|Overall Study|Physician Decision|3|||
131134710|NCT03905863|472120622|FG000|Overall Study|Lost to Follow-up|1|||
131134711|NCT03905863|472120623|FG001|Overall Study|Lost to Follow-up|0|||
131050388|NCT00593840|471818182|FG000|Overall Study|Withdrawal by Subject|1|||
131050389|NCT00655499|471819148|FG000|Overall Study|not eligible|4|||
131050390|NCT02285270|471819152|FG000|Overall Study|Lost to Follow-up|1|||
131050391|NCT02285270|471819152|FG000|Overall Study|Physician Decision|3|||
131050392|NCT02285270|471819152|FG000|Overall Study|Determined to be ineligible|1|||
131050393|NCT00777049|471819153|FG000|Overall Study|Withdrawal by Subject|1|||
131050394|NCT00777049|471819154|FG001|Overall Study|Withdrawal by Subject|0|||
131050395|NCT00777049|471819153|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
131050396|NCT00777049|471819154|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
131050397|NCT01627561|471819155|FG000|Overall Study|Lost to Follow-up|1|||
131050398|NCT01627561|471819156|FG001|Overall Study|Lost to Follow-up|0|||
131050399|NCT01627561|471819155|FG000|Overall Study|Withdrawal by Subject|0|||
131050400|NCT01627561|471819156|FG001|Overall Study|Withdrawal by Subject|1|||
131050401|NCT01627561|471819155|FG000|Overall Study|Migrated/moved from study area|0|||
131050402|NCT01627561|471819156|FG001|Overall Study|Migrated/moved from study area|2|||
131050403|NCT00890591|471819158|FG000|Overall Study|Lack of Efficacy|20|||
131050404|NCT00739934|471819161|FG000|Voriconazole IV|Adverse Event|6|||
131050405|NCT00739934|471819161|FG000|Voriconazole Oral|Other|3|||
131050406|NCT01579318|471819164|FG000|Overall Study|Disease Progression|1|||
131050407|NCT02347332|471819165|FG000|Overall Study|Not treated|5|||
131050408|NCT02347332|471819166|FG001|Overall Study|Not treated|2|||
131050409|NCT02347332|471819165|FG000|Overall Study|Progressive disease|141|||
131050410|NCT02347332|471819166|FG001|Overall Study|Progressive disease|159|||
131050411|NCT02347332|471819165|FG000|Overall Study|Adverse Event|50|||
131050412|NCT02347332|471819166|FG001|Overall Study|Adverse Event|41|||
131050413|NCT02347332|471819165|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
131050414|NCT02347332|471819166|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
131050415|NCT02347332|471819165|FG000|Overall Study|Protocol Violation|1|||
131050416|NCT02347332|471819166|FG001|Overall Study|Protocol Violation|1|||
131050417|NCT02347332|471819165|FG000|Overall Study|Lost to Follow-up|2|||
131050418|NCT02347332|471819166|FG001|Overall Study|Lost to Follow-up|1|||
131050419|NCT02347332|471819165|FG000|Overall Study|Physician Decision|4|||
131050420|NCT02347332|471819166|FG001|Overall Study|Physician Decision|3|||
131050421|NCT02347332|471819165|FG000|Overall Study|Withdrawal by Subject|20|||
131050422|NCT02347332|471819166|FG001|Overall Study|Withdrawal by Subject|14|||
131050423|NCT02347332|471819165|FG000|Overall Study|Protocol requirement|1|||
131050424|NCT02347332|471819166|FG001|Overall Study|Protocol requirement|1|||
131050425|NCT02347332|471819165|FG000|Overall Study|Switch Post-Trial program|0|||
131050426|NCT02347332|471819166|FG001|Overall Study|Switch Post-Trial program|1|||
131050427|NCT02502526|471819167|FG000|Overall Study|Lost to Follow-up|2|||
131050428|NCT02502526|471819168|FG001|Overall Study|Lost to Follow-up|2|||
131050429|NCT02502526|471819169|FG002|Overall Study|Lost to Follow-up|3|||
131050430|NCT02502526|471819167|FG000|Overall Study|Withdrawal by Subject|0|||
131050431|NCT02502526|471819168|FG001|Overall Study|Withdrawal by Subject|1|||
131050432|NCT02502526|471819169|FG002|Overall Study|Withdrawal by Subject|1|||
131050433|NCT02502526|471819167|FG000|Overall Study|Disqualified due to cataract grading|0|||
131050434|NCT02502526|471819168|FG001|Overall Study|Disqualified due to cataract grading|0|||
131050435|NCT02502526|471819169|FG002|Overall Study|Disqualified due to cataract grading|1|||
131050436|NCT02502526|471819167|FG000|Overall Study|Enrollment suspension|4|||
131050437|NCT02502526|471819168|FG001|Overall Study|Enrollment suspension|1|||
131050438|NCT02502526|471819169|FG002|Overall Study|Enrollment suspension|1|||
131050439|NCT01970007|471819170|FG000|Overall Study|Death|5|||
131050440|NCT01970007|471819170|FG000|Overall Study|Withdrawal by Subject|23|||
130779284|NCT01178125|470819483|FG000|Overall Study|Other Reason|39|||
130779285|NCT01178125|470819483|FG000|Overall Study|Sponsor Decision|28|||
130779286|NCT01178125|470819483|FG000|Overall Study|Protocol Violation|17|||
130779287|NCT01178125|470819483|FG000|Overall Study|Investigator Decision|5|||
130779288|NCT02948829|470819484|FG000|Overall Study|Lost to Follow-up|2|||
130779289|NCT02948829|470819484|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
130779290|NCT02948829|470819484|FG000|Overall Study|Pregnancy|1|||
130779291|NCT02948829|470819484|FG000|Overall Study|Other: Reason not Specified|8|||
130779292|NCT01004978|470819485|FG000|Overall Study|Disease progression|31|||
130779293|NCT01004978|470819486|FG001|Overall Study|Disease progression|48|||
130779294|NCT01004978|470819485|FG000|Overall Study|Adverse Event|42|||
130779295|NCT01004978|470819486|FG001|Overall Study|Adverse Event|22|||
130779296|NCT01004978|470819485|FG000|Overall Study|Death|3|||
131050441|NCT01970007|471819170|FG000|Overall Study|Lost to Follow-up|24|||
131050442|NCT01970007|471819170|FG000|Overall Study|"Other endpoint"|3|||
131050443|NCT01342367|471819172|FG000|Overall Study|Death|1|||
131050444|NCT01342367|471819173|FG001|Overall Study|Death|0|||
131050445|NCT01342367|471819172|FG000|Overall Study|Withdrawal by Subject|1|||
131050446|NCT01342367|471819173|FG001|Overall Study|Withdrawal by Subject|2|||
130779297|NCT01004978|470819486|FG001|Overall Study|Death|2|||
130779298|NCT01004978|470819485|FG000|Overall Study|Withdrawal by Subject|16|||
131050447|NCT01211184|471819175|FG000|Overall Study|Withdrawal by Subject|0|||
131050448|NCT01211184|471819176|FG001|Overall Study|Withdrawal by Subject|2|||
131050449|NCT01211184|471819177|FG002|Overall Study|Withdrawal by Subject|1|||
131134712|NCT03905863|472120622|FG000|Overall Study|Protocol Violation|0|||
131134713|NCT03905863|472120623|FG001|Overall Study|Protocol Violation|2|||
131134714|NCT03905863|472120622|FG000|Overall Study|Death|0|||
131134715|NCT03905863|472120623|FG001|Overall Study|Death|1|||
131134716|NCT02354703|472120625|FG000|Overall Study|Withdrawal by Subject|1|||
131134717|NCT02354703|472120626|FG001|Overall Study|Withdrawal by Subject|1|||
131134718|NCT02354703|472120627|FG002|Overall Study|Withdrawal by Subject|1|||
131050450|NCT02844439|471819179|FG000|Overall Study|Withdrawal by Subject|1|||
131050451|NCT02844439|471819179|FG000|Overall Study|Lost to Follow-up|2|||
131050452|NCT02844439|471819179|FG000|Overall Study|Termination by Sponsor|4|||
131050453|NCT02844439|471819179|FG000|Overall Study|Death|28|||
131050454|NCT02844439|471819179|FG000|Overall Study|Other|5|||
131050455|NCT03170648|471819184|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
131050456|NCT03170648|471819184|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
131050457|NCT03509909|471819185|FG000|Overall Study|Withdrawal by Subject|16|||
131050458|NCT03509909|471819186|FG001|Overall Study|Withdrawal by Subject|9|||
131050459|NCT03509909|471819185|FG000|Overall Study|Lost to Follow-up|3|||
131134719|NCT02354703|472120628|FG003|Overall Study|Withdrawal by Subject|1|||
131050460|NCT03509909|471819186|FG001|Overall Study|Lost to Follow-up|4|||
131050461|NCT03509909|471819185|FG000|Overall Study|Adverse Event|2|||
131050462|NCT03509909|471819186|FG001|Overall Study|Adverse Event|0|||
131050463|NCT04337931|471819191|FG000|Overall Study|Death|4|||
131050464|NCT04337931|471819192|FG001|Overall Study|Death|1|||
131050465|NCT04337931|471819193|FG002|Overall Study|Death|7|||
131050466|NCT04337931|471819191|FG000|Overall Study|Withdrawal by Subject|0|||
131050467|NCT04337931|471819192|FG001|Overall Study|Withdrawal by Subject|1|||
131050468|NCT04337931|471819193|FG002|Overall Study|Withdrawal by Subject|0|||
131050469|NCT04337931|471819191|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
131050470|NCT04337931|471819192|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
131050471|NCT04337931|471819193|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
131050472|NCT04337931|471819191|FG000|Overall Study|Study terminated by sponsor|3|||
131050473|NCT04337931|471819192|FG001|Overall Study|Study terminated by sponsor|6|||
131050474|NCT04337931|471819193|FG002|Overall Study|Study terminated by sponsor|2|||
131050475|NCT04337931|471819191|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
131050476|NCT04337931|471819192|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
131050477|NCT04337931|471819193|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
131050478|NCT04337931|471819191|FG000|Overall Study|Colorectal cancer treatment|1|||
131050479|NCT04337931|471819192|FG001|Overall Study|Colorectal cancer treatment|0|||
131050480|NCT04337931|471819193|FG002|Overall Study|Colorectal cancer treatment|0|||
131050481|NCT04337931|471819191|FG000|Overall Study|Participant decision|0|||
131050482|NCT04337931|471819192|FG001|Overall Study|Participant decision|1|||
131050483|NCT04337931|471819193|FG002|Overall Study|Participant decision|0|||
131050484|NCT01738438|471819194|FG000|Overall Study|Disease Progression|32|||
131050485|NCT01738438|471819194|FG000|Overall Study|Adverse Event|3|||
131050486|NCT04436289|471819195|FG000|Overall Study|Death prior to hospital discharge|8|||
131050487|NCT04436289|471819196|FG001|Overall Study|Death prior to hospital discharge|5|||
131050488|NCT04436289|471819197|FG002|Overall Study|Death prior to hospital discharge|0|||
131050489|NCT04436289|471819198|FG003|Overall Study|Death prior to hospital discharge|1|||
131050490|NCT04436289|471819195|FG000|Overall Study|Withdrawal by Subject|0|||
131050491|NCT04436289|471819196|FG001|Overall Study|Withdrawal by Subject|1|||
131050492|NCT04436289|471819197|FG002|Overall Study|Withdrawal by Subject|4|||
131050493|NCT04436289|471819198|FG003|Overall Study|Withdrawal by Subject|0|||
131050494|NCT04436289|471819195|FG000|Overall Study|Extended hospital stay|0|||
131050495|NCT04436289|471819196|FG001|Overall Study|Extended hospital stay|1|||
131050496|NCT04436289|471819197|FG002|Overall Study|Extended hospital stay|0|||
131050497|NCT04436289|471819198|FG003|Overall Study|Extended hospital stay|0|||
131050498|NCT04436289|471819195|FG000|Overall Study|Lost to Follow-up|0|||
131050499|NCT04436289|471819196|FG001|Overall Study|Lost to Follow-up|4|||
130722094|NCT03400943|470608167|FG000|Treatment Period 1|Protocol Violation|0|||
130722095|NCT03400943|470608168|FG001|Treatment Period 1|Protocol Violation|1|||
130722096|NCT03400943|470608169|FG002|Treatment Period 1|Protocol Violation|1|||
130722097|NCT03400943|470608170|FG003|Treatment Period 1|Protocol Violation|0|||
130722098|NCT03400943|470608167|FG000|Treatment Period 1|Study terminated by sponsor|2|||
130722099|NCT03400943|470608168|FG001|Treatment Period 1|Study terminated by sponsor|0|||
130722100|NCT03400943|470608169|FG002|Treatment Period 1|Study terminated by sponsor|0|||
130722101|NCT03400943|470608170|FG003|Treatment Period 1|Study terminated by sponsor|1|||
130722102|NCT03400943|470608167|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130722103|NCT03400943|470608168|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130722104|NCT03400943|470608169|FG002|Treatment Period 1|Withdrawal by Subject|3|||
130722105|NCT03400943|470608170|FG003|Treatment Period 1|Withdrawal by Subject|1|||
130722106|NCT03400943|470608167|FG000|Treatment Period 1|Other|2|||
131134720|NCT02354703|472120625|FG000|Overall Study|Lost to Follow-up|2|||
131134721|NCT02354703|472120626|FG001|Overall Study|Lost to Follow-up|7|||
131134722|NCT02354703|472120627|FG002|Overall Study|Lost to Follow-up|9|||
131134723|NCT02354703|472120628|FG003|Overall Study|Lost to Follow-up|2|||
131050500|NCT04436289|471819197|FG002|Overall Study|Lost to Follow-up|1|||
131050501|NCT04436289|471819198|FG003|Overall Study|Lost to Follow-up|3|||
131050502|NCT02928172|471819199|FG000|Overall Study|Device did not record data|1|||
131050503|NCT04066075|471819200|FG000|Overall Study|Lost to Follow-up|3|||
131050504|NCT04066075|471819201|FG001|Overall Study|Lost to Follow-up|3|||
131050505|NCT04066075|471819200|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
131050506|NCT04066075|471819201|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
131050507|NCT04066075|471819200|FG000|Overall Study|Withdrawal by Subject|2|||
131050508|NCT04066075|471819201|FG001|Overall Study|Withdrawal by Subject|2|||
131050509|NCT00309166|471819202|FG000|Overall Study|Adverse event, non-fatal|1|||
131050510|NCT00309166|471819203|FG001|Overall Study|Adverse event, non-fatal|0|||
131050511|NCT00309166|471819202|FG000|Overall Study|Withdrawal by Subject|4|||
131050512|NCT00309166|471819203|FG001|Overall Study|Withdrawal by Subject|3|||
131050513|NCT02016872|471819208|FG000|Overall Study|Withdrawal by Subject|10|||
131050514|NCT02016872|471819208|FG000|Overall Study|Death Progression|2|||
131050515|NCT02016872|471819208|FG000|Overall Study|No FMISO scan|1|||
131050516|NCT02016872|471819208|FG000|Overall Study|Ineligible|2|||
131050517|NCT02415127|471819211|FG000|Overall Study|Adverse Event|1|||
131050518|NCT02415127|471819212|FG001|Overall Study|Adverse Event|0|||
131050519|NCT03789110|471819213|FG000|Overall Study|Adverse Event|2|||
131050520|NCT03789110|471819213|FG000|Overall Study|Physician Decision|1|||
131050521|NCT03789110|471819213|FG000|Overall Study|Withdrawal by Subject|2|||
131050522|NCT03789110|471819213|FG000|Overall Study|Lack of Efficacy|22|||
131050523|NCT03789110|471819213|FG000|Overall Study|still on treatment|3|||
131050524|NCT05464732|471819214|FG000|Overall Study|Lost to Follow-up|0|||
131050525|NCT05464732|471819215|FG001|Overall Study|Lost to Follow-up|1|||
131050526|NCT05464732|471819214|FG000|Overall Study|Adverse Event|1|||
131050527|NCT05464732|471819215|FG001|Overall Study|Adverse Event|0|||
131050528|NCT02761187|471819216|FG000|Overall Study|Too ill to Participate|13|||
131050529|NCT02761187|471819217|FG001|Overall Study|Too ill to Participate|8|||
131050530|NCT02761187|471819216|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
131050531|NCT02761187|471819217|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
131050532|NCT02761187|471819216|FG000|Overall Study|Patient withdrew consent|64|||
131050533|NCT02761187|471819217|FG001|Overall Study|Patient withdrew consent|58|||
131050534|NCT02761187|471819216|FG000|Overall Study|Physician discretion|4|||
131050535|NCT02761187|471819217|FG001|Overall Study|Physician discretion|8|||
131050536|NCT02761187|471819216|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
131050537|NCT02761187|471819217|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
131050538|NCT02761187|471819216|FG000|Overall Study|On Hospice|20|||
131050539|NCT02761187|471819217|FG001|Overall Study|On Hospice|26|||
131050540|NCT02761187|471819216|FG000|Overall Study|Deceased|474|||
131050541|NCT02761187|471819217|FG001|Overall Study|Deceased|642|||
131050542|NCT02761187|471819216|FG000|Overall Study|Lost to Follow-up|73|||
131050543|NCT02761187|471819217|FG001|Overall Study|Lost to Follow-up|63|||
131050544|NCT02761187|471819216|FG000|Overall Study|Due to study discontinued at site|100|||
131050545|NCT02761187|471819217|FG001|Overall Study|Due to study discontinued at site|85|||
131050546|NCT02761187|471819216|FG000|Overall Study|Reason not Specified|1484|||
131050547|NCT02761187|471819217|FG001|Overall Study|Reason not Specified|937|||
131050560|NCT05630833|471819222|FG000|Overall Study|Adverse Event|3|||
131050561|NCT05630833|471819223|FG001|Overall Study|Adverse Event|0|||
131050562|NCT05630833|471819222|FG000|Overall Study|Lack of Efficacy|0|||
131050563|NCT05630833|471819223|FG001|Overall Study|Lack of Efficacy|1|||
131050564|NCT05630833|471819222|FG000|Overall Study|Lost to Follow-up|1|||
131050565|NCT05630833|471819223|FG001|Overall Study|Lost to Follow-up|0|||
131050566|NCT05630833|471819222|FG000|Overall Study|Withdrawal by Subject|3|||
131050567|NCT05630833|471819223|FG001|Overall Study|Withdrawal by Subject|1|||
131050568|NCT03170349|471819225|FG000|From Implant to the 30-Day Visit|Death|1|||
131050569|NCT03170349|471819225|FG000|From 30-Day to 6-Month Visit|Death|3|||
131050570|NCT03170349|471819225|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
131050571|NCT03170349|471819225|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
131050572|NCT03170349|471819225|FG000|From 6-Month to 1-Year Visit|Death|6|||
131050573|NCT03170349|471819225|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
131050574|NCT03170349|471819225|FG000|From 1-Year to 2-Year Visit|Death|13|||
131050575|NCT03170349|471819225|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
131050576|NCT03170349|471819225|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
131050577|NCT03170349|471819225|FG000|From 2-Year to 3-Year Visit|Death|10|||
131050578|NCT03170349|471819225|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
131050579|NCT03170349|471819225|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
131050580|NCT03170349|471819225|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
131050581|NCT04530487|471820662|FG000|Overall Study|Death|1|||
131050582|NCT01036724|471820663|FG000|Overall Study|Adverse Event|1|||
131050583|NCT01036724|471820664|FG001|Overall Study|Adverse Event|2|||
131050584|NCT01036724|471820663|FG000|Overall Study|Lack of Efficacy|1|||
131134724|NCT02354703|472120625|FG000|Overall Study|Adverse Event|0|||
131134725|NCT02354703|472120626|FG001|Overall Study|Adverse Event|0|||
131134726|NCT02354703|472120627|FG002|Overall Study|Adverse Event|1|||
131134727|NCT02354703|472120628|FG003|Overall Study|Adverse Event|0|||
131134728|NCT02944448|472120629|FG000|Overall Study|Adverse Event|37|||
131134729|NCT02944448|472120630|FG001|Overall Study|Adverse Event|6|||
131134730|NCT02944448|472120629|FG000|Overall Study|Lack of Efficacy|8|||
131134731|NCT02944448|472120630|FG001|Overall Study|Lack of Efficacy|5|||
131134732|NCT02944448|472120629|FG000|Overall Study|Lost to Follow-up|3|||
131134733|NCT02944448|472120630|FG001|Overall Study|Lost to Follow-up|1|||
131134734|NCT02944448|472120629|FG000|Overall Study|Protocol Violation|25|||
131134735|NCT02944448|472120630|FG001|Overall Study|Protocol Violation|7|||
131134736|NCT02944448|472120629|FG000|Overall Study|Withdrawal by Subject|14|||
131134737|NCT02944448|472120630|FG001|Overall Study|Withdrawal by Subject|4|||
131134738|NCT02944448|472120629|FG000|Overall Study|Sponsor did not supply drug in time|0|||
131134739|NCT02944448|472120630|FG001|Overall Study|Sponsor did not supply drug in time|1|||
131134740|NCT02944448|472120629|FG000|Overall Study|Noncompliant with dosing|1|||
131134741|NCT02944448|472120630|FG001|Overall Study|Noncompliant with dosing|0|||
131134742|NCT02944448|472120629|FG000|Overall Study|Abnormal laboratory values|1|||
131134743|NCT02944448|472120630|FG001|Overall Study|Abnormal laboratory values|0|||
131134744|NCT01415752|472120632|FG000|Induction (Step 1)|Ineligible|4|||
131134745|NCT01415752|472120633|FG001|Induction (Step 1)|Ineligible|3|||
131134746|NCT01415752|472120634|FG002|Induction (Step 1)|Ineligible|4|||
131134747|NCT01415752|472120635|FG003|Induction (Step 1)|Ineligible|4|||
131134748|NCT01415752|472120632|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
131134749|NCT01415752|472120633|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
131134750|NCT01415752|472120634|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
131134751|NCT01415752|472120635|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
131134752|NCT01415752|472120632|FG000|Maintenance (Step 2)|Adverse Event|3|||
131134753|NCT01415752|472120633|FG001|Maintenance (Step 2)|Adverse Event|4|||
131134754|NCT01415752|472120634|FG002|Maintenance (Step 2)|Adverse Event|9|||
131134755|NCT01415752|472120635|FG003|Maintenance (Step 2)|Adverse Event|6|||
131134756|NCT01415752|472120632|FG000|Maintenance (Step 2)|Death|1|||
131134757|NCT01415752|472120633|FG001|Maintenance (Step 2)|Death|1|||
131134758|NCT01415752|472120634|FG002|Maintenance (Step 2)|Death|2|||
131134759|NCT01415752|472120635|FG003|Maintenance (Step 2)|Death|0|||
131134760|NCT01415752|472120632|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
131134761|NCT01415752|472120633|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
131134762|NCT01415752|472120634|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
131134763|NCT01415752|472120635|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
131134764|NCT01415752|472120632|FG000|Maintenance (Step 2)|Alternative therapy|0|||
131134765|NCT01415752|472120633|FG001|Maintenance (Step 2)|Alternative therapy|1|||
131134766|NCT01415752|472120634|FG002|Maintenance (Step 2)|Alternative therapy|0|||
131134767|NCT01415752|472120635|FG003|Maintenance (Step 2)|Alternative therapy|0|||
131134768|NCT01415752|472120632|FG000|Maintenance (Step 2)|Other reasons|3|||
131134769|NCT01415752|472120633|FG001|Maintenance (Step 2)|Other reasons|6|||
131134770|NCT01415752|472120634|FG002|Maintenance (Step 2)|Other reasons|4|||
131134771|NCT01415752|472120635|FG003|Maintenance (Step 2)|Other reasons|6|||
131050585|NCT01036724|471820664|FG001|Overall Study|Lack of Efficacy|1|||
131050586|NCT01036724|471820663|FG000|Overall Study|Protocol Violation|4|||
131050587|NCT01036724|471820664|FG001|Overall Study|Protocol Violation|5|||
131050588|NCT01637402|471820670|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
131134772|NCT01415752|472120632|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
131134773|NCT01415752|472120633|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
131050589|NCT01637402|471820671|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
131134774|NCT01415752|472120634|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
131050590|NCT01637402|471820670|FG000|Standard Dose Regimen|Adverse Event|1|||
131050591|NCT01637402|471820671|FG001|Standard Dose Regimen|Adverse Event|0|||
131050592|NCT01637402|471820670|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
131134775|NCT01415752|472120635|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
131134776|NCT01415752|472120632|FG000|Maintenance (Step 2)|ineligible|1|||
131134777|NCT01415752|472120633|FG001|Maintenance (Step 2)|ineligible|1|||
131134778|NCT01415752|472120634|FG002|Maintenance (Step 2)|ineligible|1|||
131134779|NCT01415752|472120635|FG003|Maintenance (Step 2)|ineligible|0|||
131134780|NCT01415752|472120632|FG000|Maintenance (Step 2)|Missing|4|||
131134781|NCT01415752|472120633|FG001|Maintenance (Step 2)|Missing|1|||
131134782|NCT01415752|472120634|FG002|Maintenance (Step 2)|Missing|4|||
131050593|NCT01637402|471820671|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
131050594|NCT01637402|471820670|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
131050595|NCT01637402|471820671|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
131050596|NCT01637402|471820670|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
131050597|NCT01637402|471820671|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
131050598|NCT01637402|471820670|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
131050599|NCT01637402|471820671|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
131050600|NCT02866942|471820672|FG000|Overall Study|Invalid consent|1|||
131050601|NCT02185794|471820678|FG000|Overall Study|Enrolled but Never Dosed|1|||
131050602|NCT02185794|471820679|FG001|Overall Study|Enrolled but Never Dosed|6|||
131050603|NCT02185794|471820680|FG002|Overall Study|Enrolled but Never Dosed|3|||
131050604|NCT02185794|471820681|FG003|Overall Study|Enrolled but Never Dosed|1|||
131050605|NCT02185794|471820682|FG004|Overall Study|Enrolled but Never Dosed|1|||
131050606|NCT02185794|471820683|FG005|Overall Study|Enrolled but Never Dosed|0|||
131050607|NCT02185794|471820678|FG000|Overall Study|Investigator's Discretion|1|||
131050608|NCT02185794|471820679|FG001|Overall Study|Investigator's Discretion|0|||
131050609|NCT02185794|471820680|FG002|Overall Study|Investigator's Discretion|1|||
131050610|NCT02185794|471820681|FG003|Overall Study|Investigator's Discretion|2|||
131050611|NCT02185794|471820682|FG004|Overall Study|Investigator's Discretion|2|||
131050612|NCT02185794|471820683|FG005|Overall Study|Investigator's Discretion|15|||
131050613|NCT02185794|471820678|FG000|Overall Study|Withdrew Consent|2|||
131050614|NCT02185794|471820679|FG001|Overall Study|Withdrew Consent|5|||
131050615|NCT02185794|471820680|FG002|Overall Study|Withdrew Consent|10|||
131050616|NCT02185794|471820681|FG003|Overall Study|Withdrew Consent|2|||
131050617|NCT02185794|471820682|FG004|Overall Study|Withdrew Consent|0|||
131050618|NCT02185794|471820683|FG005|Overall Study|Withdrew Consent|0|||
131050619|NCT02185794|471820678|FG000|Overall Study|Lost to Follow-up|1|||
131050620|NCT02185794|471820679|FG001|Overall Study|Lost to Follow-up|2|||
131050621|NCT02185794|471820680|FG002|Overall Study|Lost to Follow-up|2|||
131050622|NCT02185794|471820681|FG003|Overall Study|Lost to Follow-up|3|||
131050623|NCT02185794|471820682|FG004|Overall Study|Lost to Follow-up|0|||
131050624|NCT02185794|471820683|FG005|Overall Study|Lost to Follow-up|1|||
131050625|NCT01092416|471820684|FG000|Enrollment|Atherectomy device not inserted|3|||
131050626|NCT01092416|471820684|FG000|30-Day Follow-up|Death|2|||
131050627|NCT01092416|471820684|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
131050628|NCT01092416|471820684|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
131050629|NCT01092416|471820684|FG000|12-Month Follow-up|Death|16|||
131050630|NCT01092416|471820684|FG000|12-Month Follow-up|Lost to Follow-up|4|||
131050631|NCT01092416|471820684|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
131050632|NCT01092416|471820684|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
131050633|NCT01092416|471820684|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
131050634|NCT01561300|471820685|FG000|Run in on Placebo|Adverse Event|1|||
131050635|NCT01561300|471820686|FG001|Run in on Placebo|Adverse Event|0|||
131050636|NCT00246805|471820687|FG000|Phase 1|Lost to Follow-up|1|||
131050637|NCT00246805|471820688|FG001|Phase 1|Lost to Follow-up|0|||
131050638|NCT00609869|471820689|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
131050639|NCT00609869|471820689|FG000|Overall Study|Severe hematologic toxicity|1|||
131050640|NCT00609869|471820689|FG000|Overall Study|Withdrawal by Subject|1|||
131050641|NCT00609869|471820689|FG000|Overall Study|Seizures|1|||
131050642|NCT00609869|471820689|FG000|Overall Study|Severe tumor flare reaction|1|||
131050643|NCT00609869|471820689|FG000|Overall Study|Hepatitis B infection|1|||
131050644|NCT00609869|471820689|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
131050645|NCT00609869|471820689|FG000|Overall Study|Mantle cell: not evaluable|4|||
131050646|NCT01952366|471820690|FG000|Overall Study|Death|22|||
131050647|NCT01952366|471820690|FG000|Overall Study|Withdrawal by Subject|9|||
131050648|NCT00571649|471820691|FG000|Treatment Period|Adverse Event|438|||
131050649|NCT00571649|471820692|FG001|Treatment Period|Adverse Event|385|||
131050650|NCT00571649|471820691|FG000|Treatment Period|Clinical endpoint reached|50|||
131050651|NCT00571649|471820692|FG001|Treatment Period|Clinical endpoint reached|56|||
131050652|NCT00571649|471820691|FG000|Treatment Period|Withdrawal by Subject|285|||
131050653|NCT00571649|471820692|FG001|Treatment Period|Withdrawal by Subject|255|||
131050654|NCT00571649|471820691|FG000|Treatment Period|Death|76|||
131050655|NCT00571649|471820692|FG001|Treatment Period|Death|59|||
131050656|NCT00571649|471820691|FG000|Treatment Period|Physician Decision|8|||
131050657|NCT00571649|471820692|FG001|Treatment Period|Physician Decision|9|||
131050658|NCT00571649|471820691|FG000|Treatment Period|Lost to Follow-up|43|||
131050659|NCT00571649|471820692|FG001|Treatment Period|Lost to Follow-up|41|||
131050660|NCT00571649|471820691|FG000|Treatment Period|Non-compliant with study medication|88|||
131050661|NCT00571649|471820692|FG001|Treatment Period|Non-compliant with study medication|89|||
131050662|NCT00571649|471820691|FG000|Treatment Period|Patient convenience|11|||
131050663|NCT00571649|471820692|FG001|Treatment Period|Patient convenience|13|||
131050664|NCT00571649|471820691|FG000|Treatment Period|Protocol Violation|90|||
131050665|NCT00571649|471820692|FG001|Treatment Period|Protocol Violation|92|||
131050666|NCT00571649|471820691|FG000|Treatment Period|Technical problems|3|||
131134783|NCT01415752|472120635|FG003|Maintenance (Step 2)|Missing|3|||
131050667|NCT00571649|471820692|FG001|Treatment Period|Technical problems|5|||
131050668|NCT00571649|471820691|FG000|Follow-up Period|Adverse Event|46|||
131050669|NCT00571649|471820692|FG001|Follow-up Period|Adverse Event|40|||
131050670|NCT00571649|471820691|FG000|Follow-up Period|Clinical endpoint reached|5|||
131050671|NCT00571649|471820692|FG001|Follow-up Period|Clinical endpoint reached|2|||
131050672|NCT00571649|471820691|FG000|Follow-up Period|Withdrawal by Subject|119|||
131050673|NCT00571649|471820692|FG001|Follow-up Period|Withdrawal by Subject|115|||
131050674|NCT00571649|471820691|FG000|Follow-up Period|Death|132|||
131050675|NCT00571649|471820692|FG001|Follow-up Period|Death|133|||
131050676|NCT00571649|471820691|FG000|Follow-up Period|Physician Decision|7|||
131050677|NCT00571649|471820692|FG001|Follow-up Period|Physician Decision|13|||
131050678|NCT00571649|471820691|FG000|Follow-up Period|Lost to Follow-up|95|||
131050679|NCT00571649|471820692|FG001|Follow-up Period|Lost to Follow-up|92|||
131050680|NCT00571649|471820691|FG000|Follow-up Period|Patient convenience|136|||
131050681|NCT00571649|471820692|FG001|Follow-up Period|Patient convenience|121|||
131050682|NCT00571649|471820691|FG000|Follow-up Period|Protocol Violation|5|||
131050683|NCT00571649|471820692|FG001|Follow-up Period|Protocol Violation|12|||
131050684|NCT00582972|471820693|FG000|Overall Study|Protocol Violation|2|||
131050685|NCT01566890|471820696|FG000|Overall Study|Adverse Event|1|||
131050686|NCT01566890|471820697|FG001|Overall Study|Adverse Event|0|||
131050687|NCT01566890|471820698|FG002|Overall Study|Adverse Event|0|||
131050688|NCT01566890|471820699|FG003|Overall Study|Adverse Event|0|||
131050689|NCT01566890|471820700|FG004|Overall Study|Adverse Event|0|||
131050690|NCT01566890|471820696|FG000|Overall Study|Withdrawal by Subject|3|||
131050691|NCT01566890|471820697|FG001|Overall Study|Withdrawal by Subject|1|||
131050692|NCT01566890|471820698|FG002|Overall Study|Withdrawal by Subject|1|||
131050693|NCT01566890|471820699|FG003|Overall Study|Withdrawal by Subject|1|||
131050694|NCT01566890|471820700|FG004|Overall Study|Withdrawal by Subject|0|||
131050695|NCT01566890|471820696|FG000|Overall Study|Screen failure|6|||
131050696|NCT01566890|471820697|FG001|Overall Study|Screen failure|0|||
131050697|NCT01566890|471820698|FG002|Overall Study|Screen failure|1|||
131050698|NCT01566890|471820699|FG003|Overall Study|Screen failure|1|||
131050699|NCT01566890|471820700|FG004|Overall Study|Screen failure|0|||
131050700|NCT01566890|471820696|FG000|Overall Study|Incomplete CEU data|1|||
131050701|NCT01566890|471820697|FG001|Overall Study|Incomplete CEU data|3|||
131050702|NCT01566890|471820698|FG002|Overall Study|Incomplete CEU data|5|||
131050703|NCT01566890|471820699|FG003|Overall Study|Incomplete CEU data|8|||
131050704|NCT01566890|471820700|FG004|Overall Study|Incomplete CEU data|0|||
131050705|NCT01566890|471820696|FG000|Overall Study|Lost to Follow-up|0|||
131050706|NCT01566890|471820697|FG001|Overall Study|Lost to Follow-up|0|||
131050707|NCT01566890|471820698|FG002|Overall Study|Lost to Follow-up|4|||
131050708|NCT01566890|471820699|FG003|Overall Study|Lost to Follow-up|4|||
131050709|NCT01566890|471820700|FG004|Overall Study|Lost to Follow-up|0|||
131050710|NCT01566890|471820696|FG000|Overall Study|Other|0|||
131050711|NCT01566890|471820697|FG001|Overall Study|Other|0|||
131050712|NCT01566890|471820698|FG002|Overall Study|Other|0|||
131050713|NCT01566890|471820699|FG003|Overall Study|Other|0|||
131050714|NCT01566890|471820700|FG004|Overall Study|Other|7|||
131050715|NCT01421667|471820706|FG000|Overall Study|Withdrawal by Subject|0|||
131050716|NCT01421667|471820707|FG001|Overall Study|Withdrawal by Subject|1|||
131050717|NCT01421667|471820708|FG002|Overall Study|Withdrawal by Subject|2|||
131050718|NCT01421667|471820709|FG003|Overall Study|Withdrawal by Subject|1|||
131050719|NCT01421667|471820706|FG000|Overall Study|Lost to Follow-up|0|||
131050720|NCT01421667|471820707|FG001|Overall Study|Lost to Follow-up|1|||
131050721|NCT01421667|471820708|FG002|Overall Study|Lost to Follow-up|0|||
131050722|NCT01421667|471820709|FG003|Overall Study|Lost to Follow-up|0|||
131050723|NCT01324310|471820710|FG000|Overall Study|Adverse Event|1|||
131050724|NCT01324310|471820710|FG000|Overall Study|Disease Progression|1|||
131050725|NCT03170882|471820712|FG000|Overall Study|Death|17|||
131050726|NCT03170882|471820713|FG001|Overall Study|Death|29|||
131050727|NCT03170882|471820712|FG000|Overall Study|Lost to Follow-up|0|||
131050728|NCT03170882|471820713|FG001|Overall Study|Lost to Follow-up|1|||
131050729|NCT03170882|471820712|FG000|Overall Study|Withdrawal by Subject|4|||
131050730|NCT03170882|471820713|FG001|Overall Study|Withdrawal by Subject|7|||
131050731|NCT03170882|471820712|FG000|Overall Study|Reason not Specified|28|||
131050732|NCT03170882|471820713|FG001|Overall Study|Reason not Specified|36|||
131050733|NCT02787005|471820733|FG000|Overall Study|Adverse Event|24|||
131050734|NCT02787005|471820734|FG001|Overall Study|Adverse Event|9|||
131050735|NCT02787005|471820735|FG002|Overall Study|Adverse Event|9|||
131050736|NCT02787005|471820736|FG003|Overall Study|Adverse Event|7|||
131050737|NCT02787005|471820737|FG004|Overall Study|Adverse Event|2|||
131050738|NCT02787005|471820733|FG000|Overall Study|Death|100|||
131050739|NCT02787005|471820734|FG001|Overall Study|Death|53|||
131050740|NCT02787005|471820735|FG002|Overall Study|Death|48|||
131050741|NCT02787005|471820736|FG003|Overall Study|Death|69|||
131050742|NCT02787005|471820737|FG004|Overall Study|Death|38|||
131050743|NCT02787005|471820733|FG000|Overall Study|Sponsor Decision|7|||
131050744|NCT02787005|471820734|FG001|Overall Study|Sponsor Decision|4|||
131050745|NCT02787005|471820735|FG002|Overall Study|Sponsor Decision|0|||
131050746|NCT02787005|471820736|FG003|Overall Study|Sponsor Decision|4|||
131050747|NCT02787005|471820737|FG004|Overall Study|Sponsor Decision|5|||
131050748|NCT02787005|471820733|FG000|Overall Study|Withdrawal by Subject|2|||
131050749|NCT02787005|471820734|FG001|Overall Study|Withdrawal by Subject|1|||
131050750|NCT02787005|471820735|FG002|Overall Study|Withdrawal by Subject|1|||
131050751|NCT02787005|471820736|FG003|Overall Study|Withdrawal by Subject|0|||
131050752|NCT02787005|471820737|FG004|Overall Study|Withdrawal by Subject|1|||
131050753|NCT02787005|471820733|FG000|Overall Study|Screen Failure|0|||
131050754|NCT02787005|471820734|FG001|Overall Study|Screen Failure|2|||
131050755|NCT02787005|471820735|FG002|Overall Study|Screen Failure|0|||
131050756|NCT02787005|471820736|FG003|Overall Study|Screen Failure|0|||
131050757|NCT02787005|471820737|FG004|Overall Study|Screen Failure|1|||
131050758|NCT02787005|471820733|FG000|Overall Study|Lost to Follow-up|0|||
131050759|NCT02787005|471820734|FG001|Overall Study|Lost to Follow-up|0|||
131050760|NCT02787005|471820735|FG002|Overall Study|Lost to Follow-up|0|||
131050761|NCT02787005|471820736|FG003|Overall Study|Lost to Follow-up|1|||
131050762|NCT02787005|471820737|FG004|Overall Study|Lost to Follow-up|0|||
131050763|NCT05580003|471820738|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050764|NCT05580003|471820739|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050765|NCT05580003|471820740|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050766|NCT05580003|471820741|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050767|NCT05580003|471820742|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050768|NCT05580003|471820743|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050769|NCT05580003|471820744|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
131050770|NCT05580003|471820745|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050771|NCT05580003|471820746|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050772|NCT05580003|471820747|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050773|NCT05580003|471820748|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050774|NCT05580003|471820749|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050775|NCT05580003|471820750|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050776|NCT05580003|471820751|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050777|NCT05580003|471820752|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050778|NCT05580003|471820753|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050779|NCT05580003|471820754|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050780|NCT05580003|471820755|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050781|NCT05580003|471820756|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050782|NCT05580003|471820757|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050783|NCT05580003|471820758|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050784|NCT05580003|471820759|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050785|NCT05580003|471820760|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050786|NCT05580003|471820761|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050787|NCT05580003|471820762|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050788|NCT05580003|471820763|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050789|NCT05580003|471820764|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050790|NCT05580003|471820765|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131050791|NCT05580003|471820738|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050792|NCT05580003|471820739|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050793|NCT05580003|471820740|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050794|NCT05580003|471820741|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050795|NCT05580003|471820742|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050796|NCT05580003|471820743|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
131050797|NCT05580003|471820744|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050798|NCT05580003|471820745|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131134784|NCT01926782|472120637|FG000|Overall Study|Participant moved|2|||
131134785|NCT01926782|472120638|FG001|Overall Study|Participant moved|0|||
131134786|NCT01926782|472120639|FG002|Overall Study|Participant moved|1|||
131134787|NCT01926782|472120640|FG003|Overall Study|Participant moved|1|||
131134788|NCT01926782|472120641|FG004|Overall Study|Participant moved|0|||
131134789|NCT01926782|472120642|FG005|Overall Study|Participant moved|3|||
131134790|NCT01926782|472120637|FG000|Overall Study|Physician Decision|0|||
131050799|NCT05580003|471820746|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050800|NCT05580003|471820747|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050801|NCT05580003|471820748|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050802|NCT05580003|471820749|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050803|NCT05580003|471820750|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050804|NCT05580003|471820751|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131134791|NCT01926782|472120638|FG001|Overall Study|Physician Decision|2|||
130722107|NCT03400943|470608168|FG001|Treatment Period 1|Other|1|||
130722108|NCT03400943|470608169|FG002|Treatment Period 1|Other|2|||
131134792|NCT01926782|472120639|FG002|Overall Study|Physician Decision|1|||
131134793|NCT01926782|472120640|FG003|Overall Study|Physician Decision|1|||
131134794|NCT01926782|472120641|FG004|Overall Study|Physician Decision|0|||
131134795|NCT01926782|472120642|FG005|Overall Study|Physician Decision|0|||
131134796|NCT01926782|472120637|FG000|Overall Study|Other than specified|2|||
131134797|NCT01926782|472120638|FG001|Overall Study|Other than specified|3|||
131134798|NCT01926782|472120639|FG002|Overall Study|Other than specified|5|||
131134799|NCT01926782|472120640|FG003|Overall Study|Other than specified|12|||
131134800|NCT01926782|472120641|FG004|Overall Study|Other than specified|4|||
131134801|NCT01926782|472120642|FG005|Overall Study|Other than specified|11|||
131134802|NCT01926782|472120637|FG000|Overall Study|Adverse Event|13|||
131134803|NCT01926782|472120638|FG001|Overall Study|Adverse Event|4|||
131134804|NCT01926782|472120639|FG002|Overall Study|Adverse Event|17|||
131134805|NCT01926782|472120640|FG003|Overall Study|Adverse Event|4|||
131134806|NCT01926782|472120641|FG004|Overall Study|Adverse Event|3|||
131134807|NCT01926782|472120642|FG005|Overall Study|Adverse Event|14|||
131134808|NCT01926782|472120637|FG000|Overall Study|Poor compliance to protocol|5|||
131134809|NCT01926782|472120638|FG001|Overall Study|Poor compliance to protocol|3|||
131134810|NCT01926782|472120639|FG002|Overall Study|Poor compliance to protocol|8|||
131134811|NCT01926782|472120640|FG003|Overall Study|Poor compliance to protocol|0|||
131050805|NCT05580003|471820752|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050806|NCT05580003|471820753|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130722109|NCT03400943|470608170|FG003|Treatment Period 1|Other|2|||
130722110|NCT03400943|470608167|FG000|Post-treatment Period 1|Adverse Event|2|||
131050807|NCT05580003|471820754|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050808|NCT05580003|471820755|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050809|NCT05580003|471820756|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050810|NCT05580003|471820757|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050811|NCT05580003|471820758|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050812|NCT05580003|471820759|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050813|NCT05580003|471820760|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050814|NCT05580003|471820761|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050815|NCT05580003|471820762|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050816|NCT05580003|471820763|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050817|NCT05580003|471820764|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050818|NCT05580003|471820765|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
131050819|NCT05580003|471820738|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050820|NCT05580003|471820739|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050821|NCT05580003|471820740|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050822|NCT05580003|471820741|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
131050823|NCT05580003|471820742|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050824|NCT05580003|471820743|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050825|NCT05580003|471820744|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050826|NCT05580003|471820745|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050827|NCT05580003|471820746|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050828|NCT05580003|471820747|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050829|NCT05580003|471820748|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050830|NCT05580003|471820749|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050831|NCT05580003|471820750|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050832|NCT05580003|471820751|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050833|NCT05580003|471820752|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050834|NCT05580003|471820753|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050835|NCT05580003|471820754|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050836|NCT05580003|471820755|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050837|NCT05580003|471820756|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050838|NCT05580003|471820757|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050839|NCT05580003|471820758|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050840|NCT05580003|471820759|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050841|NCT05580003|471820760|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050842|NCT05580003|471820761|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050843|NCT05580003|471820762|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050844|NCT05580003|471820763|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050845|NCT05580003|471820764|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131050846|NCT05580003|471820765|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
131134812|NCT01926782|472120641|FG004|Overall Study|Poor compliance to protocol|1|||
131134813|NCT01926782|472120642|FG005|Overall Study|Poor compliance to protocol|6|||
131134814|NCT01926782|472120637|FG000|Overall Study|Randomized and not treated|0|||
131134815|NCT01926782|472120638|FG001|Overall Study|Randomized and not treated|0|||
131134816|NCT01926782|472120639|FG002|Overall Study|Randomized and not treated|0|||
131134817|NCT01926782|472120640|FG003|Overall Study|Randomized and not treated|1|||
131134818|NCT01926782|472120641|FG004|Overall Study|Randomized and not treated|0|||
131134819|NCT01926782|472120642|FG005|Overall Study|Randomized and not treated|0|||
131134820|NCT01926782|472120637|FG000|Overall Study|Withdrawal by Subject|6|||
131134821|NCT01926782|472120638|FG001|Overall Study|Withdrawal by Subject|1|||
131134822|NCT01926782|472120639|FG002|Overall Study|Withdrawal by Subject|8|||
131134823|NCT01926782|472120640|FG003|Overall Study|Withdrawal by Subject|1|||
131134824|NCT01926782|472120641|FG004|Overall Study|Withdrawal by Subject|0|||
131134825|NCT01926782|472120642|FG005|Overall Study|Withdrawal by Subject|5|||
131134826|NCT01926782|472120637|FG000|Overall Study|Related to study drug administration|0|||
131134827|NCT01926782|472120638|FG001|Overall Study|Related to study drug administration|0|||
131134828|NCT01926782|472120639|FG002|Overall Study|Related to study drug administration|0|||
131134829|NCT01926782|472120640|FG003|Overall Study|Related to study drug administration|0|||
131134830|NCT01926782|472120641|FG004|Overall Study|Related to study drug administration|0|||
131134831|NCT01926782|472120642|FG005|Overall Study|Related to study drug administration|2|||
131134832|NCT04372927|472120643|FG000|Overall Study|Death|1|||
131134833|NCT00070941|472120644|FG000|Overall Study|Adverse Event|10|||
131134834|NCT00070941|472120645|FG001|Overall Study|Adverse Event|8|||
131134835|NCT00070941|472120646|FG002|Overall Study|Adverse Event|4|||
131134836|NCT00094055|472120647|FG000|Overall Study|Adverse Event|11|||
130722111|NCT03400943|470608168|FG001|Post-treatment Period 1|Adverse Event|0|||
131134837|NCT00094055|472120647|FG000|Overall Study|Death|4|||
131134838|NCT00094055|472120647|FG000|Overall Study|Lack of Efficacy|17|||
131134839|NCT00094055|472120647|FG000|Overall Study|Lost to Follow-up|2|||
131134840|NCT00094055|472120647|FG000|Overall Study|progressive disease|2|||
131134841|NCT00094055|472120647|FG000|Overall Study|clinical progression|1|||
131134842|NCT00094055|472120647|FG000|Overall Study|roll-over to another study|14|||
131134843|NCT00094055|472120647|FG000|Overall Study|Withdrawal by Subject|9|||
131134844|NCT00661271|472120649|FG000|Overall Study|Lost to Follow-up|28|||
131134845|NCT00661271|472120650|FG001|Overall Study|Lost to Follow-up|25|||
131134846|NCT00430508|472120652|FG000|Overall Study|Adverse Event|2|||
131134847|NCT00430508|472120653|FG001|Overall Study|Adverse Event|3|||
131134848|NCT00430508|472120654|FG002|Overall Study|Adverse Event|5|||
131134849|NCT00430508|472120655|FG003|Overall Study|Adverse Event|3|||
131134850|NCT00430508|472120652|FG000|Overall Study|Withdrawal by Subject|0|||
131134851|NCT00430508|472120653|FG001|Overall Study|Withdrawal by Subject|1|||
131134852|NCT00430508|472120654|FG002|Overall Study|Withdrawal by Subject|1|||
131134853|NCT00430508|472120655|FG003|Overall Study|Withdrawal by Subject|1|||
131134854|NCT00430508|472120652|FG000|Overall Study|responder at visit 4|0|||
131134855|NCT00430508|472120653|FG001|Overall Study|responder at visit 4|0|||
131134856|NCT00430508|472120654|FG002|Overall Study|responder at visit 4|2|||
131134857|NCT00430508|472120655|FG003|Overall Study|responder at visit 4|0|||
131134858|NCT00430508|472120652|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
131134859|NCT00430508|472120653|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
131134860|NCT00430508|472120654|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
131134861|NCT00430508|472120655|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
131134862|NCT00430508|472120652|FG000|Overall Study|Other|1|||
131134863|NCT00430508|472120653|FG001|Overall Study|Other|1|||
131134864|NCT00430508|472120654|FG002|Overall Study|Other|3|||
131134865|NCT00430508|472120655|FG003|Overall Study|Other|0|||
131134866|NCT01707693|472120660|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
131134867|NCT01707693|472120661|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
131134868|NCT01707693|472120660|FG000|Overall Study Allocation|Protocol Violation|4|||
131134869|NCT01707693|472120661|FG001|Overall Study Allocation|Protocol Violation|3|||
131134870|NCT01707693|472120660|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
131134871|NCT01707693|472120661|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
131134872|NCT01707693|472120660|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
131134873|NCT01707693|472120661|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
131134874|NCT04673786|472120663|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
131134875|NCT04673786|472120664|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
131134876|NCT04673786|472120665|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
131134877|NCT04673786|472120663|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
131134878|NCT04673786|472120664|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
130722112|NCT03400943|470608169|FG002|Post-treatment Period 1|Adverse Event|0|||
130722113|NCT03400943|470608170|FG003|Post-treatment Period 1|Adverse Event|0|||
130722114|NCT03400943|470608167|FG000|Post-treatment Period 1|Protocol Violation|1|||
130722115|NCT03400943|470608168|FG001|Post-treatment Period 1|Protocol Violation|0|||
130722116|NCT03400943|470608169|FG002|Post-treatment Period 1|Protocol Violation|0|||
131134879|NCT04673786|472120665|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
131134880|NCT04673786|472120663|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
131134881|NCT04673786|472120664|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
131134882|NCT04673786|472120665|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
131134883|NCT04673786|472120663|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
131134884|NCT04673786|472120664|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
131134885|NCT04673786|472120665|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
131134886|NCT04673786|472120663|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
131134887|NCT04673786|472120664|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
131134888|NCT04673786|472120665|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
131050847|NCT05580003|471820738|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050848|NCT05580003|471820739|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
131050849|NCT05580003|471820740|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050850|NCT05580003|471820741|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050851|NCT05580003|471820742|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050852|NCT05580003|471820743|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050853|NCT05580003|471820744|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050854|NCT05580003|471820745|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050855|NCT05580003|471820746|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050856|NCT05580003|471820747|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050857|NCT05580003|471820748|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050858|NCT05580003|471820749|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050859|NCT05580003|471820750|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050860|NCT05580003|471820751|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050861|NCT05580003|471820752|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050862|NCT05580003|471820753|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050863|NCT05580003|471820754|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050864|NCT05580003|471820755|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050865|NCT05580003|471820756|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050866|NCT05580003|471820757|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050867|NCT05580003|471820758|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050868|NCT05580003|471820759|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050869|NCT05580003|471820760|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050870|NCT05580003|471820761|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050871|NCT05580003|471820762|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050872|NCT05580003|471820763|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050873|NCT05580003|471820764|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050874|NCT05580003|471820765|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
131050875|NCT05580003|471820738|FG000|Part 2 (up to 10 Days)|Other|0|||
131050876|NCT05580003|471820739|FG001|Part 2 (up to 10 Days)|Other|0|||
131050877|NCT05580003|471820740|FG002|Part 2 (up to 10 Days)|Other|0|||
131050878|NCT05580003|471820741|FG003|Part 2 (up to 10 Days)|Other|0|||
131050879|NCT05580003|471820742|FG004|Part 2 (up to 10 Days)|Other|0|||
131050880|NCT05580003|471820743|FG005|Part 2 (up to 10 Days)|Other|0|||
131050881|NCT05580003|471820744|FG006|Part 2 (up to 10 Days)|Other|0|||
131050882|NCT05580003|471820745|FG007|Part 2 (up to 10 Days)|Other|0|||
131050883|NCT05580003|471820746|FG008|Part 2 (up to 10 Days)|Other|0|||
131050884|NCT05580003|471820747|FG009|Part 2 (up to 10 Days)|Other|1|||
131050885|NCT05580003|471820748|FG010|Part 2 (up to 10 Days)|Other|0|||
131050886|NCT05580003|471820749|FG011|Part 2 (up to 10 Days)|Other|0|||
131050887|NCT05580003|471820750|FG012|Part 2 (up to 10 Days)|Other|0|||
131050888|NCT05580003|471820751|FG013|Part 2 (up to 10 Days)|Other|0|||
131050889|NCT05580003|471820752|FG014|Part 2 (up to 10 Days)|Other|0|||
131050890|NCT05580003|471820753|FG015|Part 2 (up to 10 Days)|Other|0|||
131050891|NCT05580003|471820754|FG016|Part 2 (up to 10 Days)|Other|0|||
131050892|NCT05580003|471820755|FG017|Part 2 (up to 10 Days)|Other|0|||
131050893|NCT05580003|471820756|FG018|Part 2 (up to 10 Days)|Other|0|||
131050894|NCT05580003|471820757|FG019|Part 2 (up to 10 Days)|Other|0|||
131050895|NCT05580003|471820758|FG020|Part 2 (up to 10 Days)|Other|0|||
131050896|NCT05580003|471820759|FG021|Part 2 (up to 10 Days)|Other|0|||
131050897|NCT05580003|471820760|FG022|Part 2 (up to 10 Days)|Other|0|||
131050898|NCT05580003|471820761|FG023|Part 2 (up to 10 Days)|Other|0|||
131050899|NCT05580003|471820762|FG024|Part 2 (up to 10 Days)|Other|0|||
131050900|NCT05580003|471820763|FG025|Part 2 (up to 10 Days)|Other|0|||
131050901|NCT05580003|471820764|FG026|Part 2 (up to 10 Days)|Other|0|||
131050902|NCT05580003|471820765|FG027|Part 2 (up to 10 Days)|Other|0|||
131050903|NCT05580003|471820738|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050904|NCT05580003|471820739|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050905|NCT05580003|471820740|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050906|NCT05580003|471820741|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050907|NCT05580003|471820742|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050908|NCT05580003|471820743|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050909|NCT05580003|471820744|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050910|NCT05580003|471820745|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050911|NCT05580003|471820746|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131134889|NCT04673786|472120663|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
131134890|NCT04673786|472120664|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
131050912|NCT05580003|471820747|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131134891|NCT04673786|472120665|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
131050913|NCT05580003|471820748|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050914|NCT05580003|471820749|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050915|NCT05580003|471820750|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131134892|NCT01325428|472120666|FG000|Part A|Progressive disease according to RECIST|9|||
131134893|NCT01325428|472120666|FG000|Part A|Clinical signs, symptoms of progression|2|||
131134894|NCT01325428|472120666|FG000|Part A|Other adverse event|1|||
131134895|NCT01325428|472120666|FG000|Part A|Refused continue taking trial medication|2|||
131134896|NCT01325428|472120666|FG000|Part A|Other reason not defined above|2|||
131134897|NCT01325428|472120666|FG000|Part B|Refused continue taking trial medication|2|||
131134898|NCT01325428|472120666|FG000|Part B|Other reason not defined above|1|||
131134899|NCT02682901|472120667|FG000|Overall Study|Adverse Event|10|||
131134900|NCT02682901|472120668|FG001|Overall Study|Adverse Event|3|||
131134901|NCT02682901|472120667|FG000|Overall Study|Lack of Efficacy|0|||
131134902|NCT02682901|472120668|FG001|Overall Study|Lack of Efficacy|1|||
131134903|NCT00343889|472120682|FG000|Overall Study|Lost to Follow-up|2|||
131134904|NCT00343889|472120683|FG001|Overall Study|Lost to Follow-up|0|||
131134905|NCT00343889|472120682|FG000|Overall Study|Withdrawal by Subject|0|||
131134906|NCT00343889|472120683|FG001|Overall Study|Withdrawal by Subject|1|||
131134907|NCT00343889|472120682|FG000|Overall Study|Protocol Violation|1|||
131134908|NCT00343889|472120683|FG001|Overall Study|Protocol Violation|0|||
131134909|NCT01294579|472120686|FG000|Overall Study|Disease progression|12|||
131134910|NCT01294579|472120686|FG000|Overall Study|Adverse Event|11|||
131134911|NCT01294579|472120686|FG000|Overall Study|Study closed/terminated|3|||
131134912|NCT01294579|472120686|FG000|Overall Study|Lost to Follow-up|1|||
131134913|NCT01294579|472120686|FG000|Overall Study|Physician Decision|3|||
131134914|NCT01294579|472120686|FG000|Overall Study|Withdrawal by Subject|5|||
131134915|NCT02573155|472120687|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
131134916|NCT02573155|472120688|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
131134917|NCT02573155|472120687|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
131134918|NCT02573155|472120688|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
131134919|NCT02573155|472120687|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
131134920|NCT02573155|472120688|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
131134921|NCT02573155|472120687|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
131134922|NCT02573155|472120688|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
131134923|NCT02573155|472120687|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
131134924|NCT02573155|472120688|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
131134925|NCT02573155|472120687|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
131134926|NCT02573155|472120688|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
131134927|NCT02573155|472120687|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
131134928|NCT02573155|472120688|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
131134929|NCT02573155|472120687|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
131134930|NCT02573155|472120688|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
131134931|NCT00903929|472120691|FG000|Overall Study|Withdrawal by Subject|0|||
131134932|NCT00903929|472120692|FG001|Overall Study|Withdrawal by Subject|0|||
131134933|NCT00903929|472120693|FG002|Overall Study|Withdrawal by Subject|1|||
131134934|NCT00903929|472120694|FG003|Overall Study|Withdrawal by Subject|2|||
131134935|NCT00903929|472120691|FG000|Overall Study|Adverse Event|0|||
131134936|NCT00903929|472120692|FG001|Overall Study|Adverse Event|0|||
130722117|NCT03400943|470608170|FG003|Post-treatment Period 1|Protocol Violation|0|||
131050916|NCT05580003|471820751|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050917|NCT05580003|471820752|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050918|NCT05580003|471820753|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050919|NCT05580003|471820754|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050920|NCT05580003|471820755|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050921|NCT05580003|471820756|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050922|NCT05580003|471820757|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
131050923|NCT05580003|471820758|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050924|NCT05580003|471820759|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050925|NCT05580003|471820760|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050926|NCT05580003|471820761|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050927|NCT05580003|471820762|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050928|NCT05580003|471820763|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050929|NCT05580003|471820764|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050930|NCT05580003|471820765|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
131050931|NCT05580003|471820738|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050932|NCT05580003|471820739|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050933|NCT05580003|471820740|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050934|NCT05580003|471820741|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050935|NCT05580003|471820742|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050936|NCT05580003|471820743|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050937|NCT05580003|471820744|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050938|NCT05580003|471820745|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050939|NCT05580003|471820746|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050940|NCT05580003|471820747|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050941|NCT05580003|471820748|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131134937|NCT00903929|472120693|FG002|Overall Study|Adverse Event|0|||
131134938|NCT00903929|472120694|FG003|Overall Study|Adverse Event|1|||
131134939|NCT00516737|472120698|FG000|Overall Study|Lost to Follow-up|2|||
131134940|NCT00516737|472120699|FG001|Overall Study|Lost to Follow-up|0|||
131134941|NCT00516737|472120698|FG000|Overall Study|Physician Decision|0|||
131134942|NCT00516737|472120699|FG001|Overall Study|Physician Decision|1|||
131134943|NCT00516737|472120698|FG000|Overall Study|Withdrawal by Subject|0|||
131134944|NCT00516737|472120699|FG001|Overall Study|Withdrawal by Subject|1|||
131134945|NCT00516737|472120698|FG000|Overall Study|Lack of Qualifying Event|9|||
131134946|NCT00516737|472120699|FG001|Overall Study|Lack of Qualifying Event|6|||
131134947|NCT00512798|472120700|FG000|Overall Study|Death|0|||
131134948|NCT00512798|472120701|FG001|Overall Study|Death|3|||
131134949|NCT00512798|472120700|FG000|Overall Study|Adverse Event|2|||
131134950|NCT00512798|472120701|FG001|Overall Study|Adverse Event|4|||
131134951|NCT00512798|472120700|FG000|Overall Study|Progression of disease|14|||
131134952|NCT00512798|472120701|FG001|Overall Study|Progression of disease|20|||
131134953|NCT00512798|472120700|FG000|Overall Study|Withdrawal by Subject|3|||
131134954|NCT00512798|472120701|FG001|Overall Study|Withdrawal by Subject|0|||
131134955|NCT00454805|472120705|FG000|Overall Study|Withdrawal by Subject|9|||
131134956|NCT00454805|472120706|FG001|Overall Study|Withdrawal by Subject|2|||
131134957|NCT00454805|472120705|FG000|Overall Study|Death|0|||
131134958|NCT00454805|472120706|FG001|Overall Study|Death|2|||
131134959|NCT00454805|472120705|FG000|Overall Study|Disease progression|16|||
131050942|NCT05580003|471820749|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131134960|NCT00454805|472120706|FG001|Overall Study|Disease progression|19|||
131134961|NCT00454805|472120705|FG000|Overall Study|In order to begin radiotherapy|1|||
131134962|NCT00454805|472120706|FG001|Overall Study|In order to begin radiotherapy|0|||
131134963|NCT01627899|472120717|FG000|Overall Study|Study terminated early by sponsor.|5|||
131134964|NCT03692052|472120718|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
131134965|NCT03692052|472120718|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
131134966|NCT03692052|472120718|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
131134967|NCT03692052|472120718|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
131134968|NCT05600309|472120721|FG000|Overall Study|Death|41|||
131134969|NCT05600309|472120722|FG001|Overall Study|Death|38|||
131134970|NCT05600309|472120721|FG000|Overall Study|Sponsor Decision|9|||
131134971|NCT05600309|472120722|FG001|Overall Study|Sponsor Decision|6|||
131134972|NCT01358864|472120728|FG000|Overall Study|Adverse Event|0|||
131134973|NCT01358864|472120729|FG001|Overall Study|Adverse Event|6|||
131134974|NCT01358864|472120730|FG002|Overall Study|Adverse Event|9|||
131050943|NCT05580003|471820750|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050944|NCT05580003|471820751|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050945|NCT05580003|471820752|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050946|NCT05580003|471820753|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050947|NCT05580003|471820754|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050948|NCT05580003|471820755|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050949|NCT05580003|471820756|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050950|NCT05580003|471820757|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050951|NCT05580003|471820758|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
131050952|NCT05580003|471820759|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050953|NCT05580003|471820760|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050954|NCT05580003|471820761|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050955|NCT05580003|471820762|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050956|NCT05580003|471820763|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050957|NCT05580003|471820764|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050958|NCT05580003|471820765|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
131050959|NCT05580003|471820738|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050960|NCT05580003|471820739|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050961|NCT05580003|471820740|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050962|NCT05580003|471820741|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050963|NCT05580003|471820742|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131134975|NCT01358864|472120731|FG003|Overall Study|Adverse Event|0|||
131134976|NCT01358864|472120732|FG004|Overall Study|Adverse Event|4|||
131134977|NCT01358864|472120733|FG005|Overall Study|Adverse Event|8|||
131134978|NCT01358864|472120734|FG006|Overall Study|Adverse Event|12|||
131050964|NCT05580003|471820743|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131134979|NCT01358864|472120735|FG007|Overall Study|Adverse Event|7|||
131134980|NCT01358864|472120728|FG000|Overall Study|Lack of Efficacy|26|||
131134981|NCT01358864|472120729|FG001|Overall Study|Lack of Efficacy|3|||
131134982|NCT01358864|472120730|FG002|Overall Study|Lack of Efficacy|4|||
131134983|NCT01358864|472120731|FG003|Overall Study|Lack of Efficacy|19|||
131134984|NCT01358864|472120732|FG004|Overall Study|Lack of Efficacy|7|||
131134985|NCT01358864|472120733|FG005|Overall Study|Lack of Efficacy|4|||
131134986|NCT01358864|472120734|FG006|Overall Study|Lack of Efficacy|49|||
131134987|NCT01358864|472120735|FG007|Overall Study|Lack of Efficacy|44|||
131050965|NCT05580003|471820744|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050966|NCT05580003|471820745|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050967|NCT05580003|471820746|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050968|NCT05580003|471820747|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050969|NCT05580003|471820748|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050970|NCT05580003|471820749|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050971|NCT05580003|471820750|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050972|NCT05580003|471820751|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131134988|NCT01358864|472120728|FG000|Overall Study|Lost to Follow-up|0|||
131134989|NCT01358864|472120729|FG001|Overall Study|Lost to Follow-up|0|||
131134990|NCT01358864|472120730|FG002|Overall Study|Lost to Follow-up|1|||
131134991|NCT01358864|472120731|FG003|Overall Study|Lost to Follow-up|0|||
131134992|NCT01358864|472120732|FG004|Overall Study|Lost to Follow-up|0|||
131134993|NCT01358864|472120733|FG005|Overall Study|Lost to Follow-up|0|||
131134994|NCT01358864|472120734|FG006|Overall Study|Lost to Follow-up|0|||
131134995|NCT01358864|472120735|FG007|Overall Study|Lost to Follow-up|1|||
131134996|NCT01358864|472120728|FG000|Overall Study|Withdrawal by Subject|3|||
131134997|NCT01358864|472120729|FG001|Overall Study|Withdrawal by Subject|4|||
131134998|NCT01358864|472120730|FG002|Overall Study|Withdrawal by Subject|2|||
131134999|NCT01358864|472120731|FG003|Overall Study|Withdrawal by Subject|0|||
131135000|NCT01358864|472120732|FG004|Overall Study|Withdrawal by Subject|0|||
131135001|NCT01358864|472120733|FG005|Overall Study|Withdrawal by Subject|1|||
131135002|NCT01358864|472120734|FG006|Overall Study|Withdrawal by Subject|1|||
131135003|NCT01358864|472120735|FG007|Overall Study|Withdrawal by Subject|3|||
131135004|NCT01358864|472120728|FG000|Overall Study|Other reason not defined above|2|||
131135005|NCT01358864|472120729|FG001|Overall Study|Other reason not defined above|0|||
131135006|NCT01358864|472120730|FG002|Overall Study|Other reason not defined above|0|||
131135007|NCT01358864|472120731|FG003|Overall Study|Other reason not defined above|0|||
131135008|NCT01358864|472120732|FG004|Overall Study|Other reason not defined above|0|||
131135009|NCT01358864|472120733|FG005|Overall Study|Other reason not defined above|0|||
131135010|NCT01358864|472120734|FG006|Overall Study|Other reason not defined above|2|||
131135011|NCT01358864|472120735|FG007|Overall Study|Other reason not defined above|0|||
131135012|NCT01358864|472120728|FG000|Overall Study|Not treated|0|||
131135013|NCT01358864|472120729|FG001|Overall Study|Not treated|0|||
131135014|NCT01358864|472120730|FG002|Overall Study|Not treated|0|||
131135015|NCT01358864|472120731|FG003|Overall Study|Not treated|0|||
131135016|NCT01358864|472120732|FG004|Overall Study|Not treated|0|||
131135017|NCT01358864|472120733|FG005|Overall Study|Not treated|0|||
131135018|NCT01358864|472120734|FG006|Overall Study|Not treated|1|||
131135019|NCT01358864|472120735|FG007|Overall Study|Not treated|0|||
131135020|NCT04158648|472120739|FG000|Overall Study|Ongoing in the Study|69|||
131135021|NCT04158648|472120739|FG000|Overall Study|Withdrawal by Subject|4|||
131135022|NCT04209855|472120740|FG000|Overall Study|Death|161|||
131135023|NCT04209855|472120741|FG001|Overall Study|Death|177|||
131135024|NCT04209855|472120740|FG000|Overall Study|PI Discretion|1|||
131135025|NCT04209855|472120741|FG001|Overall Study|PI Discretion|1|||
131135026|NCT04209855|472120740|FG000|Overall Study|Lost to Follow-up|5|||
131135027|NCT04209855|472120741|FG001|Overall Study|Lost to Follow-up|2|||
131135028|NCT04209855|472120740|FG000|Overall Study|Withdrew consent|10|||
131135029|NCT04209855|472120741|FG001|Overall Study|Withdrew consent|24|||
131135030|NCT04209855|472120740|FG000|Overall Study|Sponsor decision|44|||
131135031|NCT04209855|472120741|FG001|Overall Study|Sponsor decision|18|||
131135032|NCT04209855|472120740|FG000|Overall Study|Other than specified|6|||
131135033|NCT04209855|472120741|FG001|Overall Study|Other than specified|4|||
131135034|NCT01250379|472120742|FG000|Overall Study|Death|141|||
131135035|NCT01250379|472120743|FG001|Overall Study|Death|148|||
131135036|NCT01250379|472120742|FG000|Overall Study|Withdrawal by Subject|32|||
131135037|NCT01250379|472120743|FG001|Overall Study|Withdrawal by Subject|20|||
131135038|NCT01250379|472120742|FG000|Overall Study|Physician Decision|11|||
131135039|NCT01250379|472120743|FG001|Overall Study|Physician Decision|3|||
131135040|NCT01250379|472120742|FG000|Overall Study|Protocol Violation|2|||
131135041|NCT01250379|472120743|FG001|Overall Study|Protocol Violation|8|||
131135042|NCT01250379|472120742|FG000|Overall Study|Lost to Follow-up|9|||
131135043|NCT01250379|472120743|FG001|Overall Study|Lost to Follow-up|6|||
131135044|NCT01250379|472120742|FG000|Overall Study|Adverse Event|5|||
131135045|NCT01250379|472120743|FG001|Overall Study|Adverse Event|4|||
131135046|NCT01250379|472120742|FG000|Overall Study|Other|0|||
131135047|NCT01250379|472120743|FG001|Overall Study|Other|4|||
131135048|NCT01250379|472120742|FG000|Overall Study|Participant noncompliance|2|||
131135049|NCT01250379|472120743|FG001|Overall Study|Participant noncompliance|0|||
131135050|NCT01489527|472120745|FG000|Overall Study|Pregnancy|9|||
131135051|NCT01489527|472120746|FG001|Overall Study|Pregnancy|14|||
131135052|NCT01489527|472120745|FG000|Overall Study|Participant moved|6|||
131135053|NCT01489527|472120746|FG001|Overall Study|Participant moved|7|||
131135054|NCT01489527|472120745|FG000|Overall Study|Withdrawal by Subject|0|||
131135055|NCT01489527|472120746|FG001|Overall Study|Withdrawal by Subject|4|||
131135056|NCT01489527|472120745|FG000|Overall Study|Lost to Follow-up|5|||
131135057|NCT01489527|472120746|FG001|Overall Study|Lost to Follow-up|1|||
131135058|NCT01489527|472120745|FG000|Overall Study|Procedures|1|||
131135059|NCT01489527|472120746|FG001|Overall Study|Procedures|0|||
131135060|NCT01489527|472120745|FG000|Overall Study|Not compliant|1|||
131135061|NCT01489527|472120746|FG001|Overall Study|Not compliant|0|||
131135062|NCT01984268|472120747|FG000|Overall Study|Study Terminated|15|||
131135063|NCT01344876|472120749|FG000|Overall Study|Adverse Event|0|||
131135064|NCT01344876|472120750|FG001|Overall Study|Adverse Event|0|||
131135065|NCT01344876|472120751|FG002|Overall Study|Adverse Event|0|||
131135066|NCT01344876|472120752|FG003|Overall Study|Adverse Event|0|||
131135067|NCT01344876|472120753|FG004|Overall Study|Adverse Event|1|||
131135068|NCT01344876|472120749|FG000|Overall Study|Withdrawal by Subject|0|||
131135069|NCT01344876|472120750|FG001|Overall Study|Withdrawal by Subject|0|||
131135070|NCT01344876|472120751|FG002|Overall Study|Withdrawal by Subject|1|||
131135071|NCT01344876|472120752|FG003|Overall Study|Withdrawal by Subject|0|||
131135072|NCT01344876|472120753|FG004|Overall Study|Withdrawal by Subject|0|||
131135073|NCT01344876|472120749|FG000|Overall Study|Definite progression of primary disease|1|||
131135074|NCT01344876|472120750|FG001|Overall Study|Definite progression of primary disease|0|||
131135075|NCT01344876|472120751|FG002|Overall Study|Definite progression of primary disease|0|||
131135076|NCT01344876|472120752|FG003|Overall Study|Definite progression of primary disease|3|||
131135077|NCT01344876|472120753|FG004|Overall Study|Definite progression of primary disease|0|||
131135078|NCT02926950|472120754|FG000|Overall Study|Adverse Event|4|||
131135079|NCT02926950|472120755|FG001|Overall Study|Adverse Event|6|||
131135080|NCT02926950|472120754|FG000|Overall Study|At the participant's own request|21|||
131135081|NCT02926950|472120755|FG001|Overall Study|At the participant's own request|25|||
131135082|NCT02926950|472120754|FG000|Overall Study|Reason not Specified|17|||
131135083|NCT02926950|472120755|FG001|Overall Study|Reason not Specified|9|||
131135084|NCT02926950|472120754|FG000|Overall Study|Lost to Follow-up|7|||
131135085|NCT02926950|472120755|FG001|Overall Study|Lost to Follow-up|8|||
131135086|NCT00049673|472122376|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
131135087|NCT00049673|472122377|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
131135088|NCT02475681|472122378|FG000|Overall Study|Death|16|||
131135089|NCT02475681|472122379|FG001|Overall Study|Death|6|||
131135090|NCT02475681|472122380|FG002|Overall Study|Death|9|||
131135091|NCT02475681|472122378|FG000|Overall Study|Physician Decision|0|||
131135092|NCT02475681|472122379|FG001|Overall Study|Physician Decision|3|||
131135093|NCT02475681|472122380|FG002|Overall Study|Physician Decision|1|||
131135094|NCT02475681|472122378|FG000|Overall Study|Withdrawal by Subject|12|||
131135095|NCT02475681|472122379|FG001|Overall Study|Withdrawal by Subject|6|||
131135096|NCT02475681|472122380|FG002|Overall Study|Withdrawal by Subject|9|||
131135097|NCT02475681|472122378|FG000|Overall Study|Lost to Follow-up|2|||
131135098|NCT02475681|472122379|FG001|Overall Study|Lost to Follow-up|1|||
131135099|NCT02475681|472122380|FG002|Overall Study|Lost to Follow-up|3|||
131135100|NCT02475681|472122378|FG000|Overall Study|Ongoing in Study|0|||
131135101|NCT02475681|472122379|FG001|Overall Study|Ongoing in Study|163|||
131135102|NCT02475681|472122380|FG002|Overall Study|Ongoing in Study|157|||
131135103|NCT02475681|472122378|FG000|Overall Study|Reasons other than above listed|2|||
131135104|NCT02475681|472122379|FG001|Overall Study|Reasons other than above listed|0|||
131135105|NCT02475681|472122380|FG002|Overall Study|Reasons other than above listed|0|||
131135106|NCT01262365|472122383|FG000|Overall Study|Lack of Efficacy|35|||
131135107|NCT01262365|472122384|FG001|Overall Study|Lack of Efficacy|30|||
131135108|NCT01262365|472122385|FG002|Overall Study|Lack of Efficacy|47|||
131135109|NCT01262365|472122383|FG000|Overall Study|Protocol Violation|3|||
131135110|NCT01262365|472122384|FG001|Overall Study|Protocol Violation|1|||
131135111|NCT01262365|472122385|FG002|Overall Study|Protocol Violation|1|||
131135112|NCT01262365|472122383|FG000|Overall Study|Lost to Follow-up|3|||
131135113|NCT01262365|472122384|FG001|Overall Study|Lost to Follow-up|7|||
131135114|NCT01262365|472122385|FG002|Overall Study|Lost to Follow-up|6|||
131135115|NCT01262365|472122383|FG000|Overall Study|Withdrawal by Subject|17|||
131135116|NCT01262365|472122384|FG001|Overall Study|Withdrawal by Subject|22|||
131135117|NCT01262365|472122385|FG002|Overall Study|Withdrawal by Subject|22|||
131135118|NCT01262365|472122383|FG000|Overall Study|Death|1|||
131135119|NCT01262365|472122384|FG001|Overall Study|Death|2|||
131135120|NCT01262365|472122385|FG002|Overall Study|Death|1|||
131135121|NCT01262365|472122383|FG000|Overall Study|Adverse Event|26|||
131135122|NCT01262365|472122384|FG001|Overall Study|Adverse Event|16|||
131135123|NCT01262365|472122385|FG002|Overall Study|Adverse Event|11|||
130779299|NCT01004978|470819486|FG001|Overall Study|Withdrawal by Subject|16|||
131135124|NCT01262365|472122383|FG000|Overall Study|sponsor decision|1|||
131135125|NCT01262365|472122384|FG001|Overall Study|sponsor decision|1|||
130779300|NCT01004978|470819485|FG000|Overall Study|Alternative therapy|4|||
130779301|NCT01004978|470819486|FG001|Overall Study|Alternative therapy|8|||
130779302|NCT01004978|470819485|FG000|Overall Study|Physician Decision|6|||
130779303|NCT01004978|470819486|FG001|Overall Study|Physician Decision|3|||
130779304|NCT01004978|470819485|FG000|Overall Study|Other complicating disease|2|||
130779305|NCT01004978|470819486|FG001|Overall Study|Other complicating disease|2|||
131135126|NCT01262365|472122385|FG002|Overall Study|sponsor decision|0|||
130779306|NCT01004978|470819485|FG000|Overall Study|Protocol Violation|2|||
131135127|NCT01262365|472122383|FG000|Overall Study|Randomization error|1|||
130722118|NCT03400943|470608167|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
130722119|NCT03400943|470608168|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
130722120|NCT03400943|470608169|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
130722121|NCT03400943|470608170|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
130722122|NCT03400943|470608167|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
130722123|NCT03400943|470608168|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
130722124|NCT03400943|470608169|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
131050973|NCT05580003|471820752|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050974|NCT05580003|471820753|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050975|NCT05580003|471820754|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050976|NCT05580003|471820755|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050977|NCT05580003|471820756|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050978|NCT05580003|471820757|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050979|NCT05580003|471820758|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050980|NCT05580003|471820759|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
131050981|NCT05580003|471820760|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050982|NCT05580003|471820761|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050983|NCT05580003|471820762|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050984|NCT05580003|471820763|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050985|NCT05580003|471820764|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050986|NCT05580003|471820765|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
131050987|NCT05580003|471820738|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050988|NCT05580003|471820739|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050989|NCT05580003|471820740|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050990|NCT05580003|471820741|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050991|NCT05580003|471820742|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050992|NCT05580003|471820743|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050993|NCT05580003|471820744|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050994|NCT05580003|471820745|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050995|NCT05580003|471820746|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050996|NCT05580003|471820747|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050997|NCT05580003|471820748|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050998|NCT05580003|471820749|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131050999|NCT05580003|471820750|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051000|NCT05580003|471820751|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051001|NCT05580003|471820752|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051002|NCT05580003|471820753|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051003|NCT05580003|471820754|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051004|NCT05580003|471820755|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051005|NCT05580003|471820756|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051006|NCT05580003|471820757|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051007|NCT05580003|471820758|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051008|NCT05580003|471820759|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051009|NCT05580003|471820760|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051010|NCT05580003|471820761|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051011|NCT05580003|471820762|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051012|NCT05580003|471820763|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051013|NCT05580003|471820764|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
131051014|NCT05580003|471820765|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
131051015|NCT05580003|471820738|FG000|Part 6 Period 2 (Day 1)|Other|0|||
131051016|NCT05580003|471820739|FG001|Part 6 Period 2 (Day 1)|Other|0|||
131051017|NCT05580003|471820740|FG002|Part 6 Period 2 (Day 1)|Other|0|||
131051018|NCT05580003|471820741|FG003|Part 6 Period 2 (Day 1)|Other|0|||
131051019|NCT05580003|471820742|FG004|Part 6 Period 2 (Day 1)|Other|0|||
131051020|NCT05580003|471820743|FG005|Part 6 Period 2 (Day 1)|Other|0|||
131051021|NCT05580003|471820744|FG006|Part 6 Period 2 (Day 1)|Other|0|||
131051022|NCT05580003|471820745|FG007|Part 6 Period 2 (Day 1)|Other|0|||
131051023|NCT05580003|471820746|FG008|Part 6 Period 2 (Day 1)|Other|0|||
131051024|NCT05580003|471820747|FG009|Part 6 Period 2 (Day 1)|Other|0|||
131051025|NCT05580003|471820748|FG010|Part 6 Period 2 (Day 1)|Other|0|||
131051026|NCT05580003|471820749|FG011|Part 6 Period 2 (Day 1)|Other|0|||
131051027|NCT05580003|471820750|FG012|Part 6 Period 2 (Day 1)|Other|0|||
131051028|NCT05580003|471820751|FG013|Part 6 Period 2 (Day 1)|Other|0|||
131051029|NCT05580003|471820752|FG014|Part 6 Period 2 (Day 1)|Other|0|||
131051030|NCT05580003|471820753|FG015|Part 6 Period 2 (Day 1)|Other|0|||
131051031|NCT05580003|471820754|FG016|Part 6 Period 2 (Day 1)|Other|0|||
131051032|NCT05580003|471820755|FG017|Part 6 Period 2 (Day 1)|Other|0|||
131051033|NCT05580003|471820756|FG018|Part 6 Period 2 (Day 1)|Other|0|||
131051034|NCT05580003|471820757|FG019|Part 6 Period 2 (Day 1)|Other|0|||
131051035|NCT05580003|471820758|FG020|Part 6 Period 2 (Day 1)|Other|0|||
131051036|NCT05580003|471820759|FG021|Part 6 Period 2 (Day 1)|Other|0|||
131051037|NCT05580003|471820760|FG022|Part 6 Period 2 (Day 1)|Other|0|||
131051038|NCT05580003|471820761|FG023|Part 6 Period 2 (Day 1)|Other|0|||
131051039|NCT05580003|471820762|FG024|Part 6 Period 2 (Day 1)|Other|1|||
131051040|NCT05580003|471820763|FG025|Part 6 Period 2 (Day 1)|Other|0|||
131051041|NCT05580003|471820764|FG026|Part 6 Period 2 (Day 1)|Other|0|||
131051042|NCT05580003|471820765|FG027|Part 6 Period 2 (Day 1)|Other|0|||
130722125|NCT03400943|470608170|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
130722126|NCT03400943|470608167|FG000|Post-treatment Period 1|Other|2|||
130722127|NCT03400943|470608168|FG001|Post-treatment Period 1|Other|0|||
130722128|NCT03400943|470608169|FG002|Post-treatment Period 1|Other|4|||
131051043|NCT02029235|471820766|FG000|Overall Study|Non-compliance with study meds or diary|4|||
131051044|NCT02029235|471820767|FG001|Overall Study|Non-compliance with study meds or diary|1|||
131051045|NCT01387516|471820768|FG000|Overall Study|Lost to Follow-up|4|||
131051046|NCT01387516|471820769|FG001|Overall Study|Lost to Follow-up|4|||
131051047|NCT01387516|471820770|FG002|Overall Study|Lost to Follow-up|2|||
131051048|NCT01387516|471820771|FG003|Overall Study|Lost to Follow-up|3|||
131051049|NCT01387516|471820768|FG000|Overall Study|Withdrawal by Subject|1|||
131051050|NCT01387516|471820769|FG001|Overall Study|Withdrawal by Subject|1|||
131051051|NCT01387516|471820770|FG002|Overall Study|Withdrawal by Subject|2|||
131051052|NCT01387516|471820771|FG003|Overall Study|Withdrawal by Subject|0|||
131051053|NCT01387516|471820768|FG000|Overall Study|Death|0|||
131051054|NCT01387516|471820769|FG001|Overall Study|Death|0|||
131051055|NCT01387516|471820770|FG002|Overall Study|Death|0|||
131051056|NCT01387516|471820771|FG003|Overall Study|Death|1|||
131051057|NCT00701701|471820773|FG000|Overall Study|Withdrawal by Subject|0|||
131051058|NCT00701701|471820774|FG001|Overall Study|Withdrawal by Subject|1|||
131051059|NCT00701701|471820773|FG000|Overall Study|Adverse Event|0|||
131051060|NCT00701701|471820774|FG001|Overall Study|Adverse Event|1|||
131051061|NCT00589875|471820775|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
131051062|NCT00589875|471820775|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
131051063|NCT05139992|471820776|FG000|Overall Study|Withdrawal by Subject|12|||
131051064|NCT05139992|471820776|FG000|Overall Study|Lost to Follow-up|6|||
131051065|NCT04305327|471820777|FG000|Overall Study|Study early termination|2|||
131051066|NCT04305327|471820778|FG001|Overall Study|Study early termination|5|||
131051067|NCT04305327|471820779|FG002|Overall Study|Study early termination|2|||
131051068|NCT04305327|471820780|FG003|Overall Study|Study early termination|2|||
131051069|NCT04305327|471820777|FG000|Overall Study|Withdrawal by Subject|0|||
131051070|NCT04305327|471820778|FG001|Overall Study|Withdrawal by Subject|1|||
131051071|NCT04305327|471820779|FG002|Overall Study|Withdrawal by Subject|0|||
131051072|NCT04305327|471820780|FG003|Overall Study|Withdrawal by Subject|0|||
131051073|NCT03593226|471820781|FG000|Overall Study|Disease progression|6|||
131051074|NCT03593226|471820782|FG001|Overall Study|Disease progression|13|||
131051075|NCT03593226|471820783|FG002|Overall Study|Disease progression|5|||
131051076|NCT03593226|471820784|FG003|Overall Study|Disease progression|6|||
131051077|NCT03593226|471820781|FG000|Overall Study|Adverse Event|0|||
131051078|NCT03593226|471820782|FG001|Overall Study|Adverse Event|1|||
131051079|NCT03593226|471820783|FG002|Overall Study|Adverse Event|0|||
131051080|NCT03593226|471820784|FG003|Overall Study|Adverse Event|0|||
131051081|NCT03593226|471820781|FG000|Overall Study|Withdrawal by Subject|0|||
131051082|NCT03593226|471820782|FG001|Overall Study|Withdrawal by Subject|4|||
131051083|NCT03593226|471820783|FG002|Overall Study|Withdrawal by Subject|1|||
131051084|NCT03593226|471820784|FG003|Overall Study|Withdrawal by Subject|0|||
131051085|NCT03593226|471820781|FG000|Overall Study|Physician Decision|0|||
131051086|NCT03593226|471820782|FG001|Overall Study|Physician Decision|1|||
131051087|NCT03593226|471820783|FG002|Overall Study|Physician Decision|0|||
131051088|NCT03593226|471820784|FG003|Overall Study|Physician Decision|0|||
131051089|NCT03593226|471820781|FG000|Overall Study|Clinical disease progression|0|||
131135128|NCT01262365|472122384|FG001|Overall Study|Randomization error|0|||
131135129|NCT01262365|472122385|FG002|Overall Study|Randomization error|2|||
131135130|NCT01262365|472122383|FG000|Overall Study|Non-compliance|1|||
131135131|NCT01262365|472122384|FG001|Overall Study|Non-compliance|0|||
131135132|NCT01262365|472122385|FG002|Overall Study|Non-compliance|2|||
131135133|NCT01262365|472122383|FG000|Overall Study|Suspected pregnancy|1|||
131135134|NCT01262365|472122384|FG001|Overall Study|Suspected pregnancy|0|||
131135135|NCT01262365|472122385|FG002|Overall Study|Suspected pregnancy|0|||
131135136|NCT01262365|472122383|FG000|Overall Study|Patient pregnant|1|||
131135137|NCT01262365|472122384|FG001|Overall Study|Patient pregnant|0|||
131135138|NCT01262365|472122385|FG002|Overall Study|Patient pregnant|1|||
131135139|NCT01262365|472122383|FG000|Overall Study|Toxicity related to study drug|0|||
131135140|NCT01262365|472122384|FG001|Overall Study|Toxicity related to study drug|1|||
131135141|NCT01262365|472122385|FG002|Overall Study|Toxicity related to study drug|0|||
131135142|NCT01262365|472122383|FG000|Overall Study|Cannot tolerate the protocol|0|||
130722129|NCT03400943|470608170|FG003|Post-treatment Period 1|Other|5|||
131051090|NCT03593226|471820782|FG001|Overall Study|Clinical disease progression|0|||
131051091|NCT03593226|471820783|FG002|Overall Study|Clinical disease progression|1|||
131051092|NCT03593226|471820784|FG003|Overall Study|Clinical disease progression|0|||
131051093|NCT04517435|471820801|FG000|Overall Study|Withdrawal by Subject|0|||
131135143|NCT01262365|472122384|FG001|Overall Study|Cannot tolerate the protocol|1|||
131135144|NCT01262365|472122385|FG002|Overall Study|Cannot tolerate the protocol|0|||
131135145|NCT01262365|472122383|FG000|Overall Study|Patient unavailable|0|||
131051094|NCT04517435|471820802|FG001|Overall Study|Withdrawal by Subject|0|||
131051095|NCT04517435|471820803|FG002|Overall Study|Withdrawal by Subject|1|||
131051096|NCT04517435|471820801|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
131051097|NCT04517435|471820802|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
131051098|NCT04517435|471820803|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
131051099|NCT04057131|471820804|FG000|Overall Study|Protocol Violation|24|||
131051100|NCT03160885|471820805|FG000|Initial Treatment Period|Not dosed|2|||
131051101|NCT03160885|471820806|FG001|Initial Treatment Period|Not dosed|0|||
131051102|NCT03160885|471820807|FG002|Initial Treatment Period|Not dosed|0|||
131051103|NCT03160885|471820808|FG003|Initial Treatment Period|Not dosed|0|||
131051104|NCT03160885|471820809|FG004|Initial Treatment Period|Not dosed|0|||
131051105|NCT03160885|471820810|FG005|Initial Treatment Period|Not dosed|0|||
131051106|NCT03160885|471820811|FG006|Initial Treatment Period|Not dosed|0|||
131051107|NCT03160885|471820805|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
131051108|NCT03160885|471820806|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
131051109|NCT03160885|471820807|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131051110|NCT03160885|471820808|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131051111|NCT03160885|471820809|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131051112|NCT03160885|471820810|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131051113|NCT03160885|471820811|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
131051114|NCT03160885|471820805|FG000|Open-label Treatment|Not dosed|0|||
131051115|NCT03160885|471820806|FG001|Open-label Treatment|Not dosed|0|||
131051116|NCT03160885|471820807|FG002|Open-label Treatment|Not dosed|0|||
131051117|NCT03160885|471820808|FG003|Open-label Treatment|Not dosed|0|||
131051118|NCT03160885|471820809|FG004|Open-label Treatment|Not dosed|0|||
131051119|NCT03160885|471820810|FG005|Open-label Treatment|Not dosed|0|||
131051120|NCT03160885|471820811|FG006|Open-label Treatment|Not dosed|2|||
131051121|NCT03160885|471820805|FG000|Open-label Treatment|Discontinued IMP|0|||
131051122|NCT03160885|471820806|FG001|Open-label Treatment|Discontinued IMP|0|||
131051123|NCT03160885|471820807|FG002|Open-label Treatment|Discontinued IMP|0|||
131051124|NCT03160885|471820808|FG003|Open-label Treatment|Discontinued IMP|0|||
131051125|NCT03160885|471820809|FG004|Open-label Treatment|Discontinued IMP|0|||
131051126|NCT03160885|471820810|FG005|Open-label Treatment|Discontinued IMP|0|||
131051127|NCT03160885|471820811|FG006|Open-label Treatment|Discontinued IMP|131|||
131051128|NCT03160885|471820805|FG000|Open-label Treatment|Completed Week 50|0|||
131051129|NCT03160885|471820806|FG001|Open-label Treatment|Completed Week 50|0|||
131051130|NCT03160885|471820807|FG002|Open-label Treatment|Completed Week 50|0|||
131051131|NCT03160885|471820808|FG003|Open-label Treatment|Completed Week 50|0|||
131051132|NCT03160885|471820809|FG004|Open-label Treatment|Completed Week 50|0|||
131051133|NCT03160885|471820810|FG005|Open-label Treatment|Completed Week 50|0|||
131051134|NCT03160885|471820811|FG006|Open-label Treatment|Completed Week 50|4|||
131051135|NCT03160885|471820805|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131051136|NCT03160885|471820806|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131051137|NCT03160885|471820807|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131051138|NCT03160885|471820808|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
131051139|NCT03160885|471820809|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131051140|NCT03160885|471820810|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131051141|NCT03160885|471820811|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
131051142|NCT03160885|471820805|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
131051143|NCT03160885|471820806|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
131051144|NCT03160885|471820807|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
131051145|NCT03160885|471820808|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
131051146|NCT03160885|471820809|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
131051147|NCT03160885|471820810|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
131051148|NCT03160885|471820811|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
131051149|NCT03160885|471820805|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131051150|NCT03160885|471820806|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131051151|NCT03160885|471820807|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
131051152|NCT03160885|471820808|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
131051153|NCT03160885|471820809|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
131051154|NCT03160885|471820810|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
131051155|NCT03160885|471820811|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
131051156|NCT03160885|471820805|FG000|Maintenance Treatment Period|Completed Week 50|0|||
131051157|NCT03160885|471820806|FG001|Maintenance Treatment Period|Completed Week 50|0|||
131051158|NCT03160885|471820807|FG002|Maintenance Treatment Period|Completed Week 50|1|||
131051159|NCT03160885|471820808|FG003|Maintenance Treatment Period|Completed Week 50|0|||
131051160|NCT03160885|471820809|FG004|Maintenance Treatment Period|Completed Week 50|0|||
131051161|NCT03160885|471820810|FG005|Maintenance Treatment Period|Completed Week 50|0|||
131051162|NCT03160885|471820811|FG006|Maintenance Treatment Period|Completed Week 50|0|||
130779307|NCT01004978|470819486|FG001|Overall Study|Protocol Violation|3|||
131051163|NCT05704725|471820815|FG000|Overall Study|Lost to Follow-up|0|||
131051164|NCT05704725|471820816|FG001|Overall Study|Lost to Follow-up|1|||
131051165|NCT05704725|471820815|FG000|Overall Study|Withdrawal by Subject|1|||
131051166|NCT05704725|471820816|FG001|Overall Study|Withdrawal by Subject|0|||
131051167|NCT05529992|471820817|FG000|Overall Study|Withdrawal by Subject|1|||
131051168|NCT00210106|471822144|FG000|Overall Study|Death|1|||
131051169|NCT00210106|471822144|FG000|Overall Study|Protocol Violation|13|||
131051170|NCT04213807|471822152|FG000|Overall Study|Physician Decision|0|||
131051171|NCT04213807|471822153|FG001|Overall Study|Physician Decision|0|||
131051172|NCT04213807|471822154|FG002|Overall Study|Physician Decision|1|||
131051173|NCT00945321|471822155|FG000|Period 1|Adverse Event|0|||
131051174|NCT00945321|471822156|FG001|Period 1|Adverse Event|0|||
131051175|NCT00945321|471822157|FG002|Period 1|Adverse Event|0|||
131051176|NCT00945321|471822158|FG003|Period 1|Adverse Event|0|||
131051177|NCT00945321|471822159|FG004|Period 1|Adverse Event|1|||
131051178|NCT00945321|471822160|FG005|Period 1|Adverse Event|0|||
131051179|NCT00945321|471822155|FG000|Period 4|Lost to Follow-up|0|||
131051180|NCT00945321|471822156|FG001|Period 4|Lost to Follow-up|0|||
131051181|NCT00945321|471822157|FG002|Period 4|Lost to Follow-up|0|||
131051182|NCT00945321|471822158|FG003|Period 4|Lost to Follow-up|0|||
131051183|NCT00945321|471822159|FG004|Period 4|Lost to Follow-up|0|||
131051184|NCT00945321|471822160|FG005|Period 4|Lost to Follow-up|1|||
131051185|NCT02633215|471822161|FG000|Overall Study|Lost to Follow-up|2|||
131051186|NCT02633215|471822162|FG001|Overall Study|Lost to Follow-up|3|||
131051187|NCT00692913|471822163|FG000|Overall Study|Adverse Event|8|||
131051188|NCT00692913|471822164|FG001|Overall Study|Adverse Event|4|||
131051189|NCT00692913|471822163|FG000|Overall Study|Lost to Follow-up|3|||
131051190|NCT00692913|471822164|FG001|Overall Study|Lost to Follow-up|5|||
131051191|NCT00692913|471822163|FG000|Overall Study|Physician Decision|2|||
131051192|NCT00692913|471822164|FG001|Overall Study|Physician Decision|0|||
131051193|NCT00692913|471822163|FG000|Overall Study|Protocol Violation|1|||
131051194|NCT00692913|471822164|FG001|Overall Study|Protocol Violation|1|||
130722130|NCT03400943|470608167|FG000|Treatment Period 2|Study terminated by sponsor|0|||
130722131|NCT03400943|470608168|FG001|Treatment Period 2|Study terminated by sponsor|1|||
130722132|NCT03400943|470608169|FG002|Treatment Period 2|Study terminated by sponsor|0|||
131051195|NCT00692913|471822163|FG000|Overall Study|Withdrawal by Subject|15|||
130722133|NCT03400943|470608170|FG003|Treatment Period 2|Study terminated by sponsor|0|||
131051196|NCT00692913|471822164|FG001|Overall Study|Withdrawal by Subject|20|||
131051197|NCT04017611|471822165|FG000|Overall Study|Withdrawn prior to completion|1|||
131051198|NCT02291913|471822166|FG000|Overall Study|Progressive Disease|32|||
131051199|NCT02291913|471822166|FG000|Overall Study|Adverse Event|11|||
131051200|NCT02291913|471822166|FG000|Overall Study|Death|2|||
131051201|NCT02291913|471822166|FG000|Overall Study|Physician Decision|1|||
131051202|NCT02291913|471822166|FG000|Overall Study|Withdrawal by Subject|1|||
131051203|NCT02291913|471822166|FG000|Overall Study|Protocol Violation|1|||
131051204|NCT01268306|471822175|FG000|Overall Study|Lost to Follow-up|1|||
131051205|NCT04334317|471822176|FG000|Overall Study|Adverse Event|1|||
131051206|NCT04334317|471822177|FG001|Overall Study|Adverse Event|2|||
131051207|NCT04334317|471822178|FG002|Overall Study|Adverse Event|0|||
131051208|NCT04334317|471822179|FG003|Overall Study|Adverse Event|0|||
131051209|NCT04334317|471822176|FG000|Overall Study|Protocol Deviation|0|||
131051210|NCT04334317|471822177|FG001|Overall Study|Protocol Deviation|1|||
131051211|NCT04334317|471822178|FG002|Overall Study|Protocol Deviation|0|||
131051212|NCT04334317|471822179|FG003|Overall Study|Protocol Deviation|0|||
131051213|NCT04334317|471822176|FG000|Overall Study|Withdrawal by Subject|2|||
131051214|NCT04334317|471822177|FG001|Overall Study|Withdrawal by Subject|2|||
131051215|NCT04334317|471822178|FG002|Overall Study|Withdrawal by Subject|0|||
131051216|NCT04334317|471822179|FG003|Overall Study|Withdrawal by Subject|0|||
131051217|NCT01128595|471822180|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131051218|NCT01128595|471822181|FG001|Treatment Period 3|Withdrawal by Subject|1|||
131051219|NCT01128595|471822182|FG002|Treatment Period 3|Withdrawal by Subject|0|||
131051220|NCT01128595|471822183|FG003|Treatment Period 3|Withdrawal by Subject|0|||
131051221|NCT00605306|471822184|FG000|Overall Study|Adverse Event|0|||
131051222|NCT00605306|471822185|FG001|Overall Study|Adverse Event|1|||
131051223|NCT00372775|471822186|FG000|Overall Study|Adverse Event|8|||
131051224|NCT00372775|471822186|FG000|Overall Study|Death|15|||
131051225|NCT00372775|471822186|FG000|Overall Study|Objective progression or relapse|30|||
131051226|NCT00372775|471822186|FG000|Overall Study|Global deterioration of health status|6|||
131051227|NCT00372775|471822186|FG000|Overall Study|Withdrawal by Subject|1|||
131051228|NCT00372775|471822186|FG000|Overall Study|Other|1|||
131051229|NCT00372775|471822186|FG000|Overall Study|Not Treated|2|||
131051230|NCT00336505|471822187|FG000|Overall Study|Adverse Event|10|||
131051231|NCT00336505|471822188|FG001|Overall Study|Adverse Event|9|||
131051232|NCT00336505|471822187|FG000|Overall Study|Lack of Efficacy|8|||
131051233|NCT00336505|471822188|FG001|Overall Study|Lack of Efficacy|4|||
131051234|NCT00336505|471822187|FG000|Overall Study|Lost to Follow-up|7|||
131051235|NCT00336505|471822188|FG001|Overall Study|Lost to Follow-up|4|||
131051236|NCT00336505|471822187|FG000|Overall Study|Withdrawal by Subject|5|||
131051237|NCT00336505|471822188|FG001|Overall Study|Withdrawal by Subject|3|||
131051238|NCT00336505|471822187|FG000|Overall Study|Other|7|||
130722134|NCT03400943|470608167|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130722135|NCT03400943|470608168|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130722136|NCT03400943|470608169|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130722137|NCT03400943|470608170|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130722138|NCT03400943|470608167|FG000|Treatment Period 2|Other|1|||
130722139|NCT03400943|470608168|FG001|Treatment Period 2|Other|6|||
130722140|NCT03400943|470608169|FG002|Treatment Period 2|Other|0|||
130722141|NCT03400943|470608170|FG003|Treatment Period 2|Other|0|||
130722142|NCT03400943|470608167|FG000|Follow-up Period|Withdrawal by Subject|1|||
130722143|NCT03400943|470608168|FG001|Follow-up Period|Withdrawal by Subject|0|||
130722144|NCT03400943|470608169|FG002|Follow-up Period|Withdrawal by Subject|0|||
130722145|NCT03400943|470608170|FG003|Follow-up Period|Withdrawal by Subject|0|||
131051239|NCT00336505|471822188|FG001|Overall Study|Other|7|||
131051240|NCT00366249|471822189|FG000|Overall Study|Adverse Event|53|||
131051241|NCT00366249|471822190|FG001|Overall Study|Adverse Event|28|||
131051242|NCT00366249|471822189|FG000|Overall Study|Death|0|||
131051243|NCT00366249|471822190|FG001|Overall Study|Death|1|||
131051244|NCT00366249|471822189|FG000|Overall Study|Physician Decision|5|||
131051245|NCT00366249|471822190|FG001|Overall Study|Physician Decision|2|||
131051246|NCT00366249|471822189|FG000|Overall Study|Lost to Follow-up|2|||
131051247|NCT00366249|471822190|FG001|Overall Study|Lost to Follow-up|0|||
131051248|NCT00366249|471822189|FG000|Overall Study|Protocol Violation|1|||
131051249|NCT00366249|471822190|FG001|Overall Study|Protocol Violation|2|||
131051250|NCT00366249|471822189|FG000|Overall Study|Withdrawal by Subject|18|||
131051251|NCT00366249|471822190|FG001|Overall Study|Withdrawal by Subject|4|||
131051252|NCT00366249|471822189|FG000|Overall Study|Lack of Efficacy|21|||
131051253|NCT00366249|471822190|FG001|Overall Study|Lack of Efficacy|21|||
131051254|NCT00366249|471822189|FG000|Overall Study|Most due to osteomylitis status|31|||
131051255|NCT00366249|471822190|FG001|Overall Study|Most due to osteomylitis status|20|||
131051256|NCT00724126|471822192|FG000|Overall Study|Adverse Event|2|||
131051257|NCT00724126|471822193|FG001|Overall Study|Adverse Event|0|||
131051258|NCT00724126|471822192|FG000|Overall Study|Withdrawal by Subject|8|||
131051259|NCT00724126|471822193|FG001|Overall Study|Withdrawal by Subject|6|||
131051260|NCT00724126|471822192|FG000|Overall Study|Lost to Follow-up|6|||
131051261|NCT00724126|471822193|FG001|Overall Study|Lost to Follow-up|6|||
131051262|NCT00724126|471822192|FG000|Overall Study|Noncompliance|2|||
131051263|NCT00724126|471822193|FG001|Overall Study|Noncompliance|1|||
131051264|NCT00724126|471822192|FG000|Overall Study|Subject randomized although ineligible|1|||
131051265|NCT00724126|471822193|FG001|Overall Study|Subject randomized although ineligible|1|||
131051266|NCT00724126|471822192|FG000|Overall Study|Subject had to leave vicinity of site|0|||
131051267|NCT00724126|471822193|FG001|Overall Study|Subject had to leave vicinity of site|1|||
131051268|NCT01436175|471822194|FG000|Overall Study|Adverse Event|111|||
131135146|NCT01262365|472122384|FG001|Overall Study|Patient unavailable|0|||
131135147|NCT01262365|472122385|FG002|Overall Study|Patient unavailable|1|||
131135148|NCT02322710|472122387|FG000|Overall Study|No efficacy assessment post-baseline|0|||
131135149|NCT02322710|472122388|FG001|Overall Study|No efficacy assessment post-baseline|1|||
131135150|NCT02322710|472122387|FG000|Overall Study|Protocol Violation|20|||
131135151|NCT02322710|472122388|FG001|Overall Study|Protocol Violation|25|||
131135152|NCT04161131|472122389|FG000|Overall Study|Ineligible|2|||
131135153|NCT04161131|472122389|FG000|Overall Study|Lost to Follow-up|4|||
131135154|NCT03733392|472122390|FG000|Overall Study|Withdrawal by Subject|11|||
131135155|NCT03733392|472122391|FG001|Overall Study|Withdrawal by Subject|1|||
131135156|NCT03733392|472122390|FG000|Overall Study|Death|1|||
131135157|NCT03733392|472122391|FG001|Overall Study|Death|0|||
131135158|NCT03733392|472122390|FG000|Overall Study|Lost to Follow-up|5|||
131135159|NCT03733392|472122391|FG001|Overall Study|Lost to Follow-up|0|||
131135160|NCT03733392|472122390|FG000|Overall Study|Protocol Violation|0|||
131135161|NCT03733392|472122391|FG001|Overall Study|Protocol Violation|1|||
131135162|NCT03733392|472122390|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
131135163|NCT03733392|472122391|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
131135164|NCT03733392|472122390|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
131135165|NCT03733392|472122391|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
130722146|NCT02563106|470608171|FG000|Overall Study|Withdrawal by Subject|7|||
130722147|NCT02563106|470608172|FG001|Overall Study|Withdrawal by Subject|8|||
130722148|NCT02563106|470608171|FG000|Overall Study|Adverse Event|17|||
131135166|NCT03733392|472122390|FG000|Overall Study|Patient Non-Compliance|2|||
131135167|NCT03733392|472122391|FG001|Overall Study|Patient Non-Compliance|1|||
130722149|NCT02563106|470608172|FG001|Overall Study|Adverse Event|15|||
130722150|NCT02563106|470608171|FG000|Overall Study|Protocol Violation|1|||
131051269|NCT01436175|471822194|FG000|Overall Study|Protocol Violation|49|||
130722151|NCT02563106|470608172|FG001|Overall Study|Protocol Violation|0|||
130722152|NCT02563106|470608171|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
131051270|NCT01436175|471822194|FG000|Overall Study|Withdrawal by Subject|108|||
131051271|NCT01436175|471822194|FG000|Overall Study|Lost to Follow-up|89|||
131051272|NCT01436175|471822194|FG000|Overall Study|Lack of Efficacy|24|||
131135168|NCT03733392|472122390|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
131051273|NCT01436175|471822194|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
131051274|NCT01436175|471822194|FG000|Overall Study|Other|826|||
131051275|NCT03418922|471822195|FG000|Overall Study|Withdrawal by Subject|0|||
131051276|NCT03418922|471822196|FG001|Overall Study|Withdrawal by Subject|2|||
131051277|NCT03418922|471822195|FG000|Overall Study|Adverse Event|2|||
131051278|NCT03418922|471822196|FG001|Overall Study|Adverse Event|2|||
131051279|NCT03418922|471822195|FG000|Overall Study|Death|0|||
131051280|NCT03418922|471822196|FG001|Overall Study|Death|1|||
131051281|NCT03418922|471822195|FG000|Overall Study|Physician Decision|0|||
131051282|NCT03418922|471822196|FG001|Overall Study|Physician Decision|1|||
131051283|NCT03577106|471822197|FG000|Overall Study|Withdrawal by Subject|3|||
131051284|NCT04860505|471822201|FG000|Overall Study|Lost to Follow-up|2|||
131051285|NCT03066609|471822204|FG000|INDUCTION|Pregnancy|0|||
131051286|NCT03066609|471822205|FG001|INDUCTION|Pregnancy|0|||
131051287|NCT03066609|471822206|FG002|INDUCTION|Pregnancy|1|||
131051288|NCT03066609|471822207|FG003|INDUCTION|Pregnancy|0|||
131051289|NCT03066609|471822204|FG000|INDUCTION|Lack of Efficacy|0|||
131051290|NCT03066609|471822205|FG001|INDUCTION|Lack of Efficacy|0|||
131051291|NCT03066609|471822206|FG002|INDUCTION|Lack of Efficacy|1|||
131051292|NCT03066609|471822207|FG003|INDUCTION|Lack of Efficacy|0|||
131051293|NCT03066609|471822204|FG000|INDUCTION|Adverse Event|2|||
131051294|NCT03066609|471822205|FG001|INDUCTION|Adverse Event|2|||
131051295|NCT03066609|471822206|FG002|INDUCTION|Adverse Event|0|||
131051296|NCT03066609|471822207|FG003|INDUCTION|Adverse Event|0|||
131051297|NCT03066609|471822204|FG000|MAINTENANCE|Adverse Event|0|||
131051298|NCT03066609|471822205|FG001|MAINTENANCE|Adverse Event|0|||
131051299|NCT03066609|471822206|FG002|MAINTENANCE|Adverse Event|0|||
131051300|NCT03066609|471822207|FG003|MAINTENANCE|Adverse Event|1|||
131051301|NCT03066609|471822204|FG000|MAINTENANCE|Withdrawal by Subject|4|||
131051302|NCT03066609|471822205|FG001|MAINTENANCE|Withdrawal by Subject|2|||
131051303|NCT03066609|471822206|FG002|MAINTENANCE|Withdrawal by Subject|1|||
130722153|NCT02563106|470608172|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
130722154|NCT02563106|470608171|FG000|Overall Study|Lost to Follow-up|3|||
130722155|NCT02563106|470608172|FG001|Overall Study|Lost to Follow-up|2|||
130722156|NCT02563106|470608171|FG000|Overall Study|Physician Decision|3|||
130722157|NCT02563106|470608172|FG001|Overall Study|Physician Decision|1|||
131051304|NCT03066609|471822207|FG003|MAINTENANCE|Withdrawal by Subject|1|||
131051305|NCT03066609|471822204|FG000|MAINTENANCE|Lost to Follow-up|0|||
131051306|NCT03066609|471822205|FG001|MAINTENANCE|Lost to Follow-up|1|||
131051307|NCT03066609|471822206|FG002|MAINTENANCE|Lost to Follow-up|1|||
131051308|NCT03066609|471822207|FG003|MAINTENANCE|Lost to Follow-up|0|||
131051309|NCT03066609|471822204|FG000|MAINTENANCE|Pregnancy|1|||
131051310|NCT03066609|471822205|FG001|MAINTENANCE|Pregnancy|0|||
131051311|NCT03066609|471822206|FG002|MAINTENANCE|Pregnancy|0|||
131135169|NCT03733392|472122391|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
131135170|NCT03733392|472122390|FG000|Overall Study|Withdrawal prior to procedure|5|||
131135171|NCT03733392|472122391|FG001|Overall Study|Withdrawal prior to procedure|2|||
131135172|NCT04316585|472122392|FG000|Overall Study|Adverse Event|2|||
131135173|NCT04316585|472122393|FG001|Overall Study|Adverse Event|1|||
131135174|NCT04316585|472122392|FG000|Overall Study|Lost to Follow-up|1|||
131135175|NCT04316585|472122393|FG001|Overall Study|Lost to Follow-up|0|||
131135176|NCT04316585|472122392|FG000|Overall Study|Withdrawal by Subject|2|||
131135177|NCT04316585|472122393|FG001|Overall Study|Withdrawal by Subject|3|||
131135178|NCT04316585|472122392|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
131135179|NCT04316585|472122393|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
131135180|NCT04316585|472122392|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
131135181|NCT04316585|472122393|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
131135182|NCT00984204|472122405|FG000|Overall Study|Death|1|||
131135183|NCT00984204|472122405|FG000|Overall Study|Lost to Follow-up|4|||
131135184|NCT00984204|472122405|FG000|Overall Study|Lack of Efficacy|10|||
130722158|NCT02563106|470608171|FG000|Overall Study|Other reason - not specified|2|||
131051312|NCT03066609|471822207|FG003|MAINTENANCE|Pregnancy|0|||
131135185|NCT00699348|472122406|FG000|Overall Study|Death|6|||
131051313|NCT03066609|471822204|FG000|MAINTENANCE|Lack of Efficacy|2|||
131135186|NCT00699348|472122406|FG000|Overall Study|Adverse Event|15|||
131135187|NCT00699348|472122406|FG000|Overall Study|Withdrawal by Subject|11|||
130722159|NCT02563106|470608172|FG001|Overall Study|Other reason - not specified|1|||
131051314|NCT03066609|471822205|FG001|MAINTENANCE|Lack of Efficacy|1|||
131051315|NCT03066609|471822206|FG002|MAINTENANCE|Lack of Efficacy|0|||
131051316|NCT03066609|471822207|FG003|MAINTENANCE|Lack of Efficacy|1|||
131051317|NCT03066609|471822204|FG000|OVERALL STUDY|Adverse Event|2|||
131051318|NCT03066609|471822205|FG001|OVERALL STUDY|Adverse Event|2|||
131051319|NCT03066609|471822206|FG002|OVERALL STUDY|Adverse Event|0|||
131051320|NCT03066609|471822207|FG003|OVERALL STUDY|Adverse Event|1|||
131051321|NCT03066609|471822204|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
131135188|NCT00699348|472122406|FG000|Overall Study|Protocol Violation|10|||
131135189|NCT00699348|472122406|FG000|Overall Study|Lack of Efficacy|8|||
131135190|NCT00699348|472122406|FG000|Overall Study|Failure to return|1|||
131135191|NCT00699348|472122406|FG000|Overall Study|Blood transfusion|24|||
130722160|NCT01059539|470608173|FG000|Overall Study|Adverse Event|66|||
131135192|NCT00699348|472122406|FG000|Overall Study|Renal transplantation|10|||
131135193|NCT00699348|472122406|FG000|Overall Study|Other|5|||
131135194|NCT01407926|472122415|FG000|Overall Study|Lost to Follow-up|55|||
131135195|NCT02814565|472122416|FG000|Overall Study|Lack of Efficacy|0|||
131135196|NCT02814565|472122417|FG001|Overall Study|Lack of Efficacy|1|||
131135197|NCT02814565|472122416|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
131135198|NCT02814565|472122417|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
131135199|NCT04656652|472122418|FG000|Overall Study|Lost to Follow-up|2|||
131135200|NCT04656652|472122419|FG001|Overall Study|Lost to Follow-up|2|||
131135201|NCT04656652|472122418|FG000|Overall Study|Death|213|||
131135202|NCT04656652|472122419|FG001|Overall Study|Death|212|||
131135203|NCT04656652|472122418|FG000|Overall Study|Other|1|||
131135204|NCT04656652|472122419|FG001|Overall Study|Other|0|||
131135205|NCT04656652|472122418|FG000|Overall Study|Withdrawal by Subject|15|||
131135206|NCT04656652|472122419|FG001|Overall Study|Withdrawal by Subject|29|||
131135207|NCT01885000|472122422|FG000|Overall Study|Adverse Event|1|||
130722161|NCT01059539|470608173|FG000|Overall Study|Insufficient Therapeutic Response|26|||
131051322|NCT03066609|471822205|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
131051323|NCT03066609|471822206|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
131135208|NCT01885000|472122423|FG001|Overall Study|Adverse Event|0|||
131135209|NCT01885000|472122422|FG000|Overall Study|Withdrawal by Subject|1|||
131135210|NCT01885000|472122423|FG001|Overall Study|Withdrawal by Subject|1|||
131135211|NCT01885000|472122422|FG000|Overall Study|Protocol Violation|0|||
131135212|NCT01885000|472122423|FG001|Overall Study|Protocol Violation|1|||
131135213|NCT03124784|472122424|FG000|Overall Study|Adverse Event|1|||
131135214|NCT03124784|472122424|FG000|Overall Study|Computer/Equip Malfunction|1|||
131135215|NCT05702515|472122425|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
131135216|NCT01777152|472122430|FG000|Overall Study|Withdrawal by Subject|22|||
131051324|NCT03066609|471822207|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
131051325|NCT03066609|471822204|FG000|OVERALL STUDY|Lost to Follow-up|1|||
131135217|NCT01777152|472122431|FG001|Overall Study|Withdrawal by Subject|16|||
131135218|NCT01777152|472122430|FG000|Overall Study|Lost to Follow-up|3|||
131135219|NCT01777152|472122431|FG001|Overall Study|Lost to Follow-up|5|||
131135220|NCT01777152|472122430|FG000|Overall Study|Death|68|||
131135221|NCT01777152|472122431|FG001|Overall Study|Death|89|||
131135222|NCT01777152|472122430|FG000|Overall Study|Not eligible, no study drug received|1|||
131135223|NCT01777152|472122431|FG001|Overall Study|Not eligible, no study drug received|0|||
131135224|NCT01777152|472122430|FG000|Overall Study|Change of diagnosis|1|||
131135225|NCT01777152|472122431|FG001|Overall Study|Change of diagnosis|0|||
131051326|NCT03066609|471822205|FG001|OVERALL STUDY|Lost to Follow-up|1|||
131051327|NCT03066609|471822206|FG002|OVERALL STUDY|Lost to Follow-up|1|||
131051328|NCT03066609|471822207|FG003|OVERALL STUDY|Lost to Follow-up|1|||
131051329|NCT03066609|471822204|FG000|OVERALL STUDY|Pregnancy|1|||
131051330|NCT03066609|471822205|FG001|OVERALL STUDY|Pregnancy|0|||
131051331|NCT03066609|471822206|FG002|OVERALL STUDY|Pregnancy|1|||
131051332|NCT03066609|471822207|FG003|OVERALL STUDY|Pregnancy|0|||
131051333|NCT03066609|471822204|FG000|OVERALL STUDY|Lack of Efficacy|2|||
131051334|NCT03066609|471822205|FG001|OVERALL STUDY|Lack of Efficacy|1|||
131051335|NCT03066609|471822206|FG002|OVERALL STUDY|Lack of Efficacy|1|||
131051336|NCT03066609|471822207|FG003|OVERALL STUDY|Lack of Efficacy|1|||
131051337|NCT03066609|471822204|FG000|OVERALL STUDY|discontinued follow up|0|||
131051338|NCT03066609|471822205|FG001|OVERALL STUDY|discontinued follow up|2|||
131051339|NCT03066609|471822206|FG002|OVERALL STUDY|discontinued follow up|0|||
131051340|NCT03066609|471822207|FG003|OVERALL STUDY|discontinued follow up|0|||
131051341|NCT00293397|471822211|FG000|Overall Study|Death|2|||
131051342|NCT00523419|471822213|FG000|Overall Study|Adverse Event|1|||
131051343|NCT00523419|471822213|FG000|Overall Study|Withdrawal by Subject|1|||
131051344|NCT00523419|471822213|FG000|Overall Study|Physician Decision|2|||
131051345|NCT00523419|471822213|FG000|Overall Study|Progressive Disease|22|||
131051346|NCT00523419|471822213|FG000|Overall Study|Death due to Study Disease|4|||
131051347|NCT00523419|471822213|FG000|Overall Study|Death due to Adverse Event|2|||
131051348|NCT00822120|471822214|FG000|Initial Registration|Adverse Event|1|||
131135226|NCT02792842|472122434|FG000|Overall Study|Adverse Event|4|||
131135227|NCT02792842|472122435|FG001|Overall Study|Adverse Event|2|||
131135228|NCT02792842|472122436|FG002|Overall Study|Adverse Event|3|||
131135229|NCT02792842|472122434|FG000|Overall Study|Withdrawal by Subject|0|||
131135230|NCT02792842|472122435|FG001|Overall Study|Withdrawal by Subject|1|||
130722162|NCT01059539|470608173|FG000|Overall Study|Protocol Violation|55|||
131051349|NCT00822120|471822215|FG001|Initial Registration|Adverse Event|0|||
131051350|NCT00822120|471822216|FG002|Initial Registration|Adverse Event|0|||
131051351|NCT00822120|471822217|FG003|Initial Registration|Adverse Event|0|||
131051352|NCT00822120|471822218|FG004|Initial Registration|Adverse Event|0|||
131135231|NCT02792842|472122436|FG002|Overall Study|Withdrawal by Subject|2|||
131135232|NCT02792842|472122434|FG000|Overall Study|Lost to Follow-up|0|||
131135233|NCT02792842|472122435|FG001|Overall Study|Lost to Follow-up|0|||
131135234|NCT02792842|472122436|FG002|Overall Study|Lost to Follow-up|1|||
131135235|NCT02792842|472122434|FG000|Overall Study|Schedule delay|0|||
131135236|NCT02792842|472122435|FG001|Overall Study|Schedule delay|1|||
131051353|NCT00822120|471822219|FG005|Initial Registration|Adverse Event|0|||
131051354|NCT00822120|471822214|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
131051355|NCT00822120|471822215|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131051356|NCT00822120|471822216|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131051357|NCT00822120|471822217|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131051358|NCT00822120|471822218|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131051359|NCT00822120|471822219|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131051360|NCT00822120|471822214|FG000|Initial Registration|Reasons not Protocol Specified|2|||
131051361|NCT00822120|471822215|FG001|Initial Registration|Reasons not Protocol Specified|0|||
131051362|NCT00822120|471822216|FG002|Initial Registration|Reasons not Protocol Specified|0|||
131051363|NCT00822120|471822217|FG003|Initial Registration|Reasons not Protocol Specified|0|||
131051364|NCT00822120|471822218|FG004|Initial Registration|Reasons not Protocol Specified|0|||
131051365|NCT00822120|471822219|FG005|Initial Registration|Reasons not Protocol Specified|0|||
131051366|NCT00822120|471822214|FG000|Initial Registration|Ineligible|22|||
131051367|NCT00822120|471822215|FG001|Initial Registration|Ineligible|1|||
131051368|NCT00822120|471822216|FG002|Initial Registration|Ineligible|0|||
131051369|NCT00822120|471822217|FG003|Initial Registration|Ineligible|0|||
131051370|NCT00822120|471822218|FG004|Initial Registration|Ineligible|0|||
131051371|NCT00822120|471822219|FG005|Initial Registration|Ineligible|0|||
131051372|NCT00822120|471822214|FG000|PET-directed Therapy|Adverse Event|0|||
131051373|NCT00822120|471822215|FG001|PET-directed Therapy|Adverse Event|0|||
130722163|NCT01059539|470608173|FG000|Overall Study|Withdrawal of Consent|80|||
130722164|NCT01059539|470608173|FG000|Overall Study|Lost to Follow-up|42|||
130722165|NCT01059539|470608173|FG000|Overall Study|Reason Not Specified|2|||
130722166|NCT04091659|470608174|FG000|Overall Study|Protocol Violation|3|||
130722167|NCT04091659|470608175|FG001|Overall Study|Protocol Violation|0|||
130722168|NCT04091659|470608174|FG000|Overall Study|Lost to Follow-up|0|||
131051374|NCT00822120|471822216|FG002|PET-directed Therapy|Adverse Event|0|||
131051375|NCT00822120|471822217|FG003|PET-directed Therapy|Adverse Event|1|||
131051376|NCT00822120|471822218|FG004|PET-directed Therapy|Adverse Event|0|||
131051377|NCT00822120|471822219|FG005|PET-directed Therapy|Adverse Event|0|||
131051378|NCT00822120|471822214|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
131051379|NCT00822120|471822215|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
131051380|NCT00822120|471822216|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
131051381|NCT00822120|471822217|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
131051382|NCT00822120|471822218|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
131051383|NCT00822120|471822219|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
131051384|NCT00822120|471822214|FG000|PET-directed Therapy|Death|0|||
131051385|NCT00822120|471822215|FG001|PET-directed Therapy|Death|0|||
131051386|NCT00822120|471822216|FG002|PET-directed Therapy|Death|0|||
131051387|NCT00822120|471822217|FG003|PET-directed Therapy|Death|2|||
131051388|NCT00822120|471822218|FG004|PET-directed Therapy|Death|0|||
131051389|NCT00822120|471822219|FG005|PET-directed Therapy|Death|0|||
131051390|NCT00822120|471822214|FG000|PET-directed Therapy|Protocol Violation|0|||
131051391|NCT00822120|471822215|FG001|PET-directed Therapy|Protocol Violation|0|||
131051392|NCT00822120|471822216|FG002|PET-directed Therapy|Protocol Violation|0|||
131051393|NCT00822120|471822217|FG003|PET-directed Therapy|Protocol Violation|6|||
131051394|NCT00822120|471822218|FG004|PET-directed Therapy|Protocol Violation|0|||
131051395|NCT00822120|471822219|FG005|PET-directed Therapy|Protocol Violation|0|||
131051396|NCT01218009|471822220|FG000|Overall Study|Protocol Violation|2|||
131051397|NCT01218009|471822221|FG001|Overall Study|Protocol Violation|1|||
131051398|NCT01218009|471822220|FG000|Overall Study|Withdrawal by Subject|3|||
131051399|NCT01218009|471822221|FG001|Overall Study|Withdrawal by Subject|1|||
131051400|NCT01218009|471822220|FG000|Overall Study|Sponsor terminated study|161|||
131051401|NCT01218009|471822221|FG001|Overall Study|Sponsor terminated study|163|||
131051402|NCT00503906|471822222|FG000|Overall Study|Withdrawal by Subject|1|||
131051403|NCT00811941|471822223|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
131051404|NCT00811941|471822224|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
131051405|NCT00811941|471822223|FG000|All Treated Patients|Adverse Event|2|||
131051406|NCT00811941|471822224|FG001|All Treated Patients|Adverse Event|43|||
131051407|NCT00811941|471822223|FG000|All Treated Patients|Lack of Efficacy|2|||
131051408|NCT00811941|471822224|FG001|All Treated Patients|Lack of Efficacy|3|||
131051409|NCT00811941|471822223|FG000|All Treated Patients|Non-compliance|1|||
131051410|NCT00811941|471822224|FG001|All Treated Patients|Non-compliance|8|||
131051411|NCT00811941|471822223|FG000|All Treated Patients|Protocol Violation|5|||
131051412|NCT00811941|471822224|FG001|All Treated Patients|Protocol Violation|17|||
131051413|NCT00811941|471822223|FG000|All Treated Patients|Withdrawal by Subject|35|||
131051414|NCT00811941|471822224|FG001|All Treated Patients|Withdrawal by Subject|94|||
131051415|NCT00811941|471822223|FG000|All Treated Patients|Lost to Follow-up|3|||
131051416|NCT00811941|471822224|FG001|All Treated Patients|Lost to Follow-up|12|||
131051417|NCT00811941|471822223|FG000|All Treated Patients|Other Reason|4|||
131051418|NCT00811941|471822224|FG001|All Treated Patients|Other Reason|14|||
130722169|NCT04091659|470608175|FG001|Overall Study|Lost to Follow-up|1|||
130722170|NCT03678285|470608180|FG000|Overall Study|Adverse Event|2|||
130722171|NCT03678285|470608180|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
130722172|NCT03678285|470608180|FG000|Overall Study|Dehydrated prior to start of workout|1|||
130722173|NCT00616629|470608181|FG000|Overall Study|Protocol Violation|1|||
131051419|NCT03802994|471822225|FG000|Overall Study|Lost to Follow-up|0|||
131051420|NCT03802994|471822226|FG001|Overall Study|Lost to Follow-up|2|||
131051421|NCT03802994|471822227|FG002|Overall Study|Lost to Follow-up|3|||
131051422|NCT03802994|471822228|FG003|Overall Study|Lost to Follow-up|2|||
131051423|NCT03802994|471822229|FG004|Overall Study|Lost to Follow-up|2|||
131051424|NCT00622700|471822233|FG000|Core Treatment Period|Randomized but Not Treated|0|||
131051425|NCT00622700|471822234|FG001|Core Treatment Period|Randomized but Not Treated|2|||
131051426|NCT00622700|471822235|FG002|Core Treatment Period|Randomized but Not Treated|2|||
131051427|NCT00622700|471822236|FG003|Core Treatment Period|Randomized but Not Treated|0|||
131051428|NCT00622700|471822237|FG004|Core Treatment Period|Randomized but Not Treated|0|||
131051429|NCT00622700|471822238|FG005|Core Treatment Period|Randomized but Not Treated|0|||
131051430|NCT00622700|471822239|FG006|Core Treatment Period|Randomized but Not Treated|0|||
131051431|NCT00622700|471822233|FG000|Core Treatment Period|Adverse Event|18|||
131051432|NCT00622700|471822234|FG001|Core Treatment Period|Adverse Event|25|||
131051433|NCT00622700|471822235|FG002|Core Treatment Period|Adverse Event|18|||
131051434|NCT00622700|471822236|FG003|Core Treatment Period|Adverse Event|0|||
131051435|NCT00622700|471822237|FG004|Core Treatment Period|Adverse Event|0|||
131051436|NCT00622700|471822238|FG005|Core Treatment Period|Adverse Event|0|||
131051437|NCT00622700|471822239|FG006|Core Treatment Period|Adverse Event|0|||
131051438|NCT00622700|471822233|FG000|Core Treatment Period|Lack of Efficacy|19|||
131051439|NCT00622700|471822234|FG001|Core Treatment Period|Lack of Efficacy|6|||
131051440|NCT00622700|471822235|FG002|Core Treatment Period|Lack of Efficacy|12|||
131051441|NCT00622700|471822236|FG003|Core Treatment Period|Lack of Efficacy|0|||
131051442|NCT00622700|471822237|FG004|Core Treatment Period|Lack of Efficacy|0|||
131051443|NCT00622700|471822238|FG005|Core Treatment Period|Lack of Efficacy|0|||
131051444|NCT00622700|471822239|FG006|Core Treatment Period|Lack of Efficacy|0|||
131051445|NCT00622700|471822233|FG000|Core Treatment Period|Lost to Follow-up|1|||
131051446|NCT00622700|471822234|FG001|Core Treatment Period|Lost to Follow-up|1|||
131051447|NCT00622700|471822235|FG002|Core Treatment Period|Lost to Follow-up|1|||
131051448|NCT00622700|471822236|FG003|Core Treatment Period|Lost to Follow-up|0|||
131051449|NCT00622700|471822237|FG004|Core Treatment Period|Lost to Follow-up|0|||
131051450|NCT00622700|471822238|FG005|Core Treatment Period|Lost to Follow-up|0|||
131051451|NCT00622700|471822239|FG006|Core Treatment Period|Lost to Follow-up|0|||
131051452|NCT00622700|471822233|FG000|Core Treatment Period|Death|1|||
131051453|NCT00622700|471822234|FG001|Core Treatment Period|Death|0|||
131051454|NCT00622700|471822235|FG002|Core Treatment Period|Death|0|||
131051455|NCT00622700|471822236|FG003|Core Treatment Period|Death|0|||
131051456|NCT00622700|471822237|FG004|Core Treatment Period|Death|0|||
131051457|NCT00622700|471822238|FG005|Core Treatment Period|Death|0|||
131051458|NCT00622700|471822239|FG006|Core Treatment Period|Death|0|||
131051459|NCT00622700|471822233|FG000|Core Treatment Period|Progressive Disease|3|||
131051460|NCT00622700|471822234|FG001|Core Treatment Period|Progressive Disease|1|||
131051461|NCT00622700|471822235|FG002|Core Treatment Period|Progressive Disease|0|||
131051462|NCT00622700|471822236|FG003|Core Treatment Period|Progressive Disease|0|||
131051463|NCT00622700|471822237|FG004|Core Treatment Period|Progressive Disease|0|||
131051464|NCT00622700|471822238|FG005|Core Treatment Period|Progressive Disease|0|||
131135237|NCT02792842|472122436|FG002|Overall Study|Schedule delay|1|||
131135238|NCT02469090|472122437|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
131135239|NCT02469090|472122438|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
131135240|NCT02469090|472122439|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
131051465|NCT00622700|471822239|FG006|Core Treatment Period|Progressive Disease|0|||
131051466|NCT00622700|471822233|FG000|Core Treatment Period|Withdrawal by Subject|12|||
131051467|NCT00622700|471822234|FG001|Core Treatment Period|Withdrawal by Subject|18|||
131051468|NCT00622700|471822235|FG002|Core Treatment Period|Withdrawal by Subject|15|||
131051469|NCT00622700|471822236|FG003|Core Treatment Period|Withdrawal by Subject|0|||
131051470|NCT00622700|471822237|FG004|Core Treatment Period|Withdrawal by Subject|0|||
131051471|NCT00622700|471822238|FG005|Core Treatment Period|Withdrawal by Subject|0|||
131051472|NCT00622700|471822239|FG006|Core Treatment Period|Withdrawal by Subject|0|||
131051473|NCT00622700|471822233|FG000|Core Treatment Period|Other than specified above|2|||
131051474|NCT00622700|471822234|FG001|Core Treatment Period|Other than specified above|2|||
131051475|NCT00622700|471822235|FG002|Core Treatment Period|Other than specified above|5|||
131051476|NCT00622700|471822236|FG003|Core Treatment Period|Other than specified above|0|||
130722174|NCT00616629|470608182|FG001|Overall Study|Protocol Violation|2|||
131051477|NCT00622700|471822237|FG004|Core Treatment Period|Other than specified above|0|||
131051478|NCT00622700|471822238|FG005|Core Treatment Period|Other than specified above|0|||
131051479|NCT00622700|471822239|FG006|Core Treatment Period|Other than specified above|0|||
131051480|NCT00622700|471822233|FG000|Extension Treatment Period|Adverse Event|0|||
131051481|NCT00622700|471822234|FG001|Extension Treatment Period|Adverse Event|0|||
131051482|NCT00622700|471822235|FG002|Extension Treatment Period|Adverse Event|0|||
131051483|NCT00622700|471822236|FG003|Extension Treatment Period|Adverse Event|5|||
131051484|NCT00622700|471822237|FG004|Extension Treatment Period|Adverse Event|9|||
131051485|NCT00622700|471822238|FG005|Extension Treatment Period|Adverse Event|6|||
131051486|NCT00622700|471822239|FG006|Extension Treatment Period|Adverse Event|8|||
131051487|NCT00622700|471822233|FG000|Extension Treatment Period|Lack of Efficacy|0|||
131051488|NCT00622700|471822234|FG001|Extension Treatment Period|Lack of Efficacy|0|||
131051489|NCT00622700|471822235|FG002|Extension Treatment Period|Lack of Efficacy|0|||
131051490|NCT00622700|471822236|FG003|Extension Treatment Period|Lack of Efficacy|2|||
131051491|NCT00622700|471822237|FG004|Extension Treatment Period|Lack of Efficacy|8|||
131051492|NCT00622700|471822238|FG005|Extension Treatment Period|Lack of Efficacy|1|||
131051493|NCT00622700|471822239|FG006|Extension Treatment Period|Lack of Efficacy|9|||
131051494|NCT00622700|471822233|FG000|Extension Treatment Period|Protocol Violation|0|||
131051495|NCT00622700|471822234|FG001|Extension Treatment Period|Protocol Violation|0|||
131051496|NCT00622700|471822235|FG002|Extension Treatment Period|Protocol Violation|0|||
131051497|NCT00622700|471822236|FG003|Extension Treatment Period|Protocol Violation|0|||
131051498|NCT00622700|471822237|FG004|Extension Treatment Period|Protocol Violation|0|||
131051499|NCT00622700|471822238|FG005|Extension Treatment Period|Protocol Violation|2|||
131051500|NCT00622700|471822239|FG006|Extension Treatment Period|Protocol Violation|0|||
131051501|NCT00622700|471822233|FG000|Extension Treatment Period|Lost to Follow-up|0|||
131051502|NCT00622700|471822234|FG001|Extension Treatment Period|Lost to Follow-up|0|||
131051503|NCT00622700|471822235|FG002|Extension Treatment Period|Lost to Follow-up|0|||
131051504|NCT00622700|471822236|FG003|Extension Treatment Period|Lost to Follow-up|0|||
131051505|NCT00622700|471822237|FG004|Extension Treatment Period|Lost to Follow-up|1|||
131051506|NCT00622700|471822238|FG005|Extension Treatment Period|Lost to Follow-up|0|||
131051507|NCT00622700|471822239|FG006|Extension Treatment Period|Lost to Follow-up|0|||
131051508|NCT00622700|471822233|FG000|Extension Treatment Period|Progressive Disease|0|||
131051509|NCT00622700|471822234|FG001|Extension Treatment Period|Progressive Disease|0|||
131051510|NCT00622700|471822235|FG002|Extension Treatment Period|Progressive Disease|0|||
131051511|NCT00622700|471822236|FG003|Extension Treatment Period|Progressive Disease|1|||
131051512|NCT00622700|471822237|FG004|Extension Treatment Period|Progressive Disease|2|||
131051513|NCT00622700|471822238|FG005|Extension Treatment Period|Progressive Disease|0|||
131051514|NCT00622700|471822239|FG006|Extension Treatment Period|Progressive Disease|2|||
131051515|NCT00622700|471822233|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
131051516|NCT00622700|471822234|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
131051517|NCT00622700|471822235|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
131051518|NCT00622700|471822236|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
131051519|NCT00622700|471822237|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
131051520|NCT00622700|471822238|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
131051521|NCT00622700|471822239|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
131051522|NCT00622700|471822233|FG000|Extension Treatment Period|Missing|0|||
131051523|NCT00622700|471822234|FG001|Extension Treatment Period|Missing|0|||
131051524|NCT00622700|471822235|FG002|Extension Treatment Period|Missing|0|||
131051525|NCT00622700|471822236|FG003|Extension Treatment Period|Missing|2|||
131051526|NCT00622700|471822237|FG004|Extension Treatment Period|Missing|3|||
131051527|NCT00622700|471822238|FG005|Extension Treatment Period|Missing|1|||
131051528|NCT00622700|471822239|FG006|Extension Treatment Period|Missing|0|||
131051529|NCT00622700|471822233|FG000|Extension Treatment Period|Other than specified above|0|||
131051530|NCT00622700|471822234|FG001|Extension Treatment Period|Other than specified above|0|||
131051531|NCT00622700|471822235|FG002|Extension Treatment Period|Other than specified above|0|||
131051532|NCT00622700|471822236|FG003|Extension Treatment Period|Other than specified above|0|||
131051533|NCT00622700|471822237|FG004|Extension Treatment Period|Other than specified above|0|||
131051534|NCT00622700|471822238|FG005|Extension Treatment Period|Other than specified above|1|||
131051535|NCT00622700|471822239|FG006|Extension Treatment Period|Other than specified above|1|||
131051536|NCT02646618|471822240|FG000|Overall Study|Lost to Follow-up|10|||
131051537|NCT02646618|471822241|FG001|Overall Study|Lost to Follow-up|14|||
131051538|NCT00390884|471822242|FG000|Overall Study|Withdrawal by Subject|2|||
131051539|NCT00390884|471822243|FG001|Overall Study|Withdrawal by Subject|2|||
131051540|NCT04035447|471822244|FG000|Treatment Period|Lost to Follow-up|6|||
131051541|NCT04035447|471822245|FG001|Treatment Period|Lost to Follow-up|5|||
131051542|NCT04035447|471822244|FG000|Treatment Period|Physician Decision|0|||
131051543|NCT04035447|471822245|FG001|Treatment Period|Physician Decision|2|||
131051544|NCT02130557|471822246|FG000|Overall Study|Withdrawal by Subject|12|||
131051545|NCT02130557|471822247|FG001|Overall Study|Withdrawal by Subject|12|||
131051546|NCT02130557|471822246|FG000|Overall Study|Investigator Request|0|||
131051547|NCT02130557|471822247|FG001|Overall Study|Investigator Request|2|||
131051548|NCT02130557|471822246|FG000|Overall Study|Deceased|14|||
130722175|NCT00616629|470608183|FG002|Overall Study|Protocol Violation|1|||
130722176|NCT00616629|470608184|FG003|Overall Study|Protocol Violation|0|||
130722177|NCT00616629|470608185|FG004|Overall Study|Protocol Violation|0|||
130722178|NCT00616629|470608181|FG000|Overall Study|AV-block|1|||
130722179|NCT00616629|470608182|FG001|Overall Study|AV-block|0|||
130722180|NCT00616629|470608183|FG002|Overall Study|AV-block|0|||
131051549|NCT02130557|471822247|FG001|Overall Study|Deceased|14|||
130722181|NCT00616629|470608184|FG003|Overall Study|AV-block|0|||
131051550|NCT02130557|471822246|FG000|Overall Study|Lost to Follow-up|6|||
131051551|NCT02130557|471822247|FG001|Overall Study|Lost to Follow-up|7|||
131051552|NCT02130557|471822246|FG000|Overall Study|Other|2|||
131051553|NCT02130557|471822247|FG001|Overall Study|Other|1|||
131051554|NCT02130557|471822246|FG000|Overall Study|Missing|2|||
131051555|NCT02130557|471822247|FG001|Overall Study|Missing|1|||
131051556|NCT01855750|471822249|FG000|Overall Study|Death|78|||
131051557|NCT01855750|471822250|FG001|Overall Study|Death|78|||
131051558|NCT01855750|471822249|FG000|Overall Study|Lost to Follow-up|9|||
131051559|NCT01855750|471822250|FG001|Overall Study|Lost to Follow-up|23|||
131051560|NCT01855750|471822249|FG000|Overall Study|Withdrawal by Subject|35|||
131051561|NCT01855750|471822250|FG001|Overall Study|Withdrawal by Subject|28|||
131229643|NCT05751629|472467650|FG000|Overall Study|Withdrawal by Subject|6|||
131229644|NCT05751629|472467650|FG000|Overall Study|Death|25|||
131229645|NCT05751629|472467650|FG000|Overall Study|Study Site Closed|9|||
131229646|NCT05751629|472467650|FG000|Overall Study|Physician Decision|1|||
131051562|NCT01855750|471822249|FG000|Overall Study|Sponsor ends the study|297|||
131051563|NCT01855750|471822250|FG001|Overall Study|Sponsor ends the study|290|||
131051564|NCT04300023|471822251|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
131051565|NCT04300023|471822252|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
131051566|NCT02307682|471822253|FG000|Overall Study|Adverse Event|9|||
131051567|NCT02307682|471822254|FG001|Overall Study|Adverse Event|8|||
131051568|NCT02307682|471822255|FG002|Overall Study|Adverse Event|12|||
131051569|NCT02307682|471822253|FG000|Overall Study|Lack of Efficacy|1|||
131051570|NCT02307682|471822254|FG001|Overall Study|Lack of Efficacy|0|||
131051571|NCT02307682|471822255|FG002|Overall Study|Lack of Efficacy|1|||
131051572|NCT02307682|471822253|FG000|Overall Study|Physician Decision|2|||
131051573|NCT02307682|471822254|FG001|Overall Study|Physician Decision|2|||
131051574|NCT02307682|471822255|FG002|Overall Study|Physician Decision|8|||
131051575|NCT02307682|471822253|FG000|Overall Study|Progressive Disease|1|||
131051576|NCT02307682|471822254|FG001|Overall Study|Progressive Disease|0|||
131051577|NCT02307682|471822255|FG002|Overall Study|Progressive Disease|0|||
131051578|NCT02307682|471822253|FG000|Overall Study|Withdrawal by Subject|26|||
131051579|NCT02307682|471822254|FG001|Overall Study|Withdrawal by Subject|34|||
131051580|NCT02307682|471822255|FG002|Overall Study|Withdrawal by Subject|23|||
131051581|NCT02307682|471822253|FG000|Overall Study|Death|9|||
131051582|NCT02307682|471822254|FG001|Overall Study|Death|7|||
131051583|NCT02307682|471822255|FG002|Overall Study|Death|12|||
131051584|NCT02307682|471822253|FG000|Overall Study|Lost to Follow-up|1|||
131051585|NCT02307682|471822254|FG001|Overall Study|Lost to Follow-up|5|||
131051586|NCT02307682|471822255|FG002|Overall Study|Lost to Follow-up|6|||
131051587|NCT02307682|471822253|FG000|Overall Study|Protocol Deviation|0|||
131051588|NCT02307682|471822254|FG001|Overall Study|Protocol Deviation|0|||
131135241|NCT02469090|472122437|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
131135242|NCT02469090|472122438|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
131135243|NCT02469090|472122439|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
131135244|NCT02469090|472122437|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
131135245|NCT02469090|472122438|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
131135246|NCT02469090|472122439|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
131135247|NCT02469090|472122437|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
131135248|NCT02469090|472122438|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
131135249|NCT02469090|472122439|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
131135250|NCT02469090|472122437|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
131135251|NCT02469090|472122438|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
131135252|NCT02469090|472122439|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
131135253|NCT02469090|472122437|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
131135254|NCT02469090|472122438|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
131051589|NCT02307682|471822255|FG002|Overall Study|Protocol Deviation|2|||
131051590|NCT02307682|471822253|FG000|Overall Study|Other|1|||
131051591|NCT02307682|471822254|FG001|Overall Study|Other|1|||
131051592|NCT02307682|471822255|FG002|Overall Study|Other|0|||
131051593|NCT03227861|471822258|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
131229647|NCT04081337|472467651|FG000|Overall Study|Adverse Event|0|||
130722182|NCT00616629|470608185|FG004|Overall Study|AV-block|0|||
130722183|NCT01777620|470608186|FG000|Overall Study|Subject Withdrawal|1|||
130722184|NCT01777620|470608187|FG001|Overall Study|Subject Withdrawal|0|||
130722185|NCT04005352|470608189|FG000|Overall Study|Adverse Event|4|||
130722186|NCT04005352|470608190|FG001|Overall Study|Adverse Event|5|||
130722187|NCT04005352|470608189|FG000|Overall Study|Death|4|||
131051594|NCT03227861|471822258|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
131051595|NCT03227861|471822258|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
131051596|NCT03227861|471822258|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
131051597|NCT03227861|471822258|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
130722188|NCT04005352|470608190|FG001|Overall Study|Death|2|||
131051598|NCT03227861|471822258|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
131229648|NCT04081337|472467652|FG001|Overall Study|Adverse Event|1|||
131229649|NCT04081337|472467651|FG000|Overall Study|Withdrawal by Subject|2|||
131135255|NCT02469090|472122439|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
131135256|NCT02469090|472122437|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
130722189|NCT04005352|470608189|FG000|Overall Study|Lost to Follow-up|6|||
130722190|NCT04005352|470608190|FG001|Overall Study|Lost to Follow-up|2|||
131135257|NCT02469090|472122438|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
131135258|NCT02469090|472122439|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
131135259|NCT02469090|472122437|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
131135260|NCT02469090|472122438|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
131135261|NCT02469090|472122439|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
130722191|NCT04005352|470608189|FG000|Overall Study|Physician Decision|7|||
130722192|NCT04005352|470608190|FG001|Overall Study|Physician Decision|13|||
130722193|NCT04005352|470608189|FG000|Overall Study|Protocol Violation|0|||
130722194|NCT04005352|470608190|FG001|Overall Study|Protocol Violation|1|||
131051599|NCT03227861|471822258|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
131051600|NCT03227861|471822258|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
131051601|NCT03227861|471822258|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
131051602|NCT03227861|471822258|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
131051603|NCT05349838|471822259|FG000|Overall Study|Virological Failure|1|||
131051604|NCT05349838|471822260|FG001|Overall Study|Virological Failure|2|||
131051605|NCT05349838|471822259|FG000|Overall Study|Withdrawal by Subject|2|||
131051606|NCT05349838|471822260|FG001|Overall Study|Withdrawal by Subject|3|||
131051607|NCT05349838|471822259|FG000|Overall Study|Adverse Event|3|||
131051608|NCT05349838|471822260|FG001|Overall Study|Adverse Event|1|||
131051609|NCT05349838|471822259|FG000|Overall Study|Lost to Follow-up|1|||
131051610|NCT05349838|471822260|FG001|Overall Study|Lost to Follow-up|2|||
131051611|NCT05349838|471822259|FG000|Overall Study|Other reasons|5|||
131051612|NCT05349838|471822260|FG001|Overall Study|Other reasons|1|||
131051613|NCT05071430|471822261|FG000|Overall Study|Adverse Event|1|||
131051614|NCT05071430|471822262|FG001|Overall Study|Adverse Event|2|||
131051615|NCT05071430|471822261|FG000|Overall Study|Lost to Follow-up|4|||
131051616|NCT05071430|471822262|FG001|Overall Study|Lost to Follow-up|4|||
131051617|NCT05071430|471822261|FG000|Overall Study|Protocol Violation|1|||
131051618|NCT05071430|471822262|FG001|Overall Study|Protocol Violation|0|||
131051619|NCT05071430|471822261|FG000|Overall Study|Withdrawal by Subject|3|||
131051620|NCT05071430|471822262|FG001|Overall Study|Withdrawal by Subject|2|||
131051621|NCT05071430|471822261|FG000|Overall Study|Other|1|||
131051622|NCT05071430|471822262|FG001|Overall Study|Other|1|||
131051623|NCT00490139|471822264|FG000|Overall Study|Lost to Follow-up|249|||
131051624|NCT00490139|471822265|FG001|Overall Study|Lost to Follow-up|216|||
131051625|NCT00490139|471822266|FG002|Overall Study|Lost to Follow-up|205|||
131051626|NCT00490139|471822267|FG003|Overall Study|Lost to Follow-up|229|||
131051627|NCT00490139|471822264|FG000|Overall Study|Withdrawal by Subject|333|||
131051628|NCT00490139|471822265|FG001|Overall Study|Withdrawal by Subject|322|||
131051629|NCT00490139|471822266|FG002|Overall Study|Withdrawal by Subject|396|||
131051630|NCT00490139|471822267|FG003|Overall Study|Withdrawal by Subject|295|||
131051631|NCT00490139|471822264|FG000|Overall Study|Patient did not sign ICF 12|169|||
131051632|NCT00490139|471822265|FG001|Overall Study|Patient did not sign ICF 12|176|||
131051633|NCT00490139|471822266|FG002|Overall Study|Patient did not sign ICF 12|139|||
131051634|NCT00490139|471822267|FG003|Overall Study|Patient did not sign ICF 12|167|||
131051635|NCT00490139|471822264|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
131051636|NCT00490139|471822265|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
131051637|NCT00490139|471822266|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
131051638|NCT00490139|471822267|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
131051639|NCT00490139|471822264|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
131051640|NCT00490139|471822265|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
131051641|NCT00490139|471822266|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
131051642|NCT00490139|471822267|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
131051643|NCT00490139|471822264|FG000|Overall Study|Other reasons as defined per protocol|98|||
131051644|NCT00490139|471822265|FG001|Overall Study|Other reasons as defined per protocol|84|||
131051645|NCT00490139|471822266|FG002|Overall Study|Other reasons as defined per protocol|82|||
131051646|NCT00490139|471822267|FG003|Overall Study|Other reasons as defined per protocol|105|||
131051647|NCT04484623|471822268|FG000|Overall Study|Lost to Follow-up|0|||
131051648|NCT04484623|471822269|FG001|Overall Study|Lost to Follow-up|1|||
131051649|NCT04484623|471822268|FG000|Overall Study|Protocol Deviation|1|||
130722195|NCT04005352|470608189|FG000|Overall Study|Withdrawal by Subject|28|||
130722196|NCT04005352|470608190|FG001|Overall Study|Withdrawal by Subject|38|||
130779308|NCT01004978|470819485|FG000|Overall Study|Non-compliance|3|||
131051650|NCT04484623|471822269|FG001|Overall Study|Protocol Deviation|0|||
130779309|NCT01004978|470819486|FG001|Overall Study|Non-compliance|2|||
131051651|NCT04484623|471822268|FG000|Overall Study|Physician Decision|1|||
131051652|NCT04484623|471822269|FG001|Overall Study|Physician Decision|0|||
131051653|NCT04484623|471822268|FG000|Overall Study|Withdrawal by Subject|11|||
131051654|NCT04484623|471822269|FG001|Overall Study|Withdrawal by Subject|8|||
130779310|NCT01004978|470819485|FG000|Overall Study|Ineligible|1|||
131135262|NCT01391507|472122443|FG000|Overall Study|Death|0|||
131135263|NCT01391507|472122444|FG001|Overall Study|Death|0|||
131135264|NCT01391507|472122445|FG002|Overall Study|Death|0|||
131135265|NCT01391507|472122446|FG003|Overall Study|Death|1|||
131135266|NCT01391507|472122443|FG000|Overall Study|Adverse Event|1|||
131135267|NCT01391507|472122444|FG001|Overall Study|Adverse Event|1|||
131135268|NCT01391507|472122445|FG002|Overall Study|Adverse Event|2|||
131135269|NCT01391507|472122446|FG003|Overall Study|Adverse Event|2|||
131135270|NCT01391507|472122443|FG000|Overall Study|Withdrawal by Subject|1|||
131135271|NCT01391507|472122444|FG001|Overall Study|Withdrawal by Subject|2|||
131135272|NCT01391507|472122445|FG002|Overall Study|Withdrawal by Subject|1|||
131135273|NCT01391507|472122446|FG003|Overall Study|Withdrawal by Subject|1|||
131135274|NCT01391507|472122443|FG000|Overall Study|Lack of Efficacy|0|||
131135275|NCT01391507|472122444|FG001|Overall Study|Lack of Efficacy|0|||
131135276|NCT01391507|472122445|FG002|Overall Study|Lack of Efficacy|0|||
131135277|NCT01391507|472122446|FG003|Overall Study|Lack of Efficacy|1|||
131135278|NCT01391507|472122443|FG000|Overall Study|Protocol Violation|2|||
131135279|NCT01391507|472122444|FG001|Overall Study|Protocol Violation|1|||
131051655|NCT04484623|471822268|FG000|Overall Study|Ongoing|94|||
131051656|NCT04484623|471822269|FG001|Overall Study|Ongoing|84|||
131051657|NCT04551066|471822270|FG000|Overall Study|Death|5|||
131051658|NCT04551066|471822271|FG001|Overall Study|Death|3|||
131051659|NCT04551066|471822270|FG000|Overall Study|Lost to Follow-up|1|||
131051660|NCT04551066|471822271|FG001|Overall Study|Lost to Follow-up|0|||
131051661|NCT04551066|471822270|FG000|Overall Study|Sponsor Decision|103|||
131051662|NCT04551066|471822271|FG001|Overall Study|Sponsor Decision|117|||
131051663|NCT04551066|471822270|FG000|Overall Study|Withdrawal by Subject|8|||
131051664|NCT04551066|471822271|FG001|Overall Study|Withdrawal by Subject|2|||
131051665|NCT04551066|471822270|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
131051666|NCT04551066|471822271|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
131051667|NCT04551066|471822270|FG000|Overall Study|Adverse Event|2|||
131051668|NCT04551066|471822271|FG001|Overall Study|Adverse Event|0|||
131051669|NCT04551066|471822270|FG000|Overall Study|Physician Decision|2|||
131051670|NCT04551066|471822271|FG001|Overall Study|Physician Decision|0|||
131051671|NCT04551066|471822270|FG000|Overall Study|Protocol Violation|1|||
131051672|NCT04551066|471822271|FG001|Overall Study|Protocol Violation|0|||
131051673|NCT04551066|471822270|FG000|Overall Study|Lack of Efficacy|0|||
131051674|NCT04551066|471822271|FG001|Overall Study|Lack of Efficacy|1|||
131051675|NCT04551066|471822270|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
131051676|NCT04551066|471822271|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
131051677|NCT02798471|471822272|FG000|Overall Study|Adverse Event|7|||
131051678|NCT02798471|471822273|FG001|Overall Study|Adverse Event|2|||
131051679|NCT02798471|471822272|FG000|Overall Study|Physician Decision|3|||
131051680|NCT02798471|471822273|FG001|Overall Study|Physician Decision|7|||
131051681|NCT02798471|471822272|FG000|Overall Study|Death|2|||
131051682|NCT02798471|471822273|FG001|Overall Study|Death|3|||
131051683|NCT02798471|471822272|FG000|Overall Study|Lost to Follow-up|0|||
131051684|NCT02798471|471822273|FG001|Overall Study|Lost to Follow-up|1|||
131051685|NCT02798471|471822272|FG000|Overall Study|Other|5|||
131051686|NCT02798471|471822273|FG001|Overall Study|Other|3|||
131051687|NCT02798471|471822272|FG000|Overall Study|Subject withdrew consent|0|||
131051688|NCT02798471|471822273|FG001|Overall Study|Subject withdrew consent|6|||
131051689|NCT02798471|471822272|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
131051690|NCT02798471|471822273|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
131051691|NCT02798471|471822272|FG000|Overall Study|Randomized, but not treated|0|||
131051692|NCT02798471|471822273|FG001|Overall Study|Randomized, but not treated|2|||
131051693|NCT04503681|471823651|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
131051694|NCT04503681|471823652|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
131051695|NCT03752684|471823653|FG000|Overall Study|Lost to Follow-up|4|||
131051696|NCT01982682|471823656|FG000|Overall Study|Physician Decision|1|||
131051697|NCT02760654|471823657|FG000|Overall Study|Lost to Follow-up|3|||
131051698|NCT02760654|471823658|FG001|Overall Study|Lost to Follow-up|3|||
131051699|NCT02760654|471823657|FG000|Overall Study|Withdrawal by Subject|4|||
131051700|NCT02760654|471823658|FG001|Overall Study|Withdrawal by Subject|3|||
131051701|NCT01084694|471823660|FG000|Overall Study|Withdrawal by Subject|2|||
131051702|NCT01084694|471823661|FG001|Overall Study|Withdrawal by Subject|1|||
131051703|NCT01084694|471823660|FG000|Overall Study|Death|2|||
131051704|NCT01084694|471823661|FG001|Overall Study|Death|12|||
131051705|NCT01084694|471823660|FG000|Overall Study|eligibility not maintained|2|||
131051706|NCT01084694|471823661|FG001|Overall Study|eligibility not maintained|7|||
131051707|NCT00065182|471823665|FG000|Overall Study|Adverse Event|24|||
131051708|NCT00065182|471823666|FG001|Overall Study|Adverse Event|17|||
131051709|NCT00065182|471823665|FG000|Overall Study|Lost to Follow-up|0|||
131051710|NCT00065182|471823666|FG001|Overall Study|Lost to Follow-up|4|||
131051711|NCT00065182|471823665|FG000|Overall Study|Protocol Violation|3|||
131135280|NCT01391507|472122445|FG002|Overall Study|Protocol Violation|1|||
131135281|NCT01391507|472122446|FG003|Overall Study|Protocol Violation|2|||
131051712|NCT00065182|471823666|FG001|Overall Study|Protocol Violation|4|||
131051713|NCT00065182|471823665|FG000|Overall Study|Serious adverse events (SAE)|1|||
131051714|NCT00065182|471823666|FG001|Overall Study|Serious adverse events (SAE)|0|||
131051715|NCT00065182|471823665|FG000|Overall Study|Sponsor Decision|11|||
131051716|NCT00065182|471823666|FG001|Overall Study|Sponsor Decision|7|||
131051717|NCT00065182|471823665|FG000|Overall Study|Withdrawal by Subject|8|||
131051718|NCT00065182|471823666|FG001|Overall Study|Withdrawal by Subject|3|||
131051719|NCT00065182|471823665|FG000|Overall Study|No clinical benefit|1|||
131051720|NCT00065182|471823666|FG001|Overall Study|No clinical benefit|0|||
131051721|NCT00065182|471823665|FG000|Overall Study|Death|0|||
131051722|NCT00065182|471823666|FG001|Overall Study|Death|1|||
131051723|NCT00065182|471823665|FG000|Overall Study|Decline in Status|0|||
131051724|NCT00065182|471823666|FG001|Overall Study|Decline in Status|1|||
131051725|NCT04876417|471823669|FG000|Overall Study|Lost to Follow-up|5|||
131051726|NCT04876417|471823670|FG001|Overall Study|Lost to Follow-up|8|||
131051727|NCT04876417|471823671|FG002|Overall Study|Lost to Follow-up|0|||
131051728|NCT04876417|471823672|FG003|Overall Study|Lost to Follow-up|0|||
131051729|NCT03801148|471823673|FG000|Period 1 (2 Days)|Adverse Event|1|||
131051730|NCT03801148|471823674|FG001|Period 1 (2 Days)|Adverse Event|1|||
131051731|NCT03801148|471823675|FG002|Period 1 (2 Days)|Adverse Event|0|||
131051732|NCT03801148|471823676|FG003|Period 1 (2 Days)|Adverse Event|0|||
131051733|NCT03801148|471823673|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
131051734|NCT03801148|471823674|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
131051735|NCT03801148|471823675|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
131051736|NCT03801148|471823676|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
131051737|NCT03801148|471823673|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131051738|NCT03801148|471823674|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131051739|NCT03801148|471823675|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
131051740|NCT03801148|471823676|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
131051741|NCT03801148|471823673|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
131051742|NCT03801148|471823674|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
131051743|NCT03801148|471823675|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
131051744|NCT03801148|471823676|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
131051745|NCT02568215|471823680|FG000|Overall Study|Death|1|||
131051746|NCT02568215|471823681|FG001|Overall Study|Death|2|||
131051747|NCT02568215|471823682|FG002|Overall Study|Death|0|||
131051748|NCT02568215|471823680|FG000|Overall Study|Physician Decision|2|||
131051749|NCT02568215|471823681|FG001|Overall Study|Physician Decision|2|||
131051750|NCT02568215|471823682|FG002|Overall Study|Physician Decision|2|||
131051751|NCT02568215|471823680|FG000|Overall Study|Lost to Follow-up|29|||
131051752|NCT02568215|471823681|FG001|Overall Study|Lost to Follow-up|32|||
131051753|NCT02568215|471823682|FG002|Overall Study|Lost to Follow-up|41|||
130722197|NCT00936897|470608193|FG000|Overall Study|Withdrawal by Subject|9|||
130722198|NCT00936897|470608194|FG001|Overall Study|Withdrawal by Subject|19|||
130722199|NCT00936897|470608193|FG000|Overall Study|Adverse Event|4|||
131051754|NCT02568215|471823680|FG000|Overall Study|Withdrawal by Subject|21|||
131051755|NCT02568215|471823681|FG001|Overall Study|Withdrawal by Subject|19|||
131051756|NCT02568215|471823682|FG002|Overall Study|Withdrawal by Subject|22|||
131051757|NCT02568215|471823680|FG000|Overall Study|Protocol Violation|1|||
131051758|NCT02568215|471823681|FG001|Overall Study|Protocol Violation|1|||
131051759|NCT02568215|471823682|FG002|Overall Study|Protocol Violation|0|||
131051760|NCT02568215|471823680|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
131051761|NCT02568215|471823681|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
131051762|NCT02568215|471823682|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
131051763|NCT02568215|471823680|FG000|Overall Study|Other|0|||
131051764|NCT02568215|471823681|FG001|Overall Study|Other|1|||
131051765|NCT02568215|471823682|FG002|Overall Study|Other|4|||
131051766|NCT03478969|471823683|FG000|Overall Study|Withdrawal by Subject|4|||
131051767|NCT03478969|471823684|FG001|Overall Study|Withdrawal by Subject|7|||
131051768|NCT03478969|471823685|FG002|Overall Study|Withdrawal by Subject|6|||
131051769|NCT03478969|471823683|FG000|Overall Study|Adverse Event|2|||
131051770|NCT03478969|471823684|FG001|Overall Study|Adverse Event|0|||
131051771|NCT03478969|471823685|FG002|Overall Study|Adverse Event|1|||
131135282|NCT02926209|472122447|FG000|Study Cohort|Poor Bowel Preparation|1|||
131135283|NCT02926209|472122448|FG001|Study Cohort|Poor Bowel Preparation|0|||
131051772|NCT03478969|471823683|FG000|Overall Study|Pregnancy|1|||
131051773|NCT03478969|471823684|FG001|Overall Study|Pregnancy|0|||
131051774|NCT03478969|471823685|FG002|Overall Study|Pregnancy|0|||
131051775|NCT03478969|471823683|FG000|Overall Study|Personal Reasons|1|||
131051776|NCT03478969|471823684|FG001|Overall Study|Personal Reasons|0|||
130722200|NCT00936897|470608194|FG001|Overall Study|Adverse Event|13|||
131051777|NCT03478969|471823685|FG002|Overall Study|Personal Reasons|1|||
131051778|NCT03478969|471823683|FG000|Overall Study|Covid-19|1|||
131051779|NCT03478969|471823684|FG001|Overall Study|Covid-19|4|||
130722201|NCT00936897|470608193|FG000|Overall Study|Other|3|||
131051780|NCT03478969|471823685|FG002|Overall Study|Covid-19|3|||
131051781|NCT03478969|471823683|FG000|Overall Study|Multiple Reasons|0|||
131051782|NCT03478969|471823684|FG001|Overall Study|Multiple Reasons|1|||
131051783|NCT03478969|471823685|FG002|Overall Study|Multiple Reasons|1|||
131051784|NCT03478969|471823683|FG000|Overall Study|Eligibility Criteria|0|||
131051785|NCT03478969|471823684|FG001|Overall Study|Eligibility Criteria|0|||
131051786|NCT03478969|471823685|FG002|Overall Study|Eligibility Criteria|5|||
131051787|NCT03478969|471823683|FG000|Overall Study|Lost to Follow-up|0|||
131051788|NCT03478969|471823684|FG001|Overall Study|Lost to Follow-up|0|||
131051789|NCT03478969|471823685|FG002|Overall Study|Lost to Follow-up|1|||
131051790|NCT01185600|471823686|FG000|Overall Study|Adverse Event|1|||
131051791|NCT01185600|471823687|FG001|Overall Study|Adverse Event|1|||
131051792|NCT01185600|471823686|FG000|Overall Study|Death|0|||
131051793|NCT01185600|471823687|FG001|Overall Study|Death|1|||
131051794|NCT01185600|471823686|FG000|Overall Study|Lost to Follow-up|0|||
131051795|NCT01185600|471823687|FG001|Overall Study|Lost to Follow-up|5|||
131051796|NCT01185600|471823686|FG000|Overall Study|Physician Decision|29|||
131051797|NCT01185600|471823687|FG001|Overall Study|Physician Decision|35|||
131051798|NCT01185600|471823686|FG000|Overall Study|Withdrawal by Subject|1|||
131051799|NCT01185600|471823687|FG001|Overall Study|Withdrawal by Subject|1|||
131051800|NCT01185600|471823686|FG000|Overall Study|Hold by DSMB|1|||
131051801|NCT01185600|471823687|FG001|Overall Study|Hold by DSMB|2|||
131051802|NCT05405244|471823688|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
131051803|NCT05405244|471823689|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
131051804|NCT05405244|471823688|FG000|Washout (2 Weeks)|Adverse Event|2|||
131051805|NCT05405244|471823689|FG001|Washout (2 Weeks)|Adverse Event|0|||
131051806|NCT05405244|471823688|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
131051807|NCT05405244|471823689|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
131051808|NCT01500200|471823690|FG000|Stage 1|Adverse Event|1|||
131051809|NCT01500200|471823691|FG001|Stage 1|Adverse Event|4|||
131051810|NCT01500200|471823692|FG002|Stage 1|Adverse Event|5|||
131051811|NCT01500200|471823693|FG003|Stage 1|Adverse Event|0|||
131051812|NCT01500200|471823694|FG004|Stage 1|Adverse Event|0|||
131051813|NCT01500200|471823695|FG005|Stage 1|Adverse Event|0|||
131051814|NCT01500200|471823690|FG000|Stage 1|Lost to Follow-up|2|||
131051815|NCT01500200|471823691|FG001|Stage 1|Lost to Follow-up|2|||
131051816|NCT01500200|471823692|FG002|Stage 1|Lost to Follow-up|1|||
131051817|NCT01500200|471823693|FG003|Stage 1|Lost to Follow-up|0|||
131051818|NCT01500200|471823694|FG004|Stage 1|Lost to Follow-up|0|||
131051819|NCT01500200|471823695|FG005|Stage 1|Lost to Follow-up|0|||
131051820|NCT01500200|471823690|FG000|Stage 1|Withdrawal by Subject|3|||
131051821|NCT01500200|471823691|FG001|Stage 1|Withdrawal by Subject|0|||
131051822|NCT01500200|471823692|FG002|Stage 1|Withdrawal by Subject|0|||
131051823|NCT01500200|471823693|FG003|Stage 1|Withdrawal by Subject|0|||
131051824|NCT01500200|471823694|FG004|Stage 1|Withdrawal by Subject|0|||
131051825|NCT01500200|471823695|FG005|Stage 1|Withdrawal by Subject|0|||
131051826|NCT01500200|471823690|FG000|Stage 1|Noncompliance with Study Drug|1|||
131051827|NCT01500200|471823691|FG001|Stage 1|Noncompliance with Study Drug|0|||
131051828|NCT01500200|471823692|FG002|Stage 1|Noncompliance with Study Drug|0|||
131051829|NCT01500200|471823693|FG003|Stage 1|Noncompliance with Study Drug|0|||
131051830|NCT01500200|471823694|FG004|Stage 1|Noncompliance with Study Drug|0|||
131051831|NCT01500200|471823695|FG005|Stage 1|Noncompliance with Study Drug|0|||
131051832|NCT01500200|471823690|FG000|Stage 1|Physician Decision|1|||
131051833|NCT01500200|471823691|FG001|Stage 1|Physician Decision|0|||
131135284|NCT00577993|472122451|FG000|Overall Study|Adverse Event|1|||
131135285|NCT00577993|472122452|FG001|Overall Study|Adverse Event|0|||
131135286|NCT00577993|472122453|FG002|Overall Study|Adverse Event|0|||
131135287|NCT00577993|472122451|FG000|Overall Study|Death|0|||
131135288|NCT00577993|472122452|FG001|Overall Study|Death|1|||
131135289|NCT00577993|472122453|FG002|Overall Study|Death|1|||
131135290|NCT00577993|472122451|FG000|Overall Study|Lack of Efficacy|0|||
130779311|NCT01004978|470819486|FG001|Overall Study|Ineligible|0|||
131051834|NCT01500200|471823692|FG002|Stage 1|Physician Decision|0|||
131051835|NCT01500200|471823693|FG003|Stage 1|Physician Decision|0|||
131051836|NCT01500200|471823694|FG004|Stage 1|Physician Decision|0|||
131051837|NCT01500200|471823695|FG005|Stage 1|Physician Decision|0|||
131051838|NCT01500200|471823690|FG000|Stage 2|Adverse Event|0|||
131135291|NCT00577993|472122452|FG001|Overall Study|Lack of Efficacy|1|||
131135292|NCT00577993|472122453|FG002|Overall Study|Lack of Efficacy|0|||
131135293|NCT00577993|472122451|FG000|Overall Study|Protocol Violation|2|||
131135294|NCT00577993|472122452|FG001|Overall Study|Protocol Violation|3|||
131135295|NCT00577993|472122453|FG002|Overall Study|Protocol Violation|0|||
131135296|NCT00577993|472122451|FG000|Overall Study|Withdrawal by Subject|1|||
131051839|NCT01500200|471823691|FG001|Stage 2|Adverse Event|0|||
131051840|NCT01500200|471823692|FG002|Stage 2|Adverse Event|0|||
131051841|NCT01500200|471823693|FG003|Stage 2|Adverse Event|0|||
131135297|NCT00577993|472122452|FG001|Overall Study|Withdrawal by Subject|0|||
131135298|NCT00577993|472122453|FG002|Overall Study|Withdrawal by Subject|2|||
131135299|NCT00577993|472122451|FG000|Overall Study|Conversion|2|||
131051842|NCT01500200|471823694|FG004|Stage 2|Adverse Event|5|||
131051843|NCT01500200|471823695|FG005|Stage 2|Adverse Event|4|||
131051844|NCT01218659|471823696|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
131051845|NCT01218659|471823697|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
131135300|NCT00577993|472122452|FG001|Overall Study|Conversion|5|||
131135301|NCT00577993|472122453|FG002|Overall Study|Conversion|0|||
130722202|NCT00936897|470608194|FG001|Overall Study|Other|9|||
130722203|NCT00936897|470608193|FG000|Overall Study|Lost to Follow-up|1|||
130722204|NCT00936897|470608194|FG001|Overall Study|Lost to Follow-up|10|||
131051846|NCT01218659|471823698|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
131051847|NCT01218659|471823696|FG000|18-Month Randomized Period|Did not receive study drug|0|||
131051848|NCT01218659|471823697|FG001|18-Month Randomized Period|Did not receive study drug|3|||
131051849|NCT01218659|471823698|FG002|18-Month Randomized Period|Did not receive study drug|0|||
131051850|NCT01218659|471823696|FG000|12-Month OLE|Withdrawal by Subject|0|||
131051851|NCT01218659|471823697|FG001|12-Month OLE|Withdrawal by Subject|0|||
131051852|NCT01218659|471823698|FG002|12-Month OLE|Withdrawal by Subject|2|||
131051853|NCT01218659|471823696|FG000|12-Month OLE|Physician Decision|0|||
131051854|NCT01218659|471823697|FG001|12-Month OLE|Physician Decision|0|||
131051855|NCT01218659|471823698|FG002|12-Month OLE|Physician Decision|1|||
131051856|NCT01218659|471823696|FG000|12-Month OLE|Lost to Follow-up|0|||
131051857|NCT01218659|471823697|FG001|12-Month OLE|Lost to Follow-up|0|||
131051858|NCT01218659|471823698|FG002|12-Month OLE|Lost to Follow-up|1|||
131051859|NCT01218659|471823696|FG000|12-Month OLE|Pregnancy|0|||
131051860|NCT01218659|471823697|FG001|12-Month OLE|Pregnancy|0|||
131051861|NCT01218659|471823698|FG002|12-Month OLE|Pregnancy|1|||
131051862|NCT01218659|471823696|FG000|12-Month OLE|Lack of Efficacy|0|||
131051863|NCT01218659|471823697|FG001|12-Month OLE|Lack of Efficacy|0|||
131051864|NCT01218659|471823698|FG002|12-Month OLE|Lack of Efficacy|1|||
131051865|NCT01218659|471823696|FG000|12-Month OLE|Declined to participate in the OLE|0|||
131051866|NCT01218659|471823697|FG001|12-Month OLE|Declined to participate in the OLE|0|||
131051867|NCT01218659|471823698|FG002|12-Month OLE|Declined to participate in the OLE|4|||
131051868|NCT04191824|471823705|FG000|Overall Study|Death|13|||
131051869|NCT04191824|471823706|FG001|Overall Study|Death|12|||
131051870|NCT04191824|471823705|FG000|Overall Study|Lost to Follow-up|456|||
131051871|NCT04191824|471823706|FG001|Overall Study|Lost to Follow-up|435|||
131051872|NCT04191824|471823705|FG000|Overall Study|Physician Decision|2|||
131051873|NCT04191824|471823706|FG001|Overall Study|Physician Decision|1|||
131051874|NCT04191824|471823705|FG000|Overall Study|Protocol Violation|0|||
131051875|NCT04191824|471823706|FG001|Overall Study|Protocol Violation|2|||
131051876|NCT04191824|471823705|FG000|Overall Study|Withdrawal by Subject|16|||
130722205|NCT00936897|470608193|FG000|Overall Study|Administrative Decision|1|||
130722206|NCT00936897|470608194|FG001|Overall Study|Administrative Decision|2|||
130722207|NCT00936897|470608193|FG000|Overall Study|Protocol Violation|1|||
130722208|NCT00936897|470608194|FG001|Overall Study|Protocol Violation|1|||
130779312|NCT01004978|470819485|FG000|Overall Study|Unblinded|0|||
130779313|NCT01004978|470819486|FG001|Overall Study|Unblinded|1|||
130779314|NCT01004978|470819485|FG000|Overall Study|Performance status worsening|0|||
130779315|NCT01004978|470819486|FG001|Overall Study|Performance status worsening|1|||
130779316|NCT01004978|470819485|FG000|Overall Study|Never started treatment|8|||
130779317|NCT01004978|470819486|FG001|Overall Study|Never started treatment|9|||
130779318|NCT00369915|470819487|FG000|Overall Study|expected side effects|2|||
130779319|NCT00369915|470819488|FG001|Overall Study|expected side effects|1|||
130779320|NCT00369915|470819487|FG000|Overall Study|Withdrawal by Subject|4|||
130779321|NCT00369915|470819488|FG001|Overall Study|Withdrawal by Subject|1|||
130779322|NCT00369915|470819487|FG000|Overall Study|W/drawl by investigators|0|||
131051877|NCT04191824|471823706|FG001|Overall Study|Withdrawal by Subject|18|||
131051878|NCT04191824|471823705|FG000|Overall Study|Early site closure|24|||
131051879|NCT04191824|471823706|FG001|Overall Study|Early site closure|22|||
131051880|NCT01499849|471823712|FG000|Overall Study|Adverse Event|28|||
130722209|NCT00936897|470608193|FG000|Overall Study|Ineligibility Determined|0|||
130722210|NCT00936897|470608194|FG001|Overall Study|Ineligibility Determined|3|||
130722211|NCT00936897|470608193|FG000|Overall Study|Noncompliance|0|||
130722212|NCT00936897|470608194|FG001|Overall Study|Noncompliance|2|||
130722213|NCT00936897|470608193|FG000|Overall Study|Death|0|||
130722214|NCT00936897|470608194|FG001|Overall Study|Death|1|||
130722215|NCT04058067|470608195|FG000|Overall Study|Adverse Event|2|||
130722216|NCT04058067|470608196|FG001|Overall Study|Adverse Event|0|||
130722217|NCT04058067|470608195|FG000|Overall Study|Death|0|||
130722218|NCT04058067|470608196|FG001|Overall Study|Death|1|||
130722219|NCT04058067|470608195|FG000|Overall Study|Physician Decision|3|||
130722220|NCT04058067|470608196|FG001|Overall Study|Physician Decision|1|||
130722221|NCT04058067|470608195|FG000|Overall Study|Protocol Violation|0|||
130722222|NCT04058067|470608196|FG001|Overall Study|Protocol Violation|1|||
130722223|NCT04058067|470608195|FG000|Overall Study|Withdrawal by Subject|7|||
130722224|NCT04058067|470608196|FG001|Overall Study|Withdrawal by Subject|8|||
130722225|NCT00417170|470608197|FG000|Overall Study|Adverse Event|1|||
130779323|NCT00369915|470819488|FG001|Overall Study|W/drawl by investigators|1|||
131051881|NCT01499849|471823713|FG001|Overall Study|Adverse Event|32|||
131051882|NCT01499849|471823712|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
130779324|NCT01711983|470819489|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
131051883|NCT01499849|471823713|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
131051884|NCT01499849|471823712|FG000|Overall Study|Withdrawal by Subject|43|||
130722226|NCT00417170|470608198|FG001|Overall Study|Adverse Event|1|||
130722227|NCT00417170|470608197|FG000|Overall Study|Withdrawal by Subject|1|||
131051885|NCT01499849|471823713|FG001|Overall Study|Withdrawal by Subject|43|||
131051886|NCT01499849|471823712|FG000|Overall Study|Death|5|||
131051887|NCT01499849|471823713|FG001|Overall Study|Death|7|||
131051888|NCT01499849|471823712|FG000|Overall Study|Disease Progression|11|||
131051889|NCT01499849|471823713|FG001|Overall Study|Disease Progression|10|||
131051890|NCT01499849|471823712|FG000|Overall Study|Protocol Violation|11|||
131051891|NCT01499849|471823713|FG001|Overall Study|Protocol Violation|11|||
131051892|NCT01499849|471823712|FG000|Overall Study|Physician Decision|20|||
131051893|NCT01499849|471823713|FG001|Overall Study|Physician Decision|19|||
131051894|NCT01499849|471823712|FG000|Overall Study|Lack of Efficacy|3|||
131051895|NCT01499849|471823713|FG001|Overall Study|Lack of Efficacy|4|||
131051896|NCT01499849|471823712|FG000|Overall Study|Lost to Follow-up|6|||
131051897|NCT01499849|471823713|FG001|Overall Study|Lost to Follow-up|3|||
131051898|NCT01499849|471823712|FG000|Overall Study|Other Reasons|27|||
131051899|NCT01499849|471823713|FG001|Overall Study|Other Reasons|30|||
131051900|NCT01437319|471823714|FG000|Phase I|Lost to Follow-up|2|||
131051901|NCT01437319|471823715|FG001|Phase I|Lost to Follow-up|0|||
131051902|NCT01437319|471823716|FG002|Phase I|Lost to Follow-up|0|||
131051903|NCT01437319|471823714|FG000|Phase I|Protocol Violation|1|||
131051904|NCT01437319|471823715|FG001|Phase I|Protocol Violation|0|||
131051905|NCT01437319|471823716|FG002|Phase I|Protocol Violation|0|||
131051906|NCT01437319|471823714|FG000|Phase I|Study related symptoms/complaints|27|||
131051907|NCT01437319|471823715|FG001|Phase I|Study related symptoms/complaints|0|||
131051908|NCT01437319|471823716|FG002|Phase I|Study related symptoms/complaints|0|||
131051909|NCT01437319|471823714|FG000|Phase I|Withdrawal by Subject|25|||
131051910|NCT01437319|471823715|FG001|Phase I|Withdrawal by Subject|0|||
131051911|NCT01437319|471823716|FG002|Phase I|Withdrawal by Subject|0|||
131051912|NCT01437319|471823714|FG000|Phase II|Withdrawal by Subject|0|||
131051913|NCT01437319|471823715|FG001|Phase II|Withdrawal by Subject|8|||
131051914|NCT01437319|471823716|FG002|Phase II|Withdrawal by Subject|16|||
131051915|NCT01437319|471823714|FG000|Phase II|Lost to Follow-up|0|||
131051916|NCT01437319|471823715|FG001|Phase II|Lost to Follow-up|7|||
131051917|NCT01437319|471823716|FG002|Phase II|Lost to Follow-up|2|||
131051918|NCT01437319|471823714|FG000|Phase II|Study related symptoms/complaints|0|||
131051919|NCT01437319|471823715|FG001|Phase II|Study related symptoms/complaints|28|||
131051920|NCT01437319|471823716|FG002|Phase II|Study related symptoms/complaints|19|||
131051921|NCT01437319|471823714|FG000|Phase II|Protocol Violation|0|||
131051922|NCT01437319|471823715|FG001|Phase II|Protocol Violation|1|||
131051923|NCT01437319|471823716|FG002|Phase II|Protocol Violation|0|||
131051924|NCT00174252|471823717|FG000|Overall Study|Protocol Violation|2|||
131135302|NCT00577993|472122451|FG000|Overall Study|Uninsured|1|||
131135303|NCT00577993|472122452|FG001|Overall Study|Uninsured|0|||
131135304|NCT00577993|472122453|FG002|Overall Study|Uninsured|0|||
131135305|NCT01847885|472122454|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
131135306|NCT01847885|472122455|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
131135307|NCT01847885|472122456|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
131135308|NCT01847885|472122454|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
131135309|NCT01847885|472122455|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
131135310|NCT01847885|472122456|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
131135311|NCT01847885|472122454|FG000|Initial Enrollment (Consented)|Screen failure|39|||
131135312|NCT01847885|472122455|FG001|Initial Enrollment (Consented)|Screen failure|0|||
131135313|NCT01847885|472122456|FG002|Initial Enrollment (Consented)|Screen failure|0|||
131135314|NCT01847885|472122454|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
131135315|NCT01847885|472122455|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
131135316|NCT01847885|472122456|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
131135317|NCT01847885|472122454|FG000|Randomization|Protocol Violation|0|||
131135318|NCT01847885|472122455|FG001|Randomization|Protocol Violation|1|||
130779325|NCT01711983|470819489|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
130779326|NCT01711983|470819489|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
130779327|NCT01711983|470819489|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
131051925|NCT03611556|471823720|FG000|Overall Study|Death|7|||
131051926|NCT03611556|471823721|FG001|Overall Study|Death|7|||
131051927|NCT03611556|471823722|FG002|Overall Study|Death|3|||
131051928|NCT03611556|471823723|FG003|Overall Study|Death|8|||
131051929|NCT03611556|471823724|FG004|Overall Study|Death|47|||
131051930|NCT03611556|471823725|FG005|Overall Study|Death|32|||
131051931|NCT03611556|471823726|FG006|Overall Study|Death|53|||
131051932|NCT03611556|471823720|FG000|Overall Study|Withdrawal by Subject|0|||
131051933|NCT03611556|471823721|FG001|Overall Study|Withdrawal by Subject|0|||
131051934|NCT03611556|471823722|FG002|Overall Study|Withdrawal by Subject|0|||
131051935|NCT03611556|471823723|FG003|Overall Study|Withdrawal by Subject|0|||
131051936|NCT03611556|471823724|FG004|Overall Study|Withdrawal by Subject|4|||
131051937|NCT03611556|471823725|FG005|Overall Study|Withdrawal by Subject|2|||
131051938|NCT03611556|471823726|FG006|Overall Study|Withdrawal by Subject|4|||
131051939|NCT03611556|471823720|FG000|Overall Study|Sponsor decision|0|||
131051940|NCT03611556|471823721|FG001|Overall Study|Sponsor decision|0|||
131051941|NCT03611556|471823722|FG002|Overall Study|Sponsor decision|0|||
131051942|NCT03611556|471823723|FG003|Overall Study|Sponsor decision|0|||
131051943|NCT03611556|471823724|FG004|Overall Study|Sponsor decision|9|||
131051944|NCT03611556|471823725|FG005|Overall Study|Sponsor decision|4|||
131051945|NCT03611556|471823726|FG006|Overall Study|Sponsor decision|12|||
131051946|NCT03611556|471823720|FG000|Overall Study|Reasons|0|||
131051947|NCT03611556|471823721|FG001|Overall Study|Reasons|0|||
131051948|NCT03611556|471823722|FG002|Overall Study|Reasons|0|||
131051949|NCT03611556|471823723|FG003|Overall Study|Reasons|0|||
131051950|NCT03611556|471823724|FG004|Overall Study|Reasons|2|||
131051951|NCT03611556|471823725|FG005|Overall Study|Reasons|0|||
131051952|NCT03611556|471823726|FG006|Overall Study|Reasons|1|||
131051953|NCT03304587|471823727|FG000|Overall Study|Headache after intervention|0|||
131051954|NCT03304587|471823728|FG001|Overall Study|Headache after intervention|1|||
131051955|NCT03304587|471823727|FG000|Overall Study|Withdrawal by Subject|1|||
131051956|NCT03304587|471823728|FG001|Overall Study|Withdrawal by Subject|0|||
131051957|NCT01458366|471823730|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
131051958|NCT01458366|471823731|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
131051959|NCT01458366|471823732|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
131051960|NCT01458366|471823733|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
131051961|NCT01458366|471823734|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
131051962|NCT01458366|471823730|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
131051963|NCT01458366|471823731|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
131051964|NCT01458366|471823732|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
131051965|NCT01458366|471823733|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
131051966|NCT01458366|471823734|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
131051967|NCT02397096|471823735|FG000|Day 1 to Week 24|Adverse Event|7|||
131051968|NCT02397096|471823736|FG001|Day 1 to Week 24|Adverse Event|1|||
131051969|NCT02397096|471823735|FG000|Day 1 to Week 24|Death|1|||
131051970|NCT02397096|471823736|FG001|Day 1 to Week 24|Death|0|||
131051971|NCT02397096|471823735|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
131051972|NCT02397096|471823736|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
131051973|NCT02397096|471823735|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
130722228|NCT00417170|470608198|FG001|Overall Study|Withdrawal by Subject|1|||
130722229|NCT00417170|470608197|FG000|Overall Study|Lost to Follow-up|0|||
130722230|NCT00417170|470608198|FG001|Overall Study|Lost to Follow-up|1|||
131051974|NCT02397096|471823736|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
131051975|NCT02397096|471823735|FG000|Day 1 to Week 24|Physician Decision|2|||
131051976|NCT02397096|471823736|FG001|Day 1 to Week 24|Physician Decision|3|||
131051977|NCT02397096|471823735|FG000|Day 1 to Week 24|Protocol Violation|1|||
131051978|NCT02397096|471823736|FG001|Day 1 to Week 24|Protocol Violation|4|||
131051979|NCT02397096|471823735|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
131135319|NCT01847885|472122456|FG002|Randomization|Protocol Violation|0|||
131135320|NCT01847885|472122454|FG000|Randomization|Withdrawal by Subject|0|||
131135321|NCT01847885|472122455|FG001|Randomization|Withdrawal by Subject|0|||
131135322|NCT01847885|472122456|FG002|Randomization|Withdrawal by Subject|2|||
131135323|NCT01847885|472122454|FG000|Randomization|Screen Failure|0|||
131135324|NCT01847885|472122455|FG001|Randomization|Screen Failure|3|||
131135325|NCT01847885|472122456|FG002|Randomization|Screen Failure|0|||
131135326|NCT04029519|472122458|FG000|Overall Study|Protocol Violation|1|||
131135327|NCT04029519|472122458|FG000|Overall Study|Withdrawal by Subject|3|||
131135328|NCT04029519|472122458|FG000|Overall Study|Lost to Follow-up|1|||
131135329|NCT00411554|472122461|FG000|Overall Study|Adverse Event|2|||
131135330|NCT00411554|472122462|FG001|Overall Study|Adverse Event|4|||
131135331|NCT00411554|472122461|FG000|Overall Study|Lack of Efficacy|2|||
131135332|NCT00411554|472122462|FG001|Overall Study|Lack of Efficacy|5|||
131135333|NCT00411554|472122461|FG000|Overall Study|Withdrawal by Subject|3|||
131051980|NCT02397096|471823736|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
131051981|NCT02397096|471823735|FG000|Day 1 to Week 24|Randomized, not treated|3|||
131135334|NCT00411554|472122462|FG001|Overall Study|Withdrawal by Subject|0|||
131135335|NCT00411554|472122461|FG000|Overall Study|Patient Moved|1|||
130722231|NCT05005312|470608199|FG000|Overall Study|Enrolled, but not treated|0|||
131135336|NCT00411554|472122462|FG001|Overall Study|Patient Moved|0|||
131135337|NCT02462473|472122463|FG000|Overall Study|Death|1|||
131135338|NCT02462473|472122463|FG000|Overall Study|Other|3|||
131135339|NCT03728309|472122464|FG000|Overall Study|Randomized but not Treated|0|||
131135340|NCT03728309|472122465|FG001|Overall Study|Randomized but not Treated|1|||
131135341|NCT03728309|472122464|FG000|Overall Study|Adverse Event|0|||
131135342|NCT03728309|472122465|FG001|Overall Study|Adverse Event|1|||
131135343|NCT03728309|472122464|FG000|Overall Study|Withdrawal by Subject|2|||
131229650|NCT04081337|472467652|FG001|Overall Study|Withdrawal by Subject|0|||
131229651|NCT04081337|472467651|FG000|Overall Study|Physician Decision|1|||
131229652|NCT04081337|472467652|FG001|Overall Study|Physician Decision|2|||
131229653|NCT04081337|472467651|FG000|Overall Study|Lost to Follow-up|1|||
130722232|NCT05005312|470608200|FG001|Overall Study|Enrolled, but not treated|1|||
131229654|NCT04081337|472467652|FG001|Overall Study|Lost to Follow-up|0|||
131229655|NCT01799590|472467653|FG000|Overall Study|Adverse Event|13|||
131051982|NCT02397096|471823736|FG001|Day 1 to Week 24|Randomized, not treated|0|||
131051983|NCT02397096|471823735|FG000|Week 24 to Week 48|Adverse Event|6|||
131229656|NCT01799590|472467654|FG001|Overall Study|Adverse Event|7|||
130722233|NCT01283035|470608201|FG000|Overall Study|Subject later found ineligible|1|||
130722234|NCT00867503|470608203|FG000|Overall Study|Withdrawal by Subject|1|||
130722235|NCT02704403|470608204|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
130722236|NCT02704403|470608205|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
130722237|NCT02704403|470608204|FG000|Overall Study|Administrative reasons by sponsor|1251|||
130722238|NCT02704403|470608205|FG001|Overall Study|Administrative reasons by sponsor|616|||
130722239|NCT02704403|470608204|FG000|Overall Study|Death|4|||
130722240|NCT02704403|470608205|FG001|Overall Study|Death|3|||
130722241|NCT02704403|470608204|FG000|Overall Study|Endpoint event|52|||
130722242|NCT02704403|470608205|FG001|Overall Study|Endpoint event|24|||
130722243|NCT02704403|470608204|FG000|Overall Study|Lost to Follow-up|22|||
130722244|NCT02704403|470608205|FG001|Overall Study|Lost to Follow-up|11|||
130722245|NCT02704403|470608204|FG000|Overall Study|Protocol Violation|15|||
130722246|NCT02704403|470608205|FG001|Overall Study|Protocol Violation|15|||
130722247|NCT02704403|470608204|FG000|Overall Study|Adverse Event|2|||
130722248|NCT02704403|470608205|FG001|Overall Study|Adverse Event|0|||
130722249|NCT02704403|470608204|FG000|Overall Study|Withdrawal by Subject|85|||
130722250|NCT02704403|470608205|FG001|Overall Study|Withdrawal by Subject|45|||
130722251|NCT02704403|470608204|FG000|Overall Study|Investigator decision|1|||
130722252|NCT02704403|470608205|FG001|Overall Study|Investigator decision|1|||
130722253|NCT02704403|470608204|FG000|Overall Study|Follow-up not possible|1|||
130722254|NCT02704403|470608205|FG001|Overall Study|Follow-up not possible|2|||
130722255|NCT02792699|470608206|FG000|Overall Study|Adverse Event|1|||
130722256|NCT02792699|470608207|FG001|Overall Study|Adverse Event|2|||
130722257|NCT02792699|470608208|FG002|Overall Study|Adverse Event|4|||
130722258|NCT02792699|470608206|FG000|Overall Study|Withdrawal by Subject|4|||
130722259|NCT02792699|470608207|FG001|Overall Study|Withdrawal by Subject|4|||
130722260|NCT02792699|470608208|FG002|Overall Study|Withdrawal by Subject|3|||
130722261|NCT02792699|470608206|FG000|Overall Study|Lost to Follow-up|0|||
130722262|NCT02792699|470608207|FG001|Overall Study|Lost to Follow-up|1|||
130722263|NCT02792699|470608208|FG002|Overall Study|Lost to Follow-up|2|||
130722264|NCT02792699|470608206|FG000|Overall Study|Physician Decision|2|||
130722265|NCT02792699|470608207|FG001|Overall Study|Physician Decision|0|||
130722266|NCT02792699|470608208|FG002|Overall Study|Physician Decision|0|||
130722267|NCT02792699|470608206|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
130722268|NCT02792699|470608207|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
130722269|NCT02792699|470608208|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
130722270|NCT02792699|470608206|FG000|Overall Study|Other|1|||
130722271|NCT02792699|470608207|FG001|Overall Study|Other|0|||
131135344|NCT03728309|472122465|FG001|Overall Study|Withdrawal by Subject|8|||
131135345|NCT03728309|472122464|FG000|Overall Study|Lost to Follow-up|9|||
131135346|NCT03728309|472122465|FG001|Overall Study|Lost to Follow-up|10|||
131135347|NCT03728309|472122464|FG000|Overall Study|Protocol Deviation|0|||
131135348|NCT03728309|472122465|FG001|Overall Study|Protocol Deviation|1|||
131135349|NCT03728309|472122464|FG000|Overall Study|Due to COVID|1|||
131135350|NCT03728309|472122465|FG001|Overall Study|Due to COVID|3|||
131135351|NCT00953758|472122468|FG000|Overall Study|Death|2|||
131135352|NCT00953758|472122469|FG001|Overall Study|Death|0|||
131135353|NCT00953758|472122470|FG002|Overall Study|Death|1|||
131135354|NCT00953758|472122471|FG003|Overall Study|Death|1|||
131135355|NCT00953758|472122472|FG004|Overall Study|Death|1|||
131135356|NCT00953758|472122473|FG005|Overall Study|Death|1|||
131135357|NCT00953758|472122474|FG006|Overall Study|Death|1|||
130722272|NCT02792699|470608208|FG002|Overall Study|Other|0|||
130722273|NCT01755767|470608209|FG000|Overall Study|Progressive Disease|8|||
130722274|NCT01755767|470608210|FG001|Overall Study|Progressive Disease|7|||
130722275|NCT01755767|470608211|FG002|Overall Study|Progressive Disease|91|||
130722276|NCT01755767|470608212|FG003|Overall Study|Progressive Disease|43|||
130722277|NCT01755767|470608209|FG000|Overall Study|Clinical Disease Progression|4|||
130722278|NCT01755767|470608210|FG001|Overall Study|Clinical Disease Progression|2|||
130722279|NCT01755767|470608211|FG002|Overall Study|Clinical Disease Progression|29|||
130722280|NCT01755767|470608212|FG003|Overall Study|Clinical Disease Progression|20|||
130722281|NCT01755767|470608209|FG000|Overall Study|Radiographic Disease Progression|9|||
130722282|NCT01755767|470608210|FG001|Overall Study|Radiographic Disease Progression|4|||
130722283|NCT01755767|470608211|FG002|Overall Study|Radiographic Disease Progression|44|||
130722284|NCT01755767|470608212|FG003|Overall Study|Radiographic Disease Progression|27|||
131135358|NCT00953758|472122475|FG007|Overall Study|Death|3|||
131135359|NCT00953758|472122476|FG008|Overall Study|Death|1|||
131135360|NCT00953758|472122477|FG009|Overall Study|Death|0|||
131135361|NCT00953758|472122468|FG000|Overall Study|Participant refused further follow-up|0|||
131135362|NCT00953758|472122469|FG001|Overall Study|Participant refused further follow-up|0|||
131135363|NCT00953758|472122470|FG002|Overall Study|Participant refused further follow-up|1|||
131135364|NCT00953758|472122471|FG003|Overall Study|Participant refused further follow-up|0|||
130722285|NCT01755767|470608209|FG000|Overall Study|Adverse Event|6|||
130722286|NCT01755767|470608210|FG001|Overall Study|Adverse Event|0|||
131135365|NCT00953758|472122472|FG004|Overall Study|Participant refused further follow-up|3|||
130722287|NCT01755767|470608211|FG002|Overall Study|Adverse Event|28|||
131135366|NCT00953758|472122473|FG005|Overall Study|Participant refused further follow-up|0|||
131135367|NCT00953758|472122474|FG006|Overall Study|Participant refused further follow-up|0|||
131135368|NCT00953758|472122475|FG007|Overall Study|Participant refused further follow-up|0|||
131135369|NCT00953758|472122476|FG008|Overall Study|Participant refused further follow-up|1|||
131135370|NCT00953758|472122477|FG009|Overall Study|Participant refused further follow-up|0|||
131135371|NCT00953758|472122468|FG000|Overall Study|Lost to Follow-up|0|||
131135372|NCT00953758|472122469|FG001|Overall Study|Lost to Follow-up|0|||
131135373|NCT00953758|472122470|FG002|Overall Study|Lost to Follow-up|0|||
131135374|NCT00953758|472122471|FG003|Overall Study|Lost to Follow-up|1|||
131135375|NCT00953758|472122472|FG004|Overall Study|Lost to Follow-up|0|||
131135376|NCT00953758|472122473|FG005|Overall Study|Lost to Follow-up|0|||
131135377|NCT00953758|472122474|FG006|Overall Study|Lost to Follow-up|0|||
131135378|NCT00953758|472122475|FG007|Overall Study|Lost to Follow-up|1|||
131135379|NCT00953758|472122476|FG008|Overall Study|Lost to Follow-up|0|||
131135380|NCT00953758|472122477|FG009|Overall Study|Lost to Follow-up|1|||
131135381|NCT00953758|472122468|FG000|Overall Study|Physician Decision|0|||
131135382|NCT00953758|472122469|FG001|Overall Study|Physician Decision|0|||
131135383|NCT00953758|472122470|FG002|Overall Study|Physician Decision|0|||
131135384|NCT00953758|472122471|FG003|Overall Study|Physician Decision|0|||
131135385|NCT00953758|472122472|FG004|Overall Study|Physician Decision|1|||
131135386|NCT00953758|472122473|FG005|Overall Study|Physician Decision|0|||
131135387|NCT00953758|472122474|FG006|Overall Study|Physician Decision|0|||
131135388|NCT00953758|472122475|FG007|Overall Study|Physician Decision|0|||
131135389|NCT00953758|472122476|FG008|Overall Study|Physician Decision|0|||
131135390|NCT00953758|472122477|FG009|Overall Study|Physician Decision|0|||
131135391|NCT00953758|472122468|FG000|Overall Study|Disease progression|0|||
131135392|NCT00953758|472122469|FG001|Overall Study|Disease progression|0|||
131135393|NCT00953758|472122470|FG002|Overall Study|Disease progression|0|||
131135394|NCT00953758|472122471|FG003|Overall Study|Disease progression|0|||
131135395|NCT00953758|472122472|FG004|Overall Study|Disease progression|1|||
131135396|NCT00953758|472122473|FG005|Overall Study|Disease progression|0|||
131135397|NCT00953758|472122474|FG006|Overall Study|Disease progression|0|||
131135398|NCT00953758|472122475|FG007|Overall Study|Disease progression|0|||
131135399|NCT00953758|472122476|FG008|Overall Study|Disease progression|0|||
131229657|NCT01799590|472467655|FG002|Overall Study|Adverse Event|5|||
131229658|NCT01799590|472467653|FG000|Overall Study|Pregnancy|2|||
131229659|NCT01799590|472467654|FG001|Overall Study|Pregnancy|0|||
131051984|NCT02397096|471823736|FG001|Week 24 to Week 48|Adverse Event|2|||
131051985|NCT02397096|471823735|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
131051986|NCT02397096|471823736|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
131051987|NCT02397096|471823735|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
131051988|NCT02397096|471823736|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
131051989|NCT02397096|471823735|FG000|Week 24 to Week 48|Physician Decision|2|||
131051990|NCT02397096|471823736|FG001|Week 24 to Week 48|Physician Decision|1|||
131051991|NCT02397096|471823735|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
131051992|NCT02397096|471823736|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
131051993|NCT02397096|471823735|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
131051994|NCT02397096|471823736|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
131051995|NCT02397096|471823735|FG000|Study Extension 1|Adverse Event|7|||
131051996|NCT02397096|471823736|FG001|Study Extension 1|Adverse Event|5|||
131051997|NCT02397096|471823735|FG000|Study Extension 1|Death|1|||
131051998|NCT02397096|471823736|FG001|Study Extension 1|Death|0|||
131051999|NCT02397096|471823735|FG000|Study Extension 1|Lack of Efficacy|2|||
131052000|NCT02397096|471823736|FG001|Study Extension 1|Lack of Efficacy|5|||
131052001|NCT02397096|471823735|FG000|Study Extension 1|Lost to Follow-up|2|||
131052002|NCT02397096|471823736|FG001|Study Extension 1|Lost to Follow-up|3|||
131052003|NCT02397096|471823735|FG000|Study Extension 1|Non-compliance with study drug|3|||
131052004|NCT02397096|471823736|FG001|Study Extension 1|Non-compliance with study drug|0|||
131052005|NCT02397096|471823735|FG000|Study Extension 1|Physician Decision|4|||
131052006|NCT02397096|471823736|FG001|Study Extension 1|Physician Decision|2|||
131052007|NCT02397096|471823735|FG000|Study Extension 1|Pregnancy|1|||
131052008|NCT02397096|471823736|FG001|Study Extension 1|Pregnancy|0|||
131052009|NCT02397096|471823735|FG000|Study Extension 1|Protocol Violation|0|||
131052010|NCT02397096|471823736|FG001|Study Extension 1|Protocol Violation|1|||
131052011|NCT02397096|471823735|FG000|Study Extension 1|Withdrawal by Subject|21|||
131135400|NCT00953758|472122477|FG009|Overall Study|Disease progression|0|||
131052012|NCT02397096|471823736|FG001|Study Extension 1|Withdrawal by Subject|7|||
131135401|NCT00953758|472122468|FG000|Overall Study|Participant went for transplant|0|||
131052013|NCT02397096|471823735|FG000|Study Extension 2|Adverse Event|3|||
131052014|NCT02397096|471823736|FG001|Study Extension 2|Adverse Event|3|||
131052015|NCT02397096|471823735|FG000|Study Extension 2|Availability of study medication locally|152|||
131135402|NCT00953758|472122469|FG001|Overall Study|Participant went for transplant|0|||
131135403|NCT00953758|472122470|FG002|Overall Study|Participant went for transplant|0|||
131135404|NCT00953758|472122471|FG003|Overall Study|Participant went for transplant|0|||
131135405|NCT00953758|472122472|FG004|Overall Study|Participant went for transplant|0|||
131229660|NCT01799590|472467655|FG002|Overall Study|Pregnancy|0|||
131229661|NCT01799590|472467653|FG000|Overall Study|Lack of Efficacy|3|||
131135406|NCT00953758|472122473|FG005|Overall Study|Participant went for transplant|0|||
131135407|NCT00953758|472122474|FG006|Overall Study|Participant went for transplant|0|||
131135408|NCT00953758|472122475|FG007|Overall Study|Participant went for transplant|0|||
131135409|NCT00953758|472122476|FG008|Overall Study|Participant went for transplant|1|||
131135410|NCT00953758|472122477|FG009|Overall Study|Participant went for transplant|0|||
131135411|NCT03298022|472122478|FG000|Overall Study|Lack of Efficacy|4|||
131135412|NCT03298022|472122478|FG000|Overall Study|Withdrawal by Subject|7|||
131135413|NCT03298022|472122478|FG000|Overall Study|Adverse Event|1|||
131135414|NCT03298022|472122478|FG000|Overall Study|disease relapse|1|||
131135415|NCT01422239|472122481|FG000|Overall Study|Lost to Follow-up|4|||
131135416|NCT01422239|472122482|FG001|Overall Study|Lost to Follow-up|3|||
131135417|NCT03167073|472122483|FG000|Overall Study|Stillbirth|1|||
131135418|NCT03167073|472122484|FG001|Overall Study|Stillbirth|0|||
131135419|NCT01276236|472122485|FG000|Overall Study|Lack of Efficacy|2|||
131135420|NCT01276236|472122485|FG000|Overall Study|Withdrawal by Subject|4|||
131135421|NCT01400451|472122486|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
131135422|NCT01400451|472122487|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
131135423|NCT01400451|472122488|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
131135424|NCT01400451|472122486|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
131135425|NCT01400451|472122487|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
131135426|NCT01400451|472122488|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
131135427|NCT01400451|472122486|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
131135428|NCT01400451|472122487|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
131135429|NCT01400451|472122488|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
131135430|NCT01400451|472122486|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
131135431|NCT01400451|472122487|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
131135432|NCT01400451|472122488|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
131135433|NCT01400451|472122486|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
131135434|NCT01400451|472122487|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
131135435|NCT01400451|472122488|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
131135436|NCT00044512|472122489|FG000|Follow Up|Lost to Follow-up|2|||
131135437|NCT02799069|472122491|FG000|Overall Study|Adverse Event|0|||
131135438|NCT02799069|472122492|FG001|Overall Study|Adverse Event|2|||
131135439|NCT02799069|472122493|FG002|Overall Study|Adverse Event|2|||
131135440|NCT02799069|472122491|FG000|Overall Study|Lack of Efficacy|2|||
131135441|NCT02799069|472122492|FG001|Overall Study|Lack of Efficacy|0|||
131135442|NCT02799069|472122493|FG002|Overall Study|Lack of Efficacy|0|||
131135443|NCT02799069|472122491|FG000|Overall Study|Lost to Follow-up|1|||
131135444|NCT02799069|472122492|FG001|Overall Study|Lost to Follow-up|1|||
131135445|NCT02799069|472122493|FG002|Overall Study|Lost to Follow-up|0|||
131135446|NCT02799069|472122491|FG000|Overall Study|Withdrawal by Subject|4|||
131135447|NCT02799069|472122492|FG001|Overall Study|Withdrawal by Subject|4|||
131135448|NCT02799069|472122493|FG002|Overall Study|Withdrawal by Subject|3|||
131135449|NCT02799069|472122491|FG000|Overall Study|Protocol Violation|1|||
131135450|NCT02799069|472122492|FG001|Overall Study|Protocol Violation|0|||
131135451|NCT02799069|472122493|FG002|Overall Study|Protocol Violation|2|||
131135452|NCT02695628|472122498|FG000|Overall Study|Withdrawal by Subject|1|||
131135453|NCT01681433|472122499|FG000|Overall Study|Lack of Efficacy|23|||
131135454|NCT01681433|472122500|FG001|Overall Study|Lack of Efficacy|23|||
131135455|NCT01681433|472122499|FG000|Overall Study|Withdrawal by Subject|5|||
131135456|NCT01681433|472122500|FG001|Overall Study|Withdrawal by Subject|5|||
131135457|NCT01681433|472122499|FG000|Overall Study|Protocol Violation|2|||
131135458|NCT01681433|472122500|FG001|Overall Study|Protocol Violation|0|||
131135459|NCT01681433|472122499|FG000|Overall Study|Adverse Event|2|||
131135460|NCT01681433|472122500|FG001|Overall Study|Adverse Event|4|||
131135461|NCT01681433|472122499|FG000|Overall Study|Lost to Follow-up|0|||
131135462|NCT01681433|472122500|FG001|Overall Study|Lost to Follow-up|1|||
131052016|NCT02397096|471823736|FG001|Study Extension 2|Availability of study medication locally|64|||
131052017|NCT02397096|471823735|FG000|Study Extension 2|Death|2|||
131052018|NCT02397096|471823736|FG001|Study Extension 2|Death|0|||
131052019|NCT02397096|471823735|FG000|Study Extension 2|Lack of Efficacy|1|||
131052020|NCT02397096|471823736|FG001|Study Extension 2|Lack of Efficacy|0|||
131052021|NCT02397096|471823735|FG000|Study Extension 2|Lost to Follow-up|2|||
131052022|NCT02397096|471823736|FG001|Study Extension 2|Lost to Follow-up|1|||
131052023|NCT02397096|471823735|FG000|Study Extension 2|Non-compliance with study drug|1|||
131052024|NCT02397096|471823736|FG001|Study Extension 2|Non-compliance with study drug|0|||
131052025|NCT02397096|471823735|FG000|Study Extension 2|Physician Decision|2|||
131052026|NCT02397096|471823736|FG001|Study Extension 2|Physician Decision|5|||
131052027|NCT02397096|471823735|FG000|Study Extension 2|Pregnancy|1|||
131052028|NCT02397096|471823736|FG001|Study Extension 2|Pregnancy|0|||
131135463|NCT01844895|472122501|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
131135464|NCT01844895|472122501|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
131135465|NCT01844895|472122501|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
131135466|NCT01844895|472122501|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
131229662|NCT01799590|472467654|FG001|Overall Study|Lack of Efficacy|1|||
130722288|NCT01755767|470608212|FG003|Overall Study|Adverse Event|11|||
130722289|NCT01755767|470608209|FG000|Overall Study|Death|1|||
130722290|NCT01755767|470608210|FG001|Overall Study|Death|2|||
131052029|NCT02397096|471823735|FG000|Study Extension 2|Withdrawal by Subject|10|||
131052030|NCT02397096|471823736|FG001|Study Extension 2|Withdrawal by Subject|3|||
131052031|NCT02397096|471823735|FG000|Study Extension 3|Adverse Event|1|||
131052032|NCT02397096|471823736|FG001|Study Extension 3|Adverse Event|0|||
131052033|NCT02397096|471823735|FG000|Study Extension 3|Availability of study medication locally|11|||
131052034|NCT02397096|471823736|FG001|Study Extension 3|Availability of study medication locally|3|||
131052035|NCT02397096|471823735|FG000|Study Extension 3|Lost to Follow-up|1|||
131052036|NCT02397096|471823736|FG001|Study Extension 3|Lost to Follow-up|0|||
131052037|NCT02397096|471823735|FG000|Study Extension 3|Withdrawal by Subject|2|||
131052038|NCT02397096|471823736|FG001|Study Extension 3|Withdrawal by Subject|1|||
131052039|NCT01753999|471823737|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
131052040|NCT01753999|471823738|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
131052041|NCT01753999|471823737|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
131052042|NCT01753999|471823738|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
131052043|NCT01753999|471823737|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
131052044|NCT01753999|471823738|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
131052045|NCT01753999|471823737|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
131052046|NCT01753999|471823738|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
131052047|NCT01753999|471823737|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
131052048|NCT01753999|471823738|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
131052049|NCT01753999|471823737|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
131052050|NCT01753999|471823738|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
131052051|NCT02392234|471823739|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
131052052|NCT02392234|471823740|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
131052053|NCT02392234|471823741|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
131052054|NCT02392234|471823742|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
131052055|NCT02392234|471823743|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
131135467|NCT01844895|472122501|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
131135468|NCT01844895|472122501|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
131135469|NCT01844895|472122501|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
131135470|NCT00511355|472122505|FG000|Overall Study|Adverse Event|4|||
131135471|NCT00511355|472122506|FG001|Overall Study|Adverse Event|4|||
131135472|NCT00511355|472122505|FG000|Overall Study|Pregnancy Wish|1|||
131135473|NCT00511355|472122506|FG001|Overall Study|Pregnancy Wish|0|||
131135474|NCT00511355|472122505|FG000|Overall Study|Lost to Follow-up|2|||
131135475|NCT00511355|472122506|FG001|Overall Study|Lost to Follow-up|1|||
131135476|NCT00511355|472122505|FG000|Overall Study|Other Reason|0|||
131135477|NCT00511355|472122506|FG001|Overall Study|Other Reason|1|||
131135478|NCT00511355|472122505|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
131135479|NCT00511355|472122506|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
131135480|NCT00511355|472122505|FG000|Overall Study|Withdrawal of informed consent|0|||
131135481|NCT00511355|472122506|FG001|Overall Study|Withdrawal of informed consent|1|||
131135482|NCT00511355|472122505|FG000|Overall Study|Other reason pre-treatment|0|||
131135483|NCT00511355|472122506|FG001|Overall Study|Other reason pre-treatment|1|||
131135484|NCT04770779|472122509|FG000|Overall Study|Randomized, never treated|0|||
131135485|NCT04770779|472122510|FG001|Overall Study|Randomized, never treated|1|||
131135486|NCT04770779|472122509|FG000|Overall Study|Adverse Event|9|||
131135487|NCT04770779|472122510|FG001|Overall Study|Adverse Event|1|||
131135488|NCT04770779|472122509|FG000|Overall Study|Withdrawal by Subject|7|||
131135489|NCT04770779|472122510|FG001|Overall Study|Withdrawal by Subject|1|||
131135490|NCT04770779|472122509|FG000|Overall Study|Pregnancy|0|||
131135491|NCT04770779|472122510|FG001|Overall Study|Pregnancy|1|||
131135492|NCT02289950|472122511|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
131135493|NCT02289950|472122512|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
131135494|NCT02289950|472122511|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
131135495|NCT02289950|472122512|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
131135496|NCT02289950|472122511|FG000|Overall Study|Lost to Follow-up|1|||
131135497|NCT02289950|472122512|FG001|Overall Study|Lost to Follow-up|0|||
131135498|NCT02289950|472122511|FG000|Overall Study|Physician Decision|9|||
131135499|NCT02289950|472122512|FG001|Overall Study|Physician Decision|3|||
131135500|NCT02289950|472122511|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
131135501|NCT02289950|472122512|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
131135502|NCT02289950|472122511|FG000|Overall Study|Withdrawal by Subject|1|||
131135503|NCT02289950|472122512|FG001|Overall Study|Withdrawal by Subject|3|||
131135504|NCT02289950|472122511|FG000|Overall Study|Test article held for greater than 28 days|0|||
131135505|NCT02289950|472122512|FG001|Overall Study|Test article held for greater than 28 days|1|||
131135506|NCT02289950|472122511|FG000|Overall Study|Adverse Event|11|||
131135507|NCT02289950|472122512|FG001|Overall Study|Adverse Event|3|||
131135508|NCT02289950|472122511|FG000|Overall Study|Death|1|||
131135509|NCT02289950|472122512|FG001|Overall Study|Death|1|||
131052056|NCT02392234|471823744|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
131052057|NCT02392234|471823739|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
131052058|NCT02392234|471823740|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
131052059|NCT02392234|471823741|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
131052060|NCT02392234|471823742|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
131052061|NCT02392234|471823743|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
131052062|NCT02392234|471823744|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
131052063|NCT02392234|471823739|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131052064|NCT02392234|471823740|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131052065|NCT02392234|471823741|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131052066|NCT02392234|471823742|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131052067|NCT02392234|471823743|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
131052068|NCT02392234|471823744|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
131052069|NCT02392234|471823739|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
131052070|NCT02392234|471823740|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
131052071|NCT02392234|471823741|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
131052072|NCT02392234|471823742|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
131052073|NCT02392234|471823743|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
131052074|NCT02392234|471823744|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
131052075|NCT02392234|471823739|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
131052076|NCT02392234|471823740|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
131052077|NCT02392234|471823741|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
131052078|NCT02392234|471823742|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
131052079|NCT02392234|471823743|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
131052080|NCT02392234|471823744|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
131052081|NCT02392234|471823739|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
131052082|NCT02392234|471823740|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
131052083|NCT02392234|471823741|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
131052084|NCT02392234|471823742|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
131052085|NCT02392234|471823743|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
131052086|NCT02392234|471823744|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
131052087|NCT02392234|471823739|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
131052088|NCT02392234|471823740|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
131052089|NCT02392234|471823741|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
131052090|NCT02392234|471823742|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
131052091|NCT02392234|471823743|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
131052092|NCT02392234|471823744|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
131052093|NCT02392234|471823739|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
131052094|NCT02392234|471823740|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
131052095|NCT02392234|471823741|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
131052096|NCT02392234|471823742|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
131052097|NCT02392234|471823743|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
131052098|NCT02392234|471823744|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
131052099|NCT02052440|471823749|FG000|Overall Study|Withdrawal by Subject|0|||
131052100|NCT02052440|471823750|FG001|Overall Study|Withdrawal by Subject|1|||
131052101|NCT02408887|471823751|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
131052102|NCT02408887|471823752|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
131052103|NCT02408887|471823751|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
131052104|NCT02408887|471823752|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
131052105|NCT03333109|471823753|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
131052106|NCT03333109|471823754|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
131052107|NCT03333109|471823755|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
131052108|NCT03333109|471823753|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131052109|NCT03333109|471823754|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
131052110|NCT03333109|471823755|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
131052111|NCT03333109|471823753|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
131052112|NCT03333109|471823754|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
131052113|NCT03333109|471823755|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
131052114|NCT03333109|471823753|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
131052115|NCT03333109|471823754|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
131052116|NCT03333109|471823755|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
131052117|NCT03333109|471823753|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
131052118|NCT03333109|471823754|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
131052119|NCT03333109|471823755|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
131052120|NCT03333109|471823753|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
131052121|NCT03333109|471823754|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
131052122|NCT03333109|471823755|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
131052123|NCT03333109|471823753|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
131052124|NCT03333109|471823754|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
131052125|NCT03333109|471823755|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
131052126|NCT03333109|471823753|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
131052127|NCT03333109|471823754|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
131052128|NCT03333109|471823755|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
131052129|NCT02078648|471823758|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
131052130|NCT02078648|471823759|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
131052131|NCT02078648|471823758|FG000|Overall Study|Adverse Event|0|||
131229663|NCT01799590|472467655|FG002|Overall Study|Lack of Efficacy|3|||
131229664|NCT01799590|472467653|FG000|Overall Study|Participants convenience|4|||
131229665|NCT01799590|472467654|FG001|Overall Study|Participants convenience|4|||
131229666|NCT01799590|472467655|FG002|Overall Study|Participants convenience|2|||
131229667|NCT01799590|472467653|FG000|Overall Study|Aggravation of complications|0|||
131229668|NCT01799590|472467654|FG001|Overall Study|Aggravation of complications|1|||
131229669|NCT01799590|472467655|FG002|Overall Study|Aggravation of complications|1|||
131229670|NCT01799590|472467653|FG000|Overall Study|Using drugs with restricted days of use|0|||
131052132|NCT02078648|471823759|FG001|Overall Study|Adverse Event|1|||
131052133|NCT02078648|471823758|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
131052134|NCT02078648|471823759|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
131052135|NCT02078648|471823758|FG000|Overall Study|Withdrawal by Subject|3|||
131052136|NCT02078648|471823759|FG001|Overall Study|Withdrawal by Subject|1|||
131052137|NCT02078648|471823758|FG000|Overall Study|Investigator Decision|5|||
131052138|NCT02078648|471823759|FG001|Overall Study|Investigator Decision|7|||
131052139|NCT02078648|471823758|FG000|Overall Study|Death|1|||
131052140|NCT02078648|471823759|FG001|Overall Study|Death|1|||
131052141|NCT02078648|471823758|FG000|Overall Study|Undefined|0|||
131052142|NCT02078648|471823759|FG001|Overall Study|Undefined|1|||
131052143|NCT04088227|471823760|FG000|Overall Study|Withdrawal by Subject|1|||
131052144|NCT04088227|471823761|FG001|Overall Study|Withdrawal by Subject|0|||
131052145|NCT04088227|471823760|FG000|Overall Study|Surgery postponed >5weeks|1|||
131052146|NCT04088227|471823761|FG001|Overall Study|Surgery postponed >5weeks|0|||
131052147|NCT05525572|471823762|FG000|Overall Study|Lost to Follow-up|2|||
131052148|NCT03425682|471823763|FG000|Overall Study|Lost to Follow-up|2|||
131052149|NCT03425682|471823764|FG001|Overall Study|Lost to Follow-up|4|||
131052150|NCT03425682|471823763|FG000|Overall Study|Withdrawal by Subject|0|||
131052151|NCT03425682|471823764|FG001|Overall Study|Withdrawal by Subject|3|||
131052152|NCT03425682|471823763|FG000|Overall Study|Subject did not meet I/E|4|||
131052153|NCT03425682|471823764|FG001|Overall Study|Subject did not meet I/E|10|||
131052154|NCT03277989|471823769|FG000|Overall Study|Lost to Follow-up|6|||
131052155|NCT03277989|471823769|FG000|Overall Study|Adverse Event|6|||
131052156|NCT03277989|471823769|FG000|Overall Study|Withdrawal by Subject|3|||
131052157|NCT03277989|471823769|FG000|Overall Study|Didn't Receive Study Device|7|||
131052158|NCT03277989|471823769|FG000|Overall Study|Site Closure|26|||
131052159|NCT03277989|471823769|FG000|Overall Study|Sponsor Closure|107|||
131052160|NCT03516942|471823770|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
131052161|NCT03516942|471823770|FG000|Registration Through Baseline Survey Com|Death|8|||
131052162|NCT03516942|471823770|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
131052163|NCT03516942|471823770|FG000|T0: Baseline|LOST|13|||
131052164|NCT03516942|471823770|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
131052165|NCT03516942|471823770|FG000|T1: 3 Months Survey|Death|10|||
131052166|NCT03516942|471823770|FG000|T1: 3 Months Survey|Lost|163|||
131052167|NCT03516942|471823770|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
131052168|NCT03516942|471823770|FG000|T2: 6 Month Survey|Death|14|||
131052169|NCT03516942|471823770|FG000|T2: 6 Month Survey|Lost|180|||
131052170|NCT03516942|471823770|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
131052171|NCT03516942|471823770|FG000|T3: 12 Month Survey|Death|19|||
131052172|NCT03516942|471823770|FG000|T3: 12 Month Survey|Lost|209|||
131052173|NCT02401815|471823771|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131229671|NCT01799590|472467654|FG001|Overall Study|Using drugs with restricted days of use|3|||
131229672|NCT01799590|472467655|FG002|Overall Study|Using drugs with restricted days of use|2|||
131229673|NCT01799590|472467653|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
130722291|NCT01755767|470608211|FG002|Overall Study|Death|15|||
131052174|NCT02401815|471823772|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131052175|NCT02401815|471823773|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131052176|NCT02401815|471823774|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
131052177|NCT02401815|471823775|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131052178|NCT02401815|471823776|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131052179|NCT02401815|471823777|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131052180|NCT02401815|471823778|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131052181|NCT02401815|471823779|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131052182|NCT02401815|471823780|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
131229674|NCT01799590|472467654|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
130722292|NCT01755767|470608212|FG003|Overall Study|Death|4|||
130722293|NCT01755767|470608209|FG000|Overall Study|Subject Decision|0|||
131229675|NCT01799590|472467655|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
131229676|NCT01799590|472467653|FG000|Overall Study|Other|3|||
131229677|NCT01799590|472467654|FG001|Overall Study|Other|0|||
131229678|NCT01799590|472467655|FG002|Overall Study|Other|1|||
131229679|NCT01489956|472467656|FG000|Overall Study|Lost to Follow-up|1|||
131229680|NCT01489956|472467657|FG001|Overall Study|Lost to Follow-up|0|||
131229681|NCT01489956|472467658|FG002|Overall Study|Lost to Follow-up|0|||
131229682|NCT01489956|472467656|FG000|Overall Study|Withdrawal by Subject|0|||
131229683|NCT01489956|472467657|FG001|Overall Study|Withdrawal by Subject|0|||
131229684|NCT01489956|472467658|FG002|Overall Study|Withdrawal by Subject|1|||
131229685|NCT03341507|472467659|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
131229686|NCT02927847|472467660|FG000|Overall Study|Lost to Follow-up|1|||
131229687|NCT02927847|472467661|FG001|Overall Study|Lost to Follow-up|0|||
131229688|NCT02927847|472467660|FG000|Overall Study|Withdrawal by Subject|4|||
131229689|NCT02927847|472467661|FG001|Overall Study|Withdrawal by Subject|2|||
131229690|NCT02927847|472467660|FG000|Overall Study|PI withdrawn due to missed visits|1|||
131229691|NCT02927847|472467661|FG001|Overall Study|PI withdrawn due to missed visits|1|||
131229692|NCT03687125|472467665|FG000|Overall Study|Progressive Disease|2|||
131229693|NCT03687125|472467666|FG001|Overall Study|Progressive Disease|1|||
131229694|NCT03687125|472467665|FG000|Overall Study|Protocol Violation|1|||
131229695|NCT03687125|472467666|FG001|Overall Study|Protocol Violation|0|||
131229696|NCT01992107|472467669|FG000|Overall Study|Administrative reasons|2|||
131229697|NCT01992107|472467670|FG001|Overall Study|Administrative reasons|0|||
131229698|NCT01992107|472467671|FG002|Overall Study|Administrative reasons|0|||
131229699|NCT01992107|472467669|FG000|Overall Study|Adverse Event|0|||
131229700|NCT01992107|472467670|FG001|Overall Study|Adverse Event|1|||
131229701|NCT01992107|472467671|FG002|Overall Study|Adverse Event|0|||
131229702|NCT01992107|472467669|FG000|Overall Study|Lost to Follow-up|46|||
131229703|NCT01992107|472467670|FG001|Overall Study|Lost to Follow-up|22|||
131229704|NCT01992107|472467671|FG002|Overall Study|Lost to Follow-up|26|||
131229705|NCT01992107|472467669|FG000|Overall Study|noncompliance and were unavailable|7|||
131229706|NCT01992107|472467670|FG001|Overall Study|noncompliance and were unavailable|3|||
131229707|NCT01992107|472467671|FG002|Overall Study|noncompliance and were unavailable|2|||
131229708|NCT01992107|472467669|FG000|Overall Study|Withdrawal by Subject|13|||
131229709|NCT01992107|472467670|FG001|Overall Study|Withdrawal by Subject|7|||
131229710|NCT01992107|472467671|FG002|Overall Study|Withdrawal by Subject|8|||
131229711|NCT02022007|472467672|FG000|Overall Study|Withdrawal by Subject|1|||
131229712|NCT02022007|472467673|FG001|Overall Study|Withdrawal by Subject|1|||
131229713|NCT02022007|472467674|FG002|Overall Study|Withdrawal by Subject|1|||
131229714|NCT02022007|472467672|FG000|Overall Study|Noncompliant|0|||
131229715|NCT02022007|472467673|FG001|Overall Study|Noncompliant|0|||
131229716|NCT02022007|472467674|FG002|Overall Study|Noncompliant|1|||
131229717|NCT02087046|472467675|FG000|Overall Study|Adverse Event|4|||
131229718|NCT02087046|472467675|FG000|Overall Study|Death|1|||
131229719|NCT02087046|472467675|FG000|Overall Study|Lost to Follow-up|3|||
131229720|NCT02087046|472467675|FG000|Overall Study|Withdrawal by Subject|2|||
131229721|NCT02087046|472467675|FG000|Overall Study|Physician Decision|1|||
131229722|NCT01107535|472467676|FG000|Overall Study|Death|5|||
131229723|NCT01214603|472467677|FG000|Overall Study|Adverse Event|0|||
131229724|NCT01214603|472467678|FG001|Overall Study|Adverse Event|0|||
131229725|NCT01214603|472467679|FG002|Overall Study|Adverse Event|1|||
131052183|NCT02401815|471823771|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
131052184|NCT02401815|471823772|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131052185|NCT02401815|471823773|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131052186|NCT02401815|471823774|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
131052187|NCT02401815|471823775|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131052188|NCT02401815|471823776|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131052189|NCT02401815|471823777|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131052190|NCT02401815|471823778|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131052191|NCT02401815|471823779|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131052192|NCT02401815|471823780|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
131052193|NCT02401815|471823771|FG000|Dose Escalation (up to 670 Days)|Death|1|||
130722294|NCT01755767|470608210|FG001|Overall Study|Subject Decision|0|||
131052194|NCT02401815|471823772|FG001|Dose Escalation (up to 670 Days)|Death|2|||
131229726|NCT01214603|472467677|FG000|Overall Study|Death|1|||
131229727|NCT01214603|472467678|FG001|Overall Study|Death|0|||
131229728|NCT01214603|472467679|FG002|Overall Study|Death|0|||
131229729|NCT01214603|472467677|FG000|Overall Study|Progressive Disease|4|||
131229730|NCT01214603|472467678|FG001|Overall Study|Progressive Disease|1|||
131229731|NCT01214603|472467679|FG002|Overall Study|Progressive Disease|3|||
130722295|NCT01755767|470608211|FG002|Overall Study|Subject Decision|10|||
131229732|NCT01388647|472467680|FG000|Overall Study|Adverse Event|1|||
131229733|NCT01388647|472467681|FG001|Overall Study|Adverse Event|2|||
131229734|NCT02444533|472467682|FG000|Overall Study|Not able to complete forms|0|||
131229735|NCT02444533|472467683|FG001|Overall Study|Not able to complete forms|2|||
131229736|NCT02444533|472467682|FG000|Overall Study|Only gave post-procedure complications|2|||
130722296|NCT01755767|470608212|FG003|Overall Study|Subject Decision|3|||
130722297|NCT01755767|470608209|FG000|Overall Study|Withdrawal by Subject|0|||
130722298|NCT01755767|470608210|FG001|Overall Study|Withdrawal by Subject|0|||
130722299|NCT01755767|470608211|FG002|Overall Study|Withdrawal by Subject|2|||
130722300|NCT01755767|470608212|FG003|Overall Study|Withdrawal by Subject|1|||
131052195|NCT02401815|471823773|FG002|Dose Escalation (up to 670 Days)|Death|3|||
131052196|NCT02401815|471823774|FG003|Dose Escalation (up to 670 Days)|Death|5|||
131052197|NCT02401815|471823775|FG004|Dose Escalation (up to 670 Days)|Death|4|||
131052198|NCT02401815|471823776|FG005|Dose Escalation (up to 670 Days)|Death|0|||
131052199|NCT02401815|471823777|FG006|Dose Escalation (up to 670 Days)|Death|0|||
131052200|NCT02401815|471823778|FG007|Dose Escalation (up to 670 Days)|Death|0|||
131052201|NCT02401815|471823779|FG008|Dose Escalation (up to 670 Days)|Death|0|||
131052202|NCT02401815|471823780|FG009|Dose Escalation (up to 670 Days)|Death|0|||
131052203|NCT02401815|471823771|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131052204|NCT02401815|471823772|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
131052205|NCT02401815|471823773|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131052206|NCT02401815|471823774|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131052207|NCT02401815|471823775|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
131052208|NCT02401815|471823776|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131052209|NCT02401815|471823777|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131052210|NCT02401815|471823778|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131052211|NCT02401815|471823779|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131052212|NCT02401815|471823780|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
131052213|NCT02401815|471823771|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
131052214|NCT02401815|471823772|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131052215|NCT02401815|471823773|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131052216|NCT02401815|471823774|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131052217|NCT02401815|471823775|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
131052218|NCT02401815|471823776|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131052219|NCT02401815|471823777|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131052220|NCT02401815|471823778|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131052221|NCT02401815|471823779|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131052222|NCT02401815|471823780|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
131052223|NCT02401815|471823771|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131052224|NCT02401815|471823772|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131052225|NCT02401815|471823773|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131052226|NCT02401815|471823774|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131052227|NCT02401815|471823775|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131052228|NCT02401815|471823776|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
131052229|NCT02401815|471823777|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131052230|NCT02401815|471823778|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131052231|NCT02401815|471823779|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131052232|NCT02401815|471823780|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
131052233|NCT02401815|471823771|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052234|NCT02401815|471823772|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052235|NCT02401815|471823773|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052236|NCT02401815|471823774|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052237|NCT02401815|471823775|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052238|NCT02401815|471823776|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052239|NCT02401815|471823777|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
131052240|NCT02401815|471823778|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052241|NCT02401815|471823779|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052242|NCT02401815|471823780|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052243|NCT02401815|471823771|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131052244|NCT02401815|471823772|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131052245|NCT02401815|471823773|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131052246|NCT02401815|471823774|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131052247|NCT02401815|471823775|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131052248|NCT02401815|471823776|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
131052249|NCT02401815|471823777|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
131052250|NCT02401815|471823778|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131052251|NCT02401815|471823779|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131052252|NCT02401815|471823780|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
131135510|NCT02289950|472122511|FG000|Overall Study|Other|5|||
130722301|NCT01755767|470608209|FG000|Overall Study|Other|0|||
130722302|NCT01755767|470608210|FG001|Overall Study|Other|0|||
131052253|NCT02401815|471823771|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131052254|NCT02401815|471823772|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131052255|NCT02401815|471823773|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
130722303|NCT01755767|470608211|FG002|Overall Study|Other|2|||
130722304|NCT01755767|470608212|FG003|Overall Study|Other|3|||
130722305|NCT01755767|470608209|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
130722306|NCT01755767|470608210|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
131052256|NCT02401815|471823774|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131052257|NCT02401815|471823775|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131052258|NCT02401815|471823776|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
131052259|NCT02401815|471823777|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131052260|NCT02401815|471823778|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131052261|NCT02401815|471823779|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131052262|NCT02401815|471823780|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
131052263|NCT02401815|471823771|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131052264|NCT02401815|471823772|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131052265|NCT02401815|471823773|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131052266|NCT02401815|471823774|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131052267|NCT02401815|471823775|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131052268|NCT02401815|471823776|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131052269|NCT02401815|471823777|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
131052270|NCT02401815|471823778|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
131052271|NCT02401815|471823779|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
131052272|NCT02401815|471823780|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
131052273|NCT02401815|471823771|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052274|NCT02401815|471823772|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052275|NCT02401815|471823773|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052276|NCT02401815|471823774|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052277|NCT02401815|471823775|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052278|NCT02401815|471823776|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052279|NCT02401815|471823777|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052280|NCT02401815|471823778|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
131052281|NCT02401815|471823779|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
131052282|NCT02401815|471823780|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
131052283|NCT02401815|471823771|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131052284|NCT02401815|471823772|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131052285|NCT02401815|471823773|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131052286|NCT02401815|471823774|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131052287|NCT02401815|471823775|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131052288|NCT02401815|471823776|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131052289|NCT02401815|471823777|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131052290|NCT02401815|471823778|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131052291|NCT02401815|471823779|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
131052292|NCT02401815|471823780|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
131052293|NCT02401815|471823771|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131052294|NCT02401815|471823772|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131052295|NCT02401815|471823773|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131052296|NCT02401815|471823774|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131052297|NCT02401815|471823775|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131052298|NCT02401815|471823776|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131052299|NCT02401815|471823777|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131052300|NCT02401815|471823778|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131052301|NCT02401815|471823779|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
131052302|NCT02401815|471823780|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
131052303|NCT02401815|471823771|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131052304|NCT02401815|471823772|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131052305|NCT02401815|471823773|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131052306|NCT02401815|471823774|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131052307|NCT02401815|471823775|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
130722307|NCT01755767|470608211|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
130722308|NCT01755767|470608212|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
131052308|NCT02401815|471823776|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131052309|NCT02401815|471823777|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131052310|NCT02401815|471823778|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
131052311|NCT02401815|471823779|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
131052312|NCT02401815|471823780|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
131052313|NCT05613907|471823781|FG000|Overall Study|Lost to Follow-up|5|||
131052314|NCT05613907|471823781|FG000|Overall Study|Death|3|||
131052315|NCT05613907|471823781|FG000|Overall Study|Withdrawal by Subject|2|||
131052316|NCT02751528|471823782|FG000|Overall Study|Withdrawal by Subject|1|||
131052317|NCT02751528|471823782|FG000|Overall Study|Adverse Event|1|||
131052318|NCT04218357|471823783|FG000|1st Allocation|Withdrawal by Subject|1|||
131052319|NCT04218357|471823784|FG001|1st Allocation|Withdrawal by Subject|0|||
131052320|NCT01958021|471823786|FG000|Treatment|Progressive disease|206|||
131052321|NCT01958021|471823787|FG001|Treatment|Progressive disease|265|||
131052322|NCT01958021|471823786|FG000|Treatment|Adverse Event|38|||
131052323|NCT01958021|471823787|FG001|Treatment|Adverse Event|10|||
131052324|NCT01958021|471823786|FG000|Treatment|Subject/guardian decision|29|||
131052325|NCT01958021|471823787|FG001|Treatment|Subject/guardian decision|25|||
131052326|NCT01958021|471823786|FG000|Treatment|Physician Decision|28|||
131052327|NCT01958021|471823787|FG001|Treatment|Physician Decision|21|||
131052328|NCT01958021|471823786|FG000|Treatment|Death|6|||
131052329|NCT01958021|471823787|FG001|Treatment|Death|1|||
131052330|NCT01958021|471823786|FG000|Treatment|Protocol deviation|3|||
131052331|NCT01958021|471823787|FG001|Treatment|Protocol deviation|1|||
131052332|NCT01958021|471823786|FG000|Treatment|Sponsor decision|24|||
131052333|NCT01958021|471823787|FG001|Treatment|Sponsor decision|11|||
131052334|NCT01958021|471823786|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
131052335|NCT01958021|471823787|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131052336|NCT01958021|471823786|FG000|Post-treatment Efficacy Follow-up|Death|1|||
131052337|NCT01958021|471823787|FG001|Post-treatment Efficacy Follow-up|Death|0|||
131052338|NCT01958021|471823786|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
131052339|NCT01958021|471823787|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131052340|NCT01958021|471823786|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131052341|NCT01958021|471823787|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
131052342|NCT01958021|471823786|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
131052343|NCT01958021|471823787|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
131052344|NCT01958021|471823786|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
131052345|NCT01958021|471823787|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
131052346|NCT01958021|471823786|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
131052347|NCT01958021|471823787|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
131052348|NCT03664804|471823789|FG000|Overall Study|Withdrawal by Subject|7|||
131052349|NCT04701203|471823790|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
131052350|NCT04701203|471823791|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
131052351|NCT04701203|471823792|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
131052352|NCT04701203|471823790|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
131052353|NCT04701203|471823791|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
131052354|NCT04701203|471823792|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
131052355|NCT04701203|471823790|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
131052356|NCT04701203|471823791|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
131052357|NCT04701203|471823792|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
131052358|NCT04701203|471823790|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
131052359|NCT04701203|471823791|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
131052360|NCT04701203|471823792|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
131052361|NCT06140290|471823794|FG000|Period 1|Adverse Event|1|||
131052362|NCT06140290|471823795|FG001|Period 1|Adverse Event|0|||
131052363|NCT06140290|471823794|FG000|Period 2|Assigned but not treated|0|||
131052364|NCT06140290|471823795|FG001|Period 2|Assigned but not treated|1|||
131052365|NCT06140290|471823794|FG000|Period 2|Withdrawal by Subject|0|||
131052366|NCT06140290|471823795|FG001|Period 2|Withdrawal by Subject|1|||
131052367|NCT01812759|471824911|FG000|Overall Study|Physician Decision|0|||
131052368|NCT01812759|471824912|FG001|Overall Study|Physician Decision|0|||
131052369|NCT01812759|471824913|FG002|Overall Study|Physician Decision|1|||
131052370|NCT00536120|471824914|FG000|Overall Study|Lost to Follow-up|1|||
131052371|NCT00536120|471824915|FG001|Overall Study|Lost to Follow-up|0|||
131052372|NCT00536120|471824914|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
131052373|NCT00536120|471824915|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
131052374|NCT00536120|471824914|FG000|Overall Study|Non-compliance|1|||
131052375|NCT00536120|471824915|FG001|Overall Study|Non-compliance|0|||
131052376|NCT00536120|471824914|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
131052377|NCT00536120|471824915|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
131052378|NCT00536120|471824914|FG000|Overall Study|Steroid Use|0|||
131052379|NCT00536120|471824915|FG001|Overall Study|Steroid Use|2|||
131052380|NCT00536120|471824914|FG000|Overall Study|Missed Study Visit|0|||
131052381|NCT00536120|471824915|FG001|Overall Study|Missed Study Visit|1|||
131052382|NCT02722434|471824916|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
131052383|NCT02722434|471824917|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
131135511|NCT02289950|472122512|FG001|Overall Study|Other|2|||
131135512|NCT02289950|472122511|FG000|Overall Study|Not Treated|2|||
131135513|NCT02289950|472122512|FG001|Overall Study|Not Treated|1|||
131135514|NCT05902364|472122515|FG000|Overall Study|Adverse Event|1|||
131135515|NCT05902364|472122516|FG001|Overall Study|Adverse Event|0|||
131135516|NCT00644787|472122517|FG000|Period 1: Titration Phase|Adverse Event|11|||
131135517|NCT00644787|472122518|FG001|Period 1: Titration Phase|Adverse Event|0|||
131135518|NCT00644787|472122519|FG002|Period 1: Titration Phase|Adverse Event|0|||
131135519|NCT00644787|472122517|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
131135520|NCT00644787|472122518|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
131135521|NCT00644787|472122519|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
131135522|NCT00644787|472122517|FG000|Period 1: Titration Phase|Physician Decision|1|||
131135523|NCT00644787|472122518|FG001|Period 1: Titration Phase|Physician Decision|0|||
131135524|NCT00644787|472122519|FG002|Period 1: Titration Phase|Physician Decision|0|||
131135525|NCT00644787|472122517|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
131135526|NCT00644787|472122518|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
131135527|NCT00644787|472122519|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
131135528|NCT00644787|472122517|FG000|Period 1: Titration Phase|Worsening of complications|1|||
131052384|NCT02722434|471824916|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
131052385|NCT02722434|471824917|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
131052386|NCT04989816|471824918|FG000|Overall Study|Death|77|||
131052387|NCT04989816|471824918|FG000|Overall Study|Lost to Follow-up|3|||
131052388|NCT00754325|471824919|FG000|Initial Treatment|Continuing Active Treatment|4|||
131052389|NCT00754325|471824920|FG001|Initial Treatment|Continuing Active Treatment|5|||
131052390|NCT00754325|471824919|FG000|Initial Treatment|Adverse Event|7|||
131052391|NCT00754325|471824920|FG001|Initial Treatment|Adverse Event|6|||
131052392|NCT00754325|471824919|FG000|Initial Treatment|Withdrawal by Subject|2|||
131052393|NCT00754325|471824920|FG001|Initial Treatment|Withdrawal by Subject|2|||
131052394|NCT00754325|471824919|FG000|Initial Treatment|Physician Decision|2|||
131052395|NCT00754325|471824920|FG001|Initial Treatment|Physician Decision|0|||
131052396|NCT00754325|471824919|FG000|Initial Treatment|Sponsor Request|0|||
131052397|NCT00754325|471824920|FG001|Initial Treatment|Sponsor Request|1|||
131052398|NCT00754325|471824919|FG000|Initial Treatment|Disease Progression|35|||
131052399|NCT00754325|471824920|FG001|Initial Treatment|Disease Progression|35|||
131052400|NCT03442777|471824921|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
131052401|NCT03442777|471824922|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
131052402|NCT03442777|471824923|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
131052403|NCT00439270|471824924|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
131052404|NCT00439270|471824925|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
131052405|NCT00439270|471824926|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
131052406|NCT00439270|471824927|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
131052407|NCT00439270|471824928|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
131052408|NCT00439270|471824924|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
131052409|NCT00439270|471824925|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
131052410|NCT00439270|471824926|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
131052411|NCT00439270|471824927|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
131052412|NCT00439270|471824928|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
131052413|NCT00439270|471824924|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
131052414|NCT00439270|471824925|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
131052415|NCT00439270|471824926|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
131052416|NCT00439270|471824927|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
131052417|NCT00439270|471824928|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
131052418|NCT00439270|471824924|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
131052419|NCT00439270|471824925|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
131052420|NCT00439270|471824926|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
131052421|NCT00439270|471824927|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
131052422|NCT00439270|471824928|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
131052423|NCT00439270|471824924|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
131052424|NCT00439270|471824925|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
131052425|NCT00439270|471824926|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
131052426|NCT00439270|471824927|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
131052427|NCT00439270|471824928|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
131052428|NCT00439270|471824924|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
131052429|NCT00439270|471824925|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
131052430|NCT00439270|471824926|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
131052431|NCT00439270|471824927|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
131135529|NCT00644787|472122518|FG001|Period 1: Titration Phase|Worsening of complications|0|||
131052432|NCT00439270|471824928|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
131052433|NCT00439270|471824924|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
131052434|NCT00439270|471824925|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
131052435|NCT00439270|471824926|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
131135530|NCT00644787|472122519|FG002|Period 1: Titration Phase|Worsening of complications|0|||
131135531|NCT00644787|472122517|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
131135532|NCT00644787|472122518|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
131135533|NCT00644787|472122519|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
131135534|NCT00644787|472122517|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
131135535|NCT00644787|472122518|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
131135536|NCT00644787|472122519|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
131135537|NCT00644787|472122517|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
131135538|NCT00644787|472122518|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
131135539|NCT00644787|472122519|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
131135540|NCT00644787|472122517|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
131135541|NCT00644787|472122518|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
131135542|NCT00644787|472122519|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
131135543|NCT00644787|472122517|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
131135544|NCT00644787|472122518|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
131135545|NCT00644787|472122519|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
131135546|NCT00644787|472122517|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
131135547|NCT00644787|472122518|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
131135548|NCT00644787|472122519|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
131135549|NCT00644787|472122517|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
131135550|NCT00644787|472122518|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
131135551|NCT00644787|472122519|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
131135552|NCT00936208|472122520|FG000|Overall Study|Protocol Violation|37|||
131135553|NCT00936208|472122521|FG001|Overall Study|Protocol Violation|22|||
131135554|NCT04428424|472122524|FG000|Overall Study|Does not meet entrance criteria|132|||
131135555|NCT04428424|472122524|FG000|Overall Study|Lost to Follow-up|115|||
131135556|NCT04818593|472122525|FG000|Overall Study|Low Oocyte Yield|8|||
131135557|NCT04818593|472122526|FG001|Overall Study|Low Oocyte Yield|8|||
131135558|NCT04818593|472122525|FG000|Overall Study|Not ICSI Insemination|7|||
131135559|NCT04818593|472122526|FG001|Overall Study|Not ICSI Insemination|7|||
131135560|NCT04818593|472122525|FG000|Overall Study|Poor Sperm Quality|2|||
131135561|NCT04818593|472122526|FG001|Overall Study|Poor Sperm Quality|2|||
131135562|NCT04818593|472122525|FG000|Overall Study|Withdrawal by Subject|2|||
131135563|NCT04818593|472122526|FG001|Overall Study|Withdrawal by Subject|2|||
131135564|NCT04818593|472122525|FG000|Overall Study|Conversion to IUI due to low response|1|||
131135565|NCT04818593|472122526|FG001|Overall Study|Conversion to IUI due to low response|1|||
131135566|NCT05036083|472122527|FG000|Overall Study|Physician Decision|1|||
131135567|NCT05036083|472122527|FG000|Overall Study|Withdrawal by Subject|1|||
131135568|NCT05036083|472122527|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
131135569|NCT05036083|472122527|FG000|Overall Study|IV not sustainable|1|||
131135570|NCT02968810|472124254|FG000|Overall Study|Lost to Follow-up|1|||
131135571|NCT02968810|472124255|FG001|Overall Study|Lost to Follow-up|0|||
131135572|NCT02968810|472124254|FG000|Overall Study|Physician Decision|1|||
131135573|NCT02968810|472124255|FG001|Overall Study|Physician Decision|0|||
131135574|NCT02968810|472124254|FG000|Overall Study|Withdrawal by Subject|1|||
131135575|NCT02968810|472124255|FG001|Overall Study|Withdrawal by Subject|3|||
131135576|NCT02968810|472124254|FG000|Overall Study|Disease Progression|0|||
131135577|NCT02968810|472124255|FG001|Overall Study|Disease Progression|1|||
131135578|NCT01790503|472124256|FG000|Overall Study|Adverse Event|1|||
131135579|NCT01790503|472124257|FG001|Overall Study|Adverse Event|0|||
131135580|NCT01790503|472124258|FG002|Overall Study|Adverse Event|0|||
131135581|NCT01790503|472124259|FG003|Overall Study|Adverse Event|0|||
131135582|NCT01790503|472124260|FG004|Overall Study|Adverse Event|0|||
131135583|NCT01790503|472124261|FG005|Overall Study|Adverse Event|2|||
131135584|NCT01790503|472124262|FG006|Overall Study|Adverse Event|0|||
131135585|NCT01790503|472124263|FG007|Overall Study|Adverse Event|0|||
131135586|NCT01790503|472124264|FG008|Overall Study|Adverse Event|2|||
131135587|NCT01790503|472124265|FG009|Overall Study|Adverse Event|4|||
131135588|NCT01790503|472124266|FG010|Overall Study|Adverse Event|7|||
131135589|NCT01790503|472124256|FG000|Overall Study|Withdrawal by Subject|0|||
131135590|NCT01790503|472124257|FG001|Overall Study|Withdrawal by Subject|0|||
131135591|NCT01790503|472124258|FG002|Overall Study|Withdrawal by Subject|1|||
131135592|NCT01790503|472124259|FG003|Overall Study|Withdrawal by Subject|1|||
131135593|NCT01790503|472124260|FG004|Overall Study|Withdrawal by Subject|1|||
131135594|NCT01790503|472124261|FG005|Overall Study|Withdrawal by Subject|2|||
131135595|NCT01790503|472124262|FG006|Overall Study|Withdrawal by Subject|1|||
131135596|NCT01790503|472124263|FG007|Overall Study|Withdrawal by Subject|0|||
131135597|NCT01790503|472124264|FG008|Overall Study|Withdrawal by Subject|0|||
131135598|NCT01790503|472124265|FG009|Overall Study|Withdrawal by Subject|0|||
131135599|NCT01790503|472124266|FG010|Overall Study|Withdrawal by Subject|1|||
131135600|NCT01790503|472124256|FG000|Overall Study|Disease progression|2|||
131229737|NCT02444533|472467683|FG001|Overall Study|Only gave post-procedure complications|2|||
130722309|NCT03464630|470608213|FG000|Overall Study|Lost to Follow-up|62|||
131052436|NCT00439270|471824927|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
131052437|NCT00439270|471824928|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
130722310|NCT03464630|470608214|FG001|Overall Study|Lost to Follow-up|52|||
130722311|NCT03464630|470608213|FG000|Overall Study|Withdrawal by Subject|16|||
130722312|NCT03464630|470608214|FG001|Overall Study|Withdrawal by Subject|10|||
130722313|NCT03464630|470608213|FG000|Overall Study|Passive Disengagement|8|||
130722314|NCT03464630|470608214|FG001|Overall Study|Passive Disengagement|4|||
130722315|NCT00191165|470608215|FG000|Overall Study|Adverse Event|2|||
130722316|NCT00191165|470608216|FG001|Overall Study|Adverse Event|0|||
131052438|NCT00439270|471824924|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
131052439|NCT00439270|471824925|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
131052440|NCT00439270|471824926|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
131052441|NCT00439270|471824927|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
131052442|NCT00439270|471824928|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
131052443|NCT00439270|471824924|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
131052444|NCT00439270|471824925|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
131052445|NCT00439270|471824926|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
131052446|NCT00439270|471824927|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
131052447|NCT00439270|471824928|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
131052448|NCT00439270|471824924|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
131052449|NCT00439270|471824925|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
131052450|NCT00439270|471824926|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
131052451|NCT00439270|471824927|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
131052452|NCT00439270|471824928|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
131052453|NCT01750684|471824929|FG000|Overall Study|Death|1|||
131052454|NCT01750684|471824930|FG001|Overall Study|Death|0|||
131052455|NCT01750684|471824929|FG000|Overall Study|Non-compliance with Study Drug|0|||
131052456|NCT01750684|471824930|FG001|Overall Study|Non-compliance with Study Drug|1|||
131052457|NCT01750684|471824929|FG000|Overall Study|Withdrawn by Sponsor|0|||
131052458|NCT01750684|471824930|FG001|Overall Study|Withdrawn by Sponsor|1|||
131052459|NCT01750684|471824929|FG000|Overall Study|Protocol Violation|1|||
131052460|NCT01750684|471824930|FG001|Overall Study|Protocol Violation|0|||
131052461|NCT01641900|471824931|FG000|Overall Study|Withdrawal by Subject|2|||
131052462|NCT01641900|471824932|FG001|Overall Study|Withdrawal by Subject|2|||
131052463|NCT02941549|471824933|FG000|Overall Study|Adverse Event|1|||
131052464|NCT02941549|471824934|FG001|Overall Study|Adverse Event|0|||
131052465|NCT02941549|471824935|FG002|Overall Study|Adverse Event|0|||
131052466|NCT02941549|471824933|FG000|Overall Study|Withdrawal by Subject|2|||
131052467|NCT02941549|471824934|FG001|Overall Study|Withdrawal by Subject|1|||
131052468|NCT02941549|471824935|FG002|Overall Study|Withdrawal by Subject|2|||
131052469|NCT03451422|471824938|FG000|Overall Study|Lost to Follow-up|0|||
131052470|NCT03451422|471824939|FG001|Overall Study|Lost to Follow-up|0|||
131052471|NCT03451422|471824940|FG002|Overall Study|Lost to Follow-up|0|||
131052472|NCT03451422|471824941|FG003|Overall Study|Lost to Follow-up|0|||
131052473|NCT03451422|471824942|FG004|Overall Study|Lost to Follow-up|0|||
131052474|NCT03451422|471824943|FG005|Overall Study|Lost to Follow-up|1|||
131052475|NCT03451422|471824938|FG000|Overall Study|Decision by sponsor|1|||
131052476|NCT03451422|471824939|FG001|Overall Study|Decision by sponsor|0|||
131052477|NCT03451422|471824940|FG002|Overall Study|Decision by sponsor|1|||
131052478|NCT03451422|471824941|FG003|Overall Study|Decision by sponsor|0|||
131052479|NCT03451422|471824942|FG004|Overall Study|Decision by sponsor|0|||
131052480|NCT03451422|471824943|FG005|Overall Study|Decision by sponsor|0|||
131052481|NCT03451422|471824938|FG000|Overall Study|Withdrawal by Subject|0|||
131052482|NCT03451422|471824939|FG001|Overall Study|Withdrawal by Subject|0|||
131052483|NCT03451422|471824940|FG002|Overall Study|Withdrawal by Subject|2|||
131052484|NCT03451422|471824941|FG003|Overall Study|Withdrawal by Subject|3|||
131052485|NCT03451422|471824942|FG004|Overall Study|Withdrawal by Subject|2|||
131052486|NCT03451422|471824943|FG005|Overall Study|Withdrawal by Subject|1|||
131052487|NCT00918333|471824944|FG000|Overall Study|Drug not taken per protocol|1|||
131052488|NCT00918333|471824945|FG001|Overall Study|Drug not taken per protocol|0|||
130722317|NCT00191165|470608215|FG000|Overall Study|Protocol Violation|0|||
130722318|NCT00191165|470608216|FG001|Overall Study|Protocol Violation|1|||
131052489|NCT00918333|471824944|FG000|Overall Study|Inadequate amount of drugs provided|1|||
131052490|NCT00918333|471824945|FG001|Overall Study|Inadequate amount of drugs provided|4|||
131052491|NCT00918333|471824944|FG000|Overall Study|Ineligible|1|||
131052492|NCT00918333|471824945|FG001|Overall Study|Ineligible|0|||
131052493|NCT00918333|471824944|FG000|Overall Study|Withdrawal by Subject|0|||
131052494|NCT00918333|471824945|FG001|Overall Study|Withdrawal by Subject|1|||
131052495|NCT01313884|471824947|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
131052496|NCT02463448|471824948|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
131052497|NCT02463448|471824948|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
131052498|NCT02463448|471824948|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
131052499|NCT02463448|471824948|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
130722319|NCT00191165|470608215|FG000|Overall Study|Participant Moved Away|0|||
131135601|NCT01790503|472124257|FG001|Overall Study|Disease progression|1|||
131135602|NCT01790503|472124258|FG002|Overall Study|Disease progression|0|||
131052500|NCT02964741|471824949|FG000|Overall Study|Protocol Violation|1|||
131052501|NCT02964741|471824950|FG001|Overall Study|Protocol Violation|0|||
131052502|NCT02964741|471824951|FG002|Overall Study|Protocol Violation|0|||
131052503|NCT02964741|471824949|FG000|Overall Study|Withdrawal by Subject|0|||
131052504|NCT02964741|471824950|FG001|Overall Study|Withdrawal by Subject|1|||
131052505|NCT02964741|471824951|FG002|Overall Study|Withdrawal by Subject|0|||
131135603|NCT01790503|472124259|FG003|Overall Study|Disease progression|1|||
131135604|NCT01790503|472124260|FG004|Overall Study|Disease progression|2|||
131135605|NCT01790503|472124261|FG005|Overall Study|Disease progression|1|||
131135606|NCT01790503|472124262|FG006|Overall Study|Disease progression|0|||
131135607|NCT01790503|472124263|FG007|Overall Study|Disease progression|1|||
131135608|NCT01790503|472124264|FG008|Overall Study|Disease progression|0|||
131135609|NCT01790503|472124265|FG009|Overall Study|Disease progression|17|||
131135610|NCT01790503|472124266|FG010|Overall Study|Disease progression|7|||
131135611|NCT01790503|472124256|FG000|Overall Study|Protocol Violation|0|||
131135612|NCT01790503|472124257|FG001|Overall Study|Protocol Violation|0|||
131135613|NCT01790503|472124258|FG002|Overall Study|Protocol Violation|0|||
131135614|NCT01790503|472124259|FG003|Overall Study|Protocol Violation|0|||
131135615|NCT01790503|472124260|FG004|Overall Study|Protocol Violation|0|||
131135616|NCT01790503|472124261|FG005|Overall Study|Protocol Violation|0|||
131135617|NCT01790503|472124262|FG006|Overall Study|Protocol Violation|0|||
131135618|NCT01790503|472124263|FG007|Overall Study|Protocol Violation|0|||
131135619|NCT01790503|472124264|FG008|Overall Study|Protocol Violation|0|||
131135620|NCT01790503|472124265|FG009|Overall Study|Protocol Violation|1|||
131135621|NCT01790503|472124266|FG010|Overall Study|Protocol Violation|0|||
131135622|NCT01790503|472124256|FG000|Overall Study|Physician Decision|0|||
131135623|NCT01790503|472124257|FG001|Overall Study|Physician Decision|0|||
131135624|NCT01790503|472124258|FG002|Overall Study|Physician Decision|0|||
131135625|NCT01790503|472124259|FG003|Overall Study|Physician Decision|0|||
131135626|NCT01790503|472124260|FG004|Overall Study|Physician Decision|0|||
131135627|NCT01790503|472124261|FG005|Overall Study|Physician Decision|0|||
131135628|NCT01790503|472124262|FG006|Overall Study|Physician Decision|0|||
131135629|NCT01790503|472124263|FG007|Overall Study|Physician Decision|0|||
131135630|NCT01790503|472124264|FG008|Overall Study|Physician Decision|0|||
131052506|NCT02964741|471824949|FG000|Overall Study|claustrophobia|1|||
131052507|NCT02964741|471824950|FG001|Overall Study|claustrophobia|0|||
131052508|NCT02964741|471824951|FG002|Overall Study|claustrophobia|0|||
131052509|NCT00640159|471824955|FG000|Overall Study|Lost to Follow-up|2|||
131052510|NCT00857766|471824962|FG000|Overall Study|Adverse Event|13|||
131052511|NCT00857766|471824963|FG001|Overall Study|Adverse Event|12|||
131052512|NCT00857766|471824962|FG000|Overall Study|Protocol Violation|11|||
131052513|NCT00857766|471824963|FG001|Overall Study|Protocol Violation|11|||
131052514|NCT00857766|471824962|FG000|Overall Study|Lost to Follow-up|1|||
131052515|NCT00857766|471824963|FG001|Overall Study|Lost to Follow-up|0|||
131052516|NCT00857766|471824962|FG000|Overall Study|Investigator Discretion|2|||
131052517|NCT00857766|471824963|FG001|Overall Study|Investigator Discretion|3|||
131052518|NCT00857766|471824962|FG000|Overall Study|Participant Withdrew Consent|4|||
131052519|NCT00857766|471824963|FG001|Overall Study|Participant Withdrew Consent|4|||
131052520|NCT01212744|471824970|FG000|Overall Study|Withdrawal by Subject|1|||
131052521|NCT02167451|471824971|FG000|Overall Study|Withdrawal by Subject|1|||
131052522|NCT03355573|471824972|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
131052523|NCT03355573|471824972|FG000|Overall Study|Sponsor's decision|1|||
131052524|NCT03355573|471824972|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
131052525|NCT03355573|471824972|FG000|Overall Study|PI's decision|2|||
131052526|NCT03355573|471824972|FG000|Overall Study|Withdrawal by Subject|23|||
131052527|NCT03355573|471824972|FG000|Overall Study|Lost to Follow-up|4|||
131052528|NCT03355573|471824972|FG000|Overall Study|Lack of Efficacy|2|||
131052529|NCT03355573|471824972|FG000|Overall Study|Adverse Event, non-fatal|17|||
131135631|NCT01790503|472124265|FG009|Overall Study|Physician Decision|1|||
131135632|NCT01790503|472124266|FG010|Overall Study|Physician Decision|1|||
131135633|NCT01790503|472124256|FG000|Overall Study|Death|0|||
131135634|NCT01790503|472124257|FG001|Overall Study|Death|0|||
131135635|NCT01790503|472124258|FG002|Overall Study|Death|0|||
131135636|NCT01790503|472124259|FG003|Overall Study|Death|0|||
131135637|NCT01790503|472124260|FG004|Overall Study|Death|0|||
131135638|NCT01790503|472124261|FG005|Overall Study|Death|0|||
131135639|NCT01790503|472124262|FG006|Overall Study|Death|0|||
131052530|NCT03355573|471824972|FG000|Overall Study|Adverse Event, serious fatal|2|||
131052531|NCT01536093|471824975|FG000|Overall Study|Death|1|||
131052532|NCT01536093|471824976|FG001|Overall Study|Death|2|||
131052533|NCT01536093|471824975|FG000|Overall Study|absence of maternal colostrum|2|||
131135640|NCT01790503|472124263|FG007|Overall Study|Death|0|||
131135641|NCT01790503|472124264|FG008|Overall Study|Death|0|||
131135642|NCT01790503|472124265|FG009|Overall Study|Death|1|||
131135643|NCT01790503|472124266|FG010|Overall Study|Death|0|||
131135644|NCT01790503|472124256|FG000|Overall Study|Non Compliance|0|||
131135645|NCT01790503|472124257|FG001|Overall Study|Non Compliance|0|||
131135646|NCT01790503|472124258|FG002|Overall Study|Non Compliance|0|||
131052534|NCT01536093|471824976|FG001|Overall Study|absence of maternal colostrum|0|||
131052535|NCT01536093|471824975|FG000|Overall Study|Withdrawal by Subject|0|||
131052536|NCT01536093|471824976|FG001|Overall Study|Withdrawal by Subject|1|||
131052537|NCT03631407|471824977|FG000|Overall Study|Withdrawal by Subject|3|||
131052538|NCT03631407|471824978|FG001|Overall Study|Withdrawal by Subject|2|||
131052539|NCT03631407|471824977|FG000|Overall Study|Sponsor Decision|0|||
131135647|NCT01790503|472124259|FG003|Overall Study|Non Compliance|0|||
131135648|NCT01790503|472124260|FG004|Overall Study|Non Compliance|1|||
131135649|NCT01790503|472124261|FG005|Overall Study|Non Compliance|0|||
131135650|NCT01790503|472124262|FG006|Overall Study|Non Compliance|0|||
131135651|NCT01790503|472124263|FG007|Overall Study|Non Compliance|0|||
131135652|NCT01790503|472124264|FG008|Overall Study|Non Compliance|0|||
131135653|NCT01790503|472124265|FG009|Overall Study|Non Compliance|0|||
131135654|NCT01790503|472124266|FG010|Overall Study|Non Compliance|0|||
131135655|NCT01790503|472124256|FG000|Overall Study|Other|0|||
131135656|NCT01790503|472124257|FG001|Overall Study|Other|0|||
131135657|NCT01790503|472124258|FG002|Overall Study|Other|0|||
131135658|NCT01790503|472124259|FG003|Overall Study|Other|0|||
131135659|NCT01790503|472124260|FG004|Overall Study|Other|1|||
131135660|NCT01790503|472124261|FG005|Overall Study|Other|0|||
131135661|NCT01790503|472124262|FG006|Overall Study|Other|0|||
131135662|NCT01790503|472124263|FG007|Overall Study|Other|0|||
131135663|NCT01790503|472124264|FG008|Overall Study|Other|1|||
131135664|NCT01790503|472124265|FG009|Overall Study|Other|2|||
131135665|NCT01790503|472124266|FG010|Overall Study|Other|0|||
131135666|NCT02605642|472124267|FG000|Overall Study|Other|11|||
131135667|NCT02605642|472124268|FG001|Overall Study|Other|1|||
131135668|NCT02605642|472124267|FG000|Overall Study|Participant non-compliance|2|||
131135669|NCT02605642|472124268|FG001|Overall Study|Participant non-compliance|4|||
131135670|NCT02605642|472124267|FG000|Overall Study|Physician Decision|10|||
131135671|NCT02605642|472124268|FG001|Overall Study|Physician Decision|0|||
131052540|NCT03631407|471824978|FG001|Overall Study|Sponsor Decision|2|||
131052541|NCT03631407|471824977|FG000|Overall Study|Death|16|||
131052542|NCT03631407|471824978|FG001|Overall Study|Death|16|||
131052543|NCT03631407|471824977|FG000|Overall Study|Randomized by mistake without study treatment|1|||
131052544|NCT03631407|471824978|FG001|Overall Study|Randomized by mistake without study treatment|0|||
131052545|NCT00942266|471824979|FG000|Overall Study|Withdrawal by Subject|1|||
131052546|NCT00942266|471824980|FG001|Overall Study|Withdrawal by Subject|0|||
131052547|NCT00942266|471824979|FG000|Overall Study|Adverse Event|2|||
131052548|NCT00942266|471824980|FG001|Overall Study|Adverse Event|1|||
131052549|NCT00942266|471824979|FG000|Overall Study|Disease Progression|38|||
131052550|NCT00942266|471824980|FG001|Overall Study|Disease Progression|11|||
131052551|NCT00942266|471824979|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
131052552|NCT00942266|471824980|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
131052553|NCT00942266|471824979|FG000|Overall Study|Intercurrent illness|0|||
131052554|NCT00942266|471824980|FG001|Overall Study|Intercurrent illness|1|||
131052555|NCT00942266|471824979|FG000|Overall Study|Physician Decision|2|||
131052556|NCT00942266|471824980|FG001|Overall Study|Physician Decision|0|||
131052557|NCT00942266|471824979|FG000|Overall Study|medical deterioration (pneumonia)|0|||
131052558|NCT00942266|471824980|FG001|Overall Study|medical deterioration (pneumonia)|1|||
131052559|NCT00756574|471824984|FG000|Overall Study|Withdrawal by Subject|9|||
131052560|NCT00756574|471824985|FG001|Overall Study|Withdrawal by Subject|7|||
131052561|NCT00756574|471824984|FG000|Overall Study|Lost to Follow-up|4|||
131052562|NCT00756574|471824985|FG001|Overall Study|Lost to Follow-up|4|||
131135672|NCT02605642|472124267|FG000|Overall Study|Lost to Follow-up|12|||
131135673|NCT02605642|472124268|FG001|Overall Study|Lost to Follow-up|1|||
131135674|NCT02605642|472124267|FG000|Overall Study|Adverse Event|14|||
131135675|NCT02605642|472124268|FG001|Overall Study|Adverse Event|2|||
131135676|NCT02605642|472124267|FG000|Overall Study|Withdrawal by Subject|23|||
131135677|NCT02605642|472124268|FG001|Overall Study|Withdrawal by Subject|2|||
131135678|NCT02605642|472124267|FG000|Overall Study|Lack of response|24|||
131135679|NCT02605642|472124268|FG001|Overall Study|Lack of response|11|||
131135680|NCT03269344|472124270|FG000|Overall Study|Protocol Violation|4|||
131135681|NCT03269344|472124271|FG001|Overall Study|Protocol Violation|3|||
131135682|NCT02597855|472124274|FG000|Overall Study|Lost to Follow-up|2|||
131135683|NCT02597855|472124275|FG001|Overall Study|Lost to Follow-up|1|||
131052563|NCT04795167|471824986|FG000|Overall Study|Death|1|||
131052564|NCT04795167|471824987|FG001|Overall Study|Death|18|||
131052565|NCT04795167|471824988|FG002|Overall Study|Death|1|||
131135684|NCT01449708|472124276|FG000|Overall Study|Protocol Violation|0|||
131135685|NCT01449708|472124277|FG001|Overall Study|Protocol Violation|1|||
131052566|NCT04795167|471824986|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
131052567|NCT04795167|471824987|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
131135686|NCT01449708|472124276|FG000|Overall Study|surgical complication|1|||
131135687|NCT01449708|472124277|FG001|Overall Study|surgical complication|2|||
131135688|NCT01449708|472124276|FG000|Overall Study|respiratory failure|1|||
131135689|NCT01449708|472124277|FG001|Overall Study|respiratory failure|0|||
131135690|NCT03704194|472124283|FG000|Overall Study|Withdrawal by Subject|0|||
131135691|NCT03704194|472124284|FG001|Overall Study|Withdrawal by Subject|1|||
131052568|NCT04795167|471824988|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
131052569|NCT00918203|471824990|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
131052570|NCT00918203|471824991|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
131052571|NCT00918203|471824992|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
131052572|NCT00918203|471824990|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
131052573|NCT00918203|471824991|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
131052574|NCT00918203|471824992|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
131052575|NCT00918203|471824990|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
131052576|NCT00918203|471824991|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
131052577|NCT00918203|471824992|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
131052578|NCT00918203|471824990|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
131052579|NCT00918203|471824991|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
131052580|NCT00918203|471824992|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
131052581|NCT03488719|471824997|FG000|Overall Study|Adverse Event|0|||
131052582|NCT03488719|471824998|FG001|Overall Study|Adverse Event|4|||
131052583|NCT03488719|471824999|FG002|Overall Study|Adverse Event|2|||
131052584|NCT03488719|471824997|FG000|Overall Study|Other|0|||
131052585|NCT03488719|471824998|FG001|Overall Study|Other|0|||
131052586|NCT03488719|471824999|FG002|Overall Study|Other|5|||
131052587|NCT03477175|471825004|FG000|Overall Study|Unable to travel due to COVID-19|0|||
131052588|NCT03477175|471825005|FG001|Overall Study|Unable to travel due to COVID-19|1|||
131052589|NCT03477175|471825004|FG000|Overall Study|Physician Decision|1|||
131052590|NCT03477175|471825005|FG001|Overall Study|Physician Decision|0|||
131052591|NCT03477175|471825004|FG000|Overall Study|Transitioned to commercial drug|6|||
131052592|NCT03477175|471825005|FG001|Overall Study|Transitioned to commercial drug|6|||
131052593|NCT03477175|471825004|FG000|Overall Study|Lost to Follow-up|1|||
131052594|NCT03477175|471825005|FG001|Overall Study|Lost to Follow-up|1|||
131052595|NCT03477175|471825004|FG000|Overall Study|Withdrawal by Subject|3|||
131135692|NCT00559507|472124285|FG000|Overall Study|Not treated, patient ineligible|3|||
131135693|NCT02889796|472124286|FG000|Overall Study|Withdrew Consent|18|||
131135694|NCT02889796|472124287|FG001|Overall Study|Withdrew Consent|29|||
131135695|NCT02889796|472124288|FG002|Overall Study|Withdrew Consent|20|||
131135696|NCT02889796|472124289|FG003|Overall Study|Withdrew Consent|1|||
131052596|NCT03477175|471825005|FG001|Overall Study|Withdrawal by Subject|1|||
131052597|NCT03477175|471825004|FG000|Overall Study|Adverse Event|1|||
131052598|NCT03477175|471825005|FG001|Overall Study|Adverse Event|5|||
131052599|NCT03477175|471825004|FG000|Overall Study|Disease Progression|7|||
131052600|NCT03477175|471825005|FG001|Overall Study|Disease Progression|7|||
131052601|NCT01675492|471825006|FG000|Overall Study|study completed early - product approval|42|||
131052602|NCT05025384|471825007|FG000|Overall Study|Physician Decision|5|||
131052603|NCT05025384|471825008|FG001|Overall Study|Physician Decision|6|||
131052604|NCT03610581|471825009|FG000|Overall Study|Study terminated by sponsor|2|||
131052605|NCT03610581|471825010|FG001|Overall Study|Study terminated by sponsor|0|||
131052606|NCT03610581|471825009|FG000|Overall Study|Other|0|||
131052607|NCT03610581|471825010|FG001|Overall Study|Other|1|||
131052608|NCT03610581|471825009|FG000|Overall Study|Withdrawal by Subject|1|||
131052609|NCT03610581|471825010|FG001|Overall Study|Withdrawal by Subject|0|||
131052610|NCT05485805|471825011|FG000|Overall Study|Withdrawal by Subject|1|||
131052611|NCT05485805|471825012|FG001|Overall Study|Withdrawal by Subject|2|||
131052612|NCT05485805|471825013|FG002|Overall Study|Withdrawal by Subject|2|||
131052613|NCT05485805|471825014|FG003|Overall Study|Withdrawal by Subject|0|||
131052614|NCT05485805|471825015|FG004|Overall Study|Withdrawal by Subject|2|||
131052615|NCT05485805|471825011|FG000|Overall Study|Adverse Event|0|||
131052616|NCT05485805|471825012|FG001|Overall Study|Adverse Event|1|||
131052617|NCT05485805|471825013|FG002|Overall Study|Adverse Event|0|||
131052618|NCT05485805|471825014|FG003|Overall Study|Adverse Event|0|||
131052619|NCT05485805|471825015|FG004|Overall Study|Adverse Event|0|||
131052620|NCT05485805|471825011|FG000|Overall Study|Lost to Follow-up|1|||
131052621|NCT05485805|471825012|FG001|Overall Study|Lost to Follow-up|1|||
131052622|NCT05485805|471825013|FG002|Overall Study|Lost to Follow-up|3|||
131052623|NCT05485805|471825014|FG003|Overall Study|Lost to Follow-up|1|||
131135697|NCT02889796|472124290|FG004|Overall Study|Withdrew Consent|2|||
131135698|NCT02889796|472124291|FG005|Overall Study|Withdrew Consent|35|||
131135699|NCT02889796|472124286|FG000|Overall Study|Investigator's Discretion|10|||
131135700|NCT02889796|472124287|FG001|Overall Study|Investigator's Discretion|9|||
131052624|NCT05485805|471825015|FG004|Overall Study|Lost to Follow-up|0|||
131052625|NCT02488408|471825017|FG000|Part A|Adverse Event|2|||
131052626|NCT02488408|471825018|FG001|Part A|Adverse Event|0|||
131052627|NCT02488408|471825019|FG002|Part A|Adverse Event|0|||
131135701|NCT02889796|472124288|FG002|Overall Study|Investigator's Discretion|10|||
131135702|NCT02889796|472124289|FG003|Overall Study|Investigator's Discretion|3|||
131052628|NCT02488408|471825020|FG003|Part A|Adverse Event|0|||
131052629|NCT02488408|471825021|FG004|Part A|Adverse Event|0|||
131052630|NCT02488408|471825022|FG005|Part A|Adverse Event|0|||
131052631|NCT02488408|471825023|FG006|Part A|Adverse Event|0|||
131052632|NCT02488408|471825024|FG007|Part A|Adverse Event|0|||
130722320|NCT00191165|470608216|FG001|Overall Study|Participant Moved Away|1|||
131052633|NCT02488408|471825025|FG008|Part A|Adverse Event|0|||
131052634|NCT02488408|471825026|FG009|Part A|Adverse Event|0|||
131052635|NCT02488408|471825017|FG000|Part A|Death|1|||
131052636|NCT02488408|471825018|FG001|Part A|Death|5|||
131052637|NCT02488408|471825019|FG002|Part A|Death|0|||
131052638|NCT02488408|471825020|FG003|Part A|Death|0|||
131052639|NCT02488408|471825021|FG004|Part A|Death|3|||
131052640|NCT02488408|471825022|FG005|Part A|Death|0|||
131052641|NCT02488408|471825023|FG006|Part A|Death|0|||
130722321|NCT03196635|470608217|FG000|Overall Study|Withdrawal by Subject|1|||
130722322|NCT00380744|470608221|FG000|Overall Study|Death|0|||
130722323|NCT00380744|470608222|FG001|Overall Study|Death|0|||
130722324|NCT00380744|470608223|FG002|Overall Study|Death|0|||
130722325|NCT00380744|470608224|FG003|Overall Study|Death|0|||
130722326|NCT00380744|470608225|FG004|Overall Study|Death|0|||
130722327|NCT00380744|470608226|FG005|Overall Study|Death|0|||
130722328|NCT00380744|470608227|FG006|Overall Study|Death|1|||
130722329|NCT00380744|470608221|FG000|Overall Study|Withdrawal by Subject|1|||
130722330|NCT00380744|470608222|FG001|Overall Study|Withdrawal by Subject|0|||
130722331|NCT00380744|470608223|FG002|Overall Study|Withdrawal by Subject|0|||
130722332|NCT00380744|470608224|FG003|Overall Study|Withdrawal by Subject|0|||
131052642|NCT02488408|471825024|FG007|Part A|Death|0|||
131052643|NCT02488408|471825025|FG008|Part A|Death|0|||
131052644|NCT02488408|471825026|FG009|Part A|Death|0|||
131052645|NCT02488408|471825017|FG000|Part A|Disease Progression|2|||
131052646|NCT02488408|471825018|FG001|Part A|Disease Progression|8|||
131052647|NCT02488408|471825019|FG002|Part A|Disease Progression|2|||
131052648|NCT02488408|471825020|FG003|Part A|Disease Progression|3|||
131052649|NCT02488408|471825021|FG004|Part A|Disease Progression|4|||
131052650|NCT02488408|471825022|FG005|Part A|Disease Progression|0|||
131052651|NCT02488408|471825023|FG006|Part A|Disease Progression|0|||
131052652|NCT02488408|471825024|FG007|Part A|Disease Progression|0|||
131052653|NCT02488408|471825025|FG008|Part A|Disease Progression|0|||
131052654|NCT02488408|471825026|FG009|Part A|Disease Progression|0|||
131052655|NCT02488408|471825017|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
131052656|NCT02488408|471825018|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
131052657|NCT02488408|471825019|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
131052658|NCT02488408|471825020|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
131052659|NCT02488408|471825021|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
131052660|NCT02488408|471825022|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
131052661|NCT02488408|471825023|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
131052662|NCT02488408|471825024|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
131052663|NCT02488408|471825025|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
131052664|NCT02488408|471825026|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
131052665|NCT02488408|471825017|FG000|Part A|Investigator Decision|0|||
131052666|NCT02488408|471825018|FG001|Part A|Investigator Decision|1|||
131052667|NCT02488408|471825019|FG002|Part A|Investigator Decision|1|||
131052668|NCT02488408|471825020|FG003|Part A|Investigator Decision|0|||
131052669|NCT02488408|471825021|FG004|Part A|Investigator Decision|0|||
131052670|NCT02488408|471825022|FG005|Part A|Investigator Decision|0|||
131052671|NCT02488408|471825023|FG006|Part A|Investigator Decision|0|||
131052672|NCT02488408|471825024|FG007|Part A|Investigator Decision|0|||
131052673|NCT02488408|471825025|FG008|Part A|Investigator Decision|0|||
131052674|NCT02488408|471825026|FG009|Part A|Investigator Decision|0|||
131052675|NCT02488408|471825017|FG000|Part A|Withdrawal by Subject|0|||
131052676|NCT02488408|471825018|FG001|Part A|Withdrawal by Subject|0|||
131052677|NCT02488408|471825019|FG002|Part A|Withdrawal by Subject|2|||
131052678|NCT02488408|471825020|FG003|Part A|Withdrawal by Subject|0|||
130722333|NCT00380744|470608225|FG004|Overall Study|Withdrawal by Subject|0|||
130722334|NCT00380744|470608226|FG005|Overall Study|Withdrawal by Subject|0|||
130722335|NCT00380744|470608227|FG006|Overall Study|Withdrawal by Subject|0|||
130722336|NCT01338870|470608228|FG000|Overall Study|Lost to Follow-up|0|||
130722337|NCT01338870|470608229|FG001|Overall Study|Lost to Follow-up|0|||
130722338|NCT01338870|470608230|FG002|Overall Study|Lost to Follow-up|1|||
131052679|NCT02488408|471825021|FG004|Part A|Withdrawal by Subject|0|||
131052680|NCT02488408|471825022|FG005|Part A|Withdrawal by Subject|0|||
131052681|NCT02488408|471825023|FG006|Part A|Withdrawal by Subject|0|||
131052682|NCT02488408|471825024|FG007|Part A|Withdrawal by Subject|0|||
130722339|NCT01338870|470608231|FG003|Overall Study|Lost to Follow-up|0|||
130722340|NCT01338870|470608232|FG004|Overall Study|Lost to Follow-up|1|||
131052683|NCT02488408|471825025|FG008|Part A|Withdrawal by Subject|0|||
131052684|NCT02488408|471825026|FG009|Part A|Withdrawal by Subject|0|||
131052685|NCT02488408|471825017|FG000|Part A|Other|1|||
131052686|NCT02488408|471825018|FG001|Part A|Other|0|||
131052687|NCT02488408|471825019|FG002|Part A|Other|0|||
130722341|NCT01338870|470608233|FG005|Overall Study|Lost to Follow-up|0|||
131052688|NCT02488408|471825020|FG003|Part A|Other|0|||
131052689|NCT02488408|471825021|FG004|Part A|Other|0|||
131052690|NCT02488408|471825022|FG005|Part A|Other|0|||
131052691|NCT02488408|471825023|FG006|Part A|Other|0|||
131052692|NCT02488408|471825024|FG007|Part A|Other|0|||
131052693|NCT02488408|471825025|FG008|Part A|Other|0|||
131052694|NCT02488408|471825026|FG009|Part A|Other|0|||
131052695|NCT02488408|471825017|FG000|Part B|Adverse Event|0|||
131052696|NCT02488408|471825018|FG001|Part B|Adverse Event|0|||
131052697|NCT02488408|471825019|FG002|Part B|Adverse Event|0|||
131052698|NCT02488408|471825020|FG003|Part B|Adverse Event|0|||
131052699|NCT02488408|471825021|FG004|Part B|Adverse Event|0|||
131052700|NCT02488408|471825022|FG005|Part B|Adverse Event|2|||
131052701|NCT02488408|471825023|FG006|Part B|Adverse Event|2|||
131052702|NCT02488408|471825024|FG007|Part B|Adverse Event|7|||
131052703|NCT02488408|471825025|FG008|Part B|Adverse Event|2|||
131052704|NCT02488408|471825026|FG009|Part B|Adverse Event|2|||
131052705|NCT02488408|471825017|FG000|Part B|Death|0|||
131052706|NCT02488408|471825018|FG001|Part B|Death|0|||
131052707|NCT02488408|471825019|FG002|Part B|Death|0|||
131052708|NCT02488408|471825020|FG003|Part B|Death|0|||
131052709|NCT02488408|471825021|FG004|Part B|Death|0|||
131052710|NCT02488408|471825022|FG005|Part B|Death|3|||
131052711|NCT02488408|471825023|FG006|Part B|Death|1|||
131052712|NCT02488408|471825024|FG007|Part B|Death|2|||
131052713|NCT02488408|471825025|FG008|Part B|Death|2|||
131052714|NCT02488408|471825026|FG009|Part B|Death|2|||
131052715|NCT02488408|471825017|FG000|Part B|Death due to Disease Progression|0|||
131052716|NCT02488408|471825018|FG001|Part B|Death due to Disease Progression|0|||
131052717|NCT02488408|471825019|FG002|Part B|Death due to Disease Progression|0|||
131052718|NCT02488408|471825020|FG003|Part B|Death due to Disease Progression|0|||
131052719|NCT02488408|471825021|FG004|Part B|Death due to Disease Progression|0|||
130722342|NCT01338870|470608228|FG000|Overall Study|Withdrawal by Subject|2|||
130722343|NCT01338870|470608229|FG001|Overall Study|Withdrawal by Subject|3|||
130722344|NCT01338870|470608230|FG002|Overall Study|Withdrawal by Subject|4|||
131052720|NCT02488408|471825022|FG005|Part B|Death due to Disease Progression|2|||
131052721|NCT02488408|471825023|FG006|Part B|Death due to Disease Progression|2|||
131052722|NCT02488408|471825024|FG007|Part B|Death due to Disease Progression|1|||
131052723|NCT02488408|471825025|FG008|Part B|Death due to Disease Progression|1|||
131052724|NCT02488408|471825026|FG009|Part B|Death due to Disease Progression|1|||
131052725|NCT02488408|471825017|FG000|Part B|Disease Progression|0|||
131052726|NCT02488408|471825018|FG001|Part B|Disease Progression|0|||
131052727|NCT02488408|471825019|FG002|Part B|Disease Progression|0|||
131052728|NCT02488408|471825020|FG003|Part B|Disease Progression|0|||
131052729|NCT02488408|471825021|FG004|Part B|Disease Progression|0|||
131052730|NCT02488408|471825022|FG005|Part B|Disease Progression|6|||
131052731|NCT02488408|471825023|FG006|Part B|Disease Progression|9|||
131052732|NCT02488408|471825024|FG007|Part B|Disease Progression|7|||
131052733|NCT02488408|471825025|FG008|Part B|Disease Progression|9|||
131052734|NCT02488408|471825026|FG009|Part B|Disease Progression|11|||
131052735|NCT02488408|471825017|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
131052736|NCT02488408|471825018|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
131052737|NCT02488408|471825019|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
131052738|NCT02488408|471825020|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
131052739|NCT02488408|471825021|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
131052740|NCT02488408|471825022|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
131052741|NCT02488408|471825023|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
131052742|NCT02488408|471825024|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
131052743|NCT02488408|471825025|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
131052744|NCT02488408|471825026|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
131052745|NCT02488408|471825017|FG000|Part B|Investigator Decision|0|||
131052746|NCT02488408|471825018|FG001|Part B|Investigator Decision|0|||
131052747|NCT02488408|471825019|FG002|Part B|Investigator Decision|0|||
131052748|NCT02488408|471825020|FG003|Part B|Investigator Decision|0|||
131052749|NCT02488408|471825021|FG004|Part B|Investigator Decision|0|||
131052750|NCT02488408|471825022|FG005|Part B|Investigator Decision|0|||
131052751|NCT02488408|471825023|FG006|Part B|Investigator Decision|1|||
131052752|NCT02488408|471825024|FG007|Part B|Investigator Decision|0|||
131052753|NCT02488408|471825025|FG008|Part B|Investigator Decision|2|||
131052754|NCT02488408|471825026|FG009|Part B|Investigator Decision|1|||
131052755|NCT05886777|471825029|FG000|Overall Study|Lost to Follow-up|1|||
131052756|NCT05886777|471825030|FG001|Overall Study|Lost to Follow-up|0|||
130722345|NCT01338870|470608231|FG003|Overall Study|Withdrawal by Subject|0|||
130722346|NCT01338870|470608232|FG004|Overall Study|Withdrawal by Subject|0|||
131052757|NCT05886777|471825031|FG002|Overall Study|Lost to Follow-up|2|||
131052758|NCT05886777|471825032|FG003|Overall Study|Lost to Follow-up|1|||
131052759|NCT05886777|471825033|FG004|Overall Study|Lost to Follow-up|0|||
131052760|NCT05886777|471825034|FG005|Overall Study|Lost to Follow-up|2|||
131052761|NCT05886777|471825035|FG006|Overall Study|Lost to Follow-up|0|||
131052762|NCT05886777|471825029|FG000|Overall Study|Other|0|||
131052763|NCT05886777|471825030|FG001|Overall Study|Other|2|||
131052764|NCT05886777|471825031|FG002|Overall Study|Other|1|||
131052765|NCT05886777|471825032|FG003|Overall Study|Other|0|||
131052766|NCT05886777|471825033|FG004|Overall Study|Other|0|||
131052767|NCT05886777|471825034|FG005|Overall Study|Other|0|||
131052768|NCT05886777|471825035|FG006|Overall Study|Other|0|||
131052769|NCT05886777|471825029|FG000|Overall Study|Withdrawal by Subject|1|||
131052770|NCT05886777|471825030|FG001|Overall Study|Withdrawal by Subject|0|||
131052771|NCT05886777|471825031|FG002|Overall Study|Withdrawal by Subject|1|||
131052772|NCT05886777|471825032|FG003|Overall Study|Withdrawal by Subject|4|||
131052773|NCT05886777|471825033|FG004|Overall Study|Withdrawal by Subject|3|||
131052774|NCT05886777|471825034|FG005|Overall Study|Withdrawal by Subject|1|||
131052775|NCT05886777|471825035|FG006|Overall Study|Withdrawal by Subject|1|||
131052776|NCT05886777|471825029|FG000|Overall Study|Protocol Violation|0|||
131052777|NCT05886777|471825030|FG001|Overall Study|Protocol Violation|0|||
131052778|NCT05886777|471825031|FG002|Overall Study|Protocol Violation|1|||
131052779|NCT05886777|471825032|FG003|Overall Study|Protocol Violation|0|||
131052780|NCT05886777|471825033|FG004|Overall Study|Protocol Violation|0|||
131052781|NCT05886777|471825034|FG005|Overall Study|Protocol Violation|0|||
131052782|NCT05886777|471825035|FG006|Overall Study|Protocol Violation|0|||
131052783|NCT05886777|471825029|FG000|Overall Study|No longer met eligibility criteria|0|||
131052784|NCT05886777|471825030|FG001|Overall Study|No longer met eligibility criteria|1|||
131052785|NCT05886777|471825031|FG002|Overall Study|No longer met eligibility criteria|0|||
131052786|NCT05886777|471825032|FG003|Overall Study|No longer met eligibility criteria|0|||
131052787|NCT05886777|471825033|FG004|Overall Study|No longer met eligibility criteria|0|||
131052788|NCT05886777|471825034|FG005|Overall Study|No longer met eligibility criteria|0|||
131052789|NCT05886777|471825035|FG006|Overall Study|No longer met eligibility criteria|0|||
131052790|NCT05293717|471825036|FG000|Overall Study|Physician Decision|1|||
131052791|NCT03083366|471826476|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
131052792|NCT03083366|471826477|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
131052793|NCT03083366|471826476|FG000|Enrollment Period|Lack of Efficacy|1|||
131052794|NCT03083366|471826477|FG001|Enrollment Period|Lack of Efficacy|0|||
131052795|NCT02036970|471826482|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
131052796|NCT02036970|471826483|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
131052797|NCT02036970|471826484|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
131052798|NCT02036970|471826485|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
131052799|NCT02036970|471826486|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
131052800|NCT02036970|471826487|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
131052801|NCT02036970|471826488|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
131052802|NCT02036970|471826489|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
131052803|NCT02036970|471826490|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
131052804|NCT02036970|471826491|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
131052805|NCT02036970|471826482|FG000|Part 1: Day 1 Through Week 16|Death|0|||
131052806|NCT02036970|471826483|FG001|Part 1: Day 1 Through Week 16|Death|0|||
131052807|NCT02036970|471826484|FG002|Part 1: Day 1 Through Week 16|Death|0|||
131052808|NCT02036970|471826485|FG003|Part 1: Day 1 Through Week 16|Death|0|||
131052809|NCT02036970|471826486|FG004|Part 1: Day 1 Through Week 16|Death|0|||
131052810|NCT02036970|471826487|FG005|Part 1: Day 1 Through Week 16|Death|0|||
131052811|NCT02036970|471826488|FG006|Part 1: Day 1 Through Week 16|Death|0|||
131052812|NCT02036970|471826489|FG007|Part 1: Day 1 Through Week 16|Death|0|||
131052813|NCT02036970|471826490|FG008|Part 1: Day 1 Through Week 16|Death|1|||
131052814|NCT02036970|471826491|FG009|Part 1: Day 1 Through Week 16|Death|0|||
131052815|NCT02036970|471826482|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
131052816|NCT02036970|471826483|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131052817|NCT02036970|471826484|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
131052818|NCT02036970|471826485|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131052819|NCT02036970|471826486|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131052820|NCT02036970|471826487|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131052821|NCT02036970|471826488|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131052822|NCT02036970|471826489|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131052823|NCT02036970|471826490|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
131052824|NCT02036970|471826491|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
131052825|NCT02036970|471826482|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131052826|NCT02036970|471826483|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131052827|NCT02036970|471826484|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131052828|NCT02036970|471826485|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131052829|NCT02036970|471826486|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
131052830|NCT02036970|471826487|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131052831|NCT02036970|471826488|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131052832|NCT02036970|471826489|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
131052833|NCT02036970|471826490|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
131052834|NCT02036970|471826491|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
131052835|NCT02036970|471826482|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131052836|NCT02036970|471826483|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131052837|NCT02036970|471826484|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131052838|NCT02036970|471826485|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
131052839|NCT02036970|471826486|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131052840|NCT02036970|471826487|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131229738|NCT03567057|472467684|FG000|Overall Study|Adverse Event|56|||
130722347|NCT01338870|470608233|FG005|Overall Study|Withdrawal by Subject|2|||
130722348|NCT01338870|470608228|FG000|Overall Study|Other|3|||
130722349|NCT01338870|470608229|FG001|Overall Study|Other|3|||
130722350|NCT01338870|470608230|FG002|Overall Study|Other|3|||
130722351|NCT01338870|470608231|FG003|Overall Study|Other|2|||
130722352|NCT01338870|470608232|FG004|Overall Study|Other|0|||
131052841|NCT02036970|471826488|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131052842|NCT02036970|471826489|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131052843|NCT02036970|471826490|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131052844|NCT02036970|471826491|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
131052845|NCT02036970|471826482|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
131052846|NCT02036970|471826483|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
131052847|NCT02036970|471826484|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
131052848|NCT02036970|471826485|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
131052849|NCT02036970|471826486|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
131052850|NCT02036970|471826487|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
131052851|NCT02036970|471826488|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
131052852|NCT02036970|471826489|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
131052853|NCT02036970|471826490|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
131052854|NCT02036970|471826491|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
131052855|NCT02036970|471826482|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
131052856|NCT02036970|471826483|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
131052857|NCT02036970|471826484|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
131052858|NCT02036970|471826485|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
131052859|NCT02036970|471826486|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
131052860|NCT02036970|471826487|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
131052861|NCT02036970|471826488|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
131052862|NCT02036970|471826489|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
131052863|NCT02036970|471826490|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
131052864|NCT02036970|471826491|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
131052865|NCT02036970|471826482|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131052866|NCT02036970|471826483|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
131052867|NCT02036970|471826484|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
131052868|NCT02036970|471826485|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131052869|NCT02036970|471826486|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131052870|NCT02036970|471826487|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131052871|NCT02036970|471826488|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131052872|NCT02036970|471826489|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131052873|NCT02036970|471826490|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
131052874|NCT02036970|471826491|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
131052875|NCT02036970|471826482|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
131052876|NCT02036970|471826483|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
131052877|NCT02036970|471826484|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
131052878|NCT02036970|471826485|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
131052879|NCT02036970|471826486|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
131052880|NCT02036970|471826487|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
131052881|NCT02036970|471826488|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
131052882|NCT02036970|471826489|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
131052883|NCT02036970|471826490|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
131052884|NCT02036970|471826491|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
131052885|NCT02386098|471826494|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
131052886|NCT02386098|471826495|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
131052887|NCT02386098|471826496|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
131052888|NCT02386098|471826497|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
131052889|NCT02386098|471826498|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
131052890|NCT02386098|471826494|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
131052891|NCT02386098|471826495|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
131052892|NCT02386098|471826496|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
131052893|NCT02386098|471826497|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
131052894|NCT02386098|471826498|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
131052895|NCT02386098|471826494|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
130722353|NCT01338870|470608233|FG005|Overall Study|Other|2|||
131052896|NCT02386098|471826495|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
131052897|NCT02386098|471826496|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
131052898|NCT02386098|471826497|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
131052899|NCT02386098|471826498|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
131052900|NCT02386098|471826494|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
131052901|NCT02386098|471826495|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
131052902|NCT02386098|471826496|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
130722354|NCT01338870|470608228|FG000|Overall Study|Protocol Violation|0|||
130722355|NCT01338870|470608229|FG001|Overall Study|Protocol Violation|2|||
130722356|NCT01338870|470608230|FG002|Overall Study|Protocol Violation|2|||
131135703|NCT02889796|472124290|FG004|Overall Study|Investigator's Discretion|0|||
131135704|NCT02889796|472124291|FG005|Overall Study|Investigator's Discretion|15|||
131135705|NCT02889796|472124286|FG000|Overall Study|Adverse Event|17|||
131135706|NCT02889796|472124287|FG001|Overall Study|Adverse Event|8|||
131135707|NCT02889796|472124288|FG002|Overall Study|Adverse Event|8|||
131135708|NCT02889796|472124289|FG003|Overall Study|Adverse Event|4|||
131135709|NCT02889796|472124290|FG004|Overall Study|Adverse Event|1|||
131135710|NCT02889796|472124291|FG005|Overall Study|Adverse Event|7|||
131135711|NCT02889796|472124286|FG000|Overall Study|Lost to Follow-up|5|||
131135712|NCT02889796|472124287|FG001|Overall Study|Lost to Follow-up|7|||
131135713|NCT02889796|472124288|FG002|Overall Study|Lost to Follow-up|2|||
131135714|NCT02889796|472124289|FG003|Overall Study|Lost to Follow-up|0|||
131135715|NCT02889796|472124290|FG004|Overall Study|Lost to Follow-up|2|||
131135716|NCT02889796|472124291|FG005|Overall Study|Lost to Follow-up|6|||
131135717|NCT02889796|472124286|FG000|Overall Study|Protocol Violation|0|||
131135718|NCT02889796|472124287|FG001|Overall Study|Protocol Violation|1|||
131135719|NCT02889796|472124288|FG002|Overall Study|Protocol Violation|3|||
131135720|NCT02889796|472124289|FG003|Overall Study|Protocol Violation|0|||
131135721|NCT02889796|472124290|FG004|Overall Study|Protocol Violation|0|||
131135722|NCT02889796|472124291|FG005|Overall Study|Protocol Violation|4|||
130722357|NCT01338870|470608231|FG003|Overall Study|Protocol Violation|2|||
130722358|NCT01338870|470608232|FG004|Overall Study|Protocol Violation|1|||
130722359|NCT01338870|470608233|FG005|Overall Study|Protocol Violation|1|||
130722360|NCT01338870|470608228|FG000|Overall Study|Adverse Event|4|||
130722361|NCT01338870|470608229|FG001|Overall Study|Adverse Event|4|||
131052903|NCT02386098|471826497|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
131052904|NCT02386098|471826498|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
131052905|NCT02386098|471826494|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
131052906|NCT02386098|471826495|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
131052907|NCT02386098|471826496|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
131052908|NCT02386098|471826497|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
131052909|NCT02386098|471826498|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
131052910|NCT02386098|471826494|FG000|Stage 1 (96 Weeks)|Other|1|||
131052911|NCT02386098|471826495|FG001|Stage 1 (96 Weeks)|Other|0|||
131052912|NCT02386098|471826496|FG002|Stage 1 (96 Weeks)|Other|0|||
131052913|NCT02386098|471826497|FG003|Stage 1 (96 Weeks)|Other|0|||
131052914|NCT02386098|471826498|FG004|Stage 1 (96 Weeks)|Other|0|||
131052915|NCT02386098|471826494|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
131052916|NCT02386098|471826495|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
131052917|NCT02386098|471826496|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
131052918|NCT02386098|471826497|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
131052919|NCT02386098|471826498|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
131052920|NCT03352713|471826502|FG000|Overall Study|Lost to Follow-up|8|||
131052921|NCT03352713|471826502|FG000|Overall Study|Withdrawn by investigator|5|||
131052922|NCT03352713|471826502|FG000|Overall Study|Completed 0 EMAs|8|||
131052923|NCT03352713|471826502|FG000|Overall Study|Device incompatible/stolen|5|||
131052924|NCT00360269|471826503|FG000|Overall Study|Lost to Follow-up|7|||
131052925|NCT00360269|471826504|FG001|Overall Study|Lost to Follow-up|9|||
131052926|NCT00360269|471826503|FG000|Overall Study|Physician Decision|1|||
131052927|NCT00360269|471826504|FG001|Overall Study|Physician Decision|2|||
131052928|NCT00360269|471826503|FG000|Overall Study|Adverse Event|1|||
131052929|NCT00360269|471826504|FG001|Overall Study|Adverse Event|0|||
131052930|NCT00360269|471826503|FG000|Overall Study|Withdrawal by Subject|1|||
131052931|NCT00360269|471826504|FG001|Overall Study|Withdrawal by Subject|1|||
131052932|NCT03002194|471826505|FG000|Overall Study|Lost to Follow-up|6|||
131052933|NCT03002194|471826505|FG000|Overall Study|Adverse Event|1|||
131052934|NCT03002194|471826505|FG000|Overall Study|Lack of Efficacy|1|||
131052935|NCT03002194|471826505|FG000|Overall Study|Withdrawal by Subject|2|||
131052936|NCT00048932|471826508|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
131052937|NCT00048932|471826509|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
131052938|NCT00048932|471826510|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
131052939|NCT00048932|471826508|FG000|Double Blind Period (DB)|Adverse Event|51|||
131052940|NCT00048932|471826509|FG001|Double Blind Period (DB)|Adverse Event|19|||
131052941|NCT00048932|471826510|FG002|Double Blind Period (DB)|Adverse Event|0|||
131052942|NCT00048932|471826508|FG000|Double Blind Period (DB)|Death|5|||
131052943|NCT00048932|471826509|FG001|Double Blind Period (DB)|Death|3|||
131052944|NCT00048932|471826510|FG002|Double Blind Period (DB)|Death|0|||
131052945|NCT00048932|471826508|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
131052946|NCT00048932|471826509|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
131052947|NCT00048932|471826510|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
131052948|NCT00048932|471826508|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
131135723|NCT02889796|472124286|FG000|Overall Study|Non-compliance With Study Drug|0|||
130722362|NCT01338870|470608230|FG002|Overall Study|Adverse Event|1|||
131135724|NCT02889796|472124287|FG001|Overall Study|Non-compliance With Study Drug|2|||
131135725|NCT02889796|472124288|FG002|Overall Study|Non-compliance With Study Drug|0|||
131229739|NCT03567057|472467685|FG001|Overall Study|Adverse Event|53|||
130722363|NCT01338870|470608231|FG003|Overall Study|Adverse Event|5|||
131135726|NCT02889796|472124289|FG003|Overall Study|Non-compliance With Study Drug|0|||
131135727|NCT02889796|472124290|FG004|Overall Study|Non-compliance With Study Drug|1|||
131135728|NCT02889796|472124291|FG005|Overall Study|Non-compliance With Study Drug|2|||
131135729|NCT02889796|472124286|FG000|Overall Study|Death|1|||
131135730|NCT02889796|472124287|FG001|Overall Study|Death|1|||
131135731|NCT02889796|472124288|FG002|Overall Study|Death|0|||
131135732|NCT02889796|472124289|FG003|Overall Study|Death|1|||
131135733|NCT02889796|472124290|FG004|Overall Study|Death|0|||
131135734|NCT02889796|472124291|FG005|Overall Study|Death|1|||
131052949|NCT00048932|471826509|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
131052950|NCT00048932|471826510|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
131052951|NCT00048932|471826508|FG000|Double Blind Period (DB)|Relocation|1|||
131052952|NCT00048932|471826509|FG001|Double Blind Period (DB)|Relocation|0|||
131052953|NCT00048932|471826510|FG002|Double Blind Period (DB)|Relocation|0|||
131052954|NCT00048932|471826508|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
131052955|NCT00048932|471826509|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
131052956|NCT00048932|471826510|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
131052957|NCT00048932|471826508|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
131052958|NCT00048932|471826509|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
131052959|NCT00048932|471826510|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
131052960|NCT00048932|471826508|FG000|Double Blind Period (DB)|Pregnancy|1|||
131052961|NCT00048932|471826509|FG001|Double Blind Period (DB)|Pregnancy|0|||
131052962|NCT00048932|471826510|FG002|Double Blind Period (DB)|Pregnancy|0|||
131052963|NCT00048932|471826508|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
131052964|NCT00048932|471826509|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
131052965|NCT00048932|471826510|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
131052966|NCT00048932|471826508|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
131052967|NCT00048932|471826509|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
131052968|NCT00048932|471826510|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
131052969|NCT00048932|471826508|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
131052970|NCT00048932|471826509|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
131135735|NCT02889796|472124286|FG000|Overall Study|Pregnancy|0|||
131135736|NCT02889796|472124287|FG001|Overall Study|Pregnancy|1|||
131135737|NCT02889796|472124288|FG002|Overall Study|Pregnancy|1|||
131135738|NCT02889796|472124289|FG003|Overall Study|Pregnancy|0|||
131135739|NCT02889796|472124290|FG004|Overall Study|Pregnancy|0|||
131135740|NCT02889796|472124291|FG005|Overall Study|Pregnancy|0|||
131135741|NCT02889796|472124286|FG000|Overall Study|Randomized but not Dosed|2|||
131135742|NCT02889796|472124287|FG001|Overall Study|Randomized but not Dosed|0|||
131135743|NCT02889796|472124288|FG002|Overall Study|Randomized but not Dosed|0|||
131135744|NCT02889796|472124289|FG003|Overall Study|Randomized but not Dosed|0|||
131135745|NCT02889796|472124290|FG004|Overall Study|Randomized but not Dosed|0|||
131135746|NCT02889796|472124291|FG005|Overall Study|Randomized but not Dosed|2|||
131135747|NCT02479802|472124293|FG000|Overall Study|Lost to Follow-up|1|||
131135748|NCT02479802|472124293|FG000|Overall Study|Adverse Event|1|||
131135749|NCT01882907|472124294|FG000|Overall Study|Adverse Event|3|||
131135750|NCT01882907|472124295|FG001|Overall Study|Adverse Event|1|||
131135751|NCT01882907|472124294|FG000|Overall Study|Lack of Efficacy|0|||
131135752|NCT01882907|472124295|FG001|Overall Study|Lack of Efficacy|3|||
131135753|NCT01882907|472124294|FG000|Overall Study|Lost to Follow-up|1|||
131135754|NCT01882907|472124295|FG001|Overall Study|Lost to Follow-up|4|||
131135755|NCT01882907|472124294|FG000|Overall Study|Protocol Violation|10|||
131135756|NCT01882907|472124295|FG001|Overall Study|Protocol Violation|14|||
131135757|NCT01882907|472124294|FG000|Overall Study|Withdrawal by Subject|0|||
131135758|NCT01882907|472124295|FG001|Overall Study|Withdrawal by Subject|6|||
131135759|NCT01978093|472124296|FG000|Overall Study|Death|1|||
131135760|NCT01978093|472124297|FG001|Overall Study|Death|0|||
131135761|NCT01978093|472124296|FG000|Overall Study|Adverse Event|0|||
131135762|NCT01978093|472124297|FG001|Overall Study|Adverse Event|5|||
131135763|NCT01978093|472124296|FG000|Overall Study|Protocol Violation|8|||
131135764|NCT01978093|472124297|FG001|Overall Study|Protocol Violation|2|||
131135765|NCT01978093|472124296|FG000|Overall Study|Withdrawal by Subject|29|||
131135766|NCT01978093|472124297|FG001|Overall Study|Withdrawal by Subject|25|||
131052971|NCT00048932|471826510|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
131052972|NCT00048932|471826508|FG000|Open Label Period (OL)|Death|0|||
131135767|NCT01978093|472124296|FG000|Overall Study|Lost to Follow-up|11|||
131135768|NCT01978093|472124297|FG001|Overall Study|Lost to Follow-up|15|||
131135769|NCT01978093|472124296|FG000|Overall Study|Migrated/moved from study area|11|||
131135770|NCT01978093|472124297|FG001|Overall Study|Migrated/moved from study area|13|||
131135771|NCT01978093|472124296|FG000|Overall Study|Loss of kaiser coverage|4|||
131135772|NCT01978093|472124297|FG001|Overall Study|Loss of kaiser coverage|10|||
131135773|NCT01978093|472124296|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
131135774|NCT01978093|472124297|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
131135775|NCT01978093|472124296|FG000|Overall Study|Mother lost custody of child|0|||
131229740|NCT03567057|472467686|FG002|Overall Study|Adverse Event|28|||
131229741|NCT03567057|472467684|FG000|Overall Study|Withdrawal by Subject|22|||
131052973|NCT00048932|471826509|FG001|Open Label Period (OL)|Death|0|||
131052974|NCT00048932|471826510|FG002|Open Label Period (OL)|Death|25|||
131052975|NCT00048932|471826508|FG000|Open Label Period (OL)|Adverse Event|0|||
131052976|NCT00048932|471826509|FG001|Open Label Period (OL)|Adverse Event|0|||
131052977|NCT00048932|471826510|FG002|Open Label Period (OL)|Adverse Event|103|||
131052978|NCT00048932|471826508|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
131052979|NCT00048932|471826509|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
131052980|NCT00048932|471826510|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
131052981|NCT00048932|471826508|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
131052982|NCT00048932|471826509|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
131052983|NCT00048932|471826510|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
131052984|NCT00048932|471826508|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
131052985|NCT00048932|471826509|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
131052986|NCT00048932|471826510|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
131052987|NCT00048932|471826508|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
131052988|NCT00048932|471826509|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
131052989|NCT00048932|471826510|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
131052990|NCT00048932|471826508|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
131052991|NCT00048932|471826509|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
131052992|NCT00048932|471826510|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
131052993|NCT00048932|471826508|FG000|Open Label Period (OL)|Pregnancy|0|||
131052994|NCT00048932|471826509|FG001|Open Label Period (OL)|Pregnancy|0|||
131052995|NCT00048932|471826510|FG002|Open Label Period (OL)|Pregnancy|6|||
131052996|NCT00048932|471826508|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
131052997|NCT00048932|471826509|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
131052998|NCT00048932|471826510|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
131052999|NCT00048932|471826508|FG000|Open Label Period (OL)|Investigator Retiring|0|||
131053000|NCT00048932|471826509|FG001|Open Label Period (OL)|Investigator Retiring|0|||
131053001|NCT00048932|471826510|FG002|Open Label Period (OL)|Investigator Retiring|2|||
131053002|NCT00048932|471826508|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
131053003|NCT00048932|471826509|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
131053004|NCT00048932|471826510|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
131053005|NCT00048932|471826508|FG000|Open Label Period (OL)|Participant Relocated|0|||
131053006|NCT00048932|471826509|FG001|Open Label Period (OL)|Participant Relocated|0|||
131053007|NCT00048932|471826510|FG002|Open Label Period (OL)|Participant Relocated|6|||
131053008|NCT00048932|471826508|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
131053009|NCT00048932|471826509|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
131053010|NCT00048932|471826510|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
131053011|NCT00048932|471826508|FG000|Open Label Period (OL)|Site Closure|0|||
131053012|NCT00048932|471826509|FG001|Open Label Period (OL)|Site Closure|0|||
131053013|NCT00048932|471826510|FG002|Open Label Period (OL)|Site Closure|3|||
131053014|NCT00048932|471826508|FG000|Open Label Period (OL)|Trial Terminated|0|||
131053015|NCT00048932|471826509|FG001|Open Label Period (OL)|Trial Terminated|0|||
131053016|NCT00048932|471826510|FG002|Open Label Period (OL)|Trial Terminated|1|||
131053017|NCT00048932|471826508|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
131053018|NCT00048932|471826509|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
131053019|NCT00048932|471826510|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
131053020|NCT00048932|471826508|FG000|Open Label Period (OL)|Patient Decision|0|||
131053021|NCT00048932|471826509|FG001|Open Label Period (OL)|Patient Decision|0|||
131053022|NCT00048932|471826510|FG002|Open Label Period (OL)|Patient Decision|4|||
131053023|NCT00048932|471826508|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
131053024|NCT00048932|471826509|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
131053025|NCT00048932|471826510|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
131053026|NCT00048932|471826508|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
131053027|NCT00048932|471826509|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
131053028|NCT00048932|471826510|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
131053029|NCT00048932|471826508|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
131053030|NCT00048932|471826509|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
131053031|NCT00048932|471826510|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
131053032|NCT00048932|471826508|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
131053033|NCT00048932|471826509|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
130722364|NCT01338870|470608232|FG004|Overall Study|Adverse Event|4|||
130722365|NCT01338870|470608233|FG005|Overall Study|Adverse Event|1|||
131053034|NCT00048932|471826510|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
131053035|NCT00048932|471826508|FG000|Open Label Period (OL)|Investigator Decision|0|||
131053036|NCT00048932|471826509|FG001|Open Label Period (OL)|Investigator Decision|0|||
131053037|NCT00048932|471826510|FG002|Open Label Period (OL)|Investigator Decision|4|||
131053038|NCT00048932|471826508|FG000|Open Label Period (OL)|Site Staff Issues|0|||
131053039|NCT00048932|471826509|FG001|Open Label Period (OL)|Site Staff Issues|0|||
130722366|NCT00077857|470608236|FG000|Overall Study|Adverse Event|30|||
131053040|NCT00048932|471826510|FG002|Open Label Period (OL)|Site Staff Issues|2|||
131053041|NCT00048932|471826508|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
131053042|NCT00048932|471826509|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
131053043|NCT00048932|471826510|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
131053044|NCT00048932|471826508|FG000|Open Label Period (OL)|Participant Surgery|0|||
131053045|NCT00048932|471826509|FG001|Open Label Period (OL)|Participant Surgery|0|||
131053046|NCT00048932|471826510|FG002|Open Label Period (OL)|Participant Surgery|1|||
131053047|NCT02232737|471826511|FG000|Overall Study|Lost to Follow-up|18|||
131053048|NCT02232737|471826512|FG001|Overall Study|Lost to Follow-up|28|||
131053049|NCT02232737|471826513|FG002|Overall Study|Lost to Follow-up|33|||
131053050|NCT02232737|471826511|FG000|Overall Study|Personal reasons|7|||
131053051|NCT02232737|471826512|FG001|Overall Study|Personal reasons|8|||
131053052|NCT02232737|471826513|FG002|Overall Study|Personal reasons|14|||
131053053|NCT02232737|471826511|FG000|Overall Study|Adverse Event|6|||
131053054|NCT02232737|471826512|FG001|Overall Study|Adverse Event|3|||
131053055|NCT02232737|471826513|FG002|Overall Study|Adverse Event|8|||
131053056|NCT02232737|471826511|FG000|Overall Study|Incarcerated|2|||
131053057|NCT02232737|471826512|FG001|Overall Study|Incarcerated|1|||
131053058|NCT02232737|471826513|FG002|Overall Study|Incarcerated|2|||
131053059|NCT02232737|471826511|FG000|Overall Study|Withdrawal by Subject|0|||
131053060|NCT02232737|471826512|FG001|Overall Study|Withdrawal by Subject|1|||
131053061|NCT02232737|471826513|FG002|Overall Study|Withdrawal by Subject|2|||
131053062|NCT02232737|471826511|FG000|Overall Study|Death|0|||
131053063|NCT02232737|471826512|FG001|Overall Study|Death|1|||
131053064|NCT02232737|471826513|FG002|Overall Study|Death|1|||
131053065|NCT02232737|471826511|FG000|Overall Study|Physician Decision|1|||
131053066|NCT02232737|471826512|FG001|Overall Study|Physician Decision|3|||
131053067|NCT02232737|471826513|FG002|Overall Study|Physician Decision|1|||
131053068|NCT02232737|471826511|FG000|Overall Study|Protocol Violation|1|||
131053069|NCT02232737|471826512|FG001|Overall Study|Protocol Violation|0|||
131053070|NCT02232737|471826513|FG002|Overall Study|Protocol Violation|1|||
131053071|NCT02232737|471826511|FG000|Overall Study|Reason unknown|1|||
131053072|NCT02232737|471826512|FG001|Overall Study|Reason unknown|0|||
131053073|NCT02232737|471826513|FG002|Overall Study|Reason unknown|0|||
131053074|NCT04559698|471826514|FG000|Overall Study|Lost to Follow-up|14|||
131053075|NCT04559698|471826515|FG001|Overall Study|Lost to Follow-up|15|||
131053076|NCT04559698|471826514|FG000|Overall Study|Withdrawal by Subject|0|||
131053077|NCT04559698|471826515|FG001|Overall Study|Withdrawal by Subject|1|||
131053078|NCT02200705|471826525|FG000|Overall Study|Excluded|12|||
131053079|NCT02200705|471826525|FG000|Overall Study|Death|21|||
131053080|NCT02200705|471826525|FG000|Overall Study|Withdrawal by Subject|22|||
131053081|NCT02200705|471826525|FG000|Overall Study|Lost to Follow-up|13|||
131053082|NCT02200705|471826525|FG000|Overall Study|Physician Decision|5|||
131053083|NCT02200705|471826525|FG000|Overall Study|Adverse Event|2|||
131053084|NCT03437733|471826526|FG000|Overall Study|Eligibility criteria not met|0|||
131053085|NCT03437733|471826527|FG001|Overall Study|Eligibility criteria not met|3|||
131053086|NCT00786864|471826528|FG000|Overall Study|Lost to Follow-up|0|||
131053087|NCT00786864|471826529|FG001|Overall Study|Lost to Follow-up|1|||
131053088|NCT00786864|471826528|FG000|Overall Study|Sustained serious back injury|1|||
131053089|NCT00786864|471826529|FG001|Overall Study|Sustained serious back injury|0|||
131053090|NCT04162210|471826537|FG000|Overall Study|Lost to Follow-up|4|||
131053091|NCT04162210|471826538|FG001|Overall Study|Lost to Follow-up|1|||
131053092|NCT04162210|471826537|FG000|Overall Study|Withdrawal by Subject|17|||
131053093|NCT04162210|471826538|FG001|Overall Study|Withdrawal by Subject|9|||
131053094|NCT04162210|471826537|FG000|Overall Study|Ongoing|113|||
131053095|NCT04162210|471826538|FG001|Overall Study|Ongoing|59|||
131053096|NCT03220724|471826544|FG000|Overall Study|Lost to Follow-up|2|||
131053097|NCT03220724|471826545|FG001|Overall Study|Lost to Follow-up|2|||
131053098|NCT03220724|471826546|FG002|Overall Study|Lost to Follow-up|0|||
131053099|NCT03220724|471826547|FG003|Overall Study|Lost to Follow-up|3|||
131053100|NCT03220724|471826548|FG004|Overall Study|Lost to Follow-up|1|||
131053101|NCT03220724|471826549|FG005|Overall Study|Lost to Follow-up|0|||
130722367|NCT00077857|470608237|FG001|Overall Study|Adverse Event|32|||
131053102|NCT03220724|471826550|FG006|Overall Study|Lost to Follow-up|2|||
131053103|NCT03220724|471826551|FG007|Overall Study|Lost to Follow-up|1|||
131053104|NCT03220724|471826552|FG008|Overall Study|Lost to Follow-up|0|||
131053105|NCT03220724|471826544|FG000|Overall Study|Withdrawal by Subject|1|||
131053106|NCT03220724|471826545|FG001|Overall Study|Withdrawal by Subject|0|||
131053107|NCT03220724|471826546|FG002|Overall Study|Withdrawal by Subject|1|||
130722368|NCT00077857|470608236|FG000|Overall Study|Death|7|||
130722369|NCT00077857|470608237|FG001|Overall Study|Death|3|||
130722370|NCT00077857|470608236|FG000|Overall Study|Insufficient therapeutic response|112|||
130722371|NCT00077857|470608237|FG001|Overall Study|Insufficient therapeutic response|128|||
131053108|NCT03220724|471826547|FG003|Overall Study|Withdrawal by Subject|0|||
131053109|NCT03220724|471826548|FG004|Overall Study|Withdrawal by Subject|0|||
131053110|NCT03220724|471826549|FG005|Overall Study|Withdrawal by Subject|0|||
131053111|NCT03220724|471826550|FG006|Overall Study|Withdrawal by Subject|0|||
131135776|NCT01978093|472124297|FG001|Overall Study|Mother lost custody of child|1|||
131053112|NCT03220724|471826551|FG007|Overall Study|Withdrawal by Subject|0|||
131053113|NCT03220724|471826552|FG008|Overall Study|Withdrawal by Subject|0|||
131053114|NCT03601715|471826553|FG000|Second Intervention|Lost to Follow-up|1|||
131053115|NCT03601715|471826554|FG001|Second Intervention|Lost to Follow-up|1|||
131053116|NCT03601715|471826555|FG002|Second Intervention|Lost to Follow-up|0|||
131053117|NCT00263757|471826558|FG000|Overall Study|Withdrawal by Subject|5|||
131053118|NCT00263757|471826559|FG001|Overall Study|Withdrawal by Subject|4|||
131053119|NCT00263757|471826558|FG000|Overall Study|Screen failure|0|||
131053120|NCT00263757|471826559|FG001|Overall Study|Screen failure|1|||
131053121|NCT00263757|471826558|FG000|Overall Study|Adverse Event|3|||
131053122|NCT00263757|471826559|FG001|Overall Study|Adverse Event|3|||
131053123|NCT01767467|471826560|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
131053124|NCT01767467|471826561|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
130722372|NCT00077857|470608236|FG000|Overall Study|Violation of selection criteria at entry|3|||
131053125|NCT01767467|471826560|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
131053126|NCT01767467|471826561|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
131053127|NCT01767467|471826560|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
131053128|NCT01767467|471826561|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
131053129|NCT01767467|471826560|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
131053130|NCT01767467|471826561|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
131053131|NCT01767467|471826560|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
131053132|NCT01767467|471826561|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
131053133|NCT01767467|471826560|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
131053134|NCT01767467|471826561|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
131053135|NCT01767467|471826560|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
131053136|NCT01767467|471826561|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
131053137|NCT01767467|471826560|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
131053138|NCT01767467|471826561|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
131053139|NCT01767467|471826560|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
131053140|NCT01767467|471826561|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
131053141|NCT01767467|471826560|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
131053142|NCT01767467|471826561|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
131053143|NCT01767467|471826560|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
131053144|NCT01767467|471826561|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
131053145|NCT01767467|471826560|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
131053146|NCT01767467|471826561|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
131053147|NCT01767467|471826560|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
131053148|NCT01767467|471826561|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
131053149|NCT01767467|471826560|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
131053150|NCT01767467|471826561|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
131053151|NCT01640951|471826562|FG000|Overall Study|Adverse Event|8|||
131053152|NCT01640951|471826563|FG001|Overall Study|Adverse Event|3|||
131053153|NCT01640951|471826564|FG002|Overall Study|Adverse Event|10|||
131053154|NCT01640951|471826565|FG003|Overall Study|Adverse Event|6|||
131053155|NCT01640951|471826566|FG004|Overall Study|Adverse Event|1|||
131053156|NCT01640951|471826567|FG005|Overall Study|Adverse Event|11|||
131053157|NCT01640951|471826568|FG006|Overall Study|Adverse Event|1|||
131053158|NCT01640951|471826569|FG007|Overall Study|Adverse Event|3|||
131053159|NCT01640951|471826562|FG000|Overall Study|Lack of Efficacy|20|||
131053160|NCT01640951|471826563|FG001|Overall Study|Lack of Efficacy|1|||
131053161|NCT01640951|471826564|FG002|Overall Study|Lack of Efficacy|7|||
131053162|NCT01640951|471826565|FG003|Overall Study|Lack of Efficacy|14|||
131053163|NCT01640951|471826566|FG004|Overall Study|Lack of Efficacy|0|||
131053164|NCT01640951|471826567|FG005|Overall Study|Lack of Efficacy|6|||
131053165|NCT01640951|471826568|FG006|Overall Study|Lack of Efficacy|5|||
131053166|NCT01640951|471826569|FG007|Overall Study|Lack of Efficacy|6|||
131053167|NCT01640951|471826562|FG000|Overall Study|Lost to Follow-up|1|||
131053168|NCT01640951|471826563|FG001|Overall Study|Lost to Follow-up|0|||
131053169|NCT01640951|471826564|FG002|Overall Study|Lost to Follow-up|6|||
131053170|NCT01640951|471826565|FG003|Overall Study|Lost to Follow-up|2|||
131053171|NCT01640951|471826566|FG004|Overall Study|Lost to Follow-up|2|||
130722373|NCT00077857|470608237|FG001|Overall Study|Violation of selection criteria at entry|1|||
131053172|NCT01640951|471826567|FG005|Overall Study|Lost to Follow-up|3|||
131053173|NCT01640951|471826568|FG006|Overall Study|Lost to Follow-up|1|||
131053174|NCT01640951|471826569|FG007|Overall Study|Lost to Follow-up|1|||
131053175|NCT01640951|471826562|FG000|Overall Study|Non-compliance with study treatment|0|||
131053176|NCT01640951|471826563|FG001|Overall Study|Non-compliance with study treatment|0|||
131053177|NCT01640951|471826564|FG002|Overall Study|Non-compliance with study treatment|1|||
131053178|NCT01640951|471826565|FG003|Overall Study|Non-compliance with study treatment|1|||
131053179|NCT01640951|471826566|FG004|Overall Study|Non-compliance with study treatment|1|||
131053180|NCT01640951|471826567|FG005|Overall Study|Non-compliance with study treatment|4|||
131053181|NCT01640951|471826568|FG006|Overall Study|Non-compliance with study treatment|1|||
131053182|NCT01640951|471826569|FG007|Overall Study|Non-compliance with study treatment|0|||
131053183|NCT01640951|471826562|FG000|Overall Study|Physician Decision|2|||
131053184|NCT01640951|471826563|FG001|Overall Study|Physician Decision|5|||
131053185|NCT01640951|471826564|FG002|Overall Study|Physician Decision|2|||
131053186|NCT01640951|471826565|FG003|Overall Study|Physician Decision|2|||
131053187|NCT01640951|471826566|FG004|Overall Study|Physician Decision|2|||
131053188|NCT01640951|471826567|FG005|Overall Study|Physician Decision|3|||
131053189|NCT01640951|471826568|FG006|Overall Study|Physician Decision|3|||
131053190|NCT01640951|471826569|FG007|Overall Study|Physician Decision|0|||
131053191|NCT01640951|471826562|FG000|Overall Study|Pregnancy|3|||
131053192|NCT01640951|471826563|FG001|Overall Study|Pregnancy|0|||
131053193|NCT01640951|471826564|FG002|Overall Study|Pregnancy|0|||
131053194|NCT01640951|471826565|FG003|Overall Study|Pregnancy|4|||
130722374|NCT00077857|470608236|FG000|Overall Study|Other protocol violation|0|||
130722375|NCT00077857|470608237|FG001|Overall Study|Other protocol violation|1|||
130722376|NCT00077857|470608236|FG000|Overall Study|Refused treatment|29|||
131053195|NCT01640951|471826566|FG004|Overall Study|Pregnancy|0|||
131053196|NCT01640951|471826567|FG005|Overall Study|Pregnancy|0|||
131053197|NCT01640951|471826568|FG006|Overall Study|Pregnancy|2|||
131053198|NCT01640951|471826569|FG007|Overall Study|Pregnancy|0|||
131053199|NCT01640951|471826562|FG000|Overall Study|Protocol Deviation|0|||
131053200|NCT01640951|471826563|FG001|Overall Study|Protocol Deviation|1|||
131053201|NCT01640951|471826564|FG002|Overall Study|Protocol Deviation|2|||
131053202|NCT01640951|471826565|FG003|Overall Study|Protocol Deviation|1|||
131053203|NCT01640951|471826566|FG004|Overall Study|Protocol Deviation|0|||
131053204|NCT01640951|471826567|FG005|Overall Study|Protocol Deviation|1|||
131053205|NCT01640951|471826568|FG006|Overall Study|Protocol Deviation|0|||
131053206|NCT01640951|471826569|FG007|Overall Study|Protocol Deviation|0|||
131053207|NCT01640951|471826562|FG000|Overall Study|Subject/Guardian decision|12|||
131053208|NCT01640951|471826563|FG001|Overall Study|Subject/Guardian decision|4|||
131053209|NCT01640951|471826564|FG002|Overall Study|Subject/Guardian decision|13|||
131053210|NCT01640951|471826565|FG003|Overall Study|Subject/Guardian decision|15|||
131053211|NCT01640951|471826566|FG004|Overall Study|Subject/Guardian decision|7|||
131053212|NCT01640951|471826567|FG005|Overall Study|Subject/Guardian decision|19|||
131053213|NCT01640951|471826568|FG006|Overall Study|Subject/Guardian decision|5|||
131053214|NCT01640951|471826569|FG007|Overall Study|Subject/Guardian decision|4|||
131053215|NCT01640951|471826562|FG000|Overall Study|Death|0|||
131053216|NCT01640951|471826563|FG001|Overall Study|Death|1|||
131053217|NCT01640951|471826564|FG002|Overall Study|Death|1|||
131053218|NCT01640951|471826565|FG003|Overall Study|Death|0|||
131053219|NCT01640951|471826566|FG004|Overall Study|Death|0|||
131053220|NCT01640951|471826567|FG005|Overall Study|Death|0|||
131053221|NCT01640951|471826568|FG006|Overall Study|Death|0|||
131053222|NCT01640951|471826569|FG007|Overall Study|Death|2|||
131053223|NCT04971733|471826570|FG000|Overall Study|Adverse Event|1|||
131053224|NCT04971733|471826571|FG001|Overall Study|Adverse Event|1|||
131053225|NCT04971733|471826570|FG000|Overall Study|Subject choice|2|||
131053226|NCT04971733|471826571|FG001|Overall Study|Subject choice|0|||
131053227|NCT04971733|471826570|FG000|Overall Study|Withdrawal by Subject|1|||
131053228|NCT04971733|471826571|FG001|Overall Study|Withdrawal by Subject|0|||
131053229|NCT04971733|471826570|FG000|Overall Study|Other|1|||
131053230|NCT04971733|471826571|FG001|Overall Study|Other|0|||
131053231|NCT02406092|471826572|FG000|Overall Study|Screen failure|10|||
131053232|NCT02406092|471826573|FG001|Overall Study|Screen failure|7|||
131053233|NCT02406092|471826572|FG000|Overall Study|Death|22|||
131053234|NCT02406092|471826573|FG001|Overall Study|Death|5|||
131053235|NCT02406092|471826572|FG000|Overall Study|Lost to Follow-up|4|||
131053236|NCT02406092|471826573|FG001|Overall Study|Lost to Follow-up|1|||
131053237|NCT02406092|471826572|FG000|Overall Study|Adverse Event|1|||
131053238|NCT02406092|471826573|FG001|Overall Study|Adverse Event|0|||
131053239|NCT02406092|471826572|FG000|Overall Study|Withdrawal by Subject|1|||
131053240|NCT02406092|471826573|FG001|Overall Study|Withdrawal by Subject|0|||
131053241|NCT01593020|471826580|FG000|Overall Study|Adverse Event|1|||
131053242|NCT01593020|471826581|FG001|Overall Study|Adverse Event|1|||
131053243|NCT01593020|471826580|FG000|Overall Study|Death|0|||
131053244|NCT01593020|471826581|FG001|Overall Study|Death|1|||
130722377|NCT00077857|470608237|FG001|Overall Study|Refused treatment|21|||
131053245|NCT01593020|471826580|FG000|Overall Study|Ineligible|1|||
131053246|NCT01593020|471826581|FG001|Overall Study|Ineligible|0|||
131053247|NCT03598907|471826589|FG000|Overall Study|Physician Decision|14|||
131053248|NCT03598907|471826590|FG001|Overall Study|Physician Decision|19|||
131053249|NCT05251363|471826591|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
131053250|NCT05251363|471826591|FG000|Overall Study After Implant Period|Death|9|||
131053251|NCT05251363|471826591|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
131053252|NCT05251363|471826591|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
131053253|NCT05251363|471826591|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
130722378|NCT00077857|470608236|FG000|Overall Study|Failure to return|5|||
131053254|NCT05251363|471826591|FG000|Overall Study After Implant Period|Physician Decision|1|||
131053255|NCT05251363|471826591|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
131053256|NCT03835754|471826592|FG000|Overall Study|Death|4|||
131053257|NCT04686266|471826595|FG000|Overall Study|Withdrawal by Subject|0|||
131053258|NCT04686266|471826596|FG001|Overall Study|Withdrawal by Subject|1|||
131053259|NCT04445831|471826597|FG000|Overall Study|Withdrawal by Subject|2|||
131053260|NCT04445831|471826598|FG001|Overall Study|Withdrawal by Subject|1|||
131053261|NCT04445831|471826599|FG002|Overall Study|Withdrawal by Subject|1|||
131053262|NCT04445831|471826600|FG003|Overall Study|Withdrawal by Subject|0|||
131053263|NCT04445831|471826601|FG004|Overall Study|Withdrawal by Subject|0|||
131053264|NCT04445831|471826602|FG005|Overall Study|Withdrawal by Subject|0|||
131053265|NCT04445831|471826603|FG006|Overall Study|Withdrawal by Subject|0|||
131135777|NCT01978093|472124296|FG000|Overall Study|Child was in care of grandmother|0|||
131135778|NCT01978093|472124297|FG001|Overall Study|Child was in care of grandmother|1|||
131135779|NCT01978093|472124296|FG000|Overall Study|N/A for vaccine administration|0|||
131135780|NCT01978093|472124297|FG001|Overall Study|N/A for vaccine administration|1|||
131135781|NCT03823391|472124298|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
131135782|NCT03823391|472124299|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
131135783|NCT03823391|472124298|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
131135784|NCT03823391|472124299|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
131135785|NCT01491178|472124300|FG000|Overall Study|Adverse Event|1016|||
131135786|NCT01491178|472124300|FG000|Overall Study|Improvement of NVAF|210|||
131135787|NCT01491178|472124300|FG000|Overall Study|To conduct invasive treatment|59|||
131135788|NCT01491178|472124300|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
131135789|NCT01491178|472124300|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
131135790|NCT01491178|472124300|FG000|Overall Study|To take a contraindication|20|||
131135791|NCT01491178|472124300|FG000|Overall Study|Other than specified above|657|||
131135792|NCT05689047|472124301|FG000|Overall Study|Lost to Follow-up|0|||
131135793|NCT05689047|472124302|FG001|Overall Study|Lost to Follow-up|1|||
131135794|NCT05689047|472124301|FG000|Overall Study|Protocol Deviation|1|||
131135795|NCT05689047|472124302|FG001|Overall Study|Protocol Deviation|0|||
131135796|NCT01604512|472124303|FG000|Overall Study|Withdrawal by Subject|3|||
131135797|NCT01604512|472124303|FG000|Overall Study|Not treated|4|||
131135798|NCT03132636|472124304|FG000|Overall Study|Adverse Event|1|||
131135799|NCT03132636|472124305|FG001|Overall Study|Adverse Event|2|||
131135800|NCT03132636|472124304|FG000|Overall Study|Death|4|||
131135801|NCT03132636|472124305|FG001|Overall Study|Death|7|||
131135802|NCT03132636|472124304|FG000|Overall Study|Lost to Follow-up|3|||
131135803|NCT03132636|472124305|FG001|Overall Study|Lost to Follow-up|2|||
131135804|NCT03132636|472124304|FG000|Overall Study|Non compliance with protocol by participant|1|||
131135805|NCT03132636|472124305|FG001|Overall Study|Non compliance with protocol by participant|1|||
131135806|NCT03132636|472124304|FG000|Overall Study|Subject decision|1|||
131135807|NCT03132636|472124305|FG001|Overall Study|Subject decision|9|||
131135808|NCT03132636|472124304|FG000|Overall Study|Sponsor decision|0|||
131135809|NCT03132636|472124305|FG001|Overall Study|Sponsor decision|1|||
131135810|NCT03132636|472124304|FG000|Overall Study|Physician Decision|1|||
131135811|NCT03132636|472124305|FG001|Overall Study|Physician Decision|0|||
131135812|NCT03132636|472124304|FG000|Overall Study|Progressive disease|33|||
131135813|NCT03132636|472124305|FG001|Overall Study|Progressive disease|36|||
131135814|NCT03132636|472124304|FG000|Overall Study|Withdrawal of consent|2|||
131135815|NCT03132636|472124305|FG001|Overall Study|Withdrawal of consent|5|||
131135816|NCT03132636|472124304|FG000|Overall Study|Did not re-consent|1|||
131135817|NCT03132636|472124305|FG001|Overall Study|Did not re-consent|0|||
131135818|NCT03132636|472124304|FG000|Overall Study|Lost insurance coverage|1|||
131135819|NCT03132636|472124305|FG001|Overall Study|Lost insurance coverage|0|||
131135820|NCT03132636|472124304|FG000|Overall Study|Related to radiological outcomes|0|||
131135821|NCT03132636|472124305|FG001|Overall Study|Related to radiological outcomes|1|||
131135822|NCT03132636|472124304|FG000|Overall Study|Unable to come to site for continued visits|0|||
131135823|NCT03132636|472124305|FG001|Overall Study|Unable to come to site for continued visits|1|||
131135824|NCT00493038|472124317|FG000|Treatment|Adverse Event|8|||
131135825|NCT00493038|472124318|FG001|Treatment|Adverse Event|4|||
131135826|NCT00493038|472124317|FG000|Treatment|Lost to Follow-up|5|||
131135827|NCT00493038|472124318|FG001|Treatment|Lost to Follow-up|3|||
131135828|NCT00493038|472124317|FG000|Treatment|Withdrawal by Subject|11|||
131053266|NCT04445831|471826597|FG000|Overall Study|Subject withdrawal by caregiver|0|||
130779328|NCT02326272|470819490|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779329|NCT02326272|470819491|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
130779330|NCT02326272|470819492|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
131053267|NCT04445831|471826598|FG001|Overall Study|Subject withdrawal by caregiver|1|||
131053268|NCT04445831|471826599|FG002|Overall Study|Subject withdrawal by caregiver|0|||
131135829|NCT00493038|472124318|FG001|Treatment|Withdrawal by Subject|12|||
131135830|NCT00493038|472124317|FG000|Treatment|Other|0|||
131135831|NCT00493038|472124318|FG001|Treatment|Other|1|||
131135832|NCT00493038|472124317|FG000|Follow-up|Lost to Follow-up|1|||
131135833|NCT00493038|472124318|FG001|Follow-up|Lost to Follow-up|0|||
131135834|NCT04418765|472124319|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
131135835|NCT04418765|472124320|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
131135836|NCT04418765|472124321|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
131053269|NCT04445831|471826600|FG003|Overall Study|Subject withdrawal by caregiver|0|||
131053270|NCT04445831|471826601|FG004|Overall Study|Subject withdrawal by caregiver|0|||
131053271|NCT04445831|471826602|FG005|Overall Study|Subject withdrawal by caregiver|0|||
131053272|NCT04445831|471826603|FG006|Overall Study|Subject withdrawal by caregiver|0|||
131053273|NCT04306367|471826608|FG000|Overall Study|Progression of Disease|9|||
131053274|NCT04306367|471826608|FG000|Overall Study|Adverse Event|3|||
131053275|NCT04306367|471826608|FG000|Overall Study|Withdrawal by Subject|1|||
131053276|NCT04912856|471826614|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
131053277|NCT04912856|471826615|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
131053278|NCT04912856|471826614|FG000|Overall Study|Not reported in synoptic CSR.|0|||
131053279|NCT04912856|471826615|FG001|Overall Study|Not reported in synoptic CSR.|1|||
131053280|NCT00748709|471826618|FG000|Overall Study|Progressive disease|15|||
131053281|NCT00748709|471826618|FG000|Overall Study|Drug reducing Toxity|2|||
131053282|NCT00748709|471826618|FG000|Overall Study|Other Adverse Event|1|||
131053283|NCT00748709|471826618|FG000|Overall Study|Withdrawal by Subject|1|||
131053284|NCT00748709|471826618|FG000|Overall Study|Other Reasons|1|||
131053285|NCT05864209|471827746|FG000|Overall Study|Lost to Follow-up|2|||
131053286|NCT05864209|471827747|FG001|Overall Study|Lost to Follow-up|3|||
131053287|NCT03762850|471827748|FG000|Overall Study|Death|0|||
131053288|NCT03762850|471827749|FG001|Overall Study|Death|1|||
131053289|NCT03762850|471827748|FG000|Overall Study|Lost to Follow-up|0|||
131053290|NCT03762850|471827749|FG001|Overall Study|Lost to Follow-up|1|||
131053291|NCT03762850|471827748|FG000|Overall Study|Physician Decision|0|||
131053292|NCT03762850|471827749|FG001|Overall Study|Physician Decision|1|||
131053293|NCT03762850|471827748|FG000|Overall Study|Withdrawal by Subject|4|||
131053294|NCT03762850|471827749|FG001|Overall Study|Withdrawal by Subject|9|||
131053295|NCT00092534|471827752|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
131053296|NCT00092534|471827753|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
131053297|NCT00092534|471827754|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
131053298|NCT00092534|471827755|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
131053299|NCT00092534|471827756|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
131053300|NCT00092534|471827752|FG000|Base Study Vaccination Period|Adverse Event|3|||
131053301|NCT00092534|471827753|FG001|Base Study Vaccination Period|Adverse Event|1|||
131053302|NCT00092534|471827754|FG002|Base Study Vaccination Period|Adverse Event|0|||
131053303|NCT00092534|471827755|FG003|Base Study Vaccination Period|Adverse Event|0|||
131053304|NCT00092534|471827756|FG004|Base Study Vaccination Period|Adverse Event|0|||
131053305|NCT00092534|471827752|FG000|Base Study Vaccination Period|Death|5|||
131053306|NCT00092534|471827753|FG001|Base Study Vaccination Period|Death|4|||
131053307|NCT00092534|471827754|FG002|Base Study Vaccination Period|Death|0|||
131053308|NCT00092534|471827755|FG003|Base Study Vaccination Period|Death|0|||
131053309|NCT00092534|471827756|FG004|Base Study Vaccination Period|Death|0|||
131053310|NCT00092534|471827752|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
131053311|NCT00092534|471827753|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
131053312|NCT00092534|471827754|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
131053313|NCT00092534|471827755|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
131053314|NCT00092534|471827756|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
131053315|NCT00092534|471827752|FG000|Base Study Vaccination Period|Physician Decision|1|||
131053316|NCT00092534|471827753|FG001|Base Study Vaccination Period|Physician Decision|0|||
131053317|NCT00092534|471827754|FG002|Base Study Vaccination Period|Physician Decision|0|||
131053318|NCT00092534|471827755|FG003|Base Study Vaccination Period|Physician Decision|0|||
131053319|NCT00092534|471827756|FG004|Base Study Vaccination Period|Physician Decision|0|||
131053320|NCT00092534|471827752|FG000|Base Study Vaccination Period|Pregnancy|9|||
131053321|NCT00092534|471827753|FG001|Base Study Vaccination Period|Pregnancy|7|||
131053322|NCT00092534|471827754|FG002|Base Study Vaccination Period|Pregnancy|0|||
131135837|NCT04418765|472124319|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
131135838|NCT04418765|472124320|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
130722379|NCT00077857|470608237|FG001|Overall Study|Failure to return|5|||
130722380|NCT00077857|470608236|FG000|Overall Study|Other|15|||
130722381|NCT00077857|470608237|FG001|Overall Study|Other|13|||
130722382|NCT00423319|470608238|FG000|Overall Study|Death|2|||
131053323|NCT00092534|471827755|FG003|Base Study Vaccination Period|Pregnancy|0|||
131053324|NCT00092534|471827756|FG004|Base Study Vaccination Period|Pregnancy|0|||
131135839|NCT04418765|472124321|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
131135840|NCT04418765|472124319|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
131053325|NCT00092534|471827752|FG000|Base Study Vaccination Period|Protocol Violation|2|||
131053326|NCT00092534|471827753|FG001|Base Study Vaccination Period|Protocol Violation|1|||
131135841|NCT04418765|472124320|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
131135842|NCT04418765|472124321|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
131053327|NCT00092534|471827754|FG002|Base Study Vaccination Period|Protocol Violation|0|||
131053328|NCT00092534|471827755|FG003|Base Study Vaccination Period|Protocol Violation|0|||
131053329|NCT00092534|471827756|FG004|Base Study Vaccination Period|Protocol Violation|0|||
131053330|NCT00092534|471827752|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
131053331|NCT00092534|471827753|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
131053332|NCT00092534|471827754|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
131053333|NCT00092534|471827755|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
131053334|NCT00092534|471827756|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
131053335|NCT00092534|471827752|FG000|Base Study Vaccination Period|Moved|14|||
131053336|NCT00092534|471827753|FG001|Base Study Vaccination Period|Moved|12|||
131053337|NCT00092534|471827754|FG002|Base Study Vaccination Period|Moved|0|||
131053338|NCT00092534|471827755|FG003|Base Study Vaccination Period|Moved|0|||
131053339|NCT00092534|471827756|FG004|Base Study Vaccination Period|Moved|0|||
131053340|NCT00092534|471827752|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
131053341|NCT00092534|471827753|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
131053342|NCT00092534|471827754|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
131053343|NCT00092534|471827755|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
131053344|NCT00092534|471827756|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
131053345|NCT00092534|471827752|FG000|Base Study Vaccination Period|Travel|1|||
131053346|NCT00092534|471827753|FG001|Base Study Vaccination Period|Travel|0|||
131053347|NCT00092534|471827754|FG002|Base Study Vaccination Period|Travel|0|||
131053348|NCT00092534|471827755|FG003|Base Study Vaccination Period|Travel|0|||
131053349|NCT00092534|471827756|FG004|Base Study Vaccination Period|Travel|0|||
131053350|NCT00092534|471827752|FG000|Base Study Vaccination Period|Site Closed|0|||
131053351|NCT00092534|471827753|FG001|Base Study Vaccination Period|Site Closed|1|||
131053352|NCT00092534|471827754|FG002|Base Study Vaccination Period|Site Closed|0|||
131053353|NCT00092534|471827755|FG003|Base Study Vaccination Period|Site Closed|0|||
131053354|NCT00092534|471827756|FG004|Base Study Vaccination Period|Site Closed|0|||
131053355|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Adverse Event|2|||
131053356|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Adverse Event|4|||
131053357|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Adverse Event|0|||
131053358|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Adverse Event|0|||
131053359|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Adverse Event|0|||
131053360|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Death|2|||
131053361|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Death|1|||
131053362|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Death|0|||
131053363|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Death|0|||
131053364|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Death|0|||
131053365|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
131053366|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
131053367|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
131053368|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
131053369|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
131053370|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Pregnancy|6|||
131053371|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Pregnancy|10|||
131053372|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Pregnancy|0|||
131053373|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Pregnancy|0|||
131053374|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Pregnancy|0|||
131053375|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
131053376|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
131053377|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
131053378|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
131053379|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
131053380|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
131053381|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
131053382|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
131053383|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
131053384|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
131053385|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Moved|62|||
131053386|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Moved|58|||
131053387|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Moved|0|||
131053388|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Moved|0|||
131135843|NCT04418765|472124319|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
131135844|NCT04418765|472124320|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
131053389|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Moved|0|||
131053390|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Travel|10|||
131053391|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Travel|7|||
131053392|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Travel|0|||
131053393|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Travel|0|||
131053394|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Travel|0|||
131053395|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Site Closed|0|||
131135845|NCT04418765|472124321|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
131135846|NCT04418765|472124319|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
131053396|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Site Closed|2|||
131053397|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Site Closed|0|||
131053398|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Site Closed|0|||
131053399|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Site Closed|0|||
131135847|NCT04418765|472124320|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
131135848|NCT04418765|472124321|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
131135849|NCT04418765|472124319|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
131135850|NCT04418765|472124320|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
131135851|NCT04418765|472124321|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
131135852|NCT04418765|472124319|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
131135853|NCT04418765|472124320|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
131135854|NCT04418765|472124321|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
131135855|NCT04418765|472124319|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
131135856|NCT04418765|472124320|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
131135857|NCT04418765|472124321|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
131135858|NCT04418765|472124319|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
131135859|NCT04418765|472124320|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
131135860|NCT04418765|472124321|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
131135861|NCT04418765|472124319|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
131135862|NCT04418765|472124320|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
131135863|NCT04418765|472124321|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
131053400|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
131053401|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
131053402|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
131053403|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
131053404|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
131053405|NCT00092534|471827752|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
131053406|NCT00092534|471827753|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
131053407|NCT00092534|471827754|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
131053408|NCT00092534|471827755|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
131053409|NCT00092534|471827756|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
131053410|NCT00092534|471827752|FG000|Base Study EXT|Lost to Follow-up|0|||
131053411|NCT00092534|471827753|FG001|Base Study EXT|Lost to Follow-up|0|||
131053412|NCT00092534|471827754|FG002|Base Study EXT|Lost to Follow-up|41|||
131053413|NCT00092534|471827755|FG003|Base Study EXT|Lost to Follow-up|0|||
131053414|NCT00092534|471827756|FG004|Base Study EXT|Lost to Follow-up|0|||
131053415|NCT00092534|471827752|FG000|Base Study EXT|Physician Decision|0|||
131053416|NCT00092534|471827753|FG001|Base Study EXT|Physician Decision|0|||
131053417|NCT00092534|471827754|FG002|Base Study EXT|Physician Decision|1|||
131053418|NCT00092534|471827755|FG003|Base Study EXT|Physician Decision|0|||
131053419|NCT00092534|471827756|FG004|Base Study EXT|Physician Decision|0|||
131053420|NCT00092534|471827752|FG000|Base Study EXT|Pregnancy|0|||
131053421|NCT00092534|471827753|FG001|Base Study EXT|Pregnancy|0|||
131053422|NCT00092534|471827754|FG002|Base Study EXT|Pregnancy|12|||
131053423|NCT00092534|471827755|FG003|Base Study EXT|Pregnancy|0|||
131053424|NCT00092534|471827756|FG004|Base Study EXT|Pregnancy|0|||
131053425|NCT00092534|471827752|FG000|Base Study EXT|Withdrawal by Subject|0|||
131053426|NCT00092534|471827753|FG001|Base Study EXT|Withdrawal by Subject|0|||
131053427|NCT00092534|471827754|FG002|Base Study EXT|Withdrawal by Subject|18|||
131053428|NCT00092534|471827755|FG003|Base Study EXT|Withdrawal by Subject|0|||
131053429|NCT00092534|471827756|FG004|Base Study EXT|Withdrawal by Subject|0|||
131135864|NCT04418765|472124319|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
131135865|NCT04418765|472124320|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
131135866|NCT04418765|472124321|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
131135867|NCT04418765|472124319|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
131135868|NCT04418765|472124320|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
131135869|NCT04418765|472124321|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
131135870|NCT04418765|472124319|FG000|Extension Period (48 Weeks)|Other than specified|0|||
131135871|NCT04418765|472124320|FG001|Extension Period (48 Weeks)|Other than specified|5|||
131135872|NCT04418765|472124321|FG002|Extension Period (48 Weeks)|Other than specified|2|||
131135873|NCT03345472|472124322|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
131135874|NCT03345472|472124322|FG000|Implant to 3 Months|Physician Decision|1|||
131229742|NCT03567057|472467685|FG001|Overall Study|Withdrawal by Subject|24|||
130722383|NCT00423319|470608239|FG001|Overall Study|Death|0|||
130722384|NCT00423319|470608238|FG000|Overall Study|Adverse Event|93|||
130722385|NCT00423319|470608239|FG001|Overall Study|Adverse Event|112|||
131053430|NCT00092534|471827752|FG000|Base Study EXT|Participant moved|0|||
130722386|NCT00423319|470608238|FG000|Overall Study|Withdrawal by Subject|86|||
131053431|NCT00092534|471827753|FG001|Base Study EXT|Participant moved|0|||
131053432|NCT00092534|471827754|FG002|Base Study EXT|Participant moved|6|||
131229743|NCT03567057|472467686|FG002|Overall Study|Withdrawal by Subject|13|||
130722387|NCT00423319|470608239|FG001|Overall Study|Withdrawal by Subject|99|||
130722388|NCT00423319|470608238|FG000|Overall Study|Lost to Follow-up|4|||
131053433|NCT00092534|471827755|FG003|Base Study EXT|Participant moved|0|||
131053434|NCT00092534|471827756|FG004|Base Study EXT|Participant moved|0|||
131053435|NCT00092534|471827752|FG000|Base Study EXT|Travel|0|||
131135875|NCT03345472|472124322|FG000|Implant to 3 Months|Adverse Event|1|||
131135876|NCT03345472|472124322|FG000|3 Months to 12 Months|Physician Decision|3|||
131053436|NCT00092534|471827753|FG001|Base Study EXT|Travel|0|||
131053437|NCT00092534|471827754|FG002|Base Study EXT|Travel|2|||
131053438|NCT00092534|471827755|FG003|Base Study EXT|Travel|0|||
131053439|NCT00092534|471827756|FG004|Base Study EXT|Travel|0|||
131053440|NCT00092534|471827752|FG000|Base Study EXT|Site closed|0|||
131053441|NCT00092534|471827753|FG001|Base Study EXT|Site closed|0|||
131053442|NCT00092534|471827754|FG002|Base Study EXT|Site closed|21|||
131053443|NCT00092534|471827755|FG003|Base Study EXT|Site closed|0|||
131053444|NCT00092534|471827756|FG004|Base Study EXT|Site closed|0|||
131053445|NCT00092534|471827752|FG000|Base Study EXT|Study ended|0|||
131053446|NCT00092534|471827753|FG001|Base Study EXT|Study ended|0|||
131053447|NCT00092534|471827754|FG002|Base Study EXT|Study ended|29|||
131053448|NCT00092534|471827755|FG003|Base Study EXT|Study ended|0|||
131053449|NCT00092534|471827756|FG004|Base Study EXT|Study ended|0|||
131053450|NCT00092534|471827752|FG000|Base Study EXT|Protocol Violation|0|||
131053451|NCT00092534|471827753|FG001|Base Study EXT|Protocol Violation|0|||
131053452|NCT00092534|471827754|FG002|Base Study EXT|Protocol Violation|15|||
131053453|NCT00092534|471827755|FG003|Base Study EXT|Protocol Violation|0|||
131053454|NCT00092534|471827756|FG004|Base Study EXT|Protocol Violation|0|||
131053455|NCT00092534|471827752|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
131053456|NCT00092534|471827753|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
131053457|NCT00092534|471827754|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
131053458|NCT00092534|471827755|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
131053459|NCT00092534|471827756|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
131053460|NCT00371345|471827762|FG000|Overall Study|Disease Progression|21|||
131053461|NCT00371345|471827763|FG001|Overall Study|Disease Progression|35|||
131053462|NCT00371345|471827762|FG000|Overall Study|Study Drug Toxicity|1|||
131053463|NCT00371345|471827763|FG001|Overall Study|Study Drug Toxicity|7|||
131053464|NCT00371345|471827762|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
131053465|NCT00371345|471827763|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
131053466|NCT00371345|471827762|FG000|Overall Study|Participant Request|1|||
131053467|NCT00371345|471827763|FG001|Overall Study|Participant Request|1|||
131053468|NCT00371345|471827762|FG000|Overall Study|Participant Withdrew Consent|0|||
131053469|NCT00371345|471827763|FG001|Overall Study|Participant Withdrew Consent|1|||
131053470|NCT01478594|471827767|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
131053471|NCT01478594|471827768|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
131053472|NCT01478594|471827767|FG000|Overall Study|Death|45|||
131053473|NCT01478594|471827768|FG001|Overall Study|Death|18|||
131053474|NCT01478594|471827767|FG000|Overall Study|Lost to Follow-up|3|||
131053475|NCT01478594|471827768|FG001|Overall Study|Lost to Follow-up|1|||
131053476|NCT01478594|471827767|FG000|Overall Study|Withdrawal by Subject|9|||
131053477|NCT01478594|471827768|FG001|Overall Study|Withdrawal by Subject|3|||
131053478|NCT01478594|471827767|FG000|Overall Study|Study Closed by Sponsor|8|||
131053479|NCT01478594|471827768|FG001|Overall Study|Study Closed by Sponsor|5|||
131053480|NCT00713596|471827769|FG000|Overall Study|Study was terminated|2|||
131053481|NCT00713596|471827770|FG001|Overall Study|Study was terminated|3|||
131053482|NCT00713596|471827771|FG002|Overall Study|Study was terminated|2|||
131053483|NCT04545619|471827772|FG000|Overall Study|due to equipment challenges|1|||
131053484|NCT04885998|471827773|FG000|Overall Study|Withdrawal by Subject|0|||
131053485|NCT04885998|471827774|FG001|Overall Study|Withdrawal by Subject|2|||
131053486|NCT04885998|471827775|FG002|Overall Study|Withdrawal by Subject|0|||
131053487|NCT04885998|471827776|FG003|Overall Study|Withdrawal by Subject|3|||
131053488|NCT04885998|471827773|FG000|Overall Study|Lost to Follow-up|1|||
131053489|NCT04885998|471827774|FG001|Overall Study|Lost to Follow-up|1|||
131053490|NCT04885998|471827775|FG002|Overall Study|Lost to Follow-up|0|||
131053491|NCT04885998|471827776|FG003|Overall Study|Lost to Follow-up|0|||
131053492|NCT04885998|471827773|FG000|Overall Study|Death|2|||
131053493|NCT04885998|471827774|FG001|Overall Study|Death|1|||
131053494|NCT04885998|471827775|FG002|Overall Study|Death|2|||
131053495|NCT04885998|471827776|FG003|Overall Study|Death|2|||
131053496|NCT04885998|471827773|FG000|Overall Study|Decision by sponsor|1|||
131053497|NCT04885998|471827774|FG001|Overall Study|Decision by sponsor|1|||
131053498|NCT04885998|471827775|FG002|Overall Study|Decision by sponsor|0|||
131053499|NCT04885998|471827776|FG003|Overall Study|Decision by sponsor|0|||
130722389|NCT00423319|470608239|FG001|Overall Study|Lost to Follow-up|3|||
131053500|NCT03712371|471827778|FG000|Overall Study|Lack of Efficacy|0|||
131053501|NCT03712371|471827779|FG001|Overall Study|Lack of Efficacy|0|||
131053502|NCT03712371|471827780|FG002|Overall Study|Lack of Efficacy|0|||
131053503|NCT03712371|471827781|FG003|Overall Study|Lack of Efficacy|1|||
131053504|NCT02788981|471827788|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
131053505|NCT02788981|471827789|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
131053506|NCT01359150|471827790|FG000|Overall Study|Lack of Efficacy|1|||
131053507|NCT01359150|471827791|FG001|Overall Study|Lack of Efficacy|1|||
131053508|NCT01359150|471827790|FG000|Overall Study|Withdrawal by Subject|1|||
131053509|NCT01359150|471827791|FG001|Overall Study|Withdrawal by Subject|1|||
131053510|NCT01359150|471827790|FG000|Overall Study|Adverse Event|4|||
131053511|NCT01359150|471827791|FG001|Overall Study|Adverse Event|3|||
131053512|NCT01359150|471827790|FG000|Overall Study|Other|1|||
131053513|NCT01359150|471827791|FG001|Overall Study|Other|0|||
131053514|NCT03113409|471827792|FG000|Overall Study|Withdrawal by Subject|5|||
131053515|NCT03113409|471827793|FG001|Overall Study|Withdrawal by Subject|0|||
131053516|NCT03113409|471827794|FG002|Overall Study|Withdrawal by Subject|0|||
131053517|NCT00776009|471827797|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
131053518|NCT00776009|471827798|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
131053519|NCT00776009|471827799|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
131053520|NCT00776009|471827800|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
131053521|NCT00776009|471827801|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
131053522|NCT00776009|471827802|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
131053523|NCT00776009|471827797|FG000|Period 1: First Intervention|Protocol Violation|0|||
131053524|NCT00776009|471827798|FG001|Period 1: First Intervention|Protocol Violation|1|||
131053525|NCT00776009|471827799|FG002|Period 1: First Intervention|Protocol Violation|0|||
131053526|NCT00776009|471827800|FG003|Period 1: First Intervention|Protocol Violation|0|||
131053527|NCT00776009|471827801|FG004|Period 1: First Intervention|Protocol Violation|1|||
131053528|NCT00776009|471827802|FG005|Period 1: First Intervention|Protocol Violation|0|||
131053529|NCT00776009|471827797|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
131053530|NCT00776009|471827798|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
131053531|NCT00776009|471827799|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
131053532|NCT00776009|471827800|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
131053533|NCT00776009|471827801|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
131053534|NCT00776009|471827802|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
131053535|NCT00776009|471827797|FG000|Period 2: Second Intervention|Protocol Violation|1|||
131053536|NCT00776009|471827798|FG001|Period 2: Second Intervention|Protocol Violation|0|||
131053537|NCT00776009|471827799|FG002|Period 2: Second Intervention|Protocol Violation|1|||
131053538|NCT00776009|471827800|FG003|Period 2: Second Intervention|Protocol Violation|0|||
131053539|NCT00776009|471827801|FG004|Period 2: Second Intervention|Protocol Violation|0|||
131053540|NCT00776009|471827802|FG005|Period 2: Second Intervention|Protocol Violation|0|||
131053541|NCT00776009|471827797|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
131053542|NCT00776009|471827798|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
131053543|NCT00776009|471827799|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
131053544|NCT00776009|471827800|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
131053545|NCT00776009|471827801|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
131053546|NCT00776009|471827802|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
131053547|NCT02040870|471827803|FG000|Overall Study|Completed treatment phase|6|||
131053548|NCT02040870|471827803|FG000|Overall Study|Adverse Event|7|||
131053549|NCT02040870|471827803|FG000|Overall Study|Progressive disease|58|||
131053550|NCT02040870|471827803|FG000|Overall Study|Physician Decision|6|||
131053551|NCT02040870|471827803|FG000|Overall Study|Subject/guardian decision|10|||
131053552|NCT02040870|471827803|FG000|Overall Study|Lost to Follow-up|3|||
131053553|NCT02040870|471827803|FG000|Overall Study|Death|13|||
131053554|NCT02275611|471827806|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
131053555|NCT02275611|471827807|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
131053556|NCT02275611|471827808|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
131053557|NCT02275611|471827809|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
131053558|NCT01759862|471827815|FG000|Overall Study|Physician Decision|3|||
131053559|NCT01759862|471827816|FG001|Overall Study|Physician Decision|1|||
131053560|NCT01759862|471827815|FG000|Overall Study|Adverse Event|0|||
131053561|NCT01759862|471827816|FG001|Overall Study|Adverse Event|1|||
131053562|NCT03890289|471827819|FG000|Overall Study|Adverse Event|1|||
131053563|NCT03890289|471827819|FG000|Overall Study|Physician Decision|1|||
131053564|NCT03890289|471827819|FG000|Overall Study|Lack of Efficacy|2|||
131053565|NCT02816398|471827822|FG000|Overall Study|Death|5|||
131053566|NCT02816398|471827822|FG000|Overall Study|Lack of Efficacy|8|||
131053567|NCT02816398|471827822|FG000|Overall Study|Lost to Follow-up|1|||
131053568|NCT01588951|471827829|FG000|Overall Study|Ineligible in retrospect|0|||
131053569|NCT01588951|471827830|FG001|Overall Study|Ineligible in retrospect|0|||
131053570|NCT01588951|471827831|FG002|Overall Study|Ineligible in retrospect|1|||
131053571|NCT02628626|471827832|FG000|Overall Study|Withdrawal by Subject|2|||
131053572|NCT02628626|471827833|FG001|Overall Study|Withdrawal by Subject|2|||
131053573|NCT02972359|471827834|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
131053574|NCT02972359|471827834|FG000|Overall Study|Lack of Efficacy|1|||
131053575|NCT02972359|471827834|FG000|Overall Study|Adverse Event|4|||
131053576|NCT02972359|471827834|FG000|Overall Study|Death|1|||
131053577|NCT02972359|471827834|FG000|Overall Study|Withdrawal by Subject|30|||
131053578|NCT02972359|471827834|FG000|Overall Study|Protocol Violation|1|||
131053579|NCT02972359|471827834|FG000|Overall Study|Lost to Follow-up|26|||
131053580|NCT02972359|471827834|FG000|Overall Study|Other reasons|5|||
131053581|NCT02972359|471827834|FG000|Overall Study|Missing|1|||
131053582|NCT02063659|471827835|FG000|Double-Blind Treatment Period|Adverse Event|1|||
131053583|NCT02063659|471827836|FG001|Double-Blind Treatment Period|Adverse Event|2|||
131053584|NCT02063659|471827837|FG002|Double-Blind Treatment Period|Adverse Event|0|||
131053585|NCT02063659|471827838|FG003|Double-Blind Treatment Period|Adverse Event|0|||
131053586|NCT02063659|471827835|FG000|Double-Blind Treatment Period|Physician Decision|1|||
131053587|NCT02063659|471827836|FG001|Double-Blind Treatment Period|Physician Decision|0|||
131053588|NCT02063659|471827837|FG002|Double-Blind Treatment Period|Physician Decision|0|||
131053589|NCT02063659|471827838|FG003|Double-Blind Treatment Period|Physician Decision|0|||
131053590|NCT02063659|471827835|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
131053591|NCT02063659|471827836|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
131053592|NCT02063659|471827837|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
131053593|NCT02063659|471827838|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
131053594|NCT02063659|471827835|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
131053595|NCT02063659|471827836|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
131053596|NCT02063659|471827837|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
131053597|NCT02063659|471827838|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
131053598|NCT02063659|471827835|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131053599|NCT02063659|471827836|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131053600|NCT02063659|471827837|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
131053601|NCT02063659|471827838|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
131053602|NCT02063659|471827835|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131053603|NCT02063659|471827836|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
131053604|NCT02063659|471827837|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
130722390|NCT00423319|470608238|FG000|Overall Study|Poor compliance or noncompliance|1|||
130722391|NCT00423319|470608239|FG001|Overall Study|Poor compliance or noncompliance|1|||
130722392|NCT00423319|470608238|FG000|Overall Study|No longer meets study criteria|15|||
130722393|NCT00423319|470608239|FG001|Overall Study|No longer meets study criteria|15|||
130722394|NCT00423319|470608238|FG000|Overall Study|Other|23|||
131053605|NCT02063659|471827838|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
131053606|NCT02063659|471827835|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
131053607|NCT02063659|471827836|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
131053608|NCT02063659|471827837|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
131053609|NCT02063659|471827838|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
131053610|NCT02063659|471827835|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131053611|NCT02063659|471827836|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131053612|NCT02063659|471827837|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
131053613|NCT02063659|471827838|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
131053614|NCT01532999|471827839|FG000|Overall Study|Lost to Follow-up|14|||
131053615|NCT01532999|471827840|FG001|Overall Study|Lost to Follow-up|8|||
131053616|NCT01532999|471827839|FG000|Overall Study|Physician Decision|1|||
131053617|NCT01532999|471827840|FG001|Overall Study|Physician Decision|2|||
130722395|NCT00423319|470608239|FG001|Overall Study|Other|22|||
131053618|NCT01532999|471827839|FG000|Overall Study|Withdrawal by Subject|5|||
131053619|NCT01532999|471827840|FG001|Overall Study|Withdrawal by Subject|0|||
131053620|NCT01532999|471827839|FG000|Overall Study|Relocated|2|||
131053621|NCT01532999|471827840|FG001|Overall Study|Relocated|0|||
131053622|NCT01532999|471827839|FG000|Overall Study|should not have been randomized|1|||
131053623|NCT01532999|471827840|FG001|Overall Study|should not have been randomized|0|||
131053624|NCT01532999|471827839|FG000|Overall Study|substantial noncompliance|2|||
131053625|NCT01532999|471827840|FG001|Overall Study|substantial noncompliance|0|||
131053626|NCT01532999|471827839|FG000|Overall Study|no show for week 9 assessments|6|||
131053627|NCT01532999|471827840|FG001|Overall Study|no show for week 9 assessments|4|||
131053628|NCT01532999|471827839|FG000|Overall Study|Adverse Event|0|||
131053629|NCT01532999|471827840|FG001|Overall Study|Adverse Event|1|||
131053630|NCT01532999|471827839|FG000|Overall Study|incarcerated|0|||
131053631|NCT01532999|471827840|FG001|Overall Study|incarcerated|1|||
131053632|NCT01532999|471827839|FG000|Overall Study|New job|0|||
130722396|NCT02348723|470608241|FG000|Overall Study|No ablation|21|||
131053633|NCT01532999|471827840|FG001|Overall Study|New job|2|||
131053634|NCT02830204|471827843|FG000|Overall Study|Death|9|||
130722397|NCT02348723|470608242|FG001|Overall Study|No ablation|20|||
130722398|NCT02348723|470608241|FG000|Overall Study|Non-compliant with Protocol|1|||
130722399|NCT02348723|470608242|FG001|Overall Study|Non-compliant with Protocol|0|||
130722400|NCT02348723|470608241|FG000|Overall Study|Lost to Follow-up|1|||
130722401|NCT02348723|470608242|FG001|Overall Study|Lost to Follow-up|1|||
130722402|NCT02348723|470608241|FG000|Overall Study|Consent withdrawn|1|||
131053635|NCT02830204|471827843|FG000|Overall Study|Withdrawal by Subject|1|||
131053636|NCT05470114|471827857|FG000|Overall Study|Withdrawal by Subject|1|||
131053637|NCT05470114|471827858|FG001|Overall Study|Withdrawal by Subject|0|||
131053638|NCT05470114|471827857|FG000|Overall Study|Lost to Follow-up|1|||
131053639|NCT05470114|471827858|FG001|Overall Study|Lost to Follow-up|0|||
131135877|NCT03345472|472124322|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
130722403|NCT02348723|470608242|FG001|Overall Study|Consent withdrawn|3|||
130722404|NCT02348723|470608241|FG000|Overall Study|Reason other than specified|1|||
130779331|NCT02326272|470819493|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130722405|NCT02348723|470608242|FG001|Overall Study|Reason other than specified|1|||
130722406|NCT02348723|470608241|FG000|Overall Study|Adverse Event|3|||
131053640|NCT05037513|471827859|FG000|Intervention Period|Lost to Follow-up|1|||
131053641|NCT05037513|471827860|FG001|Intervention Period|Lost to Follow-up|2|||
131053642|NCT05037513|471827859|FG000|Follow Up Period|Lost to Follow-up|16|||
131053643|NCT05037513|471827860|FG001|Follow Up Period|Lost to Follow-up|21|||
131053644|NCT05037513|471827859|FG000|Follow Up Period|Death|0|||
131053645|NCT05037513|471827860|FG001|Follow Up Period|Death|1|||
131053646|NCT05037513|471827859|FG000|Follow Up Period|Incarcerated|4|||
131053647|NCT05037513|471827860|FG001|Follow Up Period|Incarcerated|2|||
131053648|NCT01563185|471827864|FG000|Overall Study|Withdrawal by Subject|1|||
131053649|NCT01563185|471827864|FG000|Overall Study|Non-Compliance with study drug|1|||
131053650|NCT06056310|471829368|FG000|Overall Study|Other Reasons|2|||
131053651|NCT06056310|471829368|FG000|Overall Study|Sponsor Request|16|||
131053652|NCT05029284|471829371|FG000|Overall Study|Lost to Follow-up|1|||
131053653|NCT04001829|471829372|FG000|Overall Study|Never start protocol therapy|5|||
131053654|NCT04001829|471829373|FG001|Overall Study|Never start protocol therapy|5|||
131053655|NCT04001829|471829372|FG000|Overall Study|Adverse Event|11|||
131053656|NCT04001829|471829373|FG001|Overall Study|Adverse Event|7|||
131053657|NCT04001829|471829372|FG000|Overall Study|Alternative therapy|1|||
131053658|NCT04001829|471829373|FG001|Overall Study|Alternative therapy|2|||
131053659|NCT04001829|471829372|FG000|Overall Study|Disease progression/relapse|2|||
131053660|NCT04001829|471829373|FG001|Overall Study|Disease progression/relapse|1|||
131053661|NCT04001829|471829372|FG000|Overall Study|Other complicating disease|1|||
131053662|NCT04001829|471829373|FG001|Overall Study|Other complicating disease|0|||
131053663|NCT04001829|471829372|FG000|Overall Study|Withdrawal by Subject|1|||
131053664|NCT04001829|471829373|FG001|Overall Study|Withdrawal by Subject|4|||
131053665|NCT04001829|471829372|FG000|Overall Study|Ineligible|2|||
131053666|NCT04001829|471829373|FG001|Overall Study|Ineligible|2|||
131053667|NCT04001829|471829372|FG000|Overall Study|Reason missing due to delinquent data|1|||
131053668|NCT04001829|471829373|FG001|Overall Study|Reason missing due to delinquent data|0|||
131053669|NCT00985088|471829374|FG000|Overall Study|Serious Adverse Event|1|||
131053670|NCT00985088|471829375|FG001|Overall Study|Serious Adverse Event|1|||
131053671|NCT00985088|471829376|FG002|Overall Study|Serious Adverse Event|0|||
131053672|NCT00985088|471829377|FG003|Overall Study|Serious Adverse Event|0|||
131053673|NCT00985088|471829378|FG004|Overall Study|Serious Adverse Event|0|||
131053674|NCT00985088|471829379|FG005|Overall Study|Serious Adverse Event|0|||
131053675|NCT00985088|471829380|FG006|Overall Study|Serious Adverse Event|0|||
131053676|NCT00985088|471829381|FG007|Overall Study|Serious Adverse Event|1|||
131053677|NCT00985088|471829374|FG000|Overall Study|Adverse Event|0|||
131053678|NCT00985088|471829375|FG001|Overall Study|Adverse Event|0|||
131053679|NCT00985088|471829376|FG002|Overall Study|Adverse Event|1|||
131053680|NCT00985088|471829377|FG003|Overall Study|Adverse Event|0|||
131053681|NCT00985088|471829378|FG004|Overall Study|Adverse Event|0|||
131053682|NCT00985088|471829379|FG005|Overall Study|Adverse Event|0|||
131053683|NCT00985088|471829380|FG006|Overall Study|Adverse Event|0|||
131053684|NCT00985088|471829381|FG007|Overall Study|Adverse Event|0|||
131053685|NCT00985088|471829374|FG000|Overall Study|Withdrawal by Subject|4|||
131053686|NCT00985088|471829375|FG001|Overall Study|Withdrawal by Subject|0|||
131053687|NCT00985088|471829376|FG002|Overall Study|Withdrawal by Subject|0|||
131053688|NCT00985088|471829377|FG003|Overall Study|Withdrawal by Subject|1|||
131053689|NCT00985088|471829378|FG004|Overall Study|Withdrawal by Subject|3|||
131053690|NCT00985088|471829379|FG005|Overall Study|Withdrawal by Subject|2|||
131053691|NCT00985088|471829380|FG006|Overall Study|Withdrawal by Subject|1|||
131053692|NCT00985088|471829381|FG007|Overall Study|Withdrawal by Subject|2|||
131053693|NCT00985088|471829374|FG000|Overall Study|Migrated/moved from study area|0|||
131053694|NCT00985088|471829375|FG001|Overall Study|Migrated/moved from study area|0|||
131053695|NCT00985088|471829376|FG002|Overall Study|Migrated/moved from study area|1|||
131053696|NCT00985088|471829377|FG003|Overall Study|Migrated/moved from study area|0|||
131053697|NCT00985088|471829378|FG004|Overall Study|Migrated/moved from study area|0|||
131053698|NCT00985088|471829379|FG005|Overall Study|Migrated/moved from study area|0|||
131053699|NCT00985088|471829380|FG006|Overall Study|Migrated/moved from study area|0|||
131053700|NCT00985088|471829381|FG007|Overall Study|Migrated/moved from study area|1|||
131053701|NCT00985088|471829374|FG000|Overall Study|Lost to Follow-up|6|||
131053702|NCT00985088|471829375|FG001|Overall Study|Lost to Follow-up|1|||
131053703|NCT00985088|471829376|FG002|Overall Study|Lost to Follow-up|2|||
131053704|NCT00985088|471829377|FG003|Overall Study|Lost to Follow-up|6|||
131053705|NCT00985088|471829378|FG004|Overall Study|Lost to Follow-up|6|||
131053706|NCT00985088|471829379|FG005|Overall Study|Lost to Follow-up|5|||
131053707|NCT00985088|471829380|FG006|Overall Study|Lost to Follow-up|3|||
131053708|NCT00985088|471829381|FG007|Overall Study|Lost to Follow-up|2|||
131053709|NCT01737398|471829382|FG000|Overall Study|Adverse event or SAE|16|||
131053710|NCT01737398|471829383|FG001|Overall Study|Adverse event or SAE|1|||
131053711|NCT01737398|471829382|FG000|Overall Study|Stopping rule met|2|||
131053712|NCT01737398|471829383|FG001|Overall Study|Stopping rule met|1|||
131053713|NCT01737398|471829382|FG000|Overall Study|Voluntary withdrawal|2|||
131053714|NCT01737398|471829383|FG001|Overall Study|Voluntary withdrawal|3|||
131053715|NCT01737398|471829382|FG000|Overall Study|Ineligibility|1|||
131053716|NCT01737398|471829383|FG001|Overall Study|Ineligibility|0|||
131053717|NCT01737398|471829382|FG000|Overall Study|Liver transplant|1|||
131053718|NCT01737398|471829383|FG001|Overall Study|Liver transplant|0|||
131053719|NCT01737398|471829382|FG000|Overall Study|Disease progression|2|||
131053720|NCT01737398|471829383|FG001|Overall Study|Disease progression|3|||
131053721|NCT01737398|471829382|FG000|Overall Study|Sponsor's decision|2|||
131053722|NCT01737398|471829383|FG001|Overall Study|Sponsor's decision|0|||
131053723|NCT05250115|471829384|FG000|Overall Study|Premature study end|40|||
131053724|NCT05250115|471829384|FG000|Overall Study|Adverse Event|8|||
131053725|NCT05250115|471829384|FG000|Overall Study|Lost to Follow-up|7|||
131053726|NCT05250115|471829384|FG000|Overall Study|Withdrawal by Subject|6|||
131053727|NCT05250115|471829384|FG000|Overall Study|Withdrawal of informed consent|1|||
131053728|NCT05250115|471829384|FG000|Overall Study|Other|7|||
131053729|NCT00790569|471829389|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
131053730|NCT00790569|471829390|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
131053731|NCT00790569|471829391|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
131053732|NCT00790569|471829389|FG000|End of Treatment (6 Month Interview)|Death|0|||
131053733|NCT00790569|471829390|FG001|End of Treatment (6 Month Interview)|Death|2|||
131053734|NCT00790569|471829391|FG002|End of Treatment (6 Month Interview)|Death|1|||
131053735|NCT00790569|471829389|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
131053736|NCT00790569|471829390|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
131053737|NCT00790569|471829391|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
131053738|NCT00790569|471829389|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
131053739|NCT00790569|471829390|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
131053740|NCT00790569|471829391|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
131053741|NCT00790569|471829389|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
131053742|NCT00790569|471829390|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
131053743|NCT00790569|471829391|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
131053744|NCT00790569|471829389|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
131053745|NCT00790569|471829390|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
131053746|NCT00790569|471829391|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
131053747|NCT03244800|471829393|FG000|Overall Study|Adverse Event|0|||
131053748|NCT03244800|471829394|FG001|Overall Study|Adverse Event|1|||
131053749|NCT03244800|471829395|FG002|Overall Study|Adverse Event|0|||
131053750|NCT03244800|471829396|FG003|Overall Study|Adverse Event|1|||
131053751|NCT03244800|471829393|FG000|Overall Study|Withdrew treatment|0|||
131053752|NCT03244800|471829394|FG001|Overall Study|Withdrew treatment|0|||
131053753|NCT03244800|471829395|FG002|Overall Study|Withdrew treatment|0|||
131053754|NCT03244800|471829396|FG003|Overall Study|Withdrew treatment|1|||
131053755|NCT00442104|471829398|FG000|Overall Study|Adverse Event|5|||
131053756|NCT00442104|471829398|FG000|Overall Study|Death|2|||
131053757|NCT00442104|471829398|FG000|Overall Study|Lost to Follow-up|3|||
131053758|NCT00442104|471829398|FG000|Overall Study|Withdrawal by Subject|5|||
131053759|NCT00442104|471829398|FG000|Overall Study|Insufficient Clinical Response|10|||
131053760|NCT00442104|471829398|FG000|Overall Study|Other|21|||
131053761|NCT00442104|471829398|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
131053762|NCT02362035|471829399|FG000|Overall Study|Death|67|||
131053763|NCT02362035|471829399|FG000|Overall Study|Lost to Follow-up|3|||
131053764|NCT02362035|471829399|FG000|Overall Study|Adverse Event|1|||
131053765|NCT02362035|471829399|FG000|Overall Study|Physician Decision|1|||
131053766|NCT02362035|471829399|FG000|Overall Study|Subject started another cancer therapy|10|||
131053767|NCT02362035|471829399|FG000|Overall Study|Study terminated by sponsor|45|||
131135878|NCT03345472|472124322|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
131135879|NCT03345472|472124322|FG000|3 Months to 12 Months|Adverse Event|1|||
131135880|NCT03345472|472124322|FG000|3 Months to 12 Months|Death|1|||
131135881|NCT01100944|472124323|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
131135882|NCT01100944|472124324|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
131135883|NCT01100944|472124325|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
131135884|NCT01100944|472124323|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
131135885|NCT01100944|472124324|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
131135886|NCT01100944|472124325|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
131135887|NCT01100944|472124323|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
131135888|NCT01100944|472124324|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
130722407|NCT02348723|470608242|FG001|Overall Study|Adverse Event|1|||
131053768|NCT02362035|471829399|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
131053769|NCT02362035|471829399|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
131053770|NCT02362035|471829399|FG000|Overall Study|Disease progression|11|||
131053771|NCT02362035|471829399|FG000|Overall Study|Withdrawal by Subject|20|||
131053772|NCT04250194|471829402|FG000|Overall Study|Declined to schedule biopsy|6|||
131053773|NCT04250194|471829403|FG001|Overall Study|Declined to schedule biopsy|10|||
131053774|NCT04250194|471829402|FG000|Overall Study|Medically Unfit for Biopsy|2|||
131053775|NCT04250194|471829403|FG001|Overall Study|Medically Unfit for Biopsy|1|||
131229744|NCT03567057|472467684|FG000|Overall Study|Lost to Follow-up|3|||
130722408|NCT01268501|470608243|FG000|Overall Study|Lost to Follow-up|1|||
131053776|NCT04250194|471829402|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
131053777|NCT04250194|471829403|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
131053778|NCT04250194|471829402|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
131053779|NCT04250194|471829403|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
131053780|NCT04250194|471829402|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
131053781|NCT04250194|471829403|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
131053782|NCT00229658|471829408|FG000|Overall Study|Administrative|2|||
131053783|NCT00229658|471829409|FG001|Overall Study|Administrative|1|||
131053784|NCT00229658|471829408|FG000|Overall Study|Investigator decision|13|||
131053785|NCT00229658|471829409|FG001|Overall Study|Investigator decision|10|||
131053786|NCT00229658|471829408|FG000|Overall Study|Other|80|||
131053787|NCT00229658|471829409|FG001|Overall Study|Other|60|||
131053788|NCT00229658|471829408|FG000|Overall Study|Lost to Follow-up|82|||
131053789|NCT00229658|471829409|FG001|Overall Study|Lost to Follow-up|55|||
131053790|NCT00229658|471829408|FG000|Overall Study|Serious Adverse Event|2|||
131053791|NCT00229658|471829409|FG001|Overall Study|Serious Adverse Event|2|||
131053792|NCT00229658|471829408|FG000|Overall Study|Withdrawal of consent|46|||
131053793|NCT00229658|471829409|FG001|Overall Study|Withdrawal of consent|39|||
131053794|NCT00249769|471829410|FG000|Overall Study|Withdrawal by Subject|1|||
131053795|NCT00249769|471829411|FG001|Overall Study|Withdrawal by Subject|10|||
131053796|NCT00249769|471829412|FG002|Overall Study|Withdrawal by Subject|6|||
131053797|NCT00249769|471829410|FG000|Overall Study|Migration from Study Area|1|||
131053798|NCT00249769|471829411|FG001|Overall Study|Migration from Study Area|3|||
131053799|NCT00249769|471829412|FG002|Overall Study|Migration from Study Area|14|||
131053800|NCT00249769|471829410|FG000|Overall Study|Miscellaneous|0|||
131053801|NCT00249769|471829411|FG001|Overall Study|Miscellaneous|2|||
131053802|NCT00249769|471829412|FG002|Overall Study|Miscellaneous|2|||
131053803|NCT00249769|471829410|FG000|Overall Study|Adverse Event|0|||
131053804|NCT00249769|471829411|FG001|Overall Study|Adverse Event|0|||
131053805|NCT00249769|471829412|FG002|Overall Study|Adverse Event|1|||
131053806|NCT00249769|471829410|FG000|Overall Study|Physician Decision|0|||
131053807|NCT00249769|471829411|FG001|Overall Study|Physician Decision|0|||
131053808|NCT00249769|471829412|FG002|Overall Study|Physician Decision|2|||
131053809|NCT00249769|471829410|FG000|Overall Study|Lost to Follow-up|0|||
131053810|NCT00249769|471829411|FG001|Overall Study|Lost to Follow-up|0|||
131053811|NCT00249769|471829412|FG002|Overall Study|Lost to Follow-up|3|||
131053812|NCT01953224|471829413|FG000|Overall Study|Lost to Follow-up|1|||
131053813|NCT01953224|471829414|FG001|Overall Study|Lost to Follow-up|1|||
131053814|NCT01953224|471829413|FG000|Overall Study|Withdrawal by Subject|1|||
131053815|NCT01953224|471829414|FG001|Overall Study|Withdrawal by Subject|2|||
131053816|NCT00463229|471829415|FG000|Overall Study|Lost to Follow-up|5|||
131053817|NCT00463229|471829416|FG001|Overall Study|Lost to Follow-up|7|||
131053818|NCT00463229|471829415|FG000|Overall Study|Death|4|||
131053819|NCT00463229|471829416|FG001|Overall Study|Death|3|||
131053820|NCT01932970|471829417|FG000|Overall Study|Withdrawal by Subject|5|||
131053821|NCT01932970|471829417|FG000|Overall Study|Death|1|||
131053822|NCT01932970|471829417|FG000|Overall Study|Lost to Follow-up|2|||
131053823|NCT01932970|471829417|FG000|Overall Study|Protocol Specified Criteria|10|||
131053824|NCT01787032|471829426|FG000|Overall Study|Protocol Violation|0|||
131053825|NCT01787032|471829427|FG001|Overall Study|Protocol Violation|0|||
131053826|NCT01787032|471829428|FG002|Overall Study|Protocol Violation|0|||
131053827|NCT01787032|471829429|FG003|Overall Study|Protocol Violation|0|||
131053828|NCT01787032|471829430|FG004|Overall Study|Protocol Violation|1|||
131053829|NCT01787032|471829431|FG005|Overall Study|Protocol Violation|1|||
131135889|NCT01100944|472124325|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
131135890|NCT01100944|472124323|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
131135891|NCT01100944|472124324|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
131135892|NCT01100944|472124325|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
131135893|NCT00699907|472124328|FG000|Overall Study|Withdrawal by Subject|2|||
131135894|NCT00699907|472124329|FG001|Overall Study|Withdrawal by Subject|1|||
131135895|NCT00699907|472124330|FG002|Overall Study|Withdrawal by Subject|0|||
131053830|NCT03041233|471829432|FG000|Overall Study|Death|5|||
131135896|NCT00699907|472124328|FG000|Overall Study|No usable sample|0|||
131229745|NCT03567057|472467685|FG001|Overall Study|Lost to Follow-up|5|||
131053831|NCT03041233|471829432|FG000|Overall Study|Physician Decision|1|||
131053832|NCT03041233|471829432|FG000|Overall Study|Lost to Follow-up|16|||
131053833|NCT03041233|471829432|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
131053834|NCT03041233|471829432|FG000|Overall Study|Sponsor Request|1|||
131053835|NCT03041233|471829432|FG000|Overall Study|Duplicate subject|1|||
131135897|NCT00699907|472124329|FG001|Overall Study|No usable sample|9|||
131053836|NCT03041233|471829432|FG000|Overall Study|Re-ablation|1|||
131053837|NCT03229408|471829433|FG000|Overall Study|Withdrawal by Subject|4|||
131053838|NCT03229408|471829434|FG001|Overall Study|Withdrawal by Subject|1|||
131053839|NCT03229408|471829433|FG000|Overall Study|Adverse Event|2|||
131053840|NCT03229408|471829434|FG001|Overall Study|Adverse Event|0|||
131135898|NCT00699907|472124330|FG002|Overall Study|No usable sample|8|||
131135899|NCT02161211|472124331|FG000|Overall Study|Lost to Follow-up|21|||
131053841|NCT03229408|471829433|FG000|Overall Study|Pregnancy|0|||
131053842|NCT03229408|471829434|FG001|Overall Study|Pregnancy|1|||
131053843|NCT03229408|471829433|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
131053844|NCT03229408|471829434|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
131053845|NCT03516812|471829437|FG000|Overall Study|Adverse Event|4|||
131053846|NCT03516812|471829437|FG000|Overall Study|Lack of Efficacy|2|||
131053847|NCT00274261|471829440|FG000|Overall Study|Adverse Event|19|||
131053848|NCT00274261|471829441|FG001|Overall Study|Adverse Event|11|||
131053849|NCT00274261|471829440|FG000|Overall Study|Pregnancy|114|||
131053850|NCT00274261|471829441|FG001|Overall Study|Pregnancy|83|||
131053851|NCT00274261|471829440|FG000|Overall Study|Withdrawal by Subject|179|||
131053852|NCT00274261|471829441|FG001|Overall Study|Withdrawal by Subject|126|||
131053853|NCT00274261|471829440|FG000|Overall Study|Protocol Violation|71|||
131053854|NCT00274261|471829441|FG001|Overall Study|Protocol Violation|42|||
131053855|NCT00274261|471829440|FG000|Overall Study|Lost to Follow-up|106|||
131053856|NCT00274261|471829441|FG001|Overall Study|Lost to Follow-up|75|||
131053857|NCT03362190|471829443|FG000|Overall Study|Adverse Event|0|||
131053858|NCT03362190|471829444|FG001|Overall Study|Adverse Event|0|||
131053859|NCT03362190|471829445|FG002|Overall Study|Adverse Event|0|||
131053860|NCT03362190|471829446|FG003|Overall Study|Adverse Event|1|||
131053861|NCT03362190|471829443|FG000|Overall Study|Withdrawal by Subject|0|||
131053862|NCT03362190|471829444|FG001|Overall Study|Withdrawal by Subject|0|||
131053863|NCT03362190|471829445|FG002|Overall Study|Withdrawal by Subject|0|||
131053864|NCT03362190|471829446|FG003|Overall Study|Withdrawal by Subject|1|||
131053865|NCT00687219|471829447|FG000|Overall Study|Adverse Event|8|||
131053866|NCT00687219|471829447|FG000|Overall Study|Discontinuance criteria met|7|||
131053867|NCT00687219|471829447|FG000|Overall Study|HCV-RNA positive conversion|34|||
131053868|NCT00687219|471829447|FG000|Overall Study|Withdrawal by Subject|1|||
131053869|NCT00687219|471829447|FG000|Overall Study|Lack of Efficacy|1|||
131053870|NCT01400958|471829458|FG000|Overall Study|Physician Decision|0|||
131053871|NCT01400958|471829459|FG001|Overall Study|Physician Decision|1|||
131053872|NCT01400958|471829458|FG000|Overall Study|Withdrawal by Subject|0|||
131053873|NCT01400958|471829459|FG001|Overall Study|Withdrawal by Subject|1|||
131053874|NCT01400958|471829458|FG000|Overall Study|Adverse Event|1|||
131053875|NCT01400958|471829459|FG001|Overall Study|Adverse Event|0|||
131053876|NCT04021862|471829467|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
131053877|NCT04021862|471829468|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
131053878|NCT04021862|471829469|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
131053879|NCT04021862|471829470|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
131053880|NCT04021862|471829471|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
131053881|NCT04021862|471829472|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
131053882|NCT04021862|471829467|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
131053883|NCT04021862|471829468|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
131053884|NCT04021862|471829469|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
131053885|NCT04021862|471829470|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
131053886|NCT04021862|471829471|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
131053887|NCT04021862|471829472|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
131053888|NCT04021862|471829467|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
131135900|NCT02161211|472124332|FG001|Overall Study|Lost to Follow-up|27|||
131135901|NCT02161211|472124333|FG002|Overall Study|Lost to Follow-up|21|||
131053889|NCT04021862|471829468|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
131053890|NCT04021862|471829469|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
131053891|NCT04021862|471829470|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
131053892|NCT04021862|471829471|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
131053893|NCT04021862|471829472|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
131053894|NCT04021862|471829467|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
131053895|NCT04021862|471829468|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
131053896|NCT04021862|471829469|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
131135902|NCT02161211|472124331|FG000|Overall Study|Dropped|12|||
131135903|NCT02161211|472124332|FG001|Overall Study|Dropped|5|||
131135904|NCT02161211|472124333|FG002|Overall Study|Dropped|9|||
131135905|NCT01536860|472124334|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
131053897|NCT04021862|471829470|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
131053898|NCT04021862|471829471|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
131053899|NCT04021862|471829472|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
131053900|NCT04021862|471829467|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
131053901|NCT04021862|471829468|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
131135906|NCT01536860|472124335|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
131135907|NCT01536860|472124336|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
131053902|NCT04021862|471829469|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
131135908|NCT01164722|472124337|FG000|Overall Study|Adverse Event|0|||
131053903|NCT04021862|471829470|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
131053904|NCT04021862|471829471|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
131053905|NCT04021862|471829472|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
131053906|NCT01690624|471829473|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
131053907|NCT01690624|471829474|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
131053908|NCT01690624|471829475|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
131053909|NCT01690624|471829476|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
131053910|NCT01690624|471829473|FG000|Overall Study|Adverse event (other than DLT)|3|||
131053911|NCT01690624|471829474|FG001|Overall Study|Adverse event (other than DLT)|1|||
131053912|NCT01690624|471829475|FG002|Overall Study|Adverse event (other than DLT)|1|||
131053913|NCT01690624|471829476|FG003|Overall Study|Adverse event (other than DLT)|1|||
131053914|NCT01690624|471829473|FG000|Overall Study|Withdrawal by Subject|0|||
131053915|NCT01690624|471829474|FG001|Overall Study|Withdrawal by Subject|0|||
131053916|NCT01690624|471829475|FG002|Overall Study|Withdrawal by Subject|1|||
131053917|NCT01690624|471829476|FG003|Overall Study|Withdrawal by Subject|0|||
131053918|NCT01690624|471829473|FG000|Overall Study|Sponsor is ending trial|0|||
131053919|NCT01690624|471829474|FG001|Overall Study|Sponsor is ending trial|0|||
131053920|NCT01690624|471829475|FG002|Overall Study|Sponsor is ending trial|0|||
131053921|NCT01690624|471829476|FG003|Overall Study|Sponsor is ending trial|1|||
131053922|NCT01690624|471829473|FG000|Overall Study|Physician Decision|0|||
131053923|NCT01690624|471829474|FG001|Overall Study|Physician Decision|0|||
131053924|NCT01690624|471829475|FG002|Overall Study|Physician Decision|0|||
131053925|NCT01690624|471829476|FG003|Overall Study|Physician Decision|1|||
131053926|NCT01690624|471829473|FG000|Overall Study|Withdrawal by Subject|0|||
131053927|NCT01690624|471829474|FG001|Overall Study|Withdrawal by Subject|1|||
131053928|NCT01690624|471829475|FG002|Overall Study|Withdrawal by Subject|0|||
131053929|NCT01690624|471829476|FG003|Overall Study|Withdrawal by Subject|0|||
131053930|NCT01690624|471829473|FG000|Overall Study|Lack of Efficacy|1|||
131053931|NCT01690624|471829474|FG001|Overall Study|Lack of Efficacy|1|||
131053932|NCT01690624|471829475|FG002|Overall Study|Lack of Efficacy|3|||
131053933|NCT01690624|471829476|FG003|Overall Study|Lack of Efficacy|0|||
131053934|NCT02517268|471829478|FG000|Overall Study|Withdrawal by Subject|1|||
131053935|NCT02517268|471829479|FG001|Overall Study|Withdrawal by Subject|0|||
131053936|NCT04649047|471829489|FG000|Overall Study|Withdrawal by Subject|3|||
131053937|NCT00719888|471829490|FG000|Overall Study|Death|24|||
131053938|NCT00719888|471829491|FG001|Overall Study|Death|9|||
131053939|NCT00719888|471829490|FG000|Overall Study|Relapse|8|||
131053940|NCT00719888|471829491|FG001|Overall Study|Relapse|3|||
131053941|NCT00719888|471829490|FG000|Overall Study|Physician Decision|1|||
131053942|NCT00719888|471829491|FG001|Overall Study|Physician Decision|0|||
131053943|NCT00719888|471829490|FG000|Overall Study|Withdrawal by Subject|1|||
131053944|NCT00719888|471829491|FG001|Overall Study|Withdrawal by Subject|0|||
131053945|NCT03773107|471829492|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
131053946|NCT03773107|471829493|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
131053947|NCT03773107|471829494|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
131053948|NCT03773107|471829495|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
131053949|NCT04577651|471829496|FG000|Overall Study|Screen Failure|7|||
131053950|NCT04577651|471829496|FG000|Overall Study|Adverse Event|1|||
131053951|NCT04577651|471829496|FG000|Overall Study|Death|1|||
131053952|NCT04577651|471829496|FG000|Overall Study|Physician Decision|1|||
131053953|NCT04577651|471829496|FG000|Overall Study|Withdrawal by Subject|3|||
131053954|NCT02328014|471830827|FG000|Overall Study|Adverse Event|1|||
131053955|NCT02328014|471830828|FG001|Overall Study|Adverse Event|0|||
131053956|NCT02328014|471830829|FG002|Overall Study|Adverse Event|0|||
131053957|NCT02328014|471830830|FG003|Overall Study|Adverse Event|1|||
131053958|NCT02328014|471830827|FG000|Overall Study|Death|0|||
131053959|NCT02328014|471830828|FG001|Overall Study|Death|0|||
131053960|NCT02328014|471830829|FG002|Overall Study|Death|0|||
131053961|NCT02328014|471830830|FG003|Overall Study|Death|4|||
131053962|NCT02328014|471830827|FG000|Overall Study|Physician Decision|0|||
131053963|NCT02328014|471830828|FG001|Overall Study|Physician Decision|0|||
131053964|NCT02328014|471830829|FG002|Overall Study|Physician Decision|0|||
131053965|NCT02328014|471830830|FG003|Overall Study|Physician Decision|1|||
131053966|NCT02328014|471830827|FG000|Overall Study|Disease Progression|1|||
131053967|NCT02328014|471830828|FG001|Overall Study|Disease Progression|0|||
131053968|NCT02328014|471830829|FG002|Overall Study|Disease Progression|1|||
131053969|NCT02328014|471830830|FG003|Overall Study|Disease Progression|3|||
131053970|NCT02328014|471830827|FG000|Overall Study|Study Terminated by Sponsor|4|||
131053971|NCT02328014|471830828|FG001|Overall Study|Study Terminated by Sponsor|1|||
131053972|NCT02328014|471830829|FG002|Overall Study|Study Terminated by Sponsor|1|||
131053973|NCT02328014|471830830|FG003|Overall Study|Study Terminated by Sponsor|0|||
131053974|NCT02328014|471830827|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
131053975|NCT02328014|471830828|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
131053976|NCT02328014|471830829|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
131053977|NCT02328014|471830830|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
131135909|NCT01164722|472124338|FG001|Overall Study|Adverse Event|1|||
131135910|NCT01164722|472124337|FG000|Overall Study|Withdrawal by Subject|3|||
131135911|NCT01164722|472124338|FG001|Overall Study|Withdrawal by Subject|4|||
131135912|NCT01164722|472124337|FG000|Overall Study|Lost to Follow-up|3|||
131135913|NCT01164722|472124338|FG001|Overall Study|Lost to Follow-up|6|||
131135914|NCT01164722|472124337|FG000|Overall Study|met protocol criteria for non-treatment|11|||
131135915|NCT01164722|472124338|FG001|Overall Study|met protocol criteria for non-treatment|1|||
131135916|NCT01164722|472124337|FG000|Overall Study|enrolled on other study, concomitant med|1|||
131135917|NCT01164722|472124338|FG001|Overall Study|enrolled on other study, concomitant med|3|||
131135918|NCT01543087|472124342|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
131135919|NCT01543087|472124343|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
131135920|NCT01543087|472124344|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
131135921|NCT01543087|472124345|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
131135922|NCT01543087|472124346|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
131135923|NCT01543087|472124347|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
131135924|NCT01543087|472124342|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
131135925|NCT01543087|472124343|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
131135926|NCT01543087|472124344|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
131135927|NCT01543087|472124345|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
131135928|NCT01543087|472124346|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
131135929|NCT01543087|472124347|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
131135930|NCT01543087|472124342|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
131135931|NCT01543087|472124343|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
131135932|NCT01543087|472124344|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
131135933|NCT01543087|472124345|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
131135934|NCT01543087|472124346|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
131135935|NCT01543087|472124347|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
131135936|NCT01543087|472124342|FG000|Stage 1 (48 Months)|Other than specified|5|||
131135937|NCT01543087|472124343|FG001|Stage 1 (48 Months)|Other than specified|0|||
131135938|NCT01543087|472124344|FG002|Stage 1 (48 Months)|Other than specified|9|||
131135939|NCT01543087|472124345|FG003|Stage 1 (48 Months)|Other than specified|0|||
131135940|NCT01543087|472124346|FG004|Stage 1 (48 Months)|Other than specified|0|||
131135941|NCT01543087|472124347|FG005|Stage 1 (48 Months)|Other than specified|0|||
131135942|NCT01543087|472124342|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
131135943|NCT01543087|472124343|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
131135944|NCT01543087|472124344|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
131135945|NCT01543087|472124345|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
131135946|NCT01543087|472124346|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
131135947|NCT01543087|472124347|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
131135948|NCT01543087|472124342|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
131135949|NCT01543087|472124343|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
131135950|NCT01543087|472124344|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
131135951|NCT01543087|472124345|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
130722409|NCT01268501|470608243|FG000|Overall Study|Withdrawal by Subject|3|||
130722410|NCT01268501|470608243|FG000|Overall Study|Unacceptable Subjective Vision|3|||
131053978|NCT02328014|471830827|FG000|Overall Study|Withdrawal by Subject|0|||
131053979|NCT02328014|471830828|FG001|Overall Study|Withdrawal by Subject|0|||
131053980|NCT02328014|471830829|FG002|Overall Study|Withdrawal by Subject|0|||
131053981|NCT02328014|471830830|FG003|Overall Study|Withdrawal by Subject|1|||
131053982|NCT01274338|471830831|FG000|Overall Study|Lack of Efficacy|72|||
131053983|NCT01274338|471830832|FG001|Overall Study|Lack of Efficacy|108|||
131053984|NCT01274338|471830833|FG002|Overall Study|Lack of Efficacy|116|||
131053985|NCT01274338|471830834|FG003|Overall Study|Lack of Efficacy|0|||
131053986|NCT01274338|471830835|FG004|Overall Study|Lack of Efficacy|0|||
131053987|NCT01274338|471830836|FG005|Overall Study|Lack of Efficacy|0|||
131053988|NCT01274338|471830831|FG000|Overall Study|Adverse Event|272|||
131053989|NCT01274338|471830832|FG001|Overall Study|Adverse Event|105|||
131053990|NCT01274338|471830833|FG002|Overall Study|Adverse Event|180|||
131053991|NCT01274338|471830834|FG003|Overall Study|Adverse Event|1|||
131053992|NCT01274338|471830835|FG004|Overall Study|Adverse Event|0|||
131053993|NCT01274338|471830836|FG005|Overall Study|Adverse Event|0|||
131053994|NCT01274338|471830831|FG000|Overall Study|Death|8|||
131053995|NCT01274338|471830832|FG001|Overall Study|Death|1|||
130722411|NCT01268501|470608243|FG000|Overall Study|Handling Difficulties|2|||
130722412|NCT00678886|470608244|FG000|Overall Study|Withdrawal by Subject|0|||
131053996|NCT01274338|471830833|FG002|Overall Study|Death|0|||
131135952|NCT01543087|472124346|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
131135953|NCT01543087|472124347|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
131135954|NCT01543087|472124342|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
131053997|NCT01274338|471830834|FG003|Overall Study|Death|0|||
131053998|NCT01274338|471830835|FG004|Overall Study|Death|0|||
131053999|NCT01274338|471830836|FG005|Overall Study|Death|0|||
131054000|NCT01274338|471830831|FG000|Overall Study|Withdrawal by Subject|27|||
131054001|NCT01274338|471830832|FG001|Overall Study|Withdrawal by Subject|99|||
131054002|NCT01274338|471830833|FG002|Overall Study|Withdrawal by Subject|17|||
131054003|NCT01274338|471830834|FG003|Overall Study|Withdrawal by Subject|0|||
131054004|NCT01274338|471830835|FG004|Overall Study|Withdrawal by Subject|0|||
131054005|NCT01274338|471830836|FG005|Overall Study|Withdrawal by Subject|0|||
131054006|NCT01274338|471830831|FG000|Overall Study|Did not start treatment|8|||
131054007|NCT01274338|471830832|FG001|Overall Study|Did not start treatment|116|||
131054008|NCT01274338|471830833|FG002|Overall Study|Did not start treatment|7|||
131054009|NCT01274338|471830834|FG003|Overall Study|Did not start treatment|0|||
131054010|NCT01274338|471830835|FG004|Overall Study|Did not start treatment|0|||
131054011|NCT01274338|471830836|FG005|Overall Study|Did not start treatment|0|||
130779332|NCT02326272|470819494|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779333|NCT02326272|470819495|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779334|NCT02326272|470819496|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779335|NCT02326272|470819497|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779336|NCT02326272|470819498|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131054012|NCT01274338|471830831|FG000|Overall Study|Alternative therapy|0|||
131054013|NCT01274338|471830832|FG001|Overall Study|Alternative therapy|1|||
131054014|NCT01274338|471830833|FG002|Overall Study|Alternative therapy|0|||
131054015|NCT01274338|471830834|FG003|Overall Study|Alternative therapy|0|||
131054016|NCT01274338|471830835|FG004|Overall Study|Alternative therapy|0|||
131054017|NCT01274338|471830836|FG005|Overall Study|Alternative therapy|0|||
131054018|NCT01274338|471830831|FG000|Overall Study|Other complicating diseases|0|||
131054019|NCT01274338|471830832|FG001|Overall Study|Other complicating diseases|3|||
131054020|NCT01274338|471830833|FG002|Overall Study|Other complicating diseases|1|||
131054021|NCT01274338|471830834|FG003|Overall Study|Other complicating diseases|0|||
131054022|NCT01274338|471830835|FG004|Overall Study|Other complicating diseases|0|||
131054023|NCT01274338|471830836|FG005|Overall Study|Other complicating diseases|0|||
131054024|NCT01274338|471830831|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
131054025|NCT01274338|471830832|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
131054026|NCT01274338|471830833|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
131054027|NCT01274338|471830834|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
131054028|NCT01274338|471830835|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
131054029|NCT01274338|471830836|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
131054030|NCT01274338|471830831|FG000|Overall Study|Pregnancy|0|||
131054031|NCT01274338|471830832|FG001|Overall Study|Pregnancy|0|||
131054032|NCT01274338|471830833|FG002|Overall Study|Pregnancy|1|||
131054033|NCT01274338|471830834|FG003|Overall Study|Pregnancy|0|||
131054034|NCT01274338|471830835|FG004|Overall Study|Pregnancy|0|||
131054035|NCT01274338|471830836|FG005|Overall Study|Pregnancy|0|||
131054036|NCT01274338|471830831|FG000|Overall Study|Reason not reported|12|||
131054037|NCT01274338|471830832|FG001|Overall Study|Reason not reported|21|||
131054038|NCT01274338|471830833|FG002|Overall Study|Reason not reported|3|||
131054039|NCT01274338|471830834|FG003|Overall Study|Reason not reported|0|||
131054040|NCT01274338|471830835|FG004|Overall Study|Reason not reported|1|||
131054041|NCT01274338|471830836|FG005|Overall Study|Reason not reported|0|||
131054042|NCT05422339|471830837|FG000|Overall Study|Withdrawal by Subject|17|||
131054043|NCT05422339|471830838|FG001|Overall Study|Withdrawal by Subject|15|||
131054044|NCT03678688|471830845|FG000|Overall Study|Reason not Specified|0|||
130779337|NCT02326272|470819499|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779338|NCT02326272|470819500|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779339|NCT02326272|470819501|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779340|NCT02326272|470819502|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779341|NCT02326272|470819503|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779342|NCT02326272|470819504|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130779343|NCT02326272|470819490|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
130779344|NCT02326272|470819491|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
130779345|NCT02326272|470819492|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130779346|NCT02326272|470819493|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130779347|NCT02326272|470819494|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131054045|NCT03678688|471830846|FG001|Overall Study|Reason not Specified|0|||
131054046|NCT03678688|471830847|FG002|Overall Study|Reason not Specified|3|||
131054047|NCT03678688|471830848|FG003|Overall Study|Reason not Specified|0|||
130779348|NCT02326272|470819495|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130779349|NCT02326272|470819496|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131054048|NCT03678688|471830849|FG004|Overall Study|Reason not Specified|1|||
131054049|NCT03678688|471830850|FG005|Overall Study|Reason not Specified|0|||
131054050|NCT03678688|471830851|FG006|Overall Study|Reason not Specified|0|||
131054051|NCT03678688|471830852|FG007|Overall Study|Reason not Specified|0|||
131054052|NCT03678688|471830853|FG008|Overall Study|Reason not Specified|0|||
131054053|NCT03678688|471830845|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
131054054|NCT03678688|471830846|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
131054055|NCT03678688|471830847|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
131054056|NCT03678688|471830848|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
131054057|NCT03678688|471830849|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
131054058|NCT03678688|471830850|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
131054059|NCT03678688|471830851|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
131054060|NCT03678688|471830852|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
131054061|NCT03678688|471830853|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
131054062|NCT03678688|471830845|FG000|Overall Study|Covid Related Adverse Event|0|||
131135955|NCT01543087|472124343|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
131135956|NCT01543087|472124344|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
131135957|NCT01543087|472124345|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
131135958|NCT01543087|472124346|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
131135959|NCT01543087|472124347|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
131135960|NCT00706030|472124348|FG000|Overall Study|Disease Progression|4|||
131135961|NCT00706030|472124349|FG001|Overall Study|Disease Progression|6|||
131054063|NCT03678688|471830846|FG001|Overall Study|Covid Related Adverse Event|0|||
131054064|NCT03678688|471830847|FG002|Overall Study|Covid Related Adverse Event|0|||
131054065|NCT03678688|471830848|FG003|Overall Study|Covid Related Adverse Event|0|||
131054066|NCT03678688|471830849|FG004|Overall Study|Covid Related Adverse Event|0|||
131135962|NCT00706030|472124350|FG002|Overall Study|Disease Progression|46|||
131135963|NCT00706030|472124351|FG003|Overall Study|Disease Progression|12|||
131135964|NCT00706030|472124348|FG000|Overall Study|Adverse Event|1|||
130722413|NCT00678886|470608245|FG001|Overall Study|Withdrawal by Subject|0|||
130722414|NCT00678886|470608246|FG002|Overall Study|Withdrawal by Subject|4|||
131135965|NCT00706030|472124349|FG001|Overall Study|Adverse Event|0|||
131135966|NCT00706030|472124350|FG002|Overall Study|Adverse Event|4|||
131135967|NCT00706030|472124351|FG003|Overall Study|Adverse Event|2|||
131135968|NCT00706030|472124348|FG000|Overall Study|Withdrawal by Subject|1|||
131135969|NCT00706030|472124349|FG001|Overall Study|Withdrawal by Subject|0|||
131135970|NCT00706030|472124350|FG002|Overall Study|Withdrawal by Subject|2|||
131135971|NCT00706030|472124351|FG003|Overall Study|Withdrawal by Subject|0|||
131135972|NCT00706030|472124348|FG000|Overall Study|Physician Decision|0|||
131135973|NCT00706030|472124349|FG001|Overall Study|Physician Decision|0|||
131135974|NCT00706030|472124350|FG002|Overall Study|Physician Decision|2|||
131135975|NCT00706030|472124351|FG003|Overall Study|Physician Decision|0|||
131135976|NCT00706030|472124348|FG000|Overall Study|Not recorded|0|||
130722415|NCT00678886|470608247|FG003|Overall Study|Withdrawal by Subject|6|||
130722416|NCT00678886|470608244|FG000|Overall Study|Physician Decision|0|||
130722417|NCT00678886|470608245|FG001|Overall Study|Physician Decision|0|||
130722418|NCT00678886|470608246|FG002|Overall Study|Physician Decision|1|||
130722419|NCT00678886|470608247|FG003|Overall Study|Physician Decision|1|||
131054067|NCT03678688|471830850|FG005|Overall Study|Covid Related Adverse Event|3|||
131054068|NCT03678688|471830851|FG006|Overall Study|Covid Related Adverse Event|1|||
131054069|NCT03678688|471830852|FG007|Overall Study|Covid Related Adverse Event|1|||
131054070|NCT03678688|471830853|FG008|Overall Study|Covid Related Adverse Event|0|||
131054071|NCT03678688|471830845|FG000|Overall Study|Physician Decision|0|||
131054072|NCT03678688|471830846|FG001|Overall Study|Physician Decision|0|||
131054073|NCT03678688|471830847|FG002|Overall Study|Physician Decision|0|||
131054074|NCT03678688|471830848|FG003|Overall Study|Physician Decision|0|||
131054075|NCT03678688|471830849|FG004|Overall Study|Physician Decision|0|||
131054076|NCT03678688|471830850|FG005|Overall Study|Physician Decision|1|||
131054077|NCT03678688|471830851|FG006|Overall Study|Physician Decision|0|||
131054078|NCT03678688|471830852|FG007|Overall Study|Physician Decision|0|||
131054079|NCT03678688|471830853|FG008|Overall Study|Physician Decision|0|||
131054080|NCT03678688|471830845|FG000|Overall Study|Withdrawal by Subject|0|||
131054081|NCT03678688|471830846|FG001|Overall Study|Withdrawal by Subject|0|||
131054082|NCT03678688|471830847|FG002|Overall Study|Withdrawal by Subject|0|||
131054083|NCT03678688|471830848|FG003|Overall Study|Withdrawal by Subject|0|||
131054084|NCT03678688|471830849|FG004|Overall Study|Withdrawal by Subject|0|||
131135977|NCT00706030|472124349|FG001|Overall Study|Not recorded|0|||
131135978|NCT00706030|472124350|FG002|Overall Study|Not recorded|2|||
131135979|NCT00706030|472124351|FG003|Overall Study|Not recorded|0|||
131135980|NCT00706030|472124348|FG000|Overall Study|Protocol Violation|0|||
131135981|NCT00706030|472124349|FG001|Overall Study|Protocol Violation|0|||
131135982|NCT00706030|472124350|FG002|Overall Study|Protocol Violation|1|||
131135983|NCT00706030|472124351|FG003|Overall Study|Protocol Violation|1|||
131135984|NCT00706030|472124348|FG000|Overall Study|Failed to return|0|||
131135985|NCT00706030|472124349|FG001|Overall Study|Failed to return|0|||
131135986|NCT00706030|472124350|FG002|Overall Study|Failed to return|1|||
131054085|NCT03678688|471830850|FG005|Overall Study|Withdrawal by Subject|0|||
131054086|NCT03678688|471830851|FG006|Overall Study|Withdrawal by Subject|2|||
131054087|NCT03678688|471830852|FG007|Overall Study|Withdrawal by Subject|1|||
131054088|NCT03678688|471830853|FG008|Overall Study|Withdrawal by Subject|0|||
131054089|NCT01278030|471830860|FG000|Overall Study|Withdrawal by Subject|8|||
131054090|NCT01278030|471830861|FG001|Overall Study|Withdrawal by Subject|4|||
131054091|NCT00458783|471830863|FG000|Overall Study|Protocol Violation|1228|||
131054092|NCT00458783|471830864|FG001|Overall Study|Protocol Violation|1220|||
131135987|NCT00706030|472124351|FG003|Overall Study|Failed to return|0|||
131135988|NCT00706030|472124348|FG000|Overall Study|Symptomatic Deterioration|0|||
131054093|NCT04401267|471830866|FG000|Overall Study|Death|0|||
131054094|NCT04401267|471830867|FG001|Overall Study|Death|1|||
131054095|NCT04401267|471830866|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
131054096|NCT04401267|471830867|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
131054097|NCT04401267|471830866|FG000|Overall Study|Found to be Ineligible|1|||
131054098|NCT04401267|471830867|FG001|Overall Study|Found to be Ineligible|0|||
131054099|NCT03214081|471830868|FG000|Overall Study|Case Report Forms Uncollected|9|||
131054100|NCT03214081|471830868|FG000|Overall Study|Protocol Deviation|54|||
131054101|NCT02962284|471830869|FG000|Overall Study|Death|2|||
131054102|NCT02962284|471830870|FG001|Overall Study|Death|0|||
131054103|NCT02962284|471830869|FG000|Overall Study|Progressive disease|2|||
131054104|NCT02962284|471830870|FG001|Overall Study|Progressive disease|3|||
131054105|NCT02962284|471830869|FG000|Overall Study|Withdrawal by Subject|1|||
131054106|NCT02962284|471830870|FG001|Overall Study|Withdrawal by Subject|0|||
131054107|NCT05815342|471830871|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
131054108|NCT05815342|471830871|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
131054109|NCT05815342|471830871|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
131054110|NCT05815342|471830871|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
131054111|NCT05815342|471830871|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
131054112|NCT00345046|471830874|FG000|Overall Study|Protocol Violation|1|||
131054113|NCT00345046|471830875|FG001|Overall Study|Protocol Violation|1|||
131054114|NCT00345046|471830876|FG002|Overall Study|Protocol Violation|2|||
131054115|NCT01613417|471830877|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
131054116|NCT01613417|471830878|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
131054117|NCT00512252|471830879|FG000|Overall Study|Lost to Follow-up|0|||
131054118|NCT00512252|471830880|FG001|Overall Study|Lost to Follow-up|0|||
131054119|NCT00512252|471830881|FG002|Overall Study|Lost to Follow-up|1|||
131054120|NCT00512252|471830879|FG000|Overall Study|Protocol Violation|0|||
131054121|NCT00512252|471830880|FG001|Overall Study|Protocol Violation|0|||
131054122|NCT00512252|471830881|FG002|Overall Study|Protocol Violation|1|||
131054123|NCT00512252|471830879|FG000|Overall Study|Death|0|||
131054124|NCT00512252|471830880|FG001|Overall Study|Death|0|||
131054125|NCT00512252|471830881|FG002|Overall Study|Death|1|||
131054126|NCT02357966|471830882|FG000|Overall Study|Death|0|||
131054127|NCT02357966|471830883|FG001|Overall Study|Death|0|||
131054128|NCT02357966|471830884|FG002|Overall Study|Death|1|||
131054129|NCT02357966|471830885|FG003|Overall Study|Death|0|||
131054130|NCT02357966|471830886|FG004|Overall Study|Death|2|||
131054131|NCT02357966|471830887|FG005|Overall Study|Death|0|||
131054132|NCT02357966|471830882|FG000|Overall Study|Physician Decision|1|||
131054133|NCT02357966|471830883|FG001|Overall Study|Physician Decision|0|||
131054134|NCT02357966|471830884|FG002|Overall Study|Physician Decision|0|||
131054135|NCT02357966|471830885|FG003|Overall Study|Physician Decision|0|||
131054136|NCT02357966|471830886|FG004|Overall Study|Physician Decision|1|||
131054137|NCT02357966|471830887|FG005|Overall Study|Physician Decision|0|||
131054138|NCT00705406|471830888|FG000|Overall Study|Lost to Follow-up|3|||
131054139|NCT00705406|471830889|FG001|Overall Study|Lost to Follow-up|3|||
131054140|NCT00705406|471830888|FG000|Overall Study|Did not receive study drug|1|||
131054141|NCT00705406|471830889|FG001|Overall Study|Did not receive study drug|2|||
131135989|NCT00706030|472124349|FG001|Overall Study|Symptomatic Deterioration|0|||
131135990|NCT00706030|472124350|FG002|Overall Study|Symptomatic Deterioration|1|||
131135991|NCT00706030|472124351|FG003|Overall Study|Symptomatic Deterioration|0|||
131135992|NCT00706030|472124348|FG000|Overall Study|No treatment received|0|||
131135993|NCT00706030|472124349|FG001|Overall Study|No treatment received|0|||
131135994|NCT00706030|472124350|FG002|Overall Study|No treatment received|0|||
131054148|NCT02157116|471830899|FG000|Overall Study|Withdrawal by Subject|4|||
131054149|NCT02157116|471830899|FG000|Overall Study|Physician Decision|3|||
131054150|NCT02157116|471830899|FG000|Overall Study|Failed Screening|2|||
131054151|NCT00093496|471830900|FG000|Overall Study|Protocol Violation|1|||
131054152|NCT00093496|471830901|FG001|Overall Study|Protocol Violation|3|||
131054153|NCT02101775|471830904|FG000|Overall Study|Adverse Event|4|||
131054154|NCT02101775|471830905|FG001|Overall Study|Adverse Event|0|||
131054155|NCT02101775|471830906|FG002|Overall Study|Adverse Event|0|||
131054156|NCT02101775|471830904|FG000|Overall Study|Admission to Hospital|0|||
131054157|NCT02101775|471830905|FG001|Overall Study|Admission to Hospital|1|||
131054158|NCT02101775|471830906|FG002|Overall Study|Admission to Hospital|0|||
131054159|NCT04200664|471830909|FG000|Overall Study|Withdrawal by Subject|1|||
131054160|NCT04200664|471830910|FG001|Overall Study|Withdrawal by Subject|0|||
131054161|NCT04200664|471830911|FG002|Overall Study|Withdrawal by Subject|0|||
131135995|NCT00706030|472124351|FG003|Overall Study|No treatment received|1|||
131135996|NCT00706030|472124348|FG000|Overall Study|Death|0|||
131135997|NCT00706030|472124349|FG001|Overall Study|Death|0|||
131135998|NCT00706030|472124350|FG002|Overall Study|Death|1|||
131135999|NCT00706030|472124351|FG003|Overall Study|Death|0|||
131136000|NCT05779072|472124353|FG000|Overall Study|Lost to Follow-up|0|||
131136001|NCT05779072|472124354|FG001|Overall Study|Lost to Follow-up|1|||
131136002|NCT05779072|472124353|FG000|Overall Study|Withdrawal by Subject|1|||
131136003|NCT05779072|472124354|FG001|Overall Study|Withdrawal by Subject|5|||
131136004|NCT00357500|472124369|FG000|Overall Study|Adverse Event|3|||
130722420|NCT00678886|470608244|FG000|Overall Study|Lost to Follow-up|0|||
131136005|NCT00357500|472124369|FG000|Overall Study|Withdrawal by Subject|5|||
131136006|NCT00357500|472124369|FG000|Overall Study|Progressive Disease|65|||
131136007|NCT00357500|472124369|FG000|Overall Study|Not Started Protocol Therapy|4|||
131136008|NCT02301403|472124370|FG000|Overall Study|Withdrawal by Subject|28|||
131136009|NCT02301403|472124371|FG001|Overall Study|Withdrawal by Subject|41|||
131136010|NCT00730639|472124372|FG000|Overall Study|Adverse Event|3|||
131136011|NCT00730639|472124373|FG001|Overall Study|Adverse Event|0|||
131136012|NCT00730639|472124374|FG002|Overall Study|Adverse Event|9|||
131054178|NCT03745313|471830914|FG000|At 30 Days Follow-up|Death|2|||
131054179|NCT03745313|471830914|FG000|At 6 Months Follow-up|Death|1|||
131054180|NCT03745313|471830914|FG000|At 6 Months Follow-up|Missed Visit|1|||
131054181|NCT03745313|471830914|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
131054182|NCT03745313|471830914|FG000|At 1 Year Follow-up|Death|2|||
131054183|NCT03745313|471830914|FG000|At 1 Year Follow-up|Missed Visit|2|||
131054184|NCT03745313|471830914|FG000|At 2 Year Follow-up|Missed Visit|1|||
131054185|NCT03389802|471830915|FG000|Overall Study|Lack of Efficacy|3|||
131054186|NCT03389802|471830916|FG001|Overall Study|Lack of Efficacy|3|||
131054187|NCT03389802|471830917|FG002|Overall Study|Lack of Efficacy|13|||
131054188|NCT03389802|471830918|FG003|Overall Study|Lack of Efficacy|6|||
131054189|NCT03389802|471830919|FG004|Overall Study|Lack of Efficacy|1|||
131054190|NCT03389802|471830915|FG000|Overall Study|Adverse Event|0|||
131054191|NCT03389802|471830916|FG001|Overall Study|Adverse Event|0|||
131054192|NCT03389802|471830917|FG002|Overall Study|Adverse Event|1|||
131054193|NCT03389802|471830918|FG003|Overall Study|Adverse Event|0|||
131054194|NCT03389802|471830919|FG004|Overall Study|Adverse Event|4|||
131054195|NCT03389802|471830915|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
131054196|NCT03389802|471830916|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
131054197|NCT03389802|471830917|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
131054198|NCT03389802|471830918|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
131054199|NCT03389802|471830919|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
131054200|NCT02426138|471830920|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
131054201|NCT02426138|471830921|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
131054202|NCT01367236|471830929|FG000|Overall Study|Withdrawal by Subject|3|||
131054203|NCT01367236|471830930|FG001|Overall Study|Withdrawal by Subject|1|||
131054204|NCT02350634|471830935|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
131054205|NCT00914966|471830938|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
131054206|NCT00914966|471830938|FG000|Step 1: 1500 Units|Physician Decision|1|||
131054207|NCT00914966|471830938|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
131054208|NCT04827732|471830939|FG000|Overall Study|Did not start treatment|0|||
131054209|NCT04827732|471830940|FG001|Overall Study|Did not start treatment|1|||
131054210|NCT04827732|471830941|FG002|Overall Study|Did not start treatment|0|||
131054211|NCT04827732|471830942|FG003|Overall Study|Did not start treatment|1|||
131054212|NCT03414684|471830944|FG000|First-course Treatment|Complete response|0|||
131054213|NCT03414684|471830945|FG001|First-course Treatment|Complete response|1|||
131054214|NCT03414684|471830944|FG000|First-course Treatment|Intercurrent illness|1|||
131054215|NCT03414684|471830945|FG001|First-course Treatment|Intercurrent illness|0|||
131054216|NCT03414684|471830944|FG000|First-course Treatment|Progressive Disease|31|||
131136013|NCT00730639|472124375|FG003|Overall Study|Adverse Event|8|||
131136014|NCT00730639|472124376|FG004|Overall Study|Adverse Event|23|||
131136015|NCT00730639|472124372|FG000|Overall Study|Complete Response|0|||
131136016|NCT00730639|472124373|FG001|Overall Study|Complete Response|0|||
131136017|NCT00730639|472124374|FG002|Overall Study|Complete Response|2|||
131136018|NCT00730639|472124375|FG003|Overall Study|Complete Response|2|||
131136019|NCT00730639|472124376|FG004|Overall Study|Complete Response|1|||
131136020|NCT00730639|472124372|FG000|Overall Study|Completed Maximum Cycles|0|||
131136021|NCT00730639|472124373|FG001|Overall Study|Completed Maximum Cycles|0|||
131136022|NCT00730639|472124374|FG002|Overall Study|Completed Maximum Cycles|11|||
131136023|NCT00730639|472124375|FG003|Overall Study|Completed Maximum Cycles|3|||
131136024|NCT00730639|472124376|FG004|Overall Study|Completed Maximum Cycles|6|||
131136025|NCT00730639|472124372|FG000|Overall Study|Death|0|||
131229746|NCT03567057|472467686|FG002|Overall Study|Lost to Follow-up|2|||
131054217|NCT03414684|471830945|FG001|First-course Treatment|Progressive Disease|32|||
131054218|NCT03414684|471830944|FG000|First-course Treatment|Adverse Event|1|||
131136026|NCT00730639|472124373|FG001|Overall Study|Death|0|||
131136027|NCT00730639|472124374|FG002|Overall Study|Death|0|||
131136028|NCT00730639|472124375|FG003|Overall Study|Death|0|||
131136029|NCT00730639|472124376|FG004|Overall Study|Death|2|||
131136030|NCT00730639|472124372|FG000|Overall Study|Disease Progression|12|||
131229747|NCT03567057|472467684|FG000|Overall Study|COVID-19 pandemic|4|||
131054219|NCT03414684|471830945|FG001|First-course Treatment|Adverse Event|2|||
131054220|NCT03414684|471830944|FG000|First-course Treatment|Physician Decision|0|||
131054221|NCT03414684|471830945|FG001|First-course Treatment|Physician Decision|1|||
131136031|NCT00730639|472124373|FG001|Overall Study|Disease Progression|13|||
131136032|NCT00730639|472124374|FG002|Overall Study|Disease Progression|48|||
131136033|NCT00730639|472124375|FG003|Overall Study|Disease Progression|32|||
131229748|NCT03567057|472467685|FG001|Overall Study|COVID-19 pandemic|3|||
130779350|NCT02326272|470819497|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131054222|NCT03414684|471830944|FG000|First-course Treatment|Withdrawal by Subject|0|||
131054223|NCT03414684|471830945|FG001|First-course Treatment|Withdrawal by Subject|1|||
131054224|NCT03414684|471830944|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
131054225|NCT03414684|471830945|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
131054226|NCT03414684|471830944|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
131054227|NCT03414684|471830945|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
131054228|NCT03414684|471830944|FG000|First-course Treatment|Still on treatment|3|||
131054229|NCT03414684|471830945|FG001|First-course Treatment|Still on treatment|0|||
131054230|NCT03414684|471830944|FG000|First-course Treatment|Never started protocol therapy|2|||
131054231|NCT03414684|471830945|FG001|First-course Treatment|Never started protocol therapy|1|||
131054232|NCT03414684|471830944|FG000|Crossover Treatment|Progressive disease|0|||
131054233|NCT03414684|471830945|FG001|Crossover Treatment|Progressive disease|12|||
131054234|NCT03414684|471830944|FG000|Crossover Treatment|Adverse Event|0|||
131054235|NCT03414684|471830945|FG001|Crossover Treatment|Adverse Event|3|||
131054236|NCT03414684|471830944|FG000|Crossover Treatment|Physician Decision|0|||
131054237|NCT03414684|471830945|FG001|Crossover Treatment|Physician Decision|1|||
131054238|NCT03414684|471830944|FG000|Crossover Treatment|Still on treatment|0|||
131054239|NCT03414684|471830945|FG001|Crossover Treatment|Still on treatment|2|||
131054240|NCT04038580|471830946|FG000|Washout 1|Death|0|||
131054241|NCT04038580|471830947|FG001|Washout 1|Death|0|||
131054242|NCT04038580|471830948|FG002|Washout 1|Death|0|||
131054243|NCT04038580|471830949|FG003|Washout 1|Death|1|||
131054244|NCT04038580|471830950|FG004|Washout 1|Death|0|||
131054245|NCT04038580|471830951|FG005|Washout 1|Death|0|||
131054246|NCT04038580|471830946|FG000|Washout 1|Withdrawal by Subject|0|||
131054247|NCT04038580|471830947|FG001|Washout 1|Withdrawal by Subject|0|||
131054248|NCT04038580|471830948|FG002|Washout 1|Withdrawal by Subject|0|||
131054249|NCT04038580|471830949|FG003|Washout 1|Withdrawal by Subject|0|||
131054250|NCT04038580|471830950|FG004|Washout 1|Withdrawal by Subject|1|||
131054251|NCT04038580|471830951|FG005|Washout 1|Withdrawal by Subject|0|||
131054252|NCT04038580|471830946|FG000|Wash-out 2|Withdrawal by Subject|1|||
131054253|NCT04038580|471830947|FG001|Wash-out 2|Withdrawal by Subject|0|||
131054254|NCT04038580|471830948|FG002|Wash-out 2|Withdrawal by Subject|0|||
131054255|NCT04038580|471830949|FG003|Wash-out 2|Withdrawal by Subject|2|||
131054256|NCT04038580|471830950|FG004|Wash-out 2|Withdrawal by Subject|0|||
131054257|NCT04038580|471830951|FG005|Wash-out 2|Withdrawal by Subject|1|||
131054258|NCT04038580|471830946|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
131054259|NCT04038580|471830947|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
131054260|NCT04038580|471830948|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
131054261|NCT04038580|471830949|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
131054262|NCT04038580|471830950|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
131054263|NCT04038580|471830951|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
131054264|NCT04038580|471830946|FG000|Wash-out 3|Withdrawal by Subject|1|||
131054265|NCT04038580|471830947|FG001|Wash-out 3|Withdrawal by Subject|0|||
131054266|NCT04038580|471830948|FG002|Wash-out 3|Withdrawal by Subject|2|||
131054267|NCT04038580|471830949|FG003|Wash-out 3|Withdrawal by Subject|0|||
131054268|NCT04038580|471830950|FG004|Wash-out 3|Withdrawal by Subject|0|||
131054269|NCT04038580|471830951|FG005|Wash-out 3|Withdrawal by Subject|0|||
131054270|NCT02278796|471832216|FG000|Overall Study|Death|2|||
131054271|NCT02278796|471832217|FG001|Overall Study|Death|3|||
131054272|NCT00357994|471832218|FG000|Overall Study|Adverse Event|1|||
131054273|NCT00357994|471832219|FG001|Overall Study|Adverse Event|2|||
131054274|NCT00357994|471832218|FG000|Overall Study|Lack of Efficacy|0|||
131054275|NCT00357994|471832219|FG001|Overall Study|Lack of Efficacy|1|||
131054276|NCT00357994|471832218|FG000|Overall Study|Protocol Violation|1|||
131054277|NCT00357994|471832219|FG001|Overall Study|Protocol Violation|0|||
131054278|NCT01079806|471832222|FG000|Day 1 to Week 96|Adverse Event|0|||
131054279|NCT01079806|471832223|FG001|Day 1 to Week 96|Adverse Event|3|||
131054280|NCT01079806|471832222|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
131054281|NCT01079806|471832223|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
131054282|NCT01079806|471832222|FG000|Day 1 to Week 96|Pregnancy|0|||
130779351|NCT02326272|470819498|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130779352|NCT02326272|470819499|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130779353|NCT02326272|470819500|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131054283|NCT01079806|471832223|FG001|Day 1 to Week 96|Pregnancy|1|||
131054284|NCT01079806|471832222|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
131054285|NCT01079806|471832223|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
131054286|NCT01079806|471832222|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
131054287|NCT01079806|471832223|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
131054288|NCT01079806|471832222|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
131054289|NCT01079806|471832223|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
131054290|NCT01079806|471832222|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
131054291|NCT01079806|471832223|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
131054292|NCT01079806|471832222|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
131054293|NCT01079806|471832223|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
131054294|NCT01079806|471832222|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
131054295|NCT01079806|471832223|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
131054296|NCT01079806|471832222|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
131054297|NCT01079806|471832223|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
131054298|NCT03732807|471832224|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
131054299|NCT03732807|471832225|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
131054300|NCT03732807|471832226|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
131054301|NCT03732807|471832227|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
131054302|NCT03732807|471832228|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
131054303|NCT03732807|471832229|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
131054304|NCT03732807|471832230|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
131054305|NCT03732807|471832224|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
131054306|NCT03732807|471832225|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
131054307|NCT03732807|471832226|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
131054308|NCT03732807|471832227|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
131054309|NCT03732807|471832228|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
131054310|NCT03732807|471832229|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
131054311|NCT03732807|471832230|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
131054312|NCT03732807|471832224|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
131054313|NCT03732807|471832225|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
131054314|NCT03732807|471832226|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
131054315|NCT03732807|471832227|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
131054316|NCT03732807|471832228|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
131054317|NCT03732807|471832229|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
131054318|NCT03732807|471832230|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
131054319|NCT03732807|471832224|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
131054320|NCT03732807|471832225|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
131054321|NCT03732807|471832226|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
131054322|NCT03732807|471832227|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
131054323|NCT03732807|471832228|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
131054324|NCT03732807|471832229|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
131054325|NCT03732807|471832230|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
131054326|NCT03732807|471832224|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
131054327|NCT03732807|471832225|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
131054328|NCT03732807|471832226|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
131054329|NCT03732807|471832227|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
131054330|NCT03732807|471832228|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
131054331|NCT03732807|471832229|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
131054332|NCT03732807|471832230|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
131054333|NCT03732807|471832224|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
131054334|NCT03732807|471832225|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
131054335|NCT03732807|471832226|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
131054336|NCT03732807|471832227|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
131054337|NCT03732807|471832228|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
131054338|NCT03732807|471832229|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
131054339|NCT03732807|471832230|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
131054340|NCT03732807|471832224|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131054341|NCT03732807|471832225|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131054342|NCT03732807|471832226|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131054343|NCT03732807|471832227|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131054344|NCT03732807|471832228|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131054345|NCT03732807|471832229|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
131054346|NCT03732807|471832230|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
131054347|NCT03732807|471832224|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
131054348|NCT03732807|471832225|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
131054349|NCT03732807|471832226|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
131054350|NCT03732807|471832227|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
131054351|NCT03732807|471832228|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
131054352|NCT03732807|471832229|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
131054353|NCT03732807|471832230|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
131054354|NCT03732807|471832224|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
131054355|NCT03732807|471832225|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
131054356|NCT03732807|471832226|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
131054357|NCT03732807|471832227|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
131054358|NCT03732807|471832228|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
131136034|NCT00730639|472124376|FG004|Overall Study|Disease Progression|88|||
131054359|NCT03732807|471832229|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
131054360|NCT03732807|471832230|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
131054361|NCT03732807|471832224|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
131054362|NCT03732807|471832225|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
131054363|NCT03732807|471832226|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
131054364|NCT03732807|471832227|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
131054365|NCT03732807|471832228|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
131054366|NCT03732807|471832229|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
131054367|NCT03732807|471832230|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
131054368|NCT03732807|471832224|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131054369|NCT03732807|471832225|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
131054370|NCT03732807|471832226|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131054371|NCT03732807|471832227|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131054372|NCT03732807|471832228|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131054373|NCT03732807|471832229|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131054374|NCT03732807|471832230|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
131054375|NCT03732807|471832224|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
131054376|NCT03732807|471832225|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
131054377|NCT03732807|471832226|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
131054378|NCT03732807|471832227|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
131054379|NCT03732807|471832228|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
131054380|NCT03732807|471832229|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
131054381|NCT03732807|471832230|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
131054382|NCT03732807|471832224|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
131054383|NCT03732807|471832225|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
131054384|NCT03732807|471832226|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
131054385|NCT03732807|471832227|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
131054386|NCT03732807|471832228|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
131054387|NCT03732807|471832229|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
131054388|NCT03732807|471832230|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
131054389|NCT03732807|471832224|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
131054390|NCT03732807|471832225|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
131054391|NCT03732807|471832226|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
131054392|NCT03732807|471832227|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
131054393|NCT03732807|471832228|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
131054394|NCT03732807|471832229|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
131054395|NCT03732807|471832230|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
131054396|NCT01779700|471832231|FG000|Overall Study|Adverse Event|4|||
131054397|NCT01779700|471832232|FG001|Overall Study|Adverse Event|3|||
131054398|NCT01779700|471832231|FG000|Overall Study|Withdrawal by Subject|0|||
131054399|NCT01779700|471832232|FG001|Overall Study|Withdrawal by Subject|2|||
131054400|NCT00019604|471832233|FG000|Overall Study|Death|1|||
131054401|NCT00019604|471832233|FG000|Overall Study|Progressive disease|23|||
131054402|NCT00019604|471832233|FG000|Overall Study|Refused treatment|1|||
131054403|NCT00019604|471832233|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
131054404|NCT00019604|471832233|FG000|Overall Study|Going to have liver transplant|1|||
131054405|NCT00019604|471832233|FG000|Overall Study|Move to a different study|1|||
131054406|NCT00019604|471832233|FG000|Overall Study|Non compliant on systemic CH|1|||
131054407|NCT00019604|471832233|FG000|Overall Study|Non compliant|1|||
131054408|NCT00019604|471832233|FG000|Overall Study|Resectable disease|1|||
131054409|NCT00019604|471832233|FG000|Overall Study|Started new chemo regimen|1|||
131054410|NCT00019604|471832233|FG000|Overall Study|Pt going to immunotherapy study|1|||
131054411|NCT00019604|471832233|FG000|Overall Study|Too much disease|1|||
131054412|NCT00019604|471832233|FG000|Overall Study|Unable to evaluate|1|||
131054413|NCT00019604|471832233|FG000|Overall Study|Details for other not available|4|||
131054414|NCT00734578|471832236|FG000|Overall Study|Adverse Event|4|||
131054415|NCT00734578|471832237|FG001|Overall Study|Adverse Event|6|||
131054416|NCT00734578|471832238|FG002|Overall Study|Adverse Event|1|||
131054417|NCT00734578|471832236|FG000|Overall Study|Protocol Violation|8|||
131054418|NCT00734578|471832237|FG001|Overall Study|Protocol Violation|6|||
131054419|NCT00734578|471832238|FG002|Overall Study|Protocol Violation|3|||
131054420|NCT00734578|471832236|FG000|Overall Study|Withdrawal by Subject|7|||
131054421|NCT00734578|471832237|FG001|Overall Study|Withdrawal by Subject|8|||
131054422|NCT00734578|471832238|FG002|Overall Study|Withdrawal by Subject|11|||
131054423|NCT00734578|471832236|FG000|Overall Study|Lost to Follow-up|9|||
131054424|NCT00734578|471832237|FG001|Overall Study|Lost to Follow-up|3|||
131054425|NCT00734578|471832238|FG002|Overall Study|Lost to Follow-up|5|||
131054426|NCT00734578|471832236|FG000|Overall Study|Lack of Efficacy|3|||
131054427|NCT00734578|471832237|FG001|Overall Study|Lack of Efficacy|2|||
131054428|NCT00734578|471832238|FG002|Overall Study|Lack of Efficacy|5|||
131136035|NCT00730639|472124372|FG000|Overall Study|non-specified|0|||
131136036|NCT00730639|472124373|FG001|Overall Study|non-specified|0|||
131136037|NCT00730639|472124374|FG002|Overall Study|non-specified|4|||
131136038|NCT00730639|472124375|FG003|Overall Study|non-specified|2|||
131136039|NCT00730639|472124376|FG004|Overall Study|non-specified|3|||
131136040|NCT00730639|472124372|FG000|Overall Study|Protocol Violation|0|||
131136041|NCT00730639|472124373|FG001|Overall Study|Protocol Violation|0|||
131136042|NCT00730639|472124374|FG002|Overall Study|Protocol Violation|1|||
131136043|NCT00730639|472124375|FG003|Overall Study|Protocol Violation|0|||
131136044|NCT00730639|472124376|FG004|Overall Study|Protocol Violation|0|||
131136045|NCT00730639|472124372|FG000|Overall Study|Withdrawal by Subject|0|||
131136046|NCT00730639|472124373|FG001|Overall Study|Withdrawal by Subject|0|||
131136047|NCT00730639|472124374|FG002|Overall Study|Withdrawal by Subject|6|||
131136048|NCT00730639|472124375|FG003|Overall Study|Withdrawal by Subject|3|||
131136049|NCT00730639|472124376|FG004|Overall Study|Withdrawal by Subject|4|||
131136050|NCT00730639|472124372|FG000|Overall Study|Treatment on-going|2|||
131136051|NCT00730639|472124373|FG001|Overall Study|Treatment on-going|5|||
131136052|NCT00730639|472124374|FG002|Overall Study|Treatment on-going|5|||
131136053|NCT00730639|472124375|FG003|Overall Study|Treatment on-going|4|||
131136054|NCT00730639|472124376|FG004|Overall Study|Treatment on-going|4|||
131054429|NCT00734578|471832236|FG000|Overall Study|Randomized in error|1|||
131054430|NCT00734578|471832237|FG001|Overall Study|Randomized in error|0|||
131054431|NCT00734578|471832238|FG002|Overall Study|Randomized in error|0|||
131054432|NCT00734578|471832236|FG000|Overall Study|Exclusion criteria|1|||
131054433|NCT00734578|471832237|FG001|Overall Study|Exclusion criteria|0|||
131054434|NCT00734578|471832238|FG002|Overall Study|Exclusion criteria|0|||
131054435|NCT02085941|471832239|FG000|Overall Study|Lack of Efficacy|1|||
131054436|NCT02085941|471832240|FG001|Overall Study|Lack of Efficacy|0|||
131054437|NCT02085941|471832239|FG000|Overall Study|Death|6|||
131054438|NCT02085941|471832240|FG001|Overall Study|Death|1|||
131054439|NCT02085941|471832239|FG000|Overall Study|Lost to Follow-up|1|||
131054440|NCT02085941|471832240|FG001|Overall Study|Lost to Follow-up|0|||
131054441|NCT02085941|471832239|FG000|Overall Study|Physician Decision|0|||
131054442|NCT02085941|471832240|FG001|Overall Study|Physician Decision|2|||
131054443|NCT03274076|471832242|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
131054444|NCT03274076|471832243|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
131054445|NCT03274076|471832244|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
131054446|NCT03274076|471832245|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
131054447|NCT03274076|471832242|FG000|24 Weeks Open Label|Adverse Event|0|||
131054448|NCT03274076|471832243|FG001|24 Weeks Open Label|Adverse Event|0|||
131054449|NCT03274076|471832244|FG002|24 Weeks Open Label|Adverse Event|2|||
131054450|NCT03274076|471832245|FG003|24 Weeks Open Label|Adverse Event|0|||
131054451|NCT03274076|471832242|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
131054452|NCT03274076|471832243|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
131054453|NCT03274076|471832244|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
131054454|NCT03274076|471832245|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
131054455|NCT00975585|471832246|FG000|Overall Study|Adverse Event|0|||
131054456|NCT00975585|471832247|FG001|Overall Study|Adverse Event|4|||
131054457|NCT00975585|471832246|FG000|Overall Study|Lost to Follow-up|3|||
131054458|NCT00975585|471832247|FG001|Overall Study|Lost to Follow-up|5|||
131054459|NCT00975585|471832246|FG000|Overall Study|Withdrawal by Subject|2|||
131054460|NCT00975585|471832247|FG001|Overall Study|Withdrawal by Subject|1|||
131054461|NCT00975585|471832246|FG000|Overall Study|Lens issue|2|||
131054462|NCT00975585|471832247|FG001|Overall Study|Lens issue|2|||
131054463|NCT00683800|471832248|FG000|Overall Study|Adverse Event|195|||
131054464|NCT00683800|471832249|FG001|Overall Study|Adverse Event|102|||
131054465|NCT00683800|471832248|FG000|Overall Study|Death|0|||
131054466|NCT00683800|471832249|FG001|Overall Study|Death|1|||
131054467|NCT00683800|471832248|FG000|Overall Study|Lost to Follow-up|57|||
131054468|NCT00683800|471832249|FG001|Overall Study|Lost to Follow-up|44|||
131054469|NCT00683800|471832248|FG000|Overall Study|Other|5|||
131054470|NCT00683800|471832249|FG001|Overall Study|Other|2|||
131054471|NCT00683800|471832248|FG000|Overall Study|Protocol Violation|13|||
131054472|NCT00683800|471832249|FG001|Overall Study|Protocol Violation|16|||
131054473|NCT00683800|471832248|FG000|Overall Study|Withdrawal by Subject|66|||
131054474|NCT00683800|471832249|FG001|Overall Study|Withdrawal by Subject|64|||
131136055|NCT02665286|472124377|FG000|Overall Study|Lost to Follow-up|3|||
131136056|NCT02665286|472124378|FG001|Overall Study|Lost to Follow-up|2|||
131054475|NCT00683800|471832248|FG000|Overall Study|Lack of Efficacy|61|||
131054476|NCT00683800|471832249|FG001|Overall Study|Lack of Efficacy|104|||
131054477|NCT00683800|471832248|FG000|Overall Study|Randomized, not treated|35|||
131054478|NCT00683800|471832249|FG001|Overall Study|Randomized, not treated|33|||
131054479|NCT01953692|471832254|FG000|Overall Study|Adverse Event|5|||
131136057|NCT02665286|472124379|FG002|Overall Study|Lost to Follow-up|1|||
131136058|NCT03064841|472124380|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
131054480|NCT01953692|471832255|FG001|Overall Study|Adverse Event|2|||
131054481|NCT01953692|471832256|FG002|Overall Study|Adverse Event|4|||
131229749|NCT03567057|472467686|FG002|Overall Study|COVID-19 pandemic|0|||
130722421|NCT00678886|470608245|FG001|Overall Study|Lost to Follow-up|0|||
131054482|NCT01953692|471832257|FG003|Overall Study|Adverse Event|2|||
131054483|NCT01953692|471832258|FG004|Overall Study|Adverse Event|1|||
131054484|NCT01953692|471832259|FG005|Overall Study|Adverse Event|2|||
131054485|NCT01953692|471832260|FG006|Overall Study|Adverse Event|0|||
131054486|NCT01953692|471832261|FG007|Overall Study|Adverse Event|0|||
131054487|NCT01953692|471832262|FG008|Overall Study|Adverse Event|0|||
131054488|NCT01953692|471832254|FG000|Overall Study|Clinical Progression|0|||
131054489|NCT01953692|471832255|FG001|Overall Study|Clinical Progression|15|||
131054490|NCT01953692|471832256|FG002|Overall Study|Clinical Progression|7|||
131054491|NCT01953692|471832257|FG003|Overall Study|Clinical Progression|5|||
131054492|NCT01953692|471832258|FG004|Overall Study|Clinical Progression|0|||
131054493|NCT01953692|471832259|FG005|Overall Study|Clinical Progression|7|||
131054494|NCT01953692|471832260|FG006|Overall Study|Clinical Progression|20|||
131054495|NCT01953692|471832261|FG007|Overall Study|Clinical Progression|3|||
131054496|NCT01953692|471832262|FG008|Overall Study|Clinical Progression|3|||
131054497|NCT01953692|471832254|FG000|Overall Study|Death|5|||
131054498|NCT01953692|471832255|FG001|Overall Study|Death|0|||
131054499|NCT01953692|471832256|FG002|Overall Study|Death|2|||
131054500|NCT01953692|471832257|FG003|Overall Study|Death|2|||
131054501|NCT01953692|471832258|FG004|Overall Study|Death|1|||
131054502|NCT01953692|471832259|FG005|Overall Study|Death|3|||
131054503|NCT01953692|471832260|FG006|Overall Study|Death|6|||
131054504|NCT01953692|471832261|FG007|Overall Study|Death|2|||
131054505|NCT01953692|471832262|FG008|Overall Study|Death|1|||
131054506|NCT01953692|471832254|FG000|Overall Study|Excluded Medication|1|||
131054507|NCT01953692|471832255|FG001|Overall Study|Excluded Medication|0|||
131054508|NCT01953692|471832256|FG002|Overall Study|Excluded Medication|0|||
131054509|NCT01953692|471832257|FG003|Overall Study|Excluded Medication|0|||
131054510|NCT01953692|471832258|FG004|Overall Study|Excluded Medication|0|||
131054511|NCT01953692|471832259|FG005|Overall Study|Excluded Medication|0|||
131054512|NCT01953692|471832260|FG006|Overall Study|Excluded Medication|0|||
131054513|NCT01953692|471832261|FG007|Overall Study|Excluded Medication|0|||
131054514|NCT01953692|471832262|FG008|Overall Study|Excluded Medication|0|||
131054515|NCT01953692|471832254|FG000|Overall Study|Lost to Follow-up|1|||
131054516|NCT01953692|471832255|FG001|Overall Study|Lost to Follow-up|0|||
131054517|NCT01953692|471832256|FG002|Overall Study|Lost to Follow-up|3|||
131054518|NCT01953692|471832257|FG003|Overall Study|Lost to Follow-up|1|||
131054519|NCT01953692|471832258|FG004|Overall Study|Lost to Follow-up|0|||
131054520|NCT01953692|471832259|FG005|Overall Study|Lost to Follow-up|1|||
131054521|NCT01953692|471832260|FG006|Overall Study|Lost to Follow-up|0|||
131054522|NCT01953692|471832261|FG007|Overall Study|Lost to Follow-up|0|||
131054523|NCT01953692|471832262|FG008|Overall Study|Lost to Follow-up|0|||
131054524|NCT01953692|471832254|FG000|Overall Study|Physician Decision|11|||
131054525|NCT01953692|471832255|FG001|Overall Study|Physician Decision|4|||
131054526|NCT01953692|471832256|FG002|Overall Study|Physician Decision|2|||
131054527|NCT01953692|471832257|FG003|Overall Study|Physician Decision|2|||
131054528|NCT01953692|471832258|FG004|Overall Study|Physician Decision|1|||
131054529|NCT01953692|471832259|FG005|Overall Study|Physician Decision|2|||
131054530|NCT01953692|471832260|FG006|Overall Study|Physician Decision|4|||
131054531|NCT01953692|471832261|FG007|Overall Study|Physician Decision|1|||
131054532|NCT01953692|471832262|FG008|Overall Study|Physician Decision|0|||
131054533|NCT01953692|471832254|FG000|Overall Study|Protocol Violation|0|||
131054534|NCT01953692|471832255|FG001|Overall Study|Protocol Violation|2|||
131054535|NCT01953692|471832256|FG002|Overall Study|Protocol Violation|1|||
131054536|NCT01953692|471832257|FG003|Overall Study|Protocol Violation|0|||
131054537|NCT01953692|471832258|FG004|Overall Study|Protocol Violation|0|||
131054538|NCT01953692|471832259|FG005|Overall Study|Protocol Violation|0|||
131054539|NCT01953692|471832260|FG006|Overall Study|Protocol Violation|0|||
131054540|NCT01953692|471832261|FG007|Overall Study|Protocol Violation|1|||
131054541|NCT01953692|471832262|FG008|Overall Study|Protocol Violation|0|||
131054542|NCT01953692|471832254|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131054543|NCT01953692|471832255|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131054544|NCT01953692|471832256|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131054545|NCT01953692|471832257|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131054546|NCT01953692|471832258|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131054547|NCT01953692|471832259|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131054548|NCT01953692|471832260|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131054549|NCT01953692|471832261|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
131054550|NCT01953692|471832262|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
131054551|NCT01953692|471832254|FG000|Overall Study|Withdrawal by Subject|4|||
131136059|NCT03064841|472124380|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
131136060|NCT03064841|472124380|FG000|Overall Study|Screen failure|2|||
131054552|NCT01953692|471832255|FG001|Overall Study|Withdrawal by Subject|2|||
131054553|NCT01953692|471832256|FG002|Overall Study|Withdrawal by Subject|1|||
131054554|NCT01953692|471832257|FG003|Overall Study|Withdrawal by Subject|2|||
131054555|NCT01953692|471832258|FG004|Overall Study|Withdrawal by Subject|0|||
131054556|NCT01953692|471832259|FG005|Overall Study|Withdrawal by Subject|3|||
131054557|NCT01953692|471832260|FG006|Overall Study|Withdrawal by Subject|2|||
131054558|NCT01953692|471832261|FG007|Overall Study|Withdrawal by Subject|1|||
131054559|NCT01953692|471832262|FG008|Overall Study|Withdrawal by Subject|1|||
131054560|NCT01328496|471832270|FG000|Overall Study|Significant Change in Health Status|1|||
131054561|NCT01328496|471832271|FG001|Overall Study|Significant Change in Health Status|0|||
131054562|NCT01886872|471832272|FG000|Overall Study|Ineligible|7|||
131054563|NCT01886872|471832273|FG001|Overall Study|Ineligible|4|||
131054564|NCT01886872|471832274|FG002|Overall Study|Ineligible|12|||
131054565|NCT04941482|471832275|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
131054566|NCT04941482|471832276|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
131054567|NCT05966155|471832277|FG000|Overall Study|Death|1|||
131054568|NCT05966155|471832278|FG001|Overall Study|Death|2|||
131054569|NCT05966155|471832277|FG000|Overall Study|Lost to Follow-up|63|||
131054570|NCT05966155|471832278|FG001|Overall Study|Lost to Follow-up|67|||
131054571|NCT05966155|471832277|FG000|Overall Study|Protocol Violation|1|||
131054572|NCT05966155|471832278|FG001|Overall Study|Protocol Violation|0|||
131054573|NCT05966155|471832277|FG000|Overall Study|Withdrawal by Subject|8|||
131136061|NCT00217087|472124381|FG000|Overall Study|decided to have esophagectomy|1|||
131136062|NCT00217087|472124382|FG001|Overall Study|decided to have esophagectomy|2|||
131136063|NCT00217087|472124381|FG000|Overall Study|completed less than 12 months return|10|||
131136064|NCT00217087|472124382|FG001|Overall Study|completed less than 12 months return|18|||
131136065|NCT03208231|472124383|FG000|Overall Study|Death|1|||
131136066|NCT03208231|472124384|FG001|Overall Study|Death|2|||
131136067|NCT03208231|472124383|FG000|Overall Study|Moved and unable to get to clinic|1|||
131136068|NCT03208231|472124384|FG001|Overall Study|Moved and unable to get to clinic|0|||
131136069|NCT03208231|472124383|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
131136070|NCT03208231|472124384|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
131136071|NCT04622046|472124402|FG000|Intervention Period|Adverse Event|1|||
131136072|NCT04622046|472124402|FG000|Intervention Period|Withdrawal by Subject|2|||
131136073|NCT04622046|472124402|FG000|Extension Period|Ongoing in the Extension Period|21|||
131136074|NCT01844986|472124403|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
131136075|NCT01844986|472124404|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
131136076|NCT01844986|472124403|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
131136077|NCT01844986|472124404|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
131136078|NCT01844986|472124403|FG000|Overall Study (Global Cohort)|Death|55|||
131136079|NCT01844986|472124404|FG001|Overall Study (Global Cohort)|Death|26|||
131136080|NCT01844986|472124403|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
131136081|NCT01844986|472124404|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
131136082|NCT01844986|472124403|FG000|Overall Study (China Cohort)|Death|10|||
131136083|NCT01844986|472124404|FG001|Overall Study (China Cohort)|Death|6|||
131136084|NCT03266016|472126448|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
131136085|NCT03266016|472126449|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
130779354|NCT02326272|470819501|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131054574|NCT05966155|471832278|FG001|Overall Study|Withdrawal by Subject|9|||
131054575|NCT05966155|471832277|FG000|Overall Study|Enrolled Erroneously|0|||
131054576|NCT05966155|471832278|FG001|Overall Study|Enrolled Erroneously|1|||
131054577|NCT05966155|471832277|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
131054578|NCT05966155|471832278|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
131054579|NCT02743819|471832279|FG000|Overall Study|Lack of Efficacy|5|||
131054580|NCT02743819|471832279|FG000|Overall Study|Death|2|||
131054581|NCT02743819|471832279|FG000|Overall Study|Adverse Event|1|||
131054582|NCT03582475|471832284|FG000|Treatment Period|Withdrawal by Subject|0|||
131054583|NCT03582475|471832285|FG001|Treatment Period|Withdrawal by Subject|1|||
131054584|NCT03582475|471832284|FG000|Follow-up Period|Withdrawal by Subject|0|||
131054585|NCT03582475|471832285|FG001|Follow-up Period|Withdrawal by Subject|1|||
131054586|NCT01706159|471832286|FG000|Overall Study|Withdrawal Criteria|2|||
131054587|NCT01706159|471832287|FG001|Overall Study|Withdrawal Criteria|1|||
131054588|NCT01706159|471832286|FG000|Overall Study|Unclassified|6|||
131054589|NCT01706159|471832287|FG001|Overall Study|Unclassified|1|||
131054590|NCT00553332|471832292|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
131054591|NCT03775486|471832293|FG000|Initial Therapy Phase|Other reason provided|0|||
131054592|NCT03775486|471832294|FG001|Initial Therapy Phase|Other reason provided|15|||
131054593|NCT03775486|471832293|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
131136086|NCT03266016|472126450|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
131136087|NCT03266016|472126451|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
131136088|NCT03266016|472126448|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
131136089|NCT03266016|472126449|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
131054594|NCT03775486|471832294|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
131054595|NCT03775486|471832293|FG000|Initial Therapy Phase|Protocol Violation|0|||
131054596|NCT03775486|471832294|FG001|Initial Therapy Phase|Protocol Violation|2|||
131054597|NCT03775486|471832293|FG000|Initial Therapy Phase|Adverse Event|0|||
131054598|NCT03775486|471832294|FG001|Initial Therapy Phase|Adverse Event|34|||
131054599|NCT03775486|471832293|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
131054600|NCT03775486|471832294|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
131136090|NCT03266016|472126450|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
131136091|NCT03266016|472126451|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
131136092|NCT04183335|472126452|FG000|Overall Study|Adverse Event|1|||
131136093|NCT04183335|472126453|FG001|Overall Study|Adverse Event|0|||
131136094|NCT04183335|472126452|FG000|Overall Study|Withdrawal by Subject|12|||
131136095|NCT04183335|472126453|FG001|Overall Study|Withdrawal by Subject|3|||
131136096|NCT01268293|472126457|FG000|Overall Study|Disease progression|7|||
131136097|NCT01268293|472126457|FG000|Overall Study|Adverse Event|1|||
131136098|NCT01268293|472126457|FG000|Overall Study|Subject choice|1|||
131136099|NCT00223496|472126458|FG000|Overall Study|screen failure|9|||
131136100|NCT00223496|472126458|FG000|Overall Study|Lost to Follow-up|4|||
130722422|NCT00678886|470608246|FG002|Overall Study|Lost to Follow-up|3|||
130722423|NCT00678886|470608247|FG003|Overall Study|Lost to Follow-up|2|||
130722424|NCT00678886|470608244|FG000|Overall Study|Other|0|||
131054601|NCT03775486|471832293|FG000|Maintenance Phase|Withdrawal by Subject|13|||
131054602|NCT03775486|471832294|FG001|Maintenance Phase|Withdrawal by Subject|12|||
131054603|NCT03775486|471832293|FG000|Maintenance Phase|Death|44|||
131054604|NCT03775486|471832294|FG001|Maintenance Phase|Death|45|||
131054605|NCT02235298|471832296|FG000|Overall Study|Lost to Follow-up|6|||
131054606|NCT02235298|471832297|FG001|Overall Study|Lost to Follow-up|5|||
131054607|NCT02235298|471832296|FG000|Overall Study|Adverse Event|2|||
131054608|NCT02235298|471832297|FG001|Overall Study|Adverse Event|2|||
131054609|NCT02235298|471832296|FG000|Overall Study|Withdrawal by Subject|0|||
131054610|NCT02235298|471832297|FG001|Overall Study|Withdrawal by Subject|1|||
131054611|NCT02744066|471832298|FG000|Overall Study|Withdrawal by parent|0|||
131054612|NCT02744066|471832299|FG001|Overall Study|Withdrawal by parent|1|||
131054613|NCT02744066|471832298|FG000|Overall Study|Discharged from NICU prior to completion|0|||
131054614|NCT02744066|471832299|FG001|Overall Study|Discharged from NICU prior to completion|4|||
131054615|NCT02454959|471832300|FG000|Overall Study|Protocol-Specified Criteria|3|||
131054616|NCT02454959|471832300|FG000|Overall Study|Physician Decision|1|||
131054617|NCT02454959|471832300|FG000|Overall Study|Withdrawal by Subject|3|||
131054618|NCT02454959|471832300|FG000|Overall Study|Adverse Event|2|||
131054619|NCT04745676|471832301|FG000|Overall Study|Death|1|||
131054620|NCT04745676|471832302|FG001|Overall Study|Death|0|||
131054621|NCT04745676|471832303|FG002|Overall Study|Death|0|||
131054622|NCT03102034|471832306|FG000|Overall Study|Withdrawal by Subject|1|||
131054623|NCT03102034|471832307|FG001|Overall Study|Withdrawal by Subject|0|||
131054624|NCT05810285|471832317|FG000|Overall Study|Death|4|||
131054625|NCT05810285|471832318|FG001|Overall Study|Death|21|||
131054626|NCT05810285|471832317|FG000|Overall Study|Adverse Event|18|||
131054627|NCT05810285|471832318|FG001|Overall Study|Adverse Event|16|||
131054628|NCT03147287|471832319|FG000|Overall Study|Randomized Not Treated|2|||
131054629|NCT03147287|471832320|FG001|Overall Study|Randomized Not Treated|1|||
131054630|NCT03147287|471832321|FG002|Overall Study|Randomized Not Treated|1|||
131054631|NCT03147287|471832319|FG000|Overall Study|Progressive Disease RECIST|31|||
131054632|NCT03147287|471832320|FG001|Overall Study|Progressive Disease RECIST|72|||
131054633|NCT03147287|471832321|FG002|Overall Study|Progressive Disease RECIST|32|||
131054634|NCT03147287|471832319|FG000|Overall Study|Progressive Disease not RECIST|13|||
131054635|NCT03147287|471832320|FG001|Overall Study|Progressive Disease not RECIST|21|||
131054636|NCT03147287|471832321|FG002|Overall Study|Progressive Disease not RECIST|13|||
131054637|NCT03147287|471832319|FG000|Overall Study|Physician Decision|1|||
131054638|NCT03147287|471832320|FG001|Overall Study|Physician Decision|2|||
131054639|NCT03147287|471832321|FG002|Overall Study|Physician Decision|1|||
131054640|NCT03147287|471832319|FG000|Overall Study|Intercurrent illness|0|||
131054641|NCT03147287|471832320|FG001|Overall Study|Intercurrent illness|1|||
131054642|NCT03147287|471832321|FG002|Overall Study|Intercurrent illness|0|||
131054643|NCT03147287|471832319|FG000|Overall Study|Withdrawal by Subject|2|||
131054644|NCT03147287|471832320|FG001|Overall Study|Withdrawal by Subject|3|||
130722425|NCT00678886|470608245|FG001|Overall Study|Other|0|||
130722426|NCT00678886|470608246|FG002|Overall Study|Other|1|||
130722427|NCT00678886|470608247|FG003|Overall Study|Other|0|||
130722428|NCT00206323|470608248|FG000|Overall Study|Lack of Efficacy|4|||
131054645|NCT03147287|471832321|FG002|Overall Study|Withdrawal by Subject|2|||
130722429|NCT00206323|470608249|FG001|Overall Study|Lack of Efficacy|1|||
130722430|NCT00206323|470608248|FG000|Overall Study|Adverse Event|1|||
130722431|NCT00206323|470608249|FG001|Overall Study|Adverse Event|1|||
130779355|NCT02326272|470819502|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131054646|NCT03147287|471832319|FG000|Overall Study|Patient Non-Compliance|0|||
131054647|NCT03147287|471832320|FG001|Overall Study|Patient Non-Compliance|2|||
131054648|NCT03147287|471832321|FG002|Overall Study|Patient Non-Compliance|0|||
131054649|NCT03147287|471832319|FG000|Overall Study|Patient moved|0|||
131054650|NCT03147287|471832320|FG001|Overall Study|Patient moved|1|||
131136101|NCT00223496|472126458|FG000|Overall Study|Lack of Efficacy|6|||
131136102|NCT00223496|472126458|FG000|Overall Study|Withdrawal by Subject|1|||
131054651|NCT03147287|471832321|FG002|Overall Study|Patient moved|0|||
131054652|NCT03147287|471832319|FG000|Overall Study|Arm A crossover without PD|1|||
131054653|NCT03147287|471832320|FG001|Overall Study|Arm A crossover without PD|0|||
131054654|NCT03147287|471832321|FG002|Overall Study|Arm A crossover without PD|0|||
131136103|NCT00223496|472126458|FG000|Overall Study|Physician Decision|2|||
131054655|NCT03147287|471832319|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
131054656|NCT03147287|471832320|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
131054657|NCT03147287|471832321|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
131054658|NCT03945773|471833235|FG000|Overall Study|Consent Withdrawn|1|||
131136104|NCT01414257|472126459|FG000|Overall Study|No Visit After First Day of Treatment|12|||
131136105|NCT01414257|472126459|FG000|Overall Study|Protocol Violation|10|||
131136106|NCT01784965|472126462|FG000|Overall Study|Withdrawal by Subject|6|||
131136107|NCT01784965|472126463|FG001|Overall Study|Withdrawal by Subject|3|||
131136108|NCT01784965|472126462|FG000|Overall Study|Adverse Event|0|||
131136109|NCT01784965|472126463|FG001|Overall Study|Adverse Event|8|||
131136110|NCT03757988|472126464|FG000|Overall Study|Withdrawal by Subject|1|||
131136111|NCT01562548|472126468|FG000|Overall Study|Lost to Follow-up|0|||
131136112|NCT01562548|472126469|FG001|Overall Study|Lost to Follow-up|0|||
131136113|NCT01562548|472126470|FG002|Overall Study|Lost to Follow-up|1|||
131136114|NCT01562548|472126471|FG003|Overall Study|Lost to Follow-up|0|||
131136115|NCT01496066|472126472|FG000|Overall Study|Lost to Follow-up|8|||
131136116|NCT01496066|472126473|FG001|Overall Study|Lost to Follow-up|5|||
131136117|NCT01496066|472126472|FG000|Overall Study|Explant|3|||
131136118|NCT01496066|472126473|FG001|Overall Study|Explant|0|||
131136119|NCT01496066|472126472|FG000|Overall Study|Death|1|||
131136120|NCT01496066|472126473|FG001|Overall Study|Death|4|||
131136121|NCT03237065|472126474|FG000|Overall Study|Adverse Event|0|||
131136122|NCT03237065|472126475|FG001|Overall Study|Adverse Event|2|||
131136123|NCT03237065|472126474|FG000|Overall Study|Protocol Violation|0|||
131136124|NCT03237065|472126475|FG001|Overall Study|Protocol Violation|1|||
131136125|NCT03237065|472126474|FG000|Overall Study|Withdrawal by Subject|3|||
131136126|NCT03237065|472126475|FG001|Overall Study|Withdrawal by Subject|0|||
131136127|NCT03237065|472126474|FG000|Overall Study|Lost to Follow-up|1|||
131136128|NCT03237065|472126475|FG001|Overall Study|Lost to Follow-up|0|||
131136129|NCT03237065|472126474|FG000|Overall Study|Unable to obtain venous access|0|||
131136130|NCT03237065|472126475|FG001|Overall Study|Unable to obtain venous access|1|||
131136131|NCT00209339|472126476|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
131136132|NCT00209339|472126476|FG000|At 12 Months Follow-up|Death|1|||
131136133|NCT00209339|472126476|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
131136134|NCT00209339|472126476|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
131136135|NCT00209339|472126476|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
131136136|NCT00209339|472126476|FG000|At 24 Months Follow-up|Death|1|||
131136137|NCT00209339|472126476|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
131054659|NCT03945773|471833236|FG001|Overall Study|Consent Withdrawn|1|||
131054660|NCT03945773|471833235|FG000|Overall Study|Lost to Follow-up|1|||
131054661|NCT03945773|471833236|FG001|Overall Study|Lost to Follow-up|0|||
131054662|NCT03945773|471833235|FG000|Overall Study|Death|46|||
131054663|NCT03945773|471833236|FG001|Overall Study|Death|22|||
131054664|NCT03945773|471833235|FG000|Overall Study|Physician Decision|1|||
131054665|NCT03945773|471833236|FG001|Overall Study|Physician Decision|0|||
131054666|NCT03945773|471833235|FG000|Overall Study|Other|1|||
131054667|NCT03945773|471833236|FG001|Overall Study|Other|0|||
131054668|NCT03945773|471833235|FG000|Overall Study|Ongoing at the time of DCO|4|||
131054669|NCT03945773|471833236|FG001|Overall Study|Ongoing at the time of DCO|3|||
131054670|NCT01970878|471833238|FG000|Overall Study|Withdrawal by Subject|11|||
131054671|NCT01970878|471833239|FG001|Overall Study|Withdrawal by Subject|10|||
131054672|NCT01970878|471833240|FG002|Overall Study|Withdrawal by Subject|14|||
131054673|NCT01970878|471833241|FG003|Overall Study|Withdrawal by Subject|7|||
131054674|NCT01970878|471833238|FG000|Overall Study|Lost to Follow-up|1|||
131054675|NCT01970878|471833239|FG001|Overall Study|Lost to Follow-up|3|||
131054676|NCT01970878|471833240|FG002|Overall Study|Lost to Follow-up|2|||
131136138|NCT00209339|472126476|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
131136139|NCT00209339|472126476|FG000|At 4 Years Follow-up|Death|1|||
131136140|NCT00209339|472126476|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
131136141|NCT00209339|472126476|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
131136142|NCT00209339|472126476|FG000|At 5 Years Follow-up|Death|1|||
131136143|NCT01587079|472126477|FG000|Overall Study|Protocol-specified criteria|9|||
131136144|NCT01587079|472126477|FG000|Overall Study|Protocol Violation|5|||
131136145|NCT01587079|472126477|FG000|Overall Study|Lost to Follow-up|2|||
131136146|NCT01587079|472126477|FG000|Overall Study|Physician Decision|2|||
131136147|NCT01587079|472126477|FG000|Overall Study|Withdrawal by Subject|7|||
131136148|NCT01587079|472126477|FG000|Overall Study|Adverse Event|14|||
131136149|NCT01764633|472126478|FG000|Overall Study|Withdrawal by Subject|105|||
131136150|NCT01764633|472126479|FG001|Overall Study|Withdrawal by Subject|88|||
131136151|NCT01764633|472126478|FG000|Overall Study|Lost to Follow-up|13|||
131136152|NCT01764633|472126479|FG001|Overall Study|Lost to Follow-up|5|||
131054677|NCT01970878|471833241|FG003|Overall Study|Lost to Follow-up|4|||
131054678|NCT01970878|471833238|FG000|Overall Study|Administrative Reasons|1|||
131054679|NCT01970878|471833239|FG001|Overall Study|Administrative Reasons|0|||
131136153|NCT02268058|472126480|FG000|Overall Study|Protocol Violation|1|||
131136154|NCT02268058|472126481|FG001|Overall Study|Protocol Violation|0|||
131136155|NCT02268058|472126482|FG002|Overall Study|Protocol Violation|0|||
131054680|NCT01970878|471833240|FG002|Overall Study|Administrative Reasons|0|||
131054681|NCT01970878|471833241|FG003|Overall Study|Administrative Reasons|4|||
131054682|NCT01970878|471833238|FG000|Overall Study|Lack of Efficacy|2|||
131054683|NCT01970878|471833239|FG001|Overall Study|Lack of Efficacy|1|||
131054684|NCT01970878|471833240|FG002|Overall Study|Lack of Efficacy|2|||
131054685|NCT01970878|471833241|FG003|Overall Study|Lack of Efficacy|0|||
131054686|NCT01970878|471833238|FG000|Overall Study|Adverse Event|12|||
131054687|NCT01970878|471833239|FG001|Overall Study|Adverse Event|7|||
131054688|NCT01970878|471833240|FG002|Overall Study|Adverse Event|4|||
131054689|NCT01970878|471833241|FG003|Overall Study|Adverse Event|3|||
131054690|NCT01970878|471833238|FG000|Overall Study|Protocol Specified Criteria|10|||
131054691|NCT01970878|471833239|FG001|Overall Study|Protocol Specified Criteria|4|||
131054692|NCT01970878|471833240|FG002|Overall Study|Protocol Specified Criteria|3|||
131054693|NCT01970878|471833241|FG003|Overall Study|Protocol Specified Criteria|6|||
131054694|NCT01970878|471833238|FG000|Overall Study|Physician Decision|0|||
131054695|NCT01970878|471833239|FG001|Overall Study|Physician Decision|1|||
131054696|NCT01970878|471833240|FG002|Overall Study|Physician Decision|1|||
131054697|NCT01970878|471833241|FG003|Overall Study|Physician Decision|0|||
131054698|NCT01970878|471833238|FG000|Overall Study|No Completion Status|0|||
131054699|NCT01970878|471833239|FG001|Overall Study|No Completion Status|1|||
131054700|NCT01970878|471833240|FG002|Overall Study|No Completion Status|0|||
131054701|NCT01970878|471833241|FG003|Overall Study|No Completion Status|0|||
131054702|NCT04608409|471833246|FG000|Overall Study|Physician Decision|1|||
131054703|NCT04608409|471833247|FG001|Overall Study|Physician Decision|1|||
131054704|NCT04608409|471833248|FG002|Overall Study|Physician Decision|2|||
131054705|NCT00599196|471833249|FG000|Overall Study|Lack of Efficacy|22|||
131054706|NCT00599196|471833249|FG000|Overall Study|Adverse Event|93|||
131054707|NCT00599196|471833249|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
131054708|NCT00599196|471833249|FG000|Overall Study|Subject withdrew consent|43|||
131054709|NCT00599196|471833249|FG000|Overall Study|Study ended per sponsor|197|||
131054710|NCT00599196|471833249|FG000|Overall Study|Lost to Follow-up|17|||
131054711|NCT00599196|471833249|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
131054712|NCT00599196|471833249|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
131054713|NCT00599196|471833249|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
131054714|NCT00599196|471833249|FG000|Overall Study|Other: Pt Moved To Australia|1|||
131054715|NCT00599196|471833249|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
131054716|NCT00599196|471833249|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
131054717|NCT00795184|471833258|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
131054718|NCT00795184|471833259|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
131054719|NCT00205179|471833261|FG000|Overall Study|Death|0|||
131054720|NCT00205179|471833262|FG001|Overall Study|Death|2|||
131054721|NCT00205179|471833261|FG000|Overall Study|Physician Decision|1|||
131054722|NCT00205179|471833262|FG001|Overall Study|Physician Decision|1|||
131054723|NCT00205179|471833261|FG000|Overall Study|Adverse Event|1|||
131054724|NCT00205179|471833262|FG001|Overall Study|Adverse Event|1|||
131054725|NCT00586313|471833263|FG000|Overall Study|Lack of Efficacy|2|||
131054726|NCT02079649|471833264|FG000|Overall Study|Lost to Follow-up|0|||
131054727|NCT02079649|471833265|FG001|Overall Study|Lost to Follow-up|0|||
131054728|NCT02079649|471833266|FG002|Overall Study|Lost to Follow-up|0|||
131054729|NCT02079649|471833267|FG003|Overall Study|Lost to Follow-up|1|||
131054730|NCT02079649|471833264|FG000|Overall Study|Withdrawal by Subject|0|||
131054731|NCT02079649|471833265|FG001|Overall Study|Withdrawal by Subject|0|||
131054732|NCT02079649|471833266|FG002|Overall Study|Withdrawal by Subject|0|||
131054733|NCT02079649|471833267|FG003|Overall Study|Withdrawal by Subject|1|||
131054734|NCT02079649|471833264|FG000|Overall Study|Randomization error (prior to treatment)|1|||
131054735|NCT02079649|471833265|FG001|Overall Study|Randomization error (prior to treatment)|0|||
131054736|NCT02079649|471833266|FG002|Overall Study|Randomization error (prior to treatment)|1|||
131054737|NCT02079649|471833267|FG003|Overall Study|Randomization error (prior to treatment)|0|||
131054738|NCT00388726|471833270|FG000|Overall Study|Adverse Event|50|||
131054739|NCT00388726|471833271|FG001|Overall Study|Adverse Event|24|||
131054740|NCT00388726|471833270|FG000|Overall Study|Progressive Disease|336|||
131054741|NCT00388726|471833271|FG001|Overall Study|Progressive Disease|153|||
131054742|NCT00388726|471833270|FG000|Overall Study|Clinical Progression|61|||
131054743|NCT00388726|471833271|FG001|Overall Study|Clinical Progression|36|||
131054744|NCT00388726|471833270|FG000|Overall Study|Withdrawal by Subject|10|||
131054745|NCT00388726|471833271|FG001|Overall Study|Withdrawal by Subject|7|||
130722432|NCT00206323|470608248|FG000|Overall Study|Lost to Follow-up|1|||
130722433|NCT00206323|470608249|FG001|Overall Study|Lost to Follow-up|1|||
130722434|NCT03918109|470608262|FG000|Overall Study|Withdrawal by Subject|0|||
131054746|NCT00388726|471833270|FG000|Overall Study|Administrative|6|||
131054747|NCT00388726|471833271|FG001|Overall Study|Administrative|9|||
131054748|NCT00388726|471833270|FG000|Overall Study|Physician Decision|18|||
131054749|NCT00388726|471833271|FG001|Overall Study|Physician Decision|13|||
131054750|NCT00388726|471833270|FG000|Overall Study|Death|3|||
131054751|NCT00388726|471833271|FG001|Overall Study|Death|2|||
131054752|NCT00983294|471833273|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
131054753|NCT00983294|471833273|FG000|Colchicine With Azithromycin|Adverse Event|1|||
131136156|NCT02268058|472126483|FG003|Overall Study|Protocol Violation|0|||
131136157|NCT00704964|472126489|FG000|Overall Study|Not completed on time|328|||
131136158|NCT02217566|472126491|FG000|Overall Study|Lost to Follow-up|2|||
131136159|NCT02217566|472126491|FG000|Overall Study|Death|3|||
131136160|NCT02217566|472126491|FG000|Overall Study|Early study termination|6|||
131136161|NCT02574637|472126498|FG000|Double-blind Period|Adverse Event|1|||
131136162|NCT02574637|472126499|FG001|Double-blind Period|Adverse Event|0|||
131136163|NCT02574637|472126500|FG002|Double-blind Period|Adverse Event|0|||
131136164|NCT02574637|472126501|FG003|Double-blind Period|Adverse Event|0|||
131136165|NCT02574637|472126502|FG004|Double-blind Period|Adverse Event|0|||
131136166|NCT02574637|472126503|FG005|Double-blind Period|Adverse Event|0|||
131136167|NCT02574637|472126504|FG006|Double-blind Period|Adverse Event|0|||
131136168|NCT02574637|472126505|FG007|Double-blind Period|Adverse Event|0|||
131136169|NCT02574637|472126506|FG008|Double-blind Period|Adverse Event|0|||
131136170|NCT02574637|472126507|FG009|Double-blind Period|Adverse Event|0|||
131136171|NCT02574637|472126498|FG000|Double-blind Period|Lack of Efficacy|0|||
131136172|NCT02574637|472126499|FG001|Double-blind Period|Lack of Efficacy|0|||
131136173|NCT02574637|472126500|FG002|Double-blind Period|Lack of Efficacy|2|||
131136174|NCT02574637|472126501|FG003|Double-blind Period|Lack of Efficacy|0|||
131136175|NCT02574637|472126502|FG004|Double-blind Period|Lack of Efficacy|0|||
131136176|NCT02574637|472126503|FG005|Double-blind Period|Lack of Efficacy|0|||
131136177|NCT02574637|472126504|FG006|Double-blind Period|Lack of Efficacy|0|||
131136178|NCT02574637|472126505|FG007|Double-blind Period|Lack of Efficacy|0|||
131136179|NCT02574637|472126506|FG008|Double-blind Period|Lack of Efficacy|0|||
131136180|NCT02574637|472126507|FG009|Double-blind Period|Lack of Efficacy|0|||
131136181|NCT02574637|472126498|FG000|Double-blind Period|Protocol Deviation|1|||
131136182|NCT02574637|472126499|FG001|Double-blind Period|Protocol Deviation|0|||
131136183|NCT02574637|472126500|FG002|Double-blind Period|Protocol Deviation|0|||
131136184|NCT02574637|472126501|FG003|Double-blind Period|Protocol Deviation|0|||
131136185|NCT02574637|472126502|FG004|Double-blind Period|Protocol Deviation|0|||
131136186|NCT02574637|472126503|FG005|Double-blind Period|Protocol Deviation|0|||
131136187|NCT02574637|472126504|FG006|Double-blind Period|Protocol Deviation|0|||
131054754|NCT00853593|471833274|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
131054755|NCT00853593|471833274|FG000|Overall Study|Model 4396 lead not attempted|29|||
131054756|NCT00853593|471833274|FG000|Overall Study|Implant not attempted|4|||
131054757|NCT00600353|471833279|FG000|Overall Study|history of malignancy within 5 years|1|||
131054758|NCT00600353|471833280|FG001|Overall Study|history of malignancy within 5 years|0|||
131054759|NCT00600353|471833279|FG000|Overall Study|History of prepartive regimen|0|||
131054760|NCT00600353|471833280|FG001|Overall Study|History of prepartive regimen|1|||
131054761|NCT03683576|471833287|FG000|Overall Study|Withdrawal by Subject|2|||
131054762|NCT03683576|471833288|FG001|Overall Study|Withdrawal by Subject|0|||
131054763|NCT03683576|471833289|FG002|Overall Study|Withdrawal by Subject|8|||
131054764|NCT03683576|471833290|FG003|Overall Study|Withdrawal by Subject|3|||
131054765|NCT03683576|471833287|FG000|Overall Study|Adverse Event|3|||
131054766|NCT03683576|471833288|FG001|Overall Study|Adverse Event|0|||
131054767|NCT03683576|471833289|FG002|Overall Study|Adverse Event|0|||
131054768|NCT03683576|471833290|FG003|Overall Study|Adverse Event|4|||
131054769|NCT03683576|471833287|FG000|Overall Study|Lack of Efficacy|1|||
131054770|NCT03683576|471833288|FG001|Overall Study|Lack of Efficacy|0|||
131054771|NCT03683576|471833289|FG002|Overall Study|Lack of Efficacy|1|||
131136188|NCT02574637|472126505|FG007|Double-blind Period|Protocol Deviation|0|||
131136189|NCT02574637|472126506|FG008|Double-blind Period|Protocol Deviation|0|||
131136190|NCT02574637|472126507|FG009|Double-blind Period|Protocol Deviation|0|||
131136191|NCT02574637|472126498|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
131136192|NCT02574637|472126499|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
131136193|NCT02574637|472126500|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
131136194|NCT02574637|472126501|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
131136195|NCT02574637|472126502|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
131136196|NCT02574637|472126503|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
131136197|NCT02574637|472126504|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
131136198|NCT02574637|472126505|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
131136199|NCT02574637|472126506|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
131136200|NCT02574637|472126507|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
131136201|NCT02574637|472126498|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
131054772|NCT03683576|471833290|FG003|Overall Study|Lack of Efficacy|1|||
131136202|NCT02574637|472126499|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
131136203|NCT02574637|472126500|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
131136204|NCT02574637|472126501|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
131136205|NCT02574637|472126502|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
130722435|NCT03918109|470608263|FG001|Overall Study|Withdrawal by Subject|0|||
130722436|NCT03918109|470608264|FG002|Overall Study|Withdrawal by Subject|2|||
131054773|NCT03683576|471833287|FG000|Overall Study|Lost to Follow-up|0|||
131054774|NCT03683576|471833288|FG001|Overall Study|Lost to Follow-up|1|||
131054775|NCT03683576|471833289|FG002|Overall Study|Lost to Follow-up|2|||
131229750|NCT03567057|472467684|FG000|Overall Study|Non-compliance with study drug|4|||
131229751|NCT03567057|472467685|FG001|Overall Study|Non-compliance with study drug|2|||
131229752|NCT03567057|472467686|FG002|Overall Study|Non-compliance with study drug|0|||
131229753|NCT03567057|472467684|FG000|Overall Study|Lack of Efficacy|3|||
131229754|NCT03567057|472467685|FG001|Overall Study|Lack of Efficacy|0|||
131229755|NCT03567057|472467686|FG002|Overall Study|Lack of Efficacy|1|||
130722437|NCT03918109|470608265|FG003|Overall Study|Withdrawal by Subject|1|||
130722438|NCT03918109|470608262|FG000|Overall Study|Lost to Follow-up|0|||
131054776|NCT03683576|471833290|FG003|Overall Study|Lost to Follow-up|0|||
131054777|NCT03683576|471833287|FG000|Overall Study|Other, Not Specified|0|||
131054778|NCT03683576|471833288|FG001|Overall Study|Other, Not Specified|2|||
131054779|NCT03683576|471833289|FG002|Overall Study|Other, Not Specified|0|||
131054780|NCT03683576|471833290|FG003|Overall Study|Other, Not Specified|0|||
131054781|NCT03683576|471833287|FG000|Overall Study|Protocol Violation|0|||
131054782|NCT03683576|471833288|FG001|Overall Study|Protocol Violation|1|||
131054783|NCT03683576|471833289|FG002|Overall Study|Protocol Violation|1|||
131054784|NCT03683576|471833290|FG003|Overall Study|Protocol Violation|0|||
131054785|NCT03611075|471833292|FG000|Overall Study|Physician Decision|0|||
131054786|NCT03611075|471833293|FG001|Overall Study|Physician Decision|1|||
131054787|NCT03611075|471833294|FG002|Overall Study|Physician Decision|1|||
131054788|NCT03611075|471833295|FG003|Overall Study|Physician Decision|0|||
131054789|NCT03611075|471833296|FG004|Overall Study|Physician Decision|0|||
131054790|NCT03611075|471833297|FG005|Overall Study|Physician Decision|0|||
131054791|NCT03611075|471833298|FG006|Overall Study|Physician Decision|0|||
131054792|NCT03611075|471833299|FG007|Overall Study|Physician Decision|0|||
131054793|NCT03611075|471833300|FG008|Overall Study|Physician Decision|0|||
131054794|NCT03611075|471833292|FG000|Overall Study|Lost to Follow-up|1|||
131054795|NCT03611075|471833293|FG001|Overall Study|Lost to Follow-up|0|||
131054796|NCT03611075|471833294|FG002|Overall Study|Lost to Follow-up|0|||
131054797|NCT03611075|471833295|FG003|Overall Study|Lost to Follow-up|2|||
131054798|NCT03611075|471833296|FG004|Overall Study|Lost to Follow-up|0|||
131054799|NCT03611075|471833297|FG005|Overall Study|Lost to Follow-up|0|||
131054800|NCT03611075|471833298|FG006|Overall Study|Lost to Follow-up|0|||
131054801|NCT03611075|471833299|FG007|Overall Study|Lost to Follow-up|0|||
131054802|NCT03611075|471833300|FG008|Overall Study|Lost to Follow-up|0|||
131054803|NCT03611075|471833292|FG000|Overall Study|Withdrawal by Subject|0|||
131054804|NCT03611075|471833293|FG001|Overall Study|Withdrawal by Subject|1|||
131054805|NCT03611075|471833294|FG002|Overall Study|Withdrawal by Subject|1|||
131054806|NCT03611075|471833295|FG003|Overall Study|Withdrawal by Subject|1|||
131054807|NCT03611075|471833296|FG004|Overall Study|Withdrawal by Subject|0|||
131054808|NCT03611075|471833297|FG005|Overall Study|Withdrawal by Subject|0|||
131054809|NCT03611075|471833298|FG006|Overall Study|Withdrawal by Subject|1|||
131054810|NCT03611075|471833299|FG007|Overall Study|Withdrawal by Subject|0|||
131054811|NCT03611075|471833300|FG008|Overall Study|Withdrawal by Subject|0|||
131054812|NCT03611075|471833292|FG000|Overall Study|Reason unknown|0|||
131054813|NCT03611075|471833293|FG001|Overall Study|Reason unknown|0|||
131054814|NCT03611075|471833294|FG002|Overall Study|Reason unknown|0|||
131054815|NCT03611075|471833295|FG003|Overall Study|Reason unknown|1|||
131054816|NCT03611075|471833296|FG004|Overall Study|Reason unknown|0|||
131054817|NCT03611075|471833297|FG005|Overall Study|Reason unknown|0|||
131054818|NCT03611075|471833298|FG006|Overall Study|Reason unknown|1|||
131054819|NCT03611075|471833299|FG007|Overall Study|Reason unknown|0|||
131054820|NCT03611075|471833300|FG008|Overall Study|Reason unknown|0|||
131054821|NCT00676091|471833301|FG000|Infant Series|Parent or legal guardian request|10|||
131054822|NCT00676091|471833302|FG001|Infant Series|Parent or legal guardian request|8|||
131054823|NCT00676091|471833301|FG000|Infant Series|Protocol Violation|6|||
131054824|NCT00676091|471833302|FG001|Infant Series|Protocol Violation|3|||
131054825|NCT00676091|471833301|FG000|Infant Series|Adverse Event|2|||
131054826|NCT00676091|471833302|FG001|Infant Series|Adverse Event|3|||
131054827|NCT00676091|471833301|FG000|Infant Series|Failed to return|1|||
131054828|NCT00676091|471833302|FG001|Infant Series|Failed to return|3|||
131229756|NCT03567057|472467684|FG000|Overall Study|Death|1|||
131229757|NCT03567057|472467685|FG001|Overall Study|Death|0|||
130722439|NCT03918109|470608263|FG001|Overall Study|Lost to Follow-up|0|||
130722440|NCT03918109|470608264|FG002|Overall Study|Lost to Follow-up|0|||
130722441|NCT03918109|470608265|FG003|Overall Study|Lost to Follow-up|1|||
130722442|NCT00758680|470608268|FG000|Overall Study|Adverse Event|0|||
131054829|NCT00676091|471833301|FG000|Infant Series|Lost to Follow-up|1|||
131054830|NCT00676091|471833302|FG001|Infant Series|Lost to Follow-up|0|||
131054831|NCT00676091|471833301|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
131054832|NCT00676091|471833302|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
131054833|NCT00676091|471833301|FG000|After Infant Series|Adverse Event|0|||
131054834|NCT00676091|471833302|FG001|After Infant Series|Adverse Event|1|||
131054835|NCT00676091|471833301|FG000|After Infant Series|Protocol Violation|0|||
131054836|NCT00676091|471833302|FG001|After Infant Series|Protocol Violation|1|||
131054837|NCT00676091|471833301|FG000|After Infant Series|Failed to return|1|||
131054838|NCT00676091|471833302|FG001|After Infant Series|Failed to return|1|||
131054839|NCT00676091|471833301|FG000|Toddler Dose|Failed to return|2|||
131229758|NCT03567057|472467686|FG002|Overall Study|Death|0|||
131054840|NCT00676091|471833302|FG001|Toddler Dose|Failed to return|0|||
131054841|NCT00676091|471833301|FG000|Toddler Dose|Parent or legal guardian request|1|||
131054842|NCT00676091|471833302|FG001|Toddler Dose|Parent or legal guardian request|0|||
131054843|NCT01701401|471833306|FG000|Overall Study|Randomized But Not Treated|3|||
131054844|NCT01701401|471833307|FG001|Overall Study|Randomized But Not Treated|1|||
131054845|NCT01701401|471833308|FG002|Overall Study|Randomized But Not Treated|0|||
131054846|NCT01701401|471833309|FG003|Overall Study|Randomized But Not Treated|1|||
131054847|NCT01701401|471833306|FG000|Overall Study|Lost to Follow-up|5|||
131054848|NCT01701401|471833307|FG001|Overall Study|Lost to Follow-up|5|||
131054849|NCT01701401|471833308|FG002|Overall Study|Lost to Follow-up|1|||
131054850|NCT01701401|471833309|FG003|Overall Study|Lost to Follow-up|3|||
131054851|NCT01701401|471833306|FG000|Overall Study|Withdrew Consent|0|||
131054852|NCT01701401|471833307|FG001|Overall Study|Withdrew Consent|3|||
131054853|NCT01701401|471833308|FG002|Overall Study|Withdrew Consent|1|||
131054854|NCT01701401|471833309|FG003|Overall Study|Withdrew Consent|2|||
131054855|NCT01701401|471833306|FG000|Overall Study|Lack of Efficacy|1|||
131054856|NCT01701401|471833307|FG001|Overall Study|Lack of Efficacy|0|||
131054857|NCT01701401|471833308|FG002|Overall Study|Lack of Efficacy|2|||
131054858|NCT01701401|471833309|FG003|Overall Study|Lack of Efficacy|0|||
131054859|NCT01701401|471833306|FG000|Overall Study|Adverse Event|1|||
131054860|NCT01701401|471833307|FG001|Overall Study|Adverse Event|0|||
131054861|NCT01701401|471833308|FG002|Overall Study|Adverse Event|0|||
131054862|NCT01701401|471833309|FG003|Overall Study|Adverse Event|0|||
131054863|NCT01701401|471833306|FG000|Overall Study|Protocol Violation|0|||
131054864|NCT01701401|471833307|FG001|Overall Study|Protocol Violation|0|||
131054865|NCT01701401|471833308|FG002|Overall Study|Protocol Violation|1|||
131054866|NCT01701401|471833309|FG003|Overall Study|Protocol Violation|0|||
131054867|NCT05366751|471833310|FG000|Overall Study|Adverse Event|25|||
131054868|NCT05366751|471833310|FG000|Overall Study|Physician Decision|3|||
131054869|NCT05366751|471833310|FG000|Overall Study|Lost to Follow-up|2|||
131054870|NCT05366751|471833310|FG000|Overall Study|Withdrawal by Subject|14|||
131054871|NCT05366751|471833310|FG000|Overall Study|Study Terminated by Sponsor|50|||
131054872|NCT05366751|471833310|FG000|Overall Study|Site Terminated by Sponsor|3|||
131054873|NCT00647387|471833317|FG000|Overall Study|Lost to Follow-up|6|||
131054874|NCT00647387|471833317|FG000|Overall Study|Unsuccessful implant|5|||
131054875|NCT00647387|471833317|FG000|Overall Study|Device explanted|3|||
131054876|NCT00647387|471833317|FG000|Overall Study|Other Reason|3|||
131054877|NCT00647387|471833317|FG000|Overall Study|Death|2|||
131054878|NCT02969356|471833318|FG000|Overall Study|Adverse Event|7|||
131054879|NCT02969356|471833318|FG000|Overall Study|Consent withdrawn|2|||
131054880|NCT02969356|471833318|FG000|Overall Study|Lost to Follow-up|3|||
131054881|NCT02969356|471833318|FG000|Overall Study|Did not need to be reinjected|6|||
131054882|NCT02969356|471833318|FG000|Overall Study|Personal reasons|5|||
131054883|NCT02972034|471834505|FG000|Overall Study|Death|11|||
131054884|NCT02972034|471834506|FG001|Overall Study|Death|1|||
131054885|NCT02972034|471834507|FG002|Overall Study|Death|3|||
131054886|NCT02972034|471834508|FG003|Overall Study|Death|3|||
131054887|NCT02972034|471834509|FG004|Overall Study|Death|2|||
131054888|NCT02972034|471834510|FG005|Overall Study|Death|2|||
131054889|NCT02972034|471834511|FG006|Overall Study|Death|3|||
131054890|NCT02972034|471834512|FG007|Overall Study|Death|4|||
131054891|NCT02972034|471834513|FG008|Overall Study|Death|8|||
131054892|NCT02972034|471834514|FG009|Overall Study|Death|11|||
131054893|NCT02972034|471834515|FG010|Overall Study|Death|3|||
131136206|NCT02574637|472126503|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
131136207|NCT02574637|472126504|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
131136208|NCT02574637|472126505|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
131136209|NCT02574637|472126506|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
131136210|NCT02574637|472126507|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
131054894|NCT02972034|471834516|FG011|Overall Study|Death|2|||
131054895|NCT02972034|471834517|FG012|Overall Study|Death|11|||
131054896|NCT02972034|471834518|FG013|Overall Study|Death|10|||
131054897|NCT02972034|471834519|FG014|Overall Study|Death|9|||
131054898|NCT02972034|471834505|FG000|Overall Study|Lost to Follow-up|0|||
131054899|NCT02972034|471834506|FG001|Overall Study|Lost to Follow-up|0|||
131054900|NCT02972034|471834507|FG002|Overall Study|Lost to Follow-up|0|||
131054901|NCT02972034|471834508|FG003|Overall Study|Lost to Follow-up|0|||
131229759|NCT03567057|472467684|FG000|Overall Study|Physician Decision|1|||
131054902|NCT02972034|471834509|FG004|Overall Study|Lost to Follow-up|1|||
131054903|NCT02972034|471834510|FG005|Overall Study|Lost to Follow-up|0|||
131054904|NCT02972034|471834511|FG006|Overall Study|Lost to Follow-up|0|||
131054905|NCT02972034|471834512|FG007|Overall Study|Lost to Follow-up|1|||
131054906|NCT02972034|471834513|FG008|Overall Study|Lost to Follow-up|0|||
131054907|NCT02972034|471834514|FG009|Overall Study|Lost to Follow-up|0|||
131054908|NCT02972034|471834515|FG010|Overall Study|Lost to Follow-up|0|||
131054909|NCT02972034|471834516|FG011|Overall Study|Lost to Follow-up|0|||
131054910|NCT02972034|471834517|FG012|Overall Study|Lost to Follow-up|0|||
131054911|NCT02972034|471834518|FG013|Overall Study|Lost to Follow-up|0|||
131054912|NCT02972034|471834519|FG014|Overall Study|Lost to Follow-up|1|||
131054913|NCT02972034|471834505|FG000|Overall Study|Physician Decision|0|||
131054914|NCT02972034|471834506|FG001|Overall Study|Physician Decision|0|||
130722443|NCT00758680|470608269|FG001|Overall Study|Adverse Event|0|||
130722444|NCT00758680|470608270|FG002|Overall Study|Adverse Event|0|||
130722445|NCT00758680|470608271|FG003|Overall Study|Adverse Event|0|||
130722446|NCT00758680|470608272|FG004|Overall Study|Adverse Event|0|||
130722447|NCT00758680|470608273|FG005|Overall Study|Adverse Event|0|||
131136211|NCT02574637|472126498|FG000|Double-blind Period|Reason Not Specified|0|||
131136212|NCT02574637|472126499|FG001|Double-blind Period|Reason Not Specified|0|||
131136213|NCT02574637|472126500|FG002|Double-blind Period|Reason Not Specified|0|||
131136214|NCT02574637|472126501|FG003|Double-blind Period|Reason Not Specified|1|||
131136215|NCT02574637|472126502|FG004|Double-blind Period|Reason Not Specified|0|||
131136216|NCT02574637|472126503|FG005|Double-blind Period|Reason Not Specified|0|||
131136217|NCT02574637|472126504|FG006|Double-blind Period|Reason Not Specified|0|||
131136218|NCT02574637|472126505|FG007|Double-blind Period|Reason Not Specified|0|||
131136219|NCT02574637|472126506|FG008|Double-blind Period|Reason Not Specified|0|||
131136220|NCT02574637|472126507|FG009|Double-blind Period|Reason Not Specified|0|||
131136221|NCT02574637|472126498|FG000|Open-label (OL) Period|Adverse Event|0|||
131136222|NCT02574637|472126499|FG001|Open-label (OL) Period|Adverse Event|0|||
131136223|NCT02574637|472126500|FG002|Open-label (OL) Period|Adverse Event|0|||
131136224|NCT02574637|472126501|FG003|Open-label (OL) Period|Adverse Event|0|||
131136225|NCT02574637|472126502|FG004|Open-label (OL) Period|Adverse Event|0|||
131136226|NCT02574637|472126503|FG005|Open-label (OL) Period|Adverse Event|0|||
131136227|NCT02574637|472126504|FG006|Open-label (OL) Period|Adverse Event|0|||
131136228|NCT02574637|472126505|FG007|Open-label (OL) Period|Adverse Event|0|||
131136229|NCT02574637|472126506|FG008|Open-label (OL) Period|Adverse Event|1|||
131136230|NCT02574637|472126507|FG009|Open-label (OL) Period|Adverse Event|0|||
131136231|NCT02574637|472126498|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
131136232|NCT02574637|472126499|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
131136233|NCT02574637|472126500|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
131136234|NCT02574637|472126501|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
131136235|NCT02574637|472126502|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
131136236|NCT02574637|472126503|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
131229760|NCT03567057|472467685|FG001|Overall Study|Physician Decision|0|||
130722448|NCT00758680|470608274|FG006|Overall Study|Adverse Event|0|||
131054915|NCT02972034|471834507|FG002|Overall Study|Physician Decision|0|||
131054916|NCT02972034|471834508|FG003|Overall Study|Physician Decision|0|||
130722449|NCT00758680|470608275|FG007|Overall Study|Adverse Event|1|||
130722450|NCT00758680|470608276|FG008|Overall Study|Adverse Event|0|||
130779356|NCT02326272|470819503|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
131054917|NCT02972034|471834509|FG004|Overall Study|Physician Decision|0|||
131054918|NCT02972034|471834510|FG005|Overall Study|Physician Decision|0|||
131054919|NCT02972034|471834511|FG006|Overall Study|Physician Decision|0|||
131054920|NCT02972034|471834512|FG007|Overall Study|Physician Decision|1|||
131054921|NCT02972034|471834513|FG008|Overall Study|Physician Decision|0|||
131054922|NCT02972034|471834514|FG009|Overall Study|Physician Decision|0|||
131054923|NCT02972034|471834515|FG010|Overall Study|Physician Decision|1|||
131054924|NCT02972034|471834516|FG011|Overall Study|Physician Decision|0|||
131054925|NCT02972034|471834517|FG012|Overall Study|Physician Decision|0|||
131054926|NCT02972034|471834518|FG013|Overall Study|Physician Decision|0|||
131054927|NCT02972034|471834519|FG014|Overall Study|Physician Decision|0|||
131054928|NCT02972034|471834505|FG000|Overall Study|Sponsor Decision|0|||
131054929|NCT02972034|471834506|FG001|Overall Study|Sponsor Decision|0|||
131054930|NCT02972034|471834507|FG002|Overall Study|Sponsor Decision|0|||
131054931|NCT02972034|471834508|FG003|Overall Study|Sponsor Decision|1|||
131054932|NCT02972034|471834509|FG004|Overall Study|Sponsor Decision|0|||
131054933|NCT02972034|471834510|FG005|Overall Study|Sponsor Decision|0|||
131054934|NCT02972034|471834511|FG006|Overall Study|Sponsor Decision|1|||
131054935|NCT02972034|471834512|FG007|Overall Study|Sponsor Decision|1|||
131054936|NCT02972034|471834513|FG008|Overall Study|Sponsor Decision|1|||
131054937|NCT02972034|471834514|FG009|Overall Study|Sponsor Decision|2|||
131054938|NCT02972034|471834515|FG010|Overall Study|Sponsor Decision|2|||
131054939|NCT02972034|471834516|FG011|Overall Study|Sponsor Decision|0|||
131054940|NCT02972034|471834517|FG012|Overall Study|Sponsor Decision|1|||
131054941|NCT02972034|471834518|FG013|Overall Study|Sponsor Decision|0|||
131054942|NCT02972034|471834519|FG014|Overall Study|Sponsor Decision|1|||
130722451|NCT00758680|470608277|FG009|Overall Study|Adverse Event|1|||
131054943|NCT02972034|471834505|FG000|Overall Study|Withdrawal by Subject|3|||
131054944|NCT02972034|471834506|FG001|Overall Study|Withdrawal by Subject|0|||
131136237|NCT02574637|472126504|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
131136238|NCT02574637|472126505|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
131136239|NCT02574637|472126506|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
131136240|NCT02574637|472126507|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
131229761|NCT03567057|472467686|FG002|Overall Study|Physician Decision|0|||
131054945|NCT02972034|471834507|FG002|Overall Study|Withdrawal by Subject|0|||
131054946|NCT02972034|471834508|FG003|Overall Study|Withdrawal by Subject|0|||
131054947|NCT02972034|471834509|FG004|Overall Study|Withdrawal by Subject|1|||
131054948|NCT02972034|471834510|FG005|Overall Study|Withdrawal by Subject|1|||
130722452|NCT00758680|470608268|FG000|Overall Study|Laboratory Adverse Event|0|||
131054949|NCT02972034|471834511|FG006|Overall Study|Withdrawal by Subject|0|||
131054950|NCT02972034|471834512|FG007|Overall Study|Withdrawal by Subject|0|||
131054951|NCT02972034|471834513|FG008|Overall Study|Withdrawal by Subject|1|||
131054952|NCT02972034|471834514|FG009|Overall Study|Withdrawal by Subject|1|||
131054953|NCT02972034|471834515|FG010|Overall Study|Withdrawal by Subject|2|||
131054954|NCT02972034|471834516|FG011|Overall Study|Withdrawal by Subject|1|||
131136241|NCT02574637|472126498|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131136242|NCT02574637|472126499|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131136243|NCT02574637|472126500|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131136244|NCT02574637|472126501|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131136245|NCT02574637|472126502|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131136246|NCT02574637|472126503|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
131136247|NCT02574637|472126504|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
131136248|NCT02574637|472126505|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
131136249|NCT02574637|472126506|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
131136250|NCT02574637|472126507|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
131136251|NCT04016311|472126508|FG000|Overall Study|Withdrawal by Subject|1|||
131136252|NCT04016311|472126509|FG001|Overall Study|Withdrawal by Subject|0|||
131136253|NCT02064387|472126512|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131136254|NCT02064387|472126513|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131136255|NCT02064387|472126514|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131136256|NCT02064387|472126515|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131136257|NCT02064387|472126516|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131136258|NCT02064387|472126517|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131136259|NCT02064387|472126518|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131136260|NCT02064387|472126519|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
131136261|NCT02064387|472126520|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131136262|NCT02064387|472126521|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
131136263|NCT02064387|472126522|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131136264|NCT02064387|472126523|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
131136265|NCT02064387|472126512|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131136266|NCT02064387|472126513|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131136267|NCT02064387|472126514|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131136268|NCT02064387|472126515|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131136269|NCT02064387|472126516|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130722453|NCT00758680|470608269|FG001|Overall Study|Laboratory Adverse Event|0|||
130722454|NCT00758680|470608270|FG002|Overall Study|Laboratory Adverse Event|0|||
130722455|NCT00758680|470608271|FG003|Overall Study|Laboratory Adverse Event|0|||
131054955|NCT02972034|471834517|FG012|Overall Study|Withdrawal by Subject|1|||
131054956|NCT02972034|471834518|FG013|Overall Study|Withdrawal by Subject|1|||
131054957|NCT02972034|471834519|FG014|Overall Study|Withdrawal by Subject|0|||
131054958|NCT02972034|471834505|FG000|Overall Study|Screen Failure|0|||
131054959|NCT02972034|471834506|FG001|Overall Study|Screen Failure|0|||
131054960|NCT02972034|471834507|FG002|Overall Study|Screen Failure|0|||
131054961|NCT02972034|471834508|FG003|Overall Study|Screen Failure|0|||
131054962|NCT02972034|471834509|FG004|Overall Study|Screen Failure|0|||
131054963|NCT02972034|471834510|FG005|Overall Study|Screen Failure|0|||
131054964|NCT02972034|471834511|FG006|Overall Study|Screen Failure|0|||
131054965|NCT02972034|471834512|FG007|Overall Study|Screen Failure|0|||
131054966|NCT02972034|471834513|FG008|Overall Study|Screen Failure|0|||
131054967|NCT02972034|471834514|FG009|Overall Study|Screen Failure|0|||
131054968|NCT02972034|471834515|FG010|Overall Study|Screen Failure|0|||
131054969|NCT02972034|471834516|FG011|Overall Study|Screen Failure|0|||
131054970|NCT02972034|471834517|FG012|Overall Study|Screen Failure|1|||
131054971|NCT02972034|471834518|FG013|Overall Study|Screen Failure|0|||
131054972|NCT02972034|471834519|FG014|Overall Study|Screen Failure|0|||
131054973|NCT00378898|471834520|FG000|Overall Study|Withdrawal by Subject|10|||
131136270|NCT02064387|472126517|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131136271|NCT02064387|472126518|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131136272|NCT02064387|472126519|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
131136273|NCT02064387|472126520|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131136274|NCT02064387|472126521|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131136275|NCT02064387|472126522|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131136276|NCT02064387|472126523|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
131136277|NCT02064387|472126512|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131136278|NCT02064387|472126513|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131136279|NCT02064387|472126514|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131054974|NCT00378898|471834521|FG001|Overall Study|Withdrawal by Subject|5|||
131054975|NCT00378898|471834520|FG000|Overall Study|Protocol Violation|1|||
131054976|NCT00378898|471834521|FG001|Overall Study|Protocol Violation|1|||
131136280|NCT02064387|472126515|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131136281|NCT02064387|472126516|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131136282|NCT02064387|472126517|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131136283|NCT02064387|472126518|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131136284|NCT02064387|472126519|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131136285|NCT02064387|472126520|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
131136286|NCT02064387|472126521|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131136287|NCT02064387|472126522|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131136288|NCT02064387|472126523|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
131136289|NCT02064387|472126512|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
131136290|NCT02064387|472126513|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
131136291|NCT02064387|472126514|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
131136292|NCT02064387|472126515|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
131136293|NCT02064387|472126516|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
131054977|NCT03136159|471834522|FG000|Overall Study|chorioamnionitis|2|||
131054978|NCT03136159|471834523|FG001|Overall Study|chorioamnionitis|0|||
131054979|NCT03136159|471834522|FG000|Overall Study|vertical skin incision|1|||
131054980|NCT03136159|471834523|FG001|Overall Study|vertical skin incision|0|||
131054981|NCT03136159|471834522|FG000|Overall Study|additional dressing|1|||
131054982|NCT03136159|471834523|FG001|Overall Study|additional dressing|0|||
131054983|NCT03136159|471834522|FG000|Overall Study|never got dressing placed|1|||
131054984|NCT03136159|471834523|FG001|Overall Study|never got dressing placed|0|||
131054985|NCT04926857|471834524|FG000|Overall Study|Withdrawal by Subject|40|||
131054986|NCT04926857|471834524|FG000|Overall Study|Death|9|||
131054987|NCT04926857|471834524|FG000|Overall Study|Study product no longer in use|44|||
131054988|NCT04926857|471834524|FG000|Overall Study|Inadequate data to address primary objective|16|||
131054989|NCT00089609|471834527|FG000|Overall Study|Withdrawal by Subject|3|||
131054990|NCT00089609|471834528|FG001|Overall Study|Withdrawal by Subject|1|||
131054991|NCT00747006|471834530|FG000|Overall Study|Adverse Event|1|||
131054992|NCT00747006|471834531|FG001|Overall Study|Adverse Event|0|||
131054993|NCT00747006|471834532|FG002|Overall Study|Adverse Event|0|||
131054994|NCT00747006|471834530|FG000|Overall Study|Lost to Follow-up|0|||
131054995|NCT00747006|471834531|FG001|Overall Study|Lost to Follow-up|1|||
131054996|NCT00747006|471834532|FG002|Overall Study|Lost to Follow-up|0|||
131054997|NCT00747006|471834530|FG000|Overall Study|Physician Decision|2|||
131054998|NCT00747006|471834531|FG001|Overall Study|Physician Decision|0|||
131054999|NCT00747006|471834532|FG002|Overall Study|Physician Decision|1|||
131055000|NCT00745875|471834537|FG000|Overall Study|Continuing study treatment|4|||
131055001|NCT00745875|471834538|FG001|Overall Study|Continuing study treatment|4|||
131055002|NCT01372085|471834539|FG000|Washout Period 2|Physician Decision|0|||
131055003|NCT01372085|471834540|FG001|Washout Period 2|Physician Decision|0|||
131055004|NCT01372085|471834541|FG002|Washout Period 2|Physician Decision|0|||
131055005|NCT01372085|471834542|FG003|Washout Period 2|Physician Decision|0|||
131055006|NCT01372085|471834543|FG004|Washout Period 2|Physician Decision|1|||
131055007|NCT01372085|471834544|FG005|Washout Period 2|Physician Decision|0|||
131055008|NCT01372085|471834545|FG006|Washout Period 2|Physician Decision|0|||
131055009|NCT01372085|471834546|FG007|Washout Period 2|Physician Decision|0|||
131136294|NCT02064387|472126517|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
131136295|NCT02064387|472126518|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
131136296|NCT02064387|472126519|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
130722456|NCT00758680|470608272|FG004|Overall Study|Laboratory Adverse Event|0|||
130722457|NCT00758680|470608273|FG005|Overall Study|Laboratory Adverse Event|0|||
131055010|NCT01372085|471834547|FG008|Washout Period 2|Physician Decision|0|||
131055011|NCT01372085|471834548|FG009|Washout Period 2|Physician Decision|0|||
131055012|NCT01372085|471834539|FG000|Washout Period 3|Withdrawal by Subject|0|||
130722458|NCT00758680|470608274|FG006|Overall Study|Laboratory Adverse Event|0|||
131055013|NCT01372085|471834540|FG001|Washout Period 3|Withdrawal by Subject|0|||
131055014|NCT01372085|471834541|FG002|Washout Period 3|Withdrawal by Subject|0|||
131055015|NCT01372085|471834542|FG003|Washout Period 3|Withdrawal by Subject|0|||
131055016|NCT01372085|471834543|FG004|Washout Period 3|Withdrawal by Subject|0|||
131055017|NCT01372085|471834544|FG005|Washout Period 3|Withdrawal by Subject|2|||
131055018|NCT01372085|471834545|FG006|Washout Period 3|Withdrawal by Subject|0|||
131055019|NCT01372085|471834546|FG007|Washout Period 3|Withdrawal by Subject|0|||
131136297|NCT02064387|472126520|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
131136298|NCT02064387|472126521|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
131136299|NCT02064387|472126522|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
131136300|NCT02064387|472126523|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
131136301|NCT02064387|472126512|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131136302|NCT02064387|472126513|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131136303|NCT02064387|472126514|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131229762|NCT03567057|472467684|FG000|Overall Study|Unstable medical condition|1|||
131055020|NCT01372085|471834547|FG008|Washout Period 3|Withdrawal by Subject|0|||
130722459|NCT00758680|470608275|FG007|Overall Study|Laboratory Adverse Event|0|||
130722460|NCT00758680|470608276|FG008|Overall Study|Laboratory Adverse Event|1|||
130722461|NCT00758680|470608277|FG009|Overall Study|Laboratory Adverse Event|0|||
130722462|NCT00758680|470608268|FG000|Overall Study|Withdrawal by Subject|0|||
131055021|NCT01372085|471834548|FG009|Washout Period 3|Withdrawal by Subject|0|||
131055022|NCT02824198|471834549|FG000|Overall Study|Non-compliance with the protocol|5|||
131055023|NCT02824198|471834550|FG001|Overall Study|Non-compliance with the protocol|1|||
131055024|NCT02824198|471834549|FG000|Overall Study|Lost to Follow-up|5|||
131055025|NCT02824198|471834550|FG001|Overall Study|Lost to Follow-up|2|||
131055026|NCT02824198|471834549|FG000|Overall Study|Withdrawal by Subject|5|||
131055027|NCT02824198|471834550|FG001|Overall Study|Withdrawal by Subject|0|||
131055028|NCT03689946|471834551|FG000|Overall Study|Withdrawal by Subject|3|||
131055029|NCT03689946|471834551|FG000|Overall Study|Lost to Follow-up|3|||
131055030|NCT03689946|471834551|FG000|Overall Study|Data corruption|2|||
131055031|NCT01256359|471834554|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
131055032|NCT01256359|471834555|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
131055033|NCT01256359|471834554|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
131055034|NCT01256359|471834555|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
131055035|NCT04693637|471834569|FG000|Overall Study|Death|4|||
131055036|NCT04693637|471834569|FG000|Overall Study|Withdrawal by Subject|3|||
131055037|NCT04693637|471834569|FG000|Overall Study|Physician Decision|2|||
131055038|NCT04693637|471834569|FG000|Overall Study|Lost to Follow-up|1|||
131055039|NCT00853580|471834572|FG000|Overall Study|Lost to Follow-up|3|||
131055040|NCT00853580|471834573|FG001|Overall Study|Lost to Follow-up|5|||
131055041|NCT00853580|471834572|FG000|Overall Study|Protocol Violation|2|||
131055042|NCT00853580|471834573|FG001|Overall Study|Protocol Violation|1|||
131055043|NCT00853580|471834572|FG000|Overall Study|Withdrawal by Subject|2|||
131055044|NCT00853580|471834573|FG001|Overall Study|Withdrawal by Subject|8|||
131055045|NCT00853580|471834572|FG000|Overall Study|Commenced contraindicated therapy|0|||
131055046|NCT00853580|471834573|FG001|Overall Study|Commenced contraindicated therapy|2|||
131055047|NCT01728324|471834574|FG000|Termination of DBV|Adverse Event|14|||
131055048|NCT01728324|471834575|FG001|Termination of DBV|Adverse Event|13|||
131055049|NCT01728324|471834576|FG002|Termination of DBV|Adverse Event|4|||
131055050|NCT01728324|471834574|FG000|Termination of DBV|Lack of Efficacy|14|||
131055051|NCT01728324|471834575|FG001|Termination of DBV|Lack of Efficacy|12|||
131055052|NCT01728324|471834576|FG002|Termination of DBV|Lack of Efficacy|8|||
131055053|NCT01728324|471834574|FG000|Termination of DBV|Withdrawal by Subject|9|||
131055054|NCT01728324|471834575|FG001|Termination of DBV|Withdrawal by Subject|6|||
131055055|NCT01728324|471834576|FG002|Termination of DBV|Withdrawal by Subject|2|||
131055056|NCT01728324|471834574|FG000|Termination of DBV|Other than stated|1|||
131055057|NCT01728324|471834575|FG001|Termination of DBV|Other than stated|3|||
131055058|NCT01728324|471834576|FG002|Termination of DBV|Other than stated|0|||
131055059|NCT01728324|471834574|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
131055060|NCT01728324|471834575|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
131055061|NCT01728324|471834576|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
131055062|NCT01728324|471834574|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
131055063|NCT01728324|471834575|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
131055064|NCT01728324|471834576|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
131055065|NCT01728324|471834574|FG000|Termination of FDV|Adverse Event|14|||
131055066|NCT01728324|471834575|FG001|Termination of FDV|Adverse Event|13|||
131055067|NCT01728324|471834576|FG002|Termination of FDV|Adverse Event|4|||
131055068|NCT01728324|471834574|FG000|Termination of FDV|Lack of Efficacy|14|||
131055069|NCT01728324|471834575|FG001|Termination of FDV|Lack of Efficacy|12|||
131055070|NCT01728324|471834576|FG002|Termination of FDV|Lack of Efficacy|8|||
131055071|NCT01728324|471834574|FG000|Termination of FDV|Withdrawal by Subject|9|||
131055072|NCT01728324|471834575|FG001|Termination of FDV|Withdrawal by Subject|6|||
131055073|NCT01728324|471834576|FG002|Termination of FDV|Withdrawal by Subject|2|||
131055074|NCT01728324|471834574|FG000|Termination of FDV|Other than stated|1|||
131055075|NCT01728324|471834575|FG001|Termination of FDV|Other than stated|3|||
131055076|NCT01728324|471834576|FG002|Termination of FDV|Other than stated|0|||
131055077|NCT01728324|471834574|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
130722463|NCT00758680|470608269|FG001|Overall Study|Withdrawal by Subject|0|||
131055078|NCT01728324|471834575|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
131055079|NCT01728324|471834576|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
131055080|NCT01728324|471834574|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
131055081|NCT01728324|471834575|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
131055082|NCT01728324|471834576|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
131055083|NCT01728324|471834574|FG000|Termination of RBV|Adverse Event|15|||
131055084|NCT01728324|471834575|FG001|Termination of RBV|Adverse Event|16|||
131055085|NCT01728324|471834576|FG002|Termination of RBV|Adverse Event|5|||
131055086|NCT01728324|471834574|FG000|Termination of RBV|Lack of Efficacy|14|||
131055087|NCT01728324|471834575|FG001|Termination of RBV|Lack of Efficacy|11|||
131055088|NCT01728324|471834576|FG002|Termination of RBV|Lack of Efficacy|7|||
131055089|NCT01728324|471834574|FG000|Termination of RBV|Withdrawal by Subject|9|||
131055090|NCT01728324|471834575|FG001|Termination of RBV|Withdrawal by Subject|5|||
131055091|NCT01728324|471834576|FG002|Termination of RBV|Withdrawal by Subject|2|||
131055092|NCT01728324|471834574|FG000|Termination of RBV|Other than stated|1|||
131055093|NCT01728324|471834575|FG001|Termination of RBV|Other than stated|3|||
131055094|NCT01728324|471834576|FG002|Termination of RBV|Other than stated|1|||
131055095|NCT01728324|471834574|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
131055096|NCT01728324|471834575|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
131055097|NCT01728324|471834576|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
131055098|NCT01728324|471834574|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
131055099|NCT01728324|471834575|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
131055100|NCT01728324|471834576|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
131055101|NCT01170208|471834579|FG000|Overall Study|Withdrawal by Subject|5|||
131055102|NCT01170208|471834580|FG001|Overall Study|Withdrawal by Subject|0|||
131055103|NCT01170208|471834581|FG002|Overall Study|Withdrawal by Subject|1|||
131055104|NCT01170208|471834579|FG000|Overall Study|Protocol Violation|1|||
131055105|NCT01170208|471834580|FG001|Overall Study|Protocol Violation|0|||
131055106|NCT01170208|471834581|FG002|Overall Study|Protocol Violation|1|||
131055107|NCT03335488|471834584|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
131055108|NCT03335488|471834585|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
131055109|NCT03335488|471834584|FG000|Safety Extension Period|Adverse Event|1|||
131055110|NCT03335488|471834585|FG001|Safety Extension Period|Adverse Event|0|||
131055111|NCT03335488|471834584|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
131055112|NCT03335488|471834585|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
131055113|NCT02022670|471834586|FG000|Overall Study|Adverse Event|1|||
131055114|NCT02022670|471834587|FG001|Overall Study|Adverse Event|0|||
131055115|NCT02022670|471834588|FG002|Overall Study|Adverse Event|1|||
131055116|NCT02113449|471834589|FG000|Overall Study|Adverse Event|4|||
131055117|NCT04638816|471834590|FG000|Overall Study|Withdrawal by Subject|0|||
131055118|NCT04638816|471834591|FG001|Overall Study|Withdrawal by Subject|1|||
131055119|NCT04638816|471834590|FG000|Overall Study|Lost to Follow-up|0|||
131055120|NCT04638816|471834591|FG001|Overall Study|Lost to Follow-up|1|||
131055121|NCT02251652|471834592|FG000|Overall Study|Withdrawal by Subject|1|||
131055122|NCT01160354|471834595|FG000|Overall Study|Death|0|||
131055123|NCT01160354|471834596|FG001|Overall Study|Death|1|||
131055124|NCT01160354|471834597|FG002|Overall Study|Death|1|||
131055125|NCT01822756|471834598|FG000|Overall Study|Adverse Event|0|||
131055126|NCT01822756|471834599|FG001|Overall Study|Adverse Event|0|||
131055127|NCT01822756|471834600|FG002|Overall Study|Adverse Event|0|||
131055128|NCT01822756|471834601|FG003|Overall Study|Adverse Event|2|||
131055129|NCT01822756|471834602|FG004|Overall Study|Adverse Event|0|||
131055130|NCT01822756|471834598|FG000|Overall Study|Disease progression|11|||
131055131|NCT01822756|471834599|FG001|Overall Study|Disease progression|1|||
131055132|NCT01822756|471834600|FG002|Overall Study|Disease progression|7|||
131055133|NCT01822756|471834601|FG003|Overall Study|Disease progression|2|||
131055134|NCT01822756|471834602|FG004|Overall Study|Disease progression|6|||
131055135|NCT01822756|471834598|FG000|Overall Study|Death|2|||
131055136|NCT01822756|471834599|FG001|Overall Study|Death|2|||
131055137|NCT01822756|471834600|FG002|Overall Study|Death|1|||
131055138|NCT01822756|471834601|FG003|Overall Study|Death|0|||
131055139|NCT01822756|471834602|FG004|Overall Study|Death|0|||
131055140|NCT01822756|471834598|FG000|Overall Study|Lost to Follow-up|1|||
131055141|NCT01822756|471834599|FG001|Overall Study|Lost to Follow-up|0|||
131055142|NCT01822756|471834600|FG002|Overall Study|Lost to Follow-up|1|||
131055143|NCT01822756|471834601|FG003|Overall Study|Lost to Follow-up|0|||
131055144|NCT01822756|471834602|FG004|Overall Study|Lost to Follow-up|1|||
131055145|NCT01822756|471834598|FG000|Overall Study|Physician Decision|0|||
131055146|NCT01822756|471834599|FG001|Overall Study|Physician Decision|1|||
131055147|NCT01822756|471834600|FG002|Overall Study|Physician Decision|0|||
131055148|NCT01822756|471834601|FG003|Overall Study|Physician Decision|0|||
130722464|NCT00758680|470608270|FG002|Overall Study|Withdrawal by Subject|0|||
130722465|NCT00758680|470608271|FG003|Overall Study|Withdrawal by Subject|0|||
130722466|NCT00758680|470608272|FG004|Overall Study|Withdrawal by Subject|0|||
131055149|NCT01822756|471834602|FG004|Overall Study|Physician Decision|0|||
131055150|NCT01822756|471834598|FG000|Overall Study|disease progression & patient preference|2|||
131055151|NCT01822756|471834599|FG001|Overall Study|disease progression & patient preference|0|||
131055152|NCT01822756|471834600|FG002|Overall Study|disease progression & patient preference|1|||
131055153|NCT01822756|471834601|FG003|Overall Study|disease progression & patient preference|0|||
131055154|NCT01822756|471834602|FG004|Overall Study|disease progression & patient preference|0|||
131055155|NCT01827839|471834615|FG000|Overall Study|Adverse Event|1|||
131055156|NCT01827839|471834615|FG000|Overall Study|Consent Withdrawal|2|||
131055157|NCT05824559|471834624|FG000|Overall Study|Adverse Event|2|||
131055158|NCT05824559|471834624|FG000|Overall Study|Physician Decision|2|||
131055159|NCT05824559|471834624|FG000|Overall Study|Progressive Disease|16|||
131055160|NCT05824559|471834624|FG000|Overall Study|Study Terminated by Sponsor|1|||
131055161|NCT05824559|471834624|FG000|Overall Study|Withdrawal by Subject|2|||
131055162|NCT02409680|471834629|FG000|Overall Study|Lost to Follow-up|15|||
131055163|NCT02409680|471834630|FG001|Overall Study|Lost to Follow-up|30|||
131055164|NCT05325294|471834634|FG000|Overall Study|Adverse Event|3|||
131055165|NCT05325294|471834635|FG001|Overall Study|Adverse Event|3|||
131055166|NCT05325294|471834634|FG000|Overall Study|Physician Decision|0|||
131055167|NCT05325294|471834635|FG001|Overall Study|Physician Decision|1|||
131055168|NCT05325294|471834634|FG000|Overall Study|Withdrawal by Subject|0|||
131055169|NCT05325294|471834635|FG001|Overall Study|Withdrawal by Subject|3|||
131055170|NCT05325294|471834634|FG000|Overall Study|Lost to Follow-up|1|||
131055171|NCT05325294|471834635|FG001|Overall Study|Lost to Follow-up|0|||
131055172|NCT05325294|471834634|FG000|Overall Study|Sponsor Request|0|||
131055173|NCT05325294|471834635|FG001|Overall Study|Sponsor Request|2|||
131055174|NCT00491894|471834636|FG000|Overall Study|Adverse Event|14|||
131055175|NCT00491894|471834636|FG000|Overall Study|Withdrawal by Subject|5|||
131055176|NCT00491894|471834636|FG000|Overall Study|Death|3|||
131055177|NCT00491894|471834636|FG000|Overall Study|Lost to Follow-up|3|||
131055178|NCT00491894|471834636|FG000|Overall Study|Lack of Efficacy|2|||
131055179|NCT00491894|471834636|FG000|Overall Study|Other-Failed to meet any criteria|2|||
131055180|NCT00491894|471834636|FG000|Overall Study|Physician Decision|2|||
131055181|NCT00491894|471834636|FG000|Overall Study|Protocol Violation|2|||
131055182|NCT00491894|471834636|FG000|Overall Study|Other-Intake of prohibited medication|1|||
131055183|NCT00302211|471834642|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
131055184|NCT00302211|471834643|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
131055185|NCT00302211|471834644|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
131055186|NCT00302211|471834645|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
131055187|NCT00302211|471834646|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
131055188|NCT00302211|471834642|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
131055189|NCT00302211|471834643|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
131055190|NCT00302211|471834644|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
131055191|NCT00302211|471834645|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
131055192|NCT00302211|471834646|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
131055193|NCT00302211|471834642|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
131055194|NCT00302211|471834643|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
131055195|NCT00302211|471834644|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
131055196|NCT00302211|471834645|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
131055197|NCT00302211|471834646|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
131055198|NCT00302211|471834642|FG000|Double Blind Period (New Patients)|Disease progression|0|||
131055199|NCT00302211|471834643|FG001|Double Blind Period (New Patients)|Disease progression|1|||
131055200|NCT00302211|471834644|FG002|Double Blind Period (New Patients)|Disease progression|1|||
131055201|NCT00302211|471834645|FG003|Double Blind Period (New Patients)|Disease progression|0|||
131055202|NCT00302211|471834646|FG004|Double Blind Period (New Patients)|Disease progression|0|||
131055203|NCT00302211|471834642|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
131055204|NCT00302211|471834643|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
131055205|NCT00302211|471834644|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
131055206|NCT00302211|471834645|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
131055207|NCT00302211|471834646|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
131055208|NCT00302211|471834642|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
131055209|NCT00302211|471834643|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
131055210|NCT00302211|471834644|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
131055211|NCT00302211|471834645|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
131055212|NCT00302211|471834646|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
131055213|NCT00302211|471834642|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
131055214|NCT00302211|471834643|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
131055215|NCT00302211|471834644|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
131055216|NCT00302211|471834645|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
131055217|NCT00302211|471834646|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
131055218|NCT00302211|471834642|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
131055219|NCT00302211|471834643|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
131055220|NCT00302211|471834644|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
131055221|NCT00302211|471834645|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
131055222|NCT00302211|471834646|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
131055223|NCT00302211|471834642|FG000|Open Label-Patients From Double-Blind|Death|0|||
131055224|NCT00302211|471834643|FG001|Open Label-Patients From Double-Blind|Death|0|||
131055225|NCT00302211|471834644|FG002|Open Label-Patients From Double-Blind|Death|0|||
131055226|NCT00302211|471834645|FG003|Open Label-Patients From Double-Blind|Death|1|||
131055227|NCT00302211|471834646|FG004|Open Label-Patients From Double-Blind|Death|1|||
131055228|NCT00302211|471834642|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
131055229|NCT00302211|471834643|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
131055230|NCT00302211|471834644|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
131055231|NCT00302211|471834645|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
131229763|NCT03567057|472467685|FG001|Overall Study|Unstable medical condition|0|||
131055232|NCT00302211|471834646|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
131055233|NCT00302211|471834642|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
131055234|NCT00302211|471834643|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
131055235|NCT00302211|471834644|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
131055236|NCT00302211|471834645|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
131055237|NCT00302211|471834646|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
131055238|NCT00302211|471834642|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
131055239|NCT00302211|471834643|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
131055240|NCT00302211|471834644|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
131055241|NCT00302211|471834645|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
131055242|NCT00302211|471834646|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
131229764|NCT03567057|472467686|FG002|Overall Study|Unstable medical condition|0|||
131229765|NCT03567057|472467684|FG000|Overall Study|Medical history event|0|||
131229766|NCT03567057|472467685|FG001|Overall Study|Medical history event|0|||
131229767|NCT03567057|472467686|FG002|Overall Study|Medical history event|1|||
131229768|NCT03567057|472467684|FG000|Overall Study|Other|0|||
131229769|NCT03567057|472467685|FG001|Overall Study|Other|0|||
131229770|NCT03567057|472467686|FG002|Overall Study|Other|1|||
131229771|NCT00490061|472467687|FG000|Overall Study|Physician Decision|1|||
131229772|NCT00886483|472467696|FG000|Overall Study|Lost to Follow-up|0|||
131229773|NCT00886483|472467697|FG001|Overall Study|Lost to Follow-up|1|||
131229774|NCT00886483|472467696|FG000|Overall Study|Pursue medications|1|||
131229775|NCT00886483|472467697|FG001|Overall Study|Pursue medications|2|||
131229776|NCT00886483|472467696|FG000|Overall Study|Distance to center, poor grades|1|||
131229777|NCT00886483|472467697|FG001|Overall Study|Distance to center, poor grades|0|||
131229778|NCT01580020|472467698|FG000|Overall Study|Lack of Efficacy|0|||
131229779|NCT01580020|472467699|FG001|Overall Study|Lack of Efficacy|5|||
131229780|NCT01580020|472467700|FG002|Overall Study|Lack of Efficacy|0|||
131229781|NCT01580020|472467701|FG003|Overall Study|Lack of Efficacy|1|||
131229782|NCT01580020|472467698|FG000|Overall Study|Withdrawal by Subject|0|||
131229783|NCT01580020|472467699|FG001|Overall Study|Withdrawal by Subject|1|||
130722467|NCT00758680|470608273|FG005|Overall Study|Withdrawal by Subject|0|||
130722468|NCT00758680|470608274|FG006|Overall Study|Withdrawal by Subject|1|||
130722469|NCT00758680|470608275|FG007|Overall Study|Withdrawal by Subject|0|||
130722470|NCT00758680|470608276|FG008|Overall Study|Withdrawal by Subject|1|||
130722471|NCT00758680|470608277|FG009|Overall Study|Withdrawal by Subject|0|||
130722472|NCT00761865|470608278|FG000|Overall Study|Lost to Follow-up|8|||
130722473|NCT00761865|470608279|FG001|Overall Study|Lost to Follow-up|7|||
130722474|NCT00319982|470608280|FG000|Overall Study|Withdrawal by Subject|1|||
131055285|NCT05432986|471834655|FG000|Overall Study|Withdrawal by Subject|2|||
131055286|NCT05432986|471834655|FG000|Overall Study|incomplete measurement|7|||
131055287|NCT04172675|471836378|FG000|Overall Study|Withdrawal by Subject|7|||
131055288|NCT04172675|471836379|FG001|Overall Study|Withdrawal by Subject|5|||
131055289|NCT04172675|471836380|FG002|Overall Study|Withdrawal by Subject|1|||
131055290|NCT04172675|471836381|FG003|Overall Study|Withdrawal by Subject|4|||
131055291|NCT03861052|471836382|FG000|Overall Study|Adverse Event|1|||
131055292|NCT03861052|471836383|FG001|Overall Study|Adverse Event|1|||
131055293|NCT03861052|471836384|FG002|Overall Study|Adverse Event|2|||
131055294|NCT03861052|471836385|FG003|Overall Study|Adverse Event|4|||
131055295|NCT03861052|471836382|FG000|Overall Study|Lost to Follow-up|0|||
131055296|NCT03861052|471836383|FG001|Overall Study|Lost to Follow-up|0|||
131055297|NCT03861052|471836384|FG002|Overall Study|Lost to Follow-up|0|||
131055298|NCT03861052|471836385|FG003|Overall Study|Lost to Follow-up|1|||
131055299|NCT03861052|471836382|FG000|Overall Study|Physician Decision|0|||
131055300|NCT03861052|471836383|FG001|Overall Study|Physician Decision|1|||
131055301|NCT03861052|471836384|FG002|Overall Study|Physician Decision|0|||
131055302|NCT03861052|471836385|FG003|Overall Study|Physician Decision|0|||
131055303|NCT03861052|471836382|FG000|Overall Study|Withdrawal by Subject|2|||
131055304|NCT03861052|471836383|FG001|Overall Study|Withdrawal by Subject|5|||
131055305|NCT03861052|471836384|FG002|Overall Study|Withdrawal by Subject|3|||
131055306|NCT03861052|471836385|FG003|Overall Study|Withdrawal by Subject|0|||
131055307|NCT03861052|471836382|FG000|Overall Study|Relocation to other city|1|||
131055308|NCT03861052|471836383|FG001|Overall Study|Relocation to other city|0|||
131055309|NCT03861052|471836384|FG002|Overall Study|Relocation to other city|0|||
131055310|NCT03861052|471836385|FG003|Overall Study|Relocation to other city|0|||
131055311|NCT03009344|471836386|FG000|Overall Study|Lack of Efficacy|5|||
131055312|NCT03009344|471836386|FG000|Overall Study|Withdrawal by Subject|1|||
131055313|NCT03009344|471836386|FG000|Overall Study|Adverse Event|1|||
131055314|NCT02534233|471836389|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
131055315|NCT03823703|471836390|FG000|Overall Study|Sponsor request|0|||
131055316|NCT03823703|471836391|FG001|Overall Study|Sponsor request|3|||
131055317|NCT03823703|471836392|FG002|Overall Study|Sponsor request|4|||
131055318|NCT03823703|471836390|FG000|Overall Study|Adverse Event|3|||
131055319|NCT03823703|471836391|FG001|Overall Study|Adverse Event|1|||
131055320|NCT03823703|471836392|FG002|Overall Study|Adverse Event|0|||
131055321|NCT03823703|471836390|FG000|Overall Study|Withdrawal by Subject|0|||
131055322|NCT03823703|471836391|FG001|Overall Study|Withdrawal by Subject|1|||
131055323|NCT03823703|471836392|FG002|Overall Study|Withdrawal by Subject|0|||
131055324|NCT03137459|471836393|FG000|2-month Assessment|Withdrawal by Subject|13|||
131055325|NCT03137459|471836394|FG001|2-month Assessment|Withdrawal by Subject|3|||
131055326|NCT03137459|471836393|FG000|2-month Assessment|Unable to reach|42|||
131055327|NCT03137459|471836394|FG001|2-month Assessment|Unable to reach|32|||
131055328|NCT03137459|471836393|FG000|2-month Assessment|Refused assessment|7|||
131055329|NCT03137459|471836394|FG001|2-month Assessment|Refused assessment|5|||
131055330|NCT03137459|471836393|FG000|2-month Assessment|Acutely ill|6|||
131055331|NCT03137459|471836394|FG001|2-month Assessment|Acutely ill|2|||
131055332|NCT03137459|471836393|FG000|4-month Assessment|Death|4|||
131055333|NCT03137459|471836394|FG001|4-month Assessment|Death|2|||
131055334|NCT03137459|471836393|FG000|4-month Assessment|Withdrawal by Subject|4|||
131055335|NCT03137459|471836394|FG001|4-month Assessment|Withdrawal by Subject|2|||
131055336|NCT03137459|471836393|FG000|4-month Assessment|Unable to reach|44|||
131055337|NCT03137459|471836394|FG001|4-month Assessment|Unable to reach|29|||
131055338|NCT03137459|471836393|FG000|4-month Assessment|Refused assessment|24|||
131055339|NCT03137459|471836394|FG001|4-month Assessment|Refused assessment|10|||
131055340|NCT03137459|471836393|FG000|4-month Assessment|Acutely ill|2|||
131055341|NCT03137459|471836394|FG001|4-month Assessment|Acutely ill|3|||
131055342|NCT03137459|471836393|FG000|6-months|Lost to Follow-up|14|||
131055343|NCT03137459|471836394|FG001|6-months|Lost to Follow-up|11|||
131055344|NCT03137459|471836393|FG000|6-months|Death|0|||
131055345|NCT03137459|471836394|FG001|6-months|Death|2|||
131055346|NCT03137459|471836393|FG000|6-months|Refused assessment|6|||
131055347|NCT03137459|471836394|FG001|6-months|Refused assessment|3|||
131055348|NCT03137459|471836393|FG000|6-months|Acutely ill|1|||
131055349|NCT03137459|471836394|FG001|6-months|Acutely ill|1|||
131055350|NCT01732757|471836395|FG000|Overall Study|Lost to Follow-up|1|||
131055351|NCT01732757|471836396|FG001|Overall Study|Lost to Follow-up|0|||
131055352|NCT01732757|471836397|FG002|Overall Study|Lost to Follow-up|0|||
131055353|NCT00925548|471836398|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
131055354|NCT00925548|471836399|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
131055355|NCT04921358|471836400|FG000|Overall Study|Withdrawal by Subject|6|||
131055356|NCT04921358|471836401|FG001|Overall Study|Withdrawal by Subject|13|||
131055357|NCT04921358|471836400|FG000|Overall Study|Lost to Follow-up|3|||
131055358|NCT04921358|471836401|FG001|Overall Study|Lost to Follow-up|6|||
131055359|NCT04921358|471836400|FG000|Overall Study|Study Terminated by Sponsor|86|||
131055360|NCT04921358|471836401|FG001|Overall Study|Study Terminated by Sponsor|89|||
131055361|NCT04921358|471836400|FG000|Overall Study|Death|92|||
131055362|NCT04921358|471836401|FG001|Overall Study|Death|82|||
131055363|NCT02372799|471836402|FG000|Treatment Period|Adverse Event|3|||
131055364|NCT02372799|471836403|FG001|Treatment Period|Adverse Event|10|||
131055365|NCT02372799|471836404|FG002|Treatment Period|Adverse Event|6|||
131055366|NCT02372799|471836402|FG000|Treatment Period|Insufficient therapeutic response|2|||
131055367|NCT02372799|471836403|FG001|Treatment Period|Insufficient therapeutic response|2|||
131055368|NCT02372799|471836404|FG002|Treatment Period|Insufficient therapeutic response|0|||
131055369|NCT02372799|471836402|FG000|Treatment Period|Withdrawal by Subject|10|||
131055370|NCT02372799|471836403|FG001|Treatment Period|Withdrawal by Subject|10|||
131055371|NCT02372799|471836404|FG002|Treatment Period|Withdrawal by Subject|2|||
131055372|NCT02372799|471836402|FG000|Treatment Period|Lost to Follow-up|11|||
131055373|NCT02372799|471836403|FG001|Treatment Period|Lost to Follow-up|5|||
131055374|NCT02372799|471836404|FG002|Treatment Period|Lost to Follow-up|3|||
131055375|NCT02372799|471836402|FG000|Treatment Period|Protocol Violation|3|||
131055376|NCT02372799|471836403|FG001|Treatment Period|Protocol Violation|0|||
131055377|NCT02372799|471836404|FG002|Treatment Period|Protocol Violation|0|||
131055378|NCT02372799|471836402|FG000|Treatment Period|Non-compliance with study drug|4|||
131055379|NCT02372799|471836403|FG001|Treatment Period|Non-compliance with study drug|4|||
131055380|NCT02372799|471836404|FG002|Treatment Period|Non-compliance with study drug|4|||
131055381|NCT02372799|471836402|FG000|Treatment Period|Miscellaneous Reasons|1|||
131055382|NCT02372799|471836403|FG001|Treatment Period|Miscellaneous Reasons|1|||
131055383|NCT02372799|471836404|FG002|Treatment Period|Miscellaneous Reasons|0|||
131055384|NCT02372799|471836402|FG000|Down-taper Period|Lost to Follow-up|1|||
131055385|NCT02372799|471836403|FG001|Down-taper Period|Lost to Follow-up|2|||
131055386|NCT02372799|471836404|FG002|Down-taper Period|Lost to Follow-up|2|||
131055387|NCT03116464|471836405|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
131055388|NCT00491400|471836406|FG000|Overall Study|Withdrawal by Subject|5|||
131055389|NCT00491400|471836407|FG001|Overall Study|Withdrawal by Subject|4|||
131055390|NCT00597376|471836408|FG000|Overall Study|Withdrawal by Subject|4|||
131055391|NCT00597376|471836409|FG001|Overall Study|Withdrawal by Subject|3|||
131055392|NCT00597376|471836408|FG000|Overall Study|Adverse Event|4|||
131055393|NCT00597376|471836409|FG001|Overall Study|Adverse Event|1|||
131055394|NCT01532648|471836412|FG000|Overall Study|Lost to Follow-up|3|||
131055395|NCT01532648|471836413|FG001|Overall Study|Lost to Follow-up|4|||
131055396|NCT01532648|471836412|FG000|Overall Study|Lack of Efficacy|4|||
131055397|NCT01532648|471836413|FG001|Overall Study|Lack of Efficacy|1|||
131055398|NCT01532648|471836412|FG000|Overall Study|Protocol Violation|1|||
131055399|NCT01532648|471836413|FG001|Overall Study|Protocol Violation|1|||
131055400|NCT01532648|471836412|FG000|Overall Study|Adverse Event|12|||
131055401|NCT01532648|471836413|FG001|Overall Study|Adverse Event|9|||
131055402|NCT01532648|471836412|FG000|Overall Study|Withdrawal by Subject|16|||
131055403|NCT01532648|471836413|FG001|Overall Study|Withdrawal by Subject|2|||
131055404|NCT01583166|471836414|FG000|Overall Study|Withdrawal by Subject|4|||
131055405|NCT01583166|471836415|FG001|Overall Study|Withdrawal by Subject|6|||
131055406|NCT04652869|471836420|FG000|Overall Study|Withdrawal by Subject|0|||
131055407|NCT04652869|471836421|FG001|Overall Study|Withdrawal by Subject|2|||
131055408|NCT04652869|471836422|FG002|Overall Study|Withdrawal by Subject|0|||
131055409|NCT01833455|471836423|FG000|Overall Study|Withdrawal by Subject|1|||
131055410|NCT01833455|471836424|FG001|Overall Study|Withdrawal by Subject|0|||
131055411|NCT00562094|471836425|FG000|Overall Study|Lost to Follow-up|62|||
131055412|NCT00887224|471836426|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
131055413|NCT00887224|471836427|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
131055414|NCT00887224|471836428|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
131055415|NCT00887224|471836426|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
131055416|NCT00887224|471836427|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
131055417|NCT00887224|471836428|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
131055418|NCT00887224|471836426|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
131055419|NCT00887224|471836427|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
131055420|NCT00887224|471836428|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
131055421|NCT00887224|471836426|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
131055422|NCT00887224|471836427|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
131055423|NCT00887224|471836428|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
131055424|NCT00887224|471836426|FG000|Open-label Response (OLR) Phase|Other|1|||
131055425|NCT00887224|471836427|FG001|Open-label Response (OLR) Phase|Other|0|||
131055426|NCT00887224|471836428|FG002|Open-label Response (OLR) Phase|Other|0|||
131055427|NCT00887224|471836426|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
131055428|NCT00887224|471836427|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
131055429|NCT00887224|471836428|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
131055430|NCT00887224|471836426|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
131055431|NCT00887224|471836427|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
131055432|NCT00887224|471836428|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
131055433|NCT00887224|471836426|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
131055434|NCT00887224|471836427|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
131055435|NCT00887224|471836428|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
131055436|NCT00887224|471836426|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
131055437|NCT00887224|471836427|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
131055438|NCT00887224|471836428|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
131055439|NCT00887224|471836426|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
131055440|NCT00887224|471836427|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
131055441|NCT00887224|471836428|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
131055442|NCT00887224|471836426|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
131055443|NCT00887224|471836427|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
131055444|NCT00887224|471836428|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
131055445|NCT00887224|471836426|FG000|Open-label Stability (OLS) Phase|Other|1|||
131055446|NCT00887224|471836427|FG001|Open-label Stability (OLS) Phase|Other|0|||
131055447|NCT00887224|471836428|FG002|Open-label Stability (OLS) Phase|Other|0|||
131055448|NCT00887224|471836426|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
131055449|NCT00887224|471836427|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
131055450|NCT00887224|471836428|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
131055451|NCT00887224|471836426|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
131055452|NCT00887224|471836427|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
131055453|NCT00887224|471836428|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
131055454|NCT00887224|471836426|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
131055455|NCT00887224|471836427|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
131055456|NCT00887224|471836428|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
131055457|NCT00887224|471836426|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
131055458|NCT00887224|471836427|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
131055459|NCT00887224|471836428|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
131055460|NCT00887224|471836426|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
131055461|NCT00887224|471836427|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
131055462|NCT00887224|471836428|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
131055463|NCT00887224|471836426|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
131055464|NCT00887224|471836427|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
131055465|NCT00887224|471836428|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
131055466|NCT00887224|471836426|FG000|OL Taper Phase / OL Follow Up|Other|30|||
131055467|NCT00887224|471836427|FG001|OL Taper Phase / OL Follow Up|Other|0|||
131055468|NCT00887224|471836428|FG002|OL Taper Phase / OL Follow Up|Other|0|||
131055469|NCT00887224|471836426|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
131055470|NCT00887224|471836427|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
131055471|NCT00887224|471836428|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
131055472|NCT00887224|471836426|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
131055473|NCT00887224|471836427|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
131055474|NCT00887224|471836428|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
131055475|NCT00887224|471836426|FG000|Double-blind (DB) Phase|Adverse Event|0|||
131055476|NCT00887224|471836427|FG001|Double-blind (DB) Phase|Adverse Event|7|||
131055477|NCT00887224|471836428|FG002|Double-blind (DB) Phase|Adverse Event|2|||
131055478|NCT00887224|471836426|FG000|Double-blind (DB) Phase|Failed to return|0|||
131055479|NCT00887224|471836427|FG001|Double-blind (DB) Phase|Failed to return|2|||
131055480|NCT00887224|471836428|FG002|Double-blind (DB) Phase|Failed to return|2|||
131055481|NCT00887224|471836426|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
131055482|NCT00887224|471836427|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
131055483|NCT00887224|471836428|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
131055484|NCT00887224|471836426|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
131055485|NCT00887224|471836427|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
131055486|NCT00887224|471836428|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
131055487|NCT00887224|471836426|FG000|Double-blind (DB) Phase|Other|0|||
131055488|NCT00887224|471836427|FG001|Double-blind (DB) Phase|Other|2|||
130722475|NCT00319982|470608281|FG001|Overall Study|Withdrawal by Subject|0|||
130722476|NCT01094886|470608282|FG000|Overall Study|Adverse Event|2|||
130722477|NCT01094886|470608282|FG000|Overall Study|Withdrawal by Subject|5|||
130722478|NCT03866902|470608283|FG000|Overall Study|Lost to Follow-up|98|||
131055489|NCT00887224|471836428|FG002|Double-blind (DB) Phase|Other|0|||
131055490|NCT00887224|471836426|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
131055491|NCT00887224|471836427|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
131055492|NCT00887224|471836428|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
131055493|NCT00887224|471836426|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
131055494|NCT00887224|471836427|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
131055495|NCT00887224|471836428|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
131055496|NCT00887224|471836426|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
131055497|NCT00887224|471836427|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
131055498|NCT00887224|471836428|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
131055499|NCT00887224|471836426|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
131055500|NCT00887224|471836427|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
131055501|NCT00887224|471836428|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
131055502|NCT00887224|471836426|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
131055503|NCT00887224|471836427|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
131055504|NCT00887224|471836428|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
131055505|NCT00887224|471836426|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
131055506|NCT00887224|471836427|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
131055507|NCT00887224|471836428|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
131055508|NCT00887224|471836426|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
131055509|NCT00887224|471836427|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
131055510|NCT00887224|471836428|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
131055511|NCT00887224|471836426|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
131055512|NCT00887224|471836427|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
131055513|NCT00887224|471836428|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
131055514|NCT00887224|471836426|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
131055515|NCT00887224|471836427|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
131055516|NCT00887224|471836428|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
131055517|NCT01555138|471836431|FG000|Overall Study|Death|0|||
131055518|NCT01555138|471836432|FG001|Overall Study|Death|1|||
131055519|NCT01555138|471836431|FG000|Overall Study|Lost to Follow-up|1|||
131055520|NCT01555138|471836432|FG001|Overall Study|Lost to Follow-up|0|||
131055521|NCT01555138|471836431|FG000|Overall Study|Abnormal Lab reults|1|||
131055522|NCT01555138|471836432|FG001|Overall Study|Abnormal Lab reults|3|||
131055523|NCT01555138|471836431|FG000|Overall Study|Lack of Efficacy|2|||
131055524|NCT01555138|471836432|FG001|Overall Study|Lack of Efficacy|2|||
131055525|NCT01555138|471836431|FG000|Overall Study|Protocol Violation|5|||
131055526|NCT01555138|471836432|FG001|Overall Study|Protocol Violation|3|||
131055527|NCT01555138|471836431|FG000|Overall Study|Administrative problems|8|||
131055528|NCT01555138|471836432|FG001|Overall Study|Administrative problems|0|||
131055529|NCT01555138|471836431|FG000|Overall Study|Withdrawal by Subject|16|||
131055530|NCT01555138|471836432|FG001|Overall Study|Withdrawal by Subject|15|||
131055531|NCT01555138|471836431|FG000|Overall Study|Adverse Event|14|||
131055532|NCT01555138|471836432|FG001|Overall Study|Adverse Event|14|||
131055533|NCT02000752|471836433|FG000|Overall Study|Dystocic delivery|19|||
131055534|NCT02000752|471836434|FG001|Overall Study|Dystocic delivery|8|||
131055535|NCT02000752|471836433|FG000|Overall Study|Shift Changes|12|||
131055536|NCT02000752|471836434|FG001|Overall Study|Shift Changes|5|||
131055537|NCT04938453|471836438|FG000|Washout Period 1|Adverse Event|1|||
131055538|NCT04938453|471836439|FG001|Washout Period 1|Adverse Event|0|||
131055539|NCT04938453|471836438|FG000|Washout Period 1|Physician Decision|0|||
131055540|NCT04938453|471836439|FG001|Washout Period 1|Physician Decision|1|||
131055541|NCT04497415|471836442|FG000|Overall Study|Lost to Follow-up|43|||
131055542|NCT04497415|471836443|FG001|Overall Study|Lost to Follow-up|27|||
131055543|NCT04237792|471836447|FG000|Treatment (Day 1)|Adverse Event|1|||
131136304|NCT02064387|472126515|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131136305|NCT02064387|472126516|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131136306|NCT02064387|472126517|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131136307|NCT02064387|472126518|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131055544|NCT04237792|471836448|FG001|Treatment (Day 1)|Adverse Event|0|||
131055545|NCT04237792|471836449|FG002|Treatment (Day 1)|Adverse Event|0|||
131055546|NCT04237792|471836450|FG003|Treatment (Day 1)|Adverse Event|0|||
131055547|NCT04237792|471836451|FG004|Treatment (Day 1)|Adverse Event|1|||
131055548|NCT04237792|471836452|FG005|Treatment (Day 1)|Adverse Event|1|||
131055549|NCT04237792|471836447|FG000|Treatment (Day 1)|Other|0|||
131055550|NCT04237792|471836448|FG001|Treatment (Day 1)|Other|0|||
131055551|NCT04237792|471836449|FG002|Treatment (Day 1)|Other|1|||
131055552|NCT04237792|471836450|FG003|Treatment (Day 1)|Other|0|||
131055553|NCT04237792|471836451|FG004|Treatment (Day 1)|Other|0|||
131055554|NCT04237792|471836452|FG005|Treatment (Day 1)|Other|1|||
131055555|NCT04237792|471836447|FG000|Treatment (Day 1)|Not treated|1|||
131055556|NCT04237792|471836448|FG001|Treatment (Day 1)|Not treated|1|||
131055557|NCT04237792|471836449|FG002|Treatment (Day 1)|Not treated|2|||
131136308|NCT02064387|472126519|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131055558|NCT04237792|471836450|FG003|Treatment (Day 1)|Not treated|1|||
131055559|NCT04237792|471836451|FG004|Treatment (Day 1)|Not treated|0|||
131055560|NCT04237792|471836452|FG005|Treatment (Day 1)|Not treated|1|||
131055561|NCT05553366|471836454|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
131055562|NCT05553366|471836455|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
131055563|NCT05553366|471836456|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
131055564|NCT05553366|471836454|FG000|Overall Study|Lost to Follow-up|3|||
131136309|NCT02064387|472126520|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131136310|NCT02064387|472126521|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131055565|NCT05553366|471836455|FG001|Overall Study|Lost to Follow-up|3|||
131055566|NCT05553366|471836456|FG002|Overall Study|Lost to Follow-up|3|||
131055567|NCT05553366|471836454|FG000|Overall Study|Other non-compliance|1|||
131055568|NCT05553366|471836455|FG001|Overall Study|Other non-compliance|1|||
131055569|NCT05553366|471836456|FG002|Overall Study|Other non-compliance|0|||
131055570|NCT05553366|471836454|FG000|Overall Study|Randomized but not dosed|0|||
131055571|NCT05553366|471836455|FG001|Overall Study|Randomized but not dosed|0|||
131055572|NCT05553366|471836456|FG002|Overall Study|Randomized but not dosed|2|||
131055573|NCT02022657|471836460|FG000|Overall Study|Withdrawal by Subject|2|||
131055574|NCT02022657|471836461|FG001|Overall Study|Withdrawal by Subject|0|||
131055575|NCT02022657|471836462|FG002|Overall Study|Withdrawal by Subject|1|||
131055576|NCT02022657|471836463|FG003|Overall Study|Withdrawal by Subject|0|||
131055577|NCT02022657|471836464|FG004|Overall Study|Withdrawal by Subject|0|||
131055578|NCT02022657|471836465|FG005|Overall Study|Withdrawal by Subject|0|||
131055579|NCT02022657|471836460|FG000|Overall Study|Physician Decision|0|||
131055580|NCT02022657|471836461|FG001|Overall Study|Physician Decision|0|||
131055581|NCT02022657|471836462|FG002|Overall Study|Physician Decision|0|||
131055582|NCT02022657|471836463|FG003|Overall Study|Physician Decision|0|||
131055583|NCT02022657|471836464|FG004|Overall Study|Physician Decision|0|||
131055584|NCT02022657|471836465|FG005|Overall Study|Physician Decision|1|||
131055585|NCT03739866|471836489|FG000|Overall Study|Lost to Follow-up|0|||
131055586|NCT03739866|471836490|FG001|Overall Study|Lost to Follow-up|0|||
131055587|NCT03739866|471836491|FG002|Overall Study|Lost to Follow-up|0|||
131055588|NCT03739866|471836492|FG003|Overall Study|Lost to Follow-up|1|||
131055589|NCT03739866|471836493|FG004|Overall Study|Lost to Follow-up|0|||
131055590|NCT03739866|471836494|FG005|Overall Study|Lost to Follow-up|0|||
131055591|NCT03739866|471836495|FG006|Overall Study|Lost to Follow-up|0|||
131055592|NCT03739866|471836496|FG007|Overall Study|Lost to Follow-up|0|||
131055593|NCT03739866|471836489|FG000|Overall Study|Enrolled but not treated|0|||
131055594|NCT03739866|471836490|FG001|Overall Study|Enrolled but not treated|0|||
131055595|NCT03739866|471836491|FG002|Overall Study|Enrolled but not treated|1|||
131055596|NCT03739866|471836492|FG003|Overall Study|Enrolled but not treated|0|||
131136311|NCT02064387|472126522|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
131136312|NCT02064387|472126523|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
131136313|NCT02706730|472126524|FG000|Overall Study|Adverse Event|3|||
131055597|NCT03739866|471836493|FG004|Overall Study|Enrolled but not treated|1|||
131055598|NCT03739866|471836494|FG005|Overall Study|Enrolled but not treated|0|||
131055599|NCT03739866|471836495|FG006|Overall Study|Enrolled but not treated|0|||
131055600|NCT03739866|471836496|FG007|Overall Study|Enrolled but not treated|0|||
131055601|NCT01700205|471836497|FG000|Overall Study|Withdrawal by Subject|13|||
131055602|NCT01700205|471836498|FG001|Overall Study|Withdrawal by Subject|13|||
131055603|NCT01700205|471836497|FG000|Overall Study|Protocol Violation|2|||
131055604|NCT01700205|471836498|FG001|Overall Study|Protocol Violation|2|||
131055605|NCT01034306|471836499|FG000|Overall Study|Adverse Event|1|||
131055606|NCT01034306|471836500|FG001|Overall Study|Adverse Event|0|||
131055607|NCT01034306|471836499|FG000|Overall Study|Lost to Follow-up|0|||
131055608|NCT01034306|471836500|FG001|Overall Study|Lost to Follow-up|1|||
131055609|NCT01034306|471836499|FG000|Overall Study|Withdrawal by Subject|2|||
131055610|NCT01034306|471836500|FG001|Overall Study|Withdrawal by Subject|2|||
131055611|NCT01034306|471836499|FG000|Overall Study|hospitalized and decided to stop|1|||
131055612|NCT01034306|471836500|FG001|Overall Study|hospitalized and decided to stop|0|||
131136314|NCT02706730|472126524|FG000|Overall Study|Lack of Efficacy|5|||
131055613|NCT01034306|471836499|FG000|Overall Study|Noncomplience|1|||
131055614|NCT01034306|471836500|FG001|Overall Study|Noncomplience|0|||
131055615|NCT01619059|471836503|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
131055616|NCT01619059|471836504|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
131055617|NCT01619059|471836503|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
131055618|NCT01619059|471836504|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
131055619|NCT01619059|471836503|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
131055620|NCT01619059|471836504|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
131055621|NCT01619059|471836503|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
131055622|NCT01619059|471836504|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
131055623|NCT01619059|471836503|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
130722479|NCT03866902|470608284|FG001|Overall Study|Lost to Follow-up|82|||
131055624|NCT01619059|471836504|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
131055625|NCT01619059|471836503|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
131055626|NCT01619059|471836504|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
131055627|NCT01619059|471836503|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
131055628|NCT01619059|471836504|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
131055629|NCT01619059|471836503|FG000|Long-Term (LT) Treatment Period|Death|1|||
131055630|NCT01619059|471836504|FG001|Long-Term (LT) Treatment Period|Death|0|||
131055631|NCT01619059|471836503|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
131055632|NCT01619059|471836504|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
131055633|NCT01619059|471836503|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
131055634|NCT01619059|471836504|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
131055635|NCT03057600|471836505|FG000|Overall Study|Adverse Event|0|||
131055636|NCT03057600|471836506|FG001|Overall Study|Adverse Event|0|||
131055637|NCT03057600|471836507|FG002|Overall Study|Adverse Event|4|||
131055638|NCT03057600|471836508|FG003|Overall Study|Adverse Event|0|||
131055639|NCT03057600|471836505|FG000|Overall Study|Radiologic Disease Progression|8|||
131055640|NCT03057600|471836506|FG001|Overall Study|Radiologic Disease Progression|7|||
131055641|NCT03057600|471836507|FG002|Overall Study|Radiologic Disease Progression|13|||
131055642|NCT03057600|471836508|FG003|Overall Study|Radiologic Disease Progression|10|||
131055643|NCT03057600|471836505|FG000|Overall Study|Symptomatic Deterioration|0|||
131055644|NCT03057600|471836506|FG001|Overall Study|Symptomatic Deterioration|1|||
131136315|NCT02706730|472126524|FG000|Overall Study|Withdrawal by Subject|11|||
131136316|NCT02706730|472126524|FG000|Overall Study|Study Terminated by Sponsor|11|||
131136317|NCT02706730|472126524|FG000|Overall Study|Subject chose not to receive injection|3|||
131229784|NCT01580020|472467700|FG002|Overall Study|Withdrawal by Subject|1|||
131229785|NCT01580020|472467701|FG003|Overall Study|Withdrawal by Subject|0|||
131229786|NCT01580020|472467698|FG000|Overall Study|Adverse Event|1|||
131229787|NCT01580020|472467699|FG001|Overall Study|Adverse Event|1|||
131229788|NCT01580020|472467700|FG002|Overall Study|Adverse Event|1|||
131055645|NCT03057600|471836507|FG002|Overall Study|Symptomatic Deterioration|1|||
131055646|NCT03057600|471836508|FG003|Overall Study|Symptomatic Deterioration|0|||
131055647|NCT03057600|471836505|FG000|Overall Study|Investigator Decision|0|||
131055648|NCT03057600|471836506|FG001|Overall Study|Investigator Decision|0|||
131055649|NCT03057600|471836507|FG002|Overall Study|Investigator Decision|1|||
131055650|NCT03057600|471836508|FG003|Overall Study|Investigator Decision|0|||
131136318|NCT02499029|472126529|FG000|Overall Study|Lost to Follow-up|2|||
131136319|NCT02499029|472126530|FG001|Overall Study|Lost to Follow-up|2|||
131136320|NCT02499029|472126529|FG000|Overall Study|Physician Decision|2|||
131136321|NCT02499029|472126530|FG001|Overall Study|Physician Decision|1|||
131229789|NCT01580020|472467701|FG003|Overall Study|Adverse Event|1|||
130779357|NCT02326272|470819504|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130779358|NCT02326272|470819490|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
131055651|NCT03057600|471836505|FG000|Overall Study|Study Termination by Sponsor|0|||
131055652|NCT03057600|471836506|FG001|Overall Study|Study Termination by Sponsor|0|||
131055653|NCT03057600|471836507|FG002|Overall Study|Study Termination by Sponsor|0|||
131055654|NCT03057600|471836508|FG003|Overall Study|Study Termination by Sponsor|2|||
131055655|NCT03057600|471836505|FG000|Overall Study|Withdrawal by Subject|0|||
131055656|NCT03057600|471836506|FG001|Overall Study|Withdrawal by Subject|1|||
131055657|NCT03057600|471836507|FG002|Overall Study|Withdrawal by Subject|0|||
131055658|NCT03057600|471836508|FG003|Overall Study|Withdrawal by Subject|0|||
131055659|NCT03057600|471836505|FG000|Overall Study|Other, Not Specified|1|||
131136322|NCT02499029|472126529|FG000|Overall Study|Death|1|||
131229790|NCT01580020|472467698|FG000|Overall Study|Administrative Problems|0|||
131229791|NCT01580020|472467699|FG001|Overall Study|Administrative Problems|0|||
131229792|NCT01580020|472467700|FG002|Overall Study|Administrative Problems|1|||
130722480|NCT03866902|470608283|FG000|Overall Study|Pregnancy|18|||
130722481|NCT03866902|470608284|FG001|Overall Study|Pregnancy|24|||
130722482|NCT04730349|470608287|FG000|Overall Study|Participant withdrew consent|1|||
130722483|NCT04730349|470608288|FG001|Overall Study|Participant withdrew consent|0|||
130722484|NCT04730349|470608287|FG000|Overall Study|Disease progression|6|||
130722485|NCT04730349|470608288|FG001|Overall Study|Disease progression|4|||
130722486|NCT04730349|470608287|FG000|Overall Study|Study drug toxicity|0|||
130722487|NCT04730349|470608288|FG001|Overall Study|Study drug toxicity|1|||
130722488|NCT00638027|470608290|FG000|Overall Study|Adverse Event|0|||
130722489|NCT00638027|470608291|FG001|Overall Study|Adverse Event|2|||
130722490|NCT00371397|470608292|FG000|Session 1|Withdrawal by Subject|1|||
130722491|NCT00371397|470608293|FG001|Session 1|Withdrawal by Subject|0|||
130722492|NCT00371397|470608294|FG002|Session 1|Withdrawal by Subject|0|||
130722493|NCT00371397|470608295|FG003|Session 1|Withdrawal by Subject|0|||
130722494|NCT00371397|470608296|FG004|Session 1|Withdrawal by Subject|0|||
130722495|NCT00371397|470608297|FG005|Session 1|Withdrawal by Subject|0|||
130722496|NCT00371397|470608298|FG006|Session 1|Withdrawal by Subject|0|||
130722497|NCT00371397|470608299|FG007|Session 1|Withdrawal by Subject|1|||
130722498|NCT00371397|470608300|FG008|Session 1|Withdrawal by Subject|0|||
130722499|NCT00371397|470608301|FG009|Session 1|Withdrawal by Subject|0|||
130722500|NCT00371397|470608302|FG010|Session 1|Withdrawal by Subject|0|||
131055660|NCT03057600|471836506|FG001|Overall Study|Other, Not Specified|1|||
131055661|NCT03057600|471836507|FG002|Overall Study|Other, Not Specified|1|||
131055662|NCT03057600|471836508|FG003|Overall Study|Other, Not Specified|1|||
131055663|NCT01968967|471836511|FG000|Treatment Period|Other|22|||
131055664|NCT01968967|471836512|FG001|Treatment Period|Other|22|||
131055665|NCT01968967|471836513|FG002|Treatment Period|Other|0|||
131055666|NCT01968967|471836514|FG003|Treatment Period|Other|0|||
131055667|NCT01968967|471836515|FG004|Treatment Period|Other|0|||
131055668|NCT01968967|471836511|FG000|Treatment Period|Withdrawal by Subject|71|||
131055669|NCT01968967|471836512|FG001|Treatment Period|Withdrawal by Subject|61|||
131055670|NCT01968967|471836513|FG002|Treatment Period|Withdrawal by Subject|0|||
131055671|NCT01968967|471836514|FG003|Treatment Period|Withdrawal by Subject|0|||
131055672|NCT01968967|471836515|FG004|Treatment Period|Withdrawal by Subject|0|||
131055673|NCT01968967|471836511|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
131055674|NCT01968967|471836512|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
131055675|NCT01968967|471836513|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
131055676|NCT01968967|471836514|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
131055677|NCT01968967|471836515|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
131055678|NCT01968967|471836511|FG000|Treatment Period|Lost to Follow-up|26|||
131055679|NCT01968967|471836512|FG001|Treatment Period|Lost to Follow-up|31|||
131055680|NCT01968967|471836513|FG002|Treatment Period|Lost to Follow-up|0|||
131055681|NCT01968967|471836514|FG003|Treatment Period|Lost to Follow-up|0|||
131055682|NCT01968967|471836515|FG004|Treatment Period|Lost to Follow-up|0|||
131055683|NCT01968967|471836511|FG000|Treatment Period|Protocol Violation|1|||
131055684|NCT01968967|471836512|FG001|Treatment Period|Protocol Violation|2|||
131055685|NCT01968967|471836513|FG002|Treatment Period|Protocol Violation|0|||
131055686|NCT01968967|471836514|FG003|Treatment Period|Protocol Violation|0|||
131055687|NCT01968967|471836515|FG004|Treatment Period|Protocol Violation|0|||
131055688|NCT01968967|471836511|FG000|Treatment Period|Adverse Event|9|||
131055689|NCT01968967|471836512|FG001|Treatment Period|Adverse Event|8|||
131055690|NCT01968967|471836513|FG002|Treatment Period|Adverse Event|0|||
131055691|NCT01968967|471836514|FG003|Treatment Period|Adverse Event|0|||
131055692|NCT01968967|471836515|FG004|Treatment Period|Adverse Event|0|||
131055693|NCT01968967|471836511|FG000|Treatment Period|Death|9|||
131055694|NCT01968967|471836512|FG001|Treatment Period|Death|2|||
131055695|NCT01968967|471836513|FG002|Treatment Period|Death|0|||
131055696|NCT01968967|471836514|FG003|Treatment Period|Death|0|||
131055697|NCT01968967|471836515|FG004|Treatment Period|Death|0|||
131055698|NCT01968967|471836511|FG000|Treatment Period|Randomized Not Treated|6|||
131055699|NCT01968967|471836512|FG001|Treatment Period|Randomized Not Treated|5|||
131055700|NCT01968967|471836513|FG002|Treatment Period|Randomized Not Treated|0|||
131055701|NCT01968967|471836514|FG003|Treatment Period|Randomized Not Treated|0|||
131055702|NCT01968967|471836515|FG004|Treatment Period|Randomized Not Treated|0|||
131055703|NCT01968967|471836511|FG000|Extension Period|Withdrew Consent|0|||
131055704|NCT01968967|471836512|FG001|Extension Period|Withdrew Consent|0|||
131055705|NCT01968967|471836513|FG002|Extension Period|Withdrew Consent|2|||
131055706|NCT01968967|471836514|FG003|Extension Period|Withdrew Consent|0|||
131055707|NCT01968967|471836515|FG004|Extension Period|Withdrew Consent|5|||
131055708|NCT03489369|471836516|FG000|Overall Study|Documented Progressive Disease|3|||
131055709|NCT03489369|471836517|FG001|Overall Study|Documented Progressive Disease|2|||
131055710|NCT03489369|471836518|FG002|Overall Study|Documented Progressive Disease|3|||
131055711|NCT03489369|471836519|FG003|Overall Study|Documented Progressive Disease|6|||
131055712|NCT03489369|471836516|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
131055713|NCT03489369|471836517|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
131055714|NCT03489369|471836518|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
131055715|NCT03489369|471836519|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
131055716|NCT00614614|471836526|FG000|Primary Vaccination Phase|Adverse Event|6|||
131055717|NCT00614614|471836527|FG001|Primary Vaccination Phase|Adverse Event|0|||
131055718|NCT00614614|471836528|FG002|Primary Vaccination Phase|Adverse Event|0|||
131055719|NCT00614614|471836529|FG003|Primary Vaccination Phase|Adverse Event|0|||
131055720|NCT00614614|471836530|FG004|Primary Vaccination Phase|Adverse Event|0|||
131055721|NCT00614614|471836526|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
131055722|NCT00614614|471836527|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
131136323|NCT02499029|472126530|FG001|Overall Study|Death|0|||
131136324|NCT01999582|472126531|FG000|Overall Study|Withdrawal by Subject|0|||
131136325|NCT01999582|472126532|FG001|Overall Study|Withdrawal by Subject|0|||
131136326|NCT01999582|472126533|FG002|Overall Study|Withdrawal by Subject|0|||
131136327|NCT01999582|472126534|FG003|Overall Study|Withdrawal by Subject|1|||
131136328|NCT01999582|472126535|FG004|Overall Study|Withdrawal by Subject|0|||
131136329|NCT01999582|472126536|FG005|Overall Study|Withdrawal by Subject|0|||
131136330|NCT01999582|472126531|FG000|Overall Study|Adverse Event|0|||
131055723|NCT00614614|471836528|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
131055724|NCT00614614|471836529|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
131055725|NCT00614614|471836530|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
131055726|NCT00614614|471836526|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
131055727|NCT00614614|471836527|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
131055728|NCT00614614|471836528|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
131055729|NCT00614614|471836529|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
131055730|NCT00614614|471836530|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
131055731|NCT00614614|471836526|FG000|Primary Vaccination Phase|Protocol Violation|9|||
131055732|NCT00614614|471836527|FG001|Primary Vaccination Phase|Protocol Violation|3|||
131055733|NCT00614614|471836528|FG002|Primary Vaccination Phase|Protocol Violation|0|||
131055734|NCT00614614|471836529|FG003|Primary Vaccination Phase|Protocol Violation|0|||
131055735|NCT00614614|471836530|FG004|Primary Vaccination Phase|Protocol Violation|0|||
131055736|NCT00614614|471836526|FG000|Primary Vaccination Phase|Other|4|||
131055737|NCT00614614|471836527|FG001|Primary Vaccination Phase|Other|0|||
131055738|NCT00614614|471836528|FG002|Primary Vaccination Phase|Other|0|||
131055739|NCT00614614|471836529|FG003|Primary Vaccination Phase|Other|0|||
131055740|NCT00614614|471836530|FG004|Primary Vaccination Phase|Other|0|||
131055741|NCT00614614|471836526|FG000|Booster Vaccination Phase|Adverse Event|0|||
131055742|NCT00614614|471836527|FG001|Booster Vaccination Phase|Adverse Event|0|||
131055743|NCT00614614|471836528|FG002|Booster Vaccination Phase|Adverse Event|1|||
131055744|NCT00614614|471836529|FG003|Booster Vaccination Phase|Adverse Event|1|||
131055745|NCT00614614|471836530|FG004|Booster Vaccination Phase|Adverse Event|0|||
131055746|NCT00614614|471836526|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
131055747|NCT00614614|471836527|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
131055748|NCT00614614|471836528|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
131055749|NCT00614614|471836529|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
131055750|NCT00614614|471836530|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
131055751|NCT00614614|471836526|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
131055752|NCT00614614|471836527|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
131055753|NCT00614614|471836528|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
131055754|NCT00614614|471836529|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
131055755|NCT00614614|471836530|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
131055756|NCT00614614|471836526|FG000|Booster Vaccination Phase|Protocol Violation|0|||
131055757|NCT00614614|471836527|FG001|Booster Vaccination Phase|Protocol Violation|0|||
131055758|NCT00614614|471836528|FG002|Booster Vaccination Phase|Protocol Violation|2|||
131055759|NCT00614614|471836529|FG003|Booster Vaccination Phase|Protocol Violation|3|||
131055760|NCT00614614|471836530|FG004|Booster Vaccination Phase|Protocol Violation|0|||
131055761|NCT00614614|471836526|FG000|Booster Vaccination Phase|Other|0|||
131055762|NCT00614614|471836527|FG001|Booster Vaccination Phase|Other|1|||
131055763|NCT00614614|471836528|FG002|Booster Vaccination Phase|Other|3|||
131055764|NCT00614614|471836529|FG003|Booster Vaccination Phase|Other|2|||
131055765|NCT00614614|471836530|FG004|Booster Vaccination Phase|Other|1|||
131055766|NCT00933270|471836531|FG000|Overall Study|Withdrawal by Subject|26|||
131055767|NCT00933270|471836531|FG000|Overall Study|Insufficient Follow-up|10|||
131055768|NCT00933270|471836531|FG000|Overall Study|Lost to Follow-up|14|||
131055769|NCT00933270|471836531|FG000|Overall Study|Adverse Event|1|||
131055770|NCT00933270|471836531|FG000|Overall Study|Missed Visit|2|||
131055771|NCT00933270|471836531|FG000|Overall Study|Death|24|||
131055772|NCT00933270|471836531|FG000|Overall Study|Moved or would not return|10|||
131055773|NCT01000805|471836532|FG000|Overall Study|Adverse Event|21|||
131055774|NCT01000805|471836533|FG001|Overall Study|Adverse Event|9|||
131055775|NCT01000805|471836532|FG000|Overall Study|Lack of Efficacy|5|||
131055776|NCT01000805|471836533|FG001|Overall Study|Lack of Efficacy|16|||
131055777|NCT01000805|471836532|FG000|Overall Study|Lost to Follow-up|16|||
131055778|NCT01000805|471836533|FG001|Overall Study|Lost to Follow-up|21|||
131055779|NCT01000805|471836532|FG000|Overall Study|Physician Decision|0|||
131055780|NCT01000805|471836533|FG001|Overall Study|Physician Decision|1|||
131055781|NCT01000805|471836532|FG000|Overall Study|Protocol Violation|12|||
131055782|NCT01000805|471836533|FG001|Overall Study|Protocol Violation|8|||
131055783|NCT01000805|471836532|FG000|Overall Study|Withdrawal by Subject|16|||
131055784|NCT01000805|471836533|FG001|Overall Study|Withdrawal by Subject|6|||
131055785|NCT01000805|471836532|FG000|Overall Study|Sponsor Decision|0|||
131055786|NCT01000805|471836533|FG001|Overall Study|Sponsor Decision|1|||
131055787|NCT00989196|471836534|FG000|Treatment Period|Lost to Follow-up|1|||
131055788|NCT00989196|471836535|FG001|Treatment Period|Lost to Follow-up|0|||
131055789|NCT03476798|471836536|FG000|Overall Study|Death|1|||
131055790|NCT03476798|471836536|FG000|Overall Study|Withdrawal by Subject|2|||
131055791|NCT03476798|471836536|FG000|Overall Study|Protocol Violation|2|||
131055792|NCT03343704|471836542|FG000|Overall Study|Refused to complete follow up|0|||
131055793|NCT03343704|471836543|FG001|Overall Study|Refused to complete follow up|1|||
131055794|NCT03343704|471836542|FG000|Overall Study|Death|0|||
131055795|NCT03343704|471836543|FG001|Overall Study|Death|1|||
131055796|NCT03343704|471836542|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
131055797|NCT03343704|471836543|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
131055798|NCT03789656|471836544|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
131055799|NCT03789656|471836545|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
131055800|NCT03789656|471836546|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
131055801|NCT03789656|471836547|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
131136331|NCT01999582|472126532|FG001|Overall Study|Adverse Event|0|||
131229793|NCT01580020|472467701|FG003|Overall Study|Administrative Problems|0|||
131229794|NCT01580020|472467698|FG000|Overall Study|Lost to Follow-up|0|||
131229795|NCT01580020|472467699|FG001|Overall Study|Lost to Follow-up|0|||
131229796|NCT01580020|472467700|FG002|Overall Study|Lost to Follow-up|1|||
131229797|NCT01580020|472467701|FG003|Overall Study|Lost to Follow-up|0|||
131229798|NCT01724359|472467702|FG000|Overall Study|Adverse Event|10|||
131229799|NCT01724359|472467702|FG000|Overall Study|Death|1|||
131229800|NCT01724359|472467702|FG000|Overall Study|Other|20|||
131229801|NCT00593333|472467704|FG000|Overall Study|Lost to Follow-up|10|||
131229802|NCT00593333|472467705|FG001|Overall Study|Lost to Follow-up|11|||
131229803|NCT01752920|472467706|FG000|Overall Study|Adverse Event|1|||
131229804|NCT01752920|472467707|FG001|Overall Study|Adverse Event|0|||
131229805|NCT01752920|472467708|FG002|Overall Study|Adverse Event|5|||
131055802|NCT03789656|471836548|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
131229806|NCT01752920|472467709|FG003|Overall Study|Adverse Event|10|||
131229807|NCT01752920|472467706|FG000|Overall Study|Clinical Disease Progression|6|||
131229808|NCT01752920|472467707|FG001|Overall Study|Clinical Disease Progression|4|||
131229809|NCT01752920|472467708|FG002|Overall Study|Clinical Disease Progression|1|||
131229810|NCT01752920|472467709|FG003|Overall Study|Clinical Disease Progression|13|||
131229811|NCT01752920|472467706|FG000|Overall Study|Physician Decision|1|||
131055803|NCT03789656|471836544|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
131055804|NCT03789656|471836545|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
131055805|NCT03789656|471836546|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
131055806|NCT03789656|471836547|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
131055807|NCT03789656|471836548|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
131055808|NCT03789656|471836544|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
131055809|NCT03789656|471836545|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
131055810|NCT03789656|471836546|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
131055811|NCT03789656|471836547|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
131055812|NCT03789656|471836548|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
131055813|NCT03789656|471836544|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
131055814|NCT03789656|471836545|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
131055815|NCT03789656|471836546|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
131055816|NCT03789656|471836547|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
131055817|NCT03789656|471836548|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
131055818|NCT05349721|471837987|FG000|Part A (24 Weeks)|Adverse Event|9|||
131055819|NCT05349721|471837988|FG001|Part A (24 Weeks)|Adverse Event|2|||
131055820|NCT05349721|471837987|FG000|Part A (24 Weeks)|Death|8|||
131055821|NCT05349721|471837988|FG001|Part A (24 Weeks)|Death|3|||
131055822|NCT05349721|471837987|FG000|Part A (24 Weeks)|Disease Progression|1|||
131055823|NCT05349721|471837988|FG001|Part A (24 Weeks)|Disease Progression|1|||
131055824|NCT05349721|471837987|FG000|Part A (24 Weeks)|Screen Failure|2|||
131055825|NCT05349721|471837988|FG001|Part A (24 Weeks)|Screen Failure|0|||
131055826|NCT05349721|471837987|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
131055827|NCT05349721|471837988|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
131055828|NCT05349721|471837987|FG000|Part A (24 Weeks)|Other Than Specified|5|||
131055829|NCT05349721|471837988|FG001|Part A (24 Weeks)|Other Than Specified|1|||
131055830|NCT05349721|471837987|FG000|Part B (28 Weeks)|Adverse Event|3|||
131055831|NCT05349721|471837988|FG001|Part B (28 Weeks)|Adverse Event|0|||
131055832|NCT05349721|471837987|FG000|Part B (28 Weeks)|Death|21|||
131055833|NCT05349721|471837988|FG001|Part B (28 Weeks)|Death|11|||
131055834|NCT05349721|471837987|FG000|Part B (28 Weeks)|Disease Progression|2|||
131055835|NCT05349721|471837988|FG001|Part B (28 Weeks)|Disease Progression|1|||
131055836|NCT05349721|471837987|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
131055837|NCT05349721|471837988|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
131055838|NCT05349721|471837987|FG000|Part B (28 Weeks)|Physician Decision|1|||
131055839|NCT05349721|471837988|FG001|Part B (28 Weeks)|Physician Decision|0|||
131055840|NCT05349721|471837987|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
131055841|NCT05349721|471837988|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
131055842|NCT05349721|471837987|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
131055843|NCT05349721|471837988|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
131055844|NCT05349721|471837987|FG000|Part B (28 Weeks)|Other Than Specified|4|||
131055845|NCT05349721|471837988|FG001|Part B (28 Weeks)|Other Than Specified|2|||
131055846|NCT05349721|471837987|FG000|Part C (108 Weeks)|Death|0|||
131055847|NCT05349721|471837988|FG001|Part C (108 Weeks)|Death|1|||
131055848|NCT05349721|471837987|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
131055849|NCT05349721|471837988|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
131055850|NCT05349721|471837987|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
131055851|NCT05349721|471837988|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
131055852|NCT05349721|471837987|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
131055853|NCT05349721|471837988|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
131055854|NCT03070392|471837989|FG000|Overall Study|Not Treated|7|||
131055855|NCT03070392|471837990|FG001|Overall Study|Not Treated|0|||
131055856|NCT03070392|471837991|FG002|Overall Study|Not Treated|3|||
130722501|NCT00371397|470608303|FG011|Session 1|Withdrawal by Subject|0|||
130722502|NCT03014180|470608304|FG000|Overall Study|Protocol Violation|2|||
130722503|NCT01284621|470608305|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130722504|NCT01284621|470608306|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
131055857|NCT03070392|471837992|FG003|Overall Study|Not Treated|12|||
131055858|NCT03070392|471837989|FG000|Overall Study|Death|3|||
131055859|NCT03070392|471837990|FG001|Overall Study|Death|0|||
131055860|NCT03070392|471837991|FG002|Overall Study|Death|0|||
131055861|NCT03070392|471837992|FG003|Overall Study|Death|1|||
131055862|NCT03070392|471837989|FG000|Overall Study|Withdrawal by Subject|7|||
131055863|NCT03070392|471837990|FG001|Overall Study|Withdrawal by Subject|0|||
131055864|NCT03070392|471837991|FG002|Overall Study|Withdrawal by Subject|0|||
131055865|NCT03070392|471837992|FG003|Overall Study|Withdrawal by Subject|3|||
131055866|NCT03070392|471837989|FG000|Overall Study|Physician Decision|1|||
131055867|NCT03070392|471837990|FG001|Overall Study|Physician Decision|0|||
131055868|NCT03070392|471837991|FG002|Overall Study|Physician Decision|0|||
131055869|NCT03070392|471837992|FG003|Overall Study|Physician Decision|2|||
131055870|NCT03070392|471837989|FG000|Overall Study|Progressive Disease|154|||
131055871|NCT03070392|471837990|FG001|Overall Study|Progressive Disease|6|||
131055872|NCT03070392|471837991|FG002|Overall Study|Progressive Disease|2|||
131055873|NCT03070392|471837992|FG003|Overall Study|Progressive Disease|70|||
131055874|NCT03070392|471837989|FG000|Overall Study|Adverse Event|6|||
131055875|NCT03070392|471837990|FG001|Overall Study|Adverse Event|1|||
131055876|NCT03070392|471837991|FG002|Overall Study|Adverse Event|1|||
131055877|NCT03070392|471837992|FG003|Overall Study|Adverse Event|3|||
131055878|NCT03070392|471837989|FG000|Overall Study|Alternate anticancer treatment|1|||
131055879|NCT03070392|471837990|FG001|Overall Study|Alternate anticancer treatment|0|||
131055880|NCT03070392|471837991|FG002|Overall Study|Alternate anticancer treatment|0|||
131055881|NCT03070392|471837992|FG003|Overall Study|Alternate anticancer treatment|1|||
131055882|NCT03070392|471837989|FG000|Overall Study|Ongoing|73|||
131055883|NCT03070392|471837990|FG001|Overall Study|Ongoing|0|||
131055884|NCT03070392|471837991|FG002|Overall Study|Ongoing|0|||
131055885|NCT03070392|471837992|FG003|Overall Study|Ongoing|11|||
131055886|NCT02310581|471837994|FG000|Overall Study|Adverse Event|1|||
131055887|NCT02310581|471837995|FG001|Overall Study|Adverse Event|1|||
131055888|NCT02310581|471837996|FG002|Overall Study|Adverse Event|1|||
131055889|NCT02310581|471837997|FG003|Overall Study|Adverse Event|0|||
131055890|NCT02310581|471837994|FG000|Overall Study|Withdrawal by Subject|2|||
131055891|NCT02310581|471837995|FG001|Overall Study|Withdrawal by Subject|1|||
131055892|NCT02310581|471837996|FG002|Overall Study|Withdrawal by Subject|0|||
131055893|NCT02310581|471837997|FG003|Overall Study|Withdrawal by Subject|1|||
131055894|NCT03883828|471837998|FG000|Overall Study|Did not start radiotherapy|1|||
131055895|NCT03883828|471837999|FG001|Overall Study|Did not start radiotherapy|2|||
131055896|NCT04658784|471838002|FG000|6-month Follow-up|Lost to Follow-up|2|||
131055897|NCT04658784|471838003|FG001|6-month Follow-up|Lost to Follow-up|5|||
131055898|NCT00454194|471838005|FG000|Overall Study|Adverse Event|7|||
131055899|NCT00454194|471838006|FG001|Overall Study|Adverse Event|2|||
131055900|NCT00454194|471838005|FG000|Overall Study|Withdrawal by Subject|12|||
131055901|NCT00454194|471838006|FG001|Overall Study|Withdrawal by Subject|8|||
131055902|NCT00454194|471838005|FG000|Overall Study|Other Medical Problems|1|||
131055903|NCT00454194|471838006|FG001|Overall Study|Other Medical Problems|2|||
131055904|NCT00454194|471838005|FG000|Overall Study|Other Unspecified Reason|2|||
131055905|NCT00454194|471838006|FG001|Overall Study|Other Unspecified Reason|2|||
131055906|NCT02827201|471838007|FG000|Overall Study|Death|1|||
131055907|NCT02827201|471838008|FG001|Overall Study|Death|2|||
131055908|NCT02827201|471838007|FG000|Overall Study|Patients not treated|1|||
131055909|NCT02827201|471838008|FG001|Overall Study|Patients not treated|1|||
131055910|NCT00620854|471838009|FG000|Washout 1|Withdrawal by Subject|0|||
131055911|NCT00620854|471838010|FG001|Washout 1|Withdrawal by Subject|0|||
131055912|NCT00620854|471838011|FG002|Washout 1|Withdrawal by Subject|1|||
131055913|NCT00620854|471838012|FG003|Washout 1|Withdrawal by Subject|1|||
131055914|NCT00620854|471838013|FG004|Washout 1|Withdrawal by Subject|0|||
131055915|NCT00620854|471838014|FG005|Washout 1|Withdrawal by Subject|0|||
131055916|NCT02095145|471838015|FG000|Overall Study|Withdrawal by Subject|1|||
131055917|NCT02095145|471838016|FG001|Overall Study|Withdrawal by Subject|0|||
131055918|NCT01124045|471838021|FG000|Overall Study|Lost to Follow-up|0|||
131055919|NCT01124045|471838022|FG001|Overall Study|Lost to Follow-up|1|||
131055920|NCT01124045|471838021|FG000|Overall Study|Physician Decision|0|||
131136332|NCT01999582|472126533|FG002|Overall Study|Adverse Event|3|||
131055921|NCT01124045|471838022|FG001|Overall Study|Physician Decision|2|||
131055922|NCT03205566|471838025|FG000|Phase 1|Protocol Violation|1|||
131136333|NCT01999582|472126534|FG003|Overall Study|Adverse Event|0|||
131055923|NCT03205566|471838026|FG001|Phase 1|Protocol Violation|1|||
131055924|NCT02384382|471838030|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
131136334|NCT01999582|472126535|FG004|Overall Study|Adverse Event|1|||
131055925|NCT02384382|471838030|FG000|Overall Study|Death|1|||
131055926|NCT02384382|471838030|FG000|Overall Study|Adverse Event|1|||
131055927|NCT02384382|471838030|FG000|Overall Study|Disease progression|16|||
131136335|NCT01999582|472126536|FG005|Overall Study|Adverse Event|0|||
131055928|NCT00109031|471838037|FG000|Overall Study|Adverse Event|0|||
131055929|NCT00109031|471838038|FG001|Overall Study|Adverse Event|0|||
131055930|NCT00109031|471838039|FG002|Overall Study|Adverse Event|1|||
131055931|NCT00109031|471838040|FG003|Overall Study|Adverse Event|0|||
131055932|NCT00109031|471838037|FG000|Overall Study|Withdrawal by Subject|0|||
131055933|NCT00109031|471838038|FG001|Overall Study|Withdrawal by Subject|1|||
131055934|NCT00109031|471838039|FG002|Overall Study|Withdrawal by Subject|0|||
131136336|NCT01999582|472126531|FG000|Overall Study|Other Reasons|1|||
131136337|NCT01999582|472126532|FG001|Overall Study|Other Reasons|0|||
131136338|NCT01999582|472126533|FG002|Overall Study|Other Reasons|3|||
131136339|NCT01999582|472126534|FG003|Overall Study|Other Reasons|1|||
131136340|NCT01999582|472126535|FG004|Overall Study|Other Reasons|1|||
131136341|NCT01999582|472126536|FG005|Overall Study|Other Reasons|2|||
131136342|NCT01999582|472126531|FG000|Overall Study|Protocol Violation|1|||
131136343|NCT01999582|472126532|FG001|Overall Study|Protocol Violation|0|||
131136344|NCT01999582|472126533|FG002|Overall Study|Protocol Violation|0|||
131136345|NCT01999582|472126534|FG003|Overall Study|Protocol Violation|0|||
131136346|NCT01999582|472126535|FG004|Overall Study|Protocol Violation|0|||
131136347|NCT01999582|472126536|FG005|Overall Study|Protocol Violation|1|||
131136348|NCT01999582|472126531|FG000|Overall Study|Lack of Efficacy|1|||
131136349|NCT01999582|472126532|FG001|Overall Study|Lack of Efficacy|3|||
131136350|NCT01999582|472126533|FG002|Overall Study|Lack of Efficacy|0|||
131136351|NCT01999582|472126534|FG003|Overall Study|Lack of Efficacy|1|||
131136352|NCT01999582|472126535|FG004|Overall Study|Lack of Efficacy|0|||
131136353|NCT01999582|472126536|FG005|Overall Study|Lack of Efficacy|0|||
131136354|NCT02436876|472126543|FG000|Overall Study|Lost to Follow-up|0|||
131136355|NCT02436876|472126544|FG001|Overall Study|Lost to Follow-up|1|||
131136356|NCT02436876|472126545|FG002|Overall Study|Lost to Follow-up|1|||
131136357|NCT02436876|472126546|FG003|Overall Study|Lost to Follow-up|1|||
131136358|NCT02436876|472126543|FG000|Overall Study|Withdrawal by Subject|1|||
131136359|NCT02436876|472126544|FG001|Overall Study|Withdrawal by Subject|0|||
131136360|NCT02436876|472126545|FG002|Overall Study|Withdrawal by Subject|0|||
131136361|NCT02436876|472126546|FG003|Overall Study|Withdrawal by Subject|1|||
131136362|NCT02436876|472126543|FG000|Overall Study|Physician Decision|0|||
131136363|NCT02436876|472126544|FG001|Overall Study|Physician Decision|2|||
131136364|NCT02436876|472126545|FG002|Overall Study|Physician Decision|1|||
131136365|NCT02436876|472126546|FG003|Overall Study|Physician Decision|0|||
131136366|NCT02436876|472126543|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
131136367|NCT02436876|472126544|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
131136368|NCT02436876|472126545|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
131136369|NCT02436876|472126546|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
131136370|NCT00999908|472126547|FG000|Treatment Period 1|Subject withdrew consent|2|||
131229812|NCT01752920|472467707|FG001|Overall Study|Physician Decision|0|||
131055935|NCT00109031|471838040|FG003|Overall Study|Withdrawal by Subject|0|||
131055936|NCT00109031|471838037|FG000|Overall Study|Physician Decision|0|||
131055937|NCT00109031|471838038|FG001|Overall Study|Physician Decision|1|||
131055938|NCT00109031|471838039|FG002|Overall Study|Physician Decision|0|||
131055939|NCT00109031|471838040|FG003|Overall Study|Physician Decision|0|||
131055940|NCT00109031|471838037|FG000|Overall Study|Protocol Violation|0|||
131055941|NCT00109031|471838038|FG001|Overall Study|Protocol Violation|0|||
131055942|NCT00109031|471838039|FG002|Overall Study|Protocol Violation|1|||
131055943|NCT00109031|471838040|FG003|Overall Study|Protocol Violation|0|||
131055944|NCT01957163|471838046|FG000|Overall Study|Adverse Event|5|||
131055945|NCT01957163|471838047|FG001|Overall Study|Adverse Event|2|||
131055946|NCT01957163|471838048|FG002|Overall Study|Adverse Event|4|||
131055947|NCT01957163|471838046|FG000|Overall Study|Lack of Efficacy|5|||
131055948|NCT01957163|471838047|FG001|Overall Study|Lack of Efficacy|4|||
131055949|NCT01957163|471838048|FG002|Overall Study|Lack of Efficacy|9|||
131055950|NCT01957163|471838046|FG000|Overall Study|Protocol Violation|1|||
131055951|NCT01957163|471838047|FG001|Overall Study|Protocol Violation|2|||
131055952|NCT01957163|471838048|FG002|Overall Study|Protocol Violation|0|||
131055953|NCT01957163|471838046|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
131229813|NCT01752920|472467708|FG002|Overall Study|Physician Decision|0|||
131229814|NCT01752920|472467709|FG003|Overall Study|Physician Decision|3|||
131229815|NCT01752920|472467706|FG000|Overall Study|Radiographic Disease Progression|20|||
131229816|NCT01752920|472467707|FG001|Overall Study|Radiographic Disease Progression|7|||
131229817|NCT01752920|472467708|FG002|Overall Study|Radiographic Disease Progression|12|||
131136371|NCT00999908|472126548|FG001|Treatment Period 1|Subject withdrew consent|0|||
131055954|NCT01957163|471838047|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
131055955|NCT01957163|471838048|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
131055956|NCT01957163|471838046|FG000|Overall Study|Lost to Follow-up|0|||
131055957|NCT01957163|471838047|FG001|Overall Study|Lost to Follow-up|1|||
131136372|NCT00999908|472126549|FG002|Treatment Period 1|Subject withdrew consent|0|||
131136373|NCT00999908|472126547|FG000|Treatment Period 2|Protocol Violation|1|||
131136374|NCT00999908|472126548|FG001|Treatment Period 2|Protocol Violation|0|||
131136375|NCT00999908|472126549|FG002|Treatment Period 2|Protocol Violation|0|||
131136376|NCT03889639|472126552|FG000|Overall Study|Withdrawal by Subject|0|||
131055958|NCT01957163|471838048|FG002|Overall Study|Lost to Follow-up|0|||
131055959|NCT01957163|471838046|FG000|Overall Study|Withdrawal by Subject|4|||
131055960|NCT01957163|471838047|FG001|Overall Study|Withdrawal by Subject|2|||
131055961|NCT01957163|471838048|FG002|Overall Study|Withdrawal by Subject|4|||
131055962|NCT01065779|471838049|FG000|Overall Study|Duplicate Investigation|1|||
131055963|NCT01065779|471838049|FG000|Overall Study|Investigation Before Contract Date|37|||
131055964|NCT01065779|471838049|FG000|Overall Study|Non-enrollment Period Administration|10|||
131055965|NCT01065779|471838049|FG000|Overall Study|Not Administered With Study Drug|17|||
131055966|NCT01065779|471838049|FG000|Overall Study|Failed to Follow-up|10|||
131055967|NCT01065779|471838049|FG000|Overall Study|Inclusion Criteria Violation|7|||
131055968|NCT00641537|471838050|FG000|96-week Period|Adverse Event|0|||
131055969|NCT00641537|471838051|FG001|96-week Period|Adverse Event|1|||
131055970|NCT00641537|471838052|FG002|96-week Period|Adverse Event|3|||
131055971|NCT00641537|471838053|FG003|96-week Period|Adverse Event|0|||
131055972|NCT00641537|471838054|FG004|96-week Period|Adverse Event|2|||
131055973|NCT00641537|471838055|FG005|96-week Period|Adverse Event|0|||
131055974|NCT00641537|471838056|FG006|96-week Period|Adverse Event|0|||
131055975|NCT00641537|471838057|FG007|96-week Period|Adverse Event|0|||
131055976|NCT00641537|471838050|FG000|96-week Period|Lost to Follow-up|3|||
131055977|NCT00641537|471838051|FG001|96-week Period|Lost to Follow-up|1|||
131055978|NCT00641537|471838052|FG002|96-week Period|Lost to Follow-up|2|||
131055979|NCT00641537|471838053|FG003|96-week Period|Lost to Follow-up|2|||
131055980|NCT00641537|471838054|FG004|96-week Period|Lost to Follow-up|4|||
131055981|NCT00641537|471838055|FG005|96-week Period|Lost to Follow-up|0|||
131055982|NCT00641537|471838056|FG006|96-week Period|Lost to Follow-up|1|||
131055983|NCT00641537|471838057|FG007|96-week Period|Lost to Follow-up|0|||
131055984|NCT00641537|471838050|FG000|96-week Period|Protocol Violation|0|||
131055985|NCT00641537|471838051|FG001|96-week Period|Protocol Violation|1|||
131055986|NCT00641537|471838052|FG002|96-week Period|Protocol Violation|0|||
131055987|NCT00641537|471838053|FG003|96-week Period|Protocol Violation|1|||
131055988|NCT00641537|471838054|FG004|96-week Period|Protocol Violation|0|||
131055989|NCT00641537|471838055|FG005|96-week Period|Protocol Violation|1|||
131055990|NCT00641537|471838056|FG006|96-week Period|Protocol Violation|0|||
131055991|NCT00641537|471838057|FG007|96-week Period|Protocol Violation|0|||
131055992|NCT00641537|471838050|FG000|96-week Period|Death|2|||
131055993|NCT00641537|471838051|FG001|96-week Period|Death|0|||
131055994|NCT00641537|471838052|FG002|96-week Period|Death|1|||
130722505|NCT01284621|470608307|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130722506|NCT01284621|470608308|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130722507|NCT01284621|470608309|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
130722508|NCT01284621|470608310|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130722509|NCT02802631|470608313|FG000|Overall Study|Withdrawal by Subject|1|||
130722510|NCT02802631|470608314|FG001|Overall Study|Withdrawal by Subject|0|||
130722511|NCT02802631|470608315|FG002|Overall Study|Withdrawal by Subject|0|||
130722512|NCT02802631|470608316|FG003|Overall Study|Withdrawal by Subject|0|||
131055995|NCT00641537|471838053|FG003|96-week Period|Death|0|||
131055996|NCT00641537|471838054|FG004|96-week Period|Death|0|||
131055997|NCT00641537|471838055|FG005|96-week Period|Death|0|||
131055998|NCT00641537|471838056|FG006|96-week Period|Death|0|||
131055999|NCT00641537|471838057|FG007|96-week Period|Death|0|||
131056000|NCT00641537|471838050|FG000|96-week Period|Other|4|||
131056001|NCT00641537|471838051|FG001|96-week Period|Other|7|||
131056002|NCT00641537|471838052|FG002|96-week Period|Other|14|||
131056003|NCT00641537|471838053|FG003|96-week Period|Other|9|||
131056004|NCT00641537|471838054|FG004|96-week Period|Other|11|||
131056005|NCT00641537|471838055|FG005|96-week Period|Other|6|||
131056006|NCT00641537|471838056|FG006|96-week Period|Other|4|||
131056007|NCT00641537|471838057|FG007|96-week Period|Other|6|||
131056008|NCT00641537|471838050|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
131056009|NCT00641537|471838051|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
131056010|NCT00641537|471838052|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
131056011|NCT00641537|471838053|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
131056012|NCT00641537|471838054|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
131056013|NCT00641537|471838055|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
131056014|NCT00641537|471838056|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
131056015|NCT00641537|471838057|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
131056016|NCT00641537|471838050|FG000|24-Week Supplemental Follow-up Period|Other|0|||
131056017|NCT00641537|471838051|FG001|24-Week Supplemental Follow-up Period|Other|2|||
131056018|NCT00641537|471838052|FG002|24-Week Supplemental Follow-up Period|Other|2|||
131056019|NCT00641537|471838053|FG003|24-Week Supplemental Follow-up Period|Other|1|||
131056020|NCT00641537|471838054|FG004|24-Week Supplemental Follow-up Period|Other|3|||
131056021|NCT00641537|471838055|FG005|24-Week Supplemental Follow-up Period|Other|0|||
131056022|NCT00641537|471838056|FG006|24-Week Supplemental Follow-up Period|Other|1|||
131056023|NCT00641537|471838057|FG007|24-Week Supplemental Follow-up Period|Other|1|||
131056024|NCT01801007|471838058|FG000|Overall Study|Adverse Event|2|||
131056025|NCT01801007|471838058|FG000|Overall Study|Lost to Follow-up|4|||
131056026|NCT01801007|471838058|FG000|Overall Study|Withdrawal by Subject|5|||
131136377|NCT03889639|472126553|FG001|Overall Study|Withdrawal by Subject|0|||
131136378|NCT03889639|472126554|FG002|Overall Study|Withdrawal by Subject|0|||
131136379|NCT03889639|472126555|FG003|Overall Study|Withdrawal by Subject|0|||
131136380|NCT03889639|472126556|FG004|Overall Study|Withdrawal by Subject|0|||
131136381|NCT03889639|472126557|FG005|Overall Study|Withdrawal by Subject|0|||
131136382|NCT03889639|472126558|FG006|Overall Study|Withdrawal by Subject|0|||
131136383|NCT03889639|472126559|FG007|Overall Study|Withdrawal by Subject|1|||
131136384|NCT01703858|472126561|FG000|Overall Study|Withdrawal by Subject|0|||
131136385|NCT01703858|472126562|FG001|Overall Study|Withdrawal by Subject|1|||
131136386|NCT01703858|472126563|FG002|Overall Study|Withdrawal by Subject|0|||
131136387|NCT00927095|472126565|FG000|Overall Study|Adverse Event|3|||
131136388|NCT00927095|472126566|FG001|Overall Study|Adverse Event|1|||
131229818|NCT01752920|472467709|FG003|Overall Study|Radiographic Disease Progression|29|||
131229819|NCT01752920|472467706|FG000|Overall Study|Study Terminated by Sponsor|0|||
131056027|NCT00665392|471838059|FG000|Overall Study|not treated|1|||
131056028|NCT01321073|471838065|FG000|Overall Study|Did not attempt implant|4|||
131056029|NCT01321073|471838065|FG000|Overall Study|Death|3|||
131056030|NCT05352230|471838074|FG000|First Intervention (3 Months)|study terminated|2|||
131056031|NCT05352230|471838075|FG001|First Intervention (3 Months)|study terminated|2|||
131056032|NCT03697603|471838076|FG000|Overall Study|Adverse Event|3|||
131056033|NCT03697603|471838077|FG001|Overall Study|Adverse Event|18|||
131056034|NCT03697603|471838078|FG002|Overall Study|Adverse Event|3|||
131056035|NCT03697603|471838076|FG000|Overall Study|Physician Decision|1|||
131056036|NCT03697603|471838077|FG001|Overall Study|Physician Decision|0|||
131056037|NCT03697603|471838078|FG002|Overall Study|Physician Decision|2|||
131056038|NCT03697603|471838076|FG000|Overall Study|Protocol Violation|3|||
131056039|NCT03697603|471838077|FG001|Overall Study|Protocol Violation|8|||
131056040|NCT03697603|471838078|FG002|Overall Study|Protocol Violation|5|||
131056041|NCT03697603|471838076|FG000|Overall Study|Withdrawal by Subject|5|||
131056042|NCT03697603|471838077|FG001|Overall Study|Withdrawal by Subject|1|||
131056043|NCT03697603|471838078|FG002|Overall Study|Withdrawal by Subject|1|||
131056044|NCT03697603|471838076|FG000|Overall Study|Protocol Violation|0|||
131056045|NCT03697603|471838077|FG001|Overall Study|Protocol Violation|0|||
131056046|NCT03697603|471838078|FG002|Overall Study|Protocol Violation|1|||
131056047|NCT02686658|471838079|FG000|Overall Study|Adverse Event|0|||
131056048|NCT02686658|471838080|FG001|Overall Study|Adverse Event|0|||
131056049|NCT02686658|471838081|FG002|Overall Study|Adverse Event|1|||
131056050|NCT02686658|471838082|FG003|Overall Study|Adverse Event|1|||
131056051|NCT02686658|471838083|FG004|Overall Study|Adverse Event|2|||
131056052|NCT02686658|471838084|FG005|Overall Study|Adverse Event|1|||
131056053|NCT02686658|471838079|FG000|Overall Study|Investigator decision|0|||
131056054|NCT02686658|471838080|FG001|Overall Study|Investigator decision|0|||
131056055|NCT02686658|471838081|FG002|Overall Study|Investigator decision|0|||
131056056|NCT02686658|471838082|FG003|Overall Study|Investigator decision|1|||
131056057|NCT02686658|471838083|FG004|Overall Study|Investigator decision|2|||
131056058|NCT02686658|471838084|FG005|Overall Study|Investigator decision|1|||
131056059|NCT02686658|471838079|FG000|Overall Study|Sponsor decision|1|||
131056060|NCT02686658|471838080|FG001|Overall Study|Sponsor decision|2|||
131056061|NCT02686658|471838081|FG002|Overall Study|Sponsor decision|1|||
131056062|NCT02686658|471838082|FG003|Overall Study|Sponsor decision|5|||
131056063|NCT02686658|471838083|FG004|Overall Study|Sponsor decision|13|||
131056064|NCT02686658|471838084|FG005|Overall Study|Sponsor decision|2|||
131056065|NCT02686658|471838079|FG000|Overall Study|Lost to Follow-up|0|||
131056066|NCT02686658|471838080|FG001|Overall Study|Lost to Follow-up|0|||
131056067|NCT02686658|471838081|FG002|Overall Study|Lost to Follow-up|2|||
131056068|NCT02686658|471838082|FG003|Overall Study|Lost to Follow-up|0|||
131056069|NCT02686658|471838083|FG004|Overall Study|Lost to Follow-up|0|||
131056070|NCT02686658|471838084|FG005|Overall Study|Lost to Follow-up|1|||
131056071|NCT02686658|471838079|FG000|Overall Study|Death|1|||
131056072|NCT02686658|471838080|FG001|Overall Study|Death|0|||
131056073|NCT02686658|471838081|FG002|Overall Study|Death|0|||
131056074|NCT02686658|471838082|FG003|Overall Study|Death|1|||
131056075|NCT02686658|471838083|FG004|Overall Study|Death|1|||
131136389|NCT00927095|472126567|FG002|Overall Study|Adverse Event|0|||
131136390|NCT00927095|472126565|FG000|Overall Study|Withdrawal by Subject|2|||
131229820|NCT01752920|472467707|FG001|Overall Study|Study Terminated by Sponsor|0|||
131229821|NCT01752920|472467708|FG002|Overall Study|Study Terminated by Sponsor|0|||
131056076|NCT02686658|471838084|FG005|Overall Study|Death|1|||
131056077|NCT02686658|471838079|FG000|Overall Study|Withdrawal by Subject|2|||
131056078|NCT02686658|471838080|FG001|Overall Study|Withdrawal by Subject|5|||
131056079|NCT02686658|471838081|FG002|Overall Study|Withdrawal by Subject|4|||
131229822|NCT01752920|472467709|FG003|Overall Study|Study Terminated by Sponsor|1|||
131056080|NCT02686658|471838082|FG003|Overall Study|Withdrawal by Subject|4|||
131136391|NCT00927095|472126566|FG001|Overall Study|Withdrawal by Subject|1|||
131056081|NCT02686658|471838083|FG004|Overall Study|Withdrawal by Subject|17|||
131056082|NCT02686658|471838084|FG005|Overall Study|Withdrawal by Subject|8|||
131056083|NCT02686658|471838079|FG000|Overall Study|Placed in hospice care|0|||
131056084|NCT02686658|471838080|FG001|Overall Study|Placed in hospice care|0|||
130722513|NCT02802631|470608317|FG004|Overall Study|Withdrawal by Subject|0|||
130722514|NCT02802631|470608318|FG005|Overall Study|Withdrawal by Subject|0|||
130722515|NCT02802631|470608319|FG006|Overall Study|Withdrawal by Subject|0|||
130722516|NCT02802631|470608320|FG007|Overall Study|Withdrawal by Subject|0|||
130722517|NCT02802631|470608313|FG000|Overall Study|Physician Decision|1|||
130722518|NCT02802631|470608314|FG001|Overall Study|Physician Decision|0|||
130722519|NCT02802631|470608315|FG002|Overall Study|Physician Decision|0|||
130722520|NCT02802631|470608316|FG003|Overall Study|Physician Decision|0|||
130722521|NCT02802631|470608317|FG004|Overall Study|Physician Decision|0|||
130722522|NCT02802631|470608318|FG005|Overall Study|Physician Decision|0|||
130722523|NCT02802631|470608319|FG006|Overall Study|Physician Decision|1|||
130722524|NCT02802631|470608320|FG007|Overall Study|Physician Decision|0|||
130722525|NCT02802631|470608313|FG000|Overall Study|Adverse Event|0|||
130722526|NCT02802631|470608314|FG001|Overall Study|Adverse Event|2|||
130722527|NCT02802631|470608315|FG002|Overall Study|Adverse Event|0|||
130722528|NCT02802631|470608316|FG003|Overall Study|Adverse Event|1|||
131056085|NCT02686658|471838081|FG002|Overall Study|Placed in hospice care|1|||
131056086|NCT02686658|471838082|FG003|Overall Study|Placed in hospice care|0|||
131056087|NCT02686658|471838083|FG004|Overall Study|Placed in hospice care|0|||
131056088|NCT02686658|471838084|FG005|Overall Study|Placed in hospice care|0|||
131056089|NCT02686658|471838079|FG000|Overall Study|Participant non-compliance|0|||
131056090|NCT02686658|471838080|FG001|Overall Study|Participant non-compliance|0|||
131056091|NCT02686658|471838081|FG002|Overall Study|Participant non-compliance|0|||
131056092|NCT02686658|471838082|FG003|Overall Study|Participant non-compliance|0|||
131056093|NCT02686658|471838083|FG004|Overall Study|Participant non-compliance|0|||
131056094|NCT02686658|471838084|FG005|Overall Study|Participant non-compliance|1|||
131056095|NCT02686658|471838079|FG000|Overall Study|Concern over coronavirus disease care|0|||
131056096|NCT02686658|471838080|FG001|Overall Study|Concern over coronavirus disease care|0|||
131056097|NCT02686658|471838081|FG002|Overall Study|Concern over coronavirus disease care|0|||
131056098|NCT02686658|471838082|FG003|Overall Study|Concern over coronavirus disease care|0|||
131056099|NCT02686658|471838083|FG004|Overall Study|Concern over coronavirus disease care|2|||
131056100|NCT02686658|471838084|FG005|Overall Study|Concern over coronavirus disease care|1|||
131056101|NCT02309294|471838087|FG000|Overall Study|Withdrawal by Subject|2|||
131056102|NCT03520036|471838088|FG000|Overall Study|Adverse Event|1|||
131056103|NCT03520036|471838089|FG001|Overall Study|Adverse Event|2|||
131056104|NCT03520036|471838090|FG002|Overall Study|Adverse Event|0|||
131056105|NCT03520036|471838088|FG000|Overall Study|Protocol Violation|1|||
131056106|NCT03520036|471838089|FG001|Overall Study|Protocol Violation|0|||
131056107|NCT03520036|471838090|FG002|Overall Study|Protocol Violation|0|||
131056108|NCT03520036|471838088|FG000|Overall Study|Withdrawal by Subject|0|||
131056109|NCT03520036|471838089|FG001|Overall Study|Withdrawal by Subject|1|||
131056110|NCT03520036|471838090|FG002|Overall Study|Withdrawal by Subject|4|||
131056111|NCT03520036|471838088|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
131056112|NCT03520036|471838089|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
131056113|NCT03520036|471838090|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
131056114|NCT00467272|471838093|FG000|Overall Study|Pneumonia|2|||
131056115|NCT00467272|471838093|FG000|Overall Study|Thrombophlebitis|1|||
131056116|NCT00570505|471838094|FG000|Overall Study|Adverse Event|7|||
131056117|NCT00570505|471838094|FG000|Overall Study|Withdrawal by Subject|7|||
131056118|NCT00570505|471838094|FG000|Overall Study|Lost to Follow-up|23|||
131056119|NCT00570505|471838094|FG000|Overall Study|Other loss to follow-up|4|||
131056120|NCT05426109|471838095|FG000|Overall Study|Withdrawal by Subject|0|||
131056121|NCT05426109|471838096|FG001|Overall Study|Withdrawal by Subject|1|||
131056122|NCT05212285|471838097|FG000|Overall Study|Lack of Efficacy|12|||
131056123|NCT05212285|471838098|FG001|Overall Study|Lack of Efficacy|8|||
131056124|NCT05212285|471838097|FG000|Overall Study|Withdrawal by Subject|8|||
131056125|NCT05212285|471838098|FG001|Overall Study|Withdrawal by Subject|1|||
131056126|NCT05212285|471838097|FG000|Overall Study|Lost to Follow-up|13|||
131056127|NCT05212285|471838098|FG001|Overall Study|Lost to Follow-up|1|||
131056128|NCT05212285|471838097|FG000|Overall Study|miss data|21|||
131056129|NCT05212285|471838098|FG001|Overall Study|miss data|2|||
131056130|NCT02222493|471838099|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
131056131|NCT02222493|471838100|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
131056132|NCT02222493|471838099|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
131056133|NCT02222493|471838100|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
131056134|NCT02222493|471838099|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
131056135|NCT02222493|471838100|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
131056136|NCT02222493|471838099|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
131056137|NCT02222493|471838100|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
131056138|NCT02222493|471838099|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
131056139|NCT02222493|471838100|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
131056140|NCT02222493|471838099|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
130722529|NCT02802631|470608317|FG004|Overall Study|Adverse Event|6|||
131056141|NCT02222493|471838100|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
131056142|NCT02222493|471838099|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
131056143|NCT02222493|471838100|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
131056144|NCT02222493|471838099|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
131056145|NCT02222493|471838100|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
131056146|NCT02222493|471838099|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
131056147|NCT02222493|471838100|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
131056148|NCT02222493|471838099|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
131056149|NCT02222493|471838100|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
131056150|NCT02222493|471838099|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
131056151|NCT02222493|471838100|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
131056152|NCT02222493|471838099|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
131056153|NCT02222493|471838100|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
131056154|NCT02222493|471838099|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
131056155|NCT02222493|471838100|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
131056156|NCT02222493|471838099|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
131056157|NCT02222493|471838100|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
131056158|NCT02222493|471838099|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
131056159|NCT02222493|471838100|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
131056160|NCT02222493|471838099|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
131056161|NCT02222493|471838100|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
131056162|NCT02222493|471838099|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
131056163|NCT02222493|471838100|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
131056164|NCT02222493|471838099|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
131056165|NCT02222493|471838100|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
131056166|NCT02222493|471838099|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
131056167|NCT02222493|471838100|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
131056168|NCT02222493|471838099|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
131056169|NCT02222493|471838100|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
131056170|NCT02222493|471838099|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
131056171|NCT02222493|471838100|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
131056172|NCT02222493|471838099|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
131056173|NCT02222493|471838100|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
131056174|NCT03924869|471838104|FG000|Overall Study|Death|66|||
131056175|NCT03924869|471838105|FG001|Overall Study|Death|53|||
131056176|NCT03924869|471838104|FG000|Overall Study|Lost to Follow-up|2|||
131056177|NCT03924869|471838105|FG001|Overall Study|Lost to Follow-up|0|||
131056178|NCT03924869|471838104|FG000|Overall Study|Physician Decision|0|||
131056179|NCT03924869|471838105|FG001|Overall Study|Physician Decision|3|||
131056180|NCT03924869|471838104|FG000|Overall Study|Withdrawal by Subject|5|||
131056181|NCT03924869|471838105|FG001|Overall Study|Withdrawal by Subject|1|||
131056182|NCT03924869|471838104|FG000|Overall Study|Participants Ongoing|154|||
131056183|NCT03924869|471838105|FG001|Overall Study|Participants Ongoing|164|||
131056184|NCT02542943|471838106|FG000|Overall Study|Lost to Follow-up|1|||
131056185|NCT02542943|471838107|FG001|Overall Study|Lost to Follow-up|0|||
131056186|NCT02542943|471838108|FG002|Overall Study|Lost to Follow-up|0|||
131056187|NCT02542943|471838106|FG000|Overall Study|Withdrawal by Subject|0|||
131056188|NCT02542943|471838107|FG001|Overall Study|Withdrawal by Subject|1|||
131056189|NCT02542943|471838108|FG002|Overall Study|Withdrawal by Subject|0|||
131056190|NCT05865392|471838117|FG000|Overall Study|Withdrawal by Subject|4|||
131056191|NCT05865392|471838118|FG001|Overall Study|Withdrawal by Subject|0|||
131056192|NCT05865392|471838117|FG000|Overall Study|Didn't meet inclusion criteria|4|||
131056193|NCT05865392|471838118|FG001|Overall Study|Didn't meet inclusion criteria|0|||
131056194|NCT02434328|471838122|FG000|Overall Study|Adverse Event|9|||
131056195|NCT02434328|471838123|FG001|Overall Study|Adverse Event|4|||
131056196|NCT02434328|471838122|FG000|Overall Study|Lack of Efficacy|0|||
131056197|NCT02434328|471838123|FG001|Overall Study|Lack of Efficacy|2|||
131056198|NCT02434328|471838122|FG000|Overall Study|Physician Decision|0|||
131056199|NCT02434328|471838123|FG001|Overall Study|Physician Decision|1|||
131056200|NCT02434328|471838122|FG000|Overall Study|Withdrawal by Subject|12|||
131056201|NCT02434328|471838123|FG001|Overall Study|Withdrawal by Subject|21|||
131056202|NCT02434328|471838122|FG000|Overall Study|Death|4|||
131056203|NCT02434328|471838123|FG001|Overall Study|Death|7|||
131056204|NCT02434328|471838122|FG000|Overall Study|Lost to Follow-up|1|||
130779359|NCT02326272|470819491|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
131056205|NCT02434328|471838123|FG001|Overall Study|Lost to Follow-up|6|||
131056206|NCT02434328|471838122|FG000|Overall Study|Other|4|||
131056207|NCT02434328|471838123|FG001|Overall Study|Other|1|||
131056208|NCT02637063|471839246|FG000|Overall Study|Lost to Follow-up|3|||
131056209|NCT02637063|471839247|FG001|Overall Study|Lost to Follow-up|2|||
130779360|NCT02326272|470819492|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
130779361|NCT02326272|470819493|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131056210|NCT02637063|471839248|FG002|Overall Study|Lost to Follow-up|3|||
131056211|NCT02637063|471839246|FG000|Overall Study|Withdrawal by Subject|2|||
131056212|NCT02637063|471839247|FG001|Overall Study|Withdrawal by Subject|2|||
131056213|NCT02637063|471839248|FG002|Overall Study|Withdrawal by Subject|3|||
131056214|NCT02634307|471839253|FG000|Overall Study|Adverse Event|50|||
131056215|NCT02634307|471839254|FG001|Overall Study|Adverse Event|24|||
131056216|NCT02634307|471839255|FG002|Overall Study|Adverse Event|14|||
131056217|NCT02634307|471839253|FG000|Overall Study|Lost to Follow-up|21|||
131056218|NCT02634307|471839254|FG001|Overall Study|Lost to Follow-up|5|||
131056219|NCT02634307|471839255|FG002|Overall Study|Lost to Follow-up|6|||
131056220|NCT02634307|471839253|FG000|Overall Study|Pregnancy|5|||
131056221|NCT02634307|471839254|FG001|Overall Study|Pregnancy|1|||
131056222|NCT02634307|471839255|FG002|Overall Study|Pregnancy|3|||
131056223|NCT02634307|471839253|FG000|Overall Study|Withdrawal by Subject|38|||
131056224|NCT02634307|471839254|FG001|Overall Study|Withdrawal by Subject|24|||
131056225|NCT02634307|471839255|FG002|Overall Study|Withdrawal by Subject|18|||
131056226|NCT02634307|471839253|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131056227|NCT02634307|471839254|FG001|Overall Study|Non-Compliance with Study Drug|2|||
131056228|NCT02634307|471839255|FG002|Overall Study|Non-Compliance with Study Drug|2|||
131056229|NCT02634307|471839253|FG000|Overall Study|Lack of Efficacy|1|||
131056230|NCT02634307|471839254|FG001|Overall Study|Lack of Efficacy|5|||
131056231|NCT02634307|471839255|FG002|Overall Study|Lack of Efficacy|3|||
131056232|NCT02634307|471839253|FG000|Overall Study|Physician Decision|7|||
131056233|NCT02634307|471839254|FG001|Overall Study|Physician Decision|5|||
131056234|NCT02634307|471839255|FG002|Overall Study|Physician Decision|5|||
131056235|NCT02634307|471839253|FG000|Overall Study|Reason not Specified|3|||
131056236|NCT02634307|471839254|FG001|Overall Study|Reason not Specified|5|||
131056237|NCT02634307|471839255|FG002|Overall Study|Reason not Specified|10|||
131056238|NCT02698475|471839256|FG000|Main Study Period|Lack of Efficacy|1|||
131056239|NCT02698475|471839256|FG000|Main Study Period|Protocol Violation|2|||
131056240|NCT02698475|471839256|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
131056241|NCT02698475|471839256|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
131056242|NCT02698475|471839256|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
131056243|NCT02698475|471839256|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
131056244|NCT02698475|471839256|FG000|Long-Term Extension Period|Other|1|||
131056245|NCT02132949|471839257|FG000|Overall Study|Death|7|||
131056246|NCT02132949|471839258|FG001|Overall Study|Death|13|||
131056247|NCT02132949|471839257|FG000|Overall Study|Lost to Follow-up|14|||
131056248|NCT02132949|471839258|FG001|Overall Study|Lost to Follow-up|4|||
131056249|NCT02132949|471839257|FG000|Overall Study|Withdrawal by Subject|6|||
131056250|NCT02132949|471839258|FG001|Overall Study|Withdrawal by Subject|5|||
131056251|NCT02132949|471839257|FG000|Overall Study|Noncompliance|5|||
131056252|NCT02132949|471839258|FG001|Overall Study|Noncompliance|1|||
131056253|NCT02132949|471839257|FG000|Overall Study|Physician Decision|3|||
131056254|NCT02132949|471839258|FG001|Overall Study|Physician Decision|1|||
131056255|NCT02132949|471839257|FG000|Overall Study|Disease Progression|3|||
131056256|NCT02132949|471839258|FG001|Overall Study|Disease Progression|0|||
131056257|NCT02132949|471839257|FG000|Overall Study|Adverse Event|2|||
131056258|NCT02132949|471839258|FG001|Overall Study|Adverse Event|1|||
131056259|NCT02132949|471839257|FG000|Overall Study|Withdrew Prior to Treatment|1|||
131056260|NCT02132949|471839258|FG001|Overall Study|Withdrew Prior to Treatment|2|||
131056261|NCT02132949|471839257|FG000|Overall Study|Reason Unspecified|0|||
131056262|NCT02132949|471839258|FG001|Overall Study|Reason Unspecified|1|||
131056263|NCT01673594|471839264|FG000|Overall Study|Adverse Event|3|||
131056264|NCT01673594|471839265|FG001|Overall Study|Adverse Event|1|||
131056265|NCT01673594|471839264|FG000|Overall Study|Lost to Follow-up|1|||
131056266|NCT01673594|471839265|FG001|Overall Study|Lost to Follow-up|0|||
131056267|NCT01673594|471839264|FG000|Overall Study|Physician Decision|2|||
131056268|NCT01673594|471839265|FG001|Overall Study|Physician Decision|4|||
131056269|NCT01673594|471839264|FG000|Overall Study|Withdrawal by Subject|0|||
131056270|NCT01673594|471839265|FG001|Overall Study|Withdrawal by Subject|1|||
131056271|NCT03392194|471839268|FG000|Overall Study|Withdrawal by Subject|1|||
131056272|NCT03392194|471839269|FG001|Overall Study|Withdrawal by Subject|2|||
131056273|NCT03392194|471839268|FG000|Overall Study|Conflicts with personal schedule|1|||
131056274|NCT03392194|471839269|FG001|Overall Study|Conflicts with personal schedule|0|||
131056275|NCT03865732|471839270|FG000|Overall Study|Adverse Event|0|||
131056276|NCT03865732|471839271|FG001|Overall Study|Adverse Event|1|||
131056277|NCT03345979|471839276|FG000|Overall Study|Withdrawal by Subject|20|||
131056278|NCT03345979|471839277|FG001|Overall Study|Withdrawal by Subject|31|||
131056279|NCT03345979|471839276|FG000|Overall Study|Adverse Event|10|||
131056280|NCT03345979|471839277|FG001|Overall Study|Adverse Event|11|||
131056281|NCT03345979|471839276|FG000|Overall Study|Lost to Follow-up|8|||
131056282|NCT03345979|471839277|FG001|Overall Study|Lost to Follow-up|9|||
131056283|NCT03345979|471839276|FG000|Overall Study|Lack of Efficacy|4|||
131056284|NCT03345979|471839277|FG001|Overall Study|Lack of Efficacy|2|||
131056285|NCT03345979|471839276|FG000|Overall Study|Protocol Violation|1|||
131056286|NCT03345979|471839277|FG001|Overall Study|Protocol Violation|3|||
131056287|NCT03345979|471839276|FG000|Overall Study|Physician Decision|0|||
131056288|NCT03345979|471839277|FG001|Overall Study|Physician Decision|2|||
131056289|NCT00487240|471839278|FG000|Overall Study|Withdrawal by Subject|12|||
131056290|NCT00487240|471839279|FG001|Overall Study|Withdrawal by Subject|6|||
131056291|NCT00487240|471839278|FG000|Overall Study|Lost to Follow-up|7|||
131056292|NCT00487240|471839279|FG001|Overall Study|Lost to Follow-up|6|||
131056293|NCT00487240|471839278|FG000|Overall Study|Adverse Event|0|||
131056294|NCT00487240|471839279|FG001|Overall Study|Adverse Event|4|||
131056295|NCT00487240|471839278|FG000|Overall Study|Protocol Violation|5|||
131056296|NCT00487240|471839279|FG001|Overall Study|Protocol Violation|5|||
131056297|NCT00487240|471839278|FG000|Overall Study|Entry Criteria Not Met|3|||
131056298|NCT00487240|471839279|FG001|Overall Study|Entry Criteria Not Met|4|||
131056299|NCT00487240|471839278|FG000|Overall Study|Sponsor Decision|2|||
131056300|NCT00487240|471839279|FG001|Overall Study|Sponsor Decision|1|||
131056301|NCT00487240|471839278|FG000|Overall Study|Physician Decision|2|||
131056302|NCT00487240|471839279|FG001|Overall Study|Physician Decision|0|||
131056303|NCT00999596|471839282|FG000|Overall Study|Statistical population not required|101|||
131056304|NCT01698918|471839283|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
131056305|NCT01698918|471839283|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
131056306|NCT01698918|471839283|FG000|First Line Treatment (Core+Extension)|Death|2|||
131056307|NCT01698918|471839283|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
131056308|NCT01698918|471839283|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
131056309|NCT01698918|471839283|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
131056310|NCT01698918|471839283|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
131056311|NCT01698918|471839283|FG000|Second Line Treatment (Core+Extension)|Death|1|||
131056312|NCT01698918|471839283|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
131056313|NCT01698918|471839283|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
131056314|NCT02630186|471839284|FG000|Overall Study|Withdrawal by Subject|1|||
131056315|NCT01019135|471839285|FG000|Overall Study|Did not receive allocated intervention|12|||
131056316|NCT01019135|471839286|FG001|Overall Study|Did not receive allocated intervention|6|||
131056317|NCT01019135|471839287|FG002|Overall Study|Did not receive allocated intervention|25|||
131056318|NCT01019135|471839285|FG000|Overall Study|Did not attend CR|8|||
131056319|NCT01019135|471839286|FG001|Overall Study|Did not attend CR|13|||
131056320|NCT01019135|471839287|FG002|Overall Study|Did not attend CR|6|||
131056321|NCT00439218|471839290|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
131056322|NCT03176407|471839291|FG000|Overall Study|Protocol Violation|1|||
131056323|NCT03176407|471839291|FG000|Overall Study|human failure|1|||
131056324|NCT03176407|471839291|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
131056325|NCT01428583|471839293|FG000|Overall Study|Adverse Event|75|||
131056326|NCT01428583|471839293|FG000|Overall Study|Withdrawal by Subject|51|||
131056327|NCT01428583|471839293|FG000|Overall Study|Lack of Efficacy|37|||
131056328|NCT01428583|471839293|FG000|Overall Study|Lost to Follow-up|17|||
131056329|NCT01428583|471839293|FG000|Overall Study|Death|1|||
131056330|NCT01428583|471839293|FG000|Overall Study|Pregnancy|1|||
131056331|NCT01428583|471839293|FG000|Overall Study|Protocol Violation|1|||
131056332|NCT01428583|471839293|FG000|Overall Study|Physician Decision|12|||
131056333|NCT01428583|471839293|FG000|Overall Study|Non-compliant|25|||
131056334|NCT01428583|471839293|FG000|Overall Study|Confirmed positive urine drug test|8|||
131136392|NCT00927095|472126567|FG002|Overall Study|Withdrawal by Subject|1|||
131136393|NCT00927095|472126565|FG000|Overall Study|Physician Decision|1|||
131136394|NCT00927095|472126566|FG001|Overall Study|Physician Decision|2|||
131136395|NCT00927095|472126567|FG002|Overall Study|Physician Decision|1|||
131136396|NCT02556255|472126568|FG000|Overall Study|Lost to Follow-up|4|||
131136397|NCT00993031|472126572|FG000|Overall Study|Death|0|||
131136398|NCT00993031|472126573|FG001|Overall Study|Death|1|||
131136399|NCT00993031|472126572|FG000|Overall Study|Physician Decision|0|||
131136400|NCT00993031|472126573|FG001|Overall Study|Physician Decision|2|||
131136401|NCT00993031|472126572|FG000|Overall Study|Withdrawal by Subject|3|||
131136402|NCT00993031|472126573|FG001|Overall Study|Withdrawal by Subject|3|||
131056335|NCT01428583|471839293|FG000|Overall Study|Sponsor's request|3|||
131056336|NCT01428583|471839293|FG000|Overall Study|Other|6|||
131056337|NCT00670488|471839294|FG000|Overall Study|Adverse Event|0|||
131056338|NCT00670488|471839295|FG001|Overall Study|Adverse Event|7|||
131056339|NCT00670488|471839296|FG002|Overall Study|Adverse Event|0|||
131056340|NCT00670488|471839297|FG003|Overall Study|Adverse Event|3|||
131056341|NCT00670488|471839298|FG004|Overall Study|Adverse Event|1|||
131056342|NCT00670488|471839299|FG005|Overall Study|Adverse Event|1|||
131056343|NCT00670488|471839300|FG006|Overall Study|Adverse Event|5|||
131056344|NCT00670488|471839301|FG007|Overall Study|Adverse Event|1|||
131056345|NCT00670488|471839302|FG008|Overall Study|Adverse Event|0|||
131056346|NCT00670488|471839303|FG009|Overall Study|Adverse Event|1|||
131056347|NCT00670488|471839294|FG000|Overall Study|Physician Decision|1|||
131056348|NCT00670488|471839295|FG001|Overall Study|Physician Decision|9|||
131136403|NCT00993031|472126572|FG000|Overall Study|Lost to Follow-up|19|||
131136404|NCT00993031|472126573|FG001|Overall Study|Lost to Follow-up|13|||
130779362|NCT02326272|470819494|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131056349|NCT00670488|471839296|FG002|Overall Study|Physician Decision|0|||
131056350|NCT00670488|471839297|FG003|Overall Study|Physician Decision|1|||
131056351|NCT00670488|471839298|FG004|Overall Study|Physician Decision|0|||
131056352|NCT00670488|471839299|FG005|Overall Study|Physician Decision|0|||
131056353|NCT00670488|471839300|FG006|Overall Study|Physician Decision|0|||
131056354|NCT00670488|471839301|FG007|Overall Study|Physician Decision|0|||
131056355|NCT00670488|471839302|FG008|Overall Study|Physician Decision|0|||
131056356|NCT00670488|471839303|FG009|Overall Study|Physician Decision|0|||
131056357|NCT00670488|471839294|FG000|Overall Study|Progressive Disease|2|||
131056358|NCT00670488|471839295|FG001|Overall Study|Progressive Disease|41|||
131056359|NCT00670488|471839296|FG002|Overall Study|Progressive Disease|3|||
131056360|NCT00670488|471839297|FG003|Overall Study|Progressive Disease|2|||
131056361|NCT00670488|471839298|FG004|Overall Study|Progressive Disease|2|||
131056362|NCT00670488|471839299|FG005|Overall Study|Progressive Disease|4|||
131056363|NCT00670488|471839300|FG006|Overall Study|Progressive Disease|11|||
131056364|NCT00670488|471839301|FG007|Overall Study|Progressive Disease|2|||
131056365|NCT00670488|471839302|FG008|Overall Study|Progressive Disease|2|||
131056366|NCT00670488|471839303|FG009|Overall Study|Progressive Disease|1|||
131056367|NCT00670488|471839294|FG000|Overall Study|Withdrawal by Subject|0|||
131056368|NCT00670488|471839295|FG001|Overall Study|Withdrawal by Subject|1|||
131056369|NCT00670488|471839296|FG002|Overall Study|Withdrawal by Subject|0|||
131056370|NCT00670488|471839297|FG003|Overall Study|Withdrawal by Subject|1|||
131056371|NCT00670488|471839298|FG004|Overall Study|Withdrawal by Subject|0|||
131056372|NCT00670488|471839299|FG005|Overall Study|Withdrawal by Subject|0|||
131056373|NCT00670488|471839300|FG006|Overall Study|Withdrawal by Subject|1|||
131056374|NCT00670488|471839301|FG007|Overall Study|Withdrawal by Subject|0|||
131056375|NCT00670488|471839302|FG008|Overall Study|Withdrawal by Subject|1|||
131056376|NCT00670488|471839303|FG009|Overall Study|Withdrawal by Subject|0|||
131056377|NCT00836498|471839307|FG000|Overall Study|Adverse Event|1|||
131056378|NCT00836498|471839308|FG001|Overall Study|Adverse Event|0|||
131056379|NCT00836498|471839307|FG000|Overall Study|Lost to Follow-up|1|||
131056380|NCT00836498|471839308|FG001|Overall Study|Lost to Follow-up|0|||
131056381|NCT00836498|471839307|FG000|Overall Study|Withdrawal by Subject|2|||
131056382|NCT00836498|471839308|FG001|Overall Study|Withdrawal by Subject|1|||
131056383|NCT03418545|471839309|FG000|Overall Study|Withdrawal by Participant|2|||
131056384|NCT03418545|471839310|FG001|Overall Study|Withdrawal by Participant|4|||
131056385|NCT03418545|471839309|FG000|Overall Study|Lost to Follow-up|3|||
131056386|NCT03418545|471839310|FG001|Overall Study|Lost to Follow-up|5|||
131056387|NCT03418545|471839309|FG000|Overall Study|Reason Not Specified|0|||
131056388|NCT03418545|471839310|FG001|Overall Study|Reason Not Specified|1|||
131056389|NCT03418545|471839309|FG000|Overall Study|Missing Completion Status|0|||
131056390|NCT03418545|471839310|FG001|Overall Study|Missing Completion Status|1|||
131056391|NCT01074242|471839315|FG000|Overall Study|Case report before date of contract|40|||
131056392|NCT01074242|471839315|FG000|Overall Study|Lost to Follow-up|1|||
131056393|NCT01074242|471839315|FG000|Overall Study|Case report unclear|6|||
131056394|NCT01074242|471839315|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
131056395|NCT01074242|471839315|FG000|Overall Study|Duplicate Case Report Form|5|||
131056396|NCT03567616|471839316|FG000|Overall Study|Disease progression|4|||
131056397|NCT03567616|471839316|FG000|Overall Study|Withdrawal by Subject|1|||
131056398|NCT03567616|471839316|FG000|Overall Study|Physician Decision|1|||
131056399|NCT03567616|471839316|FG000|Overall Study|Death|1|||
131056400|NCT03567616|471839316|FG000|Overall Study|Adverse Event|1|||
131056401|NCT02630966|471839319|FG000|Overall Study|Adverse Event|1|||
131056402|NCT02630966|471839320|FG001|Overall Study|Adverse Event|3|||
131056403|NCT02630966|471839319|FG000|Overall Study|Significant Protocol Deviation|0|||
131056404|NCT02630966|471839320|FG001|Overall Study|Significant Protocol Deviation|2|||
131056405|NCT02630966|471839319|FG000|Overall Study|Voluntary Withdrawal|1|||
131056406|NCT02630966|471839320|FG001|Overall Study|Voluntary Withdrawal|1|||
131056407|NCT02630966|471839319|FG000|Overall Study|Lack of Efficacy|0|||
131056408|NCT02630966|471839320|FG001|Overall Study|Lack of Efficacy|2|||
131056409|NCT01683409|471839323|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
131056410|NCT01683409|471839324|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
131056411|NCT01683409|471839325|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
131056412|NCT01683409|471839326|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
131056413|NCT01683409|471839327|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
131056414|NCT01683409|471839323|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
131056415|NCT01683409|471839324|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
131056416|NCT01683409|471839325|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
131056417|NCT01683409|471839326|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
131056418|NCT01683409|471839327|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
131056419|NCT01683409|471839323|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
131056420|NCT01683409|471839324|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
131056421|NCT01683409|471839325|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
131056422|NCT01683409|471839326|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
131056423|NCT01683409|471839327|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
131136405|NCT03115151|472126574|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
131136406|NCT03115151|472126575|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
131136407|NCT03115151|472126574|FG000|Overall Study|Epidural catheter removal|1|||
131136408|NCT03115151|472126575|FG001|Overall Study|Epidural catheter removal|0|||
131136409|NCT03115151|472126574|FG000|Overall Study|Withdrawal by Subject|0|||
131136410|NCT03115151|472126575|FG001|Overall Study|Withdrawal by Subject|1|||
131136411|NCT03115151|472126574|FG000|Overall Study|Intervention not received according to the protocol.|1|||
131136412|NCT03115151|472126575|FG001|Overall Study|Intervention not received according to the protocol.|1|||
131136413|NCT03115151|472126574|FG000|Overall Study|Physician Decision|1|||
131136414|NCT03115151|472126575|FG001|Overall Study|Physician Decision|0|||
131136415|NCT03115151|472126574|FG000|Overall Study|Randomization not applied|1|||
131136416|NCT03115151|472126575|FG001|Overall Study|Randomization not applied|1|||
131136417|NCT03870555|472126581|FG000|Period 3 (2 Days)|Adverse Event|1|||
131136418|NCT03870555|472126582|FG001|Period 3 (2 Days)|Adverse Event|0|||
131136419|NCT03870555|472126583|FG002|Period 3 (2 Days)|Adverse Event|0|||
131229823|NCT01752920|472467706|FG000|Overall Study|Withdrawal by Subject|0|||
131229824|NCT01752920|472467707|FG001|Overall Study|Withdrawal by Subject|1|||
131229825|NCT01752920|472467708|FG002|Overall Study|Withdrawal by Subject|0|||
131229826|NCT01752920|472467709|FG003|Overall Study|Withdrawal by Subject|1|||
131056424|NCT01683409|471839323|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
131056425|NCT01683409|471839324|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
131056426|NCT01683409|471839325|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
131056427|NCT01683409|471839326|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
131056428|NCT01683409|471839327|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
131056429|NCT01683409|471839323|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
131056430|NCT01683409|471839324|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
131056431|NCT01683409|471839325|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
131056432|NCT01683409|471839326|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
131056433|NCT01683409|471839327|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
131056434|NCT01683409|471839323|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
131056435|NCT01683409|471839324|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
131056436|NCT01683409|471839325|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
131056437|NCT01683409|471839326|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
131056438|NCT01683409|471839327|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
131056439|NCT01683409|471839323|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
131056440|NCT01683409|471839324|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
131056441|NCT01683409|471839325|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
131056442|NCT01683409|471839326|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
131056443|NCT01683409|471839327|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
131056444|NCT01683409|471839323|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
131056445|NCT01683409|471839324|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
131056446|NCT01683409|471839325|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
131056447|NCT01683409|471839326|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
131056448|NCT01683409|471839327|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
131056449|NCT01683409|471839323|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
131056450|NCT01683409|471839324|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
131056451|NCT01683409|471839325|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
131056452|NCT01683409|471839326|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
131056453|NCT01683409|471839327|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
131056454|NCT01683409|471839323|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
131056455|NCT01683409|471839324|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
131056456|NCT01683409|471839325|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
131056457|NCT01683409|471839326|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
131056458|NCT01683409|471839327|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
131056459|NCT01683409|471839323|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
131056460|NCT01683409|471839324|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
131056461|NCT01683409|471839325|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
131056462|NCT01683409|471839326|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
131056463|NCT01683409|471839327|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
131056464|NCT04218864|471839328|FG000|Overall Study|Lost to Follow-up|8|||
131056465|NCT04218864|471839329|FG001|Overall Study|Lost to Follow-up|4|||
131056466|NCT04218864|471839328|FG000|Overall Study|Withdrawal by Subject|1|||
131056467|NCT04218864|471839329|FG001|Overall Study|Withdrawal by Subject|3|||
131056468|NCT01227421|471839331|FG000|Overall Study|Lost to Follow-up|6|||
131056469|NCT01227421|471839332|FG001|Overall Study|Lost to Follow-up|7|||
131056470|NCT01227421|471839333|FG002|Overall Study|Lost to Follow-up|5|||
131056471|NCT01227421|471839331|FG000|Overall Study|Adverse Event|2|||
131056472|NCT01227421|471839332|FG001|Overall Study|Adverse Event|7|||
131136420|NCT03694925|472126585|FG000|Overall Study|Inadequate laboratory testing|0|||
131136421|NCT03694925|472126586|FG001|Overall Study|Inadequate laboratory testing|3|||
131136422|NCT03694925|472126587|FG002|Overall Study|Inadequate laboratory testing|0|||
131136423|NCT03434977|472126597|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
131136424|NCT03434977|472126598|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
131136425|NCT03920670|472126599|FG000|Overall Study|Protocol Violation|2|||
131136426|NCT03920670|472126600|FG001|Overall Study|Protocol Violation|2|||
131056473|NCT01227421|471839333|FG002|Overall Study|Adverse Event|2|||
131056474|NCT01227421|471839331|FG000|Overall Study|Withdrawal by Subject|1|||
131056475|NCT01227421|471839332|FG001|Overall Study|Withdrawal by Subject|2|||
131056476|NCT01227421|471839333|FG002|Overall Study|Withdrawal by Subject|1|||
131056477|NCT01227421|471839331|FG000|Overall Study|Protocol Violation|1|||
131056478|NCT01227421|471839332|FG001|Overall Study|Protocol Violation|1|||
131056479|NCT01227421|471839333|FG002|Overall Study|Protocol Violation|2|||
131056480|NCT01227421|471839331|FG000|Overall Study|Randomized in error|1|||
131056481|NCT01227421|471839332|FG001|Overall Study|Randomized in error|1|||
131056482|NCT01227421|471839333|FG002|Overall Study|Randomized in error|0|||
131056483|NCT00145470|471839334|FG000|Overall Study|Adverse Event|19|||
131056484|NCT00145470|471839335|FG001|Overall Study|Adverse Event|25|||
131056485|NCT00145470|471839334|FG000|Overall Study|Lack of Efficacy|27|||
131056486|NCT00145470|471839335|FG001|Overall Study|Lack of Efficacy|13|||
131056487|NCT00145470|471839334|FG000|Overall Study|Withdrawal by Subject|36|||
131056488|NCT00145470|471839335|FG001|Overall Study|Withdrawal by Subject|34|||
131056489|NCT00145470|471839334|FG000|Overall Study|Lost to Follow-up|21|||
131056490|NCT00145470|471839335|FG001|Overall Study|Lost to Follow-up|17|||
131056491|NCT00145470|471839334|FG000|Overall Study|Reason Not Reported|9|||
131056492|NCT00145470|471839335|FG001|Overall Study|Reason Not Reported|9|||
131056493|NCT02485925|471839337|FG000|Overall Study|Withdrawal by Subject|3|||
131056494|NCT02485925|471839337|FG000|Overall Study|Death|1|||
131056495|NCT02485925|471839337|FG000|Overall Study|Lost to Follow-up|11|||
131056496|NCT04181788|471839340|FG000|TREATMENT|Adverse Event|0|||
131056497|NCT04181788|471839341|FG001|TREATMENT|Adverse Event|2|||
131056498|NCT04181788|471839342|FG002|TREATMENT|Adverse Event|1|||
131056499|NCT04181788|471839343|FG003|TREATMENT|Adverse Event|0|||
131056500|NCT04181788|471839344|FG004|TREATMENT|Adverse Event|1|||
131056501|NCT04181788|471839345|FG005|TREATMENT|Adverse Event|3|||
131056502|NCT04181788|471839340|FG000|TREATMENT|Death|0|||
131056503|NCT04181788|471839341|FG001|TREATMENT|Death|0|||
131056504|NCT04181788|471839342|FG002|TREATMENT|Death|0|||
131056505|NCT04181788|471839343|FG003|TREATMENT|Death|0|||
131056506|NCT04181788|471839344|FG004|TREATMENT|Death|8|||
131056507|NCT04181788|471839345|FG005|TREATMENT|Death|8|||
131056508|NCT04181788|471839340|FG000|TREATMENT|Physician Decision|0|||
131056509|NCT04181788|471839341|FG001|TREATMENT|Physician Decision|0|||
131056510|NCT04181788|471839342|FG002|TREATMENT|Physician Decision|0|||
131056511|NCT04181788|471839343|FG003|TREATMENT|Physician Decision|0|||
131056512|NCT04181788|471839344|FG004|TREATMENT|Physician Decision|0|||
131056513|NCT04181788|471839345|FG005|TREATMENT|Physician Decision|1|||
131056514|NCT04181788|471839340|FG000|TREATMENT|Progressive disease|3|||
131056515|NCT04181788|471839341|FG001|TREATMENT|Progressive disease|3|||
131056516|NCT04181788|471839342|FG002|TREATMENT|Progressive disease|5|||
131056517|NCT04181788|471839343|FG003|TREATMENT|Progressive disease|7|||
131056518|NCT04181788|471839344|FG004|TREATMENT|Progressive disease|20|||
131056519|NCT04181788|471839345|FG005|TREATMENT|Progressive disease|38|||
131056520|NCT04181788|471839340|FG000|TREATMENT|Global deterioration of health status|0|||
131056521|NCT04181788|471839341|FG001|TREATMENT|Global deterioration of health status|2|||
131056522|NCT04181788|471839342|FG002|TREATMENT|Global deterioration of health status|0|||
131056523|NCT04181788|471839343|FG003|TREATMENT|Global deterioration of health status|0|||
131136427|NCT03920670|472126599|FG000|Overall Study|Adverse Event|1|||
131136428|NCT03920670|472126600|FG001|Overall Study|Adverse Event|0|||
131136429|NCT04820309|472126606|FG000|Overall Study|Adverse Event|96|||
131136430|NCT04820309|472126606|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
131136431|NCT04820309|472126606|FG000|Overall Study|Consent Withdrawn|93|||
131136432|NCT04820309|472126606|FG000|Overall Study|failure to adhere to protocol|32|||
131136433|NCT04820309|472126606|FG000|Overall Study|alcohol or drug use|6|||
130779363|NCT02326272|470819495|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130779364|NCT02326272|470819496|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131056524|NCT04181788|471839344|FG004|TREATMENT|Global deterioration of health status|2|||
131056525|NCT04181788|471839345|FG005|TREATMENT|Global deterioration of health status|8|||
131056526|NCT04181788|471839340|FG000|TREATMENT|Withdrawal by Subject|1|||
131056527|NCT04181788|471839341|FG001|TREATMENT|Withdrawal by Subject|2|||
131056528|NCT04181788|471839342|FG002|TREATMENT|Withdrawal by Subject|0|||
131056529|NCT04181788|471839343|FG003|TREATMENT|Withdrawal by Subject|0|||
131056530|NCT04181788|471839344|FG004|TREATMENT|Withdrawal by Subject|3|||
131056531|NCT04181788|471839345|FG005|TREATMENT|Withdrawal by Subject|5|||
131056532|NCT04181788|471839340|FG000|TREATMENT|Other unspecified|0|||
131056533|NCT04181788|471839341|FG001|TREATMENT|Other unspecified|0|||
131056534|NCT04181788|471839342|FG002|TREATMENT|Other unspecified|0|||
131056535|NCT04181788|471839343|FG003|TREATMENT|Other unspecified|0|||
131056536|NCT04181788|471839344|FG004|TREATMENT|Other unspecified|0|||
131056537|NCT04181788|471839345|FG005|TREATMENT|Other unspecified|2|||
131056538|NCT04181788|471839340|FG000|TREATMENT|Ongoing|0|||
131056539|NCT04181788|471839341|FG001|TREATMENT|Ongoing|3|||
131136434|NCT04820309|472126606|FG000|Overall Study|Lost to Follow-up|46|||
131136435|NCT04820309|472126606|FG000|Overall Study|Death|2|||
131136436|NCT04820309|472126606|FG000|Overall Study|Pregnancy|1|||
131136437|NCT04820309|472126606|FG000|Overall Study|Other reasons|12|||
131136438|NCT02270242|472126611|FG000|Overall Study|Withdrawal by Subject|18|||
131136439|NCT02270242|472126612|FG001|Overall Study|Withdrawal by Subject|25|||
131136440|NCT02270242|472126611|FG000|Overall Study|Lost to Follow-up|41|||
131136441|NCT02270242|472126612|FG001|Overall Study|Lost to Follow-up|27|||
131136442|NCT02270242|472126611|FG000|Overall Study|Physician Decision|0|||
131136443|NCT02270242|472126612|FG001|Overall Study|Physician Decision|1|||
131136444|NCT02321436|472126613|FG000|Overall Study|Withdrawal by Subject|1|||
131136445|NCT02321436|472126614|FG001|Overall Study|Withdrawal by Subject|0|||
131136446|NCT02321436|472126613|FG000|Overall Study|Lost to Follow-up|0|||
131136447|NCT02321436|472126614|FG001|Overall Study|Lost to Follow-up|1|||
131136448|NCT03355300|472126615|FG000|Overall Study|Physician Decision|0|||
131136449|NCT03355300|472126616|FG001|Overall Study|Physician Decision|1|||
131136450|NCT03355300|472126615|FG000|Overall Study|Lack of Efficacy|2|||
131136451|NCT03355300|472126616|FG001|Overall Study|Lack of Efficacy|1|||
131136452|NCT03355300|472126615|FG000|Overall Study|Other reason|1|||
131136453|NCT03355300|472126616|FG001|Overall Study|Other reason|0|||
131136454|NCT03048422|472126617|FG000|Overall Study|Death|1|||
131136455|NCT03048422|472126618|FG001|Overall Study|Death|0|||
131136456|NCT03048422|472126619|FG002|Overall Study|Death|0|||
131136457|NCT03048422|472126617|FG000|Overall Study|Lost to Follow-up|5|||
131136458|NCT03048422|472126618|FG001|Overall Study|Lost to Follow-up|0|||
131136459|NCT03048422|472126619|FG002|Overall Study|Lost to Follow-up|1|||
131136460|NCT03048422|472126617|FG000|Overall Study|Withdrawal by Subject|5|||
131136461|NCT03048422|472126618|FG001|Overall Study|Withdrawal by Subject|7|||
131136462|NCT03048422|472126619|FG002|Overall Study|Withdrawal by Subject|4|||
131136463|NCT03048422|472126617|FG000|Overall Study|Moved|3|||
131136464|NCT03048422|472126618|FG001|Overall Study|Moved|2|||
131136465|NCT03048422|472126619|FG002|Overall Study|Moved|2|||
131136466|NCT03048422|472126617|FG000|Overall Study|Noncompliant with Study Requirements|2|||
131136467|NCT03048422|472126618|FG001|Overall Study|Noncompliant with Study Requirements|1|||
131136468|NCT03048422|472126619|FG002|Overall Study|Noncompliant with Study Requirements|2|||
131136469|NCT03048422|472126617|FG000|Overall Study|Not Able to Get to Clinic|1|||
131136470|NCT03048422|472126618|FG001|Overall Study|Not Able to Get to Clinic|0|||
131136471|NCT03048422|472126619|FG002|Overall Study|Not Able to Get to Clinic|0|||
131136472|NCT03505021|472126620|FG000|Overall Study|Protocol Violation|1|||
131136473|NCT03505021|472126621|FG001|Overall Study|Protocol Violation|0|||
131136474|NCT03505021|472126620|FG000|Overall Study|Death|9|||
131136475|NCT03505021|472126621|FG001|Overall Study|Death|8|||
131136476|NCT03505021|472126620|FG000|Overall Study|Consent withdrawn by subject|6|||
131136477|NCT03505021|472126621|FG001|Overall Study|Consent withdrawn by subject|1|||
130779365|NCT02326272|470819497|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130779366|NCT02326272|470819498|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130779367|NCT02326272|470819499|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131056540|NCT04181788|471839342|FG002|TREATMENT|Ongoing|0|||
131056541|NCT04181788|471839343|FG003|TREATMENT|Ongoing|5|||
131056542|NCT04181788|471839344|FG004|TREATMENT|Ongoing|7|||
131056543|NCT04181788|471839345|FG005|TREATMENT|Ongoing|15|||
131056544|NCT04181788|471839340|FG000|FOLLOW-UP|Death|0|||
131056545|NCT04181788|471839341|FG001|FOLLOW-UP|Death|0|||
131056546|NCT04181788|471839342|FG002|FOLLOW-UP|Death|1|||
131056547|NCT04181788|471839343|FG003|FOLLOW-UP|Death|2|||
131056548|NCT04181788|471839344|FG004|FOLLOW-UP|Death|8|||
131056549|NCT04181788|471839345|FG005|FOLLOW-UP|Death|20|||
131056550|NCT04181788|471839340|FG000|FOLLOW-UP|Lost to Follow-up|0|||
131056551|NCT04181788|471839341|FG001|FOLLOW-UP|Lost to Follow-up|0|||
131056552|NCT04181788|471839342|FG002|FOLLOW-UP|Lost to Follow-up|0|||
131056553|NCT04181788|471839343|FG003|FOLLOW-UP|Lost to Follow-up|0|||
131056554|NCT04181788|471839344|FG004|FOLLOW-UP|Lost to Follow-up|0|||
131056555|NCT04181788|471839345|FG005|FOLLOW-UP|Lost to Follow-up|2|||
131056556|NCT04181788|471839340|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
131056557|NCT04181788|471839341|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
131056558|NCT04181788|471839342|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
131056559|NCT04181788|471839343|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
130779368|NCT02326272|470819500|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131056560|NCT04181788|471839344|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
131056561|NCT04181788|471839345|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
131056562|NCT04181788|471839340|FG000|FOLLOW-UP|Other unspecified|0|||
131056563|NCT04181788|471839341|FG001|FOLLOW-UP|Other unspecified|1|||
131056564|NCT04181788|471839342|FG002|FOLLOW-UP|Other unspecified|0|||
131136478|NCT03505021|472126620|FG000|Overall Study|Lost to Follow-up|5|||
131136479|NCT03505021|472126621|FG001|Overall Study|Lost to Follow-up|3|||
131136480|NCT03505021|472126620|FG000|Overall Study|Adverse Event|26|||
131136481|NCT03505021|472126621|FG001|Overall Study|Adverse Event|9|||
131136482|NCT03505021|472126620|FG000|Overall Study|Disease progression|33|||
131136483|NCT03505021|472126621|FG001|Overall Study|Disease progression|17|||
131136484|NCT03505021|472126620|FG000|Overall Study|Other|11|||
131136485|NCT03505021|472126621|FG001|Overall Study|Other|5|||
131056565|NCT04181788|471839343|FG003|FOLLOW-UP|Other unspecified|0|||
131056566|NCT04181788|471839344|FG004|FOLLOW-UP|Other unspecified|0|||
131056567|NCT04181788|471839345|FG005|FOLLOW-UP|Other unspecified|3|||
131056568|NCT04181788|471839340|FG000|FOLLOW-UP|Ongoing|0|||
131056569|NCT04181788|471839341|FG001|FOLLOW-UP|Ongoing|0|||
131056570|NCT04181788|471839342|FG002|FOLLOW-UP|Ongoing|1|||
131056571|NCT04181788|471839343|FG003|FOLLOW-UP|Ongoing|3|||
131056572|NCT04181788|471839344|FG004|FOLLOW-UP|Ongoing|2|||
131056573|NCT04181788|471839345|FG005|FOLLOW-UP|Ongoing|2|||
131056574|NCT04937504|471839346|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
131056575|NCT04937504|471839347|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
131056576|NCT04937504|471839346|FG000|9 Months Assessment|Lost to Follow-up|3|||
131056577|NCT04937504|471839347|FG001|9 Months Assessment|Lost to Follow-up|2|||
131056578|NCT03662659|471839348|FG000|Pre-treatment|Participant no longer met study criteria|1|||
131056579|NCT03662659|471839349|FG001|Pre-treatment|Participant no longer met study criteria|1|||
131056580|NCT03662659|471839348|FG000|Pre-treatment|Other reasons|1|||
131056581|NCT03662659|471839349|FG001|Pre-treatment|Other reasons|0|||
131056582|NCT03662659|471839348|FG000|Treatment|Completed Treatment|0|||
131056583|NCT03662659|471839349|FG001|Treatment|Completed Treatment|2|||
131056584|NCT03662659|471839348|FG000|Treatment|Disease Progression|85|||
131056585|NCT03662659|471839349|FG001|Treatment|Disease Progression|97|||
131056586|NCT03662659|471839348|FG000|Treatment|Study Drug Toxicity|19|||
131056587|NCT03662659|471839349|FG001|Treatment|Study Drug Toxicity|9|||
131056588|NCT03662659|471839348|FG000|Treatment|Death|11|||
131056589|NCT03662659|471839349|FG001|Treatment|Death|9|||
131056590|NCT03662659|471839348|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
131056591|NCT03662659|471839349|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
131056592|NCT03662659|471839348|FG000|Treatment|Withdrawal by Subject|1|||
131056593|NCT03662659|471839349|FG001|Treatment|Withdrawal by Subject|1|||
131056594|NCT03662659|471839348|FG000|Treatment|Poor/Non-compliance|1|||
131056595|NCT03662659|471839349|FG001|Treatment|Poor/Non-compliance|0|||
131056596|NCT03662659|471839348|FG000|Treatment|Participant no longer meets study criteria|1|||
131056597|NCT03662659|471839349|FG001|Treatment|Participant no longer meets study criteria|0|||
131056598|NCT03662659|471839348|FG000|Treatment|Other reasons|10|||
131056599|NCT03662659|471839349|FG001|Treatment|Other reasons|8|||
131056600|NCT03662659|471839348|FG000|Treatment|Administrative reasons by sponsor|1|||
131056601|NCT03662659|471839349|FG001|Treatment|Administrative reasons by sponsor|0|||
131056602|NCT03662659|471839348|FG000|Treatment|maximum clinical benefit|0|||
131056603|NCT03662659|471839349|FG001|Treatment|maximum clinical benefit|2|||
131056604|NCT02556918|471841191|FG000|Overall Study|Protocol Violation|5|||
131056605|NCT02556918|471841192|FG001|Overall Study|Protocol Violation|6|||
131056606|NCT02556918|471841191|FG000|Overall Study|Withdrawal by Subject|4|||
131056607|NCT02556918|471841192|FG001|Overall Study|Withdrawal by Subject|4|||
131056608|NCT00551421|471841203|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
131056609|NCT04323800|471841206|FG000|Overall Study|Withdrawal by Subject|4|||
131056610|NCT04323800|471841207|FG001|Overall Study|Withdrawal by Subject|4|||
131056611|NCT04323800|471841206|FG000|Overall Study|Incomplete transfusion|1|||
131056612|NCT04323800|471841207|FG001|Overall Study|Incomplete transfusion|0|||
131056613|NCT04323800|471841206|FG000|Overall Study|Other|0|||
131056614|NCT04323800|471841207|FG001|Overall Study|Other|1|||
131056615|NCT04323800|471841206|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
131056616|NCT04323800|471841207|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
131056617|NCT00489554|471841208|FG000|Overall Study|Adverse Event|2|||
131056618|NCT00489554|471841208|FG000|Overall Study|Withdrawal by Subject|1|||
131056619|NCT00489554|471841208|FG000|Overall Study|Lost to Follow-up|1|||
131056620|NCT06571695|471841209|FG000|Overall Study|Lost to Follow-up|1|||
131056621|NCT06571695|471841210|FG001|Overall Study|Lost to Follow-up|6|||
131056622|NCT01380145|471841214|FG000|Overall Study|Progressive disease|4|||
131056623|NCT02038049|471841219|FG000|Overall Study|Lost to Follow-up|1|||
131056624|NCT02038049|471841220|FG001|Overall Study|Lost to Follow-up|0|||
131056625|NCT02771366|471841221|FG000|Period 1|Withdrawal by Subject|0|||
131056626|NCT02771366|471841222|FG001|Period 1|Withdrawal by Subject|2|||
131056627|NCT02771366|471841221|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
131056628|NCT02771366|471841222|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
131056629|NCT01808534|471841223|FG000|Overall Study|Disease progression|3|||
131056630|NCT01808534|471841223|FG000|Overall Study|Physician Decision|1|||
131056631|NCT02148705|471841229|FG000|Overall Study|Death|2|||
131056632|NCT02148705|471841230|FG001|Overall Study|Death|0|||
131056633|NCT02148705|471841231|FG002|Overall Study|Death|0|||
131056634|NCT02148705|471841229|FG000|Overall Study|Lost to Follow-up|13|||
131056635|NCT02148705|471841230|FG001|Overall Study|Lost to Follow-up|4|||
131056636|NCT02148705|471841231|FG002|Overall Study|Lost to Follow-up|10|||
131056637|NCT02148705|471841229|FG000|Overall Study|Withdrawal by Subject|3|||
131056638|NCT02148705|471841230|FG001|Overall Study|Withdrawal by Subject|0|||
131056639|NCT02148705|471841231|FG002|Overall Study|Withdrawal by Subject|2|||
131056640|NCT02148705|471841229|FG000|Overall Study|Not Treated|0|||
131056641|NCT02148705|471841230|FG001|Overall Study|Not Treated|1|||
131056642|NCT02148705|471841231|FG002|Overall Study|Not Treated|5|||
131056643|NCT01737021|471841232|FG000|Overall Study|Lost to Follow-up|5|||
131229827|NCT01752920|472467706|FG000|Overall Study|Lack of clinical benefit|1|||
131229828|NCT01752920|472467707|FG001|Overall Study|Lack of clinical benefit|1|||
131229829|NCT01752920|472467708|FG002|Overall Study|Lack of clinical benefit|1|||
131229830|NCT01752920|472467709|FG003|Overall Study|Lack of clinical benefit|1|||
131056644|NCT01737021|471841233|FG001|Overall Study|Lost to Follow-up|3|||
131056645|NCT02575365|471841240|FG000|Overall Study|Lost to Follow-up|4|||
131056646|NCT01009645|471841247|FG000|Overall Study|Lost to Follow-up|2|||
131056647|NCT01009645|471841248|FG001|Overall Study|Lost to Follow-up|8|||
131056648|NCT01009645|471841249|FG002|Overall Study|Lost to Follow-up|4|||
131056649|NCT01009645|471841250|FG003|Overall Study|Lost to Follow-up|5|||
131056650|NCT05124210|471841251|FG000|Overall Study|Lost to Follow-up|1|||
131056651|NCT05124210|471841252|FG001|Overall Study|Lost to Follow-up|0|||
131056652|NCT05124210|471841251|FG000|Overall Study|Withdrawal by Subject|1|||
131056653|NCT05124210|471841252|FG001|Overall Study|Withdrawal by Subject|0|||
131056654|NCT00768755|471841255|FG000|Phase 1|Death|6|||
131056655|NCT00768755|471841256|FG001|Phase 1|Death|0|||
131056656|NCT00768755|471841257|FG002|Phase 1|Death|0|||
131056657|NCT00768755|471841258|FG003|Phase 1|Death|0|||
131056658|NCT00768755|471841255|FG000|Phase 1|Other|4|||
131056659|NCT00768755|471841256|FG001|Phase 1|Other|0|||
131056660|NCT00768755|471841257|FG002|Phase 1|Other|0|||
131056661|NCT00768755|471841258|FG003|Phase 1|Other|0|||
131056662|NCT00768755|471841255|FG000|Phase 2|Death|0|||
131056663|NCT00768755|471841256|FG001|Phase 2|Death|37|||
131056664|NCT00768755|471841257|FG002|Phase 2|Death|48|||
131056665|NCT00768755|471841258|FG003|Phase 2|Death|31|||
131056666|NCT00768755|471841255|FG000|Phase 2|Protocol Violation|0|||
131056667|NCT00768755|471841256|FG001|Phase 2|Protocol Violation|2|||
131056668|NCT00768755|471841257|FG002|Phase 2|Protocol Violation|0|||
131056669|NCT00768755|471841258|FG003|Phase 2|Protocol Violation|1|||
131056670|NCT00768755|471841255|FG000|Phase 2|Lost to Follow-up|0|||
131056671|NCT00768755|471841256|FG001|Phase 2|Lost to Follow-up|1|||
131056672|NCT00768755|471841257|FG002|Phase 2|Lost to Follow-up|1|||
131056673|NCT00768755|471841258|FG003|Phase 2|Lost to Follow-up|4|||
131056674|NCT00768755|471841255|FG000|Phase 2|Withdrawal by Subject|0|||
131056675|NCT00768755|471841256|FG001|Phase 2|Withdrawal by Subject|1|||
131056676|NCT00768755|471841257|FG002|Phase 2|Withdrawal by Subject|0|||
131056677|NCT00768755|471841258|FG003|Phase 2|Withdrawal by Subject|1|||
131056678|NCT00768755|471841255|FG000|Phase 2|Other|0|||
131056679|NCT00768755|471841256|FG001|Phase 2|Other|1|||
131056680|NCT00768755|471841257|FG002|Phase 2|Other|2|||
131056681|NCT00768755|471841258|FG003|Phase 2|Other|4|||
131056682|NCT00768755|471841255|FG000|Phase 2|Study Terminated by Sponsor|0|||
131056683|NCT00768755|471841256|FG001|Phase 2|Study Terminated by Sponsor|13|||
131056684|NCT00768755|471841257|FG002|Phase 2|Study Terminated by Sponsor|7|||
131056685|NCT00768755|471841258|FG003|Phase 2|Study Terminated by Sponsor|14|||
131056686|NCT00768755|471841255|FG000|Phase 2|Randomized but not treated|0|||
131056687|NCT00768755|471841256|FG001|Phase 2|Randomized but not treated|0|||
131056688|NCT00768755|471841257|FG002|Phase 2|Randomized but not treated|0|||
131056689|NCT00768755|471841258|FG003|Phase 2|Randomized but not treated|2|||
131056690|NCT00310037|471841259|FG000|Overall Study|Adverse Event|7|||
131056691|NCT00310037|471841260|FG001|Overall Study|Adverse Event|14|||
131056692|NCT00310037|471841259|FG000|Overall Study|Withdrawal by Subject|4|||
131056693|NCT00310037|471841260|FG001|Overall Study|Withdrawal by Subject|3|||
131056694|NCT00310037|471841259|FG000|Overall Study|Progression|6|||
131056695|NCT00310037|471841260|FG001|Overall Study|Progression|0|||
131056696|NCT00310037|471841259|FG000|Overall Study|Non-protocol treatment|1|||
131056697|NCT00310037|471841260|FG001|Overall Study|Non-protocol treatment|0|||
131056698|NCT03052517|471841261|FG000|Overall Study|Study Terminated By Sponsor|928|||
131056699|NCT03052517|471841262|FG001|Overall Study|Study Terminated By Sponsor|938|||
131056700|NCT03052517|471841263|FG002|Overall Study|Study Terminated By Sponsor|296|||
131056701|NCT03052517|471841261|FG000|Overall Study|Subject/Guardian Decision|50|||
131056702|NCT03052517|471841262|FG001|Overall Study|Subject/Guardian Decision|45|||
131056703|NCT03052517|471841263|FG002|Overall Study|Subject/Guardian Decision|22|||
131056704|NCT03052517|471841261|FG000|Overall Study|Lack of Efficacy|23|||
131056705|NCT03052517|471841262|FG001|Overall Study|Lack of Efficacy|14|||
131056706|NCT03052517|471841263|FG002|Overall Study|Lack of Efficacy|7|||
131056707|NCT03052517|471841261|FG000|Overall Study|Adverse Event|6|||
131056708|NCT03052517|471841262|FG001|Overall Study|Adverse Event|5|||
131056709|NCT03052517|471841263|FG002|Overall Study|Adverse Event|0|||
131056710|NCT03052517|471841261|FG000|Overall Study|Physician Decision|4|||
131056711|NCT03052517|471841262|FG001|Overall Study|Physician Decision|5|||
131056712|NCT03052517|471841263|FG002|Overall Study|Physician Decision|1|||
131229831|NCT01738581|472467710|FG000|Overall Study|Lost to Follow-up|1|||
131056713|NCT03052517|471841261|FG000|Overall Study|Death|3|||
131056714|NCT03052517|471841262|FG001|Overall Study|Death|0|||
131056715|NCT03052517|471841263|FG002|Overall Study|Death|1|||
131056716|NCT03052517|471841261|FG000|Overall Study|Lost to Follow-up|2|||
131229832|NCT01738581|472467711|FG001|Overall Study|Lost to Follow-up|0|||
131056717|NCT03052517|471841262|FG001|Overall Study|Lost to Follow-up|4|||
131056718|NCT03052517|471841263|FG002|Overall Study|Lost to Follow-up|0|||
131056719|NCT03052517|471841261|FG000|Overall Study|Pregnancy|1|||
131056720|NCT03052517|471841262|FG001|Overall Study|Pregnancy|0|||
130722530|NCT02802631|470608318|FG005|Overall Study|Adverse Event|1|||
130722531|NCT02802631|470608319|FG006|Overall Study|Adverse Event|4|||
130722532|NCT02802631|470608320|FG007|Overall Study|Adverse Event|0|||
130722533|NCT02802631|470608313|FG000|Overall Study|Sponsor Decision|0|||
131056721|NCT03052517|471841263|FG002|Overall Study|Pregnancy|1|||
131056722|NCT03052517|471841261|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
131056723|NCT03052517|471841262|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
131056724|NCT03052517|471841263|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
131056725|NCT03052517|471841261|FG000|Overall Study|Technical Problems|0|||
131056726|NCT03052517|471841262|FG001|Overall Study|Technical Problems|1|||
131056727|NCT03052517|471841263|FG002|Overall Study|Technical Problems|0|||
131056728|NCT03298087|471841266|FG000|Overall Study|Withdrawal by Subject|4|||
131056729|NCT01530334|471841272|FG000|Overall Study|Adverse Event|3|||
131056730|NCT01530334|471841272|FG000|Overall Study|unknown reason|1|||
131056731|NCT01530334|471841272|FG000|Overall Study|Progressive disease|47|||
131136486|NCT03505021|472126620|FG000|Overall Study|Personal reason|21|||
131056732|NCT03781375|471841273|FG000|Double-blind Phase|Adverse Event|0|||
131056733|NCT03781375|471841274|FG001|Double-blind Phase|Adverse Event|1|||
131056734|NCT03781375|471841273|FG000|Double-blind Phase|Lack of Response|6|||
131056735|NCT03781375|471841274|FG001|Double-blind Phase|Lack of Response|2|||
131056736|NCT03781375|471841273|FG000|Double-blind Phase|Other|1|||
131056737|NCT03781375|471841274|FG001|Double-blind Phase|Other|3|||
131056738|NCT03781375|471841273|FG000|Open-label Phase|Protocol Issues|0|||
131056739|NCT03781375|471841274|FG001|Open-label Phase|Protocol Issues|1|||
131056740|NCT03781375|471841273|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
131056741|NCT03781375|471841274|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
131056742|NCT03781375|471841273|FG000|Open-label Phase|Other|2|||
131056743|NCT03781375|471841274|FG001|Open-label Phase|Other|2|||
131056744|NCT01485887|471841275|FG000|Overall Study|Withdrawal by Subject|2|||
131056745|NCT01485887|471841275|FG000|Overall Study|Adverse Event|8|||
131056746|NCT01485887|471841275|FG000|Overall Study|Deterioration of primary disease|1|||
131056747|NCT01485887|471841275|FG000|Overall Study|Primary disease markedly improved|1|||
131056748|NCT03184987|471841279|FG000|Overall Study|Withdrawal by Subject|0|||
131056749|NCT03184987|471841280|FG001|Overall Study|Withdrawal by Subject|1|||
131056750|NCT03184987|471841281|FG002|Overall Study|Withdrawal by Subject|2|||
131056751|NCT03184987|471841279|FG000|Overall Study|Physician Decision|0|||
131056752|NCT03184987|471841280|FG001|Overall Study|Physician Decision|0|||
131056753|NCT03184987|471841281|FG002|Overall Study|Physician Decision|1|||
131056754|NCT03184987|471841279|FG000|Overall Study|Adverse Event|1|||
131056755|NCT03184987|471841280|FG001|Overall Study|Adverse Event|0|||
131056756|NCT03184987|471841281|FG002|Overall Study|Adverse Event|1|||
131056757|NCT02203799|471841282|FG000|Overall Study|Withdrawal by Subject|3|||
131056758|NCT02106884|471841283|FG000|Overall Study|Change of diagnosis/exclusion|0|||
131056759|NCT02106884|471841284|FG001|Overall Study|Change of diagnosis/exclusion|1|||
131056760|NCT00659373|471841285|FG000|Overall Study|Withdrawal by Subject|3|||
131056761|NCT00659373|471841286|FG001|Overall Study|Withdrawal by Subject|5|||
131056762|NCT00659373|471841285|FG000|Overall Study|Assessment Missed|2|||
131056763|NCT00659373|471841286|FG001|Overall Study|Assessment Missed|2|||
131056764|NCT02382640|471841287|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
131056765|NCT02382640|471841288|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
131056766|NCT02382640|471841289|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
131056767|NCT02382640|471841290|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
131056768|NCT01560429|471841293|FG000|Overall Study|Protocol Violation|3|||
131056769|NCT01560429|471841294|FG001|Overall Study|Protocol Violation|6|||
131056770|NCT03162614|471841295|FG000|Overall Study|Lost to Follow-up|2|||
131056771|NCT03162614|471841296|FG001|Overall Study|Lost to Follow-up|1|||
130722534|NCT02802631|470608314|FG001|Overall Study|Sponsor Decision|0|||
131056772|NCT03162614|471841297|FG002|Overall Study|Lost to Follow-up|1|||
131056773|NCT03162614|471841298|FG003|Overall Study|Lost to Follow-up|1|||
131056774|NCT03162614|471841299|FG004|Overall Study|Lost to Follow-up|2|||
130722535|NCT02802631|470608315|FG002|Overall Study|Sponsor Decision|6|||
130722536|NCT02802631|470608316|FG003|Overall Study|Sponsor Decision|0|||
130722537|NCT02802631|470608317|FG004|Overall Study|Sponsor Decision|2|||
130722538|NCT02802631|470608318|FG005|Overall Study|Sponsor Decision|0|||
130722539|NCT02802631|470608319|FG006|Overall Study|Sponsor Decision|0|||
131056775|NCT03162614|471841300|FG005|Overall Study|Lost to Follow-up|0|||
131056776|NCT03162614|471841295|FG000|Overall Study|Protocol Violation|0|||
131056777|NCT03162614|471841296|FG001|Overall Study|Protocol Violation|1|||
131056778|NCT03162614|471841297|FG002|Overall Study|Protocol Violation|0|||
131056779|NCT03162614|471841298|FG003|Overall Study|Protocol Violation|1|||
131056780|NCT03162614|471841299|FG004|Overall Study|Protocol Violation|0|||
131056781|NCT03162614|471841300|FG005|Overall Study|Protocol Violation|0|||
131056782|NCT03162614|471841295|FG000|Overall Study|Withdrawal by Subject|2|||
131056783|NCT03162614|471841296|FG001|Overall Study|Withdrawal by Subject|1|||
131056784|NCT03162614|471841297|FG002|Overall Study|Withdrawal by Subject|1|||
131136487|NCT03505021|472126621|FG001|Overall Study|Personal reason|12|||
130722540|NCT02802631|470608320|FG007|Overall Study|Sponsor Decision|4|||
130722541|NCT02377427|470608321|FG000|Part A (Up to Week 20)|Physician Decision|1|||
131056785|NCT03162614|471841298|FG003|Overall Study|Withdrawal by Subject|1|||
131056786|NCT03162614|471841299|FG004|Overall Study|Withdrawal by Subject|0|||
131056787|NCT03162614|471841300|FG005|Overall Study|Withdrawal by Subject|0|||
131056788|NCT03162614|471841295|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
131056789|NCT03162614|471841296|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
131056790|NCT03162614|471841297|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
131056791|NCT03162614|471841298|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
131056792|NCT03162614|471841299|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
131056793|NCT03162614|471841300|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
131056794|NCT00380250|471841311|FG000|Overall Study|Withdrawal by Subject|39|||
131056795|NCT00380250|471841312|FG001|Overall Study|Withdrawal by Subject|28|||
131056796|NCT00380250|471841311|FG000|Overall Study|Adverse Event|20|||
131056797|NCT00380250|471841312|FG001|Overall Study|Adverse Event|9|||
131056798|NCT00380250|471841311|FG000|Overall Study|Lack of Efficacy|10|||
131056799|NCT00380250|471841312|FG001|Overall Study|Lack of Efficacy|8|||
131056800|NCT00380250|471841311|FG000|Overall Study|Protocol Violation|15|||
131056801|NCT00380250|471841312|FG001|Overall Study|Protocol Violation|5|||
131056802|NCT00380250|471841311|FG000|Overall Study|Lost to Follow-up|14|||
131056803|NCT00380250|471841312|FG001|Overall Study|Lost to Follow-up|5|||
131056804|NCT00380250|471841311|FG000|Overall Study|Physician Decision|1|||
131056805|NCT00380250|471841312|FG001|Overall Study|Physician Decision|0|||
131056806|NCT04029090|471841313|FG000|Overall Study|Protocol Violation|1|||
131056807|NCT04029090|471841314|FG001|Overall Study|Protocol Violation|0|||
131056808|NCT04029090|471841315|FG002|Overall Study|Protocol Violation|0|||
131056809|NCT04029090|471841313|FG000|Overall Study|Withdrawal by Subject|0|||
131056810|NCT04029090|471841314|FG001|Overall Study|Withdrawal by Subject|1|||
131056811|NCT04029090|471841315|FG002|Overall Study|Withdrawal by Subject|0|||
131056812|NCT02157948|471841316|FG000|Overall Study|Withdrawal by Subject|4|||
131056813|NCT02157948|471841317|FG001|Overall Study|Withdrawal by Subject|5|||
131056814|NCT02157948|471841316|FG000|Overall Study|Lost to Follow-up|3|||
131056815|NCT02157948|471841317|FG001|Overall Study|Lost to Follow-up|2|||
131056816|NCT02157948|471841316|FG000|Overall Study|Protocol Specified Criteria|2|||
131056817|NCT02157948|471841317|FG001|Overall Study|Protocol Specified Criteria|1|||
131056818|NCT02157948|471841316|FG000|Overall Study|Decision by Sponsor|0|||
131056819|NCT02157948|471841317|FG001|Overall Study|Decision by Sponsor|1|||
131056820|NCT01604824|471841318|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
131056821|NCT01604824|471841319|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
131056822|NCT01604824|471841320|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
131056823|NCT01604824|471841321|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
131056824|NCT01604824|471841322|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
131056825|NCT01604824|471841323|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
131056826|NCT01604824|471841318|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
131056827|NCT01604824|471841319|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
131056828|NCT01604824|471841320|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
131056829|NCT01604824|471841321|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
131056830|NCT01604824|471841322|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
131056831|NCT01604824|471841323|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
131056832|NCT00243867|471841324|FG000|Overall Study|Adverse Event|24|||
131056833|NCT00243867|471841325|FG001|Overall Study|Adverse Event|34|||
131056834|NCT00243867|471841324|FG000|Overall Study|Lack of Efficacy|115|||
131056835|NCT00243867|471841325|FG001|Overall Study|Lack of Efficacy|78|||
131056836|NCT00243867|471841324|FG000|Overall Study|Withdrawal by Subject|11|||
131056837|NCT00243867|471841325|FG001|Overall Study|Withdrawal by Subject|23|||
131056838|NCT00243867|471841324|FG000|Overall Study|Lost to Follow-up|2|||
131056839|NCT00243867|471841325|FG001|Overall Study|Lost to Follow-up|1|||
131056840|NCT00243867|471841324|FG000|Overall Study|Physician Decision|2|||
131056841|NCT00243867|471841325|FG001|Overall Study|Physician Decision|7|||
131056842|NCT00243867|471841324|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
131056843|NCT00243867|471841325|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
131056844|NCT02499328|471841334|FG000|Overall Study|Withdrawal by Subject|1|||
131056845|NCT02499328|471841335|FG001|Overall Study|Withdrawal by Subject|1|||
131056846|NCT02499328|471841336|FG002|Overall Study|Withdrawal by Subject|5|||
131056847|NCT02499328|471841337|FG003|Overall Study|Withdrawal by Subject|3|||
131056848|NCT02499328|471841338|FG004|Overall Study|Withdrawal by Subject|5|||
131056849|NCT02499328|471841339|FG005|Overall Study|Withdrawal by Subject|0|||
131056850|NCT02499328|471841340|FG006|Overall Study|Withdrawal by Subject|0|||
131056851|NCT02499328|471841341|FG007|Overall Study|Withdrawal by Subject|0|||
131056852|NCT02499328|471841342|FG008|Overall Study|Withdrawal by Subject|2|||
131056853|NCT02499328|471841343|FG009|Overall Study|Withdrawal by Subject|2|||
131056854|NCT02499328|471841344|FG010|Overall Study|Withdrawal by Subject|0|||
131056855|NCT02499328|471841345|FG011|Overall Study|Withdrawal by Subject|3|||
131056856|NCT02499328|471841346|FG012|Overall Study|Withdrawal by Subject|7|||
131056857|NCT02499328|471841347|FG013|Overall Study|Withdrawal by Subject|3|||
131056858|NCT02499328|471841348|FG014|Overall Study|Withdrawal by Subject|1|||
131056859|NCT02499328|471841349|FG015|Overall Study|Withdrawal by Subject|0|||
131056860|NCT02499328|471841350|FG016|Overall Study|Withdrawal by Subject|0|||
131056861|NCT02499328|471841351|FG017|Overall Study|Withdrawal by Subject|3|||
131056862|NCT02499328|471841352|FG018|Overall Study|Withdrawal by Subject|0|||
131056863|NCT02499328|471841334|FG000|Overall Study|Lost to Follow-up|0|||
131056864|NCT02499328|471841335|FG001|Overall Study|Lost to Follow-up|1|||
131056865|NCT02499328|471841336|FG002|Overall Study|Lost to Follow-up|1|||
131056866|NCT02499328|471841337|FG003|Overall Study|Lost to Follow-up|2|||
131056867|NCT02499328|471841338|FG004|Overall Study|Lost to Follow-up|0|||
131056868|NCT02499328|471841339|FG005|Overall Study|Lost to Follow-up|0|||
131056869|NCT02499328|471841340|FG006|Overall Study|Lost to Follow-up|0|||
131056870|NCT02499328|471841341|FG007|Overall Study|Lost to Follow-up|2|||
131056871|NCT02499328|471841342|FG008|Overall Study|Lost to Follow-up|3|||
131056872|NCT02499328|471841343|FG009|Overall Study|Lost to Follow-up|0|||
131056873|NCT02499328|471841344|FG010|Overall Study|Lost to Follow-up|0|||
131056874|NCT02499328|471841345|FG011|Overall Study|Lost to Follow-up|0|||
131056875|NCT02499328|471841346|FG012|Overall Study|Lost to Follow-up|0|||
131056876|NCT02499328|471841347|FG013|Overall Study|Lost to Follow-up|0|||
131056877|NCT02499328|471841348|FG014|Overall Study|Lost to Follow-up|0|||
131056878|NCT02499328|471841349|FG015|Overall Study|Lost to Follow-up|0|||
131056879|NCT02499328|471841350|FG016|Overall Study|Lost to Follow-up|0|||
131056880|NCT02499328|471841351|FG017|Overall Study|Lost to Follow-up|0|||
131056881|NCT02499328|471841352|FG018|Overall Study|Lost to Follow-up|1|||
131056882|NCT02499328|471841334|FG000|Overall Study|Death|0|||
131056883|NCT02499328|471841335|FG001|Overall Study|Death|3|||
131056884|NCT02499328|471841336|FG002|Overall Study|Death|3|||
131056885|NCT02499328|471841337|FG003|Overall Study|Death|2|||
131056886|NCT02499328|471841338|FG004|Overall Study|Death|4|||
131056887|NCT02499328|471841339|FG005|Overall Study|Death|7|||
131056888|NCT02499328|471841340|FG006|Overall Study|Death|3|||
131056889|NCT02499328|471841341|FG007|Overall Study|Death|0|||
131056890|NCT02499328|471841342|FG008|Overall Study|Death|2|||
131056891|NCT02499328|471841343|FG009|Overall Study|Death|6|||
131056892|NCT02499328|471841344|FG010|Overall Study|Death|6|||
131056893|NCT02499328|471841345|FG011|Overall Study|Death|20|||
131056894|NCT02499328|471841346|FG012|Overall Study|Death|9|||
131056895|NCT02499328|471841347|FG013|Overall Study|Death|7|||
131056896|NCT02499328|471841348|FG014|Overall Study|Death|3|||
131056897|NCT02499328|471841349|FG015|Overall Study|Death|1|||
131056898|NCT02499328|471841350|FG016|Overall Study|Death|1|||
131056899|NCT02499328|471841351|FG017|Overall Study|Death|16|||
131056900|NCT02499328|471841352|FG018|Overall Study|Death|5|||
131056901|NCT02499328|471841334|FG000|Overall Study|"Other"|2|||
131056902|NCT02499328|471841335|FG001|Overall Study|"Other"|2|||
131056903|NCT02499328|471841336|FG002|Overall Study|"Other"|1|||
131056904|NCT02499328|471841337|FG003|Overall Study|"Other"|3|||
131056905|NCT02499328|471841338|FG004|Overall Study|"Other"|6|||
131056906|NCT02499328|471841339|FG005|Overall Study|"Other"|2|||
131056907|NCT02499328|471841340|FG006|Overall Study|"Other"|3|||
131056908|NCT02499328|471841341|FG007|Overall Study|"Other"|4|||
131056909|NCT02499328|471841342|FG008|Overall Study|"Other"|6|||
131056910|NCT02499328|471841343|FG009|Overall Study|"Other"|16|||
131056911|NCT02499328|471841344|FG010|Overall Study|"Other"|13|||
131056912|NCT02499328|471841345|FG011|Overall Study|"Other"|31|||
131056913|NCT02499328|471841346|FG012|Overall Study|"Other"|8|||
131056914|NCT02499328|471841347|FG013|Overall Study|"Other"|7|||
131056915|NCT02499328|471841348|FG014|Overall Study|"Other"|6|||
131056916|NCT02499328|471841349|FG015|Overall Study|"Other"|0|||
131056917|NCT02499328|471841350|FG016|Overall Study|"Other"|0|||
131056918|NCT02499328|471841351|FG017|Overall Study|"Other"|34|||
131056919|NCT02499328|471841352|FG018|Overall Study|"Other"|43|||
131056920|NCT02499328|471841334|FG000|Overall Study|Disease Progression|0|||
131056921|NCT02499328|471841335|FG001|Overall Study|Disease Progression|0|||
131056922|NCT02499328|471841336|FG002|Overall Study|Disease Progression|0|||
131056923|NCT02499328|471841337|FG003|Overall Study|Disease Progression|0|||
131056924|NCT02499328|471841338|FG004|Overall Study|Disease Progression|0|||
131056925|NCT02499328|471841339|FG005|Overall Study|Disease Progression|0|||
131056926|NCT02499328|471841340|FG006|Overall Study|Disease Progression|1|||
131056927|NCT02499328|471841341|FG007|Overall Study|Disease Progression|0|||
131056928|NCT02499328|471841342|FG008|Overall Study|Disease Progression|1|||
131056929|NCT02499328|471841343|FG009|Overall Study|Disease Progression|0|||
131056930|NCT02499328|471841344|FG010|Overall Study|Disease Progression|1|||
131056931|NCT02499328|471841345|FG011|Overall Study|Disease Progression|0|||
131056932|NCT02499328|471841346|FG012|Overall Study|Disease Progression|0|||
131056933|NCT02499328|471841347|FG013|Overall Study|Disease Progression|0|||
131056934|NCT02499328|471841348|FG014|Overall Study|Disease Progression|0|||
131056935|NCT02499328|471841349|FG015|Overall Study|Disease Progression|0|||
131056936|NCT02499328|471841350|FG016|Overall Study|Disease Progression|0|||
131056937|NCT02499328|471841351|FG017|Overall Study|Disease Progression|2|||
131056938|NCT02499328|471841352|FG018|Overall Study|Disease Progression|0|||
131056939|NCT02499328|471841334|FG000|Overall Study|Adverse Event|1|||
131056940|NCT02499328|471841335|FG001|Overall Study|Adverse Event|0|||
131056941|NCT02499328|471841336|FG002|Overall Study|Adverse Event|0|||
131056942|NCT02499328|471841337|FG003|Overall Study|Adverse Event|1|||
131056943|NCT02499328|471841338|FG004|Overall Study|Adverse Event|0|||
131056944|NCT02499328|471841339|FG005|Overall Study|Adverse Event|0|||
131056945|NCT02499328|471841340|FG006|Overall Study|Adverse Event|0|||
131056946|NCT02499328|471841341|FG007|Overall Study|Adverse Event|0|||
131056947|NCT02499328|471841342|FG008|Overall Study|Adverse Event|0|||
131056948|NCT02499328|471841343|FG009|Overall Study|Adverse Event|0|||
131056949|NCT02499328|471841344|FG010|Overall Study|Adverse Event|0|||
131056950|NCT02499328|471841345|FG011|Overall Study|Adverse Event|0|||
131056951|NCT02499328|471841346|FG012|Overall Study|Adverse Event|1|||
131056952|NCT02499328|471841347|FG013|Overall Study|Adverse Event|0|||
131056953|NCT02499328|471841348|FG014|Overall Study|Adverse Event|0|||
131056954|NCT02499328|471841349|FG015|Overall Study|Adverse Event|0|||
131056955|NCT02499328|471841350|FG016|Overall Study|Adverse Event|0|||
131056956|NCT02499328|471841351|FG017|Overall Study|Adverse Event|0|||
131056957|NCT02499328|471841352|FG018|Overall Study|Adverse Event|0|||
131056958|NCT02831049|471841355|FG000|Overall Study|Lost to Follow-up|0|||
131056959|NCT02831049|471841356|FG001|Overall Study|Lost to Follow-up|0|||
131056960|NCT02831049|471841357|FG002|Overall Study|Lost to Follow-up|1|||
131056961|NCT02831049|471841355|FG000|Overall Study|Withdrawal by Subject|0|||
131056962|NCT02831049|471841356|FG001|Overall Study|Withdrawal by Subject|1|||
131056963|NCT02831049|471841357|FG002|Overall Study|Withdrawal by Subject|1|||
131056964|NCT02831049|471841355|FG000|Overall Study|Pandemic shutdown|1|||
131136488|NCT02392429|472128126|FG000|Screening|Screen failure|15|||
131136489|NCT02392429|472128126|FG000|Enrolled Participants|Ineligible due to disease|3|||
131136490|NCT02392429|472128126|FG000|Enrolled Participants|Withdrawal by Subject|4|||
131136491|NCT02392429|472128126|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
131136492|NCT02392429|472128126|FG000|Evaluable|Death|5|||
131136493|NCT02392429|472128126|FG000|Evaluable|Withdrawal by Subject|1|||
131136494|NCT02392429|472128126|FG000|Evaluable|Adverse Event|1|||
131136495|NCT02392429|472128126|FG000|Evaluable|remission bone marrow biopsy|3|||
131136496|NCT00482014|472128127|FG000|Overall Study|Withdrawal by Subject|1|||
131136497|NCT00482014|472128128|FG001|Overall Study|Withdrawal by Subject|2|||
131136498|NCT00482014|472128129|FG002|Overall Study|Withdrawal by Subject|3|||
131136499|NCT00482014|472128130|FG003|Overall Study|Withdrawal by Subject|4|||
131136500|NCT00482014|472128127|FG000|Overall Study|Adverse Event|3|||
131136501|NCT00482014|472128128|FG001|Overall Study|Adverse Event|0|||
131136502|NCT00482014|472128129|FG002|Overall Study|Adverse Event|2|||
131136503|NCT00482014|472128130|FG003|Overall Study|Adverse Event|8|||
131136504|NCT00482014|472128127|FG000|Overall Study|Death|1|||
131136505|NCT00482014|472128128|FG001|Overall Study|Death|2|||
131229833|NCT00696709|472467712|FG000|Overall Study|Withdrawal by Subject|1|||
131229834|NCT00696709|472467713|FG001|Overall Study|Withdrawal by Subject|2|||
131056965|NCT02831049|471841356|FG001|Overall Study|Pandemic shutdown|0|||
131056966|NCT02831049|471841357|FG002|Overall Study|Pandemic shutdown|0|||
131056967|NCT04224272|471841358|FG000|Part 1 - Dose Finding|Death|4|||
131056968|NCT04224272|471841358|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
131056969|NCT04224272|471841358|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
131056970|NCT04224272|471841358|FG000|Part 2 - Dose Expansion|Death|10|||
131056971|NCT04224272|471841358|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
131056972|NCT02609048|471841359|FG000|Overall Study|Adverse Event|3|||
131056973|NCT02609048|471841360|FG001|Overall Study|Adverse Event|0|||
131056974|NCT02609048|471841361|FG002|Overall Study|Adverse Event|0|||
131056975|NCT02609048|471841359|FG000|Overall Study|Randomized but never treated|1|||
131056976|NCT02609048|471841360|FG001|Overall Study|Randomized but never treated|1|||
131056977|NCT02609048|471841361|FG002|Overall Study|Randomized but never treated|1|||
131056978|NCT02609048|471841359|FG000|Overall Study|Withdrawal of informed consent|1|||
131229835|NCT00696709|472467714|FG002|Overall Study|Withdrawal by Subject|1|||
131229836|NCT00696709|472467715|FG003|Overall Study|Withdrawal by Subject|4|||
131229837|NCT00696709|472467716|FG004|Overall Study|Withdrawal by Subject|3|||
131056979|NCT02609048|471841360|FG001|Overall Study|Withdrawal of informed consent|0|||
131056980|NCT02609048|471841361|FG002|Overall Study|Withdrawal of informed consent|0|||
131056981|NCT02609048|471841359|FG000|Overall Study|Reason not specified|6|||
131056982|NCT02609048|471841360|FG001|Overall Study|Reason not specified|9|||
131056983|NCT02609048|471841361|FG002|Overall Study|Reason not specified|9|||
131056984|NCT05995977|471841362|FG000|Overall Study|Withdrawal by Subject|1|||
131136506|NCT00482014|472128129|FG002|Overall Study|Death|1|||
131136507|NCT00482014|472128130|FG003|Overall Study|Death|4|||
131229838|NCT00696709|472467712|FG000|Overall Study|Protocol Violation|1|||
131229839|NCT00696709|472467713|FG001|Overall Study|Protocol Violation|0|||
131056985|NCT05995977|471841363|FG001|Overall Study|Withdrawal by Subject|4|||
131056986|NCT05995977|471841362|FG000|Overall Study|Lost to Follow-up|2|||
131056987|NCT05995977|471841363|FG001|Overall Study|Lost to Follow-up|0|||
131056988|NCT04186247|471841364|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
131136508|NCT00482014|472128127|FG000|Overall Study|Lack of Efficacy|1|||
131136509|NCT00482014|472128128|FG001|Overall Study|Lack of Efficacy|0|||
131136510|NCT00482014|472128129|FG002|Overall Study|Lack of Efficacy|4|||
131136511|NCT00482014|472128130|FG003|Overall Study|Lack of Efficacy|6|||
131136512|NCT00482014|472128127|FG000|Overall Study|Sponsor Decision|1|||
131136513|NCT00482014|472128128|FG001|Overall Study|Sponsor Decision|2|||
131136514|NCT00482014|472128129|FG002|Overall Study|Sponsor Decision|1|||
131136515|NCT00482014|472128130|FG003|Overall Study|Sponsor Decision|1|||
131136516|NCT03686397|472128131|FG000|Overall Study|Lack of Efficacy|3|||
131136517|NCT03686397|472128132|FG001|Overall Study|Lack of Efficacy|5|||
131136518|NCT03686397|472128131|FG000|Overall Study|Adverse Event|0|||
131136519|NCT03686397|472128132|FG001|Overall Study|Adverse Event|1|||
131136520|NCT03686397|472128131|FG000|Overall Study|Protocol Violation|0|||
131136521|NCT03686397|472128132|FG001|Overall Study|Protocol Violation|1|||
131136522|NCT03686397|472128131|FG000|Overall Study|Withdrawal by Subject|0|||
131136523|NCT03686397|472128132|FG001|Overall Study|Withdrawal by Subject|1|||
131136524|NCT03686397|472128131|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
131136525|NCT03686397|472128132|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
131136526|NCT00598975|472128135|FG000|Overall Study|Adverse Event|1|||
131136527|NCT00598975|472128136|FG001|Overall Study|Adverse Event|1|||
131136528|NCT00598975|472128135|FG000|Overall Study|Brain metastases|1|||
131136529|NCT00598975|472128136|FG001|Overall Study|Brain metastases|0|||
131136530|NCT00598975|472128135|FG000|Overall Study|Withdrawal by Subject|1|||
131136531|NCT00598975|472128136|FG001|Overall Study|Withdrawal by Subject|1|||
131136532|NCT00598975|472128135|FG000|Overall Study|Withdrawal of consent|0|||
131136533|NCT00598975|472128136|FG001|Overall Study|Withdrawal of consent|1|||
131136534|NCT00598975|472128135|FG000|Overall Study|Disease progression|8|||
131136535|NCT00598975|472128136|FG001|Overall Study|Disease progression|3|||
131136536|NCT00598975|472128135|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
131136537|NCT00598975|472128136|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
131136538|NCT01178138|472128137|FG000|Overall Study|Lost to Follow-up|8|||
131136539|NCT01178138|472128137|FG000|Overall Study|Withdrawal by Subject|7|||
131136540|NCT01178138|472128137|FG000|Overall Study|Physician Decision|8|||
131136541|NCT01241708|472128138|FG000|Overall Study|Withdrawal by Subject|6|||
131136542|NCT01241708|472128138|FG000|Overall Study|Screen Failure|6|||
131136543|NCT01241708|472128138|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
131136544|NCT01241708|472128138|FG000|Overall Study|Lost to Follow-up|5|||
131056989|NCT04186247|471841365|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
131056990|NCT04186247|471841366|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
131056991|NCT04186247|471841367|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
131056992|NCT04186247|471841368|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
131056993|NCT04118894|471841370|FG000|Overall Study|Lost to Follow-up|21|||
131056994|NCT04118894|471841370|FG000|Overall Study|Withdrawal by Subject|10|||
131056995|NCT04118894|471841370|FG000|Overall Study|Adverse Event|4|||
131056996|NCT02713594|471842708|FG000|Overall Study|Withdrawal by Subject|32|||
131056997|NCT02713594|471842709|FG001|Overall Study|Withdrawal by Subject|22|||
131056998|NCT02713594|471842708|FG000|Overall Study|Lost to Follow-up|358|||
131056999|NCT02713594|471842709|FG001|Overall Study|Lost to Follow-up|374|||
131057000|NCT01214200|471842712|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
131057001|NCT01214200|471842712|FG000|Overall Study|Withdrawal by Subject|2|||
131057002|NCT01823224|471842713|FG000|Overall Study|Lost to Follow-up|5|||
131057003|NCT01823224|471842714|FG001|Overall Study|Lost to Follow-up|6|||
131057004|NCT01823224|471842713|FG000|Overall Study|didn't qualify|1|||
131057005|NCT01823224|471842714|FG001|Overall Study|didn't qualify|2|||
131057006|NCT01823224|471842713|FG000|Overall Study|pharmacy error|0|||
131057007|NCT01823224|471842714|FG001|Overall Study|pharmacy error|1|||
131057008|NCT01823224|471842713|FG000|Overall Study|missed med dose|0|||
131057009|NCT01823224|471842714|FG001|Overall Study|missed med dose|1|||
131057010|NCT01823224|471842713|FG000|Overall Study|Withdrawal by Subject|0|||
131057011|NCT01823224|471842714|FG001|Overall Study|Withdrawal by Subject|1|||
131057012|NCT03292406|471842717|FG000|Overall Study|Progressive Disease|6|||
131057013|NCT03292406|471842718|FG001|Overall Study|Progressive Disease|3|||
131057014|NCT03292406|471842719|FG002|Overall Study|Progressive Disease|4|||
131057015|NCT03292406|471842717|FG000|Overall Study|Adverse Event|7|||
131057016|NCT03292406|471842718|FG001|Overall Study|Adverse Event|1|||
131136545|NCT04137887|472128141|FG000|Overall Study|Death|102|||
131136546|NCT04137887|472128142|FG001|Overall Study|Death|92|||
131136547|NCT04137887|472128141|FG000|Overall Study|Withdrawal by Subject|2|||
131136548|NCT04137887|472128142|FG001|Overall Study|Withdrawal by Subject|3|||
131057017|NCT03292406|471842719|FG002|Overall Study|Adverse Event|4|||
131057018|NCT03292406|471842717|FG000|Overall Study|Withdrawal by Subject|0|||
131057019|NCT03292406|471842718|FG001|Overall Study|Withdrawal by Subject|7|||
131057020|NCT03292406|471842719|FG002|Overall Study|Withdrawal by Subject|2|||
131057021|NCT03292406|471842717|FG000|Overall Study|Protocol Violation|0|||
131136549|NCT04137887|472128141|FG000|Overall Study|Randomized but not treated|0|||
131136550|NCT04137887|472128142|FG001|Overall Study|Randomized but not treated|1|||
131136551|NCT01396005|472128150|FG000|Overall Study|Withdrawal by Subject|0|||
131136552|NCT01396005|472128151|FG001|Overall Study|Withdrawal by Subject|1|||
131136553|NCT01396005|472128150|FG000|Overall Study|Non-compliance with protocol|0|||
131136554|NCT01396005|472128151|FG001|Overall Study|Non-compliance with protocol|1|||
130779369|NCT02326272|470819501|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130779370|NCT02326272|470819502|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131057022|NCT03292406|471842718|FG001|Overall Study|Protocol Violation|1|||
131057023|NCT03292406|471842719|FG002|Overall Study|Protocol Violation|1|||
131057024|NCT03292406|471842717|FG000|Overall Study|Other|0|||
131057025|NCT03292406|471842718|FG001|Overall Study|Other|1|||
131057026|NCT03292406|471842719|FG002|Overall Study|Other|2|||
131057027|NCT03737110|471842720|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
131057028|NCT03737110|471842721|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
131057029|NCT03737110|471842722|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
131057030|NCT03737110|471842723|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
131057031|NCT03737110|471842724|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
131057032|NCT03737110|471842725|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
131057033|NCT03737110|471842720|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
131057034|NCT03737110|471842721|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
131057035|NCT03737110|471842722|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
131057036|NCT03737110|471842723|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
131057037|NCT03737110|471842724|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
131057038|NCT03737110|471842725|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
131057039|NCT03737110|471842720|FG000|Run-in (RI) Period|Adverse Event|4|||
131057040|NCT03737110|471842721|FG001|Run-in (RI) Period|Adverse Event|0|||
131057041|NCT03737110|471842722|FG002|Run-in (RI) Period|Adverse Event|0|||
131057042|NCT03737110|471842723|FG003|Run-in (RI) Period|Adverse Event|0|||
131057043|NCT03737110|471842724|FG004|Run-in (RI) Period|Adverse Event|0|||
131057044|NCT03737110|471842725|FG005|Run-in (RI) Period|Adverse Event|0|||
131057045|NCT03737110|471842720|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
131057046|NCT03737110|471842721|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
131057047|NCT03737110|471842722|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
131057048|NCT03737110|471842723|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
131057049|NCT03737110|471842724|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
131057050|NCT03737110|471842725|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
131057051|NCT03737110|471842720|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131057052|NCT03737110|471842721|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131057053|NCT03737110|471842722|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
131057054|NCT03737110|471842723|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131057055|NCT03737110|471842724|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131057056|NCT03737110|471842725|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
131057057|NCT03737110|471842720|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131057058|NCT03737110|471842721|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131057059|NCT03737110|471842722|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131057060|NCT03737110|471842723|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
131057061|NCT03737110|471842724|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131057062|NCT03737110|471842725|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131057063|NCT03737110|471842720|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
131057064|NCT03737110|471842721|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
131057065|NCT03737110|471842722|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
131057066|NCT03737110|471842723|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
131057067|NCT03737110|471842724|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
131057068|NCT03737110|471842725|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
131057069|NCT03737110|471842720|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
131057070|NCT03737110|471842721|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
131057071|NCT03737110|471842722|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
131057072|NCT03737110|471842723|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
131057073|NCT03737110|471842724|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
131057074|NCT03737110|471842725|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
131057075|NCT00047385|471842730|FG000|Overall Study|Death before any screening|2|||
131057076|NCT00047385|471842731|FG001|Overall Study|Death before any screening|5|||
131057077|NCT00047385|471842730|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
131057078|NCT00047385|471842731|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
131057079|NCT00047385|471842730|FG000|Overall Study|Eligible for screening but had no screen|260|||
131057080|NCT00047385|471842731|FG001|Overall Study|Eligible for screening but had no screen|492|||
131057081|NCT00273052|471842734|FG000|Overall Study|Withdrawal by Subject|16|||
131057082|NCT00273052|471842735|FG001|Overall Study|Withdrawal by Subject|19|||
131057083|NCT00273052|471842734|FG000|Overall Study|Adverse Event|21|||
131057084|NCT00273052|471842735|FG001|Overall Study|Adverse Event|19|||
131057085|NCT00273052|471842734|FG000|Overall Study|Protocol Violation|14|||
131057086|NCT00273052|471842735|FG001|Overall Study|Protocol Violation|18|||
131057087|NCT00273052|471842734|FG000|Overall Study|Lost to Follow-up|7|||
131057088|NCT00273052|471842735|FG001|Overall Study|Lost to Follow-up|25|||
131057089|NCT00273052|471842734|FG000|Overall Study|Lack of Efficacy|6|||
131057090|NCT00273052|471842735|FG001|Overall Study|Lack of Efficacy|4|||
131057091|NCT00273052|471842734|FG000|Overall Study|Non-Compliance|3|||
131057092|NCT00273052|471842735|FG001|Overall Study|Non-Compliance|1|||
131057093|NCT00273052|471842734|FG000|Overall Study|Other|2|||
131057094|NCT00273052|471842735|FG001|Overall Study|Other|0|||
131057095|NCT00273052|471842734|FG000|Overall Study|Worsening serum lipid levels|0|||
131057096|NCT00273052|471842735|FG001|Overall Study|Worsening serum lipid levels|2|||
131057097|NCT01951703|471842738|FG000|First Intervention|Withdrawal by Subject|1|||
131057098|NCT01951703|471842739|FG001|First Intervention|Withdrawal by Subject|0|||
131057099|NCT01951703|471842738|FG000|First Intervention|Subject was not compliant|1|||
131057100|NCT01951703|471842739|FG001|First Intervention|Subject was not compliant|1|||
131057101|NCT01951703|471842738|FG000|First Intervention|Physician Decision|1|||
131057102|NCT01951703|471842739|FG001|First Intervention|Physician Decision|0|||
131057103|NCT01951703|471842738|FG000|Second Intervention|Protocol Violation|0|||
131057104|NCT01951703|471842739|FG001|Second Intervention|Protocol Violation|1|||
131057105|NCT01951703|471842738|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
131057106|NCT01951703|471842739|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
131057107|NCT02708498|471842740|FG000|Overall Study|Death|20|||
131057108|NCT02708498|471842741|FG001|Overall Study|Death|19|||
131057109|NCT02708498|471842742|FG002|Overall Study|Death|0|||
131057110|NCT02708498|471842743|FG003|Overall Study|Death|0|||
131057111|NCT02708498|471842744|FG004|Overall Study|Death|1|||
131057112|NCT02708498|471842745|FG005|Overall Study|Death|0|||
131057113|NCT02708498|471842746|FG006|Overall Study|Death|0|||
131057114|NCT02708498|471842747|FG007|Overall Study|Death|0|||
131057115|NCT02708498|471842740|FG000|Overall Study|Unknown reason, missing data|0|||
131057116|NCT02708498|471842741|FG001|Overall Study|Unknown reason, missing data|0|||
131057117|NCT02708498|471842742|FG002|Overall Study|Unknown reason, missing data|62|||
131057118|NCT02708498|471842743|FG003|Overall Study|Unknown reason, missing data|51|||
131057119|NCT02708498|471842744|FG004|Overall Study|Unknown reason, missing data|195|||
131057120|NCT02708498|471842745|FG005|Overall Study|Unknown reason, missing data|132|||
131057121|NCT02708498|471842746|FG006|Overall Study|Unknown reason, missing data|0|||
131057122|NCT02708498|471842747|FG007|Overall Study|Unknown reason, missing data|0|||
131057123|NCT00195819|471842752|FG000|Double-Blind|Withdrawal by Subject|1|||
131057124|NCT00195819|471842753|FG001|Double-Blind|Withdrawal by Subject|0|||
131057125|NCT00195819|471842752|FG000|Double-Blind|Moved|1|||
131057126|NCT00195819|471842753|FG001|Double-Blind|Moved|0|||
131057127|NCT00195819|471842752|FG000|Open-label|Adverse Event|0|||
131057128|NCT00195819|471842753|FG001|Open-label|Adverse Event|9|||
131136555|NCT00424827|472128152|FG000|Overall Study|Adverse Event|1|||
131136556|NCT03806127|472128153|FG000|Overall Study|Withdrawal by Subject|4|||
131136557|NCT03806127|472128154|FG001|Overall Study|Withdrawal by Subject|5|||
131136558|NCT03806127|472128153|FG000|Overall Study|Protocol Violation|3|||
131136559|NCT03806127|472128154|FG001|Overall Study|Protocol Violation|1|||
131136560|NCT03806127|472128153|FG000|Overall Study|Adverse Event|3|||
131136561|NCT03806127|472128154|FG001|Overall Study|Adverse Event|0|||
131136562|NCT03806127|472128153|FG000|Overall Study|Unable to Complete Procedures|0|||
131136563|NCT03806127|472128154|FG001|Overall Study|Unable to Complete Procedures|1|||
131136564|NCT03806127|472128153|FG000|Overall Study|Pregnancy|0|||
131136565|NCT03806127|472128154|FG001|Overall Study|Pregnancy|1|||
131136566|NCT03806127|472128153|FG000|Overall Study|Lost to Follow-up|5|||
131136567|NCT03806127|472128154|FG001|Overall Study|Lost to Follow-up|1|||
131136568|NCT03806127|472128153|FG000|Overall Study|Physician Decision|1|||
131136569|NCT03806127|472128154|FG001|Overall Study|Physician Decision|1|||
131136570|NCT03806127|472128153|FG000|Overall Study|Could Not Come Due to Covid|1|||
131136571|NCT03806127|472128154|FG001|Overall Study|Could Not Come Due to Covid|0|||
131136572|NCT03806127|472128153|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
131136573|NCT03806127|472128154|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
131136574|NCT03806127|472128153|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
131136575|NCT03806127|472128154|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
131136576|NCT03806127|472128153|FG000|Overall Study|Covid 19 Restrictions|2|||
131057129|NCT00195819|471842752|FG000|Open-label|Lack of Efficacy|0|||
131057130|NCT00195819|471842753|FG001|Open-label|Lack of Efficacy|2|||
131057131|NCT00195819|471842752|FG000|Open-label|Pregnancy|0|||
131057132|NCT00195819|471842753|FG001|Open-label|Pregnancy|1|||
131057133|NCT00195819|471842752|FG000|Open-label|Protocol Violation|0|||
131057134|NCT00195819|471842753|FG001|Open-label|Protocol Violation|2|||
131136577|NCT03806127|472128154|FG001|Overall Study|Covid 19 Restrictions|0|||
131229840|NCT00696709|472467714|FG002|Overall Study|Protocol Violation|0|||
131057135|NCT00195819|471842752|FG000|Open-label|Moved|0|||
131057136|NCT00195819|471842753|FG001|Open-label|Moved|1|||
131136578|NCT03806127|472128153|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
131136579|NCT03806127|472128154|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
131136580|NCT03806127|472128153|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
131229841|NCT00696709|472467715|FG003|Overall Study|Protocol Violation|0|||
131057137|NCT00195819|471842752|FG000|Open-label|Withdrawal by Subject|0|||
131057138|NCT00195819|471842753|FG001|Open-label|Withdrawal by Subject|5|||
131057139|NCT01629589|471842754|FG000|Overall Study|Protocol Violation|4|||
131057140|NCT01629589|471842755|FG001|Overall Study|Protocol Violation|2|||
131057141|NCT01629589|471842754|FG000|Overall Study|Lost to Follow-up|2|||
131057142|NCT01629589|471842755|FG001|Overall Study|Lost to Follow-up|1|||
131057143|NCT01629589|471842754|FG000|Overall Study|Withdrawal by Subject|2|||
131057144|NCT01629589|471842755|FG001|Overall Study|Withdrawal by Subject|3|||
131057145|NCT01629589|471842754|FG000|Overall Study|Did not receive study vaccine|0|||
131057146|NCT01629589|471842755|FG001|Overall Study|Did not receive study vaccine|1|||
131057147|NCT01303510|471842756|FG000|Overall Study|Lost to Follow-up|1|||
131057148|NCT01303510|471842757|FG001|Overall Study|Lost to Follow-up|0|||
131057149|NCT00822900|471842758|FG000|Overall Study|Withdrawal by Subject|14|||
131057150|NCT00822900|471842759|FG001|Overall Study|Withdrawal by Subject|14|||
131057151|NCT00822900|471842758|FG000|Overall Study|Lost to Follow-up|9|||
131057152|NCT00822900|471842759|FG001|Overall Study|Lost to Follow-up|9|||
131057153|NCT00822900|471842758|FG000|Overall Study|Death|83|||
131057154|NCT00822900|471842759|FG001|Overall Study|Death|69|||
131057155|NCT00822900|471842758|FG000|Overall Study|Became a ward of the state|2|||
131057156|NCT00822900|471842759|FG001|Overall Study|Became a ward of the state|1|||
131057157|NCT04660799|471842760|FG000|Overall Study|Progressive Disease|1|||
131057158|NCT04660799|471842761|FG001|Overall Study|Progressive Disease|1|||
131057159|NCT04660799|471842760|FG000|Overall Study|Death|2|||
131057160|NCT04660799|471842761|FG001|Overall Study|Death|1|||
131057161|NCT04660799|471842760|FG000|Overall Study|Adverse Event|2|||
131057162|NCT04660799|471842761|FG001|Overall Study|Adverse Event|1|||
131057163|NCT04660799|471842760|FG000|Overall Study|Withdrawal by Subject|2|||
131057164|NCT04660799|471842761|FG001|Overall Study|Withdrawal by Subject|5|||
131057165|NCT02161458|471842762|FG000|Overall Study|Withdrawal by Subject|0|||
131057166|NCT02161458|471842763|FG001|Overall Study|Withdrawal by Subject|4|||
131057167|NCT02161458|471842764|FG002|Overall Study|Withdrawal by Subject|4|||
131057168|NCT02161458|471842765|FG003|Overall Study|Withdrawal by Subject|0|||
131057169|NCT02161458|471842762|FG000|Overall Study|Lost to Follow-up|0|||
131057170|NCT02161458|471842763|FG001|Overall Study|Lost to Follow-up|2|||
131057171|NCT02161458|471842764|FG002|Overall Study|Lost to Follow-up|1|||
131057172|NCT02161458|471842765|FG003|Overall Study|Lost to Follow-up|0|||
131057173|NCT00391170|471842768|FG000|Overall Study|Withdrawal by Subject|1|||
131057174|NCT00391170|471842769|FG001|Overall Study|Withdrawal by Subject|0|||
131057175|NCT00391170|471842768|FG000|Overall Study|Adverse Event|3|||
131057176|NCT00391170|471842769|FG001|Overall Study|Adverse Event|2|||
131057177|NCT00391170|471842768|FG000|Overall Study|Physician Decision|2|||
131057178|NCT00391170|471842769|FG001|Overall Study|Physician Decision|2|||
131057179|NCT00705159|471842775|FG000|Overall Study|Withdrawal by Subject|0|||
131057180|NCT00705159|471842776|FG001|Overall Study|Withdrawal by Subject|1|||
131057181|NCT00705159|471842777|FG002|Overall Study|Withdrawal by Subject|1|||
131057182|NCT00705159|471842778|FG003|Overall Study|Withdrawal by Subject|1|||
131057183|NCT00705159|471842775|FG000|Overall Study|Protocol Violation|0|||
131057184|NCT00705159|471842776|FG001|Overall Study|Protocol Violation|1|||
131057185|NCT00705159|471842777|FG002|Overall Study|Protocol Violation|0|||
131057186|NCT00705159|471842778|FG003|Overall Study|Protocol Violation|0|||
131057187|NCT00705159|471842775|FG000|Overall Study|Adverse Event|0|||
131057188|NCT00705159|471842776|FG001|Overall Study|Adverse Event|0|||
131057189|NCT00705159|471842777|FG002|Overall Study|Adverse Event|1|||
131057190|NCT00705159|471842778|FG003|Overall Study|Adverse Event|0|||
131057191|NCT00705159|471842775|FG000|Overall Study|Lost to Follow-up|0|||
131057192|NCT00705159|471842776|FG001|Overall Study|Lost to Follow-up|0|||
131057193|NCT00705159|471842777|FG002|Overall Study|Lost to Follow-up|3|||
131057194|NCT00705159|471842778|FG003|Overall Study|Lost to Follow-up|2|||
131057195|NCT00705159|471842775|FG000|Overall Study|Screen Failure|0|||
131057196|NCT00705159|471842776|FG001|Overall Study|Screen Failure|0|||
131057197|NCT00705159|471842777|FG002|Overall Study|Screen Failure|0|||
131057198|NCT00705159|471842778|FG003|Overall Study|Screen Failure|1|||
131057199|NCT03026166|471842781|FG000|Overall Study|Death|22|||
131057200|NCT03026166|471842782|FG001|Overall Study|Death|7|||
131057201|NCT03026166|471842781|FG000|Overall Study|Physician Decision|2|||
131057202|NCT03026166|471842782|FG001|Overall Study|Physician Decision|0|||
131057203|NCT03026166|471842781|FG000|Overall Study|Withdrawal by Subject|1|||
131057204|NCT03026166|471842782|FG001|Overall Study|Withdrawal by Subject|2|||
131057205|NCT03026166|471842781|FG000|Overall Study|Lost to Follow-up|1|||
131057206|NCT03026166|471842782|FG001|Overall Study|Lost to Follow-up|0|||
131057207|NCT03026166|471842781|FG000|Overall Study|Study Terminated by Sponsor|3|||
131057208|NCT03026166|471842782|FG001|Overall Study|Study Terminated by Sponsor|3|||
131057209|NCT03026166|471842781|FG000|Overall Study|Other|1|||
131057210|NCT03026166|471842782|FG001|Overall Study|Other|0|||
131057211|NCT03035942|471842783|FG000|Overall Study|Adverse Event|8|||
131057212|NCT03035942|471842784|FG001|Overall Study|Adverse Event|4|||
131057213|NCT03035942|471842785|FG002|Overall Study|Adverse Event|5|||
131057214|NCT05270460|471842786|FG000|Overall Study|Adverse Event|0|||
131057215|NCT05270460|471842787|FG001|Overall Study|Adverse Event|1|||
131057216|NCT05270460|471842788|FG002|Overall Study|Adverse Event|0|||
130722542|NCT02377427|470608322|FG001|Part A (Up to Week 20)|Physician Decision|0|||
131057217|NCT05270460|471842786|FG000|Overall Study|Early Termination|0|||
131057218|NCT05270460|471842787|FG001|Overall Study|Early Termination|1|||
131057219|NCT05270460|471842788|FG002|Overall Study|Early Termination|0|||
131057220|NCT02091752|471842789|FG000|Overall Study|Study terminated by Sponsor|2|||
131057221|NCT02091752|471842789|FG000|Overall Study|Adverse Event|1|||
131057222|NCT01989104|471842790|FG000|Overall Study|Withdrawal by Subject|3|||
131057223|NCT01989104|471842791|FG001|Overall Study|Withdrawal by Subject|0|||
131057224|NCT01989104|471842792|FG002|Overall Study|Withdrawal by Subject|0|||
131057225|NCT01989104|471842793|FG003|Overall Study|Withdrawal by Subject|0|||
131057226|NCT01989104|471842794|FG004|Overall Study|Withdrawal by Subject|0|||
131057227|NCT01638000|471842800|FG000|Overall Study|Randomized but Never Received Drug|7|||
131057228|NCT01638000|471842801|FG001|Overall Study|Randomized but Never Received Drug|10|||
131057229|NCT01638000|471842800|FG000|Overall Study|Adverse Event|14|||
131057230|NCT01638000|471842801|FG001|Overall Study|Adverse Event|16|||
131057231|NCT01638000|471842800|FG000|Overall Study|Lack of Efficacy|5|||
131057232|NCT01638000|471842801|FG001|Overall Study|Lack of Efficacy|6|||
131057233|NCT01638000|471842800|FG000|Overall Study|Protocol Violation|11|||
131057234|NCT01638000|471842801|FG001|Overall Study|Protocol Violation|13|||
131057235|NCT01638000|471842800|FG000|Overall Study|Withdrawal by Subject|21|||
131057236|NCT01638000|471842801|FG001|Overall Study|Withdrawal by Subject|24|||
131057237|NCT01638000|471842800|FG000|Overall Study|Miscellaneous|2|||
131057238|NCT01638000|471842801|FG001|Overall Study|Miscellaneous|2|||
131057239|NCT04821271|471842802|FG000|Period 1|Withdrawal by Subject|2|||
131057240|NCT04821271|471842803|FG001|Period 1|Withdrawal by Subject|0|||
131057241|NCT04076059|471842804|FG000|Double Blind Phase|Progressive disease|22|||
131057242|NCT04076059|471842805|FG001|Double Blind Phase|Progressive disease|26|||
131057243|NCT04076059|471842806|FG002|Double Blind Phase|Progressive disease|0|||
130722543|NCT02377427|470608323|FG002|Part A (Up to Week 20)|Physician Decision|0|||
131057244|NCT04076059|471842804|FG000|Double Blind Phase|Withdrawal by Subject|4|||
131057245|NCT04076059|471842805|FG001|Double Blind Phase|Withdrawal by Subject|11|||
131057246|NCT04076059|471842806|FG002|Double Blind Phase|Withdrawal by Subject|0|||
131229842|NCT00696709|472467716|FG004|Overall Study|Protocol Violation|0|||
131057247|NCT04076059|471842804|FG000|Double Blind Phase|Death|1|||
131057248|NCT04076059|471842805|FG001|Double Blind Phase|Death|1|||
131057249|NCT04076059|471842806|FG002|Double Blind Phase|Death|0|||
131057250|NCT04076059|471842804|FG000|Double Blind Phase|Lost to Follow-up|1|||
131057251|NCT04076059|471842805|FG001|Double Blind Phase|Lost to Follow-up|0|||
131057252|NCT04076059|471842806|FG002|Double Blind Phase|Lost to Follow-up|0|||
131057253|NCT04076059|471842804|FG000|Double Blind Phase|Adverse Event|5|||
131057254|NCT04076059|471842805|FG001|Double Blind Phase|Adverse Event|1|||
131057255|NCT04076059|471842806|FG002|Double Blind Phase|Adverse Event|0|||
131057256|NCT04076059|471842804|FG000|Double Blind Phase|Ongoing Participants|82|||
131057257|NCT04076059|471842805|FG001|Double Blind Phase|Ongoing Participants|18|||
131057258|NCT04076059|471842806|FG002|Double Blind Phase|Ongoing Participants|0|||
131057259|NCT04076059|471842804|FG000|Double Blind Phase|Miscellaneous|3|||
131057260|NCT04076059|471842805|FG001|Double Blind Phase|Miscellaneous|1|||
131057261|NCT04076059|471842806|FG002|Double Blind Phase|Miscellaneous|0|||
131057262|NCT04076059|471842804|FG000|Double Blind Phase|Protocol Deviation|1|||
131057263|NCT04076059|471842805|FG001|Double Blind Phase|Protocol Deviation|1|||
131057264|NCT04076059|471842806|FG002|Double Blind Phase|Protocol Deviation|0|||
131057265|NCT04076059|471842804|FG000|Double Blind Phase|Did not take study drug|1|||
131057266|NCT04076059|471842805|FG001|Double Blind Phase|Did not take study drug|1|||
131057267|NCT04076059|471842806|FG002|Double Blind Phase|Did not take study drug|0|||
131057268|NCT04076059|471842804|FG000|Open Label Phase|Progressive disease|0|||
131057269|NCT04076059|471842805|FG001|Open Label Phase|Progressive disease|0|||
131057270|NCT04076059|471842806|FG002|Open Label Phase|Progressive disease|7|||
131057271|NCT04076059|471842804|FG000|Open Label Phase|Withdrawal by Subject|0|||
131057272|NCT04076059|471842805|FG001|Open Label Phase|Withdrawal by Subject|0|||
131057273|NCT04076059|471842806|FG002|Open Label Phase|Withdrawal by Subject|3|||
131057274|NCT04076059|471842804|FG000|Open Label Phase|Death|0|||
131057275|NCT04076059|471842805|FG001|Open Label Phase|Death|0|||
131057276|NCT04076059|471842806|FG002|Open Label Phase|Death|2|||
131057277|NCT04076059|471842804|FG000|Open Label Phase|Ongoing Participants|0|||
131057278|NCT04076059|471842805|FG001|Open Label Phase|Ongoing Participants|0|||
131057279|NCT04076059|471842806|FG002|Open Label Phase|Ongoing Participants|11|||
131057280|NCT06269003|471842811|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
131057281|NCT06269003|471842812|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
131057282|NCT06269003|471842813|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
131229843|NCT00696709|472467712|FG000|Overall Study|Lost to Follow-up|1|||
131057283|NCT06269003|471842814|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
131229844|NCT00696709|472467713|FG001|Overall Study|Lost to Follow-up|1|||
131057284|NCT04602728|471842815|FG000|Overall Study|Lost to Follow-up|4|||
131057285|NCT04602728|471842816|FG001|Overall Study|Lost to Follow-up|4|||
131057286|NCT04447027|471842819|FG000|Dose Escalation|Withdrawal by Subject|1|||
131057287|NCT04447027|471842820|FG001|Dose Escalation|Withdrawal by Subject|4|||
131057288|NCT04447027|471842821|FG002|Dose Escalation|Withdrawal by Subject|3|||
131136581|NCT03806127|472128154|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
131136582|NCT01467492|472128157|FG000|Overall Study|Withdrawal by Subject|6|||
131136583|NCT01467492|472128158|FG001|Overall Study|Withdrawal by Subject|4|||
130722544|NCT02377427|470608324|FG003|Part A (Up to Week 20)|Physician Decision|0|||
130722545|NCT02377427|470608325|FG004|Part A (Up to Week 20)|Physician Decision|0|||
131057289|NCT04447027|471842822|FG003|Dose Escalation|Withdrawal by Subject|3|||
131057290|NCT04447027|471842823|FG004|Dose Escalation|Withdrawal by Subject|1|||
131057291|NCT04447027|471842824|FG005|Dose Escalation|Withdrawal by Subject|0|||
131057292|NCT04447027|471842825|FG006|Dose Escalation|Withdrawal by Subject|0|||
131057293|NCT04447027|471842826|FG007|Dose Escalation|Withdrawal by Subject|0|||
131057294|NCT04447027|471842827|FG008|Dose Escalation|Withdrawal by Subject|0|||
131057295|NCT04447027|471842819|FG000|Dose Escalation|Refused further treatment|0|||
131057296|NCT04447027|471842820|FG001|Dose Escalation|Refused further treatment|1|||
131057297|NCT04447027|471842821|FG002|Dose Escalation|Refused further treatment|1|||
131057298|NCT04447027|471842822|FG003|Dose Escalation|Refused further treatment|0|||
131057299|NCT04447027|471842823|FG004|Dose Escalation|Refused further treatment|0|||
131057300|NCT04447027|471842824|FG005|Dose Escalation|Refused further treatment|0|||
131057301|NCT04447027|471842825|FG006|Dose Escalation|Refused further treatment|0|||
131057302|NCT04447027|471842826|FG007|Dose Escalation|Refused further treatment|0|||
131057303|NCT04447027|471842827|FG008|Dose Escalation|Refused further treatment|0|||
131057304|NCT04447027|471842819|FG000|Dose Expansion|Withdrawal by Subject|0|||
131057305|NCT04447027|471842820|FG001|Dose Expansion|Withdrawal by Subject|0|||
131057306|NCT04447027|471842821|FG002|Dose Expansion|Withdrawal by Subject|0|||
131057307|NCT04447027|471842822|FG003|Dose Expansion|Withdrawal by Subject|0|||
131057308|NCT04447027|471842823|FG004|Dose Expansion|Withdrawal by Subject|0|||
131057309|NCT04447027|471842824|FG005|Dose Expansion|Withdrawal by Subject|2|||
131057310|NCT04447027|471842825|FG006|Dose Expansion|Withdrawal by Subject|0|||
131057311|NCT04447027|471842826|FG007|Dose Expansion|Withdrawal by Subject|2|||
131057312|NCT04447027|471842827|FG008|Dose Expansion|Withdrawal by Subject|0|||
131057313|NCT00799409|471843990|FG000|Overall Study|Withdrawal by Subject|1|||
131057314|NCT00799409|471843991|FG001|Overall Study|Withdrawal by Subject|0|||
131057315|NCT00799409|471843992|FG002|Overall Study|Withdrawal by Subject|0|||
131057316|NCT00799409|471843990|FG000|Overall Study|Lost to Follow-up|1|||
131057317|NCT00799409|471843991|FG001|Overall Study|Lost to Follow-up|0|||
131057318|NCT00799409|471843992|FG002|Overall Study|Lost to Follow-up|0|||
131057319|NCT00799409|471843990|FG000|Overall Study|Optimal Dose Not Achieved|2|||
131057320|NCT00799409|471843991|FG001|Overall Study|Optimal Dose Not Achieved|0|||
131057321|NCT00799409|471843992|FG002|Overall Study|Optimal Dose Not Achieved|0|||
131057322|NCT00799409|471843990|FG000|Overall Study|Failure to follow study protocol)|1|||
131057323|NCT00799409|471843991|FG001|Overall Study|Failure to follow study protocol)|0|||
131057324|NCT00799409|471843992|FG002|Overall Study|Failure to follow study protocol)|0|||
131057325|NCT00799409|471843990|FG000|Overall Study|Did not attend lab school day 1|1|||
131057326|NCT00799409|471843991|FG001|Overall Study|Did not attend lab school day 1|0|||
131057327|NCT00799409|471843992|FG002|Overall Study|Did not attend lab school day 1|0|||
131057328|NCT00799409|471843990|FG000|Overall Study|medication compliance|1|||
131057329|NCT00799409|471843991|FG001|Overall Study|medication compliance|0|||
131057330|NCT00799409|471843992|FG002|Overall Study|medication compliance|0|||
131057331|NCT03964974|471843993|FG000|Overall Study|Lost to Follow-up|3|||
131057332|NCT03964974|471843994|FG001|Overall Study|Lost to Follow-up|2|||
131057333|NCT03964974|471843993|FG000|Overall Study|Withdrawal by Subject|0|||
131057334|NCT03964974|471843994|FG001|Overall Study|Withdrawal by Subject|3|||
131057335|NCT02660086|471843995|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
131057336|NCT02660086|471843996|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
131057337|NCT02660086|471843995|FG000|Overall Study- 12-month|Left full-time employment|12|||
131057338|NCT02660086|471843996|FG001|Overall Study- 12-month|Left full-time employment|20|||
131057339|NCT02660086|471843995|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
131057340|NCT02660086|471843996|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
131057341|NCT02660086|471843995|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
131057342|NCT02660086|471843996|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
131057343|NCT02660086|471843995|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
131136584|NCT01467492|472128157|FG000|Overall Study|Study Terminated by Sponsor|6|||
131136585|NCT01467492|472128158|FG001|Overall Study|Study Terminated by Sponsor|4|||
131057344|NCT02660086|471843996|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
131057345|NCT02660086|471843995|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
131057346|NCT02660086|471843996|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
131057347|NCT00667017|471843999|FG000|Overall Study|Withdrawal by Subject|1|||
131057348|NCT02605174|471844003|FG000|Overall Study|Adverse Event|0|||
131057349|NCT02605174|471844004|FG001|Overall Study|Adverse Event|0|||
131057350|NCT02605174|471844005|FG002|Overall Study|Adverse Event|1|||
131057351|NCT02605174|471844006|FG003|Overall Study|Adverse Event|0|||
131057352|NCT02605174|471844007|FG004|Overall Study|Adverse Event|4|||
131136586|NCT01467492|472128157|FG000|Overall Study|Adverse Event|4|||
131136587|NCT01467492|472128158|FG001|Overall Study|Adverse Event|3|||
131136588|NCT01467492|472128157|FG000|Overall Study|Lost to Follow-up|3|||
131136589|NCT01467492|472128158|FG001|Overall Study|Lost to Follow-up|2|||
131136590|NCT01467492|472128157|FG000|Overall Study|Undefined|2|||
131136591|NCT01467492|472128158|FG001|Overall Study|Undefined|0|||
131136592|NCT01467492|472128157|FG000|Overall Study|Enrolled But Not Treated|1|||
131136593|NCT01467492|472128158|FG001|Overall Study|Enrolled But Not Treated|0|||
131136594|NCT02450487|472128160|FG000|Overall Study|Lost to Follow-up|3|||
131136595|NCT01790048|472128161|FG000|Overall Study|Incorrect Age|9|||
131136596|NCT01790048|472128162|FG001|Overall Study|Incorrect Age|14|||
131136597|NCT01790048|472128161|FG000|Overall Study|data entry error|0|||
131136598|NCT01790048|472128162|FG001|Overall Study|data entry error|1|||
131136599|NCT01790048|472128161|FG000|Overall Study|Other|0|||
131136600|NCT01790048|472128162|FG001|Overall Study|Other|2|||
131136601|NCT01790048|472128161|FG000|Overall Study|SAM at Enrollment|2|||
131136602|NCT01790048|472128162|FG001|Overall Study|SAM at Enrollment|0|||
131136603|NCT01790048|472128161|FG000|Overall Study|Measurement error|1|||
131136604|NCT01790048|472128162|FG001|Overall Study|Measurement error|0|||
131136605|NCT00159432|472128163|FG000|Overall Study|Adverse Event|1|||
131136606|NCT00159432|472128163|FG000|Overall Study|Death|1|||
131136607|NCT00159432|472128163|FG000|Overall Study|Lack of Efficacy|8|||
131136608|NCT05030311|472128164|FG000|Overall Study|Technical problems|0|||
131136609|NCT05030311|472128165|FG001|Overall Study|Technical problems|1|||
131136610|NCT05030311|472128164|FG000|Overall Study|Withdrawal by Subject|31|||
131136611|NCT05030311|472128165|FG001|Overall Study|Withdrawal by Subject|17|||
131136612|NCT05030311|472128164|FG000|Overall Study|Adverse Event|13|||
131136613|NCT05030311|472128165|FG001|Overall Study|Adverse Event|5|||
131136614|NCT05030311|472128164|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131136615|NCT05030311|472128165|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131136616|NCT05030311|472128164|FG000|Overall Study|Physician Decision|5|||
131136617|NCT05030311|472128165|FG001|Overall Study|Physician Decision|2|||
131136618|NCT05030311|472128164|FG000|Overall Study|Lost to Follow-up|5|||
131136619|NCT05030311|472128165|FG001|Overall Study|Lost to Follow-up|1|||
131136620|NCT05030311|472128164|FG000|Overall Study|Protocol Violation|4|||
131136621|NCT05030311|472128165|FG001|Overall Study|Protocol Violation|4|||
131136622|NCT03042468|472128167|FG000|Overall Study|Death|0|||
131136623|NCT03042468|472128168|FG001|Overall Study|Death|1|||
131136624|NCT03042468|472128169|FG002|Overall Study|Death|1|||
131229845|NCT00696709|472467714|FG002|Overall Study|Lost to Follow-up|0|||
131057353|NCT02605174|471844008|FG005|Overall Study|Adverse Event|0|||
131057354|NCT02605174|471844009|FG006|Overall Study|Adverse Event|0|||
131057355|NCT02605174|471844003|FG000|Overall Study|Lost to Follow-up|20|||
131057356|NCT02605174|471844004|FG001|Overall Study|Lost to Follow-up|7|||
131057357|NCT02605174|471844005|FG002|Overall Study|Lost to Follow-up|27|||
131057358|NCT02605174|471844006|FG003|Overall Study|Lost to Follow-up|10|||
131057359|NCT02605174|471844007|FG004|Overall Study|Lost to Follow-up|20|||
131057360|NCT02605174|471844008|FG005|Overall Study|Lost to Follow-up|10|||
131057361|NCT02605174|471844009|FG006|Overall Study|Lost to Follow-up|29|||
131057362|NCT02605174|471844003|FG000|Overall Study|Protocol Violation|10|||
131057363|NCT02605174|471844004|FG001|Overall Study|Protocol Violation|4|||
131057364|NCT02605174|471844005|FG002|Overall Study|Protocol Violation|14|||
131057365|NCT02605174|471844006|FG003|Overall Study|Protocol Violation|6|||
131057366|NCT02605174|471844007|FG004|Overall Study|Protocol Violation|7|||
131057367|NCT02605174|471844008|FG005|Overall Study|Protocol Violation|7|||
131057368|NCT02605174|471844009|FG006|Overall Study|Protocol Violation|12|||
131057369|NCT02605174|471844003|FG000|Overall Study|Pregnancy|1|||
131057370|NCT02605174|471844004|FG001|Overall Study|Pregnancy|0|||
131057371|NCT02605174|471844005|FG002|Overall Study|Pregnancy|0|||
131057372|NCT02605174|471844006|FG003|Overall Study|Pregnancy|2|||
131057373|NCT02605174|471844007|FG004|Overall Study|Pregnancy|0|||
131057374|NCT02605174|471844008|FG005|Overall Study|Pregnancy|0|||
131057375|NCT02605174|471844009|FG006|Overall Study|Pregnancy|0|||
131057376|NCT02605174|471844003|FG000|Overall Study|Withdrawal by Subject|9|||
131057377|NCT02605174|471844004|FG001|Overall Study|Withdrawal by Subject|6|||
131057378|NCT02605174|471844005|FG002|Overall Study|Withdrawal by Subject|14|||
131057379|NCT02605174|471844006|FG003|Overall Study|Withdrawal by Subject|11|||
131057380|NCT02605174|471844007|FG004|Overall Study|Withdrawal by Subject|6|||
131057381|NCT02605174|471844008|FG005|Overall Study|Withdrawal by Subject|4|||
131057382|NCT02605174|471844009|FG006|Overall Study|Withdrawal by Subject|15|||
131057383|NCT02605174|471844003|FG000|Overall Study|Physician Decision|2|||
131136625|NCT03042468|472128170|FG003|Overall Study|Death|0|||
131136626|NCT03042468|472128171|FG004|Overall Study|Death|0|||
131136627|NCT03042468|472128172|FG005|Overall Study|Death|0|||
131136628|NCT03042468|472128167|FG000|Overall Study|Withdrawal by Subject|0|||
131136629|NCT03042468|472128168|FG001|Overall Study|Withdrawal by Subject|0|||
131136630|NCT03042468|472128169|FG002|Overall Study|Withdrawal by Subject|0|||
131136631|NCT03042468|472128170|FG003|Overall Study|Withdrawal by Subject|0|||
131136632|NCT03042468|472128171|FG004|Overall Study|Withdrawal by Subject|0|||
131136633|NCT03042468|472128172|FG005|Overall Study|Withdrawal by Subject|1|||
131136634|NCT03042468|472128167|FG000|Overall Study|Lost to Follow-up|0|||
131136635|NCT03042468|472128168|FG001|Overall Study|Lost to Follow-up|0|||
130722546|NCT02377427|470608321|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
131057384|NCT02605174|471844004|FG001|Overall Study|Physician Decision|0|||
131057385|NCT02605174|471844005|FG002|Overall Study|Physician Decision|0|||
131057386|NCT02605174|471844006|FG003|Overall Study|Physician Decision|0|||
131057387|NCT02605174|471844007|FG004|Overall Study|Physician Decision|0|||
131057388|NCT02605174|471844008|FG005|Overall Study|Physician Decision|0|||
131057389|NCT02605174|471844009|FG006|Overall Study|Physician Decision|3|||
131057390|NCT02605174|471844003|FG000|Overall Study|Randomization Failure|22|||
131057391|NCT02605174|471844004|FG001|Overall Study|Randomization Failure|6|||
131057392|NCT02605174|471844005|FG002|Overall Study|Randomization Failure|20|||
131057393|NCT02605174|471844006|FG003|Overall Study|Randomization Failure|7|||
131057394|NCT02605174|471844007|FG004|Overall Study|Randomization Failure|16|||
131057395|NCT02605174|471844008|FG005|Overall Study|Randomization Failure|11|||
131057396|NCT02605174|471844009|FG006|Overall Study|Randomization Failure|30|||
131057397|NCT01779050|471844010|FG000|Overall Study|Withdrawal by Subject|1|||
131057398|NCT01779050|471844011|FG001|Overall Study|Withdrawal by Subject|0|||
131057399|NCT01409837|471844012|FG000|Overall Study|Withdrawal by Subject|2|||
131057400|NCT01409837|471844013|FG001|Overall Study|Withdrawal by Subject|1|||
131057401|NCT01409837|471844012|FG000|Overall Study|Lost to Follow-up|1|||
131057402|NCT01409837|471844013|FG001|Overall Study|Lost to Follow-up|0|||
131057403|NCT01409837|471844012|FG000|Overall Study|Physician Decision|0|||
131057404|NCT01409837|471844013|FG001|Overall Study|Physician Decision|1|||
131057405|NCT03960645|471844014|FG000|Overall Study|Protocol Violation|1|||
131057406|NCT03960645|471844015|FG001|Overall Study|Protocol Violation|0|||
131057407|NCT00022672|471844017|FG000|Main Phase: 24 Months|Adverse Event|6|||
131057408|NCT00022672|471844018|FG001|Main Phase: 24 Months|Adverse Event|0|||
131057409|NCT00022672|471844017|FG000|Main Phase: 24 Months|Death|0|||
131057410|NCT00022672|471844018|FG001|Main Phase: 24 Months|Death|3|||
131057411|NCT00022672|471844017|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
131057412|NCT00022672|471844018|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
131057413|NCT00022672|471844017|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
131057414|NCT00022672|471844018|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
131057415|NCT00022672|471844017|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
131057416|NCT00022672|471844018|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
131057417|NCT00022672|471844017|FG000|Main Phase: 24 Months|Refused Treatment|3|||
131057418|NCT00022672|471844018|FG001|Main Phase: 24 Months|Refused Treatment|4|||
131057419|NCT00022672|471844017|FG000|Main Phase: 24 Months|Failure to Return|1|||
131057420|NCT00022672|471844018|FG001|Main Phase: 24 Months|Failure to Return|1|||
131057421|NCT00022672|471844017|FG000|Main Phase: 24 Months|Other|1|||
131057422|NCT00022672|471844018|FG001|Main Phase: 24 Months|Other|0|||
131057423|NCT00022672|471844017|FG000|Extension Phase|Adverse Event|1|||
131057424|NCT00022672|471844018|FG001|Extension Phase|Adverse Event|3|||
131057425|NCT00022672|471844017|FG000|Extension Phase|Death|0|||
131057426|NCT00022672|471844018|FG001|Extension Phase|Death|1|||
131057427|NCT00022672|471844017|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
131057428|NCT00022672|471844018|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
131057429|NCT00022672|471844017|FG000|Extension Phase|Refused Treatment|0|||
131057430|NCT00022672|471844018|FG001|Extension Phase|Refused Treatment|2|||
131057431|NCT00022672|471844017|FG000|Extension Phase|Other|1|||
131057432|NCT00022672|471844018|FG001|Extension Phase|Other|1|||
131057433|NCT00403494|471844019|FG000|Overall Study|Adverse Event|10|||
131057434|NCT00403494|471844020|FG001|Overall Study|Adverse Event|8|||
131057435|NCT00403494|471844019|FG000|Overall Study|Withdrew Consent|3|||
131057436|NCT00403494|471844020|FG001|Overall Study|Withdrew Consent|2|||
131057437|NCT00403494|471844019|FG000|Overall Study|Inappropriately enrolled|0|||
131057438|NCT00403494|471844020|FG001|Overall Study|Inappropriately enrolled|1|||
131057439|NCT00403494|471844019|FG000|Overall Study|Lost to Follow-up|0|||
131057440|NCT00403494|471844020|FG001|Overall Study|Lost to Follow-up|2|||
131057441|NCT00403494|471844019|FG000|Overall Study|Protocol noncompliance|0|||
131057442|NCT00403494|471844020|FG001|Overall Study|Protocol noncompliance|1|||
131057443|NCT00403494|471844019|FG000|Overall Study|Death|1|||
131057444|NCT00403494|471844020|FG001|Overall Study|Death|0|||
131057445|NCT00403494|471844019|FG000|Overall Study|Sponsor Request|1|||
131057446|NCT00403494|471844020|FG001|Overall Study|Sponsor Request|0|||
131057447|NCT03490032|471844023|FG000|Overall Study|family issue (child custody)|1|||
131057448|NCT03490032|471844024|FG001|Overall Study|family issue (child custody)|0|||
131057449|NCT03490032|471844025|FG002|Overall Study|family issue (child custody)|0|||
131057450|NCT02224755|471844028|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
131057451|NCT02224755|471844029|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
131057452|NCT02224755|471844028|FG000|Two Year Follow up Post-implant|Death|103|||
131057453|NCT02224755|471844029|FG001|Two Year Follow up Post-implant|Death|98|||
131057454|NCT02224755|471844028|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
131229846|NCT00696709|472467715|FG003|Overall Study|Lost to Follow-up|0|||
131057455|NCT02224755|471844029|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
131057456|NCT02224755|471844028|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
130722547|NCT02377427|470608322|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
131136636|NCT03042468|472128169|FG002|Overall Study|Lost to Follow-up|0|||
131136637|NCT03042468|472128170|FG003|Overall Study|Lost to Follow-up|0|||
131136638|NCT03042468|472128171|FG004|Overall Study|Lost to Follow-up|1|||
131136639|NCT03042468|472128172|FG005|Overall Study|Lost to Follow-up|1|||
131136640|NCT03286842|472128173|FG000|Overall Study|Patients rolled over to another study|80|||
131136641|NCT03178487|472128174|FG000|Period 1|Adverse Event|1|||
131136642|NCT03178487|472128175|FG001|Period 1|Adverse Event|2|||
131136643|NCT03178487|472128174|FG000|Period 1|Withdrawal by Subject|2|||
131136644|NCT03178487|472128175|FG001|Period 1|Withdrawal by Subject|1|||
131136645|NCT03178487|472128174|FG000|Period 1|Lost to Follow-up|1|||
131136646|NCT03178487|472128175|FG001|Period 1|Lost to Follow-up|0|||
131136647|NCT03178487|472128174|FG000|Period 1|Other|0|||
131136648|NCT03178487|472128175|FG001|Period 1|Other|1|||
131136649|NCT03178487|472128174|FG000|Period 2|Adverse Event|4|||
131136650|NCT03178487|472128175|FG001|Period 2|Adverse Event|4|||
131136651|NCT03178487|472128174|FG000|Period 2|Withdrawal by Subject|6|||
131136652|NCT03178487|472128175|FG001|Period 2|Withdrawal by Subject|6|||
131136653|NCT03178487|472128174|FG000|Period 2|Lost to Follow-up|2|||
131136654|NCT03178487|472128175|FG001|Period 2|Lost to Follow-up|2|||
131136655|NCT03178487|472128174|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
131057457|NCT02224755|471844029|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
131057458|NCT02224755|471844028|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
131057459|NCT02224755|471844029|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
131057460|NCT01852045|471844030|FG000|Overall Study|Adverse Event|1|||
131057461|NCT01852045|471844031|FG001|Overall Study|Adverse Event|0|||
131057462|NCT01852045|471844032|FG002|Overall Study|Adverse Event|0|||
131057463|NCT01852045|471844030|FG000|Overall Study|Lack of Efficacy|3|||
131057464|NCT01852045|471844031|FG001|Overall Study|Lack of Efficacy|0|||
131057465|NCT01852045|471844032|FG002|Overall Study|Lack of Efficacy|0|||
131057466|NCT01852045|471844030|FG000|Overall Study|Lost to Follow-up|0|||
131057467|NCT01852045|471844031|FG001|Overall Study|Lost to Follow-up|1|||
131057468|NCT01852045|471844032|FG002|Overall Study|Lost to Follow-up|1|||
131057469|NCT01852045|471844030|FG000|Overall Study|Withdrawal by Subject|1|||
131057470|NCT01852045|471844031|FG001|Overall Study|Withdrawal by Subject|0|||
131057471|NCT01852045|471844032|FG002|Overall Study|Withdrawal by Subject|1|||
131057472|NCT01852045|471844030|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131057473|NCT01852045|471844031|FG001|Overall Study|Other Miscellaneous Reasons|3|||
131057474|NCT01852045|471844032|FG002|Overall Study|Other Miscellaneous Reasons|2|||
131057475|NCT02736188|471844033|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
131057476|NCT02736188|471844033|FG000|Overall Study|Adverse Event|1|||
131057477|NCT02736188|471844033|FG000|Overall Study|Withdrawal by Subject|1|||
131057478|NCT02736188|471844033|FG000|Overall Study|Other|6|||
131057479|NCT02007070|471844035|FG000|Overall Study|Adverse Event|4|||
131057480|NCT02007070|471844035|FG000|Overall Study|Clinical Progression|4|||
131057481|NCT02007070|471844035|FG000|Overall Study|Death|1|||
131057482|NCT02007070|471844035|FG000|Overall Study|Protocol Violation|2|||
131057483|NCT02007070|471844035|FG000|Overall Study|Physician Decision|1|||
131057484|NCT02007070|471844035|FG000|Overall Study|Progressive Disease|21|||
131057485|NCT04803734|471844036|FG000|Overall Study|Withdrawal by Subject|0|||
131057486|NCT04803734|471844037|FG001|Overall Study|Withdrawal by Subject|1|||
131057487|NCT04803734|471844036|FG000|Overall Study|Protocol Violation|0|||
131057488|NCT04803734|471844037|FG001|Overall Study|Protocol Violation|1|||
131136656|NCT03178487|472128175|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
131136657|NCT03178487|472128174|FG000|Period 2|Other|8|||
131136658|NCT03178487|472128175|FG001|Period 2|Other|7|||
131136659|NCT01453855|472128176|FG000|Overall Study|Adverse Event|3|||
131136660|NCT01453855|472128177|FG001|Overall Study|Adverse Event|4|||
131136661|NCT01453855|472128176|FG000|Overall Study|Lost to Follow-up|2|||
131057489|NCT01640288|471844038|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
131057490|NCT01640288|471844039|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
131057491|NCT01640288|471844038|FG000|Overall Study|Screen Failure|20|||
131057492|NCT01640288|471844039|FG001|Overall Study|Screen Failure|18|||
131057493|NCT01640288|471844038|FG000|Overall Study|Withdrawn by PI|5|||
131136662|NCT01453855|472128177|FG001|Overall Study|Lost to Follow-up|1|||
131229847|NCT00696709|472467716|FG004|Overall Study|Lost to Follow-up|0|||
131057494|NCT01640288|471844039|FG001|Overall Study|Withdrawn by PI|0|||
131057495|NCT01640288|471844038|FG000|Overall Study|Withdrawal by Subject|1|||
131057496|NCT01640288|471844039|FG001|Overall Study|Withdrawal by Subject|0|||
131057497|NCT05260437|471844040|FG000|Overall Study|Lost to Follow-up|5|||
131136663|NCT01453855|472128176|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
131136664|NCT01453855|472128177|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
131136665|NCT01453855|472128176|FG000|Overall Study|Noncompliance|1|||
131229848|NCT00696709|472467712|FG000|Overall Study|Adverse Event|0|||
131136666|NCT01453855|472128177|FG001|Overall Study|Noncompliance|0|||
131057498|NCT05260437|471844041|FG001|Overall Study|Lost to Follow-up|2|||
131136667|NCT01453855|472128176|FG000|Overall Study|Inadequate Control of IOP|1|||
131136668|NCT01453855|472128177|FG001|Overall Study|Inadequate Control of IOP|5|||
131136669|NCT01453855|472128176|FG000|Overall Study|Other|0|||
131057499|NCT05260437|471844042|FG002|Overall Study|Lost to Follow-up|1|||
131057500|NCT05260437|471844043|FG003|Overall Study|Lost to Follow-up|2|||
131057501|NCT05260437|471844044|FG004|Overall Study|Lost to Follow-up|2|||
131057502|NCT05260437|471844040|FG000|Overall Study|Withdrawal by Subject|3|||
131057503|NCT05260437|471844041|FG001|Overall Study|Withdrawal by Subject|0|||
131057504|NCT05260437|471844042|FG002|Overall Study|Withdrawal by Subject|4|||
131057505|NCT05260437|471844043|FG003|Overall Study|Withdrawal by Subject|5|||
131057506|NCT05260437|471844044|FG004|Overall Study|Withdrawal by Subject|0|||
131057507|NCT05260437|471844040|FG000|Overall Study|Vaccine Not Administered|0|||
131057508|NCT05260437|471844041|FG001|Overall Study|Vaccine Not Administered|1|||
131057509|NCT05260437|471844042|FG002|Overall Study|Vaccine Not Administered|0|||
131057510|NCT05260437|471844043|FG003|Overall Study|Vaccine Not Administered|0|||
131057511|NCT05260437|471844044|FG004|Overall Study|Vaccine Not Administered|0|||
131057512|NCT00910962|471844045|FG000|Overall Study|Adverse Event|5|||
131057513|NCT00910962|471844046|FG001|Overall Study|Adverse Event|20|||
131057514|NCT00910962|471844047|FG002|Overall Study|Adverse Event|17|||
131057515|NCT00910962|471844045|FG000|Overall Study|Protocol Violation|1|||
131057516|NCT00910962|471844046|FG001|Overall Study|Protocol Violation|3|||
131057517|NCT00910962|471844047|FG002|Overall Study|Protocol Violation|3|||
131057518|NCT00910962|471844045|FG000|Overall Study|Lost to Follow-up|0|||
131057519|NCT00910962|471844046|FG001|Overall Study|Lost to Follow-up|3|||
131057520|NCT00910962|471844047|FG002|Overall Study|Lost to Follow-up|1|||
131057521|NCT00910962|471844045|FG000|Overall Study|Physician Decision|0|||
131057522|NCT00910962|471844046|FG001|Overall Study|Physician Decision|6|||
131057523|NCT00910962|471844047|FG002|Overall Study|Physician Decision|6|||
131057524|NCT00910962|471844045|FG000|Overall Study|Withdrawal by Subject|25|||
131057525|NCT00910962|471844046|FG001|Overall Study|Withdrawal by Subject|32|||
131057526|NCT00910962|471844047|FG002|Overall Study|Withdrawal by Subject|32|||
131057527|NCT00910962|471844045|FG000|Overall Study|Reached defined stopping criteria|12|||
131057528|NCT00910962|471844046|FG001|Overall Study|Reached defined stopping criteria|14|||
131057529|NCT00910962|471844047|FG002|Overall Study|Reached defined stopping criteria|17|||
131057530|NCT00787176|471844048|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
131057531|NCT00787176|471844049|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
131057532|NCT00787176|471844050|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
131057533|NCT00787176|471844051|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
131057534|NCT02095678|471844055|FG000|Overall Study|Withdrawal by Subject|0|||
131057535|NCT02095678|471844056|FG001|Overall Study|Withdrawal by Subject|1|||
131057536|NCT02095678|471844055|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
131057537|NCT02095678|471844056|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
131057538|NCT02095678|471844055|FG000|Overall Study|lesion impacted by previous treatment|1|||
131057539|NCT02095678|471844056|FG001|Overall Study|lesion impacted by previous treatment|1|||
131057540|NCT02095678|471844055|FG000|Overall Study|No Confirmed Diagnosis|0|||
131057541|NCT02095678|471844056|FG001|Overall Study|No Confirmed Diagnosis|3|||
131057542|NCT02095678|471844055|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
131057543|NCT02095678|471844056|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
130722548|NCT02377427|470608323|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130722549|NCT02377427|470608324|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130722550|NCT02377427|470608325|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130722551|NCT02377427|470608321|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
130722552|NCT02377427|470608322|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
131057544|NCT02095678|471844055|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
131057545|NCT02095678|471844056|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
131057546|NCT00681109|471844057|FG000|Overall Study|Lost to Follow-up|2|||
131057547|NCT00681109|471844058|FG001|Overall Study|Lost to Follow-up|6|||
131057548|NCT00681109|471844059|FG002|Overall Study|Lost to Follow-up|0|||
131057549|NCT00701415|471844062|FG000|Overall Study|Adverse Event|0|||
131057550|NCT00701415|471844063|FG001|Overall Study|Adverse Event|1|||
131057551|NCT00701415|471844062|FG000|Overall Study|Social/family issues and needle phobia|1|||
131136670|NCT01453855|472128177|FG001|Overall Study|Other|1|||
131136671|NCT01239160|472128178|FG000|Overall Study|Lost to Follow-up|3|||
130722553|NCT02377427|470608323|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
131136672|NCT01239160|472128179|FG001|Overall Study|Lost to Follow-up|5|||
130722554|NCT02377427|470608324|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
131057552|NCT00701415|471844063|FG001|Overall Study|Social/family issues and needle phobia|0|||
131057553|NCT02066636|471844064|FG000|Overall Study|Disease progression|51|||
131057554|NCT02066636|471844065|FG001|Overall Study|Disease progression|60|||
131057555|NCT02066636|471844066|FG002|Overall Study|Disease progression|700|||
131057556|NCT02066636|471844064|FG000|Overall Study|Study drug toxicity|13|||
131057557|NCT02066636|471844065|FG001|Overall Study|Study drug toxicity|2|||
131057558|NCT02066636|471844066|FG002|Overall Study|Study drug toxicity|58|||
131057559|NCT02066636|471844064|FG000|Overall Study|Death|4|||
131136673|NCT01239160|472128180|FG002|Overall Study|Lost to Follow-up|0|||
131136674|NCT01239160|472128178|FG000|Overall Study|Withdrawal by Subject|17|||
131136675|NCT01239160|472128179|FG001|Overall Study|Withdrawal by Subject|6|||
131057560|NCT02066636|471844065|FG001|Overall Study|Death|2|||
131057561|NCT02066636|471844066|FG002|Overall Study|Death|158|||
131057562|NCT02066636|471844064|FG000|Overall Study|Adverse event unrelated to study drug|6|||
131057563|NCT02066636|471844065|FG001|Overall Study|Adverse event unrelated to study drug|4|||
131057564|NCT02066636|471844066|FG002|Overall Study|Adverse event unrelated to study drug|45|||
131057565|NCT02066636|471844064|FG000|Overall Study|Participant request to discontinue treatment|12|||
131057566|NCT02066636|471844065|FG001|Overall Study|Participant request to discontinue treatment|12|||
131057567|NCT02066636|471844066|FG002|Overall Study|Participant request to discontinue treatment|70|||
131057568|NCT02066636|471844064|FG000|Overall Study|Participant withdrew consent|10|||
131057569|NCT02066636|471844065|FG001|Overall Study|Participant withdrew consent|18|||
131057570|NCT02066636|471844066|FG002|Overall Study|Participant withdrew consent|61|||
131057571|NCT02066636|471844064|FG000|Overall Study|Lost to Follow-up|0|||
131057572|NCT02066636|471844065|FG001|Overall Study|Lost to Follow-up|2|||
131057573|NCT02066636|471844066|FG002|Overall Study|Lost to Follow-up|2|||
131057574|NCT02066636|471844064|FG000|Overall Study|Maximum clinical benefit|2|||
131057575|NCT02066636|471844065|FG001|Overall Study|Maximum clinical benefit|2|||
131057576|NCT02066636|471844066|FG002|Overall Study|Maximum clinical benefit|3|||
131057577|NCT02066636|471844064|FG000|Overall Study|Poor/non-compliance|2|||
131057578|NCT02066636|471844065|FG001|Overall Study|Poor/non-compliance|1|||
131057579|NCT02066636|471844066|FG002|Overall Study|Poor/non-compliance|1|||
131057580|NCT02066636|471844064|FG000|Overall Study|Participant no loner meets study criteria|3|||
131057581|NCT02066636|471844065|FG001|Overall Study|Participant no loner meets study criteria|2|||
131057582|NCT02066636|471844066|FG002|Overall Study|Participant no loner meets study criteria|28|||
131057583|NCT02066636|471844064|FG000|Overall Study|Administrative reasons by sponsor|8|||
131057584|NCT02066636|471844065|FG001|Overall Study|Administrative reasons by sponsor|5|||
131057585|NCT02066636|471844066|FG002|Overall Study|Administrative reasons by sponsor|0|||
131057586|NCT02066636|471844064|FG000|Overall Study|Other reasons|16|||
131057587|NCT02066636|471844065|FG001|Overall Study|Other reasons|15|||
131057588|NCT02066636|471844066|FG002|Overall Study|Other reasons|50|||
131057589|NCT02833948|471844068|FG000|Overall Study|Death|2|||
131057590|NCT02833948|471844069|FG001|Overall Study|Death|3|||
131057591|NCT02833948|471844068|FG000|Overall Study|were not scanned|8|||
131057592|NCT02833948|471844069|FG001|Overall Study|were not scanned|13|||
131057593|NCT02833948|471844068|FG000|Overall Study|scans could not be evaluated|5|||
131057594|NCT02833948|471844069|FG001|Overall Study|scans could not be evaluated|2|||
131057595|NCT03539055|471844073|FG000|Overall Study|Death|4|||
131057596|NCT03539055|471844073|FG000|Overall Study|Lost to Follow-up|1|||
131057597|NCT03539055|471844073|FG000|Overall Study|Withdrawal by Subject|2|||
131057598|NCT03539055|471844073|FG000|Overall Study|Screen Fail|7|||
131057599|NCT03539055|471844073|FG000|Overall Study|Drug Intolerance|2|||
131057600|NCT02521493|471844074|FG000|Overall Study|Death|3|||
131057601|NCT02521493|471844075|FG001|Overall Study|Death|4|||
131057602|NCT02521493|471844076|FG002|Overall Study|Death|1|||
131057603|NCT02521493|471844074|FG000|Overall Study|Physician Decision|19|||
131057604|NCT02521493|471844075|FG001|Overall Study|Physician Decision|1|||
131057605|NCT02521493|471844076|FG002|Overall Study|Physician Decision|2|||
131057606|NCT02521493|471844074|FG000|Overall Study|Withdrawal by Subject|3|||
131057607|NCT02521493|471844075|FG001|Overall Study|Withdrawal by Subject|0|||
131057608|NCT02521493|471844076|FG002|Overall Study|Withdrawal by Subject|0|||
131057609|NCT02521493|471844074|FG000|Overall Study|Ineligible|0|||
131057610|NCT02521493|471844075|FG001|Overall Study|Ineligible|1|||
131057611|NCT02521493|471844076|FG002|Overall Study|Ineligible|0|||
131057612|NCT02521493|471844074|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
131057613|NCT02521493|471844075|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
131057614|NCT02521493|471844076|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
131057615|NCT02521493|471844074|FG000|Overall Study|No MRD result|0|||
131057616|NCT02521493|471844075|FG001|Overall Study|No MRD result|0|||
131057617|NCT02521493|471844076|FG002|Overall Study|No MRD result|4|||
131057618|NCT01218594|471844077|FG000|Overall Study|Death|1|||
131057619|NCT01218594|471844077|FG000|Overall Study|Withdrawal by Subject|3|||
131057620|NCT01218594|471844077|FG000|Overall Study|Adverse Event|2|||
131057621|NCT01218594|471844077|FG000|Overall Study|Physician Decision|6|||
131057622|NCT04748341|471844078|FG000|Overall Study|Lost to Follow-up|1|||
131057623|NCT04748341|471844079|FG001|Overall Study|Lost to Follow-up|1|||
131057624|NCT00452114|471844081|FG000|Overall Study|Physician Decision|3|||
131057625|NCT00452114|471844082|FG001|Overall Study|Physician Decision|3|||
131057626|NCT02334215|471844083|FG000|Overall Study|Death|1|||
131057627|NCT02334215|471844084|FG001|Overall Study|Death|1|||
131057628|NCT02334215|471844085|FG002|Overall Study|Death|0|||
131057629|NCT02334215|471844083|FG000|Overall Study|Lost to Follow-up|1|||
131057630|NCT02334215|471844084|FG001|Overall Study|Lost to Follow-up|0|||
131057631|NCT02334215|471844085|FG002|Overall Study|Lost to Follow-up|4|||
131057632|NCT02334215|471844083|FG000|Overall Study|Withdrawal by Subject|2|||
131057633|NCT02334215|471844084|FG001|Overall Study|Withdrawal by Subject|2|||
131057634|NCT02334215|471844085|FG002|Overall Study|Withdrawal by Subject|1|||
131057635|NCT02334215|471844083|FG000|Overall Study|Not released from incarceration on time|3|||
131057636|NCT02334215|471844084|FG001|Overall Study|Not released from incarceration on time|3|||
131057637|NCT02334215|471844085|FG002|Overall Study|Not released from incarceration on time|3|||
131057638|NCT02334215|471844083|FG000|Overall Study|Incarcerated|0|||
131057639|NCT02334215|471844084|FG001|Overall Study|Incarcerated|0|||
131057640|NCT02334215|471844085|FG002|Overall Study|Incarcerated|7|||
130722555|NCT02377427|470608325|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
130722556|NCT02377427|470608321|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130722557|NCT02377427|470608322|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130722558|NCT02377427|470608323|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
131057641|NCT03905642|471844086|FG000|Overall Study|Withdrawal by Subject|3|||
131057642|NCT03905642|471844086|FG000|Overall Study|Pregnancy|1|||
131057643|NCT03905642|471844086|FG000|Overall Study|Adverse Event|1|||
131057644|NCT03905642|471844086|FG000|Overall Study|Lack of Efficacy|1|||
131057645|NCT03905642|471844086|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
131057646|NCT04535414|471844090|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
131057647|NCT04535414|471844091|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
131057648|NCT04535414|471844090|FG000|Overall Study|Cancelled appointment|1|||
131057649|NCT04535414|471844091|FG001|Overall Study|Cancelled appointment|0|||
131057650|NCT04535414|471844090|FG000|Overall Study|cancelled - food in stomach|2|||
131057651|NCT04535414|471844091|FG001|Overall Study|cancelled - food in stomach|0|||
131057652|NCT04535414|471844090|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
131057653|NCT04535414|471844091|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
131057654|NCT04535414|471844090|FG000|Overall Study|Withdrawal by Subject|0|||
131057655|NCT04535414|471844091|FG001|Overall Study|Withdrawal by Subject|1|||
131057656|NCT00949117|471845653|FG000|Overall Study|Lack of Efficacy|2|||
131057657|NCT00949117|471845654|FG001|Overall Study|Lack of Efficacy|3|||
131057658|NCT00949117|471845653|FG000|Overall Study|Protocol Violation|1|||
131057659|NCT00949117|471845654|FG001|Overall Study|Protocol Violation|1|||
131057660|NCT00949117|471845653|FG000|Overall Study|Adverse Event|0|||
131057661|NCT00949117|471845654|FG001|Overall Study|Adverse Event|1|||
131057662|NCT03769090|471845655|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
131057663|NCT03769090|471845656|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
131057664|NCT03769090|471845657|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
131057665|NCT03769090|471845655|FG000|Overall Study|Withdrawal by Subject|52|||
131057666|NCT03769090|471845656|FG001|Overall Study|Withdrawal by Subject|62|||
131057667|NCT03769090|471845657|FG002|Overall Study|Withdrawal by Subject|74|||
131057668|NCT03769090|471845655|FG000|Overall Study|Death|4|||
131057669|NCT03769090|471845656|FG001|Overall Study|Death|2|||
131057670|NCT03769090|471845657|FG002|Overall Study|Death|2|||
131057671|NCT03769090|471845655|FG000|Overall Study|Adverse Event|7|||
131057672|NCT03769090|471845656|FG001|Overall Study|Adverse Event|7|||
131057673|NCT03769090|471845657|FG002|Overall Study|Adverse Event|8|||
131057674|NCT03769090|471845655|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
131057675|NCT03769090|471845656|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
131057676|NCT03769090|471845657|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
131057677|NCT03769090|471845655|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
131057678|NCT03769090|471845656|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
131057679|NCT03769090|471845657|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
131057680|NCT03769090|471845655|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
131057681|NCT03769090|471845656|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
131057682|NCT03769090|471845657|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
131057683|NCT03769090|471845655|FG000|Overall Study|Protocol Violation|5|||
131057684|NCT03769090|471845656|FG001|Overall Study|Protocol Violation|6|||
131057685|NCT03769090|471845657|FG002|Overall Study|Protocol Violation|8|||
131057686|NCT03769090|471845655|FG000|Overall Study|Pregnancy|1|||
131057687|NCT03769090|471845656|FG001|Overall Study|Pregnancy|0|||
131057688|NCT03769090|471845657|FG002|Overall Study|Pregnancy|3|||
131057689|NCT03769090|471845655|FG000|Overall Study|Lost to Follow-up|19|||
131057690|NCT03769090|471845656|FG001|Overall Study|Lost to Follow-up|25|||
131057691|NCT03769090|471845657|FG002|Overall Study|Lost to Follow-up|21|||
131057692|NCT03769090|471845655|FG000|Overall Study|Condition under investigation worsened|2|||
131057693|NCT03769090|471845656|FG001|Overall Study|Condition under investigation worsened|0|||
131057694|NCT03769090|471845657|FG002|Overall Study|Condition under investigation worsened|1|||
131057695|NCT03769090|471845655|FG000|Overall Study|Lack of Efficacy|1|||
131057696|NCT03769090|471845656|FG001|Overall Study|Lack of Efficacy|2|||
131057697|NCT03769090|471845657|FG002|Overall Study|Lack of Efficacy|2|||
131057698|NCT03769090|471845655|FG000|Overall Study|Other reasons|8|||
131057699|NCT03769090|471845656|FG001|Overall Study|Other reasons|12|||
131057700|NCT03769090|471845657|FG002|Overall Study|Other reasons|15|||
131057701|NCT01567852|471845658|FG000|Overall Study|Withdrawal by Subject|3|||
131057702|NCT01567852|471845659|FG001|Overall Study|Withdrawal by Subject|6|||
131057703|NCT01567852|471845658|FG000|Overall Study|ECT discontinued|1|||
131057704|NCT01567852|471845659|FG001|Overall Study|ECT discontinued|1|||
131057705|NCT02014402|471845663|FG000|Overall Study|Adverse Event|1|||
131057706|NCT02014402|471845664|FG001|Overall Study|Adverse Event|0|||
131057707|NCT02014402|471845665|FG002|Overall Study|Adverse Event|0|||
131057708|NCT02014402|471845666|FG003|Overall Study|Adverse Event|0|||
131057709|NCT02014402|471845663|FG000|Overall Study|Withdrawal by Subject|1|||
131057710|NCT02014402|471845664|FG001|Overall Study|Withdrawal by Subject|2|||
131057711|NCT02014402|471845665|FG002|Overall Study|Withdrawal by Subject|2|||
131057712|NCT02014402|471845666|FG003|Overall Study|Withdrawal by Subject|1|||
131057713|NCT02014402|471845663|FG000|Overall Study|Subject did not have transportation|0|||
131057714|NCT02014402|471845664|FG001|Overall Study|Subject did not have transportation|1|||
131057715|NCT02014402|471845665|FG002|Overall Study|Subject did not have transportation|0|||
131057716|NCT02014402|471845666|FG003|Overall Study|Subject did not have transportation|0|||
131057717|NCT02014402|471845663|FG000|Overall Study|Lost to Follow-up|0|||
131057718|NCT02014402|471845664|FG001|Overall Study|Lost to Follow-up|0|||
131057719|NCT02014402|471845665|FG002|Overall Study|Lost to Follow-up|1|||
131057720|NCT02014402|471845666|FG003|Overall Study|Lost to Follow-up|2|||
131057721|NCT00443820|471845667|FG000|Overall Study|Adverse Event|1|||
131057722|NCT00443820|471845668|FG001|Overall Study|Adverse Event|1|||
131057723|NCT00443820|471845669|FG002|Overall Study|Adverse Event|0|||
131057724|NCT00443820|471845670|FG003|Overall Study|Adverse Event|0|||
131057725|NCT00443820|471845667|FG000|Overall Study|Lack of Efficacy|3|||
131057726|NCT00443820|471845668|FG001|Overall Study|Lack of Efficacy|2|||
131057727|NCT00443820|471845669|FG002|Overall Study|Lack of Efficacy|1|||
131057728|NCT00443820|471845670|FG003|Overall Study|Lack of Efficacy|1|||
131057729|NCT00443820|471845667|FG000|Overall Study|Protocol Violation|2|||
131057730|NCT00443820|471845668|FG001|Overall Study|Protocol Violation|1|||
131057731|NCT00443820|471845669|FG002|Overall Study|Protocol Violation|2|||
131057732|NCT00443820|471845670|FG003|Overall Study|Protocol Violation|1|||
131057733|NCT00443820|471845667|FG000|Overall Study|Withdrawal by Subject|6|||
131057734|NCT00443820|471845668|FG001|Overall Study|Withdrawal by Subject|7|||
131057735|NCT00443820|471845669|FG002|Overall Study|Withdrawal by Subject|8|||
131057736|NCT00443820|471845670|FG003|Overall Study|Withdrawal by Subject|9|||
131057737|NCT00443820|471845667|FG000|Overall Study|Lost to Follow-up|9|||
131057738|NCT00443820|471845668|FG001|Overall Study|Lost to Follow-up|8|||
131057739|NCT00443820|471845669|FG002|Overall Study|Lost to Follow-up|6|||
131057740|NCT00443820|471845670|FG003|Overall Study|Lost to Follow-up|5|||
131057741|NCT00443820|471845667|FG000|Overall Study|Administrative problems|0|||
131057742|NCT00443820|471845668|FG001|Overall Study|Administrative problems|0|||
131057743|NCT00443820|471845669|FG002|Overall Study|Administrative problems|0|||
131057744|NCT00443820|471845670|FG003|Overall Study|Administrative problems|1|||
131057745|NCT00443820|471845667|FG000|Overall Study|Death|0|||
131057746|NCT00443820|471845668|FG001|Overall Study|Death|0|||
131057747|NCT00443820|471845669|FG002|Overall Study|Death|1|||
131057748|NCT00443820|471845670|FG003|Overall Study|Death|0|||
131057749|NCT04633200|471845671|FG000|Overall Study|Lost to Follow-up|3|||
131057750|NCT04633200|471845672|FG001|Overall Study|Lost to Follow-up|5|||
131057751|NCT03493282|471845673|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
131057752|NCT03493282|471845674|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
131057753|NCT03493282|471845675|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
131057754|NCT03493282|471845673|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
131057755|NCT03493282|471845674|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
131057756|NCT03493282|471845675|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
131057757|NCT00670449|471845676|FG000|Overall Study|Adverse Event|6|||
131057758|NCT00670449|471845677|FG001|Overall Study|Adverse Event|2|||
131057759|NCT00670449|471845678|FG002|Overall Study|Adverse Event|8|||
131057760|NCT00670449|471845679|FG003|Overall Study|Adverse Event|5|||
131057761|NCT00670449|471845676|FG000|Overall Study|Protocol Deviation|1|||
131057762|NCT00670449|471845677|FG001|Overall Study|Protocol Deviation|2|||
131057763|NCT00670449|471845678|FG002|Overall Study|Protocol Deviation|0|||
131057764|NCT00670449|471845679|FG003|Overall Study|Protocol Deviation|1|||
131057765|NCT00670449|471845676|FG000|Overall Study|Administrative Problems|0|||
131057766|NCT00670449|471845677|FG001|Overall Study|Administrative Problems|2|||
131057767|NCT00670449|471845678|FG002|Overall Study|Administrative Problems|0|||
131057768|NCT00670449|471845679|FG003|Overall Study|Administrative Problems|1|||
131057769|NCT00670449|471845676|FG000|Overall Study|Subject Withdrew Consent|0|||
131057770|NCT00670449|471845677|FG001|Overall Study|Subject Withdrew Consent|2|||
131057771|NCT00670449|471845678|FG002|Overall Study|Subject Withdrew Consent|0|||
131057772|NCT00670449|471845679|FG003|Overall Study|Subject Withdrew Consent|1|||
131057773|NCT00670449|471845676|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
130722559|NCT02377427|470608324|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
131057774|NCT00670449|471845677|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131057775|NCT00670449|471845678|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
131057776|NCT00670449|471845679|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131057777|NCT00670449|471845676|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
131057778|NCT00670449|471845677|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
131057779|NCT00670449|471845678|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
131057780|NCT00670449|471845679|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
131057781|NCT01523392|471845680|FG000|Treatment Period 1|Withdrawal by Subject|2|||
131057782|NCT01523392|471845681|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131057783|NCT01523392|471845680|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
131057784|NCT01523392|471845681|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
131057785|NCT01523392|471845680|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
131057786|NCT01523392|471845681|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
131057787|NCT04809623|471845682|FG000|Overall Study|Study Terminated by Sponsor|1|||
131057788|NCT04809623|471845683|FG001|Overall Study|Study Terminated by Sponsor|0|||
131057789|NCT00671853|471845685|FG000|Overall Study|Lack of Efficacy|3|||
131057790|NCT00671853|471845686|FG001|Overall Study|Lack of Efficacy|7|||
131057791|NCT00671853|471845685|FG000|Overall Study|Adverse Event|7|||
131057792|NCT00671853|471845686|FG001|Overall Study|Adverse Event|1|||
131057793|NCT00671853|471845685|FG000|Overall Study|Withdrawal by Subject|1|||
131057794|NCT00671853|471845686|FG001|Overall Study|Withdrawal by Subject|5|||
131057795|NCT00671853|471845685|FG000|Overall Study|Lost to Follow-up|8|||
131057796|NCT00671853|471845686|FG001|Overall Study|Lost to Follow-up|8|||
131057797|NCT00671853|471845685|FG000|Overall Study|Physician Decision|0|||
131057798|NCT00671853|471845686|FG001|Overall Study|Physician Decision|2|||
131057799|NCT00671853|471845685|FG000|Overall Study|Non-adherence with study procedures|1|||
131057800|NCT00671853|471845686|FG001|Overall Study|Non-adherence with study procedures|4|||
131057801|NCT01719172|471845688|FG000|Overall Study|Lost to Follow-up|1|||
131057802|NCT01719172|471845688|FG000|Overall Study|Death|1|||
131057803|NCT00587171|471845689|FG000|Overall Study|Lost to Follow-up|1|||
131057804|NCT00587171|471845690|FG001|Overall Study|Lost to Follow-up|1|||
131057805|NCT01148017|471845691|FG000|Overall Study|Withdrawal by Subject|31|||
131057806|NCT01148017|471845692|FG001|Overall Study|Withdrawal by Subject|14|||
131057807|NCT01148017|471845693|FG002|Overall Study|Withdrawal by Subject|0|||
131057808|NCT01148017|471845694|FG003|Overall Study|Withdrawal by Subject|0|||
131057809|NCT01148017|471845691|FG000|Overall Study|Lost to Follow-up|23|||
131057810|NCT01148017|471845692|FG001|Overall Study|Lost to Follow-up|10|||
131057811|NCT01148017|471845693|FG002|Overall Study|Lost to Follow-up|0|||
131057812|NCT01148017|471845694|FG003|Overall Study|Lost to Follow-up|0|||
131057813|NCT01148017|471845691|FG000|Overall Study|Inappropriate enrollment|1|||
131057814|NCT01148017|471845692|FG001|Overall Study|Inappropriate enrollment|0|||
131057815|NCT01148017|471845693|FG002|Overall Study|Inappropriate enrollment|0|||
131057816|NCT01148017|471845694|FG003|Overall Study|Inappropriate enrollment|0|||
131057817|NCT01148017|471845691|FG000|Overall Study|Administrative reason|22|||
131057818|NCT01148017|471845692|FG001|Overall Study|Administrative reason|9|||
131057819|NCT01148017|471845693|FG002|Overall Study|Administrative reason|0|||
131057820|NCT01148017|471845694|FG003|Overall Study|Administrative reason|0|||
131057821|NCT01148017|471845691|FG000|Overall Study|Unable to classify|3|||
131057822|NCT01148017|471845692|FG001|Overall Study|Unable to classify|1|||
131057823|NCT01148017|471845693|FG002|Overall Study|Unable to classify|0|||
131057824|NCT01148017|471845694|FG003|Overall Study|Unable to classify|0|||
131057825|NCT01848483|471845695|FG000|Overall Study|Death|2|||
131057826|NCT01848483|471845696|FG001|Overall Study|Death|1|||
131057827|NCT01848483|471845695|FG000|Overall Study|Lost to Follow-up|6|||
131057828|NCT01848483|471845696|FG001|Overall Study|Lost to Follow-up|8|||
131057829|NCT01848483|471845695|FG000|Overall Study|Withdrawal by Subject|1|||
131057830|NCT01848483|471845696|FG001|Overall Study|Withdrawal by Subject|0|||
131057831|NCT01848483|471845695|FG000|Overall Study|Incarceration|2|||
131057832|NCT01848483|471845696|FG001|Overall Study|Incarceration|2|||
131057833|NCT04250636|471845699|FG000|Overall Study|Lost to Follow-up|2|||
131057834|NCT03041090|471845700|FG000|Overall Study|technical error|0|||
131057835|NCT03041090|471845701|FG001|Overall Study|technical error|3|||
131057836|NCT02202317|471845703|FG000|Overall Study|Lost to Follow-up|1|||
131057837|NCT01353274|471845704|FG000|Overall Study|No case report form (CRF) collected|28|||
131057838|NCT01332266|471845706|FG000|Phase 1b|Death|3|||
131057839|NCT01332266|471845707|FG001|Phase 1b|Death|3|||
131057840|NCT01332266|471845708|FG002|Phase 1b|Death|2|||
131057841|NCT01332266|471845709|FG003|Phase 1b|Death|0|||
131057842|NCT01332266|471845710|FG004|Phase 1b|Death|0|||
131057843|NCT01332266|471845706|FG000|Phase 1b|Lost to Follow-up|0|||
131057844|NCT01332266|471845707|FG001|Phase 1b|Lost to Follow-up|1|||
131057845|NCT01332266|471845708|FG002|Phase 1b|Lost to Follow-up|0|||
131057846|NCT01332266|471845709|FG003|Phase 1b|Lost to Follow-up|0|||
131057847|NCT01332266|471845710|FG004|Phase 1b|Lost to Follow-up|0|||
131057848|NCT01332266|471845706|FG000|Phase 1b|Withdrawal by Subject|1|||
131057849|NCT01332266|471845707|FG001|Phase 1b|Withdrawal by Subject|1|||
131057850|NCT01332266|471845708|FG002|Phase 1b|Withdrawal by Subject|1|||
131057851|NCT01332266|471845709|FG003|Phase 1b|Withdrawal by Subject|0|||
131057852|NCT01332266|471845710|FG004|Phase 1b|Withdrawal by Subject|0|||
131057853|NCT01332266|471845706|FG000|Phase 2|Death|0|||
131057854|NCT01332266|471845707|FG001|Phase 2|Death|0|||
131057855|NCT01332266|471845708|FG002|Phase 2|Death|0|||
131057856|NCT01332266|471845709|FG003|Phase 2|Death|33|||
131057857|NCT01332266|471845710|FG004|Phase 2|Death|36|||
131057858|NCT01332266|471845706|FG000|Phase 2|Lost to Follow-up|0|||
131057859|NCT01332266|471845707|FG001|Phase 2|Lost to Follow-up|0|||
131057860|NCT01332266|471845708|FG002|Phase 2|Lost to Follow-up|0|||
131057861|NCT01332266|471845709|FG003|Phase 2|Lost to Follow-up|2|||
131057862|NCT01332266|471845710|FG004|Phase 2|Lost to Follow-up|0|||
131057863|NCT01332266|471845706|FG000|Phase 2|Physician Decision|0|||
131057864|NCT01332266|471845707|FG001|Phase 2|Physician Decision|0|||
131057865|NCT01332266|471845708|FG002|Phase 2|Physician Decision|0|||
131057866|NCT01332266|471845709|FG003|Phase 2|Physician Decision|3|||
131057867|NCT01332266|471845710|FG004|Phase 2|Physician Decision|1|||
131057868|NCT01332266|471845706|FG000|Phase 2|Symptomatic deterioration|0|||
131057869|NCT01332266|471845707|FG001|Phase 2|Symptomatic deterioration|0|||
131057870|NCT01332266|471845708|FG002|Phase 2|Symptomatic deterioration|0|||
131057871|NCT01332266|471845709|FG003|Phase 2|Symptomatic deterioration|0|||
131057872|NCT01332266|471845710|FG004|Phase 2|Symptomatic deterioration|1|||
131057873|NCT01332266|471845706|FG000|Phase 2|Progression Disease|0|||
131057874|NCT01332266|471845707|FG001|Phase 2|Progression Disease|0|||
131057875|NCT01332266|471845708|FG002|Phase 2|Progression Disease|0|||
131057876|NCT01332266|471845709|FG003|Phase 2|Progression Disease|2|||
131057877|NCT01332266|471845710|FG004|Phase 2|Progression Disease|1|||
131057878|NCT01332266|471845706|FG000|Phase 2|Withdrawal by Subject|0|||
131057879|NCT01332266|471845707|FG001|Phase 2|Withdrawal by Subject|0|||
131057880|NCT01332266|471845708|FG002|Phase 2|Withdrawal by Subject|0|||
131057881|NCT01332266|471845709|FG003|Phase 2|Withdrawal by Subject|2|||
131057882|NCT01332266|471845710|FG004|Phase 2|Withdrawal by Subject|2|||
131057883|NCT02128269|471845717|FG000|Treatment Period|Adverse Event|1|||
131057884|NCT02128269|471845717|FG000|Treatment Period|Physician Decision|1|||
131057885|NCT00878189|471845718|FG000|Overall Study|Death|0|||
131057886|NCT00878189|471845719|FG001|Overall Study|Death|1|||
131057887|NCT00878189|471845720|FG002|Overall Study|Death|0|||
131057888|NCT00878189|471845721|FG003|Overall Study|Death|1|||
131057889|NCT00878189|471845722|FG004|Overall Study|Death|0|||
131057890|NCT00878189|471845723|FG005|Overall Study|Death|0|||
131057891|NCT00878189|471845724|FG006|Overall Study|Death|0|||
131057892|NCT00878189|471845725|FG007|Overall Study|Death|0|||
131057893|NCT00878189|471845726|FG008|Overall Study|Death|1|||
131057894|NCT00878189|471845718|FG000|Overall Study|Participant Refused to Follow-up|0|||
131057895|NCT00878189|471845719|FG001|Overall Study|Participant Refused to Follow-up|0|||
131057896|NCT00878189|471845720|FG002|Overall Study|Participant Refused to Follow-up|0|||
131057897|NCT00878189|471845721|FG003|Overall Study|Participant Refused to Follow-up|0|||
131057898|NCT00878189|471845722|FG004|Overall Study|Participant Refused to Follow-up|0|||
131057899|NCT00878189|471845723|FG005|Overall Study|Participant Refused to Follow-up|4|||
131057900|NCT00878189|471845724|FG006|Overall Study|Participant Refused to Follow-up|0|||
131057901|NCT00878189|471845725|FG007|Overall Study|Participant Refused to Follow-up|0|||
131057902|NCT00878189|471845726|FG008|Overall Study|Participant Refused to Follow-up|0|||
131057903|NCT00878189|471845718|FG000|Overall Study|Other|3|||
131057904|NCT00878189|471845719|FG001|Overall Study|Other|2|||
131057905|NCT00878189|471845720|FG002|Overall Study|Other|4|||
131057906|NCT00878189|471845721|FG003|Overall Study|Other|7|||
131057907|NCT00878189|471845722|FG004|Overall Study|Other|4|||
131057908|NCT00878189|471845723|FG005|Overall Study|Other|18|||
131057909|NCT00878189|471845724|FG006|Overall Study|Other|15|||
131057910|NCT00878189|471845725|FG007|Overall Study|Other|3|||
131057911|NCT00878189|471845726|FG008|Overall Study|Other|4|||
131057912|NCT00878189|471845718|FG000|Overall Study|Lost to Follow-up|0|||
131136676|NCT01239160|472128180|FG002|Overall Study|Withdrawal by Subject|2|||
131136677|NCT01239160|472128178|FG000|Overall Study|Physician Decision|5|||
131136678|NCT01239160|472128179|FG001|Overall Study|Physician Decision|7|||
131136679|NCT01239160|472128180|FG002|Overall Study|Physician Decision|2|||
131136680|NCT01239160|472128178|FG000|Overall Study|Early Termination Due to Study Closure|0|||
131136681|NCT01239160|472128179|FG001|Overall Study|Early Termination Due to Study Closure|1|||
131057913|NCT00878189|471845719|FG001|Overall Study|Lost to Follow-up|0|||
131057914|NCT00878189|471845720|FG002|Overall Study|Lost to Follow-up|0|||
131136682|NCT01239160|472128180|FG002|Overall Study|Early Termination Due to Study Closure|6|||
131057915|NCT00878189|471845721|FG003|Overall Study|Lost to Follow-up|0|||
131057916|NCT00878189|471845722|FG004|Overall Study|Lost to Follow-up|0|||
131057917|NCT00878189|471845723|FG005|Overall Study|Lost to Follow-up|1|||
131136683|NCT04781816|472128181|FG000|Overall Study|Adverse Event|0|||
131136684|NCT04781816|472128182|FG001|Overall Study|Adverse Event|1|||
131136685|NCT04781816|472128181|FG000|Overall Study|Withdrawal by Subject|1|||
130722560|NCT02377427|470608325|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130722561|NCT02342639|470608326|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
131057918|NCT00878189|471845724|FG006|Overall Study|Lost to Follow-up|1|||
131136686|NCT04781816|472128182|FG001|Overall Study|Withdrawal by Subject|1|||
131057919|NCT00878189|471845725|FG007|Overall Study|Lost to Follow-up|0|||
131057920|NCT00878189|471845726|FG008|Overall Study|Lost to Follow-up|0|||
131057921|NCT00878189|471845718|FG000|Overall Study|Objection Progression or Relapse|0|||
131057922|NCT00878189|471845719|FG001|Overall Study|Objection Progression or Relapse|0|||
131057923|NCT00878189|471845720|FG002|Overall Study|Objection Progression or Relapse|0|||
131057924|NCT00878189|471845721|FG003|Overall Study|Objection Progression or Relapse|0|||
131057925|NCT00878189|471845722|FG004|Overall Study|Objection Progression or Relapse|0|||
131057926|NCT00878189|471845723|FG005|Overall Study|Objection Progression or Relapse|0|||
131057927|NCT00878189|471845724|FG006|Overall Study|Objection Progression or Relapse|0|||
131057928|NCT00878189|471845725|FG007|Overall Study|Objection Progression or Relapse|0|||
131057929|NCT00878189|471845726|FG008|Overall Study|Objection Progression or Relapse|3|||
131057930|NCT00703092|471845727|FG000|Overall Study|Withdrawal by Subject|2|||
131057931|NCT01021748|471845728|FG000|Overall Study|Adverse Event|2|||
131057932|NCT01021748|471845729|FG001|Overall Study|Adverse Event|1|||
131057933|NCT01021748|471845730|FG002|Overall Study|Adverse Event|2|||
131057934|NCT01021748|471845731|FG003|Overall Study|Adverse Event|0|||
131057935|NCT01021748|471845732|FG004|Overall Study|Adverse Event|2|||
131057936|NCT01021748|471845733|FG005|Overall Study|Adverse Event|0|||
131057937|NCT01021748|471845734|FG006|Overall Study|Adverse Event|1|||
131057938|NCT01021748|471845735|FG007|Overall Study|Adverse Event|0|||
131057939|NCT01021748|471845736|FG008|Overall Study|Adverse Event|7|||
131057940|NCT01021748|471845728|FG000|Overall Study|Physician Decision|1|||
131057941|NCT01021748|471845729|FG001|Overall Study|Physician Decision|0|||
131057942|NCT01021748|471845730|FG002|Overall Study|Physician Decision|1|||
131057943|NCT01021748|471845731|FG003|Overall Study|Physician Decision|1|||
131057944|NCT01021748|471845732|FG004|Overall Study|Physician Decision|0|||
131057945|NCT01021748|471845733|FG005|Overall Study|Physician Decision|0|||
131057946|NCT01021748|471845734|FG006|Overall Study|Physician Decision|1|||
131057947|NCT01021748|471845735|FG007|Overall Study|Physician Decision|1|||
131057948|NCT01021748|471845736|FG008|Overall Study|Physician Decision|2|||
131057949|NCT01021748|471845728|FG000|Overall Study|Progressive Disease|3|||
131057950|NCT01021748|471845729|FG001|Overall Study|Progressive Disease|3|||
131057951|NCT01021748|471845730|FG002|Overall Study|Progressive Disease|4|||
131057952|NCT01021748|471845731|FG003|Overall Study|Progressive Disease|6|||
131057953|NCT01021748|471845732|FG004|Overall Study|Progressive Disease|7|||
131057954|NCT01021748|471845733|FG005|Overall Study|Progressive Disease|3|||
131057955|NCT01021748|471845734|FG006|Overall Study|Progressive Disease|0|||
131057956|NCT01021748|471845735|FG007|Overall Study|Progressive Disease|5|||
131057957|NCT01021748|471845736|FG008|Overall Study|Progressive Disease|6|||
131229849|NCT00696709|472467713|FG001|Overall Study|Adverse Event|0|||
131229850|NCT00696709|472467714|FG002|Overall Study|Adverse Event|0|||
131229851|NCT00696709|472467715|FG003|Overall Study|Adverse Event|1|||
131229852|NCT00696709|472467716|FG004|Overall Study|Adverse Event|0|||
131057958|NCT01021748|471845728|FG000|Overall Study|Withdrawal by Subject|0|||
131057959|NCT01021748|471845729|FG001|Overall Study|Withdrawal by Subject|0|||
131229853|NCT00321711|472467717|FG000|Part A|Adverse Event|3|||
131229854|NCT00321711|472467718|FG001|Part A|Adverse Event|3|||
131229855|NCT00321711|472467719|FG002|Part A|Adverse Event|2|||
131229856|NCT00321711|472467720|FG003|Part A|Adverse Event|0|||
131229857|NCT00321711|472467721|FG004|Part A|Adverse Event|0|||
131229858|NCT00321711|472467717|FG000|Part A|Withdrawal by Subject|1|||
131229859|NCT00321711|472467718|FG001|Part A|Withdrawal by Subject|1|||
131229860|NCT00321711|472467719|FG002|Part A|Withdrawal by Subject|1|||
131229861|NCT00321711|472467720|FG003|Part A|Withdrawal by Subject|0|||
131229862|NCT00321711|472467721|FG004|Part A|Withdrawal by Subject|0|||
131229863|NCT00321711|472467717|FG000|Part A|Disease progression|0|||
131229864|NCT00321711|472467718|FG001|Part A|Disease progression|1|||
131229865|NCT00321711|472467719|FG002|Part A|Disease progression|0|||
131229866|NCT00321711|472467720|FG003|Part A|Disease progression|0|||
131057960|NCT01021748|471845730|FG002|Overall Study|Withdrawal by Subject|0|||
131057961|NCT01021748|471845731|FG003|Overall Study|Withdrawal by Subject|0|||
131057962|NCT01021748|471845732|FG004|Overall Study|Withdrawal by Subject|0|||
131057963|NCT01021748|471845733|FG005|Overall Study|Withdrawal by Subject|0|||
131057964|NCT01021748|471845734|FG006|Overall Study|Withdrawal by Subject|1|||
131057965|NCT01021748|471845735|FG007|Overall Study|Withdrawal by Subject|0|||
131057966|NCT01021748|471845736|FG008|Overall Study|Withdrawal by Subject|1|||
131057967|NCT01021748|471845728|FG000|Overall Study|Not Treated|0|||
131057968|NCT01021748|471845729|FG001|Overall Study|Not Treated|1|||
131057969|NCT01021748|471845730|FG002|Overall Study|Not Treated|0|||
131057970|NCT01021748|471845731|FG003|Overall Study|Not Treated|0|||
131057971|NCT01021748|471845732|FG004|Overall Study|Not Treated|0|||
131057972|NCT01021748|471845733|FG005|Overall Study|Not Treated|0|||
131057973|NCT01021748|471845734|FG006|Overall Study|Not Treated|0|||
130779371|NCT02326272|470819503|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130779372|NCT02326272|470819504|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131057974|NCT01021748|471845735|FG007|Overall Study|Not Treated|0|||
131057975|NCT01021748|471845736|FG008|Overall Study|Not Treated|0|||
131057976|NCT01829711|471845741|FG000|Overall Study|Lost to Follow-up|2|||
131057977|NCT01829711|471845741|FG000|Overall Study|Withdrawal by Subject|3|||
131229867|NCT00321711|472467721|FG004|Part A|Disease progression|0|||
131229868|NCT00321711|472467717|FG000|Part A|Requirement for alternative therapy|0|||
131057978|NCT01829711|471845741|FG000|Overall Study|Death|4|||
131057979|NCT01829711|471845741|FG000|Overall Study|Started new therapies|17|||
131057980|NCT01829711|471845741|FG000|Overall Study|Adverse Event|3|||
131229869|NCT00321711|472467718|FG001|Part A|Requirement for alternative therapy|2|||
131229870|NCT00321711|472467719|FG002|Part A|Requirement for alternative therapy|1|||
131057981|NCT01829711|471845741|FG000|Overall Study|Due to progression of disease|13|||
131057982|NCT01829711|471845741|FG000|Overall Study|Due to lack of response|1|||
131057983|NCT01480258|471845744|FG000|Infant Series|Protocol Violation|2|||
131057984|NCT01480258|471845745|FG001|Infant Series|Protocol Violation|0|||
131057985|NCT01480258|471845744|FG000|Infant Series|Physician Decision|0|||
131057986|NCT01480258|471845745|FG001|Infant Series|Physician Decision|1|||
131057987|NCT01480258|471845744|FG000|Infant Series|Not Vaccinated|3|||
131057988|NCT01480258|471845745|FG001|Infant Series|Not Vaccinated|0|||
131057989|NCT01480258|471845744|FG000|Infant Series|Adverse Event|1|||
131057990|NCT01480258|471845745|FG001|Infant Series|Adverse Event|1|||
131057991|NCT01480258|471845744|FG000|Infant Series|Withdrawal by Subject|1|||
131057992|NCT01480258|471845745|FG001|Infant Series|Withdrawal by Subject|6|||
131057993|NCT01480258|471845744|FG000|Interim Period|Lost to Follow-up|0|||
131057994|NCT01480258|471845745|FG001|Interim Period|Lost to Follow-up|2|||
131057995|NCT01480258|471845744|FG000|Interim Period|Physician Decision|1|||
131057996|NCT01480258|471845745|FG001|Interim Period|Physician Decision|0|||
131057997|NCT01480258|471845744|FG000|Interim Period|Protocol Violation|0|||
131057998|NCT01480258|471845745|FG001|Interim Period|Protocol Violation|1|||
131057999|NCT01480258|471845744|FG000|Interim Period|Withdrawal by Subject|9|||
131058000|NCT01480258|471845745|FG001|Interim Period|Withdrawal by Subject|6|||
130722562|NCT02342639|470608327|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
130722563|NCT02342639|470608326|FG000|Overall Study|Protocol Violation|0|||
131058001|NCT03316170|471845746|FG000|Overall Study|Death|1|||
131058002|NCT03316170|471845747|FG001|Overall Study|Death|0|||
131058003|NCT03316170|471845746|FG000|Overall Study|Lost to Follow-up|6|||
131058004|NCT03316170|471845747|FG001|Overall Study|Lost to Follow-up|7|||
131058005|NCT02169414|471845748|FG000|Overall Study|Withdrawal by Subject|1|||
131058006|NCT02169414|471845749|FG001|Overall Study|Withdrawal by Subject|0|||
131058007|NCT02169414|471845750|FG002|Overall Study|Withdrawal by Subject|0|||
131058008|NCT02169414|471845751|FG003|Overall Study|Withdrawal by Subject|0|||
131058009|NCT02169414|471845748|FG000|Overall Study|Adverse Event|0|||
131058010|NCT02169414|471845749|FG001|Overall Study|Adverse Event|1|||
131058011|NCT02169414|471845750|FG002|Overall Study|Adverse Event|0|||
131058012|NCT02169414|471845751|FG003|Overall Study|Adverse Event|0|||
131058013|NCT03374254|471845752|FG000|Overall Study|Death|5|||
131058014|NCT03374254|471845753|FG001|Overall Study|Death|16|||
131058015|NCT03374254|471845754|FG002|Overall Study|Death|13|||
131058016|NCT03374254|471845755|FG003|Overall Study|Death|11|||
131058017|NCT03374254|471845756|FG004|Overall Study|Death|9|||
131058018|NCT03374254|471845757|FG005|Overall Study|Death|12|||
131058019|NCT03374254|471845758|FG006|Overall Study|Death|11|||
131058020|NCT03374254|471845759|FG007|Overall Study|Death|6|||
131058021|NCT03374254|471845760|FG008|Overall Study|Death|7|||
131058022|NCT03374254|471845752|FG000|Overall Study|Lost to Follow-up|0|||
131058023|NCT03374254|471845753|FG001|Overall Study|Lost to Follow-up|0|||
131058024|NCT03374254|471845754|FG002|Overall Study|Lost to Follow-up|0|||
131058025|NCT03374254|471845755|FG003|Overall Study|Lost to Follow-up|0|||
131058026|NCT03374254|471845756|FG004|Overall Study|Lost to Follow-up|0|||
131058027|NCT03374254|471845757|FG005|Overall Study|Lost to Follow-up|0|||
131136687|NCT04781816|472128181|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
131136688|NCT04781816|472128182|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
131136689|NCT01789970|472128183|FG000|Open-label Titration Period|Adverse Event|68|||
131136690|NCT01789970|472128184|FG001|Open-label Titration Period|Adverse Event|0|||
131136691|NCT01789970|472128185|FG002|Open-label Titration Period|Adverse Event|0|||
130722564|NCT02342639|470608327|FG001|Overall Study|Protocol Violation|2|||
131058028|NCT03374254|471845758|FG006|Overall Study|Lost to Follow-up|2|||
131136692|NCT01789970|472128183|FG000|Open-label Titration Period|Lack of Efficacy|31|||
130722565|NCT02212379|470608328|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
130722566|NCT02212379|470608328|FG000|From Baseline to Week 48|Adverse Event|7|||
131058029|NCT03374254|471845759|FG007|Overall Study|Lost to Follow-up|0|||
131058030|NCT03374254|471845760|FG008|Overall Study|Lost to Follow-up|0|||
131136693|NCT01789970|472128184|FG001|Open-label Titration Period|Lack of Efficacy|0|||
131136694|NCT01789970|472128185|FG002|Open-label Titration Period|Lack of Efficacy|0|||
131136695|NCT01789970|472128183|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
131136696|NCT01789970|472128184|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
130722567|NCT02212379|470608328|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
130722568|NCT02212379|470608328|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
131058031|NCT03374254|471845752|FG000|Overall Study|Sponsor Decision|1|||
131058032|NCT03374254|471845753|FG001|Overall Study|Sponsor Decision|0|||
131058033|NCT03374254|471845754|FG002|Overall Study|Sponsor Decision|2|||
131058034|NCT03374254|471845755|FG003|Overall Study|Sponsor Decision|3|||
130722569|NCT02212379|470608328|FG000|From Week 48 to Week 96|Adverse Event|1|||
130722570|NCT02212379|470608328|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
131058035|NCT03374254|471845756|FG004|Overall Study|Sponsor Decision|2|||
131058036|NCT03374254|471845757|FG005|Overall Study|Sponsor Decision|3|||
131058037|NCT03374254|471845758|FG006|Overall Study|Sponsor Decision|3|||
131058038|NCT03374254|471845759|FG007|Overall Study|Sponsor Decision|3|||
131058039|NCT03374254|471845760|FG008|Overall Study|Sponsor Decision|4|||
131058040|NCT03374254|471845752|FG000|Overall Study|Withdrawal by Subject|0|||
131058041|NCT03374254|471845753|FG001|Overall Study|Withdrawal by Subject|0|||
131058042|NCT03374254|471845754|FG002|Overall Study|Withdrawal by Subject|0|||
131058043|NCT03374254|471845755|FG003|Overall Study|Withdrawal by Subject|2|||
131058044|NCT03374254|471845756|FG004|Overall Study|Withdrawal by Subject|0|||
131058045|NCT03374254|471845757|FG005|Overall Study|Withdrawal by Subject|1|||
131058046|NCT03374254|471845758|FG006|Overall Study|Withdrawal by Subject|0|||
131058047|NCT03374254|471845759|FG007|Overall Study|Withdrawal by Subject|0|||
131058048|NCT03374254|471845760|FG008|Overall Study|Withdrawal by Subject|0|||
131058049|NCT02309515|471845761|FG000|Overall Study|Withdrawal by Subject|0|||
131058050|NCT02309515|471845762|FG001|Overall Study|Withdrawal by Subject|1|||
131058051|NCT04070105|471845766|FG000|Overall Study|Lost to Follow-up|0|||
131058052|NCT04070105|471845767|FG001|Overall Study|Lost to Follow-up|0|||
131058053|NCT04070105|471845768|FG002|Overall Study|Lost to Follow-up|0|||
131058054|NCT04070105|471845769|FG003|Overall Study|Lost to Follow-up|0|||
131058055|NCT04070105|471845770|FG004|Overall Study|Lost to Follow-up|0|||
131058056|NCT04070105|471845771|FG005|Overall Study|Lost to Follow-up|1|||
131058057|NCT01858688|471845777|FG000|Overall Study|Withdrawal by Subject|8|||
131058058|NCT01858688|471845777|FG000|Overall Study|Participant began another therapy|3|||
131058059|NCT01858688|471845777|FG000|Overall Study|Physician Decision|2|||
131058060|NCT01858688|471845777|FG000|Overall Study|Progressive Disease|2|||
131058061|NCT01858688|471845777|FG000|Overall Study|Reason not reproted|5|||
131058062|NCT01999335|471845778|FG000|Overall Study|Discontinued before receiving treatment|0|||
131058063|NCT01999335|471845779|FG001|Overall Study|Discontinued before receiving treatment|0|||
131058064|NCT01999335|471845780|FG002|Overall Study|Discontinued before receiving treatment|0|||
131058065|NCT01999335|471845781|FG003|Overall Study|Discontinued before receiving treatment|0|||
131058066|NCT01999335|471845782|FG004|Overall Study|Discontinued before receiving treatment|2|||
131058067|NCT02234141|471845783|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
131058068|NCT02234141|471845784|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
131058069|NCT02234141|471845785|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
131058070|NCT02234141|471845786|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
131058071|NCT02234141|471845787|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
131058072|NCT02234141|471845788|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
131058073|NCT02234141|471845789|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
131058074|NCT02234141|471845783|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131058075|NCT02234141|471845784|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
131058076|NCT02234141|471845785|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131058077|NCT02234141|471845786|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131058078|NCT02234141|471845787|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131058079|NCT02234141|471845788|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131058080|NCT02234141|471845789|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
131058081|NCT02234141|471845783|FG000|Treatment Period (24 Weeks)|Death|1|||
131058082|NCT02234141|471845784|FG001|Treatment Period (24 Weeks)|Death|2|||
131058083|NCT02234141|471845785|FG002|Treatment Period (24 Weeks)|Death|0|||
131058084|NCT02234141|471845786|FG003|Treatment Period (24 Weeks)|Death|1|||
131058085|NCT02234141|471845787|FG004|Treatment Period (24 Weeks)|Death|0|||
131058086|NCT02234141|471845788|FG005|Treatment Period (24 Weeks)|Death|0|||
131058087|NCT02234141|471845789|FG006|Treatment Period (24 Weeks)|Death|0|||
131058088|NCT02234141|471845783|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
131058089|NCT02234141|471845784|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
131058090|NCT02234141|471845785|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
131058091|NCT02234141|471845786|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
131058092|NCT02234141|471845787|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
131058093|NCT02234141|471845788|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
131058094|NCT02234141|471845789|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
131058095|NCT02234141|471845783|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131058096|NCT02234141|471845784|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
131058097|NCT02234141|471845785|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131058098|NCT02234141|471845786|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131058099|NCT02234141|471845787|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131058100|NCT02234141|471845788|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131058101|NCT02234141|471845789|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
131058102|NCT02234141|471845783|FG000|Long-Term Treatment Period|Death|0|||
131058103|NCT02234141|471845784|FG001|Long-Term Treatment Period|Death|0|||
131136697|NCT01789970|472128185|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
131058104|NCT02234141|471845785|FG002|Long-Term Treatment Period|Death|0|||
131058105|NCT02234141|471845786|FG003|Long-Term Treatment Period|Death|0|||
131058106|NCT02234141|471845787|FG004|Long-Term Treatment Period|Death|0|||
131058107|NCT02234141|471845788|FG005|Long-Term Treatment Period|Death|1|||
131136698|NCT01789970|472128183|FG000|Open-label Titration Period|Protocol Violation|18|||
131136699|NCT01789970|472128184|FG001|Open-label Titration Period|Protocol Violation|0|||
131058108|NCT02234141|471845789|FG006|Long-Term Treatment Period|Death|0|||
131058109|NCT02234141|471845783|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
131058110|NCT02234141|471845784|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
131136700|NCT01789970|472128185|FG002|Open-label Titration Period|Protocol Violation|0|||
131136701|NCT01789970|472128183|FG000|Open-label Titration Period|Lost to Follow-up|5|||
131058111|NCT02234141|471845785|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
131058112|NCT02234141|471845786|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
131058113|NCT02234141|471845787|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
131058114|NCT02234141|471845788|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
131058115|NCT02234141|471845789|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
131058116|NCT02234141|471845783|FG000|Long-Term Treatment Period|Adverse Event|4|||
131058117|NCT02234141|471845784|FG001|Long-Term Treatment Period|Adverse Event|0|||
131058118|NCT02234141|471845785|FG002|Long-Term Treatment Period|Adverse Event|5|||
131058119|NCT02234141|471845786|FG003|Long-Term Treatment Period|Adverse Event|0|||
131058120|NCT02234141|471845787|FG004|Long-Term Treatment Period|Adverse Event|1|||
131058121|NCT02234141|471845788|FG005|Long-Term Treatment Period|Adverse Event|1|||
131058122|NCT02234141|471845789|FG006|Long-Term Treatment Period|Adverse Event|1|||
131058123|NCT02234141|471845783|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
131058124|NCT02234141|471845784|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
131058125|NCT02234141|471845785|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
131058126|NCT02234141|471845786|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
131058127|NCT02234141|471845787|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
131058128|NCT02234141|471845788|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
131058129|NCT02234141|471845789|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
131058130|NCT02234141|471845783|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
131058131|NCT02234141|471845784|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
131058132|NCT02234141|471845785|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
131058133|NCT02234141|471845786|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
131058134|NCT02234141|471845787|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
131058135|NCT02234141|471845788|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
131058136|NCT02234141|471845789|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
131058137|NCT00895245|471845790|FG000|Overall Study|Lack of Efficacy|6|||
131058138|NCT04248868|471845791|FG000|Overall Study|Death|1|||
131058139|NCT04248868|471845791|FG000|Overall Study|Lost to Follow-up|3|||
131058140|NCT04248868|471845791|FG000|Overall Study|Protocol Violation|2|||
131058141|NCT03131713|471845794|FG000|Overall Study|Lost to Follow-up|5|||
131058142|NCT03131713|471845795|FG001|Overall Study|Lost to Follow-up|0|||
131058143|NCT02208843|471845798|FG000|Overall Study|Clinical symptoms of progression|2|||
131058144|NCT02208843|471845798|FG000|Overall Study|Progression disease according to RECIST|24|||
131058145|NCT02208843|471845798|FG000|Overall Study|Adverse Event|12|||
131058146|NCT02208843|471845798|FG000|Overall Study|Protocol Violation|1|||
131058147|NCT02208843|471845798|FG000|Overall Study|Withdrawal by Subject|1|||
131058148|NCT02208843|471845798|FG000|Overall Study|Switched to commercial afatinib|20|||
131058149|NCT00089791|471845804|FG000|Overall Study|Physician Decision|6|||
131058150|NCT00089791|471845805|FG001|Overall Study|Physician Decision|3|||
131058151|NCT00089791|471845804|FG000|Overall Study|Adverse Event|81|||
131058152|NCT00089791|471845805|FG001|Overall Study|Adverse Event|93|||
131058153|NCT00089791|471845804|FG000|Overall Study|Withdrawal by Subject|403|||
131058154|NCT00089791|471845805|FG001|Overall Study|Withdrawal by Subject|344|||
131058155|NCT00089791|471845804|FG000|Overall Study|Death|78|||
131058156|NCT00089791|471845805|FG001|Overall Study|Death|62|||
131058157|NCT00089791|471845804|FG000|Overall Study|Disease progression|7|||
131058158|NCT00089791|471845805|FG001|Overall Study|Disease progression|3|||
131058159|NCT00089791|471845804|FG000|Overall Study|Ineligibility determined|12|||
131058160|NCT00089791|471845805|FG001|Overall Study|Ineligibility determined|9|||
131058161|NCT00089791|471845804|FG000|Overall Study|Lost to Follow-up|57|||
131058162|NCT00089791|471845805|FG001|Overall Study|Lost to Follow-up|57|||
131058163|NCT00089791|471845804|FG000|Overall Study|Noncompliance|17|||
131058164|NCT00089791|471845805|FG001|Overall Study|Noncompliance|13|||
131058165|NCT00089791|471845804|FG000|Overall Study|Other|20|||
131058166|NCT00089791|471845805|FG001|Overall Study|Other|32|||
131058167|NCT00089791|471845804|FG000|Overall Study|Protocol deviation|12|||
131058168|NCT00089791|471845805|FG001|Overall Study|Protocol deviation|10|||
131058169|NCT00089791|471845804|FG000|Overall Study|Requirement for alternative therapy|7|||
131058170|NCT00089791|471845805|FG001|Overall Study|Requirement for alternative therapy|4|||
131058171|NCT00148122|471845806|FG000|Overall Study|Withdrawal by Subject|2|||
131058172|NCT01543204|471845807|FG000|Overall Study|Non-compliance|1|||
131058173|NCT01543204|471845807|FG000|Overall Study|Adverse Event|1|||
131058174|NCT01543204|471845807|FG000|Overall Study|Withdrawal by Subject|4|||
131058175|NCT01543204|471845807|FG000|Overall Study|Requirement for Alternative Therapy|1|||
131058176|NCT01543204|471845807|FG000|Overall Study|Lost to Follow-up|1|||
131058177|NCT02449902|471845809|FG000|Overall Study|Adverse Event|0|||
131058178|NCT02449902|471845810|FG001|Overall Study|Adverse Event|1|||
131058179|NCT02449902|471845809|FG000|Overall Study|Withdrawal by Subject|0|||
131058180|NCT02449902|471845810|FG001|Overall Study|Withdrawal by Subject|1|||
131058181|NCT02362789|471845811|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
131058182|NCT02362789|471845812|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
131058183|NCT02362789|471845813|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
131058184|NCT02362789|471845811|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
131058185|NCT02362789|471845812|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
131058186|NCT02362789|471845813|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
131058187|NCT02362789|471845811|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
131058188|NCT02362789|471845812|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
131058189|NCT02362789|471845813|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
131058190|NCT02362789|471845811|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
131058191|NCT02362789|471845812|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
131058192|NCT02362789|471845813|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
131058193|NCT02362789|471845811|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
131058194|NCT02362789|471845812|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
131058195|NCT02362789|471845813|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
131058196|NCT03326856|471845814|FG000|Overall Study|Lost to Follow-up|1|||
131058197|NCT03326856|471845815|FG001|Overall Study|Lost to Follow-up|1|||
131058198|NCT03326856|471845816|FG002|Overall Study|Lost to Follow-up|0|||
131058199|NCT03326856|471845817|FG003|Overall Study|Lost to Follow-up|0|||
131058200|NCT03326856|471845818|FG004|Overall Study|Lost to Follow-up|0|||
131058201|NCT03928743|471848091|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
131058202|NCT03928743|471848092|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
131058203|NCT03928743|471848093|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
131058204|NCT03928743|471848091|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
131058205|NCT03928743|471848092|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
131058206|NCT03928743|471848093|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
131058207|NCT03928743|471848091|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
131058208|NCT03928743|471848092|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
131058209|NCT03928743|471848093|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
131058210|NCT03928743|471848091|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
131058211|NCT03928743|471848092|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
131058212|NCT03928743|471848093|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
131058213|NCT03928743|471848091|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
131058214|NCT03928743|471848092|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
131058215|NCT03928743|471848093|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
131058216|NCT03928743|471848091|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
131058217|NCT03928743|471848092|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
131058218|NCT03928743|471848093|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
131058219|NCT03928743|471848091|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
131058220|NCT03928743|471848092|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
131058221|NCT03928743|471848093|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
131058222|NCT03928743|471848091|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
131058223|NCT03928743|471848092|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
131058224|NCT03928743|471848093|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
131058225|NCT03928743|471848091|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
131058226|NCT03928743|471848092|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
131058227|NCT03928743|471848093|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
131058228|NCT03928743|471848091|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
131058229|NCT03928743|471848092|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
131058230|NCT03928743|471848093|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
131058231|NCT03928743|471848091|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
131058232|NCT03928743|471848092|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
131058233|NCT03928743|471848093|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
131058234|NCT02236611|471848095|FG000|Overall Study|Adverse Event|10|||
131058235|NCT02236611|471848096|FG001|Overall Study|Adverse Event|16|||
131058236|NCT02236611|471848095|FG000|Overall Study|Lack of Efficacy|4|||
131058237|NCT02236611|471848096|FG001|Overall Study|Lack of Efficacy|7|||
131058238|NCT02236611|471848095|FG000|Overall Study|Lost to Follow-up|0|||
131058239|NCT02236611|471848096|FG001|Overall Study|Lost to Follow-up|2|||
131058240|NCT02236611|471848095|FG000|Overall Study|Protocol deviation|3|||
131058241|NCT02236611|471848096|FG001|Overall Study|Protocol deviation|5|||
131058242|NCT02236611|471848095|FG000|Overall Study|Withdrew consent|9|||
131058243|NCT02236611|471848096|FG001|Overall Study|Withdrew consent|4|||
131058244|NCT01450007|471848097|FG000|Overall Study|Late exclusion before treatment|2|||
131058245|NCT01450007|471848098|FG001|Overall Study|Late exclusion before treatment|3|||
131058246|NCT01450007|471848099|FG002|Overall Study|Late exclusion before treatment|2|||
131058247|NCT01450007|471848097|FG000|Overall Study|Protocol Violation|0|||
131058248|NCT01450007|471848098|FG001|Overall Study|Protocol Violation|1|||
131058249|NCT01450007|471848099|FG002|Overall Study|Protocol Violation|1|||
131058250|NCT01450007|471848097|FG000|Overall Study|Adverse Event|0|||
130722571|NCT02105974|470608329|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
130722572|NCT02105974|470608330|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
130722573|NCT02105974|470608331|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
130722574|NCT02105974|470608329|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
131058251|NCT01450007|471848098|FG001|Overall Study|Adverse Event|1|||
131058252|NCT01450007|471848099|FG002|Overall Study|Adverse Event|0|||
131058253|NCT03851094|471848101|FG000|Overall Study|Withdrawal by Subject|0|||
131058254|NCT03851094|471848102|FG001|Overall Study|Withdrawal by Subject|1|||
131058255|NCT03851094|471848101|FG000|Overall Study|Participant lost device|0|||
131058256|NCT03851094|471848102|FG001|Overall Study|Participant lost device|1|||
131058257|NCT03851094|471848101|FG000|Overall Study|Participant returned device|0|||
131058258|NCT03851094|471848102|FG001|Overall Study|Participant returned device|2|||
131058259|NCT01536704|471848103|FG000|Washout Period 1|Withdrawal by Subject|1|||
131058260|NCT01536704|471848104|FG001|Washout Period 1|Withdrawal by Subject|2|||
131058261|NCT01536704|471848105|FG002|Washout Period 1|Withdrawal by Subject|0|||
131058262|NCT01536704|471848106|FG003|Washout Period 1|Withdrawal by Subject|0|||
131058263|NCT01536704|471848103|FG000|Washout Period 2|Adverse Event|1|||
131058264|NCT01536704|471848104|FG001|Washout Period 2|Adverse Event|0|||
131058265|NCT01536704|471848105|FG002|Washout Period 2|Adverse Event|0|||
131058266|NCT01536704|471848106|FG003|Washout Period 2|Adverse Event|0|||
131058267|NCT01536704|471848103|FG000|Washout Period 2|Withdrawal by Subject|0|||
131058268|NCT01536704|471848104|FG001|Washout Period 2|Withdrawal by Subject|0|||
131058269|NCT01536704|471848105|FG002|Washout Period 2|Withdrawal by Subject|0|||
131058270|NCT01536704|471848106|FG003|Washout Period 2|Withdrawal by Subject|1|||
131058271|NCT01536704|471848103|FG000|Period 3|Adverse Event|0|||
131058272|NCT01536704|471848104|FG001|Period 3|Adverse Event|0|||
131058273|NCT01536704|471848105|FG002|Period 3|Adverse Event|0|||
131058274|NCT01536704|471848106|FG003|Period 3|Adverse Event|1|||
131058275|NCT01536704|471848103|FG000|Washout Period 3|Adverse Event|0|||
131058276|NCT01536704|471848104|FG001|Washout Period 3|Adverse Event|0|||
131058277|NCT01536704|471848105|FG002|Washout Period 3|Adverse Event|1|||
131058278|NCT01536704|471848106|FG003|Washout Period 3|Adverse Event|0|||
131058279|NCT02392507|471848107|FG000|Induction Regimen|Death|3|||
131058280|NCT02392507|471848107|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
131058281|NCT02392507|471848107|FG000|Induction Regimen|Physician Decision|1|||
131058282|NCT02392507|471848107|FG000|Induction Regimen|Withdrawal by Subject|2|||
131058283|NCT02392507|471848107|FG000|Maintenance Regimen|Death|1|||
131058284|NCT02392507|471848107|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
131058285|NCT00240994|471848108|FG000|Overall Study|Lost to Follow-up|1|||
131058286|NCT00240994|471848108|FG000|Overall Study|Protocol Violation|1|||
131058287|NCT00240994|471848108|FG000|Overall Study|Graft failure|1|||
131058288|NCT00749944|471848111|FG000|Overall Study|Lost to Follow-up|2|||
131058289|NCT00749944|471848112|FG001|Overall Study|Lost to Follow-up|1|||
131058290|NCT00749944|471848111|FG000|Overall Study|Other|1|||
131058291|NCT00749944|471848112|FG001|Overall Study|Other|0|||
131058292|NCT00749944|471848111|FG000|Overall Study|Withdrawal by Subject|2|||
131058293|NCT00749944|471848112|FG001|Overall Study|Withdrawal by Subject|0|||
131058294|NCT00624377|471848115|FG000|Overall Study|Lost to Follow-up|355|||
131058295|NCT00624377|471848115|FG000|Overall Study|Withdrawal by Subject|100|||
131058296|NCT00624377|471848115|FG000|Overall Study|Adverse Event|14|||
131058297|NCT00624377|471848115|FG000|Overall Study|Other|91|||
131058298|NCT00624377|471848115|FG000|Overall Study|Non-evaluable population|84|||
131058299|NCT00923078|471848116|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
131058300|NCT00923078|471848117|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
131058301|NCT00923078|471848118|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
131058302|NCT00923078|471848116|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
131058303|NCT00923078|471848117|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
131058304|NCT00923078|471848118|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
131058305|NCT02404441|471848135|FG000|Phase 1 Part|Adverse Event|1|||
130722575|NCT02105974|470608330|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
130722576|NCT02105974|470608331|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
131058306|NCT02404441|471848136|FG001|Phase 1 Part|Adverse Event|0|||
131058307|NCT02404441|471848137|FG002|Phase 1 Part|Adverse Event|0|||
130722577|NCT02105974|470608329|FG000|2 Week Run-in Period|Adverse Event|6|||
130722578|NCT02105974|470608330|FG001|2 Week Run-in Period|Adverse Event|0|||
131058308|NCT02404441|471848138|FG003|Phase 1 Part|Adverse Event|0|||
131058309|NCT02404441|471848139|FG004|Phase 1 Part|Adverse Event|0|||
131058310|NCT02404441|471848140|FG005|Phase 1 Part|Adverse Event|0|||
131058311|NCT02404441|471848141|FG006|Phase 1 Part|Adverse Event|0|||
130722579|NCT02105974|470608331|FG002|2 Week Run-in Period|Adverse Event|0|||
131058312|NCT02404441|471848142|FG007|Phase 1 Part|Adverse Event|0|||
131058313|NCT02404441|471848143|FG008|Phase 1 Part|Adverse Event|0|||
131058314|NCT02404441|471848144|FG009|Phase 1 Part|Adverse Event|0|||
131058315|NCT02404441|471848135|FG000|Phase 1 Part|Physician Decision|0|||
131058316|NCT02404441|471848136|FG001|Phase 1 Part|Physician Decision|1|||
131058317|NCT02404441|471848137|FG002|Phase 1 Part|Physician Decision|0|||
131136702|NCT01789970|472128184|FG001|Open-label Titration Period|Lost to Follow-up|0|||
131136703|NCT01789970|472128185|FG002|Open-label Titration Period|Lost to Follow-up|0|||
131136704|NCT01789970|472128183|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
131136705|NCT01789970|472128184|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
131136706|NCT01789970|472128185|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
131136707|NCT01789970|472128183|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
131136708|NCT01789970|472128184|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
131136709|NCT01789970|472128185|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
131058318|NCT02404441|471848138|FG003|Phase 1 Part|Physician Decision|0|||
131058319|NCT02404441|471848139|FG004|Phase 1 Part|Physician Decision|0|||
131058320|NCT02404441|471848140|FG005|Phase 1 Part|Physician Decision|0|||
131058321|NCT02404441|471848141|FG006|Phase 1 Part|Physician Decision|0|||
131058322|NCT02404441|471848142|FG007|Phase 1 Part|Physician Decision|0|||
131058323|NCT02404441|471848143|FG008|Phase 1 Part|Physician Decision|0|||
131058324|NCT02404441|471848144|FG009|Phase 1 Part|Physician Decision|0|||
131058325|NCT02404441|471848135|FG000|Phase 1 Part|Progressive Disease|14|||
131058326|NCT02404441|471848136|FG001|Phase 1 Part|Progressive Disease|11|||
131058327|NCT02404441|471848137|FG002|Phase 1 Part|Progressive Disease|7|||
131058328|NCT02404441|471848138|FG003|Phase 1 Part|Progressive Disease|6|||
131058329|NCT02404441|471848139|FG004|Phase 1 Part|Progressive Disease|9|||
131058330|NCT02404441|471848140|FG005|Phase 1 Part|Progressive Disease|0|||
131058331|NCT02404441|471848141|FG006|Phase 1 Part|Progressive Disease|0|||
131058332|NCT02404441|471848142|FG007|Phase 1 Part|Progressive Disease|0|||
131058333|NCT02404441|471848143|FG008|Phase 1 Part|Progressive Disease|0|||
131058334|NCT02404441|471848144|FG009|Phase 1 Part|Progressive Disease|0|||
131058335|NCT02404441|471848135|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
131058336|NCT02404441|471848136|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
131058337|NCT02404441|471848137|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
131058338|NCT02404441|471848138|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
131058339|NCT02404441|471848139|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
131058340|NCT02404441|471848140|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
131058341|NCT02404441|471848141|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
131058342|NCT02404441|471848142|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
131058343|NCT02404441|471848143|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
131058344|NCT02404441|471848144|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
131058345|NCT02404441|471848135|FG000|Phase 1 Part|Death|1|||
131058346|NCT02404441|471848136|FG001|Phase 1 Part|Death|1|||
131058347|NCT02404441|471848137|FG002|Phase 1 Part|Death|1|||
131058348|NCT02404441|471848138|FG003|Phase 1 Part|Death|0|||
131058349|NCT02404441|471848139|FG004|Phase 1 Part|Death|1|||
131058350|NCT02404441|471848140|FG005|Phase 1 Part|Death|0|||
131136710|NCT01789970|472128183|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
131136711|NCT01789970|472128184|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
131136712|NCT01789970|472128185|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
131136713|NCT01789970|472128183|FG000|Open-label Titration Period|Pregnancy|2|||
131136714|NCT01789970|472128184|FG001|Open-label Titration Period|Pregnancy|0|||
131136715|NCT01789970|472128185|FG002|Open-label Titration Period|Pregnancy|0|||
131136716|NCT01789970|472128183|FG000|Open-label Titration Period|Other|76|||
131058351|NCT02404441|471848141|FG006|Phase 1 Part|Death|0|||
131058352|NCT02404441|471848142|FG007|Phase 1 Part|Death|0|||
131058353|NCT02404441|471848143|FG008|Phase 1 Part|Death|0|||
131058354|NCT02404441|471848144|FG009|Phase 1 Part|Death|0|||
131058355|NCT02404441|471848135|FG000|Phase 2 Part|Adverse Event|0|||
131058356|NCT02404441|471848136|FG001|Phase 2 Part|Adverse Event|0|||
131058357|NCT02404441|471848137|FG002|Phase 2 Part|Adverse Event|0|||
131058358|NCT02404441|471848138|FG003|Phase 2 Part|Adverse Event|0|||
131058359|NCT02404441|471848139|FG004|Phase 2 Part|Adverse Event|0|||
131058360|NCT02404441|471848140|FG005|Phase 2 Part|Adverse Event|2|||
131136717|NCT01789970|472128184|FG001|Open-label Titration Period|Other|0|||
131136718|NCT01789970|472128185|FG002|Open-label Titration Period|Other|0|||
131136719|NCT01789970|472128183|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
131229871|NCT00321711|472467720|FG003|Part A|Requirement for alternative therapy|0|||
131058361|NCT02404441|471848141|FG006|Phase 2 Part|Adverse Event|3|||
131058362|NCT02404441|471848142|FG007|Phase 2 Part|Adverse Event|3|||
131058363|NCT02404441|471848143|FG008|Phase 2 Part|Adverse Event|6|||
131136720|NCT01789970|472128184|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
131229872|NCT00321711|472467721|FG004|Part A|Requirement for alternative therapy|0|||
131058364|NCT02404441|471848144|FG009|Phase 2 Part|Adverse Event|1|||
131058365|NCT02404441|471848135|FG000|Phase 2 Part|Physician Decision|0|||
131058366|NCT02404441|471848136|FG001|Phase 2 Part|Physician Decision|0|||
131058367|NCT02404441|471848137|FG002|Phase 2 Part|Physician Decision|0|||
131058368|NCT02404441|471848138|FG003|Phase 2 Part|Physician Decision|0|||
131058369|NCT02404441|471848139|FG004|Phase 2 Part|Physician Decision|0|||
131058370|NCT02404441|471848140|FG005|Phase 2 Part|Physician Decision|7|||
131058371|NCT02404441|471848141|FG006|Phase 2 Part|Physician Decision|9|||
131058372|NCT02404441|471848142|FG007|Phase 2 Part|Physician Decision|2|||
131058373|NCT02404441|471848143|FG008|Phase 2 Part|Physician Decision|1|||
130722580|NCT02105974|470608329|FG000|2 Week Run-in Period|Study closed/terminated|1|||
130722581|NCT02105974|470608330|FG001|2 Week Run-in Period|Study closed/terminated|0|||
130722582|NCT02105974|470608331|FG002|2 Week Run-in Period|Study closed/terminated|0|||
130722583|NCT02105974|470608329|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
130722584|NCT02105974|470608330|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
130722585|NCT02105974|470608331|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
130722586|NCT02105974|470608329|FG000|2 Week Run-in Period|Withdrew consent|23|||
130722587|NCT02105974|470608330|FG001|2 Week Run-in Period|Withdrew consent|0|||
130722588|NCT02105974|470608331|FG002|2 Week Run-in Period|Withdrew consent|0|||
130722589|NCT02105974|470608329|FG000|2 Week Run-in Period|Investigator discretion|8|||
130722590|NCT02105974|470608330|FG001|2 Week Run-in Period|Investigator discretion|0|||
130722591|NCT02105974|470608331|FG002|2 Week Run-in Period|Investigator discretion|0|||
130722592|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
130722593|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
130722594|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
130722595|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
130722596|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
130722597|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
130722598|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
130722599|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
130722600|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
130722601|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
130722602|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
130722603|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
131058374|NCT02404441|471848144|FG009|Phase 2 Part|Physician Decision|3|||
131058375|NCT02404441|471848135|FG000|Phase 2 Part|Progressive disease|0|||
131058376|NCT02404441|471848136|FG001|Phase 2 Part|Progressive disease|0|||
131058377|NCT02404441|471848137|FG002|Phase 2 Part|Progressive disease|0|||
131058378|NCT02404441|471848138|FG003|Phase 2 Part|Progressive disease|0|||
131058379|NCT02404441|471848139|FG004|Phase 2 Part|Progressive disease|0|||
131058380|NCT02404441|471848140|FG005|Phase 2 Part|Progressive disease|43|||
131058381|NCT02404441|471848141|FG006|Phase 2 Part|Progressive disease|32|||
131058382|NCT02404441|471848142|FG007|Phase 2 Part|Progressive disease|31|||
131058383|NCT02404441|471848143|FG008|Phase 2 Part|Progressive disease|39|||
131058384|NCT02404441|471848144|FG009|Phase 2 Part|Progressive disease|27|||
131058385|NCT02404441|471848135|FG000|Phase 2 Part|Subject/guardian decision|0|||
131058386|NCT02404441|471848136|FG001|Phase 2 Part|Subject/guardian decision|0|||
131058387|NCT02404441|471848137|FG002|Phase 2 Part|Subject/guardian decision|0|||
131058388|NCT02404441|471848138|FG003|Phase 2 Part|Subject/guardian decision|0|||
131058389|NCT02404441|471848139|FG004|Phase 2 Part|Subject/guardian decision|0|||
131058390|NCT02404441|471848140|FG005|Phase 2 Part|Subject/guardian decision|3|||
131058391|NCT02404441|471848141|FG006|Phase 2 Part|Subject/guardian decision|9|||
131058392|NCT02404441|471848142|FG007|Phase 2 Part|Subject/guardian decision|0|||
131058393|NCT02404441|471848143|FG008|Phase 2 Part|Subject/guardian decision|3|||
131058394|NCT02404441|471848144|FG009|Phase 2 Part|Subject/guardian decision|2|||
131058395|NCT02404441|471848135|FG000|Phase 2 Part|Death|0|||
131058396|NCT02404441|471848136|FG001|Phase 2 Part|Death|0|||
131058397|NCT02404441|471848137|FG002|Phase 2 Part|Death|0|||
131058398|NCT02404441|471848138|FG003|Phase 2 Part|Death|0|||
131058399|NCT02404441|471848139|FG004|Phase 2 Part|Death|0|||
131058400|NCT02404441|471848140|FG005|Phase 2 Part|Death|4|||
131058401|NCT02404441|471848141|FG006|Phase 2 Part|Death|8|||
131058402|NCT02404441|471848142|FG007|Phase 2 Part|Death|4|||
131058403|NCT02404441|471848143|FG008|Phase 2 Part|Death|10|||
131058404|NCT02404441|471848144|FG009|Phase 2 Part|Death|9|||
131058405|NCT02706483|471848145|FG000|Overall Study|Adverse Event|97|||
131058406|NCT02706483|471848145|FG000|Overall Study|Death|1|||
131058407|NCT02706483|471848145|FG000|Overall Study|Lack of Efficacy|39|||
131058408|NCT02706483|471848145|FG000|Overall Study|Lost to Follow-up|101|||
131058409|NCT02706483|471848145|FG000|Overall Study|Non-compliance with study drug|15|||
131058410|NCT02706483|471848145|FG000|Overall Study|Physician Decision|6|||
131058411|NCT02706483|471848145|FG000|Overall Study|Pregnancy|6|||
131058412|NCT02706483|471848145|FG000|Overall Study|Protocol Violation|18|||
130722604|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
130722605|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
130722606|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
130779373|NCT02326272|470819490|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
131058413|NCT02706483|471848145|FG000|Overall Study|Withdrawal by Subject|136|||
131058414|NCT02706483|471848145|FG000|Overall Study|Non-compliance with visits|6|||
131058415|NCT02706483|471848145|FG000|Overall Study|Site closure|4|||
131058416|NCT02706483|471848145|FG000|Overall Study|Subject moved|1|||
131058417|NCT01976507|471848146|FG000|Overall Study|Adverse Event|6|||
131058418|NCT01976507|471848146|FG000|Overall Study|ablation not done, drug not given|1|||
131058419|NCT01972776|471848155|FG000|Part 1|Withdrawal by Subject|0|||
131058420|NCT01972776|471848156|FG001|Part 1|Withdrawal by Subject|0|||
131058421|NCT01972776|471848157|FG002|Part 1|Withdrawal by Subject|1|||
131058422|NCT01972776|471848158|FG003|Part 1|Withdrawal by Subject|0|||
131058423|NCT01972776|471848159|FG004|Part 1|Withdrawal by Subject|0|||
131058424|NCT01972776|471848160|FG005|Part 1|Withdrawal by Subject|0|||
131058425|NCT01972776|471848155|FG000|Part 1|Adverse Event|0|||
131058426|NCT01972776|471848156|FG001|Part 1|Adverse Event|0|||
131058427|NCT01972776|471848157|FG002|Part 1|Adverse Event|1|||
131058428|NCT01972776|471848158|FG003|Part 1|Adverse Event|1|||
131058429|NCT01972776|471848159|FG004|Part 1|Adverse Event|0|||
131058430|NCT01972776|471848160|FG005|Part 1|Adverse Event|0|||
131058431|NCT01972776|471848155|FG000|Part 2|Adverse Event|0|||
131058432|NCT01972776|471848156|FG001|Part 2|Adverse Event|0|||
131058433|NCT01972776|471848157|FG002|Part 2|Adverse Event|0|||
131058434|NCT01972776|471848158|FG003|Part 2|Adverse Event|0|||
131058435|NCT01972776|471848159|FG004|Part 2|Adverse Event|3|||
131058436|NCT01972776|471848160|FG005|Part 2|Adverse Event|0|||
131058437|NCT01972776|471848155|FG000|Part 2|Administrative problems|0|||
131058438|NCT01972776|471848156|FG001|Part 2|Administrative problems|0|||
131058439|NCT01972776|471848157|FG002|Part 2|Administrative problems|0|||
131058440|NCT01972776|471848158|FG003|Part 2|Administrative problems|0|||
131058441|NCT01972776|471848159|FG004|Part 2|Administrative problems|10|||
131058442|NCT01972776|471848160|FG005|Part 2|Administrative problems|7|||
131058443|NCT03042767|471848161|FG000|Overall Study|Lost to Follow-up|1|||
131058444|NCT03042767|471848162|FG001|Overall Study|Lost to Follow-up|2|||
131058445|NCT01220999|471848163|FG000|Overall Study|Progressive disease|0|||
131058446|NCT01220999|471848164|FG001|Overall Study|Progressive disease|0|||
131058447|NCT01220999|471848165|FG002|Overall Study|Progressive disease|1|||
131058448|NCT01220999|471848166|FG003|Overall Study|Progressive disease|0|||
131058449|NCT01220999|471848167|FG004|Overall Study|Progressive disease|0|||
131058450|NCT02037568|471848170|FG000|Overall Study|Withdrawal by Subject|17|||
131058451|NCT02037568|471848171|FG001|Overall Study|Withdrawal by Subject|24|||
131058452|NCT02037568|471848170|FG000|Overall Study|Lost to Follow-up|16|||
131058453|NCT02037568|471848171|FG001|Overall Study|Lost to Follow-up|13|||
131058454|NCT02037568|471848170|FG000|Overall Study|Screen Failure|3|||
131058455|NCT02037568|471848171|FG001|Overall Study|Screen Failure|1|||
131058456|NCT02037568|471848170|FG000|Overall Study|Patient did not receive transplant|0|||
131058457|NCT02037568|471848171|FG001|Overall Study|Patient did not receive transplant|1|||
131058458|NCT00721734|471848175|FG000|Overall Study|Progressive Disease|3|||
131058459|NCT00721734|471848176|FG001|Overall Study|Progressive Disease|10|||
131058460|NCT00721734|471848177|FG002|Overall Study|Progressive Disease|4|||
131058461|NCT00721734|471848178|FG003|Overall Study|Progressive Disease|5|||
131058462|NCT00721734|471848179|FG004|Overall Study|Progressive Disease|2|||
131058463|NCT00721734|471848175|FG000|Overall Study|Adverse Event|3|||
131058464|NCT00721734|471848176|FG001|Overall Study|Adverse Event|1|||
131058465|NCT00721734|471848177|FG002|Overall Study|Adverse Event|4|||
131058466|NCT00721734|471848178|FG003|Overall Study|Adverse Event|0|||
131058467|NCT00721734|471848179|FG004|Overall Study|Adverse Event|3|||
131058468|NCT00721734|471848175|FG000|Overall Study|Withdrawal by Subject|2|||
131058469|NCT00721734|471848176|FG001|Overall Study|Withdrawal by Subject|1|||
131058470|NCT00721734|471848177|FG002|Overall Study|Withdrawal by Subject|0|||
131058471|NCT00721734|471848178|FG003|Overall Study|Withdrawal by Subject|0|||
131058472|NCT00721734|471848179|FG004|Overall Study|Withdrawal by Subject|1|||
131058473|NCT00721734|471848175|FG000|Overall Study|Other|0|||
131058474|NCT00721734|471848176|FG001|Overall Study|Other|0|||
131058475|NCT00721734|471848177|FG002|Overall Study|Other|0|||
131058476|NCT00721734|471848178|FG003|Overall Study|Other|1|||
131058477|NCT00721734|471848179|FG004|Overall Study|Other|0|||
131058478|NCT03861234|471848180|FG000|Overall Study|Not treated|0|||
131058479|NCT03861234|471848181|FG001|Overall Study|Not treated|0|||
131136721|NCT01789970|472128185|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
131058480|NCT03861234|471848182|FG002|Overall Study|Not treated|0|||
131058481|NCT03861234|471848183|FG003|Overall Study|Not treated|0|||
131136722|NCT01789970|472128183|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
131136723|NCT01789970|472128184|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
130722607|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
131058482|NCT03861234|471848184|FG004|Overall Study|Not treated|0|||
131058483|NCT03861234|471848185|FG005|Overall Study|Not treated|1|||
131058484|NCT03861234|471848186|FG006|Overall Study|Not treated|0|||
131058485|NCT03861234|471848187|FG007|Overall Study|Not treated|0|||
131058486|NCT03861234|471848180|FG000|Overall Study|Adverse Event|0|||
131058487|NCT03861234|471848181|FG001|Overall Study|Adverse Event|0|||
131058488|NCT03861234|471848182|FG002|Overall Study|Adverse Event|0|||
131058489|NCT03861234|471848183|FG003|Overall Study|Adverse Event|0|||
131136724|NCT01789970|472128185|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
131058490|NCT03861234|471848184|FG004|Overall Study|Adverse Event|0|||
131058491|NCT03861234|471848185|FG005|Overall Study|Adverse Event|1|||
131058492|NCT03861234|471848186|FG006|Overall Study|Adverse Event|0|||
131058493|NCT03861234|471848187|FG007|Overall Study|Adverse Event|0|||
131058494|NCT03861234|471848180|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
131058495|NCT03861234|471848181|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
130779374|NCT02326272|470819491|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779375|NCT02326272|470819492|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
130779376|NCT02326272|470819493|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779377|NCT02326272|470819494|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779378|NCT02326272|470819495|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779379|NCT02326272|470819496|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779380|NCT02326272|470819497|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779381|NCT02326272|470819498|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779382|NCT02326272|470819499|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779383|NCT02326272|470819500|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779384|NCT02326272|470819501|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779385|NCT02326272|470819502|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779386|NCT02326272|470819503|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779387|NCT02326272|470819504|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130779388|NCT02326272|470819490|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779389|NCT02326272|470819491|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779390|NCT02326272|470819492|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
131058496|NCT03861234|471848182|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
131058497|NCT03861234|471848183|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
131058498|NCT03861234|471848184|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
131058499|NCT03861234|471848185|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
131058500|NCT03861234|471848186|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
131058501|NCT03861234|471848187|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
131058502|NCT03861234|471848180|FG000|Overall Study|As per sponsor decision|0|||
131058503|NCT03861234|471848181|FG001|Overall Study|As per sponsor decision|0|||
131058504|NCT03861234|471848182|FG002|Overall Study|As per sponsor decision|0|||
131058505|NCT03861234|471848183|FG003|Overall Study|As per sponsor decision|0|||
131058506|NCT03861234|471848184|FG004|Overall Study|As per sponsor decision|0|||
131058507|NCT03861234|471848185|FG005|Overall Study|As per sponsor decision|0|||
131058508|NCT03861234|471848186|FG006|Overall Study|As per sponsor decision|1|||
131058509|NCT03861234|471848187|FG007|Overall Study|As per sponsor decision|0|||
131058510|NCT03861234|471848180|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
131058511|NCT03861234|471848181|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
131058512|NCT03861234|471848182|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
131058513|NCT03861234|471848183|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
131058514|NCT03861234|471848184|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
131058515|NCT03861234|471848185|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
131058516|NCT03861234|471848186|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
131058517|NCT03861234|471848187|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
131058518|NCT00621842|471848188|FG000|Overall Study|Adverse Event|6|||
131058519|NCT00621842|471848188|FG000|Overall Study|Withdrawal by Subject|7|||
131058520|NCT00621842|471848188|FG000|Overall Study|Protocol Violation|4|||
131058521|NCT00621842|471848188|FG000|Overall Study|Lack of Efficacy|2|||
131058522|NCT01989689|471848190|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
131058523|NCT01989689|471848191|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
131058524|NCT01989689|471848190|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
131058525|NCT01989689|471848191|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
131058526|NCT00526994|471848192|FG000|Overall Study|Lost to Follow-up|98|||
131058527|NCT00526994|471848193|FG001|Overall Study|Lost to Follow-up|108|||
131058528|NCT00526994|471848194|FG002|Overall Study|Lost to Follow-up|96|||
131058529|NCT00526994|471848192|FG000|Overall Study|Death|4|||
131058530|NCT00526994|471848193|FG001|Overall Study|Death|3|||
131058531|NCT00526994|471848194|FG002|Overall Study|Death|3|||
131058532|NCT00526994|471848192|FG000|Overall Study|Withdrawal by Subject|2|||
131136725|NCT01789970|472128183|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
131136726|NCT01789970|472128184|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
131136727|NCT01789970|472128185|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
131136728|NCT01789970|472128183|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131136729|NCT01789970|472128184|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
131136730|NCT01789970|472128185|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
131136731|NCT01789970|472128183|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
131136732|NCT01789970|472128184|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
131058533|NCT00526994|471848193|FG001|Overall Study|Withdrawal by Subject|7|||
131058534|NCT00526994|471848194|FG002|Overall Study|Withdrawal by Subject|5|||
131058535|NCT00526994|471848192|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
131058536|NCT00526994|471848193|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
131058537|NCT00526994|471848194|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
131058538|NCT03938272|471848195|FG000|Overall Study|Withdrawal by Subject|1|||
131058539|NCT03938272|471848196|FG001|Overall Study|Withdrawal by Subject|0|||
131058540|NCT03938272|471848195|FG000|Overall Study|Physician Decision|0|||
131058541|NCT03938272|471848196|FG001|Overall Study|Physician Decision|2|||
131058542|NCT03938272|471848195|FG000|Overall Study|Study termination by sponsor|10|||
131058543|NCT03938272|471848196|FG001|Overall Study|Study termination by sponsor|8|||
131058544|NCT01419184|471848200|FG000|Overall Study|Site data not available|3|||
131058545|NCT01419184|471848201|FG001|Overall Study|Site data not available|2|||
131058546|NCT01419184|471848200|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
131058547|NCT01419184|471848201|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
131058548|NCT01419184|471848200|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
131058549|NCT01419184|471848201|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
131058550|NCT01419184|471848200|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
131058551|NCT01419184|471848201|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
131058552|NCT01419184|471848200|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
131058553|NCT01419184|471848201|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
131058554|NCT01419184|471848200|FG000|Overall Study|Participant randomized, not treated|1|||
131058555|NCT01419184|471848201|FG001|Overall Study|Participant randomized, not treated|0|||
131058556|NCT03692871|471848204|FG000|Overall Study|Death|1|||
131058557|NCT03692871|471848205|FG001|Overall Study|Death|1|||
131058558|NCT03692871|471848204|FG000|Overall Study|Lost to Follow-up|24|||
131058559|NCT03692871|471848205|FG001|Overall Study|Lost to Follow-up|9|||
131058560|NCT03692871|471848204|FG000|Overall Study|Physician Decision|22|||
131058561|NCT03692871|471848205|FG001|Overall Study|Physician Decision|7|||
131058562|NCT03692871|471848204|FG000|Overall Study|Protocol Deviation|1|||
131058563|NCT03692871|471848205|FG001|Overall Study|Protocol Deviation|0|||
131058564|NCT03692871|471848204|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
131058565|NCT03692871|471848205|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
131058566|NCT03989232|471848208|FG000|Overall Study|Lost to Follow-up|3|||
131058567|NCT03989232|471848209|FG001|Overall Study|Lost to Follow-up|10|||
131058568|NCT03989232|471848208|FG000|Overall Study|Withdrawal by Subject|6|||
131058569|NCT03989232|471848209|FG001|Overall Study|Withdrawal by Subject|6|||
131058570|NCT03989232|471848208|FG000|Overall Study|Death|1|||
131058571|NCT03989232|471848209|FG001|Overall Study|Death|2|||
131058572|NCT02644122|471848211|FG000|Overall Study|Withdrawal by Subject|1|||
131058573|NCT03182244|471848212|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
131058574|NCT03182244|471848213|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
131058575|NCT03182244|471848212|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
131058576|NCT03182244|471848213|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
131058577|NCT03182244|471848212|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
131058578|NCT03182244|471848213|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
131058579|NCT03182244|471848212|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
131058580|NCT03182244|471848213|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
131058581|NCT03182244|471848212|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
131058582|NCT03182244|471848213|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
130722608|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
130722609|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
130722610|NCT02105974|470608329|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
130722611|NCT02105974|470608330|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
130722612|NCT02105974|470608331|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
130722613|NCT01177059|470608333|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
130722614|NCT01177059|470608333|FG000|Overall Study|Withdrew consent|2|||
130722615|NCT01177059|470608333|FG000|Overall Study|Lost to Follow-up|18|||
130722616|NCT02585934|470609655|FG000|Overall Study|Lost to Follow-up|2|||
130722617|NCT02585934|470609656|FG001|Overall Study|Lost to Follow-up|2|||
130722618|NCT02585934|470609655|FG000|Overall Study|Protocol Violation|14|||
130722619|NCT02585934|470609656|FG001|Overall Study|Protocol Violation|11|||
130722620|NCT02585934|470609655|FG000|Overall Study|Adverse Event|21|||
131058583|NCT03182244|471848212|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
131058584|NCT03182244|471848213|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
130722621|NCT02585934|470609656|FG001|Overall Study|Adverse Event|22|||
131058585|NCT03182244|471848212|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
131058586|NCT03182244|471848213|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
131058587|NCT03182244|471848212|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
131058588|NCT03182244|471848213|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
131058589|NCT03182244|471848212|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
131058590|NCT03182244|471848213|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
131058591|NCT03182244|471848212|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
131058592|NCT03182244|471848213|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
131058593|NCT03182244|471848212|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
131058594|NCT03182244|471848213|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
131058595|NCT03182244|471848212|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
131058596|NCT03182244|471848213|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
131058597|NCT03182244|471848212|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
131058598|NCT03182244|471848213|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
131058599|NCT02852824|471848221|FG000|Overall Study|Withdrawal by Subject|1|||
131058600|NCT02852824|471848222|FG001|Overall Study|Withdrawal by Subject|0|||
131058601|NCT02852824|471848223|FG002|Overall Study|Withdrawal by Subject|0|||
131058602|NCT02852824|471848224|FG003|Overall Study|Withdrawal by Subject|0|||
131058603|NCT02852824|471848225|FG004|Overall Study|Withdrawal by Subject|0|||
131058604|NCT02852824|471848226|FG005|Overall Study|Withdrawal by Subject|0|||
131058605|NCT02852824|471848227|FG006|Overall Study|Withdrawal by Subject|0|||
131058606|NCT02852824|471848221|FG000|Overall Study|Adverse Event|0|||
131058607|NCT02852824|471848222|FG001|Overall Study|Adverse Event|0|||
131058608|NCT02852824|471848223|FG002|Overall Study|Adverse Event|0|||
131058609|NCT02852824|471848224|FG003|Overall Study|Adverse Event|0|||
131058610|NCT02852824|471848225|FG004|Overall Study|Adverse Event|2|||
131058611|NCT02852824|471848226|FG005|Overall Study|Adverse Event|0|||
131058612|NCT02852824|471848227|FG006|Overall Study|Adverse Event|0|||
131058613|NCT00680771|471848228|FG000|Overall Study|Withdrawal by Subject|1|||
131058614|NCT00680771|471848229|FG001|Overall Study|Withdrawal by Subject|0|||
131058615|NCT00680771|471848228|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
131058616|NCT00680771|471848229|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
131058617|NCT00680771|471848228|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
131058618|NCT00680771|471848229|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
131058619|NCT01316913|471848230|FG000|Overall Study|Adverse Event|17|||
131058620|NCT01316913|471848231|FG001|Overall Study|Adverse Event|20|||
131058621|NCT01316913|471848232|FG002|Overall Study|Adverse Event|15|||
131058622|NCT01316913|471848233|FG003|Overall Study|Adverse Event|11|||
131058623|NCT01316913|471848230|FG000|Overall Study|Lack of Efficacy|22|||
131058624|NCT01316913|471848231|FG001|Overall Study|Lack of Efficacy|12|||
131058625|NCT01316913|471848232|FG002|Overall Study|Lack of Efficacy|9|||
131058626|NCT01316913|471848233|FG003|Overall Study|Lack of Efficacy|13|||
131058627|NCT01316913|471848230|FG000|Overall Study|Protocol Violation|1|||
131058628|NCT01316913|471848231|FG001|Overall Study|Protocol Violation|4|||
131058629|NCT01316913|471848232|FG002|Overall Study|Protocol Violation|4|||
131058630|NCT01316913|471848233|FG003|Overall Study|Protocol Violation|1|||
131058631|NCT01316913|471848230|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
131058632|NCT01316913|471848231|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
131058633|NCT01316913|471848232|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
131058634|NCT01316913|471848233|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
131058635|NCT01316913|471848230|FG000|Overall Study|Lost to Follow-up|0|||
131058636|NCT01316913|471848231|FG001|Overall Study|Lost to Follow-up|1|||
131058637|NCT01316913|471848232|FG002|Overall Study|Lost to Follow-up|0|||
131058638|NCT01316913|471848233|FG003|Overall Study|Lost to Follow-up|2|||
131058639|NCT01316913|471848230|FG000|Overall Study|Withdrawal by Subject|10|||
131058640|NCT01316913|471848231|FG001|Overall Study|Withdrawal by Subject|9|||
131058641|NCT01316913|471848232|FG002|Overall Study|Withdrawal by Subject|10|||
131058642|NCT01316913|471848233|FG003|Overall Study|Withdrawal by Subject|6|||
131058643|NCT02691702|471848234|FG000|Overall Study|Adverse Event|1|||
131136733|NCT01789970|472128185|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
131136734|NCT01789970|472128183|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
131136735|NCT01789970|472128184|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
131136736|NCT01789970|472128185|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
131136737|NCT01789970|472128183|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
131136738|NCT01789970|472128184|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
131136739|NCT01789970|472128185|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
131136740|NCT01789970|472128183|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
131136741|NCT01789970|472128184|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130779391|NCT02326272|470819493|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131058644|NCT02691702|471848235|FG001|Overall Study|Adverse Event|0|||
130779392|NCT02326272|470819494|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131058645|NCT02691702|471848236|FG002|Overall Study|Adverse Event|0|||
131058646|NCT02691702|471848237|FG003|Overall Study|Adverse Event|0|||
131058647|NCT02691702|471848238|FG004|Overall Study|Adverse Event|0|||
131058648|NCT02691702|471848239|FG005|Overall Study|Adverse Event|0|||
131058649|NCT02691702|471848240|FG006|Overall Study|Adverse Event|0|||
131058650|NCT02691702|471848241|FG007|Overall Study|Adverse Event|0|||
131058651|NCT02691702|471848242|FG008|Overall Study|Adverse Event|1|||
131058652|NCT02691702|471848243|FG009|Overall Study|Adverse Event|0|||
131058653|NCT02691702|471848244|FG010|Overall Study|Adverse Event|1|||
131058654|NCT02691702|471848234|FG000|Overall Study|Lost to Follow-up|0|||
131058655|NCT02691702|471848235|FG001|Overall Study|Lost to Follow-up|0|||
131058656|NCT02691702|471848236|FG002|Overall Study|Lost to Follow-up|1|||
130779393|NCT02326272|470819495|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
131136742|NCT01789970|472128185|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
131136743|NCT01789970|472128183|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
131136744|NCT01789970|472128184|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
131136745|NCT01789970|472128185|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
131136746|NCT01789970|472128183|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
131136747|NCT01789970|472128184|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
130779394|NCT02326272|470819496|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779395|NCT02326272|470819497|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779396|NCT02326272|470819498|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779397|NCT02326272|470819499|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779398|NCT02326272|470819500|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779399|NCT02326272|470819501|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779400|NCT02326272|470819502|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779401|NCT02326272|470819503|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779402|NCT02326272|470819504|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130779403|NCT02326272|470819490|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130779404|NCT02326272|470819491|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131058657|NCT02691702|471848237|FG003|Overall Study|Lost to Follow-up|0|||
131058658|NCT02691702|471848238|FG004|Overall Study|Lost to Follow-up|0|||
131058659|NCT02691702|471848239|FG005|Overall Study|Lost to Follow-up|2|||
131058660|NCT02691702|471848240|FG006|Overall Study|Lost to Follow-up|0|||
131058661|NCT02691702|471848241|FG007|Overall Study|Lost to Follow-up|0|||
131058662|NCT02691702|471848242|FG008|Overall Study|Lost to Follow-up|0|||
131058663|NCT02691702|471848243|FG009|Overall Study|Lost to Follow-up|0|||
131058664|NCT02691702|471848244|FG010|Overall Study|Lost to Follow-up|1|||
131058665|NCT02691702|471848234|FG000|Overall Study|Withdrawal by Subject|1|||
131058666|NCT02691702|471848235|FG001|Overall Study|Withdrawal by Subject|1|||
131058667|NCT02691702|471848236|FG002|Overall Study|Withdrawal by Subject|0|||
131058668|NCT02691702|471848237|FG003|Overall Study|Withdrawal by Subject|0|||
131058669|NCT02691702|471848238|FG004|Overall Study|Withdrawal by Subject|0|||
131058670|NCT02691702|471848239|FG005|Overall Study|Withdrawal by Subject|1|||
131058671|NCT02691702|471848240|FG006|Overall Study|Withdrawal by Subject|2|||
131058672|NCT02691702|471848241|FG007|Overall Study|Withdrawal by Subject|0|||
131058673|NCT02691702|471848242|FG008|Overall Study|Withdrawal by Subject|0|||
131058674|NCT02691702|471848243|FG009|Overall Study|Withdrawal by Subject|0|||
131058675|NCT02691702|471848244|FG010|Overall Study|Withdrawal by Subject|0|||
131058676|NCT02691702|471848234|FG000|Overall Study|Other|0|||
131058677|NCT02691702|471848235|FG001|Overall Study|Other|0|||
131058678|NCT02691702|471848236|FG002|Overall Study|Other|0|||
131058679|NCT02691702|471848237|FG003|Overall Study|Other|0|||
131058680|NCT02691702|471848238|FG004|Overall Study|Other|0|||
131058681|NCT02691702|471848239|FG005|Overall Study|Other|0|||
131058682|NCT02691702|471848240|FG006|Overall Study|Other|1|||
131058683|NCT02691702|471848241|FG007|Overall Study|Other|0|||
131058684|NCT02691702|471848242|FG008|Overall Study|Other|1|||
131058685|NCT02691702|471848243|FG009|Overall Study|Other|0|||
131058686|NCT02691702|471848244|FG010|Overall Study|Other|0|||
130722622|NCT02585934|470609655|FG000|Overall Study|Physician Decision|3|||
130722623|NCT02585934|470609656|FG001|Overall Study|Physician Decision|2|||
130722624|NCT02585934|470609655|FG000|Overall Study|Withdrawal by Subject|7|||
130722625|NCT02585934|470609656|FG001|Overall Study|Withdrawal by Subject|21|||
130722626|NCT02585934|470609655|FG000|Overall Study|Lack of Efficacy|2|||
130722627|NCT02585934|470609656|FG001|Overall Study|Lack of Efficacy|1|||
130722628|NCT02585934|470609655|FG000|Overall Study|Death|2|||
130722629|NCT02585934|470609656|FG001|Overall Study|Death|0|||
130722630|NCT02585934|470609655|FG000|Overall Study|Caregiver Withdrew Consent|7|||
130722631|NCT02585934|470609656|FG001|Overall Study|Caregiver Withdrew Consent|7|||
131058687|NCT02691702|471848234|FG000|Overall Study|Protocol Violation|0|||
131136748|NCT01789970|472128185|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
131136749|NCT01789970|472128183|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
131136750|NCT01789970|472128184|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
131136751|NCT01789970|472128185|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
131136752|NCT01121393|472128186|FG000|Overall Study|Progressive disease|201|||
131136753|NCT01121393|472128187|FG001|Overall Study|Progressive disease|20|||
131136754|NCT01121393|472128186|FG000|Overall Study|Other Adverse events|24|||
130722632|NCT02585934|470609655|FG000|Overall Study|Sponsor Termination|1|||
130722633|NCT02585934|470609656|FG001|Overall Study|Sponsor Termination|2|||
130779405|NCT02326272|470819492|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
130722634|NCT02585934|470609655|FG000|Overall Study|Another Reason|10|||
130722635|NCT02585934|470609656|FG001|Overall Study|Another Reason|5|||
131058688|NCT02691702|471848235|FG001|Overall Study|Protocol Violation|0|||
131058689|NCT02691702|471848236|FG002|Overall Study|Protocol Violation|0|||
131058690|NCT02691702|471848237|FG003|Overall Study|Protocol Violation|0|||
131058691|NCT02691702|471848238|FG004|Overall Study|Protocol Violation|0|||
130722636|NCT03972163|470609657|FG000|Overall Study|Death|0|||
131058692|NCT02691702|471848239|FG005|Overall Study|Protocol Violation|0|||
131058693|NCT02691702|471848240|FG006|Overall Study|Protocol Violation|0|||
131058694|NCT02691702|471848241|FG007|Overall Study|Protocol Violation|0|||
131058695|NCT02691702|471848242|FG008|Overall Study|Protocol Violation|0|||
131058696|NCT02691702|471848243|FG009|Overall Study|Protocol Violation|2|||
131058697|NCT02691702|471848244|FG010|Overall Study|Protocol Violation|0|||
131058698|NCT05169684|471848245|FG000|Overall Study|Adverse Event|1|||
131058699|NCT05169684|471848246|FG001|Overall Study|Adverse Event|3|||
131058700|NCT05169684|471848245|FG000|Overall Study|Physician Decision|0|||
131058701|NCT05169684|471848246|FG001|Overall Study|Physician Decision|1|||
131058702|NCT05169684|471848245|FG000|Overall Study|Progressive Disease|1|||
131058703|NCT05169684|471848246|FG001|Overall Study|Progressive Disease|1|||
131058704|NCT05169684|471848245|FG000|Overall Study|Participant request to discontinue treatment|0|||
131058705|NCT05169684|471848246|FG001|Overall Study|Participant request to discontinue treatment|1|||
131058706|NCT05169684|471848245|FG000|Overall Study|Other Reason|0|||
131058707|NCT05169684|471848246|FG001|Overall Study|Other Reason|1|||
131058708|NCT01668719|471848247|FG000|Phase I|On treatment|1|||
131058709|NCT01668719|471848248|FG001|Phase I|On treatment|0|||
131058710|NCT01668719|471848249|FG002|Phase I|On treatment|0|||
131058711|NCT01668719|471848247|FG000|Phase I|Adverse Event|2|||
131058712|NCT01668719|471848248|FG001|Phase I|Adverse Event|0|||
131058713|NCT01668719|471848249|FG002|Phase I|Adverse Event|0|||
131058714|NCT01668719|471848247|FG000|Phase I|Progression/relapse|1|||
131058715|NCT01668719|471848248|FG001|Phase I|Progression/relapse|0|||
131058716|NCT01668719|471848249|FG002|Phase I|Progression/relapse|0|||
131058717|NCT01668719|471848247|FG000|Phase I|not protocol specified|2|||
131058718|NCT01668719|471848248|FG001|Phase I|not protocol specified|0|||
131058719|NCT01668719|471848249|FG002|Phase I|not protocol specified|0|||
131058720|NCT01668719|471848247|FG000|Phase II|On treatment|0|||
131058721|NCT01668719|471848248|FG001|Phase II|On treatment|4|||
131058722|NCT01668719|471848249|FG002|Phase II|On treatment|3|||
131058723|NCT01668719|471848247|FG000|Phase II|Adverse Event|0|||
131058724|NCT01668719|471848248|FG001|Phase II|Adverse Event|18|||
131058725|NCT01668719|471848249|FG002|Phase II|Adverse Event|18|||
131058726|NCT01668719|471848247|FG000|Phase II|Refusal unrelated to adverse event|0|||
131058727|NCT01668719|471848248|FG001|Phase II|Refusal unrelated to adverse event|4|||
131058728|NCT01668719|471848249|FG002|Phase II|Refusal unrelated to adverse event|1|||
131058729|NCT01668719|471848247|FG000|Phase II|Progression/relapse|0|||
131058730|NCT01668719|471848248|FG001|Phase II|Progression/relapse|13|||
131058731|NCT01668719|471848249|FG002|Phase II|Progression/relapse|17|||
131058732|NCT01668719|471848247|FG000|Phase II|Death|0|||
131058733|NCT01668719|471848248|FG001|Phase II|Death|0|||
131058734|NCT01668719|471848249|FG002|Phase II|Death|2|||
131058735|NCT01668719|471848247|FG000|Phase II|not protocol specified|0|||
131058736|NCT01668719|471848248|FG001|Phase II|not protocol specified|13|||
131058737|NCT01668719|471848249|FG002|Phase II|not protocol specified|7|||
131058738|NCT02060487|471848250|FG000|Overall Study|Other|1|||
131058739|NCT02060487|471848251|FG001|Overall Study|Other|2|||
131058740|NCT02060487|471848252|FG002|Overall Study|Other|1|||
131136755|NCT01121393|472128187|FG001|Overall Study|Other Adverse events|45|||
131136756|NCT01121393|472128186|FG000|Overall Study|Non-compliant with protocol|0|||
131136757|NCT01121393|472128187|FG001|Overall Study|Non-compliant with protocol|3|||
130722637|NCT03972163|470609658|FG001|Overall Study|Death|1|||
130722638|NCT01161407|470609661|FG000|Overall Study|Protocol Violation|3|||
130722639|NCT01161407|470609662|FG001|Overall Study|Protocol Violation|1|||
130722640|NCT00849186|470609665|FG000|Overall Study|Adverse Event|2|||
131058741|NCT02060487|471848250|FG000|Overall Study|Lack of Efficacy|0|||
131136758|NCT01121393|472128186|FG000|Overall Study|Lost to Follow-up|1|||
131136759|NCT01121393|472128187|FG001|Overall Study|Lost to Follow-up|0|||
131136760|NCT01121393|472128186|FG000|Overall Study|Refused cont. medication|7|||
131136761|NCT01121393|472128187|FG001|Overall Study|Refused cont. medication|7|||
131136762|NCT01121393|472128186|FG000|Overall Study|Not treated|3|||
131136763|NCT01121393|472128187|FG001|Overall Study|Not treated|9|||
131136764|NCT01121393|472128186|FG000|Overall Study|Other than listed|6|||
131058742|NCT02060487|471848251|FG001|Overall Study|Lack of Efficacy|1|||
131058743|NCT02060487|471848252|FG002|Overall Study|Lack of Efficacy|0|||
131136765|NCT01121393|472128187|FG001|Overall Study|Other than listed|0|||
130722641|NCT00849186|470609665|FG000|Overall Study|Withdrawal by Subject|1|||
130722642|NCT00849186|470609665|FG000|Overall Study|not treated|6|||
131058744|NCT02060487|471848250|FG000|Overall Study|Withdrawal by Subject|3|||
131058745|NCT02060487|471848251|FG001|Overall Study|Withdrawal by Subject|10|||
131058746|NCT02060487|471848252|FG002|Overall Study|Withdrawal by Subject|4|||
131058747|NCT02060487|471848250|FG000|Overall Study|Study Terminated By Sponsor|87|||
131058748|NCT02060487|471848251|FG001|Overall Study|Study Terminated By Sponsor|89|||
131058749|NCT02060487|471848252|FG002|Overall Study|Study Terminated By Sponsor|100|||
131058750|NCT02060487|471848250|FG000|Overall Study|Randomized in error|1|||
131136766|NCT02161562|472128188|FG000|Overall Study|Withdrawal by Subject|5|||
131229873|NCT00321711|472467717|FG000|Part A|Physician Decision|0|||
131058751|NCT02060487|471848251|FG001|Overall Study|Randomized in error|0|||
131058752|NCT02060487|471848252|FG002|Overall Study|Randomized in error|0|||
131136767|NCT02161562|472128189|FG001|Overall Study|Withdrawal by Subject|8|||
131229874|NCT00321711|472467718|FG001|Part A|Physician Decision|1|||
131229875|NCT00321711|472467719|FG002|Part A|Physician Decision|3|||
131229876|NCT00321711|472467720|FG003|Part A|Physician Decision|0|||
130722643|NCT00849186|470609665|FG000|Overall Study|Other|1|||
130722644|NCT00492024|470609666|FG000|Treatment|Adverse Event|3|||
130722645|NCT00492024|470609667|FG001|Treatment|Adverse Event|1|||
130722646|NCT00492024|470609666|FG000|Treatment|Lack of Efficacy|21|||
130722647|NCT00492024|470609667|FG001|Treatment|Lack of Efficacy|20|||
130722648|NCT00492024|470609666|FG000|Treatment|Lost to Follow-up|3|||
131136768|NCT02161562|472128188|FG000|Overall Study|Protocol Violation|9|||
131136769|NCT02161562|472128189|FG001|Overall Study|Protocol Violation|4|||
131136770|NCT02161562|472128188|FG000|Overall Study|Pregnancy|1|||
131136771|NCT02161562|472128189|FG001|Overall Study|Pregnancy|2|||
131136772|NCT02161562|472128188|FG000|Overall Study|Lost to Follow-up|3|||
131136773|NCT02161562|472128189|FG001|Overall Study|Lost to Follow-up|1|||
131136774|NCT02161562|472128188|FG000|Overall Study|Lack of Efficacy|4|||
131136775|NCT02161562|472128189|FG001|Overall Study|Lack of Efficacy|1|||
131136776|NCT02161562|472128188|FG000|Overall Study|Adverse Event|1|||
131136777|NCT02161562|472128189|FG001|Overall Study|Adverse Event|1|||
131136778|NCT02161562|472128188|FG000|Overall Study|Participant moved back to home country|1|||
131136779|NCT02161562|472128189|FG001|Overall Study|Participant moved back to home country|0|||
131136780|NCT02161562|472128188|FG000|Overall Study|Withdrew due to being out of the country|1|||
131136781|NCT02161562|472128189|FG001|Overall Study|Withdrew due to being out of the country|0|||
131136782|NCT02161562|472128188|FG000|Overall Study|Participant moved out of province|1|||
131136783|NCT02161562|472128189|FG001|Overall Study|Participant moved out of province|0|||
131136784|NCT02475655|472128190|FG000|Overall Study|Lost to Follow-up|0|||
131136785|NCT02475655|472128191|FG001|Overall Study|Lost to Follow-up|1|||
131136786|NCT02296242|472128197|FG000|Overall Study|Death|1|||
131136787|NCT02296242|472128198|FG001|Overall Study|Death|1|||
131136788|NCT02296242|472128199|FG002|Overall Study|Death|1|||
131136789|NCT02296242|472128200|FG003|Overall Study|Death|1|||
131136790|NCT02296242|472128201|FG004|Overall Study|Death|1|||
131136791|NCT02296242|472128197|FG000|Overall Study|Withdrawal by Subject|0|||
131136792|NCT02296242|472128198|FG001|Overall Study|Withdrawal by Subject|0|||
131136793|NCT02296242|472128199|FG002|Overall Study|Withdrawal by Subject|1|||
131136794|NCT02296242|472128200|FG003|Overall Study|Withdrawal by Subject|1|||
131136795|NCT02296242|472128201|FG004|Overall Study|Withdrawal by Subject|3|||
131136796|NCT02296242|472128197|FG000|Overall Study|Disease Progression|1|||
131136797|NCT02296242|472128198|FG001|Overall Study|Disease Progression|3|||
131136798|NCT02296242|472128199|FG002|Overall Study|Disease Progression|2|||
131136799|NCT02296242|472128200|FG003|Overall Study|Disease Progression|8|||
131136800|NCT02296242|472128201|FG004|Overall Study|Disease Progression|11|||
131136801|NCT02296242|472128197|FG000|Overall Study|Unacceptable Toxicity|0|||
131136802|NCT02296242|472128198|FG001|Overall Study|Unacceptable Toxicity|0|||
131136803|NCT02296242|472128199|FG002|Overall Study|Unacceptable Toxicity|0|||
131136804|NCT02296242|472128200|FG003|Overall Study|Unacceptable Toxicity|0|||
131136805|NCT02296242|472128201|FG004|Overall Study|Unacceptable Toxicity|1|||
131136806|NCT02296242|472128197|FG000|Overall Study|Patient Condition Changed|0|||
131136807|NCT02296242|472128198|FG001|Overall Study|Patient Condition Changed|0|||
130722649|NCT00492024|470609667|FG001|Treatment|Lost to Follow-up|1|||
130722650|NCT00492024|470609666|FG000|Treatment|Withdrawal by Subject|2|||
130722651|NCT00492024|470609667|FG001|Treatment|Withdrawal by Subject|0|||
131058753|NCT02060487|471848250|FG000|Overall Study|Protocol Violation|0|||
131058754|NCT02060487|471848251|FG001|Overall Study|Protocol Violation|1|||
131058755|NCT02060487|471848252|FG002|Overall Study|Protocol Violation|1|||
131058756|NCT02060487|471848250|FG000|Overall Study|Lost to Follow-up|3|||
131058757|NCT02060487|471848251|FG001|Overall Study|Lost to Follow-up|0|||
131058758|NCT02060487|471848252|FG002|Overall Study|Lost to Follow-up|2|||
131058759|NCT02060487|471848250|FG000|Overall Study|Death|34|||
131058760|NCT02060487|471848251|FG001|Overall Study|Death|25|||
131058761|NCT02060487|471848252|FG002|Overall Study|Death|19|||
131058762|NCT02060487|471848250|FG000|Overall Study|Adverse Event|0|||
131058763|NCT02060487|471848251|FG001|Overall Study|Adverse Event|0|||
131058764|NCT02060487|471848252|FG002|Overall Study|Adverse Event|1|||
131058765|NCT05484661|471848253|FG000|Overall Study|Withdrawal by Subject|1|||
131058766|NCT05484661|471848254|FG001|Overall Study|Withdrawal by Subject|0|||
131058767|NCT00875706|471848260|FG000|Overall Study|Withdrawal by Subject|1|||
131058768|NCT00875706|471848261|FG001|Overall Study|Withdrawal by Subject|0|||
131058769|NCT00875706|471848262|FG002|Overall Study|Withdrawal by Subject|0|||
131058770|NCT03775213|471848263|FG000|Overall Study|Withdrawal by Subject|51|||
131058771|NCT03775213|471848264|FG001|Overall Study|Withdrawal by Subject|53|||
131136808|NCT02296242|472128199|FG002|Overall Study|Patient Condition Changed|2|||
131058772|NCT03775213|471848263|FG000|Overall Study|Incomplete Survey|7|||
131136809|NCT02296242|472128200|FG003|Overall Study|Patient Condition Changed|0|||
131136810|NCT02296242|472128201|FG004|Overall Study|Patient Condition Changed|1|||
131229877|NCT00321711|472467721|FG004|Part A|Physician Decision|0|||
131229878|NCT00321711|472467717|FG000|Part A|Other|1|||
131058773|NCT03775213|471848264|FG001|Overall Study|Incomplete Survey|7|||
131136811|NCT02296242|472128197|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
131229879|NCT00321711|472467718|FG001|Part A|Other|2|||
131058774|NCT00786188|471848265|FG000|Overall Study|Adverse Event|3|||
131058775|NCT00786188|471848266|FG001|Overall Study|Adverse Event|1|||
131058776|NCT00786188|471848265|FG000|Overall Study|Withdrawal by Subject|2|||
131058777|NCT00786188|471848266|FG001|Overall Study|Withdrawal by Subject|0|||
131058778|NCT02970318|471848267|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
131058779|NCT02970318|471848268|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
131058780|NCT02970318|471848269|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
131058781|NCT02970318|471848270|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
131058782|NCT02970318|471848267|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
131058783|NCT02970318|471848268|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
131058784|NCT02970318|471848269|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
131058785|NCT02970318|471848270|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
131058786|NCT02970318|471848267|FG000|Overall for Arm A & Main for Arm B|Death|41|||
131058787|NCT02970318|471848268|FG001|Overall for Arm A & Main for Arm B|Death|33|||
131058788|NCT02970318|471848269|FG002|Overall for Arm A & Main for Arm B|Death|0|||
131058789|NCT02970318|471848270|FG003|Overall for Arm A & Main for Arm B|Death|0|||
131058790|NCT02970318|471848267|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
131058791|NCT02970318|471848268|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
131058792|NCT02970318|471848269|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
131058793|NCT02970318|471848270|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
131058794|NCT02970318|471848267|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
131058795|NCT02970318|471848268|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
131058796|NCT02970318|471848269|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
131058797|NCT02970318|471848270|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
131058798|NCT02970318|471848267|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
131058799|NCT02970318|471848268|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
131058800|NCT02970318|471848269|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
131058801|NCT02970318|471848270|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
131058802|NCT02970318|471848267|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
131136812|NCT02296242|472128198|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
131136813|NCT02296242|472128199|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
131136814|NCT02296242|472128200|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
131136815|NCT02296242|472128201|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
131136816|NCT02296242|472128197|FG000|Overall Study|Lost to Follow-up|1|||
131136817|NCT02296242|472128198|FG001|Overall Study|Lost to Follow-up|0|||
131136818|NCT02296242|472128199|FG002|Overall Study|Lost to Follow-up|0|||
131136819|NCT02296242|472128200|FG003|Overall Study|Lost to Follow-up|0|||
131136820|NCT02296242|472128201|FG004|Overall Study|Lost to Follow-up|0|||
131136821|NCT02296242|472128197|FG000|Overall Study|Need for Hydroxyurea|2|||
131136822|NCT02296242|472128198|FG001|Overall Study|Need for Hydroxyurea|0|||
131136823|NCT02296242|472128199|FG002|Overall Study|Need for Hydroxyurea|0|||
131136824|NCT02296242|472128200|FG003|Overall Study|Need for Hydroxyurea|0|||
131136825|NCT02296242|472128201|FG004|Overall Study|Need for Hydroxyurea|0|||
131136826|NCT02296242|472128197|FG000|Overall Study|Screened for Other Protocol|0|||
131136827|NCT02296242|472128198|FG001|Overall Study|Screened for Other Protocol|1|||
131136828|NCT02296242|472128199|FG002|Overall Study|Screened for Other Protocol|0|||
131136829|NCT02296242|472128200|FG003|Overall Study|Screened for Other Protocol|0|||
131136830|NCT02296242|472128201|FG004|Overall Study|Screened for Other Protocol|0|||
131136831|NCT02296242|472128197|FG000|Overall Study|Physician Decision|0|||
131136832|NCT02296242|472128198|FG001|Overall Study|Physician Decision|1|||
131136833|NCT02296242|472128199|FG002|Overall Study|Physician Decision|0|||
131136834|NCT02296242|472128200|FG003|Overall Study|Physician Decision|1|||
131136835|NCT02296242|472128201|FG004|Overall Study|Physician Decision|0|||
131136836|NCT02296242|472128197|FG000|Overall Study|Alternative Treatment|0|||
131136837|NCT02296242|472128198|FG001|Overall Study|Alternative Treatment|0|||
131136838|NCT02296242|472128199|FG002|Overall Study|Alternative Treatment|0|||
131136839|NCT02296242|472128200|FG003|Overall Study|Alternative Treatment|1|||
131136840|NCT02296242|472128201|FG004|Overall Study|Alternative Treatment|0|||
131136841|NCT02296242|472128197|FG000|Overall Study|Adverse Event|0|||
131136842|NCT02296242|472128198|FG001|Overall Study|Adverse Event|0|||
131136843|NCT02296242|472128199|FG002|Overall Study|Adverse Event|0|||
131136844|NCT02296242|472128200|FG003|Overall Study|Adverse Event|1|||
131136845|NCT02296242|472128201|FG004|Overall Study|Adverse Event|0|||
131136846|NCT02296242|472128197|FG000|Overall Study|Lack of Efficacy|0|||
131136847|NCT02296242|472128198|FG001|Overall Study|Lack of Efficacy|0|||
131136848|NCT02296242|472128199|FG002|Overall Study|Lack of Efficacy|0|||
131136849|NCT02296242|472128200|FG003|Overall Study|Lack of Efficacy|0|||
131136850|NCT02296242|472128201|FG004|Overall Study|Lack of Efficacy|3|||
131136851|NCT01639833|472128202|FG000|Overall Study|Death|4|||
131136852|NCT01639833|472128203|FG001|Overall Study|Death|2|||
131136853|NCT01639833|472128202|FG000|Overall Study|Withdrawal by Subject|2|||
131136854|NCT01639833|472128203|FG001|Overall Study|Withdrawal by Subject|2|||
131058803|NCT02970318|471848268|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
131058804|NCT02970318|471848269|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
131058805|NCT02970318|471848270|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
131058806|NCT00824408|471848271|FG000|Run-in Phase|Progressive disease|4|||
131058807|NCT00824408|471848272|FG001|Run-in Phase|Progressive disease|4|||
131058808|NCT00824408|471848273|FG002|Run-in Phase|Progressive disease|0|||
131058809|NCT00824408|471848274|FG003|Run-in Phase|Progressive disease|0|||
131058810|NCT00824408|471848275|FG004|Run-in Phase|Progressive disease|0|||
131058811|NCT00824408|471848271|FG000|Run-in Phase|Adverse Event|1|||
131058812|NCT00824408|471848272|FG001|Run-in Phase|Adverse Event|1|||
131058813|NCT00824408|471848273|FG002|Run-in Phase|Adverse Event|0|||
131058814|NCT00824408|471848274|FG003|Run-in Phase|Adverse Event|0|||
131058815|NCT00824408|471848275|FG004|Run-in Phase|Adverse Event|0|||
131058816|NCT00824408|471848271|FG000|Run-in Phase|Refused to continue medication|1|||
131058817|NCT00824408|471848272|FG001|Run-in Phase|Refused to continue medication|0|||
131058818|NCT00824408|471848273|FG002|Run-in Phase|Refused to continue medication|0|||
131058819|NCT00824408|471848274|FG003|Run-in Phase|Refused to continue medication|0|||
131058820|NCT00824408|471848275|FG004|Run-in Phase|Refused to continue medication|0|||
131058821|NCT00824408|471848271|FG000|Run-in Phase|Other reason not defined above|0|||
131058822|NCT00824408|471848272|FG001|Run-in Phase|Other reason not defined above|1|||
131058823|NCT00824408|471848273|FG002|Run-in Phase|Other reason not defined above|0|||
131058824|NCT00824408|471848274|FG003|Run-in Phase|Other reason not defined above|0|||
131058825|NCT00824408|471848275|FG004|Run-in Phase|Other reason not defined above|0|||
131058826|NCT00824408|471848271|FG000|Randomized Phase|Not treated|0|||
131058827|NCT00824408|471848272|FG001|Randomized Phase|Not treated|0|||
131058828|NCT00824408|471848273|FG002|Randomized Phase|Not treated|1|||
131058829|NCT00824408|471848274|FG003|Randomized Phase|Not treated|1|||
131058830|NCT00824408|471848275|FG004|Randomized Phase|Not treated|1|||
131058831|NCT00824408|471848271|FG000|Randomized Phase|Progressive disease|0|||
131058832|NCT00824408|471848272|FG001|Randomized Phase|Progressive disease|0|||
131058833|NCT00824408|471848273|FG002|Randomized Phase|Progressive disease|25|||
131058834|NCT00824408|471848274|FG003|Randomized Phase|Progressive disease|36|||
131058835|NCT00824408|471848275|FG004|Randomized Phase|Progressive disease|34|||
131058836|NCT00824408|471848271|FG000|Randomized Phase|Adverse Event|0|||
131058837|NCT00824408|471848272|FG001|Randomized Phase|Adverse Event|0|||
131136855|NCT00608985|472128207|FG000|Overall Study|Adverse Event|2|||
131136856|NCT00608985|472128208|FG001|Overall Study|Adverse Event|7|||
131136857|NCT00608985|472128209|FG002|Overall Study|Adverse Event|4|||
131136858|NCT00608985|472128210|FG003|Overall Study|Adverse Event|6|||
131136859|NCT00608985|472128207|FG000|Overall Study|Administrative/Other|7|||
131136860|NCT00608985|472128208|FG001|Overall Study|Administrative/Other|4|||
131136861|NCT00608985|472128209|FG002|Overall Study|Administrative/Other|1|||
131136862|NCT00608985|472128210|FG003|Overall Study|Administrative/Other|2|||
131136863|NCT00608985|472128207|FG000|Overall Study|Withdrawal of Consent|5|||
131136864|NCT00608985|472128208|FG001|Overall Study|Withdrawal of Consent|1|||
131136865|NCT00608985|472128209|FG002|Overall Study|Withdrawal of Consent|1|||
131136866|NCT00608985|472128210|FG003|Overall Study|Withdrawal of Consent|1|||
131136867|NCT00608985|472128207|FG000|Overall Study|Lost to Follow-up|2|||
131136868|NCT00608985|472128208|FG001|Overall Study|Lost to Follow-up|1|||
131136869|NCT00608985|472128209|FG002|Overall Study|Lost to Follow-up|0|||
131136870|NCT00608985|472128210|FG003|Overall Study|Lost to Follow-up|0|||
131136871|NCT03033745|472128211|FG000|Overall Study|Protocol Violation|0|||
131136872|NCT03033745|472128212|FG001|Overall Study|Protocol Violation|0|||
131136873|NCT03033745|472128213|FG002|Overall Study|Protocol Violation|1|||
131136874|NCT03033745|472128211|FG000|Overall Study|Adverse Event|1|||
131136875|NCT03033745|472128212|FG001|Overall Study|Adverse Event|0|||
131136876|NCT03033745|472128213|FG002|Overall Study|Adverse Event|1|||
131136877|NCT03033745|472128211|FG000|Overall Study|Withdrawal by Subject|0|||
131136878|NCT03033745|472128212|FG001|Overall Study|Withdrawal by Subject|1|||
131136879|NCT03033745|472128213|FG002|Overall Study|Withdrawal by Subject|0|||
131136880|NCT00441545|472128214|FG000|First Intervention|Adverse Event|6|||
131136881|NCT00441545|472128215|FG001|First Intervention|Adverse Event|5|||
131058838|NCT00824408|471848273|FG002|Randomized Phase|Adverse Event|4|||
131058839|NCT00824408|471848274|FG003|Randomized Phase|Adverse Event|5|||
131058840|NCT00824408|471848275|FG004|Randomized Phase|Adverse Event|5|||
131136882|NCT00441545|472128214|FG000|First Intervention|Protocol Violation|2|||
131136883|NCT00441545|472128215|FG001|First Intervention|Protocol Violation|2|||
131136884|NCT00441545|472128214|FG000|First Intervention|Withdrawal by Subject|3|||
131136885|NCT00441545|472128215|FG001|First Intervention|Withdrawal by Subject|3|||
131136886|NCT00441545|472128214|FG000|First Intervention|Kidney transplant|1|||
131136887|NCT00441545|472128215|FG001|First Intervention|Kidney transplant|1|||
131136888|NCT00441545|472128214|FG000|First Intervention|Lack of Efficacy|2|||
131136889|NCT00441545|472128215|FG001|First Intervention|Lack of Efficacy|0|||
131136890|NCT00441545|472128214|FG000|First Intervention|Subject exceeded safety criteria|0|||
131058841|NCT00824408|471848271|FG000|Randomized Phase|Refused to continue medication|0|||
131058842|NCT00824408|471848272|FG001|Randomized Phase|Refused to continue medication|0|||
131229880|NCT00321711|472467719|FG002|Part A|Other|3|||
131058843|NCT00824408|471848273|FG002|Randomized Phase|Refused to continue medication|2|||
131058844|NCT00824408|471848274|FG003|Randomized Phase|Refused to continue medication|2|||
131058845|NCT00824408|471848275|FG004|Randomized Phase|Refused to continue medication|2|||
131058846|NCT00824408|471848271|FG000|Randomized Phase|Other reason not defined above|0|||
131058847|NCT00824408|471848272|FG001|Randomized Phase|Other reason not defined above|0|||
131058848|NCT00824408|471848273|FG002|Randomized Phase|Other reason not defined above|4|||
131058849|NCT00824408|471848274|FG003|Randomized Phase|Other reason not defined above|2|||
131058850|NCT00824408|471848275|FG004|Randomized Phase|Other reason not defined above|4|||
131058851|NCT01263496|471848284|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
131058852|NCT01263496|471848285|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131058853|NCT01263496|471848286|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131058854|NCT01263496|471848287|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131058855|NCT01263496|471848288|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131058856|NCT01263496|471848289|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131058857|NCT01263496|471848290|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131058858|NCT01263496|471848291|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131058859|NCT01263496|471848292|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
131058860|NCT01263496|471848284|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131058861|NCT01263496|471848285|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131058862|NCT01263496|471848286|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131058863|NCT01263496|471848287|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
131058864|NCT01263496|471848288|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
131058865|NCT01263496|471848289|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131058866|NCT01263496|471848290|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131058867|NCT01263496|471848291|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131058868|NCT01263496|471848292|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131058869|NCT01263496|471848284|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
131058870|NCT01263496|471848285|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
131058871|NCT01263496|471848286|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
131058872|NCT01263496|471848287|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
131058873|NCT01263496|471848288|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
131058874|NCT01263496|471848289|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
131058875|NCT01263496|471848290|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
131058876|NCT01263496|471848291|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
131058877|NCT01263496|471848292|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
131058878|NCT01263496|471848284|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131058879|NCT01263496|471848285|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
131058880|NCT01263496|471848286|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131058881|NCT01263496|471848287|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131058882|NCT01263496|471848288|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131058883|NCT01263496|471848289|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131058884|NCT01263496|471848290|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131058885|NCT01263496|471848291|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131058886|NCT01263496|471848292|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131058887|NCT01263496|471848284|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131058888|NCT01263496|471848285|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131136891|NCT00441545|472128215|FG001|First Intervention|Subject exceeded safety criteria|1|||
131136892|NCT00441545|472128214|FG000|First Intervention|Subject met an exclusionary criteria|1|||
131136893|NCT00441545|472128215|FG001|First Intervention|Subject met an exclusionary criteria|0|||
131136894|NCT00441545|472128214|FG000|First Intervention|Extended hospitalization|1|||
131136895|NCT00441545|472128215|FG001|First Intervention|Extended hospitalization|0|||
131136896|NCT00441545|472128214|FG000|First Intervention|Site error|1|||
131136897|NCT00441545|472128215|FG001|First Intervention|Site error|0|||
131136898|NCT00441545|472128214|FG000|First Intervention|Sponsor's request|1|||
131136899|NCT00441545|472128215|FG001|First Intervention|Sponsor's request|0|||
131136900|NCT00441545|472128214|FG000|Second Intervention|Adverse Event|5|||
131136901|NCT00441545|472128215|FG001|Second Intervention|Adverse Event|2|||
131136902|NCT00441545|472128214|FG000|Second Intervention|Protocol Violation|4|||
131136903|NCT00441545|472128215|FG001|Second Intervention|Protocol Violation|1|||
131136904|NCT00441545|472128214|FG000|Second Intervention|Withdrawal by Subject|1|||
130822726|NCT00887159|470980585|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
131058889|NCT01263496|471848286|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131058890|NCT01263496|471848287|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131058891|NCT01263496|471848288|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
131058892|NCT01263496|471848289|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131058893|NCT01263496|471848290|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131058894|NCT01263496|471848291|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131058895|NCT01263496|471848292|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131058896|NCT01263496|471848284|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
131058897|NCT01263496|471848285|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
131058898|NCT01263496|471848286|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
131058899|NCT01263496|471848287|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
131058900|NCT01263496|471848288|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
131058901|NCT01263496|471848289|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131058902|NCT01263496|471848290|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131058903|NCT01263496|471848291|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131058904|NCT01263496|471848292|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
131058905|NCT01263496|471848284|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131058906|NCT01263496|471848285|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131058907|NCT01263496|471848286|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131058908|NCT01263496|471848287|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131058909|NCT01263496|471848288|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131058910|NCT01263496|471848289|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131058911|NCT01263496|471848290|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131058912|NCT01263496|471848291|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
131058913|NCT01263496|471848292|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131058914|NCT02950961|471848294|FG000|Overall Study|Study had to stop due to COVID.|7|||
131058915|NCT02241785|471848297|FG000|Overall Study|Sponsor Termination|43|||
131058916|NCT02241785|471848297|FG000|Overall Study|Withdrawal by Subject|1|||
131058917|NCT02241785|471848297|FG000|Overall Study|Lost to Follow-up|2|||
131058918|NCT02241785|471848297|FG000|Overall Study|Adverse Event|1|||
131058919|NCT01736475|471848298|FG000|Overall Study|Adverse Event|4|||
131058920|NCT01736475|471848299|FG001|Overall Study|Adverse Event|0|||
131058921|NCT01736475|471848298|FG000|Overall Study|Withdrawal by Subject|2|||
131058922|NCT01736475|471848299|FG001|Overall Study|Withdrawal by Subject|0|||
131058923|NCT01736475|471848298|FG000|Overall Study|Protocol Violation|4|||
131058924|NCT01736475|471848299|FG001|Overall Study|Protocol Violation|0|||
131058925|NCT01736475|471848298|FG000|Overall Study|Other - Screen failure|1|||
131058926|NCT01736475|471848299|FG001|Overall Study|Other - Screen failure|0|||
131058927|NCT01736475|471848298|FG000|Overall Study|Other - Surgical procedure|1|||
131058928|NCT01736475|471848299|FG001|Overall Study|Other - Surgical procedure|0|||
131058929|NCT01668355|471849792|FG000|Overall Study|Death|3|||
131058930|NCT01668355|471849793|FG001|Overall Study|Death|1|||
131058931|NCT01668355|471849792|FG000|Overall Study|Withdrawal by Subject|6|||
131058932|NCT01668355|471849793|FG001|Overall Study|Withdrawal by Subject|1|||
131058933|NCT00535626|471849794|FG000|Overall Study|Death|15|||
131058934|NCT00535626|471849794|FG000|Overall Study|Lost to Follow-up|29|||
131058935|NCT00535626|471849794|FG000|Overall Study|Withdrawal by Subject|20|||
131058936|NCT00535626|471849794|FG000|Overall Study|Removal/revision of study component|8|||
131058937|NCT00535626|471849794|FG000|Overall Study|Subject terminated|31|||
131058938|NCT00535626|471849794|FG000|Overall Study|Unable to return|2|||
131058939|NCT01277302|471849795|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
131058940|NCT01277302|471849796|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
131058941|NCT01277302|471849797|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
131058942|NCT01277302|471849795|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
131058943|NCT01277302|471849796|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
131058944|NCT01277302|471849797|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
131058945|NCT01277302|471849795|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
131058946|NCT01277302|471849796|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
131058947|NCT01277302|471849797|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
131058948|NCT01277302|471849795|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
131058949|NCT01277302|471849796|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
131058950|NCT01277302|471849797|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
131058951|NCT01277302|471849795|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
131058952|NCT01277302|471849796|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
131058953|NCT01277302|471849797|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
131058954|NCT01277302|471849795|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
131058955|NCT01277302|471849796|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
131058956|NCT01277302|471849797|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
131058957|NCT01277302|471849795|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
131136905|NCT00441545|472128215|FG001|Second Intervention|Withdrawal by Subject|1|||
131136906|NCT00441545|472128214|FG000|Second Intervention|Kidney Transplant|1|||
131136907|NCT00441545|472128215|FG001|Second Intervention|Kidney Transplant|1|||
131136908|NCT00441545|472128214|FG000|Second Intervention|Lack of Efficacy|0|||
131136909|NCT00441545|472128215|FG001|Second Intervention|Lack of Efficacy|1|||
130722652|NCT00492024|470609666|FG000|Follow up|Lack of Efficacy|0|||
131229881|NCT00321711|472467720|FG003|Part A|Other|0|||
130722653|NCT00492024|470609667|FG001|Follow up|Lack of Efficacy|1|||
131229882|NCT00321711|472467721|FG004|Part A|Other|0|||
131229883|NCT00321711|472467717|FG000|Part A|Protocol deviation|0|||
131229884|NCT00321711|472467718|FG001|Part A|Protocol deviation|0|||
131229885|NCT00321711|472467719|FG002|Part A|Protocol deviation|1|||
131229886|NCT00321711|472467720|FG003|Part A|Protocol deviation|0|||
131229887|NCT00321711|472467721|FG004|Part A|Protocol deviation|0|||
131229888|NCT00321711|472467717|FG000|Part B|Noncompliance|0|||
131229889|NCT00321711|472467718|FG001|Part B|Noncompliance|0|||
131229890|NCT00321711|472467719|FG002|Part B|Noncompliance|0|||
131229891|NCT00321711|472467720|FG003|Part B|Noncompliance|0|||
131229892|NCT00321711|472467721|FG004|Part B|Noncompliance|1|||
131229893|NCT00321711|472467717|FG000|Part B|Adverse Event|0|||
131229894|NCT00321711|472467718|FG001|Part B|Adverse Event|0|||
131229895|NCT00321711|472467719|FG002|Part B|Adverse Event|0|||
131229896|NCT00321711|472467720|FG003|Part B|Adverse Event|2|||
131229897|NCT00321711|472467721|FG004|Part B|Adverse Event|1|||
131229898|NCT00321711|472467717|FG000|Part B|Disease progression|0|||
131229899|NCT00321711|472467718|FG001|Part B|Disease progression|0|||
131229900|NCT00321711|472467719|FG002|Part B|Disease progression|0|||
131229901|NCT00321711|472467720|FG003|Part B|Disease progression|1|||
131229902|NCT00321711|472467721|FG004|Part B|Disease progression|0|||
131229903|NCT00321711|472467717|FG000|Part B|Physician Decision|0|||
131229904|NCT00321711|472467718|FG001|Part B|Physician Decision|0|||
131229905|NCT00321711|472467719|FG002|Part B|Physician Decision|0|||
131229906|NCT00321711|472467720|FG003|Part B|Physician Decision|1|||
131229907|NCT00321711|472467721|FG004|Part B|Physician Decision|2|||
131058958|NCT01277302|471849796|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
131058959|NCT01277302|471849797|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
131058960|NCT01277302|471849795|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
131058961|NCT01277302|471849796|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
131058962|NCT01277302|471849797|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
131058963|NCT01277302|471849795|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
131058964|NCT01277302|471849796|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
131058965|NCT01277302|471849797|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
131058966|NCT02710669|471849798|FG000|Overall Study|Physician Decision|2|||
131058967|NCT02710669|471849799|FG001|Overall Study|Physician Decision|1|||
131058968|NCT02710669|471849800|FG002|Overall Study|Physician Decision|0|||
131058969|NCT02710669|471849798|FG000|Overall Study|Institutional delays (including COVID)|2|||
131058970|NCT02710669|471849799|FG001|Overall Study|Institutional delays (including COVID)|2|||
131058971|NCT02710669|471849800|FG002|Overall Study|Institutional delays (including COVID)|0|||
131058972|NCT02710669|471849798|FG000|Overall Study|arrived in afib/aflutter|10|||
131058973|NCT02710669|471849799|FG001|Overall Study|arrived in afib/aflutter|8|||
131058974|NCT02710669|471849800|FG002|Overall Study|arrived in afib/aflutter|2|||
131058975|NCT01190124|471849803|FG000|Overall Study|Death|3|||
131058976|NCT01190124|471849804|FG001|Overall Study|Death|0|||
131058977|NCT01190124|471849805|FG002|Overall Study|Death|0|||
131058978|NCT01190124|471849803|FG000|Overall Study|Therapeutic Failure|12|||
131058979|NCT01190124|471849804|FG001|Overall Study|Therapeutic Failure|0|||
131058980|NCT01190124|471849805|FG002|Overall Study|Therapeutic Failure|1|||
131058981|NCT01190124|471849803|FG000|Overall Study|Lost to Follow-up|2|||
131058982|NCT01190124|471849804|FG001|Overall Study|Lost to Follow-up|0|||
131058983|NCT01190124|471849805|FG002|Overall Study|Lost to Follow-up|0|||
131058984|NCT00070707|471849806|FG000|Overall Study|Adverse Event|1|||
131058985|NCT00070707|471849807|FG001|Overall Study|Adverse Event|2|||
131058986|NCT00070707|471849806|FG000|Overall Study|Lack of Efficacy|4|||
131058987|NCT00070707|471849807|FG001|Overall Study|Lack of Efficacy|1|||
131229908|NCT00321711|472467717|FG000|Part B|Death|0|||
131229909|NCT00321711|472467718|FG001|Part B|Death|0|||
131229910|NCT00321711|472467719|FG002|Part B|Death|0|||
131229911|NCT00321711|472467720|FG003|Part B|Death|2|||
131229912|NCT00321711|472467721|FG004|Part B|Death|1|||
131229913|NCT01186978|472467722|FG000|Overall Study|Withdrawal by Subject|1|||
131229914|NCT01227668|472467723|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
131229915|NCT01227668|472467724|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
131229916|NCT01227668|472467723|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
131229917|NCT01227668|472467724|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
131229918|NCT01227668|472467723|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
131229919|NCT01227668|472467724|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
131229920|NCT01227668|472467723|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
131229921|NCT01227668|472467724|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
131229922|NCT01227668|472467723|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
131229923|NCT01227668|472467724|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
131229924|NCT01227668|472467723|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
131229925|NCT01227668|472467724|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
131229926|NCT01227668|472467723|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
131229927|NCT01227668|472467724|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
131229928|NCT01227668|472467723|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
130722654|NCT00492024|470609666|FG000|Follow up|Lost to Follow-up|1|||
130722655|NCT00492024|470609667|FG001|Follow up|Lost to Follow-up|1|||
130722656|NCT03247816|470609672|FG000|Overall Study|Adverse Event|12|||
130722657|NCT03247816|470609672|FG000|Overall Study|Physician Decision|3|||
130722658|NCT03247816|470609672|FG000|Overall Study|Lack of Efficacy|1|||
130722659|NCT03247816|470609672|FG000|Overall Study|Lost to Follow-up|10|||
130722660|NCT03247816|470609672|FG000|Overall Study|Missing Feraccru stop date|3|||
131058988|NCT00070707|471849806|FG000|Overall Study|Protocol Violation|8|||
131058989|NCT00070707|471849807|FG001|Overall Study|Protocol Violation|4|||
131058990|NCT00070707|471849806|FG000|Overall Study|Unrelated to Study Medication|1|||
131058991|NCT00070707|471849807|FG001|Overall Study|Unrelated to Study Medication|0|||
131058992|NCT02002689|471849812|FG000|Overall Study|Disease Progression|7|||
131058993|NCT02002689|471849812|FG000|Overall Study|Adverse Event|3|||
131058994|NCT00087516|471849813|FG000|Overall Study|Adverse Event|10|||
131058995|NCT00087516|471849814|FG001|Overall Study|Adverse Event|10|||
131058996|NCT00087516|471849815|FG002|Overall Study|Adverse Event|3|||
131058997|NCT00087516|471849816|FG003|Overall Study|Adverse Event|6|||
131058998|NCT00087516|471849813|FG000|Overall Study|Lack of Efficacy|82|||
131058999|NCT00087516|471849814|FG001|Overall Study|Lack of Efficacy|80|||
131059000|NCT00087516|471849815|FG002|Overall Study|Lack of Efficacy|39|||
131059001|NCT00087516|471849816|FG003|Overall Study|Lack of Efficacy|29|||
131059002|NCT00087516|471849813|FG000|Overall Study|Lost to Follow-up|8|||
131059003|NCT00087516|471849814|FG001|Overall Study|Lost to Follow-up|6|||
131059004|NCT00087516|471849815|FG002|Overall Study|Lost to Follow-up|5|||
131059005|NCT00087516|471849816|FG003|Overall Study|Lost to Follow-up|5|||
131059006|NCT00087516|471849813|FG000|Overall Study|Protocol Violation|4|||
131059007|NCT00087516|471849814|FG001|Overall Study|Protocol Violation|8|||
131059008|NCT00087516|471849815|FG002|Overall Study|Protocol Violation|3|||
131059009|NCT00087516|471849816|FG003|Overall Study|Protocol Violation|6|||
131059010|NCT00087516|471849813|FG000|Overall Study|Withdrawal by Subject|16|||
131059011|NCT00087516|471849814|FG001|Overall Study|Withdrawal by Subject|27|||
131059012|NCT00087516|471849815|FG002|Overall Study|Withdrawal by Subject|11|||
131059013|NCT00087516|471849816|FG003|Overall Study|Withdrawal by Subject|12|||
131059014|NCT00087516|471849813|FG000|Overall Study|Site terminated|0|||
131059015|NCT00087516|471849814|FG001|Overall Study|Site terminated|2|||
131059016|NCT00087516|471849815|FG002|Overall Study|Site terminated|1|||
131059017|NCT00087516|471849816|FG003|Overall Study|Site terminated|0|||
131059018|NCT00087516|471849813|FG000|Overall Study|Protocol specified discontinuation|35|||
131059019|NCT00087516|471849814|FG001|Overall Study|Protocol specified discontinuation|33|||
131059020|NCT00087516|471849815|FG002|Overall Study|Protocol specified discontinuation|33|||
131059021|NCT00087516|471849816|FG003|Overall Study|Protocol specified discontinuation|26|||
131059022|NCT00087516|471849813|FG000|Overall Study|Patient moved|3|||
131059023|NCT00087516|471849814|FG001|Overall Study|Patient moved|2|||
131059024|NCT00087516|471849815|FG002|Overall Study|Patient moved|1|||
131059025|NCT00087516|471849816|FG003|Overall Study|Patient moved|0|||
131059026|NCT00087516|471849813|FG000|Overall Study|Patient was non-compliant|3|||
131059027|NCT00087516|471849814|FG001|Overall Study|Patient was non-compliant|1|||
131059028|NCT00087516|471849815|FG002|Overall Study|Patient was non-compliant|0|||
131059029|NCT00087516|471849816|FG003|Overall Study|Patient was non-compliant|0|||
131059030|NCT00087516|471849813|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
131059031|NCT00087516|471849814|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
131059032|NCT00087516|471849815|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
131059033|NCT00087516|471849816|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
131059034|NCT00087516|471849813|FG000|Overall Study|Other|0|||
131059035|NCT00087516|471849814|FG001|Overall Study|Other|0|||
131059036|NCT00087516|471849815|FG002|Overall Study|Other|1|||
131059037|NCT00087516|471849816|FG003|Overall Study|Other|0|||
131059038|NCT01128959|471849821|FG000|Lead in Period|Adverse Event|3|||
131059039|NCT01128959|471849821|FG000|Treatment Period|Adverse Event|3|||
131059040|NCT01128959|471849821|FG000|Treatment Period|Withdrawal by Subject|1|||
131059041|NCT02338999|471849822|FG000|First Intervention|Withdrawal by Subject|3|||
131059042|NCT02338999|471849823|FG001|First Intervention|Withdrawal by Subject|1|||
131059043|NCT02338999|471849822|FG000|Washout Period|Withdrawal by Subject|0|||
131059044|NCT02338999|471849823|FG001|Washout Period|Withdrawal by Subject|2|||
131059045|NCT02338999|471849822|FG000|Second Intervention|Withdrawal by Subject|0|||
130722661|NCT04623086|470609673|FG000|Overall Study|Withdrawal by Subject|0|||
131059046|NCT02338999|471849823|FG001|Second Intervention|Withdrawal by Subject|2|||
131059047|NCT02701296|471849824|FG000|Overall Study|Incomplete Data|0|||
131059048|NCT02701296|471849825|FG001|Overall Study|Incomplete Data|2|||
131059049|NCT00569166|471849826|FG000|Overall Study|Withdrawal by Subject|7|||
131059050|NCT00569166|471849827|FG001|Overall Study|Withdrawal by Subject|5|||
131059051|NCT00569166|471849828|FG002|Overall Study|Withdrawal by Subject|3|||
130722662|NCT04623086|470609674|FG001|Overall Study|Withdrawal by Subject|0|||
131059052|NCT00569166|471849826|FG000|Overall Study|Lost to Follow-up|2|||
131059053|NCT00569166|471849827|FG001|Overall Study|Lost to Follow-up|1|||
131059054|NCT00569166|471849828|FG002|Overall Study|Lost to Follow-up|1|||
131059055|NCT05005247|471849829|FG000|Overall Study|Withdrawal by Subject|0|||
130722663|NCT04623086|470609675|FG002|Overall Study|Withdrawal by Subject|10|||
131059056|NCT05005247|471849830|FG001|Overall Study|Withdrawal by Subject|1|||
131059057|NCT05005247|471849831|FG002|Overall Study|Withdrawal by Subject|0|||
130722664|NCT04546724|470609676|FG000|Overall Study|Withdrawal by Subject|145|||
130722665|NCT04546724|470609677|FG001|Overall Study|Withdrawal by Subject|41|||
130722666|NCT04546724|470609676|FG000|Overall Study|Adverse Event|1|||
130722667|NCT04546724|470609677|FG001|Overall Study|Adverse Event|1|||
130722668|NCT04546724|470609676|FG000|Overall Study|Lost to Follow-up|186|||
130722669|NCT04546724|470609677|FG001|Overall Study|Lost to Follow-up|63|||
130722670|NCT04546724|470609676|FG000|Overall Study|Physician Decision|8|||
130722671|NCT04546724|470609677|FG001|Overall Study|Physician Decision|2|||
130722672|NCT04546724|470609676|FG000|Overall Study|Death|2|||
131059058|NCT03142932|471849832|FG000|Overall Study|Lost to Follow-up|2|||
131059059|NCT03142932|471849833|FG001|Overall Study|Lost to Follow-up|11|||
131059060|NCT00929526|471849834|FG000|Overall Study|Withdrawal by Subject|1|||
131059061|NCT00929526|471849835|FG001|Overall Study|Withdrawal by Subject|11|||
131059062|NCT00929526|471849834|FG000|Overall Study|Lost to Follow-up|8|||
131059063|NCT00929526|471849835|FG001|Overall Study|Lost to Follow-up|12|||
131059064|NCT00929526|471849834|FG000|Overall Study|Other|8|||
131059065|NCT00929526|471849835|FG001|Overall Study|Other|6|||
131059066|NCT02547974|471849836|FG000|Overall Study|Withdrawal by Subject|1|||
131059067|NCT02547974|471849837|FG001|Overall Study|Withdrawal by Subject|0|||
131059068|NCT02547974|471849838|FG002|Overall Study|Withdrawal by Subject|0|||
131059069|NCT02547974|471849839|FG003|Overall Study|Withdrawal by Subject|0|||
131059070|NCT04766996|471849840|FG000|Overall Study|Withdrawal by Subject|1|||
131059071|NCT04766996|471849841|FG001|Overall Study|Withdrawal by Subject|0|||
131059072|NCT04766996|471849842|FG002|Overall Study|Withdrawal by Subject|13|||
131059073|NCT03547154|471849846|FG000|Overall Study|Disease Progression/Recurrence|6|||
131059074|NCT03547154|471849847|FG001|Overall Study|Disease Progression/Recurrence|14|||
131059075|NCT03547154|471849846|FG000|Overall Study|Adverse Event|26|||
131059076|NCT03547154|471849847|FG001|Overall Study|Adverse Event|31|||
131059077|NCT03547154|471849846|FG000|Overall Study|Protocol Violation|6|||
131059078|NCT03547154|471849847|FG001|Overall Study|Protocol Violation|1|||
131059079|NCT03547154|471849846|FG000|Overall Study|Physician Decision|4|||
131059080|NCT03547154|471849847|FG001|Overall Study|Physician Decision|3|||
131059081|NCT03547154|471849846|FG000|Overall Study|Insufficient Therapeutic Response|13|||
131059082|NCT03547154|471849847|FG001|Overall Study|Insufficient Therapeutic Response|10|||
131059083|NCT03547154|471849846|FG000|Overall Study|Withdrawal by Subject|10|||
131059084|NCT03547154|471849847|FG001|Overall Study|Withdrawal by Subject|6|||
131059085|NCT03547154|471849846|FG000|Overall Study|Not Selected|0|||
131059086|NCT03547154|471849847|FG001|Overall Study|Not Selected|1|||
131059087|NCT03547154|471849846|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
131059088|NCT03547154|471849847|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
131059089|NCT02988713|471849848|FG000|Overall Study|Withdrawal by Subject|1|||
131059090|NCT02988713|471849848|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
131059091|NCT01918033|471849849|FG000|Overall Study|Adverse Event|1|||
131059092|NCT01918033|471849850|FG001|Overall Study|Adverse Event|0|||
131059093|NCT01918033|471849851|FG002|Overall Study|Adverse Event|2|||
131059094|NCT01918033|471849849|FG000|Overall Study|Lost to Follow-up|0|||
131059095|NCT01918033|471849850|FG001|Overall Study|Lost to Follow-up|1|||
131059096|NCT01918033|471849851|FG002|Overall Study|Lost to Follow-up|0|||
131059097|NCT01918033|471849849|FG000|Overall Study|Protocol Violation|2|||
131059098|NCT01918033|471849850|FG001|Overall Study|Protocol Violation|0|||
131059099|NCT01918033|471849851|FG002|Overall Study|Protocol Violation|1|||
131059100|NCT01918033|471849849|FG000|Overall Study|Withdrawal by Subject|2|||
131059101|NCT01918033|471849850|FG001|Overall Study|Withdrawal by Subject|1|||
131059102|NCT01918033|471849851|FG002|Overall Study|Withdrawal by Subject|0|||
131059103|NCT04679675|471849852|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
131059104|NCT04679675|471849853|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
131059105|NCT04679675|471849854|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
131059106|NCT04679675|471849855|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
131059107|NCT04679675|471849852|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
131059108|NCT04679675|471849853|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
131059109|NCT04679675|471849854|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
131059110|NCT04679675|471849855|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
131059111|NCT03259568|471849860|FG000|Overall Study|Participant performance was low|3|||
131059112|NCT01794299|471849862|FG000|Overall Study|ATIR manufacturing not possible|1|||
131059113|NCT01794299|471849862|FG000|Overall Study|Death|14|||
131059114|NCT01794299|471849862|FG000|Overall Study|Graft failure|1|||
131059115|NCT01794299|471849862|FG000|Overall Study|ATIR batch rejected|2|||
131059116|NCT01794299|471849862|FG000|Overall Study|Relapse|2|||
131059117|NCT01794299|471849862|FG000|Overall Study|Discontinued from active follow-up|1|||
131059118|NCT01794299|471849862|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
130722673|NCT04546724|470609677|FG001|Overall Study|Death|1|||
131059119|NCT01029704|471849863|FG000|Overall Study|Adverse Event|0|||
131059120|NCT01029704|471849864|FG001|Overall Study|Adverse Event|0|||
131136910|NCT00441545|472128214|FG000|Second Intervention|Subject exceeded safety criteria|1|||
131136911|NCT00441545|472128215|FG001|Second Intervention|Subject exceeded safety criteria|0|||
131136912|NCT00441545|472128214|FG000|Second Intervention|Subject moved|0|||
131136913|NCT00441545|472128215|FG001|Second Intervention|Subject moved|1|||
131136914|NCT02347176|472128216|FG000|Overall Study|Lost to Follow-up|2|||
131136915|NCT02347176|472128217|FG001|Overall Study|Lost to Follow-up|3|||
131136916|NCT02347176|472128218|FG002|Overall Study|Lost to Follow-up|1|||
131136917|NCT02347176|472128219|FG003|Overall Study|Lost to Follow-up|1|||
131136918|NCT02347176|472128216|FG000|Overall Study|Withdrawal by Subject|9|||
131136919|NCT02347176|472128217|FG001|Overall Study|Withdrawal by Subject|5|||
131136920|NCT02347176|472128218|FG002|Overall Study|Withdrawal by Subject|5|||
131136921|NCT02347176|472128219|FG003|Overall Study|Withdrawal by Subject|3|||
131136922|NCT02347176|472128216|FG000|Overall Study|Other|1|||
131136923|NCT02347176|472128217|FG001|Overall Study|Other|2|||
131136924|NCT02347176|472128218|FG002|Overall Study|Other|2|||
131136925|NCT02347176|472128219|FG003|Overall Study|Other|0|||
131136926|NCT01290692|472128220|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
131136927|NCT02387580|472128223|FG000|Overall Study|Withdrawal by Subject|0|||
131136928|NCT02387580|472128224|FG001|Overall Study|Withdrawal by Subject|0|||
131136929|NCT02387580|472128225|FG002|Overall Study|Withdrawal by Subject|0|||
131136930|NCT02387580|472128226|FG003|Overall Study|Withdrawal by Subject|1|||
131136931|NCT02387580|472128227|FG004|Overall Study|Withdrawal by Subject|0|||
131136932|NCT02387580|472128228|FG005|Overall Study|Withdrawal by Subject|0|||
131136933|NCT04925752|472128229|FG000|Overall Study|Still on Study|1826|||
131136934|NCT04925752|472128230|FG001|Overall Study|Still on Study|926|||
131059121|NCT01029704|471849865|FG002|Overall Study|Adverse Event|0|||
131059122|NCT01029704|471849866|FG003|Overall Study|Adverse Event|0|||
131059123|NCT01029704|471849867|FG004|Overall Study|Adverse Event|0|||
131059124|NCT01029704|471849868|FG005|Overall Study|Adverse Event|0|||
131059125|NCT01029704|471849869|FG006|Overall Study|Adverse Event|1|||
131059126|NCT01029704|471849870|FG007|Overall Study|Adverse Event|1|||
131059127|NCT01029704|471849871|FG008|Overall Study|Adverse Event|0|||
131059128|NCT01029704|471849863|FG000|Overall Study|Withdrawal by Subject|0|||
131059129|NCT01029704|471849864|FG001|Overall Study|Withdrawal by Subject|0|||
131059130|NCT01029704|471849865|FG002|Overall Study|Withdrawal by Subject|0|||
131059131|NCT01029704|471849866|FG003|Overall Study|Withdrawal by Subject|0|||
131059132|NCT01029704|471849867|FG004|Overall Study|Withdrawal by Subject|2|||
131059133|NCT01029704|471849868|FG005|Overall Study|Withdrawal by Subject|1|||
131059134|NCT01029704|471849869|FG006|Overall Study|Withdrawal by Subject|1|||
131059135|NCT01029704|471849870|FG007|Overall Study|Withdrawal by Subject|1|||
131059136|NCT01029704|471849871|FG008|Overall Study|Withdrawal by Subject|0|||
131059137|NCT01029704|471849863|FG000|Overall Study|Lost to Follow-up|0|||
131059138|NCT01029704|471849864|FG001|Overall Study|Lost to Follow-up|0|||
131059139|NCT01029704|471849865|FG002|Overall Study|Lost to Follow-up|0|||
131059140|NCT01029704|471849866|FG003|Overall Study|Lost to Follow-up|0|||
131059141|NCT01029704|471849867|FG004|Overall Study|Lost to Follow-up|0|||
131059142|NCT01029704|471849868|FG005|Overall Study|Lost to Follow-up|0|||
131059143|NCT01029704|471849869|FG006|Overall Study|Lost to Follow-up|1|||
131059144|NCT01029704|471849870|FG007|Overall Study|Lost to Follow-up|1|||
131059145|NCT01029704|471849871|FG008|Overall Study|Lost to Follow-up|1|||
131059146|NCT01029704|471849863|FG000|Overall Study|Lack of Efficacy|0|||
131059147|NCT01029704|471849864|FG001|Overall Study|Lack of Efficacy|0|||
131059148|NCT01029704|471849865|FG002|Overall Study|Lack of Efficacy|0|||
131059149|NCT01029704|471849866|FG003|Overall Study|Lack of Efficacy|0|||
131059150|NCT01029704|471849867|FG004|Overall Study|Lack of Efficacy|2|||
131059151|NCT01029704|471849868|FG005|Overall Study|Lack of Efficacy|3|||
131059152|NCT01029704|471849869|FG006|Overall Study|Lack of Efficacy|1|||
131136935|NCT04925752|472128229|FG000|Overall Study|Withdrew Consent|128|||
131229929|NCT01227668|472467724|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
130779406|NCT02326272|470819493|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131059153|NCT01029704|471849870|FG007|Overall Study|Lack of Efficacy|2|||
131059154|NCT01029704|471849871|FG008|Overall Study|Lack of Efficacy|0|||
131059155|NCT01029704|471849863|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
130779407|NCT02326272|470819494|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131059156|NCT01029704|471849864|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
131059157|NCT01029704|471849865|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
131059158|NCT01029704|471849866|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
131059159|NCT01029704|471849867|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
131059160|NCT01029704|471849868|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
131136936|NCT04925752|472128230|FG001|Overall Study|Withdrew Consent|59|||
131136937|NCT04925752|472128229|FG000|Overall Study|Lost to Follow-up|73|||
131136938|NCT04925752|472128230|FG001|Overall Study|Lost to Follow-up|47|||
131136939|NCT04925752|472128229|FG000|Overall Study|Randomized but Never Treated|12|||
131136940|NCT04925752|472128230|FG001|Overall Study|Randomized but Never Treated|9|||
131136941|NCT04925752|472128229|FG000|Overall Study|Hiv-1 Infection|6|||
131136942|NCT04925752|472128230|FG001|Overall Study|Hiv-1 Infection|7|||
131136943|NCT04925752|472128229|FG000|Overall Study|Investigator's discretion|8|||
131136944|NCT04925752|472128230|FG001|Overall Study|Investigator's discretion|5|||
131136945|NCT04925752|472128229|FG000|Overall Study|Non-compliance with Study Drug|8|||
131059161|NCT01029704|471849869|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
131059162|NCT01029704|471849870|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
131059163|NCT01029704|471849871|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
131059164|NCT03006393|471849872|FG000|Overall Study|Withdrawal by Subject|1|||
131059165|NCT03006393|471849873|FG001|Overall Study|Withdrawal by Subject|1|||
131059166|NCT03006393|471849872|FG000|Overall Study|Pregnancy|0|||
131059167|NCT03006393|471849873|FG001|Overall Study|Pregnancy|1|||
131059168|NCT03006393|471849872|FG000|Overall Study|Lost to Follow-up|0|||
131059169|NCT03006393|471849873|FG001|Overall Study|Lost to Follow-up|1|||
131059170|NCT01365546|471849874|FG000|Overall Study|Withdrawal by Subject|1|||
131059171|NCT01365546|471849874|FG000|Overall Study|Screen failure|9|||
131059172|NCT01365546|471849874|FG000|Overall Study|Study termination|1|||
131059173|NCT00472082|471849875|FG000|Overall Study|Study prematurely terminated|5|||
131059174|NCT00761267|471849876|FG000|Overall Study|Death|1|||
131059175|NCT00761267|471849877|FG001|Overall Study|Death|2|||
131059176|NCT00761267|471849878|FG002|Overall Study|Death|5|||
131059177|NCT00761267|471849876|FG000|Overall Study|Lost to Follow-up|0|||
131059178|NCT00761267|471849877|FG001|Overall Study|Lost to Follow-up|0|||
131059179|NCT00761267|471849878|FG002|Overall Study|Lost to Follow-up|1|||
131059180|NCT00761267|471849876|FG000|Overall Study|Randomized but not treated|1|||
131059181|NCT00761267|471849877|FG001|Overall Study|Randomized but not treated|1|||
131059182|NCT00761267|471849878|FG002|Overall Study|Randomized but not treated|0|||
131059183|NCT00761267|471849876|FG000|Overall Study|Withdrawal by Subject|0|||
131059184|NCT00761267|471849877|FG001|Overall Study|Withdrawal by Subject|1|||
131059185|NCT00761267|471849878|FG002|Overall Study|Withdrawal by Subject|0|||
131059186|NCT03200574|471849893|FG000|Overall Study|Death|4|||
131059187|NCT03200574|471849893|FG000|Overall Study|Withdrawal by Subject|8|||
131059188|NCT03200574|471849893|FG000|Overall Study|Long-Term need for anticoagulation|1|||
131059189|NCT03200574|471849893|FG000|Overall Study|Relocation|2|||
131059190|NCT03200574|471849893|FG000|Overall Study|Lost to Follow-up|2|||
131059191|NCT04183491|471849894|FG000|Overall Study|Withdrawal by Subject|0|||
131059192|NCT04183491|471849895|FG001|Overall Study|Withdrawal by Subject|0|||
131059193|NCT04183491|471849896|FG002|Overall Study|Withdrawal by Subject|1|||
131059194|NCT04183491|471849897|FG003|Overall Study|Withdrawal by Subject|0|||
131059195|NCT04183491|471849898|FG004|Overall Study|Withdrawal by Subject|0|||
131059196|NCT04183491|471849899|FG005|Overall Study|Withdrawal by Subject|1|||
131059197|NCT04183491|471849900|FG006|Overall Study|Withdrawal by Subject|0|||
131059198|NCT01856569|471849903|FG000|Overall Study|Other|1|||
131059199|NCT01856569|471849903|FG000|Overall Study|Changed Site/Structure|1|||
131059200|NCT01856569|471849903|FG000|Overall Study|Lost to Follow-up|3|||
131059201|NCT01856569|471849903|FG000|Overall Study|Did not met inclusion criteria|8|||
131059202|NCT03652610|471849904|FG000|Overall Study|Lost to Follow-up|1|||
131059203|NCT03652610|471849905|FG001|Overall Study|Lost to Follow-up|0|||
131059204|NCT03652610|471849904|FG000|Overall Study|Withdrawal by Subject|3|||
131059205|NCT03652610|471849905|FG001|Overall Study|Withdrawal by Subject|5|||
131059206|NCT00326183|471849906|FG000|Overall Study|Lost to Follow-up|104|||
131059207|NCT00326183|471849907|FG001|Overall Study|Lost to Follow-up|56|||
131059208|NCT00326183|471849906|FG000|Overall Study|Protocol Violation|6|||
131059209|NCT00326183|471849907|FG001|Overall Study|Protocol Violation|3|||
131059210|NCT00326183|471849906|FG000|Overall Study|Withdrawal by Subject|35|||
131059211|NCT00326183|471849907|FG001|Overall Study|Withdrawal by Subject|7|||
131059212|NCT00326183|471849906|FG000|Overall Study|Subject Moved|7|||
131059213|NCT00326183|471849907|FG001|Overall Study|Subject Moved|4|||
131059214|NCT00326183|471849906|FG000|Overall Study|Other|47|||
131059215|NCT00326183|471849907|FG001|Overall Study|Other|13|||
131059216|NCT00326183|471849906|FG000|Overall Study|Adverse Event|1|||
131059217|NCT00326183|471849907|FG001|Overall Study|Adverse Event|0|||
131059218|NCT02279732|471849908|FG000|Overall Study|Death|23|||
131059219|NCT02279732|471849909|FG001|Overall Study|Death|20|||
131059220|NCT02279732|471849908|FG000|Overall Study|Disease Progression|13|||
131059221|NCT02279732|471849909|FG001|Overall Study|Disease Progression|3|||
131059222|NCT02279732|471849908|FG000|Overall Study|Withdrawal by Subject|2|||
131059223|NCT02279732|471849909|FG001|Overall Study|Withdrawal by Subject|7|||
131059224|NCT02279732|471849908|FG000|Overall Study|Adverse Event|1|||
131059225|NCT02279732|471849909|FG001|Overall Study|Adverse Event|2|||
131059226|NCT02279732|471849908|FG000|Overall Study|Administrative Reason By Sponsor|0|||
131059227|NCT02279732|471849909|FG001|Overall Study|Administrative Reason By Sponsor|2|||
131059228|NCT02279732|471849908|FG000|Overall Study|Study Drug Toxicity|2|||
131059229|NCT02279732|471849909|FG001|Overall Study|Study Drug Toxicity|0|||
131059230|NCT02279732|471849908|FG000|Overall Study|Lost to Follow-up|0|||
131059231|NCT02279732|471849909|FG001|Overall Study|Lost to Follow-up|1|||
131136946|NCT04925752|472128230|FG001|Overall Study|Non-compliance with Study Drug|5|||
131136947|NCT04925752|472128229|FG000|Overall Study|Adverse Event|5|||
131059232|NCT02279732|471849908|FG000|Overall Study|Maximum Clinical Benefit|1|||
131059233|NCT02279732|471849909|FG001|Overall Study|Maximum Clinical Benefit|0|||
131059234|NCT02279732|471849908|FG000|Overall Study|Subject Requested to Discontinue|0|||
131059235|NCT02279732|471849909|FG001|Overall Study|Subject Requested to Discontinue|1|||
131059236|NCT02279732|471849908|FG000|Overall Study|Other|53|||
131059237|NCT02279732|471849909|FG001|Overall Study|Other|67|||
131059238|NCT02279732|471849908|FG000|Overall Study|Other|3|||
131059239|NCT02279732|471849909|FG001|Overall Study|Other|3|||
131059240|NCT02915783|471849910|FG000|Overall Study|Death|21|||
131059241|NCT02915783|471849910|FG000|Overall Study|Lost to Follow-up|1|||
131059242|NCT02915783|471849910|FG000|Overall Study|Withdrawal by Subject|2|||
131059243|NCT02203032|471849911|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
131059244|NCT02203032|471849912|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
131059245|NCT02203032|471849913|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
131059246|NCT02203032|471849914|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
131059247|NCT02203032|471849911|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
131059248|NCT02203032|471849912|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
131059249|NCT02203032|471849913|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
131059250|NCT02203032|471849914|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
131059251|NCT02203032|471849911|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
131059252|NCT02203032|471849912|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
131059253|NCT02203032|471849913|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
131059254|NCT02203032|471849914|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
131059255|NCT02203032|471849911|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
131059256|NCT02203032|471849912|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
131059257|NCT02203032|471849913|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
131136948|NCT04925752|472128230|FG001|Overall Study|Adverse Event|2|||
131136949|NCT04925752|472128229|FG000|Overall Study|Death|4|||
131136950|NCT04925752|472128230|FG001|Overall Study|Death|2|||
131136951|NCT04925752|472128229|FG000|Overall Study|Protocol Violation|1|||
131136952|NCT04925752|472128230|FG001|Overall Study|Protocol Violation|3|||
131136953|NCT04925752|472128229|FG000|Overall Study|Withdrew Assent|1|||
131059258|NCT02203032|471849914|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
131059259|NCT02203032|471849911|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
131059260|NCT02203032|471849912|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
131059261|NCT02203032|471849913|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
131059262|NCT02203032|471849914|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
131059263|NCT02203032|471849911|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
131059264|NCT02203032|471849912|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
131059265|NCT02203032|471849913|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
131059266|NCT02203032|471849914|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
131059267|NCT02203032|471849911|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
131059268|NCT02203032|471849912|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
131059269|NCT02203032|471849913|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
131059270|NCT02203032|471849914|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
131059271|NCT02203032|471849911|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
131059272|NCT02203032|471849912|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
131059273|NCT02203032|471849913|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
131059274|NCT02203032|471849914|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
131229930|NCT01227668|472467723|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
131229931|NCT01227668|472467724|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
131229932|NCT01227668|472467723|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
131229933|NCT01227668|472467724|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
131059275|NCT02203032|471849911|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
131059276|NCT02203032|471849912|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
131059277|NCT02203032|471849913|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
131136954|NCT04925752|472128230|FG001|Overall Study|Withdrew Assent|0|||
131136955|NCT03467958|472128231|FG000|Overall Study|Adverse Event|20|||
131229934|NCT01227668|472467723|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
131059278|NCT02203032|471849914|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
131059279|NCT02203032|471849911|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
131059280|NCT02203032|471849912|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
131059281|NCT02203032|471849913|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
131229935|NCT01227668|472467724|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
131059282|NCT02203032|471849914|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
131059283|NCT02203032|471849911|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
131059284|NCT02203032|471849912|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
131136956|NCT03467958|472128232|FG001|Overall Study|Adverse Event|32|||
131136957|NCT03467958|472128233|FG002|Overall Study|Adverse Event|5|||
131136958|NCT03467958|472128234|FG003|Overall Study|Adverse Event|3|||
130722674|NCT04546724|470609676|FG000|Overall Study|subject has been out of town|1|||
130722675|NCT04546724|470609677|FG001|Overall Study|subject has been out of town|0|||
130722676|NCT04546724|470609676|FG000|Overall Study|subject is incarcerated|2|||
130722677|NCT04546724|470609677|FG001|Overall Study|subject is incarcerated|0|||
130722678|NCT04546724|470609676|FG000|Overall Study|subject is relocating|12|||
130722679|NCT04546724|470609677|FG001|Overall Study|subject is relocating|4|||
130722680|NCT04546724|470609676|FG000|Overall Study|Subject in another study|1|||
130722681|NCT04546724|470609677|FG001|Overall Study|Subject in another study|1|||
130722682|NCT04874155|470609680|FG000|Overall Study|Lost to Follow-up|1|||
131059285|NCT02203032|471849913|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
131059286|NCT02203032|471849914|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
131059287|NCT02203032|471849911|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
131059288|NCT02203032|471849912|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
131059289|NCT02203032|471849913|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
131059290|NCT02203032|471849914|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
131059291|NCT03055988|471849915|FG000|Period 1|Adverse Event|0|||
131059292|NCT03055988|471849916|FG001|Period 1|Adverse Event|1|||
131059293|NCT03055988|471849915|FG000|Period 1|Lost to Follow-up|1|||
131059294|NCT03055988|471849916|FG001|Period 1|Lost to Follow-up|0|||
131059295|NCT03055988|471849915|FG000|Period 1|Withdrawal by Subject|0|||
131059296|NCT03055988|471849916|FG001|Period 1|Withdrawal by Subject|4|||
131059297|NCT03055988|471849915|FG000|Period 2|Adverse Event|0|||
131059298|NCT03055988|471849916|FG001|Period 2|Adverse Event|1|||
131059299|NCT03055988|471849915|FG000|Period 2|Other than listed|1|||
131059300|NCT03055988|471849916|FG001|Period 2|Other than listed|1|||
131059301|NCT01915914|471849917|FG000|Acute Phase|Withdrawal by Subject|4|||
131059302|NCT01915914|471849918|FG001|Acute Phase|Withdrawal by Subject|0|||
131059303|NCT01915914|471849919|FG002|Acute Phase|Withdrawal by Subject|0|||
131059304|NCT01915914|471849920|FG003|Acute Phase|Withdrawal by Subject|0|||
131059305|NCT01915914|471849917|FG000|Acute Phase|Lost to Follow-up|4|||
131059306|NCT01915914|471849918|FG001|Acute Phase|Lost to Follow-up|0|||
131059307|NCT01915914|471849919|FG002|Acute Phase|Lost to Follow-up|0|||
131059308|NCT01915914|471849920|FG003|Acute Phase|Lost to Follow-up|0|||
131059309|NCT01915914|471849917|FG000|Acute Phase|Physician Decision|1|||
131059310|NCT01915914|471849918|FG001|Acute Phase|Physician Decision|0|||
131059311|NCT01915914|471849919|FG002|Acute Phase|Physician Decision|0|||
131059312|NCT01915914|471849920|FG003|Acute Phase|Physician Decision|0|||
131059313|NCT01915914|471849917|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
131059314|NCT01915914|471849918|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
131059315|NCT01915914|471849919|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
131059316|NCT01915914|471849920|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
131059317|NCT01915914|471849917|FG000|Acute Phase|"Not Achieved treatment success"|1|||
131059318|NCT01915914|471849918|FG001|Acute Phase|"Not Achieved treatment success"|0|||
131059319|NCT01915914|471849919|FG002|Acute Phase|"Not Achieved treatment success"|0|||
131059320|NCT01915914|471849920|FG003|Acute Phase|"Not Achieved treatment success"|0|||
131059321|NCT01915914|471849917|FG000|Acute Phase|Missing|1|||
131059322|NCT01915914|471849918|FG001|Acute Phase|Missing|0|||
131059323|NCT01915914|471849919|FG002|Acute Phase|Missing|0|||
131059324|NCT01915914|471849920|FG003|Acute Phase|Missing|0|||
131059325|NCT01915914|471849917|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131059326|NCT01915914|471849918|FG001|Maintenance Phase|Withdrawal by Subject|1|||
131059327|NCT01915914|471849919|FG002|Maintenance Phase|Withdrawal by Subject|1|||
131059328|NCT01915914|471849920|FG003|Maintenance Phase|Withdrawal by Subject|0|||
131059329|NCT01915914|471849917|FG000|Maintenance Phase|Lost to Follow-up|0|||
131059330|NCT01915914|471849918|FG001|Maintenance Phase|Lost to Follow-up|4|||
131059331|NCT01915914|471849919|FG002|Maintenance Phase|Lost to Follow-up|1|||
131059332|NCT01915914|471849920|FG003|Maintenance Phase|Lost to Follow-up|0|||
131059333|NCT01915914|471849917|FG000|Maintenance Phase|Missing|0|||
131059334|NCT01915914|471849918|FG001|Maintenance Phase|Missing|1|||
131059335|NCT01915914|471849919|FG002|Maintenance Phase|Missing|0|||
131059336|NCT01915914|471849920|FG003|Maintenance Phase|Missing|0|||
131059337|NCT01915914|471849917|FG000|Follow-up Phase|Withdrawal by Subject|0|||
131059338|NCT01915914|471849918|FG001|Follow-up Phase|Withdrawal by Subject|0|||
131059339|NCT01915914|471849919|FG002|Follow-up Phase|Withdrawal by Subject|0|||
131059340|NCT01915914|471849920|FG003|Follow-up Phase|Withdrawal by Subject|1|||
131059341|NCT01915914|471849917|FG000|Follow-up Phase|Physician Decision|0|||
131059342|NCT01915914|471849918|FG001|Follow-up Phase|Physician Decision|0|||
131059343|NCT01915914|471849919|FG002|Follow-up Phase|Physician Decision|0|||
131059344|NCT01915914|471849920|FG003|Follow-up Phase|Physician Decision|1|||
131059345|NCT01528605|471849921|FG000|Overall Study|Lost to Follow-up|1|||
131059346|NCT01528605|471849922|FG001|Overall Study|Lost to Follow-up|0|||
131059347|NCT01528605|471849923|FG002|Overall Study|Lost to Follow-up|1|||
131059348|NCT01528605|471849924|FG003|Overall Study|Lost to Follow-up|1|||
131059349|NCT01528605|471849925|FG004|Overall Study|Lost to Follow-up|0|||
131059350|NCT01528605|471849926|FG005|Overall Study|Lost to Follow-up|0|||
131059351|NCT01528605|471849921|FG000|Overall Study|Death|1|||
130722683|NCT04874155|470609681|FG001|Overall Study|Lost to Follow-up|1|||
131059352|NCT01528605|471849922|FG001|Overall Study|Death|0|||
131136959|NCT03467958|472128235|FG004|Overall Study|Adverse Event|3|||
130722684|NCT04874155|470609680|FG000|Overall Study|Withdrawal by Subject|2|||
130722685|NCT04874155|470609681|FG001|Overall Study|Withdrawal by Subject|2|||
130722686|NCT01147107|470609688|FG000|Overall Study|Lack of Efficacy|5|||
130722687|NCT01147107|470609689|FG001|Overall Study|Lack of Efficacy|0|||
130722688|NCT01147107|470609688|FG000|Overall Study|Withdrawal by Subject|1|||
130722689|NCT01147107|470609689|FG001|Overall Study|Withdrawal by Subject|1|||
130722690|NCT03201965|470609692|FG000|Overall Study|Death|5|||
130722691|NCT03201965|470609693|FG001|Overall Study|Death|27|||
130722692|NCT03201965|470609694|FG002|Overall Study|Death|27|||
130722693|NCT03201965|470609692|FG000|Overall Study|Lost to Follow-up|0|||
130722694|NCT03201965|470609693|FG001|Overall Study|Lost to Follow-up|1|||
130722695|NCT03201965|470609694|FG002|Overall Study|Lost to Follow-up|0|||
130722696|NCT03201965|470609692|FG000|Overall Study|Withdrawal by Subject|3|||
130722697|NCT03201965|470609693|FG001|Overall Study|Withdrawal by Subject|13|||
130722698|NCT03201965|470609694|FG002|Overall Study|Withdrawal by Subject|4|||
130722699|NCT03201965|470609692|FG000|Overall Study|Ongoing|20|||
130722700|NCT03201965|470609693|FG001|Overall Study|Ongoing|152|||
130722701|NCT03201965|470609694|FG002|Overall Study|Ongoing|164|||
131059353|NCT01528605|471849923|FG002|Overall Study|Death|0|||
131059354|NCT01528605|471849924|FG003|Overall Study|Death|0|||
131059355|NCT01528605|471849925|FG004|Overall Study|Death|0|||
131059356|NCT01528605|471849926|FG005|Overall Study|Death|0|||
131059357|NCT00845520|471849927|FG000|Overall Study|Death|1|||
131059358|NCT00845520|471849928|FG001|Overall Study|Death|2|||
131059359|NCT00845520|471849929|FG002|Overall Study|Death|0|||
131059360|NCT00845520|471849927|FG000|Overall Study|Lost to Follow-up|1|||
131059361|NCT00845520|471849928|FG001|Overall Study|Lost to Follow-up|0|||
131059362|NCT00845520|471849929|FG002|Overall Study|Lost to Follow-up|0|||
131059363|NCT00845520|471849927|FG000|Overall Study|Adverse Event|0|||
131059364|NCT00845520|471849928|FG001|Overall Study|Adverse Event|0|||
131059365|NCT00845520|471849929|FG002|Overall Study|Adverse Event|1|||
131059366|NCT02807857|471849930|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
131059367|NCT02807857|471849930|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
131059368|NCT02807857|471849930|FG000|Follow-Up Set|Withdrawal by Subject|8|||
131059369|NCT02807857|471849930|FG000|Follow-Up Set|Lost to Follow-up|7|||
131059370|NCT02807857|471849930|FG000|Follow-Up Set|Physician Decision|6|||
131059371|NCT02807857|471849930|FG000|Follow-Up Set|Adverse Event|3|||
131059372|NCT02807857|471849930|FG000|Follow-Up Set|Death|27|||
131059373|NCT02807857|471849930|FG000|Follow-Up Set|Relocation|2|||
131059374|NCT00513071|471849933|FG000|Overall Study|Adverse Event|1|||
131059375|NCT00513071|471849933|FG000|Overall Study|Withdrawal by Subject|1|||
131059376|NCT00513071|471849933|FG000|Overall Study|Physician Decision|3|||
131059377|NCT00667732|471849937|FG000|Run -In (8 Weeks)|Adverse Event|4|||
131059378|NCT00667732|471849938|FG001|Run -In (8 Weeks)|Adverse Event|0|||
131059379|NCT00667732|471849939|FG002|Run -In (8 Weeks)|Adverse Event|0|||
131059380|NCT00667732|471849937|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
131059381|NCT00667732|471849938|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
131059382|NCT00667732|471849939|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
131059383|NCT00667732|471849937|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
131059384|NCT00667732|471849938|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
131059385|NCT00667732|471849939|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
131059386|NCT01240590|471849940|FG000|Phase I|Refused further treatment|0|||
131059387|NCT01240590|471849941|FG001|Phase I|Refused further treatment|0|||
131059388|NCT01240590|471849942|FG002|Phase I|Refused further treatment|3|||
131059389|NCT01240590|471849943|FG003|Phase I|Refused further treatment|0|||
131059390|NCT01240590|471849944|FG004|Phase I|Refused further treatment|0|||
131059391|NCT01240590|471849940|FG000|Phase II|Refused further treatment|0|||
131059392|NCT01240590|471849941|FG001|Phase II|Refused further treatment|0|||
131059393|NCT01240590|471849942|FG002|Phase II|Refused further treatment|0|||
131059394|NCT01240590|471849943|FG003|Phase II|Refused further treatment|2|||
131059395|NCT01240590|471849944|FG004|Phase II|Refused further treatment|1|||
131059396|NCT02659540|471849947|FG000|Overall Study|Adverse Event|3|||
131059397|NCT02659540|471849948|FG001|Overall Study|Adverse Event|2|||
131136960|NCT03467958|472128236|FG005|Overall Study|Adverse Event|3|||
130722702|NCT02329847|470609695|FG000|Overall Study|Death|4|||
131059398|NCT02659540|471849947|FG000|Overall Study|Death|1|||
131059399|NCT02659540|471849948|FG001|Overall Study|Death|0|||
131059400|NCT02659540|471849947|FG000|Overall Study|Progressive disease|2|||
131059401|NCT02659540|471849948|FG001|Overall Study|Progressive disease|6|||
131059402|NCT02106325|471849951|FG000|Phase 1|Lost to Follow-up|2|||
131059403|NCT02106325|471849952|FG001|Phase 1|Lost to Follow-up|2|||
131059404|NCT02106325|471849951|FG000|Phase 2|Lost to Follow-up|2|||
131059405|NCT02106325|471849952|FG001|Phase 2|Lost to Follow-up|3|||
131059406|NCT02106325|471849951|FG000|Phase 3|Lost to Follow-up|2|||
131059407|NCT02106325|471849952|FG001|Phase 3|Lost to Follow-up|1|||
130722703|NCT02329847|470609696|FG001|Overall Study|Death|4|||
130722704|NCT02329847|470609697|FG002|Overall Study|Death|22|||
130722705|NCT02329847|470609698|FG003|Overall Study|Death|12|||
130722706|NCT02329847|470609699|FG004|Overall Study|Death|20|||
130722707|NCT02329847|470609700|FG005|Overall Study|Death|13|||
131059408|NCT03890484|471849953|FG000|Overall Study|Lost to Follow-up|1|||
131059409|NCT03890484|471849954|FG001|Overall Study|Lost to Follow-up|1|||
131059410|NCT01075152|471849955|FG000|Overall Study|Withdrawal by Subject|1|||
131059411|NCT01075152|471849956|FG001|Overall Study|Withdrawal by Subject|0|||
131059412|NCT00731692|471851879|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
131059413|NCT00731692|471851880|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
131059414|NCT00731692|471851881|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
131059415|NCT00731692|471851879|FG000|Core Study (36 Months)|Physician Decision|1|||
131059416|NCT00731692|471851880|FG001|Core Study (36 Months)|Physician Decision|0|||
131059417|NCT00731692|471851881|FG002|Core Study (36 Months)|Physician Decision|2|||
131059418|NCT00731692|471851879|FG000|Core Study (36 Months)|Death|2|||
131059419|NCT00731692|471851880|FG001|Core Study (36 Months)|Death|1|||
131059420|NCT00731692|471851881|FG002|Core Study (36 Months)|Death|2|||
131059421|NCT00731692|471851879|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
131059422|NCT00731692|471851880|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
131059423|NCT00731692|471851881|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
131059424|NCT00731692|471851879|FG000|Core Study (36 Months)|Administrative|2|||
131059425|NCT00731692|471851880|FG001|Core Study (36 Months)|Administrative|2|||
131059426|NCT00731692|471851881|FG002|Core Study (36 Months)|Administrative|6|||
131059427|NCT00731692|471851879|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
131059428|NCT00731692|471851880|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
131059429|NCT00731692|471851881|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
131059430|NCT00731692|471851879|FG000|Core Study (36 Months)|Protocol Violation|4|||
131059431|NCT00731692|471851880|FG001|Core Study (36 Months)|Protocol Violation|5|||
131059432|NCT00731692|471851881|FG002|Core Study (36 Months)|Protocol Violation|8|||
131059433|NCT00731692|471851879|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
131059434|NCT00731692|471851880|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
131059435|NCT00731692|471851881|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
131059436|NCT00731692|471851879|FG000|Core Study (36 Months)|Adverse Event|25|||
131059437|NCT00731692|471851880|FG001|Core Study (36 Months)|Adverse Event|28|||
131059438|NCT00731692|471851881|FG002|Core Study (36 Months)|Adverse Event|29|||
131059439|NCT00731692|471851879|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
131059440|NCT00731692|471851880|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
131059441|NCT00731692|471851881|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
131059442|NCT00731692|471851879|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
131059443|NCT00731692|471851880|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
131059444|NCT00731692|471851881|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
131059445|NCT00731692|471851879|FG000|Extension Phase|Abnormal test procedure|0|||
131059446|NCT00731692|471851880|FG001|Extension Phase|Abnormal test procedure|0|||
131059447|NCT00731692|471851881|FG002|Extension Phase|Abnormal test procedure|1|||
131059448|NCT00731692|471851879|FG000|Extension Phase|Abnormal lab values|0|||
131059449|NCT00731692|471851880|FG001|Extension Phase|Abnormal lab values|0|||
131059450|NCT00731692|471851881|FG002|Extension Phase|Abnormal lab values|1|||
131136961|NCT03467958|472128237|FG006|Overall Study|Adverse Event|6|||
131136962|NCT03467958|472128238|FG007|Overall Study|Adverse Event|5|||
131136963|NCT03467958|472128239|FG008|Overall Study|Adverse Event|0|||
131136964|NCT03467958|472128231|FG000|Overall Study|Lack of Efficacy|59|||
131136965|NCT03467958|472128232|FG001|Overall Study|Lack of Efficacy|120|||
131136966|NCT03467958|472128233|FG002|Overall Study|Lack of Efficacy|6|||
131136967|NCT03467958|472128234|FG003|Overall Study|Lack of Efficacy|9|||
131136968|NCT03467958|472128235|FG004|Overall Study|Lack of Efficacy|8|||
131136969|NCT03467958|472128236|FG005|Overall Study|Lack of Efficacy|9|||
131136970|NCT03467958|472128237|FG006|Overall Study|Lack of Efficacy|11|||
130722708|NCT02329847|470609695|FG000|Overall Study|Lost to Follow-up|0|||
130722709|NCT02329847|470609696|FG001|Overall Study|Lost to Follow-up|0|||
130722710|NCT02329847|470609697|FG002|Overall Study|Lost to Follow-up|2|||
130722711|NCT02329847|470609698|FG003|Overall Study|Lost to Follow-up|3|||
130722712|NCT02329847|470609699|FG004|Overall Study|Lost to Follow-up|0|||
130722713|NCT02329847|470609700|FG005|Overall Study|Lost to Follow-up|1|||
130722714|NCT02329847|470609695|FG000|Overall Study|Physician Decision|0|||
130722715|NCT02329847|470609696|FG001|Overall Study|Physician Decision|0|||
130722716|NCT02329847|470609697|FG002|Overall Study|Physician Decision|0|||
130722717|NCT02329847|470609698|FG003|Overall Study|Physician Decision|0|||
130722718|NCT02329847|470609699|FG004|Overall Study|Physician Decision|1|||
130722719|NCT02329847|470609700|FG005|Overall Study|Physician Decision|0|||
130722720|NCT02329847|470609695|FG000|Overall Study|Withdrawal by Subject|2|||
130722721|NCT02329847|470609696|FG001|Overall Study|Withdrawal by Subject|1|||
131059451|NCT00731692|471851879|FG000|Extension Phase|Lost to Follow-up|0|||
131059452|NCT00731692|471851880|FG001|Extension Phase|Lost to Follow-up|1|||
131059453|NCT00731692|471851881|FG002|Extension Phase|Lost to Follow-up|4|||
131059454|NCT00731692|471851879|FG000|Extension Phase|Withdrawal by Subject|4|||
131059455|NCT00731692|471851880|FG001|Extension Phase|Withdrawal by Subject|5|||
131059456|NCT00731692|471851881|FG002|Extension Phase|Withdrawal by Subject|3|||
131059457|NCT00731692|471851879|FG000|Extension Phase|Adverse Event|1|||
131136971|NCT03467958|472128238|FG007|Overall Study|Lack of Efficacy|9|||
131136972|NCT03467958|472128239|FG008|Overall Study|Lack of Efficacy|3|||
131059458|NCT00731692|471851880|FG001|Extension Phase|Adverse Event|1|||
131059459|NCT00731692|471851881|FG002|Extension Phase|Adverse Event|15|||
131059460|NCT03332589|471851882|FG000|Overall Study|Lack of Efficacy|2|||
131059461|NCT03332589|471851883|FG001|Overall Study|Lack of Efficacy|0|||
131059462|NCT03332589|471851884|FG002|Overall Study|Lack of Efficacy|0|||
131059463|NCT03332589|471851882|FG000|Overall Study|Adverse Event|1|||
131059464|NCT03332589|471851883|FG001|Overall Study|Adverse Event|0|||
131059465|NCT03332589|471851884|FG002|Overall Study|Adverse Event|0|||
131059466|NCT03332589|471851882|FG000|Overall Study|Death|1|||
131059467|NCT03332589|471851883|FG001|Overall Study|Death|0|||
131059468|NCT03332589|471851884|FG002|Overall Study|Death|0|||
131059469|NCT00108355|471851889|FG000|Overall Study|Peritonitis at index paracentesis|1|||
131059470|NCT00108355|471851890|FG001|Overall Study|Peritonitis at index paracentesis|1|||
131059471|NCT00108355|471851889|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
131059472|NCT00108355|471851890|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
131059473|NCT02958553|471851891|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
131059474|NCT02958553|471851891|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
131059475|NCT03340961|471851892|FG000|Overall Study|Adverse Event|1|||
131059476|NCT03340961|471851893|FG001|Overall Study|Adverse Event|3|||
131059477|NCT03340961|471851894|FG002|Overall Study|Adverse Event|2|||
131059478|NCT03340961|471851895|FG003|Overall Study|Adverse Event|4|||
131059479|NCT03340961|471851892|FG000|Overall Study|Lost to Follow-up|0|||
131059480|NCT03340961|471851893|FG001|Overall Study|Lost to Follow-up|1|||
131059481|NCT03340961|471851894|FG002|Overall Study|Lost to Follow-up|0|||
131059482|NCT03340961|471851895|FG003|Overall Study|Lost to Follow-up|1|||
131059483|NCT03340961|471851892|FG000|Overall Study|Withdrawal by Subject|3|||
131059484|NCT03340961|471851893|FG001|Overall Study|Withdrawal by Subject|2|||
131059485|NCT03340961|471851894|FG002|Overall Study|Withdrawal by Subject|4|||
131059486|NCT03340961|471851895|FG003|Overall Study|Withdrawal by Subject|7|||
131059487|NCT03340961|471851892|FG000|Overall Study|Use of prohibited treatment|0|||
131059488|NCT03340961|471851893|FG001|Overall Study|Use of prohibited treatment|3|||
131059489|NCT03340961|471851894|FG002|Overall Study|Use of prohibited treatment|2|||
131059490|NCT03340961|471851895|FG003|Overall Study|Use of prohibited treatment|4|||
131059491|NCT03340961|471851892|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
131059492|NCT03340961|471851893|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
131059493|NCT03340961|471851894|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
131059494|NCT03340961|471851895|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
131059495|NCT03340961|471851892|FG000|Overall Study|Subject developed an exclusion criterion|0|||
131059496|NCT03340961|471851893|FG001|Overall Study|Subject developed an exclusion criterion|1|||
131059497|NCT03340961|471851894|FG002|Overall Study|Subject developed an exclusion criterion|0|||
131059498|NCT03340961|471851895|FG003|Overall Study|Subject developed an exclusion criterion|0|||
131059499|NCT03340961|471851892|FG000|Overall Study|Protocol Violation|1|||
131059500|NCT03340961|471851893|FG001|Overall Study|Protocol Violation|0|||
131059501|NCT03340961|471851894|FG002|Overall Study|Protocol Violation|1|||
131059502|NCT03340961|471851895|FG003|Overall Study|Protocol Violation|0|||
131059503|NCT03340961|471851892|FG000|Overall Study|Adverse Event|1|||
131059504|NCT03340961|471851893|FG001|Overall Study|Adverse Event|1|||
131059505|NCT03340961|471851894|FG002|Overall Study|Adverse Event|0|||
131059506|NCT03340961|471851895|FG003|Overall Study|Adverse Event|0|||
131059507|NCT03340961|471851892|FG000|Overall Study|Lack of Efficacy|0|||
131059508|NCT03340961|471851893|FG001|Overall Study|Lack of Efficacy|0|||
131059509|NCT03340961|471851894|FG002|Overall Study|Lack of Efficacy|0|||
131059510|NCT03340961|471851895|FG003|Overall Study|Lack of Efficacy|1|||
131059511|NCT00308308|471851896|FG000|Overall Study|Adverse Event|17|||
131059512|NCT00308308|471851897|FG001|Overall Study|Adverse Event|2|||
131059513|NCT00308308|471851896|FG000|Overall Study|Lost to Follow-up|5|||
130722722|NCT02329847|470609697|FG002|Overall Study|Withdrawal by Subject|5|||
130722723|NCT02329847|470609698|FG003|Overall Study|Withdrawal by Subject|7|||
130722724|NCT02329847|470609699|FG004|Overall Study|Withdrawal by Subject|8|||
131059514|NCT00308308|471851897|FG001|Overall Study|Lost to Follow-up|5|||
131059515|NCT00308308|471851896|FG000|Overall Study|Physician Decision|15|||
131059516|NCT00308308|471851897|FG001|Overall Study|Physician Decision|7|||
131059517|NCT00308308|471851896|FG000|Overall Study|Protocol Violation|3|||
131059518|NCT00308308|471851897|FG001|Overall Study|Protocol Violation|14|||
131059519|NCT00308308|471851896|FG000|Overall Study|Withdrawal by Subject|47|||
131059520|NCT00308308|471851897|FG001|Overall Study|Withdrawal by Subject|19|||
131059521|NCT00308308|471851896|FG000|Overall Study|Various|7|||
131059522|NCT00308308|471851897|FG001|Overall Study|Various|5|||
131059523|NCT00308308|471851896|FG000|Overall Study|Randomized but not dosed|8|||
131059524|NCT00308308|471851897|FG001|Overall Study|Randomized but not dosed|16|||
131059525|NCT00308308|471851896|FG000|Overall Study|Other|1|||
131059526|NCT00308308|471851897|FG001|Overall Study|Other|0|||
131229936|NCT01227668|472467723|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
131059527|NCT01686152|471851898|FG000|Overall Study|Withdrawal by Subject|11|||
131059528|NCT01686152|471851899|FG001|Overall Study|Withdrawal by Subject|11|||
131059529|NCT01686152|471851900|FG002|Overall Study|Withdrawal by Subject|3|||
131059530|NCT01686152|471851898|FG000|Overall Study|Drug Code Unblinded|0|||
130722725|NCT02329847|470609700|FG005|Overall Study|Withdrawal by Subject|3|||
130722726|NCT02329847|470609695|FG000|Overall Study|Other|1|||
130722727|NCT02329847|470609696|FG001|Overall Study|Other|2|||
130722728|NCT02329847|470609697|FG002|Overall Study|Other|6|||
130722729|NCT02329847|470609698|FG003|Overall Study|Other|13|||
130722730|NCT02329847|470609699|FG004|Overall Study|Other|10|||
130722731|NCT02329847|470609700|FG005|Overall Study|Other|3|||
130722732|NCT05293639|470609701|FG000|Overall Study|Withdrawal by Subject|1|||
130722733|NCT05293639|470609702|FG001|Overall Study|Withdrawal by Subject|1|||
130722734|NCT05293639|470609703|FG002|Overall Study|Withdrawal by Subject|2|||
130722735|NCT05293639|470609701|FG000|Overall Study|Death|0|||
130722736|NCT05293639|470609702|FG001|Overall Study|Death|1|||
130722737|NCT05293639|470609703|FG002|Overall Study|Death|0|||
130722738|NCT05293639|470609701|FG000|Overall Study|Lost to Follow-up|0|||
130722739|NCT05293639|470609702|FG001|Overall Study|Lost to Follow-up|0|||
130722740|NCT05293639|470609703|FG002|Overall Study|Lost to Follow-up|5|||
130722741|NCT05293639|470609701|FG000|Overall Study|Other|0|||
130722742|NCT05293639|470609702|FG001|Overall Study|Other|0|||
130722743|NCT05293639|470609703|FG002|Overall Study|Other|1|||
130722744|NCT02365558|470609707|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
130722745|NCT02365558|470609708|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
130722746|NCT02365558|470609707|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
130722747|NCT02365558|470609708|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
130722748|NCT00369317|470609709|FG000|Overall Study|Adverse Event|3|||
130722749|NCT00369317|470609709|FG000|Overall Study|Death|1|||
130722750|NCT00369317|470609709|FG000|Overall Study|Lack of Efficacy|5|||
130722751|NCT00369317|470609709|FG000|Overall Study|Physician Decision|2|||
130722752|NCT00369317|470609709|FG000|Overall Study|Withdrawal by Subject|8|||
130722753|NCT00369317|470609709|FG000|Overall Study|Ineligible|1|||
130722754|NCT02828241|470609718|FG000|Overall Study|Adverse Event|7|||
131059531|NCT01686152|471851899|FG001|Overall Study|Drug Code Unblinded|1|||
131059532|NCT01686152|471851900|FG002|Overall Study|Drug Code Unblinded|0|||
131059533|NCT01686152|471851898|FG000|Overall Study|Protocol Violation|6|||
131059534|NCT01686152|471851899|FG001|Overall Study|Protocol Violation|1|||
131059535|NCT01686152|471851900|FG002|Overall Study|Protocol Violation|0|||
131059536|NCT01686152|471851898|FG000|Overall Study|Adverse Event|12|||
131059537|NCT01686152|471851899|FG001|Overall Study|Adverse Event|11|||
131059538|NCT01686152|471851900|FG002|Overall Study|Adverse Event|0|||
131059539|NCT01686152|471851898|FG000|Overall Study|Lack of Efficacy|0|||
131059540|NCT01686152|471851899|FG001|Overall Study|Lack of Efficacy|0|||
131059541|NCT01686152|471851900|FG002|Overall Study|Lack of Efficacy|1|||
131059542|NCT01686152|471851898|FG000|Overall Study|IP Non-compliance|5|||
131059543|NCT01686152|471851899|FG001|Overall Study|IP Non-compliance|5|||
131059544|NCT01686152|471851900|FG002|Overall Study|IP Non-compliance|0|||
131059545|NCT01686152|471851898|FG000|Overall Study|Lost to Follow-up|7|||
131059546|NCT01686152|471851899|FG001|Overall Study|Lost to Follow-up|6|||
131059547|NCT01686152|471851900|FG002|Overall Study|Lost to Follow-up|5|||
131059548|NCT01853384|471851901|FG000|Randomized|Adverse Event|5|||
131059549|NCT01853384|471851902|FG001|Randomized|Adverse Event|3|||
131059550|NCT01853384|471851901|FG000|Randomized|Death|1|||
131059551|NCT01853384|471851902|FG001|Randomized|Death|2|||
131059552|NCT01853384|471851901|FG000|Randomized|Lost to Follow-up|1|||
131059553|NCT01853384|471851902|FG001|Randomized|Lost to Follow-up|1|||
131059554|NCT01853384|471851901|FG000|Randomized|Withdrawal by Subject|5|||
131059555|NCT01853384|471851902|FG001|Randomized|Withdrawal by Subject|3|||
131059556|NCT01853384|471851901|FG000|Randomized|Sponsor Decision|47|||
131059557|NCT01853384|471851902|FG001|Randomized|Sponsor Decision|34|||
131059558|NCT01853384|471851901|FG000|Randomized|Other|3|||
131059559|NCT01853384|471851902|FG001|Randomized|Other|3|||
131059560|NCT01853384|471851901|FG000|Completed Follow up Visit 1|Early Termination|13|||
131059561|NCT01853384|471851902|FG001|Completed Follow up Visit 1|Early Termination|9|||
131059562|NCT01853384|471851901|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
131059563|NCT01853384|471851902|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
131059564|NCT01853384|471851901|FG000|Completed Follow up Visit 2|Adverse Event|1|||
131059565|NCT01853384|471851902|FG001|Completed Follow up Visit 2|Adverse Event|0|||
131059566|NCT01853384|471851901|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
130722755|NCT02828241|470609719|FG001|Overall Study|Adverse Event|2|||
130722756|NCT02828241|470609718|FG000|Overall Study|Protocol Violation|1|||
131059567|NCT01853384|471851902|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
131059568|NCT01853384|471851901|FG000|Completed Follow up Visit 2|Death|1|||
131059569|NCT01853384|471851902|FG001|Completed Follow up Visit 2|Death|0|||
131059570|NCT01853384|471851901|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
131059571|NCT01853384|471851902|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
131059572|NCT01802333|471851903|FG000|Overall Study|Ineligible|2|||
130722757|NCT02828241|470609719|FG001|Overall Study|Protocol Violation|0|||
130722758|NCT03185013|470609724|FG000|Overall Study|Withdrawal by Subject|5|||
130722759|NCT03185013|470609725|FG001|Overall Study|Withdrawal by Subject|3|||
131059573|NCT01802333|471851904|FG001|Overall Study|Ineligible|6|||
131059574|NCT01802333|471851905|FG002|Overall Study|Ineligible|8|||
131059575|NCT01802333|471851903|FG000|Overall Study|Adverse Event|1|||
131059576|NCT01802333|471851904|FG001|Overall Study|Adverse Event|8|||
131059577|NCT01802333|471851905|FG002|Overall Study|Adverse Event|8|||
131059578|NCT01802333|471851903|FG000|Overall Study|Withdrawal by Subject|6|||
131059579|NCT01802333|471851904|FG001|Overall Study|Withdrawal by Subject|6|||
131059580|NCT01802333|471851905|FG002|Overall Study|Withdrawal by Subject|5|||
131059581|NCT01802333|471851903|FG000|Overall Study|Progression/relapse|1|||
131059582|NCT01802333|471851904|FG001|Overall Study|Progression/relapse|3|||
131059583|NCT01802333|471851905|FG002|Overall Study|Progression/relapse|0|||
131059584|NCT01802333|471851903|FG000|Overall Study|Death|7|||
131059585|NCT01802333|471851904|FG001|Overall Study|Death|14|||
131059586|NCT01802333|471851905|FG002|Overall Study|Death|13|||
131059587|NCT01802333|471851903|FG000|Overall Study|Other - not protocol specified|32|||
131059588|NCT01802333|471851904|FG001|Overall Study|Other - not protocol specified|22|||
131059589|NCT01802333|471851905|FG002|Overall Study|Other - not protocol specified|24|||
131059590|NCT01802333|471851903|FG000|Overall Study|Did not start treatment|0|||
131059591|NCT01802333|471851904|FG001|Overall Study|Did not start treatment|2|||
131059592|NCT01802333|471851905|FG002|Overall Study|Did not start treatment|5|||
131059593|NCT01947491|471851906|FG000|Overall Study|Lost to Follow-up|5|||
131059594|NCT01947491|471851907|FG001|Overall Study|Lost to Follow-up|3|||
131059595|NCT01947491|471851908|FG002|Overall Study|Lost to Follow-up|1|||
131059596|NCT01947491|471851909|FG003|Overall Study|Lost to Follow-up|2|||
131059597|NCT01947491|471851906|FG000|Overall Study|Lack of Efficacy|1|||
131059598|NCT01947491|471851907|FG001|Overall Study|Lack of Efficacy|0|||
131059599|NCT01947491|471851908|FG002|Overall Study|Lack of Efficacy|0|||
131059600|NCT01947491|471851909|FG003|Overall Study|Lack of Efficacy|1|||
131059601|NCT01947491|471851906|FG000|Overall Study|Protocol Violation|1|||
131059602|NCT01947491|471851907|FG001|Overall Study|Protocol Violation|0|||
131059603|NCT01947491|471851908|FG002|Overall Study|Protocol Violation|0|||
131059604|NCT01947491|471851909|FG003|Overall Study|Protocol Violation|0|||
131059605|NCT01947491|471851906|FG000|Overall Study|Withdrawal by Subject|1|||
131059606|NCT01947491|471851907|FG001|Overall Study|Withdrawal by Subject|1|||
131059607|NCT01947491|471851908|FG002|Overall Study|Withdrawal by Subject|1|||
131059608|NCT01947491|471851909|FG003|Overall Study|Withdrawal by Subject|0|||
131059609|NCT01947491|471851906|FG000|Overall Study|Worsening of condition|0|||
130722760|NCT03185013|470609724|FG000|Overall Study|Adverse Event|1|||
130722761|NCT03185013|470609725|FG001|Overall Study|Adverse Event|0|||
130722762|NCT03185013|470609724|FG000|Overall Study|Progressive Disease|1|||
130722763|NCT03185013|470609725|FG001|Overall Study|Progressive Disease|0|||
130722764|NCT03185013|470609724|FG000|Overall Study|Lost to Follow-up|8|||
130722765|NCT03185013|470609725|FG001|Overall Study|Lost to Follow-up|2|||
130722766|NCT03185013|470609724|FG000|Overall Study|Physician Decision|1|||
130722767|NCT03185013|470609725|FG001|Overall Study|Physician Decision|0|||
130722768|NCT03185013|470609724|FG000|Overall Study|Protocol Deviation|2|||
130722769|NCT03185013|470609725|FG001|Overall Study|Protocol Deviation|0|||
130722770|NCT03185013|470609724|FG000|Overall Study|Reason not Specified|3|||
130722771|NCT03185013|470609725|FG001|Overall Study|Reason not Specified|2|||
130722772|NCT03185013|470609724|FG000|Overall Study|Death|1|||
130722773|NCT03185013|470609725|FG001|Overall Study|Death|0|||
130722774|NCT00510289|470609729|FG000|Overall Study|Withdrawal by Subject|7|||
130722775|NCT00510289|470609729|FG000|Overall Study|Refused bone marrow biopsy|2|||
130722776|NCT00510289|470609729|FG000|Overall Study|Lost to Follow-up|1|||
130722777|NCT00510289|470609729|FG000|Overall Study|Progressed prior to starting drug|2|||
130722778|NCT00673387|470609732|FG000|Overall Study|Withdrawal by Subject|15|||
130722779|NCT00673387|470609733|FG001|Overall Study|Withdrawal by Subject|16|||
130722780|NCT00673387|470609734|FG002|Overall Study|Withdrawal by Subject|20|||
130722781|NCT00673387|470609735|FG003|Overall Study|Withdrawal by Subject|16|||
130722782|NCT00673387|470609736|FG004|Overall Study|Withdrawal by Subject|18|||
130722783|NCT00673387|470609737|FG005|Overall Study|Withdrawal by Subject|21|||
130722784|NCT00673387|470609738|FG006|Overall Study|Withdrawal by Subject|15|||
130779408|NCT02326272|470819495|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131059610|NCT01947491|471851907|FG001|Overall Study|Worsening of condition|1|||
131059611|NCT01947491|471851908|FG002|Overall Study|Worsening of condition|0|||
130722785|NCT00673387|470609739|FG007|Overall Study|Withdrawal by Subject|21|||
130722786|NCT00673387|470609732|FG000|Overall Study|Adverse Event|3|||
130722787|NCT00673387|470609733|FG001|Overall Study|Adverse Event|1|||
130722788|NCT00673387|470609734|FG002|Overall Study|Adverse Event|5|||
131059612|NCT01947491|471851909|FG003|Overall Study|Worsening of condition|0|||
131059613|NCT01947491|471851906|FG000|Overall Study|Adverse Event|0|||
131059614|NCT01947491|471851907|FG001|Overall Study|Adverse Event|1|||
131059615|NCT01947491|471851908|FG002|Overall Study|Adverse Event|0|||
131059616|NCT01947491|471851909|FG003|Overall Study|Adverse Event|2|||
131059617|NCT02067663|471851911|FG000|Overall Study|Lost to Follow-up|13|||
131059618|NCT02067663|471851912|FG001|Overall Study|Lost to Follow-up|14|||
130722789|NCT00673387|470609735|FG003|Overall Study|Adverse Event|2|||
130722790|NCT00673387|470609736|FG004|Overall Study|Adverse Event|6|||
131059619|NCT03137784|471851913|FG000|Overall Study|Adverse Event|1|||
131059620|NCT03137784|471851914|FG001|Overall Study|Adverse Event|1|||
131059621|NCT03137784|471851915|FG002|Overall Study|Adverse Event|0|||
131059622|NCT03137784|471851916|FG003|Overall Study|Adverse Event|0|||
131059623|NCT03137784|471851917|FG004|Overall Study|Adverse Event|0|||
131059624|NCT03137784|471851918|FG005|Overall Study|Adverse Event|0|||
131059625|NCT03137784|471851913|FG000|Overall Study|Subject/guardian decision|1|||
131059626|NCT03137784|471851914|FG001|Overall Study|Subject/guardian decision|0|||
131059627|NCT03137784|471851915|FG002|Overall Study|Subject/guardian decision|0|||
131059628|NCT03137784|471851916|FG003|Overall Study|Subject/guardian decision|0|||
131059629|NCT03137784|471851917|FG004|Overall Study|Subject/guardian decision|0|||
131059630|NCT03137784|471851918|FG005|Overall Study|Subject/guardian decision|0|||
131059631|NCT03137784|471851913|FG000|Overall Study|Non-compliance with study treatment|0|||
131059632|NCT03137784|471851914|FG001|Overall Study|Non-compliance with study treatment|0|||
131059633|NCT03137784|471851915|FG002|Overall Study|Non-compliance with study treatment|0|||
131059634|NCT03137784|471851916|FG003|Overall Study|Non-compliance with study treatment|0|||
131059635|NCT03137784|471851917|FG004|Overall Study|Non-compliance with study treatment|1|||
131059636|NCT03137784|471851918|FG005|Overall Study|Non-compliance with study treatment|0|||
131059637|NCT01437540|471851919|FG000|Overall Study|Not listed below|7|||
131059638|NCT01437540|471851920|FG001|Overall Study|Not listed below|6|||
131059639|NCT01437540|471851919|FG000|Overall Study|COPD exacerbation|13|||
131059640|NCT01437540|471851920|FG001|Overall Study|COPD exacerbation|3|||
131059641|NCT01437540|471851919|FG000|Overall Study|Lost to Follow-up|3|||
131059642|NCT01437540|471851920|FG001|Overall Study|Lost to Follow-up|5|||
131059643|NCT01437540|471851919|FG000|Overall Study|Lack of Efficacy|23|||
131059644|NCT01437540|471851920|FG001|Overall Study|Lack of Efficacy|11|||
131059645|NCT01437540|471851919|FG000|Overall Study|Protocol Violation|24|||
131059646|NCT01437540|471851920|FG001|Overall Study|Protocol Violation|12|||
131059647|NCT01437540|471851919|FG000|Overall Study|Adverse Event|26|||
131059648|NCT01437540|471851920|FG001|Overall Study|Adverse Event|13|||
131059649|NCT01437540|471851919|FG000|Overall Study|Withdrawal by Subject|31|||
131059650|NCT01437540|471851920|FG001|Overall Study|Withdrawal by Subject|15|||
131059651|NCT01205126|471851922|FG000|Titration Phase|Adverse Event|5|||
131059652|NCT01205126|471851923|FG001|Titration Phase|Adverse Event|3|||
131059653|NCT01205126|471851922|FG000|Titration Phase|Withdrawal by Subject|5|||
131059654|NCT01205126|471851923|FG001|Titration Phase|Withdrawal by Subject|5|||
131059655|NCT01205126|471851922|FG000|Titration Phase|Lost to Follow-up|2|||
131059656|NCT01205126|471851923|FG001|Titration Phase|Lost to Follow-up|2|||
131059657|NCT01205126|471851922|FG000|Titration Phase|No stable titration dose|1|||
131059658|NCT01205126|471851923|FG001|Titration Phase|No stable titration dose|0|||
131059659|NCT01205126|471851922|FG000|Titration Phase|More than maximum dosage required|2|||
131059660|NCT01205126|471851923|FG001|Titration Phase|More than maximum dosage required|3|||
131059661|NCT01205126|471851922|FG000|Titration Phase|Other|8|||
131059662|NCT01205126|471851923|FG001|Titration Phase|Other|6|||
131059663|NCT01205126|471851922|FG000|Between Titration & Maintenance Phase|Other|0|||
131059664|NCT01205126|471851923|FG001|Between Titration & Maintenance Phase|Other|4|||
131059665|NCT01205126|471851922|FG000|Maintenance Phase|Adverse Event|3|||
131059666|NCT01205126|471851923|FG001|Maintenance Phase|Adverse Event|7|||
131059667|NCT01205126|471851922|FG000|Maintenance Phase|Death|4|||
131059668|NCT01205126|471851923|FG001|Maintenance Phase|Death|4|||
131059669|NCT01205126|471851922|FG000|Maintenance Phase|More than the maximum dosage required|5|||
131059670|NCT01205126|471851923|FG001|Maintenance Phase|More than the maximum dosage required|5|||
131059671|NCT01205126|471851922|FG000|Maintenance Phase|Prohibited drugs used|1|||
131059672|NCT01205126|471851923|FG001|Maintenance Phase|Prohibited drugs used|0|||
131059673|NCT01205126|471851922|FG000|Maintenance Phase|Other|11|||
131059674|NCT01205126|471851923|FG001|Maintenance Phase|Other|8|||
131059675|NCT01205126|471851922|FG000|Maintenance Phase|Lost to Follow-up|5|||
131059676|NCT01205126|471851923|FG001|Maintenance Phase|Lost to Follow-up|5|||
131059677|NCT01205126|471851922|FG000|Maintenance Phase|Withdrawal by Subject|8|||
131059678|NCT01205126|471851923|FG001|Maintenance Phase|Withdrawal by Subject|11|||
131059679|NCT00486954|471851924|FG000|Pilot Part|Adverse Event|4|||
131059680|NCT00486954|471851925|FG001|Pilot Part|Adverse Event|0|||
131059681|NCT00486954|471851926|FG002|Pilot Part|Adverse Event|5|||
131059682|NCT00486954|471851927|FG003|Pilot Part|Adverse Event|0|||
131059683|NCT00486954|471851928|FG004|Pilot Part|Adverse Event|0|||
131136973|NCT03467958|472128231|FG000|Overall Study|Lost to Follow-up|1|||
131136974|NCT03467958|472128232|FG001|Overall Study|Lost to Follow-up|2|||
131136975|NCT03467958|472128233|FG002|Overall Study|Lost to Follow-up|1|||
131059684|NCT00486954|471851924|FG000|Pilot Part|Disease Progression|2|||
131059685|NCT00486954|471851925|FG001|Pilot Part|Disease Progression|0|||
131059686|NCT00486954|471851926|FG002|Pilot Part|Disease Progression|1|||
131059687|NCT00486954|471851927|FG003|Pilot Part|Disease Progression|0|||
131059688|NCT00486954|471851928|FG004|Pilot Part|Disease Progression|0|||
131059689|NCT00486954|471851924|FG000|Randomized Part|Lost to Follow-up|0|||
131059690|NCT00486954|471851925|FG001|Randomized Part|Lost to Follow-up|0|||
131059691|NCT00486954|471851926|FG002|Randomized Part|Lost to Follow-up|0|||
131059692|NCT00486954|471851927|FG003|Randomized Part|Lost to Follow-up|0|||
131059693|NCT00486954|471851928|FG004|Randomized Part|Lost to Follow-up|1|||
131059694|NCT00486954|471851924|FG000|Randomized Part|Withdrawal by Subject|0|||
131059695|NCT00486954|471851925|FG001|Randomized Part|Withdrawal by Subject|0|||
131059696|NCT00486954|471851926|FG002|Randomized Part|Withdrawal by Subject|0|||
131136976|NCT03467958|472128234|FG003|Overall Study|Lost to Follow-up|0|||
131229937|NCT01227668|472467724|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
131229938|NCT01709383|472467734|FG000|Overall Study|Lost to Follow-up|1|||
131229939|NCT01709383|472467735|FG001|Overall Study|Lost to Follow-up|0|||
131229940|NCT03264066|472467736|FG000|Overall Study|Adverse Event|1|||
131229941|NCT03264066|472467737|FG001|Overall Study|Adverse Event|1|||
131229942|NCT03264066|472467738|FG002|Overall Study|Adverse Event|0|||
131229943|NCT03264066|472467739|FG003|Overall Study|Adverse Event|0|||
131229944|NCT03264066|472467740|FG004|Overall Study|Adverse Event|0|||
131229945|NCT03264066|472467741|FG005|Overall Study|Adverse Event|0|||
131059697|NCT00486954|471851927|FG003|Randomized Part|Withdrawal by Subject|1|||
131059698|NCT00486954|471851928|FG004|Randomized Part|Withdrawal by Subject|0|||
131059699|NCT00486954|471851924|FG000|Randomized Part|Sponsor Terminated Study|0|||
131059700|NCT00486954|471851925|FG001|Randomized Part|Sponsor Terminated Study|0|||
131059701|NCT00486954|471851926|FG002|Randomized Part|Sponsor Terminated Study|0|||
131059702|NCT00486954|471851927|FG003|Randomized Part|Sponsor Terminated Study|19|||
131059703|NCT00486954|471851928|FG004|Randomized Part|Sponsor Terminated Study|13|||
131059704|NCT01836523|471851929|FG000|Overall Study|Adverse Event|15|||
131229946|NCT03264066|472467736|FG000|Overall Study|Death|12|||
131229947|NCT03264066|472467737|FG001|Overall Study|Death|12|||
131059705|NCT01836523|471851930|FG001|Overall Study|Adverse Event|41|||
131059706|NCT01836523|471851931|FG002|Overall Study|Adverse Event|49|||
131059707|NCT01836523|471851932|FG003|Overall Study|Adverse Event|14|||
131059708|NCT01836523|471851929|FG000|Overall Study|Protocol Violation|6|||
131059709|NCT01836523|471851930|FG001|Overall Study|Protocol Violation|3|||
131059710|NCT01836523|471851931|FG002|Overall Study|Protocol Violation|2|||
131059711|NCT01836523|471851932|FG003|Overall Study|Protocol Violation|4|||
131059712|NCT01836523|471851929|FG000|Overall Study|Met Withdrawal Criteria|13|||
131059713|NCT01836523|471851930|FG001|Overall Study|Met Withdrawal Criteria|13|||
131059714|NCT01836523|471851931|FG002|Overall Study|Met Withdrawal Criteria|21|||
131059715|NCT01836523|471851932|FG003|Overall Study|Met Withdrawal Criteria|27|||
131059716|NCT01836523|471851929|FG000|Overall Study|Unclassified|17|||
131059717|NCT01836523|471851930|FG001|Overall Study|Unclassified|28|||
131059718|NCT01836523|471851931|FG002|Overall Study|Unclassified|19|||
131059719|NCT01836523|471851932|FG003|Overall Study|Unclassified|29|||
131059720|NCT01393600|471851938|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
131059721|NCT01393600|471851939|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
131059722|NCT01393600|471851940|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
131059723|NCT01393600|471851941|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
131059724|NCT01393600|471851938|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
131059725|NCT01393600|471851939|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
131059726|NCT01393600|471851940|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
131059727|NCT01393600|471851941|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
131059728|NCT01393600|471851938|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
131059729|NCT01393600|471851939|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
131059730|NCT01393600|471851940|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
131059731|NCT01393600|471851941|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
131059732|NCT01393600|471851938|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
131059733|NCT01393600|471851939|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
131059734|NCT01393600|471851940|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
131059735|NCT01393600|471851941|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
131059736|NCT01393600|471851938|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
131059737|NCT01393600|471851939|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
131059738|NCT01393600|471851940|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
131059739|NCT01393600|471851941|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
131059740|NCT01393600|471851938|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
131059741|NCT01393600|471851939|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
131059742|NCT01393600|471851940|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
131059743|NCT01393600|471851941|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
131059744|NCT01393600|471851938|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
131059745|NCT01393600|471851939|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
131059746|NCT01393600|471851940|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
131059747|NCT01393600|471851941|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
131059748|NCT01102426|471851942|FG000|Overall Study|Randomized but not treated|4|||
130722791|NCT00673387|470609737|FG005|Overall Study|Adverse Event|2|||
131059749|NCT01102426|471851943|FG001|Overall Study|Randomized but not treated|1|||
131059750|NCT01102426|471851942|FG000|Overall Study|Adverse Events (treatment-related)|15|||
131059751|NCT01102426|471851943|FG001|Overall Study|Adverse Events (treatment-related)|8|||
131059752|NCT01102426|471851942|FG000|Overall Study|Physician Decision|9|||
131059753|NCT01102426|471851943|FG001|Overall Study|Physician Decision|6|||
131059754|NCT01102426|471851942|FG000|Overall Study|Progressive Disease|85|||
131059755|NCT01102426|471851943|FG001|Overall Study|Progressive Disease|44|||
131059756|NCT01102426|471851942|FG000|Overall Study|Adverse Events (unrelated to|9|||
131229948|NCT03264066|472467738|FG002|Overall Study|Death|8|||
131136977|NCT03467958|472128235|FG004|Overall Study|Lost to Follow-up|4|||
131136978|NCT03467958|472128236|FG005|Overall Study|Lost to Follow-up|0|||
131136979|NCT03467958|472128237|FG006|Overall Study|Lost to Follow-up|0|||
131136980|NCT03467958|472128238|FG007|Overall Study|Lost to Follow-up|0|||
131136981|NCT03467958|472128239|FG008|Overall Study|Lost to Follow-up|0|||
131136982|NCT03467958|472128231|FG000|Overall Study|Other reasons|8|||
131136983|NCT03467958|472128232|FG001|Overall Study|Other reasons|14|||
131059757|NCT01102426|471851943|FG001|Overall Study|Adverse Events (unrelated to|1|||
131059758|NCT01102426|471851942|FG000|Overall Study|Patient Refusal|24|||
131059759|NCT01102426|471851943|FG001|Overall Study|Patient Refusal|12|||
131059760|NCT01102426|471851942|FG000|Overall Study|Death (due to adverse events|0|||
131059761|NCT01102426|471851943|FG001|Overall Study|Death (due to adverse events|1|||
131059762|NCT01102426|471851942|FG000|Overall Study|Death (non-related to the study|19|||
131059763|NCT01102426|471851943|FG001|Overall Study|Death (non-related to the study|8|||
131059764|NCT03136861|471851946|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
131059765|NCT03136861|471851947|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
131059766|NCT03136861|471851948|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
131059767|NCT03136861|471851949|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
131059768|NCT03136861|471851950|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
131059769|NCT03136861|471851951|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
131059770|NCT03136861|471851952|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
131059771|NCT03136861|471851946|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
131059772|NCT03136861|471851947|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
130722792|NCT00673387|470609738|FG006|Overall Study|Adverse Event|5|||
130722793|NCT00673387|470609739|FG007|Overall Study|Adverse Event|5|||
130722794|NCT00673387|470609732|FG000|Overall Study|Physician Decision|0|||
130722795|NCT00673387|470609733|FG001|Overall Study|Physician Decision|0|||
130722796|NCT00673387|470609734|FG002|Overall Study|Physician Decision|0|||
130722797|NCT00673387|470609735|FG003|Overall Study|Physician Decision|0|||
130722798|NCT00673387|470609736|FG004|Overall Study|Physician Decision|0|||
130722799|NCT00673387|470609737|FG005|Overall Study|Physician Decision|5|||
130722800|NCT00673387|470609738|FG006|Overall Study|Physician Decision|1|||
130722801|NCT00673387|470609739|FG007|Overall Study|Physician Decision|1|||
130722802|NCT00673387|470609732|FG000|Overall Study|Protocol Violation|3|||
130722803|NCT00673387|470609733|FG001|Overall Study|Protocol Violation|0|||
130722804|NCT00673387|470609734|FG002|Overall Study|Protocol Violation|1|||
130722805|NCT00673387|470609735|FG003|Overall Study|Protocol Violation|2|||
130722806|NCT00673387|470609736|FG004|Overall Study|Protocol Violation|0|||
130722807|NCT00673387|470609737|FG005|Overall Study|Protocol Violation|1|||
130722808|NCT00673387|470609738|FG006|Overall Study|Protocol Violation|1|||
130722809|NCT00673387|470609739|FG007|Overall Study|Protocol Violation|3|||
131059773|NCT03136861|471851948|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
131059774|NCT03136861|471851949|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
131059775|NCT03136861|471851950|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
131059776|NCT03136861|471851951|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
131059777|NCT03136861|471851952|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
131059778|NCT03136861|471851946|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
131059779|NCT03136861|471851947|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
131059780|NCT03136861|471851948|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
131059781|NCT03136861|471851949|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
131059782|NCT03136861|471851950|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
131059783|NCT03136861|471851951|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
131059784|NCT03136861|471851952|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
131059785|NCT03136861|471851946|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131059786|NCT03136861|471851947|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
131059787|NCT03136861|471851948|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131059788|NCT03136861|471851949|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131059789|NCT03136861|471851950|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131059790|NCT03136861|471851951|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131059791|NCT03136861|471851952|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
131059792|NCT03136861|471851946|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
131136984|NCT03467958|472128233|FG002|Overall Study|Other reasons|2|||
131136985|NCT03467958|472128234|FG003|Overall Study|Other reasons|1|||
130722810|NCT00673387|470609732|FG000|Overall Study|Lost to Follow-up|8|||
130722811|NCT00673387|470609733|FG001|Overall Study|Lost to Follow-up|6|||
131136986|NCT03467958|472128235|FG004|Overall Study|Other reasons|4|||
131136987|NCT03467958|472128236|FG005|Overall Study|Other reasons|0|||
130722812|NCT00673387|470609734|FG002|Overall Study|Lost to Follow-up|5|||
130722813|NCT00673387|470609735|FG003|Overall Study|Lost to Follow-up|6|||
130722814|NCT00673387|470609736|FG004|Overall Study|Lost to Follow-up|6|||
130722815|NCT00673387|470609737|FG005|Overall Study|Lost to Follow-up|5|||
131136988|NCT03467958|472128237|FG006|Overall Study|Other reasons|1|||
131059793|NCT03136861|471851947|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
131059794|NCT03136861|471851948|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
131059795|NCT03136861|471851949|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
131059796|NCT03136861|471851950|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
131059797|NCT03136861|471851951|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
131059798|NCT03136861|471851952|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
131059799|NCT03136861|471851946|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
131059800|NCT03136861|471851947|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
131059801|NCT03136861|471851948|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
131059802|NCT03136861|471851949|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
131059803|NCT03136861|471851950|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
131059804|NCT03136861|471851951|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
131059805|NCT03136861|471851952|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
131059806|NCT03136861|471851946|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131059807|NCT03136861|471851947|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131059808|NCT03136861|471851948|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
131059809|NCT03136861|471851949|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131059810|NCT03136861|471851950|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131059811|NCT03136861|471851951|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131059812|NCT03136861|471851952|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
131059813|NCT03136861|471851946|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131059814|NCT03136861|471851947|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131059815|NCT03136861|471851948|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
131059816|NCT03136861|471851949|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131059817|NCT03136861|471851950|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131059818|NCT03136861|471851951|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131059819|NCT03136861|471851952|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
131059820|NCT05376397|471851957|FG000|Overall Study|Lost to Follow-up|1|||
131059821|NCT01328756|471851958|FG000|Overall Study|Protocol Violation|4|||
131059822|NCT01328756|471851958|FG000|Overall Study|Adverse Event|39|||
131059823|NCT01328756|471851958|FG000|Overall Study|Lack of Efficacy|5|||
131059824|NCT01328756|471851958|FG000|Overall Study|Withdrawal by Subject|41|||
131059825|NCT01328756|471851958|FG000|Overall Study|Lost to Follow-up|5|||
131059826|NCT01328756|471851958|FG000|Overall Study|Other|29|||
131059827|NCT04492475|471851962|FG000|Overall Study|Enrolled but not treated|8|||
131059828|NCT04492475|471851963|FG001|Overall Study|Enrolled but not treated|8|||
131059829|NCT04492475|471851962|FG000|Overall Study|Withdrawal by Subject|4|||
131059830|NCT04492475|471851963|FG001|Overall Study|Withdrawal by Subject|0|||
131059831|NCT04492475|471851962|FG000|Overall Study|Became ineligible after enrollment|2|||
131059832|NCT04492475|471851963|FG001|Overall Study|Became ineligible after enrollment|0|||
131059833|NCT02538094|471851965|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
131059834|NCT02538094|471851966|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
131059835|NCT02538094|471851965|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
131059836|NCT02538094|471851966|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
131059837|NCT00068107|471851967|FG000|Overall Study|end-stage renal disease|6|||
131059838|NCT00068107|471851967|FG000|Overall Study|Death|2|||
131059839|NCT00068107|471851967|FG000|Overall Study|Withdrawal by Subject|1|||
131059840|NCT03288506|471851968|FG000|Overall Study|Withdrawal by Subject|52|||
131059841|NCT03205488|471851969|FG000|Overall Study|Adverse Event|1|||
131059842|NCT03205488|471851970|FG001|Overall Study|Adverse Event|2|||
131059843|NCT03205488|471851971|FG002|Overall Study|Adverse Event|4|||
131059844|NCT03205488|471851969|FG000|Overall Study|Protocol Violation|0|||
131059845|NCT03205488|471851970|FG001|Overall Study|Protocol Violation|0|||
131059846|NCT03205488|471851971|FG002|Overall Study|Protocol Violation|1|||
131059847|NCT01860079|471851974|FG000|Overall Study|Physician Decision|14|||
131059848|NCT01860079|471851975|FG001|Overall Study|Physician Decision|22|||
131059849|NCT01323790|471851977|FG000|Overall Study|Other|3|||
131059850|NCT01323790|471851978|FG001|Overall Study|Other|2|||
131059851|NCT01323790|471851979|FG002|Overall Study|Other|1|||
131059852|NCT01323790|471851977|FG000|Overall Study|Lost to Follow-up|11|||
131059853|NCT01323790|471851978|FG001|Overall Study|Lost to Follow-up|9|||
131059854|NCT01323790|471851979|FG002|Overall Study|Lost to Follow-up|9|||
131229949|NCT03264066|472467739|FG003|Overall Study|Death|10|||
131229950|NCT03264066|472467740|FG004|Overall Study|Death|6|||
131059855|NCT01323790|471851977|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
131059856|NCT01323790|471851978|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
131059857|NCT01323790|471851979|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
131059858|NCT01323790|471851977|FG000|Overall Study|Lack of Efficacy|3|||
131059859|NCT01323790|471851978|FG001|Overall Study|Lack of Efficacy|0|||
131059860|NCT01323790|471851979|FG002|Overall Study|Lack of Efficacy|3|||
131059861|NCT01323790|471851977|FG000|Overall Study|Adverse Event|11|||
131136989|NCT03467958|472128238|FG007|Overall Study|Other reasons|0|||
131136990|NCT03467958|472128239|FG008|Overall Study|Other reasons|1|||
131136991|NCT03467958|472128231|FG000|Overall Study|Pregnancy|1|||
131136992|NCT03467958|472128232|FG001|Overall Study|Pregnancy|0|||
131136993|NCT03467958|472128233|FG002|Overall Study|Pregnancy|0|||
131136994|NCT03467958|472128234|FG003|Overall Study|Pregnancy|0|||
131136995|NCT03467958|472128235|FG004|Overall Study|Pregnancy|0|||
131136996|NCT03467958|472128236|FG005|Overall Study|Pregnancy|1|||
131136997|NCT03467958|472128237|FG006|Overall Study|Pregnancy|0|||
131136998|NCT03467958|472128238|FG007|Overall Study|Pregnancy|0|||
131136999|NCT03467958|472128239|FG008|Overall Study|Pregnancy|0|||
131137000|NCT03467958|472128231|FG000|Overall Study|Study terminated by sponsor|65|||
131137001|NCT03467958|472128232|FG001|Overall Study|Study terminated by sponsor|117|||
131137002|NCT03467958|472128233|FG002|Overall Study|Study terminated by sponsor|45|||
131137003|NCT03467958|472128234|FG003|Overall Study|Study terminated by sponsor|64|||
131137004|NCT03467958|472128235|FG004|Overall Study|Study terminated by sponsor|66|||
131137005|NCT03467958|472128236|FG005|Overall Study|Study terminated by sponsor|17|||
131137006|NCT03467958|472128237|FG006|Overall Study|Study terminated by sponsor|11|||
131137007|NCT03467958|472128238|FG007|Overall Study|Study terminated by sponsor|5|||
131137008|NCT03467958|472128239|FG008|Overall Study|Study terminated by sponsor|5|||
131137009|NCT03467958|472128231|FG000|Overall Study|Withdrawal by Subject|25|||
131059862|NCT01323790|471851978|FG001|Overall Study|Adverse Event|24|||
131059863|NCT01323790|471851979|FG002|Overall Study|Adverse Event|12|||
131059864|NCT01323790|471851977|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131059865|NCT01323790|471851978|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131059866|NCT01323790|471851979|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
131059867|NCT01323790|471851977|FG000|Overall Study|Withdrawal by Subject|23|||
131059868|NCT01323790|471851978|FG001|Overall Study|Withdrawal by Subject|20|||
131059869|NCT01323790|471851979|FG002|Overall Study|Withdrawal by Subject|13|||
131059870|NCT01323790|471851977|FG000|Overall Study|Did Not Receive Treatment|2|||
131059871|NCT01323790|471851978|FG001|Overall Study|Did Not Receive Treatment|0|||
131059872|NCT01323790|471851979|FG002|Overall Study|Did Not Receive Treatment|1|||
131059873|NCT01323790|471851977|FG000|Overall Study|Severe non-compliance with protocol|2|||
131059874|NCT01323790|471851978|FG001|Overall Study|Severe non-compliance with protocol|2|||
131059875|NCT01323790|471851979|FG002|Overall Study|Severe non-compliance with protocol|2|||
131059876|NCT01880736|471851980|FG000|Overall Study|Adverse Event|0|||
131059877|NCT01880736|471851981|FG001|Overall Study|Adverse Event|0|||
131059878|NCT01880736|471851982|FG002|Overall Study|Adverse Event|0|||
131059879|NCT01880736|471851983|FG003|Overall Study|Adverse Event|1|||
131059880|NCT01880736|471851980|FG000|Overall Study|Withdrawal Criteria|1|||
131059881|NCT01880736|471851981|FG001|Overall Study|Withdrawal Criteria|2|||
131059882|NCT01880736|471851982|FG002|Overall Study|Withdrawal Criteria|1|||
131059883|NCT01880736|471851983|FG003|Overall Study|Withdrawal Criteria|5|||
131059884|NCT00266656|471851993|FG000|Overall Study|Death|1|||
131059885|NCT00266656|471851994|FG001|Overall Study|Death|0|||
131059886|NCT00266656|471851993|FG000|Overall Study|Lost to Follow-up|4|||
131059887|NCT00266656|471851994|FG001|Overall Study|Lost to Follow-up|1|||
131059888|NCT00266656|471851993|FG000|Overall Study|Withdrawal by Subject|4|||
131059889|NCT00266656|471851994|FG001|Overall Study|Withdrawal by Subject|2|||
131059890|NCT00266656|471851993|FG000|Overall Study|Did Not Reach Final Height|4|||
131059891|NCT00266656|471851994|FG001|Overall Study|Did Not Reach Final Height|8|||
131059892|NCT00266656|471851993|FG000|Overall Study|Parent/Caregiver Decision|1|||
131059893|NCT00266656|471851994|FG001|Overall Study|Parent/Caregiver Decision|2|||
131059894|NCT00428714|471851998|FG000|Overall Study|Progressive Disease|28|||
131059895|NCT00428714|471851999|FG001|Overall Study|Progressive Disease|36|||
131059896|NCT00428714|471851998|FG000|Overall Study|Withdrawal by Subject|0|||
131059897|NCT00428714|471851999|FG001|Overall Study|Withdrawal by Subject|3|||
131059898|NCT00428714|471851998|FG000|Overall Study|Adverse Event|0|||
131059899|NCT00428714|471851999|FG001|Overall Study|Adverse Event|2|||
131059900|NCT00428714|471851998|FG000|Overall Study|Physician Decision|1|||
131059901|NCT00428714|471851999|FG001|Overall Study|Physician Decision|1|||
131137010|NCT03467958|472128232|FG001|Overall Study|Withdrawal by Subject|44|||
131137011|NCT03467958|472128233|FG002|Overall Study|Withdrawal by Subject|7|||
131137012|NCT03467958|472128234|FG003|Overall Study|Withdrawal by Subject|8|||
131059902|NCT00428714|471851998|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
131137013|NCT03467958|472128235|FG004|Overall Study|Withdrawal by Subject|6|||
131137014|NCT03467958|472128236|FG005|Overall Study|Withdrawal by Subject|8|||
131059903|NCT00428714|471851999|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
131059904|NCT00428714|471851998|FG000|Overall Study|Death due to other then PD|1|||
131059905|NCT00428714|471851999|FG001|Overall Study|Death due to other then PD|0|||
131059906|NCT02432274|471852013|FG000|Overall Study|Death|2|||
131059907|NCT02432274|471852014|FG001|Overall Study|Death|6|||
131059908|NCT02432274|471852015|FG002|Overall Study|Death|7|||
131059909|NCT02432274|471852016|FG003|Overall Study|Death|0|||
131059910|NCT02432274|471852017|FG004|Overall Study|Death|27|||
131059911|NCT02432274|471852018|FG005|Overall Study|Death|7|||
131137015|NCT03467958|472128237|FG006|Overall Study|Withdrawal by Subject|4|||
131137016|NCT03467958|472128238|FG007|Overall Study|Withdrawal by Subject|1|||
131059912|NCT02432274|471852019|FG006|Overall Study|Death|9|||
131059913|NCT02432274|471852020|FG007|Overall Study|Death|14|||
131059914|NCT02432274|471852013|FG000|Overall Study|Withdrawal of Consent|0|||
131059915|NCT02432274|471852014|FG001|Overall Study|Withdrawal of Consent|0|||
131059916|NCT02432274|471852015|FG002|Overall Study|Withdrawal of Consent|0|||
131059917|NCT02432274|471852016|FG003|Overall Study|Withdrawal of Consent|0|||
131059918|NCT02432274|471852017|FG004|Overall Study|Withdrawal of Consent|2|||
131059919|NCT02432274|471852018|FG005|Overall Study|Withdrawal of Consent|0|||
131059920|NCT02432274|471852019|FG006|Overall Study|Withdrawal of Consent|1|||
131059921|NCT02432274|471852020|FG007|Overall Study|Withdrawal of Consent|2|||
131059922|NCT00116649|471852021|FG000|Overall Study|Adverse Event|20|||
131059923|NCT00116649|471852021|FG000|Overall Study|Lack of Efficacy|1|||
131059924|NCT00116649|471852021|FG000|Overall Study|Lost to Follow-up|32|||
131059925|NCT00116649|471852021|FG000|Overall Study|Withdrawal by Subject|68|||
131059926|NCT00116649|471852021|FG000|Overall Study|Local Skin Reaction|9|||
131059927|NCT00116649|471852021|FG000|Overall Study|Various Reasons|18|||
131059928|NCT00116649|471852021|FG000|Overall Study|Protocol Specified|7|||
131059929|NCT02326220|471852022|FG000|Double-blind Treatment Period|Adverse Event|1|||
131059930|NCT02326220|471852023|FG001|Double-blind Treatment Period|Adverse Event|2|||
131059931|NCT02326220|471852024|FG002|Double-blind Treatment Period|Adverse Event|0|||
131059932|NCT02326220|471852022|FG000|Double-blind Treatment Period|Protocol Violation|0|||
131059933|NCT02326220|471852023|FG001|Double-blind Treatment Period|Protocol Violation|1|||
131059934|NCT02326220|471852024|FG002|Double-blind Treatment Period|Protocol Violation|0|||
131059935|NCT02326220|471852022|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
131059936|NCT02326220|471852023|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
131059937|NCT02326220|471852024|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131059938|NCT02326220|471852022|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
131059939|NCT02326220|471852023|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
131059940|NCT02326220|471852024|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
131059941|NCT02326220|471852022|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
131059942|NCT02326220|471852023|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
131059943|NCT02326220|471852024|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
131059944|NCT02114515|471852025|FG000|Overall Study|Lost to Follow-up|52|||
131059945|NCT02114515|471852026|FG001|Overall Study|Lost to Follow-up|55|||
131059946|NCT02114515|471852025|FG000|Overall Study|Death|12|||
131059947|NCT02114515|471852026|FG001|Overall Study|Death|12|||
131059948|NCT02114515|471852025|FG000|Overall Study|Withdrawal by Subject|4|||
131059949|NCT02114515|471852026|FG001|Overall Study|Withdrawal by Subject|22|||
131059950|NCT02114515|471852025|FG000|Overall Study|Other|65|||
131059951|NCT02114515|471852026|FG001|Overall Study|Other|61|||
131059952|NCT02699099|471852028|FG000|Overall Study|Adverse Event|1|||
131059953|NCT02699099|471852029|FG001|Overall Study|Adverse Event|0|||
131137017|NCT03467958|472128239|FG008|Overall Study|Withdrawal by Subject|4|||
131137018|NCT02925156|472128241|FG000|Overall Study|Lost to Follow-up|27|||
131137019|NCT02925156|472128242|FG001|Overall Study|Lost to Follow-up|53|||
131137020|NCT02925156|472128243|FG002|Overall Study|Lost to Follow-up|51|||
131137021|NCT02925156|472128244|FG003|Overall Study|Lost to Follow-up|59|||
131137022|NCT02925156|472128245|FG004|Overall Study|Lost to Follow-up|89|||
131137023|NCT02925156|472128246|FG005|Overall Study|Lost to Follow-up|107|||
131137024|NCT02925156|472128247|FG006|Overall Study|Lost to Follow-up|34|||
131137025|NCT02925156|472128248|FG007|Overall Study|Lost to Follow-up|36|||
131137026|NCT02925156|472128249|FG008|Overall Study|Lost to Follow-up|73|||
131137027|NCT02925156|472128250|FG009|Overall Study|Lost to Follow-up|34|||
131137028|NCT00866307|472128253|FG000|Induction|Adverse Event|5|||
131137029|NCT00866307|472128254|FG001|Induction|Adverse Event|0|||
131137030|NCT00866307|472128255|FG002|Induction|Adverse Event|0|||
131137031|NCT00866307|472128253|FG000|Induction|Death|2|||
131137032|NCT00866307|472128254|FG001|Induction|Death|0|||
131137033|NCT00866307|472128255|FG002|Induction|Death|0|||
131137034|NCT00866307|472128253|FG000|Induction|Physician Decision|5|||
131137035|NCT00866307|472128254|FG001|Induction|Physician Decision|0|||
131137036|NCT00866307|472128255|FG002|Induction|Physician Decision|0|||
131137037|NCT00866307|472128253|FG000|Induction|Progressive Disease|1|||
131137038|NCT00866307|472128254|FG001|Induction|Progressive Disease|0|||
131059954|NCT02699099|471852030|FG002|Overall Study|Adverse Event|2|||
131059955|NCT02699099|471852028|FG000|Overall Study|Lost to Follow-up|0|||
131059956|NCT02699099|471852029|FG001|Overall Study|Lost to Follow-up|1|||
131059957|NCT02699099|471852030|FG002|Overall Study|Lost to Follow-up|0|||
131059958|NCT02699099|471852028|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
131059959|NCT02699099|471852029|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
131059960|NCT02699099|471852030|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
131137039|NCT00866307|472128255|FG002|Induction|Progressive Disease|0|||
131137040|NCT00866307|472128253|FG000|Induction|Identification of Patients with Day 29 M|3|||
131137041|NCT00866307|472128254|FG001|Induction|Identification of Patients with Day 29 M|0|||
131137042|NCT00866307|472128255|FG002|Induction|Identification of Patients with Day 29 M|0|||
131137043|NCT00866307|472128253|FG000|Induction|Inadequate cytognetic samples th|1|||
131137044|NCT00866307|472128254|FG001|Induction|Inadequate cytognetic samples th|0|||
131059961|NCT00824850|471852032|FG000|Overall Study|Withdrawal by Subject|0|||
131059962|NCT00824850|471852033|FG001|Overall Study|Withdrawal by Subject|1|||
131059963|NCT04820491|471852034|FG000|Overall Study|Withdrawal by Subject|1|||
131059964|NCT04820491|471852035|FG001|Overall Study|Withdrawal by Subject|0|||
131059965|NCT02144285|471852038|FG000|Overall Study|Withdrawal by Subject|0|||
131059966|NCT02144285|471852039|FG001|Overall Study|Withdrawal by Subject|0|||
131059967|NCT02144285|471852040|FG002|Overall Study|Withdrawal by Subject|0|||
131059968|NCT02144285|471852041|FG003|Overall Study|Withdrawal by Subject|0|||
131059969|NCT02144285|471852042|FG004|Overall Study|Withdrawal by Subject|1|||
131059970|NCT02144285|471852043|FG005|Overall Study|Withdrawal by Subject|0|||
131059971|NCT02144285|471852044|FG006|Overall Study|Withdrawal by Subject|0|||
131059972|NCT02144285|471852045|FG007|Overall Study|Withdrawal by Subject|0|||
131059973|NCT02144285|471852046|FG008|Overall Study|Withdrawal by Subject|0|||
131059974|NCT02144285|471852047|FG009|Overall Study|Withdrawal by Subject|0|||
131059975|NCT03659136|471852049|FG000|Overall Study|Not treated|2|||
131059976|NCT03659136|471852050|FG001|Overall Study|Not treated|0|||
131059977|NCT03659136|471852049|FG000|Overall Study|Covid-19 related|1|||
131059978|NCT03659136|471852050|FG001|Overall Study|Covid-19 related|1|||
131059979|NCT03659136|471852049|FG000|Overall Study|Withdrawal by Subject|1|||
131059980|NCT03659136|471852050|FG001|Overall Study|Withdrawal by Subject|6|||
131059981|NCT03659136|471852049|FG000|Overall Study|Adverse Event|4|||
131059982|NCT03659136|471852050|FG001|Overall Study|Adverse Event|6|||
131059983|NCT03659136|471852049|FG000|Overall Study|Progressive disease|37|||
131059984|NCT03659136|471852050|FG001|Overall Study|Progressive disease|31|||
131059985|NCT03659136|471852049|FG000|Overall Study|Study closure|2|||
131059986|NCT03659136|471852050|FG001|Overall Study|Study closure|2|||
131059987|NCT03659136|471852049|FG000|Overall Study|Sponsor decision/recommendation|3|||
131059988|NCT03659136|471852050|FG001|Overall Study|Sponsor decision/recommendation|2|||
131059989|NCT03659136|471852049|FG000|Overall Study|Switched to other drug/therapy|2|||
131059990|NCT03659136|471852050|FG001|Overall Study|Switched to other drug/therapy|2|||
131059991|NCT03659136|471852049|FG000|Overall Study|Lack of clinical benefit|0|||
131059992|NCT03659136|471852050|FG001|Overall Study|Lack of clinical benefit|1|||
131059993|NCT03786471|471852051|FG000|Overall Study|Death|254|||
131059994|NCT03786471|471852052|FG001|Overall Study|Death|223|||
131059995|NCT03786471|471852053|FG002|Overall Study|Death|37|||
131059996|NCT03786471|471852051|FG000|Overall Study|Lost to Follow-up|63|||
131059997|NCT03786471|471852052|FG001|Overall Study|Lost to Follow-up|50|||
131059998|NCT03786471|471852053|FG002|Overall Study|Lost to Follow-up|15|||
131059999|NCT03786471|471852051|FG000|Overall Study|Withdrawal by Subject|99|||
131060000|NCT03786471|471852052|FG001|Overall Study|Withdrawal by Subject|81|||
131060001|NCT03786471|471852053|FG002|Overall Study|Withdrawal by Subject|11|||
131060002|NCT01276509|471853266|FG000|Overall Study|Adverse Event|9|||
131060003|NCT01276509|471853267|FG001|Overall Study|Adverse Event|8|||
131060004|NCT01276509|471853268|FG002|Overall Study|Adverse Event|4|||
131060005|NCT01276509|471853269|FG003|Overall Study|Adverse Event|3|||
131060006|NCT01276509|471853266|FG000|Overall Study|Lack of Efficacy|2|||
131060007|NCT01276509|471853267|FG001|Overall Study|Lack of Efficacy|1|||
131060008|NCT01276509|471853268|FG002|Overall Study|Lack of Efficacy|1|||
131060009|NCT01276509|471853269|FG003|Overall Study|Lack of Efficacy|2|||
131060010|NCT01276509|471853266|FG000|Overall Study|Pregnancy|1|||
131060011|NCT01276509|471853267|FG001|Overall Study|Pregnancy|0|||
131060012|NCT01276509|471853268|FG002|Overall Study|Pregnancy|0|||
131060013|NCT01276509|471853269|FG003|Overall Study|Pregnancy|0|||
131060014|NCT01276509|471853266|FG000|Overall Study|Withdrawal by Subject|1|||
131060015|NCT01276509|471853267|FG001|Overall Study|Withdrawal by Subject|2|||
131060016|NCT01276509|471853268|FG002|Overall Study|Withdrawal by Subject|0|||
131060017|NCT01276509|471853269|FG003|Overall Study|Withdrawal by Subject|0|||
131060018|NCT01276509|471853266|FG000|Overall Study|Other|0|||
131060019|NCT01276509|471853267|FG001|Overall Study|Other|1|||
131060020|NCT01276509|471853268|FG002|Overall Study|Other|0|||
131060021|NCT01276509|471853269|FG003|Overall Study|Other|0|||
131060022|NCT00647699|471853271|FG000|Overall Study|Lost to Follow-up|5|||
131060023|NCT00647699|471853272|FG001|Overall Study|Lost to Follow-up|4|||
131060024|NCT00647699|471853271|FG000|Overall Study|Withdrawal by Subject|3|||
131060025|NCT00647699|471853272|FG001|Overall Study|Withdrawal by Subject|8|||
131060026|NCT00413283|471853273|FG000|Overall Study|Withdrawal by Subject|1|||
131060027|NCT00413283|471853274|FG001|Overall Study|Withdrawal by Subject|0|||
131060028|NCT00413283|471853275|FG002|Overall Study|Withdrawal by Subject|0|||
131060029|NCT00413283|471853276|FG003|Overall Study|Withdrawal by Subject|1|||
131060030|NCT00413283|471853273|FG000|Overall Study|Death|0|||
131060031|NCT00413283|471853274|FG001|Overall Study|Death|0|||
131060032|NCT00413283|471853275|FG002|Overall Study|Death|1|||
131060033|NCT00413283|471853276|FG003|Overall Study|Death|1|||
131060034|NCT00413283|471853273|FG000|Overall Study|Adverse Event|0|||
130722816|NCT00673387|470609738|FG006|Overall Study|Lost to Follow-up|8|||
131060035|NCT00413283|471853274|FG001|Overall Study|Adverse Event|0|||
131060036|NCT00413283|471853275|FG002|Overall Study|Adverse Event|0|||
131060037|NCT00413283|471853276|FG003|Overall Study|Adverse Event|1|||
131060038|NCT00413283|471853273|FG000|Overall Study|Ineligibility determined|0|||
131060039|NCT00413283|471853274|FG001|Overall Study|Ineligibility determined|0|||
131060040|NCT00413283|471853275|FG002|Overall Study|Ineligibility determined|0|||
131060041|NCT00413283|471853276|FG003|Overall Study|Ineligibility determined|1|||
131060042|NCT00413283|471853273|FG000|Overall Study|Protocol deviation|0|||
131060043|NCT00413283|471853274|FG001|Overall Study|Protocol deviation|1|||
131060044|NCT00413283|471853275|FG002|Overall Study|Protocol deviation|0|||
131060045|NCT00413283|471853276|FG003|Overall Study|Protocol deviation|0|||
131060046|NCT00413283|471853273|FG000|Overall Study|Requirement for alternative therapy|0|||
131060047|NCT00413283|471853274|FG001|Overall Study|Requirement for alternative therapy|2|||
131060048|NCT00413283|471853275|FG002|Overall Study|Requirement for alternative therapy|0|||
131060049|NCT00413283|471853276|FG003|Overall Study|Requirement for alternative therapy|0|||
131060050|NCT00413283|471853273|FG000|Overall Study|Other|0|||
131060051|NCT00413283|471853274|FG001|Overall Study|Other|0|||
131060052|NCT00413283|471853275|FG002|Overall Study|Other|1|||
131060053|NCT00413283|471853276|FG003|Overall Study|Other|0|||
131060054|NCT02354417|471853277|FG000|Overall Study|Physician Decision|1|||
131060055|NCT01377844|471853278|FG000|Overall Study|Withdrawal by Subject|25|||
131060056|NCT01377844|471853279|FG001|Overall Study|Withdrawal by Subject|28|||
131060057|NCT01377844|471853278|FG000|Overall Study|Protocol Violation|2|||
131060058|NCT01377844|471853279|FG001|Overall Study|Protocol Violation|3|||
131060059|NCT01377844|471853278|FG000|Overall Study|Adverse Event|3|||
131060060|NCT01377844|471853279|FG001|Overall Study|Adverse Event|0|||
131060061|NCT01377844|471853278|FG000|Overall Study|Physician Decision|6|||
131060062|NCT01377844|471853279|FG001|Overall Study|Physician Decision|3|||
131060063|NCT01377844|471853278|FG000|Overall Study|Study terminated by Sponsor|0|||
131060064|NCT01377844|471853279|FG001|Overall Study|Study terminated by Sponsor|1|||
131060065|NCT01185340|471853282|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
131060066|NCT01185340|471853283|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131060067|NCT01185340|471853284|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131060068|NCT01185340|471853285|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131060069|NCT01185340|471853282|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
131060070|NCT01185340|471853283|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131060071|NCT01185340|471853284|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131060072|NCT01185340|471853285|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131060073|NCT01185340|471853282|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
131060074|NCT01185340|471853283|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131060075|NCT01185340|471853284|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131060076|NCT01185340|471853285|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131060077|NCT01185340|471853282|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
131060078|NCT01185340|471853283|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131060079|NCT01185340|471853284|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131060080|NCT01185340|471853285|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131060081|NCT01185340|471853282|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
131060082|NCT01185340|471853283|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131060083|NCT01185340|471853284|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131060084|NCT01185340|471853285|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131060085|NCT01185340|471853282|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
131060086|NCT01185340|471853283|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131060087|NCT01185340|471853284|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131060088|NCT01185340|471853285|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131060089|NCT01185340|471853282|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
131060090|NCT01185340|471853283|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131060091|NCT01185340|471853284|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131060092|NCT01185340|471853285|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131060093|NCT01185340|471853282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
130722817|NCT00673387|470609739|FG007|Overall Study|Lost to Follow-up|5|||
131060094|NCT01185340|471853283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
130722818|NCT00960115|470609742|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
130722819|NCT00960115|470609743|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
131060095|NCT01185340|471853284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
131060096|NCT01185340|471853285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
131060097|NCT01185340|471853282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
130722820|NCT00861198|470609744|FG000|Overall Study|SpyGlass Failed|5|||
130722821|NCT02011386|470609745|FG000|Overall Study|Non-compliance|2|||
131060098|NCT01185340|471853283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
131060099|NCT01185340|471853284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
131060100|NCT01185340|471853285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
131060101|NCT01185340|471853282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
131060102|NCT01185340|471853283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
131060103|NCT01185340|471853284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
131060104|NCT01185340|471853285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
131060105|NCT01185340|471853282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131060106|NCT01185340|471853283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
131060107|NCT01185340|471853284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131060108|NCT01185340|471853285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
131060109|NCT01185340|471853282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
131060110|NCT01185340|471853283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
131060111|NCT01185340|471853284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
131060112|NCT01185340|471853285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
131060113|NCT01185340|471853282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
131060114|NCT01185340|471853283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
131060115|NCT01185340|471853284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
131060116|NCT01185340|471853285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
131060117|NCT01185340|471853282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
131060118|NCT01185340|471853283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
131060119|NCT01185340|471853284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
131060120|NCT01185340|471853285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
131060121|NCT02065895|471853286|FG000|Overall Study|Protocol Violation|1|||
131060122|NCT02065895|471853287|FG001|Overall Study|Protocol Violation|0|||
131060123|NCT02065895|471853288|FG002|Overall Study|Protocol Violation|0|||
131060124|NCT02065895|471853289|FG003|Overall Study|Protocol Violation|1|||
131060125|NCT02065895|471853290|FG004|Overall Study|Protocol Violation|0|||
131060126|NCT02065895|471853291|FG005|Overall Study|Protocol Violation|0|||
131060127|NCT02065895|471853286|FG000|Overall Study|Scheduling conflicts|0|||
131060128|NCT02065895|471853287|FG001|Overall Study|Scheduling conflicts|1|||
131060129|NCT02065895|471853288|FG002|Overall Study|Scheduling conflicts|0|||
131060130|NCT02065895|471853289|FG003|Overall Study|Scheduling conflicts|0|||
131060131|NCT02065895|471853290|FG004|Overall Study|Scheduling conflicts|0|||
131060132|NCT02065895|471853291|FG005|Overall Study|Scheduling conflicts|0|||
131060133|NCT03469258|471853292|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
131060134|NCT03403036|471853299|FG000|Overall Study|Lack of Efficacy|5|||
131060135|NCT00484198|471853302|FG000|Overall Study|Participant Withdrew Consent|12|||
131060136|NCT00484198|471853303|FG001|Overall Study|Participant Withdrew Consent|21|||
131060137|NCT00484198|471853304|FG002|Overall Study|Participant Withdrew Consent|47|||
131060138|NCT00484198|471853305|FG003|Overall Study|Participant Withdrew Consent|59|||
131060139|NCT00484198|471853302|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
131060140|NCT00484198|471853303|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
131060141|NCT00484198|471853304|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
131060142|NCT00484198|471853305|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
131060143|NCT00484198|471853302|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
131060144|NCT00484198|471853303|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
131060145|NCT00484198|471853304|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
131060146|NCT00484198|471853305|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
131060147|NCT00484198|471853302|FG000|Overall Study|Adverse Event|3|||
131060148|NCT00484198|471853303|FG001|Overall Study|Adverse Event|11|||
131060149|NCT00484198|471853304|FG002|Overall Study|Adverse Event|32|||
131060150|NCT00484198|471853305|FG003|Overall Study|Adverse Event|31|||
131060151|NCT00484198|471853302|FG000|Overall Study|Protocol Violation|0|||
131060152|NCT00484198|471853303|FG001|Overall Study|Protocol Violation|5|||
131060153|NCT00484198|471853304|FG002|Overall Study|Protocol Violation|6|||
131060154|NCT00484198|471853305|FG003|Overall Study|Protocol Violation|8|||
131060155|NCT00484198|471853302|FG000|Overall Study|Other|7|||
131060156|NCT00484198|471853303|FG001|Overall Study|Other|10|||
131060157|NCT00484198|471853304|FG002|Overall Study|Other|31|||
131060158|NCT00484198|471853305|FG003|Overall Study|Other|28|||
131137045|NCT00866307|472128255|FG002|Induction|Inadequate cytognetic samples th|0|||
131137046|NCT00866307|472128253|FG000|Induction|Improper post-induction consent|2|||
131137047|NCT00866307|472128254|FG001|Induction|Improper post-induction consent|0|||
131137048|NCT00866307|472128255|FG002|Induction|Improper post-induction consent|0|||
131137049|NCT00866307|472128253|FG000|Induction|Study was closed at the time|1|||
131137050|NCT00866307|472128254|FG001|Induction|Study was closed at the time|0|||
131137051|NCT00866307|472128255|FG002|Induction|Study was closed at the time|0|||
131137052|NCT00866307|472128253|FG000|Consolidation/Maintenance|Adverse Event|0|||
131060159|NCT00704340|471853306|FG000|Overall Study|Lost to Follow-up|2|||
131060160|NCT00704340|471853307|FG001|Overall Study|Lost to Follow-up|1|||
131060161|NCT00704340|471853306|FG000|Overall Study|Death|0|||
131060162|NCT00704340|471853307|FG001|Overall Study|Death|1|||
131060163|NCT04311983|471853308|FG000|Overall Study|Lost to Follow-up|421|||
131060164|NCT04311983|471853309|FG001|Overall Study|Lost to Follow-up|456|||
131060165|NCT04311983|471853308|FG000|Overall Study|Incomplete survey|7|||
131060166|NCT04311983|471853309|FG001|Overall Study|Incomplete survey|9|||
131060167|NCT04311983|471853308|FG000|Overall Study|Death|1|||
131137053|NCT00866307|472128254|FG001|Consolidation/Maintenance|Adverse Event|0|||
131137054|NCT00866307|472128255|FG002|Consolidation/Maintenance|Adverse Event|8|||
131137055|NCT00866307|472128253|FG000|Consolidation/Maintenance|Death|0|||
131137056|NCT00866307|472128254|FG001|Consolidation/Maintenance|Death|0|||
131060168|NCT04311983|471853309|FG001|Overall Study|Death|0|||
131060169|NCT00638456|471853312|FG000|Overall Study|Withdrawal by Subject|6|||
131060170|NCT00638456|471853313|FG001|Overall Study|Withdrawal by Subject|2|||
131060171|NCT03236779|471853314|FG000|Overall Study|Lost to Follow-up|13|||
131060172|NCT03236779|471853315|FG001|Overall Study|Lost to Follow-up|21|||
131060173|NCT02935673|471853316|FG000|Overall Study|Adverse Event|0|||
131060174|NCT02935673|471853317|FG001|Overall Study|Adverse Event|1|||
131060175|NCT02935673|471853318|FG002|Overall Study|Adverse Event|0|||
131060176|NCT02935673|471853316|FG000|Overall Study|Withdrawal by Subject|1|||
131060177|NCT02935673|471853317|FG001|Overall Study|Withdrawal by Subject|2|||
131060178|NCT02935673|471853318|FG002|Overall Study|Withdrawal by Subject|0|||
131060179|NCT00813709|471853319|FG000|Double Blind Period|Adverse Event|4|||
131060180|NCT00813709|471853320|FG001|Double Blind Period|Adverse Event|1|||
131060181|NCT00813709|471853321|FG002|Double Blind Period|Adverse Event|4|||
131060182|NCT00813709|471853322|FG003|Double Blind Period|Adverse Event|0|||
131060183|NCT00813709|471853323|FG004|Double Blind Period|Adverse Event|0|||
131060184|NCT00813709|471853324|FG005|Double Blind Period|Adverse Event|0|||
131060185|NCT00813709|471853319|FG000|Double Blind Period|Lost to Follow-up|3|||
131060186|NCT00813709|471853320|FG001|Double Blind Period|Lost to Follow-up|2|||
131060187|NCT00813709|471853321|FG002|Double Blind Period|Lost to Follow-up|2|||
131060188|NCT00813709|471853322|FG003|Double Blind Period|Lost to Follow-up|0|||
131060189|NCT00813709|471853323|FG004|Double Blind Period|Lost to Follow-up|0|||
131060190|NCT00813709|471853324|FG005|Double Blind Period|Lost to Follow-up|0|||
131060191|NCT00813709|471853319|FG000|Double Blind Period|Switched to open label phase|9|||
131060192|NCT00813709|471853320|FG001|Double Blind Period|Switched to open label phase|26|||
131060193|NCT00813709|471853321|FG002|Double Blind Period|Switched to open label phase|18|||
131060194|NCT00813709|471853322|FG003|Double Blind Period|Switched to open label phase|0|||
131060195|NCT00813709|471853323|FG004|Double Blind Period|Switched to open label phase|0|||
131060196|NCT00813709|471853324|FG005|Double Blind Period|Switched to open label phase|0|||
131060197|NCT00813709|471853319|FG000|Double Blind Period|Randomized but not treated|1|||
131060198|NCT00813709|471853320|FG001|Double Blind Period|Randomized but not treated|3|||
131060199|NCT00813709|471853321|FG002|Double Blind Period|Randomized but not treated|1|||
131060200|NCT00813709|471853322|FG003|Double Blind Period|Randomized but not treated|0|||
131060201|NCT00813709|471853323|FG004|Double Blind Period|Randomized but not treated|0|||
131060202|NCT00813709|471853324|FG005|Double Blind Period|Randomized but not treated|0|||
131060203|NCT00813709|471853319|FG000|Double Blind Period|Other|14|||
131060204|NCT00813709|471853320|FG001|Double Blind Period|Other|9|||
131060205|NCT00813709|471853321|FG002|Double Blind Period|Other|6|||
131060206|NCT00813709|471853322|FG003|Double Blind Period|Other|0|||
131060207|NCT00813709|471853323|FG004|Double Blind Period|Other|0|||
131060208|NCT00813709|471853324|FG005|Double Blind Period|Other|0|||
131060209|NCT00813709|471853319|FG000|Open Label Period|Adverse Event|0|||
131060210|NCT00813709|471853320|FG001|Open Label Period|Adverse Event|0|||
131060211|NCT00813709|471853321|FG002|Open Label Period|Adverse Event|0|||
131060212|NCT00813709|471853322|FG003|Open Label Period|Adverse Event|5|||
131060213|NCT00813709|471853323|FG004|Open Label Period|Adverse Event|4|||
131060214|NCT00813709|471853324|FG005|Open Label Period|Adverse Event|3|||
131060215|NCT00813709|471853319|FG000|Open Label Period|Lack of Efficacy|0|||
131060216|NCT00813709|471853320|FG001|Open Label Period|Lack of Efficacy|0|||
131060217|NCT00813709|471853321|FG002|Open Label Period|Lack of Efficacy|0|||
131060218|NCT00813709|471853322|FG003|Open Label Period|Lack of Efficacy|3|||
131060219|NCT00813709|471853323|FG004|Open Label Period|Lack of Efficacy|1|||
131060220|NCT00813709|471853324|FG005|Open Label Period|Lack of Efficacy|1|||
131060221|NCT00813709|471853319|FG000|Open Label Period|Randomized but not treated|0|||
131060222|NCT00813709|471853320|FG001|Open Label Period|Randomized but not treated|0|||
131060223|NCT00813709|471853321|FG002|Open Label Period|Randomized but not treated|0|||
131137057|NCT00866307|472128255|FG002|Consolidation/Maintenance|Death|1|||
131060224|NCT00813709|471853322|FG003|Open Label Period|Randomized but not treated|1|||
131060225|NCT00813709|471853323|FG004|Open Label Period|Randomized but not treated|0|||
131060226|NCT00813709|471853324|FG005|Open Label Period|Randomized but not treated|1|||
131060227|NCT00813709|471853319|FG000|Open Label Period|Other|0|||
131060228|NCT00813709|471853320|FG001|Open Label Period|Other|0|||
131060229|NCT00813709|471853321|FG002|Open Label Period|Other|0|||
131137058|NCT00866307|472128253|FG000|Consolidation/Maintenance|Physician Decision|0|||
131137059|NCT00866307|472128254|FG001|Consolidation/Maintenance|Physician Decision|3|||
131060230|NCT00813709|471853322|FG003|Open Label Period|Other|11|||
131060231|NCT00813709|471853323|FG004|Open Label Period|Other|5|||
131060232|NCT00813709|471853324|FG005|Open Label Period|Other|6|||
131137060|NCT00866307|472128255|FG002|Consolidation/Maintenance|Physician Decision|2|||
131060233|NCT02152384|471853325|FG000|Period 1|Withdrawal by Subject|0|||
131060234|NCT02152384|471853326|FG001|Period 1|Withdrawal by Subject|1|||
131060235|NCT02152384|471853325|FG000|Period 1|Adverse Event|1|||
131060236|NCT02152384|471853326|FG001|Period 1|Adverse Event|1|||
131060237|NCT00603798|471853327|FG000|Overall Study|Adverse Event|4|||
131060238|NCT00603798|471853328|FG001|Overall Study|Adverse Event|2|||
131137061|NCT00866307|472128253|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
131060239|NCT00603798|471853329|FG002|Overall Study|Adverse Event|1|||
131060240|NCT00603798|471853327|FG000|Overall Study|Withdrawal by Subject|4|||
131060241|NCT00603798|471853328|FG001|Overall Study|Withdrawal by Subject|3|||
131060242|NCT00603798|471853329|FG002|Overall Study|Withdrawal by Subject|4|||
131060243|NCT00603798|471853327|FG000|Overall Study|Lost to Follow-up|1|||
131060244|NCT00603798|471853328|FG001|Overall Study|Lost to Follow-up|0|||
131060245|NCT00603798|471853329|FG002|Overall Study|Lost to Follow-up|1|||
131060246|NCT00603798|471853327|FG000|Overall Study|Non-compliance with study procedures|0|||
131060247|NCT00603798|471853328|FG001|Overall Study|Non-compliance with study procedures|1|||
131060248|NCT00603798|471853329|FG002|Overall Study|Non-compliance with study procedures|0|||
131060249|NCT00603798|471853327|FG000|Overall Study|Not due to AE|1|||
131060250|NCT00603798|471853328|FG001|Overall Study|Not due to AE|1|||
131060251|NCT00603798|471853329|FG002|Overall Study|Not due to AE|4|||
131060252|NCT02245620|471853330|FG000|Overall Study|Physician Decision|1|||
131060253|NCT02245620|471853331|FG001|Overall Study|Physician Decision|1|||
131060254|NCT00889863|471853332|FG000|Part I: Open Label|Death|1|||
131060255|NCT00889863|471853333|FG001|Part I: Open Label|Death|0|||
131060256|NCT00889863|471853332|FG000|Part I: Open Label|Adverse Event|4|||
131060257|NCT00889863|471853333|FG001|Part I: Open Label|Adverse Event|0|||
131060258|NCT00889863|471853332|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
131060259|NCT00889863|471853333|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
131060260|NCT00889863|471853332|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
131060261|NCT00889863|471853333|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
131060262|NCT00889863|471853332|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
131060263|NCT00889863|471853333|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
131060264|NCT00889863|471853332|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
131060265|NCT00889863|471853333|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
131060266|NCT00889863|471853332|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
131060267|NCT00889863|471853333|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
131060268|NCT04361617|471853334|FG000|Overall Study|Withdrawal by Subject|0|||
131060269|NCT04361617|471853335|FG001|Overall Study|Withdrawal by Subject|1|||
131060270|NCT01393964|471853336|FG000|Overall Study|Disease Progression|4|||
131060271|NCT01393964|471853337|FG001|Overall Study|Disease Progression|3|||
131060272|NCT01393964|471853338|FG002|Overall Study|Disease Progression|5|||
131060273|NCT01393964|471853336|FG000|Overall Study|Study drug toxicity|1|||
131060274|NCT01393964|471853337|FG001|Overall Study|Study drug toxicity|0|||
131060275|NCT01393964|471853338|FG002|Overall Study|Study drug toxicity|0|||
131060276|NCT01393964|471853336|FG000|Overall Study|Withdrawal by Subject|0|||
131060277|NCT01393964|471853337|FG001|Overall Study|Withdrawal by Subject|0|||
131060278|NCT01393964|471853338|FG002|Overall Study|Withdrawal by Subject|1|||
131060279|NCT01393964|471853336|FG000|Overall Study|Adverse event unrelated to study drug|0|||
131060280|NCT01393964|471853337|FG001|Overall Study|Adverse event unrelated to study drug|3|||
131060281|NCT01393964|471853338|FG002|Overall Study|Adverse event unrelated to study drug|0|||
131060282|NCT01393964|471853336|FG000|Overall Study|Subject request stop study treatment|0|||
131060283|NCT01393964|471853337|FG001|Overall Study|Subject request stop study treatment|1|||
131060284|NCT01393964|471853338|FG002|Overall Study|Subject request stop study treatment|0|||
131060285|NCT01393964|471853336|FG000|Overall Study|Subject decided to move to transplant|1|||
131060286|NCT01393964|471853337|FG001|Overall Study|Subject decided to move to transplant|0|||
131060287|NCT01393964|471853338|FG002|Overall Study|Subject decided to move to transplant|0|||
131060288|NCT01393964|471853336|FG000|Overall Study|Subject switched to commercial supply|1|||
131060289|NCT01393964|471853337|FG001|Overall Study|Subject switched to commercial supply|0|||
131060290|NCT01393964|471853338|FG002|Overall Study|Subject switched to commercial supply|2|||
131060291|NCT01393964|471853336|FG000|Overall Study|Subject plateaued in terms of effect|1|||
131060292|NCT01393964|471853337|FG001|Overall Study|Subject plateaued in terms of effect|0|||
131060293|NCT01393964|471853338|FG002|Overall Study|Subject plateaued in terms of effect|0|||
131060294|NCT01393964|471853336|FG000|Overall Study|Investigator removed subject from study|0|||
131060295|NCT01393964|471853337|FG001|Overall Study|Investigator removed subject from study|1|||
131060296|NCT01393964|471853338|FG002|Overall Study|Investigator removed subject from study|0|||
131060297|NCT01393964|471853336|FG000|Overall Study|Subject converted to roll-over study|0|||
131137062|NCT00866307|472128254|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
131137063|NCT00866307|472128255|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
130822727|NCT00887159|470980583|FG000|Overall Study|Received more tx instead of observation|1|||
131060298|NCT01393964|471853337|FG001|Overall Study|Subject converted to roll-over study|1|||
131060299|NCT01393964|471853338|FG002|Overall Study|Subject converted to roll-over study|0|||
131060300|NCT01393964|471853336|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
131060301|NCT01393964|471853337|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
131060302|NCT01393964|471853338|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
131060303|NCT00687297|471853343|FG000|Randomization|Withdrawal by Subject|2|||
131060304|NCT00687297|471853344|FG001|Randomization|Withdrawal by Subject|0|||
131060305|NCT00687297|471853343|FG000|Randomization|Withdrew before treatment, ineligible|1|||
131229951|NCT03264066|472467741|FG005|Overall Study|Death|1|||
131060306|NCT00687297|471853344|FG001|Randomization|Withdrew before treatment, ineligible|1|||
131060307|NCT00687297|471853343|FG000|Induction|Withdrawal by Subject|4|||
131060308|NCT00687297|471853344|FG001|Induction|Withdrawal by Subject|4|||
131060309|NCT00687297|471853343|FG000|Induction|Adverse Event|16|||
131060310|NCT00687297|471853344|FG001|Induction|Adverse Event|15|||
131060311|NCT00687297|471853343|FG000|Induction|Death|7|||
131060312|NCT00687297|471853344|FG001|Induction|Death|11|||
131060313|NCT00687297|471853343|FG000|Induction|Lack of Efficacy|17|||
131060314|NCT00687297|471853344|FG001|Induction|Lack of Efficacy|21|||
131060315|NCT00687297|471853343|FG000|Induction|Ineligible|0|||
131060316|NCT00687297|471853344|FG001|Induction|Ineligible|1|||
131060317|NCT00687297|471853343|FG000|Induction|Patient Noncompliance|1|||
131060318|NCT00687297|471853344|FG001|Induction|Patient Noncompliance|0|||
131060319|NCT00687297|471853343|FG000|Induction|Physician Decision|0|||
131060320|NCT00687297|471853344|FG001|Induction|Physician Decision|2|||
131060321|NCT00687297|471853343|FG000|Induction|Other|0|||
131060322|NCT00687297|471853344|FG001|Induction|Other|1|||
131060323|NCT01228734|471853345|FG000|Overall Study|Randomized, but not treated|0|||
131060324|NCT01228734|471853346|FG001|Overall Study|Randomized, but not treated|4|||
131060325|NCT03128099|471853347|FG000|Overall Study|High dose task was too long|0|||
131060326|NCT03128099|471853348|FG001|Overall Study|High dose task was too long|4|||
131060327|NCT03128099|471853349|FG002|Overall Study|High dose task was too long|0|||
131060328|NCT03128099|471853347|FG000|Overall Study|Participant got a full time job.|1|||
131060329|NCT03128099|471853348|FG001|Overall Study|Participant got a full time job.|0|||
131060330|NCT03128099|471853349|FG002|Overall Study|Participant got a full time job.|0|||
131060331|NCT03128099|471853347|FG000|Overall Study|Became homeless and lost contact|1|||
131060332|NCT03128099|471853348|FG001|Overall Study|Became homeless and lost contact|0|||
131060333|NCT03128099|471853349|FG002|Overall Study|Became homeless and lost contact|0|||
131060334|NCT03128099|471853347|FG000|Overall Study|Did not complete all the assessments|0|||
131060335|NCT03128099|471853348|FG001|Overall Study|Did not complete all the assessments|0|||
131060336|NCT03128099|471853349|FG002|Overall Study|Did not complete all the assessments|1|||
131060337|NCT03390166|471853353|FG000|Overall Study|Death|0|||
131060338|NCT03390166|471853354|FG001|Overall Study|Death|1|||
131060339|NCT03390166|471853353|FG000|Overall Study|Lost to Follow-up|6|||
131060340|NCT03390166|471853354|FG001|Overall Study|Lost to Follow-up|4|||
131060341|NCT03390166|471853353|FG000|Overall Study|Physician Decision|2|||
131060342|NCT03390166|471853354|FG001|Overall Study|Physician Decision|1|||
131060343|NCT03390166|471853353|FG000|Overall Study|Move from study area|3|||
131060344|NCT03390166|471853354|FG001|Overall Study|Move from study area|2|||
131060345|NCT03390166|471853353|FG000|Overall Study|To militarycamp for conscript|1|||
131060346|NCT03390166|471853354|FG001|Overall Study|To militarycamp for conscript|0|||
131060347|NCT03390166|471853353|FG000|Overall Study|To drug therapy course|0|||
131060348|NCT03390166|471853354|FG001|Overall Study|To drug therapy course|1|||
131060349|NCT03390166|471853353|FG000|Overall Study|Move to work oversea|0|||
131060350|NCT03390166|471853354|FG001|Overall Study|Move to work oversea|1|||
131060351|NCT01137682|471853355|FG000|Overall Study|Adverse Event-CORE|2|||
131060352|NCT01137682|471853356|FG001|Overall Study|Adverse Event-CORE|4|||
131060353|NCT01137682|471853357|FG002|Overall Study|Adverse Event-CORE|0|||
131060354|NCT01137682|471853355|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
131060355|NCT01137682|471853356|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
131060356|NCT01137682|471853357|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
131060357|NCT01137682|471853355|FG000|Overall Study|Administrative problems-CORE|2|||
131060358|NCT01137682|471853356|FG001|Overall Study|Administrative problems-CORE|1|||
131060359|NCT01137682|471853357|FG002|Overall Study|Administrative problems-CORE|0|||
131060360|NCT01137682|471853355|FG000|Overall Study|Protocol Violation-CORE|0|||
131060361|NCT01137682|471853356|FG001|Overall Study|Protocol Violation-CORE|1|||
131060362|NCT01137682|471853357|FG002|Overall Study|Protocol Violation-CORE|1|||
131060363|NCT01137682|471853355|FG000|Overall Study|Adverse Event-Extension|4|||
131060364|NCT01137682|471853356|FG001|Overall Study|Adverse Event-Extension|8|||
131060365|NCT01137682|471853357|FG002|Overall Study|Adverse Event-Extension|7|||
131060366|NCT01137682|471853355|FG000|Overall Study|Lack of Efficacy-Extension|15|||
131137064|NCT00866307|472128253|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
131137065|NCT00866307|472128254|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
131060367|NCT01137682|471853356|FG001|Overall Study|Lack of Efficacy-Extension|9|||
131060368|NCT01137682|471853357|FG002|Overall Study|Lack of Efficacy-Extension|13|||
131060369|NCT01137682|471853355|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
131060370|NCT01137682|471853356|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
131060371|NCT01137682|471853357|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
131060372|NCT01137682|471853355|FG000|Overall Study|Lost to Follow Up-Extension|0|||
131060373|NCT01137682|471853356|FG001|Overall Study|Lost to Follow Up-Extension|1|||
131137066|NCT00866307|472128255|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
131060374|NCT01137682|471853357|FG002|Overall Study|Lost to Follow Up-Extension|0|||
131060375|NCT01137682|471853355|FG000|Overall Study|Administrative problems-Extension|0|||
131060376|NCT01137682|471853356|FG001|Overall Study|Administrative problems-Extension|2|||
131060377|NCT01137682|471853357|FG002|Overall Study|Administrative problems-Extension|0|||
131060378|NCT01137682|471853355|FG000|Overall Study|Death-Extension|2|||
131060379|NCT01137682|471853356|FG001|Overall Study|Death-Extension|0|||
131060380|NCT01137682|471853357|FG002|Overall Study|Death-Extension|0|||
131060381|NCT01137682|471853355|FG000|Overall Study|Protocol Violation-Extension|2|||
131060382|NCT01137682|471853356|FG001|Overall Study|Protocol Violation-Extension|1|||
131060383|NCT01137682|471853357|FG002|Overall Study|Protocol Violation-Extension|0|||
131060384|NCT01137682|471853355|FG000|Overall Study|Did not enter extension|2|||
131060385|NCT01137682|471853356|FG001|Overall Study|Did not enter extension|3|||
131060386|NCT01137682|471853357|FG002|Overall Study|Did not enter extension|2|||
131060387|NCT01137682|471853355|FG000|Overall Study|Did not receive treatment in extension|0|||
131060388|NCT01137682|471853356|FG001|Overall Study|Did not receive treatment in extension|0|||
131060389|NCT01137682|471853357|FG002|Overall Study|Did not receive treatment in extension|1|||
131060390|NCT00274287|471853358|FG000|Overall Study|Withdrawal by Subject|1|||
131060391|NCT00274287|471853358|FG000|Overall Study|subject non-compliance|1|||
131060392|NCT04617847|471853359|FG000|Overall Study|Withdrawal by Subject|1|||
131060393|NCT04617847|471853360|FG001|Overall Study|Withdrawal by Subject|0|||
131060394|NCT04617847|471853359|FG000|Overall Study|Adverse Event|0|||
131060395|NCT04617847|471853360|FG001|Overall Study|Adverse Event|2|||
131060396|NCT04617847|471853359|FG000|Overall Study|Death|0|||
131060397|NCT04617847|471853360|FG001|Overall Study|Death|1|||
131060398|NCT04617847|471853359|FG000|Overall Study|Termination of Study by Sponsor|2|||
131060399|NCT04617847|471853360|FG001|Overall Study|Termination of Study by Sponsor|21|||
131060400|NCT02206607|471853361|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
131060401|NCT02206607|471853362|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
131060402|NCT02206607|471853363|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
131060403|NCT02206607|471853364|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
131060404|NCT02206607|471853365|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
131060405|NCT02206607|471853361|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
131060406|NCT02206607|471853362|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
131060407|NCT02206607|471853363|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
131060408|NCT02206607|471853364|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
131060409|NCT02206607|471853365|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
131060410|NCT05445557|471853366|FG000|Double Blind Part|Lost to Follow-up|1|||
131060411|NCT01681511|471853367|FG000|Overall Study|No Treatment Received|1|||
131060412|NCT01681511|471853368|FG001|Overall Study|No Treatment Received|3|||
131060413|NCT01681511|471853367|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
131060414|NCT01681511|471853368|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
131060415|NCT01681511|471853367|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
131060416|NCT01681511|471853368|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
131060417|NCT01681511|471853367|FG000|Overall Study|No Daily Urine Sample Collected|0|||
131060418|NCT01681511|471853368|FG001|Overall Study|No Daily Urine Sample Collected|1|||
131060419|NCT01681511|471853367|FG000|Overall Study|No post-catheter sample collected|11|||
131060420|NCT01681511|471853368|FG001|Overall Study|No post-catheter sample collected|4|||
131060421|NCT01079949|471853369|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
131060422|NCT01079949|471853370|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
131060423|NCT01079949|471853369|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
131060424|NCT01079949|471853370|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
131060425|NCT01079949|471853369|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
131060426|NCT01079949|471853370|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
131060427|NCT01079949|471853369|FG000|Overall Study|Randomized but not treated|1|||
131060428|NCT01079949|471853370|FG001|Overall Study|Randomized but not treated|0|||
131060429|NCT01529632|471853371|FG000|Overall Study|Administrative problem|2|||
131060430|NCT01529632|471853372|FG001|Overall Study|Administrative problem|1|||
131060431|NCT01529632|471853371|FG000|Overall Study|Protocol Violation|0|||
131060432|NCT01529632|471853372|FG001|Overall Study|Protocol Violation|1|||
131060433|NCT01529632|471853371|FG000|Overall Study|Adverse Event|1|||
131060434|NCT01529632|471853372|FG001|Overall Study|Adverse Event|1|||
131060435|NCT05184062|471853373|FG000|Overall Study|Lost to Follow-up|5|||
131060436|NCT05184062|471853374|FG001|Overall Study|Lost to Follow-up|1|||
131060437|NCT05184062|471853373|FG000|Overall Study|Withdrawal by Subject|1|||
131060438|NCT05184062|471853374|FG001|Overall Study|Withdrawal by Subject|0|||
131060439|NCT00747149|471854808|FG000|Overall Study|Adverse Event|0|||
131060440|NCT00747149|471854809|FG001|Overall Study|Adverse Event|15|||
131060441|NCT00747149|471854808|FG000|Overall Study|Lost to Follow-up|0|||
131060442|NCT00747149|471854809|FG001|Overall Study|Lost to Follow-up|10|||
131060443|NCT00747149|471854808|FG000|Overall Study|Withdrawal by Subject|0|||
131060444|NCT00747149|471854809|FG001|Overall Study|Withdrawal by Subject|6|||
131060445|NCT00747149|471854808|FG000|Overall Study|Did not receive treatment|0|||
131060446|NCT00747149|471854809|FG001|Overall Study|Did not receive treatment|1|||
131060447|NCT00747149|471854808|FG000|Overall Study|Incorrect enrollment|0|||
131060448|NCT00747149|471854809|FG001|Overall Study|Incorrect enrollment|6|||
131060449|NCT00747149|471854808|FG000|Overall Study|Severe non-compliance to protocol|0|||
131060450|NCT00747149|471854809|FG001|Overall Study|Severe non-compliance to protocol|1|||
131060451|NCT00747149|471854808|FG000|Overall Study|Not reported|1|||
131060452|NCT00747149|471854809|FG001|Overall Study|Not reported|4|||
131060453|NCT02196259|471854810|FG000|Overall Study|Researcher choice|0|||
131060454|NCT02196259|471854811|FG001|Overall Study|Researcher choice|0|||
131060455|NCT02196259|471854812|FG002|Overall Study|Researcher choice|1|||
131060456|NCT02196259|471854810|FG000|Overall Study|Partial data analysis|0|||
131060457|NCT02196259|471854811|FG001|Overall Study|Partial data analysis|3|||
131060458|NCT02196259|471854812|FG002|Overall Study|Partial data analysis|0|||
131060459|NCT02830893|471854813|FG000|Overall Study|Relocation to out of the country|1|||
131060460|NCT02830893|471854814|FG001|Overall Study|Relocation to out of the country|0|||
131060461|NCT02830893|471854813|FG000|Overall Study|Lost to Follow-up|0|||
131060462|NCT02830893|471854814|FG001|Overall Study|Lost to Follow-up|2|||
131060463|NCT02830893|471854813|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
131060464|NCT02830893|471854814|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
131060465|NCT00215943|471854815|FG000|Overall Study|Disease Progression|3|||
131060466|NCT00215943|471854816|FG001|Overall Study|Disease Progression|5|||
131060467|NCT00215943|471854815|FG000|Overall Study|Alternate therapy|0|||
131060468|NCT00215943|471854816|FG001|Overall Study|Alternate therapy|1|||
131060469|NCT00215943|471854815|FG000|Overall Study|Adverse Event|3|||
131060470|NCT00215943|471854816|FG001|Overall Study|Adverse Event|6|||
131060471|NCT00215943|471854815|FG000|Overall Study|Other disease|0|||
131060472|NCT00215943|471854816|FG001|Overall Study|Other disease|1|||
131060473|NCT00215943|471854815|FG000|Overall Study|Other complications|3|||
131060474|NCT00215943|471854816|FG001|Overall Study|Other complications|1|||
131060475|NCT00246129|471854818|FG000|Overall Study|Lost to Follow-up|1|||
131060476|NCT00246129|471854819|FG001|Overall Study|Lost to Follow-up|0|||
131060477|NCT00246129|471854818|FG000|Overall Study|Death|2|||
131060478|NCT00246129|471854819|FG001|Overall Study|Death|1|||
131060479|NCT00246129|471854818|FG000|Overall Study|suffered primary non-function|1|||
131060480|NCT00246129|471854819|FG001|Overall Study|suffered primary non-function|0|||
131060481|NCT00246129|471854818|FG000|Overall Study|grafts failed|3|||
131060482|NCT00246129|471854819|FG001|Overall Study|grafts failed|1|||
131060483|NCT01286311|471854820|FG000|Overall Study|Physician did not want outreach sent|14|||
131060484|NCT01286311|471854821|FG001|Overall Study|Physician did not want outreach sent|0|||
131060485|NCT00403845|471854825|FG000|Treatment Period 1|Subject withdrew consent|1|||
131060486|NCT00403845|471854826|FG001|Treatment Period 1|Subject withdrew consent|0|||
131060487|NCT00403845|471854827|FG002|Treatment Period 1|Subject withdrew consent|0|||
131060488|NCT00403845|471854828|FG003|Treatment Period 1|Subject withdrew consent|0|||
131060489|NCT00403845|471854825|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
131060490|NCT00403845|471854826|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
131060491|NCT00403845|471854827|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
131060492|NCT00403845|471854828|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
131060493|NCT00403845|471854825|FG000|Treatment Period 2|Subject withdrew consent|1|||
131060494|NCT00403845|471854826|FG001|Treatment Period 2|Subject withdrew consent|0|||
131060495|NCT00403845|471854827|FG002|Treatment Period 2|Subject withdrew consent|0|||
131060496|NCT00403845|471854828|FG003|Treatment Period 2|Subject withdrew consent|0|||
131060497|NCT00403845|471854825|FG000|Treatment Period 3|Subject withdrew consent|0|||
131060498|NCT00403845|471854826|FG001|Treatment Period 3|Subject withdrew consent|0|||
131060499|NCT00403845|471854827|FG002|Treatment Period 3|Subject withdrew consent|0|||
131060500|NCT00403845|471854828|FG003|Treatment Period 3|Subject withdrew consent|1|||
131060501|NCT00403845|471854825|FG000|Treatment Period 3|Adverse Event|0|||
131060502|NCT00403845|471854826|FG001|Treatment Period 3|Adverse Event|0|||
131060503|NCT00403845|471854827|FG002|Treatment Period 3|Adverse Event|0|||
131060504|NCT00403845|471854828|FG003|Treatment Period 3|Adverse Event|1|||
131060505|NCT00805792|471854829|FG000|Overall Study|Death|3|||
131060506|NCT00805792|471854829|FG000|Overall Study|Lost to Follow-up|2|||
131060507|NCT00578344|471854830|FG000|Overall Study|Insurance problems|1|||
131060508|NCT00578344|471854830|FG000|Overall Study|Graft failure|1|||
131060509|NCT04328467|471854832|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
131060510|NCT04328467|471854833|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
131060511|NCT04328467|471854834|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
131060512|NCT02753075|471854837|FG000|Overall Study|Adverse Event|2|||
131060513|NCT02753075|471854838|FG001|Overall Study|Adverse Event|1|||
131060514|NCT02753075|471854839|FG002|Overall Study|Adverse Event|0|||
131060515|NCT02753075|471854837|FG000|Overall Study|Lost to Follow-up|2|||
131060516|NCT02753075|471854838|FG001|Overall Study|Lost to Follow-up|0|||
131060517|NCT02753075|471854839|FG002|Overall Study|Lost to Follow-up|0|||
131060518|NCT02753075|471854837|FG000|Overall Study|Withdrawal of Consent|1|||
131060519|NCT02753075|471854838|FG001|Overall Study|Withdrawal of Consent|1|||
131060520|NCT02753075|471854839|FG002|Overall Study|Withdrawal of Consent|3|||
131060521|NCT02753075|471854837|FG000|Overall Study|Physician Decision|3|||
131060522|NCT02753075|471854838|FG001|Overall Study|Physician Decision|1|||
131060523|NCT02753075|471854839|FG002|Overall Study|Physician Decision|0|||
131060524|NCT00930644|471854844|FG000|Overall Study|Withdrawal by Subject|4|||
131060525|NCT00930644|471854844|FG000|Overall Study|Physician Decision|2|||
131060526|NCT00930644|471854844|FG000|Overall Study|Death|1|||
131060527|NCT00930644|471854844|FG000|Overall Study|Adverse Event|16|||
131060528|NCT03265132|471854851|FG000|Overall Study|Adverse Event|0|||
131060529|NCT03265132|471854852|FG001|Overall Study|Adverse Event|1|||
131060530|NCT03265132|471854851|FG000|Overall Study|Lack of Efficacy|0|||
131060531|NCT03265132|471854852|FG001|Overall Study|Lack of Efficacy|2|||
131060532|NCT03265132|471854851|FG000|Overall Study|Progressive disease|0|||
131060533|NCT03265132|471854852|FG001|Overall Study|Progressive disease|2|||
131060534|NCT03265132|471854851|FG000|Overall Study|Withdrawal by Subject|0|||
131060535|NCT03265132|471854852|FG001|Overall Study|Withdrawal by Subject|1|||
131060536|NCT03909100|471854853|FG000|Overall Study|Protocol Deviation|2|||
131060537|NCT03909100|471854853|FG000|Overall Study|Technical Problems|4|||
131060538|NCT03909100|471854853|FG000|Overall Study|Withdrawal by Subject|4|||
131060539|NCT03909100|471854853|FG000|Overall Study|Lost to Follow-up|1|||
131060540|NCT03909100|471854853|FG000|Overall Study|Reason not Specified|4|||
131060541|NCT00088166|471854854|FG000|Overall Study|Adverse Event|11|||
131060542|NCT00088166|471854855|FG001|Overall Study|Adverse Event|9|||
131060543|NCT00088166|471854854|FG000|Overall Study|Death|3|||
131060544|NCT00088166|471854855|FG001|Overall Study|Death|1|||
131060545|NCT00088166|471854854|FG000|Overall Study|Lost to Follow-up|0|||
131060546|NCT00088166|471854855|FG001|Overall Study|Lost to Follow-up|1|||
131060547|NCT00088166|471854854|FG000|Overall Study|Physician Decision|4|||
131060548|NCT00088166|471854855|FG001|Overall Study|Physician Decision|1|||
131060549|NCT00088166|471854854|FG000|Overall Study|Protocol Violation|1|||
131060550|NCT00088166|471854855|FG001|Overall Study|Protocol Violation|5|||
131060551|NCT00088166|471854854|FG000|Overall Study|Patient deterioration|29|||
131060552|NCT00088166|471854855|FG001|Overall Study|Patient deterioration|39|||
131060553|NCT00088166|471854854|FG000|Overall Study|Withdrawal by Subject|5|||
131060554|NCT00088166|471854855|FG001|Overall Study|Withdrawal by Subject|5|||
131060555|NCT02671266|471854856|FG000|Overall Study|Withdrawal by Subject|1|||
131060556|NCT02671266|471854857|FG001|Overall Study|Withdrawal by Subject|1|||
131060557|NCT00666705|471854858|FG000|Overall Study|Withdrawal by Subject|1|||
131060558|NCT01109979|471854859|FG000|Overall Study|Physician Decision|2|||
131060559|NCT01109979|471854860|FG001|Overall Study|Physician Decision|0|||
131060560|NCT01109979|471854859|FG000|Overall Study|Withdrawal by Subject|0|||
131060561|NCT01109979|471854860|FG001|Overall Study|Withdrawal by Subject|1|||
131060562|NCT00807599|471854861|FG000|Overall Study|Not treated on protocol study|0|||
131060563|NCT00807599|471854862|FG001|Overall Study|Not treated on protocol study|0|||
131060564|NCT00807599|471854863|FG002|Overall Study|Not treated on protocol study|2|||
131060565|NCT00807599|471854861|FG000|Overall Study|Adverse Event|0|||
131060566|NCT00807599|471854862|FG001|Overall Study|Adverse Event|0|||
131060567|NCT00807599|471854863|FG002|Overall Study|Adverse Event|5|||
131060568|NCT00807599|471854861|FG000|Overall Study|Inadequate response to induction|0|||
131060569|NCT00807599|471854862|FG001|Overall Study|Inadequate response to induction|0|||
131060570|NCT00807599|471854863|FG002|Overall Study|Inadequate response to induction|9|||
131060571|NCT00807599|471854861|FG000|Overall Study|Withdrawal by Subject|0|||
131060572|NCT00807599|471854862|FG001|Overall Study|Withdrawal by Subject|0|||
131060573|NCT00807599|471854863|FG002|Overall Study|Withdrawal by Subject|1|||
131060574|NCT03456856|471854864|FG000|Overall Study|Lost to Follow-up|2|||
131060575|NCT03456856|471854864|FG000|Overall Study|Withdrawal by Subject|1|||
131060576|NCT02542696|471854869|FG000|Overall Study|Adverse Event|167|||
131060577|NCT02542696|471854869|FG000|Overall Study|Lack of Efficacy|26|||
131060578|NCT02542696|471854869|FG000|Overall Study|Lost to Follow-up|6|||
131060579|NCT02542696|471854869|FG000|Overall Study|Withdrawal by Subject|104|||
131060580|NCT02542696|471854869|FG000|Overall Study|Protocol Violation|5|||
131060581|NCT02542696|471854869|FG000|Overall Study|Death|8|||
131060582|NCT02542696|471854869|FG000|Overall Study|DECREASED OFF TIME|1|||
131060583|NCT02542696|471854869|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
131060584|NCT02542696|471854869|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
131060585|NCT02542696|471854869|FG000|Overall Study|MEDICAL HISTORY|1|||
131060586|NCT02542696|471854869|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
131060587|NCT02542696|471854869|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
131060588|NCT02542696|471854869|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
131060589|NCT02542696|471854869|FG000|Overall Study|SPONSOR DECISION|3|||
131060590|NCT02542696|471854869|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
131060591|NCT02542696|471854869|FG000|Overall Study|SUBJECT DECISION|2|||
131060592|NCT02137785|471854870|FG000|Overall Study|Lost to Follow-up|1|||
131060593|NCT02137785|471854871|FG001|Overall Study|Lost to Follow-up|0|||
131060594|NCT02137785|471854870|FG000|Overall Study|Withdrawal by Subject|1|||
131060595|NCT02137785|471854871|FG001|Overall Study|Withdrawal by Subject|4|||
131060596|NCT02137785|471854870|FG000|Overall Study|subject moved out of state|1|||
131060597|NCT02137785|471854871|FG001|Overall Study|subject moved out of state|0|||
131060598|NCT01584648|471854872|FG000|Overall Study|Death|136|||
131060599|NCT01584648|471854873|FG001|Overall Study|Death|146|||
131060600|NCT01584648|471854872|FG000|Overall Study|Lost to Follow-up|9|||
131060601|NCT01584648|471854873|FG001|Overall Study|Lost to Follow-up|9|||
131060602|NCT01584648|471854872|FG000|Overall Study|Investigator discretion|3|||
131060603|NCT01584648|471854873|FG001|Overall Study|Investigator discretion|2|||
131060604|NCT01584648|471854872|FG000|Overall Study|Withdrew consent|13|||
131060605|NCT01584648|471854873|FG001|Overall Study|Withdrew consent|4|||
131137067|NCT00866307|472128253|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
131137068|NCT00866307|472128254|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
131137069|NCT00866307|472128255|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
131137070|NCT00866307|472128253|FG000|Consolidation/Maintenance|Therapy error|0|||
131060606|NCT01584648|471854872|FG000|Overall Study|Study closed/terminated|50|||
131060607|NCT01584648|471854873|FG001|Overall Study|Study closed/terminated|23|||
131060608|NCT01584648|471854872|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
131060609|NCT01584648|471854873|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
131060610|NCT02825550|471854876|FG000|Overall Study|Physician Decision|1|||
131060611|NCT04421456|471854881|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
131060612|NCT04421456|471854882|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
131060613|NCT04421456|471854883|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
131060614|NCT04421456|471854881|FG000|Randomized Treatment Period|Adverse Event|0|||
131060615|NCT04421456|471854882|FG001|Randomized Treatment Period|Adverse Event|1|||
131060616|NCT04421456|471854883|FG002|Randomized Treatment Period|Adverse Event|0|||
131060617|NCT04421456|471854881|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
131060618|NCT04421456|471854882|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
131060619|NCT04421456|471854883|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
131060620|NCT04421456|471854881|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
131060621|NCT04421456|471854882|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
131060622|NCT04421456|471854883|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
131060623|NCT04421456|471854881|FG000|Randomized Treatment Period|Participant non-compliance|1|||
131060624|NCT04421456|471854882|FG001|Randomized Treatment Period|Participant non-compliance|1|||
131060625|NCT04421456|471854883|FG002|Randomized Treatment Period|Participant non-compliance|2|||
131060626|NCT04421456|471854881|FG000|Randomized Treatment Period|Other|0|||
131060627|NCT04421456|471854882|FG001|Randomized Treatment Period|Other|1|||
131060628|NCT04421456|471854883|FG002|Randomized Treatment Period|Other|3|||
131060629|NCT00244751|471854884|FG000|Overall Study|Adverse Event|7|||
131060630|NCT00244751|471854885|FG001|Overall Study|Adverse Event|7|||
131060631|NCT00244751|471854886|FG002|Overall Study|Adverse Event|5|||
131060632|NCT00244751|471854884|FG000|Overall Study|Lost to Follow-up|0|||
131060633|NCT00244751|471854885|FG001|Overall Study|Lost to Follow-up|1|||
131060634|NCT00244751|471854886|FG002|Overall Study|Lost to Follow-up|0|||
131060635|NCT00244751|471854884|FG000|Overall Study|Protocol Violation|1|||
131060636|NCT00244751|471854885|FG001|Overall Study|Protocol Violation|0|||
131060637|NCT00244751|471854886|FG002|Overall Study|Protocol Violation|1|||
131060638|NCT00244751|471854884|FG000|Overall Study|Withdrawal by Subject|7|||
131060639|NCT00244751|471854885|FG001|Overall Study|Withdrawal by Subject|5|||
131060640|NCT00244751|471854886|FG002|Overall Study|Withdrawal by Subject|3|||
131060641|NCT00244751|471854884|FG000|Overall Study|Elevated liver enzymes|1|||
131060642|NCT00244751|471854885|FG001|Overall Study|Elevated liver enzymes|0|||
131060643|NCT00244751|471854886|FG002|Overall Study|Elevated liver enzymes|0|||
131060644|NCT00244751|471854884|FG000|Overall Study|Lack of compliance with protocol|0|||
131060645|NCT00244751|471854885|FG001|Overall Study|Lack of compliance with protocol|1|||
131060646|NCT00244751|471854886|FG002|Overall Study|Lack of compliance with protocol|0|||
131060647|NCT00244751|471854884|FG000|Overall Study|Safety reasons|0|||
131060648|NCT00244751|471854885|FG001|Overall Study|Safety reasons|1|||
131060649|NCT00244751|471854886|FG002|Overall Study|Safety reasons|0|||
131060650|NCT00244751|471854884|FG000|Overall Study|Participant randomized by mistake|0|||
131060651|NCT00244751|471854885|FG001|Overall Study|Participant randomized by mistake|0|||
131060652|NCT00244751|471854886|FG002|Overall Study|Participant randomized by mistake|1|||
131060653|NCT01262456|471854889|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
131060654|NCT01262456|471854890|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
131060655|NCT01262456|471854891|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
131060656|NCT01262456|471854889|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
131060657|NCT01262456|471854890|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
131060658|NCT01262456|471854891|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
131060659|NCT01262456|471854889|FG000|3-Month Double-Blind Period|Adverse Event|6|||
131060660|NCT01262456|471854890|FG001|3-Month Double-Blind Period|Adverse Event|4|||
131060661|NCT01262456|471854891|FG002|3-Month Double-Blind Period|Adverse Event|8|||
131060662|NCT01262456|471854889|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
131060663|NCT01262456|471854890|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
131137071|NCT00866307|472128254|FG001|Consolidation/Maintenance|Therapy error|1|||
131137072|NCT00866307|472128255|FG002|Consolidation/Maintenance|Therapy error|0|||
131137073|NCT00866307|472128253|FG000|Consolidation/Maintenance|Non-compliance|0|||
131137074|NCT00866307|472128254|FG001|Consolidation/Maintenance|Non-compliance|0|||
131229952|NCT03264066|472467736|FG000|Overall Study|Lost to Follow-up|1|||
131060664|NCT01262456|471854891|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
131060665|NCT01262456|471854889|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
131060666|NCT01262456|471854890|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
131060667|NCT01262456|471854891|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
131060668|NCT01262456|471854889|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
131060669|NCT01262456|471854890|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
131060670|NCT01262456|471854891|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
131060671|NCT01262456|471854889|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
131060672|NCT01262456|471854890|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
131060673|NCT01262456|471854891|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
131060674|NCT01262456|471854889|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
131060675|NCT01262456|471854890|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
131060676|NCT01262456|471854891|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
131060677|NCT01262456|471854889|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
131060678|NCT01262456|471854890|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
131060679|NCT01262456|471854891|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
131060680|NCT02399449|471854892|FG000|Overall Study|Withdrawal by Subject|3|||
131060681|NCT02399449|471854893|FG001|Overall Study|Withdrawal by Subject|9|||
131060682|NCT02399449|471854892|FG000|Overall Study|Physician Decision|0|||
131060683|NCT02399449|471854893|FG001|Overall Study|Physician Decision|1|||
131060684|NCT00337610|471854894|FG000|Overall Study|Adverse Event|2|||
131060685|NCT00337610|471854895|FG001|Overall Study|Adverse Event|2|||
131060686|NCT00337610|471854894|FG000|Overall Study|Death|0|||
131060687|NCT00337610|471854895|FG001|Overall Study|Death|1|||
131060688|NCT00337610|471854894|FG000|Overall Study|Lack of Efficacy|6|||
131060689|NCT00337610|471854895|FG001|Overall Study|Lack of Efficacy|3|||
131060690|NCT00337610|471854894|FG000|Overall Study|Lost to Follow-up|3|||
131060691|NCT00337610|471854895|FG001|Overall Study|Lost to Follow-up|3|||
131060692|NCT00337610|471854894|FG000|Overall Study|Withdrawal by Subject|6|||
131060693|NCT00337610|471854895|FG001|Overall Study|Withdrawal by Subject|5|||
131060694|NCT03979040|471854896|FG000|Overall Study|Withdrawal by Subject|24|||
131060695|NCT03979040|471854897|FG001|Overall Study|Withdrawal by Subject|32|||
131060696|NCT03979040|471854896|FG000|Overall Study|randomized but never started treatment|32|||
131060697|NCT03979040|471854897|FG001|Overall Study|randomized but never started treatment|39|||
131060698|NCT03979040|471854896|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
131060699|NCT03979040|471854897|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
131060700|NCT03541369|471854900|FG000|Overall Study|Death|0|||
131060701|NCT03541369|471854901|FG001|Overall Study|Death|0|||
131060702|NCT03541369|471854902|FG002|Overall Study|Death|0|||
131060703|NCT03541369|471854903|FG003|Overall Study|Death|0|||
131060704|NCT03541369|471854904|FG004|Overall Study|Death|1|||
131060705|NCT03541369|471854905|FG005|Overall Study|Death|1|||
131060706|NCT03541369|471854906|FG006|Overall Study|Death|0|||
131060707|NCT03541369|471854907|FG007|Overall Study|Death|2|||
131060708|NCT03541369|471854908|FG008|Overall Study|Death|1|||
131060709|NCT03541369|471854909|FG009|Overall Study|Death|2|||
131060710|NCT03541369|471854910|FG010|Overall Study|Death|1|||
131060711|NCT03541369|471854911|FG011|Overall Study|Death|0|||
131060712|NCT03541369|471854912|FG012|Overall Study|Death|2|||
131060713|NCT03541369|471854913|FG013|Overall Study|Death|1|||
131060714|NCT03541369|471854914|FG014|Overall Study|Death|1|||
131060715|NCT03541369|471854915|FG015|Overall Study|Death|1|||
131060716|NCT03541369|471854916|FG016|Overall Study|Death|0|||
131060717|NCT03541369|471854917|FG017|Overall Study|Death|1|||
131060718|NCT03541369|471854900|FG000|Overall Study|Decision by sponsor|0|||
131060719|NCT03541369|471854901|FG001|Overall Study|Decision by sponsor|0|||
131060720|NCT03541369|471854902|FG002|Overall Study|Decision by sponsor|0|||
131060721|NCT03541369|471854903|FG003|Overall Study|Decision by sponsor|1|||
131060722|NCT03541369|471854904|FG004|Overall Study|Decision by sponsor|0|||
131060723|NCT03541369|471854905|FG005|Overall Study|Decision by sponsor|2|||
131060724|NCT03541369|471854906|FG006|Overall Study|Decision by sponsor|0|||
131060725|NCT03541369|471854907|FG007|Overall Study|Decision by sponsor|1|||
131060726|NCT03541369|471854908|FG008|Overall Study|Decision by sponsor|2|||
131060727|NCT03541369|471854909|FG009|Overall Study|Decision by sponsor|0|||
131060728|NCT03541369|471854910|FG010|Overall Study|Decision by sponsor|0|||
131060729|NCT03541369|471854911|FG011|Overall Study|Decision by sponsor|0|||
131060730|NCT03541369|471854912|FG012|Overall Study|Decision by sponsor|2|||
131060731|NCT03541369|471854913|FG013|Overall Study|Decision by sponsor|2|||
131060732|NCT03541369|471854914|FG014|Overall Study|Decision by sponsor|0|||
131060733|NCT03541369|471854915|FG015|Overall Study|Decision by sponsor|1|||
131060734|NCT03541369|471854916|FG016|Overall Study|Decision by sponsor|1|||
131060735|NCT03541369|471854917|FG017|Overall Study|Decision by sponsor|1|||
131060736|NCT03541369|471854900|FG000|Overall Study|Withdrawal by Subject|0|||
131060737|NCT03541369|471854901|FG001|Overall Study|Withdrawal by Subject|0|||
131060738|NCT03541369|471854902|FG002|Overall Study|Withdrawal by Subject|0|||
131060739|NCT03541369|471854903|FG003|Overall Study|Withdrawal by Subject|0|||
131060740|NCT03541369|471854904|FG004|Overall Study|Withdrawal by Subject|0|||
131060741|NCT03541369|471854905|FG005|Overall Study|Withdrawal by Subject|0|||
131060742|NCT03541369|471854906|FG006|Overall Study|Withdrawal by Subject|1|||
131060743|NCT03541369|471854907|FG007|Overall Study|Withdrawal by Subject|0|||
131060744|NCT03541369|471854908|FG008|Overall Study|Withdrawal by Subject|0|||
131060745|NCT03541369|471854909|FG009|Overall Study|Withdrawal by Subject|0|||
131060746|NCT03541369|471854910|FG010|Overall Study|Withdrawal by Subject|0|||
131060747|NCT03541369|471854911|FG011|Overall Study|Withdrawal by Subject|1|||
131060748|NCT03541369|471854912|FG012|Overall Study|Withdrawal by Subject|0|||
131060749|NCT03541369|471854913|FG013|Overall Study|Withdrawal by Subject|0|||
131060750|NCT03541369|471854914|FG014|Overall Study|Withdrawal by Subject|3|||
131060751|NCT03541369|471854915|FG015|Overall Study|Withdrawal by Subject|0|||
131137075|NCT00866307|472128255|FG002|Consolidation/Maintenance|Non-compliance|1|||
131137076|NCT00866307|472128253|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
131137077|NCT00866307|472128254|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
131137078|NCT00866307|472128255|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
131137079|NCT02286947|472128256|FG000|Overall Study|Withdrawal by Subject|2|||
131137080|NCT01972074|472128264|FG000|Overall Study|Adverse Event|4|||
131137081|NCT01972074|472128265|FG001|Overall Study|Adverse Event|1|||
131137082|NCT01972074|472128266|FG002|Overall Study|Adverse Event|0|||
131137083|NCT01972074|472128264|FG000|Overall Study|Lack of Efficacy|1|||
131137084|NCT01972074|472128265|FG001|Overall Study|Lack of Efficacy|1|||
131137085|NCT01972074|472128266|FG002|Overall Study|Lack of Efficacy|0|||
131137086|NCT01972074|472128264|FG000|Overall Study|Lost to Follow-up|0|||
131137087|NCT01972074|472128265|FG001|Overall Study|Lost to Follow-up|1|||
131137088|NCT01972074|472128266|FG002|Overall Study|Lost to Follow-up|1|||
131137089|NCT01972074|472128264|FG000|Overall Study|Withdrawal by Subject|1|||
131137090|NCT01972074|472128265|FG001|Overall Study|Withdrawal by Subject|1|||
131060752|NCT03541369|471854916|FG016|Overall Study|Withdrawal by Subject|4|||
131060753|NCT03541369|471854917|FG017|Overall Study|Withdrawal by Subject|2|||
131060754|NCT03541369|471854900|FG000|Overall Study|Lost to Follow-up|0|||
131060755|NCT03541369|471854901|FG001|Overall Study|Lost to Follow-up|0|||
131060756|NCT03541369|471854902|FG002|Overall Study|Lost to Follow-up|0|||
131060757|NCT03541369|471854903|FG003|Overall Study|Lost to Follow-up|0|||
131060758|NCT03541369|471854904|FG004|Overall Study|Lost to Follow-up|1|||
131060759|NCT03541369|471854905|FG005|Overall Study|Lost to Follow-up|0|||
131060760|NCT03541369|471854906|FG006|Overall Study|Lost to Follow-up|0|||
131060761|NCT03541369|471854907|FG007|Overall Study|Lost to Follow-up|0|||
131060762|NCT03541369|471854908|FG008|Overall Study|Lost to Follow-up|1|||
131060763|NCT03541369|471854909|FG009|Overall Study|Lost to Follow-up|0|||
131060764|NCT03541369|471854910|FG010|Overall Study|Lost to Follow-up|0|||
131060765|NCT03541369|471854911|FG011|Overall Study|Lost to Follow-up|0|||
131060766|NCT03541369|471854912|FG012|Overall Study|Lost to Follow-up|1|||
131060767|NCT03541369|471854913|FG013|Overall Study|Lost to Follow-up|0|||
131060768|NCT03541369|471854914|FG014|Overall Study|Lost to Follow-up|0|||
131060769|NCT03541369|471854915|FG015|Overall Study|Lost to Follow-up|0|||
131060770|NCT03541369|471854916|FG016|Overall Study|Lost to Follow-up|0|||
131060771|NCT03541369|471854917|FG017|Overall Study|Lost to Follow-up|0|||
131060772|NCT04867382|471854924|FG000|Overall Study|Did not complete the survey|2|||
131060773|NCT04867382|471854925|FG001|Overall Study|Did not complete the survey|1|||
131060774|NCT02102724|471854930|FG000|Overall Study|Lost to Follow-up|1|||
131060775|NCT02102724|471854931|FG001|Overall Study|Lost to Follow-up|0|||
131060776|NCT02102724|471854930|FG000|Overall Study|surgery for brain aneurysm|1|||
131060777|NCT02102724|471854931|FG001|Overall Study|surgery for brain aneurysm|1|||
131060778|NCT02008916|471854935|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
131060779|NCT02008916|471854936|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
131060780|NCT02008916|471854937|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
131060781|NCT02008916|471854935|FG000|Week 16 - 156|Adverse Event|4|||
131060782|NCT02008916|471854936|FG001|Week 16 - 156|Adverse Event|2|||
131060783|NCT02008916|471854937|FG002|Week 16 - 156|Adverse Event|3|||
131060784|NCT02008916|471854935|FG000|Week 16 - 156|Withdrawal by Subject|7|||
131060785|NCT02008916|471854936|FG001|Week 16 - 156|Withdrawal by Subject|3|||
131060786|NCT02008916|471854937|FG002|Week 16 - 156|Withdrawal by Subject|5|||
131060787|NCT02008916|471854935|FG000|Week 16 - 156|No longer requires treatment|0|||
131060788|NCT02008916|471854936|FG001|Week 16 - 156|No longer requires treatment|1|||
131060789|NCT02008916|471854937|FG002|Week 16 - 156|No longer requires treatment|0|||
131060790|NCT02008916|471854935|FG000|Week 16 - 156|Lost to Follow-up|5|||
131060791|NCT02008916|471854936|FG001|Week 16 - 156|Lost to Follow-up|0|||
131137091|NCT01972074|472128266|FG002|Overall Study|Withdrawal by Subject|1|||
131137092|NCT01972074|472128264|FG000|Overall Study|Scanner Unavailable|0|||
131137093|NCT01972074|472128265|FG001|Overall Study|Scanner Unavailable|0|||
131137094|NCT01972074|472128266|FG002|Overall Study|Scanner Unavailable|1|||
131137095|NCT05574062|472128267|FG000|Pre Run-In|Screening failure|3|||
131137096|NCT05574062|472128268|FG001|Pre Run-In|Screening failure|0|||
131137097|NCT05574062|472128269|FG002|Pre Run-In|Screening failure|0|||
131060792|NCT02008916|471854937|FG002|Week 16 - 156|Lost to Follow-up|0|||
131060793|NCT02008916|471854935|FG000|Week 16 - 156|Lack of Efficacy|3|||
131060794|NCT02008916|471854936|FG001|Week 16 - 156|Lack of Efficacy|5|||
131060795|NCT02008916|471854937|FG002|Week 16 - 156|Lack of Efficacy|2|||
131060796|NCT02008916|471854935|FG000|Week 16 - 156|Pregnancy|0|||
131060797|NCT02008916|471854936|FG001|Week 16 - 156|Pregnancy|1|||
131060798|NCT02008916|471854937|FG002|Week 16 - 156|Pregnancy|0|||
131137098|NCT05574062|472128270|FG003|Pre Run-In|Screening failure|0|||
131060799|NCT02008916|471854935|FG000|Week 16 - 156|Physician Decision|0|||
131060800|NCT02008916|471854936|FG001|Week 16 - 156|Physician Decision|1|||
131060801|NCT02008916|471854937|FG002|Week 16 - 156|Physician Decision|0|||
131060802|NCT03803475|471854938|FG000|Overall Study|Physician Decision|1|||
131060803|NCT00392197|471854940|FG000|Overall Study|Adverse Event|4|||
131060804|NCT00392197|471854941|FG001|Overall Study|Adverse Event|12|||
131060805|NCT00392197|471854940|FG000|Overall Study|Lack of Efficacy|3|||
131060806|NCT00392197|471854941|FG001|Overall Study|Lack of Efficacy|4|||
131060807|NCT00392197|471854940|FG000|Overall Study|Lost to Follow-up|0|||
131060808|NCT00392197|471854941|FG001|Overall Study|Lost to Follow-up|1|||
131060809|NCT00392197|471854940|FG000|Overall Study|Physician Decision|3|||
131060810|NCT00392197|471854941|FG001|Overall Study|Physician Decision|2|||
131060811|NCT00392197|471854940|FG000|Overall Study|Protocol Violation|7|||
131060812|NCT00392197|471854941|FG001|Overall Study|Protocol Violation|5|||
131060813|NCT00392197|471854940|FG000|Overall Study|Withdrawal by Subject|4|||
131060814|NCT00392197|471854941|FG001|Overall Study|Withdrawal by Subject|6|||
131060815|NCT01156675|471854942|FG000|Overall Study|Death|5|||
131060816|NCT01156675|471854943|FG001|Overall Study|Death|3|||
131060817|NCT01156675|471854944|FG002|Overall Study|Death|0|||
131060818|NCT01156675|471854942|FG000|Overall Study|No data|29|||
131060819|NCT01156675|471854943|FG001|Overall Study|No data|22|||
131060820|NCT01156675|471854944|FG002|Overall Study|No data|2|||
131060821|NCT04919499|471854948|FG000|Overall Study|Adverse Event|0|||
131060822|NCT04919499|471854949|FG001|Overall Study|Adverse Event|0|||
131060823|NCT04919499|471854950|FG002|Overall Study|Adverse Event|0|||
131060824|NCT04919499|471854951|FG003|Overall Study|Adverse Event|0|||
131060825|NCT04919499|471854952|FG004|Overall Study|Adverse Event|2|||
131060826|NCT04919499|471854948|FG000|Overall Study|Not treated|0|||
131060827|NCT04919499|471854949|FG001|Overall Study|Not treated|0|||
131060828|NCT04919499|471854950|FG002|Overall Study|Not treated|0|||
131060829|NCT04919499|471854951|FG003|Overall Study|Not treated|1|||
131060830|NCT04919499|471854952|FG004|Overall Study|Not treated|0|||
131060831|NCT04369664|471856730|FG000|Overall Study|Physician Decision|1|||
131060832|NCT04369664|471856731|FG001|Overall Study|Physician Decision|0|||
131060833|NCT03840200|471856734|FG000|Overall Study|Death|6|||
131060834|NCT03840200|471856735|FG001|Overall Study|Death|3|||
131060835|NCT03840200|471856736|FG002|Overall Study|Death|6|||
131060836|NCT03840200|471856737|FG003|Overall Study|Death|10|||
131060837|NCT03840200|471856734|FG000|Overall Study|Reason Not Specified|2|||
131060838|NCT03840200|471856735|FG001|Overall Study|Reason Not Specified|2|||
131060839|NCT03840200|471856736|FG002|Overall Study|Reason Not Specified|1|||
131060840|NCT03840200|471856737|FG003|Overall Study|Reason Not Specified|15|||
131060841|NCT03840200|471856734|FG000|Overall Study|Physician Decision|0|||
131060842|NCT03840200|471856735|FG001|Overall Study|Physician Decision|0|||
131060843|NCT03840200|471856736|FG002|Overall Study|Physician Decision|0|||
131060844|NCT03840200|471856737|FG003|Overall Study|Physician Decision|2|||
131060845|NCT03840200|471856734|FG000|Overall Study|Progressive Disease|0|||
131060846|NCT03840200|471856735|FG001|Overall Study|Progressive Disease|0|||
131060847|NCT03840200|471856736|FG002|Overall Study|Progressive Disease|0|||
131060848|NCT03840200|471856737|FG003|Overall Study|Progressive Disease|1|||
131060849|NCT03840200|471856734|FG000|Overall Study|Withdrawal by Subject|0|||
131060850|NCT03840200|471856735|FG001|Overall Study|Withdrawal by Subject|1|||
131060851|NCT03840200|471856736|FG002|Overall Study|Withdrawal by Subject|0|||
131060852|NCT03840200|471856737|FG003|Overall Study|Withdrawal by Subject|2|||
131060853|NCT05522777|471856738|FG000|Overall Study|Lack of Efficacy|1|||
131060854|NCT05522777|471856738|FG000|Overall Study|Withdrawal by Subject|1|||
131060855|NCT05487300|471856741|FG000|Overall Study|Withdrawal by Subject|1|||
131060856|NCT05487300|471856742|FG001|Overall Study|Withdrawal by Subject|0|||
131060857|NCT05006703|471856743|FG000|Overall Study|Withdrawal by Subject|1|||
131060858|NCT05006703|471856744|FG001|Overall Study|Withdrawal by Subject|0|||
131060859|NCT05006703|471856743|FG000|Overall Study|Lost to Follow-up|13|||
131060860|NCT05006703|471856744|FG001|Overall Study|Lost to Follow-up|5|||
131060861|NCT04620733|471856745|FG000|Overall Study|Adverse Event|4|||
131060862|NCT04620733|471856746|FG001|Overall Study|Adverse Event|3|||
131060863|NCT04620733|471856745|FG000|Overall Study|Withdrawal by Subject|2|||
131060864|NCT04620733|471856746|FG001|Overall Study|Withdrawal by Subject|5|||
131060865|NCT04620733|471856745|FG000|Overall Study|Lost to Follow-up|1|||
131060866|NCT04620733|471856746|FG001|Overall Study|Lost to Follow-up|1|||
131060867|NCT04620733|471856745|FG000|Overall Study|Protocol Deviation|1|||
131060868|NCT04620733|471856746|FG001|Overall Study|Protocol Deviation|1|||
131060869|NCT04620733|471856745|FG000|Overall Study|Reason Not Specified|0|||
131060870|NCT04620733|471856746|FG001|Overall Study|Reason Not Specified|1|||
131060871|NCT02507297|471856751|FG000|Overall Study|Withdrawal by Subject|1|||
131060872|NCT02507297|471856752|FG001|Overall Study|Withdrawal by Subject|0|||
131060873|NCT02507297|471856751|FG000|Overall Study|Lost to Follow-up|0|||
131060874|NCT02507297|471856752|FG001|Overall Study|Lost to Follow-up|1|||
131060875|NCT01018992|471856753|FG000|Overall Study|Adverse Event|8|||
131060876|NCT01018992|471856754|FG001|Overall Study|Adverse Event|3|||
131060877|NCT01018992|471856753|FG000|Overall Study|Withdrawal by Subject|3|||
131060878|NCT01018992|471856754|FG001|Overall Study|Withdrawal by Subject|8|||
131060879|NCT01018992|471856753|FG000|Overall Study|Protocol Violation|0|||
131060880|NCT01018992|471856754|FG001|Overall Study|Protocol Violation|4|||
130722822|NCT02011386|470609745|FG000|Overall Study|Lack of Efficacy|3|||
131060881|NCT01018992|471856753|FG000|Overall Study|Lost to Follow-up|5|||
131060882|NCT01018992|471856754|FG001|Overall Study|Lost to Follow-up|1|||
131060883|NCT03029585|471856755|FG000|Overall Study|Death|1|||
131060884|NCT03029585|471856756|FG001|Overall Study|Death|1|||
131060885|NCT03029585|471856755|FG000|Overall Study|Withdrawal by Subject|1|||
131060886|NCT03029585|471856756|FG001|Overall Study|Withdrawal by Subject|0|||
131060887|NCT02092285|471856757|FG000|Induction Phase|Adverse Event|7|||
131060888|NCT02092285|471856757|FG000|Induction Phase|Physician Decision|4|||
131060889|NCT02092285|471856757|FG000|Induction Phase|Pregnancy|1|||
131060890|NCT02092285|471856757|FG000|Induction Phase|Relapse/Recurrence|7|||
131060891|NCT02092285|471856757|FG000|Induction Phase|Withdrawal by Subject|2|||
131060892|NCT02092285|471856757|FG000|Induction Phase|Lack of Efficacy|14|||
131060893|NCT02092285|471856757|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
131060894|NCT02092285|471856757|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
131060895|NCT02092285|471856757|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
131060896|NCT02092285|471856757|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
131060897|NCT02092285|471856757|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
131060898|NCT02092285|471856757|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
131060899|NCT02092285|471856757|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
131060900|NCT02092285|471856757|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
131060901|NCT02092285|471856757|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
131060902|NCT01825785|471856758|FG000|Overall Study|Adverse Event|0|||
131060903|NCT01825785|471856759|FG001|Overall Study|Adverse Event|0|||
131060904|NCT01825785|471856760|FG002|Overall Study|Adverse Event|0|||
131060905|NCT01825785|471856761|FG003|Overall Study|Adverse Event|0|||
131060906|NCT01825785|471856762|FG004|Overall Study|Adverse Event|1|||
131060907|NCT01825785|471856763|FG005|Overall Study|Adverse Event|0|||
131060908|NCT01825785|471856764|FG006|Overall Study|Adverse Event|0|||
131060909|NCT01825785|471856758|FG000|Overall Study|Withdrawal by Subject|0|||
131060910|NCT01825785|471856759|FG001|Overall Study|Withdrawal by Subject|0|||
131060911|NCT01825785|471856760|FG002|Overall Study|Withdrawal by Subject|0|||
131060912|NCT01825785|471856761|FG003|Overall Study|Withdrawal by Subject|0|||
131060913|NCT01825785|471856762|FG004|Overall Study|Withdrawal by Subject|1|||
131060914|NCT01825785|471856763|FG005|Overall Study|Withdrawal by Subject|1|||
131060915|NCT01825785|471856764|FG006|Overall Study|Withdrawal by Subject|0|||
131060916|NCT01304940|471856766|FG000|Overall Study|not meet symptom severity requirement|3|||
131060917|NCT01304940|471856767|FG001|Overall Study|not meet symptom severity requirement|0|||
131060918|NCT00278395|471856770|FG000|Overall Study|Adverse Event|2|||
131060919|NCT00278395|471856770|FG000|Overall Study|Nonevaluable|1|||
131060920|NCT01655498|471856778|FG000|Overall Study|Unrelated health issue|2|||
131060921|NCT01655498|471856778|FG000|Overall Study|Protocol Violation|2|||
131060922|NCT01655498|471856778|FG000|Overall Study|Withdrawal by Subject|1|||
131060923|NCT02784834|471856779|FG000|Overall Study|Lack of Efficacy|1|||
131060924|NCT01090739|471856780|FG000|Enrollment|Withdrawal by Subject|24|||
131060925|NCT01090739|471856780|FG000|Enrollment|Protocol Violation|14|||
131060926|NCT01090739|471856780|FG000|Enrollment|Lost to Follow-up|5|||
131060927|NCT01090739|471856780|FG000|Enrollment|Physician Decision|5|||
131060928|NCT01090739|471856780|FG000|Enrollment|Sponsor termination of site|4|||
131060929|NCT01090739|471856780|FG000|Enrollment|Study implant limit reached|2|||
131060930|NCT01090739|471856780|FG000|Enrollment|Adverse Event|1|||
131060931|NCT01090739|471856780|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
131060932|NCT01090739|471856780|FG000|12 Month Follow-up|Lost to Follow-up|1|||
131060933|NCT01090739|471856780|FG000|12 Month Follow-up|Physician Decision|1|||
131060934|NCT01090739|471856780|FG000|12 Month Follow-up|Death|1|||
131060935|NCT01090739|471856780|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
131060936|NCT01090739|471856780|FG000|24 Month Follow-up|Lost to Follow-up|1|||
131060937|NCT01090739|471856780|FG000|24 Month Follow-up|Death|1|||
131060938|NCT01090739|471856780|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
131060939|NCT01090739|471856780|FG000|36 Month Follow-up|Visit still pending|17|||
131060940|NCT03693989|471856782|FG000|Overall Study|Protocol Violation|3|||
131137099|NCT05574062|472128271|FG004|Pre Run-In|Screening failure|0|||
131137100|NCT05574062|472128267|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
131060941|NCT03693989|471856783|FG001|Overall Study|Protocol Violation|4|||
131060942|NCT00113529|471856786|FG000|Overall Study|Adverse Event|4|||
131060943|NCT00113529|471856786|FG000|Overall Study|Lack of Efficacy|20|||
131060944|NCT00113529|471856786|FG000|Overall Study|Decision of sponsor|6|||
131060945|NCT00113529|471856786|FG000|Overall Study|Withdrawal by Subject|4|||
131060946|NCT01535261|471856787|FG000|Overall Study|Physician Decision|8|||
131060947|NCT01535261|471856787|FG000|Overall Study|Protocol Violation|3|||
131060948|NCT01535261|471856787|FG000|Overall Study|Death|5|||
131060949|NCT01535261|471856787|FG000|Overall Study|Lost to Follow-up|8|||
131060950|NCT01535261|471856787|FG000|Overall Study|Withdrawal by Subject|14|||
131060951|NCT01535261|471856787|FG000|Overall Study|Adverse Event|12|||
131060952|NCT01757288|471856790|FG000|Overall Study|Consent withdrawal|0|||
131137101|NCT05574062|472128268|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
131137102|NCT05574062|472128269|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
131060953|NCT01757288|471856791|FG001|Overall Study|Consent withdrawal|4|||
131060954|NCT01757288|471856792|FG002|Overall Study|Consent withdrawal|4|||
131060955|NCT01757288|471856790|FG000|Overall Study|Patient off study, IRB hold.|0|||
131060956|NCT01757288|471856791|FG001|Overall Study|Patient off study, IRB hold.|0|||
131060957|NCT01757288|471856792|FG002|Overall Study|Patient off study, IRB hold.|1|||
131060958|NCT01757288|471856790|FG000|Overall Study|Patient death prior to starting treatment|0|||
131060959|NCT01757288|471856791|FG001|Overall Study|Patient death prior to starting treatment|0|||
131060960|NCT01757288|471856792|FG002|Overall Study|Patient death prior to starting treatment|1|||
131060961|NCT01757288|471856790|FG000|Overall Study|Wrong medication administered|0|||
131060962|NCT01757288|471856791|FG001|Overall Study|Wrong medication administered|1|||
131060963|NCT01757288|471856792|FG002|Overall Study|Wrong medication administered|0|||
131060964|NCT01757288|471856790|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
131060965|NCT01757288|471856791|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
131060966|NCT01757288|471856792|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
131060967|NCT01757288|471856790|FG000|Overall Study|Not meeting protocol constraints|0|||
131060968|NCT01757288|471856791|FG001|Overall Study|Not meeting protocol constraints|1|||
131060969|NCT01757288|471856792|FG002|Overall Study|Not meeting protocol constraints|1|||
131060970|NCT01757288|471856790|FG000|Overall Study|Multiple missed appointments|0|||
131060971|NCT01757288|471856791|FG001|Overall Study|Multiple missed appointments|1|||
131060972|NCT01757288|471856792|FG002|Overall Study|Multiple missed appointments|0|||
131060973|NCT01757288|471856790|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
131060974|NCT01757288|471856791|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
131060975|NCT01757288|471856792|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
131060976|NCT01757288|471856790|FG000|Overall Study|>2 weeks treatment break|0|||
131060977|NCT01757288|471856791|FG001|Overall Study|>2 weeks treatment break|0|||
131060978|NCT01757288|471856792|FG002|Overall Study|>2 weeks treatment break|1|||
131060979|NCT00042939|471856796|FG000|Overall Study|Adverse Event|6|||
131060980|NCT00042939|471856797|FG001|Overall Study|Adverse Event|7|||
131060981|NCT00042939|471856796|FG000|Overall Study|Death|3|||
131060982|NCT00042939|471856797|FG001|Overall Study|Death|2|||
131060983|NCT00042939|471856796|FG000|Overall Study|Withdrawal by Subject|3|||
131060984|NCT00042939|471856797|FG001|Overall Study|Withdrawal by Subject|4|||
131060985|NCT00042939|471856796|FG000|Overall Study|Other disease|1|||
131060986|NCT00042939|471856797|FG001|Overall Study|Other disease|0|||
131060987|NCT00042939|471856796|FG000|Overall Study|Ineligible|2|||
131060988|NCT00042939|471856797|FG001|Overall Study|Ineligible|2|||
131060989|NCT00042939|471856796|FG000|Overall Study|Deterioration of health|3|||
131060990|NCT00042939|471856797|FG001|Overall Study|Deterioration of health|4|||
131060991|NCT00042939|471856796|FG000|Overall Study|QOL diminished|1|||
131060992|NCT00042939|471856797|FG001|Overall Study|QOL diminished|0|||
131060993|NCT00042939|471856796|FG000|Overall Study|Rising ca 19-9|1|||
131060994|NCT00042939|471856797|FG001|Overall Study|Rising ca 19-9|0|||
131060995|NCT00042939|471856796|FG000|Overall Study|Patient non-compliance|1|||
131060996|NCT00042939|471856797|FG001|Overall Study|Patient non-compliance|0|||
131060997|NCT00042939|471856796|FG000|Overall Study|Still on treatment|1|||
131060998|NCT00042939|471856797|FG001|Overall Study|Still on treatment|0|||
131060999|NCT00042939|471856796|FG000|Overall Study|Treatment break > 4 weeks|0|||
131061000|NCT00042939|471856797|FG001|Overall Study|Treatment break > 4 weeks|1|||
131061001|NCT00042939|471856796|FG000|Overall Study|Did not start treatment|2|||
131061002|NCT00042939|471856797|FG001|Overall Study|Did not start treatment|1|||
131061003|NCT03349476|471856798|FG000|Overall Study|Physician Decision|3|||
131061004|NCT02525744|471856799|FG000|Period 1|Physician Decision|0|||
131061005|NCT02525744|471856800|FG001|Period 1|Physician Decision|0|||
131061006|NCT02525744|471856801|FG002|Period 1|Physician Decision|1|||
131061007|NCT02525744|471856802|FG003|Period 1|Physician Decision|0|||
131061008|NCT02525744|471856799|FG000|Period 3|Adverse Event|0|||
131061009|NCT02525744|471856800|FG001|Period 3|Adverse Event|1|||
131061010|NCT02525744|471856801|FG002|Period 3|Adverse Event|0|||
131061011|NCT02525744|471856802|FG003|Period 3|Adverse Event|0|||
131061012|NCT02525744|471856799|FG000|Period 4|Withdrawal by Subject|1|||
131061013|NCT02525744|471856800|FG001|Period 4|Withdrawal by Subject|0|||
131061014|NCT02525744|471856801|FG002|Period 4|Withdrawal by Subject|0|||
131061015|NCT02525744|471856802|FG003|Period 4|Withdrawal by Subject|0|||
131061016|NCT02525744|471856799|FG000|Period 5|Physician Decision|1|||
131061017|NCT02525744|471856800|FG001|Period 5|Physician Decision|0|||
131229953|NCT03264066|472467737|FG001|Overall Study|Lost to Follow-up|0|||
131061018|NCT02525744|471856801|FG002|Period 5|Physician Decision|0|||
131061019|NCT02525744|471856802|FG003|Period 5|Physician Decision|0|||
131061020|NCT00879710|471856805|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
131061021|NCT00879710|471856806|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
131061022|NCT00879710|471856807|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
131061023|NCT00879710|471856808|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
131061024|NCT00879710|471856805|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
131061025|NCT00879710|471856806|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
131061026|NCT00879710|471856807|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
131061027|NCT00879710|471856808|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
131061028|NCT01777932|471856809|FG000|Overall Study|Disease progression|136|||
131061029|NCT01777932|471856809|FG000|Overall Study|Death|3|||
131061030|NCT01777932|471856809|FG000|Overall Study|Adverse Event|34|||
131061031|NCT01777932|471856809|FG000|Overall Study|Lost to Follow-up|3|||
131061032|NCT01777932|471856809|FG000|Overall Study|Investigator decision|10|||
131061033|NCT01777932|471856809|FG000|Overall Study|Reimbursement limit|9|||
131061034|NCT01777932|471856809|FG000|Overall Study|Patient refused further treatment|10|||
131061035|NCT02514824|471856813|FG000|Overall Study|Withdrawal by Subject|1|||
131061036|NCT02514824|471856814|FG001|Overall Study|Withdrawal by Subject|0|||
131061037|NCT02514824|471856815|FG002|Overall Study|Withdrawal by Subject|0|||
131061038|NCT02514824|471856816|FG003|Overall Study|Withdrawal by Subject|0|||
131061039|NCT02514824|471856813|FG000|Overall Study|Dose-Limiting Toxicity|0|||
131061040|NCT02514824|471856814|FG001|Overall Study|Dose-Limiting Toxicity|1|||
131061041|NCT02514824|471856815|FG002|Overall Study|Dose-Limiting Toxicity|0|||
131061042|NCT02514824|471856816|FG003|Overall Study|Dose-Limiting Toxicity|0|||
131061043|NCT01930188|471856817|FG000|Overall Study|unclassified|4|||
131061044|NCT01930188|471856818|FG001|Overall Study|unclassified|5|||
131061045|NCT01930188|471856819|FG002|Overall Study|unclassified|3|||
131061046|NCT01930188|471856817|FG000|Overall Study|Missing follow-up information|2|||
131061047|NCT01930188|471856818|FG001|Overall Study|Missing follow-up information|2|||
131061048|NCT01930188|471856819|FG002|Overall Study|Missing follow-up information|3|||
131061049|NCT01930188|471856817|FG000|Overall Study|Lost to Follow-up|5|||
131061050|NCT01930188|471856818|FG001|Overall Study|Lost to Follow-up|2|||
131061051|NCT01930188|471856819|FG002|Overall Study|Lost to Follow-up|2|||
131061052|NCT01930188|471856817|FG000|Overall Study|Death|2|||
131061053|NCT01930188|471856818|FG001|Overall Study|Death|1|||
131061054|NCT01930188|471856819|FG002|Overall Study|Death|3|||
131061055|NCT01930188|471856817|FG000|Overall Study|Withdrawal by Subject|9|||
131061056|NCT01930188|471856818|FG001|Overall Study|Withdrawal by Subject|11|||
131061057|NCT01930188|471856819|FG002|Overall Study|Withdrawal by Subject|8|||
131061058|NCT04085614|471856820|FG000|Overall Study|Protocol Violation|9|||
131061059|NCT04085614|471856821|FG001|Overall Study|Protocol Violation|6|||
131061060|NCT02516202|471856822|FG000|Overall Study|Withdrawal by Subject|1|||
131061061|NCT02516202|471856823|FG001|Overall Study|Withdrawal by Subject|0|||
131061062|NCT02516202|471856824|FG002|Overall Study|Withdrawal by Subject|1|||
131061063|NCT02516202|471856822|FG000|Overall Study|Lost to Follow-up|1|||
131061064|NCT02516202|471856823|FG001|Overall Study|Lost to Follow-up|1|||
131061065|NCT02516202|471856824|FG002|Overall Study|Lost to Follow-up|1|||
131061066|NCT02516202|471856822|FG000|Overall Study|Stopped Follow-up|0|||
131061067|NCT02516202|471856823|FG001|Overall Study|Stopped Follow-up|0|||
131061068|NCT02516202|471856824|FG002|Overall Study|Stopped Follow-up|1|||
131061069|NCT00696241|471856825|FG000|Overall Study|Adverse Event|11|||
131061070|NCT00696241|471856826|FG001|Overall Study|Adverse Event|3|||
131061071|NCT00696241|471856827|FG002|Overall Study|Adverse Event|6|||
131061072|NCT00696241|471856828|FG003|Overall Study|Adverse Event|4|||
131061073|NCT00696241|471856829|FG004|Overall Study|Adverse Event|5|||
131061074|NCT00696241|471856825|FG000|Overall Study|Protocol Violation|1|||
131061075|NCT00696241|471856826|FG001|Overall Study|Protocol Violation|1|||
131061076|NCT00696241|471856827|FG002|Overall Study|Protocol Violation|2|||
131061077|NCT00696241|471856828|FG003|Overall Study|Protocol Violation|0|||
131061078|NCT00696241|471856829|FG004|Overall Study|Protocol Violation|3|||
131061079|NCT00696241|471856825|FG000|Overall Study|Lost to Follow-up|1|||
131061080|NCT00696241|471856826|FG001|Overall Study|Lost to Follow-up|4|||
131061081|NCT00696241|471856827|FG002|Overall Study|Lost to Follow-up|1|||
131061082|NCT00696241|471856828|FG003|Overall Study|Lost to Follow-up|2|||
131061083|NCT00696241|471856829|FG004|Overall Study|Lost to Follow-up|0|||
131061084|NCT00696241|471856825|FG000|Overall Study|Withdrawal by Subject|4|||
131061085|NCT00696241|471856826|FG001|Overall Study|Withdrawal by Subject|8|||
131061086|NCT00696241|471856827|FG002|Overall Study|Withdrawal by Subject|6|||
131061087|NCT00696241|471856828|FG003|Overall Study|Withdrawal by Subject|1|||
131061088|NCT00696241|471856829|FG004|Overall Study|Withdrawal by Subject|0|||
131137103|NCT05574062|472128270|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
131137104|NCT05574062|472128271|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
131137105|NCT05574062|472128267|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
130822728|NCT00887159|470980584|FG001|Overall Study|Received more tx instead of observation|0|||
131061089|NCT00696241|471856825|FG000|Overall Study|Lack of Efficacy|1|||
131061090|NCT00696241|471856826|FG001|Overall Study|Lack of Efficacy|5|||
131061091|NCT00696241|471856827|FG002|Overall Study|Lack of Efficacy|4|||
131061092|NCT00696241|471856828|FG003|Overall Study|Lack of Efficacy|5|||
131061093|NCT00696241|471856829|FG004|Overall Study|Lack of Efficacy|3|||
131061094|NCT00696241|471856825|FG000|Overall Study|Other|6|||
131061095|NCT00696241|471856826|FG001|Overall Study|Other|1|||
131061096|NCT00696241|471856827|FG002|Overall Study|Other|5|||
131061097|NCT00696241|471856828|FG003|Overall Study|Other|2|||
131137106|NCT05574062|472128268|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
131061098|NCT00696241|471856829|FG004|Overall Study|Other|1|||
131061099|NCT02203513|471856830|FG000|Overall Study|Refused further treatment|2|||
131061100|NCT02203513|471856831|FG001|Overall Study|Refused further treatment|0|||
131061101|NCT02203513|471856832|FG002|Overall Study|Refused further treatment|1|||
131137107|NCT05574062|472128269|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
131137108|NCT05574062|472128270|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
131137109|NCT05574062|472128271|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
131137110|NCT05574062|472128267|FG000|Continuation Phase Period 1|Physician Decision|1|||
131137111|NCT05574062|472128268|FG001|Continuation Phase Period 1|Physician Decision|0|||
131137112|NCT05574062|472128269|FG002|Continuation Phase Period 1|Physician Decision|0|||
131137113|NCT05574062|472128270|FG003|Continuation Phase Period 1|Physician Decision|0|||
131137114|NCT05574062|472128271|FG004|Continuation Phase Period 1|Physician Decision|0|||
131137115|NCT05574062|472128267|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
131137116|NCT05574062|472128268|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
131137117|NCT05574062|472128269|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
131137118|NCT05574062|472128270|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
131137119|NCT05574062|472128271|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
131137120|NCT05574062|472128267|FG000|Continuation Phase Period 1|Adverse Event|1|||
131137121|NCT05574062|472128268|FG001|Continuation Phase Period 1|Adverse Event|0|||
131137122|NCT05574062|472128269|FG002|Continuation Phase Period 1|Adverse Event|0|||
131137123|NCT05574062|472128270|FG003|Continuation Phase Period 1|Adverse Event|0|||
131137124|NCT05574062|472128271|FG004|Continuation Phase Period 1|Adverse Event|0|||
131137125|NCT05574062|472128267|FG000|Continuation Phase Period 1|Death|1|||
131137126|NCT05574062|472128268|FG001|Continuation Phase Period 1|Death|0|||
131137127|NCT05574062|472128269|FG002|Continuation Phase Period 1|Death|0|||
131137128|NCT05574062|472128270|FG003|Continuation Phase Period 1|Death|0|||
131137129|NCT05574062|472128271|FG004|Continuation Phase Period 1|Death|0|||
131137130|NCT05574062|472128267|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
131137131|NCT05574062|472128268|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
131137132|NCT05574062|472128269|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
131137133|NCT05574062|472128270|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
131137134|NCT05574062|472128271|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
131137135|NCT01777581|472128272|FG000|Overall Study|Lost to Follow-up|1|||
131137136|NCT01777581|472128273|FG001|Overall Study|Lost to Follow-up|1|||
131137137|NCT01777581|472128272|FG000|Overall Study|Adverse Event|2|||
131137138|NCT01777581|472128273|FG001|Overall Study|Adverse Event|0|||
131137139|NCT01777581|472128272|FG000|Overall Study|Lack of Efficacy|0|||
131137140|NCT01777581|472128273|FG001|Overall Study|Lack of Efficacy|1|||
131137141|NCT04202679|472128282|FG000|Overall Study|Adverse Event|2|||
131137142|NCT04202679|472128283|FG001|Overall Study|Adverse Event|0|||
131137143|NCT04202679|472128282|FG000|Overall Study|Poor compliance to protocol|1|||
131061102|NCT02203513|471856833|FG003|Overall Study|Refused further treatment|0|||
131061103|NCT02203513|471856834|FG004|Overall Study|Refused further treatment|0|||
131061104|NCT02203513|471856830|FG000|Overall Study|Switched to alternative treatment|3|||
131061105|NCT02203513|471856831|FG001|Overall Study|Switched to alternative treatment|4|||
131061106|NCT02203513|471856832|FG002|Overall Study|Switched to alternative treatment|0|||
131061107|NCT02203513|471856833|FG003|Overall Study|Switched to alternative treatment|0|||
131061108|NCT02203513|471856834|FG004|Overall Study|Switched to alternative treatment|4|||
131061109|NCT02203513|471856830|FG000|Overall Study|Did not receive investigational product (IP)|0|||
131061110|NCT02203513|471856831|FG001|Overall Study|Did not receive investigational product (IP)|1|||
131061111|NCT02203513|471856832|FG002|Overall Study|Did not receive investigational product (IP)|0|||
131061112|NCT02203513|471856833|FG003|Overall Study|Did not receive investigational product (IP)|0|||
131061113|NCT02203513|471856834|FG004|Overall Study|Did not receive investigational product (IP)|0|||
131061114|NCT02203513|471856830|FG000|Overall Study|Death (unrelated to study therapy)|1|||
131061115|NCT02203513|471856831|FG001|Overall Study|Death (unrelated to study therapy)|3|||
131061116|NCT02203513|471856832|FG002|Overall Study|Death (unrelated to study therapy)|1|||
131061117|NCT02203513|471856833|FG003|Overall Study|Death (unrelated to study therapy)|0|||
131061118|NCT02203513|471856834|FG004|Overall Study|Death (unrelated to study therapy)|2|||
131061119|NCT02203513|471856830|FG000|Overall Study|Lost to Follow-up|0|||
131061120|NCT02203513|471856831|FG001|Overall Study|Lost to Follow-up|0|||
131061121|NCT02203513|471856832|FG002|Overall Study|Lost to Follow-up|1|||
131061122|NCT02203513|471856833|FG003|Overall Study|Lost to Follow-up|1|||
131061123|NCT02203513|471856834|FG004|Overall Study|Lost to Follow-up|0|||
131061124|NCT02513667|471856835|FG000|Overall Study|Withdrawal by Subject|0|||
131061125|NCT02513667|471856836|FG001|Overall Study|Withdrawal by Subject|1|||
131061126|NCT03347396|471856843|FG000|Part A (26 Weeks)|Adverse Event|1|||
131061127|NCT03347396|471856844|FG001|Part A (26 Weeks)|Adverse Event|0|||
131061128|NCT03347396|471856843|FG000|Part A (26 Weeks)|Death|0|||
131061129|NCT03347396|471856844|FG001|Part A (26 Weeks)|Death|1|||
131137144|NCT04202679|472128283|FG001|Overall Study|Poor compliance to protocol|0|||
131137145|NCT04202679|472128282|FG000|Overall Study|Withdrawal by Subject|23|||
131137146|NCT04202679|472128283|FG001|Overall Study|Withdrawal by Subject|6|||
131061130|NCT03347396|471856843|FG000|Part B (149 Weeks)|Adverse Event|1|||
131061131|NCT03347396|471856844|FG001|Part B (149 Weeks)|Adverse Event|1|||
131061132|NCT03347396|471856843|FG000|Part B (149 Weeks)|Death|1|||
131061133|NCT03347396|471856844|FG001|Part B (149 Weeks)|Death|0|||
131061134|NCT03060525|471856846|FG000|Overall Study|moved out of state|1|||
131061135|NCT03060525|471856847|FG001|Overall Study|moved out of state|1|||
131061136|NCT03060525|471856848|FG002|Overall Study|moved out of state|1|||
131061137|NCT03060525|471856849|FG003|Overall Study|moved out of state|1|||
131061138|NCT03060525|471856846|FG000|Overall Study|unable to meet time commitment required of study|2|||
131061139|NCT03060525|471856847|FG001|Overall Study|unable to meet time commitment required of study|3|||
131061140|NCT03060525|471856848|FG002|Overall Study|unable to meet time commitment required of study|3|||
130722823|NCT01197755|470609746|FG000|Overall Study|Adverse Event|8|||
130722824|NCT01197755|470609747|FG001|Overall Study|Adverse Event|10|||
130722825|NCT01197755|470609748|FG002|Overall Study|Adverse Event|10|||
131061141|NCT03060525|471856849|FG003|Overall Study|unable to meet time commitment required of study|1|||
131061142|NCT03060525|471856846|FG000|Overall Study|no longer interested in doing intervention|0|||
131061143|NCT03060525|471856847|FG001|Overall Study|no longer interested in doing intervention|0|||
131061144|NCT03060525|471856848|FG002|Overall Study|no longer interested in doing intervention|0|||
131061145|NCT03060525|471856849|FG003|Overall Study|no longer interested in doing intervention|1|||
131061146|NCT00912964|471856850|FG000|Overall Study|Eligibility criterion not met|1|||
131061147|NCT00912964|471856851|FG001|Overall Study|Eligibility criterion not met|1|||
131061148|NCT00912964|471856852|FG002|Overall Study|Eligibility criterion not met|0|||
131061149|NCT00912964|471856850|FG000|Overall Study|Adverse Event|15|||
131061150|NCT00912964|471856851|FG001|Overall Study|Adverse Event|18|||
131061151|NCT00912964|471856852|FG002|Overall Study|Adverse Event|12|||
131061152|NCT00912964|471856850|FG000|Overall Study|Lack of Efficacy|11|||
131229954|NCT03264066|472467738|FG002|Overall Study|Lost to Follow-up|0|||
131229955|NCT03264066|472467739|FG003|Overall Study|Lost to Follow-up|0|||
131229956|NCT03264066|472467740|FG004|Overall Study|Lost to Follow-up|0|||
131229957|NCT03264066|472467741|FG005|Overall Study|Lost to Follow-up|0|||
131229958|NCT03264066|472467736|FG000|Overall Study|Progressive Disease|0|||
131229959|NCT03264066|472467737|FG001|Overall Study|Progressive Disease|2|||
131229960|NCT03264066|472467738|FG002|Overall Study|Progressive Disease|1|||
131229961|NCT03264066|472467739|FG003|Overall Study|Progressive Disease|0|||
131229962|NCT03264066|472467740|FG004|Overall Study|Progressive Disease|0|||
131229963|NCT03264066|472467741|FG005|Overall Study|Progressive Disease|0|||
131229964|NCT03264066|472467736|FG000|Overall Study|Study Terminated by Sponsor|5|||
131229965|NCT03264066|472467737|FG001|Overall Study|Study Terminated by Sponsor|5|||
131229966|NCT03264066|472467738|FG002|Overall Study|Study Terminated by Sponsor|8|||
131229967|NCT03264066|472467739|FG003|Overall Study|Study Terminated by Sponsor|5|||
131229968|NCT03264066|472467740|FG004|Overall Study|Study Terminated by Sponsor|1|||
131229969|NCT03264066|472467741|FG005|Overall Study|Study Terminated by Sponsor|2|||
131229970|NCT03264066|472467736|FG000|Overall Study|Withdrawal by Subject|1|||
131229971|NCT03264066|472467737|FG001|Overall Study|Withdrawal by Subject|0|||
131229972|NCT03264066|472467738|FG002|Overall Study|Withdrawal by Subject|0|||
131229973|NCT03264066|472467739|FG003|Overall Study|Withdrawal by Subject|5|||
131229974|NCT03264066|472467740|FG004|Overall Study|Withdrawal by Subject|0|||
131229975|NCT03264066|472467741|FG005|Overall Study|Withdrawal by Subject|0|||
131229976|NCT01484028|472467742|FG000|Period 1|Lost to Follow-up|0|||
131229977|NCT01484028|472467743|FG001|Period 1|Lost to Follow-up|1|||
131229978|NCT01484028|472467744|FG002|Period 1|Lost to Follow-up|0|||
131229979|NCT01484028|472467745|FG003|Period 1|Lost to Follow-up|0|||
131229980|NCT01484028|472467742|FG000|Period 1|Non-Compliance to Protocol|0|||
131061153|NCT00912964|471856851|FG001|Overall Study|Lack of Efficacy|4|||
131061154|NCT00912964|471856852|FG002|Overall Study|Lack of Efficacy|3|||
131061155|NCT00912964|471856850|FG000|Overall Study|Withdrawal by Subject|20|||
131061156|NCT00912964|471856851|FG001|Overall Study|Withdrawal by Subject|12|||
131061157|NCT00912964|471856852|FG002|Overall Study|Withdrawal by Subject|18|||
131061158|NCT00912964|471856850|FG000|Overall Study|Lost to Follow-up|4|||
131061159|NCT00912964|471856851|FG001|Overall Study|Lost to Follow-up|3|||
131061160|NCT00912964|471856852|FG002|Overall Study|Lost to Follow-up|3|||
131061161|NCT00912964|471856850|FG000|Overall Study|Protocol Violation|5|||
131061162|NCT00912964|471856851|FG001|Overall Study|Protocol Violation|3|||
131061163|NCT00912964|471856852|FG002|Overall Study|Protocol Violation|8|||
131061164|NCT00912964|471856850|FG000|Overall Study|Taking exclusionary medications|7|||
131061165|NCT00912964|471856851|FG001|Overall Study|Taking exclusionary medications|4|||
131061166|NCT00912964|471856852|FG002|Overall Study|Taking exclusionary medications|8|||
131061167|NCT00912964|471856850|FG000|Overall Study|Medical History|1|||
131229981|NCT01484028|472467743|FG001|Period 1|Non-Compliance to Protocol|1|||
131229982|NCT01484028|472467744|FG002|Period 1|Non-Compliance to Protocol|0|||
131229983|NCT01484028|472467745|FG003|Period 1|Non-Compliance to Protocol|1|||
130722826|NCT01197755|470609746|FG000|Overall Study|Study-specific discontinuation criteria|2|||
131061168|NCT00912964|471856851|FG001|Overall Study|Medical History|0|||
131061169|NCT00912964|471856852|FG002|Overall Study|Medical History|0|||
131061170|NCT00912964|471856850|FG000|Overall Study|Non-compliance with study procedures|2|||
131061171|NCT00912964|471856851|FG001|Overall Study|Non-compliance with study procedures|0|||
131229984|NCT01484028|472467742|FG000|Period 1|Lens Discomfort|0|||
131229985|NCT01484028|472467743|FG001|Period 1|Lens Discomfort|1|||
131229986|NCT01484028|472467744|FG002|Period 1|Lens Discomfort|0|||
131229987|NCT01484028|472467745|FG003|Period 1|Lens Discomfort|0|||
131061172|NCT00912964|471856852|FG002|Overall Study|Non-compliance with study procedures|0|||
131061173|NCT00912964|471856850|FG000|Overall Study|Violation of exclusion criterion|0|||
131061174|NCT00912964|471856851|FG001|Overall Study|Violation of exclusion criterion|0|||
131061175|NCT00912964|471856852|FG002|Overall Study|Violation of exclusion criterion|2|||
131061176|NCT00912964|471856850|FG000|Overall Study|Randomized but never received study drug|0|||
131061177|NCT00912964|471856851|FG001|Overall Study|Randomized but never received study drug|1|||
131061178|NCT00912964|471856852|FG002|Overall Study|Randomized but never received study drug|0|||
131061179|NCT00090519|471856853|FG000|Overall Study|Adverse Event|5|||
131061180|NCT00090519|471856854|FG001|Overall Study|Adverse Event|4|||
131061181|NCT00090519|471856853|FG000|Overall Study|Death|9|||
131061182|NCT00090519|471856854|FG001|Overall Study|Death|9|||
131061183|NCT00090519|471856853|FG000|Overall Study|Lost to Follow-up|26|||
131061184|NCT00090519|471856854|FG001|Overall Study|Lost to Follow-up|29|||
131061185|NCT00090519|471856853|FG000|Overall Study|Withdrawal by Subject|28|||
131061186|NCT00090519|471856854|FG001|Overall Study|Withdrawal by Subject|29|||
131061187|NCT00090519|471856853|FG000|Overall Study|Physician Decision|2|||
131061188|NCT00090519|471856854|FG001|Overall Study|Physician Decision|3|||
131061189|NCT00090519|471856853|FG000|Overall Study|Sponsor Decision|3|||
131061190|NCT00090519|471856854|FG001|Overall Study|Sponsor Decision|1|||
131061191|NCT02161146|471856857|FG000|Overall Study|Adverse Event|1|||
131061192|NCT02161146|471856858|FG001|Overall Study|Adverse Event|1|||
131061193|NCT02161146|471856859|FG002|Overall Study|Adverse Event|0|||
131061194|NCT02161146|471856860|FG003|Overall Study|Adverse Event|1|||
131061195|NCT02161146|471856861|FG004|Overall Study|Adverse Event|0|||
131061196|NCT02161146|471856857|FG000|Overall Study|Lost to Follow-up|0|||
131061197|NCT02161146|471856858|FG001|Overall Study|Lost to Follow-up|1|||
131061198|NCT02161146|471856859|FG002|Overall Study|Lost to Follow-up|0|||
131061199|NCT02161146|471856860|FG003|Overall Study|Lost to Follow-up|0|||
131061200|NCT02161146|471856861|FG004|Overall Study|Lost to Follow-up|0|||
131061201|NCT02161146|471856857|FG000|Overall Study|Personal Reasons|0|||
131061202|NCT02161146|471856858|FG001|Overall Study|Personal Reasons|1|||
131061203|NCT02161146|471856859|FG002|Overall Study|Personal Reasons|0|||
131061204|NCT02161146|471856860|FG003|Overall Study|Personal Reasons|2|||
131061205|NCT02161146|471856861|FG004|Overall Study|Personal Reasons|1|||
131061206|NCT02161146|471856857|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131061207|NCT02161146|471856858|FG001|Overall Study|Other Miscellaneous Reasons|1|||
131061208|NCT02161146|471856859|FG002|Overall Study|Other Miscellaneous Reasons|0|||
131061209|NCT02161146|471856860|FG003|Overall Study|Other Miscellaneous Reasons|0|||
131061210|NCT02161146|471856861|FG004|Overall Study|Other Miscellaneous Reasons|0|||
131061211|NCT02613403|471856864|FG000|Overall Study|Lost to Follow-up|0|||
131061212|NCT02613403|471856865|FG001|Overall Study|Lost to Follow-up|1|||
131061213|NCT02613403|471856866|FG002|Overall Study|Lost to Follow-up|0|||
131061214|NCT02613403|471856867|FG003|Overall Study|Lost to Follow-up|0|||
131061215|NCT02613403|471856868|FG004|Overall Study|Lost to Follow-up|0|||
131061216|NCT02613403|471856864|FG000|Overall Study|Withdrawal by Subject|2|||
131061217|NCT02613403|471856865|FG001|Overall Study|Withdrawal by Subject|0|||
131061218|NCT02613403|471856866|FG002|Overall Study|Withdrawal by Subject|0|||
131061219|NCT02613403|471856867|FG003|Overall Study|Withdrawal by Subject|0|||
131061220|NCT02613403|471856868|FG004|Overall Study|Withdrawal by Subject|0|||
131061221|NCT02189759|471856869|FG000|Overall Study|Lost to Follow-up|0|||
131061222|NCT02189759|471856870|FG001|Overall Study|Lost to Follow-up|0|||
131061223|NCT02189759|471856871|FG002|Overall Study|Lost to Follow-up|2|||
131061224|NCT02189759|471856872|FG003|Overall Study|Lost to Follow-up|5|||
131061225|NCT01147471|471856873|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
131061226|NCT01147471|471856874|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
131061227|NCT01147471|471856873|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
131061228|NCT01147471|471856874|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
131061229|NCT01147471|471856873|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
131061230|NCT01147471|471856874|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
131061231|NCT01147471|471856873|FG000|3 Month Follow Up|Lost to Follow-up|1|||
131061232|NCT01147471|471856874|FG001|3 Month Follow Up|Lost to Follow-up|1|||
131061233|NCT01147471|471856873|FG000|3 Month Follow Up|Physician Decision|0|||
131061234|NCT01147471|471856874|FG001|3 Month Follow Up|Physician Decision|1|||
131061235|NCT01147471|471856873|FG000|6 Month Follow Up|Lost to Follow-up|4|||
131061236|NCT01147471|471856874|FG001|6 Month Follow Up|Lost to Follow-up|2|||
131061237|NCT00800176|471856879|FG000|Overall Study|Adverse Event|2|||
131061238|NCT00800176|471856880|FG001|Overall Study|Adverse Event|1|||
131061239|NCT00800176|471856881|FG002|Overall Study|Adverse Event|0|||
131061240|NCT00800176|471856882|FG003|Overall Study|Adverse Event|2|||
131061241|NCT00800176|471856883|FG004|Overall Study|Adverse Event|1|||
131061242|NCT00800176|471856884|FG005|Overall Study|Adverse Event|1|||
131061243|NCT00800176|471856879|FG000|Overall Study|Refused treatment|3|||
131061244|NCT00800176|471856880|FG001|Overall Study|Refused treatment|2|||
131061245|NCT00800176|471856881|FG002|Overall Study|Refused treatment|0|||
131061246|NCT00800176|471856882|FG003|Overall Study|Refused treatment|0|||
131061247|NCT00800176|471856883|FG004|Overall Study|Refused treatment|1|||
131061248|NCT00800176|471856884|FG005|Overall Study|Refused treatment|4|||
131061249|NCT00800176|471856879|FG000|Overall Study|Failure to return|3|||
131061250|NCT00800176|471856880|FG001|Overall Study|Failure to return|3|||
131061251|NCT00800176|471856881|FG002|Overall Study|Failure to return|0|||
131061252|NCT00800176|471856882|FG003|Overall Study|Failure to return|2|||
131061253|NCT00800176|471856883|FG004|Overall Study|Failure to return|0|||
131061254|NCT00800176|471856884|FG005|Overall Study|Failure to return|0|||
131061255|NCT00800176|471856879|FG000|Overall Study|Other|1|||
131061256|NCT00800176|471856880|FG001|Overall Study|Other|0|||
131061257|NCT00800176|471856881|FG002|Overall Study|Other|0|||
131061258|NCT00800176|471856882|FG003|Overall Study|Other|0|||
131061259|NCT00800176|471856883|FG004|Overall Study|Other|2|||
131061260|NCT00800176|471856884|FG005|Overall Study|Other|0|||
131061261|NCT01294644|471856892|FG000|Overall Study|Adverse Event|2|||
131229988|NCT01193517|472467753|FG000|Overall Study|Early Progression|1|||
131061262|NCT01294644|471856893|FG001|Overall Study|Adverse Event|0|||
131061263|NCT01294644|471856894|FG002|Overall Study|Adverse Event|1|||
131061264|NCT01294644|471856892|FG000|Overall Study|Withdrawal by Subject|3|||
131061265|NCT01294644|471856893|FG001|Overall Study|Withdrawal by Subject|7|||
131061266|NCT01294644|471856894|FG002|Overall Study|Withdrawal by Subject|4|||
131061267|NCT01294644|471856892|FG000|Overall Study|Lost to Follow-up|3|||
131061268|NCT01294644|471856893|FG001|Overall Study|Lost to Follow-up|2|||
131061269|NCT01294644|471856894|FG002|Overall Study|Lost to Follow-up|5|||
131061270|NCT01294644|471856892|FG000|Overall Study|Miscellaneous Reason|2|||
131061271|NCT01294644|471856893|FG001|Overall Study|Miscellaneous Reason|1|||
131061272|NCT01294644|471856894|FG002|Overall Study|Miscellaneous Reason|4|||
131061273|NCT02188459|471856895|FG000|Overall Study|Lost to Follow-up|3|||
131061274|NCT02188459|471856896|FG001|Overall Study|Lost to Follow-up|4|||
131061275|NCT02188459|471856895|FG000|Overall Study|Early Termination|0|||
131061276|NCT02188459|471856896|FG001|Overall Study|Early Termination|3|||
131061277|NCT02612285|471856897|FG000|Overall Study|Withdrawal by Subject|1|||
131061278|NCT01986348|471856898|FG000|Overall Study|Death|8|||
131061279|NCT01986348|471856899|FG001|Overall Study|Death|22|||
131061280|NCT01986348|471856900|FG002|Overall Study|Death|10|||
131061281|NCT01986348|471856901|FG003|Overall Study|Death|21|||
131061282|NCT01986348|471856898|FG000|Overall Study|Lost to Follow-up|0|||
131061283|NCT01986348|471856899|FG001|Overall Study|Lost to Follow-up|0|||
131061284|NCT01986348|471856900|FG002|Overall Study|Lost to Follow-up|0|||
131061285|NCT01986348|471856901|FG003|Overall Study|Lost to Follow-up|2|||
131061286|NCT01986348|471856898|FG000|Overall Study|Physician Decision|0|||
131061287|NCT01986348|471856899|FG001|Overall Study|Physician Decision|0|||
131061288|NCT01986348|471856900|FG002|Overall Study|Physician Decision|0|||
131061289|NCT01986348|471856901|FG003|Overall Study|Physician Decision|1|||
131061290|NCT01986348|471856898|FG000|Overall Study|Progressive Disease|0|||
131061291|NCT01986348|471856899|FG001|Overall Study|Progressive Disease|0|||
131061292|NCT01986348|471856900|FG002|Overall Study|Progressive Disease|2|||
131061293|NCT01986348|471856901|FG003|Overall Study|Progressive Disease|0|||
131061294|NCT01986348|471856898|FG000|Overall Study|Withdrawal by Participant|0|||
131061295|NCT01986348|471856899|FG001|Overall Study|Withdrawal by Participant|1|||
131061296|NCT01986348|471856900|FG002|Overall Study|Withdrawal by Participant|2|||
131061297|NCT01986348|471856901|FG003|Overall Study|Withdrawal by Participant|1|||
131061298|NCT01986348|471856898|FG000|Overall Study|Study Terminated by Sponsor|0|||
131061299|NCT01986348|471856899|FG001|Overall Study|Study Terminated by Sponsor|0|||
131061300|NCT01986348|471856900|FG002|Overall Study|Study Terminated by Sponsor|0|||
131061301|NCT01986348|471856901|FG003|Overall Study|Study Terminated by Sponsor|3|||
131061302|NCT01986348|471856898|FG000|Overall Study|Other-unspecified|0|||
131061303|NCT01986348|471856899|FG001|Overall Study|Other-unspecified|1|||
131061304|NCT01986348|471856900|FG002|Overall Study|Other-unspecified|0|||
131061305|NCT01986348|471856901|FG003|Overall Study|Other-unspecified|2|||
131061306|NCT02548585|471856902|FG000|Overall Study|Withdrawal by Subject|0|||
131061307|NCT02548585|471856903|FG001|Overall Study|Withdrawal by Subject|0|||
131061308|NCT02548585|471856904|FG002|Overall Study|Withdrawal by Subject|0|||
131061309|NCT02548585|471856905|FG003|Overall Study|Withdrawal by Subject|0|||
131061310|NCT02548585|471856906|FG004|Overall Study|Withdrawal by Subject|0|||
131061311|NCT02548585|471856907|FG005|Overall Study|Withdrawal by Subject|1|||
131061312|NCT02548585|471856908|FG006|Overall Study|Withdrawal by Subject|0|||
131061313|NCT02548585|471856902|FG000|Overall Study|Lost to Follow-up|1|||
131061314|NCT02548585|471856903|FG001|Overall Study|Lost to Follow-up|0|||
131061315|NCT02548585|471856904|FG002|Overall Study|Lost to Follow-up|0|||
131061316|NCT02548585|471856905|FG003|Overall Study|Lost to Follow-up|0|||
131061317|NCT02548585|471856906|FG004|Overall Study|Lost to Follow-up|0|||
131061318|NCT02548585|471856907|FG005|Overall Study|Lost to Follow-up|0|||
131061319|NCT02548585|471856908|FG006|Overall Study|Lost to Follow-up|0|||
131061320|NCT02548585|471856902|FG000|Overall Study|Other|1|||
131061321|NCT02548585|471856903|FG001|Overall Study|Other|0|||
131061322|NCT02548585|471856904|FG002|Overall Study|Other|0|||
131061323|NCT02548585|471856905|FG003|Overall Study|Other|2|||
131061324|NCT02548585|471856906|FG004|Overall Study|Other|3|||
131061325|NCT02548585|471856907|FG005|Overall Study|Other|0|||
131061326|NCT02548585|471856908|FG006|Overall Study|Other|1|||
131061327|NCT02548585|471856902|FG000|Overall Study|Randomized but not treated|0|||
131061328|NCT02548585|471856903|FG001|Overall Study|Randomized but not treated|0|||
131061329|NCT02548585|471856904|FG002|Overall Study|Randomized but not treated|0|||
131061330|NCT02548585|471856905|FG003|Overall Study|Randomized but not treated|0|||
131061331|NCT02548585|471856906|FG004|Overall Study|Randomized but not treated|0|||
131061332|NCT02548585|471856907|FG005|Overall Study|Randomized but not treated|1|||
131061333|NCT02548585|471856908|FG006|Overall Study|Randomized but not treated|0|||
131061334|NCT00805441|471856909|FG000|Overall Study|Adverse Event|5|||
131061335|NCT00805441|471856910|FG001|Overall Study|Adverse Event|2|||
131061336|NCT00805441|471856909|FG000|Overall Study|Lack of Efficacy|0|||
131061337|NCT00805441|471856910|FG001|Overall Study|Lack of Efficacy|2|||
131061338|NCT00805441|471856909|FG000|Overall Study|Protocol Violation|4|||
131061339|NCT00805441|471856910|FG001|Overall Study|Protocol Violation|8|||
131061340|NCT00805441|471856909|FG000|Overall Study|Lost to Follow-up|10|||
131061341|NCT00805441|471856910|FG001|Overall Study|Lost to Follow-up|13|||
131061342|NCT00805441|471856909|FG000|Overall Study|Withdrawal by Subject|15|||
131061343|NCT00805441|471856910|FG001|Overall Study|Withdrawal by Subject|9|||
131061344|NCT00805441|471856909|FG000|Overall Study|Physician Decision|0|||
131061345|NCT00805441|471856910|FG001|Overall Study|Physician Decision|1|||
131061346|NCT00805441|471856909|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
131061347|NCT00805441|471856910|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
131061348|NCT02935894|471856912|FG000|Overall Study|Subject dismissed|1|||
131061349|NCT03242863|471856915|FG000|Study Week 1|Withdrawal by Subject|0|||
131061350|NCT03242863|471856916|FG001|Study Week 1|Withdrawal by Subject|1|||
131061351|NCT03242863|471856917|FG002|Study Week 1|Withdrawal by Subject|0|||
131061352|NCT03242863|471856918|FG003|Study Week 1|Withdrawal by Subject|0|||
131061353|NCT03242863|471856919|FG004|Study Week 1|Withdrawal by Subject|3|||
131061354|NCT03242863|471856920|FG005|Study Week 1|Withdrawal by Subject|0|||
131061355|NCT01898299|471856922|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
131061356|NCT01898299|471856923|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
131061357|NCT00264576|471858582|FG000|Overall Study|Lost to Follow-up|1|||
131061358|NCT00264576|471858583|FG001|Overall Study|Lost to Follow-up|1|||
131061359|NCT02659059|471858586|FG000|Overall Study|Other reasons|6|||
131061360|NCT02659059|471858587|FG001|Overall Study|Other reasons|1|||
131061361|NCT02659059|471858586|FG000|Overall Study|Disease Progression|143|||
131061362|NCT02659059|471858587|FG001|Overall Study|Disease Progression|16|||
131061363|NCT02659059|471858586|FG000|Overall Study|Study Drug toxicity|56|||
131061364|NCT02659059|471858587|FG001|Overall Study|Study Drug toxicity|9|||
131061365|NCT02659059|471858586|FG000|Overall Study|Death|3|||
131061366|NCT02659059|471858587|FG001|Overall Study|Death|1|||
131061367|NCT02659059|471858586|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
131061368|NCT02659059|471858587|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
131061369|NCT02659059|471858586|FG000|Overall Study|Participant request to discontinue study treatment|5|||
131061370|NCT02659059|471858587|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131061371|NCT02659059|471858586|FG000|Overall Study|Participant withdrew consent|6|||
131061372|NCT02659059|471858587|FG001|Overall Study|Participant withdrew consent|1|||
131061373|NCT03976102|471858590|FG000|Overall Study|Withdrawal by Subject|4|||
131061374|NCT03976102|471858591|FG001|Overall Study|Withdrawal by Subject|4|||
131061375|NCT03976102|471858590|FG000|Overall Study|Adverse Event|2|||
131061376|NCT03976102|471858591|FG001|Overall Study|Adverse Event|4|||
131137157|NCT03864653|472128285|FG000|Overall Study|Withdrawal by Subject|1|||
131061377|NCT03976102|471858590|FG000|Overall Study|Not related to Covid-19|9|||
131061378|NCT03976102|471858591|FG001|Overall Study|Not related to Covid-19|13|||
131061379|NCT03976102|471858590|FG000|Overall Study|Lost to Follow-up|0|||
131061380|NCT03976102|471858591|FG001|Overall Study|Lost to Follow-up|2|||
131137158|NCT00546052|472128286|FG000|Overall Study|Adverse Event|47|||
131061381|NCT03976102|471858590|FG000|Overall Study|Death|3|||
131061382|NCT03976102|471858591|FG001|Overall Study|Death|2|||
131061383|NCT03976102|471858590|FG000|Overall Study|Physician Decision|1|||
131061384|NCT03976102|471858591|FG001|Overall Study|Physician Decision|1|||
131061385|NCT00092456|471858592|FG000|Overall Study|Adverse Event|0|||
131061386|NCT00092456|471858593|FG001|Overall Study|Adverse Event|0|||
131061387|NCT00092456|471858594|FG002|Overall Study|Adverse Event|1|||
131061388|NCT00092456|471858595|FG003|Overall Study|Adverse Event|1|||
131061389|NCT00092456|471858592|FG000|Overall Study|Lost to Follow-up|2|||
131061390|NCT00092456|471858593|FG001|Overall Study|Lost to Follow-up|2|||
131061391|NCT00092456|471858594|FG002|Overall Study|Lost to Follow-up|1|||
131061392|NCT00092456|471858595|FG003|Overall Study|Lost to Follow-up|2|||
131061393|NCT00092456|471858592|FG000|Overall Study|Protocol Violation|5|||
131137159|NCT00546052|472128286|FG000|Overall Study|Lost to Follow-up|144|||
131061394|NCT00092456|471858593|FG001|Overall Study|Protocol Violation|7|||
131061395|NCT00092456|471858594|FG002|Overall Study|Protocol Violation|8|||
131061396|NCT00092456|471858595|FG003|Overall Study|Protocol Violation|6|||
131061397|NCT00092456|471858592|FG000|Overall Study|Withdrawal by Subject|13|||
131061398|NCT00092456|471858593|FG001|Overall Study|Withdrawal by Subject|5|||
131061399|NCT00092456|471858594|FG002|Overall Study|Withdrawal by Subject|16|||
131061400|NCT00092456|471858595|FG003|Overall Study|Withdrawal by Subject|6|||
131061401|NCT00092456|471858592|FG000|Overall Study|Moved|1|||
131061402|NCT00092456|471858593|FG001|Overall Study|Moved|1|||
131061403|NCT00092456|471858594|FG002|Overall Study|Moved|0|||
131061404|NCT00092456|471858595|FG003|Overall Study|Moved|1|||
131061405|NCT00092456|471858592|FG000|Overall Study|Other|4|||
131061406|NCT00092456|471858593|FG001|Overall Study|Other|2|||
131061407|NCT00092456|471858594|FG002|Overall Study|Other|3|||
131061408|NCT00092456|471858595|FG003|Overall Study|Other|0|||
131061409|NCT04783389|471858598|FG000|Overall Study|Withdrawal by Subject|2|||
131061410|NCT04783389|471858599|FG001|Overall Study|Withdrawal by Subject|0|||
131061411|NCT04783389|471858600|FG002|Overall Study|Withdrawal by Subject|0|||
131061412|NCT04783389|471858598|FG000|Overall Study|Termination of Study by Sponsor|10|||
131061413|NCT04783389|471858599|FG001|Overall Study|Termination of Study by Sponsor|12|||
131061414|NCT04783389|471858600|FG002|Overall Study|Termination of Study by Sponsor|14|||
131061415|NCT02121808|471858601|FG000|Overall Study|Technical problem|3|||
131061416|NCT05066230|471858602|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
131061417|NCT05066230|471858603|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
131137160|NCT00546052|472128286|FG000|Overall Study|Protocol Violation|9|||
131137161|NCT00546052|472128286|FG000|Overall Study|Withdrawal by Subject|20|||
131137162|NCT00546052|472128286|FG000|Overall Study|Non Compliance|7|||
131137163|NCT02482129|472128289|FG000|Overall Study|Adverse Event-prior to treatment|0|||
131137164|NCT02482129|472128290|FG001|Overall Study|Adverse Event-prior to treatment|1|||
131137165|NCT02482129|472128289|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
131061418|NCT05066230|471858602|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
131061419|NCT05066230|471858603|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
131061420|NCT05066230|471858602|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
131061421|NCT05066230|471858603|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
131061422|NCT05066230|471858602|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
131061423|NCT05066230|471858603|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
131061424|NCT05066230|471858602|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
131061425|NCT05066230|471858603|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
131061426|NCT05066230|471858602|FG000|After Week 48|Adverse Event|1|||
131061427|NCT05066230|471858603|FG001|After Week 48|Adverse Event|0|||
131061428|NCT05066230|471858602|FG000|After Week 48|Non-compliance with study schedule|1|||
131061429|NCT05066230|471858603|FG001|After Week 48|Non-compliance with study schedule|0|||
131061430|NCT05066230|471858602|FG000|After Week 48|Withdrawal by Subject|0|||
131061431|NCT05066230|471858603|FG001|After Week 48|Withdrawal by Subject|1|||
131061432|NCT05066230|471858602|FG000|After Week 48|Lost to Follow-up|3|||
131061433|NCT05066230|471858603|FG001|After Week 48|Lost to Follow-up|3|||
131061434|NCT05066230|471858602|FG000|After Week 48|Sponsor Request|115|||
131061435|NCT05066230|471858603|FG001|After Week 48|Sponsor Request|111|||
131061436|NCT02164578|471858604|FG000|Treatment Period|Withdrawal by Subject|3|||
131061437|NCT02164578|471858605|FG001|Treatment Period|Withdrawal by Subject|3|||
131061438|NCT02164578|471858604|FG000|Treatment Period|Adverse Event|13|||
131061439|NCT02164578|471858605|FG001|Treatment Period|Adverse Event|6|||
131061440|NCT02164578|471858604|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
131061441|NCT02164578|471858605|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
131061442|NCT02164578|471858604|FG000|Treatment Period|Protocol Violation|0|||
131061443|NCT02164578|471858605|FG001|Treatment Period|Protocol Violation|2|||
131061444|NCT02164578|471858604|FG000|Extension Period|Withdrawal by Subject|2|||
131061445|NCT02164578|471858605|FG001|Extension Period|Withdrawal by Subject|0|||
131061446|NCT02164578|471858604|FG000|Extension Period|Adverse Event|4|||
131137166|NCT02482129|472128290|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
131137167|NCT02482129|472128289|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
131137168|NCT02482129|472128290|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
131137169|NCT02482129|472128289|FG000|Overall Study|Criteria not met-prior to treatment|1|||
131137170|NCT02482129|472128290|FG001|Overall Study|Criteria not met-prior to treatment|0|||
131137171|NCT02482129|472128289|FG000|Overall Study|Adverse Event|1|||
131061447|NCT02164578|471858605|FG001|Extension Period|Adverse Event|0|||
131061448|NCT02164578|471858604|FG000|Extension Period|Expiry of study medication|1|||
131061449|NCT02164578|471858605|FG001|Extension Period|Expiry of study medication|0|||
131061450|NCT02164578|471858604|FG000|Extension Period|Protocol Violation|0|||
131061451|NCT02164578|471858605|FG001|Extension Period|Protocol Violation|1|||
131061452|NCT03924193|471858606|FG000|Overall Study|Adverse Event|10|||
131061453|NCT03924193|471858607|FG001|Overall Study|Adverse Event|0|||
131061454|NCT03924193|471858608|FG002|Overall Study|Adverse Event|10|||
131061455|NCT03924193|471858606|FG000|Overall Study|Withdrawal by Subject|5|||
131061456|NCT03924193|471858607|FG001|Overall Study|Withdrawal by Subject|10|||
131061457|NCT03924193|471858608|FG002|Overall Study|Withdrawal by Subject|2|||
131061458|NCT02489799|471858609|FG000|Overall Study|Lost to Follow-up|4|||
131061459|NCT02489799|471858610|FG001|Overall Study|Lost to Follow-up|1|||
131061460|NCT02489799|471858609|FG000|Overall Study|Failure to Maintain Eligibility|4|||
131061461|NCT02489799|471858610|FG001|Overall Study|Failure to Maintain Eligibility|6|||
131061462|NCT02489799|471858609|FG000|Overall Study|Withdrawal by Subject|1|||
131061463|NCT02489799|471858610|FG001|Overall Study|Withdrawal by Subject|1|||
131061464|NCT02489799|471858609|FG000|Overall Study|Death|0|||
131061465|NCT02489799|471858610|FG001|Overall Study|Death|1|||
131061466|NCT04909593|471858611|FG000|Overall Study|Withdrawal by Subject|1|||
131061467|NCT01241448|471858612|FG000|Overall Study|Adverse Event|1|||
131061468|NCT01241448|471858613|FG001|Overall Study|Adverse Event|0|||
131061469|NCT01241448|471858614|FG002|Overall Study|Adverse Event|2|||
131061470|NCT01241448|471858615|FG003|Overall Study|Adverse Event|2|||
131061471|NCT01241448|471858612|FG000|Overall Study|Lost to Follow-up|2|||
131061472|NCT01241448|471858613|FG001|Overall Study|Lost to Follow-up|1|||
131061473|NCT01241448|471858614|FG002|Overall Study|Lost to Follow-up|1|||
131061474|NCT01241448|471858615|FG003|Overall Study|Lost to Follow-up|1|||
131061475|NCT01241448|471858612|FG000|Overall Study|Physician Decision|0|||
131061476|NCT01241448|471858613|FG001|Overall Study|Physician Decision|2|||
131061477|NCT01241448|471858614|FG002|Overall Study|Physician Decision|0|||
131061478|NCT01241448|471858615|FG003|Overall Study|Physician Decision|0|||
131061479|NCT01241448|471858612|FG000|Overall Study|Protocol Violation|10|||
131061480|NCT01241448|471858613|FG001|Overall Study|Protocol Violation|5|||
131061481|NCT01241448|471858614|FG002|Overall Study|Protocol Violation|3|||
131061482|NCT01241448|471858615|FG003|Overall Study|Protocol Violation|6|||
131061483|NCT01241448|471858612|FG000|Overall Study|Sponsor Decision|17|||
131061484|NCT01241448|471858613|FG001|Overall Study|Sponsor Decision|14|||
131061485|NCT01241448|471858614|FG002|Overall Study|Sponsor Decision|12|||
131061486|NCT01241448|471858615|FG003|Overall Study|Sponsor Decision|6|||
131061487|NCT01241448|471858612|FG000|Overall Study|Withdrawal by Subject|4|||
131061488|NCT01241448|471858613|FG001|Overall Study|Withdrawal by Subject|5|||
131061489|NCT01241448|471858614|FG002|Overall Study|Withdrawal by Subject|3|||
131061490|NCT01241448|471858615|FG003|Overall Study|Withdrawal by Subject|6|||
131061491|NCT01241448|471858612|FG000|Overall Study|Excluded due to data integrity issues|3|||
131061492|NCT01241448|471858613|FG001|Overall Study|Excluded due to data integrity issues|2|||
131061493|NCT01241448|471858614|FG002|Overall Study|Excluded due to data integrity issues|2|||
131061494|NCT01241448|471858615|FG003|Overall Study|Excluded due to data integrity issues|2|||
131061495|NCT03740737|471858616|FG000|Overall Study|Protocol deviation|13|||
131061496|NCT03740737|471858617|FG001|Overall Study|Protocol deviation|0|||
131061497|NCT03740737|471858616|FG000|Overall Study|Adverse Event|2|||
131061498|NCT03740737|471858617|FG001|Overall Study|Adverse Event|0|||
131061499|NCT03740737|471858616|FG000|Overall Study|Lost to Follow-up|1|||
131061500|NCT03740737|471858617|FG001|Overall Study|Lost to Follow-up|0|||
131061501|NCT03740737|471858616|FG000|Overall Study|Randomization failure|1|||
131061502|NCT03740737|471858617|FG001|Overall Study|Randomization failure|0|||
131061503|NCT03740737|471858616|FG000|Overall Study|Participant withdrew consent|1|||
131061504|NCT03740737|471858617|FG001|Overall Study|Participant withdrew consent|0|||
131061505|NCT03740737|471858616|FG000|Overall Study|Participant withdrew from trial|2|||
131061506|NCT03740737|471858617|FG001|Overall Study|Participant withdrew from trial|1|||
131061507|NCT01381549|471858624|FG000|Overall Study|Ineligible: No organisms isolated|0|||
131061508|NCT01381549|471858625|FG001|Overall Study|Ineligible: No organisms isolated|0|||
131061509|NCT01381549|471858626|FG002|Overall Study|Ineligible: No organisms isolated|1|||
131061510|NCT02981953|471858627|FG000|Overall Study|Death|9|||
131061511|NCT02981953|471858627|FG000|Overall Study|Withdrawal by Subject|1|||
131061512|NCT02981953|471858627|FG000|Overall Study|Withdrawal to non-compliance|1|||
131061513|NCT02889900|471858630|FG000|Overall Study|Adverse Event|11|||
131061514|NCT02889900|471858630|FG000|Overall Study|Condition under investigation worsened|32|||
131061515|NCT02889900|471858630|FG000|Overall Study|Other|5|||
131061516|NCT02889900|471858630|FG000|Overall Study|Withdrawal by Subject|7|||
131061517|NCT02889900|471858630|FG000|Overall Study|Not treated|2|||
131061518|NCT01416285|471858632|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
131061519|NCT01416285|471858633|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
131061520|NCT00990184|471858638|FG000|Overall Study|Physician Decision|1|||
131061521|NCT01322386|471858642|FG000|Overall Study|Protocol Violation|0|||
131061522|NCT01322386|471858643|FG001|Overall Study|Protocol Violation|1|||
131061523|NCT01322386|471858642|FG000|Overall Study|Physician Decision|0|||
131061524|NCT01322386|471858643|FG001|Overall Study|Physician Decision|1|||
131061525|NCT00441168|471858644|FG000|Treatment Period|Death|3|||
131061526|NCT00441168|471858645|FG001|Treatment Period|Death|0|||
131061527|NCT00441168|471858644|FG000|Treatment Period|Adverse Event|1|||
131061528|NCT00441168|471858645|FG001|Treatment Period|Adverse Event|2|||
131061529|NCT00441168|471858644|FG000|Treatment Period|Progressive Disease|0|||
131061530|NCT00441168|471858645|FG001|Treatment Period|Progressive Disease|2|||
131061531|NCT00441168|471858644|FG000|Treatment Period|Protocol Violation|0|||
131061532|NCT00441168|471858645|FG001|Treatment Period|Protocol Violation|1|||
131061533|NCT00441168|471858644|FG000|Treatment Period|Lost to Follow-up|0|||
131061534|NCT00441168|471858645|FG001|Treatment Period|Lost to Follow-up|1|||
131061535|NCT00441168|471858644|FG000|Treatment Period|Withdrawal by Subject|3|||
131061536|NCT00441168|471858645|FG001|Treatment Period|Withdrawal by Subject|0|||
131061537|NCT00441168|471858644|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
131061538|NCT00441168|471858645|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
131061539|NCT00441168|471858644|FG000|Treatment Period|refractory disease|1|||
131061540|NCT00441168|471858645|FG001|Treatment Period|refractory disease|0|||
131061541|NCT00441168|471858644|FG000|Follow-up Period|Death|3|||
131061542|NCT00441168|471858645|FG001|Follow-up Period|Death|0|||
131061543|NCT00441168|471858644|FG000|Follow-up Period|Lost to Follow-up|5|||
131061544|NCT00441168|471858645|FG001|Follow-up Period|Lost to Follow-up|6|||
131061545|NCT00441168|471858644|FG000|Follow-up Period|Withdrawal by Subject|3|||
131061546|NCT00441168|471858645|FG001|Follow-up Period|Withdrawal by Subject|0|||
131061547|NCT00441168|471858644|FG000|Follow-up Period|Other|1|||
131061548|NCT00441168|471858645|FG001|Follow-up Period|Other|3|||
131061549|NCT02291861|471858646|FG000|Overall Study|Adverse Event|2|||
131061550|NCT02291861|471858647|FG001|Overall Study|Adverse Event|4|||
131061551|NCT02291861|471858648|FG002|Overall Study|Adverse Event|1|||
131061552|NCT02291861|471858649|FG003|Overall Study|Adverse Event|2|||
131061553|NCT02291861|471858646|FG000|Overall Study|Death|0|||
131061554|NCT02291861|471858647|FG001|Overall Study|Death|0|||
131061555|NCT02291861|471858648|FG002|Overall Study|Death|1|||
131061556|NCT02291861|471858649|FG003|Overall Study|Death|1|||
131061557|NCT02291861|471858646|FG000|Overall Study|Protocol Violation|1|||
131061558|NCT02291861|471858647|FG001|Overall Study|Protocol Violation|0|||
131061559|NCT02291861|471858648|FG002|Overall Study|Protocol Violation|0|||
131061560|NCT02291861|471858649|FG003|Overall Study|Protocol Violation|1|||
131061561|NCT02291861|471858646|FG000|Overall Study|Withdrawal by Subject|1|||
131061562|NCT02291861|471858647|FG001|Overall Study|Withdrawal by Subject|2|||
131061563|NCT02291861|471858648|FG002|Overall Study|Withdrawal by Subject|1|||
131061564|NCT02291861|471858649|FG003|Overall Study|Withdrawal by Subject|4|||
131061565|NCT02291861|471858646|FG000|Overall Study|Noncompliance|1|||
131061566|NCT02291861|471858647|FG001|Overall Study|Noncompliance|1|||
131061567|NCT02291861|471858648|FG002|Overall Study|Noncompliance|2|||
131061568|NCT02291861|471858649|FG003|Overall Study|Noncompliance|1|||
131061569|NCT02291861|471858646|FG000|Overall Study|Lost to Follow-up|2|||
131061570|NCT02291861|471858647|FG001|Overall Study|Lost to Follow-up|1|||
131061571|NCT02291861|471858648|FG002|Overall Study|Lost to Follow-up|4|||
131061572|NCT02291861|471858649|FG003|Overall Study|Lost to Follow-up|0|||
131061573|NCT02291861|471858646|FG000|Overall Study|Other|0|||
131061574|NCT02291861|471858647|FG001|Overall Study|Other|0|||
131061575|NCT02291861|471858648|FG002|Overall Study|Other|0|||
131061576|NCT02291861|471858649|FG003|Overall Study|Other|1|||
131061577|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
131061578|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
131061579|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
131061580|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
131061581|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Death|0|||
131061582|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Death|0|||
131061583|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Death|1|||
131061584|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Death|0|||
131061585|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
131061586|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
131061587|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
131061588|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
131061589|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
131061590|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
131061591|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
131061592|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
131061593|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
131061594|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
131061595|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
130722827|NCT01197755|470609747|FG001|Overall Study|Study-specific discontinuation criteria|1|||
131061596|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
131061597|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
131061598|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
131061599|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
131061600|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
131061601|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
131061602|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
131061603|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
131061604|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
131061605|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Other|2|||
131061606|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Other|0|||
131061607|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Other|0|||
131061608|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Other|0|||
131061609|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
131061610|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
131061611|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
131061612|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
131061613|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
131061614|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
131061615|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
131061616|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
131061617|NCT03845517|471858658|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
131061618|NCT03845517|471858659|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
131061619|NCT03845517|471858660|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
131061620|NCT03845517|471858661|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
131061621|NCT03845517|471858658|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
131061622|NCT03845517|471858659|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
131061623|NCT03845517|471858660|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
131061624|NCT03845517|471858661|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
131061625|NCT03845517|471858658|FG000|Follow-up Period (4 Weeks)|Death|0|||
131061626|NCT03845517|471858659|FG001|Follow-up Period (4 Weeks)|Death|0|||
131061627|NCT03845517|471858660|FG002|Follow-up Period (4 Weeks)|Death|1|||
131061628|NCT03845517|471858661|FG003|Follow-up Period (4 Weeks)|Death|1|||
131061629|NCT03845517|471858658|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
131061630|NCT03845517|471858659|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
131061631|NCT03845517|471858660|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
131061632|NCT03845517|471858661|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
131061633|NCT03845517|471858658|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
131061634|NCT03845517|471858659|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
131061635|NCT03845517|471858660|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
131061636|NCT03845517|471858661|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
131061637|NCT03845517|471858658|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
131061638|NCT03845517|471858659|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
131061639|NCT03845517|471858660|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
131061640|NCT03845517|471858661|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
131061641|NCT03845517|471858658|FG000|Follow-up Period (4 Weeks)|Other|1|||
131061642|NCT03845517|471858659|FG001|Follow-up Period (4 Weeks)|Other|0|||
131061643|NCT03845517|471858660|FG002|Follow-up Period (4 Weeks)|Other|1|||
131061644|NCT03845517|471858661|FG003|Follow-up Period (4 Weeks)|Other|0|||
131061645|NCT03845517|471858658|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
131061646|NCT03845517|471858659|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
131061647|NCT03845517|471858660|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
131061648|NCT03845517|471858661|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
131061649|NCT03845517|471858658|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
131061650|NCT03845517|471858659|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
131061651|NCT03845517|471858660|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
131061652|NCT03845517|471858661|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
131061653|NCT03845517|471858658|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
131061654|NCT03845517|471858659|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
131061655|NCT03845517|471858660|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
131061656|NCT03845517|471858661|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
131061657|NCT02410278|471858664|FG000|Run-in Period|Adverse Event|5|||
131061658|NCT02410278|471858665|FG001|Run-in Period|Adverse Event|0|||
131061659|NCT02410278|471858666|FG002|Run-in Period|Adverse Event|0|||
131061660|NCT02410278|471858664|FG000|Run-in Period|GSRS Threshold Not Met|30|||
131061661|NCT02410278|471858665|FG001|Run-in Period|GSRS Threshold Not Met|0|||
131061662|NCT02410278|471858666|FG002|Run-in Period|GSRS Threshold Not Met|0|||
131061663|NCT02410278|471858664|FG000|Run-in Period|Lost to Follow-up|1|||
131061664|NCT02410278|471858665|FG001|Run-in Period|Lost to Follow-up|0|||
131061665|NCT02410278|471858666|FG002|Run-in Period|Lost to Follow-up|0|||
131061666|NCT02410278|471858664|FG000|Run-in Period|Withdrawal by Subject|1|||
131061667|NCT02410278|471858665|FG001|Run-in Period|Withdrawal by Subject|0|||
131061668|NCT02410278|471858666|FG002|Run-in Period|Withdrawal by Subject|0|||
131061669|NCT02410278|471858664|FG000|Run-in Period|Pregnancy|1|||
131137172|NCT02482129|472128290|FG001|Overall Study|Adverse Event|0|||
131137173|NCT02482129|472128289|FG000|Overall Study|Withdrawal by Subject|2|||
131061670|NCT02410278|471858665|FG001|Run-in Period|Pregnancy|0|||
131061671|NCT02410278|471858666|FG002|Run-in Period|Pregnancy|0|||
131061672|NCT02410278|471858664|FG000|Study Treatment Period|Adverse Event|0|||
131061673|NCT02410278|471858665|FG001|Study Treatment Period|Adverse Event|6|||
131137174|NCT02482129|472128290|FG001|Overall Study|Withdrawal by Subject|0|||
131137175|NCT02482129|472128289|FG000|Overall Study|Criteria not met|1|||
131137176|NCT02482129|472128290|FG001|Overall Study|Criteria not met|0|||
131061674|NCT02410278|471858666|FG002|Study Treatment Period|Adverse Event|3|||
131061675|NCT02410278|471858664|FG000|Study Treatment Period|Physician Decision|0|||
131061676|NCT02410278|471858665|FG001|Study Treatment Period|Physician Decision|0|||
131061677|NCT02410278|471858666|FG002|Study Treatment Period|Physician Decision|1|||
131061678|NCT02410278|471858664|FG000|Study Treatment Period|Withdrawal by Subject|0|||
131061679|NCT02410278|471858665|FG001|Study Treatment Period|Withdrawal by Subject|1|||
131061680|NCT02410278|471858666|FG002|Study Treatment Period|Withdrawal by Subject|0|||
131061681|NCT02410278|471858664|FG000|Study Treatment Period|Other|0|||
131061682|NCT02410278|471858665|FG001|Study Treatment Period|Other|3|||
131061683|NCT02410278|471858666|FG002|Study Treatment Period|Other|0|||
131061684|NCT02410278|471858664|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
131061685|NCT02410278|471858665|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
131061686|NCT02410278|471858666|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
131061687|NCT03695185|471858667|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
131061688|NCT03695185|471858667|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
131061689|NCT03695185|471858667|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
131061690|NCT03695185|471858667|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
131061691|NCT03695185|471858667|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
131061692|NCT03695185|471858667|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
131061693|NCT02584257|471858668|FG000|Period 1|Withdrawal by Subject|0|||
131061694|NCT02584257|471858669|FG001|Period 1|Withdrawal by Subject|0|||
131061695|NCT02584257|471858670|FG002|Period 1|Withdrawal by Subject|0|||
131061696|NCT02584257|471858671|FG003|Period 1|Withdrawal by Subject|0|||
131061697|NCT02584257|471858672|FG004|Period 1|Withdrawal by Subject|0|||
131061698|NCT02584257|471858673|FG005|Period 1|Withdrawal by Subject|0|||
131061699|NCT02584257|471858674|FG006|Period 1|Withdrawal by Subject|1|||
131061700|NCT02584257|471858675|FG007|Period 1|Withdrawal by Subject|0|||
131061701|NCT02584257|471858676|FG008|Period 1|Withdrawal by Subject|0|||
131061702|NCT02584257|471858668|FG000|Period 2|Physician Decision|1|||
131061703|NCT02584257|471858669|FG001|Period 2|Physician Decision|0|||
131061704|NCT02584257|471858670|FG002|Period 2|Physician Decision|0|||
131061705|NCT02584257|471858671|FG003|Period 2|Physician Decision|0|||
131061706|NCT02584257|471858672|FG004|Period 2|Physician Decision|0|||
131061707|NCT02584257|471858673|FG005|Period 2|Physician Decision|0|||
131061708|NCT02584257|471858674|FG006|Period 2|Physician Decision|0|||
131061709|NCT02584257|471858675|FG007|Period 2|Physician Decision|0|||
131061710|NCT02584257|471858676|FG008|Period 2|Physician Decision|0|||
131061711|NCT02584257|471858668|FG000|Period 2|Adverse Event|0|||
131061712|NCT02584257|471858669|FG001|Period 2|Adverse Event|1|||
131061713|NCT02584257|471858670|FG002|Period 2|Adverse Event|0|||
131061714|NCT02584257|471858671|FG003|Period 2|Adverse Event|0|||
131061715|NCT02584257|471858672|FG004|Period 2|Adverse Event|0|||
131061716|NCT02584257|471858673|FG005|Period 2|Adverse Event|0|||
131061717|NCT02584257|471858674|FG006|Period 2|Adverse Event|0|||
131061718|NCT02584257|471858675|FG007|Period 2|Adverse Event|0|||
131061719|NCT02584257|471858676|FG008|Period 2|Adverse Event|0|||
131061720|NCT01670877|471858677|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
131061721|NCT01670877|471858678|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
131061722|NCT01670877|471858679|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
131061723|NCT01670877|471858680|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
131061724|NCT01670877|471858681|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
131061725|NCT01670877|471858682|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
131061726|NCT01670877|471858677|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
131061727|NCT01670877|471858678|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
131061728|NCT01670877|471858679|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
131061729|NCT01670877|471858680|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
131061730|NCT01670877|471858681|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
131061731|NCT01670877|471858682|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
131061732|NCT01670877|471858677|FG000|Part I and Part 2|Grade 2 vomiting|0|||
131061733|NCT01670877|471858678|FG001|Part I and Part 2|Grade 2 vomiting|0|||
131061734|NCT01670877|471858679|FG002|Part I and Part 2|Grade 2 vomiting|0|||
131061735|NCT01670877|471858680|FG003|Part I and Part 2|Grade 2 vomiting|1|||
131061736|NCT01670877|471858681|FG004|Part I and Part 2|Grade 2 vomiting|0|||
131061737|NCT01670877|471858682|FG005|Part I and Part 2|Grade 2 vomiting|0|||
131061738|NCT01670877|471858677|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
131061739|NCT01670877|471858678|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
131061740|NCT01670877|471858679|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
131061741|NCT01670877|471858680|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
131061742|NCT01670877|471858681|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
130722828|NCT01197755|470609748|FG002|Overall Study|Study-specific discontinuation criteria|0|||
131061743|NCT01670877|471858682|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
131061744|NCT01670877|471858677|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
131061745|NCT01670877|471858678|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
131061746|NCT01670877|471858679|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
131061747|NCT01670877|471858680|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
131061748|NCT01670877|471858681|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
131229989|NCT01193517|472467754|FG001|Overall Study|Early Progression|0|||
131137177|NCT01928381|472128291|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
131137178|NCT01928381|472128292|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131137179|NCT01928381|472128293|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131137180|NCT01928381|472128294|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131137181|NCT01928381|472128295|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131137182|NCT01928381|472128296|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131061749|NCT01670877|471858682|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
131061750|NCT03146845|471858684|FG000|Overall Study|Reference ulcer healed|1|||
131061751|NCT03146845|471858685|FG001|Overall Study|Reference ulcer healed|0|||
131061752|NCT03146845|471858684|FG000|Overall Study|Physician Decision|1|||
131061753|NCT03146845|471858685|FG001|Overall Study|Physician Decision|0|||
131061754|NCT03146845|471858684|FG000|Overall Study|Adverse Event|1|||
131061755|NCT03146845|471858685|FG001|Overall Study|Adverse Event|0|||
131061756|NCT03146845|471858684|FG000|Overall Study|Withdrawal by Subject|2|||
131061757|NCT03146845|471858685|FG001|Overall Study|Withdrawal by Subject|0|||
131061758|NCT03146845|471858684|FG000|Overall Study|Noncompliance|0|||
131061759|NCT03146845|471858685|FG001|Overall Study|Noncompliance|1|||
131061760|NCT03146845|471858684|FG000|Overall Study|Protocol Violation|0|||
131061761|NCT03146845|471858685|FG001|Overall Study|Protocol Violation|2|||
131061762|NCT03146845|471858684|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
131061763|NCT03146845|471858685|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
131061764|NCT00795639|471858692|FG000|Overall Study|Death|1|||
131061765|NCT00795639|471858693|FG001|Overall Study|Death|6|||
131061766|NCT00795639|471858692|FG000|Overall Study|Withdrawal by Subject|1|||
131061767|NCT00795639|471858693|FG001|Overall Study|Withdrawal by Subject|3|||
131061768|NCT00795639|471858692|FG000|Overall Study|Pregnancy|1|||
131061769|NCT00795639|471858693|FG001|Overall Study|Pregnancy|0|||
131061770|NCT00795639|471858692|FG000|Overall Study|Adverse Event|5|||
131061771|NCT00795639|471858693|FG001|Overall Study|Adverse Event|2|||
131061772|NCT00795639|471858692|FG000|Overall Study|Other|0|||
131061773|NCT00795639|471858693|FG001|Overall Study|Other|2|||
131061774|NCT00795639|471858692|FG000|Overall Study|Terminated by sponsor|13|||
131061775|NCT00795639|471858693|FG001|Overall Study|Terminated by sponsor|12|||
131061776|NCT00795639|471858692|FG000|Overall Study|Randomized and not treated|0|||
131061777|NCT00795639|471858693|FG001|Overall Study|Randomized and not treated|1|||
131061778|NCT03150589|471858696|FG000|Overall Study|Withdrawal by Subject|16|||
131061779|NCT03150589|471858697|FG001|Overall Study|Withdrawal by Subject|9|||
131061780|NCT03150589|471858696|FG000|Overall Study|Adverse Event|7|||
131061781|NCT03150589|471858697|FG001|Overall Study|Adverse Event|6|||
131061782|NCT03150589|471858696|FG000|Overall Study|Protocol Violation|4|||
131061783|NCT03150589|471858697|FG001|Overall Study|Protocol Violation|3|||
131061784|NCT03150589|471858696|FG000|Overall Study|Lost to Follow-up|3|||
131061785|NCT03150589|471858697|FG001|Overall Study|Lost to Follow-up|3|||
131061786|NCT03150589|471858696|FG000|Overall Study|Death|2|||
131061787|NCT03150589|471858697|FG001|Overall Study|Death|3|||
131061788|NCT03150589|471858696|FG000|Overall Study|IP non-compliance and other reasons|12|||
131061789|NCT03150589|471858697|FG001|Overall Study|IP non-compliance and other reasons|3|||
131061790|NCT01020435|471858700|FG000|Overall Study|Lost to Follow-up|0|||
131061791|NCT01020435|471858701|FG001|Overall Study|Lost to Follow-up|1|||
131061792|NCT01000649|471858702|FG000|Overall Study|Adverse Event|5|||
131061793|NCT01000649|471858703|FG001|Overall Study|Adverse Event|1|||
131061794|NCT01000649|471858704|FG002|Overall Study|Adverse Event|2|||
131061795|NCT01000649|471858705|FG003|Overall Study|Adverse Event|4|||
131061796|NCT01000649|471858702|FG000|Overall Study|Lost to Follow-up|0|||
131061797|NCT01000649|471858703|FG001|Overall Study|Lost to Follow-up|2|||
131061798|NCT01000649|471858704|FG002|Overall Study|Lost to Follow-up|0|||
131061799|NCT01000649|471858705|FG003|Overall Study|Lost to Follow-up|2|||
131061800|NCT00346398|471858706|FG000|Overall Study|Lost to Follow-up|3|||
131061801|NCT00346398|471858707|FG001|Overall Study|Lost to Follow-up|0|||
131061802|NCT00346398|471858706|FG000|Overall Study|Withdrawal by Subject|0|||
131061803|NCT00346398|471858707|FG001|Overall Study|Withdrawal by Subject|2|||
131061804|NCT02607956|471858708|FG000|Double-Blinded Phase|Withdrew Consent|17|||
131061805|NCT02607956|471858709|FG001|Double-Blinded Phase|Withdrew Consent|19|||
131061806|NCT02607956|471858710|FG002|Double-Blinded Phase|Withdrew Consent|0|||
131061807|NCT02607956|471858711|FG003|Double-Blinded Phase|Withdrew Consent|0|||
131061808|NCT02607956|471858708|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
130722829|NCT01197755|470609746|FG000|Overall Study|Entered the long-term extension study|18|||
131061809|NCT02607956|471858709|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
131061810|NCT02607956|471858710|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
131061811|NCT02607956|471858711|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
131061812|NCT02607956|471858708|FG000|Double-Blinded Phase|Randomized but never treated|7|||
131061813|NCT02607956|471858709|FG001|Double-Blinded Phase|Randomized but never treated|5|||
131061814|NCT02607956|471858710|FG002|Double-Blinded Phase|Randomized but never treated|0|||
131061815|NCT02607956|471858711|FG003|Double-Blinded Phase|Randomized but never treated|0|||
131061816|NCT02607956|471858708|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
131061817|NCT02607956|471858709|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
131061818|NCT02607956|471858710|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
131061819|NCT02607956|471858711|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
131061820|NCT02607956|471858708|FG000|Double-Blinded Phase|Death|4|||
131061821|NCT02607956|471858709|FG001|Double-Blinded Phase|Death|4|||
131061822|NCT02607956|471858710|FG002|Double-Blinded Phase|Death|0|||
131061823|NCT02607956|471858711|FG003|Double-Blinded Phase|Death|0|||
131061824|NCT02607956|471858708|FG000|Double-Blinded Phase|Adverse Event|4|||
131061825|NCT02607956|471858709|FG001|Double-Blinded Phase|Adverse Event|3|||
131061826|NCT02607956|471858710|FG002|Double-Blinded Phase|Adverse Event|0|||
131061827|NCT02607956|471858711|FG003|Double-Blinded Phase|Adverse Event|0|||
131061828|NCT02607956|471858708|FG000|Double-Blinded Phase|Protocol Violation|3|||
131061829|NCT02607956|471858709|FG001|Double-Blinded Phase|Protocol Violation|1|||
131061830|NCT02607956|471858710|FG002|Double-Blinded Phase|Protocol Violation|0|||
131061831|NCT02607956|471858711|FG003|Double-Blinded Phase|Protocol Violation|0|||
131061832|NCT02607956|471858708|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
131061833|NCT02607956|471858709|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
131061834|NCT02607956|471858710|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
131061835|NCT02607956|471858711|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
131061836|NCT02607956|471858708|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
131061837|NCT02607956|471858709|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
131061838|NCT02607956|471858710|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
131061839|NCT02607956|471858711|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
131061840|NCT02607956|471858708|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
131061841|NCT02607956|471858709|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
131061842|NCT02607956|471858710|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
131061843|NCT02607956|471858711|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
131061844|NCT02607956|471858708|FG000|Open-Label Extension Phase|Death|0|||
131061845|NCT02607956|471858709|FG001|Open-Label Extension Phase|Death|0|||
131061846|NCT02607956|471858710|FG002|Open-Label Extension Phase|Death|1|||
131061847|NCT02607956|471858711|FG003|Open-Label Extension Phase|Death|3|||
131061848|NCT02607956|471858708|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
131061849|NCT02607956|471858709|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
131061850|NCT02607956|471858710|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
131061851|NCT02607956|471858711|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
130779409|NCT02326272|470819496|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130779410|NCT02326272|470819497|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130779411|NCT02326272|470819498|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131061852|NCT02607956|471858708|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
131061853|NCT02607956|471858709|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
131061854|NCT02607956|471858710|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
131061855|NCT02607956|471858711|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
131061856|NCT02607956|471858708|FG000|Open-Label Extension Phase|Protocol Violation|0|||
131061857|NCT02607956|471858709|FG001|Open-Label Extension Phase|Protocol Violation|0|||
131061858|NCT02607956|471858710|FG002|Open-Label Extension Phase|Protocol Violation|0|||
131061859|NCT02607956|471858711|FG003|Open-Label Extension Phase|Protocol Violation|2|||
131061860|NCT02607956|471858708|FG000|Open-Label Extension Phase|Pregnancy|0|||
131061861|NCT02607956|471858709|FG001|Open-Label Extension Phase|Pregnancy|0|||
131061862|NCT02607956|471858710|FG002|Open-Label Extension Phase|Pregnancy|0|||
131061863|NCT02607956|471858711|FG003|Open-Label Extension Phase|Pregnancy|1|||
131061864|NCT00853957|471858712|FG000|Overall Study|Adverse Event|9|||
131061865|NCT00853957|471858713|FG001|Overall Study|Adverse Event|3|||
131061866|NCT00853957|471858712|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131061867|NCT00853957|471858713|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131061868|NCT00853957|471858712|FG000|Overall Study|Subject withdrew consent|4|||
131061869|NCT00853957|471858713|FG001|Overall Study|Subject withdrew consent|5|||
131061870|NCT00853957|471858712|FG000|Overall Study|Lost to Follow-up|1|||
131061871|NCT00853957|471858713|FG001|Overall Study|Lost to Follow-up|6|||
131061872|NCT00853957|471858712|FG000|Overall Study|Protocol deviation|0|||
131061873|NCT00853957|471858713|FG001|Overall Study|Protocol deviation|3|||
131061874|NCT02158806|471858714|FG000|Overall Study|Death|2|||
131061875|NCT02158806|471858715|FG001|Overall Study|Death|0|||
131061876|NCT02158806|471858714|FG000|Overall Study|Withdrawal by Subject|2|||
131061877|NCT02158806|471858715|FG001|Overall Study|Withdrawal by Subject|0|||
131061878|NCT02158806|471858714|FG000|Overall Study|Lost to Follow-up|0|||
131061879|NCT02158806|471858715|FG001|Overall Study|Lost to Follow-up|3|||
131061880|NCT02158806|471858714|FG000|Overall Study|Moved out of area|0|||
131061881|NCT02158806|471858715|FG001|Overall Study|Moved out of area|1|||
131061882|NCT02158806|471858714|FG000|Overall Study|Transferred to palliative care|0|||
131061883|NCT02158806|471858715|FG001|Overall Study|Transferred to palliative care|1|||
131061884|NCT00452452|471858716|FG000|Overall Study|Protocol Violation|0|||
131061885|NCT00452452|471858717|FG001|Overall Study|Protocol Violation|0|||
131061886|NCT00452452|471858718|FG002|Overall Study|Protocol Violation|1|||
131061887|NCT00452452|471858716|FG000|Overall Study|Withdrawal by Subject|1|||
131061888|NCT00452452|471858717|FG001|Overall Study|Withdrawal by Subject|0|||
131061889|NCT00452452|471858718|FG002|Overall Study|Withdrawal by Subject|0|||
131061890|NCT00452452|471858716|FG000|Overall Study|Lost to Follow-up|1|||
131061891|NCT00452452|471858717|FG001|Overall Study|Lost to Follow-up|0|||
131061892|NCT00452452|471858718|FG002|Overall Study|Lost to Follow-up|0|||
131061893|NCT04520256|471858721|FG000|Overall Study|Lost to Follow-up|6|||
131061894|NCT04520256|471858722|FG001|Overall Study|Lost to Follow-up|4|||
131061895|NCT04520256|471858723|FG002|Overall Study|Lost to Follow-up|2|||
131061896|NCT04520256|471858724|FG003|Overall Study|Lost to Follow-up|3|||
131061897|NCT04520256|471858725|FG004|Overall Study|Lost to Follow-up|6|||
131061898|NCT04520256|471858726|FG005|Overall Study|Lost to Follow-up|6|||
131061899|NCT04520256|471858727|FG006|Overall Study|Lost to Follow-up|4|||
131061900|NCT04520256|471858728|FG007|Overall Study|Lost to Follow-up|6|||
131061901|NCT04520256|471858729|FG008|Overall Study|Lost to Follow-up|1|||
131061902|NCT04520256|471858730|FG009|Overall Study|Lost to Follow-up|3|||
131061903|NCT04520256|471858731|FG010|Overall Study|Lost to Follow-up|3|||
131061904|NCT04520256|471858732|FG011|Overall Study|Lost to Follow-up|2|||
131061905|NCT04520256|471858733|FG012|Overall Study|Lost to Follow-up|5|||
131061906|NCT04520256|471858734|FG013|Overall Study|Lost to Follow-up|3|||
131061907|NCT04520256|471858735|FG014|Overall Study|Lost to Follow-up|3|||
131061908|NCT04520256|471858736|FG015|Overall Study|Lost to Follow-up|6|||
131061909|NCT04520256|471858737|FG016|Overall Study|Lost to Follow-up|6|||
131061910|NCT04520256|471858738|FG017|Overall Study|Lost to Follow-up|4|||
131061911|NCT04520256|471858739|FG018|Overall Study|Lost to Follow-up|3|||
131061912|NCT04520256|471858740|FG019|Overall Study|Lost to Follow-up|3|||
131061913|NCT04520256|471858741|FG020|Overall Study|Lost to Follow-up|7|||
131137183|NCT01928381|472128297|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
131137184|NCT01928381|472128291|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
131137185|NCT01928381|472128292|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
131137186|NCT01928381|472128293|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
131137187|NCT01928381|472128294|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
131137188|NCT01928381|472128295|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
131137189|NCT01928381|472128296|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
131137190|NCT01928381|472128297|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
131137191|NCT01928381|472128291|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
131137192|NCT01928381|472128292|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
131137193|NCT01928381|472128293|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
131137194|NCT01928381|472128294|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
131137195|NCT01928381|472128295|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
131137196|NCT01928381|472128296|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
131137197|NCT01928381|472128297|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
131137198|NCT01928381|472128291|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
131137199|NCT01928381|472128292|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
131137200|NCT01928381|472128293|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
131137201|NCT01928381|472128294|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
131137202|NCT01928381|472128295|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
131137203|NCT01928381|472128296|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
131137204|NCT01928381|472128297|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
131137205|NCT01928381|472128291|FG000|Part 1 - Pain Training|Protocol Violation|1|||
131137206|NCT01928381|472128292|FG001|Part 1 - Pain Training|Protocol Violation|0|||
131137207|NCT01928381|472128293|FG002|Part 1 - Pain Training|Protocol Violation|0|||
131137208|NCT01928381|472128294|FG003|Part 1 - Pain Training|Protocol Violation|0|||
131137209|NCT01928381|472128295|FG004|Part 1 - Pain Training|Protocol Violation|0|||
131137210|NCT01928381|472128296|FG005|Part 1 - Pain Training|Protocol Violation|0|||
131137211|NCT01928381|472128297|FG006|Part 1 - Pain Training|Protocol Violation|0|||
131137212|NCT01928381|472128291|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
131137213|NCT01928381|472128292|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131137214|NCT01928381|472128293|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131137215|NCT01928381|472128294|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131137216|NCT01928381|472128295|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131137217|NCT01928381|472128296|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131137218|NCT01928381|472128297|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
131137219|NCT01928381|472128291|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
131137220|NCT01928381|472128292|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131137221|NCT01928381|472128293|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131137222|NCT01928381|472128294|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131137223|NCT01928381|472128295|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131137224|NCT01928381|472128296|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131137225|NCT01928381|472128297|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
131137226|NCT01928381|472128291|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
131061914|NCT04520256|471858742|FG021|Overall Study|Lost to Follow-up|3|||
131061915|NCT04520256|471858743|FG022|Overall Study|Lost to Follow-up|3|||
131061916|NCT04520256|471858744|FG023|Overall Study|Lost to Follow-up|8|||
131061917|NCT04520256|471858745|FG024|Overall Study|Lost to Follow-up|5|||
131061918|NCT04520256|471858746|FG025|Overall Study|Lost to Follow-up|4|||
131061919|NCT04520256|471858747|FG026|Overall Study|Lost to Follow-up|3|||
131061920|NCT04520256|471858748|FG027|Overall Study|Lost to Follow-up|4|||
131061921|NCT04520256|471858749|FG028|Overall Study|Lost to Follow-up|3|||
131061922|NCT04520256|471858750|FG029|Overall Study|Lost to Follow-up|4|||
131061923|NCT04520256|471858751|FG030|Overall Study|Lost to Follow-up|4|||
131061924|NCT04520256|471858752|FG031|Overall Study|Lost to Follow-up|4|||
131061925|NCT01072149|471860464|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061926|NCT01072149|471860465|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061927|NCT01072149|471860466|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
131061928|NCT01072149|471860467|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061929|NCT01072149|471860468|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061930|NCT01072149|471860469|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061931|NCT01072149|471860470|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061932|NCT01072149|471860471|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061933|NCT01072149|471860472|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061934|NCT01072149|471860473|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061935|NCT01072149|471860474|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061936|NCT01072149|471860475|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061937|NCT01072149|471860476|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061938|NCT01072149|471860477|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061939|NCT01072149|471860478|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061940|NCT01072149|471860479|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061941|NCT01072149|471860480|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061942|NCT01072149|471860481|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
131061943|NCT01072149|471860464|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061944|NCT01072149|471860465|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061945|NCT01072149|471860466|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061946|NCT01072149|471860467|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061947|NCT01072149|471860468|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061948|NCT01072149|471860469|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061949|NCT01072149|471860470|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061950|NCT01072149|471860471|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061951|NCT01072149|471860472|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061952|NCT01072149|471860473|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061953|NCT01072149|471860474|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061954|NCT01072149|471860475|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061955|NCT01072149|471860476|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061956|NCT01072149|471860477|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061957|NCT01072149|471860478|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131137227|NCT01928381|472128292|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131137228|NCT01928381|472128293|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131137229|NCT01928381|472128294|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131137230|NCT01928381|472128295|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131137231|NCT01928381|472128296|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131137232|NCT01928381|472128297|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
131137233|NCT01928381|472128291|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
131137234|NCT01928381|472128292|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131137235|NCT01928381|472128293|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131137236|NCT01928381|472128294|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131137237|NCT01928381|472128295|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131137238|NCT01928381|472128296|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131137239|NCT01928381|472128297|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
131137240|NCT01928381|472128291|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
131137241|NCT01928381|472128292|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
131137242|NCT01928381|472128293|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
131137243|NCT01928381|472128294|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
131137244|NCT01928381|472128295|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
131229990|NCT01193517|472467755|FG002|Overall Study|Early Progression|0|||
131061958|NCT01072149|471860479|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061959|NCT01072149|471860480|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
131061960|NCT01072149|471860481|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
131061961|NCT01072149|471860464|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061962|NCT01072149|471860465|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061963|NCT01072149|471860466|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130779412|NCT02326272|470819499|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130722830|NCT01197755|470609747|FG001|Overall Study|Entered the long-term extension study|21|||
131061964|NCT01072149|471860467|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061965|NCT01072149|471860468|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061966|NCT01072149|471860469|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061967|NCT01072149|471860470|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061968|NCT01072149|471860471|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061969|NCT01072149|471860472|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061970|NCT01072149|471860473|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061971|NCT01072149|471860474|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
131061972|NCT01072149|471860475|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061973|NCT01072149|471860476|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061974|NCT01072149|471860477|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061975|NCT01072149|471860478|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061976|NCT01072149|471860479|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061977|NCT01072149|471860480|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061978|NCT01072149|471860481|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
131061979|NCT01072149|471860464|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061980|NCT01072149|471860465|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
131061981|NCT01072149|471860466|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061982|NCT01072149|471860467|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061983|NCT01072149|471860468|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061984|NCT01072149|471860469|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061985|NCT01072149|471860470|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061986|NCT01072149|471860471|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061987|NCT01072149|471860472|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061988|NCT01072149|471860473|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061989|NCT01072149|471860474|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061990|NCT01072149|471860475|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061991|NCT01072149|471860476|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061992|NCT01072149|471860477|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061993|NCT01072149|471860478|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061994|NCT01072149|471860479|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061995|NCT01072149|471860480|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061996|NCT01072149|471860481|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
131061997|NCT01072149|471860464|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131061998|NCT01072149|471860465|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131061999|NCT01072149|471860466|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
131062000|NCT01072149|471860467|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062001|NCT01072149|471860468|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062002|NCT01072149|471860469|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062003|NCT01072149|471860470|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062004|NCT01072149|471860471|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062005|NCT01072149|471860472|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062006|NCT01072149|471860473|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062007|NCT01072149|471860474|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062008|NCT01072149|471860475|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062009|NCT01072149|471860476|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062010|NCT01072149|471860477|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062011|NCT01072149|471860478|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062012|NCT01072149|471860479|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062013|NCT01072149|471860480|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062014|NCT01072149|471860481|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
131062015|NCT01072149|471860464|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062016|NCT01072149|471860465|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062017|NCT01072149|471860466|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062018|NCT01072149|471860467|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062019|NCT01072149|471860468|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062020|NCT01072149|471860469|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062021|NCT01072149|471860470|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062022|NCT01072149|471860471|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
131062023|NCT01072149|471860472|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
131137245|NCT01928381|472128296|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
131062024|NCT01072149|471860473|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062025|NCT01072149|471860474|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062026|NCT01072149|471860475|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062027|NCT01072149|471860476|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062028|NCT01072149|471860477|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
131137246|NCT01928381|472128297|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
130722831|NCT01197755|470609748|FG002|Overall Study|Entered the long-term extension study|35|||
130722832|NCT01197755|470609746|FG000|Overall Study|Lack of therapeutic response|0|||
130722833|NCT01197755|470609747|FG001|Overall Study|Lack of therapeutic response|7|||
130722834|NCT01197755|470609748|FG002|Overall Study|Lack of therapeutic response|4|||
130722835|NCT01197755|470609746|FG000|Overall Study|Severe non-compliance to the protocol|2|||
130722836|NCT01197755|470609747|FG001|Overall Study|Severe non-compliance to the protocol|1|||
130722837|NCT01197755|470609748|FG002|Overall Study|Severe non-compliance to the protocol|2|||
130722838|NCT01197755|470609746|FG000|Overall Study|Withdrawal by Subject|1|||
130722839|NCT01197755|470609747|FG001|Overall Study|Withdrawal by Subject|0|||
130779413|NCT02326272|470819500|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130779414|NCT02326272|470819501|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130779415|NCT02326272|470819502|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131062029|NCT01072149|471860478|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062030|NCT01072149|471860479|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062031|NCT01072149|471860480|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062032|NCT01072149|471860481|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
131062033|NCT01072149|471860464|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
131062034|NCT01072149|471860465|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
131062035|NCT01072149|471860466|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
131062036|NCT01072149|471860467|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
131062037|NCT01072149|471860468|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
131062038|NCT01072149|471860469|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
131062039|NCT01072149|471860470|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
131062040|NCT01072149|471860471|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
131062041|NCT01072149|471860472|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
131062042|NCT01072149|471860473|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
131062043|NCT01072149|471860474|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
131062044|NCT01072149|471860475|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
131062045|NCT01072149|471860476|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
131062046|NCT01072149|471860477|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
131062047|NCT01072149|471860478|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
131062048|NCT01072149|471860479|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
131062049|NCT01072149|471860480|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
131062050|NCT01072149|471860481|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
131062051|NCT01072149|471860464|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062052|NCT01072149|471860465|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062053|NCT01072149|471860466|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062054|NCT01072149|471860467|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062055|NCT01072149|471860468|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062056|NCT01072149|471860469|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062057|NCT01072149|471860470|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062058|NCT01072149|471860471|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062059|NCT01072149|471860472|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062060|NCT01072149|471860473|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062061|NCT01072149|471860474|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062062|NCT01072149|471860475|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062063|NCT01072149|471860476|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062064|NCT01072149|471860477|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062065|NCT01072149|471860478|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062066|NCT01072149|471860479|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
131062067|NCT01072149|471860480|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062068|NCT01072149|471860481|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
131062069|NCT01072149|471860464|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
131062070|NCT01072149|471860465|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
131062071|NCT01072149|471860466|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
131062072|NCT01072149|471860467|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
131062073|NCT01072149|471860468|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
131062074|NCT01072149|471860469|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
131062075|NCT01072149|471860470|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
131062076|NCT01072149|471860471|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
131062077|NCT01072149|471860472|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
131062078|NCT01072149|471860473|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
131062079|NCT01072149|471860474|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
131062080|NCT01072149|471860475|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
131062081|NCT01072149|471860476|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
131062082|NCT01072149|471860477|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
131062083|NCT01072149|471860478|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
131062084|NCT01072149|471860479|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
130722840|NCT01197755|470609748|FG002|Overall Study|Withdrawal by Subject|0|||
130722841|NCT01197755|470609746|FG000|Overall Study|Lost to Follow-up|0|||
131062085|NCT01072149|471860480|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
131062086|NCT01072149|471860481|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
131062087|NCT01072149|471860464|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062088|NCT01072149|471860465|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062089|NCT01072149|471860466|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062090|NCT01072149|471860467|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062091|NCT01072149|471860468|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062092|NCT01072149|471860469|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062093|NCT01072149|471860470|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062094|NCT01072149|471860471|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062095|NCT01072149|471860472|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062096|NCT01072149|471860473|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062097|NCT01072149|471860474|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062098|NCT01072149|471860475|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062099|NCT01072149|471860476|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
131062100|NCT01072149|471860477|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062101|NCT01072149|471860478|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062102|NCT01072149|471860479|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062103|NCT01072149|471860480|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062104|NCT01072149|471860481|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
131062105|NCT01072149|471860464|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062106|NCT01072149|471860465|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062107|NCT01072149|471860466|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
131062108|NCT01072149|471860467|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062109|NCT01072149|471860468|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062110|NCT01072149|471860469|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062111|NCT01072149|471860470|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062112|NCT01072149|471860471|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062113|NCT01072149|471860472|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062114|NCT01072149|471860473|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062115|NCT01072149|471860474|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131137247|NCT01928381|472128291|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131137248|NCT01928381|472128292|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131137249|NCT01928381|472128293|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
131137250|NCT01928381|472128294|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131137251|NCT01928381|472128295|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131137252|NCT01928381|472128296|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131137253|NCT01928381|472128297|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
131137254|NCT01928381|472128291|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
131137255|NCT01928381|472128292|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
131137256|NCT01928381|472128293|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
131137257|NCT01928381|472128294|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
131137258|NCT01928381|472128295|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
131137259|NCT01928381|472128296|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
131137260|NCT01928381|472128297|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
131137261|NCT01928381|472128291|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
130722842|NCT01197755|470609747|FG001|Overall Study|Lost to Follow-up|0|||
130722843|NCT01197755|470609748|FG002|Overall Study|Lost to Follow-up|1|||
130722844|NCT01197755|470609746|FG000|Overall Study|eg, change in circumstances|7|||
131062116|NCT01072149|471860475|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062117|NCT01072149|471860476|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062118|NCT01072149|471860477|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
131062119|NCT01072149|471860478|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062120|NCT01072149|471860479|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062121|NCT01072149|471860480|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062122|NCT01072149|471860481|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
131062123|NCT01912599|471860483|FG000|Overall Study|Withdrawal by Subject|0|||
131137262|NCT01928381|472128292|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
131137263|NCT01928381|472128293|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
130722845|NCT01197755|470609747|FG001|Overall Study|eg, change in circumstances|3|||
130722846|NCT01197755|470609748|FG002|Overall Study|eg, change in circumstances|2|||
131062124|NCT01912599|471860484|FG001|Overall Study|Withdrawal by Subject|1|||
130722847|NCT03365011|470609749|FG000|Overall Study|Withdrawal by Subject|1|||
131062125|NCT03386344|471860486|FG000|Overall Study|Adverse Event|6|||
131062126|NCT03386344|471860487|FG001|Overall Study|Adverse Event|3|||
131062127|NCT03386344|471860488|FG002|Overall Study|Adverse Event|1|||
131062128|NCT03386344|471860486|FG000|Overall Study|Poor Compliance to Protocol|0|||
131137264|NCT01928381|472128294|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
131062129|NCT03386344|471860487|FG001|Overall Study|Poor Compliance to Protocol|1|||
131062130|NCT03386344|471860488|FG002|Overall Study|Poor Compliance to Protocol|0|||
131062131|NCT03386344|471860486|FG000|Overall Study|Study Terminated by Sponsor|101|||
131062132|NCT03386344|471860487|FG001|Overall Study|Study Terminated by Sponsor|102|||
131062133|NCT03386344|471860488|FG002|Overall Study|Study Terminated by Sponsor|106|||
131062134|NCT03386344|471860486|FG000|Overall Study|Lost to Follow-up|3|||
131062135|NCT03386344|471860487|FG001|Overall Study|Lost to Follow-up|2|||
131062136|NCT03386344|471860488|FG002|Overall Study|Lost to Follow-up|1|||
131062137|NCT03386344|471860486|FG000|Overall Study|At the Participant's own Request|7|||
131062138|NCT03386344|471860487|FG001|Overall Study|At the Participant's own Request|7|||
131062139|NCT03386344|471860488|FG002|Overall Study|At the Participant's own Request|8|||
131062140|NCT03386344|471860486|FG000|Overall Study|Reason not Specified|0|||
131062141|NCT03386344|471860487|FG001|Overall Study|Reason not Specified|1|||
131062142|NCT03386344|471860488|FG002|Overall Study|Reason not Specified|0|||
131062143|NCT01280721|471860491|FG000|Overall Study|Adverse Event|4|||
131062144|NCT01280721|471860491|FG000|Overall Study|Physician Decision|3|||
131062145|NCT01280721|471860491|FG000|Overall Study|Withdrawal by Subject|6|||
131062146|NCT01280721|471860491|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
131062147|NCT01280721|471860491|FG000|Overall Study|No tolerability for the lowest dose|2|||
131062148|NCT01180400|471860492|FG000|Overall Study|Withdrawal by Subject|5|||
131062149|NCT01180400|471860493|FG001|Overall Study|Withdrawal by Subject|6|||
131062150|NCT01180400|471860492|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
131062151|NCT01180400|471860493|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
131062152|NCT01180400|471860492|FG000|Overall Study|Adverse Event|12|||
131062153|NCT01180400|471860493|FG001|Overall Study|Adverse Event|10|||
131062154|NCT01180400|471860492|FG000|Overall Study|Severe non-compliance to protocol|1|||
131062155|NCT01180400|471860493|FG001|Overall Study|Severe non-compliance to protocol|2|||
131062156|NCT01180400|471860492|FG000|Overall Study|Condition under investigation worsened|2|||
131062157|NCT01180400|471860493|FG001|Overall Study|Condition under investigation worsened|1|||
131062158|NCT01180400|471860492|FG000|Overall Study|Lack of Efficacy|2|||
131062159|NCT01180400|471860493|FG001|Overall Study|Lack of Efficacy|0|||
131062160|NCT01180400|471860492|FG000|Overall Study|Study-specific withdrawal criteria|1|||
131062161|NCT01180400|471860493|FG001|Overall Study|Study-specific withdrawal criteria|2|||
131062162|NCT01180400|471860492|FG000|Overall Study|Lost to Follow-up|2|||
131062163|NCT01180400|471860493|FG001|Overall Study|Lost to Follow-up|3|||
131062164|NCT01180400|471860492|FG000|Overall Study|Other|0|||
131062165|NCT01180400|471860493|FG001|Overall Study|Other|1|||
131062166|NCT00963924|471860494|FG000|Overall Study|Adverse Event|1|||
131062167|NCT00963924|471860495|FG001|Overall Study|Adverse Event|0|||
131062168|NCT00963924|471860494|FG000|Overall Study|Withdrawal by Subject|0|||
131062169|NCT00963924|471860495|FG001|Overall Study|Withdrawal by Subject|1|||
131062170|NCT00963924|471860494|FG000|Overall Study|Changed antipsychotic|0|||
131062171|NCT00963924|471860495|FG001|Overall Study|Changed antipsychotic|1|||
131062172|NCT00963924|471860494|FG000|Overall Study|Lost to Follow-up|0|||
131062173|NCT00963924|471860495|FG001|Overall Study|Lost to Follow-up|1|||
131062174|NCT03031782|471860500|FG000|Treatment Period 1|Lack of Efficacy|3|||
131062175|NCT03031782|471860501|FG001|Treatment Period 1|Lack of Efficacy|0|||
131062176|NCT03031782|471860502|FG002|Treatment Period 1|Lack of Efficacy|0|||
131229991|NCT02115256|472467758|FG000|Overall Study|Withdrawal by Subject|0|||
131229992|NCT02115256|472467759|FG001|Overall Study|Withdrawal by Subject|1|||
131229993|NCT00905489|472467764|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
130722848|NCT03365011|470609750|FG001|Overall Study|Withdrawal by Subject|2|||
131062177|NCT03031782|471860503|FG003|Treatment Period 1|Lack of Efficacy|0|||
131062178|NCT03031782|471860504|FG004|Treatment Period 1|Lack of Efficacy|0|||
131062179|NCT03031782|471860500|FG000|Treatment Period 2|Physician Decision|0|||
131062180|NCT03031782|471860501|FG001|Treatment Period 2|Physician Decision|1|||
131062181|NCT03031782|471860502|FG002|Treatment Period 2|Physician Decision|0|||
131062182|NCT03031782|471860503|FG003|Treatment Period 2|Physician Decision|0|||
131062183|NCT03031782|471860504|FG004|Treatment Period 2|Physician Decision|3|||
131062184|NCT03031782|471860500|FG000|Treatment Period 2|Lack of Efficacy|0|||
131062185|NCT03031782|471860501|FG001|Treatment Period 2|Lack of Efficacy|1|||
131062186|NCT03031782|471860502|FG002|Treatment Period 2|Lack of Efficacy|0|||
131062187|NCT03031782|471860503|FG003|Treatment Period 2|Lack of Efficacy|0|||
131062188|NCT03031782|471860504|FG004|Treatment Period 2|Lack of Efficacy|1|||
131062189|NCT03031782|471860500|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131062190|NCT03031782|471860501|FG001|Treatment Period 2|Withdrawal by Subject|3|||
131062191|NCT03031782|471860502|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131062192|NCT03031782|471860503|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131062193|NCT03031782|471860504|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131062194|NCT03031782|471860500|FG000|Treatment Period 2|Adverse Event|0|||
131062195|NCT03031782|471860501|FG001|Treatment Period 2|Adverse Event|1|||
131062196|NCT03031782|471860502|FG002|Treatment Period 2|Adverse Event|2|||
131062197|NCT03031782|471860503|FG003|Treatment Period 2|Adverse Event|0|||
131062198|NCT03031782|471860504|FG004|Treatment Period 2|Adverse Event|0|||
131229994|NCT00905489|472467764|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
130722849|NCT00499174|470609751|FG000|Overall Study|Physician Decision|78|||
131062199|NCT03031782|471860500|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131062200|NCT03031782|471860501|FG001|Treatment Period 3|Withdrawal by Subject|0|||
131062201|NCT03031782|471860502|FG002|Treatment Period 3|Withdrawal by Subject|0|||
131062202|NCT03031782|471860503|FG003|Treatment Period 3|Withdrawal by Subject|1|||
131062203|NCT03031782|471860504|FG004|Treatment Period 3|Withdrawal by Subject|0|||
131062204|NCT02170207|471860507|FG000|Overall Study|Case report forms unavailable|5|||
131062205|NCT00886834|471860508|FG000|Overall Study|Protocol Violation|0|||
131062206|NCT00886834|471860509|FG001|Overall Study|Protocol Violation|3|||
131062207|NCT03122860|471860510|FG000|Overall Study|Discontinued Before Treatment|1|||
131062208|NCT03122860|471860511|FG001|Overall Study|Discontinued Before Treatment|1|||
131062209|NCT03122860|471860512|FG002|Overall Study|Discontinued Before Treatment|2|||
131062210|NCT03122860|471860513|FG003|Overall Study|Discontinued Before Treatment|0|||
131062211|NCT03122860|471860514|FG004|Overall Study|Discontinued Before Treatment|1|||
131062212|NCT03122860|471860515|FG005|Overall Study|Discontinued Before Treatment|0|||
131062213|NCT03122860|471860510|FG000|Overall Study|Adverse Event|1|||
131062214|NCT03122860|471860511|FG001|Overall Study|Adverse Event|0|||
131062215|NCT03122860|471860512|FG002|Overall Study|Adverse Event|1|||
131062216|NCT03122860|471860513|FG003|Overall Study|Adverse Event|1|||
131062217|NCT03122860|471860514|FG004|Overall Study|Adverse Event|0|||
131062218|NCT03122860|471860515|FG005|Overall Study|Adverse Event|0|||
131062219|NCT03122860|471860510|FG000|Overall Study|Lost to Follow-up|5|||
131062220|NCT03122860|471860511|FG001|Overall Study|Lost to Follow-up|2|||
131062221|NCT03122860|471860512|FG002|Overall Study|Lost to Follow-up|3|||
131062222|NCT03122860|471860513|FG003|Overall Study|Lost to Follow-up|3|||
131062223|NCT03122860|471860514|FG004|Overall Study|Lost to Follow-up|5|||
131062224|NCT03122860|471860515|FG005|Overall Study|Lost to Follow-up|4|||
131062225|NCT03122860|471860510|FG000|Overall Study|Subject Non-Compliance|0|||
131062226|NCT03122860|471860511|FG001|Overall Study|Subject Non-Compliance|0|||
131062227|NCT03122860|471860512|FG002|Overall Study|Subject Non-Compliance|1|||
131062228|NCT03122860|471860513|FG003|Overall Study|Subject Non-Compliance|0|||
131062229|NCT03122860|471860514|FG004|Overall Study|Subject Non-Compliance|0|||
131062230|NCT03122860|471860515|FG005|Overall Study|Subject Non-Compliance|0|||
131062231|NCT03122860|471860510|FG000|Overall Study|Withdrawal by Subject|3|||
131062232|NCT03122860|471860511|FG001|Overall Study|Withdrawal by Subject|2|||
131062233|NCT03122860|471860512|FG002|Overall Study|Withdrawal by Subject|5|||
131062234|NCT03122860|471860513|FG003|Overall Study|Withdrawal by Subject|7|||
131062235|NCT03122860|471860514|FG004|Overall Study|Withdrawal by Subject|9|||
131062236|NCT03122860|471860515|FG005|Overall Study|Withdrawal by Subject|8|||
131062237|NCT01138657|471860516|FG000|Overall Study|Adverse Event|3|||
131062238|NCT01138657|471860517|FG001|Overall Study|Adverse Event|10|||
131062239|NCT01138657|471860516|FG000|Overall Study|Lack of Efficacy|2|||
131062240|NCT01138657|471860517|FG001|Overall Study|Lack of Efficacy|1|||
131062241|NCT01138657|471860516|FG000|Overall Study|Lost to Follow-up|0|||
131062242|NCT01138657|471860517|FG001|Overall Study|Lost to Follow-up|3|||
131062243|NCT01138657|471860516|FG000|Overall Study|Miscellaneous Reasons|3|||
131062244|NCT01138657|471860517|FG001|Overall Study|Miscellaneous Reasons|4|||
131062245|NCT03875729|471860518|FG000|Overall Study|Adverse Event|0|||
131062246|NCT03875729|471860519|FG001|Overall Study|Adverse Event|5|||
131062247|NCT03875729|471860518|FG000|Overall Study|Withdrawal by Subject|8|||
131062248|NCT03875729|471860519|FG001|Overall Study|Withdrawal by Subject|11|||
131062249|NCT03875729|471860518|FG000|Overall Study|Pregnancy|0|||
131062250|NCT03875729|471860519|FG001|Overall Study|Pregnancy|1|||
131062251|NCT03875729|471860518|FG000|Overall Study|Lost to Follow-up|0|||
131062252|NCT03875729|471860519|FG001|Overall Study|Lost to Follow-up|5|||
131137265|NCT01928381|472128295|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
131137266|NCT01928381|472128296|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
131137267|NCT01928381|472128297|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
131137268|NCT01928381|472128291|FG000|Washout First Intervention|Protocol Violation|0|||
131062253|NCT03875729|471860518|FG000|Overall Study|Personal reasons|2|||
131062254|NCT03875729|471860519|FG001|Overall Study|Personal reasons|0|||
131062255|NCT01405508|471860522|FG000|Overall Study|AE, non-serious non-fatal|1|||
131062256|NCT01405508|471860523|FG001|Overall Study|AE, non-serious non-fatal|1|||
131062257|NCT01405508|471860524|FG002|Overall Study|AE, non-serious non-fatal|0|||
131062258|NCT01405508|471860525|FG003|Overall Study|AE, non-serious non-fatal|0|||
131137269|NCT01928381|472128292|FG001|Washout First Intervention|Protocol Violation|0|||
131137270|NCT01928381|472128293|FG002|Washout First Intervention|Protocol Violation|0|||
131137271|NCT01928381|472128294|FG003|Washout First Intervention|Protocol Violation|0|||
131137272|NCT01928381|472128295|FG004|Washout First Intervention|Protocol Violation|1|||
131062259|NCT00476957|471860526|FG000|Overall Study|Lost to Follow-up|176|||
131062260|NCT00476957|471860527|FG001|Overall Study|Lost to Follow-up|193|||
131137273|NCT01928381|472128296|FG005|Washout First Intervention|Protocol Violation|0|||
131062261|NCT02159352|471860532|FG000|Overall Study|Adverse Event|3|||
131062262|NCT02159352|471860533|FG001|Overall Study|Adverse Event|1|||
131062263|NCT02159352|471860532|FG000|Overall Study|Withdrawal by Subject|0|||
131062264|NCT02159352|471860533|FG001|Overall Study|Withdrawal by Subject|1|||
131062265|NCT00529529|471860534|FG000|Overall Study|Adverse Event|12|||
131062266|NCT00529529|471860535|FG001|Overall Study|Adverse Event|17|||
131062267|NCT00529529|471860536|FG002|Overall Study|Adverse Event|8|||
131062268|NCT00529529|471860534|FG000|Overall Study|Subject withdrew consent|12|||
131062269|NCT00529529|471860535|FG001|Overall Study|Subject withdrew consent|9|||
131062270|NCT00529529|471860536|FG002|Overall Study|Subject withdrew consent|12|||
131062271|NCT00529529|471860534|FG000|Overall Study|Protocol deviation|8|||
131062272|NCT00529529|471860535|FG001|Overall Study|Protocol deviation|12|||
131062273|NCT00529529|471860536|FG002|Overall Study|Protocol deviation|5|||
131062274|NCT00529529|471860534|FG000|Overall Study|Lost to Follow-up|5|||
131062275|NCT00529529|471860535|FG001|Overall Study|Lost to Follow-up|3|||
131062276|NCT00529529|471860536|FG002|Overall Study|Lost to Follow-up|1|||
131062277|NCT00529529|471860534|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131062278|NCT00529529|471860535|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131062279|NCT00529529|471860536|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
131062280|NCT00529529|471860534|FG000|Overall Study|Death|2|||
131062281|NCT00529529|471860535|FG001|Overall Study|Death|0|||
131062282|NCT00529529|471860536|FG002|Overall Study|Death|0|||
131062283|NCT00529529|471860534|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131062284|NCT00529529|471860535|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131062285|NCT00529529|471860536|FG002|Overall Study|Abnormal test procedure result(s)|0|||
131062286|NCT00529529|471860534|FG000|Overall Study|Administrative problems|1|||
131062287|NCT00529529|471860535|FG001|Overall Study|Administrative problems|0|||
131062288|NCT00529529|471860536|FG002|Overall Study|Administrative problems|3|||
131062289|NCT01916109|471860541|FG000|Overall Study|Withdrawal by Subject|1|||
131062290|NCT00103857|471860542|FG000|54-Week Base Study|Adverse Event|12|||
131062291|NCT00103857|471860543|FG001|54-Week Base Study|Adverse Event|9|||
131062292|NCT00103857|471860544|FG002|54-Week Base Study|Adverse Event|11|||
131062293|NCT00103857|471860545|FG003|54-Week Base Study|Adverse Event|6|||
131062294|NCT00103857|471860546|FG004|54-Week Base Study|Adverse Event|5|||
131062295|NCT00103857|471860547|FG005|54-Week Base Study|Adverse Event|11|||
131062296|NCT00103857|471860548|FG006|54-Week Base Study|Adverse Event|3|||
131062297|NCT00103857|471860542|FG000|54-Week Base Study|Death|0|||
131062298|NCT00103857|471860543|FG001|54-Week Base Study|Death|0|||
131062299|NCT00103857|471860544|FG002|54-Week Base Study|Death|0|||
131062300|NCT00103857|471860545|FG003|54-Week Base Study|Death|0|||
131062301|NCT00103857|471860546|FG004|54-Week Base Study|Death|1|||
131062302|NCT00103857|471860547|FG005|54-Week Base Study|Death|1|||
131062303|NCT00103857|471860548|FG006|54-Week Base Study|Death|0|||
131062304|NCT00103857|471860542|FG000|54-Week Base Study|Lack of Efficacy|11|||
131062305|NCT00103857|471860543|FG001|54-Week Base Study|Lack of Efficacy|14|||
131062306|NCT00103857|471860544|FG002|54-Week Base Study|Lack of Efficacy|8|||
131062307|NCT00103857|471860545|FG003|54-Week Base Study|Lack of Efficacy|4|||
131062308|NCT00103857|471860546|FG004|54-Week Base Study|Lack of Efficacy|3|||
131062309|NCT00103857|471860547|FG005|54-Week Base Study|Lack of Efficacy|14|||
131062310|NCT00103857|471860548|FG006|54-Week Base Study|Lack of Efficacy|19|||
131062311|NCT00103857|471860542|FG000|54-Week Base Study|Lost to Follow-up|5|||
131062312|NCT00103857|471860543|FG001|54-Week Base Study|Lost to Follow-up|4|||
131062313|NCT00103857|471860544|FG002|54-Week Base Study|Lost to Follow-up|7|||
131062314|NCT00103857|471860545|FG003|54-Week Base Study|Lost to Follow-up|5|||
131062315|NCT00103857|471860546|FG004|54-Week Base Study|Lost to Follow-up|10|||
131062316|NCT00103857|471860547|FG005|54-Week Base Study|Lost to Follow-up|9|||
131062317|NCT00103857|471860548|FG006|54-Week Base Study|Lost to Follow-up|3|||
131137274|NCT01928381|472128297|FG006|Washout First Intervention|Protocol Violation|0|||
131137275|NCT01928381|472128291|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
131137276|NCT01928381|472128292|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
131137277|NCT01928381|472128293|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
131137278|NCT01928381|472128294|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
131137279|NCT01928381|472128295|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
131062318|NCT00103857|471860542|FG000|54-Week Base Study|Physician Decision|1|||
131062319|NCT00103857|471860543|FG001|54-Week Base Study|Physician Decision|1|||
131137280|NCT01928381|472128296|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
130722850|NCT00499174|470609752|FG001|Overall Study|Physician Decision|9|||
131062320|NCT00103857|471860544|FG002|54-Week Base Study|Physician Decision|0|||
131062321|NCT00103857|471860545|FG003|54-Week Base Study|Physician Decision|0|||
131062322|NCT00103857|471860546|FG004|54-Week Base Study|Physician Decision|1|||
131062323|NCT00103857|471860547|FG005|54-Week Base Study|Physician Decision|0|||
131062324|NCT00103857|471860548|FG006|54-Week Base Study|Physician Decision|0|||
131062325|NCT00103857|471860542|FG000|54-Week Base Study|Pregnancy|1|||
131062326|NCT00103857|471860543|FG001|54-Week Base Study|Pregnancy|0|||
131062327|NCT00103857|471860544|FG002|54-Week Base Study|Pregnancy|0|||
131062328|NCT00103857|471860545|FG003|54-Week Base Study|Pregnancy|0|||
131062329|NCT00103857|471860546|FG004|54-Week Base Study|Pregnancy|1|||
131062330|NCT00103857|471860547|FG005|54-Week Base Study|Pregnancy|0|||
131062331|NCT00103857|471860548|FG006|54-Week Base Study|Pregnancy|1|||
131062332|NCT00103857|471860542|FG000|54-Week Base Study|Protocol Violation|6|||
131062333|NCT00103857|471860543|FG001|54-Week Base Study|Protocol Violation|4|||
131062334|NCT00103857|471860544|FG002|54-Week Base Study|Protocol Violation|2|||
131062335|NCT00103857|471860545|FG003|54-Week Base Study|Protocol Violation|4|||
131062336|NCT00103857|471860546|FG004|54-Week Base Study|Protocol Violation|0|||
131062337|NCT00103857|471860547|FG005|54-Week Base Study|Protocol Violation|3|||
131062338|NCT00103857|471860548|FG006|54-Week Base Study|Protocol Violation|3|||
131062339|NCT00103857|471860542|FG000|54-Week Base Study|Withdrawal by Subject|17|||
131062340|NCT00103857|471860543|FG001|54-Week Base Study|Withdrawal by Subject|16|||
131062341|NCT00103857|471860544|FG002|54-Week Base Study|Withdrawal by Subject|16|||
131062342|NCT00103857|471860545|FG003|54-Week Base Study|Withdrawal by Subject|15|||
131062343|NCT00103857|471860546|FG004|54-Week Base Study|Withdrawal by Subject|10|||
131062344|NCT00103857|471860547|FG005|54-Week Base Study|Withdrawal by Subject|15|||
131062345|NCT00103857|471860548|FG006|54-Week Base Study|Withdrawal by Subject|4|||
131062346|NCT00103857|471860542|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
131062347|NCT00103857|471860543|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
131062348|NCT00103857|471860544|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
131062349|NCT00103857|471860545|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
131062350|NCT00103857|471860546|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
131062351|NCT00103857|471860547|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
131062352|NCT00103857|471860548|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
131062353|NCT00103857|471860542|FG000|54-Week Base Study|patient moved|0|||
131062354|NCT00103857|471860543|FG001|54-Week Base Study|patient moved|1|||
131062355|NCT00103857|471860544|FG002|54-Week Base Study|patient moved|1|||
131062356|NCT00103857|471860545|FG003|54-Week Base Study|patient moved|2|||
131062357|NCT00103857|471860546|FG004|54-Week Base Study|patient moved|3|||
131062358|NCT00103857|471860547|FG005|54-Week Base Study|patient moved|1|||
131062359|NCT00103857|471860548|FG006|54-Week Base Study|patient moved|0|||
131062360|NCT00103857|471860542|FG000|54-Week Base Study|non-compliance with study procedures|1|||
131062361|NCT00103857|471860543|FG001|54-Week Base Study|non-compliance with study procedures|2|||
131062362|NCT00103857|471860544|FG002|54-Week Base Study|non-compliance with study procedures|0|||
131062363|NCT00103857|471860545|FG003|54-Week Base Study|non-compliance with study procedures|0|||
131062364|NCT00103857|471860546|FG004|54-Week Base Study|non-compliance with study procedures|0|||
131062365|NCT00103857|471860547|FG005|54-Week Base Study|non-compliance with study procedures|2|||
131062366|NCT00103857|471860548|FG006|54-Week Base Study|non-compliance with study procedures|0|||
131062367|NCT00103857|471860542|FG000|54-Week Base Study|patient incarcerated|0|||
131062368|NCT00103857|471860543|FG001|54-Week Base Study|patient incarcerated|0|||
131062369|NCT00103857|471860544|FG002|54-Week Base Study|patient incarcerated|0|||
131062370|NCT00103857|471860545|FG003|54-Week Base Study|patient incarcerated|0|||
131062371|NCT00103857|471860546|FG004|54-Week Base Study|patient incarcerated|1|||
131062372|NCT00103857|471860547|FG005|54-Week Base Study|patient incarcerated|1|||
131062373|NCT00103857|471860548|FG006|54-Week Base Study|patient incarcerated|0|||
131062374|NCT00103857|471860542|FG000|54-Week Base Study|laboratory reporting error|0|||
131062375|NCT00103857|471860543|FG001|54-Week Base Study|laboratory reporting error|0|||
131062376|NCT00103857|471860544|FG002|54-Week Base Study|laboratory reporting error|0|||
131062377|NCT00103857|471860545|FG003|54-Week Base Study|laboratory reporting error|0|||
131062378|NCT00103857|471860546|FG004|54-Week Base Study|laboratory reporting error|1|||
131062379|NCT00103857|471860547|FG005|54-Week Base Study|laboratory reporting error|0|||
131062380|NCT00103857|471860548|FG006|54-Week Base Study|laboratory reporting error|0|||
131062381|NCT00103857|471860542|FG000|54-Week Base Study|site error|0|||
131062382|NCT00103857|471860543|FG001|54-Week Base Study|site error|0|||
131062383|NCT00103857|471860544|FG002|54-Week Base Study|site error|0|||
131062384|NCT00103857|471860545|FG003|54-Week Base Study|site error|0|||
131062385|NCT00103857|471860546|FG004|54-Week Base Study|site error|0|||
131062386|NCT00103857|471860547|FG005|54-Week Base Study|site error|1|||
131062387|NCT00103857|471860548|FG006|54-Week Base Study|site error|0|||
131062388|NCT00103857|471860542|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
131062389|NCT00103857|471860543|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
131062390|NCT00103857|471860544|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
131062391|NCT00103857|471860545|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
131062392|NCT00103857|471860546|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
131062393|NCT00103857|471860547|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
131062394|NCT00103857|471860548|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
131062395|NCT00103857|471860542|FG000|50-Week Extension Study|Adverse Event|2|||
131062396|NCT00103857|471860543|FG001|50-Week Extension Study|Adverse Event|3|||
131062397|NCT00103857|471860544|FG002|50-Week Extension Study|Adverse Event|2|||
131062398|NCT00103857|471860545|FG003|50-Week Extension Study|Adverse Event|0|||
131062399|NCT00103857|471860546|FG004|50-Week Extension Study|Adverse Event|1|||
131137281|NCT01928381|472128297|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
131137282|NCT01928381|472128291|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
131062400|NCT00103857|471860547|FG005|50-Week Extension Study|Adverse Event|1|||
131062401|NCT00103857|471860548|FG006|50-Week Extension Study|Adverse Event|0|||
131062402|NCT00103857|471860542|FG000|50-Week Extension Study|Death|0|||
131062403|NCT00103857|471860543|FG001|50-Week Extension Study|Death|0|||
131062404|NCT00103857|471860544|FG002|50-Week Extension Study|Death|0|||
131137283|NCT01928381|472128292|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
131062405|NCT00103857|471860545|FG003|50-Week Extension Study|Death|1|||
131062406|NCT00103857|471860546|FG004|50-Week Extension Study|Death|0|||
131062407|NCT00103857|471860547|FG005|50-Week Extension Study|Death|1|||
131062408|NCT00103857|471860548|FG006|50-Week Extension Study|Death|0|||
131062409|NCT00103857|471860542|FG000|50-Week Extension Study|Lack of Efficacy|26|||
131062410|NCT00103857|471860543|FG001|50-Week Extension Study|Lack of Efficacy|15|||
131062411|NCT00103857|471860544|FG002|50-Week Extension Study|Lack of Efficacy|13|||
131062412|NCT00103857|471860545|FG003|50-Week Extension Study|Lack of Efficacy|16|||
131062413|NCT00103857|471860546|FG004|50-Week Extension Study|Lack of Efficacy|8|||
131062414|NCT00103857|471860547|FG005|50-Week Extension Study|Lack of Efficacy|8|||
131062415|NCT00103857|471860548|FG006|50-Week Extension Study|Lack of Efficacy|0|||
131062416|NCT00103857|471860542|FG000|50-Week Extension Study|Lost to Follow-up|4|||
131062417|NCT00103857|471860543|FG001|50-Week Extension Study|Lost to Follow-up|0|||
131062418|NCT00103857|471860544|FG002|50-Week Extension Study|Lost to Follow-up|1|||
131062419|NCT00103857|471860545|FG003|50-Week Extension Study|Lost to Follow-up|4|||
131062420|NCT00103857|471860546|FG004|50-Week Extension Study|Lost to Follow-up|3|||
131062421|NCT00103857|471860547|FG005|50-Week Extension Study|Lost to Follow-up|3|||
131062422|NCT00103857|471860548|FG006|50-Week Extension Study|Lost to Follow-up|0|||
131062423|NCT00103857|471860542|FG000|50-Week Extension Study|Physician Decision|0|||
131062424|NCT00103857|471860543|FG001|50-Week Extension Study|Physician Decision|1|||
131062425|NCT00103857|471860544|FG002|50-Week Extension Study|Physician Decision|1|||
131062426|NCT00103857|471860545|FG003|50-Week Extension Study|Physician Decision|0|||
131062427|NCT00103857|471860546|FG004|50-Week Extension Study|Physician Decision|0|||
131062428|NCT00103857|471860547|FG005|50-Week Extension Study|Physician Decision|0|||
131062429|NCT00103857|471860548|FG006|50-Week Extension Study|Physician Decision|0|||
131062430|NCT00103857|471860542|FG000|50-Week Extension Study|Pregnancy|0|||
131062431|NCT00103857|471860543|FG001|50-Week Extension Study|Pregnancy|0|||
131062432|NCT00103857|471860544|FG002|50-Week Extension Study|Pregnancy|1|||
131062433|NCT00103857|471860545|FG003|50-Week Extension Study|Pregnancy|0|||
131062434|NCT00103857|471860546|FG004|50-Week Extension Study|Pregnancy|1|||
131062435|NCT00103857|471860547|FG005|50-Week Extension Study|Pregnancy|0|||
131062436|NCT00103857|471860548|FG006|50-Week Extension Study|Pregnancy|0|||
131062437|NCT00103857|471860542|FG000|50-Week Extension Study|Protocol Violation|1|||
131062438|NCT00103857|471860543|FG001|50-Week Extension Study|Protocol Violation|1|||
131062439|NCT00103857|471860544|FG002|50-Week Extension Study|Protocol Violation|1|||
131062440|NCT00103857|471860545|FG003|50-Week Extension Study|Protocol Violation|2|||
131062441|NCT00103857|471860546|FG004|50-Week Extension Study|Protocol Violation|0|||
131137284|NCT01928381|472128293|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
131137285|NCT01928381|472128294|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
131137286|NCT01928381|472128295|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
131137287|NCT01928381|472128296|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
131137288|NCT01928381|472128297|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
131137289|NCT03406897|472128299|FG000|Overall Study|Lost to Follow-up|1|||
131137290|NCT03406897|472128300|FG001|Overall Study|Lost to Follow-up|2|||
131137291|NCT03406897|472128299|FG000|Overall Study|Withdrawal by Subject|4|||
131137292|NCT03406897|472128300|FG001|Overall Study|Withdrawal by Subject|4|||
131137293|NCT03406897|472128299|FG000|Overall Study|Physician Decision|0|||
131137294|NCT03406897|472128300|FG001|Overall Study|Physician Decision|1|||
131137295|NCT03087955|472130556|FG000|Overall Study|Death|4|||
131137296|NCT03087955|472130557|FG001|Overall Study|Death|0|||
131137297|NCT03087955|472130556|FG000|Overall Study|Lack of Efficacy|2|||
131137298|NCT03087955|472130557|FG001|Overall Study|Lack of Efficacy|0|||
131137299|NCT03087955|472130556|FG000|Overall Study|Lost to Follow-up|1|||
131137300|NCT03087955|472130557|FG001|Overall Study|Lost to Follow-up|0|||
131137301|NCT04441905|472130558|FG000|Overall Study|Lost to Follow-up|1|||
131137302|NCT04441905|472130559|FG001|Overall Study|Lost to Follow-up|0|||
131137303|NCT04441905|472130560|FG002|Overall Study|Lost to Follow-up|0|||
131137304|NCT04441905|472130561|FG003|Overall Study|Lost to Follow-up|0|||
131137305|NCT04441905|472130562|FG004|Overall Study|Lost to Follow-up|0|||
131062442|NCT00103857|471860547|FG005|50-Week Extension Study|Protocol Violation|1|||
131062443|NCT00103857|471860548|FG006|50-Week Extension Study|Protocol Violation|0|||
131062444|NCT00103857|471860542|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
131062445|NCT00103857|471860543|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
131137306|NCT04441905|472130563|FG005|Overall Study|Lost to Follow-up|0|||
131062446|NCT00103857|471860544|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
131062447|NCT00103857|471860545|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
131062448|NCT00103857|471860546|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
131062449|NCT00103857|471860547|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
131062450|NCT00103857|471860548|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
131062451|NCT00103857|471860542|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
131062452|NCT00103857|471860543|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
131137307|NCT04441905|472130558|FG000|Overall Study|Enrolled but treatment not administered|0|||
131137308|NCT04441905|472130559|FG001|Overall Study|Enrolled but treatment not administered|1|||
131137309|NCT04441905|472130560|FG002|Overall Study|Enrolled but treatment not administered|0|||
131062453|NCT00103857|471860544|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
131062454|NCT00103857|471860545|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
131062455|NCT00103857|471860546|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
131062456|NCT00103857|471860547|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
131062457|NCT00103857|471860548|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
131062458|NCT00103857|471860542|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
131062459|NCT00103857|471860543|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
131062460|NCT00103857|471860544|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
131062461|NCT00103857|471860545|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
131062462|NCT00103857|471860546|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
131062463|NCT00103857|471860547|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
131062464|NCT00103857|471860548|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
131062465|NCT00103857|471860542|FG000|50-Week Extension Study|patient moved|0|||
131062466|NCT00103857|471860543|FG001|50-Week Extension Study|patient moved|0|||
131062467|NCT00103857|471860544|FG002|50-Week Extension Study|patient moved|1|||
131062468|NCT00103857|471860545|FG003|50-Week Extension Study|patient moved|2|||
131062469|NCT00103857|471860546|FG004|50-Week Extension Study|patient moved|0|||
131062470|NCT00103857|471860547|FG005|50-Week Extension Study|patient moved|0|||
131062471|NCT00103857|471860548|FG006|50-Week Extension Study|patient moved|0|||
131062472|NCT00103857|471860542|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
131062473|NCT00103857|471860543|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
131062474|NCT00103857|471860544|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
131062475|NCT00103857|471860545|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
131062476|NCT00103857|471860546|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
131062477|NCT00103857|471860547|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
131062478|NCT00103857|471860548|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
131062479|NCT00103857|471860542|FG000|50-Week Extension Study|reason unspecified|0|||
131062480|NCT00103857|471860543|FG001|50-Week Extension Study|reason unspecified|0|||
131062481|NCT00103857|471860544|FG002|50-Week Extension Study|reason unspecified|0|||
131062482|NCT00103857|471860545|FG003|50-Week Extension Study|reason unspecified|0|||
131062483|NCT00103857|471860546|FG004|50-Week Extension Study|reason unspecified|1|||
131062484|NCT00103857|471860547|FG005|50-Week Extension Study|reason unspecified|0|||
131062485|NCT00103857|471860548|FG006|50-Week Extension Study|reason unspecified|0|||
131062486|NCT00636168|471860551|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
131062487|NCT00636168|471860552|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
131062488|NCT00636168|471860551|FG000|Randomized to Study Drug|Adverse Event|1|||
131062489|NCT00636168|471860552|FG001|Randomized to Study Drug|Adverse Event|0|||
131062490|NCT00636168|471860551|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
131062491|NCT00636168|471860552|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
131062492|NCT00636168|471860551|FG000|Treated With Study Drug|Recurrence of disease|135|||
131062493|NCT00636168|471860552|FG001|Treated With Study Drug|Recurrence of disease|282|||
131062494|NCT00636168|471860551|FG000|Treated With Study Drug|Adverse Event|250|||
131062495|NCT00636168|471860552|FG001|Treated With Study Drug|Adverse Event|22|||
131062496|NCT00636168|471860551|FG000|Treated With Study Drug|Participant withdrew consent|16|||
131062497|NCT00636168|471860552|FG001|Treated With Study Drug|Participant withdrew consent|21|||
131062498|NCT00636168|471860551|FG000|Treated With Study Drug|Poor/non-compliance|1|||
131062499|NCT00636168|471860552|FG001|Treated With Study Drug|Poor/non-compliance|3|||
131062500|NCT00636168|471860551|FG000|Treated With Study Drug|Death|3|||
131062501|NCT00636168|471860552|FG001|Treated With Study Drug|Death|0|||
131062502|NCT00636168|471860551|FG000|Treated With Study Drug|Pregnancy|1|||
131062503|NCT00636168|471860552|FG001|Treated With Study Drug|Pregnancy|0|||
131062504|NCT00636168|471860551|FG000|Treated With Study Drug|No longer meets study criteria|1|||
130722851|NCT02351960|470609755|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
131062505|NCT00636168|471860552|FG001|Treated With Study Drug|No longer meets study criteria|0|||
131062506|NCT00636168|471860551|FG000|Treated With Study Drug|Other reason|1|||
131062507|NCT00636168|471860552|FG001|Treated With Study Drug|Other reason|3|||
131062508|NCT00636168|471860551|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
131062509|NCT00636168|471860552|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
131062510|NCT00636168|471860551|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
131062511|NCT00636168|471860552|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
131062512|NCT00636168|471860551|FG000|Long Term Follow-Up|Death|8|||
131062513|NCT00636168|471860552|FG001|Long Term Follow-Up|Death|9|||
131062514|NCT01005914|471860553|FG000|Overall Study|Adverse Event|4|||
131062515|NCT01005914|471860553|FG000|Overall Study|Death|4|||
131062516|NCT01005914|471860553|FG000|Overall Study|Lack of Efficacy|1|||
131062517|NCT01005914|471860553|FG000|Overall Study|Withdrawal by Subject|1|||
131062518|NCT02707952|471860554|FG000|Overall Study|Adverse Event|1|||
131062519|NCT02707952|471860555|FG001|Overall Study|Adverse Event|0|||
131062520|NCT02707952|471860556|FG002|Overall Study|Adverse Event|0|||
131137310|NCT04441905|472130561|FG003|Overall Study|Enrolled but treatment not administered|0|||
131062521|NCT02707952|471860557|FG003|Overall Study|Adverse Event|0|||
131062522|NCT02707952|471860554|FG000|Overall Study|Lost to Follow-up|1|||
131062523|NCT02707952|471860555|FG001|Overall Study|Lost to Follow-up|0|||
131062524|NCT02707952|471860556|FG002|Overall Study|Lost to Follow-up|0|||
131062525|NCT02707952|471860557|FG003|Overall Study|Lost to Follow-up|0|||
131062526|NCT02707952|471860554|FG000|Overall Study|Withdrawal by Subject|0|||
131062527|NCT02707952|471860555|FG001|Overall Study|Withdrawal by Subject|1|||
131062528|NCT02707952|471860556|FG002|Overall Study|Withdrawal by Subject|2|||
131062529|NCT02707952|471860557|FG003|Overall Study|Withdrawal by Subject|0|||
131062530|NCT01240785|471860559|FG000|Overall Study|Lost to Follow-up|1|||
131062531|NCT01240785|471860560|FG001|Overall Study|Lost to Follow-up|0|||
131062532|NCT01240785|471860559|FG000|Overall Study|Protocol Violation|0|||
131062533|NCT01240785|471860560|FG001|Overall Study|Protocol Violation|3|||
131062534|NCT00237809|471860561|FG000|Overall Study|Lost to Follow-up|11|||
131062535|NCT00237809|471860562|FG001|Overall Study|Lost to Follow-up|10|||
131062536|NCT00237809|471860563|FG002|Overall Study|Lost to Follow-up|9|||
131062537|NCT00237809|471860564|FG003|Overall Study|Lost to Follow-up|9|||
131062538|NCT02006641|471860565|FG000|Overall Study|Withdrawal before treatment|2|||
131062539|NCT02006641|471860566|FG001|Overall Study|Withdrawal before treatment|5|||
131062540|NCT02006641|471860567|FG002|Overall Study|Withdrawal before treatment|3|||
131062541|NCT02006641|471860565|FG000|Overall Study|Adverse Event|15|||
131229995|NCT00905489|472467764|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
131229996|NCT02668302|472467768|FG000|Overall Study|Withdrawal by Subject|1|||
130722852|NCT02351960|470609756|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
130722853|NCT02351960|470609755|FG000|Overall Study|Voluntary Withdrawal|5|||
130722854|NCT02351960|470609756|FG001|Overall Study|Voluntary Withdrawal|4|||
130722855|NCT02351960|470609755|FG000|Overall Study|Significant Protocol Deviation|0|||
130722856|NCT02351960|470609756|FG001|Overall Study|Significant Protocol Deviation|5|||
131062542|NCT02006641|471860566|FG001|Overall Study|Adverse Event|11|||
131062543|NCT02006641|471860567|FG002|Overall Study|Adverse Event|15|||
131062544|NCT02006641|471860565|FG000|Overall Study|Protocol Violation|0|||
131062545|NCT02006641|471860566|FG001|Overall Study|Protocol Violation|2|||
131062546|NCT02006641|471860567|FG002|Overall Study|Protocol Violation|2|||
131062547|NCT02006641|471860565|FG000|Overall Study|Lost to Follow-up|0|||
131062548|NCT02006641|471860566|FG001|Overall Study|Lost to Follow-up|1|||
131062549|NCT02006641|471860567|FG002|Overall Study|Lost to Follow-up|0|||
131062550|NCT02006641|471860565|FG000|Overall Study|Withdrawal by Subject|7|||
131062551|NCT02006641|471860566|FG001|Overall Study|Withdrawal by Subject|12|||
131062552|NCT02006641|471860567|FG002|Overall Study|Withdrawal by Subject|11|||
131062553|NCT02006641|471860565|FG000|Overall Study|Other reason: patient didn't show up|1|||
131062554|NCT02006641|471860566|FG001|Overall Study|Other reason: patient didn't show up|0|||
131062555|NCT02006641|471860567|FG002|Overall Study|Other reason: patient didn't show up|0|||
131062556|NCT02006641|471860565|FG000|Overall Study|Other reason:patient didn't want to come|0|||
131062557|NCT02006641|471860566|FG001|Overall Study|Other reason:patient didn't want to come|0|||
131062558|NCT02006641|471860567|FG002|Overall Study|Other reason:patient didn't want to come|1|||
131062559|NCT02006641|471860565|FG000|Overall Study|Other reason: patient has moved|1|||
131062560|NCT02006641|471860566|FG001|Overall Study|Other reason: patient has moved|0|||
131062561|NCT02006641|471860567|FG002|Overall Study|Other reason: patient has moved|1|||
131062562|NCT02006641|471860565|FG000|Overall Study|Other reason: caregiver in hospital|0|||
131062563|NCT02006641|471860566|FG001|Overall Study|Other reason: caregiver in hospital|1|||
131062564|NCT02006641|471860567|FG002|Overall Study|Other reason: caregiver in hospital|0|||
131062565|NCT02006641|471860565|FG000|Overall Study|Other reason: patient's wife has died|0|||
131062566|NCT02006641|471860566|FG001|Overall Study|Other reason: patient's wife has died|0|||
131062567|NCT02006641|471860567|FG002|Overall Study|Other reason: patient's wife has died|1|||
131062568|NCT02006641|471860565|FG000|Overall Study|Other reason: hospitalisation|0|||
131062569|NCT02006641|471860566|FG001|Overall Study|Other reason: hospitalisation|1|||
131062570|NCT02006641|471860567|FG002|Overall Study|Other reason: hospitalisation|0|||
131062571|NCT02006641|471860565|FG000|Overall Study|Other reason: caregiver impossibility|0|||
131062572|NCT02006641|471860566|FG001|Overall Study|Other reason: caregiver impossibility|0|||
131062573|NCT02006641|471860567|FG002|Overall Study|Other reason: caregiver impossibility|1|||
131062574|NCT02006641|471860565|FG000|Overall Study|Other reason: protocol non-compliance|0|||
131062575|NCT02006641|471860566|FG001|Overall Study|Other reason: protocol non-compliance|0|||
131062576|NCT02006641|471860567|FG002|Overall Study|Other reason: protocol non-compliance|1|||
131062577|NCT02132195|471860570|FG000|Initial Assignment|Relapsed|14|||
131062578|NCT02132195|471860571|FG001|Initial Assignment|Relapsed|0|||
131062579|NCT02132195|471860572|FG002|Initial Assignment|Relapsed|0|||
131062580|NCT02132195|471860570|FG000|Rescue Therapy|Relapsed|0|||
131062581|NCT02132195|471860571|FG001|Rescue Therapy|Relapsed|0|||
131062582|NCT02132195|471860572|FG002|Rescue Therapy|Relapsed|7|||
131062583|NCT02132195|471860570|FG000|Rescue Therapy|Physician Decision|0|||
131062584|NCT02132195|471860571|FG001|Rescue Therapy|Physician Decision|0|||
131062585|NCT02132195|471860572|FG002|Rescue Therapy|Physician Decision|1|||
131062586|NCT02132195|471860570|FG000|Rescue Therapy|Withdrawal by Subject|0|||
131062587|NCT02132195|471860571|FG001|Rescue Therapy|Withdrawal by Subject|0|||
131062588|NCT02132195|471860572|FG002|Rescue Therapy|Withdrawal by Subject|1|||
131062589|NCT02132195|471860570|FG000|Rescue Therapy|Adverse Event|0|||
131062590|NCT02132195|471860571|FG001|Rescue Therapy|Adverse Event|0|||
131062591|NCT02132195|471860572|FG002|Rescue Therapy|Adverse Event|2|||
131062592|NCT01287832|471860573|FG000|Overall Study|Adverse Event|1|||
131062593|NCT01287832|471860574|FG001|Overall Study|Adverse Event|0|||
131062594|NCT01287832|471860573|FG000|Overall Study|Death|0|||
131062595|NCT01287832|471860574|FG001|Overall Study|Death|1|||
131062596|NCT03065400|471860576|FG000|Overall Study|Adverse Event|1|||
131062597|NCT03065400|471860576|FG000|Overall Study|Physician Decision|3|||
131062598|NCT03065400|471860576|FG000|Overall Study|Withdrawal by Subject|1|||
131062599|NCT03065400|471860576|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
131062600|NCT04749797|471860577|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
131062601|NCT04749797|471860578|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
131062602|NCT04749797|471860579|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
131062603|NCT03072862|471860580|FG000|Overall Study|Withdrawal by Subject|4|||
131062604|NCT03072862|471860580|FG000|Overall Study|Lost to Follow-up|6|||
131062605|NCT03072862|471860580|FG000|Overall Study|Protocol Violation|4|||
131062606|NCT03072862|471860580|FG000|Overall Study|Physician Decision|2|||
131062607|NCT03072862|471860580|FG000|Overall Study|Death|1|||
131062608|NCT03072862|471860580|FG000|Overall Study|Adverse Event|1|||
131062609|NCT01441596|471860581|FG000|Overall Study|Other reason not defined below|0|||
131062610|NCT01441596|471860582|FG001|Overall Study|Other reason not defined below|2|||
131062611|NCT01441596|471860583|FG002|Overall Study|Other reason not defined below|1|||
131062612|NCT01441596|471860581|FG000|Overall Study|Withdrawal by Subject|4|||
131062613|NCT01441596|471860582|FG001|Overall Study|Withdrawal by Subject|0|||
131062614|NCT01441596|471860583|FG002|Overall Study|Withdrawal by Subject|2|||
131062615|NCT01441596|471860581|FG000|Overall Study|Not treated|0|||
131062616|NCT01441596|471860582|FG001|Overall Study|Not treated|1|||
131062617|NCT01441596|471860583|FG002|Overall Study|Not treated|1|||
131062618|NCT00871715|471860590|FG000|Overall Study|Withdrawal by Subject|6|||
131062619|NCT00871715|471860591|FG001|Overall Study|Withdrawal by Subject|10|||
131062620|NCT00871715|471860592|FG002|Overall Study|Withdrawal by Subject|15|||
131062621|NCT00871715|471860590|FG000|Overall Study|Physician Decision|6|||
131062622|NCT00871715|471860591|FG001|Overall Study|Physician Decision|0|||
131062623|NCT00871715|471860592|FG002|Overall Study|Physician Decision|2|||
131062624|NCT00871715|471860590|FG000|Overall Study|Lost to Follow-up|3|||
131062625|NCT00871715|471860591|FG001|Overall Study|Lost to Follow-up|6|||
131062626|NCT00871715|471860592|FG002|Overall Study|Lost to Follow-up|9|||
131062627|NCT01670526|471860594|FG000|Overall Study|Withdrawal by Subject|3|||
131062628|NCT01670526|471860595|FG001|Overall Study|Withdrawal by Subject|1|||
131062629|NCT01670526|471860594|FG000|Overall Study|Lost to Follow-up|9|||
131062630|NCT01670526|471860595|FG001|Overall Study|Lost to Follow-up|5|||
131062631|NCT02291549|471860596|FG000|Overall Study|Lost to Follow-up|1|||
131062632|NCT02291549|471860597|FG001|Overall Study|Lost to Follow-up|0|||
131062633|NCT02291549|471860596|FG000|Overall Study|Withdrawal by Subject|0|||
131062634|NCT02291549|471860597|FG001|Overall Study|Withdrawal by Subject|1|||
131062635|NCT01794689|471860598|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
131062636|NCT01794689|471860599|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
131062637|NCT01794689|471860600|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
131062638|NCT01794689|471860601|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
131062639|NCT01794689|471860598|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
131062640|NCT01794689|471860599|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
131062641|NCT01794689|471860600|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
131062642|NCT01794689|471860601|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
131062643|NCT01794689|471860598|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
131062644|NCT01794689|471860599|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
131062645|NCT01794689|471860600|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
131062646|NCT01794689|471860601|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
131062647|NCT01794689|471860598|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
131062648|NCT01794689|471860599|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
131062649|NCT01794689|471860600|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
131062650|NCT01794689|471860601|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
131062651|NCT01697956|471860602|FG000|Overall Study|Protocol Violation|1|||
131062652|NCT01697956|471860603|FG001|Overall Study|Protocol Violation|1|||
131062653|NCT02978716|471860607|FG000|Overall Study|Death|25|||
131062654|NCT02978716|471860608|FG001|Overall Study|Death|13|||
131062655|NCT02978716|471860609|FG002|Overall Study|Death|20|||
131062656|NCT02978716|471860607|FG000|Overall Study|Lost to Follow-up|0|||
131062657|NCT02978716|471860608|FG001|Overall Study|Lost to Follow-up|0|||
131062658|NCT02978716|471860609|FG002|Overall Study|Lost to Follow-up|1|||
131062659|NCT02978716|471860607|FG000|Overall Study|Withdrawal by Subject|6|||
131062660|NCT02978716|471860608|FG001|Overall Study|Withdrawal by Subject|4|||
131062661|NCT02978716|471860609|FG002|Overall Study|Withdrawal by Subject|5|||
131062662|NCT02978716|471860607|FG000|Overall Study|Sponsor terminated|2|||
131062663|NCT02978716|471860608|FG001|Overall Study|Sponsor terminated|13|||
131062664|NCT02978716|471860609|FG002|Overall Study|Sponsor terminated|9|||
131062665|NCT02978716|471860607|FG000|Overall Study|Other|1|||
131062666|NCT02978716|471860608|FG001|Overall Study|Other|3|||
131062667|NCT02978716|471860609|FG002|Overall Study|Other|0|||
131062668|NCT00960206|471860610|FG000|Overall Study|Death|7|||
131062669|NCT00960206|471860611|FG001|Overall Study|Death|4|||
131062670|NCT00960206|471860612|FG002|Overall Study|Death|1|||
131062671|NCT00960206|471860610|FG000|Overall Study|Unwilling/Unable to return|1|||
131062672|NCT00960206|471860611|FG001|Overall Study|Unwilling/Unable to return|2|||
131062673|NCT00960206|471860612|FG002|Overall Study|Unwilling/Unable to return|0|||
131062674|NCT00960206|471860610|FG000|Overall Study|Lost to Follow-up|8|||
131062675|NCT00960206|471860611|FG001|Overall Study|Lost to Follow-up|14|||
131062676|NCT00960206|471860612|FG002|Overall Study|Lost to Follow-up|8|||
131137311|NCT04441905|472130562|FG004|Overall Study|Enrolled but treatment not administered|0|||
131137312|NCT04441905|472130563|FG005|Overall Study|Enrolled but treatment not administered|0|||
131137313|NCT04441905|472130558|FG000|Overall Study|Became ineligible after enrollment|0|||
131137314|NCT04441905|472130559|FG001|Overall Study|Became ineligible after enrollment|0|||
131137315|NCT04441905|472130560|FG002|Overall Study|Became ineligible after enrollment|0|||
131137316|NCT04441905|472130561|FG003|Overall Study|Became ineligible after enrollment|0|||
131137317|NCT04441905|472130562|FG004|Overall Study|Became ineligible after enrollment|1|||
131137318|NCT04441905|472130563|FG005|Overall Study|Became ineligible after enrollment|0|||
131137319|NCT04770753|472130564|FG000|Overall Study|Randomized, never treated|1|||
131137320|NCT04770753|472130565|FG001|Overall Study|Randomized, never treated|1|||
131137321|NCT04770753|472130564|FG000|Overall Study|Withdrawal by Subject|3|||
131137322|NCT04770753|472130565|FG001|Overall Study|Withdrawal by Subject|1|||
131137323|NCT04770753|472130564|FG000|Overall Study|Adverse Event|2|||
131137324|NCT04770753|472130565|FG001|Overall Study|Adverse Event|0|||
131137325|NCT04770753|472130564|FG000|Overall Study|Pregnancy|1|||
131137326|NCT04770753|472130565|FG001|Overall Study|Pregnancy|0|||
131137327|NCT04770753|472130564|FG000|Overall Study|Other un-specified|1|||
131137328|NCT04770753|472130565|FG001|Overall Study|Other un-specified|0|||
131137329|NCT02775851|472130566|FG000|Overall Study|Adverse Event|1|||
131137330|NCT02775851|472130567|FG001|Overall Study|Adverse Event|10|||
131137331|NCT02775851|472130566|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
131137332|NCT02775851|472130567|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
131137333|NCT02775851|472130566|FG000|Overall Study|Progression/Relapse|0|||
131137334|NCT02775851|472130567|FG001|Overall Study|Progression/Relapse|4|||
131137335|NCT02775851|472130566|FG000|Overall Study|Other - Not Protocol Specified|0|||
131137336|NCT02775851|472130567|FG001|Overall Study|Other - Not Protocol Specified|7|||
131137337|NCT02775851|472130566|FG000|Overall Study|Withdrawal by Subject|1|||
131137338|NCT02775851|472130567|FG001|Overall Study|Withdrawal by Subject|0|||
131137339|NCT01934140|472130569|FG000|Persistence Phase (Year 6-10)|Other|24|||
131137340|NCT01934140|472130570|FG001|Persistence Phase (Year 6-10)|Other|6|||
131137341|NCT01934140|472130569|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
131137342|NCT01934140|472130570|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
131137343|NCT01934140|472130569|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
131137344|NCT01934140|472130570|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
131137345|NCT01934140|472130569|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
131137346|NCT01934140|472130570|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
131137347|NCT01934140|472130569|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
131137348|NCT01934140|472130570|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
131137349|NCT01934140|472130569|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
131137350|NCT01934140|472130570|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
131137351|NCT01934140|472130569|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
131137352|NCT01934140|472130570|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
131137353|NCT01934140|472130569|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
131137354|NCT01934140|472130570|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
131137355|NCT00618748|472130576|FG000|Overall Study|Adverse Event|4|||
131137356|NCT00618748|472130577|FG001|Overall Study|Adverse Event|3|||
131137357|NCT00618748|472130578|FG002|Overall Study|Adverse Event|8|||
131062677|NCT00960206|471860610|FG000|Overall Study|Withdrawal by Subject|2|||
131062678|NCT00960206|471860611|FG001|Overall Study|Withdrawal by Subject|4|||
131137358|NCT00618748|472130576|FG000|Overall Study|Physician Decision|3|||
131137359|NCT00618748|472130577|FG001|Overall Study|Physician Decision|1|||
131137360|NCT00618748|472130578|FG002|Overall Study|Physician Decision|1|||
130722857|NCT02968849|470609761|FG000|Overall Study|Death|8|||
131137361|NCT00618748|472130576|FG000|Overall Study|Withdrawal by Subject|4|||
131137362|NCT00618748|472130577|FG001|Overall Study|Withdrawal by Subject|1|||
131137363|NCT00618748|472130578|FG002|Overall Study|Withdrawal by Subject|5|||
131137364|NCT00200850|472130579|FG000|Overall Study|relocation|1|||
131137365|NCT00200850|472130580|FG001|Overall Study|relocation|0|||
131137366|NCT00200850|472130581|FG002|Overall Study|relocation|1|||
131137367|NCT00200850|472130579|FG000|Overall Study|too busy|1|||
130722858|NCT02968849|470609762|FG001|Overall Study|Death|10|||
131062679|NCT00960206|471860612|FG002|Overall Study|Withdrawal by Subject|0|||
131062680|NCT00960206|471860610|FG000|Overall Study|Revision of study component|2|||
131137368|NCT00200850|472130580|FG001|Overall Study|too busy|0|||
131137369|NCT00200850|472130581|FG002|Overall Study|too busy|0|||
131137370|NCT00200850|472130579|FG000|Overall Study|Pregnancy|0|||
131137371|NCT00200850|472130580|FG001|Overall Study|Pregnancy|0|||
131137372|NCT00200850|472130581|FG002|Overall Study|Pregnancy|1|||
131137373|NCT00200850|472130579|FG000|Overall Study|Poor adherence|0|||
131137374|NCT00200850|472130580|FG001|Overall Study|Poor adherence|0|||
131137375|NCT00200850|472130581|FG002|Overall Study|Poor adherence|1|||
131137376|NCT00200850|472130579|FG000|Overall Study|optic neuritis|0|||
131137377|NCT00200850|472130580|FG001|Overall Study|optic neuritis|0|||
131137378|NCT00200850|472130581|FG002|Overall Study|optic neuritis|1|||
131137379|NCT00200850|472130579|FG000|Overall Study|Adverse Event|1|||
131062681|NCT00960206|471860611|FG001|Overall Study|Revision of study component|2|||
131062682|NCT00960206|471860612|FG002|Overall Study|Revision of study component|2|||
131062683|NCT00960206|471860610|FG000|Overall Study|Missing 10 year data|20|||
131062684|NCT00960206|471860611|FG001|Overall Study|Missing 10 year data|1|||
131062685|NCT00960206|471860612|FG002|Overall Study|Missing 10 year data|1|||
131062686|NCT00091572|471860620|FG000|Overall Study|Lost to Follow-up|1|||
131062687|NCT00091572|471860621|FG001|Overall Study|Lost to Follow-up|1|||
131062688|NCT00091572|471860620|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
131062689|NCT00091572|471860621|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
131062690|NCT00091572|471860620|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
131062691|NCT00091572|471860621|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
131062692|NCT00091572|471860620|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
131062693|NCT00091572|471860621|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
131062694|NCT00091572|471860620|FG000|Overall Study|Other Reason|6|||
131062695|NCT00091572|471860621|FG001|Overall Study|Other Reason|13|||
131062696|NCT00091572|471860620|FG000|Overall Study|Ongoing (still on treatment)|8|||
131062697|NCT00091572|471860621|FG001|Overall Study|Ongoing (still on treatment)|12|||
131062698|NCT00091572|471860620|FG000|Overall Study|Major Protocol Violation|2|||
131062699|NCT00091572|471860621|FG001|Overall Study|Major Protocol Violation|0|||
131062700|NCT00091572|471860620|FG000|Overall Study|Toxicity (Related AE)|53|||
131062701|NCT00091572|471860621|FG001|Overall Study|Toxicity (Related AE)|9|||
131062702|NCT02942771|471860622|FG000|Overall Study|Adverse Event|1|||
131062703|NCT02942771|471860623|FG001|Overall Study|Adverse Event|0|||
131062704|NCT02942771|471860624|FG002|Overall Study|Adverse Event|0|||
131062705|NCT02942771|471860625|FG003|Overall Study|Adverse Event|0|||
131062706|NCT02942771|471860626|FG004|Overall Study|Adverse Event|2|||
131062707|NCT02942771|471860622|FG000|Overall Study|Lost to Follow-up|1|||
131062708|NCT02942771|471860623|FG001|Overall Study|Lost to Follow-up|0|||
131062709|NCT02942771|471860624|FG002|Overall Study|Lost to Follow-up|0|||
131062710|NCT02942771|471860625|FG003|Overall Study|Lost to Follow-up|0|||
131062711|NCT02942771|471860626|FG004|Overall Study|Lost to Follow-up|0|||
131062712|NCT02942771|471860622|FG000|Overall Study|Withdrawal by Subject|1|||
131062713|NCT02942771|471860623|FG001|Overall Study|Withdrawal by Subject|0|||
131062714|NCT02942771|471860624|FG002|Overall Study|Withdrawal by Subject|0|||
131062715|NCT02942771|471860625|FG003|Overall Study|Withdrawal by Subject|0|||
131062716|NCT02942771|471860626|FG004|Overall Study|Withdrawal by Subject|2|||
131062717|NCT02340806|471860630|FG000|Overall Study|Protocol Violation|2|||
131062718|NCT02340806|471860631|FG001|Overall Study|Protocol Violation|0|||
131062719|NCT02340806|471860630|FG000|Overall Study|epidural catheter replaced|2|||
131062720|NCT02340806|471860631|FG001|Overall Study|epidural catheter replaced|1|||
131062721|NCT02340806|471860630|FG000|Overall Study|history of chronic pain medication|1|||
131062722|NCT02340806|471860631|FG001|Overall Study|history of chronic pain medication|0|||
131062723|NCT02340806|471860630|FG000|Overall Study|re-dose < 90 min of CSE|1|||
131062724|NCT02340806|471860631|FG001|Overall Study|re-dose < 90 min of CSE|3|||
131062725|NCT01186809|471860632|FG000|Overall Study|Death|30|||
131062726|NCT04895085|471860633|FG000|Overall Study|Death|1|||
131062727|NCT04895085|471860633|FG000|Overall Study|Withdrawal by Subject|1|||
131062728|NCT04895085|471860633|FG000|Overall Study|No longer eligible: Moved from area|1|||
131062729|NCT01159600|471860639|FG000|Overall Study|Not treated|0|||
131062730|NCT01159600|471860640|FG001|Overall Study|Not treated|0|||
131137380|NCT00200850|472130580|FG001|Overall Study|Adverse Event|1|||
131137381|NCT00200850|472130581|FG002|Overall Study|Adverse Event|2|||
131137382|NCT02595879|472130586|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
131062731|NCT01159600|471860641|FG002|Overall Study|Not treated|1|||
131062732|NCT01159600|471860642|FG003|Overall Study|Not treated|0|||
131062733|NCT01159600|471860643|FG004|Overall Study|Not treated|0|||
131062734|NCT01159600|471860644|FG005|Overall Study|Not treated|1|||
131062735|NCT01159600|471860645|FG006|Overall Study|Not treated|2|||
131062736|NCT01159600|471860646|FG007|Overall Study|Not treated|2|||
131062737|NCT01159600|471860639|FG000|Overall Study|Adverse Event|7|||
131137383|NCT02595879|472130587|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
131137384|NCT04294459|472130588|FG000|Overall Study|Adverse Event|0|||
131137385|NCT04294459|472130589|FG001|Overall Study|Adverse Event|1|||
131062738|NCT01159600|471860640|FG001|Overall Study|Adverse Event|2|||
131062739|NCT01159600|471860641|FG002|Overall Study|Adverse Event|5|||
131062740|NCT01159600|471860642|FG003|Overall Study|Adverse Event|1|||
131062741|NCT01159600|471860643|FG004|Overall Study|Adverse Event|8|||
131062742|NCT01159600|471860644|FG005|Overall Study|Adverse Event|6|||
131062743|NCT01159600|471860645|FG006|Overall Study|Adverse Event|7|||
131062744|NCT01159600|471860646|FG007|Overall Study|Adverse Event|5|||
131062745|NCT01159600|471860639|FG000|Overall Study|Lack of Efficacy|0|||
131062746|NCT01159600|471860640|FG001|Overall Study|Lack of Efficacy|0|||
131062747|NCT01159600|471860641|FG002|Overall Study|Lack of Efficacy|0|||
131062748|NCT01159600|471860642|FG003|Overall Study|Lack of Efficacy|0|||
131062749|NCT01159600|471860643|FG004|Overall Study|Lack of Efficacy|2|||
131062750|NCT01159600|471860644|FG005|Overall Study|Lack of Efficacy|0|||
131062751|NCT01159600|471860645|FG006|Overall Study|Lack of Efficacy|0|||
131062752|NCT01159600|471860646|FG007|Overall Study|Lack of Efficacy|1|||
131062753|NCT01159600|471860639|FG000|Overall Study|Non compliant with protocol|2|||
131062754|NCT01159600|471860640|FG001|Overall Study|Non compliant with protocol|1|||
131062755|NCT01159600|471860641|FG002|Overall Study|Non compliant with protocol|0|||
131062756|NCT01159600|471860642|FG003|Overall Study|Non compliant with protocol|0|||
131062757|NCT01159600|471860643|FG004|Overall Study|Non compliant with protocol|2|||
131062758|NCT01159600|471860644|FG005|Overall Study|Non compliant with protocol|0|||
131062759|NCT01159600|471860645|FG006|Overall Study|Non compliant with protocol|2|||
131062760|NCT01159600|471860646|FG007|Overall Study|Non compliant with protocol|0|||
131062761|NCT01159600|471860639|FG000|Overall Study|Lost to Follow-up|2|||
131062762|NCT01159600|471860640|FG001|Overall Study|Lost to Follow-up|3|||
131062763|NCT01159600|471860641|FG002|Overall Study|Lost to Follow-up|4|||
130722859|NCT02968849|470609761|FG000|Overall Study|Lost to Follow-up|31|||
131062764|NCT01159600|471860642|FG003|Overall Study|Lost to Follow-up|3|||
131062765|NCT01159600|471860643|FG004|Overall Study|Lost to Follow-up|3|||
131062766|NCT01159600|471860644|FG005|Overall Study|Lost to Follow-up|0|||
131062767|NCT01159600|471860645|FG006|Overall Study|Lost to Follow-up|3|||
131062768|NCT01159600|471860646|FG007|Overall Study|Lost to Follow-up|2|||
131062769|NCT01159600|471860639|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
131062770|NCT01159600|471860640|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
131062771|NCT01159600|471860641|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
131062772|NCT01159600|471860642|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
131062773|NCT01159600|471860643|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
131062774|NCT01159600|471860644|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
131062775|NCT01159600|471860645|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
131062776|NCT01159600|471860646|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
131062777|NCT01159600|471860639|FG000|Overall Study|Other reason not defined above|3|||
131062778|NCT01159600|471860640|FG001|Overall Study|Other reason not defined above|0|||
131062779|NCT01159600|471860641|FG002|Overall Study|Other reason not defined above|4|||
131062780|NCT01159600|471860642|FG003|Overall Study|Other reason not defined above|2|||
131062781|NCT01159600|471860643|FG004|Overall Study|Other reason not defined above|5|||
131062782|NCT01159600|471860644|FG005|Overall Study|Other reason not defined above|7|||
131062783|NCT01159600|471860645|FG006|Overall Study|Other reason not defined above|3|||
131062784|NCT01159600|471860646|FG007|Overall Study|Other reason not defined above|3|||
131062785|NCT04433091|471860647|FG000|Overall Study|Lost to Follow-up|1|||
131062786|NCT04433091|471860648|FG001|Overall Study|Lost to Follow-up|0|||
131062787|NCT04433091|471860647|FG000|Overall Study|Withdrawn .|2|||
131062788|NCT04433091|471860648|FG001|Overall Study|Withdrawn .|4|||
131062789|NCT04097535|471860649|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
131062790|NCT03070301|471860650|FG000|Overall Study|Progression of disease|16|||
131062791|NCT03070301|471860650|FG000|Overall Study|Physician Decision|3|||
131062792|NCT03070301|471860650|FG000|Overall Study|Withdrawal by Subject|1|||
131062793|NCT00451906|471862304|FG000|Overall Study|Adverse Event|515|||
131062794|NCT00451906|471862304|FG000|Overall Study|Lost to Follow-up|31|||
131062795|NCT00451906|471862304|FG000|Overall Study|Withdrawal by Subject|111|||
131062796|NCT00451906|471862304|FG000|Overall Study|Protocol Violation|21|||
131062797|NCT00451906|471862304|FG000|Overall Study|Progressive disease|1328|||
131062798|NCT00451906|471862304|FG000|Overall Study|Termination of the study|108|||
130722860|NCT02968849|470609762|FG001|Overall Study|Lost to Follow-up|29|||
130722861|NCT02968849|470609761|FG000|Overall Study|Withdrawal by Subject|73|||
130722862|NCT02968849|470609762|FG001|Overall Study|Withdrawal by Subject|64|||
131062799|NCT00451906|471862304|FG000|Overall Study|Other Reasons|121|||
131062800|NCT00451906|471862304|FG000|Overall Study|Did not complete final visit|4|||
131062801|NCT03072238|471862309|FG000|Overall Study|Withdrawal by Subject|44|||
131062802|NCT03072238|471862310|FG001|Overall Study|Withdrawal by Subject|64|||
131062803|NCT03072238|471862309|FG000|Overall Study|Lost to Follow-up|14|||
131062804|NCT03072238|471862310|FG001|Overall Study|Lost to Follow-up|5|||
131062805|NCT03072238|471862309|FG000|Overall Study|Physician Decision|4|||
131062806|NCT03072238|471862310|FG001|Overall Study|Physician Decision|6|||
131062807|NCT03072238|471862309|FG000|Overall Study|Death|351|||
131062808|NCT03072238|471862310|FG001|Overall Study|Death|318|||
131062809|NCT03072238|471862309|FG000|Overall Study|Progressive Disease|3|||
131062810|NCT03072238|471862310|FG001|Overall Study|Progressive Disease|4|||
131062811|NCT03072238|471862309|FG000|Overall Study|Reason Not Specified|138|||
131062812|NCT03072238|471862310|FG001|Overall Study|Reason Not Specified|150|||
130722863|NCT02968849|470609761|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
131062813|NCT00307489|471862311|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
131062814|NCT00307489|471862312|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
131062815|NCT00307489|471862311|FG000|Baseline Through Week 48|Physician Decision|1|||
131062816|NCT00307489|471862312|FG001|Baseline Through Week 48|Physician Decision|0|||
131062817|NCT00307489|471862311|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
131062818|NCT00307489|471862312|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
130722864|NCT02968849|470609762|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
130722865|NCT02968849|470609761|FG000|Overall Study|Physician Decision|6|||
130722866|NCT02968849|470609762|FG001|Overall Study|Physician Decision|9|||
130722867|NCT02968849|470609761|FG000|Overall Study|Other|16|||
130722868|NCT02968849|470609762|FG001|Overall Study|Other|10|||
130722869|NCT02013674|470609765|FG000|Overall Study|Death|0|||
130722870|NCT02013674|470609766|FG001|Overall Study|Death|1|||
130722871|NCT02013674|470609765|FG000|Overall Study|Lost to Follow-up|1|||
130722872|NCT02013674|470609766|FG001|Overall Study|Lost to Follow-up|0|||
130722873|NCT00416884|470609767|FG000|Overall Study|Study terminated due to low accrual|1|||
130722874|NCT02203331|470609768|FG000|Overall Study|Pregnancy|1|||
130722875|NCT02203331|470609769|FG001|Overall Study|Pregnancy|0|||
130722876|NCT02203331|470609770|FG002|Overall Study|Pregnancy|0|||
130722877|NCT02203331|470609771|FG003|Overall Study|Pregnancy|0|||
130722878|NCT02203331|470609772|FG004|Overall Study|Pregnancy|2|||
130722879|NCT02203331|470609773|FG005|Overall Study|Pregnancy|0|||
130722880|NCT02203331|470609768|FG000|Overall Study|Withdrawal by Subject|1|||
130722881|NCT02203331|470609769|FG001|Overall Study|Withdrawal by Subject|0|||
130722882|NCT02203331|470609770|FG002|Overall Study|Withdrawal by Subject|1|||
130722883|NCT02203331|470609771|FG003|Overall Study|Withdrawal by Subject|0|||
130722884|NCT02203331|470609772|FG004|Overall Study|Withdrawal by Subject|0|||
130722885|NCT02203331|470609773|FG005|Overall Study|Withdrawal by Subject|3|||
130722886|NCT02203331|470609768|FG000|Overall Study|Adverse Event|4|||
130722887|NCT02203331|470609769|FG001|Overall Study|Adverse Event|8|||
130722888|NCT02203331|470609770|FG002|Overall Study|Adverse Event|3|||
130722889|NCT02203331|470609771|FG003|Overall Study|Adverse Event|4|||
130722890|NCT02203331|470609772|FG004|Overall Study|Adverse Event|3|||
130722891|NCT02203331|470609773|FG005|Overall Study|Adverse Event|3|||
130722892|NCT02203331|470609768|FG000|Overall Study|Other Reasons|1|||
130722893|NCT02203331|470609769|FG001|Overall Study|Other Reasons|2|||
130722894|NCT02203331|470609770|FG002|Overall Study|Other Reasons|0|||
130722895|NCT02203331|470609771|FG003|Overall Study|Other Reasons|2|||
130722896|NCT02203331|470609772|FG004|Overall Study|Other Reasons|0|||
130722897|NCT02203331|470609773|FG005|Overall Study|Other Reasons|0|||
130722898|NCT02203331|470609768|FG000|Overall Study|Lack of Efficacy|0|||
130722899|NCT02203331|470609769|FG001|Overall Study|Lack of Efficacy|2|||
130722900|NCT02203331|470609770|FG002|Overall Study|Lack of Efficacy|1|||
130722901|NCT02203331|470609771|FG003|Overall Study|Lack of Efficacy|0|||
130722902|NCT02203331|470609772|FG004|Overall Study|Lack of Efficacy|0|||
130722903|NCT02203331|470609773|FG005|Overall Study|Lack of Efficacy|1|||
130722904|NCT02203331|470609768|FG000|Overall Study|Protocol Violation|0|||
130722905|NCT02203331|470609769|FG001|Overall Study|Protocol Violation|2|||
130722906|NCT02203331|470609770|FG002|Overall Study|Protocol Violation|0|||
130722907|NCT02203331|470609771|FG003|Overall Study|Protocol Violation|1|||
130722908|NCT02203331|470609772|FG004|Overall Study|Protocol Violation|1|||
130722909|NCT02203331|470609773|FG005|Overall Study|Protocol Violation|0|||
130722910|NCT02203331|470609768|FG000|Overall Study|Lost to Follow-up|0|||
130722911|NCT02203331|470609769|FG001|Overall Study|Lost to Follow-up|0|||
130722912|NCT02203331|470609770|FG002|Overall Study|Lost to Follow-up|0|||
130722913|NCT02203331|470609771|FG003|Overall Study|Lost to Follow-up|0|||
130722914|NCT02203331|470609772|FG004|Overall Study|Lost to Follow-up|1|||
130722915|NCT02203331|470609773|FG005|Overall Study|Lost to Follow-up|0|||
130722916|NCT00704730|470609780|FG000|Overall Study|Adverse Event|35|||
130722917|NCT00704730|470609781|FG001|Overall Study|Adverse Event|9|||
130722918|NCT00704730|470609780|FG000|Overall Study|Death|11|||
130722919|NCT00704730|470609781|FG001|Overall Study|Death|5|||
130722920|NCT00704730|470609780|FG000|Overall Study|Physician Decision|2|||
130722921|NCT00704730|470609781|FG001|Overall Study|Physician Decision|0|||
130722922|NCT00704730|470609780|FG000|Overall Study|Did not receive drug|5|||
130722923|NCT00704730|470609781|FG001|Overall Study|Did not receive drug|2|||
130722924|NCT00704730|470609780|FG000|Overall Study|Disease progression per PI|58|||
130722925|NCT00704730|470609781|FG001|Overall Study|Disease progression per PI|67|||
130722926|NCT00704730|470609780|FG000|Overall Study|data unavailable|1|||
130722927|NCT00704730|470609781|FG001|Overall Study|data unavailable|0|||
130722928|NCT00704730|470609780|FG000|Overall Study|Withdrawal by Subject|9|||
130722929|NCT00704730|470609781|FG001|Overall Study|Withdrawal by Subject|13|||
131062819|NCT00307489|471862311|FG000|Week 48 Through Week 168|Adverse Event|1|||
131062820|NCT00307489|471862312|FG001|Week 48 Through Week 168|Adverse Event|0|||
130722930|NCT05065567|470609783|FG000|Overall Study|Lost to Follow-up|10|||
130722931|NCT05065567|470609784|FG001|Overall Study|Lost to Follow-up|9|||
130722932|NCT05065567|470609785|FG002|Overall Study|Lost to Follow-up|6|||
130722933|NCT04051619|470609786|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
130722934|NCT04051619|470609787|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
130722935|NCT04051619|470609786|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
130722936|NCT04051619|470609787|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
130722937|NCT03510598|470611256|FG000|Overall Study|Withdrawal by Subject|1|||
130722938|NCT02886624|470611259|FG000|12-week Post Treatment Follow-up|Death|1|||
130722939|NCT02886624|470611259|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
130722940|NCT01664130|470611264|FG000|Overall Study|competing secondary disease|2|||
130722941|NCT00554606|470611265|FG000|Overall Study|Adverse Event|3|||
130722942|NCT00554606|470611265|FG000|Overall Study|Abnormal laboratory values|1|||
130722943|NCT00554606|470611265|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
130722944|NCT00554606|470611265|FG000|Overall Study|Subject withdrew consent|2|||
130722945|NCT00554606|470611265|FG000|Overall Study|Lost to Follow-up|2|||
130722946|NCT00554606|470611265|FG000|Overall Study|Administrative problems|60|||
130722947|NCT00554606|470611265|FG000|Overall Study|Death|1|||
130722948|NCT00554606|470611265|FG000|Overall Study|Protocol deviation|2|||
130722949|NCT03323437|470611266|FG000|Overall Study|Withdrawal by Subject|0|||
130722950|NCT03323437|470611267|FG001|Overall Study|Withdrawal by Subject|4|||
130722951|NCT01305044|470611273|FG000|Overall Study|Withdrawal by Subject|3|||
130722952|NCT01305044|470611274|FG001|Overall Study|Withdrawal by Subject|6|||
130722953|NCT03257865|470611281|FG000|Overall Study|Adverse Event|4|||
130722954|NCT03257865|470611282|FG001|Overall Study|Adverse Event|8|||
130722955|NCT03257865|470611281|FG000|Overall Study|Lack of Efficacy|1|||
131062821|NCT00307489|471862311|FG000|Week 48 Through Week 168|Physician Decision|1|||
131062822|NCT00307489|471862312|FG001|Week 48 Through Week 168|Physician Decision|0|||
131062823|NCT00307489|471862311|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
131062824|NCT00307489|471862312|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
131062825|NCT00307489|471862311|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
131062826|NCT00307489|471862312|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
131062827|NCT00307489|471862311|FG000|Week 48 Through Week 168|Death|0|||
131062828|NCT00307489|471862312|FG001|Week 48 Through Week 168|Death|1|||
131062829|NCT00307489|471862311|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
131062830|NCT00307489|471862312|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
131062831|NCT00307489|471862311|FG000|Week 48 Through Week 168|Seroconversion|1|||
131062832|NCT00307489|471862312|FG001|Week 48 Through Week 168|Seroconversion|0|||
131062833|NCT04025762|471862314|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
131062834|NCT04025762|471862315|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
131062835|NCT02165202|471862322|FG000|Oral Phase|Refused further participation|5|||
131062836|NCT02165202|471862323|FG001|Oral Phase|Refused further participation|1|||
131062837|NCT02165202|471862322|FG000|Oral Phase|Study product Related Toxicity|1|||
131062838|NCT02165202|471862323|FG001|Oral Phase|Study product Related Toxicity|0|||
131062839|NCT02165202|471862322|FG000|Oral Phase|Unable to contact Participant|1|||
131062840|NCT02165202|471862323|FG001|Oral Phase|Unable to contact Participant|1|||
131062841|NCT02165202|471862322|FG000|Oral Phase|Clinical reasons|1|||
131062842|NCT02165202|471862323|FG001|Oral Phase|Clinical reasons|0|||
131062843|NCT02165202|471862322|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
131062844|NCT02165202|471862323|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
131062845|NCT02165202|471862322|FG000|Oral Phase|CMC advised termination|1|||
131062846|NCT02165202|471862323|FG001|Oral Phase|CMC advised termination|0|||
131062847|NCT02165202|471862322|FG000|Oral Phase|Relocated, no follow-up planned|1|||
131062848|NCT02165202|471862323|FG001|Oral Phase|Relocated, no follow-up planned|0|||
131062849|NCT02165202|471862322|FG000|Oral Phase|Abnormal EKG|0|||
131062850|NCT02165202|471862323|FG001|Oral Phase|Abnormal EKG|1|||
131062851|NCT02165202|471862322|FG000|Injection Phase|Abnormal Lab Value|5|||
131062852|NCT02165202|471862323|FG001|Injection Phase|Abnormal Lab Value|1|||
131062853|NCT02165202|471862322|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
131062854|NCT02165202|471862323|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
131062855|NCT02165202|471862322|FG000|Injection Phase|Unable to attend within Visit Window|1|||
131062856|NCT02165202|471862323|FG001|Injection Phase|Unable to attend within Visit Window|0|||
131137386|NCT01534676|472130590|FG000|Overall Study|Study closed due to poor enrollment|2|||
131137387|NCT01534676|472130591|FG001|Overall Study|Study closed due to poor enrollment|1|||
130722956|NCT03257865|470611282|FG001|Overall Study|Lack of Efficacy|2|||
130722957|NCT03257865|470611281|FG000|Overall Study|Non-compliance with Study Drug|0|||
130722958|NCT03257865|470611282|FG001|Overall Study|Non-compliance with Study Drug|2|||
130722959|NCT03257865|470611281|FG000|Overall Study|Withdrawal by Subject|23|||
130722960|NCT03257865|470611282|FG001|Overall Study|Withdrawal by Subject|17|||
130722961|NCT03257865|470611281|FG000|Overall Study|Physician Decision|3|||
130722962|NCT03257865|470611282|FG001|Overall Study|Physician Decision|1|||
131062857|NCT02165202|471862322|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
131062858|NCT02165202|471862323|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
131062859|NCT02165202|471862322|FG000|Injection Phase|End of Study|2|||
131062860|NCT02165202|471862323|FG001|Injection Phase|End of Study|1|||
131062861|NCT02165202|471862322|FG000|Injection Phase|Study Product related Toxicity|1|||
130722963|NCT03257865|470611281|FG000|Overall Study|Other|0|||
130722964|NCT03257865|470611282|FG001|Overall Study|Other|1|||
131062862|NCT02165202|471862323|FG001|Injection Phase|Study Product related Toxicity|0|||
131062863|NCT02165202|471862322|FG000|Injection Phase|No longer interested|0|||
131062864|NCT02165202|471862323|FG001|Injection Phase|No longer interested|1|||
131062865|NCT02165202|471862322|FG000|Injection Phase|Participant unwilling to comply|1|||
131062866|NCT02165202|471862323|FG001|Injection Phase|Participant unwilling to comply|0|||
131062867|NCT01975701|471862330|FG000|Overall Study|Lost to Follow-up|1|||
131062868|NCT01975701|471862330|FG000|Overall Study|Death|23|||
131062869|NCT01975701|471862330|FG000|Overall Study|Physician Decision|1|||
131062870|NCT02446015|471862331|FG000|Overall Study|Adverse Event|0|||
131062871|NCT02446015|471862332|FG001|Overall Study|Adverse Event|1|||
131062872|NCT02446015|471862331|FG000|Overall Study|Withdrawal by Subject|1|||
131062873|NCT02446015|471862332|FG001|Overall Study|Withdrawal by Subject|0|||
131062874|NCT02143713|471862337|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
131062875|NCT02143713|471862338|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
131062876|NCT02143713|471862339|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
131062877|NCT02143713|471862340|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
131062878|NCT02143713|471862337|FG000|Treatment Period (6 Months)|Adverse Event|7|||
131062879|NCT02143713|471862338|FG001|Treatment Period (6 Months)|Adverse Event|8|||
131062880|NCT02143713|471862339|FG002|Treatment Period (6 Months)|Adverse Event|8|||
131062881|NCT02143713|471862340|FG003|Treatment Period (6 Months)|Adverse Event|9|||
131062882|NCT02143713|471862337|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
131062883|NCT02143713|471862338|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
131062884|NCT02143713|471862339|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
131062885|NCT02143713|471862340|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
131062886|NCT02143713|471862337|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
131062887|NCT02143713|471862338|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
131062888|NCT02143713|471862339|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
131062889|NCT02143713|471862340|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
131062890|NCT02143713|471862337|FG000|Treatment Period (6 Months)|Pregnancy|0|||
131062891|NCT02143713|471862338|FG001|Treatment Period (6 Months)|Pregnancy|2|||
131062892|NCT02143713|471862339|FG002|Treatment Period (6 Months)|Pregnancy|2|||
131062893|NCT02143713|471862340|FG003|Treatment Period (6 Months)|Pregnancy|0|||
131062894|NCT02143713|471862337|FG000|Treatment Period (6 Months)|Non-compliance|1|||
131062895|NCT02143713|471862338|FG001|Treatment Period (6 Months)|Non-compliance|0|||
131062896|NCT02143713|471862339|FG002|Treatment Period (6 Months)|Non-compliance|0|||
131062897|NCT02143713|471862340|FG003|Treatment Period (6 Months)|Non-compliance|3|||
131062898|NCT02143713|471862337|FG000|Treatment Period (6 Months)|Other|3|||
131062899|NCT02143713|471862338|FG001|Treatment Period (6 Months)|Other|0|||
131062900|NCT02143713|471862339|FG002|Treatment Period (6 Months)|Other|3|||
131062901|NCT02143713|471862340|FG003|Treatment Period (6 Months)|Other|2|||
130722965|NCT03257865|470611281|FG000|Overall Study|Lost to Follow-up|4|||
130722966|NCT03257865|470611282|FG001|Overall Study|Lost to Follow-up|4|||
130722967|NCT02677714|470611283|FG000|Overall Study|Withdrawal by Subject|2|||
130722968|NCT02677714|470611284|FG001|Overall Study|Withdrawal by Subject|0|||
130722969|NCT04628793|470611285|FG000|Overall Study|Study terminated by sponsor|0|||
130722970|NCT04628793|470611286|FG001|Overall Study|Study terminated by sponsor|0|||
130722971|NCT04628793|470611287|FG002|Overall Study|Study terminated by sponsor|8|||
130722972|NCT04628793|470611285|FG000|Overall Study|Withdrawal by Subject|2|||
130722973|NCT04628793|470611286|FG001|Overall Study|Withdrawal by Subject|3|||
130722974|NCT04628793|470611287|FG002|Overall Study|Withdrawal by Subject|0|||
130722975|NCT04628793|470611285|FG000|Overall Study|Lost to Follow-up|0|||
130722976|NCT04628793|470611286|FG001|Overall Study|Lost to Follow-up|1|||
130722977|NCT04628793|470611287|FG002|Overall Study|Lost to Follow-up|0|||
130722978|NCT04015908|470611290|FG000|Overall Study|Lost to Follow-up|0|||
130722979|NCT04015908|470611291|FG001|Overall Study|Lost to Follow-up|1|||
130722980|NCT02538965|470611292|FG000|Treatment Period|Other = Death due to disease progression|1|||
130722981|NCT02538965|470611292|FG000|Treatment Period|Adverse Event|2|||
130722982|NCT02538965|470611292|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
130722983|NCT02538965|470611292|FG000|Treatment Period|Treatment Failure|9|||
130722984|NCT02538965|470611292|FG000|Treatment Period|Disease Progression|1|||
130722985|NCT02538965|470611292|FG000|Treatment Period|Physician Decision|2|||
130722986|NCT02538965|470611292|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
130722987|NCT02538965|470611292|FG000|Follow-Up Period|Withdrawal by Parent|4|||
130722988|NCT03200912|470611293|FG000|Overall Study|Adverse Event|3|||
130722989|NCT03200912|470611294|FG001|Overall Study|Adverse Event|0|||
130722990|NCT03200912|470611295|FG002|Overall Study|Adverse Event|0|||
131062902|NCT02143713|471862337|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
131062903|NCT02143713|471862338|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
131062904|NCT02143713|471862339|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
131062905|NCT02143713|471862340|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
130722991|NCT03200912|470611293|FG000|Overall Study|Withdrawal by Subject|1|||
130722992|NCT03200912|470611294|FG001|Overall Study|Withdrawal by Subject|2|||
131062906|NCT02143713|471862337|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
131062907|NCT02143713|471862338|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
131062908|NCT02143713|471862339|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
131062909|NCT02143713|471862340|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
131062910|NCT02143713|471862337|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
131062911|NCT02143713|471862338|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
131062912|NCT02143713|471862339|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
131062913|NCT02143713|471862340|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
131062914|NCT02143713|471862337|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
131062915|NCT02143713|471862338|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
131062916|NCT02143713|471862339|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
131062917|NCT02143713|471862340|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
131062918|NCT02143713|471862337|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
131062919|NCT02143713|471862338|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
131062920|NCT02143713|471862339|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
131062921|NCT02143713|471862340|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
131062922|NCT02143713|471862337|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
131062923|NCT02143713|471862338|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
131062924|NCT02143713|471862339|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
131062925|NCT02143713|471862340|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
131062926|NCT02143713|471862337|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
131062927|NCT02143713|471862338|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
131062928|NCT02143713|471862339|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
131062929|NCT02143713|471862340|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
131062930|NCT02143713|471862337|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
131062931|NCT02143713|471862338|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
131062932|NCT02143713|471862339|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
131062933|NCT02143713|471862340|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
131062934|NCT02143713|471862337|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
131062935|NCT02143713|471862338|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
131062936|NCT02143713|471862339|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
131062937|NCT02143713|471862340|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
131062938|NCT01768572|471862343|FG000|Overall Study|Adverse Event|7|||
131062939|NCT01768572|471862344|FG001|Overall Study|Adverse Event|8|||
131062940|NCT01768572|471862345|FG002|Overall Study|Adverse Event|4|||
131062941|NCT01768572|471862343|FG000|Overall Study|Lack of Efficacy|1|||
131062942|NCT01768572|471862344|FG001|Overall Study|Lack of Efficacy|3|||
131062943|NCT01768572|471862345|FG002|Overall Study|Lack of Efficacy|1|||
131062944|NCT01768572|471862343|FG000|Overall Study|Other, Not due to an adverse event|1|||
131062945|NCT01768572|471862344|FG001|Overall Study|Other, Not due to an adverse event|1|||
131062946|NCT01768572|471862345|FG002|Overall Study|Other, Not due to an adverse event|1|||
131062947|NCT00080119|471862346|FG000|Overall Study|Discontinued because of study closure|0|||
131062948|NCT00080119|471862347|FG001|Overall Study|Discontinued because of study closure|0|||
131062949|NCT00080119|471862348|FG002|Overall Study|Discontinued because of study closure|130|||
131062950|NCT00080119|471862349|FG003|Overall Study|Discontinued because of study closure|141|||
131062951|NCT00080119|471862346|FG000|Overall Study|Unable to get to clinic|24|||
131062952|NCT00080119|471862347|FG001|Overall Study|Unable to get to clinic|24|||
131062953|NCT00080119|471862348|FG002|Overall Study|Unable to get to clinic|7|||
131062954|NCT00080119|471862349|FG003|Overall Study|Unable to get to clinic|1|||
131062955|NCT00080119|471862346|FG000|Overall Study|Consent withdrawn|13|||
131062956|NCT00080119|471862347|FG001|Overall Study|Consent withdrawn|17|||
131062957|NCT00080119|471862348|FG002|Overall Study|Consent withdrawn|4|||
131062958|NCT00080119|471862349|FG003|Overall Study|Consent withdrawn|6|||
131062959|NCT00080119|471862346|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
131062960|NCT00080119|471862347|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
131062961|NCT00080119|471862348|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
131062962|NCT00080119|471862349|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
131062963|NCT00080119|471862346|FG000|Overall Study|Lost to Follow-up|16|||
131062964|NCT00080119|471862347|FG001|Overall Study|Lost to Follow-up|19|||
131062965|NCT00080119|471862348|FG002|Overall Study|Lost to Follow-up|19|||
131062966|NCT00080119|471862349|FG003|Overall Study|Lost to Follow-up|14|||
131062967|NCT01919489|471862350|FG000|Overall Study|Rejected the need of injections|4|||
131062968|NCT01919489|471862351|FG001|Overall Study|Rejected the need of injections|7|||
131062969|NCT01919489|471862350|FG000|Overall Study|Adverse Event|10|||
131062970|NCT01919489|471862351|FG001|Overall Study|Adverse Event|0|||
131062971|NCT01919489|471862350|FG000|Overall Study|Hospital readmission|2|||
131062972|NCT01919489|471862351|FG001|Overall Study|Hospital readmission|9|||
131062973|NCT01919489|471862350|FG000|Overall Study|Death|2|||
130779416|NCT02326272|470819503|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
131062974|NCT01919489|471862351|FG001|Overall Study|Death|1|||
131062975|NCT01919489|471862350|FG000|Overall Study|Lost to Follow-up|38|||
131062976|NCT01919489|471862351|FG001|Overall Study|Lost to Follow-up|27|||
131062977|NCT00871494|471862354|FG000|Overall Study|Protocol Violation|5|||
131062978|NCT00871494|471862354|FG000|Overall Study|Lack of Efficacy|4|||
131062979|NCT00871494|471862354|FG000|Overall Study|Adverse Event|4|||
131062980|NCT00871494|471862354|FG000|Overall Study|Lost to Follow-up|1|||
131062981|NCT01190436|471862359|FG000|Overall Study|Lost to Follow-up|35|||
131062982|NCT01190436|471862359|FG000|Overall Study|Other|4|||
131062983|NCT02721147|471862360|FG000|Overall Study|Lost to Follow-up|2|||
131062984|NCT02721147|471862361|FG001|Overall Study|Lost to Follow-up|0|||
131062985|NCT02721147|471862362|FG002|Overall Study|Lost to Follow-up|0|||
131062986|NCT01722097|471862364|FG000|Overall Study|Patient sheets not returned|6|||
131062987|NCT01722097|471862365|FG001|Overall Study|Patient sheets not returned|5|||
131062988|NCT02009332|471862366|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
131062989|NCT02009332|471862367|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
131062990|NCT02009332|471862368|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
131062991|NCT02009332|471862369|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
131062992|NCT02009332|471862370|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
131062993|NCT02009332|471862371|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
131062994|NCT02009332|471862366|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
131062995|NCT02009332|471862367|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
131062996|NCT02009332|471862368|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
131062997|NCT02009332|471862369|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
131062998|NCT02009332|471862370|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
131062999|NCT02009332|471862371|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
131063000|NCT02009332|471862366|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
131063001|NCT02009332|471862367|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
131063002|NCT02009332|471862368|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
131063003|NCT02009332|471862369|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
131063004|NCT02009332|471862370|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
131063005|NCT02009332|471862371|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
131063006|NCT00248794|471862373|FG000|Overall Study|Lost to Follow-up|6|||
131063007|NCT00248794|471862374|FG001|Overall Study|Lost to Follow-up|8|||
131063008|NCT00248794|471862375|FG002|Overall Study|Lost to Follow-up|3|||
131063009|NCT02632747|471862376|FG000|Wash-out Period|Adverse Event|1|||
131063010|NCT02632747|471862377|FG001|Wash-out Period|Adverse Event|0|||
131063011|NCT03449979|471862378|FG000|Overall Study|Technical difficulty|0|||
131063012|NCT03449979|471862379|FG001|Overall Study|Technical difficulty|0|||
131063013|NCT03449979|471862380|FG002|Overall Study|Technical difficulty|0|||
131063014|NCT03449979|471862381|FG003|Overall Study|Technical difficulty|1|||
131063015|NCT02069379|471862382|FG000|Baseline Measurements|Lost to Follow-up|1|||
131063016|NCT02069379|471862383|FG001|Baseline Measurements|Lost to Follow-up|0|||
131063017|NCT02069379|471862384|FG002|Baseline Measurements|Lost to Follow-up|0|||
131063018|NCT02069379|471862385|FG003|Baseline Measurements|Lost to Follow-up|0|||
131063019|NCT02069379|471862382|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
131063020|NCT02069379|471862383|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
131063021|NCT02069379|471862384|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
131137388|NCT02908880|472130593|FG000|Overall Study|Lost to Follow-up|4|||
131137389|NCT02908880|472130593|FG000|Overall Study|Explantation of the device|1|||
131137390|NCT02908880|472130593|FG000|Overall Study|Withdrawal by Subject|17|||
131137391|NCT02908880|472130593|FG000|Overall Study|Death|5|||
131137392|NCT02421887|472130594|FG000|Overall Study|Lost to Follow-up|5|||
131137393|NCT02421887|472130595|FG001|Overall Study|Lost to Follow-up|0|||
131137394|NCT02421887|472130594|FG000|Overall Study|Withdrawal by Subject|8|||
131137395|NCT02421887|472130595|FG001|Overall Study|Withdrawal by Subject|5|||
131137396|NCT02421887|472130594|FG000|Overall Study|Physician Decision|2|||
131137397|NCT02421887|472130595|FG001|Overall Study|Physician Decision|4|||
131137398|NCT02421887|472130594|FG000|Overall Study|Adverse Event|2|||
131137399|NCT02421887|472130595|FG001|Overall Study|Adverse Event|0|||
131137400|NCT03946670|472130601|FG000|Overall Study|Progressive Disease|26|||
131137401|NCT03946670|472130602|FG001|Overall Study|Progressive Disease|23|||
131137402|NCT03946670|472130601|FG000|Overall Study|Adverse Event|7|||
131137403|NCT03946670|472130602|FG001|Overall Study|Adverse Event|9|||
131137404|NCT03946670|472130601|FG000|Overall Study|Death|5|||
131137405|NCT03946670|472130602|FG001|Overall Study|Death|6|||
131137406|NCT03946670|472130601|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
131137407|NCT03946670|472130602|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
131063022|NCT02069379|471862385|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
131063023|NCT02069379|471862382|FG000|First Treatment Arm|Lost to Follow-up|0|||
131063024|NCT02069379|471862383|FG001|First Treatment Arm|Lost to Follow-up|1|||
131063025|NCT02069379|471862384|FG002|First Treatment Arm|Lost to Follow-up|1|||
131063026|NCT02069379|471862385|FG003|First Treatment Arm|Lost to Follow-up|0|||
131137408|NCT03946670|472130601|FG000|Overall Study|Subject Decision|4|||
131137409|NCT03946670|472130602|FG001|Overall Study|Subject Decision|4|||
130779417|NCT02326272|470819504|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130722993|NCT03200912|470611295|FG002|Overall Study|Withdrawal by Subject|4|||
130722994|NCT03200912|470611293|FG000|Overall Study|Non-compliance with study drug|0|||
130722995|NCT03200912|470611294|FG001|Overall Study|Non-compliance with study drug|1|||
130722996|NCT03200912|470611295|FG002|Overall Study|Non-compliance with study drug|0|||
130722997|NCT02309138|470611296|FG000|Overall Study|Withdrawal by Subject|44|||
130722998|NCT02309138|470611297|FG001|Overall Study|Withdrawal by Subject|15|||
130722999|NCT02309138|470611296|FG000|Overall Study|Protocol Violation|4|||
130723000|NCT02309138|470611297|FG001|Overall Study|Protocol Violation|2|||
130723001|NCT02309138|470611296|FG000|Overall Study|delivered before visit 2|0|||
130723002|NCT02309138|470611297|FG001|Overall Study|delivered before visit 2|1|||
131063027|NCT02069379|471862382|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
131063028|NCT02069379|471862383|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
131063029|NCT02069379|471862384|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
131063030|NCT02069379|471862385|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
131063031|NCT02069379|471862382|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
131063032|NCT02069379|471862383|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
131063033|NCT02069379|471862384|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
131063034|NCT02069379|471862385|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
131063035|NCT02069379|471862382|FG000|Second Treatment Arm|Lost to Follow-up|0|||
131063036|NCT02069379|471862383|FG001|Second Treatment Arm|Lost to Follow-up|0|||
131063037|NCT02069379|471862384|FG002|Second Treatment Arm|Lost to Follow-up|1|||
131063038|NCT02069379|471862385|FG003|Second Treatment Arm|Lost to Follow-up|0|||
131063039|NCT00700999|471862388|FG000|Overall Study|Lost to Follow-up|7|||
131063040|NCT00700999|471862389|FG001|Overall Study|Lost to Follow-up|7|||
131063041|NCT00700999|471862388|FG000|Overall Study|Excluded - did not meet study criteria|0|||
131063042|NCT00700999|471862389|FG001|Overall Study|Excluded - did not meet study criteria|1|||
131063043|NCT00700999|471862388|FG000|Overall Study|Withdrawal by Subject|8|||
131063044|NCT00700999|471862389|FG001|Overall Study|Withdrawal by Subject|1|||
131063045|NCT03481725|471862390|FG000|Overall Study|Withdrawal by Subject|1|||
131063046|NCT03481725|471862391|FG001|Overall Study|Withdrawal by Subject|0|||
131063047|NCT03651271|471862392|FG000|Overall Study|Death|4|||
131063048|NCT03651271|471862393|FG001|Overall Study|Death|37|||
131063049|NCT03651271|471862394|FG002|Overall Study|Death|0|||
131063050|NCT03651271|471862395|FG003|Overall Study|Death|2|||
131063051|NCT03651271|471862396|FG004|Overall Study|Death|6|||
131063052|NCT03651271|471862392|FG000|Overall Study|Lost to Follow-up|1|||
131063053|NCT03651271|471862393|FG001|Overall Study|Lost to Follow-up|5|||
131063054|NCT03651271|471862394|FG002|Overall Study|Lost to Follow-up|0|||
131063055|NCT03651271|471862395|FG003|Overall Study|Lost to Follow-up|1|||
131063056|NCT03651271|471862396|FG004|Overall Study|Lost to Follow-up|0|||
131063057|NCT03651271|471862392|FG000|Overall Study|Physician Decision|0|||
131063058|NCT03651271|471862393|FG001|Overall Study|Physician Decision|2|||
131063059|NCT03651271|471862394|FG002|Overall Study|Physician Decision|0|||
131063060|NCT03651271|471862395|FG003|Overall Study|Physician Decision|0|||
131063061|NCT03651271|471862396|FG004|Overall Study|Physician Decision|0|||
131063062|NCT03651271|471862392|FG000|Overall Study|Withdrawal by Subject|1|||
131063063|NCT03651271|471862393|FG001|Overall Study|Withdrawal by Subject|15|||
131063064|NCT03651271|471862394|FG002|Overall Study|Withdrawal by Subject|0|||
131063065|NCT03651271|471862395|FG003|Overall Study|Withdrawal by Subject|0|||
131063066|NCT03651271|471862396|FG004|Overall Study|Withdrawal by Subject|1|||
131063067|NCT03651271|471862392|FG000|Overall Study|Patient medically unable to continue|0|||
131063068|NCT03651271|471862393|FG001|Overall Study|Patient medically unable to continue|0|||
131063069|NCT03651271|471862394|FG002|Overall Study|Patient medically unable to continue|0|||
131063070|NCT03651271|471862395|FG003|Overall Study|Patient medically unable to continue|1|||
131063071|NCT03651271|471862396|FG004|Overall Study|Patient medically unable to continue|0|||
131063072|NCT03444155|471862399|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
131063073|NCT03444155|471862400|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
131063074|NCT01133678|471862405|FG000|Overall Study|Death|1|||
131063075|NCT01133678|471862406|FG001|Overall Study|Death|1|||
131137410|NCT03946670|472130601|FG000|Overall Study|Physician Decision|3|||
131137411|NCT03946670|472130602|FG001|Overall Study|Physician Decision|3|||
130723003|NCT03421730|470611306|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723004|NCT03421730|470611307|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
131063076|NCT00446095|471862407|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
131063077|NCT00446095|471862408|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
131063078|NCT00446095|471862409|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
131063079|NCT00446095|471862410|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
131063080|NCT00446095|471862411|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
131063081|NCT00446095|471862407|FG000|Phase II (8 Weeks)|Adverse Event|0|||
131063082|NCT00446095|471862408|FG001|Phase II (8 Weeks)|Adverse Event|1|||
131063083|NCT00446095|471862409|FG002|Phase II (8 Weeks)|Adverse Event|1|||
131063084|NCT00446095|471862410|FG003|Phase II (8 Weeks)|Adverse Event|0|||
131063085|NCT00446095|471862411|FG004|Phase II (8 Weeks)|Adverse Event|0|||
131063086|NCT00446095|471862407|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
131063087|NCT00446095|471862408|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
131063088|NCT00446095|471862409|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
131063089|NCT00446095|471862410|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
131063090|NCT00446095|471862411|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
131063091|NCT00446095|471862407|FG000|Phase II (8 Weeks)|Physician Decision|1|||
131063092|NCT00446095|471862408|FG001|Phase II (8 Weeks)|Physician Decision|0|||
131063093|NCT00446095|471862409|FG002|Phase II (8 Weeks)|Physician Decision|0|||
131063094|NCT00446095|471862410|FG003|Phase II (8 Weeks)|Physician Decision|0|||
131063095|NCT00446095|471862411|FG004|Phase II (8 Weeks)|Physician Decision|0|||
131063096|NCT00446095|471862407|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
131063097|NCT00446095|471862408|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
131063098|NCT00446095|471862409|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
131063099|NCT00446095|471862410|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
131063100|NCT00446095|471862411|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
131063101|NCT00446095|471862407|FG000|Phase II (8 Weeks)|Ongoing|0|||
131063102|NCT00446095|471862408|FG001|Phase II (8 Weeks)|Ongoing|0|||
131063103|NCT00446095|471862409|FG002|Phase II (8 Weeks)|Ongoing|1|||
131063104|NCT00446095|471862410|FG003|Phase II (8 Weeks)|Ongoing|0|||
131063105|NCT00446095|471862411|FG004|Phase II (8 Weeks)|Ongoing|0|||
131063106|NCT00446095|471862407|FG000|Phase I (28 Days)|Adverse Event|0|||
131063107|NCT00446095|471862408|FG001|Phase I (28 Days)|Adverse Event|0|||
131063108|NCT00446095|471862409|FG002|Phase I (28 Days)|Adverse Event|0|||
131063109|NCT00446095|471862410|FG003|Phase I (28 Days)|Adverse Event|1|||
131063110|NCT00446095|471862411|FG004|Phase I (28 Days)|Adverse Event|0|||
131063111|NCT00446095|471862407|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
131063112|NCT00446095|471862408|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
131063113|NCT00446095|471862409|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
131063114|NCT00446095|471862410|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
131063115|NCT00446095|471862411|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
131063116|NCT02574286|471862412|FG000|Overall Study|Adverse Event|3|||
131063117|NCT02574286|471862412|FG000|Overall Study|Withdrawal by Subject|2|||
131063118|NCT01280656|471862413|FG000|Overall Study|Adverse Event|1|||
131063119|NCT01280656|471862414|FG001|Overall Study|Adverse Event|14|||
131063120|NCT01280656|471862415|FG002|Overall Study|Adverse Event|13|||
131063121|NCT01280656|471862413|FG000|Overall Study|Lack of Efficacy|1|||
131063122|NCT01280656|471862414|FG001|Overall Study|Lack of Efficacy|22|||
131063123|NCT01280656|471862415|FG002|Overall Study|Lack of Efficacy|38|||
131063124|NCT01280656|471862413|FG000|Overall Study|Treatment shortening (RGT)|0|||
131063125|NCT01280656|471862414|FG001|Overall Study|Treatment shortening (RGT)|4|||
131063126|NCT01280656|471862415|FG002|Overall Study|Treatment shortening (RGT)|5|||
131063127|NCT01280656|471862413|FG000|Overall Study|Other|1|||
131063128|NCT01280656|471862414|FG001|Overall Study|Other|7|||
131063129|NCT01280656|471862415|FG002|Overall Study|Other|7|||
131063130|NCT03015220|471862416|FG000|Overall Study|Withdrawal by Subject|3|||
131063131|NCT03015220|471862417|FG001|Overall Study|Withdrawal by Subject|2|||
131063132|NCT03015220|471862418|FG002|Overall Study|Withdrawal by Subject|2|||
131063133|NCT03015220|471862419|FG003|Overall Study|Withdrawal by Subject|2|||
131063134|NCT03015220|471862416|FG000|Overall Study|Lost to Follow-up|0|||
131063135|NCT03015220|471862417|FG001|Overall Study|Lost to Follow-up|0|||
131063136|NCT03015220|471862418|FG002|Overall Study|Lost to Follow-up|1|||
131063137|NCT03015220|471862419|FG003|Overall Study|Lost to Follow-up|0|||
131063138|NCT01970527|471862420|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
131063139|NCT01970527|471862421|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
131063140|NCT01970527|471862420|FG000|Treatment|Disease progression|0|||
130723005|NCT03421730|470611308|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723006|NCT03421730|470611309|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723007|NCT03421730|470611310|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723008|NCT03421730|470611311|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723009|NCT03421730|470611312|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131063141|NCT01970527|471862421|FG001|Treatment|Disease progression|1|||
131063142|NCT01970527|471862420|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
131063143|NCT01970527|471862421|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
130723010|NCT03421730|470611313|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723011|NCT03421730|470611314|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723012|NCT03421730|470611315|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
131063144|NCT01970527|471862420|FG000|Treatment|Death|0|||
131063145|NCT01970527|471862421|FG001|Treatment|Death|1|||
131063146|NCT01970527|471862420|FG000|Follow-up Clinic Visit|Disease progression|1|||
131063147|NCT01970527|471862421|FG001|Follow-up Clinic Visit|Disease progression|1|||
131063148|NCT01970527|471862420|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
131137412|NCT03946670|472130601|FG000|Overall Study|New Therapy for Study Indication|1|||
131063149|NCT01970527|471862421|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
131063150|NCT01970527|471862420|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
131063151|NCT01970527|471862421|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
131063152|NCT01964547|471862422|FG000|Overall Study|Adverse Event|8|||
131063153|NCT01964547|471862423|FG001|Overall Study|Adverse Event|2|||
131063154|NCT01964547|471862422|FG000|Overall Study|Withdrawal by Subject|4|||
131063155|NCT01964547|471862423|FG001|Overall Study|Withdrawal by Subject|7|||
131063156|NCT01964547|471862422|FG000|Overall Study|Lost to Follow-up|0|||
131063157|NCT01964547|471862423|FG001|Overall Study|Lost to Follow-up|1|||
131063158|NCT01964547|471862422|FG000|Overall Study|Withdrawal by Investigator|0|||
131063159|NCT01964547|471862423|FG001|Overall Study|Withdrawal by Investigator|1|||
131063160|NCT01115309|471862424|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
131063161|NCT01115309|471862424|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
131063162|NCT01115309|471862424|FG000|Long-term Follow-up|Lost to Follow-up|6|||
131063163|NCT04447287|471862425|FG000|Period 1: Run-in Period|Adverse Event|3|||
131063164|NCT04447287|471862426|FG001|Period 1: Run-in Period|Adverse Event|0|||
131063165|NCT04447287|471862427|FG002|Period 1: Run-in Period|Adverse Event|0|||
131063166|NCT04447287|471862425|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
131063167|NCT04447287|471862426|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
131063168|NCT04447287|471862427|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
131063169|NCT04447287|471862425|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
131063170|NCT04447287|471862426|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
131063171|NCT04447287|471862427|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
131063172|NCT02147093|471862428|FG000|Period 1|Lost to Follow-up|0|||
131063173|NCT02147093|471862429|FG001|Period 1|Lost to Follow-up|1|||
131063174|NCT02147093|471862428|FG000|Period 2|Protocol Violation|2|||
131063175|NCT02147093|471862429|FG001|Period 2|Protocol Violation|0|||
131063176|NCT03246724|471862430|FG000|Overall Study|Withdrawal by Subject|5|||
131063177|NCT03246724|471862431|FG001|Overall Study|Withdrawal by Subject|2|||
131063178|NCT03246724|471862432|FG002|Overall Study|Withdrawal by Subject|4|||
131063179|NCT03246724|471862433|FG003|Overall Study|Withdrawal by Subject|2|||
131063180|NCT03246724|471862430|FG000|Overall Study|Ineligible on day of surgery|7|||
131063181|NCT03246724|471862431|FG001|Overall Study|Ineligible on day of surgery|2|||
131063182|NCT03246724|471862432|FG002|Overall Study|Ineligible on day of surgery|0|||
131063183|NCT03246724|471862433|FG003|Overall Study|Ineligible on day of surgery|3|||
131063184|NCT03246724|471862430|FG000|Overall Study|Study completed before surgical date|2|||
131063185|NCT03246724|471862431|FG001|Overall Study|Study completed before surgical date|1|||
131063186|NCT03246724|471862432|FG002|Overall Study|Study completed before surgical date|8|||
131063187|NCT03246724|471862433|FG003|Overall Study|Study completed before surgical date|1|||
131063188|NCT03246724|471862430|FG000|Overall Study|Transferred to other arm|0|||
131063189|NCT03246724|471862431|FG001|Overall Study|Transferred to other arm|0|||
131063190|NCT03246724|471862432|FG002|Overall Study|Transferred to other arm|1|||
131063191|NCT03246724|471862433|FG003|Overall Study|Transferred to other arm|0|||
131063192|NCT03246724|471862430|FG000|Overall Study|Unable to obtain medication timely|0|||
131063193|NCT03246724|471862431|FG001|Overall Study|Unable to obtain medication timely|2|||
131063194|NCT03246724|471862432|FG002|Overall Study|Unable to obtain medication timely|2|||
131063195|NCT03246724|471862433|FG003|Overall Study|Unable to obtain medication timely|1|||
131063196|NCT03246724|471862430|FG000|Overall Study|Re-consented to participate|0|||
131063197|NCT03246724|471862431|FG001|Overall Study|Re-consented to participate|0|||
131063198|NCT03246724|471862432|FG002|Overall Study|Re-consented to participate|0|||
131063199|NCT03246724|471862433|FG003|Overall Study|Re-consented to participate|1|||
131063200|NCT00655824|471862434|FG000|Overall Study|Adverse Event|3|||
131063201|NCT00655824|471862434|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
131063202|NCT00655824|471862434|FG000|Overall Study|Protocol Violation|1|||
131063203|NCT00655824|471862434|FG000|Overall Study|Withdrawal by Subject|4|||
131063204|NCT00655824|471862434|FG000|Overall Study|Deterioration of Trial Disease|2|||
131063205|NCT03032198|471862436|FG000|Overall Study|Screen Fail|1|||
131063206|NCT02470806|471862437|FG000|Overall Study|Lost to Follow-up|1|||
131063207|NCT02470806|471862438|FG001|Overall Study|Lost to Follow-up|1|||
131063208|NCT02470806|471862437|FG000|Overall Study|Adverse Event|5|||
131063209|NCT02470806|471862438|FG001|Overall Study|Adverse Event|2|||
131063210|NCT02470806|471862437|FG000|Overall Study|Protocol Violation|4|||
131063211|NCT02470806|471862438|FG001|Overall Study|Protocol Violation|11|||
131063212|NCT02470806|471862437|FG000|Overall Study|Physician Decision|0|||
131063213|NCT02470806|471862438|FG001|Overall Study|Physician Decision|3|||
131063214|NCT02470806|471862437|FG000|Overall Study|Withdrawal by Subject|3|||
131063215|NCT02470806|471862438|FG001|Overall Study|Withdrawal by Subject|10|||
131063216|NCT02470806|471862437|FG000|Overall Study|Lack of Efficacy|5|||
131063217|NCT02470806|471862438|FG001|Overall Study|Lack of Efficacy|15|||
131063218|NCT00689351|471862439|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
131063219|NCT00689351|471862440|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
131063220|NCT00689351|471862439|FG000|Infant Series of Dosing|Adverse Event|1|||
131063221|NCT00689351|471862440|FG001|Infant Series of Dosing|Adverse Event|0|||
131063222|NCT00689351|471862439|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
131063223|NCT00689351|471862440|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
131063224|NCT00689351|471862439|FG000|After Infant Series|Parent/legal guardian request|1|||
131063225|NCT00689351|471862440|FG001|After Infant Series|Parent/legal guardian request|0|||
131063226|NCT01662505|471862441|FG000|Overall Study|Progressive disease|6|||
131063227|NCT01662505|471862442|FG001|Overall Study|Progressive disease|1|||
131063228|NCT01662505|471862443|FG002|Overall Study|Progressive disease|5|||
131063229|NCT01662505|471862441|FG000|Overall Study|Refused cont. medication|0|||
131063230|NCT01662505|471862442|FG001|Overall Study|Refused cont. medication|0|||
131063231|NCT01662505|471862443|FG002|Overall Study|Refused cont. medication|1|||
131063232|NCT01662505|471862441|FG000|Overall Study|Not specified above|1|||
131063233|NCT01662505|471862442|FG001|Overall Study|Not specified above|3|||
131063234|NCT01662505|471862443|FG002|Overall Study|Not specified above|2|||
131063235|NCT01229176|471862444|FG000|Overall Study|Withdrawal by Subject|0|||
131063236|NCT01229176|471862445|FG001|Overall Study|Withdrawal by Subject|0|||
131063237|NCT01229176|471862446|FG002|Overall Study|Withdrawal by Subject|0|||
131063238|NCT01229176|471862447|FG003|Overall Study|Withdrawal by Subject|1|||
131063239|NCT01229176|471862448|FG004|Overall Study|Withdrawal by Subject|1|||
131063240|NCT01229176|471862449|FG005|Overall Study|Withdrawal by Subject|1|||
131063241|NCT01229176|471862450|FG006|Overall Study|Withdrawal by Subject|0|||
131063242|NCT01229176|471862451|FG007|Overall Study|Withdrawal by Subject|1|||
131063243|NCT01229176|471862444|FG000|Overall Study|Lost to Follow-up|0|||
131063244|NCT01229176|471862445|FG001|Overall Study|Lost to Follow-up|3|||
131063245|NCT01229176|471862446|FG002|Overall Study|Lost to Follow-up|0|||
131063246|NCT01229176|471862447|FG003|Overall Study|Lost to Follow-up|0|||
131063247|NCT01229176|471862448|FG004|Overall Study|Lost to Follow-up|1|||
131063248|NCT01229176|471862449|FG005|Overall Study|Lost to Follow-up|1|||
131063249|NCT01229176|471862450|FG006|Overall Study|Lost to Follow-up|0|||
131063250|NCT01229176|471862451|FG007|Overall Study|Lost to Follow-up|2|||
131063251|NCT03075878|471862456|FG000|Overall Study|Physician Decision|1|||
131063252|NCT00882050|471862462|FG000|Overall Study|Physician Decision|1|||
131063253|NCT00882050|471862463|FG001|Overall Study|Physician Decision|0|||
131063254|NCT00882050|471862464|FG002|Overall Study|Physician Decision|0|||
131063255|NCT02367794|471862465|FG000|Overall Study|Death|252|||
131063256|NCT02367794|471862466|FG001|Overall Study|Death|245|||
131063257|NCT02367794|471862467|FG002|Overall Study|Death|243|||
131063258|NCT02367794|471862465|FG000|Overall Study|Lost to Follow-up|1|||
131063259|NCT02367794|471862466|FG001|Overall Study|Lost to Follow-up|2|||
131063260|NCT02367794|471862467|FG002|Overall Study|Lost to Follow-up|2|||
131063261|NCT02367794|471862465|FG000|Overall Study|Physician Decision|0|||
131063262|NCT02367794|471862466|FG001|Overall Study|Physician Decision|5|||
131063263|NCT02367794|471862467|FG002|Overall Study|Physician Decision|3|||
131063264|NCT02367794|471862465|FG000|Overall Study|Protocol Violation|1|||
131063265|NCT02367794|471862466|FG001|Overall Study|Protocol Violation|0|||
131063266|NCT02367794|471862467|FG002|Overall Study|Protocol Violation|1|||
131063267|NCT02367794|471862465|FG000|Overall Study|Withdrawal by Subject|25|||
131063268|NCT02367794|471862466|FG001|Overall Study|Withdrawal by Subject|12|||
131063269|NCT02367794|471862467|FG002|Overall Study|Withdrawal by Subject|20|||
131063270|NCT02367794|471862465|FG000|Overall Study|Brain metastasis|1|||
131063271|NCT02367794|471862466|FG001|Overall Study|Brain metastasis|0|||
131063272|NCT02367794|471862467|FG002|Overall Study|Brain metastasis|0|||
131063273|NCT02367794|471862465|FG000|Overall Study|Randomized in error|0|||
131063274|NCT02367794|471862466|FG001|Overall Study|Randomized in error|0|||
131063275|NCT02367794|471862467|FG002|Overall Study|Randomized in error|1|||
131063276|NCT02367794|471862465|FG000|Overall Study|Patient unable to receive carboplatin|0|||
131063277|NCT02367794|471862466|FG001|Overall Study|Patient unable to receive carboplatin|0|||
131063278|NCT02367794|471862467|FG002|Overall Study|Patient unable to receive carboplatin|1|||
131063279|NCT02367794|471862465|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
131063280|NCT02367794|471862466|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
131063281|NCT02367794|471862467|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
131063282|NCT02367794|471862465|FG000|Overall Study|Adverse Event|0|||
131063283|NCT02367794|471862466|FG001|Overall Study|Adverse Event|0|||
131063284|NCT02367794|471862467|FG002|Overall Study|Adverse Event|2|||
131063285|NCT02367794|471862465|FG000|Overall Study|Study Terminated By Sponsor|0|||
131063286|NCT02367794|471862466|FG001|Overall Study|Study Terminated By Sponsor|1|||
131063287|NCT02367794|471862467|FG002|Overall Study|Study Terminated By Sponsor|1|||
131137413|NCT03946670|472130602|FG001|Overall Study|New Therapy for Study Indication|0|||
131137414|NCT03946670|472130601|FG000|Overall Study|Not treated|1|||
131137415|NCT03946670|472130602|FG001|Overall Study|Not treated|1|||
131063288|NCT02367794|471862465|FG000|Overall Study|Moved to Roll-Over Study|0|||
131063289|NCT02367794|471862466|FG001|Overall Study|Moved to Roll-Over Study|15|||
130822729|NCT00887159|470980585|FG002|Overall Study|Received more tx instead of observation|0|||
131063290|NCT02367794|471862467|FG002|Overall Study|Moved to Roll-Over Study|13|||
131063291|NCT02367794|471862465|FG000|Overall Study|Sponsor Request|60|||
131063292|NCT02367794|471862466|FG001|Overall Study|Sponsor Request|57|||
131063293|NCT02367794|471862467|FG002|Overall Study|Sponsor Request|45|||
131137416|NCT04537208|472130605|FG000|Overall Study|Adverse Event|0|||
131063294|NCT02367794|471862465|FG000|Overall Study|Moved into PTAP Study|0|||
131063295|NCT02367794|471862466|FG001|Overall Study|Moved into PTAP Study|2|||
131063296|NCT02367794|471862467|FG002|Overall Study|Moved into PTAP Study|3|||
131137417|NCT04537208|472130606|FG001|Overall Study|Adverse Event|0|||
131063297|NCT02367794|471862465|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
131063298|NCT02367794|471862466|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
131063299|NCT02367794|471862467|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
131063300|NCT02367794|471862465|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
131063301|NCT02367794|471862466|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
131063302|NCT02367794|471862467|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
131063303|NCT02367794|471862465|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
131063304|NCT02367794|471862466|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
131063305|NCT02367794|471862467|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
131063306|NCT02367794|471862465|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
131063307|NCT02367794|471862466|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
131063308|NCT02367794|471862467|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
131063309|NCT02010684|471862468|FG000|Overall Study|Lost to Follow-up|8|||
131063310|NCT02010684|471862469|FG001|Overall Study|Lost to Follow-up|18|||
131063311|NCT02010684|471862468|FG000|Overall Study|Withdrawal by Subject|4|||
131063312|NCT02010684|471862469|FG001|Overall Study|Withdrawal by Subject|5|||
131063313|NCT01884571|471862474|FG000|Overall Study|Adverse Event|1|||
131063314|NCT01884571|471862474|FG000|Overall Study|Death|2|||
131063315|NCT01884571|471862474|FG000|Overall Study|Withdrawal by Subject|2|||
131063316|NCT01884571|471862474|FG000|Overall Study|Disease progression|3|||
131063317|NCT02880293|471863931|FG000|Overall Study|Inevaluable|5|||
131063318|NCT04820023|471863932|FG000|Overall Study|Death|0|||
131063319|NCT04820023|471863933|FG001|Overall Study|Death|0|||
131063320|NCT04820023|471863934|FG002|Overall Study|Death|0|||
131063321|NCT04820023|471863935|FG003|Overall Study|Death|0|||
131063322|NCT04820023|471863936|FG004|Overall Study|Death|0|||
131063323|NCT04820023|471863937|FG005|Overall Study|Death|0|||
131063324|NCT04820023|471863938|FG006|Overall Study|Death|1|||
131063325|NCT04820023|471863939|FG007|Overall Study|Death|0|||
131063326|NCT04820023|471863940|FG008|Overall Study|Death|1|||
131063327|NCT04820023|471863932|FG000|Overall Study|Withdrawal by Subject|1|||
131063328|NCT04820023|471863933|FG001|Overall Study|Withdrawal by Subject|2|||
131063329|NCT04820023|471863934|FG002|Overall Study|Withdrawal by Subject|2|||
131063330|NCT04820023|471863935|FG003|Overall Study|Withdrawal by Subject|1|||
131063331|NCT04820023|471863936|FG004|Overall Study|Withdrawal by Subject|4|||
131063332|NCT04820023|471863937|FG005|Overall Study|Withdrawal by Subject|3|||
131063333|NCT04820023|471863938|FG006|Overall Study|Withdrawal by Subject|3|||
131063334|NCT04820023|471863939|FG007|Overall Study|Withdrawal by Subject|6|||
131063335|NCT04820023|471863940|FG008|Overall Study|Withdrawal by Subject|5|||
131063336|NCT04820023|471863932|FG000|Overall Study|Progressive Disease|3|||
131063337|NCT04820023|471863933|FG001|Overall Study|Progressive Disease|0|||
131063338|NCT04820023|471863934|FG002|Overall Study|Progressive Disease|2|||
131063339|NCT04820023|471863935|FG003|Overall Study|Progressive Disease|2|||
131063340|NCT04820023|471863936|FG004|Overall Study|Progressive Disease|2|||
131063341|NCT04820023|471863937|FG005|Overall Study|Progressive Disease|0|||
131063342|NCT04820023|471863938|FG006|Overall Study|Progressive Disease|1|||
131063343|NCT04820023|471863939|FG007|Overall Study|Progressive Disease|1|||
131063344|NCT04820023|471863940|FG008|Overall Study|Progressive Disease|0|||
131063345|NCT04820023|471863932|FG000|Overall Study|New anti-cancer therapy|0|||
131063346|NCT04820023|471863933|FG001|Overall Study|New anti-cancer therapy|0|||
131063347|NCT04820023|471863934|FG002|Overall Study|New anti-cancer therapy|0|||
131063348|NCT04820023|471863935|FG003|Overall Study|New anti-cancer therapy|0|||
131063349|NCT04820023|471863936|FG004|Overall Study|New anti-cancer therapy|2|||
131063350|NCT04820023|471863937|FG005|Overall Study|New anti-cancer therapy|0|||
131063351|NCT04820023|471863938|FG006|Overall Study|New anti-cancer therapy|0|||
131063352|NCT04820023|471863939|FG007|Overall Study|New anti-cancer therapy|0|||
131063353|NCT04820023|471863940|FG008|Overall Study|New anti-cancer therapy|0|||
131063354|NCT04820023|471863932|FG000|Overall Study|Other|0|||
131063355|NCT04820023|471863933|FG001|Overall Study|Other|1|||
131063356|NCT04820023|471863934|FG002|Overall Study|Other|0|||
131063357|NCT04820023|471863935|FG003|Overall Study|Other|0|||
131137418|NCT04537208|472130607|FG002|Overall Study|Adverse Event|0|||
131137419|NCT04537208|472130608|FG003|Overall Study|Adverse Event|0|||
131063358|NCT04820023|471863936|FG004|Overall Study|Other|0|||
131063359|NCT04820023|471863937|FG005|Overall Study|Other|0|||
131063360|NCT04820023|471863938|FG006|Overall Study|Other|0|||
131063361|NCT04820023|471863939|FG007|Overall Study|Other|2|||
131063362|NCT04820023|471863940|FG008|Overall Study|Other|0|||
131063363|NCT01863368|471863946|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
131063364|NCT01863368|471863947|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
131063365|NCT01863368|471863946|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
131063366|NCT01863368|471863947|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
131063367|NCT01863368|471863946|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
131137420|NCT04537208|472130609|FG004|Overall Study|Adverse Event|0|||
131063368|NCT01863368|471863947|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
131063369|NCT01863368|471863946|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
131063370|NCT01863368|471863947|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
131063371|NCT01863368|471863946|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
131063372|NCT01863368|471863947|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
131063373|NCT01863368|471863946|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
131063374|NCT01863368|471863947|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
131063375|NCT00515112|471863949|FG000|Overall Study|Death|0|||
131063376|NCT00515112|471863950|FG001|Overall Study|Death|1|||
131063377|NCT00515112|471863949|FG000|Overall Study|The study was terminated|3|||
131063378|NCT00515112|471863950|FG001|Overall Study|The study was terminated|2|||
131063379|NCT01020487|471863951|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
131063380|NCT01020487|471863952|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
131063381|NCT01020487|471863953|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
131063382|NCT01020487|471863951|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
131063383|NCT01020487|471863952|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
131063384|NCT01020487|471863953|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
131063385|NCT01020487|471863951|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
131063386|NCT01020487|471863952|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
131063387|NCT01020487|471863953|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
131063388|NCT01020487|471863951|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
131063389|NCT01020487|471863952|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
131063390|NCT01020487|471863953|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
131063391|NCT01020487|471863951|FG000|Part 2 Open-label Period|Adverse Event|0|||
131063392|NCT01020487|471863952|FG001|Part 2 Open-label Period|Adverse Event|4|||
131063393|NCT01020487|471863953|FG002|Part 2 Open-label Period|Adverse Event|1|||
131063394|NCT02400749|471863956|FG000|Week 0 -16|Withdrawal by Subject|5|||
131063395|NCT02400749|471863957|FG001|Week 0 -16|Withdrawal by Subject|5|||
131063396|NCT02400749|471863956|FG000|Week 0 -16|Adverse Event|3|||
131063397|NCT02400749|471863957|FG001|Week 0 -16|Adverse Event|1|||
131063398|NCT02400749|471863956|FG000|Week 0 -16|Lost to Follow-up|2|||
131063399|NCT02400749|471863957|FG001|Week 0 -16|Lost to Follow-up|0|||
131063400|NCT02400749|471863956|FG000|Week 0 -16|Protocol Violation|1|||
131063401|NCT02400749|471863957|FG001|Week 0 -16|Protocol Violation|0|||
131063402|NCT02400749|471863956|FG000|Week 17 - 32|Withdrawal by Subject|3|||
131063403|NCT02400749|471863957|FG001|Week 17 - 32|Withdrawal by Subject|2|||
131063404|NCT02400749|471863956|FG000|Week 17 - 32|Adverse Event|2|||
130723013|NCT03421730|470611316|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723014|NCT03421730|470611317|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130723015|NCT03421730|470611306|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723016|NCT03421730|470611307|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723017|NCT03421730|470611308|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723018|NCT03421730|470611309|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723019|NCT03421730|470611310|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
130723020|NCT03421730|470611311|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723021|NCT03421730|470611312|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723022|NCT03421730|470611313|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723023|NCT03421730|470611314|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723024|NCT03421730|470611315|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723025|NCT03421730|470611316|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723026|NCT03421730|470611317|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130723027|NCT02901548|470611322|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
130723028|NCT01955083|470611323|FG000|Overall Study|Lost to Follow-up|1|||
130723029|NCT01955083|470611324|FG001|Overall Study|Lost to Follow-up|1|||
130723030|NCT02871492|470611333|FG000|Overall Study|Lost to Follow-up|6|||
130723031|NCT02871492|470611334|FG001|Overall Study|Lost to Follow-up|3|||
130723032|NCT02871492|470611335|FG002|Overall Study|Lost to Follow-up|5|||
130723033|NCT02871492|470611333|FG000|Overall Study|Withdrawal by Subject|0|||
130723034|NCT02871492|470611334|FG001|Overall Study|Withdrawal by Subject|0|||
130723035|NCT02871492|470611335|FG002|Overall Study|Withdrawal by Subject|1|||
131063405|NCT02400749|471863957|FG001|Week 17 - 32|Adverse Event|1|||
131063406|NCT04425252|471863960|FG000|Overall Study|Withdrawal by Subject|2|||
131063407|NCT04425252|471863961|FG001|Overall Study|Withdrawal by Subject|1|||
131063408|NCT04425252|471863960|FG000|Overall Study|Lost to Follow-up|1|||
131063409|NCT04425252|471863961|FG001|Overall Study|Lost to Follow-up|0|||
131137421|NCT04537208|472130610|FG005|Overall Study|Adverse Event|0|||
130822730|NCT00887159|470980583|FG000|Overall Study|Ineligible|5|||
131063410|NCT04425252|471863960|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
131063411|NCT04425252|471863961|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
131063412|NCT01279447|471863965|FG000|Overall Study|Lost to Follow-up|3|||
131063413|NCT01279447|471863966|FG001|Overall Study|Lost to Follow-up|1|||
131137422|NCT04537208|472130611|FG006|Overall Study|Adverse Event|0|||
131137423|NCT04537208|472130612|FG007|Overall Study|Adverse Event|0|||
131063414|NCT01215253|471863967|FG000|Overall Study|Withdrawal by Subject|57|||
131063415|NCT01215253|471863968|FG001|Overall Study|Withdrawal by Subject|35|||
131063416|NCT01215253|471863967|FG000|Overall Study|Physician Decision|9|||
131063417|NCT01215253|471863968|FG001|Overall Study|Physician Decision|12|||
131063418|NCT01215253|471863967|FG000|Overall Study|Lost to Follow-up|6|||
131063419|NCT01215253|471863968|FG001|Overall Study|Lost to Follow-up|4|||
131063420|NCT01215253|471863967|FG000|Overall Study|Other|14|||
131063421|NCT01215253|471863968|FG001|Overall Study|Other|12|||
131063422|NCT01131325|471863973|FG000|Overall Study|Adverse Event|1|||
131063423|NCT01131325|471863973|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
131063424|NCT03761849|471863974|FG000|Overall Study|transferred to OpenLabelExtension|35|||
131063425|NCT03761849|471863975|FG001|Overall Study|transferred to OpenLabelExtension|34|||
131063426|NCT03761849|471863976|FG002|Overall Study|transferred to OpenLabelExtension|36|||
131063427|NCT03761849|471863977|FG003|Overall Study|transferred to OpenLabelExtension|0|||
131063428|NCT03761849|471863978|FG004|Overall Study|transferred to OpenLabelExtension|0|||
131063429|NCT03761849|471863979|FG005|Overall Study|transferred to OpenLabelExtension|0|||
131063430|NCT03761849|471863974|FG000|Overall Study|Adverse Event|1|||
131063431|NCT03761849|471863975|FG001|Overall Study|Adverse Event|0|||
131063432|NCT03761849|471863976|FG002|Overall Study|Adverse Event|0|||
131063433|NCT03761849|471863977|FG003|Overall Study|Adverse Event|0|||
131063434|NCT03761849|471863978|FG004|Overall Study|Adverse Event|2|||
131063435|NCT03761849|471863979|FG005|Overall Study|Adverse Event|3|||
131063436|NCT03761849|471863974|FG000|Overall Study|Withdrawal by Subject|0|||
131063437|NCT03761849|471863975|FG001|Overall Study|Withdrawal by Subject|0|||
131063438|NCT03761849|471863976|FG002|Overall Study|Withdrawal by Subject|0|||
131063439|NCT03761849|471863977|FG003|Overall Study|Withdrawal by Subject|41|||
131063440|NCT03761849|471863978|FG004|Overall Study|Withdrawal by Subject|43|||
131063441|NCT03761849|471863979|FG005|Overall Study|Withdrawal by Subject|35|||
131063442|NCT03761849|471863974|FG000|Overall Study|Lost to Follow-up|0|||
131063443|NCT03761849|471863975|FG001|Overall Study|Lost to Follow-up|1|||
131063444|NCT03761849|471863976|FG002|Overall Study|Lost to Follow-up|0|||
131063445|NCT03761849|471863977|FG003|Overall Study|Lost to Follow-up|2|||
131063446|NCT03761849|471863978|FG004|Overall Study|Lost to Follow-up|4|||
131063447|NCT03761849|471863979|FG005|Overall Study|Lost to Follow-up|5|||
131063448|NCT03761849|471863974|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
131063449|NCT03761849|471863975|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
131063450|NCT03761849|471863976|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
131063451|NCT03761849|471863977|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
131063452|NCT03761849|471863978|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
131063453|NCT03761849|471863979|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
131063454|NCT03761849|471863974|FG000|Overall Study|Physician Decision|0|||
131063455|NCT03761849|471863975|FG001|Overall Study|Physician Decision|0|||
131063456|NCT03761849|471863976|FG002|Overall Study|Physician Decision|0|||
131063457|NCT03761849|471863977|FG003|Overall Study|Physician Decision|1|||
131063458|NCT03761849|471863978|FG004|Overall Study|Physician Decision|4|||
131063459|NCT03761849|471863979|FG005|Overall Study|Physician Decision|4|||
131063460|NCT03761849|471863974|FG000|Overall Study|Death|0|||
131063461|NCT03761849|471863975|FG001|Overall Study|Death|0|||
131063462|NCT03761849|471863976|FG002|Overall Study|Death|0|||
131063463|NCT03761849|471863977|FG003|Overall Study|Death|1|||
131063464|NCT03761849|471863978|FG004|Overall Study|Death|1|||
130723036|NCT02256436|470611336|FG000|Overall Study|Adverse Event|9|||
130723037|NCT02256436|470611337|FG001|Overall Study|Adverse Event|14|||
130723038|NCT02256436|470611336|FG000|Overall Study|Death|216|||
131063465|NCT03761849|471863979|FG005|Overall Study|Death|3|||
131063466|NCT03761849|471863974|FG000|Overall Study|Protocol Violation|0|||
130723039|NCT02256436|470611337|FG001|Overall Study|Death|208|||
130723040|NCT02256436|470611336|FG000|Overall Study|Lost to Follow-up|1|||
130723041|NCT02256436|470611337|FG001|Overall Study|Lost to Follow-up|2|||
130723042|NCT02256436|470611336|FG000|Overall Study|Physician Decision|1|||
130723043|NCT02256436|470611337|FG001|Overall Study|Physician Decision|0|||
130723044|NCT02256436|470611336|FG000|Overall Study|Protocol Violation|0|||
131063467|NCT03761849|471863975|FG001|Overall Study|Protocol Violation|0|||
131063468|NCT03761849|471863976|FG002|Overall Study|Protocol Violation|0|||
131063469|NCT03761849|471863977|FG003|Overall Study|Protocol Violation|2|||
130723045|NCT02256436|470611337|FG001|Overall Study|Protocol Violation|1|||
130723046|NCT02256436|470611336|FG000|Overall Study|Withdrawal by Subject|26|||
130723047|NCT02256436|470611337|FG001|Overall Study|Withdrawal by Subject|10|||
131063470|NCT03761849|471863978|FG004|Overall Study|Protocol Violation|2|||
131063471|NCT03761849|471863979|FG005|Overall Study|Protocol Violation|1|||
131063472|NCT03761849|471863974|FG000|Overall Study|Participant could not come to site|0|||
131063473|NCT03761849|471863975|FG001|Overall Study|Participant could not come to site|0|||
131063474|NCT03761849|471863976|FG002|Overall Study|Participant could not come to site|0|||
131063475|NCT03761849|471863977|FG003|Overall Study|Participant could not come to site|0|||
130723048|NCT02256436|470611336|FG000|Overall Study|Transferred to Extension Study|11|||
131063476|NCT03761849|471863978|FG004|Overall Study|Participant could not come to site|1|||
131063477|NCT03761849|471863979|FG005|Overall Study|Participant could not come to site|0|||
131063478|NCT03761849|471863974|FG000|Overall Study|SF- safety Finding|0|||
131063479|NCT03761849|471863975|FG001|Overall Study|SF- safety Finding|0|||
131063480|NCT03761849|471863976|FG002|Overall Study|SF- safety Finding|0|||
131063481|NCT03761849|471863977|FG003|Overall Study|SF- safety Finding|0|||
131063482|NCT03761849|471863978|FG004|Overall Study|SF- safety Finding|0|||
131063483|NCT03761849|471863979|FG005|Overall Study|SF- safety Finding|1|||
131063484|NCT03761849|471863974|FG000|Overall Study|Patient did not attend visit|0|||
131063485|NCT03761849|471863975|FG001|Overall Study|Patient did not attend visit|0|||
131063486|NCT03761849|471863976|FG002|Overall Study|Patient did not attend visit|0|||
131063487|NCT03761849|471863977|FG003|Overall Study|Patient did not attend visit|0|||
131063488|NCT03761849|471863978|FG004|Overall Study|Patient did not attend visit|0|||
131063489|NCT03761849|471863979|FG005|Overall Study|Patient did not attend visit|1|||
131063490|NCT03840993|471863980|FG000|Overall Study|Adverse Event|1|||
131063491|NCT03840993|471863981|FG001|Overall Study|Adverse Event|0|||
131063492|NCT03840993|471863980|FG000|Overall Study|Lost to Follow-up|4|||
131063493|NCT03840993|471863981|FG001|Overall Study|Lost to Follow-up|0|||
131063494|NCT03840993|471863980|FG000|Overall Study|Physician Decision|0|||
131063495|NCT03840993|471863981|FG001|Overall Study|Physician Decision|1|||
131063496|NCT03840993|471863980|FG000|Overall Study|Pregnancy|0|||
131063497|NCT03840993|471863981|FG001|Overall Study|Pregnancy|1|||
131063498|NCT03840993|471863980|FG000|Overall Study|Withdrawal by Subject|1|||
131063499|NCT03840993|471863981|FG001|Overall Study|Withdrawal by Subject|3|||
131063500|NCT03840993|471863980|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
131063501|NCT03840993|471863981|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
131063502|NCT02213094|471863982|FG000|Overall Study|Adverse Event|1|||
131063503|NCT02213094|471863983|FG001|Overall Study|Adverse Event|0|||
131063504|NCT00988429|471863984|FG000|Overall Study|Adverse Event|9|||
131063505|NCT00988429|471863985|FG001|Overall Study|Adverse Event|21|||
131063506|NCT00988429|471863986|FG002|Overall Study|Adverse Event|45|||
131063507|NCT00988429|471863984|FG000|Overall Study|Lack of Efficacy|0|||
131063508|NCT00988429|471863985|FG001|Overall Study|Lack of Efficacy|0|||
131063509|NCT00988429|471863986|FG002|Overall Study|Lack of Efficacy|1|||
131063510|NCT00988429|471863984|FG000|Overall Study|Non-Compliance with Study Drug|5|||
131063511|NCT00988429|471863985|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131063512|NCT00988429|471863986|FG002|Overall Study|Non-Compliance with Study Drug|3|||
131063513|NCT00988429|471863984|FG000|Overall Study|Physician Decision|1|||
131063514|NCT00988429|471863985|FG001|Overall Study|Physician Decision|0|||
131063515|NCT00988429|471863986|FG002|Overall Study|Physician Decision|3|||
131063516|NCT00988429|471863984|FG000|Overall Study|Pregnancy|2|||
130723049|NCT02256436|470611337|FG001|Overall Study|Transferred to Extension Study|23|||
130723050|NCT02256436|470611336|FG000|Overall Study|Did Not Continue on Extension Study|8|||
130723051|NCT02256436|470611337|FG001|Overall Study|Did Not Continue on Extension Study|12|||
130723052|NCT03583086|470611338|FG000|Overall Study|Death|2|||
130723053|NCT03583086|470611339|FG001|Overall Study|Death|6|||
130723054|NCT03583086|470611340|FG002|Overall Study|Death|12|||
130723055|NCT03583086|470611341|FG003|Overall Study|Death|10|||
130723056|NCT03583086|470611342|FG004|Overall Study|Death|14|||
130723057|NCT03583086|470611343|FG005|Overall Study|Death|14|||
130723058|NCT03583086|470611344|FG006|Overall Study|Death|4|||
130723059|NCT03583086|470611338|FG000|Overall Study|Withdrawal by Subject|0|||
130723060|NCT03583086|470611339|FG001|Overall Study|Withdrawal by Subject|0|||
130723061|NCT03583086|470611340|FG002|Overall Study|Withdrawal by Subject|1|||
130723062|NCT03583086|470611341|FG003|Overall Study|Withdrawal by Subject|0|||
130723063|NCT03583086|470611342|FG004|Overall Study|Withdrawal by Subject|0|||
130723064|NCT03583086|470611343|FG005|Overall Study|Withdrawal by Subject|0|||
130723065|NCT03583086|470611344|FG006|Overall Study|Withdrawal by Subject|1|||
130723066|NCT03583086|470611338|FG000|Overall Study|Refused follow-up|0|||
130723067|NCT03583086|470611339|FG001|Overall Study|Refused follow-up|0|||
130723068|NCT03583086|470611340|FG002|Overall Study|Refused follow-up|1|||
130723069|NCT03583086|470611341|FG003|Overall Study|Refused follow-up|0|||
130723070|NCT03583086|470611342|FG004|Overall Study|Refused follow-up|1|||
130723071|NCT03583086|470611343|FG005|Overall Study|Refused follow-up|0|||
130723072|NCT03583086|470611344|FG006|Overall Study|Refused follow-up|0|||
131063517|NCT00988429|471863985|FG001|Overall Study|Pregnancy|1|||
131063518|NCT00988429|471863986|FG002|Overall Study|Pregnancy|0|||
131063519|NCT00988429|471863984|FG000|Overall Study|Protocol Violation|4|||
131063520|NCT00988429|471863985|FG001|Overall Study|Protocol Violation|3|||
131063521|NCT00988429|471863986|FG002|Overall Study|Protocol Violation|3|||
131063522|NCT00988429|471863984|FG000|Overall Study|Withdrawal by Subject|7|||
131063523|NCT00988429|471863985|FG001|Overall Study|Withdrawal by Subject|7|||
131063524|NCT00988429|471863986|FG002|Overall Study|Withdrawal by Subject|12|||
130723073|NCT03583086|470611338|FG000|Overall Study|Declining Performance Status|0|||
130723074|NCT03583086|470611339|FG001|Overall Study|Declining Performance Status|0|||
131063525|NCT00988429|471863984|FG000|Overall Study|Administrative Reasons|1|||
130723075|NCT03583086|470611340|FG002|Overall Study|Declining Performance Status|1|||
130723076|NCT03583086|470611341|FG003|Overall Study|Declining Performance Status|0|||
131063526|NCT00988429|471863985|FG001|Overall Study|Administrative Reasons|2|||
131063527|NCT00988429|471863986|FG002|Overall Study|Administrative Reasons|1|||
131063528|NCT00988429|471863984|FG000|Overall Study|other reasons|8|||
131063529|NCT00988429|471863985|FG001|Overall Study|other reasons|8|||
131063530|NCT00988429|471863986|FG002|Overall Study|other reasons|1|||
131063531|NCT01074229|471863987|FG000|Overall Study|Lost to Follow-up|1|||
131063532|NCT01074229|471863988|FG001|Overall Study|Lost to Follow-up|0|||
131063533|NCT01074229|471863989|FG002|Overall Study|Lost to Follow-up|0|||
131063534|NCT01074229|471863987|FG000|Overall Study|Change to open surgical procedure|1|||
131063535|NCT01074229|471863988|FG001|Overall Study|Change to open surgical procedure|3|||
131063536|NCT01074229|471863989|FG002|Overall Study|Change to open surgical procedure|4|||
131063537|NCT02964234|471863990|FG000|Overall Study|Lost to Follow-up|22|||
131063538|NCT02964234|471863991|FG001|Overall Study|Lost to Follow-up|13|||
131063539|NCT02163499|471863994|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
131063540|NCT02163499|471863994|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
131063541|NCT02163499|471863994|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
131063542|NCT02163499|471863994|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
131063543|NCT02163499|471863994|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
131063544|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
131063545|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
131063546|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
131063547|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
131063548|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
131063549|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
131063550|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
131063551|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
131063552|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
131063553|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Death|8|||
131063554|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
131063555|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
131063556|NCT02163499|471863994|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
131063557|NCT01540474|471863995|FG000|Vaccination Period|Lost to Follow-up|0|||
131063558|NCT01540474|471863996|FG001|Vaccination Period|Lost to Follow-up|1|||
131063559|NCT01540474|471863997|FG002|Vaccination Period|Lost to Follow-up|0|||
131063560|NCT01540474|471863998|FG003|Vaccination Period|Lost to Follow-up|0|||
131063561|NCT00857311|471863999|FG000|Overall Study|Lost to Follow-up|1|||
131063562|NCT00857311|471864000|FG001|Overall Study|Lost to Follow-up|0|||
131063563|NCT00857311|471864001|FG002|Overall Study|Lost to Follow-up|0|||
131063564|NCT00857311|471864002|FG003|Overall Study|Lost to Follow-up|0|||
131063565|NCT01799993|471864004|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
131063566|NCT01799993|471864005|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
131063567|NCT01799993|471864004|FG000|Overall Study|Death|61|||
131063568|NCT01799993|471864005|FG001|Overall Study|Death|45|||
131063569|NCT01799993|471864004|FG000|Overall Study|Withdrawal by Subject|23|||
131063570|NCT01799993|471864005|FG001|Overall Study|Withdrawal by Subject|24|||
131063571|NCT01799993|471864004|FG000|Overall Study|Lost to Follow-up|5|||
131063572|NCT01799993|471864005|FG001|Overall Study|Lost to Follow-up|8|||
131063573|NCT01799993|471864004|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
131063574|NCT01799993|471864005|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
131063575|NCT01799993|471864004|FG000|Overall Study|Protocol driven decision point|0|||
131063576|NCT01799993|471864005|FG001|Overall Study|Protocol driven decision point|3|||
131063577|NCT01799993|471864004|FG000|Overall Study|Protocol Violation|1|||
131063578|NCT01799993|471864005|FG001|Overall Study|Protocol Violation|1|||
131063579|NCT01799993|471864004|FG000|Overall Study|Deterioration of general conditions|2|||
131063580|NCT01799993|471864005|FG001|Overall Study|Deterioration of general conditions|0|||
131063581|NCT01799993|471864004|FG000|Overall Study|Screen failure|0|||
131063582|NCT01799993|471864005|FG001|Overall Study|Screen failure|1|||
131063583|NCT01799993|471864004|FG000|Overall Study|Adverse Event|1|||
131063584|NCT01799993|471864005|FG001|Overall Study|Adverse Event|0|||
131063585|NCT01799993|471864004|FG000|Overall Study|Lack of Efficacy|1|||
131063586|NCT01799993|471864005|FG001|Overall Study|Lack of Efficacy|0|||
131063587|NCT01799993|471864004|FG000|Overall Study|Recovery|0|||
131229997|NCT02668302|472467769|FG001|Overall Study|Withdrawal by Subject|0|||
131229998|NCT03775681|472467770|FG000|Overall Study|Physician Decision|3|||
130723077|NCT03583086|470611342|FG004|Overall Study|Declining Performance Status|0|||
130723078|NCT03583086|470611343|FG005|Overall Study|Declining Performance Status|0|||
131063588|NCT01799993|471864005|FG001|Overall Study|Recovery|1|||
131063589|NCT01799993|471864004|FG000|Overall Study|Logistical difficulties|1|||
131063590|NCT01799993|471864005|FG001|Overall Study|Logistical difficulties|0|||
131063591|NCT01799993|471864004|FG000|Overall Study|Protocol deviation|1|||
131063592|NCT01799993|471864005|FG001|Overall Study|Protocol deviation|0|||
131229999|NCT00616928|472467771|FG000|Overall Study|Adverse Event|6|||
130723079|NCT03583086|470611344|FG006|Overall Study|Declining Performance Status|0|||
131063593|NCT01799993|471864004|FG000|Overall Study|Non-compliance with medical device|1|||
131063594|NCT01799993|471864005|FG001|Overall Study|Non-compliance with medical device|0|||
131063595|NCT01799993|471864004|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130723080|NCT03583086|470611338|FG000|Overall Study|Still on study|0|||
130723081|NCT03583086|470611339|FG001|Overall Study|Still on study|0|||
131063596|NCT01799993|471864005|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131063597|NCT01799993|471864004|FG000|Overall Study|Other|1|||
131063598|NCT01799993|471864005|FG001|Overall Study|Other|0|||
131063599|NCT01799993|471864004|FG000|Overall Study|Subject didn't return for follow-up|0|||
131063600|NCT01799993|471864005|FG001|Overall Study|Subject didn't return for follow-up|1|||
131063601|NCT04271254|471864006|FG000|Overall Study|Withdrawal by Subject|3|||
131063602|NCT04410445|471864007|FG000|Overall Study|Lost to Follow-up|3|||
131063603|NCT04410445|471864008|FG001|Overall Study|Lost to Follow-up|9|||
131063604|NCT04410445|471864007|FG000|Overall Study|Withdrawal by Subject|27|||
131063605|NCT04410445|471864008|FG001|Overall Study|Withdrawal by Subject|15|||
131063606|NCT01320683|471864009|FG000|Overall Study|Positive antibody response|1|||
131063607|NCT01123356|471864010|FG000|Overall Study|Adverse Event|2|||
131063608|NCT01123356|471864010|FG000|Overall Study|Lack of Efficacy|4|||
131063609|NCT01123356|471864010|FG000|Overall Study|Withdrawal by Subject|1|||
131063610|NCT00759681|471864011|FG000|Overall Study|Death|2|||
131063611|NCT00759681|471864012|FG001|Overall Study|Death|5|||
131063612|NCT00759681|471864011|FG000|Overall Study|Lost to Follow-up|8|||
131063613|NCT00759681|471864012|FG001|Overall Study|Lost to Follow-up|5|||
131063614|NCT02005484|471864015|FG000|Overall Study|Death|1|||
131063615|NCT02005484|471864015|FG000|Overall Study|Disease progression|1|||
131063616|NCT02005484|471864015|FG000|Overall Study|Changed to a Different Study|1|||
131063617|NCT02005484|471864015|FG000|Overall Study|Sponsor decision|1|||
131063618|NCT01129011|471864016|FG000|Overall Study|Adverse Event|20|||
131063619|NCT01129011|471864017|FG001|Overall Study|Adverse Event|30|||
131063620|NCT01129011|471864016|FG000|Overall Study|Withdrawal by Subject|24|||
131063621|NCT01129011|471864017|FG001|Overall Study|Withdrawal by Subject|8|||
131063622|NCT01129011|471864016|FG000|Overall Study|Lost to Follow-up|6|||
131063623|NCT01129011|471864017|FG001|Overall Study|Lost to Follow-up|7|||
131063624|NCT01129011|471864016|FG000|Overall Study|Duodenal Ulcer|2|||
131063625|NCT01129011|471864017|FG001|Overall Study|Duodenal Ulcer|8|||
131063626|NCT01129011|471864016|FG000|Overall Study|misc|7|||
131063627|NCT01129011|471864017|FG001|Overall Study|misc|4|||
131230000|NCT00616928|472467772|FG001|Overall Study|Adverse Event|3|||
131230001|NCT00616928|472467773|FG002|Overall Study|Adverse Event|2|||
131230002|NCT00616928|472467774|FG003|Overall Study|Adverse Event|2|||
131230003|NCT00616928|472467771|FG000|Overall Study|Other|51|||
131230004|NCT00616928|472467772|FG001|Overall Study|Other|8|||
131230005|NCT00616928|472467773|FG002|Overall Study|Other|15|||
131063628|NCT02823574|471864021|FG000|Randomization|Disease Progression|0|||
131063629|NCT02823574|471864022|FG001|Randomization|Disease Progression|0|||
131063630|NCT02823574|471864023|FG002|Randomization|Disease Progression|1|||
131063631|NCT02823574|471864024|FG003|Randomization|Disease Progression|0|||
131063632|NCT02823574|471864021|FG000|Randomization|AE unrelated to Study Drug|1|||
131063633|NCT02823574|471864022|FG001|Randomization|AE unrelated to Study Drug|0|||
131063634|NCT02823574|471864023|FG002|Randomization|AE unrelated to Study Drug|0|||
131063635|NCT02823574|471864024|FG003|Randomization|AE unrelated to Study Drug|0|||
131063636|NCT02823574|471864021|FG000|Treatment Period|Poor/Non Compliance|1|||
131063637|NCT02823574|471864022|FG001|Treatment Period|Poor/Non Compliance|0|||
131063638|NCT02823574|471864023|FG002|Treatment Period|Poor/Non Compliance|0|||
131063639|NCT02823574|471864024|FG003|Treatment Period|Poor/Non Compliance|1|||
131063640|NCT02823574|471864021|FG000|Treatment Period|Maximum Clinical Benefit|8|||
131063641|NCT02823574|471864022|FG001|Treatment Period|Maximum Clinical Benefit|4|||
131063642|NCT02823574|471864023|FG002|Treatment Period|Maximum Clinical Benefit|7|||
131063643|NCT02823574|471864024|FG003|Treatment Period|Maximum Clinical Benefit|1|||
131063644|NCT02823574|471864021|FG000|Treatment Period|Lost to Follow-up|1|||
131063645|NCT02823574|471864022|FG001|Treatment Period|Lost to Follow-up|1|||
131063646|NCT02823574|471864023|FG002|Treatment Period|Lost to Follow-up|0|||
131063647|NCT02823574|471864024|FG003|Treatment Period|Lost to Follow-up|0|||
131063648|NCT02823574|471864021|FG000|Treatment Period|Participant withdrew consent|4|||
131063649|NCT02823574|471864022|FG001|Treatment Period|Participant withdrew consent|0|||
131063650|NCT02823574|471864023|FG002|Treatment Period|Participant withdrew consent|0|||
131063651|NCT02823574|471864024|FG003|Treatment Period|Participant withdrew consent|1|||
131063652|NCT02823574|471864021|FG000|Treatment Period|Participant request to discontinue|5|||
131063653|NCT02823574|471864022|FG001|Treatment Period|Participant request to discontinue|0|||
131063654|NCT02823574|471864023|FG002|Treatment Period|Participant request to discontinue|3|||
131063655|NCT02823574|471864024|FG003|Treatment Period|Participant request to discontinue|2|||
131063656|NCT02823574|471864021|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
131063657|NCT02823574|471864022|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
131063658|NCT02823574|471864023|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
131230006|NCT00616928|472467774|FG003|Overall Study|Other|5|||
130723082|NCT03583086|470611340|FG002|Overall Study|Still on study|0|||
131063659|NCT02823574|471864024|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
131063660|NCT02823574|471864021|FG000|Treatment Period|Study Drug Toxicity|11|||
131230007|NCT00616928|472467771|FG000|Overall Study|Lost to Follow-up|5|||
131063661|NCT02823574|471864022|FG001|Treatment Period|Study Drug Toxicity|2|||
131063662|NCT02823574|471864023|FG002|Treatment Period|Study Drug Toxicity|14|||
131230008|NCT00616928|472467772|FG001|Overall Study|Lost to Follow-up|7|||
131063663|NCT02823574|471864024|FG003|Treatment Period|Study Drug Toxicity|4|||
131063664|NCT02823574|471864021|FG000|Treatment Period|Disease Progression|113|||
131063665|NCT02823574|471864022|FG001|Treatment Period|Disease Progression|64|||
131063666|NCT02823574|471864023|FG002|Treatment Period|Disease Progression|82|||
131063667|NCT02823574|471864024|FG003|Treatment Period|Disease Progression|43|||
131063668|NCT02823574|471864021|FG000|Treatment Period|Other reasons|5|||
131063669|NCT02823574|471864022|FG001|Treatment Period|Other reasons|9|||
131063670|NCT02823574|471864023|FG002|Treatment Period|Other reasons|3|||
131063671|NCT02823574|471864024|FG003|Treatment Period|Other reasons|6|||
131063672|NCT02823574|471864021|FG000|Treatment Period|Participant no longer meets study criteria|0|||
131063673|NCT02823574|471864022|FG001|Treatment Period|Participant no longer meets study criteria|0|||
131063674|NCT02823574|471864023|FG002|Treatment Period|Participant no longer meets study criteria|1|||
131063675|NCT02823574|471864024|FG003|Treatment Period|Participant no longer meets study criteria|0|||
131063676|NCT02823574|471864021|FG000|Treatment Period|Death|0|||
131063677|NCT02823574|471864022|FG001|Treatment Period|Death|0|||
131063678|NCT02823574|471864023|FG002|Treatment Period|Death|3|||
131063679|NCT02823574|471864024|FG003|Treatment Period|Death|1|||
131063680|NCT00590759|471864025|FG000|Overall Study|Death|52|||
131063681|NCT00590759|471864025|FG000|Overall Study|Lost to Follow-up|28|||
131063682|NCT00417885|471864026|FG000|Overall Study|Adverse Event|1|||
131063683|NCT00417885|471864026|FG000|Overall Study|Objective Progression or Relapse|3|||
131063684|NCT00417885|471864026|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
131063685|NCT00096278|471864027|FG000|Overall Study|No follow-up data|15|||
131063686|NCT00096278|471864028|FG001|Overall Study|No follow-up data|18|||
131063687|NCT00096278|471864027|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
131063688|NCT00096278|471864028|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
131063689|NCT01894620|471864031|FG000|Overall Study|Withdrawal by Subject|0|||
131063690|NCT01894620|471864032|FG001|Overall Study|Withdrawal by Subject|1|||
131063691|NCT02877680|471864033|FG000|Overall Study|Lost to Follow-up|1|||
131063692|NCT02877680|471864034|FG001|Overall Study|Lost to Follow-up|1|||
131063693|NCT05104242|471864041|FG000|Overall Study|Withdrawal by Subject|1|||
131063694|NCT05104242|471864042|FG001|Overall Study|Withdrawal by Subject|5|||
131063695|NCT05104242|471864041|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
131063696|NCT05104242|471864042|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
131063697|NCT01864200|471864043|FG000|Overall Study|Lost to Follow-up|1|||
131063698|NCT01864200|471864044|FG001|Overall Study|Lost to Follow-up|3|||
131063699|NCT01864200|471864043|FG000|Overall Study|Protocol Violation|1|||
131063700|NCT01864200|471864044|FG001|Overall Study|Protocol Violation|0|||
131063701|NCT02991118|471864045|FG000|Overall Study|Death|3|||
131063702|NCT02991118|471864046|FG001|Overall Study|Death|8|||
131063703|NCT02991118|471864045|FG000|Overall Study|Protocol Violation|0|||
131063704|NCT02991118|471864046|FG001|Overall Study|Protocol Violation|3|||
131063705|NCT02991118|471864045|FG000|Overall Study|Physician Decision|0|||
131063706|NCT02991118|471864046|FG001|Overall Study|Physician Decision|1|||
131063707|NCT02991118|471864045|FG000|Overall Study|Moved out of the country|0|||
131063708|NCT02991118|471864046|FG001|Overall Study|Moved out of the country|1|||
131063709|NCT02991118|471864045|FG000|Overall Study|Adverse Event|2|||
131063710|NCT02991118|471864046|FG001|Overall Study|Adverse Event|2|||
130723083|NCT03583086|470611341|FG003|Overall Study|Still on study|1|||
130723084|NCT03583086|470611342|FG004|Overall Study|Still on study|0|||
130723085|NCT03583086|470611343|FG005|Overall Study|Still on study|0|||
130723086|NCT03583086|470611344|FG006|Overall Study|Still on study|1|||
130723087|NCT03583086|470611338|FG000|Overall Study|Disease progression|0|||
130723088|NCT03583086|470611339|FG001|Overall Study|Disease progression|0|||
130723089|NCT03583086|470611340|FG002|Overall Study|Disease progression|0|||
130723090|NCT03583086|470611341|FG003|Overall Study|Disease progression|0|||
130723091|NCT03583086|470611342|FG004|Overall Study|Disease progression|0|||
130723092|NCT03583086|470611343|FG005|Overall Study|Disease progression|0|||
130723093|NCT03583086|470611344|FG006|Overall Study|Disease progression|1|||
130723094|NCT03583086|470611338|FG000|Overall Study|Undergoing radiation therapy|0|||
130723095|NCT03583086|470611339|FG001|Overall Study|Undergoing radiation therapy|0|||
131063711|NCT02991118|471864045|FG000|Overall Study|Withdrawal by Subject|1|||
131063712|NCT02991118|471864046|FG001|Overall Study|Withdrawal by Subject|7|||
131137424|NCT04537208|472130613|FG008|Overall Study|Adverse Event|1|||
131063713|NCT02991118|471864045|FG000|Overall Study|Could not attend study visits|0|||
131063714|NCT02991118|471864046|FG001|Overall Study|Could not attend study visits|1|||
130723096|NCT03583086|470611340|FG002|Overall Study|Undergoing radiation therapy|0|||
130723097|NCT03583086|470611341|FG003|Overall Study|Undergoing radiation therapy|0|||
131063715|NCT02991118|471864045|FG000|Overall Study|Lost to Follow-up|1|||
131063716|NCT02991118|471864046|FG001|Overall Study|Lost to Follow-up|9|||
131063717|NCT00595959|471864047|FG000|Overall Study|Withdrawal by Subject|1|||
131063718|NCT00595959|471864047|FG000|Overall Study|Lost to Follow-up|1|||
131063719|NCT00424476|471864051|FG000|Overall Study|Withdrawal by Subject|7|||
130723098|NCT03583086|470611342|FG004|Overall Study|Undergoing radiation therapy|0|||
130723099|NCT03583086|470611343|FG005|Overall Study|Undergoing radiation therapy|0|||
131063720|NCT00424476|471864052|FG001|Overall Study|Withdrawal by Subject|6|||
131063721|NCT00424476|471864053|FG002|Overall Study|Withdrawal by Subject|3|||
131063722|NCT00424476|471864051|FG000|Overall Study|Adverse Event|19|||
131063723|NCT00424476|471864052|FG001|Overall Study|Adverse Event|16|||
131063724|NCT00424476|471864053|FG002|Overall Study|Adverse Event|15|||
131063725|NCT00424476|471864051|FG000|Overall Study|Lack of Efficacy|16|||
131063726|NCT00424476|471864052|FG001|Overall Study|Lack of Efficacy|12|||
131063727|NCT00424476|471864053|FG002|Overall Study|Lack of Efficacy|12|||
131063728|NCT00424476|471864051|FG000|Overall Study|Lack of Compliance|1|||
131063729|NCT00424476|471864052|FG001|Overall Study|Lack of Compliance|1|||
131063730|NCT00424476|471864053|FG002|Overall Study|Lack of Compliance|1|||
131063731|NCT00424476|471864051|FG000|Overall Study|Lost to Follow-up|4|||
131063732|NCT00424476|471864052|FG001|Overall Study|Lost to Follow-up|6|||
131063733|NCT00424476|471864053|FG002|Overall Study|Lost to Follow-up|3|||
131063734|NCT00424476|471864051|FG000|Overall Study|Protocol Violation|7|||
131063735|NCT00424476|471864052|FG001|Overall Study|Protocol Violation|2|||
131063736|NCT00424476|471864053|FG002|Overall Study|Protocol Violation|3|||
131063737|NCT00424476|471864051|FG000|Overall Study|Physician Decision|3|||
131063738|NCT00424476|471864052|FG001|Overall Study|Physician Decision|2|||
131063739|NCT00424476|471864053|FG002|Overall Study|Physician Decision|3|||
131063740|NCT00424476|471864051|FG000|Overall Study|Other|4|||
131063741|NCT00424476|471864052|FG001|Overall Study|Other|3|||
131063742|NCT00424476|471864053|FG002|Overall Study|Other|9|||
131063743|NCT02764320|471864054|FG000|Overall Study|Withdrawal by Subject|35|||
131063744|NCT02764320|471864055|FG001|Overall Study|Withdrawal by Subject|38|||
131063745|NCT02764320|471864054|FG000|Overall Study|Protocol Violation|11|||
131063746|NCT02764320|471864055|FG001|Overall Study|Protocol Violation|6|||
131063747|NCT02764320|471864054|FG000|Overall Study|Adverse Event|2|||
131063748|NCT02764320|471864055|FG001|Overall Study|Adverse Event|0|||
131063749|NCT02764320|471864054|FG000|Overall Study|Health Issues unable to continue|2|||
131063750|NCT02764320|471864055|FG001|Overall Study|Health Issues unable to continue|0|||
131063751|NCT02764320|471864054|FG000|Overall Study|Did not meet inclusion criteria|1|||
131137425|NCT04537208|472130614|FG009|Overall Study|Adverse Event|0|||
131137426|NCT04537208|472130615|FG010|Overall Study|Adverse Event|0|||
131137427|NCT04537208|472130605|FG000|Overall Study|Protocol deviation|0|||
131137428|NCT04537208|472130606|FG001|Overall Study|Protocol deviation|0|||
131137429|NCT04537208|472130607|FG002|Overall Study|Protocol deviation|2|||
131137430|NCT04537208|472130608|FG003|Overall Study|Protocol deviation|0|||
131137431|NCT04537208|472130609|FG004|Overall Study|Protocol deviation|0|||
131137432|NCT04537208|472130610|FG005|Overall Study|Protocol deviation|2|||
131137433|NCT04537208|472130611|FG006|Overall Study|Protocol deviation|4|||
131137434|NCT04537208|472130612|FG007|Overall Study|Protocol deviation|0|||
131137435|NCT04537208|472130613|FG008|Overall Study|Protocol deviation|1|||
131137436|NCT04537208|472130614|FG009|Overall Study|Protocol deviation|0|||
131137437|NCT04537208|472130615|FG010|Overall Study|Protocol deviation|2|||
131137438|NCT04537208|472130605|FG000|Overall Study|Withdrawal by Subject|4|||
131137439|NCT04537208|472130606|FG001|Overall Study|Withdrawal by Subject|2|||
131137440|NCT04537208|472130607|FG002|Overall Study|Withdrawal by Subject|1|||
131137441|NCT04537208|472130608|FG003|Overall Study|Withdrawal by Subject|3|||
131137442|NCT04537208|472130609|FG004|Overall Study|Withdrawal by Subject|5|||
131137443|NCT04537208|472130610|FG005|Overall Study|Withdrawal by Subject|1|||
131137444|NCT04537208|472130611|FG006|Overall Study|Withdrawal by Subject|6|||
131137445|NCT04537208|472130612|FG007|Overall Study|Withdrawal by Subject|1|||
131137446|NCT04537208|472130613|FG008|Overall Study|Withdrawal by Subject|7|||
131137447|NCT04537208|472130614|FG009|Overall Study|Withdrawal by Subject|2|||
131137448|NCT04537208|472130615|FG010|Overall Study|Withdrawal by Subject|4|||
131137449|NCT04537208|472130605|FG000|Overall Study|Lost to Follow-up|4|||
131137450|NCT04537208|472130606|FG001|Overall Study|Lost to Follow-up|1|||
130723100|NCT03583086|470611344|FG006|Overall Study|Undergoing radiation therapy|1|||
130723101|NCT03583086|470611338|FG000|Overall Study|Lost to Follow-up|0|||
130723102|NCT03583086|470611339|FG001|Overall Study|Lost to Follow-up|0|||
131063752|NCT02764320|471864055|FG001|Overall Study|Did not meet inclusion criteria|0|||
131063753|NCT02764320|471864054|FG000|Overall Study|Subject moved|0|||
131063754|NCT02764320|471864055|FG001|Overall Study|Subject moved|2|||
131063755|NCT02764320|471864054|FG000|Overall Study|Overused medication unavailable|0|||
131063756|NCT02764320|471864055|FG001|Overall Study|Overused medication unavailable|1|||
130723103|NCT03583086|470611340|FG002|Overall Study|Lost to Follow-up|0|||
131063757|NCT02764320|471864054|FG000|Overall Study|Seeking care outside site|0|||
131063758|NCT02764320|471864055|FG001|Overall Study|Seeking care outside site|1|||
131063759|NCT02764320|471864054|FG000|Overall Study|Technology barriers|0|||
131137451|NCT04537208|472130607|FG002|Overall Study|Lost to Follow-up|3|||
131137452|NCT04537208|472130608|FG003|Overall Study|Lost to Follow-up|4|||
130723104|NCT03583086|470611341|FG003|Overall Study|Lost to Follow-up|0|||
131137453|NCT04537208|472130609|FG004|Overall Study|Lost to Follow-up|3|||
131137454|NCT04537208|472130610|FG005|Overall Study|Lost to Follow-up|2|||
131137455|NCT04537208|472130611|FG006|Overall Study|Lost to Follow-up|3|||
131137456|NCT04537208|472130612|FG007|Overall Study|Lost to Follow-up|2|||
131137457|NCT04537208|472130613|FG008|Overall Study|Lost to Follow-up|7|||
131137458|NCT04537208|472130614|FG009|Overall Study|Lost to Follow-up|2|||
131137459|NCT04537208|472130615|FG010|Overall Study|Lost to Follow-up|2|||
131137460|NCT03083886|472130616|FG000|Overall Study|Withdrawal by Subject|51|||
131137461|NCT03083886|472130617|FG001|Overall Study|Withdrawal by Subject|73|||
131137462|NCT03083886|472130618|FG002|Overall Study|Withdrawal by Subject|104|||
131137463|NCT03083886|472130616|FG000|Overall Study|Missing Baseline data|43|||
131137464|NCT03083886|472130617|FG001|Overall Study|Missing Baseline data|42|||
131137465|NCT03083886|472130618|FG002|Overall Study|Missing Baseline data|31|||
131137466|NCT03083886|472130616|FG000|Overall Study|Investigator terminated|1|||
131137467|NCT03083886|472130617|FG001|Overall Study|Investigator terminated|6|||
131137468|NCT03083886|472130618|FG002|Overall Study|Investigator terminated|3|||
131137469|NCT04161495|472130619|FG000|Overall Study|Withdrawal by Subject|3|||
131137470|NCT04161495|472130620|FG001|Overall Study|Withdrawal by Subject|0|||
131137471|NCT04161495|472130619|FG000|Overall Study|Protocol Violation|1|||
131137472|NCT04161495|472130620|FG001|Overall Study|Protocol Violation|0|||
131137473|NCT04161495|472130619|FG000|Overall Study|Prohibited concomitant medication|3|||
131137474|NCT04161495|472130620|FG001|Overall Study|Prohibited concomitant medication|0|||
131137475|NCT04161495|472130619|FG000|Overall Study|Adverse Event|1|||
131137476|NCT04161495|472130620|FG001|Overall Study|Adverse Event|0|||
131137477|NCT04161495|472130619|FG000|Overall Study|Other - Unspecified|1|||
131230009|NCT00616928|472467773|FG002|Overall Study|Lost to Follow-up|0|||
131230010|NCT00616928|472467774|FG003|Overall Study|Lost to Follow-up|0|||
131230011|NCT03529955|472467779|FG000|Overall Study|Adverse Event|1|||
131230012|NCT03529955|472467779|FG000|Overall Study|Lack of Efficacy|1|||
131230013|NCT00580983|472467780|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
131230014|NCT02468557|472469255|FG000|Overall Study|Adverse Event|1|||
131230015|NCT02468557|472469255|FG000|Overall Study|Death|1|||
131230016|NCT02468557|472469255|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
130723105|NCT03583086|470611342|FG004|Overall Study|Lost to Follow-up|0|||
131063760|NCT02764320|471864055|FG001|Overall Study|Technology barriers|1|||
131063761|NCT00632736|471864061|FG000|Overall Study|Adverse Event|104|||
131063762|NCT00632736|471864061|FG000|Overall Study|Lost to Follow-up|15|||
131063763|NCT00632736|471864061|FG000|Overall Study|Protocol Violation|14|||
131063764|NCT00632736|471864061|FG000|Overall Study|Withdrawal by Subject|99|||
131063765|NCT00632736|471864061|FG000|Overall Study|Lack of Efficacy|5|||
131063766|NCT00632736|471864061|FG000|Overall Study|Sponsor terminated study|5|||
131063767|NCT00632736|471864061|FG000|Overall Study|Non-compliance|10|||
131063768|NCT00632736|471864061|FG000|Overall Study|Other|16|||
131063769|NCT05700851|471864062|FG000|Overall Study|Received a kidney transplant|1|||
131063770|NCT05700851|471864062|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
131063771|NCT05700851|471864062|FG000|Overall Study|Withdrawal by Subject|1|||
131063772|NCT00589628|471864063|FG000|Overall Study|Lost to Follow-up|0|||
131063773|NCT00589628|471864064|FG001|Overall Study|Lost to Follow-up|1|||
131063774|NCT00736502|471864074|FG000|Overall Study|Adverse Event|22|||
131063775|NCT00736502|471864074|FG000|Overall Study|Lack of Efficacy|16|||
131063776|NCT00736502|471864074|FG000|Overall Study|Lost to Follow-up|27|||
131063777|NCT03100370|471864076|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131063778|NCT03100370|471864077|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131063779|NCT03100370|471864078|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131063780|NCT03100370|471864079|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131063781|NCT03100370|471864080|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131063782|NCT03100370|471864081|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
131063783|NCT01307800|471864082|FG000|Overall Study|Adverse Event|9|||
131063784|NCT01307800|471864083|FG001|Overall Study|Adverse Event|8|||
131063785|NCT01307800|471864084|FG002|Overall Study|Adverse Event|10|||
131063786|NCT01307800|471864085|FG003|Overall Study|Adverse Event|14|||
131063787|NCT01307800|471864082|FG000|Overall Study|Entry Criteria Not Met|0|||
131063788|NCT01307800|471864083|FG001|Overall Study|Entry Criteria Not Met|0|||
131063789|NCT01307800|471864084|FG002|Overall Study|Entry Criteria Not Met|0|||
131063790|NCT01307800|471864085|FG003|Overall Study|Entry Criteria Not Met|2|||
131063791|NCT01307800|471864082|FG000|Overall Study|Lost to Follow-up|5|||
131063792|NCT01307800|471864083|FG001|Overall Study|Lost to Follow-up|6|||
131063793|NCT01307800|471864084|FG002|Overall Study|Lost to Follow-up|2|||
131063794|NCT01307800|471864085|FG003|Overall Study|Lost to Follow-up|8|||
131137478|NCT04161495|472130620|FG001|Overall Study|Other - Unspecified|0|||
131137479|NCT04161495|472130619|FG000|Overall Study|Death|0|||
131137480|NCT04161495|472130620|FG001|Overall Study|Death|1|||
131137481|NCT03655756|472130621|FG000|Overall Study|Death|1|||
131137482|NCT00253630|472130622|FG000|Overall Study|ineligible|2|||
131137483|NCT00429858|472130623|FG000|Overall Study|Withdrawal by Subject|1|||
131137484|NCT00429858|472130623|FG000|Overall Study|Study Termination|1|||
131137485|NCT02062658|472130625|FG000|Overall Study|Withdrawal by Subject|1|||
131137486|NCT02062658|472130625|FG000|Overall Study|Lack of Efficacy|1|||
131230017|NCT02468557|472469255|FG000|Overall Study|All Enrolled but Never Dosed|4|||
130723106|NCT03583086|470611343|FG005|Overall Study|Lost to Follow-up|1|||
131137487|NCT00643994|472130626|FG000|Overall Study|Death|24|||
131137488|NCT00643994|472130626|FG000|Overall Study|Lost to Follow-up|72|||
131137489|NCT00257010|472130645|FG000|Overall Study|Lack of Efficacy|11|||
131063795|NCT01307800|471864082|FG000|Overall Study|Perceived Lack of Efficacy|24|||
131063796|NCT01307800|471864083|FG001|Overall Study|Perceived Lack of Efficacy|23|||
131063797|NCT01307800|471864084|FG002|Overall Study|Perceived Lack of Efficacy|20|||
131063798|NCT01307800|471864085|FG003|Overall Study|Perceived Lack of Efficacy|33|||
131063799|NCT01307800|471864082|FG000|Overall Study|Protocol Violation|0|||
131063800|NCT01307800|471864083|FG001|Overall Study|Protocol Violation|3|||
131063801|NCT01307800|471864084|FG002|Overall Study|Protocol Violation|4|||
131063802|NCT01307800|471864085|FG003|Overall Study|Protocol Violation|5|||
131063803|NCT01307800|471864082|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
131063804|NCT01307800|471864083|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
131063805|NCT01307800|471864084|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
131063806|NCT01307800|471864085|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
131063807|NCT01307800|471864082|FG000|Overall Study|Sponsor Decision|6|||
131063808|NCT01307800|471864083|FG001|Overall Study|Sponsor Decision|9|||
131063809|NCT01307800|471864084|FG002|Overall Study|Sponsor Decision|12|||
131063810|NCT01307800|471864085|FG003|Overall Study|Sponsor Decision|28|||
131063811|NCT01307800|471864082|FG000|Overall Study|Withdrawal by Subject|10|||
131063812|NCT01307800|471864083|FG001|Overall Study|Withdrawal by Subject|11|||
131063813|NCT01307800|471864084|FG002|Overall Study|Withdrawal by Subject|8|||
131063814|NCT01307800|471864085|FG003|Overall Study|Withdrawal by Subject|15|||
131063815|NCT01307800|471864082|FG000|Overall Study|Participant Moved|0|||
131063816|NCT01307800|471864083|FG001|Overall Study|Participant Moved|2|||
131063817|NCT01307800|471864084|FG002|Overall Study|Participant Moved|1|||
131063818|NCT01307800|471864085|FG003|Overall Study|Participant Moved|3|||
131063819|NCT01766206|471864086|FG000|Overall Study|Withdrawal by Subject|22|||
131063820|NCT01766206|471864086|FG000|Overall Study|Lost to Follow-up|10|||
131063821|NCT01766206|471864086|FG000|Overall Study|Inappropriate enrollment|18|||
131063822|NCT01766206|471864086|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
131063823|NCT02255474|471864087|FG000|Overall Study|Lost to Follow-up|1|||
131063824|NCT02255474|471864088|FG001|Overall Study|Lost to Follow-up|1|||
131063825|NCT02255474|471864089|FG002|Overall Study|Lost to Follow-up|3|||
131063826|NCT02255474|471864087|FG000|Overall Study|Withdrawal by Subject|1|||
131063827|NCT02255474|471864088|FG001|Overall Study|Withdrawal by Subject|1|||
131063828|NCT02255474|471864089|FG002|Overall Study|Withdrawal by Subject|0|||
131137490|NCT00257010|472130645|FG000|Overall Study|Lost to Follow-up|53|||
131137491|NCT00257010|472130645|FG000|Overall Study|Withdrawal by Subject|34|||
131137492|NCT00257010|472130645|FG000|Overall Study|Adverse Event|10|||
131137493|NCT00257010|472130645|FG000|Overall Study|various|11|||
131137494|NCT00257010|472130645|FG000|Overall Study|no headache reported|9|||
131137495|NCT00197054|472130646|FG000|Overall Study|Withdrawal by Subject|9|||
131137496|NCT00197054|472130647|FG001|Overall Study|Withdrawal by Subject|3|||
131137497|NCT00197054|472130648|FG002|Overall Study|Withdrawal by Subject|3|||
131137498|NCT00197054|472130646|FG000|Overall Study|Moved from area|7|||
131137499|NCT00197054|472130647|FG001|Overall Study|Moved from area|14|||
130723107|NCT03583086|470611344|FG006|Overall Study|Lost to Follow-up|0|||
130723108|NCT03583086|470611338|FG000|Overall Study|Adverse Event|0|||
130723109|NCT03583086|470611339|FG001|Overall Study|Adverse Event|0|||
130723110|NCT03583086|470611340|FG002|Overall Study|Adverse Event|0|||
130723111|NCT03583086|470611341|FG003|Overall Study|Adverse Event|0|||
131063829|NCT03978130|471865784|FG000|Overall Study|Lost to Follow-up|13|||
131063830|NCT03978130|471865785|FG001|Overall Study|Lost to Follow-up|14|||
131063831|NCT03978130|471865784|FG000|Overall Study|Withdrawal by Subject|12|||
131063832|NCT03978130|471865785|FG001|Overall Study|Withdrawal by Subject|2|||
131063833|NCT03978130|471865784|FG000|Overall Study|Adverse Event|2|||
131063834|NCT03978130|471865785|FG001|Overall Study|Adverse Event|1|||
131063835|NCT01562275|471865786|FG000|Stage 1|Adverse Event|0|||
131063836|NCT01562275|471865787|FG001|Stage 1|Adverse Event|0|||
131063837|NCT01562275|471865788|FG002|Stage 1|Adverse Event|0|||
131137500|NCT00197054|472130648|FG002|Overall Study|Moved from area|9|||
131137501|NCT00197054|472130646|FG000|Overall Study|Lost to Follow-up|1|||
131137502|NCT00197054|472130647|FG001|Overall Study|Lost to Follow-up|4|||
131137503|NCT00197054|472130648|FG002|Overall Study|Lost to Follow-up|0|||
131137504|NCT00323557|472130649|FG000|Overall Study|Physician Decision|1|||
131137505|NCT00323557|472130650|FG001|Overall Study|Physician Decision|0|||
131063838|NCT01562275|471865789|FG003|Stage 1|Adverse Event|1|||
131137506|NCT02450578|472130651|FG000|Overall Study|ECG abnormality so not treated|1|||
131063839|NCT01562275|471865790|FG004|Stage 1|Adverse Event|1|||
131063840|NCT01562275|471865791|FG005|Stage 1|Adverse Event|0|||
131063841|NCT01562275|471865792|FG006|Stage 1|Adverse Event|0|||
131063842|NCT01562275|471865793|FG007|Stage 1|Adverse Event|0|||
131063843|NCT01562275|471865794|FG008|Stage 1|Adverse Event|0|||
131063844|NCT01562275|471865795|FG009|Stage 1|Adverse Event|1|||
131063845|NCT01562275|471865796|FG010|Stage 1|Adverse Event|0|||
131063846|NCT01562275|471865797|FG011|Stage 1|Adverse Event|0|||
131063847|NCT01562275|471865798|FG012|Stage 1|Adverse Event|0|||
131063848|NCT01562275|471865786|FG000|Stage 1|Death|1|||
131063849|NCT01562275|471865787|FG001|Stage 1|Death|0|||
131063850|NCT01562275|471865788|FG002|Stage 1|Death|0|||
131137507|NCT02450578|472130652|FG001|Overall Study|ECG abnormality so not treated|0|||
131137508|NCT02450578|472130653|FG002|Overall Study|ECG abnormality so not treated|0|||
131063851|NCT01562275|471865789|FG003|Stage 1|Death|0|||
131063852|NCT01562275|471865790|FG004|Stage 1|Death|0|||
131063853|NCT01562275|471865791|FG005|Stage 1|Death|0|||
131063854|NCT01562275|471865792|FG006|Stage 1|Death|0|||
131063855|NCT01562275|471865793|FG007|Stage 1|Death|0|||
131063856|NCT01562275|471865794|FG008|Stage 1|Death|0|||
131063857|NCT01562275|471865795|FG009|Stage 1|Death|0|||
131063858|NCT01562275|471865796|FG010|Stage 1|Death|0|||
131063859|NCT01562275|471865797|FG011|Stage 1|Death|0|||
131063860|NCT01562275|471865798|FG012|Stage 1|Death|0|||
131063861|NCT01562275|471865786|FG000|Stage 1|Non Compliance|0|||
131063862|NCT01562275|471865787|FG001|Stage 1|Non Compliance|0|||
131063863|NCT01562275|471865788|FG002|Stage 1|Non Compliance|1|||
131063864|NCT01562275|471865789|FG003|Stage 1|Non Compliance|0|||
131063865|NCT01562275|471865790|FG004|Stage 1|Non Compliance|0|||
131063866|NCT01562275|471865791|FG005|Stage 1|Non Compliance|0|||
131063867|NCT01562275|471865792|FG006|Stage 1|Non Compliance|0|||
131063868|NCT01562275|471865793|FG007|Stage 1|Non Compliance|0|||
131063869|NCT01562275|471865794|FG008|Stage 1|Non Compliance|0|||
131063870|NCT01562275|471865795|FG009|Stage 1|Non Compliance|0|||
131063871|NCT01562275|471865796|FG010|Stage 1|Non Compliance|0|||
131063872|NCT01562275|471865797|FG011|Stage 1|Non Compliance|0|||
131063873|NCT01562275|471865798|FG012|Stage 1|Non Compliance|0|||
131063874|NCT01562275|471865786|FG000|Stage 1|Physician Decision|0|||
131063875|NCT01562275|471865787|FG001|Stage 1|Physician Decision|0|||
131063876|NCT01562275|471865788|FG002|Stage 1|Physician Decision|0|||
131063877|NCT01562275|471865789|FG003|Stage 1|Physician Decision|0|||
131063878|NCT01562275|471865790|FG004|Stage 1|Physician Decision|1|||
131063879|NCT01562275|471865791|FG005|Stage 1|Physician Decision|0|||
131063880|NCT01562275|471865792|FG006|Stage 1|Physician Decision|1|||
131063881|NCT01562275|471865793|FG007|Stage 1|Physician Decision|0|||
131063882|NCT01562275|471865794|FG008|Stage 1|Physician Decision|1|||
131063883|NCT01562275|471865795|FG009|Stage 1|Physician Decision|0|||
131063884|NCT01562275|471865796|FG010|Stage 1|Physician Decision|0|||
131063885|NCT01562275|471865797|FG011|Stage 1|Physician Decision|0|||
131063886|NCT01562275|471865798|FG012|Stage 1|Physician Decision|0|||
131063887|NCT01562275|471865786|FG000|Stage 1|Progression of Disease|2|||
131063888|NCT01562275|471865787|FG001|Stage 1|Progression of Disease|6|||
131063889|NCT01562275|471865788|FG002|Stage 1|Progression of Disease|2|||
131063890|NCT01562275|471865789|FG003|Stage 1|Progression of Disease|1|||
131063891|NCT01562275|471865790|FG004|Stage 1|Progression of Disease|2|||
131063892|NCT01562275|471865791|FG005|Stage 1|Progression of Disease|4|||
131063893|NCT01562275|471865792|FG006|Stage 1|Progression of Disease|1|||
131063894|NCT01562275|471865793|FG007|Stage 1|Progression of Disease|7|||
131063895|NCT01562275|471865794|FG008|Stage 1|Progression of Disease|2|||
131063896|NCT01562275|471865795|FG009|Stage 1|Progression of Disease|5|||
131063897|NCT01562275|471865796|FG010|Stage 1|Progression of Disease|3|||
131063898|NCT01562275|471865797|FG011|Stage 1|Progression of Disease|0|||
131063899|NCT01562275|471865798|FG012|Stage 1|Progression of Disease|0|||
131063900|NCT01562275|471865786|FG000|Stage 1|Withdrawal by Subject|0|||
131063901|NCT01562275|471865787|FG001|Stage 1|Withdrawal by Subject|1|||
131063902|NCT01562275|471865788|FG002|Stage 1|Withdrawal by Subject|0|||
131063903|NCT01562275|471865789|FG003|Stage 1|Withdrawal by Subject|2|||
131063904|NCT01562275|471865790|FG004|Stage 1|Withdrawal by Subject|0|||
131063905|NCT01562275|471865791|FG005|Stage 1|Withdrawal by Subject|0|||
131063906|NCT01562275|471865792|FG006|Stage 1|Withdrawal by Subject|1|||
130779418|NCT02326272|470819490|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130779419|NCT02326272|470819491|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131063907|NCT01562275|471865793|FG007|Stage 1|Withdrawal by Subject|0|||
131063908|NCT01562275|471865794|FG008|Stage 1|Withdrawal by Subject|0|||
131063909|NCT01562275|471865795|FG009|Stage 1|Withdrawal by Subject|1|||
131063910|NCT01562275|471865796|FG010|Stage 1|Withdrawal by Subject|0|||
131063911|NCT01562275|471865797|FG011|Stage 1|Withdrawal by Subject|0|||
130779420|NCT02326272|470819492|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
130822731|NCT00887159|470980584|FG001|Overall Study|Ineligible|1|||
131063912|NCT01562275|471865798|FG012|Stage 1|Withdrawal by Subject|0|||
131063913|NCT01562275|471865786|FG000|Stage 2|Death|0|||
131063914|NCT01562275|471865787|FG001|Stage 2|Death|0|||
131063915|NCT01562275|471865788|FG002|Stage 2|Death|0|||
131063916|NCT01562275|471865789|FG003|Stage 2|Death|0|||
131063917|NCT01562275|471865790|FG004|Stage 2|Death|0|||
131063918|NCT01562275|471865791|FG005|Stage 2|Death|0|||
131063919|NCT01562275|471865792|FG006|Stage 2|Death|0|||
131063920|NCT01562275|471865793|FG007|Stage 2|Death|0|||
131063921|NCT01562275|471865794|FG008|Stage 2|Death|0|||
131063922|NCT01562275|471865795|FG009|Stage 2|Death|0|||
131063923|NCT01562275|471865796|FG010|Stage 2|Death|0|||
131063924|NCT01562275|471865797|FG011|Stage 2|Death|2|||
131063925|NCT01562275|471865798|FG012|Stage 2|Death|1|||
131063926|NCT01562275|471865786|FG000|Stage 2|Progression of Disease|0|||
131063927|NCT01562275|471865787|FG001|Stage 2|Progression of Disease|0|||
131063928|NCT01562275|471865788|FG002|Stage 2|Progression of Disease|0|||
131063929|NCT01562275|471865789|FG003|Stage 2|Progression of Disease|0|||
131063930|NCT01562275|471865790|FG004|Stage 2|Progression of Disease|0|||
131063931|NCT01562275|471865791|FG005|Stage 2|Progression of Disease|0|||
130822732|NCT00887159|470980585|FG002|Overall Study|Ineligible|0|||
131063932|NCT01562275|471865792|FG006|Stage 2|Progression of Disease|0|||
131063933|NCT01562275|471865793|FG007|Stage 2|Progression of Disease|0|||
131063934|NCT01562275|471865794|FG008|Stage 2|Progression of Disease|0|||
131063935|NCT01562275|471865795|FG009|Stage 2|Progression of Disease|0|||
131063936|NCT01562275|471865796|FG010|Stage 2|Progression of Disease|0|||
131063937|NCT01562275|471865797|FG011|Stage 2|Progression of Disease|12|||
131063938|NCT01562275|471865798|FG012|Stage 2|Progression of Disease|4|||
131063939|NCT00304278|471865799|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
131063940|NCT00304278|471865799|FG000|Overall Study|PT had medical condition preventing TX|1|||
131063941|NCT00507429|471865800|FG000|Treatment Phase|Disease Progression|12|||
131063942|NCT00507429|471865801|FG001|Treatment Phase|Disease Progression|5|||
131063943|NCT00507429|471865800|FG000|Treatment Phase|Adverse Event|12|||
131063944|NCT00507429|471865801|FG001|Treatment Phase|Adverse Event|5|||
131063945|NCT00507429|471865800|FG000|Treatment Phase|Withdrawal by Subject|3|||
131063946|NCT00507429|471865801|FG001|Treatment Phase|Withdrawal by Subject|3|||
131063947|NCT00507429|471865800|FG000|Treatment Phase|Physician Decision|4|||
131063948|NCT00507429|471865801|FG001|Treatment Phase|Physician Decision|2|||
131063949|NCT00507429|471865800|FG000|Treatment Phase|Other|6|||
131063950|NCT00507429|471865801|FG001|Treatment Phase|Other|3|||
131063951|NCT00507429|471865800|FG000|Maintenance Phase|Progressive Disease|14|||
131063952|NCT00507429|471865801|FG001|Maintenance Phase|Progressive Disease|0|||
131063953|NCT01587703|471865802|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
131063954|NCT01587703|471865803|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063955|NCT01587703|471865804|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063956|NCT01587703|471865805|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063957|NCT01587703|471865806|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063958|NCT01587703|471865807|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063959|NCT01587703|471865808|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063960|NCT01587703|471865809|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063961|NCT01587703|471865810|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063962|NCT01587703|471865811|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063963|NCT01587703|471865812|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063964|NCT01587703|471865813|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063965|NCT01587703|471865814|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063966|NCT01587703|471865815|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063967|NCT01587703|471865816|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063968|NCT01587703|471865817|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063969|NCT01587703|471865818|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063970|NCT01587703|471865819|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063971|NCT01587703|471865820|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
131063972|NCT01587703|471865802|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063973|NCT01587703|471865803|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063974|NCT01587703|471865804|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063975|NCT01587703|471865805|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063976|NCT01587703|471865806|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063977|NCT01587703|471865807|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
131063978|NCT01587703|471865808|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063979|NCT01587703|471865809|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
131063980|NCT01587703|471865810|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063981|NCT01587703|471865811|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063982|NCT01587703|471865812|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063983|NCT01587703|471865813|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063984|NCT01587703|471865814|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063985|NCT01587703|471865815|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063986|NCT01587703|471865816|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063987|NCT01587703|471865817|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063988|NCT01587703|471865818|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063989|NCT01587703|471865819|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063990|NCT01587703|471865820|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
131063991|NCT01587703|471865802|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131063992|NCT01587703|471865803|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131063993|NCT01587703|471865804|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131063994|NCT01587703|471865805|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131063995|NCT01587703|471865806|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131063996|NCT01587703|471865807|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131063997|NCT01587703|471865808|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
131063998|NCT01587703|471865809|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131063999|NCT01587703|471865810|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064000|NCT01587703|471865811|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064001|NCT01587703|471865812|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064002|NCT01587703|471865813|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064003|NCT01587703|471865814|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064004|NCT01587703|471865815|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064005|NCT01587703|471865816|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064006|NCT01587703|471865817|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064007|NCT01587703|471865818|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064008|NCT01587703|471865819|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064009|NCT01587703|471865820|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
131064010|NCT01587703|471865802|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
131064011|NCT01587703|471865803|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
131064012|NCT01587703|471865804|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
131064013|NCT01587703|471865805|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
131064014|NCT01587703|471865806|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
131064015|NCT01587703|471865807|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
131064016|NCT01587703|471865808|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
131064017|NCT01587703|471865809|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
131064018|NCT01587703|471865810|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064019|NCT01587703|471865811|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064020|NCT01587703|471865812|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064021|NCT01587703|471865813|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064022|NCT01587703|471865814|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064023|NCT01587703|471865815|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064024|NCT01587703|471865816|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064025|NCT01587703|471865817|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064026|NCT01587703|471865818|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064027|NCT01587703|471865819|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064028|NCT01587703|471865820|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
131064029|NCT01587703|471865802|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064030|NCT01587703|471865803|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064031|NCT01587703|471865804|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064032|NCT01587703|471865805|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064033|NCT01587703|471865806|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064034|NCT01587703|471865807|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064035|NCT01587703|471865808|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064036|NCT01587703|471865809|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064037|NCT01587703|471865810|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
131064038|NCT01587703|471865811|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
131064039|NCT01587703|471865812|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
131064040|NCT01587703|471865813|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064041|NCT01587703|471865814|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064042|NCT01587703|471865815|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064043|NCT01587703|471865816|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064044|NCT01587703|471865817|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064045|NCT01587703|471865818|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064046|NCT01587703|471865819|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064047|NCT01587703|471865820|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
131064048|NCT01587703|471865802|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064049|NCT01587703|471865803|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064050|NCT01587703|471865804|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064051|NCT01587703|471865805|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064052|NCT01587703|471865806|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064053|NCT01587703|471865807|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064054|NCT01587703|471865808|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064055|NCT01587703|471865809|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064056|NCT01587703|471865810|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
131064057|NCT01587703|471865811|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064058|NCT01587703|471865812|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
131064059|NCT01587703|471865813|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064060|NCT01587703|471865814|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131230018|NCT03381248|472469259|FG000|0-6 Months|Withdrawal by Subject|4|||
130723112|NCT03583086|470611342|FG004|Overall Study|Adverse Event|0|||
130723113|NCT03583086|470611343|FG005|Overall Study|Adverse Event|1|||
130723114|NCT03583086|470611344|FG006|Overall Study|Adverse Event|0|||
130723115|NCT01696279|470611345|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
130723116|NCT01696279|470611346|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
131230019|NCT03381248|472469260|FG001|0-6 Months|Withdrawal by Subject|1|||
131230020|NCT03381248|472469259|FG000|0-6 Months|Lost to Follow-up|3|||
131230021|NCT03381248|472469260|FG001|0-6 Months|Lost to Follow-up|2|||
131230022|NCT03381248|472469259|FG000|0-6 Months|Lack of Efficacy|1|||
131230023|NCT03381248|472469260|FG001|0-6 Months|Lack of Efficacy|0|||
131230024|NCT03381248|472469259|FG000|0-6 Months|Adverse Event|1|||
131230025|NCT03381248|472469260|FG001|0-6 Months|Adverse Event|0|||
131230026|NCT03381248|472469259|FG000|0-6 Months|Protocol Violation|2|||
131230027|NCT03381248|472469260|FG001|0-6 Months|Protocol Violation|1|||
131230028|NCT03381248|472469259|FG000|0-6 Months|Physician Decision|1|||
131230029|NCT03381248|472469260|FG001|0-6 Months|Physician Decision|0|||
131230030|NCT03381248|472469259|FG000|0-6 Months|Planning another procedure|1|||
131230031|NCT03381248|472469260|FG001|0-6 Months|Planning another procedure|2|||
131230032|NCT03381248|472469259|FG000|6-12 Months|Withdrawal by Subject|1|||
131230033|NCT03381248|472469260|FG001|6-12 Months|Withdrawal by Subject|3|||
131230034|NCT03381248|472469259|FG000|6-12 Months|Lost to Follow-up|0|||
131230035|NCT03381248|472469260|FG001|6-12 Months|Lost to Follow-up|2|||
131230036|NCT03381248|472469259|FG000|6-12 Months|Protocol Violation|3|||
131230037|NCT03381248|472469260|FG001|6-12 Months|Protocol Violation|2|||
131230038|NCT03381248|472469259|FG000|6-12 Months|Planning another procedure|6|||
130723117|NCT01696279|470611347|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
130723118|NCT01696279|470611348|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
130723119|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
131230039|NCT03381248|472469260|FG001|6-12 Months|Planning another procedure|2|||
131230040|NCT03381248|472469259|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
131230041|NCT03381248|472469260|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
131230042|NCT03381248|472469259|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
131230043|NCT03381248|472469260|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
131230044|NCT03381248|472469259|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
131230045|NCT03381248|472469260|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
131230046|NCT00759148|472469261|FG000|Overall Study|Adverse Event|1|||
130723120|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
131064061|NCT01587703|471865815|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064062|NCT01587703|471865816|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064063|NCT01587703|471865817|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064064|NCT01587703|471865818|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064065|NCT01587703|471865819|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064066|NCT01587703|471865820|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
131064067|NCT01587703|471865802|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064068|NCT01587703|471865803|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064069|NCT01587703|471865804|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064070|NCT01587703|471865805|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064071|NCT01587703|471865806|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064072|NCT01587703|471865807|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064073|NCT01587703|471865808|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064074|NCT01587703|471865809|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064075|NCT01587703|471865810|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064076|NCT01587703|471865811|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
131064077|NCT01587703|471865812|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
131064078|NCT01587703|471865813|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064079|NCT01587703|471865814|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064080|NCT01587703|471865815|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064081|NCT01587703|471865816|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064082|NCT01587703|471865817|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064083|NCT01587703|471865818|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130723121|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
131064084|NCT01587703|471865819|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131064085|NCT01587703|471865820|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
131230047|NCT00759148|472469262|FG001|Overall Study|Adverse Event|6|||
131230048|NCT00759148|472469261|FG000|Overall Study|Withdrawal by Subject|3|||
131230049|NCT00759148|472469262|FG001|Overall Study|Withdrawal by Subject|7|||
131230050|NCT00759148|472469261|FG000|Overall Study|Lost to Follow-up|3|||
130723122|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
131230051|NCT00759148|472469262|FG001|Overall Study|Lost to Follow-up|9|||
131230052|NCT00759148|472469261|FG000|Overall Study|Treatment Failure|6|||
131230053|NCT00759148|472469262|FG001|Overall Study|Treatment Failure|10|||
131230054|NCT00759148|472469261|FG000|Overall Study|Reason not given|1|||
131230055|NCT00759148|472469262|FG001|Overall Study|Reason not given|0|||
131230056|NCT01133821|472469263|FG000|Overall Study|Lost to Follow-up|8|||
131230057|NCT01133821|472469264|FG001|Overall Study|Lost to Follow-up|11|||
131230058|NCT01133821|472469263|FG000|Overall Study|Withdrawal by Subject|8|||
130723123|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
130723124|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
130723125|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
131064086|NCT01587703|471865802|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064087|NCT01587703|471865803|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064088|NCT01587703|471865804|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064089|NCT01587703|471865805|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064090|NCT01587703|471865806|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064091|NCT01587703|471865807|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064092|NCT01587703|471865808|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064093|NCT01587703|471865809|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064094|NCT01587703|471865810|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
131064095|NCT01587703|471865811|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064096|NCT01587703|471865812|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064097|NCT01587703|471865813|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064098|NCT01587703|471865814|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064099|NCT01587703|471865815|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064100|NCT01587703|471865816|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064101|NCT01587703|471865817|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064102|NCT01587703|471865818|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064103|NCT01587703|471865819|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064104|NCT01587703|471865820|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
131064105|NCT01587703|471865802|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064106|NCT01587703|471865803|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064107|NCT01587703|471865804|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064108|NCT01587703|471865805|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064109|NCT01587703|471865806|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064110|NCT01587703|471865807|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064111|NCT01587703|471865808|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064112|NCT01587703|471865809|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064113|NCT01587703|471865810|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064114|NCT01587703|471865811|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064115|NCT01587703|471865812|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064116|NCT01587703|471865813|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064117|NCT01587703|471865814|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064118|NCT01587703|471865815|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064119|NCT01587703|471865816|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064120|NCT01587703|471865817|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064121|NCT01587703|471865818|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064122|NCT01587703|471865819|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
131064123|NCT01587703|471865820|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
131064124|NCT01587703|471865802|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064125|NCT01587703|471865803|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064126|NCT01587703|471865804|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064127|NCT01587703|471865805|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064128|NCT01587703|471865806|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064129|NCT01587703|471865807|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064130|NCT01587703|471865808|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064131|NCT01587703|471865809|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064132|NCT01587703|471865810|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064133|NCT01587703|471865811|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064134|NCT01587703|471865812|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064135|NCT01587703|471865813|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064136|NCT01587703|471865814|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064137|NCT01587703|471865815|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064138|NCT01587703|471865816|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064139|NCT01587703|471865817|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064140|NCT01587703|471865818|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
131064141|NCT01587703|471865819|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
131064142|NCT01587703|471865820|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
131064143|NCT01587703|471865802|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064144|NCT01587703|471865803|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131230059|NCT01133821|472469264|FG001|Overall Study|Withdrawal by Subject|3|||
131230060|NCT01133821|472469263|FG000|Overall Study|preferred other treatment|1|||
131064145|NCT01587703|471865804|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064146|NCT01587703|471865805|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064147|NCT01587703|471865806|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064148|NCT01587703|471865807|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064149|NCT01587703|471865808|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064150|NCT01587703|471865809|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064151|NCT01587703|471865810|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064152|NCT01587703|471865811|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064153|NCT01587703|471865812|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064154|NCT01587703|471865813|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064155|NCT01587703|471865814|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064156|NCT01587703|471865815|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064157|NCT01587703|471865816|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064158|NCT01587703|471865817|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
131064159|NCT01587703|471865818|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064160|NCT01587703|471865819|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064161|NCT01587703|471865820|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
131064162|NCT01587703|471865802|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064163|NCT01587703|471865803|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064164|NCT01587703|471865804|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064165|NCT01587703|471865805|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064166|NCT01587703|471865806|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064167|NCT01587703|471865807|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064168|NCT01587703|471865808|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064169|NCT01587703|471865809|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064170|NCT01587703|471865810|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064171|NCT01587703|471865811|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064172|NCT01587703|471865812|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064173|NCT01587703|471865813|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
131064174|NCT01587703|471865814|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064175|NCT01587703|471865815|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064176|NCT01587703|471865816|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
131064177|NCT01587703|471865817|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064178|NCT01587703|471865818|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064179|NCT01587703|471865819|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064180|NCT01587703|471865820|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
131064181|NCT01587703|471865802|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064182|NCT01587703|471865803|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064183|NCT01587703|471865804|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064184|NCT01587703|471865805|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064185|NCT01587703|471865806|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064186|NCT01587703|471865807|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064187|NCT01587703|471865808|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064188|NCT01587703|471865809|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064189|NCT01587703|471865810|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064190|NCT01587703|471865811|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064191|NCT01587703|471865812|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064192|NCT01587703|471865813|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
131064193|NCT01587703|471865814|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
131064194|NCT01587703|471865815|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
131064195|NCT01587703|471865816|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
131064196|NCT01587703|471865817|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
131064197|NCT01587703|471865818|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
131064198|NCT01587703|471865819|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064199|NCT01587703|471865820|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
131064200|NCT01587703|471865802|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064201|NCT01587703|471865803|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064202|NCT01587703|471865804|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064203|NCT01587703|471865805|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064204|NCT01587703|471865806|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064205|NCT01587703|471865807|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064206|NCT01587703|471865808|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064207|NCT01587703|471865809|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064208|NCT01587703|471865810|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064209|NCT01587703|471865811|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064210|NCT01587703|471865812|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064211|NCT01587703|471865813|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
131064212|NCT01587703|471865814|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
131064213|NCT01587703|471865815|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
131064214|NCT01587703|471865816|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
131064215|NCT01587703|471865817|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
131064216|NCT01587703|471865818|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
131064217|NCT01587703|471865819|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064218|NCT01587703|471865820|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
131064219|NCT01587703|471865802|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064220|NCT01587703|471865803|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064221|NCT01587703|471865804|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064222|NCT01587703|471865805|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064223|NCT01587703|471865806|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064224|NCT01587703|471865807|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064225|NCT01587703|471865808|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064226|NCT01587703|471865809|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064227|NCT01587703|471865810|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064228|NCT01587703|471865811|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064229|NCT01587703|471865812|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064230|NCT01587703|471865813|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
131064231|NCT01587703|471865814|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064232|NCT01587703|471865815|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064233|NCT01587703|471865816|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064234|NCT01587703|471865817|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064235|NCT01587703|471865818|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064236|NCT01587703|471865819|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064237|NCT01587703|471865820|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
131064238|NCT00476151|471865821|FG000|Overall Study|Adverse Event|0|||
131064239|NCT00476151|471865822|FG001|Overall Study|Adverse Event|2|||
131064240|NCT00476151|471865821|FG000|Overall Study|Protocol Violation|1|||
131064241|NCT00476151|471865822|FG001|Overall Study|Protocol Violation|3|||
131064242|NCT00476151|471865821|FG000|Overall Study|Withdrawal by Subject|2|||
131064243|NCT00476151|471865822|FG001|Overall Study|Withdrawal by Subject|0|||
131064244|NCT00476151|471865821|FG000|Overall Study|Physician Decision|0|||
131064245|NCT00476151|471865822|FG001|Overall Study|Physician Decision|2|||
131064246|NCT01767376|471865833|FG000|Overall Study|Lost to Follow-up|3|||
131064247|NCT01767376|471865834|FG001|Overall Study|Lost to Follow-up|2|||
131064248|NCT01767376|471865835|FG002|Overall Study|Lost to Follow-up|0|||
131064249|NCT01767376|471865833|FG000|Overall Study|Withdrawal by Subject|1|||
131064250|NCT01767376|471865834|FG001|Overall Study|Withdrawal by Subject|1|||
131064251|NCT01767376|471865835|FG002|Overall Study|Withdrawal by Subject|0|||
131064252|NCT01113541|471865839|FG000|Overall Study|Withdrawal by Subject|1|||
131064253|NCT01113541|471865839|FG000|Overall Study|Protocol Violation|1|||
131064254|NCT01113541|471865839|FG000|Overall Study|Study Terminated by Sponsor|7|||
131064255|NCT01113541|471865839|FG000|Overall Study|Adverse Event|4|||
131064256|NCT03745651|471865840|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
131064257|NCT03745651|471865841|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
131064258|NCT03745651|471865842|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131064259|NCT03745651|471865843|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131064260|NCT03745651|471865844|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131064261|NCT03745651|471865845|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131064262|NCT03745651|471865846|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
131064263|NCT03745651|471865840|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
131064264|NCT03745651|471865841|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
131064265|NCT03745651|471865842|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
131064266|NCT03745651|471865843|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131064267|NCT03745651|471865844|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131064268|NCT03745651|471865845|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131064269|NCT03745651|471865846|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
131064270|NCT03745651|471865840|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
131064271|NCT03745651|471865841|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131064272|NCT03745651|471865842|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
131064273|NCT03745651|471865843|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131064274|NCT03745651|471865844|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131064275|NCT03745651|471865845|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131064276|NCT03745651|471865846|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
131064277|NCT03745651|471865840|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131064278|NCT03745651|471865841|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
131064279|NCT03745651|471865842|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131064280|NCT03745651|471865843|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131064281|NCT03745651|471865844|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131064282|NCT03745651|471865845|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131064283|NCT03745651|471865846|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
131064284|NCT03745651|471865840|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
131064285|NCT03745651|471865841|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
131064286|NCT03745651|471865842|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
131064287|NCT03745651|471865843|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131064288|NCT03745651|471865844|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131064289|NCT03745651|471865845|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131064290|NCT03745651|471865846|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
131064291|NCT03745651|471865840|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
131064292|NCT03745651|471865841|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
131064293|NCT03745651|471865842|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
131064294|NCT03745651|471865843|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
131064295|NCT03745651|471865844|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
131064296|NCT03745651|471865845|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
131064297|NCT03745651|471865846|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
131064298|NCT03745651|471865840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131064299|NCT03745651|471865841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131064300|NCT03745651|471865842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131064301|NCT03745651|471865843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131064302|NCT03745651|471865844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131064303|NCT03745651|471865845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
131064304|NCT03745651|471865846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
131064305|NCT03745651|471865840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131064306|NCT03745651|471865841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131064307|NCT03745651|471865842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131064308|NCT03745651|471865843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
131064309|NCT03745651|471865844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
131064310|NCT03745651|471865845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
131064311|NCT03745651|471865846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
131064312|NCT03745651|471865840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131064313|NCT03745651|471865841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131064314|NCT03745651|471865842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
131064315|NCT03745651|471865843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
131064316|NCT03745651|471865844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
131064317|NCT03745651|471865845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
131064318|NCT03745651|471865846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
131064319|NCT03745651|471865840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131064320|NCT03745651|471865841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131064321|NCT03745651|471865842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131064322|NCT03745651|471865843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
131064323|NCT03745651|471865844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
131064324|NCT03745651|471865845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
131064325|NCT03745651|471865846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
131064326|NCT03745651|471865840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
131064327|NCT03745651|471865841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
131064328|NCT03745651|471865842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
131064329|NCT03745651|471865843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
131064330|NCT03745651|471865844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
131064331|NCT03745651|471865845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
131064332|NCT03745651|471865846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
131064333|NCT03745651|471865840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131064334|NCT03745651|471865841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131064335|NCT03745651|471865842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131064336|NCT03745651|471865843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131064337|NCT03745651|471865844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131064338|NCT03745651|471865845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
131064339|NCT03745651|471865846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
131064340|NCT03745651|471865840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131064341|NCT03745651|471865841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131064342|NCT03745651|471865842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
131064343|NCT03745651|471865843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
131064344|NCT03745651|471865844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
131064345|NCT03745651|471865845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
131064346|NCT03745651|471865846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
131064347|NCT03745651|471865840|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
131064348|NCT03745651|471865841|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
131064349|NCT03745651|471865842|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
131064350|NCT03745651|471865843|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
131064351|NCT03745651|471865844|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
131064352|NCT03745651|471865845|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
131064353|NCT03745651|471865846|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
131064354|NCT04175834|471865847|FG000|Overall Study|Withdrawal by Subject|1|||
131064355|NCT04175834|471865848|FG001|Overall Study|Withdrawal by Subject|0|||
131064356|NCT01494467|471865853|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
131064357|NCT01494467|471865854|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
131064358|NCT01494467|471865853|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
131064359|NCT01494467|471865854|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
131064360|NCT01494467|471865853|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
131064361|NCT01494467|471865854|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
131064362|NCT01494467|471865853|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
131064363|NCT01494467|471865854|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
131064364|NCT01494467|471865853|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
131064365|NCT01494467|471865854|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
131064366|NCT01494467|471865853|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
131064367|NCT01494467|471865854|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
131064368|NCT01494467|471865853|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
131064369|NCT01494467|471865854|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
131064370|NCT01494467|471865853|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
131064371|NCT01494467|471865854|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
131064372|NCT01494467|471865853|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
131064373|NCT01494467|471865854|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
131064374|NCT01494467|471865853|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
131064375|NCT01494467|471865854|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
131064376|NCT01494467|471865853|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
131064377|NCT01494467|471865854|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
131064378|NCT01494467|471865853|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
131064379|NCT01494467|471865854|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
131064380|NCT01494467|471865853|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
131064381|NCT01494467|471865854|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
131064382|NCT01494467|471865853|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
131064383|NCT01494467|471865854|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
131064384|NCT02309892|471865855|FG000|Overall Study|Physician Decision|1|||
131064385|NCT02309892|471865856|FG001|Overall Study|Physician Decision|0|||
131064386|NCT02309892|471865857|FG002|Overall Study|Physician Decision|0|||
131064387|NCT02309892|471865858|FG003|Overall Study|Physician Decision|0|||
131064388|NCT02309892|471865859|FG004|Overall Study|Physician Decision|0|||
131064389|NCT02309892|471865860|FG005|Overall Study|Physician Decision|0|||
131064390|NCT02309892|471865861|FG006|Overall Study|Physician Decision|0|||
131064391|NCT02309892|471865855|FG000|Overall Study|Adverse Event|1|||
131064392|NCT02309892|471865856|FG001|Overall Study|Adverse Event|0|||
131064393|NCT02309892|471865857|FG002|Overall Study|Adverse Event|1|||
131064394|NCT02309892|471865858|FG003|Overall Study|Adverse Event|0|||
131064395|NCT02309892|471865859|FG004|Overall Study|Adverse Event|0|||
131064396|NCT02309892|471865860|FG005|Overall Study|Adverse Event|0|||
131064397|NCT02309892|471865861|FG006|Overall Study|Adverse Event|0|||
131064398|NCT02309892|471865855|FG000|Overall Study|Progressive Disease|0|||
131064399|NCT02309892|471865856|FG001|Overall Study|Progressive Disease|1|||
131064400|NCT02309892|471865857|FG002|Overall Study|Progressive Disease|0|||
131064401|NCT02309892|471865858|FG003|Overall Study|Progressive Disease|0|||
131064402|NCT02309892|471865859|FG004|Overall Study|Progressive Disease|1|||
131064403|NCT02309892|471865860|FG005|Overall Study|Progressive Disease|0|||
131064404|NCT02309892|471865861|FG006|Overall Study|Progressive Disease|0|||
131064405|NCT02309892|471865855|FG000|Overall Study|Death|0|||
131064406|NCT02309892|471865856|FG001|Overall Study|Death|0|||
131064407|NCT02309892|471865857|FG002|Overall Study|Death|0|||
131064408|NCT02309892|471865858|FG003|Overall Study|Death|0|||
131064409|NCT02309892|471865859|FG004|Overall Study|Death|0|||
131064410|NCT02309892|471865860|FG005|Overall Study|Death|1|||
130723126|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
131064411|NCT02309892|471865861|FG006|Overall Study|Death|0|||
130723127|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
131137509|NCT02450578|472130654|FG003|Overall Study|ECG abnormality so not treated|0|||
131137510|NCT00662792|472130657|FG000|Period 1|Personal Reasons|0|||
131137511|NCT00662792|472130658|FG001|Period 1|Personal Reasons|0|||
131137512|NCT00662792|472130659|FG002|Period 1|Personal Reasons|1|||
130723128|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
130723129|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
131064412|NCT03262389|471865862|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
131064413|NCT03262389|471865862|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
131064414|NCT03262389|471865862|FG000|Overall Study|opted out of PET/MR|1|||
131064415|NCT01052272|471865863|FG000|Overall Study|Death|0|||
131064416|NCT01052272|471865864|FG001|Overall Study|Death|0|||
131064417|NCT01052272|471865865|FG002|Overall Study|Death|1|||
131064418|NCT01052272|471865866|FG003|Overall Study|Death|1|||
131064419|NCT01052272|471865863|FG000|Overall Study|Physician Decision|0|||
131064420|NCT01052272|471865864|FG001|Overall Study|Physician Decision|1|||
131064421|NCT01052272|471865865|FG002|Overall Study|Physician Decision|0|||
131064422|NCT01052272|471865866|FG003|Overall Study|Physician Decision|0|||
131064423|NCT01052272|471865863|FG000|Overall Study|patient refuses follow-up|5|||
131064424|NCT01052272|471865864|FG001|Overall Study|patient refuses follow-up|4|||
131064425|NCT01052272|471865865|FG002|Overall Study|patient refuses follow-up|2|||
131064426|NCT01052272|471865866|FG003|Overall Study|patient refuses follow-up|4|||
131064427|NCT01052272|471865863|FG000|Overall Study|Withdrawal by Subject|0|||
131064428|NCT01052272|471865864|FG001|Overall Study|Withdrawal by Subject|2|||
131064429|NCT01052272|471865865|FG002|Overall Study|Withdrawal by Subject|3|||
131064430|NCT01052272|471865866|FG003|Overall Study|Withdrawal by Subject|2|||
131064431|NCT01052272|471865863|FG000|Overall Study|placed in long-term care|0|||
131064432|NCT01052272|471865864|FG001|Overall Study|placed in long-term care|0|||
131064433|NCT01052272|471865865|FG002|Overall Study|placed in long-term care|1|||
131064434|NCT01052272|471865866|FG003|Overall Study|placed in long-term care|0|||
131064435|NCT01052272|471865863|FG000|Overall Study|decline in health|0|||
131064436|NCT01052272|471865864|FG001|Overall Study|decline in health|0|||
131064437|NCT01052272|471865865|FG002|Overall Study|decline in health|1|||
131064438|NCT01052272|471865866|FG003|Overall Study|decline in health|0|||
131064439|NCT04739306|471865867|FG000|Main Study Period|Adverse Event|6|||
131064440|NCT04739306|471865868|FG001|Main Study Period|Adverse Event|7|||
131064441|NCT04739306|471865867|FG000|Main Study Period|Lost to Follow-up|4|||
131064442|NCT04739306|471865868|FG001|Main Study Period|Lost to Follow-up|6|||
131064443|NCT04739306|471865867|FG000|Main Study Period|Physician Decision|1|||
131064444|NCT04739306|471865868|FG001|Main Study Period|Physician Decision|1|||
131064445|NCT04739306|471865867|FG000|Main Study Period|Withdrawal by Subject|8|||
131064446|NCT04739306|471865868|FG001|Main Study Period|Withdrawal by Subject|6|||
131064447|NCT04739306|471865867|FG000|Main Study Period|Protocol Violation|0|||
131064448|NCT04739306|471865868|FG001|Main Study Period|Protocol Violation|1|||
131064449|NCT04739306|471865867|FG000|Main Study Period|War in Ukraine|1|||
131064450|NCT04739306|471865868|FG001|Main Study Period|War in Ukraine|1|||
131064451|NCT01077284|471865869|FG000|Overall Study|Adverse Event|2|||
131064452|NCT01077284|471865870|FG001|Overall Study|Adverse Event|0|||
131064453|NCT01077284|471865871|FG002|Overall Study|Adverse Event|1|||
131064454|NCT01077284|471865869|FG000|Overall Study|Lost to Follow-up|1|||
131064455|NCT01077284|471865870|FG001|Overall Study|Lost to Follow-up|2|||
131064456|NCT01077284|471865871|FG002|Overall Study|Lost to Follow-up|0|||
131064457|NCT01077284|471865869|FG000|Overall Study|Withdrawal by Subject|2|||
131064458|NCT01077284|471865870|FG001|Overall Study|Withdrawal by Subject|3|||
131064459|NCT01077284|471865871|FG002|Overall Study|Withdrawal by Subject|1|||
131064460|NCT01077284|471865869|FG000|Overall Study|Other|0|||
131064461|NCT01077284|471865870|FG001|Overall Study|Other|0|||
131064462|NCT01077284|471865871|FG002|Overall Study|Other|1|||
131064463|NCT03209492|471865872|FG000|Overall Study|Case Report Forms Uncollected|5|||
131064464|NCT01762345|471865873|FG000|Overall Study|Adverse Event|5|||
131064465|NCT01762345|471865873|FG000|Overall Study|Protocol Violation|2|||
131064466|NCT02379078|471865874|FG000|Overall Study|Lost to Follow-up|33|||
131064467|NCT02379078|471865875|FG001|Overall Study|Lost to Follow-up|30|||
131064468|NCT02379078|471865874|FG000|Overall Study|Withdrawal by Subject|6|||
131064469|NCT02379078|471865875|FG001|Overall Study|Withdrawal by Subject|5|||
131064470|NCT04908488|471865876|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
131064471|NCT04908488|471865877|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
131064472|NCT04908488|471865876|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
131064473|NCT04908488|471865877|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
131064474|NCT02077374|471865882|FG000|Overall Study|Withdrawal by Subject|0|||
131064475|NCT02077374|471865883|FG001|Overall Study|Withdrawal by Subject|1|||
131064476|NCT02077374|471865882|FG000|Overall Study|Protocol Violation|0|||
131064477|NCT02077374|471865883|FG001|Overall Study|Protocol Violation|1|||
131137513|NCT00662792|472130660|FG003|Period 1|Personal Reasons|0|||
131137514|NCT00662792|472130657|FG000|Period 1|Refused continuing medication|0|||
131137515|NCT00662792|472130658|FG001|Period 1|Refused continuing medication|1|||
131064478|NCT00657709|471865885|FG000|Overall Study|AE or Death|7|||
131137516|NCT00662792|472130659|FG002|Period 1|Refused continuing medication|1|||
131064479|NCT00657709|471865886|FG001|Overall Study|AE or Death|7|||
131064480|NCT00657709|471865887|FG002|Overall Study|AE or Death|6|||
131064481|NCT00657709|471865888|FG003|Overall Study|AE or Death|7|||
131064482|NCT00657709|471865889|FG004|Overall Study|AE or Death|1|||
131064483|NCT00657709|471865885|FG000|Overall Study|Withdrawal by Subject|7|||
131064484|NCT00657709|471865886|FG001|Overall Study|Withdrawal by Subject|15|||
131064485|NCT00657709|471865887|FG002|Overall Study|Withdrawal by Subject|15|||
131064486|NCT00657709|471865888|FG003|Overall Study|Withdrawal by Subject|5|||
131064487|NCT00657709|471865889|FG004|Overall Study|Withdrawal by Subject|9|||
131064488|NCT00657709|471865885|FG000|Overall Study|Lost to Follow-up|9|||
131064489|NCT00657709|471865886|FG001|Overall Study|Lost to Follow-up|9|||
131064490|NCT00657709|471865887|FG002|Overall Study|Lost to Follow-up|7|||
131064491|NCT00657709|471865888|FG003|Overall Study|Lost to Follow-up|1|||
131064492|NCT00657709|471865889|FG004|Overall Study|Lost to Follow-up|21|||
131064493|NCT00657709|471865885|FG000|Overall Study|Protocol Violation|0|||
131064494|NCT00657709|471865886|FG001|Overall Study|Protocol Violation|2|||
131064495|NCT00657709|471865887|FG002|Overall Study|Protocol Violation|0|||
131064496|NCT00657709|471865888|FG003|Overall Study|Protocol Violation|1|||
131064497|NCT00657709|471865889|FG004|Overall Study|Protocol Violation|2|||
131064498|NCT02959866|471865890|FG000|Overall Study|Withdrawal by Subject|1|||
131064499|NCT00952523|471865891|FG000|Overall Study|Withdrawal by Subject|7|||
131064500|NCT01029925|471865892|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
131064501|NCT01029925|471865892|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
131064502|NCT01029925|471865892|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
131064503|NCT05265247|471865893|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
131064504|NCT05265247|471865894|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
131064505|NCT05265247|471865893|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
131064506|NCT05265247|471865894|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
131064507|NCT05265247|471865893|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
131064508|NCT05265247|471865894|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
131064509|NCT00409747|471865897|FG000|Overall Study|Withdrawal by Subject|1|||
131064510|NCT02555397|471865902|FG000|Overall Study|Withdrawal by Subject|1|||
131064511|NCT02555397|471865903|FG001|Overall Study|Withdrawal by Subject|0|||
131064512|NCT02555397|471865904|FG002|Overall Study|Withdrawal by Subject|0|||
131064513|NCT02555397|471865905|FG003|Overall Study|Withdrawal by Subject|0|||
131064514|NCT02555397|471865906|FG004|Overall Study|Withdrawal by Subject|0|||
131064515|NCT00321555|471865907|FG000|Overall Study|Developed antibodies|1|||
131064516|NCT00321555|471865907|FG000|Overall Study|Switched to alternative treatment|3|||
131064517|NCT00321555|471865907|FG000|Overall Study|Physician Decision|1|||
131064518|NCT00321555|471865907|FG000|Overall Study|Disease progression on study|1|||
131064519|NCT00537914|471865908|FG000|Overall Study|Death|1|||
131064520|NCT00537914|471865908|FG000|Overall Study|Adverse Event|7|||
131064521|NCT00537914|471865908|FG000|Overall Study|Treatment failure|10|||
131064522|NCT00537914|471865908|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
131064523|NCT00537914|471865908|FG000|Overall Study|Lost to Follow-up|19|||
131064524|NCT00537914|471865908|FG000|Overall Study|Withdrawal of informed consent|59|||
131064525|NCT02312258|471865909|FG000|Overall Study|Lost to Follow-up|8|||
131064526|NCT02312258|471865910|FG001|Overall Study|Lost to Follow-up|8|||
131064527|NCT02312258|471865909|FG000|Overall Study|Withdrawal by Patient|49|||
131064528|NCT02312258|471865910|FG001|Overall Study|Withdrawal by Patient|76|||
131064529|NCT02312258|471865909|FG000|Overall Study|Reason not Specified|107|||
131064530|NCT02312258|471865910|FG001|Overall Study|Reason not Specified|159|||
131064531|NCT02312258|471865909|FG000|Overall Study|Missing|2|||
131064532|NCT02312258|471865910|FG001|Overall Study|Missing|1|||
131064533|NCT02312258|471865909|FG000|Overall Study|Death|115|||
131064534|NCT02312258|471865910|FG001|Overall Study|Death|181|||
131064535|NCT01468597|471865912|FG000|Overall Study|Found ineligible|17|||
131064536|NCT01468597|471865912|FG000|Overall Study|concomitant valves|12|||
131064537|NCT01468597|471865912|FG000|Overall Study|off-pump CABG|1|||
131064538|NCT01468597|471865912|FG000|Overall Study|no platelet function data|5|||
131064539|NCT02892019|471865918|FG000|Overall Study|randomized but not treated|0|||
131064540|NCT02892019|471865919|FG001|Overall Study|randomized but not treated|1|||
131064541|NCT02892019|471865918|FG000|Overall Study|Withdrawal by Subject|0|||
131064542|NCT02892019|471865919|FG001|Overall Study|Withdrawal by Subject|1|||
131064543|NCT02892019|471865918|FG000|Overall Study|Adverse Event|1|||
131064544|NCT02892019|471865919|FG001|Overall Study|Adverse Event|1|||
131064545|NCT01313663|471865920|FG000|Overall Study|Study Closed/Terminated|2|||
131064546|NCT01313663|471865921|FG001|Overall Study|Study Closed/Terminated|4|||
131064547|NCT01313663|471865920|FG000|Overall Study|Lost to Follow-up|0|||
131064548|NCT01313663|471865921|FG001|Overall Study|Lost to Follow-up|1|||
131064549|NCT01313663|471865920|FG000|Overall Study|Physician Decision|0|||
131064550|NCT01313663|471865921|FG001|Overall Study|Physician Decision|2|||
131064551|NCT01313663|471865920|FG000|Overall Study|Withdrawal by Subject|2|||
131064552|NCT01313663|471865921|FG001|Overall Study|Withdrawal by Subject|1|||
131064553|NCT01199302|471865922|FG000|Overall Study|Adverse Event|1|||
131064554|NCT01199302|471865923|FG001|Overall Study|Adverse Event|1|||
131064555|NCT01199302|471865924|FG002|Overall Study|Adverse Event|2|||
131064556|NCT01199302|471865925|FG003|Overall Study|Adverse Event|0|||
131064557|NCT01199302|471865922|FG000|Overall Study|Withdrawal by Subject|2|||
131064558|NCT01199302|471865923|FG001|Overall Study|Withdrawal by Subject|2|||
131064559|NCT01199302|471865924|FG002|Overall Study|Withdrawal by Subject|3|||
131064560|NCT01199302|471865925|FG003|Overall Study|Withdrawal by Subject|0|||
131064561|NCT01199302|471865922|FG000|Overall Study|Disease Progression|3|||
131064562|NCT01199302|471865923|FG001|Overall Study|Disease Progression|4|||
131064563|NCT01199302|471865924|FG002|Overall Study|Disease Progression|4|||
131064564|NCT01199302|471865925|FG003|Overall Study|Disease Progression|2|||
131064565|NCT01199302|471865922|FG000|Overall Study|Study Termination|13|||
131064566|NCT01199302|471865923|FG001|Overall Study|Study Termination|8|||
131064567|NCT01199302|471865924|FG002|Overall Study|Study Termination|11|||
131064568|NCT01199302|471865925|FG003|Overall Study|Study Termination|9|||
131064569|NCT01199302|471865922|FG000|Overall Study|Lost to Follow-up|0|||
131064570|NCT01199302|471865923|FG001|Overall Study|Lost to Follow-up|1|||
131064571|NCT01199302|471865924|FG002|Overall Study|Lost to Follow-up|0|||
131064572|NCT01199302|471865925|FG003|Overall Study|Lost to Follow-up|0|||
131064573|NCT01199302|471865922|FG000|Overall Study|Other|1|||
131064574|NCT01199302|471865923|FG001|Overall Study|Other|0|||
131064575|NCT01199302|471865924|FG002|Overall Study|Other|0|||
131064576|NCT01199302|471865925|FG003|Overall Study|Other|0|||
131064577|NCT01634165|471865928|FG000|Period 2|Adverse Event|0|||
131064578|NCT01634165|471865929|FG001|Period 2|Adverse Event|1|||
131064579|NCT01634165|471865930|FG002|Period 2|Adverse Event|0|||
131064580|NCT01634165|471865931|FG003|Period 2|Adverse Event|0|||
131064581|NCT03820024|471865932|FG000|Overall Study|Physician Decision|1|||
131064582|NCT03820024|471865933|FG001|Overall Study|Physician Decision|2|||
131064583|NCT00946998|471868034|FG000|Overall Study|Exited prior to first outcome assessment|5|||
131064584|NCT00946998|471868035|FG001|Overall Study|Exited prior to first outcome assessment|3|||
131064585|NCT04914897|471868038|FG000|Overall Study|Withdrawal by Subject|3|||
131064586|NCT04914897|471868039|FG001|Overall Study|Withdrawal by Subject|1|||
131064587|NCT04914897|471868040|FG002|Overall Study|Withdrawal by Subject|1|||
131064588|NCT04914897|471868041|FG003|Overall Study|Withdrawal by Subject|1|||
131064589|NCT04914897|471868038|FG000|Overall Study|Poor compliance to protocol|0|||
131064590|NCT04914897|471868039|FG001|Overall Study|Poor compliance to protocol|0|||
131064591|NCT04914897|471868040|FG002|Overall Study|Poor compliance to protocol|1|||
131064592|NCT04914897|471868041|FG003|Overall Study|Poor compliance to protocol|0|||
131064593|NCT04914897|471868038|FG000|Overall Study|Progressive disease|5|||
131064594|NCT04914897|471868039|FG001|Overall Study|Progressive disease|14|||
131064595|NCT04914897|471868040|FG002|Overall Study|Progressive disease|30|||
131064596|NCT04914897|471868041|FG003|Overall Study|Progressive disease|21|||
131064597|NCT04914897|471868038|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
131064598|NCT04914897|471868039|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
131064599|NCT04914897|471868040|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
131064600|NCT04914897|471868041|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
131064601|NCT04914897|471868038|FG000|Overall Study|Other|1|||
131064602|NCT04914897|471868039|FG001|Overall Study|Other|0|||
131064603|NCT04914897|471868040|FG002|Overall Study|Other|0|||
131064604|NCT04914897|471868041|FG003|Overall Study|Other|1|||
131064605|NCT03020914|471868042|FG000|Overall Study|Surgery Cancelled|1|||
131064606|NCT03020914|471868043|FG001|Overall Study|Surgery Cancelled|0|||
131064607|NCT04049578|471868046|FG000|Overall Study|Physician Decision|1|||
131064608|NCT00409006|471868050|FG000|Overall Study|Death|15|||
131064609|NCT00409006|471868051|FG001|Overall Study|Death|6|||
131064610|NCT00409006|471868050|FG000|Overall Study|Lost to Follow-up|1|||
131064611|NCT00409006|471868051|FG001|Overall Study|Lost to Follow-up|2|||
131064612|NCT00409006|471868050|FG000|Overall Study|Withdrawal by Subject|3|||
131064613|NCT00409006|471868051|FG001|Overall Study|Withdrawal by Subject|2|||
130723130|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
130723131|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
131064614|NCT00409006|471868050|FG000|Overall Study|Physician Decision|1|||
131064615|NCT00409006|471868051|FG001|Overall Study|Physician Decision|2|||
131064616|NCT01945593|471868052|FG000|Overall Study|Adverse Event|0|||
131064617|NCT01945593|471868053|FG001|Overall Study|Adverse Event|0|||
131064618|NCT01945593|471868054|FG002|Overall Study|Adverse Event|0|||
131230061|NCT01133821|472469264|FG001|Overall Study|preferred other treatment|1|||
131064619|NCT01945593|471868055|FG003|Overall Study|Adverse Event|5|||
131064620|NCT01945593|471868052|FG000|Overall Study|Physician Decision|0|||
131064621|NCT01945593|471868053|FG001|Overall Study|Physician Decision|0|||
131064622|NCT01945593|471868054|FG002|Overall Study|Physician Decision|1|||
131064623|NCT01945593|471868055|FG003|Overall Study|Physician Decision|1|||
131064624|NCT01945593|471868052|FG000|Overall Study|Withdrawal by Subject|0|||
131064625|NCT01945593|471868053|FG001|Overall Study|Withdrawal by Subject|2|||
131064626|NCT01945593|471868054|FG002|Overall Study|Withdrawal by Subject|0|||
131064627|NCT01945593|471868055|FG003|Overall Study|Withdrawal by Subject|4|||
131064628|NCT01945593|471868052|FG000|Overall Study|Protocol Violation|0|||
131064629|NCT01945593|471868053|FG001|Overall Study|Protocol Violation|2|||
131064630|NCT01945593|471868054|FG002|Overall Study|Protocol Violation|1|||
131064631|NCT01945593|471868055|FG003|Overall Study|Protocol Violation|3|||
131064632|NCT01945593|471868052|FG000|Overall Study|Death|0|||
131064633|NCT01945593|471868053|FG001|Overall Study|Death|0|||
131064634|NCT01945593|471868054|FG002|Overall Study|Death|1|||
131064635|NCT01945593|471868055|FG003|Overall Study|Death|0|||
131064636|NCT01945593|471868052|FG000|Overall Study|Other: Terminated|0|||
131064637|NCT01945593|471868053|FG001|Overall Study|Other: Terminated|0|||
131064638|NCT01945593|471868054|FG002|Overall Study|Other: Terminated|0|||
131064639|NCT01945593|471868055|FG003|Overall Study|Other: Terminated|1|||
131064640|NCT01945593|471868052|FG000|Overall Study|Other: Surgical Procedure|0|||
131064641|NCT01945593|471868053|FG001|Overall Study|Other: Surgical Procedure|2|||
131064642|NCT01945593|471868054|FG002|Overall Study|Other: Surgical Procedure|0|||
131064643|NCT01945593|471868055|FG003|Overall Study|Other: Surgical Procedure|6|||
131064644|NCT01945593|471868052|FG000|Overall Study|Other: Screen Failure|0|||
131064645|NCT01945593|471868053|FG001|Overall Study|Other: Screen Failure|2|||
131064646|NCT01945593|471868054|FG002|Overall Study|Other: Screen Failure|0|||
131064647|NCT01945593|471868055|FG003|Overall Study|Other: Screen Failure|0|||
131064648|NCT00608959|471868056|FG000|Part 1|Did not meet eligibility criteria|1|||
131064649|NCT01005602|471868057|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
131064650|NCT01005602|471868058|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
131064651|NCT01248715|471868059|FG000|Overall Study|Not influenza positive|501|||
131064652|NCT01248715|471868060|FG001|Overall Study|Not influenza positive|510|||
131064653|NCT03605745|471868064|FG000|Overall Study|Study was terminated for business reasons|47|||
131064654|NCT03344458|471868068|FG000|Overall Study|Physician Decision|1|||
131064655|NCT03344458|471868068|FG000|Overall Study|Withdrawal by Subject|16|||
131064656|NCT03344458|471868068|FG000|Overall Study|Other reasons|10|||
131064657|NCT03344458|471868068|FG000|Overall Study|Lost to Follow-up|9|||
131064658|NCT03344458|471868068|FG000|Overall Study|Protocol Violation|3|||
131064659|NCT03884478|471868069|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
131064660|NCT03884478|471868070|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
131064661|NCT03884478|471868071|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
131064662|NCT03884478|471868069|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
131064663|NCT03884478|471868070|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
131064664|NCT03884478|471868071|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
131064665|NCT03884478|471868069|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
131137517|NCT00662792|472130660|FG003|Period 1|Refused continuing medication|0|||
131137518|NCT00662792|472130657|FG000|Period 1|Lost to Follow-up|1|||
131137519|NCT00662792|472130658|FG001|Period 1|Lost to Follow-up|0|||
131137520|NCT00662792|472130659|FG002|Period 1|Lost to Follow-up|0|||
131137521|NCT00662792|472130660|FG003|Period 1|Lost to Follow-up|0|||
131137522|NCT00662792|472130657|FG000|Period 1|Other adverse event (AE)|0|||
131137523|NCT00662792|472130658|FG001|Period 1|Other adverse event (AE)|2|||
131137524|NCT00662792|472130659|FG002|Period 1|Other adverse event (AE)|0|||
131137525|NCT00662792|472130660|FG003|Period 1|Other adverse event (AE)|0|||
131137526|NCT00662792|472130657|FG000|Period 1|Worsening of disease under study (AE)|1|||
131137527|NCT00662792|472130658|FG001|Period 1|Worsening of disease under study (AE)|3|||
131137528|NCT00662792|472130659|FG002|Period 1|Worsening of disease under study (AE)|2|||
131137529|NCT00662792|472130660|FG003|Period 1|Worsening of disease under study (AE)|0|||
131137530|NCT00662792|472130657|FG000|Period 1|Not treated|0|||
131137531|NCT00662792|472130658|FG001|Period 1|Not treated|1|||
131230062|NCT01133821|472469263|FG000|Overall Study|Protocol Violation|0|||
131230063|NCT01133821|472469264|FG001|Overall Study|Protocol Violation|1|||
131064666|NCT03884478|471868070|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
131064667|NCT03884478|471868071|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
131064668|NCT03884478|471868069|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
131064669|NCT03884478|471868070|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
131064670|NCT03884478|471868071|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
131064671|NCT01807234|471868074|FG000|Overall Study|Lost to Follow-up|2|||
131064672|NCT01807234|471868075|FG001|Overall Study|Lost to Follow-up|5|||
131064673|NCT01807234|471868076|FG002|Overall Study|Lost to Follow-up|1|||
131064674|NCT01807234|471868077|FG003|Overall Study|Lost to Follow-up|1|||
131064675|NCT01807234|471868078|FG004|Overall Study|Lost to Follow-up|1|||
131137532|NCT00662792|472130659|FG002|Period 1|Not treated|0|||
131137533|NCT00662792|472130660|FG003|Period 1|Not treated|0|||
131137534|NCT00662792|472130657|FG000|Period 2|Worsening of disease under study|1|||
131137535|NCT00662792|472130658|FG001|Period 2|Worsening of disease under study|0|||
131137536|NCT00662792|472130659|FG002|Period 2|Worsening of disease under study|0|||
131137537|NCT00662792|472130660|FG003|Period 2|Worsening of disease under study|3|||
131137538|NCT00662792|472130657|FG000|Period 3|Refused continuing medication|1|||
131137539|NCT00662792|472130658|FG001|Period 3|Refused continuing medication|0|||
131137540|NCT00662792|472130659|FG002|Period 3|Refused continuing medication|1|||
131137541|NCT00662792|472130660|FG003|Period 3|Refused continuing medication|0|||
131137542|NCT00662792|472130657|FG000|Period 3|Other adverse event (AE)|0|||
131137543|NCT00662792|472130658|FG001|Period 3|Other adverse event (AE)|0|||
131064676|NCT01807234|471868079|FG005|Overall Study|Lost to Follow-up|2|||
131064677|NCT01807234|471868074|FG000|Overall Study|Withdrawal by Subject|3|||
131064678|NCT01807234|471868075|FG001|Overall Study|Withdrawal by Subject|1|||
131064679|NCT01807234|471868076|FG002|Overall Study|Withdrawal by Subject|1|||
131064680|NCT01807234|471868077|FG003|Overall Study|Withdrawal by Subject|1|||
131064681|NCT01807234|471868078|FG004|Overall Study|Withdrawal by Subject|2|||
131064682|NCT01807234|471868079|FG005|Overall Study|Withdrawal by Subject|1|||
131064683|NCT01807234|471868074|FG000|Overall Study|Lack of Efficacy|0|||
131064684|NCT01807234|471868075|FG001|Overall Study|Lack of Efficacy|0|||
131064685|NCT01807234|471868076|FG002|Overall Study|Lack of Efficacy|0|||
131064686|NCT01807234|471868077|FG003|Overall Study|Lack of Efficacy|0|||
131064687|NCT01807234|471868078|FG004|Overall Study|Lack of Efficacy|1|||
131064688|NCT01807234|471868079|FG005|Overall Study|Lack of Efficacy|1|||
131064689|NCT00538629|471868080|FG000|Overall Study|At subject's request|1|||
131064690|NCT00538629|471868080|FG000|Overall Study|Adverse Event|2|||
131064691|NCT00538629|471868080|FG000|Overall Study|Lack of Efficacy|12|||
131064692|NCT00538629|471868080|FG000|Overall Study|Lost to Follow-up|6|||
131064693|NCT00538629|471868080|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
131064694|NCT04454125|471868081|FG000|Overall Study|Lost to Follow-up|0|||
131064695|NCT04454125|471868082|FG001|Overall Study|Lost to Follow-up|1|||
131064696|NCT00555620|471868088|FG000|Overall Study|Death|0|||
131064697|NCT00555620|471868089|FG001|Overall Study|Death|1|||
131064698|NCT00555620|471868090|FG002|Overall Study|Death|0|||
131064699|NCT00555620|471868091|FG003|Overall Study|Death|0|||
131064700|NCT00555620|471868092|FG004|Overall Study|Death|0|||
131064701|NCT00555620|471868093|FG005|Overall Study|Death|1|||
131064702|NCT00555620|471868088|FG000|Overall Study|Study terminated by sponsor|0|||
131064703|NCT00555620|471868089|FG001|Overall Study|Study terminated by sponsor|0|||
131064704|NCT00555620|471868090|FG002|Overall Study|Study terminated by sponsor|1|||
131064705|NCT00555620|471868091|FG003|Overall Study|Study terminated by sponsor|0|||
131064706|NCT00555620|471868092|FG004|Overall Study|Study terminated by sponsor|0|||
131064707|NCT00555620|471868093|FG005|Overall Study|Study terminated by sponsor|0|||
131064708|NCT00555620|471868088|FG000|Overall Study|Adverse Event|0|||
131064709|NCT00555620|471868089|FG001|Overall Study|Adverse Event|0|||
131064710|NCT00555620|471868090|FG002|Overall Study|Adverse Event|1|||
131064711|NCT00555620|471868091|FG003|Overall Study|Adverse Event|5|||
131064712|NCT00555620|471868092|FG004|Overall Study|Adverse Event|0|||
131064713|NCT00555620|471868093|FG005|Overall Study|Adverse Event|1|||
131064714|NCT00555620|471868088|FG000|Overall Study|Objective progression or relapse|6|||
131064715|NCT00555620|471868089|FG001|Overall Study|Objective progression or relapse|5|||
131064716|NCT00555620|471868090|FG002|Overall Study|Objective progression or relapse|12|||
131064717|NCT00555620|471868091|FG003|Overall Study|Objective progression or relapse|17|||
131064718|NCT00555620|471868092|FG004|Overall Study|Objective progression or relapse|3|||
131064719|NCT00555620|471868093|FG005|Overall Study|Objective progression or relapse|16|||
131064720|NCT00555620|471868088|FG000|Overall Study|Participant refused treatment|0|||
131064721|NCT00555620|471868089|FG001|Overall Study|Participant refused treatment|1|||
131064722|NCT00555620|471868090|FG002|Overall Study|Participant refused treatment|1|||
131064723|NCT00555620|471868091|FG003|Overall Study|Participant refused treatment|0|||
131064724|NCT00555620|471868092|FG004|Overall Study|Participant refused treatment|0|||
131064725|NCT00555620|471868093|FG005|Overall Study|Participant refused treatment|1|||
131064726|NCT00555620|471868088|FG000|Overall Study|Other|0|||
131064727|NCT00555620|471868089|FG001|Overall Study|Other|0|||
131064728|NCT00555620|471868090|FG002|Overall Study|Other|0|||
131064729|NCT00555620|471868091|FG003|Overall Study|Other|1|||
131064730|NCT00555620|471868092|FG004|Overall Study|Other|0|||
131064731|NCT00555620|471868093|FG005|Overall Study|Other|3|||
131064732|NCT00828139|471868094|FG000|Overall Study|Adverse Event|8|||
131064733|NCT00828139|471868095|FG001|Overall Study|Adverse Event|1|||
131064734|NCT00828139|471868096|FG002|Overall Study|Adverse Event|10|||
131064735|NCT00828139|471868097|FG003|Overall Study|Adverse Event|5|||
131064736|NCT00828139|471868094|FG000|Overall Study|Death|2|||
131064737|NCT00828139|471868095|FG001|Overall Study|Death|1|||
131064738|NCT00828139|471868096|FG002|Overall Study|Death|0|||
131064739|NCT00828139|471868097|FG003|Overall Study|Death|2|||
130723132|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
130723133|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
130723134|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
130723135|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
131064740|NCT00828139|471868094|FG000|Overall Study|Refusal unrelated to toxicity|3|||
131064741|NCT00828139|471868095|FG001|Overall Study|Refusal unrelated to toxicity|4|||
131064742|NCT00828139|471868096|FG002|Overall Study|Refusal unrelated to toxicity|5|||
131064743|NCT00828139|471868097|FG003|Overall Study|Refusal unrelated to toxicity|3|||
131064744|NCT00828139|471868094|FG000|Overall Study|Disease Progression|24|||
131064745|NCT00828139|471868095|FG001|Overall Study|Disease Progression|33|||
131064746|NCT00828139|471868096|FG002|Overall Study|Disease Progression|35|||
131064747|NCT00828139|471868097|FG003|Overall Study|Disease Progression|39|||
131064748|NCT00828139|471868094|FG000|Overall Study|Other|4|||
131064749|NCT00828139|471868095|FG001|Overall Study|Other|2|||
131064750|NCT00828139|471868096|FG002|Overall Study|Other|5|||
131064751|NCT00828139|471868097|FG003|Overall Study|Other|2|||
131064752|NCT01714947|471868098|FG000|Part B|Progressive Disease|3|||
131064753|NCT01922102|471868099|FG000|Overall Study|Withdrawal by Subject|7|||
131064754|NCT01922102|471868100|FG001|Overall Study|Withdrawal by Subject|3|||
131064755|NCT01922102|471868101|FG002|Overall Study|Withdrawal by Subject|7|||
131064756|NCT01922102|471868099|FG000|Overall Study|Physician Decision|0|||
131064757|NCT01922102|471868100|FG001|Overall Study|Physician Decision|2|||
131064758|NCT01922102|471868101|FG002|Overall Study|Physician Decision|1|||
131064759|NCT01922102|471868099|FG000|Overall Study|Adverse Event|1|||
131064760|NCT01922102|471868100|FG001|Overall Study|Adverse Event|2|||
131064761|NCT01922102|471868101|FG002|Overall Study|Adverse Event|0|||
131064762|NCT01922102|471868099|FG000|Overall Study|Lost to Follow-up|1|||
131064763|NCT01922102|471868100|FG001|Overall Study|Lost to Follow-up|0|||
131064764|NCT01922102|471868101|FG002|Overall Study|Lost to Follow-up|0|||
131064765|NCT01922102|471868099|FG000|Overall Study|Administrative problems|0|||
131064766|NCT01922102|471868100|FG001|Overall Study|Administrative problems|2|||
131064767|NCT01922102|471868101|FG002|Overall Study|Administrative problems|0|||
131064768|NCT05203822|471868102|FG000|Overall Study|Adverse Event|1|||
131064769|NCT05203822|471868102|FG000|Overall Study|Withdrawal by Subject|1|||
131064770|NCT03696342|471868103|FG000|Overall Study|Lost to Follow-up|1|||
131064771|NCT03696342|471868104|FG001|Overall Study|Lost to Follow-up|0|||
131064772|NCT01345253|471868108|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
131064773|NCT01345253|471868109|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
131064774|NCT01345253|471868108|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
131064775|NCT01345253|471868109|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
131064776|NCT01345253|471868108|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
131064777|NCT01345253|471868109|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
131064778|NCT01345253|471868108|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
131064779|NCT01345253|471868109|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
131064780|NCT01345253|471868108|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
131064781|NCT01345253|471868109|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
131064782|NCT01345253|471868108|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
131064783|NCT01345253|471868109|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
131064784|NCT01345253|471868108|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
131064785|NCT01345253|471868109|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
131064786|NCT01345253|471868108|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
131064787|NCT01345253|471868109|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
131064788|NCT01345253|471868108|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
131064789|NCT01345253|471868109|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
131064790|NCT01345253|471868108|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
131064791|NCT01345253|471868109|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
131064792|NCT01345253|471868108|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
131064793|NCT01345253|471868109|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
131064794|NCT01345253|471868108|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
131064795|NCT01345253|471868109|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
131064796|NCT01345253|471868108|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
131064797|NCT01345253|471868109|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
131064798|NCT01345253|471868108|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
131064799|NCT01345253|471868109|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
131064800|NCT01345253|471868108|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
131064801|NCT01345253|471868109|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
131064802|NCT01877720|471868115|FG000|Overall Study|Adverse Event|1|||
131064803|NCT01877720|471868116|FG001|Overall Study|Adverse Event|0|||
131064804|NCT00447499|471868117|FG000|Overall Study|Adverse Event|1|||
131064805|NCT00447499|471868117|FG000|Overall Study|Patient Decision|4|||
131064806|NCT00447499|471868117|FG000|Overall Study|Sponsor Decision|1|||
131137544|NCT00662792|472130659|FG002|Period 3|Other adverse event (AE)|1|||
131137545|NCT00662792|472130660|FG003|Period 3|Other adverse event (AE)|1|||
131064807|NCT00447499|471868117|FG000|Overall Study|Physician Decision|1|||
131064808|NCT02068352|471868118|FG000|Overall Study|Lost to Follow-up|0|||
131064809|NCT02068352|471868119|FG001|Overall Study|Lost to Follow-up|2|||
131064810|NCT02068352|471868120|FG002|Overall Study|Lost to Follow-up|0|||
131064811|NCT02068352|471868118|FG000|Overall Study|Adverse Event|4|||
131064812|NCT02068352|471868119|FG001|Overall Study|Adverse Event|2|||
131064813|NCT02068352|471868120|FG002|Overall Study|Adverse Event|7|||
131064814|NCT02068352|471868118|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
131064815|NCT02068352|471868119|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
131137546|NCT00662792|472130657|FG000|Period 4|Refused continuing medication|0|||
131137547|NCT00662792|472130658|FG001|Period 4|Refused continuing medication|1|||
131137548|NCT00662792|472130659|FG002|Period 4|Refused continuing medication|0|||
131137549|NCT00662792|472130660|FG003|Period 4|Refused continuing medication|0|||
131064816|NCT02068352|471868120|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
131064817|NCT02068352|471868118|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
131064818|NCT02068352|471868119|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
131064819|NCT02068352|471868120|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
131064820|NCT02068352|471868118|FG000|Overall Study|Protocol Deviation|0|||
131064821|NCT02068352|471868119|FG001|Overall Study|Protocol Deviation|0|||
131064822|NCT02068352|471868120|FG002|Overall Study|Protocol Deviation|1|||
131064823|NCT01322347|471868121|FG000|Overall Study|Adverse Event|7|||
131064824|NCT01322347|471868122|FG001|Overall Study|Adverse Event|2|||
131064825|NCT01322347|471868121|FG000|Overall Study|Death|5|||
131064826|NCT01322347|471868122|FG001|Overall Study|Death|3|||
131064827|NCT01322347|471868121|FG000|Overall Study|Physician Decision|2|||
131064828|NCT01322347|471868122|FG001|Overall Study|Physician Decision|1|||
131064829|NCT01322347|471868121|FG000|Overall Study|Protocol Violation|5|||
131064830|NCT01322347|471868122|FG001|Overall Study|Protocol Violation|2|||
131064831|NCT01322347|471868121|FG000|Overall Study|Withdrawal by Subject|1|||
131064832|NCT01322347|471868122|FG001|Overall Study|Withdrawal by Subject|4|||
131064833|NCT01322347|471868121|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
131064834|NCT01322347|471868122|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
131064835|NCT01322347|471868121|FG000|Overall Study|blood transfusion|5|||
131064836|NCT01322347|471868122|FG001|Overall Study|blood transfusion|5|||
131064837|NCT01322347|471868121|FG000|Overall Study|sponsor decision|1|||
131064838|NCT01322347|471868122|FG001|Overall Study|sponsor decision|3|||
131064839|NCT01322347|471868121|FG000|Overall Study|ineligible|6|||
131064840|NCT01322347|471868122|FG001|Overall Study|ineligible|3|||
131064841|NCT01322347|471868121|FG000|Overall Study|kidney transplant|3|||
131064842|NCT01322347|471868122|FG001|Overall Study|kidney transplant|1|||
131064843|NCT01322347|471868121|FG000|Overall Study|study drug withheld > 12 wks|0|||
131064844|NCT01322347|471868122|FG001|Overall Study|study drug withheld > 12 wks|1|||
131064845|NCT01322347|471868121|FG000|Overall Study|moved/changed dialysis|2|||
131064846|NCT01322347|471868122|FG001|Overall Study|moved/changed dialysis|4|||
131064847|NCT01369147|471868124|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
131064848|NCT01369147|471868125|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
131064849|NCT01369147|471868126|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
131064850|NCT00648895|471868132|FG000|Overall Study|Lack of Efficacy|0|||
131064851|NCT00648895|471868133|FG001|Overall Study|Lack of Efficacy|1|||
131064852|NCT02865083|471868134|FG000|Overall Study|Early Termination|3|||
131064853|NCT02865083|471868135|FG001|Overall Study|Early Termination|1|||
131064854|NCT04626128|471868136|FG000|Overall Study|Withdrawal by Subject|0|||
131064855|NCT04626128|471868137|FG001|Overall Study|Withdrawal by Subject|1|||
131064856|NCT04626128|471868138|FG002|Overall Study|Withdrawal by Subject|0|||
131064857|NCT04626128|471868139|FG003|Overall Study|Withdrawal by Subject|0|||
131064858|NCT01182285|471868140|FG000|First Intervention Week 1-10|Disease progression|1|||
131064859|NCT01182285|471868141|FG001|First Intervention Week 1-10|Disease progression|0|||
131064860|NCT01182285|471868142|FG002|First Intervention Week 1-10|Disease progression|0|||
131064861|NCT01182285|471868140|FG000|First Intervention Week 1-10|Adverse Event|1|||
131064862|NCT01182285|471868141|FG001|First Intervention Week 1-10|Adverse Event|0|||
131064863|NCT01182285|471868142|FG002|First Intervention Week 1-10|Adverse Event|0|||
131064864|NCT01182285|471868140|FG000|First Intervention Week 1-10|Non-compliance|1|||
131137550|NCT00662792|472130657|FG000|Period 4|Other adverse event (AE)|1|||
131137551|NCT00662792|472130658|FG001|Period 4|Other adverse event (AE)|0|||
131137552|NCT00662792|472130659|FG002|Period 4|Other adverse event (AE)|0|||
131137553|NCT00662792|472130660|FG003|Period 4|Other adverse event (AE)|0|||
131137554|NCT00662792|472130657|FG000|Period 4|Worsening of disease under study (AE)|0|||
131230064|NCT01133821|472469263|FG000|Overall Study|Refused participation|1|||
130723136|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
130723137|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
130723138|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
130723139|NCT01696279|470611345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
130723140|NCT01696279|470611346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
130723141|NCT01696279|470611347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
131064865|NCT01182285|471868141|FG001|First Intervention Week 1-10|Non-compliance|0|||
131064866|NCT01182285|471868142|FG002|First Intervention Week 1-10|Non-compliance|0|||
131064867|NCT01182285|471868140|FG000|Third Intervention Week 11-52|Disease Progression|0|||
131064868|NCT01182285|471868141|FG001|Third Intervention Week 11-52|Disease Progression|0|||
131064869|NCT01182285|471868142|FG002|Third Intervention Week 11-52|Disease Progression|6|||
131064870|NCT01182285|471868140|FG000|Third Intervention Week 11-52|Other|0|||
131064871|NCT01182285|471868141|FG001|Third Intervention Week 11-52|Other|0|||
131064872|NCT01182285|471868142|FG002|Third Intervention Week 11-52|Other|2|||
131137555|NCT00662792|472130658|FG001|Period 4|Worsening of disease under study (AE)|0|||
131137556|NCT00662792|472130659|FG002|Period 4|Worsening of disease under study (AE)|0|||
131137557|NCT00662792|472130660|FG003|Period 4|Worsening of disease under study (AE)|1|||
131137558|NCT01699087|472130662|FG000|Overall Study|Lost to Follow-up|7|||
131064873|NCT00841321|471868143|FG000|Overall Study|Lost to Follow-up|1|||
131064874|NCT00841321|471868144|FG001|Overall Study|Lost to Follow-up|1|||
131064875|NCT00841321|471868143|FG000|Overall Study|Adverse Event|0|||
131064876|NCT00841321|471868144|FG001|Overall Study|Adverse Event|2|||
131064877|NCT00379210|471868147|FG000|Overall Study|Withdrawal by Subject|10|||
131064878|NCT00379210|471868148|FG001|Overall Study|Withdrawal by Subject|7|||
131064879|NCT01358175|471868149|FG000|Overall Study|Death|1|||
131064880|NCT01358175|471868150|FG001|Overall Study|Death|0|||
131064881|NCT01358175|471868151|FG002|Overall Study|Death|1|||
131064882|NCT01358175|471868149|FG000|Overall Study|Withdrawal by Subject|9|||
131064883|NCT01358175|471868150|FG001|Overall Study|Withdrawal by Subject|5|||
131064884|NCT01358175|471868151|FG002|Overall Study|Withdrawal by Subject|10|||
131064885|NCT01358175|471868149|FG000|Overall Study|Technical issues|0|||
131064886|NCT01358175|471868150|FG001|Overall Study|Technical issues|1|||
131064887|NCT01358175|471868151|FG002|Overall Study|Technical issues|0|||
131064888|NCT01358175|471868149|FG000|Overall Study|Pregnancy|0|||
131064889|NCT01358175|471868150|FG001|Overall Study|Pregnancy|1|||
131064890|NCT01358175|471868151|FG002|Overall Study|Pregnancy|0|||
131064891|NCT01358175|471868149|FG000|Overall Study|Physician Decision|1|||
131064892|NCT01358175|471868150|FG001|Overall Study|Physician Decision|0|||
131064893|NCT01358175|471868151|FG002|Overall Study|Physician Decision|0|||
131064894|NCT01358175|471868149|FG000|Overall Study|Non Compliance with Study Treatment|0|||
131064895|NCT01358175|471868150|FG001|Overall Study|Non Compliance with Study Treatment|1|||
131064896|NCT01358175|471868151|FG002|Overall Study|Non Compliance with Study Treatment|1|||
131064897|NCT01358175|471868149|FG000|Overall Study|Lost to Follow-up|1|||
131064898|NCT01358175|471868150|FG001|Overall Study|Lost to Follow-up|1|||
131064899|NCT01358175|471868151|FG002|Overall Study|Lost to Follow-up|3|||
131064900|NCT01358175|471868149|FG000|Overall Study|Lack of Efficacy|3|||
131064901|NCT01358175|471868150|FG001|Overall Study|Lack of Efficacy|8|||
131064902|NCT01358175|471868151|FG002|Overall Study|Lack of Efficacy|6|||
131064903|NCT01358175|471868149|FG000|Overall Study|Adverse Event|6|||
131064904|NCT01358175|471868150|FG001|Overall Study|Adverse Event|11|||
131064905|NCT01358175|471868151|FG002|Overall Study|Adverse Event|11|||
131064906|NCT01525875|471868152|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
131064907|NCT01525875|471868153|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
131064908|NCT01525875|471868152|FG000|Open-label Period|Lost to Follow-up|0|||
131064909|NCT01525875|471868153|FG001|Open-label Period|Lost to Follow-up|2|||
131064910|NCT00821093|471868154|FG000|Overall Study|Adverse Event|20|||
131064911|NCT00821093|471868155|FG001|Overall Study|Adverse Event|12|||
131064912|NCT00821093|471868154|FG000|Overall Study|Withdrawal by Subject|9|||
131064913|NCT00821093|471868155|FG001|Overall Study|Withdrawal by Subject|13|||
131064914|NCT00821093|471868154|FG000|Overall Study|Lost to Follow-up|9|||
131064915|NCT00821093|471868155|FG001|Overall Study|Lost to Follow-up|3|||
131064916|NCT00821093|471868154|FG000|Overall Study|Protocol deviation|3|||
131064917|NCT00821093|471868155|FG001|Overall Study|Protocol deviation|6|||
131064918|NCT00821093|471868154|FG000|Overall Study|Abnormal laboratory value(s)|2|||
131064919|NCT00821093|471868155|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131064920|NCT00821093|471868154|FG000|Overall Study|Lack of Efficacy|2|||
131064921|NCT00821093|471868155|FG001|Overall Study|Lack of Efficacy|2|||
131064922|NCT00821093|471868154|FG000|Overall Study|Death|2|||
131064923|NCT00821093|471868155|FG001|Overall Study|Death|1|||
131064924|NCT00821093|471868154|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131064925|NCT00821093|471868155|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131064926|NCT00821093|471868154|FG000|Overall Study|Administrative problems|1|||
131064927|NCT00821093|471868155|FG001|Overall Study|Administrative problems|2|||
131064928|NCT01107912|471868156|FG000|Period 1|Adverse Event|0|||
131064929|NCT01107912|471868157|FG001|Period 1|Adverse Event|0|||
131064930|NCT01107912|471868158|FG002|Period 1|Adverse Event|0|||
131064931|NCT01107912|471868159|FG003|Period 1|Adverse Event|0|||
131137559|NCT01699087|472130662|FG000|Overall Study|Screen failure (prior to treatment)|15|||
131064932|NCT01107912|471868160|FG004|Period 1|Adverse Event|2|||
131064933|NCT01107912|471868161|FG005|Period 1|Adverse Event|0|||
131064934|NCT01107912|471868156|FG000|Period 1|Physician Decision|0|||
131064935|NCT01107912|471868157|FG001|Period 1|Physician Decision|0|||
131064936|NCT01107912|471868158|FG002|Period 1|Physician Decision|0|||
131137560|NCT01699087|472130662|FG000|Overall Study|Unable to make future visits|2|||
131137561|NCT03021642|472130665|FG000|Washout Period (21 Days)|Adverse Event|1|||
131137562|NCT03021642|472130666|FG001|Washout Period (21 Days)|Adverse Event|1|||
131137563|NCT00756938|472130667|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
131137564|NCT00756938|472130668|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
131064937|NCT01107912|471868159|FG003|Period 1|Physician Decision|0|||
131064938|NCT01107912|471868160|FG004|Period 1|Physician Decision|1|||
131064939|NCT01107912|471868161|FG005|Period 1|Physician Decision|0|||
131064940|NCT01107912|471868156|FG000|Period 1|Withdrawal by Subject|1|||
131064941|NCT01107912|471868157|FG001|Period 1|Withdrawal by Subject|0|||
131064942|NCT01107912|471868158|FG002|Period 1|Withdrawal by Subject|0|||
131064943|NCT01107912|471868159|FG003|Period 1|Withdrawal by Subject|0|||
131064944|NCT01107912|471868160|FG004|Period 1|Withdrawal by Subject|0|||
131137565|NCT00756938|472130669|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
131064945|NCT01107912|471868161|FG005|Period 1|Withdrawal by Subject|0|||
131064946|NCT01107912|471868156|FG000|Period 2|Physician Decision|0|||
131064947|NCT01107912|471868157|FG001|Period 2|Physician Decision|0|||
131064948|NCT01107912|471868158|FG002|Period 2|Physician Decision|1|||
131064949|NCT01107912|471868159|FG003|Period 2|Physician Decision|0|||
131064950|NCT01107912|471868160|FG004|Period 2|Physician Decision|0|||
131064951|NCT01107912|471868161|FG005|Period 2|Physician Decision|0|||
131064952|NCT01107912|471868156|FG000|Period 3|Adverse Event|0|||
131064953|NCT01107912|471868157|FG001|Period 3|Adverse Event|1|||
131064954|NCT01107912|471868158|FG002|Period 3|Adverse Event|1|||
131064955|NCT01107912|471868159|FG003|Period 3|Adverse Event|0|||
131064956|NCT01107912|471868160|FG004|Period 3|Adverse Event|0|||
131064957|NCT01107912|471868161|FG005|Period 3|Adverse Event|0|||
131064958|NCT01107912|471868156|FG000|Period 3|Withdrawal by Subject|0|||
131064959|NCT01107912|471868157|FG001|Period 3|Withdrawal by Subject|0|||
131064960|NCT01107912|471868158|FG002|Period 3|Withdrawal by Subject|0|||
131064961|NCT01107912|471868159|FG003|Period 3|Withdrawal by Subject|1|||
131064962|NCT01107912|471868160|FG004|Period 3|Withdrawal by Subject|0|||
131064963|NCT01107912|471868161|FG005|Period 3|Withdrawal by Subject|0|||
131064964|NCT01721109|471868164|FG000|Overall Study|Lack of Efficacy|1|||
131064965|NCT01721109|471868164|FG000|Overall Study|Non- Compliance with Study Drug|3|||
131064966|NCT01721109|471868164|FG000|Overall Study|Withdrew Consent|1|||
131064967|NCT01721109|471868164|FG000|Overall Study|Lost to Follow-up|2|||
131064968|NCT00134056|471868165|FG000|Randomization|Not eligible for assigned treatment|22|||
131064969|NCT00134056|471868166|FG001|Randomization|Not eligible for assigned treatment|20|||
131064970|NCT00134056|471868165|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
131064971|NCT00134056|471868166|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
131064972|NCT00134056|471868165|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
131064973|NCT00134056|471868166|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
131064974|NCT00134056|471868165|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
131064975|NCT00134056|471868166|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
131064976|NCT00134056|471868165|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
131064977|NCT00134056|471868166|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
131064978|NCT02924051|471868171|FG000|Overall Study|Withdrawal by Subject|1|||
131064979|NCT02924051|471868172|FG001|Overall Study|Withdrawal by Subject|9|||
131064980|NCT02260154|471868173|FG000|Overall Study|Screening failure|2|||
131064981|NCT02561195|471868175|FG000|Vaccination 1 to 3|Adverse Event|4|||
131064982|NCT02561195|471868176|FG001|Vaccination 1 to 3|Adverse Event|5|||
131064983|NCT02561195|471868177|FG002|Vaccination 1 to 3|Adverse Event|0|||
131064984|NCT02561195|471868178|FG003|Vaccination 1 to 3|Adverse Event|3|||
131064985|NCT02561195|471868179|FG004|Vaccination 1 to 3|Adverse Event|4|||
131064986|NCT02561195|471868180|FG005|Vaccination 1 to 3|Adverse Event|0|||
131064987|NCT02561195|471868181|FG006|Vaccination 1 to 3|Adverse Event|0|||
131064988|NCT02561195|471868182|FG007|Vaccination 1 to 3|Adverse Event|0|||
131064989|NCT02561195|471868183|FG008|Vaccination 1 to 3|Adverse Event|0|||
131064990|NCT02561195|471868184|FG009|Vaccination 1 to 3|Adverse Event|0|||
131064991|NCT02561195|471868185|FG010|Vaccination 1 to 3|Adverse Event|0|||
131064992|NCT02561195|471868186|FG011|Vaccination 1 to 3|Adverse Event|0|||
131064993|NCT02561195|471868187|FG012|Vaccination 1 to 3|Adverse Event|0|||
131064994|NCT02561195|471868188|FG013|Vaccination 1 to 3|Adverse Event|0|||
131064995|NCT02561195|471868175|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
131064996|NCT02561195|471868176|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
131064997|NCT02561195|471868177|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
131064998|NCT02561195|471868178|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
131064999|NCT02561195|471868179|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
131065000|NCT02561195|471868180|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
131065001|NCT02561195|471868181|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
131065002|NCT02561195|471868182|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
131065003|NCT02561195|471868183|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
131065004|NCT02561195|471868184|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
131065005|NCT02561195|471868185|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
131065006|NCT02561195|471868186|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
131065007|NCT02561195|471868187|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
131065008|NCT02561195|471868188|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
131230065|NCT01133821|472469264|FG001|Overall Study|Refused participation|3|||
130779421|NCT02326272|470819493|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131065009|NCT02561195|471868175|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131065010|NCT02561195|471868176|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
131065011|NCT02561195|471868177|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131230066|NCT01387282|472469265|FG000|Overall Study|Death|47|||
131230067|NCT01387282|472469266|FG001|Overall Study|Death|16|||
131065012|NCT02561195|471868178|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
131065013|NCT02561195|471868179|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
131065014|NCT02561195|471868180|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
131065015|NCT02561195|471868181|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131065016|NCT02561195|471868182|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131065017|NCT02561195|471868183|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131065018|NCT02561195|471868184|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131065019|NCT02561195|471868185|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131065020|NCT02561195|471868186|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131065021|NCT02561195|471868187|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131065022|NCT02561195|471868188|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
131065023|NCT02561195|471868175|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
131065024|NCT02561195|471868176|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
131065025|NCT02561195|471868177|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
131065026|NCT02561195|471868178|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
131065027|NCT02561195|471868179|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
131065028|NCT02561195|471868180|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
131065029|NCT02561195|471868181|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
131065030|NCT02561195|471868182|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
131065031|NCT02561195|471868183|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
131065032|NCT02561195|471868184|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
131065033|NCT02561195|471868185|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
131065034|NCT02561195|471868186|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
131065035|NCT02561195|471868187|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
131065036|NCT02561195|471868188|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
131065037|NCT02561195|471868175|FG000|Vaccination 1 to 3|Other|7|||
131065038|NCT02561195|471868176|FG001|Vaccination 1 to 3|Other|3|||
131065039|NCT02561195|471868177|FG002|Vaccination 1 to 3|Other|1|||
131065040|NCT02561195|471868178|FG003|Vaccination 1 to 3|Other|7|||
131065041|NCT02561195|471868179|FG004|Vaccination 1 to 3|Other|5|||
131065042|NCT02561195|471868180|FG005|Vaccination 1 to 3|Other|1|||
131065043|NCT02561195|471868181|FG006|Vaccination 1 to 3|Other|0|||
131065044|NCT02561195|471868182|FG007|Vaccination 1 to 3|Other|0|||
131065045|NCT02561195|471868183|FG008|Vaccination 1 to 3|Other|0|||
131065046|NCT02561195|471868184|FG009|Vaccination 1 to 3|Other|0|||
131065047|NCT02561195|471868185|FG010|Vaccination 1 to 3|Other|0|||
131065048|NCT02561195|471868186|FG011|Vaccination 1 to 3|Other|0|||
131065049|NCT02561195|471868187|FG012|Vaccination 1 to 3|Other|0|||
131065050|NCT02561195|471868188|FG013|Vaccination 1 to 3|Other|0|||
131065051|NCT02561195|471868175|FG000|Vaccination 1 to 3|Protocol Violation|1|||
131065052|NCT02561195|471868176|FG001|Vaccination 1 to 3|Protocol Violation|0|||
131065053|NCT02561195|471868177|FG002|Vaccination 1 to 3|Protocol Violation|1|||
131065054|NCT02561195|471868178|FG003|Vaccination 1 to 3|Protocol Violation|2|||
131065055|NCT02561195|471868179|FG004|Vaccination 1 to 3|Protocol Violation|5|||
131065056|NCT02561195|471868180|FG005|Vaccination 1 to 3|Protocol Violation|2|||
131065057|NCT02561195|471868181|FG006|Vaccination 1 to 3|Protocol Violation|0|||
131065058|NCT02561195|471868182|FG007|Vaccination 1 to 3|Protocol Violation|0|||
131065059|NCT02561195|471868183|FG008|Vaccination 1 to 3|Protocol Violation|0|||
131065060|NCT02561195|471868184|FG009|Vaccination 1 to 3|Protocol Violation|0|||
131065061|NCT02561195|471868185|FG010|Vaccination 1 to 3|Protocol Violation|0|||
131065062|NCT02561195|471868186|FG011|Vaccination 1 to 3|Protocol Violation|0|||
131065063|NCT02561195|471868187|FG012|Vaccination 1 to 3|Protocol Violation|0|||
131065064|NCT02561195|471868188|FG013|Vaccination 1 to 3|Protocol Violation|0|||
131065065|NCT02561195|471868175|FG000|Vaccination 1 to 3|Death|2|||
131065066|NCT02561195|471868176|FG001|Vaccination 1 to 3|Death|1|||
131065067|NCT02561195|471868177|FG002|Vaccination 1 to 3|Death|0|||
131065068|NCT02561195|471868178|FG003|Vaccination 1 to 3|Death|2|||
131065069|NCT02561195|471868179|FG004|Vaccination 1 to 3|Death|0|||
131065070|NCT02561195|471868180|FG005|Vaccination 1 to 3|Death|0|||
131065071|NCT02561195|471868181|FG006|Vaccination 1 to 3|Death|0|||
131065072|NCT02561195|471868182|FG007|Vaccination 1 to 3|Death|0|||
131065073|NCT02561195|471868183|FG008|Vaccination 1 to 3|Death|0|||
131230068|NCT01387282|472469265|FG000|Overall Study|Other|5|||
131065074|NCT02561195|471868184|FG009|Vaccination 1 to 3|Death|0|||
131065075|NCT02561195|471868185|FG010|Vaccination 1 to 3|Death|0|||
131065076|NCT02561195|471868186|FG011|Vaccination 1 to 3|Death|0|||
131065077|NCT02561195|471868187|FG012|Vaccination 1 to 3|Death|0|||
131065078|NCT02561195|471868188|FG013|Vaccination 1 to 3|Death|0|||
131065079|NCT02561195|471868175|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
131065080|NCT02561195|471868176|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
131230069|NCT01387282|472469266|FG001|Overall Study|Other|1|||
131230070|NCT01387282|472469265|FG000|Overall Study|Unrelated AE|6|||
131230071|NCT01387282|472469266|FG001|Overall Study|Unrelated AE|4|||
131065081|NCT02561195|471868177|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
131065082|NCT02561195|471868178|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
131065083|NCT02561195|471868179|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
131065084|NCT02561195|471868180|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
131065085|NCT02561195|471868181|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
131065086|NCT02561195|471868182|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
131065087|NCT02561195|471868183|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
131065088|NCT02561195|471868184|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
131230072|NCT01387282|472469265|FG000|Overall Study|Withdrawal by patient|33|||
131065089|NCT02561195|471868185|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
131065090|NCT02561195|471868186|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
131065091|NCT02561195|471868187|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
131065092|NCT02561195|471868188|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
131065093|NCT02561195|471868175|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
131065094|NCT02561195|471868176|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
131065095|NCT02561195|471868177|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
131065096|NCT02561195|471868178|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
131065097|NCT02561195|471868179|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
131065098|NCT02561195|471868180|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
131065099|NCT02561195|471868181|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
131065100|NCT02561195|471868182|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
131065101|NCT02561195|471868183|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
131065102|NCT02561195|471868184|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
131065103|NCT02561195|471868185|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
131065104|NCT02561195|471868186|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
131065105|NCT02561195|471868187|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
131065106|NCT02561195|471868188|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
131065107|NCT02561195|471868175|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131065108|NCT02561195|471868176|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131065109|NCT02561195|471868177|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131065110|NCT02561195|471868178|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131065111|NCT02561195|471868179|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131065112|NCT02561195|471868180|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131065113|NCT02561195|471868181|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131065114|NCT02561195|471868182|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131065115|NCT02561195|471868183|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
131065116|NCT02561195|471868184|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
131065117|NCT02561195|471868185|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
131065118|NCT02561195|471868186|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
131065119|NCT02561195|471868187|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
131065120|NCT02561195|471868188|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
131065121|NCT02561195|471868175|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065122|NCT02561195|471868176|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065123|NCT02561195|471868177|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065124|NCT02561195|471868178|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065125|NCT02561195|471868179|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065126|NCT02561195|471868180|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065127|NCT02561195|471868181|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065128|NCT02561195|471868182|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065129|NCT02561195|471868183|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065130|NCT02561195|471868184|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065131|NCT02561195|471868185|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065132|NCT02561195|471868186|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065133|NCT02561195|471868187|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
131065134|NCT02561195|471868188|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
131065135|NCT02561195|471868175|FG000|Extension Stage (Vaccination 4)|Death|0|||
131065136|NCT02561195|471868176|FG001|Extension Stage (Vaccination 4)|Death|0|||
131065137|NCT02561195|471868177|FG002|Extension Stage (Vaccination 4)|Death|0|||
131065138|NCT02561195|471868178|FG003|Extension Stage (Vaccination 4)|Death|0|||
131065139|NCT02561195|471868179|FG004|Extension Stage (Vaccination 4)|Death|0|||
131065140|NCT02561195|471868180|FG005|Extension Stage (Vaccination 4)|Death|0|||
131065141|NCT02561195|471868181|FG006|Extension Stage (Vaccination 4)|Death|0|||
131065142|NCT02561195|471868182|FG007|Extension Stage (Vaccination 4)|Death|0|||
131065143|NCT02561195|471868183|FG008|Extension Stage (Vaccination 4)|Death|0|||
131065144|NCT02561195|471868184|FG009|Extension Stage (Vaccination 4)|Death|1|||
131065145|NCT02561195|471868185|FG010|Extension Stage (Vaccination 4)|Death|0|||
131065146|NCT02561195|471868186|FG011|Extension Stage (Vaccination 4)|Death|0|||
131065147|NCT02561195|471868187|FG012|Extension Stage (Vaccination 4)|Death|0|||
131065148|NCT02561195|471868188|FG013|Extension Stage (Vaccination 4)|Death|0|||
131065149|NCT02561195|471868175|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131065150|NCT02561195|471868176|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131137566|NCT00756938|472130670|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
131137567|NCT00756938|472130667|FG000|12-week Base Study|Protocol Violation|0|||
131137568|NCT00756938|472130668|FG001|12-week Base Study|Protocol Violation|0|||
131137569|NCT00756938|472130669|FG002|12-week Base Study|Protocol Violation|1|||
131137570|NCT00756938|472130670|FG003|12-week Base Study|Protocol Violation|0|||
131137571|NCT00756938|472130667|FG000|12-week Base Study|Lost to Follow-up|1|||
131230073|NCT01387282|472469266|FG001|Overall Study|Withdrawal by patient|23|||
131137572|NCT00756938|472130668|FG001|12-week Base Study|Lost to Follow-up|0|||
131137573|NCT00756938|472130669|FG002|12-week Base Study|Lost to Follow-up|0|||
131137574|NCT00756938|472130670|FG003|12-week Base Study|Lost to Follow-up|0|||
131065151|NCT02561195|471868177|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131065152|NCT02561195|471868178|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131065153|NCT02561195|471868179|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131065154|NCT02561195|471868180|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131065155|NCT02561195|471868181|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
131065156|NCT02561195|471868182|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
131065157|NCT02561195|471868183|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131065158|NCT02561195|471868184|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
131065159|NCT02561195|471868185|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
131065160|NCT02561195|471868186|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
131065161|NCT02561195|471868187|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
131065162|NCT02561195|471868188|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
131065163|NCT02561195|471868175|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065164|NCT02561195|471868176|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065165|NCT02561195|471868177|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065166|NCT02561195|471868178|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065167|NCT02561195|471868179|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065168|NCT02561195|471868180|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065169|NCT02561195|471868181|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065170|NCT02561195|471868182|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065171|NCT02561195|471868183|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065172|NCT02561195|471868184|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065173|NCT02561195|471868185|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
131065174|NCT02561195|471868186|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
131065175|NCT02561195|471868187|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
131065176|NCT02561195|471868188|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
131065177|NCT02561195|471868175|FG000|Extension Stage (Vaccination 4)|Other|0|||
131065178|NCT02561195|471868176|FG001|Extension Stage (Vaccination 4)|Other|0|||
131065179|NCT02561195|471868177|FG002|Extension Stage (Vaccination 4)|Other|0|||
131065180|NCT02561195|471868178|FG003|Extension Stage (Vaccination 4)|Other|0|||
131065181|NCT02561195|471868179|FG004|Extension Stage (Vaccination 4)|Other|0|||
131065182|NCT02561195|471868180|FG005|Extension Stage (Vaccination 4)|Other|0|||
131065183|NCT02561195|471868181|FG006|Extension Stage (Vaccination 4)|Other|0|||
131065184|NCT02561195|471868182|FG007|Extension Stage (Vaccination 4)|Other|0|||
131065185|NCT02561195|471868183|FG008|Extension Stage (Vaccination 4)|Other|0|||
131065186|NCT02561195|471868184|FG009|Extension Stage (Vaccination 4)|Other|0|||
131065187|NCT02561195|471868185|FG010|Extension Stage (Vaccination 4)|Other|2|||
131065188|NCT02561195|471868186|FG011|Extension Stage (Vaccination 4)|Other|2|||
131065189|NCT02561195|471868187|FG012|Extension Stage (Vaccination 4)|Other|1|||
131065190|NCT02561195|471868188|FG013|Extension Stage (Vaccination 4)|Other|0|||
131065191|NCT02561195|471868175|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131065192|NCT02561195|471868176|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131065193|NCT02561195|471868177|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131065194|NCT02561195|471868178|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131065195|NCT02561195|471868179|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131065196|NCT02561195|471868180|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131065197|NCT02561195|471868181|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
130723142|NCT01696279|470611348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
130723143|NCT01696279|470611345|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
130723144|NCT01696279|470611346|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
130723145|NCT01696279|470611347|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
130723146|NCT01696279|470611348|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
130723147|NCT01696279|470611345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
130723148|NCT01696279|470611346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
130723149|NCT01696279|470611347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
130779422|NCT02326272|470819494|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130779423|NCT02326272|470819495|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131065198|NCT02561195|471868182|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131065199|NCT02561195|471868183|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131065200|NCT02561195|471868184|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131065201|NCT02561195|471868185|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
131065202|NCT02561195|471868186|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
131065203|NCT02561195|471868187|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
131065204|NCT02561195|471868188|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
131230074|NCT01387282|472469265|FG000|Overall Study|Study drug-related AE|2|||
131230075|NCT01387282|472469266|FG001|Overall Study|Study drug-related AE|2|||
131065205|NCT03905512|471868189|FG000|Overall Study|Withdrawal by Subject|9|||
131065206|NCT03905512|471868190|FG001|Overall Study|Withdrawal by Subject|8|||
131065207|NCT03905512|471868189|FG000|Overall Study|Adverse Event|1|||
131065208|NCT03905512|471868190|FG001|Overall Study|Adverse Event|2|||
131065209|NCT03905512|471868189|FG000|Overall Study|Lost to Follow-up|4|||
131065210|NCT03905512|471868190|FG001|Overall Study|Lost to Follow-up|3|||
131065211|NCT03905512|471868189|FG000|Overall Study|Other than Specified|7|||
131065212|NCT03905512|471868190|FG001|Overall Study|Other than Specified|4|||
131065213|NCT03547167|471868193|FG000|Overall Study|Withdrawal by Subject|34|||
131065214|NCT03547167|471868194|FG001|Overall Study|Withdrawal by Subject|12|||
131065215|NCT03547167|471868193|FG000|Overall Study|Screen Failure|0|||
131065216|NCT03547167|471868194|FG001|Overall Study|Screen Failure|1|||
131065217|NCT03547167|471868193|FG000|Overall Study|Lost to Follow-up|59|||
131065218|NCT03547167|471868194|FG001|Overall Study|Lost to Follow-up|15|||
131065219|NCT03547167|471868193|FG000|Overall Study|Death|4|||
131065220|NCT03547167|471868194|FG001|Overall Study|Death|2|||
131065221|NCT00866619|471868195|FG000|Overall Study|Adverse Event|112|||
131065222|NCT00866619|471868196|FG001|Overall Study|Adverse Event|106|||
131065223|NCT00866619|471868197|FG002|Overall Study|Adverse Event|47|||
131065224|NCT00866619|471868198|FG003|Overall Study|Adverse Event|44|||
131065225|NCT00866619|471868195|FG000|Overall Study|Protocol Violation|2|||
131065226|NCT00866619|471868196|FG001|Overall Study|Protocol Violation|39|||
131065227|NCT00866619|471868197|FG002|Overall Study|Protocol Violation|2|||
131065228|NCT00866619|471868198|FG003|Overall Study|Protocol Violation|17|||
131065229|NCT00866619|471868195|FG000|Overall Study|Withdrawal by Subject|587|||
131065230|NCT00866619|471868196|FG001|Overall Study|Withdrawal by Subject|295|||
131065231|NCT00866619|471868197|FG002|Overall Study|Withdrawal by Subject|272|||
131065232|NCT00866619|471868198|FG003|Overall Study|Withdrawal by Subject|144|||
131065233|NCT00866619|471868195|FG000|Overall Study|Lost to Follow-up|1145|||
131065234|NCT00866619|471868196|FG001|Overall Study|Lost to Follow-up|830|||
131065235|NCT00866619|471868197|FG002|Overall Study|Lost to Follow-up|568|||
131065236|NCT00866619|471868198|FG003|Overall Study|Lost to Follow-up|425|||
131065237|NCT00645411|471868199|FG000|Overall Study|Adverse Event|0|||
131065238|NCT00645411|471868200|FG001|Overall Study|Adverse Event|0|||
131065239|NCT00645411|471868201|FG002|Overall Study|Adverse Event|0|||
131065240|NCT00645411|471868202|FG003|Overall Study|Adverse Event|2|||
131065241|NCT00645411|471868199|FG000|Overall Study|Withdrawal by Subject|2|||
131065242|NCT00645411|471868200|FG001|Overall Study|Withdrawal by Subject|1|||
131065243|NCT00645411|471868201|FG002|Overall Study|Withdrawal by Subject|19|||
131065244|NCT00645411|471868202|FG003|Overall Study|Withdrawal by Subject|21|||
131065245|NCT00645411|471868199|FG000|Overall Study|Lost to Follow-up|10|||
131065246|NCT00645411|471868200|FG001|Overall Study|Lost to Follow-up|5|||
131065247|NCT00645411|471868201|FG002|Overall Study|Lost to Follow-up|124|||
131065248|NCT00645411|471868202|FG003|Overall Study|Lost to Follow-up|75|||
131065249|NCT00645411|471868199|FG000|Overall Study|Protocol Violation|1|||
131065250|NCT00645411|471868200|FG001|Overall Study|Protocol Violation|0|||
131065251|NCT00645411|471868201|FG002|Overall Study|Protocol Violation|1|||
131065252|NCT00645411|471868202|FG003|Overall Study|Protocol Violation|0|||
131065253|NCT00645411|471868199|FG000|Overall Study|Inappropriate enrollment|0|||
131065254|NCT00645411|471868200|FG001|Overall Study|Inappropriate enrollment|0|||
131065255|NCT00645411|471868201|FG002|Overall Study|Inappropriate enrollment|4|||
131065256|NCT00645411|471868202|FG003|Overall Study|Inappropriate enrollment|1|||
131065257|NCT00645411|471868199|FG000|Overall Study|Unable to classify|0|||
131065258|NCT00645411|471868200|FG001|Overall Study|Unable to classify|0|||
131065259|NCT00645411|471868201|FG002|Overall Study|Unable to classify|3|||
131065260|NCT00645411|471868202|FG003|Overall Study|Unable to classify|4|||
131065261|NCT02138838|471868205|FG000|Overall Study|Study Closure|7|||
131065262|NCT02138838|471868206|FG001|Overall Study|Study Closure|6|||
131065263|NCT02138838|471868205|FG000|Overall Study|Withdrawal by Subject|1|||
131065264|NCT02138838|471868206|FG001|Overall Study|Withdrawal by Subject|5|||
131065265|NCT00518206|471868207|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
131065266|NCT00518206|471868208|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
131065267|NCT00518206|471868207|FG000|Overall Study|Withdrawal by Subject|2|||
131065268|NCT00518206|471868208|FG001|Overall Study|Withdrawal by Subject|0|||
131065269|NCT00518206|471868207|FG000|Overall Study|Drug Supply Issue|1|||
131230076|NCT01387282|472469265|FG000|Overall Study|Lost to Follow-up|4|||
131065270|NCT00518206|471868208|FG001|Overall Study|Drug Supply Issue|0|||
131065271|NCT00518206|471868207|FG000|Overall Study|Reason Unknown|1|||
131065272|NCT00518206|471868208|FG001|Overall Study|Reason Unknown|0|||
131065273|NCT00518206|471868207|FG000|Overall Study|Completion Status Unknown|1|||
131065274|NCT00518206|471868208|FG001|Overall Study|Completion Status Unknown|0|||
131065275|NCT00760877|471869400|FG000|Overall Study|Protocol Violation|1|||
131065276|NCT00760877|471869401|FG001|Overall Study|Protocol Violation|0|||
131065277|NCT00760877|471869400|FG000|Overall Study|Non-compliance with protocol treatment|2|||
131065278|NCT00760877|471869401|FG001|Overall Study|Non-compliance with protocol treatment|1|||
131065279|NCT00760877|471869400|FG000|Overall Study|Pregnancy|1|||
131065280|NCT00760877|471869401|FG001|Overall Study|Pregnancy|4|||
131065281|NCT00760877|471869400|FG000|Overall Study|Death|2|||
131065282|NCT00760877|471869401|FG001|Overall Study|Death|1|||
131065283|NCT00760877|471869400|FG000|Overall Study|Withdrawal by Subject|7|||
131065284|NCT00760877|471869401|FG001|Overall Study|Withdrawal by Subject|3|||
131065285|NCT00760877|471869400|FG000|Overall Study|Adverse Event|19|||
131065286|NCT00760877|471869401|FG001|Overall Study|Adverse Event|12|||
131065287|NCT00760877|471869400|FG000|Overall Study|Participant diagnosed with AML|0|||
131065288|NCT00760877|471869401|FG001|Overall Study|Participant diagnosed with AML|1|||
131065289|NCT00760877|471869400|FG000|Overall Study|Participant not eligible to cross-over|0|||
131065290|NCT00760877|471869401|FG001|Overall Study|Participant not eligible to cross-over|1|||
131065291|NCT00760877|471869400|FG000|Overall Study|Physician Decision|1|||
131065292|NCT00760877|471869401|FG001|Overall Study|Physician Decision|2|||
131065293|NCT00760877|471869400|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
131065294|NCT00760877|471869401|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
131065295|NCT00760877|471869400|FG000|Overall Study|Treatment failure|1|||
131065296|NCT00760877|471869401|FG001|Overall Study|Treatment failure|0|||
131065297|NCT00711555|471869402|FG000|Overall Study|Adverse Event|3|||
131065298|NCT05379400|471869406|FG000|Overall Study|Lost to Follow-up|1|||
131065299|NCT05379400|471869407|FG001|Overall Study|Lost to Follow-up|1|||
131065300|NCT05356130|471869409|FG000|Overall Study|Withdrawal by Subject|0|||
131065301|NCT05356130|471869410|FG001|Overall Study|Withdrawal by Subject|0|||
131065302|NCT05356130|471869411|FG002|Overall Study|Withdrawal by Subject|3|||
131065303|NCT03141177|471869412|FG000|Overall Study|Death|62|||
131065304|NCT03141177|471869413|FG001|Overall Study|Death|13|||
131065305|NCT03141177|471869414|FG002|Overall Study|Death|84|||
131065306|NCT03141177|471869412|FG000|Overall Study|Participant withdrew consent|9|||
131065307|NCT03141177|471869413|FG001|Overall Study|Participant withdrew consent|2|||
131065308|NCT03141177|471869414|FG002|Overall Study|Participant withdrew consent|13|||
131065309|NCT03141177|471869412|FG000|Overall Study|Not reported|1|||
131065310|NCT03141177|471869413|FG001|Overall Study|Not reported|0|||
131065311|NCT03141177|471869414|FG002|Overall Study|Not reported|1|||
131065312|NCT03141177|471869412|FG000|Overall Study|Lost to Follow-up|2|||
131065313|NCT03141177|471869413|FG001|Overall Study|Lost to Follow-up|1|||
131065314|NCT03141177|471869414|FG002|Overall Study|Lost to Follow-up|1|||
131065315|NCT03141177|471869412|FG000|Overall Study|Other reasons|4|||
131065316|NCT03141177|471869413|FG001|Overall Study|Other reasons|0|||
131065317|NCT03141177|471869414|FG002|Overall Study|Other reasons|11|||
131065318|NCT03141177|471869412|FG000|Overall Study|Participants did not start treatment period|3|||
131065319|NCT03141177|471869413|FG001|Overall Study|Participants did not start treatment period|0|||
131065320|NCT03141177|471869414|FG002|Overall Study|Participants did not start treatment period|8|||
131065321|NCT00228813|471869419|FG000|Overall Study|Death|4|||
131065322|NCT03409276|471869425|FG000|Overall Study|Withdrawal by Subject|0|||
131065323|NCT03409276|471869426|FG001|Overall Study|Withdrawal by Subject|0|||
131065324|NCT03409276|471869427|FG002|Overall Study|Withdrawal by Subject|0|||
131065325|NCT03409276|471869428|FG003|Overall Study|Withdrawal by Subject|0|||
131065326|NCT03409276|471869429|FG004|Overall Study|Withdrawal by Subject|1|||
131065327|NCT03409276|471869425|FG000|Overall Study|Lost to Follow-up|0|||
131065328|NCT03409276|471869426|FG001|Overall Study|Lost to Follow-up|0|||
131065329|NCT03409276|471869427|FG002|Overall Study|Lost to Follow-up|0|||
131065330|NCT03409276|471869428|FG003|Overall Study|Lost to Follow-up|2|||
131065331|NCT03409276|471869429|FG004|Overall Study|Lost to Follow-up|2|||
131065332|NCT05361304|471869436|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
131065333|NCT05361304|471869437|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
131065334|NCT05361304|471869436|FG000|Overall Study|COVID-19 Related|1|||
131065335|NCT05361304|471869437|FG001|Overall Study|COVID-19 Related|2|||
131065336|NCT05361304|471869436|FG000|Overall Study|Withdrawal by Subject|1|||
131065337|NCT05361304|471869437|FG001|Overall Study|Withdrawal by Subject|0|||
131065338|NCT01816165|471869438|FG000|Overall Study|Adverse Event|1|||
131065339|NCT01816165|471869439|FG001|Overall Study|Adverse Event|0|||
131137575|NCT00756938|472130667|FG000|Optional Extension|Lack of Efficacy|0|||
131137576|NCT00756938|472130668|FG001|Optional Extension|Lack of Efficacy|0|||
131137577|NCT00756938|472130669|FG002|Optional Extension|Lack of Efficacy|0|||
131137578|NCT00756938|472130670|FG003|Optional Extension|Lack of Efficacy|1|||
131065340|NCT01816165|471869440|FG002|Overall Study|Adverse Event|0|||
131065341|NCT01816165|471869441|FG003|Overall Study|Adverse Event|0|||
131137579|NCT00756938|472130667|FG000|Optional Extension|End of Study|0|||
131137580|NCT00756938|472130668|FG001|Optional Extension|End of Study|0|||
131137581|NCT00756938|472130669|FG002|Optional Extension|End of Study|0|||
130723150|NCT01696279|470611348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
130723151|NCT01696279|470611345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
131065342|NCT00946088|471869442|FG000|Overall Study|Withdrawal by Subject|0|||
131065343|NCT00946088|471869443|FG001|Overall Study|Withdrawal by Subject|1|||
131065344|NCT04883541|471869444|FG000|Overall Study|Not attending regular yoga class|16|||
131065345|NCT04883541|471869445|FG001|Overall Study|Not attending regular yoga class|0|||
131065346|NCT04883541|471869444|FG000|Overall Study|Not attending the pregnancy school|0|||
131137582|NCT00756938|472130670|FG003|Optional Extension|End of Study|11|||
131137583|NCT00756938|472130667|FG000|Optional Extension|Protocol-specific criteria met|0|||
131065347|NCT04883541|471869445|FG001|Overall Study|Not attending the pregnancy school|9|||
131065348|NCT04239911|471869446|FG000|Overall Study|Lost to Follow-up|2|||
131065349|NCT04239911|471869447|FG001|Overall Study|Lost to Follow-up|1|||
131065350|NCT02092909|471869455|FG000|Overall Study|Adverse Event|0|||
131065351|NCT02092909|471869456|FG001|Overall Study|Adverse Event|0|||
131065352|NCT02092909|471869457|FG002|Overall Study|Adverse Event|4|||
131065353|NCT02092909|471869458|FG003|Overall Study|Adverse Event|2|||
131065354|NCT02092909|471869455|FG000|Overall Study|Lack of Efficacy|0|||
131065355|NCT02092909|471869456|FG001|Overall Study|Lack of Efficacy|2|||
131065356|NCT02092909|471869457|FG002|Overall Study|Lack of Efficacy|1|||
131065357|NCT02092909|471869458|FG003|Overall Study|Lack of Efficacy|0|||
131065358|NCT02092909|471869455|FG000|Overall Study|Withdrawal by Subject|0|||
130723152|NCT01696279|470611346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
130723153|NCT01696279|470611347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
131065359|NCT02092909|471869456|FG001|Overall Study|Withdrawal by Subject|0|||
131065360|NCT02092909|471869457|FG002|Overall Study|Withdrawal by Subject|2|||
131065361|NCT02092909|471869458|FG003|Overall Study|Withdrawal by Subject|1|||
131065362|NCT02092909|471869455|FG000|Overall Study|Study terminated by Sponsor|0|||
131065363|NCT02092909|471869456|FG001|Overall Study|Study terminated by Sponsor|0|||
131065364|NCT02092909|471869457|FG002|Overall Study|Study terminated by Sponsor|0|||
131065365|NCT02092909|471869458|FG003|Overall Study|Study terminated by Sponsor|2|||
131065366|NCT02092909|471869455|FG000|Overall Study|Miscellaneous|1|||
131065367|NCT02092909|471869456|FG001|Overall Study|Miscellaneous|1|||
131065368|NCT02092909|471869457|FG002|Overall Study|Miscellaneous|2|||
131065369|NCT02092909|471869458|FG003|Overall Study|Miscellaneous|1|||
131065370|NCT05072795|471869459|FG000|Overall Study|Lost to Follow-up|5|||
131065371|NCT01124916|471869465|FG000|Overall Study|Lost to Follow-up|3|||
131065372|NCT01124916|471869466|FG001|Overall Study|Lost to Follow-up|2|||
131065373|NCT01901302|471869467|FG000|Overall Study|Adverse Event|2|||
131065374|NCT01901302|471869468|FG001|Overall Study|Adverse Event|1|||
131065375|NCT01901302|471869467|FG000|Overall Study|Lack of Efficacy|0|||
131065376|NCT01901302|471869468|FG001|Overall Study|Lack of Efficacy|2|||
131065377|NCT01901302|471869467|FG000|Overall Study|Study Terminated by Sponsor|23|||
131065378|NCT01901302|471869468|FG001|Overall Study|Study Terminated by Sponsor|20|||
131065379|NCT01901302|471869467|FG000|Overall Study|Withdrawal by Subject|2|||
131065380|NCT01901302|471869468|FG001|Overall Study|Withdrawal by Subject|0|||
131065381|NCT00901459|471869477|FG000|Overall Study|Withdrawal by Subject|6|||
131065382|NCT04765046|471869478|FG000|Overall Study|Screen Failure|2|||
131065383|NCT04765046|471869478|FG000|Overall Study|Withdrawal by Subject|4|||
131065384|NCT04765046|471869478|FG000|Overall Study|Physician Decision|4|||
131065385|NCT04765046|471869478|FG000|Overall Study|Surgery Cancelled|8|||
131065386|NCT00753896|471869480|FG000|Overall Study|Adverse Event|4|||
131065387|NCT00753896|471869480|FG000|Overall Study|Death|1|||
131065388|NCT00753896|471869480|FG000|Overall Study|Lost to Follow-up|2|||
131065389|NCT00753896|471869480|FG000|Overall Study|Protocol Violation|1|||
131065390|NCT00753896|471869480|FG000|Overall Study|Withdrawal by Subject|4|||
131065391|NCT00753896|471869480|FG000|Overall Study|Entry Criteria Not Met|4|||
131065392|NCT00848198|471869482|FG000|Overall Study|Incomplete Case Report Forms|15|||
131065393|NCT03529942|471869486|FG000|Overall Study|Withdrawal by Subject|13|||
131065394|NCT03529942|471869486|FG000|Overall Study|Physician Decision|1|||
131065395|NCT03529942|471869486|FG000|Overall Study|Lost to Follow-up|7|||
131065396|NCT03529942|471869486|FG000|Overall Study|Needle inserted but no drug administered|1|||
131065397|NCT03529942|471869486|FG000|Overall Study|Personal reasons|1|||
131065398|NCT04930263|471869487|FG000|Overall Study|Withdrawal by Subject|3|||
131065399|NCT04930263|471869488|FG001|Overall Study|Withdrawal by Subject|5|||
131065400|NCT01699178|471869490|FG000|Overall Study|Adverse Event|1|||
131065401|NCT01699178|471869491|FG001|Overall Study|Adverse Event|5|||
131065402|NCT01699178|471869490|FG000|Overall Study|Lost to Follow-up|1|||
131065403|NCT01699178|471869491|FG001|Overall Study|Lost to Follow-up|6|||
131065404|NCT01699178|471869490|FG000|Overall Study|Non-compliance with Study Drug|3|||
131065405|NCT01699178|471869491|FG001|Overall Study|Non-compliance with Study Drug|1|||
131065406|NCT01699178|471869490|FG000|Overall Study|Physician Decision|1|||
131065407|NCT01699178|471869491|FG001|Overall Study|Physician Decision|0|||
131065408|NCT01699178|471869490|FG000|Overall Study|Withdrawal by Subject|4|||
131065409|NCT01699178|471869491|FG001|Overall Study|Withdrawal by Subject|12|||
131065410|NCT01699178|471869490|FG000|Overall Study|Hematocrit >54%|1|||
131065411|NCT01699178|471869491|FG001|Overall Study|Hematocrit >54%|1|||
131065412|NCT01699178|471869490|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
131065413|NCT01699178|471869491|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
131065414|NCT01699178|471869490|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
131065415|NCT01699178|471869491|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
131065416|NCT01755598|471869494|FG000|Overall Study|Other|109|||
131065417|NCT01755598|471869495|FG001|Overall Study|Other|109|||
131065418|NCT01755598|471869494|FG000|Overall Study|Lost to Follow-up|32|||
131065419|NCT01755598|471869495|FG001|Overall Study|Lost to Follow-up|43|||
131065420|NCT01755598|471869494|FG000|Overall Study|Migrated/moved from study area|76|||
131065421|NCT01755598|471869495|FG001|Overall Study|Migrated/moved from study area|65|||
131065422|NCT01755598|471869494|FG000|Overall Study|Withdrawal by Subject|22|||
131065423|NCT01755598|471869495|FG001|Overall Study|Withdrawal by Subject|31|||
131065424|NCT01755598|471869494|FG000|Overall Study|Protocol Violation|7|||
131065425|NCT01755598|471869495|FG001|Overall Study|Protocol Violation|7|||
131065426|NCT01755598|471869494|FG000|Overall Study|Adverse Event|19|||
131065427|NCT01755598|471869495|FG001|Overall Study|Adverse Event|28|||
131065428|NCT03560206|471869499|FG000|Overall Study|Lost to Follow-up|19|||
131065429|NCT03560206|471869500|FG001|Overall Study|Lost to Follow-up|11|||
131065430|NCT03560206|471869499|FG000|Overall Study|Withdrawal by Subject|2|||
131065431|NCT03560206|471869500|FG001|Overall Study|Withdrawal by Subject|4|||
131065432|NCT03560206|471869499|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
131065433|NCT03560206|471869500|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
131065434|NCT03560206|471869499|FG000|Overall Study|Busy schedule|14|||
131065435|NCT03560206|471869500|FG001|Overall Study|Busy schedule|2|||
131065436|NCT03560206|471869499|FG000|Overall Study|patients' new health condition such as cancer|10|||
131065437|NCT03560206|471869500|FG001|Overall Study|patients' new health condition such as cancer|1|||
131065438|NCT03987074|471869501|FG000|Overall Study|Withdrew Consent|1|||
131065439|NCT03987074|471869502|FG001|Overall Study|Withdrew Consent|1|||
131065440|NCT03987074|471869503|FG002|Overall Study|Withdrew Consent|0|||
131065441|NCT03987074|471869504|FG003|Overall Study|Withdrew Consent|2|||
131065442|NCT03987074|471869505|FG004|Overall Study|Withdrew Consent|1|||
131065443|NCT03987074|471869501|FG000|Overall Study|Adverse Event|2|||
131065444|NCT03987074|471869502|FG001|Overall Study|Adverse Event|1|||
131065445|NCT03987074|471869503|FG002|Overall Study|Adverse Event|0|||
131065446|NCT03987074|471869504|FG003|Overall Study|Adverse Event|0|||
131065447|NCT03987074|471869505|FG004|Overall Study|Adverse Event|1|||
131065448|NCT03987074|471869501|FG000|Overall Study|Lost to Follow-up|0|||
131065449|NCT03987074|471869502|FG001|Overall Study|Lost to Follow-up|0|||
131065450|NCT03987074|471869503|FG002|Overall Study|Lost to Follow-up|1|||
131065451|NCT03987074|471869504|FG003|Overall Study|Lost to Follow-up|1|||
131065452|NCT03987074|471869505|FG004|Overall Study|Lost to Follow-up|0|||
131065453|NCT03987074|471869501|FG000|Overall Study|Investigator's Discretion|0|||
131065454|NCT03987074|471869502|FG001|Overall Study|Investigator's Discretion|0|||
131065455|NCT03987074|471869503|FG002|Overall Study|Investigator's Discretion|0|||
131065456|NCT03987074|471869504|FG003|Overall Study|Investigator's Discretion|1|||
131065457|NCT03987074|471869505|FG004|Overall Study|Investigator's Discretion|0|||
131065458|NCT01334606|471869508|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
131065459|NCT02674399|471869509|FG000|Overall Study|Lost to Follow-up|2|||
131065460|NCT02674399|471869510|FG001|Overall Study|Lost to Follow-up|0|||
131065461|NCT02993926|471869513|FG000|Enantone Treatment Phase|Adverse Event|1|||
131065462|NCT02993926|471869514|FG001|Enantone Treatment Phase|Adverse Event|0|||
131065463|NCT02993926|471869515|FG002|Enantone Treatment Phase|Adverse Event|0|||
131065464|NCT02993926|471869513|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
131065465|NCT02993926|471869514|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
131065466|NCT02993926|471869515|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
131065467|NCT02993926|471869513|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
131065468|NCT02993926|471869514|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
131065469|NCT02993926|471869515|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
131065470|NCT02993926|471869513|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
131065471|NCT02993926|471869514|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
131065472|NCT02993926|471869515|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
131065473|NCT01084772|471869517|FG000|Baseline|Withdrawal by Subject|7|||
131065474|NCT01084772|471869518|FG001|Baseline|Withdrawal by Subject|6|||
131065475|NCT01084772|471869517|FG000|3 Months|Death|1|||
131065476|NCT01084772|471869518|FG001|3 Months|Death|0|||
131065477|NCT01084772|471869517|FG000|3 Months|Study Termination|2|||
131065478|NCT01084772|471869518|FG001|3 Months|Study Termination|2|||
131065479|NCT01084772|471869517|FG000|1 Year|Withdrawal by Subject|0|||
131065480|NCT01084772|471869518|FG001|1 Year|Withdrawal by Subject|1|||
131065481|NCT01084772|471869517|FG000|1 Year|Lost to Follow-up|3|||
131065482|NCT01084772|471869518|FG001|1 Year|Lost to Follow-up|0|||
131065483|NCT01084772|471869517|FG000|1 Year|Study Termination|0|||
131065484|NCT01084772|471869518|FG001|1 Year|Study Termination|7|||
131065485|NCT01084772|471869517|FG000|2 Years|Withdrawal by Subject|1|||
131065486|NCT01084772|471869518|FG001|2 Years|Withdrawal by Subject|0|||
131065487|NCT01084772|471869517|FG000|2 Years|Lost to Follow-up|5|||
131065488|NCT01084772|471869518|FG001|2 Years|Lost to Follow-up|2|||
131065489|NCT01084772|471869517|FG000|2 Years|Study Termination|3|||
131065490|NCT01084772|471869518|FG001|2 Years|Study Termination|2|||
131065491|NCT01867307|471869519|FG000|Overall Study|Protocol Violation|2|||
131065492|NCT01867307|471869520|FG001|Overall Study|Protocol Violation|0|||
131065493|NCT01867307|471869519|FG000|Overall Study|Other Adverse Event|1|||
131065494|NCT01867307|471869520|FG001|Overall Study|Other Adverse Event|3|||
131065495|NCT02332889|471869532|FG000|Overall Study|Physician Decision|1|||
131065496|NCT04198428|471870803|FG000|Overall Study|Withdrawal by Subject|150|||
131065497|NCT04198428|471870804|FG001|Overall Study|Withdrawal by Subject|156|||
131065498|NCT00668746|471870805|FG000|Overall Study|Lost to Follow-up|2|||
131065499|NCT00668746|471870806|FG001|Overall Study|Lost to Follow-up|1|||
131065500|NCT02109172|471870807|FG000|Overall Study|Withdrawal by Subject|1|||
131065501|NCT02109172|471870808|FG001|Overall Study|Withdrawal by Subject|0|||
131065502|NCT02109172|471870809|FG002|Overall Study|Withdrawal by Subject|0|||
131065503|NCT02109172|471870810|FG003|Overall Study|Withdrawal by Subject|1|||
131065504|NCT02109172|471870811|FG004|Overall Study|Withdrawal by Subject|0|||
131065505|NCT02109172|471870812|FG005|Overall Study|Withdrawal by Subject|0|||
131065506|NCT02109172|471870807|FG000|Overall Study|Adverse Event|0|||
131065507|NCT02109172|471870808|FG001|Overall Study|Adverse Event|0|||
131065508|NCT02109172|471870809|FG002|Overall Study|Adverse Event|1|||
131065509|NCT02109172|471870810|FG003|Overall Study|Adverse Event|0|||
131065510|NCT02109172|471870811|FG004|Overall Study|Adverse Event|0|||
131065511|NCT02109172|471870812|FG005|Overall Study|Adverse Event|1|||
131065512|NCT02109172|471870807|FG000|Overall Study|Death|0|||
131065513|NCT02109172|471870808|FG001|Overall Study|Death|0|||
131065514|NCT02109172|471870809|FG002|Overall Study|Death|0|||
131065515|NCT02109172|471870810|FG003|Overall Study|Death|0|||
131065516|NCT02109172|471870811|FG004|Overall Study|Death|1|||
131065517|NCT02109172|471870812|FG005|Overall Study|Death|0|||
131065518|NCT02409732|471870815|FG000|Overall Study|Withdrawal by Subject|4|||
131065519|NCT02409732|471870815|FG000|Overall Study|Lost to Follow-up|2|||
131065520|NCT03960437|471870819|FG000|Overall Study|Removed by PI|4|||
131065521|NCT03960437|471870819|FG000|Overall Study|Lost to Follow-up|2|||
131065522|NCT03960437|471870819|FG000|Overall Study|Withdrawal by Subject|1|||
131065523|NCT03960437|471870819|FG000|Overall Study|Death|2|||
131065524|NCT00473512|471870820|FG000|Period 1 (Phase 1)|Adverse Event|0|||
131065525|NCT00473512|471870821|FG001|Period 1 (Phase 1)|Adverse Event|0|||
131065526|NCT00473512|471870822|FG002|Period 1 (Phase 1)|Adverse Event|0|||
131065527|NCT00473512|471870823|FG003|Period 1 (Phase 1)|Adverse Event|5|||
131065528|NCT00473512|471870824|FG004|Period 1 (Phase 1)|Adverse Event|0|||
131065529|NCT00473512|471870820|FG000|Period 1 (Phase 1)|Death|0|||
131065530|NCT00473512|471870821|FG001|Period 1 (Phase 1)|Death|0|||
131065531|NCT00473512|471870822|FG002|Period 1 (Phase 1)|Death|0|||
131065532|NCT00473512|471870823|FG003|Period 1 (Phase 1)|Death|1|||
131065533|NCT00473512|471870824|FG004|Period 1 (Phase 1)|Death|0|||
131065534|NCT00473512|471870820|FG000|Period 1 (Phase 1)|Disease Progression|1|||
131065535|NCT00473512|471870821|FG001|Period 1 (Phase 1)|Disease Progression|1|||
131065536|NCT00473512|471870822|FG002|Period 1 (Phase 1)|Disease Progression|0|||
131065537|NCT00473512|471870823|FG003|Period 1 (Phase 1)|Disease Progression|10|||
131065538|NCT00473512|471870824|FG004|Period 1 (Phase 1)|Disease Progression|1|||
131065539|NCT00473512|471870820|FG000|Period 1 (Phase 1)|Other|0|||
131065540|NCT00473512|471870821|FG001|Period 1 (Phase 1)|Other|0|||
131065541|NCT00473512|471870822|FG002|Period 1 (Phase 1)|Other|0|||
131065542|NCT00473512|471870823|FG003|Period 1 (Phase 1)|Other|1|||
131065543|NCT00473512|471870824|FG004|Period 1 (Phase 1)|Other|0|||
131065544|NCT00473512|471870820|FG000|Period 2 (Phase 2)|Adverse Event|0|||
131065545|NCT00473512|471870821|FG001|Period 2 (Phase 2)|Adverse Event|0|||
131065546|NCT00473512|471870822|FG002|Period 2 (Phase 2)|Adverse Event|0|||
131065547|NCT00473512|471870823|FG003|Period 2 (Phase 2)|Adverse Event|1|||
131065548|NCT00473512|471870824|FG004|Period 2 (Phase 2)|Adverse Event|0|||
131065549|NCT00473512|471870820|FG000|Period 2 (Phase 2)|Death|0|||
131065550|NCT00473512|471870821|FG001|Period 2 (Phase 2)|Death|0|||
131065551|NCT00473512|471870822|FG002|Period 2 (Phase 2)|Death|0|||
131065552|NCT00473512|471870823|FG003|Period 2 (Phase 2)|Death|1|||
131065553|NCT00473512|471870824|FG004|Period 2 (Phase 2)|Death|1|||
131065554|NCT00473512|471870820|FG000|Period 2 (Phase 2)|Disease Progression|0|||
131065555|NCT00473512|471870821|FG001|Period 2 (Phase 2)|Disease Progression|2|||
131065556|NCT00473512|471870822|FG002|Period 2 (Phase 2)|Disease Progression|2|||
131065557|NCT00473512|471870823|FG003|Period 2 (Phase 2)|Disease Progression|17|||
131065558|NCT00473512|471870824|FG004|Period 2 (Phase 2)|Disease Progression|1|||
131065559|NCT00473512|471870820|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
131065560|NCT00473512|471870821|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
131065561|NCT00473512|471870822|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
131065562|NCT00473512|471870823|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
131065563|NCT00473512|471870824|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
130779424|NCT02326272|470819496|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131065564|NCT00473512|471870820|FG000|Period 2 (Phase 2)|Other|1|||
131065565|NCT00473512|471870821|FG001|Period 2 (Phase 2)|Other|0|||
131065566|NCT00473512|471870822|FG002|Period 2 (Phase 2)|Other|0|||
131065567|NCT00473512|471870823|FG003|Period 2 (Phase 2)|Other|3|||
131065568|NCT00473512|471870824|FG004|Period 2 (Phase 2)|Other|0|||
131065569|NCT00267956|471870825|FG000|Controlled Period|Adverse Event|4|||
131065570|NCT00267956|471870826|FG001|Controlled Period|Adverse Event|1|||
131065571|NCT00267956|471870827|FG002|Controlled Period|Adverse Event|0|||
131137584|NCT00756938|472130668|FG001|Optional Extension|Protocol-specific criteria met|0|||
131065572|NCT00267956|471870828|FG003|Controlled Period|Adverse Event|0|||
131065573|NCT00267956|471870825|FG000|Controlled Period|Lack of Efficacy|4|||
131065574|NCT00267956|471870826|FG001|Controlled Period|Lack of Efficacy|2|||
131065575|NCT00267956|471870827|FG002|Controlled Period|Lack of Efficacy|0|||
131065576|NCT00267956|471870828|FG003|Controlled Period|Lack of Efficacy|0|||
131065577|NCT00267956|471870825|FG000|Controlled Period|Lost to Follow-up|2|||
131065578|NCT00267956|471870826|FG001|Controlled Period|Lost to Follow-up|0|||
131065579|NCT00267956|471870827|FG002|Controlled Period|Lost to Follow-up|0|||
131065580|NCT00267956|471870828|FG003|Controlled Period|Lost to Follow-up|0|||
131065581|NCT00267956|471870825|FG000|Controlled Period|Withdrew consent|3|||
131065582|NCT00267956|471870826|FG001|Controlled Period|Withdrew consent|1|||
131065583|NCT00267956|471870827|FG002|Controlled Period|Withdrew consent|0|||
131065584|NCT00267956|471870828|FG003|Controlled Period|Withdrew consent|0|||
131065585|NCT00267956|471870825|FG000|After Controlled Period|Adverse Event|0|||
131065586|NCT00267956|471870826|FG001|After Controlled Period|Adverse Event|0|||
131065587|NCT00267956|471870827|FG002|After Controlled Period|Adverse Event|2|||
131065588|NCT00267956|471870828|FG003|After Controlled Period|Adverse Event|1|||
131065589|NCT00267956|471870825|FG000|After Controlled Period|Lack of Efficacy|0|||
131065590|NCT00267956|471870826|FG001|After Controlled Period|Lack of Efficacy|0|||
131065591|NCT00267956|471870827|FG002|After Controlled Period|Lack of Efficacy|1|||
131065592|NCT00267956|471870828|FG003|After Controlled Period|Lack of Efficacy|1|||
131065593|NCT00267956|471870825|FG000|After Controlled Period|Lost to Follow-up|0|||
131065594|NCT00267956|471870826|FG001|After Controlled Period|Lost to Follow-up|0|||
131065595|NCT00267956|471870827|FG002|After Controlled Period|Lost to Follow-up|1|||
131065596|NCT00267956|471870828|FG003|After Controlled Period|Lost to Follow-up|0|||
131065597|NCT00267956|471870825|FG000|After Controlled Period|Withdrew consent|0|||
131065598|NCT00267956|471870826|FG001|After Controlled Period|Withdrew consent|0|||
131065599|NCT00267956|471870827|FG002|After Controlled Period|Withdrew consent|1|||
131065600|NCT00267956|471870828|FG003|After Controlled Period|Withdrew consent|0|||
131065601|NCT01263223|471870829|FG000|Period 2|Withdrawal by Subject|0|||
131065602|NCT01263223|471870830|FG001|Period 2|Withdrawal by Subject|1|||
131065603|NCT01263223|471870829|FG000|7-day Follow-up|Withdrawal by Subject|0|||
131065604|NCT01263223|471870830|FG001|7-day Follow-up|Withdrawal by Subject|1|||
131065605|NCT01263223|471870829|FG000|7-day Follow-up|Lost to Follow-up|1|||
131065606|NCT01263223|471870830|FG001|7-day Follow-up|Lost to Follow-up|0|||
131065607|NCT02246647|471870831|FG000|Overall Study|Withdrawal by Subject|1|||
131065608|NCT02246647|471870832|FG001|Overall Study|Withdrawal by Subject|1|||
131065609|NCT03557307|471870833|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
131065610|NCT03557307|471870833|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
131065611|NCT03557307|471870833|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
131065612|NCT03557307|471870833|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
131065613|NCT03557307|471870833|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
131065614|NCT03557307|471870833|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
131065615|NCT03557307|471870833|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
131065616|NCT03557307|471870833|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
131065617|NCT03557307|471870833|FG000|Period 2: Maintenance Phase|Death|3|||
131065618|NCT03557307|471870833|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
131065619|NCT03557307|471870833|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
131065620|NCT03557307|471870833|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
131065621|NCT03557307|471870833|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
131065622|NCT03557307|471870833|FG000|Period 2: Maintenance Phase|other|3|||
131065623|NCT03184519|471870834|FG000|Overall Study|Lost to Follow-up|6|||
131065624|NCT03184519|471870834|FG000|Overall Study|Physician Decision|21|||
131065625|NCT00584909|471870835|FG000|Overall Study|Adverse Event|4|||
131065626|NCT03345407|471870836|FG000|Overall Study|Withdrawal by Subject|11|||
131065627|NCT03345407|471870837|FG001|Overall Study|Withdrawal by Subject|1|||
131065628|NCT03345407|471870838|FG002|Overall Study|Withdrawal by Subject|5|||
131065629|NCT03345407|471870839|FG003|Overall Study|Withdrawal by Subject|6|||
131065630|NCT03345407|471870840|FG004|Overall Study|Withdrawal by Subject|3|||
131065631|NCT03345407|471870841|FG005|Overall Study|Withdrawal by Subject|6|||
131065632|NCT03345407|471870842|FG006|Overall Study|Withdrawal by Subject|16|||
131137585|NCT00756938|472130669|FG002|Optional Extension|Protocol-specific criteria met|0|||
130779425|NCT02326272|470819497|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130779426|NCT02326272|470819498|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130779427|NCT02326272|470819499|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130779428|NCT02326272|470819500|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130779429|NCT02326272|470819501|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131065633|NCT03345407|471870836|FG000|Overall Study|Physician Decision|3|||
131065634|NCT03345407|471870837|FG001|Overall Study|Physician Decision|1|||
131065635|NCT03345407|471870838|FG002|Overall Study|Physician Decision|0|||
131065636|NCT03345407|471870839|FG003|Overall Study|Physician Decision|0|||
131065637|NCT03345407|471870840|FG004|Overall Study|Physician Decision|1|||
131065638|NCT03345407|471870841|FG005|Overall Study|Physician Decision|2|||
131065639|NCT03345407|471870842|FG006|Overall Study|Physician Decision|3|||
131065640|NCT03345407|471870836|FG000|Overall Study|Lost to Follow-up|2|||
131065641|NCT03345407|471870837|FG001|Overall Study|Lost to Follow-up|0|||
131065642|NCT03345407|471870838|FG002|Overall Study|Lost to Follow-up|1|||
131065643|NCT03345407|471870839|FG003|Overall Study|Lost to Follow-up|0|||
131137586|NCT00756938|472130670|FG003|Optional Extension|Protocol-specific criteria met|9|||
131137587|NCT00756938|472130667|FG000|Optional Extension|Physician Decision|0|||
131137588|NCT00756938|472130668|FG001|Optional Extension|Physician Decision|0|||
131137589|NCT00756938|472130669|FG002|Optional Extension|Physician Decision|0|||
131137590|NCT00756938|472130670|FG003|Optional Extension|Physician Decision|3|||
131137591|NCT00756938|472130667|FG000|Optional Extension|Lost to Follow-up|0|||
131137592|NCT00756938|472130668|FG001|Optional Extension|Lost to Follow-up|0|||
131137593|NCT00756938|472130669|FG002|Optional Extension|Lost to Follow-up|0|||
131137594|NCT00756938|472130670|FG003|Optional Extension|Lost to Follow-up|1|||
131137595|NCT00756938|472130667|FG000|Optional Extension|Protocol Violation|0|||
131137596|NCT00756938|472130668|FG001|Optional Extension|Protocol Violation|0|||
131137597|NCT00756938|472130669|FG002|Optional Extension|Protocol Violation|0|||
131137598|NCT00756938|472130670|FG003|Optional Extension|Protocol Violation|1|||
131137599|NCT00756938|472130667|FG000|Optional Extension|Withdrawal by Subject|0|||
131137600|NCT00756938|472130668|FG001|Optional Extension|Withdrawal by Subject|0|||
131137601|NCT00756938|472130669|FG002|Optional Extension|Withdrawal by Subject|0|||
131137602|NCT00756938|472130670|FG003|Optional Extension|Withdrawal by Subject|10|||
131137603|NCT00756938|472130667|FG000|Optional Extension|Adverse Event|0|||
131137604|NCT00756938|472130668|FG001|Optional Extension|Adverse Event|0|||
131137605|NCT00756938|472130669|FG002|Optional Extension|Adverse Event|0|||
131137606|NCT00756938|472130670|FG003|Optional Extension|Adverse Event|1|||
131137607|NCT02474082|472130671|FG000|Overall Study|Adverse Event|2|||
131137608|NCT02474082|472130672|FG001|Overall Study|Adverse Event|32|||
131137609|NCT02474082|472130671|FG000|Overall Study|Withdrawal of informed consent|1|||
131137610|NCT02474082|472130672|FG001|Overall Study|Withdrawal of informed consent|11|||
131137611|NCT02474082|472130671|FG000|Overall Study|Lost to Follow-up|2|||
131137612|NCT02474082|472130672|FG001|Overall Study|Lost to Follow-up|2|||
131137613|NCT02474082|472130671|FG000|Overall Study|Dose tapering not achieved|0|||
130779430|NCT02326272|470819502|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
131065644|NCT03345407|471870840|FG004|Overall Study|Lost to Follow-up|1|||
131065645|NCT03345407|471870841|FG005|Overall Study|Lost to Follow-up|2|||
131065646|NCT03345407|471870842|FG006|Overall Study|Lost to Follow-up|3|||
131065647|NCT03345407|471870836|FG000|Overall Study|Protocol-defined stopping criteria|9|||
131065648|NCT03345407|471870837|FG001|Overall Study|Protocol-defined stopping criteria|0|||
131065649|NCT03345407|471870838|FG002|Overall Study|Protocol-defined stopping criteria|0|||
131065650|NCT03345407|471870839|FG003|Overall Study|Protocol-defined stopping criteria|0|||
131065651|NCT03345407|471870840|FG004|Overall Study|Protocol-defined stopping criteria|2|||
131065652|NCT03345407|471870841|FG005|Overall Study|Protocol-defined stopping criteria|1|||
131065653|NCT03345407|471870842|FG006|Overall Study|Protocol-defined stopping criteria|1|||
131065654|NCT03345407|471870836|FG000|Overall Study|Protocol Violation|2|||
131065655|NCT03345407|471870837|FG001|Overall Study|Protocol Violation|0|||
131065656|NCT03345407|471870838|FG002|Overall Study|Protocol Violation|0|||
131065657|NCT03345407|471870839|FG003|Overall Study|Protocol Violation|0|||
131065658|NCT03345407|471870840|FG004|Overall Study|Protocol Violation|1|||
131065659|NCT03345407|471870841|FG005|Overall Study|Protocol Violation|0|||
131065660|NCT03345407|471870842|FG006|Overall Study|Protocol Violation|3|||
131065661|NCT03345407|471870836|FG000|Overall Study|Lack of Efficacy|1|||
131065662|NCT03345407|471870837|FG001|Overall Study|Lack of Efficacy|1|||
131065663|NCT03345407|471870838|FG002|Overall Study|Lack of Efficacy|1|||
131065664|NCT03345407|471870839|FG003|Overall Study|Lack of Efficacy|1|||
130779431|NCT02326272|470819503|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130779432|NCT02326272|470819504|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130779433|NCT02326272|470819490|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130779434|NCT02326272|470819491|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130779435|NCT02326272|470819492|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130779436|NCT02326272|470819493|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131065665|NCT03345407|471870840|FG004|Overall Study|Lack of Efficacy|1|||
131065666|NCT03345407|471870841|FG005|Overall Study|Lack of Efficacy|0|||
131065667|NCT03345407|471870842|FG006|Overall Study|Lack of Efficacy|3|||
131065668|NCT03345407|471870836|FG000|Overall Study|Adverse Event|4|||
131065669|NCT03345407|471870837|FG001|Overall Study|Adverse Event|0|||
131065670|NCT03345407|471870838|FG002|Overall Study|Adverse Event|5|||
131065671|NCT03345407|471870839|FG003|Overall Study|Adverse Event|4|||
131065672|NCT03345407|471870840|FG004|Overall Study|Adverse Event|6|||
131065673|NCT03345407|471870841|FG005|Overall Study|Adverse Event|5|||
131065674|NCT03345407|471870842|FG006|Overall Study|Adverse Event|16|||
131065675|NCT03708744|471870847|FG000|Overall Study|Withdrawal by Subject|0|||
131065676|NCT03708744|471870848|FG001|Overall Study|Withdrawal by Subject|0|||
131065677|NCT03708744|471870849|FG002|Overall Study|Withdrawal by Subject|1|||
131137614|NCT02474082|472130672|FG001|Overall Study|Dose tapering not achieved|4|||
131137615|NCT02474082|472130671|FG000|Overall Study|Participant/guardian decision|1|||
131137616|NCT02474082|472130672|FG001|Overall Study|Participant/guardian decision|2|||
131137617|NCT02474082|472130671|FG000|Overall Study|Non-compliance with study treatment|0|||
131065678|NCT03708744|471870850|FG003|Overall Study|Withdrawal by Subject|0|||
131065679|NCT01989156|471870862|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
131137618|NCT02474082|472130672|FG001|Overall Study|Non-compliance with study treatment|2|||
131065680|NCT01989156|471870863|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
131065681|NCT01989156|471870864|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
131065682|NCT01989156|471870862|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
131065683|NCT01989156|471870863|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
131065684|NCT01989156|471870864|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
131065685|NCT01989156|471870862|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
131065686|NCT01989156|471870863|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
131065687|NCT01989156|471870864|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
131065688|NCT01989156|471870862|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
131065689|NCT01989156|471870863|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
131065690|NCT01989156|471870864|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
131065691|NCT01989156|471870862|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
131065692|NCT01989156|471870863|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
131065693|NCT01989156|471870864|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
131065694|NCT01989156|471870862|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
131065695|NCT01989156|471870863|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
131065696|NCT01989156|471870864|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
131065697|NCT01989156|471870862|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
131065698|NCT01989156|471870863|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
131065699|NCT01989156|471870864|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
131065700|NCT01989156|471870862|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
131065701|NCT01989156|471870863|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
131065702|NCT01989156|471870864|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
131065703|NCT00850993|471870865|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
131065704|NCT00850993|471870866|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
131065705|NCT00850993|471870867|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
131065706|NCT00850993|471870868|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
131065707|NCT03839355|471870869|FG000|Overall Study|Withdrawal by Subject|1|||
131065708|NCT03839355|471870870|FG001|Overall Study|Withdrawal by Subject|0|||
131065709|NCT04362176|471870878|FG000|Overall Study|Lost to Follow-up|5|||
131065710|NCT04362176|471870879|FG001|Overall Study|Lost to Follow-up|8|||
131065711|NCT04362176|471870878|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
131065712|NCT04362176|471870879|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
131065713|NCT00742560|471870880|FG000|Overall Study|Adverse Event|0|||
131065714|NCT00742560|471870881|FG001|Overall Study|Adverse Event|0|||
131065715|NCT00742560|471870882|FG002|Overall Study|Adverse Event|1|||
131065716|NCT00742560|471870883|FG003|Overall Study|Adverse Event|1|||
131065717|NCT00742560|471870884|FG004|Overall Study|Adverse Event|1|||
131065718|NCT00742560|471870880|FG000|Overall Study|Death|0|||
131065719|NCT00742560|471870881|FG001|Overall Study|Death|2|||
131065720|NCT00742560|471870882|FG002|Overall Study|Death|0|||
131065721|NCT00742560|471870883|FG003|Overall Study|Death|2|||
131065722|NCT00742560|471870884|FG004|Overall Study|Death|3|||
131065723|NCT00742560|471870880|FG000|Overall Study|Subject's Decision|1|||
131065724|NCT00742560|471870881|FG001|Overall Study|Subject's Decision|0|||
131065725|NCT00742560|471870882|FG002|Overall Study|Subject's Decision|2|||
131065726|NCT00742560|471870883|FG003|Overall Study|Subject's Decision|3|||
131065727|NCT00742560|471870884|FG004|Overall Study|Subject's Decision|3|||
131065728|NCT00742560|471870880|FG000|Overall Study|Investigator's Decision|0|||
131065729|NCT00742560|471870881|FG001|Overall Study|Investigator's Decision|0|||
131065730|NCT00742560|471870882|FG002|Overall Study|Investigator's Decision|4|||
131065731|NCT00742560|471870883|FG003|Overall Study|Investigator's Decision|1|||
131065732|NCT00742560|471870884|FG004|Overall Study|Investigator's Decision|0|||
131065733|NCT00742560|471870880|FG000|Overall Study|Disease Progression|1|||
131065734|NCT00742560|471870881|FG001|Overall Study|Disease Progression|0|||
131065735|NCT00742560|471870882|FG002|Overall Study|Disease Progression|5|||
131065736|NCT00742560|471870883|FG003|Overall Study|Disease Progression|17|||
131065737|NCT00742560|471870884|FG004|Overall Study|Disease Progression|16|||
131065738|NCT00742560|471870880|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
131065739|NCT00742560|471870881|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
131065740|NCT00742560|471870882|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
131065741|NCT00742560|471870883|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
131065742|NCT00742560|471870884|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
131065743|NCT00742560|471870880|FG000|Overall Study|Other|0|||
131137619|NCT02474082|472130671|FG000|Overall Study|Protocol deviation|0|||
130779437|NCT02326272|470819494|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
131065744|NCT00742560|471870881|FG001|Overall Study|Other|1|||
131065745|NCT00742560|471870882|FG002|Overall Study|Other|8|||
131065746|NCT00742560|471870883|FG003|Overall Study|Other|9|||
131065747|NCT00742560|471870884|FG004|Overall Study|Other|9|||
131065748|NCT00742560|471870880|FG000|Overall Study|MIssing|0|||
131065749|NCT00742560|471870881|FG001|Overall Study|MIssing|0|||
131230077|NCT01387282|472469266|FG001|Overall Study|Lost to Follow-up|1|||
131230078|NCT00633152|472469270|FG000|Overall Study|Adverse Event|1|||
131230079|NCT00633152|472469271|FG001|Overall Study|Adverse Event|0|||
131230080|NCT00633152|472469270|FG000|Overall Study|Randomized, did not receive study drug|5|||
131230081|NCT00633152|472469271|FG001|Overall Study|Randomized, did not receive study drug|2|||
130723154|NCT01696279|470611348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
130723155|NCT01696279|470611345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
130723156|NCT01696279|470611346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
130723157|NCT01696279|470611347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
130723158|NCT01696279|470611348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
130723159|NCT01441947|470611351|FG000|Overall Study|Withdrawal by Subject|3|||
130723160|NCT01441947|470611352|FG001|Overall Study|Withdrawal by Subject|0|||
130723161|NCT04106661|470611354|FG000|Overall Study|Protocol Violation|3|||
130723162|NCT04106661|470611355|FG001|Overall Study|Protocol Violation|0|||
130723163|NCT04106661|470611354|FG000|Overall Study|Scheduling difficulties|1|||
130723164|NCT04106661|470611355|FG001|Overall Study|Scheduling difficulties|1|||
130723165|NCT00468650|470611356|FG000|Overall Study|Lost to Follow-up|4|||
130723166|NCT00468650|470611356|FG000|Overall Study|Withdrawal by Subject|2|||
130723167|NCT00468650|470611356|FG000|Overall Study|Protocol Violation|1|||
130723168|NCT02639052|470611357|FG000|Overall Study|Lost to Follow-up|1|||
130723169|NCT02730351|470611359|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
130723170|NCT02730351|470611360|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
130723171|NCT02730351|470611359|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
130723172|NCT02730351|470611360|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
130723173|NCT02730351|470611359|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
130723174|NCT02730351|470611360|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
130723175|NCT02730351|470611359|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
130723176|NCT02730351|470611360|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
130723177|NCT02730351|470611359|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
130723178|NCT02730351|470611360|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
130723179|NCT00128830|470611361|FG000|Overall Study|Adverse Event|10|||
130723180|NCT00128830|470611361|FG000|Overall Study|Withdrawal by Subject|14|||
130723181|NCT00128830|470611361|FG000|Overall Study|Lost to Follow-up|4|||
130723182|NCT00128830|470611361|FG000|Overall Study|Reached a virologic endpoint|29|||
130723183|NCT00128830|470611361|FG000|Overall Study|Non-compliant|4|||
130723184|NCT00128830|470611361|FG000|Overall Study|Discontinued or ineligible for study|2|||
130723185|NCT00128830|470611361|FG000|Overall Study|Other|9|||
130723186|NCT00838435|470611362|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
130779438|NCT02326272|470819495|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
131065750|NCT00742560|471870882|FG002|Overall Study|MIssing|0|||
131065751|NCT00742560|471870883|FG003|Overall Study|MIssing|0|||
131065752|NCT00742560|471870884|FG004|Overall Study|MIssing|1|||
131065753|NCT01536795|471870885|FG000|Overall Study|Lost to Follow-up|0|||
131065754|NCT01536795|471870886|FG001|Overall Study|Lost to Follow-up|2|||
131065755|NCT01536795|471870885|FG000|Overall Study|Lack of Efficacy|1|||
131065756|NCT01536795|471870886|FG001|Overall Study|Lack of Efficacy|0|||
131065757|NCT04501614|471870887|FG000|Overall Study|Study Terminated by Sponsor|6|||
131065758|NCT04501614|471870888|FG001|Overall Study|Study Terminated by Sponsor|3|||
131065759|NCT04501614|471870887|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
131065760|NCT04501614|471870888|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
131065761|NCT04529941|471870889|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
131065762|NCT04529941|471870890|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
131065763|NCT02066389|471870894|FG000|Overall Study|Adverse Event|1|||
131065764|NCT02066389|471870895|FG001|Overall Study|Adverse Event|1|||
131065765|NCT02066389|471870896|FG002|Overall Study|Adverse Event|1|||
131065766|NCT02066389|471870897|FG003|Overall Study|Adverse Event|1|||
131065767|NCT02066389|471870898|FG004|Overall Study|Adverse Event|5|||
131065768|NCT02066389|471870899|FG005|Overall Study|Adverse Event|1|||
131065769|NCT02066389|471870894|FG000|Overall Study|Withdrawal by Subject|4|||
131065770|NCT02066389|471870895|FG001|Overall Study|Withdrawal by Subject|0|||
131230082|NCT00633152|472469270|FG000|Overall Study|Withdrawal by Subject|1|||
131230083|NCT00633152|472469271|FG001|Overall Study|Withdrawal by Subject|1|||
131230084|NCT00633152|472469270|FG000|Overall Study|Lost to Follow-up|4|||
130723187|NCT00838435|470611362|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
130723188|NCT00838435|470611362|FG000|Part 2 (7 Years)|Adverse Event|2|||
131065771|NCT02066389|471870896|FG002|Overall Study|Withdrawal by Subject|5|||
131065772|NCT02066389|471870897|FG003|Overall Study|Withdrawal by Subject|1|||
131065773|NCT02066389|471870898|FG004|Overall Study|Withdrawal by Subject|1|||
131065774|NCT02066389|471870899|FG005|Overall Study|Withdrawal by Subject|2|||
130723189|NCT00838435|470611362|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
130723190|NCT00838435|470611362|FG000|Part 2 (7 Years)|Physician Decision|1|||
130723191|NCT00838435|470611362|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
130723192|NCT00838435|470611362|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
131065775|NCT02066389|471870894|FG000|Overall Study|Lost to Follow-up|0|||
131065776|NCT02066389|471870895|FG001|Overall Study|Lost to Follow-up|0|||
131065777|NCT02066389|471870896|FG002|Overall Study|Lost to Follow-up|0|||
131065778|NCT02066389|471870897|FG003|Overall Study|Lost to Follow-up|1|||
131065779|NCT02066389|471870898|FG004|Overall Study|Lost to Follow-up|1|||
131065780|NCT02066389|471870899|FG005|Overall Study|Lost to Follow-up|1|||
131065781|NCT02066389|471870894|FG000|Overall Study|Randomized in Error|0|||
131065782|NCT02066389|471870895|FG001|Overall Study|Randomized in Error|0|||
131065783|NCT02066389|471870896|FG002|Overall Study|Randomized in Error|0|||
131065784|NCT02066389|471870897|FG003|Overall Study|Randomized in Error|0|||
131065785|NCT02066389|471870898|FG004|Overall Study|Randomized in Error|0|||
131065786|NCT02066389|471870899|FG005|Overall Study|Randomized in Error|1|||
131065787|NCT05615870|471870902|FG000|Overall Study|Lost to Follow-up|10|||
131065788|NCT05615870|471870903|FG001|Overall Study|Lost to Follow-up|13|||
131065789|NCT05615870|471870902|FG000|Overall Study|Physician Decision|2|||
131065790|NCT05615870|471870903|FG001|Overall Study|Physician Decision|0|||
131065791|NCT05615870|471870902|FG000|Overall Study|Withdrawal by Subject|0|||
131065792|NCT05615870|471870903|FG001|Overall Study|Withdrawal by Subject|2|||
131065793|NCT05615870|471870902|FG000|Overall Study|Protocol Violation|0|||
131065794|NCT05615870|471870903|FG001|Overall Study|Protocol Violation|3|||
131065795|NCT05615870|471870902|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
130723193|NCT03796039|470611364|FG000|Overall Study|Death|2|||
130723194|NCT03796039|470611365|FG001|Overall Study|Death|1|||
131065796|NCT05615870|471870903|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
131065797|NCT05615870|471870902|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
131065798|NCT05615870|471870903|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
131065799|NCT05615870|471870902|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
131065800|NCT05615870|471870903|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
131065801|NCT00070317|471870906|FG000|Overall Study|Inevaluable (Never Treated)|1|||
131065802|NCT00070317|471870906|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
131065803|NCT00070317|471870906|FG000|Overall Study|Ineligible required test not done|1|||
131065804|NCT00070317|471870906|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
131065805|NCT00070317|471870906|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
131065806|NCT00508144|471870910|FG000|Overall Study|Not eligible|6|||
131065807|NCT00508144|471870910|FG000|Overall Study|Death|5|||
131065808|NCT01661972|471870911|FG000|Overall Study|Adverse Event|1|||
131065809|NCT01661972|471870912|FG001|Overall Study|Adverse Event|2|||
131065810|NCT01661972|471870911|FG000|Overall Study|Death during Treatment period|1|||
131065811|NCT01661972|471870912|FG001|Overall Study|Death during Treatment period|1|||
131065812|NCT01661972|471870911|FG000|Overall Study|Withdrawal by Subject|0|||
131065813|NCT01661972|471870912|FG001|Overall Study|Withdrawal by Subject|1|||
131065814|NCT02009865|471870916|FG000|Overall Study|Adverse Event|0|||
131065815|NCT02009865|471870917|FG001|Overall Study|Adverse Event|2|||
131065816|NCT02009865|471870916|FG000|Overall Study|Protocol Violation|0|||
131065817|NCT02009865|471870917|FG001|Overall Study|Protocol Violation|2|||
131065818|NCT02009865|471870916|FG000|Overall Study|Withdrawal by Subject|1|||
131065819|NCT02009865|471870917|FG001|Overall Study|Withdrawal by Subject|1|||
131065820|NCT01517282|471870920|FG000|Overall Study|Consent withdrawn|0|||
131065821|NCT01517282|471870921|FG001|Overall Study|Consent withdrawn|1|||
131065822|NCT01517282|471870922|FG002|Overall Study|Consent withdrawn|1|||
131065823|NCT01517282|471870923|FG003|Overall Study|Consent withdrawn|1|||
131065824|NCT01517282|471870920|FG000|Overall Study|Physician Decision|1|||
131065825|NCT01517282|471870921|FG001|Overall Study|Physician Decision|0|||
131065826|NCT01517282|471870922|FG002|Overall Study|Physician Decision|0|||
131065827|NCT01517282|471870923|FG003|Overall Study|Physician Decision|0|||
131065828|NCT00525915|471870924|FG000|Overall Study|Non-Compliance|0|||
131065829|NCT00525915|471870925|FG001|Overall Study|Non-Compliance|1|||
131065830|NCT00525915|471870924|FG000|Overall Study|Disease Progression|5|||
131065831|NCT00525915|471870925|FG001|Overall Study|Disease Progression|6|||
131065832|NCT00525915|471870924|FG000|Overall Study|Withdrawal by Subject|1|||
131065833|NCT00525915|471870925|FG001|Overall Study|Withdrawal by Subject|0|||
131065834|NCT00525915|471870924|FG000|Overall Study|Refused Surgery|1|||
131065835|NCT00525915|471870925|FG001|Overall Study|Refused Surgery|2|||
131065836|NCT00525915|471870924|FG000|Overall Study|Unrelated illness|1|||
131065837|NCT00525915|471870925|FG001|Overall Study|Unrelated illness|0|||
131065844|NCT02011568|471871734|FG000|Overall Study|Withdrawal by Subject|8|||
131065845|NCT02011568|471871735|FG001|Overall Study|Withdrawal by Subject|10|||
131065846|NCT02011568|471871734|FG000|Overall Study|Physician Decision|1|||
130723195|NCT03796039|470611364|FG000|Overall Study|Withdrawal by Subject|7|||
131065847|NCT02011568|471871735|FG001|Overall Study|Physician Decision|3|||
131065848|NCT04751929|471871737|FG000|Overall Study|Withdrawal by Subject|2|||
131065849|NCT04751929|471871738|FG001|Overall Study|Withdrawal by Subject|0|||
130723196|NCT03796039|470611365|FG001|Overall Study|Withdrawal by Subject|4|||
130723197|NCT02927366|470611366|FG000|Overall Study|Adverse Event|1|||
130723198|NCT02927366|470611367|FG001|Overall Study|Adverse Event|0|||
130723199|NCT02927366|470611366|FG000|Overall Study|Patient schedule|1|||
130723200|NCT02927366|470611367|FG001|Overall Study|Patient schedule|0|||
130723201|NCT00587990|470611372|FG000|Overall Study|Death|0|||
131065850|NCT04751929|471871739|FG002|Overall Study|Withdrawal by Subject|0|||
131065851|NCT04751929|471871740|FG003|Overall Study|Withdrawal by Subject|0|||
131065852|NCT04751929|471871737|FG000|Overall Study|Rising PSA|0|||
131065853|NCT04751929|471871738|FG001|Overall Study|Rising PSA|1|||
131065854|NCT04751929|471871739|FG002|Overall Study|Rising PSA|0|||
131065855|NCT04751929|471871740|FG003|Overall Study|Rising PSA|0|||
131065856|NCT04751929|471871737|FG000|Overall Study|Adverse Event|1|||
131065857|NCT04751929|471871738|FG001|Overall Study|Adverse Event|2|||
131065858|NCT04751929|471871739|FG002|Overall Study|Adverse Event|0|||
131065859|NCT04751929|471871740|FG003|Overall Study|Adverse Event|0|||
131065860|NCT04751929|471871737|FG000|Overall Study|Progressive Disease|3|||
131065861|NCT04751929|471871738|FG001|Overall Study|Progressive Disease|4|||
131065862|NCT04751929|471871739|FG002|Overall Study|Progressive Disease|4|||
131065863|NCT04751929|471871740|FG003|Overall Study|Progressive Disease|0|||
131065864|NCT04751929|471871737|FG000|Overall Study|Death|1|||
131065865|NCT04751929|471871738|FG001|Overall Study|Death|1|||
131065866|NCT04751929|471871739|FG002|Overall Study|Death|0|||
131065867|NCT04751929|471871740|FG003|Overall Study|Death|0|||
131065868|NCT00376259|471871741|FG000|Overall Study|Sponsor request - study termination|21|||
131065869|NCT00376259|471871742|FG001|Overall Study|Sponsor request - study termination|21|||
131065870|NCT00376259|471871741|FG000|Overall Study|Patient request|1|||
131065871|NCT00376259|471871742|FG001|Overall Study|Patient request|0|||
131065872|NCT01012999|471871744|FG000|Overall Study|Protocol Violation|1|||
131065873|NCT02069366|471871745|FG000|Overall Study|Lost to Follow-up|0|||
131065874|NCT02069366|471871746|FG001|Overall Study|Lost to Follow-up|0|||
131065875|NCT02069366|471871747|FG002|Overall Study|Lost to Follow-up|1|||
131065876|NCT02069366|471871748|FG003|Overall Study|Lost to Follow-up|0|||
131065877|NCT02069366|471871749|FG004|Overall Study|Lost to Follow-up|0|||
131065878|NCT02069366|471871750|FG005|Overall Study|Lost to Follow-up|2|||
131065879|NCT02069366|471871745|FG000|Overall Study|Protocol Violation|0|||
131065880|NCT02069366|471871746|FG001|Overall Study|Protocol Violation|0|||
131065881|NCT02069366|471871747|FG002|Overall Study|Protocol Violation|1|||
131065882|NCT02069366|471871748|FG003|Overall Study|Protocol Violation|0|||
131065883|NCT02069366|471871749|FG004|Overall Study|Protocol Violation|0|||
131065884|NCT02069366|471871750|FG005|Overall Study|Protocol Violation|0|||
131065885|NCT02069366|471871745|FG000|Overall Study|Withdrawal by Subject|1|||
131065886|NCT02069366|471871746|FG001|Overall Study|Withdrawal by Subject|0|||
131065887|NCT02069366|471871747|FG002|Overall Study|Withdrawal by Subject|1|||
131065888|NCT02069366|471871748|FG003|Overall Study|Withdrawal by Subject|2|||
131065889|NCT02069366|471871749|FG004|Overall Study|Withdrawal by Subject|0|||
131065890|NCT02069366|471871750|FG005|Overall Study|Withdrawal by Subject|0|||
131065891|NCT02256553|471871751|FG000|Period I|Adverse Event|5|||
131065892|NCT02256553|471871751|FG000|Period I|Protocol Violation|1|||
131065893|NCT02256553|471871751|FG000|Period II|Adverse Event|1|||
131065894|NCT02256553|471871751|FG000|Period II|Subject Moved|1|||
131065895|NCT02256553|471871751|FG000|Period III|Adverse Event|3|||
131065896|NCT03436797|471871752|FG000|Main Study|Withdrawal by Subject|2|||
131065897|NCT03436797|471871752|FG000|Main Study|Adverse Event|4|||
131065898|NCT03436797|471871752|FG000|Main Study|Lost to Follow-up|1|||
131065899|NCT03436797|471871752|FG000|Main Study|Death|1|||
131065900|NCT03436797|471871752|FG000|Main Study|Non-Specific|2|||
131065901|NCT03436797|471871752|FG000|Extended Dosing|Patient decision|1|||
131065902|NCT01951105|471871757|FG000|Overall Study|Adverse Event|0|||
131065903|NCT01951105|471871758|FG001|Overall Study|Adverse Event|5|||
131065904|NCT01951105|471871759|FG002|Overall Study|Adverse Event|0|||
131065905|NCT01951105|471871757|FG000|Overall Study|Lost to Follow-up|0|||
131065906|NCT01951105|471871758|FG001|Overall Study|Lost to Follow-up|1|||
131065907|NCT01951105|471871759|FG002|Overall Study|Lost to Follow-up|0|||
131065908|NCT01951105|471871757|FG000|Overall Study|Protocol Violation|1|||
131065909|NCT01951105|471871758|FG001|Overall Study|Protocol Violation|1|||
131065910|NCT01951105|471871759|FG002|Overall Study|Protocol Violation|1|||
131065911|NCT01951105|471871757|FG000|Overall Study|Withdrawal by Subject|0|||
131065912|NCT01951105|471871758|FG001|Overall Study|Withdrawal by Subject|3|||
131065913|NCT01951105|471871759|FG002|Overall Study|Withdrawal by Subject|1|||
131065914|NCT04175392|471871760|FG000|Overall Study|Withdrawal by Subject|3|||
131065915|NCT04175392|471871761|FG001|Overall Study|Withdrawal by Subject|2|||
131065916|NCT02727998|471871762|FG000|Overall Study|Lost to Follow-up|3|||
131065917|NCT02727998|471871763|FG001|Overall Study|Lost to Follow-up|3|||
131065918|NCT02727998|471871762|FG000|Overall Study|Withdrawal by Subject|0|||
130723202|NCT00587990|470611373|FG001|Overall Study|Death|0|||
130723203|NCT00587990|470611374|FG002|Overall Study|Death|1|||
131065919|NCT02727998|471871763|FG001|Overall Study|Withdrawal by Subject|1|||
131065920|NCT02105688|471871764|FG000|Part A: Double-Blind|Adverse Event|1|||
131065921|NCT02105688|471871765|FG001|Part A: Double-Blind|Adverse Event|0|||
131065922|NCT02105688|471871764|FG000|Part A: Double-Blind|Death|0|||
131065923|NCT02105688|471871765|FG001|Part A: Double-Blind|Death|1|||
131065924|NCT02105688|471871764|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
131065925|NCT02105688|471871765|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
131065926|NCT02105688|471871764|FG000|Part A: Double-Blind|Physician Decision|0|||
131065927|NCT02105688|471871765|FG001|Part A: Double-Blind|Physician Decision|1|||
131065928|NCT02105688|471871764|FG000|Part A: Double-Blind|Status Unknown|0|||
131065929|NCT02105688|471871765|FG001|Part A: Double-Blind|Status Unknown|2|||
131065930|NCT02105688|471871764|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
131065931|NCT02105688|471871765|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
131065932|NCT02105688|471871764|FG000|Part B: Observational Follow-up|Death|2|||
131065933|NCT02105688|471871765|FG001|Part B: Observational Follow-up|Death|1|||
131065934|NCT02105688|471871764|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
131065935|NCT02105688|471871765|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
131065936|NCT02105688|471871764|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
131065937|NCT02105688|471871765|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
131065938|NCT02105688|471871764|FG000|Part B: Observational Follow-up|Physician Decision|3|||
131065939|NCT02105688|471871765|FG001|Part B: Observational Follow-up|Physician Decision|1|||
131065940|NCT01601821|471871767|FG000|Overall Study|Death|2|||
131065941|NCT01601821|471871768|FG001|Overall Study|Death|5|||
131065942|NCT01601821|471871767|FG000|Overall Study|Protocol Violation|2|||
131065943|NCT01601821|471871768|FG001|Overall Study|Protocol Violation|2|||
131065944|NCT01601821|471871767|FG000|Overall Study|Lost to Follow-up|6|||
131065945|NCT01601821|471871768|FG001|Overall Study|Lost to Follow-up|14|||
131065946|NCT01601821|471871767|FG000|Overall Study|Withdrawal by Subject|1|||
131065947|NCT01601821|471871768|FG001|Overall Study|Withdrawal by Subject|0|||
131065948|NCT01601821|471871767|FG000|Overall Study|Graft Loss|6|||
131065949|NCT01601821|471871768|FG001|Overall Study|Graft Loss|6|||
131065950|NCT01601821|471871767|FG000|Overall Study|Study Events|7|||
131065951|NCT01601821|471871768|FG001|Overall Study|Study Events|1|||
131065952|NCT01601821|471871767|FG000|Overall Study|Other|5|||
131065953|NCT01601821|471871768|FG001|Overall Study|Other|1|||
131065954|NCT02469155|471871769|FG000|Overall Study|Adverse Event|6|||
131065955|NCT02469155|471871770|FG001|Overall Study|Adverse Event|0|||
131065956|NCT02469155|471871771|FG002|Overall Study|Adverse Event|1|||
131065957|NCT02469155|471871772|FG003|Overall Study|Adverse Event|10|||
131065958|NCT02469155|471871769|FG000|Overall Study|Lack of Efficacy|13|||
131065959|NCT02469155|471871770|FG001|Overall Study|Lack of Efficacy|10|||
131065960|NCT02469155|471871771|FG002|Overall Study|Lack of Efficacy|10|||
131065961|NCT02469155|471871772|FG003|Overall Study|Lack of Efficacy|8|||
131065962|NCT02469155|471871769|FG000|Overall Study|Death|0|||
131065963|NCT02469155|471871770|FG001|Overall Study|Death|0|||
131065964|NCT02469155|471871771|FG002|Overall Study|Death|0|||
131065965|NCT02469155|471871772|FG003|Overall Study|Death|1|||
131065966|NCT02469155|471871769|FG000|Overall Study|Lost to Follow-up|5|||
131065967|NCT02469155|471871770|FG001|Overall Study|Lost to Follow-up|2|||
131065968|NCT02469155|471871771|FG002|Overall Study|Lost to Follow-up|7|||
131065969|NCT02469155|471871772|FG003|Overall Study|Lost to Follow-up|2|||
131065970|NCT02469155|471871769|FG000|Overall Study|Physician Decision|0|||
131065971|NCT02469155|471871770|FG001|Overall Study|Physician Decision|0|||
131065972|NCT02469155|471871771|FG002|Overall Study|Physician Decision|1|||
131065973|NCT02469155|471871772|FG003|Overall Study|Physician Decision|0|||
131065974|NCT02469155|471871769|FG000|Overall Study|Withdrawal by Subject|34|||
131065975|NCT02469155|471871770|FG001|Overall Study|Withdrawal by Subject|30|||
131065976|NCT02469155|471871771|FG002|Overall Study|Withdrawal by Subject|20|||
131065977|NCT02469155|471871772|FG003|Overall Study|Withdrawal by Subject|37|||
131065978|NCT02469155|471871769|FG000|Overall Study|Other|3|||
131065979|NCT02469155|471871770|FG001|Overall Study|Other|3|||
131065980|NCT02469155|471871771|FG002|Overall Study|Other|2|||
131065981|NCT02469155|471871772|FG003|Overall Study|Other|10|||
131065982|NCT02469155|471871769|FG000|Overall Study|Protocol Violation|0|||
131065983|NCT02469155|471871770|FG001|Overall Study|Protocol Violation|1|||
131065984|NCT02469155|471871771|FG002|Overall Study|Protocol Violation|0|||
131065985|NCT02469155|471871772|FG003|Overall Study|Protocol Violation|1|||
131065986|NCT00442559|471871773|FG000|Overall Study|Lost to Follow-up|32|||
131065987|NCT00442559|471871774|FG001|Overall Study|Lost to Follow-up|34|||
131065988|NCT00442559|471871773|FG000|Overall Study|Protocol Violation|1|||
131065989|NCT00442559|471871774|FG001|Overall Study|Protocol Violation|1|||
131065990|NCT00442559|471871773|FG000|Overall Study|Withdrawal by Subject|1|||
131065991|NCT00442559|471871774|FG001|Overall Study|Withdrawal by Subject|0|||
131065992|NCT02604199|471871778|FG000|Overall Study|Pregnancy|0|||
131065993|NCT02604199|471871779|FG001|Overall Study|Pregnancy|0|||
131065994|NCT02604199|471871780|FG002|Overall Study|Pregnancy|0|||
131065995|NCT02604199|471871781|FG003|Overall Study|Pregnancy|1|||
131065996|NCT02604199|471871778|FG000|Overall Study|Study terminated by sponsor|0|||
131137620|NCT02474082|472130672|FG001|Overall Study|Protocol deviation|1|||
131065997|NCT02604199|471871779|FG001|Overall Study|Study terminated by sponsor|2|||
131065998|NCT02604199|471871780|FG002|Overall Study|Study terminated by sponsor|0|||
131065999|NCT02604199|471871781|FG003|Overall Study|Study terminated by sponsor|2|||
131066000|NCT02604199|471871778|FG000|Overall Study|Withdrawal by Subject|0|||
131066001|NCT02604199|471871779|FG001|Overall Study|Withdrawal by Subject|1|||
131066002|NCT02604199|471871780|FG002|Overall Study|Withdrawal by Subject|0|||
131066003|NCT02604199|471871781|FG003|Overall Study|Withdrawal by Subject|0|||
131066004|NCT02812706|471871782|FG000|Phase 1|Adverse Event|0|||
131066005|NCT02812706|471871783|FG001|Phase 1|Adverse Event|2|||
131066006|NCT02812706|471871784|FG002|Phase 1|Adverse Event|0|||
131066007|NCT02812706|471871782|FG000|Phase 1|Progressive disease|3|||
131066008|NCT02812706|471871783|FG001|Phase 1|Progressive disease|3|||
131066009|NCT02812706|471871784|FG002|Phase 1|Progressive disease|0|||
131066010|NCT02812706|471871782|FG000|Phase 2|Adverse Event|0|||
131066011|NCT02812706|471871783|FG001|Phase 2|Adverse Event|0|||
131066012|NCT02812706|471871784|FG002|Phase 2|Adverse Event|2|||
131066013|NCT02812706|471871782|FG000|Phase 2|Progressive disease|0|||
131066014|NCT02812706|471871783|FG001|Phase 2|Progressive disease|0|||
131066015|NCT02812706|471871784|FG002|Phase 2|Progressive disease|22|||
131066016|NCT02812706|471871782|FG000|Phase 2|Other-Unspecified|0|||
131066017|NCT02812706|471871783|FG001|Phase 2|Other-Unspecified|0|||
131066018|NCT02812706|471871784|FG002|Phase 2|Other-Unspecified|4|||
131066019|NCT03166215|471871788|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
131066020|NCT03166215|471871789|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
131066021|NCT03166215|471871790|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
131066022|NCT03166215|471871788|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
131066023|NCT03166215|471871789|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
131066024|NCT03166215|471871790|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
131066025|NCT01426217|471871792|FG000|Overall Study|lost sample|8|||
131066026|NCT01426217|471871793|FG001|Overall Study|lost sample|14|||
131066027|NCT01812837|471871794|FG000|Overall Study|Lost to Follow-up|1|||
131066028|NCT01812837|471871795|FG001|Overall Study|Lost to Follow-up|1|||
131066029|NCT01812837|471871796|FG002|Overall Study|Lost to Follow-up|0|||
131066030|NCT01812837|471871794|FG000|Overall Study|Protocol Violation|1|||
131066031|NCT01812837|471871795|FG001|Overall Study|Protocol Violation|0|||
131066032|NCT01812837|471871796|FG002|Overall Study|Protocol Violation|0|||
131066033|NCT05234632|471871797|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
131066034|NCT05234632|471871798|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
131066035|NCT05234632|471871797|FG000|Overall Study|Withdrawal by Subject|2|||
131066036|NCT05234632|471871798|FG001|Overall Study|Withdrawal by Subject|0|||
131066037|NCT05234632|471871797|FG000|Overall Study|Adverse Event|0|||
131066038|NCT05234632|471871798|FG001|Overall Study|Adverse Event|4|||
131066039|NCT05234632|471871797|FG000|Overall Study|Physician Decision|1|||
131066040|NCT05234632|471871798|FG001|Overall Study|Physician Decision|1|||
131066041|NCT05234632|471871797|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
131066042|NCT05234632|471871798|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
131066043|NCT05234632|471871797|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
131066044|NCT05234632|471871798|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
131066045|NCT00658632|471871799|FG000|Overall Study|Adverse Event|13|||
131066046|NCT00658632|471871800|FG001|Overall Study|Adverse Event|11|||
131066047|NCT00658632|471871799|FG000|Overall Study|Lost to Follow-up|25|||
131066048|NCT00658632|471871800|FG001|Overall Study|Lost to Follow-up|23|||
131066049|NCT00658632|471871799|FG000|Overall Study|Withdrawal by Subject|10|||
131066050|NCT00658632|471871800|FG001|Overall Study|Withdrawal by Subject|7|||
131066051|NCT00658632|471871799|FG000|Overall Study|Lack of Efficacy|0|||
131066052|NCT00658632|471871800|FG001|Overall Study|Lack of Efficacy|1|||
131066053|NCT00658632|471871799|FG000|Overall Study|Withdrawal of consent|8|||
131066054|NCT00658632|471871800|FG001|Overall Study|Withdrawal of consent|14|||
131066055|NCT00658632|471871799|FG000|Overall Study|Pregnancy|1|||
131066056|NCT00658632|471871800|FG001|Overall Study|Pregnancy|1|||
131066057|NCT00658632|471871799|FG000|Overall Study|Other|7|||
131066058|NCT00658632|471871800|FG001|Overall Study|Other|8|||
131066059|NCT02632045|471871801|FG000|Overall Study|Withdrawal by Subject|1|||
131066060|NCT02632045|471871802|FG001|Overall Study|Withdrawal by Subject|2|||
131066061|NCT05263492|471871803|FG000|Overall Study|Adverse Event|1|||
131066062|NCT05263492|471871803|FG000|Overall Study|Disease progression during active treatment|3|||
131066063|NCT02991456|471871805|FG000|Overall Study|Adverse Event|2|||
131066064|NCT02991456|471871806|FG001|Overall Study|Adverse Event|0|||
131066065|NCT02991456|471871805|FG000|Overall Study|Lost to Follow-up|0|||
131066066|NCT02991456|471871806|FG001|Overall Study|Lost to Follow-up|2|||
131066067|NCT02991456|471871805|FG000|Overall Study|Withdrawal by Subject|1|||
131066068|NCT02991456|471871806|FG001|Overall Study|Withdrawal by Subject|0|||
131066069|NCT04016415|471871807|FG000|Overall Study|Adverse Event|2|||
131066070|NCT04016415|471871808|FG001|Overall Study|Adverse Event|1|||
131066071|NCT04016415|471871807|FG000|Overall Study|Lost to Follow-up|6|||
131066072|NCT04016415|471871808|FG001|Overall Study|Lost to Follow-up|2|||
131066073|NCT04016415|471871807|FG000|Overall Study|Physician Decision|5|||
131066074|NCT04016415|471871808|FG001|Overall Study|Physician Decision|1|||
131066075|NCT04016415|471871807|FG000|Overall Study|Pregnancy|0|||
131066076|NCT04016415|471871808|FG001|Overall Study|Pregnancy|1|||
131066077|NCT04016415|471871807|FG000|Overall Study|Withdrawal by Subject|24|||
131066078|NCT04016415|471871808|FG001|Overall Study|Withdrawal by Subject|27|||
131066079|NCT04016415|471871807|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
131066080|NCT04016415|471871808|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
131066081|NCT01885559|471871809|FG000|Overall Study|Lost to Follow-up|15|||
131066082|NCT01885559|471871810|FG001|Overall Study|Lost to Follow-up|16|||
131066083|NCT01885559|471871809|FG000|Overall Study|Less than full participation|9|||
131066084|NCT01885559|471871810|FG001|Overall Study|Less than full participation|19|||
131066085|NCT01885559|471871809|FG000|Overall Study|Protocol Violation|0|||
131066086|NCT01885559|471871810|FG001|Overall Study|Protocol Violation|1|||
131066087|NCT01760876|471871813|FG000|Overall Study|Non-cardiac death (head injury)|1|||
131066088|NCT01760876|471871813|FG000|Overall Study|Carcinoma of prostate|1|||
131066089|NCT01760876|471871813|FG000|Overall Study|Impaired renal function|1|||
131066090|NCT01760876|471871813|FG000|Overall Study|Major depression|1|||
131066091|NCT01760876|471871813|FG000|Overall Study|Very poor baseline OCT quality|2|||
131066092|NCT02819141|471871814|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
131066093|NCT02819141|471871815|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
131066094|NCT03556891|471871816|FG000|Initial Pivotal Study|Adverse Event|4|||
131066095|NCT03556891|471871816|FG000|Initial Pivotal Study|MRI Need|3|||
131066096|NCT03556891|471871816|FG000|Initial Pivotal Study|Device Failure|1|||
131066097|NCT03556891|471871816|FG000|Initial Pivotal Study|Death|1|||
131066098|NCT03556891|471871816|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
131066099|NCT03556891|471871816|FG000|Initial Pivotal Study|Missing at random|1|||
131066100|NCT03556891|471871816|FG000|Initial Pivotal Study|Missing due to COVID|1|||
131066101|NCT03556891|471871816|FG000|Initial Pivotal Study|Protocol Violation|1|||
131066102|NCT05927753|471872324|FG000|Overall Study|Withdrawal by Subject|0|||
131066103|NCT05927753|471872325|FG001|Overall Study|Withdrawal by Subject|2|||
131066104|NCT05927753|471872324|FG000|Overall Study|Physician Decision|0|||
131066105|NCT05927753|471872325|FG001|Overall Study|Physician Decision|1|||
131066106|NCT02062827|471872330|FG000|Overall Study|Death|1|||
131066107|NCT02062827|471872331|FG001|Overall Study|Death|0|||
131066108|NCT02062827|471872332|FG002|Overall Study|Death|0|||
131066109|NCT02062827|471872333|FG003|Overall Study|Death|0|||
131066110|NCT02062827|471872334|FG004|Overall Study|Death|0|||
131066111|NCT02062827|471872335|FG005|Overall Study|Death|0|||
131066112|NCT02062827|471872336|FG006|Overall Study|Death|0|||
131066113|NCT02062827|471872337|FG007|Overall Study|Death|0|||
131066114|NCT02062827|471872330|FG000|Overall Study|Withdrawal by Subject|3|||
131066115|NCT02062827|471872331|FG001|Overall Study|Withdrawal by Subject|1|||
131066116|NCT02062827|471872332|FG002|Overall Study|Withdrawal by Subject|1|||
131066117|NCT02062827|471872333|FG003|Overall Study|Withdrawal by Subject|2|||
131066118|NCT02062827|471872334|FG004|Overall Study|Withdrawal by Subject|6|||
131066119|NCT02062827|471872335|FG005|Overall Study|Withdrawal by Subject|0|||
131066120|NCT02062827|471872336|FG006|Overall Study|Withdrawal by Subject|5|||
131066121|NCT02062827|471872337|FG007|Overall Study|Withdrawal by Subject|0|||
131066122|NCT02062827|471872330|FG000|Overall Study|Screen Fail|0|||
131066123|NCT02062827|471872331|FG001|Overall Study|Screen Fail|0|||
131066124|NCT02062827|471872332|FG002|Overall Study|Screen Fail|0|||
131066125|NCT02062827|471872333|FG003|Overall Study|Screen Fail|0|||
131066126|NCT02062827|471872334|FG004|Overall Study|Screen Fail|0|||
131066127|NCT02062827|471872335|FG005|Overall Study|Screen Fail|0|||
131066128|NCT02062827|471872336|FG006|Overall Study|Screen Fail|0|||
131066129|NCT02062827|471872337|FG007|Overall Study|Screen Fail|8|||
131066130|NCT00288353|471872338|FG000|Overall Study|Lack of Efficacy|2|||
131066131|NCT00288353|471872339|FG001|Overall Study|Lack of Efficacy|2|||
131066132|NCT00288353|471872338|FG000|Overall Study|Withdrawal by Subject|5|||
131066133|NCT00288353|471872339|FG001|Overall Study|Withdrawal by Subject|5|||
131066134|NCT05008224|471872340|FG000|Overall Study|Death|3|||
131066135|NCT05008224|471872340|FG000|Overall Study|Lost to Follow-up|2|||
130723204|NCT02754856|470611375|FG000|Overall Study|Withdrawal by Subject|1|||
130723205|NCT00530218|470611376|FG000|Overall Study|CMV Not Detected|13|||
130723206|NCT00530218|470611376|FG000|Overall Study|Death|12|||
130723207|NCT03477903|470611377|FG000|Overall Study|Study Terminated by Sponsor|1|||
130723208|NCT00426361|470611378|FG000|Overall Study|Lost to Follow-up|3|||
130723209|NCT00426361|470611379|FG001|Overall Study|Lost to Follow-up|2|||
130723210|NCT00426361|470611380|FG002|Overall Study|Lost to Follow-up|5|||
130723211|NCT00426361|470611378|FG000|Overall Study|Withdrawal by Subject|1|||
130723212|NCT00426361|470611379|FG001|Overall Study|Withdrawal by Subject|3|||
131066136|NCT05008224|471872340|FG000|Overall Study|Did Not Continue on Extension Study|39|||
131066137|NCT05008224|471872340|FG000|Overall Study|Transferred to Extension Study|100|||
131066138|NCT05008224|471872340|FG000|Overall Study|Withdrawal by Subject|2|||
131066139|NCT04985604|471872341|FG000|Overall Study|Death|4|||
130723213|NCT00426361|470611380|FG002|Overall Study|Withdrawal by Subject|0|||
131066140|NCT04985604|471872342|FG001|Overall Study|Death|6|||
131066141|NCT04985604|471872341|FG000|Overall Study|Withdrawal by Subject|0|||
131066142|NCT04985604|471872342|FG001|Overall Study|Withdrawal by Subject|1|||
131066143|NCT02282761|471872343|FG000|Overall Study|Death|0|||
131066144|NCT02282761|471872344|FG001|Overall Study|Death|0|||
131066145|NCT02282761|471872345|FG002|Overall Study|Death|1|||
131066146|NCT02282761|471872343|FG000|Overall Study|Adverse Event|6|||
131066147|NCT02282761|471872344|FG001|Overall Study|Adverse Event|2|||
131066148|NCT02282761|471872345|FG002|Overall Study|Adverse Event|0|||
131066149|NCT02282761|471872343|FG000|Overall Study|Lack of Efficacy|11|||
131066150|NCT02282761|471872344|FG001|Overall Study|Lack of Efficacy|6|||
131066151|NCT02282761|471872345|FG002|Overall Study|Lack of Efficacy|17|||
131066152|NCT02282761|471872343|FG000|Overall Study|Lost to Follow-up|2|||
131066153|NCT02282761|471872344|FG001|Overall Study|Lost to Follow-up|2|||
131066154|NCT02282761|471872345|FG002|Overall Study|Lost to Follow-up|1|||
131066155|NCT02282761|471872343|FG000|Overall Study|Physician Decision|0|||
131066156|NCT02282761|471872344|FG001|Overall Study|Physician Decision|0|||
131066157|NCT02282761|471872345|FG002|Overall Study|Physician Decision|2|||
131066158|NCT02282761|471872343|FG000|Overall Study|Withdrawal by Subject|8|||
131066159|NCT02282761|471872344|FG001|Overall Study|Withdrawal by Subject|10|||
131066160|NCT02282761|471872345|FG002|Overall Study|Withdrawal by Subject|16|||
131066161|NCT02282761|471872343|FG000|Overall Study|Other|3|||
131066162|NCT02282761|471872344|FG001|Overall Study|Other|2|||
131066163|NCT02282761|471872345|FG002|Overall Study|Other|1|||
131066164|NCT05878522|471872346|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066165|NCT05878522|471872347|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066166|NCT05878522|471872348|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066167|NCT05878522|471872349|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066168|NCT05878522|471872350|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066169|NCT05878522|471872351|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066170|NCT05878522|471872352|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066171|NCT05878522|471872353|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066172|NCT05878522|471872354|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
131066173|NCT05878522|471872355|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066174|NCT05878522|471872356|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066175|NCT05878522|471872357|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
131066176|NCT05878522|471872346|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
131066177|NCT05878522|471872347|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131066178|NCT05878522|471872348|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131066179|NCT05878522|471872349|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131066180|NCT05878522|471872350|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131066181|NCT05878522|471872351|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131066182|NCT05878522|471872352|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131066183|NCT05878522|471872353|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131066184|NCT05878522|471872354|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131066185|NCT05878522|471872355|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
131066186|NCT05878522|471872356|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131066187|NCT05878522|471872357|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
131066188|NCT05878522|471872346|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131066189|NCT05878522|471872347|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
131066190|NCT05878522|471872348|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131066191|NCT05878522|471872349|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
131066192|NCT05878522|471872350|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131066193|NCT05878522|471872351|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131066194|NCT05878522|471872352|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130723214|NCT02478320|470611381|FG000|Overall Study|Adverse Event|2|||
131066195|NCT05878522|471872353|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131066196|NCT05878522|471872354|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131066197|NCT05878522|471872355|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131066198|NCT05878522|471872356|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
131066199|NCT05878522|471872357|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130723215|NCT02478320|470611382|FG001|Overall Study|Adverse Event|0|||
130723216|NCT02478320|470611381|FG000|Overall Study|Death|1|||
130723217|NCT02478320|470611382|FG001|Overall Study|Death|0|||
130723218|NCT02478320|470611381|FG000|Overall Study|Lack of Efficacy|4|||
131066200|NCT05878522|471872346|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131066201|NCT05878522|471872347|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131066202|NCT05878522|471872348|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130723219|NCT02478320|470611382|FG001|Overall Study|Lack of Efficacy|0|||
130723220|NCT02478320|470611381|FG000|Overall Study|Withdrawal by Subject|2|||
130723221|NCT02478320|470611382|FG001|Overall Study|Withdrawal by Subject|0|||
131066203|NCT05878522|471872349|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131066204|NCT05878522|471872350|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
131066205|NCT05878522|471872351|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131066206|NCT05878522|471872352|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131230085|NCT00633152|472469271|FG001|Overall Study|Lost to Follow-up|1|||
130723222|NCT02478320|470611381|FG000|Overall Study|Screen Failure|3|||
130723223|NCT02478320|470611382|FG001|Overall Study|Screen Failure|0|||
131066207|NCT05878522|471872353|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131066208|NCT05878522|471872354|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131066209|NCT05878522|471872355|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131066210|NCT05878522|471872356|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131066211|NCT05878522|471872357|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
131066212|NCT03345420|471872360|FG000|Overall Study|Withdrawal by Subject|1|||
131066217|NCT05216835|471872363|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
131066218|NCT05216835|471872364|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
131066219|NCT05216835|471872365|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
131066220|NCT05216835|471872366|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
131066221|NCT05216835|471872367|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
131066222|NCT05216835|471872368|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
131066223|NCT05216835|471872369|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
131066224|NCT05216835|471872370|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
131066225|NCT05216835|471872363|FG000|Overall Study|Death|0|||
130723224|NCT03255655|470611383|FG000|Overall Study|Lost to Follow-up|7|||
130723225|NCT03255655|470611384|FG001|Overall Study|Lost to Follow-up|4|||
130723226|NCT04428333|470611387|FG000|Overall Study|Physician Decision|5|||
130723227|NCT04428333|470611388|FG001|Overall Study|Physician Decision|6|||
130723228|NCT04428333|470611387|FG000|Overall Study|Withdrawal by Subject|1|||
130723229|NCT04428333|470611388|FG001|Overall Study|Withdrawal by Subject|3|||
130723230|NCT04428333|470611387|FG000|Overall Study|Study Terminated By Sponsor|14|||
130723231|NCT04428333|470611388|FG001|Overall Study|Study Terminated By Sponsor|16|||
130723232|NCT04853992|470611389|FG000|Treatment Period A|Adverse Event|0|||
130723233|NCT04853992|470611390|FG001|Treatment Period A|Adverse Event|1|||
130723234|NCT04853992|470611389|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
130723235|NCT04853992|470611390|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
130723236|NCT03582826|470611391|FG000|Overall Study|Lost to Follow-up|39|||
130723237|NCT03582826|470611392|FG001|Overall Study|Lost to Follow-up|0|||
130723238|NCT03582826|470611391|FG000|Overall Study|Withdrawal by Subject|2|||
130723239|NCT03582826|470611392|FG001|Overall Study|Withdrawal by Subject|0|||
130723240|NCT02269163|470611393|FG000|Overall Study|Lost to Follow-up|1|||
130723241|NCT02269163|470611394|FG001|Overall Study|Lost to Follow-up|0|||
130723242|NCT02269163|470611393|FG000|Overall Study|Major protocol violation|0|||
130723243|NCT02269163|470611394|FG001|Overall Study|Major protocol violation|1|||
130723244|NCT02269163|470611393|FG000|Overall Study|Other|2|||
130723245|NCT02269163|470611394|FG001|Overall Study|Other|2|||
130723246|NCT02269163|470611393|FG000|Overall Study|Withdrawal by Subject|0|||
130723247|NCT02269163|470611394|FG001|Overall Study|Withdrawal by Subject|3|||
130723248|NCT02269163|470611393|FG000|Overall Study|Physician Decision|0|||
130723249|NCT02269163|470611394|FG001|Overall Study|Physician Decision|1|||
130723250|NCT03480386|470611395|FG000|Overall Study|Did not complete measures at 3-months|17|||
131066226|NCT05216835|471872364|FG001|Overall Study|Death|0|||
131066227|NCT05216835|471872365|FG002|Overall Study|Death|0|||
131066228|NCT05216835|471872366|FG003|Overall Study|Death|1|||
131066229|NCT05216835|471872367|FG004|Overall Study|Death|1|||
131066230|NCT05216835|471872368|FG005|Overall Study|Death|1|||
131066231|NCT05216835|471872369|FG006|Overall Study|Death|1|||
131066232|NCT05216835|471872370|FG007|Overall Study|Death|1|||
131066233|NCT05216835|471872363|FG000|Overall Study|Physician Decision|0|||
131066234|NCT05216835|471872364|FG001|Overall Study|Physician Decision|0|||
131066235|NCT05216835|471872365|FG002|Overall Study|Physician Decision|0|||
130723251|NCT03480386|470611396|FG001|Overall Study|Did not complete measures at 3-months|14|||
130779439|NCT02326272|470819496|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
130779440|NCT02326272|470819497|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
131066236|NCT05216835|471872366|FG003|Overall Study|Physician Decision|0|||
131066237|NCT05216835|471872367|FG004|Overall Study|Physician Decision|0|||
131066238|NCT05216835|471872368|FG005|Overall Study|Physician Decision|1|||
131066239|NCT05216835|471872369|FG006|Overall Study|Physician Decision|1|||
131066240|NCT05216835|471872370|FG007|Overall Study|Physician Decision|0|||
131066241|NCT05216835|471872363|FG000|Overall Study|Study terminated by Sponsor|0|||
131066242|NCT05216835|471872364|FG001|Overall Study|Study terminated by Sponsor|0|||
131066243|NCT05216835|471872365|FG002|Overall Study|Study terminated by Sponsor|0|||
131066244|NCT05216835|471872366|FG003|Overall Study|Study terminated by Sponsor|0|||
130723252|NCT03480386|470611395|FG000|Overall Study|No baseline measures|11|||
130723253|NCT03480386|470611396|FG001|Overall Study|No baseline measures|14|||
130723254|NCT03480386|470611395|FG000|Overall Study|Death|0|||
130723255|NCT03480386|470611396|FG001|Overall Study|Death|5|||
130723256|NCT03480386|470611395|FG000|Overall Study|Withdrawal by Subject|12|||
130723257|NCT03480386|470611396|FG001|Overall Study|Withdrawal by Subject|8|||
130779441|NCT02326272|470819498|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
131066245|NCT05216835|471872367|FG004|Overall Study|Study terminated by Sponsor|0|||
131230086|NCT00633152|472469270|FG000|Overall Study|Miscellaneous Other|3|||
131066246|NCT05216835|471872368|FG005|Overall Study|Study terminated by Sponsor|0|||
131066247|NCT05216835|471872369|FG006|Overall Study|Study terminated by Sponsor|0|||
131066248|NCT05216835|471872370|FG007|Overall Study|Study terminated by Sponsor|1|||
131066249|NCT05216835|471872363|FG000|Overall Study|Withdrawal by Subject|1|||
131066250|NCT05216835|471872364|FG001|Overall Study|Withdrawal by Subject|0|||
131066251|NCT05216835|471872365|FG002|Overall Study|Withdrawal by Subject|1|||
131066252|NCT05216835|471872366|FG003|Overall Study|Withdrawal by Subject|0|||
131066253|NCT05216835|471872367|FG004|Overall Study|Withdrawal by Subject|1|||
131066254|NCT05216835|471872368|FG005|Overall Study|Withdrawal by Subject|0|||
131066255|NCT05216835|471872369|FG006|Overall Study|Withdrawal by Subject|0|||
131066256|NCT05216835|471872370|FG007|Overall Study|Withdrawal by Subject|1|||
131066257|NCT05216835|471872363|FG000|Overall Study|Other|0|||
131066258|NCT05216835|471872364|FG001|Overall Study|Other|1|||
131066259|NCT05216835|471872365|FG002|Overall Study|Other|0|||
131066260|NCT05216835|471872366|FG003|Overall Study|Other|0|||
131066261|NCT05216835|471872367|FG004|Overall Study|Other|0|||
131066262|NCT05216835|471872368|FG005|Overall Study|Other|0|||
131066263|NCT05216835|471872369|FG006|Overall Study|Other|0|||
131066264|NCT05216835|471872370|FG007|Overall Study|Other|0|||
131066265|NCT05179603|471872371|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
131066266|NCT05179603|471872371|FG000|Overall Study|Withdrawal by Subject|1|||
131066267|NCT05179603|471872371|FG000|Overall Study|Progressive disease|4|||
131066268|NCT05179603|471872371|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
131066269|NCT05740371|471872374|FG000|Overall Study|Death|1|||
131066270|NCT00738400|471872375|FG000|Overall Study|Adverse Event|3|||
131066271|NCT00738400|471872376|FG001|Overall Study|Adverse Event|1|||
131066272|NCT00738400|471872375|FG000|Overall Study|Withdrawal by Subject|0|||
131066273|NCT00738400|471872376|FG001|Overall Study|Withdrawal by Subject|1|||
131066274|NCT00738400|471872375|FG000|Overall Study|Lack of Efficacy|0|||
131066275|NCT00738400|471872376|FG001|Overall Study|Lack of Efficacy|1|||
131066276|NCT00738400|471872375|FG000|Overall Study|Lost to Follow-up|0|||
131066277|NCT00738400|471872376|FG001|Overall Study|Lost to Follow-up|3|||
131066278|NCT00738400|471872375|FG000|Overall Study|Protocol Violation|1|||
131066279|NCT00738400|471872376|FG001|Overall Study|Protocol Violation|0|||
131066280|NCT00738400|471872375|FG000|Overall Study|Non-compliant with study medication|0|||
131066281|NCT00738400|471872376|FG001|Overall Study|Non-compliant with study medication|1|||
131066282|NCT03138499|471872377|FG000|Overall Study|Lost to Follow-up|1|||
131066283|NCT03138499|471872378|FG001|Overall Study|Lost to Follow-up|0|||
131066284|NCT03138499|471872377|FG000|Overall Study|Participants withdrew consent|1|||
131066285|NCT03138499|471872378|FG001|Overall Study|Participants withdrew consent|0|||
131066286|NCT03138499|471872377|FG000|Overall Study|Participant discontinued study before treatment|0|||
131066287|NCT03138499|471872378|FG001|Overall Study|Participant discontinued study before treatment|1|||
131066288|NCT03138499|471872377|FG000|Overall Study|Disease Progression|2|||
131066289|NCT03138499|471872378|FG001|Overall Study|Disease Progression|6|||
131066290|NCT03138499|471872377|FG000|Overall Study|Study drug toxicity|2|||
131066291|NCT03138499|471872378|FG001|Overall Study|Study drug toxicity|2|||
131066292|NCT03138499|471872377|FG000|Overall Study|Participant request to discontinue study treatment|1|||
131066293|NCT03138499|471872378|FG001|Overall Study|Participant request to discontinue study treatment|1|||
131066294|NCT03138499|471872377|FG000|Overall Study|Other reasons|2|||
131066295|NCT03138499|471872378|FG001|Overall Study|Other reasons|0|||
131066296|NCT02312245|471872379|FG000|Overall Study|Death|0|||
131066297|NCT02312245|471872380|FG001|Overall Study|Death|0|||
131066298|NCT02312245|471872381|FG002|Overall Study|Death|0|||
131066299|NCT02312245|471872382|FG003|Overall Study|Death|1|||
131066300|NCT02312245|471872379|FG000|Overall Study|Withdrawal by Subject|1|||
131066301|NCT02312245|471872380|FG001|Overall Study|Withdrawal by Subject|1|||
131066302|NCT02312245|471872381|FG002|Overall Study|Withdrawal by Subject|0|||
131066303|NCT02312245|471872382|FG003|Overall Study|Withdrawal by Subject|2|||
131066304|NCT02312245|471872379|FG000|Overall Study|Alternative Therapy|1|||
131066305|NCT02312245|471872380|FG001|Overall Study|Alternative Therapy|0|||
131066306|NCT02312245|471872381|FG002|Overall Study|Alternative Therapy|0|||
131066307|NCT02312245|471872382|FG003|Overall Study|Alternative Therapy|0|||
131066308|NCT02312245|471872379|FG000|Overall Study|Progression|0|||
131066309|NCT02312245|471872380|FG001|Overall Study|Progression|0|||
131066310|NCT02312245|471872381|FG002|Overall Study|Progression|0|||
131066311|NCT02312245|471872382|FG003|Overall Study|Progression|5|||
131066312|NCT02312245|471872379|FG000|Overall Study|Patient went to hospice|0|||
131066313|NCT02312245|471872380|FG001|Overall Study|Patient went to hospice|0|||
131230087|NCT00633152|472469271|FG001|Overall Study|Miscellaneous Other|2|||
131066314|NCT02312245|471872381|FG002|Overall Study|Patient went to hospice|0|||
131066315|NCT02312245|471872382|FG003|Overall Study|Patient went to hospice|1|||
131066316|NCT02312245|471872379|FG000|Overall Study|Ineligible|1|||
131066317|NCT02312245|471872380|FG001|Overall Study|Ineligible|0|||
131066318|NCT02312245|471872381|FG002|Overall Study|Ineligible|0|||
131066319|NCT02312245|471872382|FG003|Overall Study|Ineligible|0|||
131066320|NCT01123200|471872383|FG000|Overall Study|Withdrawal by Subject|1|||
131230088|NCT03273387|472469272|FG000|Overall Study|Death|2|||
131066321|NCT01730118|471873825|FG000|Dose Escalation|Death on study|5|||
131230089|NCT03273387|472469273|FG001|Overall Study|Death|2|||
131066322|NCT01730118|471873826|FG001|Dose Escalation|Death on study|7|||
131066323|NCT01730118|471873827|FG002|Dose Escalation|Death on study|2|||
131066324|NCT01730118|471873828|FG003|Dose Escalation|Death on study|6|||
131066325|NCT01730118|471873829|FG004|Dose Escalation|Death on study|0|||
131066326|NCT01730118|471873830|FG005|Dose Escalation|Death on study|0|||
131066327|NCT01730118|471873831|FG006|Dose Escalation|Death on study|0|||
131066328|NCT01730118|471873825|FG000|Dose Escalation|Died before treatment|0|||
131066329|NCT01730118|471873826|FG001|Dose Escalation|Died before treatment|0|||
131066330|NCT01730118|471873827|FG002|Dose Escalation|Died before treatment|0|||
131066331|NCT01730118|471873828|FG003|Dose Escalation|Died before treatment|0|||
131066332|NCT01730118|471873829|FG004|Dose Escalation|Died before treatment|0|||
131066333|NCT01730118|471873830|FG005|Dose Escalation|Died before treatment|0|||
131066334|NCT01730118|471873831|FG006|Dose Escalation|Died before treatment|1|||
131066335|NCT01730118|471873825|FG000|Dose Escalation|Chose to start a different treatment|1|||
131066336|NCT01730118|471873826|FG001|Dose Escalation|Chose to start a different treatment|0|||
131066337|NCT01730118|471873827|FG002|Dose Escalation|Chose to start a different treatment|0|||
131066338|NCT01730118|471873828|FG003|Dose Escalation|Chose to start a different treatment|0|||
131066339|NCT01730118|471873829|FG004|Dose Escalation|Chose to start a different treatment|0|||
131066340|NCT01730118|471873830|FG005|Dose Escalation|Chose to start a different treatment|0|||
131066341|NCT01730118|471873831|FG006|Dose Escalation|Chose to start a different treatment|0|||
131066342|NCT01730118|471873825|FG000|Dose Escalation|Withdrawal by Subject|0|||
131066343|NCT01730118|471873826|FG001|Dose Escalation|Withdrawal by Subject|0|||
131066344|NCT01730118|471873827|FG002|Dose Escalation|Withdrawal by Subject|1|||
131066345|NCT01730118|471873828|FG003|Dose Escalation|Withdrawal by Subject|0|||
131066346|NCT01730118|471873829|FG004|Dose Escalation|Withdrawal by Subject|0|||
131066347|NCT01730118|471873830|FG005|Dose Escalation|Withdrawal by Subject|0|||
131066348|NCT01730118|471873831|FG006|Dose Escalation|Withdrawal by Subject|0|||
130723258|NCT03480386|470611395|FG000|Overall Study|Lost to Follow-up|2|||
130723259|NCT03480386|470611396|FG001|Overall Study|Lost to Follow-up|1|||
131066349|NCT01730118|471873825|FG000|Dose Escalation|Disease progression prior to treatment|0|||
131066350|NCT01730118|471873826|FG001|Dose Escalation|Disease progression prior to treatment|0|||
131066351|NCT01730118|471873827|FG002|Dose Escalation|Disease progression prior to treatment|0|||
131066352|NCT01730118|471873828|FG003|Dose Escalation|Disease progression prior to treatment|0|||
131066353|NCT01730118|471873829|FG004|Dose Escalation|Disease progression prior to treatment|0|||
131066354|NCT01730118|471873830|FG005|Dose Escalation|Disease progression prior to treatment|0|||
131066355|NCT01730118|471873831|FG006|Dose Escalation|Disease progression prior to treatment|1|||
131066356|NCT01730118|471873825|FG000|Dose Expansion|Death|0|||
131066357|NCT01730118|471873826|FG001|Dose Expansion|Death|0|||
131066358|NCT01730118|471873827|FG002|Dose Expansion|Death|0|||
131066359|NCT01730118|471873828|FG003|Dose Expansion|Death|0|||
131066360|NCT01730118|471873829|FG004|Dose Expansion|Death|1|||
131066361|NCT01730118|471873830|FG005|Dose Expansion|Death|0|||
131066362|NCT01730118|471873831|FG006|Dose Expansion|Death|0|||
131066363|NCT01730118|471873825|FG000|Dose Expansion|Other medical condition|0|||
131066364|NCT01730118|471873826|FG001|Dose Expansion|Other medical condition|0|||
131066365|NCT01730118|471873827|FG002|Dose Expansion|Other medical condition|0|||
131066366|NCT01730118|471873828|FG003|Dose Expansion|Other medical condition|0|||
131066367|NCT01730118|471873829|FG004|Dose Expansion|Other medical condition|1|||
131066368|NCT01730118|471873830|FG005|Dose Expansion|Other medical condition|0|||
131066369|NCT01730118|471873831|FG006|Dose Expansion|Other medical condition|0|||
131066370|NCT01730118|471873825|FG000|Dose Expansion|Withdrawal by Subject|0|||
131066371|NCT01730118|471873826|FG001|Dose Expansion|Withdrawal by Subject|0|||
131066372|NCT01730118|471873827|FG002|Dose Expansion|Withdrawal by Subject|0|||
131066373|NCT01730118|471873828|FG003|Dose Expansion|Withdrawal by Subject|0|||
131066374|NCT01730118|471873829|FG004|Dose Expansion|Withdrawal by Subject|1|||
131066375|NCT01730118|471873830|FG005|Dose Expansion|Withdrawal by Subject|0|||
131066376|NCT01730118|471873831|FG006|Dose Expansion|Withdrawal by Subject|0|||
131066377|NCT01730118|471873825|FG000|Dose Expansion|Disease progression|0|||
131066378|NCT01730118|471873826|FG001|Dose Expansion|Disease progression|0|||
131066379|NCT01730118|471873827|FG002|Dose Expansion|Disease progression|0|||
131066380|NCT01730118|471873828|FG003|Dose Expansion|Disease progression|0|||
131066381|NCT01730118|471873829|FG004|Dose Expansion|Disease progression|0|||
131066382|NCT01730118|471873830|FG005|Dose Expansion|Disease progression|1|||
131137621|NCT03403205|472130675|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
131137622|NCT03403205|472130676|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
131137623|NCT03403205|472130677|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
131137624|NCT03403205|472130678|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
131137625|NCT03403205|472130679|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131137626|NCT03403205|472130680|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131137627|NCT03403205|472130675|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
131137628|NCT03403205|472130676|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131137629|NCT03403205|472130677|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
131137630|NCT03403205|472130678|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131066383|NCT01730118|471873831|FG006|Dose Expansion|Disease progression|0|||
131066384|NCT01730118|471873825|FG000|Dose Expansion|Inability to return|0|||
131066385|NCT01730118|471873826|FG001|Dose Expansion|Inability to return|0|||
131066386|NCT01730118|471873827|FG002|Dose Expansion|Inability to return|0|||
131066387|NCT01730118|471873828|FG003|Dose Expansion|Inability to return|0|||
131066388|NCT01730118|471873829|FG004|Dose Expansion|Inability to return|0|||
131066389|NCT01730118|471873830|FG005|Dose Expansion|Inability to return|1|||
131066390|NCT01730118|471873831|FG006|Dose Expansion|Inability to return|0|||
131066391|NCT01730118|471873825|FG000|Dose Expansion|Physician Decision|0|||
131066392|NCT01730118|471873826|FG001|Dose Expansion|Physician Decision|0|||
131066393|NCT01730118|471873827|FG002|Dose Expansion|Physician Decision|0|||
131066394|NCT01730118|471873828|FG003|Dose Expansion|Physician Decision|0|||
131066395|NCT01730118|471873829|FG004|Dose Expansion|Physician Decision|0|||
131066396|NCT01730118|471873830|FG005|Dose Expansion|Physician Decision|1|||
131066397|NCT01730118|471873831|FG006|Dose Expansion|Physician Decision|0|||
131066398|NCT00489489|471873833|FG000|Overall Study|Not treated due to protocol violation|0|||
131066399|NCT00489489|471873834|FG001|Overall Study|Not treated due to protocol violation|1|||
131066400|NCT00489489|471873835|FG002|Overall Study|Not treated due to protocol violation|1|||
131066401|NCT00489489|471873833|FG000|Overall Study|Adverse Event|1|||
131066402|NCT00489489|471873834|FG001|Overall Study|Adverse Event|1|||
131066403|NCT00489489|471873835|FG002|Overall Study|Adverse Event|1|||
131066404|NCT00489489|471873833|FG000|Overall Study|Protocol Violation|1|||
131066405|NCT00489489|471873834|FG001|Overall Study|Protocol Violation|0|||
131066406|NCT00489489|471873835|FG002|Overall Study|Protocol Violation|1|||
131066407|NCT00489489|471873833|FG000|Overall Study|Progressive disease|0|||
131066408|NCT00489489|471873834|FG001|Overall Study|Progressive disease|1|||
131066409|NCT00489489|471873835|FG002|Overall Study|Progressive disease|0|||
131066410|NCT00489489|471873833|FG000|Overall Study|Participant did not wish to continue|1|||
131066411|NCT00489489|471873834|FG001|Overall Study|Participant did not wish to continue|1|||
131066412|NCT00489489|471873835|FG002|Overall Study|Participant did not wish to continue|0|||
131066413|NCT00489489|471873833|FG000|Overall Study|Other than above|0|||
131066414|NCT00489489|471873834|FG001|Overall Study|Other than above|1|||
131066415|NCT00489489|471873835|FG002|Overall Study|Other than above|0|||
131066416|NCT02101554|471873841|FG000|Overall Study|Protocol Violation|0|||
131066417|NCT02101554|471873842|FG001|Overall Study|Protocol Violation|1|||
131066418|NCT02101554|471873843|FG002|Overall Study|Protocol Violation|0|||
131066419|NCT02101554|471873841|FG000|Overall Study|Insufficient Clinical Response|0|||
131066420|NCT02101554|471873842|FG001|Overall Study|Insufficient Clinical Response|2|||
131066421|NCT02101554|471873843|FG002|Overall Study|Insufficient Clinical Response|0|||
131066422|NCT02101554|471873841|FG000|Overall Study|Adverse Event|2|||
131066423|NCT02101554|471873842|FG001|Overall Study|Adverse Event|1|||
131066424|NCT02101554|471873843|FG002|Overall Study|Adverse Event|1|||
131066425|NCT02101554|471873841|FG000|Overall Study|Lost to Follow-up|0|||
131066426|NCT02101554|471873842|FG001|Overall Study|Lost to Follow-up|1|||
131066427|NCT02101554|471873843|FG002|Overall Study|Lost to Follow-up|0|||
131066428|NCT02101554|471873841|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
131066429|NCT02101554|471873842|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
131066430|NCT02101554|471873843|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
131066431|NCT01350102|471873844|FG000|Overall Study|Adverse Event|0|||
131066432|NCT01350102|471873845|FG001|Overall Study|Adverse Event|0|||
131066433|NCT01350102|471873846|FG002|Overall Study|Adverse Event|1|||
131066434|NCT01350102|471873847|FG003|Overall Study|Adverse Event|0|||
131066435|NCT04523571|471873849|FG000|Received 2 Doses|Withdrawal by Subject|0|||
131066436|NCT04523571|471873850|FG001|Received 2 Doses|Withdrawal by Subject|0|||
131066437|NCT04523571|471873851|FG002|Received 2 Doses|Withdrawal by Subject|0|||
131066438|NCT04523571|471873852|FG003|Received 2 Doses|Withdrawal by Subject|1|||
131066439|NCT04523571|471873853|FG004|Received 2 Doses|Withdrawal by Subject|1|||
131066440|NCT04523571|471873854|FG005|Received 2 Doses|Withdrawal by Subject|0|||
131066441|NCT04523571|471873849|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
131066442|NCT04523571|471873850|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
131066443|NCT04523571|471873851|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
130779442|NCT02326272|470819499|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131066444|NCT04523571|471873852|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
131066445|NCT04523571|471873853|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
131066446|NCT04523571|471873854|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
131066447|NCT04523571|471873849|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
131066448|NCT04523571|471873850|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
131066449|NCT04523571|471873851|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
131066450|NCT04523571|471873852|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
131066451|NCT04523571|471873853|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
131066452|NCT04523571|471873854|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
131137631|NCT03403205|472130679|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131066453|NCT04523571|471873849|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
130779443|NCT02326272|470819500|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130779444|NCT02326272|470819501|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130779445|NCT02326272|470819502|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130779446|NCT02326272|470819503|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130779447|NCT02326272|470819504|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
131066454|NCT04523571|471873850|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
131066455|NCT04523571|471873851|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
131066456|NCT04523571|471873852|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
131066457|NCT04523571|471873853|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
131066458|NCT04523571|471873854|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
131066459|NCT04385849|471873856|FG000|Overall Study|Lost to Follow-up|1|||
131066460|NCT04385849|471873857|FG001|Overall Study|Lost to Follow-up|0|||
131066461|NCT01375777|471873858|FG000|Overall Study|Withdrawal by Subject|0|||
131066462|NCT01375777|471873859|FG001|Overall Study|Withdrawal by Subject|2|||
131066463|NCT01375777|471873860|FG002|Overall Study|Withdrawal by Subject|1|||
131066464|NCT01375777|471873861|FG003|Overall Study|Withdrawal by Subject|0|||
131066465|NCT01375777|471873862|FG004|Overall Study|Withdrawal by Subject|1|||
131066466|NCT01375777|471873863|FG005|Overall Study|Withdrawal by Subject|1|||
131066467|NCT01375777|471873864|FG006|Overall Study|Withdrawal by Subject|1|||
131066468|NCT01375777|471873865|FG007|Overall Study|Withdrawal by Subject|2|||
131066469|NCT01375777|471873866|FG008|Overall Study|Withdrawal by Subject|1|||
131066470|NCT01375777|471873858|FG000|Overall Study|Lost to Follow-up|1|||
131066471|NCT01375777|471873859|FG001|Overall Study|Lost to Follow-up|0|||
131066472|NCT01375777|471873860|FG002|Overall Study|Lost to Follow-up|0|||
131066473|NCT01375777|471873861|FG003|Overall Study|Lost to Follow-up|0|||
131066474|NCT01375777|471873862|FG004|Overall Study|Lost to Follow-up|0|||
131066475|NCT01375777|471873863|FG005|Overall Study|Lost to Follow-up|0|||
131066476|NCT01375777|471873864|FG006|Overall Study|Lost to Follow-up|1|||
131066477|NCT01375777|471873865|FG007|Overall Study|Lost to Follow-up|0|||
131066478|NCT01375777|471873866|FG008|Overall Study|Lost to Follow-up|0|||
131066479|NCT01375777|471873858|FG000|Overall Study|Other|1|||
131066480|NCT01375777|471873859|FG001|Overall Study|Other|1|||
131066481|NCT01375777|471873860|FG002|Overall Study|Other|0|||
131066482|NCT01375777|471873861|FG003|Overall Study|Other|0|||
131066483|NCT01375777|471873862|FG004|Overall Study|Other|0|||
131066484|NCT01375777|471873863|FG005|Overall Study|Other|0|||
131066485|NCT01375777|471873864|FG006|Overall Study|Other|0|||
131066486|NCT01375777|471873865|FG007|Overall Study|Other|0|||
131066487|NCT01375777|471873866|FG008|Overall Study|Other|1|||
131066488|NCT05878990|471873867|FG000|Overall Study|Lost to Follow-up|7|||
131066489|NCT05878990|471873867|FG000|Overall Study|Withdrawal by Subject|1|||
131066490|NCT01136733|471873870|FG000|Phase 1b|Adverse Event|0|||
131066491|NCT01136733|471873871|FG001|Phase 1b|Adverse Event|3|||
131066492|NCT01136733|471873872|FG002|Phase 1b|Adverse Event|1|||
131066493|NCT01136733|471873873|FG003|Phase 1b|Adverse Event|0|||
131066494|NCT01136733|471873874|FG004|Phase 1b|Adverse Event|0|||
131066495|NCT01136733|471873875|FG005|Phase 1b|Adverse Event|0|||
131066496|NCT01136733|471873876|FG006|Phase 1b|Adverse Event|0|||
131066497|NCT01136733|471873870|FG000|Phase 1b|Participant Choice|0|||
131066498|NCT01136733|471873871|FG001|Phase 1b|Participant Choice|0|||
131066499|NCT01136733|471873872|FG002|Phase 1b|Participant Choice|1|||
131066500|NCT01136733|471873873|FG003|Phase 1b|Participant Choice|0|||
131066501|NCT01136733|471873874|FG004|Phase 1b|Participant Choice|0|||
131137632|NCT03403205|472130680|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131137633|NCT03403205|472130675|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
131137634|NCT03403205|472130676|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
131137635|NCT03403205|472130677|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
131137636|NCT03403205|472130678|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
131137637|NCT03403205|472130679|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
131137638|NCT03403205|472130680|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
131066502|NCT01136733|471873875|FG005|Phase 1b|Participant Choice|0|||
131066503|NCT01136733|471873876|FG006|Phase 1b|Participant Choice|0|||
131066504|NCT01136733|471873870|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
131066505|NCT01136733|471873871|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
131066506|NCT01136733|471873872|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
131066507|NCT01136733|471873873|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
131066508|NCT01136733|471873874|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
131066509|NCT01136733|471873875|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
131066510|NCT01136733|471873876|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
131066511|NCT01136733|471873870|FG000|Phase 1b|Clinical Progression|1|||
131066512|NCT01136733|471873871|FG001|Phase 1b|Clinical Progression|1|||
131066513|NCT01136733|471873872|FG002|Phase 1b|Clinical Progression|0|||
131066514|NCT01136733|471873873|FG003|Phase 1b|Clinical Progression|0|||
131066515|NCT01136733|471873874|FG004|Phase 1b|Clinical Progression|0|||
131066516|NCT01136733|471873875|FG005|Phase 1b|Clinical Progression|0|||
131066517|NCT01136733|471873876|FG006|Phase 1b|Clinical Progression|0|||
131066518|NCT01136733|471873870|FG000|Phase 2|Disease Progression|0|||
131066519|NCT01136733|471873871|FG001|Phase 2|Disease Progression|0|||
131066520|NCT01136733|471873872|FG002|Phase 2|Disease Progression|0|||
131066521|NCT01136733|471873873|FG003|Phase 2|Disease Progression|0|||
131066522|NCT01136733|471873874|FG004|Phase 2|Disease Progression|30|||
131066523|NCT01136733|471873875|FG005|Phase 2|Disease Progression|32|||
131066524|NCT01136733|471873876|FG006|Phase 2|Disease Progression|38|||
131066525|NCT01136733|471873870|FG000|Phase 2|Adverse Event|0|||
131066526|NCT01136733|471873871|FG001|Phase 2|Adverse Event|0|||
131066527|NCT01136733|471873872|FG002|Phase 2|Adverse Event|0|||
131066528|NCT01136733|471873873|FG003|Phase 2|Adverse Event|0|||
131066529|NCT01136733|471873874|FG004|Phase 2|Adverse Event|11|||
131066530|NCT01136733|471873875|FG005|Phase 2|Adverse Event|13|||
131066531|NCT01136733|471873876|FG006|Phase 2|Adverse Event|5|||
131066532|NCT01136733|471873870|FG000|Phase 2|Participant Choice|0|||
131066533|NCT01136733|471873871|FG001|Phase 2|Participant Choice|0|||
131066534|NCT01136733|471873872|FG002|Phase 2|Participant Choice|0|||
131066535|NCT01136733|471873873|FG003|Phase 2|Participant Choice|0|||
131066536|NCT01136733|471873874|FG004|Phase 2|Participant Choice|3|||
131066537|NCT01136733|471873875|FG005|Phase 2|Participant Choice|0|||
131066538|NCT01136733|471873876|FG006|Phase 2|Participant Choice|1|||
131066539|NCT01136733|471873870|FG000|Phase 2|Administrative-Withdrew Consent|0|||
131066540|NCT01136733|471873871|FG001|Phase 2|Administrative-Withdrew Consent|0|||
131066541|NCT01136733|471873872|FG002|Phase 2|Administrative-Withdrew Consent|0|||
131066542|NCT01136733|471873873|FG003|Phase 2|Administrative-Withdrew Consent|0|||
131066543|NCT01136733|471873874|FG004|Phase 2|Administrative-Withdrew Consent|1|||
131066544|NCT01136733|471873875|FG005|Phase 2|Administrative-Withdrew Consent|0|||
131066545|NCT01136733|471873876|FG006|Phase 2|Administrative-Withdrew Consent|0|||
131066546|NCT01136733|471873870|FG000|Phase 2|Other|0|||
131066547|NCT01136733|471873871|FG001|Phase 2|Other|0|||
131066548|NCT01136733|471873872|FG002|Phase 2|Other|0|||
131066549|NCT01136733|471873873|FG003|Phase 2|Other|0|||
131066550|NCT01136733|471873874|FG004|Phase 2|Other|6|||
131066551|NCT01136733|471873875|FG005|Phase 2|Other|7|||
131066552|NCT01136733|471873876|FG006|Phase 2|Other|6|||
131066553|NCT03314233|471873883|FG000|Overall Study|No longer eligible at time of delivery|1|||
131066554|NCT00168805|471873885|FG000|Overall Study|Adverse Event|7|||
131066555|NCT00168805|471873886|FG001|Overall Study|Adverse Event|11|||
131066556|NCT00168805|471873887|FG002|Overall Study|Adverse Event|16|||
131066557|NCT00168805|471873885|FG000|Overall Study|Protocol Violation|12|||
131066558|NCT00168805|471873886|FG001|Overall Study|Protocol Violation|11|||
131066559|NCT00168805|471873887|FG002|Overall Study|Protocol Violation|8|||
131066560|NCT00168805|471873885|FG000|Overall Study|Lost to Follow-up|12|||
131066561|NCT00168805|471873886|FG001|Overall Study|Lost to Follow-up|17|||
131066562|NCT00168805|471873887|FG002|Overall Study|Lost to Follow-up|11|||
131066563|NCT00168805|471873885|FG000|Overall Study|Withdrawal by Subject|16|||
131066564|NCT00168805|471873886|FG001|Overall Study|Withdrawal by Subject|18|||
131066565|NCT00168805|471873887|FG002|Overall Study|Withdrawal by Subject|21|||
131066566|NCT00168805|471873885|FG000|Overall Study|Other|24|||
131066567|NCT00168805|471873886|FG001|Overall Study|Other|21|||
131066568|NCT00168805|471873887|FG002|Overall Study|Other|22|||
131066569|NCT00168805|471873885|FG000|Treatment|Adverse Event|25|||
131066570|NCT00168805|471873886|FG001|Treatment|Adverse Event|26|||
131066571|NCT00168805|471873887|FG002|Treatment|Adverse Event|32|||
131066572|NCT00168805|471873885|FG000|Treatment|Protocol Violation|3|||
131066573|NCT00168805|471873886|FG001|Treatment|Protocol Violation|5|||
131066574|NCT00168805|471873887|FG002|Treatment|Protocol Violation|5|||
131066575|NCT00168805|471873885|FG000|Treatment|Withdrawal by Subject|3|||
131066576|NCT00168805|471873886|FG001|Treatment|Withdrawal by Subject|7|||
131066577|NCT00168805|471873887|FG002|Treatment|Withdrawal by Subject|8|||
131066578|NCT00168805|471873885|FG000|Treatment|Other|18|||
131066579|NCT00168805|471873886|FG001|Treatment|Other|18|||
131230090|NCT03273387|472469272|FG000|Overall Study|Withdrawal by Subject|1|||
131066580|NCT00168805|471873887|FG002|Treatment|Other|17|||
131066581|NCT01114217|471873888|FG000|Overall Study|Adverse Event|5|||
131066582|NCT01114217|471873889|FG001|Overall Study|Adverse Event|3|||
131066583|NCT01114217|471873888|FG000|Overall Study|Lost to Follow-up|17|||
131066584|NCT01114217|471873889|FG001|Overall Study|Lost to Follow-up|33|||
131066585|NCT01114217|471873888|FG000|Overall Study|Withdrawal by Subject|21|||
131066586|NCT01114217|471873889|FG001|Overall Study|Withdrawal by Subject|28|||
131066587|NCT01114217|471873888|FG000|Overall Study|Other-Clerical Error|3|||
131066588|NCT01114217|471873889|FG001|Overall Study|Other-Clerical Error|0|||
131066589|NCT01114217|471873888|FG000|Overall Study|Other-Early termination|6|||
131066590|NCT01114217|471873889|FG001|Overall Study|Other-Early termination|10|||
131066591|NCT01114217|471873888|FG000|Overall Study|Other-Procedure|1|||
131066592|NCT01114217|471873889|FG001|Overall Study|Other-Procedure|1|||
131066593|NCT01114217|471873888|FG000|Overall Study|Other-Pregnancy|2|||
131066594|NCT01114217|471873889|FG001|Overall Study|Other-Pregnancy|4|||
131066595|NCT01114217|471873888|FG000|Overall Study|Other-Protocol Violation|1|||
131066596|NCT01114217|471873889|FG001|Overall Study|Other-Protocol Violation|3|||
131066597|NCT01114217|471873888|FG000|Overall Study|Other-Lack of Efficacy|1|||
131066598|NCT01114217|471873889|FG001|Overall Study|Other-Lack of Efficacy|0|||
131066599|NCT01114217|471873888|FG000|Overall Study|Other-Non Compliance|2|||
131066600|NCT01114217|471873889|FG001|Overall Study|Other-Non Compliance|0|||
131066601|NCT01114217|471873888|FG000|Overall Study|Other-Physician Decision|1|||
131066602|NCT01114217|471873889|FG001|Overall Study|Other-Physician Decision|1|||
131066603|NCT01114217|471873888|FG000|Overall Study|Other-Sponsor Decision|10|||
131066604|NCT01114217|471873889|FG001|Overall Study|Other-Sponsor Decision|12|||
131066605|NCT01114217|471873888|FG000|Overall Study|Other-Study Termination|0|||
131066606|NCT01114217|471873889|FG001|Overall Study|Other-Study Termination|1|||
131066607|NCT01114217|471873888|FG000|Overall Study|Other-Study Withdrawn|1|||
131066608|NCT01114217|471873889|FG001|Overall Study|Other-Study Withdrawn|1|||
131066609|NCT01114217|471873888|FG000|Overall Study|Other-Site Stopped Communicating|2|||
131066610|NCT01114217|471873889|FG001|Overall Study|Other-Site Stopped Communicating|0|||
131066611|NCT01114217|471873888|FG000|Overall Study|Other-Lost to Follow-up|1|||
131066612|NCT01114217|471873889|FG001|Overall Study|Other-Lost to Follow-up|0|||
131066613|NCT01114217|471873888|FG000|Overall Study|Other-Withdrawal by Subject|1|||
131066614|NCT01114217|471873889|FG001|Overall Study|Other-Withdrawal by Subject|1|||
131066615|NCT01183013|471873892|FG000|Overall Study|Adverse Event|6|||
131066616|NCT01183013|471873893|FG001|Overall Study|Adverse Event|8|||
131066617|NCT01183013|471873894|FG002|Overall Study|Adverse Event|5|||
131066618|NCT01183013|471873895|FG003|Overall Study|Adverse Event|5|||
131066619|NCT01183013|471873896|FG004|Overall Study|Adverse Event|10|||
131066620|NCT01183013|471873897|FG005|Overall Study|Adverse Event|10|||
131066621|NCT01183013|471873898|FG006|Overall Study|Adverse Event|6|||
131066622|NCT01183013|471873892|FG000|Overall Study|Lack of Efficacy|3|||
131066623|NCT01183013|471873893|FG001|Overall Study|Lack of Efficacy|2|||
131066624|NCT01183013|471873894|FG002|Overall Study|Lack of Efficacy|1|||
131066625|NCT01183013|471873895|FG003|Overall Study|Lack of Efficacy|2|||
130723260|NCT03480386|470611395|FG000|Overall Study|Complicating disease|0|||
131066626|NCT01183013|471873896|FG004|Overall Study|Lack of Efficacy|1|||
131066627|NCT01183013|471873897|FG005|Overall Study|Lack of Efficacy|2|||
130723261|NCT03480386|470611396|FG001|Overall Study|Complicating disease|1|||
131066628|NCT01183013|471873898|FG006|Overall Study|Lack of Efficacy|0|||
131066629|NCT01183013|471873892|FG000|Overall Study|Protocol Violation|5|||
131066630|NCT01183013|471873893|FG001|Overall Study|Protocol Violation|2|||
131066631|NCT01183013|471873894|FG002|Overall Study|Protocol Violation|4|||
131066632|NCT01183013|471873895|FG003|Overall Study|Protocol Violation|0|||
131066633|NCT01183013|471873896|FG004|Overall Study|Protocol Violation|4|||
131066634|NCT01183013|471873897|FG005|Overall Study|Protocol Violation|3|||
131066635|NCT01183013|471873898|FG006|Overall Study|Protocol Violation|3|||
131066636|NCT01183013|471873892|FG000|Overall Study|Lost to Follow-up|7|||
131066637|NCT01183013|471873893|FG001|Overall Study|Lost to Follow-up|3|||
131066638|NCT01183013|471873894|FG002|Overall Study|Lost to Follow-up|4|||
131066639|NCT01183013|471873895|FG003|Overall Study|Lost to Follow-up|3|||
131066640|NCT01183013|471873896|FG004|Overall Study|Lost to Follow-up|2|||
131066641|NCT01183013|471873897|FG005|Overall Study|Lost to Follow-up|6|||
131066642|NCT01183013|471873898|FG006|Overall Study|Lost to Follow-up|5|||
131066643|NCT01183013|471873892|FG000|Overall Study|Withdrawal by Subject|9|||
131066644|NCT01183013|471873893|FG001|Overall Study|Withdrawal by Subject|13|||
131066645|NCT01183013|471873894|FG002|Overall Study|Withdrawal by Subject|10|||
131066646|NCT01183013|471873895|FG003|Overall Study|Withdrawal by Subject|8|||
131066647|NCT01183013|471873896|FG004|Overall Study|Withdrawal by Subject|7|||
131066648|NCT01183013|471873897|FG005|Overall Study|Withdrawal by Subject|9|||
131066649|NCT01183013|471873898|FG006|Overall Study|Withdrawal by Subject|10|||
131066650|NCT01183013|471873892|FG000|Overall Study|Reasons other than stated above|15|||
131066651|NCT01183013|471873893|FG001|Overall Study|Reasons other than stated above|11|||
131066652|NCT01183013|471873894|FG002|Overall Study|Reasons other than stated above|17|||
131066653|NCT01183013|471873895|FG003|Overall Study|Reasons other than stated above|12|||
131066654|NCT01183013|471873896|FG004|Overall Study|Reasons other than stated above|12|||
131066655|NCT01183013|471873897|FG005|Overall Study|Reasons other than stated above|15|||
131066656|NCT01183013|471873898|FG006|Overall Study|Reasons other than stated above|13|||
131066657|NCT03785210|471873899|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
131066658|NCT03785210|471873900|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
131066659|NCT00472199|471873904|FG000|Overall Study|Adverse Event|19|||
131137639|NCT03403205|472130675|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
131137640|NCT03403205|472130676|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
131066660|NCT00472199|471873905|FG001|Overall Study|Adverse Event|23|||
131066661|NCT00472199|471873904|FG000|Overall Study|Lack of Efficacy|4|||
131066662|NCT00472199|471873905|FG001|Overall Study|Lack of Efficacy|25|||
131066663|NCT00472199|471873904|FG000|Overall Study|Lost to Follow-up|2|||
131066664|NCT00472199|471873905|FG001|Overall Study|Lost to Follow-up|4|||
131066665|NCT00472199|471873904|FG000|Overall Study|Protocol Violation|3|||
131066666|NCT00472199|471873905|FG001|Overall Study|Protocol Violation|2|||
130723262|NCT03480386|470611395|FG000|Overall Study|Disease progression|3|||
130723263|NCT03480386|470611396|FG001|Overall Study|Disease progression|0|||
131066667|NCT00472199|471873904|FG000|Overall Study|Withdrawal by Subject|6|||
131066668|NCT00472199|471873905|FG001|Overall Study|Withdrawal by Subject|5|||
131066669|NCT00472199|471873904|FG000|Overall Study|personal reason|0|||
131066670|NCT00472199|471873905|FG001|Overall Study|personal reason|1|||
131066671|NCT00472199|471873904|FG000|Overall Study|patient was asymptomatic|1|||
131066672|NCT00472199|471873905|FG001|Overall Study|patient was asymptomatic|0|||
131066673|NCT01757171|471873906|FG000|Overall Study|Adverse Event|5|||
131066674|NCT01757171|471873907|FG001|Overall Study|Adverse Event|1|||
131066675|NCT01757171|471873906|FG000|Overall Study|Disease Progression|1|||
131066676|NCT01757171|471873907|FG001|Overall Study|Disease Progression|0|||
131066677|NCT01757171|471873906|FG000|Overall Study|Hospitalization|1|||
131066678|NCT01757171|471873907|FG001|Overall Study|Hospitalization|0|||
131066679|NCT01757171|471873906|FG000|Overall Study|ECOG decline|1|||
131066680|NCT01757171|471873907|FG001|Overall Study|ECOG decline|0|||
131066681|NCT01014013|471873911|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
131066682|NCT01014013|471873912|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
131066683|NCT01014013|471873911|FG000|Overall Study|Clinical adverse experience|4|||
131066684|NCT01014013|471873912|FG001|Overall Study|Clinical adverse experience|2|||
131066685|NCT01014013|471873911|FG000|Overall Study|Laboratory adverse experience|1|||
131066686|NCT01014013|471873912|FG001|Overall Study|Laboratory adverse experience|1|||
131066687|NCT01014013|471873911|FG000|Overall Study|Protocol Violation|1|||
131066688|NCT01014013|471873912|FG001|Overall Study|Protocol Violation|3|||
131066689|NCT01014013|471873911|FG000|Overall Study|Withdrawal by Subject|7|||
131066690|NCT01014013|471873912|FG001|Overall Study|Withdrawal by Subject|4|||
131066691|NCT01014013|471873911|FG000|Overall Study|Clinical/microbiologic failure|1|||
131066692|NCT01014013|471873912|FG001|Overall Study|Clinical/microbiologic failure|2|||
131066693|NCT01014013|471873911|FG000|Overall Study|Pathogen culture = no growth|26|||
131066694|NCT01014013|471873912|FG001|Overall Study|Pathogen culture = no growth|34|||
131066695|NCT01014013|471873911|FG000|Overall Study|Negative urine culture|2|||
131066696|NCT01014013|471873912|FG001|Overall Study|Negative urine culture|0|||
131066697|NCT01014013|471873911|FG000|Overall Study|Pathogen resistant|7|||
131066698|NCT01014013|471873912|FG001|Overall Study|Pathogen resistant|4|||
131066699|NCT01014013|471873911|FG000|Overall Study|Physician Decision|0|||
131066700|NCT01014013|471873912|FG001|Overall Study|Physician Decision|1|||
131066701|NCT01014013|471873911|FG000|Overall Study|Another antibiotic therapy required|0|||
131066702|NCT01014013|471873912|FG001|Overall Study|Another antibiotic therapy required|1|||
131066703|NCT01014013|471873911|FG000|Overall Study|Appendectomy|1|||
131066704|NCT01014013|471873912|FG001|Overall Study|Appendectomy|0|||
131066705|NCT01014013|471873911|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
131066706|NCT01014013|471873912|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
131066707|NCT00316121|471873913|FG000|Overall Study|Death|1|||
131066708|NCT00316121|471873914|FG001|Overall Study|Death|0|||
131066709|NCT00316121|471873913|FG000|Overall Study|Lost to Follow-up|14|||
131066710|NCT00316121|471873914|FG001|Overall Study|Lost to Follow-up|8|||
131066711|NCT00316121|471873913|FG000|Overall Study|Withdrawal by Subject|2|||
131066712|NCT00316121|471873914|FG001|Overall Study|Withdrawal by Subject|0|||
131066713|NCT00316121|471873913|FG000|Overall Study|Reason is missing|1|||
131066714|NCT00316121|471873914|FG001|Overall Study|Reason is missing|0|||
131066715|NCT00316121|471873913|FG000|Overall Study|Subject relocated|1|||
131066716|NCT00316121|471873914|FG001|Overall Study|Subject relocated|1|||
131066717|NCT00316121|471873913|FG000|Overall Study|Subject refused to return|1|||
131066718|NCT00316121|471873914|FG001|Overall Study|Subject refused to return|0|||
131066719|NCT00316121|471873913|FG000|Overall Study|Subject no show for visit x 3|1|||
131066720|NCT00316121|471873914|FG001|Overall Study|Subject no show for visit x 3|0|||
131066721|NCT00316121|471873913|FG000|Overall Study|Subject did not have 24 month visit|1|||
131066722|NCT00316121|471873914|FG001|Overall Study|Subject did not have 24 month visit|0|||
131066723|NCT05274906|471873915|FG000|Overall Study|Withdrawal by Subject|2|||
131066724|NCT05274906|471873916|FG001|Overall Study|Withdrawal by Subject|1|||
131066725|NCT02213458|471873919|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
131066726|NCT02213458|471873920|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
131066727|NCT02213458|471873919|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
131066728|NCT02213458|471873920|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
131066729|NCT02213458|471873919|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
131066730|NCT02213458|471873920|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
131066731|NCT02213458|471873919|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
131066732|NCT02213458|471873920|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
131066733|NCT02213458|471873919|FG000|Overall Study|Refused re-consent|6|||
131066734|NCT02213458|471873920|FG001|Overall Study|Refused re-consent|0|||
131066735|NCT02213458|471873919|FG000|Overall Study|Lost to Follow-up|2|||
131066736|NCT02213458|471873920|FG001|Overall Study|Lost to Follow-up|2|||
131066737|NCT02213458|471873919|FG000|Overall Study|Withdrawal by Subject|26|||
131066738|NCT02213458|471873920|FG001|Overall Study|Withdrawal by Subject|8|||
131066739|NCT00910871|471873921|FG000|Overall Study|Adverse Event|5|||
131066740|NCT00910871|471873921|FG000|Overall Study|Death|12|||
131066741|NCT00910871|471873921|FG000|Overall Study|Lost to Follow-up|8|||
131066742|NCT00910871|471873921|FG000|Overall Study|Protocol Violation|11|||
131066743|NCT00910871|471873921|FG000|Overall Study|Withdrawal by Subject|12|||
131066744|NCT00910871|471873921|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
131066745|NCT00910871|471873921|FG000|Overall Study|Undefined|1|||
131066746|NCT04551053|471873922|FG000|Overall Study|Death|10|||
131066747|NCT04551053|471873923|FG001|Overall Study|Death|9|||
131066748|NCT04551053|471873922|FG000|Overall Study|Lost to Follow-up|0|||
131066749|NCT04551053|471873923|FG001|Overall Study|Lost to Follow-up|2|||
131066750|NCT04551053|471873922|FG000|Overall Study|Study Terminated by Sponsor|57|||
131066751|NCT04551053|471873923|FG001|Overall Study|Study Terminated by Sponsor|65|||
131066752|NCT04551053|471873922|FG000|Overall Study|Withdrawal by Subject|12|||
131066753|NCT04551053|471873923|FG001|Overall Study|Withdrawal by Subject|5|||
131066754|NCT04551053|471873922|FG000|Overall Study|Adverse Event|2|||
131066755|NCT04551053|471873923|FG001|Overall Study|Adverse Event|0|||
131066756|NCT04551053|471873922|FG000|Overall Study|Lack of Efficacy|2|||
131066757|NCT04551053|471873923|FG001|Overall Study|Lack of Efficacy|1|||
131066758|NCT04551053|471873922|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
131066759|NCT04551053|471873923|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
131066760|NCT04551053|471873922|FG000|Overall Study|Splenapendectomi|1|||
131066761|NCT04551053|471873923|FG001|Overall Study|Splenapendectomi|0|||
131066762|NCT04551053|471873922|FG000|Overall Study|Medical Decision|1|||
131066763|NCT04551053|471873923|FG001|Overall Study|Medical Decision|1|||
131066764|NCT01075815|471873924|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
131066765|NCT01075815|471873925|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
131066766|NCT01075815|471873924|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
131066767|NCT01075815|471873925|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
131066768|NCT01075815|471873924|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
131066769|NCT01075815|471873925|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
131066770|NCT03503188|471873926|FG000|Overall Study|Non eligible in the sub study|0|||
131066771|NCT03503188|471873927|FG001|Overall Study|Non eligible in the sub study|1|||
131066772|NCT03747575|471873934|FG000|Overall Study|Withdrawal by Subject|6|||
131066773|NCT03747575|471873935|FG001|Overall Study|Withdrawal by Subject|3|||
131066774|NCT03747575|471873934|FG000|Overall Study|Lost to Follow-up|3|||
131066775|NCT03747575|471873935|FG001|Overall Study|Lost to Follow-up|3|||
131066776|NCT03747575|471873934|FG000|Overall Study|Adverse Event|0|||
131066777|NCT03747575|471873935|FG001|Overall Study|Adverse Event|1|||
131066778|NCT03005106|471873936|FG000|Overall Study|Lost to Follow-up|16|||
131066779|NCT03005106|471873936|FG000|Overall Study|Adverse Event|1|||
131066780|NCT03005106|471873936|FG000|Overall Study|Physician Decision|1|||
131066781|NCT03005106|471873936|FG000|Overall Study|Death|2|||
131066782|NCT03019289|471873937|FG000|Overall Study|Adverse Event|1|||
131066783|NCT03019289|471873938|FG001|Overall Study|Adverse Event|0|||
131066784|NCT03019289|471873939|FG002|Overall Study|Adverse Event|0|||
131066785|NCT03019289|471873940|FG003|Overall Study|Adverse Event|0|||
131066786|NCT03019289|471873941|FG004|Overall Study|Adverse Event|0|||
131066787|NCT03019289|471873942|FG005|Overall Study|Adverse Event|0|||
131066788|NCT03019289|471873943|FG006|Overall Study|Adverse Event|0|||
131066789|NCT03019289|471873944|FG007|Overall Study|Adverse Event|0|||
131066790|NCT03019289|471873945|FG008|Overall Study|Adverse Event|1|||
131066791|NCT03019289|471873937|FG000|Overall Study|Other|1|||
131066792|NCT03019289|471873938|FG001|Overall Study|Other|0|||
131066793|NCT03019289|471873939|FG002|Overall Study|Other|0|||
131066794|NCT03019289|471873940|FG003|Overall Study|Other|0|||
131066795|NCT03019289|471873941|FG004|Overall Study|Other|0|||
131066796|NCT03019289|471873942|FG005|Overall Study|Other|0|||
131066797|NCT03019289|471873943|FG006|Overall Study|Other|0|||
131066798|NCT03019289|471873944|FG007|Overall Study|Other|0|||
131066799|NCT03019289|471873945|FG008|Overall Study|Other|0|||
131066800|NCT02389894|471873946|FG000|Overall Study|Death|4|||
131066801|NCT02389894|471873947|FG001|Overall Study|Death|5|||
131066802|NCT02389894|471873948|FG002|Overall Study|Death|3|||
131066803|NCT02389894|471873946|FG000|Overall Study|Withdrawal by Subject|2|||
131066804|NCT02389894|471873947|FG001|Overall Study|Withdrawal by Subject|4|||
131066805|NCT02389894|471873948|FG002|Overall Study|Withdrawal by Subject|5|||
131066806|NCT02389894|471873946|FG000|Overall Study|Lost to Follow-up|2|||
131066807|NCT02389894|471873947|FG001|Overall Study|Lost to Follow-up|1|||
130723264|NCT03480386|470611395|FG000|Overall Study|Became ineligible|0|||
130723265|NCT03480386|470611396|FG001|Overall Study|Became ineligible|2|||
130723266|NCT00574912|470611397|FG000|Overall Study|Could not place IV lines.|3|||
131066808|NCT02389894|471873948|FG002|Overall Study|Lost to Follow-up|1|||
131066809|NCT01549951|471873949|FG000|Overall Study|Adverse Event|15|||
131066810|NCT01549951|471873949|FG000|Overall Study|Withdrawal by Subject|2|||
131066811|NCT01549951|471873949|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
131137641|NCT03403205|472130677|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
131137642|NCT03403205|472130678|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
131066812|NCT01549951|471873949|FG000|Overall Study|Progressive disease|29|||
131066813|NCT01549951|471873949|FG000|Overall Study|Symptomatic deterioration|1|||
131066814|NCT01549951|471873949|FG000|Overall Study|Other|2|||
131066815|NCT01052714|471873953|FG000|Overall Study|Adverse Event|6|||
131230091|NCT03273387|472469273|FG001|Overall Study|Withdrawal by Subject|1|||
131230092|NCT02049359|472469274|FG000|Overall Study|Lost to Follow-up|26|||
131230093|NCT02049359|472469275|FG001|Overall Study|Lost to Follow-up|19|||
131230094|NCT02180061|472469276|FG000|Overall Study|Adverse Event|4|||
131230095|NCT02180061|472469277|FG001|Overall Study|Adverse Event|2|||
131230096|NCT02180061|472469276|FG000|Overall Study|Clinical Progression|5|||
131230097|NCT02180061|472469277|FG001|Overall Study|Clinical Progression|1|||
131230098|NCT02180061|472469276|FG000|Overall Study|Progressive Disease|15|||
131230099|NCT02180061|472469277|FG001|Overall Study|Progressive Disease|5|||
131230100|NCT02180061|472469276|FG000|Overall Study|Physician Decision|1|||
131230101|NCT02180061|472469277|FG001|Overall Study|Physician Decision|0|||
131230102|NCT02040428|472469297|FG000|Overall Study|Death|4|||
131230103|NCT02040428|472469298|FG001|Overall Study|Death|3|||
131230104|NCT02040428|472469297|FG000|Overall Study|Withdrawal by Subject|1|||
131230105|NCT02040428|472469298|FG001|Overall Study|Withdrawal by Subject|1|||
131230106|NCT03551730|472469299|FG000|Overall Study|Adverse Event|1|||
131230107|NCT03551730|472469300|FG001|Overall Study|Adverse Event|0|||
131230108|NCT03551730|472469301|FG002|Overall Study|Adverse Event|0|||
131230109|NCT03551730|472469302|FG003|Overall Study|Adverse Event|0|||
131230110|NCT01165996|472469316|FG000|Overall Study|Death|1|||
131230111|NCT01165996|472469316|FG000|Overall Study|Physician Decision|1|||
131230112|NCT03907280|472469333|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
131230113|NCT03907280|472469334|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
131230114|NCT03907280|472469335|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
131230115|NCT01927757|472469336|FG000|Overall Study|Withdrawal by Subject|14|||
131230116|NCT01927757|472469336|FG000|Overall Study|Lost to Follow-up|2|||
131230117|NCT01927757|472469336|FG000|Overall Study|Decision by Sponsor|2|||
131230118|NCT01927757|472469336|FG000|Overall Study|Other|1|||
131230119|NCT01927757|472469336|FG000|Overall Study|Ethical Reasons|4|||
131230120|NCT01399723|472469337|FG000|Overall Study|Lost to Follow-up|0|||
131230121|NCT01399723|472469338|FG001|Overall Study|Lost to Follow-up|1|||
131230122|NCT00673361|472469344|FG000|Overall Study|Screen Failure|2|||
131230123|NCT01464827|472469345|FG000|Overall Study|Adverse Event|0|||
131230124|NCT01464827|472469346|FG001|Overall Study|Adverse Event|0|||
131230125|NCT01464827|472469347|FG002|Overall Study|Adverse Event|0|||
131230126|NCT01464827|472469348|FG003|Overall Study|Adverse Event|0|||
131230127|NCT01464827|472469349|FG004|Overall Study|Adverse Event|0|||
131230128|NCT01464827|472469350|FG005|Overall Study|Adverse Event|0|||
131230129|NCT01464827|472469351|FG006|Overall Study|Adverse Event|0|||
131230130|NCT01464827|472469352|FG007|Overall Study|Adverse Event|0|||
131230131|NCT01464827|472469353|FG008|Overall Study|Adverse Event|0|||
131230132|NCT01464827|472469354|FG009|Overall Study|Adverse Event|0|||
131230133|NCT01464827|472469355|FG010|Overall Study|Adverse Event|0|||
131230134|NCT01464827|472469356|FG011|Overall Study|Adverse Event|0|||
131230135|NCT01464827|472469357|FG012|Overall Study|Adverse Event|1|||
131230136|NCT01464827|472469358|FG013|Overall Study|Adverse Event|0|||
131230137|NCT01464827|472469345|FG000|Overall Study|Withdrawal by Subject|1|||
131230138|NCT01464827|472469346|FG001|Overall Study|Withdrawal by Subject|0|||
131230139|NCT01464827|472469347|FG002|Overall Study|Withdrawal by Subject|0|||
131230140|NCT01464827|472469348|FG003|Overall Study|Withdrawal by Subject|0|||
131230141|NCT01464827|472469349|FG004|Overall Study|Withdrawal by Subject|1|||
131230142|NCT01464827|472469350|FG005|Overall Study|Withdrawal by Subject|0|||
131230143|NCT01464827|472469351|FG006|Overall Study|Withdrawal by Subject|0|||
131230144|NCT01464827|472469352|FG007|Overall Study|Withdrawal by Subject|1|||
131230145|NCT01464827|472469353|FG008|Overall Study|Withdrawal by Subject|0|||
131230146|NCT01464827|472469354|FG009|Overall Study|Withdrawal by Subject|0|||
130723267|NCT00574912|470611397|FG000|Overall Study|scheduling conflicts|3|||
130723268|NCT00574912|470611397|FG000|Overall Study|Physician Decision|2|||
131066816|NCT01052714|471873954|FG001|Overall Study|Adverse Event|3|||
130723269|NCT02099682|470611402|FG000|Overall Study|Data Not Available|51|||
130723270|NCT02099682|470611402|FG000|Overall Study|Lost to Follow-up|31|||
131066817|NCT01052714|471873955|FG002|Overall Study|Adverse Event|0|||
131066818|NCT01052714|471873953|FG000|Overall Study|Death|1|||
131066819|NCT01052714|471873954|FG001|Overall Study|Death|2|||
131066820|NCT01052714|471873955|FG002|Overall Study|Death|0|||
131230147|NCT01464827|472469355|FG010|Overall Study|Withdrawal by Subject|0|||
131230148|NCT01464827|472469356|FG011|Overall Study|Withdrawal by Subject|0|||
131230149|NCT01464827|472469357|FG012|Overall Study|Withdrawal by Subject|0|||
131230150|NCT01464827|472469358|FG013|Overall Study|Withdrawal by Subject|0|||
131230151|NCT01464827|472469345|FG000|Overall Study|Lost to Follow-up|0|||
131230152|NCT01464827|472469346|FG001|Overall Study|Lost to Follow-up|2|||
131230153|NCT01464827|472469347|FG002|Overall Study|Lost to Follow-up|0|||
131230154|NCT01464827|472469348|FG003|Overall Study|Lost to Follow-up|2|||
131230155|NCT01464827|472469349|FG004|Overall Study|Lost to Follow-up|3|||
130723271|NCT02099682|470611402|FG000|Overall Study|Other|29|||
131066821|NCT01052714|471873953|FG000|Overall Study|Lost to Follow-up|2|||
131066822|NCT01052714|471873954|FG001|Overall Study|Lost to Follow-up|3|||
131230156|NCT01464827|472469350|FG005|Overall Study|Lost to Follow-up|1|||
130723272|NCT02551666|470611403|FG000|Overall Study|Withdrawal by Subject|1|||
130723273|NCT02551666|470611404|FG001|Overall Study|Withdrawal by Subject|3|||
130723274|NCT00805467|470613410|FG000|Overall Study|Lack of Efficacy|0|||
130723275|NCT00805467|470613411|FG001|Overall Study|Lack of Efficacy|8|||
130723276|NCT00805467|470613412|FG002|Overall Study|Lack of Efficacy|13|||
130723277|NCT00805467|470613413|FG003|Overall Study|Lack of Efficacy|86|||
131066823|NCT01052714|471873955|FG002|Overall Study|Lost to Follow-up|0|||
131066824|NCT01052714|471873953|FG000|Overall Study|Physician Decision|9|||
131066825|NCT01052714|471873954|FG001|Overall Study|Physician Decision|9|||
131066826|NCT01052714|471873955|FG002|Overall Study|Physician Decision|1|||
131066827|NCT01052714|471873953|FG000|Overall Study|Withdrawal by Subject|7|||
131066828|NCT01052714|471873954|FG001|Overall Study|Withdrawal by Subject|12|||
131066829|NCT01052714|471873955|FG002|Overall Study|Withdrawal by Subject|1|||
131066830|NCT03689452|471873958|FG000|Overall Study|Lost to Follow-up|1|||
131066831|NCT03689452|471873959|FG001|Overall Study|Lost to Follow-up|1|||
131066832|NCT02676778|471873961|FG000|Overall Study|Disease Progression|7|||
131066833|NCT02676778|471873962|FG001|Overall Study|Disease Progression|3|||
131066834|NCT02676778|471873963|FG002|Overall Study|Disease Progression|1|||
131137643|NCT03403205|472130679|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
131137644|NCT03403205|472130680|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
131137645|NCT03403205|472130675|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
131137646|NCT03403205|472130676|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
131137647|NCT03403205|472130677|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
131137648|NCT03403205|472130678|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
131137649|NCT03403205|472130679|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
131137650|NCT03403205|472130680|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
131137651|NCT03403205|472130675|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
131137652|NCT03403205|472130676|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
131137653|NCT03403205|472130677|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
131137654|NCT03403205|472130678|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
131137655|NCT03403205|472130679|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
131137656|NCT03403205|472130680|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
131137657|NCT03403205|472130675|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
131137658|NCT03403205|472130676|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
131137659|NCT03403205|472130677|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
131137660|NCT03403205|472130678|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
131137661|NCT03403205|472130679|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
131137662|NCT03403205|472130680|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
131137663|NCT03403205|472130675|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
131137664|NCT03403205|472130676|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
131137665|NCT03403205|472130677|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
131137666|NCT03403205|472130678|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
131137667|NCT03403205|472130679|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
131137668|NCT03403205|472130680|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
131137669|NCT03403205|472130675|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
131137670|NCT03403205|472130676|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
131137671|NCT03403205|472130677|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
131137672|NCT03403205|472130678|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
131137673|NCT03403205|472130679|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
131137674|NCT03403205|472130680|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
131137675|NCT03403205|472130675|FG000|Extension Period (Up to 60 Months)|Death|1|||
131137676|NCT03403205|472130676|FG001|Extension Period (Up to 60 Months)|Death|0|||
131137677|NCT03403205|472130677|FG002|Extension Period (Up to 60 Months)|Death|0|||
131137678|NCT03403205|472130678|FG003|Extension Period (Up to 60 Months)|Death|0|||
131137679|NCT03403205|472130679|FG004|Extension Period (Up to 60 Months)|Death|0|||
131137680|NCT03403205|472130680|FG005|Extension Period (Up to 60 Months)|Death|0|||
131137681|NCT03403205|472130675|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
131137682|NCT03403205|472130676|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
131137683|NCT03403205|472130677|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
131137684|NCT03403205|472130678|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
131137685|NCT03403205|472130679|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
131137686|NCT03403205|472130680|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
131137687|NCT03403205|472130675|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
131137688|NCT03403205|472130676|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
131137689|NCT03403205|472130677|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
131137690|NCT03403205|472130678|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
131137691|NCT03403205|472130679|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
131137692|NCT03403205|472130680|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
131137693|NCT03403205|472130675|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
131137694|NCT03403205|472130676|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130723278|NCT00805467|470613410|FG000|Overall Study|Lost to Follow-up|0|||
130723279|NCT00805467|470613411|FG001|Overall Study|Lost to Follow-up|1|||
130723280|NCT00805467|470613412|FG002|Overall Study|Lost to Follow-up|7|||
131066835|NCT02676778|471873961|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
131066836|NCT02676778|471873962|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
131066837|NCT02676778|471873963|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
131066838|NCT02676778|471873961|FG000|Overall Study|Withdrawal by Subject|3|||
131066839|NCT02676778|471873962|FG001|Overall Study|Withdrawal by Subject|2|||
131066840|NCT02676778|471873963|FG002|Overall Study|Withdrawal by Subject|0|||
131066841|NCT02676778|471873961|FG000|Overall Study|Other|4|||
131066842|NCT02676778|471873962|FG001|Overall Study|Other|3|||
131066843|NCT02676778|471873963|FG002|Overall Study|Other|0|||
131066844|NCT02676778|471873961|FG000|Overall Study|Adverse Event|2|||
131066845|NCT02676778|471873962|FG001|Overall Study|Adverse Event|3|||
131066846|NCT02676778|471873963|FG002|Overall Study|Adverse Event|0|||
131066847|NCT00732498|471873964|FG000|Overall Study|Ineligible|1|||
131066848|NCT00732498|471873964|FG000|Overall Study|Adverse Event|2|||
131066849|NCT00732498|471873964|FG000|Overall Study|Physician Decision|3|||
131066850|NCT03394508|471873970|FG000|Overall Study|Protocol Violation|0|||
131066851|NCT03394508|471873971|FG001|Overall Study|Protocol Violation|3|||
131137695|NCT03403205|472130677|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
131137696|NCT03403205|472130678|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
131137697|NCT03403205|472130679|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
131137698|NCT03403205|472130680|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
131137699|NCT03403205|472130675|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
131137700|NCT03403205|472130676|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
131137701|NCT03403205|472130677|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
131137702|NCT03403205|472130678|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
131137703|NCT03403205|472130679|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
131137704|NCT03403205|472130680|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
131137705|NCT03403205|472130675|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
131137706|NCT03403205|472130676|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
131137707|NCT03403205|472130677|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
131137708|NCT03403205|472130678|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
131137709|NCT03403205|472130679|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
131137710|NCT03403205|472130680|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
131137711|NCT03403205|472130675|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
131137712|NCT03403205|472130676|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
131137713|NCT03403205|472130677|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
131137714|NCT03403205|472130678|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
131137715|NCT03403205|472130679|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
131137716|NCT03403205|472130680|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
131137717|NCT01834729|472130681|FG000|Overall Study|Did not return bowel diaries|0|||
131137718|NCT01834729|472130682|FG001|Overall Study|Did not return bowel diaries|0|||
131137719|NCT01834729|472130683|FG002|Overall Study|Did not return bowel diaries|3|||
131137720|NCT01834729|472130684|FG003|Overall Study|Did not return bowel diaries|0|||
131137721|NCT01834729|472130681|FG000|Overall Study|Withdrawal by Subject|1|||
131137722|NCT01834729|472130682|FG001|Overall Study|Withdrawal by Subject|1|||
131137723|NCT01834729|472130683|FG002|Overall Study|Withdrawal by Subject|0|||
131137724|NCT01834729|472130684|FG003|Overall Study|Withdrawal by Subject|0|||
131137725|NCT01834729|472130681|FG000|Overall Study|Adverse Event|0|||
131137726|NCT01834729|472130682|FG001|Overall Study|Adverse Event|0|||
131137727|NCT01834729|472130683|FG002|Overall Study|Adverse Event|0|||
131137728|NCT01834729|472130684|FG003|Overall Study|Adverse Event|2|||
131137729|NCT02971670|472130685|FG000|Overall Study|Withdrawal by Subject|4|||
131137730|NCT02971670|472130686|FG001|Overall Study|Withdrawal by Subject|1|||
131137731|NCT02971670|472130687|FG002|Overall Study|Withdrawal by Subject|1|||
131137732|NCT02971670|472130688|FG003|Overall Study|Withdrawal by Subject|2|||
131137733|NCT00288080|472130689|FG000|Overall Study|Withdrawal by Subject|1|||
131137734|NCT00288080|472130690|FG001|Overall Study|Withdrawal by Subject|3|||
131137735|NCT00288080|472130689|FG000|Overall Study|Protocol Violation|25|||
131137736|NCT00288080|472130690|FG001|Overall Study|Protocol Violation|20|||
131137737|NCT00763321|472130692|FG000|Open-label Period|Adverse Event|24|||
131137738|NCT00763321|472130693|FG001|Open-label Period|Adverse Event|0|||
131137739|NCT00763321|472130694|FG002|Open-label Period|Adverse Event|0|||
131137740|NCT00763321|472130692|FG000|Open-label Period|Lost to Follow-up|14|||
131137741|NCT00763321|472130693|FG001|Open-label Period|Lost to Follow-up|0|||
131137742|NCT00763321|472130694|FG002|Open-label Period|Lost to Follow-up|0|||
130723281|NCT00805467|470613413|FG003|Overall Study|Lost to Follow-up|21|||
131066852|NCT03394508|471873970|FG000|Overall Study|Lost to Follow-up|1|||
131066853|NCT03394508|471873971|FG001|Overall Study|Lost to Follow-up|0|||
131066854|NCT03214198|471873976|FG000|Overall Study|Case Report Forms Uncollected|18|||
131066855|NCT03214198|471873976|FG000|Overall Study|Protocol Deviation|18|||
131066856|NCT04295499|471873977|FG000|Overall Study|moving out of state|1|||
131066857|NCT04295499|471873978|FG001|Overall Study|moving out of state|0|||
131066858|NCT04295499|471873977|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
131066859|NCT04295499|471873978|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
131066860|NCT03122548|471873979|FG000|Overall Study|Death|2|||
131066861|NCT03122548|471873979|FG000|Overall Study|Progression - subject went into hospice|1|||
131066862|NCT03122548|471873979|FG000|Overall Study|Study Terminated by Sponsor|2|||
131066863|NCT02135445|471873980|FG000|Overall Study|Lost to Follow-up|1|||
131066864|NCT02135445|471873981|FG001|Overall Study|Lost to Follow-up|0|||
131066865|NCT02135445|471873980|FG000|Overall Study|Withdrawal by Subject|1|||
131066866|NCT02135445|471873981|FG001|Overall Study|Withdrawal by Subject|0|||
131066867|NCT04448561|471873987|FG000|Overall Study|Noncompliance|1|||
131066868|NCT04448561|471873988|FG001|Overall Study|Noncompliance|0|||
131066869|NCT04851587|471875469|FG000|Overall Study|Lost to Follow-up|18|||
131066870|NCT02136797|471875470|FG000|Overall Study|Not Treated|8|||
131066871|NCT03694210|471875471|FG000|Overall Study|Death|1|||
131066872|NCT03694210|471875471|FG000|Overall Study|Screen Failure|7|||
131066873|NCT02706834|471875472|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131066874|NCT02706834|471875473|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
131066875|NCT02706834|471875474|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131066876|NCT02706834|471875475|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
131066877|NCT02706834|471875476|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
131066878|NCT02706834|471875477|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
131066879|NCT02706834|471875478|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
131066880|NCT02706834|471875479|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
131066881|NCT02706834|471875480|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
131066882|NCT02706834|471875481|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
131066883|NCT02706834|471875482|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
131066884|NCT02706834|471875472|FG000|Overall Study|Lost to Follow-up|0|||
131066885|NCT02706834|471875473|FG001|Overall Study|Lost to Follow-up|0|||
131066886|NCT02706834|471875474|FG002|Overall Study|Lost to Follow-up|1|||
131066887|NCT02706834|471875475|FG003|Overall Study|Lost to Follow-up|0|||
131066888|NCT02706834|471875476|FG004|Overall Study|Lost to Follow-up|0|||
131066889|NCT02706834|471875477|FG005|Overall Study|Lost to Follow-up|0|||
131066890|NCT02706834|471875478|FG006|Overall Study|Lost to Follow-up|0|||
131066891|NCT02706834|471875479|FG007|Overall Study|Lost to Follow-up|0|||
131066892|NCT02706834|471875480|FG008|Overall Study|Lost to Follow-up|0|||
131066893|NCT02706834|471875481|FG009|Overall Study|Lost to Follow-up|0|||
131066894|NCT02706834|471875482|FG010|Overall Study|Lost to Follow-up|0|||
131066895|NCT02706834|471875472|FG000|Overall Study|Voluntary Withdrawal|1|||
131066896|NCT02706834|471875473|FG001|Overall Study|Voluntary Withdrawal|0|||
131066897|NCT02706834|471875474|FG002|Overall Study|Voluntary Withdrawal|0|||
131066898|NCT02706834|471875475|FG003|Overall Study|Voluntary Withdrawal|0|||
131066899|NCT02706834|471875476|FG004|Overall Study|Voluntary Withdrawal|0|||
131066900|NCT02706834|471875477|FG005|Overall Study|Voluntary Withdrawal|0|||
131066901|NCT02706834|471875478|FG006|Overall Study|Voluntary Withdrawal|0|||
131066902|NCT02706834|471875479|FG007|Overall Study|Voluntary Withdrawal|0|||
131066903|NCT02706834|471875480|FG008|Overall Study|Voluntary Withdrawal|0|||
131066904|NCT02706834|471875481|FG009|Overall Study|Voluntary Withdrawal|1|||
131066905|NCT02706834|471875482|FG010|Overall Study|Voluntary Withdrawal|0|||
131066906|NCT02706834|471875472|FG000|Overall Study|Other Reason Not Specified|1|||
131066907|NCT02706834|471875473|FG001|Overall Study|Other Reason Not Specified|0|||
131066908|NCT02706834|471875474|FG002|Overall Study|Other Reason Not Specified|0|||
131066909|NCT02706834|471875475|FG003|Overall Study|Other Reason Not Specified|0|||
131066910|NCT02706834|471875476|FG004|Overall Study|Other Reason Not Specified|1|||
131066911|NCT02706834|471875477|FG005|Overall Study|Other Reason Not Specified|0|||
131066912|NCT02706834|471875478|FG006|Overall Study|Other Reason Not Specified|0|||
131066913|NCT02706834|471875479|FG007|Overall Study|Other Reason Not Specified|0|||
131066914|NCT02706834|471875480|FG008|Overall Study|Other Reason Not Specified|0|||
131066915|NCT02706834|471875481|FG009|Overall Study|Other Reason Not Specified|0|||
131066916|NCT02706834|471875482|FG010|Overall Study|Other Reason Not Specified|0|||
131066917|NCT00627523|471875483|FG000|Overall Study|Lack of Efficacy|1|||
131066918|NCT00627523|471875484|FG001|Overall Study|Lack of Efficacy|0|||
131137743|NCT00763321|472130692|FG000|Open-label Period|Withdrawal by Subject|7|||
131066919|NCT00627523|471875483|FG000|Overall Study|Withdrawal by Subject|0|||
131066920|NCT00627523|471875484|FG001|Overall Study|Withdrawal by Subject|2|||
131066921|NCT00627523|471875483|FG000|Overall Study|Other|1|||
131066922|NCT00627523|471875484|FG001|Overall Study|Other|0|||
131137744|NCT00763321|472130693|FG001|Open-label Period|Withdrawal by Subject|0|||
131137745|NCT00763321|472130694|FG002|Open-label Period|Withdrawal by Subject|0|||
131137746|NCT00763321|472130692|FG000|Open-label Period|Subject noncompliant|7|||
131066923|NCT02543294|471875487|FG000|Overall Study|Lost to Follow-up|3|||
131066924|NCT02543294|471875487|FG000|Overall Study|Physician Decision|2|||
131066925|NCT02543294|471875487|FG000|Overall Study|Withdrawal by Subject|7|||
131066926|NCT01038128|471875489|FG000|Overall Study|Lack of Efficacy|1|||
131066927|NCT01038128|471875489|FG000|Overall Study|Lost to Follow-up|1|||
131066928|NCT01038128|471875489|FG000|Overall Study|Withdrawal by Subject|2|||
131066929|NCT03672188|471875496|FG000|Overall Study|Withdrawal by Subject|0|||
131066930|NCT03672188|471875497|FG001|Overall Study|Withdrawal by Subject|0|||
131066931|NCT03672188|471875498|FG002|Overall Study|Withdrawal by Subject|0|||
131066932|NCT03672188|471875499|FG003|Overall Study|Withdrawal by Subject|3|||
131066933|NCT03672188|471875500|FG004|Overall Study|Withdrawal by Subject|0|||
131066934|NCT03672188|471875501|FG005|Overall Study|Withdrawal by Subject|0|||
131066935|NCT03672188|471875502|FG006|Overall Study|Withdrawal by Subject|0|||
131066936|NCT03672188|471875503|FG007|Overall Study|Withdrawal by Subject|0|||
131066937|NCT03672188|471875504|FG008|Overall Study|Withdrawal by Subject|0|||
131066938|NCT03672188|471875505|FG009|Overall Study|Withdrawal by Subject|0|||
131066939|NCT03672188|471875506|FG010|Overall Study|Withdrawal by Subject|0|||
131066940|NCT03672188|471875507|FG011|Overall Study|Withdrawal by Subject|0|||
131066941|NCT03672188|471875508|FG012|Overall Study|Withdrawal by Subject|0|||
131066942|NCT03672188|471875509|FG013|Overall Study|Withdrawal by Subject|0|||
131230157|NCT01464827|472469351|FG006|Overall Study|Lost to Follow-up|2|||
131230158|NCT01464827|472469352|FG007|Overall Study|Lost to Follow-up|2|||
131230159|NCT01464827|472469353|FG008|Overall Study|Lost to Follow-up|0|||
131230160|NCT01464827|472469354|FG009|Overall Study|Lost to Follow-up|0|||
131066943|NCT03672188|471875510|FG014|Overall Study|Withdrawal by Subject|0|||
131066944|NCT03672188|471875496|FG000|Overall Study|Death|0|||
131066945|NCT03672188|471875497|FG001|Overall Study|Death|0|||
131230161|NCT01464827|472469355|FG010|Overall Study|Lost to Follow-up|0|||
131230162|NCT01464827|472469356|FG011|Overall Study|Lost to Follow-up|1|||
130723282|NCT00805467|470613410|FG000|Overall Study|Withdrawal by Subject|0|||
130723283|NCT00805467|470613411|FG001|Overall Study|Withdrawal by Subject|6|||
131066946|NCT03672188|471875498|FG002|Overall Study|Death|0|||
131066947|NCT03672188|471875499|FG003|Overall Study|Death|0|||
131066948|NCT03672188|471875500|FG004|Overall Study|Death|0|||
131066949|NCT03672188|471875501|FG005|Overall Study|Death|0|||
131066950|NCT03672188|471875502|FG006|Overall Study|Death|0|||
131066951|NCT03672188|471875503|FG007|Overall Study|Death|0|||
131066952|NCT03672188|471875504|FG008|Overall Study|Death|0|||
131066953|NCT03672188|471875505|FG009|Overall Study|Death|0|||
131066954|NCT03672188|471875506|FG010|Overall Study|Death|0|||
131066955|NCT03672188|471875507|FG011|Overall Study|Death|0|||
131066956|NCT03672188|471875508|FG012|Overall Study|Death|1|||
131066957|NCT03672188|471875509|FG013|Overall Study|Death|0|||
131066958|NCT03672188|471875510|FG014|Overall Study|Death|0|||
131066959|NCT03672188|471875496|FG000|Overall Study|Lost to Follow-up|0|||
131066960|NCT03672188|471875497|FG001|Overall Study|Lost to Follow-up|0|||
131066961|NCT03672188|471875498|FG002|Overall Study|Lost to Follow-up|1|||
131066962|NCT03672188|471875499|FG003|Overall Study|Lost to Follow-up|0|||
131066963|NCT03672188|471875500|FG004|Overall Study|Lost to Follow-up|0|||
131066964|NCT03672188|471875501|FG005|Overall Study|Lost to Follow-up|0|||
131066965|NCT03672188|471875502|FG006|Overall Study|Lost to Follow-up|0|||
131066966|NCT03672188|471875503|FG007|Overall Study|Lost to Follow-up|0|||
131066967|NCT03672188|471875504|FG008|Overall Study|Lost to Follow-up|0|||
131066968|NCT03672188|471875505|FG009|Overall Study|Lost to Follow-up|0|||
131066969|NCT03672188|471875506|FG010|Overall Study|Lost to Follow-up|0|||
131066970|NCT03672188|471875507|FG011|Overall Study|Lost to Follow-up|0|||
131066971|NCT03672188|471875508|FG012|Overall Study|Lost to Follow-up|0|||
131066972|NCT03672188|471875509|FG013|Overall Study|Lost to Follow-up|0|||
131066973|NCT03672188|471875510|FG014|Overall Study|Lost to Follow-up|0|||
131066974|NCT03320941|471875520|FG000|Overall Study|subject/guardian decision|0|||
131066975|NCT03320941|471875521|FG001|Overall Study|subject/guardian decision|0|||
131066976|NCT03320941|471875522|FG002|Overall Study|subject/guardian decision|0|||
131066977|NCT03320941|471875523|FG003|Overall Study|subject/guardian decision|1|||
131066978|NCT03320941|471875524|FG004|Overall Study|subject/guardian decision|0|||
131066979|NCT01838499|471875525|FG000|Overall Study|Protocol Violation|0|||
131066980|NCT01838499|471875526|FG001|Overall Study|Protocol Violation|1|||
131066981|NCT01838499|471875525|FG000|Overall Study|Lost to Follow-up|2|||
131066982|NCT01838499|471875526|FG001|Overall Study|Lost to Follow-up|4|||
130723284|NCT00805467|470613412|FG002|Overall Study|Withdrawal by Subject|45|||
130723285|NCT00805467|470613413|FG003|Overall Study|Withdrawal by Subject|50|||
131066983|NCT01838499|471875525|FG000|Overall Study|Lack of Efficacy|1|||
131066984|NCT01838499|471875526|FG001|Overall Study|Lack of Efficacy|2|||
131066985|NCT01838499|471875525|FG000|Overall Study|Adverse Event|2|||
131066986|NCT01838499|471875526|FG001|Overall Study|Adverse Event|1|||
131066987|NCT01838499|471875525|FG000|Overall Study|Withdrawal by Subject|19|||
131066988|NCT01838499|471875526|FG001|Overall Study|Withdrawal by Subject|9|||
131066989|NCT03614923|471875527|FG000|Overall Study|Withdrawal by Subject|2|||
131066990|NCT03614923|471875528|FG001|Overall Study|Withdrawal by Subject|1|||
131066991|NCT03614923|471875529|FG002|Overall Study|Withdrawal by Subject|1|||
131066992|NCT03614923|471875527|FG000|Overall Study|Adverse Event|0|||
131066993|NCT03614923|471875528|FG001|Overall Study|Adverse Event|2|||
131066994|NCT03614923|471875529|FG002|Overall Study|Adverse Event|1|||
131230163|NCT01464827|472469357|FG012|Overall Study|Lost to Follow-up|0|||
131230164|NCT01464827|472469358|FG013|Overall Study|Lost to Follow-up|1|||
131230165|NCT01464827|472469345|FG000|Overall Study|Other|2|||
131230166|NCT01464827|472469346|FG001|Overall Study|Other|3|||
131230167|NCT01464827|472469347|FG002|Overall Study|Other|0|||
131230168|NCT01464827|472469348|FG003|Overall Study|Other|2|||
131230169|NCT01464827|472469349|FG004|Overall Study|Other|3|||
131230170|NCT01464827|472469350|FG005|Overall Study|Other|0|||
131230171|NCT01464827|472469351|FG006|Overall Study|Other|1|||
131230172|NCT01464827|472469352|FG007|Overall Study|Other|0|||
131230173|NCT01464827|472469353|FG008|Overall Study|Other|3|||
131230174|NCT01464827|472469354|FG009|Overall Study|Other|1|||
131230175|NCT01464827|472469355|FG010|Overall Study|Other|2|||
131230176|NCT01464827|472469356|FG011|Overall Study|Other|0|||
131230177|NCT01464827|472469357|FG012|Overall Study|Other|1|||
131230178|NCT01464827|472469358|FG013|Overall Study|Other|0|||
131230179|NCT01464827|472469345|FG000|Overall Study|Not Treated|0|||
131230180|NCT01464827|472469346|FG001|Overall Study|Not Treated|2|||
131230181|NCT01464827|472469347|FG002|Overall Study|Not Treated|0|||
131230182|NCT01464827|472469348|FG003|Overall Study|Not Treated|0|||
131230183|NCT01464827|472469349|FG004|Overall Study|Not Treated|1|||
131230184|NCT01464827|472469350|FG005|Overall Study|Not Treated|0|||
131230185|NCT01464827|472469351|FG006|Overall Study|Not Treated|1|||
131230186|NCT01464827|472469352|FG007|Overall Study|Not Treated|0|||
131230187|NCT01464827|472469353|FG008|Overall Study|Not Treated|0|||
131230188|NCT01464827|472469354|FG009|Overall Study|Not Treated|2|||
131230189|NCT01464827|472469355|FG010|Overall Study|Not Treated|0|||
131230190|NCT01464827|472469356|FG011|Overall Study|Not Treated|1|||
131230191|NCT01464827|472469357|FG012|Overall Study|Not Treated|0|||
131230192|NCT01464827|472469358|FG013|Overall Study|Not Treated|2|||
131230193|NCT00268346|472469359|FG000|Overall Study|Adverse Event|0|||
131230194|NCT00268346|472469360|FG001|Overall Study|Adverse Event|1|||
131230195|NCT00268346|472469359|FG000|Overall Study|Death|0|||
131066995|NCT03614923|471875527|FG000|Overall Study|Lost to Follow-up|1|||
131066996|NCT03614923|471875528|FG001|Overall Study|Lost to Follow-up|0|||
131230196|NCT00268346|472469360|FG001|Overall Study|Death|1|||
131230197|NCT00268346|472469359|FG000|Overall Study|Withdrawal by Subject|0|||
131230198|NCT00268346|472469360|FG001|Overall Study|Withdrawal by Subject|1|||
131230199|NCT05487456|472469361|FG000|Overall Study|Withdrawal by Subject|0|||
131230200|NCT05487456|472469362|FG001|Overall Study|Withdrawal by Subject|0|||
131230201|NCT05487456|472469363|FG002|Overall Study|Withdrawal by Subject|1|||
131230202|NCT05487456|472469364|FG003|Overall Study|Withdrawal by Subject|0|||
131230203|NCT00294723|472469367|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
130723286|NCT00805467|470613410|FG000|Overall Study|Protocol Violation|0|||
130723287|NCT00805467|470613411|FG001|Overall Study|Protocol Violation|3|||
130723288|NCT00805467|470613412|FG002|Overall Study|Protocol Violation|0|||
131066997|NCT03614923|471875529|FG002|Overall Study|Lost to Follow-up|1|||
131066998|NCT03614923|471875527|FG000|Overall Study|Lack of Efficacy|2|||
131066999|NCT03614923|471875528|FG001|Overall Study|Lack of Efficacy|0|||
131067000|NCT03614923|471875529|FG002|Overall Study|Lack of Efficacy|1|||
131067001|NCT03614923|471875527|FG000|Overall Study|Non-compliance|0|||
131067002|NCT03614923|471875528|FG001|Overall Study|Non-compliance|1|||
131067003|NCT03614923|471875529|FG002|Overall Study|Non-compliance|0|||
131067004|NCT03614923|471875527|FG000|Overall Study|Other|0|||
131067005|NCT03614923|471875528|FG001|Overall Study|Other|1|||
131067006|NCT03614923|471875529|FG002|Overall Study|Other|1|||
131067007|NCT01107353|471875530|FG000|Overall Study|Positive Drug Screen|1|||
131067008|NCT01107353|471875531|FG001|Overall Study|Positive Drug Screen|0|||
131067009|NCT03360071|471875532|FG000|Overall Study|Lost to Follow-up|1|||
131067010|NCT03360071|471875533|FG001|Overall Study|Lost to Follow-up|0|||
131067011|NCT01745380|471875534|FG000|Overall Study|Lost to Follow-up|1|||
131067012|NCT01745380|471875535|FG001|Overall Study|Lost to Follow-up|0|||
130723289|NCT00805467|470613413|FG003|Overall Study|Protocol Violation|5|||
130723290|NCT00805467|470613410|FG000|Overall Study|Adverse Event|0|||
130723291|NCT00805467|470613411|FG001|Overall Study|Adverse Event|13|||
131067013|NCT01745380|471875534|FG000|Overall Study|Lack of Efficacy|0|||
131067014|NCT01745380|471875535|FG001|Overall Study|Lack of Efficacy|1|||
131067015|NCT01882088|471875536|FG000|Overall Study|Intolerance of esophageal manometry|1|||
131067016|NCT01882088|471875536|FG000|Overall Study|no possibility to place the catheter|1|||
131067017|NCT01882088|471875536|FG000|Overall Study|Protocol Violation|1|||
131067018|NCT01882088|471875536|FG000|Overall Study|inadequate pH-impedance tracings|2|||
131230204|NCT00294723|472469368|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
131230205|NCT00294723|472469369|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
131230206|NCT00294723|472469367|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
131230207|NCT00294723|472469368|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
131067019|NCT01193283|471875540|FG000|Overall Study|Death|1|||
131230208|NCT00294723|472469369|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
130723292|NCT00805467|470613412|FG002|Overall Study|Adverse Event|26|||
130723293|NCT00805467|470613413|FG003|Overall Study|Adverse Event|57|||
131067020|NCT02368691|471875541|FG000|Overall Study|Death|13|||
131067021|NCT02368691|471875541|FG000|Overall Study|Lack of Efficacy|15|||
131230209|NCT00294723|472469367|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
131230210|NCT00294723|472469368|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
131230211|NCT00294723|472469369|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
131067022|NCT02368691|471875541|FG000|Overall Study|Physician Decision|4|||
131067023|NCT02720198|471875542|FG000|Overall Study|Withdrawal by Subject|0|||
131067024|NCT02720198|471875543|FG001|Overall Study|Withdrawal by Subject|1|||
131067025|NCT01268488|471875569|FG000|Overall Study|Adverse Event|3|||
131067026|NCT01268488|471875569|FG000|Overall Study|Physician Decision|2|||
131067027|NCT00460577|471875572|FG000|Overall Study|Protocol Violation|2|||
131067028|NCT00460577|471875573|FG001|Overall Study|Protocol Violation|6|||
131067029|NCT01047306|471875574|FG000|Overall Study|Withdrawal by Subject|2|||
131067030|NCT01047306|471875575|FG001|Overall Study|Withdrawal by Subject|0|||
131067031|NCT01047306|471875574|FG000|Overall Study|Lost to Follow-up|1|||
131067032|NCT01047306|471875575|FG001|Overall Study|Lost to Follow-up|0|||
131067033|NCT01878253|471875576|FG000|Overall Study|Death|1|||
131067034|NCT01878253|471875576|FG000|Overall Study|SIdus System Removal|3|||
131067035|NCT01878253|471875576|FG000|Overall Study|Withdrawal by Subject|1|||
131067036|NCT01878253|471875576|FG000|Overall Study|Lost to Follow-up|2|||
131067037|NCT01878253|471875576|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
131067038|NCT04043806|471875577|FG000|Overall Study|Commercial drug is available for participants|13|||
131067039|NCT04043806|471875577|FG000|Overall Study|Physician Decision|2|||
131067040|NCT04043806|471875577|FG000|Overall Study|Other|12|||
131067041|NCT04043806|471875577|FG000|Overall Study|Adverse Event|2|||
131067042|NCT04043806|471875577|FG000|Overall Study|Lost to Follow-up|6|||
131067043|NCT04043806|471875577|FG000|Overall Study|Other non-compliance|2|||
131067044|NCT04043806|471875577|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
131067045|NCT04043806|471875577|FG000|Overall Study|Never Dosed|1|||
131067046|NCT04799587|471875579|FG000|Overall Study|Withdrawal by Subject|0|||
131067047|NCT04799587|471875580|FG001|Overall Study|Withdrawal by Subject|1|||
131067048|NCT01613599|471875583|FG000|Overall Study|Death|9|||
131067049|NCT01613599|471875583|FG000|Overall Study|Lost to Follow-up|5|||
131067050|NCT01613599|471875583|FG000|Overall Study|Withdrawal by Subject|8|||
131067051|NCT01613599|471875583|FG000|Overall Study|Reason not specified|3|||
131067052|NCT00617708|471875585|FG000|Overall Study|Adverse Event|0|||
131067053|NCT00617708|471875586|FG001|Overall Study|Adverse Event|6|||
131067054|NCT00617708|471875587|FG002|Overall Study|Adverse Event|9|||
131067055|NCT00617708|471875585|FG000|Overall Study|Withdrawal by Subject|1|||
131067056|NCT00617708|471875586|FG001|Overall Study|Withdrawal by Subject|1|||
131067057|NCT00617708|471875587|FG002|Overall Study|Withdrawal by Subject|7|||
131067058|NCT00617708|471875585|FG000|Overall Study|Death|0|||
131067059|NCT00617708|471875586|FG001|Overall Study|Death|6|||
131067060|NCT00617708|471875587|FG002|Overall Study|Death|5|||
131067061|NCT00617708|471875585|FG000|Overall Study|Progression/Relapse|7|||
131067062|NCT00617708|471875586|FG001|Overall Study|Progression/Relapse|40|||
131067063|NCT00617708|471875587|FG002|Overall Study|Progression/Relapse|36|||
131067064|NCT00617708|471875585|FG000|Overall Study|Not protocol specified|1|||
131067065|NCT00617708|471875586|FG001|Overall Study|Not protocol specified|4|||
131067066|NCT00617708|471875587|FG002|Overall Study|Not protocol specified|2|||
131067067|NCT00617708|471875585|FG000|Overall Study|Not eligible|1|||
131067068|NCT00617708|471875586|FG001|Overall Study|Not eligible|3|||
131067069|NCT00617708|471875587|FG002|Overall Study|Not eligible|5|||
131067070|NCT02058992|471875590|FG000|Overall Study|Lost to Follow-up|4|||
131067071|NCT02058992|471875590|FG000|Overall Study|Protocol Violation|92|||
131067072|NCT02058992|471875590|FG000|Overall Study|CRF Uncollected|20|||
131067073|NCT02130401|471875593|FG000|Overall Study|Poor enrollment|6|||
131067074|NCT00321672|471875594|FG000|Overall Study|Withdrawal by Subject|5|||
131067075|NCT00321672|471875595|FG001|Overall Study|Withdrawal by Subject|1|||
131067076|NCT00321672|471875596|FG002|Overall Study|Withdrawal by Subject|2|||
131067077|NCT00321672|471875597|FG003|Overall Study|Withdrawal by Subject|0|||
131067078|NCT00321672|471875594|FG000|Overall Study|Noncompliance|1|||
131067079|NCT00321672|471875595|FG001|Overall Study|Noncompliance|2|||
131067080|NCT00321672|471875596|FG002|Overall Study|Noncompliance|1|||
131067081|NCT00321672|471875597|FG003|Overall Study|Noncompliance|0|||
131067082|NCT00321672|471875594|FG000|Overall Study|Adverse Event|1|||
131067083|NCT00321672|471875595|FG001|Overall Study|Adverse Event|1|||
131067084|NCT00321672|471875596|FG002|Overall Study|Adverse Event|0|||
131067085|NCT00321672|471875597|FG003|Overall Study|Adverse Event|0|||
131067086|NCT00321672|471875594|FG000|Overall Study|Lack of Efficacy|1|||
131230212|NCT00294723|472469367|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
130723294|NCT00805467|470613410|FG000|Overall Study|Death|0|||
131067087|NCT00321672|471875595|FG001|Overall Study|Lack of Efficacy|1|||
131067088|NCT00321672|471875596|FG002|Overall Study|Lack of Efficacy|0|||
131067089|NCT00321672|471875597|FG003|Overall Study|Lack of Efficacy|0|||
131067090|NCT00321672|471875594|FG000|Overall Study|Lost to Follow-up|2|||
131067091|NCT00321672|471875595|FG001|Overall Study|Lost to Follow-up|0|||
131067092|NCT00321672|471875596|FG002|Overall Study|Lost to Follow-up|4|||
131067093|NCT00321672|471875597|FG003|Overall Study|Lost to Follow-up|2|||
131067094|NCT00321672|471875594|FG000|Overall Study|Death|1|||
131067095|NCT00321672|471875595|FG001|Overall Study|Death|0|||
131067096|NCT00321672|471875596|FG002|Overall Study|Death|0|||
131067097|NCT00321672|471875597|FG003|Overall Study|Death|0|||
131067098|NCT00321672|471875594|FG000|Overall Study|Too far to travel for visits|1|||
131067099|NCT00321672|471875595|FG001|Overall Study|Too far to travel for visits|0|||
131067100|NCT00321672|471875596|FG002|Overall Study|Too far to travel for visits|0|||
131067101|NCT00321672|471875597|FG003|Overall Study|Too far to travel for visits|0|||
131067102|NCT00321672|471875594|FG000|Overall Study|Incarcerated|0|||
131230213|NCT00294723|472469368|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
131230214|NCT00294723|472469369|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
131230215|NCT00294723|472469367|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
131230216|NCT00294723|472469368|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
130723295|NCT00805467|470613411|FG001|Overall Study|Death|2|||
130723296|NCT00805467|470613412|FG002|Overall Study|Death|7|||
130723297|NCT00805467|470613413|FG003|Overall Study|Death|5|||
130723298|NCT00805467|470613410|FG000|Overall Study|Physician Decision|0|||
130723299|NCT00805467|470613411|FG001|Overall Study|Physician Decision|1|||
130723300|NCT00805467|470613412|FG002|Overall Study|Physician Decision|2|||
131067103|NCT00321672|471875595|FG001|Overall Study|Incarcerated|0|||
131067104|NCT00321672|471875596|FG002|Overall Study|Incarcerated|2|||
131067105|NCT00321672|471875597|FG003|Overall Study|Incarcerated|0|||
131067106|NCT00321672|471875594|FG000|Overall Study|Moved out of state|0|||
131067107|NCT00321672|471875595|FG001|Overall Study|Moved out of state|1|||
131067108|NCT00321672|471875596|FG002|Overall Study|Moved out of state|1|||
131067109|NCT00321672|471875597|FG003|Overall Study|Moved out of state|0|||
131067110|NCT00321672|471875594|FG000|Overall Study|Protocol Violation|0|||
131067111|NCT00321672|471875595|FG001|Overall Study|Protocol Violation|0|||
131067112|NCT00321672|471875596|FG002|Overall Study|Protocol Violation|1|||
131067113|NCT00321672|471875597|FG003|Overall Study|Protocol Violation|0|||
131067114|NCT00321672|471875594|FG000|Overall Study|Diagnosis of testicular cancer|0|||
131067115|NCT00321672|471875595|FG001|Overall Study|Diagnosis of testicular cancer|1|||
131067116|NCT00321672|471875596|FG002|Overall Study|Diagnosis of testicular cancer|0|||
131067117|NCT00321672|471875597|FG003|Overall Study|Diagnosis of testicular cancer|0|||
131067118|NCT00321672|471875594|FG000|Overall Study|Extensive travel required for new job|0|||
131067119|NCT00321672|471875595|FG001|Overall Study|Extensive travel required for new job|1|||
131067120|NCT00321672|471875596|FG002|Overall Study|Extensive travel required for new job|0|||
131067121|NCT00321672|471875597|FG003|Overall Study|Extensive travel required for new job|0|||
131067122|NCT00512902|471875600|FG000|Overall Study|Adverse Event|7|||
131067123|NCT00512902|471875600|FG000|Overall Study|Lost to Follow-up|1|||
131067124|NCT00936065|471875601|FG000|Overall Study|Adverse Event|1|||
131067125|NCT00936065|471875602|FG001|Overall Study|Adverse Event|0|||
131067126|NCT00936065|471875603|FG002|Overall Study|Adverse Event|1|||
131067127|NCT00936065|471875601|FG000|Overall Study|Lack of Efficacy|1|||
131067128|NCT00936065|471875602|FG001|Overall Study|Lack of Efficacy|0|||
131067129|NCT00936065|471875603|FG002|Overall Study|Lack of Efficacy|1|||
131067130|NCT00936065|471875601|FG000|Overall Study|Lost to Follow-up|1|||
131067131|NCT00936065|471875602|FG001|Overall Study|Lost to Follow-up|0|||
131067132|NCT00936065|471875603|FG002|Overall Study|Lost to Follow-up|0|||
131067133|NCT00936065|471875601|FG000|Overall Study|Protocol Violation|1|||
131067134|NCT00936065|471875602|FG001|Overall Study|Protocol Violation|2|||
131067135|NCT00936065|471875603|FG002|Overall Study|Protocol Violation|1|||
131067136|NCT00936065|471875601|FG000|Overall Study|Withdrawal by Subject|0|||
131067137|NCT00936065|471875602|FG001|Overall Study|Withdrawal by Subject|2|||
131067138|NCT00936065|471875603|FG002|Overall Study|Withdrawal by Subject|4|||
131067139|NCT00145496|471875604|FG000|Overall Study|Adverse Event|42|||
131067140|NCT00145496|471875605|FG001|Overall Study|Adverse Event|30|||
131067141|NCT00145496|471875604|FG000|Overall Study|Lack of Efficacy|12|||
131067142|NCT00145496|471875605|FG001|Overall Study|Lack of Efficacy|7|||
131067143|NCT00145496|471875604|FG000|Overall Study|Withdrawal by Subject|32|||
131067144|NCT00145496|471875605|FG001|Overall Study|Withdrawal by Subject|26|||
131067145|NCT00145496|471875604|FG000|Overall Study|Lost to Follow-up|12|||
131067146|NCT00145496|471875605|FG001|Overall Study|Lost to Follow-up|5|||
131067147|NCT00145496|471875604|FG000|Overall Study|Other|25|||
131067148|NCT00145496|471875605|FG001|Overall Study|Other|13|||
131067149|NCT01429285|471875606|FG000|Overall Study|Protocol Violation|9|||
131067150|NCT01429285|471875607|FG001|Overall Study|Protocol Violation|4|||
131067151|NCT01429285|471875606|FG000|Overall Study|Missing Data|5|||
131067152|NCT01429285|471875607|FG001|Overall Study|Missing Data|3|||
131067153|NCT01429285|471875606|FG000|Overall Study|Erroneously Enrolled Twice|8|||
131067154|NCT01429285|471875607|FG001|Overall Study|Erroneously Enrolled Twice|2|||
131067155|NCT00448344|471875608|FG000|Overall Study|Lost to Follow-up|20|||
131067156|NCT00448344|471875609|FG001|Overall Study|Lost to Follow-up|22|||
131067157|NCT00448344|471875608|FG000|Overall Study|Withdrawal by Subject|6|||
131067158|NCT00448344|471875609|FG001|Overall Study|Withdrawal by Subject|8|||
131067159|NCT00448344|471875608|FG000|Overall Study|Death|3|||
131067160|NCT00448344|471875609|FG001|Overall Study|Death|4|||
131230217|NCT00294723|472469369|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
130723301|NCT00805467|470613413|FG003|Overall Study|Physician Decision|6|||
130723302|NCT00805467|470613410|FG000|Overall Study|Not reported|0|||
131067161|NCT00448344|471875608|FG000|Overall Study|Physician Decision|1|||
131067162|NCT00448344|471875609|FG001|Overall Study|Physician Decision|2|||
131067163|NCT01288729|471875614|FG000|Overall Study|Withdrawal by Subject|1|||
131067164|NCT01288729|471875615|FG001|Overall Study|Withdrawal by Subject|0|||
131067165|NCT00267865|471875616|FG000|Induction Treatment|Died before completing.|2|||
131067166|NCT00267865|471875616|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
131067167|NCT03686176|471875617|FG000|Overall Study|Procedure cancelled|1|||
131067168|NCT03686176|471875618|FG001|Overall Study|Procedure cancelled|0|||
131067169|NCT03686176|471875619|FG002|Overall Study|Procedure cancelled|0|||
131067170|NCT03686176|471875617|FG000|Overall Study|VR Malfunction|1|||
131067171|NCT03686176|471875618|FG001|Overall Study|VR Malfunction|0|||
131067172|NCT03686176|471875619|FG002|Overall Study|VR Malfunction|0|||
131230218|NCT00294723|472469367|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
131230219|NCT00294723|472469368|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
131230220|NCT00294723|472469369|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
131230221|NCT00294723|472469367|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
131230222|NCT00294723|472469368|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
131230223|NCT00294723|472469369|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
131230224|NCT00294723|472469367|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
131230225|NCT00294723|472469368|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
131230226|NCT00294723|472469369|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
131230227|NCT00294723|472469367|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
131230228|NCT00294723|472469368|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
131230229|NCT00294723|472469369|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
131230230|NCT00294723|472469367|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
131230231|NCT00294723|472469368|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
131230232|NCT00294723|472469369|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
130723303|NCT00805467|470613411|FG001|Overall Study|Not reported|0|||
131067173|NCT03050372|471877002|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
131067174|NCT03050372|471877003|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
131067175|NCT03050372|471877002|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
131067176|NCT03050372|471877003|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
131067177|NCT00396409|471877004|FG000|Period 1 - 2007|Adverse Event|0|||
131067178|NCT00396409|471877005|FG001|Period 1 - 2007|Adverse Event|1|||
131067179|NCT00396409|471877004|FG000|Period 1 - 2007|Lack of Efficacy|0|||
131067180|NCT00396409|471877005|FG001|Period 1 - 2007|Lack of Efficacy|1|||
131067181|NCT00396409|471877004|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
131067182|NCT00396409|471877005|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
131067183|NCT00396409|471877004|FG000|Period 1 - 2007|Lost to Follow-up|2|||
131067184|NCT00396409|471877005|FG001|Period 1 - 2007|Lost to Follow-up|3|||
131067185|NCT00396409|471877004|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
131067186|NCT00396409|471877005|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
131067187|NCT00396409|471877004|FG000|Period 2 - 2008|Protocol Violation|1|||
131067188|NCT00396409|471877005|FG001|Period 2 - 2008|Protocol Violation|0|||
131067189|NCT00396409|471877004|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
131067190|NCT00396409|471877005|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
131067191|NCT00396409|471877004|FG000|Period 2 - 2008|Lost to Follow-up|3|||
131067192|NCT00396409|471877005|FG001|Period 2 - 2008|Lost to Follow-up|1|||
131067193|NCT00331799|471877006|FG000|Overall Study|Withdrawal by Subject|2|||
131067194|NCT00331799|471877006|FG000|Overall Study|Sedation|1|||
131067195|NCT04203199|471877009|FG000|First Intervention Period|Lost to Follow-up|0|||
131067196|NCT04203199|471877010|FG001|First Intervention Period|Lost to Follow-up|1|||
131067197|NCT04203199|471877009|FG000|Second Intervention Period|Medication change|1|||
131067198|NCT04203199|471877010|FG001|Second Intervention Period|Medication change|0|||
131067199|NCT01870999|471877014|FG000|Overall Study|Adverse Event|0|||
131067200|NCT01870999|471877015|FG001|Overall Study|Adverse Event|4|||
131067201|NCT01870999|471877016|FG002|Overall Study|Adverse Event|1|||
130723304|NCT00805467|470613412|FG002|Overall Study|Not reported|3|||
130723305|NCT00805467|470613413|FG003|Overall Study|Not reported|7|||
131067202|NCT01870999|471877014|FG000|Overall Study|Subject met withdrawal criteria|3|||
131067203|NCT01870999|471877015|FG001|Overall Study|Subject met withdrawal criteria|2|||
131067204|NCT01870999|471877016|FG002|Overall Study|Subject met withdrawal criteria|0|||
131067205|NCT01870999|471877014|FG000|Overall Study|Subject withdrawn by Investigator|1|||
131067206|NCT01870999|471877015|FG001|Overall Study|Subject withdrawn by Investigator|0|||
131067207|NCT01870999|471877016|FG002|Overall Study|Subject withdrawn by Investigator|0|||
131067208|NCT01870999|471877014|FG000|Overall Study|Withdrawal by Subject|0|||
131067209|NCT01870999|471877015|FG001|Overall Study|Withdrawal by Subject|2|||
131067210|NCT01870999|471877016|FG002|Overall Study|Withdrawal by Subject|5|||
131067211|NCT01870999|471877014|FG000|Overall Study|Protocol Violation|0|||
131067212|NCT01870999|471877015|FG001|Overall Study|Protocol Violation|0|||
131067213|NCT01870999|471877016|FG002|Overall Study|Protocol Violation|1|||
131067214|NCT03034772|471877017|FG000|Overall Study|Adverse Event|0|||
131067215|NCT03034772|471877018|FG001|Overall Study|Adverse Event|1|||
131067216|NCT03034772|471877017|FG000|Overall Study|Withdrawal by Subject|0|||
131067217|NCT03034772|471877018|FG001|Overall Study|Withdrawal by Subject|1|||
131067218|NCT02660034|471877019|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
130723306|NCT05307510|470613416|FG000|Overall Study|Lost to Follow-up|3|||
131067219|NCT02660034|471877020|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
131067220|NCT02660034|471877021|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
131067221|NCT02660034|471877022|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
131067222|NCT02660034|471877023|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
131067223|NCT02660034|471877024|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
131067224|NCT02660034|471877025|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
131067225|NCT02660034|471877026|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
131067226|NCT02660034|471877027|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
131067227|NCT02660034|471877028|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
131067228|NCT02660034|471877029|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
131067229|NCT02660034|471877030|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
131067230|NCT02660034|471877031|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
131067231|NCT02660034|471877032|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
131067232|NCT02660034|471877019|FG000|Overall Study|Progressive Disease (Clinical)|7|||
131067233|NCT02660034|471877020|FG001|Overall Study|Progressive Disease (Clinical)|8|||
131067234|NCT02660034|471877021|FG002|Overall Study|Progressive Disease (Clinical)|3|||
131067235|NCT02660034|471877022|FG003|Overall Study|Progressive Disease (Clinical)|9|||
131067236|NCT02660034|471877023|FG004|Overall Study|Progressive Disease (Clinical)|3|||
131067237|NCT02660034|471877024|FG005|Overall Study|Progressive Disease (Clinical)|0|||
131067238|NCT02660034|471877025|FG006|Overall Study|Progressive Disease (Clinical)|0|||
131067239|NCT02660034|471877026|FG007|Overall Study|Progressive Disease (Clinical)|0|||
131067240|NCT02660034|471877027|FG008|Overall Study|Progressive Disease (Clinical)|0|||
131067241|NCT02660034|471877028|FG009|Overall Study|Progressive Disease (Clinical)|0|||
131067242|NCT02660034|471877029|FG010|Overall Study|Progressive Disease (Clinical)|0|||
131067243|NCT02660034|471877030|FG011|Overall Study|Progressive Disease (Clinical)|0|||
131067244|NCT02660034|471877031|FG012|Overall Study|Progressive Disease (Clinical)|0|||
131067245|NCT02660034|471877032|FG013|Overall Study|Progressive Disease (Clinical)|0|||
131067246|NCT02660034|471877019|FG000|Overall Study|Lost to Follow-up|0|||
131067247|NCT02660034|471877020|FG001|Overall Study|Lost to Follow-up|0|||
131067248|NCT02660034|471877021|FG002|Overall Study|Lost to Follow-up|1|||
131067249|NCT02660034|471877022|FG003|Overall Study|Lost to Follow-up|1|||
131067250|NCT02660034|471877023|FG004|Overall Study|Lost to Follow-up|0|||
131067251|NCT02660034|471877024|FG005|Overall Study|Lost to Follow-up|0|||
131067252|NCT02660034|471877025|FG006|Overall Study|Lost to Follow-up|0|||
131067253|NCT02660034|471877026|FG007|Overall Study|Lost to Follow-up|0|||
131067254|NCT02660034|471877027|FG008|Overall Study|Lost to Follow-up|0|||
131067255|NCT02660034|471877028|FG009|Overall Study|Lost to Follow-up|1|||
131067256|NCT02660034|471877029|FG010|Overall Study|Lost to Follow-up|1|||
131067257|NCT02660034|471877030|FG011|Overall Study|Lost to Follow-up|1|||
131067258|NCT02660034|471877031|FG012|Overall Study|Lost to Follow-up|0|||
131067259|NCT02660034|471877032|FG013|Overall Study|Lost to Follow-up|0|||
131067260|NCT02660034|471877019|FG000|Overall Study|Participant moved into special access scheme|1|||
131067261|NCT02660034|471877020|FG001|Overall Study|Participant moved into special access scheme|2|||
131067262|NCT02660034|471877021|FG002|Overall Study|Participant moved into special access scheme|0|||
131067263|NCT02660034|471877022|FG003|Overall Study|Participant moved into special access scheme|0|||
131067264|NCT02660034|471877023|FG004|Overall Study|Participant moved into special access scheme|0|||
131067265|NCT02660034|471877024|FG005|Overall Study|Participant moved into special access scheme|0|||
131067266|NCT02660034|471877025|FG006|Overall Study|Participant moved into special access scheme|0|||
131067267|NCT02660034|471877026|FG007|Overall Study|Participant moved into special access scheme|0|||
131067268|NCT02660034|471877027|FG008|Overall Study|Participant moved into special access scheme|0|||
131067269|NCT02660034|471877028|FG009|Overall Study|Participant moved into special access scheme|0|||
131067270|NCT02660034|471877029|FG010|Overall Study|Participant moved into special access scheme|0|||
131067271|NCT02660034|471877030|FG011|Overall Study|Participant moved into special access scheme|0|||
131067272|NCT02660034|471877031|FG012|Overall Study|Participant moved into special access scheme|0|||
131067273|NCT02660034|471877032|FG013|Overall Study|Participant moved into special access scheme|0|||
131067274|NCT02660034|471877019|FG000|Overall Study|Adverse Event|1|||
131067275|NCT02660034|471877020|FG001|Overall Study|Adverse Event|0|||
131067276|NCT02660034|471877021|FG002|Overall Study|Adverse Event|0|||
131067277|NCT02660034|471877022|FG003|Overall Study|Adverse Event|0|||
131067278|NCT02660034|471877023|FG004|Overall Study|Adverse Event|0|||
131067279|NCT02660034|471877024|FG005|Overall Study|Adverse Event|0|||
131067280|NCT02660034|471877025|FG006|Overall Study|Adverse Event|0|||
131067281|NCT02660034|471877026|FG007|Overall Study|Adverse Event|0|||
131067282|NCT02660034|471877027|FG008|Overall Study|Adverse Event|0|||
131067283|NCT02660034|471877028|FG009|Overall Study|Adverse Event|0|||
131067284|NCT02660034|471877029|FG010|Overall Study|Adverse Event|0|||
131067285|NCT02660034|471877030|FG011|Overall Study|Adverse Event|0|||
131067286|NCT02660034|471877031|FG012|Overall Study|Adverse Event|0|||
131067287|NCT02660034|471877032|FG013|Overall Study|Adverse Event|0|||
130723307|NCT05307510|470613417|FG001|Overall Study|Lost to Follow-up|6|||
130723308|NCT05307510|470613416|FG000|Overall Study|Withdrawal by Subject|0|||
131067288|NCT02660034|471877019|FG000|Overall Study|Sponsor Decision|0|||
131067289|NCT02660034|471877020|FG001|Overall Study|Sponsor Decision|1|||
131067290|NCT02660034|471877021|FG002|Overall Study|Sponsor Decision|2|||
131067291|NCT02660034|471877022|FG003|Overall Study|Sponsor Decision|2|||
131067292|NCT02660034|471877023|FG004|Overall Study|Sponsor Decision|3|||
131067293|NCT02660034|471877024|FG005|Overall Study|Sponsor Decision|0|||
131067294|NCT02660034|471877025|FG006|Overall Study|Sponsor Decision|0|||
131067295|NCT02660034|471877026|FG007|Overall Study|Sponsor Decision|0|||
131067296|NCT02660034|471877027|FG008|Overall Study|Sponsor Decision|0|||
131067297|NCT02660034|471877028|FG009|Overall Study|Sponsor Decision|0|||
131067298|NCT02660034|471877029|FG010|Overall Study|Sponsor Decision|0|||
131067299|NCT02660034|471877030|FG011|Overall Study|Sponsor Decision|0|||
131067300|NCT02660034|471877031|FG012|Overall Study|Sponsor Decision|0|||
131067301|NCT02660034|471877032|FG013|Overall Study|Sponsor Decision|1|||
131067302|NCT02660034|471877019|FG000|Overall Study|Withdrawal by Subject|0|||
131067303|NCT02660034|471877020|FG001|Overall Study|Withdrawal by Subject|0|||
131067304|NCT02660034|471877021|FG002|Overall Study|Withdrawal by Subject|0|||
131067305|NCT02660034|471877022|FG003|Overall Study|Withdrawal by Subject|0|||
131067306|NCT02660034|471877023|FG004|Overall Study|Withdrawal by Subject|0|||
131067307|NCT02660034|471877024|FG005|Overall Study|Withdrawal by Subject|0|||
131067308|NCT02660034|471877025|FG006|Overall Study|Withdrawal by Subject|1|||
131067309|NCT02660034|471877026|FG007|Overall Study|Withdrawal by Subject|1|||
131067310|NCT02660034|471877027|FG008|Overall Study|Withdrawal by Subject|1|||
131067311|NCT02660034|471877028|FG009|Overall Study|Withdrawal by Subject|0|||
131067312|NCT02660034|471877029|FG010|Overall Study|Withdrawal by Subject|0|||
131067313|NCT02660034|471877030|FG011|Overall Study|Withdrawal by Subject|1|||
131067314|NCT02660034|471877031|FG012|Overall Study|Withdrawal by Subject|2|||
131067315|NCT02660034|471877032|FG013|Overall Study|Withdrawal by Subject|0|||
131067316|NCT02660034|471877019|FG000|Overall Study|Death|0|||
131067317|NCT02660034|471877020|FG001|Overall Study|Death|0|||
131067318|NCT02660034|471877021|FG002|Overall Study|Death|0|||
131067319|NCT02660034|471877022|FG003|Overall Study|Death|0|||
131067320|NCT02660034|471877023|FG004|Overall Study|Death|0|||
131067321|NCT02660034|471877024|FG005|Overall Study|Death|13|||
131067322|NCT02660034|471877025|FG006|Overall Study|Death|14|||
131067323|NCT02660034|471877026|FG007|Overall Study|Death|10|||
131067324|NCT02660034|471877027|FG008|Overall Study|Death|9|||
131067325|NCT02660034|471877028|FG009|Overall Study|Death|21|||
131067326|NCT02660034|471877029|FG010|Overall Study|Death|17|||
131067327|NCT02660034|471877030|FG011|Overall Study|Death|15|||
131067328|NCT02660034|471877031|FG012|Overall Study|Death|18|||
131067329|NCT02660034|471877032|FG013|Overall Study|Death|7|||
131067330|NCT02660034|471877019|FG000|Overall Study|Physician Decision|0|||
131067331|NCT02660034|471877020|FG001|Overall Study|Physician Decision|0|||
131067332|NCT02660034|471877021|FG002|Overall Study|Physician Decision|0|||
131067333|NCT02660034|471877022|FG003|Overall Study|Physician Decision|0|||
131067334|NCT02660034|471877023|FG004|Overall Study|Physician Decision|0|||
131067335|NCT02660034|471877024|FG005|Overall Study|Physician Decision|0|||
131067336|NCT02660034|471877025|FG006|Overall Study|Physician Decision|0|||
131067337|NCT02660034|471877026|FG007|Overall Study|Physician Decision|0|||
131067338|NCT02660034|471877027|FG008|Overall Study|Physician Decision|0|||
131067339|NCT02660034|471877028|FG009|Overall Study|Physician Decision|0|||
131067340|NCT02660034|471877029|FG010|Overall Study|Physician Decision|0|||
131067341|NCT02660034|471877030|FG011|Overall Study|Physician Decision|0|||
130723309|NCT05307510|470613417|FG001|Overall Study|Withdrawal by Subject|1|||
130723310|NCT03610516|470613420|FG000|Treatment Epoch|Adverse Event|3|||
130723311|NCT03610516|470613421|FG001|Treatment Epoch|Adverse Event|1|||
130723312|NCT03610516|470613420|FG000|Treatment Epoch|Death|1|||
130723313|NCT03610516|470613421|FG001|Treatment Epoch|Death|0|||
130723314|NCT03610516|470613420|FG000|Treatment Epoch|Lack of Efficacy|0|||
131067342|NCT02660034|471877031|FG012|Overall Study|Physician Decision|0|||
131067343|NCT02660034|471877032|FG013|Overall Study|Physician Decision|1|||
131067344|NCT02660034|471877019|FG000|Overall Study|Participants transferred to LTE|0|||
131067345|NCT02660034|471877020|FG001|Overall Study|Participants transferred to LTE|0|||
131067346|NCT02660034|471877021|FG002|Overall Study|Participants transferred to LTE|0|||
131067347|NCT02660034|471877022|FG003|Overall Study|Participants transferred to LTE|0|||
131067348|NCT02660034|471877023|FG004|Overall Study|Participants transferred to LTE|0|||
131067349|NCT02660034|471877024|FG005|Overall Study|Participants transferred to LTE|10|||
131067350|NCT02660034|471877025|FG006|Overall Study|Participants transferred to LTE|8|||
131067351|NCT02660034|471877026|FG007|Overall Study|Participants transferred to LTE|8|||
131067352|NCT02660034|471877027|FG008|Overall Study|Participants transferred to LTE|10|||
131067353|NCT02660034|471877028|FG009|Overall Study|Participants transferred to LTE|1|||
131067354|NCT02660034|471877029|FG010|Overall Study|Participants transferred to LTE|2|||
131067355|NCT02660034|471877030|FG011|Overall Study|Participants transferred to LTE|4|||
130723315|NCT03610516|470613421|FG001|Treatment Epoch|Lack of Efficacy|1|||
130723316|NCT03610516|470613420|FG000|Treatment Epoch|No longer requires treatment|1|||
131067356|NCT02660034|471877031|FG012|Overall Study|Participants transferred to LTE|1|||
131067357|NCT02660034|471877032|FG013|Overall Study|Participants transferred to LTE|1|||
131067358|NCT01533181|471877035|FG000|Overall Study|Disease progression pre-active treatment|0|||
131067359|NCT01533181|471877036|FG001|Overall Study|Disease progression pre-active treatment|1|||
131067360|NCT01533181|471877035|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
131067361|NCT01533181|471877036|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
131067362|NCT06247488|471877039|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
131067363|NCT06247488|471877040|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
131067364|NCT06247488|471877041|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
131067365|NCT06247488|471877042|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
131067366|NCT06247488|471877043|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
131067367|NCT06247488|471877044|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
131067368|NCT06247488|471877039|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
131067369|NCT06247488|471877040|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
131067370|NCT06247488|471877041|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
131067371|NCT06247488|471877042|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
131067372|NCT06247488|471877043|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
131067373|NCT06247488|471877044|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
131067374|NCT06247488|471877039|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
131067375|NCT06247488|471877040|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
131067376|NCT06247488|471877041|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
131067377|NCT06247488|471877042|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
131067378|NCT06247488|471877043|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
131067379|NCT06247488|471877044|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
131067380|NCT06247488|471877039|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
131067381|NCT06247488|471877040|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
131067382|NCT06247488|471877041|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
131067383|NCT06247488|471877042|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
131067384|NCT06247488|471877043|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
131067385|NCT06247488|471877044|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
131067386|NCT06247488|471877039|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
131067387|NCT06247488|471877040|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
131067388|NCT06247488|471877041|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
131067389|NCT06247488|471877042|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
131067390|NCT06247488|471877043|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
131067391|NCT06247488|471877044|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
131067392|NCT06247488|471877039|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
131067393|NCT06247488|471877040|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
131067394|NCT06247488|471877041|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
131067395|NCT06247488|471877042|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
131067396|NCT06247488|471877043|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
131067397|NCT06247488|471877044|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
131067398|NCT06247488|471877039|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
131067399|NCT06247488|471877040|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
131067400|NCT06247488|471877041|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
131067401|NCT06247488|471877042|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
131067402|NCT06247488|471877043|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
131067403|NCT06247488|471877044|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
131067404|NCT02995733|471877045|FG000|Overall Study|Study site closed|9|||
131067405|NCT02995733|471877046|FG001|Overall Study|Study site closed|10|||
131067406|NCT02995733|471877045|FG000|Overall Study|Death|3|||
131067407|NCT02995733|471877046|FG001|Overall Study|Death|4|||
131067408|NCT02995733|471877045|FG000|Overall Study|Withdrawal by Subject|6|||
131067409|NCT02995733|471877046|FG001|Overall Study|Withdrawal by Subject|2|||
131067410|NCT02995733|471877045|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
131067411|NCT02995733|471877046|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
131067412|NCT02995733|471877045|FG000|Overall Study|Lost to Follow-up|48|||
131067413|NCT02995733|471877046|FG001|Overall Study|Lost to Follow-up|37|||
131067414|NCT02995733|471877045|FG000|Overall Study|Other|0|||
131067415|NCT02995733|471877046|FG001|Overall Study|Other|1|||
131067416|NCT04879823|471877047|FG000|Overall Study|Physician Decision|3|||
131067417|NCT04879823|471877048|FG001|Overall Study|Physician Decision|1|||
130723317|NCT03610516|470613421|FG001|Treatment Epoch|No longer requires treatment|0|||
130723318|NCT03610516|470613420|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
131067418|NCT04879823|471877047|FG000|Overall Study|Protocol Violation|2|||
131067419|NCT04879823|471877048|FG001|Overall Study|Protocol Violation|3|||
131137747|NCT00763321|472130693|FG001|Open-label Period|Subject noncompliant|0|||
131137748|NCT00763321|472130694|FG002|Open-label Period|Subject noncompliant|0|||
131137749|NCT00763321|472130692|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
131137750|NCT00763321|472130693|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
131067420|NCT04879823|471877047|FG000|Overall Study|Lost to Follow-up|43|||
131067421|NCT04879823|471877048|FG001|Overall Study|Lost to Follow-up|35|||
131067422|NCT02722278|471877053|FG000|Overall Study|Withdrawal by Subject|5|||
131067423|NCT02722278|471877054|FG001|Overall Study|Withdrawal by Subject|3|||
131067424|NCT02722278|471877053|FG000|Overall Study|Adverse Event|4|||
131067425|NCT02722278|471877054|FG001|Overall Study|Adverse Event|1|||
131067426|NCT02722278|471877053|FG000|Overall Study|Lost to Follow-up|2|||
131067427|NCT02722278|471877054|FG001|Overall Study|Lost to Follow-up|0|||
131067428|NCT02722278|471877053|FG000|Overall Study|Protocol Violation|1|||
131067429|NCT02722278|471877054|FG001|Overall Study|Protocol Violation|0|||
131067430|NCT02722278|471877053|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
131067431|NCT02722278|471877054|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
131067432|NCT02722278|471877053|FG000|Overall Study|Subject declined after tx assignment|0|||
131067433|NCT02722278|471877054|FG001|Overall Study|Subject declined after tx assignment|1|||
131067434|NCT02722278|471877053|FG000|Overall Study|Site closure not study related|0|||
131067435|NCT02722278|471877054|FG001|Overall Study|Site closure not study related|1|||
131067436|NCT02465866|471877055|FG000|Period 3|Withdrawal by Subject|0|||
131067437|NCT02465866|471877056|FG001|Period 3|Withdrawal by Subject|1|||
131067438|NCT02465866|471877057|FG002|Period 3|Withdrawal by Subject|0|||
131067439|NCT02465866|471877058|FG003|Period 3|Withdrawal by Subject|0|||
131067440|NCT02023099|471877059|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
131067441|NCT02023099|471877060|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
131067442|NCT02023099|471877061|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
131067443|NCT02023099|471877059|FG000|Overall Study|Withdrawn Consent|3|||
131067444|NCT02023099|471877060|FG001|Overall Study|Withdrawn Consent|0|||
131067445|NCT02023099|471877061|FG002|Overall Study|Withdrawn Consent|1|||
131067446|NCT02023099|471877059|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
131067447|NCT02023099|471877060|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
131067448|NCT02023099|471877061|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
131067449|NCT00203502|471877062|FG000|Overall Study|Death|1|||
131067450|NCT01469819|471877063|FG000|Overall Study|Withdrawal by Subject|1|||
131067451|NCT01469819|471877063|FG000|Overall Study|Did not meet inclusionary criteria|2|||
131067452|NCT01469819|471877063|FG000|Overall Study|Could not swallow SmartPill|2|||
131067453|NCT01469819|471877063|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
131067454|NCT04057937|471877064|FG000|Placebo-controlled Phase|Adverse Event|3|||
131067455|NCT04057937|471877065|FG001|Placebo-controlled Phase|Adverse Event|0|||
131067456|NCT04057937|471877064|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
131067457|NCT04057937|471877065|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
131067458|NCT04057937|471877064|FG000|Active-treatment Phase|Pregnancy|0|||
131067459|NCT04057937|471877065|FG001|Active-treatment Phase|Pregnancy|1|||
130723319|NCT03610516|470613421|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
130723320|NCT03610516|470613420|FG000|Treatment Epoch|Physician Decision|8|||
131067460|NCT04057937|471877064|FG000|Active-treatment Phase|Physician Decision|0|||
131067461|NCT04057937|471877065|FG001|Active-treatment Phase|Physician Decision|1|||
131067462|NCT02446912|471877066|FG000|Overall Study|Adverse Event|3|||
131067463|NCT02446912|471877067|FG001|Overall Study|Adverse Event|13|||
131067464|NCT02446912|471877068|FG002|Overall Study|Adverse Event|5|||
131067465|NCT02446912|471877066|FG000|Overall Study|Condition under investigation worsened|0|||
131067466|NCT02446912|471877067|FG001|Overall Study|Condition under investigation worsened|1|||
131067467|NCT02446912|471877068|FG002|Overall Study|Condition under investigation worsened|1|||
131067468|NCT02446912|471877066|FG000|Overall Study|Study-specific withdrawal criteria|1|||
131067469|NCT02446912|471877067|FG001|Overall Study|Study-specific withdrawal criteria|0|||
131067470|NCT02446912|471877068|FG002|Overall Study|Study-specific withdrawal criteria|0|||
131067471|NCT02446912|471877066|FG000|Overall Study|Lack of Efficacy|1|||
131067472|NCT02446912|471877067|FG001|Overall Study|Lack of Efficacy|4|||
131067473|NCT02446912|471877068|FG002|Overall Study|Lack of Efficacy|7|||
131067474|NCT02446912|471877066|FG000|Overall Study|Lost to Follow-up|0|||
130723321|NCT03610516|470613421|FG001|Treatment Epoch|Physician Decision|5|||
130723322|NCT03610516|470613420|FG000|Treatment Epoch|Protocol Deviation|1|||
131067475|NCT02446912|471877067|FG001|Overall Study|Lost to Follow-up|0|||
131067476|NCT02446912|471877068|FG002|Overall Study|Lost to Follow-up|2|||
131067477|NCT02446912|471877066|FG000|Overall Study|Severe non-compliance to protocol|1|||
131067478|NCT02446912|471877067|FG001|Overall Study|Severe non-compliance to protocol|0|||
130723323|NCT03610516|470613421|FG001|Treatment Epoch|Protocol Deviation|0|||
130723324|NCT03610516|470613420|FG000|Treatment Epoch|Withdrawal by Subject|3|||
131067479|NCT02446912|471877068|FG002|Overall Study|Severe non-compliance to protocol|1|||
131067480|NCT02446912|471877066|FG000|Overall Study|Withdrawal by Subject|10|||
131067481|NCT02446912|471877067|FG001|Overall Study|Withdrawal by Subject|15|||
131067482|NCT02446912|471877068|FG002|Overall Study|Withdrawal by Subject|15|||
131067483|NCT02446912|471877066|FG000|Overall Study|Miscellaneous|2|||
131067484|NCT02446912|471877067|FG001|Overall Study|Miscellaneous|2|||
131067485|NCT02446912|471877068|FG002|Overall Study|Miscellaneous|4|||
131067486|NCT00147745|471877069|FG000|Overall Study|Withdrawal by Subject|1|||
131067487|NCT00147745|471877070|FG001|Overall Study|Withdrawal by Subject|0|||
131067488|NCT00147745|471877071|FG002|Overall Study|Withdrawal by Subject|0|||
131067489|NCT00510783|471877078|FG000|Overall Study|Lost to Follow-up|29|||
131067490|NCT00510783|471877079|FG001|Overall Study|Lost to Follow-up|25|||
131067491|NCT00510783|471877078|FG000|Overall Study|Withdrawal by Subject|2|||
131067492|NCT00510783|471877079|FG001|Overall Study|Withdrawal by Subject|3|||
131067493|NCT00510783|471877078|FG000|Overall Study|Protocol Violation|0|||
131067494|NCT00510783|471877079|FG001|Overall Study|Protocol Violation|1|||
131067495|NCT02305797|471877080|FG000|Overall Study|Adverse Event|11|||
131067496|NCT02305797|471877081|FG001|Overall Study|Adverse Event|2|||
131067497|NCT02305797|471877080|FG000|Overall Study|Withdrawal by Subject|9|||
131067498|NCT02305797|471877081|FG001|Overall Study|Withdrawal by Subject|10|||
131067499|NCT02305797|471877080|FG000|Overall Study|Lack of Efficacy|6|||
131067500|NCT02305797|471877081|FG001|Overall Study|Lack of Efficacy|0|||
131067501|NCT02305797|471877080|FG000|Overall Study|Lost to Follow-up|5|||
131067502|NCT02305797|471877081|FG001|Overall Study|Lost to Follow-up|11|||
131067503|NCT02305797|471877080|FG000|Overall Study|Pregnancy|0|||
131067504|NCT02305797|471877081|FG001|Overall Study|Pregnancy|2|||
131067505|NCT02305797|471877080|FG000|Overall Study|Noncompliance|14|||
131067506|NCT02305797|471877081|FG001|Overall Study|Noncompliance|12|||
131067507|NCT02305797|471877080|FG000|Overall Study|Reason not collected|0|||
131067508|NCT02305797|471877081|FG001|Overall Study|Reason not collected|1|||
131067509|NCT00422162|471877082|FG000|Overall Study|Adverse Event|11|||
131067510|NCT00422162|471877083|FG001|Overall Study|Adverse Event|9|||
131067511|NCT00422162|471877082|FG000|Overall Study|Lack of Efficacy|4|||
131067512|NCT00422162|471877083|FG001|Overall Study|Lack of Efficacy|10|||
131067513|NCT00422162|471877082|FG000|Overall Study|Withdrawal by Subject|7|||
131067514|NCT00422162|471877083|FG001|Overall Study|Withdrawal by Subject|6|||
131067515|NCT00422162|471877082|FG000|Overall Study|Lost to Follow-up|1|||
131067516|NCT00422162|471877083|FG001|Overall Study|Lost to Follow-up|2|||
131067517|NCT00422162|471877082|FG000|Overall Study|Non-Compliant with Protocol|1|||
131067518|NCT00422162|471877083|FG001|Overall Study|Non-Compliant with Protocol|1|||
131067519|NCT00422162|471877082|FG000|Overall Study|Other|0|||
131067520|NCT00422162|471877083|FG001|Overall Study|Other|1|||
131067521|NCT00422162|471877082|FG000|Overall Study|Didn't Receive Treatment|0|||
131067522|NCT00422162|471877083|FG001|Overall Study|Didn't Receive Treatment|1|||
131067523|NCT02522299|471877084|FG000|Overall Study|Adverse Event|2|||
131067524|NCT02522299|471877085|FG001|Overall Study|Adverse Event|0|||
131067525|NCT02522299|471877084|FG000|Overall Study|Physician Decision|0|||
131067526|NCT02522299|471877085|FG001|Overall Study|Physician Decision|1|||
131067527|NCT02522299|471877084|FG000|Overall Study|Withdrawal by Subject|2|||
131067528|NCT02522299|471877085|FG001|Overall Study|Withdrawal by Subject|0|||
131067529|NCT01622088|471877086|FG000|Overall Study|Adverse Event|20|||
131067530|NCT01622088|471877086|FG000|Overall Study|Lost to Follow-up|1|||
131067531|NCT01622088|471877086|FG000|Overall Study|Withdrawal by Subject|20|||
131067532|NCT01622088|471877086|FG000|Overall Study|Investigator Decision|1|||
131067533|NCT01622088|471877086|FG000|Overall Study|Death|53|||
131067534|NCT01622088|471877086|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
131067535|NCT00274846|471877089|FG000|Overall Study|Did not receive adequate NK cells|1|||
131067536|NCT03045302|471877090|FG000|Overall Study|Pre-treatment adverse event|1|||
131067537|NCT05287178|471877093|FG000|Overall Study|Lost to Follow-up|2|||
131067538|NCT01648699|471877094|FG000|Overall Study|Death|1|||
131067539|NCT01648699|471877094|FG000|Overall Study|Lost to Follow-up|2|||
131067540|NCT01648699|471877094|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
131067541|NCT02267746|471877095|FG000|Overall Study|Adverse Event|0|||
131067542|NCT02267746|471877096|FG001|Overall Study|Adverse Event|2|||
131067543|NCT02267746|471877097|FG002|Overall Study|Adverse Event|1|||
131067544|NCT02267746|471877095|FG000|Overall Study|Protocol Violation|8|||
131067545|NCT02267746|471877096|FG001|Overall Study|Protocol Violation|7|||
131067546|NCT02267746|471877097|FG002|Overall Study|Protocol Violation|3|||
131067547|NCT02267746|471877095|FG000|Overall Study|Lack of Efficacy|11|||
131067548|NCT02267746|471877096|FG001|Overall Study|Lack of Efficacy|11|||
130723325|NCT03610516|470613421|FG001|Treatment Epoch|Withdrawal by Subject|1|||
130723326|NCT03610516|470613420|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
130723327|NCT03610516|470613421|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
130723328|NCT03610516|470613420|FG000|Post-Treatment Follow-up|Death|1|||
130723329|NCT03610516|470613421|FG001|Post-Treatment Follow-up|Death|0|||
131067549|NCT02267746|471877097|FG002|Overall Study|Lack of Efficacy|15|||
130723330|NCT01056289|470613424|FG000|Open-label Phase|Adverse Event|29|||
131067550|NCT02267746|471877095|FG000|Overall Study|Protocol Violation|1|||
131067551|NCT02267746|471877096|FG001|Overall Study|Protocol Violation|2|||
131067552|NCT02267746|471877097|FG002|Overall Study|Protocol Violation|1|||
131067553|NCT02267746|471877095|FG000|Overall Study|Miscellaneous|1|||
131067554|NCT02267746|471877096|FG001|Overall Study|Miscellaneous|0|||
131067555|NCT02267746|471877097|FG002|Overall Study|Miscellaneous|1|||
131067556|NCT00990314|471877109|FG000|Overall Study|Death|2|||
131067557|NCT00990314|471877109|FG000|Overall Study|Adverse Event|2|||
131067558|NCT00990314|471877109|FG000|Overall Study|Withdrawal by Subject|3|||
131067559|NCT00990314|471877109|FG000|Overall Study|Non-Compliance|1|||
131067560|NCT00990314|471877109|FG000|Overall Study|Physician Decision|3|||
131067561|NCT00990314|471877109|FG000|Overall Study|Lack of Efficacy|1|||
131067562|NCT01636778|471877114|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
131067563|NCT01636778|471877115|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
131230233|NCT00294723|472469367|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
131230234|NCT00294723|472469368|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
131230235|NCT00294723|472469369|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
131230236|NCT00294723|472469367|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
131067564|NCT01636778|471877116|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
131067565|NCT01636778|471877114|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
131067566|NCT01636778|471877115|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
131067567|NCT01636778|471877116|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
131067568|NCT01636778|471877114|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
131067569|NCT01636778|471877115|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
131067570|NCT01636778|471877116|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
131067571|NCT01636778|471877114|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
131067572|NCT01636778|471877115|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
131067573|NCT01636778|471877116|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
131067574|NCT01636778|471877114|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
131067575|NCT01636778|471877115|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
131067576|NCT01636778|471877116|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
131067577|NCT01636778|471877114|FG000|Follow-up Period After Part 2|Other|0|||
131067578|NCT01636778|471877115|FG001|Follow-up Period After Part 2|Other|0|||
131067579|NCT01636778|471877116|FG002|Follow-up Period After Part 2|Other|1|||
131067580|NCT01636778|471877114|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
131067581|NCT01636778|471877115|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
131067582|NCT01636778|471877116|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
131067583|NCT01636778|471877114|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
131067584|NCT01636778|471877115|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
131067585|NCT01636778|471877116|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
131067586|NCT03530345|471877125|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
131067587|NCT03530345|471877126|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
131067588|NCT03530345|471877125|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
131067589|NCT03530345|471877126|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
131067590|NCT03530345|471877125|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
131067591|NCT03530345|471877126|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
131067592|NCT03530345|471877125|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
131067593|NCT03530345|471877126|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
131067594|NCT04853394|471877132|FG000|Follow-up Interviews|Lost to Follow-up|22|||
131067595|NCT04853394|471877133|FG001|Follow-up Interviews|Lost to Follow-up|15|||
131067596|NCT04212299|471877136|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
131067597|NCT04413149|471878875|FG000|Overall Study|Death|10|||
131067598|NCT04413149|471878876|FG001|Overall Study|Death|5|||
131067599|NCT04413149|471878875|FG000|Overall Study|Lung transplantation|1|||
131067600|NCT04413149|471878876|FG001|Overall Study|Lung transplantation|0|||
131067601|NCT00705614|471878877|FG000|Initial Intervention|Adverse Event|40|||
131067602|NCT00705614|471878878|FG001|Initial Intervention|Adverse Event|21|||
131067603|NCT00705614|471878877|FG000|Initial Intervention|Lost to Follow-up|310|||
131067604|NCT00705614|471878878|FG001|Initial Intervention|Lost to Follow-up|191|||
131067605|NCT00705614|471878877|FG000|Initial Intervention|Withdrawal by Subject|114|||
131067606|NCT00705614|471878878|FG001|Initial Intervention|Withdrawal by Subject|71|||
131067607|NCT00705614|471878877|FG000|Initial Intervention|Administrative Reason|51|||
131067608|NCT00705614|471878878|FG001|Initial Intervention|Administrative Reason|38|||
131067609|NCT00705614|471878877|FG000|Initial Intervention|Status completion unknown|3|||
131067610|NCT00705614|471878878|FG001|Initial Intervention|Status completion unknown|0|||
131067611|NCT00705614|471878877|FG000|Switch to Remicade|Adverse Event|0|||
131067612|NCT00705614|471878878|FG001|Switch to Remicade|Adverse Event|5|||
131067613|NCT00705614|471878877|FG000|Switch to Remicade|Lost to Follow-up|0|||
131067614|NCT00705614|471878878|FG001|Switch to Remicade|Lost to Follow-up|23|||
131067615|NCT00705614|471878877|FG000|Switch to Remicade|Withdrawal by Subject|0|||
131067616|NCT00705614|471878878|FG001|Switch to Remicade|Withdrawal by Subject|12|||
131067617|NCT00705614|471878877|FG000|Switch to Remicade|Administrative Reason|0|||
131067618|NCT00705614|471878878|FG001|Switch to Remicade|Administrative Reason|9|||
131067619|NCT00676195|471878881|FG000|Overall Study|Lost to Follow-up|1|||
131067620|NCT00676195|471878881|FG000|Overall Study|Adverse Event|1|||
131067621|NCT00676195|471878881|FG000|Overall Study|Physician Decision|1|||
131067622|NCT02661490|471878882|FG000|Overall Study|Lost to Follow-up|0|||
131067623|NCT02661490|471878883|FG001|Overall Study|Lost to Follow-up|1|||
131067624|NCT02661490|471878884|FG002|Overall Study|Lost to Follow-up|0|||
131067625|NCT02661490|471878885|FG003|Overall Study|Lost to Follow-up|0|||
131067626|NCT02661490|471878886|FG004|Overall Study|Lost to Follow-up|2|||
131067627|NCT02661490|471878882|FG000|Overall Study|Withdrawal by Subject|2|||
131067628|NCT02661490|471878883|FG001|Overall Study|Withdrawal by Subject|0|||
131067629|NCT02661490|471878884|FG002|Overall Study|Withdrawal by Subject|2|||
131067630|NCT02661490|471878885|FG003|Overall Study|Withdrawal by Subject|0|||
131067631|NCT02661490|471878886|FG004|Overall Study|Withdrawal by Subject|0|||
131067632|NCT02661490|471878882|FG000|Overall Study|Death|1|||
131067633|NCT02661490|471878883|FG001|Overall Study|Death|1|||
131067634|NCT02661490|471878884|FG002|Overall Study|Death|0|||
131067635|NCT02661490|471878885|FG003|Overall Study|Death|1|||
131067636|NCT02661490|471878886|FG004|Overall Study|Death|0|||
131067637|NCT02661490|471878882|FG000|Overall Study|Reason not Specified|0|||
131067638|NCT02661490|471878883|FG001|Overall Study|Reason not Specified|0|||
131067639|NCT02661490|471878884|FG002|Overall Study|Reason not Specified|0|||
131067640|NCT02661490|471878885|FG003|Overall Study|Reason not Specified|0|||
131067641|NCT02661490|471878886|FG004|Overall Study|Reason not Specified|1|||
131067642|NCT00814632|471878887|FG000|Overall Study|Lack of Efficacy|2|||
131067643|NCT05335005|471878888|FG000|Overall Study|Lost to Follow-up|1|||
131067644|NCT04050722|471878889|FG000|Overall Study|Withdrawal by Subject|1|||
131067645|NCT04050722|471878890|FG001|Overall Study|Withdrawal by Subject|0|||
131067646|NCT00644332|471878891|FG000|Overall Study|Adverse Event|11|||
131067647|NCT00644332|471878891|FG000|Overall Study|Withdrawal by Subject|6|||
131067648|NCT00644332|471878891|FG000|Overall Study|Completion Status Unknown|2|||
131067649|NCT00644332|471878891|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
131067650|NCT00644332|471878891|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
131067651|NCT00355784|471878893|FG000|Overall Study|Withdrawal by Subject|0|||
131067652|NCT00355784|471878894|FG001|Overall Study|Withdrawal by Subject|0|||
131067653|NCT00355784|471878895|FG002|Overall Study|Withdrawal by Subject|2|||
131067654|NCT03602053|471878898|FG000|Overall Study|Withdrawal by Subject|7|||
131067655|NCT03602053|471878899|FG001|Overall Study|Withdrawal by Subject|9|||
131067656|NCT03602053|471878900|FG002|Overall Study|Withdrawal by Subject|7|||
131067657|NCT03602053|471878898|FG000|Overall Study|Lost to Follow-up|5|||
131067658|NCT03602053|471878899|FG001|Overall Study|Lost to Follow-up|6|||
131067659|NCT03602053|471878900|FG002|Overall Study|Lost to Follow-up|0|||
131067660|NCT03602053|471878898|FG000|Overall Study|Protocol Violation|3|||
131067661|NCT03602053|471878899|FG001|Overall Study|Protocol Violation|0|||
131067662|NCT03602053|471878900|FG002|Overall Study|Protocol Violation|4|||
131067663|NCT03602053|471878898|FG000|Overall Study|Physician Decision|1|||
131067664|NCT03602053|471878899|FG001|Overall Study|Physician Decision|0|||
131067665|NCT03602053|471878900|FG002|Overall Study|Physician Decision|0|||
131067666|NCT03602053|471878898|FG000|Overall Study|migration|2|||
131067667|NCT03602053|471878899|FG001|Overall Study|migration|3|||
131067668|NCT03602053|471878900|FG002|Overall Study|migration|0|||
131067669|NCT03602053|471878898|FG000|Overall Study|Other|1|||
131067670|NCT03602053|471878899|FG001|Overall Study|Other|0|||
131067671|NCT03602053|471878900|FG002|Overall Study|Other|0|||
131067672|NCT01572493|471878901|FG000|Overall Study|Physician Decision|1|||
131067673|NCT01572493|471878902|FG001|Overall Study|Physician Decision|0|||
131067674|NCT01572493|471878903|FG002|Overall Study|Physician Decision|0|||
131067675|NCT01572493|471878904|FG003|Overall Study|Physician Decision|0|||
131067676|NCT01572493|471878905|FG004|Overall Study|Physician Decision|0|||
131067677|NCT01572493|471878906|FG005|Overall Study|Physician Decision|0|||
131067678|NCT01572493|471878907|FG006|Overall Study|Physician Decision|0|||
131067679|NCT01572493|471878908|FG007|Overall Study|Physician Decision|0|||
131067680|NCT01572493|471878909|FG008|Overall Study|Physician Decision|0|||
131067681|NCT01572493|471878901|FG000|Overall Study|Switched to alternative treatment|0|||
131067682|NCT01572493|471878902|FG001|Overall Study|Switched to alternative treatment|1|||
131067683|NCT01572493|471878903|FG002|Overall Study|Switched to alternative treatment|2|||
131067684|NCT01572493|471878904|FG003|Overall Study|Switched to alternative treatment|1|||
131067685|NCT01572493|471878905|FG004|Overall Study|Switched to alternative treatment|2|||
131067686|NCT01572493|471878906|FG005|Overall Study|Switched to alternative treatment|0|||
131067687|NCT01572493|471878907|FG006|Overall Study|Switched to alternative treatment|2|||
131067688|NCT01572493|471878908|FG007|Overall Study|Switched to alternative treatment|0|||
131067689|NCT01572493|471878909|FG008|Overall Study|Switched to alternative treatment|2|||
131067690|NCT01572493|471878901|FG000|Overall Study|Death|0|||
131067691|NCT01572493|471878902|FG001|Overall Study|Death|0|||
131067692|NCT01572493|471878903|FG002|Overall Study|Death|0|||
131067693|NCT01572493|471878904|FG003|Overall Study|Death|1|||
131067694|NCT01572493|471878905|FG004|Overall Study|Death|0|||
131067695|NCT01572493|471878906|FG005|Overall Study|Death|1|||
131067696|NCT01572493|471878907|FG006|Overall Study|Death|0|||
131067697|NCT01572493|471878908|FG007|Overall Study|Death|0|||
131067698|NCT01572493|471878909|FG008|Overall Study|Death|0|||
131067699|NCT01572493|471878901|FG000|Overall Study|Adverse Event|0|||
131067700|NCT01572493|471878902|FG001|Overall Study|Adverse Event|0|||
131067701|NCT01572493|471878903|FG002|Overall Study|Adverse Event|0|||
131067702|NCT01572493|471878904|FG003|Overall Study|Adverse Event|0|||
131067703|NCT01572493|471878905|FG004|Overall Study|Adverse Event|0|||
131067704|NCT01572493|471878906|FG005|Overall Study|Adverse Event|0|||
131067705|NCT01572493|471878907|FG006|Overall Study|Adverse Event|1|||
131067706|NCT01572493|471878908|FG007|Overall Study|Adverse Event|0|||
131067707|NCT01572493|471878909|FG008|Overall Study|Adverse Event|0|||
131067708|NCT00609245|471878910|FG000|Overall Study|Adverse Event|1|||
131230237|NCT00294723|472469368|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
131230238|NCT00294723|472469369|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
131230239|NCT00752791|472469370|FG000|Overall Study|Adverse Event|7|||
131230240|NCT00752791|472469370|FG000|Overall Study|Withdrawal by Subject|1|||
131230241|NCT00752791|472469370|FG000|Overall Study|Physician Decision|1|||
131230242|NCT00752791|472469370|FG000|Overall Study|Death|1|||
131230243|NCT00752791|472469370|FG000|Overall Study|Renal transplant|3|||
131230244|NCT00752791|472469370|FG000|Overall Study|Switched to hemodialysis|2|||
131230245|NCT00752791|472469370|FG000|Overall Study|Protocol deviation|1|||
131230246|NCT03882047|472469371|FG000|Overall Study|Adverse Event|0|||
131230247|NCT03882047|472469372|FG001|Overall Study|Adverse Event|2|||
131230248|NCT03882047|472469373|FG002|Overall Study|Adverse Event|2|||
131230249|NCT03882047|472469371|FG000|Overall Study|Treatment Failure|3|||
131230250|NCT03882047|472469372|FG001|Overall Study|Treatment Failure|3|||
131230251|NCT03882047|472469373|FG002|Overall Study|Treatment Failure|12|||
131230252|NCT03882047|472469371|FG000|Overall Study|Lost to Follow-up|0|||
131230253|NCT03882047|472469372|FG001|Overall Study|Lost to Follow-up|1|||
131230254|NCT03882047|472469373|FG002|Overall Study|Lost to Follow-up|0|||
131230255|NCT03882047|472469371|FG000|Overall Study|Did Not Wish to Continue|1|||
131067709|NCT01234675|471878911|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
131067710|NCT01234675|471878912|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
131067711|NCT01234675|471878911|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
131067712|NCT01234675|471878912|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
131067713|NCT02889809|471878913|FG000|Overall Study|Withdrawal by Subject|30|||
131067714|NCT02889809|471878914|FG001|Overall Study|Withdrawal by Subject|21|||
131067715|NCT02889809|471878913|FG000|Overall Study|Lost to Follow-up|1|||
131067716|NCT02889809|471878914|FG001|Overall Study|Lost to Follow-up|1|||
131067717|NCT02889809|471878913|FG000|Overall Study|Site Closed|12|||
131067718|NCT02889809|471878914|FG001|Overall Study|Site Closed|11|||
131067719|NCT02798861|471878921|FG000|Overall Study|Lost to Follow-up|22|||
131067720|NCT02798861|471878921|FG000|Overall Study|Withdrawal by Subject|1|||
131067721|NCT02186015|471878922|FG000|Overall Study|Physician Decision|1|||
131067722|NCT02186015|471878923|FG001|Overall Study|Physician Decision|0|||
131067723|NCT01797705|471878924|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
131230256|NCT03882047|472469372|FG001|Overall Study|Did Not Wish to Continue|4|||
131230257|NCT03882047|472469373|FG002|Overall Study|Did Not Wish to Continue|1|||
131067724|NCT01797705|471878924|FG000|Overall Study|Withdrawal by Subject|1|||
131067725|NCT01838447|471878925|FG000|Overall Study|Change in surgical plan|1|||
131067726|NCT01838447|471878926|FG001|Overall Study|Change in surgical plan|2|||
131067727|NCT01838447|471878925|FG000|Overall Study|Withdrawal by Subject|1|||
131067728|NCT01838447|471878926|FG001|Overall Study|Withdrawal by Subject|1|||
131067729|NCT02030847|471878927|FG000|Overall Study|Death|10|||
131067730|NCT02030847|471878927|FG000|Overall Study|Disease Progression|15|||
131067731|NCT02030847|471878927|FG000|Overall Study|New Cancer Therapy|8|||
131067732|NCT02030847|471878927|FG000|Overall Study|Physician Decision|3|||
131067733|NCT02030847|471878927|FG000|Overall Study|Withdrawal by Subject|1|||
131067734|NCT01837719|471878928|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
131067735|NCT01837719|471878928|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
131067736|NCT01703988|471878929|FG000|Overall Study|Investigator Judgment|0|||
131067737|NCT01703988|471878930|FG001|Overall Study|Investigator Judgment|0|||
131067738|NCT01703988|471878931|FG002|Overall Study|Investigator Judgment|0|||
131067739|NCT01703988|471878932|FG003|Overall Study|Investigator Judgment|1|||
131067740|NCT04468633|471878933|FG000|Overall Study|Withdrawal by Subject|4|||
131067741|NCT04468633|471878934|FG001|Overall Study|Withdrawal by Subject|0|||
131067742|NCT00460434|471878935|FG000|Overall Study|Lost to Follow-up|3|||
131067743|NCT00460434|471878936|FG001|Overall Study|Lost to Follow-up|7|||
131067744|NCT01403805|471878937|FG000|Overall Study|Withdrawal by Subject|0|||
131067745|NCT01403805|471878938|FG001|Overall Study|Withdrawal by Subject|4|||
131067746|NCT01403805|471878937|FG000|Overall Study|Lost to Follow-up|0|||
131067747|NCT01403805|471878938|FG001|Overall Study|Lost to Follow-up|2|||
131067748|NCT01403805|471878937|FG000|Overall Study|Death|0|||
131067749|NCT01403805|471878938|FG001|Overall Study|Death|1|||
131230258|NCT03882047|472469371|FG000|Overall Study|Noncompliance With Protocol|2|||
131230259|NCT03882047|472469372|FG001|Overall Study|Noncompliance With Protocol|0|||
131067750|NCT01103141|471878941|FG000|Overall Study|Death|0|||
131067751|NCT01103141|471878942|FG001|Overall Study|Death|1|||
131067752|NCT01103141|471878941|FG000|Overall Study|Lost to Follow-up|2|||
131230260|NCT03882047|472469373|FG002|Overall Study|Noncompliance With Protocol|0|||
131230261|NCT03882047|472469371|FG000|Overall Study|Did Not Meet Eligibility|0|||
131230262|NCT03882047|472469372|FG001|Overall Study|Did Not Meet Eligibility|0|||
131230263|NCT03882047|472469373|FG002|Overall Study|Did Not Meet Eligibility|1|||
131067753|NCT01103141|471878942|FG001|Overall Study|Lost to Follow-up|1|||
131067754|NCT01695993|471878943|FG000|Overall Study|Lost to Follow-up|2|||
131067755|NCT01695993|471878944|FG001|Overall Study|Lost to Follow-up|1|||
131067756|NCT01695993|471878945|FG002|Overall Study|Lost to Follow-up|3|||
131230264|NCT00441584|472469374|FG000|Overall Study|Lack of Efficacy|79|||
131230265|NCT00441584|472469374|FG000|Overall Study|Withdrawal by Subject|8|||
131067757|NCT01695993|471878943|FG000|Overall Study|Withdrawal by Subject|2|||
131067758|NCT01695993|471878944|FG001|Overall Study|Withdrawal by Subject|2|||
131067759|NCT01695993|471878945|FG002|Overall Study|Withdrawal by Subject|2|||
131067760|NCT01695993|471878943|FG000|Overall Study|To ill to continue|1|||
131067761|NCT01695993|471878944|FG001|Overall Study|To ill to continue|2|||
131067762|NCT01695993|471878945|FG002|Overall Study|To ill to continue|0|||
131067763|NCT01695993|471878943|FG000|Overall Study|Changed Medical Facility|0|||
131067764|NCT01695993|471878944|FG001|Overall Study|Changed Medical Facility|0|||
131067765|NCT01695993|471878945|FG002|Overall Study|Changed Medical Facility|1|||
131067766|NCT02029521|471878946|FG000|Overall Study|Protocol Violation|1|||
131067767|NCT02029521|471878947|FG001|Overall Study|Protocol Violation|0|||
131067768|NCT02029521|471878946|FG000|Overall Study|Withdrawal by Subject|1|||
131067769|NCT02029521|471878947|FG001|Overall Study|Withdrawal by Subject|1|||
131067770|NCT01072396|471878949|FG000|Period One|Adverse Event|1|||
131067771|NCT01072396|471878950|FG001|Period One|Adverse Event|1|||
131067772|NCT01072396|471878949|FG000|Period One|Protocol Violation|2|||
131067773|NCT01072396|471878950|FG001|Period One|Protocol Violation|1|||
131067774|NCT01072396|471878949|FG000|Period One|Withdrawal by Subject|2|||
131067775|NCT01072396|471878950|FG001|Period One|Withdrawal by Subject|0|||
131067776|NCT01072396|471878949|FG000|Washout Period|Missing termination information|0|||
131067777|NCT01072396|471878950|FG001|Washout Period|Missing termination information|1|||
131067778|NCT01072396|471878949|FG000|Period Two|Adverse Event|0|||
131067779|NCT01072396|471878950|FG001|Period Two|Adverse Event|3|||
131067780|NCT01072396|471878949|FG000|Period Two|Lost to Follow-up|1|||
131067781|NCT01072396|471878950|FG001|Period Two|Lost to Follow-up|0|||
131067782|NCT00105521|471878953|FG000|Overall Study|Other|1|||
131067783|NCT00105521|471878954|FG001|Overall Study|Other|1|||
131067784|NCT00105521|471878955|FG002|Overall Study|Other|2|||
131067785|NCT00105521|471878956|FG003|Overall Study|Other|0|||
131067786|NCT00105521|471878953|FG000|Overall Study|Adverse Event|10|||
131067787|NCT00105521|471878954|FG001|Overall Study|Adverse Event|4|||
131067788|NCT00105521|471878955|FG002|Overall Study|Adverse Event|10|||
131067789|NCT00105521|471878956|FG003|Overall Study|Adverse Event|8|||
131067790|NCT00105521|471878953|FG000|Overall Study|Withdrawal by Subject|1|||
131067791|NCT00105521|471878954|FG001|Overall Study|Withdrawal by Subject|0|||
131067792|NCT00105521|471878955|FG002|Overall Study|Withdrawal by Subject|1|||
131067793|NCT00105521|471878956|FG003|Overall Study|Withdrawal by Subject|4|||
131067794|NCT00105521|471878953|FG000|Overall Study|Lack of Efficacy|0|||
131067795|NCT00105521|471878954|FG001|Overall Study|Lack of Efficacy|0|||
131067796|NCT00105521|471878955|FG002|Overall Study|Lack of Efficacy|0|||
131067797|NCT00105521|471878956|FG003|Overall Study|Lack of Efficacy|1|||
131067798|NCT00105521|471878953|FG000|Overall Study|Protocol Violation|3|||
131067799|NCT00105521|471878954|FG001|Overall Study|Protocol Violation|5|||
131067800|NCT00105521|471878955|FG002|Overall Study|Protocol Violation|4|||
131067801|NCT00105521|471878956|FG003|Overall Study|Protocol Violation|4|||
131067802|NCT00105521|471878953|FG000|Overall Study|Lost to Follow-up|0|||
131067803|NCT00105521|471878954|FG001|Overall Study|Lost to Follow-up|1|||
131067804|NCT00105521|471878955|FG002|Overall Study|Lost to Follow-up|0|||
131067805|NCT00105521|471878956|FG003|Overall Study|Lost to Follow-up|0|||
131067806|NCT02504502|471878957|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
131067807|NCT02504502|471878958|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
131067808|NCT02504502|471878957|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
131067809|NCT02504502|471878958|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
131067810|NCT02744898|471878962|FG000|Overall Study|Progressive Disease|2|||
131067811|NCT02744898|471878962|FG000|Overall Study|Physician Decision|1|||
131067812|NCT02744898|471878962|FG000|Overall Study|Toxicity|1|||
131067813|NCT03508830|471878969|FG000|Overall Study|Withdrawal by Subject|3|||
131067814|NCT03508830|471878970|FG001|Overall Study|Withdrawal by Subject|4|||
131067815|NCT03508830|471878969|FG000|Overall Study|Physician Decision|2|||
131067816|NCT03508830|471878970|FG001|Overall Study|Physician Decision|2|||
131067817|NCT04908800|471878975|FG000|Overall Study|Adverse Event|0|||
131067818|NCT04908800|471878976|FG001|Overall Study|Adverse Event|0|||
131067819|NCT04908800|471878977|FG002|Overall Study|Adverse Event|0|||
131067820|NCT04908800|471878978|FG003|Overall Study|Adverse Event|0|||
131067821|NCT04908800|471878979|FG004|Overall Study|Adverse Event|0|||
131067822|NCT04908800|471878980|FG005|Overall Study|Adverse Event|0|||
131067823|NCT04908800|471878981|FG006|Overall Study|Adverse Event|0|||
131067824|NCT04908800|471878982|FG007|Overall Study|Adverse Event|0|||
131067825|NCT04908800|471878983|FG008|Overall Study|Adverse Event|0|||
131067826|NCT04908800|471878984|FG009|Overall Study|Adverse Event|0|||
131067827|NCT04908800|471878985|FG010|Overall Study|Adverse Event|1|||
131067828|NCT04908800|471878986|FG011|Overall Study|Adverse Event|0|||
131067829|NCT04908800|471878987|FG012|Overall Study|Adverse Event|0|||
131067830|NCT04598776|471878996|FG000|Overall Study|Protocol Violation|5|||
131067831|NCT04598776|471878996|FG000|Overall Study|Physician Decision|4|||
131067832|NCT00728884|471878997|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
131067833|NCT00728884|471878997|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
131067834|NCT00348283|471878998|FG000|Induction|Adverse Event|0|||
131067835|NCT00348283|471878999|FG001|Induction|Adverse Event|2|||
131230266|NCT00441584|472469374|FG000|Overall Study|Adverse Event|6|||
131230267|NCT00441584|472469374|FG000|Overall Study|Protocol Violation|5|||
131230268|NCT00441584|472469374|FG000|Overall Study|Lost to Follow-up|4|||
131230269|NCT00441584|472469374|FG000|Overall Study|Failure to meet eligibility criteria|3|||
131230270|NCT01333033|472469377|FG000|Overall Study|Ineligible|0|||
131230271|NCT01333033|472469378|FG001|Overall Study|Ineligible|0|||
131230272|NCT01333033|472469379|FG002|Overall Study|Ineligible|0|||
131230273|NCT01333033|472469380|FG003|Overall Study|Ineligible|0|||
131230274|NCT01333033|472469381|FG004|Overall Study|Ineligible|6|||
131230275|NCT01333033|472469382|FG005|Overall Study|Ineligible|8|||
131230276|NCT01333033|472469377|FG000|Overall Study|Withdrawal by Subject|0|||
131230277|NCT01333033|472469378|FG001|Overall Study|Withdrawal by Subject|0|||
131230278|NCT01333033|472469379|FG002|Overall Study|Withdrawal by Subject|0|||
131230279|NCT01333033|472469380|FG003|Overall Study|Withdrawal by Subject|0|||
131230280|NCT01333033|472469381|FG004|Overall Study|Withdrawal by Subject|4|||
131230281|NCT01333033|472469382|FG005|Overall Study|Withdrawal by Subject|2|||
131230282|NCT01333033|472469377|FG000|Overall Study|PET inevaluable|0|||
131230283|NCT01333033|472469378|FG001|Overall Study|PET inevaluable|0|||
131230284|NCT01333033|472469379|FG002|Overall Study|PET inevaluable|0|||
131230285|NCT01333033|472469380|FG003|Overall Study|PET inevaluable|0|||
131230286|NCT01333033|472469381|FG004|Overall Study|PET inevaluable|2|||
131230287|NCT01333033|472469382|FG005|Overall Study|PET inevaluable|4|||
131230288|NCT01333033|472469377|FG000|Overall Study|Adverse Event|0|||
131230289|NCT01333033|472469378|FG001|Overall Study|Adverse Event|0|||
131230290|NCT01333033|472469379|FG002|Overall Study|Adverse Event|0|||
131230291|NCT01333033|472469380|FG003|Overall Study|Adverse Event|0|||
131230292|NCT01333033|472469381|FG004|Overall Study|Adverse Event|2|||
131230293|NCT01333033|472469382|FG005|Overall Study|Adverse Event|1|||
131230294|NCT01333033|472469377|FG000|Overall Study|Progression|0|||
131230295|NCT01333033|472469378|FG001|Overall Study|Progression|0|||
131230296|NCT01333033|472469379|FG002|Overall Study|Progression|0|||
131230297|NCT01333033|472469380|FG003|Overall Study|Progression|0|||
131230298|NCT01333033|472469381|FG004|Overall Study|Progression|0|||
131230299|NCT01333033|472469382|FG005|Overall Study|Progression|1|||
131230300|NCT01333033|472469377|FG000|Overall Study|MD Decision|0|||
131230301|NCT01333033|472469378|FG001|Overall Study|MD Decision|0|||
131230302|NCT01333033|472469379|FG002|Overall Study|MD Decision|0|||
131230303|NCT01333033|472469380|FG003|Overall Study|MD Decision|0|||
131230304|NCT01333033|472469381|FG004|Overall Study|MD Decision|0|||
131230305|NCT01333033|472469382|FG005|Overall Study|MD Decision|2|||
131230306|NCT01155583|472469383|FG000|Phase I|Screen failure - did not start treatment|0|||
131230307|NCT01155583|472469384|FG001|Phase I|Screen failure - did not start treatment|0|||
131230308|NCT01155583|472469385|FG002|Phase I|Screen failure - did not start treatment|0|||
131230309|NCT01155583|472469386|FG003|Phase I|Screen failure - did not start treatment|0|||
131230310|NCT01155583|472469387|FG004|Phase I|Screen failure - did not start treatment|1|||
131230311|NCT01155583|472469388|FG005|Phase I|Screen failure - did not start treatment|0|||
131230312|NCT01155583|472469389|FG006|Phase I|Screen failure - did not start treatment|0|||
131230313|NCT01155583|472469390|FG007|Phase I|Screen failure - did not start treatment|2|||
131230314|NCT01155583|472469391|FG008|Phase I|Screen failure - did not start treatment|0|||
131230315|NCT01155583|472469383|FG000|Phase I|Withdrawal by Subject|0|||
131230316|NCT01155583|472469384|FG001|Phase I|Withdrawal by Subject|0|||
131230317|NCT01155583|472469385|FG002|Phase I|Withdrawal by Subject|0|||
131230318|NCT01155583|472469386|FG003|Phase I|Withdrawal by Subject|0|||
131230319|NCT01155583|472469387|FG004|Phase I|Withdrawal by Subject|0|||
130723331|NCT01056289|470613425|FG001|Open-label Phase|Adverse Event|0|||
131067836|NCT00348283|471878998|FG000|Induction|Protocol Violation|0|||
131067837|NCT00348283|471878999|FG001|Induction|Protocol Violation|4|||
131067838|NCT00348283|471878998|FG000|Double Blind|Adverse Event|2|||
131067839|NCT00348283|471878999|FG001|Double Blind|Adverse Event|5|||
131067840|NCT00348283|471878998|FG000|Double Blind|Withdrawal by Subject|1|||
131067841|NCT00348283|471878999|FG001|Double Blind|Withdrawal by Subject|1|||
131230320|NCT01155583|472469388|FG005|Phase I|Withdrawal by Subject|0|||
130723332|NCT01056289|470613426|FG002|Open-label Phase|Adverse Event|0|||
131230321|NCT01155583|472469389|FG006|Phase I|Withdrawal by Subject|0|||
130723333|NCT01056289|470613427|FG003|Open-label Phase|Adverse Event|0|||
131230322|NCT01155583|472469390|FG007|Phase I|Withdrawal by Subject|1|||
131230323|NCT01155583|472469391|FG008|Phase I|Withdrawal by Subject|0|||
131230324|NCT00952484|472469392|FG000|Overall Study|Withdrawal by Subject|0|||
130723334|NCT01056289|470613424|FG000|Open-label Phase|Lost to Follow-up|30|||
130723335|NCT01056289|470613425|FG001|Open-label Phase|Lost to Follow-up|0|||
130723336|NCT01056289|470613426|FG002|Open-label Phase|Lost to Follow-up|0|||
131230325|NCT00952484|472469393|FG001|Overall Study|Withdrawal by Subject|1|||
131230326|NCT00952484|472469394|FG002|Overall Study|Withdrawal by Subject|0|||
131230327|NCT00192296|472469399|FG000|Overall Study|Withdrawal by Subject|0|||
131230328|NCT00192296|472469400|FG001|Overall Study|Withdrawal by Subject|1|||
131230329|NCT00192296|472469401|FG002|Overall Study|Withdrawal by Subject|0|||
130723337|NCT01056289|470613427|FG003|Open-label Phase|Lost to Follow-up|0|||
130723338|NCT01056289|470613424|FG000|Open-label Phase|Other|9|||
131230330|NCT00192296|472469402|FG003|Overall Study|Withdrawal by Subject|0|||
131067842|NCT00348283|471878998|FG000|Double Blind|Protocol Violation|0|||
131067843|NCT00348283|471878999|FG001|Double Blind|Protocol Violation|1|||
131067844|NCT00348283|471878998|FG000|Double Blind|Lack of Efficacy|2|||
131067845|NCT00348283|471878999|FG001|Double Blind|Lack of Efficacy|2|||
131067846|NCT00348283|471878998|FG000|Double Blind|Pregnancy|0|||
131067847|NCT00348283|471878999|FG001|Double Blind|Pregnancy|1|||
131067848|NCT00348283|471878998|FG000|Open Label|Adverse Event|0|||
131067849|NCT00348283|471878999|FG001|Open Label|Adverse Event|8|||
131067850|NCT00348283|471878998|FG000|Open Label|Withdrawal by Subject|0|||
131067851|NCT00348283|471878999|FG001|Open Label|Withdrawal by Subject|4|||
131067852|NCT00348283|471878998|FG000|Open Label|Lost to Follow-up|0|||
131067853|NCT00348283|471878999|FG001|Open Label|Lost to Follow-up|1|||
131067854|NCT00348283|471878998|FG000|Open Label|Lack of Efficacy|0|||
131067855|NCT00348283|471878999|FG001|Open Label|Lack of Efficacy|13|||
131067856|NCT00348283|471878998|FG000|Open Label|Administrative reasons|0|||
131067857|NCT00348283|471878999|FG001|Open Label|Administrative reasons|5|||
131067858|NCT00348283|471878998|FG000|Open Label|Subject moved to the United States|0|||
131067859|NCT00348283|471878999|FG001|Open Label|Subject moved to the United States|1|||
131067860|NCT00348283|471878998|FG000|Open Label|Pregnancy|0|||
131067861|NCT00348283|471878999|FG001|Open Label|Pregnancy|1|||
131067862|NCT00348283|471878998|FG000|Open Label|Sponsor decision|0|||
131067863|NCT00348283|471878999|FG001|Open Label|Sponsor decision|1|||
131067864|NCT06312566|471879004|FG000|Overall Study|Protocol Violation|0|||
131067865|NCT06312566|471879005|FG001|Overall Study|Protocol Violation|1|||
131067866|NCT04736472|471879006|FG000|Overall Study|Lost to Follow-up|1|||
131067867|NCT04736472|471879007|FG001|Overall Study|Lost to Follow-up|0|||
131067868|NCT04736472|471879008|FG002|Overall Study|Lost to Follow-up|0|||
131067869|NCT04736472|471879006|FG000|Overall Study|Withdrawal by Subject|2|||
131067870|NCT04736472|471879007|FG001|Overall Study|Withdrawal by Subject|0|||
131067871|NCT04736472|471879008|FG002|Overall Study|Withdrawal by Subject|0|||
131067872|NCT04736472|471879006|FG000|Overall Study|Protocol Violation|48|||
131067873|NCT04736472|471879007|FG001|Overall Study|Protocol Violation|0|||
131067874|NCT04736472|471879008|FG002|Overall Study|Protocol Violation|6|||
131067875|NCT03861078|471879009|FG000|Overall Study|COVID-19 shut down|4|||
131067876|NCT03861078|471879009|FG000|Overall Study|Lost to Follow-up|1|||
131067877|NCT03861078|471879009|FG000|Overall Study|Protocol Violation|2|||
131067878|NCT03861078|471879009|FG000|Overall Study|lack of venous access|1|||
131067879|NCT02971683|471879010|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
131067880|NCT02971683|471879011|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
131067881|NCT02971683|471879010|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
131067882|NCT02971683|471879011|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
131067883|NCT02971683|471879010|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
131067884|NCT02971683|471879011|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
131067885|NCT02971683|471879010|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
131067886|NCT02971683|471879011|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
131067887|NCT02971683|471879010|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
131067888|NCT02971683|471879011|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
131067889|NCT02971683|471879010|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
131067890|NCT02971683|471879011|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
131067891|NCT02971683|471879010|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
131067892|NCT02971683|471879011|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
131067893|NCT02971683|471879010|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
131067894|NCT02971683|471879011|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
131067895|NCT02971683|471879010|FG000|Open-Label|Lost to Follow-up|1|||
131067896|NCT02971683|471879011|FG001|Open-Label|Lost to Follow-up|0|||
131067897|NCT02971683|471879010|FG000|Open-Label|Participants withdrew consent|0|||
131067898|NCT02971683|471879011|FG001|Open-Label|Participants withdrew consent|2|||
131067899|NCT02971683|471879010|FG000|Open-Label|Participant request to discontinue study treatment|1|||
131067900|NCT02971683|471879011|FG001|Open-Label|Participant request to discontinue study treatment|0|||
131067901|NCT02971683|471879010|FG000|Open-Label|Lack of Efficacy|2|||
131230331|NCT03465891|472469403|FG000|Overall Study|Withdrawal by Subject|0|||
131067902|NCT02971683|471879011|FG001|Open-Label|Lack of Efficacy|0|||
131230332|NCT03465891|472469404|FG001|Overall Study|Withdrawal by Subject|1|||
130723339|NCT01056289|470613425|FG001|Open-label Phase|Other|0|||
131067903|NCT02971683|471879010|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
131067904|NCT02971683|471879011|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
131067905|NCT02971683|471879010|FG000|Long-Term Open Label|Participant withdrew consent|1|||
131067906|NCT02971683|471879011|FG001|Long-Term Open Label|Participant withdrew consent|0|||
131067907|NCT02971683|471879010|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
131067908|NCT02971683|471879011|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
131067909|NCT02971683|471879010|FG000|Long-Term Open Label|Adverse Event|1|||
131067910|NCT02971683|471879011|FG001|Long-Term Open Label|Adverse Event|2|||
131067911|NCT02971683|471879010|FG000|Long-Term Open Label|Lack of Efficacy|1|||
131067912|NCT02971683|471879011|FG001|Long-Term Open Label|Lack of Efficacy|1|||
131067913|NCT02268526|471879014|FG000|Overall Study|Adverse Event|0|||
131067914|NCT02268526|471879015|FG001|Overall Study|Adverse Event|2|||
131067915|NCT02268526|471879016|FG002|Overall Study|Adverse Event|1|||
131067916|NCT02268526|471879014|FG000|Overall Study|Death|1|||
131067917|NCT02268526|471879015|FG001|Overall Study|Death|11|||
131067918|NCT02268526|471879016|FG002|Overall Study|Death|0|||
131067919|NCT02268526|471879014|FG000|Overall Study|protocol deviation|0|||
131067920|NCT02268526|471879015|FG001|Overall Study|protocol deviation|1|||
131067921|NCT02268526|471879016|FG002|Overall Study|protocol deviation|0|||
131067922|NCT02268526|471879014|FG000|Overall Study|Physician Decision|0|||
131067923|NCT02268526|471879015|FG001|Overall Study|Physician Decision|0|||
131067924|NCT02268526|471879016|FG002|Overall Study|Physician Decision|1|||
131067925|NCT02268526|471879014|FG000|Overall Study|Subject/guardian decision|0|||
131067926|NCT02268526|471879015|FG001|Overall Study|Subject/guardian decision|7|||
131067927|NCT02268526|471879016|FG002|Overall Study|Subject/guardian decision|3|||
131067928|NCT00596960|471879017|FG000|Overall Study|Death|1|||
131067929|NCT00596960|471879018|FG001|Overall Study|Death|2|||
131067930|NCT00596960|471879017|FG000|Overall Study|Lost to Follow-up|6|||
131067931|NCT00596960|471879018|FG001|Overall Study|Lost to Follow-up|5|||
131067932|NCT00596960|471879017|FG000|Overall Study|Withdrawal by Subject|1|||
131067933|NCT00596960|471879018|FG001|Overall Study|Withdrawal by Subject|0|||
131067934|NCT00596960|471879017|FG000|Overall Study|Incarcerated|2|||
131067935|NCT00596960|471879018|FG001|Overall Study|Incarcerated|0|||
131067936|NCT00596960|471879017|FG000|Overall Study|Physician Decision|1|||
131067937|NCT00596960|471879018|FG001|Overall Study|Physician Decision|0|||
131067938|NCT00596960|471879017|FG000|Overall Study|Protocol Violation|0|||
131067939|NCT00596960|471879018|FG001|Overall Study|Protocol Violation|1|||
131067940|NCT00596960|471879017|FG000|Overall Study|No alcohol use data|0|||
131067941|NCT00596960|471879018|FG001|Overall Study|No alcohol use data|1|||
131067942|NCT02374476|471879021|FG000|VT Induced Ablation|Screening Failures|36|||
131067943|NCT02374476|471879022|FG001|VT Induced Ablation|Screening Failures|0|||
131067944|NCT02374476|471879023|FG002|VT Induced Ablation|Screening Failures|0|||
131067945|NCT02374476|471879021|FG000|Arm Assignment|Withdrawal by Subject|0|||
131067946|NCT02374476|471879022|FG001|Arm Assignment|Withdrawal by Subject|0|||
131067947|NCT02374476|471879023|FG002|Arm Assignment|Withdrawal by Subject|1|||
131067948|NCT03305458|471879024|FG000|Overall Study|Withdrawal by Subject|50|||
131067949|NCT03305458|471879025|FG001|Overall Study|Withdrawal by Subject|46|||
131067950|NCT03305458|471879026|FG002|Overall Study|Withdrawal by Subject|93|||
131067951|NCT03305458|471879024|FG000|Overall Study|Lost to Follow-up|85|||
131067952|NCT03305458|471879025|FG001|Overall Study|Lost to Follow-up|85|||
131067953|NCT03305458|471879026|FG002|Overall Study|Lost to Follow-up|35|||
131067954|NCT05431543|471879029|FG000|Overall Study|Medical History|1|||
131067955|NCT05431543|471879030|FG001|Overall Study|Medical History|0|||
131067956|NCT05431543|471879031|FG002|Overall Study|Medical History|0|||
131067957|NCT00440037|471879032|FG000|Overall Study|Withdrawal by Subject|6|||
131067958|NCT00440037|471879032|FG000|Overall Study|Administrative decision|3|||
131067959|NCT02878590|471880602|FG000|Overall Study|Withdrawal by Subject|2|||
131067960|NCT03322514|471880603|FG000|Overall Study|Withdrawal by Subject|1|||
131067961|NCT03322514|471880604|FG001|Overall Study|Withdrawal by Subject|1|||
131067962|NCT01904019|471880605|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
131067963|NCT01904019|471880605|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
131067964|NCT01904019|471880605|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
131067965|NCT01904019|471880605|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
131067966|NCT01904019|471880605|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
131067967|NCT01904019|471880605|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
131067968|NCT02388932|471880607|FG000|Overall Study|Death|1|||
131067969|NCT00678899|471880616|FG000|Overall Study|Adverse Event|1|||
131067970|NCT03451292|471880617|FG000|Overall Study|Death|44|||
131067971|NCT03451292|471880618|FG001|Overall Study|Death|59|||
131067972|NCT03451292|471880617|FG000|Overall Study|Withdrawal by Subject|18|||
130779448|NCT02326272|470819490|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130779449|NCT02326272|470819491|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131067973|NCT03451292|471880618|FG001|Overall Study|Withdrawal by Subject|13|||
131067974|NCT03451292|471880617|FG000|Overall Study|Transplantation|18|||
131067975|NCT03451292|471880618|FG001|Overall Study|Transplantation|12|||
131067976|NCT03451292|471880617|FG000|Overall Study|Lost to Follow-up|4|||
131067977|NCT03451292|471880618|FG001|Overall Study|Lost to Follow-up|12|||
131067978|NCT03451292|471880617|FG000|Overall Study|Physician Decision|4|||
131067979|NCT03451292|471880618|FG001|Overall Study|Physician Decision|3|||
131067980|NCT03451292|471880617|FG000|Overall Study|Adverse Event|3|||
131067981|NCT03451292|471880618|FG001|Overall Study|Adverse Event|3|||
131067982|NCT03451292|471880617|FG000|Overall Study|Non-compliance with Study Drug|2|||
130779450|NCT02326272|470819492|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131067983|NCT03451292|471880618|FG001|Overall Study|Non-compliance with Study Drug|0|||
131067984|NCT01636258|471880626|FG000|Overall Study|Lost to Follow-up|1|||
131067985|NCT01636258|471880627|FG001|Overall Study|Lost to Follow-up|0|||
131067986|NCT01498445|471880633|FG000|Overall Study|Lack of Efficacy|0|||
131067987|NCT01498445|471880634|FG001|Overall Study|Lack of Efficacy|0|||
131067988|NCT01498445|471880635|FG002|Overall Study|Lack of Efficacy|1|||
131067989|NCT01498445|471880636|FG003|Overall Study|Lack of Efficacy|2|||
131067990|NCT01498445|471880637|FG004|Overall Study|Lack of Efficacy|0|||
131067991|NCT01498445|471880638|FG005|Overall Study|Lack of Efficacy|0|||
131067992|NCT01498445|471880633|FG000|Overall Study|Screen Failure|0|||
131067993|NCT01498445|471880634|FG001|Overall Study|Screen Failure|0|||
131067994|NCT01498445|471880635|FG002|Overall Study|Screen Failure|0|||
131067995|NCT01498445|471880636|FG003|Overall Study|Screen Failure|0|||
131067996|NCT01498445|471880637|FG004|Overall Study|Screen Failure|1|||
131067997|NCT01498445|471880638|FG005|Overall Study|Screen Failure|1|||
131067998|NCT02592434|471880639|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
131067999|NCT02592434|471880640|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
131068000|NCT02592434|471880641|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
131068001|NCT02592434|471880639|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
131068002|NCT02592434|471880640|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
131068003|NCT02592434|471880641|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
131068004|NCT02592434|471880639|FG000|Open-Label Phase (18 Weeks)|Other|3|||
131068005|NCT02592434|471880640|FG001|Open-Label Phase (18 Weeks)|Other|0|||
131068006|NCT02592434|471880641|FG002|Open-Label Phase (18 Weeks)|Other|0|||
131068007|NCT02592434|471880639|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
131068008|NCT02592434|471880640|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
131068009|NCT02592434|471880641|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
131068010|NCT02592434|471880639|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
131068011|NCT02592434|471880640|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
131068012|NCT02592434|471880641|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
131068013|NCT02592434|471880639|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
131068014|NCT02592434|471880640|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
131068015|NCT02592434|471880641|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
131068016|NCT02592434|471880639|FG000|Double Blind Phase (26 Weeks)|Other|0|||
131068017|NCT02592434|471880640|FG001|Double Blind Phase (26 Weeks)|Other|1|||
131068018|NCT02592434|471880641|FG002|Double Blind Phase (26 Weeks)|Other|0|||
131068019|NCT02592434|471880639|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
131068020|NCT02592434|471880640|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
131068021|NCT02592434|471880641|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
131068022|NCT02592434|471880639|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
131068023|NCT02592434|471880640|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
131068024|NCT02592434|471880641|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
131068025|NCT02592434|471880639|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
131068026|NCT02592434|471880640|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
131068027|NCT02592434|471880641|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
131068028|NCT00561678|471880642|FG000|Overall Study|Withdrawal by Subject|4|||
131068029|NCT00561678|471880643|FG001|Overall Study|Withdrawal by Subject|3|||
131068030|NCT00561678|471880642|FG000|Overall Study|surgery cancelled|1|||
131068031|NCT00561678|471880643|FG001|Overall Study|surgery cancelled|1|||
131068032|NCT00561678|471880642|FG000|Overall Study|surgery rescheduled to different site|2|||
131068033|NCT00561678|471880643|FG001|Overall Study|surgery rescheduled to different site|2|||
131068034|NCT00561678|471880642|FG000|Overall Study|anesthesia provider refusal|1|||
131068035|NCT00561678|471880643|FG001|Overall Study|anesthesia provider refusal|0|||
131068036|NCT04748445|471880644|FG000|Overall Study|No longer met eligibility criteria|12|||
131068037|NCT04748445|471880644|FG000|Overall Study|Other|36|||
131068038|NCT04748445|471880644|FG000|Overall Study|Withdrawal by Subject|553|||
131068039|NCT04748445|471880644|FG000|Overall Study|Lost to Follow-up|30|||
131068040|NCT01106586|471880645|FG000|Overall Study|Adverse Event|9|||
131068041|NCT01106586|471880646|FG001|Overall Study|Adverse Event|15|||
131068042|NCT01106586|471880645|FG000|Overall Study|Death|1|||
131068043|NCT01106586|471880646|FG001|Overall Study|Death|3|||
131068044|NCT01106586|471880645|FG000|Overall Study|Pregnancy|2|||
131068045|NCT01106586|471880646|FG001|Overall Study|Pregnancy|2|||
131068046|NCT01106586|471880645|FG000|Overall Study|Lack of Efficacy|1|||
131068047|NCT01106586|471880646|FG001|Overall Study|Lack of Efficacy|0|||
131068048|NCT01106586|471880645|FG000|Overall Study|Investigator's Discretion|5|||
131068049|NCT01106586|471880646|FG001|Overall Study|Investigator's Discretion|8|||
131068050|NCT01106586|471880645|FG000|Overall Study|Withdrew Consent|18|||
131068051|NCT01106586|471880646|FG001|Overall Study|Withdrew Consent|30|||
131068052|NCT01106586|471880645|FG000|Overall Study|Lost to Follow-up|24|||
131068053|NCT01106586|471880646|FG001|Overall Study|Lost to Follow-up|20|||
131068054|NCT01106586|471880645|FG000|Overall Study|Participant Noncompliance|12|||
131068055|NCT01106586|471880646|FG001|Overall Study|Participant Noncompliance|10|||
131068056|NCT01106586|471880645|FG000|Overall Study|Protocol Violation|1|||
131068057|NCT01106586|471880646|FG001|Overall Study|Protocol Violation|0|||
131068058|NCT01106586|471880645|FG000|Overall Study|Participant Transferred to Another Study|212|||
131068059|NCT01106586|471880646|FG001|Overall Study|Participant Transferred to Another Study|197|||
131068060|NCT01379521|471880647|FG000|Overall Study -Treatment Period|Adverse Event|3|||
131068061|NCT01379521|471880648|FG001|Overall Study -Treatment Period|Adverse Event|0|||
131068062|NCT01379521|471880647|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
131068063|NCT01379521|471880648|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
131068064|NCT01379521|471880647|FG000|Overall Study -Treatment Period|Disease Progression|23|||
131068065|NCT01379521|471880648|FG001|Overall Study -Treatment Period|Disease Progression|22|||
131068066|NCT01379521|471880647|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
131068067|NCT01379521|471880648|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
131068068|NCT01379521|471880647|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
131068069|NCT01379521|471880648|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
131068070|NCT01379521|471880647|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
131068071|NCT01379521|471880648|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
131068072|NCT01379521|471880647|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
131068073|NCT01379521|471880648|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
131068074|NCT01379521|471880647|FG000|Overall Study -Treatment Period|Death|2|||
131068075|NCT01379521|471880648|FG001|Overall Study -Treatment Period|Death|1|||
131068076|NCT01379521|471880647|FG000|Post-Treatment Evaluations|Disease Progression|22|||
131068077|NCT01379521|471880648|FG001|Post-Treatment Evaluations|Disease Progression|20|||
131068078|NCT01379521|471880647|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
131068079|NCT01379521|471880648|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
131068080|NCT01379521|471880647|FG000|Post-Treatment Evaluations|Death|1|||
131068081|NCT01379521|471880648|FG001|Post-Treatment Evaluations|Death|0|||
131068082|NCT00938041|471880649|FG000|Overall Study|Lost to Follow-up|6|||
131068083|NCT00938041|471880649|FG000|Overall Study|Received Alternative Therapy|1|||
131068084|NCT00938041|471880649|FG000|Overall Study|Progressive Disease|5|||
131068085|NCT00938041|471880649|FG000|Overall Study|Death|12|||
131068086|NCT00938041|471880649|FG000|Overall Study|Adrenal Insufficiency|3|||
131068087|NCT01026103|471880650|FG000|Overall Study|Physician Decision|1|||
131068088|NCT01026103|471880650|FG000|Overall Study|did not receive study device bc of error|1|||
131068089|NCT00428441|471880651|FG000|Overall Study|Lost to Follow-up|1|||
131068090|NCT02475733|471880652|FG000|Overall Study|Withdrawal by Subject|1|||
131068091|NCT02475733|471880653|FG001|Overall Study|Withdrawal by Subject|0|||
131068092|NCT02475733|471880652|FG000|Overall Study|Physician Decision|1|||
131068093|NCT02475733|471880653|FG001|Overall Study|Physician Decision|0|||
131068094|NCT00404547|471880656|FG000|Overall Study|Adverse Event|39|||
131068095|NCT00404547|471880657|FG001|Overall Study|Adverse Event|6|||
131068096|NCT00404547|471880656|FG000|Overall Study|Withdrawal by Subject|19|||
131068097|NCT00404547|471880657|FG001|Overall Study|Withdrawal by Subject|2|||
131068098|NCT00404547|471880656|FG000|Overall Study|Protocol Violation|0|||
131068099|NCT00404547|471880657|FG001|Overall Study|Protocol Violation|1|||
131068100|NCT00404547|471880656|FG000|Overall Study|Lost to Follow-up|20|||
131068101|NCT00404547|471880657|FG001|Overall Study|Lost to Follow-up|9|||
131068102|NCT00404547|471880656|FG000|Overall Study|Lack of compliance|5|||
131068103|NCT00404547|471880657|FG001|Overall Study|Lack of compliance|1|||
131068104|NCT00404547|471880656|FG000|Overall Study|Other|4|||
131068105|NCT00404547|471880657|FG001|Overall Study|Other|0|||
131068106|NCT00404547|471880656|FG000|Overall Study|Reason not stated|3|||
131068107|NCT00404547|471880657|FG001|Overall Study|Reason not stated|6|||
131068108|NCT03906240|471880658|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
131068109|NCT03906240|471880659|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
131068110|NCT03906240|471880658|FG000|Overall Study|Lost to Follow-up|1|||
131068111|NCT03906240|471880659|FG001|Overall Study|Lost to Follow-up|0|||
131068112|NCT03906240|471880658|FG000|Overall Study|Withdrawal by Subject|0|||
131068113|NCT03906240|471880659|FG001|Overall Study|Withdrawal by Subject|1|||
131068114|NCT00296504|471880665|FG000|Interim Analysis|Withdrawal by Subject|8|||
131068115|NCT00296504|471880666|FG001|Interim Analysis|Withdrawal by Subject|0|||
131068116|NCT00296504|471880667|FG002|Interim Analysis|Withdrawal by Subject|12|||
131068117|NCT00296504|471880668|FG003|Interim Analysis|Withdrawal by Subject|0|||
131068118|NCT00296504|471880669|FG004|Interim Analysis|Withdrawal by Subject|5|||
131068119|NCT00296504|471880670|FG005|Interim Analysis|Withdrawal by Subject|5|||
131068120|NCT00296504|471880671|FG006|Interim Analysis|Withdrawal by Subject|9|||
131068121|NCT00296504|471880672|FG007|Interim Analysis|Withdrawal by Subject|3|||
131068122|NCT00296504|471880673|FG008|Interim Analysis|Withdrawal by Subject|0|||
131068123|NCT00296504|471880665|FG000|Interim Analysis|Lost to Follow-up|13|||
131068124|NCT00296504|471880666|FG001|Interim Analysis|Lost to Follow-up|3|||
131068125|NCT00296504|471880667|FG002|Interim Analysis|Lost to Follow-up|26|||
131068126|NCT00296504|471880668|FG003|Interim Analysis|Lost to Follow-up|8|||
131068127|NCT00296504|471880669|FG004|Interim Analysis|Lost to Follow-up|14|||
131068128|NCT00296504|471880670|FG005|Interim Analysis|Lost to Follow-up|4|||
131068129|NCT00296504|471880671|FG006|Interim Analysis|Lost to Follow-up|11|||
131068130|NCT00296504|471880672|FG007|Interim Analysis|Lost to Follow-up|4|||
131068131|NCT00296504|471880673|FG008|Interim Analysis|Lost to Follow-up|0|||
131068132|NCT00296504|471880665|FG000|Interim Analysis|Clinical Progression|1|||
131068133|NCT00296504|471880666|FG001|Interim Analysis|Clinical Progression|0|||
131068134|NCT00296504|471880667|FG002|Interim Analysis|Clinical Progression|1|||
131230333|NCT03465891|472469403|FG000|Overall Study|Disease progression|1|||
131068135|NCT00296504|471880668|FG003|Interim Analysis|Clinical Progression|1|||
131068136|NCT00296504|471880669|FG004|Interim Analysis|Clinical Progression|0|||
131068137|NCT00296504|471880670|FG005|Interim Analysis|Clinical Progression|2|||
131068138|NCT00296504|471880671|FG006|Interim Analysis|Clinical Progression|1|||
131068139|NCT00296504|471880672|FG007|Interim Analysis|Clinical Progression|2|||
131068140|NCT00296504|471880673|FG008|Interim Analysis|Clinical Progression|0|||
131068141|NCT00296504|471880665|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
131068142|NCT00296504|471880666|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
131068143|NCT00296504|471880667|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
131068144|NCT00296504|471880668|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
131068145|NCT00296504|471880669|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
131068146|NCT00296504|471880670|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
131068147|NCT00296504|471880671|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
131068148|NCT00296504|471880672|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
131068149|NCT00296504|471880673|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
131068150|NCT00296504|471880665|FG000|Interim Analysis|Adverse Event|0|||
131068151|NCT00296504|471880666|FG001|Interim Analysis|Adverse Event|0|||
131068152|NCT00296504|471880667|FG002|Interim Analysis|Adverse Event|13|||
131068153|NCT00296504|471880668|FG003|Interim Analysis|Adverse Event|4|||
131068154|NCT00296504|471880669|FG004|Interim Analysis|Adverse Event|6|||
131068155|NCT00296504|471880670|FG005|Interim Analysis|Adverse Event|3|||
131068156|NCT00296504|471880671|FG006|Interim Analysis|Adverse Event|4|||
131068157|NCT00296504|471880672|FG007|Interim Analysis|Adverse Event|5|||
131068158|NCT00296504|471880673|FG008|Interim Analysis|Adverse Event|0|||
131068159|NCT00296504|471880665|FG000|Interim Analysis|Protocol Violation|0|||
131068160|NCT00296504|471880666|FG001|Interim Analysis|Protocol Violation|0|||
131068161|NCT00296504|471880667|FG002|Interim Analysis|Protocol Violation|2|||
131068162|NCT00296504|471880668|FG003|Interim Analysis|Protocol Violation|0|||
131068163|NCT00296504|471880669|FG004|Interim Analysis|Protocol Violation|1|||
131068164|NCT00296504|471880670|FG005|Interim Analysis|Protocol Violation|0|||
131068165|NCT00296504|471880671|FG006|Interim Analysis|Protocol Violation|0|||
131068166|NCT00296504|471880672|FG007|Interim Analysis|Protocol Violation|1|||
131068167|NCT00296504|471880673|FG008|Interim Analysis|Protocol Violation|0|||
131068168|NCT00296504|471880665|FG000|Interim Analysis|Insufficient CD4 Response|0|||
131068169|NCT00296504|471880666|FG001|Interim Analysis|Insufficient CD4 Response|0|||
131068170|NCT00296504|471880667|FG002|Interim Analysis|Insufficient CD4 Response|0|||
131068171|NCT00296504|471880668|FG003|Interim Analysis|Insufficient CD4 Response|0|||
131068172|NCT00296504|471880669|FG004|Interim Analysis|Insufficient CD4 Response|1|||
131068173|NCT00296504|471880670|FG005|Interim Analysis|Insufficient CD4 Response|1|||
131068174|NCT00296504|471880671|FG006|Interim Analysis|Insufficient CD4 Response|0|||
131068175|NCT00296504|471880672|FG007|Interim Analysis|Insufficient CD4 Response|0|||
131068176|NCT00296504|471880673|FG008|Interim Analysis|Insufficient CD4 Response|0|||
131068177|NCT00296504|471880665|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
131068178|NCT00296504|471880666|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
131068179|NCT00296504|471880667|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
131068180|NCT00296504|471880668|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
131068181|NCT00296504|471880669|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
131068182|NCT00296504|471880670|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
131068183|NCT00296504|471880671|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
131068184|NCT00296504|471880672|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
131068185|NCT00296504|471880673|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
131068186|NCT00296504|471880665|FG000|Interim Analysis|Pregnancy|4|||
131068187|NCT00296504|471880666|FG001|Interim Analysis|Pregnancy|1|||
131068188|NCT00296504|471880667|FG002|Interim Analysis|Pregnancy|4|||
131068189|NCT00296504|471880668|FG003|Interim Analysis|Pregnancy|2|||
131068190|NCT00296504|471880669|FG004|Interim Analysis|Pregnancy|0|||
131068191|NCT00296504|471880670|FG005|Interim Analysis|Pregnancy|1|||
131068192|NCT00296504|471880671|FG006|Interim Analysis|Pregnancy|1|||
131068193|NCT00296504|471880672|FG007|Interim Analysis|Pregnancy|1|||
131068194|NCT00296504|471880673|FG008|Interim Analysis|Pregnancy|0|||
131068195|NCT00296504|471880665|FG000|Interim Analysis|Death|1|||
130723340|NCT01056289|470613426|FG002|Open-label Phase|Other|0|||
130723341|NCT01056289|470613427|FG003|Open-label Phase|Other|0|||
131068196|NCT00296504|471880666|FG001|Interim Analysis|Death|0|||
130723342|NCT01056289|470613424|FG000|Open-label Phase|Protocol Violation|6|||
131068197|NCT00296504|471880667|FG002|Interim Analysis|Death|3|||
131068198|NCT00296504|471880668|FG003|Interim Analysis|Death|0|||
130723343|NCT01056289|470613425|FG001|Open-label Phase|Protocol Violation|0|||
131068199|NCT00296504|471880669|FG004|Interim Analysis|Death|0|||
131068200|NCT00296504|471880670|FG005|Interim Analysis|Death|0|||
131068201|NCT00296504|471880671|FG006|Interim Analysis|Death|0|||
131068202|NCT00296504|471880672|FG007|Interim Analysis|Death|0|||
131068203|NCT00296504|471880673|FG008|Interim Analysis|Death|0|||
130723344|NCT01056289|470613426|FG002|Open-label Phase|Protocol Violation|0|||
130723345|NCT01056289|470613427|FG003|Open-label Phase|Protocol Violation|0|||
130723346|NCT01056289|470613424|FG000|Open-label Phase|Withdrawal by Subject|26|||
130723347|NCT01056289|470613425|FG001|Open-label Phase|Withdrawal by Subject|0|||
130723348|NCT01056289|470613426|FG002|Open-label Phase|Withdrawal by Subject|0|||
130723349|NCT01056289|470613427|FG003|Open-label Phase|Withdrawal by Subject|0|||
130723350|NCT01056289|470613424|FG000|Open-label Phase|Lack of Efficacy|18|||
130723351|NCT01056289|470613425|FG001|Open-label Phase|Lack of Efficacy|0|||
130723352|NCT01056289|470613426|FG002|Open-label Phase|Lack of Efficacy|0|||
130723353|NCT01056289|470613427|FG003|Open-label Phase|Lack of Efficacy|0|||
130723354|NCT01056289|470613424|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
131068204|NCT00296504|471880665|FG000|Interim Analysis|Participant Non-compliant|0|||
130723355|NCT01056289|470613425|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
131068205|NCT00296504|471880666|FG001|Interim Analysis|Participant Non-compliant|1|||
131068206|NCT00296504|471880667|FG002|Interim Analysis|Participant Non-compliant|2|||
131068207|NCT00296504|471880668|FG003|Interim Analysis|Participant Non-compliant|1|||
131068208|NCT00296504|471880669|FG004|Interim Analysis|Participant Non-compliant|1|||
131068209|NCT00296504|471880670|FG005|Interim Analysis|Participant Non-compliant|3|||
131068210|NCT00296504|471880671|FG006|Interim Analysis|Participant Non-compliant|6|||
131068211|NCT00296504|471880672|FG007|Interim Analysis|Participant Non-compliant|2|||
131068212|NCT00296504|471880673|FG008|Interim Analysis|Participant Non-compliant|0|||
131068213|NCT00296504|471880665|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131068214|NCT00296504|471880666|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131068215|NCT00296504|471880667|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
131068216|NCT00296504|471880668|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131068217|NCT00296504|471880669|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131068218|NCT00296504|471880670|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
131068219|NCT00296504|471880671|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131068220|NCT00296504|471880672|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131068221|NCT00296504|471880673|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
131068222|NCT00296504|471880665|FG000|Interim Analysis|To Simplify Treatment|0|||
131068223|NCT00296504|471880666|FG001|Interim Analysis|To Simplify Treatment|0|||
131068224|NCT00296504|471880667|FG002|Interim Analysis|To Simplify Treatment|1|||
131068225|NCT00296504|471880668|FG003|Interim Analysis|To Simplify Treatment|0|||
131068226|NCT00296504|471880669|FG004|Interim Analysis|To Simplify Treatment|0|||
131068227|NCT00296504|471880670|FG005|Interim Analysis|To Simplify Treatment|0|||
130723356|NCT01056289|470613426|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
130723357|NCT01056289|470613427|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
130723358|NCT01056289|470613424|FG000|Double-blind Phase|Adverse Event|0|||
130723359|NCT01056289|470613425|FG001|Double-blind Phase|Adverse Event|1|||
130779451|NCT02326272|470819493|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130779452|NCT02326272|470819494|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130779453|NCT02326272|470819495|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
130779454|NCT02326272|470819496|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
130779455|NCT02326272|470819497|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
131068228|NCT00296504|471880671|FG006|Interim Analysis|To Simplify Treatment|2|||
131068229|NCT00296504|471880672|FG007|Interim Analysis|To Simplify Treatment|0|||
131068230|NCT00296504|471880673|FG008|Interim Analysis|To Simplify Treatment|0|||
131068231|NCT00296504|471880665|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
131068232|NCT00296504|471880666|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
131068233|NCT00296504|471880667|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
131068234|NCT00296504|471880668|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
131068235|NCT00296504|471880669|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
131068236|NCT00296504|471880670|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
131068237|NCT00296504|471880671|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
131068238|NCT00296504|471880672|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
131068239|NCT00296504|471880673|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
131068240|NCT00296504|471880665|FG000|Interim Analysis|Participant Moved|1|||
131068241|NCT00296504|471880666|FG001|Interim Analysis|Participant Moved|0|||
131068242|NCT00296504|471880667|FG002|Interim Analysis|Participant Moved|1|||
131068243|NCT00296504|471880668|FG003|Interim Analysis|Participant Moved|0|||
131068244|NCT00296504|471880669|FG004|Interim Analysis|Participant Moved|0|||
131068245|NCT00296504|471880670|FG005|Interim Analysis|Participant Moved|1|||
131068246|NCT00296504|471880671|FG006|Interim Analysis|Participant Moved|1|||
131068247|NCT00296504|471880672|FG007|Interim Analysis|Participant Moved|0|||
131068248|NCT00296504|471880673|FG008|Interim Analysis|Participant Moved|0|||
131068249|NCT00296504|471880665|FG000|Interim Analysis|Participant Was Incarcerated|2|||
131068250|NCT00296504|471880666|FG001|Interim Analysis|Participant Was Incarcerated|0|||
131068251|NCT00296504|471880667|FG002|Interim Analysis|Participant Was Incarcerated|1|||
131230334|NCT03465891|472469404|FG001|Overall Study|Disease progression|0|||
130723360|NCT01056289|470613426|FG002|Double-blind Phase|Adverse Event|2|||
130723361|NCT01056289|470613427|FG003|Double-blind Phase|Adverse Event|1|||
130779456|NCT02326272|470819498|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
131068252|NCT00296504|471880668|FG003|Interim Analysis|Participant Was Incarcerated|0|||
131068253|NCT00296504|471880669|FG004|Interim Analysis|Participant Was Incarcerated|0|||
131068254|NCT00296504|471880670|FG005|Interim Analysis|Participant Was Incarcerated|0|||
131068255|NCT00296504|471880671|FG006|Interim Analysis|Participant Was Incarcerated|0|||
131068256|NCT00296504|471880672|FG007|Interim Analysis|Participant Was Incarcerated|0|||
131068257|NCT00296504|471880673|FG008|Interim Analysis|Participant Was Incarcerated|0|||
131068258|NCT00296504|471880665|FG000|Interim Analysis|Resistance to FPV|0|||
131068259|NCT00296504|471880666|FG001|Interim Analysis|Resistance to FPV|0|||
131068260|NCT00296504|471880667|FG002|Interim Analysis|Resistance to FPV|1|||
131068261|NCT00296504|471880668|FG003|Interim Analysis|Resistance to FPV|0|||
131068262|NCT00296504|471880669|FG004|Interim Analysis|Resistance to FPV|0|||
131068263|NCT00296504|471880670|FG005|Interim Analysis|Resistance to FPV|0|||
131068264|NCT00296504|471880671|FG006|Interim Analysis|Resistance to FPV|0|||
131068265|NCT00296504|471880672|FG007|Interim Analysis|Resistance to FPV|0|||
131068266|NCT00296504|471880673|FG008|Interim Analysis|Resistance to FPV|0|||
131068267|NCT00296504|471880665|FG000|Interim Analysis|Physician Decision|0|||
131068268|NCT00296504|471880666|FG001|Interim Analysis|Physician Decision|0|||
131068269|NCT00296504|471880667|FG002|Interim Analysis|Physician Decision|1|||
131068270|NCT00296504|471880668|FG003|Interim Analysis|Physician Decision|0|||
131068271|NCT00296504|471880669|FG004|Interim Analysis|Physician Decision|0|||
131068272|NCT00296504|471880670|FG005|Interim Analysis|Physician Decision|0|||
131068273|NCT00296504|471880671|FG006|Interim Analysis|Physician Decision|0|||
131068274|NCT00296504|471880672|FG007|Interim Analysis|Physician Decision|0|||
131068275|NCT00296504|471880673|FG008|Interim Analysis|Physician Decision|0|||
131068276|NCT00296504|471880665|FG000|Interim Analysis|Principle Investigator Discretion|2|||
131068277|NCT00296504|471880666|FG001|Interim Analysis|Principle Investigator Discretion|0|||
131068278|NCT00296504|471880667|FG002|Interim Analysis|Principle Investigator Discretion|1|||
131068279|NCT00296504|471880668|FG003|Interim Analysis|Principle Investigator Discretion|1|||
131068280|NCT00296504|471880669|FG004|Interim Analysis|Principle Investigator Discretion|0|||
131068281|NCT00296504|471880670|FG005|Interim Analysis|Principle Investigator Discretion|0|||
131068282|NCT00296504|471880671|FG006|Interim Analysis|Principle Investigator Discretion|0|||
131068283|NCT00296504|471880672|FG007|Interim Analysis|Principle Investigator Discretion|0|||
131068284|NCT00296504|471880673|FG008|Interim Analysis|Principle Investigator Discretion|0|||
131068285|NCT00296504|471880665|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
131068286|NCT00296504|471880666|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
131068287|NCT00296504|471880667|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
131068288|NCT00296504|471880668|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
131068289|NCT00296504|471880669|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
131068290|NCT00296504|471880670|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
131068291|NCT00296504|471880671|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
131068292|NCT00296504|471880672|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
131068293|NCT00296504|471880673|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
130723362|NCT01056289|470613424|FG000|Double-blind Phase|Lost to Follow-up|0|||
130723363|NCT01056289|470613425|FG001|Double-blind Phase|Lost to Follow-up|2|||
130723364|NCT01056289|470613426|FG002|Double-blind Phase|Lost to Follow-up|2|||
130723365|NCT01056289|470613427|FG003|Double-blind Phase|Lost to Follow-up|2|||
131068294|NCT00296504|471880665|FG000|Interim Analysis|Non-adherence|2|||
131068295|NCT00296504|471880666|FG001|Interim Analysis|Non-adherence|0|||
131068296|NCT00296504|471880667|FG002|Interim Analysis|Non-adherence|0|||
131068297|NCT00296504|471880668|FG003|Interim Analysis|Non-adherence|0|||
131068298|NCT00296504|471880669|FG004|Interim Analysis|Non-adherence|1|||
131068299|NCT00296504|471880670|FG005|Interim Analysis|Non-adherence|0|||
131068300|NCT00296504|471880671|FG006|Interim Analysis|Non-adherence|0|||
131068301|NCT00296504|471880672|FG007|Interim Analysis|Non-adherence|1|||
131068302|NCT00296504|471880673|FG008|Interim Analysis|Non-adherence|0|||
130723366|NCT01056289|470613424|FG000|Double-blind Phase|Other|0|||
130723367|NCT01056289|470613425|FG001|Double-blind Phase|Other|0|||
130723368|NCT01056289|470613426|FG002|Double-blind Phase|Other|1|||
131068303|NCT00296504|471880665|FG000|Interim Analysis|Site Closing|1|||
131068304|NCT00296504|471880666|FG001|Interim Analysis|Site Closing|0|||
131068305|NCT00296504|471880667|FG002|Interim Analysis|Site Closing|0|||
131068306|NCT00296504|471880668|FG003|Interim Analysis|Site Closing|0|||
131068307|NCT00296504|471880669|FG004|Interim Analysis|Site Closing|0|||
131068308|NCT00296504|471880670|FG005|Interim Analysis|Site Closing|1|||
131068309|NCT00296504|471880671|FG006|Interim Analysis|Site Closing|2|||
131068310|NCT00296504|471880672|FG007|Interim Analysis|Site Closing|0|||
131068311|NCT00296504|471880673|FG008|Interim Analysis|Site Closing|0|||
131068312|NCT00296504|471880665|FG000|Interim Analysis|Lack of Personnel at Site|1|||
131068313|NCT00296504|471880666|FG001|Interim Analysis|Lack of Personnel at Site|0|||
130723369|NCT01056289|470613427|FG003|Double-blind Phase|Other|2|||
130723370|NCT01056289|470613424|FG000|Double-blind Phase|Protocol Violation|0|||
131068314|NCT00296504|471880667|FG002|Interim Analysis|Lack of Personnel at Site|0|||
131068315|NCT00296504|471880668|FG003|Interim Analysis|Lack of Personnel at Site|0|||
130723371|NCT01056289|470613425|FG001|Double-blind Phase|Protocol Violation|0|||
131068316|NCT00296504|471880669|FG004|Interim Analysis|Lack of Personnel at Site|0|||
131068317|NCT00296504|471880670|FG005|Interim Analysis|Lack of Personnel at Site|0|||
131068318|NCT00296504|471880671|FG006|Interim Analysis|Lack of Personnel at Site|0|||
131068319|NCT00296504|471880672|FG007|Interim Analysis|Lack of Personnel at Site|0|||
131068320|NCT00296504|471880673|FG008|Interim Analysis|Lack of Personnel at Site|0|||
131068321|NCT00296504|471880665|FG000|Interim Analysis|Missed Schedule Date|1|||
131068322|NCT00296504|471880666|FG001|Interim Analysis|Missed Schedule Date|0|||
131068323|NCT00296504|471880667|FG002|Interim Analysis|Missed Schedule Date|0|||
131068324|NCT00296504|471880668|FG003|Interim Analysis|Missed Schedule Date|0|||
131068325|NCT00296504|471880669|FG004|Interim Analysis|Missed Schedule Date|0|||
131068326|NCT00296504|471880670|FG005|Interim Analysis|Missed Schedule Date|0|||
131068327|NCT00296504|471880671|FG006|Interim Analysis|Missed Schedule Date|0|||
131068328|NCT00296504|471880672|FG007|Interim Analysis|Missed Schedule Date|0|||
131068329|NCT00296504|471880673|FG008|Interim Analysis|Missed Schedule Date|0|||
131068330|NCT00296504|471880665|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
131068331|NCT00296504|471880666|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
131068332|NCT00296504|471880667|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
131068333|NCT00296504|471880668|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
131068334|NCT00296504|471880669|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
131068335|NCT00296504|471880670|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
131068336|NCT00296504|471880671|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
131068337|NCT00296504|471880672|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
131068338|NCT00296504|471880673|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
131068339|NCT00296504|471880665|FG000|Interim Analysis|Participant Stopped|0|||
131068340|NCT00296504|471880666|FG001|Interim Analysis|Participant Stopped|0|||
131068341|NCT00296504|471880667|FG002|Interim Analysis|Participant Stopped|0|||
131068342|NCT00296504|471880668|FG003|Interim Analysis|Participant Stopped|0|||
131068343|NCT00296504|471880669|FG004|Interim Analysis|Participant Stopped|1|||
131068344|NCT00296504|471880670|FG005|Interim Analysis|Participant Stopped|0|||
131068345|NCT00296504|471880671|FG006|Interim Analysis|Participant Stopped|0|||
131068346|NCT00296504|471880672|FG007|Interim Analysis|Participant Stopped|0|||
131068347|NCT00296504|471880673|FG008|Interim Analysis|Participant Stopped|0|||
131068348|NCT00296504|471880665|FG000|Interim Analysis|Physician and Participant Decision|0|||
131068349|NCT00296504|471880666|FG001|Interim Analysis|Physician and Participant Decision|0|||
131068350|NCT00296504|471880667|FG002|Interim Analysis|Physician and Participant Decision|0|||
131068351|NCT00296504|471880668|FG003|Interim Analysis|Physician and Participant Decision|0|||
131068352|NCT00296504|471880669|FG004|Interim Analysis|Physician and Participant Decision|0|||
131068353|NCT00296504|471880670|FG005|Interim Analysis|Physician and Participant Decision|1|||
131068354|NCT00296504|471880671|FG006|Interim Analysis|Physician and Participant Decision|0|||
131068355|NCT00296504|471880672|FG007|Interim Analysis|Physician and Participant Decision|0|||
131068356|NCT00296504|471880673|FG008|Interim Analysis|Physician and Participant Decision|0|||
131068357|NCT00296504|471880665|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
131068358|NCT00296504|471880666|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
131068359|NCT00296504|471880667|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
130723372|NCT01056289|470613426|FG002|Double-blind Phase|Protocol Violation|1|||
130723373|NCT01056289|470613427|FG003|Double-blind Phase|Protocol Violation|1|||
130723374|NCT01056289|470613424|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130723375|NCT01056289|470613425|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130723376|NCT01056289|470613426|FG002|Double-blind Phase|Withdrawal by Subject|4|||
130723377|NCT01056289|470613427|FG003|Double-blind Phase|Withdrawal by Subject|2|||
130723378|NCT01056289|470613424|FG000|Double-blind Phase|Discontinuation symptom|0|||
130723379|NCT01056289|470613425|FG001|Double-blind Phase|Discontinuation symptom|1|||
130723380|NCT01056289|470613426|FG002|Double-blind Phase|Discontinuation symptom|2|||
131068360|NCT00296504|471880668|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
131068361|NCT00296504|471880669|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
131068362|NCT00296504|471880670|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
131068363|NCT00296504|471880671|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
131068364|NCT00296504|471880672|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
131068365|NCT00296504|471880673|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
131230335|NCT01001169|472469405|FG000|Overall Study|Withdrawal by Subject|2|||
131230336|NCT01001169|472469406|FG001|Overall Study|Withdrawal by Subject|1|||
131230337|NCT02536378|472469411|FG000|Overall Study|Physician Decision|0|||
131230338|NCT02536378|472469412|FG001|Overall Study|Physician Decision|2|||
131230339|NCT02536378|472469411|FG000|Overall Study|Withdrawal by Subject|0|||
131230340|NCT02536378|472469412|FG001|Overall Study|Withdrawal by Subject|1|||
131230341|NCT02536378|472469411|FG000|Overall Study|Death|1|||
131230342|NCT02536378|472469412|FG001|Overall Study|Death|2|||
131230343|NCT02536378|472469411|FG000|Overall Study|Patient refused further follow up|6|||
130723381|NCT01056289|470613427|FG003|Double-blind Phase|Discontinuation symptom|2|||
131068366|NCT00296504|471880665|FG000|Interim Analysis|Study Ended|0|||
131068367|NCT00296504|471880666|FG001|Interim Analysis|Study Ended|0|||
131230344|NCT02536378|472469412|FG001|Overall Study|Patient refused further follow up|2|||
131230345|NCT00798889|472469413|FG000|Overall Study|Adverse Event|53|||
131230346|NCT00798889|472469413|FG000|Overall Study|Protocol Violation|2|||
131230347|NCT00798889|472469413|FG000|Overall Study|Withdrawal by Subject|31|||
131230348|NCT00798889|472469413|FG000|Overall Study|Lost to Follow-up|1|||
131230349|NCT00798889|472469413|FG000|Overall Study|Lack of Efficacy|213|||
131230350|NCT00798889|472469413|FG000|Overall Study|Decision of Sponsor|11|||
131230351|NCT00798889|472469413|FG000|Overall Study|Enrolled, Not treated|3|||
131230352|NCT00617461|472469414|FG000|First Treatment Intervention Period|Adverse Event|2|||
130723382|NCT01056289|470613424|FG000|Double-blind Phase|Physician Decision|0|||
130723383|NCT01056289|470613425|FG001|Double-blind Phase|Physician Decision|0|||
130723384|NCT01056289|470613426|FG002|Double-blind Phase|Physician Decision|1|||
130723385|NCT01056289|470613427|FG003|Double-blind Phase|Physician Decision|0|||
130723386|NCT01199471|470613430|FG000|Overall Study|Protocol Violation|4|||
130723387|NCT01199471|470613430|FG000|Overall Study|Withdrawal by Subject|1|||
130723388|NCT01199471|470613430|FG000|Overall Study|Physician Decision|1|||
130723389|NCT03511326|470613438|FG000|Overall Study|Withdrawal by Subject|1|||
130723390|NCT04746794|470613441|FG000|Overall Study|Did not complete any study assessment|50303|||
130723391|NCT04746794|470613442|FG001|Overall Study|Did not complete any study assessment|44997|||
131068368|NCT00296504|471880667|FG002|Interim Analysis|Study Ended|0|||
131068369|NCT00296504|471880668|FG003|Interim Analysis|Study Ended|0|||
131068370|NCT00296504|471880669|FG004|Interim Analysis|Study Ended|0|||
131068371|NCT00296504|471880670|FG005|Interim Analysis|Study Ended|0|||
131068372|NCT00296504|471880671|FG006|Interim Analysis|Study Ended|1|||
131068373|NCT00296504|471880672|FG007|Interim Analysis|Study Ended|0|||
131068374|NCT00296504|471880673|FG008|Interim Analysis|Study Ended|0|||
131068375|NCT00296504|471880665|FG000|Interim Analysis|Participant Needed Interferon|0|||
131068376|NCT00296504|471880666|FG001|Interim Analysis|Participant Needed Interferon|0|||
131068377|NCT00296504|471880667|FG002|Interim Analysis|Participant Needed Interferon|0|||
131068378|NCT00296504|471880668|FG003|Interim Analysis|Participant Needed Interferon|0|||
131068379|NCT00296504|471880669|FG004|Interim Analysis|Participant Needed Interferon|0|||
131068380|NCT00296504|471880670|FG005|Interim Analysis|Participant Needed Interferon|0|||
131068381|NCT00296504|471880671|FG006|Interim Analysis|Participant Needed Interferon|0|||
131068382|NCT00296504|471880672|FG007|Interim Analysis|Participant Needed Interferon|1|||
131068383|NCT00296504|471880673|FG008|Interim Analysis|Participant Needed Interferon|0|||
131068384|NCT00296504|471880665|FG000|Interim Analysis|Ongoing|32|||
131068385|NCT00296504|471880666|FG001|Interim Analysis|Ongoing|12|||
131068386|NCT00296504|471880667|FG002|Interim Analysis|Ongoing|16|||
131068387|NCT00296504|471880668|FG003|Interim Analysis|Ongoing|22|||
131068388|NCT00296504|471880669|FG004|Interim Analysis|Ongoing|0|||
131068389|NCT00296504|471880670|FG005|Interim Analysis|Ongoing|0|||
131068390|NCT00296504|471880671|FG006|Interim Analysis|Ongoing|30|||
131068391|NCT00296504|471880672|FG007|Interim Analysis|Ongoing|1|||
131068392|NCT00296504|471880673|FG008|Interim Analysis|Ongoing|0|||
131068393|NCT00296504|471880665|FG000|Final Analysis|Withdrawal by Subject|0|||
131068394|NCT00296504|471880666|FG001|Final Analysis|Withdrawal by Subject|0|||
131068395|NCT00296504|471880667|FG002|Final Analysis|Withdrawal by Subject|0|||
131068396|NCT00296504|471880668|FG003|Final Analysis|Withdrawal by Subject|0|||
131068397|NCT00296504|471880669|FG004|Final Analysis|Withdrawal by Subject|0|||
131068398|NCT00296504|471880670|FG005|Final Analysis|Withdrawal by Subject|0|||
131068399|NCT00296504|471880671|FG006|Final Analysis|Withdrawal by Subject|0|||
131068400|NCT00296504|471880672|FG007|Final Analysis|Withdrawal by Subject|0|||
131068401|NCT00296504|471880673|FG008|Final Analysis|Withdrawal by Subject|1|||
131068402|NCT00296504|471880665|FG000|Final Analysis|Lost to Follow-up|0|||
131068403|NCT00296504|471880666|FG001|Final Analysis|Lost to Follow-up|0|||
131068404|NCT00296504|471880667|FG002|Final Analysis|Lost to Follow-up|0|||
131068405|NCT00296504|471880668|FG003|Final Analysis|Lost to Follow-up|0|||
131068406|NCT00296504|471880669|FG004|Final Analysis|Lost to Follow-up|0|||
131068407|NCT00296504|471880670|FG005|Final Analysis|Lost to Follow-up|0|||
131068408|NCT00296504|471880671|FG006|Final Analysis|Lost to Follow-up|0|||
131068409|NCT00296504|471880672|FG007|Final Analysis|Lost to Follow-up|0|||
131068410|NCT00296504|471880673|FG008|Final Analysis|Lost to Follow-up|5|||
131068411|NCT00296504|471880665|FG000|Final Analysis|Insufficient Viral Load Response|0|||
131068412|NCT00296504|471880666|FG001|Final Analysis|Insufficient Viral Load Response|0|||
131068413|NCT00296504|471880667|FG002|Final Analysis|Insufficient Viral Load Response|0|||
131068414|NCT00296504|471880668|FG003|Final Analysis|Insufficient Viral Load Response|0|||
131068415|NCT00296504|471880669|FG004|Final Analysis|Insufficient Viral Load Response|0|||
130723392|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
130723393|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
130723394|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
131068416|NCT00296504|471880670|FG005|Final Analysis|Insufficient Viral Load Response|0|||
131068417|NCT00296504|471880671|FG006|Final Analysis|Insufficient Viral Load Response|0|||
131068418|NCT00296504|471880672|FG007|Final Analysis|Insufficient Viral Load Response|0|||
131068419|NCT00296504|471880673|FG008|Final Analysis|Insufficient Viral Load Response|6|||
131068420|NCT00296504|471880665|FG000|Final Analysis|Adverse Event|0|||
131230353|NCT00617461|472469415|FG001|First Treatment Intervention Period|Adverse Event|0|||
130723395|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
130723396|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
130723397|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
130723398|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
130723399|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
130723400|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
131068421|NCT00296504|471880666|FG001|Final Analysis|Adverse Event|0|||
131068422|NCT00296504|471880667|FG002|Final Analysis|Adverse Event|0|||
131068423|NCT00296504|471880668|FG003|Final Analysis|Adverse Event|0|||
131068424|NCT00296504|471880669|FG004|Final Analysis|Adverse Event|0|||
131068425|NCT00296504|471880670|FG005|Final Analysis|Adverse Event|0|||
131068426|NCT00296504|471880671|FG006|Final Analysis|Adverse Event|0|||
131068427|NCT00296504|471880672|FG007|Final Analysis|Adverse Event|0|||
131068428|NCT00296504|471880673|FG008|Final Analysis|Adverse Event|2|||
130723401|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
131068429|NCT00296504|471880665|FG000|Final Analysis|Pregnancy|0|||
131068430|NCT00296504|471880666|FG001|Final Analysis|Pregnancy|0|||
131068431|NCT00296504|471880667|FG002|Final Analysis|Pregnancy|0|||
131068432|NCT00296504|471880668|FG003|Final Analysis|Pregnancy|0|||
131068433|NCT00296504|471880669|FG004|Final Analysis|Pregnancy|0|||
131068434|NCT00296504|471880670|FG005|Final Analysis|Pregnancy|0|||
131068435|NCT00296504|471880671|FG006|Final Analysis|Pregnancy|0|||
131068436|NCT00296504|471880672|FG007|Final Analysis|Pregnancy|0|||
131068437|NCT00296504|471880673|FG008|Final Analysis|Pregnancy|4|||
131068438|NCT00296504|471880665|FG000|Final Analysis|Tuberculosis|0|||
131068439|NCT00296504|471880666|FG001|Final Analysis|Tuberculosis|0|||
131068440|NCT00296504|471880667|FG002|Final Analysis|Tuberculosis|0|||
131068441|NCT00296504|471880668|FG003|Final Analysis|Tuberculosis|0|||
131068442|NCT00296504|471880669|FG004|Final Analysis|Tuberculosis|0|||
131068443|NCT00296504|471880670|FG005|Final Analysis|Tuberculosis|0|||
131068444|NCT00296504|471880671|FG006|Final Analysis|Tuberculosis|0|||
131068445|NCT00296504|471880672|FG007|Final Analysis|Tuberculosis|0|||
131068446|NCT00296504|471880673|FG008|Final Analysis|Tuberculosis|1|||
131068447|NCT00296504|471880665|FG000|Final Analysis|Participant Moved to Another Country|0|||
131068448|NCT00296504|471880666|FG001|Final Analysis|Participant Moved to Another Country|0|||
131068449|NCT00296504|471880667|FG002|Final Analysis|Participant Moved to Another Country|0|||
131068450|NCT00296504|471880668|FG003|Final Analysis|Participant Moved to Another Country|0|||
131068451|NCT00296504|471880669|FG004|Final Analysis|Participant Moved to Another Country|0|||
131068452|NCT00296504|471880670|FG005|Final Analysis|Participant Moved to Another Country|0|||
131068453|NCT00296504|471880671|FG006|Final Analysis|Participant Moved to Another Country|0|||
131068454|NCT00296504|471880672|FG007|Final Analysis|Participant Moved to Another Country|0|||
131068455|NCT00296504|471880673|FG008|Final Analysis|Participant Moved to Another Country|1|||
131068456|NCT00296504|471880665|FG000|Final Analysis|Poor Adherence|0|||
131068457|NCT00296504|471880666|FG001|Final Analysis|Poor Adherence|0|||
131068458|NCT00296504|471880667|FG002|Final Analysis|Poor Adherence|0|||
131068459|NCT00296504|471880668|FG003|Final Analysis|Poor Adherence|0|||
131068460|NCT00296504|471880669|FG004|Final Analysis|Poor Adherence|0|||
131068461|NCT00296504|471880670|FG005|Final Analysis|Poor Adherence|0|||
131068462|NCT00296504|471880671|FG006|Final Analysis|Poor Adherence|0|||
131068463|NCT00296504|471880672|FG007|Final Analysis|Poor Adherence|0|||
131068464|NCT00296504|471880673|FG008|Final Analysis|Poor Adherence|1|||
131068465|NCT01348763|471880674|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
131068466|NCT01348763|471880674|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
131068467|NCT03647709|471880682|FG000|Overall Study|Lost to Follow-up|5|||
131068468|NCT03647709|471880682|FG000|Overall Study|Physician Decision|6|||
131068469|NCT03647709|471880682|FG000|Overall Study|Withdrawal by Subject|3|||
131068470|NCT00449033|471880685|FG000|Treatment Period|Adverse Event|117|||
131068471|NCT00449033|471880686|FG001|Treatment Period|Adverse Event|83|||
131068472|NCT00449033|471880685|FG000|Treatment Period|Death|21|||
131068473|NCT00449033|471880686|FG001|Treatment Period|Death|12|||
131068474|NCT00449033|471880685|FG000|Treatment Period|Lost to Follow-up|0|||
131068475|NCT00449033|471880686|FG001|Treatment Period|Lost to Follow-up|2|||
131068476|NCT00449033|471880685|FG000|Treatment Period|Physician Decision|4|||
131068477|NCT00449033|471880686|FG001|Treatment Period|Physician Decision|5|||
131068478|NCT00449033|471880685|FG000|Treatment Period|Protocol Violation|8|||
131068479|NCT00449033|471880686|FG001|Treatment Period|Protocol Violation|7|||
131068480|NCT00449033|471880685|FG000|Treatment Period|Disease Progression|231|||
131068481|NCT00449033|471880686|FG001|Treatment Period|Disease Progression|288|||
131068482|NCT00449033|471880685|FG000|Treatment Period|Consent Withdrawn|36|||
131068483|NCT00449033|471880686|FG001|Treatment Period|Consent Withdrawn|20|||
131068484|NCT00449033|471880685|FG000|Treatment Period|Amended Protocol Criteria|22|||
131068485|NCT00449033|471880686|FG001|Treatment Period|Amended Protocol Criteria|18|||
131068486|NCT00449033|471880685|FG000|Treatment Period|Non-compliance|7|||
131068487|NCT00449033|471880686|FG001|Treatment Period|Non-compliance|8|||
131068488|NCT00449033|471880685|FG000|Treatment Period|Second Malignancy|0|||
131068489|NCT00449033|471880686|FG001|Treatment Period|Second Malignancy|1|||
131068490|NCT00449033|471880685|FG000|Treatment Period|Reason Missing|0|||
131068491|NCT00449033|471880686|FG001|Treatment Period|Reason Missing|4|||
131068492|NCT00449033|471880685|FG000|Treatment Period|Treatment Ongoing|6|||
131068493|NCT00449033|471880686|FG001|Treatment Period|Treatment Ongoing|4|||
131068494|NCT00449033|471880685|FG000|Follow-up Period|Death|299|||
131068495|NCT00449033|471880686|FG001|Follow-up Period|Death|311|||
131068496|NCT00449033|471880685|FG000|Follow-up Period|Lost to Follow-up|6|||
131068497|NCT00449033|471880686|FG001|Follow-up Period|Lost to Follow-up|10|||
131068498|NCT00449033|471880685|FG000|Follow-up Period|Reason Missing|120|||
131068499|NCT00449033|471880686|FG001|Follow-up Period|Reason Missing|113|||
131068500|NCT01257698|471880687|FG000|Overall Study|Protocol Violation|4|||
131068501|NCT01257698|471880688|FG001|Overall Study|Protocol Violation|0|||
131068502|NCT04393779|471880689|FG000|Overall Study|Death|1|||
131068503|NCT04393779|471880689|FG000|Overall Study|Device reintervention or explant|4|||
131068504|NCT01190228|471880690|FG000|Overall Study|Protocol Violation|4|||
131068505|NCT01190228|471880691|FG001|Overall Study|Protocol Violation|0|||
131068506|NCT01190228|471880692|FG002|Overall Study|Protocol Violation|0|||
131068507|NCT01190228|471880690|FG000|Overall Study|Withdrawal by Subject|1|||
131068508|NCT01190228|471880691|FG001|Overall Study|Withdrawal by Subject|0|||
131068509|NCT01190228|471880692|FG002|Overall Study|Withdrawal by Subject|0|||
131068510|NCT02038803|471880698|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
131068511|NCT02038803|471880698|FG000|Overall Study|Lost to Follow-up|1|||
131068512|NCT04372186|471880699|FG000|Overall Study|Death|24|||
131068513|NCT04372186|471880700|FG001|Overall Study|Death|11|||
131068514|NCT04372186|471880699|FG000|Overall Study|Transferred to a different facility for care|0|||
131068515|NCT04372186|471880700|FG001|Overall Study|Transferred to a different facility for care|2|||
131068516|NCT03219216|471880701|FG000|Overall Study|Lost to Follow-up|0|||
131068517|NCT03219216|471880702|FG001|Overall Study|Lost to Follow-up|1|||
131068518|NCT02332824|471880703|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
131068519|NCT02332824|471880704|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
131068520|NCT02332824|471880705|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
131068521|NCT02332824|471880706|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
130723402|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
130723403|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
130723404|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
130723405|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
130723406|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
131068522|NCT02332824|471880707|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
131068523|NCT02332824|471880708|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
131068524|NCT02332824|471880703|FG000|Overall Study|Voluntary Withdrawal|1|||
131068525|NCT02332824|471880704|FG001|Overall Study|Voluntary Withdrawal|0|||
131068526|NCT02332824|471880705|FG002|Overall Study|Voluntary Withdrawal|0|||
131068527|NCT02332824|471880706|FG003|Overall Study|Voluntary Withdrawal|0|||
131068528|NCT02332824|471880707|FG004|Overall Study|Voluntary Withdrawal|0|||
131068529|NCT02332824|471880708|FG005|Overall Study|Voluntary Withdrawal|0|||
131068530|NCT02332824|471880703|FG000|Overall Study|Inconvenient schedule|1|||
131068531|NCT02332824|471880704|FG001|Overall Study|Inconvenient schedule|1|||
131068532|NCT02332824|471880705|FG002|Overall Study|Inconvenient schedule|0|||
131068533|NCT02332824|471880706|FG003|Overall Study|Inconvenient schedule|0|||
131068534|NCT02332824|471880707|FG004|Overall Study|Inconvenient schedule|0|||
131068535|NCT02332824|471880708|FG005|Overall Study|Inconvenient schedule|0|||
131068536|NCT02332824|471880703|FG000|Overall Study|Transfer|0|||
131068537|NCT02332824|471880704|FG001|Overall Study|Transfer|0|||
131068538|NCT02332824|471880705|FG002|Overall Study|Transfer|1|||
131068539|NCT02332824|471880706|FG003|Overall Study|Transfer|1|||
131068540|NCT02332824|471880707|FG004|Overall Study|Transfer|0|||
131068541|NCT02332824|471880708|FG005|Overall Study|Transfer|0|||
131068542|NCT00498797|471880709|FG000|Overall Study|Withdrawal by Subject|4|||
131068543|NCT00498797|471880710|FG001|Overall Study|Withdrawal by Subject|2|||
131068544|NCT00498797|471880709|FG000|Overall Study|Adverse Event|12|||
131068545|NCT00498797|471880710|FG001|Overall Study|Adverse Event|5|||
131068546|NCT00498797|471880709|FG000|Overall Study|Condition under investigation worsened|19|||
131068547|NCT00498797|471880710|FG001|Overall Study|Condition under investigation worsened|21|||
131068548|NCT00498797|471880709|FG000|Overall Study|Other|3|||
131068549|NCT00498797|471880710|FG001|Overall Study|Other|1|||
131068550|NCT00914732|471880711|FG000|Overall Study|Lost to Follow-up|6|||
131068551|NCT00914732|471880712|FG001|Overall Study|Lost to Follow-up|7|||
131068552|NCT00914732|471880713|FG002|Overall Study|Lost to Follow-up|9|||
131068553|NCT00914732|471880711|FG000|Overall Study|Withdrawal by Subject|3|||
131068554|NCT00914732|471880712|FG001|Overall Study|Withdrawal by Subject|0|||
131068555|NCT00914732|471880713|FG002|Overall Study|Withdrawal by Subject|2|||
131068556|NCT00914732|471880711|FG000|Overall Study|Adverse Event|1|||
131068557|NCT00914732|471880712|FG001|Overall Study|Adverse Event|0|||
131068558|NCT00914732|471880713|FG002|Overall Study|Adverse Event|0|||
131068559|NCT01855399|471880714|FG000|6 Month|Lost to Follow-up|12|||
131068560|NCT01855399|471880715|FG001|6 Month|Lost to Follow-up|9|||
131068561|NCT01855399|471880714|FG000|6 Month|Withdrawal by Subject|8|||
131068562|NCT01855399|471880715|FG001|6 Month|Withdrawal by Subject|6|||
131068563|NCT01855399|471880714|FG000|12 Month|Lost to Follow-up|7|||
131068564|NCT01855399|471880715|FG001|12 Month|Lost to Follow-up|11|||
131068565|NCT03953079|471880716|FG000|Core Study|Withdrawal by Subject|1|||
131068566|NCT03953079|471880717|FG001|Core Study|Withdrawal by Subject|2|||
131068567|NCT03953079|471880718|FG002|Core Study|Withdrawal by Subject|1|||
131068568|NCT03953079|471880716|FG000|Core Study|COVID-19|0|||
131068569|NCT03953079|471880717|FG001|Core Study|COVID-19|1|||
131068570|NCT03953079|471880718|FG002|Core Study|COVID-19|0|||
131068571|NCT03953079|471880716|FG000|Core Study|Difficulties leaving the house|0|||
131068572|NCT03953079|471880717|FG001|Core Study|Difficulties leaving the house|1|||
131068573|NCT03953079|471880718|FG002|Core Study|Difficulties leaving the house|0|||
131068574|NCT03953079|471880716|FG000|Extension Study|Withdrawal by Subject|1|||
131068575|NCT03953079|471880717|FG001|Extension Study|Withdrawal by Subject|0|||
131068576|NCT03953079|471880718|FG002|Extension Study|Withdrawal by Subject|0|||
131068577|NCT03953079|471880716|FG000|Extension Study|Received Rescue Treatment|5|||
131068578|NCT03953079|471880717|FG001|Extension Study|Received Rescue Treatment|6|||
131068579|NCT03953079|471880718|FG002|Extension Study|Received Rescue Treatment|5|||
131068580|NCT04394624|471880719|FG000|Overall Study|Adverse Event|6|||
131068581|NCT04394624|471880720|FG001|Overall Study|Adverse Event|0|||
131068582|NCT04394624|471880719|FG000|Overall Study|Progressive disease|24|||
131068583|NCT04394624|471880720|FG001|Overall Study|Progressive disease|0|||
131068584|NCT04394624|471880719|FG000|Overall Study|Not related to COVID-19|1|||
131068585|NCT04394624|471880720|FG001|Overall Study|Not related to COVID-19|0|||
131068586|NCT00141271|471880723|FG000|Overall Study|Adverse Event|31|||
131068587|NCT00141271|471880724|FG001|Overall Study|Adverse Event|19|||
131068588|NCT00141271|471880725|FG002|Overall Study|Adverse Event|17|||
131068589|NCT00141271|471880723|FG000|Overall Study|Laboratory Abnormality|2|||
131068590|NCT00141271|471880724|FG001|Overall Study|Laboratory Abnormality|1|||
131068591|NCT00141271|471880725|FG002|Overall Study|Laboratory Abnormality|1|||
131068592|NCT00141271|471880723|FG000|Overall Study|Lack of Efficacy|7|||
131068593|NCT00141271|471880724|FG001|Overall Study|Lack of Efficacy|7|||
131068594|NCT00141271|471880725|FG002|Overall Study|Lack of Efficacy|3|||
131068595|NCT00141271|471880723|FG000|Overall Study|Lost to Follow-up|15|||
131068596|NCT00141271|471880724|FG001|Overall Study|Lost to Follow-up|15|||
131068597|NCT00141271|471880725|FG002|Overall Study|Lost to Follow-up|21|||
131068598|NCT00141271|471880723|FG000|Overall Study|Withdrawal by Subject|14|||
131068599|NCT00141271|471880724|FG001|Overall Study|Withdrawal by Subject|9|||
131068600|NCT00141271|471880725|FG002|Overall Study|Withdrawal by Subject|10|||
131068601|NCT00141271|471880723|FG000|Overall Study|Other|11|||
131068602|NCT00141271|471880724|FG001|Overall Study|Other|12|||
131068603|NCT00141271|471880725|FG002|Overall Study|Other|5|||
131068604|NCT00990821|471880734|FG000|Overall Study|Withdrawal by Subject|0|||
131068605|NCT00990821|471880735|FG001|Overall Study|Withdrawal by Subject|2|||
131068606|NCT00990821|471880736|FG002|Overall Study|Withdrawal by Subject|0|||
131068607|NCT00990821|471880737|FG003|Overall Study|Withdrawal by Subject|0|||
131068608|NCT00990821|471880738|FG004|Overall Study|Withdrawal by Subject|3|||
131068609|NCT00990821|471880739|FG005|Overall Study|Withdrawal by Subject|3|||
131068610|NCT00990821|471880740|FG006|Overall Study|Withdrawal by Subject|1|||
131068611|NCT00990821|471880741|FG007|Overall Study|Withdrawal by Subject|0|||
131068612|NCT00990821|471880742|FG008|Overall Study|Withdrawal by Subject|0|||
131068613|NCT00990821|471880743|FG009|Overall Study|Withdrawal by Subject|1|||
131068614|NCT00990821|471880744|FG010|Overall Study|Withdrawal by Subject|3|||
131068615|NCT00990821|471880745|FG011|Overall Study|Withdrawal by Subject|5|||
131068616|NCT00990821|471880746|FG012|Overall Study|Withdrawal by Subject|2|||
131068617|NCT00990821|471880747|FG013|Overall Study|Withdrawal by Subject|1|||
131068618|NCT04150250|471880748|FG000|Overall Study|Lost to Follow-up|0|||
131068619|NCT04150250|471880749|FG001|Overall Study|Lost to Follow-up|2|||
131068620|NCT01786551|471880750|FG000|Overall Study|Participant withdrew consent|2|||
131068621|NCT00308113|471880751|FG000|Overall Study|Protocol closure|0|||
131068622|NCT00308113|471880752|FG001|Overall Study|Protocol closure|0|||
131068623|NCT00308113|471880753|FG002|Overall Study|Protocol closure|0|||
131068624|NCT00308113|471880754|FG003|Overall Study|Protocol closure|1|||
131068625|NCT02442622|471880758|FG000|Overall Study|Withdrawal by Subject|3|||
131068626|NCT02442622|471880759|FG001|Overall Study|Withdrawal by Subject|1|||
131068627|NCT01123642|471880762|FG000|Overall Study|Lost to Follow-up|23|||
131068628|NCT01123642|471880762|FG000|Overall Study|Withdrawal by Subject|9|||
131068629|NCT01123642|471880762|FG000|Overall Study|ineligible at baseline assessment|36|||
131068630|NCT01184859|471882542|FG000|Period 1: Single Dose|Insufficient urine production|0|||
131068631|NCT01184859|471882543|FG001|Period 1: Single Dose|Insufficient urine production|1|||
131068632|NCT01184859|471882544|FG002|Period 1: Single Dose|Insufficient urine production|0|||
131068633|NCT01184859|471882545|FG003|Period 1: Single Dose|Insufficient urine production|0|||
131068634|NCT01184859|471882546|FG004|Period 1: Single Dose|Insufficient urine production|0|||
131068635|NCT01184859|471882542|FG000|Period 1: Single Dose|Protocol Violation|0|||
131068636|NCT01184859|471882543|FG001|Period 1: Single Dose|Protocol Violation|1|||
131068637|NCT01184859|471882544|FG002|Period 1: Single Dose|Protocol Violation|0|||
131068638|NCT01184859|471882545|FG003|Period 1: Single Dose|Protocol Violation|0|||
131068639|NCT01184859|471882546|FG004|Period 1: Single Dose|Protocol Violation|0|||
131068640|NCT01184859|471882542|FG000|Period 1: Single Dose|Adverse Event|0|||
131068641|NCT01184859|471882543|FG001|Period 1: Single Dose|Adverse Event|0|||
131068642|NCT01184859|471882544|FG002|Period 1: Single Dose|Adverse Event|0|||
131068643|NCT01184859|471882545|FG003|Period 1: Single Dose|Adverse Event|0|||
131068644|NCT01184859|471882546|FG004|Period 1: Single Dose|Adverse Event|1|||
131068645|NCT01184859|471882542|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
131068646|NCT01184859|471882543|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
131068647|NCT01184859|471882544|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
131068648|NCT01184859|471882545|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
131068649|NCT01184859|471882546|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
131068650|NCT01184859|471882542|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
131068651|NCT01184859|471882543|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
131068652|NCT01184859|471882544|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
131068653|NCT01184859|471882545|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
131068654|NCT01184859|471882546|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
131068655|NCT00961298|471882547|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
131068656|NCT00961298|471882547|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
131068657|NCT00961298|471882547|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
131068658|NCT01232569|471882548|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
131068659|NCT01232569|471882549|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
131068660|NCT01232569|471882550|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131068661|NCT01232569|471882551|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
131068662|NCT01232569|471882548|FG000|Double-blind Treatment Period|Escape|2|||
131068663|NCT01232569|471882549|FG001|Double-blind Treatment Period|Escape|2|||
131068664|NCT01232569|471882550|FG002|Double-blind Treatment Period|Escape|0|||
131068665|NCT01232569|471882551|FG003|Double-blind Treatment Period|Escape|0|||
131068666|NCT01232569|471882548|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
131068667|NCT01232569|471882549|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
131068668|NCT01232569|471882550|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
131068669|NCT01232569|471882551|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
131068670|NCT01232569|471882548|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
131068671|NCT01232569|471882549|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
131068672|NCT01232569|471882550|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
131068673|NCT01232569|471882551|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
131068674|NCT01232569|471882548|FG000|Double-blind Treatment Period|Physician Decision|1|||
131068675|NCT01232569|471882549|FG001|Double-blind Treatment Period|Physician Decision|0|||
131068676|NCT01232569|471882550|FG002|Double-blind Treatment Period|Physician Decision|0|||
131068677|NCT01232569|471882551|FG003|Double-blind Treatment Period|Physician Decision|0|||
131068678|NCT01232569|471882548|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
131068679|NCT01232569|471882549|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
131068680|NCT01232569|471882550|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
131068681|NCT01232569|471882551|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
131068682|NCT01232569|471882548|FG000|Double-blind Treatment Period|Death|2|||
131068683|NCT01232569|471882549|FG001|Double-blind Treatment Period|Death|0|||
131068684|NCT01232569|471882550|FG002|Double-blind Treatment Period|Death|0|||
131068685|NCT01232569|471882551|FG003|Double-blind Treatment Period|Death|0|||
131068686|NCT01503515|471882556|FG000|Overall Study|Adverse Event|4|||
131068687|NCT01503515|471882557|FG001|Overall Study|Adverse Event|5|||
131068688|NCT01503515|471882556|FG000|Overall Study|Death|0|||
131068689|NCT01503515|471882557|FG001|Overall Study|Death|1|||
131068690|NCT01503515|471882556|FG000|Overall Study|Physician Decision|14|||
131068691|NCT01503515|471882557|FG001|Overall Study|Physician Decision|23|||
131068692|NCT01503515|471882556|FG000|Overall Study|Withdrawal by Subject|0|||
131068693|NCT01503515|471882557|FG001|Overall Study|Withdrawal by Subject|1|||
131068694|NCT01503515|471882556|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
131068695|NCT01503515|471882557|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
131068696|NCT01503515|471882556|FG000|Overall Study|Ineligible|1|||
131068697|NCT01503515|471882557|FG001|Overall Study|Ineligible|1|||
131068698|NCT03087851|471882559|FG000|Overall Study|Withdraw on medical grounds|0|||
131068699|NCT03087851|471882560|FG001|Overall Study|Withdraw on medical grounds|1|||
131068700|NCT03087851|471882561|FG002|Overall Study|Withdraw on medical grounds|2|||
131068701|NCT02123797|471882564|FG000|Baseline Intervention|Death|9|||
131068702|NCT02123797|471882565|FG001|Baseline Intervention|Death|16|||
131068703|NCT02123797|471882566|FG002|Baseline Intervention|Death|0|||
130723407|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
131068704|NCT02123797|471882567|FG003|Baseline Intervention|Death|0|||
131068705|NCT02123797|471882568|FG004|Baseline Intervention|Death|0|||
131068706|NCT02123797|471882564|FG000|Baseline Intervention|Withdrawal by Subject|2|||
131068707|NCT02123797|471882565|FG001|Baseline Intervention|Withdrawal by Subject|8|||
131068708|NCT02123797|471882566|FG002|Baseline Intervention|Withdrawal by Subject|0|||
131068709|NCT02123797|471882567|FG003|Baseline Intervention|Withdrawal by Subject|0|||
131230354|NCT00617461|472469414|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
131230355|NCT00617461|472469415|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
131230356|NCT00617461|472469414|FG000|First Treatment Intervention Period|Protocol Violation|2|||
131230357|NCT00617461|472469415|FG001|First Treatment Intervention Period|Protocol Violation|1|||
131230358|NCT00617461|472469414|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
131230359|NCT00617461|472469415|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
131230360|NCT00617461|472469414|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
131230361|NCT00617461|472469415|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
131230362|NCT00617461|472469414|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
131230363|NCT00617461|472469415|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
131230364|NCT00617461|472469414|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
131230365|NCT00617461|472469415|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
131230366|NCT00617461|472469414|FG000|Second Treatment Intervention Period|Adverse Event|0|||
131230367|NCT00617461|472469415|FG001|Second Treatment Intervention Period|Adverse Event|1|||
131230368|NCT00617461|472469414|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
131230369|NCT00617461|472469415|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
131230370|NCT00617461|472469414|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
131230371|NCT00617461|472469415|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
131230372|NCT00617461|472469414|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
131230373|NCT00617461|472469415|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
131230374|NCT00358826|472469416|FG000|Core Study|Adverse Event|1|||
131230375|NCT00358826|472469417|FG001|Core Study|Adverse Event|3|||
131230376|NCT00358826|472469418|FG002|Core Study|Adverse Event|1|||
131068710|NCT02123797|471882568|FG004|Baseline Intervention|Withdrawal by Subject|0|||
131068711|NCT02123797|471882564|FG000|Baseline Intervention|Relocation|2|||
131068712|NCT02123797|471882565|FG001|Baseline Intervention|Relocation|0|||
131068713|NCT02123797|471882566|FG002|Baseline Intervention|Relocation|0|||
131230377|NCT00358826|472469419|FG003|Core Study|Adverse Event|1|||
131230378|NCT00358826|472469420|FG004|Core Study|Adverse Event|0|||
131230379|NCT00358826|472469421|FG005|Core Study|Adverse Event|0|||
130723408|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
131068714|NCT02123797|471882567|FG003|Baseline Intervention|Relocation|0|||
131068715|NCT02123797|471882568|FG004|Baseline Intervention|Relocation|0|||
131068716|NCT02123797|471882564|FG000|Baseline Intervention|Out of window for initial survey|6|||
131068717|NCT02123797|471882565|FG001|Baseline Intervention|Out of window for initial survey|13|||
131068718|NCT02123797|471882566|FG002|Baseline Intervention|Out of window for initial survey|0|||
131068719|NCT02123797|471882567|FG003|Baseline Intervention|Out of window for initial survey|0|||
131068720|NCT02123797|471882568|FG004|Baseline Intervention|Out of window for initial survey|0|||
131068721|NCT02123797|471882564|FG000|Baseline Intervention|Lost to Follow-up|0|||
131068722|NCT02123797|471882565|FG001|Baseline Intervention|Lost to Follow-up|5|||
131068723|NCT02123797|471882566|FG002|Baseline Intervention|Lost to Follow-up|0|||
131068724|NCT02123797|471882567|FG003|Baseline Intervention|Lost to Follow-up|0|||
131068725|NCT02123797|471882568|FG004|Baseline Intervention|Lost to Follow-up|0|||
131068726|NCT02123797|471882564|FG000|Baseline Intervention|Other Disease|3|||
131068727|NCT02123797|471882565|FG001|Baseline Intervention|Other Disease|0|||
131068728|NCT02123797|471882566|FG002|Baseline Intervention|Other Disease|0|||
131068729|NCT02123797|471882567|FG003|Baseline Intervention|Other Disease|0|||
131068730|NCT02123797|471882568|FG004|Baseline Intervention|Other Disease|0|||
131068731|NCT02123797|471882564|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
131068732|NCT02123797|471882565|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
131068733|NCT02123797|471882566|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
131068734|NCT02123797|471882567|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
131068735|NCT02123797|471882568|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
131068736|NCT02123797|471882564|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
131068737|NCT02123797|471882565|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
131068738|NCT02123797|471882566|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
131068739|NCT02123797|471882567|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
131068740|NCT02123797|471882568|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
131068741|NCT02123797|471882564|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
131068742|NCT02123797|471882565|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
131068743|NCT02123797|471882566|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131068744|NCT02123797|471882567|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131068745|NCT02123797|471882568|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131068746|NCT02123797|471882564|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
131230380|NCT00358826|472469422|FG006|Core Study|Adverse Event|0|||
130723409|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
130723410|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
131068747|NCT02123797|471882565|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
131230381|NCT00358826|472469423|FG007|Core Study|Adverse Event|0|||
131230382|NCT00358826|472469416|FG000|Core Study|Withdrawal by Subject|2|||
131230383|NCT00358826|472469417|FG001|Core Study|Withdrawal by Subject|2|||
131230384|NCT00358826|472469418|FG002|Core Study|Withdrawal by Subject|0|||
131230385|NCT00358826|472469419|FG003|Core Study|Withdrawal by Subject|0|||
131230386|NCT00358826|472469420|FG004|Core Study|Withdrawal by Subject|0|||
131230387|NCT00358826|472469421|FG005|Core Study|Withdrawal by Subject|0|||
131230388|NCT00358826|472469422|FG006|Core Study|Withdrawal by Subject|0|||
131230389|NCT00358826|472469423|FG007|Core Study|Withdrawal by Subject|0|||
131230390|NCT00358826|472469416|FG000|Core Study|Lost to Follow-up|0|||
131230391|NCT00358826|472469417|FG001|Core Study|Lost to Follow-up|0|||
131230392|NCT00358826|472469418|FG002|Core Study|Lost to Follow-up|0|||
131230393|NCT00358826|472469419|FG003|Core Study|Lost to Follow-up|1|||
131230394|NCT00358826|472469420|FG004|Core Study|Lost to Follow-up|0|||
131230395|NCT00358826|472469421|FG005|Core Study|Lost to Follow-up|0|||
131230396|NCT00358826|472469422|FG006|Core Study|Lost to Follow-up|0|||
131230397|NCT00358826|472469423|FG007|Core Study|Lost to Follow-up|0|||
131230398|NCT00358826|472469416|FG000|Core Study|Physician Decision|0|||
131230399|NCT00358826|472469417|FG001|Core Study|Physician Decision|0|||
131230400|NCT00358826|472469418|FG002|Core Study|Physician Decision|1|||
131230401|NCT00358826|472469419|FG003|Core Study|Physician Decision|0|||
131230402|NCT00358826|472469420|FG004|Core Study|Physician Decision|0|||
131230403|NCT00358826|472469421|FG005|Core Study|Physician Decision|0|||
131230404|NCT00358826|472469422|FG006|Core Study|Physician Decision|0|||
131230405|NCT00358826|472469423|FG007|Core Study|Physician Decision|0|||
131230406|NCT00358826|472469416|FG000|MDCT Substudy|Adverse Event|0|||
131230407|NCT00358826|472469417|FG001|MDCT Substudy|Adverse Event|0|||
131230408|NCT00358826|472469418|FG002|MDCT Substudy|Adverse Event|0|||
131230409|NCT00358826|472469419|FG003|MDCT Substudy|Adverse Event|0|||
131230410|NCT00358826|472469420|FG004|MDCT Substudy|Adverse Event|1|||
131230411|NCT00358826|472469421|FG005|MDCT Substudy|Adverse Event|0|||
131230412|NCT00358826|472469422|FG006|MDCT Substudy|Adverse Event|0|||
131230413|NCT00358826|472469423|FG007|MDCT Substudy|Adverse Event|0|||
131230414|NCT00358826|472469416|FG000|MDCT Substudy|Lost to Follow-up|0|||
131230415|NCT00358826|472469417|FG001|MDCT Substudy|Lost to Follow-up|0|||
131230416|NCT00358826|472469418|FG002|MDCT Substudy|Lost to Follow-up|0|||
131230417|NCT00358826|472469419|FG003|MDCT Substudy|Lost to Follow-up|0|||
131230418|NCT00358826|472469420|FG004|MDCT Substudy|Lost to Follow-up|0|||
131230419|NCT00358826|472469421|FG005|MDCT Substudy|Lost to Follow-up|1|||
131230420|NCT00358826|472469422|FG006|MDCT Substudy|Lost to Follow-up|0|||
131230421|NCT00358826|472469423|FG007|MDCT Substudy|Lost to Follow-up|0|||
131230422|NCT00358826|472469416|FG000|MDCT Substudy|Withdrawal by Subject|0|||
131230423|NCT00358826|472469417|FG001|MDCT Substudy|Withdrawal by Subject|0|||
131230424|NCT00358826|472469418|FG002|MDCT Substudy|Withdrawal by Subject|0|||
131230425|NCT00358826|472469419|FG003|MDCT Substudy|Withdrawal by Subject|0|||
131230426|NCT00358826|472469420|FG004|MDCT Substudy|Withdrawal by Subject|0|||
131230427|NCT00358826|472469421|FG005|MDCT Substudy|Withdrawal by Subject|1|||
131230428|NCT00358826|472469422|FG006|MDCT Substudy|Withdrawal by Subject|0|||
131230429|NCT00358826|472469423|FG007|MDCT Substudy|Withdrawal by Subject|0|||
131230430|NCT00903383|472469427|FG000|Overall Study|Adverse Event|1|||
131230431|NCT00903383|472469428|FG001|Overall Study|Adverse Event|2|||
131230432|NCT00903383|472469429|FG002|Overall Study|Adverse Event|3|||
131230433|NCT00903383|472469430|FG003|Overall Study|Adverse Event|1|||
131230434|NCT00903383|472469427|FG000|Overall Study|Physician Decision|1|||
131230435|NCT00903383|472469428|FG001|Overall Study|Physician Decision|2|||
131230436|NCT00903383|472469429|FG002|Overall Study|Physician Decision|0|||
131230437|NCT00903383|472469430|FG003|Overall Study|Physician Decision|0|||
131230438|NCT00903383|472469427|FG000|Overall Study|Lost to Follow-up|0|||
131230439|NCT00903383|472469428|FG001|Overall Study|Lost to Follow-up|0|||
131230440|NCT00903383|472469429|FG002|Overall Study|Lost to Follow-up|0|||
131230441|NCT00903383|472469430|FG003|Overall Study|Lost to Follow-up|1|||
131230442|NCT00903383|472469427|FG000|Overall Study|Decision of Sponsor|1|||
131230443|NCT00903383|472469428|FG001|Overall Study|Decision of Sponsor|0|||
131230444|NCT00903383|472469429|FG002|Overall Study|Decision of Sponsor|0|||
131230445|NCT00903383|472469430|FG003|Overall Study|Decision of Sponsor|0|||
131230446|NCT00903383|472469427|FG000|Overall Study|Withdrawal by Subject|4|||
131230447|NCT00903383|472469428|FG001|Overall Study|Withdrawal by Subject|1|||
131230448|NCT00903383|472469429|FG002|Overall Study|Withdrawal by Subject|0|||
131230449|NCT00903383|472469430|FG003|Overall Study|Withdrawal by Subject|2|||
131230450|NCT00903383|472469427|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
130779457|NCT02326272|470819499|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
131068748|NCT02123797|471882566|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
131230451|NCT00903383|472469428|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
131230452|NCT00903383|472469429|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
131230453|NCT00903383|472469430|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
131230454|NCT00903383|472469427|FG000|Overall Study|Patient Decision|0|||
131230455|NCT00903383|472469428|FG001|Overall Study|Patient Decision|0|||
131230456|NCT00903383|472469429|FG002|Overall Study|Patient Decision|0|||
131230457|NCT00903383|472469430|FG003|Overall Study|Patient Decision|1|||
131230458|NCT01821625|472469433|FG000|Overall Study|Withdrawal by Subject|2|||
131230459|NCT01821625|472469433|FG000|Overall Study|Lack of Efficacy|2|||
131068749|NCT02123797|471882567|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
131068750|NCT02123797|471882568|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
131068751|NCT02123797|471882564|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
131068752|NCT02123797|471882565|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
131068753|NCT02123797|471882566|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
131068754|NCT02123797|471882567|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
131068755|NCT02123797|471882568|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
131068756|NCT02123797|471882564|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
131068757|NCT02123797|471882565|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
131068758|NCT02123797|471882566|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
131068759|NCT02123797|471882567|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
131068760|NCT02123797|471882568|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
131068761|NCT02123797|471882564|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
131068762|NCT02123797|471882565|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
131068763|NCT02123797|471882566|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
131068764|NCT02123797|471882567|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
131068765|NCT02123797|471882568|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
131068766|NCT02123797|471882564|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
131068767|NCT02123797|471882565|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
131068768|NCT02123797|471882566|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131068769|NCT02123797|471882567|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131068770|NCT02123797|471882568|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
131068771|NCT02123797|471882564|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
131068772|NCT02123797|471882565|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
131068773|NCT02123797|471882566|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
131068774|NCT02123797|471882567|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
131068775|NCT02123797|471882568|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
131068776|NCT00443755|471882569|FG000|Overall Study|Withdrawal by Subject|2|||
131068777|NCT00443755|471882570|FG001|Overall Study|Withdrawal by Subject|1|||
131068778|NCT02339506|471882580|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
131068779|NCT02339506|471882581|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
131068780|NCT02339506|471882580|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
131068781|NCT02339506|471882581|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
131068782|NCT03997409|471882582|FG000|Overall Study|Protocol Violation|1|||
131068783|NCT03997409|471882583|FG001|Overall Study|Protocol Violation|1|||
131068784|NCT03997409|471882584|FG002|Overall Study|Protocol Violation|0|||
131068785|NCT03997409|471882582|FG000|Overall Study|Withdrawal by Subject|3|||
131068786|NCT03997409|471882583|FG001|Overall Study|Withdrawal by Subject|0|||
131068787|NCT03997409|471882584|FG002|Overall Study|Withdrawal by Subject|0|||
131068788|NCT03997409|471882582|FG000|Overall Study|Lost to Follow-up|0|||
131068789|NCT03997409|471882583|FG001|Overall Study|Lost to Follow-up|0|||
131068790|NCT03997409|471882584|FG002|Overall Study|Lost to Follow-up|1|||
131068791|NCT01090076|471882585|FG000|Overall Study|Death|1|||
131068792|NCT01090076|471882586|FG001|Overall Study|Death|1|||
131068793|NCT01090076|471882585|FG000|Overall Study|Withdrawal by Subject|0|||
131068794|NCT01090076|471882586|FG001|Overall Study|Withdrawal by Subject|1|||
131068795|NCT01753323|471882587|FG000|Overall Study|Lack of Efficacy|0|||
131068796|NCT01753323|471882588|FG001|Overall Study|Lack of Efficacy|0|||
131068797|NCT01753323|471882589|FG002|Overall Study|Lack of Efficacy|8|||
131068798|NCT01753323|471882587|FG000|Overall Study|Protocol deviation|1|||
131068799|NCT01753323|471882588|FG001|Overall Study|Protocol deviation|0|||
131068800|NCT01753323|471882589|FG002|Overall Study|Protocol deviation|0|||
131068801|NCT01753323|471882587|FG000|Overall Study|Adverse Event|0|||
131068802|NCT01753323|471882588|FG001|Overall Study|Adverse Event|0|||
131068803|NCT01753323|471882589|FG002|Overall Study|Adverse Event|1|||
131068804|NCT01116440|471882591|FG000|Treatment|Withdrawal by Subject|2|||
131068805|NCT01116440|471882592|FG001|Treatment|Withdrawal by Subject|2|||
131068806|NCT01116440|471882591|FG000|Treatment|Lost to Follow-up|1|||
131068807|NCT01116440|471882592|FG001|Treatment|Lost to Follow-up|1|||
131068808|NCT01116440|471882591|FG000|Treatment|Protocol Violation|0|||
131068809|NCT01116440|471882592|FG001|Treatment|Protocol Violation|2|||
131068810|NCT01116440|471882591|FG000|Treatment|Lack of Efficacy|0|||
131068811|NCT01116440|471882592|FG001|Treatment|Lack of Efficacy|1|||
131068812|NCT01116440|471882591|FG000|Treatment|Adverse Event|0|||
131068813|NCT01116440|471882592|FG001|Treatment|Adverse Event|1|||
131068814|NCT01116440|471882591|FG000|Withdrawal|Withdrawal by Subject|0|||
131068815|NCT01116440|471882592|FG001|Withdrawal|Withdrawal by Subject|1|||
131068816|NCT01116440|471882591|FG000|Withdrawal|Lost to Follow-up|0|||
131068817|NCT01116440|471882592|FG001|Withdrawal|Lost to Follow-up|1|||
131068818|NCT01116440|471882591|FG000|Follow-up|Lost to Follow-up|0|||
131068819|NCT01116440|471882592|FG001|Follow-up|Lost to Follow-up|1|||
131068820|NCT01116440|471882591|FG000|Follow-up|Withdrawal by Subject|0|||
131068821|NCT01116440|471882592|FG001|Follow-up|Withdrawal by Subject|1|||
131068822|NCT00116584|471882607|FG000|Overall Study|Withdrawal by Subject|1|||
130723411|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
130723412|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
130723413|NCT04040192|470613443|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
131068823|NCT00116584|471882608|FG001|Overall Study|Withdrawal by Subject|0|||
131068824|NCT00116584|471882607|FG000|Overall Study|Protocol Violation|1|||
131068825|NCT00116584|471882608|FG001|Overall Study|Protocol Violation|1|||
131068826|NCT00907517|471882609|FG000|Overall Study|Progressive Disease|3|||
131068827|NCT00907517|471882610|FG001|Overall Study|Progressive Disease|3|||
131068828|NCT00907517|471882611|FG002|Overall Study|Progressive Disease|4|||
131068829|NCT00907517|471882612|FG003|Overall Study|Progressive Disease|4|||
131068830|NCT00907517|471882613|FG004|Overall Study|Progressive Disease|4|||
131068831|NCT00907517|471882609|FG000|Overall Study|Symptomatic Deterioration|0|||
131068832|NCT00907517|471882610|FG001|Overall Study|Symptomatic Deterioration|0|||
131068833|NCT00907517|471882611|FG002|Overall Study|Symptomatic Deterioration|0|||
131068834|NCT00907517|471882612|FG003|Overall Study|Symptomatic Deterioration|0|||
131068835|NCT00907517|471882613|FG004|Overall Study|Symptomatic Deterioration|1|||
131068836|NCT01446042|471882616|FG000|Overall Study|Withdrawal by Subject|12|||
131068837|NCT01446042|471882617|FG001|Overall Study|Withdrawal by Subject|2|||
131068838|NCT01446042|471882618|FG002|Overall Study|Withdrawal by Subject|4|||
131068839|NCT01446042|471882616|FG000|Overall Study|Adverse Event|1|||
131068840|NCT01446042|471882617|FG001|Overall Study|Adverse Event|0|||
131068841|NCT01446042|471882618|FG002|Overall Study|Adverse Event|4|||
131068842|NCT01446042|471882616|FG000|Overall Study|Lost to Follow-up|5|||
131068843|NCT01446042|471882617|FG001|Overall Study|Lost to Follow-up|0|||
131068844|NCT01446042|471882618|FG002|Overall Study|Lost to Follow-up|0|||
131068845|NCT01446042|471882616|FG000|Overall Study|Other reasons|2|||
131068846|NCT01446042|471882617|FG001|Overall Study|Other reasons|1|||
131068847|NCT01446042|471882618|FG002|Overall Study|Other reasons|1|||
131068848|NCT03575572|471882620|FG000|Overall Study|Withdrawal by Subject|2|||
131068849|NCT03575572|471882620|FG000|Overall Study|Physician Decision|2|||
131068850|NCT00157209|471882621|FG000|Overall Study|Ongoing at data cut-off|10|||
131068851|NCT00157209|471882622|FG001|Overall Study|Ongoing at data cut-off|0|||
131068852|NCT03751280|471882623|FG000|Overall Study|Adverse Event|0|||
131068853|NCT03751280|471882624|FG001|Overall Study|Adverse Event|1|||
131068854|NCT03751280|471882623|FG000|Overall Study|Lost to Follow-up|3|||
131068855|NCT03751280|471882624|FG001|Overall Study|Lost to Follow-up|5|||
131068856|NCT03751280|471882623|FG000|Overall Study|Physician Decision|0|||
131068857|NCT03751280|471882624|FG001|Overall Study|Physician Decision|2|||
131068858|NCT03751280|471882623|FG000|Overall Study|Protocol Violation|0|||
131068859|NCT03751280|471882624|FG001|Overall Study|Protocol Violation|2|||
131068860|NCT03751280|471882623|FG000|Overall Study|Withdrawal by Subject|5|||
131068861|NCT03751280|471882624|FG001|Overall Study|Withdrawal by Subject|2|||
130779458|NCT02326272|470819500|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130779459|NCT02326272|470819501|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130779460|NCT02326272|470819502|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130779461|NCT02326272|470819503|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130779462|NCT02326272|470819504|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130779463|NCT02326272|470819490|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779464|NCT02326272|470819491|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779465|NCT02326272|470819492|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779466|NCT02326272|470819493|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779467|NCT02326272|470819494|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779468|NCT02326272|470819495|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
130779469|NCT02326272|470819496|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779470|NCT02326272|470819497|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
130779471|NCT02326272|470819498|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779472|NCT02326272|470819499|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779473|NCT02326272|470819500|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779474|NCT02326272|470819501|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779475|NCT02326272|470819502|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779476|NCT02326272|470819503|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130723414|NCT04040192|470613444|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
130723415|NCT04040192|470613445|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
130723416|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
130723417|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
131068862|NCT02162771|471882625|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
131068863|NCT02162771|471882626|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
131068864|NCT02162771|471882625|FG000|Core Study Period (Part 2)|Adverse Event|4|||
131068865|NCT02162771|471882626|FG001|Core Study Period (Part 2)|Adverse Event|1|||
130723418|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
131068866|NCT02162771|471882625|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
131068867|NCT02162771|471882626|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
131230460|NCT01821625|472469433|FG000|Overall Study|Adverse Event|1|||
131068868|NCT02162771|471882625|FG000|Core Study Period (Part 2)|Physician Decision|0|||
131068869|NCT02162771|471882626|FG001|Core Study Period (Part 2)|Physician Decision|2|||
131068870|NCT02162771|471882625|FG000|Core Study Period (Part 2)|Death|1|||
131068871|NCT02162771|471882626|FG001|Core Study Period (Part 2)|Death|0|||
131068872|NCT02162771|471882625|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
131068873|NCT02162771|471882626|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
131068874|NCT02162771|471882625|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
131068875|NCT02162771|471882626|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
131068876|NCT02162771|471882625|FG000|Maintenance Study Period (Part 2)|Death|2|||
131068877|NCT02162771|471882626|FG001|Maintenance Study Period (Part 2)|Death|1|||
131068878|NCT02162771|471882625|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
131068879|NCT02162771|471882626|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
131068880|NCT02162771|471882625|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
131068881|NCT02162771|471882626|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
131068882|NCT02162771|471882625|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
131068883|NCT02162771|471882626|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
131230461|NCT01821625|472469433|FG000|Overall Study|Medical contraindication|1|||
131230462|NCT00320593|472469434|FG000|Overall Study|Lost to Follow-up|3|||
131230463|NCT00320593|472469435|FG001|Overall Study|Lost to Follow-up|0|||
131230464|NCT00320593|472469434|FG000|Overall Study|Moved to another state|1|||
131230465|NCT00320593|472469435|FG001|Overall Study|Moved to another state|0|||
131230466|NCT00320593|472469434|FG000|Overall Study|Withdrawal by Subject|2|||
131230467|NCT00320593|472469435|FG001|Overall Study|Withdrawal by Subject|1|||
131230468|NCT00320593|472469434|FG000|Overall Study|Withdrawal by clinical center|1|||
131230469|NCT00320593|472469435|FG001|Overall Study|Withdrawal by clinical center|0|||
131230470|NCT00457665|472469438|FG000|12 Months|Drug allergy|1|||
131230471|NCT00457665|472469439|FG001|12 Months|Drug allergy|1|||
131068884|NCT01078571|471882627|FG000|Overall Study|Adverse Event|36|||
131068885|NCT01078571|471882627|FG000|Overall Study|Lack of effectiveness|36|||
131068886|NCT01078571|471882627|FG000|Overall Study|Reason not reported|21|||
131068887|NCT01078571|471882627|FG000|Overall Study|Withdrawal by Subject|12|||
131068888|NCT01078571|471882627|FG000|Overall Study|Lost to Follow-up|8|||
131068889|NCT01078571|471882627|FG000|Overall Study|Protocol Violation|2|||
131068890|NCT03802513|471882628|FG000|Overall Study|Lost to Follow-up|1|||
131068891|NCT02588027|471882642|FG000|Overall Study|Withdrawal by Subject|1|||
131068892|NCT02588027|471882643|FG001|Overall Study|Withdrawal by Subject|3|||
131068893|NCT02588027|471882642|FG000|Overall Study|Protocol Violation|4|||
131068894|NCT02588027|471882643|FG001|Overall Study|Protocol Violation|1|||
131068895|NCT02116582|471882644|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
131068896|NCT02116582|471882644|FG000|Overall Study|Adverse Event|22|||
131068897|NCT02116582|471882644|FG000|Overall Study|Death|9|||
131068898|NCT02116582|471882644|FG000|Overall Study|Progressive Disease|148|||
131068899|NCT02116582|471882644|FG000|Overall Study|Protocol Violation|3|||
131230472|NCT00457665|472469438|FG000|12 Months|High HIV viral load|5|||
131230473|NCT00457665|472469439|FG001|12 Months|High HIV viral load|1|||
131230474|NCT00457665|472469438|FG000|12 Months|Lipodystrophy|2|||
131230475|NCT00457665|472469439|FG001|12 Months|Lipodystrophy|0|||
131230476|NCT00457665|472469438|FG000|12 Months|Withdrawal by Subject|0|||
131230477|NCT00457665|472469439|FG001|12 Months|Withdrawal by Subject|2|||
131230478|NCT00457665|472469438|FG000|12 Months|Abnormal Liver function tests|0|||
131230479|NCT00457665|472469439|FG001|12 Months|Abnormal Liver function tests|5|||
131230480|NCT00457665|472469438|FG000|24 Months|Withdrawal by Subject|3|||
131068900|NCT02116582|471882644|FG000|Overall Study|Withdrawal by Subject|8|||
131068901|NCT02116582|471882644|FG000|Overall Study|Other: Miscellaneous|11|||
131068902|NCT02116582|471882644|FG000|Overall Study|Lost to Follow-up|1|||
131068903|NCT02116582|471882644|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
131068904|NCT01770509|471882645|FG000|Overall Study|Injury|0|||
131068905|NCT01770509|471882646|FG001|Overall Study|Injury|1|||
131068906|NCT01770509|471882645|FG000|Overall Study|Lost to Follow-up|1|||
131068907|NCT01770509|471882646|FG001|Overall Study|Lost to Follow-up|2|||
131068908|NCT03928821|471882647|FG000|Overall Study|Death|0|||
131068909|NCT03928821|471882648|FG001|Overall Study|Death|1|||
131068910|NCT03928821|471882649|FG002|Overall Study|Death|0|||
131068911|NCT03928821|471882650|FG003|Overall Study|Death|0|||
131068912|NCT03928821|471882647|FG000|Overall Study|Lost to Follow-up|0|||
131068913|NCT03928821|471882648|FG001|Overall Study|Lost to Follow-up|2|||
131068914|NCT03928821|471882649|FG002|Overall Study|Lost to Follow-up|3|||
130723419|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
130723420|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
131230481|NCT00457665|472469439|FG001|24 Months|Withdrawal by Subject|2|||
131068915|NCT03928821|471882650|FG003|Overall Study|Lost to Follow-up|0|||
131068916|NCT03928821|471882647|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
131068917|NCT03928821|471882648|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
131230482|NCT00457665|472469438|FG000|24 Months|Lipodystrophy|1|||
131230483|NCT00457665|472469439|FG001|24 Months|Lipodystrophy|1|||
131230484|NCT00457665|472469438|FG000|24 Months|Abnormal liver function tests|1|||
131230485|NCT00457665|472469439|FG001|24 Months|Abnormal liver function tests|5|||
131068918|NCT03928821|471882649|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
131068919|NCT03928821|471882650|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
131068920|NCT03840148|471882657|FG000|Study Drug Disposition|Adverse Event|13|||
131068921|NCT03840148|471882658|FG001|Study Drug Disposition|Adverse Event|2|||
131068922|NCT03840148|471882657|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
131068923|NCT03840148|471882658|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
131068924|NCT03840148|471882657|FG000|Study Drug Disposition|Lack of Efficacy|3|||
131068925|NCT03840148|471882658|FG001|Study Drug Disposition|Lack of Efficacy|0|||
131068926|NCT03840148|471882657|FG000|Study Drug Disposition|Physician Decision|2|||
131068927|NCT03840148|471882658|FG001|Study Drug Disposition|Physician Decision|0|||
131068928|NCT03840148|471882657|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
131068929|NCT03840148|471882658|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
131068930|NCT03840148|471882657|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
131068931|NCT03840148|471882658|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
131068932|NCT03840148|471882657|FG000|Study Completion Disposition|Physician Decision|2|||
131068933|NCT03840148|471882658|FG001|Study Completion Disposition|Physician Decision|0|||
131068934|NCT03840148|471882657|FG000|Study Completion Disposition|Covid-19 related|2|||
130779477|NCT02326272|470819504|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130779478|NCT02326272|470819490|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130779479|NCT02326272|470819491|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130779480|NCT02326272|470819492|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130779481|NCT02326272|470819493|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131068935|NCT03840148|471882658|FG001|Study Completion Disposition|Covid-19 related|0|||
131068936|NCT03840148|471882657|FG000|Study Completion Disposition|Lost to Follow-up|1|||
131068937|NCT03840148|471882658|FG001|Study Completion Disposition|Lost to Follow-up|1|||
131068938|NCT03840148|471882657|FG000|Study Completion Disposition|Death|1|||
131068939|NCT03840148|471882658|FG001|Study Completion Disposition|Death|0|||
131068940|NCT03840148|471882657|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
131068941|NCT03840148|471882658|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
131068942|NCT03615404|471882659|FG000|Overall Study|Death|1|||
131068943|NCT03615404|471882659|FG000|Overall Study|vaccine did not pass quality assurance|1|||
131068944|NCT01774929|471882660|FG000|Overall Study|Adverse Event|3|||
131068945|NCT00603278|471882661|FG000|Overall Study|Lack of Efficacy|35|||
131068946|NCT00603278|471882662|FG001|Overall Study|Lack of Efficacy|10|||
131068947|NCT00603278|471882663|FG002|Overall Study|Lack of Efficacy|11|||
131068948|NCT00603278|471882664|FG003|Overall Study|Lack of Efficacy|8|||
131068949|NCT00603278|471882665|FG004|Overall Study|Lack of Efficacy|7|||
131068950|NCT00603278|471882666|FG005|Overall Study|Lack of Efficacy|14|||
131068951|NCT00603278|471882661|FG000|Overall Study|Adverse Event|0|||
131068952|NCT00603278|471882662|FG001|Overall Study|Adverse Event|3|||
131068953|NCT00603278|471882663|FG002|Overall Study|Adverse Event|1|||
131230486|NCT00481247|472469442|FG000|Overall Study|Death|0|||
131068954|NCT00603278|471882664|FG003|Overall Study|Adverse Event|0|||
131068955|NCT00603278|471882665|FG004|Overall Study|Adverse Event|2|||
131068956|NCT00603278|471882666|FG005|Overall Study|Adverse Event|1|||
131068957|NCT00603278|471882661|FG000|Overall Study|Withdrawal by Subject|2|||
131068958|NCT00603278|471882662|FG001|Overall Study|Withdrawal by Subject|3|||
131068959|NCT00603278|471882663|FG002|Overall Study|Withdrawal by Subject|1|||
131068960|NCT00603278|471882664|FG003|Overall Study|Withdrawal by Subject|2|||
131068961|NCT00603278|471882665|FG004|Overall Study|Withdrawal by Subject|1|||
131068962|NCT00603278|471882666|FG005|Overall Study|Withdrawal by Subject|2|||
131068963|NCT00603278|471882661|FG000|Overall Study|Protocol Violation|3|||
131068964|NCT00603278|471882662|FG001|Overall Study|Protocol Violation|0|||
131068965|NCT00603278|471882663|FG002|Overall Study|Protocol Violation|1|||
131068966|NCT00603278|471882664|FG003|Overall Study|Protocol Violation|1|||
131068967|NCT00603278|471882665|FG004|Overall Study|Protocol Violation|0|||
131068968|NCT00603278|471882666|FG005|Overall Study|Protocol Violation|1|||
131068969|NCT00603278|471882661|FG000|Overall Study|Physician Decision|0|||
131230487|NCT00481247|472469443|FG001|Overall Study|Death|1|||
131230488|NCT00481247|472469442|FG000|Overall Study|Disease progression|18|||
131230489|NCT00481247|472469443|FG001|Overall Study|Disease progression|22|||
131230490|NCT00481247|472469442|FG000|Overall Study|Intolerance|42|||
131230491|NCT00481247|472469443|FG001|Overall Study|Intolerance|17|||
131230492|NCT00481247|472469442|FG000|Overall Study|Treatment failure|10|||
131230493|NCT00481247|472469443|FG001|Overall Study|Treatment failure|14|||
131230494|NCT00481247|472469442|FG000|Overall Study|AE unrelated to study drug|13|||
131230495|NCT00481247|472469443|FG001|Overall Study|AE unrelated to study drug|4|||
131230496|NCT00481247|472469442|FG000|Overall Study|Withdrawal by Subject|8|||
131230497|NCT00481247|472469443|FG001|Overall Study|Withdrawal by Subject|13|||
131230498|NCT00481247|472469442|FG000|Overall Study|Pregnancy|2|||
131230499|NCT00481247|472469443|FG001|Overall Study|Pregnancy|1|||
131230500|NCT00481247|472469442|FG000|Overall Study|Lost to Follow-up|1|||
131230501|NCT00481247|472469443|FG001|Overall Study|Lost to Follow-up|2|||
131230502|NCT00481247|472469442|FG000|Overall Study|Poor compliance/noncompliance|1|||
131230503|NCT00481247|472469443|FG001|Overall Study|Poor compliance/noncompliance|7|||
131230504|NCT00481247|472469442|FG000|Overall Study|Administrative reason by sponsor|157|||
131230505|NCT00481247|472469443|FG001|Overall Study|Administrative reason by sponsor|162|||
131230506|NCT00481247|472469442|FG000|Overall Study|Varied|6|||
131230507|NCT00481247|472469443|FG001|Overall Study|Varied|15|||
131230508|NCT00481247|472469442|FG000|Overall Study|Did not receive treatment|1|||
131230509|NCT00481247|472469443|FG001|Overall Study|Did not receive treatment|2|||
131230510|NCT01716754|472469444|FG000|Overall Study|Death|0|||
131230511|NCT01716754|472469445|FG001|Overall Study|Death|0|||
131230512|NCT01716754|472469446|FG002|Overall Study|Death|0|||
131230513|NCT01716754|472469447|FG003|Overall Study|Death|1|||
131230514|NCT01716754|472469444|FG000|Overall Study|Protocol deviation|0|||
131230515|NCT01716754|472469445|FG001|Overall Study|Protocol deviation|2|||
131230516|NCT01716754|472469446|FG002|Overall Study|Protocol deviation|7|||
131230517|NCT01716754|472469447|FG003|Overall Study|Protocol deviation|2|||
131230518|NCT01716754|472469444|FG000|Overall Study|Non-compliance with study treatment|0|||
131230519|NCT01716754|472469445|FG001|Overall Study|Non-compliance with study treatment|0|||
131230520|NCT01716754|472469446|FG002|Overall Study|Non-compliance with study treatment|1|||
131230521|NCT01716754|472469447|FG003|Overall Study|Non-compliance with study treatment|0|||
131230522|NCT01716754|472469444|FG000|Overall Study|Physician Decision|1|||
131230523|NCT01716754|472469445|FG001|Overall Study|Physician Decision|0|||
131230524|NCT01716754|472469446|FG002|Overall Study|Physician Decision|0|||
131068970|NCT00603278|471882662|FG001|Overall Study|Physician Decision|1|||
131068971|NCT00603278|471882663|FG002|Overall Study|Physician Decision|0|||
131068972|NCT00603278|471882664|FG003|Overall Study|Physician Decision|0|||
131068973|NCT00603278|471882665|FG004|Overall Study|Physician Decision|2|||
131068974|NCT00603278|471882666|FG005|Overall Study|Physician Decision|1|||
131068975|NCT00603278|471882661|FG000|Overall Study|Lost to Follow-up|1|||
131068976|NCT00603278|471882662|FG001|Overall Study|Lost to Follow-up|0|||
131068977|NCT00603278|471882663|FG002|Overall Study|Lost to Follow-up|0|||
131068978|NCT00603278|471882664|FG003|Overall Study|Lost to Follow-up|0|||
131068979|NCT00603278|471882665|FG004|Overall Study|Lost to Follow-up|1|||
131068980|NCT00603278|471882666|FG005|Overall Study|Lost to Follow-up|0|||
131068981|NCT04374253|471882670|FG000|Overall Study|Adverse Event|0|||
131068982|NCT04374253|471882671|FG001|Overall Study|Adverse Event|26|||
131068983|NCT04374253|471882672|FG002|Overall Study|Adverse Event|2|||
131068984|NCT04374253|471882673|FG003|Overall Study|Adverse Event|12|||
131068985|NCT04374253|471882670|FG000|Overall Study|Study terminated by sponsor|13|||
131068986|NCT04374253|471882671|FG001|Overall Study|Study terminated by sponsor|593|||
131068987|NCT04374253|471882672|FG002|Overall Study|Study terminated by sponsor|21|||
131230525|NCT01716754|472469447|FG003|Overall Study|Physician Decision|0|||
131230526|NCT01716754|472469444|FG000|Overall Study|Lost to Follow-up|1|||
131230527|NCT01716754|472469445|FG001|Overall Study|Lost to Follow-up|0|||
131230528|NCT01716754|472469446|FG002|Overall Study|Lost to Follow-up|0|||
131230529|NCT01716754|472469447|FG003|Overall Study|Lost to Follow-up|1|||
131230530|NCT01716754|472469444|FG000|Overall Study|Adverse Event|4|||
131230531|NCT01716754|472469445|FG001|Overall Study|Adverse Event|2|||
131230532|NCT01716754|472469446|FG002|Overall Study|Adverse Event|2|||
131230533|NCT01716754|472469447|FG003|Overall Study|Adverse Event|1|||
131230534|NCT01716754|472469444|FG000|Overall Study|Withdrawal by Subject|5|||
131230535|NCT01716754|472469445|FG001|Overall Study|Withdrawal by Subject|0|||
131230536|NCT01716754|472469446|FG002|Overall Study|Withdrawal by Subject|4|||
131230537|NCT01716754|472469447|FG003|Overall Study|Withdrawal by Subject|3|||
131230538|NCT02535000|472469449|FG000|Overall Study|Cancellation of surgery.|1|||
131230539|NCT02535000|472469450|FG001|Overall Study|Cancellation of surgery.|2|||
131230540|NCT04317781|472469451|FG000|Overall Study|Adverse Event|1|||
131230541|NCT04317781|472469451|FG000|Overall Study|Disease relapse|1|||
130779482|NCT02326272|470819494|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130779483|NCT02326272|470819495|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
131068988|NCT04374253|471882673|FG003|Overall Study|Study terminated by sponsor|567|||
131230542|NCT04317781|472469451|FG000|Overall Study|Withdrawal by Subject|1|||
131230543|NCT01620489|472469452|FG000|Overall Study|Adverse Event|17|||
131230544|NCT01620489|472469453|FG001|Overall Study|Adverse Event|4|||
131230545|NCT01620489|472469452|FG000|Overall Study|Protocol Violation|0|||
131230546|NCT01620489|472469453|FG001|Overall Study|Protocol Violation|3|||
131230547|NCT01620489|472469452|FG000|Overall Study|Withdrawal Criteria|17|||
131068989|NCT04374253|471882670|FG000|Overall Study|Withdrawal by Subject|0|||
131068990|NCT04374253|471882671|FG001|Overall Study|Withdrawal by Subject|55|||
131068991|NCT04374253|471882672|FG002|Overall Study|Withdrawal by Subject|3|||
131230548|NCT01620489|472469453|FG001|Overall Study|Withdrawal Criteria|25|||
131230549|NCT01620489|472469452|FG000|Overall Study|Unclassified|1|||
131230550|NCT01620489|472469453|FG001|Overall Study|Unclassified|2|||
131230551|NCT02649231|472469454|FG000|Overall Study|Adverse Event|0|||
131230552|NCT02649231|472469455|FG001|Overall Study|Adverse Event|0|||
131230553|NCT02649231|472469456|FG002|Overall Study|Adverse Event|0|||
131230554|NCT02649231|472469457|FG003|Overall Study|Adverse Event|1|||
131230555|NCT02649231|472469454|FG000|Overall Study|Lost to Follow-up|2|||
131230556|NCT02649231|472469455|FG001|Overall Study|Lost to Follow-up|1|||
131230557|NCT02649231|472469456|FG002|Overall Study|Lost to Follow-up|1|||
131230558|NCT02649231|472469457|FG003|Overall Study|Lost to Follow-up|0|||
131230559|NCT02649231|472469454|FG000|Overall Study|Withdrawal by Subject|0|||
131230560|NCT02649231|472469455|FG001|Overall Study|Withdrawal by Subject|1|||
131230561|NCT02649231|472469456|FG002|Overall Study|Withdrawal by Subject|0|||
131230562|NCT02649231|472469457|FG003|Overall Study|Withdrawal by Subject|1|||
131230563|NCT02649231|472469454|FG000|Overall Study|Protocol Violation|2|||
131230564|NCT02649231|472469455|FG001|Overall Study|Protocol Violation|1|||
131230565|NCT02649231|472469456|FG002|Overall Study|Protocol Violation|1|||
131230566|NCT02649231|472469457|FG003|Overall Study|Protocol Violation|0|||
131230567|NCT02995837|472469459|FG000|Overall Study|Lost to Follow-up|9|||
131230568|NCT02995837|472469460|FG001|Overall Study|Lost to Follow-up|8|||
131230569|NCT01859702|472469461|FG000|Overall Study|Protocol deviation|3|||
131230570|NCT01859702|472469461|FG000|Overall Study|Adverse Event|2|||
131230571|NCT01077713|472469466|FG000|Overall Study|Withdrawal by Subject|1|||
131230572|NCT01077713|472469467|FG001|Overall Study|Withdrawal by Subject|2|||
131230573|NCT01077713|472469466|FG000|Overall Study|Progressive Disease (PD)|0|||
131230574|NCT01077713|472469467|FG001|Overall Study|Progressive Disease (PD)|1|||
131230575|NCT01077713|472469466|FG000|Overall Study|Death|28|||
131230576|NCT01077713|472469467|FG001|Overall Study|Death|29|||
131230577|NCT01077713|472469466|FG000|Overall Study|Lost to Follow-up|1|||
131230578|NCT01077713|472469467|FG001|Overall Study|Lost to Follow-up|1|||
131230579|NCT01077713|472469466|FG000|Overall Study|Adverse Event|2|||
131230580|NCT01077713|472469467|FG001|Overall Study|Adverse Event|1|||
131230581|NCT01077713|472469466|FG000|Overall Study|Other|4|||
131230582|NCT01077713|472469467|FG001|Overall Study|Other|2|||
131230583|NCT00289458|472469468|FG000|Overall Study|Death|1|||
131230584|NCT00289458|472469469|FG001|Overall Study|Death|0|||
131230585|NCT00289458|472469470|FG002|Overall Study|Death|0|||
131230586|NCT00289458|472469468|FG000|Overall Study|Physician Decision|3|||
131230587|NCT00289458|472469469|FG001|Overall Study|Physician Decision|4|||
131230588|NCT00289458|472469470|FG002|Overall Study|Physician Decision|2|||
131230589|NCT00289458|472469468|FG000|Overall Study|Withdrawal by Subject|2|||
131230590|NCT00289458|472469469|FG001|Overall Study|Withdrawal by Subject|2|||
131230591|NCT00289458|472469470|FG002|Overall Study|Withdrawal by Subject|4|||
131230592|NCT00874757|472469471|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
131230593|NCT04014959|472471265|FG000|Baseline MRI and Assessments|Physician Decision|2|||
131230594|NCT04014959|472471265|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
131230595|NCT04014959|472471265|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
131230596|NCT03997448|472471275|FG000|Study Treatment|Disease Progression|1|||
131230597|NCT03997448|472471275|FG000|Study Treatment|Symptomatic Deterioration|1|||
131230598|NCT03997448|472471275|FG000|Follow up|Death|2|||
131230599|NCT03997448|472471275|FG000|Follow up|study terminated|1|||
131230600|NCT00125359|472471278|FG000|Overall Study|Death|4|||
131230601|NCT00125359|472471278|FG000|Overall Study|Adverse Event|5|||
131230602|NCT00125359|472471278|FG000|Overall Study|Physician Decision|14|||
131230603|NCT01513551|472471279|FG000|Overall Study|Death|0|||
131230604|NCT01513551|472471280|FG001|Overall Study|Death|1|||
131230605|NCT01513551|472471281|FG002|Overall Study|Death|0|||
131230606|NCT01513551|472471279|FG000|Overall Study|Lost to Follow-up|3|||
131230607|NCT01513551|472471280|FG001|Overall Study|Lost to Follow-up|5|||
131230608|NCT01513551|472471281|FG002|Overall Study|Lost to Follow-up|2|||
131230609|NCT01513551|472471279|FG000|Overall Study|Withdrawal by Subject|1|||
131230610|NCT01513551|472471280|FG001|Overall Study|Withdrawal by Subject|0|||
131230611|NCT01513551|472471281|FG002|Overall Study|Withdrawal by Subject|2|||
131230612|NCT01513551|472471279|FG000|Overall Study|Randomized but not vaccinated|0|||
131230613|NCT01513551|472471280|FG001|Overall Study|Randomized but not vaccinated|0|||
131230614|NCT01513551|472471281|FG002|Overall Study|Randomized but not vaccinated|1|||
131230615|NCT02482805|472471284|FG000|Overall Study|Lost to Follow-up|4|||
131230616|NCT02482805|472471285|FG001|Overall Study|Lost to Follow-up|4|||
131230617|NCT02482805|472471286|FG002|Overall Study|Lost to Follow-up|0|||
131230618|NCT01144663|472471287|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
131230619|NCT01144663|472471288|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
131230620|NCT01144663|472471289|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
131230621|NCT01144663|472471290|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
131230622|NCT01144663|472471287|FG000|Primary Vaccination Phase|Adverse Event|1|||
131230623|NCT01144663|472471288|FG001|Primary Vaccination Phase|Adverse Event|0|||
131230624|NCT01144663|472471289|FG002|Primary Vaccination Phase|Adverse Event|0|||
131230625|NCT01144663|472471290|FG003|Primary Vaccination Phase|Adverse Event|1|||
131230626|NCT01144663|472471287|FG000|Primary Vaccination Phase|Protocol Violation|2|||
131230627|NCT01144663|472471288|FG001|Primary Vaccination Phase|Protocol Violation|0|||
131230628|NCT01144663|472471289|FG002|Primary Vaccination Phase|Protocol Violation|1|||
131230629|NCT01144663|472471290|FG003|Primary Vaccination Phase|Protocol Violation|0|||
131230630|NCT01144663|472471287|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
131230631|NCT01144663|472471288|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
131230632|NCT01144663|472471289|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
131068992|NCT04374253|471882673|FG003|Overall Study|Withdrawal by Subject|40|||
131068993|NCT04374253|471882670|FG000|Overall Study|Physician Decision|1|||
131068994|NCT04374253|471882671|FG001|Overall Study|Physician Decision|10|||
131068995|NCT04374253|471882672|FG002|Overall Study|Physician Decision|1|||
131068996|NCT04374253|471882673|FG003|Overall Study|Physician Decision|10|||
131068997|NCT04374253|471882670|FG000|Overall Study|Protocol Violation|0|||
131068998|NCT04374253|471882671|FG001|Overall Study|Protocol Violation|0|||
131068999|NCT04374253|471882672|FG002|Overall Study|Protocol Violation|0|||
131069000|NCT04374253|471882673|FG003|Overall Study|Protocol Violation|2|||
131069001|NCT04374253|471882670|FG000|Overall Study|Death|0|||
131069002|NCT04374253|471882671|FG001|Overall Study|Death|3|||
131069003|NCT04374253|471882672|FG002|Overall Study|Death|1|||
131069004|NCT04374253|471882673|FG003|Overall Study|Death|1|||
131069005|NCT04374253|471882670|FG000|Overall Study|Lack of Efficacy|0|||
131069006|NCT04374253|471882671|FG001|Overall Study|Lack of Efficacy|0|||
131069007|NCT04374253|471882672|FG002|Overall Study|Lack of Efficacy|0|||
131069008|NCT04374253|471882673|FG003|Overall Study|Lack of Efficacy|1|||
131069009|NCT04374253|471882670|FG000|Overall Study|Lost to Follow-up|1|||
131069010|NCT04374253|471882671|FG001|Overall Study|Lost to Follow-up|1|||
131069011|NCT04374253|471882672|FG002|Overall Study|Lost to Follow-up|0|||
131069012|NCT04374253|471882673|FG003|Overall Study|Lost to Follow-up|2|||
131069013|NCT04374253|471882670|FG000|Overall Study|Reason Not Specified|0|||
131069014|NCT04374253|471882671|FG001|Overall Study|Reason Not Specified|8|||
131069015|NCT04374253|471882672|FG002|Overall Study|Reason Not Specified|0|||
131069016|NCT04374253|471882673|FG003|Overall Study|Reason Not Specified|8|||
131069017|NCT04382053|471882674|FG000|Overall Study|Death|6|||
131069018|NCT04382053|471882675|FG001|Overall Study|Death|8|||
131069019|NCT04382053|471882674|FG000|Overall Study|Lost to Follow-up|0|||
131069020|NCT04382053|471882675|FG001|Overall Study|Lost to Follow-up|2|||
131069021|NCT04382053|471882674|FG000|Overall Study|Protocol Deviation|1|||
131069022|NCT04382053|471882675|FG001|Overall Study|Protocol Deviation|2|||
131069023|NCT04382053|471882674|FG000|Overall Study|Withdrawal by Subject|2|||
131069024|NCT04382053|471882675|FG001|Overall Study|Withdrawal by Subject|1|||
131069025|NCT01399905|471882679|FG000|Overall Study|Withdrawal by Subject|1|||
131069026|NCT01399905|471882680|FG001|Overall Study|Withdrawal by Subject|1|||
131069027|NCT02577315|471882681|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131069028|NCT02577315|471882682|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
131069029|NCT00417989|471882685|FG000|Overall Study|Withdrawal by Subject|13|||
131069030|NCT00417989|471882686|FG001|Overall Study|Withdrawal by Subject|13|||
131069031|NCT00417989|471882685|FG000|Overall Study|Lost to Follow-up|1|||
131069032|NCT00417989|471882686|FG001|Overall Study|Lost to Follow-up|6|||
131069033|NCT00417989|471882685|FG000|Overall Study|Protocol Violation|1|||
131069034|NCT00417989|471882686|FG001|Overall Study|Protocol Violation|0|||
131069035|NCT00417989|471882685|FG000|Overall Study|Death|0|||
131069036|NCT00417989|471882686|FG001|Overall Study|Death|1|||
131069037|NCT00417989|471882685|FG000|Overall Study|Physician Decision|5|||
131069038|NCT00417989|471882686|FG001|Overall Study|Physician Decision|2|||
131069039|NCT01945086|471882689|FG000|Overall Study|Withdrawal by Subject|1|||
131069040|NCT01945086|471882690|FG001|Overall Study|Withdrawal by Subject|0|||
131069041|NCT01945086|471882691|FG002|Overall Study|Withdrawal by Subject|1|||
131069042|NCT01945086|471882689|FG000|Overall Study|Adverse Event|0|||
131069043|NCT01945086|471882690|FG001|Overall Study|Adverse Event|0|||
131069044|NCT01945086|471882691|FG002|Overall Study|Adverse Event|1|||
131069045|NCT00748098|471882692|FG000|First Treatment Intervention Period|Adverse Event|1|||
131069046|NCT00748098|471882693|FG001|First Treatment Intervention Period|Adverse Event|1|||
131069047|NCT00748098|471882692|FG000|First Treatment Intervention Period|Protocol Violation|1|||
131069048|NCT00748098|471882693|FG001|First Treatment Intervention Period|Protocol Violation|0|||
131069049|NCT00748098|471882692|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
131069050|NCT00748098|471882693|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
131069051|NCT00748098|471882692|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
131069052|NCT00748098|471882693|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
131069053|NCT00748098|471882692|FG000|First Taper Period|Protocol Violation|1|||
131069054|NCT00748098|471882693|FG001|First Taper Period|Protocol Violation|0|||
131069055|NCT00748098|471882692|FG000|First Taper Period|Withdrawal by Subject|2|||
131069056|NCT00748098|471882693|FG001|First Taper Period|Withdrawal by Subject|0|||
131069057|NCT00748098|471882692|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
131069058|NCT00748098|471882693|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
131069059|NCT00748098|471882692|FG000|1-Week Washout Period|Adverse Event|0|||
131069060|NCT00748098|471882693|FG001|1-Week Washout Period|Adverse Event|1|||
131069061|NCT00748098|471882692|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
131069062|NCT00748098|471882693|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
131069063|NCT00748098|471882692|FG000|Second Treatment Intervention Period|Adverse Event|4|||
131069064|NCT00748098|471882693|FG001|Second Treatment Intervention Period|Adverse Event|1|||
131069065|NCT00748098|471882692|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
131069066|NCT00748098|471882693|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
131069067|NCT00748098|471882692|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
131069068|NCT00748098|471882693|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
131069069|NCT04044352|471884288|FG000|Overall Study|Lost to Follow-up|9|||
131069070|NCT04044352|471884288|FG000|Overall Study|Withdrawal by Subject|2|||
131069071|NCT00651937|471884289|FG000|Overall Study|Withdrawal by Subject|4|||
131069072|NCT00651937|471884290|FG001|Overall Study|Withdrawal by Subject|1|||
131069073|NCT01537120|471884299|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
131069074|NCT01537120|471884299|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
131069075|NCT02514577|471884300|FG000|Overall Study|Lost to Follow-up|6|||
131069076|NCT02514577|471884301|FG001|Overall Study|Lost to Follow-up|6|||
131069077|NCT02514577|471884300|FG000|Overall Study|Protocol Violation|1|||
131069078|NCT02514577|471884301|FG001|Overall Study|Protocol Violation|0|||
131069079|NCT02514577|471884300|FG000|Overall Study|Withdrawal by Subject|6|||
131069080|NCT02514577|471884301|FG001|Overall Study|Withdrawal by Subject|6|||
131069081|NCT02514577|471884300|FG000|Overall Study|Adverse Event|1|||
131069082|NCT02514577|471884301|FG001|Overall Study|Adverse Event|1|||
131069083|NCT04816708|471884304|FG000|Overall Study|Lost to Follow-up|10|||
131069084|NCT04816708|471884305|FG001|Overall Study|Lost to Follow-up|4|||
131069085|NCT03568708|471884306|FG000|Overall Study|Withdrawal by Subject|1|||
131069086|NCT03568708|471884307|FG001|Overall Study|Withdrawal by Subject|1|||
131069087|NCT03568708|471884306|FG000|Overall Study|Lost to Follow-up|0|||
131069088|NCT03568708|471884307|FG001|Overall Study|Lost to Follow-up|1|||
131069089|NCT00511147|471884308|FG000|Overall Study|Withdrawal by Subject|1|||
131069090|NCT00511147|471884308|FG000|Overall Study|Disease progression|5|||
131069091|NCT00511147|471884308|FG000|Overall Study|Required platelet transfusion|1|||
131069092|NCT00809783|471884309|FG000|Overall Study|Death|1|||
131069093|NCT00809783|471884310|FG001|Overall Study|Death|0|||
131069094|NCT00809783|471884311|FG002|Overall Study|Death|0|||
131069095|NCT00809783|471884309|FG000|Overall Study|Adverse Event|34|||
131069096|NCT00809783|471884310|FG001|Overall Study|Adverse Event|52|||
131230633|NCT01144663|472471290|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
131230634|NCT01144663|472471287|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
131230635|NCT01144663|472471288|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
131230636|NCT01144663|472471289|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
131230637|NCT01144663|472471290|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
131230638|NCT01144663|472471287|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
131230639|NCT01144663|472471288|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
131230640|NCT01144663|472471289|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
131230641|NCT01144663|472471290|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
131069097|NCT00809783|471884311|FG002|Overall Study|Adverse Event|71|||
131069098|NCT00809783|471884309|FG000|Overall Study|Lack of Efficacy|39|||
131069099|NCT00809783|471884310|FG001|Overall Study|Lack of Efficacy|52|||
131069100|NCT00809783|471884311|FG002|Overall Study|Lack of Efficacy|63|||
131069101|NCT00809783|471884309|FG000|Overall Study|Lost to Follow-up|0|||
131069102|NCT00809783|471884310|FG001|Overall Study|Lost to Follow-up|3|||
131069103|NCT00809783|471884311|FG002|Overall Study|Lost to Follow-up|4|||
131069104|NCT00809783|471884309|FG000|Overall Study|Withdrawal by Subject|47|||
131069105|NCT00809783|471884310|FG001|Overall Study|Withdrawal by Subject|72|||
131069106|NCT00809783|471884311|FG002|Overall Study|Withdrawal by Subject|64|||
131069107|NCT00809783|471884309|FG000|Overall Study|Protocol Violation|2|||
131069108|NCT00809783|471884310|FG001|Overall Study|Protocol Violation|6|||
131069109|NCT00809783|471884311|FG002|Overall Study|Protocol Violation|5|||
131069110|NCT00809783|471884309|FG000|Overall Study|Randomized, but not treated|3|||
131069111|NCT00809783|471884310|FG001|Overall Study|Randomized, but not treated|0|||
131069112|NCT00809783|471884311|FG002|Overall Study|Randomized, but not treated|2|||
131069113|NCT00809783|471884309|FG000|Overall Study|Study Terminated by Sponsor|378|||
131069114|NCT00809783|471884310|FG001|Overall Study|Study Terminated by Sponsor|626|||
131069115|NCT00809783|471884311|FG002|Overall Study|Study Terminated by Sponsor|565|||
131069116|NCT00809783|471884309|FG000|Overall Study|Other|21|||
131230642|NCT01144663|472471287|FG000|Primary Vaccination Phase|Other|0|||
131230643|NCT01144663|472471288|FG001|Primary Vaccination Phase|Other|1|||
131230644|NCT01144663|472471289|FG002|Primary Vaccination Phase|Other|0|||
131230645|NCT01144663|472471290|FG003|Primary Vaccination Phase|Other|2|||
131230646|NCT01144663|472471287|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
131230647|NCT01144663|472471288|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
131230648|NCT01144663|472471289|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
131230649|NCT01144663|472471290|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
131230650|NCT01144663|472471287|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
131230651|NCT01144663|472471288|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
131069117|NCT00809783|471884310|FG001|Overall Study|Other|21|||
131069118|NCT00809783|471884311|FG002|Overall Study|Other|16|||
131069119|NCT00126555|471884312|FG000|Overall Study|Withdrawal by Subject|1|||
131069120|NCT00126555|471884312|FG000|Overall Study|Adverse Event|2|||
131069121|NCT00126555|471884312|FG000|Overall Study|Progressive Disease|3|||
131069122|NCT01732588|471884316|FG000|First Intervention (7 Days)|Adverse Event|0|||
131069123|NCT01732588|471884317|FG001|First Intervention (7 Days)|Adverse Event|1|||
131230652|NCT01144663|472471289|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
131069124|NCT01732588|471884318|FG002|First Intervention (7 Days)|Adverse Event|0|||
131069125|NCT00730925|471884321|FG000|Overall Study|Progressive Disease|21|||
131069126|NCT00730925|471884321|FG000|Overall Study|Dose reducing Event|2|||
131069127|NCT00730925|471884321|FG000|Overall Study|Other Averse Event|7|||
131069128|NCT00730925|471884321|FG000|Overall Study|Protocol Violation|1|||
131069129|NCT00730925|471884321|FG000|Overall Study|Withdrawal by Subject|1|||
131069130|NCT00730925|471884321|FG000|Overall Study|Switch to combination therapy|8|||
131069131|NCT00730925|471884321|FG000|Overall Study|Other|1|||
131069132|NCT00191984|471884328|FG000|Overall Study|Disease Progression|21|||
131069133|NCT00191984|471884328|FG000|Overall Study|Adverse Event|4|||
131069134|NCT00191984|471884328|FG000|Overall Study|Death|2|||
131069135|NCT00191984|471884328|FG000|Overall Study|Entry Criteria Exclusion|1|||
131069136|NCT00191984|471884328|FG000|Overall Study|Withdrawal by Subject|7|||
131069137|NCT00191984|471884328|FG000|Overall Study|Physician Decision|4|||
131069138|NCT01732627|471884329|FG000|Overall Study|Withdrawal by Subject|1|||
131069139|NCT01732627|471884330|FG001|Overall Study|Withdrawal by Subject|0|||
131069140|NCT00005908|471884333|FG000|Overall Study|Withdrawal by Subject|1|||
131069141|NCT00005908|471884334|FG001|Overall Study|Withdrawal by Subject|0|||
131069142|NCT04736602|471884341|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
131069143|NCT04736602|471884341|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
131069144|NCT02131155|471884343|FG000|Overall Study|Adverse Event|1|||
131069145|NCT02131155|471884344|FG001|Overall Study|Adverse Event|0|||
131069146|NCT02131155|471884343|FG000|Overall Study|Treatment completed|1|||
131069147|NCT02131155|471884344|FG001|Overall Study|Treatment completed|0|||
131069148|NCT02131155|471884343|FG000|Overall Study|Primary tumour recurrence|2|||
131069149|NCT02131155|471884344|FG001|Overall Study|Primary tumour recurrence|1|||
131069150|NCT02131155|471884343|FG000|Overall Study|Refused to continue study medication|1|||
131069151|NCT02131155|471884344|FG001|Overall Study|Refused to continue study medication|0|||
131069152|NCT02131155|471884343|FG000|Overall Study|Study early termination|20|||
131069153|NCT02131155|471884344|FG001|Overall Study|Study early termination|10|||
131069154|NCT01887418|471884345|FG000|Overall Study|Travelling difficulties|0|||
131069155|NCT01887418|471884346|FG001|Overall Study|Travelling difficulties|0|||
131069156|NCT01887418|471884347|FG002|Overall Study|Travelling difficulties|1|||
131069157|NCT00475735|471884348|FG000|Treatment Period 1|Adverse Event|2|||
131069158|NCT00475735|471884349|FG001|Treatment Period 1|Adverse Event|0|||
131069159|NCT00475735|471884350|FG002|Treatment Period 1|Adverse Event|0|||
131069160|NCT00475735|471884351|FG003|Treatment Period 1|Adverse Event|0|||
131069161|NCT00475735|471884352|FG004|Treatment Period 1|Adverse Event|0|||
131069162|NCT00475735|471884353|FG005|Treatment Period 1|Adverse Event|0|||
131069163|NCT00475735|471884348|FG000|Treatment Period 1|Lack of Efficacy|1|||
131069164|NCT00475735|471884349|FG001|Treatment Period 1|Lack of Efficacy|0|||
131069165|NCT00475735|471884350|FG002|Treatment Period 1|Lack of Efficacy|0|||
131069166|NCT00475735|471884351|FG003|Treatment Period 1|Lack of Efficacy|0|||
131069167|NCT00475735|471884352|FG004|Treatment Period 1|Lack of Efficacy|0|||
131069168|NCT00475735|471884353|FG005|Treatment Period 1|Lack of Efficacy|0|||
131069169|NCT00475735|471884348|FG000|Treatment Period 1|Lost to Follow-up|0|||
131069170|NCT00475735|471884349|FG001|Treatment Period 1|Lost to Follow-up|0|||
131069171|NCT00475735|471884350|FG002|Treatment Period 1|Lost to Follow-up|0|||
131069172|NCT00475735|471884351|FG003|Treatment Period 1|Lost to Follow-up|0|||
131069173|NCT00475735|471884352|FG004|Treatment Period 1|Lost to Follow-up|0|||
131069174|NCT00475735|471884353|FG005|Treatment Period 1|Lost to Follow-up|1|||
131069175|NCT00475735|471884348|FG000|Treatment Period 1|Protocol Violation|0|||
131069176|NCT00475735|471884349|FG001|Treatment Period 1|Protocol Violation|0|||
131069177|NCT00475735|471884350|FG002|Treatment Period 1|Protocol Violation|0|||
131069178|NCT00475735|471884351|FG003|Treatment Period 1|Protocol Violation|1|||
131069179|NCT00475735|471884352|FG004|Treatment Period 1|Protocol Violation|0|||
131069180|NCT00475735|471884353|FG005|Treatment Period 1|Protocol Violation|0|||
131069181|NCT00475735|471884348|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131069182|NCT00475735|471884349|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131069183|NCT00475735|471884350|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131069184|NCT00475735|471884351|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131069185|NCT00475735|471884352|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131069186|NCT00475735|471884353|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131069187|NCT00475735|471884348|FG000|Treatment Period 1|DC due to AE but continuing|0|||
131069188|NCT00475735|471884349|FG001|Treatment Period 1|DC due to AE but continuing|0|||
131069189|NCT00475735|471884350|FG002|Treatment Period 1|DC due to AE but continuing|0|||
131069190|NCT00475735|471884351|FG003|Treatment Period 1|DC due to AE but continuing|1|||
131069191|NCT00475735|471884352|FG004|Treatment Period 1|DC due to AE but continuing|2|||
131069192|NCT00475735|471884353|FG005|Treatment Period 1|DC due to AE but continuing|2|||
131069193|NCT00475735|471884348|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
131069194|NCT00475735|471884349|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
131069195|NCT00475735|471884350|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
131069196|NCT00475735|471884351|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
131069197|NCT00475735|471884352|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
131069198|NCT00475735|471884353|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
130723421|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
130723422|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
130723423|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
130723424|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
130723425|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
130723426|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
131069199|NCT00475735|471884348|FG000|Treatment Washout|Lost to Follow-up|0|||
131069200|NCT00475735|471884349|FG001|Treatment Washout|Lost to Follow-up|1|||
131069201|NCT00475735|471884350|FG002|Treatment Washout|Lost to Follow-up|0|||
131069202|NCT00475735|471884351|FG003|Treatment Washout|Lost to Follow-up|0|||
131069203|NCT00475735|471884352|FG004|Treatment Washout|Lost to Follow-up|0|||
131069204|NCT00475735|471884353|FG005|Treatment Washout|Lost to Follow-up|0|||
131069205|NCT00475735|471884348|FG000|Treatment Washout|Protocol Violation|0|||
131069206|NCT00475735|471884349|FG001|Treatment Washout|Protocol Violation|1|||
131069207|NCT00475735|471884350|FG002|Treatment Washout|Protocol Violation|0|||
131069208|NCT00475735|471884351|FG003|Treatment Washout|Protocol Violation|0|||
131069209|NCT00475735|471884352|FG004|Treatment Washout|Protocol Violation|0|||
131069210|NCT00475735|471884353|FG005|Treatment Washout|Protocol Violation|0|||
131069211|NCT00475735|471884348|FG000|Treatment Period 2|Adverse Event|0|||
131069212|NCT00475735|471884349|FG001|Treatment Period 2|Adverse Event|1|||
131069213|NCT00475735|471884350|FG002|Treatment Period 2|Adverse Event|0|||
131069214|NCT00475735|471884351|FG003|Treatment Period 2|Adverse Event|2|||
131069215|NCT00475735|471884352|FG004|Treatment Period 2|Adverse Event|0|||
131069216|NCT00475735|471884353|FG005|Treatment Period 2|Adverse Event|0|||
131069217|NCT00475735|471884348|FG000|Treatment Period 2|Lack of Efficacy|0|||
131069218|NCT00475735|471884349|FG001|Treatment Period 2|Lack of Efficacy|0|||
131069219|NCT00475735|471884350|FG002|Treatment Period 2|Lack of Efficacy|0|||
131069220|NCT00475735|471884351|FG003|Treatment Period 2|Lack of Efficacy|0|||
131069221|NCT00475735|471884352|FG004|Treatment Period 2|Lack of Efficacy|0|||
131069222|NCT00475735|471884353|FG005|Treatment Period 2|Lack of Efficacy|1|||
131069223|NCT00475735|471884348|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131069224|NCT00475735|471884349|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131069225|NCT00475735|471884350|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131069226|NCT00475735|471884351|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131069227|NCT00475735|471884352|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131069228|NCT00475735|471884353|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131069229|NCT03132753|471884354|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
131069230|NCT03132753|471884355|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
131069231|NCT03132753|471884354|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
131069232|NCT03132753|471884355|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
131069233|NCT00125853|471884356|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
131069234|NCT00125853|471884357|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
131069235|NCT02097056|471884361|FG000|Overall Study|Protocol Violation|2|||
131069236|NCT02097056|471884361|FG000|Overall Study|Withdrawal by Subject|15|||
131069237|NCT02097056|471884361|FG000|Overall Study|Lost to Follow-up|2|||
131069238|NCT02097056|471884361|FG000|Overall Study|Adverse Event|37|||
131069239|NCT02097056|471884361|FG000|Overall Study|Other|2|||
131069240|NCT02350127|471884362|FG000|4-Month Assessment|Withdrawal by Subject|10|||
131069241|NCT02350127|471884363|FG001|4-Month Assessment|Withdrawal by Subject|9|||
131069242|NCT02350127|471884362|FG000|4-Month Assessment|Death|1|||
131069243|NCT02350127|471884363|FG001|4-Month Assessment|Death|0|||
131069244|NCT02350127|471884362|FG000|8-Month Assessment|Death|1|||
131069245|NCT02350127|471884363|FG001|8-Month Assessment|Death|1|||
131069246|NCT02350127|471884362|FG000|8-Month Assessment|Withdrawal by Subject|5|||
131069247|NCT02350127|471884363|FG001|8-Month Assessment|Withdrawal by Subject|8|||
131069248|NCT02359552|471884370|FG000|Overall Study|Lost to Follow-up|3|||
131069249|NCT02359552|471884371|FG001|Overall Study|Lost to Follow-up|4|||
131069250|NCT01395914|471884379|FG000|Overall Study|Unrelated to study drug AE|6|||
131069251|NCT01395914|471884380|FG001|Overall Study|Unrelated to study drug AE|1|||
131069252|NCT01395914|471884379|FG000|Overall Study|Death|23|||
131069253|NCT01395914|471884380|FG001|Overall Study|Death|17|||
131069254|NCT01395914|471884379|FG000|Overall Study|Other|9|||
131069255|NCT01395914|471884380|FG001|Overall Study|Other|3|||
131069256|NCT01395914|471884379|FG000|Overall Study|Withdrawal by patient|27|||
130723427|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
131069257|NCT01395914|471884380|FG001|Overall Study|Withdrawal by patient|14|||
131069258|NCT01395914|471884379|FG000|Overall Study|Study drug-related AE|1|||
131069259|NCT01395914|471884380|FG001|Overall Study|Study drug-related AE|0|||
131069260|NCT01395914|471884379|FG000|Overall Study|Lost to Follow-up|6|||
131069261|NCT01395914|471884380|FG001|Overall Study|Lost to Follow-up|2|||
131069262|NCT03023878|471884381|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
131069263|NCT03023878|471884381|FG000|Pre-Study Run-In Period|Death|1|||
131069264|NCT03023878|471884381|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
131069265|NCT03023878|471884381|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
131069266|NCT03023878|471884381|FG000|Treatment Period|Disease Progression|1|||
131069267|NCT03023878|471884381|FG000|Treatment Period|Withdrawal by Subject|1|||
131069268|NCT03023878|471884381|FG000|Treatment Period|Adverse Event|1|||
131069269|NCT03023878|471884381|FG000|Long Term Follow-Up Period|Death|2|||
131069270|NCT01247922|471884385|FG000|Overall Study|Disease progression|4|||
131069271|NCT01876823|471884388|FG000|Overall Study|Withdrawal by Subject|5|||
131069272|NCT01876823|471884388|FG000|Overall Study|Physician Decision|2|||
131069273|NCT01876823|471884388|FG000|Overall Study|Patients moved|2|||
131069274|NCT02849509|471884389|FG000|Overall Study|Worsening of disease under study|1|||
131069275|NCT02849509|471884390|FG001|Overall Study|Worsening of disease under study|1|||
131069276|NCT02849509|471884391|FG002|Overall Study|Worsening of disease under study|1|||
131069277|NCT02849509|471884389|FG000|Overall Study|Worsening of other pre-existing disease|0|||
131069278|NCT02849509|471884390|FG001|Overall Study|Worsening of other pre-existing disease|1|||
131069279|NCT02849509|471884391|FG002|Overall Study|Worsening of other pre-existing disease|2|||
131069280|NCT02849509|471884389|FG000|Overall Study|Other adverse event|36|||
131069281|NCT02849509|471884390|FG001|Overall Study|Other adverse event|41|||
131069282|NCT02849509|471884391|FG002|Overall Study|Other adverse event|8|||
131069283|NCT02849509|471884389|FG000|Overall Study|Withdrawal by Subject|6|||
131069284|NCT02849509|471884390|FG001|Overall Study|Withdrawal by Subject|17|||
131069285|NCT02849509|471884391|FG002|Overall Study|Withdrawal by Subject|12|||
131069286|NCT02849509|471884389|FG000|Overall Study|Lost to Follow-up|27|||
131069287|NCT02849509|471884390|FG001|Overall Study|Lost to Follow-up|67|||
131069288|NCT02849509|471884391|FG002|Overall Study|Lost to Follow-up|36|||
131069289|NCT02849509|471884389|FG000|Overall Study|Other, reason not specified|14|||
131069290|NCT02849509|471884390|FG001|Overall Study|Other, reason not specified|29|||
131069291|NCT02849509|471884391|FG002|Overall Study|Other, reason not specified|25|||
131069292|NCT02849509|471884389|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
131069293|NCT02849509|471884390|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
131069294|NCT02849509|471884391|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
131069295|NCT00985621|471884394|FG000|Overall Study|Adverse Event|2|||
131069296|NCT00985621|471884395|FG001|Overall Study|Adverse Event|3|||
131069297|NCT00985621|471884396|FG002|Overall Study|Adverse Event|4|||
131069298|NCT00985621|471884397|FG003|Overall Study|Adverse Event|16|||
131069299|NCT00985621|471884394|FG000|Overall Study|Lack of Efficacy|10|||
131069300|NCT00985621|471884395|FG001|Overall Study|Lack of Efficacy|6|||
131069301|NCT00985621|471884396|FG002|Overall Study|Lack of Efficacy|5|||
131069302|NCT00985621|471884397|FG003|Overall Study|Lack of Efficacy|12|||
131069303|NCT00985621|471884394|FG000|Overall Study|Lost to Follow-up|2|||
131069304|NCT00985621|471884395|FG001|Overall Study|Lost to Follow-up|3|||
131069305|NCT00985621|471884396|FG002|Overall Study|Lost to Follow-up|4|||
131069306|NCT00985621|471884397|FG003|Overall Study|Lost to Follow-up|4|||
131069307|NCT00985621|471884394|FG000|Overall Study|Study Terminated by Sponsor|89|||
131069308|NCT00985621|471884395|FG001|Overall Study|Study Terminated by Sponsor|108|||
131069309|NCT00985621|471884396|FG002|Overall Study|Study Terminated by Sponsor|99|||
131069310|NCT00985621|471884397|FG003|Overall Study|Study Terminated by Sponsor|92|||
131069311|NCT00985621|471884394|FG000|Overall Study|Protocol Violation|1|||
131069312|NCT00985621|471884395|FG001|Overall Study|Protocol Violation|1|||
131069313|NCT00985621|471884396|FG002|Overall Study|Protocol Violation|1|||
131069314|NCT00985621|471884397|FG003|Overall Study|Protocol Violation|0|||
131069315|NCT00985621|471884394|FG000|Overall Study|Withdrawal by Subject|8|||
131069316|NCT00985621|471884395|FG001|Overall Study|Withdrawal by Subject|10|||
131069317|NCT00985621|471884396|FG002|Overall Study|Withdrawal by Subject|8|||
131069318|NCT00985621|471884397|FG003|Overall Study|Withdrawal by Subject|12|||
131069319|NCT00985621|471884394|FG000|Overall Study|Other|1|||
131069320|NCT00985621|471884395|FG001|Overall Study|Other|0|||
131069321|NCT00985621|471884396|FG002|Overall Study|Other|0|||
131069322|NCT00985621|471884397|FG003|Overall Study|Other|0|||
131069323|NCT00985621|471884394|FG000|Overall Study|Randomized but not Treated|1|||
131069324|NCT00985621|471884395|FG001|Overall Study|Randomized but not Treated|0|||
131069325|NCT00985621|471884396|FG002|Overall Study|Randomized but not Treated|2|||
131069326|NCT00985621|471884397|FG003|Overall Study|Randomized but not Treated|1|||
131069327|NCT01911819|471884398|FG000|Overall Study|Adverse Event|0|||
131069328|NCT01911819|471884399|FG001|Overall Study|Adverse Event|1|||
131069329|NCT01911819|471884400|FG002|Overall Study|Adverse Event|0|||
131069330|NCT01911819|471884398|FG000|Overall Study|Withdrawal by Subject|1|||
131069331|NCT01911819|471884399|FG001|Overall Study|Withdrawal by Subject|1|||
130779484|NCT02326272|470819496|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131069332|NCT01911819|471884400|FG002|Overall Study|Withdrawal by Subject|0|||
131069333|NCT00257556|471884401|FG000|Overall Study|Adverse Event|1|||
131069334|NCT00257556|471884402|FG001|Overall Study|Adverse Event|4|||
131069335|NCT00257556|471884401|FG000|Overall Study|Physician Decision|6|||
131069336|NCT00257556|471884402|FG001|Overall Study|Physician Decision|0|||
131069337|NCT00257556|471884401|FG000|Overall Study|Did not meet hCG criterion|3|||
131069338|NCT00257556|471884402|FG001|Overall Study|Did not meet hCG criterion|0|||
131069339|NCT00257556|471884401|FG000|Overall Study|other reason|4|||
131069340|NCT00257556|471884402|FG001|Overall Study|other reason|6|||
131069341|NCT03849300|471884403|FG000|Overall Study|move out to different area|1|||
131069342|NCT03849300|471884404|FG001|Overall Study|move out to different area|3|||
131069343|NCT03849300|471884405|FG002|Overall Study|move out to different area|1|||
131069344|NCT03849300|471884406|FG003|Overall Study|move out to different area|4|||
131069345|NCT03849300|471884403|FG000|Overall Study|scheduling/transportation conflict|4|||
131069346|NCT03849300|471884404|FG001|Overall Study|scheduling/transportation conflict|4|||
131069347|NCT03849300|471884405|FG002|Overall Study|scheduling/transportation conflict|3|||
131069348|NCT03849300|471884406|FG003|Overall Study|scheduling/transportation conflict|2|||
131069349|NCT04839289|471884407|FG000|Overall Study|Withdrawal by Subject|1|||
131069350|NCT04839289|471884408|FG001|Overall Study|Withdrawal by Subject|0|||
131069351|NCT04743999|471884411|FG000|3-month Questionnaire|Death|1|||
131069352|NCT04743999|471884411|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
131069353|NCT04743999|471884411|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
131069354|NCT04743999|471884411|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
131069355|NCT00464737|471884412|FG000|Overall Study|Adverse Event|12|||
131069356|NCT00464737|471884413|FG001|Overall Study|Adverse Event|17|||
131069357|NCT00464737|471884414|FG002|Overall Study|Adverse Event|33|||
131069358|NCT00464737|471884412|FG000|Overall Study|Lack of Efficacy|7|||
131069359|NCT00464737|471884413|FG001|Overall Study|Lack of Efficacy|7|||
131069360|NCT00464737|471884414|FG002|Overall Study|Lack of Efficacy|4|||
131069361|NCT00464737|471884412|FG000|Overall Study|Withdrawal by Subject|5|||
131069362|NCT00464737|471884413|FG001|Overall Study|Withdrawal by Subject|3|||
131069363|NCT00464737|471884414|FG002|Overall Study|Withdrawal by Subject|5|||
131069364|NCT00464737|471884412|FG000|Overall Study|Protocol Violation|1|||
131069365|NCT00464737|471884413|FG001|Overall Study|Protocol Violation|1|||
131069366|NCT00464737|471884414|FG002|Overall Study|Protocol Violation|5|||
131069367|NCT00464737|471884412|FG000|Overall Study|Non-compliance|0|||
131069368|NCT00464737|471884413|FG001|Overall Study|Non-compliance|1|||
131069369|NCT00464737|471884414|FG002|Overall Study|Non-compliance|1|||
131069370|NCT00464737|471884412|FG000|Overall Study|Lost to Follow-up|5|||
131069371|NCT00464737|471884413|FG001|Overall Study|Lost to Follow-up|2|||
131069372|NCT00464737|471884414|FG002|Overall Study|Lost to Follow-up|5|||
131069373|NCT00464737|471884412|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
131069374|NCT00464737|471884413|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
131069375|NCT00464737|471884414|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
131069376|NCT00464737|471884412|FG000|Overall Study|Other: Subject left town; family illness|1|||
131069377|NCT00464737|471884413|FG001|Overall Study|Other: Subject left town; family illness|0|||
131069378|NCT00464737|471884414|FG002|Overall Study|Other: Subject left town; family illness|0|||
131069379|NCT00464737|471884412|FG000|Overall Study|Other: Study demands too great|0|||
131069380|NCT00464737|471884413|FG001|Overall Study|Other: Study demands too great|1|||
131069381|NCT00464737|471884414|FG002|Overall Study|Other: Study demands too great|0|||
131069382|NCT00464737|471884412|FG000|Overall Study|Other: Personal family reasons|0|||
131069383|NCT00464737|471884413|FG001|Overall Study|Other: Personal family reasons|0|||
131069384|NCT00464737|471884414|FG002|Overall Study|Other: Personal family reasons|1|||
131069385|NCT00464737|471884412|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
131069386|NCT00464737|471884413|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
131069387|NCT00464737|471884414|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
131069388|NCT01207453|471884417|FG000|First Intervention|Adverse Event|2|||
131069389|NCT01207453|471884418|FG001|First Intervention|Adverse Event|1|||
131069390|NCT01207453|471884417|FG000|Washout|Adverse Event|1|||
131069391|NCT01207453|471884418|FG001|Washout|Adverse Event|0|||
131069392|NCT01207453|471884417|FG000|Washout|Lost to Follow-up|1|||
131069393|NCT01207453|471884418|FG001|Washout|Lost to Follow-up|0|||
131069394|NCT01207453|471884417|FG000|2nd Intervention|Adverse Event|1|||
131069395|NCT01207453|471884418|FG001|2nd Intervention|Adverse Event|2|||
131069396|NCT01207453|471884417|FG000|2nd Intervention|Lost to Follow-up|1|||
131069397|NCT01207453|471884418|FG001|2nd Intervention|Lost to Follow-up|0|||
131069398|NCT00676663|471884419|FG000|Overall Study|Death|43|||
131069399|NCT00676663|471884420|FG001|Overall Study|Death|27|||
131069400|NCT00676663|471884419|FG000|Overall Study|Withdrew Consent|1|||
131069401|NCT00676663|471884420|FG001|Overall Study|Withdrew Consent|8|||
131069402|NCT00676663|471884419|FG000|Overall Study|Lost to Follow-up|1|||
131069403|NCT00676663|471884420|FG001|Overall Study|Lost to Follow-up|3|||
131069404|NCT00580047|471884421|FG000|Overall Study|Lost to Follow-up|1|||
131069405|NCT00580047|471884422|FG001|Overall Study|Lost to Follow-up|1|||
131069406|NCT00580047|471884423|FG002|Overall Study|Lost to Follow-up|0|||
131069407|NCT00580047|471884421|FG000|Overall Study|Withdrawal by Subject|1|||
131069408|NCT00580047|471884422|FG001|Overall Study|Withdrawal by Subject|1|||
131230653|NCT01144663|472471290|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
131069409|NCT00580047|471884423|FG002|Overall Study|Withdrawal by Subject|2|||
131069410|NCT00580047|471884421|FG000|Overall Study|Withdrawal by Subject|1|||
131069411|NCT00580047|471884422|FG001|Overall Study|Withdrawal by Subject|0|||
131069412|NCT00580047|471884423|FG002|Overall Study|Withdrawal by Subject|0|||
131069413|NCT00170950|471884435|FG000|Overall Study|Death|236|||
131069414|NCT00170950|471884436|FG001|Overall Study|Death|274|||
131069415|NCT00170950|471884435|FG000|Overall Study|Withdrawal by Subject|496|||
131069416|NCT00170950|471884436|FG001|Overall Study|Withdrawal by Subject|498|||
131069417|NCT00170950|471884435|FG000|Overall Study|Lost to Follow-up|134|||
131069418|NCT00170950|471884436|FG001|Overall Study|Lost to Follow-up|115|||
131069419|NCT00170950|471884435|FG000|Overall Study|Missing|2|||
131069420|NCT00170950|471884436|FG001|Overall Study|Missing|1|||
131069421|NCT00170950|471884435|FG000|Overall Study|Termination Data Not Recorded|17|||
131069422|NCT00170950|471884436|FG001|Overall Study|Termination Data Not Recorded|22|||
131069423|NCT00635570|471886109|FG000|Overall Study|Lost to Follow-up|8|||
131069424|NCT00635570|471886110|FG001|Overall Study|Lost to Follow-up|8|||
131069425|NCT00635570|471886109|FG000|Overall Study|Withdrawal by Subject|1|||
131069426|NCT00635570|471886110|FG001|Overall Study|Withdrawal by Subject|1|||
131069427|NCT00635570|471886109|FG000|Overall Study|Adverse Event|2|||
131069428|NCT00635570|471886110|FG001|Overall Study|Adverse Event|0|||
131069429|NCT00635570|471886109|FG000|Overall Study|Physician Decision|1|||
131069430|NCT00635570|471886110|FG001|Overall Study|Physician Decision|0|||
131069431|NCT00635570|471886109|FG000|Overall Study|Did not complete survey|2|||
131069432|NCT00635570|471886110|FG001|Overall Study|Did not complete survey|1|||
131069433|NCT00635570|471886109|FG000|Overall Study|Early termination(No sexual activity)|1|||
131069434|NCT00635570|471886110|FG001|Overall Study|Early termination(No sexual activity)|1|||
131069435|NCT00377312|471886121|FG000|Overall Study|Adverse Event|1|||
131069436|NCT00377312|471886122|FG001|Overall Study|Adverse Event|1|||
131069437|NCT02775214|471886123|FG000|Overall Study|Withdrawal by Subject|2|||
131069438|NCT02775214|471886124|FG001|Overall Study|Withdrawal by Subject|0|||
131069439|NCT00762723|471886125|FG000|Overall Study|Study Terminated slow enrollement|5|||
131069440|NCT00762723|471886126|FG001|Overall Study|Study Terminated slow enrollement|5|||
131069441|NCT00762723|471886127|FG002|Overall Study|Study Terminated slow enrollement|3|||
131069442|NCT01145417|471886128|FG000|Overall Study|Death|1|||
131069443|NCT01145417|471886129|FG001|Overall Study|Death|0|||
131069444|NCT01145417|471886128|FG000|Overall Study|Lost to Follow-up|2|||
131069445|NCT01145417|471886129|FG001|Overall Study|Lost to Follow-up|1|||
131069446|NCT01145417|471886128|FG000|Overall Study|Withdrawal by Subject|1|||
131069447|NCT01145417|471886129|FG001|Overall Study|Withdrawal by Subject|2|||
131069448|NCT01145417|471886128|FG000|Overall Study|Pregnancy|1|||
131069449|NCT01145417|471886129|FG001|Overall Study|Pregnancy|0|||
131069450|NCT01145417|471886128|FG000|Overall Study|Adverse Event|0|||
131069451|NCT01145417|471886129|FG001|Overall Study|Adverse Event|1|||
131069452|NCT01145417|471886128|FG000|Overall Study|Study terminated by sponsor|35|||
131069453|NCT01145417|471886129|FG001|Overall Study|Study terminated by sponsor|43|||
131069454|NCT01145417|471886128|FG000|Overall Study|Other|1|||
131069455|NCT01145417|471886129|FG001|Overall Study|Other|0|||
131069456|NCT01191697|471886130|FG000|Overall Study|Death|1|||
131069457|NCT01191697|471886130|FG000|Overall Study|Physician Decision|2|||
131069458|NCT01191697|471886130|FG000|Overall Study|Pursue chemoradiation|2|||
131069459|NCT01191697|471886130|FG000|Overall Study|Break from chemotherapy|2|||
131069460|NCT01191697|471886130|FG000|Overall Study|Withdrawal by Subject|1|||
131069461|NCT01191697|471886130|FG000|Overall Study|Surveillance|1|||
131069462|NCT01191697|471886130|FG000|Overall Study|Adverse Event|2|||
131069463|NCT01191697|471886130|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
131069464|NCT01191697|471886130|FG000|Overall Study|Not completed but analyzed|25|||
131069465|NCT00396097|471886148|FG000|Overall Study|Withdrawal by Subject|17|||
131069466|NCT00396097|471886149|FG001|Overall Study|Withdrawal by Subject|17|||
130723428|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130723429|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
130723430|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
130723431|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
130723432|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
130723433|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
131069467|NCT00396097|471886148|FG000|Overall Study|Lost to Follow-up|4|||
131069468|NCT00396097|471886149|FG001|Overall Study|Lost to Follow-up|9|||
131069469|NCT00396097|471886148|FG000|Overall Study|Other|3|||
131069470|NCT00396097|471886149|FG001|Overall Study|Other|5|||
131069471|NCT00396097|471886148|FG000|Overall Study|Protocol Violation|0|||
131069472|NCT00396097|471886149|FG001|Overall Study|Protocol Violation|6|||
130723434|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
130723435|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
130723436|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
130723437|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
131069473|NCT00396097|471886148|FG000|Overall Study|Adverse Event|1|||
131069474|NCT00396097|471886149|FG001|Overall Study|Adverse Event|5|||
131069475|NCT00396097|471886148|FG000|Overall Study|Insufficient Clinical Response|1|||
131069476|NCT00396097|471886149|FG001|Overall Study|Insufficient Clinical Response|4|||
131069477|NCT01284634|471886150|FG000|Overall Study|Adverse Event|1|||
131069478|NCT01284634|471886151|FG001|Overall Study|Adverse Event|0|||
131069479|NCT01284634|471886152|FG002|Overall Study|Adverse Event|2|||
131069480|NCT01284634|471886153|FG003|Overall Study|Adverse Event|1|||
131069481|NCT03772041|471886155|FG000|Overall Study|Adverse Event|8|||
131069482|NCT03772041|471886156|FG001|Overall Study|Adverse Event|3|||
131069483|NCT03772041|471886155|FG000|Overall Study|Withdrawal by Subject|0|||
131069484|NCT03772041|471886156|FG001|Overall Study|Withdrawal by Subject|2|||
131069485|NCT03772041|471886155|FG000|Overall Study|Protocol Violation|4|||
131069486|NCT03772041|471886156|FG001|Overall Study|Protocol Violation|2|||
131069487|NCT03772041|471886155|FG000|Overall Study|Physician Decision|2|||
131069488|NCT03772041|471886156|FG001|Overall Study|Physician Decision|3|||
131069489|NCT01525641|471886157|FG000|Overall Study|Case report form not collected|25|||
131069490|NCT01525641|471886157|FG000|Overall Study|No visit since the first visit|16|||
131069491|NCT01525641|471886157|FG000|Overall Study|Adverse Event|73|||
131069492|NCT01525641|471886157|FG000|Overall Study|Lack of Efficacy|24|||
131069493|NCT01525641|471886157|FG000|Overall Study|Improvement|5|||
131069494|NCT01525641|471886157|FG000|Overall Study|Lost to follow-up (relocation)|1|||
131069495|NCT01525641|471886157|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
131069496|NCT01525641|471886157|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
131069497|NCT01525641|471886157|FG000|Overall Study|Other than stated above|7|||
131069498|NCT05012397|471886167|FG000|Overall Study|Death|10|||
131069499|NCT05012397|471886167|FG000|Overall Study|Physician Decision|9|||
131069500|NCT05012397|471886167|FG000|Overall Study|Withdrawal by Subject|5|||
131069501|NCT05012397|471886167|FG000|Overall Study|Lost to Follow-up|2|||
131069502|NCT03334747|471886168|FG000|Treatment Phase|Technical problems|0|||
131069503|NCT03334747|471886169|FG001|Treatment Phase|Technical problems|0|||
131069504|NCT03334747|471886170|FG002|Treatment Phase|Technical problems|0|||
131069505|NCT03334747|471886171|FG003|Treatment Phase|Technical problems|0|||
131069506|NCT03334747|471886172|FG004|Treatment Phase|Technical problems|1|||
131069507|NCT03334747|471886173|FG005|Treatment Phase|Technical problems|0|||
131069508|NCT03334747|471886174|FG006|Treatment Phase|Technical problems|0|||
131069509|NCT03334747|471886175|FG007|Treatment Phase|Technical problems|0|||
131069510|NCT03334747|471886176|FG008|Treatment Phase|Technical problems|0|||
131069511|NCT03334747|471886168|FG000|Treatment Phase|Subject/guardian decision|1|||
131069512|NCT03334747|471886169|FG001|Treatment Phase|Subject/guardian decision|0|||
131069513|NCT03334747|471886170|FG002|Treatment Phase|Subject/guardian decision|0|||
131069514|NCT03334747|471886171|FG003|Treatment Phase|Subject/guardian decision|0|||
131069515|NCT03334747|471886172|FG004|Treatment Phase|Subject/guardian decision|0|||
131069516|NCT03334747|471886173|FG005|Treatment Phase|Subject/guardian decision|1|||
131069517|NCT03334747|471886174|FG006|Treatment Phase|Subject/guardian decision|0|||
131069518|NCT03334747|471886175|FG007|Treatment Phase|Subject/guardian decision|0|||
131069519|NCT03334747|471886176|FG008|Treatment Phase|Subject/guardian decision|0|||
131069520|NCT03334747|471886168|FG000|Follow-Up Phase|Subject/guardian decision|0|||
131069521|NCT03334747|471886169|FG001|Follow-Up Phase|Subject/guardian decision|0|||
131069522|NCT03334747|471886170|FG002|Follow-Up Phase|Subject/guardian decision|0|||
131069523|NCT03334747|471886171|FG003|Follow-Up Phase|Subject/guardian decision|0|||
131069524|NCT03334747|471886172|FG004|Follow-Up Phase|Subject/guardian decision|0|||
131069525|NCT03334747|471886173|FG005|Follow-Up Phase|Subject/guardian decision|0|||
131069526|NCT03334747|471886174|FG006|Follow-Up Phase|Subject/guardian decision|1|||
131069527|NCT03334747|471886175|FG007|Follow-Up Phase|Subject/guardian decision|0|||
131069528|NCT03334747|471886176|FG008|Follow-Up Phase|Subject/guardian decision|1|||
131069529|NCT02567227|471886177|FG000|9 Weeks|Adverse Event|5|||
131069530|NCT02567227|471886178|FG001|9 Weeks|Adverse Event|5|||
131069531|NCT02567227|471886177|FG000|9 Weeks|Withdrawal by Subject|18|||
131069532|NCT02567227|471886178|FG001|9 Weeks|Withdrawal by Subject|8|||
131069533|NCT02567227|471886177|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
131069534|NCT02567227|471886178|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
131069535|NCT02567227|471886177|FG000|6 Month|Death|2|||
131069536|NCT02567227|471886178|FG001|6 Month|Death|0|||
131069537|NCT02567227|471886177|FG000|6 Month|Lost to Follow-up|43|||
131069538|NCT02567227|471886178|FG001|6 Month|Lost to Follow-up|40|||
131069539|NCT02567227|471886177|FG000|12 Months|Lost to Follow-up|31|||
131069540|NCT02567227|471886178|FG001|12 Months|Lost to Follow-up|32|||
131069541|NCT02567227|471886177|FG000|12 Months|Death|0|||
131069542|NCT02567227|471886178|FG001|12 Months|Death|2|||
131069543|NCT02137239|471886179|FG000|Overall Study|Discontinued Study Treatment|0|||
131069544|NCT02137239|471886180|FG001|Overall Study|Discontinued Study Treatment|3|||
131069545|NCT02137239|471886179|FG000|Overall Study|Withdrew Consent|1|||
131069546|NCT02137239|471886180|FG001|Overall Study|Withdrew Consent|1|||
131069547|NCT02137239|471886179|FG000|Overall Study|Adverse Event|2|||
131069548|NCT02137239|471886180|FG001|Overall Study|Adverse Event|2|||
131069549|NCT02498418|471886184|FG000|Overall Study|Lack of Efficacy|0|||
131069550|NCT02498418|471886185|FG001|Overall Study|Lack of Efficacy|0|||
131069551|NCT02498418|471886186|FG002|Overall Study|Lack of Efficacy|1|||
131069552|NCT02498418|471886184|FG000|Overall Study|Withdrawal by Subject|2|||
131069553|NCT02498418|471886185|FG001|Overall Study|Withdrawal by Subject|0|||
131069554|NCT02498418|471886186|FG002|Overall Study|Withdrawal by Subject|3|||
131069555|NCT02498418|471886184|FG000|Overall Study|Lost to Follow-up|0|||
131069556|NCT02498418|471886185|FG001|Overall Study|Lost to Follow-up|1|||
131069557|NCT02498418|471886186|FG002|Overall Study|Lost to Follow-up|1|||
131069558|NCT02498418|471886184|FG000|Overall Study|Participant taken prohibited medication|0|||
131069559|NCT02498418|471886185|FG001|Overall Study|Participant taken prohibited medication|1|||
131069560|NCT02498418|471886186|FG002|Overall Study|Participant taken prohibited medication|1|||
131069561|NCT00762502|471886187|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
131069562|NCT00762502|471886188|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
131069563|NCT00762502|471886189|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
131069564|NCT00762502|471886187|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
131069565|NCT00762502|471886188|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
131069566|NCT00762502|471886189|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
131069567|NCT00762502|471886187|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
131069568|NCT00762502|471886188|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
131069569|NCT00762502|471886189|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
131069570|NCT03042559|471886190|FG000|Overall Study|drop out|1|||
131069571|NCT03042559|471886191|FG001|Overall Study|drop out|1|||
131069572|NCT01485991|471886195|FG000|Overall Study|Adverse Event|0|||
131069573|NCT01485991|471886196|FG001|Overall Study|Adverse Event|4|||
131069574|NCT01485991|471886195|FG000|Overall Study|Lost to Follow-up|13|||
131069575|NCT01485991|471886196|FG001|Overall Study|Lost to Follow-up|10|||
131069576|NCT01485991|471886195|FG000|Overall Study|Withdrawal by Subject|13|||
131069577|NCT01485991|471886196|FG001|Overall Study|Withdrawal by Subject|20|||
131069578|NCT01485991|471886195|FG000|Overall Study|randomized but not treated|6|||
131069579|NCT01485991|471886196|FG001|Overall Study|randomized but not treated|2|||
131069580|NCT00385697|471886197|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
131069581|NCT00385697|471886198|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
131069582|NCT00385697|471886199|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
131069583|NCT00385697|471886200|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
131069584|NCT00385697|471886201|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
131069585|NCT00385697|471886197|FG000|Open-label Segment 1|Lost to Follow-up|1|||
131069586|NCT00385697|471886198|FG001|Open-label Segment 1|Lost to Follow-up|0|||
131069587|NCT00385697|471886199|FG002|Open-label Segment 1|Lost to Follow-up|0|||
131069588|NCT00385697|471886200|FG003|Open-label Segment 1|Lost to Follow-up|0|||
131069589|NCT00385697|471886201|FG004|Open-label Segment 1|Lost to Follow-up|0|||
131069590|NCT00385697|471886197|FG000|Double-blind Segment 2|Adverse Event|0|||
131069591|NCT00385697|471886198|FG001|Double-blind Segment 2|Adverse Event|3|||
131069592|NCT00385697|471886199|FG002|Double-blind Segment 2|Adverse Event|1|||
131069593|NCT00385697|471886200|FG003|Double-blind Segment 2|Adverse Event|0|||
131069594|NCT00385697|471886201|FG004|Double-blind Segment 2|Adverse Event|0|||
131069595|NCT00385697|471886197|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
131069596|NCT00385697|471886198|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
131069597|NCT00385697|471886199|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
131069598|NCT00385697|471886200|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
131069599|NCT00385697|471886201|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
131069600|NCT00385697|471886197|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
131069601|NCT00385697|471886198|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
131069602|NCT00385697|471886199|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
131069603|NCT00385697|471886200|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
131069604|NCT00385697|471886201|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
131069605|NCT00385697|471886197|FG000|Double-blind Segment 2|Other|0|||
131069606|NCT00385697|471886198|FG001|Double-blind Segment 2|Other|2|||
131069607|NCT00385697|471886199|FG002|Double-blind Segment 2|Other|0|||
131069608|NCT00385697|471886200|FG003|Double-blind Segment 2|Other|0|||
131069609|NCT00385697|471886201|FG004|Double-blind Segment 2|Other|0|||
131069610|NCT02538471|471886203|FG000|Overall Study|Progression of disease|2|||
131069611|NCT01475370|471886204|FG000|Overall Study|Exacerbation of primary disease|2|||
131069612|NCT01475370|471886205|FG001|Overall Study|Exacerbation of primary disease|2|||
131069613|NCT01475370|471886206|FG002|Overall Study|Exacerbation of primary disease|2|||
131069614|NCT01475370|471886204|FG000|Overall Study|Study drug administration difficult|0|||
131069615|NCT01475370|471886205|FG001|Overall Study|Study drug administration difficult|1|||
131069616|NCT01475370|471886206|FG002|Overall Study|Study drug administration difficult|1|||
131069617|NCT01475370|471886204|FG000|Overall Study|Other than specified|1|||
131069618|NCT01475370|471886205|FG001|Overall Study|Other than specified|0|||
130723438|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
130723439|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
130723440|NCT04040192|470613443|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
130723441|NCT04040192|470613444|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
130723442|NCT04040192|470613445|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
130723443|NCT01422187|470613450|FG000|Overall Study|Personal reason|1|||
130723444|NCT01422187|470613451|FG001|Overall Study|Personal reason|0|||
130779485|NCT02326272|470819497|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
131069619|NCT01475370|471886206|FG002|Overall Study|Other than specified|0|||
131069620|NCT00084747|471886209|FG000|Overall Study|Relapsed|8|||
131069621|NCT00084747|471886209|FG000|Overall Study|Death|3|||
131069622|NCT00084747|471886209|FG000|Overall Study|Withdrawal by Subject|2|||
131069623|NCT02382406|471886214|FG000|Study Treatment|Disease Progression|8|||
131069624|NCT02382406|471886215|FG001|Study Treatment|Disease Progression|0|||
131069625|NCT02382406|471886216|FG002|Study Treatment|Disease Progression|20|||
131069626|NCT02382406|471886214|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
131069627|NCT02382406|471886215|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
131230654|NCT01144663|472471287|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
131230655|NCT01144663|472471288|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
131069628|NCT02382406|471886216|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
131069629|NCT02382406|471886214|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
131069630|NCT02382406|471886215|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
131069631|NCT02382406|471886216|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
131069632|NCT02382406|471886214|FG000|Study Treatment|symptomatic deterioration|1|||
131069633|NCT02382406|471886215|FG001|Study Treatment|symptomatic deterioration|0|||
131069634|NCT02382406|471886216|FG002|Study Treatment|symptomatic deterioration|1|||
131069635|NCT02382406|471886214|FG000|Study Treatment|Death|0|||
131069636|NCT02382406|471886215|FG001|Study Treatment|Death|0|||
131069637|NCT02382406|471886216|FG002|Study Treatment|Death|2|||
131069638|NCT02382406|471886214|FG000|Follow up|Death|11|||
131069639|NCT02382406|471886215|FG001|Follow up|Death|0|||
131069640|NCT02382406|471886216|FG002|Follow up|Death|19|||
131069641|NCT02382406|471886214|FG000|Follow up|Symptomatic deterioration|1|||
131069642|NCT02382406|471886215|FG001|Follow up|Symptomatic deterioration|0|||
131069643|NCT02382406|471886216|FG002|Follow up|Symptomatic deterioration|1|||
131069644|NCT02382406|471886214|FG000|Follow up|Patient Refused Follow-up|1|||
131069645|NCT02382406|471886215|FG001|Follow up|Patient Refused Follow-up|0|||
131069646|NCT02382406|471886216|FG002|Follow up|Patient Refused Follow-up|0|||
131069647|NCT02382406|471886214|FG000|Follow up|Study Terminated|1|||
131069648|NCT02382406|471886215|FG001|Follow up|Study Terminated|0|||
131069649|NCT02382406|471886216|FG002|Follow up|Study Terminated|8|||
131069650|NCT02382406|471886214|FG000|Follow up|Withdrawal by Subject|0|||
131069651|NCT02382406|471886215|FG001|Follow up|Withdrawal by Subject|0|||
131069652|NCT02382406|471886216|FG002|Follow up|Withdrawal by Subject|2|||
131069653|NCT04543942|471886219|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
131069654|NCT04543942|471886220|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
131069655|NCT04543942|471886219|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
131069656|NCT04543942|471886220|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
131069657|NCT01323309|471886221|FG000|Overall Study|Death|9|||
131069658|NCT01323309|471886222|FG001|Overall Study|Death|15|||
131069659|NCT01323309|471886223|FG002|Overall Study|Death|5|||
131069660|NCT01323309|471886221|FG000|Overall Study|Lost to Follow-up|11|||
131069661|NCT01323309|471886222|FG001|Overall Study|Lost to Follow-up|14|||
131069662|NCT01323309|471886223|FG002|Overall Study|Lost to Follow-up|24|||
131069663|NCT01323309|471886221|FG000|Overall Study|Withdrawal by Subject|14|||
131069664|NCT01323309|471886222|FG001|Overall Study|Withdrawal by Subject|14|||
131069665|NCT01323309|471886223|FG002|Overall Study|Withdrawal by Subject|18|||
131069666|NCT01323309|471886221|FG000|Overall Study|Disease progression|5|||
131069667|NCT01323309|471886222|FG001|Overall Study|Disease progression|11|||
131069668|NCT01323309|471886223|FG002|Overall Study|Disease progression|4|||
131069669|NCT03048058|471886229|FG000|Overall Study|Lost to Follow-up|4|||
131069670|NCT03048058|471886230|FG001|Overall Study|Lost to Follow-up|0|||
131069671|NCT03048058|471886229|FG000|Overall Study|Withdrawal by Subject|0|||
131069672|NCT03048058|471886230|FG001|Overall Study|Withdrawal by Subject|4|||
131069673|NCT00577096|471886243|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
131069674|NCT00577096|471886244|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
131069675|NCT00577096|471886243|FG000|Short Term Participation|Withdrawal by Subject|3|||
131069676|NCT00577096|471886244|FG001|Short Term Participation|Withdrawal by Subject|5|||
131069677|NCT00577096|471886243|FG000|Short Term Participation|Death|1|||
131069678|NCT00577096|471886244|FG001|Short Term Participation|Death|1|||
131069679|NCT00794573|471886250|FG000|Overall Study|Death|3|||
131069680|NCT00794573|471886251|FG001|Overall Study|Death|0|||
131069681|NCT00794573|471886250|FG000|Overall Study|Withdrawal by Subject|9|||
131069682|NCT00794573|471886251|FG001|Overall Study|Withdrawal by Subject|12|||
131069683|NCT00794573|471886250|FG000|Overall Study|Lost to Follow-up|26|||
131069684|NCT00794573|471886251|FG001|Overall Study|Lost to Follow-up|33|||
131230656|NCT01144663|472471289|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
131230657|NCT01144663|472471290|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
131230658|NCT01144663|472471287|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
131069685|NCT02418819|471886257|FG000|Overall Study|Adverse Event|0|||
131069686|NCT02418819|471886258|FG001|Overall Study|Adverse Event|0|||
131069687|NCT02418819|471886259|FG002|Overall Study|Adverse Event|1|||
131069688|NCT02418819|471886260|FG003|Overall Study|Adverse Event|0|||
131069689|NCT02418819|471886257|FG000|Overall Study|Lost to Follow-up|1|||
131069690|NCT02418819|471886258|FG001|Overall Study|Lost to Follow-up|0|||
131069691|NCT02418819|471886259|FG002|Overall Study|Lost to Follow-up|0|||
131069692|NCT02418819|471886260|FG003|Overall Study|Lost to Follow-up|0|||
131069693|NCT02418819|471886257|FG000|Overall Study|No longer meets eligibility criteria|0|||
131069694|NCT02418819|471886258|FG001|Overall Study|No longer meets eligibility criteria|0|||
131069695|NCT02418819|471886259|FG002|Overall Study|No longer meets eligibility criteria|1|||
131069696|NCT02418819|471886260|FG003|Overall Study|No longer meets eligibility criteria|0|||
131069697|NCT02418819|471886257|FG000|Overall Study|No longer willing to participate|0|||
131069698|NCT02418819|471886258|FG001|Overall Study|No longer willing to participate|0|||
131069699|NCT02418819|471886259|FG002|Overall Study|No longer willing to participate|2|||
131069700|NCT02418819|471886260|FG003|Overall Study|No longer willing to participate|1|||
131069701|NCT01721759|471886261|FG000|Treatment Period|Disease Progression|85|||
130723445|NCT01422187|470613452|FG002|Overall Study|Personal reason|0|||
130723446|NCT01422187|470613450|FG000|Overall Study|Lost to Follow-up|0|||
130723447|NCT01422187|470613451|FG001|Overall Study|Lost to Follow-up|1|||
130723448|NCT01422187|470613452|FG002|Overall Study|Lost to Follow-up|0|||
130723449|NCT02227446|470613453|FG000|Overall Study|not eligible post randomization|18|||
130723450|NCT02227446|470613454|FG001|Overall Study|not eligible post randomization|29|||
130723451|NCT02227446|470613453|FG000|Overall Study|Withdrawal by Subject|4|||
130723452|NCT02227446|470613454|FG001|Overall Study|Withdrawal by Subject|5|||
130723453|NCT00875797|470613455|FG000|Overall Study|Protocol Violation|6|||
130723454|NCT00875797|470613456|FG001|Overall Study|Protocol Violation|3|||
130723455|NCT00715624|470613457|FG000|Overall Study|Adverse Event|12|||
130723456|NCT00715624|470613458|FG001|Overall Study|Adverse Event|37|||
130723457|NCT00715624|470613457|FG000|Overall Study|Lack of Efficacy|11|||
130723458|NCT00715624|470613458|FG001|Overall Study|Lack of Efficacy|11|||
130723459|NCT00715624|470613457|FG000|Overall Study|Lost to Follow-up|1|||
130723460|NCT00715624|470613458|FG001|Overall Study|Lost to Follow-up|2|||
130723461|NCT00715624|470613457|FG000|Overall Study|Protocol Violation|1|||
130723462|NCT00715624|470613458|FG001|Overall Study|Protocol Violation|0|||
130723463|NCT00715624|470613457|FG000|Overall Study|Withdrawal by Subject|11|||
130723464|NCT00715624|470613458|FG001|Overall Study|Withdrawal by Subject|25|||
130723465|NCT00715624|470613457|FG000|Overall Study|Familial and personal reasons|10|||
130723466|NCT00715624|470613458|FG001|Overall Study|Familial and personal reasons|22|||
130723467|NCT00715624|470613457|FG000|Overall Study|Poor compliance|6|||
130723468|NCT00715624|470613458|FG001|Overall Study|Poor compliance|13|||
130723469|NCT00715624|470613457|FG000|Overall Study|Sponsor decision|0|||
130723470|NCT00715624|470613458|FG001|Overall Study|Sponsor decision|4|||
130723471|NCT00715624|470613457|FG000|Overall Study|Incorrect randomization (not treated)|0|||
130723472|NCT00715624|470613458|FG001|Overall Study|Incorrect randomization (not treated)|1|||
131069702|NCT01721759|471886261|FG000|Treatment Period|Study drug toxicity|14|||
131069703|NCT01721759|471886261|FG000|Treatment Period|Death|1|||
131069704|NCT01721759|471886261|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
131069705|NCT01721759|471886261|FG000|Treatment Period|Participant request to withdraw|3|||
131069706|NCT01721759|471886261|FG000|Treatment Period|Other Reasons|3|||
131069707|NCT01721759|471886261|FG000|End of Study Period|Participant Withdrew Consent|5|||
131069708|NCT01721759|471886261|FG000|End of Study Period|Death|101|||
131069709|NCT01721759|471886261|FG000|End of Study Period|Lost to Follow-up|1|||
131069710|NCT01721759|471886261|FG000|End of Study Period|Other Reasons|10|||
131069711|NCT00390806|471886262|FG000|Overall Study|Lost to Follow-up|7|||
131069712|NCT00390806|471886263|FG001|Overall Study|Lost to Follow-up|6|||
131069713|NCT00390806|471886262|FG000|Overall Study|Protocol Violation|2|||
131069714|NCT00390806|471886263|FG001|Overall Study|Protocol Violation|2|||
131069715|NCT00390806|471886262|FG000|Overall Study|Withdrawal by Subject|12|||
131069716|NCT00390806|471886263|FG001|Overall Study|Withdrawal by Subject|15|||
131069717|NCT00390806|471886262|FG000|Overall Study|Investigator Decision|4|||
131069718|NCT00390806|471886263|FG001|Overall Study|Investigator Decision|6|||
131069719|NCT00390806|471886262|FG000|Overall Study|Death|1|||
131069720|NCT00390806|471886263|FG001|Overall Study|Death|0|||
131069721|NCT00390806|471886262|FG000|Overall Study|Physician Decision|0|||
131069722|NCT00390806|471886263|FG001|Overall Study|Physician Decision|1|||
131069723|NCT00390806|471886262|FG000|Overall Study|Ongoing|4|||
131069724|NCT00390806|471886263|FG001|Overall Study|Ongoing|2|||
131069725|NCT00714688|471886267|FG000|Overall Study|Lack of Efficacy|14|||
131069726|NCT00714688|471886268|FG001|Overall Study|Lack of Efficacy|1|||
131069727|NCT00714688|471886269|FG002|Overall Study|Lack of Efficacy|4|||
131069728|NCT00714688|471886267|FG000|Overall Study|Withdrawal by Subject|4|||
131069729|NCT00714688|471886268|FG001|Overall Study|Withdrawal by Subject|3|||
131069730|NCT00714688|471886269|FG002|Overall Study|Withdrawal by Subject|3|||
130723473|NCT00715624|470613457|FG000|Overall Study|Other|0|||
130723474|NCT00715624|470613458|FG001|Overall Study|Other|1|||
130723475|NCT00229723|470613459|FG000|Concomitant Phase|Adverse Event|4|||
130723476|NCT00229723|470613460|FG001|Concomitant Phase|Adverse Event|2|||
130723477|NCT00229723|470613461|FG002|Concomitant Phase|Adverse Event|5|||
131069731|NCT00714688|471886267|FG000|Overall Study|Lost to Follow-up|5|||
131069732|NCT00714688|471886268|FG001|Overall Study|Lost to Follow-up|2|||
131069733|NCT00714688|471886269|FG002|Overall Study|Lost to Follow-up|0|||
131069734|NCT00714688|471886267|FG000|Overall Study|Adverse Event|2|||
131069735|NCT00714688|471886268|FG001|Overall Study|Adverse Event|15|||
131069736|NCT00714688|471886269|FG002|Overall Study|Adverse Event|19|||
131069737|NCT00714688|471886267|FG000|Overall Study|Subject Non-compliant|3|||
131069738|NCT00714688|471886268|FG001|Overall Study|Subject Non-compliant|5|||
131069739|NCT00714688|471886269|FG002|Overall Study|Subject Non-compliant|5|||
131069740|NCT00714688|471886267|FG000|Overall Study|Ineligible to Continue the Study|0|||
131069741|NCT00714688|471886268|FG001|Overall Study|Ineligible to Continue the Study|1|||
131069742|NCT00714688|471886269|FG002|Overall Study|Ineligible to Continue the Study|1|||
131069743|NCT00714688|471886267|FG000|Overall Study|Sponsor's Decision|0|||
131069744|NCT00714688|471886268|FG001|Overall Study|Sponsor's Decision|2|||
131069745|NCT00714688|471886269|FG002|Overall Study|Sponsor's Decision|0|||
131069746|NCT00714688|471886267|FG000|Overall Study|Other|1|||
131069747|NCT00714688|471886268|FG001|Overall Study|Other|6|||
131069748|NCT00714688|471886269|FG002|Overall Study|Other|5|||
131069749|NCT01808144|471886271|FG000|Overall Study|Death|1|||
131069750|NCT01808144|471886272|FG001|Overall Study|Death|0|||
131069751|NCT01808144|471886271|FG000|Overall Study|Withdrawal by Subject|16|||
131069752|NCT01808144|471886272|FG001|Overall Study|Withdrawal by Subject|23|||
131069753|NCT01808144|471886271|FG000|Overall Study|Lost to Follow-up|6|||
131069754|NCT01808144|471886272|FG001|Overall Study|Lost to Follow-up|3|||
131069755|NCT01808144|471886271|FG000|Overall Study|Protocol Violation|6|||
131069756|NCT01808144|471886272|FG001|Overall Study|Protocol Violation|6|||
131069757|NCT01808144|471886271|FG000|Overall Study|Gout flare|0|||
131069758|NCT01808144|471886272|FG001|Overall Study|Gout flare|1|||
131069759|NCT01808144|471886271|FG000|Overall Study|Adverse Event|11|||
131069760|NCT01808144|471886272|FG001|Overall Study|Adverse Event|15|||
131069761|NCT00383500|471886273|FG000|Overall Study|Withdrawal by Subject|8|||
131069762|NCT00383500|471886274|FG001|Overall Study|Withdrawal by Subject|3|||
131069763|NCT00383500|471886275|FG002|Overall Study|Withdrawal by Subject|0|||
131069764|NCT00383500|471886273|FG000|Overall Study|Lost to Follow-up|0|||
131069765|NCT00383500|471886274|FG001|Overall Study|Lost to Follow-up|0|||
131069766|NCT00383500|471886275|FG002|Overall Study|Lost to Follow-up|2|||
131069767|NCT00925288|471887844|FG000|Overall Study|Lost to Follow-up|9|||
131069768|NCT00925288|471887845|FG001|Overall Study|Lost to Follow-up|7|||
131069769|NCT02176356|471887846|FG000|Overall Study|Screen Failure|14|||
131069770|NCT02176356|471887846|FG000|Overall Study|Lost to Follow-up|4|||
131069771|NCT02176356|471887846|FG000|Overall Study|Personal Reasons|3|||
131069772|NCT02176356|471887846|FG000|Overall Study|Other Miscellaneous Reasons|2|||
131069773|NCT00332488|471887847|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
131069774|NCT00332488|471887848|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
131069775|NCT00332488|471887849|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
131069776|NCT00332488|471887847|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
131069777|NCT00332488|471887848|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
131069778|NCT00332488|471887849|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
131069779|NCT00332488|471887847|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
131069780|NCT00332488|471887848|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
131069781|NCT00332488|471887849|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
131069782|NCT00332488|471887847|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
131069783|NCT00332488|471887848|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
131069784|NCT00332488|471887849|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
131069785|NCT00332488|471887847|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
131069786|NCT00332488|471887848|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
131069787|NCT00332488|471887849|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
131069788|NCT00332488|471887847|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
131069789|NCT00332488|471887848|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
131069790|NCT00332488|471887849|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
131069791|NCT00332488|471887847|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
131069792|NCT00332488|471887848|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
131230659|NCT01144663|472471288|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
131230660|NCT01144663|472471289|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
131230661|NCT01144663|472471290|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
131230662|NCT01144663|472471287|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
131069793|NCT00332488|471887849|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
131230663|NCT01144663|472471288|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
130723478|NCT00229723|470613462|FG003|Concomitant Phase|Adverse Event|2|||
130723479|NCT00229723|470613463|FG004|Concomitant Phase|Adverse Event|0|||
130723480|NCT00229723|470613464|FG005|Concomitant Phase|Adverse Event|1|||
130723481|NCT00229723|470613465|FG006|Concomitant Phase|Adverse Event|2|||
131069794|NCT00332488|471887847|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
131069795|NCT00332488|471887848|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
131069796|NCT00332488|471887849|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
131069797|NCT00332488|471887847|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
131069798|NCT00332488|471887848|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
131069799|NCT00332488|471887849|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
131069800|NCT00332488|471887847|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
131069801|NCT00332488|471887848|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
131069802|NCT00332488|471887849|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
131069803|NCT00332488|471887847|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
131069804|NCT00332488|471887848|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
131069805|NCT00332488|471887849|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
130779486|NCT02326272|470819498|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131069806|NCT00332488|471887847|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
131069807|NCT00332488|471887848|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
131069808|NCT00332488|471887849|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
131069809|NCT00371462|471887850|FG000|Overall Study|Withdrawal by Subject|1|||
131069810|NCT00371462|471887851|FG001|Overall Study|Withdrawal by Subject|0|||
131069811|NCT00371462|471887850|FG000|Overall Study|Other|7|||
131069812|NCT00371462|471887851|FG001|Overall Study|Other|8|||
131069813|NCT02507687|471887852|FG000|Overall Study|Adverse Event|3|||
131069814|NCT02507687|471887853|FG001|Overall Study|Adverse Event|2|||
131069815|NCT02507687|471887854|FG002|Overall Study|Adverse Event|2|||
131069816|NCT02507687|471887855|FG003|Overall Study|Adverse Event|2|||
131069817|NCT02507687|471887852|FG000|Overall Study|Withdrawal by Subject|1|||
131069818|NCT02507687|471887853|FG001|Overall Study|Withdrawal by Subject|4|||
131069819|NCT02507687|471887854|FG002|Overall Study|Withdrawal by Subject|6|||
131069820|NCT02507687|471887855|FG003|Overall Study|Withdrawal by Subject|6|||
131069821|NCT02507687|471887852|FG000|Overall Study|Protocol Violation|1|||
131069822|NCT02507687|471887853|FG001|Overall Study|Protocol Violation|0|||
131069823|NCT02507687|471887854|FG002|Overall Study|Protocol Violation|2|||
131069824|NCT02507687|471887855|FG003|Overall Study|Protocol Violation|0|||
131069825|NCT02507687|471887852|FG000|Overall Study|Lost to Follow-up|0|||
131069826|NCT02507687|471887853|FG001|Overall Study|Lost to Follow-up|0|||
131069827|NCT02507687|471887854|FG002|Overall Study|Lost to Follow-up|2|||
131069828|NCT02507687|471887855|FG003|Overall Study|Lost to Follow-up|1|||
131069829|NCT02507687|471887852|FG000|Overall Study|Screen Failure|0|||
131069830|NCT02507687|471887853|FG001|Overall Study|Screen Failure|0|||
131069831|NCT02507687|471887854|FG002|Overall Study|Screen Failure|1|||
131069832|NCT02507687|471887855|FG003|Overall Study|Screen Failure|0|||
131069833|NCT02507687|471887852|FG000|Overall Study|Other, Not Specified|0|||
131069834|NCT02507687|471887853|FG001|Overall Study|Other, Not Specified|0|||
131069835|NCT02507687|471887854|FG002|Overall Study|Other, Not Specified|2|||
131069836|NCT02507687|471887855|FG003|Overall Study|Other, Not Specified|4|||
131069837|NCT05372913|471887860|FG000|Overall Study|Withdrawal by Subject|0|||
131069838|NCT05372913|471887861|FG001|Overall Study|Withdrawal by Subject|2|||
131069839|NCT05372913|471887860|FG000|Overall Study|Protocol Violation|2|||
131069840|NCT05372913|471887861|FG001|Overall Study|Protocol Violation|2|||
131069841|NCT05372913|471887860|FG000|Overall Study|Adverse Event|0|||
131069842|NCT05372913|471887861|FG001|Overall Study|Adverse Event|1|||
131069843|NCT03275402|471887862|FG000|Overall Study|Death|17|||
131069844|NCT03275402|471887862|FG000|Overall Study|Study terminated by sponsor|21|||
131069845|NCT03275402|471887862|FG000|Overall Study|Withdrawal by Subject|1|||
131069846|NCT05135156|471887863|FG000|Overall Study|Lost to Follow-up|0|||
131069847|NCT05135156|471887864|FG001|Overall Study|Lost to Follow-up|0|||
131069848|NCT05135156|471887865|FG002|Overall Study|Lost to Follow-up|2|||
131069849|NCT02986659|471887866|FG000|First Intervention Period|Adverse Event|3|||
131069850|NCT02986659|471887867|FG001|First Intervention Period|Adverse Event|1|||
131069851|NCT02986659|471887866|FG000|First Intervention Period|Lost to Follow-up|1|||
131069852|NCT02986659|471887867|FG001|First Intervention Period|Lost to Follow-up|0|||
131069853|NCT02986659|471887866|FG000|First Intervention Period|Withdrawal by Subject|0|||
131069854|NCT02986659|471887867|FG001|First Intervention Period|Withdrawal by Subject|1|||
131069855|NCT02986659|471887866|FG000|Second Intervention Period|Adverse Event|0|||
131069856|NCT02986659|471887867|FG001|Second Intervention Period|Adverse Event|6|||
131069857|NCT03461211|471887873|FG000|Overall Study|Adverse Event|1|||
131069858|NCT03461211|471887874|FG001|Overall Study|Adverse Event|1|||
131069859|NCT03461211|471887873|FG000|Overall Study|Lack of Efficacy|0|||
131230664|NCT01144663|472471289|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
130779487|NCT02326272|470819499|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130779488|NCT02326272|470819500|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131069860|NCT03461211|471887874|FG001|Overall Study|Lack of Efficacy|1|||
131069861|NCT01059526|471887875|FG000|Overall Study|Patient enrolled but not treated|20|||
131069862|NCT01059526|471887876|FG001|Overall Study|Patient enrolled but not treated|17|||
131069863|NCT01059526|471887875|FG000|Overall Study|Adverse Event|2|||
131069864|NCT01059526|471887876|FG001|Overall Study|Adverse Event|2|||
131069865|NCT01059526|471887875|FG000|Overall Study|Protocol Violation|0|||
131069866|NCT01059526|471887876|FG001|Overall Study|Protocol Violation|1|||
131069867|NCT01059526|471887875|FG000|Overall Study|Withdrawal by Subject|3|||
131069868|NCT01059526|471887876|FG001|Overall Study|Withdrawal by Subject|1|||
131069869|NCT01059526|471887875|FG000|Overall Study|Lost to Follow-up|4|||
131069870|NCT01059526|471887876|FG001|Overall Study|Lost to Follow-up|1|||
131069871|NCT01059526|471887875|FG000|Overall Study|Patient found to be dermatographic|1|||
131069872|NCT01059526|471887876|FG001|Overall Study|Patient found to be dermatographic|0|||
131069873|NCT02720081|471887877|FG000|Overall Study|Adverse Event|0|||
131069874|NCT02720081|471887878|FG001|Overall Study|Adverse Event|3|||
131069875|NCT02720081|471887877|FG000|Overall Study|Protocol Violation|4|||
131069876|NCT02720081|471887878|FG001|Overall Study|Protocol Violation|1|||
131069877|NCT02005029|471887880|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
131069878|NCT02005029|471887881|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
131069879|NCT01370018|471887882|FG000|Overall Study|Did not meet criteria for analysis|1|||
131069880|NCT01536535|471887886|FG000|Overall Study|Withdrawal by Subject|10|||
131069881|NCT01536535|471887887|FG001|Overall Study|Withdrawal by Subject|5|||
131069882|NCT01536535|471887886|FG000|Overall Study|Lost to Follow-up|4|||
131069883|NCT01536535|471887887|FG001|Overall Study|Lost to Follow-up|6|||
131069884|NCT01536535|471887886|FG000|Overall Study|Physician Decision|1|||
131069885|NCT01536535|471887887|FG001|Overall Study|Physician Decision|1|||
131069886|NCT01536535|471887886|FG000|Overall Study|Participant moved|0|||
131069887|NCT01536535|471887887|FG001|Overall Study|Participant moved|1|||
131069888|NCT03794609|471887889|FG000|Overall Study|Other|10|||
131069889|NCT03794609|471887889|FG000|Overall Study|Withdrawal by Subject|66|||
131069890|NCT03794609|471887889|FG000|Overall Study|The child is enrolled in an interventional study|70|||
131069891|NCT03794609|471887889|FG000|Overall Study|Inclusion/exclusion criteria|8|||
131230665|NCT01144663|472471290|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
131230666|NCT01144663|472471287|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
131230667|NCT01144663|472471288|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
131230668|NCT01144663|472471289|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
131230669|NCT01144663|472471290|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
131230670|NCT01335477|472471292|FG000|Overall Study|Adverse Event|30|||
131230671|NCT01335477|472471293|FG001|Overall Study|Adverse Event|42|||
131230672|NCT01335477|472471292|FG000|Overall Study|Non compliant with protocol|0|||
131230673|NCT01335477|472471293|FG001|Overall Study|Non compliant with protocol|2|||
131230674|NCT01335477|472471292|FG000|Overall Study|Lost to Follow-up|1|||
131230675|NCT01335477|472471293|FG001|Overall Study|Lost to Follow-up|2|||
131230676|NCT01335477|472471292|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
131230677|NCT01335477|472471293|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
131230678|NCT01335477|472471292|FG000|Overall Study|Not treated|1|||
131230679|NCT01335477|472471293|FG001|Overall Study|Not treated|2|||
131230680|NCT01335477|472471292|FG000|Overall Study|Reason other than those stated above|2|||
131230681|NCT01335477|472471293|FG001|Overall Study|Reason other than those stated above|2|||
131230682|NCT02497391|472471298|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
131230683|NCT02497391|472471299|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
131230684|NCT02497391|472471300|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
131230685|NCT02497391|472471301|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
131230686|NCT02497391|472471302|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
131230687|NCT02497391|472471303|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
131230688|NCT02497391|472471298|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
131230689|NCT02497391|472471299|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
131069892|NCT03794609|471887889|FG000|Overall Study|At sponsor's request|151|||
131069893|NCT03794609|471887889|FG000|Overall Study|Physician Decision|1|||
131069894|NCT03794609|471887889|FG000|Overall Study|Lost to Follow-up|5|||
131069895|NCT04474691|471887896|FG000|Overall Study|Withdrawal by Subject|9|||
131069896|NCT00139659|471887897|FG000|Overall Study|Adverse Event|12|||
131069897|NCT00139659|471887898|FG001|Overall Study|Adverse Event|1|||
131069898|NCT00139659|471887897|FG000|Overall Study|Lack of Efficacy|1|||
131069899|NCT00139659|471887898|FG001|Overall Study|Lack of Efficacy|1|||
131069900|NCT00139659|471887897|FG000|Overall Study|Lost to Follow-up|7|||
131069901|NCT00139659|471887898|FG001|Overall Study|Lost to Follow-up|3|||
131069902|NCT00139659|471887897|FG000|Overall Study|Reason not Specified|6|||
131069903|NCT00139659|471887898|FG001|Overall Study|Reason not Specified|3|||
131069904|NCT00139659|471887897|FG000|Overall Study|Withdrawal by Subject|14|||
131069905|NCT00139659|471887898|FG001|Overall Study|Withdrawal by Subject|10|||
131069906|NCT02625922|471887900|FG000|Overall Study|Non-availability of IMP|1|||
131069907|NCT02625922|471887901|FG001|Overall Study|Non-availability of IMP|1|||
131069908|NCT02625922|471887900|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
131069909|NCT02625922|471887901|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
131069910|NCT02391116|471887902|FG000|Treatment|Withdrawal by Subject|1|||
131069911|NCT02391116|471887902|FG000|Treatment|Protocol Violation|1|||
131069912|NCT02391116|471887902|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
131230690|NCT02497391|472471300|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
131230691|NCT02497391|472471301|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
131230692|NCT02497391|472471302|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
131230693|NCT02497391|472471303|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
131230694|NCT02497391|472471298|FG000|Period 3 (14 Days)|Adverse Event|0|||
131230695|NCT02497391|472471299|FG001|Period 3 (14 Days)|Adverse Event|1|||
131069913|NCT02391116|471887902|FG000|Treatment|AE with Clinical PD|3|||
131069914|NCT02391116|471887902|FG000|Safety Follow-up|Adverse Event|1|||
131069915|NCT02391116|471887902|FG000|Safety Follow-up|Withdrawal by Subject|4|||
131069916|NCT02391116|471887902|FG000|Safety Follow-up|Switching to Other Therapy|4|||
131069917|NCT02391116|471887902|FG000|Safety Follow-up|No Follow Up|1|||
131069918|NCT02391116|471887902|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
131069919|NCT02391116|471887902|FG000|Active Follow-up|Withdrawal by Subject|1|||
131069920|NCT02391116|471887902|FG000|Active Follow-up|Switching to Other Therapy|2|||
131230696|NCT02497391|472471300|FG002|Period 3 (14 Days)|Adverse Event|0|||
131069921|NCT02391116|471887902|FG000|Survival Follow-up|Withdrawal by Subject|3|||
131069922|NCT02391116|471887902|FG000|Survival Follow-up|Switching to Other Therapy|1|||
131069923|NCT01747629|471887903|FG000|Overall Study|Adverse Event|1|||
131069924|NCT01747629|471887904|FG001|Overall Study|Adverse Event|2|||
131069925|NCT01747629|471887903|FG000|Overall Study|Withdrawal by Subject|2|||
131069926|NCT01747629|471887904|FG001|Overall Study|Withdrawal by Subject|2|||
131069927|NCT01747629|471887903|FG000|Overall Study|Noncompliance|1|||
131069928|NCT01747629|471887904|FG001|Overall Study|Noncompliance|1|||
131069929|NCT01747629|471887903|FG000|Overall Study|Inclusion criteria not met|1|||
131069930|NCT01747629|471887904|FG001|Overall Study|Inclusion criteria not met|0|||
131069931|NCT01747629|471887903|FG000|Overall Study|Not treated|1|||
131069932|NCT01747629|471887904|FG001|Overall Study|Not treated|0|||
131069933|NCT01747629|471887903|FG000|Overall Study|Other|2|||
131069934|NCT01747629|471887904|FG001|Overall Study|Other|1|||
131069935|NCT04414397|471887905|FG000|Control Period|Withdrawal by Subject|2|||
131069936|NCT04414397|471887906|FG001|Control Period|Withdrawal by Subject|2|||
131069937|NCT04414397|471887905|FG000|Control Period|Lost to Follow-up|0|||
131069938|NCT04414397|471887906|FG001|Control Period|Lost to Follow-up|4|||
131069939|NCT04414397|471887905|FG000|Control Period|Protocol deviation|0|||
131069940|NCT04414397|471887906|FG001|Control Period|Protocol deviation|1|||
131069941|NCT04414397|471887905|FG000|Post-Control Period|Withdrawal by Subject|3|||
131069942|NCT04414397|471887906|FG001|Post-Control Period|Withdrawal by Subject|6|||
131069943|NCT04414397|471887905|FG000|Post-Control Period|Lost to Follow-up|4|||
131069944|NCT04414397|471887906|FG001|Post-Control Period|Lost to Follow-up|9|||
131069945|NCT04414397|471887905|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
131069946|NCT04414397|471887906|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
131069947|NCT04414397|471887905|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
131069948|NCT04414397|471887906|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
131069949|NCT01920178|471887910|FG000|Overall Study|Lost to Follow-up|2|||
131069950|NCT01920178|471887911|FG001|Overall Study|Lost to Follow-up|1|||
131069951|NCT01261793|471887914|FG000|Overall Study|Lack of Efficacy|44|||
131069952|NCT01261793|471887915|FG001|Overall Study|Lack of Efficacy|37|||
131069953|NCT01261793|471887916|FG002|Overall Study|Lack of Efficacy|32|||
131069954|NCT01261793|471887914|FG000|Overall Study|Protocol Violation|3|||
131069955|NCT01261793|471887915|FG001|Overall Study|Protocol Violation|5|||
131069956|NCT01261793|471887916|FG002|Overall Study|Protocol Violation|6|||
131069957|NCT01261793|471887914|FG000|Overall Study|Lost to Follow-up|10|||
131069958|NCT01261793|471887915|FG001|Overall Study|Lost to Follow-up|3|||
131069959|NCT01261793|471887916|FG002|Overall Study|Lost to Follow-up|7|||
131069960|NCT01261793|471887914|FG000|Overall Study|Withdrawal by Subject|12|||
131069961|NCT01261793|471887915|FG001|Overall Study|Withdrawal by Subject|14|||
131069962|NCT01261793|471887916|FG002|Overall Study|Withdrawal by Subject|14|||
131069963|NCT01261793|471887914|FG000|Overall Study|Death|3|||
131069964|NCT01261793|471887915|FG001|Overall Study|Death|1|||
131069965|NCT01261793|471887916|FG002|Overall Study|Death|0|||
131069966|NCT01261793|471887914|FG000|Overall Study|Adverse Event|9|||
131069967|NCT01261793|471887915|FG001|Overall Study|Adverse Event|24|||
131069968|NCT01261793|471887916|FG002|Overall Study|Adverse Event|19|||
131069969|NCT01261793|471887914|FG000|Overall Study|Patient non-availability|1|||
131069970|NCT01261793|471887915|FG001|Overall Study|Patient non-availability|1|||
131069971|NCT01261793|471887916|FG002|Overall Study|Patient non-availability|1|||
131069972|NCT01261793|471887914|FG000|Overall Study|Suspected pregnancy|1|||
131069973|NCT01261793|471887915|FG001|Overall Study|Suspected pregnancy|1|||
131069974|NCT01261793|471887916|FG002|Overall Study|Suspected pregnancy|0|||
131069975|NCT01261793|471887914|FG000|Overall Study|Patient non-compliance|1|||
131069976|NCT01261793|471887915|FG001|Overall Study|Patient non-compliance|0|||
131069977|NCT01261793|471887916|FG002|Overall Study|Patient non-compliance|1|||
131069978|NCT01261793|471887914|FG000|Overall Study|Patient pregnant|1|||
131069979|NCT01261793|471887915|FG001|Overall Study|Patient pregnant|0|||
131069980|NCT01261793|471887916|FG002|Overall Study|Patient pregnant|0|||
131069981|NCT01261793|471887914|FG000|Overall Study|Outside the study area|0|||
131069982|NCT01261793|471887915|FG001|Overall Study|Outside the study area|2|||
131069983|NCT01261793|471887916|FG002|Overall Study|Outside the study area|1|||
131069984|NCT01261793|471887914|FG000|Overall Study|Lack of efficacy & patient not available|0|||
131069985|NCT01261793|471887915|FG001|Overall Study|Lack of efficacy & patient not available|1|||
131230697|NCT02497391|472471301|FG003|Period 3 (14 Days)|Adverse Event|0|||
131069986|NCT01261793|471887916|FG002|Overall Study|Lack of efficacy & patient not available|0|||
131069987|NCT01261793|471887914|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
131069988|NCT01261793|471887915|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
131069989|NCT01261793|471887916|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
131069990|NCT01261793|471887914|FG000|Overall Study|Randomization error|0|||
131069991|NCT01261793|471887915|FG001|Overall Study|Randomization error|1|||
131069992|NCT01261793|471887916|FG002|Overall Study|Randomization error|0|||
131069993|NCT01261793|471887914|FG000|Overall Study|Patient unable to start IV line|0|||
131069994|NCT01261793|471887915|FG001|Overall Study|Patient unable to start IV line|0|||
131069995|NCT01261793|471887916|FG002|Overall Study|Patient unable to start IV line|1|||
131069996|NCT00832650|471887917|FG000|Overall Study|Randomized but not treated|0|||
130723482|NCT00229723|470613459|FG000|Concomitant Phase|Objective disease progression|0|||
131069997|NCT00832650|471887918|FG001|Overall Study|Randomized but not treated|0|||
131069998|NCT00832650|471887919|FG002|Overall Study|Randomized but not treated|1|||
131069999|NCT03562117|471887920|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
131070000|NCT03562117|471887921|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
131070001|NCT03562117|471887922|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
131070002|NCT01294358|471887923|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
131070003|NCT01294358|471887924|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
131070004|NCT01294358|471887925|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
131070005|NCT01294358|471887926|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
131070006|NCT01294358|471887927|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
131070007|NCT01294358|471887923|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
131070008|NCT01294358|471887924|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
131070009|NCT01294358|471887925|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
131070010|NCT01294358|471887926|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
131070011|NCT01294358|471887927|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
131070012|NCT01294358|471887923|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
131070013|NCT01294358|471887924|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
131070014|NCT01294358|471887925|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
131070015|NCT01294358|471887926|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
131070016|NCT01294358|471887927|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
131070017|NCT01294358|471887923|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
131070018|NCT01294358|471887924|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
131070019|NCT01294358|471887925|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
131070020|NCT01294358|471887926|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
131070021|NCT01294358|471887927|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
131070022|NCT02784535|471887934|FG000|Overall Study|Adverse Event|1|||
131070023|NCT02784535|471887935|FG001|Overall Study|Adverse Event|0|||
131070024|NCT02784535|471887934|FG000|Overall Study|Withdrawal by Subject|0|||
131070025|NCT02784535|471887935|FG001|Overall Study|Withdrawal by Subject|1|||
131070026|NCT02784535|471887934|FG000|Overall Study|Physician Decision|0|||
131070027|NCT02784535|471887935|FG001|Overall Study|Physician Decision|1|||
131070028|NCT02335242|471887940|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
131070029|NCT02335242|471887941|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
131070030|NCT02335242|471887940|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
131070031|NCT02335242|471887941|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
131070032|NCT02335242|471887940|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
131070033|NCT02335242|471887941|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
131070034|NCT03740919|471887942|FG000|Lead-in Period|Lost to Follow-up|1|||
131070035|NCT03740919|471887943|FG001|Lead-in Period|Lost to Follow-up|0|||
131070036|NCT03740919|471887944|FG002|Lead-in Period|Lost to Follow-up|0|||
131070037|NCT03740919|471887945|FG003|Lead-in Period|Lost to Follow-up|0|||
131070038|NCT03740919|471887942|FG000|Lead-in Period|Physician Decision|2|||
131070039|NCT03740919|471887943|FG001|Lead-in Period|Physician Decision|0|||
131070040|NCT03740919|471887944|FG002|Lead-in Period|Physician Decision|0|||
131070041|NCT03740919|471887945|FG003|Lead-in Period|Physician Decision|0|||
131070042|NCT03740919|471887942|FG000|Lead-in Period|Protocol Violation|1|||
131070043|NCT03740919|471887943|FG001|Lead-in Period|Protocol Violation|0|||
131070044|NCT03740919|471887944|FG002|Lead-in Period|Protocol Violation|0|||
131070045|NCT03740919|471887945|FG003|Lead-in Period|Protocol Violation|0|||
131070046|NCT03740919|471887942|FG000|Lead-in Period|Withdrawal by Subject|10|||
131070047|NCT03740919|471887943|FG001|Lead-in Period|Withdrawal by Subject|0|||
131070048|NCT03740919|471887944|FG002|Lead-in Period|Withdrawal by Subject|0|||
131070049|NCT03740919|471887945|FG003|Lead-in Period|Withdrawal by Subject|0|||
131070050|NCT03740919|471887942|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
131070051|NCT03740919|471887943|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
131070052|NCT03740919|471887944|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
131070053|NCT03740919|471887945|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
130723483|NCT00229723|470613460|FG001|Concomitant Phase|Objective disease progression|0|||
130723484|NCT00229723|470613461|FG002|Concomitant Phase|Objective disease progression|0|||
130723485|NCT00229723|470613462|FG003|Concomitant Phase|Objective disease progression|0|||
130723486|NCT00229723|470613463|FG004|Concomitant Phase|Objective disease progression|0|||
131070054|NCT03740919|471887942|FG000|Lead-in Period|Study Task Too Burdensome|1|||
130723487|NCT00229723|470613464|FG005|Concomitant Phase|Objective disease progression|0|||
131070055|NCT03740919|471887943|FG001|Lead-in Period|Study Task Too Burdensome|0|||
131070056|NCT03740919|471887944|FG002|Lead-in Period|Study Task Too Burdensome|0|||
131070057|NCT03740919|471887945|FG003|Lead-in Period|Study Task Too Burdensome|0|||
131070058|NCT03740919|471887942|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
131070059|NCT03740919|471887943|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
131070060|NCT03740919|471887944|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
131070061|NCT03740919|471887945|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
130723488|NCT00229723|470613465|FG006|Concomitant Phase|Objective disease progression|0|||
130723489|NCT00229723|470613459|FG000|Concomitant Phase|Clinical progression|0|||
130723490|NCT00229723|470613460|FG001|Concomitant Phase|Clinical progression|0|||
130723491|NCT00229723|470613461|FG002|Concomitant Phase|Clinical progression|0|||
130723492|NCT00229723|470613462|FG003|Concomitant Phase|Clinical progression|0|||
130723493|NCT00229723|470613463|FG004|Concomitant Phase|Clinical progression|0|||
130723494|NCT00229723|470613464|FG005|Concomitant Phase|Clinical progression|0|||
130723495|NCT00229723|470613465|FG006|Concomitant Phase|Clinical progression|1|||
130723496|NCT00229723|470613459|FG000|Concomitant Phase|Lost to Follow-up|0|||
130723497|NCT00229723|470613460|FG001|Concomitant Phase|Lost to Follow-up|0|||
130723498|NCT00229723|470613461|FG002|Concomitant Phase|Lost to Follow-up|0|||
130723499|NCT00229723|470613462|FG003|Concomitant Phase|Lost to Follow-up|0|||
130723500|NCT00229723|470613463|FG004|Concomitant Phase|Lost to Follow-up|1|||
130723501|NCT00229723|470613464|FG005|Concomitant Phase|Lost to Follow-up|0|||
130723502|NCT00229723|470613465|FG006|Concomitant Phase|Lost to Follow-up|0|||
130723503|NCT00229723|470613459|FG000|Concomitant Phase|Informed consent withdrawn|3|||
130723504|NCT00229723|470613460|FG001|Concomitant Phase|Informed consent withdrawn|2|||
130723505|NCT00229723|470613461|FG002|Concomitant Phase|Informed consent withdrawn|0|||
130723506|NCT00229723|470613462|FG003|Concomitant Phase|Informed consent withdrawn|2|||
130723507|NCT00229723|470613463|FG004|Concomitant Phase|Informed consent withdrawn|0|||
130723508|NCT00229723|470613464|FG005|Concomitant Phase|Informed consent withdrawn|0|||
130723509|NCT00229723|470613465|FG006|Concomitant Phase|Informed consent withdrawn|0|||
130723510|NCT00229723|470613459|FG000|Concomitant Phase|Severe non-compliance|0|||
130723511|NCT00229723|470613460|FG001|Concomitant Phase|Severe non-compliance|1|||
130723512|NCT00229723|470613461|FG002|Concomitant Phase|Severe non-compliance|0|||
130723513|NCT00229723|470613462|FG003|Concomitant Phase|Severe non-compliance|0|||
130723514|NCT00229723|470613463|FG004|Concomitant Phase|Severe non-compliance|1|||
130723515|NCT00229723|470613464|FG005|Concomitant Phase|Severe non-compliance|0|||
131070062|NCT03740919|471887942|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
131070063|NCT03740919|471887943|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
131070064|NCT03740919|471887944|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
131070065|NCT03740919|471887945|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
131070066|NCT03740919|471887942|FG000|Treatment Period|Adverse Event|0|||
131070067|NCT03740919|471887943|FG001|Treatment Period|Adverse Event|0|||
131070068|NCT03740919|471887944|FG002|Treatment Period|Adverse Event|2|||
131070069|NCT03740919|471887945|FG003|Treatment Period|Adverse Event|0|||
131070070|NCT03740919|471887942|FG000|Treatment Period|Protocol Violation|0|||
131070071|NCT03740919|471887943|FG001|Treatment Period|Protocol Violation|1|||
131070072|NCT03740919|471887944|FG002|Treatment Period|Protocol Violation|0|||
131070073|NCT03740919|471887945|FG003|Treatment Period|Protocol Violation|0|||
131070074|NCT03740919|471887942|FG000|Treatment Period|Withdrawal by Subject|0|||
131070075|NCT03740919|471887943|FG001|Treatment Period|Withdrawal by Subject|7|||
131070076|NCT03740919|471887944|FG002|Treatment Period|Withdrawal by Subject|6|||
131070077|NCT03740919|471887945|FG003|Treatment Period|Withdrawal by Subject|2|||
131070078|NCT03740919|471887942|FG000|Treatment Period|Terminated by Sponsor|0|||
131070079|NCT03740919|471887943|FG001|Treatment Period|Terminated by Sponsor|1|||
131070080|NCT03740919|471887944|FG002|Treatment Period|Terminated by Sponsor|0|||
131070081|NCT03740919|471887945|FG003|Treatment Period|Terminated by Sponsor|0|||
131070082|NCT03740919|471887942|FG000|Treatment Period|Issue with Insulin Pump|0|||
130723516|NCT00229723|470613465|FG006|Concomitant Phase|Severe non-compliance|0|||
130723517|NCT00229723|470613459|FG000|Concomitant Phase|Other|3|||
130723518|NCT00229723|470613460|FG001|Concomitant Phase|Other|0|||
130723519|NCT00229723|470613461|FG002|Concomitant Phase|Other|1|||
130723520|NCT00229723|470613462|FG003|Concomitant Phase|Other|1|||
130723521|NCT00229723|470613463|FG004|Concomitant Phase|Other|0|||
130723522|NCT00229723|470613464|FG005|Concomitant Phase|Other|2|||
130723523|NCT00229723|470613465|FG006|Concomitant Phase|Other|0|||
130723524|NCT00229723|470613459|FG000|Maintenance Phase|Adverse Event|7|||
130723525|NCT00229723|470613460|FG001|Maintenance Phase|Adverse Event|2|||
130723526|NCT00229723|470613461|FG002|Maintenance Phase|Adverse Event|1|||
130723527|NCT00229723|470613462|FG003|Maintenance Phase|Adverse Event|4|||
130723528|NCT00229723|470613463|FG004|Maintenance Phase|Adverse Event|7|||
131070083|NCT03740919|471887943|FG001|Treatment Period|Issue with Insulin Pump|1|||
131070084|NCT03740919|471887944|FG002|Treatment Period|Issue with Insulin Pump|0|||
130723529|NCT00229723|470613464|FG005|Maintenance Phase|Adverse Event|5|||
130723530|NCT00229723|470613465|FG006|Maintenance Phase|Adverse Event|2|||
130723531|NCT00229723|470613459|FG000|Maintenance Phase|Objective disease progression|5|||
130723532|NCT00229723|470613460|FG001|Maintenance Phase|Objective disease progression|5|||
130723533|NCT00229723|470613461|FG002|Maintenance Phase|Objective disease progression|3|||
130723534|NCT00229723|470613462|FG003|Maintenance Phase|Objective disease progression|6|||
131070085|NCT03740919|471887945|FG003|Treatment Period|Issue with Insulin Pump|0|||
131070086|NCT03740919|471887942|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
131070087|NCT03740919|471887943|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
131070088|NCT03740919|471887944|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
131070089|NCT03740919|471887945|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
131070090|NCT03740919|471887942|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
131070091|NCT03740919|471887943|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
131070092|NCT03740919|471887944|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
131070093|NCT03740919|471887945|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
131070094|NCT03740919|471887942|FG000|Treatment Period|Not Completing Diary|0|||
131070095|NCT03740919|471887943|FG001|Treatment Period|Not Completing Diary|0|||
131070096|NCT03740919|471887944|FG002|Treatment Period|Not Completing Diary|1|||
131070097|NCT03740919|471887945|FG003|Treatment Period|Not Completing Diary|0|||
131070098|NCT03740919|471887942|FG000|Treatment Period|Insulin Painful to Participant|0|||
131070099|NCT03740919|471887943|FG001|Treatment Period|Insulin Painful to Participant|0|||
131070100|NCT03740919|471887944|FG002|Treatment Period|Insulin Painful to Participant|1|||
131070101|NCT03740919|471887945|FG003|Treatment Period|Insulin Painful to Participant|0|||
131070102|NCT03873038|471887948|FG000|Part 2|Withdrawal by Subject|0|||
131070103|NCT03873038|471887949|FG001|Part 2|Withdrawal by Subject|0|||
131070104|NCT03873038|471887950|FG002|Part 2|Withdrawal by Subject|0|||
131070105|NCT03873038|471887951|FG003|Part 2|Withdrawal by Subject|0|||
131070106|NCT03873038|471887952|FG004|Part 2|Withdrawal by Subject|0|||
131070107|NCT03873038|471887953|FG005|Part 2|Withdrawal by Subject|1|||
131070108|NCT03873038|471887948|FG000|Part 2|Unknon|0|||
131070109|NCT03873038|471887949|FG001|Part 2|Unknon|0|||
131070110|NCT03873038|471887950|FG002|Part 2|Unknon|0|||
131070111|NCT03873038|471887951|FG003|Part 2|Unknon|0|||
131070112|NCT03873038|471887952|FG004|Part 2|Unknon|1|||
131070113|NCT03873038|471887953|FG005|Part 2|Unknon|0|||
131070114|NCT04222088|471887954|FG000|Overall Study|Lost to Follow-up|5|||
131070115|NCT04222088|471887955|FG001|Overall Study|Lost to Follow-up|1|||
131070116|NCT04222088|471887954|FG000|Overall Study|Withdrawal by Subject|4|||
131070117|NCT04222088|471887955|FG001|Overall Study|Withdrawal by Subject|0|||
131070118|NCT00905255|471887956|FG000|Overall Study|Adverse Event|7|||
131070119|NCT00905255|471887957|FG001|Overall Study|Adverse Event|5|||
131070120|NCT00905255|471887956|FG000|Overall Study|Withdrawal by Subject|5|||
131070121|NCT00905255|471887957|FG001|Overall Study|Withdrawal by Subject|4|||
131070122|NCT00905255|471887956|FG000|Overall Study|Familial and Personal Reasons|1|||
131070123|NCT00905255|471887957|FG001|Overall Study|Familial and Personal Reasons|0|||
131070124|NCT02133131|471887960|FG000|Overall Study|Adverse Event|0|||
131070125|NCT02133131|471887961|FG001|Overall Study|Adverse Event|0|||
131070126|NCT02133131|471887962|FG002|Overall Study|Adverse Event|0|||
131070127|NCT02133131|471887963|FG003|Overall Study|Adverse Event|1|||
131070128|NCT02133131|471887964|FG004|Overall Study|Adverse Event|0|||
131070129|NCT02133131|471887965|FG005|Overall Study|Adverse Event|0|||
131070130|NCT02133131|471887966|FG006|Overall Study|Adverse Event|0|||
131070131|NCT02133131|471887960|FG000|Overall Study|Lost to Follow-up|1|||
131070132|NCT02133131|471887961|FG001|Overall Study|Lost to Follow-up|0|||
131070133|NCT02133131|471887962|FG002|Overall Study|Lost to Follow-up|0|||
131070134|NCT02133131|471887963|FG003|Overall Study|Lost to Follow-up|1|||
131070135|NCT02133131|471887964|FG004|Overall Study|Lost to Follow-up|0|||
131070136|NCT02133131|471887965|FG005|Overall Study|Lost to Follow-up|0|||
131070137|NCT02133131|471887966|FG006|Overall Study|Lost to Follow-up|0|||
131070138|NCT02133131|471887960|FG000|Overall Study|Status not recorded|4|||
131070139|NCT02133131|471887961|FG001|Overall Study|Status not recorded|5|||
131070140|NCT02133131|471887962|FG002|Overall Study|Status not recorded|1|||
131070141|NCT02133131|471887963|FG003|Overall Study|Status not recorded|4|||
131070142|NCT02133131|471887964|FG004|Overall Study|Status not recorded|0|||
131070143|NCT02133131|471887965|FG005|Overall Study|Status not recorded|0|||
131070144|NCT02133131|471887966|FG006|Overall Study|Status not recorded|0|||
131070145|NCT02133131|471887960|FG000|Overall Study|Ongoing in study|0|||
130723535|NCT00229723|470613463|FG004|Maintenance Phase|Objective disease progression|2|||
130723536|NCT00229723|470613464|FG005|Maintenance Phase|Objective disease progression|9|||
130723537|NCT00229723|470613465|FG006|Maintenance Phase|Objective disease progression|5|||
130723538|NCT00229723|470613459|FG000|Maintenance Phase|Clinical progression|4|||
130723539|NCT00229723|470613460|FG001|Maintenance Phase|Clinical progression|1|||
131070146|NCT02133131|471887961|FG001|Overall Study|Ongoing in study|0|||
131070147|NCT02133131|471887962|FG002|Overall Study|Ongoing in study|0|||
131070148|NCT02133131|471887963|FG003|Overall Study|Ongoing in study|0|||
131070149|NCT02133131|471887964|FG004|Overall Study|Ongoing in study|15|||
131070150|NCT02133131|471887965|FG005|Overall Study|Ongoing in study|14|||
131070151|NCT02133131|471887966|FG006|Overall Study|Ongoing in study|11|||
131070152|NCT02133131|471887960|FG000|Overall Study|Protocol Violation|0|||
131070153|NCT02133131|471887961|FG001|Overall Study|Protocol Violation|0|||
131070154|NCT02133131|471887962|FG002|Overall Study|Protocol Violation|0|||
131070155|NCT02133131|471887963|FG003|Overall Study|Protocol Violation|0|||
131070156|NCT02133131|471887964|FG004|Overall Study|Protocol Violation|0|||
131070157|NCT02133131|471887965|FG005|Overall Study|Protocol Violation|0|||
131070158|NCT02133131|471887966|FG006|Overall Study|Protocol Violation|1|||
131070159|NCT01544153|471887967|FG000|Overall Study|Under 18|0|||
131070160|NCT01544153|471887968|FG001|Overall Study|Under 18|1|||
131070161|NCT01544153|471887969|FG002|Overall Study|Under 18|0|||
131070162|NCT01544153|471887970|FG003|Overall Study|Under 18|0|||
131070163|NCT01544153|471887967|FG000|Overall Study|Non-smoker|0|||
131070164|NCT01544153|471887968|FG001|Overall Study|Non-smoker|0|||
131070165|NCT01544153|471887969|FG002|Overall Study|Non-smoker|1|||
131070166|NCT01544153|471887970|FG003|Overall Study|Non-smoker|0|||
131070167|NCT04783519|471887975|FG000|Overall Study|Withdrawal by Subject|2|||
131070168|NCT04783519|471887976|FG001|Overall Study|Withdrawal by Subject|7|||
131070169|NCT04783519|471887977|FG002|Overall Study|Withdrawal by Subject|3|||
131070170|NCT04783519|471887975|FG000|Overall Study|Lost to Follow-up|9|||
131070171|NCT04783519|471887976|FG001|Overall Study|Lost to Follow-up|7|||
131070172|NCT04783519|471887977|FG002|Overall Study|Lost to Follow-up|6|||
131070173|NCT00884793|471887978|FG000|Overall Study|Withdrawal by Subject|1|||
131070174|NCT01032200|471887979|FG000|Overall Study|Death|1|||
131070175|NCT01032200|471887980|FG001|Overall Study|Death|1|||
131070176|NCT01032200|471887979|FG000|Overall Study|Withdrawal by Subject|1|||
131070177|NCT01032200|471887980|FG001|Overall Study|Withdrawal by Subject|3|||
131070178|NCT01032200|471887979|FG000|Overall Study|Toxicity|0|||
131070179|NCT01032200|471887980|FG001|Overall Study|Toxicity|2|||
131070180|NCT01032200|471887979|FG000|Overall Study|Progression|1|||
131070181|NCT01032200|471887980|FG001|Overall Study|Progression|0|||
131070182|NCT01032200|471887979|FG000|Overall Study|Multiple|1|||
131070183|NCT01032200|471887980|FG001|Overall Study|Multiple|1|||
131070184|NCT02785900|471887981|FG000|Overall Study|Study Termination by Sponsor|64|||
131070185|NCT02785900|471887982|FG001|Overall Study|Study Termination by Sponsor|81|||
131070186|NCT02785900|471887981|FG000|Overall Study|Death|46|||
131070187|NCT02785900|471887982|FG001|Overall Study|Death|32|||
131070188|NCT02785900|471887981|FG000|Overall Study|Withdrawal by Subject|4|||
131070189|NCT02785900|471887982|FG001|Overall Study|Withdrawal by Subject|8|||
131070190|NCT02785900|471887981|FG000|Overall Study|Physician Decision|3|||
131070191|NCT02785900|471887982|FG001|Overall Study|Physician Decision|2|||
131070192|NCT03993054|471887983|FG000|Overall Study|PI Decision|1|||
131070193|NCT00497198|471887988|FG000|Overall Study|Adverse Event|4|||
131070194|NCT00497198|471887989|FG001|Overall Study|Adverse Event|2|||
131070195|NCT00497198|471887988|FG000|Overall Study|Physician Decision|1|||
131070196|NCT00497198|471887989|FG001|Overall Study|Physician Decision|2|||
131070197|NCT00497198|471887988|FG000|Overall Study|Withdrawal by Subject|0|||
131070198|NCT00497198|471887989|FG001|Overall Study|Withdrawal by Subject|1|||
131070199|NCT02799745|471887990|FG000|Overall Study|Participant moved out of state|1|||
131070200|NCT02799745|471887991|FG001|Overall Study|Participant moved out of state|0|||
131070201|NCT02799745|471887990|FG000|Overall Study|Discontinued due to planned surgery|1|||
131070202|NCT02799745|471887991|FG001|Overall Study|Discontinued due to planned surgery|0|||
131070203|NCT02799745|471887990|FG000|Overall Study|Withdrawal by Subject|16|||
131070204|NCT02799745|471887991|FG001|Overall Study|Withdrawal by Subject|25|||
131070205|NCT02799745|471887990|FG000|Overall Study|Protocol Deviation|4|||
131070206|NCT02799745|471887991|FG001|Overall Study|Protocol Deviation|5|||
131070207|NCT02799745|471887990|FG000|Overall Study|Progressive Disease|28|||
131070208|NCT02799745|471887991|FG001|Overall Study|Progressive Disease|38|||
131070209|NCT02799745|471887990|FG000|Overall Study|Lost to Follow-up|3|||
131070210|NCT02799745|471887991|FG001|Overall Study|Lost to Follow-up|2|||
131070211|NCT02799745|471887990|FG000|Overall Study|Death|3|||
131070212|NCT02799745|471887991|FG001|Overall Study|Death|0|||
131070213|NCT02799745|471887990|FG000|Overall Study|Adverse Event|0|||
131070214|NCT02799745|471887991|FG001|Overall Study|Adverse Event|1|||
131070215|NCT04853238|471887992|FG000|Overall Study|Death|4|||
131070216|NCT04853238|471887993|FG001|Overall Study|Death|0|||
131070217|NCT04853238|471887994|FG002|Overall Study|Death|2|||
131070218|NCT04853238|471887992|FG000|Overall Study|Lost to Follow-up|16|||
130723540|NCT00229723|470613461|FG002|Maintenance Phase|Clinical progression|2|||
130723541|NCT00229723|470613462|FG003|Maintenance Phase|Clinical progression|2|||
130723542|NCT00229723|470613463|FG004|Maintenance Phase|Clinical progression|1|||
130723543|NCT00229723|470613464|FG005|Maintenance Phase|Clinical progression|1|||
130723544|NCT00229723|470613465|FG006|Maintenance Phase|Clinical progression|1|||
130723545|NCT00229723|470613459|FG000|Maintenance Phase|Lost to Follow-up|0|||
130723546|NCT00229723|470613460|FG001|Maintenance Phase|Lost to Follow-up|1|||
131070219|NCT04853238|471887993|FG001|Overall Study|Lost to Follow-up|2|||
130723547|NCT00229723|470613461|FG002|Maintenance Phase|Lost to Follow-up|2|||
131070220|NCT04853238|471887994|FG002|Overall Study|Lost to Follow-up|37|||
131070221|NCT04853238|471887992|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
131070222|NCT04853238|471887993|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
131070223|NCT04853238|471887994|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
131070224|NCT04853238|471887992|FG000|Overall Study|Withdrawal by Subject|6|||
131070225|NCT04853238|471887993|FG001|Overall Study|Withdrawal by Subject|0|||
131070226|NCT04853238|471887994|FG002|Overall Study|Withdrawal by Subject|21|||
131070227|NCT04853238|471887992|FG000|Overall Study|Physician Decision|0|||
131070228|NCT04853238|471887993|FG001|Overall Study|Physician Decision|0|||
131070229|NCT04853238|471887994|FG002|Overall Study|Physician Decision|2|||
131070230|NCT04853238|471887992|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
131070231|NCT04853238|471887993|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
131070232|NCT04853238|471887994|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
131070233|NCT00434577|471889691|FG000|Months 0-3|Serious Adverse Event|0|||
131070234|NCT00434577|471889692|FG001|Months 0-3|Serious Adverse Event|0|||
131070235|NCT00434577|471889693|FG002|Months 0-3|Serious Adverse Event|1|||
131070236|NCT00434577|471889694|FG003|Months 0-3|Serious Adverse Event|0|||
131070237|NCT00434577|471889695|FG004|Months 0-3|Serious Adverse Event|0|||
131070238|NCT00434577|471889691|FG000|Months 0-3|Adverse Event|0|||
131070239|NCT00434577|471889692|FG001|Months 0-3|Adverse Event|1|||
131070240|NCT00434577|471889693|FG002|Months 0-3|Adverse Event|1|||
131070241|NCT00434577|471889694|FG003|Months 0-3|Adverse Event|0|||
131070242|NCT00434577|471889695|FG004|Months 0-3|Adverse Event|0|||
131070243|NCT00434577|471889691|FG000|Months 0-3|Lost to Follow-up|0|||
131070244|NCT00434577|471889692|FG001|Months 0-3|Lost to Follow-up|0|||
131070245|NCT00434577|471889693|FG002|Months 0-3|Lost to Follow-up|0|||
131070246|NCT00434577|471889694|FG003|Months 0-3|Lost to Follow-up|0|||
131070247|NCT00434577|471889695|FG004|Months 0-3|Lost to Follow-up|2|||
131070248|NCT00434577|471889691|FG000|Months 0-3|Protocol Violation|1|||
131070249|NCT00434577|471889692|FG001|Months 0-3|Protocol Violation|0|||
131070250|NCT00434577|471889693|FG002|Months 0-3|Protocol Violation|1|||
131070251|NCT00434577|471889694|FG003|Months 0-3|Protocol Violation|0|||
131070252|NCT00434577|471889695|FG004|Months 0-3|Protocol Violation|0|||
131070253|NCT00434577|471889691|FG000|Months 0-3|Withdrawal by Subject|2|||
131070254|NCT00434577|471889692|FG001|Months 0-3|Withdrawal by Subject|1|||
131070255|NCT00434577|471889693|FG002|Months 0-3|Withdrawal by Subject|1|||
131070256|NCT00434577|471889694|FG003|Months 0-3|Withdrawal by Subject|1|||
131070257|NCT00434577|471889695|FG004|Months 0-3|Withdrawal by Subject|1|||
131070258|NCT01589523|471889708|FG000|Overall Study|Withdrawal by Subject|1|||
131070259|NCT00961896|471889709|FG000|Overall Study|Abnormal laboratory value|0|||
131070260|NCT00961896|471889710|FG001|Overall Study|Abnormal laboratory value|0|||
131070261|NCT00961896|471889711|FG002|Overall Study|Abnormal laboratory value|1|||
131070262|NCT00506922|471889712|FG000|Overall Study|Physician Decision|0|||
131070263|NCT00506922|471889713|FG001|Overall Study|Physician Decision|0|||
131070264|NCT00506922|471889714|FG002|Overall Study|Physician Decision|0|||
131070265|NCT00506922|471889715|FG003|Overall Study|Physician Decision|2|||
131070266|NCT00506922|471889716|FG004|Overall Study|Physician Decision|0|||
131070267|NCT00506922|471889712|FG000|Overall Study|Withdrawal by Subject|0|||
131070268|NCT00506922|471889713|FG001|Overall Study|Withdrawal by Subject|0|||
131070269|NCT00506922|471889714|FG002|Overall Study|Withdrawal by Subject|0|||
131070270|NCT00506922|471889715|FG003|Overall Study|Withdrawal by Subject|0|||
131070271|NCT00506922|471889716|FG004|Overall Study|Withdrawal by Subject|1|||
131070272|NCT00792259|471889717|FG000|Overall Study|Poor Quality Scans|1|||
131070273|NCT00792259|471889718|FG001|Overall Study|Poor Quality Scans|0|||
131070274|NCT00792259|471889719|FG002|Overall Study|Poor Quality Scans|0|||
131070275|NCT03721978|471889721|FG000|Overall Study|Withdrawal by Subject|6|||
131070276|NCT03721978|471889722|FG001|Overall Study|Withdrawal by Subject|1|||
131070277|NCT03721978|471889721|FG000|Overall Study|Adverse Event|1|||
131070278|NCT03721978|471889722|FG001|Overall Study|Adverse Event|1|||
131070279|NCT03721978|471889721|FG000|Overall Study|Progressive Disease|1|||
131070280|NCT03721978|471889722|FG001|Overall Study|Progressive Disease|0|||
131070281|NCT03721978|471889721|FG000|Overall Study|Lost to Follow-up|5|||
131070282|NCT03721978|471889722|FG001|Overall Study|Lost to Follow-up|1|||
131070283|NCT03721978|471889721|FG000|Overall Study|Reason not Specified|0|||
131070284|NCT03721978|471889722|FG001|Overall Study|Reason not Specified|2|||
131070285|NCT05244226|471889723|FG000|Overall Study|Adverse Event|1|||
131070286|NCT05244226|471889724|FG001|Overall Study|Adverse Event|0|||
131070287|NCT05244226|471889725|FG002|Overall Study|Adverse Event|0|||
131070288|NCT05244226|471889723|FG000|Overall Study|Lost to Follow-up|0|||
131070289|NCT05244226|471889724|FG001|Overall Study|Lost to Follow-up|0|||
131070290|NCT05244226|471889725|FG002|Overall Study|Lost to Follow-up|1|||
131070291|NCT05244226|471889723|FG000|Overall Study|Protocol Violation|0|||
131070292|NCT05244226|471889724|FG001|Overall Study|Protocol Violation|2|||
131070293|NCT05244226|471889725|FG002|Overall Study|Protocol Violation|2|||
131070294|NCT02675998|471889732|FG000|8-Week Treatment Period|Adverse Event|6|||
131070295|NCT02675998|471889733|FG001|8-Week Treatment Period|Adverse Event|5|||
131070296|NCT02675998|471889734|FG002|8-Week Treatment Period|Adverse Event|6|||
131070297|NCT02675998|471889735|FG003|8-Week Treatment Period|Adverse Event|0|||
131070298|NCT02675998|471889732|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
131070299|NCT02675998|471889733|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
131070300|NCT02675998|471889734|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
131070301|NCT02675998|471889735|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
131070302|NCT02675998|471889732|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
131070303|NCT02675998|471889733|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
131070304|NCT02675998|471889734|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
131070305|NCT02675998|471889735|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
131070306|NCT02675998|471889732|FG000|8-Week Treatment Period|Physician Decision|1|||
131070307|NCT02675998|471889733|FG001|8-Week Treatment Period|Physician Decision|0|||
131070308|NCT02675998|471889734|FG002|8-Week Treatment Period|Physician Decision|2|||
131070309|NCT02675998|471889735|FG003|8-Week Treatment Period|Physician Decision|0|||
131070310|NCT02675998|471889732|FG000|8-Week Treatment Period|GI side Effects|1|||
131070311|NCT02675998|471889733|FG001|8-Week Treatment Period|GI side Effects|4|||
131070312|NCT02675998|471889734|FG002|8-Week Treatment Period|GI side Effects|2|||
131070313|NCT02675998|471889735|FG003|8-Week Treatment Period|GI side Effects|0|||
131070314|NCT02675998|471889732|FG000|8-Week Treatment Period|Protocol Violation|1|||
131070315|NCT02675998|471889733|FG001|8-Week Treatment Period|Protocol Violation|1|||
131070316|NCT02675998|471889734|FG002|8-Week Treatment Period|Protocol Violation|1|||
131070317|NCT02675998|471889735|FG003|8-Week Treatment Period|Protocol Violation|0|||
131070318|NCT02675998|471889732|FG000|8-Week Treatment Period|Other|3|||
131070319|NCT02675998|471889733|FG001|8-Week Treatment Period|Other|1|||
131070320|NCT02675998|471889734|FG002|8-Week Treatment Period|Other|2|||
131070321|NCT02675998|471889735|FG003|8-Week Treatment Period|Other|0|||
131070322|NCT02675998|471889732|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
131070323|NCT02675998|471889733|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
131070324|NCT02675998|471889734|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
131070325|NCT02675998|471889735|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
131070326|NCT02675998|471889732|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
131070327|NCT02675998|471889733|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
131070328|NCT02675998|471889734|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
131070329|NCT02675998|471889735|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
131070330|NCT02675998|471889732|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
131070331|NCT02675998|471889733|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
131070332|NCT02675998|471889734|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
131070333|NCT02675998|471889735|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
131070334|NCT02675998|471889732|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
131070335|NCT02675998|471889733|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
131070336|NCT02675998|471889734|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
131070337|NCT02675998|471889735|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
131070338|NCT02675998|471889732|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
131070339|NCT02675998|471889733|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
131070340|NCT02675998|471889734|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
131070341|NCT02675998|471889735|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
131070342|NCT00275301|471889736|FG000|Overall Study|Adverse Event|5|||
131070343|NCT04357964|471889737|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
131070344|NCT04357964|471889738|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
131070345|NCT04357964|471889737|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
131070346|NCT04357964|471889738|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
131070347|NCT04357964|471889737|FG000|Overall Study|Adipose sample was insufficient quality|0|||
131070348|NCT04357964|471889738|FG001|Overall Study|Adipose sample was insufficient quality|1|||
131070349|NCT00733226|471889741|FG000|Overall Study|Withdrawal by Subject|1|||
131070350|NCT00733226|471889742|FG001|Overall Study|Withdrawal by Subject|0|||
131070351|NCT00733226|471889741|FG000|Overall Study|Lost to Follow-up|2|||
131070352|NCT00733226|471889742|FG001|Overall Study|Lost to Follow-up|0|||
131070353|NCT00733226|471889741|FG000|Overall Study|moved to another place|2|||
131070354|NCT00733226|471889742|FG001|Overall Study|moved to another place|0|||
131070355|NCT00848393|471889749|FG000|Overall Study|Protocol Violation|0|||
131070356|NCT00848393|471889750|FG001|Overall Study|Protocol Violation|0|||
131070357|NCT00848393|471889751|FG002|Overall Study|Protocol Violation|1|||
131070358|NCT00848393|471889749|FG000|Overall Study|surgical complications unrelated to stud|0|||
131070359|NCT00848393|471889750|FG001|Overall Study|surgical complications unrelated to stud|0|||
131070360|NCT00848393|471889751|FG002|Overall Study|surgical complications unrelated to stud|2|||
131070361|NCT02561078|471889752|FG000|Overall Study|Adverse Event|5|||
131070362|NCT02561078|471889753|FG001|Overall Study|Adverse Event|2|||
131070363|NCT02561078|471889752|FG000|Overall Study|Death|2|||
131070364|NCT02561078|471889753|FG001|Overall Study|Death|1|||
131070365|NCT02561078|471889752|FG000|Overall Study|Lost to Follow-up|2|||
131070366|NCT02561078|471889753|FG001|Overall Study|Lost to Follow-up|6|||
131070367|NCT02561078|471889752|FG000|Overall Study|Non-Compliance with Study Drug|6|||
131070368|NCT02561078|471889753|FG001|Overall Study|Non-Compliance with Study Drug|3|||
131070369|NCT02561078|471889752|FG000|Overall Study|Physician Decision|2|||
131070370|NCT02561078|471889753|FG001|Overall Study|Physician Decision|3|||
131070371|NCT02561078|471889752|FG000|Overall Study|Withdrawal by Subject|13|||
131070372|NCT02561078|471889753|FG001|Overall Study|Withdrawal by Subject|10|||
131070373|NCT00043186|471889760|FG000|Overall Study|Physician Decision|0|||
131070374|NCT00043186|471889761|FG001|Overall Study|Physician Decision|0|||
131070375|NCT00043186|471889762|FG002|Overall Study|Physician Decision|3|||
131070376|NCT00043186|471889763|FG003|Overall Study|Physician Decision|0|||
131070377|NCT00043186|471889764|FG004|Overall Study|Physician Decision|1|||
131070378|NCT00043186|471889765|FG005|Overall Study|Physician Decision|0|||
131070379|NCT00043186|471889766|FG006|Overall Study|Physician Decision|0|||
131070380|NCT00043186|471889767|FG007|Overall Study|Physician Decision|1|||
131070381|NCT00043186|471889768|FG008|Overall Study|Physician Decision|1|||
131070382|NCT00043186|471889760|FG000|Overall Study|Adverse Event|2|||
131070383|NCT00043186|471889761|FG001|Overall Study|Adverse Event|2|||
131070384|NCT00043186|471889762|FG002|Overall Study|Adverse Event|2|||
131070385|NCT00043186|471889763|FG003|Overall Study|Adverse Event|3|||
131070386|NCT00043186|471889764|FG004|Overall Study|Adverse Event|2|||
131070387|NCT00043186|471889765|FG005|Overall Study|Adverse Event|1|||
131070388|NCT00043186|471889766|FG006|Overall Study|Adverse Event|2|||
131070389|NCT00043186|471889767|FG007|Overall Study|Adverse Event|1|||
131070390|NCT00043186|471889768|FG008|Overall Study|Adverse Event|3|||
131070391|NCT00043186|471889760|FG000|Overall Study|Withdrawal by Subject|11|||
131070392|NCT00043186|471889761|FG001|Overall Study|Withdrawal by Subject|8|||
131070393|NCT00043186|471889762|FG002|Overall Study|Withdrawal by Subject|11|||
131070394|NCT00043186|471889763|FG003|Overall Study|Withdrawal by Subject|13|||
131070395|NCT00043186|471889764|FG004|Overall Study|Withdrawal by Subject|14|||
131070396|NCT00043186|471889765|FG005|Overall Study|Withdrawal by Subject|6|||
131070397|NCT00043186|471889766|FG006|Overall Study|Withdrawal by Subject|12|||
131070398|NCT00043186|471889767|FG007|Overall Study|Withdrawal by Subject|9|||
131070399|NCT00043186|471889768|FG008|Overall Study|Withdrawal by Subject|10|||
131070400|NCT00043186|471889760|FG000|Overall Study|Death|0|||
131070401|NCT00043186|471889761|FG001|Overall Study|Death|0|||
131070402|NCT00043186|471889762|FG002|Overall Study|Death|1|||
131070403|NCT00043186|471889763|FG003|Overall Study|Death|0|||
131070404|NCT00043186|471889764|FG004|Overall Study|Death|0|||
131070405|NCT00043186|471889765|FG005|Overall Study|Death|0|||
131070406|NCT00043186|471889766|FG006|Overall Study|Death|2|||
131070407|NCT00043186|471889767|FG007|Overall Study|Death|0|||
131070408|NCT00043186|471889768|FG008|Overall Study|Death|0|||
131070409|NCT00043186|471889760|FG000|Overall Study|Disease progression|1|||
131070410|NCT00043186|471889761|FG001|Overall Study|Disease progression|0|||
131070411|NCT00043186|471889762|FG002|Overall Study|Disease progression|0|||
131070412|NCT00043186|471889763|FG003|Overall Study|Disease progression|3|||
131070413|NCT00043186|471889764|FG004|Overall Study|Disease progression|0|||
131070414|NCT00043186|471889765|FG005|Overall Study|Disease progression|0|||
131070415|NCT00043186|471889766|FG006|Overall Study|Disease progression|0|||
131070416|NCT00043186|471889767|FG007|Overall Study|Disease progression|4|||
131070417|NCT00043186|471889768|FG008|Overall Study|Disease progression|0|||
131070418|NCT00043186|471889760|FG000|Overall Study|Ineligibility determined|0|||
131070419|NCT00043186|471889761|FG001|Overall Study|Ineligibility determined|0|||
131070420|NCT00043186|471889762|FG002|Overall Study|Ineligibility determined|0|||
131070421|NCT00043186|471889763|FG003|Overall Study|Ineligibility determined|0|||
131070422|NCT00043186|471889764|FG004|Overall Study|Ineligibility determined|0|||
131070423|NCT00043186|471889765|FG005|Overall Study|Ineligibility determined|0|||
131070424|NCT00043186|471889766|FG006|Overall Study|Ineligibility determined|0|||
131070425|NCT00043186|471889767|FG007|Overall Study|Ineligibility determined|0|||
131070426|NCT00043186|471889768|FG008|Overall Study|Ineligibility determined|1|||
131070427|NCT00043186|471889760|FG000|Overall Study|Lost to Follow-up|3|||
131070428|NCT00043186|471889761|FG001|Overall Study|Lost to Follow-up|5|||
131070429|NCT00043186|471889762|FG002|Overall Study|Lost to Follow-up|1|||
131070430|NCT00043186|471889763|FG003|Overall Study|Lost to Follow-up|1|||
131070431|NCT00043186|471889764|FG004|Overall Study|Lost to Follow-up|1|||
131070432|NCT00043186|471889765|FG005|Overall Study|Lost to Follow-up|1|||
131070433|NCT00043186|471889766|FG006|Overall Study|Lost to Follow-up|1|||
131070434|NCT00043186|471889767|FG007|Overall Study|Lost to Follow-up|1|||
131070435|NCT00043186|471889768|FG008|Overall Study|Lost to Follow-up|2|||
131070436|NCT00043186|471889760|FG000|Overall Study|Noncompliance|0|||
131070437|NCT00043186|471889761|FG001|Overall Study|Noncompliance|0|||
131070438|NCT00043186|471889762|FG002|Overall Study|Noncompliance|1|||
131070439|NCT00043186|471889763|FG003|Overall Study|Noncompliance|1|||
131070440|NCT00043186|471889764|FG004|Overall Study|Noncompliance|0|||
131070441|NCT00043186|471889765|FG005|Overall Study|Noncompliance|0|||
131070442|NCT00043186|471889766|FG006|Overall Study|Noncompliance|0|||
130723548|NCT00229723|470613462|FG003|Maintenance Phase|Lost to Follow-up|2|||
131070443|NCT00043186|471889767|FG007|Overall Study|Noncompliance|0|||
131070444|NCT00043186|471889768|FG008|Overall Study|Noncompliance|0|||
131070445|NCT00043186|471889760|FG000|Overall Study|Other|0|||
131070446|NCT00043186|471889761|FG001|Overall Study|Other|0|||
131070447|NCT00043186|471889762|FG002|Overall Study|Other|1|||
131070448|NCT00043186|471889763|FG003|Overall Study|Other|1|||
131070449|NCT00043186|471889764|FG004|Overall Study|Other|0|||
130723549|NCT00229723|470613463|FG004|Maintenance Phase|Lost to Follow-up|0|||
131070450|NCT00043186|471889765|FG005|Overall Study|Other|0|||
131070451|NCT00043186|471889766|FG006|Overall Study|Other|0|||
131070452|NCT00043186|471889767|FG007|Overall Study|Other|0|||
131070453|NCT00043186|471889768|FG008|Overall Study|Other|0|||
131070454|NCT03722485|471889769|FG000|Overall Study|Withdrawal by Subject|1|||
131070455|NCT03722485|471889770|FG001|Overall Study|Withdrawal by Subject|0|||
131070456|NCT03722485|471889769|FG000|Overall Study|Adverse Event|0|||
131070457|NCT03722485|471889770|FG001|Overall Study|Adverse Event|2|||
131070458|NCT03722485|471889769|FG000|Overall Study|subject discharged prior to study completion|1|||
131070459|NCT03722485|471889770|FG001|Overall Study|subject discharged prior to study completion|5|||
131070460|NCT03722485|471889769|FG000|Overall Study|eligibility criteria not met|2|||
130723550|NCT00229723|470613464|FG005|Maintenance Phase|Lost to Follow-up|0|||
130723551|NCT00229723|470613465|FG006|Maintenance Phase|Lost to Follow-up|1|||
130723552|NCT00229723|470613459|FG000|Maintenance Phase|Informed consent withdrawn|1|||
131070461|NCT03722485|471889770|FG001|Overall Study|eligibility criteria not met|0|||
131070462|NCT00349622|471889771|FG000|Overall Study|Death|168|||
131070463|NCT00349622|471889772|FG001|Overall Study|Death|86|||
131070464|NCT00349622|471889771|FG000|Overall Study|Lost to Follow-up|5|||
131070465|NCT00349622|471889772|FG001|Overall Study|Lost to Follow-up|1|||
131070466|NCT00349622|471889771|FG000|Overall Study|Withdrawal by Subject|5|||
131070467|NCT00349622|471889772|FG001|Overall Study|Withdrawal by Subject|9|||
131070468|NCT01902381|471889773|FG000|Overall Study|Withdrawal by Subject|1|||
131070469|NCT00755716|471889777|FG000|Overall Study|Adverse Event|1|||
131070470|NCT00755716|471889778|FG001|Overall Study|Adverse Event|4|||
131070471|NCT00755716|471889779|FG002|Overall Study|Adverse Event|1|||
131070472|NCT00755716|471889777|FG000|Overall Study|Lack of Efficacy|2|||
131070473|NCT00755716|471889778|FG001|Overall Study|Lack of Efficacy|0|||
131070474|NCT00755716|471889779|FG002|Overall Study|Lack of Efficacy|0|||
131070475|NCT00755716|471889777|FG000|Overall Study|Lost to Follow-up|5|||
131070476|NCT00755716|471889778|FG001|Overall Study|Lost to Follow-up|3|||
131070477|NCT00755716|471889779|FG002|Overall Study|Lost to Follow-up|1|||
131070478|NCT00755716|471889777|FG000|Overall Study|work schedule issues|0|||
131070479|NCT00755716|471889778|FG001|Overall Study|work schedule issues|1|||
131070480|NCT00755716|471889779|FG002|Overall Study|work schedule issues|1|||
131070481|NCT02762500|471889780|FG000|Overall Study|Lack of Efficacy|1|||
131070482|NCT02762500|471889781|FG001|Overall Study|Lack of Efficacy|0|||
131070483|NCT02762500|471889780|FG000|Overall Study|Withdrawal by Subject|1|||
131070484|NCT02762500|471889781|FG001|Overall Study|Withdrawal by Subject|1|||
131070485|NCT02762500|471889780|FG000|Overall Study|Adverse Event|0|||
131070486|NCT02762500|471889781|FG001|Overall Study|Adverse Event|2|||
131070487|NCT02229396|471889782|FG000|Overall Study|Adverse Event|6|||
131070488|NCT02229396|471889783|FG001|Overall Study|Adverse Event|12|||
131070489|NCT02229396|471889784|FG002|Overall Study|Adverse Event|12|||
131070490|NCT02229396|471889782|FG000|Overall Study|Death|2|||
131070491|NCT02229396|471889783|FG001|Overall Study|Death|3|||
131070492|NCT02229396|471889784|FG002|Overall Study|Death|1|||
131070493|NCT02229396|471889782|FG000|Overall Study|Lost to Follow-up|14|||
131070494|NCT02229396|471889783|FG001|Overall Study|Lost to Follow-up|14|||
131070495|NCT02229396|471889784|FG002|Overall Study|Lost to Follow-up|21|||
131070496|NCT02229396|471889782|FG000|Overall Study|Protocol Violation|2|||
131070497|NCT02229396|471889783|FG001|Overall Study|Protocol Violation|1|||
131070498|NCT02229396|471889784|FG002|Overall Study|Protocol Violation|0|||
131070499|NCT02229396|471889782|FG000|Overall Study|Patient Incorrectly Randomized|0|||
131070500|NCT02229396|471889783|FG001|Overall Study|Patient Incorrectly Randomized|0|||
131070501|NCT02229396|471889784|FG002|Overall Study|Patient Incorrectly Randomized|1|||
131070502|NCT02229396|471889782|FG000|Overall Study|Other|10|||
131070503|NCT02229396|471889783|FG001|Overall Study|Other|18|||
131070504|NCT02229396|471889784|FG002|Overall Study|Other|15|||
131070505|NCT02229396|471889782|FG000|Overall Study|Withdrawal by Subject|42|||
131070506|NCT02229396|471889783|FG001|Overall Study|Withdrawal by Subject|28|||
131070507|NCT02229396|471889784|FG002|Overall Study|Withdrawal by Subject|41|||
131070508|NCT02229396|471889782|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
131070509|NCT02229396|471889783|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
131070510|NCT02229396|471889784|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
131070511|NCT02229396|471889782|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
131070512|NCT02229396|471889783|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
131070513|NCT02229396|471889784|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
131070514|NCT00730847|471889785|FG000|Overall Study|Adverse Event|1|||
131070515|NCT00730847|471889785|FG000|Overall Study|Protocol Violation|2|||
131070516|NCT00730847|471889785|FG000|Overall Study|Withdrawal by Subject|16|||
131070517|NCT00730847|471889785|FG000|Overall Study|Lost to Follow-up|67|||
131070518|NCT00730847|471889785|FG000|Overall Study|Unknown completion status|21|||
131070519|NCT00730847|471889785|FG000|Overall Study|Other|24|||
131070520|NCT03022578|471889786|FG000|Overall Study|Adverse Event|1|||
131070521|NCT03022578|471889786|FG000|Overall Study|Lack of Efficacy|2|||
131070522|NCT03022578|471889786|FG000|Overall Study|Withdrawal by Subject|1|||
131070523|NCT03681353|471889792|FG000|Overall Study|Lost to Follow-up|2|||
131070524|NCT03681353|471889792|FG000|Overall Study|Withdrawal by Subject|3|||
131070525|NCT03681353|471889792|FG000|Overall Study|withdrawn by PI|2|||
131070526|NCT00726388|471889795|FG000|Overall Study|Withdrawal by Subject|5|||
131070527|NCT00726388|471889795|FG000|Overall Study|Adverse Event|3|||
131070528|NCT00726388|471889795|FG000|Overall Study|Lost to Follow-up|10|||
131070529|NCT00726388|471889795|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
131070530|NCT00726388|471889795|FG000|Overall Study|Other|5|||
131070531|NCT00726388|471889795|FG000|Overall Study|Enrolled, Not Treated|79|||
131070532|NCT00111839|471889796|FG000|Overall Study|Disease Progression|30|||
131070533|NCT00111839|471889797|FG001|Overall Study|Disease Progression|33|||
131070534|NCT00111839|471889798|FG002|Overall Study|Disease Progression|33|||
131070535|NCT00111839|471889796|FG000|Overall Study|Adverse Event|5|||
131070536|NCT00111839|471889797|FG001|Overall Study|Adverse Event|3|||
131070537|NCT00111839|471889798|FG002|Overall Study|Adverse Event|1|||
131070538|NCT00111839|471889796|FG000|Overall Study|Protocol Violation|2|||
131070539|NCT00111839|471889797|FG001|Overall Study|Protocol Violation|4|||
131070540|NCT00111839|471889798|FG002|Overall Study|Protocol Violation|2|||
131070541|NCT00111839|471889796|FG000|Overall Study|Death|1|||
131070542|NCT00111839|471889797|FG001|Overall Study|Death|1|||
131070543|NCT00111839|471889798|FG002|Overall Study|Death|6|||
131070544|NCT00111839|471889796|FG000|Overall Study|Withdrawal by Subject|2|||
131070545|NCT00111839|471889797|FG001|Overall Study|Withdrawal by Subject|2|||
131070546|NCT00111839|471889798|FG002|Overall Study|Withdrawal by Subject|2|||
131070547|NCT00111839|471889796|FG000|Overall Study|Lost to Follow-up|1|||
131070548|NCT00111839|471889797|FG001|Overall Study|Lost to Follow-up|0|||
131070549|NCT00111839|471889798|FG002|Overall Study|Lost to Follow-up|0|||
131070550|NCT00111839|471889796|FG000|Overall Study|Logistical Constraint|1|||
131070551|NCT00111839|471889797|FG001|Overall Study|Logistical Constraint|0|||
131070552|NCT00111839|471889798|FG002|Overall Study|Logistical Constraint|0|||
131070553|NCT00111839|471889796|FG000|Overall Study|Other|6|||
131070554|NCT00111839|471889797|FG001|Overall Study|Other|3|||
131070555|NCT00111839|471889798|FG002|Overall Study|Other|3|||
131070556|NCT00111839|471889796|FG000|Overall Study|Randomized but Not Treated|0|||
131070557|NCT00111839|471889797|FG001|Overall Study|Randomized but Not Treated|0|||
131070558|NCT00111839|471889798|FG002|Overall Study|Randomized but Not Treated|2|||
131070559|NCT01011049|471889799|FG000|Overall Study|Protocol Violation|0|||
131070560|NCT01011049|471889800|FG001|Overall Study|Protocol Violation|0|||
131070561|NCT01011049|471889801|FG002|Overall Study|Protocol Violation|2|||
131070562|NCT01011049|471889802|FG003|Overall Study|Protocol Violation|0|||
131070563|NCT01011049|471889799|FG000|Overall Study|Lost to Follow-up|1|||
131070564|NCT01011049|471889800|FG001|Overall Study|Lost to Follow-up|2|||
131070565|NCT01011049|471889801|FG002|Overall Study|Lost to Follow-up|1|||
131070566|NCT01011049|471889802|FG003|Overall Study|Lost to Follow-up|0|||
131070567|NCT01011049|471889799|FG000|Overall Study|Withdrawal by Subject|0|||
131070568|NCT01011049|471889800|FG001|Overall Study|Withdrawal by Subject|0|||
131070569|NCT01011049|471889801|FG002|Overall Study|Withdrawal by Subject|1|||
131070570|NCT01011049|471889802|FG003|Overall Study|Withdrawal by Subject|0|||
131070571|NCT00382408|471889803|FG000|Overall Study|Did not meet protocol requirement|3|||
131070572|NCT00382408|471889804|FG001|Overall Study|Did not meet protocol requirement|3|||
131070573|NCT00382408|471889803|FG000|Overall Study|Protocol Violation|2|||
131070574|NCT00382408|471889804|FG001|Overall Study|Protocol Violation|2|||
131070575|NCT00382408|471889803|FG000|Overall Study|Physician Decision|1|||
131070576|NCT00382408|471889804|FG001|Overall Study|Physician Decision|0|||
131070577|NCT00382408|471889803|FG000|Overall Study|Withdrawal by Subject|17|||
131070578|NCT00382408|471889804|FG001|Overall Study|Withdrawal by Subject|6|||
131070579|NCT00382408|471889803|FG000|Overall Study|Pregnancy|2|||
131070580|NCT00382408|471889804|FG001|Overall Study|Pregnancy|0|||
131070581|NCT00382408|471889803|FG000|Overall Study|Lost to Follow-up|19|||
131070582|NCT00382408|471889804|FG001|Overall Study|Lost to Follow-up|8|||
131070583|NCT00382408|471889803|FG000|Overall Study|Other|100|||
131070584|NCT00382408|471889804|FG001|Overall Study|Other|35|||
131070585|NCT00352053|471889807|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
131070586|NCT00352053|471889808|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
131070587|NCT00352053|471889807|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
131070588|NCT00352053|471889808|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
131070589|NCT00352053|471889807|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
131070590|NCT00352053|471889808|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
131070591|NCT00352053|471889807|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
131070592|NCT00352053|471889808|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
131070593|NCT00352053|471889807|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
131070594|NCT00352053|471889808|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
131070595|NCT00352053|471889807|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
131070596|NCT00352053|471889808|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
131070597|NCT00352053|471889807|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
131070598|NCT00352053|471889808|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
131070599|NCT00352053|471889807|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
131070600|NCT00352053|471889808|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
131070601|NCT00352053|471889807|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
131070602|NCT00352053|471889808|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
131070603|NCT00352053|471889807|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
131070604|NCT00352053|471889808|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
131070605|NCT00352053|471889807|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
131070606|NCT00352053|471889808|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
131070607|NCT00352053|471889807|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
131070608|NCT00352053|471889808|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
130723553|NCT00229723|470613460|FG001|Maintenance Phase|Informed consent withdrawn|0|||
131230698|NCT02497391|472471302|FG004|Period 3 (14 Days)|Adverse Event|0|||
131230699|NCT02497391|472471303|FG005|Period 3 (14 Days)|Adverse Event|0|||
131230700|NCT02497391|472471298|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
131230701|NCT02497391|472471299|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
131230702|NCT02497391|472471300|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
131230703|NCT02497391|472471301|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
131230704|NCT02497391|472471302|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
131230705|NCT02497391|472471303|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
131230706|NCT02497391|472471298|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
131230707|NCT02497391|472471299|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
131230708|NCT02497391|472471300|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
131230709|NCT02497391|472471301|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
131230710|NCT02497391|472471302|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
131230711|NCT02497391|472471303|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
131230712|NCT01469364|472471314|FG000|Overall Study|Adverse Event|1|||
131230713|NCT01469364|472471314|FG000|Overall Study|Withdrawal by Subject|1|||
131230714|NCT03433001|472471322|FG000|Overall Study|Lack of Efficacy|109|||
131230715|NCT03433001|472471322|FG000|Overall Study|Adverse Event|69|||
131230716|NCT03433001|472471322|FG000|Overall Study|Withdrawal by Subject|10|||
131230717|NCT03433001|472471322|FG000|Overall Study|Death|12|||
131230718|NCT03433001|472471322|FG000|Overall Study|Lost to Follow-up|4|||
131230719|NCT03433001|472471322|FG000|Overall Study|Other|25|||
131230720|NCT01007916|472471325|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
131230721|NCT01007916|472471326|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
131230722|NCT01007916|472471325|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
131230723|NCT01007916|472471326|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
131230724|NCT01958281|472471327|FG000|Overall Study|Lack of Efficacy|5|||
131230725|NCT01958281|472471328|FG001|Overall Study|Lack of Efficacy|2|||
131230726|NCT01958281|472471329|FG002|Overall Study|Lack of Efficacy|0|||
131230727|NCT01958281|472471327|FG000|Overall Study|Adverse Event|0|||
131230728|NCT01958281|472471328|FG001|Overall Study|Adverse Event|2|||
131230729|NCT01958281|472471329|FG002|Overall Study|Adverse Event|0|||
131230730|NCT01958281|472471327|FG000|Overall Study|Withdrew Consent|1|||
131230731|NCT01958281|472471328|FG001|Overall Study|Withdrew Consent|0|||
131230732|NCT01958281|472471329|FG002|Overall Study|Withdrew Consent|0|||
131230733|NCT02784106|472471330|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
131230734|NCT02784106|472471331|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
131230735|NCT02784106|472471332|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
131230736|NCT02784106|472471333|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
131230737|NCT02784106|472471330|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
131230738|NCT02784106|472471331|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
131230739|NCT02784106|472471332|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131230740|NCT02784106|472471333|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
131070609|NCT00352053|471889807|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
131070610|NCT00352053|471889808|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
131070611|NCT02402465|471889809|FG000|Overall Study|Withdrawal by Subject|0|||
131070612|NCT02402465|471889810|FG001|Overall Study|Withdrawal by Subject|0|||
131070613|NCT02402465|471889811|FG002|Overall Study|Withdrawal by Subject|0|||
131070614|NCT02402465|471889812|FG003|Overall Study|Withdrawal by Subject|0|||
131070615|NCT02402465|471889813|FG004|Overall Study|Withdrawal by Subject|0|||
131070616|NCT02402465|471889814|FG005|Overall Study|Withdrawal by Subject|1|||
131070617|NCT02402465|471889809|FG000|Overall Study|Lost to Follow-up|0|||
131230741|NCT02784106|472471330|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
131230742|NCT02784106|472471331|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
130723554|NCT00229723|470613461|FG002|Maintenance Phase|Informed consent withdrawn|0|||
130723555|NCT00229723|470613462|FG003|Maintenance Phase|Informed consent withdrawn|1|||
130723556|NCT00229723|470613463|FG004|Maintenance Phase|Informed consent withdrawn|1|||
130723557|NCT00229723|470613464|FG005|Maintenance Phase|Informed consent withdrawn|1|||
130723558|NCT00229723|470613465|FG006|Maintenance Phase|Informed consent withdrawn|0|||
130723559|NCT00229723|470613459|FG000|Maintenance Phase|Severe non-compliance|3|||
131070618|NCT02402465|471889810|FG001|Overall Study|Lost to Follow-up|1|||
131230743|NCT02784106|472471332|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
131230744|NCT02784106|472471333|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
131230745|NCT02784106|472471330|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
131230746|NCT02784106|472471331|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
131230747|NCT02784106|472471332|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
131230748|NCT02784106|472471333|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
131230749|NCT02784106|472471330|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
131230750|NCT02784106|472471331|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
131230751|NCT02784106|472471332|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
131230752|NCT02784106|472471333|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
131070619|NCT02402465|471889811|FG002|Overall Study|Lost to Follow-up|0|||
131070620|NCT02402465|471889812|FG003|Overall Study|Lost to Follow-up|0|||
131070621|NCT02402465|471889813|FG004|Overall Study|Lost to Follow-up|1|||
131070622|NCT02402465|471889814|FG005|Overall Study|Lost to Follow-up|0|||
131070623|NCT03807700|471889815|FG000|Overall Study|Withdrawal by Subject|2|||
131070624|NCT03807700|471889816|FG001|Overall Study|Withdrawal by Subject|1|||
131070625|NCT01675050|471889817|FG000|Period One Treatment|Withdrawal by Subject|1|||
131070626|NCT01675050|471889818|FG001|Period One Treatment|Withdrawal by Subject|0|||
131070627|NCT02282917|471889820|FG000|Overall Study|Withdrawal by Subject|1|||
131070628|NCT02282917|471889820|FG000|Overall Study|Screen Failure/Not Eligible|1|||
131070629|NCT00655668|471889827|FG000|Overall Study|Adverse Event|6|||
131070630|NCT00655668|471889827|FG000|Overall Study|Death|5|||
131070631|NCT00655668|471889827|FG000|Overall Study|Disease Progression|27|||
131070632|NCT00655668|471889827|FG000|Overall Study|Study Terminated|9|||
131070633|NCT00655668|471889827|FG000|Overall Study|Other|1|||
131070634|NCT00655668|471889827|FG000|Overall Study|New Lymphoma Treatment Started|4|||
131070635|NCT00655668|471889827|FG000|Overall Study|Withdrawal by Subject|2|||
131070636|NCT00595764|471889828|FG000|Overall Study|Protocol Violation|24|||
131070637|NCT00595764|471889829|FG001|Overall Study|Protocol Violation|19|||
131070638|NCT00595764|471889828|FG000|Overall Study|Missed Medication >1 week|10|||
131070639|NCT00595764|471889829|FG001|Overall Study|Missed Medication >1 week|17|||
131070640|NCT00595764|471889828|FG000|Overall Study|Missed 3 PM visits|1|||
131070641|NCT00595764|471889829|FG001|Overall Study|Missed 3 PM visits|7|||
131070642|NCT00595764|471889828|FG000|Overall Study|Withdrawal by Subject|4|||
131070643|NCT00595764|471889829|FG001|Overall Study|Withdrawal by Subject|0|||
131070644|NCT01894256|471889830|FG000|Part A|Adverse Event|0|||
131070645|NCT01894256|471889831|FG001|Part A|Adverse Event|1|||
131070646|NCT01894256|471889832|FG002|Part A|Adverse Event|0|||
131070647|NCT01894256|471889830|FG000|Part B|Death|0|||
131070648|NCT01894256|471889831|FG001|Part B|Death|1|||
131070649|NCT01894256|471889832|FG002|Part B|Death|1|||
131070650|NCT01894256|471889830|FG000|Part B|Withdrawal by Subject|0|||
131070651|NCT01894256|471889831|FG001|Part B|Withdrawal by Subject|1|||
131070652|NCT01894256|471889832|FG002|Part B|Withdrawal by Subject|0|||
131070653|NCT01894256|471889830|FG000|Part B|Lack of Efficacy|15|||
131070654|NCT01894256|471889831|FG001|Part B|Lack of Efficacy|12|||
131070655|NCT01894256|471889832|FG002|Part B|Lack of Efficacy|13|||
131070656|NCT00500539|471889836|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
131070657|NCT00500539|471889836|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
131070658|NCT00500539|471889836|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
131070659|NCT00500539|471889836|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
131070660|NCT00500539|471889836|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
131070661|NCT00500539|471889836|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
131070662|NCT00500539|471889836|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
130723560|NCT00229723|470613460|FG001|Maintenance Phase|Severe non-compliance|1|||
130723561|NCT00229723|470613461|FG002|Maintenance Phase|Severe non-compliance|0|||
131070663|NCT00500539|471889836|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
131070664|NCT00500539|471889836|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
131070665|NCT00500539|471889836|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
131070666|NCT00500539|471889836|FG000|Follow-up Period (16 Weeks)|Death|1|||
131070667|NCT00500539|471889836|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
131070668|NCT00500539|471889836|FG000|Follow-up Period (16 Weeks)|Missing|3|||
131070669|NCT02316171|471889840|FG000|Overall Study|difficulties with urinary catheter|1|||
131070670|NCT02316171|471889841|FG001|Overall Study|difficulties with urinary catheter|0|||
131070671|NCT02316171|471889842|FG002|Overall Study|difficulties with urinary catheter|0|||
131070672|NCT02316171|471889843|FG003|Overall Study|difficulties with urinary catheter|0|||
131070673|NCT04341584|471889844|FG000|Overall Study|Withdrew consent|0|||
131070674|NCT04341584|471889845|FG001|Overall Study|Withdrew consent|2|||
131070675|NCT04341584|471889846|FG002|Overall Study|Withdrew consent|2|||
131070676|NCT04341584|471889847|FG003|Overall Study|Withdrew consent|1|||
131070677|NCT04267393|471889848|FG000|Randomization|Adverse Event|1|||
131070678|NCT04267393|471889849|FG001|Randomization|Adverse Event|0|||
130723562|NCT00229723|470613462|FG003|Maintenance Phase|Severe non-compliance|0|||
130723563|NCT00229723|470613463|FG004|Maintenance Phase|Severe non-compliance|1|||
131070679|NCT04267393|471889850|FG002|Randomization|Adverse Event|0|||
131070680|NCT04267393|471889848|FG000|Randomization|Administrative Reasons by Sponsor|0|||
131070681|NCT04267393|471889849|FG001|Randomization|Administrative Reasons by Sponsor|1|||
131070682|NCT04267393|471889850|FG002|Randomization|Administrative Reasons by Sponsor|0|||
131070683|NCT04267393|471889848|FG000|Treatment Period|Adverse Event|0|||
131070684|NCT04267393|471889849|FG001|Treatment Period|Adverse Event|2|||
131070685|NCT04267393|471889850|FG002|Treatment Period|Adverse Event|3|||
131070686|NCT04267393|471889848|FG000|Treatment Period|Participant Withdrew Consent|0|||
131070687|NCT04267393|471889849|FG001|Treatment Period|Participant Withdrew Consent|0|||
131070688|NCT04267393|471889850|FG002|Treatment Period|Participant Withdrew Consent|1|||
131070689|NCT04267393|471889848|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
131070690|NCT04267393|471889849|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
131070691|NCT04267393|471889850|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
131070692|NCT01002547|471891663|FG000|Overall Study|Withdrawal by Subject|4|||
131070693|NCT01002547|471891664|FG001|Overall Study|Withdrawal by Subject|0|||
131070694|NCT01002547|471891665|FG002|Overall Study|Withdrawal by Subject|5|||
131070695|NCT01002547|471891663|FG000|Overall Study|Lost to Follow-up|2|||
131070696|NCT01002547|471891664|FG001|Overall Study|Lost to Follow-up|1|||
131070697|NCT01002547|471891665|FG002|Overall Study|Lost to Follow-up|1|||
131070698|NCT01002547|471891663|FG000|Overall Study|Physician Decision|1|||
131070699|NCT01002547|471891664|FG001|Overall Study|Physician Decision|0|||
131070700|NCT01002547|471891665|FG002|Overall Study|Physician Decision|0|||
131070701|NCT01002547|471891663|FG000|Overall Study|Death|0|||
131070702|NCT01002547|471891664|FG001|Overall Study|Death|2|||
131230753|NCT02784106|472471330|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
131230754|NCT02784106|472471331|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
131230755|NCT02784106|472471332|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
131230756|NCT02784106|472471333|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
131230757|NCT03222141|472471336|FG000|Overall Study|Death|15|||
131230758|NCT03222141|472471336|FG000|Overall Study|Lost to Follow-up|3|||
131230759|NCT01851590|472471348|FG000|Overall Study|Withdrawal by Subject|0|||
131070703|NCT01002547|471891665|FG002|Overall Study|Death|2|||
131070704|NCT01002547|471891663|FG000|Overall Study|Adverse Event|1|||
131070705|NCT01002547|471891664|FG001|Overall Study|Adverse Event|0|||
131070706|NCT01002547|471891665|FG002|Overall Study|Adverse Event|0|||
131070707|NCT00088452|471891670|FG000|Overall Study|Did not receive intervention|1|||
131070708|NCT00088452|471891671|FG001|Overall Study|Did not receive intervention|0|||
131070709|NCT00088452|471891672|FG002|Overall Study|Did not receive intervention|1|||
131070710|NCT02081196|471891674|FG000|Overall Study|Lost to Follow-up|1|||
131070711|NCT02329223|471891679|FG000|Overall Study|Withdrawal by Subject|1|||
131070712|NCT02329223|471891680|FG001|Overall Study|Withdrawal by Subject|2|||
131070713|NCT02329223|471891681|FG002|Overall Study|Withdrawal by Subject|5|||
131230760|NCT01851590|472471349|FG001|Overall Study|Withdrawal by Subject|0|||
131230761|NCT01851590|472471350|FG002|Overall Study|Withdrawal by Subject|1|||
131070714|NCT02329223|471891679|FG000|Overall Study|Physician Decision|0|||
131070715|NCT02329223|471891680|FG001|Overall Study|Physician Decision|0|||
131230762|NCT01851590|472471348|FG000|Overall Study|Adverse Event|0|||
131230763|NCT01851590|472471349|FG001|Overall Study|Adverse Event|0|||
131230764|NCT01851590|472471350|FG002|Overall Study|Adverse Event|2|||
131230765|NCT01851590|472471348|FG000|Overall Study|Lack of Efficacy|0|||
131230766|NCT01851590|472471349|FG001|Overall Study|Lack of Efficacy|1|||
131230767|NCT01851590|472471350|FG002|Overall Study|Lack of Efficacy|0|||
131230768|NCT02611752|472471354|FG000|Overall Study|Adverse Event|0|||
131230769|NCT02611752|472471355|FG001|Overall Study|Adverse Event|1|||
131230770|NCT00310856|472471356|FG000|Overall Study|Withdrawal by Subject|2|||
131230771|NCT00310856|472471357|FG001|Overall Study|Withdrawal by Subject|2|||
131230772|NCT00310856|472471358|FG002|Overall Study|Withdrawal by Subject|2|||
131230773|NCT00310856|472471356|FG000|Overall Study|Lost to Follow-up|1|||
131230774|NCT00310856|472471357|FG001|Overall Study|Lost to Follow-up|2|||
131230775|NCT00310856|472471358|FG002|Overall Study|Lost to Follow-up|6|||
131230776|NCT00310856|472471356|FG000|Overall Study|Inappropriate enrollment|1|||
131230777|NCT00310856|472471357|FG001|Overall Study|Inappropriate enrollment|1|||
131230778|NCT00310856|472471358|FG002|Overall Study|Inappropriate enrollment|0|||
131230779|NCT00310856|472471356|FG000|Overall Study|Unable to classify|1|||
131230780|NCT00310856|472471357|FG001|Overall Study|Unable to classify|0|||
131230781|NCT00310856|472471358|FG002|Overall Study|Unable to classify|0|||
131230782|NCT00543439|472471360|FG000|Period 1|Adverse Event|0|||
131230783|NCT00543439|472471361|FG001|Period 1|Adverse Event|2|||
131230784|NCT00543439|472471362|FG002|Period 1|Adverse Event|1|||
131230785|NCT00543439|472471360|FG000|Period 1|Withdrawal by Subject|1|||
131230786|NCT00543439|472471361|FG001|Period 1|Withdrawal by Subject|1|||
131230787|NCT00543439|472471362|FG002|Period 1|Withdrawal by Subject|0|||
131230788|NCT00543439|472471360|FG000|Period 1|Physician Decision|0|||
131070716|NCT02329223|471891681|FG002|Overall Study|Physician Decision|1|||
131230789|NCT00543439|472471361|FG001|Period 1|Physician Decision|0|||
131070717|NCT02329223|471891679|FG000|Overall Study|Adverse Event|0|||
131070718|NCT02329223|471891680|FG001|Overall Study|Adverse Event|1|||
131070719|NCT02329223|471891681|FG002|Overall Study|Adverse Event|0|||
131070720|NCT00381888|471891682|FG000|Overall Study|Death|1|||
131230790|NCT00543439|472471362|FG002|Period 1|Physician Decision|1|||
131230791|NCT00543439|472471360|FG000|Period 2|Protocol Violation|1|||
131230792|NCT00543439|472471361|FG001|Period 2|Protocol Violation|0|||
131230793|NCT00543439|472471362|FG002|Period 2|Protocol Violation|1|||
131230794|NCT00543439|472471360|FG000|Period 2|Adverse Event|0|||
131230795|NCT00543439|472471361|FG001|Period 2|Adverse Event|1|||
131230796|NCT00543439|472471362|FG002|Period 2|Adverse Event|1|||
131070721|NCT00381888|471891682|FG000|Overall Study|Withdrawal by Subject|1|||
131070722|NCT00381888|471891682|FG000|Overall Study|Physician Decision|1|||
131070723|NCT00381888|471891682|FG000|Overall Study|Protocol Violation|9|||
131070724|NCT00381888|471891682|FG000|Overall Study|Had laparoscopic surgery|2|||
131230797|NCT01211769|472471363|FG000|Overall Study|Lost to Follow-up|7|||
131230798|NCT01211769|472471364|FG001|Overall Study|Lost to Follow-up|9|||
131070725|NCT00381888|471891682|FG000|Overall Study|Surgery was cancelled|2|||
131070726|NCT00381888|471891682|FG000|Overall Study|Adverse Event|1|||
131070727|NCT01580995|471891686|FG000|Overall Study|Lost to Follow-up|2|||
131070728|NCT01580995|471891687|FG001|Overall Study|Lost to Follow-up|2|||
131070729|NCT02916706|471891688|FG000|Overall Study|Adverse Event|0|||
131070730|NCT02916706|471891689|FG001|Overall Study|Adverse Event|1|||
131070731|NCT02916706|471891688|FG000|Overall Study|Lost to Follow-up|0|||
131070732|NCT02916706|471891689|FG001|Overall Study|Lost to Follow-up|1|||
131070733|NCT02916706|471891688|FG000|Overall Study|Physician Decision|1|||
131070734|NCT02916706|471891689|FG001|Overall Study|Physician Decision|0|||
131070735|NCT02916706|471891688|FG000|Overall Study|Protocol Violation|3|||
131070736|NCT02916706|471891689|FG001|Overall Study|Protocol Violation|1|||
131070737|NCT02916706|471891688|FG000|Overall Study|Withdrawal by Subject|6|||
131070738|NCT02916706|471891689|FG001|Overall Study|Withdrawal by Subject|9|||
131070739|NCT02916706|471891688|FG000|Overall Study|Other|5|||
131070740|NCT02916706|471891689|FG001|Overall Study|Other|19|||
131070741|NCT00598871|471891690|FG000|Overall Study|Adverse Event|0|||
131070742|NCT00598871|471891691|FG001|Overall Study|Adverse Event|1|||
131070743|NCT00381797|471891692|FG000|Overall Study|Withdrawal by Subject|1|||
131070744|NCT00381797|471891693|FG001|Overall Study|Withdrawal by Subject|1|||
131070745|NCT00381797|471891694|FG002|Overall Study|Withdrawal by Subject|0|||
131070746|NCT00381797|471891695|FG003|Overall Study|Withdrawal by Subject|0|||
131070747|NCT00381797|471891696|FG004|Overall Study|Withdrawal by Subject|2|||
131070748|NCT00381797|471891692|FG000|Overall Study|Ineligible|0|||
131070749|NCT00381797|471891693|FG001|Overall Study|Ineligible|0|||
131070750|NCT00381797|471891694|FG002|Overall Study|Ineligible|0|||
131070751|NCT00381797|471891695|FG003|Overall Study|Ineligible|1|||
131070752|NCT00381797|471891696|FG004|Overall Study|Ineligible|0|||
131070753|NCT00958711|471891697|FG000|Overall Study|Withdrawal by Subject|0|||
131070754|NCT00958711|471891698|FG001|Overall Study|Withdrawal by Subject|4|||
131070755|NCT00958711|471891697|FG000|Overall Study|Physician Decision|5|||
131070756|NCT00958711|471891698|FG001|Overall Study|Physician Decision|7|||
131070757|NCT00958711|471891697|FG000|Overall Study|Lost to Follow-up|4|||
131070758|NCT00958711|471891698|FG001|Overall Study|Lost to Follow-up|1|||
131070759|NCT00958711|471891697|FG000|Overall Study|Other|2|||
131070760|NCT00958711|471891698|FG001|Overall Study|Other|5|||
131070761|NCT00958711|471891697|FG000|Overall Study|Death|1|||
131070762|NCT00958711|471891698|FG001|Overall Study|Death|2|||
131070763|NCT00958711|471891697|FG000|Overall Study|Adverse Event|1|||
131070764|NCT00958711|471891698|FG001|Overall Study|Adverse Event|2|||
131070765|NCT00550771|471891701|FG000|Overall Study|Adverse Event|11|||
131070766|NCT00550771|471891702|FG001|Overall Study|Adverse Event|3|||
131070767|NCT00550771|471891701|FG000|Overall Study|Discontinued for study-related reasons|0|||
131070768|NCT00550771|471891702|FG001|Overall Study|Discontinued for study-related reasons|1|||
131070769|NCT00550771|471891701|FG000|Overall Study|Physician Decision|2|||
131070770|NCT00550771|471891702|FG001|Overall Study|Physician Decision|0|||
131070771|NCT00550771|471891701|FG000|Overall Study|Withdrawal by Subject|0|||
131070772|NCT00550771|471891702|FG001|Overall Study|Withdrawal by Subject|1|||
131070773|NCT00550771|471891701|FG000|Overall Study|Protocol Violation|4|||
131070774|NCT00550771|471891702|FG001|Overall Study|Protocol Violation|5|||
131070775|NCT00839306|471891706|FG000|Overall Study|Adverse Event|3|||
131070776|NCT00839306|471891707|FG001|Overall Study|Adverse Event|5|||
131070777|NCT00839306|471891706|FG000|Overall Study|Lost to Follow-up|6|||
131070778|NCT00839306|471891707|FG001|Overall Study|Lost to Follow-up|9|||
131070779|NCT00839306|471891706|FG000|Overall Study|Withdrawal by Subject|5|||
131070780|NCT00839306|471891707|FG001|Overall Study|Withdrawal by Subject|7|||
131070781|NCT00839306|471891706|FG000|Overall Study|Lack of Efficacy|5|||
131070782|NCT00839306|471891707|FG001|Overall Study|Lack of Efficacy|4|||
131070783|NCT00839306|471891706|FG000|Overall Study|Other|6|||
131070784|NCT00839306|471891707|FG001|Overall Study|Other|18|||
131070785|NCT01066897|471891708|FG000|Overall Study|Withdrawal by Subject|1|||
131070786|NCT01066897|471891709|FG001|Overall Study|Withdrawal by Subject|0|||
131070787|NCT01066897|471891708|FG000|Overall Study|stopped study after developing the flu.|1|||
131070788|NCT01066897|471891709|FG001|Overall Study|stopped study after developing the flu.|0|||
131070789|NCT01697592|471891710|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
131070790|NCT01697592|471891711|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131070791|NCT01697592|471891712|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131070792|NCT01697592|471891713|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131070793|NCT01697592|471891714|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131070794|NCT01697592|471891715|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131070795|NCT01697592|471891716|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131070796|NCT01697592|471891717|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131070797|NCT01697592|471891718|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131070798|NCT01697592|471891719|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
131070799|NCT01697592|471891710|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131070800|NCT01697592|471891711|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131070801|NCT01697592|471891712|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131070802|NCT01697592|471891713|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131230799|NCT01211769|472471365|FG002|Overall Study|Lost to Follow-up|5|||
131230800|NCT01211769|472471366|FG003|Overall Study|Lost to Follow-up|9|||
131230801|NCT01211769|472471363|FG000|Overall Study|Physician Decision|2|||
131230802|NCT01211769|472471364|FG001|Overall Study|Physician Decision|0|||
131230803|NCT01211769|472471365|FG002|Overall Study|Physician Decision|2|||
131230804|NCT01211769|472471366|FG003|Overall Study|Physician Decision|1|||
131230805|NCT01211769|472471363|FG000|Overall Study|Adverse Event|0|||
131230806|NCT01211769|472471364|FG001|Overall Study|Adverse Event|1|||
131230807|NCT01211769|472471365|FG002|Overall Study|Adverse Event|1|||
131230808|NCT01211769|472471366|FG003|Overall Study|Adverse Event|1|||
131230809|NCT01214330|472471367|FG000|Overall Study|Withdrawal by Subject|2|||
131230810|NCT01214330|472471367|FG000|Overall Study|Withdrawal by Subject|2|||
131230811|NCT01348542|472471369|FG000|Overall Study|Withdrawal by Subject|3|||
131230812|NCT01348542|472471370|FG001|Overall Study|Withdrawal by Subject|0|||
131230813|NCT03402893|472471371|FG000|Overall Study|Withdrawal by Subject|1|||
131230814|NCT00686036|472471372|FG000|Overall Study|Adverse Event|3|||
131230815|NCT00686036|472471373|FG001|Overall Study|Adverse Event|0|||
131230816|NCT00686036|472471372|FG000|Overall Study|Withdrawal by Subject|3|||
131230817|NCT00686036|472471373|FG001|Overall Study|Withdrawal by Subject|1|||
131230818|NCT00686036|472471372|FG000|Overall Study|Study terminated by AstraZeneca|2|||
131230819|NCT00686036|472471373|FG001|Overall Study|Study terminated by AstraZeneca|1|||
131230820|NCT00686036|472471372|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
131230821|NCT00686036|472471373|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
131230822|NCT00686036|472471372|FG000|Overall Study|Other reasons not identified|0|||
131230823|NCT00686036|472471373|FG001|Overall Study|Other reasons not identified|4|||
131230824|NCT00926289|472471374|FG000|Overall Study|Adverse Event|9|||
131230825|NCT00926289|472471375|FG001|Overall Study|Adverse Event|11|||
131230826|NCT00926289|472471374|FG000|Overall Study|Protocol Violation|8|||
131230827|NCT00926289|472471375|FG001|Overall Study|Protocol Violation|12|||
131230828|NCT00926289|472471374|FG000|Overall Study|Lost to Follow-up|3|||
131230829|NCT00926289|472471375|FG001|Overall Study|Lost to Follow-up|6|||
131230830|NCT00926289|472471374|FG000|Overall Study|Withdrawal by Subject|4|||
131230831|NCT00926289|472471375|FG001|Overall Study|Withdrawal by Subject|4|||
131230832|NCT00926289|472471374|FG000|Overall Study|Other|1|||
131230833|NCT00926289|472471375|FG001|Overall Study|Other|3|||
130723564|NCT00229723|470613464|FG005|Maintenance Phase|Severe non-compliance|0|||
130723565|NCT00229723|470613465|FG006|Maintenance Phase|Severe non-compliance|0|||
130723566|NCT00229723|470613459|FG000|Maintenance Phase|Other|5|||
130723567|NCT00229723|470613460|FG001|Maintenance Phase|Other|4|||
130723568|NCT00229723|470613461|FG002|Maintenance Phase|Other|1|||
130723569|NCT00229723|470613462|FG003|Maintenance Phase|Other|2|||
130723570|NCT00229723|470613463|FG004|Maintenance Phase|Other|3|||
130723571|NCT00229723|470613464|FG005|Maintenance Phase|Other|3|||
130723572|NCT00229723|470613465|FG006|Maintenance Phase|Other|1|||
130723573|NCT00735397|470613468|FG000|Overall Study|Adverse Event|194|||
131070803|NCT01697592|471891714|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131070804|NCT01697592|471891715|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
131070805|NCT01697592|471891716|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131070806|NCT01697592|471891717|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131070807|NCT01697592|471891718|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131070808|NCT01697592|471891719|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
131070809|NCT01697592|471891710|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
131070810|NCT01697592|471891711|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131070811|NCT01697592|471891712|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131070812|NCT01697592|471891713|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131070813|NCT01697592|471891714|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131070814|NCT01697592|471891715|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131070815|NCT01697592|471891716|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131070816|NCT01697592|471891717|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131070817|NCT01697592|471891718|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131070818|NCT01697592|471891719|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
131070819|NCT01697592|471891710|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
131070820|NCT01697592|471891711|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
131070821|NCT01697592|471891712|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131230834|NCT00146770|472471377|FG000|Overall Study|Adverse Event|2|||
131230835|NCT00146770|472471378|FG001|Overall Study|Adverse Event|0|||
131230836|NCT00146770|472471377|FG000|Overall Study|Pregnancy|1|||
131230837|NCT00146770|472471378|FG001|Overall Study|Pregnancy|0|||
131230838|NCT00146770|472471377|FG000|Overall Study|Withdrawal by Subject|2|||
131230839|NCT00146770|472471378|FG001|Overall Study|Withdrawal by Subject|0|||
131230840|NCT01855126|472471381|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
131230841|NCT01855126|472471382|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
131230842|NCT01855126|472471381|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
130723574|NCT00735397|470613468|FG000|Overall Study|Lost to Follow-up|33|||
130723575|NCT00735397|470613468|FG000|Overall Study|Participant choice|252|||
131070822|NCT01697592|471891713|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
130779489|NCT02326272|470819501|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131070823|NCT01697592|471891714|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131070824|NCT01697592|471891715|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131070825|NCT01697592|471891716|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
131070826|NCT01697592|471891717|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131070827|NCT01697592|471891718|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
131070828|NCT01697592|471891719|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
131070829|NCT01697592|471891710|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131070830|NCT01697592|471891711|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
131070831|NCT01697592|471891712|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
131070832|NCT01697592|471891713|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
131070833|NCT01697592|471891714|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131070834|NCT01697592|471891715|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131070835|NCT01697592|471891716|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
131070836|NCT01697592|471891717|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131070837|NCT01697592|471891718|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
131070838|NCT01697592|471891719|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
131070839|NCT01697592|471891710|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
131070840|NCT01697592|471891711|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131070841|NCT01697592|471891712|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131070842|NCT01697592|471891713|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
131070843|NCT01697592|471891714|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131070844|NCT01697592|471891715|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131070845|NCT01697592|471891716|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131070846|NCT01697592|471891717|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131070847|NCT01697592|471891718|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131070848|NCT01697592|471891719|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
131070849|NCT01697592|471891710|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
131070850|NCT01697592|471891711|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131070851|NCT01697592|471891712|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131070852|NCT01697592|471891713|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131070853|NCT01697592|471891714|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131070854|NCT01697592|471891715|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
131070855|NCT01697592|471891716|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131070856|NCT01697592|471891717|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
131070857|NCT01697592|471891718|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131070858|NCT01697592|471891719|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
131070859|NCT01697592|471891710|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
131070860|NCT01697592|471891711|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
131070861|NCT01697592|471891712|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
131070862|NCT01697592|471891713|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
131070863|NCT01697592|471891714|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
131070864|NCT01697592|471891715|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
131070865|NCT01697592|471891716|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
131070866|NCT01697592|471891717|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
131070867|NCT01697592|471891718|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
131070868|NCT01697592|471891719|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
131070869|NCT01126879|471891720|FG000|Overall Study|Progressive Disease|3|||
131070870|NCT01126879|471891721|FG001|Overall Study|Progressive Disease|1|||
131070871|NCT01126879|471891720|FG000|Overall Study|Withdrawal by Subject|1|||
131070872|NCT01126879|471891721|FG001|Overall Study|Withdrawal by Subject|0|||
131070873|NCT01126879|471891720|FG000|Overall Study|Adverse Event|0|||
131137751|NCT00763321|472130694|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
131070874|NCT01126879|471891721|FG001|Overall Study|Adverse Event|1|||
131070875|NCT01126879|471891720|FG000|Overall Study|Physician Decision|1|||
131070876|NCT01126879|471891721|FG001|Overall Study|Physician Decision|0|||
131070877|NCT00498433|471891722|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
131070878|NCT00498433|471891723|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
131070879|NCT00498433|471891724|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
131070880|NCT00498433|471891722|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
131070881|NCT00498433|471891723|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
131070882|NCT00498433|471891724|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
131070883|NCT00498433|471891722|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
131070884|NCT00498433|471891723|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
131070885|NCT00498433|471891724|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
131070886|NCT00498433|471891722|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
131070887|NCT00498433|471891723|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
131070888|NCT00498433|471891724|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
131070889|NCT03193216|471891728|FG000|Overall Study|Lost to Follow-up|1|||
131070890|NCT03193216|471891729|FG001|Overall Study|Lost to Follow-up|0|||
131070891|NCT03193216|471891728|FG000|Overall Study|Withdrawal by Subject|5|||
131070892|NCT03193216|471891729|FG001|Overall Study|Withdrawal by Subject|0|||
131070893|NCT03193216|471891728|FG000|Overall Study|Physician Decision|4|||
131070894|NCT03193216|471891729|FG001|Overall Study|Physician Decision|0|||
131070895|NCT01514864|471891730|FG000|Overall Study|Disease progression|7|||
131070896|NCT01514864|471891731|FG001|Overall Study|Disease progression|5|||
131070897|NCT01514864|471891730|FG000|Overall Study|Study drug toxicity|2|||
131070898|NCT01514864|471891731|FG001|Overall Study|Study drug toxicity|0|||
131070899|NCT02253147|471891732|FG000|Overall Study|Protocol Violation|30|||
131070900|NCT02253147|471891732|FG000|Overall Study|Did not consent to study extension|9|||
131070901|NCT02253147|471891732|FG000|Overall Study|Conditional re-treatment at W52|5|||
131070902|NCT02253147|471891732|FG000|Overall Study|Lost to Follow-up|2|||
131070903|NCT02253147|471891732|FG000|Overall Study|Withdrawal by Subject|1|||
131070904|NCT02254681|471891734|FG000|Overall Study|Lack of Efficacy|6|||
131070905|NCT02316847|471891735|FG000|Overall Study|Adverse Event|0|||
131070906|NCT02316847|471891736|FG001|Overall Study|Adverse Event|3|||
131070907|NCT02316847|471891735|FG000|Overall Study|Lost to Follow-up|0|||
131070908|NCT02316847|471891736|FG001|Overall Study|Lost to Follow-up|2|||
131070909|NCT02316847|471891735|FG000|Overall Study|Physician Decision|0|||
131070910|NCT02316847|471891736|FG001|Overall Study|Physician Decision|1|||
131070911|NCT02316847|471891735|FG000|Overall Study|Pregnancy|0|||
131070912|NCT02316847|471891736|FG001|Overall Study|Pregnancy|1|||
131070913|NCT02316847|471891735|FG000|Overall Study|Withdrawal by Subject|2|||
131070914|NCT02316847|471891736|FG001|Overall Study|Withdrawal by Subject|9|||
131070915|NCT02316847|471891735|FG000|Overall Study|Noncompliance with study drug|0|||
131070916|NCT02316847|471891736|FG001|Overall Study|Noncompliance with study drug|3|||
131070917|NCT02316847|471891735|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
131070918|NCT02316847|471891736|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
131070919|NCT02621047|471891737|FG000|Overall Study|Adverse Event|0|||
131070920|NCT02621047|471891738|FG001|Overall Study|Adverse Event|0|||
131070921|NCT02621047|471891739|FG002|Overall Study|Adverse Event|1|||
131070922|NCT02236598|471891745|FG000|Overall Study|Adverse Event|0|||
131070923|NCT02236598|471891746|FG001|Overall Study|Adverse Event|1|||
131070924|NCT02236598|471891745|FG000|Overall Study|Withdrawal by Subject|0|||
131070925|NCT02236598|471891746|FG001|Overall Study|Withdrawal by Subject|1|||
131070926|NCT01264887|471891748|FG000|Overall Study|Adverse Event|5|||
131070927|NCT01264887|471891748|FG000|Overall Study|Death|7|||
131070928|NCT01264887|471891748|FG000|Overall Study|Lack of Efficacy|5|||
131070929|NCT01264887|471891748|FG000|Overall Study|Physician Decision|4|||
131070930|NCT01264887|471891748|FG000|Overall Study|Withdrawal by Subject|6|||
131070931|NCT01264887|471891748|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
131070932|NCT01264887|471891748|FG000|Overall Study|Other|2|||
131070933|NCT02171130|471891749|FG000|Overall Study|Death|1|||
131070934|NCT02171130|471891749|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
131070935|NCT02171130|471891749|FG000|Overall Study|Discontinued; Site Termination|5|||
131070936|NCT02171130|471891749|FG000|Overall Study|Withdrawal by Subject|3|||
131070937|NCT02171130|471891749|FG000|Overall Study|Physician Decision|1|||
131070938|NCT02171130|471891749|FG000|Overall Study|Lost to Follow-up|1|||
131070939|NCT02171130|471891749|FG000|Overall Study|Met Exclusion Criteria|1|||
131070940|NCT03544229|471891750|FG000|Overall Study|Adverse Event|1|||
131070941|NCT03544229|471891751|FG001|Overall Study|Adverse Event|0|||
131070942|NCT03544229|471891752|FG002|Overall Study|Adverse Event|1|||
131070943|NCT03544229|471891753|FG003|Overall Study|Adverse Event|0|||
131070944|NCT03544229|471891750|FG000|Overall Study|Protocol Deviation|0|||
131070945|NCT03544229|471891751|FG001|Overall Study|Protocol Deviation|0|||
131070946|NCT03544229|471891752|FG002|Overall Study|Protocol Deviation|1|||
131070947|NCT03544229|471891753|FG003|Overall Study|Protocol Deviation|0|||
131070948|NCT03544229|471891750|FG000|Overall Study|Lost to Follow-up|3|||
131070949|NCT03544229|471891751|FG001|Overall Study|Lost to Follow-up|0|||
131070950|NCT03544229|471891752|FG002|Overall Study|Lost to Follow-up|0|||
131070951|NCT03544229|471891753|FG003|Overall Study|Lost to Follow-up|2|||
131070952|NCT03544229|471891750|FG000|Overall Study|Voluntary Withdrawal|2|||
131070953|NCT03544229|471891751|FG001|Overall Study|Voluntary Withdrawal|1|||
131070954|NCT03544229|471891752|FG002|Overall Study|Voluntary Withdrawal|3|||
131070955|NCT03544229|471891753|FG003|Overall Study|Voluntary Withdrawal|0|||
131070956|NCT03544229|471891750|FG000|Overall Study|Lack of Efficacy|0|||
131070957|NCT03544229|471891751|FG001|Overall Study|Lack of Efficacy|1|||
131070958|NCT03544229|471891752|FG002|Overall Study|Lack of Efficacy|0|||
131070959|NCT03544229|471891753|FG003|Overall Study|Lack of Efficacy|0|||
131070960|NCT03187353|471891755|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
131070961|NCT03187353|471891756|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
131070962|NCT03187353|471891755|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
131070963|NCT03187353|471891756|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
131070964|NCT03187353|471891755|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
131070965|NCT03187353|471891756|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
131070966|NCT03187353|471891755|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
131070967|NCT03187353|471891756|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
131070968|NCT03187353|471891755|FG000|Washout (2 Weeks)|Adverse Event|2|||
131230843|NCT01855126|472471382|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
131230844|NCT01748890|472471393|FG000|Overall Study|Insufficient recruitment for analysis|4|||
131230845|NCT03740100|472471394|FG000|Overall Study|Adverse Event|1|||
131230846|NCT03740100|472471394|FG000|Overall Study|Death|1|||
131230847|NCT03387059|472471396|FG000|Overall Study|Study termination|5|||
131230848|NCT03387059|472471397|FG001|Overall Study|Study termination|4|||
131230849|NCT01098240|472471398|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
131230850|NCT01098240|472471399|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
131230851|NCT01098240|472471400|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
131230852|NCT01098240|472471398|FG000|Open-Label Phase|Protocol Violation|4|||
131230853|NCT01098240|472471399|FG001|Open-Label Phase|Protocol Violation|0|||
131230854|NCT01098240|472471400|FG002|Open-Label Phase|Protocol Violation|0|||
131230855|NCT01098240|472471398|FG000|Open-Label Phase|Lost to Follow-up|13|||
131230856|NCT01098240|472471399|FG001|Open-Label Phase|Lost to Follow-up|0|||
131230857|NCT01098240|472471400|FG002|Open-Label Phase|Lost to Follow-up|0|||
131230858|NCT01098240|472471398|FG000|Open-Label Phase|Other|19|||
130723576|NCT00735397|470613468|FG000|Overall Study|Inadequate therapeutic effect|202|||
130723577|NCT00735397|470613468|FG000|Overall Study|Administrative/Other|502|||
130723578|NCT03016975|470613473|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
130723579|NCT03016975|470613474|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
131070969|NCT03187353|471891756|FG001|Washout (2 Weeks)|Adverse Event|0|||
131070970|NCT03187353|471891755|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
131070971|NCT03187353|471891756|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
131070972|NCT01061775|471891757|FG000|Overall Study|Physician Decision|2|||
131070973|NCT01061775|471891757|FG000|Overall Study|Lost to Follow-up|1|||
131070974|NCT03303521|471891758|FG000|Overall Study|Withdrawal by Subject|2|||
131070975|NCT03303521|471891759|FG001|Overall Study|Withdrawal by Subject|0|||
131070976|NCT03303521|471891758|FG000|Overall Study|Death|1|||
131070977|NCT03303521|471891759|FG001|Overall Study|Death|0|||
131070978|NCT03303521|471891758|FG000|Overall Study|Kidney transplantation|0|||
131070979|NCT03303521|471891759|FG001|Overall Study|Kidney transplantation|1|||
131070980|NCT03303521|471891758|FG000|Overall Study|Investigational product discontinuation|0|||
131070981|NCT03303521|471891759|FG001|Overall Study|Investigational product discontinuation|1|||
131070982|NCT03303521|471891758|FG000|Overall Study|Transferred to non-study dialysis center|1|||
131070983|NCT03303521|471891759|FG001|Overall Study|Transferred to non-study dialysis center|0|||
131070984|NCT03303521|471891758|FG000|Overall Study|Non-comliance to study protocol|0|||
131070985|NCT03303521|471891759|FG001|Overall Study|Non-comliance to study protocol|1|||
131070986|NCT03303521|471891758|FG000|Overall Study|Adverse Event|1|||
131070987|NCT03303521|471891759|FG001|Overall Study|Adverse Event|0|||
131070988|NCT02642159|471891760|FG000|Overall Study|Randomized but not treated|1|||
131070989|NCT02642159|471891761|FG001|Overall Study|Randomized but not treated|0|||
131070990|NCT02642159|471891760|FG000|Overall Study|Adverse Event|10|||
131070991|NCT02642159|471891761|FG001|Overall Study|Adverse Event|4|||
131070992|NCT02642159|471891760|FG000|Overall Study|Withdrawal by Subject|9|||
131070993|NCT02642159|471891761|FG001|Overall Study|Withdrawal by Subject|1|||
131070994|NCT02642159|471891760|FG000|Overall Study|Poor compliance to study protocol|1|||
131070995|NCT02642159|471891761|FG001|Overall Study|Poor compliance to study protocol|0|||
131070996|NCT02642159|471891760|FG000|Overall Study|Other than specified above|10|||
131070997|NCT02642159|471891761|FG001|Overall Study|Other than specified above|3|||
131070998|NCT02205476|471891762|FG000|Overall Study|Study termination by Sponsor|7|||
131070999|NCT02205476|471891763|FG001|Overall Study|Study termination by Sponsor|3|||
131071000|NCT01313299|471891764|FG000|Overall Study|Adverse Event|3|||
131071001|NCT01313299|471891765|FG001|Overall Study|Adverse Event|1|||
131071002|NCT01313299|471891766|FG002|Overall Study|Adverse Event|1|||
131071003|NCT01313299|471891764|FG000|Overall Study|Lost to Follow-up|1|||
131071004|NCT01313299|471891765|FG001|Overall Study|Lost to Follow-up|0|||
131071005|NCT01313299|471891766|FG002|Overall Study|Lost to Follow-up|0|||
131071006|NCT01313299|471891764|FG000|Overall Study|Protocol Violation|2|||
131071007|NCT01313299|471891765|FG001|Overall Study|Protocol Violation|0|||
131071008|NCT01313299|471891766|FG002|Overall Study|Protocol Violation|0|||
131230859|NCT01098240|472471399|FG001|Open-Label Phase|Other|0|||
131071009|NCT01313299|471891764|FG000|Overall Study|Withdrawal by Subject|1|||
131071010|NCT01313299|471891765|FG001|Overall Study|Withdrawal by Subject|0|||
131071011|NCT01313299|471891766|FG002|Overall Study|Withdrawal by Subject|2|||
131071012|NCT01313299|471891764|FG000|Overall Study|Family reason and moved out of state|0|||
131071013|NCT01313299|471891765|FG001|Overall Study|Family reason and moved out of state|2|||
131071014|NCT01313299|471891766|FG002|Overall Study|Family reason and moved out of state|0|||
131071015|NCT01313299|471891764|FG000|Overall Study|Lack of subject compliance|0|||
131071016|NCT01313299|471891765|FG001|Overall Study|Lack of subject compliance|0|||
131230860|NCT01098240|472471400|FG002|Open-Label Phase|Other|0|||
131071017|NCT01313299|471891766|FG002|Overall Study|Lack of subject compliance|1|||
131230861|NCT01098240|472471398|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
131230862|NCT01098240|472471399|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130723580|NCT03016975|470613475|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
130723581|NCT03016975|470613473|FG000|At 6 Months Follow-up|Death|2|||
131071018|NCT02391545|471891767|FG000|Overall Study|Death|0|||
131071019|NCT02391545|471891768|FG001|Overall Study|Death|2|||
131071020|NCT02391545|471891767|FG000|Overall Study|Lost to Follow-up|0|||
131071021|NCT02391545|471891768|FG001|Overall Study|Lost to Follow-up|1|||
131071022|NCT02391545|471891767|FG000|Overall Study|Termination of study by sponsor|20|||
131071023|NCT02391545|471891768|FG001|Overall Study|Termination of study by sponsor|20|||
131071024|NCT02391545|471891767|FG000|Overall Study|Withdrawal by Subject|0|||
131071025|NCT02391545|471891768|FG001|Overall Study|Withdrawal by Subject|1|||
131071026|NCT02391545|471891767|FG000|Overall Study|Other Reasons|6|||
131071027|NCT02391545|471891768|FG001|Overall Study|Other Reasons|4|||
131071028|NCT04754594|471891769|FG000|Blinded Period|Withdrawal by Subject|4|||
131071029|NCT04754594|471891770|FG001|Blinded Period|Withdrawal by Subject|9|||
131071030|NCT04754594|471891771|FG002|Blinded Period|Withdrawal by Subject|0|||
131071031|NCT04754594|471891772|FG003|Blinded Period|Withdrawal by Subject|0|||
131071032|NCT04754594|471891769|FG000|Blinded Period|Protocol Violation|2|||
131071033|NCT04754594|471891770|FG001|Blinded Period|Protocol Violation|2|||
131071034|NCT04754594|471891771|FG002|Blinded Period|Protocol Violation|0|||
131071035|NCT04754594|471891772|FG003|Blinded Period|Protocol Violation|0|||
131071036|NCT04754594|471891769|FG000|Blinded Period|Lost to Follow-up|1|||
131071037|NCT04754594|471891770|FG001|Blinded Period|Lost to Follow-up|1|||
131071038|NCT04754594|471891771|FG002|Blinded Period|Lost to Follow-up|0|||
131071039|NCT04754594|471891772|FG003|Blinded Period|Lost to Follow-up|0|||
131230863|NCT01098240|472471400|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
131230864|NCT01098240|472471398|FG000|Open-Label Phase|Pregnancy|1|||
131071040|NCT04754594|471891769|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
131071041|NCT04754594|471891770|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
131071042|NCT04754594|471891771|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
131071043|NCT04754594|471891772|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
131071044|NCT04754594|471891769|FG000|Unblinded Period|Withdrawal by Subject|6|||
131071045|NCT04754594|471891770|FG001|Unblinded Period|Withdrawal by Subject|8|||
131071046|NCT04754594|471891771|FG002|Unblinded Period|Withdrawal by Subject|0|||
131071047|NCT04754594|471891772|FG003|Unblinded Period|Withdrawal by Subject|0|||
131071048|NCT04754594|471891769|FG000|Unblinded Period|Lost to Follow-up|5|||
131071049|NCT04754594|471891770|FG001|Unblinded Period|Lost to Follow-up|3|||
131071050|NCT04754594|471891771|FG002|Unblinded Period|Lost to Follow-up|0|||
131071051|NCT04754594|471891772|FG003|Unblinded Period|Lost to Follow-up|0|||
131071052|NCT04754594|471891769|FG000|Unblinded Period|Protocol Violation|2|||
131071053|NCT04754594|471891770|FG001|Unblinded Period|Protocol Violation|4|||
131071054|NCT04754594|471891771|FG002|Unblinded Period|Protocol Violation|0|||
131071055|NCT04754594|471891772|FG003|Unblinded Period|Protocol Violation|0|||
131071056|NCT04754594|471891769|FG000|Unblinded Period|Other|3|||
131071057|NCT04754594|471891770|FG001|Unblinded Period|Other|0|||
131071058|NCT04754594|471891771|FG002|Unblinded Period|Other|0|||
131071059|NCT04754594|471891772|FG003|Unblinded Period|Other|0|||
131071060|NCT04754594|471891769|FG000|Infant Participants|Withdrawal by Subject|0|||
131071061|NCT04754594|471891770|FG001|Infant Participants|Withdrawal by Subject|0|||
131071062|NCT04754594|471891771|FG002|Infant Participants|Withdrawal by Subject|9|||
131071063|NCT04754594|471891772|FG003|Infant Participants|Withdrawal by Subject|17|||
131071064|NCT04754594|471891769|FG000|Infant Participants|Lost to Follow-up|0|||
131071065|NCT04754594|471891770|FG001|Infant Participants|Lost to Follow-up|0|||
131071066|NCT04754594|471891771|FG002|Infant Participants|Lost to Follow-up|4|||
131071067|NCT04754594|471891772|FG003|Infant Participants|Lost to Follow-up|10|||
131071068|NCT04754594|471891769|FG000|Infant Participants|Death|0|||
131071069|NCT04754594|471891770|FG001|Infant Participants|Death|0|||
131071070|NCT04754594|471891771|FG002|Infant Participants|Death|1|||
131071071|NCT04754594|471891772|FG003|Infant Participants|Death|1|||
131071072|NCT04754594|471891769|FG000|Infant Participants|Other|0|||
131230865|NCT01098240|472471399|FG001|Open-Label Phase|Pregnancy|0|||
131230866|NCT01098240|472471400|FG002|Open-Label Phase|Pregnancy|0|||
131230867|NCT01098240|472471398|FG000|Open-Label Phase|Withdrawal by Subject|9|||
131230868|NCT01098240|472471399|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131230869|NCT01098240|472471400|FG002|Open-Label Phase|Withdrawal by Subject|0|||
131230870|NCT01098240|472471398|FG000|Open-Label Phase|Adverse Event|12|||
131230871|NCT01098240|472471399|FG001|Open-Label Phase|Adverse Event|0|||
131230872|NCT01098240|472471400|FG002|Open-Label Phase|Adverse Event|0|||
131071073|NCT04754594|471891770|FG001|Infant Participants|Other|0|||
131071074|NCT04754594|471891771|FG002|Infant Participants|Other|1|||
131071075|NCT04754594|471891772|FG003|Infant Participants|Other|1|||
131071076|NCT03340766|471891775|FG000|Overall Study|Withdrawal by Subject|2|||
131071077|NCT03340766|471891776|FG001|Overall Study|Withdrawal by Subject|1|||
131071078|NCT03340766|471891777|FG002|Overall Study|Withdrawal by Subject|3|||
131071079|NCT03340766|471891775|FG000|Overall Study|Lost to Follow-up|0|||
131071080|NCT03340766|471891776|FG001|Overall Study|Lost to Follow-up|0|||
131071081|NCT03340766|471891777|FG002|Overall Study|Lost to Follow-up|1|||
131071082|NCT03340766|471891775|FG000|Overall Study|Death|6|||
131071083|NCT03340766|471891776|FG001|Overall Study|Death|7|||
131071084|NCT03340766|471891777|FG002|Overall Study|Death|4|||
131071085|NCT00975130|471891783|FG000|Study Part 1|Adverse Event|150|||
130779490|NCT02326272|470819502|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130779491|NCT02326272|470819503|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
131071086|NCT00975130|471891784|FG001|Study Part 1|Adverse Event|0|||
131071087|NCT00975130|471891785|FG002|Study Part 1|Adverse Event|0|||
131071088|NCT00975130|471891783|FG000|Study Part 1|Lost to Follow-up|19|||
131071089|NCT00975130|471891784|FG001|Study Part 1|Lost to Follow-up|0|||
131071090|NCT00975130|471891785|FG002|Study Part 1|Lost to Follow-up|0|||
131071091|NCT00975130|471891783|FG000|Study Part 1|Withdrawal by Subject|61|||
131071092|NCT00975130|471891784|FG001|Study Part 1|Withdrawal by Subject|0|||
131071093|NCT00975130|471891785|FG002|Study Part 1|Withdrawal by Subject|0|||
131071094|NCT00975130|471891783|FG000|Study Part 1|Protocol Violation|13|||
131071095|NCT00975130|471891784|FG001|Study Part 1|Protocol Violation|0|||
131071096|NCT00975130|471891785|FG002|Study Part 1|Protocol Violation|0|||
131071097|NCT00975130|471891783|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
131071098|NCT00975130|471891784|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
131071099|NCT00975130|471891785|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
131071100|NCT00975130|471891783|FG000|Study Part 1|Administrative|4|||
131071101|NCT00975130|471891784|FG001|Study Part 1|Administrative|0|||
131071102|NCT00975130|471891785|FG002|Study Part 1|Administrative|0|||
131071103|NCT00975130|471891783|FG000|Study Part 1|Withdrew Consent|24|||
131071104|NCT00975130|471891784|FG001|Study Part 1|Withdrew Consent|0|||
131071105|NCT00975130|471891785|FG002|Study Part 1|Withdrew Consent|0|||
131071106|NCT00975130|471891783|FG000|Study Part 2|Adverse Event|0|||
131071107|NCT00975130|471891784|FG001|Study Part 2|Adverse Event|14|||
131071108|NCT00975130|471891785|FG002|Study Part 2|Adverse Event|7|||
131071109|NCT00975130|471891783|FG000|Study Part 2|Lost to Follow-up|0|||
131071110|NCT00975130|471891784|FG001|Study Part 2|Lost to Follow-up|0|||
131071111|NCT00975130|471891785|FG002|Study Part 2|Lost to Follow-up|1|||
131071112|NCT00975130|471891783|FG000|Study Part 2|Withdrawal by Subject|0|||
131071113|NCT00975130|471891784|FG001|Study Part 2|Withdrawal by Subject|13|||
131071114|NCT00975130|471891785|FG002|Study Part 2|Withdrawal by Subject|5|||
131071115|NCT00975130|471891783|FG000|Study Part 2|Withdrew Consent|0|||
131071116|NCT00975130|471891784|FG001|Study Part 2|Withdrew Consent|6|||
131071117|NCT00975130|471891785|FG002|Study Part 2|Withdrew Consent|2|||
131071118|NCT00975130|471891783|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
131071119|NCT00975130|471891784|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
131071120|NCT00975130|471891785|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
131071121|NCT00975130|471891783|FG000|Study Part 2|Administrative|0|||
131071122|NCT00975130|471891784|FG001|Study Part 2|Administrative|1|||
131071123|NCT00975130|471891785|FG002|Study Part 2|Administrative|0|||
131071124|NCT00975130|471891783|FG000|Study Part 2|Protocol Violation|0|||
131071125|NCT00975130|471891784|FG001|Study Part 2|Protocol Violation|0|||
131071126|NCT00975130|471891785|FG002|Study Part 2|Protocol Violation|1|||
131071127|NCT00734851|471891786|FG000|Overall Study|Withdrawal by Subject|2|||
131071128|NCT00734851|471891786|FG000|Overall Study|Lost to Follow-up|1|||
131071129|NCT00734851|471891786|FG000|Overall Study|Physician Decision|18|||
131071130|NCT01332318|471891792|FG000|Overall Study|Adverse Event|0|||
131071131|NCT01332318|471891793|FG001|Overall Study|Adverse Event|3|||
131071132|NCT01332318|471891794|FG002|Overall Study|Adverse Event|0|||
131071133|NCT01332318|471891795|FG003|Overall Study|Adverse Event|0|||
131071134|NCT01332318|471891792|FG000|Overall Study|Withdrawal by Subject|1|||
131071135|NCT01332318|471891793|FG001|Overall Study|Withdrawal by Subject|1|||
131071136|NCT01332318|471891794|FG002|Overall Study|Withdrawal by Subject|0|||
131071137|NCT01332318|471891795|FG003|Overall Study|Withdrawal by Subject|1|||
131071138|NCT01332318|471891792|FG000|Overall Study|Protocol Violation|1|||
131071139|NCT01332318|471891793|FG001|Overall Study|Protocol Violation|0|||
131071140|NCT01332318|471891794|FG002|Overall Study|Protocol Violation|1|||
131071141|NCT01332318|471891795|FG003|Overall Study|Protocol Violation|1|||
131071142|NCT02820298|471891796|FG000|Overall Study|Withdrawal by Subject|0|||
131071143|NCT02820298|471891797|FG001|Overall Study|Withdrawal by Subject|1|||
131071144|NCT02820298|471891796|FG000|Overall Study|Physician Decision|1|||
131071145|NCT02820298|471891797|FG001|Overall Study|Physician Decision|0|||
131071146|NCT02820298|471891796|FG000|Overall Study|Protocol Violation|0|||
131071147|NCT02820298|471891797|FG001|Overall Study|Protocol Violation|1|||
131071148|NCT01780584|471891798|FG000|Overall Study|Death|1|||
131071149|NCT01780584|471891799|FG001|Overall Study|Death|0|||
131071150|NCT01780584|471891800|FG002|Overall Study|Death|1|||
131071151|NCT01780584|471891798|FG000|Overall Study|Adverse Event|0|||
131071152|NCT01780584|471891799|FG001|Overall Study|Adverse Event|1|||
131071153|NCT01780584|471891800|FG002|Overall Study|Adverse Event|0|||
131071154|NCT01780584|471891798|FG000|Overall Study|Protocol Violation|0|||
131071155|NCT01780584|471891799|FG001|Overall Study|Protocol Violation|0|||
131071156|NCT01780584|471891800|FG002|Overall Study|Protocol Violation|1|||
131071157|NCT00727259|471891801|FG000|Overall Study|Not all questionnaires completed|1055|||
131071158|NCT01021683|471891802|FG000|Overall Study|Lack of Efficacy|12|||
131071159|NCT01021683|471891802|FG000|Overall Study|Recovery of neutrophil count|51|||
131071160|NCT01021683|471891802|FG000|Overall Study|Other|8|||
131071161|NCT00645099|471891803|FG000|Overall Study|Lack of Efficacy|15|||
131071162|NCT00645099|471891804|FG001|Overall Study|Lack of Efficacy|6|||
130779492|NCT02326272|470819504|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130779493|NCT02326272|470819490|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779494|NCT02326272|470819491|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779495|NCT02326272|470819492|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779496|NCT02326272|470819493|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779497|NCT02326272|470819494|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779498|NCT02326272|470819495|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779499|NCT02326272|470819496|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131071163|NCT00645099|471891803|FG000|Overall Study|Withdrawal by Subject|30|||
131071164|NCT00645099|471891804|FG001|Overall Study|Withdrawal by Subject|22|||
131071165|NCT00645099|471891803|FG000|Overall Study|Lost to Follow-up|6|||
131071166|NCT00645099|471891804|FG001|Overall Study|Lost to Follow-up|4|||
131071167|NCT00645099|471891803|FG000|Overall Study|Adverse Event|11|||
131071168|NCT00645099|471891804|FG001|Overall Study|Adverse Event|5|||
131071169|NCT00645099|471891803|FG000|Overall Study|Other|9|||
131071170|NCT00645099|471891804|FG001|Overall Study|Other|5|||
131071171|NCT01201915|471891805|FG000|Overall Study|Adverse Event|2|||
131071172|NCT01201915|471891806|FG001|Overall Study|Adverse Event|1|||
131071173|NCT01201915|471891807|FG002|Overall Study|Adverse Event|1|||
131071174|NCT01201915|471891805|FG000|Overall Study|Lost to Follow-up|0|||
131071175|NCT01201915|471891806|FG001|Overall Study|Lost to Follow-up|4|||
131071176|NCT01201915|471891807|FG002|Overall Study|Lost to Follow-up|0|||
131071177|NCT01201915|471891805|FG000|Overall Study|Physician Decision|3|||
131071178|NCT01201915|471891806|FG001|Overall Study|Physician Decision|0|||
131071179|NCT01201915|471891807|FG002|Overall Study|Physician Decision|0|||
131071180|NCT01201915|471891805|FG000|Overall Study|Subject Decision|3|||
131071181|NCT01201915|471891806|FG001|Overall Study|Subject Decision|3|||
131071182|NCT01201915|471891807|FG002|Overall Study|Subject Decision|5|||
131071183|NCT01201915|471891805|FG000|Overall Study|Target Lesion Progression|0|||
131071184|NCT01201915|471891806|FG001|Overall Study|Target Lesion Progression|3|||
131071185|NCT01201915|471891807|FG002|Overall Study|Target Lesion Progression|0|||
131071186|NCT03406507|471891808|FG000|Extension Period|Lack of Efficacy|0|||
131071187|NCT03406507|471891809|FG001|Extension Period|Lack of Efficacy|1|||
131071188|NCT00663923|471891810|FG000|Overall Study|Lost to Follow-up|2|||
131071189|NCT01804140|471891811|FG000|Overall Study|No sampling or biopsy procedures done|114|||
131071190|NCT01524887|471891812|FG000|Overall Study|Withdrawal by Subject|6|||
131071191|NCT01524887|471891813|FG001|Overall Study|Withdrawal by Subject|2|||
131071192|NCT01524887|471891814|FG002|Overall Study|Withdrawal by Subject|3|||
131071193|NCT01524887|471891812|FG000|Overall Study|Adverse Event|5|||
131071194|NCT01524887|471891813|FG001|Overall Study|Adverse Event|1|||
131071195|NCT01524887|471891814|FG002|Overall Study|Adverse Event|1|||
131071196|NCT01524887|471891812|FG000|Overall Study|Protocol Violation|0|||
131071197|NCT01524887|471891813|FG001|Overall Study|Protocol Violation|0|||
131071198|NCT01524887|471891814|FG002|Overall Study|Protocol Violation|1|||
131071199|NCT01524887|471891812|FG000|Overall Study|Study termination|73|||
131071200|NCT01524887|471891813|FG001|Overall Study|Study termination|87|||
131071201|NCT01524887|471891814|FG002|Overall Study|Study termination|79|||
131071202|NCT01524887|471891812|FG000|Overall Study|Withdrawal by Caregiver|0|||
131071203|NCT01524887|471891813|FG001|Overall Study|Withdrawal by Caregiver|0|||
131071204|NCT01524887|471891814|FG002|Overall Study|Withdrawal by Caregiver|2|||
131071205|NCT01524887|471891812|FG000|Overall Study|Use of prohibited medication|1|||
131071206|NCT01524887|471891813|FG001|Overall Study|Use of prohibited medication|0|||
131071207|NCT01524887|471891814|FG002|Overall Study|Use of prohibited medication|0|||
131071208|NCT00547300|471891815|FG000|Overall Study|Study was Administratively Terminated|25|||
131071209|NCT00547300|471891816|FG001|Overall Study|Study was Administratively Terminated|24|||
131071210|NCT00547300|471891815|FG000|Overall Study|Did not Meet Entry Criteria|0|||
131071211|NCT00547300|471891816|FG001|Overall Study|Did not Meet Entry Criteria|2|||
131071212|NCT04380688|471891819|FG000|Overall Study|Death|2|||
131071213|NCT04380688|471891820|FG001|Overall Study|Death|2|||
131071214|NCT04380688|471891819|FG000|Overall Study|Lost to Follow-up|2|||
131071215|NCT04380688|471891820|FG001|Overall Study|Lost to Follow-up|4|||
131071216|NCT04380688|471891819|FG000|Overall Study|Withdrawal by Subject|3|||
131071217|NCT04380688|471891820|FG001|Overall Study|Withdrawal by Subject|3|||
131137752|NCT00763321|472130692|FG000|Open-label Period|Lack of Efficacy|2|||
131137753|NCT00763321|472130693|FG001|Open-label Period|Lack of Efficacy|0|||
131137754|NCT00763321|472130694|FG002|Open-label Period|Lack of Efficacy|0|||
131137755|NCT00763321|472130692|FG000|Open-label Period|Other|4|||
131137756|NCT00763321|472130693|FG001|Open-label Period|Other|0|||
131137757|NCT00763321|472130694|FG002|Open-label Period|Other|0|||
131137758|NCT00763321|472130692|FG000|Double-blind Period|Lack of Efficacy|0|||
131137759|NCT00763321|472130693|FG001|Double-blind Period|Lack of Efficacy|9|||
131137760|NCT00763321|472130694|FG002|Double-blind Period|Lack of Efficacy|17|||
131137761|NCT00763321|472130692|FG000|Double-blind Period|Adverse Event|0|||
131137762|NCT00763321|472130693|FG001|Double-blind Period|Adverse Event|4|||
131137763|NCT00763321|472130694|FG002|Double-blind Period|Adverse Event|4|||
131137764|NCT00763321|472130692|FG000|Double-blind Period|Lost to Follow-up|0|||
131071218|NCT02093897|471893678|FG000|Overall Study|Physician Decision|1|||
131071219|NCT02093897|471893678|FG000|Overall Study|Planned age group closure - no's reached|17|||
131071220|NCT02093897|471893678|FG000|Overall Study|Adverse event, non-fatal|1|||
131071221|NCT03098797|471893679|FG000|Part 2 Open Label Extension|Adverse Event|2|||
131071222|NCT03098797|471893680|FG001|Part 2 Open Label Extension|Adverse Event|0|||
131071223|NCT01967719|471893681|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
131071224|NCT01967719|471893682|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
131071225|NCT01967719|471893683|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
131071226|NCT01967719|471893684|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
131071227|NCT01967719|471893681|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
131071228|NCT01967719|471893682|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
131071229|NCT01967719|471893683|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
131071230|NCT01967719|471893684|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
131071231|NCT01231464|471893685|FG000|Overall Study|Adverse Event|0|||
131071232|NCT01231464|471893686|FG001|Overall Study|Adverse Event|1|||
131071233|NCT01231464|471893685|FG000|Overall Study|Protocol Violation|1|||
131071234|NCT01231464|471893686|FG001|Overall Study|Protocol Violation|2|||
131071235|NCT01231464|471893685|FG000|Overall Study|Lost to Follow-up|1|||
131071236|NCT01231464|471893686|FG001|Overall Study|Lost to Follow-up|2|||
131071237|NCT01231464|471893685|FG000|Overall Study|Withdrawal by Subject|3|||
131071238|NCT01231464|471893686|FG001|Overall Study|Withdrawal by Subject|2|||
131071239|NCT03449134|471893687|FG000|52-Week Treatment Period|Death|2|||
131071240|NCT03449134|471893688|FG001|52-Week Treatment Period|Death|1|||
131071241|NCT03449134|471893689|FG002|52-Week Treatment Period|Death|0|||
131071242|NCT03449134|471893687|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
131071243|NCT03449134|471893688|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
131071244|NCT03449134|471893689|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
131071245|NCT03449134|471893687|FG000|52-Week Treatment Period|Physician Decision|2|||
131071246|NCT03449134|471893688|FG001|52-Week Treatment Period|Physician Decision|3|||
131071247|NCT03449134|471893689|FG002|52-Week Treatment Period|Physician Decision|3|||
131071248|NCT03449134|471893687|FG000|52-Week Treatment Period|Screen Failure|1|||
131071249|NCT03449134|471893688|FG001|52-Week Treatment Period|Screen Failure|0|||
131071250|NCT03449134|471893689|FG002|52-Week Treatment Period|Screen Failure|1|||
131071251|NCT03449134|471893687|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
131071252|NCT03449134|471893688|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
131071253|NCT03449134|471893689|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
131071254|NCT03449134|471893687|FG000|52-Week Treatment Period|Site Closure|1|||
131071255|NCT03449134|471893688|FG001|52-Week Treatment Period|Site Closure|0|||
131071256|NCT03449134|471893689|FG002|52-Week Treatment Period|Site Closure|0|||
131071257|NCT00957996|471893695|FG000|Overall Study|Death|4|||
131071258|NCT00957996|471893696|FG001|Overall Study|Death|10|||
131071259|NCT00957996|471893695|FG000|Overall Study|Lost to Follow-up|4|||
131071260|NCT00957996|471893696|FG001|Overall Study|Lost to Follow-up|7|||
131071261|NCT00957996|471893695|FG000|Overall Study|Withdrawal by Subject|9|||
131071262|NCT00957996|471893696|FG001|Overall Study|Withdrawal by Subject|2|||
131071263|NCT00957996|471893695|FG000|Overall Study|Adverse Event|2|||
131071264|NCT00957996|471893696|FG001|Overall Study|Adverse Event|1|||
131071265|NCT00957996|471893695|FG000|Overall Study|Physician Decision|1|||
131071266|NCT00957996|471893696|FG001|Overall Study|Physician Decision|1|||
131071267|NCT00957996|471893695|FG000|Overall Study|Influenza-related complication|0|||
131071268|NCT00957996|471893696|FG001|Overall Study|Influenza-related complication|1|||
131071269|NCT00957996|471893695|FG000|Overall Study|Missing|1|||
131071270|NCT00957996|471893696|FG001|Overall Study|Missing|0|||
131071271|NCT00957996|471893695|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
131071272|NCT00957996|471893696|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
131071273|NCT01194271|471893701|FG000|Overall Study|Withdrawal by Subject|1|||
131071274|NCT01194271|471893701|FG000|Overall Study|Ineligible, Screen Failure|1|||
131071275|NCT01194271|471893701|FG000|Overall Study|Death|1|||
131071276|NCT01983462|471893702|FG000|Overall Study|Adverse Event|1|||
131071277|NCT01983462|471893703|FG001|Overall Study|Adverse Event|0|||
131071278|NCT01983462|471893704|FG002|Overall Study|Adverse Event|0|||
131071279|NCT00443898|471893705|FG000|Overall Study|Adverse Event|0|||
131071280|NCT00443898|471893706|FG001|Overall Study|Adverse Event|0|||
131071281|NCT00443898|471893707|FG002|Overall Study|Adverse Event|1|||
131071282|NCT00443898|471893708|FG003|Overall Study|Adverse Event|1|||
131071283|NCT00443898|471893705|FG000|Overall Study|Lack of Efficacy|2|||
131071284|NCT00443898|471893706|FG001|Overall Study|Lack of Efficacy|3|||
131071285|NCT00443898|471893707|FG002|Overall Study|Lack of Efficacy|3|||
131071286|NCT00443898|471893708|FG003|Overall Study|Lack of Efficacy|1|||
131071287|NCT00443898|471893705|FG000|Overall Study|Protocol Violation|1|||
131071288|NCT00443898|471893706|FG001|Overall Study|Protocol Violation|1|||
131071289|NCT00443898|471893707|FG002|Overall Study|Protocol Violation|1|||
131071290|NCT00443898|471893708|FG003|Overall Study|Protocol Violation|0|||
131071291|NCT00443898|471893705|FG000|Overall Study|Withdrawal by Subject|11|||
131071292|NCT00443898|471893706|FG001|Overall Study|Withdrawal by Subject|10|||
131071293|NCT00443898|471893707|FG002|Overall Study|Withdrawal by Subject|10|||
131071294|NCT00443898|471893708|FG003|Overall Study|Withdrawal by Subject|6|||
131071295|NCT00443898|471893705|FG000|Overall Study|Lost to Follow-up|10|||
131071296|NCT00443898|471893706|FG001|Overall Study|Lost to Follow-up|10|||
131071297|NCT00443898|471893707|FG002|Overall Study|Lost to Follow-up|14|||
131071298|NCT00443898|471893708|FG003|Overall Study|Lost to Follow-up|10|||
131071299|NCT00443898|471893705|FG000|Overall Study|Death|0|||
131071300|NCT00443898|471893706|FG001|Overall Study|Death|1|||
131071301|NCT00443898|471893707|FG002|Overall Study|Death|0|||
131071302|NCT00443898|471893708|FG003|Overall Study|Death|0|||
131071303|NCT00508274|471893713|FG000|Overall Study|Adverse Event|5|||
131071304|NCT00508274|471893713|FG000|Overall Study|Death|7|||
131071305|NCT00508274|471893713|FG000|Overall Study|Disease progression|32|||
131071306|NCT00508274|471893713|FG000|Overall Study|Withdrawal by Subject|1|||
131071307|NCT00508274|471893713|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
131071308|NCT00508274|471893713|FG000|Overall Study|Missing|3|||
131071309|NCT03296566|471893714|FG000|Overall Study|Lost to Follow-up|19|||
131071310|NCT03296566|471893715|FG001|Overall Study|Lost to Follow-up|46|||
131071311|NCT03296566|471893714|FG000|Overall Study|Withdrawal by Subject|0|||
131071312|NCT03296566|471893715|FG001|Overall Study|Withdrawal by Subject|3|||
131071313|NCT01084239|471893720|FG000|28-Day Follow-up|Lost to Follow-up|4|||
131071314|NCT01084239|471893721|FG001|28-Day Follow-up|Lost to Follow-up|9|||
131071315|NCT02679079|471893723|FG000|Overall Study|Adverse Event|2|||
131071316|NCT02679079|471893724|FG001|Overall Study|Adverse Event|0|||
131071317|NCT02679079|471893725|FG002|Overall Study|Adverse Event|2|||
131071318|NCT02679079|471893723|FG000|Overall Study|Protocol Violation|0|||
131071319|NCT02679079|471893724|FG001|Overall Study|Protocol Violation|1|||
131071320|NCT02679079|471893725|FG002|Overall Study|Protocol Violation|0|||
131071321|NCT02679079|471893723|FG000|Overall Study|Withdrawal by Subject|2|||
131071322|NCT02679079|471893724|FG001|Overall Study|Withdrawal by Subject|1|||
131071323|NCT02679079|471893725|FG002|Overall Study|Withdrawal by Subject|0|||
131071324|NCT00520403|471893726|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
131071325|NCT00520403|471893726|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
131071326|NCT00520403|471893726|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
131071327|NCT00520403|471893726|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
131071328|NCT00520403|471893726|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
131071329|NCT00520403|471893726|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
131071330|NCT00520403|471893726|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
131071331|NCT00520403|471893726|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
131071332|NCT02435381|471893727|FG000|Overall Study|Lost to Follow-up|2|||
131071333|NCT02435381|471893728|FG001|Overall Study|Lost to Follow-up|1|||
131071334|NCT04150341|471893731|FG000|Overall Study|Physician Decision|0|||
131071335|NCT04150341|471893732|FG001|Overall Study|Physician Decision|0|||
131071336|NCT04150341|471893733|FG002|Overall Study|Physician Decision|1|||
131071337|NCT04150341|471893734|FG003|Overall Study|Physician Decision|0|||
131071338|NCT04150341|471893735|FG004|Overall Study|Physician Decision|0|||
131071339|NCT04150341|471893736|FG005|Overall Study|Physician Decision|0|||
131071340|NCT04150341|471893731|FG000|Overall Study|Adverse Event|0|||
131071341|NCT04150341|471893732|FG001|Overall Study|Adverse Event|0|||
131071342|NCT04150341|471893733|FG002|Overall Study|Adverse Event|0|||
131071343|NCT04150341|471893734|FG003|Overall Study|Adverse Event|0|||
131071344|NCT04150341|471893735|FG004|Overall Study|Adverse Event|1|||
131071345|NCT04150341|471893736|FG005|Overall Study|Adverse Event|0|||
131071346|NCT00405912|471893737|FG000|Overall Study|Withdrawal by Subject|12|||
131071347|NCT00405912|471893738|FG001|Overall Study|Withdrawal by Subject|11|||
131071348|NCT00405912|471893739|FG002|Overall Study|Withdrawal by Subject|12|||
131071349|NCT00405912|471893737|FG000|Overall Study|Lost to Follow-up|4|||
131071350|NCT00405912|471893738|FG001|Overall Study|Lost to Follow-up|8|||
131071351|NCT00405912|471893739|FG002|Overall Study|Lost to Follow-up|4|||
131071352|NCT03730662|471893740|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
131071353|NCT03730662|471893741|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
131071354|NCT03730662|471893742|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
131071355|NCT03730662|471893743|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
131071356|NCT03730662|471893740|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
131071357|NCT03730662|471893741|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
131071358|NCT03730662|471893742|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
131071359|NCT03730662|471893743|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
131071360|NCT03730662|471893740|FG000|Treatment Period (52 Weeks)|Death|6|||
131071361|NCT03730662|471893741|FG001|Treatment Period (52 Weeks)|Death|2|||
131071362|NCT03730662|471893742|FG002|Treatment Period (52 Weeks)|Death|2|||
131071363|NCT03730662|471893743|FG003|Treatment Period (52 Weeks)|Death|9|||
131071364|NCT03730662|471893740|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
131071365|NCT03730662|471893741|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
131071366|NCT03730662|471893742|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
131071367|NCT03730662|471893743|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
131071368|NCT03730662|471893740|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
131071369|NCT03730662|471893741|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
131071370|NCT03730662|471893742|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
131071371|NCT03730662|471893743|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
131071372|NCT03730662|471893740|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
131071373|NCT03730662|471893741|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
131071374|NCT03730662|471893742|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
131071375|NCT03730662|471893743|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
131071376|NCT03730662|471893740|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
131071377|NCT03730662|471893741|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
131071378|NCT03730662|471893742|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
131071379|NCT03730662|471893743|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
131071380|NCT03730662|471893740|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
131071381|NCT03730662|471893741|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
131071382|NCT03730662|471893742|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
131071383|NCT03730662|471893743|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
131071384|NCT03730662|471893740|FG000|Variable Treatment Period|Adverse Event|1|||
131071385|NCT03730662|471893741|FG001|Variable Treatment Period|Adverse Event|2|||
131071386|NCT03730662|471893742|FG002|Variable Treatment Period|Adverse Event|0|||
131071387|NCT03730662|471893743|FG003|Variable Treatment Period|Adverse Event|7|||
131071388|NCT03730662|471893740|FG000|Variable Treatment Period|Death|9|||
131071389|NCT03730662|471893741|FG001|Variable Treatment Period|Death|0|||
131071390|NCT03730662|471893742|FG002|Variable Treatment Period|Death|6|||
131071391|NCT03730662|471893743|FG003|Variable Treatment Period|Death|26|||
131071392|NCT03730662|471893740|FG000|Variable Treatment Period|Lost to Follow-up|2|||
131071393|NCT03730662|471893741|FG001|Variable Treatment Period|Lost to Follow-up|1|||
131071394|NCT03730662|471893742|FG002|Variable Treatment Period|Lost to Follow-up|4|||
131071395|NCT03730662|471893743|FG003|Variable Treatment Period|Lost to Follow-up|11|||
131071396|NCT03730662|471893740|FG000|Variable Treatment Period|Personal Reason|0|||
131071397|NCT03730662|471893741|FG001|Variable Treatment Period|Personal Reason|2|||
131071398|NCT03730662|471893742|FG002|Variable Treatment Period|Personal Reason|1|||
131071399|NCT03730662|471893743|FG003|Variable Treatment Period|Personal Reason|6|||
131071400|NCT03730662|471893740|FG000|Variable Treatment Period|Physician Decision|0|||
131071401|NCT03730662|471893741|FG001|Variable Treatment Period|Physician Decision|0|||
131071402|NCT03730662|471893742|FG002|Variable Treatment Period|Physician Decision|0|||
131071403|NCT03730662|471893743|FG003|Variable Treatment Period|Physician Decision|3|||
131071404|NCT03730662|471893740|FG000|Variable Treatment Period|Protocol Violation|0|||
131071405|NCT03730662|471893741|FG001|Variable Treatment Period|Protocol Violation|1|||
131071406|NCT03730662|471893742|FG002|Variable Treatment Period|Protocol Violation|1|||
131071407|NCT03730662|471893743|FG003|Variable Treatment Period|Protocol Violation|1|||
131071408|NCT03730662|471893740|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
131071409|NCT03730662|471893741|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
131071410|NCT03730662|471893742|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
131071411|NCT03730662|471893743|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
131071412|NCT01797562|471893744|FG000|Overall Study|Protocol Violation|5|||
131071413|NCT01309243|471893745|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
131071414|NCT01309243|471893746|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
131071415|NCT01309243|471893745|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
131071416|NCT01309243|471893746|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
131071417|NCT01309243|471893745|FG000|Randomized Phase Through Week 96|Death|0|||
131071418|NCT01309243|471893746|FG001|Randomized Phase Through Week 96|Death|1|||
131071419|NCT01309243|471893745|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
131071420|NCT01309243|471893746|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
131071421|NCT01309243|471893745|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
131071422|NCT01309243|471893746|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
131071423|NCT01309243|471893745|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
131071424|NCT01309243|471893746|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
131071425|NCT01309243|471893745|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
131071426|NCT01309243|471893746|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
131071427|NCT01309243|471893745|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
131071428|NCT01309243|471893746|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
131071429|NCT01309243|471893745|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
131071430|NCT01309243|471893746|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
131071431|NCT01309243|471893745|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
131071432|NCT01309243|471893746|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
131071433|NCT01309243|471893745|FG000|Extension Phase|Lost to Follow-up|6|||
131071434|NCT01309243|471893746|FG001|Extension Phase|Lost to Follow-up|0|||
131071435|NCT00632931|471893749|FG000|Part 1, Period 1|Protocol Violation|1|||
131071436|NCT00632931|471893750|FG001|Part 1, Period 1|Protocol Violation|0|||
131071437|NCT00632931|471893751|FG002|Part 1, Period 1|Protocol Violation|0|||
131071438|NCT00632931|471893749|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
131071439|NCT00632931|471893750|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
131071440|NCT00632931|471893751|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
130723582|NCT03016975|470613474|FG001|At 6 Months Follow-up|Death|0|||
130723583|NCT03016975|470613475|FG002|At 6 Months Follow-up|Death|0|||
131071441|NCT00632931|471893749|FG000|Part 2|Adverse Event|0|||
131071442|NCT00632931|471893750|FG001|Part 2|Adverse Event|0|||
131071443|NCT00632931|471893751|FG002|Part 2|Adverse Event|3|||
130723584|NCT03016975|470613473|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
130723585|NCT03016975|470613474|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
130723586|NCT03016975|470613475|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
130723587|NCT03016975|470613473|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
130723588|NCT03016975|470613474|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
130723589|NCT03016975|470613475|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
130723590|NCT03016975|470613473|FG000|At 6 Months Follow-up|Aborted implant|1|||
130723591|NCT03016975|470613474|FG001|At 6 Months Follow-up|Aborted implant|0|||
130723592|NCT03016975|470613475|FG002|At 6 Months Follow-up|Aborted implant|0|||
130723593|NCT03016975|470613473|FG000|At 2 Year Follow-up|Death|1|||
130723594|NCT03016975|470613474|FG001|At 2 Year Follow-up|Death|0|||
130723595|NCT03016975|470613475|FG002|At 2 Year Follow-up|Death|0|||
130723596|NCT03016975|470613473|FG000|At 3 Year Follow-up|Death|1|||
130723597|NCT03016975|470613474|FG001|At 3 Year Follow-up|Death|0|||
130723598|NCT03016975|470613475|FG002|At 3 Year Follow-up|Death|0|||
130723599|NCT03016975|470613473|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
130723600|NCT03016975|470613474|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
130723601|NCT03016975|470613475|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
130723602|NCT03016975|470613473|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
130723603|NCT03016975|470613474|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
130723604|NCT03016975|470613475|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
130723605|NCT01590797|470613476|FG000|Overall Study|Adverse Event|4|||
130723606|NCT01590797|470613477|FG001|Overall Study|Adverse Event|3|||
130723607|NCT01590797|470613476|FG000|Overall Study|Lack of Efficacy|0|||
130723608|NCT01590797|470613477|FG001|Overall Study|Lack of Efficacy|2|||
130723609|NCT01590797|470613476|FG000|Overall Study|Lost to Follow-up|0|||
130723610|NCT01590797|470613477|FG001|Overall Study|Lost to Follow-up|1|||
130723611|NCT01590797|470613476|FG000|Overall Study|Protocol Violation|4|||
130723612|NCT01590797|470613477|FG001|Overall Study|Protocol Violation|1|||
130723613|NCT01590797|470613476|FG000|Overall Study|Withdrawal by Subject|7|||
130723614|NCT01590797|470613477|FG001|Overall Study|Withdrawal by Subject|5|||
130723615|NCT01590797|470613476|FG000|Overall Study|Other Protocol Specified Criteria|2|||
130723616|NCT01590797|470613477|FG001|Overall Study|Other Protocol Specified Criteria|4|||
131071444|NCT00632931|471893749|FG000|Part 2|Death|0|||
131071445|NCT00632931|471893750|FG001|Part 2|Death|0|||
131071446|NCT00632931|471893751|FG002|Part 2|Death|1|||
131071447|NCT00632931|471893749|FG000|Part 2|Lack of Efficacy|0|||
131071448|NCT00632931|471893750|FG001|Part 2|Lack of Efficacy|0|||
131071449|NCT00632931|471893751|FG002|Part 2|Lack of Efficacy|17|||
131071450|NCT00632931|471893749|FG000|Part 2|Withdrawal by Subject|0|||
131071451|NCT00632931|471893750|FG001|Part 2|Withdrawal by Subject|0|||
131071452|NCT00632931|471893751|FG002|Part 2|Withdrawal by Subject|3|||
131071453|NCT01441583|471893754|FG000|Overall Study|Withdrawal by Subject|1|||
131071454|NCT01441583|471893755|FG001|Overall Study|Withdrawal by Subject|1|||
131137765|NCT00763321|472130693|FG001|Double-blind Period|Lost to Follow-up|4|||
131137766|NCT00763321|472130694|FG002|Double-blind Period|Lost to Follow-up|2|||
131137767|NCT00763321|472130692|FG000|Double-blind Period|Withdrawal by Subject|0|||
131137768|NCT00763321|472130693|FG001|Double-blind Period|Withdrawal by Subject|2|||
131137769|NCT00763321|472130694|FG002|Double-blind Period|Withdrawal by Subject|3|||
131137770|NCT00763321|472130692|FG000|Double-blind Period|Other|0|||
131230873|NCT01098240|472471398|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
131230874|NCT01098240|472471399|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
131230875|NCT01098240|472471400|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
131230876|NCT01098240|472471398|FG000|Double-Blind Phase|Protocol Violation|0|||
131137771|NCT00763321|472130693|FG001|Double-blind Period|Other|2|||
131137772|NCT00763321|472130694|FG002|Double-blind Period|Other|3|||
131137773|NCT03175549|472130695|FG000|Overall Study|Lost to Follow-up|2|||
131137774|NCT03175549|472130696|FG001|Overall Study|Lost to Follow-up|2|||
131137775|NCT03175549|472130695|FG000|Overall Study|Medication non-compliance|2|||
131137776|NCT03175549|472130696|FG001|Overall Study|Medication non-compliance|2|||
131137777|NCT01064167|472130697|FG000|Overall Study|Protocol Violation|14|||
131137778|NCT01064167|472130698|FG001|Overall Study|Protocol Violation|15|||
131137779|NCT02340663|472130700|FG000|Overall Study|Lost to Follow-up|1|||
131137780|NCT02340663|472130701|FG001|Overall Study|Lost to Follow-up|0|||
131230877|NCT01098240|472471399|FG001|Double-Blind Phase|Protocol Violation|2|||
130723617|NCT00901576|470613485|FG000|Second Intervention|Withdrawal by Subject|0|||
130723618|NCT00901576|470613486|FG001|Second Intervention|Withdrawal by Subject|0|||
130723619|NCT00901576|470613487|FG002|Second Intervention|Withdrawal by Subject|0|||
130723620|NCT00901576|470613488|FG003|Second Intervention|Withdrawal by Subject|1|||
131137781|NCT02340663|472130700|FG000|Overall Study|Protocol Violation|1|||
131230878|NCT01098240|472471400|FG002|Double-Blind Phase|Protocol Violation|4|||
130723621|NCT00901576|470613489|FG004|Second Intervention|Withdrawal by Subject|0|||
131071455|NCT01441583|471893756|FG002|Overall Study|Withdrawal by Subject|1|||
131230879|NCT01098240|472471398|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131230880|NCT01098240|472471399|FG001|Double-Blind Phase|Lost to Follow-up|2|||
131230881|NCT01098240|472471400|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131230882|NCT01098240|472471398|FG000|Double-Blind Phase|Other|0|||
131230883|NCT01098240|472471399|FG001|Double-Blind Phase|Other|2|||
131230884|NCT01098240|472471400|FG002|Double-Blind Phase|Other|2|||
131230885|NCT01098240|472471398|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
131230886|NCT01098240|472471399|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
131230887|NCT01098240|472471400|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
131230888|NCT01098240|472471398|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
131230889|NCT01098240|472471399|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
131230890|NCT01098240|472471400|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
131230891|NCT01098240|472471398|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
131230892|NCT01098240|472471399|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
131230893|NCT01098240|472471400|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
131230894|NCT01098240|472471398|FG000|Double-Blind Phase|Adverse Event|0|||
131230895|NCT01098240|472471399|FG001|Double-Blind Phase|Adverse Event|3|||
131230896|NCT01098240|472471400|FG002|Double-Blind Phase|Adverse Event|3|||
131230897|NCT01070394|472471401|FG000|Overall Study|Adverse Event|6|||
131230898|NCT01070394|472471401|FG000|Overall Study|Withdrawal by Subject|1|||
131230899|NCT03280537|472471402|FG000|Overall Study|Withdrawal by Subject|2|||
131230900|NCT03280537|472471403|FG001|Overall Study|Withdrawal by Subject|4|||
131230901|NCT01588106|472471404|FG000|Overall Study|Withdrawal by Subject|5|||
131230902|NCT01588106|472471405|FG001|Overall Study|Withdrawal by Subject|4|||
131230903|NCT03083132|472471406|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
131230904|NCT03083132|472471407|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
131230905|NCT03083132|472471406|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
131230906|NCT03083132|472471407|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
131230907|NCT03083132|472471406|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
131230908|NCT03083132|472471407|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
131230909|NCT03118739|472471408|FG000|Overall Study|Physician Decision|0|||
131230910|NCT03118739|472471409|FG001|Overall Study|Physician Decision|1|||
131230911|NCT03118739|472471408|FG000|Overall Study|Withdrawal by Subject|5|||
131230912|NCT03118739|472471409|FG001|Overall Study|Withdrawal by Subject|3|||
131230913|NCT03118739|472471408|FG000|Overall Study|Lost to Follow-up|2|||
130723622|NCT00901576|470613490|FG005|Second Intervention|Withdrawal by Subject|1|||
130723623|NCT00901576|470613485|FG000|Second Intervention|Physician Decision|1|||
130723624|NCT00901576|470613486|FG001|Second Intervention|Physician Decision|0|||
130723625|NCT00901576|470613487|FG002|Second Intervention|Physician Decision|0|||
130723626|NCT00901576|470613488|FG003|Second Intervention|Physician Decision|0|||
130723627|NCT00901576|470613489|FG004|Second Intervention|Physician Decision|0|||
130723628|NCT00901576|470613490|FG005|Second Intervention|Physician Decision|0|||
130723629|NCT01559389|470613491|FG000|Overall Study|Withdrawal by Subject|20|||
130723630|NCT01559389|470613492|FG001|Overall Study|Withdrawal by Subject|20|||
130723631|NCT03201445|470613493|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
130723632|NCT03201445|470613494|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
130723633|NCT03201445|470613493|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
130723634|NCT03201445|470613494|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
130723635|NCT03201445|470613493|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
130723636|NCT03201445|470613494|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
131071456|NCT01441583|471893754|FG000|Overall Study|Death|1|||
131071457|NCT01441583|471893755|FG001|Overall Study|Death|0|||
130723637|NCT03201445|470613493|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
130723638|NCT03201445|470613494|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
130779500|NCT02326272|470819497|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
131071458|NCT01441583|471893756|FG002|Overall Study|Death|4|||
131071459|NCT01441583|471893754|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
131071460|NCT01441583|471893755|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
131071461|NCT01441583|471893756|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
131071462|NCT03341312|471893757|FG000|Period 1|Withdrawal by Subject|0|||
131071463|NCT03341312|471893758|FG001|Period 1|Withdrawal by Subject|1|||
131071464|NCT03341312|471893759|FG002|Period 1|Withdrawal by Subject|0|||
131071465|NCT03341312|471893760|FG003|Period 1|Withdrawal by Subject|0|||
131230914|NCT03118739|472471409|FG001|Overall Study|Lost to Follow-up|0|||
131071466|NCT01812707|471893761|FG000|Overall Study|Adverse Event|0|||
131071467|NCT01812707|471893762|FG001|Overall Study|Adverse Event|0|||
131071468|NCT01812707|471893763|FG002|Overall Study|Adverse Event|0|||
131230915|NCT00669955|472471410|FG000|Overall Study|Adverse Event|3|||
131230916|NCT00669955|472471411|FG001|Overall Study|Adverse Event|5|||
131230917|NCT00669955|472471410|FG000|Overall Study|Death|0|||
131230918|NCT00669955|472471411|FG001|Overall Study|Death|1|||
131230919|NCT00669955|472471410|FG000|Overall Study|Withdrawal by Subject|2|||
131230920|NCT00669955|472471411|FG001|Overall Study|Withdrawal by Subject|3|||
131230921|NCT00669955|472471410|FG000|Overall Study|Lost to Follow-up|5|||
131071469|NCT01812707|471893764|FG003|Overall Study|Adverse Event|2|||
131071470|NCT01812707|471893761|FG000|Overall Study|Poor compliance to protocol|1|||
131071471|NCT01812707|471893762|FG001|Overall Study|Poor compliance to protocol|0|||
131071472|NCT01812707|471893763|FG002|Overall Study|Poor compliance to protocol|0|||
131071473|NCT01812707|471893764|FG003|Overall Study|Poor compliance to protocol|0|||
131071474|NCT01812707|471893761|FG000|Overall Study|Consent withdrawn by participant|1|||
131071475|NCT01812707|471893762|FG001|Overall Study|Consent withdrawn by participant|0|||
131071476|NCT01812707|471893763|FG002|Overall Study|Consent withdrawn by participant|0|||
131071477|NCT01812707|471893764|FG003|Overall Study|Consent withdrawn by participant|0|||
131071478|NCT05060237|471893765|FG000|Overall Study|Withdrawal by Subject|4|||
131071479|NCT05060237|471893765|FG000|Overall Study|Screening failure|8|||
131071480|NCT02396758|471893766|FG000|Overall Study|Withdrawal by Subject|2|||
131071481|NCT02396758|471893767|FG001|Overall Study|Withdrawal by Subject|0|||
131071482|NCT02396758|471893768|FG002|Overall Study|Withdrawal by Subject|0|||
131071483|NCT02396758|471893769|FG003|Overall Study|Withdrawal by Subject|1|||
131071484|NCT02396758|471893766|FG000|Overall Study|Lost to Follow-up|8|||
131071485|NCT02396758|471893767|FG001|Overall Study|Lost to Follow-up|5|||
131071486|NCT02396758|471893768|FG002|Overall Study|Lost to Follow-up|3|||
131071487|NCT02396758|471893769|FG003|Overall Study|Lost to Follow-up|3|||
131071488|NCT02396758|471893766|FG000|Overall Study|Death|1|||
131071489|NCT02396758|471893767|FG001|Overall Study|Death|1|||
131071490|NCT02396758|471893768|FG002|Overall Study|Death|0|||
131071491|NCT02396758|471893769|FG003|Overall Study|Death|1|||
131071492|NCT02396758|471893766|FG000|Overall Study|Randomized but not treated|1|||
131071493|NCT02396758|471893767|FG001|Overall Study|Randomized but not treated|0|||
131071494|NCT02396758|471893768|FG002|Overall Study|Randomized but not treated|1|||
131071495|NCT02396758|471893769|FG003|Overall Study|Randomized but not treated|0|||
131071496|NCT00265096|471893770|FG000|Overall Study|Adverse Event|14|||
131071497|NCT00265096|471893771|FG001|Overall Study|Adverse Event|18|||
131071498|NCT00265096|471893772|FG002|Overall Study|Adverse Event|18|||
131071499|NCT00265096|471893770|FG000|Overall Study|Lost to Follow-up|2|||
131071500|NCT00265096|471893771|FG001|Overall Study|Lost to Follow-up|5|||
131071501|NCT00265096|471893772|FG002|Overall Study|Lost to Follow-up|3|||
131071502|NCT00265096|471893770|FG000|Overall Study|Death|0|||
131071503|NCT00265096|471893771|FG001|Overall Study|Death|1|||
131071504|NCT00265096|471893772|FG002|Overall Study|Death|2|||
131071505|NCT00265096|471893770|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
131071506|NCT00265096|471893771|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
131071507|NCT00265096|471893772|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
131071508|NCT00265096|471893770|FG000|Overall Study|Other|11|||
131071509|NCT00265096|471893771|FG001|Overall Study|Other|19|||
131071510|NCT00265096|471893772|FG002|Overall Study|Other|10|||
131071511|NCT00774306|471893773|FG000|Overall Study|Adverse Event|3|||
131071512|NCT00774306|471893774|FG001|Overall Study|Adverse Event|0|||
131071513|NCT00774306|471893775|FG002|Overall Study|Adverse Event|0|||
131071514|NCT00774306|471893776|FG003|Overall Study|Adverse Event|0|||
131071515|NCT00774306|471893773|FG000|Overall Study|Protocol Violation|2|||
131071516|NCT00774306|471893774|FG001|Overall Study|Protocol Violation|0|||
131071517|NCT00774306|471893775|FG002|Overall Study|Protocol Violation|3|||
131071518|NCT00774306|471893776|FG003|Overall Study|Protocol Violation|0|||
131071519|NCT00774306|471893773|FG000|Overall Study|Withdrawal by Subject|6|||
131071520|NCT00774306|471893774|FG001|Overall Study|Withdrawal by Subject|1|||
131071521|NCT00774306|471893775|FG002|Overall Study|Withdrawal by Subject|1|||
131071522|NCT00774306|471893776|FG003|Overall Study|Withdrawal by Subject|0|||
131071523|NCT00774306|471893773|FG000|Overall Study|Lost to Follow-up|6|||
131071524|NCT00774306|471893774|FG001|Overall Study|Lost to Follow-up|0|||
131071525|NCT00774306|471893775|FG002|Overall Study|Lost to Follow-up|4|||
131071526|NCT00774306|471893776|FG003|Overall Study|Lost to Follow-up|5|||
131071527|NCT00774306|471893773|FG000|Overall Study|Death|1|||
131071528|NCT00774306|471893774|FG001|Overall Study|Death|1|||
131071529|NCT00774306|471893775|FG002|Overall Study|Death|0|||
131071530|NCT00774306|471893776|FG003|Overall Study|Death|0|||
131071531|NCT00666835|471893777|FG000|Overall Study|Withdrawal by Subject|5|||
131071532|NCT00666835|471893778|FG001|Overall Study|Withdrawal by Subject|2|||
131071533|NCT00666835|471893777|FG000|Overall Study|Lack of Efficacy|0|||
131071534|NCT00666835|471893778|FG001|Overall Study|Lack of Efficacy|1|||
131071535|NCT00666835|471893777|FG000|Overall Study|Incl./excl. not fulfilled|7|||
131071536|NCT00666835|471893778|FG001|Overall Study|Incl./excl. not fulfilled|2|||
131071537|NCT00666835|471893777|FG000|Overall Study|Adverse Event|7|||
131137782|NCT02340663|472130701|FG001|Overall Study|Protocol Violation|0|||
130723639|NCT03201445|470613493|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
130723640|NCT03201445|470613494|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
130723641|NCT03201445|470613493|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
130723642|NCT03201445|470613494|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
130723643|NCT03201445|470613493|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
130723644|NCT03201445|470613494|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
131071538|NCT00666835|471893778|FG001|Overall Study|Adverse Event|6|||
131071539|NCT00666835|471893777|FG000|Overall Study|Protocol Violation|2|||
131071540|NCT00666835|471893778|FG001|Overall Study|Protocol Violation|0|||
131230922|NCT00669955|472471411|FG001|Overall Study|Lost to Follow-up|7|||
131230923|NCT00669955|472471410|FG000|Overall Study|Protocol Violation|2|||
131230924|NCT00669955|472471411|FG001|Overall Study|Protocol Violation|7|||
131230925|NCT00669955|472471410|FG000|Overall Study|Investigator Sponsor Judgement|0|||
131230926|NCT00669955|472471411|FG001|Overall Study|Investigator Sponsor Judgement|1|||
131230927|NCT00669955|472471410|FG000|Overall Study|not compliant with study drug/visit|2|||
131230928|NCT00669955|472471411|FG001|Overall Study|not compliant with study drug/visit|3|||
131230929|NCT03507439|472471415|FG000|Overall Study|Other|2|||
131071541|NCT00666835|471893777|FG000|Overall Study|Death|15|||
131071542|NCT00666835|471893778|FG001|Overall Study|Death|4|||
131071543|NCT00666835|471893777|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
131071544|NCT00666835|471893778|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
131071545|NCT00666835|471893777|FG000|Overall Study|Hemoglobulin concentration|4|||
131071546|NCT00666835|471893778|FG001|Overall Study|Hemoglobulin concentration|3|||
131071547|NCT00666835|471893777|FG000|Overall Study|Planned operation|2|||
131071548|NCT00666835|471893778|FG001|Overall Study|Planned operation|0|||
131071549|NCT00666835|471893777|FG000|Overall Study|Physician Decision|1|||
131071550|NCT00666835|471893778|FG001|Overall Study|Physician Decision|2|||
131071551|NCT03319719|471893781|FG000|Overall Study|Lost to Follow-up|1|||
131071552|NCT00744796|471893782|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
131071553|NCT04772313|471893783|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
131071554|NCT04772313|471893783|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
131071555|NCT01836198|471893784|FG000|Part A, Period 2|Protocol Violation|0|||
131071556|NCT01836198|471893785|FG001|Part A, Period 2|Protocol Violation|1|||
131071557|NCT01836198|471893786|FG002|Part A, Period 2|Protocol Violation|0|||
131071558|NCT02215954|471893787|FG000|Overall Study|Adverse Event|0|||
131071559|NCT02215954|471893788|FG001|Overall Study|Adverse Event|0|||
131071560|NCT02215954|471893789|FG002|Overall Study|Adverse Event|1|||
131071561|NCT02215954|471893787|FG000|Overall Study|Withdrawal by Subject|0|||
131071562|NCT02215954|471893788|FG001|Overall Study|Withdrawal by Subject|0|||
131071563|NCT02215954|471893789|FG002|Overall Study|Withdrawal by Subject|2|||
131071564|NCT02215954|471893787|FG000|Overall Study|Not exposed|1|||
131071565|NCT02215954|471893788|FG001|Overall Study|Not exposed|1|||
131071566|NCT02215954|471893789|FG002|Overall Study|Not exposed|3|||
131071567|NCT02460562|471893790|FG000|Overall Study|Lost to Follow-up|15|||
131071568|NCT02460562|471893791|FG001|Overall Study|Lost to Follow-up|16|||
131071569|NCT01654289|471893792|FG000|Overall Study|Withdrawal by Subject|10|||
131071570|NCT01654289|471893793|FG001|Overall Study|Withdrawal by Subject|8|||
131071571|NCT01654289|471893794|FG002|Overall Study|Withdrawal by Subject|5|||
131071572|NCT01654289|471893792|FG000|Overall Study|Withdrew from intervention only|17|||
131230930|NCT03507439|472471416|FG001|Overall Study|Other|1|||
131230931|NCT03507439|472471415|FG000|Overall Study|Withdrawal by Subject|1|||
131071573|NCT01654289|471893793|FG001|Overall Study|Withdrew from intervention only|20|||
131071574|NCT01654289|471893794|FG002|Overall Study|Withdrew from intervention only|0|||
131071575|NCT04194541|471893795|FG000|Day 1 Through 13|Lost to Follow-up|3|||
131071576|NCT04194541|471893795|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
131071577|NCT04194541|471893795|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
131071578|NCT03746483|471893796|FG000|Overall Study|Adverse Event|0|||
131071579|NCT03746483|471893797|FG001|Overall Study|Adverse Event|1|||
131071580|NCT03746483|471893796|FG000|Overall Study|Lack of Efficacy|3|||
131071581|NCT03746483|471893797|FG001|Overall Study|Lack of Efficacy|2|||
131071582|NCT03746483|471893796|FG000|Overall Study|Lost to Follow-up|1|||
131071583|NCT03746483|471893797|FG001|Overall Study|Lost to Follow-up|0|||
131071584|NCT03746483|471893796|FG000|Overall Study|Protocol Violation|2|||
131071585|NCT03746483|471893797|FG001|Overall Study|Protocol Violation|0|||
131071586|NCT00187135|471893798|FG000|Visit One|Withdrawal by Subject|1|||
131071587|NCT00187135|471893799|FG001|Visit One|Withdrawal by Subject|0|||
131071588|NCT00187135|471893800|FG002|Visit One|Withdrawal by Subject|0|||
131071589|NCT00187135|471893801|FG003|Visit One|Withdrawal by Subject|0|||
131071590|NCT00187135|471893802|FG004|Visit One|Withdrawal by Subject|0|||
131071591|NCT00187135|471893803|FG005|Visit One|Withdrawal by Subject|1|||
131071592|NCT00187135|471893798|FG000|Visit One|Physician Decision|3|||
131071593|NCT00187135|471893799|FG001|Visit One|Physician Decision|1|||
131071594|NCT00187135|471893800|FG002|Visit One|Physician Decision|0|||
131071595|NCT00187135|471893801|FG003|Visit One|Physician Decision|0|||
131071596|NCT00187135|471893802|FG004|Visit One|Physician Decision|0|||
131071597|NCT00187135|471893803|FG005|Visit One|Physician Decision|1|||
131071598|NCT00187135|471893798|FG000|Visit Two|Death|0|||
131071599|NCT00187135|471893799|FG001|Visit Two|Death|0|||
131071600|NCT00187135|471893800|FG002|Visit Two|Death|0|||
131071601|NCT00187135|471893801|FG003|Visit Two|Death|1|||
131071602|NCT00187135|471893802|FG004|Visit Two|Death|0|||
131071603|NCT00187135|471893803|FG005|Visit Two|Death|1|||
131071604|NCT00187135|471893798|FG000|Visit Two|Physician Decision|1|||
131071605|NCT00187135|471893799|FG001|Visit Two|Physician Decision|0|||
131071606|NCT00187135|471893800|FG002|Visit Two|Physician Decision|0|||
131071607|NCT00187135|471893801|FG003|Visit Two|Physician Decision|0|||
131071608|NCT00187135|471893802|FG004|Visit Two|Physician Decision|0|||
131230932|NCT03507439|472471416|FG001|Overall Study|Withdrawal by Subject|0|||
131071609|NCT00187135|471893803|FG005|Visit Two|Physician Decision|0|||
131071610|NCT00187135|471893798|FG000|Visit Two|Withdrawal by Subject|1|||
131071611|NCT00187135|471893799|FG001|Visit Two|Withdrawal by Subject|1|||
131071612|NCT00187135|471893800|FG002|Visit Two|Withdrawal by Subject|1|||
131071613|NCT00187135|471893801|FG003|Visit Two|Withdrawal by Subject|0|||
131071614|NCT00187135|471893802|FG004|Visit Two|Withdrawal by Subject|1|||
131071615|NCT00187135|471893803|FG005|Visit Two|Withdrawal by Subject|1|||
131071616|NCT00187135|471893798|FG000|Visit Two|Study Discontinued|3|||
131071617|NCT00187135|471893799|FG001|Visit Two|Study Discontinued|2|||
131071618|NCT00187135|471893800|FG002|Visit Two|Study Discontinued|1|||
131071619|NCT00187135|471893801|FG003|Visit Two|Study Discontinued|7|||
131071620|NCT00187135|471893802|FG004|Visit Two|Study Discontinued|5|||
131071621|NCT00187135|471893803|FG005|Visit Two|Study Discontinued|6|||
131071622|NCT00187135|471893798|FG000|Visit Three|Death|0|||
131071623|NCT00187135|471893799|FG001|Visit Three|Death|0|||
131071624|NCT00187135|471893800|FG002|Visit Three|Death|1|||
131071625|NCT00187135|471893801|FG003|Visit Three|Death|0|||
131071626|NCT00187135|471893802|FG004|Visit Three|Death|1|||
131071627|NCT00187135|471893803|FG005|Visit Three|Death|0|||
131071628|NCT00187135|471893798|FG000|Visit Three|Withdrawal by Subject|0|||
131071629|NCT00187135|471893799|FG001|Visit Three|Withdrawal by Subject|1|||
131071630|NCT00187135|471893800|FG002|Visit Three|Withdrawal by Subject|1|||
131071631|NCT00187135|471893801|FG003|Visit Three|Withdrawal by Subject|2|||
131071632|NCT00187135|471893802|FG004|Visit Three|Withdrawal by Subject|0|||
131071633|NCT00187135|471893803|FG005|Visit Three|Withdrawal by Subject|0|||
131071634|NCT00187135|471893798|FG000|Visit Three|Study Discontinued|7|||
131071635|NCT00187135|471893799|FG001|Visit Three|Study Discontinued|6|||
131071636|NCT00187135|471893800|FG002|Visit Three|Study Discontinued|7|||
131071637|NCT00187135|471893801|FG003|Visit Three|Study Discontinued|7|||
131071638|NCT00187135|471893802|FG004|Visit Three|Study Discontinued|7|||
131071639|NCT00187135|471893803|FG005|Visit Three|Study Discontinued|6|||
131071640|NCT01951261|471893806|FG000|Overall Study|Death|1|||
131071641|NCT01951261|471893807|FG001|Overall Study|Death|0|||
131071642|NCT01951261|471893806|FG000|Overall Study|Lost to Follow-up|4|||
131071643|NCT01951261|471893807|FG001|Overall Study|Lost to Follow-up|3|||
131071644|NCT01951261|471893806|FG000|Overall Study|Protocol Violation|4|||
131071645|NCT01951261|471893807|FG001|Overall Study|Protocol Violation|3|||
131071646|NCT01924806|471893808|FG000|Overall Study|Physician Decision|2|||
131071647|NCT01924806|471893809|FG001|Overall Study|Physician Decision|1|||
131071648|NCT00297778|471893813|FG000|Overall Study|Adverse Event|16|||
131071649|NCT00297778|471893814|FG001|Overall Study|Adverse Event|10|||
131071650|NCT00297778|471893813|FG000|Overall Study|Withdrawal by Subject|1|||
131071651|NCT00297778|471893814|FG001|Overall Study|Withdrawal by Subject|5|||
131071652|NCT00297778|471893813|FG000|Overall Study|Lack of Efficacy|2|||
131071653|NCT00297778|471893814|FG001|Overall Study|Lack of Efficacy|1|||
131071654|NCT00297778|471893813|FG000|Overall Study|Non-compliant with trial protocol|0|||
131071655|NCT00297778|471893814|FG001|Overall Study|Non-compliant with trial protocol|3|||
131071656|NCT00297778|471893813|FG000|Overall Study|Other|0|||
131071657|NCT00297778|471893814|FG001|Overall Study|Other|1|||
131071658|NCT00679549|471893815|FG000|Overall Study|dropout|2|||
131071659|NCT00679549|471893816|FG001|Overall Study|dropout|4|||
131071660|NCT00679549|471893815|FG000|Overall Study|missing outcome echocardiograms|4|||
131071661|NCT00679549|471893816|FG001|Overall Study|missing outcome echocardiograms|5|||
131071662|NCT03280108|471893817|FG000|Overall Study|Lost to Follow-up|2|||
131071663|NCT03280108|471893818|FG001|Overall Study|Lost to Follow-up|0|||
131071664|NCT02201771|471893819|FG000|Overall Study|Death|3|||
131071665|NCT02201771|471893820|FG001|Overall Study|Death|2|||
131071666|NCT02201771|471893821|FG002|Overall Study|Death|0|||
131071667|NCT02201771|471893819|FG000|Overall Study|Protocol Violation|10|||
131071668|NCT02201771|471893820|FG001|Overall Study|Protocol Violation|8|||
131071669|NCT02201771|471893821|FG002|Overall Study|Protocol Violation|10|||
131071670|NCT01820637|471893822|FG000|Overall Study|Death|2|||
131071671|NCT01820637|471893822|FG000|Overall Study|Withdrawal by Subject|1|||
131071672|NCT00264498|471893823|FG000|Randomized Treatment|Death|0|||
131071673|NCT00264498|471893824|FG001|Randomized Treatment|Death|3|||
131071674|NCT00264498|471893823|FG000|Randomized Treatment|Withdrawal by Subject|0|||
131071675|NCT00264498|471893824|FG001|Randomized Treatment|Withdrawal by Subject|1|||
131071676|NCT00264498|471893823|FG000|Randomized Treatment|Objective disease Progression|13|||
131071677|NCT00264498|471893824|FG001|Randomized Treatment|Objective disease Progression|14|||
131071678|NCT00264498|471893823|FG000|Randomized Treatment|Physician Decision|1|||
131071679|NCT00264498|471893824|FG001|Randomized Treatment|Physician Decision|0|||
131071680|NCT00264498|471893823|FG000|Randomized Treatment|Incorrectly randomized|1|||
131071681|NCT00264498|471893824|FG001|Randomized Treatment|Incorrectly randomized|0|||
131071682|NCT00264498|471893823|FG000|Randomized Treatment|Study Closure|1|||
131071683|NCT00264498|471893824|FG001|Randomized Treatment|Study Closure|0|||
131071684|NCT00264498|471893823|FG000|Randomized Treatment|Protocol Violation|1|||
131071685|NCT00264498|471893824|FG001|Randomized Treatment|Protocol Violation|0|||
131071686|NCT00264498|471893823|FG000|Crossover Treatment|Death|1|||
131071687|NCT00264498|471893824|FG001|Crossover Treatment|Death|3|||
131071688|NCT00264498|471893823|FG000|Crossover Treatment|Objective disease progression|4|||
130723645|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
131071689|NCT00264498|471893824|FG001|Crossover Treatment|Objective disease progression|5|||
131071690|NCT00264498|471893823|FG000|Crossover Treatment|Study closure|0|||
131071691|NCT00264498|471893824|FG001|Crossover Treatment|Study closure|1|||
131071692|NCT00264498|471893823|FG000|Crossover Treatment|Withdrawal by Subject|1|||
131071693|NCT00264498|471893824|FG001|Crossover Treatment|Withdrawal by Subject|0|||
131071694|NCT04089332|471893828|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
131071695|NCT04089332|471893828|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
131071696|NCT04089332|471893828|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
131071697|NCT02256488|471893829|FG000|Overall Study|Lost to Follow-up|6|||
131071698|NCT02256488|471893830|FG001|Overall Study|Lost to Follow-up|6|||
130723646|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
130723647|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
130723648|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
130723649|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
130779501|NCT02326272|470819498|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130723650|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
130723651|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
130723652|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
130723653|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
130723654|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
130723655|NCT03201445|470613493|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
130723656|NCT03201445|470613494|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
130723657|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
130723658|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
130723659|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
130723660|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
130723661|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
130723662|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
130723663|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
130723664|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
130723665|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
130723666|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
130723667|NCT03201445|470613493|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
130723668|NCT03201445|470613494|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
130723669|NCT03201445|470613493|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
130723670|NCT03201445|470613494|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
130723671|NCT03201445|470613493|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
130723672|NCT03201445|470613494|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
130723673|NCT01228019|470613495|FG000|Overall Study|Dose Violation|70|||
130723674|NCT01228019|470613495|FG000|Overall Study|Duplicate enrollment|1|||
130723675|NCT01228019|470613495|FG000|Overall Study|Missing pre-treatment data|72|||
130723676|NCT01228019|470613495|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
130723677|NCT01228019|470613495|FG000|Overall Study|Violation of Entry Criterion|9|||
130723678|NCT01346293|470613498|FG000|Overall Study|Protocol Violation|30|||
130723679|NCT01346293|470613499|FG001|Overall Study|Protocol Violation|9|||
130723680|NCT01346293|470613498|FG000|Overall Study|Lost to Follow-up|21|||
130723681|NCT01346293|470613499|FG001|Overall Study|Lost to Follow-up|8|||
130723682|NCT01346293|470613498|FG000|Overall Study|Withdrawal by Subject|15|||
131071699|NCT02256488|471893831|FG002|Overall Study|Lost to Follow-up|9|||
131071700|NCT02256488|471893832|FG003|Overall Study|Lost to Follow-up|3|||
131071701|NCT02256488|471893829|FG000|Overall Study|OTHER|1|||
131071702|NCT02256488|471893830|FG001|Overall Study|OTHER|0|||
131071703|NCT02256488|471893831|FG002|Overall Study|OTHER|1|||
131071704|NCT02256488|471893832|FG003|Overall Study|OTHER|1|||
131071705|NCT02256488|471893829|FG000|Overall Study|Withdrawal by Subject|1|||
130779502|NCT02326272|470819499|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
131071706|NCT02256488|471893830|FG001|Overall Study|Withdrawal by Subject|0|||
131071707|NCT02256488|471893831|FG002|Overall Study|Withdrawal by Subject|0|||
131071708|NCT02256488|471893832|FG003|Overall Study|Withdrawal by Subject|2|||
131071709|NCT00240097|471893833|FG000|Part I|Adverse Event|1|||
131071710|NCT00240097|471893833|FG000|Part I|Death|1|||
131071711|NCT00240097|471893833|FG000|Part I|histology|1|||
131071712|NCT00240097|471893833|FG000|Part I|unevaluable|1|||
131071713|NCT00240097|471893833|FG000|Part II|did not continue from Part I|23|||
131071714|NCT00818519|471893834|FG000|Overall Study|Adverse Event|2|||
131230933|NCT03507439|472471415|FG000|Overall Study|Death|1|||
131071715|NCT00818519|471893835|FG001|Overall Study|Adverse Event|2|||
131071716|NCT00818519|471893834|FG000|Overall Study|Lost to Follow-up|4|||
131071717|NCT00818519|471893835|FG001|Overall Study|Lost to Follow-up|6|||
131230934|NCT03507439|472471416|FG001|Overall Study|Death|1|||
131071718|NCT00818519|471893834|FG000|Overall Study|Protocol Violation|2|||
131071719|NCT00818519|471893835|FG001|Overall Study|Protocol Violation|1|||
131071720|NCT00818519|471893834|FG000|Overall Study|Pregnancy|0|||
131071721|NCT00818519|471893835|FG001|Overall Study|Pregnancy|1|||
131071722|NCT00818519|471893834|FG000|Overall Study|Withdrawal by Subject|4|||
131071723|NCT00818519|471893835|FG001|Overall Study|Withdrawal by Subject|9|||
131071724|NCT00818519|471893834|FG000|Overall Study|participant recovered completely|1|||
131071725|NCT00818519|471893835|FG001|Overall Study|participant recovered completely|0|||
131071726|NCT00818519|471893834|FG000|Overall Study|participant will leave for long tme|1|||
131071727|NCT00818519|471893835|FG001|Overall Study|participant will leave for long tme|0|||
131071728|NCT03613454|471893838|FG000|Overall Study|Protocol Violation|1|||
131071729|NCT03613454|471893839|FG001|Overall Study|Protocol Violation|0|||
131071730|NCT03613454|471893838|FG000|Overall Study|Protocol Violation|0|||
131071731|NCT03613454|471893839|FG001|Overall Study|Protocol Violation|1|||
131071732|NCT03356145|471893840|FG000|Overall Study|Withdrawal by Subject|2|||
131071733|NCT03356145|471893841|FG001|Overall Study|Withdrawal by Subject|1|||
131071734|NCT03356145|471893840|FG000|Overall Study|Did not meet inclusion criteria|1|||
131071735|NCT03356145|471893841|FG001|Overall Study|Did not meet inclusion criteria|0|||
131071736|NCT02963922|471893842|FG000|Overall Study|Adverse Event|15|||
131071737|NCT02963922|471893843|FG001|Overall Study|Adverse Event|6|||
131071738|NCT02963922|471893842|FG000|Overall Study|Protocol deviation|6|||
131071739|NCT02963922|471893843|FG001|Overall Study|Protocol deviation|6|||
131071740|NCT02963922|471893842|FG000|Overall Study|Lack of Efficacy|1|||
131071741|NCT02963922|471893843|FG001|Overall Study|Lack of Efficacy|1|||
131071742|NCT02963922|471893842|FG000|Overall Study|Lost to Follow-up|2|||
131071743|NCT02963922|471893843|FG001|Overall Study|Lost to Follow-up|3|||
131071744|NCT02963922|471893842|FG000|Overall Study|Other|8|||
131071745|NCT02963922|471893843|FG001|Overall Study|Other|14|||
131071746|NCT02040532|471893845|FG000|Overall Study|Lost to Follow-up|1|||
131071747|NCT02040532|471893845|FG000|Overall Study|Physician Decision|4|||
131071748|NCT02040532|471893845|FG000|Overall Study|Adverse Event|4|||
131071749|NCT02040532|471893845|FG000|Overall Study|Withdrawal by Subject|3|||
131071750|NCT03640754|471893848|FG000|Overall Study|Withdrawal by Subject|1|||
131071751|NCT03640754|471893849|FG001|Overall Study|Withdrawal by Subject|0|||
131071752|NCT03640754|471893848|FG000|Overall Study|Lost to Follow-up|0|||
131071753|NCT03640754|471893849|FG001|Overall Study|Lost to Follow-up|1|||
131071754|NCT01679613|471893855|FG000|Overall Study|other than stated above|0|||
131071755|NCT01679613|471893856|FG001|Overall Study|other than stated above|1|||
131071756|NCT01679613|471893857|FG002|Overall Study|other than stated above|2|||
131071757|NCT01679613|471893858|FG003|Overall Study|other than stated above|2|||
131071758|NCT03169530|471893859|FG000|Overall Study|Study ended by NIH|15|||
131071759|NCT03169530|471893860|FG001|Overall Study|Study ended by NIH|17|||
131071760|NCT02965599|471893861|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
131071761|NCT02965599|471893862|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
131071762|NCT02956278|471895402|FG000|Overall Study|Withdrawal by Subject|6|||
131071763|NCT02956278|471895403|FG001|Overall Study|Withdrawal by Subject|2|||
131071764|NCT02956278|471895404|FG002|Overall Study|Withdrawal by Subject|0|||
131071765|NCT00796614|471895414|FG000|Overall Study|Adverse Event|1|||
131071766|NCT00796614|471895415|FG001|Overall Study|Adverse Event|2|||
131071767|NCT00796614|471895416|FG002|Overall Study|Adverse Event|0|||
131071768|NCT00796614|471895417|FG003|Overall Study|Adverse Event|0|||
131071769|NCT00796614|471895414|FG000|Overall Study|Protocol Violation|0|||
131071770|NCT00796614|471895415|FG001|Overall Study|Protocol Violation|0|||
131071771|NCT00796614|471895416|FG002|Overall Study|Protocol Violation|2|||
131071772|NCT00796614|471895417|FG003|Overall Study|Protocol Violation|0|||
131071773|NCT00796614|471895414|FG000|Overall Study|Lost to Follow-up|2|||
131071774|NCT00796614|471895415|FG001|Overall Study|Lost to Follow-up|2|||
131071775|NCT00796614|471895416|FG002|Overall Study|Lost to Follow-up|1|||
131071776|NCT00796614|471895417|FG003|Overall Study|Lost to Follow-up|0|||
131071777|NCT00796614|471895414|FG000|Overall Study|Withdrawal by Subject|1|||
131071778|NCT00796614|471895415|FG001|Overall Study|Withdrawal by Subject|0|||
131071779|NCT00796614|471895416|FG002|Overall Study|Withdrawal by Subject|0|||
131071780|NCT00796614|471895417|FG003|Overall Study|Withdrawal by Subject|1|||
131071781|NCT00796614|471895414|FG000|Overall Study|Other than stated|1|||
131071782|NCT00796614|471895415|FG001|Overall Study|Other than stated|0|||
131071783|NCT00796614|471895416|FG002|Overall Study|Other than stated|0|||
131071784|NCT00796614|471895417|FG003|Overall Study|Other than stated|0|||
131071785|NCT00509821|471895418|FG000|Study Period 1 (Induction)|Death|0|||
131071786|NCT00509821|471895419|FG001|Study Period 1 (Induction)|Death|1|||
131071787|NCT00509821|471895418|FG000|Study Period 1 (Induction)|Adverse Event|0|||
131071788|NCT00509821|471895419|FG001|Study Period 1 (Induction)|Adverse Event|2|||
131071789|NCT00509821|471895418|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
131071790|NCT00509821|471895419|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
131071791|NCT02720185|471895421|FG000|Overall Study|Lost to Follow-up|1|||
131071792|NCT01960348|471895422|FG000|Overall Study|Adverse event, not serious|2|||
131071793|NCT01960348|471895423|FG001|Overall Study|Adverse event, not serious|2|||
131071794|NCT01960348|471895422|FG000|Overall Study|Adverse event, serious fatal|6|||
131071795|NCT01960348|471895423|FG001|Overall Study|Adverse event, serious fatal|5|||
131071796|NCT01960348|471895422|FG000|Overall Study|Adverse event, serious non-fatal|0|||
131071797|NCT01960348|471895423|FG001|Overall Study|Adverse event, serious non-fatal|3|||
131071798|NCT01960348|471895422|FG000|Overall Study|Withdrawal by Subject|1|||
131071799|NCT01960348|471895423|FG001|Overall Study|Withdrawal by Subject|11|||
131071800|NCT01960348|471895422|FG000|Overall Study|Physician Decision|0|||
131071801|NCT01960348|471895423|FG001|Overall Study|Physician Decision|1|||
131071802|NCT01960348|471895422|FG000|Overall Study|Protocol Violation|1|||
131071803|NCT01960348|471895423|FG001|Overall Study|Protocol Violation|0|||
131071804|NCT02151643|471895424|FG000|Overall Study|Adverse Event|2|||
131071805|NCT02151643|471895425|FG001|Overall Study|Adverse Event|0|||
131071806|NCT02151643|471895426|FG002|Overall Study|Adverse Event|1|||
131071807|NCT02151643|471895427|FG003|Overall Study|Adverse Event|4|||
131071808|NCT02151643|471895428|FG004|Overall Study|Adverse Event|0|||
131071809|NCT02151643|471895424|FG000|Overall Study|Withdrawal by Subject|0|||
131071810|NCT02151643|471895425|FG001|Overall Study|Withdrawal by Subject|1|||
131071811|NCT02151643|471895426|FG002|Overall Study|Withdrawal by Subject|1|||
131071812|NCT02151643|471895427|FG003|Overall Study|Withdrawal by Subject|1|||
131071813|NCT02151643|471895428|FG004|Overall Study|Withdrawal by Subject|1|||
131071814|NCT02151643|471895424|FG000|Overall Study|Hyperphosphataemia|1|||
131071815|NCT02151643|471895425|FG001|Overall Study|Hyperphosphataemia|0|||
131071816|NCT02151643|471895426|FG002|Overall Study|Hyperphosphataemia|0|||
131071817|NCT02151643|471895427|FG003|Overall Study|Hyperphosphataemia|0|||
131071818|NCT02151643|471895428|FG004|Overall Study|Hyperphosphataemia|1|||
131071819|NCT02151643|471895424|FG000|Overall Study|High Ferritin levels|3|||
131071820|NCT02151643|471895425|FG001|Overall Study|High Ferritin levels|3|||
131071821|NCT02151643|471895426|FG002|Overall Study|High Ferritin levels|2|||
131071822|NCT02151643|471895427|FG003|Overall Study|High Ferritin levels|2|||
131071823|NCT02151643|471895428|FG004|Overall Study|High Ferritin levels|1|||
131071824|NCT00197106|471895429|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
131071825|NCT00197106|471895430|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
131071826|NCT00197106|471895431|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
131071827|NCT00197106|471895429|FG000|Overall Treatment Period|Lack of Efficacy|0|||
131071828|NCT00197106|471895430|FG001|Overall Treatment Period|Lack of Efficacy|1|||
131071829|NCT00197106|471895431|FG002|Overall Treatment Period|Lack of Efficacy|0|||
131071830|NCT00197106|471895429|FG000|Overall Treatment Period|Lost to Follow-up|0|||
131071831|NCT00197106|471895430|FG001|Overall Treatment Period|Lost to Follow-up|0|||
131071832|NCT00197106|471895431|FG002|Overall Treatment Period|Lost to Follow-up|2|||
131071833|NCT00197106|471895429|FG000|Overall Treatment Period|Protocol Violation|0|||
131071834|NCT00197106|471895430|FG001|Overall Treatment Period|Protocol Violation|0|||
131071835|NCT00197106|471895431|FG002|Overall Treatment Period|Protocol Violation|2|||
131071836|NCT00197106|471895429|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
131071837|NCT00197106|471895430|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
131071838|NCT00197106|471895431|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
131071839|NCT03924947|471895434|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
131071840|NCT03924947|471895435|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
131071841|NCT03924947|471895436|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
131071842|NCT03924947|471895437|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
131071843|NCT03924947|471895438|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
131071844|NCT03924947|471895439|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
131071845|NCT00833898|471895445|FG000|Overall Study|Withdrawal by Subject|33|||
131071846|NCT00833898|471895446|FG001|Overall Study|Withdrawal by Subject|27|||
131071847|NCT00833898|471895445|FG000|Overall Study|Lost to Follow-up|7|||
131071848|NCT00833898|471895446|FG001|Overall Study|Lost to Follow-up|7|||
131071849|NCT00833898|471895445|FG000|Overall Study|Patient did not receive transplant|0|||
131071850|NCT00833898|471895446|FG001|Overall Study|Patient did not receive transplant|2|||
131071851|NCT00805285|471895447|FG000|Overall Study|Lack of Efficacy|1|||
131071852|NCT00917462|471895448|FG000|Overall Study|Clinical Deterioration|1|||
131071853|NCT01402063|471895449|FG000|Overall Study|Withdrawal by Subject|3|||
131071854|NCT01402063|471895450|FG001|Overall Study|Withdrawal by Subject|3|||
131071855|NCT01631825|471895454|FG000|Overall Study|Adverse Event|42|||
131071856|NCT01631825|471895454|FG000|Overall Study|Lack of Efficacy|7|||
131071857|NCT01631825|471895454|FG000|Overall Study|Withdrawal by Subject|9|||
131071858|NCT01631825|471895454|FG000|Overall Study|Protocol Violation|4|||
131071859|NCT01631825|471895454|FG000|Overall Study|Discontinuation criteria|1|||
131071860|NCT01631825|471895454|FG000|Overall Study|Physician Decision|2|||
131071861|NCT02110225|471895455|FG000|Overall Study|Lost to Follow-up|0|||
131071862|NCT02110225|471895456|FG001|Overall Study|Lost to Follow-up|1|||
131071863|NCT02110225|471895457|FG002|Overall Study|Lost to Follow-up|0|||
131071864|NCT02176018|471895458|FG000|Overall Study|Adverse Event|0|||
131071865|NCT02176018|471895459|FG001|Overall Study|Adverse Event|2|||
131071866|NCT02176018|471895458|FG000|Overall Study|Lost to Follow-up|3|||
131071867|NCT02176018|471895459|FG001|Overall Study|Lost to Follow-up|1|||
131071868|NCT02176018|471895458|FG000|Overall Study|Protocol Violation|1|||
131071869|NCT02176018|471895459|FG001|Overall Study|Protocol Violation|1|||
131071870|NCT02176018|471895458|FG000|Overall Study|Withdrawal by Subject|1|||
130723683|NCT01346293|470613499|FG001|Overall Study|Withdrawal by Subject|4|||
131071871|NCT02176018|471895459|FG001|Overall Study|Withdrawal by Subject|2|||
131071872|NCT03022045|471895460|FG000|Overall Study|Adverse Event|0|||
131071873|NCT03022045|471895461|FG001|Overall Study|Adverse Event|1|||
131071874|NCT03022045|471895460|FG000|Overall Study|Withdrawal by Subject|1|||
131071875|NCT03022045|471895461|FG001|Overall Study|Withdrawal by Subject|1|||
131071876|NCT05109117|471895465|FG000|Overall Study|Lost to Follow-up|1|||
131071877|NCT05109117|471895465|FG000|Overall Study|Discontinued for non-compliance|1|||
131071878|NCT02499835|471895466|FG000|Overall Study|Withdrawal by Subject|1|||
131071879|NCT02499835|471895467|FG001|Overall Study|Withdrawal by Subject|0|||
131071880|NCT02499835|471895468|FG002|Overall Study|Withdrawal by Subject|0|||
131071881|NCT02499835|471895469|FG003|Overall Study|Withdrawal by Subject|1|||
131071882|NCT02499835|471895466|FG000|Overall Study|Physician Decision|0|||
131071883|NCT02499835|471895467|FG001|Overall Study|Physician Decision|3|||
131071884|NCT02499835|471895468|FG002|Overall Study|Physician Decision|18|||
131071885|NCT02499835|471895469|FG003|Overall Study|Physician Decision|7|||
131071886|NCT02499835|471895466|FG000|Overall Study|Adverse Event|0|||
131071887|NCT02499835|471895467|FG001|Overall Study|Adverse Event|0|||
131071888|NCT02499835|471895468|FG002|Overall Study|Adverse Event|0|||
131071889|NCT02499835|471895469|FG003|Overall Study|Adverse Event|1|||
131071890|NCT02499835|471895466|FG000|Overall Study|Disease progression|2|||
131071891|NCT02499835|471895467|FG001|Overall Study|Disease progression|1|||
131071892|NCT02499835|471895468|FG002|Overall Study|Disease progression|0|||
131071893|NCT02499835|471895469|FG003|Overall Study|Disease progression|7|||
131071894|NCT03972137|471895473|FG000|Overall Study|Lost to Follow-up|2|||
131071895|NCT03972137|471895473|FG000|Overall Study|Withdrawal by Subject|4|||
131071896|NCT00899379|471895474|FG000|Overall Study|Adverse Event|2|||
131071897|NCT00899379|471895475|FG001|Overall Study|Adverse Event|2|||
131071898|NCT00899379|471895476|FG002|Overall Study|Adverse Event|1|||
131071899|NCT00899379|471895477|FG003|Overall Study|Adverse Event|1|||
131071900|NCT00899379|471895478|FG004|Overall Study|Adverse Event|2|||
131071901|NCT00899379|471895474|FG000|Overall Study|Lack of Efficacy|0|||
131071902|NCT00899379|471895475|FG001|Overall Study|Lack of Efficacy|4|||
131071903|NCT00899379|471895476|FG002|Overall Study|Lack of Efficacy|3|||
131071904|NCT00899379|471895477|FG003|Overall Study|Lack of Efficacy|0|||
131071905|NCT00899379|471895478|FG004|Overall Study|Lack of Efficacy|1|||
131071906|NCT00899379|471895474|FG000|Overall Study|Lost to Follow-up|9|||
131071907|NCT00899379|471895475|FG001|Overall Study|Lost to Follow-up|3|||
131071908|NCT00899379|471895476|FG002|Overall Study|Lost to Follow-up|0|||
131071909|NCT00899379|471895477|FG003|Overall Study|Lost to Follow-up|6|||
131071910|NCT00899379|471895478|FG004|Overall Study|Lost to Follow-up|2|||
131071911|NCT00899379|471895474|FG000|Overall Study|Protocol Violation|0|||
131071912|NCT00899379|471895475|FG001|Overall Study|Protocol Violation|0|||
131071913|NCT00899379|471895476|FG002|Overall Study|Protocol Violation|1|||
131071914|NCT00899379|471895477|FG003|Overall Study|Protocol Violation|1|||
131071915|NCT00899379|471895478|FG004|Overall Study|Protocol Violation|0|||
131071916|NCT00899379|471895474|FG000|Overall Study|Withdrawal by Subject|2|||
131071917|NCT00899379|471895475|FG001|Overall Study|Withdrawal by Subject|4|||
131071918|NCT00899379|471895476|FG002|Overall Study|Withdrawal by Subject|2|||
131071919|NCT00899379|471895477|FG003|Overall Study|Withdrawal by Subject|3|||
131071920|NCT00899379|471895478|FG004|Overall Study|Withdrawal by Subject|6|||
131071921|NCT00899379|471895474|FG000|Overall Study|Pregnancy|0|||
131071922|NCT00899379|471895475|FG001|Overall Study|Pregnancy|0|||
131071923|NCT00899379|471895476|FG002|Overall Study|Pregnancy|1|||
131071924|NCT00899379|471895477|FG003|Overall Study|Pregnancy|0|||
131071925|NCT00899379|471895478|FG004|Overall Study|Pregnancy|1|||
131071926|NCT00899379|471895474|FG000|Overall Study|Patient Uncooperative|0|||
131071927|NCT00899379|471895475|FG001|Overall Study|Patient Uncooperative|1|||
131071928|NCT00899379|471895476|FG002|Overall Study|Patient Uncooperative|0|||
131071929|NCT00899379|471895477|FG003|Overall Study|Patient Uncooperative|1|||
131071930|NCT00899379|471895478|FG004|Overall Study|Patient Uncooperative|2|||
131071931|NCT00899379|471895474|FG000|Overall Study|Abnormal Baseline ECG|0|||
131071932|NCT00899379|471895475|FG001|Overall Study|Abnormal Baseline ECG|0|||
131071933|NCT00899379|471895476|FG002|Overall Study|Abnormal Baseline ECG|0|||
131071934|NCT00899379|471895477|FG003|Overall Study|Abnormal Baseline ECG|1|||
131071935|NCT00899379|471895478|FG004|Overall Study|Abnormal Baseline ECG|0|||
131071936|NCT00899379|471895474|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
131230935|NCT04274192|472471417|FG000|Overall Study|Protocol Violation|1|||
131230936|NCT04274192|472471418|FG001|Overall Study|Protocol Violation|0|||
130723684|NCT01346293|470613498|FG000|Overall Study|Other|1|||
131071937|NCT00899379|471895475|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
131071938|NCT00899379|471895476|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
131071939|NCT00899379|471895477|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131071940|NCT00899379|471895478|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131071941|NCT00899379|471895474|FG000|Overall Study|Not Completed/Entered Extn|5|||
131071942|NCT00899379|471895475|FG001|Overall Study|Not Completed/Entered Extn|1|||
131071943|NCT00899379|471895476|FG002|Overall Study|Not Completed/Entered Extn|6|||
131071944|NCT00899379|471895477|FG003|Overall Study|Not Completed/Entered Extn|4|||
131071945|NCT00899379|471895478|FG004|Overall Study|Not Completed/Entered Extn|3|||
131071946|NCT00899379|471895474|FG000|Overall Study|Study Terminated|3|||
131071947|NCT00899379|471895475|FG001|Overall Study|Study Terminated|0|||
131071948|NCT00899379|471895476|FG002|Overall Study|Study Terminated|3|||
131071949|NCT00899379|471895477|FG003|Overall Study|Study Terminated|3|||
131071950|NCT00899379|471895478|FG004|Overall Study|Study Terminated|1|||
131071951|NCT00899379|471895474|FG000|Overall Study|Lost to Follow-up|3|||
131071952|NCT00899379|471895475|FG001|Overall Study|Lost to Follow-up|1|||
131071953|NCT00899379|471895476|FG002|Overall Study|Lost to Follow-up|0|||
131071954|NCT00899379|471895477|FG003|Overall Study|Lost to Follow-up|2|||
131071955|NCT00899379|471895478|FG004|Overall Study|Lost to Follow-up|5|||
131071956|NCT00899379|471895474|FG000|Overall Study|Withdrawal by Subject|4|||
131071957|NCT00899379|471895475|FG001|Overall Study|Withdrawal by Subject|7|||
131071958|NCT00899379|471895476|FG002|Overall Study|Withdrawal by Subject|4|||
131071959|NCT00899379|471895477|FG003|Overall Study|Withdrawal by Subject|7|||
131071960|NCT00899379|471895478|FG004|Overall Study|Withdrawal by Subject|2|||
131071961|NCT00899379|471895474|FG000|Overall Study|Pregnancy|1|||
131071962|NCT00899379|471895475|FG001|Overall Study|Pregnancy|0|||
131071963|NCT00899379|471895476|FG002|Overall Study|Pregnancy|0|||
131071964|NCT00899379|471895477|FG003|Overall Study|Pregnancy|0|||
131071965|NCT00899379|471895478|FG004|Overall Study|Pregnancy|0|||
131071966|NCT00899379|471895474|FG000|Overall Study|Patient Uncooperative|0|||
131071967|NCT00899379|471895475|FG001|Overall Study|Patient Uncooperative|0|||
131071968|NCT00899379|471895476|FG002|Overall Study|Patient Uncooperative|0|||
131071969|NCT00899379|471895477|FG003|Overall Study|Patient Uncooperative|1|||
131071970|NCT00899379|471895478|FG004|Overall Study|Patient Uncooperative|0|||
131230937|NCT02806232|472473203|FG000|Overall Study|Lost to Follow-up|1|||
131230938|NCT02806232|472473204|FG001|Overall Study|Lost to Follow-up|2|||
131230939|NCT02806232|472473205|FG002|Overall Study|Lost to Follow-up|1|||
131230940|NCT02806232|472473206|FG003|Overall Study|Lost to Follow-up|0|||
131230941|NCT02806232|472473207|FG004|Overall Study|Lost to Follow-up|0|||
131230942|NCT02806232|472473208|FG005|Overall Study|Lost to Follow-up|1|||
131230943|NCT02806232|472473209|FG006|Overall Study|Lost to Follow-up|0|||
131230944|NCT02806232|472473210|FG007|Overall Study|Lost to Follow-up|0|||
131230945|NCT02806232|472473211|FG008|Overall Study|Lost to Follow-up|0|||
131230946|NCT02806232|472473203|FG000|Overall Study|Withdrawal by Subject|0|||
131230947|NCT02806232|472473204|FG001|Overall Study|Withdrawal by Subject|2|||
131230948|NCT02806232|472473205|FG002|Overall Study|Withdrawal by Subject|0|||
131230949|NCT02806232|472473206|FG003|Overall Study|Withdrawal by Subject|0|||
131230950|NCT02806232|472473207|FG004|Overall Study|Withdrawal by Subject|2|||
131230951|NCT02806232|472473208|FG005|Overall Study|Withdrawal by Subject|1|||
131230952|NCT02806232|472473209|FG006|Overall Study|Withdrawal by Subject|0|||
131230953|NCT02806232|472473210|FG007|Overall Study|Withdrawal by Subject|0|||
131230954|NCT02806232|472473211|FG008|Overall Study|Withdrawal by Subject|0|||
131230955|NCT01621490|472473212|FG000|Overall Study|Subject no longer meets study criteria|0|||
131230956|NCT01621490|472473213|FG001|Overall Study|Subject no longer meets study criteria|0|||
131230957|NCT01621490|472473214|FG002|Overall Study|Subject no longer meets study criteria|0|||
131230958|NCT01621490|472473215|FG003|Overall Study|Subject no longer meets study criteria|0|||
131230959|NCT01621490|472473216|FG004|Overall Study|Subject no longer meets study criteria|1|||
131230960|NCT01621490|472473217|FG005|Overall Study|Subject no longer meets study criteria|0|||
131230961|NCT01621490|472473218|FG006|Overall Study|Subject no longer meets study criteria|0|||
131230962|NCT01621490|472473219|FG007|Overall Study|Subject no longer meets study criteria|0|||
130723685|NCT01346293|470613499|FG001|Overall Study|Other|0|||
130723686|NCT03503864|470613502|FG000|Overall Study|Protocol Violation|6|||
131071971|NCT00899379|471895474|FG000|Overall Study|Abnormal Prestudy Labs|0|||
131071972|NCT00899379|471895475|FG001|Overall Study|Abnormal Prestudy Labs|0|||
131071973|NCT00899379|471895476|FG002|Overall Study|Abnormal Prestudy Labs|0|||
131071974|NCT00899379|471895477|FG003|Overall Study|Abnormal Prestudy Labs|0|||
131071975|NCT00899379|471895478|FG004|Overall Study|Abnormal Prestudy Labs|2|||
131071976|NCT00899379|471895474|FG000|Overall Study|Abnormal Baseline ECG|0|||
131071977|NCT00899379|471895475|FG001|Overall Study|Abnormal Baseline ECG|0|||
131071978|NCT00899379|471895476|FG002|Overall Study|Abnormal Baseline ECG|1|||
131230963|NCT01621490|472473220|FG008|Overall Study|Subject no longer meets study criteria|0|||
131230964|NCT01621490|472473221|FG009|Overall Study|Subject no longer meets study criteria|0|||
130723687|NCT03503864|470613502|FG000|Overall Study|Withdrawal by Subject|7|||
131230965|NCT01621490|472473222|FG010|Overall Study|Subject no longer meets study criteria|0|||
131230966|NCT01621490|472473212|FG000|Overall Study|Maximum clinical benefit|3|||
131230967|NCT01621490|472473213|FG001|Overall Study|Maximum clinical benefit|2|||
131230968|NCT01621490|472473214|FG002|Overall Study|Maximum clinical benefit|0|||
131071979|NCT00899379|471895477|FG003|Overall Study|Abnormal Baseline ECG|1|||
131071980|NCT00899379|471895478|FG004|Overall Study|Abnormal Baseline ECG|0|||
131071981|NCT00899379|471895474|FG000|Overall Study|No Attack Pretreatment|3|||
131071982|NCT00899379|471895475|FG001|Overall Study|No Attack Pretreatment|5|||
131071983|NCT00899379|471895476|FG002|Overall Study|No Attack Pretreatment|5|||
131071984|NCT00899379|471895477|FG003|Overall Study|No Attack Pretreatment|6|||
131071985|NCT00899379|471895478|FG004|Overall Study|No Attack Pretreatment|4|||
130723688|NCT02910063|470613504|FG000|Phase 2|Withdrawal by Subject|3|||
130723689|NCT02910063|470613505|FG001|Phase 2|Withdrawal by Subject|0|||
130723690|NCT02910063|470613506|FG002|Phase 2|Withdrawal by Subject|0|||
130723691|NCT02910063|470613504|FG000|Phase 2|Lost to Follow-up|1|||
130723692|NCT02910063|470613505|FG001|Phase 2|Lost to Follow-up|0|||
130723693|NCT02910063|470613506|FG002|Phase 2|Lost to Follow-up|0|||
130723694|NCT02910063|470613504|FG000|Phase 2|Death|24|||
130723695|NCT02910063|470613505|FG001|Phase 2|Death|0|||
130723696|NCT02910063|470613506|FG002|Phase 2|Death|0|||
130723697|NCT04693416|470613507|FG000|Overall Study|Lost to Follow-up|13|||
130723698|NCT04693416|470613508|FG001|Overall Study|Lost to Follow-up|0|||
130723699|NCT00474266|470613509|FG000|Overall Study|Withdrawal by Subject|7|||
130723700|NCT00474266|470613510|FG001|Overall Study|Withdrawal by Subject|20|||
131071986|NCT00899379|471895474|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
131071987|NCT00899379|471895475|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131071988|NCT00899379|471895476|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131071989|NCT00899379|471895477|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131071990|NCT00899379|471895478|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
131071991|NCT00899379|471895474|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
131071992|NCT00899379|471895475|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
131071993|NCT00899379|471895476|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
131071994|NCT00899379|471895477|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
131071995|NCT00899379|471895478|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
131071996|NCT03220776|471895483|FG000|Overall Study|Claustrophobia|0|||
131071997|NCT03220776|471895484|FG001|Overall Study|Claustrophobia|1|||
131071998|NCT03220776|471895485|FG002|Overall Study|Claustrophobia|1|||
131071999|NCT03220776|471895486|FG003|Overall Study|Claustrophobia|0|||
131072000|NCT03220776|471895487|FG004|Overall Study|Claustrophobia|1|||
131072001|NCT03220776|471895488|FG005|Overall Study|Claustrophobia|0|||
131072002|NCT03220776|471895483|FG000|Overall Study|MRI Equipment Failure|1|||
131072003|NCT03220776|471895484|FG001|Overall Study|MRI Equipment Failure|0|||
131072004|NCT03220776|471895485|FG002|Overall Study|MRI Equipment Failure|0|||
131072005|NCT03220776|471895486|FG003|Overall Study|MRI Equipment Failure|0|||
131072006|NCT03220776|471895487|FG004|Overall Study|MRI Equipment Failure|0|||
131072007|NCT03220776|471895488|FG005|Overall Study|MRI Equipment Failure|0|||
131072008|NCT03220776|471895483|FG000|Overall Study|Inclimate Weather|0|||
131072009|NCT03220776|471895484|FG001|Overall Study|Inclimate Weather|0|||
131072010|NCT03220776|471895485|FG002|Overall Study|Inclimate Weather|0|||
131072011|NCT03220776|471895486|FG003|Overall Study|Inclimate Weather|0|||
131072012|NCT03220776|471895487|FG004|Overall Study|Inclimate Weather|0|||
131072013|NCT03220776|471895488|FG005|Overall Study|Inclimate Weather|1|||
131072014|NCT03220776|471895483|FG000|Overall Study|Physician Decision|0|||
131072015|NCT03220776|471895484|FG001|Overall Study|Physician Decision|0|||
131072016|NCT03220776|471895485|FG002|Overall Study|Physician Decision|0|||
131072017|NCT03220776|471895486|FG003|Overall Study|Physician Decision|1|||
131072018|NCT03220776|471895487|FG004|Overall Study|Physician Decision|0|||
131072019|NCT03220776|471895488|FG005|Overall Study|Physician Decision|0|||
131072020|NCT03220776|471895483|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
131072021|NCT03220776|471895484|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
131072022|NCT03220776|471895485|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
131072023|NCT03220776|471895486|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
131072024|NCT03220776|471895487|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
131072025|NCT03220776|471895488|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
131072026|NCT03220776|471895483|FG000|Overall Study|Protocol Violation|0|||
131072027|NCT03220776|471895484|FG001|Overall Study|Protocol Violation|0|||
131072028|NCT03220776|471895485|FG002|Overall Study|Protocol Violation|0|||
131072029|NCT03220776|471895486|FG003|Overall Study|Protocol Violation|2|||
131072030|NCT03220776|471895487|FG004|Overall Study|Protocol Violation|0|||
130723701|NCT00474266|470613511|FG002|Overall Study|Withdrawal by Subject|4|||
130723702|NCT00474266|470613512|FG003|Overall Study|Withdrawal by Subject|7|||
130723703|NCT02774642|470613513|FG000|Overall Study|Lost to Follow-up|9|||
130723704|NCT02774642|470613514|FG001|Overall Study|Lost to Follow-up|7|||
130723705|NCT04642365|470613524|FG000|Overall Study|Death|3|||
130723706|NCT04642365|470613525|FG001|Overall Study|Death|2|||
130723707|NCT04642365|470613526|FG002|Overall Study|Death|4|||
130723708|NCT04642365|470613527|FG003|Overall Study|Death|5|||
130723709|NCT04642365|470613528|FG004|Overall Study|Death|5|||
130723710|NCT04642365|470613529|FG005|Overall Study|Death|3|||
131072031|NCT03220776|471895488|FG005|Overall Study|Protocol Violation|1|||
131072032|NCT03220776|471895483|FG000|Overall Study|Withdrawal by Subject|1|||
131072033|NCT03220776|471895484|FG001|Overall Study|Withdrawal by Subject|0|||
131072034|NCT03220776|471895485|FG002|Overall Study|Withdrawal by Subject|0|||
131072035|NCT03220776|471895486|FG003|Overall Study|Withdrawal by Subject|0|||
131072036|NCT03220776|471895487|FG004|Overall Study|Withdrawal by Subject|0|||
131072037|NCT03220776|471895488|FG005|Overall Study|Withdrawal by Subject|0|||
131072038|NCT03226353|471895489|FG000|Overall Study|Withdrawal by Subject|1|||
130723711|NCT04642365|470613530|FG006|Overall Study|Death|2|||
131072039|NCT03226353|471895489|FG000|Overall Study|Screen Failure|5|||
131072040|NCT03441789|471895491|FG000|Overall Study|Withdrawal by Subject|1|||
131072041|NCT03441789|471895492|FG001|Overall Study|Withdrawal by Subject|1|||
131072042|NCT03441789|471895491|FG000|Overall Study|Adverse Event|0|||
131072043|NCT03441789|471895492|FG001|Overall Study|Adverse Event|1|||
131072044|NCT03441789|471895491|FG000|Overall Study|Protocol Violation|0|||
131072045|NCT03441789|471895492|FG001|Overall Study|Protocol Violation|1|||
131072046|NCT03441789|471895491|FG000|Overall Study|Lost to Follow-up|0|||
131072047|NCT03441789|471895492|FG001|Overall Study|Lost to Follow-up|1|||
131072048|NCT01780545|471895493|FG000|Overall Study|Withdrawal by Subject|3|||
131072049|NCT01780545|471895494|FG001|Overall Study|Withdrawal by Subject|1|||
131072050|NCT01780545|471895493|FG000|Overall Study|Lost to Follow-up|1|||
131072051|NCT01780545|471895494|FG001|Overall Study|Lost to Follow-up|1|||
131072052|NCT02581189|471895500|FG000|Overall Study|Failure to return|36|||
131072053|NCT02581189|471895500|FG000|Overall Study|Withdrew consent|5|||
131072054|NCT02581189|471895500|FG000|Overall Study|Death|3|||
131072055|NCT02581189|471895500|FG000|Overall Study|Insufficient virological response|2|||
131072056|NCT02581189|471895500|FG000|Overall Study|Other, not specified|7|||
131072057|NCT00797511|471895501|FG000|Overall Study|Withdrawal by Subject|1|||
131072058|NCT01037413|471895502|FG000|Part A: Skin Testing|Adverse Event|1|||
131072059|NCT01037413|471895503|FG001|Part A: Skin Testing|Adverse Event|0|||
131072060|NCT01037413|471895502|FG000|Part A: Skin Testing|Protocol Violation|1|||
131072061|NCT01037413|471895503|FG001|Part A: Skin Testing|Protocol Violation|0|||
131072062|NCT01037413|471895502|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
131072063|NCT01037413|471895503|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
131072064|NCT01037413|471895502|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
131072065|NCT01037413|471895503|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
131072066|NCT02204319|471895508|FG000|Overall Study|Pregnancy|1|||
131072067|NCT02204319|471895508|FG000|Overall Study|Withdrawal by Subject|2|||
131072068|NCT03371485|471895509|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
131072069|NCT03371485|471895509|FG000|2-year Follow-up|Death|5|||
131072070|NCT02853305|471895510|FG000|Overall Study|Death|287|||
131072071|NCT02853305|471895511|FG001|Overall Study|Death|249|||
131072072|NCT02853305|471895512|FG002|Overall Study|Death|300|||
131072073|NCT02853305|471895510|FG000|Overall Study|Withdrawal by Subject|2|||
131072074|NCT02853305|471895511|FG001|Overall Study|Withdrawal by Subject|8|||
131072075|NCT02853305|471895512|FG002|Overall Study|Withdrawal by Subject|3|||
131072076|NCT02853305|471895510|FG000|Overall Study|Transferred to Extension Study|46|||
131072077|NCT02853305|471895511|FG001|Overall Study|Transferred to Extension Study|30|||
131072078|NCT02853305|471895512|FG002|Overall Study|Transferred to Extension Study|25|||
131072079|NCT02853305|471895510|FG000|Overall Study|Did Not Continue on Extension Study|16|||
131072080|NCT02853305|471895511|FG001|Overall Study|Did Not Continue on Extension Study|20|||
131072081|NCT02853305|471895512|FG002|Overall Study|Did Not Continue on Extension Study|24|||
131072082|NCT01287416|471895513|FG000|Pre-post Training|Withdrawal by Subject|17|||
131072083|NCT01287416|471895514|FG001|Pre-post Training|Withdrawal by Subject|24|||
131072084|NCT01287416|471895513|FG000|Pre-post Training|Lost to Follow-up|5|||
131072085|NCT01287416|471895514|FG001|Pre-post Training|Lost to Follow-up|1|||
131072086|NCT01287416|471895513|FG000|6 Month Follow-up|Lost to Follow-up|3|||
131072087|NCT01287416|471895514|FG001|6 Month Follow-up|Lost to Follow-up|2|||
131072088|NCT02506881|471895520|FG000|First Intervention (Day 1)|Protocol Violation|0|||
131072089|NCT02506881|471895521|FG001|First Intervention (Day 1)|Protocol Violation|0|||
131072090|NCT02506881|471895522|FG002|First Intervention (Day 1)|Protocol Violation|1|||
131072091|NCT02506881|471895523|FG003|First Intervention (Day 1)|Protocol Violation|0|||
131230969|NCT01621490|472473215|FG003|Overall Study|Maximum clinical benefit|0|||
131230970|NCT01621490|472473216|FG004|Overall Study|Maximum clinical benefit|0|||
131230971|NCT01621490|472473217|FG005|Overall Study|Maximum clinical benefit|0|||
131072092|NCT02506881|471895520|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
131072093|NCT02506881|471895521|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
131072094|NCT02506881|471895522|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
131072095|NCT02506881|471895523|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
131072096|NCT02506881|471895520|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
131072097|NCT02506881|471895521|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
131072098|NCT02506881|471895522|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
131072099|NCT02506881|471895523|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
131072100|NCT01919398|471895524|FG000|Overall Study|Progressive Disease|0|||
131072101|NCT01919398|471895525|FG001|Overall Study|Progressive Disease|0|||
131072102|NCT01919398|471895526|FG002|Overall Study|Progressive Disease|4|||
131072103|NCT02016690|471895529|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
131072104|NCT02016690|471895529|FG000|Overall Study|Excluded from SAS: Duplication|2|||
131072105|NCT02016690|471895529|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
131230972|NCT01621490|472473218|FG006|Overall Study|Maximum clinical benefit|1|||
131072106|NCT02016690|471895529|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
131072107|NCT02016690|471895529|FG000|Overall Study|Did not meet inclusion criteria|13|||
131230973|NCT01621490|472473219|FG007|Overall Study|Maximum clinical benefit|2|||
131072108|NCT02016690|471895529|FG000|Overall Study|Hospitalized for RSV at study start|3|||
131072109|NCT00050167|471895530|FG000|Overall Study|not eligible not invasive|1|||
131072110|NCT00050167|471895531|FG001|Overall Study|not eligible not invasive|1|||
131072111|NCT00495612|471895534|FG000|Overall Study|Lost to Follow-up|1|||
131072112|NCT00495612|471895535|FG001|Overall Study|Lost to Follow-up|0|||
131072113|NCT00495612|471895534|FG000|Overall Study|Subject's Decision to Withdraw|3|||
131072114|NCT00495612|471895535|FG001|Overall Study|Subject's Decision to Withdraw|0|||
131072115|NCT06016127|471895538|FG000|Overall Study|Withdrawal by Subject|4|||
131072116|NCT06016127|471895539|FG001|Overall Study|Withdrawal by Subject|3|||
131072117|NCT02864147|471895545|FG000|Overall Study|Withdrawal by Subject|3|||
131072118|NCT02864147|471895546|FG001|Overall Study|Withdrawal by Subject|2|||
131072119|NCT02864147|471895547|FG002|Overall Study|Withdrawal by Subject|1|||
131072120|NCT02864147|471895545|FG000|Overall Study|Lost to Follow-up|0|||
131072121|NCT02864147|471895546|FG001|Overall Study|Lost to Follow-up|4|||
131072122|NCT02864147|471895547|FG002|Overall Study|Lost to Follow-up|0|||
131072123|NCT02864147|471895545|FG000|Overall Study|Adverse Event|0|||
131072124|NCT02864147|471895546|FG001|Overall Study|Adverse Event|1|||
131072125|NCT02864147|471895547|FG002|Overall Study|Adverse Event|0|||
131072126|NCT02864147|471895545|FG000|Overall Study|Pregnancy|4|||
131072127|NCT02864147|471895546|FG001|Overall Study|Pregnancy|0|||
131072128|NCT02864147|471895547|FG002|Overall Study|Pregnancy|0|||
131072129|NCT02864147|471895545|FG000|Overall Study|Physician Decision|0|||
131072130|NCT02864147|471895546|FG001|Overall Study|Physician Decision|0|||
131072131|NCT02864147|471895547|FG002|Overall Study|Physician Decision|1|||
131072132|NCT02864147|471895545|FG000|Overall Study|Opted for excisional procedures|0|||
131072133|NCT02864147|471895546|FG001|Overall Study|Opted for excisional procedures|0|||
131072134|NCT02864147|471895547|FG002|Overall Study|Opted for excisional procedures|3|||
131072135|NCT02269917|471895548|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
131072136|NCT02269917|471895549|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
131072137|NCT02269917|471895550|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
131072138|NCT02269917|471895548|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
131072139|NCT02269917|471895549|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
131072140|NCT02269917|471895550|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
131072141|NCT02269917|471895548|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
131072142|NCT02269917|471895549|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
131072143|NCT02269917|471895550|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
131072144|NCT02269917|471895548|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
131072145|NCT02269917|471895549|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
131072146|NCT02269917|471895550|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
131072147|NCT02269917|471895548|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
131072148|NCT02269917|471895549|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
131072149|NCT02269917|471895550|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
131072150|NCT02269917|471895548|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
131072151|NCT02269917|471895549|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
131072152|NCT02269917|471895550|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
131072153|NCT02269917|471895548|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
131072154|NCT02269917|471895549|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
131072155|NCT02269917|471895550|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
131072156|NCT02269917|471895548|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
131072157|NCT02269917|471895549|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
131072158|NCT02269917|471895550|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
131072159|NCT02269917|471895548|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
131072160|NCT02269917|471895549|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
131072161|NCT02269917|471895550|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
131072162|NCT02269917|471895548|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
130779503|NCT02326272|470819500|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779504|NCT02326272|470819501|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779505|NCT02326272|470819502|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779506|NCT02326272|470819503|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779507|NCT02326272|470819504|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130779508|NCT02326272|470819490|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130779509|NCT02326272|470819491|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130779510|NCT02326272|470819492|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130779511|NCT02326272|470819493|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130779512|NCT02326272|470819494|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130779513|NCT02326272|470819495|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131072163|NCT02269917|471895549|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
131072164|NCT02269917|471895550|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
131072165|NCT02269917|471895548|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
131072166|NCT02269917|471895549|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
131072167|NCT02269917|471895550|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
131072168|NCT02269917|471895548|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
131072169|NCT02269917|471895549|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
131072170|NCT02269917|471895550|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
131072171|NCT02269917|471895548|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
131072172|NCT02269917|471895549|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
131072173|NCT02269917|471895550|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
131072174|NCT02269917|471895548|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
131072175|NCT02269917|471895549|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
131072176|NCT02269917|471895550|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
131072177|NCT02269917|471895548|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
131072178|NCT02269917|471895549|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
131072179|NCT02269917|471895550|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
131072180|NCT02269917|471895548|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
131072181|NCT02269917|471895549|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
131072182|NCT02269917|471895550|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
131072183|NCT02383927|471895551|FG000|Overall Study|Disease Progression|8|||
131072184|NCT02383927|471895552|FG001|Overall Study|Disease Progression|8|||
131072185|NCT02383927|471895553|FG002|Overall Study|Disease Progression|15|||
131072186|NCT02383927|471895554|FG003|Overall Study|Disease Progression|4|||
131072187|NCT02383927|471895551|FG000|Overall Study|Physician Decision|0|||
131072188|NCT02383927|471895552|FG001|Overall Study|Physician Decision|0|||
131072189|NCT02383927|471895553|FG002|Overall Study|Physician Decision|2|||
131072190|NCT02383927|471895554|FG003|Overall Study|Physician Decision|0|||
131072191|NCT02383927|471895551|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
131072192|NCT02383927|471895552|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
131072193|NCT02383927|471895553|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
131072194|NCT02383927|471895554|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
131072195|NCT02383927|471895551|FG000|Overall Study|Adverse Event|4|||
131072196|NCT02383927|471895552|FG001|Overall Study|Adverse Event|1|||
131137783|NCT02340663|472130700|FG000|Overall Study|Withdrawal by Subject|3|||
131137784|NCT02340663|472130701|FG001|Overall Study|Withdrawal by Subject|1|||
131137785|NCT02979431|472130702|FG000|Overall Study|Parent/guardian withdrew consent|2|||
131137786|NCT02979431|472130703|FG001|Overall Study|Parent/guardian withdrew consent|1|||
131137787|NCT02979431|472130704|FG002|Overall Study|Parent/guardian withdrew consent|1|||
131137788|NCT02979431|472130705|FG003|Overall Study|Parent/guardian withdrew consent|1|||
131137789|NCT02979431|472130702|FG000|Overall Study|Randomized but received no study drug|1|||
131137790|NCT02979431|472130703|FG001|Overall Study|Randomized but received no study drug|1|||
131137791|NCT02979431|472130704|FG002|Overall Study|Randomized but received no study drug|0|||
131137792|NCT02979431|472130705|FG003|Overall Study|Randomized but received no study drug|0|||
131137793|NCT02979431|472130702|FG000|Overall Study|Adverse Event|0|||
131137794|NCT02979431|472130703|FG001|Overall Study|Adverse Event|0|||
131137795|NCT02979431|472130704|FG002|Overall Study|Adverse Event|1|||
131137796|NCT02979431|472130705|FG003|Overall Study|Adverse Event|0|||
131137797|NCT02979431|472130702|FG000|Overall Study|Subject left country after Day14|1|||
131137798|NCT02979431|472130703|FG001|Overall Study|Subject left country after Day14|0|||
131137799|NCT02979431|472130704|FG002|Overall Study|Subject left country after Day14|0|||
131137800|NCT02979431|472130705|FG003|Overall Study|Subject left country after Day14|0|||
131137801|NCT01656434|472130706|FG000|Overall Study|Adverse Event|199|||
131137802|NCT01656434|472130707|FG001|Overall Study|Adverse Event|63|||
131137803|NCT01656434|472130706|FG000|Overall Study|Enrollment terminated at trial site|2|||
131137804|NCT01656434|472130707|FG001|Overall Study|Enrollment terminated at trial site|0|||
131137805|NCT01656434|472130706|FG000|Overall Study|Lost to Follow-up|309|||
131137806|NCT01656434|472130707|FG001|Overall Study|Lost to Follow-up|76|||
131137807|NCT01656434|472130706|FG000|Overall Study|Site discontinued study participation|24|||
131137808|NCT01656434|472130707|FG001|Overall Study|Site discontinued study participation|9|||
131137809|NCT01656434|472130706|FG000|Overall Study|Screen failure|2|||
131137810|NCT01656434|472130707|FG001|Overall Study|Screen failure|0|||
131137811|NCT01656434|472130706|FG000|Overall Study|Protocol Violation|7|||
131137812|NCT01656434|472130707|FG001|Overall Study|Protocol Violation|0|||
131137813|NCT01656434|472130706|FG000|Overall Study|Pregnancy wish|18|||
131137814|NCT01656434|472130707|FG001|Overall Study|Pregnancy wish|6|||
131137815|NCT01656434|472130706|FG000|Overall Study|Pregnancy|45|||
131137816|NCT01656434|472130707|FG001|Overall Study|Pregnancy|10|||
131137817|NCT01656434|472130706|FG000|Overall Study|Physician Decision|7|||
131137818|NCT01656434|472130707|FG001|Overall Study|Physician Decision|2|||
131137819|NCT01656434|472130706|FG000|Overall Study|Non-compliance with study drug|48|||
131137820|NCT01656434|472130707|FG001|Overall Study|Non-compliance with study drug|9|||
131137821|NCT01656434|472130706|FG000|Overall Study|Study terminated by sponsor|1501|||
131137822|NCT01656434|472130707|FG001|Overall Study|Study terminated by sponsor|348|||
131137823|NCT01656434|472130706|FG000|Overall Study|Participant discontinued; drug related|13|||
131137824|NCT01656434|472130707|FG001|Overall Study|Participant discontinued; drug related|4|||
131137825|NCT01656434|472130706|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
131072197|NCT02383927|471895553|FG002|Overall Study|Adverse Event|3|||
131072198|NCT02383927|471895554|FG003|Overall Study|Adverse Event|5|||
131072199|NCT02383927|471895551|FG000|Overall Study|Miscellaneous|1|||
131072200|NCT02383927|471895552|FG001|Overall Study|Miscellaneous|0|||
131072201|NCT02383927|471895553|FG002|Overall Study|Miscellaneous|0|||
131072202|NCT02383927|471895554|FG003|Overall Study|Miscellaneous|1|||
131072203|NCT02383927|471895551|FG000|Overall Study|Withdrawal by Subject|0|||
131072204|NCT02383927|471895552|FG001|Overall Study|Withdrawal by Subject|1|||
131072205|NCT02383927|471895553|FG002|Overall Study|Withdrawal by Subject|4|||
131072206|NCT02383927|471895554|FG003|Overall Study|Withdrawal by Subject|0|||
131072207|NCT02154516|471895557|FG000|Overall Study|Withdrawal by Subject|0|||
131072208|NCT02154516|471895558|FG001|Overall Study|Withdrawal by Subject|1|||
131072209|NCT02154516|471895557|FG000|Overall Study|Lost to Follow-up|1|||
131072210|NCT02154516|471895558|FG001|Overall Study|Lost to Follow-up|0|||
131072211|NCT02154516|471895557|FG000|Overall Study|Removal/revision of device|1|||
131072212|NCT02154516|471895558|FG001|Overall Study|Removal/revision of device|0|||
131072213|NCT02154516|471895557|FG000|Overall Study|Death|2|||
131072214|NCT02154516|471895558|FG001|Overall Study|Death|1|||
131072215|NCT00230971|471895559|FG000|Randomization|No study drug administered|3|||
131072216|NCT00230971|471895560|FG001|Randomization|No study drug administered|3|||
131072217|NCT00230971|471895559|FG000|Baseline Participants|Lost to Follow-up|5|||
131072218|NCT00230971|471895560|FG001|Baseline Participants|Lost to Follow-up|12|||
131072219|NCT00230971|471895559|FG000|Baseline Participants|Death|6|||
131072220|NCT00230971|471895560|FG001|Baseline Participants|Death|5|||
131072221|NCT00230971|471895559|FG000|Baseline Participants|Withdrawal by Subject|7|||
131072222|NCT00230971|471895560|FG001|Baseline Participants|Withdrawal by Subject|1|||
131072223|NCT00230971|471895559|FG000|Baseline Participants|Adverse Event|1|||
131072224|NCT00230971|471895560|FG001|Baseline Participants|Adverse Event|0|||
131072225|NCT00230971|471895559|FG000|Baseline Participants|No bacteria observed|1|||
131072226|NCT00230971|471895560|FG001|Baseline Participants|No bacteria observed|0|||
131072227|NCT00230971|471895559|FG000|Baseline Participants|Failure to return|1|||
131072228|NCT00230971|471895560|FG001|Baseline Participants|Failure to return|1|||
131072229|NCT00230971|471895559|FG000|Baseline Participants|Reintervention|1|||
131072230|NCT00230971|471895560|FG001|Baseline Participants|Reintervention|0|||
131072231|NCT01772147|471897427|FG000|Overall Study|Adverse Event|13|||
131072232|NCT01772147|471897428|FG001|Overall Study|Adverse Event|10|||
131072233|NCT01772147|471897429|FG002|Overall Study|Adverse Event|6|||
131072234|NCT01772147|471897427|FG000|Overall Study|Withdrew Consent|7|||
131072235|NCT01772147|471897428|FG001|Overall Study|Withdrew Consent|8|||
131072236|NCT01772147|471897429|FG002|Overall Study|Withdrew Consent|4|||
131072237|NCT01772147|471897427|FG000|Overall Study|Lost to Follow-up|1|||
131072238|NCT01772147|471897428|FG001|Overall Study|Lost to Follow-up|0|||
131072239|NCT01772147|471897429|FG002|Overall Study|Lost to Follow-up|1|||
131072240|NCT01772147|471897427|FG000|Overall Study|Protocol Deviation|2|||
131072241|NCT01772147|471897428|FG001|Overall Study|Protocol Deviation|1|||
131072242|NCT01772147|471897429|FG002|Overall Study|Protocol Deviation|1|||
131072243|NCT01772147|471897427|FG000|Overall Study|Lack of Efficacy|8|||
131072244|NCT01772147|471897428|FG001|Overall Study|Lack of Efficacy|6|||
131072245|NCT01772147|471897429|FG002|Overall Study|Lack of Efficacy|6|||
131072246|NCT02972242|471897430|FG000|Overall Study|Withdrawal by Subject|1|||
131072247|NCT02972242|471897431|FG001|Overall Study|Withdrawal by Subject|0|||
131072248|NCT04572997|471897432|FG000|Overall Study|Adverse Event|1|||
131072249|NCT00740597|471897433|FG000|Overall Study|insurance would not cover treatment|1|||
131072250|NCT00552513|471897436|FG000|Overall Study|Lost to Follow-up|5|||
131072251|NCT00552513|471897437|FG001|Overall Study|Lost to Follow-up|1|||
131072252|NCT01816685|471897438|FG000|Overall Study|Lost to Follow-up|7|||
131072253|NCT01816685|471897439|FG001|Overall Study|Lost to Follow-up|9|||
131072254|NCT01816685|471897438|FG000|Overall Study|Surgery Cancelled|3|||
131072255|NCT01816685|471897439|FG001|Overall Study|Surgery Cancelled|2|||
131072256|NCT01157351|471897440|FG000|Overall Study|Adverse Event|5|||
131072257|NCT01157351|471897441|FG001|Overall Study|Adverse Event|4|||
131072258|NCT01157351|471897440|FG000|Overall Study|Death|1|||
131072259|NCT01157351|471897441|FG001|Overall Study|Death|0|||
131072260|NCT01157351|471897440|FG000|Overall Study|Lost to Follow-up|53|||
131072261|NCT01157351|471897441|FG001|Overall Study|Lost to Follow-up|55|||
131072262|NCT01157351|471897440|FG000|Overall Study|Withdrawal by Subject|37|||
131072263|NCT01157351|471897441|FG001|Overall Study|Withdrawal by Subject|27|||
131072264|NCT01157351|471897440|FG000|Overall Study|Physician Decision|5|||
131072265|NCT01157351|471897441|FG001|Overall Study|Physician Decision|4|||
131072266|NCT01157351|471897440|FG000|Overall Study|Protocol Violation|0|||
131072267|NCT01157351|471897441|FG001|Overall Study|Protocol Violation|1|||
131072268|NCT01157351|471897440|FG000|Overall Study|Other|32|||
130723712|NCT04642365|470613531|FG007|Overall Study|Death|1|||
131072269|NCT01157351|471897441|FG001|Overall Study|Other|36|||
131072270|NCT01157351|471897440|FG000|Overall Study|Noncompliance with Study Drug|0|||
131072271|NCT01157351|471897441|FG001|Overall Study|Noncompliance with Study Drug|3|||
131072272|NCT01157351|471897440|FG000|Overall Study|Randomized but not Treated|4|||
131072273|NCT01157351|471897441|FG001|Overall Study|Randomized but not Treated|2|||
131072274|NCT00746785|471897442|FG000|Overall Study|Lost to Follow-up|29|||
131072275|NCT00746785|471897443|FG001|Overall Study|Lost to Follow-up|25|||
131072276|NCT00746785|471897444|FG002|Overall Study|Lost to Follow-up|27|||
131072277|NCT02517528|471897446|FG000|Overall Study|Withdrawal by Subject|1|||
131072278|NCT00684203|471897447|FG000|Overall Study|Adverse Event|6|||
131072279|NCT00684203|471897448|FG001|Overall Study|Adverse Event|4|||
131072280|NCT00684203|471897449|FG002|Overall Study|Adverse Event|8|||
131072281|NCT00684203|471897450|FG003|Overall Study|Adverse Event|0|||
131072282|NCT00684203|471897451|FG004|Overall Study|Adverse Event|0|||
131072283|NCT00684203|471897452|FG005|Overall Study|Adverse Event|0|||
131072284|NCT00684203|471897447|FG000|Overall Study|Protocol-defined clinical event|3|||
131072285|NCT00684203|471897448|FG001|Overall Study|Protocol-defined clinical event|1|||
131072286|NCT00684203|471897449|FG002|Overall Study|Protocol-defined clinical event|0|||
131072287|NCT00684203|471897450|FG003|Overall Study|Protocol-defined clinical event|0|||
131072288|NCT00684203|471897451|FG004|Overall Study|Protocol-defined clinical event|0|||
131072289|NCT00684203|471897452|FG005|Overall Study|Protocol-defined clinical event|0|||
131072290|NCT00684203|471897447|FG000|Overall Study|Withdrawal by Subject|0|||
131072291|NCT00684203|471897448|FG001|Overall Study|Withdrawal by Subject|2|||
131072292|NCT00684203|471897449|FG002|Overall Study|Withdrawal by Subject|1|||
131072293|NCT00684203|471897450|FG003|Overall Study|Withdrawal by Subject|0|||
131072294|NCT00684203|471897451|FG004|Overall Study|Withdrawal by Subject|0|||
131072295|NCT00684203|471897452|FG005|Overall Study|Withdrawal by Subject|0|||
131072296|NCT00684203|471897447|FG000|Overall Study|Did not meet protocol eligibility|0|||
131072297|NCT00684203|471897448|FG001|Overall Study|Did not meet protocol eligibility|1|||
131072298|NCT00684203|471897449|FG002|Overall Study|Did not meet protocol eligibility|0|||
131072299|NCT00684203|471897450|FG003|Overall Study|Did not meet protocol eligibility|0|||
131072300|NCT00684203|471897451|FG004|Overall Study|Did not meet protocol eligibility|0|||
131072301|NCT00684203|471897452|FG005|Overall Study|Did not meet protocol eligibility|0|||
131072302|NCT03418493|471897455|FG000|Overall Study|Adverse Event|1|||
131072303|NCT03418493|471897456|FG001|Overall Study|Adverse Event|0|||
131072304|NCT03418493|471897457|FG002|Overall Study|Adverse Event|0|||
131072305|NCT03418493|471897458|FG003|Overall Study|Adverse Event|0|||
131072306|NCT03418493|471897459|FG004|Overall Study|Adverse Event|0|||
131072307|NCT03418493|471897460|FG005|Overall Study|Adverse Event|0|||
131072308|NCT03418493|471897461|FG006|Overall Study|Adverse Event|0|||
131072309|NCT03418493|471897462|FG007|Overall Study|Adverse Event|0|||
131072310|NCT03418493|471897463|FG008|Overall Study|Adverse Event|0|||
131072311|NCT03418493|471897464|FG009|Overall Study|Adverse Event|0|||
131072312|NCT03418493|471897465|FG010|Overall Study|Adverse Event|0|||
131072313|NCT03418493|471897455|FG000|Overall Study|Protocol Violation|0|||
131072314|NCT03418493|471897456|FG001|Overall Study|Protocol Violation|0|||
131072315|NCT03418493|471897457|FG002|Overall Study|Protocol Violation|0|||
131072316|NCT03418493|471897458|FG003|Overall Study|Protocol Violation|0|||
131072317|NCT03418493|471897459|FG004|Overall Study|Protocol Violation|0|||
131072318|NCT03418493|471897460|FG005|Overall Study|Protocol Violation|0|||
131072319|NCT03418493|471897461|FG006|Overall Study|Protocol Violation|0|||
131072320|NCT03418493|471897462|FG007|Overall Study|Protocol Violation|0|||
131072321|NCT03418493|471897463|FG008|Overall Study|Protocol Violation|0|||
131072322|NCT03418493|471897464|FG009|Overall Study|Protocol Violation|1|||
131072323|NCT03418493|471897465|FG010|Overall Study|Protocol Violation|0|||
131072324|NCT00719212|471897466|FG000|Overall Study|Death|41|||
131072325|NCT00719212|471897466|FG000|Overall Study|Lost to Follow-up|2|||
131072326|NCT00719212|471897466|FG000|Overall Study|Withdrawal by Subject|1|||
131072327|NCT05446714|471897467|FG000|Overall Study|Lost to Follow-up|1|||
131072328|NCT05446714|471897468|FG001|Overall Study|Lost to Follow-up|3|||
131072329|NCT05446714|471897469|FG002|Overall Study|Lost to Follow-up|2|||
131072330|NCT05446714|471897467|FG000|Overall Study|Protocol Violation|2|||
131072331|NCT05446714|471897468|FG001|Overall Study|Protocol Violation|0|||
131072332|NCT05446714|471897469|FG002|Overall Study|Protocol Violation|0|||
131072333|NCT01990313|471897472|FG000|Overall Study|Lost to Follow-up|1|||
131072334|NCT03511378|471897473|FG000|Overall Study|Withdrawal by Subject|2|||
131072335|NCT03511378|471897474|FG001|Overall Study|Withdrawal by Subject|2|||
131072336|NCT03511378|471897473|FG000|Overall Study|Patient not coming or schedule visit|1|||
131072337|NCT03511378|471897474|FG001|Overall Study|Patient not coming or schedule visit|0|||
131072338|NCT00837096|471897475|FG000|Overall Study|Physician Decision|1|||
131072339|NCT00837096|471897476|FG001|Overall Study|Physician Decision|1|||
131072340|NCT00837096|471897475|FG000|Overall Study|Not reported|9|||
131072341|NCT00837096|471897476|FG001|Overall Study|Not reported|8|||
131072342|NCT00280683|471897477|FG000|Overall Study|Withdrawal by Subject|1|||
131072343|NCT00280683|471897478|FG001|Overall Study|Withdrawal by Subject|2|||
131072344|NCT00280683|471897477|FG000|Overall Study|Adverse Event|1|||
131072345|NCT00280683|471897478|FG001|Overall Study|Adverse Event|1|||
131072346|NCT01243411|471897479|FG000|Overall Study|Withdrawal by Subject|18|||
131072347|NCT01243411|471897479|FG000|Overall Study|Lost to Follow-up|10|||
131072348|NCT01243411|471897479|FG000|Overall Study|Adverse Event|5|||
131072349|NCT01243411|471897479|FG000|Overall Study|Other|8|||
131072350|NCT02396953|471897482|FG000|Overall Study|Withdrawal by Subject|0|||
130723713|NCT04642365|470613524|FG000|Overall Study|Physician Decision|1|||
130723714|NCT04642365|470613525|FG001|Overall Study|Physician Decision|0|||
130723715|NCT04642365|470613526|FG002|Overall Study|Physician Decision|0|||
130723716|NCT04642365|470613527|FG003|Overall Study|Physician Decision|0|||
130723717|NCT04642365|470613528|FG004|Overall Study|Physician Decision|0|||
130723718|NCT04642365|470613529|FG005|Overall Study|Physician Decision|0|||
130723719|NCT04642365|470613530|FG006|Overall Study|Physician Decision|0|||
130723720|NCT04642365|470613531|FG007|Overall Study|Physician Decision|0|||
130723721|NCT04642365|470613524|FG000|Overall Study|Progressive Disease|1|||
130723722|NCT04642365|470613525|FG001|Overall Study|Progressive Disease|1|||
130723723|NCT04642365|470613526|FG002|Overall Study|Progressive Disease|1|||
130723724|NCT04642365|470613527|FG003|Overall Study|Progressive Disease|0|||
130723725|NCT04642365|470613528|FG004|Overall Study|Progressive Disease|0|||
130723726|NCT04642365|470613529|FG005|Overall Study|Progressive Disease|0|||
130723727|NCT04642365|470613530|FG006|Overall Study|Progressive Disease|1|||
130723728|NCT04642365|470613531|FG007|Overall Study|Progressive Disease|0|||
130723729|NCT04642365|470613524|FG000|Overall Study|Study Terminated By Sponsor|0|||
130723730|NCT04642365|470613525|FG001|Overall Study|Study Terminated By Sponsor|2|||
130723731|NCT04642365|470613526|FG002|Overall Study|Study Terminated By Sponsor|1|||
130723732|NCT04642365|470613527|FG003|Overall Study|Study Terminated By Sponsor|1|||
130723733|NCT04642365|470613528|FG004|Overall Study|Study Terminated By Sponsor|1|||
130723734|NCT04642365|470613529|FG005|Overall Study|Study Terminated By Sponsor|2|||
130723735|NCT04642365|470613530|FG006|Overall Study|Study Terminated By Sponsor|2|||
130723736|NCT04642365|470613531|FG007|Overall Study|Study Terminated By Sponsor|1|||
130723737|NCT04642365|470613524|FG000|Overall Study|Symptomatic Deterioration|1|||
130723738|NCT04642365|470613525|FG001|Overall Study|Symptomatic Deterioration|1|||
131072351|NCT02396953|471897483|FG001|Overall Study|Withdrawal by Subject|0|||
131072352|NCT02396953|471897484|FG002|Overall Study|Withdrawal by Subject|1|||
131072353|NCT02396953|471897482|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
131072354|NCT02396953|471897483|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
131072355|NCT02396953|471897484|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
130723739|NCT04642365|470613526|FG002|Overall Study|Symptomatic Deterioration|0|||
130723740|NCT04642365|470613527|FG003|Overall Study|Symptomatic Deterioration|0|||
130723741|NCT04642365|470613528|FG004|Overall Study|Symptomatic Deterioration|0|||
130723742|NCT04642365|470613529|FG005|Overall Study|Symptomatic Deterioration|1|||
130723743|NCT04642365|470613530|FG006|Overall Study|Symptomatic Deterioration|0|||
130723744|NCT04642365|470613531|FG007|Overall Study|Symptomatic Deterioration|0|||
130723745|NCT04642365|470613524|FG000|Overall Study|Withdrawal by Subject|0|||
130723746|NCT04642365|470613525|FG001|Overall Study|Withdrawal by Subject|0|||
130723747|NCT04642365|470613526|FG002|Overall Study|Withdrawal by Subject|1|||
130723748|NCT04642365|470613527|FG003|Overall Study|Withdrawal by Subject|1|||
130723749|NCT04642365|470613528|FG004|Overall Study|Withdrawal by Subject|0|||
130723750|NCT04642365|470613529|FG005|Overall Study|Withdrawal by Subject|0|||
130723751|NCT04642365|470613530|FG006|Overall Study|Withdrawal by Subject|2|||
130723752|NCT04642365|470613531|FG007|Overall Study|Withdrawal by Subject|0|||
130723753|NCT04642365|470613524|FG000|Overall Study|Adverse Event|0|||
130723754|NCT04642365|470613525|FG001|Overall Study|Adverse Event|0|||
130723755|NCT04642365|470613526|FG002|Overall Study|Adverse Event|0|||
131072356|NCT02396953|471897482|FG000|Overall Study|Personal Reasons|1|||
130723756|NCT04642365|470613527|FG003|Overall Study|Adverse Event|0|||
130723757|NCT04642365|470613528|FG004|Overall Study|Adverse Event|0|||
130723758|NCT04642365|470613529|FG005|Overall Study|Adverse Event|0|||
130723759|NCT04642365|470613530|FG006|Overall Study|Adverse Event|0|||
130723760|NCT04642365|470613531|FG007|Overall Study|Adverse Event|1|||
130723761|NCT01144715|470613532|FG000|Overall Study|Lost to Follow-up|2|||
130723762|NCT01144715|470613533|FG001|Overall Study|Lost to Follow-up|1|||
130723763|NCT01144715|470613532|FG000|Overall Study|Withdrawal by Subject|2|||
130723764|NCT01144715|470613533|FG001|Overall Study|Withdrawal by Subject|1|||
130723765|NCT01144715|470613532|FG000|Overall Study|Adverse Event|0|||
130723766|NCT01144715|470613533|FG001|Overall Study|Adverse Event|1|||
130779514|NCT02326272|470819496|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
130779515|NCT02326272|470819497|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130779516|NCT02326272|470819498|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130779517|NCT02326272|470819499|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131072357|NCT02396953|471897483|FG001|Overall Study|Personal Reasons|1|||
131072358|NCT02396953|471897484|FG002|Overall Study|Personal Reasons|0|||
131072359|NCT00329550|471897486|FG000|Overall Study|Adverse Event|3|||
131072360|NCT00329550|471897487|FG001|Overall Study|Adverse Event|4|||
130723767|NCT06281171|470613534|FG000|Timepoint 2|Lost to Follow-up|6|||
130723768|NCT06281171|470613535|FG001|Timepoint 2|Lost to Follow-up|4|||
130723769|NCT06281171|470613534|FG000|Timepoint 3|Lost to Follow-up|0|||
130779518|NCT02326272|470819500|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130723770|NCT06281171|470613535|FG001|Timepoint 3|Lost to Follow-up|5|||
131072361|NCT00329550|471897488|FG002|Overall Study|Adverse Event|2|||
131072362|NCT00329550|471897486|FG000|Overall Study|Withdrawal of Consent|1|||
130723771|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
130723772|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
131072363|NCT00329550|471897487|FG001|Overall Study|Withdrawal of Consent|0|||
131072364|NCT00329550|471897488|FG002|Overall Study|Withdrawal of Consent|1|||
131072365|NCT00329550|471897486|FG000|Overall Study|Due to Relocation|0|||
131072366|NCT00329550|471897487|FG001|Overall Study|Due to Relocation|0|||
131072367|NCT00329550|471897488|FG002|Overall Study|Due to Relocation|1|||
131072368|NCT03168425|471897498|FG000|Overall Study|Lost to Follow-up|5|||
131072369|NCT03168425|471897499|FG001|Overall Study|Lost to Follow-up|8|||
131072370|NCT03168425|471897498|FG000|Overall Study|unable to confirm post op opioids|2|||
131072371|NCT03168425|471897499|FG001|Overall Study|unable to confirm post op opioids|3|||
131072372|NCT04491006|471897503|FG000|Overall Study|Adverse Event|0|||
131072373|NCT04491006|471897504|FG001|Overall Study|Adverse Event|3|||
131072374|NCT04491006|471897505|FG002|Overall Study|Adverse Event|5|||
131072375|NCT04491006|471897503|FG000|Overall Study|Withdrawal by Subject|1|||
131072376|NCT04491006|471897504|FG001|Overall Study|Withdrawal by Subject|0|||
131072377|NCT04491006|471897505|FG002|Overall Study|Withdrawal by Subject|2|||
131072378|NCT01960114|471897506|FG000|Overall Study|Adverse Event|1|||
131072379|NCT01960114|471897507|FG001|Overall Study|Adverse Event|0|||
131072380|NCT01960114|471897506|FG000|Overall Study|Could not swallow study medication|0|||
131072381|NCT01960114|471897507|FG001|Overall Study|Could not swallow study medication|1|||
131072382|NCT02469077|471897508|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
131072383|NCT02469077|471897509|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
131072384|NCT02469077|471897508|FG000|Post Randomization/Intervention Period|Relocated|1|||
131072385|NCT02469077|471897509|FG001|Post Randomization/Intervention Period|Relocated|1|||
131072386|NCT02469077|471897508|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
131072387|NCT02469077|471897509|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
131072388|NCT02469077|471897508|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
131072389|NCT02469077|471897509|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
131072390|NCT01040403|471897510|FG000|Overall Study|Adverse Event|10|||
131072391|NCT01040403|471897510|FG000|Overall Study|Protocol Violation|2|||
131072392|NCT01040403|471897510|FG000|Overall Study|Lost to Follow-up|1|||
131072393|NCT01040403|471897510|FG000|Overall Study|Not treated|1|||
131072394|NCT01040403|471897510|FG000|Overall Study|Other reason not defined above|6|||
131072395|NCT01885936|471897511|FG000|Overall Study|Withdrawal by Subject|1|||
131072396|NCT01885936|471897512|FG001|Overall Study|Withdrawal by Subject|0|||
131072397|NCT03036150|471897513|FG000|Overall Study|Withdrawal by Subject|8|||
131072398|NCT03036150|471897514|FG001|Overall Study|Withdrawal by Subject|3|||
131072399|NCT03036150|471897513|FG000|Overall Study|Lost to Follow-up|2|||
131072400|NCT03036150|471897514|FG001|Overall Study|Lost to Follow-up|2|||
131072401|NCT00427778|471897515|FG000|First Intervention (4 Weeks)|no longer interested|1|||
131230974|NCT01621490|472473220|FG008|Overall Study|Maximum clinical benefit|2|||
131230975|NCT01621490|472473221|FG009|Overall Study|Maximum clinical benefit|0|||
131230976|NCT01621490|472473222|FG010|Overall Study|Maximum clinical benefit|0|||
131230977|NCT01621490|472473212|FG000|Overall Study|Withdrawal by Subject|1|||
131230978|NCT01621490|472473213|FG001|Overall Study|Withdrawal by Subject|0|||
131230979|NCT01621490|472473214|FG002|Overall Study|Withdrawal by Subject|0|||
131230980|NCT01621490|472473215|FG003|Overall Study|Withdrawal by Subject|0|||
131230981|NCT01621490|472473216|FG004|Overall Study|Withdrawal by Subject|0|||
131230982|NCT01621490|472473217|FG005|Overall Study|Withdrawal by Subject|1|||
131230983|NCT01621490|472473218|FG006|Overall Study|Withdrawal by Subject|0|||
131072402|NCT00427778|471897516|FG001|First Intervention (4 Weeks)|no longer interested|0|||
131072403|NCT00427778|471897515|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
131072404|NCT00427778|471897516|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
131230984|NCT01621490|472473219|FG007|Overall Study|Withdrawal by Subject|0|||
131230985|NCT01621490|472473220|FG008|Overall Study|Withdrawal by Subject|0|||
131230986|NCT01621490|472473221|FG009|Overall Study|Withdrawal by Subject|0|||
131230987|NCT01621490|472473222|FG010|Overall Study|Withdrawal by Subject|0|||
131230988|NCT01621490|472473212|FG000|Overall Study|Subject request to discontinue study|1|||
131230989|NCT01621490|472473213|FG001|Overall Study|Subject request to discontinue study|3|||
131230990|NCT01621490|472473214|FG002|Overall Study|Subject request to discontinue study|1|||
131072405|NCT00427778|471897515|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
131072406|NCT00427778|471897516|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
131072407|NCT00427778|471897515|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
131230991|NCT01621490|472473215|FG003|Overall Study|Subject request to discontinue study|1|||
131230992|NCT01621490|472473216|FG004|Overall Study|Subject request to discontinue study|0|||
131072408|NCT00427778|471897516|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
131230993|NCT01621490|472473217|FG005|Overall Study|Subject request to discontinue study|2|||
131072409|NCT00439647|471897517|FG000|Overall Study|Withdrawal by Subject|25|||
131072410|NCT00439647|471897518|FG001|Overall Study|Withdrawal by Subject|22|||
131230994|NCT01621490|472473218|FG006|Overall Study|Subject request to discontinue study|1|||
131230995|NCT01621490|472473219|FG007|Overall Study|Subject request to discontinue study|0|||
131230996|NCT01621490|472473220|FG008|Overall Study|Subject request to discontinue study|1|||
131072411|NCT00439647|471897517|FG000|Overall Study|Death|15|||
131072412|NCT00439647|471897518|FG001|Overall Study|Death|18|||
131072413|NCT00439647|471897517|FG000|Overall Study|Adverse Event|11|||
130723773|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
130723774|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
130723775|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
131072414|NCT00439647|471897518|FG001|Overall Study|Adverse Event|11|||
131072415|NCT00439647|471897517|FG000|Overall Study|Lost to Follow-up|4|||
131072416|NCT00439647|471897518|FG001|Overall Study|Lost to Follow-up|12|||
131072417|NCT00439647|471897517|FG000|Overall Study|Protocol Violation|3|||
131072418|NCT00439647|471897518|FG001|Overall Study|Protocol Violation|4|||
131072419|NCT00439647|471897517|FG000|Overall Study|Lack of Efficacy|0|||
131072420|NCT00439647|471897518|FG001|Overall Study|Lack of Efficacy|4|||
131072421|NCT00843115|471897519|FG000|Overall Study|Death|4|||
131072422|NCT00843115|471897519|FG000|Overall Study|Adverse Event|30|||
131072423|NCT00843115|471897519|FG000|Overall Study|Lost to Follow-up|4|||
131072424|NCT00843115|471897519|FG000|Overall Study|Withdrawal by Subject|17|||
131072425|NCT00843115|471897519|FG000|Overall Study|Family wanted meds stopped|1|||
131072426|NCT00843115|471897519|FG000|Overall Study|Family does not want continuation|1|||
131072427|NCT00843115|471897519|FG000|Overall Study|Patient forgot to take meds|1|||
131072428|NCT00843115|471897519|FG000|Overall Study|Does not meet entrance criteria|1|||
131072429|NCT00843115|471897519|FG000|Overall Study|Physician Decision|1|||
131072430|NCT00843115|471897519|FG000|Overall Study|Family discontinued meds|1|||
131072431|NCT00843115|471897519|FG000|Overall Study|patient took for 2 days then stopped|1|||
131072432|NCT00843115|471897519|FG000|Overall Study|patient never took the medication|1|||
131072433|NCT00843115|471897519|FG000|Overall Study|hospitalized due to deterioration|1|||
131072434|NCT00843115|471897519|FG000|Overall Study|week 12 not done|1|||
131072435|NCT00843115|471897519|FG000|Overall Study|Syndrome De Glissement|1|||
131072436|NCT02845375|471897520|FG000|Overall Study|upper airway obstruction|1|||
131072437|NCT02845375|471897521|FG001|Overall Study|upper airway obstruction|2|||
131072438|NCT02845375|471897522|FG002|Overall Study|upper airway obstruction|1|||
131072439|NCT00619983|471897523|FG000|Test Drug Alone|Withdrawal by Subject|1|||
131072440|NCT00619983|471897524|FG001|Test Drug Alone|Withdrawal by Subject|0|||
131072441|NCT00619983|471897525|FG002|Test Drug Alone|Withdrawal by Subject|0|||
131072442|NCT00619983|471897526|FG003|Test Drug Alone|Withdrawal by Subject|1|||
131072443|NCT00619983|471897523|FG000|Test Drug Alone|Failure of daily diary device|1|||
131072444|NCT00619983|471897524|FG001|Test Drug Alone|Failure of daily diary device|1|||
131072445|NCT00619983|471897525|FG002|Test Drug Alone|Failure of daily diary device|2|||
131072446|NCT00619983|471897526|FG003|Test Drug Alone|Failure of daily diary device|2|||
131072447|NCT01177137|471897533|FG000|Overall Study|Withdrawal by Subject|10|||
131072448|NCT01177137|471897534|FG001|Overall Study|Withdrawal by Subject|10|||
131072449|NCT01177137|471897535|FG002|Overall Study|Withdrawal by Subject|2|||
131072450|NCT02959177|471897536|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
131072451|NCT02959177|471897537|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
131072452|NCT02959177|471897538|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
131072453|NCT02959177|471897536|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
131072454|NCT02959177|471897537|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
131072455|NCT02959177|471897538|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
131072456|NCT02959177|471897536|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
131072457|NCT02959177|471897537|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
131072458|NCT02959177|471897538|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
131072459|NCT02959177|471897536|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
131072460|NCT02959177|471897537|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131072461|NCT02959177|471897538|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
131072462|NCT02959177|471897536|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
131072463|NCT02959177|471897537|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
131072464|NCT02959177|471897538|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
131072465|NCT02959177|471897536|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
131072466|NCT02959177|471897537|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
131072467|NCT02959177|471897538|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
131072468|NCT02959177|471897536|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
131072469|NCT02959177|471897537|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
131072470|NCT02959177|471897538|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
131072471|NCT04531813|471897543|FG000|Overall Study|Protocol Violation|1|||
131072472|NCT04531813|471897543|FG000|Overall Study|Withdrawal by Subject|1|||
131072473|NCT02381652|471897550|FG000|Overall Study|Withdrawal by Subject|0|||
131072474|NCT02381652|471897551|FG001|Overall Study|Withdrawal by Subject|0|||
131072475|NCT02381652|471897552|FG002|Overall Study|Withdrawal by Subject|1|||
131072476|NCT01340300|471897553|FG000|Overall Study|Lost to Follow-up|3|||
131072477|NCT01340300|471897554|FG001|Overall Study|Lost to Follow-up|0|||
131072478|NCT01340300|471897555|FG002|Overall Study|Lost to Follow-up|5|||
131072479|NCT01340300|471897556|FG003|Overall Study|Lost to Follow-up|10|||
131072480|NCT01340300|471897553|FG000|Overall Study|Withdrawal by Subject|5|||
131072481|NCT01340300|471897554|FG001|Overall Study|Withdrawal by Subject|6|||
131072482|NCT01340300|471897555|FG002|Overall Study|Withdrawal by Subject|6|||
131072483|NCT01340300|471897556|FG003|Overall Study|Withdrawal by Subject|3|||
131072484|NCT01340300|471897553|FG000|Overall Study|Adverse Event|1|||
131072485|NCT01340300|471897554|FG001|Overall Study|Adverse Event|0|||
131072486|NCT01340300|471897555|FG002|Overall Study|Adverse Event|4|||
131072487|NCT01340300|471897556|FG003|Overall Study|Adverse Event|0|||
131072488|NCT01340300|471897553|FG000|Overall Study|Physician Decision|0|||
131072489|NCT01340300|471897554|FG001|Overall Study|Physician Decision|1|||
131072490|NCT01340300|471897555|FG002|Overall Study|Physician Decision|0|||
131072491|NCT01340300|471897556|FG003|Overall Study|Physician Decision|0|||
131072492|NCT01340300|471897553|FG000|Overall Study|Unrelated sickness|0|||
131072493|NCT01340300|471897554|FG001|Overall Study|Unrelated sickness|2|||
131072494|NCT01340300|471897555|FG002|Overall Study|Unrelated sickness|0|||
131072495|NCT01340300|471897556|FG003|Overall Study|Unrelated sickness|1|||
131072496|NCT01954771|471897560|FG000|Overall Study|Missing HbA1c of end-point|1|||
131072497|NCT01954771|471897561|FG001|Overall Study|Missing HbA1c of end-point|1|||
131072498|NCT01954771|471897562|FG002|Overall Study|Missing HbA1c of end-point|0|||
131072499|NCT01954771|471897560|FG000|Overall Study|Missing CGMS of end-point|1|||
131072500|NCT01954771|471897561|FG001|Overall Study|Missing CGMS of end-point|1|||
131072501|NCT01954771|471897562|FG002|Overall Study|Missing CGMS of end-point|0|||
131072502|NCT01954771|471897560|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
131072503|NCT01954771|471897561|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
131072504|NCT01954771|471897562|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
131072505|NCT03635775|471897563|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
131072506|NCT03635775|471897564|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
131072507|NCT03635775|471897565|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
131072508|NCT03635775|471897566|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
131072509|NCT02996097|471897572|FG000|Overall Study|Lost to Follow-up|11|||
131072510|NCT02996097|471897573|FG001|Overall Study|Lost to Follow-up|11|||
131072511|NCT00583115|471897574|FG000|Overall Study|Death|1|||
131072512|NCT03569475|471897575|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
131072513|NCT03569475|471897576|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
131072514|NCT03569475|471897577|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
131072515|NCT03569475|471897575|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
131230997|NCT01621490|472473221|FG009|Overall Study|Subject request to discontinue study|0|||
131230998|NCT01621490|472473222|FG010|Overall Study|Subject request to discontinue study|0|||
131072516|NCT03569475|471897576|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
131072517|NCT03569475|471897577|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
131072518|NCT03569475|471897575|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
131072519|NCT03569475|471897576|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
131072520|NCT03569475|471897577|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
131072521|NCT03569475|471897575|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
131072522|NCT03569475|471897576|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
131072523|NCT03569475|471897577|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
131072524|NCT03569475|471897575|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
131072525|NCT03569475|471897576|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
131072526|NCT03569475|471897577|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
131072527|NCT03569475|471897575|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
131072528|NCT03569475|471897576|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
131072529|NCT03569475|471897577|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
131072530|NCT03569475|471897575|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
131072531|NCT03569475|471897576|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
131072532|NCT03569475|471897577|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
131072533|NCT03569475|471897575|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
131072534|NCT03569475|471897576|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
131072535|NCT03569475|471897577|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
131072536|NCT03569475|471897575|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
131072537|NCT03569475|471897576|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
131072538|NCT03569475|471897577|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
131072539|NCT03638258|471897578|FG000|Overall Study|Adverse Event|1|||
131072540|NCT03638258|471897579|FG001|Overall Study|Adverse Event|0|||
131072541|NCT03638258|471897580|FG002|Overall Study|Adverse Event|2|||
131072542|NCT03638258|471897578|FG000|Overall Study|Lost to Follow-up|2|||
131072543|NCT03638258|471897579|FG001|Overall Study|Lost to Follow-up|4|||
131072544|NCT03638258|471897580|FG002|Overall Study|Lost to Follow-up|5|||
131072545|NCT03638258|471897578|FG000|Overall Study|Pregnancy|0|||
131072546|NCT03638258|471897579|FG001|Overall Study|Pregnancy|0|||
131072547|NCT03638258|471897580|FG002|Overall Study|Pregnancy|1|||
131072548|NCT03638258|471897578|FG000|Overall Study|Protocol Violation|0|||
131072549|NCT03638258|471897579|FG001|Overall Study|Protocol Violation|0|||
131072550|NCT03638258|471897580|FG002|Overall Study|Protocol Violation|1|||
131072551|NCT03638258|471897578|FG000|Overall Study|Withdrawal by Subject|4|||
131072552|NCT03638258|471897579|FG001|Overall Study|Withdrawal by Subject|5|||
131072553|NCT03638258|471897580|FG002|Overall Study|Withdrawal by Subject|12|||
131072554|NCT03638258|471897578|FG000|Overall Study|Lack of Efficacy|0|||
131072555|NCT03638258|471897579|FG001|Overall Study|Lack of Efficacy|0|||
131072556|NCT03638258|471897580|FG002|Overall Study|Lack of Efficacy|2|||
131072557|NCT02109107|471897583|FG000|Overall Study|Lost to Follow-up|2|||
131072558|NCT02865135|471897584|FG000|Overall Study|Death|0|||
131072559|NCT02865135|471897585|FG001|Overall Study|Death|1|||
131072560|NCT02865135|471897586|FG002|Overall Study|Death|0|||
131072561|NCT02865135|471897584|FG000|Overall Study|Progression|6|||
131072562|NCT02865135|471897585|FG001|Overall Study|Progression|2|||
131072563|NCT02865135|471897586|FG002|Overall Study|Progression|2|||
131230999|NCT01621490|472473212|FG000|Overall Study|Adverse event unrelated to study drug|1|||
131231000|NCT01621490|472473213|FG001|Overall Study|Adverse event unrelated to study drug|1|||
131231001|NCT01621490|472473214|FG002|Overall Study|Adverse event unrelated to study drug|0|||
131231002|NCT01621490|472473215|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131231003|NCT01621490|472473216|FG004|Overall Study|Adverse event unrelated to study drug|0|||
131231004|NCT01621490|472473217|FG005|Overall Study|Adverse event unrelated to study drug|0|||
131231005|NCT01621490|472473218|FG006|Overall Study|Adverse event unrelated to study drug|0|||
131231006|NCT01621490|472473219|FG007|Overall Study|Adverse event unrelated to study drug|2|||
131231007|NCT01621490|472473220|FG008|Overall Study|Adverse event unrelated to study drug|0|||
131231008|NCT01621490|472473221|FG009|Overall Study|Adverse event unrelated to study drug|0|||
131231009|NCT01621490|472473222|FG010|Overall Study|Adverse event unrelated to study drug|0|||
131231010|NCT01621490|472473212|FG000|Overall Study|Disease progression|27|||
131231011|NCT01621490|472473213|FG001|Overall Study|Disease progression|28|||
131231012|NCT01621490|472473214|FG002|Overall Study|Disease progression|1|||
131231013|NCT01621490|472473215|FG003|Overall Study|Disease progression|5|||
131231014|NCT01621490|472473216|FG004|Overall Study|Disease progression|3|||
131231015|NCT01621490|472473217|FG005|Overall Study|Disease progression|8|||
131231016|NCT01621490|472473218|FG006|Overall Study|Disease progression|7|||
131231017|NCT01621490|472473219|FG007|Overall Study|Disease progression|1|||
131231018|NCT01621490|472473220|FG008|Overall Study|Disease progression|4|||
131231019|NCT01621490|472473221|FG009|Overall Study|Disease progression|1|||
131231020|NCT01621490|472473222|FG010|Overall Study|Disease progression|1|||
131231021|NCT01621490|472473212|FG000|Overall Study|Study drug toxicity|1|||
131231022|NCT01621490|472473213|FG001|Overall Study|Study drug toxicity|4|||
131231023|NCT01621490|472473214|FG002|Overall Study|Study drug toxicity|5|||
131231024|NCT01621490|472473215|FG003|Overall Study|Study drug toxicity|3|||
131231025|NCT01621490|472473216|FG004|Overall Study|Study drug toxicity|1|||
131231026|NCT01621490|472473217|FG005|Overall Study|Study drug toxicity|10|||
130723776|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
131072564|NCT01071317|471897587|FG000|Overall Study|Lost to Follow-up|2|||
131072565|NCT01071317|471897588|FG001|Overall Study|Lost to Follow-up|2|||
131072566|NCT03226106|471899131|FG000|Overall Study|Withdrawal by Subject|2|||
131072567|NCT03226106|471899132|FG001|Overall Study|Withdrawal by Subject|0|||
131072568|NCT03226106|471899131|FG000|Overall Study|Adverse Event|1|||
131072569|NCT03226106|471899132|FG001|Overall Study|Adverse Event|0|||
131072570|NCT03226106|471899131|FG000|Overall Study|Lost to Follow-up|2|||
131072571|NCT03226106|471899132|FG001|Overall Study|Lost to Follow-up|0|||
131072572|NCT00721214|471899133|FG000|Overall Study|Chose another center for transplant|1|||
131072573|NCT00721214|471899133|FG000|Overall Study|Death|3|||
131072574|NCT00510198|471899134|FG000|Overall Study|Withdrawal by Subject|5|||
131072575|NCT00510198|471899135|FG001|Overall Study|Withdrawal by Subject|4|||
131072576|NCT00488319|471899136|FG000|Overall Study|Adverse Event|1|||
131072577|NCT00488319|471899137|FG001|Overall Study|Adverse Event|2|||
131072578|NCT00488319|471899138|FG002|Overall Study|Adverse Event|23|||
131072579|NCT00488319|471899136|FG000|Overall Study|Lack of Efficacy|6|||
131072580|NCT00488319|471899137|FG001|Overall Study|Lack of Efficacy|12|||
131072581|NCT00488319|471899138|FG002|Overall Study|Lack of Efficacy|27|||
131072582|NCT00488319|471899136|FG000|Overall Study|Lost to Follow-up|3|||
131072583|NCT00488319|471899137|FG001|Overall Study|Lost to Follow-up|5|||
131072584|NCT00488319|471899138|FG002|Overall Study|Lost to Follow-up|16|||
131072585|NCT00488319|471899136|FG000|Overall Study|Withdrawal by Subject|5|||
131072586|NCT00488319|471899137|FG001|Overall Study|Withdrawal by Subject|20|||
131072587|NCT00488319|471899138|FG002|Overall Study|Withdrawal by Subject|44|||
131072588|NCT00488319|471899136|FG000|Overall Study|Other reasons for withdrawal|0|||
131072589|NCT00488319|471899137|FG001|Overall Study|Other reasons for withdrawal|4|||
131072590|NCT00488319|471899138|FG002|Overall Study|Other reasons for withdrawal|12|||
131072591|NCT03712449|471899142|FG000|Overall Study|Withdraw Consent|0|||
131072592|NCT03712449|471899143|FG001|Overall Study|Withdraw Consent|1|||
131072593|NCT00666198|471899149|FG000|Overall Study|Protocol Violation|10|||
131072594|NCT00666198|471899149|FG000|Overall Study|No Visit After First Day of Treatment|13|||
131072595|NCT00666198|471899149|FG000|Overall Study|Safety Not Assessable|6|||
131072596|NCT00666198|471899149|FG000|Overall Study|No Drug Administration|4|||
131072597|NCT05153499|471899150|FG000|Overall Study|Withdrawal by Subject|1|||
131072598|NCT05153499|471899151|FG001|Overall Study|Withdrawal by Subject|0|||
131072599|NCT05153499|471899150|FG000|Overall Study|Clinical Hold|1|||
131072600|NCT05153499|471899151|FG001|Overall Study|Clinical Hold|0|||
131072601|NCT05153499|471899150|FG000|Overall Study|Study Termination|6|||
131072602|NCT05153499|471899151|FG001|Overall Study|Study Termination|5|||
131072603|NCT02166047|471899153|FG000|Overall Study|Withdrawal by Participant|0|||
131072604|NCT02166047|471899154|FG001|Overall Study|Withdrawal by Participant|1|||
131072605|NCT02166047|471899155|FG002|Overall Study|Withdrawal by Participant|2|||
131072606|NCT02166047|471899156|FG003|Overall Study|Withdrawal by Participant|0|||
131072607|NCT02166047|471899157|FG004|Overall Study|Withdrawal by Participant|0|||
131072608|NCT02166047|471899158|FG005|Overall Study|Withdrawal by Participant|0|||
131072609|NCT02166047|471899159|FG006|Overall Study|Withdrawal by Participant|1|||
131072610|NCT02166047|471899160|FG007|Overall Study|Withdrawal by Participant|0|||
131072611|NCT02166047|471899161|FG008|Overall Study|Withdrawal by Participant|0|||
131072612|NCT02166047|471899162|FG009|Overall Study|Withdrawal by Participant|0|||
131072613|NCT02166047|471899163|FG010|Overall Study|Withdrawal by Participant|0|||
131072614|NCT02166047|471899164|FG011|Overall Study|Withdrawal by Participant|0|||
131072615|NCT02166047|471899153|FG000|Overall Study|Adverse Event|0|||
131072616|NCT02166047|471899154|FG001|Overall Study|Adverse Event|0|||
131072617|NCT02166047|471899155|FG002|Overall Study|Adverse Event|0|||
131072618|NCT02166047|471899156|FG003|Overall Study|Adverse Event|0|||
131072619|NCT02166047|471899157|FG004|Overall Study|Adverse Event|1|||
131072620|NCT02166047|471899158|FG005|Overall Study|Adverse Event|0|||
131072621|NCT02166047|471899159|FG006|Overall Study|Adverse Event|1|||
131072622|NCT02166047|471899160|FG007|Overall Study|Adverse Event|0|||
131072623|NCT02166047|471899161|FG008|Overall Study|Adverse Event|0|||
131072624|NCT02166047|471899162|FG009|Overall Study|Adverse Event|0|||
131072625|NCT02166047|471899163|FG010|Overall Study|Adverse Event|2|||
131072626|NCT02166047|471899164|FG011|Overall Study|Adverse Event|0|||
131072627|NCT02490878|471899171|FG000|Overall Study|deemed ineligible|0|||
131072628|NCT02490878|471899172|FG001|Overall Study|deemed ineligible|1|||
131072629|NCT02490878|471899171|FG000|Overall Study|progression prior to treatment|0|||
131072630|NCT02490878|471899172|FG001|Overall Study|progression prior to treatment|1|||
131072631|NCT02490878|471899171|FG000|Overall Study|only submitted baseline QOL|0|||
131072632|NCT02490878|471899172|FG001|Overall Study|only submitted baseline QOL|1|||
131072633|NCT00451555|471899173|FG000|Overall Study|Protocol Violation|2|||
131072634|NCT00451555|471899174|FG001|Overall Study|Protocol Violation|2|||
131072635|NCT00451555|471899173|FG000|Overall Study|Adverse Event|3|||
131072636|NCT00451555|471899174|FG001|Overall Study|Adverse Event|1|||
131072637|NCT00451555|471899173|FG000|Overall Study|Withdrawal by Subject|6|||
131072638|NCT00451555|471899174|FG001|Overall Study|Withdrawal by Subject|0|||
131072639|NCT00451555|471899173|FG000|Overall Study|Physician Decision|2|||
131072640|NCT00451555|471899174|FG001|Overall Study|Physician Decision|1|||
131072641|NCT00922441|471899177|FG000|Overall Study|Protocol Violation|0|||
131072642|NCT00922441|471899178|FG001|Overall Study|Protocol Violation|0|||
131072643|NCT00922441|471899179|FG002|Overall Study|Protocol Violation|2|||
131072644|NCT00922441|471899177|FG000|Overall Study|Withdrawal by Subject|0|||
131072645|NCT00922441|471899178|FG001|Overall Study|Withdrawal by Subject|0|||
131072646|NCT00922441|471899179|FG002|Overall Study|Withdrawal by Subject|1|||
131072647|NCT02973477|471899182|FG000|First Intervention|Lost to Follow-up|0|||
131072648|NCT02973477|471899183|FG001|First Intervention|Lost to Follow-up|2|||
131072649|NCT02973477|471899182|FG000|Washout|Withdrawal by Subject|1|||
131072650|NCT02973477|471899183|FG001|Washout|Withdrawal by Subject|0|||
131072651|NCT02973477|471899182|FG000|Second Intervention|Lost to Follow-up|1|||
131072652|NCT02973477|471899183|FG001|Second Intervention|Lost to Follow-up|0|||
131072653|NCT00317603|471899189|FG000|Overall Study|Progressive Disease|3|||
131072654|NCT00523549|471899190|FG000|Overall Study|Adverse Event|6|||
131072655|NCT00523549|471899191|FG001|Overall Study|Adverse Event|3|||
131072656|NCT00523549|471899190|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131072657|NCT00523549|471899191|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131072658|NCT00523549|471899190|FG000|Overall Study|Protocol Deviation|3|||
131072659|NCT00523549|471899191|FG001|Overall Study|Protocol Deviation|1|||
131072660|NCT00523549|471899190|FG000|Overall Study|Patient withdrew consent|7|||
131072661|NCT00523549|471899191|FG001|Overall Study|Patient withdrew consent|6|||
131072662|NCT00523549|471899190|FG000|Overall Study|Lost to Follow-up|3|||
131072663|NCT00523549|471899191|FG001|Overall Study|Lost to Follow-up|5|||
131072664|NCT00588341|471899192|FG000|Overall Study|Withdrawal by Subject|3|||
131072665|NCT00588341|471899192|FG000|Overall Study|Not treated due to metastatic disease|1|||
131072666|NCT00588341|471899192|FG000|Overall Study|Patient ineligible|1|||
131072667|NCT03041701|471899193|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
131072668|NCT03041701|471899194|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
131072669|NCT03041701|471899195|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
131072670|NCT03041701|471899193|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
131072671|NCT03041701|471899194|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
131072672|NCT03041701|471899195|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
131072673|NCT01187407|471899196|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
131231027|NCT01621490|472473218|FG006|Overall Study|Study drug toxicity|1|||
131231028|NCT01621490|472473219|FG007|Overall Study|Study drug toxicity|4|||
131231029|NCT01621490|472473220|FG008|Overall Study|Study drug toxicity|1|||
131231030|NCT01621490|472473221|FG009|Overall Study|Study drug toxicity|0|||
131231031|NCT01621490|472473222|FG010|Overall Study|Study drug toxicity|0|||
131231032|NCT01621490|472473212|FG000|Overall Study|Death|0|||
131231033|NCT01621490|472473213|FG001|Overall Study|Death|0|||
131231034|NCT01621490|472473214|FG002|Overall Study|Death|0|||
131231035|NCT01621490|472473215|FG003|Overall Study|Death|0|||
131231036|NCT01621490|472473216|FG004|Overall Study|Death|0|||
131231037|NCT01621490|472473217|FG005|Overall Study|Death|0|||
131231038|NCT01621490|472473218|FG006|Overall Study|Death|0|||
131231039|NCT01621490|472473219|FG007|Overall Study|Death|0|||
131231040|NCT01621490|472473220|FG008|Overall Study|Death|1|||
131231041|NCT01621490|472473221|FG009|Overall Study|Death|0|||
131231042|NCT01621490|472473222|FG010|Overall Study|Death|0|||
131231043|NCT01621490|472473212|FG000|Overall Study|Other reasons|7|||
131231044|NCT01621490|472473213|FG001|Overall Study|Other reasons|6|||
131231045|NCT01621490|472473214|FG002|Overall Study|Other reasons|4|||
131231046|NCT01621490|472473215|FG003|Overall Study|Other reasons|1|||
131231047|NCT01621490|472473216|FG004|Overall Study|Other reasons|1|||
131231048|NCT01621490|472473217|FG005|Overall Study|Other reasons|3|||
131231049|NCT01621490|472473218|FG006|Overall Study|Other reasons|1|||
131231050|NCT01621490|472473219|FG007|Overall Study|Other reasons|1|||
131231051|NCT01621490|472473220|FG008|Overall Study|Other reasons|1|||
131231052|NCT01621490|472473221|FG009|Overall Study|Other reasons|0|||
131231053|NCT01621490|472473222|FG010|Overall Study|Other reasons|0|||
131231054|NCT00506753|472473223|FG000|Overall Study|Lost to Follow-up|21|||
131231055|NCT00506753|472473224|FG001|Overall Study|Lost to Follow-up|15|||
131231056|NCT02451670|472473225|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
131231057|NCT02451670|472473226|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
131231058|NCT00461500|472473227|FG000|Overall Study|Adverse Event|1|||
131231059|NCT00461500|472473228|FG001|Overall Study|Adverse Event|0|||
131231060|NCT00461500|472473227|FG000|Overall Study|Lack of Efficacy|0|||
131231061|NCT00461500|472473228|FG001|Overall Study|Lack of Efficacy|1|||
131231062|NCT00461500|472473227|FG000|Overall Study|Expired Drug Treatment|1|||
131231063|NCT00461500|472473228|FG001|Overall Study|Expired Drug Treatment|1|||
131231064|NCT00461500|472473227|FG000|Overall Study|Study Stopped|1|||
131137826|NCT01656434|472130707|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
131137827|NCT01656434|472130706|FG000|Overall Study|Non-compliance with protocol|39|||
131137828|NCT01656434|472130707|FG001|Overall Study|Non-compliance with protocol|15|||
131137829|NCT01656434|472130706|FG000|Overall Study|Participant moved|40|||
131137830|NCT01656434|472130707|FG001|Overall Study|Participant moved|12|||
131137831|NCT01656434|472130706|FG000|Overall Study|Participant withdrew consent|28|||
131137832|NCT01656434|472130707|FG001|Overall Study|Participant withdrew consent|9|||
131137833|NCT01656434|472130706|FG000|Overall Study|Withdrawal by Subject|64|||
131137834|NCT01656434|472130707|FG001|Overall Study|Withdrawal by Subject|7|||
131137835|NCT01580397|472130710|FG000|Overall Study|Lack of Efficacy|14|||
131137836|NCT02004873|472130711|FG000|Overall Study|Implant unsuccessful|6|||
131137837|NCT02004873|472130711|FG000|Overall Study|Awaiting 6-month visit|390|||
131137838|NCT02004873|472130711|FG000|Overall Study|Missed 6-month visit|4|||
131137839|NCT02004873|472130711|FG000|Overall Study|Death|23|||
131137840|NCT02004873|472130711|FG000|Overall Study|Withdrawal by Subject|1|||
131137841|NCT06098729|472130721|FG000|Overall Study|Withdrawal by Subject|1|||
131137842|NCT03033875|472130727|FG000|Overall Study|Withdrawal by Subject|5|||
131137843|NCT03033875|472130728|FG001|Overall Study|Withdrawal by Subject|9|||
131137844|NCT03033875|472130729|FG002|Overall Study|Withdrawal by Subject|4|||
131137845|NCT03033875|472130727|FG000|Overall Study|Other|14|||
131137846|NCT03033875|472130728|FG001|Overall Study|Other|15|||
131231065|NCT00461500|472473228|FG001|Overall Study|Study Stopped|2|||
131231066|NCT00461500|472473227|FG000|Overall Study|Drug Treatment Misuse|1|||
131231067|NCT00461500|472473228|FG001|Overall Study|Drug Treatment Misuse|0|||
131231068|NCT00461500|472473227|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
131137847|NCT03033875|472130729|FG002|Overall Study|Other|8|||
131137848|NCT01060059|472130733|FG000|Overall Study|Adverse Event|1|||
131231069|NCT00461500|472473228|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
131137849|NCT01060059|472130734|FG001|Overall Study|Adverse Event|1|||
131137850|NCT01060059|472130733|FG000|Overall Study|Death|2|||
131137851|NCT01060059|472130734|FG001|Overall Study|Death|3|||
131137852|NCT01060059|472130733|FG000|Overall Study|Lost to Follow-up|18|||
131231070|NCT00461500|472473227|FG000|Overall Study|Lost to Follow-up|2|||
131231071|NCT00461500|472473228|FG001|Overall Study|Lost to Follow-up|2|||
131231072|NCT01806597|472473233|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
131231073|NCT01806597|472473234|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
131231074|NCT01806597|472473235|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
131231075|NCT01806597|472473236|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
131231076|NCT01806597|472473237|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
131137853|NCT01060059|472130734|FG001|Overall Study|Lost to Follow-up|34|||
131231077|NCT01806597|472473238|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
131072674|NCT01187407|471899197|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131072675|NCT01187407|471899198|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131072676|NCT01187407|471899199|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131072677|NCT01187407|471899200|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
131072678|NCT01187407|471899196|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
131072679|NCT01187407|471899197|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131072680|NCT01187407|471899198|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131072681|NCT01187407|471899199|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131072682|NCT01187407|471899200|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
131072683|NCT01187407|471899196|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
131072684|NCT01187407|471899197|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131072685|NCT01187407|471899198|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131072686|NCT01187407|471899199|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131072687|NCT01187407|471899200|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
131072688|NCT01187407|471899196|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
131072689|NCT01187407|471899197|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131072690|NCT01187407|471899198|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131072691|NCT01187407|471899199|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131072692|NCT01187407|471899200|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
131072693|NCT01187407|471899196|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
131072694|NCT01187407|471899197|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131072695|NCT01187407|471899198|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131072696|NCT01187407|471899199|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131072697|NCT01187407|471899200|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
131072698|NCT01187407|471899196|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
131072699|NCT01187407|471899197|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131072700|NCT01187407|471899198|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131072701|NCT01187407|471899199|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131072702|NCT01187407|471899200|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
131072703|NCT01187407|471899196|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
131072704|NCT01187407|471899197|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131072705|NCT01187407|471899198|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131072706|NCT01187407|471899199|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131072707|NCT01187407|471899200|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
131072708|NCT01187407|471899196|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
131072709|NCT01187407|471899197|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
131072710|NCT01187407|471899198|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
131072711|NCT01187407|471899199|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
131072712|NCT01187407|471899200|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
131072713|NCT01187407|471899196|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
131072714|NCT01187407|471899197|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
131072715|NCT01187407|471899198|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
131072716|NCT01187407|471899199|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
131072717|NCT01187407|471899200|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
131072718|NCT01187407|471899196|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
131072719|NCT01187407|471899197|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
131072720|NCT01187407|471899198|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
131072721|NCT01187407|471899199|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
131072722|NCT01187407|471899200|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
131072723|NCT01187407|471899196|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131072724|NCT01187407|471899197|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131072725|NCT01187407|471899198|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
131072726|NCT01187407|471899199|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
131137854|NCT01060059|472130733|FG000|Overall Study|entry criteria not met|4|||
131137855|NCT01060059|472130734|FG001|Overall Study|entry criteria not met|3|||
131137856|NCT01060059|472130733|FG000|Overall Study|Withdrawal by Subject|35|||
131137857|NCT01060059|472130734|FG001|Overall Study|Withdrawal by Subject|23|||
131137858|NCT01060059|472130733|FG000|Overall Study|lack of glycemic control|2|||
131072727|NCT01187407|471899200|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
131072728|NCT01187407|471899196|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
131072729|NCT01187407|471899197|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
131072730|NCT01187407|471899198|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
131072731|NCT01187407|471899199|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
131072732|NCT01187407|471899200|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
131137859|NCT01060059|472130734|FG001|Overall Study|lack of glycemic control|1|||
131137860|NCT01060059|472130733|FG000|Overall Study|lack of compliance|5|||
130779519|NCT02326272|470819501|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
131072733|NCT01187407|471899196|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
131072734|NCT01187407|471899197|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
131072735|NCT01187407|471899198|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
130779520|NCT02326272|470819502|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130779521|NCT02326272|470819503|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130779522|NCT02326272|470819504|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130779523|NCT02326272|470819490|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779524|NCT02326272|470819491|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779525|NCT02326272|470819492|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779526|NCT02326272|470819493|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779527|NCT02326272|470819494|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779528|NCT02326272|470819495|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779529|NCT02326272|470819496|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779530|NCT02326272|470819497|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779531|NCT02326272|470819498|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
130779532|NCT02326272|470819499|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131072736|NCT01187407|471899199|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
131072737|NCT01187407|471899200|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
131072738|NCT01187407|471899196|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
131072739|NCT01187407|471899197|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
131072740|NCT01187407|471899198|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
131072741|NCT01187407|471899199|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
131072742|NCT01187407|471899200|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
131072743|NCT02630706|471899208|FG000|Overall Study|Adverse Event|2|||
131072744|NCT02630706|471899209|FG001|Overall Study|Adverse Event|1|||
131072745|NCT02630706|471899210|FG002|Overall Study|Adverse Event|1|||
131072746|NCT02630706|471899208|FG000|Overall Study|Lost to Follow-up|0|||
131072747|NCT02630706|471899209|FG001|Overall Study|Lost to Follow-up|1|||
131072748|NCT02630706|471899210|FG002|Overall Study|Lost to Follow-up|2|||
131072749|NCT02630706|471899208|FG000|Overall Study|Physician Decision|1|||
131072750|NCT02630706|471899209|FG001|Overall Study|Physician Decision|1|||
131072751|NCT02630706|471899210|FG002|Overall Study|Physician Decision|0|||
131072752|NCT02630706|471899208|FG000|Overall Study|Pregnancy|0|||
131072753|NCT02630706|471899209|FG001|Overall Study|Pregnancy|1|||
131072754|NCT02630706|471899210|FG002|Overall Study|Pregnancy|0|||
131072755|NCT02630706|471899208|FG000|Overall Study|Withdrawal by Subject|4|||
131137861|NCT01060059|472130734|FG001|Overall Study|lack of compliance|2|||
131137862|NCT01614093|472130737|FG000|Overall Study|Withdrawal by Subject|1|||
131137863|NCT00848354|472130738|FG000|Phase 1|Adverse Event|5|||
131137864|NCT00848354|472130739|FG001|Phase 1|Adverse Event|4|||
131137865|NCT00848354|472130738|FG000|Phase 1|Discontinuation of study by sponsor|2|||
131137866|NCT00848354|472130739|FG001|Phase 1|Discontinuation of study by sponsor|1|||
131137867|NCT00848354|472130738|FG000|Phase 1|Failed to return|0|||
131137868|NCT00848354|472130739|FG001|Phase 1|Failed to return|1|||
131137869|NCT00848354|472130738|FG000|Phase 1|Lost to Follow-up|1|||
131137870|NCT00848354|472130739|FG001|Phase 1|Lost to Follow-up|1|||
131137871|NCT00848354|472130738|FG000|Phase 1|Unspecified Reason|1|||
131137872|NCT00848354|472130739|FG001|Phase 1|Unspecified Reason|1|||
131137873|NCT00848354|472130738|FG000|Phase 1|Protocol Violation|1|||
131231078|NCT01806597|472473233|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
131231079|NCT01806597|472473234|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
131231080|NCT01806597|472473235|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
131231081|NCT01806597|472473236|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
131231082|NCT01806597|472473237|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
130723777|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
130723778|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
130723779|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
130723780|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
130723781|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
130723782|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
130723783|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
130723784|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
130723785|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
130779533|NCT02326272|470819500|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779534|NCT02326272|470819501|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779535|NCT02326272|470819502|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
131072756|NCT02630706|471899209|FG001|Overall Study|Withdrawal by Subject|5|||
131072757|NCT02630706|471899210|FG002|Overall Study|Withdrawal by Subject|7|||
131137874|NCT00848354|472130739|FG001|Phase 1|Protocol Violation|1|||
131137875|NCT00848354|472130738|FG000|Phase 1|Withdrawal by Subject|2|||
131137876|NCT00848354|472130739|FG001|Phase 1|Withdrawal by Subject|4|||
130723786|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
130723787|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
130723788|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
130723789|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
130723790|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
130723791|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
130723792|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
130723793|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
130723794|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
130723795|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
130723796|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
130723797|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
130723798|NCT02552212|470613536|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
130723799|NCT02552212|470613537|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
130723800|NCT02552212|470613538|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
130723801|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
130723802|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
130723803|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
130723804|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
130723805|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
130723806|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
131072758|NCT00640042|471899211|FG000|Enrollment|Did not receive study drug|83|||
131072759|NCT01527500|471899214|FG000|Part A|Administrative|11|||
131072760|NCT01527500|471899215|FG001|Part A|Administrative|7|||
131072761|NCT01527500|471899214|FG000|Part A|Adverse Event|4|||
131072762|NCT01527500|471899215|FG001|Part A|Adverse Event|2|||
131072763|NCT01527500|471899214|FG000|Part A|Death|4|||
131072764|NCT01527500|471899215|FG001|Part A|Death|1|||
131072765|NCT01527500|471899214|FG000|Part A|Lost to Follow-up|0|||
130723807|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
130723808|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
130723809|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
130723810|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
130723811|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
130723812|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
130723813|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
130723814|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
130723815|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
130723816|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
130723817|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
130723818|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
130723819|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
130723820|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
130723821|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
130723822|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
130723823|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
130723824|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
130723825|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
131072766|NCT01527500|471899215|FG001|Part A|Lost to Follow-up|1|||
131072767|NCT01527500|471899214|FG000|Part A|Protocol Deviation|9|||
131072768|NCT01527500|471899215|FG001|Part A|Protocol Deviation|2|||
131137877|NCT00848354|472130738|FG000|Phase 1|Lack of Efficacy|0|||
131137878|NCT00848354|472130739|FG001|Phase 1|Lack of Efficacy|1|||
131137879|NCT00848354|472130738|FG000|Phase 2 Year 1|Adverse Event|7|||
131137880|NCT00848354|472130739|FG001|Phase 2 Year 1|Adverse Event|2|||
131137881|NCT00848354|472130738|FG000|Phase 2 Year 1|Death|1|||
131137882|NCT00848354|472130739|FG001|Phase 2 Year 1|Death|0|||
131137883|NCT00848354|472130738|FG000|Phase 2 Year 1|Failed to Return|1|||
131137884|NCT00848354|472130739|FG001|Phase 2 Year 1|Failed to Return|1|||
131137885|NCT00848354|472130738|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
131137886|NCT00848354|472130739|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
131137887|NCT00848354|472130738|FG000|Phase 2 Year 1|Unspecified Reason|3|||
131137888|NCT00848354|472130739|FG001|Phase 2 Year 1|Unspecified Reason|0|||
131137889|NCT00848354|472130738|FG000|Phase 2 Year 1|Protocol Violation|4|||
131137890|NCT00848354|472130739|FG001|Phase 2 Year 1|Protocol Violation|1|||
131137891|NCT00848354|472130738|FG000|Phase 2 Year 1|Subject Request|1|||
131137892|NCT00848354|472130739|FG001|Phase 2 Year 1|Subject Request|2|||
131137893|NCT00848354|472130738|FG000|Phase 2 Year 2|Adverse Event|12|||
131137894|NCT00848354|472130739|FG001|Phase 2 Year 2|Adverse Event|2|||
131137895|NCT00848354|472130738|FG000|Phase 2 Year 2|Death|2|||
131137896|NCT00848354|472130739|FG001|Phase 2 Year 2|Death|0|||
131137897|NCT00848354|472130738|FG000|Phase 2 Year 2|Failed to return|3|||
131137898|NCT00848354|472130739|FG001|Phase 2 Year 2|Failed to return|0|||
131137899|NCT00848354|472130738|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
131072769|NCT01527500|471899214|FG000|Part A|Withdrawal by Subject|2|||
131072770|NCT01527500|471899215|FG001|Part A|Withdrawal by Subject|0|||
131072771|NCT01527500|471899214|FG000|Part B|Adverse Event|1|||
131072772|NCT01527500|471899215|FG001|Part B|Adverse Event|0|||
131072773|NCT03078751|471899230|FG000|Overall Study|Adverse Event|4|||
131072774|NCT03078751|471899231|FG001|Overall Study|Adverse Event|0|||
131072775|NCT03078751|471899230|FG000|Overall Study|Physician Decision|1|||
131072776|NCT03078751|471899231|FG001|Overall Study|Physician Decision|0|||
131072777|NCT03078751|471899230|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
131072778|NCT03078751|471899231|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
131072779|NCT03078751|471899230|FG000|Overall Study|Subject/guardian decision|8|||
131072780|NCT03078751|471899231|FG001|Overall Study|Subject/guardian decision|1|||
131072781|NCT03078751|471899230|FG000|Overall Study|Untreated|0|||
131072782|NCT03078751|471899231|FG001|Overall Study|Untreated|4|||
131072783|NCT00607789|471899232|FG000|Overall Study|Adverse Event|3|||
131072784|NCT00607789|471899233|FG001|Overall Study|Adverse Event|0|||
131072785|NCT00607789|471899232|FG000|Overall Study|Lack of Efficacy|0|||
131072786|NCT00607789|471899233|FG001|Overall Study|Lack of Efficacy|1|||
131072787|NCT00607789|471899232|FG000|Overall Study|Inadequate adherence|3|||
131072788|NCT00607789|471899233|FG001|Overall Study|Inadequate adherence|0|||
131072789|NCT00607789|471899232|FG000|Overall Study|Lost to Follow-up|0|||
131072790|NCT00607789|471899233|FG001|Overall Study|Lost to Follow-up|5|||
131072791|NCT00607789|471899232|FG000|Overall Study|Withdrawal by Subject|1|||
131072792|NCT00607789|471899233|FG001|Overall Study|Withdrawal by Subject|0|||
131072793|NCT01209286|471899234|FG000|Overall Study|Adverse Event|4|||
131072794|NCT01209286|471899235|FG001|Overall Study|Adverse Event|3|||
131072795|NCT01209286|471899236|FG002|Overall Study|Adverse Event|1|||
131072796|NCT01209286|471899234|FG000|Overall Study|Hematological Relapse After Remission|0|||
131072797|NCT01209286|471899235|FG001|Overall Study|Hematological Relapse After Remission|1|||
131072798|NCT01209286|471899236|FG002|Overall Study|Hematological Relapse After Remission|1|||
131072799|NCT01209286|471899234|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
131072800|NCT01209286|471899235|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
131072801|NCT01209286|471899236|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
131072802|NCT01209286|471899234|FG000|Overall Study|Physician Decision|0|||
130723826|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
130723827|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
130723828|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
130723829|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
130723830|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
130723831|NCT02552212|470613536|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
130723832|NCT02552212|470613537|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
130723833|NCT02552212|470613538|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
130723834|NCT00205803|470613540|FG000|Infant Series|Lost to Follow-up|10|||
130723835|NCT00205803|470613541|FG001|Infant Series|Lost to Follow-up|4|||
130723836|NCT00205803|470613540|FG000|Infant Series|Withdrawal by Subject|2|||
130723837|NCT00205803|470613541|FG001|Infant Series|Withdrawal by Subject|5|||
130723838|NCT00205803|470613540|FG000|Infant Series|Physician Decision|3|||
130723839|NCT00205803|470613541|FG001|Infant Series|Physician Decision|1|||
130723840|NCT00205803|470613540|FG000|Infant Series|Protocol Violation|1|||
130723841|NCT00205803|470613541|FG001|Infant Series|Protocol Violation|0|||
130723842|NCT00205803|470613540|FG000|Infant Series|Lost Kaiser coverage|0|||
130723843|NCT00205803|470613541|FG001|Infant Series|Lost Kaiser coverage|1|||
130723844|NCT00205803|470613540|FG000|Infant Series|Non-compliant|1|||
130723845|NCT00205803|470613541|FG001|Infant Series|Non-compliant|0|||
130723846|NCT00205803|470613540|FG000|Infant Series|Sponsor request|1|||
130723847|NCT00205803|470613541|FG001|Infant Series|Sponsor request|0|||
130723848|NCT00205803|470613540|FG000|After Infant Series|Adverse Event|1|||
130723849|NCT00205803|470613541|FG001|After Infant Series|Adverse Event|1|||
130723850|NCT00205803|470613540|FG000|After Infant Series|Protocol Violation|1|||
130723851|NCT00205803|470613541|FG001|After Infant Series|Protocol Violation|1|||
130723852|NCT00205803|470613540|FG000|After Infant Series|Lost to Follow-up|2|||
130723853|NCT00205803|470613541|FG001|After Infant Series|Lost to Follow-up|1|||
130723854|NCT00205803|470613540|FG000|After Infant Series|Physician Decision|3|||
130723855|NCT00205803|470613541|FG001|After Infant Series|Physician Decision|2|||
130723856|NCT00205803|470613540|FG000|After Infant Series|Withdrawal by Subject|1|||
130723857|NCT00205803|470613541|FG001|After Infant Series|Withdrawal by Subject|4|||
130723858|NCT00205803|470613540|FG000|After Infant Series|Other|10|||
130723859|NCT00205803|470613541|FG001|After Infant Series|Other|4|||
131072803|NCT01209286|471899235|FG001|Overall Study|Physician Decision|2|||
131072804|NCT01209286|471899236|FG002|Overall Study|Physician Decision|0|||
130723860|NCT00205803|470613540|FG000|Toddler Dose|Lost to Follow-up|2|||
131072805|NCT01209286|471899234|FG000|Overall Study|Other|0|||
131072806|NCT01209286|471899235|FG001|Overall Study|Other|1|||
131072807|NCT01209286|471899236|FG002|Overall Study|Other|0|||
131072808|NCT03915951|471899240|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
131072809|NCT03915951|471899241|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
131072810|NCT03915951|471899240|FG000|Overall Study|Adverse Event|12|||
131072811|NCT03915951|471899241|FG001|Overall Study|Adverse Event|6|||
130723861|NCT00205803|470613541|FG001|Toddler Dose|Lost to Follow-up|3|||
130723862|NCT02369458|470613548|FG000|Overall Study|Determined to be not eligible|1|||
130723863|NCT02369458|470613549|FG001|Overall Study|Determined to be not eligible|0|||
130723864|NCT04572893|470613550|FG000|Part A|Adverse Event|1|||
130723865|NCT04572893|470613551|FG001|Part A|Adverse Event|0|||
130723866|NCT04572893|470613552|FG002|Part A|Adverse Event|0|||
130723867|NCT04572893|470613553|FG003|Part A|Adverse Event|0|||
130723868|NCT04572893|470613554|FG004|Part A|Adverse Event|0|||
130723869|NCT04572893|470613555|FG005|Part A|Adverse Event|0|||
130723870|NCT04572893|470613556|FG006|Part A|Adverse Event|0|||
130723871|NCT04572893|470613550|FG000|Part B|Withdrawal by Subject|0|||
130723872|NCT04572893|470613551|FG001|Part B|Withdrawal by Subject|0|||
130723873|NCT04572893|470613552|FG002|Part B|Withdrawal by Subject|0|||
130723874|NCT04572893|470613553|FG003|Part B|Withdrawal by Subject|0|||
130723875|NCT04572893|470613554|FG004|Part B|Withdrawal by Subject|0|||
130723876|NCT04572893|470613555|FG005|Part B|Withdrawal by Subject|1|||
130723877|NCT04572893|470613556|FG006|Part B|Withdrawal by Subject|0|||
130723878|NCT04572893|470613550|FG000|Part B|Study terminated by sponsor|0|||
130723879|NCT04572893|470613551|FG001|Part B|Study terminated by sponsor|0|||
130723880|NCT04572893|470613552|FG002|Part B|Study terminated by sponsor|0|||
130723881|NCT04572893|470613553|FG003|Part B|Study terminated by sponsor|0|||
130723882|NCT04572893|470613554|FG004|Part B|Study terminated by sponsor|7|||
130723883|NCT04572893|470613555|FG005|Part B|Study terminated by sponsor|5|||
130723884|NCT04572893|470613556|FG006|Part B|Study terminated by sponsor|3|||
130723885|NCT04572893|470613550|FG000|Part B|Lost to Follow-up|0|||
130723886|NCT04572893|470613551|FG001|Part B|Lost to Follow-up|0|||
130723887|NCT04572893|470613552|FG002|Part B|Lost to Follow-up|0|||
130723888|NCT04572893|470613553|FG003|Part B|Lost to Follow-up|0|||
130723889|NCT04572893|470613554|FG004|Part B|Lost to Follow-up|0|||
130723890|NCT04572893|470613555|FG005|Part B|Lost to Follow-up|0|||
130723891|NCT04572893|470613556|FG006|Part B|Lost to Follow-up|1|||
130723892|NCT04572893|470613550|FG000|Part B|Adverse Event|0|||
130723893|NCT04572893|470613551|FG001|Part B|Adverse Event|0|||
130723894|NCT04572893|470613552|FG002|Part B|Adverse Event|0|||
130723895|NCT04572893|470613553|FG003|Part B|Adverse Event|0|||
130723896|NCT04572893|470613554|FG004|Part B|Adverse Event|1|||
130723897|NCT04572893|470613555|FG005|Part B|Adverse Event|1|||
130723898|NCT04572893|470613556|FG006|Part B|Adverse Event|0|||
130723899|NCT00121134|470613557|FG000|Overall Study|Progression of Disease|5|||
130723900|NCT00121134|470613558|FG001|Overall Study|Progression of Disease|3|||
130723901|NCT00121134|470613559|FG002|Overall Study|Progression of Disease|4|||
130723902|NCT00121134|470613560|FG003|Overall Study|Progression of Disease|2|||
130723903|NCT00121134|470613557|FG000|Overall Study|Toxicity|4|||
130723904|NCT00121134|470613558|FG001|Overall Study|Toxicity|7|||
130723905|NCT00121134|470613559|FG002|Overall Study|Toxicity|13|||
130723906|NCT00121134|470613560|FG003|Overall Study|Toxicity|5|||
130723907|NCT00121134|470613557|FG000|Overall Study|Physician Decision|6|||
130723908|NCT00121134|470613558|FG001|Overall Study|Physician Decision|4|||
130723909|NCT00121134|470613559|FG002|Overall Study|Physician Decision|4|||
130723910|NCT00121134|470613560|FG003|Overall Study|Physician Decision|1|||
130723911|NCT00121134|470613557|FG000|Overall Study|Treatment Delay|1|||
130723912|NCT00121134|470613558|FG001|Overall Study|Treatment Delay|0|||
130723913|NCT00121134|470613559|FG002|Overall Study|Treatment Delay|0|||
130723914|NCT00121134|470613560|FG003|Overall Study|Treatment Delay|0|||
130723915|NCT00121134|470613557|FG000|Overall Study|Intercurrent Illness|0|||
130723916|NCT00121134|470613558|FG001|Overall Study|Intercurrent Illness|0|||
130723917|NCT00121134|470613559|FG002|Overall Study|Intercurrent Illness|0|||
130723918|NCT00121134|470613560|FG003|Overall Study|Intercurrent Illness|1|||
130723919|NCT00121134|470613557|FG000|Overall Study|Patient Personal Reasons|0|||
130723920|NCT00121134|470613558|FG001|Overall Study|Patient Personal Reasons|1|||
130723921|NCT00121134|470613559|FG002|Overall Study|Patient Personal Reasons|0|||
130723922|NCT00121134|470613560|FG003|Overall Study|Patient Personal Reasons|0|||
130723923|NCT01102374|470613574|FG000|Overall Study|Death|9|||
130723924|NCT01102374|470613575|FG001|Overall Study|Death|13|||
130723925|NCT01102374|470613574|FG000|Overall Study|Lost to Follow-up|7|||
130723926|NCT01102374|470613575|FG001|Overall Study|Lost to Follow-up|6|||
130723927|NCT00418821|470613576|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
130723928|NCT02071849|470613577|FG000|6-month Primary Endpoint|Did not receive device|4|||
130723929|NCT02071849|470613577|FG000|6-month Primary Endpoint|Adverse Event|1|||
130723930|NCT02071849|470613577|FG000|2-year Extended Follow-up|Adverse Event|1|||
130723931|NCT04619992|470613578|FG000|Overall Study|Withdrawal by Subject|1|||
130723932|NCT04619992|470613579|FG001|Overall Study|Withdrawal by Subject|0|||
130723933|NCT00213135|470615422|FG000|Overall Study|Adverse Event|9|||
130723934|NCT00213135|470615423|FG001|Overall Study|Adverse Event|5|||
130723935|NCT00213135|470615424|FG002|Overall Study|Adverse Event|5|||
130723936|NCT00213135|470615422|FG000|Overall Study|Lost to Follow-up|11|||
130723937|NCT00213135|470615423|FG001|Overall Study|Lost to Follow-up|8|||
130723938|NCT00213135|470615424|FG002|Overall Study|Lost to Follow-up|4|||
130723939|NCT00213135|470615422|FG000|Overall Study|Protocol Violation|4|||
130723940|NCT00213135|470615423|FG001|Overall Study|Protocol Violation|4|||
130723941|NCT00213135|470615424|FG002|Overall Study|Protocol Violation|10|||
130723942|NCT00213135|470615422|FG000|Overall Study|Death|1|||
130723943|NCT00213135|470615423|FG001|Overall Study|Death|1|||
130723944|NCT00213135|470615424|FG002|Overall Study|Death|2|||
130723945|NCT00213135|470615422|FG000|Overall Study|Disease progression|4|||
130723946|NCT00213135|470615423|FG001|Overall Study|Disease progression|5|||
130723947|NCT00213135|470615424|FG002|Overall Study|Disease progression|21|||
130723948|NCT00213135|470615422|FG000|Overall Study|Other|21|||
130723949|NCT00213135|470615423|FG001|Overall Study|Other|12|||
130723950|NCT00213135|470615424|FG002|Overall Study|Other|15|||
130723951|NCT00660907|470615428|FG000|Overall Study|Incorrect Enrollment|1|||
130723952|NCT00660907|470615429|FG001|Overall Study|Incorrect Enrollment|1|||
130723953|NCT00660907|470615428|FG000|Overall Study|Adverse Event|33|||
130723954|NCT00660907|470615429|FG001|Overall Study|Adverse Event|19|||
130723955|NCT00660907|470615428|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
130723956|NCT00660907|470615429|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
130723957|NCT00660907|470615428|FG000|Overall Study|Withdrawal by Subject|23|||
130723958|NCT00660907|470615429|FG001|Overall Study|Withdrawal by Subject|32|||
130723959|NCT00660907|470615428|FG000|Overall Study|Lost to Follow-up|3|||
130723960|NCT00660907|470615429|FG001|Overall Study|Lost to Follow-up|3|||
130723961|NCT00660907|470615428|FG000|Overall Study|Poor/Non-Compliance|5|||
130723962|NCT00660907|470615429|FG001|Overall Study|Poor/Non-Compliance|1|||
130723963|NCT00660907|470615428|FG000|Overall Study|Safety|1|||
130723964|NCT00660907|470615429|FG001|Overall Study|Safety|0|||
130723965|NCT00660907|470615428|FG000|Overall Study|Death|1|||
130723966|NCT00660907|470615429|FG001|Overall Study|Death|3|||
130723967|NCT00660907|470615428|FG000|Overall Study|Various|11|||
130723968|NCT00660907|470615429|FG001|Overall Study|Various|8|||
130723969|NCT04975191|470615432|FG000|Overall Study|Protocol Violation|1|||
130723970|NCT04975191|470615433|FG001|Overall Study|Protocol Violation|2|||
130723971|NCT04975191|470615434|FG002|Overall Study|Protocol Violation|2|||
130723972|NCT04975191|470615435|FG003|Overall Study|Protocol Violation|2|||
130723973|NCT04975191|470615432|FG000|Overall Study|Lost to Follow-up|13|||
130723974|NCT04975191|470615433|FG001|Overall Study|Lost to Follow-up|3|||
130723975|NCT04975191|470615434|FG002|Overall Study|Lost to Follow-up|8|||
130723976|NCT04975191|470615435|FG003|Overall Study|Lost to Follow-up|8|||
130723977|NCT02618759|470615462|FG000|Overall Study|Lost to Follow-up|0|||
130723978|NCT02618759|470615463|FG001|Overall Study|Lost to Follow-up|1|||
130723979|NCT02618759|470615462|FG000|Overall Study|Withdrawal by Subject|1|||
130723980|NCT02618759|470615463|FG001|Overall Study|Withdrawal by Subject|0|||
130723981|NCT02618759|470615462|FG000|Overall Study|Other Reasons|1|||
130723982|NCT02618759|470615463|FG001|Overall Study|Other Reasons|4|||
130723983|NCT02500043|470615466|FG000|Overall Study|Randomized, but not Treated|2|||
130723984|NCT02500043|470615467|FG001|Overall Study|Randomized, but not Treated|2|||
130723985|NCT02500043|470615466|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
130723986|NCT02500043|470615467|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
130723987|NCT02500043|470615466|FG000|Overall Study|Adverse Event|33|||
130723988|NCT02500043|470615467|FG001|Overall Study|Adverse Event|11|||
130723989|NCT02500043|470615466|FG000|Overall Study|Clinical Progression|54|||
130723990|NCT02500043|470615467|FG001|Overall Study|Clinical Progression|35|||
130723991|NCT02500043|470615466|FG000|Overall Study|Radiological Progression|192|||
130723992|NCT02500043|470615467|FG001|Overall Study|Radiological Progression|110|||
130723993|NCT02500043|470615466|FG000|Overall Study|Physician's Decision|11|||
130723994|NCT02500043|470615467|FG001|Overall Study|Physician's Decision|3|||
130723995|NCT02500043|470615466|FG000|Overall Study|Withdrawal by Subject|14|||
130723996|NCT02500043|470615467|FG001|Overall Study|Withdrawal by Subject|4|||
130723997|NCT02500043|470615466|FG000|Overall Study|Death|11|||
130723998|NCT02500043|470615467|FG001|Overall Study|Death|2|||
130723999|NCT02500043|470615466|FG000|Overall Study|Protocol Deviation|1|||
130724000|NCT02500043|470615467|FG001|Overall Study|Protocol Deviation|0|||
130724001|NCT02856555|470615468|FG000|Overall Study|Adverse Event|1|||
130724002|NCT02856555|470615469|FG001|Overall Study|Adverse Event|0|||
130724003|NCT02856555|470615470|FG002|Overall Study|Adverse Event|0|||
130724004|NCT02856555|470615468|FG000|Overall Study|Lost to Follow-up|1|||
130724005|NCT02856555|470615469|FG001|Overall Study|Lost to Follow-up|3|||
130724006|NCT02856555|470615470|FG002|Overall Study|Lost to Follow-up|0|||
130724007|NCT02856555|470615468|FG000|Overall Study|Withdrawal by Subject|3|||
130724008|NCT02856555|470615469|FG001|Overall Study|Withdrawal by Subject|0|||
130724009|NCT02856555|470615470|FG002|Overall Study|Withdrawal by Subject|0|||
130724010|NCT02856555|470615468|FG000|Overall Study|Randomized but Never Treated|0|||
130724011|NCT02856555|470615469|FG001|Overall Study|Randomized but Never Treated|1|||
130724012|NCT02856555|470615470|FG002|Overall Study|Randomized but Never Treated|0|||
130724013|NCT03333941|470615471|FG000|Overall Study|Lost to Follow-up|10|||
130724014|NCT03333941|470615471|FG000|Overall Study|Death|2|||
130724015|NCT03333941|470615471|FG000|Overall Study|Adverse Event|1|||
130724016|NCT02932306|470615472|FG000|Overall Study|Withdrawal by Subject|16|||
130724017|NCT02932306|470615473|FG001|Overall Study|Withdrawal by Subject|25|||
130724018|NCT02932306|470615472|FG000|Overall Study|Adverse Event|3|||
130724019|NCT02932306|470615473|FG001|Overall Study|Adverse Event|0|||
130724020|NCT02932306|470615472|FG000|Overall Study|Pregnancy|2|||
130724021|NCT02932306|470615473|FG001|Overall Study|Pregnancy|0|||
130724022|NCT02932306|470615472|FG000|Overall Study|Protocol Violation|1|||
130724023|NCT02932306|470615473|FG001|Overall Study|Protocol Violation|1|||
130724024|NCT02932306|470615472|FG000|Overall Study|Noncompliance with Study Drug|1|||
130724025|NCT02932306|470615473|FG001|Overall Study|Noncompliance with Study Drug|1|||
131231083|NCT01806597|472473238|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
131231084|NCT01806597|472473233|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
131231085|NCT01806597|472473234|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
131231086|NCT01806597|472473235|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
131231087|NCT01806597|472473236|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
131231088|NCT01806597|472473237|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
131231089|NCT01806597|472473238|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
131231090|NCT01806597|472473233|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
131231091|NCT01806597|472473234|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
131231092|NCT01806597|472473235|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
131231093|NCT01806597|472473236|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
131231094|NCT01806597|472473237|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
131231095|NCT01806597|472473238|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
131231096|NCT01806597|472473233|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
131231097|NCT01806597|472473234|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
131231098|NCT01806597|472473235|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
131231099|NCT01806597|472473236|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
131231100|NCT01806597|472473237|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
131231101|NCT01806597|472473238|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
131231102|NCT01806597|472473233|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
131231103|NCT01806597|472473234|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
131231104|NCT01806597|472473235|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
130724026|NCT02932306|470615472|FG000|Overall Study|Lost to Follow-up|36|||
130724027|NCT02932306|470615473|FG001|Overall Study|Lost to Follow-up|40|||
130724028|NCT02932306|470615472|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
130724029|NCT02932306|470615473|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
130724030|NCT02932306|470615472|FG000|Overall Study|Lack of Efficacy|0|||
130724031|NCT02932306|470615473|FG001|Overall Study|Lack of Efficacy|2|||
130724032|NCT02932306|470615472|FG000|Overall Study|Worsening condition|2|||
130724033|NCT02932306|470615473|FG001|Overall Study|Worsening condition|0|||
130724034|NCT02932306|470615472|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
130724035|NCT02932306|470615473|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
130724036|NCT05776862|470615474|FG000|Overall Study|Adverse Event|0|||
130724037|NCT05776862|470615475|FG001|Overall Study|Adverse Event|1|||
130724038|NCT05776862|470615474|FG000|Overall Study|non-compliance|1|||
130724039|NCT05776862|470615475|FG001|Overall Study|non-compliance|0|||
130724040|NCT02065700|470615476|FG000|Overall Study|Adverse Event|165|||
130724041|NCT02065700|470615477|FG001|Overall Study|Adverse Event|101|||
130724042|NCT02065700|470615476|FG000|Overall Study|Withdrawal by Subject|90|||
130724043|NCT02065700|470615477|FG001|Overall Study|Withdrawal by Subject|29|||
130724044|NCT02065700|470615476|FG000|Overall Study|Lost to Follow-up|12|||
130724045|NCT02065700|470615477|FG001|Overall Study|Lost to Follow-up|9|||
130724046|NCT02065700|470615476|FG000|Overall Study|Physician Decision|2|||
130724047|NCT02065700|470615477|FG001|Overall Study|Physician Decision|0|||
130724048|NCT02065700|470615476|FG000|Overall Study|Sponsor Request|38|||
130724049|NCT02065700|470615477|FG001|Overall Study|Sponsor Request|15|||
130724050|NCT02065700|470615476|FG000|Overall Study|Treatment Failure|3|||
130724051|NCT02065700|470615477|FG001|Overall Study|Treatment Failure|2|||
130724052|NCT02065700|470615476|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
130724053|NCT02065700|470615477|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
130724054|NCT02065700|470615476|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
130724055|NCT02065700|470615477|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
130724056|NCT02065700|470615476|FG000|Overall Study|Non-compliance with Study Procedures|2|||
130724057|NCT02065700|470615477|FG001|Overall Study|Non-compliance with Study Procedures|0|||
130724058|NCT02065700|470615476|FG000|Overall Study|Not Defined|21|||
131231105|NCT01806597|472473236|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
130724059|NCT02065700|470615477|FG001|Overall Study|Not Defined|3|||
130724060|NCT00605540|470615482|FG000|Overall Study|Death|15|||
130724061|NCT00605540|470615482|FG000|Overall Study|Lost to Follow-up|23|||
131231106|NCT01806597|472473237|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
130724062|NCT01544179|470615485|FG000|Overall Study|Death|50|||
130724063|NCT01544179|470615486|FG001|Overall Study|Death|37|||
130724064|NCT01544179|470615485|FG000|Overall Study|Lost to Follow-up|0|||
131231107|NCT01806597|472473238|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
130724065|NCT01544179|470615486|FG001|Overall Study|Lost to Follow-up|1|||
130724066|NCT01544179|470615485|FG000|Overall Study|Adverse Event|0|||
131072812|NCT03915951|471899240|FG000|Overall Study|Disease progression (radiological)|17|||
131072813|NCT03915951|471899241|FG001|Overall Study|Disease progression (radiological)|15|||
131072814|NCT03915951|471899240|FG000|Overall Study|Disease progression (clinical)|4|||
131072815|NCT03915951|471899241|FG001|Overall Study|Disease progression (clinical)|1|||
131072816|NCT03915951|471899240|FG000|Overall Study|Patient decision|0|||
131072817|NCT03915951|471899241|FG001|Overall Study|Patient decision|4|||
131072818|NCT03915951|471899240|FG000|Overall Study|Investigator decision|0|||
131072819|NCT03915951|471899241|FG001|Overall Study|Investigator decision|1|||
131072820|NCT03915951|471899240|FG000|Overall Study|Consent withdrawn|1|||
131072821|NCT03915951|471899241|FG001|Overall Study|Consent withdrawn|1|||
131072822|NCT03915951|471899240|FG000|Overall Study|Death|0|||
131072823|NCT03915951|471899241|FG001|Overall Study|Death|3|||
131072824|NCT01121185|471899245|FG000|Overall Study|Not infused|0|||
131072825|NCT01121185|471899246|FG001|Overall Study|Not infused|1|||
131072826|NCT01121185|471899245|FG000|Overall Study|Not transplanted|1|||
131072827|NCT01121185|471899246|FG001|Overall Study|Not transplanted|0|||
131072828|NCT01196741|471899247|FG000|Overall Study|Disease progression|34|||
131072829|NCT01196741|471899248|FG001|Overall Study|Disease progression|14|||
131072830|NCT01196741|471899247|FG000|Overall Study|Adverse Event|10|||
131072831|NCT01196741|471899248|FG001|Overall Study|Adverse Event|6|||
131072832|NCT01196741|471899247|FG000|Overall Study|Serious Adverse Event|3|||
131072833|NCT01196741|471899248|FG001|Overall Study|Serious Adverse Event|1|||
131072834|NCT01196741|471899247|FG000|Overall Study|Dose limiting Adverse Event|2|||
131137900|NCT00848354|472130739|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
131137901|NCT00848354|472130738|FG000|Phase 2 Year 2|Unspecified Reason|1|||
131137902|NCT00848354|472130739|FG001|Phase 2 Year 2|Unspecified Reason|0|||
131137903|NCT00848354|472130738|FG000|Phase 2 Year 2|Protocol Violation|1|||
131137904|NCT00848354|472130739|FG001|Phase 2 Year 2|Protocol Violation|1|||
131137905|NCT00848354|472130738|FG000|Phase 2 Year 2|Subject Request|1|||
131137906|NCT00848354|472130739|FG001|Phase 2 Year 2|Subject Request|1|||
131137907|NCT00848354|472130738|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
131137908|NCT00848354|472130739|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
131137909|NCT03718143|472132733|FG000|Overall Study|Death|1|||
131072835|NCT01196741|471899248|FG001|Overall Study|Dose limiting Adverse Event|1|||
131072836|NCT01196741|471899247|FG000|Overall Study|Withdrawal by Subject|3|||
131072837|NCT01196741|471899248|FG001|Overall Study|Withdrawal by Subject|0|||
131072838|NCT01196741|471899247|FG000|Overall Study|Other reason|3|||
131137910|NCT03718143|472132734|FG001|Overall Study|Death|0|||
131137911|NCT03718143|472132735|FG002|Overall Study|Death|0|||
131137912|NCT03718143|472132733|FG000|Overall Study|Progression of Disease|1|||
130724067|NCT01544179|470615486|FG001|Overall Study|Adverse Event|1|||
131072839|NCT01196741|471899248|FG001|Overall Study|Other reason|3|||
131072840|NCT01196741|471899247|FG000|Overall Study|Other|3|||
131137913|NCT03718143|472132734|FG001|Overall Study|Progression of Disease|0|||
131137914|NCT03718143|472132735|FG002|Overall Study|Progression of Disease|0|||
131137915|NCT03718143|472132733|FG000|Overall Study|Withdrawal of Informed Consent|1|||
131137916|NCT03718143|472132734|FG001|Overall Study|Withdrawal of Informed Consent|2|||
131137917|NCT03718143|472132735|FG002|Overall Study|Withdrawal of Informed Consent|1|||
130724068|NCT01544179|470615485|FG000|Overall Study|Withdrawal by Subject|12|||
130724069|NCT01544179|470615486|FG001|Overall Study|Withdrawal by Subject|7|||
130724070|NCT01544179|470615485|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
130724071|NCT01544179|470615486|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130724072|NCT00049530|470615487|FG000|Overall Study|Lack of Efficacy|25|||
130724073|NCT00049530|470615487|FG000|Overall Study|Adverse Event|2|||
130724074|NCT00049530|470615487|FG000|Overall Study|Death|1|||
130724075|NCT00049530|470615487|FG000|Overall Study|symptomatic deterioration|1|||
130724076|NCT00049530|470615487|FG000|Overall Study|ineligible|3|||
130724077|NCT01635283|470615488|FG000|Overall Study|Tumor Progression|3|||
130724078|NCT01635283|470615488|FG000|Overall Study|Lost to Follow-up|1|||
130724079|NCT01433549|470615489|FG000|Phase 2: Second Study Product|Adverse Event|0|||
130724080|NCT01433549|470615490|FG001|Phase 2: Second Study Product|Adverse Event|1|||
130724081|NCT01438996|470615491|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
130724082|NCT01438996|470615492|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
130724083|NCT01438996|470615493|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
130724084|NCT01696058|470615497|FG000|Overall Study|Adverse Event|21|||
130724085|NCT01696058|470615498|FG001|Overall Study|Adverse Event|11|||
130724086|NCT01696058|470615497|FG000|Overall Study|Lack of Efficacy|2|||
130724087|NCT01696058|470615498|FG001|Overall Study|Lack of Efficacy|3|||
130724088|NCT01696058|470615497|FG000|Overall Study|Protocol Violation|9|||
130724089|NCT01696058|470615498|FG001|Overall Study|Protocol Violation|3|||
130724090|NCT01696058|470615497|FG000|Overall Study|Lost to Follow-up|2|||
130724091|NCT01696058|470615498|FG001|Overall Study|Lost to Follow-up|5|||
130724092|NCT01696058|470615497|FG000|Overall Study|Withdrawal by Subject|4|||
130724093|NCT01696058|470615498|FG001|Overall Study|Withdrawal by Subject|6|||
130724094|NCT01696058|470615497|FG000|Overall Study|Other reason prematurely discontinued|5|||
130724095|NCT01696058|470615498|FG001|Overall Study|Other reason prematurely discontinued|3|||
130724096|NCT02278055|470615499|FG000|Overall Study|Adverse Event|1|||
130779536|NCT02326272|470819503|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779537|NCT02326272|470819504|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130779538|NCT02326272|470819490|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130779539|NCT02326272|470819491|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131072841|NCT01196741|471899248|FG001|Overall Study|Other|2|||
131072842|NCT01196741|471899247|FG000|Overall Study|Protocol Violation|2|||
131072843|NCT01196741|471899248|FG001|Overall Study|Protocol Violation|1|||
131072844|NCT01064856|471899250|FG000|Double-blind (DB) Period|Adverse Event|1|||
131137918|NCT05064059|472132736|FG000|Overall Study|Death|199|||
131137919|NCT05064059|472132737|FG001|Overall Study|Death|196|||
131137920|NCT05064059|472132736|FG000|Overall Study|Physician Decision|4|||
131137921|NCT05064059|472132737|FG001|Overall Study|Physician Decision|2|||
131137922|NCT05064059|472132736|FG000|Overall Study|Sponsor Decision|14|||
131137923|NCT05064059|472132737|FG001|Overall Study|Sponsor Decision|11|||
131137924|NCT05064059|472132736|FG000|Overall Study|Withdrawal by Subject|4|||
131137925|NCT05064059|472132737|FG001|Overall Study|Withdrawal by Subject|11|||
130724097|NCT02278055|470615499|FG000|Overall Study|Lost to Follow-up|1|||
130724098|NCT02278055|470615499|FG000|Overall Study|Withdrawal by Subject|2|||
130724099|NCT02278055|470615499|FG000|Overall Study|Progressive Disease|4|||
130724100|NCT01934335|470615500|FG000|Overall Study|Withdrawal by Subject|1|||
130724101|NCT01934335|470615501|FG001|Overall Study|Withdrawal by Subject|1|||
130724102|NCT05384171|470615502|FG000|Overall Study|Lost to Follow-up|9|||
130724103|NCT05384171|470615503|FG001|Overall Study|Lost to Follow-up|9|||
130724104|NCT05384171|470615502|FG000|Overall Study|Withdrawal by Subject|3|||
130724105|NCT05384171|470615503|FG001|Overall Study|Withdrawal by Subject|0|||
130724106|NCT01421511|470615504|FG000|Overall Study|Lost to Follow-up|11|||
130724107|NCT01421511|470615505|FG001|Overall Study|Lost to Follow-up|14|||
130724108|NCT01421511|470615504|FG000|Overall Study|Randomized but didn't receive study drug|1|||
130724109|NCT01421511|470615505|FG001|Overall Study|Randomized but didn't receive study drug|7|||
130724110|NCT01421511|470615504|FG000|Overall Study|Physician Decision|0|||
130724111|NCT01421511|470615505|FG001|Overall Study|Physician Decision|1|||
130724112|NCT01421511|470615504|FG000|Overall Study|Withdrawal by Subject|6|||
130724113|NCT01421511|470615505|FG001|Overall Study|Withdrawal by Subject|5|||
130724114|NCT01421511|470615504|FG000|Overall Study|Death|1|||
130724115|NCT01421511|470615505|FG001|Overall Study|Death|1|||
130724116|NCT00749892|470615506|FG000|Overall Study|Withdrawal by Subject|3|||
130724117|NCT01756079|470615507|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
130724118|NCT01756079|470615507|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
130724119|NCT01756079|470615507|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
130724120|NCT01756079|470615507|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
130724121|NCT01756079|470615507|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
130724122|NCT00106964|470615508|FG000|Overall Study|Lost to Follow-up|8|||
130724123|NCT00106964|470615509|FG001|Overall Study|Lost to Follow-up|6|||
130724124|NCT00106964|470615510|FG002|Overall Study|Lost to Follow-up|2|||
130724125|NCT00106964|470615508|FG000|Overall Study|Pregnancy|2|||
130724126|NCT00106964|470615509|FG001|Overall Study|Pregnancy|3|||
130724127|NCT00106964|470615510|FG002|Overall Study|Pregnancy|2|||
131072845|NCT01064856|471899251|FG001|Double-blind (DB) Period|Adverse Event|0|||
131072846|NCT01064856|471899252|FG002|Double-blind (DB) Period|Adverse Event|0|||
131072847|NCT01064856|471899253|FG003|Double-blind (DB) Period|Adverse Event|0|||
131072848|NCT01064856|471899250|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
131072849|NCT01064856|471899251|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
131072850|NCT01064856|471899252|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
131072851|NCT01064856|471899253|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
131072852|NCT01064856|471899250|FG000|Open-label (OL) Period|Adverse Event|0|||
131072853|NCT01064856|471899251|FG001|Open-label (OL) Period|Adverse Event|0|||
131072854|NCT01064856|471899252|FG002|Open-label (OL) Period|Adverse Event|12|||
131072855|NCT01064856|471899253|FG003|Open-label (OL) Period|Adverse Event|6|||
131072856|NCT01064856|471899250|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
131072857|NCT01064856|471899251|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
131072858|NCT01064856|471899252|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
131072859|NCT01064856|471899253|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
131072860|NCT01064856|471899250|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
131072861|NCT01064856|471899251|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
130724128|NCT00106964|470615508|FG000|Overall Study|Death|1|||
131072862|NCT01064856|471899252|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
131072863|NCT01064856|471899253|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
131072864|NCT01064856|471899250|FG000|Open-label (OL) Period|Other|0|||
131137926|NCT05227690|472132743|FG000|Overall Study|Adverse Event|5|||
131137927|NCT05227690|472132744|FG001|Overall Study|Adverse Event|6|||
130724129|NCT00106964|470615509|FG001|Overall Study|Death|1|||
130724130|NCT00106964|470615510|FG002|Overall Study|Death|0|||
130724131|NCT00106964|470615508|FG000|Overall Study|Incarceration|0|||
130724132|NCT00106964|470615509|FG001|Overall Study|Incarceration|1|||
130724133|NCT00106964|470615510|FG002|Overall Study|Incarceration|0|||
131072865|NCT01064856|471899251|FG001|Open-label (OL) Period|Other|0|||
131072866|NCT01064856|471899252|FG002|Open-label (OL) Period|Other|7|||
131072867|NCT01064856|471899253|FG003|Open-label (OL) Period|Other|7|||
131072868|NCT01204775|471899256|FG000|Overall Study|Poor/non-compliance|0|||
131072869|NCT01204775|471899257|FG001|Overall Study|Poor/non-compliance|1|||
131072870|NCT01204775|471899256|FG000|Overall Study|Withdrawal by Subject|1|||
131072871|NCT01204775|471899257|FG001|Overall Study|Withdrawal by Subject|0|||
131072872|NCT02273180|471899258|FG000|Overall Study|Adverse Event|2|||
131072873|NCT02273180|471899259|FG001|Overall Study|Adverse Event|2|||
131072874|NCT02273180|471899258|FG000|Overall Study|Lack of Efficacy|1|||
131072875|NCT02273180|471899259|FG001|Overall Study|Lack of Efficacy|0|||
131072876|NCT02273180|471899258|FG000|Overall Study|Protocol Violation|1|||
131072877|NCT02273180|471899259|FG001|Overall Study|Protocol Violation|7|||
131072878|NCT02273180|471899258|FG000|Overall Study|Randomized but not treated|1|||
131072879|NCT02273180|471899259|FG001|Overall Study|Randomized but not treated|0|||
131072880|NCT02273180|471899258|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
131072881|NCT02273180|471899259|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
131072882|NCT02273180|471899258|FG000|Overall Study|Other than specified above|21|||
131072883|NCT02273180|471899259|FG001|Overall Study|Other than specified above|10|||
131072884|NCT00509925|471899260|FG000|Overall Study|Personal reasons|0|||
131072885|NCT00509925|471899261|FG001|Overall Study|Personal reasons|1|||
131072886|NCT03749616|471899264|FG000|Overall Study|Lost to Follow-up|4|||
131072887|NCT03749616|471899265|FG001|Overall Study|Lost to Follow-up|7|||
131072888|NCT03749616|471899264|FG000|Overall Study|Screen Failure|1|||
131072889|NCT03749616|471899265|FG001|Overall Study|Screen Failure|1|||
131072890|NCT03749616|471899264|FG000|Overall Study|Withdrawal by Subject|2|||
131072891|NCT03749616|471899265|FG001|Overall Study|Withdrawal by Subject|0|||
131072892|NCT04435522|471899268|FG000|Overall Study|Withdrawal by Subject|2|||
131072893|NCT03302559|471899269|FG000|Overall Study|Adverse Event|2|||
131072894|NCT03302559|471899269|FG000|Overall Study|Lost to Follow-up|1|||
131072895|NCT03302559|471899269|FG000|Overall Study|Withdrew Consent|3|||
131072896|NCT00951171|471899270|FG000|Overall Study|Adverse Event|2|||
131072897|NCT00951171|471899271|FG001|Overall Study|Adverse Event|0|||
131072898|NCT00919061|471899272|FG000|Overall Study|Adverse Event|1|||
131072899|NCT00919061|471899272|FG000|Overall Study|Withdrawal by Subject|1|||
131072900|NCT04130061|471899275|FG000|Overall Study|OR team forgot to request membrane|1|||
131072901|NCT04130061|471899276|FG001|Overall Study|OR team forgot to request membrane|0|||
131072902|NCT05294328|471899283|FG000|Overall Study|Adverse Event|1|||
131072903|NCT05294328|471899284|FG001|Overall Study|Adverse Event|0|||
131072904|NCT05294328|471899285|FG002|Overall Study|Adverse Event|0|||
131072905|NCT05294328|471899283|FG000|Overall Study|Physician Decision|1|||
131072906|NCT05294328|471899284|FG001|Overall Study|Physician Decision|1|||
131072907|NCT05294328|471899285|FG002|Overall Study|Physician Decision|0|||
131072908|NCT05294328|471899283|FG000|Overall Study|Withdrawal by Subject|0|||
131072909|NCT05294328|471899284|FG001|Overall Study|Withdrawal by Subject|2|||
131072910|NCT05294328|471899285|FG002|Overall Study|Withdrawal by Subject|1|||
131072911|NCT05294328|471899283|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
131072912|NCT05294328|471899284|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
131072913|NCT05294328|471899285|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
131072914|NCT02056873|471899286|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
131072915|NCT00113269|471900939|FG000|Overall Study|Not transplanted, donor issues|4|||
131137928|NCT05227690|472132745|FG002|Overall Study|Adverse Event|10|||
131137929|NCT05227690|472132743|FG000|Overall Study|Lack of Efficacy|2|||
131137930|NCT05227690|472132744|FG001|Overall Study|Lack of Efficacy|4|||
131137931|NCT05227690|472132745|FG002|Overall Study|Lack of Efficacy|1|||
131137932|NCT05227690|472132743|FG000|Overall Study|Physician Decision|6|||
131137933|NCT05227690|472132744|FG001|Overall Study|Physician Decision|0|||
131137934|NCT05227690|472132745|FG002|Overall Study|Physician Decision|4|||
131137935|NCT05227690|472132743|FG000|Overall Study|Withdrawal of consent|28|||
131137936|NCT05227690|472132744|FG001|Overall Study|Withdrawal of consent|27|||
131137937|NCT05227690|472132745|FG002|Overall Study|Withdrawal of consent|21|||
131137938|NCT05227690|472132743|FG000|Overall Study|Other, not specified|2|||
131137939|NCT05227690|472132744|FG001|Overall Study|Other, not specified|2|||
131137940|NCT05227690|472132745|FG002|Overall Study|Other, not specified|1|||
131137941|NCT02770326|472132748|FG000|Overall Study|Death|3|||
131137942|NCT02770326|472132748|FG000|Overall Study|Lost to Follow-up|1|||
131137943|NCT02971202|472132749|FG000|Overall Study|Pregnancy|1|||
131137944|NCT02971202|472132750|FG001|Overall Study|Pregnancy|0|||
131137945|NCT02971202|472132751|FG002|Overall Study|Pregnancy|0|||
131137946|NCT02971202|472132749|FG000|Overall Study|screen fail after consent|1|||
131137947|NCT02971202|472132750|FG001|Overall Study|screen fail after consent|0|||
131137948|NCT02971202|472132751|FG002|Overall Study|screen fail after consent|1|||
131137949|NCT02634580|472132752|FG000|Double-blind Treatment Period|Subject Request|1|||
131137950|NCT02634580|472132753|FG001|Double-blind Treatment Period|Subject Request|0|||
131137951|NCT02634580|472132754|FG002|Double-blind Treatment Period|Subject Request|1|||
131137952|NCT02634580|472132755|FG003|Double-blind Treatment Period|Subject Request|1|||
131137953|NCT02634580|472132752|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
131137954|NCT02634580|472132753|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
131137955|NCT02634580|472132754|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
131137956|NCT02634580|472132755|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
131137957|NCT04269395|472132756|FG000|Overall Study|Lost to Follow-up|1|||
131137958|NCT04269395|472132757|FG001|Overall Study|Lost to Follow-up|0|||
131137959|NCT04269395|472132756|FG000|Overall Study|Study terminated by Sponsor|13|||
131137960|NCT04269395|472132757|FG001|Overall Study|Study terminated by Sponsor|10|||
131137961|NCT00584233|472132758|FG000|Overall Study|Withdrawal by Subject|5|||
131137962|NCT00584233|472132758|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
131137963|NCT02222714|472132759|FG000|Overall Study|Death|0|||
131137964|NCT02222714|472132760|FG001|Overall Study|Death|2|||
131231108|NCT01806597|472473233|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
131231109|NCT01806597|472473234|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
130724134|NCT00106964|470615508|FG000|Overall Study|Site Funding Terminated|0|||
130724135|NCT00106964|470615509|FG001|Overall Study|Site Funding Terminated|1|||
130724136|NCT00106964|470615510|FG002|Overall Study|Site Funding Terminated|1|||
130724137|NCT00106964|470615508|FG000|Overall Study|Failure to adhere|2|||
130724138|NCT00106964|470615509|FG001|Overall Study|Failure to adhere|0|||
130724139|NCT00106964|470615510|FG002|Overall Study|Failure to adhere|0|||
130724140|NCT00106964|470615508|FG000|Overall Study|Did not meet eligibility criteria|0|||
130724141|NCT00106964|470615509|FG001|Overall Study|Did not meet eligibility criteria|2|||
130724142|NCT00106964|470615510|FG002|Overall Study|Did not meet eligibility criteria|2|||
130724143|NCT00106964|470615508|FG000|Overall Study|Required disallowed medication|0|||
130724144|NCT00106964|470615509|FG001|Overall Study|Required disallowed medication|1|||
130724145|NCT00106964|470615510|FG002|Overall Study|Required disallowed medication|0|||
130724146|NCT03207243|470615513|FG000|Overall Study|Adverse Event|2|||
130724147|NCT03207243|470615514|FG001|Overall Study|Adverse Event|2|||
130724148|NCT03207243|470615513|FG000|Overall Study|Loss of Asthma Control|47|||
130724149|NCT03207243|470615514|FG001|Overall Study|Loss of Asthma Control|31|||
130724150|NCT03207243|470615513|FG000|Overall Study|Withdrawal by Subject|2|||
130724151|NCT03207243|470615514|FG001|Overall Study|Withdrawal by Subject|4|||
130724152|NCT03207243|470615513|FG000|Overall Study|Physician Decision|1|||
130724153|NCT03207243|470615514|FG001|Overall Study|Physician Decision|1|||
130724154|NCT03207243|470615513|FG000|Overall Study|Lost to Follow-up|0|||
130724155|NCT03207243|470615514|FG001|Overall Study|Lost to Follow-up|1|||
130724156|NCT03207243|470615513|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
130724157|NCT03207243|470615514|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
130724158|NCT03207243|470615513|FG000|Overall Study|Protocol Violation|0|||
130724159|NCT03207243|470615514|FG001|Overall Study|Protocol Violation|3|||
130724160|NCT00168818|470615515|FG000|Overall Study|Adverse Event|23|||
130724161|NCT00168818|470615516|FG001|Overall Study|Adverse Event|29|||
130724162|NCT00168818|470615517|FG002|Overall Study|Adverse Event|31|||
130724163|NCT00168818|470615515|FG000|Overall Study|Protocol Violation|16|||
130724164|NCT00168818|470615516|FG001|Overall Study|Protocol Violation|11|||
130724165|NCT00168818|470615517|FG002|Overall Study|Protocol Violation|11|||
130724166|NCT00168818|470615515|FG000|Overall Study|Lost to Follow-up|13|||
130724167|NCT00168818|470615516|FG001|Overall Study|Lost to Follow-up|4|||
130724168|NCT00168818|470615517|FG002|Overall Study|Lost to Follow-up|15|||
130724169|NCT00168818|470615515|FG000|Overall Study|Withdrawal by Subject|43|||
130724170|NCT00168818|470615516|FG001|Overall Study|Withdrawal by Subject|41|||
130724171|NCT00168818|470615517|FG002|Overall Study|Withdrawal by Subject|37|||
130724172|NCT00168818|470615515|FG000|Overall Study|Other|22|||
130724173|NCT00168818|470615516|FG001|Overall Study|Other|24|||
130724174|NCT00168818|470615517|FG002|Overall Study|Other|30|||
130724175|NCT00168818|470615515|FG000|Treatment|Adverse Event|77|||
130724176|NCT00168818|470615516|FG001|Treatment|Adverse Event|89|||
130724177|NCT00168818|470615517|FG002|Treatment|Adverse Event|68|||
130724178|NCT00168818|470615515|FG000|Treatment|Protocol Violation|8|||
130724179|NCT00168818|470615516|FG001|Treatment|Protocol Violation|11|||
130724180|NCT00168818|470615517|FG002|Treatment|Protocol Violation|11|||
131137965|NCT02222714|472132761|FG002|Overall Study|Death|3|||
131137966|NCT02222714|472132762|FG003|Overall Study|Death|4|||
130724181|NCT00168818|470615515|FG000|Treatment|Lost to Follow-up|0|||
130724182|NCT00168818|470615516|FG001|Treatment|Lost to Follow-up|2|||
130724183|NCT00168818|470615517|FG002|Treatment|Lost to Follow-up|1|||
130724184|NCT00168818|470615515|FG000|Treatment|Withdrawal by Subject|25|||
130724185|NCT00168818|470615516|FG001|Treatment|Withdrawal by Subject|20|||
130724186|NCT00168818|470615517|FG002|Treatment|Withdrawal by Subject|22|||
130724187|NCT00168818|470615515|FG000|Treatment|Other|23|||
130724188|NCT00168818|470615516|FG001|Treatment|Other|29|||
130724189|NCT00168818|470615517|FG002|Treatment|Other|31|||
130724190|NCT00469144|470615518|FG000|Overall Study|Death|0|||
130724191|NCT00469144|470615519|FG001|Overall Study|Death|1|||
130724192|NCT00469144|470615518|FG000|Overall Study|No Response|5|||
130724193|NCT00469144|470615519|FG001|Overall Study|No Response|5|||
131137967|NCT02222714|472132763|FG004|Overall Study|Death|6|||
131137968|NCT02222714|472132759|FG000|Overall Study|Withdrawal by Subject|0|||
131072916|NCT00113269|471900940|FG001|Overall Study|Not transplanted, donor issues|0|||
131072917|NCT00113269|471900941|FG002|Overall Study|Not transplanted, donor issues|2|||
131072918|NCT00113269|471900942|FG003|Overall Study|Not transplanted, donor issues|2|||
131072919|NCT00113269|471900939|FG000|Overall Study|Not transplanted, recipient issues|2|||
131072920|NCT00113269|471900940|FG001|Overall Study|Not transplanted, recipient issues|1|||
131072921|NCT00113269|471900941|FG002|Overall Study|Not transplanted, recipient issues|7|||
131072922|NCT00113269|471900942|FG003|Overall Study|Not transplanted, recipient issues|4|||
131072923|NCT00113269|471900939|FG000|Overall Study|Early graft loss, technical|0|||
131072924|NCT00113269|471900940|FG001|Overall Study|Early graft loss, technical|0|||
131072925|NCT00113269|471900941|FG002|Overall Study|Early graft loss, technical|2|||
130724194|NCT00469144|470615518|FG000|Overall Study|Progressive Disease|1|||
130724195|NCT00469144|470615519|FG001|Overall Study|Progressive Disease|0|||
130724196|NCT02794246|470615520|FG000|Overall Study|Withdrawal by Subject|2|||
130724197|NCT02794246|470615520|FG000|Overall Study|Physician Decision|4|||
130724198|NCT04602546|470615521|FG000|Overall Study|Training|2|||
130724199|NCT04602546|470615522|FG001|Overall Study|Training|2|||
130724200|NCT04602546|470615523|FG002|Overall Study|Training|1|||
130724201|NCT04602546|470615524|FG003|Overall Study|Training|2|||
130724202|NCT04602546|470615525|FG004|Overall Study|Training|0|||
130724203|NCT04602546|470615521|FG000|Overall Study|Randomized with disqualified data|2|||
130724204|NCT04602546|470615522|FG001|Overall Study|Randomized with disqualified data|0|||
130724205|NCT04602546|470615523|FG002|Overall Study|Randomized with disqualified data|2|||
130724206|NCT04602546|470615524|FG003|Overall Study|Randomized with disqualified data|5|||
130724207|NCT04602546|470615525|FG004|Overall Study|Randomized with disqualified data|3|||
130724208|NCT01994291|470615526|FG000|Overall Study|Adverse Event|4|||
130724209|NCT01994291|470615527|FG001|Overall Study|Adverse Event|1|||
130724210|NCT01994291|470615528|FG002|Overall Study|Adverse Event|3|||
130724211|NCT01994291|470615526|FG000|Overall Study|Lost to Follow-up|1|||
130724212|NCT01994291|470615527|FG001|Overall Study|Lost to Follow-up|1|||
130724213|NCT01994291|470615528|FG002|Overall Study|Lost to Follow-up|0|||
130724214|NCT01994291|470615526|FG000|Overall Study|Does not meet entrance criteria|1|||
130724215|NCT01994291|470615527|FG001|Overall Study|Does not meet entrance criteria|0|||
130724216|NCT01994291|470615528|FG002|Overall Study|Does not meet entrance criteria|0|||
130724217|NCT01994291|470615526|FG000|Overall Study|Medication error without associated AE|1|||
130724218|NCT01994291|470615527|FG001|Overall Study|Medication error without associated AE|0|||
130724219|NCT01994291|470615528|FG002|Overall Study|Medication error without associated AE|1|||
130724220|NCT01994291|470615526|FG000|Overall Study|Protocol Violation|1|||
130724221|NCT01994291|470615527|FG001|Overall Study|Protocol Violation|0|||
130724222|NCT01994291|470615528|FG002|Overall Study|Protocol Violation|0|||
130724223|NCT01994291|470615526|FG000|Overall Study|Withdrawal by Subject|6|||
130724224|NCT01994291|470615527|FG001|Overall Study|Withdrawal by Subject|3|||
130724225|NCT01994291|470615528|FG002|Overall Study|Withdrawal by Subject|5|||
130724226|NCT01994291|470615526|FG000|Overall Study|Other|1|||
130724227|NCT01994291|470615527|FG001|Overall Study|Other|2|||
130724228|NCT01994291|470615528|FG002|Overall Study|Other|0|||
130724229|NCT01775189|470615529|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724230|NCT01775189|470615530|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
130724231|NCT01775189|470615531|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724232|NCT01775189|470615532|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724233|NCT01775189|470615533|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724234|NCT01775189|470615534|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724235|NCT01775189|470615535|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130724236|NCT01775189|470615529|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724237|NCT01775189|470615530|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
130724238|NCT01775189|470615531|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724239|NCT01775189|470615532|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724240|NCT01775189|470615533|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724241|NCT01775189|470615534|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724242|NCT01775189|470615535|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130724243|NCT01775189|470615529|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130724244|NCT01775189|470615530|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
130724245|NCT01775189|470615531|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
131072926|NCT00113269|471900942|FG003|Overall Study|Early graft loss, technical|0|||
130724246|NCT01775189|470615532|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130724247|NCT01775189|470615533|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130724248|NCT01775189|470615534|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130724249|NCT01775189|470615535|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130779540|NCT02326272|470819492|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
131072927|NCT00113269|471900939|FG000|Overall Study|Death in operating room|0|||
131072928|NCT00113269|471900940|FG001|Overall Study|Death in operating room|0|||
131072929|NCT00113269|471900941|FG002|Overall Study|Death in operating room|0|||
131072930|NCT00113269|471900942|FG003|Overall Study|Death in operating room|1|||
130779541|NCT02326272|470819493|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130779542|NCT02326272|470819494|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130779543|NCT02326272|470819495|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
130779544|NCT02326272|470819496|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
130779545|NCT02326272|470819497|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
130779546|NCT02326272|470819498|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
130779547|NCT02326272|470819499|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130779548|NCT02326272|470819500|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130779549|NCT02326272|470819501|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130779550|NCT02326272|470819502|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130779551|NCT02326272|470819503|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130779552|NCT02326272|470819504|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130779553|NCT02326272|470819490|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779554|NCT02326272|470819491|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779555|NCT02326272|470819492|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779556|NCT02326272|470819493|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779557|NCT02326272|470819494|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779558|NCT02326272|470819495|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
130779559|NCT02326272|470819496|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779560|NCT02326272|470819497|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779561|NCT02326272|470819498|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779562|NCT02326272|470819499|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779563|NCT02326272|470819500|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779564|NCT02326272|470819501|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779565|NCT02326272|470819502|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779566|NCT02326272|470819503|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779567|NCT02326272|470819504|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130779568|NCT02326272|470819490|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779569|NCT02326272|470819491|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779570|NCT02326272|470819492|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779571|NCT02326272|470819493|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779572|NCT02326272|470819494|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779573|NCT02326272|470819495|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779574|NCT02326272|470819496|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
130779575|NCT02326272|470819497|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779576|NCT02326272|470819498|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779577|NCT02326272|470819499|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779578|NCT02326272|470819500|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779579|NCT02326272|470819501|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779580|NCT02326272|470819502|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779581|NCT02326272|470819503|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
131072931|NCT00113269|471900939|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
131072932|NCT00113269|471900940|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
131072933|NCT00113269|471900941|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
131072934|NCT00113269|471900942|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
131072935|NCT00113269|471900939|FG000|Overall Study|Adverse Event|2|||
131072936|NCT00113269|471900940|FG001|Overall Study|Adverse Event|7|||
131072937|NCT00113269|471900941|FG002|Overall Study|Adverse Event|11|||
131072938|NCT00113269|471900942|FG003|Overall Study|Adverse Event|7|||
131072939|NCT00113269|471900939|FG000|Overall Study|Withdrawal by Subject|4|||
131072940|NCT00113269|471900940|FG001|Overall Study|Withdrawal by Subject|3|||
131072941|NCT00113269|471900941|FG002|Overall Study|Withdrawal by Subject|4|||
131072942|NCT00113269|471900942|FG003|Overall Study|Withdrawal by Subject|2|||
131072943|NCT00113269|471900939|FG000|Overall Study|Graft loss|6|||
131072944|NCT00113269|471900940|FG001|Overall Study|Graft loss|6|||
131072945|NCT00113269|471900941|FG002|Overall Study|Graft loss|4|||
131072946|NCT00113269|471900942|FG003|Overall Study|Graft loss|9|||
131072947|NCT00113269|471900939|FG000|Overall Study|Protocol Violation|1|||
131072948|NCT00113269|471900940|FG001|Overall Study|Protocol Violation|0|||
131072949|NCT00113269|471900941|FG002|Overall Study|Protocol Violation|4|||
131072950|NCT00113269|471900942|FG003|Overall Study|Protocol Violation|2|||
131137969|NCT02222714|472132760|FG001|Overall Study|Withdrawal by Subject|0|||
131137970|NCT02222714|472132761|FG002|Overall Study|Withdrawal by Subject|1|||
130779582|NCT02326272|470819504|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130779583|NCT02326272|470819490|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
130779584|NCT02326272|470819491|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
130779585|NCT02326272|470819492|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
130779586|NCT02326272|470819493|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
130779587|NCT02326272|470819494|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
130779588|NCT02326272|470819495|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
130779589|NCT02326272|470819496|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
130779590|NCT02326272|470819497|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
130779591|NCT02326272|470819498|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
131137971|NCT02222714|472132762|FG003|Overall Study|Withdrawal by Subject|0|||
130724250|NCT01775189|470615529|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724251|NCT01775189|470615530|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724252|NCT01775189|470615531|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724253|NCT01775189|470615532|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724254|NCT01775189|470615533|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724255|NCT01775189|470615534|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
130724256|NCT01775189|470615535|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130724257|NCT01775189|470615529|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724258|NCT01775189|470615530|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724259|NCT01775189|470615531|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724260|NCT01775189|470615532|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
130724261|NCT01775189|470615533|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724262|NCT01775189|470615534|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724263|NCT01775189|470615535|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130724264|NCT01775189|470615529|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130724265|NCT01775189|470615530|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130724266|NCT01775189|470615531|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130724267|NCT01775189|470615532|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
130724268|NCT01775189|470615533|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130724269|NCT01775189|470615534|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130724270|NCT01775189|470615535|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
130724271|NCT00856375|470615536|FG000|Overall Study|Other|0|||
130724272|NCT00856375|470615537|FG001|Overall Study|Other|1|||
130724273|NCT00856375|470615536|FG000|Overall Study|Death|32|||
130724274|NCT00856375|470615537|FG001|Overall Study|Death|30|||
130724275|NCT00856375|470615536|FG000|Overall Study|Sponsor Terminated Study|7|||
130724276|NCT00856375|470615537|FG001|Overall Study|Sponsor Terminated Study|7|||
130724277|NCT00856375|470615536|FG000|Overall Study|Withdrawal by Subject|2|||
130724278|NCT00856375|470615537|FG001|Overall Study|Withdrawal by Subject|1|||
130724279|NCT00856375|470615536|FG000|Overall Study|Lost to Follow-up|1|||
130724280|NCT00856375|470615537|FG001|Overall Study|Lost to Follow-up|2|||
130724281|NCT02121392|470615540|FG000|Prior to Intervention|Protocol Violation|40|||
130724282|NCT02121392|470615541|FG001|Prior to Intervention|Protocol Violation|35|||
130724283|NCT02121392|470615540|FG000|Prior to Intervention|Withdrawal by Subject|8|||
130724284|NCT02121392|470615541|FG001|Prior to Intervention|Withdrawal by Subject|6|||
130724285|NCT02121392|470615540|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
130724286|NCT02121392|470615541|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
130724287|NCT02121392|470615540|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
130724288|NCT02121392|470615541|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
130724289|NCT01352416|470615542|FG000|Overall Study|Physician Decision|1|||
130724290|NCT01352416|470615543|FG001|Overall Study|Physician Decision|2|||
130724291|NCT01352416|470615544|FG002|Overall Study|Physician Decision|2|||
130724292|NCT01352416|470615545|FG003|Overall Study|Physician Decision|1|||
131137972|NCT02222714|472132763|FG004|Overall Study|Withdrawal by Subject|1|||
131137973|NCT01285908|472132764|FG000|Baseline Measurement|unable to insert catheter|1|||
131137974|NCT01285908|472132765|FG001|Baseline Measurement|unable to insert catheter|0|||
131137975|NCT01285908|472132766|FG002|Baseline Measurement|unable to insert catheter|0|||
131137976|NCT01285908|472132764|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
131137977|NCT01285908|472132765|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
131137978|NCT01285908|472132766|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
131137979|NCT01285908|472132764|FG000|Baseline Measurement|unable to tolerate procedure|1|||
130724293|NCT00811928|470615556|FG000|Overall Study|AEs and SAEs Including Death|7|||
130724294|NCT00811928|470615557|FG001|Overall Study|AEs and SAEs Including Death|11|||
130724295|NCT00811928|470615556|FG000|Overall Study|Withdrawal by Subject|18|||
130724296|NCT00811928|470615557|FG001|Overall Study|Withdrawal by Subject|12|||
131137980|NCT01285908|472132765|FG001|Baseline Measurement|unable to tolerate procedure|0|||
130779592|NCT02326272|470819499|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
131137981|NCT01285908|472132766|FG002|Baseline Measurement|unable to tolerate procedure|0|||
131137982|NCT03529773|472132767|FG000|Overall Study|Adverse Event|0|||
130724297|NCT00811928|470615556|FG000|Overall Study|Did Not Take Study Drug|3|||
131072951|NCT00113269|471900939|FG000|Overall Study|Lost to Follow-up|2|||
131072952|NCT00113269|471900940|FG001|Overall Study|Lost to Follow-up|3|||
131072953|NCT00113269|471900941|FG002|Overall Study|Lost to Follow-up|6|||
131072954|NCT00113269|471900942|FG003|Overall Study|Lost to Follow-up|3|||
131072955|NCT00113269|471900939|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
131072956|NCT00113269|471900940|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
131072957|NCT00113269|471900941|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
131072958|NCT00113269|471900942|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
131072959|NCT00113269|471900939|FG000|Overall Study|Discontinued due to rejection|0|||
131072960|NCT00113269|471900940|FG001|Overall Study|Discontinued due to rejection|0|||
131072961|NCT00113269|471900941|FG002|Overall Study|Discontinued due to rejection|1|||
131072962|NCT00113269|471900942|FG003|Overall Study|Discontinued due to rejection|0|||
131072963|NCT00113269|471900939|FG000|Overall Study|Moved|0|||
131072964|NCT00113269|471900940|FG001|Overall Study|Moved|1|||
131072965|NCT00113269|471900941|FG002|Overall Study|Moved|0|||
131072966|NCT00113269|471900942|FG003|Overall Study|Moved|3|||
131072967|NCT00113269|471900939|FG000|Overall Study|Received pancreas transplant|0|||
131072968|NCT00113269|471900940|FG001|Overall Study|Received pancreas transplant|0|||
131072969|NCT00113269|471900941|FG002|Overall Study|Received pancreas transplant|0|||
131072970|NCT00113269|471900942|FG003|Overall Study|Received pancreas transplant|2|||
131072971|NCT00113269|471900939|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
131072972|NCT00113269|471900940|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
131072973|NCT00113269|471900941|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
131072974|NCT00113269|471900942|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
131072975|NCT00113269|471900939|FG000|Overall Study|Did not meet eligibility criteria|1|||
131072976|NCT00113269|471900940|FG001|Overall Study|Did not meet eligibility criteria|0|||
131072977|NCT00113269|471900941|FG002|Overall Study|Did not meet eligibility criteria|0|||
131072978|NCT00113269|471900942|FG003|Overall Study|Did not meet eligibility criteria|1|||
131072979|NCT00113269|471900939|FG000|Overall Study|Unable to return for follow up|2|||
131072980|NCT00113269|471900940|FG001|Overall Study|Unable to return for follow up|1|||
131072981|NCT00113269|471900941|FG002|Overall Study|Unable to return for follow up|0|||
131072982|NCT00113269|471900942|FG003|Overall Study|Unable to return for follow up|0|||
131072983|NCT01821729|471900943|FG000|Overall Study|Withdrawal by Subject|1|||
131072984|NCT01093599|471900946|FG000|Overall Study|Lost to Follow-up|32|||
131072985|NCT01093599|471900947|FG001|Overall Study|Lost to Follow-up|46|||
131072986|NCT01703845|471900948|FG000|Overall Study|Adverse Event|1|||
131072987|NCT01703845|471900949|FG001|Overall Study|Adverse Event|0|||
131072988|NCT01703845|471900948|FG000|Overall Study|Protocol Violation|1|||
131072989|NCT01703845|471900949|FG001|Overall Study|Protocol Violation|0|||
131072990|NCT01703845|471900948|FG000|Overall Study|other than stated above|1|||
131072991|NCT01703845|471900949|FG001|Overall Study|other than stated above|0|||
131072992|NCT01644188|471900950|FG000|Overall Study|Adverse Event|44|||
131072993|NCT01644188|471900951|FG001|Overall Study|Adverse Event|20|||
131072994|NCT01644188|471900950|FG000|Overall Study|Poor compliance to protocol|26|||
131072995|NCT01644188|471900951|FG001|Overall Study|Poor compliance to protocol|14|||
131072996|NCT01644188|471900950|FG000|Overall Study|Physician Decision|1|||
131072997|NCT01644188|471900951|FG001|Overall Study|Physician Decision|3|||
131072998|NCT01644188|471900950|FG000|Overall Study|Participant moved|7|||
131072999|NCT01644188|471900951|FG001|Overall Study|Participant moved|2|||
131073000|NCT01644188|471900950|FG000|Overall Study|Related to auto-injector administration|2|||
131073001|NCT01644188|471900951|FG001|Overall Study|Related to auto-injector administration|2|||
131073002|NCT01644188|471900950|FG000|Overall Study|Consent withdrawn by participant|14|||
131073003|NCT01644188|471900951|FG001|Overall Study|Consent withdrawn by participant|7|||
131073004|NCT01644188|471900950|FG000|Overall Study|Selection criteria finally not met|2|||
131073005|NCT01644188|471900951|FG001|Overall Study|Selection criteria finally not met|0|||
131073006|NCT01644188|471900950|FG000|Overall Study|Lost to Follow-up|1|||
131073007|NCT01644188|471900951|FG001|Overall Study|Lost to Follow-up|0|||
131073008|NCT01644188|471900950|FG000|Overall Study|Death|4|||
131073009|NCT01644188|471900951|FG001|Overall Study|Death|3|||
131073010|NCT01644188|471900950|FG000|Overall Study|Last visit outside protocol visit window|14|||
131073011|NCT01644188|471900951|FG001|Overall Study|Last visit outside protocol visit window|16|||
131073012|NCT01644188|471900950|FG000|Overall Study|Site closure|1|||
131073013|NCT01644188|471900951|FG001|Overall Study|Site closure|1|||
131073014|NCT01644188|471900950|FG000|Overall Study|Other than specified above|6|||
131073015|NCT01644188|471900951|FG001|Overall Study|Other than specified above|7|||
131073016|NCT00966979|471900955|FG000|Overall Study|Death|1|||
131073017|NCT00966979|471900955|FG000|Overall Study|Lost to Follow-up|6|||
131073018|NCT00966979|471900955|FG000|Overall Study|Withdrawal by Subject|14|||
131073019|NCT00966979|471900955|FG000|Overall Study|Adverse Event|5|||
131073020|NCT00966979|471900955|FG000|Overall Study|Sponsor terminated early|49|||
131073021|NCT00966979|471900955|FG000|Overall Study|Censored because surgery not done|2|||
131231110|NCT01806597|472473235|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
130724298|NCT00811928|470615557|FG001|Overall Study|Did Not Take Study Drug|0|||
131073022|NCT00966979|471900955|FG000|Overall Study|Censored because study device was not implanted|14|||
131073023|NCT00966979|471900955|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
131073024|NCT04140266|471900956|FG000|Overall Study|Physician Decision|2|||
131073025|NCT04140266|471900957|FG001|Overall Study|Physician Decision|0|||
131073026|NCT04140266|471900956|FG000|Overall Study|Withdrawal by Subject|4|||
131073027|NCT04140266|471900957|FG001|Overall Study|Withdrawal by Subject|2|||
131073028|NCT03119688|471900961|FG000|Overall Study|Adverse Event|4|||
131073029|NCT01649557|471900962|FG000|Overall Study|Lost to Follow-up|5|||
131073030|NCT01649557|471900963|FG001|Overall Study|Lost to Follow-up|0|||
131073031|NCT01649557|471900964|FG002|Overall Study|Lost to Follow-up|3|||
131073032|NCT01649557|471900962|FG000|Overall Study|Adverse Event|7|||
131073033|NCT01649557|471900963|FG001|Overall Study|Adverse Event|5|||
131073034|NCT01649557|471900964|FG002|Overall Study|Adverse Event|1|||
131073035|NCT01649557|471900962|FG000|Overall Study|Met withdrawal criteria|4|||
131073036|NCT01649557|471900963|FG001|Overall Study|Met withdrawal criteria|0|||
131073037|NCT01649557|471900964|FG002|Overall Study|Met withdrawal criteria|0|||
131073038|NCT01649557|471900962|FG000|Overall Study|Physician Decision|8|||
131073039|NCT01649557|471900963|FG001|Overall Study|Physician Decision|2|||
131073040|NCT01649557|471900964|FG002|Overall Study|Physician Decision|1|||
131073041|NCT01649557|471900962|FG000|Overall Study|Withdrawal by Subject|15|||
131073042|NCT01649557|471900963|FG001|Overall Study|Withdrawal by Subject|5|||
131073043|NCT01649557|471900964|FG002|Overall Study|Withdrawal by Subject|4|||
131073044|NCT01649557|471900962|FG000|Overall Study|Protocol deviation|0|||
131073045|NCT01649557|471900963|FG001|Overall Study|Protocol deviation|2|||
131073046|NCT01649557|471900964|FG002|Overall Study|Protocol deviation|0|||
131073047|NCT01649557|471900962|FG000|Overall Study|Lack of Efficacy|5|||
131137983|NCT03529773|472132768|FG001|Overall Study|Adverse Event|0|||
131137984|NCT03529773|472132769|FG002|Overall Study|Adverse Event|0|||
131137985|NCT03529773|472132770|FG003|Overall Study|Adverse Event|0|||
131137986|NCT03529773|472132771|FG004|Overall Study|Adverse Event|0|||
131137987|NCT03529773|472132772|FG005|Overall Study|Adverse Event|0|||
131137988|NCT03529773|472132773|FG006|Overall Study|Adverse Event|0|||
131137989|NCT03529773|472132774|FG007|Overall Study|Adverse Event|0|||
131137990|NCT03529773|472132775|FG008|Overall Study|Adverse Event|0|||
131073048|NCT01649557|471900963|FG001|Overall Study|Lack of Efficacy|0|||
131073049|NCT01649557|471900964|FG002|Overall Study|Lack of Efficacy|0|||
131073050|NCT03029234|471900967|FG000|Overall Study|Sponsor Decision|1|||
131073051|NCT03029234|471900967|FG000|Overall Study|Withdrawal by Subject|5|||
131073052|NCT03029234|471900967|FG000|Overall Study|Death|91|||
131073053|NCT03029234|471900967|FG000|Overall Study|Lost to Follow-up|2|||
131073054|NCT01649297|471900968|FG000|Overall Study|Adverse Event|5|||
131073055|NCT01649297|471900969|FG001|Overall Study|Adverse Event|5|||
131073056|NCT01649297|471900970|FG002|Overall Study|Adverse Event|4|||
131073057|NCT01649297|471900971|FG003|Overall Study|Adverse Event|13|||
131073058|NCT01649297|471900972|FG004|Overall Study|Adverse Event|1|||
131073059|NCT01649297|471900968|FG000|Overall Study|Lack of Efficacy|0|||
131073060|NCT01649297|471900969|FG001|Overall Study|Lack of Efficacy|0|||
131073061|NCT01649297|471900970|FG002|Overall Study|Lack of Efficacy|0|||
131073062|NCT01649297|471900971|FG003|Overall Study|Lack of Efficacy|0|||
131073063|NCT01649297|471900972|FG004|Overall Study|Lack of Efficacy|1|||
131073064|NCT01649297|471900968|FG000|Overall Study|Non compliant with Protocol|1|||
131073065|NCT01649297|471900969|FG001|Overall Study|Non compliant with Protocol|0|||
131073066|NCT01649297|471900970|FG002|Overall Study|Non compliant with Protocol|3|||
131073067|NCT01649297|471900971|FG003|Overall Study|Non compliant with Protocol|2|||
131073068|NCT01649297|471900972|FG004|Overall Study|Non compliant with Protocol|1|||
131073069|NCT01649297|471900968|FG000|Overall Study|Lost to Follow-up|1|||
131073070|NCT01649297|471900969|FG001|Overall Study|Lost to Follow-up|1|||
131073071|NCT01649297|471900970|FG002|Overall Study|Lost to Follow-up|4|||
131073072|NCT01649297|471900971|FG003|Overall Study|Lost to Follow-up|3|||
131073073|NCT01649297|471900972|FG004|Overall Study|Lost to Follow-up|0|||
131073074|NCT01649297|471900968|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
131073075|NCT01649297|471900969|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
131073076|NCT01649297|471900970|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
131073077|NCT01649297|471900971|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
131073078|NCT01649297|471900972|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
131073079|NCT01649297|471900968|FG000|Overall Study|For other reason|4|||
131073080|NCT01649297|471900969|FG001|Overall Study|For other reason|1|||
131073081|NCT01649297|471900970|FG002|Overall Study|For other reason|2|||
131073082|NCT01649297|471900971|FG003|Overall Study|For other reason|0|||
131137991|NCT03529773|472132776|FG009|Overall Study|Adverse Event|0|||
131137992|NCT03529773|472132777|FG010|Overall Study|Adverse Event|0|||
130724299|NCT00811928|470615556|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
131073083|NCT01649297|471900972|FG004|Overall Study|For other reason|0|||
131073084|NCT01685047|471900973|FG000|Overall Study|Withdrawal by Subject|20|||
131137993|NCT03529773|472132778|FG011|Overall Study|Adverse Event|0|||
131137994|NCT03529773|472132779|FG012|Overall Study|Adverse Event|0|||
131073085|NCT01685047|471900973|FG000|Overall Study|Death|26|||
131073086|NCT01685047|471900973|FG000|Overall Study|Lost to Follow-up|8|||
131073087|NCT01685047|471900973|FG000|Overall Study|Physician Decision|25|||
131073088|NCT01685047|471900973|FG000|Overall Study|Adverse Event|5|||
131073089|NCT01685047|471900973|FG000|Overall Study|patient withdrawn by sponsor|1|||
131073090|NCT02544113|471900974|FG000|Overall Study|Death|3|||
131073091|NCT02544113|471900975|FG001|Overall Study|Death|4|||
131073092|NCT02847637|471900977|FG000|Overall Study|Withdrawal by Subject|0|||
131073093|NCT02847637|471900978|FG001|Overall Study|Withdrawal by Subject|1|||
131073094|NCT02847637|471900979|FG002|Overall Study|Withdrawal by Subject|1|||
131073095|NCT02847637|471900980|FG003|Overall Study|Withdrawal by Subject|0|||
131073096|NCT02847637|471900977|FG000|Overall Study|Lost to Follow-up|1|||
130724300|NCT00811928|470615557|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
130724301|NCT00811928|470615556|FG000|Overall Study|Investigator Decision|2|||
130724302|NCT00811928|470615557|FG001|Overall Study|Investigator Decision|1|||
130724303|NCT00811928|470615556|FG000|Overall Study|Poor Compliance|2|||
130724304|NCT00811928|470615557|FG001|Overall Study|Poor Compliance|5|||
130724305|NCT00171951|470615558|FG000|Overall Study|Adverse Event|1|||
130724306|NCT00171951|470615558|FG000|Overall Study|Abnormal Laboratory Values|2|||
131137995|NCT03529773|472132780|FG013|Overall Study|Adverse Event|0|||
131137996|NCT03529773|472132781|FG014|Overall Study|Adverse Event|0|||
131137997|NCT03529773|472132782|FG015|Overall Study|Adverse Event|0|||
131137998|NCT03529773|472132783|FG016|Overall Study|Adverse Event|0|||
130724307|NCT00171951|470615558|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130724308|NCT00171951|470615558|FG000|Overall Study|Participants Withdrew Consent|3|||
130724309|NCT00171951|470615558|FG000|Overall Study|New Cancer Therapy|5|||
130724310|NCT00171951|470615558|FG000|Overall Study|Reason not Specified|2|||
130724311|NCT00396812|470615559|FG000|Overall Study|Physician Decision|1|||
130724312|NCT00843635|470615568|FG000|Overall Study|Adverse Event|2|||
130724313|NCT00843635|470615569|FG001|Overall Study|Adverse Event|2|||
130724314|NCT00843635|470615570|FG002|Overall Study|Adverse Event|0|||
130724315|NCT03496610|470615571|FG000|Overall Study|Lost to Follow-up|3|||
130724316|NCT03496610|470615572|FG001|Overall Study|Lost to Follow-up|2|||
130724317|NCT03496610|470615571|FG000|Overall Study|Physician Decision|1|||
130724318|NCT03496610|470615572|FG001|Overall Study|Physician Decision|0|||
130724319|NCT03496610|470615571|FG000|Overall Study|Withdrawal by Subject|1|||
130724320|NCT03496610|470615572|FG001|Overall Study|Withdrawal by Subject|0|||
130724321|NCT02714426|470615576|FG000|Overall Study|Withdrawal by Subject|2|||
130724322|NCT02714426|470615577|FG001|Overall Study|Withdrawal by Subject|2|||
130724323|NCT04435184|470615578|FG000|Overall Study|follow-up blood draws missing|3|||
130724324|NCT04435184|470615579|FG001|Overall Study|follow-up blood draws missing|5|||
130724325|NCT00813800|470615583|FG000|Overall Study|Screen Failure after Consent|2|||
131073097|NCT02847637|471900978|FG001|Overall Study|Lost to Follow-up|1|||
130724326|NCT00813800|470615583|FG000|Overall Study|Adverse Event|1|||
130724327|NCT00813800|470615583|FG000|Overall Study|Worsening of depression|2|||
130724328|NCT00813800|470615583|FG000|Overall Study|Physician Decision|1|||
130724329|NCT03456453|470615584|FG000|Overall Study|Withdrawal by Subject|2|||
130724330|NCT03456453|470615585|FG001|Overall Study|Withdrawal by Subject|0|||
130724331|NCT03456453|470615584|FG000|Overall Study|Not released to community|1|||
130724332|NCT03456453|470615585|FG001|Overall Study|Not released to community|5|||
130724333|NCT03456453|470615584|FG000|Overall Study|Lost to Follow-up|0|||
130724334|NCT03456453|470615585|FG001|Overall Study|Lost to Follow-up|2|||
131073098|NCT02847637|471900979|FG002|Overall Study|Lost to Follow-up|0|||
131073099|NCT02847637|471900980|FG003|Overall Study|Lost to Follow-up|0|||
131073100|NCT01746108|471900983|FG000|Overall Study|Migrated /moved from study area|0|||
131073101|NCT01746108|471900984|FG001|Overall Study|Migrated /moved from study area|1|||
131073102|NCT01746108|471900985|FG002|Overall Study|Migrated /moved from study area|0|||
131073103|NCT01746108|471900983|FG000|Overall Study|Adverse event, non-fatal|0|||
131073104|NCT01746108|471900984|FG001|Overall Study|Adverse event, non-fatal|1|||
131073105|NCT01746108|471900985|FG002|Overall Study|Adverse event, non-fatal|0|||
131073106|NCT01746108|471900983|FG000|Overall Study|Withdrawal by Subject|0|||
131137999|NCT03529773|472132784|FG017|Overall Study|Adverse Event|0|||
131138000|NCT03529773|472132785|FG018|Overall Study|Adverse Event|0|||
131138001|NCT03529773|472132786|FG019|Overall Study|Adverse Event|0|||
131138002|NCT03529773|472132787|FG020|Overall Study|Adverse Event|0|||
131073107|NCT01746108|471900984|FG001|Overall Study|Withdrawal by Subject|1|||
131138003|NCT03529773|472132788|FG021|Overall Study|Adverse Event|0|||
131138004|NCT03529773|472132789|FG022|Overall Study|Adverse Event|0|||
130724341|NCT01860677|470615588|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
130724342|NCT01860677|470615589|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
131073108|NCT01746108|471900985|FG002|Overall Study|Withdrawal by Subject|0|||
131138005|NCT03529773|472132790|FG023|Overall Study|Adverse Event|0|||
131073109|NCT01746108|471900983|FG000|Overall Study|Lost to Follow-up|0|||
131073110|NCT01746108|471900984|FG001|Overall Study|Lost to Follow-up|1|||
131073111|NCT01746108|471900985|FG002|Overall Study|Lost to Follow-up|0|||
131073112|NCT00053352|471900995|FG000|Overall Study|Lost to Follow-up|0|||
131073113|NCT00053352|471900996|FG001|Overall Study|Lost to Follow-up|1|||
131073114|NCT00053352|471900995|FG000|Overall Study|Physician Decision|11|||
131073115|NCT00053352|471900996|FG001|Overall Study|Physician Decision|1|||
131073116|NCT00053352|471900995|FG000|Overall Study|Withdrawal by Subject|1|||
131073117|NCT00053352|471900996|FG001|Overall Study|Withdrawal by Subject|0|||
131073118|NCT00053352|471900995|FG000|Overall Study|Ineligible|8|||
131073119|NCT00053352|471900996|FG001|Overall Study|Ineligible|8|||
131073120|NCT00053352|471900995|FG000|Overall Study|Disease at new site|1|||
131073121|NCT00053352|471900996|FG001|Overall Study|Disease at new site|0|||
131073122|NCT01388478|471900997|FG000|Overall Study|Adverse Event|4|||
131073123|NCT01388478|471900997|FG000|Overall Study|Withdrawal by Subject|1|||
131073124|NCT01990664|471900998|FG000|Overall Study|Lost to Follow-up|2|||
131073125|NCT01990664|471900999|FG001|Overall Study|Lost to Follow-up|6|||
131073126|NCT01990664|471900998|FG000|Overall Study|Withdrawal by Subject|2|||
131073127|NCT01990664|471900999|FG001|Overall Study|Withdrawal by Subject|3|||
131073128|NCT01990664|471900998|FG000|Overall Study|Protocol Violation|1|||
131073129|NCT01990664|471900999|FG001|Overall Study|Protocol Violation|0|||
131073130|NCT01990664|471900998|FG000|Overall Study|Lens Discomfort|1|||
131073131|NCT01990664|471900999|FG001|Overall Study|Lens Discomfort|1|||
131073132|NCT01990664|471900998|FG000|Overall Study|Lens Handling Difficulties|1|||
131073133|NCT01990664|471900999|FG001|Overall Study|Lens Handling Difficulties|0|||
131073134|NCT01990664|471900998|FG000|Overall Study|Unsatisfactory Visual Response|0|||
131073135|NCT01990664|471900999|FG001|Overall Study|Unsatisfactory Visual Response|1|||
131073136|NCT00931918|471901000|FG000|Overall Study|Adverse Event|4|||
131073137|NCT00931918|471901001|FG001|Overall Study|Adverse Event|6|||
131073138|NCT00931918|471901000|FG000|Overall Study|Progressive Disease|2|||
131073139|NCT00931918|471901001|FG001|Overall Study|Progressive Disease|1|||
131073140|NCT00931918|471901000|FG000|Overall Study|Symptomatic Deterioration|1|||
131073141|NCT00931918|471901001|FG001|Overall Study|Symptomatic Deterioration|0|||
131073142|NCT00931918|471901000|FG000|Overall Study|Withdrawal by Patient|3|||
131073143|NCT00931918|471901001|FG001|Overall Study|Withdrawal by Patient|4|||
131073144|NCT00931918|471901000|FG000|Overall Study|Other Reason not Specified|4|||
131073145|NCT00931918|471901001|FG001|Overall Study|Other Reason not Specified|4|||
131073146|NCT00931918|471901000|FG000|Overall Study|Did not receive study drug|3|||
131073147|NCT00931918|471901001|FG001|Overall Study|Did not receive study drug|2|||
131073148|NCT00570921|471901002|FG000|Overall Study|Protocol Violation|1|||
131073149|NCT00570921|471901002|FG000|Overall Study|Physician Decision|1|||
131073150|NCT02246218|471901004|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131073151|NCT02246218|471901005|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131073152|NCT02246218|471901004|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
131073153|NCT02246218|471901005|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
131073154|NCT02246218|471901004|FG000|Overall Study|Adverse Event|1|||
131073155|NCT02246218|471901005|FG001|Overall Study|Adverse Event|1|||
131073156|NCT02246218|471901004|FG000|Overall Study|Lost to Follow-up|1|||
131073157|NCT02246218|471901005|FG001|Overall Study|Lost to Follow-up|0|||
131073158|NCT03891641|471901006|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
131073159|NCT03891641|471901007|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
131073160|NCT00784277|471901008|FG000|IR Treatment|Adverse Event|4|||
131073161|NCT00784277|471901009|FG001|IR Treatment|Adverse Event|8|||
131073162|NCT00784277|471901010|FG002|IR Treatment|Adverse Event|19|||
131073163|NCT00784277|471901011|FG003|IR Treatment|Adverse Event|35|||
131073164|NCT00784277|471901012|FG004|IR Treatment|Adverse Event|0|||
131073165|NCT00784277|471901013|FG005|IR Treatment|Adverse Event|0|||
131073166|NCT00784277|471901014|FG006|IR Treatment|Adverse Event|0|||
131073167|NCT00784277|471901008|FG000|IR Treatment|Lack of Efficacy|4|||
131073168|NCT00784277|471901009|FG001|IR Treatment|Lack of Efficacy|4|||
131073169|NCT00784277|471901010|FG002|IR Treatment|Lack of Efficacy|1|||
131073170|NCT00784277|471901011|FG003|IR Treatment|Lack of Efficacy|0|||
131073171|NCT00784277|471901012|FG004|IR Treatment|Lack of Efficacy|0|||
131138006|NCT03529773|472132791|FG024|Overall Study|Adverse Event|0|||
131138007|NCT03529773|472132792|FG025|Overall Study|Adverse Event|0|||
131138008|NCT03529773|472132793|FG026|Overall Study|Adverse Event|0|||
131073172|NCT00784277|471901013|FG005|IR Treatment|Lack of Efficacy|0|||
131073173|NCT00784277|471901014|FG006|IR Treatment|Lack of Efficacy|0|||
131073174|NCT00784277|471901008|FG000|IR Treatment|Lost to Follow-up|1|||
131073175|NCT00784277|471901009|FG001|IR Treatment|Lost to Follow-up|0|||
131073176|NCT00784277|471901010|FG002|IR Treatment|Lost to Follow-up|1|||
131073177|NCT00784277|471901011|FG003|IR Treatment|Lost to Follow-up|0|||
131073178|NCT00784277|471901012|FG004|IR Treatment|Lost to Follow-up|0|||
131073179|NCT00784277|471901013|FG005|IR Treatment|Lost to Follow-up|0|||
131073180|NCT00784277|471901014|FG006|IR Treatment|Lost to Follow-up|0|||
131073181|NCT00784277|471901008|FG000|IR Treatment|Withdrawal by Subject|5|||
131073182|NCT00784277|471901009|FG001|IR Treatment|Withdrawal by Subject|1|||
131073183|NCT00784277|471901010|FG002|IR Treatment|Withdrawal by Subject|4|||
131073184|NCT00784277|471901011|FG003|IR Treatment|Withdrawal by Subject|6|||
131138009|NCT03529773|472132794|FG027|Overall Study|Adverse Event|0|||
130779593|NCT02326272|470819500|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
130779594|NCT02326272|470819501|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
130779595|NCT02326272|470819502|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
130779596|NCT02326272|470819503|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
130779597|NCT02326272|470819504|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
130779598|NCT02326272|470819490|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779599|NCT02326272|470819491|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779600|NCT02326272|470819492|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779601|NCT02326272|470819493|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779602|NCT02326272|470819494|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779603|NCT02326272|470819495|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779604|NCT02326272|470819496|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779605|NCT02326272|470819497|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779606|NCT02326272|470819498|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779607|NCT02326272|470819499|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779608|NCT02326272|470819500|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
130779609|NCT02326272|470819501|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
130779610|NCT02326272|470819502|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
130779611|NCT02326272|470819503|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130779612|NCT02326272|470819504|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
130779613|NCT02326272|470819490|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779614|NCT02326272|470819491|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779615|NCT02326272|470819492|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779616|NCT02326272|470819493|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779617|NCT02326272|470819494|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779618|NCT02326272|470819495|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779619|NCT02326272|470819496|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779620|NCT02326272|470819497|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779621|NCT02326272|470819498|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779622|NCT02326272|470819499|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779623|NCT02326272|470819500|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130779624|NCT02326272|470819501|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779625|NCT02326272|470819502|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130779626|NCT02326272|470819503|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779627|NCT02326272|470819504|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130779628|NCT02326272|470819490|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779629|NCT02326272|470819491|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779630|NCT02326272|470819492|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779631|NCT02326272|470819493|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779632|NCT02326272|470819494|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779633|NCT02326272|470819495|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779634|NCT02326272|470819496|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779635|NCT02326272|470819497|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779636|NCT02326272|470819498|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779637|NCT02326272|470819499|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779638|NCT02326272|470819500|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779639|NCT02326272|470819501|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
130779640|NCT02326272|470819502|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779641|NCT02326272|470819503|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779642|NCT02326272|470819504|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130779643|NCT02326272|470819490|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130779644|NCT02326272|470819491|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130779645|NCT02326272|470819492|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130779646|NCT02326272|470819493|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131073185|NCT00784277|471901012|FG004|IR Treatment|Withdrawal by Subject|0|||
131073186|NCT00784277|471901013|FG005|IR Treatment|Withdrawal by Subject|0|||
131073187|NCT00784277|471901014|FG006|IR Treatment|Withdrawal by Subject|0|||
131073188|NCT00784277|471901008|FG000|IR Treatment|Resolution Of Pain|0|||
131073189|NCT00784277|471901009|FG001|IR Treatment|Resolution Of Pain|1|||
131073190|NCT00784277|471901010|FG002|IR Treatment|Resolution Of Pain|0|||
131073191|NCT00784277|471901011|FG003|IR Treatment|Resolution Of Pain|0|||
131073192|NCT00784277|471901012|FG004|IR Treatment|Resolution Of Pain|0|||
131073193|NCT00784277|471901013|FG005|IR Treatment|Resolution Of Pain|0|||
131073194|NCT00784277|471901014|FG006|IR Treatment|Resolution Of Pain|0|||
131073195|NCT00784277|471901008|FG000|IR Treatment|Other|2|||
131073196|NCT00784277|471901009|FG001|IR Treatment|Other|3|||
131073197|NCT00784277|471901010|FG002|IR Treatment|Other|3|||
131073198|NCT00784277|471901011|FG003|IR Treatment|Other|2|||
130724343|NCT00896480|470615590|FG000|Overall Study|Disease progression/recurrence|21|||
130724344|NCT00642278|470615591|FG000|Overall Study|Adverse Event|2|||
130724345|NCT00642278|470615592|FG001|Overall Study|Adverse Event|1|||
130724346|NCT00642278|470615593|FG002|Overall Study|Adverse Event|3|||
130724347|NCT00642278|470615594|FG003|Overall Study|Adverse Event|1|||
130724348|NCT00642278|470615595|FG004|Overall Study|Adverse Event|2|||
130724349|NCT00642278|470615596|FG005|Overall Study|Adverse Event|2|||
130724350|NCT00642278|470615597|FG006|Overall Study|Adverse Event|0|||
130724351|NCT00642278|470615591|FG000|Overall Study|Lack of Efficacy|0|||
130724352|NCT00642278|470615592|FG001|Overall Study|Lack of Efficacy|1|||
130724353|NCT00642278|470615593|FG002|Overall Study|Lack of Efficacy|0|||
130724354|NCT00642278|470615594|FG003|Overall Study|Lack of Efficacy|0|||
130724355|NCT00642278|470615595|FG004|Overall Study|Lack of Efficacy|0|||
130724356|NCT00642278|470615596|FG005|Overall Study|Lack of Efficacy|0|||
130724357|NCT00642278|470615597|FG006|Overall Study|Lack of Efficacy|0|||
130724358|NCT00642278|470615591|FG000|Overall Study|Lost to Follow-up|5|||
130724359|NCT00642278|470615592|FG001|Overall Study|Lost to Follow-up|1|||
130724360|NCT00642278|470615593|FG002|Overall Study|Lost to Follow-up|0|||
130724361|NCT00642278|470615594|FG003|Overall Study|Lost to Follow-up|1|||
130724362|NCT00642278|470615595|FG004|Overall Study|Lost to Follow-up|0|||
130724363|NCT00642278|470615596|FG005|Overall Study|Lost to Follow-up|1|||
130724364|NCT00642278|470615597|FG006|Overall Study|Lost to Follow-up|1|||
130724365|NCT00642278|470615591|FG000|Overall Study|Physician Decision|0|||
130724366|NCT00642278|470615592|FG001|Overall Study|Physician Decision|0|||
130724367|NCT00642278|470615593|FG002|Overall Study|Physician Decision|0|||
130724368|NCT00642278|470615594|FG003|Overall Study|Physician Decision|1|||
130724369|NCT00642278|470615595|FG004|Overall Study|Physician Decision|0|||
130724370|NCT00642278|470615596|FG005|Overall Study|Physician Decision|0|||
130724371|NCT00642278|470615597|FG006|Overall Study|Physician Decision|0|||
130724372|NCT00642278|470615591|FG000|Overall Study|Protocol Violation|0|||
130724373|NCT00642278|470615592|FG001|Overall Study|Protocol Violation|0|||
130724374|NCT00642278|470615593|FG002|Overall Study|Protocol Violation|1|||
130724375|NCT00642278|470615594|FG003|Overall Study|Protocol Violation|1|||
130724376|NCT00642278|470615595|FG004|Overall Study|Protocol Violation|0|||
130724377|NCT00642278|470615596|FG005|Overall Study|Protocol Violation|1|||
130724378|NCT00642278|470615597|FG006|Overall Study|Protocol Violation|2|||
131073199|NCT00784277|471901012|FG004|IR Treatment|Other|0|||
131073200|NCT00784277|471901013|FG005|IR Treatment|Other|0|||
131073201|NCT00784277|471901014|FG006|IR Treatment|Other|0|||
131073202|NCT00784277|471901008|FG000|ER Treatment|Adverse Event|0|||
131073203|NCT00784277|471901009|FG001|ER Treatment|Adverse Event|0|||
131073204|NCT00784277|471901010|FG002|ER Treatment|Adverse Event|0|||
131073205|NCT00784277|471901011|FG003|ER Treatment|Adverse Event|0|||
131073206|NCT00784277|471901012|FG004|ER Treatment|Adverse Event|1|||
131073207|NCT00784277|471901013|FG005|ER Treatment|Adverse Event|7|||
131073208|NCT00784277|471901014|FG006|ER Treatment|Adverse Event|7|||
131073209|NCT00784277|471901008|FG000|ER Treatment|Lack of Efficacy|0|||
131073210|NCT00784277|471901009|FG001|ER Treatment|Lack of Efficacy|0|||
131073211|NCT00784277|471901010|FG002|ER Treatment|Lack of Efficacy|0|||
131073212|NCT00784277|471901011|FG003|ER Treatment|Lack of Efficacy|0|||
131073213|NCT00784277|471901012|FG004|ER Treatment|Lack of Efficacy|3|||
131073214|NCT00784277|471901013|FG005|ER Treatment|Lack of Efficacy|4|||
131073215|NCT00784277|471901014|FG006|ER Treatment|Lack of Efficacy|0|||
131073216|NCT00784277|471901008|FG000|ER Treatment|Lost to Follow-up|0|||
131073217|NCT00784277|471901009|FG001|ER Treatment|Lost to Follow-up|0|||
131073218|NCT00784277|471901010|FG002|ER Treatment|Lost to Follow-up|0|||
131073219|NCT00784277|471901011|FG003|ER Treatment|Lost to Follow-up|0|||
131073220|NCT00784277|471901012|FG004|ER Treatment|Lost to Follow-up|0|||
131073221|NCT00784277|471901013|FG005|ER Treatment|Lost to Follow-up|2|||
131073222|NCT00784277|471901014|FG006|ER Treatment|Lost to Follow-up|0|||
130724379|NCT00642278|470615591|FG000|Overall Study|Withdrawal by Subject|1|||
130724380|NCT00642278|470615592|FG001|Overall Study|Withdrawal by Subject|1|||
130724381|NCT00642278|470615593|FG002|Overall Study|Withdrawal by Subject|1|||
130724382|NCT00642278|470615594|FG003|Overall Study|Withdrawal by Subject|3|||
131073223|NCT00784277|471901008|FG000|ER Treatment|Withdrawal by Subject|0|||
130724383|NCT00642278|470615595|FG004|Overall Study|Withdrawal by Subject|6|||
130724384|NCT00642278|470615596|FG005|Overall Study|Withdrawal by Subject|2|||
130724385|NCT00642278|470615597|FG006|Overall Study|Withdrawal by Subject|2|||
130724386|NCT00642278|470615591|FG000|Overall Study|Noncompliance with study drug regimen|0|||
130724387|NCT00642278|470615592|FG001|Overall Study|Noncompliance with study drug regimen|0|||
130724388|NCT00642278|470615593|FG002|Overall Study|Noncompliance with study drug regimen|0|||
131073224|NCT00784277|471901009|FG001|ER Treatment|Withdrawal by Subject|0|||
131073225|NCT00784277|471901010|FG002|ER Treatment|Withdrawal by Subject|0|||
131073226|NCT00784277|471901011|FG003|ER Treatment|Withdrawal by Subject|0|||
130724389|NCT00642278|470615594|FG003|Overall Study|Noncompliance with study drug regimen|1|||
130724390|NCT00642278|470615595|FG004|Overall Study|Noncompliance with study drug regimen|0|||
131073227|NCT00784277|471901012|FG004|ER Treatment|Withdrawal by Subject|2|||
131073228|NCT00784277|471901013|FG005|ER Treatment|Withdrawal by Subject|5|||
131073229|NCT00784277|471901014|FG006|ER Treatment|Withdrawal by Subject|3|||
130724391|NCT00642278|470615596|FG005|Overall Study|Noncompliance with study drug regimen|0|||
130724392|NCT00642278|470615597|FG006|Overall Study|Noncompliance with study drug regimen|0|||
130724393|NCT00642278|470615591|FG000|Overall Study|Other|2|||
130724394|NCT00642278|470615592|FG001|Overall Study|Other|1|||
130724395|NCT00642278|470615593|FG002|Overall Study|Other|0|||
130724396|NCT00642278|470615594|FG003|Overall Study|Other|1|||
130724397|NCT00642278|470615595|FG004|Overall Study|Other|0|||
130724398|NCT00642278|470615596|FG005|Overall Study|Other|1|||
130724399|NCT00642278|470615597|FG006|Overall Study|Other|0|||
130724400|NCT00090363|470615598|FG000|Overall Study|Lost to Follow-up|1|||
130724401|NCT00090363|470615599|FG001|Overall Study|Lost to Follow-up|2|||
130724402|NCT00090363|470615600|FG002|Overall Study|Lost to Follow-up|1|||
130724403|NCT00090363|470615598|FG000|Overall Study|Withdrawal by Subject|7|||
130724404|NCT00090363|470615599|FG001|Overall Study|Withdrawal by Subject|7|||
130724405|NCT00090363|470615600|FG002|Overall Study|Withdrawal by Subject|6|||
130724406|NCT00090363|470615598|FG000|Overall Study|Study-specific discontinuation criteria|75|||
130724407|NCT00090363|470615599|FG001|Overall Study|Study-specific discontinuation criteria|74|||
131073230|NCT00784277|471901008|FG000|ER Treatment|Study Medication Non-Compliant|0|||
131073231|NCT00784277|471901009|FG001|ER Treatment|Study Medication Non-Compliant|0|||
131073232|NCT00784277|471901010|FG002|ER Treatment|Study Medication Non-Compliant|0|||
131073233|NCT00784277|471901011|FG003|ER Treatment|Study Medication Non-Compliant|0|||
131073234|NCT00784277|471901012|FG004|ER Treatment|Study Medication Non-Compliant|2|||
131073235|NCT00784277|471901013|FG005|ER Treatment|Study Medication Non-Compliant|3|||
131073236|NCT00784277|471901014|FG006|ER Treatment|Study Medication Non-Compliant|3|||
131073237|NCT00784277|471901008|FG000|ER Treatment|Other|0|||
131073238|NCT00784277|471901009|FG001|ER Treatment|Other|0|||
131073239|NCT00784277|471901010|FG002|ER Treatment|Other|0|||
131073240|NCT00784277|471901011|FG003|ER Treatment|Other|0|||
131073241|NCT00784277|471901012|FG004|ER Treatment|Other|1|||
131073242|NCT00784277|471901013|FG005|ER Treatment|Other|3|||
131073243|NCT00784277|471901014|FG006|ER Treatment|Other|2|||
131073244|NCT00745121|471901018|FG000|Overall Study|Death|3|||
131073245|NCT00745121|471901019|FG001|Overall Study|Death|0|||
131073246|NCT00745121|471901018|FG000|Overall Study|Adverse Event|1|||
131073247|NCT00745121|471901019|FG001|Overall Study|Adverse Event|0|||
131073248|NCT00745121|471901018|FG000|Overall Study|Lost to Follow-up|1|||
131073249|NCT00745121|471901019|FG001|Overall Study|Lost to Follow-up|0|||
131073250|NCT00745121|471901018|FG000|Overall Study|Withdrawal by Subject|4|||
131073251|NCT00745121|471901019|FG001|Overall Study|Withdrawal by Subject|2|||
131073252|NCT01713998|471901021|FG000|Overall Study|Lost to Follow-up|2|||
131073253|NCT01713998|471901022|FG001|Overall Study|Lost to Follow-up|0|||
131073254|NCT01713998|471901023|FG002|Overall Study|Lost to Follow-up|2|||
131073255|NCT01713998|471901021|FG000|Overall Study|Withdrawal by Subject|1|||
131073256|NCT01713998|471901022|FG001|Overall Study|Withdrawal by Subject|0|||
131073257|NCT01713998|471901023|FG002|Overall Study|Withdrawal by Subject|0|||
131073258|NCT02101268|471901024|FG000|Randomized Treatment Phase|Subject Decision|8|||
131073259|NCT02101268|471901025|FG001|Randomized Treatment Phase|Subject Decision|4|||
131073260|NCT02101268|471901026|FG002|Randomized Treatment Phase|Subject Decision|0|||
131073261|NCT02101268|471901027|FG003|Randomized Treatment Phase|Subject Decision|0|||
131073262|NCT02101268|471901024|FG000|Randomized Treatment Phase|Physician Decision|4|||
131073263|NCT02101268|471901025|FG001|Randomized Treatment Phase|Physician Decision|1|||
131073264|NCT02101268|471901026|FG002|Randomized Treatment Phase|Physician Decision|0|||
131073265|NCT02101268|471901027|FG003|Randomized Treatment Phase|Physician Decision|0|||
131073266|NCT02101268|471901024|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
131073267|NCT02101268|471901025|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
131073268|NCT02101268|471901026|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
131073269|NCT02101268|471901027|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
131073270|NCT02101268|471901024|FG000|Randomized Treatment Phase|Adverse Event|6|||
131073271|NCT02101268|471901025|FG001|Randomized Treatment Phase|Adverse Event|0|||
131073272|NCT02101268|471901026|FG002|Randomized Treatment Phase|Adverse Event|0|||
131073273|NCT02101268|471901027|FG003|Randomized Treatment Phase|Adverse Event|0|||
131073274|NCT02101268|471901024|FG000|Randomized Treatment Phase|Death|5|||
131073275|NCT02101268|471901025|FG001|Randomized Treatment Phase|Death|4|||
131073276|NCT02101268|471901026|FG002|Randomized Treatment Phase|Death|0|||
131073277|NCT02101268|471901027|FG003|Randomized Treatment Phase|Death|0|||
131073278|NCT02101268|471901024|FG000|Randomized Treatment Phase|Disease Progression|4|||
131073279|NCT02101268|471901025|FG001|Randomized Treatment Phase|Disease Progression|1|||
131138010|NCT03529773|472132795|FG028|Overall Study|Adverse Event|0|||
131138011|NCT03529773|472132796|FG029|Overall Study|Adverse Event|0|||
131138012|NCT03529773|472132797|FG030|Overall Study|Adverse Event|1|||
131138013|NCT03529773|472132798|FG031|Overall Study|Adverse Event|0|||
131138014|NCT03529773|472132799|FG032|Overall Study|Adverse Event|0|||
131138015|NCT03529773|472132800|FG033|Overall Study|Adverse Event|0|||
131138016|NCT03529773|472132801|FG034|Overall Study|Adverse Event|0|||
130724408|NCT00090363|470615600|FG002|Overall Study|Study-specific discontinuation criteria|62|||
131073280|NCT02101268|471901026|FG002|Randomized Treatment Phase|Disease Progression|0|||
131073281|NCT02101268|471901027|FG003|Randomized Treatment Phase|Disease Progression|0|||
131073282|NCT02101268|471901024|FG000|Extended Treatment Phase|Subject Decision|0|||
131073283|NCT02101268|471901025|FG001|Extended Treatment Phase|Subject Decision|0|||
131073284|NCT02101268|471901026|FG002|Extended Treatment Phase|Subject Decision|3|||
131073285|NCT02101268|471901027|FG003|Extended Treatment Phase|Subject Decision|2|||
131073286|NCT02101268|471901024|FG000|Extended Treatment Phase|Physician Decision|0|||
131073287|NCT02101268|471901025|FG001|Extended Treatment Phase|Physician Decision|0|||
131073288|NCT02101268|471901026|FG002|Extended Treatment Phase|Physician Decision|5|||
131073289|NCT02101268|471901027|FG003|Extended Treatment Phase|Physician Decision|2|||
131073290|NCT02101268|471901024|FG000|Extended Treatment Phase|Adverse Event|0|||
131073291|NCT02101268|471901025|FG001|Extended Treatment Phase|Adverse Event|0|||
130724409|NCT00090363|470615598|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130724410|NCT00090363|470615599|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130724411|NCT00090363|470615600|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130724412|NCT00090363|470615598|FG000|Overall Study|Consent expired|7|||
130724413|NCT00090363|470615599|FG001|Overall Study|Consent expired|10|||
130724414|NCT00090363|470615600|FG002|Overall Study|Consent expired|9|||
130724415|NCT00090363|470615598|FG000|Overall Study|Reasons not specified|2|||
130724416|NCT00090363|470615599|FG001|Overall Study|Reasons not specified|1|||
130724417|NCT00090363|470615600|FG002|Overall Study|Reasons not specified|1|||
130724418|NCT00090363|470615598|FG000|Overall Study|Continuing on study off treatment|14|||
130724419|NCT00090363|470615599|FG001|Overall Study|Continuing on study off treatment|13|||
130724420|NCT00090363|470615600|FG002|Overall Study|Continuing on study off treatment|16|||
130724421|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
130724422|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130724423|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
130724424|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130724425|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130724426|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
130724427|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130724428|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130724429|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
130724430|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
130724431|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
130724432|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
130724433|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
130724434|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
130724435|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
130724436|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
130724437|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130724438|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130724439|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130724440|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130724441|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
130724442|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
130724443|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
130724444|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130724445|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130724446|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130724447|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130724448|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
130724449|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130724450|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130724451|NCT03713619|470615601|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
130724452|NCT03713619|470615602|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
130724453|NCT03713619|470615603|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
130724454|NCT03713619|470615604|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
130724455|NCT03713619|470615605|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
130724456|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
130724457|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
130724458|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
130724459|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
130724460|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
130724461|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
130724462|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130724463|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130724464|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
131073292|NCT02101268|471901026|FG002|Extended Treatment Phase|Adverse Event|14|||
130724465|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
131073293|NCT02101268|471901027|FG003|Extended Treatment Phase|Adverse Event|18|||
130724466|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
130724467|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
130724468|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
130724469|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
130724470|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
130724471|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
130724472|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
130724473|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
130724474|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
130724475|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
130724476|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
130724477|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
130724478|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
130724479|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
130724480|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
130724481|NCT03713619|470615601|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130724482|NCT03713619|470615602|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
130724483|NCT03713619|470615603|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130724484|NCT03713619|470615604|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
130724485|NCT03713619|470615605|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
130724486|NCT01908907|470616946|FG000|Overall Study|Physician Decision|1|||
130724487|NCT01908907|470616947|FG001|Overall Study|Physician Decision|0|||
130724488|NCT01908907|470616946|FG000|Overall Study|Protocol Violation|1|||
130724489|NCT01908907|470616947|FG001|Overall Study|Protocol Violation|0|||
130724490|NCT00761657|470616948|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
130724491|NCT00761657|470616949|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
130724492|NCT00761657|470616950|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
130724493|NCT00761657|470616951|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
130724494|NCT00761657|470616952|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
130724495|NCT00761657|470616953|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
130724496|NCT00761657|470616954|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
130724497|NCT00761657|470616955|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
130724498|NCT00761657|470616956|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
130724499|NCT00761657|470616948|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724500|NCT00761657|470616949|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724501|NCT00761657|470616950|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
130724502|NCT00761657|470616951|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
130724503|NCT00761657|470616952|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724504|NCT00761657|470616953|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724505|NCT00761657|470616954|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724506|NCT00761657|470616955|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724507|NCT00761657|470616956|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130724508|NCT00761657|470616948|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
130724509|NCT00761657|470616949|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
130724510|NCT00761657|470616950|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
130724511|NCT00761657|470616951|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
130724512|NCT00761657|470616952|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
130724513|NCT00761657|470616953|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
130724514|NCT00761657|470616954|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
130724515|NCT00761657|470616955|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
130724516|NCT00761657|470616956|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
130724517|NCT00761657|470616948|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
130724518|NCT00761657|470616949|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
130724519|NCT00761657|470616950|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
130724520|NCT00761657|470616951|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
130724521|NCT00761657|470616952|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
130724522|NCT00761657|470616953|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
130724523|NCT00761657|470616954|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
130724524|NCT00761657|470616955|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
130724525|NCT00761657|470616956|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
130724526|NCT00359801|470616957|FG000|Overall Study|Lost to Follow-up|72|||
130724527|NCT00359801|470616958|FG001|Overall Study|Lost to Follow-up|58|||
130724528|NCT00359801|470616957|FG000|Overall Study|Withdrawal by Subject|143|||
130724529|NCT00359801|470616958|FG001|Overall Study|Withdrawal by Subject|96|||
130724530|NCT00359801|470616957|FG000|Overall Study|Other|66|||
130724531|NCT00359801|470616958|FG001|Overall Study|Other|46|||
130724532|NCT00359801|470616957|FG000|Overall Study|Final Status Unknown: missing data|7|||
130724533|NCT00359801|470616958|FG001|Overall Study|Final Status Unknown: missing data|4|||
130724534|NCT00359801|470616957|FG000|Overall Study|Sponsor Decision|17|||
130724535|NCT00359801|470616958|FG001|Overall Study|Sponsor Decision|16|||
131073294|NCT02101268|471901024|FG000|Extended Treatment Phase|Death|0|||
130724536|NCT03151408|470616963|FG000|Overall Study|Adverse Event|24|||
130724537|NCT03151408|470616964|FG001|Overall Study|Adverse Event|23|||
130724538|NCT03151408|470616963|FG000|Overall Study|Death|46|||
131138017|NCT03529773|472132802|FG035|Overall Study|Adverse Event|1|||
131138018|NCT03529773|472132803|FG036|Overall Study|Adverse Event|0|||
131138019|NCT03529773|472132804|FG037|Overall Study|Adverse Event|0|||
131138020|NCT03529773|472132805|FG038|Overall Study|Adverse Event|1|||
131138021|NCT03529773|472132806|FG039|Overall Study|Adverse Event|1|||
131138022|NCT03529773|472132767|FG000|Overall Study|Death|0|||
131138023|NCT03529773|472132768|FG001|Overall Study|Death|0|||
131138024|NCT03529773|472132769|FG002|Overall Study|Death|0|||
131138025|NCT03529773|472132770|FG003|Overall Study|Death|0|||
130724539|NCT03151408|470616964|FG001|Overall Study|Death|26|||
130724540|NCT03151408|470616963|FG000|Overall Study|Physician Decision|13|||
130724541|NCT03151408|470616964|FG001|Overall Study|Physician Decision|19|||
130724542|NCT03151408|470616963|FG000|Overall Study|Withdrawal by Subject|16|||
130724543|NCT03151408|470616964|FG001|Overall Study|Withdrawal by Subject|20|||
130724544|NCT03151408|470616963|FG000|Overall Study|Progressive disease|45|||
130724545|NCT03151408|470616964|FG001|Overall Study|Progressive disease|61|||
130724546|NCT03151408|470616963|FG000|Overall Study|non-compliance by patient|1|||
130724547|NCT03151408|470616964|FG001|Overall Study|non-compliance by patient|0|||
130724548|NCT03151408|470616963|FG000|Overall Study|other reasons|56|||
130724549|NCT03151408|470616964|FG001|Overall Study|other reasons|52|||
130724550|NCT03151408|470616963|FG000|Overall Study|randomized and not treated|2|||
130724551|NCT03151408|470616964|FG001|Overall Study|randomized and not treated|2|||
130724552|NCT01473524|470616967|FG000|DB Phase|Adverse Event|4|||
130724553|NCT01473524|470616968|FG001|DB Phase|Adverse Event|8|||
130724554|NCT01473524|470616969|FG002|DB Phase|Adverse Event|2|||
130724555|NCT01473524|470616970|FG003|DB Phase|Adverse Event|0|||
130724556|NCT01473524|470616971|FG004|DB Phase|Adverse Event|0|||
130724557|NCT01473524|470616972|FG005|DB Phase|Adverse Event|0|||
130724558|NCT01473524|470616967|FG000|DB Phase|Death|1|||
130724559|NCT01473524|470616968|FG001|DB Phase|Death|0|||
130724560|NCT01473524|470616969|FG002|DB Phase|Death|0|||
130724561|NCT01473524|470616970|FG003|DB Phase|Death|0|||
130724562|NCT01473524|470616971|FG004|DB Phase|Death|0|||
130724563|NCT01473524|470616972|FG005|DB Phase|Death|0|||
130724564|NCT01473524|470616967|FG000|DB Phase|Withdrawal by Subject|2|||
130724565|NCT01473524|470616968|FG001|DB Phase|Withdrawal by Subject|1|||
130724566|NCT01473524|470616969|FG002|DB Phase|Withdrawal by Subject|1|||
130724567|NCT01473524|470616970|FG003|DB Phase|Withdrawal by Subject|0|||
130724568|NCT01473524|470616971|FG004|DB Phase|Withdrawal by Subject|0|||
130724569|NCT01473524|470616972|FG005|DB Phase|Withdrawal by Subject|0|||
130724570|NCT01473524|470616967|FG000|LTSE Phase|Withdrawal by Subject|0|||
130724571|NCT01473524|470616968|FG001|LTSE Phase|Withdrawal by Subject|0|||
130724572|NCT01473524|470616969|FG002|LTSE Phase|Withdrawal by Subject|0|||
131073295|NCT02101268|471901025|FG001|Extended Treatment Phase|Death|0|||
131073296|NCT02101268|471901026|FG002|Extended Treatment Phase|Death|5|||
131073297|NCT02101268|471901027|FG003|Extended Treatment Phase|Death|1|||
131073298|NCT02101268|471901024|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
131073299|NCT02101268|471901025|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
131073300|NCT02101268|471901026|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
131073301|NCT02101268|471901027|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
131073302|NCT02101268|471901024|FG000|Extended Treatment Phase|Disease Progression|0|||
131073303|NCT02101268|471901025|FG001|Extended Treatment Phase|Disease Progression|0|||
131073304|NCT02101268|471901026|FG002|Extended Treatment Phase|Disease Progression|13|||
131073305|NCT02101268|471901027|FG003|Extended Treatment Phase|Disease Progression|6|||
131073306|NCT02101268|471901024|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
131073307|NCT02101268|471901025|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
131073308|NCT02101268|471901026|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
131073309|NCT02101268|471901027|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
131073310|NCT00740870|471901028|FG000|Overall Study|Not Catheterized|4|||
131073311|NCT00740870|471901028|FG000|Overall Study|Further testing contraindicated implant|17|||
131138026|NCT03529773|472132771|FG004|Overall Study|Death|0|||
131138027|NCT03529773|472132772|FG005|Overall Study|Death|0|||
131138028|NCT03529773|472132773|FG006|Overall Study|Death|0|||
131138029|NCT03529773|472132774|FG007|Overall Study|Death|0|||
130724573|NCT01473524|470616970|FG003|LTSE Phase|Withdrawal by Subject|3|||
130724574|NCT01473524|470616971|FG004|LTSE Phase|Withdrawal by Subject|3|||
130724575|NCT01473524|470616972|FG005|LTSE Phase|Withdrawal by Subject|6|||
131073312|NCT00607997|471901029|FG000|Overall Study|Lack of Efficacy|6|||
131073313|NCT00607997|471901030|FG001|Overall Study|Lack of Efficacy|20|||
131073314|NCT00607997|471901031|FG002|Overall Study|Lack of Efficacy|14|||
131138030|NCT03529773|472132775|FG008|Overall Study|Death|0|||
131138031|NCT03529773|472132776|FG009|Overall Study|Death|0|||
130724576|NCT01473524|470616967|FG000|LTSE Phase|Death|0|||
130724577|NCT01473524|470616968|FG001|LTSE Phase|Death|0|||
130724578|NCT01473524|470616969|FG002|LTSE Phase|Death|0|||
130724579|NCT01473524|470616970|FG003|LTSE Phase|Death|0|||
130724580|NCT01473524|470616971|FG004|LTSE Phase|Death|1|||
130724581|NCT01473524|470616972|FG005|LTSE Phase|Death|0|||
130724582|NCT01473524|470616967|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
131138032|NCT03529773|472132777|FG010|Overall Study|Death|0|||
131138033|NCT03529773|472132778|FG011|Overall Study|Death|0|||
131138034|NCT03529773|472132779|FG012|Overall Study|Death|1|||
131138035|NCT03529773|472132780|FG013|Overall Study|Death|0|||
131138036|NCT03529773|472132781|FG014|Overall Study|Death|0|||
131138037|NCT03529773|472132782|FG015|Overall Study|Death|0|||
131138038|NCT03529773|472132783|FG016|Overall Study|Death|0|||
131138039|NCT03529773|472132784|FG017|Overall Study|Death|0|||
131138040|NCT03529773|472132785|FG018|Overall Study|Death|0|||
130724583|NCT01473524|470616968|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
130724584|NCT01473524|470616969|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
130724585|NCT01473524|470616970|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
130724586|NCT01473524|470616971|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
130724587|NCT01473524|470616972|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
130724588|NCT01473524|470616967|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
130724589|NCT01473524|470616968|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
130724590|NCT01473524|470616969|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
130724591|NCT01473524|470616970|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
130724592|NCT01473524|470616971|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
130724593|NCT01473524|470616972|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
130724594|NCT01473524|470616967|FG000|LTSE Phase|Lost to Follow-up|0|||
130724595|NCT01473524|470616968|FG001|LTSE Phase|Lost to Follow-up|0|||
130724596|NCT01473524|470616969|FG002|LTSE Phase|Lost to Follow-up|0|||
130724597|NCT01473524|470616970|FG003|LTSE Phase|Lost to Follow-up|1|||
130724598|NCT01473524|470616971|FG004|LTSE Phase|Lost to Follow-up|3|||
130724599|NCT01473524|470616972|FG005|LTSE Phase|Lost to Follow-up|2|||
131073315|NCT00607997|471901032|FG003|Overall Study|Lack of Efficacy|10|||
131073316|NCT00607997|471901029|FG000|Overall Study|Death|8|||
131073317|NCT00607997|471901030|FG001|Overall Study|Death|5|||
131073318|NCT00607997|471901031|FG002|Overall Study|Death|2|||
131073319|NCT00607997|471901032|FG003|Overall Study|Death|5|||
131073320|NCT00607997|471901029|FG000|Overall Study|Adverse Event|3|||
131073321|NCT00607997|471901030|FG001|Overall Study|Adverse Event|1|||
131073322|NCT00607997|471901031|FG002|Overall Study|Adverse Event|2|||
131073323|NCT00607997|471901032|FG003|Overall Study|Adverse Event|0|||
131073324|NCT00607997|471901029|FG000|Overall Study|Physician Decision|4|||
131073325|NCT00607997|471901030|FG001|Overall Study|Physician Decision|1|||
131073326|NCT00607997|471901031|FG002|Overall Study|Physician Decision|0|||
131073327|NCT00607997|471901032|FG003|Overall Study|Physician Decision|0|||
131073328|NCT00607997|471901029|FG000|Overall Study|Relapse, recurrent illness|4|||
131073329|NCT00607997|471901030|FG001|Overall Study|Relapse, recurrent illness|0|||
131073330|NCT00607997|471901031|FG002|Overall Study|Relapse, recurrent illness|2|||
131073331|NCT00607997|471901032|FG003|Overall Study|Relapse, recurrent illness|0|||
131073332|NCT00607997|471901029|FG000|Overall Study|Other without explanation|2|||
131073333|NCT00607997|471901030|FG001|Overall Study|Other without explanation|0|||
131073334|NCT00607997|471901031|FG002|Overall Study|Other without explanation|4|||
131073335|NCT00607997|471901032|FG003|Overall Study|Other without explanation|1|||
131073336|NCT00839332|471901033|FG000|Phase 1|Disease Progression|38|||
131073337|NCT00839332|471901034|FG001|Phase 1|Disease Progression|0|||
131073338|NCT00839332|471901035|FG002|Phase 1|Disease Progression|0|||
131073339|NCT00839332|471901033|FG000|Phase 1|Adverse Event|6|||
131073340|NCT00839332|471901034|FG001|Phase 1|Adverse Event|0|||
131073341|NCT00839332|471901035|FG002|Phase 1|Adverse Event|0|||
131073342|NCT00839332|471901033|FG000|Phase 1|Withdrawal by Subject|4|||
131073343|NCT00839332|471901034|FG001|Phase 1|Withdrawal by Subject|0|||
131073344|NCT00839332|471901035|FG002|Phase 1|Withdrawal by Subject|0|||
131073345|NCT00839332|471901033|FG000|Phase 1|Physician Decision|2|||
131073346|NCT00839332|471901034|FG001|Phase 1|Physician Decision|0|||
131073347|NCT00839332|471901035|FG002|Phase 1|Physician Decision|0|||
131073348|NCT00839332|471901033|FG000|Phase 2|Protocol Violation|0|||
131073349|NCT00839332|471901034|FG001|Phase 2|Protocol Violation|1|||
131073350|NCT00839332|471901035|FG002|Phase 2|Protocol Violation|0|||
131073351|NCT00839332|471901033|FG000|Phase 2|Disease Progression|0|||
131073352|NCT00839332|471901034|FG001|Phase 2|Disease Progression|46|||
131138041|NCT03529773|472132786|FG019|Overall Study|Death|1|||
131073353|NCT00839332|471901035|FG002|Phase 2|Disease Progression|21|||
131073354|NCT00839332|471901033|FG000|Phase 2|Adverse Event|0|||
131073355|NCT00839332|471901034|FG001|Phase 2|Adverse Event|8|||
131138042|NCT03529773|472132787|FG020|Overall Study|Death|0|||
130724600|NCT01473524|470616967|FG000|LTSE Phase|Principal Investigator Decision|0|||
130724601|NCT01473524|470616968|FG001|LTSE Phase|Principal Investigator Decision|0|||
131073356|NCT00839332|471901035|FG002|Phase 2|Adverse Event|6|||
131073357|NCT00839332|471901033|FG000|Phase 2|Death|0|||
131073358|NCT00839332|471901034|FG001|Phase 2|Death|4|||
131073359|NCT00839332|471901035|FG002|Phase 2|Death|2|||
131073360|NCT00839332|471901033|FG000|Phase 2|Withdrawal by Subject|0|||
131073361|NCT00839332|471901034|FG001|Phase 2|Withdrawal by Subject|5|||
131073362|NCT00839332|471901035|FG002|Phase 2|Withdrawal by Subject|8|||
131073363|NCT00839332|471901033|FG000|Phase 2|Physician Decision|0|||
131073364|NCT00839332|471901034|FG001|Phase 2|Physician Decision|4|||
131073365|NCT00839332|471901035|FG002|Phase 2|Physician Decision|1|||
131138043|NCT03529773|472132788|FG021|Overall Study|Death|0|||
131073366|NCT00839332|471901033|FG000|Phase 2|Lost to Follow-up|0|||
131073367|NCT00839332|471901034|FG001|Phase 2|Lost to Follow-up|0|||
131073368|NCT00839332|471901035|FG002|Phase 2|Lost to Follow-up|1|||
131073369|NCT01200485|471901036|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
131073370|NCT01200485|471901037|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
131073371|NCT01200485|471901038|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
131073372|NCT01200485|471901036|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
131073373|NCT01200485|471901037|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
131073374|NCT01200485|471901038|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
131073375|NCT06080438|471901039|FG000|Overall Study|Lost to Follow-up|2|||
131073376|NCT03589300|471901040|FG000|Overall Study|Adverse Event|2|||
131073377|NCT03589300|471901040|FG000|Overall Study|Death|4|||
131073378|NCT03589300|471901040|FG000|Overall Study|Lost to Follow-up|12|||
131073379|NCT03589300|471901040|FG000|Overall Study|Withdrawal by Subject|5|||
131073380|NCT01678898|471901043|FG000|PB-102-F01|Adverse Event|0|||
131073381|NCT01678898|471901044|FG001|PB-102-F01|Adverse Event|1|||
131073382|NCT01678898|471901045|FG002|PB-102-F01|Adverse Event|0|||
131073383|NCT01678898|471901043|FG000|PB-102-F01|Physician Decision|0|||
131073384|NCT01678898|471901044|FG001|PB-102-F01|Physician Decision|1|||
131073385|NCT01678898|471901045|FG002|PB-102-F01|Physician Decision|0|||
131073386|NCT02864342|471901047|FG000|Overall Study|Eligibility Criteria Deviation|2|||
131073387|NCT02864342|471901048|FG001|Overall Study|Eligibility Criteria Deviation|3|||
131073388|NCT02864342|471901047|FG000|Overall Study|Withdrawal by Subject|4|||
131073389|NCT02864342|471901048|FG001|Overall Study|Withdrawal by Subject|2|||
131073390|NCT02864342|471901047|FG000|Overall Study|Device Technology Issue|6|||
131073391|NCT02864342|471901048|FG001|Overall Study|Device Technology Issue|7|||
131073392|NCT02864342|471901047|FG000|Overall Study|Death|0|||
131073393|NCT02864342|471901048|FG001|Overall Study|Death|1|||
131073394|NCT02864342|471901047|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
131073395|NCT02864342|471901048|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
131073396|NCT02864342|471901047|FG000|Overall Study|Lost to Follow-up|1|||
131073397|NCT02864342|471901048|FG001|Overall Study|Lost to Follow-up|5|||
131073398|NCT02864342|471901047|FG000|Overall Study|Lost Device|1|||
131073399|NCT02864342|471901048|FG001|Overall Study|Lost Device|0|||
131073400|NCT02864342|471901047|FG000|Overall Study|Adverse Event|1|||
131073401|NCT02864342|471901048|FG001|Overall Study|Adverse Event|0|||
131073402|NCT02573883|471901051|FG000|Six Month Follow Up|Lost to Follow-up|1|||
130724602|NCT01473524|470616969|FG002|LTSE Phase|Principal Investigator Decision|0|||
130724603|NCT01473524|470616970|FG003|LTSE Phase|Principal Investigator Decision|1|||
130724604|NCT01473524|470616971|FG004|LTSE Phase|Principal Investigator Decision|1|||
130724605|NCT01473524|470616972|FG005|LTSE Phase|Principal Investigator Decision|3|||
130724606|NCT01473524|470616967|FG000|LTSE Phase|Liver Transplantation|0|||
130724607|NCT01473524|470616968|FG001|LTSE Phase|Liver Transplantation|0|||
130724608|NCT01473524|470616969|FG002|LTSE Phase|Liver Transplantation|0|||
130724609|NCT01473524|470616970|FG003|LTSE Phase|Liver Transplantation|0|||
130724610|NCT01473524|470616971|FG004|LTSE Phase|Liver Transplantation|0|||
130724611|NCT01473524|470616972|FG005|LTSE Phase|Liver Transplantation|1|||
130724612|NCT01473524|470616967|FG000|LTSE Phase|Pregnancy|0|||
130724613|NCT01473524|470616968|FG001|LTSE Phase|Pregnancy|0|||
130724614|NCT01473524|470616969|FG002|LTSE Phase|Pregnancy|0|||
130724615|NCT01473524|470616970|FG003|LTSE Phase|Pregnancy|1|||
130724616|NCT01473524|470616971|FG004|LTSE Phase|Pregnancy|0|||
130724617|NCT01473524|470616972|FG005|LTSE Phase|Pregnancy|0|||
130724618|NCT01473524|470616967|FG000|LTSE Phase|Protocol Violation|0|||
130724619|NCT01473524|470616968|FG001|LTSE Phase|Protocol Violation|0|||
130724620|NCT01473524|470616969|FG002|LTSE Phase|Protocol Violation|0|||
130724621|NCT01473524|470616970|FG003|LTSE Phase|Protocol Violation|0|||
130724622|NCT01473524|470616971|FG004|LTSE Phase|Protocol Violation|0|||
130724623|NCT01473524|470616972|FG005|LTSE Phase|Protocol Violation|1|||
130724624|NCT02383810|470616973|FG000|Overall Study|Physician Decision|1|||
130724625|NCT02383810|470616974|FG001|Overall Study|Physician Decision|1|||
130724626|NCT02383810|470616975|FG002|Overall Study|Physician Decision|0|||
130724627|NCT02383810|470616976|FG003|Overall Study|Physician Decision|0|||
130724628|NCT02383810|470616977|FG004|Overall Study|Physician Decision|0|||
131073403|NCT02573883|471901052|FG001|Six Month Follow Up|Lost to Follow-up|0|||
131073404|NCT02573883|471901053|FG002|Six Month Follow Up|Lost to Follow-up|0|||
131073405|NCT02573883|471901054|FG003|Six Month Follow Up|Lost to Follow-up|0|||
130724629|NCT02383810|470616978|FG005|Overall Study|Physician Decision|0|||
130724630|NCT02383810|470616979|FG006|Overall Study|Physician Decision|0|||
130724631|NCT02383810|470616980|FG007|Overall Study|Physician Decision|0|||
131073406|NCT02573883|471901051|FG000|One Year Follow Up|Lost to Follow-up|2|||
131073407|NCT02573883|471901052|FG001|One Year Follow Up|Lost to Follow-up|1|||
131073408|NCT02573883|471901053|FG002|One Year Follow Up|Lost to Follow-up|0|||
131073409|NCT02573883|471901054|FG003|One Year Follow Up|Lost to Follow-up|0|||
131073410|NCT02725008|471901055|FG000|Overall Study|Lost to Follow-up|7|||
131073411|NCT02725008|471901056|FG001|Overall Study|Lost to Follow-up|9|||
131073412|NCT02725008|471901055|FG000|Overall Study|Withdrawal by Subject|2|||
131073413|NCT02725008|471901056|FG001|Overall Study|Withdrawal by Subject|2|||
130779647|NCT02326272|470819494|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130779648|NCT02326272|470819495|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130779649|NCT02326272|470819496|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131231111|NCT01806597|472473236|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
131231112|NCT01806597|472473237|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
131231113|NCT01806597|472473238|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
131231114|NCT01806597|472473233|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
130779650|NCT02326272|470819497|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131073414|NCT02725008|471901055|FG000|Overall Study|Admitted to hospital|0|||
131073415|NCT02725008|471901056|FG001|Overall Study|Admitted to hospital|1|||
131073416|NCT01560585|471901057|FG000|Overall Study|Physician Decision|3|||
131073417|NCT01363297|471901058|FG000|Overall Study|Other|0|||
131073418|NCT01363297|471901059|FG001|Overall Study|Other|0|||
131073419|NCT01363297|471901060|FG002|Overall Study|Other|0|||
131073420|NCT01363297|471901061|FG003|Overall Study|Other|0|||
131073421|NCT01363297|471901062|FG004|Overall Study|Other|1|||
131073422|NCT01363297|471901058|FG000|Overall Study|Death|3|||
131073423|NCT01363297|471901059|FG001|Overall Study|Death|6|||
131073424|NCT01363297|471901060|FG002|Overall Study|Death|6|||
131073425|NCT01363297|471901061|FG003|Overall Study|Death|10|||
131073426|NCT01363297|471901062|FG004|Overall Study|Death|30|||
131073427|NCT02515097|471901063|FG000|Overall Study|Lost to Follow-up|4|||
131073428|NCT02515097|471901064|FG001|Overall Study|Lost to Follow-up|2|||
131073429|NCT02515097|471901063|FG000|Overall Study|Withdrawal by Subject|1|||
131073430|NCT02515097|471901064|FG001|Overall Study|Withdrawal by Subject|3|||
131073431|NCT02515097|471901063|FG000|Overall Study|Adverse Event|2|||
131073432|NCT02515097|471901064|FG001|Overall Study|Adverse Event|1|||
131073433|NCT01180790|471901070|FG000|Overall Study|Adverse Event|1|||
131073434|NCT01180790|471901071|FG001|Overall Study|Adverse Event|1|||
131073435|NCT01180790|471901072|FG002|Overall Study|Adverse Event|2|||
131073436|NCT01180790|471901073|FG003|Overall Study|Adverse Event|0|||
131073437|NCT01180790|471901074|FG004|Overall Study|Adverse Event|1|||
131073438|NCT01180790|471901075|FG005|Overall Study|Adverse Event|3|||
131073439|NCT01180790|471901076|FG006|Overall Study|Adverse Event|0|||
131073440|NCT01180790|471901070|FG000|Overall Study|Withdrawal by Subject|3|||
131073441|NCT01180790|471901071|FG001|Overall Study|Withdrawal by Subject|0|||
131073442|NCT01180790|471901072|FG002|Overall Study|Withdrawal by Subject|5|||
131073443|NCT01180790|471901073|FG003|Overall Study|Withdrawal by Subject|0|||
131073444|NCT01180790|471901074|FG004|Overall Study|Withdrawal by Subject|2|||
131073445|NCT01180790|471901075|FG005|Overall Study|Withdrawal by Subject|1|||
131073446|NCT01180790|471901076|FG006|Overall Study|Withdrawal by Subject|0|||
131073447|NCT01180790|471901070|FG000|Overall Study|Lost to Follow-up|3|||
131073448|NCT01180790|471901071|FG001|Overall Study|Lost to Follow-up|1|||
131073449|NCT01180790|471901072|FG002|Overall Study|Lost to Follow-up|0|||
131073450|NCT01180790|471901073|FG003|Overall Study|Lost to Follow-up|2|||
131073451|NCT01180790|471901074|FG004|Overall Study|Lost to Follow-up|1|||
131073452|NCT01180790|471901075|FG005|Overall Study|Lost to Follow-up|0|||
131073453|NCT01180790|471901076|FG006|Overall Study|Lost to Follow-up|1|||
131073454|NCT01180790|471901070|FG000|Overall Study|Physician Decision|1|||
131073455|NCT01180790|471901071|FG001|Overall Study|Physician Decision|0|||
131073456|NCT01180790|471901072|FG002|Overall Study|Physician Decision|0|||
131073457|NCT01180790|471901073|FG003|Overall Study|Physician Decision|1|||
131073458|NCT01180790|471901074|FG004|Overall Study|Physician Decision|0|||
131073459|NCT01180790|471901075|FG005|Overall Study|Physician Decision|0|||
131073460|NCT01180790|471901076|FG006|Overall Study|Physician Decision|0|||
131073461|NCT01180790|471901070|FG000|Overall Study|Lack of Efficacy|1|||
131073462|NCT01180790|471901071|FG001|Overall Study|Lack of Efficacy|2|||
131073463|NCT01180790|471901072|FG002|Overall Study|Lack of Efficacy|5|||
130779651|NCT02326272|470819498|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
131073464|NCT01180790|471901073|FG003|Overall Study|Lack of Efficacy|6|||
131073465|NCT01180790|471901074|FG004|Overall Study|Lack of Efficacy|1|||
131073466|NCT01180790|471901075|FG005|Overall Study|Lack of Efficacy|3|||
131073467|NCT01180790|471901076|FG006|Overall Study|Lack of Efficacy|0|||
131073468|NCT01180790|471901070|FG000|Overall Study|compliance|0|||
131073469|NCT01180790|471901071|FG001|Overall Study|compliance|1|||
131073470|NCT01180790|471901072|FG002|Overall Study|compliance|0|||
131073471|NCT01180790|471901073|FG003|Overall Study|compliance|0|||
131073472|NCT01180790|471901074|FG004|Overall Study|compliance|0|||
131073473|NCT01180790|471901075|FG005|Overall Study|compliance|0|||
131073474|NCT01180790|471901076|FG006|Overall Study|compliance|0|||
131073475|NCT01180790|471901070|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
131073476|NCT01180790|471901071|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
131073477|NCT01180790|471901072|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
131073478|NCT01180790|471901073|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
131073479|NCT01180790|471901074|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
131073480|NCT01180790|471901075|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
131073481|NCT01180790|471901076|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
130724632|NCT02383810|470616973|FG000|Overall Study|Withdrawal by Subject|2|||
130724633|NCT02383810|470616974|FG001|Overall Study|Withdrawal by Subject|3|||
130724634|NCT02383810|470616975|FG002|Overall Study|Withdrawal by Subject|3|||
130724635|NCT02383810|470616976|FG003|Overall Study|Withdrawal by Subject|3|||
130724636|NCT02383810|470616977|FG004|Overall Study|Withdrawal by Subject|0|||
130724637|NCT02383810|470616978|FG005|Overall Study|Withdrawal by Subject|0|||
130724638|NCT02383810|470616979|FG006|Overall Study|Withdrawal by Subject|0|||
130724639|NCT02383810|470616980|FG007|Overall Study|Withdrawal by Subject|0|||
130724640|NCT02383810|470616973|FG000|Overall Study|Adverse Event|0|||
130724641|NCT02383810|470616974|FG001|Overall Study|Adverse Event|2|||
130724642|NCT02383810|470616975|FG002|Overall Study|Adverse Event|4|||
130724643|NCT02383810|470616976|FG003|Overall Study|Adverse Event|5|||
130724644|NCT02383810|470616977|FG004|Overall Study|Adverse Event|0|||
130724645|NCT02383810|470616978|FG005|Overall Study|Adverse Event|1|||
130724646|NCT02383810|470616979|FG006|Overall Study|Adverse Event|1|||
130724647|NCT02383810|470616980|FG007|Overall Study|Adverse Event|0|||
130724648|NCT02383810|470616973|FG000|Overall Study|Lost to Follow-up|0|||
130724649|NCT02383810|470616974|FG001|Overall Study|Lost to Follow-up|1|||
130724650|NCT02383810|470616975|FG002|Overall Study|Lost to Follow-up|0|||
130724651|NCT02383810|470616976|FG003|Overall Study|Lost to Follow-up|1|||
130724652|NCT02383810|470616977|FG004|Overall Study|Lost to Follow-up|0|||
130724653|NCT02383810|470616978|FG005|Overall Study|Lost to Follow-up|0|||
130724654|NCT02383810|470616979|FG006|Overall Study|Lost to Follow-up|0|||
130724655|NCT02383810|470616980|FG007|Overall Study|Lost to Follow-up|0|||
130724656|NCT02383810|470616973|FG000|Overall Study|other|0|||
130724657|NCT02383810|470616974|FG001|Overall Study|other|0|||
130724658|NCT02383810|470616975|FG002|Overall Study|other|0|||
130724659|NCT02383810|470616976|FG003|Overall Study|other|2|||
130724660|NCT02383810|470616977|FG004|Overall Study|other|0|||
131073482|NCT01568112|471901079|FG000|Overall Study|Randomized But Not Treated|0|||
131073483|NCT01568112|471901080|FG001|Overall Study|Randomized But Not Treated|1|||
131073484|NCT01568112|471901081|FG002|Overall Study|Randomized But Not Treated|0|||
131073485|NCT01568112|471901082|FG003|Overall Study|Randomized But Not Treated|0|||
131073486|NCT01568112|471901079|FG000|Overall Study|Withdrew due to Adverse Event|2|||
131073487|NCT01568112|471901080|FG001|Overall Study|Withdrew due to Adverse Event|4|||
131073488|NCT01568112|471901081|FG002|Overall Study|Withdrew due to Adverse Event|6|||
131073489|NCT01568112|471901082|FG003|Overall Study|Withdrew due to Adverse Event|3|||
131073490|NCT01568112|471901079|FG000|Overall Study|Lost to Follow-up|0|||
131073491|NCT01568112|471901080|FG001|Overall Study|Lost to Follow-up|0|||
131073492|NCT01568112|471901081|FG002|Overall Study|Lost to Follow-up|0|||
131073493|NCT01568112|471901082|FG003|Overall Study|Lost to Follow-up|1|||
131073494|NCT01568112|471901079|FG000|Overall Study|Withdrawal by Subject|2|||
131073495|NCT01568112|471901080|FG001|Overall Study|Withdrawal by Subject|3|||
131073496|NCT01568112|471901081|FG002|Overall Study|Withdrawal by Subject|0|||
131073497|NCT01568112|471901082|FG003|Overall Study|Withdrawal by Subject|7|||
131073498|NCT01568112|471901079|FG000|Overall Study|Withdrawal by Physician|1|||
131073499|NCT01568112|471901080|FG001|Overall Study|Withdrawal by Physician|0|||
131073500|NCT01568112|471901081|FG002|Overall Study|Withdrawal by Physician|1|||
131073501|NCT01568112|471901082|FG003|Overall Study|Withdrawal by Physician|1|||
131073502|NCT00560313|471903136|FG000|Overall Study|Adverse Events or Death|2|||
131073503|NCT00560313|471903136|FG000|Overall Study|Withdrawal by Subject|2|||
131073504|NCT00560313|471903136|FG000|Overall Study|Lost to Follow-up|1|||
131073505|NCT00560313|471903136|FG000|Overall Study|Protocol Violation|1|||
131073506|NCT00526097|471903137|FG000|Overall Study|Adverse Event|6|||
131073507|NCT00526097|471903138|FG001|Overall Study|Adverse Event|44|||
131073508|NCT00526097|471903137|FG000|Overall Study|Protocol Violation|4|||
131073509|NCT00526097|471903138|FG001|Overall Study|Protocol Violation|10|||
131073510|NCT00526097|471903137|FG000|Overall Study|Withdrawal by Subject|3|||
131073511|NCT00526097|471903138|FG001|Overall Study|Withdrawal by Subject|1|||
131073512|NCT00526097|471903137|FG000|Overall Study|Other|2|||
131073513|NCT00526097|471903138|FG001|Overall Study|Other|1|||
131073514|NCT00943618|471903139|FG000|Overall Study|Lost to Follow-up|38|||
131073515|NCT00943618|471903140|FG001|Overall Study|Lost to Follow-up|48|||
131073516|NCT00943618|471903141|FG002|Overall Study|Lost to Follow-up|20|||
131073517|NCT00943618|471903139|FG000|Overall Study|Discontinued Medication|17|||
131073518|NCT00943618|471903140|FG001|Overall Study|Discontinued Medication|29|||
131073519|NCT00943618|471903141|FG002|Overall Study|Discontinued Medication|11|||
130724661|NCT02383810|470616978|FG005|Overall Study|other|0|||
130724662|NCT02383810|470616979|FG006|Overall Study|other|0|||
130724663|NCT02383810|470616980|FG007|Overall Study|other|0|||
130724664|NCT02383810|470616973|FG000|Overall Study|subject did not receive study treatment|0|||
131073520|NCT03713281|471903142|FG000|Overall Study|Lens handling difficuluties|2|||
131073521|NCT03713281|471903142|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
131073522|NCT05006417|471903145|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
131073523|NCT00875615|471903154|FG000|Overall Study|Withdrawal by Subject|1|||
131073524|NCT01772823|471903155|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
131073525|NCT01772823|471903156|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
130724665|NCT02383810|470616974|FG001|Overall Study|subject did not receive study treatment|1|||
131073526|NCT01772823|471903155|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
131073527|NCT01772823|471903156|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
131073528|NCT01772823|471903155|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
131073529|NCT01772823|471903156|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
131073530|NCT01772823|471903155|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
131073531|NCT01772823|471903156|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
131073532|NCT01772823|471903155|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
131073533|NCT01772823|471903156|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
131073534|NCT01772823|471903155|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
131073535|NCT01772823|471903156|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
131073536|NCT01772823|471903155|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
131073537|NCT01772823|471903156|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
131073538|NCT01772823|471903155|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
131073539|NCT01772823|471903156|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
131073540|NCT01772823|471903155|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
131073541|NCT01772823|471903156|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
131073542|NCT01772823|471903155|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
131073543|NCT01772823|471903156|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
131073544|NCT01772823|471903155|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
131073545|NCT01772823|471903156|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
131073546|NCT01772823|471903155|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
131073547|NCT01772823|471903156|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
131073548|NCT01772823|471903155|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
131073549|NCT01772823|471903156|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
131073550|NCT01772823|471903155|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
131073551|NCT01772823|471903156|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
131073552|NCT01772823|471903155|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
131073553|NCT01772823|471903156|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
131073554|NCT01772823|471903155|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
131073555|NCT01772823|471903156|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
131073556|NCT00468858|471903161|FG000|Overall Study|Adverse Event|0|||
131073557|NCT00468858|471903162|FG001|Overall Study|Adverse Event|1|||
131073558|NCT00468858|471903163|FG002|Overall Study|Adverse Event|0|||
131073559|NCT00468858|471903161|FG000|Overall Study|Withdrawal by Subject|7|||
131073560|NCT00468858|471903162|FG001|Overall Study|Withdrawal by Subject|4|||
131073561|NCT00468858|471903163|FG002|Overall Study|Withdrawal by Subject|5|||
131073562|NCT00468858|471903161|FG000|Overall Study|Relocation|1|||
131073563|NCT00468858|471903162|FG001|Overall Study|Relocation|3|||
131073564|NCT00468858|471903163|FG002|Overall Study|Relocation|3|||
131073565|NCT00468858|471903161|FG000|Overall Study|Lost to Follow-up|1|||
131073566|NCT00468858|471903162|FG001|Overall Study|Lost to Follow-up|2|||
131073567|NCT00468858|471903163|FG002|Overall Study|Lost to Follow-up|5|||
131073568|NCT00468858|471903161|FG000|Overall Study|Other|0|||
131073569|NCT00468858|471903162|FG001|Overall Study|Other|0|||
131073570|NCT00468858|471903163|FG002|Overall Study|Other|1|||
131073571|NCT01093222|471903164|FG000|Overall Study|Ineligible|6|||
131073572|NCT01093222|471903164|FG000|Overall Study|Adverse Event|7|||
131073573|NCT01093222|471903164|FG000|Overall Study|Progression/relapse|24|||
131073574|NCT01093222|471903164|FG000|Overall Study|Death|2|||
131073575|NCT01093222|471903164|FG000|Overall Study|Not protocol specified|1|||
131073576|NCT01670188|471903165|FG000|Overall Study|Death|0|||
131073577|NCT01670188|471903166|FG001|Overall Study|Death|1|||
131138044|NCT03529773|472132789|FG022|Overall Study|Death|1|||
131138045|NCT03529773|472132790|FG023|Overall Study|Death|0|||
131138046|NCT03529773|472132791|FG024|Overall Study|Death|0|||
131138047|NCT03529773|472132792|FG025|Overall Study|Death|0|||
131138048|NCT03529773|472132793|FG026|Overall Study|Death|0|||
131138049|NCT03529773|472132794|FG027|Overall Study|Death|0|||
131138050|NCT03529773|472132795|FG028|Overall Study|Death|0|||
131138051|NCT03529773|472132796|FG029|Overall Study|Death|0|||
131138052|NCT03529773|472132797|FG030|Overall Study|Death|0|||
131138053|NCT03529773|472132798|FG031|Overall Study|Death|0|||
131138054|NCT03529773|472132799|FG032|Overall Study|Death|0|||
131138055|NCT03529773|472132800|FG033|Overall Study|Death|1|||
131138056|NCT03529773|472132801|FG034|Overall Study|Death|1|||
131138057|NCT03529773|472132802|FG035|Overall Study|Death|0|||
131138058|NCT03529773|472132803|FG036|Overall Study|Death|1|||
131138059|NCT03529773|472132804|FG037|Overall Study|Death|0|||
131138060|NCT03529773|472132805|FG038|Overall Study|Death|0|||
131138061|NCT03529773|472132806|FG039|Overall Study|Death|0|||
131138062|NCT03529773|472132767|FG000|Overall Study|Lost to Follow-up|0|||
131138063|NCT03529773|472132768|FG001|Overall Study|Lost to Follow-up|0|||
130724666|NCT02383810|470616975|FG002|Overall Study|subject did not receive study treatment|0|||
130724667|NCT02383810|470616976|FG003|Overall Study|subject did not receive study treatment|0|||
130724668|NCT02383810|470616977|FG004|Overall Study|subject did not receive study treatment|0|||
130724669|NCT02383810|470616978|FG005|Overall Study|subject did not receive study treatment|0|||
130724670|NCT02383810|470616979|FG006|Overall Study|subject did not receive study treatment|0|||
130724671|NCT02383810|470616980|FG007|Overall Study|subject did not receive study treatment|0|||
130724672|NCT00282919|470616981|FG000|Overall Study|Lack of Efficacy|4|||
130724673|NCT00282919|470616981|FG000|Overall Study|Withdrawal by Subject|1|||
131073578|NCT02212301|471903167|FG000|Period 1|Lost to Follow-up|0|||
131073579|NCT02212301|471903168|FG001|Period 1|Lost to Follow-up|1|||
131073580|NCT03927222|471903169|FG000|Overall Study|Progression|3|||
130724674|NCT00282919|470616981|FG000|Overall Study|Asymptomatic Parasitemia|2|||
131073581|NCT03927222|471903169|FG000|Overall Study|CMV testing results inconclusive|1|||
131073582|NCT03927222|471903169|FG000|Overall Study|Unable to generate enough vaccines|1|||
131073583|NCT03927222|471903169|FG000|Overall Study|Early study termination|1|||
131073584|NCT02025985|471903172|FG000|Overall Study|Consent withdrawn|0|||
131073585|NCT02025985|471903173|FG001|Overall Study|Consent withdrawn|0|||
131073586|NCT02025985|471903174|FG002|Overall Study|Consent withdrawn|1|||
131073587|NCT02025985|471903175|FG003|Overall Study|Consent withdrawn|0|||
131073588|NCT02025985|471903176|FG004|Overall Study|Consent withdrawn|0|||
131073589|NCT02025985|471903172|FG000|Overall Study|Termination of study by Sponsor|4|||
131073590|NCT02025985|471903173|FG001|Overall Study|Termination of study by Sponsor|3|||
131073591|NCT02025985|471903174|FG002|Overall Study|Termination of study by Sponsor|1|||
131073592|NCT02025985|471903175|FG003|Overall Study|Termination of study by Sponsor|1|||
131073593|NCT02025985|471903176|FG004|Overall Study|Termination of study by Sponsor|3|||
131073594|NCT02025985|471903172|FG000|Overall Study|Death|21|||
131073595|NCT02025985|471903173|FG001|Overall Study|Death|20|||
131073596|NCT02025985|471903174|FG002|Overall Study|Death|23|||
131073597|NCT02025985|471903175|FG003|Overall Study|Death|20|||
131073598|NCT02025985|471903176|FG004|Overall Study|Death|17|||
131073599|NCT03723915|471903188|FG000|Screening|Failed to meet screening requirements.|2|||
131073600|NCT03723915|471903188|FG000|On Treatment|Failed to meet treatment requirements|2|||
131073601|NCT01978236|471903189|FG000|Overall Study|Discontinued due to study close|2|||
131073602|NCT00634920|471903191|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
131073603|NCT00634920|471903192|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
131073604|NCT00634920|471903193|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
131073605|NCT00634920|471903191|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
131073606|NCT00634920|471903192|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
131073607|NCT00634920|471903193|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
131073608|NCT00634920|471903191|FG000|Period 1 - Pre-Randomization|Rejections|0|||
131073609|NCT00634920|471903192|FG001|Period 1 - Pre-Randomization|Rejections|0|||
131073610|NCT00634920|471903193|FG002|Period 1 - Pre-Randomization|Rejections|55|||
131073611|NCT00634920|471903191|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
131073612|NCT00634920|471903192|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
131073613|NCT00634920|471903193|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
131073614|NCT00634920|471903191|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
131073615|NCT00634920|471903192|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
131073616|NCT00634920|471903193|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
131073617|NCT00634920|471903191|FG000|Period 1 - Pre-Randomization|Other issues|0|||
131073618|NCT00634920|471903192|FG001|Period 1 - Pre-Randomization|Other issues|0|||
131073619|NCT00634920|471903193|FG002|Period 1 - Pre-Randomization|Other issues|6|||
131073620|NCT00634920|471903191|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
131073621|NCT00634920|471903192|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
131073622|NCT00634920|471903193|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
131073623|NCT00634920|471903191|FG000|Period 2 - Post-Randomization|Rejection|11|||
131073624|NCT00634920|471903192|FG001|Period 2 - Post-Randomization|Rejection|5|||
131073625|NCT00634920|471903193|FG002|Period 2 - Post-Randomization|Rejection|0|||
131073626|NCT00634920|471903191|FG000|Period 2 - Post-Randomization|Death|2|||
131073627|NCT00634920|471903192|FG001|Period 2 - Post-Randomization|Death|5|||
131073628|NCT00634920|471903193|FG002|Period 2 - Post-Randomization|Death|0|||
131073629|NCT00634920|471903191|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
131073630|NCT00634920|471903192|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
131073631|NCT00634920|471903193|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
131073632|NCT00634920|471903191|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
131073633|NCT00634920|471903192|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
131073634|NCT00634920|471903193|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
131073635|NCT00819013|471903194|FG000|Overall Study|Not meeting continuing study eligibility|2|||
131073636|NCT00819013|471903195|FG001|Overall Study|Not meeting continuing study eligibility|1|||
131073637|NCT00819013|471903196|FG002|Overall Study|Not meeting continuing study eligibility|2|||
131073638|NCT00819013|471903197|FG003|Overall Study|Not meeting continuing study eligibility|1|||
131073639|NCT00819013|471903194|FG000|Overall Study|Adverse Event|0|||
131073640|NCT00819013|471903195|FG001|Overall Study|Adverse Event|0|||
131073641|NCT00819013|471903196|FG002|Overall Study|Adverse Event|1|||
131073642|NCT00819013|471903197|FG003|Overall Study|Adverse Event|0|||
131073643|NCT00819013|471903194|FG000|Overall Study|Withdrawal by Subject|1|||
131073644|NCT00819013|471903195|FG001|Overall Study|Withdrawal by Subject|0|||
131073645|NCT00819013|471903196|FG002|Overall Study|Withdrawal by Subject|1|||
131073646|NCT00819013|471903197|FG003|Overall Study|Withdrawal by Subject|0|||
131073647|NCT00819013|471903194|FG000|Overall Study|Lost to Follow-up|0|||
131073648|NCT00819013|471903195|FG001|Overall Study|Lost to Follow-up|0|||
131073649|NCT00819013|471903196|FG002|Overall Study|Lost to Follow-up|1|||
131073650|NCT00819013|471903197|FG003|Overall Study|Lost to Follow-up|2|||
131073651|NCT00819013|471903194|FG000|Overall Study|Death|0|||
131073652|NCT00819013|471903195|FG001|Overall Study|Death|0|||
131073653|NCT00819013|471903196|FG002|Overall Study|Death|0|||
131073654|NCT00819013|471903197|FG003|Overall Study|Death|1|||
131138064|NCT03529773|472132769|FG002|Overall Study|Lost to Follow-up|1|||
131138065|NCT03529773|472132770|FG003|Overall Study|Lost to Follow-up|0|||
131138066|NCT03529773|472132771|FG004|Overall Study|Lost to Follow-up|1|||
131138067|NCT03529773|472132772|FG005|Overall Study|Lost to Follow-up|1|||
131138068|NCT03529773|472132773|FG006|Overall Study|Lost to Follow-up|0|||
131138069|NCT03529773|472132774|FG007|Overall Study|Lost to Follow-up|0|||
131138070|NCT03529773|472132775|FG008|Overall Study|Lost to Follow-up|0|||
131138071|NCT03529773|472132776|FG009|Overall Study|Lost to Follow-up|0|||
131138072|NCT03529773|472132777|FG010|Overall Study|Lost to Follow-up|0|||
131138073|NCT03529773|472132778|FG011|Overall Study|Lost to Follow-up|0|||
131073655|NCT00576823|471903200|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
131073656|NCT00576823|471903201|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
131073657|NCT00576823|471903202|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
131073658|NCT00576823|471903200|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
131073659|NCT00576823|471903201|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
131073660|NCT00576823|471903202|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
131073661|NCT00510146|471903203|FG000|Double-Blind Treatment|Adverse Event|30|||
131073662|NCT00510146|471903204|FG001|Double-Blind Treatment|Adverse Event|13|||
131073663|NCT00510146|471903203|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
131073664|NCT00510146|471903204|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
131073665|NCT00510146|471903203|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
131073666|NCT00510146|471903204|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
131073667|NCT00510146|471903203|FG000|Double-Blind Treatment|Physician Decision|6|||
131073668|NCT00510146|471903204|FG001|Double-Blind Treatment|Physician Decision|0|||
131073669|NCT00510146|471903203|FG000|Double-Blind Treatment|Protocol Violation|1|||
131073670|NCT00510146|471903204|FG001|Double-Blind Treatment|Protocol Violation|2|||
131073671|NCT00510146|471903203|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
131073672|NCT00510146|471903204|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
131073673|NCT00510146|471903203|FG000|Double-Blind Treatment|Clinical Relapse|0|||
131073674|NCT00510146|471903204|FG001|Double-Blind Treatment|Clinical Relapse|1|||
131073675|NCT00510146|471903203|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
131073676|NCT00510146|471903204|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
131073677|NCT00510146|471903203|FG000|Open-Label Treatment|Adverse Event|22|||
131073678|NCT00510146|471903204|FG001|Open-Label Treatment|Adverse Event|8|||
131073679|NCT00510146|471903203|FG000|Open-Label Treatment|Death|1|||
131073680|NCT00510146|471903204|FG001|Open-Label Treatment|Death|1|||
131073681|NCT00510146|471903203|FG000|Open-Label Treatment|Lack of Efficacy|4|||
131073682|NCT00510146|471903204|FG001|Open-Label Treatment|Lack of Efficacy|0|||
131073683|NCT00510146|471903203|FG000|Open-Label Treatment|Lost to Follow-up|10|||
131073684|NCT00510146|471903204|FG001|Open-Label Treatment|Lost to Follow-up|1|||
131073685|NCT00510146|471903203|FG000|Open-Label Treatment|Physician Decision|3|||
131073686|NCT00510146|471903204|FG001|Open-Label Treatment|Physician Decision|1|||
131073687|NCT00510146|471903203|FG000|Open-Label Treatment|Protocol Violation|4|||
131073688|NCT00510146|471903204|FG001|Open-Label Treatment|Protocol Violation|2|||
131073689|NCT00510146|471903203|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
131073690|NCT00510146|471903204|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
131073691|NCT00510146|471903203|FG000|Open-Label Treatment|Clinical Relapse|1|||
131138074|NCT03529773|472132779|FG012|Overall Study|Lost to Follow-up|0|||
131138075|NCT03529773|472132780|FG013|Overall Study|Lost to Follow-up|1|||
131138076|NCT03529773|472132781|FG014|Overall Study|Lost to Follow-up|4|||
131073692|NCT00510146|471903204|FG001|Open-Label Treatment|Clinical Relapse|1|||
131073693|NCT00510146|471903203|FG000|Open-Label Treatment|Sponsor Decision|2|||
131073694|NCT00510146|471903204|FG001|Open-Label Treatment|Sponsor Decision|0|||
131073695|NCT03188536|471903207|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
131138077|NCT03529773|472132782|FG015|Overall Study|Lost to Follow-up|1|||
131138078|NCT03529773|472132783|FG016|Overall Study|Lost to Follow-up|1|||
131138079|NCT03529773|472132784|FG017|Overall Study|Lost to Follow-up|0|||
131073696|NCT03188536|471903207|FG000|Overall Study|Not participated/met inclusion criteria|1|||
131073697|NCT01930214|471903209|FG000|Overall Study|Death|4|||
131073698|NCT01930214|471903210|FG001|Overall Study|Death|4|||
131073699|NCT01930214|471903211|FG002|Overall Study|Death|11|||
131073700|NCT01930214|471903209|FG000|Overall Study|Lost to Follow-up|12|||
131073701|NCT01930214|471903210|FG001|Overall Study|Lost to Follow-up|13|||
131073702|NCT01930214|471903211|FG002|Overall Study|Lost to Follow-up|12|||
131073703|NCT01930214|471903209|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
131073704|NCT01930214|471903210|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
131073705|NCT01930214|471903211|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
131073706|NCT01930214|471903209|FG000|Overall Study|Physician Decision|2|||
131073707|NCT01930214|471903210|FG001|Overall Study|Physician Decision|0|||
131073708|NCT01930214|471903211|FG002|Overall Study|Physician Decision|0|||
131073709|NCT02132117|471903212|FG000|Overall Study|Adverse Event|6|||
131073710|NCT02132117|471903213|FG001|Overall Study|Adverse Event|1|||
131073711|NCT02132117|471903212|FG000|Overall Study|Lost to Follow-up|2|||
131073712|NCT02132117|471903213|FG001|Overall Study|Lost to Follow-up|2|||
131073713|NCT02132117|471903212|FG000|Overall Study|Personal Reasons|1|||
131073714|NCT02132117|471903213|FG001|Overall Study|Personal Reasons|2|||
131073715|NCT02132117|471903212|FG000|Overall Study|Other Miscellaneous Reasons|2|||
131073716|NCT02132117|471903213|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131073717|NCT00776984|471903218|FG000|Overall Study|Adverse Event|8|||
131073718|NCT00776984|471903219|FG001|Overall Study|Adverse Event|2|||
131073719|NCT00776984|471903218|FG000|Overall Study|Protocol Violation|4|||
131073720|NCT00776984|471903219|FG001|Overall Study|Protocol Violation|2|||
131073721|NCT00776984|471903218|FG000|Overall Study|Lost to Follow-up|2|||
131073722|NCT00776984|471903219|FG001|Overall Study|Lost to Follow-up|0|||
131073723|NCT00776984|471903218|FG000|Overall Study|Withdrawal by Subject|12|||
131073724|NCT00776984|471903219|FG001|Overall Study|Withdrawal by Subject|7|||
131073725|NCT00776984|471903218|FG000|Overall Study|Lack of Efficacy|0|||
131073726|NCT00776984|471903219|FG001|Overall Study|Lack of Efficacy|1|||
131073727|NCT00776984|471903218|FG000|Overall Study|Other|5|||
131073728|NCT00776984|471903219|FG001|Overall Study|Other|9|||
131073729|NCT01544309|471903220|FG000|Overall Study|Withdrawal by Subject|12|||
131073730|NCT01544309|471903221|FG001|Overall Study|Withdrawal by Subject|7|||
131073731|NCT01544309|471903220|FG000|Overall Study|Protocol Violation|2|||
131073732|NCT01544309|471903221|FG001|Overall Study|Protocol Violation|1|||
131073733|NCT01544309|471903220|FG000|Overall Study|Physician Decision|4|||
131073734|NCT01544309|471903221|FG001|Overall Study|Physician Decision|1|||
131073735|NCT01544309|471903220|FG000|Overall Study|Not performed pre-dose examination|1|||
131073736|NCT01544309|471903221|FG001|Overall Study|Not performed pre-dose examination|2|||
131073737|NCT01544309|471903220|FG000|Overall Study|Administered prohibit prior medication|1|||
131073738|NCT01544309|471903221|FG001|Overall Study|Administered prohibit prior medication|0|||
131073739|NCT00118703|471903222|FG000|Overall Study|Protocol Violation|1|||
131073740|NCT00118703|471903223|FG001|Overall Study|Protocol Violation|0|||
131073741|NCT00118703|471903222|FG000|Overall Study|Adverse Event|1|||
131073742|NCT00118703|471903223|FG001|Overall Study|Adverse Event|1|||
131073743|NCT00118703|471903222|FG000|Overall Study|Participant took two different treatment|0|||
131073744|NCT00118703|471903223|FG001|Overall Study|Participant took two different treatment|1|||
131073745|NCT00118703|471903222|FG000|Overall Study|Withdrawal by Subject|2|||
131073746|NCT00118703|471903223|FG001|Overall Study|Withdrawal by Subject|5|||
131073747|NCT00118703|471903222|FG000|Overall Study|Lost to Follow-up|1|||
131073748|NCT00118703|471903223|FG001|Overall Study|Lost to Follow-up|2|||
131073749|NCT03796208|471903230|FG000|Overall Study|Withdrawal by Subject|3|||
131073750|NCT03796208|471903231|FG001|Overall Study|Withdrawal by Subject|0|||
131073751|NCT03796208|471903230|FG000|Overall Study|Loss of pregnancy|1|||
131073752|NCT03796208|471903231|FG001|Overall Study|Loss of pregnancy|1|||
131073753|NCT03796208|471903230|FG000|Overall Study|Changed prenatal clinics|0|||
131073754|NCT03796208|471903231|FG001|Overall Study|Changed prenatal clinics|5|||
131073755|NCT03796208|471903230|FG000|Overall Study|Lost to Follow-up|20|||
131073756|NCT03796208|471903231|FG001|Overall Study|Lost to Follow-up|16|||
131073757|NCT00519285|471903232|FG000|Overall Study|Adverse Event|127|||
131073758|NCT00519285|471903233|FG001|Overall Study|Adverse Event|266|||
131073759|NCT00519285|471903232|FG000|Overall Study|Disease progression|334|||
131073760|NCT00519285|471903233|FG001|Overall Study|Disease progression|186|||
131073761|NCT00519285|471903232|FG000|Overall Study|Physician Decision|75|||
131073762|NCT00519285|471903233|FG001|Overall Study|Physician Decision|47|||
131073763|NCT00519285|471903232|FG000|Overall Study|Participant's request|53|||
131073764|NCT00519285|471903233|FG001|Overall Study|Participant's request|84|||
131073765|NCT00519285|471903232|FG000|Overall Study|Consent withdrawn|4|||
131073766|NCT00519285|471903233|FG001|Overall Study|Consent withdrawn|5|||
131073767|NCT00519285|471903232|FG000|Overall Study|Poor compliance to protocol|5|||
131073768|NCT00519285|471903233|FG001|Overall Study|Poor compliance to protocol|7|||
131073769|NCT00519285|471903232|FG000|Overall Study|Reason unspecified|5|||
131073770|NCT00519285|471903233|FG001|Overall Study|Reason unspecified|8|||
131073771|NCT00519285|471903232|FG000|Overall Study|Not treated|8|||
131073772|NCT00519285|471903233|FG001|Overall Study|Not treated|7|||
131073773|NCT00519285|471903232|FG000|Overall Study|Treatment ongoing|1|||
131073774|NCT00519285|471903233|FG001|Overall Study|Treatment ongoing|2|||
131073775|NCT01020747|471903238|FG000|Overall Study|Withdrawal by Subject|1|||
131073776|NCT01222078|471903239|FG000|Overall Study|Early termination of the study|1|||
131073777|NCT02175745|471903240|FG000|Overall Study|Not Eligible|1|||
131073778|NCT00808899|471903242|FG000|Overall Study|Death|1|||
131073779|NCT00808899|471903242|FG000|Overall Study|Physician Decision|3|||
131073780|NCT04688086|471903247|FG000|Overall Study|Lost to Follow-up|164|||
131073781|NCT04688086|471903247|FG000|Overall Study|Imaging error;|64|||
131073782|NCT00988117|471903248|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
131073783|NCT00988117|471903248|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
131073784|NCT00853021|471903253|FG000|Overall Study|Adverse Event|2|||
131073785|NCT00853021|471903253|FG000|Overall Study|Withdrawal by Subject|2|||
131073786|NCT00853021|471903253|FG000|Overall Study|Death|1|||
131073787|NCT01329419|471903254|FG000|Overall Study|Protocol Violation|235|||
131073788|NCT01220856|471903255|FG000|Overall Study|graft loss|3|||
131073789|NCT01220856|471903256|FG001|Overall Study|graft loss|3|||
131073790|NCT01220856|471903255|FG000|Overall Study|Lost to Follow-up|1|||
131073791|NCT01220856|471903256|FG001|Overall Study|Lost to Follow-up|0|||
131073792|NCT04088500|471903257|FG000|Overall Study|Reason unknown|1|||
131073793|NCT04088500|471903257|FG000|Overall Study|Participant withdrew consent|1|||
131073794|NCT04088500|471903257|FG000|Overall Study|Disease progression|3|||
131073795|NCT00981578|471903258|FG000|Overall Study|Death|1|||
131073796|NCT00981578|471903258|FG000|Overall Study|Withdrawal by Subject|2|||
131073797|NCT02212197|471903259|FG000|Overall Study|Need for radiotherapy|1|||
131073798|NCT02212197|471903260|FG001|Overall Study|Need for radiotherapy|0|||
131073799|NCT02212197|471903261|FG002|Overall Study|Need for radiotherapy|0|||
131073800|NCT01078584|471903262|FG000|Overall Study|Final Status Unknown|1073|||
131073801|NCT01078584|471903262|FG000|Overall Study|Lost to Follow-up|670|||
131073802|NCT01078584|471903262|FG000|Overall Study|Non-serious Adverse Event|577|||
131073803|NCT01078584|471903262|FG000|Overall Study|Withdrawal of Consent|244|||
131073804|NCT01078584|471903262|FG000|Overall Study|Physician Withdrew from Study|90|||
131073805|NCT01078584|471903262|FG000|Overall Study|Non-compliance|67|||
131073806|NCT01078584|471903262|FG000|Overall Study|Blood Pressure Controlled|49|||
131073807|NCT01078584|471903262|FG000|Overall Study|Physician Switched Medication|26|||
131073808|NCT01078584|471903262|FG000|Overall Study|Physician Discontinued Patient|12|||
131073809|NCT01078584|471903262|FG000|Overall Study|Lack of Efficacy|98|||
131073810|NCT01078584|471903262|FG000|Overall Study|Protocol Violation|75|||
131073811|NCT01078584|471903262|FG000|Overall Study|Serious Adverse Event|27|||
131073812|NCT01078584|471903262|FG000|Overall Study|Multiple Reasons|2|||
131073813|NCT01091519|471903263|FG000|Overall Study|Adverse Event|12|||
131073814|NCT01091519|471903264|FG001|Overall Study|Adverse Event|16|||
131073815|NCT01091519|471903263|FG000|Overall Study|Death|1|||
131073816|NCT01091519|471903264|FG001|Overall Study|Death|0|||
131073817|NCT01091519|471903263|FG000|Overall Study|Lack of Efficacy|16|||
131073818|NCT01091519|471903264|FG001|Overall Study|Lack of Efficacy|19|||
131073819|NCT01091519|471903263|FG000|Overall Study|Lost to Follow-up|14|||
131073820|NCT01091519|471903264|FG001|Overall Study|Lost to Follow-up|24|||
131073821|NCT01091519|471903263|FG000|Overall Study|Withdrawal by Subject|2|||
131073822|NCT01091519|471903264|FG001|Overall Study|Withdrawal by Subject|2|||
131073823|NCT01091519|471903263|FG000|Overall Study|Other|6|||
131073824|NCT01091519|471903264|FG001|Overall Study|Other|8|||
131073825|NCT01091519|471903263|FG000|Overall Study|Randomized not treated|4|||
131073826|NCT01091519|471903264|FG001|Overall Study|Randomized not treated|4|||
131073827|NCT03030599|471903267|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
131073828|NCT03030599|471903268|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
131073829|NCT03030599|471903269|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
131073830|NCT03030599|471903267|FG000|Open Label Treatment and Titration|Other|1|||
131073831|NCT03030599|471903268|FG001|Open Label Treatment and Titration|Other|0|||
131073832|NCT03030599|471903269|FG002|Open Label Treatment and Titration|Other|0|||
131073833|NCT03030599|471903267|FG000|Open Label Treatment and Titration|Physician Decision|3|||
131138080|NCT03529773|472132785|FG018|Overall Study|Lost to Follow-up|1|||
131138081|NCT03529773|472132786|FG019|Overall Study|Lost to Follow-up|1|||
131138082|NCT03529773|472132787|FG020|Overall Study|Lost to Follow-up|2|||
130724675|NCT02540850|470616984|FG000|Overall Study|Lost to Follow-up|69|||
131073834|NCT03030599|471903268|FG001|Open Label Treatment and Titration|Physician Decision|0|||
131073835|NCT03030599|471903269|FG002|Open Label Treatment and Titration|Physician Decision|0|||
131073836|NCT03030599|471903267|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
131138083|NCT03529773|472132788|FG021|Overall Study|Lost to Follow-up|4|||
131138084|NCT03529773|472132789|FG022|Overall Study|Lost to Follow-up|3|||
131138085|NCT03529773|472132790|FG023|Overall Study|Lost to Follow-up|4|||
130724676|NCT02540850|470616985|FG001|Overall Study|Lost to Follow-up|66|||
130724677|NCT02540850|470616986|FG002|Overall Study|Lost to Follow-up|34|||
130724678|NCT02861014|470616987|FG000|Primary Analysis|Adverse Event|7|||
131073837|NCT03030599|471903268|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
131073838|NCT03030599|471903269|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
131073839|NCT03030599|471903267|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
131073840|NCT03030599|471903268|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
131073841|NCT03030599|471903269|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
131073842|NCT03030599|471903267|FG000|Open Label Treatment and Titration|Adverse Event|18|||
131073843|NCT03030599|471903268|FG001|Open Label Treatment and Titration|Adverse Event|0|||
131073844|NCT03030599|471903269|FG002|Open Label Treatment and Titration|Adverse Event|0|||
131138086|NCT03529773|472132791|FG024|Overall Study|Lost to Follow-up|3|||
131073845|NCT03030599|471903267|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
131073846|NCT03030599|471903268|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
131073847|NCT03030599|471903269|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
131073848|NCT03030599|471903267|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
131073849|NCT03030599|471903268|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
131073850|NCT03030599|471903269|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
131073851|NCT03030599|471903267|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
131073852|NCT03030599|471903268|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
131073853|NCT03030599|471903269|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
131073854|NCT03030599|471903267|FG000|Stable Dose|Protocol deviation|3|||
131073855|NCT03030599|471903268|FG001|Stable Dose|Protocol deviation|0|||
131073856|NCT03030599|471903269|FG002|Stable Dose|Protocol deviation|0|||
131073857|NCT03030599|471903267|FG000|Stable Dose|Adverse Event|1|||
131073858|NCT03030599|471903268|FG001|Stable Dose|Adverse Event|0|||
131073859|NCT03030599|471903269|FG002|Stable Dose|Adverse Event|0|||
131073860|NCT03030599|471903267|FG000|Stable Dose|Lost to Follow-up|1|||
131073861|NCT03030599|471903268|FG001|Stable Dose|Lost to Follow-up|0|||
131073862|NCT03030599|471903269|FG002|Stable Dose|Lost to Follow-up|0|||
131073863|NCT03030599|471903267|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
131073864|NCT03030599|471903268|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
131073865|NCT03030599|471903269|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
131073866|NCT03030599|471903267|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
131073867|NCT03030599|471903268|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
131073868|NCT03030599|471903269|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
131073869|NCT03030599|471903267|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
131073870|NCT03030599|471903268|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
131073871|NCT03030599|471903269|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
131073872|NCT03030599|471903267|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
131073873|NCT03030599|471903268|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
131073874|NCT03030599|471903269|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
131073875|NCT03030599|471903267|FG000|Open-label Extension|Adverse Event|3|||
131073876|NCT03030599|471903268|FG001|Open-label Extension|Adverse Event|0|||
131073877|NCT03030599|471903269|FG002|Open-label Extension|Adverse Event|0|||
131073878|NCT03030599|471903267|FG000|Open-label Extension|Lost to Follow-up|2|||
131073879|NCT03030599|471903268|FG001|Open-label Extension|Lost to Follow-up|0|||
131073880|NCT03030599|471903269|FG002|Open-label Extension|Lost to Follow-up|0|||
131073881|NCT03030599|471903267|FG000|Open-label Extension|Lack of Efficacy|1|||
131073882|NCT03030599|471903268|FG001|Open-label Extension|Lack of Efficacy|0|||
131073883|NCT03030599|471903269|FG002|Open-label Extension|Lack of Efficacy|0|||
131073884|NCT03030599|471903267|FG000|Open-label Extension|Other Reason|1|||
131073885|NCT03030599|471903268|FG001|Open-label Extension|Other Reason|0|||
131073886|NCT03030599|471903269|FG002|Open-label Extension|Other Reason|0|||
131138087|NCT03529773|472132792|FG025|Overall Study|Lost to Follow-up|5|||
131138088|NCT03529773|472132793|FG026|Overall Study|Lost to Follow-up|5|||
131138089|NCT03529773|472132794|FG027|Overall Study|Lost to Follow-up|0|||
131138090|NCT03529773|472132795|FG028|Overall Study|Lost to Follow-up|0|||
131138091|NCT03529773|472132796|FG029|Overall Study|Lost to Follow-up|0|||
131138092|NCT03529773|472132797|FG030|Overall Study|Lost to Follow-up|1|||
131138093|NCT03529773|472132798|FG031|Overall Study|Lost to Follow-up|0|||
131138094|NCT03529773|472132799|FG032|Overall Study|Lost to Follow-up|0|||
131138095|NCT03529773|472132800|FG033|Overall Study|Lost to Follow-up|1|||
131138096|NCT03529773|472132801|FG034|Overall Study|Lost to Follow-up|1|||
131138097|NCT03529773|472132802|FG035|Overall Study|Lost to Follow-up|0|||
131138098|NCT03529773|472132803|FG036|Overall Study|Lost to Follow-up|0|||
131138099|NCT03529773|472132804|FG037|Overall Study|Lost to Follow-up|3|||
131138100|NCT03529773|472132805|FG038|Overall Study|Lost to Follow-up|1|||
131138101|NCT03529773|472132806|FG039|Overall Study|Lost to Follow-up|1|||
131138102|NCT03529773|472132767|FG000|Overall Study|No longer meets eligibility criteria|0|||
131138103|NCT03529773|472132768|FG001|Overall Study|No longer meets eligibility criteria|0|||
131138104|NCT03529773|472132769|FG002|Overall Study|No longer meets eligibility criteria|0|||
131138105|NCT03529773|472132770|FG003|Overall Study|No longer meets eligibility criteria|0|||
131138106|NCT03529773|472132771|FG004|Overall Study|No longer meets eligibility criteria|0|||
131138107|NCT03529773|472132772|FG005|Overall Study|No longer meets eligibility criteria|0|||
130724679|NCT02861014|470616987|FG000|Primary Analysis|Death|1|||
131073887|NCT01592383|471903270|FG000|Overall Study|Adverse Event|1|||
131138108|NCT03529773|472132773|FG006|Overall Study|No longer meets eligibility criteria|0|||
131138109|NCT03529773|472132774|FG007|Overall Study|No longer meets eligibility criteria|0|||
131138110|NCT03529773|472132775|FG008|Overall Study|No longer meets eligibility criteria|0|||
131138111|NCT03529773|472132776|FG009|Overall Study|No longer meets eligibility criteria|0|||
131138112|NCT03529773|472132777|FG010|Overall Study|No longer meets eligibility criteria|0|||
131138113|NCT03529773|472132778|FG011|Overall Study|No longer meets eligibility criteria|0|||
131073888|NCT04582864|471903271|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
131073889|NCT04582864|471903271|FG000|Overall Study|Death|1|||
131073890|NCT04167085|471903272|FG000|Baseline|Withdrawal by Subject|2|||
131073891|NCT04167085|471903273|FG001|Baseline|Withdrawal by Subject|1|||
131073892|NCT04167085|471903272|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
131073893|NCT04167085|471903273|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
131073894|NCT00702520|471903274|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
131073895|NCT00702520|471903275|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
131073896|NCT00702520|471903276|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
131073897|NCT00702520|471903277|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
131073898|NCT00702520|471903274|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
131231115|NCT01806597|472473234|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
131231116|NCT01806597|472473235|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
131231117|NCT01806597|472473236|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130724680|NCT02861014|470616987|FG000|Primary Analysis|Lack of Efficacy|3|||
131073899|NCT00702520|471903275|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
131073900|NCT00702520|471903276|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
131073901|NCT00702520|471903277|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
131073902|NCT00702520|471903274|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
131073903|NCT00702520|471903275|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
131073904|NCT00702520|471903276|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
131073905|NCT00702520|471903277|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
131073906|NCT02481934|471903278|FG000|Overall Study|Death|2|||
131073907|NCT00942188|471903279|FG000|Overall Study|Adverse Event|0|||
131073908|NCT00942188|471903280|FG001|Overall Study|Adverse Event|3|||
131073909|NCT00942188|471903281|FG002|Overall Study|Adverse Event|2|||
131073910|NCT00942188|471903282|FG003|Overall Study|Adverse Event|0|||
131073911|NCT00942188|471903279|FG000|Overall Study|Lack of Efficacy|0|||
131073912|NCT00942188|471903280|FG001|Overall Study|Lack of Efficacy|0|||
131073913|NCT00942188|471903281|FG002|Overall Study|Lack of Efficacy|0|||
131073914|NCT00942188|471903282|FG003|Overall Study|Lack of Efficacy|1|||
131073915|NCT00942188|471903279|FG000|Overall Study|Protocol Violation|1|||
131073916|NCT00942188|471903280|FG001|Overall Study|Protocol Violation|1|||
131073917|NCT00942188|471903281|FG002|Overall Study|Protocol Violation|0|||
131073918|NCT00942188|471903282|FG003|Overall Study|Protocol Violation|0|||
131073919|NCT00942188|471903279|FG000|Overall Study|Lost to Follow-up|2|||
131073920|NCT00942188|471903280|FG001|Overall Study|Lost to Follow-up|1|||
131073921|NCT00942188|471903281|FG002|Overall Study|Lost to Follow-up|2|||
131073922|NCT00942188|471903282|FG003|Overall Study|Lost to Follow-up|0|||
131073923|NCT00942188|471903279|FG000|Overall Study|Withdrawal by Subject|1|||
131073924|NCT00942188|471903280|FG001|Overall Study|Withdrawal by Subject|3|||
131073925|NCT00942188|471903281|FG002|Overall Study|Withdrawal by Subject|4|||
131073926|NCT00942188|471903282|FG003|Overall Study|Withdrawal by Subject|2|||
131073927|NCT00942188|471903279|FG000|Overall Study|Physician Decision|0|||
131073928|NCT00942188|471903280|FG001|Overall Study|Physician Decision|0|||
131073929|NCT00942188|471903281|FG002|Overall Study|Physician Decision|1|||
131073930|NCT00942188|471903282|FG003|Overall Study|Physician Decision|0|||
131073931|NCT00942188|471903279|FG000|Overall Study|Sponsor Decision|0|||
131073932|NCT00942188|471903280|FG001|Overall Study|Sponsor Decision|2|||
131073933|NCT00942188|471903281|FG002|Overall Study|Sponsor Decision|0|||
131073934|NCT00942188|471903282|FG003|Overall Study|Sponsor Decision|1|||
131073935|NCT00276016|471903283|FG000|Intervention 1|Withdrawal by Subject|0|||
131073936|NCT00276016|471903284|FG001|Intervention 1|Withdrawal by Subject|1|||
131073937|NCT00276016|471903285|FG002|Intervention 1|Withdrawal by Subject|0|||
131073938|NCT00276016|471903286|FG003|Intervention 1|Withdrawal by Subject|0|||
131073939|NCT00276016|471903287|FG004|Intervention 1|Withdrawal by Subject|0|||
131073940|NCT00276016|471903288|FG005|Intervention 1|Withdrawal by Subject|0|||
131073941|NCT01374971|471903289|FG000|Overall Study|Withdrawal by Subject|1|||
131073942|NCT01947517|471905214|FG000|Overall Study|Withdrawal by Subject|1|||
131073943|NCT01947517|471905215|FG001|Overall Study|Withdrawal by Subject|1|||
131073944|NCT00460564|471905219|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
131073945|NCT00460564|471905220|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
131073946|NCT00460564|471905221|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131073947|NCT00460564|471905222|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131073948|NCT00460564|471905223|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131073949|NCT00460564|471905224|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131073950|NCT00460564|471905225|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131073951|NCT00460564|471905226|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
131073952|NCT00460564|471905219|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
131073953|NCT00460564|471905220|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131073954|NCT00460564|471905221|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131073955|NCT00460564|471905222|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131073956|NCT00460564|471905223|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131073957|NCT00460564|471905224|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131138114|NCT03529773|472132779|FG012|Overall Study|No longer meets eligibility criteria|0|||
131138115|NCT03529773|472132780|FG013|Overall Study|No longer meets eligibility criteria|0|||
131138116|NCT03529773|472132781|FG014|Overall Study|No longer meets eligibility criteria|0|||
131138117|NCT03529773|472132782|FG015|Overall Study|No longer meets eligibility criteria|0|||
131138118|NCT03529773|472132783|FG016|Overall Study|No longer meets eligibility criteria|0|||
131138119|NCT03529773|472132784|FG017|Overall Study|No longer meets eligibility criteria|0|||
131138120|NCT03529773|472132785|FG018|Overall Study|No longer meets eligibility criteria|0|||
131138121|NCT03529773|472132786|FG019|Overall Study|No longer meets eligibility criteria|0|||
131138122|NCT03529773|472132787|FG020|Overall Study|No longer meets eligibility criteria|0|||
131138123|NCT03529773|472132788|FG021|Overall Study|No longer meets eligibility criteria|0|||
131138124|NCT03529773|472132789|FG022|Overall Study|No longer meets eligibility criteria|1|||
131138125|NCT03529773|472132790|FG023|Overall Study|No longer meets eligibility criteria|0|||
131138126|NCT03529773|472132791|FG024|Overall Study|No longer meets eligibility criteria|0|||
131138127|NCT03529773|472132792|FG025|Overall Study|No longer meets eligibility criteria|0|||
131138128|NCT03529773|472132793|FG026|Overall Study|No longer meets eligibility criteria|0|||
131138129|NCT03529773|472132794|FG027|Overall Study|No longer meets eligibility criteria|0|||
130724681|NCT02861014|470616987|FG000|Primary Analysis|Physician Decision|2|||
130724682|NCT02861014|470616987|FG000|Primary Analysis|Pregnancy|4|||
130724683|NCT02861014|470616987|FG000|Primary Analysis|Protocol Violation|2|||
130724684|NCT02861014|470616987|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
130724685|NCT02861014|470616987|FG000|Primary Analysis|Withdrawal by Subject|14|||
130724686|NCT02861014|470616987|FG000|Primary Analysis|Commercial ocrelizumab|3|||
130724687|NCT02861014|470616987|FG000|Safety Follow-up|Adverse Event|1|||
130724688|NCT02861014|470616987|FG000|Safety Follow-up|Pregnancy|1|||
130724689|NCT02861014|470616987|FG000|Safety Follow-up|Withdrawal by Subject|9|||
130724690|NCT02861014|470616987|FG000|Safety Follow-up|Study terminated by sponsor|1|||
130779652|NCT02326272|470819499|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130779653|NCT02326272|470819500|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
131138130|NCT03529773|472132795|FG028|Overall Study|No longer meets eligibility criteria|0|||
131138131|NCT03529773|472132796|FG029|Overall Study|No longer meets eligibility criteria|0|||
131138132|NCT03529773|472132797|FG030|Overall Study|No longer meets eligibility criteria|0|||
131138133|NCT03529773|472132798|FG031|Overall Study|No longer meets eligibility criteria|0|||
131138134|NCT03529773|472132799|FG032|Overall Study|No longer meets eligibility criteria|0|||
131138135|NCT03529773|472132800|FG033|Overall Study|No longer meets eligibility criteria|0|||
131138136|NCT03529773|472132801|FG034|Overall Study|No longer meets eligibility criteria|0|||
131138137|NCT03529773|472132802|FG035|Overall Study|No longer meets eligibility criteria|0|||
131138138|NCT03529773|472132803|FG036|Overall Study|No longer meets eligibility criteria|0|||
131138139|NCT03529773|472132804|FG037|Overall Study|No longer meets eligibility criteria|0|||
131138140|NCT03529773|472132805|FG038|Overall Study|No longer meets eligibility criteria|1|||
131138141|NCT03529773|472132806|FG039|Overall Study|No longer meets eligibility criteria|0|||
131138142|NCT03529773|472132767|FG000|Overall Study|Other|0|||
130779654|NCT02326272|470819501|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130779655|NCT02326272|470819502|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
130779656|NCT02326272|470819503|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130779657|NCT02326272|470819504|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
130779658|NCT02326272|470819490|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779659|NCT02326272|470819491|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779660|NCT02326272|470819492|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779661|NCT02326272|470819493|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779662|NCT02326272|470819494|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779663|NCT02326272|470819495|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779664|NCT02326272|470819496|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779665|NCT02326272|470819497|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779666|NCT02326272|470819498|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779667|NCT02326272|470819499|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779668|NCT02326272|470819500|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779669|NCT02326272|470819501|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
130779670|NCT02326272|470819502|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779671|NCT02326272|470819503|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130779672|NCT02326272|470819504|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
131138143|NCT03529773|472132768|FG001|Overall Study|Other|0|||
131138144|NCT03529773|472132769|FG002|Overall Study|Other|0|||
131138145|NCT03529773|472132770|FG003|Overall Study|Other|0|||
131138146|NCT03529773|472132771|FG004|Overall Study|Other|0|||
131138147|NCT03529773|472132772|FG005|Overall Study|Other|0|||
131138148|NCT03529773|472132773|FG006|Overall Study|Other|0|||
131138149|NCT03529773|472132774|FG007|Overall Study|Other|0|||
130724691|NCT02861014|470616987|FG000|Safety Follow-up|Physician Decision|1|||
131073958|NCT00460564|471905225|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131073959|NCT00460564|471905226|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
131073960|NCT00460564|471905219|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131073961|NCT00460564|471905220|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131073962|NCT00460564|471905221|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131073963|NCT00460564|471905222|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131073964|NCT00460564|471905223|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
131073965|NCT00460564|471905224|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
131073966|NCT00460564|471905225|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
131073967|NCT00460564|471905226|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
131073968|NCT00460564|471905219|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131073969|NCT00460564|471905220|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131073970|NCT00460564|471905221|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131073971|NCT00460564|471905222|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131073972|NCT00460564|471905223|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
131073973|NCT00460564|471905224|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
131073974|NCT00460564|471905225|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131073975|NCT00460564|471905226|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
131073976|NCT00460564|471905219|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131073977|NCT00460564|471905220|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131073978|NCT00460564|471905221|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131073979|NCT00460564|471905222|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131073980|NCT00460564|471905223|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
131073981|NCT00460564|471905224|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131073982|NCT00460564|471905225|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131073983|NCT00460564|471905226|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
131073984|NCT00320398|471905240|FG000|Overall Study|Adverse Event|1|||
131073985|NCT00320398|471905241|FG001|Overall Study|Adverse Event|4|||
131073986|NCT00320398|471905240|FG000|Overall Study|Other|1|||
131073987|NCT00320398|471905241|FG001|Overall Study|Other|0|||
131073988|NCT00630552|471905242|FG000|Overall Study|Adverse Event|0|||
131073989|NCT00630552|471905243|FG001|Overall Study|Adverse Event|1|||
131073990|NCT00630552|471905244|FG002|Overall Study|Adverse Event|5|||
131073991|NCT00630552|471905245|FG003|Overall Study|Adverse Event|4|||
131073992|NCT00630552|471905246|FG004|Overall Study|Adverse Event|2|||
131073993|NCT00630552|471905242|FG000|Overall Study|Disease progression|5|||
131073994|NCT00630552|471905243|FG001|Overall Study|Disease progression|6|||
131073995|NCT00630552|471905244|FG002|Overall Study|Disease progression|27|||
131073996|NCT00630552|471905245|FG003|Overall Study|Disease progression|22|||
131073997|NCT00630552|471905246|FG004|Overall Study|Disease progression|31|||
131073998|NCT00630552|471905242|FG000|Overall Study|Never received IP|0|||
131073999|NCT00630552|471905243|FG001|Overall Study|Never received IP|0|||
131074000|NCT00630552|471905244|FG002|Overall Study|Never received IP|0|||
131074001|NCT00630552|471905245|FG003|Overall Study|Never received IP|2|||
131074002|NCT00630552|471905246|FG004|Overall Study|Never received IP|2|||
131074003|NCT00630552|471905242|FG000|Overall Study|Ineligibility determined|0|||
131074004|NCT00630552|471905243|FG001|Overall Study|Ineligibility determined|0|||
131074005|NCT00630552|471905244|FG002|Overall Study|Ineligibility determined|0|||
131074006|NCT00630552|471905245|FG003|Overall Study|Ineligibility determined|0|||
131074007|NCT00630552|471905246|FG004|Overall Study|Ineligibility determined|1|||
131074008|NCT00630552|471905242|FG000|Overall Study|Protocol Violation|0|||
131074009|NCT00630552|471905243|FG001|Overall Study|Protocol Violation|0|||
131074010|NCT00630552|471905244|FG002|Overall Study|Protocol Violation|0|||
131074011|NCT00630552|471905245|FG003|Overall Study|Protocol Violation|1|||
131138150|NCT03529773|472132775|FG008|Overall Study|Other|0|||
131138151|NCT03529773|472132776|FG009|Overall Study|Other|0|||
131138152|NCT03529773|472132777|FG010|Overall Study|Other|0|||
131138153|NCT03529773|472132778|FG011|Overall Study|Other|0|||
131138154|NCT03529773|472132779|FG012|Overall Study|Other|1|||
131138155|NCT03529773|472132780|FG013|Overall Study|Other|0|||
131138156|NCT03529773|472132781|FG014|Overall Study|Other|2|||
131138157|NCT03529773|472132782|FG015|Overall Study|Other|0|||
131138158|NCT03529773|472132783|FG016|Overall Study|Other|0|||
131138159|NCT03529773|472132784|FG017|Overall Study|Other|3|||
131138160|NCT03529773|472132785|FG018|Overall Study|Other|0|||
131074012|NCT00630552|471905246|FG004|Overall Study|Protocol Violation|0|||
131074013|NCT00630552|471905242|FG000|Overall Study|Physician Decision|0|||
131074014|NCT00630552|471905243|FG001|Overall Study|Physician Decision|0|||
131074015|NCT00630552|471905244|FG002|Overall Study|Physician Decision|0|||
131074016|NCT00630552|471905245|FG003|Overall Study|Physician Decision|0|||
131074017|NCT00630552|471905246|FG004|Overall Study|Physician Decision|1|||
131074018|NCT00630552|471905242|FG000|Overall Study|Death|0|||
131074019|NCT00630552|471905243|FG001|Overall Study|Death|0|||
131074020|NCT00630552|471905244|FG002|Overall Study|Death|1|||
131074021|NCT00630552|471905245|FG003|Overall Study|Death|2|||
131074022|NCT00630552|471905246|FG004|Overall Study|Death|2|||
131138161|NCT03529773|472132786|FG019|Overall Study|Other|0|||
131074023|NCT00630552|471905242|FG000|Overall Study|Withdrawal by Subject|0|||
131074024|NCT00630552|471905243|FG001|Overall Study|Withdrawal by Subject|0|||
131074025|NCT00630552|471905244|FG002|Overall Study|Withdrawal by Subject|0|||
131074026|NCT00630552|471905245|FG003|Overall Study|Withdrawal by Subject|1|||
131074027|NCT00630552|471905246|FG004|Overall Study|Withdrawal by Subject|0|||
131074028|NCT00630552|471905242|FG000|Overall Study|Other|0|||
131074029|NCT00630552|471905243|FG001|Overall Study|Other|0|||
131074030|NCT00630552|471905244|FG002|Overall Study|Other|4|||
131074031|NCT00630552|471905245|FG003|Overall Study|Other|2|||
131074032|NCT00630552|471905246|FG004|Overall Study|Other|0|||
131074033|NCT04349644|471905247|FG000|Allocation/Pretest|Lost to pretest|0|||
131074034|NCT04349644|471905248|FG001|Allocation/Pretest|Lost to pretest|3|||
131074035|NCT04349644|471905247|FG000|Posttest|Lost to posttest|0|||
131074036|NCT04349644|471905248|FG001|Posttest|Lost to posttest|8|||
131074037|NCT04349644|471905247|FG000|Posttest|Discontinued intervention|6|||
131074038|NCT04349644|471905248|FG001|Posttest|Discontinued intervention|0|||
131074039|NCT04349644|471905247|FG000|Follow-up|Lost to Follow-up|0|||
131074040|NCT04349644|471905248|FG001|Follow-up|Lost to Follow-up|2|||
131074041|NCT00983905|471905250|FG000|Theophylline Alone|Adverse Event|1|||
131074042|NCT00983905|471905250|FG000|Colchicine Alone|Adverse Event|2|||
131074043|NCT02158247|471905251|FG000|Overall Study|Invisible vocal cords|5|||
131074044|NCT02741713|471905252|FG000|Overall Study|Surgery type changed intra-operatively|2|||
131074045|NCT02741713|471905253|FG001|Overall Study|Surgery type changed intra-operatively|1|||
131074046|NCT00809341|471905254|FG000|Overall Study|Physician Decision|0|||
131074047|NCT00809341|471905255|FG001|Overall Study|Physician Decision|1|||
131074048|NCT00225277|471905259|FG000|Overall Study|Adverse Event|30|||
131074049|NCT00225277|471905260|FG001|Overall Study|Adverse Event|34|||
131074050|NCT00225277|471905259|FG000|Overall Study|Lack of Efficacy|4|||
131074051|NCT00225277|471905260|FG001|Overall Study|Lack of Efficacy|1|||
131074052|NCT00225277|471905259|FG000|Overall Study|Lost to Follow-up|4|||
131074053|NCT00225277|471905260|FG001|Overall Study|Lost to Follow-up|6|||
131074054|NCT00225277|471905259|FG000|Overall Study|Physician Decision|6|||
131074055|NCT00225277|471905260|FG001|Overall Study|Physician Decision|8|||
131074056|NCT00225277|471905259|FG000|Overall Study|Protocol Violation|6|||
131074057|NCT00225277|471905260|FG001|Overall Study|Protocol Violation|3|||
131074058|NCT00225277|471905259|FG000|Overall Study|Withdrawal by Subject|40|||
131074059|NCT00225277|471905260|FG001|Overall Study|Withdrawal by Subject|34|||
131074060|NCT00225277|471905259|FG000|Overall Study|Other|7|||
131074061|NCT00225277|471905260|FG001|Overall Study|Other|9|||
131074062|NCT04582669|471905267|FG000|Overall Study|Subject missed appointment(s).|1|||
131074063|NCT04582669|471905268|FG001|Overall Study|Subject missed appointment(s).|0|||
131074064|NCT04582669|471905269|FG002|Overall Study|Subject missed appointment(s).|1|||
131074065|NCT04582669|471905270|FG003|Overall Study|Subject missed appointment(s).|2|||
131074066|NCT04582669|471905267|FG000|Overall Study|Protocol Violation|0|||
131074067|NCT04582669|471905268|FG001|Overall Study|Protocol Violation|1|||
131074068|NCT04582669|471905269|FG002|Overall Study|Protocol Violation|1|||
131074069|NCT04582669|471905270|FG003|Overall Study|Protocol Violation|0|||
131138162|NCT03529773|472132787|FG020|Overall Study|Other|1|||
131138163|NCT03529773|472132788|FG021|Overall Study|Other|0|||
131138164|NCT03529773|472132789|FG022|Overall Study|Other|1|||
131138165|NCT03529773|472132790|FG023|Overall Study|Other|0|||
131138166|NCT03529773|472132791|FG024|Overall Study|Other|3|||
131138167|NCT03529773|472132792|FG025|Overall Study|Other|2|||
131138168|NCT03529773|472132793|FG026|Overall Study|Other|2|||
131138169|NCT03529773|472132794|FG027|Overall Study|Other|0|||
131138170|NCT03529773|472132795|FG028|Overall Study|Other|0|||
131074070|NCT00591409|471905271|FG000|Overall Study|Not Treated|0|||
131074071|NCT00591409|471905272|FG001|Overall Study|Not Treated|0|||
131074072|NCT00591409|471905273|FG002|Overall Study|Not Treated|0|||
131074073|NCT00591409|471905274|FG003|Overall Study|Not Treated|0|||
131074074|NCT00591409|471905275|FG004|Overall Study|Not Treated|1|||
131074075|NCT00591409|471905276|FG005|Overall Study|Not Treated|0|||
131074076|NCT00591409|471905277|FG006|Overall Study|Not Treated|0|||
131074077|NCT00591409|471905278|FG007|Overall Study|Not Treated|0|||
131074078|NCT00591409|471905279|FG008|Overall Study|Not Treated|0|||
131074079|NCT00591409|471905280|FG009|Overall Study|Not Treated|1|||
131074080|NCT00677092|471905281|FG000|Overall Study|Adverse Event|1|||
131074081|NCT00677092|471905281|FG000|Overall Study|Lost to Follow-up|1|||
131138171|NCT03529773|472132796|FG029|Overall Study|Other|0|||
131138172|NCT03529773|472132797|FG030|Overall Study|Other|0|||
131074082|NCT00677092|471905281|FG000|Overall Study|Withdrawal by Subject|3|||
131074083|NCT00677092|471905281|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
131074084|NCT00550446|471905282|FG000|Up To Week 12|Adverse Event|2|||
131074085|NCT00550446|471905283|FG001|Up To Week 12|Adverse Event|2|||
131074086|NCT00550446|471905284|FG002|Up To Week 12|Adverse Event|0|||
131074087|NCT00550446|471905285|FG003|Up To Week 12|Adverse Event|0|||
131138173|NCT03529773|472132798|FG031|Overall Study|Other|0|||
131074088|NCT00550446|471905286|FG004|Up To Week 12|Adverse Event|2|||
131074089|NCT00550446|471905287|FG005|Up To Week 12|Adverse Event|2|||
131074090|NCT00550446|471905288|FG006|Up To Week 12|Adverse Event|1|||
131138174|NCT03529773|472132799|FG032|Overall Study|Other|0|||
131138175|NCT03529773|472132800|FG033|Overall Study|Other|0|||
131074091|NCT00550446|471905289|FG007|Up To Week 12|Adverse Event|0|||
131074092|NCT00550446|471905290|FG008|Up To Week 12|Adverse Event|0|||
131074093|NCT00550446|471905291|FG009|Up To Week 12|Adverse Event|0|||
131074094|NCT00550446|471905292|FG010|Up To Week 12|Adverse Event|0|||
131074095|NCT00550446|471905282|FG000|Up To Week 12|Lack of Efficacy|3|||
131074096|NCT00550446|471905283|FG001|Up To Week 12|Lack of Efficacy|1|||
131074097|NCT00550446|471905284|FG002|Up To Week 12|Lack of Efficacy|0|||
131074098|NCT00550446|471905285|FG003|Up To Week 12|Lack of Efficacy|1|||
131074099|NCT00550446|471905286|FG004|Up To Week 12|Lack of Efficacy|0|||
131074100|NCT00550446|471905287|FG005|Up To Week 12|Lack of Efficacy|3|||
131074101|NCT00550446|471905288|FG006|Up To Week 12|Lack of Efficacy|3|||
131074102|NCT00550446|471905289|FG007|Up To Week 12|Lack of Efficacy|0|||
131074103|NCT00550446|471905290|FG008|Up To Week 12|Lack of Efficacy|0|||
131074104|NCT00550446|471905291|FG009|Up To Week 12|Lack of Efficacy|0|||
131074105|NCT00550446|471905292|FG010|Up To Week 12|Lack of Efficacy|0|||
131074106|NCT00550446|471905282|FG000|Up To Week 12|Lost to Follow-up|0|||
131074107|NCT00550446|471905283|FG001|Up To Week 12|Lost to Follow-up|1|||
131074108|NCT00550446|471905284|FG002|Up To Week 12|Lost to Follow-up|0|||
131074109|NCT00550446|471905285|FG003|Up To Week 12|Lost to Follow-up|0|||
131074110|NCT00550446|471905286|FG004|Up To Week 12|Lost to Follow-up|1|||
131074111|NCT00550446|471905287|FG005|Up To Week 12|Lost to Follow-up|1|||
131074112|NCT00550446|471905288|FG006|Up To Week 12|Lost to Follow-up|2|||
131074113|NCT00550446|471905289|FG007|Up To Week 12|Lost to Follow-up|0|||
131074114|NCT00550446|471905290|FG008|Up To Week 12|Lost to Follow-up|0|||
131074115|NCT00550446|471905291|FG009|Up To Week 12|Lost to Follow-up|0|||
131074116|NCT00550446|471905292|FG010|Up To Week 12|Lost to Follow-up|0|||
131074117|NCT00550446|471905282|FG000|Up To Week 12|Withdrawal by Subject|2|||
131074118|NCT00550446|471905283|FG001|Up To Week 12|Withdrawal by Subject|0|||
131074119|NCT00550446|471905284|FG002|Up To Week 12|Withdrawal by Subject|3|||
131074120|NCT00550446|471905285|FG003|Up To Week 12|Withdrawal by Subject|2|||
131074121|NCT00550446|471905286|FG004|Up To Week 12|Withdrawal by Subject|0|||
131074122|NCT00550446|471905287|FG005|Up To Week 12|Withdrawal by Subject|1|||
131074123|NCT00550446|471905288|FG006|Up To Week 12|Withdrawal by Subject|3|||
131074124|NCT00550446|471905289|FG007|Up To Week 12|Withdrawal by Subject|0|||
131074125|NCT00550446|471905290|FG008|Up To Week 12|Withdrawal by Subject|0|||
131074126|NCT00550446|471905291|FG009|Up To Week 12|Withdrawal by Subject|0|||
131074127|NCT00550446|471905292|FG010|Up To Week 12|Withdrawal by Subject|0|||
131074128|NCT00550446|471905282|FG000|Up To Week 12|Other|3|||
131074129|NCT00550446|471905283|FG001|Up To Week 12|Other|0|||
131074130|NCT00550446|471905284|FG002|Up To Week 12|Other|0|||
131074131|NCT00550446|471905285|FG003|Up To Week 12|Other|0|||
131074132|NCT00550446|471905286|FG004|Up To Week 12|Other|0|||
131074133|NCT00550446|471905287|FG005|Up To Week 12|Other|1|||
131074134|NCT00550446|471905288|FG006|Up To Week 12|Other|4|||
131074135|NCT00550446|471905289|FG007|Up To Week 12|Other|0|||
131074136|NCT00550446|471905290|FG008|Up To Week 12|Other|0|||
131074137|NCT00550446|471905291|FG009|Up To Week 12|Other|0|||
131074138|NCT00550446|471905292|FG010|Up To Week 12|Other|0|||
131074139|NCT00550446|471905282|FG000|Up To Week 12|Randomized not treated|0|||
131074140|NCT00550446|471905283|FG001|Up To Week 12|Randomized not treated|1|||
131074141|NCT00550446|471905284|FG002|Up To Week 12|Randomized not treated|1|||
131074142|NCT00550446|471905285|FG003|Up To Week 12|Randomized not treated|0|||
131074143|NCT00550446|471905286|FG004|Up To Week 12|Randomized not treated|0|||
131074144|NCT00550446|471905287|FG005|Up To Week 12|Randomized not treated|0|||
131074145|NCT00550446|471905288|FG006|Up To Week 12|Randomized not treated|0|||
131074146|NCT00550446|471905289|FG007|Up To Week 12|Randomized not treated|0|||
131074147|NCT00550446|471905290|FG008|Up To Week 12|Randomized not treated|0|||
131074148|NCT00550446|471905291|FG009|Up To Week 12|Randomized not treated|0|||
131074149|NCT00550446|471905292|FG010|Up To Week 12|Randomized not treated|0|||
131074150|NCT00550446|471905282|FG000|Post Week 12|Adverse Event|2|||
131074151|NCT00550446|471905283|FG001|Post Week 12|Adverse Event|1|||
131074152|NCT00550446|471905284|FG002|Post Week 12|Adverse Event|1|||
131074153|NCT00550446|471905285|FG003|Post Week 12|Adverse Event|1|||
131074154|NCT00550446|471905286|FG004|Post Week 12|Adverse Event|1|||
131074155|NCT00550446|471905287|FG005|Post Week 12|Adverse Event|1|||
131074156|NCT00550446|471905288|FG006|Post Week 12|Adverse Event|0|||
131074157|NCT00550446|471905289|FG007|Post Week 12|Adverse Event|0|||
131074158|NCT00550446|471905290|FG008|Post Week 12|Adverse Event|0|||
131074159|NCT00550446|471905291|FG009|Post Week 12|Adverse Event|4|||
131074160|NCT00550446|471905292|FG010|Post Week 12|Adverse Event|0|||
131074161|NCT00550446|471905282|FG000|Post Week 12|Lack of Efficacy|0|||
131074162|NCT00550446|471905283|FG001|Post Week 12|Lack of Efficacy|0|||
131074163|NCT00550446|471905284|FG002|Post Week 12|Lack of Efficacy|1|||
131074164|NCT00550446|471905285|FG003|Post Week 12|Lack of Efficacy|0|||
131074165|NCT00550446|471905286|FG004|Post Week 12|Lack of Efficacy|0|||
131074166|NCT00550446|471905287|FG005|Post Week 12|Lack of Efficacy|0|||
131074167|NCT00550446|471905288|FG006|Post Week 12|Lack of Efficacy|0|||
131074168|NCT00550446|471905289|FG007|Post Week 12|Lack of Efficacy|1|||
131074169|NCT00550446|471905290|FG008|Post Week 12|Lack of Efficacy|1|||
131074170|NCT00550446|471905291|FG009|Post Week 12|Lack of Efficacy|2|||
131138176|NCT03529773|472132801|FG034|Overall Study|Other|1|||
131138177|NCT03529773|472132802|FG035|Overall Study|Other|1|||
131138178|NCT03529773|472132803|FG036|Overall Study|Other|0|||
130724692|NCT02861014|470616987|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
130724693|NCT02861014|470616987|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
130724694|NCT00926783|470616988|FG000|Overall Study|Incomplete CFAE Procedures|3|||
130724695|NCT00926783|470616989|FG001|Overall Study|Incomplete CFAE Procedures|3|||
130724696|NCT04581369|470616991|FG000|Overall Study|Death|7|||
130724697|NCT04581369|470616992|FG001|Overall Study|Death|6|||
131074171|NCT00550446|471905292|FG010|Post Week 12|Lack of Efficacy|1|||
131074172|NCT00550446|471905282|FG000|Post Week 12|Lost to Follow-up|0|||
131074173|NCT00550446|471905283|FG001|Post Week 12|Lost to Follow-up|0|||
131074174|NCT00550446|471905284|FG002|Post Week 12|Lost to Follow-up|1|||
131074175|NCT00550446|471905285|FG003|Post Week 12|Lost to Follow-up|1|||
131074176|NCT00550446|471905286|FG004|Post Week 12|Lost to Follow-up|0|||
131074177|NCT00550446|471905287|FG005|Post Week 12|Lost to Follow-up|0|||
131074178|NCT00550446|471905288|FG006|Post Week 12|Lost to Follow-up|1|||
131074179|NCT00550446|471905289|FG007|Post Week 12|Lost to Follow-up|0|||
131074180|NCT00550446|471905290|FG008|Post Week 12|Lost to Follow-up|0|||
131074181|NCT00550446|471905291|FG009|Post Week 12|Lost to Follow-up|0|||
131074182|NCT00550446|471905292|FG010|Post Week 12|Lost to Follow-up|0|||
131074183|NCT00550446|471905282|FG000|Post Week 12|Withdrawal by Subject|0|||
131074184|NCT00550446|471905283|FG001|Post Week 12|Withdrawal by Subject|0|||
131074185|NCT00550446|471905284|FG002|Post Week 12|Withdrawal by Subject|0|||
131074186|NCT00550446|471905285|FG003|Post Week 12|Withdrawal by Subject|0|||
131074187|NCT00550446|471905286|FG004|Post Week 12|Withdrawal by Subject|1|||
131074188|NCT00550446|471905287|FG005|Post Week 12|Withdrawal by Subject|0|||
131074189|NCT00550446|471905288|FG006|Post Week 12|Withdrawal by Subject|0|||
131074190|NCT00550446|471905289|FG007|Post Week 12|Withdrawal by Subject|0|||
131074191|NCT00550446|471905290|FG008|Post Week 12|Withdrawal by Subject|0|||
131074192|NCT00550446|471905291|FG009|Post Week 12|Withdrawal by Subject|0|||
131074193|NCT00550446|471905292|FG010|Post Week 12|Withdrawal by Subject|0|||
131074194|NCT00550446|471905282|FG000|Post Week 12|Other|1|||
131074195|NCT00550446|471905283|FG001|Post Week 12|Other|1|||
131074196|NCT00550446|471905284|FG002|Post Week 12|Other|0|||
131074197|NCT00550446|471905285|FG003|Post Week 12|Other|1|||
131074198|NCT00550446|471905286|FG004|Post Week 12|Other|0|||
131074199|NCT00550446|471905287|FG005|Post Week 12|Other|0|||
131074200|NCT00550446|471905288|FG006|Post Week 12|Other|1|||
131074201|NCT00550446|471905289|FG007|Post Week 12|Other|0|||
131074202|NCT00550446|471905290|FG008|Post Week 12|Other|1|||
131074203|NCT00550446|471905291|FG009|Post Week 12|Other|1|||
131074204|NCT00550446|471905292|FG010|Post Week 12|Other|0|||
131074205|NCT02716298|471905293|FG000|First Intervention (1 Month)|Lens discomfort|1|||
131074206|NCT02716298|471905294|FG001|First Intervention (1 Month)|Lens discomfort|1|||
131074207|NCT03503162|471905295|FG000|Overall Study|did not meet eligibility|1|||
131074208|NCT04952701|471905296|FG000|Control Lens|Physician Decision|4|||
131074209|NCT04952701|471905296|FG000|Test Lens|Physician Decision|1|||
131074210|NCT00578318|471905303|FG000|Overall Study|Lost to Follow-up|2|||
131074211|NCT00578318|471905304|FG001|Overall Study|Lost to Follow-up|0|||
131074212|NCT00578318|471905303|FG000|Overall Study|Physician Decision|1|||
131074213|NCT00578318|471905304|FG001|Overall Study|Physician Decision|0|||
131074214|NCT00866918|471905305|FG000|Overall Study|Death|1|||
131074215|NCT00866918|471905306|FG001|Overall Study|Death|5|||
131074216|NCT00866918|471905305|FG000|Overall Study|Lack of Efficacy|1|||
131074217|NCT00866918|471905306|FG001|Overall Study|Lack of Efficacy|1|||
131074218|NCT00866918|471905305|FG000|Overall Study|Physician Decision|10|||
131074219|NCT00866918|471905306|FG001|Overall Study|Physician Decision|2|||
131074220|NCT00866918|471905305|FG000|Overall Study|Ineligible|2|||
131074221|NCT00866918|471905306|FG001|Overall Study|Ineligible|4|||
131074222|NCT00866918|471905305|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
131074223|NCT00866918|471905306|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
131074224|NCT00866918|471905305|FG000|Overall Study|Secondary malignancy|1|||
131074225|NCT00866918|471905306|FG001|Overall Study|Secondary malignancy|0|||
131074226|NCT00527514|471905308|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
131074227|NCT00527514|471905308|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
131074228|NCT00527514|471905308|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
131074229|NCT00527514|471905308|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
130724698|NCT04581369|470616993|FG002|Overall Study|Death|0|||
131074230|NCT00527514|471905308|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
131074231|NCT00527514|471905308|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
131138179|NCT03529773|472132804|FG037|Overall Study|Other|0|||
130724699|NCT04581369|470616991|FG000|Overall Study|Lost to Follow-up|7|||
130724700|NCT04581369|470616992|FG001|Overall Study|Lost to Follow-up|3|||
131074232|NCT00527514|471905308|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
131074233|NCT00920699|471905313|FG000|Overall Study|Withdrawal by Subject|2|||
131074234|NCT00920699|471905314|FG001|Overall Study|Withdrawal by Subject|0|||
130724701|NCT04581369|470616993|FG002|Overall Study|Lost to Follow-up|0|||
131138180|NCT03529773|472132805|FG038|Overall Study|Other|0|||
131074235|NCT00920699|471905315|FG002|Overall Study|Withdrawal by Subject|2|||
131074236|NCT00920699|471905313|FG000|Overall Study|no longer met eligibility|0|||
131074237|NCT00920699|471905314|FG001|Overall Study|no longer met eligibility|1|||
131074238|NCT00920699|471905315|FG002|Overall Study|no longer met eligibility|0|||
131074239|NCT00920699|471905313|FG000|Overall Study|Lost to Follow-up|0|||
131074240|NCT00920699|471905314|FG001|Overall Study|Lost to Follow-up|0|||
131074241|NCT00920699|471905315|FG002|Overall Study|Lost to Follow-up|2|||
131074242|NCT00001941|471905318|FG000|Overall Study|not treated- rapidly progressing disease|0|||
131074243|NCT00001941|471905319|FG001|Overall Study|not treated- rapidly progressing disease|0|||
131074244|NCT00001941|471905320|FG002|Overall Study|not treated- rapidly progressing disease|0|||
131074245|NCT00001941|471905321|FG003|Overall Study|not treated- rapidly progressing disease|0|||
131074246|NCT00001941|471905322|FG004|Overall Study|not treated- rapidly progressing disease|1|||
131074247|NCT01281917|471905331|FG000|Overall Study|Withdrawal by Subject|1|||
131074248|NCT00363649|471905333|FG000|Overall Study|Withdrawal by Subject|1|||
131074249|NCT00363649|471905334|FG001|Overall Study|Withdrawal by Subject|1|||
131074250|NCT00363649|471905333|FG000|Overall Study|Adverse Event|6|||
131074251|NCT00363649|471905334|FG001|Overall Study|Adverse Event|0|||
131074252|NCT04947436|471905337|FG000|Overall Study|Lost to Follow-up|3|||
131074253|NCT04947436|471905338|FG001|Overall Study|Lost to Follow-up|7|||
131074254|NCT04947436|471905339|FG002|Overall Study|Lost to Follow-up|5|||
131074255|NCT04947436|471905337|FG000|Overall Study|Death|1|||
131074256|NCT04947436|471905338|FG001|Overall Study|Death|1|||
131138181|NCT03529773|472132806|FG039|Overall Study|Other|0|||
131138182|NCT03529773|472132767|FG000|Overall Study|Physician Decision|0|||
131138183|NCT03529773|472132768|FG001|Overall Study|Physician Decision|0|||
131138184|NCT03529773|472132769|FG002|Overall Study|Physician Decision|0|||
131138185|NCT03529773|472132770|FG003|Overall Study|Physician Decision|0|||
131138186|NCT03529773|472132771|FG004|Overall Study|Physician Decision|0|||
131138187|NCT03529773|472132772|FG005|Overall Study|Physician Decision|0|||
131138188|NCT03529773|472132773|FG006|Overall Study|Physician Decision|0|||
131138189|NCT03529773|472132774|FG007|Overall Study|Physician Decision|0|||
131138190|NCT03529773|472132775|FG008|Overall Study|Physician Decision|0|||
131138191|NCT03529773|472132776|FG009|Overall Study|Physician Decision|0|||
131138192|NCT03529773|472132777|FG010|Overall Study|Physician Decision|0|||
131138193|NCT03529773|472132778|FG011|Overall Study|Physician Decision|0|||
131138194|NCT03529773|472132779|FG012|Overall Study|Physician Decision|0|||
130724702|NCT04581369|470616991|FG000|Overall Study|liver transplant|2|||
130724703|NCT04581369|470616992|FG001|Overall Study|liver transplant|2|||
130724704|NCT04581369|470616993|FG002|Overall Study|liver transplant|0|||
130724705|NCT04581369|470616991|FG000|Overall Study|transitioned to hospice care|0|||
130724706|NCT04581369|470616992|FG001|Overall Study|transitioned to hospice care|5|||
130724707|NCT04581369|470616993|FG002|Overall Study|transitioned to hospice care|0|||
130724708|NCT00780910|470616994|FG000|Overall Study|Adverse Event|2|||
130724709|NCT01111825|470616997|FG000|Overall Study|Withdrawal by Subject|0|||
130724710|NCT01111825|470616998|FG001|Overall Study|Withdrawal by Subject|0|||
130724711|NCT01111825|470616999|FG002|Overall Study|Withdrawal by Subject|1|||
131138195|NCT03529773|472132780|FG013|Overall Study|Physician Decision|0|||
131138196|NCT03529773|472132781|FG014|Overall Study|Physician Decision|0|||
131138197|NCT03529773|472132782|FG015|Overall Study|Physician Decision|0|||
131138198|NCT03529773|472132783|FG016|Overall Study|Physician Decision|0|||
131138199|NCT03529773|472132784|FG017|Overall Study|Physician Decision|0|||
131138200|NCT03529773|472132785|FG018|Overall Study|Physician Decision|0|||
131138201|NCT03529773|472132786|FG019|Overall Study|Physician Decision|1|||
131138202|NCT03529773|472132787|FG020|Overall Study|Physician Decision|1|||
131138203|NCT03529773|472132788|FG021|Overall Study|Physician Decision|0|||
131138204|NCT03529773|472132789|FG022|Overall Study|Physician Decision|0|||
130724712|NCT01111825|470617000|FG003|Overall Study|Withdrawal by Subject|0|||
131074257|NCT04947436|471905339|FG002|Overall Study|Death|1|||
131074258|NCT02161185|471905341|FG000|Treatment Phase|Administrative/Other|7|||
131138205|NCT03529773|472132790|FG023|Overall Study|Physician Decision|0|||
131138206|NCT03529773|472132791|FG024|Overall Study|Physician Decision|0|||
131138207|NCT03529773|472132792|FG025|Overall Study|Physician Decision|0|||
130724713|NCT01111825|470616997|FG000|Overall Study|Lost to Follow-up|0|||
131074259|NCT02970305|471905347|FG000|Overall Study|Adverse Event|10|||
131138208|NCT03529773|472132793|FG026|Overall Study|Physician Decision|0|||
131138209|NCT03529773|472132794|FG027|Overall Study|Physician Decision|0|||
130724714|NCT01111825|470616998|FG001|Overall Study|Lost to Follow-up|0|||
130724715|NCT01111825|470616999|FG002|Overall Study|Lost to Follow-up|3|||
130724716|NCT01111825|470617000|FG003|Overall Study|Lost to Follow-up|1|||
130724717|NCT01111825|470616997|FG000|Overall Study|Adverse Event|2|||
131074260|NCT02970305|471905348|FG001|Overall Study|Adverse Event|6|||
131074261|NCT02970305|471905347|FG000|Overall Study|Lack of Efficacy|1|||
131074262|NCT02970305|471905348|FG001|Overall Study|Lack of Efficacy|1|||
131074263|NCT02970305|471905347|FG000|Overall Study|Noncompliance with study drug|2|||
131074264|NCT02970305|471905348|FG001|Overall Study|Noncompliance with study drug|4|||
131074265|NCT02970305|471905347|FG000|Overall Study|Protocol Violation|2|||
131074266|NCT02970305|471905348|FG001|Overall Study|Protocol Violation|2|||
131138210|NCT03529773|472132795|FG028|Overall Study|Physician Decision|0|||
131138211|NCT03529773|472132796|FG029|Overall Study|Physician Decision|0|||
131074267|NCT02970305|471905347|FG000|Overall Study|Withdrawal by Subject|12|||
131074268|NCT02970305|471905348|FG001|Overall Study|Withdrawal by Subject|11|||
131074269|NCT02970305|471905347|FG000|Overall Study|Not further specified|1|||
131074270|NCT02970305|471905348|FG001|Overall Study|Not further specified|2|||
131074271|NCT02970305|471905347|FG000|Overall Study|Lost to Follow-up|1|||
131074272|NCT02970305|471905348|FG001|Overall Study|Lost to Follow-up|2|||
131074273|NCT00983892|471905349|FG000|Overall Study|Withdrawal by Subject|10|||
131074274|NCT00983892|471905350|FG001|Overall Study|Withdrawal by Subject|12|||
131074275|NCT03512288|471905354|FG000|Overall Study|Adverse Event|1|||
131074276|NCT03512288|471905355|FG001|Overall Study|Adverse Event|0|||
131074277|NCT03512288|471905354|FG000|Overall Study|Lost to Follow-up|12|||
131074278|NCT03512288|471905355|FG001|Overall Study|Lost to Follow-up|15|||
131074279|NCT03512288|471905354|FG000|Overall Study|Physician Decision|0|||
131074280|NCT03512288|471905355|FG001|Overall Study|Physician Decision|2|||
131074281|NCT03512288|471905354|FG000|Overall Study|Protocol Violation|6|||
131074282|NCT03512288|471905355|FG001|Overall Study|Protocol Violation|4|||
131074283|NCT03512288|471905354|FG000|Overall Study|Medication error without associated adverse event|1|||
131074284|NCT03512288|471905355|FG001|Overall Study|Medication error without associated adverse event|0|||
131074285|NCT03512288|471905354|FG000|Overall Study|No longer met eligibility criteria|5|||
131074286|NCT03512288|471905355|FG001|Overall Study|No longer met eligibility criteria|2|||
131074287|NCT03512288|471905354|FG000|Overall Study|Withdrawal by parent/guardian|14|||
131074288|NCT03512288|471905355|FG001|Overall Study|Withdrawal by parent/guardian|18|||
131074289|NCT03512288|471905354|FG000|Overall Study|Other|1|||
131074290|NCT03512288|471905355|FG001|Overall Study|Other|1|||
131074291|NCT03512288|471905354|FG000|Overall Study|Randomized but not treated|1|||
131074292|NCT03512288|471905355|FG001|Overall Study|Randomized but not treated|1|||
131074293|NCT04206384|471905356|FG000|Overall Study|Withdrawal by Subject|8|||
131074294|NCT04206384|471905356|FG000|Overall Study|Adverse Event|2|||
131074295|NCT01208870|471905359|FG000|Overall Study|Lost to Follow-up|2|||
131074296|NCT01208870|471905360|FG001|Overall Study|Lost to Follow-up|8|||
131074297|NCT03015181|471905362|FG000|Overall Study|Enrolled, but product never administered|1|||
131074298|NCT03015181|471905363|FG001|Overall Study|Enrolled, but product never administered|0|||
131074299|NCT03015181|471905364|FG002|Overall Study|Enrolled, but product never administered|0|||
131074300|NCT03015181|471905365|FG003|Overall Study|Enrolled, but product never administered|0|||
131074301|NCT03015181|471905366|FG004|Overall Study|Enrolled, but product never administered|0|||
131074302|NCT03015181|471905367|FG005|Overall Study|Enrolled, but product never administered|0|||
131074303|NCT03015181|471905368|FG006|Overall Study|Enrolled, but product never administered|0|||
131074304|NCT03015181|471905362|FG000|Overall Study|Withdrawal by Subject|0|||
131074305|NCT03015181|471905363|FG001|Overall Study|Withdrawal by Subject|0|||
131074306|NCT03015181|471905364|FG002|Overall Study|Withdrawal by Subject|0|||
131074307|NCT03015181|471905365|FG003|Overall Study|Withdrawal by Subject|0|||
131074308|NCT03015181|471905366|FG004|Overall Study|Withdrawal by Subject|0|||
131074309|NCT03015181|471905367|FG005|Overall Study|Withdrawal by Subject|1|||
131074310|NCT03015181|471905368|FG006|Overall Study|Withdrawal by Subject|0|||
131074311|NCT03015181|471905362|FG000|Overall Study|Physician Decision|0|||
131074312|NCT03015181|471905363|FG001|Overall Study|Physician Decision|0|||
131074313|NCT03015181|471905364|FG002|Overall Study|Physician Decision|0|||
131074314|NCT03015181|471905365|FG003|Overall Study|Physician Decision|0|||
131074315|NCT03015181|471905366|FG004|Overall Study|Physician Decision|0|||
131074316|NCT03015181|471905367|FG005|Overall Study|Physician Decision|0|||
131074317|NCT03015181|471905368|FG006|Overall Study|Physician Decision|1|||
131074318|NCT02551692|471905371|FG000|Overall Study|Lost to Follow-up|0|||
131074319|NCT02551692|471905372|FG001|Overall Study|Lost to Follow-up|1|||
131074320|NCT02551692|471905373|FG002|Overall Study|Lost to Follow-up|4|||
131074321|NCT02551692|471905371|FG000|Overall Study|Withdrawal by Subject|1|||
131074322|NCT02551692|471905372|FG001|Overall Study|Withdrawal by Subject|0|||
131074323|NCT02551692|471905373|FG002|Overall Study|Withdrawal by Subject|1|||
131074324|NCT01177228|471905374|FG000|Overall Study|Positive tuberculosis test|0|||
131074325|NCT01177228|471905375|FG001|Overall Study|Positive tuberculosis test|1|||
131074326|NCT01177228|471905376|FG002|Overall Study|Positive tuberculosis test|0|||
131074327|NCT01177228|471905377|FG003|Overall Study|Positive tuberculosis test|0|||
131074328|NCT01177228|471905374|FG000|Overall Study|Worsening disease activity|1|||
131074329|NCT01177228|471905375|FG001|Overall Study|Worsening disease activity|0|||
131074330|NCT01177228|471905376|FG002|Overall Study|Worsening disease activity|0|||
131138212|NCT03529773|472132797|FG030|Overall Study|Physician Decision|0|||
131138213|NCT03529773|472132798|FG031|Overall Study|Physician Decision|0|||
131074331|NCT01177228|471905377|FG003|Overall Study|Worsening disease activity|0|||
131074332|NCT01177228|471905374|FG000|Overall Study|Withdrawal by Subject|0|||
131074333|NCT01177228|471905375|FG001|Overall Study|Withdrawal by Subject|1|||
131074334|NCT01177228|471905376|FG002|Overall Study|Withdrawal by Subject|0|||
131074335|NCT01177228|471905377|FG003|Overall Study|Withdrawal by Subject|0|||
131074336|NCT01494298|471905378|FG000|Overall Study|Protocol Violation|2|||
131074337|NCT01494298|471905379|FG001|Overall Study|Protocol Violation|8|||
131074338|NCT00006436|471905381|FG000|Overall Study|Refused further treatment|2|||
131074339|NCT00006436|471905381|FG000|Overall Study|Declined to participate (before treatment started)|1|||
131074340|NCT00316589|471905382|FG000|Overall Study|Withdrawal by Subject|0|||
131074341|NCT00316589|471905383|FG001|Overall Study|Withdrawal by Subject|5|||
131074342|NCT00316589|471905384|FG002|Overall Study|Withdrawal by Subject|0|||
131074343|NCT00316589|471905385|FG003|Overall Study|Withdrawal by Subject|1|||
131074344|NCT00316589|471905382|FG000|Overall Study|Subject unwilling/unable to comply|0|||
131074345|NCT00316589|471905383|FG001|Overall Study|Subject unwilling/unable to comply|6|||
131074346|NCT00316589|471905384|FG002|Overall Study|Subject unwilling/unable to comply|0|||
131074347|NCT00316589|471905385|FG003|Overall Study|Subject unwilling/unable to comply|2|||
131074348|NCT00316589|471905382|FG000|Overall Study|Adverse Event|1|||
131074349|NCT00316589|471905383|FG001|Overall Study|Adverse Event|0|||
131074350|NCT00316589|471905384|FG002|Overall Study|Adverse Event|0|||
131074351|NCT00316589|471905385|FG003|Overall Study|Adverse Event|1|||
131074352|NCT00316589|471905382|FG000|Overall Study|Physician Decision|0|||
131074353|NCT00316589|471905383|FG001|Overall Study|Physician Decision|1|||
131074354|NCT00316589|471905384|FG002|Overall Study|Physician Decision|0|||
131074355|NCT00316589|471905385|FG003|Overall Study|Physician Decision|0|||
131074356|NCT00316589|471905382|FG000|Overall Study|Other reason|0|||
131074357|NCT00316589|471905383|FG001|Overall Study|Other reason|12|||
131074358|NCT00316589|471905384|FG002|Overall Study|Other reason|1|||
131074359|NCT00316589|471905385|FG003|Overall Study|Other reason|1|||
131074360|NCT01482819|471905386|FG000|Overall Study|Lost to Follow-up|2|||
131074361|NCT00562484|471905389|FG000|Overall Study|Adverse Event|6|||
131074362|NCT00562484|471905390|FG001|Overall Study|Adverse Event|1|||
131074363|NCT00562484|471905389|FG000|Overall Study|Protocol Violation|11|||
131074364|NCT00562484|471905390|FG001|Overall Study|Protocol Violation|2|||
131074365|NCT00562484|471905389|FG000|Overall Study|Withdrawal by Subject|12|||
131074366|NCT00562484|471905390|FG001|Overall Study|Withdrawal by Subject|9|||
131074367|NCT00562484|471905389|FG000|Overall Study|Moved away from the study area|20|||
131074368|NCT00562484|471905390|FG001|Overall Study|Moved away from the study area|9|||
131074369|NCT00562484|471905389|FG000|Overall Study|Lost to Follow-up|132|||
131074370|NCT00562484|471905390|FG001|Overall Study|Lost to Follow-up|71|||
131074371|NCT00562484|471905389|FG000|Overall Study|Reason not provided or not specified|25|||
131074372|NCT00562484|471905390|FG001|Overall Study|Reason not provided or not specified|12|||
131074373|NCT05041439|471905392|FG000|Overall Study|Withdrawal by Subject|1|||
131074374|NCT05041439|471905393|FG001|Overall Study|Withdrawal by Subject|1|||
131074375|NCT05041439|471905392|FG000|Overall Study|Death|1|||
131074376|NCT05041439|471905393|FG001|Overall Study|Death|0|||
131074377|NCT01904136|471906859|FG000|Overall Study|Physician Decision|0|||
131074378|NCT01904136|471906860|FG001|Overall Study|Physician Decision|0|||
131074379|NCT01904136|471906861|FG002|Overall Study|Physician Decision|0|||
131074380|NCT01904136|471906862|FG003|Overall Study|Physician Decision|0|||
131074381|NCT01904136|471906863|FG004|Overall Study|Physician Decision|0|||
131074382|NCT01904136|471906864|FG005|Overall Study|Physician Decision|1|||
131074383|NCT01904136|471906865|FG006|Overall Study|Physician Decision|0|||
131074384|NCT01904136|471906866|FG007|Overall Study|Physician Decision|0|||
131074385|NCT01904136|471906867|FG008|Overall Study|Physician Decision|0|||
131074386|NCT01929876|471906876|FG000|Period 2|Non-Compliance|1|||
131074387|NCT01845649|471906879|FG000|Overall Study|Adverse Event|7|||
131074388|NCT01845649|471906880|FG001|Overall Study|Adverse Event|10|||
131074389|NCT01845649|471906879|FG000|Overall Study|Lack of Efficacy|1|||
131074390|NCT01845649|471906880|FG001|Overall Study|Lack of Efficacy|1|||
131074391|NCT01845649|471906879|FG000|Overall Study|Lost to Follow-up|2|||
131074392|NCT01845649|471906880|FG001|Overall Study|Lost to Follow-up|2|||
131074393|NCT01845649|471906879|FG000|Overall Study|Withdrew Consent|12|||
131074394|NCT01845649|471906880|FG001|Overall Study|Withdrew Consent|4|||
131074395|NCT01845649|471906879|FG000|Overall Study|Protocol Deviation|7|||
131074396|NCT01845649|471906880|FG001|Overall Study|Protocol Deviation|4|||
131074397|NCT01845649|471906879|FG000|Overall Study|Reason not Specified|2|||
131074398|NCT01845649|471906880|FG001|Overall Study|Reason not Specified|1|||
131074399|NCT03991988|471906881|FG000|Overall Study|Withdrawal by Subject|2|||
131074400|NCT03991988|471906882|FG001|Overall Study|Withdrawal by Subject|2|||
131074401|NCT01222533|471906883|FG000|Overall Study|Adverse Event|5|||
131074402|NCT01222533|471906883|FG000|Overall Study|Withdrawal by Subject|5|||
131074403|NCT01222533|471906883|FG000|Overall Study|Other|4|||
131074404|NCT00487552|471906884|FG000|Overall Study|Unsuccessful magnet placements|3|||
131074405|NCT00487552|471906884|FG000|Overall Study|Death due to progressive malignancy|2|||
131074406|NCT00487552|471906884|FG000|Overall Study|Stent not placed|1|||
131074407|NCT02412111|471906885|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
130779673|NCT02326272|470819490|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131074408|NCT02412111|471906886|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
131074409|NCT02412111|471906887|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
131074410|NCT02412111|471906885|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
131074411|NCT02412111|471906886|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
131138214|NCT03529773|472132799|FG032|Overall Study|Physician Decision|0|||
131138215|NCT03529773|472132800|FG033|Overall Study|Physician Decision|0|||
131138216|NCT03529773|472132801|FG034|Overall Study|Physician Decision|0|||
131074412|NCT02412111|471906887|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
131074413|NCT02412111|471906885|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
131074414|NCT02412111|471906886|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
131074415|NCT02412111|471906887|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
131074416|NCT02412111|471906885|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
131074417|NCT02412111|471906886|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
131074418|NCT02412111|471906887|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
131074419|NCT02412111|471906885|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
131074420|NCT02412111|471906886|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
131074421|NCT02412111|471906887|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
131074422|NCT02412111|471906885|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
131074423|NCT02412111|471906886|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
131074424|NCT02412111|471906887|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
131074425|NCT02412111|471906885|FG000|Active Comparator Period (8 Weeks)|Other|0|||
131074426|NCT02412111|471906886|FG001|Active Comparator Period (8 Weeks)|Other|0|||
131074427|NCT02412111|471906887|FG002|Active Comparator Period (8 Weeks)|Other|2|||
131074428|NCT01169636|471906888|FG000|Overall Study|Adverse Event|0|||
131074429|NCT01169636|471906889|FG001|Overall Study|Adverse Event|0|||
131074430|NCT01169636|471906890|FG002|Overall Study|Adverse Event|1|||
131074431|NCT01169636|471906891|FG003|Overall Study|Adverse Event|1|||
131074432|NCT01169636|471906892|FG004|Overall Study|Adverse Event|0|||
131074433|NCT01169636|471906888|FG000|Overall Study|Screen failure|0|||
131074434|NCT01169636|471906889|FG001|Overall Study|Screen failure|0|||
131074435|NCT01169636|471906890|FG002|Overall Study|Screen failure|2|||
131074436|NCT01169636|471906891|FG003|Overall Study|Screen failure|0|||
131074437|NCT01169636|471906892|FG004|Overall Study|Screen failure|0|||
131074438|NCT01169636|471906888|FG000|Overall Study|Withdrawal by Subject|0|||
131074439|NCT01169636|471906889|FG001|Overall Study|Withdrawal by Subject|0|||
131074440|NCT01169636|471906890|FG002|Overall Study|Withdrawal by Subject|0|||
131074441|NCT01169636|471906891|FG003|Overall Study|Withdrawal by Subject|0|||
131074442|NCT01169636|471906892|FG004|Overall Study|Withdrawal by Subject|3|||
131074443|NCT02705625|471906893|FG000|Overall Study|Protocol Violation|1|||
131074444|NCT02705625|471906894|FG001|Overall Study|Protocol Violation|0|||
131074445|NCT02705625|471906895|FG002|Overall Study|Protocol Violation|0|||
131074446|NCT02705625|471906893|FG000|Overall Study|Adverse Event|6|||
131074447|NCT02705625|471906894|FG001|Overall Study|Adverse Event|5|||
131138217|NCT03529773|472132802|FG035|Overall Study|Physician Decision|0|||
131138218|NCT03529773|472132803|FG036|Overall Study|Physician Decision|0|||
131138219|NCT03529773|472132804|FG037|Overall Study|Physician Decision|0|||
131138220|NCT03529773|472132805|FG038|Overall Study|Physician Decision|0|||
131138221|NCT03529773|472132806|FG039|Overall Study|Physician Decision|0|||
130724718|NCT01111825|470616998|FG001|Overall Study|Adverse Event|1|||
130724719|NCT01111825|470616999|FG002|Overall Study|Adverse Event|4|||
130724720|NCT01111825|470617000|FG003|Overall Study|Adverse Event|0|||
130724721|NCT01111825|470616997|FG000|Overall Study|Disease Progression|1|||
130724722|NCT01111825|470616998|FG001|Overall Study|Disease Progression|0|||
130724723|NCT01111825|470616999|FG002|Overall Study|Disease Progression|0|||
130724724|NCT01111825|470617000|FG003|Overall Study|Disease Progression|0|||
130779674|NCT02326272|470819491|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131074448|NCT02705625|471906895|FG002|Overall Study|Adverse Event|2|||
131074449|NCT02705625|471906893|FG000|Overall Study|Death|0|||
131138222|NCT03529773|472132767|FG000|Overall Study|Protocol Violation|0|||
131138223|NCT03529773|472132768|FG001|Overall Study|Protocol Violation|0|||
131138224|NCT03529773|472132769|FG002|Overall Study|Protocol Violation|0|||
131138225|NCT03529773|472132770|FG003|Overall Study|Protocol Violation|0|||
131138226|NCT03529773|472132771|FG004|Overall Study|Protocol Violation|0|||
131138227|NCT03529773|472132772|FG005|Overall Study|Protocol Violation|0|||
131138228|NCT03529773|472132773|FG006|Overall Study|Protocol Violation|0|||
131138229|NCT03529773|472132774|FG007|Overall Study|Protocol Violation|0|||
131138230|NCT03529773|472132775|FG008|Overall Study|Protocol Violation|0|||
131138231|NCT03529773|472132776|FG009|Overall Study|Protocol Violation|0|||
131138232|NCT03529773|472132777|FG010|Overall Study|Protocol Violation|0|||
131074450|NCT02705625|471906894|FG001|Overall Study|Death|0|||
131074451|NCT02705625|471906895|FG002|Overall Study|Death|1|||
131074452|NCT02705625|471906893|FG000|Overall Study|Withdrawal by Subject|1|||
131074453|NCT02705625|471906894|FG001|Overall Study|Withdrawal by Subject|4|||
131074454|NCT02705625|471906895|FG002|Overall Study|Withdrawal by Subject|5|||
131074455|NCT02705625|471906893|FG000|Overall Study|Lost to Follow-up|0|||
131138233|NCT03529773|472132778|FG011|Overall Study|Protocol Violation|0|||
131231118|NCT01806597|472473237|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
131138234|NCT03529773|472132779|FG012|Overall Study|Protocol Violation|0|||
131231119|NCT01806597|472473238|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130724725|NCT01111825|470616997|FG000|Overall Study|Discontinuation by Sponsor|0|||
131138235|NCT03529773|472132780|FG013|Overall Study|Protocol Violation|0|||
130724726|NCT01111825|470616998|FG001|Overall Study|Discontinuation by Sponsor|0|||
131138236|NCT03529773|472132781|FG014|Overall Study|Protocol Violation|0|||
130724727|NCT01111825|470616999|FG002|Overall Study|Discontinuation by Sponsor|0|||
130724728|NCT01111825|470617000|FG003|Overall Study|Discontinuation by Sponsor|20|||
130724729|NCT00741286|470617009|FG000|Overall Study|Lost to Follow-up|15|||
131074456|NCT02705625|471906894|FG001|Overall Study|Lost to Follow-up|0|||
131074457|NCT02705625|471906895|FG002|Overall Study|Lost to Follow-up|1|||
131074458|NCT02705625|471906893|FG000|Overall Study|Non-compliance|0|||
131074459|NCT02705625|471906894|FG001|Overall Study|Non-compliance|1|||
131074460|NCT02705625|471906895|FG002|Overall Study|Non-compliance|1|||
131074461|NCT02705625|471906893|FG000|Overall Study|Overdosing|0|||
131074462|NCT02705625|471906894|FG001|Overall Study|Overdosing|0|||
131074463|NCT02705625|471906895|FG002|Overall Study|Overdosing|1|||
131074464|NCT00494026|471906896|FG000|Overall Study|Sponsor Decision|4|||
131074465|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
131074466|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
131074467|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
131074468|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
131074469|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
131074470|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
131074471|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
131074472|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
131074473|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
131074474|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
131074475|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
131074476|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
131074477|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
131074478|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
131074479|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
131074480|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
131074481|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
131074482|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
131074483|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
131074484|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
131074485|NCT02637856|471906898|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
131074486|NCT02637856|471906899|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
131074487|NCT02637856|471906898|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
131074488|NCT02637856|471906899|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
131074489|NCT02637856|471906898|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
131074490|NCT02637856|471906899|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
131074491|NCT04544865|471906900|FG000|Overall Study|Death|0|||
131074492|NCT04544865|471906901|FG001|Overall Study|Death|2|||
131074493|NCT04544865|471906900|FG000|Overall Study|Lost to Follow-up|11|||
131074494|NCT04544865|471906901|FG001|Overall Study|Lost to Follow-up|7|||
131074495|NCT04544865|471906900|FG000|Overall Study|Withdrawal by Subject|0|||
131074496|NCT04544865|471906901|FG001|Overall Study|Withdrawal by Subject|1|||
131074497|NCT04544865|471906900|FG000|Overall Study|Other|0|||
131074498|NCT04544865|471906901|FG001|Overall Study|Other|1|||
131074499|NCT02815735|471906905|FG000|First Intervention (4 Weeks)|Discomfort|1|||
131074500|NCT02815735|471906906|FG001|First Intervention (4 Weeks)|Discomfort|0|||
131074501|NCT02815735|471906905|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
131074502|NCT02815735|471906906|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
131074503|NCT02815735|471906905|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
131074504|NCT02815735|471906906|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
131074505|NCT02815735|471906905|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
131074506|NCT02815735|471906906|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
131074507|NCT03357471|471906907|FG000|Overall Study|Adverse Event|1|||
131074508|NCT03357471|471906908|FG001|Overall Study|Adverse Event|0|||
131074509|NCT03357471|471906907|FG000|Overall Study|Lost to Follow-up|1|||
131074510|NCT03357471|471906908|FG001|Overall Study|Lost to Follow-up|0|||
131074511|NCT02973802|471906909|FG000|Overall Study|Lost to Follow-up|1|||
131074512|NCT02973802|471906909|FG000|Overall Study|Withdrawal by Subject|1|||
131074513|NCT01850823|471906910|FG000|Overall Study|Early Visit Window|0|||
131074514|NCT01850823|471906911|FG001|Overall Study|Early Visit Window|1|||
131074515|NCT01850823|471906912|FG002|Overall Study|Early Visit Window|4|||
131074516|NCT01850823|471906910|FG000|Overall Study|Enrolled in Error|0|||
131074517|NCT01850823|471906911|FG001|Overall Study|Enrolled in Error|1|||
130724730|NCT00741286|470617010|FG001|Overall Study|Lost to Follow-up|10|||
130724731|NCT00741286|470617009|FG000|Overall Study|Adverse Event|1|||
131074518|NCT01850823|471906912|FG002|Overall Study|Enrolled in Error|2|||
131074519|NCT01850823|471906910|FG000|Overall Study|Lack of Efficacy|1|||
131074520|NCT01850823|471906911|FG001|Overall Study|Lack of Efficacy|0|||
131074521|NCT01850823|471906912|FG002|Overall Study|Lack of Efficacy|0|||
131074522|NCT01850823|471906910|FG000|Overall Study|Lost to Follow-up|0|||
130724732|NCT00741286|470617010|FG001|Overall Study|Adverse Event|6|||
130724733|NCT00741286|470617009|FG000|Overall Study|Protocol Violation|3|||
130779675|NCT02326272|470819492|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131074523|NCT01850823|471906911|FG001|Overall Study|Lost to Follow-up|0|||
131138237|NCT03529773|472132782|FG015|Overall Study|Protocol Violation|0|||
131138238|NCT03529773|472132783|FG016|Overall Study|Protocol Violation|0|||
131138239|NCT03529773|472132784|FG017|Overall Study|Protocol Violation|0|||
131138240|NCT03529773|472132785|FG018|Overall Study|Protocol Violation|0|||
131138241|NCT03529773|472132786|FG019|Overall Study|Protocol Violation|0|||
131138242|NCT03529773|472132787|FG020|Overall Study|Protocol Violation|0|||
131138243|NCT03529773|472132788|FG021|Overall Study|Protocol Violation|0|||
131138244|NCT03529773|472132789|FG022|Overall Study|Protocol Violation|0|||
131138245|NCT03529773|472132790|FG023|Overall Study|Protocol Violation|0|||
131138246|NCT03529773|472132791|FG024|Overall Study|Protocol Violation|0|||
131138247|NCT03529773|472132792|FG025|Overall Study|Protocol Violation|0|||
131138248|NCT03529773|472132793|FG026|Overall Study|Protocol Violation|0|||
131138249|NCT03529773|472132794|FG027|Overall Study|Protocol Violation|0|||
131138250|NCT03529773|472132795|FG028|Overall Study|Protocol Violation|0|||
131138251|NCT03529773|472132796|FG029|Overall Study|Protocol Violation|0|||
131138252|NCT03529773|472132797|FG030|Overall Study|Protocol Violation|1|||
131138253|NCT03529773|472132798|FG031|Overall Study|Protocol Violation|0|||
131138254|NCT03529773|472132799|FG032|Overall Study|Protocol Violation|0|||
131138255|NCT03529773|472132800|FG033|Overall Study|Protocol Violation|0|||
131138256|NCT03529773|472132801|FG034|Overall Study|Protocol Violation|0|||
131138257|NCT03529773|472132802|FG035|Overall Study|Protocol Violation|0|||
131138258|NCT03529773|472132803|FG036|Overall Study|Protocol Violation|0|||
131138259|NCT03529773|472132804|FG037|Overall Study|Protocol Violation|0|||
131138260|NCT03529773|472132805|FG038|Overall Study|Protocol Violation|0|||
131138261|NCT03529773|472132806|FG039|Overall Study|Protocol Violation|0|||
131138262|NCT03529773|472132767|FG000|Overall Study|Withdrawal by Subject|0|||
131138263|NCT03529773|472132768|FG001|Overall Study|Withdrawal by Subject|0|||
131138264|NCT03529773|472132769|FG002|Overall Study|Withdrawal by Subject|0|||
130779676|NCT02326272|470819493|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131074524|NCT01850823|471906912|FG002|Overall Study|Lost to Follow-up|1|||
131074525|NCT01850823|471906910|FG000|Overall Study|Restricted Medication|0|||
131074526|NCT01850823|471906911|FG001|Overall Study|Restricted Medication|0|||
131074527|NCT01850823|471906912|FG002|Overall Study|Restricted Medication|2|||
131074528|NCT01850823|471906910|FG000|Overall Study|Significant worstening of SAR|0|||
131074529|NCT01850823|471906911|FG001|Overall Study|Significant worstening of SAR|1|||
131074530|NCT01850823|471906912|FG002|Overall Study|Significant worstening of SAR|0|||
131074531|NCT01850823|471906910|FG000|Overall Study|Withdrawal by Subject|2|||
131074532|NCT01850823|471906911|FG001|Overall Study|Withdrawal by Subject|0|||
131074533|NCT01850823|471906912|FG002|Overall Study|Withdrawal by Subject|1|||
131074534|NCT01751165|471906913|FG000|Overall Study|Adverse event, serious fatal|1|||
131074535|NCT01751165|471906914|FG001|Overall Study|Adverse event, serious fatal|0|||
131074536|NCT01751165|471906915|FG002|Overall Study|Adverse event, serious fatal|1|||
131074537|NCT01751165|471906913|FG000|Overall Study|Withdrawal by Subject|0|||
131074538|NCT01751165|471906914|FG001|Overall Study|Withdrawal by Subject|0|||
131074539|NCT01751165|471906915|FG002|Overall Study|Withdrawal by Subject|1|||
131074540|NCT01751165|471906913|FG000|Overall Study|Serious adverse event|0|||
131074541|NCT01751165|471906914|FG001|Overall Study|Serious adverse event|2|||
131074542|NCT01751165|471906915|FG002|Overall Study|Serious adverse event|0|||
131074543|NCT01751165|471906913|FG000|Overall Study|Lost to Follow-up|1|||
131074544|NCT01751165|471906914|FG001|Overall Study|Lost to Follow-up|1|||
131074545|NCT01751165|471906915|FG002|Overall Study|Lost to Follow-up|1|||
131074546|NCT02895360|471906916|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
131074547|NCT02895360|471906917|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
131074548|NCT02895360|471906918|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
131074549|NCT02895360|471906919|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
131074550|NCT02895360|471906920|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
131074551|NCT02895360|471906921|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
131074552|NCT02895360|471906916|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
131074553|NCT02895360|471906917|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
131074554|NCT02895360|471906918|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
131074555|NCT02895360|471906919|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
131074556|NCT02895360|471906920|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
131074557|NCT02895360|471906921|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
131138265|NCT03529773|472132770|FG003|Overall Study|Withdrawal by Subject|0|||
131138266|NCT03529773|472132771|FG004|Overall Study|Withdrawal by Subject|0|||
130779677|NCT02326272|470819494|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131074558|NCT02895360|471906916|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
131138267|NCT03529773|472132772|FG005|Overall Study|Withdrawal by Subject|0|||
131138268|NCT03529773|472132773|FG006|Overall Study|Withdrawal by Subject|0|||
131138269|NCT03529773|472132774|FG007|Overall Study|Withdrawal by Subject|1|||
131138270|NCT03529773|472132775|FG008|Overall Study|Withdrawal by Subject|0|||
131138271|NCT03529773|472132776|FG009|Overall Study|Withdrawal by Subject|1|||
131138272|NCT03529773|472132777|FG010|Overall Study|Withdrawal by Subject|1|||
131074559|NCT02895360|471906917|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
131074560|NCT02895360|471906918|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
131074561|NCT02895360|471906919|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
131074562|NCT02895360|471906920|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
131074563|NCT02895360|471906921|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
131074564|NCT02895360|471906916|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
131074565|NCT02895360|471906917|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
131074566|NCT02895360|471906918|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
131074567|NCT02895360|471906919|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
131074568|NCT02895360|471906920|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
131074569|NCT02895360|471906921|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
131074570|NCT02895360|471906916|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
131074571|NCT02895360|471906917|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
131074572|NCT02895360|471906918|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
131074573|NCT02895360|471906919|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
131074574|NCT02895360|471906920|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
131074575|NCT02895360|471906921|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
131074576|NCT02895360|471906916|FG000|Phase 2a|Adverse Event|0|||
131074577|NCT02895360|471906917|FG001|Phase 2a|Adverse Event|0|||
131074578|NCT02895360|471906918|FG002|Phase 2a|Adverse Event|0|||
131074579|NCT02895360|471906919|FG003|Phase 2a|Adverse Event|0|||
131074580|NCT02895360|471906920|FG004|Phase 2a|Adverse Event|0|||
131074581|NCT02895360|471906921|FG005|Phase 2a|Adverse Event|1|||
131074582|NCT02895360|471906916|FG000|Phase 2a|Progressive disease|0|||
131074583|NCT02895360|471906917|FG001|Phase 2a|Progressive disease|0|||
131074584|NCT02895360|471906918|FG002|Phase 2a|Progressive disease|0|||
131074585|NCT02895360|471906919|FG003|Phase 2a|Progressive disease|0|||
131074586|NCT02895360|471906920|FG004|Phase 2a|Progressive disease|11|||
131074587|NCT02895360|471906921|FG005|Phase 2a|Progressive disease|11|||
131074588|NCT00307164|471906924|FG000|Overall Study|Death|1|||
131074589|NCT00307164|471906925|FG001|Overall Study|Death|0|||
131074590|NCT00307164|471906924|FG000|Overall Study|Severe debilitation, unable to continue|1|||
131074591|NCT00307164|471906925|FG001|Overall Study|Severe debilitation, unable to continue|0|||
131074592|NCT00307164|471906924|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
131074593|NCT00307164|471906925|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
131074594|NCT00307164|471906924|FG000|Overall Study|Withdrawal by Subject|1|||
131074595|NCT00307164|471906925|FG001|Overall Study|Withdrawal by Subject|8|||
131074596|NCT00307164|471906924|FG000|Overall Study|Not compliant with requirements|4|||
131074597|NCT00307164|471906925|FG001|Overall Study|Not compliant with requirements|4|||
131074598|NCT00307164|471906924|FG000|Overall Study|Lost to Follow-up|6|||
131074599|NCT00307164|471906925|FG001|Overall Study|Lost to Follow-up|1|||
131074600|NCT01732926|471906927|FG000|Overall Study|Study Terminated by Sponsor|168|||
131074601|NCT01732926|471906928|FG001|Overall Study|Study Terminated by Sponsor|80|||
131074602|NCT01732926|471906927|FG000|Overall Study|Withdrawal by Subject|46|||
131074603|NCT01732926|471906928|FG001|Overall Study|Withdrawal by Subject|8|||
131074604|NCT01732926|471906927|FG000|Overall Study|Physician Decision|24|||
131074605|NCT01732926|471906928|FG001|Overall Study|Physician Decision|11|||
131074606|NCT01732926|471906927|FG000|Overall Study|Other Reason|21|||
131074607|NCT01732926|471906928|FG001|Overall Study|Other Reason|4|||
131074608|NCT01732926|471906927|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
131074609|NCT01732926|471906928|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
131074610|NCT01732926|471906927|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
131074611|NCT01732926|471906928|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
131074612|NCT02262364|471906932|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
131074613|NCT01049984|471906933|FG000|Overall Study|Withdrawal by Subject|1|||
131074614|NCT01049984|471906934|FG001|Overall Study|Withdrawal by Subject|5|||
131074615|NCT01049984|471906933|FG000|Overall Study|Protocol Violation|3|||
131074616|NCT01049984|471906934|FG001|Overall Study|Protocol Violation|4|||
131074617|NCT01049984|471906933|FG000|Overall Study|Lost to Follow-up|2|||
131074618|NCT01049984|471906934|FG001|Overall Study|Lost to Follow-up|1|||
131074619|NCT01049984|471906933|FG000|Overall Study|Adverse Event|13|||
131074620|NCT01049984|471906934|FG001|Overall Study|Adverse Event|7|||
131074621|NCT01049984|471906933|FG000|Overall Study|Treatment failure|0|||
131074622|NCT01049984|471906934|FG001|Overall Study|Treatment failure|2|||
131074623|NCT02560389|471906943|FG000|Overall Study|Lost to Follow-up|1|||
131074624|NCT02560389|471906944|FG001|Overall Study|Lost to Follow-up|2|||
131138273|NCT03529773|472132778|FG011|Overall Study|Withdrawal by Subject|0|||
131138274|NCT03529773|472132779|FG012|Overall Study|Withdrawal by Subject|0|||
131074625|NCT02560389|471906945|FG002|Overall Study|Lost to Follow-up|2|||
131074626|NCT02560389|471906943|FG000|Overall Study|Tested positive for illicit substance|0|||
131074627|NCT02560389|471906944|FG001|Overall Study|Tested positive for illicit substance|1|||
131074628|NCT02560389|471906945|FG002|Overall Study|Tested positive for illicit substance|0|||
131138275|NCT03529773|472132780|FG013|Overall Study|Withdrawal by Subject|0|||
131074629|NCT00827775|471906954|FG000|Overall Study|Withdrawal by Subject|0|||
131074630|NCT00827775|471906955|FG001|Overall Study|Withdrawal by Subject|5|||
130724734|NCT00741286|470617010|FG001|Overall Study|Protocol Violation|2|||
130724735|NCT00741286|470617009|FG000|Overall Study|Primary Outcome|1|||
130724736|NCT00741286|470617010|FG001|Overall Study|Primary Outcome|1|||
130724737|NCT01831258|470617011|FG000|Overall Study|Withdrawal by Subject|2|||
130724738|NCT01831258|470617012|FG001|Overall Study|Withdrawal by Subject|1|||
130724739|NCT01831258|470617011|FG000|Overall Study|Lost to Follow-up|3|||
131074631|NCT02287883|471906959|FG000|Overall Study|Death|8|||
131074632|NCT02287883|471906960|FG001|Overall Study|Death|7|||
131074633|NCT02287883|471906959|FG000|Overall Study|No longer eligible|222|||
131074634|NCT02287883|471906960|FG001|Overall Study|No longer eligible|182|||
131074635|NCT02287883|471906959|FG000|Overall Study|Non-response to survey|229|||
131074636|NCT02287883|471906960|FG001|Overall Study|Non-response to survey|237|||
131074637|NCT00802438|471906961|FG000|Overall Study|Screen Failure|20|||
131074638|NCT00802438|471906961|FG000|Overall Study|Withdrawal by Subject|7|||
131074639|NCT00802438|471906961|FG000|Overall Study|Physician Decision|1|||
131074640|NCT03175198|471906962|FG000|Overall Study|Adverse Event|480|||
131074641|NCT03175198|471906962|FG000|Overall Study|No actual visit|120|||
131074642|NCT03175198|471906962|FG000|Overall Study|Registration rule not followed|4|||
131074643|NCT03175198|471906962|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
131074644|NCT03175198|471906962|FG000|Overall Study|Other personal reason|509|||
131074645|NCT03175198|471906962|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
131074646|NCT03175198|471906962|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
131074647|NCT03175198|471906962|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
131074648|NCT03175198|471906962|FG000|Overall Study|To conduct invasive treatment of operation|53|||
131074649|NCT03175198|471906962|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
131074650|NCT00372255|471906964|FG000|Overall Study|Withdrawn for other reasons|2|||
131074651|NCT00372255|471906965|FG001|Overall Study|Withdrawn for other reasons|1|||
131074652|NCT03120949|471906966|FG000|Overall Study|randomized in error|1|||
131074653|NCT03120949|471906967|FG001|Overall Study|randomized in error|0|||
131074654|NCT03120949|471906966|FG000|Overall Study|Death|13|||
131074655|NCT03120949|471906967|FG001|Overall Study|Death|13|||
131074656|NCT03120949|471906966|FG000|Overall Study|Lost to Follow-up|23|||
131074657|NCT03120949|471906967|FG001|Overall Study|Lost to Follow-up|13|||
131074658|NCT03120949|471906966|FG000|Overall Study|Withdrawal by Subject|139|||
131074659|NCT03120949|471906967|FG001|Overall Study|Withdrawal by Subject|124|||
131074660|NCT03120949|471906966|FG000|Overall Study|Covid-19|43|||
131074661|NCT03120949|471906967|FG001|Overall Study|Covid-19|34|||
131074662|NCT03120949|471906966|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
131074663|NCT03120949|471906967|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
131074664|NCT03120949|471906966|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
131074665|NCT03120949|471906967|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
131074666|NCT03120949|471906966|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
131074667|NCT03120949|471906967|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
131074668|NCT03120949|471906966|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
131074669|NCT03120949|471906967|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
131074670|NCT03120949|471906966|FG000|Overall Study|Site was closed|2|||
131074671|NCT03120949|471906967|FG001|Overall Study|Site was closed|3|||
131074672|NCT03120949|471906966|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
131074673|NCT03120949|471906967|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
131074674|NCT03120949|471906966|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
131074675|NCT03120949|471906967|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
131074676|NCT03120949|471906966|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
131074677|NCT03120949|471906967|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
131074678|NCT03120949|471906966|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
131074679|NCT03120949|471906967|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
131074680|NCT03120949|471906966|FG000|Overall Study|Other: Adverse Event|0|||
131074681|NCT03120949|471906967|FG001|Overall Study|Other: Adverse Event|1|||
131074682|NCT03120949|471906966|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
131074683|NCT03120949|471906967|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
131074684|NCT03120949|471906966|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
131074685|NCT03120949|471906967|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
131074686|NCT03120949|471906966|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
130724740|NCT01831258|470617012|FG001|Overall Study|Lost to Follow-up|2|||
130724741|NCT02564887|470617013|FG000|Overall Study|Lost to Follow-up|6|||
130724742|NCT02564887|470617014|FG001|Overall Study|Lost to Follow-up|0|||
131074687|NCT03120949|471906967|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
131074688|NCT03120949|471906966|FG000|Overall Study|Personal Reasons|0|||
131074689|NCT03120949|471906967|FG001|Overall Study|Personal Reasons|1|||
131074690|NCT03120949|471906966|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
131074691|NCT03120949|471906967|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
131074692|NCT03120949|471906966|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
131074693|NCT03120949|471906967|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
131074694|NCT03120949|471906966|FG000|Overall Study|Compliance With Medication|0|||
131074695|NCT03120949|471906967|FG001|Overall Study|Compliance With Medication|1|||
131074696|NCT03120949|471906966|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
131074697|NCT03120949|471906967|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
131074698|NCT03120949|471906966|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
131074699|NCT03120949|471906967|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
131074700|NCT03120949|471906966|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
131074701|NCT03120949|471906967|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
131074702|NCT04522778|471906968|FG000|Overall Study|Patient did not want to wear the device|1|||
131074703|NCT04522778|471906969|FG001|Overall Study|Patient did not want to wear the device|0|||
131074704|NCT04522778|471906968|FG000|Overall Study|Lost to Follow-up|0|||
131074705|NCT04522778|471906969|FG001|Overall Study|Lost to Follow-up|1|||
131074706|NCT01225159|471906972|FG000|Overall Study|Change operation|1|||
131074707|NCT01225159|471906973|FG001|Overall Study|Change operation|0|||
131074708|NCT00312845|471906974|FG000|Overall Study|Adverse Event|19|||
131074709|NCT00312845|471906975|FG001|Overall Study|Adverse Event|5|||
131074710|NCT00312845|471906974|FG000|Overall Study|Death|2|||
131074711|NCT00312845|471906975|FG001|Overall Study|Death|2|||
131074712|NCT00312845|471906974|FG000|Overall Study|Withdrawal by Subject|14|||
131074713|NCT00312845|471906975|FG001|Overall Study|Withdrawal by Subject|6|||
131074714|NCT00312845|471906974|FG000|Overall Study|Disease Progression|56|||
131074715|NCT00312845|471906975|FG001|Overall Study|Disease Progression|77|||
131074716|NCT00312845|471906974|FG000|Overall Study|Lost to Follow-up|2|||
131074717|NCT00312845|471906975|FG001|Overall Study|Lost to Follow-up|0|||
131074718|NCT00312845|471906974|FG000|Overall Study|Other|6|||
131074719|NCT00312845|471906975|FG001|Overall Study|Other|5|||
131074720|NCT01260142|471906978|FG000|Treatment Period 1|Study on hold|1|||
131074721|NCT01260142|471906979|FG001|Treatment Period 1|Study on hold|1|||
131074722|NCT01260142|471906980|FG002|Treatment Period 1|Study on hold|0|||
131074723|NCT01260142|471906981|FG003|Treatment Period 1|Study on hold|0|||
131074724|NCT01260142|471906982|FG004|Treatment Period 1|Study on hold|1|||
131074725|NCT01260142|471906983|FG005|Treatment Period 1|Study on hold|2|||
131074726|NCT01260142|471906978|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
131074727|NCT01260142|471906979|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
131074728|NCT01260142|471906980|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
131074729|NCT01260142|471906981|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
131074730|NCT01260142|471906982|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
131074731|NCT01260142|471906983|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
131074732|NCT01260142|471906978|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131074733|NCT01260142|471906979|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131074734|NCT01260142|471906980|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131074735|NCT01260142|471906981|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131074736|NCT01260142|471906982|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131074737|NCT01260142|471906983|FG005|Treatment Period 1|Withdrawal by Subject|1|||
131074738|NCT00496834|471906985|FG000|Overall Study|Withdrawal by Subject|4|||
131074739|NCT00496834|471906986|FG001|Overall Study|Withdrawal by Subject|6|||
131074740|NCT00496834|471906985|FG000|Overall Study|Contraindicated medication administered|0|||
131074741|NCT00496834|471906986|FG001|Overall Study|Contraindicated medication administered|1|||
131074742|NCT00496834|471906985|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
131074743|NCT00496834|471906986|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
131074744|NCT00496834|471906985|FG000|Overall Study|Adverse Event|5|||
131074745|NCT00496834|471906986|FG001|Overall Study|Adverse Event|3|||
131074746|NCT00496834|471906985|FG000|Overall Study|IP administration violation|2|||
131074747|NCT00496834|471906986|FG001|Overall Study|IP administration violation|0|||
131138276|NCT03529773|472132781|FG014|Overall Study|Withdrawal by Subject|0|||
131138277|NCT03529773|472132782|FG015|Overall Study|Withdrawal by Subject|3|||
130724743|NCT01851330|470617015|FG000|Overall Study|Lack of Efficacy|10|||
131074748|NCT00496834|471906985|FG000|Overall Study|Lost to Follow-up|2|||
131074749|NCT00496834|471906986|FG001|Overall Study|Lost to Follow-up|0|||
131074750|NCT00496834|471906985|FG000|Overall Study|Blood Pressure control failure|2|||
131074751|NCT00496834|471906986|FG001|Overall Study|Blood Pressure control failure|1|||
131138278|NCT03529773|472132783|FG016|Overall Study|Withdrawal by Subject|0|||
131074752|NCT01227928|471906987|FG000|Overall Study|Lost to Follow-up|4|||
131074753|NCT01227928|471906988|FG001|Overall Study|Lost to Follow-up|2|||
131074754|NCT01227928|471906987|FG000|Overall Study|Withdrawal by Subject|4|||
131074755|NCT01227928|471906988|FG001|Overall Study|Withdrawal by Subject|3|||
131074756|NCT01227928|471906987|FG000|Overall Study|Death|14|||
131074757|NCT01227928|471906988|FG001|Overall Study|Death|12|||
131074758|NCT02930837|471906991|FG000|Overall Study|Adverse Event|6|||
131074759|NCT02930837|471906991|FG000|Overall Study|Lost to Follow-up|5|||
131074760|NCT02930837|471906991|FG000|Overall Study|Withdrawal by Subject|1|||
131074761|NCT01393613|471906992|FG000|Overall Study|Adverse Event|11|||
131074762|NCT01393613|471906993|FG001|Overall Study|Adverse Event|11|||
131074763|NCT01393613|471906994|FG002|Overall Study|Adverse Event|13|||
131074764|NCT01393613|471906995|FG003|Overall Study|Adverse Event|22|||
131074765|NCT01393613|471906992|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
131074766|NCT01393613|471906993|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
131074767|NCT01393613|471906994|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
131074768|NCT01393613|471906995|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
131074769|NCT01393613|471906992|FG000|Overall Study|Physician Decision|2|||
131074770|NCT01393613|471906993|FG001|Overall Study|Physician Decision|0|||
131074771|NCT01393613|471906994|FG002|Overall Study|Physician Decision|0|||
131074772|NCT01393613|471906995|FG003|Overall Study|Physician Decision|1|||
131074773|NCT01393613|471906992|FG000|Overall Study|Withdrawal by Subject|15|||
131074774|NCT01393613|471906993|FG001|Overall Study|Withdrawal by Subject|25|||
131074775|NCT01393613|471906994|FG002|Overall Study|Withdrawal by Subject|23|||
131074776|NCT01393613|471906995|FG003|Overall Study|Withdrawal by Subject|21|||
131074777|NCT01393613|471906992|FG000|Overall Study|Protocol Deviation|2|||
131074778|NCT01393613|471906993|FG001|Overall Study|Protocol Deviation|1|||
131074779|NCT01393613|471906994|FG002|Overall Study|Protocol Deviation|0|||
131074780|NCT01393613|471906995|FG003|Overall Study|Protocol Deviation|0|||
131074781|NCT01393613|471906992|FG000|Overall Study|Lack of Efficacy|9|||
131074782|NCT01393613|471906993|FG001|Overall Study|Lack of Efficacy|20|||
131074783|NCT01393613|471906994|FG002|Overall Study|Lack of Efficacy|16|||
131074784|NCT01393613|471906995|FG003|Overall Study|Lack of Efficacy|21|||
131074785|NCT03821064|471906996|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
131074786|NCT01283971|471907001|FG000|Overall Study|Adverse Event|3|||
131074787|NCT01283971|471907002|FG001|Overall Study|Adverse Event|5|||
131074788|NCT01283971|471907001|FG000|Overall Study|Insufficient therapeutic responses|3|||
131074789|NCT01283971|471907002|FG001|Overall Study|Insufficient therapeutic responses|3|||
131074790|NCT01283971|471907001|FG000|Overall Study|Protocol Violation|5|||
131074791|NCT01283971|471907002|FG001|Overall Study|Protocol Violation|1|||
131074792|NCT01283971|471907001|FG000|Overall Study|Refused treatment|3|||
131074793|NCT01283971|471907002|FG001|Overall Study|Refused treatment|1|||
131074794|NCT01283971|471907001|FG000|Overall Study|Failure to return|0|||
131074795|NCT01283971|471907002|FG001|Overall Study|Failure to return|1|||
131074796|NCT01283971|471907001|FG000|Overall Study|Administrative reasons|1|||
131074797|NCT01283971|471907002|FG001|Overall Study|Administrative reasons|1|||
131074798|NCT02598934|471907011|FG000|Overall Study|Adverse Event|11|||
131074799|NCT02598934|471907012|FG001|Overall Study|Adverse Event|13|||
131074800|NCT02598934|471907011|FG000|Overall Study|Failure to Return|3|||
131074801|NCT02598934|471907012|FG001|Overall Study|Failure to Return|3|||
131074802|NCT02598934|471907011|FG000|Overall Study|Withdrawal by Subject|2|||
131074803|NCT02598934|471907012|FG001|Overall Study|Withdrawal by Subject|3|||
131074804|NCT02598934|471907011|FG000|Overall Study|Administrative|2|||
131074805|NCT02598934|471907012|FG001|Overall Study|Administrative|1|||
130724744|NCT01851330|470617016|FG001|Overall Study|Lack of Efficacy|9|||
130724745|NCT01851330|470617017|FG002|Overall Study|Lack of Efficacy|2|||
131074806|NCT02598934|471907011|FG000|Overall Study|Protocol Violation|1|||
131074807|NCT02598934|471907012|FG001|Overall Study|Protocol Violation|2|||
131074808|NCT03325608|471907015|FG000|Overall Study|Lost to Follow-up|23|||
131074809|NCT03325608|471907016|FG001|Overall Study|Lost to Follow-up|23|||
131074810|NCT03325608|471907017|FG002|Overall Study|Lost to Follow-up|30|||
131074811|NCT03325608|471907018|FG003|Overall Study|Lost to Follow-up|30|||
131074812|NCT03325608|471907015|FG000|Overall Study|Death of Caregiver|0|||
131074813|NCT03325608|471907016|FG001|Overall Study|Death of Caregiver|0|||
130724746|NCT01851330|470617015|FG000|Overall Study|Lost to Follow-up|1|||
131074814|NCT03325608|471907017|FG002|Overall Study|Death of Caregiver|2|||
131074815|NCT03325608|471907018|FG003|Overall Study|Death of Caregiver|2|||
131074816|NCT03325608|471907015|FG000|Overall Study|Death of Care Recipient|34|||
131074817|NCT03325608|471907016|FG001|Overall Study|Death of Care Recipient|34|||
131074818|NCT03325608|471907017|FG002|Overall Study|Death of Care Recipient|28|||
131074819|NCT03325608|471907018|FG003|Overall Study|Death of Care Recipient|28|||
131138279|NCT03529773|472132784|FG017|Overall Study|Withdrawal by Subject|2|||
131138280|NCT03529773|472132785|FG018|Overall Study|Withdrawal by Subject|3|||
131138281|NCT03529773|472132786|FG019|Overall Study|Withdrawal by Subject|1|||
131074820|NCT03325608|471907015|FG000|Overall Study|Withdrawal by Subject|49|||
131074821|NCT03325608|471907016|FG001|Overall Study|Withdrawal by Subject|49|||
131074822|NCT03325608|471907017|FG002|Overall Study|Withdrawal by Subject|35|||
131074823|NCT03325608|471907018|FG003|Overall Study|Withdrawal by Subject|35|||
131074824|NCT03325608|471907015|FG000|Overall Study|Ineligible|7|||
131074825|NCT03325608|471907016|FG001|Overall Study|Ineligible|7|||
131138282|NCT03529773|472132787|FG020|Overall Study|Withdrawal by Subject|3|||
131074826|NCT03325608|471907017|FG002|Overall Study|Ineligible|5|||
131074827|NCT03325608|471907018|FG003|Overall Study|Ineligible|5|||
131074828|NCT02188784|471907019|FG000|Overall Study|Death|3|||
131074829|NCT02188784|471907020|FG001|Overall Study|Death|1|||
131074830|NCT02188784|471907019|FG000|Overall Study|Lost to Follow-up|1|||
131074831|NCT02188784|471907020|FG001|Overall Study|Lost to Follow-up|0|||
131074832|NCT02188784|471907019|FG000|Overall Study|Withdrawal by Subject|3|||
131074833|NCT02188784|471907020|FG001|Overall Study|Withdrawal by Subject|9|||
131074834|NCT02188784|471907019|FG000|Overall Study|Physician Decision|2|||
131074835|NCT02188784|471907020|FG001|Overall Study|Physician Decision|3|||
131074836|NCT04944784|471907021|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
131074837|NCT04944784|471907022|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
131074838|NCT04944784|471907023|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
131074839|NCT04944784|471907024|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
131074840|NCT04944784|471907021|FG000|Double-blind Period|Adverse Event|20|||
131074841|NCT04944784|471907022|FG001|Double-blind Period|Adverse Event|4|||
131074842|NCT04944784|471907023|FG002|Double-blind Period|Adverse Event|0|||
131074843|NCT04944784|471907024|FG003|Double-blind Period|Adverse Event|0|||
131074844|NCT04944784|471907021|FG000|Double-blind Period|Withdrawal by Subject|15|||
131074845|NCT04944784|471907022|FG001|Double-blind Period|Withdrawal by Subject|4|||
131074846|NCT04944784|471907023|FG002|Double-blind Period|Withdrawal by Subject|0|||
131074847|NCT04944784|471907024|FG003|Double-blind Period|Withdrawal by Subject|0|||
131074848|NCT04944784|471907021|FG000|Double-blind Period|Death|7|||
131074849|NCT04944784|471907022|FG001|Double-blind Period|Death|2|||
131074850|NCT04944784|471907023|FG002|Double-blind Period|Death|0|||
131074851|NCT04944784|471907024|FG003|Double-blind Period|Death|0|||
131074852|NCT04944784|471907021|FG000|Double-blind Period|Physician Decision|2|||
131074853|NCT04944784|471907022|FG001|Double-blind Period|Physician Decision|1|||
131074854|NCT04944784|471907023|FG002|Double-blind Period|Physician Decision|0|||
131074855|NCT04944784|471907024|FG003|Double-blind Period|Physician Decision|0|||
131074856|NCT04944784|471907021|FG000|Double-blind Period|Lack of Efficacy|0|||
131074857|NCT04944784|471907022|FG001|Double-blind Period|Lack of Efficacy|1|||
131074858|NCT04944784|471907023|FG002|Double-blind Period|Lack of Efficacy|0|||
131074859|NCT04944784|471907024|FG003|Double-blind Period|Lack of Efficacy|0|||
131074860|NCT04944784|471907021|FG000|Double-blind Period|Sponsor Request|2|||
131074861|NCT04944784|471907022|FG001|Double-blind Period|Sponsor Request|1|||
131074862|NCT04944784|471907023|FG002|Double-blind Period|Sponsor Request|0|||
131074863|NCT04944784|471907024|FG003|Double-blind Period|Sponsor Request|0|||
131074864|NCT04944784|471907021|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
131074865|NCT04944784|471907022|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
131074866|NCT04944784|471907023|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
131074867|NCT04944784|471907024|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
131074868|NCT04944784|471907021|FG000|Double-blind Period|Participant Choice|1|||
131074869|NCT04944784|471907022|FG001|Double-blind Period|Participant Choice|1|||
131074870|NCT04944784|471907023|FG002|Double-blind Period|Participant Choice|0|||
131074871|NCT04944784|471907024|FG003|Double-blind Period|Participant Choice|0|||
131074872|NCT04944784|471907021|FG000|Double-blind Period|Progressive Disease|2|||
131074873|NCT04944784|471907022|FG001|Double-blind Period|Progressive Disease|2|||
131074874|NCT04944784|471907023|FG002|Double-blind Period|Progressive Disease|0|||
131074875|NCT04944784|471907024|FG003|Double-blind Period|Progressive Disease|0|||
131074876|NCT04944784|471907021|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
131074877|NCT04944784|471907022|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
131074878|NCT04944784|471907023|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
131074879|NCT04944784|471907024|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
131074880|NCT04944784|471907021|FG000|Active Drug Period|Adverse Event|0|||
131074881|NCT04944784|471907022|FG001|Active Drug Period|Adverse Event|0|||
131074882|NCT04944784|471907023|FG002|Active Drug Period|Adverse Event|3|||
131074883|NCT04944784|471907024|FG003|Active Drug Period|Adverse Event|6|||
131074884|NCT04944784|471907021|FG000|Active Drug Period|Withdrawal by Subject|0|||
131074885|NCT04944784|471907022|FG001|Active Drug Period|Withdrawal by Subject|0|||
131074886|NCT04944784|471907023|FG002|Active Drug Period|Withdrawal by Subject|4|||
131074887|NCT04944784|471907024|FG003|Active Drug Period|Withdrawal by Subject|7|||
131074888|NCT04944784|471907021|FG000|Active Drug Period|Death|0|||
131074889|NCT04944784|471907022|FG001|Active Drug Period|Death|0|||
131074890|NCT04944784|471907023|FG002|Active Drug Period|Death|3|||
131231120|NCT01806597|472473233|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
131074891|NCT04944784|471907024|FG003|Active Drug Period|Death|4|||
131074892|NCT04944784|471907021|FG000|Active Drug Period|Lack of Efficacy|0|||
131074893|NCT04944784|471907022|FG001|Active Drug Period|Lack of Efficacy|0|||
131074894|NCT04944784|471907023|FG002|Active Drug Period|Lack of Efficacy|2|||
131074895|NCT04944784|471907024|FG003|Active Drug Period|Lack of Efficacy|2|||
131074896|NCT04944784|471907021|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
131074897|NCT04944784|471907022|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
131074898|NCT04944784|471907023|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
131074899|NCT04944784|471907024|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
131074900|NCT04944784|471907021|FG000|Active Drug Period|Participant Choice|0|||
131231121|NCT01806597|472473234|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
131231122|NCT01806597|472473235|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
131231123|NCT01806597|472473236|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
131231124|NCT01806597|472473237|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
131231125|NCT01806597|472473238|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
131231126|NCT01806597|472473233|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
131231127|NCT01806597|472473234|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
131231128|NCT01806597|472473235|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
131231129|NCT01806597|472473236|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
131231130|NCT01806597|472473237|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
131231131|NCT01806597|472473238|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
131231132|NCT01806597|472473233|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
131231133|NCT01806597|472473234|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
131231134|NCT01806597|472473235|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
131231135|NCT01806597|472473236|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
131231136|NCT01806597|472473237|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
131231137|NCT01806597|472473238|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
131231138|NCT01806597|472473233|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
131231139|NCT01806597|472473234|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
131231140|NCT01806597|472473235|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
131231141|NCT01806597|472473236|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
131231142|NCT01806597|472473237|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
131231143|NCT01806597|472473238|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
131231144|NCT01806597|472473233|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
131231145|NCT01806597|472473234|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
131074901|NCT04944784|471907022|FG001|Active Drug Period|Participant Choice|0|||
131074902|NCT04944784|471907023|FG002|Active Drug Period|Participant Choice|0|||
131074903|NCT04944784|471907024|FG003|Active Drug Period|Participant Choice|1|||
131074904|NCT04944784|471907021|FG000|Active Drug Period|Progressive Disease|0|||
131074905|NCT04944784|471907022|FG001|Active Drug Period|Progressive Disease|0|||
131074906|NCT04944784|471907023|FG002|Active Drug Period|Progressive Disease|4|||
131074907|NCT04944784|471907024|FG003|Active Drug Period|Progressive Disease|4|||
131074908|NCT04944784|471907021|FG000|Active Drug Period|Lost to Follow-up|0|||
131074909|NCT04944784|471907022|FG001|Active Drug Period|Lost to Follow-up|0|||
131074910|NCT04944784|471907023|FG002|Active Drug Period|Lost to Follow-up|0|||
131074911|NCT04944784|471907024|FG003|Active Drug Period|Lost to Follow-up|1|||
131074912|NCT00853372|471908789|FG000|Overall Study|Death|30|||
131074913|NCT00853372|471908790|FG001|Overall Study|Death|26|||
131074914|NCT00853372|471908789|FG000|Overall Study|Lost to Follow-up|1|||
131074915|NCT00853372|471908790|FG001|Overall Study|Lost to Follow-up|2|||
131074916|NCT00853372|471908789|FG000|Overall Study|Full Consent Withdrawn|1|||
131074917|NCT00853372|471908790|FG001|Overall Study|Full Consent Withdrawn|1|||
131074918|NCT01268098|471908791|FG000|Overall Study|Adverse Event|1|||
131074919|NCT01268098|471908792|FG001|Overall Study|Adverse Event|0|||
131074920|NCT02418845|471908795|FG000|Overall Study|Lost to Follow-up|7|||
131074921|NCT02418845|471908796|FG001|Overall Study|Lost to Follow-up|2|||
131074922|NCT02418845|471908795|FG000|Overall Study|Lack of Efficacy|0|||
131074923|NCT02418845|471908796|FG001|Overall Study|Lack of Efficacy|3|||
131074924|NCT02418845|471908795|FG000|Overall Study|Physician Decision|5|||
131074925|NCT02418845|471908796|FG001|Overall Study|Physician Decision|5|||
131074926|NCT02418845|471908795|FG000|Overall Study|Protocol Violation|1|||
131074927|NCT02418845|471908796|FG001|Overall Study|Protocol Violation|0|||
131074928|NCT02418845|471908795|FG000|Overall Study|Withdrawal by Subject|3|||
131074929|NCT02418845|471908796|FG001|Overall Study|Withdrawal by Subject|2|||
131074930|NCT02994784|471908797|FG000|6 Months Follow-up|Lost to Follow-up|3|||
131074931|NCT02466243|471908798|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
131074932|NCT02466243|471908799|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
131074933|NCT02466243|471908798|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
130724747|NCT01851330|470617016|FG001|Overall Study|Lost to Follow-up|6|||
130724748|NCT01851330|470617017|FG002|Overall Study|Lost to Follow-up|9|||
130724749|NCT01851330|470617015|FG000|Overall Study|Withdrew Consent|2|||
130724750|NCT01851330|470617016|FG001|Overall Study|Withdrew Consent|1|||
131074934|NCT02466243|471908799|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
131074935|NCT02466243|471908798|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
130724751|NCT01851330|470617017|FG002|Overall Study|Withdrew Consent|0|||
131074936|NCT02466243|471908799|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
131074937|NCT02466243|471908798|FG000|Part B Open-label Treatment Period|Missing|2|||
131074938|NCT02466243|471908799|FG001|Part B Open-label Treatment Period|Missing|2|||
131074939|NCT00863798|471908800|FG000|Overall Study|Adverse Event|5|||
131138283|NCT03529773|472132788|FG021|Overall Study|Withdrawal by Subject|1|||
131138284|NCT03529773|472132789|FG022|Overall Study|Withdrawal by Subject|1|||
131138285|NCT03529773|472132790|FG023|Overall Study|Withdrawal by Subject|2|||
131138286|NCT03529773|472132791|FG024|Overall Study|Withdrawal by Subject|2|||
131138287|NCT03529773|472132792|FG025|Overall Study|Withdrawal by Subject|4|||
131138288|NCT03529773|472132793|FG026|Overall Study|Withdrawal by Subject|2|||
131138289|NCT03529773|472132794|FG027|Overall Study|Withdrawal by Subject|1|||
131138290|NCT03529773|472132795|FG028|Overall Study|Withdrawal by Subject|1|||
131138291|NCT03529773|472132796|FG029|Overall Study|Withdrawal by Subject|0|||
131138292|NCT03529773|472132797|FG030|Overall Study|Withdrawal by Subject|0|||
131138293|NCT03529773|472132798|FG031|Overall Study|Withdrawal by Subject|0|||
131138294|NCT03529773|472132799|FG032|Overall Study|Withdrawal by Subject|0|||
131138295|NCT03529773|472132800|FG033|Overall Study|Withdrawal by Subject|0|||
131074940|NCT00863798|471908801|FG001|Overall Study|Adverse Event|2|||
131074941|NCT00863798|471908802|FG002|Overall Study|Adverse Event|4|||
131074942|NCT00863798|471908800|FG000|Overall Study|Participant failed to return|2|||
131074943|NCT00863798|471908801|FG001|Overall Study|Participant failed to return|1|||
131074944|NCT00863798|471908802|FG002|Overall Study|Participant failed to return|0|||
131074945|NCT00863798|471908800|FG000|Overall Study|Investigator request|1|||
131074946|NCT00863798|471908801|FG001|Overall Study|Investigator request|2|||
131074947|NCT00863798|471908802|FG002|Overall Study|Investigator request|1|||
131074948|NCT00863798|471908800|FG000|Overall Study|Lack of Efficacy|4|||
131074949|NCT00863798|471908801|FG001|Overall Study|Lack of Efficacy|3|||
131074950|NCT00863798|471908802|FG002|Overall Study|Lack of Efficacy|6|||
131074951|NCT00863798|471908800|FG000|Overall Study|Lost to Follow-up|6|||
131074952|NCT00863798|471908801|FG001|Overall Study|Lost to Follow-up|9|||
131074953|NCT00863798|471908802|FG002|Overall Study|Lost to Follow-up|5|||
131074954|NCT00863798|471908800|FG000|Overall Study|Other|2|||
131074955|NCT00863798|471908801|FG001|Overall Study|Other|3|||
131074956|NCT00863798|471908802|FG002|Overall Study|Other|1|||
131074957|NCT00863798|471908800|FG000|Overall Study|Protocol Violation|0|||
131074958|NCT00863798|471908801|FG001|Overall Study|Protocol Violation|1|||
131074959|NCT00863798|471908802|FG002|Overall Study|Protocol Violation|1|||
131074960|NCT00863798|471908800|FG000|Overall Study|Withdrawal by Subject|8|||
131074961|NCT00863798|471908801|FG001|Overall Study|Withdrawal by Subject|7|||
131074962|NCT00863798|471908802|FG002|Overall Study|Withdrawal by Subject|4|||
131074963|NCT00863798|471908800|FG000|Overall Study|Randomized not treated|4|||
131074964|NCT00863798|471908801|FG001|Overall Study|Randomized not treated|2|||
131074965|NCT00863798|471908802|FG002|Overall Study|Randomized not treated|3|||
131074966|NCT01470599|471908803|FG000|Overall Study|Did not meet entrance criteria|1|||
131074967|NCT01470599|471908804|FG001|Overall Study|Did not meet entrance criteria|0|||
131074968|NCT01470599|471908803|FG000|Overall Study|Lost to Follow-up|2|||
131074969|NCT01470599|471908804|FG001|Overall Study|Lost to Follow-up|1|||
131074970|NCT01470599|471908803|FG000|Overall Study|Withdrawal by Subject|3|||
131074971|NCT01470599|471908804|FG001|Overall Study|Withdrawal by Subject|4|||
131074972|NCT01470599|471908803|FG000|Overall Study|Other|1|||
131074973|NCT01470599|471908804|FG001|Overall Study|Other|0|||
131074974|NCT01470599|471908803|FG000|Overall Study|Protocol Violation|3|||
131074975|NCT01470599|471908804|FG001|Overall Study|Protocol Violation|1|||
131074976|NCT01470599|471908803|FG000|Overall Study|Adverse event related to study drug|2|||
131074977|NCT01470599|471908804|FG001|Overall Study|Adverse event related to study drug|5|||
131074978|NCT01470599|471908803|FG000|Overall Study|Insufficient clinical response|6|||
131074979|NCT01470599|471908804|FG001|Overall Study|Insufficient clinical response|27|||
131138296|NCT03529773|472132801|FG034|Overall Study|Withdrawal by Subject|1|||
131138297|NCT03529773|472132802|FG035|Overall Study|Withdrawal by Subject|2|||
131138298|NCT03529773|472132803|FG036|Overall Study|Withdrawal by Subject|0|||
131138299|NCT03529773|472132804|FG037|Overall Study|Withdrawal by Subject|2|||
131138300|NCT03529773|472132805|FG038|Overall Study|Withdrawal by Subject|1|||
131138301|NCT03529773|472132806|FG039|Overall Study|Withdrawal by Subject|1|||
131074980|NCT01470599|471908803|FG000|Overall Study|Adverse event not related to study drug|1|||
131074981|NCT01470599|471908804|FG001|Overall Study|Adverse event not related to study drug|5|||
131074982|NCT01057251|471908805|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
131074983|NCT01057251|471908806|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
131074984|NCT01057251|471908805|FG000|Overall Study|Adverse Event|4|||
130779678|NCT02326272|470819495|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131074985|NCT01057251|471908806|FG001|Overall Study|Adverse Event|2|||
131074986|NCT01057251|471908805|FG000|Overall Study|Lack of Efficacy|2|||
131138302|NCT03529773|472132767|FG000|Overall Study|Screen Failure|0|||
131074987|NCT01057251|471908806|FG001|Overall Study|Lack of Efficacy|11|||
131074988|NCT01057251|471908805|FG000|Overall Study|Protocol Violation|6|||
131074989|NCT01057251|471908806|FG001|Overall Study|Protocol Violation|2|||
131074990|NCT01057251|471908805|FG000|Overall Study|Withdrawal by Subject|4|||
131074991|NCT01057251|471908806|FG001|Overall Study|Withdrawal by Subject|5|||
131074992|NCT01057251|471908805|FG000|Overall Study|Lost to Follow-up|7|||
131138303|NCT03529773|472132768|FG001|Overall Study|Screen Failure|0|||
131138304|NCT03529773|472132769|FG002|Overall Study|Screen Failure|0|||
131074993|NCT01057251|471908806|FG001|Overall Study|Lost to Follow-up|6|||
131074994|NCT01057251|471908805|FG000|Overall Study|Other Reason|1|||
131074995|NCT01057251|471908806|FG001|Overall Study|Other Reason|1|||
131074996|NCT00706914|471908810|FG000|Overall Study|Lack of Efficacy|0|||
131074997|NCT00706914|471908811|FG001|Overall Study|Lack of Efficacy|1|||
131074998|NCT00706914|471908812|FG002|Overall Study|Lack of Efficacy|0|||
131074999|NCT00706914|471908810|FG000|Overall Study|Lost to Follow-up|1|||
131075000|NCT00706914|471908811|FG001|Overall Study|Lost to Follow-up|0|||
131075001|NCT00706914|471908812|FG002|Overall Study|Lost to Follow-up|0|||
131075002|NCT00706914|471908810|FG000|Overall Study|Adverse Event|2|||
131075003|NCT00706914|471908811|FG001|Overall Study|Adverse Event|2|||
131075004|NCT00706914|471908812|FG002|Overall Study|Adverse Event|0|||
131075005|NCT00706914|471908810|FG000|Overall Study|Protocol Violation|3|||
131075006|NCT00706914|471908811|FG001|Overall Study|Protocol Violation|1|||
131075007|NCT00706914|471908812|FG002|Overall Study|Protocol Violation|1|||
131075008|NCT00702650|471908814|FG000|Overall Study|Withdrawal by Subject|9|||
131075009|NCT00702650|471908814|FG000|Overall Study|Non-Compliance of Study Drug|3|||
131075010|NCT00702650|471908814|FG000|Overall Study|Lost to Follow-up|2|||
131075011|NCT00702650|471908814|FG000|Overall Study|Non-Compliance with Site Directives|1|||
131075012|NCT00702650|471908814|FG000|Overall Study|Sponsor Request|1|||
130724752|NCT01851330|470617015|FG000|Overall Study|Investigator's Discretion|0|||
130724753|NCT01851330|470617016|FG001|Overall Study|Investigator's Discretion|0|||
130724754|NCT01851330|470617017|FG002|Overall Study|Investigator's Discretion|1|||
131075013|NCT00702650|471908814|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
131075014|NCT00702650|471908814|FG000|Overall Study|Adverse Event|3|||
131075015|NCT00988533|471908817|FG000|Overall Study|Lost to Follow-up|3|||
131075016|NCT00943722|471908820|FG000|Base Study|Adverse Event|0|||
131075017|NCT00943722|471908821|FG001|Base Study|Adverse Event|0|||
131075018|NCT00943722|471908822|FG002|Base Study|Adverse Event|0|||
131075019|NCT00943722|471908823|FG003|Base Study|Adverse Event|1|||
131075020|NCT00943722|471908824|FG004|Base Study|Adverse Event|0|||
131075021|NCT00943722|471908825|FG005|Base Study|Adverse Event|0|||
131075022|NCT00943722|471908826|FG006|Base Study|Adverse Event|0|||
131075023|NCT00943722|471908820|FG000|Base Study|Lost to Follow-up|12|||
131075024|NCT00943722|471908821|FG001|Base Study|Lost to Follow-up|8|||
131075025|NCT00943722|471908822|FG002|Base Study|Lost to Follow-up|10|||
131075026|NCT00943722|471908823|FG003|Base Study|Lost to Follow-up|8|||
131075027|NCT00943722|471908824|FG004|Base Study|Lost to Follow-up|11|||
131138305|NCT03529773|472132770|FG003|Overall Study|Screen Failure|0|||
131138306|NCT03529773|472132771|FG004|Overall Study|Screen Failure|0|||
131138307|NCT03529773|472132772|FG005|Overall Study|Screen Failure|0|||
131138308|NCT03529773|472132773|FG006|Overall Study|Screen Failure|0|||
131138309|NCT03529773|472132774|FG007|Overall Study|Screen Failure|0|||
131138310|NCT03529773|472132775|FG008|Overall Study|Screen Failure|0|||
131138311|NCT03529773|472132776|FG009|Overall Study|Screen Failure|0|||
131138312|NCT03529773|472132777|FG010|Overall Study|Screen Failure|0|||
131138313|NCT03529773|472132778|FG011|Overall Study|Screen Failure|0|||
131138314|NCT03529773|472132779|FG012|Overall Study|Screen Failure|0|||
131138315|NCT03529773|472132780|FG013|Overall Study|Screen Failure|0|||
131138316|NCT03529773|472132781|FG014|Overall Study|Screen Failure|0|||
131138317|NCT03529773|472132782|FG015|Overall Study|Screen Failure|0|||
131138318|NCT03529773|472132783|FG016|Overall Study|Screen Failure|0|||
131138319|NCT03529773|472132784|FG017|Overall Study|Screen Failure|0|||
131138320|NCT03529773|472132785|FG018|Overall Study|Screen Failure|0|||
131138321|NCT03529773|472132786|FG019|Overall Study|Screen Failure|0|||
131138322|NCT03529773|472132787|FG020|Overall Study|Screen Failure|0|||
131138323|NCT03529773|472132788|FG021|Overall Study|Screen Failure|0|||
131138324|NCT03529773|472132789|FG022|Overall Study|Screen Failure|0|||
131138325|NCT03529773|472132790|FG023|Overall Study|Screen Failure|0|||
131138326|NCT03529773|472132791|FG024|Overall Study|Screen Failure|0|||
131138327|NCT03529773|472132792|FG025|Overall Study|Screen Failure|0|||
131138328|NCT03529773|472132793|FG026|Overall Study|Screen Failure|0|||
131138329|NCT03529773|472132794|FG027|Overall Study|Screen Failure|0|||
131138330|NCT03529773|472132795|FG028|Overall Study|Screen Failure|0|||
131138331|NCT03529773|472132796|FG029|Overall Study|Screen Failure|0|||
131138332|NCT03529773|472132797|FG030|Overall Study|Screen Failure|0|||
131138333|NCT03529773|472132798|FG031|Overall Study|Screen Failure|0|||
131075028|NCT00943722|471908825|FG005|Base Study|Lost to Follow-up|0|||
131138334|NCT03529773|472132799|FG032|Overall Study|Screen Failure|0|||
131138335|NCT03529773|472132800|FG033|Overall Study|Screen Failure|0|||
131138336|NCT03529773|472132801|FG034|Overall Study|Screen Failure|0|||
131138337|NCT03529773|472132802|FG035|Overall Study|Screen Failure|0|||
131075029|NCT00943722|471908826|FG006|Base Study|Lost to Follow-up|0|||
131075030|NCT00943722|471908820|FG000|Base Study|Physician Decision|1|||
131075031|NCT00943722|471908821|FG001|Base Study|Physician Decision|0|||
131075032|NCT00943722|471908822|FG002|Base Study|Physician Decision|0|||
131075033|NCT00943722|471908823|FG003|Base Study|Physician Decision|0|||
131138338|NCT03529773|472132803|FG036|Overall Study|Screen Failure|1|||
131138339|NCT03529773|472132804|FG037|Overall Study|Screen Failure|1|||
131138340|NCT03529773|472132805|FG038|Overall Study|Screen Failure|0|||
131138341|NCT03529773|472132806|FG039|Overall Study|Screen Failure|1|||
131075034|NCT00943722|471908824|FG004|Base Study|Physician Decision|1|||
131075035|NCT00943722|471908825|FG005|Base Study|Physician Decision|0|||
131075036|NCT00943722|471908826|FG006|Base Study|Physician Decision|0|||
131075037|NCT00943722|471908820|FG000|Base Study|Pregnancy|0|||
131075038|NCT00943722|471908821|FG001|Base Study|Pregnancy|0|||
131075039|NCT00943722|471908822|FG002|Base Study|Pregnancy|1|||
131075040|NCT00943722|471908823|FG003|Base Study|Pregnancy|0|||
131075041|NCT00943722|471908824|FG004|Base Study|Pregnancy|2|||
131075042|NCT00943722|471908825|FG005|Base Study|Pregnancy|0|||
131075043|NCT00943722|471908826|FG006|Base Study|Pregnancy|0|||
131075044|NCT00943722|471908820|FG000|Base Study|Protocol Violation|0|||
131075045|NCT00943722|471908821|FG001|Base Study|Protocol Violation|1|||
131075046|NCT00943722|471908822|FG002|Base Study|Protocol Violation|0|||
131075047|NCT00943722|471908823|FG003|Base Study|Protocol Violation|0|||
131075048|NCT00943722|471908824|FG004|Base Study|Protocol Violation|2|||
131075049|NCT00943722|471908825|FG005|Base Study|Protocol Violation|0|||
131075050|NCT00943722|471908826|FG006|Base Study|Protocol Violation|0|||
131075051|NCT00943722|471908820|FG000|Base Study|Withdrawal by Subject|12|||
131231146|NCT01806597|472473235|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
131231147|NCT01806597|472473236|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
131075052|NCT00943722|471908821|FG001|Base Study|Withdrawal by Subject|13|||
131075053|NCT00943722|471908822|FG002|Base Study|Withdrawal by Subject|2|||
131075054|NCT00943722|471908823|FG003|Base Study|Withdrawal by Subject|13|||
131075055|NCT00943722|471908824|FG004|Base Study|Withdrawal by Subject|8|||
131075056|NCT00943722|471908825|FG005|Base Study|Withdrawal by Subject|0|||
131075057|NCT00943722|471908826|FG006|Base Study|Withdrawal by Subject|0|||
131075058|NCT00943722|471908820|FG000|Base Study|Month 12 visit not completed|0|||
131075059|NCT00943722|471908821|FG001|Base Study|Month 12 visit not completed|0|||
131075060|NCT00943722|471908822|FG002|Base Study|Month 12 visit not completed|0|||
131075061|NCT00943722|471908823|FG003|Base Study|Month 12 visit not completed|0|||
131075062|NCT00943722|471908824|FG004|Base Study|Month 12 visit not completed|2|||
131075063|NCT00943722|471908825|FG005|Base Study|Month 12 visit not completed|0|||
131075064|NCT00943722|471908826|FG006|Base Study|Month 12 visit not completed|0|||
131075065|NCT00943722|471908820|FG000|First Extension Study: EXT 1|Adverse Event|0|||
131075066|NCT00943722|471908821|FG001|First Extension Study: EXT 1|Adverse Event|0|||
131075067|NCT00943722|471908822|FG002|First Extension Study: EXT 1|Adverse Event|0|||
131075068|NCT00943722|471908823|FG003|First Extension Study: EXT 1|Adverse Event|0|||
131075069|NCT00943722|471908824|FG004|First Extension Study: EXT 1|Adverse Event|0|||
131075070|NCT00943722|471908825|FG005|First Extension Study: EXT 1|Adverse Event|1|||
131075071|NCT00943722|471908826|FG006|First Extension Study: EXT 1|Adverse Event|0|||
131075072|NCT00943722|471908820|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
131075073|NCT00943722|471908821|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
131075074|NCT00943722|471908822|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
131075075|NCT00943722|471908823|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
131075076|NCT00943722|471908824|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
131075077|NCT00943722|471908825|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
131075078|NCT00943722|471908826|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
131075079|NCT00943722|471908820|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
131075080|NCT00943722|471908821|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
131075081|NCT00943722|471908822|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
131075082|NCT00943722|471908823|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
131075083|NCT00943722|471908824|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
131075084|NCT00943722|471908825|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
131075085|NCT00943722|471908826|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
131075086|NCT00943722|471908820|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
131075087|NCT00943722|471908821|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
131075088|NCT00943722|471908822|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
131075089|NCT00943722|471908823|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
131075090|NCT00943722|471908824|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
131075091|NCT00943722|471908825|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
131075092|NCT00943722|471908826|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
131075093|NCT00943722|471908820|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
131075094|NCT00943722|471908821|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
131075095|NCT00943722|471908822|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
131075096|NCT00943722|471908823|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
131075097|NCT00943722|471908824|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
131075098|NCT00943722|471908825|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
131075099|NCT00943722|471908826|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
131075100|NCT00943722|471908820|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
131075101|NCT00943722|471908821|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
131075102|NCT00943722|471908822|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
131075103|NCT00943722|471908823|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
131075104|NCT00943722|471908824|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
131075105|NCT00943722|471908825|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
131075106|NCT00943722|471908826|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
131075107|NCT00943722|471908820|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
131075108|NCT00943722|471908821|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
131075109|NCT00943722|471908822|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
131075110|NCT00943722|471908823|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
131075111|NCT00943722|471908824|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
131075112|NCT00943722|471908825|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
131075113|NCT00943722|471908826|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
131075114|NCT00943722|471908820|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
131075115|NCT00943722|471908821|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
131075116|NCT00943722|471908822|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
131075117|NCT00943722|471908823|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
131075118|NCT00943722|471908824|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
131075119|NCT00943722|471908825|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
131075120|NCT00943722|471908826|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
131075121|NCT00943722|471908820|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
131075122|NCT00943722|471908821|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
131075123|NCT00943722|471908822|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
131075124|NCT00943722|471908823|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
131075125|NCT00943722|471908824|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
131075126|NCT00943722|471908825|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
131075127|NCT00943722|471908826|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
131075128|NCT01036165|471908831|FG000|Overall Study|Adverse Event|6|||
131075129|NCT01036165|471908831|FG000|Overall Study|Lost to Follow-up|2|||
131075130|NCT01036165|471908831|FG000|Overall Study|Withdrawal by Subject|3|||
131075131|NCT01036165|471908831|FG000|Overall Study|Device Related Issues|3|||
131075132|NCT01036165|471908831|FG000|Overall Study|Problems finding proper area to inject|1|||
131075133|NCT00916305|471908838|FG000|Overall Study|Lost to Follow-up|21|||
131075134|NCT00916305|471908839|FG001|Overall Study|Lost to Follow-up|27|||
131075135|NCT00916305|471908838|FG000|Overall Study|Withdrawal by Subject|0|||
131075136|NCT00916305|471908839|FG001|Overall Study|Withdrawal by Subject|1|||
131075137|NCT01844726|471908840|FG000|Overall Study|Withdrawal by Subject|0|||
131075138|NCT01844726|471908841|FG001|Overall Study|Withdrawal by Subject|1|||
131075139|NCT01844726|471908840|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
131075140|NCT01844726|471908841|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
131075141|NCT04191148|471908846|FG000|Overall Study|Withdrawal by Subject|1|||
131075142|NCT04191148|471908847|FG001|Overall Study|Withdrawal by Subject|0|||
131075143|NCT04191148|471908846|FG000|Overall Study|Adverse Event|1|||
131075144|NCT04191148|471908847|FG001|Overall Study|Adverse Event|0|||
131075145|NCT01274559|471908848|FG000|Overall Study|Adverse Event|57|||
131075146|NCT01274559|471908849|FG001|Overall Study|Adverse Event|13|||
131075147|NCT01274559|471908848|FG000|Overall Study|Death|1|||
131075148|NCT01274559|471908849|FG001|Overall Study|Death|1|||
131075149|NCT01274559|471908848|FG000|Overall Study|Lost to Follow-up|3|||
131075150|NCT01274559|471908849|FG001|Overall Study|Lost to Follow-up|3|||
131075151|NCT01274559|471908848|FG000|Overall Study|Non-compliance with Study Drug|2|||
131075152|NCT01274559|471908849|FG001|Overall Study|Non-compliance with Study Drug|4|||
131138342|NCT03529773|472132767|FG000|Overall Study|Randomized but not vaccinated|0|||
131138343|NCT03529773|472132768|FG001|Overall Study|Randomized but not vaccinated|0|||
131138344|NCT03529773|472132769|FG002|Overall Study|Randomized but not vaccinated|0|||
131138345|NCT03529773|472132770|FG003|Overall Study|Randomized but not vaccinated|0|||
131138346|NCT03529773|472132771|FG004|Overall Study|Randomized but not vaccinated|0|||
131138347|NCT03529773|472132772|FG005|Overall Study|Randomized but not vaccinated|0|||
131138348|NCT03529773|472132773|FG006|Overall Study|Randomized but not vaccinated|0|||
131138349|NCT03529773|472132774|FG007|Overall Study|Randomized but not vaccinated|0|||
131138350|NCT03529773|472132775|FG008|Overall Study|Randomized but not vaccinated|0|||
131138351|NCT03529773|472132776|FG009|Overall Study|Randomized but not vaccinated|0|||
131138352|NCT03529773|472132777|FG010|Overall Study|Randomized but not vaccinated|0|||
131075153|NCT01274559|471908848|FG000|Overall Study|Physician Decision|2|||
131138353|NCT03529773|472132778|FG011|Overall Study|Randomized but not vaccinated|0|||
131138354|NCT03529773|472132779|FG012|Overall Study|Randomized but not vaccinated|0|||
131138355|NCT03529773|472132780|FG013|Overall Study|Randomized but not vaccinated|0|||
131138356|NCT03529773|472132781|FG014|Overall Study|Randomized but not vaccinated|0|||
131138357|NCT03529773|472132782|FG015|Overall Study|Randomized but not vaccinated|0|||
131138358|NCT03529773|472132783|FG016|Overall Study|Randomized but not vaccinated|0|||
131138359|NCT03529773|472132784|FG017|Overall Study|Randomized but not vaccinated|1|||
131138360|NCT03529773|472132785|FG018|Overall Study|Randomized but not vaccinated|0|||
131138361|NCT03529773|472132786|FG019|Overall Study|Randomized but not vaccinated|0|||
131138362|NCT03529773|472132787|FG020|Overall Study|Randomized but not vaccinated|0|||
131138363|NCT03529773|472132788|FG021|Overall Study|Randomized but not vaccinated|0|||
131138364|NCT03529773|472132789|FG022|Overall Study|Randomized but not vaccinated|0|||
131075154|NCT01274559|471908849|FG001|Overall Study|Physician Decision|1|||
131075155|NCT01274559|471908848|FG000|Overall Study|Protocol Violation|28|||
131075156|NCT01274559|471908849|FG001|Overall Study|Protocol Violation|23|||
131075157|NCT01274559|471908848|FG000|Overall Study|Study Terminated by Sponsor|79|||
131075158|NCT01274559|471908849|FG001|Overall Study|Study Terminated by Sponsor|87|||
131075159|NCT01274559|471908848|FG000|Overall Study|Withdrawal by Subject|25|||
131075160|NCT01274559|471908849|FG001|Overall Study|Withdrawal by Subject|13|||
131075161|NCT03409731|471908861|FG000|Overall Study|Withdrawal by Subject|17|||
131075162|NCT03409731|471908861|FG000|Overall Study|Death|4|||
131075163|NCT04016805|471908862|FG000|Overall Study|Sponsor's Discretion|30|||
131075164|NCT04016805|471908863|FG001|Overall Study|Sponsor's Discretion|6|||
131075165|NCT04016805|471908864|FG002|Overall Study|Sponsor's Discretion|5|||
131075166|NCT00545571|471908865|FG000|Overall Study|Administrative Reasons|1|||
131075167|NCT00545571|471908865|FG000|Overall Study|Adverse Event|2|||
131075168|NCT00545571|471908865|FG000|Overall Study|Death|5|||
131075169|NCT00545571|471908865|FG000|Overall Study|Lack of Efficacy|1|||
131075170|NCT00545571|471908865|FG000|Overall Study|Protocol Violation|2|||
131075171|NCT00545571|471908865|FG000|Overall Study|Refused Treatment|1|||
131075172|NCT00545571|471908865|FG000|Overall Study|Screen Failure|16|||
131075173|NCT00545571|471908865|FG000|Overall Study|Transfusion|12|||
131075174|NCT00545571|471908865|FG000|Overall Study|Early Termination of Study|24|||
131075175|NCT00545571|471908865|FG000|Overall Study|Kidney Transplantation|3|||
131075176|NCT01193218|471908866|FG000|0-12 Weeks|Adverse Event|6|||
131075177|NCT01193218|471908867|FG001|0-12 Weeks|Adverse Event|0|||
131075178|NCT01193218|471908868|FG002|0-12 Weeks|Adverse Event|1|||
131075179|NCT01193218|471908869|FG003|0-12 Weeks|Adverse Event|0|||
131075180|NCT01193218|471908870|FG004|0-12 Weeks|Adverse Event|0|||
131075181|NCT01193218|471908871|FG005|0-12 Weeks|Adverse Event|2|||
131075182|NCT01193218|471908872|FG006|0-12 Weeks|Adverse Event|2|||
131075183|NCT01193218|471908873|FG007|0-12 Weeks|Adverse Event|0|||
131075184|NCT01193218|471908866|FG000|0-12 Weeks|Protocol Violation|0|||
131075185|NCT01193218|471908867|FG001|0-12 Weeks|Protocol Violation|0|||
131075186|NCT01193218|471908868|FG002|0-12 Weeks|Protocol Violation|0|||
131075187|NCT01193218|471908869|FG003|0-12 Weeks|Protocol Violation|0|||
131075188|NCT01193218|471908870|FG004|0-12 Weeks|Protocol Violation|1|||
131075189|NCT01193218|471908871|FG005|0-12 Weeks|Protocol Violation|1|||
131075190|NCT01193218|471908872|FG006|0-12 Weeks|Protocol Violation|0|||
131075191|NCT01193218|471908873|FG007|0-12 Weeks|Protocol Violation|0|||
131075192|NCT01193218|471908866|FG000|0-12 Weeks|Withdrawal by Subject|3|||
131075193|NCT01193218|471908867|FG001|0-12 Weeks|Withdrawal by Subject|0|||
131075194|NCT01193218|471908868|FG002|0-12 Weeks|Withdrawal by Subject|2|||
131075195|NCT01193218|471908869|FG003|0-12 Weeks|Withdrawal by Subject|0|||
131075196|NCT01193218|471908870|FG004|0-12 Weeks|Withdrawal by Subject|0|||
131075197|NCT01193218|471908871|FG005|0-12 Weeks|Withdrawal by Subject|0|||
131075198|NCT01193218|471908872|FG006|0-12 Weeks|Withdrawal by Subject|1|||
131075199|NCT01193218|471908873|FG007|0-12 Weeks|Withdrawal by Subject|0|||
131075200|NCT01193218|471908866|FG000|12-52 Weeks|Adverse Event|1|||
131075201|NCT01193218|471908867|FG001|12-52 Weeks|Adverse Event|0|||
131075202|NCT01193218|471908868|FG002|12-52 Weeks|Adverse Event|1|||
131075203|NCT01193218|471908869|FG003|12-52 Weeks|Adverse Event|2|||
131075204|NCT01193218|471908870|FG004|12-52 Weeks|Adverse Event|3|||
131075205|NCT01193218|471908871|FG005|12-52 Weeks|Adverse Event|3|||
131075206|NCT01193218|471908872|FG006|12-52 Weeks|Adverse Event|1|||
131075207|NCT01193218|471908873|FG007|12-52 Weeks|Adverse Event|2|||
131075208|NCT01193218|471908866|FG000|12-52 Weeks|Lack of Efficacy|0|||
131075209|NCT01193218|471908867|FG001|12-52 Weeks|Lack of Efficacy|0|||
131075210|NCT01193218|471908868|FG002|12-52 Weeks|Lack of Efficacy|0|||
131075211|NCT01193218|471908869|FG003|12-52 Weeks|Lack of Efficacy|0|||
131075212|NCT01193218|471908870|FG004|12-52 Weeks|Lack of Efficacy|0|||
131075213|NCT01193218|471908871|FG005|12-52 Weeks|Lack of Efficacy|0|||
131075214|NCT01193218|471908872|FG006|12-52 Weeks|Lack of Efficacy|1|||
131075215|NCT01193218|471908873|FG007|12-52 Weeks|Lack of Efficacy|0|||
131075216|NCT01193218|471908866|FG000|12-52 Weeks|Withdrawal by Subject|3|||
131075217|NCT01193218|471908867|FG001|12-52 Weeks|Withdrawal by Subject|0|||
131075218|NCT01193218|471908868|FG002|12-52 Weeks|Withdrawal by Subject|3|||
130724755|NCT00314951|470617020|FG000|Treatment|Didn't meet criteria for mITT population|16|||
131075219|NCT01193218|471908869|FG003|12-52 Weeks|Withdrawal by Subject|0|||
131075220|NCT01193218|471908870|FG004|12-52 Weeks|Withdrawal by Subject|0|||
131075221|NCT01193218|471908871|FG005|12-52 Weeks|Withdrawal by Subject|2|||
131075222|NCT01193218|471908872|FG006|12-52 Weeks|Withdrawal by Subject|1|||
131075223|NCT01193218|471908873|FG007|12-52 Weeks|Withdrawal by Subject|2|||
131075224|NCT01193218|471908866|FG000|12-52 Weeks|Other reason than above|1|||
131075225|NCT01193218|471908867|FG001|12-52 Weeks|Other reason than above|0|||
131138365|NCT03529773|472132790|FG023|Overall Study|Randomized but not vaccinated|0|||
131075226|NCT01193218|471908868|FG002|12-52 Weeks|Other reason than above|0|||
131075227|NCT01193218|471908869|FG003|12-52 Weeks|Other reason than above|1|||
131075228|NCT01193218|471908870|FG004|12-52 Weeks|Other reason than above|1|||
131075229|NCT01193218|471908871|FG005|12-52 Weeks|Other reason than above|0|||
131075230|NCT01193218|471908872|FG006|12-52 Weeks|Other reason than above|0|||
131075231|NCT01193218|471908873|FG007|12-52 Weeks|Other reason than above|0|||
131075232|NCT01013740|471908874|FG000|Overall Study|Lost to Follow-up|3|||
131075233|NCT01013740|471908875|FG001|Overall Study|Lost to Follow-up|5|||
131075234|NCT01013740|471908874|FG000|Overall Study|Physician Decision|2|||
131075235|NCT01013740|471908875|FG001|Overall Study|Physician Decision|0|||
131075236|NCT01013740|471908874|FG000|Overall Study|Withdrawal by Subject|2|||
131075237|NCT01013740|471908875|FG001|Overall Study|Withdrawal by Subject|10|||
131075238|NCT01013740|471908874|FG000|Overall Study|study close / terminated : done in error|2|||
131075239|NCT01013740|471908875|FG001|Overall Study|study close / terminated : done in error|1|||
131075240|NCT01013740|471908874|FG000|Overall Study|Missing|2|||
131075241|NCT01013740|471908875|FG001|Overall Study|Missing|1|||
131075242|NCT01013740|471908874|FG000|Overall Study|Ongoing: Study records not completed|0|||
131075243|NCT01013740|471908875|FG001|Overall Study|Ongoing: Study records not completed|2|||
131075244|NCT00338949|471908876|FG000|Subject Screening|Screen failures|11|||
131075245|NCT00338949|471908877|FG001|Subject Screening|Screen failures|11|||
131075246|NCT00338949|471908876|FG000|Randomization|Withdrawal by Subject|1|||
131075247|NCT00338949|471908877|FG001|Randomization|Withdrawal by Subject|0|||
131075248|NCT00338949|471908876|FG000|Randomization|Adverse Event|0|||
131075249|NCT00338949|471908877|FG001|Randomization|Adverse Event|5|||
131075250|NCT03811834|471908878|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
131075251|NCT01242371|471908879|FG000|Overall Study|Withdrawal by Subject|2|||
131075252|NCT01242371|471908880|FG001|Overall Study|Withdrawal by Subject|2|||
131075253|NCT01242371|471908879|FG000|Overall Study|Protocol Violation|0|||
131075254|NCT01242371|471908880|FG001|Overall Study|Protocol Violation|3|||
131075255|NCT00025662|471908881|FG000|Overall Study|Withdrawal by Subject|2|||
131075256|NCT00025662|471908881|FG000|Overall Study|Technical failure of manipulation|1|||
131075257|NCT01349036|471908882|FG000|Overall Study|Disease progression|13|||
131075258|NCT01349036|471908883|FG001|Overall Study|Disease progression|22|||
131075259|NCT01349036|471908882|FG000|Overall Study|Other|1|||
131075260|NCT01349036|471908883|FG001|Overall Study|Other|0|||
131075261|NCT01349036|471908882|FG000|Overall Study|Withdrawal by Subject|0|||
131075262|NCT01349036|471908883|FG001|Overall Study|Withdrawal by Subject|2|||
131075263|NCT01215032|471908886|FG000|Overall Study|Adverse Event|3|||
131075264|NCT01215032|471908886|FG000|Overall Study|Lack of Efficacy|17|||
131075265|NCT01125566|471908887|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
131138366|NCT03529773|472132791|FG024|Overall Study|Randomized but not vaccinated|0|||
131138367|NCT03529773|472132792|FG025|Overall Study|Randomized but not vaccinated|0|||
131138368|NCT03529773|472132793|FG026|Overall Study|Randomized but not vaccinated|0|||
131138369|NCT03529773|472132794|FG027|Overall Study|Randomized but not vaccinated|1|||
131138370|NCT03529773|472132795|FG028|Overall Study|Randomized but not vaccinated|0|||
131138371|NCT03529773|472132796|FG029|Overall Study|Randomized but not vaccinated|0|||
131138372|NCT03529773|472132797|FG030|Overall Study|Randomized but not vaccinated|0|||
131138373|NCT03529773|472132798|FG031|Overall Study|Randomized but not vaccinated|0|||
131138374|NCT03529773|472132799|FG032|Overall Study|Randomized but not vaccinated|0|||
131138375|NCT03529773|472132800|FG033|Overall Study|Randomized but not vaccinated|0|||
131138376|NCT03529773|472132801|FG034|Overall Study|Randomized but not vaccinated|0|||
131138377|NCT03529773|472132802|FG035|Overall Study|Randomized but not vaccinated|0|||
131138378|NCT03529773|472132803|FG036|Overall Study|Randomized but not vaccinated|0|||
131138379|NCT03529773|472132804|FG037|Overall Study|Randomized but not vaccinated|0|||
131138380|NCT03529773|472132805|FG038|Overall Study|Randomized but not vaccinated|0|||
131138381|NCT03529773|472132806|FG039|Overall Study|Randomized but not vaccinated|0|||
131138382|NCT01340209|472132807|FG000|Overall Study|Adverse Event|1|||
131138383|NCT01340209|472132808|FG001|Overall Study|Adverse Event|1|||
131138384|NCT01340209|472132809|FG002|Overall Study|Adverse Event|2|||
131138385|NCT01340209|472132807|FG000|Overall Study|Protocol Violation|1|||
131138386|NCT01340209|472132808|FG001|Overall Study|Protocol Violation|2|||
131138387|NCT01340209|472132809|FG002|Overall Study|Protocol Violation|1|||
131075266|NCT01125566|471908888|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
131075267|NCT01125566|471908889|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
131138388|NCT01340209|472132807|FG000|Overall Study|Withdrawal by Subject|0|||
131138389|NCT01340209|472132808|FG001|Overall Study|Withdrawal by Subject|0|||
131138390|NCT01340209|472132809|FG002|Overall Study|Withdrawal by Subject|1|||
131138391|NCT01340209|472132807|FG000|Overall Study|Other reason not defined above|3|||
131138392|NCT01340209|472132808|FG001|Overall Study|Other reason not defined above|5|||
131138393|NCT01340209|472132809|FG002|Overall Study|Other reason not defined above|4|||
131138394|NCT01537211|472132812|FG000|Overall Study|Lost to Follow-up|0|||
131138395|NCT01537211|472132813|FG001|Overall Study|Lost to Follow-up|1|||
131138396|NCT04142983|472132814|FG000|Overall Study|Lost to Follow-up|73|||
130724756|NCT00314951|470617021|FG001|Treatment|Didn't meet criteria for mITT population|11|||
131075268|NCT01125566|471908887|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
131075269|NCT01125566|471908888|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
131075270|NCT01125566|471908889|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
131138397|NCT04142983|472132814|FG000|Overall Study|Withdrawal by Subject|10|||
131138398|NCT04142983|472132814|FG000|Overall Study|Physician Decision|1|||
131138399|NCT04142983|472132814|FG000|Overall Study|Adverse Event|1|||
131075271|NCT01125566|471908887|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
131075272|NCT01125566|471908888|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
131075273|NCT01125566|471908889|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
131075274|NCT01125566|471908887|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
131075275|NCT01125566|471908888|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
131075276|NCT01125566|471908889|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
131075277|NCT01125566|471908887|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
131075278|NCT01125566|471908888|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
131075279|NCT01125566|471908889|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
131075280|NCT01125566|471908887|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
131075281|NCT01125566|471908888|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
131075282|NCT01125566|471908889|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
131075283|NCT01125566|471908887|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
131075284|NCT01125566|471908888|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
131075285|NCT01125566|471908889|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
131075286|NCT01125566|471908887|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
131075287|NCT01125566|471908888|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
131075288|NCT01125566|471908889|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
131075289|NCT01125566|471908887|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
131075290|NCT01125566|471908888|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
131075291|NCT01125566|471908889|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
131075292|NCT01125566|471908887|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
131075293|NCT01125566|471908888|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
131075294|NCT01125566|471908889|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
131075295|NCT01125566|471908887|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
131075296|NCT01125566|471908888|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
131075297|NCT01125566|471908889|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
131075298|NCT01125566|471908887|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
131075299|NCT01125566|471908888|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
131075300|NCT01125566|471908889|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
131075301|NCT03028012|471908890|FG000|Overall Study|Lost to Follow-up|2|||
131075302|NCT03028012|471908891|FG001|Overall Study|Lost to Follow-up|3|||
131075303|NCT03028012|471908892|FG002|Overall Study|Lost to Follow-up|3|||
131138400|NCT04142983|472132814|FG000|Overall Study|No longer eligible|4|||
131138401|NCT04142983|472132814|FG000|Overall Study|Screen Failure|10|||
131138402|NCT00797823|472132822|FG000|First Period (Initial Randomization)|Physician Decision|1|||
131138403|NCT00797823|472132823|FG001|First Period (Initial Randomization)|Physician Decision|0|||
131138404|NCT00797823|472132824|FG002|First Period (Initial Randomization)|Physician Decision|0|||
131138405|NCT02809833|472132825|FG000|Overall Study|Death|3|||
131138406|NCT02809833|472132825|FG000|Overall Study|Intolerance|54|||
131138407|NCT02809833|472132825|FG000|Overall Study|Lack of Efficacy|89|||
131138408|NCT02809833|472132825|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
131138409|NCT02809833|472132825|FG000|Overall Study|Noncompliance|1|||
131138410|NCT02809833|472132825|FG000|Overall Study|Withdrawal by Subject|34|||
131138411|NCT02809833|472132825|FG000|Overall Study|Lost to Follow-up|35|||
131138412|NCT02809833|472132825|FG000|Overall Study|Adverse Event (AE)|24|||
131138413|NCT02809833|472132825|FG000|Overall Study|Other|5|||
131138414|NCT02809833|472132825|FG000|Overall Study|Missing Information|52|||
131138415|NCT00523991|472132826|FG000|Overall Study|Adverse Event|6|||
131138416|NCT00523991|472132827|FG001|Overall Study|Adverse Event|5|||
131138417|NCT00523991|472132826|FG000|Overall Study|Protocol Violation|1|||
131138418|NCT00523991|472132827|FG001|Overall Study|Protocol Violation|4|||
131138419|NCT00523991|472132826|FG000|Overall Study|Lost to Follow-up|4|||
131138420|NCT00523991|472132827|FG001|Overall Study|Lost to Follow-up|1|||
131138421|NCT00523991|472132826|FG000|Overall Study|Withdrawal by Subject|7|||
131138422|NCT00523991|472132827|FG001|Overall Study|Withdrawal by Subject|17|||
131138423|NCT00523991|472132826|FG000|Overall Study|Other reason (not specified)|3|||
131138424|NCT00523991|472132827|FG001|Overall Study|Other reason (not specified)|0|||
131138425|NCT00193063|472132828|FG000|Overall Study|Lack of Efficacy|3|||
131138426|NCT00193063|472132828|FG000|Overall Study|Adverse Event|1|||
131138427|NCT00744874|472132831|FG000|Overall Study|Lost to Follow-up|1|||
131138428|NCT00744874|472132831|FG000|Overall Study|Withdrawal by Subject|1|||
131138429|NCT00744874|472132831|FG000|Overall Study|Study Device not available at procedure|1|||
131138430|NCT00744874|472132831|FG000|Overall Study|Unable to accomodate schedule|1|||
131138431|NCT01127165|472132837|FG000|Overall Study|Adverse Event|2|||
131138432|NCT01127165|472132838|FG001|Overall Study|Adverse Event|2|||
131138433|NCT01127165|472132837|FG000|Overall Study|Lack of Efficacy|10|||
131138434|NCT01127165|472132838|FG001|Overall Study|Lack of Efficacy|8|||
131138435|NCT01127165|472132837|FG000|Overall Study|Lost to Follow-up|3|||
131075304|NCT02484547|471908899|FG000|Placebo-Controlled Period|Adverse Event|10|||
131075305|NCT02484547|471908900|FG001|Placebo-Controlled Period|Adverse Event|13|||
131075306|NCT02484547|471908901|FG002|Placebo-Controlled Period|Adverse Event|20|||
131075307|NCT02484547|471908902|FG003|Placebo-Controlled Period|Adverse Event|0|||
131075308|NCT02484547|471908903|FG004|Placebo-Controlled Period|Adverse Event|0|||
131075309|NCT02484547|471908904|FG005|Placebo-Controlled Period|Adverse Event|0|||
131075310|NCT02484547|471908905|FG006|Placebo-Controlled Period|Adverse Event|0|||
131075311|NCT02484547|471908899|FG000|Placebo-Controlled Period|Change of Treatment|0|||
131075312|NCT02484547|471908900|FG001|Placebo-Controlled Period|Change of Treatment|0|||
131075313|NCT02484547|471908901|FG002|Placebo-Controlled Period|Change of Treatment|1|||
131075314|NCT02484547|471908902|FG003|Placebo-Controlled Period|Change of Treatment|0|||
131075315|NCT02484547|471908903|FG004|Placebo-Controlled Period|Change of Treatment|0|||
131075316|NCT02484547|471908904|FG005|Placebo-Controlled Period|Change of Treatment|0|||
131075317|NCT02484547|471908905|FG006|Placebo-Controlled Period|Change of Treatment|0|||
130724757|NCT00314951|470617020|FG000|Follow-up|mITT failure|44|||
131075318|NCT02484547|471908899|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
131075319|NCT02484547|471908900|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
131075320|NCT02484547|471908901|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
131075321|NCT02484547|471908902|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
131075322|NCT02484547|471908903|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
131075323|NCT02484547|471908904|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
131075324|NCT02484547|471908905|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
131075325|NCT02484547|471908899|FG000|Placebo-Controlled Period|Death|5|||
131075326|NCT02484547|471908900|FG001|Placebo-Controlled Period|Death|0|||
131075327|NCT02484547|471908901|FG002|Placebo-Controlled Period|Death|6|||
131075328|NCT02484547|471908902|FG003|Placebo-Controlled Period|Death|0|||
131075329|NCT02484547|471908903|FG004|Placebo-Controlled Period|Death|0|||
131075330|NCT02484547|471908904|FG005|Placebo-Controlled Period|Death|0|||
131075331|NCT02484547|471908905|FG006|Placebo-Controlled Period|Death|0|||
131075332|NCT02484547|471908899|FG000|Placebo-Controlled Period|Disease Progression|2|||
131075333|NCT02484547|471908900|FG001|Placebo-Controlled Period|Disease Progression|0|||
131075334|NCT02484547|471908901|FG002|Placebo-Controlled Period|Disease Progression|1|||
131075335|NCT02484547|471908902|FG003|Placebo-Controlled Period|Disease Progression|0|||
131075336|NCT02484547|471908903|FG004|Placebo-Controlled Period|Disease Progression|0|||
131075337|NCT02484547|471908904|FG005|Placebo-Controlled Period|Disease Progression|0|||
131075338|NCT02484547|471908905|FG006|Placebo-Controlled Period|Disease Progression|0|||
131075339|NCT02484547|471908899|FG000|Placebo-Controlled Period|Investigator Decision|2|||
131075340|NCT02484547|471908900|FG001|Placebo-Controlled Period|Investigator Decision|2|||
131075341|NCT02484547|471908901|FG002|Placebo-Controlled Period|Investigator Decision|5|||
131075342|NCT02484547|471908902|FG003|Placebo-Controlled Period|Investigator Decision|0|||
131138436|NCT01127165|472132838|FG001|Overall Study|Lost to Follow-up|5|||
131138437|NCT01127165|472132837|FG000|Overall Study|Withdrawal by Subject|1|||
131138438|NCT01127165|472132838|FG001|Overall Study|Withdrawal by Subject|3|||
131138439|NCT01127165|472132837|FG000|Overall Study|Protocol Violation|0|||
131138440|NCT01127165|472132838|FG001|Overall Study|Protocol Violation|1|||
131138441|NCT02435849|472132839|FG000|Overall Study|Death|23|||
131138442|NCT02435849|472132840|FG001|Overall Study|Death|0|||
131138443|NCT02435849|472132839|FG000|Overall Study|Lack of Efficacy|10|||
131138444|NCT02435849|472132840|FG001|Overall Study|Lack of Efficacy|0|||
131138445|NCT02435849|472132839|FG000|Overall Study|New therapy for study indication|8|||
131138446|NCT02435849|472132840|FG001|Overall Study|New therapy for study indication|0|||
131138447|NCT02435849|472132839|FG000|Overall Study|Subject/guardian decision|5|||
131138448|NCT02435849|472132840|FG001|Overall Study|Subject/guardian decision|1|||
131138449|NCT02435849|472132839|FG000|Overall Study|Lost to Follow-up|1|||
131138450|NCT02435849|472132840|FG001|Overall Study|Lost to Follow-up|0|||
131138451|NCT02435849|472132839|FG000|Overall Study|Physician Decision|1|||
131138452|NCT02435849|472132840|FG001|Overall Study|Physician Decision|0|||
131138453|NCT02486757|472132841|FG000|Overall Study|Lost to Follow-up|1|||
131138454|NCT01017952|472132842|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
131138455|NCT01017952|472132843|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131138456|NCT01017952|472132844|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131138457|NCT01017952|472132845|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131138458|NCT01017952|472132846|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130724758|NCT00314951|470617021|FG001|Follow-up|mITT failure|34|||
130724759|NCT00233402|470617022|FG000|Overall Study|No pathology data|12|||
130724760|NCT00233402|470617023|FG001|Overall Study|No pathology data|9|||
131075343|NCT02484547|471908903|FG004|Placebo-Controlled Period|Investigator Decision|0|||
131138459|NCT01017952|472132842|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
131138460|NCT01017952|472132843|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
131138461|NCT01017952|472132844|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
131138462|NCT01017952|472132845|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
131075344|NCT02484547|471908904|FG005|Placebo-Controlled Period|Investigator Decision|0|||
130724761|NCT00233402|470617022|FG000|Overall Study|No Ta/T1|89|||
131075345|NCT02484547|471908905|FG006|Placebo-Controlled Period|Investigator Decision|0|||
131075346|NCT02484547|471908899|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
131075347|NCT02484547|471908900|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
131075348|NCT02484547|471908901|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
131075349|NCT02484547|471908902|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
131075350|NCT02484547|471908903|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
131075351|NCT02484547|471908904|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
131075352|NCT02484547|471908905|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
131075353|NCT02484547|471908899|FG000|Placebo-Controlled Period|Relocation|1|||
131075354|NCT02484547|471908900|FG001|Placebo-Controlled Period|Relocation|1|||
131075355|NCT02484547|471908901|FG002|Placebo-Controlled Period|Relocation|1|||
131075356|NCT02484547|471908902|FG003|Placebo-Controlled Period|Relocation|0|||
131075357|NCT02484547|471908903|FG004|Placebo-Controlled Period|Relocation|0|||
131075358|NCT02484547|471908904|FG005|Placebo-Controlled Period|Relocation|0|||
131075359|NCT02484547|471908905|FG006|Placebo-Controlled Period|Relocation|0|||
131075360|NCT02484547|471908899|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
131075361|NCT02484547|471908900|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
131075362|NCT02484547|471908901|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
131075363|NCT02484547|471908902|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
131075364|NCT02484547|471908903|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
131075365|NCT02484547|471908904|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
131075366|NCT02484547|471908905|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
131075367|NCT02484547|471908899|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
131075368|NCT02484547|471908900|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
131075369|NCT02484547|471908901|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
131075370|NCT02484547|471908902|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131075371|NCT02484547|471908903|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131075372|NCT02484547|471908904|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131075373|NCT02484547|471908905|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131075374|NCT02484547|471908899|FG000|Placebo-Controlled Period|Reason not Specified|216|||
131075375|NCT02484547|471908900|FG001|Placebo-Controlled Period|Reason not Specified|194|||
131075376|NCT02484547|471908901|FG002|Placebo-Controlled Period|Reason not Specified|183|||
131075377|NCT02484547|471908902|FG003|Placebo-Controlled Period|Reason not Specified|0|||
131075378|NCT02484547|471908903|FG004|Placebo-Controlled Period|Reason not Specified|0|||
131075379|NCT02484547|471908904|FG005|Placebo-Controlled Period|Reason not Specified|0|||
131075380|NCT02484547|471908905|FG006|Placebo-Controlled Period|Reason not Specified|0|||
131075381|NCT02484547|471908899|FG000|Long-Term Extension Period|Adverse Event|0|||
131075382|NCT02484547|471908900|FG001|Long-Term Extension Period|Adverse Event|0|||
130724762|NCT00233402|470617023|FG001|Overall Study|No Ta/T1|94|||
130724763|NCT00233402|470617022|FG000|Overall Study|Lost to follow up etc|3|||
130724764|NCT00233402|470617023|FG001|Overall Study|Lost to follow up etc|21|||
130724765|NCT02087189|470617026|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
130724766|NCT01189487|470617027|FG000|Overall Study|Lack of Efficacy|2|||
130724767|NCT01189487|470617027|FG000|Overall Study|Adverse Event|1|||
130724768|NCT04630158|470617028|FG000|Overall Study|Adverse Event|1|||
130724769|NCT04630158|470617029|FG001|Overall Study|Adverse Event|1|||
130724770|NCT04630158|470617030|FG002|Overall Study|Adverse Event|1|||
130724771|NCT04630158|470617028|FG000|Overall Study|Physician Decision|0|||
130724772|NCT04630158|470617029|FG001|Overall Study|Physician Decision|2|||
130724773|NCT04630158|470617030|FG002|Overall Study|Physician Decision|0|||
130724774|NCT04630158|470617028|FG000|Overall Study|Protocol Violation|1|||
130724775|NCT04630158|470617029|FG001|Overall Study|Protocol Violation|0|||
130724776|NCT04630158|470617030|FG002|Overall Study|Protocol Violation|1|||
130724777|NCT04630158|470617028|FG000|Overall Study|Withdrawal by Subject|2|||
130724778|NCT04630158|470617029|FG001|Overall Study|Withdrawal by Subject|1|||
130724779|NCT04630158|470617030|FG002|Overall Study|Withdrawal by Subject|2|||
130724780|NCT03136965|470617033|FG000|Overall Study|Lost to Follow-up|0|||
131075383|NCT02484547|471908901|FG002|Long-Term Extension Period|Adverse Event|0|||
131075384|NCT02484547|471908902|FG003|Long-Term Extension Period|Adverse Event|0|||
131075385|NCT02484547|471908903|FG004|Long-Term Extension Period|Adverse Event|1|||
131075386|NCT02484547|471908904|FG005|Long-Term Extension Period|Adverse Event|3|||
131075387|NCT02484547|471908905|FG006|Long-Term Extension Period|Adverse Event|2|||
131075388|NCT02484547|471908899|FG000|Long-Term Extension Period|Death|0|||
131075389|NCT02484547|471908900|FG001|Long-Term Extension Period|Death|0|||
131075390|NCT02484547|471908901|FG002|Long-Term Extension Period|Death|0|||
131075391|NCT02484547|471908902|FG003|Long-Term Extension Period|Death|0|||
131075392|NCT02484547|471908903|FG004|Long-Term Extension Period|Death|0|||
131075393|NCT02484547|471908904|FG005|Long-Term Extension Period|Death|3|||
130724781|NCT03136965|470617034|FG001|Overall Study|Lost to Follow-up|1|||
130724782|NCT03136965|470617035|FG002|Overall Study|Lost to Follow-up|0|||
131075394|NCT02484547|471908905|FG006|Long-Term Extension Period|Death|0|||
130724783|NCT04868968|470617037|FG000|Overall Study|Lost to Follow-up|1|||
130724784|NCT05038800|470617043|FG000|Overall Study|Death|1|||
130724785|NCT05038800|470617044|FG001|Overall Study|Death|1|||
130724786|NCT05038800|470617045|FG002|Overall Study|Death|5|||
130724787|NCT05038800|470617046|FG003|Overall Study|Death|3|||
130724788|NCT05038800|470617047|FG004|Overall Study|Death|1|||
130724789|NCT05038800|470617043|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130724790|NCT05038800|470617044|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130724791|NCT05038800|470617045|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130724792|NCT05038800|470617046|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130724793|NCT05038800|470617047|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130724794|NCT05038800|470617043|FG000|Overall Study|Lack of Efficacy|0|||
130724795|NCT05038800|470617044|FG001|Overall Study|Lack of Efficacy|0|||
130724796|NCT05038800|470617045|FG002|Overall Study|Lack of Efficacy|0|||
130724797|NCT05038800|470617046|FG003|Overall Study|Lack of Efficacy|0|||
130724798|NCT05038800|470617047|FG004|Overall Study|Lack of Efficacy|1|||
130724799|NCT00197496|470617048|FG000|Baseline to Discharge|not interested|1|||
130724800|NCT00197496|470617049|FG001|Baseline to Discharge|not interested|0|||
130724801|NCT00197496|470617048|FG000|Baseline to Discharge|MRSA|1|||
130724802|NCT00197496|470617049|FG001|Baseline to Discharge|MRSA|0|||
130724803|NCT00197496|470617048|FG000|Baseline to Discharge|Physician Decision|0|||
130724804|NCT00197496|470617049|FG001|Baseline to Discharge|Physician Decision|1|||
130724805|NCT00197496|470617048|FG000|Baseline to Discharge|Protocol Violation|0|||
130724806|NCT00197496|470617049|FG001|Baseline to Discharge|Protocol Violation|1|||
130724807|NCT00197496|470617048|FG000|Follow-up|Lost to Follow-up|2|||
130724808|NCT00197496|470617049|FG001|Follow-up|Lost to Follow-up|1|||
130724809|NCT00857584|470617050|FG000|Overall Study|Lack of Efficacy|1|||
130724810|NCT00857584|470617051|FG001|Overall Study|Lack of Efficacy|2|||
130724811|NCT00857584|470617050|FG000|Overall Study|Adverse Event|2|||
130724812|NCT00857584|470617051|FG001|Overall Study|Adverse Event|2|||
130724813|NCT00857584|470617050|FG000|Overall Study|Physician Decision|1|||
130724814|NCT00857584|470617051|FG001|Overall Study|Physician Decision|1|||
130724815|NCT00259272|470617053|FG000|Overall Study|Adverse Event|2|||
130724816|NCT00259272|470617054|FG001|Overall Study|Adverse Event|1|||
130724817|NCT00259272|470617055|FG002|Overall Study|Adverse Event|0|||
130724818|NCT00259272|470617056|FG003|Overall Study|Adverse Event|3|||
130724819|NCT00259272|470617053|FG000|Overall Study|Lack of Efficacy|5|||
130724820|NCT00259272|470617054|FG001|Overall Study|Lack of Efficacy|1|||
130724821|NCT00259272|470617055|FG002|Overall Study|Lack of Efficacy|2|||
130724822|NCT00259272|470617056|FG003|Overall Study|Lack of Efficacy|6|||
130724823|NCT00259272|470617053|FG000|Overall Study|Physician Decision|1|||
130724824|NCT00259272|470617054|FG001|Overall Study|Physician Decision|2|||
130724825|NCT00259272|470617055|FG002|Overall Study|Physician Decision|1|||
130724826|NCT00259272|470617056|FG003|Overall Study|Physician Decision|3|||
131075395|NCT02484547|471908899|FG000|Long-Term Extension Period|Disease Progression|0|||
131075396|NCT02484547|471908900|FG001|Long-Term Extension Period|Disease Progression|0|||
131075397|NCT02484547|471908901|FG002|Long-Term Extension Period|Disease Progression|0|||
131075398|NCT02484547|471908902|FG003|Long-Term Extension Period|Disease Progression|0|||
131075399|NCT02484547|471908903|FG004|Long-Term Extension Period|Disease Progression|2|||
131075400|NCT02484547|471908904|FG005|Long-Term Extension Period|Disease Progression|4|||
131075401|NCT02484547|471908905|FG006|Long-Term Extension Period|Disease Progression|0|||
131075402|NCT02484547|471908899|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
131075403|NCT02484547|471908900|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
131075404|NCT02484547|471908901|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
131075405|NCT02484547|471908902|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
131075406|NCT02484547|471908903|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
131075407|NCT02484547|471908904|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
131075408|NCT02484547|471908905|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
131075409|NCT02484547|471908899|FG000|Long-Term Extension Period|Loss of Capacity|0|||
131075410|NCT02484547|471908900|FG001|Long-Term Extension Period|Loss of Capacity|0|||
130724827|NCT00259272|470617053|FG000|Overall Study|Protocol Violation|2|||
130724828|NCT00259272|470617054|FG001|Overall Study|Protocol Violation|0|||
130724829|NCT00259272|470617055|FG002|Overall Study|Protocol Violation|0|||
130724830|NCT00259272|470617056|FG003|Overall Study|Protocol Violation|1|||
130779679|NCT02326272|470819496|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131075411|NCT02484547|471908901|FG002|Long-Term Extension Period|Loss of Capacity|0|||
131075412|NCT02484547|471908902|FG003|Long-Term Extension Period|Loss of Capacity|0|||
131075413|NCT02484547|471908903|FG004|Long-Term Extension Period|Loss of Capacity|1|||
130724831|NCT00259272|470617053|FG000|Overall Study|Sponsor Decision|0|||
130724832|NCT00259272|470617054|FG001|Overall Study|Sponsor Decision|1|||
130724833|NCT00259272|470617055|FG002|Overall Study|Sponsor Decision|0|||
130724834|NCT00259272|470617056|FG003|Overall Study|Sponsor Decision|0|||
130724835|NCT00259272|470617053|FG000|Overall Study|Withdrawal by Subject|4|||
130724836|NCT00259272|470617054|FG001|Overall Study|Withdrawal by Subject|2|||
130724837|NCT00259272|470617055|FG002|Overall Study|Withdrawal by Subject|2|||
130724838|NCT00259272|470617056|FG003|Overall Study|Withdrawal by Subject|7|||
130724839|NCT00259272|470617053|FG000|Overall Study|Lost to Follow-up|1|||
130724840|NCT00259272|470617054|FG001|Overall Study|Lost to Follow-up|0|||
130724841|NCT00259272|470617055|FG002|Overall Study|Lost to Follow-up|0|||
131075414|NCT02484547|471908904|FG005|Long-Term Extension Period|Loss of Capacity|0|||
131075415|NCT02484547|471908905|FG006|Long-Term Extension Period|Loss of Capacity|0|||
130724842|NCT00259272|470617056|FG003|Overall Study|Lost to Follow-up|1|||
130724843|NCT00658021|470617057|FG000|28-Week Treatment Period|Adverse Event|3|||
130724844|NCT00658021|470617058|FG001|28-Week Treatment Period|Adverse Event|1|||
131075416|NCT02484547|471908899|FG000|Long-Term Extension Period|Change of Treatment|0|||
131075417|NCT02484547|471908900|FG001|Long-Term Extension Period|Change of Treatment|0|||
131075418|NCT02484547|471908901|FG002|Long-Term Extension Period|Change of Treatment|0|||
131075419|NCT02484547|471908902|FG003|Long-Term Extension Period|Change of Treatment|0|||
131075420|NCT02484547|471908903|FG004|Long-Term Extension Period|Change of Treatment|0|||
131075421|NCT02484547|471908904|FG005|Long-Term Extension Period|Change of Treatment|0|||
131075422|NCT02484547|471908905|FG006|Long-Term Extension Period|Change of Treatment|1|||
131075423|NCT02484547|471908899|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
131075424|NCT02484547|471908900|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
131075425|NCT02484547|471908901|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
131075426|NCT02484547|471908902|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
131075427|NCT02484547|471908903|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
131075428|NCT02484547|471908904|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
131075429|NCT02484547|471908905|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
131075430|NCT02484547|471908899|FG000|Long-Term Extension Period|Investigator Decision|0|||
131075431|NCT02484547|471908900|FG001|Long-Term Extension Period|Investigator Decision|0|||
131075432|NCT02484547|471908901|FG002|Long-Term Extension Period|Investigator Decision|0|||
131075433|NCT02484547|471908902|FG003|Long-Term Extension Period|Investigator Decision|2|||
131075434|NCT02484547|471908903|FG004|Long-Term Extension Period|Investigator Decision|1|||
131075435|NCT02484547|471908904|FG005|Long-Term Extension Period|Investigator Decision|0|||
131075436|NCT02484547|471908905|FG006|Long-Term Extension Period|Investigator Decision|1|||
131075437|NCT02484547|471908899|FG000|Long-Term Extension Period|Relocation|0|||
131075438|NCT02484547|471908900|FG001|Long-Term Extension Period|Relocation|0|||
131075439|NCT02484547|471908901|FG002|Long-Term Extension Period|Relocation|0|||
130724845|NCT00658021|470617059|FG002|28-Week Treatment Period|Adverse Event|0|||
130724846|NCT00658021|470617057|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
130724847|NCT00658021|470617058|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
130724848|NCT00658021|470617059|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
130724849|NCT00658021|470617057|FG000|28-Week Treatment Period|Protocol Violation|0|||
131075440|NCT02484547|471908902|FG003|Long-Term Extension Period|Relocation|1|||
131075441|NCT02484547|471908903|FG004|Long-Term Extension Period|Relocation|1|||
131075442|NCT02484547|471908904|FG005|Long-Term Extension Period|Relocation|0|||
131075443|NCT02484547|471908905|FG006|Long-Term Extension Period|Relocation|0|||
131075444|NCT02484547|471908899|FG000|Long-Term Extension Period|Study Visit Burden|0|||
131075445|NCT02484547|471908900|FG001|Long-Term Extension Period|Study Visit Burden|0|||
131075446|NCT02484547|471908901|FG002|Long-Term Extension Period|Study Visit Burden|0|||
131075447|NCT02484547|471908902|FG003|Long-Term Extension Period|Study Visit Burden|2|||
131075448|NCT02484547|471908903|FG004|Long-Term Extension Period|Study Visit Burden|0|||
131075449|NCT02484547|471908904|FG005|Long-Term Extension Period|Study Visit Burden|0|||
131075450|NCT02484547|471908905|FG006|Long-Term Extension Period|Study Visit Burden|3|||
131075451|NCT02484547|471908899|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
131075452|NCT02484547|471908900|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
131075453|NCT02484547|471908901|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
131075454|NCT02484547|471908902|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
131075455|NCT02484547|471908903|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
131075456|NCT02484547|471908904|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
131075457|NCT02484547|471908905|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
131075458|NCT02484547|471908899|FG000|Long-Term Extension Period|Reason not Specified|0|||
131075459|NCT02484547|471908900|FG001|Long-Term Extension Period|Reason not Specified|0|||
130724850|NCT00658021|470617058|FG001|28-Week Treatment Period|Protocol Violation|2|||
131075460|NCT02484547|471908901|FG002|Long-Term Extension Period|Reason not Specified|0|||
131075461|NCT02484547|471908902|FG003|Long-Term Extension Period|Reason not Specified|119|||
131075462|NCT02484547|471908903|FG004|Long-Term Extension Period|Reason not Specified|117|||
131075463|NCT02484547|471908904|FG005|Long-Term Extension Period|Reason not Specified|223|||
131075464|NCT02484547|471908905|FG006|Long-Term Extension Period|Reason not Specified|231|||
131075465|NCT01813305|471908906|FG000|Overall Study|Withdrawal by Subject|12|||
131075466|NCT01813305|471908907|FG001|Overall Study|Withdrawal by Subject|5|||
131075467|NCT01813305|471908906|FG000|Overall Study|Safety Concern|4|||
131075468|NCT01813305|471908907|FG001|Overall Study|Safety Concern|0|||
131075469|NCT01813305|471908906|FG000|Overall Study|Ulcer became worse|4|||
131075470|NCT01813305|471908907|FG001|Overall Study|Ulcer became worse|0|||
131075471|NCT01813305|471908906|FG000|Overall Study|Physician Decision|4|||
131075472|NCT01813305|471908907|FG001|Overall Study|Physician Decision|0|||
130724851|NCT00658021|470617059|FG002|28-Week Treatment Period|Protocol Violation|1|||
130724852|NCT00658021|470617057|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
131075473|NCT01813305|471908906|FG000|Overall Study|Lost to Follow-up|3|||
130724853|NCT00658021|470617058|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
130724854|NCT00658021|470617059|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
130724855|NCT00658021|470617057|FG000|28-Week Treatment Period|Physician Decision|1|||
130724856|NCT00658021|470617058|FG001|28-Week Treatment Period|Physician Decision|2|||
131075474|NCT01813305|471908907|FG001|Overall Study|Lost to Follow-up|1|||
131075475|NCT01813305|471908906|FG000|Overall Study|Protocol Violation|1|||
131075476|NCT01813305|471908907|FG001|Overall Study|Protocol Violation|0|||
131075477|NCT01813305|471908906|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
131075478|NCT01813305|471908907|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
131075479|NCT01665599|471908911|FG000|Overall Study|Adverse Event|1|||
131075480|NCT01665599|471908911|FG000|Overall Study|Consent Withdrawn|1|||
131075481|NCT01665599|471908911|FG000|Overall Study|Investigator/Sponsor decision|1|||
131075482|NCT01665599|471908911|FG000|Overall Study|Death|1|||
131075483|NCT01665599|471908911|FG000|Overall Study|Lost to Follow-up|2|||
131075484|NCT01665599|471908911|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
131075485|NCT01665599|471908911|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
131075486|NCT01424189|471908912|FG000|Overall Study|Adverse Event|1|||
131075487|NCT01424189|471908913|FG001|Overall Study|Adverse Event|0|||
131075488|NCT01424189|471908912|FG000|Overall Study|Lost to Follow-up|4|||
131075489|NCT01424189|471908913|FG001|Overall Study|Lost to Follow-up|1|||
131075490|NCT01424189|471908912|FG000|Overall Study|Withdrawal by Subject|4|||
131075491|NCT01424189|471908913|FG001|Overall Study|Withdrawal by Subject|4|||
131075492|NCT01424189|471908912|FG000|Overall Study|Subject moved|1|||
131075493|NCT01424189|471908913|FG001|Overall Study|Subject moved|0|||
131075494|NCT01424189|471908912|FG000|Overall Study|Death|3|||
131075495|NCT01424189|471908913|FG001|Overall Study|Death|1|||
131075496|NCT01705145|471908914|FG000|Part B|Adverse Event|1|||
131075497|NCT00069277|471908915|FG000|Overall Study|Adverse Event|3|||
131075498|NCT00069277|471908915|FG000|Overall Study|Withdrawal by Subject|1|||
131075499|NCT00069277|471908915|FG000|Overall Study|Progressive Disease|15|||
131075500|NCT00069277|471908915|FG000|Overall Study|Physician Decision|2|||
131075501|NCT00361842|471908916|FG000|Overall Study|Withdrawal by Subject|2|||
131075502|NCT00361842|471908917|FG001|Overall Study|Withdrawal by Subject|3|||
131075503|NCT00361842|471908916|FG000|Overall Study|Death|2|||
131075504|NCT00361842|471908917|FG001|Overall Study|Death|1|||
131075505|NCT00361842|471908916|FG000|Overall Study|Disease progression|19|||
131075506|NCT00361842|471908917|FG001|Overall Study|Disease progression|20|||
131075507|NCT00361842|471908916|FG000|Overall Study|Adverse Event|2|||
131075508|NCT00361842|471908917|FG001|Overall Study|Adverse Event|3|||
131075509|NCT00361842|471908916|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
131075510|NCT00361842|471908917|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
131075511|NCT00361842|471908916|FG000|Overall Study|Other|1|||
131075512|NCT00361842|471908917|FG001|Overall Study|Other|0|||
131075513|NCT00361842|471908916|FG000|Overall Study|Other|0|||
131075514|NCT00361842|471908917|FG001|Overall Study|Other|2|||
131075515|NCT01077622|471908918|FG000|Overall Study|Physician Decision|2|||
131075516|NCT01077622|471908918|FG000|Overall Study|Withdrawal by Subject|1|||
131075517|NCT00424177|471908919|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
131075518|NCT00424177|471908919|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
131075519|NCT00424177|471908919|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
131075520|NCT00424177|471908919|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
131075521|NCT00424177|471908919|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
131075522|NCT00424177|471908919|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
131075523|NCT00424177|471908919|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
131075524|NCT00424177|471908919|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
131075525|NCT00424177|471908919|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
131075526|NCT00424177|471908919|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
131075527|NCT04159805|471908922|FG000|Overall Study|Withdrawal by Subject|0|||
131075528|NCT04159805|471908923|FG001|Overall Study|Withdrawal by Subject|2|||
131075529|NCT04159805|471908924|FG002|Overall Study|Withdrawal by Subject|2|||
131075530|NCT01502371|471908927|FG000|Overall Study|Withdrawal by Subject|1|||
131138463|NCT01017952|472132846|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
131138464|NCT01017952|472132842|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
130724857|NCT00658021|470617059|FG002|28-Week Treatment Period|Physician Decision|1|||
130724858|NCT00658021|470617057|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
131075531|NCT01502371|471908928|FG001|Overall Study|Withdrawal by Subject|2|||
131075532|NCT01502371|471908929|FG002|Overall Study|Withdrawal by Subject|1|||
131075533|NCT01502371|471908930|FG003|Overall Study|Withdrawal by Subject|1|||
131075534|NCT01502371|471908931|FG004|Overall Study|Withdrawal by Subject|1|||
131075535|NCT01502371|471908927|FG000|Overall Study|Adverse Event|2|||
131075536|NCT01502371|471908928|FG001|Overall Study|Adverse Event|1|||
131075537|NCT01502371|471908929|FG002|Overall Study|Adverse Event|0|||
131075538|NCT01502371|471908930|FG003|Overall Study|Adverse Event|4|||
131075539|NCT01502371|471908931|FG004|Overall Study|Adverse Event|3|||
130724859|NCT00658021|470617058|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
131075540|NCT01502371|471908927|FG000|Overall Study|Treatment Failure|22|||
131075541|NCT01502371|471908928|FG001|Overall Study|Treatment Failure|20|||
131075542|NCT01502371|471908929|FG002|Overall Study|Treatment Failure|12|||
131075543|NCT01502371|471908930|FG003|Overall Study|Treatment Failure|19|||
131075544|NCT01502371|471908931|FG004|Overall Study|Treatment Failure|30|||
131075545|NCT01502371|471908927|FG000|Overall Study|Lack of Efficacy|3|||
131075546|NCT01502371|471908928|FG001|Overall Study|Lack of Efficacy|3|||
131075547|NCT01502371|471908929|FG002|Overall Study|Lack of Efficacy|2|||
131075548|NCT01502371|471908930|FG003|Overall Study|Lack of Efficacy|2|||
131075549|NCT01502371|471908931|FG004|Overall Study|Lack of Efficacy|4|||
131075550|NCT01502371|471908927|FG000|Overall Study|Physician Decision|3|||
131075551|NCT01502371|471908928|FG001|Overall Study|Physician Decision|0|||
131075552|NCT01502371|471908929|FG002|Overall Study|Physician Decision|0|||
131075553|NCT01502371|471908930|FG003|Overall Study|Physician Decision|0|||
131075554|NCT01502371|471908931|FG004|Overall Study|Physician Decision|1|||
131075555|NCT01502371|471908927|FG000|Overall Study|Noncompliance with Study Drug|0|||
131075556|NCT01502371|471908928|FG001|Overall Study|Noncompliance with Study Drug|0|||
131075557|NCT01502371|471908929|FG002|Overall Study|Noncompliance with Study Drug|1|||
131075558|NCT01502371|471908930|FG003|Overall Study|Noncompliance with Study Drug|2|||
131075559|NCT01502371|471908931|FG004|Overall Study|Noncompliance with Study Drug|1|||
131075560|NCT01502371|471908927|FG000|Overall Study|Technical Problems|1|||
131075561|NCT01502371|471908928|FG001|Overall Study|Technical Problems|0|||
131075562|NCT01502371|471908929|FG002|Overall Study|Technical Problems|2|||
131075563|NCT01502371|471908930|FG003|Overall Study|Technical Problems|4|||
131075564|NCT01502371|471908931|FG004|Overall Study|Technical Problems|1|||
131075565|NCT01502371|471908927|FG000|Overall Study|Protocol Violation|9|||
131075566|NCT01502371|471908928|FG001|Overall Study|Protocol Violation|5|||
131075567|NCT01502371|471908929|FG002|Overall Study|Protocol Violation|6|||
131075568|NCT01502371|471908930|FG003|Overall Study|Protocol Violation|5|||
131075569|NCT01502371|471908931|FG004|Overall Study|Protocol Violation|10|||
131075570|NCT01502371|471908927|FG000|Overall Study|Excluded Medication|0|||
131075571|NCT01502371|471908928|FG001|Overall Study|Excluded Medication|1|||
131075572|NCT01502371|471908929|FG002|Overall Study|Excluded Medication|1|||
131075573|NCT01502371|471908930|FG003|Overall Study|Excluded Medication|0|||
131075574|NCT01502371|471908931|FG004|Overall Study|Excluded Medication|1|||
131075575|NCT02154347|471908932|FG000|Double-blind Period|Adverse Event|1|||
131075576|NCT02154347|471908933|FG001|Double-blind Period|Adverse Event|2|||
131075577|NCT02154347|471908932|FG000|Double-blind Period|Lack of Efficacy|1|||
131075578|NCT02154347|471908933|FG001|Double-blind Period|Lack of Efficacy|0|||
131075579|NCT02154347|471908932|FG000|Double-blind Period|Physician Decision|0|||
131075580|NCT02154347|471908933|FG001|Double-blind Period|Physician Decision|1|||
131075581|NCT02154347|471908932|FG000|Double-blind Period|Withdrawal by Subject|1|||
131075582|NCT02154347|471908933|FG001|Double-blind Period|Withdrawal by Subject|1|||
131075583|NCT02154347|471908932|FG000|Open-label Period|Adverse Event|3|||
131075584|NCT02154347|471908933|FG001|Open-label Period|Adverse Event|4|||
131075585|NCT02154347|471908932|FG000|Open-label Period|Lack of Efficacy|4|||
131075586|NCT02154347|471908933|FG001|Open-label Period|Lack of Efficacy|19|||
131075587|NCT02154347|471908932|FG000|Open-label Period|Protocol Violation|0|||
131075588|NCT02154347|471908933|FG001|Open-label Period|Protocol Violation|1|||
131075589|NCT02154347|471908932|FG000|Open-label Period|Withdrawal by Subject|0|||
131075590|NCT02154347|471908933|FG001|Open-label Period|Withdrawal by Subject|1|||
131075591|NCT02473913|471908935|FG000|Overall Study|Lost to Follow-up|3|||
131075592|NCT02473913|471908936|FG001|Overall Study|Lost to Follow-up|3|||
131075593|NCT01190449|471908939|FG000|Overall Study|Ineligible|0|||
131075594|NCT01190449|471908940|FG001|Overall Study|Ineligible|4|||
131075595|NCT03282799|471908941|FG000|Overall Study|Pregnancy|1|||
131075596|NCT03282799|471908942|FG001|Overall Study|Pregnancy|0|||
131075597|NCT03282799|471908941|FG000|Overall Study|Physician Decision|1|||
131075598|NCT03282799|471908942|FG001|Overall Study|Physician Decision|0|||
131075599|NCT02210208|471910305|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
131075600|NCT02210208|471910305|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
131075601|NCT02210208|471910305|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
131075602|NCT01171183|471910306|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
131075603|NCT01171183|471910307|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
131075604|NCT01171183|471910306|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
131075605|NCT01171183|471910307|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
131075606|NCT01171183|471910306|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
131075607|NCT01171183|471910307|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
131075608|NCT01171183|471910306|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
131075609|NCT01171183|471910307|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
131075610|NCT01171183|471910306|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
131075611|NCT01171183|471910307|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
131075612|NCT01171183|471910306|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
131075613|NCT01171183|471910307|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
131075614|NCT01066936|471910308|FG000|Overall Study|Death|2|||
131075615|NCT01066936|471910308|FG000|Overall Study|Device revised/removed|1|||
131075616|NCT01066936|471910308|FG000|Overall Study|Lost to Follow-up|3|||
131075617|NCT01066936|471910308|FG000|Overall Study|Withdrawal by Subject|4|||
131075618|NCT01726049|471910309|FG000|Overall Study|Death|1|||
131075619|NCT01726049|471910310|FG001|Overall Study|Death|1|||
131075620|NCT01726049|471910309|FG000|Overall Study|Adverse Event|4|||
131075621|NCT01726049|471910310|FG001|Overall Study|Adverse Event|1|||
131075622|NCT01726049|471910309|FG000|Overall Study|refused second HC|0|||
131075623|NCT01726049|471910310|FG001|Overall Study|refused second HC|2|||
131075624|NCT04156399|471910312|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
131075625|NCT04156399|471910312|FG000|Overall Study|study suspension due to COVID pandemic|3|||
131075626|NCT01181609|471910313|FG000|Overall Study|Adverse Event|1|||
131075627|NCT01181609|471910313|FG000|Overall Study|Withdrawal by Subject|1|||
131075628|NCT01181609|471910313|FG000|Overall Study|Lost to Follow-up|1|||
131075629|NCT01181609|471910313|FG000|Overall Study|Death|50|||
131075630|NCT01722045|471910314|FG000|Overall Study|Adverse Event|8|||
131075631|NCT01722045|471910314|FG000|Overall Study|Death|3|||
131075632|NCT01722045|471910314|FG000|Overall Study|Withdrawal by Subject|8|||
131075633|NCT01722045|471910314|FG000|Overall Study|Lost to Follow-up|4|||
131075634|NCT01722045|471910314|FG000|Overall Study|Protocol Deviation|1|||
131075635|NCT01722045|471910314|FG000|Overall Study|Physician Decision|3|||
131075636|NCT01722045|471910314|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
131075637|NCT03834623|471910326|FG000|Overall Study|Progression|0|||
131075638|NCT03834623|471910327|FG001|Overall Study|Progression|1|||
131075639|NCT00478647|471910328|FG000|Overall Study|Adverse Event|1|||
131075640|NCT00478647|471910328|FG000|Overall Study|Withdrawal by Subject|1|||
131075641|NCT00511836|471910331|FG000|Double-blind Period|Lost to Follow-up|1|||
131075642|NCT00511836|471910332|FG001|Double-blind Period|Lost to Follow-up|0|||
131075643|NCT01755546|471910333|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
131075644|NCT01755546|471910333|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
131075645|NCT01755546|471910333|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
131075646|NCT01755546|471910333|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
131075647|NCT01755546|471910333|FG000|Titration Phase|Adverse Event|11|||
131075648|NCT01755546|471910333|FG000|Titration Phase|Lack of Efficacy|18|||
131075649|NCT01755546|471910333|FG000|Titration Phase|Protocol Violation|9|||
131075650|NCT01755546|471910333|FG000|Titration Phase|Lost to Follow-up|2|||
131075651|NCT01755546|471910333|FG000|Titration Phase|Other and Continuing|22|||
131075652|NCT01755546|471910333|FG000|Titration Phase|Withdrawal by Subject|8|||
131075653|NCT01755546|471910333|FG000|Long Term Treatment|Adverse Event|12|||
131075654|NCT01755546|471910333|FG000|Long Term Treatment|Lack of Efficacy|6|||
131075655|NCT01755546|471910333|FG000|Long Term Treatment|Protocol Violation|10|||
131075656|NCT01755546|471910333|FG000|Long Term Treatment|Withdrawal by Subject|35|||
131075657|NCT01755546|471910333|FG000|Long Term Treatment|Lost to Follow-up|17|||
131075658|NCT01755546|471910333|FG000|Long Term Treatment|other and ongoing|41|||
131075659|NCT00362375|471910337|FG000|Overall Study|Lost to Follow-up|40|||
131075660|NCT00362375|471910338|FG001|Overall Study|Lost to Follow-up|35|||
131075661|NCT04984239|471910339|FG000|Overall Study|Lost to Follow-up|1|||
131075662|NCT04606199|471910340|FG000|Overall Study|Withdrawal by Subject|2|||
131075663|NCT04190225|471910341|FG000|Overall Study|Lost to Follow-up|2|||
131075664|NCT04190225|471910342|FG001|Overall Study|Lost to Follow-up|3|||
131075665|NCT04190225|471910341|FG000|Overall Study|Withdrawal by Subject|3|||
131075666|NCT04190225|471910342|FG001|Overall Study|Withdrawal by Subject|2|||
131075667|NCT04190225|471910341|FG000|Overall Study|Unrelated health condition|2|||
131075668|NCT04190225|471910342|FG001|Overall Study|Unrelated health condition|0|||
131075669|NCT00477464|471910346|FG000|Overall Study|Lost to Follow-up|1|||
131075670|NCT00477464|471910346|FG000|Overall Study|Death|36|||
131075671|NCT00477464|471910346|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
131075672|NCT00639769|471910347|FG000|Overall Study|Death|2|||
131075673|NCT00639769|471910347|FG000|Overall Study|Adverse Event|7|||
131075674|NCT00639769|471910347|FG000|Overall Study|Lack of Efficacy|1|||
131075675|NCT00639769|471910347|FG000|Overall Study|Disease progression|26|||
131138465|NCT01017952|472132843|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130724860|NCT00658021|470617059|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
130724861|NCT00658021|470617057|FG000|28-Week Treatment Period|Loss of glucose control|1|||
130724862|NCT00658021|470617058|FG001|28-Week Treatment Period|Loss of glucose control|1|||
130724863|NCT00658021|470617059|FG002|28-Week Treatment Period|Loss of glucose control|10|||
130724864|NCT00658021|470617057|FG000|28-Week Treatment Period|Other|2|||
131075676|NCT00639769|471910347|FG000|Overall Study|Withdrawal by Subject|4|||
131075677|NCT04238520|471910348|FG000|Overall Study|Withdrawal by Subject|1|||
131075678|NCT04238520|471910349|FG001|Overall Study|Withdrawal by Subject|1|||
131075679|NCT04238520|471910348|FG000|Overall Study|Lost to Follow-up|1|||
131075680|NCT04238520|471910349|FG001|Overall Study|Lost to Follow-up|2|||
131075681|NCT04238520|471910348|FG000|Overall Study|Death|0|||
131075682|NCT04238520|471910349|FG001|Overall Study|Death|2|||
131075683|NCT04238520|471910348|FG000|Overall Study|Unsafe home environment for research staff|0|||
131075684|NCT04238520|471910349|FG001|Overall Study|Unsafe home environment for research staff|1|||
131075685|NCT00195442|471910350|FG000|Overall Study|Less than expected therapeutic effect|38|||
131075686|NCT00195442|471910350|FG000|Overall Study|Lost to Follow-up|27|||
131075687|NCT00195442|471910350|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
131075688|NCT00195442|471910350|FG000|Overall Study|Intermittent product shortage|21|||
131075689|NCT00195442|471910350|FG000|Overall Study|Death|7|||
131075690|NCT00195442|471910350|FG000|Overall Study|No reason specified|4|||
131075691|NCT00195442|471910350|FG000|Overall Study|Poor cooperation|2|||
131075692|NCT00195442|471910350|FG000|Overall Study|Other|14|||
131075693|NCT01917006|471910351|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
131075694|NCT01917006|471910352|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
131075695|NCT01917006|471910353|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
131075696|NCT01917006|471910354|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
131075697|NCT01917006|471910355|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
131075698|NCT01917006|471910356|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
131075699|NCT01917006|471910357|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
131075700|NCT01917006|471910358|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
131075701|NCT01917006|471910351|FG000|Randomized-treatment Period|Personal Reasons|0|||
131075702|NCT01917006|471910352|FG001|Randomized-treatment Period|Personal Reasons|0|||
131075703|NCT01917006|471910353|FG002|Randomized-treatment Period|Personal Reasons|0|||
131075704|NCT01917006|471910354|FG003|Randomized-treatment Period|Personal Reasons|0|||
131075705|NCT01917006|471910355|FG004|Randomized-treatment Period|Personal Reasons|0|||
131075706|NCT01917006|471910356|FG005|Randomized-treatment Period|Personal Reasons|1|||
131075707|NCT01917006|471910357|FG006|Randomized-treatment Period|Personal Reasons|0|||
131075708|NCT01917006|471910358|FG007|Randomized-treatment Period|Personal Reasons|0|||
131075709|NCT01917006|471910351|FG000|Randomized-treatment Period|Protocol Violation|1|||
131075710|NCT01917006|471910352|FG001|Randomized-treatment Period|Protocol Violation|0|||
131075711|NCT01917006|471910353|FG002|Randomized-treatment Period|Protocol Violation|0|||
131075712|NCT01917006|471910354|FG003|Randomized-treatment Period|Protocol Violation|0|||
131075713|NCT01917006|471910355|FG004|Randomized-treatment Period|Protocol Violation|0|||
131075714|NCT01917006|471910356|FG005|Randomized-treatment Period|Protocol Violation|0|||
131075715|NCT01917006|471910357|FG006|Randomized-treatment Period|Protocol Violation|0|||
131075716|NCT01917006|471910358|FG007|Randomized-treatment Period|Protocol Violation|0|||
131075717|NCT01917006|471910351|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131075718|NCT01917006|471910352|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131075719|NCT01917006|471910353|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131075720|NCT01917006|471910354|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131075721|NCT01917006|471910355|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131075722|NCT01917006|471910356|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131075723|NCT01917006|471910357|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
131075724|NCT01917006|471910358|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
131075725|NCT01917006|471910351|FG000|Open-label Period|Adverse Event|0|||
131075726|NCT01917006|471910352|FG001|Open-label Period|Adverse Event|0|||
131075727|NCT01917006|471910353|FG002|Open-label Period|Adverse Event|0|||
131075728|NCT01917006|471910354|FG003|Open-label Period|Adverse Event|0|||
131075729|NCT01917006|471910355|FG004|Open-label Period|Adverse Event|0|||
131075730|NCT01917006|471910356|FG005|Open-label Period|Adverse Event|0|||
131075731|NCT01917006|471910357|FG006|Open-label Period|Adverse Event|0|||
131075732|NCT01917006|471910358|FG007|Open-label Period|Adverse Event|1|||
131075733|NCT01917006|471910351|FG000|Open-label Period|Lost to Follow-up|0|||
131075734|NCT01917006|471910352|FG001|Open-label Period|Lost to Follow-up|0|||
131075735|NCT01917006|471910353|FG002|Open-label Period|Lost to Follow-up|0|||
131075736|NCT01917006|471910354|FG003|Open-label Period|Lost to Follow-up|0|||
131075737|NCT01917006|471910355|FG004|Open-label Period|Lost to Follow-up|0|||
131075738|NCT01917006|471910356|FG005|Open-label Period|Lost to Follow-up|0|||
131075739|NCT01917006|471910357|FG006|Open-label Period|Lost to Follow-up|0|||
131075740|NCT01917006|471910358|FG007|Open-label Period|Lost to Follow-up|1|||
131075741|NCT00847132|471910359|FG000|Overall Study|Death|1|||
131075742|NCT00847132|471910360|FG001|Overall Study|Death|1|||
131075743|NCT00784147|471910361|FG000|Overall Study|Lost to Follow-up|2|||
131075744|NCT00784147|471910362|FG001|Overall Study|Lost to Follow-up|4|||
131075745|NCT00784147|471910361|FG000|Overall Study|Withdrawal by Subject|1|||
131075746|NCT00784147|471910362|FG001|Overall Study|Withdrawal by Subject|3|||
131075747|NCT00784147|471910361|FG000|Overall Study|Physician Decision|2|||
131075748|NCT00784147|471910362|FG001|Overall Study|Physician Decision|1|||
131075749|NCT00784147|471910361|FG000|Overall Study|Protocol Violation|1|||
131075750|NCT00784147|471910362|FG001|Overall Study|Protocol Violation|1|||
131075751|NCT00784147|471910361|FG000|Overall Study|Death|2|||
131075752|NCT00784147|471910362|FG001|Overall Study|Death|0|||
131075753|NCT03596242|471910363|FG000|Overall Study|Lost to Follow-up|2|||
131075754|NCT03596242|471910364|FG001|Overall Study|Lost to Follow-up|2|||
131075755|NCT02509312|471910365|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
131075756|NCT02509312|471910366|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
131075757|NCT02509312|471910365|FG000|Overall Study|Obstetrician refusal|0|||
131075758|NCT02509312|471910366|FG001|Overall Study|Obstetrician refusal|1|||
131075759|NCT02509312|471910365|FG000|Overall Study|Patient elected for TOLAC|1|||
131075760|NCT02509312|471910366|FG001|Overall Study|Patient elected for TOLAC|0|||
131075761|NCT02509312|471910365|FG000|Overall Study|Cesarean deemed stat|1|||
131075762|NCT02509312|471910366|FG001|Overall Study|Cesarean deemed stat|0|||
131075763|NCT02509312|471910365|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
131075764|NCT02509312|471910366|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
131075765|NCT00913523|471910372|FG000|Overall Study|Withdrawal by Subject|3|||
131075766|NCT00913523|471910373|FG001|Overall Study|Withdrawal by Subject|2|||
131075767|NCT00913523|471910374|FG002|Overall Study|Withdrawal by Subject|2|||
131075768|NCT00913523|471910372|FG000|Overall Study|Lost to Follow-up|1|||
131075769|NCT00913523|471910373|FG001|Overall Study|Lost to Follow-up|1|||
131075770|NCT00913523|471910374|FG002|Overall Study|Lost to Follow-up|1|||
131075771|NCT00913523|471910372|FG000|Overall Study|Adverse Event|1|||
131075772|NCT00913523|471910373|FG001|Overall Study|Adverse Event|0|||
131075773|NCT00913523|471910374|FG002|Overall Study|Adverse Event|0|||
131075774|NCT00913523|471910372|FG000|Overall Study|Protocol Violation|5|||
131075775|NCT00913523|471910373|FG001|Overall Study|Protocol Violation|8|||
131075776|NCT00913523|471910374|FG002|Overall Study|Protocol Violation|8|||
131075777|NCT00913523|471910372|FG000|Overall Study|Pregnancy|1|||
131075778|NCT00913523|471910373|FG001|Overall Study|Pregnancy|3|||
131075779|NCT00913523|471910374|FG002|Overall Study|Pregnancy|0|||
131075780|NCT00913523|471910372|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
131075781|NCT00913523|471910373|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
131075782|NCT00913523|471910374|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
131075783|NCT01475461|471910375|FG000|Run-in Period|Not meet eligibility criteria|16|||
131075784|NCT01475461|471910376|FG001|Run-in Period|Not meet eligibility criteria|0|||
131075785|NCT01475461|471910377|FG002|Run-in Period|Not meet eligibility criteria|0|||
131075786|NCT01475461|471910378|FG003|Run-in Period|Not meet eligibility criteria|0|||
131075787|NCT01475461|471910379|FG004|Run-in Period|Not meet eligibility criteria|0|||
131075788|NCT01475461|471910380|FG005|Run-in Period|Not meet eligibility criteria|0|||
131075789|NCT01475461|471910381|FG006|Run-in Period|Not meet eligibility criteria|0|||
131075790|NCT01475461|471910375|FG000|Run-in Period|Lost to Follow-up|7|||
131075791|NCT01475461|471910376|FG001|Run-in Period|Lost to Follow-up|0|||
131075792|NCT01475461|471910377|FG002|Run-in Period|Lost to Follow-up|0|||
131075793|NCT01475461|471910378|FG003|Run-in Period|Lost to Follow-up|0|||
131075794|NCT01475461|471910379|FG004|Run-in Period|Lost to Follow-up|0|||
131075795|NCT01475461|471910380|FG005|Run-in Period|Lost to Follow-up|0|||
131075796|NCT01475461|471910381|FG006|Run-in Period|Lost to Follow-up|0|||
131075797|NCT01475461|471910375|FG000|Run-in Period|Withdrawal by Subject|11|||
131075798|NCT01475461|471910376|FG001|Run-in Period|Withdrawal by Subject|0|||
131075799|NCT01475461|471910377|FG002|Run-in Period|Withdrawal by Subject|0|||
131075800|NCT01475461|471910378|FG003|Run-in Period|Withdrawal by Subject|0|||
131075801|NCT01475461|471910379|FG004|Run-in Period|Withdrawal by Subject|0|||
131075802|NCT01475461|471910380|FG005|Run-in Period|Withdrawal by Subject|0|||
131075803|NCT01475461|471910381|FG006|Run-in Period|Withdrawal by Subject|0|||
131075804|NCT01475461|471910375|FG000|Run-in Period|Other|3|||
131075805|NCT01475461|471910376|FG001|Run-in Period|Other|0|||
131075806|NCT01475461|471910377|FG002|Run-in Period|Other|0|||
131075807|NCT01475461|471910378|FG003|Run-in Period|Other|0|||
131075808|NCT01475461|471910379|FG004|Run-in Period|Other|0|||
131075809|NCT01475461|471910380|FG005|Run-in Period|Other|0|||
131075810|NCT01475461|471910381|FG006|Run-in Period|Other|0|||
131075811|NCT01475461|471910375|FG000|Run-in Period|Protocol Violation|4|||
131075812|NCT01475461|471910376|FG001|Run-in Period|Protocol Violation|0|||
131075813|NCT01475461|471910377|FG002|Run-in Period|Protocol Violation|0|||
131075814|NCT01475461|471910378|FG003|Run-in Period|Protocol Violation|0|||
131138466|NCT01017952|472132844|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130724865|NCT00658021|470617058|FG001|28-Week Treatment Period|Other|3|||
130724866|NCT00658021|470617059|FG002|28-Week Treatment Period|Other|1|||
131138467|NCT01017952|472132845|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130724867|NCT00658021|470617057|FG000|28-Week Treatment Period|Did not receive treatment|2|||
130724868|NCT00658021|470617058|FG001|28-Week Treatment Period|Did not receive treatment|0|||
131138468|NCT01017952|472132846|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
131075815|NCT01475461|471910379|FG004|Run-in Period|Protocol Violation|0|||
131075816|NCT01475461|471910380|FG005|Run-in Period|Protocol Violation|0|||
131075817|NCT01475461|471910381|FG006|Run-in Period|Protocol Violation|0|||
131075818|NCT01475461|471910375|FG000|Treatment Period|Death|0|||
131075819|NCT01475461|471910376|FG001|Treatment Period|Death|0|||
131075820|NCT01475461|471910377|FG002|Treatment Period|Death|0|||
131075821|NCT01475461|471910378|FG003|Treatment Period|Death|1|||
131075822|NCT01475461|471910379|FG004|Treatment Period|Death|0|||
131075823|NCT01475461|471910380|FG005|Treatment Period|Death|0|||
131075824|NCT01475461|471910381|FG006|Treatment Period|Death|0|||
131075825|NCT01475461|471910375|FG000|Treatment Period|Lost to Follow-up|0|||
131075826|NCT01475461|471910376|FG001|Treatment Period|Lost to Follow-up|3|||
131138469|NCT01017952|472132842|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
131075827|NCT01475461|471910377|FG002|Treatment Period|Lost to Follow-up|2|||
131075828|NCT01475461|471910378|FG003|Treatment Period|Lost to Follow-up|3|||
131075829|NCT01475461|471910379|FG004|Treatment Period|Lost to Follow-up|1|||
131075830|NCT01475461|471910380|FG005|Treatment Period|Lost to Follow-up|2|||
131075831|NCT01475461|471910381|FG006|Treatment Period|Lost to Follow-up|1|||
131075832|NCT01475461|471910375|FG000|Treatment Period|Withdrawal by Subject|0|||
131075833|NCT01475461|471910376|FG001|Treatment Period|Withdrawal by Subject|2|||
131075834|NCT01475461|471910377|FG002|Treatment Period|Withdrawal by Subject|2|||
131075835|NCT01475461|471910378|FG003|Treatment Period|Withdrawal by Subject|0|||
131075836|NCT01475461|471910379|FG004|Treatment Period|Withdrawal by Subject|2|||
131075837|NCT01475461|471910380|FG005|Treatment Period|Withdrawal by Subject|2|||
131075838|NCT01475461|471910381|FG006|Treatment Period|Withdrawal by Subject|0|||
131075839|NCT01475461|471910375|FG000|Treatment Period|Other|0|||
131075840|NCT01475461|471910376|FG001|Treatment Period|Other|1|||
131075841|NCT01475461|471910377|FG002|Treatment Period|Other|0|||
131075842|NCT01475461|471910378|FG003|Treatment Period|Other|0|||
131075843|NCT01475461|471910379|FG004|Treatment Period|Other|0|||
131075844|NCT01475461|471910380|FG005|Treatment Period|Other|0|||
131075845|NCT01475461|471910381|FG006|Treatment Period|Other|0|||
131075846|NCT01475461|471910375|FG000|Treatment Period|Protocol Violation|0|||
131075847|NCT01475461|471910376|FG001|Treatment Period|Protocol Violation|1|||
131075848|NCT01475461|471910377|FG002|Treatment Period|Protocol Violation|0|||
131075849|NCT01475461|471910378|FG003|Treatment Period|Protocol Violation|0|||
131075850|NCT01475461|471910379|FG004|Treatment Period|Protocol Violation|0|||
131075851|NCT01475461|471910380|FG005|Treatment Period|Protocol Violation|0|||
131075852|NCT01475461|471910381|FG006|Treatment Period|Protocol Violation|1|||
131075853|NCT01475461|471910375|FG000|Treatment Period|Lack of Efficacy|0|||
131075854|NCT01475461|471910376|FG001|Treatment Period|Lack of Efficacy|2|||
131075855|NCT01475461|471910377|FG002|Treatment Period|Lack of Efficacy|0|||
131075856|NCT01475461|471910378|FG003|Treatment Period|Lack of Efficacy|2|||
131075857|NCT01475461|471910379|FG004|Treatment Period|Lack of Efficacy|1|||
131075858|NCT01475461|471910380|FG005|Treatment Period|Lack of Efficacy|1|||
131075859|NCT01475461|471910381|FG006|Treatment Period|Lack of Efficacy|0|||
131075860|NCT01475461|471910375|FG000|Treatment Period|Medication Error|0|||
131075861|NCT01475461|471910376|FG001|Treatment Period|Medication Error|0|||
131075862|NCT01475461|471910377|FG002|Treatment Period|Medication Error|0|||
131075863|NCT01475461|471910378|FG003|Treatment Period|Medication Error|1|||
131075864|NCT01475461|471910379|FG004|Treatment Period|Medication Error|0|||
131075865|NCT01475461|471910380|FG005|Treatment Period|Medication Error|0|||
131075866|NCT01475461|471910381|FG006|Treatment Period|Medication Error|0|||
131075867|NCT01475461|471910375|FG000|Treatment Period|Adverse Event|0|||
131075868|NCT01475461|471910376|FG001|Treatment Period|Adverse Event|0|||
131075869|NCT01475461|471910377|FG002|Treatment Period|Adverse Event|0|||
130724869|NCT00658021|470617059|FG002|28-Week Treatment Period|Did not receive treatment|0|||
130724870|NCT00658021|470617057|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
131075870|NCT01475461|471910378|FG003|Treatment Period|Adverse Event|1|||
131075871|NCT01475461|471910379|FG004|Treatment Period|Adverse Event|0|||
131075872|NCT01475461|471910380|FG005|Treatment Period|Adverse Event|0|||
131075873|NCT01475461|471910381|FG006|Treatment Period|Adverse Event|0|||
131075874|NCT02512861|471910389|FG000|Overall Study|Protocol Violation|3|||
131075875|NCT02512861|471910390|FG001|Overall Study|Protocol Violation|7|||
131075876|NCT02512861|471910389|FG000|Overall Study|Physician Decision|3|||
131075877|NCT02512861|471910390|FG001|Overall Study|Physician Decision|1|||
131075878|NCT02512861|471910389|FG000|Overall Study|Withdrawal by Subject|0|||
131075879|NCT02512861|471910390|FG001|Overall Study|Withdrawal by Subject|1|||
131075880|NCT03214250|471910393|FG000|Overall Study|Death|5|||
131075881|NCT03214250|471910394|FG001|Overall Study|Death|5|||
131075882|NCT03214250|471910395|FG002|Overall Study|Death|7|||
131075883|NCT03214250|471910396|FG003|Overall Study|Death|4|||
131075884|NCT03214250|471910397|FG004|Overall Study|Death|23|||
131075885|NCT03214250|471910398|FG005|Overall Study|Death|23|||
131075886|NCT03214250|471910399|FG006|Overall Study|Death|24|||
131075887|NCT03214250|471910393|FG000|Overall Study|Lost to Follow-up|0|||
131075888|NCT03214250|471910394|FG001|Overall Study|Lost to Follow-up|0|||
131075889|NCT03214250|471910395|FG002|Overall Study|Lost to Follow-up|0|||
131075890|NCT03214250|471910396|FG003|Overall Study|Lost to Follow-up|1|||
131075891|NCT03214250|471910397|FG004|Overall Study|Lost to Follow-up|1|||
131075892|NCT03214250|471910398|FG005|Overall Study|Lost to Follow-up|2|||
131075893|NCT03214250|471910399|FG006|Overall Study|Lost to Follow-up|0|||
131075894|NCT03214250|471910393|FG000|Overall Study|Other|0|||
131075895|NCT03214250|471910394|FG001|Overall Study|Other|0|||
131075896|NCT03214250|471910395|FG002|Overall Study|Other|0|||
131231148|NCT01806597|472473237|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
131231149|NCT01806597|472473238|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
131075897|NCT03214250|471910396|FG003|Overall Study|Other|0|||
131075898|NCT03214250|471910397|FG004|Overall Study|Other|1|||
131075899|NCT03214250|471910398|FG005|Overall Study|Other|1|||
131075900|NCT03214250|471910399|FG006|Overall Study|Other|2|||
131075901|NCT03214250|471910393|FG000|Overall Study|Remains on Study|2|||
131075902|NCT03214250|471910394|FG001|Overall Study|Remains on Study|2|||
131075903|NCT03214250|471910395|FG002|Overall Study|Remains on Study|0|||
131075904|NCT03214250|471910396|FG003|Overall Study|Remains on Study|1|||
131075905|NCT03214250|471910397|FG004|Overall Study|Remains on Study|7|||
131075906|NCT03214250|471910398|FG005|Overall Study|Remains on Study|5|||
131075907|NCT03214250|471910399|FG006|Overall Study|Remains on Study|3|||
131075908|NCT03214250|471910393|FG000|Overall Study|Withdrawal by Subject|0|||
131075909|NCT03214250|471910394|FG001|Overall Study|Withdrawal by Subject|0|||
131075910|NCT03214250|471910395|FG002|Overall Study|Withdrawal by Subject|1|||
131075911|NCT03214250|471910396|FG003|Overall Study|Withdrawal by Subject|2|||
131075912|NCT03214250|471910397|FG004|Overall Study|Withdrawal by Subject|5|||
131075913|NCT03214250|471910398|FG005|Overall Study|Withdrawal by Subject|0|||
131075914|NCT03214250|471910399|FG006|Overall Study|Withdrawal by Subject|2|||
131075915|NCT00292981|471910403|FG000|Overall Study|Adverse Event|1|||
131075916|NCT00292981|471910403|FG000|Overall Study|Lost to Follow-up|13|||
131075917|NCT00292981|471910403|FG000|Overall Study|Withdrawal by Subject|22|||
131075918|NCT00292981|471910403|FG000|Overall Study|Other|3|||
131075919|NCT00594178|471910404|FG000|Overall Study|Physician Decision|5|||
131075920|NCT02971228|471910407|FG000|Overall Study|Withdrawal by Subject|1|||
131075921|NCT02971228|471910408|FG001|Overall Study|Withdrawal by Subject|1|||
131075922|NCT02971228|471910409|FG002|Overall Study|Withdrawal by Subject|0|||
131075923|NCT02971228|471910410|FG003|Overall Study|Withdrawal by Subject|0|||
131075924|NCT02971228|471910411|FG004|Overall Study|Withdrawal by Subject|0|||
131075925|NCT02971228|471910407|FG000|Overall Study|Logistical challenges|0|||
131075926|NCT02971228|471910408|FG001|Overall Study|Logistical challenges|1|||
131075927|NCT02971228|471910409|FG002|Overall Study|Logistical challenges|0|||
131075928|NCT02971228|471910410|FG003|Overall Study|Logistical challenges|0|||
131075929|NCT02971228|471910411|FG004|Overall Study|Logistical challenges|0|||
131075930|NCT01321723|471910412|FG000|Overall Study|Adverse Event|3|||
131075931|NCT01321723|471910413|FG001|Overall Study|Adverse Event|5|||
131075932|NCT01321723|471910414|FG002|Overall Study|Adverse Event|2|||
131075933|NCT01321723|471910412|FG000|Overall Study|Withdrawal by Subject|2|||
131075934|NCT01321723|471910413|FG001|Overall Study|Withdrawal by Subject|0|||
131075935|NCT01321723|471910414|FG002|Overall Study|Withdrawal by Subject|2|||
131075936|NCT00025506|471910415|FG000|Overall Study|Ineligible: clerical error|1|||
131075937|NCT00025506|471910415|FG000|Overall Study|Ineligible: wrong cell type|5|||
131075938|NCT00025506|471910415|FG000|Overall Study|Ineligible: inadequate pathology|2|||
131075939|NCT00025506|471910415|FG000|Overall Study|Never Treated|2|||
131075940|NCT00713206|471910416|FG000|Overall Study|Lost to Follow-up|4|||
131075941|NCT00713206|471910417|FG001|Overall Study|Lost to Follow-up|4|||
131075942|NCT00713206|471910416|FG000|Overall Study|Death|1|||
131075943|NCT00713206|471910417|FG001|Overall Study|Death|0|||
131075944|NCT02561806|471910418|FG000|Induction Period|Adverse Event|0|||
131075945|NCT02561806|471910419|FG001|Induction Period|Adverse Event|2|||
131138470|NCT01017952|472132843|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131138471|NCT01017952|472132844|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131138472|NCT01017952|472132845|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131075946|NCT02561806|471910418|FG000|Induction Period|Lack of Efficacy|1|||
131075947|NCT02561806|471910419|FG001|Induction Period|Lack of Efficacy|0|||
131075948|NCT02561806|471910418|FG000|Induction Period|Withdrawal by Subject|0|||
131075949|NCT02561806|471910419|FG001|Induction Period|Withdrawal by Subject|2|||
131075950|NCT02561806|471910418|FG000|Induction Period|Site staff became unblinded|1|||
131075951|NCT02561806|471910419|FG001|Induction Period|Site staff became unblinded|0|||
131075952|NCT02561806|471910418|FG000|Induction Period|Randomized but not treated|0|||
131075953|NCT02561806|471910419|FG001|Induction Period|Randomized but not treated|1|||
131075954|NCT02561806|471910418|FG000|Maintenance Period|Adverse Event|2|||
131075955|NCT02561806|471910419|FG001|Maintenance Period|Adverse Event|1|||
131075956|NCT02561806|471910418|FG000|Maintenance Period|Lack of Efficacy|3|||
131075957|NCT02561806|471910419|FG001|Maintenance Period|Lack of Efficacy|1|||
131075958|NCT02561806|471910418|FG000|Maintenance Period|Lost to Follow-up|2|||
131075959|NCT02561806|471910419|FG001|Maintenance Period|Lost to Follow-up|2|||
131075960|NCT02561806|471910418|FG000|Maintenance Period|Protocol Violation|1|||
131075961|NCT02561806|471910419|FG001|Maintenance Period|Protocol Violation|0|||
131075962|NCT02561806|471910418|FG000|Maintenance Period|Withdrawal by Subject|5|||
131075963|NCT02561806|471910419|FG001|Maintenance Period|Withdrawal by Subject|3|||
131075964|NCT02561806|471910418|FG000|Maintenance Period|Site staff became unblinded|0|||
131075965|NCT02561806|471910419|FG001|Maintenance Period|Site staff became unblinded|1|||
131075966|NCT02561806|471910418|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
131075967|NCT02561806|471910419|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
131075968|NCT02561806|471910418|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
131138473|NCT01017952|472132846|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131138474|NCT01017952|472132842|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
131138475|NCT01017952|472132843|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
131075969|NCT02561806|471910419|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
131075970|NCT02547441|471910420|FG000|Double-Blind Study Period|Adverse Event|4|||
131075971|NCT02547441|471910421|FG001|Double-Blind Study Period|Adverse Event|9|||
131075972|NCT02547441|471910420|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
131075973|NCT02547441|471910421|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
131075974|NCT02547441|471910420|FG000|Double-Blind Study Period|Physician Decision|1|||
131075975|NCT02547441|471910421|FG001|Double-Blind Study Period|Physician Decision|0|||
131075976|NCT02547441|471910420|FG000|Double-Blind Study Period|Protocol Violation|1|||
131075977|NCT02547441|471910421|FG001|Double-Blind Study Period|Protocol Violation|2|||
131075978|NCT02547441|471910420|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
131075979|NCT02547441|471910421|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
131075980|NCT02547441|471910420|FG000|Double-Blind Study Period|Sponsor Decision|1|||
131075981|NCT02547441|471910421|FG001|Double-Blind Study Period|Sponsor Decision|0|||
131075982|NCT02547441|471910420|FG000|Open-Label Study Period|Adverse Event|10|||
131075983|NCT02547441|471910421|FG001|Open-Label Study Period|Adverse Event|11|||
131075984|NCT02547441|471910420|FG000|Open-Label Study Period|Lack of Efficacy|3|||
131075985|NCT02547441|471910421|FG001|Open-Label Study Period|Lack of Efficacy|2|||
131075986|NCT02547441|471910420|FG000|Open-Label Study Period|Lost to Follow-up|7|||
131075987|NCT02547441|471910421|FG001|Open-Label Study Period|Lost to Follow-up|8|||
131075988|NCT02547441|471910420|FG000|Open-Label Study Period|Physician Decision|1|||
131075989|NCT02547441|471910421|FG001|Open-Label Study Period|Physician Decision|0|||
131075990|NCT02547441|471910420|FG000|Open-Label Study Period|Protocol Violation|2|||
131075991|NCT02547441|471910421|FG001|Open-Label Study Period|Protocol Violation|0|||
131075992|NCT02547441|471910420|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
131075993|NCT02547441|471910421|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
131075994|NCT02547441|471910420|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
131075995|NCT02547441|471910421|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
131075996|NCT01322009|471910423|FG000|Overall Study|Death|0|||
131075997|NCT01322009|471910424|FG001|Overall Study|Death|1|||
131075998|NCT01322009|471910423|FG000|Overall Study|Adverse Event|0|||
131075999|NCT01322009|471910424|FG001|Overall Study|Adverse Event|1|||
130724871|NCT00658021|470617058|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
130724872|NCT00658021|470617059|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
130724873|NCT00658021|470617057|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
130724874|NCT00658021|470617058|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
131076000|NCT01322009|471910423|FG000|Overall Study|ng tube discontinued|0|||
131076001|NCT01322009|471910424|FG001|Overall Study|ng tube discontinued|1|||
131076002|NCT00905034|471910425|FG000|Overall Study|Withdrawal by Subject|1|||
131076003|NCT00394589|471910426|FG000|Overall Study|Adverse Event|2|||
131076004|NCT00394589|471910427|FG001|Overall Study|Adverse Event|1|||
131076005|NCT00394589|471910428|FG002|Overall Study|Adverse Event|2|||
131076006|NCT00394589|471910426|FG000|Overall Study|Lack of Efficacy|2|||
131076007|NCT00394589|471910427|FG001|Overall Study|Lack of Efficacy|2|||
131076008|NCT00394589|471910428|FG002|Overall Study|Lack of Efficacy|3|||
131076009|NCT00394589|471910426|FG000|Overall Study|Protocol Violation|4|||
131076010|NCT00394589|471910427|FG001|Overall Study|Protocol Violation|0|||
131076011|NCT00394589|471910428|FG002|Overall Study|Protocol Violation|2|||
131076012|NCT04081389|471910429|FG000|Overall Study|Withdrawal by Subject|0|||
131076013|NCT04081389|471910430|FG001|Overall Study|Withdrawal by Subject|0|||
131076014|NCT04081389|471910431|FG002|Overall Study|Withdrawal by Subject|1|||
131076015|NCT04081389|471910432|FG003|Overall Study|Withdrawal by Subject|0|||
131076016|NCT02427958|471910438|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
131076017|NCT02427958|471910438|FG000|Overall Study|Lost to Follow-up|6|||
131076018|NCT02427958|471910438|FG000|Overall Study|Withdrawal by Subject|14|||
131076019|NCT02427958|471910438|FG000|Overall Study|Lack of Efficacy|1|||
131076020|NCT00582114|471910441|FG000|Overall Study|Death|4|||
131076021|NCT00582114|471910442|FG001|Overall Study|Death|4|||
131076022|NCT00582114|471910441|FG000|Overall Study|Kidney Transplant|3|||
131076023|NCT00582114|471910442|FG001|Overall Study|Kidney Transplant|1|||
131076024|NCT00582114|471910441|FG000|Overall Study|Lost to Follow-up|7|||
131076025|NCT00582114|471910442|FG001|Overall Study|Lost to Follow-up|6|||
131076026|NCT00582114|471910441|FG000|Overall Study|Withdrawal by Subject|8|||
131076027|NCT00582114|471910442|FG001|Overall Study|Withdrawal by Subject|16|||
131076028|NCT00582114|471910441|FG000|Overall Study|Adverse Event|1|||
131076029|NCT00582114|471910442|FG001|Overall Study|Adverse Event|1|||
131076030|NCT00582114|471910441|FG000|Overall Study|Physician Decision|0|||
131076031|NCT00582114|471910442|FG001|Overall Study|Physician Decision|6|||
131076032|NCT00582114|471910441|FG000|Overall Study|Stopped by data safety monitoring board|19|||
131076033|NCT00582114|471910442|FG001|Overall Study|Stopped by data safety monitoring board|20|||
131076034|NCT02604342|471910443|FG000|Overall Study|Death|32|||
131076035|NCT02604342|471910444|FG001|Overall Study|Death|16|||
131076036|NCT02604342|471910443|FG000|Overall Study|Progression of disease|1|||
131076037|NCT02604342|471910444|FG001|Overall Study|Progression of disease|0|||
131076038|NCT02604342|471910443|FG000|Overall Study|Withdrawal by Subject|5|||
131076039|NCT02604342|471910444|FG001|Overall Study|Withdrawal by Subject|6|||
131076040|NCT02604342|471910443|FG000|Overall Study|Other|1|||
131076041|NCT02604342|471910444|FG001|Overall Study|Other|0|||
131076042|NCT02604342|471910443|FG000|Overall Study|Study Termination by Sponsor|1|||
131138476|NCT01017952|472132844|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
130724875|NCT00658021|470617059|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
130724876|NCT02952898|470617065|FG000|Overall Study|Withdrawal by Subject|10|||
130724877|NCT02952898|470617066|FG001|Overall Study|Withdrawal by Subject|8|||
130724878|NCT02952898|470617067|FG002|Overall Study|Withdrawal by Subject|8|||
130724879|NCT02952898|470617065|FG000|Overall Study|Adverse Event|8|||
130724880|NCT02952898|470617066|FG001|Overall Study|Adverse Event|8|||
130724881|NCT02952898|470617067|FG002|Overall Study|Adverse Event|3|||
130724882|NCT02952898|470617065|FG000|Overall Study|Lost to Follow-up|3|||
130724883|NCT02952898|470617066|FG001|Overall Study|Lost to Follow-up|2|||
131076043|NCT02604342|471910444|FG001|Overall Study|Study Termination by Sponsor|0|||
131076044|NCT02604342|471910443|FG000|Overall Study|Lost to Follow-up|1|||
131076045|NCT02604342|471910444|FG001|Overall Study|Lost to Follow-up|1|||
131076046|NCT02604342|471910443|FG000|Overall Study|Physician Decision|2|||
131076047|NCT02604342|471910444|FG001|Overall Study|Physician Decision|0|||
131076048|NCT00130728|471910445|FG000|Overall Study|Death|258|||
131076049|NCT00130728|471910446|FG001|Overall Study|Death|258|||
131076050|NCT00130728|471910445|FG000|Overall Study|Lost to Follow-up|4|||
131076051|NCT00130728|471910446|FG001|Overall Study|Lost to Follow-up|0|||
131076052|NCT00130728|471910445|FG000|Overall Study|Withdrawal by Subject|0|||
131076053|NCT00130728|471910446|FG001|Overall Study|Withdrawal by Subject|2|||
131076054|NCT00746356|471910447|FG000|Overall Study|Withdrawal by Subject|2|||
131076055|NCT00746356|471910448|FG001|Overall Study|Withdrawal by Subject|3|||
131076056|NCT00746356|471910447|FG000|Overall Study|Death|7|||
131076057|NCT00746356|471910448|FG001|Overall Study|Death|3|||
131076058|NCT00746356|471910447|FG000|Overall Study|Lost to Follow-up|1|||
131076059|NCT00746356|471910448|FG001|Overall Study|Lost to Follow-up|0|||
131076060|NCT00746356|471910447|FG000|Overall Study|Removal of Device|0|||
131076061|NCT00746356|471910448|FG001|Overall Study|Removal of Device|1|||
131076062|NCT00746356|471910447|FG000|Overall Study|Patient relocated|1|||
131076063|NCT00746356|471910448|FG001|Overall Study|Patient relocated|0|||
131076064|NCT02881047|471910451|FG000|Overall Study|Adverse Event|1|||
131076065|NCT02881047|471910451|FG000|Overall Study|Withdrawal by Subject|1|||
131076066|NCT01203956|471910457|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
131076067|NCT01203956|471910458|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
131076068|NCT02230306|471910459|FG000|Overall Study|Did not receive study treatment|1|||
131076069|NCT01503164|471910463|FG000|Overall Study|Withdrawal by Subject|2|||
131076070|NCT01503164|471910464|FG001|Overall Study|Withdrawal by Subject|1|||
131076071|NCT00092521|471912082|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
131076072|NCT00092521|471912083|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
131076073|NCT00092521|471912084|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
131076074|NCT00092521|471912085|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
131076075|NCT00092521|471912082|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
131076076|NCT00092521|471912083|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
131076077|NCT00092521|471912084|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
131076078|NCT00092521|471912085|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
131076079|NCT00092521|471912082|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
131076080|NCT00092521|471912083|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
131076081|NCT00092521|471912084|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
131076082|NCT00092521|471912085|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
131076083|NCT00092521|471912082|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
131076084|NCT00092521|471912083|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
131076085|NCT00092521|471912084|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
131076086|NCT00092521|471912085|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
131076087|NCT00092521|471912082|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
131076088|NCT00092521|471912083|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
131076089|NCT00092521|471912084|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
131076090|NCT00092521|471912085|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
131076091|NCT00092521|471912082|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
130724884|NCT02952898|470617067|FG002|Overall Study|Lost to Follow-up|2|||
130724885|NCT02952898|470617065|FG000|Overall Study|Non-compliance with study drug|1|||
131076092|NCT00092521|471912083|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
131076093|NCT00092521|471912084|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
131076094|NCT00092521|471912085|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
131138477|NCT01017952|472132845|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
131138478|NCT01017952|472132846|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
131138479|NCT01017952|472132842|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
130724886|NCT02952898|470617066|FG001|Overall Study|Non-compliance with study drug|1|||
130724887|NCT02952898|470617067|FG002|Overall Study|Non-compliance with study drug|2|||
130724888|NCT04123561|470617076|FG000|Overall Study|Lost to Follow-up|20|||
131076095|NCT00092521|471912082|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
131076096|NCT00092521|471912083|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
131076097|NCT00092521|471912084|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
130724889|NCT04123561|470617077|FG001|Overall Study|Lost to Follow-up|12|||
130724890|NCT04123561|470617078|FG002|Overall Study|Lost to Follow-up|5|||
130724891|NCT04123561|470617076|FG000|Overall Study|Withdrawal by Subject|9|||
130724892|NCT04123561|470617077|FG001|Overall Study|Withdrawal by Subject|7|||
130724893|NCT04123561|470617078|FG002|Overall Study|Withdrawal by Subject|9|||
130724894|NCT04123561|470617076|FG000|Overall Study|Lack of Efficacy|7|||
130724895|NCT04123561|470617077|FG001|Overall Study|Lack of Efficacy|8|||
130724896|NCT04123561|470617078|FG002|Overall Study|Lack of Efficacy|6|||
130724897|NCT04123561|470617076|FG000|Overall Study|Adverse Event|5|||
130724898|NCT04123561|470617077|FG001|Overall Study|Adverse Event|2|||
130724899|NCT04123561|470617078|FG002|Overall Study|Adverse Event|3|||
130724900|NCT04123561|470617076|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
130724901|NCT04123561|470617077|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
130724902|NCT04123561|470617078|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
130724903|NCT04123561|470617076|FG000|Overall Study|Death|0|||
130724904|NCT04123561|470617077|FG001|Overall Study|Death|0|||
130724905|NCT04123561|470617078|FG002|Overall Study|Death|1|||
130724906|NCT04123561|470617076|FG000|Overall Study|Protocol Violation|0|||
130724907|NCT04123561|470617077|FG001|Overall Study|Protocol Violation|1|||
130724908|NCT04123561|470617078|FG002|Overall Study|Protocol Violation|0|||
130724909|NCT03462459|470617086|FG000|Overall Study|Death|1|||
130724910|NCT03462459|470617087|FG001|Overall Study|Death|0|||
130724911|NCT03462459|470617086|FG000|Overall Study|Lack of Efficacy|2|||
130724912|NCT03462459|470617087|FG001|Overall Study|Lack of Efficacy|4|||
130724913|NCT03462459|470617086|FG000|Overall Study|Lost to Follow-up|1|||
130724914|NCT03462459|470617087|FG001|Overall Study|Lost to Follow-up|3|||
130724915|NCT03462459|470617086|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
130724916|NCT03462459|470617087|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
130724917|NCT03462459|470617086|FG000|Overall Study|Withdrawal by Subject|3|||
130724918|NCT03462459|470617087|FG001|Overall Study|Withdrawal by Subject|2|||
130724919|NCT03462459|470617086|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
130724920|NCT03462459|470617087|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
130724921|NCT03132155|470619135|FG000|Overall Study|Lack of Efficacy|6|||
130724922|NCT03132155|470619135|FG000|Overall Study|Lost to Follow-up|1|||
130724923|NCT03132155|470619135|FG000|Overall Study|Withdrawal by Subject|1|||
130724924|NCT00270855|470619137|FG000|Overall Study|Withdrawal by Subject|8|||
130724925|NCT00270855|470619138|FG001|Overall Study|Withdrawal by Subject|8|||
130724926|NCT01396512|470619143|FG000|Overall Study|Withdrawal by Subject|0|||
130724927|NCT01396512|470619144|FG001|Overall Study|Withdrawal by Subject|1|||
130724928|NCT02755649|470619145|FG000|Overall Study|Transitioned into OLE study|99|||
130724929|NCT02755649|470619146|FG001|Overall Study|Transitioned into OLE study|98|||
130724930|NCT02755649|470619147|FG002|Overall Study|Transitioned into OLE study|100|||
130724931|NCT02755649|470619145|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
130724932|NCT02755649|470619146|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
130724933|NCT02755649|470619147|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
130724934|NCT02755649|470619145|FG000|Overall Study|Physician Decision|0|||
130724935|NCT02755649|470619146|FG001|Overall Study|Physician Decision|0|||
130724936|NCT02755649|470619147|FG002|Overall Study|Physician Decision|2|||
130724937|NCT02755649|470619145|FG000|Overall Study|Withdrawal by Subject|0|||
130724938|NCT02755649|470619146|FG001|Overall Study|Withdrawal by Subject|1|||
130724939|NCT02755649|470619147|FG002|Overall Study|Withdrawal by Subject|0|||
130724940|NCT02755649|470619145|FG000|Overall Study|Undecided|1|||
130724941|NCT02755649|470619146|FG001|Overall Study|Undecided|0|||
130724942|NCT02755649|470619147|FG002|Overall Study|Undecided|0|||
130724943|NCT02152605|470619148|FG000|Overall Study|Adverse Event|6|||
130724944|NCT02152605|470619149|FG001|Overall Study|Adverse Event|8|||
130724945|NCT02152605|470619148|FG000|Overall Study|Lack of Efficacy|7|||
130724946|NCT02152605|470619149|FG001|Overall Study|Lack of Efficacy|4|||
130724947|NCT02152605|470619148|FG000|Overall Study|Protocol deviation|1|||
130724948|NCT02152605|470619149|FG001|Overall Study|Protocol deviation|4|||
130724949|NCT02152605|470619148|FG000|Overall Study|Lost to Follow-up|1|||
130724950|NCT02152605|470619149|FG001|Overall Study|Lost to Follow-up|0|||
130724951|NCT02152605|470619148|FG000|Overall Study|Withdrew consent|4|||
130724952|NCT02152605|470619149|FG001|Overall Study|Withdrew consent|2|||
130724953|NCT03301649|470619150|FG000|Overall Study|Need alternate therapy due to live lice|17|||
130724954|NCT03301649|470619151|FG001|Overall Study|Need alternate therapy due to live lice|25|||
130724955|NCT03301649|470619152|FG002|Overall Study|Need alternate therapy due to live lice|81|||
130724956|NCT03301649|470619150|FG000|Overall Study|Lost to Follow-up|11|||
130724957|NCT03301649|470619151|FG001|Overall Study|Lost to Follow-up|11|||
130724958|NCT03301649|470619152|FG002|Overall Study|Lost to Follow-up|3|||
130724959|NCT03301649|470619150|FG000|Overall Study|Protocol Violation|0|||
130724960|NCT03301649|470619151|FG001|Overall Study|Protocol Violation|1|||
130724961|NCT03301649|470619152|FG002|Overall Study|Protocol Violation|1|||
130724962|NCT03301649|470619150|FG000|Overall Study|Withdrawal by Subject|10|||
130724963|NCT03301649|470619151|FG001|Overall Study|Withdrawal by Subject|4|||
130724964|NCT03301649|470619152|FG002|Overall Study|Withdrawal by Subject|0|||
131231150|NCT01806597|472473233|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
131231151|NCT01806597|472473234|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
131231152|NCT01806597|472473235|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
131231153|NCT01806597|472473236|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
131231154|NCT01806597|472473237|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
131231155|NCT01806597|472473238|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
131231156|NCT01806597|472473233|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
131231157|NCT01806597|472473234|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
131231158|NCT01806597|472473235|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
131231159|NCT01806597|472473236|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
131231160|NCT01806597|472473237|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
131231161|NCT01806597|472473238|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
131231162|NCT01806597|472473233|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
131231163|NCT01806597|472473234|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
131231164|NCT01806597|472473235|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
131231165|NCT01806597|472473236|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
131231166|NCT01806597|472473237|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
131231167|NCT01806597|472473238|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
131231168|NCT01806597|472473233|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
131231169|NCT01806597|472473234|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
131231170|NCT01806597|472473235|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
131231171|NCT01806597|472473236|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
131231172|NCT01806597|472473237|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
131231173|NCT01806597|472473238|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
131076098|NCT00092521|471912085|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
131076099|NCT00092521|471912082|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
131076100|NCT00092521|471912083|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
131076101|NCT00092521|471912084|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
131076102|NCT00092521|471912085|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
131076103|NCT00092521|471912082|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
131076104|NCT00092521|471912083|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
131076105|NCT00092521|471912084|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
131076106|NCT00092521|471912085|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
131076107|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
131076108|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
131076109|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
131076110|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
131076111|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
131076112|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
131076113|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
131076114|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
131076115|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
131076116|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
131076117|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
131076118|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
131076119|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Death|2|||
131076120|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Death|0|||
131076121|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Death|1|||
131076122|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Death|0|||
131076123|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
131076124|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
131076125|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
131076126|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
131076127|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
131076128|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
131076129|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
131076130|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
131076131|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
131076132|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
131138480|NCT01017952|472132843|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131138481|NCT01017952|472132844|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131138482|NCT01017952|472132845|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131138483|NCT01017952|472132846|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131138484|NCT01017952|472132842|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
131138485|NCT01017952|472132843|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
131138486|NCT01017952|472132844|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
131138487|NCT01017952|472132845|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
131138488|NCT01017952|472132846|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
131076133|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
131076134|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
131076135|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Moved|32|||
131076136|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Moved|2|||
131076137|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Moved|28|||
131076138|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Moved|0|||
131076139|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
131138489|NCT01017952|472132842|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131138490|NCT01017952|472132843|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
131138491|NCT01017952|472132844|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
131138492|NCT01017952|472132845|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
131138493|NCT01017952|472132846|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
131138494|NCT01017952|472132842|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
131138495|NCT01017952|472132843|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
131138496|NCT01017952|472132844|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
131138497|NCT01017952|472132845|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
131138498|NCT01017952|472132846|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
131138499|NCT01017952|472132842|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
131138500|NCT01017952|472132843|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
131138501|NCT01017952|472132844|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
131138502|NCT01017952|472132845|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
131138503|NCT01017952|472132846|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
131138504|NCT01017952|472132842|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
131138505|NCT01017952|472132843|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
131138506|NCT01017952|472132844|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
131138507|NCT01017952|472132845|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
131138508|NCT01017952|472132846|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
131138509|NCT01017952|472132842|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131138510|NCT01017952|472132843|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
131138511|NCT01017952|472132844|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
131138512|NCT01017952|472132845|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131138513|NCT01017952|472132846|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131138514|NCT01017952|472132842|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131138515|NCT01017952|472132843|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
131138516|NCT01017952|472132844|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
131138517|NCT01017952|472132845|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
131231174|NCT01806597|472473233|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
131231175|NCT01806597|472473234|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
131231176|NCT01806597|472473235|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
131231177|NCT01806597|472473236|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
131076140|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
131076141|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
131076142|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
131076143|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Travel|2|||
131138518|NCT01017952|472132846|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
131138519|NCT01017952|472132842|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
131231178|NCT01806597|472473237|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
131231179|NCT01806597|472473238|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
131231180|NCT01806597|472473233|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
131231181|NCT01806597|472473234|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
131231182|NCT01806597|472473235|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
131231183|NCT01806597|472473236|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
131231184|NCT01806597|472473237|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
131231185|NCT01806597|472473238|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
131231186|NCT02247479|472473241|FG000|Overall Study|Adverse Event|8|||
131231187|NCT02247479|472473242|FG001|Overall Study|Adverse Event|9|||
131231188|NCT02247479|472473243|FG002|Overall Study|Adverse Event|8|||
131231189|NCT02247479|472473241|FG000|Overall Study|Death|5|||
131231190|NCT02247479|472473242|FG001|Overall Study|Death|4|||
131231191|NCT02247479|472473243|FG002|Overall Study|Death|6|||
131076144|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Travel|0|||
131076145|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Travel|0|||
131231192|NCT02247479|472473241|FG000|Overall Study|Lost to Follow-up|3|||
131076146|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Travel|0|||
131076147|NCT00092521|471912082|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
131076148|NCT00092521|471912083|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
131076149|NCT00092521|471912084|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
131076150|NCT00092521|471912085|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
131076151|NCT00092521|471912082|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
131076152|NCT00092521|471912083|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
131076153|NCT00092521|471912084|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
131076154|NCT00092521|471912085|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
131076155|NCT00092521|471912082|FG000|Extension Study (Group 4)|Adverse Event|0|||
131076156|NCT00092521|471912083|FG001|Extension Study (Group 4)|Adverse Event|0|||
131076157|NCT00092521|471912084|FG002|Extension Study (Group 4)|Adverse Event|0|||
131076158|NCT00092521|471912085|FG003|Extension Study (Group 4)|Adverse Event|2|||
131076159|NCT00092521|471912082|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
131076160|NCT00092521|471912083|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
131076161|NCT00092521|471912084|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
131076162|NCT00092521|471912085|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
131076163|NCT00092521|471912082|FG000|Extension Study (Group 4)|Pregnancy|0|||
131076164|NCT00092521|471912083|FG001|Extension Study (Group 4)|Pregnancy|0|||
131076165|NCT00092521|471912084|FG002|Extension Study (Group 4)|Pregnancy|0|||
131076166|NCT00092521|471912085|FG003|Extension Study (Group 4)|Pregnancy|4|||
131076167|NCT00092521|471912082|FG000|Extension Study (Group 4)|Protocol Violation|0|||
131076168|NCT00092521|471912083|FG001|Extension Study (Group 4)|Protocol Violation|0|||
131076169|NCT00092521|471912084|FG002|Extension Study (Group 4)|Protocol Violation|0|||
131076170|NCT00092521|471912085|FG003|Extension Study (Group 4)|Protocol Violation|2|||
131076171|NCT00092521|471912082|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
131076172|NCT00092521|471912083|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
131076173|NCT00092521|471912084|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
131076174|NCT00092521|471912085|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
131076175|NCT00092521|471912082|FG000|Extension Study (Group 4)|Moved|0|||
130724965|NCT03301649|470619150|FG000|Overall Study|Other than specified|5|||
131076176|NCT00092521|471912083|FG001|Extension Study (Group 4)|Moved|0|||
131076177|NCT00092521|471912084|FG002|Extension Study (Group 4)|Moved|0|||
131076178|NCT00092521|471912085|FG003|Extension Study (Group 4)|Moved|16|||
131076179|NCT00092521|471912082|FG000|Extension Study (Group 4)|Site Terminated|0|||
130724966|NCT03301649|470619151|FG001|Overall Study|Other than specified|3|||
130724967|NCT03301649|470619152|FG002|Overall Study|Other than specified|0|||
130724968|NCT01564537|470619153|FG000|Overall Study|Site Terminated by Sponsor|1|||
130724969|NCT01564537|470619154|FG001|Overall Study|Site Terminated by Sponsor|0|||
130724970|NCT01564537|470619153|FG000|Overall Study|Withdrawal by Subject|12|||
130724971|NCT01564537|470619154|FG001|Overall Study|Withdrawal by Subject|14|||
130724972|NCT01564537|470619153|FG000|Overall Study|Lost to Follow-up|7|||
130724973|NCT01564537|470619154|FG001|Overall Study|Lost to Follow-up|3|||
130724974|NCT01564537|470619153|FG000|Overall Study|Reason not specified|81|||
130724975|NCT01564537|470619154|FG001|Overall Study|Reason not specified|82|||
130724976|NCT00837473|470619155|FG000|Overall Study|Lost to Follow-up|1|||
130724977|NCT00837473|470619155|FG000|Overall Study|Withdrawal by Subject|2|||
130724978|NCT01635218|470619156|FG000|Overall Study|Lost to Follow-up|3|||
130724979|NCT01635218|470619157|FG001|Overall Study|Lost to Follow-up|7|||
130724980|NCT01635218|470619158|FG002|Overall Study|Lost to Follow-up|6|||
130724981|NCT03559400|470619159|FG000|Overall Study|Lost to Follow-up|9|||
130724982|NCT03559400|470619160|FG001|Overall Study|Lost to Follow-up|7|||
130724983|NCT03559400|470619159|FG000|Overall Study|Death|0|||
130724984|NCT03559400|470619160|FG001|Overall Study|Death|2|||
130724985|NCT03262038|470619161|FG000|Overall Study|Withdrawal by Subject|0|||
130724986|NCT03262038|470619162|FG001|Overall Study|Withdrawal by Subject|1|||
130724987|NCT04933968|470619163|FG000|Overall Study|Adverse Event|0|||
130724988|NCT04933968|470619164|FG001|Overall Study|Adverse Event|0|||
130724989|NCT04933968|470619165|FG002|Overall Study|Adverse Event|1|||
130724990|NCT04933968|470619166|FG003|Overall Study|Adverse Event|1|||
130724991|NCT04933968|470619167|FG004|Overall Study|Adverse Event|0|||
130724992|NCT04933968|470619168|FG005|Overall Study|Adverse Event|0|||
130724993|NCT04933968|470619163|FG000|Overall Study|Lost to Follow-up|1|||
130724994|NCT04933968|470619164|FG001|Overall Study|Lost to Follow-up|0|||
130724995|NCT04933968|470619165|FG002|Overall Study|Lost to Follow-up|1|||
130724996|NCT04933968|470619166|FG003|Overall Study|Lost to Follow-up|0|||
130724997|NCT04933968|470619167|FG004|Overall Study|Lost to Follow-up|0|||
131076180|NCT00092521|471912083|FG001|Extension Study (Group 4)|Site Terminated|0|||
131076181|NCT00092521|471912084|FG002|Extension Study (Group 4)|Site Terminated|0|||
130724998|NCT04933968|470619168|FG005|Overall Study|Lost to Follow-up|0|||
130724999|NCT04933968|470619163|FG000|Overall Study|Randomized not treated|1|||
130725000|NCT04933968|470619164|FG001|Overall Study|Randomized not treated|0|||
130725001|NCT04933968|470619165|FG002|Overall Study|Randomized not treated|0|||
130725002|NCT04933968|470619166|FG003|Overall Study|Randomized not treated|0|||
130725003|NCT04933968|470619167|FG004|Overall Study|Randomized not treated|0|||
130725004|NCT04933968|470619168|FG005|Overall Study|Randomized not treated|0|||
130725005|NCT04933968|470619163|FG000|Overall Study|Sponsor terminated study|0|||
131076182|NCT00092521|471912085|FG003|Extension Study (Group 4)|Site Terminated|4|||
131076183|NCT00092521|471912082|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
131076184|NCT00092521|471912083|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
131076185|NCT00092521|471912084|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
131076186|NCT00092521|471912085|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
131076187|NCT03464383|471912086|FG000|Overall Study|Lost to Follow-up|1|||
131076188|NCT03464383|471912087|FG001|Overall Study|Lost to Follow-up|0|||
131076189|NCT03464383|471912088|FG002|Overall Study|Lost to Follow-up|0|||
131076190|NCT03464383|471912086|FG000|Overall Study|Withdrawal by Subject|0|||
131076191|NCT03464383|471912087|FG001|Overall Study|Withdrawal by Subject|1|||
131076192|NCT03464383|471912088|FG002|Overall Study|Withdrawal by Subject|0|||
131076193|NCT00605566|471912089|FG000|Overall Study|Adverse Event|1|||
131076194|NCT00605566|471912089|FG000|Overall Study|Clinical deterioration|1|||
131076195|NCT00605566|471912089|FG000|Overall Study|Poor compliance in run-in period|1|||
131076196|NCT00695136|471912097|FG000|Overall Study|Withdrawal by Subject|1|||
131076197|NCT00695136|471912097|FG000|Overall Study|unrelated adverse event|1|||
131076198|NCT02826798|471912099|FG000|Overall Study|Withdrawal by Subject|0|||
131076199|NCT02826798|471912100|FG001|Overall Study|Withdrawal by Subject|1|||
131076200|NCT02826798|471912101|FG002|Overall Study|Withdrawal by Subject|0|||
131076201|NCT02826798|471912102|FG003|Overall Study|Withdrawal by Subject|1|||
131076202|NCT02826798|471912103|FG004|Overall Study|Withdrawal by Subject|0|||
131076203|NCT02806505|471912104|FG000|Overall Study|Adverse event/intercurrent illness|1|||
131076204|NCT02806505|471912105|FG001|Overall Study|Adverse event/intercurrent illness|3|||
131076205|NCT02806505|471912104|FG000|Overall Study|Death|4|||
131076206|NCT02806505|471912105|FG001|Overall Study|Death|0|||
131076207|NCT02806505|471912104|FG000|Overall Study|Did not cooperate/refused treatment|3|||
131076208|NCT02806505|471912105|FG001|Overall Study|Did not cooperate/refused treatment|3|||
131076209|NCT02806505|471912104|FG000|Overall Study|Failure to return|0|||
131076210|NCT02806505|471912105|FG001|Overall Study|Failure to return|1|||
131076211|NCT02806505|471912104|FG000|Overall Study|Insufficient therapeutic response|2|||
131076212|NCT02806505|471912105|FG001|Overall Study|Insufficient therapeutic response|4|||
131076213|NCT03440047|471912112|FG000|Overall Study|Withdrawal by Subject|2|||
131076214|NCT01333111|471912115|FG000|Overall Study|patient undergoing major surgery|0|||
131076215|NCT01333111|471912116|FG001|Overall Study|patient undergoing major surgery|2|||
131076216|NCT01333111|471912117|FG002|Overall Study|patient undergoing major surgery|0|||
131076217|NCT01333111|471912115|FG000|Overall Study|personal reasons|0|||
131076218|NCT01333111|471912116|FG001|Overall Study|personal reasons|0|||
131076219|NCT01333111|471912117|FG002|Overall Study|personal reasons|1|||
131076220|NCT01333111|471912115|FG000|Overall Study|unclassified|1|||
131076221|NCT01333111|471912116|FG001|Overall Study|unclassified|0|||
131076222|NCT01333111|471912117|FG002|Overall Study|unclassified|0|||
131076223|NCT01333111|471912115|FG000|Overall Study|withdrawal criteria|0|||
131076224|NCT01333111|471912116|FG001|Overall Study|withdrawal criteria|1|||
131076225|NCT01333111|471912117|FG002|Overall Study|withdrawal criteria|0|||
131076226|NCT01333111|471912115|FG000|Overall Study|Non-compliance|1|||
131076227|NCT01333111|471912116|FG001|Overall Study|Non-compliance|0|||
131076228|NCT01333111|471912117|FG002|Overall Study|Non-compliance|0|||
131076229|NCT01333111|471912115|FG000|Overall Study|Ineffective therapy|0|||
131076230|NCT01333111|471912116|FG001|Overall Study|Ineffective therapy|0|||
131076231|NCT01333111|471912117|FG002|Overall Study|Ineffective therapy|1|||
131076232|NCT02161406|471912118|FG000|Overall Study|Death|2|||
131076233|NCT02161406|471912119|FG001|Overall Study|Death|1|||
131076234|NCT02161406|471912118|FG000|Overall Study|Lost to Follow-up|2|||
131076235|NCT02161406|471912119|FG001|Overall Study|Lost to Follow-up|1|||
131076236|NCT02161406|471912118|FG000|Overall Study|Withdrawal by Subject|2|||
131076237|NCT02161406|471912119|FG001|Overall Study|Withdrawal by Subject|4|||
131076238|NCT02161406|471912118|FG000|Overall Study|investigator withdrew subject|3|||
131076239|NCT02161406|471912119|FG001|Overall Study|investigator withdrew subject|1|||
131076240|NCT02161406|471912118|FG000|Overall Study|Lack of Efficacy|1|||
131076241|NCT02161406|471912119|FG001|Overall Study|Lack of Efficacy|1|||
131076242|NCT02161406|471912118|FG000|Overall Study|relocation|0|||
131076243|NCT02161406|471912119|FG001|Overall Study|relocation|1|||
131076244|NCT04732871|471912120|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
131138520|NCT01017952|472132843|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
131138521|NCT01017952|472132844|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
131138522|NCT01017952|472132845|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
131138523|NCT01017952|472132846|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
131138524|NCT04849780|472132847|FG000|Period 1|Covid-19 Related|1|||
131138525|NCT04849780|472132848|FG001|Period 1|Covid-19 Related|0|||
131138526|NCT04849780|472132847|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
131076245|NCT04732871|471912121|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
131076246|NCT04732871|471912122|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
131076247|NCT04732871|471912120|FG000|Overall Study|Lost to Follow-up|7|||
131076248|NCT04732871|471912121|FG001|Overall Study|Lost to Follow-up|4|||
131076249|NCT04732871|471912122|FG002|Overall Study|Lost to Follow-up|3|||
131076250|NCT04732871|471912120|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
131076251|NCT04732871|471912121|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
131231193|NCT02247479|472473242|FG001|Overall Study|Lost to Follow-up|3|||
131231194|NCT02247479|472473243|FG002|Overall Study|Lost to Follow-up|1|||
131231195|NCT02247479|472473241|FG000|Overall Study|Non-compliance|0|||
131231196|NCT02247479|472473242|FG001|Overall Study|Non-compliance|0|||
131231197|NCT02247479|472473243|FG002|Overall Study|Non-compliance|1|||
131231198|NCT02247479|472473241|FG000|Overall Study|Withdrawal by Subject|25|||
131231199|NCT02247479|472473242|FG001|Overall Study|Withdrawal by Subject|29|||
131076252|NCT04732871|471912122|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
131231200|NCT02247479|472473243|FG002|Overall Study|Withdrawal by Subject|24|||
131231201|NCT02247479|472473241|FG000|Overall Study|Study Terminated by Sponsor|98|||
131231202|NCT02247479|472473242|FG001|Overall Study|Study Terminated by Sponsor|88|||
131231203|NCT02247479|472473243|FG002|Overall Study|Study Terminated by Sponsor|94|||
131231204|NCT02247479|472473241|FG000|Overall Study|Physician Decision|1|||
131076253|NCT04732871|471912120|FG000|Overall Study|Migrated / moved from the study area|5|||
131076254|NCT04732871|471912121|FG001|Overall Study|Migrated / moved from the study area|0|||
131076255|NCT04732871|471912122|FG002|Overall Study|Migrated / moved from the study area|0|||
131076256|NCT04732871|471912120|FG000|Overall Study|Other|1|||
131076257|NCT04732871|471912121|FG001|Overall Study|Other|0|||
131076258|NCT04732871|471912122|FG002|Overall Study|Other|1|||
131076259|NCT04732871|471912120|FG000|Overall Study|Ongoing|6|||
131076260|NCT04732871|471912121|FG001|Overall Study|Ongoing|0|||
131076261|NCT04732871|471912122|FG002|Overall Study|Ongoing|1|||
131076262|NCT04732871|471912120|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
131076263|NCT04732871|471912121|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
131076264|NCT04732871|471912122|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
131076265|NCT02034162|471912125|FG000|Double-blind|Lost to Follow-up|3|||
131076266|NCT02034162|471912126|FG001|Double-blind|Lost to Follow-up|0|||
131076267|NCT02034162|471912127|FG002|Double-blind|Lost to Follow-up|0|||
131231205|NCT02247479|472473242|FG001|Overall Study|Physician Decision|0|||
131231206|NCT02247479|472473243|FG002|Overall Study|Physician Decision|2|||
131231207|NCT02247479|472473241|FG000|Overall Study|Unspecified Reason|2|||
131231208|NCT02247479|472473242|FG001|Overall Study|Unspecified Reason|5|||
131231209|NCT02247479|472473243|FG002|Overall Study|Unspecified Reason|2|||
131231210|NCT01073020|472473244|FG000|Overall Study|Withdrawal by Subject|6|||
131231211|NCT01073020|472473245|FG001|Overall Study|Withdrawal by Subject|4|||
131231212|NCT01073020|472473246|FG002|Overall Study|Withdrawal by Subject|1|||
131231213|NCT01073020|472473247|FG003|Overall Study|Withdrawal by Subject|2|||
131231214|NCT01073020|472473244|FG000|Overall Study|Physician Decision|1|||
131231215|NCT01073020|472473245|FG001|Overall Study|Physician Decision|0|||
131231216|NCT01073020|472473246|FG002|Overall Study|Physician Decision|2|||
131231217|NCT01073020|472473247|FG003|Overall Study|Physician Decision|0|||
131231218|NCT01073020|472473244|FG000|Overall Study|Death|0|||
131231219|NCT01073020|472473245|FG001|Overall Study|Death|1|||
131231220|NCT01073020|472473246|FG002|Overall Study|Death|0|||
131231221|NCT01073020|472473247|FG003|Overall Study|Death|0|||
131231222|NCT03031899|472473248|FG000|Overall Study|Protocol Violation|1|||
131231223|NCT03031899|472473248|FG000|Overall Study|lesion disappeared after stopping habit|1|||
131231224|NCT03740698|472473249|FG000|Overall Study|Physician Decision|0|||
131231225|NCT03740698|472473250|FG001|Overall Study|Physician Decision|1|||
131076268|NCT02034162|471912125|FG000|Double-blind|Physician Decision|1|||
131076269|NCT02034162|471912126|FG001|Double-blind|Physician Decision|0|||
131076270|NCT02034162|471912127|FG002|Double-blind|Physician Decision|0|||
131076271|NCT02034162|471912125|FG000|Double-blind|Protocol Violation|0|||
131076272|NCT02034162|471912126|FG001|Double-blind|Protocol Violation|1|||
131076273|NCT02034162|471912127|FG002|Double-blind|Protocol Violation|0|||
131076274|NCT02034162|471912125|FG000|Double-blind|Withdrawal by Subject|5|||
131076275|NCT02034162|471912126|FG001|Double-blind|Withdrawal by Subject|7|||
131076276|NCT02034162|471912127|FG002|Double-blind|Withdrawal by Subject|0|||
131076277|NCT03458728|471912129|FG000|Overall Study|Adverse Event|1|||
131076278|NCT03458728|471912130|FG001|Overall Study|Adverse Event|0|||
131076279|NCT03458728|471912129|FG000|Overall Study|Physician Decision|1|||
131076280|NCT03458728|471912130|FG001|Overall Study|Physician Decision|0|||
131076281|NCT03458728|471912129|FG000|Overall Study|Progressive disease - clinical assessment|1|||
131076282|NCT03458728|471912130|FG001|Overall Study|Progressive disease - clinical assessment|0|||
131231226|NCT03740698|472473251|FG002|Overall Study|Physician Decision|1|||
131231227|NCT00094302|472473252|FG000|Overall Study|Lost to Follow-up|43|||
131231228|NCT00094302|472473253|FG001|Overall Study|Lost to Follow-up|41|||
131231229|NCT00094302|472473252|FG000|Overall Study|Physician Decision|5|||
130725006|NCT04933968|470619164|FG001|Overall Study|Sponsor terminated study|0|||
130725007|NCT04933968|470619165|FG002|Overall Study|Sponsor terminated study|0|||
130725008|NCT04933968|470619166|FG003|Overall Study|Sponsor terminated study|1|||
131076283|NCT03458728|471912129|FG000|Overall Study|Progressive disease - radiological progression|21|||
131231230|NCT00094302|472473253|FG001|Overall Study|Physician Decision|8|||
131231231|NCT00094302|472473252|FG000|Overall Study|Withdrawal by Subject|103|||
131231232|NCT00094302|472473253|FG001|Overall Study|Withdrawal by Subject|111|||
131076284|NCT03458728|471912130|FG001|Overall Study|Progressive disease - radiological progression|6|||
131076285|NCT03458728|471912129|FG000|Overall Study|Withdrawal by Subject|0|||
131076286|NCT03458728|471912130|FG001|Overall Study|Withdrawal by Subject|1|||
131076287|NCT00908349|471912134|FG000|Overall Study|Adverse Event|10|||
131076288|NCT00908349|471912134|FG000|Overall Study|Withdrawal by Subject|9|||
131076289|NCT00908349|471912134|FG000|Overall Study|Physician Decision|5|||
131076290|NCT00908349|471912134|FG000|Overall Study|Lost to Follow-up|5|||
131076291|NCT00908349|471912134|FG000|Overall Study|Various|6|||
131076292|NCT01114139|471912139|FG000|Overall Study|Adverse Event|3|||
131076293|NCT01114139|471912140|FG001|Overall Study|Adverse Event|2|||
131076294|NCT01114139|471912139|FG000|Overall Study|Lost to Follow-up|15|||
131076295|NCT01114139|471912140|FG001|Overall Study|Lost to Follow-up|3|||
131076296|NCT01114139|471912139|FG000|Overall Study|Withdrawal by Subject|17|||
131076297|NCT01114139|471912140|FG001|Overall Study|Withdrawal by Subject|6|||
131076298|NCT01114139|471912139|FG000|Overall Study|Other-Missed 1 visit|1|||
131076299|NCT01114139|471912140|FG001|Overall Study|Other-Missed 1 visit|0|||
131076300|NCT01114139|471912139|FG000|Overall Study|Other-Protocol Violation|1|||
131076301|NCT01114139|471912140|FG001|Overall Study|Other-Protocol Violation|0|||
131076302|NCT01114139|471912139|FG000|Overall Study|Other-Out of window for study drug dose|1|||
131076303|NCT01114139|471912140|FG001|Overall Study|Other-Out of window for study drug dose|0|||
131076304|NCT01114139|471912139|FG000|Overall Study|Other-Participant falsified records|0|||
131076305|NCT01114139|471912140|FG001|Overall Study|Other-Participant falsified records|1|||
131076306|NCT01114139|471912139|FG000|Overall Study|Other-Participant went on hospice|0|||
131076307|NCT01114139|471912140|FG001|Overall Study|Other-Participant went on hospice|1|||
131076308|NCT01114139|471912139|FG000|Overall Study|Other-Physician changed treatment|1|||
131076309|NCT01114139|471912140|FG001|Overall Study|Other-Physician changed treatment|0|||
131076310|NCT01114139|471912139|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
131076311|NCT01114139|471912140|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
131076312|NCT02624869|471912141|FG000|Overall Study|Lost to Follow-up|0|||
131076313|NCT02624869|471912142|FG001|Overall Study|Lost to Follow-up|0|||
131076314|NCT02624869|471912143|FG002|Overall Study|Lost to Follow-up|1|||
131076315|NCT02624869|471912141|FG000|Overall Study|Withdrawal by Subject|1|||
131076316|NCT02624869|471912142|FG001|Overall Study|Withdrawal by Subject|3|||
131076317|NCT02624869|471912143|FG002|Overall Study|Withdrawal by Subject|1|||
131076318|NCT03294941|471912147|FG000|Overall Study|Withdrawal by Subject|0|||
131076319|NCT03294941|471912148|FG001|Overall Study|Withdrawal by Subject|2|||
131076320|NCT03927690|471912149|FG000|Overall Study|Withdrawal by Subject|3|||
131076321|NCT03927690|471912150|FG001|Overall Study|Withdrawal by Subject|1|||
131076322|NCT03927690|471912151|FG002|Overall Study|Withdrawal by Subject|1|||
131076323|NCT03927690|471912149|FG000|Overall Study|Adverse Event|1|||
131076324|NCT03927690|471912150|FG001|Overall Study|Adverse Event|0|||
131076325|NCT03927690|471912151|FG002|Overall Study|Adverse Event|0|||
131076326|NCT03927690|471912149|FG000|Overall Study|Death|1|||
131076327|NCT03927690|471912150|FG001|Overall Study|Death|0|||
131076328|NCT03927690|471912151|FG002|Overall Study|Death|0|||
131076329|NCT03927690|471912149|FG000|Overall Study|Lost to Follow-up|2|||
131076330|NCT03927690|471912150|FG001|Overall Study|Lost to Follow-up|2|||
131076331|NCT03927690|471912151|FG002|Overall Study|Lost to Follow-up|1|||
131076332|NCT04051242|471912157|FG000|Overall Study|Withdrawal by Subject|1|||
131076333|NCT04051242|471912157|FG000|Overall Study|Physician Decision|1|||
131076334|NCT01202409|471912159|FG000|Overall Study|Adverse Event|1|||
131076335|NCT01202409|471912159|FG000|Overall Study|Ineligible - KRAS mutants|7|||
131076336|NCT00337285|471912160|FG000|Overall Study|Withdrawal by Subject|42|||
131076337|NCT00337285|471912160|FG000|Overall Study|Lost to Follow-up|41|||
131076338|NCT00337285|471912160|FG000|Overall Study|Adverse Event|28|||
131076339|NCT00337285|471912160|FG000|Overall Study|Protocol Violation|27|||
131076340|NCT00337285|471912160|FG000|Overall Study|Lack of Efficacy|11|||
131138527|NCT04849780|472132848|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
131138528|NCT04849780|472132847|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
131138529|NCT04849780|472132848|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
131138530|NCT00725075|472132849|FG000|Overall Study|Use of Excluded Medication|0|||
131076341|NCT00337285|471912160|FG000|Overall Study|Death|1|||
131076342|NCT00337285|471912160|FG000|Overall Study|Physician Decision|1|||
131076343|NCT00337285|471912160|FG000|Overall Study|Lack of protocol compliance|7|||
131076344|NCT01774019|471912161|FG000|Overall Study|No longer meets protocol criteria|2|||
131076345|NCT01774019|471912162|FG001|Overall Study|No longer meets protocol criteria|0|||
131076346|NCT01774019|471912161|FG000|Overall Study|Withdrawal by Subject|1|||
131076347|NCT01774019|471912162|FG001|Overall Study|Withdrawal by Subject|0|||
131138531|NCT00725075|472132850|FG001|Overall Study|Use of Excluded Medication|1|||
131138532|NCT00725075|472132851|FG002|Overall Study|Use of Excluded Medication|0|||
131138533|NCT00725075|472132849|FG000|Overall Study|Protocol Violation|0|||
131076348|NCT01774019|471912161|FG000|Overall Study|Surgery delayed > 120 days|1|||
131076349|NCT01774019|471912162|FG001|Overall Study|Surgery delayed > 120 days|0|||
131076350|NCT01774019|471912161|FG000|Overall Study|Patient refused surgery|1|||
131076351|NCT01774019|471912162|FG001|Overall Study|Patient refused surgery|1|||
131076352|NCT01774019|471912161|FG000|Overall Study|Unable to implant study device|1|||
131076353|NCT01774019|471912162|FG001|Overall Study|Unable to implant study device|0|||
131138534|NCT00725075|472132850|FG001|Overall Study|Protocol Violation|0|||
131231233|NCT00094302|472473252|FG000|Overall Study|Death|266|||
131231234|NCT00094302|472473253|FG001|Overall Study|Death|246|||
131231235|NCT01162499|472473258|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
131231236|NCT01162499|472473259|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
131076354|NCT01774019|471912161|FG000|Overall Study|Lost to Follow-up|0|||
131076355|NCT01774019|471912162|FG001|Overall Study|Lost to Follow-up|3|||
131076356|NCT00553605|471912163|FG000|Overall Study|Did not meet entrance criteria|1|||
131076357|NCT00553605|471912164|FG001|Overall Study|Did not meet entrance criteria|3|||
131076358|NCT00553605|471912163|FG000|Overall Study|Did not receive full dose|1|||
131076359|NCT00553605|471912164|FG001|Overall Study|Did not receive full dose|0|||
131076360|NCT00553605|471912163|FG000|Overall Study|Randomized but not treated|2|||
131076361|NCT00553605|471912164|FG001|Overall Study|Randomized but not treated|0|||
131076362|NCT01004185|471912165|FG000|Overall Study|Adverse Event|1|||
131076363|NCT01004185|471912166|FG001|Overall Study|Adverse Event|1|||
131076364|NCT01004185|471912165|FG000|Overall Study|Lost to Follow-up|0|||
131076365|NCT01004185|471912166|FG001|Overall Study|Lost to Follow-up|1|||
131076366|NCT01004185|471912165|FG000|Overall Study|Lack of Efficacy|2|||
131076367|NCT01004185|471912166|FG001|Overall Study|Lack of Efficacy|1|||
131076368|NCT01004185|471912165|FG000|Overall Study|Sponsor Terminated Study|4|||
131076369|NCT01004185|471912166|FG001|Overall Study|Sponsor Terminated Study|5|||
131076370|NCT01004185|471912165|FG000|Overall Study|Withdrawal by Subject|2|||
131076371|NCT01004185|471912166|FG001|Overall Study|Withdrawal by Subject|1|||
131076372|NCT03481556|471912171|FG000|Overall Study|Adverse Event|1|||
131076373|NCT03481556|471912172|FG001|Overall Study|Adverse Event|0|||
131076374|NCT03481556|471912173|FG002|Overall Study|Adverse Event|0|||
131076375|NCT03481556|471912174|FG003|Overall Study|Adverse Event|0|||
131076376|NCT03481556|471912171|FG000|Overall Study|Death|4|||
131076377|NCT03481556|471912172|FG001|Overall Study|Death|2|||
131076378|NCT03481556|471912173|FG002|Overall Study|Death|3|||
131076379|NCT03481556|471912174|FG003|Overall Study|Death|16|||
131076380|NCT03481556|471912171|FG000|Overall Study|Study Terminated by Sponsor|10|||
131076381|NCT03481556|471912172|FG001|Overall Study|Study Terminated by Sponsor|5|||
131076382|NCT03481556|471912173|FG002|Overall Study|Study Terminated by Sponsor|2|||
131076383|NCT03481556|471912174|FG003|Overall Study|Study Terminated by Sponsor|9|||
131076384|NCT03463577|471912175|FG000|Overall Study|Lost to Follow-up|238|||
131076385|NCT03463577|471912176|FG001|Overall Study|Lost to Follow-up|435|||
131076386|NCT03463577|471912177|FG002|Overall Study|Lost to Follow-up|0|||
131076387|NCT03463577|471912178|FG003|Overall Study|Lost to Follow-up|0|||
131076388|NCT03463577|471912179|FG004|Overall Study|Lost to Follow-up|0|||
131076389|NCT03463577|471912180|FG005|Overall Study|Lost to Follow-up|0|||
131076390|NCT03463577|471912175|FG000|Overall Study|With unknown pregnancy outcome|0|||
131076391|NCT03463577|471912176|FG001|Overall Study|With unknown pregnancy outcome|5|||
131076392|NCT03463577|471912177|FG002|Overall Study|With unknown pregnancy outcome|0|||
131076393|NCT03463577|471912178|FG003|Overall Study|With unknown pregnancy outcome|0|||
131076394|NCT03463577|471912179|FG004|Overall Study|With unknown pregnancy outcome|0|||
131076395|NCT03463577|471912180|FG005|Overall Study|With unknown pregnancy outcome|0|||
131076396|NCT03463577|471912175|FG000|Overall Study|Maternal death|2|||
131076397|NCT03463577|471912176|FG001|Overall Study|Maternal death|0|||
131076398|NCT03463577|471912177|FG002|Overall Study|Maternal death|0|||
131076399|NCT03463577|471912178|FG003|Overall Study|Maternal death|0|||
131076400|NCT03463577|471912179|FG004|Overall Study|Maternal death|0|||
131076401|NCT03463577|471912180|FG005|Overall Study|Maternal death|0|||
131076402|NCT03463577|471912175|FG000|Overall Study|Neonatal death|0|||
131076403|NCT03463577|471912176|FG001|Overall Study|Neonatal death|0|||
131076404|NCT03463577|471912177|FG002|Overall Study|Neonatal death|0|||
131076405|NCT03463577|471912178|FG003|Overall Study|Neonatal death|15|||
131076406|NCT03463577|471912179|FG004|Overall Study|Neonatal death|17|||
131076407|NCT03463577|471912180|FG005|Overall Study|Neonatal death|0|||
131076408|NCT01085812|471912182|FG000|Open-Label Period|Adverse Event|0|||
131076409|NCT01085812|471912183|FG001|Open-Label Period|Adverse Event|80|||
131076410|NCT01085812|471912182|FG000|Open-Label Period|Lack of Efficacy|0|||
131076411|NCT01085812|471912183|FG001|Open-Label Period|Lack of Efficacy|26|||
131076412|NCT01085812|471912182|FG000|Open-Label Period|Protocol Violation|0|||
131076413|NCT01085812|471912183|FG001|Open-Label Period|Protocol Violation|39|||
131076414|NCT01085812|471912182|FG000|Open-Label Period|Withdrawal by Subject|0|||
131076415|NCT01085812|471912183|FG001|Open-Label Period|Withdrawal by Subject|53|||
131076416|NCT01085812|471912182|FG000|Open-Label Period|Lost to Follow-up|0|||
131076417|NCT01085812|471912183|FG001|Open-Label Period|Lost to Follow-up|42|||
131076418|NCT01085812|471912182|FG000|Double-Blind Period|Adverse Event|3|||
131076419|NCT01085812|471912183|FG001|Double-Blind Period|Adverse Event|8|||
131076420|NCT01085812|471912182|FG000|Double-Blind Period|Protocol Violation|2|||
131076421|NCT01085812|471912183|FG001|Double-Blind Period|Protocol Violation|7|||
131076422|NCT01085812|471912182|FG000|Double-Blind Period|Withdrawal by Subject|11|||
131076423|NCT01085812|471912183|FG001|Double-Blind Period|Withdrawal by Subject|24|||
131076424|NCT01085812|471912182|FG000|Double-Blind Period|Lost to Follow-up|5|||
131076425|NCT01085812|471912183|FG001|Double-Blind Period|Lost to Follow-up|17|||
131076426|NCT01085812|471912182|FG000|Double-Blind Period|Other Reasons|0|||
131231237|NCT01590433|472473260|FG000|Overall Study|Lost to Follow-up|20|||
131076427|NCT01085812|471912183|FG001|Double-Blind Period|Other Reasons|2|||
131076428|NCT01085812|471912182|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
131076429|NCT01085812|471912183|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
131076430|NCT01085812|471912182|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
131076431|NCT01085812|471912183|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
131076432|NCT01085812|471912182|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
131076433|NCT01085812|471912183|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
131076434|NCT01085812|471912182|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
131076435|NCT01085812|471912183|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
131076436|NCT01085812|471912182|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
131076437|NCT01085812|471912183|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
131076438|NCT01101997|471912184|FG000|Overall Study|Withdrawal by Subject|2|||
131076439|NCT00496626|471912187|FG000|Overall Study|Lost to Follow-up|0|||
131076440|NCT00496626|471912188|FG001|Overall Study|Lost to Follow-up|1|||
131076441|NCT00496626|471912187|FG000|Overall Study|Protocol Violation|1|||
131076442|NCT00496626|471912188|FG001|Overall Study|Protocol Violation|0|||
131076443|NCT00496626|471912187|FG000|Overall Study|Withdrawal by Subject|5|||
131076444|NCT00496626|471912188|FG001|Overall Study|Withdrawal by Subject|4|||
131076445|NCT00496626|471912187|FG000|Overall Study|Relocated|0|||
131076446|NCT00496626|471912188|FG001|Overall Study|Relocated|1|||
131076447|NCT00853229|471912190|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
131076448|NCT00853229|471912191|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
131076449|NCT03201900|471912192|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
131076450|NCT03201900|471912192|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
131076451|NCT03201900|471912192|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
131076452|NCT03201900|471912192|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
131076453|NCT03201900|471912192|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
131076454|NCT03201900|471912192|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
131076455|NCT03201900|471912192|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
131076456|NCT03201900|471912192|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
131076457|NCT03201900|471912192|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
131076458|NCT03201900|471912192|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
131076459|NCT03201900|471912192|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
131076460|NCT03201900|471912192|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
131076461|NCT03201900|471912192|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
131076462|NCT01233999|471912198|FG000|Overall Study|Withdrawal by Subject|1|||
131076463|NCT01233999|471912198|FG000|Overall Study|Lost to Follow-up|1|||
131076464|NCT01167192|471912199|FG000|Overall Study|Adverse Event|1|||
131076465|NCT01167192|471912199|FG000|Overall Study|Death|1|||
131076466|NCT01167192|471912199|FG000|Overall Study|Withdrawal by Subject|1|||
131076467|NCT01167192|471912199|FG000|Overall Study|Insurance denial|1|||
131076468|NCT00129649|471912205|FG000|Overall Study|Withdrawal by Subject|76|||
131076469|NCT00129649|471912206|FG001|Overall Study|Withdrawal by Subject|65|||
131076470|NCT01710800|471912207|FG000|Overall Study|Withdrawal by Subject|21|||
131076471|NCT01710800|471912207|FG000|Overall Study|Protocol Violation|1|||
130725009|NCT04933968|470619167|FG004|Overall Study|Sponsor terminated study|2|||
131076472|NCT00511797|471912208|FG000|Overall Study|Adverse Event|1|||
131076473|NCT00511797|471912209|FG001|Overall Study|Adverse Event|2|||
131076474|NCT00511797|471912210|FG002|Overall Study|Adverse Event|2|||
131076475|NCT00511797|471912211|FG003|Overall Study|Adverse Event|2|||
131076476|NCT00511797|471912208|FG000|Overall Study|Lost to Follow-up|1|||
131076477|NCT00511797|471912209|FG001|Overall Study|Lost to Follow-up|0|||
131076478|NCT00511797|471912210|FG002|Overall Study|Lost to Follow-up|0|||
131076479|NCT00511797|471912211|FG003|Overall Study|Lost to Follow-up|1|||
131076480|NCT00511797|471912208|FG000|Overall Study|Pregnancy|0|||
131076481|NCT00511797|471912209|FG001|Overall Study|Pregnancy|0|||
131076482|NCT00511797|471912210|FG002|Overall Study|Pregnancy|0|||
131076483|NCT00511797|471912211|FG003|Overall Study|Pregnancy|1|||
131076484|NCT00511797|471912208|FG000|Overall Study|Protocol Violation|0|||
131076485|NCT00511797|471912209|FG001|Overall Study|Protocol Violation|2|||
131076486|NCT00511797|471912210|FG002|Overall Study|Protocol Violation|2|||
131076487|NCT00511797|471912211|FG003|Overall Study|Protocol Violation|3|||
131076488|NCT00511797|471912208|FG000|Overall Study|Withdrawal by Subject|3|||
131076489|NCT00511797|471912209|FG001|Overall Study|Withdrawal by Subject|3|||
131138535|NCT00725075|472132851|FG002|Overall Study|Protocol Violation|1|||
131138536|NCT00725075|472132849|FG000|Overall Study|Lost to Follow-up|1|||
131138537|NCT00725075|472132850|FG001|Overall Study|Lost to Follow-up|0|||
130725010|NCT04933968|470619168|FG005|Overall Study|Sponsor terminated study|0|||
131076490|NCT00511797|471912210|FG002|Overall Study|Withdrawal by Subject|4|||
131076491|NCT00511797|471912211|FG003|Overall Study|Withdrawal by Subject|2|||
131076492|NCT00511797|471912208|FG000|Overall Study|Never dispensed|1|||
131076493|NCT00511797|471912209|FG001|Overall Study|Never dispensed|0|||
131138538|NCT00725075|472132851|FG002|Overall Study|Lost to Follow-up|0|||
130725011|NCT04933968|470619163|FG000|Overall Study|Other|0|||
131076494|NCT00511797|471912210|FG002|Overall Study|Never dispensed|1|||
131076495|NCT00511797|471912211|FG003|Overall Study|Never dispensed|3|||
131076496|NCT00511797|471912208|FG000|Overall Study|Study drug not taken|0|||
131076497|NCT00511797|471912209|FG001|Overall Study|Study drug not taken|1|||
131076498|NCT00511797|471912210|FG002|Overall Study|Study drug not taken|0|||
131076499|NCT00511797|471912211|FG003|Overall Study|Study drug not taken|1|||
131076500|NCT00511797|471912208|FG000|Overall Study|Partially missing diary|0|||
131138539|NCT00725075|472132849|FG000|Overall Study|Withdrawal by Subject|4|||
131076501|NCT00511797|471912209|FG001|Overall Study|Partially missing diary|0|||
131076502|NCT00511797|471912210|FG002|Overall Study|Partially missing diary|1|||
131076503|NCT00511797|471912211|FG003|Overall Study|Partially missing diary|0|||
131076504|NCT00511797|471912208|FG000|Overall Study|Other (moving etc)|1|||
131076505|NCT00511797|471912209|FG001|Overall Study|Other (moving etc)|0|||
131076506|NCT00511797|471912210|FG002|Overall Study|Other (moving etc)|1|||
131076507|NCT00511797|471912211|FG003|Overall Study|Other (moving etc)|2|||
131076508|NCT03974100|471912212|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
131076509|NCT03974100|471912213|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
131076510|NCT03974100|471912214|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
131076511|NCT03974100|471912215|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
131138540|NCT00725075|472132850|FG001|Overall Study|Withdrawal by Subject|5|||
131138541|NCT00725075|472132851|FG002|Overall Study|Withdrawal by Subject|4|||
131138542|NCT00725075|472132849|FG000|Overall Study|Adverse Event|2|||
131138543|NCT00725075|472132850|FG001|Overall Study|Adverse Event|1|||
131138544|NCT00725075|472132851|FG002|Overall Study|Adverse Event|1|||
131138545|NCT00725075|472132849|FG000|Overall Study|Worsening of Disease|2|||
131138546|NCT00725075|472132850|FG001|Overall Study|Worsening of Disease|1|||
131138547|NCT00725075|472132851|FG002|Overall Study|Worsening of Disease|2|||
131138548|NCT00725075|472132849|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
131138549|NCT00725075|472132850|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
131138550|NCT00725075|472132851|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
131138551|NCT00725075|472132849|FG000|Overall Study|Other|1|||
131138552|NCT00725075|472132850|FG001|Overall Study|Other|0|||
131138553|NCT00725075|472132851|FG002|Overall Study|Other|0|||
131138554|NCT01298492|472132852|FG000|Overall Study|Death|2|||
131138555|NCT01298492|472132852|FG000|Overall Study|Insufficient Clinical Response|22|||
131138556|NCT01298492|472132852|FG000|Overall Study|Lost to Follow-up|12|||
131138557|NCT01298492|472132852|FG000|Overall Study|Withdrawal by Subject|47|||
131138558|NCT01298492|472132852|FG000|Overall Study|Other (Unspecified)|7|||
131138559|NCT01298492|472132852|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
131138560|NCT01298492|472132852|FG000|Overall Study|Protocol Violation|2|||
131138561|NCT01298492|472132852|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
131138562|NCT01298492|472132852|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
131138563|NCT03984305|472132853|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
131138564|NCT03984305|472132854|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
131138565|NCT03984305|472132853|FG000|Overall Study|Withdrawal by Subject|3|||
131138566|NCT03984305|472132854|FG001|Overall Study|Withdrawal by Subject|3|||
131138567|NCT03984305|472132853|FG000|Overall Study|Lost to Follow-up|1|||
131138568|NCT03984305|472132854|FG001|Overall Study|Lost to Follow-up|0|||
131138569|NCT00352105|472132855|FG000|Overall Study|Death|5|||
131138570|NCT00352105|472132855|FG000|Overall Study|Withdrawal by Subject|5|||
131138571|NCT00352105|472132855|FG000|Overall Study|Lack of Efficacy|9|||
131138572|NCT00352105|472132855|FG000|Overall Study|Adverse Event|19|||
131138573|NCT00352105|472132855|FG000|Overall Study|Protocol Violation|2|||
131138574|NCT00087646|472132856|FG000|Overall Study|Adverse Event|37|||
131138575|NCT00087646|472132857|FG001|Overall Study|Adverse Event|6|||
131138576|NCT00087646|472132858|FG002|Overall Study|Adverse Event|18|||
131138577|NCT00087646|472132859|FG003|Overall Study|Adverse Event|20|||
131138578|NCT00087646|472132856|FG000|Overall Study|Death|0|||
131138579|NCT00087646|472132857|FG001|Overall Study|Death|1|||
131138580|NCT00087646|472132858|FG002|Overall Study|Death|0|||
131138581|NCT00087646|472132859|FG003|Overall Study|Death|0|||
131138582|NCT00087646|472132856|FG000|Overall Study|Withdrawal by Subject|6|||
131138583|NCT00087646|472132857|FG001|Overall Study|Withdrawal by Subject|1|||
131138584|NCT00087646|472132858|FG002|Overall Study|Withdrawal by Subject|2|||
131138585|NCT00087646|472132859|FG003|Overall Study|Withdrawal by Subject|2|||
131138586|NCT00087646|472132856|FG000|Overall Study|Insufficient therapeutic response|64|||
131138587|NCT00087646|472132857|FG001|Overall Study|Insufficient therapeutic response|24|||
131138588|NCT00087646|472132858|FG002|Overall Study|Insufficient therapeutic response|38|||
131138589|NCT00087646|472132859|FG003|Overall Study|Insufficient therapeutic response|51|||
131138590|NCT00087646|472132856|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
131138591|NCT00087646|472132857|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
131138592|NCT00087646|472132858|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
131138593|NCT00087646|472132859|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
131138594|NCT00087646|472132856|FG000|Overall Study|Failure to Return|5|||
131076512|NCT03974100|471912216|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
131076513|NCT03974100|471912212|FG000|TP1 - Day 1 to Week 52|Death|1|||
131076514|NCT03974100|471912213|FG001|TP1 - Day 1 to Week 52|Death|0|||
131231238|NCT01590433|472473261|FG001|Overall Study|Lost to Follow-up|8|||
131076515|NCT03974100|471912214|FG002|TP1 - Day 1 to Week 52|Death|0|||
131076516|NCT03974100|471912215|FG003|TP1 - Day 1 to Week 52|Death|0|||
131076517|NCT03974100|471912216|FG004|TP1 - Day 1 to Week 52|Death|0|||
131076518|NCT03974100|471912212|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
131076519|NCT03974100|471912213|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
131076520|NCT03974100|471912214|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
131076521|NCT03974100|471912215|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
131076522|NCT03974100|471912216|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
131076523|NCT03974100|471912212|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
131076524|NCT03974100|471912213|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
131076525|NCT03974100|471912214|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
131076526|NCT03974100|471912215|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
131076527|NCT03974100|471912216|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
131076528|NCT03974100|471912212|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
131076529|NCT03974100|471912213|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
131076530|NCT03974100|471912214|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
131076531|NCT03974100|471912215|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
131076532|NCT03974100|471912216|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
131076533|NCT03974100|471912212|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
131076534|NCT03974100|471912213|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
131076535|NCT03974100|471912214|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
131076536|NCT03974100|471912215|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
131138595|NCT00087646|472132857|FG001|Overall Study|Failure to Return|2|||
131138596|NCT00087646|472132858|FG002|Overall Study|Failure to Return|2|||
131138597|NCT00087646|472132859|FG003|Overall Study|Failure to Return|3|||
131138598|NCT00087646|472132856|FG000|Overall Study|Administrative/Other|6|||
131138599|NCT00087646|472132857|FG001|Overall Study|Administrative/Other|1|||
131138600|NCT00087646|472132858|FG002|Overall Study|Administrative/Other|1|||
131138601|NCT00087646|472132859|FG003|Overall Study|Administrative/Other|2|||
131138602|NCT00087646|472132856|FG000|Overall Study|Other Protocol Violation|3|||
131138603|NCT00087646|472132857|FG001|Overall Study|Other Protocol Violation|1|||
131138604|NCT00087646|472132858|FG002|Overall Study|Other Protocol Violation|0|||
131138605|NCT00087646|472132859|FG003|Overall Study|Other Protocol Violation|0|||
131138606|NCT00087646|472132856|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
131138607|NCT00087646|472132857|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
131138608|NCT00087646|472132858|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
131138609|NCT00087646|472132859|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
131138610|NCT01235962|472132860|FG000|Overall Study|Withdrawal by Subject|20|||
131138611|NCT01235962|472132861|FG001|Overall Study|Withdrawal by Subject|19|||
131138612|NCT01235962|472132862|FG002|Overall Study|Withdrawal by Subject|62|||
131138613|NCT01235962|472132863|FG003|Overall Study|Withdrawal by Subject|49|||
131138614|NCT01235962|472132860|FG000|Overall Study|Lost to Follow-up|21|||
131138615|NCT01235962|472132861|FG001|Overall Study|Lost to Follow-up|16|||
131138616|NCT01235962|472132862|FG002|Overall Study|Lost to Follow-up|47|||
131138617|NCT01235962|472132863|FG003|Overall Study|Lost to Follow-up|32|||
131138618|NCT01235962|472132860|FG000|Overall Study|Physician Decision|5|||
131138619|NCT01235962|472132861|FG001|Overall Study|Physician Decision|0|||
131138620|NCT01235962|472132862|FG002|Overall Study|Physician Decision|9|||
131138621|NCT01235962|472132863|FG003|Overall Study|Physician Decision|5|||
131138622|NCT02902120|472132865|FG000|Overall Study|Lack of Efficacy|1|||
131138623|NCT01353703|472132866|FG000|Overall Study|Migrated/moved from study area|1|||
131138624|NCT01353703|472132867|FG001|Overall Study|Migrated/moved from study area|0|||
131138625|NCT01405053|472132873|FG000|Overall Study|Adverse Event|3|||
131138626|NCT01405053|472132874|FG001|Overall Study|Adverse Event|0|||
131138627|NCT01405053|472132873|FG000|Overall Study|Lost to Follow-up|0|||
131138628|NCT01405053|472132874|FG001|Overall Study|Lost to Follow-up|1|||
131138629|NCT01405053|472132873|FG000|Overall Study|Participant choice|2|||
131138630|NCT01405053|472132874|FG001|Overall Study|Participant choice|1|||
131138631|NCT01405053|472132873|FG000|Overall Study|Inadequate therapeutic effect|2|||
131138632|NCT01405053|472132874|FG001|Overall Study|Inadequate therapeutic effect|1|||
131138633|NCT01405053|472132873|FG000|Overall Study|Withdrawal by Subject|3|||
131138634|NCT01405053|472132874|FG001|Overall Study|Withdrawal by Subject|4|||
131138635|NCT01405053|472132873|FG000|Overall Study|Other|0|||
131138636|NCT01405053|472132874|FG001|Overall Study|Other|1|||
131138637|NCT02175680|472132880|FG000|Overall Study|non-compliance|1|||
131138638|NCT02175680|472132880|FG000|Overall Study|other non-medical reason|1|||
131138639|NCT01913483|472132885|FG000|Overall Study|Withdrawal by Subject|1|||
131138640|NCT01913483|472132886|FG001|Overall Study|Withdrawal by Subject|2|||
131138641|NCT01913483|472132885|FG000|Overall Study|Lost to Follow-up|6|||
131138642|NCT01913483|472132886|FG001|Overall Study|Lost to Follow-up|3|||
131138643|NCT01913483|472132885|FG000|Overall Study|Death|14|||
131138644|NCT01913483|472132886|FG001|Overall Study|Death|17|||
131138645|NCT02302963|472132887|FG000|Overall Study|Withdrawal by Subject|2|||
130725012|NCT04933968|470619164|FG001|Overall Study|Other|0|||
130725013|NCT04933968|470619165|FG002|Overall Study|Other|0|||
131138646|NCT02302963|472132888|FG001|Overall Study|Withdrawal by Subject|1|||
130725014|NCT04933968|470619166|FG003|Overall Study|Other|1|||
131076537|NCT03974100|471912216|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
131076538|NCT03974100|471912212|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
131076539|NCT03974100|471912213|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
131076540|NCT03974100|471912214|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
131076541|NCT03974100|471912215|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
131076542|NCT03974100|471912216|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
131076543|NCT02024750|471912219|FG000|Overall Study|Withdrawal by Subject|2|||
131076544|NCT02024750|471912220|FG001|Overall Study|Withdrawal by Subject|1|||
131076545|NCT04814992|471912231|FG000|Overall Study|Withdrawal by Subject|6|||
131076546|NCT04814992|471912232|FG001|Overall Study|Withdrawal by Subject|3|||
131076547|NCT04814992|471912231|FG000|Overall Study|Lost to Follow-up|1|||
131076548|NCT04814992|471912232|FG001|Overall Study|Lost to Follow-up|4|||
131076549|NCT00691678|471912233|FG000|Overall Study|Adverse Event|5|||
131076550|NCT00691678|471912233|FG000|Overall Study|life events, pain|11|||
131076551|NCT01831726|471912234|FG000|Overall Study|Adverse Event|16|||
131076552|NCT01831726|471912234|FG000|Overall Study|Death|7|||
131076553|NCT01831726|471912234|FG000|Overall Study|Disease Progression|49|||
131076554|NCT01831726|471912234|FG000|Overall Study|Physician Decision|1|||
131076555|NCT01831726|471912234|FG000|Overall Study|Subject/guardian decision|7|||
131076556|NCT03049306|471912235|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
131076557|NCT03049306|471912236|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
131076558|NCT03151551|471912237|FG000|Open-Label Treatment Period|Adverse Event|0|||
131076559|NCT03151551|471912238|FG001|Open-Label Treatment Period|Adverse Event|2|||
131076560|NCT03151551|471912237|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
131076561|NCT03151551|471912238|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
131076562|NCT03151551|471912237|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
131076563|NCT03151551|471912238|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
131076564|NCT03151551|471912237|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
131076565|NCT03151551|471912238|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
131076566|NCT03151551|471912237|FG000|Open-Label Treatment Period|Physician Decision|3|||
131076567|NCT03151551|471912238|FG001|Open-Label Treatment Period|Physician Decision|0|||
131076568|NCT03151551|471912237|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
131076569|NCT03151551|471912238|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
131076570|NCT03151551|471912237|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
131076571|NCT03151551|471912238|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
131076572|NCT03151551|471912237|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
131076573|NCT03151551|471912238|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
131076574|NCT03151551|471912237|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
131076575|NCT03151551|471912238|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
131076576|NCT03151551|471912237|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
131076577|NCT03151551|471912238|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
131076578|NCT00514813|471912243|FG000|Overall Study|Study terminated|14|||
131076579|NCT00514813|471912244|FG001|Overall Study|Study terminated|74|||
131076580|NCT00514813|471912245|FG002|Overall Study|Study terminated|40|||
131076581|NCT00514813|471912246|FG003|Overall Study|Study terminated|2|||
131076582|NCT00514813|471912243|FG000|Overall Study|Adverse Event|0|||
131076583|NCT00514813|471912244|FG001|Overall Study|Adverse Event|2|||
131076584|NCT00514813|471912245|FG002|Overall Study|Adverse Event|2|||
131076585|NCT00514813|471912246|FG003|Overall Study|Adverse Event|0|||
131076586|NCT00514813|471912243|FG000|Overall Study|Protocol Violation|1|||
131076587|NCT00514813|471912244|FG001|Overall Study|Protocol Violation|0|||
131076588|NCT00514813|471912245|FG002|Overall Study|Protocol Violation|0|||
131076589|NCT00514813|471912246|FG003|Overall Study|Protocol Violation|0|||
131076590|NCT00514813|471912243|FG000|Overall Study|Withdrawal by Subject|0|||
131076591|NCT00514813|471912244|FG001|Overall Study|Withdrawal by Subject|1|||
131076592|NCT00514813|471912245|FG002|Overall Study|Withdrawal by Subject|0|||
131076593|NCT00514813|471912246|FG003|Overall Study|Withdrawal by Subject|0|||
131076594|NCT00514813|471912243|FG000|Overall Study|Lack of Efficacy|0|||
131076595|NCT00514813|471912244|FG001|Overall Study|Lack of Efficacy|1|||
131076596|NCT00514813|471912245|FG002|Overall Study|Lack of Efficacy|0|||
131076597|NCT00514813|471912246|FG003|Overall Study|Lack of Efficacy|0|||
131076598|NCT00514813|471912243|FG000|Overall Study|Kidney transplant|0|||
131076599|NCT00514813|471912244|FG001|Overall Study|Kidney transplant|6|||
131076600|NCT00514813|471912245|FG002|Overall Study|Kidney transplant|2|||
131076601|NCT00514813|471912246|FG003|Overall Study|Kidney transplant|0|||
131076602|NCT00514813|471912243|FG000|Overall Study|Death|0|||
131076603|NCT00514813|471912244|FG001|Overall Study|Death|2|||
131076604|NCT00514813|471912245|FG002|Overall Study|Death|3|||
131076605|NCT00514813|471912246|FG003|Overall Study|Death|2|||
131076606|NCT02979613|471912247|FG000|Double-Blind Phase|Withdrew Consent|2|||
131076607|NCT02979613|471912248|FG001|Double-Blind Phase|Withdrew Consent|4|||
131076608|NCT02979613|471912247|FG000|Double-Blind Phase|Pregnancy|2|||
131076609|NCT02979613|471912248|FG001|Double-Blind Phase|Pregnancy|2|||
131076610|NCT02979613|471912247|FG000|Double-Blind Phase|Adverse Event|2|||
131076611|NCT02979613|471912248|FG001|Double-Blind Phase|Adverse Event|0|||
131076612|NCT02979613|471912247|FG000|Double-Blind Phase|Lost to Follow-up|1|||
131231239|NCT01590433|472473260|FG000|Overall Study|Withdrawal by Subject|21|||
131231240|NCT01590433|472473261|FG001|Overall Study|Withdrawal by Subject|11|||
131231241|NCT01590433|472473260|FG000|Overall Study|Adverse Event|11|||
131231242|NCT01590433|472473261|FG001|Overall Study|Adverse Event|3|||
131231243|NCT00555009|472473262|FG000|Overall Study|Withdrawal by Subject|0|||
131231244|NCT00555009|472473263|FG001|Overall Study|Withdrawal by Subject|1|||
131231245|NCT00555009|472473262|FG000|Overall Study|Terminated by Sponsor|2|||
131231246|NCT00555009|472473263|FG001|Overall Study|Terminated by Sponsor|5|||
131231247|NCT02058628|472473264|FG000|Overall Study|Adverse Event|1|||
131231248|NCT02058628|472473265|FG001|Overall Study|Adverse Event|0|||
131231249|NCT02058628|472473264|FG000|Overall Study|Withdrawal by Subject|2|||
131231250|NCT02058628|472473265|FG001|Overall Study|Withdrawal by Subject|2|||
131231251|NCT02058628|472473264|FG000|Overall Study|Lost to Follow-up|2|||
131231252|NCT02058628|472473265|FG001|Overall Study|Lost to Follow-up|4|||
131231253|NCT02058628|472473264|FG000|Overall Study|Not in time schedule|0|||
131231254|NCT02058628|472473265|FG001|Overall Study|Not in time schedule|1|||
131231255|NCT02058628|472473264|FG000|Overall Study|The visit date was not in timeline|0|||
131231256|NCT02058628|472473265|FG001|Overall Study|The visit date was not in timeline|1|||
131231257|NCT02058628|472473264|FG000|Overall Study|A lot of time for study for participant|1|||
131231258|NCT02058628|472473265|FG001|Overall Study|A lot of time for study for participant|0|||
131231259|NCT02058628|472473264|FG000|Overall Study|Non compliance|1|||
131231260|NCT02058628|472473265|FG001|Overall Study|Non compliance|0|||
131231261|NCT03355742|472473266|FG000|Overall Study|Lost to Follow-up|4|||
131076613|NCT02979613|471912248|FG001|Double-Blind Phase|Lost to Follow-up|1|||
131076614|NCT02979613|471912247|FG000|Double-Blind Phase|Protocol Violation|1|||
131076615|NCT02979613|471912248|FG001|Double-Blind Phase|Protocol Violation|1|||
131076616|NCT02979613|471912247|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
131076617|NCT02979613|471912248|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
131076618|NCT02979613|471912247|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
131076619|NCT02979613|471912248|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
131076620|NCT02979613|471912247|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
131076621|NCT02979613|471912248|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
131231262|NCT03355742|472473266|FG000|Overall Study|Withdrawal by Subject|29|||
131231263|NCT03355742|472473266|FG000|Overall Study|Physician Decision|6|||
131231264|NCT03355742|472473266|FG000|Overall Study|Death|55|||
131231265|NCT03355742|472473266|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
131231266|NCT04527471|472473269|FG000|Overall Study|Adverse Event|1|||
131231267|NCT04527471|472473270|FG001|Overall Study|Adverse Event|0|||
131231268|NCT04527471|472473269|FG000|Overall Study|Lost to Follow-up|1|||
131231269|NCT04527471|472473270|FG001|Overall Study|Lost to Follow-up|0|||
130725015|NCT04933968|470619167|FG004|Overall Study|Other|0|||
130725016|NCT04933968|470619168|FG005|Overall Study|Other|0|||
130725017|NCT04933968|470619163|FG000|Overall Study|Missing|1|||
130725018|NCT04933968|470619164|FG001|Overall Study|Missing|3|||
130725019|NCT04933968|470619165|FG002|Overall Study|Missing|2|||
130725020|NCT04933968|470619166|FG003|Overall Study|Missing|1|||
131076622|NCT02979613|471912247|FG000|Open-Label Extension (OLE) Phase|Death|0|||
131076623|NCT02979613|471912248|FG001|Open-Label Extension (OLE) Phase|Death|1|||
131076624|NCT02979613|471912247|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
130725021|NCT04933968|470619167|FG004|Overall Study|Missing|1|||
130725022|NCT04933968|470619168|FG005|Overall Study|Missing|0|||
131076625|NCT02979613|471912248|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
131076626|NCT01878383|471913933|FG000|Overall Study|Lost to Follow-up|0|||
130725023|NCT01724489|470619169|FG000|Overall Study|Adverse Event|8|||
131076627|NCT01878383|471913934|FG001|Overall Study|Lost to Follow-up|1499|||
131076628|NCT03475056|471913935|FG000|Overall Study|Lost to Follow-up|0|||
130725024|NCT01724489|470619170|FG001|Overall Study|Adverse Event|3|||
131076629|NCT03475056|471913936|FG001|Overall Study|Lost to Follow-up|1|||
131076630|NCT03475056|471913935|FG000|Overall Study|Moved from Area|0|||
131076631|NCT03475056|471913936|FG001|Overall Study|Moved from Area|2|||
131076632|NCT01932762|471913939|FG000|Overall Study|Withdrawal by Subject|1|||
131076633|NCT01932762|471913940|FG001|Overall Study|Withdrawal by Subject|2|||
131076634|NCT01932762|471913941|FG002|Overall Study|Withdrawal by Subject|0|||
131076635|NCT01932762|471913942|FG003|Overall Study|Withdrawal by Subject|0|||
131076636|NCT01932762|471913939|FG000|Overall Study|Lost to Follow-up|4|||
131076637|NCT01932762|471913940|FG001|Overall Study|Lost to Follow-up|0|||
131076638|NCT01932762|471913941|FG002|Overall Study|Lost to Follow-up|0|||
131076639|NCT01932762|471913942|FG003|Overall Study|Lost to Follow-up|1|||
131076640|NCT01932762|471913939|FG000|Overall Study|Physician Decision|1|||
131076641|NCT01932762|471913940|FG001|Overall Study|Physician Decision|0|||
131076642|NCT01932762|471913941|FG002|Overall Study|Physician Decision|0|||
131076643|NCT01932762|471913942|FG003|Overall Study|Physician Decision|0|||
131076644|NCT00664105|471913943|FG000|Overall Study|Death|3|||
131076645|NCT00664105|471913943|FG000|Overall Study|Withdrawal by Subject|5|||
131076646|NCT00664105|471913943|FG000|Overall Study|Adverse Event|9|||
131076647|NCT00664105|471913943|FG000|Overall Study|Disease progression|7|||
130725025|NCT01724489|470619169|FG000|Overall Study|Surgery, medication|1|||
130725026|NCT01724489|470619170|FG001|Overall Study|Surgery, medication|1|||
131076648|NCT01172639|471913946|FG000|Overall Study|Death|1|||
131076649|NCT01172639|471913947|FG001|Overall Study|Death|1|||
131076650|NCT01172639|471913948|FG002|Overall Study|Death|0|||
131076651|NCT01172639|471913949|FG003|Overall Study|Death|0|||
131076652|NCT01172639|471913950|FG004|Overall Study|Death|0|||
131076653|NCT01172639|471913946|FG000|Overall Study|Lost to Follow-up|9|||
131076654|NCT01172639|471913947|FG001|Overall Study|Lost to Follow-up|7|||
131076655|NCT01172639|471913948|FG002|Overall Study|Lost to Follow-up|11|||
131076656|NCT01172639|471913949|FG003|Overall Study|Lost to Follow-up|6|||
131076657|NCT01172639|471913950|FG004|Overall Study|Lost to Follow-up|6|||
131076658|NCT01172639|471913946|FG000|Overall Study|Withdrawal by Subject|3|||
131076659|NCT01172639|471913947|FG001|Overall Study|Withdrawal by Subject|3|||
131076660|NCT01172639|471913948|FG002|Overall Study|Withdrawal by Subject|5|||
131076661|NCT01172639|471913949|FG003|Overall Study|Withdrawal by Subject|5|||
131076662|NCT01172639|471913950|FG004|Overall Study|Withdrawal by Subject|0|||
131076663|NCT02172950|471913951|FG000|Overall Study|Physician Decision|3|||
131076664|NCT02172950|471913952|FG001|Overall Study|Physician Decision|3|||
131076665|NCT02172950|471913951|FG000|Overall Study|Lack of Efficacy|1|||
131076666|NCT02172950|471913952|FG001|Overall Study|Lack of Efficacy|0|||
131076667|NCT02172950|471913951|FG000|Overall Study|Adverse Event|4|||
131076668|NCT02172950|471913952|FG001|Overall Study|Adverse Event|1|||
131076669|NCT02172950|471913951|FG000|Overall Study|Withdrawal by Subject|10|||
131076670|NCT02172950|471913952|FG001|Overall Study|Withdrawal by Subject|0|||
131076671|NCT02172950|471913951|FG000|Overall Study|Protocol Violation|1|||
131076672|NCT02172950|471913952|FG001|Overall Study|Protocol Violation|0|||
131076673|NCT02172950|471913951|FG000|Overall Study|Lost to Follow-up|1|||
131076674|NCT02172950|471913952|FG001|Overall Study|Lost to Follow-up|0|||
131076675|NCT02172950|471913951|FG000|Overall Study|Death|1|||
131076676|NCT02172950|471913952|FG001|Overall Study|Death|0|||
131076677|NCT02172950|471913951|FG000|Overall Study|Patient traveling|1|||
131076678|NCT02172950|471913952|FG001|Overall Study|Patient traveling|0|||
131076679|NCT02172950|471913951|FG000|Overall Study|Patient went to other country|1|||
131076680|NCT02172950|471913952|FG001|Overall Study|Patient went to other country|0|||
131076681|NCT02172950|471913951|FG000|Overall Study|Patient relocated overseas|1|||
131076682|NCT02172950|471913952|FG001|Overall Study|Patient relocated overseas|1|||
131076683|NCT02172950|471913951|FG000|Overall Study|Patient moving|1|||
131076684|NCT02172950|471913952|FG001|Overall Study|Patient moving|0|||
131076685|NCT00469456|471913953|FG000|Overall Study|Adverse Event|4|||
131076686|NCT00469456|471913954|FG001|Overall Study|Adverse Event|3|||
131076687|NCT00469456|471913953|FG000|Overall Study|Protocol Violation|1|||
131076688|NCT00469456|471913954|FG001|Overall Study|Protocol Violation|0|||
131076689|NCT00469456|471913953|FG000|Overall Study|Withdrawal by Subject|4|||
131076690|NCT00469456|471913954|FG001|Overall Study|Withdrawal by Subject|1|||
131076691|NCT00611715|471913955|FG000|Overall Study|Disease Progression|24|||
131076692|NCT00611715|471913956|FG001|Overall Study|Disease Progression|4|||
131076693|NCT00611715|471913955|FG000|Overall Study|Withdrawal by Subject|5|||
131076694|NCT00611715|471913956|FG001|Overall Study|Withdrawal by Subject|1|||
131076695|NCT00611715|471913955|FG000|Overall Study|Adverse Event|9|||
131076696|NCT00611715|471913956|FG001|Overall Study|Adverse Event|1|||
131076697|NCT00611715|471913955|FG000|Overall Study|Death|1|||
131076698|NCT00611715|471913956|FG001|Overall Study|Death|0|||
131076699|NCT00611715|471913955|FG000|Overall Study|two patients are still on treatment|2|||
131076700|NCT00611715|471913956|FG001|Overall Study|two patients are still on treatment|0|||
131076701|NCT00107978|471913959|FG000|Overall Study|Adverse Event|1|||
131076702|NCT00107978|471913960|FG001|Overall Study|Adverse Event|5|||
131076703|NCT00107978|471913959|FG000|Overall Study|Death|3|||
131076704|NCT00107978|471913960|FG001|Overall Study|Death|3|||
131076705|NCT00107978|471913959|FG000|Overall Study|Lost to Follow-up|20|||
131076706|NCT00107978|471913960|FG001|Overall Study|Lost to Follow-up|28|||
131076707|NCT00107978|471913959|FG000|Overall Study|Withdrawal by Subject|4|||
131076708|NCT00107978|471913960|FG001|Overall Study|Withdrawal by Subject|9|||
131076709|NCT00107978|471913959|FG000|Overall Study|Protocol Violation|0|||
131076710|NCT00107978|471913960|FG001|Overall Study|Protocol Violation|1|||
131076711|NCT00107978|471913959|FG000|Overall Study|Other|5|||
130725027|NCT01724489|470619169|FG000|Overall Study|Lost to Follow-up|1|||
130725028|NCT01724489|470619170|FG001|Overall Study|Lost to Follow-up|2|||
130725029|NCT01724489|470619169|FG000|Overall Study|Withdrawal by Subject|6|||
131076712|NCT00107978|471913960|FG001|Overall Study|Other|4|||
131076713|NCT02669407|471913963|FG000|Overall Study|Physician Decision|3|||
131076714|NCT00727415|471913964|FG000|Phase I|Dose Limiting Toxicity|2|||
130725030|NCT01724489|470619170|FG001|Overall Study|Withdrawal by Subject|6|||
131076715|NCT01874665|471913968|FG000|Overall Study|Adverse Event|6|||
131076716|NCT01874665|471913969|FG001|Overall Study|Adverse Event|2|||
131076717|NCT01874665|471913968|FG000|Overall Study|Withdrawal by Subject|4|||
130725031|NCT04576923|470619171|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
131076718|NCT01874665|471913969|FG001|Overall Study|Withdrawal by Subject|1|||
131076719|NCT01874665|471913968|FG000|Overall Study|Physician Decision|3|||
131231270|NCT01506323|472473278|FG000|Overall Study|Lost to Follow-up|5|||
131231271|NCT01506323|472473279|FG001|Overall Study|Lost to Follow-up|4|||
131231272|NCT01506323|472473278|FG000|Overall Study|Withdrawal by Subject|4|||
131231273|NCT01506323|472473279|FG001|Overall Study|Withdrawal by Subject|4|||
131231274|NCT01506323|472473278|FG000|Overall Study|Lack of Efficacy|1|||
131231275|NCT01506323|472473279|FG001|Overall Study|Lack of Efficacy|3|||
131231276|NCT01506323|472473278|FG000|Overall Study|Moved out of area|5|||
131231277|NCT01506323|472473279|FG001|Overall Study|Moved out of area|2|||
131231278|NCT01506323|472473278|FG000|Overall Study|Schedule or Transportation conflict|8|||
131231279|NCT01506323|472473279|FG001|Overall Study|Schedule or Transportation conflict|0|||
131231280|NCT01506323|472473278|FG000|Overall Study|Started another treatment|1|||
131076720|NCT01874665|471913969|FG001|Overall Study|Physician Decision|0|||
131076721|NCT01874665|471913968|FG000|Overall Study|Clinical Progressive Disease|4|||
131076722|NCT01874665|471913969|FG001|Overall Study|Clinical Progressive Disease|3|||
131076723|NCT01874665|471913968|FG000|Overall Study|Study Terminated by Sponsor|0|||
131076724|NCT01874665|471913969|FG001|Overall Study|Study Terminated by Sponsor|2|||
131076725|NCT01874665|471913968|FG000|Overall Study|Documented Progressive Disease|11|||
131076726|NCT01874665|471913969|FG001|Overall Study|Documented Progressive Disease|7|||
131076727|NCT01874665|471913968|FG000|Overall Study|Other|2|||
131076728|NCT01874665|471913969|FG001|Overall Study|Other|0|||
131076729|NCT00350298|471913970|FG000|Overall Study|Death|7|||
131076730|NCT00350298|471913971|FG001|Overall Study|Death|8|||
131076731|NCT00350298|471913970|FG000|Overall Study|Lost to Follow-up|1|||
131076732|NCT00350298|471913971|FG001|Overall Study|Lost to Follow-up|2|||
131076733|NCT00350298|471913970|FG000|Overall Study|Withdrawal by Subject|1|||
131076734|NCT00350298|471913971|FG001|Overall Study|Withdrawal by Subject|3|||
131076735|NCT03634839|471913972|FG000|First Intervention (2 Hours)|Adverse Event|0|||
131076736|NCT03634839|471913973|FG001|First Intervention (2 Hours)|Adverse Event|2|||
131076737|NCT02647788|471913974|FG000|Overall Study|Lost to Follow-up|13|||
131076738|NCT02647788|471913975|FG001|Overall Study|Lost to Follow-up|11|||
131076739|NCT02647788|471913974|FG000|Overall Study|Did not want opiate|0|||
131076740|NCT02647788|471913975|FG001|Overall Study|Did not want opiate|1|||
131076741|NCT02647788|471913974|FG000|Overall Study|Withdrawal by Subject|1|||
131076742|NCT02647788|471913975|FG001|Overall Study|Withdrawal by Subject|0|||
131076743|NCT02647788|471913974|FG000|Overall Study|Felt itchy with assigned medication|1|||
131076744|NCT02647788|471913975|FG001|Overall Study|Felt itchy with assigned medication|0|||
131076745|NCT02647788|471913974|FG000|Overall Study|Felt nauseous with assigned medication|1|||
131076746|NCT02647788|471913975|FG001|Overall Study|Felt nauseous with assigned medication|1|||
131076747|NCT02447432|471913978|FG000|Epoch 001|Adverse Event|1|||
131076748|NCT02447432|471913979|FG001|Epoch 001|Adverse Event|1|||
131076749|NCT02447432|471913978|FG000|Epoch 001|Withdrawal by Subject|0|||
131076750|NCT02447432|471913979|FG001|Epoch 001|Withdrawal by Subject|4|||
131076751|NCT02447432|471913978|FG000|Epoch 001|Migrated/moved from study area|3|||
131076752|NCT02447432|471913979|FG001|Epoch 001|Migrated/moved from study area|5|||
131076753|NCT02447432|471913978|FG000|Epoch 001|Lost to Follow-up|1|||
131076754|NCT02447432|471913979|FG001|Epoch 001|Lost to Follow-up|3|||
131076755|NCT03245619|471913985|FG000|Part A (Up to Day 22)|Physician Decision|4|||
131076756|NCT03245619|471913986|FG001|Part A (Up to Day 22)|Physician Decision|6|||
131076757|NCT03245619|471913987|FG002|Part A (Up to Day 22)|Physician Decision|6|||
131076758|NCT03245619|471913988|FG003|Part A (Up to Day 22)|Physician Decision|0|||
131076759|NCT03245619|471913989|FG004|Part A (Up to Day 22)|Physician Decision|0|||
131138647|NCT02302963|472132887|FG000|Overall Study|Steroid injection|0|||
131138648|NCT02302963|472132888|FG001|Overall Study|Steroid injection|1|||
131138649|NCT02302963|472132887|FG000|Overall Study|Physician Decision|1|||
131138650|NCT02302963|472132888|FG001|Overall Study|Physician Decision|0|||
131138651|NCT01816243|472132889|FG000|Overall Study|Adverse Event|6|||
131138652|NCT01816243|472132889|FG000|Overall Study|Lost to Follow-up|1|||
131138653|NCT01816243|472132889|FG000|Overall Study|Lack of Efficacy|1|||
131138654|NCT01816243|472132889|FG000|Overall Study|Not eligible for the study|1|||
131138655|NCT01816243|472132889|FG000|Overall Study|Amputation|3|||
131138656|NCT00915343|472132890|FG000|Part B - Open Label Period|Treatment switch|0|||
131138657|NCT00915343|472132891|FG001|Part B - Open Label Period|Treatment switch|0|||
131138658|NCT00915343|472132892|FG002|Part B - Open Label Period|Treatment switch|1|||
131138659|NCT00915343|472132890|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
131138660|NCT00915343|472132891|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
131138661|NCT00915343|472132892|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
131138662|NCT01920711|472132893|FG000|Overall Study|Death|347|||
131138663|NCT01920711|472132894|FG001|Overall Study|Death|356|||
131138664|NCT01920711|472132893|FG000|Overall Study|Lost to Follow-up|13|||
131138665|NCT01920711|472132894|FG001|Overall Study|Lost to Follow-up|14|||
131138666|NCT01920711|472132893|FG000|Overall Study|Withdrawal by Subject|4|||
131076760|NCT03245619|471913990|FG005|Part A (Up to Day 22)|Physician Decision|0|||
131076761|NCT03245619|471913991|FG006|Part A (Up to Day 22)|Physician Decision|0|||
131138667|NCT01920711|472132894|FG001|Overall Study|Withdrawal by Subject|3|||
131138668|NCT04811716|472132895|FG000|Overall Study|Withdrawal by Subject|2|||
131138669|NCT04811716|472132896|FG001|Overall Study|Withdrawal by Subject|0|||
131231281|NCT01506323|472473279|FG001|Overall Study|Started another treatment|0|||
131231282|NCT02891200|472473280|FG000|Overall Study|Lost to Follow-up|31|||
131231283|NCT02891200|472473281|FG001|Overall Study|Lost to Follow-up|36|||
131231284|NCT02891200|472473280|FG000|Overall Study|Death|10|||
131231285|NCT02891200|472473281|FG001|Overall Study|Death|9|||
131231286|NCT02891200|472473280|FG000|Overall Study|Withdrawal by Subject|1|||
131231287|NCT02891200|472473281|FG001|Overall Study|Withdrawal by Subject|4|||
131231288|NCT00988169|472473283|FG000|Overall Study|Withdrawal by Subject|1|||
131231289|NCT02710071|472473290|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
131231290|NCT02710071|472473291|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
131231291|NCT02710071|472473290|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
131231292|NCT02710071|472473291|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
131231293|NCT00613574|472473295|FG000|Overall Study|Adverse Event|3|||
131231294|NCT00613574|472473295|FG000|Overall Study|Lost to Follow-up|2|||
131231295|NCT00613574|472473295|FG000|Overall Study|Other|1|||
131231296|NCT01787825|472473298|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
131231297|NCT01787825|472473299|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
131231298|NCT01787825|472473298|FG000|Overall Study|Data Not Analyzable|5|||
131231299|NCT01787825|472473299|FG001|Overall Study|Data Not Analyzable|1|||
131231300|NCT00989261|472473304|FG000|Overall Study|Still in follow up|12|||
131231301|NCT00989261|472473305|FG001|Overall Study|Still in follow up|21|||
131231302|NCT00989261|472473304|FG000|Overall Study|Withdrawal by Subject|0|||
131231303|NCT00989261|472473305|FG001|Overall Study|Withdrawal by Subject|1|||
131231304|NCT00989261|472473304|FG000|Overall Study|Lost to Follow-up|3|||
131231305|NCT00989261|472473305|FG001|Overall Study|Lost to Follow-up|0|||
131231306|NCT01507896|472473308|FG000|Overall Study|Withdrawal by Subject|1|||
131231307|NCT01507896|472473308|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
131231308|NCT00585351|472473310|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
131231309|NCT00585351|472473311|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
131231310|NCT00585351|472473312|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
131231311|NCT00585351|472473313|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
131231312|NCT00585351|472473314|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
131231313|NCT00585351|472473315|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
131231314|NCT00585351|472473316|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
131231315|NCT00585351|472473317|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
131231316|NCT00585351|472473310|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
131231317|NCT00585351|472473311|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
131231318|NCT00585351|472473312|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
131231319|NCT00585351|472473313|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
131231320|NCT00585351|472473314|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
131231321|NCT00585351|472473315|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
131231322|NCT00585351|472473316|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
131231323|NCT00585351|472473317|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
131231324|NCT00585351|472473310|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
131231325|NCT00585351|472473311|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
131231326|NCT00585351|472473312|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
131231327|NCT00585351|472473313|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
131231328|NCT00585351|472473314|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
131231329|NCT00585351|472473315|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
131231330|NCT00585351|472473316|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
131231331|NCT00585351|472473317|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
131231332|NCT00585351|472473310|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
131231333|NCT00585351|472473311|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
131231334|NCT00585351|472473312|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131231335|NCT00585351|472473313|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131231336|NCT00585351|472473314|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131231337|NCT00585351|472473315|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131231338|NCT00585351|472473316|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131231339|NCT00585351|472473317|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
131231340|NCT00585351|472473310|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131231341|NCT00585351|472473311|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131231342|NCT00585351|472473312|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131231343|NCT00585351|472473313|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131231344|NCT00585351|472473314|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130779680|NCT02326272|470819497|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130779681|NCT02326272|470819498|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130779682|NCT02326272|470819499|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
131076762|NCT03245619|471913992|FG007|Part A (Up to Day 22)|Physician Decision|0|||
131138670|NCT01634555|472132897|FG000|Overall Study|Adverse Event|3|||
131138671|NCT01634555|472132897|FG000|Overall Study|Physician Decision|1|||
131138672|NCT01582308|472132898|FG000|Period 1|Withdrawal by Subject|0|||
131138673|NCT01582308|472132899|FG001|Period 1|Withdrawal by Subject|0|||
131138674|NCT01582308|472132900|FG002|Period 1|Withdrawal by Subject|0|||
131138675|NCT01582308|472132901|FG003|Period 1|Withdrawal by Subject|0|||
131138676|NCT01582308|472132902|FG004|Period 1|Withdrawal by Subject|0|||
131138677|NCT01582308|472132903|FG005|Period 1|Withdrawal by Subject|0|||
130725032|NCT02679235|470619174|FG000|Overall Study|Withdrawal by Subject|3|||
130725033|NCT02679235|470619174|FG000|Overall Study|Adverse Event|1|||
130725034|NCT00094861|470619175|FG000|Overall Study|Adverse Event|5|||
130725035|NCT00094861|470619176|FG001|Overall Study|Adverse Event|2|||
131076763|NCT03245619|471913993|FG008|Part A (Up to Day 22)|Physician Decision|0|||
131076764|NCT03245619|471913994|FG009|Part A (Up to Day 22)|Physician Decision|0|||
131076765|NCT03245619|471913995|FG010|Part A (Up to Day 22)|Physician Decision|0|||
131076766|NCT03245619|471913996|FG011|Part A (Up to Day 22)|Physician Decision|0|||
131076767|NCT03245619|471913997|FG012|Part A (Up to Day 22)|Physician Decision|0|||
131076768|NCT03245619|471913998|FG013|Part A (Up to Day 22)|Physician Decision|0|||
131076769|NCT03245619|471913999|FG014|Part A (Up to Day 22)|Physician Decision|0|||
131076770|NCT03245619|471914000|FG015|Part A (Up to Day 22)|Physician Decision|0|||
131076771|NCT03245619|471914001|FG016|Part A (Up to Day 22)|Physician Decision|0|||
131076772|NCT04962698|471914004|FG000|Motor Imagery|Technical difficulty|1|||
131076773|NCT04962698|471914005|FG001|Motor Imagery|Technical difficulty|0|||
131076774|NCT04962698|471914004|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
131076775|NCT04962698|471914005|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
131076776|NCT04962698|471914004|FG000|Kinesthetic MI|Technical difficulty|1|||
131076777|NCT04962698|471914005|FG001|Kinesthetic MI|Technical difficulty|0|||
131076778|NCT04962698|471914004|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
131076779|NCT04962698|471914005|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
131076780|NCT04962698|471914004|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
131076781|NCT04962698|471914005|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
131076782|NCT04962698|471914004|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
131076783|NCT04962698|471914005|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
131076784|NCT04962698|471914004|FG000|Virtual-hand Interaction|Technical difficulty|1|||
131076785|NCT04962698|471914005|FG001|Virtual-hand Interaction|Technical difficulty|0|||
131076786|NCT04962698|471914004|FG000|Robotic Action Observation|Technical difficulty|1|||
131076787|NCT04962698|471914005|FG001|Robotic Action Observation|Technical difficulty|0|||
131076788|NCT04962698|471914004|FG000|Rest|Technical difficulty|1|||
131076789|NCT04962698|471914005|FG001|Rest|Technical difficulty|0|||
131076790|NCT04962698|471914004|FG000|Rest|Exclusion criteria met after enrollment|0|||
131076791|NCT04962698|471914005|FG001|Rest|Exclusion criteria met after enrollment|2|||
131076792|NCT00776659|471914024|FG000|Overall Study|Lost to Follow-up|15|||
131076793|NCT00776659|471914024|FG000|Overall Study|Withdrawal by Subject|10|||
131076794|NCT00776659|471914024|FG000|Overall Study|Study Terminated by Sponsor|1|||
131076795|NCT01664923|471914025|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
131076796|NCT01664923|471914026|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
131076797|NCT01664923|471914025|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
131076798|NCT01664923|471914026|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
131076799|NCT01664923|471914025|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
131076800|NCT01664923|471914026|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
131076801|NCT01664923|471914025|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
131076802|NCT01664923|471914026|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
131076803|NCT01664923|471914025|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
131076804|NCT01664923|471914026|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
131076805|NCT01664923|471914025|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
131138678|NCT01582308|472132904|FG006|Period 1|Withdrawal by Subject|1|||
131138679|NCT01582308|472132905|FG007|Period 1|Withdrawal by Subject|0|||
131076806|NCT01664923|471914026|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
131076807|NCT01664923|471914025|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
131076808|NCT01664923|471914026|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
131076809|NCT01664923|471914025|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
130725036|NCT00094861|470619175|FG000|Overall Study|Withdrawal by Subject|5|||
131076810|NCT01664923|471914026|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
130725037|NCT00094861|470619176|FG001|Overall Study|Withdrawal by Subject|3|||
130725038|NCT00094861|470619175|FG000|Overall Study|Physician Decision|1|||
130725039|NCT00094861|470619176|FG001|Overall Study|Physician Decision|1|||
131076811|NCT01664923|471914025|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
131076812|NCT01664923|471914026|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
131076813|NCT01664923|471914025|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
131138680|NCT01582308|472132906|FG008|Period 1|Withdrawal by Subject|0|||
131138681|NCT01582308|472132907|FG009|Period 1|Withdrawal by Subject|0|||
130725040|NCT00094861|470619175|FG000|Overall Study|Lost to Follow-up|0|||
131076814|NCT01664923|471914026|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
131076815|NCT01664923|471914025|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
131076816|NCT01664923|471914026|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
131076817|NCT01664923|471914025|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
131076818|NCT01664923|471914026|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
131076819|NCT01664923|471914025|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
131076820|NCT01664923|471914026|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
131076821|NCT01664923|471914025|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
131076822|NCT01664923|471914026|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
131076823|NCT02835092|471914029|FG000|Overall Study|Withdrawal by Subject|3|||
131076824|NCT02835092|471914030|FG001|Overall Study|Withdrawal by Subject|6|||
131076825|NCT02835092|471914031|FG002|Overall Study|Withdrawal by Subject|3|||
131076826|NCT02835092|471914029|FG000|Overall Study|Lost to Follow-up|0|||
131076827|NCT02835092|471914030|FG001|Overall Study|Lost to Follow-up|2|||
131076828|NCT02835092|471914031|FG002|Overall Study|Lost to Follow-up|0|||
131076829|NCT01657877|471914033|FG000|Overall Study|Withdrawal by Subject|4|||
131076830|NCT01657877|471914033|FG000|Overall Study|Protocol Violation|6|||
131076831|NCT01657877|471914033|FG000|Overall Study|Adverse Event|2|||
131076832|NCT01657877|471914033|FG000|Overall Study|Other Reason|2|||
131076833|NCT01114672|471914035|FG000|Overall Study|Death|0|||
131076834|NCT01114672|471914036|FG001|Overall Study|Death|1|||
131076835|NCT01114672|471914035|FG000|Overall Study|Withdrawal by Subject|2|||
131076836|NCT01114672|471914036|FG001|Overall Study|Withdrawal by Subject|1|||
131076837|NCT01114672|471914035|FG000|Overall Study|Lost to Follow-up|1|||
131076838|NCT01114672|471914036|FG001|Overall Study|Lost to Follow-up|0|||
131076839|NCT01114672|471914035|FG000|Overall Study|transplanted|1|||
131076840|NCT01114672|471914036|FG001|Overall Study|transplanted|0|||
131076841|NCT02586415|471914041|FG000|Overall Study|Death|13|||
131076842|NCT02586415|471914042|FG001|Overall Study|Death|23|||
131076843|NCT02586415|471914041|FG000|Overall Study|Lost to Follow-up|1|||
131076844|NCT02586415|471914042|FG001|Overall Study|Lost to Follow-up|2|||
131076845|NCT02872311|471914043|FG000|Overall Study|Death|2|||
131076846|NCT02872311|471914044|FG001|Overall Study|Death|0|||
131076847|NCT02872311|471914045|FG002|Overall Study|Death|0|||
131076848|NCT02872311|471914046|FG003|Overall Study|Death|0|||
131076849|NCT02872311|471914047|FG004|Overall Study|Death|0|||
131076850|NCT02872311|471914043|FG000|Overall Study|Lost to Follow-up|2|||
131076851|NCT02872311|471914044|FG001|Overall Study|Lost to Follow-up|0|||
131076852|NCT02872311|471914045|FG002|Overall Study|Lost to Follow-up|0|||
131076853|NCT02872311|471914046|FG003|Overall Study|Lost to Follow-up|0|||
131076854|NCT02872311|471914047|FG004|Overall Study|Lost to Follow-up|0|||
131076855|NCT02872311|471914043|FG000|Overall Study|Protocol Violation|0|||
131076856|NCT02872311|471914044|FG001|Overall Study|Protocol Violation|2|||
131076857|NCT02872311|471914045|FG002|Overall Study|Protocol Violation|1|||
131076858|NCT02872311|471914046|FG003|Overall Study|Protocol Violation|0|||
131076859|NCT02872311|471914047|FG004|Overall Study|Protocol Violation|0|||
131076860|NCT04545476|471914048|FG000|Overall Study|Lost to Follow-up|1|||
131076861|NCT04545476|471914049|FG001|Overall Study|Lost to Follow-up|1|||
131076862|NCT04545476|471914050|FG002|Overall Study|Lost to Follow-up|0|||
131076863|NCT04545476|471914051|FG003|Overall Study|Lost to Follow-up|0|||
131076864|NCT00690378|471914052|FG000|Overall Study|Adverse Event|1|||
131076865|NCT00690378|471914053|FG001|Overall Study|Adverse Event|0|||
131076866|NCT00690378|471914052|FG000|Overall Study|Withdrawal by Subject|2|||
131076867|NCT00690378|471914053|FG001|Overall Study|Withdrawal by Subject|0|||
131076868|NCT00690378|471914052|FG000|Overall Study|Protocol Violation|1|||
131076869|NCT00690378|471914053|FG001|Overall Study|Protocol Violation|0|||
131076870|NCT00690378|471914052|FG000|Overall Study|Lost to Follow-up|2|||
131076871|NCT00690378|471914053|FG001|Overall Study|Lost to Follow-up|3|||
131076872|NCT00690378|471914052|FG000|Overall Study|Did not meet inc/exc criteria|13|||
131076873|NCT00690378|471914053|FG001|Overall Study|Did not meet inc/exc criteria|11|||
131076874|NCT00690378|471914052|FG000|Overall Study|Social problem|1|||
131076875|NCT00690378|471914053|FG001|Overall Study|Social problem|0|||
131076876|NCT01560871|471914054|FG000|Overall Study|transportation issues|2|||
131076877|NCT01560871|471914055|FG001|Overall Study|transportation issues|1|||
131076878|NCT01560871|471914054|FG000|Overall Study|relocation|1|||
131076879|NCT01560871|471914055|FG001|Overall Study|relocation|0|||
131076880|NCT01560871|471914054|FG000|Overall Study|readmission to a hospital|2|||
131076881|NCT01560871|471914055|FG001|Overall Study|readmission to a hospital|1|||
131076882|NCT01560871|471914054|FG000|Overall Study|Lost to Follow-up|1|||
131076883|NCT01560871|471914055|FG001|Overall Study|Lost to Follow-up|0|||
131076884|NCT00878553|471914056|FG000|Sleep Study|Withdrawal by Subject|2|||
131076885|NCT00878553|471914057|FG001|Sleep Study|Withdrawal by Subject|0|||
131076886|NCT00878553|471914058|FG002|Sleep Study|Withdrawal by Subject|0|||
131076887|NCT00878553|471914059|FG003|Sleep Study|Withdrawal by Subject|0|||
131076888|NCT00878553|471914060|FG004|Sleep Study|Withdrawal by Subject|0|||
131076889|NCT00878553|471914056|FG000|Sleep Study|Lost to Follow-up|1|||
131076890|NCT00878553|471914057|FG001|Sleep Study|Lost to Follow-up|0|||
131076891|NCT00878553|471914058|FG002|Sleep Study|Lost to Follow-up|0|||
130725041|NCT00094861|470619176|FG001|Overall Study|Lost to Follow-up|1|||
130725042|NCT00094861|470619175|FG000|Overall Study|Death|4|||
130725043|NCT00094861|470619176|FG001|Overall Study|Death|2|||
130725044|NCT00094861|470619175|FG000|Overall Study|Other|3|||
130725045|NCT00094861|470619176|FG001|Overall Study|Other|0|||
130725046|NCT02549027|470619178|FG000|Washout After Period 4|Withdrawal by Subject|0|||
130725047|NCT02549027|470619179|FG001|Washout After Period 4|Withdrawal by Subject|1|||
130725048|NCT02549027|470619180|FG002|Washout After Period 4|Withdrawal by Subject|1|||
130725049|NCT02549027|470619181|FG003|Washout After Period 4|Withdrawal by Subject|1|||
130725050|NCT02549027|470619182|FG004|Washout After Period 4|Withdrawal by Subject|0|||
130725051|NCT02549027|470619183|FG005|Washout After Period 4|Withdrawal by Subject|0|||
130725052|NCT02549027|470619178|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
131076892|NCT00878553|471914059|FG003|Sleep Study|Lost to Follow-up|0|||
131076893|NCT00878553|471914060|FG004|Sleep Study|Lost to Follow-up|0|||
131076894|NCT00878553|471914056|FG000|Sleep Study|car accident|1|||
131076895|NCT00878553|471914057|FG001|Sleep Study|car accident|0|||
131076896|NCT00878553|471914058|FG002|Sleep Study|car accident|0|||
131076897|NCT00878553|471914059|FG003|Sleep Study|car accident|0|||
131076898|NCT00878553|471914060|FG004|Sleep Study|car accident|0|||
131076899|NCT00878553|471914056|FG000|Sleep Study|family emergency|1|||
131076900|NCT00878553|471914057|FG001|Sleep Study|family emergency|0|||
131076901|NCT00878553|471914058|FG002|Sleep Study|family emergency|0|||
131076902|NCT00878553|471914059|FG003|Sleep Study|family emergency|0|||
131076903|NCT00878553|471914060|FG004|Sleep Study|family emergency|0|||
131076904|NCT00878553|471914056|FG000|PK Study|Withdrawal by Subject|0|||
131076905|NCT00878553|471914057|FG001|PK Study|Withdrawal by Subject|0|||
131076906|NCT00878553|471914058|FG002|PK Study|Withdrawal by Subject|0|||
131076907|NCT00878553|471914059|FG003|PK Study|Withdrawal by Subject|1|||
131076908|NCT00878553|471914060|FG004|PK Study|Withdrawal by Subject|0|||
131076909|NCT00912223|471914061|FG000|Overall Study|Withdrawal by Subject|1|||
131076910|NCT00912223|471914061|FG000|Overall Study|Not transplanted|1|||
131076911|NCT00912223|471914061|FG000|Overall Study|Transformed disease|1|||
131076912|NCT00461123|471914062|FG000|Overall Study|Adverse Event|1|||
131076913|NCT00461123|471914063|FG001|Overall Study|Adverse Event|0|||
131076914|NCT00461123|471914062|FG000|Overall Study|Lost to Follow-up|1|||
131076915|NCT00461123|471914063|FG001|Overall Study|Lost to Follow-up|1|||
131076916|NCT00461123|471914062|FG000|Overall Study|Protocol Violation|3|||
131076917|NCT00461123|471914063|FG001|Overall Study|Protocol Violation|2|||
131076918|NCT00461123|471914062|FG000|Overall Study|Withdrawal by Subject|1|||
131076919|NCT00461123|471914063|FG001|Overall Study|Withdrawal by Subject|3|||
131076920|NCT03029819|471914064|FG000|Overall Study|Lost to Follow-up|3|||
131076921|NCT03029819|471914065|FG001|Overall Study|Lost to Follow-up|5|||
131076922|NCT03029819|471914064|FG000|Overall Study|Removed due to disruptive behavior|0|||
131076923|NCT03029819|471914065|FG001|Overall Study|Removed due to disruptive behavior|1|||
131076924|NCT02650466|471914068|FG000|Overall Study|Physician Decision|1|||
131076925|NCT02650466|471914068|FG000|Overall Study|Withdrawal by Subject|5|||
131076926|NCT02650466|471914068|FG000|Overall Study|Lost to Follow-up|1|||
131076927|NCT01837797|471914069|FG000|Period 1|Adverse Event|9|||
131076928|NCT01837797|471914070|FG001|Period 1|Adverse Event|0|||
131076929|NCT01837797|471914071|FG002|Period 1|Adverse Event|0|||
131076930|NCT01837797|471914072|FG003|Period 1|Adverse Event|0|||
131076931|NCT01837797|471914073|FG004|Period 1|Adverse Event|0|||
131076932|NCT01837797|471914069|FG000|Period 1|Withdrawal by Subject|6|||
131076933|NCT01837797|471914070|FG001|Period 1|Withdrawal by Subject|0|||
131076934|NCT01837797|471914071|FG002|Period 1|Withdrawal by Subject|0|||
131076935|NCT01837797|471914072|FG003|Period 1|Withdrawal by Subject|0|||
131076936|NCT01837797|471914073|FG004|Period 1|Withdrawal by Subject|0|||
131076937|NCT01837797|471914069|FG000|Period 1|Administrative reasons|76|||
131076938|NCT01837797|471914070|FG001|Period 1|Administrative reasons|0|||
131076939|NCT01837797|471914071|FG002|Period 1|Administrative reasons|0|||
131076940|NCT01837797|471914072|FG003|Period 1|Administrative reasons|0|||
131138682|NCT01582308|472132898|FG000|10-day Washout Following Period 1|Physician Decision|0|||
131138683|NCT01582308|472132899|FG001|10-day Washout Following Period 1|Physician Decision|0|||
131138684|NCT01582308|472132900|FG002|10-day Washout Following Period 1|Physician Decision|0|||
131138685|NCT01582308|472132901|FG003|10-day Washout Following Period 1|Physician Decision|0|||
131138686|NCT01582308|472132902|FG004|10-day Washout Following Period 1|Physician Decision|1|||
131138687|NCT01582308|472132903|FG005|10-day Washout Following Period 1|Physician Decision|0|||
131138688|NCT01582308|472132904|FG006|10-day Washout Following Period 1|Physician Decision|0|||
131138689|NCT01582308|472132905|FG007|10-day Washout Following Period 1|Physician Decision|0|||
131138690|NCT01582308|472132906|FG008|10-day Washout Following Period 1|Physician Decision|0|||
131138691|NCT01582308|472132907|FG009|10-day Washout Following Period 1|Physician Decision|0|||
131138692|NCT01582308|472132898|FG000|Period 4|Physician Decision|1|||
131076941|NCT01837797|471914073|FG004|Period 1|Administrative reasons|0|||
131076942|NCT01837797|471914069|FG000|Period 1|Withdrawal of consent before treatment|1|||
131076943|NCT01837797|471914070|FG001|Period 1|Withdrawal of consent before treatment|0|||
131076944|NCT01837797|471914071|FG002|Period 1|Withdrawal of consent before treatment|0|||
131076945|NCT01837797|471914072|FG003|Period 1|Withdrawal of consent before treatment|0|||
131231345|NCT00585351|472473315|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
131231346|NCT00585351|472473316|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
131231347|NCT00585351|472473317|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
131231348|NCT00585351|472473310|FG000|Enrollment Period (Intervention)|Death|0|||
131231349|NCT00585351|472473311|FG001|Enrollment Period (Intervention)|Death|0|||
131231350|NCT00585351|472473312|FG002|Enrollment Period (Intervention)|Death|0|||
131231351|NCT00585351|472473313|FG003|Enrollment Period (Intervention)|Death|0|||
131076946|NCT01837797|471914073|FG004|Period 1|Withdrawal of consent before treatment|0|||
131076947|NCT01837797|471914069|FG000|Period 1|Other|10|||
131076948|NCT01837797|471914070|FG001|Period 1|Other|0|||
131076949|NCT01837797|471914071|FG002|Period 1|Other|0|||
131076950|NCT01837797|471914072|FG003|Period 1|Other|0|||
131076951|NCT01837797|471914073|FG004|Period 1|Other|0|||
131076952|NCT01837797|471914069|FG000|Period 2|Administrative or other reasons|0|||
131076953|NCT01837797|471914070|FG001|Period 2|Administrative or other reasons|5|||
131076954|NCT01837797|471914071|FG002|Period 2|Administrative or other reasons|2|||
131076955|NCT01837797|471914072|FG003|Period 2|Administrative or other reasons|4|||
131076956|NCT01837797|471914073|FG004|Period 2|Administrative or other reasons|0|||
131076957|NCT01837797|471914069|FG000|Period 2|Adverse Event|0|||
131076958|NCT01837797|471914070|FG001|Period 2|Adverse Event|0|||
131076959|NCT01837797|471914071|FG002|Period 2|Adverse Event|0|||
131076960|NCT01837797|471914072|FG003|Period 2|Adverse Event|1|||
131076961|NCT01837797|471914073|FG004|Period 2|Adverse Event|0|||
131076962|NCT01837797|471914069|FG000|Period 3|Adverse Event|0|||
131076963|NCT01837797|471914070|FG001|Period 3|Adverse Event|0|||
131076964|NCT01837797|471914071|FG002|Period 3|Adverse Event|0|||
131076965|NCT01837797|471914072|FG003|Period 3|Adverse Event|0|||
131076966|NCT01837797|471914073|FG004|Period 3|Adverse Event|1|||
131076967|NCT01837797|471914069|FG000|Period 3|Administrative reasons|0|||
131076968|NCT01837797|471914070|FG001|Period 3|Administrative reasons|0|||
131076969|NCT01837797|471914071|FG002|Period 3|Administrative reasons|0|||
131076970|NCT01837797|471914072|FG003|Period 3|Administrative reasons|0|||
131076971|NCT01837797|471914073|FG004|Period 3|Administrative reasons|20|||
131076972|NCT01837797|471914069|FG000|Period 3|Other|0|||
131076973|NCT01837797|471914070|FG001|Period 3|Other|0|||
131076974|NCT01837797|471914071|FG002|Period 3|Other|0|||
131076975|NCT01837797|471914072|FG003|Period 3|Other|0|||
131076976|NCT01837797|471914073|FG004|Period 3|Other|2|||
131076977|NCT03797989|471914074|FG000|VAC069A|Withdrawal by Subject|0|||
131076978|NCT03797989|471914075|FG001|VAC069A|Withdrawal by Subject|0|||
131076979|NCT03797989|471914076|FG002|VAC069A|Withdrawal by Subject|1|||
131076980|NCT03797989|471914077|FG003|VAC069A|Withdrawal by Subject|0|||
131076981|NCT03797989|471914078|FG004|VAC069A|Withdrawal by Subject|0|||
131076982|NCT03797989|471914079|FG005|VAC069A|Withdrawal by Subject|0|||
131076983|NCT03797989|471914080|FG006|VAC069A|Withdrawal by Subject|0|||
131076984|NCT03797989|471914081|FG007|VAC069A|Withdrawal by Subject|0|||
131076985|NCT03797989|471914082|FG008|VAC069A|Withdrawal by Subject|0|||
131076986|NCT03797989|471914083|FG009|VAC069A|Withdrawal by Subject|0|||
131076987|NCT03797989|471914084|FG010|VAC069A|Withdrawal by Subject|0|||
131076988|NCT03797989|471914085|FG011|VAC069A|Withdrawal by Subject|0|||
131076989|NCT00604188|471914087|FG000|Overall Study|Adverse Event|1|||
131076990|NCT00604188|471914088|FG001|Overall Study|Adverse Event|4|||
131076991|NCT00604188|471914087|FG000|Overall Study|Lost to Follow-up|17|||
131076992|NCT00604188|471914088|FG001|Overall Study|Lost to Follow-up|15|||
131076993|NCT00604188|471914087|FG000|Overall Study|Withdrawal by Subject|5|||
131076994|NCT00604188|471914088|FG001|Overall Study|Withdrawal by Subject|1|||
131076995|NCT00604188|471914087|FG000|Overall Study|Non-compliance with protocol|4|||
131076996|NCT00604188|471914088|FG001|Overall Study|Non-compliance with protocol|4|||
131076997|NCT00604188|471914087|FG000|Overall Study|Did not receive study drug|0|||
131076998|NCT00604188|471914088|FG001|Overall Study|Did not receive study drug|1|||
131076999|NCT00356759|471914089|FG000|Overall Study|Death|5|||
131077000|NCT00356759|471914090|FG001|Overall Study|Death|2|||
131077001|NCT00356759|471914089|FG000|Overall Study|Withdrawal by Subject|2|||
131077002|NCT00356759|471914090|FG001|Overall Study|Withdrawal by Subject|2|||
131077003|NCT00356759|471914089|FG000|Overall Study|Adverse Event|1|||
131077004|NCT00356759|471914090|FG001|Overall Study|Adverse Event|3|||
131077005|NCT00356759|471914089|FG000|Overall Study|Lost to Follow-up|1|||
131077006|NCT00356759|471914090|FG001|Overall Study|Lost to Follow-up|1|||
131231352|NCT00585351|472473314|FG004|Enrollment Period (Intervention)|Death|1|||
131077007|NCT00356759|471914089|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
131077008|NCT00356759|471914090|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
131077009|NCT00934700|471914091|FG000|Overall Study|missing scan|5|||
131077010|NCT00934700|471914092|FG001|Overall Study|missing scan|9|||
131077011|NCT00934700|471914091|FG000|Overall Study|Death|8|||
131077012|NCT00934700|471914092|FG001|Overall Study|Death|3|||
131077013|NCT01075100|471914097|FG000|Overall Study|Adverse Event|15|||
131077014|NCT01075100|471914098|FG001|Overall Study|Adverse Event|18|||
131077015|NCT01075100|471914097|FG000|Overall Study|Patient Request|4|||
131077016|NCT01075100|471914098|FG001|Overall Study|Patient Request|4|||
131077017|NCT01075100|471914097|FG000|Overall Study|Investigator Request|2|||
131077018|NCT01075100|471914098|FG001|Overall Study|Investigator Request|1|||
130725053|NCT02549027|470619179|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130725054|NCT02549027|470619180|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130725055|NCT02549027|470619181|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130725056|NCT02549027|470619182|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
130725057|NCT02549027|470619183|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130725058|NCT02186834|470619184|FG000|Dose Escalation|Death|0|||
130725059|NCT02186834|470619185|FG001|Dose Escalation|Death|0|||
130725060|NCT02186834|470619186|FG002|Dose Escalation|Death|0|||
130725061|NCT02186834|470619187|FG003|Dose Escalation|Death|1|||
130725062|NCT02186834|470619188|FG004|Dose Escalation|Death|0|||
130725063|NCT02186834|470619189|FG005|Dose Escalation|Death|0|||
130725064|NCT02186834|470619184|FG000|Treatment at RP2D|Died prior to treatment|0|||
130725065|NCT02186834|470619185|FG001|Treatment at RP2D|Died prior to treatment|0|||
130725066|NCT02186834|470619186|FG002|Treatment at RP2D|Died prior to treatment|0|||
130725067|NCT02186834|470619187|FG003|Treatment at RP2D|Died prior to treatment|0|||
130725068|NCT02186834|470619188|FG004|Treatment at RP2D|Died prior to treatment|0|||
130725069|NCT02186834|470619189|FG005|Treatment at RP2D|Died prior to treatment|1|||
130725070|NCT01199016|470619202|FG000|Overall Study|No longer meets eligibility criteria|4|||
130725071|NCT01199016|470619202|FG000|Overall Study|Entrance criteria|5|||
130725072|NCT01199016|470619202|FG000|Overall Study|Protocol Violation|9|||
130725073|NCT01199016|470619202|FG000|Overall Study|Other|13|||
130725074|NCT01199016|470619202|FG000|Overall Study|Withdrawal by Subject|21|||
130725075|NCT01199016|470619202|FG000|Overall Study|Lost to Follow-up|25|||
130725076|NCT02368314|470619210|FG000|Overall Study|Withdrawal by Subject|2|||
130725077|NCT02368314|470619211|FG001|Overall Study|Withdrawal by Subject|1|||
130725078|NCT02368314|470619210|FG000|Overall Study|Adverse Event|1|||
130725079|NCT02368314|470619211|FG001|Overall Study|Adverse Event|2|||
130725080|NCT02842073|470619216|FG000|Overall Study|Withdrawal by Subject|1|||
130725081|NCT00195338|470619217|FG000|Overall Study|Lost to Follow-up|2|||
130725082|NCT00195338|470619217|FG000|Overall Study|Adverse Event|5|||
130725083|NCT00195338|470619217|FG000|Overall Study|Lack of Efficacy|1|||
130725084|NCT00195338|470619217|FG000|Overall Study|Early closure of the site|4|||
130725085|NCT05320887|470619221|FG000|Overall Study|Lost to Follow-up|0|||
130725086|NCT05320887|470619222|FG001|Overall Study|Lost to Follow-up|3|||
130725087|NCT05320887|470619223|FG002|Overall Study|Lost to Follow-up|0|||
130725088|NCT05320887|470619224|FG003|Overall Study|Lost to Follow-up|0|||
130725089|NCT02289456|470619225|FG000|Induction Period|Death|2|||
130725090|NCT02289456|470619225|FG000|Induction Period|Adverse Event|11|||
130725091|NCT02289456|470619225|FG000|Induction Period|Progressive Disease (PD)|4|||
130725092|NCT02289456|470619225|FG000|Induction Period|Symptomatic Deterioration|4|||
130725093|NCT02289456|470619225|FG000|Induction Period|Withdrawal by Subject|2|||
130725094|NCT02289456|470619225|FG000|Induction Period|Miscellaneous|1|||
130725095|NCT02289456|470619225|FG000|Monotherapy Period|Death|1|||
130725096|NCT02289456|470619225|FG000|Monotherapy Period|Adverse Event|1|||
130725097|NCT02289456|470619225|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
130725098|NCT02289456|470619225|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
130725099|NCT02289456|470619225|FG000|Monotherapy Period|Withdrawal by Subject|2|||
130725100|NCT02289456|470619225|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
130725101|NCT02289456|470619225|FG000|Monotherapy Period|Miscellaneous|1|||
130725102|NCT01661062|470619228|FG000|Overall Study|Completed Treatment Off Study|3|||
130725103|NCT01661062|470619228|FG000|Overall Study|Withdrawal by Subject|2|||
130725104|NCT02015065|470619233|FG000|Overall Study|Death on study|1|||
130725105|NCT02015065|470619234|FG001|Overall Study|Death on study|2|||
130725106|NCT02015065|470619235|FG002|Overall Study|Death on study|1|||
130725107|NCT03485365|470619270|FG000|Overall Study|Protocol Violation|0|||
130725108|NCT03485365|470619271|FG001|Overall Study|Protocol Violation|0|||
130725109|NCT03485365|470619272|FG002|Overall Study|Protocol Violation|0|||
130725110|NCT03485365|470619273|FG003|Overall Study|Protocol Violation|1|||
130725111|NCT03485365|470619274|FG004|Overall Study|Protocol Violation|0|||
130725112|NCT03485365|470619275|FG005|Overall Study|Protocol Violation|0|||
130725113|NCT03485365|470619276|FG006|Overall Study|Protocol Violation|1|||
130725114|NCT03485365|470619277|FG007|Overall Study|Protocol Violation|0|||
130725115|NCT03485365|470619278|FG008|Overall Study|Protocol Violation|0|||
130725116|NCT01547130|470619281|FG000|Overall Study|Lost to Follow-up|9|||
130725117|NCT01547130|470619282|FG001|Overall Study|Lost to Follow-up|5|||
130725118|NCT03553576|470619283|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
130725119|NCT03553576|470619284|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
130725120|NCT03553576|470619283|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
130725121|NCT03553576|470619284|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
130725122|NCT03553576|470619283|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
130725123|NCT03553576|470619284|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
130725124|NCT03553576|470619283|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
130725125|NCT03553576|470619284|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
130725126|NCT03553576|470619283|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
131077019|NCT01075100|471914097|FG000|Overall Study|Disease Progression|25|||
131077020|NCT01075100|471914098|FG001|Overall Study|Disease Progression|29|||
131077021|NCT01075100|471914097|FG000|Overall Study|Other|3|||
131077022|NCT01075100|471914098|FG001|Overall Study|Other|1|||
131077023|NCT05896696|471914099|FG000|Overall Study|Screening Failure|7|||
131077024|NCT05896696|471914099|FG000|Overall Study|Withdrawal by Subject|2|||
131077025|NCT00143598|471914100|FG000|Overall Study|Lost to Follow-up|23|||
131077026|NCT00143598|471914101|FG001|Overall Study|Lost to Follow-up|21|||
131077027|NCT00143598|471914100|FG000|Overall Study|Withdrawal by Subject|33|||
131077028|NCT00143598|471914101|FG001|Overall Study|Withdrawal by Subject|37|||
131077029|NCT00143598|471914100|FG000|Overall Study|Death|36|||
131077030|NCT00143598|471914101|FG001|Overall Study|Death|36|||
131077031|NCT03900715|471914102|FG000|Overall Study|Protocol Deviation|1|||
131077032|NCT03900715|471914102|FG000|Overall Study|Lack of Efficacy|1|||
131077033|NCT03900715|471914102|FG000|Overall Study|Progressive Disease|6|||
131077034|NCT03900715|471914102|FG000|Overall Study|Adverse Event|2|||
131077035|NCT03900715|471914102|FG000|Overall Study|Other reasons|11|||
131077036|NCT02080403|471915920|FG000|Overall Study|Adverse Event|5|||
131077037|NCT02080403|471915921|FG001|Overall Study|Adverse Event|1|||
131077038|NCT02080403|471915920|FG000|Overall Study|Death|0|||
131077039|NCT02080403|471915921|FG001|Overall Study|Death|2|||
131077040|NCT02080403|471915920|FG000|Overall Study|Lost to Follow-up|2|||
131077041|NCT02080403|471915921|FG001|Overall Study|Lost to Follow-up|0|||
131077042|NCT02080403|471915920|FG000|Overall Study|Pregnancy|0|||
131077043|NCT02080403|471915921|FG001|Overall Study|Pregnancy|1|||
131077044|NCT02080403|471915920|FG000|Overall Study|Protocol Violation|3|||
131077045|NCT02080403|471915921|FG001|Overall Study|Protocol Violation|7|||
131077046|NCT02080403|471915920|FG000|Overall Study|Withdrawal by Subject|5|||
131077047|NCT02080403|471915921|FG001|Overall Study|Withdrawal by Subject|1|||
131077048|NCT01101334|471915922|FG000|Overall Study|Adverse Event|9|||
131077049|NCT01101334|471915923|FG001|Overall Study|Adverse Event|4|||
131077050|NCT01101334|471915922|FG000|Overall Study|Death|7|||
131077051|NCT01101334|471915923|FG001|Overall Study|Death|1|||
131077052|NCT01101334|471915922|FG000|Overall Study|Withdrawal by Subject|4|||
131077053|NCT01101334|471915923|FG001|Overall Study|Withdrawal by Subject|3|||
131077054|NCT01101334|471915922|FG000|Overall Study|Withdrawal by Sponsor|1|||
131077055|NCT01101334|471915923|FG001|Overall Study|Withdrawal by Sponsor|1|||
131077056|NCT01101334|471915922|FG000|Overall Study|Progressive Disease|22|||
131077057|NCT01101334|471915923|FG001|Overall Study|Progressive Disease|35|||
131077058|NCT01101334|471915922|FG000|Overall Study|Other|2|||
131077059|NCT01101334|471915923|FG001|Overall Study|Other|1|||
131077060|NCT03864341|471915926|FG000|Overall Study|Withdrawal by Subject|1|||
131077061|NCT02202109|471915928|FG000|Overall Study|Lost to Follow-up|88|||
131077062|NCT02202109|471915929|FG001|Overall Study|Lost to Follow-up|87|||
130779683|NCT02326272|470819500|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130779684|NCT02326272|470819501|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
130779685|NCT02326272|470819502|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
130779686|NCT02326272|470819503|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130779687|NCT02326272|470819504|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
130779688|NCT02326272|470819490|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779689|NCT02326272|470819491|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779690|NCT02326272|470819492|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779691|NCT02326272|470819493|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779692|NCT02326272|470819494|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779693|NCT02326272|470819495|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779694|NCT02326272|470819496|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779695|NCT02326272|470819497|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779696|NCT02326272|470819498|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779697|NCT02326272|470819499|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
131077063|NCT02202109|471915928|FG000|Overall Study|Withdrawal by Subject|2|||
131077064|NCT02202109|471915929|FG001|Overall Study|Withdrawal by Subject|0|||
131077065|NCT00612352|471915930|FG000|Overall Study|Adverse Event|1|||
131077066|NCT00612352|471915931|FG001|Overall Study|Adverse Event|0|||
131138693|NCT01582308|472132899|FG001|Period 4|Physician Decision|0|||
131138694|NCT01582308|472132900|FG002|Period 4|Physician Decision|0|||
131138695|NCT01582308|472132901|FG003|Period 4|Physician Decision|0|||
130779698|NCT02326272|470819500|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779699|NCT02326272|470819501|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
131077067|NCT00612352|471915930|FG000|Overall Study|Withdrawal by Subject|3|||
131077068|NCT00612352|471915931|FG001|Overall Study|Withdrawal by Subject|5|||
131077069|NCT00612352|471915930|FG000|Overall Study|moved out of state|1|||
131077070|NCT00612352|471915931|FG001|Overall Study|moved out of state|0|||
131077071|NCT00612352|471915930|FG000|Overall Study|didn't return calls/show up on test date|4|||
131077072|NCT00612352|471915931|FG001|Overall Study|didn't return calls/show up on test date|1|||
131077073|NCT00263211|471915932|FG000|Overall Study|Death|1|||
131077074|NCT00263211|471915933|FG001|Overall Study|Death|0|||
131138696|NCT01582308|472132902|FG004|Period 4|Physician Decision|0|||
131138697|NCT01582308|472132903|FG005|Period 4|Physician Decision|1|||
131138698|NCT01582308|472132904|FG006|Period 4|Physician Decision|0|||
131138699|NCT01582308|472132905|FG007|Period 4|Physician Decision|0|||
131138700|NCT01582308|472132906|FG008|Period 4|Physician Decision|0|||
131138701|NCT01582308|472132907|FG009|Period 4|Physician Decision|1|||
131138702|NCT06228586|472132910|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
131138703|NCT06228586|472132911|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
131138704|NCT01072344|472134127|FG000|Overall Study|Relasped-reached end point|7|||
131138705|NCT01072344|472134128|FG001|Overall Study|Relasped-reached end point|12|||
131138706|NCT01072344|472134127|FG000|Overall Study|Protocol Violation|1|||
131138707|NCT01072344|472134128|FG001|Overall Study|Protocol Violation|2|||
131138708|NCT01072344|472134127|FG000|Overall Study|Lost to Follow-up|3|||
131138709|NCT01072344|472134128|FG001|Overall Study|Lost to Follow-up|4|||
131138710|NCT00122135|472134129|FG000|Overall Study|Withdrawal by Subject|3|||
131138711|NCT00122135|472134130|FG001|Overall Study|Withdrawal by Subject|0|||
131138712|NCT00805740|472134131|FG000|Overall Study|Death|7|||
131138713|NCT00805740|472134132|FG001|Overall Study|Death|4|||
131138714|NCT00805740|472134131|FG000|Overall Study|Withdrawal by Subject|1|||
131138715|NCT00805740|472134132|FG001|Overall Study|Withdrawal by Subject|0|||
131138716|NCT00805740|472134131|FG000|Overall Study|Lost to Follow-up|1|||
131138717|NCT00805740|472134132|FG001|Overall Study|Lost to Follow-up|0|||
131138718|NCT00805740|472134131|FG000|Overall Study|Randomized, but not treated|2|||
131138719|NCT00805740|472134132|FG001|Overall Study|Randomized, but not treated|0|||
131138720|NCT04033367|472134133|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
131138721|NCT04033367|472134134|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
131138722|NCT04033367|472134133|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
131138723|NCT04033367|472134134|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
131138724|NCT04033367|472134133|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
131138725|NCT04033367|472134134|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
131138726|NCT04033367|472134133|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
131138727|NCT04033367|472134134|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
131138728|NCT02723201|472134135|FG000|Second Intervention Period|Protocol Violation|1|||
131138729|NCT02723201|472134136|FG001|Second Intervention Period|Protocol Violation|0|||
131138730|NCT02723201|472134137|FG002|Second Intervention Period|Protocol Violation|0|||
131138731|NCT02723201|472134135|FG000|Second Intervention Period|Adverse Event|1|||
131138732|NCT02723201|472134136|FG001|Second Intervention Period|Adverse Event|0|||
131138733|NCT02723201|472134137|FG002|Second Intervention Period|Adverse Event|0|||
131138734|NCT03472560|472134138|FG000|Overall Study|Subject transfer to continuation protocol|0|||
131138735|NCT03472560|472134139|FG001|Overall Study|Subject transfer to continuation protocol|1|||
131138736|NCT03472560|472134138|FG000|Overall Study|Withdrawal by Subject|4|||
131138737|NCT03472560|472134139|FG001|Overall Study|Withdrawal by Subject|0|||
131138738|NCT03472560|472134138|FG000|Overall Study|Progressive disease|24|||
131138739|NCT03472560|472134139|FG001|Overall Study|Progressive disease|8|||
131138740|NCT03472560|472134138|FG000|Overall Study|Physician Decision|1|||
131138741|NCT03472560|472134139|FG001|Overall Study|Physician Decision|0|||
131138742|NCT03472560|472134138|FG000|Overall Study|Death|7|||
131138743|NCT03472560|472134139|FG001|Overall Study|Death|4|||
131138744|NCT03472560|472134138|FG000|Overall Study|Adverse Event|5|||
131138745|NCT03472560|472134139|FG001|Overall Study|Adverse Event|3|||
131138746|NCT03472560|472134138|FG000|Overall Study|Global deterioration of health status|0|||
131138747|NCT03472560|472134139|FG001|Overall Study|Global deterioration of health status|4|||
131138748|NCT01946178|472134140|FG000|Overall Study|Pregnancy|1|||
131138749|NCT01946178|472134140|FG000|Overall Study|Lost to Follow-up|1|||
130725127|NCT03553576|470619284|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
130725128|NCT03553576|470619283|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
130725129|NCT03553576|470619284|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
130725130|NCT03553576|470619283|FG000|Overall Study|Physician Decision|2|||
131138750|NCT00491179|472134141|FG000|Overall Study|Adverse Event|5|||
131138751|NCT00491179|472134142|FG001|Overall Study|Adverse Event|1|||
131138752|NCT00491179|472134141|FG000|Overall Study|Withdrawal by Subject|2|||
131138753|NCT00491179|472134142|FG001|Overall Study|Withdrawal by Subject|1|||
130725131|NCT03553576|470619284|FG001|Overall Study|Physician Decision|5|||
131138754|NCT01505894|472134143|FG000|Overall Study|Adverse Event|1|||
131138755|NCT01505894|472134144|FG001|Overall Study|Adverse Event|0|||
130725132|NCT01104792|470619285|FG000|Overall Study|Adverse Event|77|||
131138756|NCT01505894|472134145|FG002|Overall Study|Adverse Event|0|||
131138757|NCT01505894|472134146|FG003|Overall Study|Adverse Event|0|||
131138758|NCT01505894|472134147|FG004|Overall Study|Adverse Event|0|||
131138759|NCT01505894|472134148|FG005|Overall Study|Adverse Event|0|||
131138760|NCT01505894|472134149|FG006|Overall Study|Adverse Event|0|||
131138761|NCT01505894|472134150|FG007|Overall Study|Adverse Event|0|||
131138762|NCT01505894|472134151|FG008|Overall Study|Adverse Event|0|||
131138763|NCT01505894|472134143|FG000|Overall Study|Other than specified|0|||
131138764|NCT01505894|472134144|FG001|Overall Study|Other than specified|0|||
131231353|NCT00585351|472473315|FG005|Enrollment Period (Intervention)|Death|0|||
131231354|NCT00585351|472473316|FG006|Enrollment Period (Intervention)|Death|1|||
131231355|NCT00585351|472473317|FG007|Enrollment Period (Intervention)|Death|0|||
131231356|NCT00585351|472473310|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131231357|NCT00585351|472473311|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131231358|NCT00585351|472473312|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131231359|NCT00585351|472473313|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131231360|NCT00585351|472473314|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
131231361|NCT00585351|472473315|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
131231362|NCT00585351|472473316|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131231363|NCT00585351|472473317|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
131231364|NCT01842958|472473319|FG000|Overall Study|Lost to Follow-up|1|||
130725133|NCT01104792|470619285|FG000|Overall Study|Insufficient Therapeutic Response|22|||
130725134|NCT01104792|470619285|FG000|Overall Study|Protocol Violation|45|||
130725135|NCT01104792|470619285|FG000|Overall Study|Withdrawal of Consent|179|||
130725136|NCT01104792|470619285|FG000|Overall Study|Lost to Follow-up|43|||
130725137|NCT01104792|470619285|FG000|Overall Study|Reasons Not Specified|27|||
130725138|NCT01104792|470619285|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
130725139|NCT00103610|470619289|FG000|Overall Study|Entered Rescue Procedure|10|||
130725140|NCT00103610|470619290|FG001|Overall Study|Entered Rescue Procedure|52|||
130725141|NCT00103610|470619289|FG000|Overall Study|Death|16|||
130725142|NCT00103610|470619290|FG001|Overall Study|Death|12|||
130725143|NCT00103610|470619289|FG000|Overall Study|Elective Withdrawal|4|||
130725144|NCT00103610|470619290|FG001|Overall Study|Elective Withdrawal|0|||
130725145|NCT00103610|470619289|FG000|Overall Study|Lost to Follow-up|3|||
130725146|NCT00103610|470619290|FG001|Overall Study|Lost to Follow-up|1|||
130725147|NCT00103610|470619289|FG000|Overall Study|Adverse Event|2|||
130725148|NCT00103610|470619290|FG001|Overall Study|Adverse Event|2|||
130725149|NCT00103610|470619289|FG000|Overall Study|Other|2|||
130725150|NCT00103610|470619290|FG001|Overall Study|Other|7|||
130725151|NCT00103610|470619289|FG000|Overall Study|Failed mobilization|1|||
130725152|NCT00103610|470619290|FG001|Overall Study|Failed mobilization|5|||
130725153|NCT00103610|470619289|FG000|Overall Study|Noncompliance|0|||
130725154|NCT00103610|470619290|FG001|Overall Study|Noncompliance|1|||
130725155|NCT03301623|470619291|FG000|Overall Study|Death|3|||
130725156|NCT03301623|470619292|FG001|Overall Study|Death|1|||
130725157|NCT03301623|470619291|FG000|Overall Study|Withdrawal by Subject|11|||
130725158|NCT03301623|470619292|FG001|Overall Study|Withdrawal by Subject|13|||
130725159|NCT03301623|470619291|FG000|Overall Study|Lost to Follow-up|3|||
130725160|NCT03301623|470619292|FG001|Overall Study|Lost to Follow-up|1|||
130725161|NCT02092467|470619293|FG000|Overall Study|Death|49|||
130725162|NCT02092467|470619294|FG001|Overall Study|Death|66|||
130725163|NCT02092467|470619295|FG002|Overall Study|Death|38|||
130725164|NCT02092467|470619293|FG000|Overall Study|Lost to Follow-up|38|||
130725165|NCT02092467|470619294|FG001|Overall Study|Lost to Follow-up|35|||
130725166|NCT02092467|470619295|FG002|Overall Study|Lost to Follow-up|40|||
130725167|NCT02092467|470619293|FG000|Overall Study|Global Deterioration of Health Status|1|||
130725168|NCT02092467|470619294|FG001|Overall Study|Global Deterioration of Health Status|0|||
130725169|NCT02092467|470619295|FG002|Overall Study|Global Deterioration of Health Status|0|||
130725170|NCT02092467|470619293|FG000|Overall Study|Other|32|||
130725171|NCT02092467|470619294|FG001|Overall Study|Other|30|||
130725172|NCT02092467|470619295|FG002|Overall Study|Other|24|||
130725173|NCT02092467|470619293|FG000|Overall Study|Withdrawal by Subject|282|||
130725174|NCT02092467|470619294|FG001|Overall Study|Withdrawal by Subject|327|||
130725175|NCT02092467|470619295|FG002|Overall Study|Withdrawal by Subject|289|||
130725176|NCT02092467|470619293|FG000|Overall Study|Randomized but not treated|2|||
130725177|NCT02092467|470619294|FG001|Overall Study|Randomized but not treated|1|||
130725178|NCT02092467|470619295|FG002|Overall Study|Randomized but not treated|7|||
130725179|NCT04844762|470619300|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725180|NCT04844762|470619301|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725181|NCT04844762|470619302|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
130725182|NCT04844762|470619303|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725183|NCT04844762|470619304|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725184|NCT04844762|470619305|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725185|NCT04844762|470619300|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
130725186|NCT04844762|470619301|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
130725187|NCT04844762|470619302|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
130725188|NCT04844762|470619303|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
130725189|NCT04844762|470619304|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
130725190|NCT04844762|470619305|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
130725191|NCT04844762|470619300|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725192|NCT04844762|470619301|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725193|NCT04844762|470619302|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130725194|NCT04844762|470619303|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
131077075|NCT00263211|471915932|FG000|Overall Study|Withdrawal by Subject|3|||
131077076|NCT00263211|471915933|FG001|Overall Study|Withdrawal by Subject|0|||
131077077|NCT00263211|471915932|FG000|Overall Study|Protocol Violation|1|||
131077078|NCT00263211|471915933|FG001|Overall Study|Protocol Violation|0|||
131077079|NCT00263211|471915932|FG000|Overall Study|Disease Progression|0|||
131077080|NCT00263211|471915933|FG001|Overall Study|Disease Progression|1|||
131077081|NCT00760513|471915934|FG000|Overall Study|Withdrawal by Subject|5|||
131077082|NCT00760513|471915935|FG001|Overall Study|Withdrawal by Subject|7|||
131077083|NCT01468077|471915938|FG000|Overall Study|Adverse Event|2|||
131077084|NCT01468077|471915939|FG001|Overall Study|Adverse Event|2|||
131077085|NCT01468077|471915938|FG000|Overall Study|Lack of Efficacy|1|||
131077086|NCT01468077|471915939|FG001|Overall Study|Lack of Efficacy|1|||
131077087|NCT01468077|471915938|FG000|Overall Study|Physician Decision|1|||
131231365|NCT01842958|472473320|FG001|Overall Study|Lost to Follow-up|1|||
131231366|NCT01829477|472473321|FG000|Overall Study|Study Terminated by Sponsor|15|||
131231367|NCT01829477|472473322|FG001|Overall Study|Study Terminated by Sponsor|15|||
131231368|NCT01829477|472473321|FG000|Overall Study|Withdrawal by Subject|1|||
131231369|NCT01829477|472473322|FG001|Overall Study|Withdrawal by Subject|0|||
131231370|NCT00818623|472473327|FG000|Overall Study|Adverse Event|1|||
131231371|NCT00818623|472473328|FG001|Overall Study|Adverse Event|0|||
131231372|NCT00818623|472473329|FG002|Overall Study|Adverse Event|1|||
131231373|NCT00818623|472473330|FG003|Overall Study|Adverse Event|0|||
131231374|NCT00818623|472473331|FG004|Overall Study|Adverse Event|0|||
131231375|NCT00818623|472473332|FG005|Overall Study|Adverse Event|1|||
131231376|NCT00818623|472473333|FG006|Overall Study|Adverse Event|0|||
131231377|NCT00818623|472473334|FG007|Overall Study|Adverse Event|0|||
131231378|NCT00818623|472473327|FG000|Overall Study|Bad prostate specific antigen response|0|||
131231379|NCT00818623|472473328|FG001|Overall Study|Bad prostate specific antigen response|3|||
131231380|NCT00818623|472473329|FG002|Overall Study|Bad prostate specific antigen response|2|||
131231381|NCT00818623|472473330|FG003|Overall Study|Bad prostate specific antigen response|5|||
131231382|NCT00818623|472473331|FG004|Overall Study|Bad prostate specific antigen response|0|||
131231383|NCT00818623|472473332|FG005|Overall Study|Bad prostate specific antigen response|1|||
131231384|NCT00818623|472473333|FG006|Overall Study|Bad prostate specific antigen response|0|||
131231385|NCT00818623|472473334|FG007|Overall Study|Bad prostate specific antigen response|0|||
131231386|NCT00818623|472473327|FG000|Overall Study|Withdrawal by Subject|0|||
131231387|NCT00818623|472473328|FG001|Overall Study|Withdrawal by Subject|1|||
131231388|NCT00818623|472473329|FG002|Overall Study|Withdrawal by Subject|1|||
131231389|NCT00818623|472473330|FG003|Overall Study|Withdrawal by Subject|0|||
131231390|NCT00818623|472473331|FG004|Overall Study|Withdrawal by Subject|0|||
131231391|NCT00818623|472473332|FG005|Overall Study|Withdrawal by Subject|1|||
131231392|NCT00818623|472473333|FG006|Overall Study|Withdrawal by Subject|1|||
131231393|NCT00818623|472473334|FG007|Overall Study|Withdrawal by Subject|1|||
131231394|NCT00818623|472473327|FG000|Overall Study|Protocol Violation|1|||
131231395|NCT00818623|472473328|FG001|Overall Study|Protocol Violation|0|||
131231396|NCT00818623|472473329|FG002|Overall Study|Protocol Violation|0|||
131231397|NCT00818623|472473330|FG003|Overall Study|Protocol Violation|0|||
131231398|NCT00818623|472473331|FG004|Overall Study|Protocol Violation|1|||
131231399|NCT00818623|472473332|FG005|Overall Study|Protocol Violation|0|||
131231400|NCT00818623|472473333|FG006|Overall Study|Protocol Violation|1|||
131231401|NCT00818623|472473334|FG007|Overall Study|Protocol Violation|0|||
131231402|NCT00818623|472473327|FG000|Overall Study|Need of additional treatment|0|||
131231403|NCT00818623|472473328|FG001|Overall Study|Need of additional treatment|0|||
131231404|NCT00818623|472473329|FG002|Overall Study|Need of additional treatment|0|||
131231405|NCT00818623|472473330|FG003|Overall Study|Need of additional treatment|0|||
131231406|NCT00818623|472473331|FG004|Overall Study|Need of additional treatment|1|||
131231407|NCT00818623|472473332|FG005|Overall Study|Need of additional treatment|0|||
131231408|NCT00818623|472473333|FG006|Overall Study|Need of additional treatment|0|||
131231409|NCT00818623|472473334|FG007|Overall Study|Need of additional treatment|0|||
131231410|NCT00818623|472473327|FG000|Overall Study|Lack of trial drug at site|0|||
131231411|NCT00818623|472473328|FG001|Overall Study|Lack of trial drug at site|0|||
131231412|NCT00818623|472473329|FG002|Overall Study|Lack of trial drug at site|0|||
131231413|NCT00818623|472473330|FG003|Overall Study|Lack of trial drug at site|0|||
131231414|NCT00818623|472473331|FG004|Overall Study|Lack of trial drug at site|2|||
131231415|NCT00818623|472473332|FG005|Overall Study|Lack of trial drug at site|0|||
131231416|NCT00818623|472473333|FG006|Overall Study|Lack of trial drug at site|1|||
131231417|NCT00818623|472473334|FG007|Overall Study|Lack of trial drug at site|0|||
131231418|NCT00818623|472473327|FG000|Overall Study|Disease progression|0|||
131231419|NCT00818623|472473328|FG001|Overall Study|Disease progression|0|||
131231420|NCT00818623|472473329|FG002|Overall Study|Disease progression|0|||
131231421|NCT00818623|472473330|FG003|Overall Study|Disease progression|0|||
131231422|NCT00818623|472473331|FG004|Overall Study|Disease progression|0|||
131077088|NCT01468077|471915939|FG001|Overall Study|Physician Decision|0|||
131077089|NCT00761956|471915940|FG000|Overall Study|Lost to Follow-up|6|||
131077090|NCT00761956|471915941|FG001|Overall Study|Lost to Follow-up|11|||
131077091|NCT00761956|471915940|FG000|Overall Study|Withdrawal by Subject|3|||
131077092|NCT00761956|471915941|FG001|Overall Study|Withdrawal by Subject|8|||
131231423|NCT00818623|472473332|FG005|Overall Study|Disease progression|0|||
131231424|NCT00818623|472473333|FG006|Overall Study|Disease progression|1|||
131077093|NCT00761956|471915940|FG000|Overall Study|Death|0|||
131077094|NCT00761956|471915941|FG001|Overall Study|Death|1|||
131077095|NCT00761956|471915940|FG000|Overall Study|Adverse Event|26|||
131077096|NCT00761956|471915941|FG001|Overall Study|Adverse Event|34|||
131077097|NCT01951378|471915944|FG000|Overall Study|Study Terminated-Not completed|23|||
131077098|NCT01951378|471915945|FG001|Overall Study|Study Terminated-Not completed|17|||
131077099|NCT00464945|471915946|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
131077100|NCT00464945|471915947|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
131077101|NCT00464945|471915946|FG000|Infant Series|Protocol Violation|1|||
131077102|NCT00464945|471915947|FG001|Infant Series|Protocol Violation|0|||
131077103|NCT00464945|471915946|FG000|Infant Series|Lost to Follow-up|1|||
131231425|NCT00818623|472473334|FG007|Overall Study|Disease progression|0|||
131231426|NCT00602030|472473335|FG000|Lead-in Phase|Disease Progression|2|||
131231427|NCT00602030|472473336|FG001|Lead-in Phase|Disease Progression|3|||
131231428|NCT00602030|472473337|FG002|Lead-in Phase|Disease Progression|0|||
131231429|NCT00602030|472473338|FG003|Lead-in Phase|Disease Progression|0|||
131231430|NCT00602030|472473339|FG004|Lead-in Phase|Disease Progression|0|||
131231431|NCT00602030|472473335|FG000|Lead-in Phase|Adverse Event|0|||
131231432|NCT00602030|472473336|FG001|Lead-in Phase|Adverse Event|2|||
130725195|NCT04844762|470619304|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725196|NCT04844762|470619305|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130725197|NCT04844762|470619300|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725198|NCT04844762|470619301|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725199|NCT04844762|470619302|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
130725200|NCT04844762|470619303|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
130725201|NCT04844762|470619304|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
130725202|NCT04844762|470619305|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725203|NCT04844762|470619300|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
130725204|NCT04844762|470619301|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
130725205|NCT04844762|470619302|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725206|NCT04844762|470619303|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725207|NCT04844762|470619304|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725208|NCT04844762|470619305|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725209|NCT04844762|470619300|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130725210|NCT04844762|470619301|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725211|NCT04844762|470619302|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725212|NCT04844762|470619303|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725213|NCT04844762|470619304|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725214|NCT04844762|470619305|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725215|NCT04844762|470619300|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725216|NCT04844762|470619301|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725217|NCT04844762|470619302|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725218|NCT04844762|470619303|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725219|NCT04844762|470619304|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
130725220|NCT04844762|470619305|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130725221|NCT04844762|470619300|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
130725222|NCT04844762|470619301|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725223|NCT04844762|470619302|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725224|NCT04844762|470619303|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725225|NCT04844762|470619304|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725226|NCT04844762|470619305|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130725227|NCT04844762|470619300|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130725228|NCT04844762|470619301|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725229|NCT04844762|470619302|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725230|NCT04844762|470619303|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725231|NCT04844762|470619304|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130725232|NCT04844762|470619305|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130725233|NCT04844762|470619300|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130725234|NCT04844762|470619301|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
130725235|NCT04844762|470619302|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
131077104|NCT00464945|471915947|FG001|Infant Series|Lost to Follow-up|0|||
131077105|NCT00464945|471915946|FG000|After Infant Series|Withdrawal by Subject|0|||
131077106|NCT00464945|471915947|FG001|After Infant Series|Withdrawal by Subject|2|||
131231433|NCT00602030|472473337|FG002|Lead-in Phase|Adverse Event|0|||
131231434|NCT00602030|472473338|FG003|Lead-in Phase|Adverse Event|0|||
131231435|NCT00602030|472473339|FG004|Lead-in Phase|Adverse Event|0|||
131231436|NCT00602030|472473335|FG000|Double-blind Phase|Disease progression|0|||
131077107|NCT00464945|471915946|FG000|Toddler Dose|Lost to Follow-up|0|||
130725236|NCT04844762|470619303|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130725237|NCT04844762|470619304|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130725238|NCT04844762|470619305|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
131077108|NCT00464945|471915947|FG001|Toddler Dose|Lost to Follow-up|1|||
131077109|NCT03065933|471915950|FG000|Overall Study|study terminated|5|||
131077110|NCT02536742|471915951|FG000|Overall Study|Did not start protocol therapy|1|||
131077111|NCT02536742|471915951|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
131077112|NCT04629443|471915952|FG000|Overall Study|Adverse Event|2|||
131077113|NCT04629443|471915953|FG001|Overall Study|Adverse Event|1|||
131077114|NCT04629443|471915954|FG002|Overall Study|Adverse Event|2|||
131077115|NCT04629443|471915952|FG000|Overall Study|Progressive Disease|2|||
131077116|NCT04629443|471915953|FG001|Overall Study|Progressive Disease|3|||
131077117|NCT04629443|471915954|FG002|Overall Study|Progressive Disease|3|||
131077118|NCT04629443|471915952|FG000|Overall Study|Physician Decision|1|||
131077119|NCT04629443|471915953|FG001|Overall Study|Physician Decision|3|||
131077120|NCT04629443|471915954|FG002|Overall Study|Physician Decision|0|||
131077121|NCT01547117|471915955|FG000|Overall Study|Physician Decision|0|||
131077122|NCT01547117|471915956|FG001|Overall Study|Physician Decision|1|||
131077123|NCT01547117|471915957|FG002|Overall Study|Physician Decision|1|||
131077124|NCT01547117|471915958|FG003|Overall Study|Physician Decision|3|||
131138765|NCT01505894|472134145|FG002|Overall Study|Other than specified|0|||
131138766|NCT01505894|472134146|FG003|Overall Study|Other than specified|0|||
131138767|NCT01505894|472134147|FG004|Overall Study|Other than specified|1|||
131138768|NCT01505894|472134148|FG005|Overall Study|Other than specified|0|||
131138769|NCT01505894|472134149|FG006|Overall Study|Other than specified|0|||
131138770|NCT01505894|472134150|FG007|Overall Study|Other than specified|0|||
131138771|NCT01505894|472134151|FG008|Overall Study|Other than specified|0|||
131138772|NCT01001702|472134152|FG000|Overall Study|Lost to Follow-up|7|||
131138773|NCT01001702|472134152|FG000|Overall Study|Adverse Event|7|||
131138774|NCT01001702|472134152|FG000|Overall Study|Sponsor Discontinued Study|4|||
131138775|NCT01001702|472134152|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
131138776|NCT01001702|472134152|FG000|Overall Study|Investigator withdrew Subject|10|||
131138777|NCT01001702|472134152|FG000|Overall Study|Withdrawal by Subject|19|||
131138778|NCT01001702|472134152|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
131138779|NCT00094757|472134153|FG000|Overall Study|Adverse Event|11|||
131138780|NCT00094757|472134154|FG001|Overall Study|Adverse Event|9|||
131138781|NCT00094757|472134155|FG002|Overall Study|Adverse Event|6|||
131138782|NCT00094757|472134153|FG000|Overall Study|Lack of Efficacy|11|||
131138783|NCT00094757|472134154|FG001|Overall Study|Lack of Efficacy|15|||
131138784|NCT00094757|472134155|FG002|Overall Study|Lack of Efficacy|8|||
131138785|NCT00094757|472134153|FG000|Overall Study|Lost to Follow-up|3|||
131138786|NCT00094757|472134154|FG001|Overall Study|Lost to Follow-up|5|||
131138787|NCT00094757|472134155|FG002|Overall Study|Lost to Follow-up|6|||
131138788|NCT00094757|472134153|FG000|Overall Study|Patient Moved|2|||
131138789|NCT00094757|472134154|FG001|Overall Study|Patient Moved|1|||
131138790|NCT00094757|472134155|FG002|Overall Study|Patient Moved|1|||
131138791|NCT00094757|472134153|FG000|Overall Study|Protocol Violation|8|||
131138792|NCT00094757|472134154|FG001|Overall Study|Protocol Violation|5|||
131138793|NCT00094757|472134155|FG002|Overall Study|Protocol Violation|3|||
131138794|NCT00094757|472134153|FG000|Overall Study|Withdrawal by Subject|14|||
131138795|NCT00094757|472134154|FG001|Overall Study|Withdrawal by Subject|21|||
131138796|NCT00094757|472134155|FG002|Overall Study|Withdrawal by Subject|5|||
131138797|NCT00094757|472134153|FG000|Overall Study|Other|3|||
131138798|NCT00094757|472134154|FG001|Overall Study|Other|3|||
131138799|NCT00094757|472134155|FG002|Overall Study|Other|1|||
131138800|NCT00094757|472134153|FG000|Overall Study|Protocol specified discontinuation|1|||
131231437|NCT00602030|472473336|FG001|Double-blind Phase|Disease progression|0|||
131231438|NCT00602030|472473337|FG002|Double-blind Phase|Disease progression|33|||
130725239|NCT04844762|470619300|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130725240|NCT04844762|470619301|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130725241|NCT04844762|470619302|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
131077125|NCT01547117|471915955|FG000|Overall Study|Withdrawal by Subject|1|||
131077126|NCT01547117|471915956|FG001|Overall Study|Withdrawal by Subject|2|||
131077127|NCT01547117|471915957|FG002|Overall Study|Withdrawal by Subject|1|||
131077128|NCT01547117|471915958|FG003|Overall Study|Withdrawal by Subject|2|||
131138801|NCT00094757|472134154|FG001|Overall Study|Protocol specified discontinuation|3|||
131138802|NCT00094757|472134155|FG002|Overall Study|Protocol specified discontinuation|0|||
131138803|NCT00090545|472134156|FG000|Overall Study|Disease progression on study|21|||
131138804|NCT00090545|472134157|FG001|Overall Study|Disease progression on study|17|||
131138805|NCT00090545|472134156|FG000|Overall Study|Refused further treatment|1|||
131138806|NCT00090545|472134157|FG001|Overall Study|Refused further treatment|4|||
131138807|NCT00090545|472134156|FG000|Overall Study|Death|0|||
131138808|NCT00090545|472134157|FG001|Overall Study|Death|1|||
131138809|NCT00090545|472134156|FG000|Overall Study|Adverse Event|0|||
131138810|NCT00090545|472134157|FG001|Overall Study|Adverse Event|2|||
130725242|NCT04844762|470619303|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
130725243|NCT04844762|470619304|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130725244|NCT04844762|470619305|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130725245|NCT04400682|470619308|FG000|Period 1|Withdrawal by Subject|1|||
131077129|NCT03491215|471915962|FG000|Overall Study|Death|6|||
131077130|NCT03491215|471915963|FG001|Overall Study|Death|2|||
131077131|NCT03491215|471915964|FG002|Overall Study|Death|1|||
131077132|NCT03491215|471915965|FG003|Overall Study|Death|0|||
131077133|NCT03491215|471915962|FG000|Overall Study|Physician Decision|1|||
131077134|NCT03491215|471915963|FG001|Overall Study|Physician Decision|0|||
131077135|NCT03491215|471915964|FG002|Overall Study|Physician Decision|0|||
131077136|NCT03491215|471915965|FG003|Overall Study|Physician Decision|0|||
131077137|NCT00704171|471915970|FG000|Overall Study|Withdrawal by Subject|1|||
131077138|NCT00704171|471915971|FG001|Overall Study|Withdrawal by Subject|0|||
131077139|NCT00233389|471915974|FG000|Overall Study|Adverse Event|5|||
131077140|NCT00233389|471915975|FG001|Overall Study|Adverse Event|5|||
131077141|NCT00233389|471915974|FG000|Overall Study|Lack of Efficacy|11|||
131077142|NCT00233389|471915975|FG001|Overall Study|Lack of Efficacy|8|||
131077143|NCT00233389|471915974|FG000|Overall Study|Lost to Follow-up|1|||
131077144|NCT00233389|471915975|FG001|Overall Study|Lost to Follow-up|1|||
131077145|NCT00233389|471915974|FG000|Overall Study|Physician Decision|1|||
131077146|NCT00233389|471915975|FG001|Overall Study|Physician Decision|0|||
131077147|NCT00233389|471915974|FG000|Overall Study|Protocol Violation|0|||
131077148|NCT00233389|471915975|FG001|Overall Study|Protocol Violation|1|||
131077149|NCT00233389|471915974|FG000|Overall Study|Withdrawal by Subject|0|||
131077150|NCT00233389|471915975|FG001|Overall Study|Withdrawal by Subject|1|||
131077151|NCT00719043|471915978|FG000|Overall Study|Adverse Event|5|||
131077152|NCT00719043|471915979|FG001|Overall Study|Adverse Event|1|||
131077153|NCT00719043|471915980|FG002|Overall Study|Adverse Event|2|||
131077154|NCT00719043|471915981|FG003|Overall Study|Adverse Event|2|||
131077155|NCT00719043|471915982|FG004|Overall Study|Adverse Event|1|||
131077156|NCT00719043|471915983|FG005|Overall Study|Adverse Event|4|||
131077157|NCT00719043|471915984|FG006|Overall Study|Adverse Event|4|||
131077158|NCT00719043|471915978|FG000|Overall Study|Lost to Follow-up|14|||
131077159|NCT00719043|471915979|FG001|Overall Study|Lost to Follow-up|10|||
131077160|NCT00719043|471915980|FG002|Overall Study|Lost to Follow-up|8|||
131077161|NCT00719043|471915981|FG003|Overall Study|Lost to Follow-up|9|||
131077162|NCT00719043|471915982|FG004|Overall Study|Lost to Follow-up|10|||
131077163|NCT00719043|471915983|FG005|Overall Study|Lost to Follow-up|9|||
131077164|NCT00719043|471915984|FG006|Overall Study|Lost to Follow-up|9|||
131077165|NCT00719043|471915978|FG000|Overall Study|Protocol Violation|0|||
131077166|NCT00719043|471915979|FG001|Overall Study|Protocol Violation|0|||
131077167|NCT00719043|471915980|FG002|Overall Study|Protocol Violation|0|||
131077168|NCT00719043|471915981|FG003|Overall Study|Protocol Violation|0|||
131077169|NCT00719043|471915982|FG004|Overall Study|Protocol Violation|0|||
131077170|NCT00719043|471915983|FG005|Overall Study|Protocol Violation|1|||
131077171|NCT00719043|471915984|FG006|Overall Study|Protocol Violation|0|||
131077172|NCT00719043|471915978|FG000|Overall Study|Other|1|||
131077173|NCT00719043|471915979|FG001|Overall Study|Other|0|||
130725246|NCT04400682|470619309|FG001|Period 1|Withdrawal by Subject|4|||
130725247|NCT02293863|470619310|FG000|Overall Study|Death|4|||
131077174|NCT00719043|471915980|FG002|Overall Study|Other|1|||
131077175|NCT00719043|471915981|FG003|Overall Study|Other|2|||
131077176|NCT00719043|471915982|FG004|Overall Study|Other|0|||
131077177|NCT00719043|471915983|FG005|Overall Study|Other|2|||
131077178|NCT00719043|471915984|FG006|Overall Study|Other|1|||
131077179|NCT00719043|471915978|FG000|Overall Study|Withdrawal by Subject|12|||
131077180|NCT00719043|471915979|FG001|Overall Study|Withdrawal by Subject|14|||
131077181|NCT00719043|471915980|FG002|Overall Study|Withdrawal by Subject|9|||
131077182|NCT00719043|471915981|FG003|Overall Study|Withdrawal by Subject|10|||
131077183|NCT00719043|471915982|FG004|Overall Study|Withdrawal by Subject|16|||
131077184|NCT00719043|471915983|FG005|Overall Study|Withdrawal by Subject|18|||
131077185|NCT00719043|471915984|FG006|Overall Study|Withdrawal by Subject|14|||
131077186|NCT01588366|471915985|FG000|Overall Study|Adverse Event|0|||
131077187|NCT01588366|471915986|FG001|Overall Study|Adverse Event|1|||
131077188|NCT01588366|471915987|FG002|Overall Study|Adverse Event|0|||
131077189|NCT01588366|471915988|FG003|Overall Study|Adverse Event|1|||
131077190|NCT01588366|471915989|FG004|Overall Study|Adverse Event|0|||
131077191|NCT01588366|471915990|FG005|Overall Study|Adverse Event|2|||
131077192|NCT00302159|471915991|FG000|Overall Study|pt declined before treatment started|1|||
131077193|NCT00302159|471915991|FG000|Overall Study|pt started Avastin|1|||
131077194|NCT01336205|471915992|FG000|Overall Study|Other|22|||
131077195|NCT01336205|471915993|FG001|Overall Study|Other|9|||
131077196|NCT01336205|471915992|FG000|Overall Study|Lost to Follow-up|40|||
131077197|NCT01336205|471915993|FG001|Overall Study|Lost to Follow-up|20|||
130725248|NCT02293863|470619311|FG001|Overall Study|Death|6|||
131077198|NCT01336205|471915992|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
131077199|NCT01336205|471915993|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
131077200|NCT01336205|471915992|FG000|Overall Study|Lack of Efficacy|4|||
131077201|NCT01336205|471915993|FG001|Overall Study|Lack of Efficacy|0|||
131231439|NCT00602030|472473338|FG003|Double-blind Phase|Disease progression|30|||
131231440|NCT00602030|472473339|FG004|Double-blind Phase|Disease progression|0|||
131231441|NCT00602030|472473335|FG000|Double-blind Phase|Adverse Event|0|||
131231442|NCT00602030|472473336|FG001|Double-blind Phase|Adverse Event|0|||
131231443|NCT00602030|472473337|FG002|Double-blind Phase|Adverse Event|9|||
131231444|NCT00602030|472473338|FG003|Double-blind Phase|Adverse Event|18|||
131231445|NCT00602030|472473339|FG004|Double-blind Phase|Adverse Event|0|||
131077202|NCT01336205|471915992|FG000|Overall Study|Severe noncompliance with protocol|9|||
131077203|NCT01336205|471915993|FG001|Overall Study|Severe noncompliance with protocol|2|||
131077204|NCT01336205|471915992|FG000|Overall Study|Adverse Event|56|||
131077205|NCT01336205|471915993|FG001|Overall Study|Adverse Event|6|||
131077206|NCT01336205|471915992|FG000|Overall Study|Death|1|||
131077207|NCT01336205|471915993|FG001|Overall Study|Death|1|||
131077208|NCT01336205|471915992|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
131077209|NCT01336205|471915993|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
131077210|NCT01336205|471915992|FG000|Overall Study|Withdrawal by Subject|72|||
131077211|NCT01336205|471915993|FG001|Overall Study|Withdrawal by Subject|38|||
131077212|NCT01336205|471915992|FG000|Overall Study|Did not receive treatment|4|||
131077213|NCT01336205|471915993|FG001|Overall Study|Did not receive treatment|0|||
131077214|NCT01006616|471915994|FG000|Period 1 (6 Months)|Adverse Event|10|||
131077215|NCT01006616|471915995|FG001|Period 1 (6 Months)|Adverse Event|31|||
131077216|NCT01006616|471915996|FG002|Period 1 (6 Months)|Adverse Event|37|||
131077217|NCT01006616|471915997|FG003|Period 1 (6 Months)|Adverse Event|9|||
131077218|NCT01006616|471915994|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
131077219|NCT01006616|471915995|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
131077220|NCT01006616|471915996|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
131077221|NCT01006616|471915997|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
131077222|NCT01006616|471915994|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
131077223|NCT01006616|471915995|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
131077224|NCT01006616|471915996|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
131077225|NCT01006616|471915997|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
131077226|NCT01006616|471915994|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
131077227|NCT01006616|471915995|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
131077228|NCT01006616|471915996|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
131077229|NCT01006616|471915997|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
131077230|NCT01006616|471915994|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
131077231|NCT01006616|471915995|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
131077232|NCT01006616|471915996|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
131077233|NCT01006616|471915997|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
131077234|NCT01006616|471915994|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
131077235|NCT01006616|471915995|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
131077236|NCT01006616|471915996|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
131077237|NCT01006616|471915997|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
131077238|NCT01006616|471915994|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
131077239|NCT01006616|471915995|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
131077240|NCT01006616|471915996|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
131077241|NCT01006616|471915997|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
131077242|NCT01006616|471915994|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
131077243|NCT01006616|471915995|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
131077244|NCT01006616|471915996|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
131077245|NCT01006616|471915997|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
131077246|NCT01006616|471915994|FG000|Period 1 (6 Months)|Not Treated|0|||
131077247|NCT01006616|471915995|FG001|Period 1 (6 Months)|Not Treated|0|||
131077248|NCT01006616|471915996|FG002|Period 1 (6 Months)|Not Treated|1|||
131077249|NCT01006616|471915997|FG003|Period 1 (6 Months)|Not Treated|1|||
131077250|NCT01006616|471915994|FG000|Period 2 (18 Months)|Adverse Event|6|||
131077251|NCT01006616|471915995|FG001|Period 2 (18 Months)|Adverse Event|6|||
131077252|NCT01006616|471915996|FG002|Period 2 (18 Months)|Adverse Event|6|||
131077253|NCT01006616|471915997|FG003|Period 2 (18 Months)|Adverse Event|4|||
131077254|NCT01006616|471915994|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
131077255|NCT01006616|471915995|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
131077256|NCT01006616|471915996|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
131077257|NCT01006616|471915997|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
131077258|NCT01006616|471915994|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
131077259|NCT01006616|471915995|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
131077260|NCT01006616|471915996|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
131077261|NCT01006616|471915997|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
131077262|NCT01006616|471915994|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
131077263|NCT01006616|471915995|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
131077264|NCT01006616|471915996|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
131231446|NCT00602030|472473335|FG000|Double-blind Phase|Consent withdrawal|0|||
131231447|NCT00602030|472473336|FG001|Double-blind Phase|Consent withdrawal|0|||
131231448|NCT00602030|472473337|FG002|Double-blind Phase|Consent withdrawal|4|||
130725249|NCT02293863|470619312|FG002|Overall Study|Death|4|||
130725250|NCT02293863|470619310|FG000|Overall Study|Lost to Follow-up|2|||
130725251|NCT02293863|470619311|FG001|Overall Study|Lost to Follow-up|2|||
130725252|NCT02293863|470619312|FG002|Overall Study|Lost to Follow-up|2|||
130725253|NCT02293863|470619310|FG000|Overall Study|Withdrawal by Subject|3|||
130725254|NCT02293863|470619311|FG001|Overall Study|Withdrawal by Subject|3|||
130725255|NCT02293863|470619312|FG002|Overall Study|Withdrawal by Subject|1|||
130725256|NCT02293863|470619310|FG000|Overall Study|Reason Not Specified|0|||
130725257|NCT02293863|470619311|FG001|Overall Study|Reason Not Specified|2|||
130725258|NCT02293863|470619312|FG002|Overall Study|Reason Not Specified|2|||
131077265|NCT01006616|471915997|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
130725259|NCT00477633|470619313|FG000|Overall Study|Did not receive treatment|23|||
130725260|NCT00477633|470619313|FG000|Overall Study|Adverse Event|143|||
130725261|NCT00477633|470619313|FG000|Overall Study|Pregnancy|23|||
130725262|NCT00477633|470619313|FG000|Overall Study|Lost to Follow-up|271|||
130725263|NCT00477633|470619313|FG000|Overall Study|Withdrawal by Subject|149|||
130725264|NCT00477633|470619313|FG000|Overall Study|Protocol Violation|25|||
130725265|NCT00477633|470619313|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
130725266|NCT01374269|470619322|FG000|Overall Study|Withdrawal by Subject|4|||
130725267|NCT01374269|470619323|FG001|Overall Study|Withdrawal by Subject|0|||
130725268|NCT01374269|470619322|FG000|Overall Study|Lost to Follow-up|1|||
130725269|NCT01374269|470619323|FG001|Overall Study|Lost to Follow-up|3|||
130725270|NCT01374269|470619322|FG000|Overall Study|closed research|1|||
130725271|NCT01374269|470619323|FG001|Overall Study|closed research|2|||
130725272|NCT00996892|470619324|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
130725273|NCT00996892|470619325|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
130725274|NCT00996892|470619326|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
130725275|NCT00996892|470619327|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
130725276|NCT00996892|470619328|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
130725277|NCT00996892|470619329|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
130725278|NCT00996892|470619330|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
130725279|NCT00996892|470619331|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
130725280|NCT00996892|470619332|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
130725281|NCT00996892|470619333|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
130725282|NCT00996892|470619334|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
130725283|NCT00996892|470619335|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
130725284|NCT00996892|470619336|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
130725285|NCT00996892|470619337|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
130725286|NCT00996892|470619338|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
130725287|NCT00996892|470619339|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
130725288|NCT00996892|470619340|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
130725289|NCT00996892|470619341|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
130725290|NCT00996892|470619342|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
130725291|NCT00996892|470619343|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
130725292|NCT00996892|470619324|FG000|Dose-Escalation Stage 1|Death|1|||
130725293|NCT00996892|470619325|FG001|Dose-Escalation Stage 1|Death|0|||
130725294|NCT00996892|470619326|FG002|Dose-Escalation Stage 1|Death|0|||
130725295|NCT00996892|470619327|FG003|Dose-Escalation Stage 1|Death|0|||
131231449|NCT00602030|472473338|FG003|Double-blind Phase|Consent withdrawal|3|||
131231450|NCT00602030|472473339|FG004|Double-blind Phase|Consent withdrawal|0|||
131231451|NCT00602030|472473335|FG000|Double-blind Phase|Death|0|||
131231452|NCT00602030|472473336|FG001|Double-blind Phase|Death|0|||
131231453|NCT00602030|472473337|FG002|Double-blind Phase|Death|3|||
131231454|NCT00602030|472473338|FG003|Double-blind Phase|Death|3|||
131231455|NCT00602030|472473339|FG004|Double-blind Phase|Death|0|||
131077266|NCT01006616|471915994|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
131077267|NCT01006616|471915995|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
131077268|NCT01006616|471915996|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
131077269|NCT01006616|471915997|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
131077270|NCT01006616|471915994|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
131077271|NCT01006616|471915995|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
131077272|NCT01006616|471915996|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
131077273|NCT01006616|471915997|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
131077274|NCT01006616|471915994|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
131077275|NCT01006616|471915995|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
130725296|NCT00996892|470619328|FG004|Dose-Escalation Stage 1|Death|0|||
131231456|NCT00602030|472473335|FG000|Double-blind Phase|Administrative decision|0|||
130725297|NCT00996892|470619329|FG005|Dose-Escalation Stage 1|Death|1|||
130725298|NCT00996892|470619330|FG006|Dose-Escalation Stage 1|Death|0|||
130725299|NCT00996892|470619331|FG007|Dose-Escalation Stage 1|Death|0|||
130725300|NCT00996892|470619332|FG008|Dose-Escalation Stage 1|Death|0|||
130725301|NCT00996892|470619333|FG009|Dose-Escalation Stage 1|Death|0|||
130725302|NCT00996892|470619334|FG010|Dose-Escalation Stage 1|Death|0|||
130725303|NCT00996892|470619335|FG011|Dose-Escalation Stage 1|Death|0|||
130725304|NCT00996892|470619336|FG012|Dose-Escalation Stage 1|Death|0|||
130725305|NCT00996892|470619337|FG013|Dose-Escalation Stage 1|Death|0|||
131077276|NCT01006616|471915996|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
131077277|NCT01006616|471915997|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
131077278|NCT01006616|471915994|FG000|Period 2 (18 Months)|Study Terminated|63|||
131077279|NCT01006616|471915995|FG001|Period 2 (18 Months)|Study Terminated|46|||
131077280|NCT01006616|471915996|FG002|Period 2 (18 Months)|Study Terminated|44|||
131077281|NCT01006616|471915997|FG003|Period 2 (18 Months)|Study Terminated|70|||
131077282|NCT02482935|471915998|FG000|Period 1|Withdrawal by Subject|1|||
131077283|NCT02482935|471915999|FG001|Period 1|Withdrawal by Subject|0|||
131077284|NCT01585298|471916004|FG000|Overall Study|Study completion was not documented.|1|||
131077285|NCT01585298|471916004|FG000|Overall Study|Protocol deviation|1|||
131077286|NCT01585298|471916004|FG000|Overall Study|Administrative problems|4|||
131077287|NCT01585298|471916004|FG000|Overall Study|Lost to Follow-up|2|||
131077288|NCT01585298|471916004|FG000|Overall Study|Withdrawal by Subject|4|||
131077289|NCT01585298|471916004|FG000|Overall Study|Abnormal test procedure results|1|||
131077290|NCT01585298|471916004|FG000|Overall Study|Adverse Event|24|||
131077291|NCT01898442|471916006|FG000|Overall Study|Hemolysis/technical problems|1|||
131077292|NCT01898442|471916007|FG001|Overall Study|Hemolysis/technical problems|2|||
131138811|NCT04317274|472134158|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
131138812|NCT04317274|472134159|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
131138813|NCT04317274|472134160|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
131138814|NCT04317274|472134161|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
131138815|NCT02568046|472134162|FG000|Overall Study|Adverse Event|0|||
131138816|NCT02568046|472134163|FG001|Overall Study|Adverse Event|1|||
131138817|NCT02568046|472134162|FG000|Overall Study|Death|2|||
131138818|NCT02568046|472134163|FG001|Overall Study|Death|0|||
131138819|NCT02568046|472134162|FG000|Overall Study|Progressive Disease|1|||
131138820|NCT02568046|472134163|FG001|Overall Study|Progressive Disease|0|||
131138821|NCT02568046|472134162|FG000|Overall Study|Withdrawal by Subject|2|||
130725306|NCT00996892|470619338|FG014|Dose-Escalation Stage 1|Death|0|||
130725307|NCT00996892|470619339|FG015|Dose-Escalation Stage 1|Death|0|||
130725308|NCT00996892|470619340|FG016|Dose-Escalation Stage 1|Death|0|||
130725309|NCT00996892|470619341|FG017|Dose-Escalation Stage 1|Death|0|||
130725310|NCT00996892|470619342|FG018|Dose-Escalation Stage 1|Death|0|||
130725311|NCT00996892|470619343|FG019|Dose-Escalation Stage 1|Death|0|||
130725312|NCT00996892|470619324|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
130725313|NCT00996892|470619325|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
130725314|NCT00996892|470619326|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
130725315|NCT00996892|470619327|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
130725316|NCT00996892|470619328|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
130725317|NCT00996892|470619329|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
130725318|NCT00996892|470619330|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
130725319|NCT00996892|470619331|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
130725320|NCT00996892|470619332|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
130725321|NCT00996892|470619333|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
130725322|NCT00996892|470619334|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
130725323|NCT00996892|470619335|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
130725324|NCT00996892|470619336|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
130725325|NCT00996892|470619337|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
130725326|NCT00996892|470619338|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
130725327|NCT00996892|470619339|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
130725328|NCT00996892|470619340|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
130725329|NCT00996892|470619341|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
130725330|NCT00996892|470619342|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
130725331|NCT00996892|470619343|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
130725332|NCT00996892|470619324|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725333|NCT00996892|470619325|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130725334|NCT00996892|470619326|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725335|NCT00996892|470619327|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
130725336|NCT00996892|470619328|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130725337|NCT00996892|470619329|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130725338|NCT00996892|470619330|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130725339|NCT00996892|470619331|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725340|NCT00996892|470619332|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725341|NCT00996892|470619333|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725342|NCT00996892|470619334|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725343|NCT00996892|470619335|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725344|NCT00996892|470619336|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131077293|NCT01898442|471916008|FG002|Overall Study|Hemolysis/technical problems|2|||
131077294|NCT01898442|471916006|FG000|Overall Study|Patient vomited pills|0|||
131077295|NCT01898442|471916007|FG001|Overall Study|Patient vomited pills|0|||
130725345|NCT00996892|470619337|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
131231457|NCT00602030|472473336|FG001|Double-blind Phase|Administrative decision|0|||
131231458|NCT00602030|472473337|FG002|Double-blind Phase|Administrative decision|0|||
131231459|NCT00602030|472473338|FG003|Double-blind Phase|Administrative decision|2|||
131231460|NCT00602030|472473339|FG004|Double-blind Phase|Administrative decision|0|||
131231461|NCT00602030|472473335|FG000|Double-blind Phase|Ineligibility|0|||
131231462|NCT00602030|472473336|FG001|Double-blind Phase|Ineligibility|0|||
131231463|NCT00602030|472473337|FG002|Double-blind Phase|Ineligibility|0|||
131231464|NCT00602030|472473338|FG003|Double-blind Phase|Ineligibility|1|||
131231465|NCT00602030|472473339|FG004|Double-blind Phase|Ineligibility|0|||
131231466|NCT00602030|472473335|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
131231467|NCT00602030|472473336|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
131231468|NCT00602030|472473337|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
131231469|NCT00602030|472473338|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
131231470|NCT00602030|472473339|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
131231471|NCT00602030|472473335|FG000|Double-blind Phase|Reason not specified|0|||
131231472|NCT00602030|472473336|FG001|Double-blind Phase|Reason not specified|0|||
131231473|NCT00602030|472473337|FG002|Double-blind Phase|Reason not specified|4|||
131231474|NCT00602030|472473338|FG003|Double-blind Phase|Reason not specified|2|||
130725346|NCT00996892|470619338|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725347|NCT00996892|470619339|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725348|NCT00996892|470619340|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725349|NCT00996892|470619341|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725350|NCT00996892|470619342|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725351|NCT00996892|470619343|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130725352|NCT00996892|470619324|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
130725353|NCT00996892|470619325|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
130725354|NCT00996892|470619326|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
130725355|NCT00996892|470619327|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
130725356|NCT00996892|470619328|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
130725357|NCT00996892|470619329|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
131231475|NCT00602030|472473339|FG004|Double-blind Phase|Reason not specified|0|||
131231476|NCT00602030|472473335|FG000|Crossover Phase|Disease Progression|0|||
130725358|NCT00996892|470619330|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
130725359|NCT00996892|470619331|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
130725360|NCT00996892|470619332|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
130725361|NCT00996892|470619333|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
130725362|NCT00996892|470619334|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
130725363|NCT00996892|470619335|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
130725364|NCT00996892|470619336|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
130725365|NCT00996892|470619337|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
131077296|NCT01898442|471916008|FG002|Overall Study|Patient vomited pills|1|||
131077297|NCT05178979|471916009|FG000|Overall Study|Death|0|||
131077298|NCT05178979|471916010|FG001|Overall Study|Death|5|||
131077299|NCT05178979|471916011|FG002|Overall Study|Death|0|||
131077300|NCT05178979|471916012|FG003|Overall Study|Death|3|||
131077301|NCT05178979|471916009|FG000|Overall Study|Adverse Event|0|||
131077302|NCT05178979|471916010|FG001|Overall Study|Adverse Event|1|||
131077303|NCT05178979|471916011|FG002|Overall Study|Adverse Event|0|||
131077304|NCT05178979|471916012|FG003|Overall Study|Adverse Event|0|||
131077305|NCT05178979|471916009|FG000|Overall Study|Lost to Follow-up|1|||
131077306|NCT05178979|471916010|FG001|Overall Study|Lost to Follow-up|8|||
131077307|NCT05178979|471916011|FG002|Overall Study|Lost to Follow-up|3|||
131077308|NCT05178979|471916012|FG003|Overall Study|Lost to Follow-up|8|||
131077309|NCT01704547|471916014|FG000|Overall Study|Physician Decision|4|||
131077310|NCT01704547|471916014|FG000|Overall Study|Withdrawal by Subject|1|||
131077311|NCT02019641|471916021|FG000|10-Week Follow up|Withdrawal by investigator|2|||
131077312|NCT02019641|471916022|FG001|10-Week Follow up|Withdrawal by investigator|0|||
131077313|NCT02019641|471916023|FG002|10-Week Follow up|Withdrawal by investigator|0|||
131077314|NCT02019641|471916021|FG000|10-Week Follow up|Withdrawal by Subject|1|||
131077315|NCT02019641|471916022|FG001|10-Week Follow up|Withdrawal by Subject|1|||
131077316|NCT02019641|471916023|FG002|10-Week Follow up|Withdrawal by Subject|0|||
131077317|NCT02019641|471916021|FG000|20-Week Follow up|Withdrawal by investigator|0|||
131077318|NCT02019641|471916022|FG001|20-Week Follow up|Withdrawal by investigator|0|||
131231477|NCT00602030|472473336|FG001|Crossover Phase|Disease Progression|0|||
131231478|NCT00602030|472473337|FG002|Crossover Phase|Disease Progression|0|||
131231479|NCT00602030|472473338|FG003|Crossover Phase|Disease Progression|0|||
131231480|NCT00602030|472473339|FG004|Crossover Phase|Disease Progression|11|||
131231481|NCT00602030|472473335|FG000|Crossover Phase|Adverse Event|0|||
131231482|NCT00602030|472473336|FG001|Crossover Phase|Adverse Event|0|||
130725366|NCT00996892|470619338|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
130725367|NCT00996892|470619339|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
130725368|NCT00996892|470619340|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
131077319|NCT02019641|471916023|FG002|20-Week Follow up|Withdrawal by investigator|1|||
131077320|NCT03318783|471916024|FG000|Overall Study|Withdrawal by Subject|0|||
131077321|NCT03318783|471916025|FG001|Overall Study|Withdrawal by Subject|1|||
131077322|NCT03318783|471916024|FG000|Overall Study|Death|0|||
131077323|NCT03318783|471916025|FG001|Overall Study|Death|1|||
131077324|NCT03410108|471916028|FG000|Overall Study|Ongoing|41|||
131077325|NCT03410108|471916028|FG000|Overall Study|Adverse Event|4|||
131077326|NCT03410108|471916028|FG000|Overall Study|Progressive Disease|58|||
131077327|NCT03410108|471916028|FG000|Overall Study|Withdrawal by Subject|1|||
131077328|NCT04035577|471916032|FG000|Overall Study|Lost to Follow-up|1|||
131077329|NCT04035577|471916032|FG000|Overall Study|Withdrawal by Subject|1|||
131077330|NCT03269695|471916033|FG000|Overall Study|Adverse Event|2|||
131077331|NCT03269695|471916034|FG001|Overall Study|Adverse Event|1|||
131077332|NCT03269695|471916033|FG000|Overall Study|Lack of Efficacy|0|||
131138822|NCT02568046|472134163|FG001|Overall Study|Withdrawal by Subject|1|||
131138823|NCT02568046|472134162|FG000|Overall Study|Other Events|0|||
131138824|NCT02568046|472134163|FG001|Overall Study|Other Events|1|||
131138825|NCT03403192|472134164|FG000|Overall Study|Lost to Follow-up|1|||
131138826|NCT03403192|472134165|FG001|Overall Study|Lost to Follow-up|2|||
131138827|NCT03403192|472134166|FG002|Overall Study|Lost to Follow-up|0|||
131138828|NCT03403192|472134167|FG003|Overall Study|Lost to Follow-up|0|||
131138829|NCT03403192|472134164|FG000|Overall Study|Unable to respond|0|||
131138830|NCT03403192|472134165|FG001|Overall Study|Unable to respond|1|||
131138831|NCT03403192|472134166|FG002|Overall Study|Unable to respond|0|||
131138832|NCT03403192|472134167|FG003|Overall Study|Unable to respond|0|||
131138833|NCT03403192|472134164|FG000|Overall Study|Incomplete|3|||
131138834|NCT03403192|472134165|FG001|Overall Study|Incomplete|1|||
131138835|NCT03403192|472134166|FG002|Overall Study|Incomplete|3|||
131138836|NCT03403192|472134167|FG003|Overall Study|Incomplete|6|||
131138837|NCT00379795|472134168|FG000|Overall Study|Death|31|||
131138838|NCT00379795|472134169|FG001|Overall Study|Death|8|||
131138839|NCT00379795|472134170|FG002|Overall Study|Death|6|||
131138840|NCT00379795|472134171|FG003|Overall Study|Death|4|||
131138841|NCT00379795|472134172|FG004|Overall Study|Death|7|||
131138842|NCT00379795|472134168|FG000|Overall Study|Adverse Event|17|||
131138843|NCT00379795|472134169|FG001|Overall Study|Adverse Event|3|||
131138844|NCT00379795|472134170|FG002|Overall Study|Adverse Event|3|||
131138845|NCT00379795|472134171|FG003|Overall Study|Adverse Event|1|||
131138846|NCT00379795|472134172|FG004|Overall Study|Adverse Event|4|||
131138847|NCT00379795|472134168|FG000|Overall Study|Lost to Follow-up|8|||
131138848|NCT00379795|472134169|FG001|Overall Study|Lost to Follow-up|1|||
131138849|NCT00379795|472134170|FG002|Overall Study|Lost to Follow-up|2|||
131138850|NCT00379795|472134171|FG003|Overall Study|Lost to Follow-up|1|||
131138851|NCT00379795|472134172|FG004|Overall Study|Lost to Follow-up|4|||
130725369|NCT00996892|470619341|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
130725370|NCT00996892|470619342|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
130725371|NCT00996892|470619343|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
130725372|NCT00996892|470619324|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
130725373|NCT00996892|470619325|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
131077333|NCT03269695|471916034|FG001|Overall Study|Lack of Efficacy|1|||
131077334|NCT03269695|471916033|FG000|Overall Study|Withdrawal by Subject|0|||
131077335|NCT03269695|471916034|FG001|Overall Study|Withdrawal by Subject|1|||
131077336|NCT00104637|471916036|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
131077337|NCT00104637|471916037|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
131077338|NCT01313624|471916038|FG000|Double-Blind Phase|Adverse Event|27|||
130725374|NCT00996892|470619326|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
131077339|NCT01313624|471916039|FG001|Double-Blind Phase|Adverse Event|4|||
131077340|NCT01313624|471916038|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
131077341|NCT01313624|471916039|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
131077342|NCT01313624|471916038|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131077343|NCT01313624|471916039|FG001|Double-Blind Phase|Lost to Follow-up|2|||
131138852|NCT00379795|472134168|FG000|Overall Study|Physician Decision|25|||
131138853|NCT00379795|472134169|FG001|Overall Study|Physician Decision|0|||
131138854|NCT00379795|472134170|FG002|Overall Study|Physician Decision|2|||
131138855|NCT00379795|472134171|FG003|Overall Study|Physician Decision|2|||
131138856|NCT00379795|472134172|FG004|Overall Study|Physician Decision|2|||
131138857|NCT00379795|472134168|FG000|Overall Study|Withdrawal by Subject|94|||
131138858|NCT00379795|472134169|FG001|Overall Study|Withdrawal by Subject|11|||
131138859|NCT00379795|472134170|FG002|Overall Study|Withdrawal by Subject|19|||
131138860|NCT00379795|472134171|FG003|Overall Study|Withdrawal by Subject|7|||
131138861|NCT00379795|472134172|FG004|Overall Study|Withdrawal by Subject|14|||
131138862|NCT00379795|472134168|FG000|Overall Study|Subject non-compliance|7|||
131138863|NCT00379795|472134169|FG001|Overall Study|Subject non-compliance|2|||
131231483|NCT00602030|472473337|FG002|Crossover Phase|Adverse Event|0|||
130725375|NCT00996892|470619327|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
131077344|NCT01313624|471916038|FG000|Double-Blind Phase|Physician Decision|1|||
131077345|NCT01313624|471916039|FG001|Double-Blind Phase|Physician Decision|0|||
131077346|NCT01313624|471916038|FG000|Double-Blind Phase|Lack of Efficacy|1|||
131077347|NCT01313624|471916039|FG001|Double-Blind Phase|Lack of Efficacy|0|||
131077348|NCT01313624|471916038|FG000|Open-Label Phase|Adverse Event|1|||
131138864|NCT00379795|472134170|FG002|Overall Study|Subject non-compliance|0|||
130725376|NCT00996892|470619328|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
130725377|NCT00996892|470619329|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
130725378|NCT00996892|470619330|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
130725379|NCT00996892|470619331|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
130725380|NCT00996892|470619332|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
130725381|NCT00996892|470619333|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
130725382|NCT00996892|470619334|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
130725383|NCT00996892|470619335|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
130725384|NCT00996892|470619336|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
130725385|NCT00996892|470619337|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
130725386|NCT00996892|470619338|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
130725387|NCT00996892|470619339|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
130725388|NCT00996892|470619340|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
130725389|NCT00996892|470619341|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
130725390|NCT00996892|470619342|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
130725391|NCT00996892|470619343|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
130725392|NCT00996892|470619324|FG000|Dose-Escalation Stage 1A|Death|0|||
130725393|NCT00996892|470619325|FG001|Dose-Escalation Stage 1A|Death|0|||
130725394|NCT00996892|470619326|FG002|Dose-Escalation Stage 1A|Death|0|||
130725395|NCT00996892|470619327|FG003|Dose-Escalation Stage 1A|Death|0|||
130725396|NCT00996892|470619328|FG004|Dose-Escalation Stage 1A|Death|0|||
130725397|NCT00996892|470619329|FG005|Dose-Escalation Stage 1A|Death|0|||
130725398|NCT00996892|470619330|FG006|Dose-Escalation Stage 1A|Death|0|||
130725399|NCT00996892|470619331|FG007|Dose-Escalation Stage 1A|Death|0|||
130725400|NCT00996892|470619332|FG008|Dose-Escalation Stage 1A|Death|0|||
130725401|NCT00996892|470619333|FG009|Dose-Escalation Stage 1A|Death|2|||
130725402|NCT00996892|470619334|FG010|Dose-Escalation Stage 1A|Death|0|||
130725403|NCT00996892|470619335|FG011|Dose-Escalation Stage 1A|Death|1|||
130725404|NCT00996892|470619336|FG012|Dose-Escalation Stage 1A|Death|1|||
130725405|NCT00996892|470619337|FG013|Dose-Escalation Stage 1A|Death|0|||
130725406|NCT00996892|470619338|FG014|Dose-Escalation Stage 1A|Death|0|||
130725407|NCT00996892|470619339|FG015|Dose-Escalation Stage 1A|Death|0|||
130725408|NCT00996892|470619340|FG016|Dose-Escalation Stage 1A|Death|0|||
130725409|NCT00996892|470619341|FG017|Dose-Escalation Stage 1A|Death|0|||
130725410|NCT00996892|470619342|FG018|Dose-Escalation Stage 1A|Death|0|||
130725411|NCT00996892|470619343|FG019|Dose-Escalation Stage 1A|Death|0|||
130725412|NCT00996892|470619324|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
130725413|NCT00996892|470619325|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
130725414|NCT00996892|470619326|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
130725415|NCT00996892|470619327|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
130725416|NCT00996892|470619328|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
130725417|NCT00996892|470619329|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
130725418|NCT00996892|470619330|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
130725419|NCT00996892|470619331|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
130725420|NCT00996892|470619332|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
130725421|NCT00996892|470619333|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
130725422|NCT00996892|470619334|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
130725423|NCT00996892|470619335|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
130725424|NCT00996892|470619336|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
130725425|NCT00996892|470619337|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
130725426|NCT00996892|470619338|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
130725427|NCT00996892|470619339|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
130725428|NCT00996892|470619340|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
130725429|NCT00996892|470619341|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
130725430|NCT00996892|470619342|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
130725431|NCT00996892|470619343|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
131077349|NCT01313624|471916039|FG001|Open-Label Phase|Adverse Event|10|||
131077350|NCT01313624|471916038|FG000|Open-Label Phase|Withdrawal by Subject|2|||
130725432|NCT00996892|470619324|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725433|NCT00996892|470619325|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725434|NCT00996892|470619326|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725435|NCT00996892|470619327|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725436|NCT00996892|470619328|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131077351|NCT01313624|471916039|FG001|Open-Label Phase|Withdrawal by Subject|2|||
131077352|NCT01313624|471916038|FG000|Open-Label Phase|Lost to Follow-up|1|||
130725437|NCT00996892|470619329|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725438|NCT00996892|470619330|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725439|NCT00996892|470619331|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725440|NCT00996892|470619332|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725441|NCT00996892|470619333|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130725442|NCT00996892|470619334|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130725443|NCT00996892|470619335|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130725444|NCT00996892|470619336|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130725445|NCT00996892|470619337|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
131138865|NCT00379795|472134171|FG003|Overall Study|Subject non-compliance|0|||
131138866|NCT00379795|472134172|FG004|Overall Study|Subject non-compliance|1|||
131138867|NCT00379795|472134168|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
131138868|NCT00379795|472134169|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
131138869|NCT00379795|472134170|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
131138870|NCT00379795|472134171|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
131138871|NCT00379795|472134172|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
131138872|NCT00379795|472134168|FG000|Overall Study|Subjects condition mandated intervention|34|||
131138873|NCT00379795|472134169|FG001|Overall Study|Subjects condition mandated intervention|9|||
131138874|NCT00379795|472134170|FG002|Overall Study|Subjects condition mandated intervention|7|||
131138875|NCT00379795|472134171|FG003|Overall Study|Subjects condition mandated intervention|5|||
131138876|NCT00379795|472134172|FG004|Overall Study|Subjects condition mandated intervention|7|||
131138877|NCT00379795|472134168|FG000|Overall Study|Sponsor's decision|257|||
131138878|NCT00379795|472134169|FG001|Overall Study|Sponsor's decision|17|||
131138879|NCT00379795|472134170|FG002|Overall Study|Sponsor's decision|54|||
131138880|NCT00379795|472134171|FG003|Overall Study|Sponsor's decision|47|||
131138881|NCT00379795|472134172|FG004|Overall Study|Sponsor's decision|10|||
131138882|NCT02551159|472134173|FG000|Overall Study|Death|352|||
131138883|NCT02551159|472134174|FG001|Overall Study|Death|174|||
131138884|NCT02551159|472134175|FG002|Overall Study|Death|161|||
131138885|NCT02551159|472134173|FG000|Overall Study|Withdrawal by Subject|8|||
131138886|NCT02551159|472134174|FG001|Overall Study|Withdrawal by Subject|5|||
131138887|NCT02551159|472134175|FG002|Overall Study|Withdrawal by Subject|16|||
131138888|NCT02551159|472134173|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
131138889|NCT02551159|472134174|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
131138890|NCT02551159|472134175|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
131138891|NCT00268242|472134176|FG000|Overall Study|Death|1|||
131138892|NCT00993928|472134177|FG000|Overall Study|Withdrawal by Subject|4|||
131138893|NCT00993928|472134178|FG001|Overall Study|Withdrawal by Subject|7|||
131138894|NCT00993928|472134177|FG000|Overall Study|ineligible|1|||
131138895|NCT00993928|472134178|FG001|Overall Study|ineligible|0|||
131138896|NCT03979274|472134179|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131138897|NCT03979274|472134180|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131077353|NCT01313624|471916039|FG001|Open-Label Phase|Lost to Follow-up|1|||
131138898|NCT01665144|472134181|FG000|Core Part|Withdrawal by Subject|96|||
131138899|NCT01665144|472134182|FG001|Core Part|Withdrawal by Subject|77|||
131138900|NCT01665144|472134183|FG002|Core Part|Withdrawal by Subject|0|||
131138901|NCT01665144|472134181|FG000|Core Part|Adverse Event|45|||
131077354|NCT00505414|471916040|FG000|Titration Phase|Adverse Event|0|||
131077355|NCT00505414|471916041|FG001|Titration Phase|Adverse Event|0|||
131077356|NCT00505414|471916042|FG002|Titration Phase|Adverse Event|0|||
131077357|NCT00505414|471916043|FG003|Titration Phase|Adverse Event|8|||
131077358|NCT00505414|471916044|FG004|Titration Phase|Adverse Event|3|||
131077359|NCT00505414|471916040|FG000|Titration Phase|Death|0|||
131077360|NCT00505414|471916041|FG001|Titration Phase|Death|0|||
131077361|NCT00505414|471916042|FG002|Titration Phase|Death|0|||
131077362|NCT00505414|471916043|FG003|Titration Phase|Death|2|||
131077363|NCT00505414|471916044|FG004|Titration Phase|Death|0|||
131077364|NCT00505414|471916040|FG000|Titration Phase|Lack of Efficacy|0|||
131077365|NCT00505414|471916041|FG001|Titration Phase|Lack of Efficacy|0|||
131077366|NCT00505414|471916042|FG002|Titration Phase|Lack of Efficacy|0|||
131077367|NCT00505414|471916043|FG003|Titration Phase|Lack of Efficacy|10|||
131138902|NCT01665144|472134182|FG001|Core Part|Adverse Event|18|||
131138903|NCT01665144|472134183|FG002|Core Part|Adverse Event|0|||
131138904|NCT01665144|472134181|FG000|Core Part|Lack of Efficacy|16|||
131138905|NCT01665144|472134182|FG001|Core Part|Lack of Efficacy|11|||
131077368|NCT00505414|471916044|FG004|Titration Phase|Lack of Efficacy|1|||
131077369|NCT00505414|471916040|FG000|Titration Phase|Protocol Violation|0|||
131077370|NCT00505414|471916041|FG001|Titration Phase|Protocol Violation|0|||
131138906|NCT01665144|472134183|FG002|Core Part|Lack of Efficacy|0|||
131138907|NCT01665144|472134181|FG000|Core Part|Lost to Follow-up|9|||
131138908|NCT01665144|472134182|FG001|Core Part|Lost to Follow-up|8|||
131138909|NCT01665144|472134183|FG002|Core Part|Lost to Follow-up|0|||
131138910|NCT01665144|472134181|FG000|Core Part|Physician Decision|13|||
131138911|NCT01665144|472134182|FG001|Core Part|Physician Decision|1|||
131138912|NCT01665144|472134183|FG002|Core Part|Physician Decision|0|||
131138913|NCT01665144|472134181|FG000|Core Part|Progressive disease|8|||
131138914|NCT01665144|472134182|FG001|Core Part|Progressive disease|4|||
131138915|NCT01665144|472134183|FG002|Core Part|Progressive disease|0|||
131138916|NCT01665144|472134181|FG000|Core Part|Non-compliance with study treatment|5|||
131138917|NCT01665144|472134182|FG001|Core Part|Non-compliance with study treatment|0|||
131138918|NCT01665144|472134183|FG002|Core Part|Non-compliance with study treatment|0|||
131138919|NCT01665144|472134181|FG000|Core Part|Death|3|||
131138920|NCT01665144|472134182|FG001|Core Part|Death|1|||
131138921|NCT01665144|472134183|FG002|Core Part|Death|0|||
131138922|NCT01665144|472134181|FG000|Core Part|Protocol deviation|3|||
131138923|NCT01665144|472134182|FG001|Core Part|Protocol deviation|1|||
131138924|NCT01665144|472134183|FG002|Core Part|Protocol deviation|0|||
130725446|NCT00996892|470619338|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725447|NCT00996892|470619339|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725448|NCT00996892|470619340|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725449|NCT00996892|470619341|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725450|NCT00996892|470619342|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725451|NCT00996892|470619343|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130725452|NCT00996892|470619324|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
130725453|NCT00996892|470619325|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
130725454|NCT00996892|470619326|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
130725455|NCT00996892|470619327|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
130725456|NCT00996892|470619328|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
130725457|NCT00996892|470619329|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
130725458|NCT00996892|470619330|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
130725459|NCT00996892|470619331|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
130725460|NCT00996892|470619332|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
130725461|NCT00996892|470619333|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
130725462|NCT00996892|470619334|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
130725463|NCT00996892|470619335|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
130725464|NCT00996892|470619336|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
130725465|NCT00996892|470619337|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
130725466|NCT00996892|470619338|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
130725467|NCT00996892|470619339|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
130725468|NCT00996892|470619340|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
130725469|NCT00996892|470619341|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
130725470|NCT00996892|470619342|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
130725471|NCT00996892|470619343|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
130725472|NCT00996892|470619324|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
130725473|NCT00996892|470619325|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
130725474|NCT00996892|470619326|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
130725475|NCT00996892|470619327|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
130725476|NCT00996892|470619328|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
130725477|NCT00996892|470619329|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
130725478|NCT00996892|470619330|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
130725479|NCT00996892|470619331|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
130725480|NCT00996892|470619332|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
130725481|NCT00996892|470619333|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
130725482|NCT00996892|470619334|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
130725483|NCT00996892|470619335|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
130725484|NCT00996892|470619336|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
130779700|NCT02326272|470819502|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779701|NCT02326272|470819503|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779702|NCT02326272|470819504|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130779703|NCT02326272|470819490|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131077371|NCT00505414|471916042|FG002|Titration Phase|Protocol Violation|0|||
131077372|NCT00505414|471916043|FG003|Titration Phase|Protocol Violation|0|||
131077373|NCT00505414|471916044|FG004|Titration Phase|Protocol Violation|1|||
131077374|NCT00505414|471916040|FG000|Titration Phase|Withdrawal by Subject|0|||
131077375|NCT00505414|471916041|FG001|Titration Phase|Withdrawal by Subject|0|||
131077376|NCT00505414|471916042|FG002|Titration Phase|Withdrawal by Subject|0|||
131077377|NCT00505414|471916043|FG003|Titration Phase|Withdrawal by Subject|3|||
131077378|NCT00505414|471916044|FG004|Titration Phase|Withdrawal by Subject|4|||
131077379|NCT00505414|471916040|FG000|Titration Phase|Underlying disease and therapy required|0|||
131077380|NCT00505414|471916041|FG001|Titration Phase|Underlying disease and therapy required|0|||
131077381|NCT00505414|471916042|FG002|Titration Phase|Underlying disease and therapy required|0|||
131077382|NCT00505414|471916043|FG003|Titration Phase|Underlying disease and therapy required|7|||
131077383|NCT00505414|471916044|FG004|Titration Phase|Underlying disease and therapy required|3|||
131077384|NCT00505414|471916040|FG000|Maintenance Phase|Adverse Event|2|||
131077385|NCT00505414|471916041|FG001|Maintenance Phase|Adverse Event|2|||
131138925|NCT01665144|472134181|FG000|Core Part|New therapy for study indication|2|||
131077386|NCT00505414|471916042|FG002|Maintenance Phase|Adverse Event|3|||
131077387|NCT00505414|471916043|FG003|Maintenance Phase|Adverse Event|0|||
130725485|NCT00996892|470619337|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
130725486|NCT00996892|470619338|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
130725487|NCT00996892|470619339|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
130725488|NCT00996892|470619340|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
130725489|NCT00996892|470619341|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
130725490|NCT00996892|470619342|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
131077388|NCT00505414|471916044|FG004|Maintenance Phase|Adverse Event|0|||
131077389|NCT00505414|471916040|FG000|Maintenance Phase|Death|2|||
131077390|NCT00505414|471916041|FG001|Maintenance Phase|Death|0|||
131077391|NCT00505414|471916042|FG002|Maintenance Phase|Death|1|||
130725491|NCT00996892|470619343|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
130725492|NCT00996892|470619324|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
130725493|NCT00996892|470619325|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
130725494|NCT00996892|470619326|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
130725495|NCT00996892|470619327|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
130725496|NCT00996892|470619328|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
130725497|NCT00996892|470619329|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
130725498|NCT00996892|470619330|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
130725499|NCT00996892|470619331|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
130725500|NCT00996892|470619332|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
130725501|NCT00996892|470619333|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
130725502|NCT00996892|470619334|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
130725503|NCT00996892|470619335|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
130725504|NCT00996892|470619336|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
130725505|NCT00996892|470619337|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
130779704|NCT02326272|470819491|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779705|NCT02326272|470819492|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
131077392|NCT00505414|471916043|FG003|Maintenance Phase|Death|0|||
131077393|NCT00505414|471916044|FG004|Maintenance Phase|Death|0|||
131077394|NCT00505414|471916040|FG000|Maintenance Phase|Lack of Efficacy|2|||
131077395|NCT00505414|471916041|FG001|Maintenance Phase|Lack of Efficacy|1|||
131077396|NCT00505414|471916042|FG002|Maintenance Phase|Lack of Efficacy|1|||
131077397|NCT00505414|471916043|FG003|Maintenance Phase|Lack of Efficacy|0|||
131077398|NCT00505414|471916044|FG004|Maintenance Phase|Lack of Efficacy|0|||
131077399|NCT00505414|471916040|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131077400|NCT00505414|471916041|FG001|Maintenance Phase|Withdrawal by Subject|0|||
131077401|NCT00505414|471916042|FG002|Maintenance Phase|Withdrawal by Subject|1|||
131077402|NCT00505414|471916043|FG003|Maintenance Phase|Withdrawal by Subject|0|||
131077403|NCT00505414|471916044|FG004|Maintenance Phase|Withdrawal by Subject|0|||
131077404|NCT00505414|471916040|FG000|Maintenance Phase|underlying disease and therapy required|0|||
131077405|NCT00505414|471916041|FG001|Maintenance Phase|underlying disease and therapy required|2|||
131077406|NCT00505414|471916042|FG002|Maintenance Phase|underlying disease and therapy required|2|||
131077407|NCT00505414|471916043|FG003|Maintenance Phase|underlying disease and therapy required|0|||
131077408|NCT00505414|471916044|FG004|Maintenance Phase|underlying disease and therapy required|0|||
131077409|NCT00846768|471916045|FG000|Overall Study|Adverse Event|0|||
131077410|NCT00846768|471916046|FG001|Overall Study|Adverse Event|1|||
131077411|NCT00846768|471916047|FG002|Overall Study|Adverse Event|0|||
131077412|NCT00846768|471916048|FG003|Overall Study|Adverse Event|0|||
131077413|NCT00644878|471916049|FG000|Overall Study|Adverse Event|2|||
131077414|NCT00644878|471916049|FG000|Overall Study|Abnormal laboratory value|3|||
131077415|NCT00644878|471916049|FG000|Overall Study|Protocol deviation|2|||
131077416|NCT00644878|471916049|FG000|Overall Study|Treatment duration completed as per protocol|11|||
131077417|NCT00468130|471916057|FG000|Overall Study|Adverse Event|2|||
131077418|NCT00468130|471916058|FG001|Overall Study|Adverse Event|1|||
131077419|NCT00468130|471916057|FG000|Overall Study|Withdrawal by Subject|0|||
131077420|NCT00468130|471916058|FG001|Overall Study|Withdrawal by Subject|1|||
131077421|NCT00436956|471916059|FG000|Overall Study|Not evaluable|1|||
131077422|NCT00436956|471916060|FG001|Overall Study|Not evaluable|0|||
131077423|NCT01841112|471916062|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
131077424|NCT01841112|471916063|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
131077425|NCT01841112|471916064|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
131077426|NCT01841112|471916065|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
131077427|NCT01841112|471916066|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
131077428|NCT00927901|471916067|FG000|Treatment Period 1|Subject withdrew consent|0|||
131077429|NCT00927901|471916068|FG001|Treatment Period 1|Subject withdrew consent|0|||
131077430|NCT00927901|471916069|FG002|Treatment Period 1|Subject withdrew consent|1|||
131077431|NCT00927901|471916070|FG003|Treatment Period 1|Subject withdrew consent|0|||
131077432|NCT00927901|471916067|FG000|Treatment Period 4|Adverse Event|0|||
131138926|NCT01665144|472134182|FG001|Core Part|New therapy for study indication|1|||
131138927|NCT01665144|472134183|FG002|Core Part|New therapy for study indication|0|||
131138928|NCT01665144|472134181|FG000|Core Part|Technical problems|2|||
131138929|NCT01665144|472134182|FG001|Core Part|Technical problems|0|||
131138930|NCT01665144|472134183|FG002|Core Part|Technical problems|0|||
131138931|NCT01665144|472134181|FG000|Extension Part|Patient/guardian decision|180|||
131138932|NCT01665144|472134182|FG001|Extension Part|Patient/guardian decision|0|||
130725506|NCT00996892|470619338|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
130725507|NCT00996892|470619339|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
131077433|NCT00927901|471916068|FG001|Treatment Period 4|Adverse Event|0|||
131077434|NCT00927901|471916069|FG002|Treatment Period 4|Adverse Event|0|||
131077435|NCT00927901|471916070|FG003|Treatment Period 4|Adverse Event|1|||
131077436|NCT00927901|471916067|FG000|Treatment Period 4|Subject withdrew consent|0|||
131077437|NCT00927901|471916068|FG001|Treatment Period 4|Subject withdrew consent|0|||
131077438|NCT00927901|471916069|FG002|Treatment Period 4|Subject withdrew consent|1|||
131077439|NCT00927901|471916070|FG003|Treatment Period 4|Subject withdrew consent|0|||
131138933|NCT01665144|472134183|FG002|Extension Part|Patient/guardian decision|98|||
131138934|NCT01665144|472134181|FG000|Extension Part|Adverse Event|104|||
131138935|NCT01665144|472134182|FG001|Extension Part|Adverse Event|0|||
131138936|NCT01665144|472134183|FG002|Extension Part|Adverse Event|59|||
131138937|NCT01665144|472134181|FG000|Extension Part|Study closed early|42|||
131138938|NCT01665144|472134182|FG001|Extension Part|Study closed early|0|||
131138939|NCT01665144|472134183|FG002|Extension Part|Study closed early|19|||
131138940|NCT01665144|472134181|FG000|Extension Part|Progressive disease|36|||
131138941|NCT01665144|472134182|FG001|Extension Part|Progressive disease|0|||
131138942|NCT01665144|472134183|FG002|Extension Part|Progressive disease|14|||
131138943|NCT01665144|472134181|FG000|Extension Part|Lack of Efficacy|37|||
131138944|NCT01665144|472134182|FG001|Extension Part|Lack of Efficacy|0|||
131138945|NCT01665144|472134183|FG002|Extension Part|Lack of Efficacy|12|||
131138946|NCT01665144|472134181|FG000|Extension Part|Physician Decision|29|||
131138947|NCT01665144|472134182|FG001|Extension Part|Physician Decision|0|||
131138948|NCT01665144|472134183|FG002|Extension Part|Physician Decision|13|||
131138949|NCT01665144|472134181|FG000|Extension Part|Technical problems|20|||
131138950|NCT01665144|472134182|FG001|Extension Part|Technical problems|0|||
131138951|NCT01665144|472134183|FG002|Extension Part|Technical problems|8|||
131138952|NCT01665144|472134181|FG000|Extension Part|Death|20|||
131138953|NCT01665144|472134182|FG001|Extension Part|Death|0|||
131138954|NCT01665144|472134183|FG002|Extension Part|Death|4|||
131138955|NCT01665144|472134181|FG000|Extension Part|Missing|12|||
131138956|NCT01665144|472134182|FG001|Extension Part|Missing|0|||
131138957|NCT01665144|472134183|FG002|Extension Part|Missing|6|||
131138958|NCT01665144|472134181|FG000|Extension Part|Lost to Follow-up|9|||
131138959|NCT01665144|472134182|FG001|Extension Part|Lost to Follow-up|0|||
130779706|NCT02326272|470819493|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779707|NCT02326272|470819494|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779708|NCT02326272|470819495|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779709|NCT02326272|470819496|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779710|NCT02326272|470819497|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779711|NCT02326272|470819498|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779712|NCT02326272|470819499|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779713|NCT02326272|470819500|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779714|NCT02326272|470819501|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779715|NCT02326272|470819502|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
130779716|NCT02326272|470819503|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779717|NCT02326272|470819504|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130779718|NCT01447407|470819506|FG000|Overall Study|Withdrawal by Subject|2|||
130779719|NCT01447407|470819507|FG001|Overall Study|Withdrawal by Subject|0|||
130779720|NCT01447407|470819508|FG002|Overall Study|Withdrawal by Subject|0|||
130779721|NCT01447407|470819509|FG003|Overall Study|Withdrawal by Subject|1|||
130779722|NCT01447407|470819506|FG000|Overall Study|Physician Decision|0|||
130779723|NCT01447407|470819507|FG001|Overall Study|Physician Decision|0|||
130779724|NCT01447407|470819508|FG002|Overall Study|Physician Decision|1|||
131138960|NCT01665144|472134183|FG002|Extension Part|Lost to Follow-up|5|||
131138961|NCT01665144|472134181|FG000|Extension Part|New therapy for study indication|3|||
131138962|NCT01665144|472134182|FG001|Extension Part|New therapy for study indication|0|||
131138963|NCT01665144|472134183|FG002|Extension Part|New therapy for study indication|2|||
131138964|NCT01665144|472134181|FG000|Extension Part|Protocol deviation|3|||
131138965|NCT01665144|472134182|FG001|Extension Part|Protocol deviation|0|||
131138966|NCT01665144|472134183|FG002|Extension Part|Protocol deviation|0|||
131077440|NCT03605368|471916071|FG000|Overall Study|Lost to Follow-up|2|||
131077441|NCT03605368|471916072|FG001|Overall Study|Lost to Follow-up|1|||
131077442|NCT03605368|471916073|FG002|Overall Study|Lost to Follow-up|3|||
131077443|NCT03605368|471916074|FG003|Overall Study|Lost to Follow-up|2|||
131077444|NCT03605368|471916071|FG000|Overall Study|Withdrawal by Subject|0|||
131077445|NCT03605368|471916072|FG001|Overall Study|Withdrawal by Subject|0|||
131077446|NCT03605368|471916073|FG002|Overall Study|Withdrawal by Subject|4|||
131077447|NCT03605368|471916074|FG003|Overall Study|Withdrawal by Subject|3|||
131077448|NCT03765164|471916079|FG000|Pre-intervention|Withdrawal by Subject|5|||
131077449|NCT03765164|471916080|FG001|Pre-intervention|Withdrawal by Subject|6|||
131077450|NCT04052997|471916081|FG000|Overall Study|Withdrawal by Subject|17|||
131138967|NCT03551743|472134188|FG000|Overall Study|Adverse Event|1|||
131077451|NCT04052997|471916081|FG000|Overall Study|Physician Decision|50|||
131077452|NCT04052997|471916081|FG000|Overall Study|Death|43|||
131138968|NCT03551743|472134189|FG001|Overall Study|Adverse Event|0|||
131231484|NCT00602030|472473338|FG003|Crossover Phase|Adverse Event|0|||
130779725|NCT01447407|470819509|FG003|Overall Study|Physician Decision|1|||
130779726|NCT01064414|470819510|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
131077453|NCT04052997|471916081|FG000|Overall Study|Lost to Follow-up|5|||
131138969|NCT03551743|472134190|FG002|Overall Study|Adverse Event|0|||
131138970|NCT03551743|472134191|FG003|Overall Study|Adverse Event|0|||
131138971|NCT03551743|472134188|FG000|Overall Study|Withdrawal by Subject|1|||
131138972|NCT03551743|472134189|FG001|Overall Study|Withdrawal by Subject|0|||
131138973|NCT03551743|472134190|FG002|Overall Study|Withdrawal by Subject|0|||
131138974|NCT03551743|472134191|FG003|Overall Study|Withdrawal by Subject|0|||
131138975|NCT02317562|472134192|FG000|Overall Study|Physician Decision|1|||
131138976|NCT02317562|472134192|FG000|Overall Study|early termination of the study|8|||
131138977|NCT02317562|472134192|FG000|Overall Study|Lack of Efficacy|4|||
131138978|NCT02317562|472134192|FG000|Overall Study|Withdrawal by Subject|1|||
131138979|NCT00911989|472134193|FG000|Overall Study|Adverse Event|1|||
131138980|NCT01145066|472134194|FG000|Overall Study|To resume NSAIDs|2|||
131138981|NCT01145066|472134195|FG001|Overall Study|To resume NSAIDs|2|||
131138982|NCT01145066|472134196|FG002|Overall Study|To resume NSAIDs|1|||
131138983|NCT01145066|472134194|FG000|Overall Study|Non-related surgery|0|||
131138984|NCT01145066|472134195|FG001|Overall Study|Non-related surgery|0|||
131138985|NCT01145066|472134196|FG002|Overall Study|Non-related surgery|1|||
131138986|NCT01145066|472134194|FG000|Overall Study|Withdrawal by Subject|0|||
131138987|NCT01145066|472134195|FG001|Overall Study|Withdrawal by Subject|0|||
131138988|NCT01145066|472134196|FG002|Overall Study|Withdrawal by Subject|2|||
131138989|NCT01145066|472134194|FG000|Overall Study|To start new med|1|||
131138990|NCT01145066|472134195|FG001|Overall Study|To start new med|0|||
131138991|NCT01145066|472134196|FG002|Overall Study|To start new med|0|||
131138992|NCT01145066|472134194|FG000|Overall Study|problems swallowing capsule|1|||
131138993|NCT01145066|472134195|FG001|Overall Study|problems swallowing capsule|0|||
131138994|NCT01145066|472134196|FG002|Overall Study|problems swallowing capsule|0|||
131138995|NCT01145066|472134194|FG000|Overall Study|Abdominal discomfort|0|||
131138996|NCT01145066|472134195|FG001|Overall Study|Abdominal discomfort|1|||
131138997|NCT01145066|472134196|FG002|Overall Study|Abdominal discomfort|0|||
131138998|NCT01145066|472134194|FG000|Overall Study|Low platelet count|0|||
131138999|NCT01145066|472134195|FG001|Overall Study|Low platelet count|1|||
131139000|NCT01145066|472134196|FG002|Overall Study|Low platelet count|0|||
131139001|NCT02026063|472134197|FG000|Overall Study|Physician Decision|0|||
131139002|NCT02026063|472134198|FG001|Overall Study|Physician Decision|10|||
131139003|NCT02026063|472134197|FG000|Overall Study|Noncompliance with Study Drug|1|||
131139004|NCT02026063|472134198|FG001|Overall Study|Noncompliance with Study Drug|1|||
131139005|NCT02026063|472134197|FG000|Overall Study|Withdrawal of Consent|1|||
131139006|NCT02026063|472134198|FG001|Overall Study|Withdrawal of Consent|6|||
131139007|NCT02026063|472134197|FG000|Overall Study|Adverse Event|5|||
131139008|NCT02026063|472134198|FG001|Overall Study|Adverse Event|20|||
131139009|NCT02026063|472134197|FG000|Overall Study|Lack of Efficacy|0|||
131139010|NCT02026063|472134198|FG001|Overall Study|Lack of Efficacy|4|||
131139011|NCT02026063|472134197|FG000|Overall Study|Lost to Follow-up|0|||
131139012|NCT02026063|472134198|FG001|Overall Study|Lost to Follow-up|1|||
131139013|NCT02026063|472134197|FG000|Overall Study|Reason not Specified|2|||
131139014|NCT02026063|472134198|FG001|Overall Study|Reason not Specified|7|||
131139015|NCT03687502|472134204|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
131139016|NCT03687502|472134204|FG000|Overall Study|Lumason not available|1|||
131139017|NCT00486278|472134208|FG000|Overall Study|Adverse Event|5|||
131139018|NCT00486278|472134208|FG000|Overall Study|Withdrawal by Subject|2|||
131139019|NCT00486278|472134208|FG000|Overall Study|Physician Decision|2|||
131139020|NCT01724528|472134209|FG000|Overall Study|Death|3|||
131139021|NCT01724528|472134210|FG001|Overall Study|Death|0|||
131139022|NCT01724528|472134209|FG000|Overall Study|Withdrawal by Subject|0|||
131139023|NCT01724528|472134210|FG001|Overall Study|Withdrawal by Subject|2|||
131139024|NCT01724528|472134209|FG000|Overall Study|Protocol Violation|0|||
131139025|NCT01724528|472134210|FG001|Overall Study|Protocol Violation|1|||
131139026|NCT01724528|472134209|FG000|Overall Study|Patient refused to attend last visit|1|||
131139027|NCT01724528|472134210|FG001|Overall Study|Patient refused to attend last visit|0|||
131139028|NCT02937350|472134218|FG000|Overall Study|Withdrawal by Subject|0|||
131139029|NCT02937350|472134219|FG001|Overall Study|Withdrawal by Subject|1|||
131139030|NCT02937350|472134220|FG002|Overall Study|Withdrawal by Subject|0|||
131139031|NCT00803179|472134224|FG000|Overall Study|Lost to Follow-up|3|||
131139032|NCT01877083|472134228|FG000|Treatment Phase|Disease Progression|10|||
131139033|NCT01877083|472134228|FG000|Treatment Phase|Clinical Progression|1|||
131139034|NCT01877083|472134228|FG000|Treatment Phase|Adverse Event|6|||
131139035|NCT01877083|472134228|FG000|Treatment Phase|Withdrawal by Subject|2|||
131139036|NCT01877083|472134228|FG000|Treatment Phase|Lost to Follow-up|1|||
131139037|NCT01877083|472134228|FG000|Extension Phase|Disease Progression|3|||
131139038|NCT01877083|472134228|FG000|Extension Phase|Adverse Event|2|||
131139039|NCT00429585|472134231|FG000|Overall Study|Death|1|||
131139040|NCT00429585|472134232|FG001|Overall Study|Death|0|||
131139041|NCT00429585|472134231|FG000|Overall Study|Lost to Follow-up|27|||
131139042|NCT00429585|472134232|FG001|Overall Study|Lost to Follow-up|20|||
131139043|NCT00429585|472134231|FG000|Overall Study|Physician Decision|2|||
131139044|NCT00429585|472134232|FG001|Overall Study|Physician Decision|0|||
131139045|NCT01227902|472135991|FG000|Overall Study|Adverse Event|12|||
131139046|NCT01227902|472135992|FG001|Overall Study|Adverse Event|8|||
131139047|NCT01227902|472135993|FG002|Overall Study|Adverse Event|11|||
131139048|NCT01227902|472135994|FG003|Overall Study|Adverse Event|4|||
131139049|NCT01227902|472135991|FG000|Overall Study|Lack of Efficacy|1|||
131139050|NCT01227902|472135992|FG001|Overall Study|Lack of Efficacy|2|||
131139051|NCT01227902|472135993|FG002|Overall Study|Lack of Efficacy|2|||
131139052|NCT01227902|472135994|FG003|Overall Study|Lack of Efficacy|1|||
131231485|NCT00602030|472473339|FG004|Crossover Phase|Adverse Event|3|||
131231486|NCT00602030|472473335|FG000|Crossover Phase|Consent withdrawal|0|||
131231487|NCT00602030|472473336|FG001|Crossover Phase|Consent withdrawal|0|||
131231488|NCT00602030|472473337|FG002|Crossover Phase|Consent withdrawal|0|||
131231489|NCT00602030|472473338|FG003|Crossover Phase|Consent withdrawal|0|||
131231490|NCT00602030|472473339|FG004|Crossover Phase|Consent withdrawal|2|||
131231491|NCT00947856|472473347|FG000|Treatment Period|Progressive Disease|33|||
131231492|NCT00947856|472473348|FG001|Treatment Period|Progressive Disease|12|||
131231493|NCT00947856|472473347|FG000|Treatment Period|Adverse Event|15|||
131231494|NCT00947856|472473348|FG001|Treatment Period|Adverse Event|9|||
131231495|NCT00947856|472473347|FG000|Treatment Period|Physician Decision|14|||
131077454|NCT04052997|471916081|FG000|Overall Study|Progression of Disease|1|||
131077455|NCT04088136|471916086|FG000|Overall Study|Withdrawal by Subject|5|||
131077456|NCT04088136|471916087|FG001|Overall Study|Withdrawal by Subject|0|||
131077457|NCT04088136|471916086|FG000|Overall Study|Lack of Efficacy|0|||
131077458|NCT04088136|471916087|FG001|Overall Study|Lack of Efficacy|1|||
131077459|NCT02250183|471916088|FG000|Overall Study|Withdrawal by Subject|2|||
131077460|NCT02250183|471916088|FG000|Overall Study|Adverse Event|5|||
131077461|NCT02250183|471916088|FG000|Overall Study|Lost to Follow-up|1|||
131077462|NCT04843579|471918448|FG000|Overall Study|Adverse Event|1|||
131077463|NCT04843579|471918448|FG000|Overall Study|Disease Progression|1|||
131077464|NCT02808975|471918450|FG000|Overall Study|Adverse Event|3|||
131077465|NCT02808975|471918451|FG001|Overall Study|Adverse Event|4|||
131077466|NCT02808975|471918450|FG000|Overall Study|Withdrew consent|9|||
131077467|NCT02808975|471918451|FG001|Overall Study|Withdrew consent|8|||
131077468|NCT02808975|471918450|FG000|Overall Study|Lost to Follow-up|4|||
131077469|NCT02808975|471918451|FG001|Overall Study|Lost to Follow-up|6|||
131077470|NCT02808975|471918450|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
131077471|NCT02808975|471918451|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
131077472|NCT02808975|471918450|FG000|Overall Study|Other, not specified|5|||
131077473|NCT02808975|471918451|FG001|Overall Study|Other, not specified|1|||
131077474|NCT03024996|471918452|FG000|Overall Study|Death|57|||
131077475|NCT03024996|471918453|FG001|Overall Study|Death|55|||
131077476|NCT03024996|471918452|FG000|Overall Study|Disease relapse|1|||
131077477|NCT03024996|471918453|FG001|Overall Study|Disease relapse|0|||
131077478|NCT03024996|471918452|FG000|Overall Study|Lost to Follow-up|5|||
131077479|NCT03024996|471918453|FG001|Overall Study|Lost to Follow-up|10|||
131231496|NCT00947856|472473348|FG001|Treatment Period|Physician Decision|6|||
131231497|NCT00947856|472473347|FG000|Treatment Period|Study Stopped by Sponsor|4|||
130725508|NCT00996892|470619340|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
131077480|NCT03024996|471918452|FG000|Overall Study|Other|3|||
131077481|NCT03024996|471918453|FG001|Overall Study|Other|3|||
131077482|NCT03024996|471918452|FG000|Overall Study|Physician Decision|0|||
131077483|NCT03024996|471918453|FG001|Overall Study|Physician Decision|1|||
131077484|NCT03024996|471918452|FG000|Overall Study|Study terminated by sponsor|303|||
131077485|NCT03024996|471918453|FG001|Overall Study|Study terminated by sponsor|283|||
131077486|NCT03024996|471918452|FG000|Overall Study|Withdrawal by Subject|21|||
131077487|NCT03024996|471918453|FG001|Overall Study|Withdrawal by Subject|36|||
131077488|NCT04333147|471918455|FG000|Overall Study|Adverse Event|43|||
131077489|NCT04333147|471918456|FG001|Overall Study|Adverse Event|40|||
131077490|NCT04333147|471918455|FG000|Overall Study|Lack of Efficacy|49|||
131077491|NCT04333147|471918456|FG001|Overall Study|Lack of Efficacy|48|||
131077492|NCT04333147|471918455|FG000|Overall Study|Lost to Follow-up|19|||
131077493|NCT04333147|471918456|FG001|Overall Study|Lost to Follow-up|16|||
131077494|NCT04333147|471918455|FG000|Overall Study|Physician Decision|17|||
131077495|NCT04333147|471918456|FG001|Overall Study|Physician Decision|20|||
131077496|NCT04333147|471918455|FG000|Overall Study|Withdrawal by Subject|65|||
131077497|NCT04333147|471918456|FG001|Overall Study|Withdrawal by Subject|68|||
131077498|NCT04333147|471918455|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
131077499|NCT04333147|471918456|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
131077500|NCT04333147|471918455|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
131077501|NCT04333147|471918456|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
131077502|NCT04333147|471918455|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
131077503|NCT04333147|471918456|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
131077504|NCT02106195|471918457|FG000|Overall Study|Adverse Event|2|||
131077505|NCT02106195|471918457|FG000|Overall Study|Protocol Violation|1|||
131077506|NCT03062449|471918458|FG000|Overall Study|Withdrawal by Subject|7|||
131077507|NCT03062449|471918459|FG001|Overall Study|Withdrawal by Subject|1|||
131077508|NCT04702893|471918461|FG000|Overall Study|Other reasons than listed|11|||
131077509|NCT04702893|471918461|FG000|Overall Study|Withdrawal by Subject|3|||
131077510|NCT04702893|471918461|FG000|Overall Study|Lost to Follow-up|7|||
131077511|NCT04702893|471918461|FG000|Overall Study|Death|10|||
131077512|NCT04702893|471918461|FG000|Overall Study|Not treated|6|||
131077513|NCT00408928|471918462|FG000|Overall Study|Withdrawal by Subject|1|||
131077514|NCT00408928|471918462|FG000|Overall Study|Death|1|||
131077515|NCT00408928|471918462|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
131077516|NCT04469465|471918464|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
131077517|NCT04469465|471918465|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
131077518|NCT04469465|471918464|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
131077519|NCT04469465|471918465|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
131077520|NCT04469465|471918464|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
131077521|NCT04469465|471918465|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
131077522|NCT04469465|471918464|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
131077523|NCT04469465|471918465|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
131077524|NCT04469465|471918464|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
131077525|NCT04469465|471918465|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
131077526|NCT04469465|471918464|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
131077527|NCT04469465|471918465|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
131077528|NCT04469465|471918464|FG000|Long-Term Extension (LTE)|Death|0|||
131077529|NCT04469465|471918465|FG001|Long-Term Extension (LTE)|Death|1|||
131077530|NCT04469465|471918464|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
131077531|NCT04469465|471918465|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
131077532|NCT03194867|471918466|FG000|Overall Study|Incorrect completion of end of study form|0|||
131077533|NCT03194867|471918467|FG001|Overall Study|Incorrect completion of end of study form|0|||
131077534|NCT03194867|471918468|FG002|Overall Study|Incorrect completion of end of study form|1|||
131077535|NCT03194867|471918469|FG003|Overall Study|Incorrect completion of end of study form|0|||
131077536|NCT03305809|471918470|FG000|Overall Study|Adverse Event|2|||
131077537|NCT03305809|471918471|FG001|Overall Study|Adverse Event|2|||
131077538|NCT03305809|471918472|FG002|Overall Study|Adverse Event|6|||
131077539|NCT03305809|471918473|FG003|Overall Study|Adverse Event|6|||
131077540|NCT03305809|471918470|FG000|Overall Study|Death|0|||
131077541|NCT03305809|471918471|FG001|Overall Study|Death|0|||
131077542|NCT03305809|471918472|FG002|Overall Study|Death|1|||
131077543|NCT03305809|471918473|FG003|Overall Study|Death|1|||
131077544|NCT03305809|471918470|FG000|Overall Study|Lost to Follow-up|1|||
131077545|NCT03305809|471918471|FG001|Overall Study|Lost to Follow-up|2|||
131077546|NCT03305809|471918472|FG002|Overall Study|Lost to Follow-up|0|||
131077547|NCT03305809|471918473|FG003|Overall Study|Lost to Follow-up|0|||
131077548|NCT03305809|471918470|FG000|Overall Study|Sponsor Decision|1|||
131077549|NCT03305809|471918471|FG001|Overall Study|Sponsor Decision|0|||
131077550|NCT03305809|471918472|FG002|Overall Study|Sponsor Decision|1|||
131077551|NCT03305809|471918473|FG003|Overall Study|Sponsor Decision|8|||
131077552|NCT03305809|471918470|FG000|Overall Study|Physician Decision|0|||
131077553|NCT03305809|471918471|FG001|Overall Study|Physician Decision|0|||
131077554|NCT03305809|471918472|FG002|Overall Study|Physician Decision|2|||
131077555|NCT03305809|471918473|FG003|Overall Study|Physician Decision|4|||
131077556|NCT03305809|471918470|FG000|Overall Study|Progressive Disease|0|||
131077557|NCT03305809|471918471|FG001|Overall Study|Progressive Disease|0|||
131077558|NCT03305809|471918472|FG002|Overall Study|Progressive Disease|1|||
131077559|NCT03305809|471918473|FG003|Overall Study|Progressive Disease|0|||
131077560|NCT03305809|471918470|FG000|Overall Study|Protocol Violation|1|||
131077561|NCT03305809|471918471|FG001|Overall Study|Protocol Violation|0|||
131077562|NCT03305809|471918472|FG002|Overall Study|Protocol Violation|2|||
131077563|NCT03305809|471918473|FG003|Overall Study|Protocol Violation|3|||
131077564|NCT03305809|471918470|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
131077565|NCT03305809|471918471|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
131077566|NCT03305809|471918472|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
131077567|NCT03305809|471918473|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
131077568|NCT03305809|471918470|FG000|Overall Study|Withdrawal by Subject|2|||
131139053|NCT01227902|472135991|FG000|Overall Study|Protocol Violation|1|||
131139054|NCT01227902|472135992|FG001|Overall Study|Protocol Violation|0|||
131139055|NCT01227902|472135993|FG002|Overall Study|Protocol Violation|0|||
131139056|NCT01227902|472135994|FG003|Overall Study|Protocol Violation|0|||
131139057|NCT01227902|472135991|FG000|Overall Study|Lost to Follow-up|0|||
131139058|NCT01227902|472135992|FG001|Overall Study|Lost to Follow-up|0|||
131139059|NCT01227902|472135993|FG002|Overall Study|Lost to Follow-up|1|||
131139060|NCT01227902|472135994|FG003|Overall Study|Lost to Follow-up|2|||
131139061|NCT01227902|472135991|FG000|Overall Study|Physician Decision|0|||
131139062|NCT01227902|472135992|FG001|Overall Study|Physician Decision|1|||
131139063|NCT01227902|472135993|FG002|Overall Study|Physician Decision|1|||
131139064|NCT01227902|472135994|FG003|Overall Study|Physician Decision|0|||
131139065|NCT01227902|472135991|FG000|Overall Study|Withdrawal by Subject|4|||
131139066|NCT01227902|472135992|FG001|Overall Study|Withdrawal by Subject|2|||
131139067|NCT01227902|472135993|FG002|Overall Study|Withdrawal by Subject|4|||
130779727|NCT01064414|470819511|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
131077569|NCT03305809|471918471|FG001|Overall Study|Withdrawal by Subject|4|||
131077570|NCT03305809|471918472|FG002|Overall Study|Withdrawal by Subject|5|||
131077571|NCT03305809|471918473|FG003|Overall Study|Withdrawal by Subject|2|||
131077572|NCT03305809|471918470|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
131077573|NCT03305809|471918471|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
131139068|NCT01227902|472135994|FG003|Overall Study|Withdrawal by Subject|3|||
131139069|NCT05280756|472135995|FG000|Overall Study|Lost to Follow-up|1|||
131139070|NCT05280756|472135996|FG001|Overall Study|Lost to Follow-up|1|||
131139071|NCT01299766|472136004|FG000|Overall Study|Death|5|||
130779728|NCT01064414|470819512|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
130779729|NCT01064414|470819510|FG000|Core Period: Baseline to Week 26|Death|0|||
130779730|NCT01064414|470819511|FG001|Core Period: Baseline to Week 26|Death|1|||
130779731|NCT01064414|470819512|FG002|Core Period: Baseline to Week 26|Death|0|||
130779732|NCT01064414|470819510|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
130779733|NCT01064414|470819511|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
130779734|NCT01064414|470819512|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
130779735|NCT01064414|470819510|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
130779736|NCT01064414|470819511|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
130779737|NCT01064414|470819512|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
130779738|NCT01064414|470819510|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130779739|NCT01064414|470819511|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130779740|NCT01064414|470819512|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130779741|NCT01064414|470819510|FG000|Core Period: Baseline to Week 26|Other|4|||
130779742|NCT01064414|470819511|FG001|Core Period: Baseline to Week 26|Other|7|||
130779743|NCT01064414|470819512|FG002|Core Period: Baseline to Week 26|Other|2|||
130779744|NCT01064414|470819510|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
130779745|NCT01064414|470819511|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130779746|NCT01064414|470819512|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
130779747|NCT01064414|470819510|FG000|Extension Period: Week 26 to Week 52|Death|0|||
130779748|NCT01064414|470819511|FG001|Extension Period: Week 26 to Week 52|Death|1|||
130779749|NCT01064414|470819512|FG002|Extension Period: Week 26 to Week 52|Death|0|||
130779750|NCT01064414|470819510|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
130779751|NCT01064414|470819511|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130779752|NCT01064414|470819512|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130779753|NCT01064414|470819510|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
130779754|NCT01064414|470819511|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130779755|NCT01064414|470819512|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130779756|NCT01064414|470819510|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130779757|NCT01064414|470819511|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130779758|NCT01064414|470819512|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130779759|NCT01064414|470819510|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
130779760|NCT01064414|470819511|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130779761|NCT01064414|470819512|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130779762|NCT01064414|470819510|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130779763|NCT01064414|470819511|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130779764|NCT01064414|470819512|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130779765|NCT01064414|470819510|FG000|Extension Period: Week 26 to Week 52|Other|5|||
130779766|NCT01064414|470819511|FG001|Extension Period: Week 26 to Week 52|Other|2|||
130779767|NCT01064414|470819512|FG002|Extension Period: Week 26 to Week 52|Other|1|||
131077574|NCT03305809|471918472|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
131077575|NCT03305809|471918473|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
131077576|NCT00816556|471918474|FG000|Overall Study|Adverse Event|1|||
131077577|NCT00816556|471918475|FG001|Overall Study|Adverse Event|1|||
131077578|NCT00816556|471918476|FG002|Overall Study|Adverse Event|1|||
131077579|NCT00816556|471918474|FG000|Overall Study|Withdrawal by Subject|1|||
131077580|NCT00816556|471918475|FG001|Overall Study|Withdrawal by Subject|1|||
131077581|NCT00816556|471918476|FG002|Overall Study|Withdrawal by Subject|1|||
131077582|NCT00816556|471918474|FG000|Overall Study|Lost to Follow-up|0|||
131077583|NCT00816556|471918475|FG001|Overall Study|Lost to Follow-up|0|||
131077584|NCT00816556|471918476|FG002|Overall Study|Lost to Follow-up|1|||
131077585|NCT03546816|471918477|FG000|Overall Study|Adverse Event|5|||
130779768|NCT00249873|470819513|FG000|Overall Study|Not treated|7|||
130779769|NCT00249873|470819514|FG001|Overall Study|Not treated|8|||
130779770|NCT00249873|470819513|FG000|Overall Study|Significant thrombocytopenia|9|||
130779771|NCT00249873|470819514|FG001|Overall Study|Significant thrombocytopenia|8|||
130779772|NCT00249873|470819513|FG000|Overall Study|Severe allergic reaction|8|||
131077586|NCT03546816|471918478|FG001|Overall Study|Adverse Event|3|||
131077587|NCT03546816|471918477|FG000|Overall Study|Lack of Efficacy|2|||
131077588|NCT03546816|471918478|FG001|Overall Study|Lack of Efficacy|4|||
131077589|NCT03546816|471918477|FG000|Overall Study|Pregnancy|1|||
131231498|NCT00947856|472473348|FG001|Treatment Period|Study Stopped by Sponsor|4|||
131231499|NCT00947856|472473347|FG000|Treatment Period|Withdrawal by Subject|12|||
130779773|NCT00249873|470819514|FG001|Overall Study|Severe allergic reaction|1|||
130779774|NCT00249873|470819513|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
130779775|NCT00249873|470819514|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
130779776|NCT00249873|470819513|FG000|Overall Study|Other Serious Adverse Event|86|||
131077590|NCT03546816|471918478|FG001|Overall Study|Pregnancy|0|||
131077591|NCT03546816|471918477|FG000|Overall Study|Physician Decision|2|||
131077592|NCT03546816|471918478|FG001|Overall Study|Physician Decision|0|||
131231500|NCT00947856|472473348|FG001|Treatment Period|Withdrawal by Subject|1|||
130725509|NCT00996892|470619341|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
130725510|NCT00996892|470619342|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
130725511|NCT00996892|470619343|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
130725512|NCT00996892|470619324|FG000|Expansion Stage 2|Adverse Event|0|||
130725513|NCT00996892|470619325|FG001|Expansion Stage 2|Adverse Event|0|||
130725514|NCT00996892|470619326|FG002|Expansion Stage 2|Adverse Event|0|||
130725515|NCT00996892|470619327|FG003|Expansion Stage 2|Adverse Event|0|||
130725516|NCT00996892|470619328|FG004|Expansion Stage 2|Adverse Event|0|||
130725517|NCT00996892|470619329|FG005|Expansion Stage 2|Adverse Event|0|||
130725518|NCT00996892|470619330|FG006|Expansion Stage 2|Adverse Event|0|||
130725519|NCT00996892|470619331|FG007|Expansion Stage 2|Adverse Event|0|||
130725520|NCT00996892|470619332|FG008|Expansion Stage 2|Adverse Event|0|||
130725521|NCT00996892|470619333|FG009|Expansion Stage 2|Adverse Event|0|||
130725522|NCT00996892|470619334|FG010|Expansion Stage 2|Adverse Event|0|||
130725523|NCT00996892|470619335|FG011|Expansion Stage 2|Adverse Event|0|||
130725524|NCT00996892|470619336|FG012|Expansion Stage 2|Adverse Event|0|||
130725525|NCT00996892|470619337|FG013|Expansion Stage 2|Adverse Event|0|||
130725526|NCT00996892|470619338|FG014|Expansion Stage 2|Adverse Event|0|||
130725527|NCT00996892|470619339|FG015|Expansion Stage 2|Adverse Event|0|||
130725528|NCT00996892|470619340|FG016|Expansion Stage 2|Adverse Event|0|||
130725529|NCT00996892|470619341|FG017|Expansion Stage 2|Adverse Event|0|||
130725530|NCT00996892|470619342|FG018|Expansion Stage 2|Adverse Event|3|||
130725531|NCT00996892|470619343|FG019|Expansion Stage 2|Adverse Event|0|||
130725532|NCT00996892|470619324|FG000|Expansion Stage 2|Death|0|||
130725533|NCT00996892|470619325|FG001|Expansion Stage 2|Death|0|||
130725534|NCT00996892|470619326|FG002|Expansion Stage 2|Death|0|||
130725535|NCT00996892|470619327|FG003|Expansion Stage 2|Death|0|||
130725536|NCT00996892|470619328|FG004|Expansion Stage 2|Death|0|||
130725537|NCT00996892|470619329|FG005|Expansion Stage 2|Death|0|||
130725538|NCT00996892|470619330|FG006|Expansion Stage 2|Death|0|||
130725539|NCT00996892|470619331|FG007|Expansion Stage 2|Death|0|||
130725540|NCT00996892|470619332|FG008|Expansion Stage 2|Death|0|||
130725541|NCT00996892|470619333|FG009|Expansion Stage 2|Death|0|||
130725542|NCT00996892|470619334|FG010|Expansion Stage 2|Death|0|||
130725543|NCT00996892|470619335|FG011|Expansion Stage 2|Death|0|||
130725544|NCT00996892|470619336|FG012|Expansion Stage 2|Death|0|||
130725545|NCT00996892|470619337|FG013|Expansion Stage 2|Death|0|||
130725546|NCT00996892|470619338|FG014|Expansion Stage 2|Death|0|||
130725547|NCT00996892|470619339|FG015|Expansion Stage 2|Death|0|||
130725548|NCT00996892|470619340|FG016|Expansion Stage 2|Death|0|||
130725549|NCT00996892|470619341|FG017|Expansion Stage 2|Death|0|||
130725550|NCT00996892|470619342|FG018|Expansion Stage 2|Death|2|||
131139072|NCT01299766|472136005|FG001|Overall Study|Death|4|||
131139073|NCT01299766|472136004|FG000|Overall Study|Withdrawal by Subject|29|||
131139074|NCT01299766|472136005|FG001|Overall Study|Withdrawal by Subject|19|||
131139075|NCT00403260|472136008|FG000|Overall Study|Adverse Event|5|||
131139076|NCT00403260|472136009|FG001|Overall Study|Adverse Event|4|||
131139077|NCT00403260|472136008|FG000|Overall Study|Withdrawal by Subject|5|||
131139078|NCT00403260|472136009|FG001|Overall Study|Withdrawal by Subject|6|||
130725551|NCT00996892|470619343|FG019|Expansion Stage 2|Death|0|||
130725552|NCT00996892|470619324|FG000|Expansion Stage 2|Physician Decision|0|||
130725553|NCT00996892|470619325|FG001|Expansion Stage 2|Physician Decision|0|||
130725554|NCT00996892|470619326|FG002|Expansion Stage 2|Physician Decision|0|||
130725555|NCT00996892|470619327|FG003|Expansion Stage 2|Physician Decision|0|||
130725556|NCT00996892|470619328|FG004|Expansion Stage 2|Physician Decision|0|||
130725557|NCT00996892|470619329|FG005|Expansion Stage 2|Physician Decision|0|||
130725558|NCT00996892|470619330|FG006|Expansion Stage 2|Physician Decision|0|||
130725559|NCT00996892|470619331|FG007|Expansion Stage 2|Physician Decision|0|||
130725560|NCT00996892|470619332|FG008|Expansion Stage 2|Physician Decision|0|||
130725561|NCT00996892|470619333|FG009|Expansion Stage 2|Physician Decision|0|||
130725562|NCT00996892|470619334|FG010|Expansion Stage 2|Physician Decision|0|||
130725563|NCT00996892|470619335|FG011|Expansion Stage 2|Physician Decision|0|||
130725564|NCT00996892|470619336|FG012|Expansion Stage 2|Physician Decision|0|||
130725565|NCT00996892|470619337|FG013|Expansion Stage 2|Physician Decision|0|||
130725566|NCT00996892|470619338|FG014|Expansion Stage 2|Physician Decision|0|||
130725567|NCT00996892|470619339|FG015|Expansion Stage 2|Physician Decision|0|||
130725568|NCT00996892|470619340|FG016|Expansion Stage 2|Physician Decision|0|||
130725569|NCT00996892|470619341|FG017|Expansion Stage 2|Physician Decision|0|||
130725570|NCT00996892|470619342|FG018|Expansion Stage 2|Physician Decision|1|||
130725571|NCT00996892|470619343|FG019|Expansion Stage 2|Physician Decision|0|||
130725572|NCT00996892|470619324|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
130725573|NCT00996892|470619325|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
130725574|NCT00996892|470619326|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
130725575|NCT00996892|470619327|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
130725576|NCT00996892|470619328|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
130725577|NCT00996892|470619329|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
130725578|NCT00996892|470619330|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
130725579|NCT00996892|470619331|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
131139079|NCT00403260|472136008|FG000|Overall Study|Lost to Follow-up|49|||
131139080|NCT00403260|472136009|FG001|Overall Study|Lost to Follow-up|25|||
131077593|NCT03546816|471918477|FG000|Overall Study|Withdrawal by Subject|8|||
131077594|NCT03546816|471918478|FG001|Overall Study|Withdrawal by Subject|10|||
131077595|NCT03546816|471918477|FG000|Overall Study|Lost to Follow-up|3|||
131077596|NCT03546816|471918478|FG001|Overall Study|Lost to Follow-up|2|||
131077597|NCT02438371|471918479|FG000|Overall Study|Lost to Follow-up|3|||
131077598|NCT02438371|471918480|FG001|Overall Study|Lost to Follow-up|2|||
131077599|NCT02438371|471918479|FG000|Overall Study|Withdrawal by Subject|1|||
131077600|NCT02438371|471918480|FG001|Overall Study|Withdrawal by Subject|1|||
131077601|NCT01161446|471918481|FG000|Overall Study|Lost to Follow-up|18|||
131077602|NCT01161446|471918482|FG001|Overall Study|Lost to Follow-up|14|||
131077603|NCT01161446|471918481|FG000|Overall Study|Withdrawal by Subject|0|||
131077604|NCT01161446|471918482|FG001|Overall Study|Withdrawal by Subject|1|||
131077605|NCT01660256|471918485|FG000|Overall Study|Adverse Event|4|||
131139081|NCT00403260|472136008|FG000|Overall Study|Re-appearance of P. falciparum|34|||
131139082|NCT00403260|472136009|FG001|Overall Study|Re-appearance of P. falciparum|25|||
131139083|NCT00403260|472136008|FG000|Overall Study|P. vivax infection|26|||
131139084|NCT00403260|472136009|FG001|Overall Study|P. vivax infection|4|||
131139085|NCT00403260|472136008|FG000|Overall Study|Mixed infection with P. vivax|2|||
131139086|NCT00403260|472136009|FG001|Overall Study|Mixed infection with P. vivax|0|||
131139087|NCT00403260|472136008|FG000|Overall Study|Mixed infection with P. falciparum|1|||
131139088|NCT00403260|472136009|FG001|Overall Study|Mixed infection with P. falciparum|0|||
131139089|NCT00403260|472136008|FG000|Overall Study|P. vivax infection at screening|1|||
131139090|NCT00403260|472136009|FG001|Overall Study|P. vivax infection at screening|0|||
131139091|NCT00403260|472136008|FG000|Overall Study|P. ovale infection|1|||
131139092|NCT00403260|472136009|FG001|Overall Study|P. ovale infection|0|||
131139093|NCT00403260|472136008|FG000|Overall Study|Gametocyte re-appearance|1|||
131139094|NCT00403260|472136009|FG001|Overall Study|Gametocyte re-appearance|1|||
131139095|NCT00403260|472136008|FG000|Overall Study|Withdrawn from study accidentally|0|||
131139096|NCT00403260|472136009|FG001|Overall Study|Withdrawn from study accidentally|1|||
131139097|NCT01354028|472136010|FG000|Overall Study|Physician Decision|0|||
131139098|NCT01354028|472136011|FG001|Overall Study|Physician Decision|2|||
131139099|NCT01354028|472136010|FG000|Overall Study|Discharged before study start|2|||
131139100|NCT01354028|472136011|FG001|Overall Study|Discharged before study start|2|||
131139101|NCT01354028|472136010|FG000|Overall Study|No quiet alert state|0|||
131139102|NCT01354028|472136011|FG001|Overall Study|No quiet alert state|1|||
131139103|NCT00935883|472136014|FG000|Treatment Period|Physician Decision|1|||
131139104|NCT00935883|472136015|FG001|Treatment Period|Physician Decision|0|||
131139105|NCT00935883|472136014|FG000|Treatment Period|Withdrawal by Subject|0|||
131139106|NCT00935883|472136015|FG001|Treatment Period|Withdrawal by Subject|2|||
131139107|NCT00808444|472136024|FG000|Overall Study|Withdrawal by Subject|1|||
131139108|NCT00808444|472136025|FG001|Overall Study|Withdrawal by Subject|0|||
131139109|NCT00808444|472136024|FG000|Overall Study|Lost to Follow-up|0|||
131139110|NCT00808444|472136025|FG001|Overall Study|Lost to Follow-up|1|||
131139111|NCT01461044|472136026|FG000|Overall Study|Death|58|||
131139112|NCT01461044|472136027|FG001|Overall Study|Death|35|||
131139113|NCT01461044|472136026|FG000|Overall Study|Lost to Follow-up|12|||
131139114|NCT01461044|472136027|FG001|Overall Study|Lost to Follow-up|5|||
131139115|NCT00716976|472136028|FG000|Overall Study|Adverse Event|2|||
131139116|NCT00716976|472136029|FG001|Overall Study|Adverse Event|0|||
131139117|NCT00716976|472136028|FG000|Overall Study|Death|1|||
131139118|NCT00716976|472136029|FG001|Overall Study|Death|0|||
131139119|NCT00716976|472136028|FG000|Overall Study|Physician Decision|2|||
131139120|NCT00716976|472136029|FG001|Overall Study|Physician Decision|2|||
131139121|NCT00716976|472136028|FG000|Overall Study|Withdrawal by Subject|5|||
131139122|NCT00716976|472136029|FG001|Overall Study|Withdrawal by Subject|1|||
131139123|NCT00716976|472136028|FG000|Overall Study|Premature discontinuation cisplatin|5|||
131139124|NCT00716976|472136029|FG001|Overall Study|Premature discontinuation cisplatin|4|||
130725580|NCT00996892|470619332|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
130725581|NCT00996892|470619333|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
130725582|NCT00996892|470619334|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
130725583|NCT00996892|470619335|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
130725584|NCT00996892|470619336|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
131077606|NCT01660256|471918486|FG001|Overall Study|Adverse Event|0|||
131077607|NCT01660256|471918487|FG002|Overall Study|Adverse Event|2|||
131077608|NCT01660256|471918485|FG000|Overall Study|Withdrawal by Subject|1|||
131139125|NCT00716976|472136028|FG000|Overall Study|Radiation during protocol|1|||
131139126|NCT00716976|472136029|FG001|Overall Study|Radiation during protocol|0|||
131139127|NCT00716976|472136028|FG000|Overall Study|Ineligibles|4|||
131139128|NCT00716976|472136029|FG001|Overall Study|Ineligibles|2|||
131139129|NCT00975156|472136035|FG000|Overall Study|Protocol Violation|0|||
131077609|NCT01660256|471918486|FG001|Overall Study|Withdrawal by Subject|0|||
131139130|NCT00975156|472136036|FG001|Overall Study|Protocol Violation|1|||
131139131|NCT00454779|472136041|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
131139132|NCT00454779|472136042|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
131139133|NCT00454779|472136041|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
130725585|NCT00996892|470619337|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
130725586|NCT00996892|470619338|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
130725587|NCT00996892|470619339|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
130725588|NCT00996892|470619340|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
130725589|NCT00996892|470619341|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
130725590|NCT00996892|470619342|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
130725591|NCT00996892|470619343|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
130725592|NCT00996892|470619324|FG000|Expansion Stage 2|Disease Progression|0|||
130725593|NCT00996892|470619325|FG001|Expansion Stage 2|Disease Progression|0|||
130725594|NCT00996892|470619326|FG002|Expansion Stage 2|Disease Progression|0|||
130725595|NCT00996892|470619327|FG003|Expansion Stage 2|Disease Progression|0|||
130725596|NCT00996892|470619328|FG004|Expansion Stage 2|Disease Progression|0|||
130725597|NCT00996892|470619329|FG005|Expansion Stage 2|Disease Progression|0|||
130725598|NCT00996892|470619330|FG006|Expansion Stage 2|Disease Progression|0|||
130725599|NCT00996892|470619331|FG007|Expansion Stage 2|Disease Progression|0|||
130725600|NCT00996892|470619332|FG008|Expansion Stage 2|Disease Progression|0|||
130725601|NCT00996892|470619333|FG009|Expansion Stage 2|Disease Progression|0|||
130725602|NCT00996892|470619334|FG010|Expansion Stage 2|Disease Progression|0|||
130725603|NCT00996892|470619335|FG011|Expansion Stage 2|Disease Progression|0|||
130725604|NCT00996892|470619336|FG012|Expansion Stage 2|Disease Progression|0|||
130725605|NCT00996892|470619337|FG013|Expansion Stage 2|Disease Progression|0|||
130725606|NCT00996892|470619338|FG014|Expansion Stage 2|Disease Progression|0|||
130725607|NCT00996892|470619339|FG015|Expansion Stage 2|Disease Progression|0|||
130725608|NCT00996892|470619340|FG016|Expansion Stage 2|Disease Progression|0|||
130725609|NCT00996892|470619341|FG017|Expansion Stage 2|Disease Progression|0|||
130725610|NCT00996892|470619342|FG018|Expansion Stage 2|Disease Progression|28|||
130725611|NCT00996892|470619343|FG019|Expansion Stage 2|Disease Progression|0|||
131077610|NCT01660256|471918487|FG002|Overall Study|Withdrawal by Subject|2|||
131077611|NCT01162135|471918489|FG000|Overall Study|Withdrawal by Subject|1|||
131077612|NCT01162135|471918489|FG000|Overall Study|Severe back pain|1|||
131077613|NCT01162135|471918489|FG000|Overall Study|Ineligible|1|||
131139134|NCT00454779|472136042|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
131139135|NCT00454779|472136041|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
131139136|NCT00454779|472136042|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
131139137|NCT00454779|472136041|FG000|First-line Treatment Phase|Protocol Violation|0|||
131139138|NCT00454779|472136042|FG001|First-line Treatment Phase|Protocol Violation|1|||
131139139|NCT00454779|472136041|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
131139140|NCT00454779|472136042|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
131139141|NCT00454779|472136041|FG000|First-line Treatment Phase|Ongoing|1|||
131139142|NCT00454779|472136042|FG001|First-line Treatment Phase|Ongoing|0|||
131077623|NCT00551135|471918491|FG000|Overall Study|Adverse Event|1|||
131077624|NCT00551135|471918492|FG001|Overall Study|Adverse Event|0|||
131077625|NCT00551135|471918493|FG002|Overall Study|Adverse Event|1|||
131077626|NCT00551135|471918494|FG003|Overall Study|Adverse Event|1|||
131077627|NCT00551135|471918491|FG000|Overall Study|Lost to Follow-up|0|||
131077628|NCT00551135|471918492|FG001|Overall Study|Lost to Follow-up|0|||
131077629|NCT00551135|471918493|FG002|Overall Study|Lost to Follow-up|0|||
131077630|NCT00551135|471918494|FG003|Overall Study|Lost to Follow-up|1|||
131077631|NCT00551135|471918491|FG000|Overall Study|Other|3|||
131077632|NCT00551135|471918492|FG001|Overall Study|Other|2|||
131231501|NCT00947856|472473347|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
131231502|NCT00947856|472473348|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
131231503|NCT00947856|472473347|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
131231504|NCT00947856|472473348|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
131231505|NCT00947856|472473347|FG000|Follow-up Period|Lost to Follow-up|7|||
131231506|NCT00947856|472473348|FG001|Follow-up Period|Lost to Follow-up|0|||
131231507|NCT00947856|472473347|FG000|Follow-up Period|Patient unavailable for site visits|1|||
131231508|NCT00947856|472473348|FG001|Follow-up Period|Patient unavailable for site visits|0|||
131231509|NCT00947856|472473347|FG000|Follow-up Period|Withdrawal by Subject|1|||
131231510|NCT00947856|472473348|FG001|Follow-up Period|Withdrawal by Subject|0|||
131231511|NCT02669264|472473354|FG000|Overall Study|Death|5|||
130725612|NCT00996892|470619324|FG000|Expansion Stage 2A|Adverse Event|0|||
130725613|NCT00996892|470619325|FG001|Expansion Stage 2A|Adverse Event|0|||
130725614|NCT00996892|470619326|FG002|Expansion Stage 2A|Adverse Event|0|||
130725615|NCT00996892|470619327|FG003|Expansion Stage 2A|Adverse Event|0|||
131077633|NCT00551135|471918493|FG002|Overall Study|Other|1|||
131077634|NCT00551135|471918494|FG003|Overall Study|Other|2|||
131077635|NCT00551135|471918491|FG000|Overall Study|Withdrawal by Subject|1|||
131077636|NCT00551135|471918492|FG001|Overall Study|Withdrawal by Subject|0|||
130725616|NCT00996892|470619328|FG004|Expansion Stage 2A|Adverse Event|0|||
130725617|NCT00996892|470619329|FG005|Expansion Stage 2A|Adverse Event|0|||
130725618|NCT00996892|470619330|FG006|Expansion Stage 2A|Adverse Event|0|||
130725619|NCT00996892|470619331|FG007|Expansion Stage 2A|Adverse Event|0|||
130725620|NCT00996892|470619332|FG008|Expansion Stage 2A|Adverse Event|0|||
130725621|NCT00996892|470619333|FG009|Expansion Stage 2A|Adverse Event|0|||
130725622|NCT00996892|470619334|FG010|Expansion Stage 2A|Adverse Event|0|||
130725623|NCT00996892|470619335|FG011|Expansion Stage 2A|Adverse Event|0|||
131139143|NCT00454779|472136041|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
131077637|NCT00551135|471918493|FG002|Overall Study|Withdrawal by Subject|3|||
131077638|NCT00551135|471918494|FG003|Overall Study|Withdrawal by Subject|1|||
131077639|NCT00858247|471918495|FG000|Baseline Assessment|Withdrawal by Subject|1|||
131077640|NCT00858247|471918496|FG001|Baseline Assessment|Withdrawal by Subject|1|||
131077641|NCT00858247|471918495|FG000|Baseline Assessment|Poor IV access|1|||
131077642|NCT00858247|471918496|FG001|Baseline Assessment|Poor IV access|0|||
131077643|NCT00858247|471918495|FG000|Baseline Assessment|Protocol Violation|0|||
131077644|NCT00858247|471918496|FG001|Baseline Assessment|Protocol Violation|1|||
131077645|NCT00858247|471918495|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
131077646|NCT00858247|471918496|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
131077647|NCT03898960|471918499|FG000|Overall Study|Death|10|||
131077648|NCT00548847|471918500|FG000|Overall Study|Disease progression|7|||
131077649|NCT01379703|471918501|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
131077650|NCT01379703|471918502|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
131077651|NCT01379703|471918503|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
131077652|NCT01379703|471918501|FG000|Study Start Through 9 Months|Adverse Event|0|||
131077653|NCT01379703|471918502|FG001|Study Start Through 9 Months|Adverse Event|14|||
131077654|NCT01379703|471918503|FG002|Study Start Through 9 Months|Adverse Event|10|||
131077655|NCT01379703|471918501|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
131077656|NCT01379703|471918502|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
131077657|NCT01379703|471918503|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
131077658|NCT01379703|471918501|FG000|Study Start Through 9 Months|Treatment Failure|0|||
131077659|NCT01379703|471918502|FG001|Study Start Through 9 Months|Treatment Failure|2|||
131077660|NCT01379703|471918503|FG002|Study Start Through 9 Months|Treatment Failure|2|||
131077661|NCT01379703|471918501|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
131077662|NCT01379703|471918502|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
131077663|NCT01379703|471918503|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
131077664|NCT01379703|471918501|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
131077665|NCT01379703|471918502|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
131077666|NCT01379703|471918503|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
131077667|NCT01379703|471918501|FG000|Study Start Through 9 Months|Medication not available|0|||
131077668|NCT01379703|471918502|FG001|Study Start Through 9 Months|Medication not available|2|||
131077669|NCT01379703|471918503|FG002|Study Start Through 9 Months|Medication not available|1|||
131077670|NCT01379703|471918501|FG000|Study Start Through 9 Months|Poor general condition|0|||
131077671|NCT01379703|471918502|FG001|Study Start Through 9 Months|Poor general condition|1|||
131077672|NCT01379703|471918503|FG002|Study Start Through 9 Months|Poor general condition|0|||
131077673|NCT01379703|471918501|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
131077674|NCT01379703|471918502|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
131077675|NCT01379703|471918503|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
131077676|NCT01379703|471918501|FG000|Study Start Through 9 Months|Reason unknown|2|||
131077677|NCT01379703|471918502|FG001|Study Start Through 9 Months|Reason unknown|31|||
131077678|NCT01379703|471918503|FG002|Study Start Through 9 Months|Reason unknown|24|||
131077679|NCT01379703|471918501|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
131077680|NCT01379703|471918502|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
131077681|NCT01379703|471918503|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
131139144|NCT00454779|472136042|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
131139145|NCT00454779|472136041|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
131139146|NCT00454779|472136042|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
131139147|NCT00454779|472136041|FG000|Second-line Treatment Phase|Ongoing|0|||
131139148|NCT00454779|472136042|FG001|Second-line Treatment Phase|Ongoing|1|||
131139149|NCT05425563|472136045|FG000|Overall Study|Withdrawal by Subject|17|||
131139150|NCT00168831|472136049|FG000|Overall Study|Adverse Event|36|||
131139151|NCT00168831|472136050|FG001|Overall Study|Adverse Event|47|||
131139152|NCT00168831|472136051|FG002|Overall Study|Adverse Event|74|||
131139153|NCT00168831|472136049|FG000|Overall Study|Lost to Follow-up|5|||
131139154|NCT00168831|472136050|FG001|Overall Study|Lost to Follow-up|6|||
130725624|NCT00996892|470619336|FG012|Expansion Stage 2A|Adverse Event|0|||
130725625|NCT00996892|470619337|FG013|Expansion Stage 2A|Adverse Event|0|||
131077682|NCT01379703|471918501|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
131077683|NCT01379703|471918502|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
131077684|NCT01379703|471918503|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
131077685|NCT01379703|471918501|FG000|9 Months Through 18 Months|Adverse Event|0|||
131077686|NCT01379703|471918502|FG001|9 Months Through 18 Months|Adverse Event|6|||
131139155|NCT00168831|472136051|FG002|Overall Study|Lost to Follow-up|4|||
131139156|NCT00168831|472136049|FG000|Overall Study|Withdrawal by Subject|7|||
131077687|NCT01379703|471918503|FG002|9 Months Through 18 Months|Adverse Event|0|||
131077688|NCT01379703|471918501|FG000|9 Months Through 18 Months|Treatment failure|0|||
131139157|NCT00168831|472136050|FG001|Overall Study|Withdrawal by Subject|14|||
131139158|NCT00168831|472136051|FG002|Overall Study|Withdrawal by Subject|19|||
131077689|NCT01379703|471918502|FG001|9 Months Through 18 Months|Treatment failure|5|||
130725626|NCT00996892|470619338|FG014|Expansion Stage 2A|Adverse Event|0|||
131077690|NCT01379703|471918503|FG002|9 Months Through 18 Months|Treatment failure|0|||
131077691|NCT01379703|471918501|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
131077692|NCT01379703|471918502|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
131077693|NCT01379703|471918503|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
131077694|NCT01379703|471918501|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
131077695|NCT01379703|471918502|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
131077696|NCT01379703|471918503|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
131077697|NCT01379703|471918501|FG000|9 Months Through 18 Months|Fatigue|0|||
131077698|NCT01379703|471918502|FG001|9 Months Through 18 Months|Fatigue|1|||
131077699|NCT01379703|471918503|FG002|9 Months Through 18 Months|Fatigue|0|||
131077700|NCT01379703|471918501|FG000|9 Months Through 18 Months|Reason Unknown|0|||
131077701|NCT01379703|471918502|FG001|9 Months Through 18 Months|Reason Unknown|23|||
131077702|NCT01379703|471918503|FG002|9 Months Through 18 Months|Reason Unknown|0|||
131077703|NCT01316887|471918504|FG000|Overall Study|Adverse Event|13|||
131077704|NCT01316887|471918505|FG001|Overall Study|Adverse Event|21|||
131077705|NCT01316887|471918506|FG002|Overall Study|Adverse Event|17|||
131077706|NCT01316887|471918504|FG000|Overall Study|Lack of Efficacy|9|||
131077707|NCT01316887|471918505|FG001|Overall Study|Lack of Efficacy|3|||
131077708|NCT01316887|471918506|FG002|Overall Study|Lack of Efficacy|1|||
131077709|NCT01316887|471918504|FG000|Overall Study|Protocol Violation|2|||
131077710|NCT01316887|471918505|FG001|Overall Study|Protocol Violation|6|||
131077711|NCT01316887|471918506|FG002|Overall Study|Protocol Violation|6|||
131077712|NCT01316887|471918504|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
131077713|NCT01316887|471918505|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
131077714|NCT01316887|471918506|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
131077715|NCT01316887|471918504|FG000|Overall Study|Study Closed/Terminated|2|||
131077716|NCT01316887|471918505|FG001|Overall Study|Study Closed/Terminated|4|||
131077717|NCT01316887|471918506|FG002|Overall Study|Study Closed/Terminated|3|||
131077718|NCT01316887|471918504|FG000|Overall Study|Lost to Follow-up|1|||
131077719|NCT01316887|471918505|FG001|Overall Study|Lost to Follow-up|7|||
131077720|NCT01316887|471918506|FG002|Overall Study|Lost to Follow-up|5|||
131077721|NCT01316887|471918504|FG000|Overall Study|Withdrawal by Subject|8|||
131077722|NCT01316887|471918505|FG001|Overall Study|Withdrawal by Subject|16|||
131077723|NCT01316887|471918506|FG002|Overall Study|Withdrawal by Subject|15|||
131077724|NCT00813098|471918509|FG000|Overall Study|Adverse Event|2|||
131077725|NCT00813098|471918510|FG001|Overall Study|Adverse Event|4|||
131077726|NCT00813098|471918511|FG002|Overall Study|Adverse Event|1|||
131077727|NCT00813098|471918509|FG000|Overall Study|Withdrawal by Subject|0|||
131077728|NCT00813098|471918510|FG001|Overall Study|Withdrawal by Subject|1|||
131077729|NCT00813098|471918511|FG002|Overall Study|Withdrawal by Subject|0|||
131077730|NCT00813098|471918509|FG000|Overall Study|Inability to complete study procedures|1|||
131077731|NCT00813098|471918510|FG001|Overall Study|Inability to complete study procedures|0|||
131077732|NCT00813098|471918511|FG002|Overall Study|Inability to complete study procedures|0|||
131077733|NCT00813098|471918509|FG000|Overall Study|Lost to Follow-up|0|||
131077734|NCT00813098|471918510|FG001|Overall Study|Lost to Follow-up|1|||
131077735|NCT00813098|471918511|FG002|Overall Study|Lost to Follow-up|0|||
131077736|NCT00813098|471918509|FG000|Overall Study|Protocol Violation|0|||
131077737|NCT00813098|471918510|FG001|Overall Study|Protocol Violation|0|||
131077738|NCT00813098|471918511|FG002|Overall Study|Protocol Violation|1|||
131077739|NCT00813098|471918509|FG000|Overall Study|Principal Investigator decision|0|||
131077740|NCT00813098|471918510|FG001|Overall Study|Principal Investigator decision|1|||
131077741|NCT00813098|471918511|FG002|Overall Study|Principal Investigator decision|0|||
131077742|NCT00813098|471918509|FG000|Overall Study|Withdrew Consent|0|||
131077743|NCT00813098|471918510|FG001|Overall Study|Withdrew Consent|1|||
131077744|NCT00813098|471918511|FG002|Overall Study|Withdrew Consent|0|||
131077745|NCT03470545|471918514|FG000|Overall Study|Death|0|||
131077746|NCT03470545|471918515|FG001|Overall Study|Death|1|||
131077747|NCT03470545|471918514|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
131077748|NCT03470545|471918515|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
131077749|NCT03470545|471918514|FG000|Overall Study|Adverse Event|2|||
131077750|NCT03470545|471918515|FG001|Overall Study|Adverse Event|0|||
131077751|NCT03470545|471918514|FG000|Overall Study|Withdrawal by Subject|1|||
131077752|NCT03470545|471918515|FG001|Overall Study|Withdrawal by Subject|1|||
131077753|NCT03470545|471918514|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
130725627|NCT00996892|470619339|FG015|Expansion Stage 2A|Adverse Event|0|||
131077754|NCT03470545|471918515|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
131077755|NCT00585975|471918516|FG000|Overall Study|Withdrawal by Subject|3|||
131077756|NCT00585975|471918517|FG001|Overall Study|Withdrawal by Subject|3|||
131077757|NCT00585975|471918516|FG000|Overall Study|Lost to Follow-up|2|||
131077758|NCT00585975|471918517|FG001|Overall Study|Lost to Follow-up|1|||
131077759|NCT00585975|471918516|FG000|Overall Study|Enrollment met/over-enrolled|10|||
131077760|NCT00585975|471918517|FG001|Overall Study|Enrollment met/over-enrolled|9|||
130725628|NCT00996892|470619340|FG016|Expansion Stage 2A|Adverse Event|0|||
131077761|NCT03672175|471918518|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
131077762|NCT03672175|471918519|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
131077763|NCT03672175|471918520|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
131077764|NCT03672175|471918518|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
131077765|NCT03672175|471918519|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
131077766|NCT03672175|471918520|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
131077767|NCT03672175|471918518|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
131077768|NCT03672175|471918519|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
131077769|NCT03672175|471918520|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
131077770|NCT03672175|471918518|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
131077771|NCT03672175|471918519|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
131077772|NCT03672175|471918520|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
131077773|NCT03672175|471918518|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
131077774|NCT03672175|471918519|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
131077775|NCT03672175|471918520|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
131077776|NCT03672175|471918518|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
131077777|NCT03672175|471918519|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
131077778|NCT03672175|471918520|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
131077779|NCT03672175|471918518|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
131077780|NCT03672175|471918519|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
131077781|NCT03672175|471918520|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
131077782|NCT03672175|471918518|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
131077783|NCT03672175|471918519|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
131077784|NCT03672175|471918520|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
131077785|NCT03672175|471918518|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
131077786|NCT03672175|471918519|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
131077787|NCT03672175|471918520|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
131077788|NCT03672175|471918518|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
131077789|NCT03672175|471918519|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
131077790|NCT03672175|471918520|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
131077791|NCT03672175|471918518|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
131077792|NCT03672175|471918519|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
131077793|NCT03672175|471918520|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
131077794|NCT03672175|471918518|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
131077795|NCT03672175|471918519|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
131077796|NCT03672175|471918520|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
131139159|NCT00168831|472136049|FG000|Overall Study|Protocol Violation|6|||
131139160|NCT00168831|472136050|FG001|Overall Study|Protocol Violation|11|||
131139161|NCT00168831|472136051|FG002|Overall Study|Protocol Violation|11|||
131139162|NCT00168831|472136049|FG000|Overall Study|Other|6|||
131139163|NCT00168831|472136050|FG001|Overall Study|Other|3|||
131139164|NCT00168831|472136051|FG002|Overall Study|Other|6|||
131139165|NCT01622569|472136052|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
131139166|NCT01622569|472136053|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
131139167|NCT01622569|472136054|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
131139168|NCT01622569|472136055|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
131139169|NCT01622569|472136052|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
131139170|NCT01622569|472136053|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
130725629|NCT00996892|470619341|FG017|Expansion Stage 2A|Adverse Event|0|||
130725630|NCT00996892|470619342|FG018|Expansion Stage 2A|Adverse Event|0|||
130725631|NCT00996892|470619343|FG019|Expansion Stage 2A|Adverse Event|8|||
130725632|NCT00996892|470619324|FG000|Expansion Stage 2A|Physician Decision|0|||
130725633|NCT00996892|470619325|FG001|Expansion Stage 2A|Physician Decision|0|||
130725634|NCT00996892|470619326|FG002|Expansion Stage 2A|Physician Decision|0|||
130725635|NCT00996892|470619327|FG003|Expansion Stage 2A|Physician Decision|0|||
130725636|NCT00996892|470619328|FG004|Expansion Stage 2A|Physician Decision|0|||
130725637|NCT00996892|470619329|FG005|Expansion Stage 2A|Physician Decision|0|||
130725638|NCT00996892|470619330|FG006|Expansion Stage 2A|Physician Decision|0|||
130725639|NCT00996892|470619331|FG007|Expansion Stage 2A|Physician Decision|0|||
130725640|NCT00996892|470619332|FG008|Expansion Stage 2A|Physician Decision|0|||
130725641|NCT00996892|470619333|FG009|Expansion Stage 2A|Physician Decision|0|||
130725642|NCT00996892|470619334|FG010|Expansion Stage 2A|Physician Decision|0|||
131077797|NCT03414047|471918521|FG000|Overall Study|Adverse Event|0|||
130725643|NCT00996892|470619335|FG011|Expansion Stage 2A|Physician Decision|0|||
131139171|NCT01622569|472136054|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
131231512|NCT02669264|472473355|FG001|Overall Study|Death|5|||
130725644|NCT00996892|470619336|FG012|Expansion Stage 2A|Physician Decision|0|||
130725645|NCT00996892|470619337|FG013|Expansion Stage 2A|Physician Decision|0|||
130725646|NCT00996892|470619338|FG014|Expansion Stage 2A|Physician Decision|0|||
131077798|NCT03414047|471918522|FG001|Overall Study|Adverse Event|0|||
131077799|NCT03414047|471918523|FG002|Overall Study|Adverse Event|1|||
131077800|NCT03414047|471918524|FG003|Overall Study|Adverse Event|1|||
131077801|NCT03414047|471918521|FG000|Overall Study|Physician Decision|1|||
131077802|NCT03414047|471918522|FG001|Overall Study|Physician Decision|0|||
131077803|NCT03414047|471918523|FG002|Overall Study|Physician Decision|0|||
131077804|NCT03414047|471918524|FG003|Overall Study|Physician Decision|1|||
131231513|NCT02669264|472473356|FG002|Overall Study|Death|3|||
131231514|NCT02669264|472473357|FG003|Overall Study|Death|3|||
131231515|NCT02669264|472473358|FG004|Overall Study|Death|3|||
131231516|NCT02669264|472473359|FG005|Overall Study|Death|6|||
131231517|NCT02669264|472473360|FG006|Overall Study|Death|3|||
131231518|NCT02669264|472473354|FG000|Overall Study|Withdrawal by Subject|0|||
131231519|NCT02669264|472473355|FG001|Overall Study|Withdrawal by Subject|1|||
131231520|NCT02669264|472473356|FG002|Overall Study|Withdrawal by Subject|0|||
131231521|NCT02669264|472473357|FG003|Overall Study|Withdrawal by Subject|0|||
131231522|NCT02669264|472473358|FG004|Overall Study|Withdrawal by Subject|1|||
131231523|NCT02669264|472473359|FG005|Overall Study|Withdrawal by Subject|0|||
131231524|NCT02669264|472473360|FG006|Overall Study|Withdrawal by Subject|0|||
131231525|NCT02669264|472473354|FG000|Overall Study|Lost to Follow-up|0|||
131231526|NCT02669264|472473355|FG001|Overall Study|Lost to Follow-up|0|||
131231527|NCT02669264|472473356|FG002|Overall Study|Lost to Follow-up|0|||
131231528|NCT02669264|472473357|FG003|Overall Study|Lost to Follow-up|0|||
131231529|NCT02669264|472473358|FG004|Overall Study|Lost to Follow-up|1|||
131231530|NCT02669264|472473359|FG005|Overall Study|Lost to Follow-up|0|||
131231531|NCT02669264|472473360|FG006|Overall Study|Lost to Follow-up|0|||
131231532|NCT02669264|472473354|FG000|Overall Study|Miscellaneous|0|||
131231533|NCT02669264|472473355|FG001|Overall Study|Miscellaneous|0|||
131231534|NCT02669264|472473356|FG002|Overall Study|Miscellaneous|0|||
131231535|NCT02669264|472473357|FG003|Overall Study|Miscellaneous|0|||
131231536|NCT02669264|472473358|FG004|Overall Study|Miscellaneous|0|||
131231537|NCT02669264|472473359|FG005|Overall Study|Miscellaneous|0|||
131231538|NCT02669264|472473360|FG006|Overall Study|Miscellaneous|2|||
131231539|NCT01688037|472473361|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
131231540|NCT01688037|472473362|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
131231541|NCT01688037|472473363|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
131231542|NCT01688037|472473361|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
131231543|NCT01688037|472473362|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
131231544|NCT01688037|472473363|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
131231545|NCT01688037|472473361|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
131231546|NCT01688037|472473362|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
131231547|NCT01688037|472473363|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
131231548|NCT01688037|472473361|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
131231549|NCT01688037|472473362|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
131231550|NCT01688037|472473363|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
131231551|NCT01688037|472473361|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
131231552|NCT01688037|472473362|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
131231553|NCT01688037|472473363|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
131231554|NCT01688037|472473361|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
130725647|NCT00996892|470619339|FG015|Expansion Stage 2A|Physician Decision|0|||
130725648|NCT00996892|470619340|FG016|Expansion Stage 2A|Physician Decision|0|||
130725649|NCT00996892|470619341|FG017|Expansion Stage 2A|Physician Decision|0|||
130725650|NCT00996892|470619342|FG018|Expansion Stage 2A|Physician Decision|0|||
130725651|NCT00996892|470619343|FG019|Expansion Stage 2A|Physician Decision|2|||
130725652|NCT00996892|470619324|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
130725653|NCT00996892|470619325|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
130725654|NCT00996892|470619326|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
130725655|NCT00996892|470619327|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
130725656|NCT00996892|470619328|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
130725657|NCT00996892|470619329|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
130725658|NCT00996892|470619330|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
130725659|NCT00996892|470619331|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
130725660|NCT00996892|470619332|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
130725661|NCT00996892|470619333|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
130725662|NCT00996892|470619334|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
130725663|NCT00996892|470619335|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
130725664|NCT00996892|470619336|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
131231555|NCT01688037|472473362|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
131231556|NCT01688037|472473363|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
131231557|NCT01688037|472473361|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
130725665|NCT00996892|470619337|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
130725666|NCT00996892|470619338|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
130725667|NCT00996892|470619339|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
131077805|NCT03414047|471918521|FG000|Overall Study|Withdrawal by Subject|1|||
131077806|NCT03414047|471918522|FG001|Overall Study|Withdrawal by Subject|0|||
130725668|NCT00996892|470619340|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
130725669|NCT00996892|470619341|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
131231558|NCT01688037|472473362|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
131231559|NCT01688037|472473363|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
131231560|NCT01688037|472473361|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
131231561|NCT01688037|472473362|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
131231562|NCT01688037|472473363|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
131231563|NCT01688037|472473361|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
131231564|NCT01688037|472473362|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
131231565|NCT01688037|472473363|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
131231566|NCT01688037|472473361|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
131231567|NCT01688037|472473362|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
131231568|NCT01688037|472473363|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
131231569|NCT02100956|472473364|FG000|At Least One Week Between Injections|Adverse Event|0|||
131231570|NCT02100956|472473365|FG001|At Least One Week Between Injections|Adverse Event|1|||
131231571|NCT00859469|472473367|FG000|Overall Study|Adverse Event|2|||
131231572|NCT00859469|472473367|FG000|Overall Study|Lack of Efficacy|9|||
131231573|NCT00859469|472473367|FG000|Overall Study|Withdrawal by Subject|1|||
131231574|NCT00859469|472473367|FG000|Overall Study|Death|16|||
131231575|NCT02220907|472473368|FG000|Overall Study|Adverse Event|7|||
131231576|NCT02220907|472473368|FG000|Overall Study|Physician Decision|1|||
131231577|NCT02220907|472473368|FG000|Overall Study|Withdrawal by Subject|2|||
131231578|NCT02220907|472473368|FG000|Overall Study|Conflict with the stopping criteria|1|||
131231579|NCT00832078|472475154|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
131231580|NCT00832078|472475155|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
131231581|NCT00832078|472475154|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
131231582|NCT00832078|472475155|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
131231583|NCT01767597|472475156|FG000|Overall Study|Incomplete intervention|3|||
131231584|NCT01767597|472475157|FG001|Overall Study|Incomplete intervention|1|||
130725670|NCT00996892|470619342|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
130725671|NCT00996892|470619343|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
130725672|NCT00996892|470619324|FG000|Expansion Stage 2A|Disease Progression|0|||
130725673|NCT00996892|470619325|FG001|Expansion Stage 2A|Disease Progression|0|||
130725674|NCT00996892|470619326|FG002|Expansion Stage 2A|Disease Progression|0|||
130725675|NCT00996892|470619327|FG003|Expansion Stage 2A|Disease Progression|0|||
130725676|NCT00996892|470619328|FG004|Expansion Stage 2A|Disease Progression|0|||
130725677|NCT00996892|470619329|FG005|Expansion Stage 2A|Disease Progression|0|||
130725678|NCT00996892|470619330|FG006|Expansion Stage 2A|Disease Progression|0|||
130725679|NCT00996892|470619331|FG007|Expansion Stage 2A|Disease Progression|0|||
130725680|NCT00996892|470619332|FG008|Expansion Stage 2A|Disease Progression|0|||
130725681|NCT00996892|470619333|FG009|Expansion Stage 2A|Disease Progression|0|||
130725682|NCT00996892|470619334|FG010|Expansion Stage 2A|Disease Progression|0|||
130725683|NCT00996892|470619335|FG011|Expansion Stage 2A|Disease Progression|0|||
130725684|NCT00996892|470619336|FG012|Expansion Stage 2A|Disease Progression|0|||
130725685|NCT00996892|470619337|FG013|Expansion Stage 2A|Disease Progression|0|||
130725686|NCT00996892|470619338|FG014|Expansion Stage 2A|Disease Progression|0|||
130725687|NCT00996892|470619339|FG015|Expansion Stage 2A|Disease Progression|0|||
130725688|NCT00996892|470619340|FG016|Expansion Stage 2A|Disease Progression|0|||
130725689|NCT00996892|470619341|FG017|Expansion Stage 2A|Disease Progression|0|||
130725690|NCT00996892|470619342|FG018|Expansion Stage 2A|Disease Progression|0|||
130725691|NCT00996892|470619343|FG019|Expansion Stage 2A|Disease Progression|31|||
130725692|NCT01987479|470619344|FG000|Overall Study|Protocol Violation|1|||
130725693|NCT01987479|470619344|FG000|Overall Study|Physician Decision|2|||
130725694|NCT01987479|470619344|FG000|Overall Study|Participant/legal guardian decision|1|||
130725695|NCT01987479|470619344|FG000|Overall Study|Other|5|||
130725696|NCT01987479|470619344|FG000|Overall Study|Lost to Follow-up|1|||
130725697|NCT01987479|470619344|FG000|Overall Study|Adverse Event|7|||
130725698|NCT00278889|470619345|FG000|Overall Study|Withdrawal by Subject|0|||
130725699|NCT00278889|470619346|FG001|Overall Study|Withdrawal by Subject|5|||
130725700|NCT00278889|470619347|FG002|Overall Study|Withdrawal by Subject|3|||
130725701|NCT00278889|470619345|FG000|Overall Study|Lost to Follow-up|1|||
130725702|NCT00278889|470619346|FG001|Overall Study|Lost to Follow-up|1|||
130725703|NCT00278889|470619347|FG002|Overall Study|Lost to Follow-up|0|||
130725704|NCT00278889|470619345|FG000|Overall Study|Death|24|||
130725705|NCT00278889|470619346|FG001|Overall Study|Death|21|||
130725706|NCT00278889|470619347|FG002|Overall Study|Death|17|||
130725707|NCT04042376|470619348|FG000|Overall Study|Withdrawal by Subject|1|||
130725708|NCT04042376|470619348|FG000|Overall Study|Death|3|||
130725709|NCT00602641|470621072|FG000|Overall Study|Never started protocol therapy|6|||
130725710|NCT00602641|470621073|FG001|Overall Study|Never started protocol therapy|2|||
130725711|NCT00602641|470621072|FG000|Overall Study|Still on treatment at time of analysis|8|||
130725712|NCT00602641|470621073|FG001|Overall Study|Still on treatment at time of analysis|15|||
130725713|NCT00602641|470621072|FG000|Overall Study|Adverse Event|62|||
130725714|NCT00602641|470621073|FG001|Overall Study|Adverse Event|53|||
130725715|NCT00602641|470621072|FG000|Overall Study|Disease progression|38|||
130725716|NCT00602641|470621073|FG001|Overall Study|Disease progression|55|||
130725717|NCT00602641|470621072|FG000|Overall Study|Death|6|||
131139172|NCT01622569|472136055|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
131139173|NCT01622569|472136052|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
131139174|NCT01622569|472136053|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
131139175|NCT01622569|472136054|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
131139176|NCT01622569|472136055|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
131139177|NCT01622569|472136052|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
131139178|NCT01622569|472136053|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
131139179|NCT01622569|472136054|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
131139180|NCT01622569|472136055|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
131139181|NCT01622569|472136052|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
131139182|NCT01622569|472136053|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
131139183|NCT01622569|472136054|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
131139184|NCT01622569|472136055|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
131139185|NCT01622569|472136052|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
131139186|NCT01622569|472136053|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
131139187|NCT01622569|472136054|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
131139188|NCT01622569|472136055|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
131139189|NCT01622569|472136052|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
131139190|NCT01622569|472136053|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
131139191|NCT01622569|472136054|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
131139192|NCT01622569|472136055|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
131139193|NCT01622569|472136052|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131139194|NCT01622569|472136053|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131139195|NCT01622569|472136054|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
131139196|NCT01622569|472136055|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
131139197|NCT02009878|472136056|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
131139198|NCT02009878|472136057|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
131139199|NCT02009878|472136058|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
131139200|NCT01940484|472136062|FG000|Overall Study|Withdrawal by Subject|3|||
131139201|NCT01940484|472136062|FG000|Overall Study|Underwent transplantation|4|||
131139202|NCT01940484|472136062|FG000|Overall Study|Death|2|||
131139203|NCT01940484|472136062|FG000|Overall Study|Adverse Event|1|||
131139204|NCT00343512|472136069|FG000|Overall Study|Withdrawal by Subject|2|||
131139205|NCT00684515|472136070|FG000|Overall Study|Adverse Event|3|||
131139206|NCT00684515|472136071|FG001|Overall Study|Adverse Event|3|||
131139207|NCT00684515|472136072|FG002|Overall Study|Adverse Event|1|||
131139208|NCT00684515|472136070|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
131139209|NCT00684515|472136071|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
131139210|NCT00684515|472136072|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
131139211|NCT04428411|472136073|FG000|Overall Study|Lost to Follow-up|114|||
131139212|NCT00634569|472136074|FG000|Overall Study|Withdrawal by Subject|0|||
131139213|NCT00634569|472136075|FG001|Overall Study|Withdrawal by Subject|4|||
130725718|NCT00602641|470621073|FG001|Overall Study|Death|5|||
130725719|NCT00602641|470621072|FG000|Overall Study|Withdrawal by Subject|15|||
130725720|NCT00602641|470621073|FG001|Overall Study|Withdrawal by Subject|12|||
130725721|NCT00602641|470621072|FG000|Overall Study|Alternative therapy|5|||
130725722|NCT00602641|470621073|FG001|Overall Study|Alternative therapy|2|||
130725723|NCT00602641|470621072|FG000|Overall Study|Other Complicating Disease|5|||
130725724|NCT00602641|470621073|FG001|Overall Study|Other Complicating Disease|2|||
130725725|NCT00602641|470621072|FG000|Overall Study|Physician Decision|5|||
130725726|NCT00602641|470621073|FG001|Overall Study|Physician Decision|4|||
130725727|NCT00602641|470621072|FG000|Overall Study|Administrative Closure|1|||
130725728|NCT00602641|470621073|FG001|Overall Study|Administrative Closure|1|||
130725729|NCT00602641|470621072|FG000|Overall Study|Other|3|||
130725730|NCT00602641|470621073|FG001|Overall Study|Other|1|||
130725731|NCT00478244|470621076|FG000|Overall Study|Did not receive transplant|1|||
130725732|NCT02929056|470621079|FG000|Overall Study|Lost to Follow-up|0|||
130725733|NCT02929056|470621080|FG001|Overall Study|Lost to Follow-up|1|||
130725734|NCT02925403|470621086|FG000|Overall Study|Lost to Follow-up|0|||
130725735|NCT02925403|470621087|FG001|Overall Study|Lost to Follow-up|1|||
130725736|NCT00459043|470621088|FG000|Overall Study|Withdrawal by Subject|1|||
130725737|NCT00459043|470621089|FG001|Overall Study|Withdrawal by Subject|0|||
130725738|NCT02899195|470621092|FG000|Concurrent Durvalumab|Adverse Event|4|||
130725739|NCT02899195|470621092|FG000|Concurrent Durvalumab|Physician Decision|1|||
130725740|NCT02899195|470621092|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
131139214|NCT00634569|472136074|FG000|Overall Study|Physician Decision|0|||
130725741|NCT02899195|470621092|FG000|Concurrent Durvalumab|Progressive Disease|5|||
130725742|NCT02899195|470621092|FG000|Maintenance Durvalumab|Adverse Event|1|||
130725743|NCT02899195|470621092|FG000|Maintenance Durvalumab|Physician Decision|1|||
130725744|NCT02899195|470621092|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
130725745|NCT02899195|470621092|FG000|Maintenance Durvalumab|Progressive Disease|31|||
130779777|NCT00249873|470819514|FG001|Overall Study|Other Serious Adverse Event|97|||
130779778|NCT00249873|470819513|FG000|Overall Study|Qualifying condition not present|20|||
130779779|NCT00249873|470819514|FG001|Overall Study|Qualifying condition not present|23|||
130779780|NCT00249873|470819513|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
130779781|NCT00249873|470819514|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
130779782|NCT00249873|470819513|FG000|Overall Study|Withdrawal by Subject|504|||
130779783|NCT00249873|470819514|FG001|Overall Study|Withdrawal by Subject|466|||
130779784|NCT00249873|470819513|FG000|Overall Study|Lost to Follow-up|4|||
130779785|NCT00249873|470819514|FG001|Overall Study|Lost to Follow-up|7|||
130779786|NCT00249873|470819513|FG000|Overall Study|Minor bleeding|99|||
130779787|NCT00249873|470819514|FG001|Overall Study|Minor bleeding|37|||
130779788|NCT00249873|470819513|FG000|Overall Study|Non-compliance|41|||
130779789|NCT00249873|470819514|FG001|Overall Study|Non-compliance|46|||
130779790|NCT00249873|470819513|FG000|Overall Study|Other non serious Adverse Event|112|||
130779791|NCT00249873|470819514|FG001|Overall Study|Other non serious Adverse Event|108|||
130779792|NCT00249873|470819513|FG000|Overall Study|Other contraindicated medication|1|||
130779793|NCT00249873|470819514|FG001|Overall Study|Other contraindicated medication|0|||
130779794|NCT00249873|470819513|FG000|Overall Study|Patient not wish to continue after May08|3|||
130779795|NCT00249873|470819514|FG001|Overall Study|Patient not wish to continue after May08|4|||
130779796|NCT00249873|470819513|FG000|Overall Study|Physician withdrew consent|59|||
130779797|NCT00249873|470819514|FG001|Overall Study|Physician withdrew consent|60|||
130779798|NCT00249873|470819513|FG000|Overall Study|Open label clopidogrel required|31|||
130779799|NCT00249873|470819514|FG001|Overall Study|Open label clopidogrel required|42|||
130779800|NCT00249873|470819513|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
131139215|NCT00634569|472136075|FG001|Overall Study|Physician Decision|1|||
131139216|NCT01163786|472136076|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
131139217|NCT01163786|472136076|FG000|Treatment With Bortezomib|Adverse Event|2|||
131139218|NCT01163786|472136076|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
131139219|NCT02918019|472136077|FG000|Overall Study|Death|0|||
130779801|NCT00249873|470819514|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
130779802|NCT00249873|470819513|FG000|Overall Study|Oral anticoagulant required|159|||
130779803|NCT00249873|470819514|FG001|Overall Study|Oral anticoagulant required|157|||
130779804|NCT00249873|470819513|FG000|Overall Study|Study drug intolerance|5|||
130779805|NCT00249873|470819514|FG001|Overall Study|Study drug intolerance|0|||
130779806|NCT00249873|470819513|FG000|Overall Study|Surgery/ procedure|9|||
130779807|NCT00249873|470819514|FG001|Overall Study|Surgery/ procedure|9|||
130779808|NCT00249873|470819513|FG000|Overall Study|Event related to cardiac condition|12|||
130779809|NCT00249873|470819514|FG001|Overall Study|Event related to cardiac condition|21|||
130779810|NCT00249873|470819513|FG000|Overall Study|Thromboembolic/outcome event|82|||
130779811|NCT00249873|470819514|FG001|Overall Study|Thromboembolic/outcome event|122|||
130779812|NCT03131167|470819515|FG000|Overall Study|Other (Unspecified)|0|||
130779813|NCT03131167|470819516|FG001|Overall Study|Other (Unspecified)|0|||
130779814|NCT03131167|470819517|FG002|Overall Study|Other (Unspecified)|0|||
130779815|NCT03131167|470819518|FG003|Overall Study|Other (Unspecified)|0|||
130779816|NCT03131167|470819519|FG004|Overall Study|Other (Unspecified)|0|||
130779817|NCT03131167|470819520|FG005|Overall Study|Other (Unspecified)|1|||
130779818|NCT03131167|470819521|FG006|Overall Study|Other (Unspecified)|0|||
130779819|NCT03131167|470819522|FG007|Overall Study|Other (Unspecified)|0|||
130779820|NCT03131167|470819523|FG008|Overall Study|Other (Unspecified)|0|||
130779821|NCT03131167|470819524|FG009|Overall Study|Other (Unspecified)|0|||
130779822|NCT03131167|470819525|FG010|Overall Study|Other (Unspecified)|0|||
130779823|NCT03131167|470819526|FG011|Overall Study|Other (Unspecified)|0|||
130779824|NCT03131167|470819527|FG012|Overall Study|Other (Unspecified)|0|||
130779825|NCT00165503|470819528|FG000|Overall Study|Death|1|||
130779826|NCT00165503|470819528|FG000|Overall Study|Lost to Follow-up|12|||
130779827|NCT00165503|470819528|FG000|Overall Study|Unresectable|3|||
131077807|NCT03414047|471918523|FG002|Overall Study|Withdrawal by Subject|2|||
131077808|NCT03414047|471918524|FG003|Overall Study|Withdrawal by Subject|0|||
131077809|NCT01772563|471918525|FG000|Cycle 1|Dose limiting toxicity|2|||
131077810|NCT01772563|471918525|FG000|Cycle 1|Progressive disease|2|||
131077811|NCT01772563|471918525|FG000|Cycle 2 and Beyond|Progressive disease|17|||
131077812|NCT01772563|471918525|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
131077813|NCT01772563|471918525|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
131077814|NCT01192776|471918526|FG000|Overall Study|Death|8|||
131139220|NCT02918019|472136078|FG001|Overall Study|Death|0|||
131139221|NCT02918019|472136079|FG002|Overall Study|Death|1|||
131139222|NCT02918019|472136080|FG003|Overall Study|Death|0|||
130779828|NCT00643201|470819529|FG000|Randomized, Completed 6 Months of Study|Death|20|||
130779829|NCT00643201|470819530|FG001|Randomized, Completed 6 Months of Study|Death|26|||
130779830|NCT00643201|470819529|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
131077815|NCT01192776|471918527|FG001|Overall Study|Death|15|||
131077816|NCT01192776|471918528|FG002|Overall Study|Death|18|||
131139223|NCT02918019|472136077|FG000|Overall Study|Lost to Follow-up|1|||
131139224|NCT02918019|472136078|FG001|Overall Study|Lost to Follow-up|1|||
131077817|NCT01192776|471918529|FG003|Overall Study|Death|15|||
131139225|NCT02918019|472136079|FG002|Overall Study|Lost to Follow-up|0|||
131077818|NCT01192776|471918526|FG000|Overall Study|Lost to Follow-up|3|||
131077819|NCT01192776|471918527|FG001|Overall Study|Lost to Follow-up|6|||
131077820|NCT01192776|471918528|FG002|Overall Study|Lost to Follow-up|3|||
131077821|NCT01192776|471918529|FG003|Overall Study|Lost to Follow-up|5|||
131077822|NCT01086384|471918532|FG000|2-week Run-in Period|Adverse Event|1|||
131077823|NCT01086384|471918533|FG001|2-week Run-in Period|Adverse Event|0|||
131077824|NCT01086384|471918534|FG002|2-week Run-in Period|Adverse Event|0|||
131077825|NCT01086384|471918532|FG000|2-week Run-in Period|Protocol Violation|1|||
131077826|NCT01086384|471918533|FG001|2-week Run-in Period|Protocol Violation|0|||
131077827|NCT01086384|471918534|FG002|2-week Run-in Period|Protocol Violation|0|||
131077828|NCT01086384|471918532|FG000|2-week Run-in Period|Lost to Follow-up|1|||
131077829|NCT01086384|471918533|FG001|2-week Run-in Period|Lost to Follow-up|0|||
131077830|NCT01086384|471918534|FG002|2-week Run-in Period|Lost to Follow-up|0|||
131077831|NCT01086384|471918532|FG000|2-week Run-in Period|Physician Decision|6|||
131077832|NCT01086384|471918533|FG001|2-week Run-in Period|Physician Decision|0|||
131077833|NCT01086384|471918534|FG002|2-week Run-in Period|Physician Decision|0|||
131077834|NCT01086384|471918532|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
131077835|NCT01086384|471918533|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130779831|NCT00643201|470819530|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
130779832|NCT00643201|470819529|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
131077836|NCT01086384|471918534|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131077837|NCT01086384|471918532|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
131077838|NCT01086384|471918533|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
131077839|NCT01086384|471918534|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
131077840|NCT01086384|471918532|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
131077841|NCT01086384|471918533|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
131077842|NCT01086384|471918534|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
131077843|NCT01086384|471918532|FG000|2-week Run-in Period|Randomized in Error|1|||
131077844|NCT01086384|471918533|FG001|2-week Run-in Period|Randomized in Error|0|||
131077845|NCT01086384|471918534|FG002|2-week Run-in Period|Randomized in Error|0|||
131077846|NCT01086384|471918532|FG000|Treatment Period|Withdrawal by Subject|0|||
131077847|NCT01086384|471918533|FG001|Treatment Period|Withdrawal by Subject|53|||
131077848|NCT01086384|471918534|FG002|Treatment Period|Withdrawal by Subject|55|||
131077849|NCT01086384|471918532|FG000|Treatment Period|Protocol Violation|0|||
131077850|NCT01086384|471918533|FG001|Treatment Period|Protocol Violation|26|||
131077851|NCT01086384|471918534|FG002|Treatment Period|Protocol Violation|17|||
131077852|NCT01086384|471918532|FG000|Treatment Period|Lack of Efficacy|0|||
131077853|NCT01086384|471918533|FG001|Treatment Period|Lack of Efficacy|22|||
131077854|NCT01086384|471918534|FG002|Treatment Period|Lack of Efficacy|13|||
131077855|NCT01086384|471918532|FG000|Treatment Period|Adverse Event|0|||
131077856|NCT01086384|471918533|FG001|Treatment Period|Adverse Event|19|||
131077857|NCT01086384|471918534|FG002|Treatment Period|Adverse Event|15|||
131077858|NCT01086384|471918532|FG000|Treatment Period|Lost to Follow-up|0|||
131077859|NCT01086384|471918533|FG001|Treatment Period|Lost to Follow-up|11|||
131077860|NCT01086384|471918534|FG002|Treatment Period|Lost to Follow-up|9|||
131077861|NCT01086384|471918532|FG000|Treatment Period|Physician Decision|0|||
131077862|NCT01086384|471918533|FG001|Treatment Period|Physician Decision|9|||
131077863|NCT01086384|471918534|FG002|Treatment Period|Physician Decision|6|||
131077864|NCT01086384|471918532|FG000|Treatment Period|Study Closed/Terminated|0|||
131077865|NCT01086384|471918533|FG001|Treatment Period|Study Closed/Terminated|7|||
131077866|NCT01086384|471918534|FG002|Treatment Period|Study Closed/Terminated|8|||
131077867|NCT01086384|471918532|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
131077868|NCT01086384|471918533|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
131077869|NCT01086384|471918534|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
131077870|NCT01086384|471918532|FG000|Treatment Period|Received Treatment in Error|0|||
131077871|NCT01086384|471918533|FG001|Treatment Period|Received Treatment in Error|1|||
131077872|NCT01086384|471918534|FG002|Treatment Period|Received Treatment in Error|0|||
131077873|NCT02777242|471918535|FG000|Overall Study|Other|2|||
131139226|NCT02918019|472136080|FG003|Overall Study|Lost to Follow-up|1|||
131139227|NCT02918019|472136077|FG000|Overall Study|Principal investigator request|0|||
131139228|NCT02918019|472136078|FG001|Overall Study|Principal investigator request|0|||
131139229|NCT02918019|472136079|FG002|Overall Study|Principal investigator request|0|||
131139230|NCT02918019|472136080|FG003|Overall Study|Principal investigator request|1|||
131139231|NCT02918019|472136077|FG000|Overall Study|Physician Decision|1|||
131139232|NCT02918019|472136078|FG001|Overall Study|Physician Decision|3|||
131139233|NCT02918019|472136079|FG002|Overall Study|Physician Decision|2|||
131139234|NCT02918019|472136080|FG003|Overall Study|Physician Decision|0|||
131139235|NCT02918019|472136077|FG000|Overall Study|Protocol deviation|1|||
131077874|NCT02777242|471918535|FG000|Overall Study|Lost to Follow-up|1|||
131077875|NCT02777242|471918535|FG000|Overall Study|Multiple|1|||
131077876|NCT02777242|471918535|FG000|Overall Study|Sponsor's request|1|||
131077877|NCT02777242|471918535|FG000|Overall Study|Withdrawal by Subject|1|||
131077878|NCT01721746|471918541|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
131139236|NCT02918019|472136078|FG001|Overall Study|Protocol deviation|1|||
130779833|NCT00643201|470819530|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
130779834|NCT00643201|470819529|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
130779835|NCT00643201|470819530|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
130779836|NCT00643201|470819529|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
130779837|NCT00643201|470819530|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
130779838|NCT00643201|470819529|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
130779839|NCT00643201|470819530|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
130779840|NCT00643201|470819529|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
130779841|NCT00643201|470819530|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
130779842|NCT00643201|470819529|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
130779843|NCT00643201|470819530|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
130779844|NCT00643201|470819529|FG000|Randomized, Completed 6 Months of Study|Other|107|||
130779845|NCT00643201|470819530|FG001|Randomized, Completed 6 Months of Study|Other|107|||
130779846|NCT00643201|470819529|FG000|Completed Study Follow Up|Death|28|||
130779847|NCT00643201|470819530|FG001|Completed Study Follow Up|Death|34|||
130779848|NCT00643201|470819529|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
130779849|NCT00643201|470819530|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
130779850|NCT00643201|470819529|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
130779851|NCT00643201|470819530|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
130779852|NCT00643201|470819529|FG000|Completed Study Follow Up|non-specified|1|||
130779853|NCT00643201|470819530|FG001|Completed Study Follow Up|non-specified|0|||
130779854|NCT02346708|470819531|FG000|Overall Study|Adverse Event|2|||
130779855|NCT02346708|470819532|FG001|Overall Study|Adverse Event|0|||
130779856|NCT02346708|470819531|FG000|Overall Study|Protocol Violation|0|||
130779857|NCT02346708|470819532|FG001|Overall Study|Protocol Violation|1|||
130779858|NCT02976519|470819533|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130779859|NCT02976519|470819534|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
130779860|NCT02976519|470819535|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130779861|NCT02976519|470819536|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130779862|NCT02976519|470819537|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130779863|NCT02976519|470819538|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130779864|NCT02976519|470819539|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130779865|NCT02976519|470819533|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130779866|NCT02976519|470819534|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130779867|NCT02976519|470819535|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
131139237|NCT02918019|472136079|FG002|Overall Study|Protocol deviation|0|||
131139238|NCT02918019|472136080|FG003|Overall Study|Protocol deviation|2|||
131139239|NCT02918019|472136077|FG000|Overall Study|Withdrawal by Subject|3|||
131139240|NCT02918019|472136078|FG001|Overall Study|Withdrawal by Subject|4|||
131139241|NCT02918019|472136079|FG002|Overall Study|Withdrawal by Subject|6|||
131139242|NCT02918019|472136080|FG003|Overall Study|Withdrawal by Subject|4|||
131139243|NCT02918019|472136077|FG000|Overall Study|Adverse Event|0|||
131139244|NCT02918019|472136078|FG001|Overall Study|Adverse Event|1|||
130779868|NCT02976519|470819536|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
130779869|NCT02976519|470819537|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130779870|NCT02976519|470819538|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130779871|NCT02976519|470819539|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130779872|NCT02976519|470819533|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130779873|NCT02976519|470819534|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130779874|NCT02976519|470819535|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130779875|NCT02976519|470819536|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130779876|NCT02976519|470819537|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130779877|NCT02976519|470819538|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130779878|NCT02976519|470819539|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
130779879|NCT02976519|470819533|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130779880|NCT02976519|470819534|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130779881|NCT02976519|470819535|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130779882|NCT02976519|470819536|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130779883|NCT02976519|470819537|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130779884|NCT02976519|470819538|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130779885|NCT02976519|470819539|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
131139245|NCT02918019|472136079|FG002|Overall Study|Adverse Event|0|||
131139246|NCT02918019|472136080|FG003|Overall Study|Adverse Event|1|||
131139247|NCT01212185|472136081|FG000|Overall Study|Protocol Violation|2|||
131139248|NCT01212185|472136082|FG001|Overall Study|Protocol Violation|1|||
130779886|NCT02976519|470819533|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130779887|NCT02976519|470819534|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130779888|NCT02976519|470819535|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
131139249|NCT04823949|472136086|FG000|Overall Study|Withdrawal by Subject|0|||
131077879|NCT01721746|471918542|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
131077880|NCT01721746|471918541|FG000|Pre-Treatment|Withdrawal by Subject|1|||
131077881|NCT01721746|471918542|FG001|Pre-Treatment|Withdrawal by Subject|16|||
131077882|NCT01721746|471918541|FG000|Pre-Treatment|Poor/Non-compliance|1|||
131077883|NCT01721746|471918542|FG001|Pre-Treatment|Poor/Non-compliance|0|||
131077884|NCT01721746|471918541|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
131077885|NCT01721746|471918542|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
131077886|NCT01721746|471918541|FG000|Treatment|Disease Progression|192|||
131077887|NCT01721746|471918542|FG001|Treatment|Disease Progression|74|||
131077888|NCT01721746|471918541|FG000|Treatment|Study Drug Toxicity|19|||
131077889|NCT01721746|471918542|FG001|Treatment|Study Drug Toxicity|11|||
131077890|NCT01721746|471918541|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
131077891|NCT01721746|471918542|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
131077892|NCT01721746|471918541|FG000|Treatment|Participant request to discontinue Study treatment|26|||
131077893|NCT01721746|471918542|FG001|Treatment|Participant request to discontinue Study treatment|7|||
131077894|NCT01721746|471918541|FG000|Treatment|Participant withdrew consent|4|||
131077895|NCT01721746|471918542|FG001|Treatment|Participant withdrew consent|2|||
131077896|NCT01721746|471918541|FG000|Treatment|Maximum Clinical Benefit|9|||
131077897|NCT01721746|471918542|FG001|Treatment|Maximum Clinical Benefit|3|||
131077898|NCT01721746|471918541|FG000|Treatment|Poor/Non-compliance|2|||
131077899|NCT01721746|471918542|FG001|Treatment|Poor/Non-compliance|0|||
131077900|NCT01721746|471918541|FG000|Treatment|Participant no longer met Study criteria|4|||
130725746|NCT03156504|470621094|FG000|Overall Study|Withdrawal by Subject|1|||
131077901|NCT01721746|471918542|FG001|Treatment|Participant no longer met Study criteria|0|||
131077902|NCT01721746|471918541|FG000|Treatment|Other reasons|6|||
131077903|NCT01721746|471918542|FG001|Treatment|Other reasons|2|||
131077904|NCT04358068|471918543|FG000|Overall Study|Did not initiate study treatment|2|||
131077905|NCT04358068|471918544|FG001|Overall Study|Did not initiate study treatment|2|||
131077906|NCT00591591|471918547|FG000|Overall Study|Withdrawal by Subject|1|||
131077907|NCT00591591|471918548|FG001|Overall Study|Withdrawal by Subject|37|||
131077908|NCT00591591|471918547|FG000|Overall Study|Lack of Efficacy|10|||
130725747|NCT00450801|470621095|FG000|Overall Study|Death|1|||
131077909|NCT00591591|471918548|FG001|Overall Study|Lack of Efficacy|2|||
131077910|NCT02143063|471918553|FG000|Overall Study|Lost to Follow-up|16|||
131077911|NCT02143063|471918554|FG001|Overall Study|Lost to Follow-up|28|||
131077912|NCT02143063|471918555|FG002|Overall Study|Lost to Follow-up|29|||
131077913|NCT02143063|471918553|FG000|Overall Study|Withdrawal by Subject|0|||
131077914|NCT02143063|471918554|FG001|Overall Study|Withdrawal by Subject|1|||
131077915|NCT02143063|471918555|FG002|Overall Study|Withdrawal by Subject|0|||
130725748|NCT00587860|470621096|FG000|Overall Study|Lost to Follow-up|2|||
130725749|NCT00587860|470621097|FG001|Overall Study|Lost to Follow-up|2|||
130725750|NCT00587860|470621096|FG000|Overall Study|Withdrawal by Subject|3|||
130725751|NCT00587860|470621097|FG001|Overall Study|Withdrawal by Subject|3|||
130725752|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
130725753|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
130725754|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
130725755|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
130725756|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
130725757|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
130725758|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
130725759|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
130725760|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
130725761|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
130725762|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
130725763|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
130725764|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
130725765|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
130725766|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
130725767|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
130725768|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
130779889|NCT02976519|470819536|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
131077916|NCT02143063|471918553|FG000|Overall Study|Death|0|||
131077917|NCT02143063|471918554|FG001|Overall Study|Death|1|||
131077918|NCT02143063|471918555|FG002|Overall Study|Death|1|||
131077919|NCT01099579|471918556|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
131077920|NCT01099579|471918557|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
131077921|NCT01099579|471918558|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
131077922|NCT01099579|471918556|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
131077923|NCT01099579|471918557|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
130725769|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
130725770|NCT00261443|470621098|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
131077924|NCT01099579|471918558|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
131077925|NCT01099579|471918556|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
131077926|NCT01099579|471918557|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
131077927|NCT01099579|471918558|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
131077928|NCT01099579|471918556|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
131077929|NCT01099579|471918557|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
131077930|NCT01099579|471918558|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
131077931|NCT01099579|471918556|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
131077932|NCT01099579|471918557|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
131077933|NCT01099579|471918558|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
131077934|NCT01099579|471918556|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
131077935|NCT01099579|471918557|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
131077936|NCT01099579|471918558|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
131077937|NCT01099579|471918556|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
131077938|NCT01099579|471918557|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
131077939|NCT01099579|471918558|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
131077940|NCT01099579|471918556|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
131077941|NCT01099579|471918557|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
131077942|NCT01099579|471918558|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
131077943|NCT01099579|471918556|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
131077944|NCT01099579|471918557|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
131077945|NCT01099579|471918558|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
131077946|NCT01099579|471918556|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
131077947|NCT01099579|471918557|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
131077948|NCT01099579|471918558|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
131077949|NCT00909532|471918559|FG000|Overall Study|Adverse Event|4|||
131139250|NCT04823949|472136087|FG001|Overall Study|Withdrawal by Subject|4|||
131139251|NCT04823949|472136086|FG000|Overall Study|Physician Decision|0|||
131139252|NCT04823949|472136087|FG001|Overall Study|Physician Decision|1|||
131139253|NCT01700192|472136089|FG000|Overall Study|Adverse Event|73|||
131139254|NCT01700192|472136090|FG001|Overall Study|Adverse Event|18|||
131139255|NCT01700192|472136089|FG000|Overall Study|Lack of Efficacy|1|||
130725771|NCT00261443|470621099|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
130725772|NCT00261443|470621100|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
130725773|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
130725774|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
130725775|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
130725776|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
130725777|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
130725778|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
130725779|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
130725780|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
130725781|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
130725782|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
130725783|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
130725784|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
130725785|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
130725786|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
130725787|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
130725788|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
130725789|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
130725790|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
130725791|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
130725792|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
130725793|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
130725794|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
130725795|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
130725796|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
130725797|NCT00261443|470621098|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
130725798|NCT00261443|470621099|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
130725799|NCT00261443|470621100|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
130725800|NCT00261443|470621098|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
131077950|NCT00909532|471918560|FG001|Overall Study|Adverse Event|1|||
131077951|NCT00909532|471918559|FG000|Overall Study|Pregnancy|0|||
131077952|NCT00909532|471918560|FG001|Overall Study|Pregnancy|1|||
131077953|NCT00909532|471918559|FG000|Overall Study|Prohibited Medication|2|||
131077954|NCT00909532|471918560|FG001|Overall Study|Prohibited Medication|1|||
131139256|NCT01700192|472136090|FG001|Overall Study|Lack of Efficacy|0|||
131139257|NCT01700192|472136089|FG000|Overall Study|Lost to Follow-up|42|||
130725801|NCT00261443|470621099|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
130725802|NCT00261443|470621100|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
130725803|NCT00261443|470621098|FG000|3: Assessment of Relapse|Adverse Event|0|||
130725804|NCT00261443|470621099|FG001|3: Assessment of Relapse|Adverse Event|15|||
130725805|NCT00261443|470621100|FG002|3: Assessment of Relapse|Adverse Event|19|||
130725806|NCT00261443|470621098|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
130725807|NCT00261443|470621099|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
130725808|NCT00261443|470621100|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
130725809|NCT00261443|470621098|FG000|3: Assessment of Relapse|Death|0|||
130725810|NCT00261443|470621099|FG001|3: Assessment of Relapse|Death|0|||
130725811|NCT00261443|470621100|FG002|3: Assessment of Relapse|Death|1|||
130725812|NCT00261443|470621098|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
130725813|NCT00261443|470621099|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
130725814|NCT00261443|470621100|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
130725815|NCT00261443|470621098|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
130725816|NCT00261443|470621099|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
130725817|NCT00261443|470621100|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
130725818|NCT00261443|470621098|FG000|3: Assessment of Relapse|Pregnancy|0|||
130725819|NCT00261443|470621099|FG001|3: Assessment of Relapse|Pregnancy|2|||
130725820|NCT00261443|470621100|FG002|3: Assessment of Relapse|Pregnancy|1|||
130725821|NCT00261443|470621098|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
130725822|NCT00261443|470621099|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
130725823|NCT00261443|470621100|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
130725824|NCT00261443|470621098|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
130725825|NCT00261443|470621099|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
130725826|NCT00261443|470621100|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
130725827|NCT00261443|470621098|FG000|3: Assessment of Relapse|Other Reasons|0|||
130725828|NCT00261443|470621099|FG001|3: Assessment of Relapse|Other Reasons|4|||
130725829|NCT00261443|470621100|FG002|3: Assessment of Relapse|Other Reasons|3|||
130725830|NCT00261443|470621098|FG000|4: Extension Phase|Adverse Event|0|||
130725831|NCT00261443|470621099|FG001|4: Extension Phase|Adverse Event|1|||
130725832|NCT00261443|470621100|FG002|4: Extension Phase|Adverse Event|0|||
130725833|NCT00261443|470621098|FG000|4: Extension Phase|Withdrawal by Subject|0|||
130725834|NCT00261443|470621099|FG001|4: Extension Phase|Withdrawal by Subject|1|||
130725835|NCT00261443|470621100|FG002|4: Extension Phase|Withdrawal by Subject|2|||
130725836|NCT00261443|470621098|FG000|4: Extension Phase|Lost to Follow-up|0|||
130725837|NCT00261443|470621099|FG001|4: Extension Phase|Lost to Follow-up|1|||
130725838|NCT00261443|470621100|FG002|4: Extension Phase|Lost to Follow-up|0|||
130725839|NCT01286753|470621103|FG000|Overall Study|Adverse Event|7|||
130725840|NCT01286753|470621104|FG001|Overall Study|Adverse Event|6|||
130725841|NCT01286753|470621103|FG000|Overall Study|Progression|11|||
130725842|NCT01286753|470621104|FG001|Overall Study|Progression|13|||
130725843|NCT01286753|470621103|FG000|Overall Study|Refused Treatment|1|||
130725844|NCT01286753|470621104|FG001|Overall Study|Refused Treatment|0|||
130725845|NCT01286753|470621103|FG000|Overall Study|Withdrawal of Consent|0|||
130725846|NCT01286753|470621104|FG001|Overall Study|Withdrawal of Consent|2|||
130725847|NCT01286753|470621103|FG000|Overall Study|Discontinued to Join Extension Study|6|||
130725848|NCT01286753|470621104|FG001|Overall Study|Discontinued to Join Extension Study|4|||
130725849|NCT01286753|470621103|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
130725850|NCT01286753|470621104|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
130725851|NCT00923273|470621114|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130725852|NCT00923273|470621115|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130725853|NCT00923273|470621116|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130725854|NCT00923273|470621117|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
130725855|NCT00923273|470621118|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130725856|NCT00923273|470621114|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130725857|NCT00923273|470621115|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130725858|NCT00923273|470621116|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130725859|NCT00923273|470621117|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
130725860|NCT00923273|470621118|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130725861|NCT00509366|470621119|FG000|Overall Study|Not Treated (Screen Failure)|1|||
130725862|NCT00509366|470621120|FG001|Overall Study|Not Treated (Screen Failure)|1|||
130725863|NCT00509366|470621121|FG002|Overall Study|Not Treated (Screen Failure)|1|||
130725864|NCT00509366|470621122|FG003|Overall Study|Not Treated (Screen Failure)|0|||
130725865|NCT00509366|470621123|FG004|Overall Study|Not Treated (Screen Failure)|0|||
130725866|NCT00264550|470621124|FG000|Overall Study|Death|0|||
130725867|NCT00264550|470621125|FG001|Overall Study|Death|3|||
130725868|NCT00264550|470621126|FG002|Overall Study|Death|0|||
130725869|NCT00264550|470621127|FG003|Overall Study|Death|0|||
130725870|NCT00264550|470621124|FG000|Overall Study|Lost to Follow-up|3|||
130725871|NCT00264550|470621125|FG001|Overall Study|Lost to Follow-up|1|||
131139258|NCT01700192|472136090|FG001|Overall Study|Lost to Follow-up|29|||
131139259|NCT01700192|472136089|FG000|Overall Study|Noncompliance with study drug|0|||
131139260|NCT01700192|472136090|FG001|Overall Study|Noncompliance with study drug|5|||
131139261|NCT01700192|472136089|FG000|Overall Study|Physician Decision|2|||
131139262|NCT01700192|472136090|FG001|Overall Study|Physician Decision|3|||
131139263|NCT01700192|472136089|FG000|Overall Study|Pregnancy|1|||
131139264|NCT01700192|472136090|FG001|Overall Study|Pregnancy|4|||
131139265|NCT01700192|472136089|FG000|Overall Study|Progressive disease|1|||
131139266|NCT01700192|472136090|FG001|Overall Study|Progressive disease|0|||
131139267|NCT01700192|472136089|FG000|Overall Study|Protocol Violation|3|||
131139268|NCT01700192|472136090|FG001|Overall Study|Protocol Violation|4|||
131139269|NCT01700192|472136089|FG000|Overall Study|Technical problems|0|||
131139270|NCT01700192|472136090|FG001|Overall Study|Technical problems|1|||
131139271|NCT01700192|472136089|FG000|Overall Study|Withdrawal by Subject|56|||
131139272|NCT01700192|472136090|FG001|Overall Study|Withdrawal by Subject|64|||
131139273|NCT01700192|472136089|FG000|Overall Study|Never received study drug|1|||
131139274|NCT01700192|472136090|FG001|Overall Study|Never received study drug|0|||
131139275|NCT02793232|472136091|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131139276|NCT02793232|472136092|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131139277|NCT02793232|472136093|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131139278|NCT02793232|472136094|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131139279|NCT02793232|472136095|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
131139280|NCT02793232|472136096|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131139281|NCT02793232|472136097|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
131139282|NCT02793232|472136098|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131139283|NCT02793232|472136099|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
131139284|NCT00626093|472136102|FG000|Overall Study|Lost to Follow-up|5|||
131139285|NCT00626093|472136102|FG000|Overall Study|Death|1|||
131139286|NCT00626093|472136102|FG000|Overall Study|Physician Decision|4|||
131139287|NCT00626093|472136102|FG000|Overall Study|Withdrawal by Subject|6|||
131139288|NCT00626093|472136102|FG000|Overall Study|Protocol Violation|1|||
131139289|NCT00626093|472136102|FG000|Overall Study|One of the required devices not implante|6|||
131139290|NCT03891901|472136103|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
131139291|NCT03891901|472136104|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131139292|NCT03891901|472136105|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131139293|NCT03891901|472136106|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131139294|NCT03891901|472136107|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131139295|NCT03891901|472136108|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131139296|NCT03891901|472136109|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131139297|NCT03891901|472136110|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131139298|NCT03891901|472136111|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
131139299|NCT03891901|472136103|FG000|Overall Study|Adverse Event|2|||
131139300|NCT03891901|472136104|FG001|Overall Study|Adverse Event|2|||
131139301|NCT03891901|472136105|FG002|Overall Study|Adverse Event|0|||
131139302|NCT03891901|472136106|FG003|Overall Study|Adverse Event|0|||
131139303|NCT03891901|472136107|FG004|Overall Study|Adverse Event|0|||
131139304|NCT03891901|472136108|FG005|Overall Study|Adverse Event|0|||
131139305|NCT03891901|472136109|FG006|Overall Study|Adverse Event|0|||
131139306|NCT03891901|472136110|FG007|Overall Study|Adverse Event|0|||
131139307|NCT03891901|472136111|FG008|Overall Study|Adverse Event|0|||
131139308|NCT03891901|472136103|FG000|Overall Study|Poor venous access|1|||
131139309|NCT03891901|472136104|FG001|Overall Study|Poor venous access|0|||
131139310|NCT03891901|472136105|FG002|Overall Study|Poor venous access|0|||
131139311|NCT03891901|472136106|FG003|Overall Study|Poor venous access|0|||
131139312|NCT03891901|472136107|FG004|Overall Study|Poor venous access|0|||
131139313|NCT03891901|472136108|FG005|Overall Study|Poor venous access|0|||
131139314|NCT03891901|472136109|FG006|Overall Study|Poor venous access|0|||
131139315|NCT03891901|472136110|FG007|Overall Study|Poor venous access|0|||
131139316|NCT03891901|472136111|FG008|Overall Study|Poor venous access|0|||
131139317|NCT03891901|472136103|FG000|Overall Study|Withdrawal by Subject|0|||
131139318|NCT03891901|472136104|FG001|Overall Study|Withdrawal by Subject|2|||
131139319|NCT03891901|472136105|FG002|Overall Study|Withdrawal by Subject|0|||
131139320|NCT03891901|472136106|FG003|Overall Study|Withdrawal by Subject|0|||
131139321|NCT03891901|472136107|FG004|Overall Study|Withdrawal by Subject|0|||
131139322|NCT03891901|472136108|FG005|Overall Study|Withdrawal by Subject|0|||
131139323|NCT03891901|472136109|FG006|Overall Study|Withdrawal by Subject|0|||
131139324|NCT03891901|472136110|FG007|Overall Study|Withdrawal by Subject|0|||
131139325|NCT03891901|472136111|FG008|Overall Study|Withdrawal by Subject|0|||
131139326|NCT00603915|472136112|FG000|Overall Study|Physician Decision|1|||
131139327|NCT02154087|472136115|FG000|Overall Study|Study Termination|1|||
131139328|NCT01116544|472136116|FG000|Overall Study|Protocol Violation|1|||
131139329|NCT01116544|472136117|FG001|Overall Study|Protocol Violation|0|||
131139330|NCT01116544|472136116|FG000|Overall Study|Withdrawal by Subject|1|||
131139331|NCT01116544|472136117|FG001|Overall Study|Withdrawal by Subject|1|||
131139332|NCT04556617|472136118|FG000|Overall Study|progressive disease|0|||
130779890|NCT02976519|470819537|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130779891|NCT02976519|470819538|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130779892|NCT02976519|470819539|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
130779893|NCT00928434|470819540|FG000|Overall Study|Adverse Event|14|||
130779894|NCT00928434|470819541|FG001|Overall Study|Adverse Event|5|||
130779895|NCT00928434|470819542|FG002|Overall Study|Adverse Event|18|||
130779896|NCT00928434|470819540|FG000|Overall Study|Protocol Violation|5|||
130779897|NCT00928434|470819541|FG001|Overall Study|Protocol Violation|0|||
130779898|NCT00928434|470819542|FG002|Overall Study|Protocol Violation|8|||
130779899|NCT00928434|470819540|FG000|Overall Study|Physician Decision|2|||
130779900|NCT00928434|470819541|FG001|Overall Study|Physician Decision|0|||
130779901|NCT00928434|470819542|FG002|Overall Study|Physician Decision|3|||
130779902|NCT00928434|470819540|FG000|Overall Study|Lost to Follow-up|1|||
130779903|NCT00928434|470819541|FG001|Overall Study|Lost to Follow-up|0|||
130779904|NCT00928434|470819542|FG002|Overall Study|Lost to Follow-up|3|||
130779905|NCT00928434|470819540|FG000|Overall Study|Withdrawal by Subject|5|||
130779906|NCT00928434|470819541|FG001|Overall Study|Withdrawal by Subject|3|||
130779907|NCT00928434|470819542|FG002|Overall Study|Withdrawal by Subject|2|||
130779908|NCT00928434|470819540|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
130779909|NCT00928434|470819541|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
130779910|NCT00928434|470819542|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
130779911|NCT00928434|470819540|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
130779912|NCT00928434|470819541|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
130779913|NCT00928434|470819542|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
130779914|NCT00928434|470819540|FG000|Overall Study|Other (not meeting above criteria)|5|||
130779915|NCT00928434|470819541|FG001|Overall Study|Other (not meeting above criteria)|1|||
130779916|NCT00928434|470819542|FG002|Overall Study|Other (not meeting above criteria)|2|||
130779917|NCT01278342|470819545|FG000|Overall Study|Physician Decision|0|||
130779918|NCT01278342|470819546|FG001|Overall Study|Physician Decision|1|||
130779919|NCT01278342|470819547|FG002|Overall Study|Physician Decision|0|||
130779920|NCT01278342|470819545|FG000|Overall Study|Lost to Follow-up|1|||
130779921|NCT01278342|470819546|FG001|Overall Study|Lost to Follow-up|0|||
130779922|NCT01278342|470819547|FG002|Overall Study|Lost to Follow-up|0|||
130779923|NCT01278342|470819545|FG000|Overall Study|Administrative problems|2|||
130779924|NCT01278342|470819546|FG001|Overall Study|Administrative problems|0|||
130779925|NCT01278342|470819547|FG002|Overall Study|Administrative problems|0|||
130779926|NCT01278342|470819545|FG000|Overall Study|Other|1|||
130779927|NCT01278342|470819546|FG001|Overall Study|Other|0|||
130779928|NCT01278342|470819547|FG002|Overall Study|Other|0|||
130779929|NCT00313846|470819551|FG000|Overall Study|Withdrawal by Subject|2|||
130779930|NCT00313846|470819552|FG001|Overall Study|Withdrawal by Subject|0|||
130779931|NCT00313846|470819551|FG000|Overall Study|Adverse Event|1|||
130779932|NCT00313846|470819552|FG001|Overall Study|Adverse Event|8|||
130779933|NCT00313846|470819551|FG000|Overall Study|Administrative|2|||
130779934|NCT00313846|470819552|FG001|Overall Study|Administrative|3|||
131077955|NCT00909532|471918559|FG000|Overall Study|Withdrawal of Consent|1|||
131077956|NCT00909532|471918560|FG001|Overall Study|Withdrawal of Consent|1|||
131077957|NCT00909532|471918559|FG000|Overall Study|Noncompliance with Study Requirements|0|||
131077958|NCT00909532|471918560|FG001|Overall Study|Noncompliance with Study Requirements|2|||
131077959|NCT00909532|471918559|FG000|Overall Study|Physician Decision|1|||
131077960|NCT00909532|471918560|FG001|Overall Study|Physician Decision|0|||
131077961|NCT00909532|471918559|FG000|Overall Study|Wrong Genotype|1|||
131077962|NCT00909532|471918560|FG001|Overall Study|Wrong Genotype|0|||
131077963|NCT00909532|471918559|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
131077964|NCT00909532|471918560|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
131077965|NCT01130168|471918561|FG000|Period 1|Withdrawal by Subject|0|||
131077966|NCT01130168|471918562|FG001|Period 1|Withdrawal by Subject|1|||
131077967|NCT01130168|471918563|FG002|Period 1|Withdrawal by Subject|0|||
131077968|NCT01130168|471918564|FG003|Period 1|Withdrawal by Subject|1|||
131077969|NCT01130168|471918565|FG004|Period 1|Withdrawal by Subject|0|||
131077970|NCT01130168|471918566|FG005|Period 1|Withdrawal by Subject|0|||
131077971|NCT01130168|471918561|FG000|Period 1|Discontinued For Other Reason|0|||
131077972|NCT01130168|471918562|FG001|Period 1|Discontinued For Other Reason|0|||
131077973|NCT01130168|471918563|FG002|Period 1|Discontinued For Other Reason|1|||
131077974|NCT01130168|471918564|FG003|Period 1|Discontinued For Other Reason|1|||
130779935|NCT02221648|470819556|FG000|Overall Study|Withdrawal by Subject|3|||
130779936|NCT02221648|470819557|FG001|Overall Study|Withdrawal by Subject|3|||
130779937|NCT01922258|470819563|FG000|Overall Study|Lost to Follow-up|1|||
130779938|NCT01922258|470819564|FG001|Overall Study|Lost to Follow-up|1|||
130779939|NCT01922258|470819563|FG000|Overall Study|Adverse Event|9|||
130779940|NCT01922258|470819564|FG001|Overall Study|Adverse Event|2|||
130779941|NCT01922258|470819563|FG000|Overall Study|Met Withdrawal Criteria|0|||
130779942|NCT01922258|470819564|FG001|Overall Study|Met Withdrawal Criteria|4|||
130779943|NCT01922258|470819563|FG000|Overall Study|Withdrawn by the Investigator|1|||
130779944|NCT01922258|470819564|FG001|Overall Study|Withdrawn by the Investigator|4|||
131139333|NCT04556617|472136119|FG001|Overall Study|progressive disease|2|||
131139334|NCT04556617|472136120|FG002|Overall Study|progressive disease|2|||
131139335|NCT04556617|472136121|FG003|Overall Study|progressive disease|1|||
131139336|NCT04556617|472136122|FG004|Overall Study|progressive disease|1|||
131139337|NCT04556617|472136118|FG000|Overall Study|Physician Decision|0|||
131139338|NCT04556617|472136119|FG001|Overall Study|Physician Decision|0|||
131139339|NCT04556617|472136120|FG002|Overall Study|Physician Decision|2|||
131139340|NCT04556617|472136121|FG003|Overall Study|Physician Decision|0|||
131139341|NCT04556617|472136122|FG004|Overall Study|Physician Decision|0|||
131139342|NCT04556617|472136118|FG000|Overall Study|Adverse Event|0|||
131139343|NCT04556617|472136119|FG001|Overall Study|Adverse Event|0|||
131139344|NCT04556617|472136120|FG002|Overall Study|Adverse Event|2|||
131139345|NCT04556617|472136121|FG003|Overall Study|Adverse Event|3|||
131139346|NCT04556617|472136122|FG004|Overall Study|Adverse Event|0|||
131139347|NCT04556617|472136118|FG000|Overall Study|Withdrawal by Subject|0|||
131139348|NCT04556617|472136119|FG001|Overall Study|Withdrawal by Subject|2|||
131139349|NCT04556617|472136120|FG002|Overall Study|Withdrawal by Subject|1|||
131139350|NCT04556617|472136121|FG003|Overall Study|Withdrawal by Subject|1|||
130725872|NCT00264550|470621126|FG002|Overall Study|Lost to Follow-up|1|||
130725873|NCT00264550|470621127|FG003|Overall Study|Lost to Follow-up|1|||
130725874|NCT00264550|470621124|FG000|Overall Study|Adverse Event|23|||
130725875|NCT00264550|470621125|FG001|Overall Study|Adverse Event|18|||
130725876|NCT00264550|470621126|FG002|Overall Study|Adverse Event|9|||
130725877|NCT00264550|470621127|FG003|Overall Study|Adverse Event|14|||
130725878|NCT00264550|470621124|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130725879|NCT00264550|470621125|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
130725880|NCT00264550|470621126|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
130725881|NCT00264550|470621127|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
130725882|NCT00264550|470621124|FG000|Overall Study|Discontinued oral study agent|0|||
130725883|NCT00264550|470621125|FG001|Overall Study|Discontinued oral study agent|1|||
130725884|NCT00264550|470621126|FG002|Overall Study|Discontinued oral study agent|0|||
130725885|NCT00264550|470621127|FG003|Overall Study|Discontinued oral study agent|0|||
130725886|NCT00264550|470621124|FG000|Overall Study|Other|13|||
130725887|NCT00264550|470621125|FG001|Overall Study|Other|7|||
130725888|NCT00264550|470621126|FG002|Overall Study|Other|3|||
130725889|NCT00264550|470621127|FG003|Overall Study|Other|9|||
130725890|NCT01439009|470621132|FG000|Overall Study|Physician Decision|5|||
130725891|NCT01439009|470621133|FG001|Overall Study|Physician Decision|3|||
130725892|NCT01439009|470621132|FG000|Overall Study|Protocol Violation|2|||
130725893|NCT01439009|470621133|FG001|Overall Study|Protocol Violation|0|||
130725894|NCT01439009|470621132|FG000|Overall Study|Deviation of exclusion criteria|1|||
130725895|NCT01439009|470621133|FG001|Overall Study|Deviation of exclusion criteria|0|||
130725896|NCT00696787|470621135|FG000|Overall Study|Adverse Event|1|||
130725897|NCT00696787|470621136|FG001|Overall Study|Adverse Event|0|||
130725898|NCT00696787|470621137|FG002|Overall Study|Adverse Event|6|||
130725899|NCT00696787|470621135|FG000|Overall Study|Discontinuation by Sponsor|9|||
130725900|NCT00696787|470621136|FG001|Overall Study|Discontinuation by Sponsor|13|||
130725901|NCT00696787|470621137|FG002|Overall Study|Discontinuation by Sponsor|14|||
130725902|NCT00696787|470621135|FG000|Overall Study|Lack of Efficacy|0|||
130725903|NCT00696787|470621136|FG001|Overall Study|Lack of Efficacy|1|||
130725904|NCT00696787|470621137|FG002|Overall Study|Lack of Efficacy|0|||
130725905|NCT00696787|470621135|FG000|Overall Study|Lost to Follow-up|4|||
130725906|NCT00696787|470621136|FG001|Overall Study|Lost to Follow-up|0|||
130725907|NCT00696787|470621137|FG002|Overall Study|Lost to Follow-up|3|||
130725908|NCT00696787|470621135|FG000|Overall Study|Withdrawal by Subject|0|||
130725909|NCT00696787|470621136|FG001|Overall Study|Withdrawal by Subject|3|||
130725910|NCT00696787|470621137|FG002|Overall Study|Withdrawal by Subject|2|||
130725911|NCT00696787|470621135|FG000|Overall Study|Failed to return|1|||
130725912|NCT00696787|470621136|FG001|Overall Study|Failed to return|3|||
130725913|NCT00696787|470621137|FG002|Overall Study|Failed to return|1|||
130725914|NCT02552303|470621143|FG000|Allocation|Withdrawal by Subject|2|||
130725915|NCT02552303|470621144|FG001|Allocation|Withdrawal by Subject|1|||
130725916|NCT02552303|470621145|FG002|Allocation|Withdrawal by Subject|1|||
131139351|NCT04556617|472136122|FG004|Overall Study|Withdrawal by Subject|0|||
131139352|NCT04556617|472136118|FG000|Overall Study|PSA increase|0|||
131139353|NCT04556617|472136119|FG001|Overall Study|PSA increase|1|||
131139354|NCT04556617|472136120|FG002|Overall Study|PSA increase|0|||
131139355|NCT04556617|472136121|FG003|Overall Study|PSA increase|0|||
131139356|NCT04556617|472136122|FG004|Overall Study|PSA increase|0|||
131139357|NCT04556617|472136118|FG000|Overall Study|Sponsor study termination|1|||
131139358|NCT04556617|472136119|FG001|Overall Study|Sponsor study termination|0|||
130725917|NCT02552303|470621146|FG003|Allocation|Withdrawal by Subject|1|||
130725918|NCT02552303|470621143|FG000|Allocation|ineligible|1|||
130725919|NCT02552303|470621144|FG001|Allocation|ineligible|1|||
130725920|NCT02552303|470621145|FG002|Allocation|ineligible|0|||
130725921|NCT02552303|470621146|FG003|Allocation|ineligible|0|||
130725922|NCT02552303|470621143|FG000|Follow-Up|Lost to Follow-up|0|||
130725923|NCT02552303|470621144|FG001|Follow-Up|Lost to Follow-up|0|||
130725924|NCT02552303|470621145|FG002|Follow-Up|Lost to Follow-up|1|||
130725925|NCT02552303|470621146|FG003|Follow-Up|Lost to Follow-up|0|||
130725926|NCT02552303|470621143|FG000|Follow-Up|ineligible|0|||
131139359|NCT04556617|472136120|FG002|Overall Study|Sponsor study termination|0|||
131139360|NCT04556617|472136121|FG003|Overall Study|Sponsor study termination|0|||
131139361|NCT04556617|472136122|FG004|Overall Study|Sponsor study termination|0|||
131139362|NCT04949841|472136123|FG000|Overall Study|Adverse Event|7|||
130779945|NCT01922258|470819563|FG000|Overall Study|Withdrawal by participant|5|||
130779946|NCT01922258|470819564|FG001|Overall Study|Withdrawal by participant|5|||
130779947|NCT00673257|470819565|FG000|Overall Study|Withdrawal by Subject|4|||
130779948|NCT00673257|470819565|FG000|Overall Study|Unable to obtain specimen|1|||
130779949|NCT04552132|470819566|FG000|Overall Study|Lost to Follow-up|4|||
130779950|NCT04552132|470819567|FG001|Overall Study|Lost to Follow-up|3|||
130779951|NCT04552132|470819566|FG000|Overall Study|Protocol Violation|1|||
130779952|NCT04552132|470819567|FG001|Overall Study|Protocol Violation|0|||
130779953|NCT02256839|470819568|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
130779954|NCT02256839|470819569|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
131139363|NCT04949841|472136123|FG000|Overall Study|Death|1|||
131139364|NCT04949841|472136123|FG000|Overall Study|Withdrawal by Subject|52|||
131139365|NCT04949841|472136123|FG000|Overall Study|Pregnancy|4|||
131139366|NCT04949841|472136123|FG000|Overall Study|Lost to Follow-up|9|||
131139367|NCT04949841|472136123|FG000|Overall Study|Lack of Efficacy|55|||
131139368|NCT04949841|472136123|FG000|Overall Study|Various reasons|9|||
131139369|NCT05168267|472136124|FG000|Overall Study|Withdrawal by Subject|2|||
131139370|NCT05168267|472136125|FG001|Overall Study|Withdrawal by Subject|1|||
131139371|NCT05168267|472136124|FG000|Overall Study|Withdrawn by Therapist|1|||
131139372|NCT05168267|472136125|FG001|Overall Study|Withdrawn by Therapist|1|||
131139373|NCT05168267|472136124|FG000|Overall Study|Left Facility|1|||
131139374|NCT05168267|472136125|FG001|Overall Study|Left Facility|0|||
131139375|NCT05702736|472136126|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
131139376|NCT05702736|472136127|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
131139377|NCT05702736|472136126|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
131139378|NCT05702736|472136127|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
131139379|NCT00500682|472136132|FG000|Overall Study|Adverse Event|37|||
131139380|NCT00500682|472136133|FG001|Overall Study|Adverse Event|29|||
131139381|NCT00500682|472136132|FG000|Overall Study|Death|25|||
131139382|NCT00500682|472136133|FG001|Overall Study|Death|16|||
131139383|NCT00500682|472136132|FG000|Overall Study|Lost to Follow-up|11|||
131139384|NCT00500682|472136133|FG001|Overall Study|Lost to Follow-up|11|||
131139385|NCT00500682|472136132|FG000|Overall Study|Physician Decision|6|||
131139386|NCT00500682|472136133|FG001|Overall Study|Physician Decision|10|||
131139387|NCT00500682|472136132|FG000|Overall Study|Pregnancy|2|||
131139388|NCT00500682|472136133|FG001|Overall Study|Pregnancy|0|||
131139389|NCT00500682|472136132|FG000|Overall Study|Protocol Violation|1|||
131139390|NCT00500682|472136133|FG001|Overall Study|Protocol Violation|3|||
131139391|NCT00500682|472136132|FG000|Overall Study|Withdrawal by Subject|80|||
131139392|NCT00500682|472136133|FG001|Overall Study|Withdrawal by Subject|74|||
131139393|NCT00500682|472136132|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
131139394|NCT00500682|472136133|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
131139395|NCT02531646|472136134|FG000|Overall Study|equip. image processing issue|5|||
131139396|NCT02531646|472136135|FG001|Overall Study|equip. image processing issue|1|||
131139397|NCT02531646|472136136|FG002|Overall Study|equip. image processing issue|0|||
131139398|NCT00772668|472136140|FG000|Overall Study|Physician Decision|3|||
131139399|NCT01182428|472136141|FG000|Overall Study|Physician Decision|1|||
131139400|NCT01182428|472136142|FG001|Overall Study|Physician Decision|0|||
131139401|NCT01182428|472136141|FG000|Overall Study|Lost to Follow-up|9|||
131139402|NCT01182428|472136142|FG001|Overall Study|Lost to Follow-up|1|||
131139403|NCT01182428|472136141|FG000|Overall Study|Withdrawal by Subject|1|||
131139404|NCT01182428|472136142|FG001|Overall Study|Withdrawal by Subject|0|||
131139405|NCT04484285|472138002|FG000|Overall Study|Unable to operate stimulator|3|||
131139406|NCT04484285|472138003|FG001|Overall Study|Unable to operate stimulator|0|||
131139407|NCT02363478|472138005|FG000|Overall Study|Lost to Follow-up|4|||
131139408|NCT02363478|472138005|FG000|Overall Study|Adverse Event|4|||
131139409|NCT00768898|472138006|FG000|Overall Study|Unrelated injury|1|||
131139410|NCT00768898|472138006|FG000|Overall Study|Headache|1|||
130779955|NCT01951417|470819584|FG000|Overall Study|Withdrawal by Subject|1|||
130779956|NCT01951417|470819584|FG000|Overall Study|Protocol Violation|2|||
131139411|NCT02527707|472138007|FG000|Overall Study|Adverse Event|1|||
131139412|NCT02527707|472138007|FG000|Overall Study|Adverse Event|1|||
131139413|NCT00930059|472138008|FG000|Overall Study|Death|1|||
131139414|NCT00930059|472138009|FG001|Overall Study|Death|0|||
131139415|NCT00930059|472138008|FG000|Overall Study|Did not meet entrance criteria|1|||
131139416|NCT00930059|472138009|FG001|Overall Study|Did not meet entrance criteria|1|||
131139417|NCT00930059|472138008|FG000|Overall Study|Withdrawal by Subject|3|||
131139418|NCT00930059|472138009|FG001|Overall Study|Withdrawal by Subject|4|||
131139419|NCT00930059|472138008|FG000|Overall Study|Other|1|||
131139420|NCT00930059|472138009|FG001|Overall Study|Other|0|||
131231585|NCT01767597|472475156|FG000|Overall Study|Withdrawal by Subject|1|||
130779957|NCT01951417|470819584|FG000|Overall Study|Lost to Follow-up|6|||
130779958|NCT01497067|470819587|FG000|Overall Study|Lost to Follow-up|56|||
130725927|NCT02552303|470621144|FG001|Follow-Up|ineligible|2|||
130725928|NCT02552303|470621145|FG002|Follow-Up|ineligible|0|||
130725929|NCT02552303|470621146|FG003|Follow-Up|ineligible|0|||
130725930|NCT01377987|470621149|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
130725931|NCT01377987|470621150|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
130725932|NCT00253448|470621151|FG000|Overall Study|Withdrawal by Subject|1|||
130725933|NCT02052011|470621152|FG000|Overall Study|Lost to Follow-up|3|||
130725934|NCT02052011|470621153|FG001|Overall Study|Lost to Follow-up|0|||
130725935|NCT02052011|470621152|FG000|Overall Study|Withdrawal by Subject|1|||
130725936|NCT02052011|470621153|FG001|Overall Study|Withdrawal by Subject|2|||
130725937|NCT00000620|470621154|FG000|Overall Study|Death|86|||
130725938|NCT00000620|470621155|FG001|Overall Study|Death|67|||
130725939|NCT00000620|470621156|FG002|Overall Study|Death|112|||
130725940|NCT00000620|470621157|FG003|Overall Study|Death|126|||
130725941|NCT00000620|470621158|FG004|Overall Study|Death|64|||
130725942|NCT00000620|470621159|FG005|Overall Study|Death|77|||
130725943|NCT00000620|470621160|FG006|Overall Study|Death|91|||
130725944|NCT00000620|470621161|FG007|Overall Study|Death|95|||
130725945|NCT00000620|470621154|FG000|Overall Study|Lost to Follow-up|14|||
130725946|NCT00000620|470621155|FG001|Overall Study|Lost to Follow-up|14|||
130725947|NCT00000620|470621156|FG002|Overall Study|Lost to Follow-up|14|||
130725948|NCT00000620|470621157|FG003|Overall Study|Lost to Follow-up|14|||
130725949|NCT00000620|470621158|FG004|Overall Study|Lost to Follow-up|15|||
130725950|NCT00000620|470621159|FG005|Overall Study|Lost to Follow-up|15|||
130725951|NCT00000620|470621160|FG006|Overall Study|Lost to Follow-up|13|||
130725952|NCT00000620|470621161|FG007|Overall Study|Lost to Follow-up|14|||
130725953|NCT00000620|470621154|FG000|Overall Study|Withdrawal by Subject|40|||
130725954|NCT00000620|470621155|FG001|Overall Study|Withdrawal by Subject|27|||
130725955|NCT00000620|470621156|FG002|Overall Study|Withdrawal by Subject|28|||
130725956|NCT00000620|470621157|FG003|Overall Study|Withdrawal by Subject|27|||
130725957|NCT00000620|470621158|FG004|Overall Study|Withdrawal by Subject|30|||
130725958|NCT00000620|470621159|FG005|Overall Study|Withdrawal by Subject|32|||
130725959|NCT00000620|470621160|FG006|Overall Study|Withdrawal by Subject|32|||
130725960|NCT00000620|470621161|FG007|Overall Study|Withdrawal by Subject|21|||
130725961|NCT00000620|470621154|FG000|Overall Study|missed closeout visit|22|||
130725962|NCT00000620|470621155|FG001|Overall Study|missed closeout visit|28|||
130725963|NCT00000620|470621156|FG002|Overall Study|missed closeout visit|16|||
130725964|NCT00000620|470621157|FG003|Overall Study|missed closeout visit|11|||
130725965|NCT00000620|470621158|FG004|Overall Study|missed closeout visit|26|||
130725966|NCT00000620|470621159|FG005|Overall Study|missed closeout visit|28|||
130725967|NCT00000620|470621160|FG006|Overall Study|missed closeout visit|13|||
130725968|NCT00000620|470621161|FG007|Overall Study|missed closeout visit|16|||
130725969|NCT02648932|470621162|FG000|Overall Study|No transplant|3|||
130725970|NCT02648932|470621163|FG001|Overall Study|No transplant|1|||
130725971|NCT02960490|470621165|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
130725972|NCT02960490|470621166|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
130725973|NCT02960490|470621167|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725974|NCT02960490|470621168|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725975|NCT02960490|470621169|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725976|NCT02960490|470621170|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725977|NCT02960490|470621171|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725978|NCT02960490|470621172|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725979|NCT02960490|470621173|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725980|NCT02960490|470621174|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130725981|NCT02960490|470621165|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725982|NCT02960490|470621166|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
130725983|NCT02960490|470621167|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725984|NCT02960490|470621168|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725985|NCT02960490|470621169|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725986|NCT02960490|470621170|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725987|NCT02960490|470621171|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725988|NCT02960490|470621172|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725989|NCT02960490|470621173|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130725990|NCT02960490|470621174|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
131139421|NCT00930059|472138008|FG000|Overall Study|1 site terminated by sponsor|1|||
130725991|NCT02960490|470621165|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
130725992|NCT02960490|470621166|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
130725993|NCT02960490|470621167|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130725994|NCT02960490|470621168|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130725995|NCT02960490|470621169|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130725996|NCT02960490|470621170|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
131139422|NCT00930059|472138009|FG001|Overall Study|1 site terminated by sponsor|1|||
130725997|NCT02960490|470621171|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
131139423|NCT00930059|472138008|FG000|Overall Study|Adverse Event|1|||
131139424|NCT00930059|472138009|FG001|Overall Study|Adverse Event|6|||
131139425|NCT04002310|472138012|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
131139426|NCT04002310|472138013|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
131139427|NCT04002310|472138014|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
131139428|NCT04002310|472138015|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
131139429|NCT04002310|472138016|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
131139430|NCT00542997|472138017|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
131139431|NCT00542997|472138017|FG000|Wash in / Wash Out Period|Adverse Event|3|||
131139432|NCT00542997|472138017|FG000|Efficacy Period|Adverse Event|3|||
130725998|NCT02960490|470621172|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130725999|NCT02960490|470621173|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130726000|NCT02960490|470621174|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130726001|NCT02960490|470621165|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
130726002|NCT02960490|470621166|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
130726003|NCT02960490|470621167|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726004|NCT02960490|470621168|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726005|NCT02960490|470621169|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726006|NCT02960490|470621170|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726007|NCT02960490|470621171|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726008|NCT02960490|470621172|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726009|NCT02960490|470621173|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726010|NCT02960490|470621174|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130726011|NCT02960490|470621165|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726012|NCT02960490|470621166|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726013|NCT02960490|470621167|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
130726014|NCT02960490|470621168|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
130726015|NCT02960490|470621169|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726016|NCT02960490|470621170|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
130726017|NCT02960490|470621171|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726018|NCT02960490|470621172|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726019|NCT02960490|470621173|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726020|NCT02960490|470621174|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130726021|NCT02960490|470621165|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726022|NCT02960490|470621166|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726023|NCT02960490|470621167|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
130726024|NCT02960490|470621168|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726025|NCT02960490|470621169|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
130726026|NCT02960490|470621170|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726027|NCT02960490|470621171|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726028|NCT02960490|470621172|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726029|NCT02960490|470621173|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726030|NCT02960490|470621174|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130726031|NCT02960490|470621165|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
130726032|NCT02960490|470621166|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
130726033|NCT02960490|470621167|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
130726034|NCT02960490|470621168|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
130726035|NCT02960490|470621169|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
130726036|NCT02960490|470621170|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
130726037|NCT02960490|470621171|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
130726038|NCT02960490|470621172|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
130726039|NCT02960490|470621173|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
130726040|NCT02960490|470621174|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
130726041|NCT02960490|470621165|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726042|NCT02960490|470621166|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726043|NCT02960490|470621167|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726044|NCT02960490|470621168|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726045|NCT02960490|470621169|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726046|NCT02960490|470621170|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726047|NCT02960490|470621171|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
130726048|NCT02960490|470621172|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
131139433|NCT02949128|472138020|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
130726049|NCT02960490|470621173|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
130726050|NCT02960490|470621174|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130726051|NCT02960490|470621165|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130779959|NCT01497067|470819587|FG000|Overall Study|Adverse Event|3|||
131231586|NCT01767597|472475157|FG001|Overall Study|Withdrawal by Subject|0|||
130779960|NCT01497067|470819587|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
130779961|NCT01497067|470819587|FG000|Overall Study|Other|13|||
130779962|NCT01598610|470819590|FG000|Overall Study|Adverse Event|1|||
130779963|NCT04346199|470819591|FG000|Overall Study|Death|8|||
131231587|NCT02961920|472475158|FG000|Overall Study|did not achive stydy protocol schedule|1|||
131231588|NCT02961920|472475159|FG001|Overall Study|did not achive stydy protocol schedule|1|||
131231589|NCT00096265|472475160|FG000|Overall Study|Ineligible|1|||
131231590|NCT00096265|472475161|FG001|Overall Study|Ineligible|0|||
130779964|NCT04346199|470819592|FG001|Overall Study|Death|9|||
130779965|NCT04346199|470819591|FG000|Overall Study|Lost to Follow-up|0|||
130779966|NCT04346199|470819592|FG001|Overall Study|Lost to Follow-up|1|||
130779967|NCT04346199|470819591|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
130779968|NCT04346199|470819592|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
130779969|NCT04346199|470819591|FG000|Overall Study|Withdrawal by Subject|5|||
130779970|NCT04346199|470819592|FG001|Overall Study|Withdrawal by Subject|1|||
130779971|NCT01705977|470819595|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
130779972|NCT01705977|470819596|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
130779973|NCT01705977|470819595|FG000|Treatment Period (Year 1)|Adverse Event|57|||
130779974|NCT01705977|470819596|FG001|Treatment Period (Year 1)|Adverse Event|49|||
130779975|NCT01705977|470819595|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
131077975|NCT01130168|471918565|FG004|Period 1|Discontinued For Other Reason|0|||
131077976|NCT01130168|471918566|FG005|Period 1|Discontinued For Other Reason|0|||
131077977|NCT01130168|471918561|FG000|Period 1|Adverse Event|0|||
131077978|NCT01130168|471918562|FG001|Period 1|Adverse Event|0|||
131077979|NCT01130168|471918563|FG002|Period 1|Adverse Event|0|||
131077980|NCT01130168|471918564|FG003|Period 1|Adverse Event|1|||
131077981|NCT01130168|471918565|FG004|Period 1|Adverse Event|0|||
131077982|NCT01130168|471918566|FG005|Period 1|Adverse Event|0|||
131077983|NCT01438840|471918567|FG000|Core Study|Adverse Event|0|||
131077984|NCT01438840|471918568|FG001|Core Study|Adverse Event|3|||
131077985|NCT01438840|471918569|FG002|Core Study|Adverse Event|0|||
131077986|NCT01438840|471918567|FG000|Core Study|Lack of Efficacy|15|||
131077987|NCT01438840|471918568|FG001|Core Study|Lack of Efficacy|7|||
131077988|NCT01438840|471918569|FG002|Core Study|Lack of Efficacy|0|||
131077989|NCT01438840|471918567|FG000|Core Study|Withdrawal of consent|1|||
131077990|NCT01438840|471918568|FG001|Core Study|Withdrawal of consent|0|||
131077991|NCT01438840|471918569|FG002|Core Study|Withdrawal of consent|0|||
131077992|NCT01438840|471918567|FG000|Extension Phase|Adverse Event|0|||
131077993|NCT01438840|471918568|FG001|Extension Phase|Adverse Event|0|||
131077994|NCT01438840|471918569|FG002|Extension Phase|Adverse Event|3|||
131077995|NCT01438840|471918567|FG000|Extension Phase|Lost to Follow-up|0|||
131077996|NCT01438840|471918568|FG001|Extension Phase|Lost to Follow-up|0|||
131077997|NCT01438840|471918569|FG002|Extension Phase|Lost to Follow-up|1|||
131077998|NCT01438840|471918567|FG000|Extension Phase|Withdrawal by Subject|0|||
131077999|NCT01438840|471918568|FG001|Extension Phase|Withdrawal by Subject|0|||
131078000|NCT01438840|471918569|FG002|Extension Phase|Withdrawal by Subject|3|||
131078001|NCT01438840|471918567|FG000|Extension Phase|Lack of Efficacy|0|||
131078002|NCT01438840|471918568|FG001|Extension Phase|Lack of Efficacy|0|||
131078003|NCT01438840|471918569|FG002|Extension Phase|Lack of Efficacy|2|||
131078004|NCT01438840|471918567|FG000|Extension Phase|Other|0|||
131078005|NCT01438840|471918568|FG001|Extension Phase|Other|0|||
131078006|NCT01438840|471918569|FG002|Extension Phase|Other|1|||
131078007|NCT01774305|471918572|FG000|Overall Study|Physician Decision|1|||
131078008|NCT01774305|471918573|FG001|Overall Study|Physician Decision|0|||
131078009|NCT01157377|471918575|FG000|Overall Study|Lost to Follow-up|0|||
131078010|NCT01157377|471918576|FG001|Overall Study|Lost to Follow-up|0|||
131078011|NCT01157377|471918577|FG002|Overall Study|Lost to Follow-up|1|||
131078012|NCT01157377|471918578|FG003|Overall Study|Lost to Follow-up|0|||
131231591|NCT00096265|472475162|FG002|Overall Study|Ineligible|0|||
130779976|NCT01705977|470819596|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
131078013|NCT01157377|471918579|FG004|Overall Study|Lost to Follow-up|1|||
131078014|NCT01157377|471918580|FG005|Overall Study|Lost to Follow-up|1|||
131078015|NCT01157377|471918581|FG006|Overall Study|Lost to Follow-up|0|||
131078016|NCT01157377|471918575|FG000|Overall Study|Personal Reasons|2|||
131078017|NCT01157377|471918576|FG001|Overall Study|Personal Reasons|1|||
131078018|NCT01157377|471918577|FG002|Overall Study|Personal Reasons|0|||
131078019|NCT01157377|471918578|FG003|Overall Study|Personal Reasons|1|||
131078020|NCT01157377|471918579|FG004|Overall Study|Personal Reasons|0|||
131078021|NCT01157377|471918580|FG005|Overall Study|Personal Reasons|0|||
131078022|NCT01157377|471918581|FG006|Overall Study|Personal Reasons|0|||
131078023|NCT01157377|471918575|FG000|Overall Study|Protocol Violation|0|||
131078024|NCT01157377|471918576|FG001|Overall Study|Protocol Violation|0|||
131078025|NCT01157377|471918577|FG002|Overall Study|Protocol Violation|0|||
131078026|NCT01157377|471918578|FG003|Overall Study|Protocol Violation|0|||
130779977|NCT01705977|470819595|FG000|Treatment Period (Year 1)|Site closure|3|||
131078027|NCT01157377|471918579|FG004|Overall Study|Protocol Violation|0|||
131078028|NCT01157377|471918580|FG005|Overall Study|Protocol Violation|1|||
131078029|NCT01157377|471918581|FG006|Overall Study|Protocol Violation|0|||
131078030|NCT01157377|471918575|FG000|Overall Study|Lack of Efficacy|0|||
131231592|NCT02232074|472475163|FG000|Overall Study|Withdrawal by Subject|5|||
131231593|NCT02232074|472475164|FG001|Overall Study|Withdrawal by Subject|3|||
131231594|NCT02232074|472475163|FG000|Overall Study|No legal concerns at baseline|36|||
131231595|NCT02232074|472475164|FG001|Overall Study|No legal concerns at baseline|41|||
131231596|NCT02232074|472475163|FG000|Overall Study|deemed ineligible|0|||
131231597|NCT02232074|472475164|FG001|Overall Study|deemed ineligible|1|||
131231598|NCT04480463|472475167|FG000|Overall Study|Death|0|||
131231599|NCT04480463|472475168|FG001|Overall Study|Death|1|||
131231600|NCT04480463|472475167|FG000|Overall Study|Adverse Event|6|||
131078031|NCT01157377|471918576|FG001|Overall Study|Lack of Efficacy|0|||
131078032|NCT01157377|471918577|FG002|Overall Study|Lack of Efficacy|0|||
131078033|NCT01157377|471918578|FG003|Overall Study|Lack of Efficacy|0|||
131078034|NCT01157377|471918579|FG004|Overall Study|Lack of Efficacy|0|||
131078035|NCT01157377|471918580|FG005|Overall Study|Lack of Efficacy|0|||
131078036|NCT01157377|471918581|FG006|Overall Study|Lack of Efficacy|1|||
131078037|NCT01157377|471918575|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131078038|NCT01157377|471918576|FG001|Overall Study|Other Miscellaneous Reasons|2|||
131078039|NCT01157377|471918577|FG002|Overall Study|Other Miscellaneous Reasons|0|||
131078040|NCT01157377|471918578|FG003|Overall Study|Other Miscellaneous Reasons|0|||
131078041|NCT01157377|471918579|FG004|Overall Study|Other Miscellaneous Reasons|1|||
131078042|NCT01157377|471918580|FG005|Overall Study|Other Miscellaneous Reasons|1|||
131078043|NCT01157377|471918581|FG006|Overall Study|Other Miscellaneous Reasons|1|||
131139434|NCT02949128|472138020|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
131139435|NCT02949128|472138020|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
131139436|NCT02949128|472138020|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
131231601|NCT04480463|472475168|FG001|Overall Study|Adverse Event|8|||
131231602|NCT04480463|472475167|FG000|Overall Study|Lost to Follow-up|3|||
131231603|NCT04480463|472475168|FG001|Overall Study|Lost to Follow-up|2|||
131231604|NCT04480463|472475167|FG000|Overall Study|Physician Decision|2|||
131231605|NCT04480463|472475168|FG001|Overall Study|Physician Decision|5|||
131231606|NCT04480463|472475167|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
131231607|NCT04480463|472475168|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
131231608|NCT04480463|472475167|FG000|Overall Study|Protocol Violation|2|||
131231609|NCT04480463|472475168|FG001|Overall Study|Protocol Violation|1|||
131231610|NCT04480463|472475167|FG000|Overall Study|Withdrawal by Subject|6|||
131231611|NCT04480463|472475168|FG001|Overall Study|Withdrawal by Subject|7|||
131231612|NCT04480463|472475167|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
131139437|NCT02949128|472138020|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
131139438|NCT02949128|472138020|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
131139439|NCT02949128|472138020|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
131139440|NCT02949128|472138020|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
131139441|NCT02949128|472138020|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
131139442|NCT02949128|472138020|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
131139443|NCT00546364|472138022|FG000|Overall Study|Disease progression|5|||
131139444|NCT00546364|472138023|FG001|Overall Study|Disease progression|11|||
131139445|NCT00546364|472138024|FG002|Overall Study|Disease progression|8|||
131139446|NCT00546364|472138022|FG000|Overall Study|Completed and off treatment|1|||
131139447|NCT00546364|472138023|FG001|Overall Study|Completed and off treatment|0|||
131139448|NCT00546364|472138024|FG002|Overall Study|Completed and off treatment|2|||
131139449|NCT00546364|472138022|FG000|Overall Study|Administrative reason by sponsor|1|||
131139450|NCT00546364|472138023|FG001|Overall Study|Administrative reason by sponsor|0|||
131139451|NCT00546364|472138024|FG002|Overall Study|Administrative reason by sponsor|0|||
131139452|NCT00546364|472138022|FG000|Overall Study|Poor compliance/noncompliance|0|||
131139453|NCT00546364|472138023|FG001|Overall Study|Poor compliance/noncompliance|0|||
131139454|NCT00546364|472138024|FG002|Overall Study|Poor compliance/noncompliance|1|||
131139455|NCT00546364|472138022|FG000|Overall Study|No longer meets study criteria|1|||
131139456|NCT00546364|472138023|FG001|Overall Study|No longer meets study criteria|1|||
131139457|NCT00546364|472138024|FG002|Overall Study|No longer meets study criteria|0|||
131139458|NCT00546364|472138022|FG000|Overall Study|Withdrawal by Subject|5|||
131139459|NCT00546364|472138023|FG001|Overall Study|Withdrawal by Subject|6|||
131139460|NCT00546364|472138024|FG002|Overall Study|Withdrawal by Subject|3|||
131139461|NCT00546364|472138022|FG000|Overall Study|Prior taxotere|1|||
131231613|NCT04480463|472475168|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
131231614|NCT04480463|472475167|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
131078044|NCT02261285|471918584|FG000|Overall Study|Disease progression|0|||
131078045|NCT02261285|471918585|FG001|Overall Study|Disease progression|0|||
131139462|NCT00546364|472138023|FG001|Overall Study|Prior taxotere|0|||
131139463|NCT00546364|472138024|FG002|Overall Study|Prior taxotere|0|||
131139464|NCT00546364|472138022|FG000|Overall Study|Mixed response|1|||
131139465|NCT00546364|472138023|FG001|Overall Study|Mixed response|0|||
131078046|NCT02261285|471918586|FG002|Overall Study|Disease progression|1|||
131078047|NCT01702519|471918587|FG000|Washout Period|Lost to Follow-up|1|||
130726052|NCT02960490|470621166|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726053|NCT02960490|470621167|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726054|NCT02960490|470621168|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726055|NCT02960490|470621169|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726056|NCT02960490|470621170|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726057|NCT02960490|470621171|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726058|NCT02960490|470621172|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
130726059|NCT02960490|470621173|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726060|NCT02960490|470621174|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130726061|NCT02960490|470621165|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726062|NCT02960490|470621166|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726063|NCT02960490|470621167|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726064|NCT02960490|470621168|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726065|NCT02960490|470621169|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726066|NCT02960490|470621170|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130726067|NCT02960490|470621171|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
130726068|NCT02960490|470621172|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
130726069|NCT02960490|470621173|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
130726070|NCT02960490|470621174|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
130726071|NCT02960490|470621165|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726072|NCT02960490|470621166|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726073|NCT02960490|470621167|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726074|NCT02960490|470621168|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726075|NCT02960490|470621169|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726076|NCT02960490|470621170|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726077|NCT02960490|470621171|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
130726078|NCT02960490|470621172|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726079|NCT02960490|470621173|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726080|NCT02960490|470621174|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130726081|NCT02960490|470621165|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
131078048|NCT01702519|471918588|FG001|Washout Period|Lost to Follow-up|0|||
131078049|NCT01702519|471918587|FG000|Washout Period|Withdrawal by Subject|0|||
131078050|NCT01702519|471918588|FG001|Washout Period|Withdrawal by Subject|2|||
131078051|NCT03738397|471918589|FG000|Overall Study|Adverse Event|3|||
131078052|NCT03738397|471918590|FG001|Overall Study|Adverse Event|7|||
131078053|NCT03738397|471918589|FG000|Overall Study|Withdrawal by Subject|8|||
131078054|NCT03738397|471918590|FG001|Overall Study|Withdrawal by Subject|11|||
131078055|NCT03738397|471918589|FG000|Overall Study|Lost to Follow-up|7|||
131078056|NCT03738397|471918590|FG001|Overall Study|Lost to Follow-up|5|||
131078057|NCT03738397|471918589|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
131078058|NCT03738397|471918590|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
131078059|NCT03738397|471918589|FG000|Overall Study|Other|4|||
131078060|NCT03738397|471918590|FG001|Overall Study|Other|6|||
131078061|NCT01263925|471918599|FG000|Overall Study|Protocol Violation|1|||
131078062|NCT01263925|471918600|FG001|Overall Study|Protocol Violation|0|||
131078063|NCT01263925|471918599|FG000|Overall Study|Lack of Efficacy|0|||
131078064|NCT01263925|471918600|FG001|Overall Study|Lack of Efficacy|1|||
131078065|NCT01263925|471918599|FG000|Overall Study|Adverse Event|23|||
131078066|NCT01263925|471918600|FG001|Overall Study|Adverse Event|22|||
131078067|NCT01263925|471918599|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
131078068|NCT01263925|471918600|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
131078069|NCT01263925|471918599|FG000|Overall Study|Withdrawal by Subject|6|||
131078070|NCT01263925|471918600|FG001|Overall Study|Withdrawal by Subject|8|||
131078071|NCT01263925|471918599|FG000|Overall Study|Other|4|||
131078072|NCT01263925|471918600|FG001|Overall Study|Other|4|||
131078073|NCT01263925|471918599|FG000|Overall Study|Lost to Follow-up|3|||
131078074|NCT01263925|471918600|FG001|Overall Study|Lost to Follow-up|1|||
131078075|NCT01263925|471918599|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
131078076|NCT01263925|471918600|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
131078077|NCT01263925|471918599|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
131078078|NCT01263925|471918600|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
131078079|NCT01263925|471918599|FG000|Overall Study|AE/ Withdrawal|1|||
131078080|NCT01263925|471918600|FG001|Overall Study|AE/ Withdrawal|4|||
131078081|NCT01263925|471918599|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
131078082|NCT01263925|471918600|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
131078083|NCT01263925|471918599|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
131078084|NCT01263925|471918600|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
131139466|NCT00546364|472138024|FG002|Overall Study|Mixed response|0|||
131139467|NCT00546364|472138022|FG000|Overall Study|Palliative treatment|1|||
131139468|NCT00546364|472138023|FG001|Overall Study|Palliative treatment|0|||
131139469|NCT00546364|472138024|FG002|Overall Study|Palliative treatment|1|||
131139470|NCT00546364|472138022|FG000|Overall Study|Target lesions resected|1|||
131139471|NCT00546364|472138023|FG001|Overall Study|Target lesions resected|0|||
131139472|NCT00546364|472138024|FG002|Overall Study|Target lesions resected|0|||
131139473|NCT00546364|472138022|FG000|Overall Study|Physician Decision|0|||
131139474|NCT00546364|472138023|FG001|Overall Study|Physician Decision|0|||
131139475|NCT00546364|472138024|FG002|Overall Study|Physician Decision|1|||
131139476|NCT00546364|472138022|FG000|Overall Study|Sponsor decision|0|||
131139477|NCT00546364|472138023|FG001|Overall Study|Sponsor decision|0|||
131139478|NCT00546364|472138024|FG002|Overall Study|Sponsor decision|1|||
131139479|NCT03064763|472138025|FG000|Overall Study|Lost to Follow-up|1|||
131139480|NCT03064763|472138025|FG000|Overall Study|Death|8|||
131139481|NCT03786432|472138026|FG000|Overall Study|Screen Failure after consent|1|||
131139482|NCT03786432|472138026|FG000|Overall Study|Lost to Follow-up|4|||
131139483|NCT03786432|472138026|FG000|Overall Study|did not complete 12 month CT scan|1|||
131139484|NCT03160560|472138029|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
131139485|NCT03160560|472138030|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131139486|NCT03160560|472138031|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131139487|NCT03160560|472138032|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
131139488|NCT03160560|472138029|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
131139489|NCT03160560|472138030|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
131139490|NCT03160560|472138031|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
131139491|NCT03160560|472138032|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
131139492|NCT00667576|472138034|FG000|Overall Study|Withdrawal by Subject|1|||
131139493|NCT00667576|472138035|FG001|Overall Study|Withdrawal by Subject|0|||
131139494|NCT00667576|472138036|FG002|Overall Study|Withdrawal by Subject|1|||
131139495|NCT00667576|472138037|FG003|Overall Study|Withdrawal by Subject|1|||
131139496|NCT00667576|472138038|FG004|Overall Study|Withdrawal by Subject|1|||
131139497|NCT00667576|472138034|FG000|Overall Study|Adverse Event|1|||
131139498|NCT00667576|472138035|FG001|Overall Study|Adverse Event|1|||
131139499|NCT00667576|472138036|FG002|Overall Study|Adverse Event|0|||
131139500|NCT00667576|472138037|FG003|Overall Study|Adverse Event|0|||
131139501|NCT00667576|472138038|FG004|Overall Study|Adverse Event|0|||
131139502|NCT00667576|472138034|FG000|Overall Study|Lost to Follow-up|0|||
131139503|NCT00667576|472138035|FG001|Overall Study|Lost to Follow-up|0|||
131139504|NCT00667576|472138036|FG002|Overall Study|Lost to Follow-up|1|||
131139505|NCT00667576|472138037|FG003|Overall Study|Lost to Follow-up|0|||
131139506|NCT00667576|472138038|FG004|Overall Study|Lost to Follow-up|0|||
131139507|NCT00667576|472138034|FG000|Overall Study|Protocol Violation|0|||
131139508|NCT00667576|472138035|FG001|Overall Study|Protocol Violation|0|||
131139509|NCT00667576|472138036|FG002|Overall Study|Protocol Violation|0|||
131139510|NCT00667576|472138037|FG003|Overall Study|Protocol Violation|1|||
131139511|NCT00667576|472138038|FG004|Overall Study|Protocol Violation|0|||
131139512|NCT00667576|472138034|FG000|Overall Study|Physician Decision|0|||
131139513|NCT00667576|472138035|FG001|Overall Study|Physician Decision|0|||
131139514|NCT00667576|472138036|FG002|Overall Study|Physician Decision|0|||
131139515|NCT00667576|472138037|FG003|Overall Study|Physician Decision|1|||
131139516|NCT00667576|472138038|FG004|Overall Study|Physician Decision|0|||
131139517|NCT00667576|472138034|FG000|Overall Study|Missed Visit|0|||
131139518|NCT00667576|472138035|FG001|Overall Study|Missed Visit|0|||
131139519|NCT00667576|472138036|FG002|Overall Study|Missed Visit|0|||
131139520|NCT00667576|472138037|FG003|Overall Study|Missed Visit|1|||
131139521|NCT00667576|472138038|FG004|Overall Study|Missed Visit|0|||
131139522|NCT03968419|472138039|FG000|Treatment Period|Adverse Event|0|||
131139523|NCT03968419|472138040|FG001|Treatment Period|Adverse Event|0|||
131139524|NCT03968419|472138041|FG002|Treatment Period|Adverse Event|1|||
131139525|NCT03968419|472138039|FG000|Safety Follow-up Period|Death|3|||
131139526|NCT03968419|472138040|FG001|Safety Follow-up Period|Death|2|||
131139527|NCT03968419|472138041|FG002|Safety Follow-up Period|Death|1|||
131139528|NCT03968419|472138039|FG000|Safety Follow-up Period|Subject Decision|2|||
131139529|NCT03968419|472138040|FG001|Safety Follow-up Period|Subject Decision|1|||
131139530|NCT03968419|472138041|FG002|Safety Follow-up Period|Subject Decision|0|||
131139531|NCT01390389|472138042|FG000|Overall Study|Withdrawal by Subject|2|||
131139532|NCT01390389|472138043|FG001|Overall Study|Withdrawal by Subject|0|||
131139533|NCT01390389|472138042|FG000|Overall Study|Screen Fail|2|||
131139534|NCT01390389|472138043|FG001|Overall Study|Screen Fail|1|||
131139535|NCT02002975|472138044|FG000|Overall Study|Case Report Forms Uncollected|135|||
131139536|NCT02002975|472138044|FG000|Overall Study|Protocol Deviation|437|||
131139537|NCT01430442|472138047|FG000|Overall Study|Subject Withdrew Consent|3|||
131139538|NCT01430442|472138048|FG001|Overall Study|Subject Withdrew Consent|0|||
131139539|NCT01430442|472138049|FG002|Overall Study|Subject Withdrew Consent|1|||
131139540|NCT01430442|472138050|FG003|Overall Study|Subject Withdrew Consent|0|||
131139541|NCT01430442|472138051|FG004|Overall Study|Subject Withdrew Consent|2|||
131139542|NCT01430442|472138052|FG005|Overall Study|Subject Withdrew Consent|1|||
131139543|NCT01430442|472138053|FG006|Overall Study|Subject Withdrew Consent|5|||
131139544|NCT01430442|472138054|FG007|Overall Study|Subject Withdrew Consent|2|||
131139545|NCT01430442|472138047|FG000|Overall Study|Lost to Follow-up|2|||
131078085|NCT01263925|471918599|FG000|Overall Study|Withdrawal/ Not specified|0|||
131078086|NCT01263925|471918600|FG001|Overall Study|Withdrawal/ Not specified|1|||
131078087|NCT01726517|471918604|FG000|Overall Study|Withdrawal by Subject|0|||
131078088|NCT01726517|471918605|FG001|Overall Study|Withdrawal by Subject|0|||
131078089|NCT01726517|471918606|FG002|Overall Study|Withdrawal by Subject|1|||
131078090|NCT01726517|471918607|FG003|Overall Study|Withdrawal by Subject|0|||
131078091|NCT01726517|471918608|FG004|Overall Study|Withdrawal by Subject|0|||
131078092|NCT00573651|471918609|FG000|Overall Study|Lost to Follow-up|3|||
131078093|NCT00573651|471918609|FG000|Overall Study|Withdrawal by Subject|1|||
131078094|NCT03448536|471918611|FG000|Overall Study|Protocol Violation|2|||
131078095|NCT03448536|471918612|FG001|Overall Study|Protocol Violation|0|||
131078096|NCT03448536|471918611|FG000|Overall Study|Pregnancy|1|||
131078097|NCT03448536|471918612|FG001|Overall Study|Pregnancy|0|||
131078098|NCT03448536|471918611|FG000|Overall Study|Withdrawal by Subject|1|||
131078099|NCT03448536|471918612|FG001|Overall Study|Withdrawal by Subject|2|||
130726082|NCT02960490|470621166|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726083|NCT02960490|470621167|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726084|NCT02960490|470621168|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726085|NCT02960490|470621169|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726086|NCT02960490|470621170|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726087|NCT02960490|470621171|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726088|NCT02960490|470621172|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
130726089|NCT02960490|470621173|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726090|NCT02960490|470621174|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
130726091|NCT01307111|470621179|FG000|IUD Insertion|Lost to Follow-up|2|||
130726092|NCT01307111|470621180|FG001|IUD Insertion|Lost to Follow-up|0|||
130726093|NCT01307111|470621179|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
130726094|NCT01307111|470621180|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
130726095|NCT01333397|470621181|FG000|Overall Study|Lost to Follow-up|1|||
130726096|NCT01333397|470621182|FG001|Overall Study|Lost to Follow-up|0|||
130726097|NCT01333397|470621183|FG002|Overall Study|Lost to Follow-up|0|||
130726098|NCT01333397|470621184|FG003|Overall Study|Lost to Follow-up|1|||
130726099|NCT01333397|470621185|FG004|Overall Study|Lost to Follow-up|0|||
130726100|NCT01085357|470621186|FG000|Overall Study|Adverse Event|1|||
130726101|NCT01085357|470621187|FG001|Overall Study|Adverse Event|1|||
130726102|NCT01085357|470621186|FG000|Overall Study|Subject Decision|4|||
130726103|NCT01085357|470621187|FG001|Overall Study|Subject Decision|3|||
130726104|NCT01085357|470621186|FG000|Overall Study|Investigator Decision|1|||
130726105|NCT01085357|470621187|FG001|Overall Study|Investigator Decision|1|||
130726106|NCT01085357|470621186|FG000|Overall Study|Death|11|||
130726107|NCT01085357|470621187|FG001|Overall Study|Death|1|||
130726108|NCT01085357|470621186|FG000|Overall Study|Lost to Follow-up|2|||
130726109|NCT01085357|470621187|FG001|Overall Study|Lost to Follow-up|0|||
130726110|NCT00920790|470621195|FG000|Overall Study|aggravation of general condition|14|||
130726111|NCT02892149|470621196|FG000|Overall Study|Death|262|||
130726112|NCT02892149|470621197|FG001|Overall Study|Death|278|||
130726113|NCT02892149|470621196|FG000|Overall Study|Withdrawal by Subject|53|||
130726114|NCT02892149|470621197|FG001|Overall Study|Withdrawal by Subject|47|||
130726115|NCT02892149|470621196|FG000|Overall Study|Lost to Follow-up|37|||
130726116|NCT02892149|470621197|FG001|Overall Study|Lost to Follow-up|31|||
130726117|NCT00478426|470621202|FG000|Overall Study|Withdrawal by Subject|1|||
130726118|NCT00384930|470621203|FG000|Overall Study|Adverse Event|5|||
130726119|NCT00384930|470621204|FG001|Overall Study|Adverse Event|4|||
130726120|NCT00384930|470621205|FG002|Overall Study|Adverse Event|12|||
130726121|NCT00384930|470621206|FG003|Overall Study|Adverse Event|11|||
130726122|NCT00384930|470621207|FG004|Overall Study|Adverse Event|14|||
130726123|NCT00384930|470621203|FG000|Overall Study|Entry Criteria Not Met|2|||
130726124|NCT00384930|470621204|FG001|Overall Study|Entry Criteria Not Met|6|||
130726125|NCT00384930|470621205|FG002|Overall Study|Entry Criteria Not Met|7|||
130726126|NCT00384930|470621206|FG003|Overall Study|Entry Criteria Not Met|8|||
130726127|NCT00384930|470621207|FG004|Overall Study|Entry Criteria Not Met|4|||
130726128|NCT00384930|470621203|FG000|Overall Study|Lack of Efficacy|1|||
130726129|NCT00384930|470621204|FG001|Overall Study|Lack of Efficacy|1|||
130726130|NCT00384930|470621205|FG002|Overall Study|Lack of Efficacy|2|||
130726131|NCT00384930|470621206|FG003|Overall Study|Lack of Efficacy|1|||
130726132|NCT00384930|470621207|FG004|Overall Study|Lack of Efficacy|2|||
130726133|NCT00384930|470621203|FG000|Overall Study|Lost to Follow-up|5|||
130726134|NCT00384930|470621204|FG001|Overall Study|Lost to Follow-up|3|||
130726135|NCT00384930|470621205|FG002|Overall Study|Lost to Follow-up|0|||
131078100|NCT03448536|471918611|FG000|Overall Study|Lost to Follow-up|3|||
131078101|NCT03448536|471918612|FG001|Overall Study|Lost to Follow-up|2|||
131078102|NCT03448536|471918611|FG000|Overall Study|Inadequate pain reporter|1|||
131078103|NCT03448536|471918612|FG001|Overall Study|Inadequate pain reporter|0|||
131078104|NCT03448536|471918611|FG000|Overall Study|Other|3|||
131078105|NCT03448536|471918612|FG001|Overall Study|Other|0|||
130726136|NCT00384930|470621206|FG003|Overall Study|Lost to Follow-up|4|||
130726137|NCT00384930|470621207|FG004|Overall Study|Lost to Follow-up|6|||
130726138|NCT00384930|470621203|FG000|Overall Study|Physician Decision|0|||
131139546|NCT01430442|472138048|FG001|Overall Study|Lost to Follow-up|0|||
131139547|NCT01430442|472138049|FG002|Overall Study|Lost to Follow-up|1|||
131139548|NCT01430442|472138050|FG003|Overall Study|Lost to Follow-up|2|||
131139549|NCT01430442|472138051|FG004|Overall Study|Lost to Follow-up|2|||
131139550|NCT01430442|472138052|FG005|Overall Study|Lost to Follow-up|1|||
131139551|NCT01430442|472138053|FG006|Overall Study|Lost to Follow-up|5|||
131139552|NCT01430442|472138054|FG007|Overall Study|Lost to Follow-up|1|||
131139553|NCT01430442|472138047|FG000|Overall Study|Pregnancy|1|||
131139554|NCT01430442|472138048|FG001|Overall Study|Pregnancy|0|||
131139555|NCT01430442|472138049|FG002|Overall Study|Pregnancy|0|||
131139556|NCT01430442|472138050|FG003|Overall Study|Pregnancy|0|||
131139557|NCT01430442|472138051|FG004|Overall Study|Pregnancy|0|||
131139558|NCT01430442|472138052|FG005|Overall Study|Pregnancy|1|||
131139559|NCT01430442|472138053|FG006|Overall Study|Pregnancy|0|||
131139560|NCT01430442|472138054|FG007|Overall Study|Pregnancy|0|||
131139561|NCT01430442|472138047|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
131139562|NCT01430442|472138048|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
131139563|NCT01430442|472138049|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
131139564|NCT01430442|472138050|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
131139565|NCT01430442|472138051|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
131139566|NCT01430442|472138052|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
131139567|NCT01430442|472138053|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
131139568|NCT01430442|472138054|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
131139569|NCT01641939|472138055|FG000|Overall Study|Death|90|||
131139570|NCT01641939|472138056|FG001|Overall Study|Death|187|||
131139571|NCT01641939|472138057|FG002|Overall Study|Death|61|||
131139572|NCT01641939|472138055|FG000|Overall Study|Lost to Follow-up|3|||
131139573|NCT01641939|472138056|FG001|Overall Study|Lost to Follow-up|2|||
131139574|NCT01641939|472138057|FG002|Overall Study|Lost to Follow-up|1|||
131139575|NCT01641939|472138055|FG000|Overall Study|Withdrawal by Subject|14|||
131139576|NCT01641939|472138056|FG001|Overall Study|Withdrawal by Subject|11|||
131139577|NCT01641939|472138057|FG002|Overall Study|Withdrawal by Subject|5|||
131139578|NCT01641939|472138055|FG000|Overall Study|Study Terminated by Sponsor|10|||
131139579|NCT01641939|472138056|FG001|Overall Study|Study Terminated by Sponsor|28|||
131139580|NCT01641939|472138057|FG002|Overall Study|Study Terminated by Sponsor|3|||
131139581|NCT00804687|472138061|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
131139582|NCT00804687|472138062|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
131139583|NCT00804687|472138063|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
131139584|NCT00804687|472138064|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
131139585|NCT00804687|472138065|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
131139586|NCT00804687|472138066|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
131139587|NCT00804687|472138061|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
131139588|NCT00804687|472138062|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
131139589|NCT00804687|472138063|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
130726139|NCT00384930|470621204|FG001|Overall Study|Physician Decision|1|||
130726140|NCT00384930|470621205|FG002|Overall Study|Physician Decision|1|||
130726141|NCT00384930|470621206|FG003|Overall Study|Physician Decision|0|||
131078106|NCT03448536|471918611|FG000|Overall Study|Physician Decision|1|||
131078107|NCT03448536|471918612|FG001|Overall Study|Physician Decision|0|||
131078108|NCT01024036|471918635|FG000|Blinded Treatment|Adverse Event|1|||
131078109|NCT01024036|471918636|FG001|Blinded Treatment|Adverse Event|1|||
131078110|NCT01024036|471918635|FG000|Blinded Treatment|Lack of Efficacy|16|||
131078111|NCT01024036|471918636|FG001|Blinded Treatment|Lack of Efficacy|14|||
131078112|NCT01024036|471918635|FG000|Blinded Treatment|Physician Decision|1|||
131078113|NCT01024036|471918636|FG001|Blinded Treatment|Physician Decision|0|||
131078114|NCT01024036|471918635|FG000|Blinded Treatment|Death|0|||
131078115|NCT01024036|471918636|FG001|Blinded Treatment|Death|2|||
131078116|NCT01024036|471918635|FG000|Blinded Treatment|Withdrawal by Subject|4|||
131078117|NCT01024036|471918636|FG001|Blinded Treatment|Withdrawal by Subject|3|||
131078118|NCT01024036|471918635|FG000|Unblinded Treatment|Adverse Event|0|||
131139590|NCT00804687|472138064|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
131139591|NCT00804687|472138065|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
131139592|NCT00804687|472138066|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
131139593|NCT00804687|472138061|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
131139594|NCT00804687|472138062|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
131139595|NCT00804687|472138063|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
131139596|NCT00804687|472138064|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
131139597|NCT00804687|472138065|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
131078119|NCT01024036|471918636|FG001|Unblinded Treatment|Adverse Event|1|||
131139598|NCT00804687|472138066|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
131139599|NCT00804687|472138061|FG000|Period 5: Treatment Period|Positive drug test|1|||
131139600|NCT00804687|472138062|FG001|Period 5: Treatment Period|Positive drug test|0|||
131078120|NCT01024036|471918635|FG000|Unblinded Treatment|Lack of Efficacy|0|||
131078121|NCT01024036|471918636|FG001|Unblinded Treatment|Lack of Efficacy|2|||
130726142|NCT00384930|470621207|FG004|Overall Study|Physician Decision|1|||
131078122|NCT01024036|471918635|FG000|Follow-Up Period|Lost to Follow-up|1|||
131078123|NCT01024036|471918636|FG001|Follow-Up Period|Lost to Follow-up|1|||
131078124|NCT01024036|471918635|FG000|Follow-Up Period|Withdrawal by Subject|0|||
131078125|NCT01024036|471918636|FG001|Follow-Up Period|Withdrawal by Subject|1|||
131078126|NCT01024036|471918635|FG000|Follow-Up Period|Adverse Event|4|||
131078127|NCT01024036|471918636|FG001|Follow-Up Period|Adverse Event|1|||
131078128|NCT00474383|471918638|FG000|Main Study|Adverse Event|11|||
131078129|NCT00474383|471918639|FG001|Main Study|Adverse Event|0|||
131078130|NCT00474383|471918638|FG000|Main Study|Symptomatic Deterioration|1|||
131078131|NCT00474383|471918639|FG001|Main Study|Symptomatic Deterioration|0|||
131078132|NCT00474383|471918638|FG000|Main Study|Progressive Disease|23|||
131078133|NCT00474383|471918639|FG001|Main Study|Progressive Disease|0|||
131078134|NCT00474383|471918638|FG000|Main Study|Other|1|||
131078135|NCT00474383|471918639|FG001|Main Study|Other|0|||
131078136|NCT00474383|471918638|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
131078137|NCT00474383|471918639|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
131078138|NCT00474383|471918638|FG000|Extension|Progressive Disease|0|||
131078139|NCT00474383|471918639|FG001|Extension|Progressive Disease|5|||
131078140|NCT02998918|471918640|FG000|Overall Study|Withdrawal by Subject|1|||
131078141|NCT02998918|471918641|FG001|Overall Study|Withdrawal by Subject|0|||
131078142|NCT00443599|471918649|FG000|Overall Study|Physician Decision|2|||
131078143|NCT00443599|471918650|FG001|Overall Study|Physician Decision|1|||
131078144|NCT00443599|471918649|FG000|Overall Study|Death|1|||
131078145|NCT00443599|471918650|FG001|Overall Study|Death|1|||
131078146|NCT00443599|471918649|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
131078147|NCT00443599|471918650|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
131078148|NCT00497874|471920371|FG000|Overall Study|Withdrawal by Subject|48|||
131078149|NCT00497874|471920372|FG001|Overall Study|Withdrawal by Subject|17|||
131078150|NCT00497874|471920371|FG000|Overall Study|Illness|8|||
131078151|NCT00497874|471920372|FG001|Overall Study|Illness|4|||
131078152|NCT00497874|471920371|FG000|Overall Study|Death|2|||
131078153|NCT00497874|471920372|FG001|Overall Study|Death|4|||
131078154|NCT00497874|471920371|FG000|Overall Study|Unable to contact|52|||
131078155|NCT00497874|471920372|FG001|Overall Study|Unable to contact|67|||
131078156|NCT00497874|471920371|FG000|Overall Study|Unable to schedule|37|||
131078157|NCT00497874|471920372|FG001|Overall Study|Unable to schedule|24|||
131078158|NCT01999972|471920373|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
131078159|NCT01999972|471920374|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
131078160|NCT01999972|471920375|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
131078161|NCT01999972|471920376|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
131078162|NCT01999972|471920377|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
131078163|NCT01999972|471920378|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
131078164|NCT01999972|471920373|FG000|Dose Escalation Part|Death|0|||
131078165|NCT01999972|471920374|FG001|Dose Escalation Part|Death|1|||
131078166|NCT01999972|471920375|FG002|Dose Escalation Part|Death|0|||
131078167|NCT01999972|471920376|FG003|Dose Escalation Part|Death|0|||
131078168|NCT01999972|471920377|FG004|Dose Escalation Part|Death|0|||
131078169|NCT01999972|471920378|FG005|Dose Escalation Part|Death|0|||
131078170|NCT01999972|471920373|FG000|Dose Escalation Part|Enrolled but not treated|0|||
131078171|NCT01999972|471920374|FG001|Dose Escalation Part|Enrolled but not treated|0|||
131078172|NCT01999972|471920375|FG002|Dose Escalation Part|Enrolled but not treated|1|||
131078173|NCT01999972|471920376|FG003|Dose Escalation Part|Enrolled but not treated|1|||
131078174|NCT01999972|471920377|FG004|Dose Escalation Part|Enrolled but not treated|0|||
131078175|NCT01999972|471920378|FG005|Dose Escalation Part|Enrolled but not treated|0|||
131078176|NCT01999972|471920373|FG000|Dose Escalation Part|Disease progression|3|||
131078177|NCT01999972|471920374|FG001|Dose Escalation Part|Disease progression|2|||
131078178|NCT01999972|471920375|FG002|Dose Escalation Part|Disease progression|3|||
131078179|NCT01999972|471920376|FG003|Dose Escalation Part|Disease progression|6|||
131078180|NCT01999972|471920377|FG004|Dose Escalation Part|Disease progression|0|||
131078181|NCT01999972|471920378|FG005|Dose Escalation Part|Disease progression|0|||
131078182|NCT01999972|471920373|FG000|Dose Escalation Part|Adverse Event|0|||
131078183|NCT01999972|471920374|FG001|Dose Escalation Part|Adverse Event|0|||
131078184|NCT01999972|471920375|FG002|Dose Escalation Part|Adverse Event|0|||
131078185|NCT01999972|471920376|FG003|Dose Escalation Part|Adverse Event|2|||
131078186|NCT01999972|471920377|FG004|Dose Escalation Part|Adverse Event|0|||
131078187|NCT01999972|471920378|FG005|Dose Escalation Part|Adverse Event|0|||
131078188|NCT01999972|471920373|FG000|Dose Escalation Part|Global deterioration of health status|1|||
131078189|NCT01999972|471920374|FG001|Dose Escalation Part|Global deterioration of health status|0|||
131078190|NCT01999972|471920375|FG002|Dose Escalation Part|Global deterioration of health status|0|||
131078191|NCT01999972|471920376|FG003|Dose Escalation Part|Global deterioration of health status|1|||
131139601|NCT00804687|472138063|FG002|Period 5: Treatment Period|Positive drug test|0|||
131139602|NCT00804687|472138064|FG003|Period 5: Treatment Period|Positive drug test|0|||
131139603|NCT00804687|472138065|FG004|Period 5: Treatment Period|Positive drug test|0|||
131139604|NCT00804687|472138066|FG005|Period 5: Treatment Period|Positive drug test|0|||
131139605|NCT03068325|472138067|FG000|Overall Study|Lost to Follow-up|5|||
131078192|NCT01999972|471920377|FG004|Dose Escalation Part|Global deterioration of health status|0|||
131078193|NCT01999972|471920378|FG005|Dose Escalation Part|Global deterioration of health status|0|||
131078194|NCT01999972|471920373|FG000|Dose Expansion Part|Death|0|||
131078195|NCT01999972|471920374|FG001|Dose Expansion Part|Death|0|||
131078196|NCT01999972|471920375|FG002|Dose Expansion Part|Death|0|||
131078197|NCT01999972|471920376|FG003|Dose Expansion Part|Death|0|||
131078198|NCT01999972|471920377|FG004|Dose Expansion Part|Death|2|||
131078199|NCT01999972|471920378|FG005|Dose Expansion Part|Death|1|||
131078200|NCT01999972|471920373|FG000|Dose Expansion Part|Disease progression|0|||
131078201|NCT01999972|471920374|FG001|Dose Expansion Part|Disease progression|0|||
131078202|NCT01999972|471920375|FG002|Dose Expansion Part|Disease progression|0|||
131078203|NCT01999972|471920376|FG003|Dose Expansion Part|Disease progression|0|||
131078204|NCT01999972|471920377|FG004|Dose Expansion Part|Disease progression|9|||
131078205|NCT01999972|471920378|FG005|Dose Expansion Part|Disease progression|3|||
131078206|NCT01999972|471920373|FG000|Dose Expansion Part|Sponsor decision|0|||
131078207|NCT01999972|471920374|FG001|Dose Expansion Part|Sponsor decision|0|||
131078208|NCT01999972|471920375|FG002|Dose Expansion Part|Sponsor decision|0|||
131078209|NCT01999972|471920376|FG003|Dose Expansion Part|Sponsor decision|0|||
131078210|NCT01999972|471920377|FG004|Dose Expansion Part|Sponsor decision|1|||
131078211|NCT01999972|471920378|FG005|Dose Expansion Part|Sponsor decision|0|||
131078212|NCT01999972|471920373|FG000|Dose Expansion Part|Adverse Event|0|||
131078213|NCT01999972|471920374|FG001|Dose Expansion Part|Adverse Event|0|||
131078214|NCT01999972|471920375|FG002|Dose Expansion Part|Adverse Event|0|||
131078215|NCT01999972|471920376|FG003|Dose Expansion Part|Adverse Event|0|||
131078216|NCT01999972|471920377|FG004|Dose Expansion Part|Adverse Event|4|||
131078217|NCT01999972|471920378|FG005|Dose Expansion Part|Adverse Event|2|||
131078218|NCT01999972|471920373|FG000|Dose Expansion Part|Participant's non-compliance|0|||
131078219|NCT01999972|471920374|FG001|Dose Expansion Part|Participant's non-compliance|0|||
131078220|NCT01999972|471920375|FG002|Dose Expansion Part|Participant's non-compliance|0|||
131078221|NCT01999972|471920376|FG003|Dose Expansion Part|Participant's non-compliance|0|||
131078222|NCT01999972|471920377|FG004|Dose Expansion Part|Participant's non-compliance|0|||
131078223|NCT01999972|471920378|FG005|Dose Expansion Part|Participant's non-compliance|1|||
131078224|NCT01999972|471920373|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
131078225|NCT01999972|471920374|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
131078226|NCT01999972|471920375|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
131078227|NCT01999972|471920376|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
131078228|NCT01999972|471920377|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
131078229|NCT01999972|471920378|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
131078230|NCT01999972|471920373|FG000|Dose Expansion Part|Changed to standard of care|0|||
131078231|NCT01999972|471920374|FG001|Dose Expansion Part|Changed to standard of care|0|||
131078232|NCT01999972|471920375|FG002|Dose Expansion Part|Changed to standard of care|0|||
131139606|NCT04093531|472138074|FG000|Overall Study|failed screening|4|||
131139607|NCT00272987|472138081|FG000|Overall Study|Adverse Event|1|||
131139608|NCT00272987|472138082|FG001|Overall Study|Adverse Event|0|||
131139609|NCT00272987|472138083|FG002|Overall Study|Adverse Event|0|||
131139610|NCT00272987|472138081|FG000|Overall Study|Lost to Follow-up|3|||
131139611|NCT00272987|472138082|FG001|Overall Study|Lost to Follow-up|1|||
131139612|NCT00272987|472138083|FG002|Overall Study|Lost to Follow-up|1|||
131139613|NCT00272987|472138081|FG000|Overall Study|Withdrawal by Subject|1|||
131139614|NCT00272987|472138082|FG001|Overall Study|Withdrawal by Subject|0|||
131139615|NCT00272987|472138083|FG002|Overall Study|Withdrawal by Subject|3|||
131139616|NCT00272987|472138081|FG000|Overall Study|Sponsor Terminated study|0|||
131139617|NCT00272987|472138082|FG001|Overall Study|Sponsor Terminated study|1|||
131139618|NCT00272987|472138083|FG002|Overall Study|Sponsor Terminated study|1|||
131139619|NCT00272987|472138081|FG000|Overall Study|Disease progression|1|||
130726143|NCT00384930|470621203|FG000|Overall Study|Protocol Violation|1|||
130726144|NCT00384930|470621204|FG001|Overall Study|Protocol Violation|0|||
130726145|NCT00384930|470621205|FG002|Overall Study|Protocol Violation|1|||
130726146|NCT00384930|470621206|FG003|Overall Study|Protocol Violation|6|||
130726147|NCT00384930|470621207|FG004|Overall Study|Protocol Violation|4|||
130726148|NCT00384930|470621203|FG000|Overall Study|Sponsor Decision|3|||
130726149|NCT00384930|470621204|FG001|Overall Study|Sponsor Decision|4|||
130726150|NCT00384930|470621205|FG002|Overall Study|Sponsor Decision|0|||
130726151|NCT00384930|470621206|FG003|Overall Study|Sponsor Decision|5|||
130726152|NCT00384930|470621207|FG004|Overall Study|Sponsor Decision|0|||
130726153|NCT00384930|470621203|FG000|Overall Study|Withdrawal by Subject|9|||
130726154|NCT00384930|470621204|FG001|Overall Study|Withdrawal by Subject|7|||
130726155|NCT00384930|470621205|FG002|Overall Study|Withdrawal by Subject|7|||
130726156|NCT00384930|470621206|FG003|Overall Study|Withdrawal by Subject|6|||
130726157|NCT00384930|470621207|FG004|Overall Study|Withdrawal by Subject|16|||
130726158|NCT00384930|470621203|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
130726159|NCT00384930|470621204|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
131078233|NCT01999972|471920376|FG003|Dose Expansion Part|Changed to standard of care|0|||
131078234|NCT01999972|471920377|FG004|Dose Expansion Part|Changed to standard of care|1|||
130726160|NCT00384930|470621205|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
131078235|NCT01999972|471920378|FG005|Dose Expansion Part|Changed to standard of care|0|||
131078236|NCT01986114|471920379|FG000|Overall Study|Adverse Event|59|||
131078237|NCT01986114|471920379|FG000|Overall Study|Lack of Efficacy|23|||
131078238|NCT01986114|471920379|FG000|Overall Study|Withdrawal by Subject|58|||
131078239|NCT01986114|471920379|FG000|Overall Study|Noncompliance|3|||
131078240|NCT01986114|471920379|FG000|Overall Study|Protocol Violation|1|||
131078241|NCT01986114|471920379|FG000|Overall Study|Lost to Follow-up|5|||
131078242|NCT01986114|471920379|FG000|Overall Study|Other reason|7|||
131078243|NCT00030823|471920382|FG000|Overall Study|Withdrawal by Subject|1|||
131078244|NCT00891046|471920383|FG000|Overall Study|Protocol Violation|1|||
131078245|NCT00891046|471920384|FG001|Overall Study|Protocol Violation|1|||
131078246|NCT00891046|471920385|FG002|Overall Study|Protocol Violation|0|||
131078247|NCT00891046|471920386|FG003|Overall Study|Protocol Violation|0|||
131078248|NCT00891046|471920387|FG004|Overall Study|Protocol Violation|1|||
131078249|NCT00891046|471920383|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
131078250|NCT00891046|471920384|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131078251|NCT00891046|471920385|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
131078252|NCT00891046|471920386|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
131078253|NCT00891046|471920387|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
131078254|NCT00891046|471920383|FG000|Overall Study|Administrative problems|0|||
131078255|NCT00891046|471920384|FG001|Overall Study|Administrative problems|0|||
131078256|NCT00891046|471920385|FG002|Overall Study|Administrative problems|0|||
131078257|NCT00891046|471920386|FG003|Overall Study|Administrative problems|0|||
131078258|NCT00891046|471920387|FG004|Overall Study|Administrative problems|1|||
131078259|NCT00891046|471920383|FG000|Overall Study|Participant no longer required drug|0|||
131078260|NCT00891046|471920384|FG001|Overall Study|Participant no longer required drug|2|||
131078261|NCT00891046|471920385|FG002|Overall Study|Participant no longer required drug|0|||
131078262|NCT00891046|471920386|FG003|Overall Study|Participant no longer required drug|0|||
131078263|NCT00891046|471920387|FG004|Overall Study|Participant no longer required drug|1|||
131078264|NCT00891046|471920383|FG000|Overall Study|Adverse Event|4|||
131078265|NCT00891046|471920384|FG001|Overall Study|Adverse Event|3|||
131078266|NCT00891046|471920385|FG002|Overall Study|Adverse Event|2|||
131078267|NCT00891046|471920386|FG003|Overall Study|Adverse Event|0|||
131078268|NCT00891046|471920387|FG004|Overall Study|Adverse Event|14|||
131078269|NCT00891046|471920383|FG000|Overall Study|Withdrawal by Subject|2|||
130726161|NCT00384930|470621206|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
130726162|NCT00384930|470621207|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
130726163|NCT02752087|470621208|FG000|Washout|Physician Decision|1|||
130726164|NCT02752087|470621209|FG001|Washout|Physician Decision|0|||
130726165|NCT00863772|470621210|FG000|Overall Study|Adverse Event|1|||
130726166|NCT00863772|470621211|FG001|Overall Study|Adverse Event|4|||
130726167|NCT00863772|470621212|FG002|Overall Study|Adverse Event|0|||
130726168|NCT00863772|470621210|FG000|Overall Study|Lack of Efficacy|4|||
130726169|NCT00863772|470621211|FG001|Overall Study|Lack of Efficacy|2|||
130726170|NCT00863772|470621212|FG002|Overall Study|Lack of Efficacy|4|||
130726171|NCT00863772|470621210|FG000|Overall Study|Lost to Follow-up|5|||
130726172|NCT00863772|470621211|FG001|Overall Study|Lost to Follow-up|1|||
130726173|NCT00863772|470621212|FG002|Overall Study|Lost to Follow-up|1|||
130726174|NCT00863772|470621210|FG000|Overall Study|Protocol Violation|2|||
130726175|NCT00863772|470621211|FG001|Overall Study|Protocol Violation|0|||
130726176|NCT00863772|470621212|FG002|Overall Study|Protocol Violation|2|||
130726177|NCT00863772|470621210|FG000|Overall Study|Withdrawal by Subject|4|||
130726178|NCT00863772|470621211|FG001|Overall Study|Withdrawal by Subject|7|||
130726179|NCT00863772|470621212|FG002|Overall Study|Withdrawal by Subject|5|||
130726180|NCT00863772|470621210|FG000|Overall Study|Study terminated by sponsor|44|||
130726181|NCT00863772|470621211|FG001|Overall Study|Study terminated by sponsor|45|||
130726182|NCT00863772|470621212|FG002|Overall Study|Study terminated by sponsor|36|||
130726183|NCT00863772|470621210|FG000|Overall Study|Entered extension study|6|||
130726184|NCT00863772|470621211|FG001|Overall Study|Entered extension study|4|||
130726185|NCT00863772|470621212|FG002|Overall Study|Entered extension study|9|||
130726186|NCT00863772|470621210|FG000|Overall Study|Other|1|||
130726187|NCT00863772|470621211|FG001|Overall Study|Other|2|||
130726188|NCT00863772|470621212|FG002|Overall Study|Other|4|||
130726189|NCT00863772|470621210|FG000|Overall Study|Randomized but not Treated|1|||
130726190|NCT00863772|470621211|FG001|Overall Study|Randomized but not Treated|0|||
130726191|NCT00863772|470621212|FG002|Overall Study|Randomized but not Treated|0|||
131078270|NCT00891046|471920384|FG001|Overall Study|Withdrawal by Subject|1|||
130726192|NCT02728843|470621213|FG000|Overall Study|Adverse Event|0|||
130726193|NCT02728843|470621214|FG001|Overall Study|Adverse Event|2|||
130726194|NCT02728843|470621215|FG002|Overall Study|Adverse Event|3|||
131078271|NCT00891046|471920385|FG002|Overall Study|Withdrawal by Subject|2|||
131078272|NCT00891046|471920386|FG003|Overall Study|Withdrawal by Subject|1|||
131078273|NCT00891046|471920387|FG004|Overall Study|Withdrawal by Subject|1|||
131078274|NCT00891046|471920383|FG000|Overall Study|Lost to Follow-up|0|||
131078275|NCT00891046|471920384|FG001|Overall Study|Lost to Follow-up|0|||
131078276|NCT00891046|471920385|FG002|Overall Study|Lost to Follow-up|0|||
131078277|NCT00891046|471920386|FG003|Overall Study|Lost to Follow-up|0|||
131078278|NCT00891046|471920387|FG004|Overall Study|Lost to Follow-up|1|||
131078279|NCT03113383|471920390|FG000|Overall Study|Death|4|||
131078280|NCT03113383|471920391|FG001|Overall Study|Death|0|||
131078281|NCT03568812|471920393|FG000|Overall Study|Physician Decision|0|||
131078282|NCT03568812|471920394|FG001|Overall Study|Physician Decision|1|||
131078283|NCT01010204|471920397|FG000|Overall Study|Lost to Follow-up|2|||
131078284|NCT01010204|471920398|FG001|Overall Study|Lost to Follow-up|2|||
131078285|NCT01010204|471920397|FG000|Overall Study|Adverse Event|1|||
131078286|NCT01010204|471920398|FG001|Overall Study|Adverse Event|3|||
131078287|NCT01010204|471920397|FG000|Overall Study|Withdrawal by Subject|2|||
131078288|NCT01010204|471920398|FG001|Overall Study|Withdrawal by Subject|3|||
131078289|NCT01010204|471920397|FG000|Overall Study|psychiatric hospitalization|2|||
131078290|NCT01010204|471920398|FG001|Overall Study|psychiatric hospitalization|1|||
131078291|NCT02330562|471920399|FG000|Overall Study|Adverse Event|0|||
131078292|NCT02330562|471920400|FG001|Overall Study|Adverse Event|0|||
131078293|NCT02330562|471920401|FG002|Overall Study|Adverse Event|3|||
131078294|NCT02330562|471920402|FG003|Overall Study|Adverse Event|0|||
131078295|NCT02330562|471920403|FG004|Overall Study|Adverse Event|3|||
131078296|NCT02330562|471920404|FG005|Overall Study|Adverse Event|1|||
131078297|NCT02330562|471920405|FG006|Overall Study|Adverse Event|0|||
131078298|NCT02330562|471920406|FG007|Overall Study|Adverse Event|0|||
131078299|NCT02330562|471920407|FG008|Overall Study|Adverse Event|0|||
131078300|NCT02330562|471920408|FG009|Overall Study|Adverse Event|1|||
131078301|NCT02330562|471920409|FG010|Overall Study|Adverse Event|1|||
131078302|NCT02330562|471920399|FG000|Overall Study|Participant decision|1|||
131078303|NCT02330562|471920400|FG001|Overall Study|Participant decision|0|||
131231615|NCT04480463|472475168|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
131231616|NCT04480463|472475167|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
131231617|NCT04480463|472475168|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
131231618|NCT04480463|472475167|FG000|Overall Study|Other|6|||
131231619|NCT04480463|472475168|FG001|Overall Study|Other|4|||
131231620|NCT00444795|472475169|FG000|Overall Study|Not Treated|1|||
131231621|NCT00444795|472475169|FG000|Overall Study|Treated Prior to the Contract Date|2|||
131231622|NCT01579474|472475171|FG000|Overall Study|Adverse Event|1|||
131231623|NCT01579474|472475172|FG001|Overall Study|Adverse Event|13|||
131231624|NCT01579474|472475173|FG002|Overall Study|Adverse Event|2|||
131231625|NCT01579474|472475174|FG003|Overall Study|Adverse Event|0|||
131231626|NCT01579474|472475175|FG004|Overall Study|Adverse Event|0|||
131078304|NCT02330562|471920401|FG002|Overall Study|Participant decision|4|||
131231627|NCT01579474|472475176|FG005|Overall Study|Adverse Event|1|||
131231628|NCT01579474|472475171|FG000|Overall Study|Lack of Efficacy|1|||
131231629|NCT01579474|472475172|FG001|Overall Study|Lack of Efficacy|0|||
131231630|NCT01579474|472475173|FG002|Overall Study|Lack of Efficacy|0|||
131231631|NCT01579474|472475174|FG003|Overall Study|Lack of Efficacy|0|||
131231632|NCT01579474|472475175|FG004|Overall Study|Lack of Efficacy|1|||
131231633|NCT01579474|472475176|FG005|Overall Study|Lack of Efficacy|0|||
131231634|NCT01579474|472475171|FG000|Overall Study|Withdrawal by Subject|1|||
131231635|NCT01579474|472475172|FG001|Overall Study|Withdrawal by Subject|0|||
131231636|NCT01579474|472475173|FG002|Overall Study|Withdrawal by Subject|0|||
131231637|NCT01579474|472475174|FG003|Overall Study|Withdrawal by Subject|0|||
131231638|NCT01579474|472475175|FG004|Overall Study|Withdrawal by Subject|0|||
131231639|NCT01579474|472475176|FG005|Overall Study|Withdrawal by Subject|0|||
131231640|NCT02637076|472475177|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
131231641|NCT02637076|472475178|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
131231642|NCT02637076|472475177|FG000|Overall Study|Withdrawal by Subject|0|||
131231643|NCT02637076|472475178|FG001|Overall Study|Withdrawal by Subject|4|||
131231644|NCT00130520|472475179|FG000|Overall Study|Adverse Event|11|||
131231645|NCT00130520|472475179|FG000|Overall Study|Death|1|||
131231646|NCT00130520|472475179|FG000|Overall Study|Physician Decision|1|||
131231647|NCT00130520|472475179|FG000|Overall Study|Withdrawal by Subject|1|||
131231648|NCT00130520|472475179|FG000|Overall Study|Disease Progression|23|||
131231649|NCT00130520|472475179|FG000|Overall Study|Protocol non-compliance|1|||
131231650|NCT00130520|472475179|FG000|Overall Study|Did not meet re-treatment criteria|1|||
131231651|NCT03083483|472475181|FG000|Overall Study|Adverse Event|1|||
131231652|NCT03083483|472475182|FG001|Overall Study|Adverse Event|1|||
130726195|NCT02728843|470621216|FG003|Overall Study|Adverse Event|1|||
131078305|NCT02330562|471920402|FG003|Overall Study|Participant decision|1|||
131078306|NCT02330562|471920403|FG004|Overall Study|Participant decision|5|||
131078307|NCT02330562|471920404|FG005|Overall Study|Participant decision|2|||
131078308|NCT02330562|471920405|FG006|Overall Study|Participant decision|0|||
131078309|NCT02330562|471920406|FG007|Overall Study|Participant decision|0|||
131078310|NCT02330562|471920407|FG008|Overall Study|Participant decision|0|||
131078311|NCT02330562|471920408|FG009|Overall Study|Participant decision|3|||
131078312|NCT02330562|471920409|FG010|Overall Study|Participant decision|0|||
131078313|NCT02330562|471920399|FG000|Overall Study|Disease progression|5|||
130726196|NCT02728843|470621217|FG004|Overall Study|Adverse Event|2|||
130726197|NCT02728843|470621213|FG000|Overall Study|Lack of Efficacy|0|||
130726198|NCT02728843|470621214|FG001|Overall Study|Lack of Efficacy|1|||
130726199|NCT02728843|470621215|FG002|Overall Study|Lack of Efficacy|1|||
130726200|NCT02728843|470621216|FG003|Overall Study|Lack of Efficacy|0|||
130726201|NCT02728843|470621217|FG004|Overall Study|Lack of Efficacy|0|||
130726202|NCT02728843|470621213|FG000|Overall Study|Protocol Violation|2|||
130726203|NCT02728843|470621214|FG001|Overall Study|Protocol Violation|0|||
130726204|NCT02728843|470621215|FG002|Overall Study|Protocol Violation|4|||
130726205|NCT02728843|470621216|FG003|Overall Study|Protocol Violation|2|||
130726206|NCT02728843|470621217|FG004|Overall Study|Protocol Violation|2|||
130726207|NCT02728843|470621213|FG000|Overall Study|Withdrawal by Subject|1|||
130726208|NCT02728843|470621214|FG001|Overall Study|Withdrawal by Subject|0|||
130726209|NCT02728843|470621215|FG002|Overall Study|Withdrawal by Subject|0|||
130726210|NCT02728843|470621216|FG003|Overall Study|Withdrawal by Subject|1|||
130726211|NCT02728843|470621217|FG004|Overall Study|Withdrawal by Subject|0|||
130726212|NCT02728843|470621213|FG000|Overall Study|Use of rescue medication|0|||
130726213|NCT02728843|470621214|FG001|Overall Study|Use of rescue medication|2|||
130726214|NCT02728843|470621215|FG002|Overall Study|Use of rescue medication|0|||
130726215|NCT02728843|470621216|FG003|Overall Study|Use of rescue medication|2|||
130726216|NCT02728843|470621217|FG004|Overall Study|Use of rescue medication|1|||
130726217|NCT01671332|470621218|FG000|Overall Study|Withdrawal by Subject|1|||
130726218|NCT01671332|470621219|FG001|Overall Study|Withdrawal by Subject|1|||
130726219|NCT00351533|470621220|FG000|Overall Study|Extubated before first BAL|1|||
130726220|NCT00351533|470621221|FG001|Overall Study|Extubated before first BAL|0|||
130726221|NCT00351533|470621220|FG000|Overall Study|Lost to Follow-up|1|||
130726222|NCT00351533|470621221|FG001|Overall Study|Lost to Follow-up|3|||
130726223|NCT00351533|470621220|FG000|Overall Study|Physician Decision|0|||
130726224|NCT00351533|470621221|FG001|Overall Study|Physician Decision|1|||
130726225|NCT00351533|470621220|FG000|Overall Study|Withdrawal by Subject|0|||
130726226|NCT00351533|470621221|FG001|Overall Study|Withdrawal by Subject|1|||
130726227|NCT01653912|470621226|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130726228|NCT01653912|470621227|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
130726229|NCT01653912|470621228|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130726230|NCT01653912|470621229|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130726231|NCT01653912|470621230|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130726232|NCT01653912|470621231|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130726233|NCT01653912|470621226|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130726234|NCT01653912|470621227|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130726235|NCT01653912|470621228|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
130726236|NCT01653912|470621229|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130726237|NCT01653912|470621230|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130726238|NCT01653912|470621231|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130726239|NCT01653912|470621226|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
131078314|NCT02330562|471920400|FG001|Overall Study|Disease progression|3|||
131078315|NCT02330562|471920401|FG002|Overall Study|Disease progression|20|||
131078316|NCT02330562|471920402|FG003|Overall Study|Disease progression|28|||
131078317|NCT02330562|471920403|FG004|Overall Study|Disease progression|23|||
131078318|NCT02330562|471920404|FG005|Overall Study|Disease progression|7|||
131078319|NCT02330562|471920405|FG006|Overall Study|Disease progression|1|||
131078320|NCT02330562|471920406|FG007|Overall Study|Disease progression|1|||
131078321|NCT02330562|471920407|FG008|Overall Study|Disease progression|1|||
131078322|NCT02330562|471920408|FG009|Overall Study|Disease progression|0|||
131078323|NCT02330562|471920409|FG010|Overall Study|Disease progression|5|||
131078324|NCT02330562|471920399|FG000|Overall Study|Other reasons|0|||
131078325|NCT02330562|471920400|FG001|Overall Study|Other reasons|0|||
131078326|NCT02330562|471920401|FG002|Overall Study|Other reasons|0|||
131078327|NCT02330562|471920402|FG003|Overall Study|Other reasons|1|||
131078328|NCT02330562|471920403|FG004|Overall Study|Other reasons|0|||
131078329|NCT02330562|471920404|FG005|Overall Study|Other reasons|0|||
131078330|NCT02330562|471920405|FG006|Overall Study|Other reasons|0|||
131078331|NCT02330562|471920406|FG007|Overall Study|Other reasons|0|||
131078332|NCT02330562|471920407|FG008|Overall Study|Other reasons|0|||
131078333|NCT02330562|471920408|FG009|Overall Study|Other reasons|0|||
131078334|NCT02330562|471920409|FG010|Overall Study|Other reasons|0|||
131078335|NCT02330562|471920399|FG000|Overall Study|Withdrawal by Subject|0|||
131078336|NCT02330562|471920400|FG001|Overall Study|Withdrawal by Subject|0|||
131078337|NCT02330562|471920401|FG002|Overall Study|Withdrawal by Subject|0|||
131078338|NCT02330562|471920402|FG003|Overall Study|Withdrawal by Subject|0|||
131078339|NCT02330562|471920403|FG004|Overall Study|Withdrawal by Subject|0|||
131078340|NCT02330562|471920404|FG005|Overall Study|Withdrawal by Subject|0|||
131078341|NCT02330562|471920405|FG006|Overall Study|Withdrawal by Subject|0|||
131078342|NCT02330562|471920406|FG007|Overall Study|Withdrawal by Subject|0|||
131078343|NCT02330562|471920407|FG008|Overall Study|Withdrawal by Subject|0|||
131078344|NCT02330562|471920408|FG009|Overall Study|Withdrawal by Subject|1|||
131078345|NCT02330562|471920409|FG010|Overall Study|Withdrawal by Subject|0|||
130726240|NCT01653912|470621227|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130726241|NCT01653912|470621228|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130726242|NCT01653912|470621229|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
130726243|NCT01653912|470621230|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130726244|NCT01653912|470621231|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130726245|NCT01653912|470621226|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726246|NCT01653912|470621227|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726247|NCT01653912|470621228|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726248|NCT01653912|470621229|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
130726249|NCT01653912|470621230|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726250|NCT01653912|470621231|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726251|NCT01653912|470621226|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130726252|NCT01653912|470621227|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130726253|NCT01653912|470621228|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130726254|NCT01653912|470621229|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130726255|NCT01653912|470621230|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130726256|NCT01653912|470621231|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
130726257|NCT01653912|470621226|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130726258|NCT01653912|470621227|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130726259|NCT01653912|470621228|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130726260|NCT01653912|470621229|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130726261|NCT01653912|470621230|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130726262|NCT01653912|470621231|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
130726263|NCT01653912|470621226|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726264|NCT01653912|470621227|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726265|NCT01653912|470621228|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
131078346|NCT03082612|471920410|FG000|Overall Study|Lost to Follow-up|2|||
131078347|NCT03082612|471920411|FG001|Overall Study|Lost to Follow-up|0|||
131078362|NCT00992992|471920418|FG000|Overall Study|Lost to Follow-up|3|||
131078363|NCT00992992|471920418|FG000|Overall Study|Death|16|||
131078364|NCT00992992|471920418|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
131078365|NCT00992992|471920418|FG000|Overall Study|Sponsor Closed the Study|4|||
131078366|NCT00832000|471920420|FG000|Overall Study|Adverse Event|2|||
131078367|NCT00832000|471920421|FG001|Overall Study|Adverse Event|0|||
131078368|NCT00832000|471920420|FG000|Overall Study|Withdrawal by Subject|1|||
131078369|NCT00832000|471920421|FG001|Overall Study|Withdrawal by Subject|0|||
131078370|NCT00832000|471920420|FG000|Overall Study|No calls to IVR in either period|1|||
131078371|NCT00832000|471920421|FG001|Overall Study|No calls to IVR in either period|1|||
131078372|NCT00832000|471920420|FG000|Overall Study|No calls to IVR in period 2|2|||
131078373|NCT00832000|471920421|FG001|Overall Study|No calls to IVR in period 2|0|||
131078374|NCT02725567|471920423|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
131078375|NCT02725567|471920424|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
131078376|NCT02725567|471920423|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
131078377|NCT02725567|471920424|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
131078378|NCT02725567|471920423|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
131078379|NCT02725567|471920424|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
131078380|NCT00255944|471920425|FG000|Overall Study|Lost to Follow-up|797|||
131078381|NCT00255944|471920426|FG001|Overall Study|Lost to Follow-up|834|||
131078382|NCT01129115|471920427|FG000|Overall Study|Adverse Event|1|||
131078383|NCT01129115|471920428|FG001|Overall Study|Adverse Event|2|||
131078384|NCT01129115|471920429|FG002|Overall Study|Adverse Event|3|||
131078385|NCT01129115|471920430|FG003|Overall Study|Adverse Event|3|||
131078386|NCT01129115|471920427|FG000|Overall Study|Withdrawal by Subject|1|||
131078387|NCT01129115|471920428|FG001|Overall Study|Withdrawal by Subject|3|||
131078388|NCT01129115|471920429|FG002|Overall Study|Withdrawal by Subject|1|||
131078389|NCT01129115|471920430|FG003|Overall Study|Withdrawal by Subject|4|||
131078390|NCT01129115|471920427|FG000|Overall Study|Protocol Violation|0|||
131078391|NCT01129115|471920428|FG001|Overall Study|Protocol Violation|2|||
130726266|NCT01653912|470621229|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726267|NCT01653912|470621230|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130726268|NCT01653912|470621231|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
130779978|NCT01705977|470819596|FG001|Treatment Period (Year 1)|Site closure|2|||
130779979|NCT01705977|470819595|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
130779980|NCT01705977|470819596|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
130779981|NCT01705977|470819595|FG000|Treatment Period (Year 1)|Physician Decision|48|||
130779982|NCT01705977|470819596|FG001|Treatment Period (Year 1)|Physician Decision|38|||
130779983|NCT01705977|470819595|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
130779984|NCT01705977|470819596|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
130779985|NCT01705977|470819595|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
130779986|NCT01705977|470819596|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
130779987|NCT01705977|470819595|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
130779988|NCT01705977|470819596|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
130779989|NCT01705977|470819595|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
130779990|NCT01705977|470819596|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
130779991|NCT01705977|470819595|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
130779992|NCT01705977|470819596|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
130779993|NCT01705977|470819595|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
130779994|NCT01705977|470819596|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
130779995|NCT03066830|470819597|FG000|Overall Study|At the Participant's own Request|16|||
130779996|NCT03066830|470819598|FG001|Overall Study|At the Participant's own Request|17|||
130779997|NCT03066830|470819597|FG000|Overall Study|Other|3|||
130779998|NCT03066830|470819598|FG001|Overall Study|Other|0|||
130726269|NCT03408639|470623044|FG000|Overall Study|Death|5|||
130726270|NCT03408639|470623045|FG001|Overall Study|Death|5|||
130726271|NCT03408639|470623044|FG000|Overall Study|Lost to Follow-up|1|||
130726272|NCT03408639|470623045|FG001|Overall Study|Lost to Follow-up|4|||
130726273|NCT03408639|470623044|FG000|Overall Study|Withdrawal by Subject|2|||
130726274|NCT03408639|470623045|FG001|Overall Study|Withdrawal by Subject|7|||
130726275|NCT03408639|470623044|FG000|Overall Study|Physician Decision|3|||
130726276|NCT03408639|470623045|FG001|Overall Study|Physician Decision|6|||
130726277|NCT02245412|470623046|FG000|Treatment Period|Death|1|||
130726278|NCT02245412|470623047|FG001|Treatment Period|Death|1|||
130726279|NCT02245412|470623048|FG002|Treatment Period|Death|0|||
130726280|NCT02245412|470623046|FG000|Treatment Period|Physician Decision|1|||
130726281|NCT02245412|470623047|FG001|Treatment Period|Physician Decision|1|||
130726282|NCT02245412|470623048|FG002|Treatment Period|Physician Decision|0|||
130726283|NCT02245412|470623046|FG000|Treatment Period|Withdrawal by Subject|2|||
130726284|NCT02245412|470623047|FG001|Treatment Period|Withdrawal by Subject|1|||
130726285|NCT02245412|470623048|FG002|Treatment Period|Withdrawal by Subject|0|||
130726286|NCT02245412|470623046|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
130726287|NCT02245412|470623047|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
130726288|NCT02245412|470623048|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
130726289|NCT02245412|470623046|FG000|Follow-Up Period|Death|4|||
130726290|NCT02245412|470623047|FG001|Follow-Up Period|Death|2|||
130726291|NCT02245412|470623048|FG002|Follow-Up Period|Death|1|||
130726292|NCT02245412|470623046|FG000|Follow-Up Period|Physician Decision|1|||
130726293|NCT02245412|470623047|FG001|Follow-Up Period|Physician Decision|0|||
130726294|NCT02245412|470623048|FG002|Follow-Up Period|Physician Decision|0|||
130726295|NCT02245412|470623046|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
130726296|NCT02245412|470623047|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
130726297|NCT02245412|470623048|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
130726298|NCT03452137|470623049|FG000|Overall Study|Death|67|||
130726299|NCT03452137|470623050|FG001|Overall Study|Death|70|||
130726300|NCT03452137|470623049|FG000|Overall Study|Lost to Follow-up|4|||
130726301|NCT03452137|470623050|FG001|Overall Study|Lost to Follow-up|2|||
130726302|NCT03452137|470623049|FG000|Overall Study|Physician Decision|0|||
130726303|NCT03452137|470623050|FG001|Overall Study|Physician Decision|1|||
130726304|NCT03452137|470623049|FG000|Overall Study|Study Terminated by Sponsor|120|||
130726305|NCT03452137|470623050|FG001|Overall Study|Study Terminated by Sponsor|121|||
130726306|NCT03452137|470623049|FG000|Overall Study|Withdrawal by Subject|12|||
130726307|NCT03452137|470623050|FG001|Overall Study|Withdrawal by Subject|9|||
130726308|NCT01371747|470623051|FG000|Overall Study|Adverse Event|4|||
130726309|NCT01371747|470623052|FG001|Overall Study|Adverse Event|2|||
130779999|NCT03066830|470819597|FG000|Overall Study|Poor Compliance to Protocol|1|||
130726310|NCT01371747|470623053|FG002|Overall Study|Adverse Event|7|||
130726311|NCT01371747|470623054|FG003|Overall Study|Adverse Event|2|||
130726312|NCT01371747|470623055|FG004|Overall Study|Adverse Event|2|||
130780000|NCT03066830|470819598|FG001|Overall Study|Poor Compliance to Protocol|0|||
130780001|NCT03066830|470819597|FG000|Overall Study|Adverse Event|2|||
130780002|NCT03066830|470819598|FG001|Overall Study|Adverse Event|2|||
130780003|NCT03066830|470819597|FG000|Overall Study|Lost to Follow-up|11|||
130726313|NCT01371747|470623056|FG005|Overall Study|Adverse Event|2|||
130726314|NCT01371747|470623051|FG000|Overall Study|Death|1|||
130726315|NCT01371747|470623052|FG001|Overall Study|Death|0|||
130726316|NCT01371747|470623053|FG002|Overall Study|Death|4|||
130726317|NCT01371747|470623054|FG003|Overall Study|Death|1|||
130726318|NCT01371747|470623055|FG004|Overall Study|Death|2|||
130726319|NCT01371747|470623056|FG005|Overall Study|Death|0|||
130726320|NCT01371747|470623051|FG000|Overall Study|Abnormal Renal Function|0|||
130726321|NCT01371747|470623052|FG001|Overall Study|Abnormal Renal Function|2|||
131078392|NCT01129115|471920429|FG002|Overall Study|Protocol Violation|2|||
131078393|NCT01129115|471920430|FG003|Overall Study|Protocol Violation|2|||
131078394|NCT01747837|471920432|FG000|Overall Study|Lost to Follow-up|5|||
131078395|NCT01747837|471920433|FG001|Overall Study|Lost to Follow-up|2|||
131078396|NCT01747837|471920432|FG000|Overall Study|Death|4|||
131078397|NCT01747837|471920433|FG001|Overall Study|Death|4|||
131078398|NCT00817336|471920435|FG000|Overall Study|Withdrawal by Subject|1|||
131078399|NCT00817336|471920436|FG001|Overall Study|Withdrawal by Subject|1|||
131078400|NCT01253447|471920437|FG000|Overall Study|Adverse Event|2|||
131231653|NCT03083483|472475183|FG002|Overall Study|Adverse Event|1|||
130726322|NCT01371747|470623053|FG002|Overall Study|Abnormal Renal Function|0|||
130726323|NCT01371747|470623054|FG003|Overall Study|Abnormal Renal Function|1|||
130726324|NCT01371747|470623055|FG004|Overall Study|Abnormal Renal Function|0|||
130726325|NCT01371747|470623056|FG005|Overall Study|Abnormal Renal Function|1|||
130726326|NCT01371747|470623051|FG000|Overall Study|High Serum Potassium Results|1|||
130726327|NCT01371747|470623052|FG001|Overall Study|High Serum Potassium Results|1|||
130726328|NCT01371747|470623053|FG002|Overall Study|High Serum Potassium Results|1|||
130726329|NCT01371747|470623054|FG003|Overall Study|High Serum Potassium Results|2|||
130726330|NCT01371747|470623055|FG004|Overall Study|High Serum Potassium Results|0|||
130726331|NCT01371747|470623056|FG005|Overall Study|High Serum Potassium Results|2|||
130726332|NCT01371747|470623051|FG000|Overall Study|Low Serum Potassium Results|1|||
130726333|NCT01371747|470623052|FG001|Overall Study|Low Serum Potassium Results|1|||
130726334|NCT01371747|470623053|FG002|Overall Study|Low Serum Potassium Results|1|||
130726335|NCT01371747|470623054|FG003|Overall Study|Low Serum Potassium Results|1|||
130726336|NCT01371747|470623055|FG004|Overall Study|Low Serum Potassium Results|0|||
130726337|NCT01371747|470623056|FG005|Overall Study|Low Serum Potassium Results|3|||
130726338|NCT01371747|470623051|FG000|Overall Study|Protocol Violation|0|||
130726339|NCT01371747|470623052|FG001|Overall Study|Protocol Violation|0|||
130726340|NCT01371747|470623053|FG002|Overall Study|Protocol Violation|1|||
130726341|NCT01371747|470623054|FG003|Overall Study|Protocol Violation|0|||
130726342|NCT01371747|470623055|FG004|Overall Study|Protocol Violation|0|||
130726343|NCT01371747|470623056|FG005|Overall Study|Protocol Violation|0|||
130726344|NCT01371747|470623051|FG000|Overall Study|Non-Compliance|3|||
130726345|NCT01371747|470623052|FG001|Overall Study|Non-Compliance|4|||
130726346|NCT01371747|470623053|FG002|Overall Study|Non-Compliance|3|||
130726347|NCT01371747|470623054|FG003|Overall Study|Non-Compliance|0|||
130726348|NCT01371747|470623055|FG004|Overall Study|Non-Compliance|0|||
130726349|NCT01371747|470623056|FG005|Overall Study|Non-Compliance|1|||
130726350|NCT01371747|470623051|FG000|Overall Study|Physician Decision|0|||
130726351|NCT01371747|470623052|FG001|Overall Study|Physician Decision|0|||
130726352|NCT01371747|470623053|FG002|Overall Study|Physician Decision|0|||
130726353|NCT01371747|470623054|FG003|Overall Study|Physician Decision|0|||
130726354|NCT01371747|470623055|FG004|Overall Study|Physician Decision|1|||
130726355|NCT01371747|470623056|FG005|Overall Study|Physician Decision|0|||
130726356|NCT01371747|470623051|FG000|Overall Study|Withdrawal by Subject|6|||
130726357|NCT01371747|470623052|FG001|Overall Study|Withdrawal by Subject|12|||
130726358|NCT01371747|470623053|FG002|Overall Study|Withdrawal by Subject|5|||
130726359|NCT01371747|470623054|FG003|Overall Study|Withdrawal by Subject|2|||
130726360|NCT01371747|470623055|FG004|Overall Study|Withdrawal by Subject|2|||
130726361|NCT01371747|470623056|FG005|Overall Study|Withdrawal by Subject|4|||
130726362|NCT01371747|470623051|FG000|Overall Study|Other Reasons|2|||
130726363|NCT01371747|470623052|FG001|Overall Study|Other Reasons|1|||
130726364|NCT01371747|470623053|FG002|Overall Study|Other Reasons|2|||
130726365|NCT01371747|470623054|FG003|Overall Study|Other Reasons|0|||
130726366|NCT01371747|470623055|FG004|Overall Study|Other Reasons|0|||
130726367|NCT01371747|470623056|FG005|Overall Study|Other Reasons|1|||
130726368|NCT02094417|470623060|FG000|Overall Study|Adverse Event|0|||
130726369|NCT02094417|470623061|FG001|Overall Study|Adverse Event|0|||
130726370|NCT02094417|470623062|FG002|Overall Study|Adverse Event|0|||
130726371|NCT02094417|470623063|FG003|Overall Study|Adverse Event|1|||
130726372|NCT02094417|470623060|FG000|Overall Study|Eligibility criteria|0|||
130726373|NCT02094417|470623061|FG001|Overall Study|Eligibility criteria|1|||
130726374|NCT02094417|470623062|FG002|Overall Study|Eligibility criteria|0|||
130726375|NCT02094417|470623063|FG003|Overall Study|Eligibility criteria|0|||
130726376|NCT02094417|470623060|FG000|Overall Study|No responder|4|||
130726377|NCT02094417|470623061|FG001|Overall Study|No responder|4|||
130726378|NCT02094417|470623062|FG002|Overall Study|No responder|4|||
130726379|NCT02094417|470623063|FG003|Overall Study|No responder|3|||
130726380|NCT02094417|470623060|FG000|Overall Study|Unable to conduct observations or assess|0|||
130726381|NCT02094417|470623061|FG001|Overall Study|Unable to conduct observations or assess|1|||
130726382|NCT02094417|470623062|FG002|Overall Study|Unable to conduct observations or assess|0|||
131078401|NCT01435798|471920438|FG000|Overall Study|Withdrawal by Subject|1|||
131078402|NCT02299427|471920439|FG000|Overall Study|Withdrawal by Subject|1|||
131078403|NCT02299427|471920440|FG001|Overall Study|Withdrawal by Subject|0|||
131078404|NCT02299427|471920439|FG000|Overall Study|Lost to Follow-up|1|||
131078405|NCT02299427|471920440|FG001|Overall Study|Lost to Follow-up|3|||
131078406|NCT02299427|471920439|FG000|Overall Study|not adherent to dog website use|21|||
131078407|NCT02299427|471920440|FG001|Overall Study|not adherent to dog website use|0|||
131078408|NCT02108652|471920441|FG000|Overall Study|Death|253|||
131078409|NCT02108652|471920441|FG000|Overall Study|Lost to Follow-up|2|||
131078410|NCT02108652|471920441|FG000|Overall Study|Withdrawal by Subject|16|||
131139620|NCT00272987|472138082|FG001|Overall Study|Disease progression|1|||
130726383|NCT02094417|470623063|FG003|Overall Study|Unable to conduct observations or assess|0|||
130726384|NCT02094417|470623060|FG000|Overall Study|Withdrawal by Subject|1|||
130726385|NCT02094417|470623061|FG001|Overall Study|Withdrawal by Subject|2|||
130726386|NCT02094417|470623062|FG002|Overall Study|Withdrawal by Subject|1|||
130726387|NCT02094417|470623063|FG003|Overall Study|Withdrawal by Subject|3|||
130726388|NCT00580788|470623064|FG000|Overall Study|Adverse Event|0|||
130726389|NCT00580788|470623065|FG001|Overall Study|Adverse Event|0|||
130726390|NCT00580788|470623066|FG002|Overall Study|Adverse Event|0|||
130726391|NCT00580788|470623067|FG003|Overall Study|Adverse Event|1|||
130726392|NCT01443728|470623068|FG000|Overall Study|Lost to Follow-up|2|||
130726393|NCT01443728|470623069|FG001|Overall Study|Lost to Follow-up|0|||
130726394|NCT01443728|470623068|FG000|Overall Study|Withdrawal by Subject|1|||
130726395|NCT01443728|470623069|FG001|Overall Study|Withdrawal by Subject|1|||
130726396|NCT01443728|470623068|FG000|Overall Study|Adverse Event|0|||
130726397|NCT01443728|470623069|FG001|Overall Study|Adverse Event|2|||
130726398|NCT04971187|470623070|FG000|Overall Study|Screen failures|2|||
130726399|NCT01403051|470623071|FG000|Overall Study|Protocol Violation|2|||
130726400|NCT01403051|470623072|FG001|Overall Study|Protocol Violation|0|||
130726401|NCT01403051|470623071|FG000|Overall Study|Death|1|||
130726402|NCT01403051|470623072|FG001|Overall Study|Death|0|||
130726403|NCT01403051|470623071|FG000|Overall Study|Withdrawal by Subject|2|||
130726404|NCT01403051|470623072|FG001|Overall Study|Withdrawal by Subject|1|||
130726405|NCT01403051|470623071|FG000|Overall Study|Lost to Follow-up|5|||
130726406|NCT01403051|470623072|FG001|Overall Study|Lost to Follow-up|5|||
130726407|NCT02135614|470623078|FG000|Overall Study|Randomized but Not Treated|2|||
130726408|NCT02135614|470623079|FG001|Overall Study|Randomized but Not Treated|1|||
130726409|NCT02135614|470623078|FG000|Overall Study|Adverse Event|0|||
130726410|NCT02135614|470623079|FG001|Overall Study|Adverse Event|1|||
130726411|NCT02135614|470623078|FG000|Overall Study|Death|1|||
130726412|NCT02135614|470623079|FG001|Overall Study|Death|0|||
130726413|NCT02135614|470623078|FG000|Overall Study|Investigator's Discretion|0|||
130726414|NCT02135614|470623079|FG001|Overall Study|Investigator's Discretion|1|||
130726415|NCT02135614|470623078|FG000|Overall Study|Withdrew Consent|2|||
130726416|NCT02135614|470623079|FG001|Overall Study|Withdrew Consent|2|||
130726417|NCT02135614|470623078|FG000|Overall Study|Lost to Follow-up|3|||
130726418|NCT02135614|470623079|FG001|Overall Study|Lost to Follow-up|0|||
130726419|NCT02906358|470623083|FG000|Overall Study|Withdrawal by Subject|10|||
130726420|NCT02906358|470623084|FG001|Overall Study|Withdrawal by Subject|7|||
130726421|NCT02906358|470623083|FG000|Overall Study|Lost to Follow-up|12|||
130726422|NCT02906358|470623084|FG001|Overall Study|Lost to Follow-up|15|||
130726423|NCT02119819|470623086|FG000|Overall Study|Adverse Event|3|||
130726424|NCT02119819|470623087|FG001|Overall Study|Adverse Event|1|||
130726425|NCT02119819|470623088|FG002|Overall Study|Adverse Event|2|||
130726426|NCT02119819|470623089|FG003|Overall Study|Adverse Event|3|||
130726427|NCT02119819|470623090|FG004|Overall Study|Adverse Event|0|||
130726428|NCT02119819|470623091|FG005|Overall Study|Adverse Event|1|||
130726429|NCT02119819|470623086|FG000|Overall Study|Lack of Efficacy|0|||
130726430|NCT02119819|470623087|FG001|Overall Study|Lack of Efficacy|0|||
130780004|NCT03066830|470819598|FG001|Overall Study|Lost to Follow-up|3|||
130726431|NCT02119819|470623088|FG002|Overall Study|Lack of Efficacy|0|||
130726432|NCT02119819|470623089|FG003|Overall Study|Lack of Efficacy|0|||
130726433|NCT02119819|470623090|FG004|Overall Study|Lack of Efficacy|0|||
130726434|NCT02119819|470623091|FG005|Overall Study|Lack of Efficacy|1|||
130726435|NCT02119819|470623086|FG000|Overall Study|Lost to Follow-up|0|||
130726436|NCT02119819|470623087|FG001|Overall Study|Lost to Follow-up|0|||
130726437|NCT02119819|470623088|FG002|Overall Study|Lost to Follow-up|1|||
130726438|NCT02119819|470623089|FG003|Overall Study|Lost to Follow-up|2|||
130726439|NCT02119819|470623090|FG004|Overall Study|Lost to Follow-up|1|||
130726440|NCT02119819|470623091|FG005|Overall Study|Lost to Follow-up|2|||
130726441|NCT02119819|470623086|FG000|Overall Study|Physician Decision|1|||
130726442|NCT02119819|470623087|FG001|Overall Study|Physician Decision|1|||
130726443|NCT02119819|470623088|FG002|Overall Study|Physician Decision|0|||
130726444|NCT02119819|470623089|FG003|Overall Study|Physician Decision|0|||
130726445|NCT02119819|470623090|FG004|Overall Study|Physician Decision|0|||
131078411|NCT02108652|471920441|FG000|Overall Study|Study Terminated By Sponsor|31|||
131078412|NCT02108652|471920441|FG000|Overall Study|Non-Compliance|1|||
131078413|NCT02108652|471920441|FG000|Overall Study|Physician Decision|6|||
131231654|NCT03083483|472475181|FG000|Overall Study|Lost to Follow-up|2|||
131231655|NCT03083483|472475182|FG001|Overall Study|Lost to Follow-up|1|||
130780005|NCT02039778|470819599|FG000|Overall Study|Death|2|||
130780006|NCT02039778|470819599|FG000|Overall Study|Withdrawal by Subject|1|||
130780007|NCT02039778|470819599|FG000|Overall Study|Never started the protocol treatment|1|||
130780008|NCT00096538|470819603|FG000|Overall Study|Withdrawal by Subject|1|||
130780009|NCT01827592|470819605|FG000|Overall Study|Adverse Event|11|||
130780010|NCT01827592|470819606|FG001|Overall Study|Adverse Event|9|||
131078414|NCT02108652|471920441|FG000|Overall Study|Progression Of Disease|1|||
131078415|NCT01121913|471920444|FG000|First Intervention Period|Adverse Event|0|||
131078416|NCT01121913|471920445|FG001|First Intervention Period|Adverse Event|0|||
130780011|NCT01827592|470819607|FG002|Overall Study|Adverse Event|2|||
130780012|NCT01827592|470819605|FG000|Overall Study|Physician Decision|0|||
130780013|NCT01827592|470819606|FG001|Overall Study|Physician Decision|2|||
130780014|NCT01827592|470819607|FG002|Overall Study|Physician Decision|1|||
130780015|NCT01827592|470819605|FG000|Overall Study|Protocol Violation|2|||
130780016|NCT01827592|470819606|FG001|Overall Study|Protocol Violation|1|||
130780017|NCT01827592|470819607|FG002|Overall Study|Protocol Violation|0|||
130780018|NCT01827592|470819605|FG000|Overall Study|Lost to Follow-up|1|||
130780019|NCT01827592|470819606|FG001|Overall Study|Lost to Follow-up|2|||
130780020|NCT01827592|470819607|FG002|Overall Study|Lost to Follow-up|2|||
130780021|NCT01827592|470819605|FG000|Overall Study|Withdrawal by Subject|12|||
130780022|NCT01827592|470819606|FG001|Overall Study|Withdrawal by Subject|11|||
130780023|NCT01827592|470819607|FG002|Overall Study|Withdrawal by Subject|11|||
130780024|NCT01827592|470819605|FG000|Overall Study|Patient's substantial non-compliance|1|||
130780025|NCT01827592|470819606|FG001|Overall Study|Patient's substantial non-compliance|1|||
130780026|NCT01827592|470819607|FG002|Overall Study|Patient's substantial non-compliance|6|||
130780027|NCT01827592|470819605|FG000|Overall Study|Trial terminated by Sponsor|47|||
130780028|NCT01827592|470819606|FG001|Overall Study|Trial terminated by Sponsor|53|||
130780029|NCT01827592|470819607|FG002|Overall Study|Trial terminated by Sponsor|51|||
130780030|NCT01827592|470819605|FG000|Overall Study|Others|0|||
130780031|NCT01827592|470819606|FG001|Overall Study|Others|1|||
130780032|NCT01827592|470819607|FG002|Overall Study|Others|3|||
130780033|NCT01931397|470819616|FG000|Overall Study|Physician Decision|2|||
130780034|NCT01931397|470819616|FG000|Overall Study|Withdrawal by Subject|8|||
130780035|NCT01931397|470819616|FG000|Overall Study|moved out of state|1|||
130780036|NCT02058589|470819619|FG000|Overall Study|Serious Adverse Event|1|||
130780037|NCT02058589|470819620|FG001|Overall Study|Serious Adverse Event|1|||
130780038|NCT02058589|470819619|FG000|Overall Study|Non-Serious Adverse Event|1|||
130780039|NCT02058589|470819620|FG001|Overall Study|Non-Serious Adverse Event|0|||
130780040|NCT02058589|470819619|FG000|Overall Study|Withdrawal by Subject|0|||
130780041|NCT02058589|470819620|FG001|Overall Study|Withdrawal by Subject|1|||
130780042|NCT02143024|470819622|FG000|Overall Study|Lost to Follow-up|1|||
130780043|NCT02143024|470819623|FG001|Overall Study|Lost to Follow-up|1|||
130780044|NCT02143024|470819622|FG000|Overall Study|Withdrawal by Subject|1|||
130780045|NCT02143024|470819623|FG001|Overall Study|Withdrawal by Subject|0|||
130780046|NCT01945944|470819624|FG000|Overall Study|Adverse Event|0|||
130780047|NCT01945944|470819625|FG001|Overall Study|Adverse Event|2|||
131078417|NCT01121913|471920446|FG002|First Intervention Period|Adverse Event|1|||
131078418|NCT01121913|471920447|FG003|First Intervention Period|Adverse Event|0|||
131078419|NCT01121913|471920444|FG000|First Washout Period|Withdrawal by Subject|1|||
131078420|NCT01121913|471920445|FG001|First Washout Period|Withdrawal by Subject|0|||
131231656|NCT03083483|472475183|FG002|Overall Study|Lost to Follow-up|1|||
131231657|NCT03083483|472475181|FG000|Overall Study|technological issues|1|||
130780048|NCT01945944|470819624|FG000|Overall Study|Physician Decision|1|||
130780049|NCT01945944|470819625|FG001|Overall Study|Physician Decision|0|||
130780050|NCT01945944|470819624|FG000|Overall Study|Withdrawal by Subject|0|||
130780051|NCT01945944|470819625|FG001|Overall Study|Withdrawal by Subject|1|||
130780052|NCT01212094|470821383|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
130780053|NCT01212094|470821384|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
130780054|NCT01212094|470821385|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
130780055|NCT01212094|470821383|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
130780056|NCT01212094|470821384|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
131078421|NCT01121913|471920446|FG002|First Washout Period|Withdrawal by Subject|0|||
131078422|NCT01121913|471920447|FG003|First Washout Period|Withdrawal by Subject|0|||
131078423|NCT01121913|471920444|FG000|Second Intervention Period|Adverse Event|0|||
131078424|NCT01121913|471920445|FG001|Second Intervention Period|Adverse Event|0|||
131078425|NCT01121913|471920446|FG002|Second Intervention Period|Adverse Event|1|||
131078426|NCT01121913|471920447|FG003|Second Intervention Period|Adverse Event|0|||
131078427|NCT01121913|471920444|FG000|Second Washout Period|Withdrawal by Subject|0|||
131078428|NCT01121913|471920445|FG001|Second Washout Period|Withdrawal by Subject|0|||
131078429|NCT01121913|471920446|FG002|Second Washout Period|Withdrawal by Subject|1|||
131078430|NCT01121913|471920447|FG003|Second Washout Period|Withdrawal by Subject|0|||
131078431|NCT01121913|471920444|FG000|Third Washout Period|Adverse Event|1|||
131078432|NCT01121913|471920445|FG001|Third Washout Period|Adverse Event|0|||
131078433|NCT01121913|471920446|FG002|Third Washout Period|Adverse Event|0|||
131078434|NCT01121913|471920447|FG003|Third Washout Period|Adverse Event|0|||
131078435|NCT02564718|471920450|FG000|Overall Study|Withdrew from treatment|0|||
131078436|NCT02564718|471920451|FG001|Overall Study|Withdrew from treatment|1|||
131078437|NCT00935259|471920452|FG000|Period 1|Administrative (scheduling conflict)|1|||
131078438|NCT00935259|471920453|FG001|Period 1|Administrative (scheduling conflict)|1|||
131078439|NCT00937521|471920455|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131078440|NCT00937521|471920456|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131078441|NCT00937521|471920457|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
131078442|NCT00937521|471920458|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131139621|NCT00272987|472138083|FG002|Overall Study|Disease progression|2|||
131139622|NCT00272987|472138081|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
131139623|NCT00272987|472138082|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
131139624|NCT00272987|472138083|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
131139625|NCT00272987|472138081|FG000|Overall Study|Death|1|||
131139626|NCT00272987|472138082|FG001|Overall Study|Death|0|||
130726446|NCT02119819|470623091|FG005|Overall Study|Physician Decision|1|||
130726447|NCT02119819|470623086|FG000|Overall Study|Withdrawal by Subject|5|||
130726448|NCT02119819|470623087|FG001|Overall Study|Withdrawal by Subject|3|||
130726449|NCT02119819|470623088|FG002|Overall Study|Withdrawal by Subject|0|||
130726450|NCT02119819|470623089|FG003|Overall Study|Withdrawal by Subject|0|||
130726451|NCT02119819|470623090|FG004|Overall Study|Withdrawal by Subject|6|||
130726452|NCT02119819|470623091|FG005|Overall Study|Withdrawal by Subject|10|||
130726453|NCT02119819|470623086|FG000|Overall Study|Jury Duty|0|||
130726454|NCT02119819|470623087|FG001|Overall Study|Jury Duty|0|||
130726455|NCT02119819|470623088|FG002|Overall Study|Jury Duty|1|||
130726456|NCT02119819|470623089|FG003|Overall Study|Jury Duty|0|||
130726457|NCT02119819|470623090|FG004|Overall Study|Jury Duty|0|||
130726458|NCT02119819|470623091|FG005|Overall Study|Jury Duty|0|||
130726459|NCT02119819|470623086|FG000|Overall Study|Protocol Violation|0|||
130726460|NCT02119819|470623087|FG001|Overall Study|Protocol Violation|0|||
130726461|NCT02119819|470623088|FG002|Overall Study|Protocol Violation|0|||
130726462|NCT02119819|470623089|FG003|Overall Study|Protocol Violation|1|||
130726463|NCT02119819|470623090|FG004|Overall Study|Protocol Violation|0|||
130726464|NCT02119819|470623091|FG005|Overall Study|Protocol Violation|0|||
130726465|NCT02119819|470623086|FG000|Overall Study|Left the city to get a job|0|||
130726466|NCT02119819|470623087|FG001|Overall Study|Left the city to get a job|0|||
130726467|NCT02119819|470623088|FG002|Overall Study|Left the city to get a job|0|||
130726468|NCT02119819|470623089|FG003|Overall Study|Left the city to get a job|1|||
130726469|NCT02119819|470623090|FG004|Overall Study|Left the city to get a job|0|||
130726470|NCT02119819|470623091|FG005|Overall Study|Left the city to get a job|0|||
130726471|NCT02699684|470623092|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
130726472|NCT02699684|470623093|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
130726473|NCT01145508|470623094|FG000|Overall Study|Adverse Event|1|||
130726474|NCT01145508|470623095|FG001|Overall Study|Adverse Event|0|||
130726475|NCT01145508|470623094|FG000|Overall Study|Death|1|||
130726476|NCT01145508|470623095|FG001|Overall Study|Death|0|||
130726477|NCT01145508|470623094|FG000|Overall Study|Physician Decision|2|||
130726478|NCT01145508|470623095|FG001|Overall Study|Physician Decision|1|||
130726479|NCT01145508|470623094|FG000|Overall Study|Never started treatment|1|||
130726480|NCT01145508|470623095|FG001|Overall Study|Never started treatment|1|||
130726481|NCT02045147|470623096|FG000|Overall Study|Withdrawal by Subject|2|||
130726482|NCT02045147|470623097|FG001|Overall Study|Withdrawal by Subject|0|||
130726483|NCT02045147|470623098|FG002|Overall Study|Withdrawal by Subject|0|||
130726484|NCT02045147|470623099|FG003|Overall Study|Withdrawal by Subject|0|||
130726485|NCT02045147|470623100|FG004|Overall Study|Withdrawal by Subject|0|||
130726486|NCT02045147|470623101|FG005|Overall Study|Withdrawal by Subject|0|||
130726487|NCT02045147|470623102|FG006|Overall Study|Withdrawal by Subject|0|||
130726488|NCT02045147|470623103|FG007|Overall Study|Withdrawal by Subject|1|||
130726489|NCT02045147|470623096|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
130726490|NCT02045147|470623097|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
130726491|NCT02045147|470623098|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
130726492|NCT02045147|470623099|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
130726493|NCT02045147|470623100|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
130726494|NCT02045147|470623101|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
130726495|NCT02045147|470623102|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
130726496|NCT02045147|470623103|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
130726497|NCT04839692|470623104|FG000|Overall Study|Withdrawal by Subject|0|||
130726498|NCT04839692|470623105|FG001|Overall Study|Withdrawal by Subject|3|||
131078443|NCT00937521|471920459|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131078444|NCT00937521|471920460|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
130726499|NCT04839692|470623104|FG000|Overall Study|Physician Decision|1|||
130726500|NCT04839692|470623105|FG001|Overall Study|Physician Decision|0|||
131139627|NCT00272987|472138083|FG002|Overall Study|Death|0|||
131139628|NCT03222349|472138084|FG000|Overall Study|Treatment B not done|5|||
130780057|NCT01212094|470821385|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
130780058|NCT01212094|470821383|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
130780059|NCT01212094|470821384|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
130780060|NCT01212094|470821385|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
130780061|NCT01212094|470821383|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
130780062|NCT01212094|470821384|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
130780063|NCT01212094|470821385|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
130780064|NCT01212094|470821383|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
130780065|NCT01212094|470821384|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
130780066|NCT01212094|470821385|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
130780067|NCT01212094|470821383|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
130780068|NCT01212094|470821384|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
130780069|NCT01212094|470821385|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
130780070|NCT02019550|470821392|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130780071|NCT02019550|470821393|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
130780072|NCT04771013|470821396|FG000|Overall Study|Withdrawal by Subject|2|||
130780073|NCT04771013|470821397|FG001|Overall Study|Withdrawal by Subject|0|||
130780074|NCT04771013|470821396|FG000|Overall Study|Death|0|||
130780075|NCT04771013|470821397|FG001|Overall Study|Death|5|||
130780076|NCT04771013|470821396|FG000|Overall Study|Referred to another hospital before day 20|0|||
131078445|NCT00937521|471920461|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
131078446|NCT00937521|471920462|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
131078447|NCT00937521|471920455|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
131078448|NCT00937521|471920456|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
131078449|NCT00937521|471920457|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
131078450|NCT00937521|471920458|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
131078451|NCT00937521|471920459|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
131078452|NCT00937521|471920460|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
131078453|NCT00937521|471920461|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
131078454|NCT00937521|471920462|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
131078455|NCT00937521|471920455|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131078456|NCT00937521|471920456|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131078457|NCT00937521|471920457|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
131078458|NCT00937521|471920458|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
131078459|NCT00937521|471920459|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131078460|NCT00937521|471920460|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131078461|NCT00937521|471920461|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131078462|NCT00937521|471920462|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
131078463|NCT00937521|471920455|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
131078464|NCT00937521|471920456|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
131078465|NCT00937521|471920457|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
131078466|NCT00937521|471920458|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
131078467|NCT00937521|471920459|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
131078468|NCT00937521|471920460|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
131078469|NCT00937521|471920461|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
131078470|NCT00937521|471920462|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
131078471|NCT00937521|471920455|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
131078472|NCT00937521|471920456|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131078473|NCT00937521|471920457|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131078474|NCT00937521|471920458|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131078475|NCT00937521|471920459|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131078476|NCT00937521|471920460|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131078477|NCT00937521|471920461|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
131078478|NCT00937521|471920462|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
131078479|NCT00937521|471920455|FG000|Booster Phase|Adverse Event|0|||
131078480|NCT00937521|471920456|FG001|Booster Phase|Adverse Event|0|||
131078481|NCT00937521|471920457|FG002|Booster Phase|Adverse Event|0|||
131078482|NCT00937521|471920458|FG003|Booster Phase|Adverse Event|0|||
131078483|NCT00937521|471920459|FG004|Booster Phase|Adverse Event|0|||
130780077|NCT04771013|470821397|FG001|Overall Study|Referred to another hospital before day 20|1|||
130780078|NCT00419757|470821399|FG000|Overall Study|Adverse Event|1|||
130780079|NCT00419757|470821400|FG001|Overall Study|Adverse Event|4|||
130780080|NCT00419757|470821399|FG000|Overall Study|Lost to Follow-up|1|||
130780081|NCT00419757|470821400|FG001|Overall Study|Lost to Follow-up|4|||
130780082|NCT00419757|470821399|FG000|Overall Study|Withdrawal by Subject|7|||
131078484|NCT00937521|471920460|FG005|Booster Phase|Adverse Event|0|||
131078485|NCT00937521|471920461|FG006|Booster Phase|Adverse Event|1|||
131078486|NCT00937521|471920462|FG007|Booster Phase|Adverse Event|0|||
130726501|NCT03146962|470623106|FG000|Overall Study|Lost to Follow-up|1|||
130726502|NCT03146962|470623107|FG001|Overall Study|Lost to Follow-up|1|||
130726503|NCT03146962|470623108|FG002|Overall Study|Lost to Follow-up|0|||
130726504|NCT03146962|470623109|FG003|Overall Study|Lost to Follow-up|0|||
130726505|NCT03146962|470623110|FG004|Overall Study|Lost to Follow-up|0|||
130726506|NCT03146962|470623111|FG005|Overall Study|Lost to Follow-up|0|||
130726507|NCT03146962|470623112|FG006|Overall Study|Lost to Follow-up|0|||
130726508|NCT03146962|470623113|FG007|Overall Study|Lost to Follow-up|0|||
130726509|NCT03146962|470623114|FG008|Overall Study|Lost to Follow-up|0|||
130726510|NCT03146962|470623115|FG009|Overall Study|Lost to Follow-up|0|||
130726511|NCT03146962|470623106|FG000|Overall Study|Adverse Event|0|||
130726512|NCT03146962|470623107|FG001|Overall Study|Adverse Event|3|||
130726513|NCT03146962|470623108|FG002|Overall Study|Adverse Event|0|||
130726514|NCT03146962|470623109|FG003|Overall Study|Adverse Event|0|||
130726515|NCT03146962|470623110|FG004|Overall Study|Adverse Event|0|||
130726516|NCT03146962|470623111|FG005|Overall Study|Adverse Event|0|||
130726517|NCT03146962|470623112|FG006|Overall Study|Adverse Event|0|||
130726518|NCT03146962|470623113|FG007|Overall Study|Adverse Event|1|||
130726519|NCT03146962|470623114|FG008|Overall Study|Adverse Event|0|||
130726520|NCT03146962|470623115|FG009|Overall Study|Adverse Event|0|||
130780083|NCT00419757|470821400|FG001|Overall Study|Withdrawal by Subject|1|||
131078487|NCT00937521|471920455|FG000|Booster Phase|Withdrawal by Subject|1|||
131078488|NCT00937521|471920456|FG001|Booster Phase|Withdrawal by Subject|0|||
131078489|NCT00937521|471920457|FG002|Booster Phase|Withdrawal by Subject|0|||
131078490|NCT00937521|471920458|FG003|Booster Phase|Withdrawal by Subject|1|||
131078491|NCT00937521|471920459|FG004|Booster Phase|Withdrawal by Subject|0|||
131078492|NCT00937521|471920460|FG005|Booster Phase|Withdrawal by Subject|0|||
131078493|NCT00937521|471920461|FG006|Booster Phase|Withdrawal by Subject|0|||
131078494|NCT00937521|471920462|FG007|Booster Phase|Withdrawal by Subject|2|||
131078495|NCT00937521|471920455|FG000|Booster Phase|Lost to Follow-up|2|||
131078496|NCT00937521|471920456|FG001|Booster Phase|Lost to Follow-up|2|||
131078497|NCT00937521|471920457|FG002|Booster Phase|Lost to Follow-up|4|||
131078498|NCT00937521|471920458|FG003|Booster Phase|Lost to Follow-up|2|||
131078499|NCT00937521|471920459|FG004|Booster Phase|Lost to Follow-up|4|||
131078500|NCT00937521|471920460|FG005|Booster Phase|Lost to Follow-up|4|||
131078501|NCT00937521|471920461|FG006|Booster Phase|Lost to Follow-up|3|||
131078502|NCT00937521|471920462|FG007|Booster Phase|Lost to Follow-up|0|||
131078503|NCT00937521|471920455|FG000|Booster Phase|Administrative Reason|0|||
131078504|NCT00937521|471920456|FG001|Booster Phase|Administrative Reason|0|||
131078505|NCT00937521|471920457|FG002|Booster Phase|Administrative Reason|1|||
131078506|NCT00937521|471920458|FG003|Booster Phase|Administrative Reason|0|||
131078507|NCT00937521|471920459|FG004|Booster Phase|Administrative Reason|1|||
131078508|NCT00937521|471920460|FG005|Booster Phase|Administrative Reason|1|||
131078509|NCT00937521|471920461|FG006|Booster Phase|Administrative Reason|0|||
131078510|NCT00937521|471920462|FG007|Booster Phase|Administrative Reason|0|||
131078511|NCT00937521|471920455|FG000|Booster Phase|Protocol Deviation|0|||
131078512|NCT00937521|471920456|FG001|Booster Phase|Protocol Deviation|0|||
131078513|NCT00937521|471920457|FG002|Booster Phase|Protocol Deviation|0|||
131078514|NCT00937521|471920458|FG003|Booster Phase|Protocol Deviation|0|||
131078515|NCT00937521|471920459|FG004|Booster Phase|Protocol Deviation|0|||
131078516|NCT00937521|471920460|FG005|Booster Phase|Protocol Deviation|0|||
131078517|NCT00937521|471920461|FG006|Booster Phase|Protocol Deviation|1|||
131078518|NCT00937521|471920462|FG007|Booster Phase|Protocol Deviation|0|||
131078519|NCT00874497|471920466|FG000|Overall Study|Lost to Follow-up|2|||
131078520|NCT00874497|471920467|FG001|Overall Study|Lost to Follow-up|4|||
131078521|NCT00874497|471920466|FG000|Overall Study|Adverse Event|9|||
131078522|NCT00874497|471920467|FG001|Overall Study|Adverse Event|4|||
131078523|NCT00874497|471920466|FG000|Overall Study|Sponsor Discontinued Trial|7|||
131078524|NCT00874497|471920467|FG001|Overall Study|Sponsor Discontinued Trial|3|||
131078525|NCT00874497|471920466|FG000|Overall Study|Met Withdrawal Criteria|4|||
131078526|NCT00874497|471920467|FG001|Overall Study|Met Withdrawal Criteria|2|||
131078527|NCT00874497|471920466|FG000|Overall Study|Physician Decision|1|||
131078528|NCT00874497|471920467|FG001|Overall Study|Physician Decision|1|||
131078529|NCT00874497|471920466|FG000|Overall Study|Withdrawal by Subject|5|||
131078530|NCT00874497|471920467|FG001|Overall Study|Withdrawal by Subject|4|||
131078531|NCT01017263|471920468|FG000|Overall Study|not eligible|12|||
131078532|NCT02980705|471920469|FG000|Overall Study|Adverse Event|0|||
130726521|NCT03146962|470623106|FG000|Overall Study|Withdrawal by Subject|0|||
130726522|NCT03146962|470623107|FG001|Overall Study|Withdrawal by Subject|0|||
131078533|NCT02980705|471920470|FG001|Overall Study|Adverse Event|1|||
131078534|NCT02980705|471920469|FG000|Overall Study|Withdrawal by Subject|6|||
131078535|NCT02980705|471920470|FG001|Overall Study|Withdrawal by Subject|9|||
131078536|NCT02980705|471920469|FG000|Overall Study|withdrew participation|0|||
131078537|NCT02980705|471920470|FG001|Overall Study|withdrew participation|1|||
131078538|NCT02980705|471920469|FG000|Overall Study|Lost to Follow-up|2|||
131078539|NCT02980705|471920470|FG001|Overall Study|Lost to Follow-up|0|||
131078540|NCT00263575|471920471|FG000|Titration Period|Adverse Event|14|||
131078541|NCT00263575|471920471|FG000|Titration Period|Withdrawal by Subject|10|||
131078542|NCT00263575|471920471|FG000|Titration Period|Protocol Violation|9|||
130726523|NCT03146962|470623108|FG002|Overall Study|Withdrawal by Subject|0|||
130726524|NCT03146962|470623109|FG003|Overall Study|Withdrawal by Subject|0|||
130726525|NCT03146962|470623110|FG004|Overall Study|Withdrawal by Subject|1|||
130726526|NCT03146962|470623111|FG005|Overall Study|Withdrawal by Subject|0|||
130726527|NCT03146962|470623112|FG006|Overall Study|Withdrawal by Subject|0|||
130726528|NCT03146962|470623113|FG007|Overall Study|Withdrawal by Subject|0|||
130726529|NCT03146962|470623114|FG008|Overall Study|Withdrawal by Subject|0|||
130726530|NCT03146962|470623115|FG009|Overall Study|Withdrawal by Subject|0|||
130726531|NCT03146962|470623106|FG000|Overall Study|Death|0|||
130726532|NCT03146962|470623107|FG001|Overall Study|Death|1|||
130726533|NCT03146962|470623108|FG002|Overall Study|Death|0|||
130726534|NCT03146962|470623109|FG003|Overall Study|Death|0|||
130726535|NCT03146962|470623110|FG004|Overall Study|Death|0|||
130726536|NCT03146962|470623111|FG005|Overall Study|Death|0|||
131078543|NCT00263575|471920471|FG000|Titration Period|Sponsor Decision|2|||
131078544|NCT00263575|471920471|FG000|Titration Period|Other|2|||
131078545|NCT00263575|471920471|FG000|Titration Period|Lack of Efficacy|6|||
131078546|NCT00263575|471920471|FG000|Maintence Period|Adverse Event|23|||
131078547|NCT00263575|471920471|FG000|Maintence Period|Withdrawal by Subject|8|||
131078548|NCT00263575|471920471|FG000|Maintence Period|Protocol Violation|4|||
131078549|NCT00263575|471920471|FG000|Maintence Period|Lack of Efficacy|4|||
131078550|NCT00263575|471920471|FG000|Maintence Period|Physician Decision|6|||
131078551|NCT00263575|471920471|FG000|Maintence Period|Lost to Follow-up|1|||
131078552|NCT00263575|471920471|FG000|Maintence Period|Sponsor Decision|24|||
131078553|NCT00263575|471920471|FG000|Maintence Period|Other|7|||
131078554|NCT04353817|471920472|FG000|Overall Study|Adverse Event|0|||
131078555|NCT04353817|471920473|FG001|Overall Study|Adverse Event|1|||
131078556|NCT02447718|471920474|FG000|Overall Study|Lost to Follow-up|8|||
131078557|NCT02447718|471920475|FG001|Overall Study|Lost to Follow-up|0|||
131078558|NCT02447718|471920474|FG000|Overall Study|Withdrawal by Subject|3|||
131078559|NCT02447718|471920475|FG001|Overall Study|Withdrawal by Subject|0|||
131078560|NCT02447718|471920474|FG000|Overall Study|Screen Failure|1|||
131078561|NCT02447718|471920475|FG001|Overall Study|Screen Failure|0|||
131078562|NCT00239681|471920476|FG000|Overall Study|Adverse Event|100|||
131078563|NCT00239681|471920477|FG001|Overall Study|Adverse Event|99|||
131078564|NCT00239681|471920476|FG000|Overall Study|Withdrawal by Subject|458|||
131078565|NCT00239681|471920477|FG001|Overall Study|Withdrawal by Subject|489|||
131078566|NCT00239681|471920476|FG000|Overall Study|Lost to Follow-up|28|||
131078567|NCT00239681|471920477|FG001|Overall Study|Lost to Follow-up|22|||
131078568|NCT00239681|471920476|FG000|Overall Study|Protocol Violation|4|||
131078569|NCT00239681|471920477|FG001|Overall Study|Protocol Violation|4|||
131078570|NCT00239681|471920476|FG000|Overall Study|Physician Decision|13|||
131078571|NCT00239681|471920477|FG001|Overall Study|Physician Decision|17|||
131078572|NCT00239681|471920476|FG000|Overall Study|No information chacked on CaseReportForm|90|||
131078573|NCT00239681|471920477|FG001|Overall Study|No information chacked on CaseReportForm|84|||
131078574|NCT03599622|471920482|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
131078575|NCT03599622|471920483|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
131078576|NCT03599622|471920484|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
131078577|NCT03599622|471920485|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
131078578|NCT03599622|471920482|FG000|Pre-Treatment Period|Other reasons|1|||
131078579|NCT03599622|471920483|FG001|Pre-Treatment Period|Other reasons|1|||
131078580|NCT03599622|471920484|FG002|Pre-Treatment Period|Other reasons|1|||
131078581|NCT03599622|471920485|FG003|Pre-Treatment Period|Other reasons|0|||
131078582|NCT03599622|471920482|FG000|Treatment Period|Adverse Event|11|||
131078583|NCT03599622|471920483|FG001|Treatment Period|Adverse Event|20|||
131078584|NCT03599622|471920484|FG002|Treatment Period|Adverse Event|18|||
131078585|NCT03599622|471920485|FG003|Treatment Period|Adverse Event|2|||
131078586|NCT03599622|471920482|FG000|Treatment Period|Lack of Efficacy|18|||
131078587|NCT03599622|471920483|FG001|Treatment Period|Lack of Efficacy|12|||
131078588|NCT03599622|471920484|FG002|Treatment Period|Lack of Efficacy|13|||
131078589|NCT03599622|471920485|FG003|Treatment Period|Lack of Efficacy|2|||
131078590|NCT03599622|471920482|FG000|Treatment Period|Withdrawal by Subject|5|||
131078591|NCT03599622|471920483|FG001|Treatment Period|Withdrawal by Subject|11|||
131078592|NCT03599622|471920484|FG002|Treatment Period|Withdrawal by Subject|16|||
130726537|NCT03146962|470623112|FG006|Overall Study|Death|0|||
130726538|NCT03146962|470623113|FG007|Overall Study|Death|0|||
130726539|NCT03146962|470623114|FG008|Overall Study|Death|0|||
130726540|NCT03146962|470623115|FG009|Overall Study|Death|0|||
130726541|NCT03146962|470623106|FG000|Overall Study|COVID Precautions|1|||
131078593|NCT03599622|471920485|FG003|Treatment Period|Withdrawal by Subject|1|||
131078594|NCT03599622|471920482|FG000|Treatment Period|Other reasons|4|||
131078595|NCT03599622|471920483|FG001|Treatment Period|Other reasons|6|||
131078596|NCT03599622|471920484|FG002|Treatment Period|Other reasons|7|||
131078597|NCT03599622|471920485|FG003|Treatment Period|Other reasons|0|||
131078598|NCT03599622|471920482|FG000|Treatment Period|Lost to Follow-up|1|||
131078599|NCT03599622|471920483|FG001|Treatment Period|Lost to Follow-up|0|||
131078600|NCT03599622|471920484|FG002|Treatment Period|Lost to Follow-up|0|||
131078601|NCT03599622|471920485|FG003|Treatment Period|Lost to Follow-up|0|||
131078602|NCT03599622|471920482|FG000|Treatment Period|Study terminated by sponsor|7|||
131078603|NCT03599622|471920483|FG001|Treatment Period|Study terminated by sponsor|20|||
131078604|NCT03599622|471920484|FG002|Treatment Period|Study terminated by sponsor|15|||
130726542|NCT03146962|470623107|FG001|Overall Study|COVID Precautions|0|||
130726543|NCT03146962|470623108|FG002|Overall Study|COVID Precautions|0|||
130726544|NCT03146962|470623109|FG003|Overall Study|COVID Precautions|0|||
130726545|NCT03146962|470623110|FG004|Overall Study|COVID Precautions|0|||
130726546|NCT03146962|470623111|FG005|Overall Study|COVID Precautions|0|||
130726547|NCT03146962|470623112|FG006|Overall Study|COVID Precautions|0|||
130726548|NCT03146962|470623113|FG007|Overall Study|COVID Precautions|0|||
130726549|NCT03146962|470623114|FG008|Overall Study|COVID Precautions|0|||
130726550|NCT03146962|470623115|FG009|Overall Study|COVID Precautions|0|||
130726551|NCT03146962|470623106|FG000|Overall Study|Physician Decision|0|||
130726552|NCT03146962|470623107|FG001|Overall Study|Physician Decision|0|||
130726553|NCT03146962|470623108|FG002|Overall Study|Physician Decision|0|||
130726554|NCT03146962|470623109|FG003|Overall Study|Physician Decision|0|||
130726555|NCT03146962|470623110|FG004|Overall Study|Physician Decision|0|||
130726556|NCT03146962|470623111|FG005|Overall Study|Physician Decision|0|||
130726557|NCT03146962|470623112|FG006|Overall Study|Physician Decision|0|||
130726558|NCT03146962|470623113|FG007|Overall Study|Physician Decision|0|||
130726559|NCT03146962|470623114|FG008|Overall Study|Physician Decision|0|||
130726560|NCT03146962|470623115|FG009|Overall Study|Physician Decision|1|||
130726561|NCT03146962|470623106|FG000|Overall Study|Started New Treatment|0|||
130726562|NCT03146962|470623107|FG001|Overall Study|Started New Treatment|1|||
130726563|NCT03146962|470623108|FG002|Overall Study|Started New Treatment|0|||
130726564|NCT03146962|470623109|FG003|Overall Study|Started New Treatment|0|||
130726565|NCT03146962|470623110|FG004|Overall Study|Started New Treatment|0|||
130726566|NCT03146962|470623111|FG005|Overall Study|Started New Treatment|0|||
130726567|NCT03146962|470623112|FG006|Overall Study|Started New Treatment|0|||
130726568|NCT03146962|470623113|FG007|Overall Study|Started New Treatment|0|||
130726569|NCT03146962|470623114|FG008|Overall Study|Started New Treatment|0|||
130726570|NCT03146962|470623115|FG009|Overall Study|Started New Treatment|0|||
130726571|NCT04497948|470623118|FG000|Overall Study|Death|2|||
130726572|NCT02246114|470623121|FG000|Overall Study|miscarriage|1|||
130726573|NCT02246114|470623122|FG001|Overall Study|miscarriage|0|||
131078605|NCT03599622|471920485|FG003|Treatment Period|Study terminated by sponsor|0|||
131078606|NCT03599622|471920482|FG000|Treatment Period|Site terminated by sponsor|0|||
131078607|NCT03599622|471920483|FG001|Treatment Period|Site terminated by sponsor|1|||
131078608|NCT03599622|471920484|FG002|Treatment Period|Site terminated by sponsor|0|||
131078609|NCT03599622|471920485|FG003|Treatment Period|Site terminated by sponsor|0|||
131078610|NCT00770588|471920486|FG000|Overall Study|Adverse Event|9|||
131078611|NCT00770588|471920487|FG001|Overall Study|Adverse Event|2|||
131078612|NCT00770588|471920486|FG000|Overall Study|Death caused by progression of disease|70|||
131078613|NCT00770588|471920487|FG001|Overall Study|Death caused by progression of disease|91|||
131078614|NCT00770588|471920486|FG000|Overall Study|Lost to Follow-up|1|||
131078615|NCT00770588|471920487|FG001|Overall Study|Lost to Follow-up|1|||
131078616|NCT00770588|471920486|FG000|Overall Study|Withdrawal by Subject|1|||
131078617|NCT00770588|471920487|FG001|Overall Study|Withdrawal by Subject|1|||
131078618|NCT00665223|471920488|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
131078619|NCT00665223|471920489|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
131078620|NCT00665223|471920490|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
131078621|NCT00665223|471920488|FG000|Randomized Phase (26 Weeks)|Death|0|||
131078622|NCT00665223|471920489|FG001|Randomized Phase (26 Weeks)|Death|0|||
131078623|NCT00665223|471920490|FG002|Randomized Phase (26 Weeks)|Death|1|||
131078624|NCT00665223|471920488|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
131078625|NCT00665223|471920489|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
131078626|NCT00665223|471920490|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
131139629|NCT03222349|472138085|FG001|Overall Study|Treatment B not done|0|||
131139630|NCT03222349|472138084|FG000|Overall Study|Lost to Follow-up|1|||
131139631|NCT03222349|472138085|FG001|Overall Study|Lost to Follow-up|2|||
131139632|NCT03222349|472138084|FG000|Overall Study|Withdrawal by Subject|1|||
131078627|NCT00665223|471920488|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
131078628|NCT00665223|471920489|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
130726574|NCT00129389|470623123|FG000|Overall Study|Adverse Event|19|||
130726575|NCT00129389|470623124|FG001|Overall Study|Adverse Event|87|||
130726576|NCT00129389|470623123|FG000|Overall Study|Death|0|||
130726577|NCT00129389|470623124|FG001|Overall Study|Death|1|||
130726578|NCT00129389|470623123|FG000|Overall Study|Lost to Follow-up|2|||
130726579|NCT00129389|470623124|FG001|Overall Study|Lost to Follow-up|1|||
130726580|NCT00129389|470623123|FG000|Overall Study|Physician Decision|0|||
130726581|NCT00129389|470623124|FG001|Overall Study|Physician Decision|4|||
130726582|NCT00129389|470623123|FG000|Overall Study|Protocol Violation|0|||
131078629|NCT00665223|471920490|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
131078630|NCT00665223|471920488|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
131078631|NCT00665223|471920489|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
131078632|NCT00665223|471920490|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
131139633|NCT03222349|472138085|FG001|Overall Study|Withdrawal by Subject|0|||
131139634|NCT03222349|472138084|FG000|Overall Study|Treatment A not done|0|||
130726583|NCT00129389|470623124|FG001|Overall Study|Protocol Violation|6|||
130726584|NCT00129389|470623123|FG000|Overall Study|Withdrawal by Subject|9|||
130726585|NCT00129389|470623124|FG001|Overall Study|Withdrawal by Subject|23|||
130726586|NCT00129389|470623123|FG000|Overall Study|Relapse|1|||
130726587|NCT00129389|470623124|FG001|Overall Study|Relapse|0|||
130726588|NCT00129389|470623123|FG000|Overall Study|Not eligible|1|||
130726589|NCT00129389|470623124|FG001|Overall Study|Not eligible|2|||
130726590|NCT00129389|470623123|FG000|Overall Study|Crossed to the other arm|1|||
130726591|NCT00129389|470623124|FG001|Overall Study|Crossed to the other arm|16|||
130726592|NCT03760185|470623125|FG000|Overall Study|Lost to Follow-up|1|||
130726593|NCT03760185|470623126|FG001|Overall Study|Lost to Follow-up|1|||
130726594|NCT01191944|470623127|FG000|Overall Study|Adverse Event|11|||
130726595|NCT01191944|470623128|FG001|Overall Study|Adverse Event|12|||
130726596|NCT01191944|470623127|FG000|Overall Study|Protocol Violation|1|||
130726597|NCT01191944|470623128|FG001|Overall Study|Protocol Violation|2|||
130726598|NCT01191944|470623127|FG000|Overall Study|Withdrawal by Subject|4|||
130726599|NCT01191944|470623128|FG001|Overall Study|Withdrawal by Subject|2|||
130726600|NCT01191944|470623127|FG000|Overall Study|Other|1|||
130726601|NCT01191944|470623128|FG001|Overall Study|Other|3|||
130726602|NCT00603837|470623131|FG000|Overall Study|Physician Decision|3|||
130726603|NCT00603837|470623132|FG001|Overall Study|Physician Decision|0|||
130726604|NCT04611529|470623133|FG000|2-day Follow up|Lost to Follow-up|5|||
130726605|NCT04611529|470623134|FG001|2-day Follow up|Lost to Follow-up|6|||
130726606|NCT04611529|470623135|FG002|2-day Follow up|Lost to Follow-up|3|||
130726607|NCT01275729|470623203|FG000|Overall Study|Death|3|||
130726608|NCT01275729|470623203|FG000|Overall Study|Withdrawal by Subject|1|||
130726609|NCT02252406|470623204|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
130726610|NCT02252406|470623205|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
130726611|NCT02252406|470623204|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
130726612|NCT02252406|470623205|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
130726613|NCT02252406|470623204|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
130726614|NCT02252406|470623205|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
130726615|NCT02252406|470623204|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
130726616|NCT02252406|470623205|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
130726617|NCT02252406|470623204|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
130726618|NCT02252406|470623205|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
130726619|NCT03717012|470623210|FG000|Overall Study|Due to trial termination|1|||
130726620|NCT03717012|470623211|FG001|Overall Study|Due to trial termination|2|||
130726621|NCT03717012|470623210|FG000|Overall Study|Protocol Violation|0|||
130726622|NCT03717012|470623211|FG001|Overall Study|Protocol Violation|2|||
130726623|NCT03717012|470623210|FG000|Overall Study|Adverse Event|0|||
130726624|NCT03717012|470623211|FG001|Overall Study|Adverse Event|1|||
130726625|NCT03717012|470623210|FG000|Overall Study|Lung transplant|0|||
130726626|NCT03717012|470623211|FG001|Overall Study|Lung transplant|1|||
130726627|NCT00789035|470623212|FG000|Overall Study|Adverse Event|0|||
130726628|NCT00789035|470623213|FG001|Overall Study|Adverse Event|2|||
130726629|NCT00789035|470623214|FG002|Overall Study|Adverse Event|0|||
130726630|NCT00789035|470623215|FG003|Overall Study|Adverse Event|1|||
130726631|NCT00789035|470623216|FG004|Overall Study|Adverse Event|3|||
130726632|NCT00789035|470623212|FG000|Overall Study|Lack of Efficacy|3|||
130726633|NCT00789035|470623213|FG001|Overall Study|Lack of Efficacy|0|||
130726634|NCT00789035|470623214|FG002|Overall Study|Lack of Efficacy|0|||
130726635|NCT00789035|470623215|FG003|Overall Study|Lack of Efficacy|0|||
130726636|NCT00789035|470623216|FG004|Overall Study|Lack of Efficacy|2|||
130726637|NCT00789035|470623212|FG000|Overall Study|Protocol Violation|1|||
130726638|NCT00789035|470623213|FG001|Overall Study|Protocol Violation|0|||
130726639|NCT00789035|470623214|FG002|Overall Study|Protocol Violation|0|||
130726640|NCT00789035|470623215|FG003|Overall Study|Protocol Violation|0|||
130726641|NCT00789035|470623216|FG004|Overall Study|Protocol Violation|0|||
130726642|NCT00789035|470623212|FG000|Overall Study|Withdrawal by Subject|0|||
130726643|NCT00789035|470623213|FG001|Overall Study|Withdrawal by Subject|2|||
130780084|NCT00419757|470821399|FG000|Overall Study|Protocol Violation|2|||
130726644|NCT00789035|470623214|FG002|Overall Study|Withdrawal by Subject|0|||
130726645|NCT00789035|470623215|FG003|Overall Study|Withdrawal by Subject|0|||
130780085|NCT00419757|470821400|FG001|Overall Study|Protocol Violation|3|||
131078633|NCT00665223|471920488|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
130726646|NCT00789035|470623216|FG004|Overall Study|Withdrawal by Subject|0|||
131078634|NCT00665223|471920489|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
130726647|NCT00789035|470623212|FG000|Overall Study|Other reason not defined above|2|||
130726648|NCT00789035|470623213|FG001|Overall Study|Other reason not defined above|3|||
130726649|NCT00789035|470623214|FG002|Overall Study|Other reason not defined above|1|||
130726650|NCT00789035|470623215|FG003|Overall Study|Other reason not defined above|0|||
130726651|NCT00789035|470623216|FG004|Overall Study|Other reason not defined above|1|||
130726652|NCT02640690|470623217|FG000|Overall Study|Lost to Follow-up|7|||
130726653|NCT02640690|470623218|FG001|Overall Study|Lost to Follow-up|7|||
130726654|NCT02640690|470623217|FG000|Overall Study|Withdrawal by Subject|16|||
130726655|NCT02640690|470623218|FG001|Overall Study|Withdrawal by Subject|20|||
130780086|NCT00419757|470821399|FG000|Overall Study|Study specific discontinuation criteria|4|||
130780087|NCT00419757|470821400|FG001|Overall Study|Study specific discontinuation criteria|8|||
130780088|NCT00419757|470821399|FG000|Overall Study|Multiple reasons|3|||
130780089|NCT00419757|470821400|FG001|Overall Study|Multiple reasons|1|||
130780090|NCT01128296|470821401|FG000|Overall Study|Physician Decision|0|||
130780091|NCT01128296|470821402|FG001|Overall Study|Physician Decision|0|||
130780092|NCT01128296|470821403|FG002|Overall Study|Physician Decision|0|||
130780093|NCT01128296|470821404|FG003|Overall Study|Physician Decision|0|||
130780094|NCT01128296|470821405|FG004|Overall Study|Physician Decision|0|||
130780095|NCT01128296|470821406|FG005|Overall Study|Physician Decision|3|||
130780096|NCT01128296|470821401|FG000|Overall Study|Withdrawal by Subject|0|||
130780097|NCT01128296|470821402|FG001|Overall Study|Withdrawal by Subject|0|||
130780098|NCT01128296|470821403|FG002|Overall Study|Withdrawal by Subject|0|||
130780099|NCT01128296|470821404|FG003|Overall Study|Withdrawal by Subject|0|||
130780100|NCT01128296|470821405|FG004|Overall Study|Withdrawal by Subject|0|||
131078635|NCT00665223|471920490|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
131078636|NCT00665223|471920488|FG000|Open-Label Period (26 Weeks)|Death|0|||
131078637|NCT00665223|471920489|FG001|Open-Label Period (26 Weeks)|Death|1|||
131078638|NCT00665223|471920490|FG002|Open-Label Period (26 Weeks)|Death|0|||
131078639|NCT00665223|471920488|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
131078640|NCT00665223|471920489|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
131078641|NCT00665223|471920490|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
131078642|NCT00665223|471920488|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
131078643|NCT00665223|471920489|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
131078644|NCT00665223|471920490|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
131078645|NCT00665223|471920488|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
131078646|NCT00665223|471920489|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
131078647|NCT00665223|471920490|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
131078648|NCT00665223|471920488|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
131078649|NCT00665223|471920489|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
131078650|NCT00665223|471920490|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
131078651|NCT00002597|471920491|FG000|Overall Study|Protocol Violation|19|||
131078652|NCT00002597|471920492|FG001|Overall Study|Protocol Violation|17|||
131078653|NCT00002597|471920491|FG000|Overall Study|Withdrawal by Subject|7|||
131078654|NCT00002597|471920492|FG001|Overall Study|Withdrawal by Subject|6|||
131078655|NCT01426113|471920493|FG000|Overall Study|Study Discontinued|1|||
131078656|NCT01426113|471920494|FG001|Overall Study|Study Discontinued|1|||
131078657|NCT01426113|471920493|FG000|Overall Study|Adverse Event|0|||
131078658|NCT01426113|471920494|FG001|Overall Study|Adverse Event|1|||
131078659|NCT02485899|471920495|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
131078660|NCT02485899|471920496|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131078661|NCT02485899|471920495|FG000|Overall Study|Withdrawal by Subject|1|||
130780101|NCT01128296|470821406|FG005|Overall Study|Withdrawal by Subject|2|||
131078662|NCT02485899|471920496|FG001|Overall Study|Withdrawal by Subject|0|||
131078663|NCT02485899|471920495|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
131078664|NCT02485899|471920496|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
131078665|NCT01918371|471920497|FG000|Overall Study|Missing Data|1|||
131078666|NCT01918371|471920498|FG001|Overall Study|Missing Data|1|||
131078667|NCT01006889|471920499|FG000|Overall Study|Withdrawal by Subject|3|||
131078668|NCT00623363|471920500|FG000|Overall Study|Adverse Event|2|||
131078669|NCT00623363|471920501|FG001|Overall Study|Adverse Event|2|||
131078670|NCT00823836|471920503|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
131078671|NCT00823836|471920504|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
131078672|NCT00823836|471920503|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
131078673|NCT00823836|471920504|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
131078674|NCT00823836|471920503|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
131078675|NCT00823836|471920504|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
131078676|NCT00823836|471920503|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
131078677|NCT00823836|471920504|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
131078678|NCT00823836|471920503|FG000|Long-term Phase|Adverse Event|3|||
131078679|NCT00823836|471920504|FG001|Long-term Phase|Adverse Event|2|||
131078680|NCT00823836|471920503|FG000|Long-term Phase|Physician Decision|1|||
130780102|NCT01914393|470821407|FG000|Overall Study|Protocol Violation|11|||
131078681|NCT00823836|471920504|FG001|Long-term Phase|Physician Decision|2|||
130780103|NCT01914393|470821408|FG001|Overall Study|Protocol Violation|3|||
130780104|NCT01914393|470821409|FG002|Overall Study|Protocol Violation|19|||
130780105|NCT01914393|470821407|FG000|Overall Study|Lack of Efficacy|11|||
130780106|NCT01914393|470821408|FG001|Overall Study|Lack of Efficacy|16|||
131078682|NCT00823836|471920503|FG000|Long-term Phase|Withdrawal by Subject|1|||
131078683|NCT00823836|471920504|FG001|Long-term Phase|Withdrawal by Subject|1|||
131078684|NCT02725528|471920509|FG000|Overall Study|Lost to Follow-up|1|||
131078685|NCT02725528|471920510|FG001|Overall Study|Lost to Follow-up|4|||
131078686|NCT02725528|471920509|FG000|Overall Study|Withdrawal by Subject|0|||
131078687|NCT02725528|471920510|FG001|Overall Study|Withdrawal by Subject|1|||
131078688|NCT02062645|471920512|FG000|Overall Study|Adverse Event|2|||
131078689|NCT02062645|471920512|FG000|Overall Study|Protocol Violation|8|||
131078690|NCT02062645|471920512|FG000|Overall Study|Lost to Follow-up|5|||
131078691|NCT00798304|471920513|FG000|Overall Study|Adverse Event|0|||
131078692|NCT00798304|471920514|FG001|Overall Study|Adverse Event|1|||
131078693|NCT00798304|471920515|FG002|Overall Study|Adverse Event|1|||
131078694|NCT00798304|471920513|FG000|Overall Study|Discontinuation by Sponsor|14|||
131078695|NCT00798304|471920514|FG001|Overall Study|Discontinuation by Sponsor|21|||
131078696|NCT00798304|471920515|FG002|Overall Study|Discontinuation by Sponsor|9|||
131078697|NCT04211389|471920516|FG000|Overall Study|Adverse Event|1|||
131078698|NCT04211389|471920517|FG001|Overall Study|Adverse Event|2|||
131078699|NCT04211389|471920516|FG000|Overall Study|Lost to Follow-up|15|||
131078700|NCT04211389|471920517|FG001|Overall Study|Lost to Follow-up|7|||
131078701|NCT04211389|471920516|FG000|Overall Study|Protocol Violation|0|||
131078702|NCT04211389|471920517|FG001|Overall Study|Protocol Violation|1|||
131078703|NCT04211389|471920516|FG000|Overall Study|Withdrawal by Subject|10|||
131078704|NCT04211389|471920517|FG001|Overall Study|Withdrawal by Subject|11|||
131078705|NCT01062971|471920520|FG000|Overall Study|Protocol Violation|1|||
131078706|NCT01062971|471920521|FG001|Overall Study|Protocol Violation|3|||
131078707|NCT01062971|471920520|FG000|Overall Study|Lost to Follow-up|3|||
131078708|NCT01062971|471920521|FG001|Overall Study|Lost to Follow-up|4|||
131078709|NCT01530087|471920522|FG000|Overall Study|Physician Decision|2|||
131078710|NCT01161628|471920523|FG000|Overall Study|Death|6|||
131078711|NCT01161628|471920523|FG000|Overall Study|Lack of Efficacy|2|||
131078712|NCT04811339|471920535|FG000|Overall Study|lack of transportation not wanting to return|4|||
131078713|NCT04811339|471920536|FG001|Overall Study|lack of transportation not wanting to return|8|||
131078714|NCT04811339|471920537|FG002|Overall Study|lack of transportation not wanting to return|0|||
131078715|NCT04811339|471920535|FG000|Overall Study|Adverse Event|3|||
131078716|NCT04811339|471920536|FG001|Overall Study|Adverse Event|0|||
131078717|NCT04811339|471920537|FG002|Overall Study|Adverse Event|0|||
131078718|NCT04811339|471920535|FG000|Overall Study|Lost to Follow-up|1|||
131078719|NCT04811339|471920536|FG001|Overall Study|Lost to Follow-up|0|||
131078720|NCT04811339|471920537|FG002|Overall Study|Lost to Follow-up|0|||
131078721|NCT04811339|471920535|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
131078722|NCT04811339|471920536|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
131078723|NCT04811339|471920537|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
131078724|NCT04811339|471920535|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
131078725|NCT04811339|471920536|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
131078726|NCT04811339|471920537|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
131078727|NCT04811339|471920535|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
131078728|NCT04811339|471920536|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
131078729|NCT04811339|471920537|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
131078730|NCT04811339|471920535|FG000|Overall Study|Withdrawal by Subject|0|||
131078731|NCT04811339|471920536|FG001|Overall Study|Withdrawal by Subject|3|||
131078732|NCT04811339|471920537|FG002|Overall Study|Withdrawal by Subject|0|||
131078733|NCT04811339|471920535|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
131078734|NCT04811339|471920536|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
131078735|NCT04811339|471920537|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
131078736|NCT04811339|471920535|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
131078737|NCT04811339|471920536|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
131078738|NCT04811339|471920537|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
131231658|NCT03083483|472475182|FG001|Overall Study|technological issues|0|||
130726656|NCT02640690|470623217|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
130726657|NCT02640690|470623218|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
130726658|NCT01118975|470623219|FG000|Overall Study|Adverse Event|0|||
131078739|NCT01256671|471922846|FG000|Overall Study|Adverse Event|29|||
131078740|NCT01256671|471922846|FG000|Overall Study|Lost to Follow-up|16|||
131078741|NCT01256671|471922846|FG000|Overall Study|Withdrawal by Subject|31|||
131078742|NCT01256671|471922846|FG000|Overall Study|Physician Decision|3|||
131078743|NCT01256671|471922846|FG000|Overall Study|Lack of Efficacy|4|||
131078744|NCT01256671|471922846|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
131078745|NCT04009629|471922847|FG000|Overall Study|Withdrawal by Subject|2|||
131078746|NCT04009629|471922848|FG001|Overall Study|Withdrawal by Subject|0|||
131078747|NCT03602586|471922849|FG000|Overall Study|Withdrawal by Subject|3|||
131078748|NCT04523207|471922854|FG000|Overall Study|Adverse Event|5|||
131078749|NCT04523207|471922855|FG001|Overall Study|Adverse Event|1|||
131078750|NCT04523207|471922854|FG000|Overall Study|Lost to Follow-up|2|||
131078751|NCT04523207|471922855|FG001|Overall Study|Lost to Follow-up|0|||
131078752|NCT04523207|471922854|FG000|Overall Study|Withdrawal by Subject|2|||
131078753|NCT04523207|471922855|FG001|Overall Study|Withdrawal by Subject|0|||
131078754|NCT04523207|471922854|FG000|Overall Study|Progressive Disease|2|||
131078755|NCT04523207|471922855|FG001|Overall Study|Progressive Disease|1|||
130726659|NCT01118975|470623220|FG001|Overall Study|Adverse Event|1|||
130726660|NCT01520870|470623221|FG000|Overall Study|Withdrawal by Subject|2|||
130726661|NCT02463357|470623222|FG000|Overall Study|Withdrawal by Subject|1|||
130726662|NCT02463357|470623223|FG001|Overall Study|Withdrawal by Subject|0|||
130726663|NCT02463357|470623224|FG002|Overall Study|Withdrawal by Subject|0|||
130726664|NCT02463357|470623225|FG003|Overall Study|Withdrawal by Subject|0|||
130726665|NCT02463357|470623226|FG004|Overall Study|Withdrawal by Subject|0|||
130726666|NCT02463357|470623222|FG000|Overall Study|Withdrawal by Subject|0|||
130726667|NCT02463357|470623223|FG001|Overall Study|Withdrawal by Subject|0|||
130726668|NCT02463357|470623224|FG002|Overall Study|Withdrawal by Subject|0|||
130726669|NCT02463357|470623225|FG003|Overall Study|Withdrawal by Subject|0|||
130726670|NCT02463357|470623226|FG004|Overall Study|Withdrawal by Subject|1|||
131078756|NCT04523207|471922854|FG000|Overall Study|Other|7|||
131078757|NCT04523207|471922855|FG001|Overall Study|Other|1|||
131078758|NCT00328562|471922858|FG000|Overall Study|Disease progression|1|||
131078759|NCT04014790|471922859|FG000|Overall Study|Death|4|||
131078760|NCT04014790|471922859|FG000|Overall Study|Adverse Event|1|||
131078761|NCT04014790|471922859|FG000|Overall Study|Withdrawal by Subject|1|||
131078762|NCT01519778|471922860|FG000|Overall Study|Withdrawal by Subject|3|||
131078763|NCT01519778|471922860|FG000|Overall Study|Lost to Follow-up|10|||
131078764|NCT01519778|471922860|FG000|Overall Study|Physician Decision|1|||
131078765|NCT01657799|471922861|FG000|Overall Study|Adverse Event Related to progression|6|||
131078766|NCT01657799|471922862|FG001|Overall Study|Adverse Event Related to progression|8|||
131078767|NCT01657799|471922863|FG002|Overall Study|Adverse Event Related to progression|12|||
131078768|NCT01657799|471922861|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
131078769|NCT01657799|471922862|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
131078770|NCT01657799|471922863|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
131078771|NCT01657799|471922861|FG000|Overall Study|Withdrawal by Subject|13|||
131078772|NCT01657799|471922862|FG001|Overall Study|Withdrawal by Subject|10|||
131078773|NCT01657799|471922863|FG002|Overall Study|Withdrawal by Subject|10|||
131078774|NCT01657799|471922861|FG000|Overall Study|Lost to Follow-up|1|||
131078775|NCT01657799|471922862|FG001|Overall Study|Lost to Follow-up|0|||
131078776|NCT01657799|471922863|FG002|Overall Study|Lost to Follow-up|1|||
131078777|NCT01657799|471922861|FG000|Overall Study|Disease Progression|2|||
131078778|NCT01657799|471922862|FG001|Overall Study|Disease Progression|4|||
131078779|NCT01657799|471922863|FG002|Overall Study|Disease Progression|4|||
131078780|NCT01657799|471922861|FG000|Overall Study|Progressive Disease Clinical|7|||
131078781|NCT01657799|471922862|FG001|Overall Study|Progressive Disease Clinical|4|||
131078782|NCT01657799|471922863|FG002|Overall Study|Progressive Disease Clinical|7|||
131078783|NCT01657799|471922861|FG000|Overall Study|Radiographic & Clinical Progression|16|||
131078784|NCT01657799|471922862|FG001|Overall Study|Radiographic & Clinical Progression|11|||
130726671|NCT01399658|470623227|FG000|Overall Study|Ineligible|1|||
130726672|NCT01399658|470623227|FG000|Overall Study|Machine Technical Issue|3|||
130726673|NCT01399658|470623227|FG000|Overall Study|Alternative therapy|1|||
130726674|NCT01399658|470623227|FG000|Overall Study|No reason given|1|||
130726675|NCT02460679|470623228|FG000|Overall Study|Investigator Decision|1|||
130726676|NCT02460679|470623228|FG000|Overall Study|Withdrawal by Subject|4|||
130726677|NCT02620579|470623234|FG000|Overall Study|Physician Decision|0|||
130726678|NCT02620579|470623235|FG001|Overall Study|Physician Decision|0|||
130726679|NCT02620579|470623236|FG002|Overall Study|Physician Decision|0|||
130726680|NCT02620579|470623237|FG003|Overall Study|Physician Decision|1|||
130726681|NCT02620579|470623234|FG000|Overall Study|Withdrawal by Subject|0|||
130726682|NCT02620579|470623235|FG001|Overall Study|Withdrawal by Subject|1|||
130726683|NCT02620579|470623236|FG002|Overall Study|Withdrawal by Subject|1|||
131078785|NCT01657799|471922863|FG002|Overall Study|Radiographic & Clinical Progression|15|||
131078786|NCT01657799|471922861|FG000|Overall Study|Other|52|||
131078787|NCT01657799|471922862|FG001|Overall Study|Other|62|||
131078788|NCT01657799|471922863|FG002|Overall Study|Other|49|||
131078789|NCT00412880|471922864|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
131078790|NCT00412880|471922864|FG000|Overall Study|Consent withdrawn|1|||
131078791|NCT00412880|471922864|FG000|Overall Study|Adverse Event|1|||
131078792|NCT00412880|471922864|FG000|Overall Study|Progressive disease|20|||
131078793|NCT01288209|471922865|FG000|Overall Study|Withdrawal by Subject|1|||
131078794|NCT01288209|471922866|FG001|Overall Study|Withdrawal by Subject|3|||
131078795|NCT01288209|471922865|FG000|Overall Study|Other|1|||
130726684|NCT02620579|470623237|FG003|Overall Study|Withdrawal by Subject|0|||
130780107|NCT01914393|470821409|FG002|Overall Study|Lack of Efficacy|5|||
131078796|NCT01288209|471922866|FG001|Overall Study|Other|0|||
130726685|NCT00796107|470623238|FG000|Overall Study|Lack of Efficacy|1|||
130726686|NCT00796107|470623238|FG000|Overall Study|Progressive Disease|5|||
130726687|NCT04411914|470623239|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
130780108|NCT01914393|470821407|FG000|Overall Study|no reason given|14|||
131078797|NCT01496365|471922867|FG000|Overall Study|Adverse Event|2|||
131078798|NCT01496365|471922868|FG001|Overall Study|Adverse Event|3|||
131078799|NCT01496365|471922869|FG002|Overall Study|Adverse Event|3|||
131078800|NCT01496365|471922870|FG003|Overall Study|Adverse Event|2|||
131078801|NCT01496365|471922871|FG004|Overall Study|Adverse Event|5|||
130726688|NCT04411914|470623240|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
130726689|NCT01721317|470623242|FG000|Overall Study|Study Closed / Terminated|2|||
130726690|NCT01721317|470623243|FG001|Overall Study|Study Closed / Terminated|2|||
130726691|NCT01721317|470623242|FG000|Overall Study|Physician Decision|0|||
130726692|NCT01721317|470623243|FG001|Overall Study|Physician Decision|1|||
131078802|NCT01496365|471922872|FG005|Overall Study|Adverse Event|6|||
131078803|NCT01496365|471922873|FG006|Overall Study|Adverse Event|4|||
131078804|NCT01496365|471922867|FG000|Overall Study|Withdrawal by Subject|6|||
131078805|NCT01496365|471922868|FG001|Overall Study|Withdrawal by Subject|6|||
131078806|NCT01496365|471922869|FG002|Overall Study|Withdrawal by Subject|0|||
131078807|NCT01496365|471922870|FG003|Overall Study|Withdrawal by Subject|1|||
131078808|NCT01496365|471922871|FG004|Overall Study|Withdrawal by Subject|3|||
131078809|NCT01496365|471922872|FG005|Overall Study|Withdrawal by Subject|2|||
131078810|NCT01496365|471922873|FG006|Overall Study|Withdrawal by Subject|1|||
131078811|NCT01496365|471922867|FG000|Overall Study|Protocol Violation|2|||
131078812|NCT01496365|471922868|FG001|Overall Study|Protocol Violation|1|||
131078813|NCT01496365|471922869|FG002|Overall Study|Protocol Violation|1|||
131078814|NCT01496365|471922870|FG003|Overall Study|Protocol Violation|0|||
131078815|NCT01496365|471922871|FG004|Overall Study|Protocol Violation|0|||
131078816|NCT01496365|471922872|FG005|Overall Study|Protocol Violation|1|||
131078817|NCT01496365|471922873|FG006|Overall Study|Protocol Violation|0|||
131078818|NCT01496365|471922867|FG000|Overall Study|Lack of Efficacy|1|||
131078819|NCT01496365|471922868|FG001|Overall Study|Lack of Efficacy|0|||
131078820|NCT01496365|471922869|FG002|Overall Study|Lack of Efficacy|0|||
131078821|NCT01496365|471922870|FG003|Overall Study|Lack of Efficacy|0|||
131078822|NCT01496365|471922871|FG004|Overall Study|Lack of Efficacy|0|||
131078823|NCT01496365|471922872|FG005|Overall Study|Lack of Efficacy|1|||
131078824|NCT01496365|471922873|FG006|Overall Study|Lack of Efficacy|0|||
131078825|NCT01496365|471922867|FG000|Overall Study|Lost to Follow-up|0|||
131078826|NCT01496365|471922868|FG001|Overall Study|Lost to Follow-up|1|||
131078827|NCT01496365|471922869|FG002|Overall Study|Lost to Follow-up|0|||
131078828|NCT01496365|471922870|FG003|Overall Study|Lost to Follow-up|0|||
131078829|NCT01496365|471922871|FG004|Overall Study|Lost to Follow-up|2|||
131078830|NCT01496365|471922872|FG005|Overall Study|Lost to Follow-up|0|||
131078831|NCT01496365|471922873|FG006|Overall Study|Lost to Follow-up|0|||
131078832|NCT01496365|471922867|FG000|Overall Study|Other|4|||
131078833|NCT01496365|471922868|FG001|Overall Study|Other|4|||
131078834|NCT01496365|471922869|FG002|Overall Study|Other|2|||
131078835|NCT01496365|471922870|FG003|Overall Study|Other|1|||
131078836|NCT01496365|471922871|FG004|Overall Study|Other|3|||
131078837|NCT01496365|471922872|FG005|Overall Study|Other|0|||
131078838|NCT01496365|471922873|FG006|Overall Study|Other|1|||
131078839|NCT01015677|471922875|FG000|Overall Study|Adverse Event|0|||
131078840|NCT01015677|471922876|FG001|Overall Study|Adverse Event|1|||
131078841|NCT01015677|471922877|FG002|Overall Study|Adverse Event|0|||
131078842|NCT01015677|471922875|FG000|Overall Study|Lack of Efficacy|0|||
131078843|NCT01015677|471922876|FG001|Overall Study|Lack of Efficacy|1|||
131078844|NCT01015677|471922877|FG002|Overall Study|Lack of Efficacy|0|||
131078845|NCT01015677|471922875|FG000|Overall Study|Protocol Violation|0|||
131078846|NCT01015677|471922876|FG001|Overall Study|Protocol Violation|1|||
131078847|NCT01015677|471922877|FG002|Overall Study|Protocol Violation|0|||
131078848|NCT01015677|471922875|FG000|Overall Study|Withdrawal by Subject|1|||
131078849|NCT01015677|471922876|FG001|Overall Study|Withdrawal by Subject|1|||
131078850|NCT01015677|471922877|FG002|Overall Study|Withdrawal by Subject|0|||
131078851|NCT01646385|471922881|FG000|Overall Study|Death|202|||
131078852|NCT01646385|471922882|FG001|Overall Study|Death|222|||
131078853|NCT01646385|471922881|FG000|Overall Study|Switched to alternate biologic|636|||
131078854|NCT01646385|471922882|FG001|Overall Study|Switched to alternate biologic|649|||
131078855|NCT01843777|471922883|FG000|Overall Study|Withdrawal by Subject|1|||
131078856|NCT01843777|471922884|FG001|Overall Study|Withdrawal by Subject|0|||
131078857|NCT04599855|471922892|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
131078858|NCT04599855|471922893|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
130726693|NCT01721317|470623242|FG000|Overall Study|Withdrawal by Subject|0|||
131078859|NCT04599855|471922894|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
131078860|NCT04599855|471922892|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
131078861|NCT04599855|471922893|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
131078862|NCT04599855|471922894|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
131078863|NCT04599855|471922892|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
131078864|NCT04599855|471922893|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
131231659|NCT03083483|472475183|FG002|Overall Study|technological issues|1|||
131231660|NCT02637557|472475190|FG000|Overall Study|Adverse Event|3|||
130726694|NCT01721317|470623243|FG001|Overall Study|Withdrawal by Subject|1|||
131078865|NCT04599855|471922894|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
131078866|NCT04599855|471922892|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
131078867|NCT04599855|471922893|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
131078868|NCT04599855|471922894|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
131078869|NCT04599855|471922892|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
131139635|NCT03222349|472138085|FG001|Overall Study|Treatment A not done|5|||
131139636|NCT03222349|472138084|FG000|Overall Study|Study terminated by sponsor|1|||
131139637|NCT03222349|472138085|FG001|Overall Study|Study terminated by sponsor|0|||
131139638|NCT01808612|472138089|FG000|Treatment Period|Adverse Event|8|||
131139639|NCT01808612|472138090|FG001|Treatment Period|Adverse Event|4|||
131139640|NCT01808612|472138091|FG002|Treatment Period|Adverse Event|3|||
131078870|NCT04599855|471922893|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
131078871|NCT04599855|471922894|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
131078872|NCT04599855|471922892|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
131078873|NCT04599855|471922893|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
131078874|NCT04599855|471922894|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
131078875|NCT04599855|471922892|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
131078876|NCT04599855|471922893|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
131078877|NCT04599855|471922894|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
131078878|NCT04599855|471922892|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
131078879|NCT04599855|471922893|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
131078880|NCT04599855|471922894|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
131078881|NCT04599855|471922892|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
131078882|NCT04599855|471922893|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
131078883|NCT04599855|471922894|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
131078884|NCT04599855|471922892|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
131078885|NCT04599855|471922893|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
131078886|NCT04599855|471922894|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
131078887|NCT04599855|471922892|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
131078888|NCT04599855|471922893|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
131078889|NCT04599855|471922894|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
131078890|NCT04599855|471922892|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
131078891|NCT04599855|471922893|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
131078892|NCT04599855|471922894|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
131078893|NCT04599855|471922892|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
131078894|NCT04599855|471922893|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
131078895|NCT04599855|471922894|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
131078896|NCT04599855|471922892|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
131078897|NCT04599855|471922893|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
131078898|NCT04599855|471922894|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
131078899|NCT02165397|471922895|FG000|Overall Study|Death|7|||
131078900|NCT02165397|471922896|FG001|Overall Study|Death|10|||
131078901|NCT02165397|471922897|FG002|Overall Study|Death|8|||
131078902|NCT02165397|471922895|FG000|Overall Study|Lost to Follow-up|1|||
131078903|NCT02165397|471922896|FG001|Overall Study|Lost to Follow-up|3|||
131078904|NCT02165397|471922897|FG002|Overall Study|Lost to Follow-up|0|||
131078905|NCT02165397|471922895|FG000|Overall Study|Withdrawal by Subject|6|||
131078906|NCT02165397|471922896|FG001|Overall Study|Withdrawal by Subject|6|||
131078907|NCT02165397|471922897|FG002|Overall Study|Withdrawal by Subject|1|||
131078908|NCT02165397|471922895|FG000|Overall Study|Other, Not Specified|0|||
131078909|NCT02165397|471922896|FG001|Overall Study|Other, Not Specified|0|||
131078910|NCT02165397|471922897|FG002|Overall Study|Other, Not Specified|1|||
131078911|NCT04799418|471922898|FG000|Overall Study|Death|1|||
131078912|NCT04799418|471922899|FG001|Overall Study|Death|1|||
131078913|NCT04799418|471922898|FG000|Overall Study|Lack of Efficacy|14|||
131078914|NCT04799418|471922899|FG001|Overall Study|Lack of Efficacy|14|||
131078915|NCT04799418|471922898|FG000|Overall Study|Withdrawal by Subject|10|||
131078916|NCT04799418|471922899|FG001|Overall Study|Withdrawal by Subject|7|||
131078917|NCT04799418|471922898|FG000|Overall Study|Adverse Event|3|||
131078918|NCT04799418|471922899|FG001|Overall Study|Adverse Event|2|||
131078919|NCT03297398|471922900|FG000|Overall Study|Sponsor's decision|6|||
131078920|NCT03297398|471922901|FG001|Overall Study|Sponsor's decision|9|||
131078921|NCT03297398|471922902|FG002|Overall Study|Sponsor's decision|7|||
131078922|NCT03297398|471922900|FG000|Overall Study|Adverse Event|1|||
131078923|NCT03297398|471922901|FG001|Overall Study|Adverse Event|4|||
131078924|NCT03297398|471922902|FG002|Overall Study|Adverse Event|4|||
131078925|NCT03297398|471922900|FG000|Overall Study|Withdrawal by Subject|1|||
131078926|NCT03297398|471922901|FG001|Overall Study|Withdrawal by Subject|2|||
131078927|NCT03297398|471922902|FG002|Overall Study|Withdrawal by Subject|2|||
131139641|NCT01808612|472138089|FG000|Treatment Period|Lost to Follow-up|2|||
131139642|NCT01808612|472138090|FG001|Treatment Period|Lost to Follow-up|2|||
131139643|NCT01808612|472138091|FG002|Treatment Period|Lost to Follow-up|1|||
131078928|NCT03297398|471922900|FG000|Overall Study|Protocol Violation|0|||
131078929|NCT03297398|471922901|FG001|Overall Study|Protocol Violation|2|||
131139644|NCT01808612|472138089|FG000|Treatment Period|Protocol Violation|1|||
131139645|NCT01808612|472138090|FG001|Treatment Period|Protocol Violation|0|||
131139646|NCT01808612|472138091|FG002|Treatment Period|Protocol Violation|0|||
131139647|NCT01808612|472138089|FG000|Treatment Period|Withdrawal by Subject|1|||
131078930|NCT03297398|471922902|FG002|Overall Study|Protocol Violation|0|||
131078931|NCT03297398|471922900|FG000|Overall Study|Physician Decision|0|||
131078932|NCT03297398|471922901|FG001|Overall Study|Physician Decision|0|||
131078933|NCT03297398|471922902|FG002|Overall Study|Physician Decision|1|||
131078934|NCT03297398|471922900|FG000|Overall Study|Lost to Follow-up|0|||
131078935|NCT03297398|471922901|FG001|Overall Study|Lost to Follow-up|0|||
131078936|NCT03297398|471922902|FG002|Overall Study|Lost to Follow-up|1|||
131139648|NCT01808612|472138090|FG001|Treatment Period|Withdrawal by Subject|0|||
131139649|NCT01808612|472138091|FG002|Treatment Period|Withdrawal by Subject|4|||
131139650|NCT01808612|472138089|FG000|Treatment Period|Physician Decision|1|||
131139651|NCT01808612|472138090|FG001|Treatment Period|Physician Decision|0|||
131139652|NCT01808612|472138091|FG002|Treatment Period|Physician Decision|4|||
131139653|NCT01808612|472138089|FG000|Treatment Period|Sponsor Decision|1|||
131139654|NCT01808612|472138090|FG001|Treatment Period|Sponsor Decision|0|||
131139655|NCT01808612|472138091|FG002|Treatment Period|Sponsor Decision|0|||
131139656|NCT01808612|472138089|FG000|Treatment Period|Lack of Efficacy|1|||
131139657|NCT01808612|472138090|FG001|Treatment Period|Lack of Efficacy|1|||
131139658|NCT01808612|472138091|FG002|Treatment Period|Lack of Efficacy|2|||
131139659|NCT01808612|472138089|FG000|Discontinuation Period|Adverse Event|1|||
131139660|NCT01808612|472138090|FG001|Discontinuation Period|Adverse Event|0|||
131139661|NCT01808612|472138091|FG002|Discontinuation Period|Adverse Event|0|||
131139662|NCT01808612|472138089|FG000|Discontinuation Period|Physician Decision|1|||
131139663|NCT01808612|472138090|FG001|Discontinuation Period|Physician Decision|0|||
131139664|NCT01808612|472138091|FG002|Discontinuation Period|Physician Decision|0|||
131139665|NCT01808612|472138089|FG000|Discontinuation Period|Lost to Follow-up|0|||
131139666|NCT01808612|472138090|FG001|Discontinuation Period|Lost to Follow-up|1|||
131139667|NCT01808612|472138091|FG002|Discontinuation Period|Lost to Follow-up|0|||
131139668|NCT01463098|472138092|FG000|Part A (11 Days)|Participant Choice|2|||
131139669|NCT01463098|472138093|FG001|Part A (11 Days)|Participant Choice|0|||
131139670|NCT01463098|472138094|FG002|Part A (11 Days)|Participant Choice|0|||
131139671|NCT01463098|472138095|FG003|Part A (11 Days)|Participant Choice|0|||
131139672|NCT01463098|472138096|FG004|Part A (11 Days)|Participant Choice|0|||
131139673|NCT01463098|472138097|FG005|Part A (11 Days)|Participant Choice|0|||
131139674|NCT01463098|472138098|FG006|Part A (11 Days)|Participant Choice|0|||
131139675|NCT01463098|472138099|FG007|Part A (11 Days)|Participant Choice|0|||
131139676|NCT01463098|472138100|FG008|Part A (11 Days)|Participant Choice|1|||
131139677|NCT01463098|472138101|FG009|Part A (11 Days)|Participant Choice|0|||
131139678|NCT01463098|472138102|FG010|Part A (11 Days)|Participant Choice|0|||
131139679|NCT01463098|472138103|FG011|Part A (11 Days)|Participant Choice|0|||
131139680|NCT01463098|472138104|FG012|Part A (11 Days)|Participant Choice|0|||
131139681|NCT01463098|472138105|FG013|Part A (11 Days)|Participant Choice|0|||
131139682|NCT01463098|472138092|FG000|Part A (11 Days)|Lost to Follow-up|0|||
131139683|NCT01463098|472138093|FG001|Part A (11 Days)|Lost to Follow-up|0|||
131139684|NCT01463098|472138094|FG002|Part A (11 Days)|Lost to Follow-up|0|||
131139685|NCT01463098|472138095|FG003|Part A (11 Days)|Lost to Follow-up|0|||
131139686|NCT01463098|472138096|FG004|Part A (11 Days)|Lost to Follow-up|1|||
131139687|NCT01463098|472138097|FG005|Part A (11 Days)|Lost to Follow-up|0|||
131139688|NCT01463098|472138098|FG006|Part A (11 Days)|Lost to Follow-up|0|||
131078937|NCT00236184|471922907|FG000|Overall Study|Adverse Event|5|||
131078938|NCT00236184|471922908|FG001|Overall Study|Adverse Event|2|||
131078939|NCT00236184|471922907|FG000|Overall Study|Lack of Efficacy|0|||
131078940|NCT00236184|471922908|FG001|Overall Study|Lack of Efficacy|1|||
131078941|NCT00236184|471922907|FG000|Overall Study|Lost to Follow-up|3|||
131139689|NCT01463098|472138099|FG007|Part A (11 Days)|Lost to Follow-up|0|||
131139690|NCT01463098|472138100|FG008|Part A (11 Days)|Lost to Follow-up|0|||
131139691|NCT01463098|472138101|FG009|Part A (11 Days)|Lost to Follow-up|0|||
131139692|NCT01463098|472138102|FG010|Part A (11 Days)|Lost to Follow-up|0|||
131139693|NCT01463098|472138103|FG011|Part A (11 Days)|Lost to Follow-up|0|||
131139694|NCT01463098|472138104|FG012|Part A (11 Days)|Lost to Follow-up|0|||
131139695|NCT01463098|472138105|FG013|Part A (11 Days)|Lost to Follow-up|0|||
131139696|NCT01463098|472138092|FG000|Part B (11 Days)|Participant Choice|0|||
131139697|NCT01463098|472138093|FG001|Part B (11 Days)|Participant Choice|0|||
131139698|NCT01463098|472138094|FG002|Part B (11 Days)|Participant Choice|0|||
131139699|NCT01463098|472138095|FG003|Part B (11 Days)|Participant Choice|0|||
131139700|NCT01463098|472138096|FG004|Part B (11 Days)|Participant Choice|0|||
131139701|NCT01463098|472138097|FG005|Part B (11 Days)|Participant Choice|0|||
131139702|NCT01463098|472138098|FG006|Part B (11 Days)|Participant Choice|0|||
131139703|NCT01463098|472138099|FG007|Part B (11 Days)|Participant Choice|0|||
131139704|NCT01463098|472138100|FG008|Part B (11 Days)|Participant Choice|0|||
131139705|NCT01463098|472138101|FG009|Part B (11 Days)|Participant Choice|0|||
131139706|NCT01463098|472138102|FG010|Part B (11 Days)|Participant Choice|0|||
131139707|NCT01463098|472138103|FG011|Part B (11 Days)|Participant Choice|1|||
131139708|NCT01463098|472138104|FG012|Part B (11 Days)|Participant Choice|0|||
131139709|NCT01463098|472138105|FG013|Part B (11 Days)|Participant Choice|0|||
131139710|NCT00939692|472138106|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
131139711|NCT00939692|472138107|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
131139712|NCT00939692|472138106|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
131139713|NCT00939692|472138107|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
131139714|NCT01528787|472138112|FG000|Overall Study|Withdrawal by Subject|0|||
131139715|NCT01528787|472138113|FG001|Overall Study|Withdrawal by Subject|0|||
131139716|NCT01528787|472138114|FG002|Overall Study|Withdrawal by Subject|0|||
131139717|NCT01528787|472138115|FG003|Overall Study|Withdrawal by Subject|1|||
131139718|NCT01528787|472138112|FG000|Overall Study|Family Emergency|0|||
131139719|NCT01528787|472138113|FG001|Overall Study|Family Emergency|0|||
131139720|NCT01528787|472138114|FG002|Overall Study|Family Emergency|1|||
131139721|NCT01528787|472138115|FG003|Overall Study|Family Emergency|0|||
131139722|NCT03433781|472138121|FG000|Overall Study|Progression of Disease|1|||
131139723|NCT03433781|472138122|FG001|Overall Study|Progression of Disease|0|||
131139724|NCT03433781|472138123|FG002|Overall Study|Progression of Disease|0|||
131139725|NCT03433781|472138121|FG000|Overall Study|Physician Decision|0|||
131139726|NCT03433781|472138122|FG001|Overall Study|Physician Decision|1|||
131139727|NCT03433781|472138123|FG002|Overall Study|Physician Decision|0|||
131139728|NCT03543410|472138127|FG000|Overall Study|Adverse Event|10|||
131139729|NCT03543410|472138128|FG001|Overall Study|Adverse Event|8|||
131139730|NCT03543410|472138129|FG002|Overall Study|Adverse Event|2|||
131139731|NCT03543410|472138127|FG000|Overall Study|Lack of Efficacy|0|||
131139732|NCT03543410|472138128|FG001|Overall Study|Lack of Efficacy|1|||
131139733|NCT03543410|472138129|FG002|Overall Study|Lack of Efficacy|0|||
131139734|NCT03543410|472138127|FG000|Overall Study|Lost to Follow-up|0|||
131139735|NCT03543410|472138128|FG001|Overall Study|Lost to Follow-up|1|||
131139736|NCT03543410|472138129|FG002|Overall Study|Lost to Follow-up|0|||
131139737|NCT03543410|472138127|FG000|Overall Study|Withdrawal by Subject|5|||
131139738|NCT03543410|472138128|FG001|Overall Study|Withdrawal by Subject|2|||
131139739|NCT03543410|472138129|FG002|Overall Study|Withdrawal by Subject|8|||
131139740|NCT03543410|472138127|FG000|Overall Study|Protocol Violation|0|||
131139741|NCT03543410|472138128|FG001|Overall Study|Protocol Violation|1|||
131139742|NCT03543410|472138129|FG002|Overall Study|Protocol Violation|0|||
131139743|NCT03543410|472138127|FG000|Overall Study|Due to COVID-19|4|||
131139744|NCT03543410|472138128|FG001|Overall Study|Due to COVID-19|0|||
131139745|NCT03543410|472138129|FG002|Overall Study|Due to COVID-19|2|||
131139746|NCT03543410|472138127|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
131139747|NCT03543410|472138128|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
131139748|NCT03543410|472138129|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
131139749|NCT03543410|472138127|FG000|Overall Study|Not Due to COVID-19|2|||
131139750|NCT03543410|472138128|FG001|Overall Study|Not Due to COVID-19|0|||
131139751|NCT03543410|472138129|FG002|Overall Study|Not Due to COVID-19|1|||
131139752|NCT02435914|472138130|FG000|Overall Study|Ocular Adverse Event|1|||
131139753|NCT02435914|472138131|FG001|Overall Study|Ocular Adverse Event|0|||
131139754|NCT02435914|472138132|FG002|Overall Study|Ocular Adverse Event|0|||
131139755|NCT02435914|472138133|FG003|Overall Study|Ocular Adverse Event|0|||
131231661|NCT02637557|472475191|FG001|Overall Study|Adverse Event|1|||
131231662|NCT02637557|472475192|FG002|Overall Study|Adverse Event|3|||
131078942|NCT00236184|471922908|FG001|Overall Study|Lost to Follow-up|4|||
131078943|NCT00236184|471922907|FG000|Overall Study|Physician Decision|1|||
131078944|NCT00236184|471922908|FG001|Overall Study|Physician Decision|1|||
131078945|NCT00236184|471922907|FG000|Overall Study|Withdrawal by Subject|3|||
131078946|NCT00236184|471922908|FG001|Overall Study|Withdrawal by Subject|0|||
131078947|NCT00236184|471922907|FG000|Overall Study|Protocol Violation|3|||
131078948|NCT00236184|471922908|FG001|Overall Study|Protocol Violation|0|||
131078949|NCT00236184|471922907|FG000|Overall Study|non-compliance with study drug|2|||
131078950|NCT00236184|471922908|FG001|Overall Study|non-compliance with study drug|1|||
131078951|NCT00236184|471922907|FG000|Overall Study|other|1|||
131078952|NCT00236184|471922908|FG001|Overall Study|other|2|||
131078953|NCT02312206|471922909|FG000|Overall Study|Adverse Event|3|||
131078954|NCT02312206|471922910|FG001|Overall Study|Adverse Event|6|||
131078955|NCT02312206|471922909|FG000|Overall Study|Withdrawal by Subject|6|||
131078956|NCT02312206|471922910|FG001|Overall Study|Withdrawal by Subject|6|||
131078957|NCT02312206|471922909|FG000|Overall Study|Physician Decision|7|||
131139756|NCT02435914|472138130|FG000|Overall Study|Withdrawal by Subject|0|||
131231663|NCT02637557|472475193|FG003|Overall Study|Adverse Event|3|||
131231664|NCT02637557|472475190|FG000|Overall Study|Lost to Follow-up|1|||
131078958|NCT02312206|471922910|FG001|Overall Study|Physician Decision|6|||
131078959|NCT02312206|471922909|FG000|Overall Study|Death|31|||
131078960|NCT02312206|471922910|FG001|Overall Study|Death|36|||
131078961|NCT02312206|471922909|FG000|Overall Study|Study Terminated by Sponsor|81|||
131139757|NCT02435914|472138131|FG001|Overall Study|Withdrawal by Subject|1|||
131139758|NCT02435914|472138132|FG002|Overall Study|Withdrawal by Subject|0|||
131139759|NCT02435914|472138133|FG003|Overall Study|Withdrawal by Subject|0|||
131139760|NCT02435914|472138130|FG000|Overall Study|Other Miscellaneous Reason|0|||
131139761|NCT02435914|472138131|FG001|Overall Study|Other Miscellaneous Reason|0|||
131139762|NCT02435914|472138132|FG002|Overall Study|Other Miscellaneous Reason|1|||
131139763|NCT02435914|472138133|FG003|Overall Study|Other Miscellaneous Reason|0|||
131139764|NCT02319044|472138153|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
131139765|NCT02319044|472138154|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
130726695|NCT02806024|470623262|FG000|Overall Study|Night Delivery|1|||
130726696|NCT02806024|470623263|FG001|Overall Study|Night Delivery|1|||
130726697|NCT02806024|470623262|FG000|Overall Study|DVT during antepartum admission|0|||
130726698|NCT02806024|470623263|FG001|Overall Study|DVT during antepartum admission|1|||
130726699|NCT01994850|470623264|FG000|Overall Study|Physician Decision|1|||
130726700|NCT01994850|470623264|FG000|Overall Study|Withdrawal by Subject|1|||
130726701|NCT00895414|470623267|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
130726702|NCT00895414|470623268|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
130726703|NCT00895414|470623267|FG000|First Intervention (14 Days)|Physician Decision|0|||
130726704|NCT00895414|470623268|FG001|First Intervention (14 Days)|Physician Decision|1|||
130726705|NCT00252239|470623269|FG000|Overall Study|Withdrawal by Subject|1|||
130726706|NCT00252239|470623270|FG001|Overall Study|Withdrawal by Subject|0|||
130726707|NCT00252239|470623271|FG002|Overall Study|Withdrawal by Subject|0|||
130726708|NCT00252239|470623272|FG003|Overall Study|Withdrawal by Subject|1|||
130726709|NCT00252239|470623269|FG000|Overall Study|Lost to Follow-up|0|||
130726710|NCT00252239|470623270|FG001|Overall Study|Lost to Follow-up|0|||
130726711|NCT00252239|470623271|FG002|Overall Study|Lost to Follow-up|2|||
130726712|NCT00252239|470623272|FG003|Overall Study|Lost to Follow-up|0|||
130726713|NCT00789737|470623273|FG000|Overall Study|Withdrawal by Subject|13|||
130726714|NCT00789737|470623274|FG001|Overall Study|Withdrawal by Subject|22|||
130726715|NCT00789737|470623273|FG000|Overall Study|Lost to Follow-up|10|||
130726716|NCT00789737|470623274|FG001|Overall Study|Lost to Follow-up|14|||
130726717|NCT00789737|470623273|FG000|Overall Study|Adverse Event|8|||
130726718|NCT00789737|470623274|FG001|Overall Study|Adverse Event|8|||
130726719|NCT00789737|470623273|FG000|Overall Study|Protocol Violation|3|||
130726720|NCT00789737|470623274|FG001|Overall Study|Protocol Violation|0|||
130726721|NCT00789737|470623273|FG000|Overall Study|Lack of Efficacy|3|||
130726722|NCT00789737|470623274|FG001|Overall Study|Lack of Efficacy|0|||
130726723|NCT00789737|470623273|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
130726724|NCT00789737|470623274|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
130726725|NCT00789737|470623273|FG000|Overall Study|Other|11|||
130726726|NCT00789737|470623274|FG001|Overall Study|Other|7|||
130726727|NCT03489109|470623281|FG000|Overall Study|Lost to Follow-up|1|||
130726728|NCT03489109|470623282|FG001|Overall Study|Lost to Follow-up|2|||
130726729|NCT02181790|470623283|FG000|Overall Study|study terminated|2|||
130726730|NCT02181790|470623284|FG001|Overall Study|study terminated|0|||
130726731|NCT02458287|470623285|FG000|Overall Study|Adverse Event|0|||
130726732|NCT02458287|470623286|FG001|Overall Study|Adverse Event|0|||
130726733|NCT02458287|470623287|FG002|Overall Study|Adverse Event|0|||
130726734|NCT02458287|470623288|FG003|Overall Study|Adverse Event|1|||
130726735|NCT02458287|470623285|FG000|Overall Study|Lost to Follow-up|0|||
130726736|NCT02458287|470623286|FG001|Overall Study|Lost to Follow-up|1|||
130726737|NCT02458287|470623287|FG002|Overall Study|Lost to Follow-up|1|||
130726738|NCT02458287|470623288|FG003|Overall Study|Lost to Follow-up|0|||
130726739|NCT02458287|470623285|FG000|Overall Study|Protocol Violation|0|||
130726740|NCT02458287|470623286|FG001|Overall Study|Protocol Violation|1|||
131078962|NCT02312206|471922910|FG001|Overall Study|Study Terminated by Sponsor|74|||
131078963|NCT02312206|471922909|FG000|Overall Study|Patient transferred to hospice|0|||
131078964|NCT02312206|471922910|FG001|Overall Study|Patient transferred to hospice|1|||
131078965|NCT02312206|471922909|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
131078966|NCT02312206|471922910|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
131078967|NCT02312206|471922909|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
131078968|NCT02312206|471922910|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
131078969|NCT02312206|471922909|FG000|Overall Study|Disease Progression|1|||
131078970|NCT02312206|471922910|FG001|Overall Study|Disease Progression|0|||
131078971|NCT00217022|471922921|FG000|Overall Study|Withdrawal by Subject|1|||
131078972|NCT00217022|471922922|FG001|Overall Study|Withdrawal by Subject|1|||
131078973|NCT01182181|471922923|FG000|First Intervention|Adverse Event|1|||
131078974|NCT01182181|471922924|FG001|First Intervention|Adverse Event|0|||
131078975|NCT01182181|471922923|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
130726741|NCT02458287|470623287|FG002|Overall Study|Protocol Violation|0|||
130726742|NCT02458287|470623288|FG003|Overall Study|Protocol Violation|0|||
130726743|NCT02458287|470623285|FG000|Overall Study|Withdrawal by Subject|0|||
130726744|NCT02458287|470623286|FG001|Overall Study|Withdrawal by Subject|2|||
130726745|NCT02458287|470623287|FG002|Overall Study|Withdrawal by Subject|2|||
130726746|NCT02458287|470623288|FG003|Overall Study|Withdrawal by Subject|1|||
130726747|NCT02458287|470623285|FG000|Overall Study|Relocated Out of State|0|||
130726748|NCT02458287|470623286|FG001|Overall Study|Relocated Out of State|0|||
130726749|NCT02458287|470623287|FG002|Overall Study|Relocated Out of State|0|||
130726750|NCT02458287|470623288|FG003|Overall Study|Relocated Out of State|1|||
130726751|NCT02613182|470623289|FG000|Overall Study|Death|6|||
130726752|NCT02613182|470623289|FG000|Overall Study|Physician Decision|1|||
130726753|NCT02613182|470623289|FG000|Overall Study|Study Terminated by Sponsor|21|||
131078976|NCT01182181|471922924|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
131078977|NCT03845075|471922925|FG000|Part 1 - DB|Withdrawal by Subject|1|||
130726754|NCT02613182|470623289|FG000|Overall Study|Withdrawal by Subject|6|||
131078978|NCT03845075|471922926|FG001|Part 1 - DB|Withdrawal by Subject|1|||
131078979|NCT03845075|471922927|FG002|Part 1 - DB|Withdrawal by Subject|0|||
131078980|NCT03845075|471922928|FG003|Part 1 - DB|Withdrawal by Subject|0|||
131078981|NCT03845075|471922925|FG000|Part 1 - DB|Adverse Event|0|||
131078982|NCT03845075|471922926|FG001|Part 1 - DB|Adverse Event|1|||
131078983|NCT03845075|471922927|FG002|Part 1 - DB|Adverse Event|0|||
131078984|NCT03845075|471922928|FG003|Part 1 - DB|Adverse Event|0|||
131078985|NCT03845075|471922925|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
131078986|NCT03845075|471922926|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
131078987|NCT03845075|471922927|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
131078988|NCT03845075|471922928|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
131078989|NCT03856047|471922929|FG000|Overall Study|Withdrawal by Subject|0|||
131078990|NCT03856047|471922930|FG001|Overall Study|Withdrawal by Subject|1|||
131078991|NCT03856047|471922931|FG002|Overall Study|Withdrawal by Subject|1|||
131078992|NCT03856047|471922932|FG003|Overall Study|Withdrawal by Subject|0|||
131078993|NCT03856047|471922933|FG004|Overall Study|Withdrawal by Subject|3|||
131078994|NCT03856047|471922934|FG005|Overall Study|Withdrawal by Subject|0|||
131078995|NCT03856047|471922935|FG006|Overall Study|Withdrawal by Subject|2|||
131078996|NCT03856047|471922929|FG000|Overall Study|Lost to Follow-up|4|||
131078997|NCT03856047|471922930|FG001|Overall Study|Lost to Follow-up|2|||
131078998|NCT03856047|471922931|FG002|Overall Study|Lost to Follow-up|3|||
131078999|NCT03856047|471922932|FG003|Overall Study|Lost to Follow-up|1|||
131079000|NCT03856047|471922933|FG004|Overall Study|Lost to Follow-up|4|||
131079001|NCT03856047|471922934|FG005|Overall Study|Lost to Follow-up|4|||
131079002|NCT03856047|471922935|FG006|Overall Study|Lost to Follow-up|4|||
131079003|NCT01278615|471922936|FG000|Overall Study|Withdrawal by Subject|2|||
131079004|NCT00905359|471922937|FG000|Overall Study|Lost to Follow-up|17|||
131079005|NCT00905359|471922938|FG001|Overall Study|Lost to Follow-up|10|||
131079006|NCT00905359|471922937|FG000|Overall Study|Death|2|||
131079007|NCT00905359|471922938|FG001|Overall Study|Death|0|||
131079008|NCT00905359|471922937|FG000|Overall Study|Withdrawal consent|5|||
131079009|NCT00905359|471922938|FG001|Overall Study|Withdrawal consent|6|||
131079010|NCT02138253|471922939|FG000|Overall Study|Adverse Event|3|||
131079011|NCT02138253|471922940|FG001|Overall Study|Adverse Event|3|||
131079012|NCT02138253|471922939|FG000|Overall Study|Lost to Follow-up|2|||
131079013|NCT02138253|471922940|FG001|Overall Study|Lost to Follow-up|1|||
131079014|NCT02138253|471922939|FG000|Overall Study|Physician Decision|2|||
131079015|NCT02138253|471922940|FG001|Overall Study|Physician Decision|0|||
131079016|NCT02138253|471922939|FG000|Overall Study|Non compliance|1|||
131079017|NCT02138253|471922940|FG001|Overall Study|Non compliance|0|||
131079018|NCT02138253|471922939|FG000|Overall Study|Withdrawal by Subject|1|||
131079019|NCT02138253|471922940|FG001|Overall Study|Withdrawal by Subject|0|||
131079020|NCT02654132|471922941|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
131079021|NCT02654132|471922942|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
131079022|NCT02654132|471922941|FG000|Treatment Period|Disease progression|43|||
131079023|NCT02654132|471922942|FG001|Treatment Period|Disease progression|38|||
131079024|NCT02654132|471922941|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
131079025|NCT02654132|471922942|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
131079026|NCT02654132|471922941|FG000|Treatment Period|Other reasons|4|||
131079027|NCT02654132|471922942|FG001|Treatment Period|Other reasons|2|||
131079028|NCT02654132|471922941|FG000|Treatment Period|Study drug toxicity|2|||
131079029|NCT02654132|471922942|FG001|Treatment Period|Study drug toxicity|2|||
131079030|NCT02654132|471922941|FG000|Treatment Period|Withdrawal by Subject|2|||
131079031|NCT02654132|471922942|FG001|Treatment Period|Withdrawal by Subject|1|||
130726755|NCT03968978|470623290|FG000|Overall Study|Adverse Event|1|||
130726756|NCT03968978|470623291|FG001|Overall Study|Adverse Event|0|||
130726757|NCT00908310|470623295|FG000|Overall Study|Death|37|||
130726758|NCT00908310|470623295|FG000|Overall Study|Withdrawal by Subject|7|||
130726759|NCT00908310|470623295|FG000|Overall Study|Lost to Follow-up|7|||
130726760|NCT00908310|470623295|FG000|Overall Study|Screening failure|5|||
130726761|NCT00908310|470623295|FG000|Overall Study|Other reasons|4|||
130726762|NCT02785952|470623298|FG000|Overall Study|Adverse Event|31|||
130726763|NCT02785952|470623299|FG001|Overall Study|Adverse Event|19|||
131079032|NCT02654132|471922941|FG000|Treatment Period|Maximum Clinical Benefit|0|||
131079033|NCT02654132|471922942|FG001|Treatment Period|Maximum Clinical Benefit|2|||
131079034|NCT02654132|471922941|FG000|Treatment Period|Participant request to discontinue|2|||
131079035|NCT02654132|471922942|FG001|Treatment Period|Participant request to discontinue|0|||
130726764|NCT02785952|470623298|FG000|Overall Study|Refusal unrelated to adverse events|10|||
130726765|NCT02785952|470623299|FG001|Overall Study|Refusal unrelated to adverse events|5|||
130726766|NCT02785952|470623298|FG000|Overall Study|Disease progression/relapse|61|||
130726767|NCT02785952|470623299|FG001|Overall Study|Disease progression/relapse|89|||
130726768|NCT02785952|470623298|FG000|Overall Study|Death|11|||
131079036|NCT02654132|471922941|FG000|Treatment Period|Administrative reasons by sponsor|0|||
131079037|NCT02654132|471922942|FG001|Treatment Period|Administrative reasons by sponsor|1|||
131079038|NCT02654132|471922941|FG000|Treatment Period|Death|1|||
131079039|NCT02654132|471922942|FG001|Treatment Period|Death|0|||
131079040|NCT02872012|471922944|FG000|Overall Study|Withdrawal by Subject|1|||
130726769|NCT02785952|470623299|FG001|Overall Study|Death|7|||
130726770|NCT02785952|470623298|FG000|Overall Study|Other- not protocol specified|6|||
130726771|NCT02785952|470623299|FG001|Overall Study|Other- not protocol specified|4|||
130726772|NCT02785952|470623298|FG000|Overall Study|On protocol treatment|6|||
130726773|NCT02785952|470623299|FG001|Overall Study|On protocol treatment|3|||
130726774|NCT01806506|470623300|FG000|Overall Study|Lost to Follow-up|2|||
130726775|NCT01806506|470623301|FG001|Overall Study|Lost to Follow-up|1|||
130726776|NCT04614246|470623302|FG000|Overall Study|Adverse Event|0|||
130726777|NCT04614246|470623303|FG001|Overall Study|Adverse Event|1|||
130726778|NCT04614246|470623304|FG002|Overall Study|Adverse Event|1|||
130726779|NCT04614246|470623305|FG003|Overall Study|Adverse Event|2|||
130726780|NCT04614246|470623306|FG004|Overall Study|Adverse Event|1|||
130726781|NCT04614246|470623302|FG000|Overall Study|Lost to Follow-up|0|||
130726782|NCT04614246|470623303|FG001|Overall Study|Lost to Follow-up|1|||
130726783|NCT04614246|470623304|FG002|Overall Study|Lost to Follow-up|0|||
130726784|NCT04614246|470623305|FG003|Overall Study|Lost to Follow-up|1|||
130726785|NCT04614246|470623306|FG004|Overall Study|Lost to Follow-up|3|||
130726786|NCT04614246|470623302|FG000|Overall Study|Other reason|0|||
130726787|NCT04614246|470623303|FG001|Overall Study|Other reason|1|||
130726788|NCT04614246|470623304|FG002|Overall Study|Other reason|2|||
130726789|NCT04614246|470623305|FG003|Overall Study|Other reason|0|||
130726790|NCT04614246|470623306|FG004|Overall Study|Other reason|0|||
130726791|NCT04614246|470623302|FG000|Overall Study|Withdrawal by Subject|4|||
130726792|NCT04614246|470623303|FG001|Overall Study|Withdrawal by Subject|2|||
130726793|NCT04614246|470623304|FG002|Overall Study|Withdrawal by Subject|4|||
130726794|NCT04614246|470623305|FG003|Overall Study|Withdrawal by Subject|3|||
130726795|NCT04614246|470623306|FG004|Overall Study|Withdrawal by Subject|4|||
130726796|NCT04614246|470623302|FG000|Overall Study|Physician Decision|0|||
130726797|NCT04614246|470623303|FG001|Overall Study|Physician Decision|2|||
130726798|NCT04614246|470623304|FG002|Overall Study|Physician Decision|1|||
131079041|NCT02872012|471922945|FG001|Overall Study|Withdrawal by Subject|0|||
131079042|NCT02872012|471922946|FG002|Overall Study|Withdrawal by Subject|0|||
131079043|NCT02872012|471922947|FG003|Overall Study|Withdrawal by Subject|0|||
131079044|NCT02872012|471922948|FG004|Overall Study|Withdrawal by Subject|0|||
131079045|NCT01728623|471922949|FG000|Overall Study|Disease progression|26|||
131079046|NCT01728623|471922949|FG000|Overall Study|Adverse Event|1|||
131079047|NCT01728623|471922949|FG000|Overall Study|Withdrawal by Subject|1|||
131079048|NCT00243022|471922950|FG000|Overall Study|Withdrawal by Subject|1|||
131079049|NCT00243022|471922951|FG001|Overall Study|Withdrawal by Subject|0|||
131079050|NCT00243022|471922950|FG000|Overall Study|Death|1|||
131079051|NCT00243022|471922951|FG001|Overall Study|Death|0|||
131079052|NCT00243022|471922950|FG000|Overall Study|Difficult Travel Distance|0|||
131079053|NCT00243022|471922951|FG001|Overall Study|Difficult Travel Distance|1|||
131079054|NCT03517111|471922956|FG000|Enrolled|Withdrawal by Subject|0|||
131079055|NCT03517111|471922957|FG001|Enrolled|Withdrawal by Subject|1|||
131079056|NCT03517111|471922958|FG002|Enrolled|Withdrawal by Subject|0|||
131079057|NCT03517111|471922956|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
131079058|NCT03517111|471922957|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
131079059|NCT03517111|471922958|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
131079060|NCT03517111|471922956|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
131079061|NCT03517111|471922957|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
131139766|NCT02319044|472138155|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
130726799|NCT04614246|470623305|FG003|Overall Study|Physician Decision|0|||
130726800|NCT04614246|470623306|FG004|Overall Study|Physician Decision|0|||
130726801|NCT04614246|470623302|FG000|Overall Study|Study terminated by sponsor|10|||
130726802|NCT04614246|470623303|FG001|Overall Study|Study terminated by sponsor|15|||
130726803|NCT04614246|470623304|FG002|Overall Study|Study terminated by sponsor|12|||
130726804|NCT04614246|470623305|FG003|Overall Study|Study terminated by sponsor|13|||
130726805|NCT04614246|470623306|FG004|Overall Study|Study terminated by sponsor|9|||
130726806|NCT04614246|470623302|FG000|Overall Study|Pregnancy|2|||
130726807|NCT04614246|470623303|FG001|Overall Study|Pregnancy|0|||
130726808|NCT04614246|470623304|FG002|Overall Study|Pregnancy|1|||
130726809|NCT04614246|470623305|FG003|Overall Study|Pregnancy|0|||
130780109|NCT01914393|470821408|FG001|Overall Study|no reason given|8|||
131139767|NCT02319044|472138153|FG000|Overall Study|Withdrawal by Subject|3|||
131139768|NCT02319044|472138154|FG001|Overall Study|Withdrawal by Subject|3|||
131139769|NCT02319044|472138155|FG002|Overall Study|Withdrawal by Subject|6|||
130726810|NCT04614246|470623306|FG004|Overall Study|Pregnancy|0|||
130726811|NCT01680497|470623307|FG000|Overall Study|Lost to Follow-up|2|||
130726812|NCT00725205|470623308|FG000|Overall Study|Adverse Event|22|||
130726813|NCT00725205|470623308|FG000|Overall Study|Investigator Discontinued|1|||
130726814|NCT00725205|470623308|FG000|Overall Study|Non-compliance With Protocol|14|||
130726815|NCT00725205|470623308|FG000|Overall Study|Other|8|||
131079062|NCT03517111|471922958|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
131079063|NCT03517111|471922956|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
131139770|NCT02319044|472138153|FG000|Overall Study|Condition under investigation worsened|100|||
131079064|NCT03517111|471922957|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
131079065|NCT03517111|471922958|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
131079066|NCT03517111|471922956|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
131079067|NCT03517111|471922957|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
131079068|NCT03517111|471922958|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
131079069|NCT00621192|471922959|FG000|Overall Study|Withdrawal by Subject|0|||
131079070|NCT00621192|471922960|FG001|Overall Study|Withdrawal by Subject|0|||
131079071|NCT00621192|471922961|FG002|Overall Study|Withdrawal by Subject|2|||
131079072|NCT00621192|471922962|FG003|Overall Study|Withdrawal by Subject|0|||
131079073|NCT00621192|471922959|FG000|Overall Study|Physician Decision|1|||
131079074|NCT00621192|471922960|FG001|Overall Study|Physician Decision|3|||
131079075|NCT00621192|471922961|FG002|Overall Study|Physician Decision|0|||
131079076|NCT00621192|471922962|FG003|Overall Study|Physician Decision|0|||
131079077|NCT00621192|471922959|FG000|Overall Study|Protocol Violation|1|||
131079078|NCT00621192|471922960|FG001|Overall Study|Protocol Violation|0|||
131079079|NCT00621192|471922961|FG002|Overall Study|Protocol Violation|0|||
131079080|NCT00621192|471922962|FG003|Overall Study|Protocol Violation|1|||
131079081|NCT00621192|471922959|FG000|Overall Study|Adverse Event|0|||
131079082|NCT00621192|471922960|FG001|Overall Study|Adverse Event|1|||
131079083|NCT00621192|471922961|FG002|Overall Study|Adverse Event|0|||
131079084|NCT00621192|471922962|FG003|Overall Study|Adverse Event|1|||
131079085|NCT00621192|471922959|FG000|Overall Study|Death|2|||
131079086|NCT00621192|471922960|FG001|Overall Study|Death|5|||
131079087|NCT00621192|471922961|FG002|Overall Study|Death|0|||
131079088|NCT00621192|471922962|FG003|Overall Study|Death|0|||
131079089|NCT00621192|471922959|FG000|Overall Study|Final Assessments not Completed|0|||
131079090|NCT00621192|471922960|FG001|Overall Study|Final Assessments not Completed|0|||
131079091|NCT00621192|471922961|FG002|Overall Study|Final Assessments not Completed|3|||
131079092|NCT00621192|471922962|FG003|Overall Study|Final Assessments not Completed|1|||
131079093|NCT04706793|471922963|FG000|Treatment|Disease worsening|10|||
131079094|NCT04706793|471922964|FG001|Treatment|Disease worsening|10|||
131079095|NCT04706793|471922963|FG000|Follow-up|Lack of Efficacy|1|||
131079096|NCT04706793|471922964|FG001|Follow-up|Lack of Efficacy|0|||
131079097|NCT04706793|471922963|FG000|Follow-up|Disease worsening|8|||
131079098|NCT04706793|471922964|FG001|Follow-up|Disease worsening|10|||
131079099|NCT04706793|471922963|FG000|Follow-up|Adverse Event|1|||
131079100|NCT04706793|471922964|FG001|Follow-up|Adverse Event|0|||
131079101|NCT03713320|471922967|FG000|Randomized Period|Adverse Event|1|||
131079102|NCT03713320|471922968|FG001|Randomized Period|Adverse Event|5|||
131079103|NCT03713320|471922969|FG002|Randomized Period|Adverse Event|0|||
131079104|NCT03713320|471922967|FG000|Randomized Period|Physician Decision|1|||
131079105|NCT03713320|471922968|FG001|Randomized Period|Physician Decision|1|||
131079106|NCT03713320|471922969|FG002|Randomized Period|Physician Decision|0|||
131079107|NCT03713320|471922967|FG000|Randomized Period|Withdrawal by Subject|4|||
131079108|NCT03713320|471922968|FG001|Randomized Period|Withdrawal by Subject|0|||
131079109|NCT03713320|471922969|FG002|Randomized Period|Withdrawal by Subject|0|||
131079110|NCT03713320|471922967|FG000|Randomized Period|Participant decision|3|||
131079111|NCT03713320|471922968|FG001|Randomized Period|Participant decision|1|||
131079112|NCT03713320|471922969|FG002|Randomized Period|Participant decision|0|||
131079113|NCT03713320|471922967|FG000|Randomized Period|Study terminated by sponsor|6|||
131079114|NCT03713320|471922968|FG001|Randomized Period|Study terminated by sponsor|3|||
131079115|NCT03713320|471922969|FG002|Randomized Period|Study terminated by sponsor|0|||
130726816|NCT00725205|470623308|FG000|Overall Study|Protocol Defined Clinical Event|1|||
130726817|NCT00725205|470623308|FG000|Overall Study|Treatment Failure|41|||
130726818|NCT01200069|470625416|FG000|Overall Study|Withdrawal by Subject|0|||
130726819|NCT01200069|470625417|FG001|Overall Study|Withdrawal by Subject|1|||
131079116|NCT03713320|471922967|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
131079117|NCT03713320|471922968|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
131079118|NCT03713320|471922969|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
131079119|NCT03713320|471922967|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
131139771|NCT02319044|472138154|FG001|Overall Study|Condition under investigation worsened|50|||
131139772|NCT02319044|472138155|FG002|Overall Study|Condition under investigation worsened|46|||
131139773|NCT02319044|472138153|FG000|Overall Study|Adverse Event|17|||
131139774|NCT02319044|472138154|FG001|Overall Study|Adverse Event|2|||
130726820|NCT04998851|470625418|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
131079120|NCT03713320|471922968|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
131079121|NCT03713320|471922969|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
131079122|NCT01880437|471922970|FG000|Overall Study|Death|12|||
131079123|NCT01880437|471922971|FG001|Overall Study|Death|4|||
131079124|NCT01880437|471922972|FG002|Overall Study|Death|17|||
131079125|NCT01880437|471922970|FG000|Overall Study|Study terminated by Sponsor|3|||
131079126|NCT01880437|471922971|FG001|Overall Study|Study terminated by Sponsor|0|||
131079127|NCT01880437|471922972|FG002|Overall Study|Study terminated by Sponsor|2|||
131079128|NCT04354168|471922974|FG000|Overall Study|Lost to Follow-up|22|||
131079129|NCT01781832|471922975|FG000|Overall Study|Withdrawal by Subject|1|||
131079130|NCT02719743|471922978|FG000|Overall Study|Consent withdrawal|0|||
131079131|NCT02719743|471922979|FG001|Overall Study|Consent withdrawal|2|||
131079132|NCT02719743|471922980|FG002|Overall Study|Consent withdrawal|0|||
131079133|NCT02719743|471922981|FG003|Overall Study|Consent withdrawal|1|||
131079134|NCT02719743|471922982|FG004|Overall Study|Consent withdrawal|0|||
131079135|NCT02719743|471922978|FG000|Overall Study|Migrated/moved from study area|0|||
131079136|NCT02719743|471922979|FG001|Overall Study|Migrated/moved from study area|0|||
131079137|NCT02719743|471922980|FG002|Overall Study|Migrated/moved from study area|0|||
131079138|NCT02719743|471922981|FG003|Overall Study|Migrated/moved from study area|0|||
131079139|NCT02719743|471922982|FG004|Overall Study|Migrated/moved from study area|2|||
131079140|NCT02719743|471922978|FG000|Overall Study|Lost to Follow-up|1|||
131079141|NCT02719743|471922979|FG001|Overall Study|Lost to Follow-up|1|||
131079142|NCT02719743|471922980|FG002|Overall Study|Lost to Follow-up|0|||
131079143|NCT02719743|471922981|FG003|Overall Study|Lost to Follow-up|0|||
131079144|NCT02719743|471922982|FG004|Overall Study|Lost to Follow-up|0|||
131079145|NCT01209598|471922983|FG000|Overall Study|Withdrawal by Subject|1|||
131079146|NCT01209598|471922984|FG001|Overall Study|Withdrawal by Subject|0|||
131079147|NCT02601209|471922985|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
131079148|NCT02601209|471922986|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
131079149|NCT02601209|471922987|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
131079150|NCT02601209|471922988|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131079151|NCT02601209|471922989|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131079152|NCT02601209|471922990|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131079153|NCT02601209|471922991|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131079154|NCT02601209|471922992|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131079155|NCT02601209|471922993|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
131079156|NCT02601209|471922985|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131079157|NCT02601209|471922986|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131079158|NCT02601209|471922987|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131079159|NCT02601209|471922988|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131079160|NCT02601209|471922989|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
131079161|NCT02601209|471922990|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
131079162|NCT02601209|471922991|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
131079163|NCT02601209|471922992|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131079164|NCT02601209|471922993|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
131079165|NCT02804399|471922996|FG000|Period 2|Adverse Event|0|||
131079166|NCT02804399|471922997|FG001|Period 2|Adverse Event|1|||
131079167|NCT03636373|471922998|FG000|Overall Study|Study closure due to Covid-19|1|||
131079168|NCT03636373|471922999|FG001|Overall Study|Study closure due to Covid-19|0|||
131079169|NCT00572533|471923000|FG000|Overall Study|Death|4|||
131079170|NCT00572533|471923001|FG001|Overall Study|Death|1|||
131079171|NCT00572533|471923000|FG000|Overall Study|Received Kidney Transplant|2|||
131079172|NCT00572533|471923001|FG001|Overall Study|Received Kidney Transplant|1|||
131079173|NCT00572533|471923000|FG000|Overall Study|Social Issues|1|||
131079174|NCT00572533|471923001|FG001|Overall Study|Social Issues|0|||
131079175|NCT00572533|471923000|FG000|Overall Study|Transfer out of Facility|0|||
131079176|NCT00572533|471923001|FG001|Overall Study|Transfer out of Facility|1|||
131079177|NCT05523219|471923008|FG000|Overall Study|Wrong inclusion|1|||
131079178|NCT05523219|471923008|FG000|Overall Study|Lost to Follow-up|7|||
131079179|NCT02760485|471923009|FG000|Phase 1|Death|3|||
131079180|NCT02760485|471923010|FG001|Phase 1|Death|6|||
131079181|NCT02760485|471923011|FG002|Phase 1|Death|0|||
131079182|NCT02760485|471923009|FG000|Phase 1|Withdrawal by Subject|2|||
131079183|NCT02760485|471923010|FG001|Phase 1|Withdrawal by Subject|0|||
131079184|NCT02760485|471923011|FG002|Phase 1|Withdrawal by Subject|0|||
131079185|NCT02760485|471923009|FG000|Phase 1|Progressive Disease|1|||
131079186|NCT02760485|471923010|FG001|Phase 1|Progressive Disease|0|||
131079187|NCT02760485|471923011|FG002|Phase 1|Progressive Disease|0|||
131079188|NCT02760485|471923009|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
131079189|NCT02760485|471923010|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
131079190|NCT02760485|471923011|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
131079191|NCT02760485|471923009|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
131079192|NCT02760485|471923010|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
131079193|NCT02760485|471923011|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
131231665|NCT02637557|472475191|FG001|Overall Study|Lost to Follow-up|1|||
131231666|NCT02637557|472475192|FG002|Overall Study|Lost to Follow-up|0|||
130780110|NCT01914393|470821409|FG002|Overall Study|no reason given|16|||
131079194|NCT02760485|471923009|FG000|Phase 2|Death|0|||
131079195|NCT02760485|471923010|FG001|Phase 2|Death|0|||
131079196|NCT02760485|471923011|FG002|Phase 2|Death|12|||
131079197|NCT02760485|471923009|FG000|Phase 2|Withdrawal by Subject|0|||
131079198|NCT02760485|471923010|FG001|Phase 2|Withdrawal by Subject|0|||
131079199|NCT02760485|471923011|FG002|Phase 2|Withdrawal by Subject|3|||
131079200|NCT02760485|471923009|FG000|Phase 2|Progressive Disease|0|||
131079201|NCT02760485|471923010|FG001|Phase 2|Progressive Disease|0|||
131079202|NCT02760485|471923011|FG002|Phase 2|Progressive Disease|1|||
131079203|NCT02760485|471923009|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
131079204|NCT02760485|471923010|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
131079205|NCT02760485|471923011|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
131079206|NCT03772613|471923012|FG000|Overall Study|Lost to Follow-up|0|||
131079207|NCT03772613|471923013|FG001|Overall Study|Lost to Follow-up|1|||
131079208|NCT03772613|471923014|FG002|Overall Study|Lost to Follow-up|1|||
131079209|NCT00904722|471923015|FG000|Overall Study|Physician Decision|1|||
131079210|NCT01182207|471923016|FG000|First Intervention|Positive Hepatitis Results|0|||
131079211|NCT01182207|471923017|FG001|First Intervention|Positive Hepatitis Results|1|||
131079212|NCT01182207|471923016|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
131079213|NCT01182207|471923017|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
131079214|NCT01087814|471923018|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
131079215|NCT01087814|471923019|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
131079216|NCT01087814|471923018|FG000|Second Intervention (5 Days)|Physician Decision|1|||
131079217|NCT01087814|471923019|FG001|Second Intervention (5 Days)|Physician Decision|0|||
131079218|NCT01891890|471923020|FG000|Overall Study|Lost to Follow-up|0|||
131079219|NCT01891890|471923021|FG001|Overall Study|Lost to Follow-up|0|||
131079220|NCT01891890|471923022|FG002|Overall Study|Lost to Follow-up|1|||
131079221|NCT01891890|471923020|FG000|Overall Study|Study ended before endpoint reached|7|||
131079222|NCT01891890|471923021|FG001|Overall Study|Study ended before endpoint reached|3|||
131079223|NCT01891890|471923022|FG002|Overall Study|Study ended before endpoint reached|6|||
131079224|NCT01427738|471923023|FG000|Overall Study|Death|12|||
131079225|NCT01427738|471923024|FG001|Overall Study|Death|9|||
131079226|NCT01427738|471923023|FG000|Overall Study|Severe debilitation, unable to continue|0|||
131079227|NCT01427738|471923024|FG001|Overall Study|Severe debilitation, unable to continue|1|||
131079228|NCT01427738|471923023|FG000|Overall Study|Subject unable to get to clinic|5|||
131079229|NCT01427738|471923024|FG001|Overall Study|Subject unable to get to clinic|2|||
131079230|NCT01427738|471923023|FG000|Overall Study|Withdrawal by Subject|0|||
131079231|NCT01427738|471923024|FG001|Overall Study|Withdrawal by Subject|2|||
131079232|NCT01427738|471923023|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
131079233|NCT01427738|471923024|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
131079234|NCT01427738|471923023|FG000|Overall Study|Lost to Follow-up|1|||
131079235|NCT01427738|471923024|FG001|Overall Study|Lost to Follow-up|5|||
131079236|NCT00661713|471923025|FG000|Overall Study|Death|1|||
131079237|NCT00661713|471923026|FG001|Overall Study|Death|0|||
131079238|NCT00661713|471923027|FG002|Overall Study|Death|0|||
131079239|NCT00661713|471923028|FG003|Overall Study|Death|0|||
131079240|NCT00661713|471923029|FG004|Overall Study|Death|1|||
131079241|NCT00661713|471923030|FG005|Overall Study|Death|0|||
131079242|NCT00661713|471923031|FG006|Overall Study|Death|0|||
131079243|NCT00661713|471923032|FG007|Overall Study|Death|0|||
131079244|NCT00661713|471923025|FG000|Overall Study|Unable to Classify|1|||
131079245|NCT00661713|471923026|FG001|Overall Study|Unable to Classify|0|||
131079246|NCT00661713|471923027|FG002|Overall Study|Unable to Classify|0|||
131079247|NCT00661713|471923028|FG003|Overall Study|Unable to Classify|0|||
131079248|NCT00661713|471923029|FG004|Overall Study|Unable to Classify|0|||
131079249|NCT00661713|471923030|FG005|Overall Study|Unable to Classify|0|||
131079250|NCT00661713|471923031|FG006|Overall Study|Unable to Classify|0|||
131079251|NCT00661713|471923032|FG007|Overall Study|Unable to Classify|0|||
131079252|NCT00661713|471923025|FG000|Overall Study|Protocol Violation|1|||
131079253|NCT00661713|471923026|FG001|Overall Study|Protocol Violation|6|||
131079254|NCT00661713|471923027|FG002|Overall Study|Protocol Violation|3|||
131079255|NCT00661713|471923028|FG003|Overall Study|Protocol Violation|3|||
131079256|NCT00661713|471923029|FG004|Overall Study|Protocol Violation|0|||
130726821|NCT04998851|470625419|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
130726822|NCT04998851|470625418|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
130726823|NCT04998851|470625419|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
130726824|NCT00070499|470625420|FG000|Overall Study|Adverse Event|6|||
131079257|NCT00661713|471923030|FG005|Overall Study|Protocol Violation|2|||
131079258|NCT00661713|471923031|FG006|Overall Study|Protocol Violation|2|||
131079259|NCT00661713|471923032|FG007|Overall Study|Protocol Violation|1|||
131079260|NCT00661713|471923025|FG000|Overall Study|Withdrawal by Subject|11|||
131079261|NCT00661713|471923026|FG001|Overall Study|Withdrawal by Subject|25|||
131079262|NCT00661713|471923027|FG002|Overall Study|Withdrawal by Subject|12|||
131079263|NCT00661713|471923028|FG003|Overall Study|Withdrawal by Subject|21|||
131079264|NCT00661713|471923029|FG004|Overall Study|Withdrawal by Subject|12|||
131079265|NCT00661713|471923030|FG005|Overall Study|Withdrawal by Subject|26|||
131079266|NCT00661713|471923031|FG006|Overall Study|Withdrawal by Subject|45|||
130726825|NCT00070499|470625421|FG001|Overall Study|Adverse Event|6|||
131079267|NCT00661713|471923032|FG007|Overall Study|Withdrawal by Subject|9|||
131079268|NCT00661713|471923025|FG000|Overall Study|Lost to Follow-up|2|||
131079269|NCT00661713|471923026|FG001|Overall Study|Lost to Follow-up|7|||
131079270|NCT00661713|471923027|FG002|Overall Study|Lost to Follow-up|2|||
131079271|NCT00661713|471923028|FG003|Overall Study|Lost to Follow-up|2|||
131079272|NCT00661713|471923029|FG004|Overall Study|Lost to Follow-up|5|||
131079273|NCT00661713|471923030|FG005|Overall Study|Lost to Follow-up|7|||
131079274|NCT00661713|471923031|FG006|Overall Study|Lost to Follow-up|14|||
131079275|NCT00661713|471923032|FG007|Overall Study|Lost to Follow-up|1|||
131079276|NCT00661713|471923025|FG000|Overall Study|Administrative Reason|0|||
131079277|NCT00661713|471923026|FG001|Overall Study|Administrative Reason|1|||
131079278|NCT00661713|471923027|FG002|Overall Study|Administrative Reason|0|||
131079279|NCT00661713|471923028|FG003|Overall Study|Administrative Reason|2|||
131079280|NCT00661713|471923029|FG004|Overall Study|Administrative Reason|2|||
131079281|NCT00661713|471923030|FG005|Overall Study|Administrative Reason|2|||
131079282|NCT00661713|471923031|FG006|Overall Study|Administrative Reason|1|||
131079283|NCT00661713|471923032|FG007|Overall Study|Administrative Reason|0|||
131079284|NCT00661713|471923025|FG000|Overall Study|Adverse Event|0|||
131079285|NCT00661713|471923026|FG001|Overall Study|Adverse Event|0|||
131079286|NCT00661713|471923027|FG002|Overall Study|Adverse Event|0|||
131079287|NCT00661713|471923028|FG003|Overall Study|Adverse Event|0|||
131079288|NCT00661713|471923029|FG004|Overall Study|Adverse Event|0|||
131079289|NCT00661713|471923030|FG005|Overall Study|Adverse Event|0|||
131079290|NCT00661713|471923031|FG006|Overall Study|Adverse Event|1|||
131079291|NCT00661713|471923032|FG007|Overall Study|Adverse Event|0|||
131079292|NCT00661713|471923025|FG000|Overall Study|Inappropriate Enrollment|0|||
131079293|NCT00661713|471923026|FG001|Overall Study|Inappropriate Enrollment|0|||
131079294|NCT00661713|471923027|FG002|Overall Study|Inappropriate Enrollment|0|||
131079295|NCT00661713|471923028|FG003|Overall Study|Inappropriate Enrollment|0|||
131079296|NCT00661713|471923029|FG004|Overall Study|Inappropriate Enrollment|0|||
131079297|NCT00661713|471923030|FG005|Overall Study|Inappropriate Enrollment|0|||
131079298|NCT00661713|471923031|FG006|Overall Study|Inappropriate Enrollment|1|||
131079299|NCT00661713|471923032|FG007|Overall Study|Inappropriate Enrollment|0|||
131079300|NCT02658175|471923033|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
131079301|NCT02658175|471923034|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
131079302|NCT02658175|471923035|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
131079303|NCT02658175|471923033|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
131079304|NCT02658175|471923034|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
131079305|NCT02658175|471923035|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
131079306|NCT02658175|471923033|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
131079307|NCT02658175|471923034|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
131079308|NCT02658175|471923035|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
131079309|NCT02658175|471923033|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
131079310|NCT02658175|471923034|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
131079311|NCT02658175|471923035|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
131079312|NCT02658175|471923033|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
131079313|NCT02658175|471923034|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
131079314|NCT02658175|471923035|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
131079315|NCT02658175|471923033|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
131079316|NCT02658175|471923034|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
131079317|NCT02658175|471923035|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
130726826|NCT00070499|470625422|FG002|Overall Study|Adverse Event|19|||
130726827|NCT00070499|470625423|FG003|Overall Study|Adverse Event|15|||
131079318|NCT02658175|471923033|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
131079319|NCT02658175|471923034|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
131079320|NCT02658175|471923035|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
131079321|NCT02658175|471923033|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
131079322|NCT02658175|471923034|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
131079323|NCT02658175|471923035|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
131079324|NCT02658175|471923033|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
131079325|NCT02658175|471923034|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
131079326|NCT02658175|471923035|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
131079327|NCT02658175|471923033|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
131079328|NCT02658175|471923034|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
131079329|NCT02658175|471923035|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
131079330|NCT04680637|471923041|FG000|Overall Study|Lost to Follow-up|0|||
131079331|NCT04680637|471923042|FG001|Overall Study|Lost to Follow-up|1|||
131079332|NCT04680637|471923043|FG002|Overall Study|Lost to Follow-up|0|||
131079333|NCT04680637|471923044|FG003|Overall Study|Lost to Follow-up|1|||
131079334|NCT04680637|471923041|FG000|Overall Study|Death|1|||
131079335|NCT04680637|471923042|FG001|Overall Study|Death|0|||
131079336|NCT04680637|471923043|FG002|Overall Study|Death|0|||
130726828|NCT00070499|470625420|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
130726829|NCT00070499|470625421|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
131079337|NCT04680637|471923044|FG003|Overall Study|Death|0|||
131079338|NCT04680637|471923041|FG000|Overall Study|Withdrawal by Subject|7|||
131079339|NCT04680637|471923042|FG001|Overall Study|Withdrawal by Subject|10|||
131079340|NCT04680637|471923043|FG002|Overall Study|Withdrawal by Subject|17|||
131079341|NCT04680637|471923044|FG003|Overall Study|Withdrawal by Subject|15|||
131079342|NCT04680637|471923041|FG000|Overall Study|Decision by Sponsor|21|||
131079343|NCT04680637|471923042|FG001|Overall Study|Decision by Sponsor|15|||
131079344|NCT04680637|471923043|FG002|Overall Study|Decision by Sponsor|7|||
131079345|NCT04680637|471923044|FG003|Overall Study|Decision by Sponsor|32|||
131079346|NCT02037256|471923045|FG000|Overall Study|Protocol Violation|0|||
131079347|NCT02037256|471923046|FG001|Overall Study|Protocol Violation|1|||
131079348|NCT02037256|471923045|FG000|Overall Study|Withdrawn prior to Velcade|0|||
131079349|NCT02037256|471923046|FG001|Overall Study|Withdrawn prior to Velcade|2|||
131079350|NCT03614676|471924469|FG000|Overall Study|Delivery before planned visit|2|||
131079351|NCT03614676|471924470|FG001|Overall Study|Delivery before planned visit|0|||
131079352|NCT03614676|471924469|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
131079353|NCT03614676|471924470|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
131079354|NCT03614676|471924469|FG000|Overall Study|Migrated / moved from the study area|30|||
131079355|NCT03614676|471924470|FG001|Overall Study|Migrated / moved from the study area|22|||
131079356|NCT03614676|471924469|FG000|Overall Study|Lost to Follow-up|17|||
131079357|NCT03614676|471924470|FG001|Overall Study|Lost to Follow-up|42|||
131079358|NCT03614676|471924469|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
131079359|NCT03614676|471924470|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
131079360|NCT03614676|471924469|FG000|Overall Study|Other|16|||
131079361|NCT03614676|471924470|FG001|Overall Study|Other|47|||
131079362|NCT03614676|471924469|FG000|Overall Study|Protocol Violation|0|||
131079363|NCT03614676|471924470|FG001|Overall Study|Protocol Violation|2|||
131079364|NCT03614676|471924469|FG000|Overall Study|Neonatal event of interest|0|||
131079365|NCT03614676|471924470|FG001|Overall Study|Neonatal event of interest|6|||
131079366|NCT03614676|471924469|FG000|Overall Study|Death in infant greater than 28 days old|0|||
131079367|NCT03614676|471924470|FG001|Overall Study|Death in infant greater than 28 days old|12|||
131079368|NCT03614676|471924469|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
131079369|NCT03614676|471924470|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
131079370|NCT04398368|471924474|FG000|Overall Study|Withdrawal by Subject|2|||
131079371|NCT02166476|471924481|FG000|Overall Study|Withdrawal by Subject|5|||
131079372|NCT02166476|471924482|FG001|Overall Study|Withdrawal by Subject|7|||
131079373|NCT02166476|471924481|FG000|Overall Study|Adverse Event|3|||
131079374|NCT02166476|471924482|FG001|Overall Study|Adverse Event|3|||
131079375|NCT02166476|471924481|FG000|Overall Study|Lost to Follow-up|5|||
131079376|NCT02166476|471924482|FG001|Overall Study|Lost to Follow-up|10|||
131079377|NCT02166476|471924481|FG000|Overall Study|Physician Decision|1|||
131079378|NCT02166476|471924482|FG001|Overall Study|Physician Decision|0|||
131079379|NCT02166476|471924481|FG000|Overall Study|Unable to Come for Visit|0|||
131079380|NCT02166476|471924482|FG001|Overall Study|Unable to Come for Visit|3|||
131079381|NCT02053610|471924486|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
131079382|NCT02053610|471924487|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
131079383|NCT02053610|471924486|FG000|Overall Study|Withdrew Consent|2|||
131079384|NCT02053610|471924487|FG001|Overall Study|Withdrew Consent|9|||
131079385|NCT02053610|471924486|FG000|Overall Study|Death|5|||
131079386|NCT02053610|471924487|FG001|Overall Study|Death|5|||
131079387|NCT02053610|471924486|FG000|Overall Study|Administrative/Other|1|||
131079388|NCT02053610|471924487|FG001|Overall Study|Administrative/Other|1|||
131079389|NCT02053610|471924486|FG000|Overall Study|Disease Progression|2|||
131139775|NCT02319044|472138155|FG002|Overall Study|Adverse Event|8|||
131139776|NCT02319044|472138153|FG000|Overall Study|Study specific discontinuation criteria|2|||
131139777|NCT02319044|472138154|FG001|Overall Study|Study specific discontinuation criteria|2|||
131079390|NCT02053610|471924487|FG001|Overall Study|Disease Progression|3|||
131079391|NCT02053610|471924486|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
131079392|NCT02053610|471924487|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
131079393|NCT02053610|471924486|FG000|Overall Study|Did not Receive Treatment|4|||
131079394|NCT02053610|471924487|FG001|Overall Study|Did not Receive Treatment|2|||
131079395|NCT02053610|471924486|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131139778|NCT02319044|472138155|FG002|Overall Study|Study specific discontinuation criteria|1|||
130726830|NCT00070499|470625422|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
130726831|NCT00070499|470625423|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
131079396|NCT02053610|471924487|FG001|Overall Study|Insufficient Therapeutic Response|1|||
131079397|NCT02053610|471924486|FG000|Overall Study|Violation of Selection Criteria|1|||
131079398|NCT02053610|471924487|FG001|Overall Study|Violation of Selection Criteria|0|||
131079399|NCT00543062|471924492|FG000|Overall Study|Withdrawal by Subject|1|||
131139779|NCT02319044|472138153|FG000|Overall Study|Not treated|0|||
131139780|NCT02319044|472138154|FG001|Overall Study|Not treated|2|||
131139781|NCT02319044|472138155|FG002|Overall Study|Not treated|2|||
130726832|NCT00070499|470625420|FG000|Overall Study|Progression/relapse|4|||
130726833|NCT00070499|470625421|FG001|Overall Study|Progression/relapse|2|||
131231667|NCT02637557|472475193|FG003|Overall Study|Lost to Follow-up|1|||
131231668|NCT02637557|472475190|FG000|Overall Study|Physician Decision|1|||
131231669|NCT02637557|472475191|FG001|Overall Study|Physician Decision|0|||
131231670|NCT02637557|472475192|FG002|Overall Study|Physician Decision|0|||
130726834|NCT00070499|470625422|FG002|Overall Study|Progression/relapse|1|||
131079400|NCT00543062|471924493|FG001|Overall Study|Withdrawal by Subject|0|||
131079401|NCT00543062|471924494|FG002|Overall Study|Withdrawal by Subject|2|||
131079402|NCT00543062|471924495|FG003|Overall Study|Withdrawal by Subject|0|||
131079403|NCT00543062|471924492|FG000|Overall Study|Adverse Event|0|||
131079404|NCT00543062|471924493|FG001|Overall Study|Adverse Event|1|||
131079405|NCT00543062|471924494|FG002|Overall Study|Adverse Event|1|||
131079406|NCT00543062|471924495|FG003|Overall Study|Adverse Event|1|||
131079407|NCT00543062|471924492|FG000|Overall Study|Protocol Violation|1|||
131079408|NCT00543062|471924493|FG001|Overall Study|Protocol Violation|0|||
131079409|NCT00543062|471924494|FG002|Overall Study|Protocol Violation|0|||
131079410|NCT00543062|471924495|FG003|Overall Study|Protocol Violation|0|||
131079411|NCT01513330|471924496|FG000|SenSura Mio First,|Adverse Event|2|||
131079412|NCT01513330|471924497|FG001|SenSura Mio First,|Adverse Event|0|||
131079413|NCT01513330|471924496|FG000|SenSura Mio First,|Lack of Efficacy|0|||
131079414|NCT01513330|471924497|FG001|SenSura Mio First,|Lack of Efficacy|1|||
131079415|NCT01513330|471924496|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
131079416|NCT01513330|471924497|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
131079417|NCT01513330|471924496|FG000|SenSura Mio First,|Other|1|||
131079418|NCT01513330|471924497|FG001|SenSura Mio First,|Other|0|||
131079419|NCT01513330|471924496|FG000|Standard Care First,|Lack of Efficacy|2|||
131079420|NCT01513330|471924497|FG001|Standard Care First,|Lack of Efficacy|2|||
131079421|NCT01513330|471924496|FG000|Standard Care First,|Withdrawal by Subject|1|||
131079422|NCT01513330|471924497|FG001|Standard Care First,|Withdrawal by Subject|2|||
131079423|NCT01513330|471924496|FG000|Standard Care First,|Other|1|||
131079424|NCT01513330|471924497|FG001|Standard Care First,|Other|0|||
131079425|NCT04486313|471924498|FG000|Overall Study|Lost to Follow-up|7|||
131079426|NCT04486313|471924499|FG001|Overall Study|Lost to Follow-up|9|||
131079427|NCT04486313|471924498|FG000|Overall Study|Withdrawal by Subject|8|||
131079428|NCT04486313|471924499|FG001|Overall Study|Withdrawal by Subject|6|||
131079429|NCT04486313|471924498|FG000|Overall Study|Physician Decision|1|||
131079430|NCT04486313|471924499|FG001|Overall Study|Physician Decision|1|||
131079431|NCT04486313|471924498|FG000|Overall Study|Death|2|||
131079432|NCT04486313|471924499|FG001|Overall Study|Death|0|||
131079433|NCT04486313|471924498|FG000|Overall Study|Protocol Violation|1|||
131079434|NCT04486313|471924499|FG001|Overall Study|Protocol Violation|1|||
131079435|NCT03021551|471924504|FG000|Overall Study|Equipment Issues|2|||
131079436|NCT03021551|471924504|FG000|Overall Study|Protocol Violation|1|||
131079437|NCT02232399|471924505|FG000|Overall Study|Adverse Event|1|||
131079438|NCT02232399|471924506|FG001|Overall Study|Adverse Event|0|||
131079439|NCT02232399|471924505|FG000|Overall Study|Withdrawal by Subject|0|||
131079440|NCT02232399|471924506|FG001|Overall Study|Withdrawal by Subject|1|||
131079441|NCT01777334|471924507|FG000|Overall Study|Adverse Event|18|||
131079442|NCT01777334|471924508|FG001|Overall Study|Adverse Event|14|||
131079443|NCT01777334|471924507|FG000|Overall Study|Lack of Efficacy|15|||
131079444|NCT01777334|471924508|FG001|Overall Study|Lack of Efficacy|29|||
131079445|NCT01777334|471924507|FG000|Overall Study|Protocol Violation|3|||
131079446|NCT01777334|471924508|FG001|Overall Study|Protocol Violation|7|||
131079447|NCT01777334|471924507|FG000|Overall Study|Lost to Follow-up|3|||
131079448|NCT01777334|471924508|FG001|Overall Study|Lost to Follow-up|2|||
131079449|NCT01777334|471924507|FG000|Overall Study|Withdrawal by Subject|14|||
131079450|NCT01777334|471924508|FG001|Overall Study|Withdrawal by Subject|11|||
131079451|NCT02250534|471924513|FG000|Overall Study|Lost to Follow-up|18|||
131079452|NCT02250534|471924514|FG001|Overall Study|Lost to Follow-up|28|||
131079453|NCT02250534|471924515|FG002|Overall Study|Lost to Follow-up|33|||
131079454|NCT02250534|471924513|FG000|Overall Study|Personal reasons|7|||
131079455|NCT02250534|471924514|FG001|Overall Study|Personal reasons|8|||
131079456|NCT02250534|471924515|FG002|Overall Study|Personal reasons|14|||
131079457|NCT02250534|471924513|FG000|Overall Study|Adverse Event|6|||
131079458|NCT02250534|471924514|FG001|Overall Study|Adverse Event|3|||
131079459|NCT02250534|471924515|FG002|Overall Study|Adverse Event|8|||
131079460|NCT02250534|471924513|FG000|Overall Study|incarcerated|2|||
131079461|NCT02250534|471924514|FG001|Overall Study|incarcerated|1|||
131079462|NCT02250534|471924515|FG002|Overall Study|incarcerated|2|||
131079463|NCT02250534|471924513|FG000|Overall Study|Withdrawal by Subject|0|||
131079464|NCT02250534|471924514|FG001|Overall Study|Withdrawal by Subject|1|||
131079465|NCT02250534|471924515|FG002|Overall Study|Withdrawal by Subject|2|||
131079466|NCT02250534|471924513|FG000|Overall Study|Death|0|||
131079467|NCT02250534|471924514|FG001|Overall Study|Death|1|||
130726835|NCT00070499|470625423|FG003|Overall Study|Progression/relapse|4|||
131079468|NCT02250534|471924515|FG002|Overall Study|Death|1|||
131079469|NCT02250534|471924513|FG000|Overall Study|Physician Decision|1|||
131079470|NCT02250534|471924514|FG001|Overall Study|Physician Decision|3|||
131079471|NCT02250534|471924515|FG002|Overall Study|Physician Decision|1|||
131079472|NCT02250534|471924513|FG000|Overall Study|Protocol Violation|1|||
131079473|NCT02250534|471924514|FG001|Overall Study|Protocol Violation|0|||
130726836|NCT00070499|470625420|FG000|Overall Study|Death|1|||
130726837|NCT00070499|470625421|FG001|Overall Study|Death|1|||
131079474|NCT02250534|471924515|FG002|Overall Study|Protocol Violation|1|||
131079475|NCT02250534|471924513|FG000|Overall Study|Reason unknown|1|||
131079476|NCT02250534|471924514|FG001|Overall Study|Reason unknown|0|||
131079477|NCT02250534|471924515|FG002|Overall Study|Reason unknown|0|||
131079478|NCT02569957|471924517|FG000|Overall Study|Withdrawal by Subject|0|||
131079479|NCT02569957|471924518|FG001|Overall Study|Withdrawal by Subject|1|||
131079480|NCT00763451|471924519|FG000|Overall Study|Adverse Event|4|||
131079481|NCT00763451|471924520|FG001|Overall Study|Adverse Event|6|||
131079482|NCT00763451|471924521|FG002|Overall Study|Adverse Event|19|||
131079483|NCT00763451|471924522|FG003|Overall Study|Adverse Event|14|||
131079484|NCT00763451|471924519|FG000|Overall Study|Lack of Efficacy|1|||
131079485|NCT00763451|471924520|FG001|Overall Study|Lack of Efficacy|4|||
131079486|NCT00763451|471924521|FG002|Overall Study|Lack of Efficacy|3|||
131079487|NCT00763451|471924522|FG003|Overall Study|Lack of Efficacy|2|||
131079488|NCT00763451|471924519|FG000|Overall Study|Withdrawal by Subject|1|||
131079489|NCT00763451|471924520|FG001|Overall Study|Withdrawal by Subject|6|||
131079490|NCT00763451|471924521|FG002|Overall Study|Withdrawal by Subject|9|||
131079491|NCT00763451|471924522|FG003|Overall Study|Withdrawal by Subject|7|||
131079492|NCT00763451|471924519|FG000|Overall Study|Protocol Violation|0|||
131079493|NCT00763451|471924520|FG001|Overall Study|Protocol Violation|0|||
131079494|NCT00763451|471924521|FG002|Overall Study|Protocol Violation|1|||
131079495|NCT00763451|471924522|FG003|Overall Study|Protocol Violation|0|||
131079496|NCT00763451|471924519|FG000|Overall Study|Poor Compliance to Protocol|1|||
131079497|NCT00763451|471924520|FG001|Overall Study|Poor Compliance to Protocol|1|||
131079498|NCT00763451|471924521|FG002|Overall Study|Poor Compliance to Protocol|2|||
131079499|NCT00763451|471924522|FG003|Overall Study|Poor Compliance to Protocol|2|||
131079500|NCT00763451|471924519|FG000|Overall Study|Familial and Personal Reasons|5|||
131079501|NCT00763451|471924520|FG001|Overall Study|Familial and Personal Reasons|3|||
131079502|NCT00763451|471924521|FG002|Overall Study|Familial and Personal Reasons|5|||
131079503|NCT00763451|471924522|FG003|Overall Study|Familial and Personal Reasons|4|||
131079504|NCT00763451|471924519|FG000|Overall Study|Randomized but not Treated|1|||
131079505|NCT00763451|471924520|FG001|Overall Study|Randomized but not Treated|1|||
131079506|NCT00763451|471924521|FG002|Overall Study|Randomized but not Treated|0|||
131079507|NCT00763451|471924522|FG003|Overall Study|Randomized but not Treated|0|||
131139782|NCT03434379|472138156|FG000|Global Period|Lost to Follow-up|3|||
131139783|NCT03434379|472138157|FG001|Global Period|Lost to Follow-up|6|||
131139784|NCT03434379|472138158|FG002|Global Period|Lost to Follow-up|0|||
131139785|NCT03434379|472138159|FG003|Global Period|Lost to Follow-up|0|||
131139786|NCT03434379|472138156|FG000|Global Period|Death|115|||
131139787|NCT03434379|472138157|FG001|Global Period|Death|228|||
131139788|NCT03434379|472138158|FG002|Global Period|Death|0|||
131139789|NCT03434379|472138159|FG003|Global Period|Death|0|||
131139790|NCT03434379|472138156|FG000|Global Period|Withdrawal by Subject|20|||
131139791|NCT03434379|472138157|FG001|Global Period|Withdrawal by Subject|21|||
131139792|NCT03434379|472138158|FG002|Global Period|Withdrawal by Subject|0|||
131139793|NCT03434379|472138159|FG003|Global Period|Withdrawal by Subject|0|||
131139794|NCT03434379|472138156|FG000|Global Period|Reason Unspecified|0|||
131139795|NCT03434379|472138157|FG001|Global Period|Reason Unspecified|1|||
131139796|NCT03434379|472138158|FG002|Global Period|Reason Unspecified|0|||
131139797|NCT03434379|472138159|FG003|Global Period|Reason Unspecified|0|||
131139798|NCT03434379|472138156|FG000|Global Period|Study Ended by Sponsor|26|||
131139799|NCT03434379|472138157|FG001|Global Period|Study Ended by Sponsor|80|||
131139800|NCT03434379|472138158|FG002|Global Period|Study Ended by Sponsor|0|||
131139801|NCT03434379|472138159|FG003|Global Period|Study Ended by Sponsor|0|||
131139802|NCT03434379|472138156|FG000|Global Period|Physician Decision|1|||
131139803|NCT03434379|472138157|FG001|Global Period|Physician Decision|0|||
131139804|NCT03434379|472138158|FG002|Global Period|Physician Decision|0|||
131139805|NCT03434379|472138159|FG003|Global Period|Physician Decision|0|||
131139806|NCT03434379|472138156|FG000|China Extension Period|Lost to Follow-up|0|||
131139807|NCT03434379|472138157|FG001|China Extension Period|Lost to Follow-up|0|||
130726838|NCT00070499|470625422|FG002|Overall Study|Death|1|||
130726839|NCT00070499|470625423|FG003|Overall Study|Death|2|||
130726840|NCT00070499|470625420|FG000|Overall Study|Other - not protocol specified|7|||
131079508|NCT00763451|471924519|FG000|Overall Study|Study Site Reason|0|||
131139808|NCT03434379|472138158|FG002|China Extension Period|Lost to Follow-up|2|||
131139809|NCT03434379|472138159|FG003|China Extension Period|Lost to Follow-up|3|||
131139810|NCT03434379|472138156|FG000|China Extension Period|Death|0|||
131139811|NCT03434379|472138157|FG001|China Extension Period|Death|0|||
130726841|NCT00070499|470625421|FG001|Overall Study|Other - not protocol specified|3|||
131231671|NCT02637557|472475193|FG003|Overall Study|Physician Decision|0|||
130726842|NCT00070499|470625422|FG002|Overall Study|Other - not protocol specified|12|||
131079509|NCT00763451|471924520|FG001|Overall Study|Study Site Reason|1|||
131079510|NCT00763451|471924521|FG002|Overall Study|Study Site Reason|1|||
131079511|NCT00763451|471924522|FG003|Overall Study|Study Site Reason|1|||
131079512|NCT00725543|471924526|FG000|Overall Study|Adverse Event|10|||
131139812|NCT03434379|472138158|FG002|China Extension Period|Death|46|||
131139813|NCT03434379|472138159|FG003|China Extension Period|Death|88|||
131139814|NCT03434379|472138156|FG000|China Extension Period|Withdrawal by Subject|0|||
131139815|NCT03434379|472138157|FG001|China Extension Period|Withdrawal by Subject|0|||
131139816|NCT03434379|472138158|FG002|China Extension Period|Withdrawal by Subject|8|||
131139817|NCT03434379|472138159|FG003|China Extension Period|Withdrawal by Subject|6|||
131139818|NCT03434379|472138156|FG000|China Extension Period|Study Ended by Sponsor|0|||
131139819|NCT03434379|472138157|FG001|China Extension Period|Study Ended by Sponsor|0|||
131139820|NCT03434379|472138158|FG002|China Extension Period|Study Ended by Sponsor|5|||
131139821|NCT03434379|472138159|FG003|China Extension Period|Study Ended by Sponsor|36|||
131139822|NCT00573794|472138165|FG000|Overall Study|Adverse Event|81|||
131139823|NCT00573794|472138165|FG000|Overall Study|Withdrew Consent|90|||
131139824|NCT00573794|472138165|FG000|Overall Study|Lost to Follow-up|13|||
131139825|NCT00573794|472138165|FG000|Overall Study|Protocol Violation|6|||
131139826|NCT00573794|472138165|FG000|Overall Study|Lack of Efficacy|94|||
131139827|NCT00573794|472138165|FG000|Overall Study|Other|46|||
131139828|NCT03179436|472138171|FG000|Overall Study|Withdrawal by Subject|1|||
131139829|NCT03179436|472138172|FG001|Overall Study|Withdrawal by Subject|0|||
131139830|NCT03179436|472138173|FG002|Overall Study|Withdrawal by Subject|0|||
131139831|NCT03179436|472138174|FG003|Overall Study|Withdrawal by Subject|4|||
131139832|NCT03179436|472138175|FG004|Overall Study|Withdrawal by Subject|2|||
131139833|NCT03179436|472138176|FG005|Overall Study|Withdrawal by Subject|2|||
131139834|NCT03179436|472138177|FG006|Overall Study|Withdrawal by Subject|5|||
131139835|NCT03179436|472138178|FG007|Overall Study|Withdrawal by Subject|0|||
131139836|NCT03179436|472138179|FG008|Overall Study|Withdrawal by Subject|3|||
131139837|NCT03179436|472138180|FG009|Overall Study|Withdrawal by Subject|0|||
131139838|NCT03179436|472138181|FG010|Overall Study|Withdrawal by Subject|0|||
131139839|NCT03179436|472138182|FG011|Overall Study|Withdrawal by Subject|0|||
131139840|NCT03179436|472138171|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131139841|NCT03179436|472138172|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131139842|NCT03179436|472138173|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131139843|NCT03179436|472138174|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131139844|NCT03179436|472138175|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131139845|NCT03179436|472138176|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
131139846|NCT03179436|472138177|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
131139847|NCT03179436|472138178|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
131139848|NCT03179436|472138179|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
131139849|NCT03179436|472138180|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
131139850|NCT03179436|472138181|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
131139851|NCT03179436|472138182|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
131139852|NCT03179436|472138171|FG000|Overall Study|Sponsor Decision|0|||
131139853|NCT03179436|472138172|FG001|Overall Study|Sponsor Decision|0|||
131139854|NCT03179436|472138173|FG002|Overall Study|Sponsor Decision|1|||
131139855|NCT03179436|472138174|FG003|Overall Study|Sponsor Decision|3|||
131139856|NCT03179436|472138175|FG004|Overall Study|Sponsor Decision|9|||
131139857|NCT03179436|472138176|FG005|Overall Study|Sponsor Decision|7|||
131139858|NCT03179436|472138177|FG006|Overall Study|Sponsor Decision|2|||
131139859|NCT03179436|472138178|FG007|Overall Study|Sponsor Decision|4|||
131139860|NCT03179436|472138179|FG008|Overall Study|Sponsor Decision|23|||
131139861|NCT03179436|472138180|FG009|Overall Study|Sponsor Decision|6|||
131139862|NCT03179436|472138181|FG010|Overall Study|Sponsor Decision|7|||
131139863|NCT03179436|472138182|FG011|Overall Study|Sponsor Decision|5|||
131139864|NCT03179436|472138171|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
131139865|NCT03179436|472138172|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
131139866|NCT03179436|472138173|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
131139867|NCT03179436|472138174|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
131139868|NCT03179436|472138175|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
131139869|NCT03179436|472138176|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
131139870|NCT03179436|472138177|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
131139871|NCT03179436|472138178|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
131139872|NCT03179436|472138179|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
131139873|NCT03179436|472138180|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
131139874|NCT03179436|472138181|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
131139875|NCT03179436|472138182|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
131139876|NCT03179436|472138171|FG000|Overall Study|Lost to Follow-up|1|||
131139877|NCT03179436|472138172|FG001|Overall Study|Lost to Follow-up|0|||
130726843|NCT00070499|470625423|FG003|Overall Study|Other - not protocol specified|20|||
130780111|NCT01914393|470821407|FG000|Overall Study|Adverse Event|29|||
131139878|NCT03179436|472138173|FG002|Overall Study|Lost to Follow-up|0|||
131139879|NCT03179436|472138174|FG003|Overall Study|Lost to Follow-up|1|||
131139880|NCT03179436|472138175|FG004|Overall Study|Lost to Follow-up|0|||
131139881|NCT03179436|472138176|FG005|Overall Study|Lost to Follow-up|1|||
131139882|NCT03179436|472138177|FG006|Overall Study|Lost to Follow-up|0|||
131139883|NCT03179436|472138178|FG007|Overall Study|Lost to Follow-up|0|||
131139884|NCT03179436|472138179|FG008|Overall Study|Lost to Follow-up|1|||
131079513|NCT00725543|471924526|FG000|Overall Study|Lack of Efficacy|3|||
131079514|NCT00725543|471924526|FG000|Overall Study|Withdrawal by Subject|10|||
131079515|NCT00725543|471924526|FG000|Overall Study|Physician Decision|5|||
131079516|NCT00725543|471924526|FG000|Overall Study|Lost to Follow-up|4|||
131079517|NCT00725543|471924526|FG000|Overall Study|Non-compliance|2|||
131079518|NCT00725543|471924526|FG000|Overall Study|Other|119|||
131079519|NCT05594589|471924527|FG000|Overall Study|Other|0|||
131079520|NCT05594589|471924528|FG001|Overall Study|Other|1|||
131079521|NCT05594589|471924529|FG002|Overall Study|Other|0|||
131079522|NCT02168478|471924530|FG000|Overall Study|Withdrawal by Subject|1|||
131079523|NCT02168478|471924530|FG000|Overall Study|Did Not Consent to Participation|2|||
131079524|NCT02168478|471924530|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
131079525|NCT02344173|471924531|FG000|Procedure|Ablation Procedure Not Performed|7|||
131079526|NCT02344173|471924531|FG000|12-month Visit|Death|8|||
131079527|NCT02344173|471924531|FG000|12-month Visit|Withdrawal by Subject|30|||
131079528|NCT02344173|471924531|FG000|12-month Visit|Lost to Follow-up|58|||
130726844|NCT00070499|470625420|FG000|Overall Study|Still on protocol treatment|10|||
130726845|NCT00070499|470625421|FG001|Overall Study|Still on protocol treatment|4|||
130726846|NCT00070499|470625422|FG002|Overall Study|Still on protocol treatment|79|||
130726847|NCT00070499|470625423|FG003|Overall Study|Still on protocol treatment|57|||
131079529|NCT05314374|471924532|FG000|Overall Study|Adverse Event|2|||
131079530|NCT05314374|471924533|FG001|Overall Study|Adverse Event|2|||
131079531|NCT02554383|471924534|FG000|Overall Study|Ineligible|3|||
131079532|NCT02554383|471924535|FG001|Overall Study|Ineligible|2|||
130726848|NCT00070499|470625420|FG000|Overall Study|Did not start treatment|1|||
130726849|NCT00070499|470625421|FG001|Overall Study|Did not start treatment|0|||
130726850|NCT00070499|470625422|FG002|Overall Study|Did not start treatment|0|||
130726851|NCT00070499|470625423|FG003|Overall Study|Did not start treatment|2|||
130726852|NCT00070499|470625420|FG000|Overall Study|Not eligible|2|||
130726853|NCT00070499|470625421|FG001|Overall Study|Not eligible|5|||
130726854|NCT00070499|470625422|FG002|Overall Study|Not eligible|3|||
130726855|NCT00070499|470625423|FG003|Overall Study|Not eligible|2|||
130726856|NCT02883049|470625424|FG000|Induction|Adverse Event|52|||
130726857|NCT02883049|470625425|FG001|Induction|Adverse Event|2|||
130726858|NCT02883049|470625426|FG002|Induction|Adverse Event|0|||
130726859|NCT02883049|470625427|FG003|Induction|Adverse Event|0|||
131079533|NCT02554383|471924534|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
131079534|NCT02554383|471924535|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
131079535|NCT02554383|471924534|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
131079536|NCT02554383|471924535|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
131079537|NCT02554383|471924534|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
131079538|NCT02554383|471924535|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
131079539|NCT01801982|471924536|FG000|Overall Study|Lost to Follow-up|1|||
131079540|NCT02918292|471924539|FG000|Study Enrollment Prior to Transplant|Death|1|||
131079541|NCT02918292|471924539|FG000|Study Follow up After Transplant|Death|6|||
131079542|NCT01185171|471924540|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
131079543|NCT01185171|471924540|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
131079544|NCT01185171|471924540|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
131079545|NCT01185171|471924540|FG000|Maintenance|Elevated liver transaminases|3|||
131079546|NCT01185171|471924540|FG000|Maintenance|Rush|2|||
131079547|NCT01185171|471924540|FG000|Maintenance|Diarrhea|1|||
131079548|NCT01185171|471924540|FG000|Maintenance|Xerostomia|1|||
131079549|NCT01185171|471924540|FG000|Maintenance|Nausea|1|||
131079550|NCT01185171|471924540|FG000|Maintenance|Comorbid Illness|2|||
131139885|NCT03179436|472138180|FG009|Overall Study|Lost to Follow-up|1|||
131139886|NCT03179436|472138181|FG010|Overall Study|Lost to Follow-up|0|||
131139887|NCT03179436|472138182|FG011|Overall Study|Lost to Follow-up|0|||
131139888|NCT03179436|472138171|FG000|Overall Study|Death|12|||
131139889|NCT03179436|472138172|FG001|Overall Study|Death|17|||
131139890|NCT03179436|472138173|FG002|Overall Study|Death|7|||
131139891|NCT03179436|472138174|FG003|Overall Study|Death|32|||
131139892|NCT03179436|472138175|FG004|Overall Study|Death|29|||
131139893|NCT03179436|472138176|FG005|Overall Study|Death|30|||
131139894|NCT03179436|472138177|FG006|Overall Study|Death|33|||
131139895|NCT03179436|472138178|FG007|Overall Study|Death|9|||
131139896|NCT03179436|472138179|FG008|Overall Study|Death|84|||
131139897|NCT03179436|472138180|FG009|Overall Study|Death|33|||
131139898|NCT03179436|472138181|FG010|Overall Study|Death|22|||
131139899|NCT03179436|472138182|FG011|Overall Study|Death|15|||
131139900|NCT02320487|472138188|FG000|Overall Study|Reason not Specified|1|||
131139901|NCT02320487|472138188|FG000|Overall Study|Physician Decision|5|||
131139902|NCT02320487|472138188|FG000|Overall Study|Withdrawal by Subject|1|||
131139903|NCT02320487|472138188|FG000|Overall Study|Death|3|||
131139904|NCT02320487|472138188|FG000|Overall Study|Adverse Event|11|||
131139905|NCT00684957|472138189|FG000|Overall Study|Withdrawal by Subject|1|||
131139906|NCT00684957|472138190|FG001|Overall Study|Withdrawal by Subject|1|||
131139907|NCT00684957|472138189|FG000|Overall Study|Lost to Follow-up|1|||
131139908|NCT00684957|472138190|FG001|Overall Study|Lost to Follow-up|0|||
131231672|NCT02637557|472475190|FG000|Overall Study|Protocol Violation|2|||
131231673|NCT02637557|472475191|FG001|Overall Study|Protocol Violation|0|||
131231674|NCT02637557|472475192|FG002|Overall Study|Protocol Violation|2|||
131231675|NCT02637557|472475193|FG003|Overall Study|Protocol Violation|1|||
131231676|NCT02637557|472475190|FG000|Overall Study|Withdrawal by Subject|1|||
131231677|NCT02637557|472475191|FG001|Overall Study|Withdrawal by Subject|3|||
131231678|NCT02637557|472475192|FG002|Overall Study|Withdrawal by Subject|4|||
131231679|NCT02637557|472475193|FG003|Overall Study|Withdrawal by Subject|2|||
131231680|NCT04604184|472475199|FG000|Overall Study|Adverse Event|5|||
131231681|NCT04604184|472475200|FG001|Overall Study|Adverse Event|5|||
131231682|NCT04604184|472475199|FG000|Overall Study|Death|2|||
131231683|NCT04604184|472475200|FG001|Overall Study|Death|1|||
131231684|NCT04604184|472475199|FG000|Overall Study|Withdrawal by Subject|1|||
131231685|NCT04604184|472475200|FG001|Overall Study|Withdrawal by Subject|3|||
131231686|NCT04604184|472475199|FG000|Overall Study|Not treated|2|||
131231687|NCT04604184|472475200|FG001|Overall Study|Not treated|2|||
131231688|NCT04604184|472475199|FG000|Overall Study|Due to sponsor decision|9|||
131231689|NCT04604184|472475200|FG001|Overall Study|Due to sponsor decision|7|||
131231690|NCT04604184|472475199|FG000|Overall Study|Physician Decision|0|||
131231691|NCT04604184|472475200|FG001|Overall Study|Physician Decision|1|||
131231692|NCT04604184|472475199|FG000|Overall Study|Transfer to healthcare|1|||
131231693|NCT04604184|472475200|FG001|Overall Study|Transfer to healthcare|0|||
131231694|NCT01751412|472475201|FG000|Overall Study|Disease Progression Before Treatment|1|||
131231695|NCT02711956|472475204|FG000|Overall Study|Adverse Event|0|||
131231696|NCT02711956|472475205|FG001|Overall Study|Adverse Event|0|||
131231697|NCT02711956|472475206|FG002|Overall Study|Adverse Event|0|||
131231698|NCT02711956|472475207|FG003|Overall Study|Adverse Event|1|||
131139909|NCT04439175|472139978|FG000|Overall Study|Never started treatment|4|||
131139910|NCT04439175|472139978|FG000|Overall Study|Ineligible|5|||
131139911|NCT04439175|472139978|FG000|Overall Study|Adverse Event|6|||
131139912|NCT04439175|472139978|FG000|Overall Study|Death|4|||
131139913|NCT04439175|472139978|FG000|Overall Study|Disease progression|44|||
131139914|NCT04439175|472139978|FG000|Overall Study|Withdrawal by Subject|4|||
131139915|NCT04439175|472139978|FG000|Overall Study|Alternative Therapy|1|||
131139916|NCT04439175|472139978|FG000|Overall Study|Other|2|||
131139917|NCT02152345|472139979|FG000|Overall Study|Case Cancellations|2|||
131139918|NCT02152345|472139980|FG001|Overall Study|Case Cancellations|4|||
131139919|NCT02152345|472139979|FG000|Overall Study|Withdrawal by Subject|2|||
131139920|NCT02152345|472139980|FG001|Overall Study|Withdrawal by Subject|1|||
131139921|NCT02554929|472139981|FG000|Overall Study|Lost to Follow-up|4|||
131139922|NCT02554929|472139982|FG001|Overall Study|Lost to Follow-up|4|||
131139923|NCT02554929|472139981|FG000|Overall Study|Withdrawal by Subject|2|||
131139924|NCT02554929|472139982|FG001|Overall Study|Withdrawal by Subject|8|||
131231699|NCT02711956|472475208|FG004|Overall Study|Adverse Event|2|||
131231700|NCT02711956|472475209|FG005|Overall Study|Adverse Event|0|||
131231701|NCT02711956|472475210|FG006|Overall Study|Adverse Event|0|||
131231702|NCT02711956|472475211|FG007|Overall Study|Adverse Event|1|||
131231703|NCT02711956|472475212|FG008|Overall Study|Adverse Event|1|||
131231704|NCT02711956|472475213|FG009|Overall Study|Adverse Event|1|||
131231705|NCT02711956|472475214|FG010|Overall Study|Adverse Event|1|||
131231706|NCT02711956|472475215|FG011|Overall Study|Adverse Event|0|||
131231707|NCT02711956|472475216|FG012|Overall Study|Adverse Event|0|||
131231708|NCT02711956|472475217|FG013|Overall Study|Adverse Event|0|||
131231709|NCT02711956|472475218|FG014|Overall Study|Adverse Event|2|||
131231710|NCT02711956|472475204|FG000|Overall Study|Physician Decision|0|||
131231711|NCT02711956|472475205|FG001|Overall Study|Physician Decision|0|||
131231712|NCT02711956|472475206|FG002|Overall Study|Physician Decision|0|||
131231713|NCT02711956|472475207|FG003|Overall Study|Physician Decision|2|||
131231714|NCT02711956|472475208|FG004|Overall Study|Physician Decision|0|||
131231715|NCT02711956|472475209|FG005|Overall Study|Physician Decision|0|||
131231716|NCT02711956|472475210|FG006|Overall Study|Physician Decision|0|||
131231717|NCT02711956|472475211|FG007|Overall Study|Physician Decision|0|||
131231718|NCT02711956|472475212|FG008|Overall Study|Physician Decision|0|||
131231719|NCT02711956|472475213|FG009|Overall Study|Physician Decision|0|||
131231720|NCT02711956|472475214|FG010|Overall Study|Physician Decision|0|||
131139925|NCT01916980|472139983|FG000|Overall Study|Adverse Event|4|||
131139926|NCT01916980|472139984|FG001|Overall Study|Adverse Event|2|||
131231721|NCT02711956|472475215|FG011|Overall Study|Physician Decision|0|||
131231722|NCT02711956|472475216|FG012|Overall Study|Physician Decision|0|||
131231723|NCT02711956|472475217|FG013|Overall Study|Physician Decision|0|||
131231724|NCT02711956|472475218|FG014|Overall Study|Physician Decision|0|||
131139927|NCT01916980|472139983|FG000|Overall Study|Lack of Efficacy|2|||
131139928|NCT01916980|472139984|FG001|Overall Study|Lack of Efficacy|2|||
131139929|NCT01916980|472139983|FG000|Overall Study|Withdrawal by Subject|1|||
131139930|NCT01916980|472139984|FG001|Overall Study|Withdrawal by Subject|0|||
131139931|NCT02324270|472139985|FG000|Overall Study|Withdrawal by Subject|0|||
131139932|NCT02324270|472139986|FG001|Overall Study|Withdrawal by Subject|1|||
131231725|NCT02711956|472475204|FG000|Overall Study|Withdrawal by Subject|0|||
131231726|NCT02711956|472475205|FG001|Overall Study|Withdrawal by Subject|0|||
131231727|NCT02711956|472475206|FG002|Overall Study|Withdrawal by Subject|0|||
130726860|NCT02883049|470625428|FG004|Induction|Adverse Event|0|||
130726861|NCT02883049|470625429|FG005|Induction|Adverse Event|0|||
130726862|NCT02883049|470625430|FG006|Induction|Adverse Event|0|||
130726863|NCT02883049|470625431|FG007|Induction|Adverse Event|0|||
130726864|NCT02883049|470625432|FG008|Induction|Adverse Event|0|||
130726865|NCT02883049|470625433|FG009|Induction|Adverse Event|0|||
130726866|NCT02883049|470625434|FG010|Induction|Adverse Event|0|||
130726867|NCT02883049|470625435|FG011|Induction|Adverse Event|0|||
130726868|NCT02883049|470625436|FG012|Induction|Adverse Event|0|||
130726869|NCT02883049|470625437|FG013|Induction|Adverse Event|0|||
130726870|NCT02883049|470625438|FG014|Induction|Adverse Event|0|||
130726871|NCT02883049|470625439|FG015|Induction|Adverse Event|0|||
130726872|NCT02883049|470625424|FG000|Induction|Death|76|||
130726873|NCT02883049|470625425|FG001|Induction|Death|8|||
130726874|NCT02883049|470625426|FG002|Induction|Death|0|||
130726875|NCT02883049|470625427|FG003|Induction|Death|0|||
130726876|NCT02883049|470625428|FG004|Induction|Death|0|||
130726877|NCT02883049|470625429|FG005|Induction|Death|0|||
130726878|NCT02883049|470625430|FG006|Induction|Death|0|||
130726879|NCT02883049|470625431|FG007|Induction|Death|0|||
130726880|NCT02883049|470625432|FG008|Induction|Death|0|||
130726881|NCT02883049|470625433|FG009|Induction|Death|0|||
130726882|NCT02883049|470625434|FG010|Induction|Death|0|||
130726883|NCT02883049|470625435|FG011|Induction|Death|0|||
130726884|NCT02883049|470625436|FG012|Induction|Death|0|||
130726885|NCT02883049|470625437|FG013|Induction|Death|0|||
130726886|NCT02883049|470625438|FG014|Induction|Death|0|||
130726887|NCT02883049|470625439|FG015|Induction|Death|0|||
130726888|NCT02883049|470625424|FG000|Induction|Lost to Follow-up|2|||
130726889|NCT02883049|470625425|FG001|Induction|Lost to Follow-up|0|||
130726890|NCT02883049|470625426|FG002|Induction|Lost to Follow-up|0|||
130726891|NCT02883049|470625427|FG003|Induction|Lost to Follow-up|0|||
130726892|NCT02883049|470625428|FG004|Induction|Lost to Follow-up|0|||
130726893|NCT02883049|470625429|FG005|Induction|Lost to Follow-up|0|||
130726894|NCT02883049|470625430|FG006|Induction|Lost to Follow-up|0|||
130726895|NCT02883049|470625431|FG007|Induction|Lost to Follow-up|0|||
130726896|NCT02883049|470625432|FG008|Induction|Lost to Follow-up|0|||
130726897|NCT02883049|470625433|FG009|Induction|Lost to Follow-up|0|||
130726898|NCT02883049|470625434|FG010|Induction|Lost to Follow-up|0|||
130726899|NCT02883049|470625435|FG011|Induction|Lost to Follow-up|0|||
130726900|NCT02883049|470625436|FG012|Induction|Lost to Follow-up|0|||
130726901|NCT02883049|470625437|FG013|Induction|Lost to Follow-up|0|||
130726902|NCT02883049|470625438|FG014|Induction|Lost to Follow-up|0|||
130726903|NCT02883049|470625439|FG015|Induction|Lost to Follow-up|0|||
130726904|NCT02883049|470625424|FG000|Induction|Physician Decision|1407|||
130726905|NCT02883049|470625425|FG001|Induction|Physician Decision|8|||
130726906|NCT02883049|470625426|FG002|Induction|Physician Decision|0|||
130726907|NCT02883049|470625427|FG003|Induction|Physician Decision|0|||
130726908|NCT02883049|470625428|FG004|Induction|Physician Decision|0|||
130726909|NCT02883049|470625429|FG005|Induction|Physician Decision|0|||
130726910|NCT02883049|470625430|FG006|Induction|Physician Decision|0|||
130726911|NCT02883049|470625431|FG007|Induction|Physician Decision|0|||
130726912|NCT02883049|470625432|FG008|Induction|Physician Decision|0|||
130726913|NCT02883049|470625433|FG009|Induction|Physician Decision|0|||
130726914|NCT02883049|470625434|FG010|Induction|Physician Decision|0|||
130726915|NCT02883049|470625435|FG011|Induction|Physician Decision|0|||
130726916|NCT02883049|470625436|FG012|Induction|Physician Decision|0|||
130726917|NCT02883049|470625437|FG013|Induction|Physician Decision|0|||
130726918|NCT02883049|470625438|FG014|Induction|Physician Decision|0|||
130726919|NCT02883049|470625439|FG015|Induction|Physician Decision|0|||
130726920|NCT02883049|470625424|FG000|Induction|Protocol Violation|6|||
130726921|NCT02883049|470625425|FG001|Induction|Protocol Violation|0|||
130726922|NCT02883049|470625426|FG002|Induction|Protocol Violation|0|||
130726923|NCT02883049|470625427|FG003|Induction|Protocol Violation|0|||
130726924|NCT02883049|470625428|FG004|Induction|Protocol Violation|0|||
130726925|NCT02883049|470625429|FG005|Induction|Protocol Violation|0|||
130726926|NCT02883049|470625430|FG006|Induction|Protocol Violation|0|||
130726927|NCT02883049|470625431|FG007|Induction|Protocol Violation|0|||
130726928|NCT02883049|470625432|FG008|Induction|Protocol Violation|0|||
130726929|NCT02883049|470625433|FG009|Induction|Protocol Violation|0|||
130726930|NCT02883049|470625434|FG010|Induction|Protocol Violation|0|||
130726931|NCT02883049|470625435|FG011|Induction|Protocol Violation|0|||
130726932|NCT02883049|470625436|FG012|Induction|Protocol Violation|0|||
130726933|NCT02883049|470625437|FG013|Induction|Protocol Violation|0|||
130726934|NCT02883049|470625438|FG014|Induction|Protocol Violation|0|||
130726935|NCT02883049|470625439|FG015|Induction|Protocol Violation|0|||
130726936|NCT02883049|470625424|FG000|Induction|Withdrawal by Subject|6|||
130726937|NCT02883049|470625425|FG001|Induction|Withdrawal by Subject|0|||
130726938|NCT02883049|470625426|FG002|Induction|Withdrawal by Subject|0|||
130726939|NCT02883049|470625427|FG003|Induction|Withdrawal by Subject|0|||
130726940|NCT02883049|470625428|FG004|Induction|Withdrawal by Subject|0|||
130726941|NCT02883049|470625429|FG005|Induction|Withdrawal by Subject|0|||
130726942|NCT02883049|470625430|FG006|Induction|Withdrawal by Subject|0|||
130726943|NCT02883049|470625431|FG007|Induction|Withdrawal by Subject|0|||
130726944|NCT02883049|470625432|FG008|Induction|Withdrawal by Subject|0|||
130726945|NCT02883049|470625433|FG009|Induction|Withdrawal by Subject|0|||
130726946|NCT02883049|470625434|FG010|Induction|Withdrawal by Subject|0|||
130726947|NCT02883049|470625435|FG011|Induction|Withdrawal by Subject|0|||
130726948|NCT02883049|470625436|FG012|Induction|Withdrawal by Subject|0|||
130726949|NCT02883049|470625437|FG013|Induction|Withdrawal by Subject|0|||
130726950|NCT02883049|470625438|FG014|Induction|Withdrawal by Subject|0|||
130726951|NCT02883049|470625439|FG015|Induction|Withdrawal by Subject|0|||
130726952|NCT02883049|470625424|FG000|Induction|Ineligible|35|||
131079551|NCT01185171|471924540|FG000|Maintenance|Withdrawal by Subject|1|||
131079552|NCT01185171|471924540|FG000|Maintenance|Disease Recurrence|1|||
131079553|NCT00727506|471924541|FG000|Overall Study|Adverse Event|0|||
131079554|NCT00727506|471924542|FG001|Overall Study|Adverse Event|0|||
131079555|NCT00727506|471924543|FG002|Overall Study|Adverse Event|4|||
131079556|NCT00727506|471924544|FG003|Overall Study|Adverse Event|4|||
131079557|NCT00727506|471924545|FG004|Overall Study|Adverse Event|1|||
131079558|NCT00727506|471924546|FG005|Overall Study|Adverse Event|8|||
131079559|NCT00727506|471924541|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130726953|NCT02883049|470625425|FG001|Induction|Ineligible|1|||
130726954|NCT02883049|470625426|FG002|Induction|Ineligible|0|||
130726955|NCT02883049|470625427|FG003|Induction|Ineligible|0|||
130726956|NCT02883049|470625428|FG004|Induction|Ineligible|0|||
130726957|NCT02883049|470625429|FG005|Induction|Ineligible|0|||
130726958|NCT02883049|470625430|FG006|Induction|Ineligible|0|||
130726959|NCT02883049|470625431|FG007|Induction|Ineligible|0|||
130726960|NCT02883049|470625432|FG008|Induction|Ineligible|0|||
130726961|NCT02883049|470625433|FG009|Induction|Ineligible|0|||
130726962|NCT02883049|470625434|FG010|Induction|Ineligible|0|||
130726963|NCT02883049|470625435|FG011|Induction|Ineligible|0|||
130726964|NCT02883049|470625436|FG012|Induction|Ineligible|0|||
131079560|NCT00727506|471924542|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131079561|NCT00727506|471924543|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
131079562|NCT00727506|471924544|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131079563|NCT00727506|471924545|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131079564|NCT00727506|471924546|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131079565|NCT00727506|471924541|FG000|Overall Study|Progressive disease|4|||
131079566|NCT00727506|471924542|FG001|Overall Study|Progressive disease|7|||
131079567|NCT00727506|471924543|FG002|Overall Study|Progressive disease|9|||
131079568|NCT00727506|471924544|FG003|Overall Study|Progressive disease|28|||
131079569|NCT00727506|471924545|FG004|Overall Study|Progressive disease|38|||
131079570|NCT00727506|471924546|FG005|Overall Study|Progressive disease|28|||
131079571|NCT00727506|471924541|FG000|Overall Study|Refused to continue medication|0|||
130726965|NCT02883049|470625437|FG013|Induction|Ineligible|0|||
130726966|NCT02883049|470625438|FG014|Induction|Ineligible|0|||
130726967|NCT02883049|470625439|FG015|Induction|Ineligible|0|||
130726968|NCT02883049|470625424|FG000|Induction|Refusal of further protocol therapy|466|||
130726969|NCT02883049|470625425|FG001|Induction|Refusal of further protocol therapy|2|||
130726970|NCT02883049|470625426|FG002|Induction|Refusal of further protocol therapy|0|||
130726971|NCT02883049|470625427|FG003|Induction|Refusal of further protocol therapy|0|||
130726972|NCT02883049|470625428|FG004|Induction|Refusal of further protocol therapy|0|||
130726973|NCT02883049|470625429|FG005|Induction|Refusal of further protocol therapy|0|||
130726974|NCT02883049|470625430|FG006|Induction|Refusal of further protocol therapy|0|||
130726975|NCT02883049|470625431|FG007|Induction|Refusal of further protocol therapy|0|||
130726976|NCT02883049|470625432|FG008|Induction|Refusal of further protocol therapy|0|||
130726977|NCT02883049|470625433|FG009|Induction|Refusal of further protocol therapy|0|||
130726978|NCT02883049|470625434|FG010|Induction|Refusal of further protocol therapy|0|||
130726979|NCT02883049|470625435|FG011|Induction|Refusal of further protocol therapy|0|||
130726980|NCT02883049|470625436|FG012|Induction|Refusal of further protocol therapy|0|||
130726981|NCT02883049|470625437|FG013|Induction|Refusal of further protocol therapy|0|||
130726982|NCT02883049|470625438|FG014|Induction|Refusal of further protocol therapy|0|||
130726983|NCT02883049|470625439|FG015|Induction|Refusal of further protocol therapy|0|||
130726984|NCT02883049|470625424|FG000|Induction|Identified as Ph+ patients|279|||
130726985|NCT02883049|470625425|FG001|Induction|Identified as Ph+ patients|1|||
131079572|NCT00727506|471924542|FG001|Overall Study|Refused to continue medication|1|||
131079573|NCT00727506|471924543|FG002|Overall Study|Refused to continue medication|2|||
131079574|NCT00727506|471924544|FG003|Overall Study|Refused to continue medication|3|||
131079575|NCT00727506|471924545|FG004|Overall Study|Refused to continue medication|1|||
131079576|NCT00727506|471924546|FG005|Overall Study|Refused to continue medication|2|||
130726986|NCT02883049|470625426|FG002|Induction|Identified as Ph+ patients|0|||
130726987|NCT02883049|470625427|FG003|Induction|Identified as Ph+ patients|0|||
131079577|NCT00727506|471924541|FG000|Overall Study|Other reason not described above|0|||
130726988|NCT02883049|470625428|FG004|Induction|Identified as Ph+ patients|0|||
130726989|NCT02883049|470625429|FG005|Induction|Identified as Ph+ patients|0|||
131079578|NCT00727506|471924542|FG001|Overall Study|Other reason not described above|0|||
131079579|NCT00727506|471924543|FG002|Overall Study|Other reason not described above|1|||
131079580|NCT00727506|471924544|FG003|Overall Study|Other reason not described above|4|||
130726990|NCT02883049|470625430|FG006|Induction|Identified as Ph+ patients|0|||
130780112|NCT01914393|470821408|FG001|Overall Study|Adverse Event|18|||
130780113|NCT01914393|470821409|FG002|Overall Study|Adverse Event|31|||
130780114|NCT01914393|470821407|FG000|Overall Study|Withdrawal by Subject|38|||
130780115|NCT01914393|470821408|FG001|Overall Study|Withdrawal by Subject|20|||
130780116|NCT01914393|470821409|FG002|Overall Study|Withdrawal by Subject|47|||
130780117|NCT01914393|470821407|FG000|Overall Study|Lost to Follow-up|12|||
130780118|NCT01914393|470821408|FG001|Overall Study|Lost to Follow-up|6|||
130780119|NCT01914393|470821409|FG002|Overall Study|Lost to Follow-up|19|||
130780120|NCT01914393|470821407|FG000|Overall Study|subject never dosed|0|||
130780121|NCT01914393|470821408|FG001|Overall Study|subject never dosed|0|||
131079581|NCT00727506|471924545|FG004|Overall Study|Other reason not described above|1|||
131079582|NCT00727506|471924546|FG005|Overall Study|Other reason not described above|1|||
131079583|NCT01482429|471924547|FG000|Care Usual|Protocol Violation|0|||
131079584|NCT01482429|471924548|FG001|Care Usual|Protocol Violation|172|||
131079585|NCT01482429|471924547|FG000|Care Usual|Lost to Follow-up|0|||
131079586|NCT01482429|471924548|FG001|Care Usual|Lost to Follow-up|1|||
131079587|NCT01482429|471924547|FG000|Protocol|Protocol Violation|275|||
131079588|NCT01482429|471924548|FG001|Protocol|Protocol Violation|0|||
131079589|NCT01214421|471924549|FG000|Overall Study|Lost to Follow-up|7|||
131079590|NCT01214421|471924550|FG001|Overall Study|Lost to Follow-up|3|||
131079591|NCT01214421|471924551|FG002|Overall Study|Lost to Follow-up|7|||
131079592|NCT01214421|471924552|FG003|Overall Study|Lost to Follow-up|3|||
131079593|NCT01214421|471924549|FG000|Overall Study|Adverse Event|16|||
131079594|NCT01214421|471924550|FG001|Overall Study|Adverse Event|35|||
131079595|NCT01214421|471924551|FG002|Overall Study|Adverse Event|14|||
131079596|NCT01214421|471924552|FG003|Overall Study|Adverse Event|3|||
131079597|NCT01214421|471924549|FG000|Overall Study|Sponsor Discontinued Site|1|||
131079598|NCT01214421|471924550|FG001|Overall Study|Sponsor Discontinued Site|2|||
131079599|NCT01214421|471924551|FG002|Overall Study|Sponsor Discontinued Site|0|||
131079600|NCT01214421|471924552|FG003|Overall Study|Sponsor Discontinued Site|0|||
131079601|NCT01214421|471924549|FG000|Overall Study|Withdrawal Criteria Met|3|||
131079602|NCT01214421|471924550|FG001|Overall Study|Withdrawal Criteria Met|0|||
131079603|NCT01214421|471924551|FG002|Overall Study|Withdrawal Criteria Met|2|||
131079604|NCT01214421|471924552|FG003|Overall Study|Withdrawal Criteria Met|1|||
131079605|NCT01214421|471924549|FG000|Overall Study|Physician Decision|2|||
131079606|NCT01214421|471924550|FG001|Overall Study|Physician Decision|0|||
131079607|NCT01214421|471924551|FG002|Overall Study|Physician Decision|4|||
131079608|NCT01214421|471924552|FG003|Overall Study|Physician Decision|0|||
131079609|NCT01214421|471924549|FG000|Overall Study|Withdrawal by Subject|21|||
131079610|NCT01214421|471924550|FG001|Overall Study|Withdrawal by Subject|18|||
131079611|NCT01214421|471924551|FG002|Overall Study|Withdrawal by Subject|11|||
131079612|NCT01214421|471924552|FG003|Overall Study|Withdrawal by Subject|2|||
131079613|NCT03561597|471924553|FG000|Overall Study|Lost to Follow-up|20|||
131079614|NCT03783689|471924555|FG000|Overall Study|Adverse Event|2|||
131079615|NCT03783689|471924556|FG001|Overall Study|Adverse Event|0|||
131079616|NCT03783689|471924555|FG000|Overall Study|Lost to Follow-up|2|||
131079617|NCT03783689|471924556|FG001|Overall Study|Lost to Follow-up|1|||
131079618|NCT03783689|471924555|FG000|Overall Study|Physician Decision|2|||
131079619|NCT03783689|471924556|FG001|Overall Study|Physician Decision|1|||
131079620|NCT03783689|471924555|FG000|Overall Study|Withdrawal by Subject|3|||
131079621|NCT03783689|471924556|FG001|Overall Study|Withdrawal by Subject|3|||
131079622|NCT02392104|471924557|FG000|Overall Study|discontinuation of warfarin|3|||
131079623|NCT02392104|471924557|FG000|Overall Study|bleeding event|1|||
131079624|NCT02392104|471924557|FG000|Overall Study|transferred care to another doctor|2|||
131079625|NCT02392104|471924557|FG000|Overall Study|INR goal range changed|1|||
131079626|NCT02392104|471924557|FG000|Overall Study|admitted to skilled nursing facility|3|||
131079627|NCT02392104|471924557|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
131079628|NCT02581059|471924560|FG000|Study Treatment|Disease Progression|1|||
131079629|NCT02581059|471924561|FG001|Study Treatment|Disease Progression|1|||
131079630|NCT02581059|471924560|FG000|Study Treatment|Adverse Event|2|||
131079631|NCT02581059|471924561|FG001|Study Treatment|Adverse Event|1|||
131079632|NCT02581059|471924560|FG000|Study Treatment|Death|1|||
131079633|NCT02581059|471924561|FG001|Study Treatment|Death|1|||
131079634|NCT02581059|471924560|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
131079635|NCT02581059|471924561|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
131079636|NCT02581059|471924560|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
130780122|NCT01914393|470821409|FG002|Overall Study|subject never dosed|1|||
130780123|NCT04547140|470821410|FG000|Overall Study|Adverse Event|0|||
130780124|NCT04547140|470821411|FG001|Overall Study|Adverse Event|1|||
131079637|NCT02581059|471924561|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
131079638|NCT02581059|471924560|FG000|Follow up|Death|1|||
131079639|NCT02581059|471924561|FG001|Follow up|Death|3|||
131079640|NCT02581059|471924560|FG000|Follow up|study terminated|1|||
131079641|NCT02581059|471924561|FG001|Follow up|study terminated|1|||
131079642|NCT02581059|471924560|FG000|Follow up|screen failure|0|||
131079643|NCT02581059|471924561|FG001|Follow up|screen failure|1|||
131079644|NCT02581059|471924560|FG000|Follow up|Patient started new clinical trial|1|||
131079645|NCT02581059|471924561|FG001|Follow up|Patient started new clinical trial|0|||
131139933|NCT02324270|472139987|FG002|Overall Study|Withdrawal by Subject|0|||
131139934|NCT02324270|472139985|FG000|Overall Study|Lost to Follow-up|4|||
131139935|NCT02324270|472139986|FG001|Overall Study|Lost to Follow-up|3|||
131139936|NCT02324270|472139987|FG002|Overall Study|Lost to Follow-up|4|||
131139937|NCT02324270|472139985|FG000|Overall Study|Protocol Violation|0|||
131139938|NCT02324270|472139986|FG001|Overall Study|Protocol Violation|1|||
131139939|NCT02324270|472139987|FG002|Overall Study|Protocol Violation|1|||
131139940|NCT02324270|472139985|FG000|Overall Study|Non Compliance with Study Drug|1|||
131139941|NCT02324270|472139986|FG001|Overall Study|Non Compliance with Study Drug|2|||
131139942|NCT02324270|472139987|FG002|Overall Study|Non Compliance with Study Drug|0|||
131139943|NCT03593915|472139988|FG000|Overall Study|Adverse Event|0|||
131139944|NCT03593915|472139989|FG001|Overall Study|Adverse Event|0|||
131139945|NCT03593915|472139990|FG002|Overall Study|Adverse Event|0|||
131139946|NCT03593915|472139991|FG003|Overall Study|Adverse Event|1|||
131139947|NCT03593915|472139992|FG004|Overall Study|Adverse Event|0|||
131139948|NCT03593915|472139993|FG005|Overall Study|Adverse Event|0|||
131139949|NCT03593915|472139988|FG000|Overall Study|Physician Decision|0|||
131139950|NCT03593915|472139989|FG001|Overall Study|Physician Decision|0|||
131139951|NCT03593915|472139990|FG002|Overall Study|Physician Decision|0|||
131139952|NCT03593915|472139991|FG003|Overall Study|Physician Decision|0|||
131139953|NCT03593915|472139992|FG004|Overall Study|Physician Decision|0|||
131139954|NCT03593915|472139993|FG005|Overall Study|Physician Decision|1|||
131139955|NCT00772629|472139996|FG000|Overall Study|Subject was not vaccinated|1|||
130726991|NCT02883049|470625431|FG007|Induction|Identified as Ph+ patients|0|||
130726992|NCT02883049|470625432|FG008|Induction|Identified as Ph+ patients|0|||
130726993|NCT02883049|470625433|FG009|Induction|Identified as Ph+ patients|0|||
130726994|NCT02883049|470625434|FG010|Induction|Identified as Ph+ patients|0|||
130726995|NCT02883049|470625435|FG011|Induction|Identified as Ph+ patients|0|||
130726996|NCT02883049|470625436|FG012|Induction|Identified as Ph+ patients|0|||
130726997|NCT02883049|470625437|FG013|Induction|Identified as Ph+ patients|0|||
130726998|NCT02883049|470625438|FG014|Induction|Identified as Ph+ patients|0|||
130726999|NCT02883049|470625439|FG015|Induction|Identified as Ph+ patients|0|||
130727000|NCT02883049|470625424|FG000|Induction|M3 Marrow at Day29|8|||
130727001|NCT02883049|470625425|FG001|Induction|M3 Marrow at Day29|1|||
130727002|NCT02883049|470625426|FG002|Induction|M3 Marrow at Day29|0|||
130727003|NCT02883049|470625427|FG003|Induction|M3 Marrow at Day29|0|||
130727004|NCT02883049|470625428|FG004|Induction|M3 Marrow at Day29|0|||
130727005|NCT02883049|470625429|FG005|Induction|M3 Marrow at Day29|0|||
130727006|NCT02883049|470625430|FG006|Induction|M3 Marrow at Day29|0|||
130727007|NCT02883049|470625431|FG007|Induction|M3 Marrow at Day29|0|||
130727008|NCT02883049|470625432|FG008|Induction|M3 Marrow at Day29|0|||
130727009|NCT02883049|470625433|FG009|Induction|M3 Marrow at Day29|0|||
130727010|NCT02883049|470625434|FG010|Induction|M3 Marrow at Day29|0|||
130727011|NCT02883049|470625435|FG011|Induction|M3 Marrow at Day29|0|||
130727012|NCT02883049|470625436|FG012|Induction|M3 Marrow at Day29|0|||
130727013|NCT02883049|470625437|FG013|Induction|M3 Marrow at Day29|0|||
130727014|NCT02883049|470625438|FG014|Induction|M3 Marrow at Day29|0|||
130727015|NCT02883049|470625439|FG015|Induction|M3 Marrow at Day29|0|||
130727016|NCT02883049|470625424|FG000|Induction|Inevaluable|33|||
130727017|NCT02883049|470625425|FG001|Induction|Inevaluable|1|||
130727018|NCT02883049|470625426|FG002|Induction|Inevaluable|0|||
130727019|NCT02883049|470625427|FG003|Induction|Inevaluable|0|||
130727020|NCT02883049|470625428|FG004|Induction|Inevaluable|0|||
130727021|NCT02883049|470625429|FG005|Induction|Inevaluable|0|||
131079646|NCT04887506|471924562|FG000|Overall Study|Death|1|||
130727022|NCT02883049|470625430|FG006|Induction|Inevaluable|0|||
130727023|NCT02883049|470625431|FG007|Induction|Inevaluable|0|||
130727024|NCT02883049|470625432|FG008|Induction|Inevaluable|0|||
130727025|NCT02883049|470625433|FG009|Induction|Inevaluable|0|||
130727026|NCT02883049|470625434|FG010|Induction|Inevaluable|0|||
130727027|NCT02883049|470625435|FG011|Induction|Inevaluable|0|||
130727028|NCT02883049|470625436|FG012|Induction|Inevaluable|0|||
131079647|NCT04887506|471924563|FG001|Overall Study|Death|1|||
131079648|NCT04887506|471924562|FG000|Overall Study|Withdrawal by Subject|0|||
131079649|NCT04887506|471924563|FG001|Overall Study|Withdrawal by Subject|3|||
131079650|NCT04887506|471924562|FG000|Overall Study|Adverse Event|4|||
131079651|NCT04887506|471924563|FG001|Overall Study|Adverse Event|3|||
131079652|NCT04887506|471924562|FG000|Overall Study|Other - Not Reported|1|||
131079653|NCT04887506|471924563|FG001|Overall Study|Other - Not Reported|1|||
131079654|NCT02394665|471924566|FG000|Overall Study|Physician Decision|1|||
131079655|NCT02394665|471924567|FG001|Overall Study|Physician Decision|0|||
131079656|NCT02394665|471924568|FG002|Overall Study|Physician Decision|0|||
131079657|NCT02636608|471924569|FG000|Overall Study|Failure to Return|4|||
131079658|NCT02636608|471924569|FG000|Overall Study|Insufficient Virological Response|1|||
131079659|NCT02636608|471924569|FG000|Overall Study|Death|3|||
131079660|NCT02636608|471924569|FG000|Overall Study|Other|2|||
131079661|NCT02636608|471924569|FG000|Overall Study|Did Not Receive Treatment|1|||
131079662|NCT01255761|471924570|FG000|Overall Study|Adverse Event|29|||
131079663|NCT01255761|471924571|FG001|Overall Study|Adverse Event|43|||
131079664|NCT01255761|471924570|FG000|Overall Study|Lack of Efficacy|86|||
130780125|NCT04547140|470821410|FG000|Overall Study|Withdrawal by Subject|0|||
130780126|NCT04547140|470821411|FG001|Overall Study|Withdrawal by Subject|1|||
130780127|NCT04547140|470821410|FG000|Overall Study|Lost to Follow-up|3|||
130780128|NCT04547140|470821411|FG001|Overall Study|Lost to Follow-up|1|||
130780129|NCT04547140|470821410|FG000|Overall Study|Death|2|||
130780130|NCT04547140|470821411|FG001|Overall Study|Death|1|||
130780131|NCT04547140|470821410|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
130780132|NCT04547140|470821411|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
130780133|NCT04547140|470821410|FG000|Overall Study|Pregnancy|1|||
130780134|NCT04547140|470821411|FG001|Overall Study|Pregnancy|0|||
130780135|NCT04547140|470821410|FG000|Overall Study|Reason Not Specified|4|||
130780136|NCT04547140|470821411|FG001|Overall Study|Reason Not Specified|1|||
130780137|NCT00003537|470821412|FG000|Overall Study|Not evalauable|1|||
130780138|NCT01051557|470821413|FG000|Overall Study|Physician Decision|1|||
130780139|NCT01051557|470821414|FG001|Overall Study|Physician Decision|0|||
130780140|NCT01051557|470821415|FG002|Overall Study|Physician Decision|0|||
130780141|NCT01051557|470821416|FG003|Overall Study|Physician Decision|0|||
130780142|NCT01051557|470821417|FG004|Overall Study|Physician Decision|0|||
130780143|NCT01051557|470821418|FG005|Overall Study|Physician Decision|0|||
130780144|NCT01051557|470821419|FG006|Overall Study|Physician Decision|0|||
130780145|NCT01051557|470821413|FG000|Overall Study|disease progression|3|||
130780146|NCT01051557|470821414|FG001|Overall Study|disease progression|3|||
130780147|NCT01051557|470821415|FG002|Overall Study|disease progression|5|||
130780148|NCT01051557|470821416|FG003|Overall Study|disease progression|2|||
130780149|NCT01051557|470821417|FG004|Overall Study|disease progression|4|||
130780150|NCT01051557|470821418|FG005|Overall Study|disease progression|3|||
130780151|NCT01051557|470821419|FG006|Overall Study|disease progression|1|||
130780152|NCT01051557|470821413|FG000|Overall Study|Withdrawal by Subject|0|||
130780153|NCT01051557|470821414|FG001|Overall Study|Withdrawal by Subject|0|||
130780154|NCT01051557|470821415|FG002|Overall Study|Withdrawal by Subject|1|||
130780155|NCT01051557|470821416|FG003|Overall Study|Withdrawal by Subject|0|||
130780156|NCT01051557|470821417|FG004|Overall Study|Withdrawal by Subject|2|||
130780157|NCT01051557|470821418|FG005|Overall Study|Withdrawal by Subject|0|||
130780158|NCT01051557|470821419|FG006|Overall Study|Withdrawal by Subject|1|||
130780159|NCT01051557|470821413|FG000|Overall Study|Adverse Event|0|||
130780160|NCT01051557|470821414|FG001|Overall Study|Adverse Event|0|||
130780161|NCT01051557|470821415|FG002|Overall Study|Adverse Event|0|||
130780162|NCT01051557|470821416|FG003|Overall Study|Adverse Event|1|||
130780163|NCT01051557|470821417|FG004|Overall Study|Adverse Event|1|||
130780164|NCT01051557|470821418|FG005|Overall Study|Adverse Event|3|||
130780165|NCT01051557|470821419|FG006|Overall Study|Adverse Event|4|||
130780166|NCT04110314|470821421|FG000|Overall Study|Did not meet inclusion criteria|35255|||
130780167|NCT04110314|470821422|FG001|Overall Study|Did not meet inclusion criteria|35104|||
130780168|NCT04110314|470821423|FG002|Overall Study|Did not meet inclusion criteria|35636|||
130780169|NCT04110314|470821424|FG003|Overall Study|Did not meet inclusion criteria|35135|||
130780170|NCT04110314|470821425|FG004|Overall Study|Did not meet inclusion criteria|35247|||
130780171|NCT04110314|470821426|FG005|Overall Study|Did not meet inclusion criteria|35727|||
130780172|NCT00737100|470821434|FG000|Overall Study|Adverse Event|6|||
130780173|NCT00737100|470821435|FG001|Overall Study|Adverse Event|5|||
130780174|NCT00737100|470821436|FG002|Overall Study|Adverse Event|3|||
130780175|NCT00737100|470821434|FG000|Overall Study|Lost to Follow-up|0|||
130780176|NCT00737100|470821435|FG001|Overall Study|Lost to Follow-up|1|||
130780177|NCT00737100|470821436|FG002|Overall Study|Lost to Follow-up|0|||
130780178|NCT00737100|470821434|FG000|Overall Study|Withdrawal by Subject|0|||
130780179|NCT00737100|470821435|FG001|Overall Study|Withdrawal by Subject|0|||
130780180|NCT00737100|470821436|FG002|Overall Study|Withdrawal by Subject|3|||
130780181|NCT00737100|470821434|FG000|Overall Study|Reason discontinued not explained above|1|||
130780182|NCT00737100|470821435|FG001|Overall Study|Reason discontinued not explained above|1|||
130780183|NCT00737100|470821436|FG002|Overall Study|Reason discontinued not explained above|1|||
130780184|NCT01265394|470821439|FG000|Overall Study|Subjects withdrawn|37|||
130780185|NCT00735943|470821440|FG000|Overall Study|Lost to Follow-up|1|||
130780186|NCT00735943|470821440|FG000|Overall Study|Adverse Event|1|||
130780187|NCT00268983|470821443|FG000|Overall Study|Death|3|||
131139956|NCT00772629|472139997|FG001|Overall Study|Subject was not vaccinated|0|||
130780188|NCT00268983|470821444|FG001|Overall Study|Death|0|||
130780189|NCT01719380|470821447|FG000|Overall Study|Adverse Event|0|||
130780190|NCT01719380|470821448|FG001|Overall Study|Adverse Event|0|||
130780191|NCT01719380|470821449|FG002|Overall Study|Adverse Event|1|||
130780192|NCT01719380|470821450|FG003|Overall Study|Adverse Event|2|||
130780193|NCT01719380|470821451|FG004|Overall Study|Adverse Event|0|||
130780194|NCT01719380|470821452|FG005|Overall Study|Adverse Event|1|||
130780195|NCT01719380|470821453|FG006|Overall Study|Adverse Event|0|||
130780196|NCT01719380|470821454|FG007|Overall Study|Adverse Event|1|||
131139957|NCT02894840|472139998|FG000|Overall Study|Lost to Follow-up|1|||
130780197|NCT01719380|470821455|FG008|Overall Study|Adverse Event|4|||
130780198|NCT01719380|470821456|FG009|Overall Study|Adverse Event|3|||
130780199|NCT01719380|470821447|FG000|Overall Study|Death|0|||
131139958|NCT02894840|472139999|FG001|Overall Study|Lost to Follow-up|0|||
131079665|NCT01255761|471924571|FG001|Overall Study|Lack of Efficacy|74|||
131079666|NCT01255761|471924570|FG000|Overall Study|Protocol Violation|9|||
131079667|NCT01255761|471924571|FG001|Overall Study|Protocol Violation|5|||
131079668|NCT01255761|471924570|FG000|Overall Study|Lost to Follow-up|10|||
131079669|NCT01255761|471924571|FG001|Overall Study|Lost to Follow-up|8|||
131079670|NCT01255761|471924570|FG000|Overall Study|Withdrawal by Subject|11|||
131079671|NCT01255761|471924571|FG001|Overall Study|Withdrawal by Subject|27|||
131079672|NCT01255761|471924570|FG000|Overall Study|Other Reasons|37|||
131079673|NCT01255761|471924571|FG001|Overall Study|Other Reasons|18|||
131079674|NCT03783871|471924577|FG000|Overall Study|Withdrawal by Subject|15|||
131079675|NCT03783871|471924577|FG000|Overall Study|Death|13|||
131079676|NCT03783871|471924577|FG000|Overall Study|Lost to Follow-up|2|||
131079677|NCT03569891|471924578|FG000|Lead-in|Ineligible during lead-in|8|||
131079678|NCT03569891|471924578|FG000|Lead-in|Withdrawal by Subject|3|||
131079679|NCT03569891|471924578|FG000|Lead-in|Risks related to COVID-19|2|||
131079680|NCT03569891|471924578|FG000|AMT-061|Adverse Event|1|||
131139959|NCT02894840|472140000|FG002|Overall Study|Lost to Follow-up|3|||
131139960|NCT02894840|472140001|FG003|Overall Study|Lost to Follow-up|0|||
131139961|NCT05162066|472140003|FG000|Overall Study|Adverse Event|1|||
131139962|NCT05162066|472140004|FG001|Overall Study|Adverse Event|0|||
131139963|NCT05162066|472140005|FG002|Overall Study|Adverse Event|0|||
131139964|NCT05162066|472140003|FG000|Overall Study|Perceived lack of efficacy|1|||
131139965|NCT05162066|472140004|FG001|Overall Study|Perceived lack of efficacy|0|||
131139966|NCT05162066|472140005|FG002|Overall Study|Perceived lack of efficacy|0|||
131139967|NCT00167245|472140006|FG000|Overall Study|Lost to Follow-up|20|||
131139968|NCT00167245|472140007|FG001|Overall Study|Lost to Follow-up|31|||
131139969|NCT00167245|472140006|FG000|Overall Study|Withdrawal by Subject|5|||
131139970|NCT00167245|472140007|FG001|Overall Study|Withdrawal by Subject|8|||
131139971|NCT00167245|472140006|FG000|Overall Study|Incarcerated|3|||
131139972|NCT00167245|472140007|FG001|Overall Study|Incarcerated|2|||
131139973|NCT00167245|472140006|FG000|Overall Study|Drowsy|1|||
131139974|NCT00167245|472140007|FG001|Overall Study|Drowsy|0|||
131139975|NCT01871090|472140008|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
131139976|NCT01871090|472140009|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
131139977|NCT01871090|472140008|FG000|Overall Study|Interrogation not completed correctly|1|||
131139978|NCT01871090|472140009|FG001|Overall Study|Interrogation not completed correctly|0|||
131139979|NCT01871090|472140008|FG000|Overall Study|Subject Non-Compliance|0|||
131139980|NCT01871090|472140009|FG001|Overall Study|Subject Non-Compliance|1|||
131139981|NCT00688909|472140014|FG000|Overall Study|Adverse Event|28|||
131139982|NCT00688909|472140014|FG000|Overall Study|Patient withdrew consent|2|||
131139983|NCT00688909|472140014|FG000|Overall Study|Administrative problems|1|||
131139984|NCT00688909|472140014|FG000|Overall Study|Protocol Violation|2|||
131139985|NCT01220414|472140015|FG000|Overall Study|Withdrawal by Subject|1|||
131139986|NCT01220414|472140016|FG001|Overall Study|Withdrawal by Subject|0|||
131139987|NCT01220414|472140017|FG002|Overall Study|Withdrawal by Subject|0|||
131139988|NCT01220414|472140018|FG003|Overall Study|Withdrawal by Subject|1|||
131139989|NCT00700180|472140021|FG000|Overall Study|Death|99|||
131139990|NCT00700180|472140022|FG001|Overall Study|Death|114|||
131139991|NCT00700180|472140021|FG000|Overall Study|Alive on treatment|5|||
131139992|NCT00700180|472140022|FG001|Overall Study|Alive on treatment|3|||
131139993|NCT00700180|472140021|FG000|Overall Study|Alive in follow-up|46|||
131079681|NCT04594733|471924579|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
131079682|NCT04594733|471924580|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
131079683|NCT04594733|471924579|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
131079684|NCT04594733|471924580|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
131079685|NCT04594733|471924579|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
131079686|NCT04594733|471924580|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
131139994|NCT00700180|472140022|FG001|Overall Study|Alive in follow-up|27|||
131139995|NCT00700180|472140021|FG000|Overall Study|Lost to Follow-up|4|||
131139996|NCT00700180|472140022|FG001|Overall Study|Lost to Follow-up|5|||
131139997|NCT03569202|472140026|FG000|Part 3|Physician Decision|1|||
131139998|NCT03569202|472140027|FG001|Part 3|Physician Decision|0|||
131139999|NCT03569202|472140026|FG000|Part 3|Other|1|||
131140000|NCT03569202|472140027|FG001|Part 3|Other|1|||
131140001|NCT02415712|472140028|FG000|Overall Study|Protocol Violation|16|||
131140002|NCT01668654|472140029|FG000|Overall Study|Study Closed/Terminated|3|||
131140003|NCT01668654|472140029|FG000|Overall Study|Withdrawal by Subject|1|||
131140004|NCT04557384|472140030|FG000|Overall Study|Study Terminated by Sponsor|1|||
131140005|NCT04557384|472140030|FG000|Overall Study|Death|1|||
131140006|NCT02397473|472140032|FG000|Treatment Phase|Adverse Event|1|||
131079687|NCT02647645|471924583|FG000|Overall Study|Lost to Follow-up|2|||
131079688|NCT02647645|471924584|FG001|Overall Study|Lost to Follow-up|1|||
131140007|NCT02397473|472140033|FG001|Treatment Phase|Adverse Event|2|||
131140008|NCT02397473|472140032|FG000|Treatment Phase|Lack of Efficacy|8|||
131140009|NCT02397473|472140033|FG001|Treatment Phase|Lack of Efficacy|1|||
131140010|NCT02397473|472140032|FG000|Treatment Phase|Lost to Follow-up|1|||
131140011|NCT02397473|472140033|FG001|Treatment Phase|Lost to Follow-up|0|||
131140012|NCT02397473|472140032|FG000|Treatment Phase|Withdrawal by Subject|2|||
130780200|NCT01719380|470821448|FG001|Overall Study|Death|1|||
130780201|NCT01719380|470821449|FG002|Overall Study|Death|0|||
130780202|NCT01719380|470821450|FG003|Overall Study|Death|0|||
130780203|NCT01719380|470821451|FG004|Overall Study|Death|0|||
130780204|NCT01719380|470821452|FG005|Overall Study|Death|0|||
130780205|NCT01719380|470821453|FG006|Overall Study|Death|0|||
130780206|NCT01719380|470821454|FG007|Overall Study|Death|0|||
130780207|NCT01719380|470821455|FG008|Overall Study|Death|3|||
130780208|NCT01719380|470821456|FG009|Overall Study|Death|3|||
130780209|NCT01719380|470821447|FG000|Overall Study|Participant/Guardian Decision|0|||
130780210|NCT01719380|470821448|FG001|Overall Study|Participant/Guardian Decision|0|||
131140013|NCT02397473|472140033|FG001|Treatment Phase|Withdrawal by Subject|1|||
131140014|NCT02397473|472140032|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
131140015|NCT02397473|472140033|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
131140016|NCT02397473|472140032|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
131140017|NCT02397473|472140033|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
131140018|NCT02397473|472140032|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
131140019|NCT02397473|472140033|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
131140020|NCT02397473|472140032|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
131140021|NCT02397473|472140033|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
131140022|NCT02397473|472140032|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
131140023|NCT02397473|472140033|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
131140024|NCT00254566|472140035|FG000|Overall Study|Death|1|||
131140025|NCT00254566|472140036|FG001|Overall Study|Death|0|||
131140026|NCT00254566|472140035|FG000|Overall Study|Adverse Event|5|||
131140027|NCT00254566|472140036|FG001|Overall Study|Adverse Event|4|||
131140028|NCT00254566|472140035|FG000|Overall Study|Lack of Efficacy|12|||
131140029|NCT00254566|472140036|FG001|Overall Study|Lack of Efficacy|9|||
131140030|NCT00254566|472140035|FG000|Overall Study|Other|1|||
131140031|NCT00254566|472140036|FG001|Overall Study|Other|5|||
131140032|NCT00254566|472140035|FG000|Overall Study|Withdrawal by Subject|5|||
131140033|NCT00254566|472140036|FG001|Overall Study|Withdrawal by Subject|6|||
131140034|NCT00254566|472140035|FG000|Overall Study|Lost to Follow-up|7|||
131140035|NCT00254566|472140036|FG001|Overall Study|Lost to Follow-up|2|||
131140036|NCT00059202|472140037|FG000|Overall Study|Withdrawal by Subject|5|||
131140037|NCT00059202|472140038|FG001|Overall Study|Withdrawal by Subject|9|||
131140038|NCT00059202|472140037|FG000|Overall Study|Protocol Violation|1|||
131140039|NCT00059202|472140038|FG001|Overall Study|Protocol Violation|3|||
131140040|NCT00059202|472140037|FG000|Overall Study|drug toxicity|0|||
131140041|NCT00059202|472140038|FG001|Overall Study|drug toxicity|3|||
131140042|NCT02658448|472140043|FG000|Overall Study|Lost to Follow-up|1|||
131140043|NCT03106779|472140044|FG000|Overall Study|Lack of Efficacy|33|||
131140044|NCT03106779|472140045|FG001|Overall Study|Lack of Efficacy|24|||
131140045|NCT03106779|472140044|FG000|Overall Study|Adverse Event|8|||
131140046|NCT03106779|472140045|FG001|Overall Study|Adverse Event|16|||
131140047|NCT03106779|472140044|FG000|Overall Study|Physician Decision|10|||
131140048|NCT03106779|472140045|FG001|Overall Study|Physician Decision|6|||
131140049|NCT03106779|472140044|FG000|Overall Study|Patient/guardian decision|4|||
131140050|NCT03106779|472140045|FG001|Overall Study|Patient/guardian decision|3|||
131140051|NCT03106779|472140044|FG000|Overall Study|Progressive disease|1|||
131140052|NCT03106779|472140045|FG001|Overall Study|Progressive disease|3|||
131140053|NCT03106779|472140044|FG000|Overall Study|Lost to Follow-up|1|||
131140054|NCT03106779|472140045|FG001|Overall Study|Lost to Follow-up|2|||
131140055|NCT03106779|472140044|FG000|Overall Study|Death|1|||
131140056|NCT03106779|472140045|FG001|Overall Study|Death|0|||
131140057|NCT03106779|472140044|FG000|Overall Study|Protocol Violation|1|||
131140058|NCT03106779|472140045|FG001|Overall Study|Protocol Violation|0|||
131140059|NCT03106779|472140044|FG000|Overall Study|Not treated|1|||
131140060|NCT03106779|472140045|FG001|Overall Study|Not treated|0|||
131140061|NCT02288247|472140046|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
131140062|NCT02288247|472140047|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
131140063|NCT02288247|472140046|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
131140064|NCT02288247|472140047|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
131140065|NCT02288247|472140046|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
130780211|NCT01719380|470821449|FG002|Overall Study|Participant/Guardian Decision|1|||
130780212|NCT01719380|470821450|FG003|Overall Study|Participant/Guardian Decision|0|||
130780213|NCT01719380|470821451|FG004|Overall Study|Participant/Guardian Decision|0|||
130780214|NCT01719380|470821452|FG005|Overall Study|Participant/Guardian Decision|0|||
130780215|NCT01719380|470821453|FG006|Overall Study|Participant/Guardian Decision|0|||
130780216|NCT01719380|470821454|FG007|Overall Study|Participant/Guardian Decision|0|||
131140066|NCT02288247|472140047|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
131140067|NCT02288247|472140046|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
131140068|NCT02288247|472140047|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
131140069|NCT02288247|472140046|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
131140070|NCT02288247|472140047|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
131140071|NCT02288247|472140046|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
131231728|NCT02711956|472475207|FG003|Overall Study|Withdrawal by Subject|0|||
131231729|NCT02711956|472475208|FG004|Overall Study|Withdrawal by Subject|0|||
131231730|NCT02711956|472475209|FG005|Overall Study|Withdrawal by Subject|0|||
131231731|NCT02711956|472475210|FG006|Overall Study|Withdrawal by Subject|1|||
131231732|NCT02711956|472475211|FG007|Overall Study|Withdrawal by Subject|0|||
131231733|NCT02711956|472475212|FG008|Overall Study|Withdrawal by Subject|0|||
131231734|NCT02711956|472475213|FG009|Overall Study|Withdrawal by Subject|0|||
131231735|NCT02711956|472475214|FG010|Overall Study|Withdrawal by Subject|0|||
131231736|NCT02711956|472475215|FG011|Overall Study|Withdrawal by Subject|1|||
131231737|NCT02711956|472475216|FG012|Overall Study|Withdrawal by Subject|6|||
131231738|NCT02711956|472475217|FG013|Overall Study|Withdrawal by Subject|0|||
131231739|NCT02711956|472475218|FG014|Overall Study|Withdrawal by Subject|1|||
131231740|NCT02711956|472475204|FG000|Overall Study|Clinical progression|1|||
131231741|NCT02711956|472475205|FG001|Overall Study|Clinical progression|0|||
131231742|NCT02711956|472475206|FG002|Overall Study|Clinical progression|0|||
131231743|NCT02711956|472475207|FG003|Overall Study|Clinical progression|0|||
131231744|NCT02711956|472475208|FG004|Overall Study|Clinical progression|0|||
131231745|NCT02711956|472475209|FG005|Overall Study|Clinical progression|0|||
131231746|NCT02711956|472475210|FG006|Overall Study|Clinical progression|1|||
131231747|NCT02711956|472475211|FG007|Overall Study|Clinical progression|0|||
131231748|NCT02711956|472475212|FG008|Overall Study|Clinical progression|1|||
131231749|NCT02711956|472475213|FG009|Overall Study|Clinical progression|0|||
131231750|NCT02711956|472475214|FG010|Overall Study|Clinical progression|0|||
131231751|NCT02711956|472475215|FG011|Overall Study|Clinical progression|2|||
131231752|NCT02711956|472475216|FG012|Overall Study|Clinical progression|4|||
131231753|NCT02711956|472475217|FG013|Overall Study|Clinical progression|1|||
131231754|NCT02711956|472475218|FG014|Overall Study|Clinical progression|1|||
131231755|NCT02711956|472475204|FG000|Overall Study|Radiographic progression|1|||
131231756|NCT02711956|472475205|FG001|Overall Study|Radiographic progression|1|||
131231757|NCT02711956|472475206|FG002|Overall Study|Radiographic progression|2|||
131231758|NCT02711956|472475207|FG003|Overall Study|Radiographic progression|0|||
131231759|NCT02711956|472475208|FG004|Overall Study|Radiographic progression|1|||
131231760|NCT02711956|472475209|FG005|Overall Study|Radiographic progression|0|||
131231761|NCT02711956|472475210|FG006|Overall Study|Radiographic progression|0|||
131231762|NCT02711956|472475211|FG007|Overall Study|Radiographic progression|0|||
131231763|NCT02711956|472475212|FG008|Overall Study|Radiographic progression|2|||
131231764|NCT02711956|472475213|FG009|Overall Study|Radiographic progression|1|||
131231765|NCT02711956|472475214|FG010|Overall Study|Radiographic progression|0|||
131231766|NCT02711956|472475215|FG011|Overall Study|Radiographic progression|5|||
131231767|NCT02711956|472475216|FG012|Overall Study|Radiographic progression|3|||
131231768|NCT02711956|472475217|FG013|Overall Study|Radiographic progression|0|||
131231769|NCT02711956|472475218|FG014|Overall Study|Radiographic progression|1|||
131231770|NCT02711956|472475204|FG000|Overall Study|PSA progression with clinical progression|0|||
131231771|NCT02711956|472475205|FG001|Overall Study|PSA progression with clinical progression|0|||
131231772|NCT02711956|472475206|FG002|Overall Study|PSA progression with clinical progression|0|||
131231773|NCT02711956|472475207|FG003|Overall Study|PSA progression with clinical progression|0|||
131231774|NCT02711956|472475208|FG004|Overall Study|PSA progression with clinical progression|1|||
131231775|NCT02711956|472475209|FG005|Overall Study|PSA progression with clinical progression|0|||
131231776|NCT02711956|472475210|FG006|Overall Study|PSA progression with clinical progression|0|||
131231777|NCT02711956|472475211|FG007|Overall Study|PSA progression with clinical progression|0|||
131231778|NCT02711956|472475212|FG008|Overall Study|PSA progression with clinical progression|0|||
131231779|NCT02711956|472475213|FG009|Overall Study|PSA progression with clinical progression|0|||
131231780|NCT02711956|472475214|FG010|Overall Study|PSA progression with clinical progression|0|||
131231781|NCT02711956|472475215|FG011|Overall Study|PSA progression with clinical progression|0|||
131231782|NCT02711956|472475216|FG012|Overall Study|PSA progression with clinical progression|1|||
131231783|NCT02711956|472475217|FG013|Overall Study|PSA progression with clinical progression|1|||
131231784|NCT02711956|472475218|FG014|Overall Study|PSA progression with clinical progression|0|||
131231785|NCT02711956|472475204|FG000|Overall Study|PSA progression with radiographic progression|0|||
131231786|NCT02711956|472475205|FG001|Overall Study|PSA progression with radiographic progression|1|||
131231787|NCT02711956|472475206|FG002|Overall Study|PSA progression with radiographic progression|0|||
131231788|NCT02711956|472475207|FG003|Overall Study|PSA progression with radiographic progression|0|||
131231789|NCT02711956|472475208|FG004|Overall Study|PSA progression with radiographic progression|0|||
131231790|NCT02711956|472475209|FG005|Overall Study|PSA progression with radiographic progression|2|||
131231791|NCT02711956|472475210|FG006|Overall Study|PSA progression with radiographic progression|2|||
131231792|NCT02711956|472475211|FG007|Overall Study|PSA progression with radiographic progression|1|||
131231793|NCT02711956|472475212|FG008|Overall Study|PSA progression with radiographic progression|0|||
131231794|NCT02711956|472475213|FG009|Overall Study|PSA progression with radiographic progression|1|||
130727029|NCT02883049|470625437|FG013|Induction|Inevaluable|0|||
130727030|NCT02883049|470625438|FG014|Induction|Inevaluable|0|||
131231795|NCT02711956|472475214|FG010|Overall Study|PSA progression with radiographic progression|0|||
131231796|NCT02711956|472475215|FG011|Overall Study|PSA progression with radiographic progression|1|||
131140072|NCT02288247|472140047|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
131140073|NCT02288247|472140046|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
131140074|NCT02288247|472140047|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
131140075|NCT02288247|472140046|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
131140076|NCT02288247|472140047|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
131140077|NCT02288247|472140046|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
131140078|NCT02288247|472140047|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
131140079|NCT02288247|472140046|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
131140080|NCT02288247|472140047|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
131140081|NCT02288247|472140046|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
131140082|NCT02288247|472140047|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
131140083|NCT02288247|472140046|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
131140084|NCT02288247|472140047|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
131140085|NCT02288247|472140046|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
131140086|NCT02288247|472140047|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
131140087|NCT02288247|472140046|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
131140088|NCT02288247|472140047|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
131140089|NCT02288247|472140046|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
131140090|NCT02288247|472140047|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
131140091|NCT02288247|472140046|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
131140092|NCT02288247|472140047|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
131140093|NCT04652804|472140048|FG000|Overall Study|Ineligible post randomization|1|||
131140094|NCT04652804|472140049|FG001|Overall Study|Ineligible post randomization|0|||
131140095|NCT04652804|472140050|FG002|Overall Study|Ineligible post randomization|1|||
131140096|NCT04652804|472140051|FG003|Overall Study|Ineligible post randomization|0|||
131140097|NCT04652804|472140052|FG004|Overall Study|Ineligible post randomization|1|||
131140098|NCT04652804|472140053|FG005|Overall Study|Ineligible post randomization|1|||
131140099|NCT04652804|472140048|FG000|Overall Study|Missing SVR lab results|2|||
131140100|NCT04652804|472140049|FG001|Overall Study|Missing SVR lab results|0|||
131140101|NCT04652804|472140050|FG002|Overall Study|Missing SVR lab results|0|||
131140102|NCT04652804|472140051|FG003|Overall Study|Missing SVR lab results|0|||
131140103|NCT04652804|472140052|FG004|Overall Study|Missing SVR lab results|0|||
131140104|NCT04652804|472140053|FG005|Overall Study|Missing SVR lab results|0|||
131140105|NCT03634800|472140054|FG000|Overall Study|Adverse Event|1|||
131140106|NCT03634800|472140054|FG000|Overall Study|Disease Progression|4|||
131140107|NCT03634800|472140054|FG000|Overall Study|Withdrawal by Subject|1|||
131140108|NCT00364689|472140058|FG000|Overall Study|Lost to Follow-up|1|||
131140109|NCT00191451|472140066|FG000|Overall Study|Withdrawal by Subject|2|||
131140110|NCT00191451|472140067|FG001|Overall Study|Withdrawal by Subject|3|||
131140111|NCT00191451|472140068|FG002|Overall Study|Withdrawal by Subject|5|||
131140112|NCT00191451|472140066|FG000|Overall Study|Physician Decision|2|||
131140113|NCT00191451|472140067|FG001|Overall Study|Physician Decision|9|||
131140114|NCT00191451|472140068|FG002|Overall Study|Physician Decision|6|||
131140115|NCT00191451|472140066|FG000|Overall Study|Sponsor Decision|1|||
131140116|NCT00191451|472140067|FG001|Overall Study|Sponsor Decision|0|||
131140117|NCT00191451|472140068|FG002|Overall Study|Sponsor Decision|0|||
131140118|NCT00191451|472140066|FG000|Overall Study|Ineligible|0|||
131140119|NCT00191451|472140067|FG001|Overall Study|Ineligible|1|||
131140120|NCT00191451|472140068|FG002|Overall Study|Ineligible|0|||
131140121|NCT00191451|472140066|FG000|Overall Study|Reason Not Specified|2|||
131140122|NCT00191451|472140067|FG001|Overall Study|Reason Not Specified|1|||
131140123|NCT00191451|472140068|FG002|Overall Study|Reason Not Specified|3|||
131140124|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
131140125|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
131140126|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
131140127|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
131140128|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
131140129|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
131140130|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
131140131|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
131140132|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
131140133|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
131140134|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
131140135|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
131140136|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
131140137|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
131140138|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
131140139|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
131140140|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
131140141|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
131140142|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
131140143|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
131140144|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
131140145|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
131140146|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
131140147|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
131140148|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Death|2|||
131140149|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Death|1|||
131140150|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Death|2|||
131140151|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Graft loss|0|||
131140152|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Graft loss|2|||
131140153|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Graft loss|0|||
131140154|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
131140155|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
131140156|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
131140157|NCT01114529|472140069|FG000|Completed Study Medication at Month 24|Missing|2|||
131140158|NCT01114529|472140070|FG001|Completed Study Medication at Month 24|Missing|0|||
131140159|NCT01114529|472140071|FG002|Completed Study Medication at Month 24|Missing|0|||
131140160|NCT01114529|472140069|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
131140161|NCT01114529|472140070|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
131140162|NCT01114529|472140071|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
131140163|NCT01114529|472140069|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
131140164|NCT01114529|472140070|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
131140165|NCT01114529|472140071|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
131140166|NCT01114529|472140069|FG000|Completed Study Phase at Month 24|Death|8|||
131140167|NCT01114529|472140070|FG001|Completed Study Phase at Month 24|Death|5|||
131140168|NCT01114529|472140071|FG002|Completed Study Phase at Month 24|Death|4|||
131140169|NCT01114529|472140069|FG000|Completed Study Phase at Month 24|Other|2|||
131140170|NCT01114529|472140070|FG001|Completed Study Phase at Month 24|Other|0|||
131140171|NCT01114529|472140071|FG002|Completed Study Phase at Month 24|Other|0|||
131140172|NCT01114529|472140069|FG000|Completed Study Phase at Month 24|Missing|2|||
131140173|NCT01114529|472140070|FG001|Completed Study Phase at Month 24|Missing|0|||
131140174|NCT01114529|472140071|FG002|Completed Study Phase at Month 24|Missing|0|||
131140175|NCT00132730|472140073|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
131140176|NCT00132730|472140074|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
131140177|NCT00132730|472140075|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
131140178|NCT00132730|472140076|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
131140179|NCT00132730|472140077|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
131140180|NCT00132730|472140078|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
131140181|NCT00132730|472140073|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
131140182|NCT00132730|472140074|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
131140183|NCT00132730|472140075|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
131140184|NCT00132730|472140076|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
131140185|NCT00132730|472140077|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
131140186|NCT00132730|472140078|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
131140187|NCT00132730|472140073|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
131140188|NCT00132730|472140074|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
131140189|NCT00132730|472140075|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
131231797|NCT02711956|472475216|FG012|Overall Study|PSA progression with radiographic progression|2|||
131231798|NCT02711956|472475217|FG013|Overall Study|PSA progression with radiographic progression|3|||
131231799|NCT02711956|472475218|FG014|Overall Study|PSA progression with radiographic progression|3|||
130727031|NCT02883049|470625439|FG015|Induction|Inevaluable|0|||
131231800|NCT03734237|472475219|FG000|Overall Study|Lost to Follow-up|1|||
131231801|NCT03734237|472475220|FG001|Overall Study|Lost to Follow-up|3|||
131231802|NCT03734237|472475221|FG002|Overall Study|Lost to Follow-up|0|||
131140190|NCT00132730|472140076|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
131140191|NCT00132730|472140077|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
131140192|NCT00132730|472140078|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
131140193|NCT00132730|472140073|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
131140194|NCT00132730|472140074|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
131140195|NCT00132730|472140075|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
131140196|NCT00132730|472140076|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
130727032|NCT02883049|470625424|FG000|Induction|Identified as VHR at end of Induction|244|||
130727033|NCT02883049|470625425|FG001|Induction|Identified as VHR at end of Induction|0|||
131231803|NCT03734237|472475219|FG000|Overall Study|Withdrawal by Subject|7|||
131231804|NCT03734237|472475220|FG001|Overall Study|Withdrawal by Subject|9|||
131231805|NCT03734237|472475221|FG002|Overall Study|Withdrawal by Subject|10|||
131231806|NCT01844583|472475222|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
131231807|NCT01844583|472475223|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
131231808|NCT01625377|472475224|FG000|Overall Study|Death|1|||
131231809|NCT01625377|472475225|FG001|Overall Study|Death|1|||
131231810|NCT01625377|472475224|FG000|Overall Study|Administrative Problem|1|||
131231811|NCT01625377|472475225|FG001|Overall Study|Administrative Problem|1|||
131231812|NCT01625377|472475224|FG000|Overall Study|Protocol Violation|0|||
131231813|NCT01625377|472475225|FG001|Overall Study|Protocol Violation|3|||
131231814|NCT01625377|472475224|FG000|Overall Study|Adverse Event|3|||
131231815|NCT01625377|472475225|FG001|Overall Study|Adverse Event|16|||
131231816|NCT01625377|472475224|FG000|Overall Study|Graft loss|1|||
131231817|NCT01625377|472475225|FG001|Overall Study|Graft loss|0|||
131231818|NCT01625377|472475224|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131231819|NCT01625377|472475225|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131231820|NCT01625377|472475224|FG000|Overall Study|Abnormal laboratory values|1|||
131231821|NCT01625377|472475225|FG001|Overall Study|Abnormal laboratory values|0|||
131231822|NCT03294538|472475230|FG000|Overall Study|Adverse Event|0|||
131079689|NCT00356811|471924585|FG000|Overall Study|Death|35|||
131079690|NCT00356811|471924585|FG000|Overall Study|Lost to Follow-up|2|||
131079691|NCT00356811|471924585|FG000|Overall Study|Withdrawal by Subject|6|||
131079692|NCT00356811|471924585|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
131079693|NCT00356811|471924585|FG000|Overall Study|Study Is Terminating|3|||
131231823|NCT03294538|472475231|FG001|Overall Study|Adverse Event|1|||
131231824|NCT03294538|472475232|FG002|Overall Study|Adverse Event|1|||
131231825|NCT03294538|472475230|FG000|Overall Study|Lost to Follow-up|1|||
131231826|NCT03294538|472475231|FG001|Overall Study|Lost to Follow-up|0|||
131231827|NCT03294538|472475232|FG002|Overall Study|Lost to Follow-up|0|||
131231828|NCT03294538|472475230|FG000|Overall Study|Outside of Visit Window|4|||
131231829|NCT03294538|472475231|FG001|Overall Study|Outside of Visit Window|4|||
131231830|NCT03294538|472475232|FG002|Overall Study|Outside of Visit Window|1|||
131231831|NCT00449072|472475239|FG000|Overall Study|Adverse Event|3|||
131231832|NCT00449072|472475240|FG001|Overall Study|Adverse Event|1|||
131231833|NCT00449072|472475239|FG000|Overall Study|Protocol Violation|14|||
131231834|NCT00449072|472475240|FG001|Overall Study|Protocol Violation|12|||
131231835|NCT00449072|472475239|FG000|Overall Study|Lost to Follow-up|5|||
131231836|NCT00449072|472475240|FG001|Overall Study|Lost to Follow-up|7|||
131231837|NCT00449072|472475239|FG000|Overall Study|Withdrawal by Subject|11|||
131231838|NCT00449072|472475240|FG001|Overall Study|Withdrawal by Subject|8|||
131231839|NCT00449072|472475239|FG000|Overall Study|Lack of Efficacy|1|||
131231840|NCT00449072|472475240|FG001|Overall Study|Lack of Efficacy|1|||
131231841|NCT00449072|472475239|FG000|Overall Study|Physician Decision|1|||
131231842|NCT00449072|472475240|FG001|Overall Study|Physician Decision|0|||
131231843|NCT00449072|472475239|FG000|Overall Study|Not treated|0|||
131231844|NCT00449072|472475240|FG001|Overall Study|Not treated|1|||
131231845|NCT00449072|472475239|FG000|Overall Study|Excluded medication|0|||
131231846|NCT00449072|472475240|FG001|Overall Study|Excluded medication|2|||
131231847|NCT00449072|472475239|FG000|Overall Study|Non-compliance|2|||
131231848|NCT00449072|472475240|FG001|Overall Study|Non-compliance|5|||
131231849|NCT00449072|472475239|FG000|Overall Study|Sponsor decision|1|||
131231850|NCT00449072|472475240|FG001|Overall Study|Sponsor decision|3|||
131231851|NCT00449072|472475239|FG000|Overall Study|Relocation|3|||
131231852|NCT00449072|472475240|FG001|Overall Study|Relocation|2|||
131231853|NCT01769378|472475241|FG000|Overall Study|Adverse Event|10|||
131231854|NCT01769378|472475242|FG001|Overall Study|Adverse Event|0|||
131231855|NCT01769378|472475241|FG000|Overall Study|Entry criteria not met|1|||
131231856|NCT01769378|472475242|FG001|Overall Study|Entry criteria not met|0|||
131231857|NCT01769378|472475241|FG000|Overall Study|Protocol Violation|1|||
131231858|NCT01769378|472475242|FG001|Overall Study|Protocol Violation|1|||
131231859|NCT01769378|472475241|FG000|Overall Study|Withdrawal by Subject|10|||
131231860|NCT01769378|472475242|FG001|Overall Study|Withdrawal by Subject|3|||
131231861|NCT01769378|472475241|FG000|Overall Study|Sponsor Decision|1|||
131231862|NCT01769378|472475242|FG001|Overall Study|Sponsor Decision|0|||
131231863|NCT01769378|472475241|FG000|Overall Study|Lost to Follow-up|2|||
131231864|NCT01769378|472475242|FG001|Overall Study|Lost to Follow-up|0|||
131231865|NCT00718159|472475244|FG000|Overall Study|Progressive Disease|3|||
131231866|NCT00718159|472475245|FG001|Overall Study|Progressive Disease|3|||
131079694|NCT00356811|471924585|FG000|Overall Study|Site Closed during Follow-up|2|||
131079695|NCT02386839|471924586|FG000|Overall Study|Death|1|||
131079696|NCT02386839|471924587|FG001|Overall Study|Death|0|||
131079697|NCT02386839|471924586|FG000|Overall Study|Withdrawal by Subject|9|||
131231867|NCT00718159|472475246|FG002|Overall Study|Progressive Disease|2|||
131231868|NCT00718159|472475247|FG003|Overall Study|Progressive Disease|0|||
131231869|NCT00718159|472475248|FG004|Overall Study|Progressive Disease|6|||
131231870|NCT00718159|472475249|FG005|Overall Study|Progressive Disease|0|||
131231871|NCT00718159|472475250|FG006|Overall Study|Progressive Disease|0|||
131231872|NCT00718159|472475244|FG000|Overall Study|Death due to Adverse Event|0|||
131231873|NCT00718159|472475245|FG001|Overall Study|Death due to Adverse Event|0|||
131231874|NCT00718159|472475246|FG002|Overall Study|Death due to Adverse Event|0|||
131231875|NCT00718159|472475247|FG003|Overall Study|Death due to Adverse Event|2|||
131231876|NCT00718159|472475248|FG004|Overall Study|Death due to Adverse Event|2|||
131231877|NCT00718159|472475249|FG005|Overall Study|Death due to Adverse Event|0|||
131231878|NCT00718159|472475250|FG006|Overall Study|Death due to Adverse Event|0|||
131231879|NCT00718159|472475244|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
131231880|NCT00718159|472475245|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
131231881|NCT00718159|472475246|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
131231882|NCT00718159|472475247|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
131231883|NCT00718159|472475248|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
131231884|NCT00718159|472475249|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
131231885|NCT00718159|472475250|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
131231886|NCT00718159|472475244|FG000|Overall Study|Investigator Decision|0|||
131231887|NCT00718159|472475245|FG001|Overall Study|Investigator Decision|0|||
131231888|NCT00718159|472475246|FG002|Overall Study|Investigator Decision|0|||
131231889|NCT00718159|472475247|FG003|Overall Study|Investigator Decision|0|||
131231890|NCT00718159|472475248|FG004|Overall Study|Investigator Decision|0|||
131231891|NCT00718159|472475249|FG005|Overall Study|Investigator Decision|1|||
131231892|NCT00718159|472475250|FG006|Overall Study|Investigator Decision|1|||
131231893|NCT01238848|472475252|FG000|Overall Study|Physician Decision|13|||
131231894|NCT01238848|472475253|FG001|Overall Study|Physician Decision|5|||
131231895|NCT00576901|472475254|FG000|Overall Study|Withdrawal by Subject|1|||
131231896|NCT00576901|472475254|FG000|Overall Study|Disease course|1|||
131231897|NCT00576901|472475254|FG000|Overall Study|Protocol Violation|1|||
131231898|NCT01755858|472475257|FG000|Overall Study|Adverse Event|1|||
131231899|NCT01755858|472475258|FG001|Overall Study|Adverse Event|1|||
131231900|NCT00782509|472475259|FG000|Overall Study|Adverse Event|20|||
131231901|NCT00782509|472475260|FG001|Overall Study|Adverse Event|10|||
131231902|NCT00782509|472475261|FG002|Overall Study|Adverse Event|20|||
131231903|NCT00782509|472475259|FG000|Overall Study|Lost to Follow-up|1|||
131231904|NCT00782509|472475260|FG001|Overall Study|Lost to Follow-up|2|||
131231905|NCT00782509|472475261|FG002|Overall Study|Lost to Follow-up|3|||
131231906|NCT00782509|472475259|FG000|Overall Study|Withdrawal by Subject|3|||
131231907|NCT00782509|472475260|FG001|Overall Study|Withdrawal by Subject|5|||
131231908|NCT00782509|472475261|FG002|Overall Study|Withdrawal by Subject|8|||
131231909|NCT00782509|472475259|FG000|Overall Study|Non compliance with protocol|2|||
131231910|NCT00782509|472475260|FG001|Overall Study|Non compliance with protocol|0|||
131231911|NCT00782509|472475261|FG002|Overall Study|Non compliance with protocol|0|||
131231912|NCT00782509|472475259|FG000|Overall Study|Other reasons not stated above|5|||
131231913|NCT00782509|472475260|FG001|Overall Study|Other reasons not stated above|2|||
131231914|NCT00782509|472475261|FG002|Overall Study|Other reasons not stated above|3|||
131231915|NCT00782509|472475259|FG000|Overall Study|Lack of Efficacy|10|||
131231916|NCT00782509|472475260|FG001|Overall Study|Lack of Efficacy|5|||
131231917|NCT00782509|472475261|FG002|Overall Study|Lack of Efficacy|2|||
131231918|NCT02398188|472475262|FG000|Overall Study|Adverse Event|2|||
131231919|NCT02398188|472475263|FG001|Overall Study|Adverse Event|3|||
131231920|NCT02398188|472475262|FG000|Overall Study|Lost to Follow-up|5|||
131231921|NCT02398188|472475263|FG001|Overall Study|Lost to Follow-up|0|||
131231922|NCT02398188|472475262|FG000|Overall Study|Non-compliance|4|||
131231923|NCT02398188|472475263|FG001|Overall Study|Non-compliance|4|||
131231924|NCT02398188|472475262|FG000|Overall Study|Protocol Violation|6|||
131231925|NCT02398188|472475263|FG001|Overall Study|Protocol Violation|10|||
131231926|NCT02398188|472475262|FG000|Overall Study|Sponsor Decision|2|||
131231927|NCT02398188|472475263|FG001|Overall Study|Sponsor Decision|1|||
131231928|NCT02398188|472475262|FG000|Overall Study|Pregnancy|1|||
131231929|NCT02398188|472475263|FG001|Overall Study|Pregnancy|0|||
131231930|NCT02398188|472475262|FG000|Overall Study|Withdrawal by Subject|7|||
131079698|NCT02386839|471924587|FG001|Overall Study|Withdrawal by Subject|10|||
131079699|NCT02386839|471924586|FG000|Overall Study|Lost to Follow-up|4|||
131079700|NCT02386839|471924587|FG001|Overall Study|Lost to Follow-up|4|||
131079701|NCT02386839|471924586|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
131079702|NCT02386839|471924587|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
131079703|NCT02386839|471924586|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
131079704|NCT02386839|471924587|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
131079705|NCT02386839|471924586|FG000|Overall Study|Other (unspecified)|1|||
131079706|NCT02386839|471924587|FG001|Overall Study|Other (unspecified)|0|||
131079707|NCT02101983|471924588|FG000|Overall Study|Physician Decision|1|||
131231931|NCT02398188|472475263|FG001|Overall Study|Withdrawal by Subject|16|||
131231932|NCT01259869|472475265|FG000|Overall Study|Duplicated registration|1|||
131231933|NCT00175019|472475266|FG000|Overall Study|Adverse Event|54|||
131231934|NCT00175019|472475267|FG001|Overall Study|Adverse Event|22|||
131231935|NCT00175019|472475268|FG002|Overall Study|Adverse Event|2|||
131231936|NCT00175019|472475266|FG000|Overall Study|Protocol Violation|6|||
131079708|NCT02101983|471924589|FG001|Overall Study|Physician Decision|0|||
131231937|NCT00175019|472475267|FG001|Overall Study|Protocol Violation|3|||
131231938|NCT00175019|472475268|FG002|Overall Study|Protocol Violation|3|||
131140197|NCT00132730|472140077|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
131140198|NCT00132730|472140078|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
131140199|NCT00132730|472140073|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
131140200|NCT00132730|472140074|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
131140201|NCT00132730|472140075|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
131140202|NCT00132730|472140076|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
131140203|NCT00132730|472140077|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
131140204|NCT00132730|472140078|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
131140205|NCT00132730|472140073|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
131140206|NCT00132730|472140074|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
131140207|NCT00132730|472140075|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
131140208|NCT00132730|472140076|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
131140209|NCT00132730|472140077|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
131140210|NCT00132730|472140078|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
131140211|NCT00132730|472140073|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
131140212|NCT00132730|472140074|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
131140213|NCT00132730|472140075|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
131140214|NCT00132730|472140076|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
131140215|NCT00132730|472140077|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
131140216|NCT00132730|472140078|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
131140217|NCT00132730|472140073|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
131140218|NCT00132730|472140074|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
131140219|NCT00132730|472140075|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
131140220|NCT00132730|472140076|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
131140221|NCT00132730|472140077|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
131140222|NCT00132730|472140078|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
131140223|NCT00132730|472140073|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
131140224|NCT00132730|472140074|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
131140225|NCT00132730|472140075|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
131140226|NCT00132730|472140076|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
131140227|NCT00132730|472140077|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
131140228|NCT00132730|472140078|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
131140229|NCT00132730|472140073|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
131140230|NCT00132730|472140074|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
131140231|NCT00132730|472140075|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
131140232|NCT00132730|472140076|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
131140233|NCT00132730|472140077|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
131140234|NCT00132730|472140078|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
131140235|NCT00132730|472140073|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
131140236|NCT00132730|472140074|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
131140237|NCT00132730|472140075|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
131140238|NCT00132730|472140076|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
131140239|NCT00132730|472140077|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
131140240|NCT00132730|472140078|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
131140241|NCT00132730|472140073|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
131140242|NCT00132730|472140074|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
131140243|NCT00132730|472140075|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
131140244|NCT00132730|472140076|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
131140245|NCT00132730|472140077|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
131079709|NCT02388347|471926198|FG000|Overall Study|Withdrawal by Subject|0|||
131079710|NCT02388347|471926199|FG001|Overall Study|Withdrawal by Subject|0|||
131079711|NCT02388347|471926200|FG002|Overall Study|Withdrawal by Subject|1|||
131079712|NCT02388347|471926201|FG003|Overall Study|Withdrawal by Subject|0|||
131079713|NCT02388347|471926202|FG004|Overall Study|Withdrawal by Subject|0|||
131079714|NCT01845805|471926203|FG000|Overall Study|Withdrawal by Subject|1|||
131079715|NCT01845805|471926204|FG001|Overall Study|Withdrawal by Subject|2|||
131079716|NCT01845805|471926203|FG000|Overall Study|Disease Progression|13|||
131079717|NCT01845805|471926204|FG001|Overall Study|Disease Progression|14|||
131079718|NCT01845805|471926203|FG000|Overall Study|Drug-related Toxicity|4|||
131079719|NCT01845805|471926204|FG001|Overall Study|Drug-related Toxicity|0|||
131079720|NCT02820597|471926206|FG000|Overall Study|Lost to Follow-up|12|||
131079721|NCT00575042|471926207|FG000|Overall Study|Adverse Event|2|||
131079722|NCT00575042|471926207|FG000|Overall Study|Lost to Follow-up|1|||
131079723|NCT04795336|471926208|FG000|Overall Study|Withdrawal by Subject|3|||
131079724|NCT04795336|471926209|FG001|Overall Study|Withdrawal by Subject|4|||
131079725|NCT04795336|471926210|FG002|Overall Study|Withdrawal by Subject|3|||
131079726|NCT04795336|471926211|FG003|Overall Study|Withdrawal by Subject|12|||
131079727|NCT04795336|471926208|FG000|Overall Study|Lost study logs|0|||
131079728|NCT04795336|471926209|FG001|Overall Study|Lost study logs|1|||
131079729|NCT04795336|471926210|FG002|Overall Study|Lost study logs|0|||
131079730|NCT04795336|471926211|FG003|Overall Study|Lost study logs|2|||
131079731|NCT04795336|471926208|FG000|Overall Study|Did not take study medication|2|||
131079732|NCT04795336|471926209|FG001|Overall Study|Did not take study medication|0|||
131140246|NCT00132730|472140078|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
131140247|NCT01554579|472140079|FG000|Overall Study|Adverse Event|6|||
131140248|NCT01554579|472140080|FG001|Overall Study|Adverse Event|25|||
131140249|NCT01554579|472140079|FG000|Overall Study|Lack of Efficacy|2|||
131140250|NCT01554579|472140080|FG001|Overall Study|Lack of Efficacy|1|||
131140251|NCT01554579|472140079|FG000|Overall Study|Withdrawal by Subject|2|||
131140252|NCT01554579|472140080|FG001|Overall Study|Withdrawal by Subject|1|||
131140253|NCT01192347|472140081|FG000|Overall Study|Death|3|||
131140254|NCT01192347|472140081|FG000|Overall Study|Lost to Follow-up|3|||
131140255|NCT01192347|472140081|FG000|Overall Study|Withdrawal by Subject|1|||
131140256|NCT01192347|472140081|FG000|Overall Study|Adverse Event|1|||
131140257|NCT01192347|472140081|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
131140258|NCT01192347|472140081|FG000|Overall Study|Patient seen in different hospital|1|||
131140259|NCT01192347|472140081|FG000|Overall Study|Patient not visiting hospital regularly|1|||
131140260|NCT01192347|472140081|FG000|Overall Study|Patient did not show up for visits|1|||
131140261|NCT02623335|472140082|FG000|Overall Study|Death|8|||
131140262|NCT02623335|472140083|FG001|Overall Study|Death|7|||
131140263|NCT02623335|472140082|FG000|Overall Study|Lost to Follow-up|15|||
131140264|NCT02623335|472140083|FG001|Overall Study|Lost to Follow-up|23|||
131140265|NCT02623335|472140082|FG000|Overall Study|Withdrawal by Subject|2|||
131140266|NCT02623335|472140083|FG001|Overall Study|Withdrawal by Subject|5|||
131140267|NCT02623335|472140082|FG000|Overall Study|Protocol Violation|2|||
131140268|NCT02623335|472140083|FG001|Overall Study|Protocol Violation|1|||
131140269|NCT03739528|472140084|FG000|Overall Study|Not treated|8|||
131140270|NCT03739528|472140085|FG001|Overall Study|Not treated|12|||
131140271|NCT03739528|472140084|FG000|Overall Study|Treatment and study discontinued|6|||
131140272|NCT03739528|472140085|FG001|Overall Study|Treatment and study discontinued|2|||
131140273|NCT03739528|472140084|FG000|Overall Study|Treatment discontinued + study completed|1|||
131140274|NCT03739528|472140085|FG001|Overall Study|Treatment discontinued + study completed|3|||
131140275|NCT01046695|472140086|FG000|Overall Study|Subject had a pacemaker|0|||
131140276|NCT01046695|472140087|FG001|Overall Study|Subject had a pacemaker|1|||
131140277|NCT01046695|472140086|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
131140278|NCT01046695|472140087|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
131140279|NCT03072160|472140088|FG000|Overall Study|Adverse Event|3|||
131140280|NCT03072160|472140089|FG001|Overall Study|Adverse Event|1|||
131140281|NCT03072160|472140088|FG000|Overall Study|Refused further treatment|6|||
131140282|NCT03072160|472140089|FG001|Overall Study|Refused further treatment|1|||
131140283|NCT03072160|472140088|FG000|Overall Study|Physician Decision|1|||
131140284|NCT03072160|472140089|FG001|Overall Study|Physician Decision|0|||
131140285|NCT03072160|472140088|FG000|Overall Study|Disease progression on study|1|||
131140286|NCT03072160|472140089|FG001|Overall Study|Disease progression on study|1|||
131140287|NCT03072160|472140088|FG000|Overall Study|No contact|0|||
131140288|NCT03072160|472140089|FG001|Overall Study|No contact|1|||
131140289|NCT00408694|472140090|FG000|Overall Study|Ineligible|1|||
131140290|NCT00408694|472140090|FG000|Overall Study|No protocol treatment|1|||
131140291|NCT00666926|472140094|FG000|Overall Study|Adverse Event|0|||
131140292|NCT00666926|472140095|FG001|Overall Study|Adverse Event|0|||
131140293|NCT00666926|472140096|FG002|Overall Study|Adverse Event|0|||
131140294|NCT00666926|472140097|FG003|Overall Study|Adverse Event|0|||
131140295|NCT00666926|472140098|FG004|Overall Study|Adverse Event|0|||
131140296|NCT00666926|472140099|FG005|Overall Study|Adverse Event|0|||
131140297|NCT00666926|472140100|FG006|Overall Study|Adverse Event|0|||
131140298|NCT00666926|472140101|FG007|Overall Study|Adverse Event|0|||
131140299|NCT00666926|472140102|FG008|Overall Study|Adverse Event|0|||
131140300|NCT00666926|472140103|FG009|Overall Study|Adverse Event|2|||
131140301|NCT00666926|472140104|FG010|Overall Study|Adverse Event|2|||
131140302|NCT00666926|472140105|FG011|Overall Study|Adverse Event|2|||
131140303|NCT00666926|472140106|FG012|Overall Study|Adverse Event|0|||
131231939|NCT00175019|472475266|FG000|Overall Study|Lost to Follow-up|42|||
131140304|NCT00666926|472140107|FG013|Overall Study|Adverse Event|1|||
131140305|NCT00666926|472140108|FG014|Overall Study|Adverse Event|0|||
131140306|NCT00666926|472140109|FG015|Overall Study|Adverse Event|0|||
131140307|NCT00666926|472140094|FG000|Overall Study|Laboratory abnormality|0|||
131140308|NCT00666926|472140095|FG001|Overall Study|Laboratory abnormality|0|||
131140309|NCT00666926|472140096|FG002|Overall Study|Laboratory abnormality|0|||
131140310|NCT00666926|472140097|FG003|Overall Study|Laboratory abnormality|0|||
131140311|NCT00666926|472140098|FG004|Overall Study|Laboratory abnormality|0|||
131079733|NCT04795336|471926210|FG002|Overall Study|Did not take study medication|0|||
131140312|NCT00666926|472140099|FG005|Overall Study|Laboratory abnormality|0|||
131231940|NCT00175019|472475267|FG001|Overall Study|Lost to Follow-up|39|||
131231941|NCT00175019|472475268|FG002|Overall Study|Lost to Follow-up|9|||
131231942|NCT00175019|472475266|FG000|Overall Study|Did not continue under Amendment 4|1|||
131231943|NCT00175019|472475267|FG001|Overall Study|Did not continue under Amendment 4|1|||
131231944|NCT00175019|472475268|FG002|Overall Study|Did not continue under Amendment 4|2|||
131231945|NCT00175019|472475266|FG000|Overall Study|Personal Reason(s)|39|||
131231946|NCT00175019|472475267|FG001|Overall Study|Personal Reason(s)|31|||
131231947|NCT00175019|472475268|FG002|Overall Study|Personal Reason(s)|8|||
131231948|NCT00175019|472475266|FG000|Overall Study|Therapeutic Failure|10|||
131231949|NCT00175019|472475267|FG001|Overall Study|Therapeutic Failure|38|||
131231950|NCT00175019|472475268|FG002|Overall Study|Therapeutic Failure|22|||
131231951|NCT00175019|472475266|FG000|Overall Study|Gout Flare|2|||
131231952|NCT00175019|472475267|FG001|Overall Study|Gout Flare|3|||
131231953|NCT00175019|472475268|FG002|Overall Study|Gout Flare|0|||
131231954|NCT00175019|472475266|FG000|Overall Study|Reason Not Specified|40|||
131231955|NCT00175019|472475267|FG001|Overall Study|Reason Not Specified|34|||
131231956|NCT00175019|472475268|FG002|Overall Study|Reason Not Specified|11|||
131231957|NCT03209570|472475273|FG000|Overall Study|Death|1|||
131231958|NCT03209570|472475274|FG001|Overall Study|Death|0|||
131231959|NCT03209570|472475273|FG000|Overall Study|Incomplete Data|8|||
131231960|NCT03209570|472475274|FG001|Overall Study|Incomplete Data|10|||
131231961|NCT03209570|472475273|FG000|Overall Study|Protocol Violation|1|||
131231962|NCT03209570|472475274|FG001|Overall Study|Protocol Violation|0|||
131231963|NCT03209570|472475273|FG000|Overall Study|Withdrawal by Subject|0|||
131231964|NCT03209570|472475274|FG001|Overall Study|Withdrawal by Subject|3|||
131231965|NCT00220701|472475285|FG000|Overall Study|Lost to Follow-up|5|||
131231966|NCT00220701|472475286|FG001|Overall Study|Lost to Follow-up|4|||
131231967|NCT00755326|472475288|FG000|Overall Study|Lost to Follow-up|2|||
131231968|NCT00755326|472475289|FG001|Overall Study|Lost to Follow-up|3|||
131231969|NCT01798485|472475295|FG000|Overall Study|Adverse Event|32|||
131231970|NCT01798485|472475296|FG001|Overall Study|Adverse Event|40|||
131231971|NCT01798485|472475295|FG000|Overall Study|Withdrawal by Subject|27|||
131231972|NCT01798485|472475296|FG001|Overall Study|Withdrawal by Subject|31|||
131231973|NCT01798485|472475295|FG000|Overall Study|Lost to Follow-up|0|||
131231974|NCT01798485|472475296|FG001|Overall Study|Lost to Follow-up|3|||
131231975|NCT01798485|472475295|FG000|Overall Study|Physician Decision|14|||
131231976|NCT01798485|472475296|FG001|Overall Study|Physician Decision|10|||
131231977|NCT01798485|472475295|FG000|Overall Study|Objective Disease Progression|152|||
131231978|NCT01798485|472475296|FG001|Overall Study|Objective Disease Progression|106|||
131231979|NCT01798485|472475295|FG000|Overall Study|Death|25|||
131231980|NCT01798485|472475296|FG001|Overall Study|Death|22|||
131231981|NCT01798485|472475295|FG000|Overall Study|Sponsor Decision|61|||
131231982|NCT01798485|472475296|FG001|Overall Study|Sponsor Decision|54|||
131231983|NCT01798485|472475295|FG000|Overall Study|Clinical Progression|35|||
131231984|NCT01798485|472475296|FG001|Overall Study|Clinical Progression|24|||
131231985|NCT00681863|472475297|FG000|Overall Study|Adverse Event|1|||
131231986|NCT00681863|472475297|FG000|Overall Study|Lost to Follow-up|2|||
131231987|NCT00681863|472475297|FG000|Overall Study|Lack of Efficacy|2|||
131231988|NCT00681863|472475297|FG000|Overall Study|Other|18|||
131231989|NCT01076166|472475298|FG000|Overall Study|Adverse Event|3|||
131231990|NCT01076166|472475298|FG000|Overall Study|Symptoms improved/resolved|6|||
131231991|NCT00638157|472475318|FG000|Overall Study|Adverse Event|0|||
131231992|NCT00638157|472475319|FG001|Overall Study|Adverse Event|1|||
131231993|NCT00638157|472475318|FG000|Overall Study|Clinical (symptomatic) failure|1|||
131231994|NCT00638157|472475319|FG001|Overall Study|Clinical (symptomatic) failure|1|||
131231995|NCT00638157|472475318|FG000|Overall Study|Microbiological failure|1|||
131231996|NCT00638157|472475319|FG001|Overall Study|Microbiological failure|0|||
131231997|NCT00638157|472475318|FG000|Overall Study|Lost to Follow-up|1|||
131231998|NCT00638157|472475319|FG001|Overall Study|Lost to Follow-up|0|||
131231999|NCT00638157|472475318|FG000|Overall Study|Physician Decision|1|||
131232000|NCT00638157|472475319|FG001|Overall Study|Physician Decision|0|||
131232001|NCT00638157|472475318|FG000|Overall Study|Other|1|||
131232002|NCT00638157|472475319|FG001|Overall Study|Other|2|||
131232003|NCT00638157|472475318|FG000|Overall Study|Randomized, not treated|2|||
131232004|NCT00638157|472475319|FG001|Overall Study|Randomized, not treated|0|||
131232005|NCT00876733|472475324|FG000|Overall Study|Adverse Event|34|||
131232006|NCT00876733|472475325|FG001|Overall Study|Adverse Event|20|||
131232007|NCT00876733|472475326|FG002|Overall Study|Adverse Event|10|||
131232008|NCT00876733|472475327|FG003|Overall Study|Adverse Event|3|||
131232009|NCT00876733|472475324|FG000|Overall Study|Lack of Efficacy|17|||
131232010|NCT00876733|472475325|FG001|Overall Study|Lack of Efficacy|9|||
131232011|NCT00876733|472475326|FG002|Overall Study|Lack of Efficacy|10|||
131232012|NCT00876733|472475327|FG003|Overall Study|Lack of Efficacy|1|||
131232013|NCT00876733|472475324|FG000|Overall Study|Lost to Follow-up|26|||
131232014|NCT00876733|472475325|FG001|Overall Study|Lost to Follow-up|10|||
131232015|NCT00876733|472475326|FG002|Overall Study|Lost to Follow-up|3|||
131232016|NCT00876733|472475327|FG003|Overall Study|Lost to Follow-up|2|||
131232017|NCT00876733|472475324|FG000|Overall Study|Data not available|14|||
131232018|NCT00876733|472475325|FG001|Overall Study|Data not available|3|||
131232019|NCT00876733|472475326|FG002|Overall Study|Data not available|7|||
131232020|NCT00876733|472475327|FG003|Overall Study|Data not available|1|||
131232021|NCT02843074|472475328|FG000|Overall Study|Withdrawal by Subject|5|||
131232022|NCT02843074|472475328|FG000|Overall Study|Progressive disease|1|||
131232023|NCT02843074|472475328|FG000|Overall Study|Physician Decision|1|||
131232024|NCT02843074|472475328|FG000|Overall Study|Lost to Follow-up|1|||
131232025|NCT02843074|472475328|FG000|Overall Study|Death|9|||
131232026|NCT05476679|472475329|FG000|Overall Study|Withdrawal by Subject|0|||
131232027|NCT05476679|472475330|FG001|Overall Study|Withdrawal by Subject|0|||
131232028|NCT05476679|472475331|FG002|Overall Study|Withdrawal by Subject|0|||
131232029|NCT05476679|472475332|FG003|Overall Study|Withdrawal by Subject|1|||
131232030|NCT05476679|472475333|FG004|Overall Study|Withdrawal by Subject|0|||
131232031|NCT05476679|472475329|FG000|Overall Study|Lost to Follow-up|0|||
131232032|NCT05476679|472475330|FG001|Overall Study|Lost to Follow-up|0|||
131232033|NCT05476679|472475331|FG002|Overall Study|Lost to Follow-up|0|||
131079734|NCT04795336|471926211|FG003|Overall Study|Did not take study medication|0|||
131079735|NCT03898700|471926212|FG000|Overall Study|Withdrawal by Subject|2|||
131079736|NCT02666664|471926213|FG000|Overall Study|Physician Decision|0|||
131079737|NCT02666664|471926214|FG001|Overall Study|Physician Decision|1|||
131079738|NCT02666664|471926213|FG000|Overall Study|Protocol Violation|0|||
131079739|NCT02666664|471926214|FG001|Overall Study|Protocol Violation|2|||
131079740|NCT02666664|471926213|FG000|Overall Study|Other|0|||
131079741|NCT02666664|471926214|FG001|Overall Study|Other|1|||
131079742|NCT02666664|471926213|FG000|Overall Study|Adverse Event|12|||
131079743|NCT02666664|471926214|FG001|Overall Study|Adverse Event|37|||
131079744|NCT02666664|471926213|FG000|Overall Study|Withdrawal by participant|23|||
131079745|NCT02666664|471926214|FG001|Overall Study|Withdrawal by participant|40|||
131079746|NCT02666664|471926213|FG000|Overall Study|Sponsor decision|0|||
131079747|NCT02666664|471926214|FG001|Overall Study|Sponsor decision|1|||
131079748|NCT02666664|471926213|FG000|Overall Study|Lost to Follow-up|1|||
131232034|NCT05476679|472475332|FG003|Overall Study|Lost to Follow-up|1|||
131232035|NCT05476679|472475333|FG004|Overall Study|Lost to Follow-up|0|||
131232036|NCT01199601|472475334|FG000|Overall Study|Lost to Follow-up|47|||
131232037|NCT01199601|472475335|FG001|Overall Study|Lost to Follow-up|66|||
131232038|NCT01199601|472475334|FG000|Overall Study|Withdrawal by Subject|15|||
131232039|NCT01199601|472475335|FG001|Overall Study|Withdrawal by Subject|3|||
131232040|NCT01199601|472475334|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
131232041|NCT01199601|472475335|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
131232042|NCT03035227|472475336|FG000|Overall Study|study stopped due to PI leaving institut|1|||
131232043|NCT03035227|472475337|FG001|Overall Study|study stopped due to PI leaving institut|1|||
131232044|NCT03111147|472475338|FG000|Overall Study|Lost to Follow-up|2|||
131232045|NCT03111147|472475339|FG001|Overall Study|Lost to Follow-up|5|||
131232046|NCT03111147|472475338|FG000|Overall Study|Withdrawal by Subject|4|||
131232047|NCT03111147|472475339|FG001|Overall Study|Withdrawal by Subject|3|||
131232048|NCT03111147|472475338|FG000|Overall Study|Protocol Violation|2|||
131232049|NCT03111147|472475339|FG001|Overall Study|Protocol Violation|1|||
131232050|NCT03111147|472475338|FG000|Overall Study|Death|1|||
131232051|NCT03111147|472475339|FG001|Overall Study|Death|1|||
131232052|NCT00095199|472475342|FG000|Overall Study|Adverse Event|40|||
131232053|NCT00095199|472475343|FG001|Overall Study|Adverse Event|22|||
131232054|NCT00095199|472475344|FG002|Overall Study|Adverse Event|26|||
131232055|NCT00095199|472475345|FG003|Overall Study|Adverse Event|11|||
131232056|NCT00095199|472475342|FG000|Overall Study|Progressive disease|213|||
131232057|NCT00095199|472475343|FG001|Overall Study|Progressive disease|179|||
131232058|NCT00095199|472475344|FG002|Overall Study|Progressive disease|105|||
131232059|NCT00095199|472475345|FG003|Overall Study|Progressive disease|98|||
131232060|NCT00095199|472475342|FG000|Overall Study|Death|10|||
131232061|NCT00095199|472475343|FG001|Overall Study|Death|6|||
131232062|NCT00095199|472475344|FG002|Overall Study|Death|11|||
131232063|NCT00095199|472475345|FG003|Overall Study|Death|9|||
131232064|NCT00095199|472475342|FG000|Overall Study|Withdrawal by Subject|21|||
131232065|NCT00095199|472475343|FG001|Overall Study|Withdrawal by Subject|16|||
131232066|NCT00095199|472475344|FG002|Overall Study|Withdrawal by Subject|13|||
131232067|NCT00095199|472475345|FG003|Overall Study|Withdrawal by Subject|22|||
131232068|NCT00095199|472475342|FG000|Overall Study|Protocol Violation|4|||
131232069|NCT00095199|472475343|FG001|Overall Study|Protocol Violation|4|||
131232070|NCT00095199|472475344|FG002|Overall Study|Protocol Violation|2|||
130780217|NCT01719380|470821455|FG008|Overall Study|Participant/Guardian Decision|2|||
131232071|NCT00095199|472475345|FG003|Overall Study|Protocol Violation|0|||
131232072|NCT00095199|472475342|FG000|Overall Study|Liver function test results elevated|0|||
131232073|NCT00095199|472475343|FG001|Overall Study|Liver function test results elevated|0|||
131232074|NCT00095199|472475344|FG002|Overall Study|Liver function test results elevated|1|||
131232075|NCT00095199|472475345|FG003|Overall Study|Liver function test results elevated|1|||
131079749|NCT02666664|471926214|FG001|Overall Study|Lost to Follow-up|2|||
131079750|NCT03616964|471926215|FG000|Overall Study|Adverse Event|15|||
131079751|NCT03616964|471926216|FG001|Overall Study|Adverse Event|10|||
131079752|NCT03616964|471926217|FG002|Overall Study|Adverse Event|16|||
131079753|NCT03616964|471926215|FG000|Overall Study|Death|3|||
131079754|NCT03616964|471926216|FG001|Overall Study|Death|0|||
131140313|NCT00666926|472140100|FG006|Overall Study|Laboratory abnormality|0|||
131232076|NCT00095199|472475342|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
131140314|NCT00666926|472140101|FG007|Overall Study|Laboratory abnormality|0|||
131140315|NCT00666926|472140102|FG008|Overall Study|Laboratory abnormality|0|||
131140316|NCT00666926|472140103|FG009|Overall Study|Laboratory abnormality|0|||
131232077|NCT00095199|472475343|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
131232078|NCT00095199|472475344|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
131232079|NCT00095199|472475345|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
131232080|NCT00095199|472475342|FG000|Overall Study|Physician Decision|5|||
131232081|NCT00095199|472475343|FG001|Overall Study|Physician Decision|6|||
131232082|NCT00095199|472475344|FG002|Overall Study|Physician Decision|1|||
131232083|NCT00095199|472475345|FG003|Overall Study|Physician Decision|1|||
131232084|NCT00095199|472475342|FG000|Overall Study|Not eligible|1|||
131232085|NCT00095199|472475343|FG001|Overall Study|Not eligible|7|||
131232086|NCT00095199|472475344|FG002|Overall Study|Not eligible|0|||
131232087|NCT00095199|472475345|FG003|Overall Study|Not eligible|1|||
131232088|NCT00095199|472475342|FG000|Overall Study|Started Palliative Radiotherapy|1|||
131232089|NCT00095199|472475343|FG001|Overall Study|Started Palliative Radiotherapy|0|||
131232090|NCT00095199|472475344|FG002|Overall Study|Started Palliative Radiotherapy|0|||
131232091|NCT00095199|472475345|FG003|Overall Study|Started Palliative Radiotherapy|0|||
131232092|NCT00095199|472475342|FG000|Overall Study|Started radiotherapy regimen|0|||
131232093|NCT00095199|472475343|FG001|Overall Study|Started radiotherapy regimen|1|||
131232094|NCT00095199|472475344|FG002|Overall Study|Started radiotherapy regimen|0|||
131232095|NCT00095199|472475345|FG003|Overall Study|Started radiotherapy regimen|0|||
131232096|NCT00095199|472475342|FG000|Overall Study|Primary tumor removed in other surgery|0|||
131232097|NCT00095199|472475343|FG001|Overall Study|Primary tumor removed in other surgery|1|||
131232098|NCT00095199|472475344|FG002|Overall Study|Primary tumor removed in other surgery|0|||
131232099|NCT00095199|472475345|FG003|Overall Study|Primary tumor removed in other surgery|0|||
131232100|NCT00095199|472475342|FG000|Overall Study|Data inadvertently lost by site|1|||
131232101|NCT00095199|472475343|FG001|Overall Study|Data inadvertently lost by site|0|||
131079755|NCT03616964|471926217|FG002|Overall Study|Death|4|||
131079756|NCT03616964|471926215|FG000|Overall Study|Lack of Efficacy|4|||
131079757|NCT03616964|471926216|FG001|Overall Study|Lack of Efficacy|8|||
131079758|NCT03616964|471926217|FG002|Overall Study|Lack of Efficacy|8|||
131079759|NCT03616964|471926215|FG000|Overall Study|Lost to Follow-up|2|||
131079760|NCT03616964|471926216|FG001|Overall Study|Lost to Follow-up|1|||
131079761|NCT03616964|471926217|FG002|Overall Study|Lost to Follow-up|3|||
131079762|NCT03616964|471926215|FG000|Overall Study|Withdrawal by Subject|18|||
131079763|NCT03616964|471926216|FG001|Overall Study|Withdrawal by Subject|14|||
131079764|NCT03616964|471926217|FG002|Overall Study|Withdrawal by Subject|21|||
131079765|NCT03616964|471926215|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
131079766|NCT03616964|471926216|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
131079767|NCT03616964|471926217|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
131079768|NCT03616964|471926215|FG000|Overall Study|Sponsor's Decision|1|||
131079769|NCT03616964|471926216|FG001|Overall Study|Sponsor's Decision|0|||
131079770|NCT03616964|471926217|FG002|Overall Study|Sponsor's Decision|0|||
131079771|NCT03616964|471926215|FG000|Overall Study|Physician Decision|0|||
131079772|NCT03616964|471926216|FG001|Overall Study|Physician Decision|2|||
131079773|NCT03616964|471926217|FG002|Overall Study|Physician Decision|0|||
131079774|NCT03616964|471926215|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
131079775|NCT03616964|471926216|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
131140317|NCT00666926|472140104|FG010|Overall Study|Laboratory abnormality|1|||
131140318|NCT00666926|472140105|FG011|Overall Study|Laboratory abnormality|0|||
131140319|NCT00666926|472140106|FG012|Overall Study|Laboratory abnormality|0|||
131140320|NCT00666926|472140107|FG013|Overall Study|Laboratory abnormality|0|||
131140321|NCT00666926|472140108|FG014|Overall Study|Laboratory abnormality|0|||
131140322|NCT00666926|472140109|FG015|Overall Study|Laboratory abnormality|1|||
131140323|NCT00666926|472140094|FG000|Overall Study|Lack of Efficacy|0|||
131140324|NCT00666926|472140095|FG001|Overall Study|Lack of Efficacy|0|||
131140325|NCT00666926|472140096|FG002|Overall Study|Lack of Efficacy|0|||
131140326|NCT00666926|472140097|FG003|Overall Study|Lack of Efficacy|0|||
131140327|NCT00666926|472140098|FG004|Overall Study|Lack of Efficacy|0|||
131079776|NCT03616964|471926217|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
131232102|NCT00095199|472475344|FG002|Overall Study|Data inadvertently lost by site|0|||
131232103|NCT00095199|472475345|FG003|Overall Study|Data inadvertently lost by site|0|||
131232104|NCT01896297|472475348|FG000|Overall Study|Died in post treatment phase|1|||
131232105|NCT05188521|472476526|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
131232106|NCT05188521|472476527|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
131232107|NCT01341639|472476528|FG000|Infant Series|Protocol Violation|1|||
130780218|NCT01719380|470821456|FG009|Overall Study|Participant/Guardian Decision|2|||
131079777|NCT03616964|471926215|FG000|Overall Study|Protocol Violation|0|||
131079778|NCT03616964|471926216|FG001|Overall Study|Protocol Violation|1|||
131079779|NCT03616964|471926217|FG002|Overall Study|Protocol Violation|0|||
131140328|NCT00666926|472140099|FG005|Overall Study|Lack of Efficacy|1|||
131232108|NCT01341639|472476529|FG001|Infant Series|Protocol Violation|0|||
131232109|NCT01341639|472476528|FG000|Infant Series|Not Vaccinated|0|||
131232110|NCT01341639|472476529|FG001|Infant Series|Not Vaccinated|1|||
131079780|NCT03616964|471926215|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
131079781|NCT03616964|471926216|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
131079782|NCT03616964|471926217|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
131079783|NCT03616964|471926215|FG000|Overall Study|Randomized but Never Treated|1|||
131079784|NCT03616964|471926216|FG001|Overall Study|Randomized but Never Treated|1|||
131232111|NCT01341639|472476528|FG000|Infant Series|Adverse Event|0|||
131232112|NCT01341639|472476529|FG001|Infant Series|Adverse Event|5|||
131232113|NCT01341639|472476528|FG000|Infant Series|Withdrawal by Subject|11|||
131232114|NCT01341639|472476529|FG001|Infant Series|Withdrawal by Subject|8|||
131232115|NCT01341639|472476528|FG000|Infant Series|Lost to Follow-up|0|||
131232116|NCT01341639|472476529|FG001|Infant Series|Lost to Follow-up|2|||
131232117|NCT01341639|472476528|FG000|Infant Series|Site 0048 Participants|17|||
131232118|NCT01341639|472476529|FG001|Infant Series|Site 0048 Participants|16|||
131232119|NCT01341639|472476528|FG000|Interim Period|Withdrawal by Subject|6|||
131232120|NCT01341639|472476529|FG001|Interim Period|Withdrawal by Subject|7|||
131232121|NCT01341639|472476528|FG000|Interim Period|Lost to Follow-up|2|||
131232122|NCT01341639|472476529|FG001|Interim Period|Lost to Follow-up|0|||
131232123|NCT01341639|472476528|FG000|Interim Period|Physician Decision|0|||
131232124|NCT01341639|472476529|FG001|Interim Period|Physician Decision|1|||
131232125|NCT01341639|472476528|FG000|Interim Period|Protocol Violation|0|||
131232126|NCT01341639|472476529|FG001|Interim Period|Protocol Violation|1|||
131232127|NCT01341639|472476528|FG000|Post-Treatment|Withdrawal by Subject|0|||
131232128|NCT01341639|472476529|FG001|Post-Treatment|Withdrawal by Subject|1|||
131232129|NCT01341639|472476528|FG000|Post-Treatment|Adverse Event|0|||
131232130|NCT01341639|472476529|FG001|Post-Treatment|Adverse Event|2|||
131232131|NCT04582266|472476530|FG000|Overall Study|Lost to Follow-up|7|||
131232132|NCT04582266|472476531|FG001|Overall Study|Lost to Follow-up|5|||
131232133|NCT04582266|472476530|FG000|Overall Study|Withdrawal by Subject|1|||
131232134|NCT04582266|472476531|FG001|Overall Study|Withdrawal by Subject|0|||
131232135|NCT04582266|472476530|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
131232136|NCT04582266|472476531|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
131232137|NCT01241461|472476532|FG000|Overall Study|Progressive Disease|3|||
131232138|NCT01241461|472476533|FG001|Overall Study|Progressive Disease|6|||
131232139|NCT01132118|472476534|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
131232140|NCT01132118|472476535|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
131232141|NCT01132118|472476534|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
131232142|NCT01132118|472476535|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
131232143|NCT01132118|472476534|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
131232144|NCT01132118|472476535|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
131232145|NCT03705351|472476538|FG000|Overall Study|Study termination|3|||
131232146|NCT03705351|472476538|FG000|Overall Study|Death|1|||
131232147|NCT03705351|472476538|FG000|Overall Study|Lack of Efficacy|2|||
131232148|NCT03705351|472476538|FG000|Overall Study|Withdrawal by Subject|1|||
131232149|NCT01299038|472476546|FG000|Overall Study|Withdrawal by Subject|1|||
131232150|NCT01299038|472476547|FG001|Overall Study|Withdrawal by Subject|0|||
131232151|NCT00322556|472476548|FG000|Overall Study|Adverse Event|1|||
131232152|NCT00322556|472476548|FG000|Overall Study|Withdrawal by Subject|1|||
131232153|NCT00322556|472476548|FG000|Overall Study|Lost to Follow-up|3|||
131232154|NCT00322556|472476548|FG000|Overall Study|Other Reason|7|||
131232155|NCT00704418|472476549|FG000|Overall Study|Withdrawal by Subject|2|||
131232156|NCT00704418|472476550|FG001|Overall Study|Withdrawal by Subject|0|||
131232157|NCT00704418|472476549|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
131232158|NCT00704418|472476550|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
131232159|NCT02322879|472476551|FG000|First Intervention|Physician Decision|1|||
131232160|NCT02322879|472476552|FG001|First Intervention|Physician Decision|0|||
131232161|NCT02295774|472476553|FG000|Overall Study|Physician Decision|1|||
131232162|NCT02295774|472476553|FG000|Overall Study|Withdrawal by Subject|2|||
131232163|NCT01673009|472476555|FG000|Overall Study|Physician Decision|5|||
131232164|NCT01673009|472476555|FG000|Overall Study|Withdrawal by Subject|8|||
131232165|NCT02623959|472476558|FG000|Overall Study|Progression|0|||
131232166|NCT02623959|472476559|FG001|Overall Study|Progression|1|||
131232167|NCT04041570|472476569|FG000|Overall Study|Moved from Area|0|||
131232168|NCT04041570|472476570|FG001|Overall Study|Moved from Area|2|||
131232169|NCT01338636|472476571|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
131079785|NCT03616964|471926217|FG002|Overall Study|Randomized but Never Treated|1|||
131232170|NCT02385526|472476572|FG000|Overall Study|Withdrawal by Subject|0|||
131232171|NCT02385526|472476573|FG001|Overall Study|Withdrawal by Subject|2|||
131232172|NCT02385526|472476574|FG002|Overall Study|Withdrawal by Subject|0|||
131232173|NCT02385526|472476572|FG000|Overall Study|Lost to Follow-up|0|||
131232174|NCT02385526|472476573|FG001|Overall Study|Lost to Follow-up|1|||
131232175|NCT02385526|472476574|FG002|Overall Study|Lost to Follow-up|0|||
131079786|NCT00971997|471926218|FG000|Overall Study|Adverse Event|2|||
131232176|NCT02385526|472476572|FG000|Overall Study|Physician Decision|1|||
131079787|NCT00971997|471926218|FG000|Overall Study|Death|1|||
131079788|NCT00971997|471926218|FG000|Overall Study|Protocol Violation|4|||
131232177|NCT02385526|472476573|FG001|Overall Study|Physician Decision|0|||
131232178|NCT02385526|472476574|FG002|Overall Study|Physician Decision|0|||
131232179|NCT02385526|472476572|FG000|Overall Study|Protocol Violation|1|||
131079789|NCT00971997|471926218|FG000|Overall Study|Withdrawal by Subject|5|||
131079790|NCT00971997|471926218|FG000|Overall Study|Physician Decision|7|||
131079791|NCT01266018|471926221|FG000|Overall Study|Physician Decision|1|||
131079792|NCT01266018|471926222|FG001|Overall Study|Physician Decision|0|||
131079793|NCT01266018|471926221|FG000|Overall Study|Progressive disease|0|||
131079794|NCT01266018|471926222|FG001|Overall Study|Progressive disease|1|||
131079795|NCT03167151|471926223|FG000|Overall Study|Withdrawal by Subject|1|||
131079796|NCT03167151|471926224|FG001|Overall Study|Withdrawal by Subject|0|||
131079797|NCT03167151|471926225|FG002|Overall Study|Withdrawal by Subject|0|||
131079798|NCT03167151|471926223|FG000|Overall Study|No evidence of tumour at surgery|0|||
131079799|NCT03167151|471926224|FG001|Overall Study|No evidence of tumour at surgery|1|||
130780219|NCT01719380|470821447|FG000|Overall Study|Physician Decision|0|||
131079800|NCT03167151|471926225|FG002|Overall Study|No evidence of tumour at surgery|1|||
131079801|NCT01458522|471926226|FG000|Overall Study|Withdrawal by Subject|2|||
131232180|NCT02385526|472476573|FG001|Overall Study|Protocol Violation|0|||
131232181|NCT02385526|472476574|FG002|Overall Study|Protocol Violation|0|||
131232182|NCT03532009|472476575|FG000|Overall Study|Other|1|||
131232183|NCT03532009|472476576|FG001|Overall Study|Other|1|||
131232184|NCT03532009|472476575|FG000|Overall Study|Death|1|||
131232185|NCT03532009|472476576|FG001|Overall Study|Death|1|||
131232186|NCT03532009|472476575|FG000|Overall Study|Withdrawal by Patient|0|||
131232187|NCT03532009|472476576|FG001|Overall Study|Withdrawal by Patient|2|||
131232188|NCT02035137|472476578|FG000|Overall Study|Physician Decision|0|||
131232189|NCT02035137|472476579|FG001|Overall Study|Physician Decision|0|||
131232190|NCT02035137|472476580|FG002|Overall Study|Physician Decision|1|||
131232191|NCT02035137|472476578|FG000|Overall Study|Withdrawal by Subject|0|||
131232192|NCT02035137|472476579|FG001|Overall Study|Withdrawal by Subject|1|||
131232193|NCT02035137|472476580|FG002|Overall Study|Withdrawal by Subject|2|||
131232194|NCT02035137|472476578|FG000|Overall Study|Ineligible|0|||
131232195|NCT02035137|472476579|FG001|Overall Study|Ineligible|1|||
131232196|NCT02035137|472476580|FG002|Overall Study|Ineligible|2|||
131232197|NCT02035137|472476578|FG000|Overall Study|Disease progression prior to treatment start|2|||
131232198|NCT02035137|472476579|FG001|Overall Study|Disease progression prior to treatment start|0|||
131232199|NCT02035137|472476580|FG002|Overall Study|Disease progression prior to treatment start|0|||
131232200|NCT00384033|472476596|FG000|Overall Study|Adverse Event|10|||
131232201|NCT00384033|472476597|FG001|Overall Study|Adverse Event|8|||
131232202|NCT00384033|472476598|FG002|Overall Study|Adverse Event|11|||
131232203|NCT00384033|472476599|FG003|Overall Study|Adverse Event|20|||
130727034|NCT02883049|470625426|FG002|Induction|Identified as VHR at end of Induction|0|||
130727035|NCT02883049|470625427|FG003|Induction|Identified as VHR at end of Induction|0|||
130727036|NCT02883049|470625428|FG004|Induction|Identified as VHR at end of Induction|0|||
130727037|NCT02883049|470625429|FG005|Induction|Identified as VHR at end of Induction|0|||
130727038|NCT02883049|470625430|FG006|Induction|Identified as VHR at end of Induction|0|||
130727039|NCT02883049|470625431|FG007|Induction|Identified as VHR at end of Induction|0|||
130727040|NCT02883049|470625432|FG008|Induction|Identified as VHR at end of Induction|0|||
130727041|NCT02883049|470625433|FG009|Induction|Identified as VHR at end of Induction|0|||
130727042|NCT02883049|470625434|FG010|Induction|Identified as VHR at end of Induction|0|||
130727043|NCT02883049|470625435|FG011|Induction|Identified as VHR at end of Induction|0|||
130727044|NCT02883049|470625436|FG012|Induction|Identified as VHR at end of Induction|0|||
130727045|NCT02883049|470625437|FG013|Induction|Identified as VHR at end of Induction|0|||
130727046|NCT02883049|470625438|FG014|Induction|Identified as VHR at end of Induction|0|||
130727047|NCT02883049|470625439|FG015|Induction|Identified as VHR at end of Induction|0|||
130727048|NCT02883049|470625424|FG000|Induction|Moved to another non-COG institution|3|||
131232204|NCT00384033|472476596|FG000|Overall Study|Failed to return|1|||
131232205|NCT00384033|472476597|FG001|Overall Study|Failed to return|3|||
130727049|NCT02883049|470625425|FG001|Induction|Moved to another non-COG institution|0|||
130727050|NCT02883049|470625426|FG002|Induction|Moved to another non-COG institution|0|||
130727051|NCT02883049|470625427|FG003|Induction|Moved to another non-COG institution|0|||
130727052|NCT02883049|470625428|FG004|Induction|Moved to another non-COG institution|0|||
131232206|NCT00384033|472476598|FG002|Overall Study|Failed to return|2|||
131232207|NCT00384033|472476599|FG003|Overall Study|Failed to return|2|||
130780220|NCT01719380|470821448|FG001|Overall Study|Physician Decision|0|||
130780221|NCT01719380|470821449|FG002|Overall Study|Physician Decision|2|||
131079802|NCT01458522|471926227|FG001|Overall Study|Withdrawal by Subject|2|||
131079803|NCT01458522|471926226|FG000|Overall Study|Physician Decision|1|||
131079804|NCT01458522|471926227|FG001|Overall Study|Physician Decision|9|||
131232208|NCT00384033|472476596|FG000|Overall Study|Physician Decision|1|||
131232209|NCT00384033|472476597|FG001|Overall Study|Physician Decision|0|||
131232210|NCT00384033|472476598|FG002|Overall Study|Physician Decision|0|||
131232211|NCT00384033|472476599|FG003|Overall Study|Physician Decision|0|||
131232212|NCT00384033|472476596|FG000|Overall Study|Lost to Follow-up|6|||
131079805|NCT02684123|471926228|FG000|Phase 1|Lack of Efficacy|5|||
131079806|NCT02684123|471926229|FG001|Phase 1|Lack of Efficacy|0|||
131079807|NCT02684123|471926228|FG000|Phase 1|Adverse Event|3|||
131079808|NCT02684123|471926229|FG001|Phase 1|Adverse Event|0|||
131079809|NCT02684123|471926228|FG000|Phase 1|Lost to Follow-up|0|||
131079810|NCT02684123|471926229|FG001|Phase 1|Lost to Follow-up|1|||
131079811|NCT02684123|471926228|FG000|Phase 2|Lack of Efficacy|1|||
131079812|NCT02684123|471926229|FG001|Phase 2|Lack of Efficacy|8|||
131079813|NCT00516139|471926230|FG000|Overall Study|Adverse Event|27|||
131079814|NCT00516139|471926230|FG000|Overall Study|Lost to Follow-up|1|||
131079815|NCT00516139|471926230|FG000|Overall Study|Protocol Violation|1|||
131079816|NCT00516139|471926230|FG000|Overall Study|Withdrawal by Subject|8|||
131079817|NCT00516139|471926230|FG000|Overall Study|Lack of Efficacy|1|||
131079818|NCT00416598|471926233|FG000|Induction & Intensification|Adverse Event|38|||
131079819|NCT00416598|471926233|FG000|Induction & Intensification|Death|32|||
131079820|NCT00416598|471926233|FG000|Induction & Intensification|Withdrawal by Subject|46|||
131079821|NCT00416598|471926233|FG000|Induction & Intensification|Alternative Treatment|135|||
131079822|NCT00416598|471926233|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
131079823|NCT00416598|471926233|FG000|Induction & Intensification|Relapse/progression|29|||
131079824|NCT00416598|471926233|FG000|Induction & Intensification|Failed induction|87|||
131079825|NCT00416598|471926233|FG000|Decitabine Maintenance|Adverse Event|5|||
131079826|NCT00416598|471926233|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
131079827|NCT00416598|471926233|FG000|Decitabine Maintenance|Progression/relapse|38|||
131079828|NCT00416598|471926233|FG000|Decitabine Maintenance|Alternative treatment|2|||
131079829|NCT00416598|471926233|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
131079830|NCT04367480|471926234|FG000|Overall Study|Adverse Event|1|||
131079831|NCT04367480|471926235|FG001|Overall Study|Adverse Event|1|||
131079832|NCT04367480|471926234|FG000|Overall Study|Death|1|||
131079833|NCT04367480|471926235|FG001|Overall Study|Death|0|||
131079834|NCT04367480|471926234|FG000|Overall Study|Lost to Follow-up|1|||
131079835|NCT04367480|471926235|FG001|Overall Study|Lost to Follow-up|1|||
131079836|NCT04367480|471926234|FG000|Overall Study|Withdrawal by Subject|0|||
131079837|NCT04367480|471926235|FG001|Overall Study|Withdrawal by Subject|3|||
131079838|NCT04367480|471926234|FG000|Overall Study|App glitch during the study|1|||
131079839|NCT04367480|471926235|FG001|Overall Study|App glitch during the study|0|||
131079840|NCT04367480|471926234|FG000|Overall Study|Device Distribution Error|0|||
131079841|NCT04367480|471926235|FG001|Overall Study|Device Distribution Error|2|||
131079842|NCT04367480|471926234|FG000|Overall Study|Ineligible after Randomization|0|||
131079843|NCT04367480|471926235|FG001|Overall Study|Ineligible after Randomization|1|||
131079844|NCT04367480|471926234|FG000|Overall Study|Other Medical Reasons|0|||
131079845|NCT04367480|471926235|FG001|Overall Study|Other Medical Reasons|2|||
131079846|NCT04120376|471926237|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
131079847|NCT04120376|471926238|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
131079848|NCT02641587|471926239|FG000|Confinement Period|Adverse Event|1|||
131079849|NCT02641587|471926240|FG001|Confinement Period|Adverse Event|0|||
131079850|NCT02641587|471926239|FG000|Confinement Period|Withdrawal by Subject|2|||
131079851|NCT02641587|471926240|FG001|Confinement Period|Withdrawal by Subject|1|||
131079852|NCT02641587|471926239|FG000|Ambulatory Period|Withdrawal by Subject|1|||
131079853|NCT02641587|471926240|FG001|Ambulatory Period|Withdrawal by Subject|0|||
131079854|NCT01165177|471926241|FG000|Overall Study|Serious Adverse Event|227|||
131079855|NCT01165177|471926242|FG001|Overall Study|Serious Adverse Event|235|||
131079856|NCT01165177|471926241|FG000|Overall Study|Withdrawal by Subject|368|||
131079857|NCT01165177|471926242|FG001|Overall Study|Withdrawal by Subject|354|||
131079858|NCT01165177|471926241|FG000|Overall Study|Protocol Violation|19|||
131079859|NCT01165177|471926242|FG001|Overall Study|Protocol Violation|21|||
131079860|NCT01165177|471926241|FG000|Overall Study|Non-serious adverse event|30|||
131079861|NCT01165177|471926242|FG001|Overall Study|Non-serious adverse event|18|||
131079862|NCT01165177|471926241|FG000|Overall Study|Other unspecified reasons|47|||
131079863|NCT01165177|471926242|FG001|Overall Study|Other unspecified reasons|35|||
131079864|NCT01165177|471926241|FG000|Overall Study|Suspected HZ episode|0|||
131079865|NCT01165177|471926242|FG001|Overall Study|Suspected HZ episode|2|||
131079866|NCT01165177|471926241|FG000|Overall Study|Lost to Follow-up|183|||
131079867|NCT01165177|471926242|FG001|Overall Study|Lost to Follow-up|194|||
131079868|NCT01165177|471926241|FG000|Overall Study|Migrated/ moved from study area|48|||
131079869|NCT01165177|471926242|FG001|Overall Study|Migrated/ moved from study area|43|||
131079870|NCT00634842|471926244|FG000|Overall Study|Adverse Event|2|||
131079871|NCT00634842|471926245|FG001|Overall Study|Adverse Event|3|||
131079872|NCT00634842|471926244|FG000|Overall Study|Protocol Violation|8|||
131079873|NCT00634842|471926245|FG001|Overall Study|Protocol Violation|4|||
131079874|NCT00634842|471926244|FG000|Overall Study|Move to another state|1|||
131079875|NCT00634842|471926245|FG001|Overall Study|Move to another state|0|||
131079876|NCT00634842|471926244|FG000|Overall Study|Inclusion criteria were not met|1|||
131079877|NCT00634842|471926245|FG001|Overall Study|Inclusion criteria were not met|0|||
131079878|NCT00634842|471926244|FG000|Overall Study|Lost to Follow-up|1|||
131079879|NCT00634842|471926245|FG001|Overall Study|Lost to Follow-up|2|||
131079880|NCT00634842|471926244|FG000|Overall Study|Physician Decision|1|||
130727053|NCT02883049|470625429|FG005|Induction|Moved to another non-COG institution|0|||
130727054|NCT02883049|470625430|FG006|Induction|Moved to another non-COG institution|0|||
130727055|NCT02883049|470625431|FG007|Induction|Moved to another non-COG institution|0|||
130727056|NCT02883049|470625432|FG008|Induction|Moved to another non-COG institution|0|||
130727057|NCT02883049|470625433|FG009|Induction|Moved to another non-COG institution|0|||
131232213|NCT00384033|472476597|FG001|Overall Study|Lost to Follow-up|12|||
131232214|NCT00384033|472476598|FG002|Overall Study|Lost to Follow-up|7|||
130727058|NCT02883049|470625434|FG010|Induction|Moved to another non-COG institution|0|||
130727059|NCT02883049|470625435|FG011|Induction|Moved to another non-COG institution|0|||
130727060|NCT02883049|470625436|FG012|Induction|Moved to another non-COG institution|0|||
130727061|NCT02883049|470625437|FG013|Induction|Moved to another non-COG institution|0|||
130727062|NCT02883049|470625438|FG014|Induction|Moved to another non-COG institution|0|||
130727063|NCT02883049|470625439|FG015|Induction|Moved to another non-COG institution|0|||
130727064|NCT02883049|470625424|FG000|Induction|Randomization closed|41|||
130727065|NCT02883049|470625425|FG001|Induction|Randomization closed|0|||
130727066|NCT02883049|470625426|FG002|Induction|Randomization closed|0|||
130727067|NCT02883049|470625427|FG003|Induction|Randomization closed|0|||
130727068|NCT02883049|470625428|FG004|Induction|Randomization closed|0|||
130727069|NCT02883049|470625429|FG005|Induction|Randomization closed|0|||
130727070|NCT02883049|470625430|FG006|Induction|Randomization closed|0|||
130727071|NCT02883049|470625431|FG007|Induction|Randomization closed|0|||
130727072|NCT02883049|470625432|FG008|Induction|Randomization closed|0|||
130727073|NCT02883049|470625433|FG009|Induction|Randomization closed|0|||
130727074|NCT02883049|470625434|FG010|Induction|Randomization closed|0|||
130727075|NCT02883049|470625435|FG011|Induction|Randomization closed|0|||
130727076|NCT02883049|470625436|FG012|Induction|Randomization closed|0|||
130727077|NCT02883049|470625437|FG013|Induction|Randomization closed|0|||
130727078|NCT02883049|470625438|FG014|Induction|Randomization closed|0|||
130727079|NCT02883049|470625439|FG015|Induction|Randomization closed|0|||
130727080|NCT02883049|470625424|FG000|Induction|MRD negative|36|||
130727081|NCT02883049|470625425|FG001|Induction|MRD negative|0|||
130727082|NCT02883049|470625426|FG002|Induction|MRD negative|0|||
130727083|NCT02883049|470625427|FG003|Induction|MRD negative|0|||
130727084|NCT02883049|470625428|FG004|Induction|MRD negative|0|||
130727085|NCT02883049|470625429|FG005|Induction|MRD negative|0|||
130727086|NCT02883049|470625430|FG006|Induction|MRD negative|0|||
130727087|NCT02883049|470625431|FG007|Induction|MRD negative|0|||
130727088|NCT02883049|470625432|FG008|Induction|MRD negative|0|||
130727089|NCT02883049|470625433|FG009|Induction|MRD negative|0|||
130727090|NCT02883049|470625434|FG010|Induction|MRD negative|0|||
130727091|NCT02883049|470625435|FG011|Induction|MRD negative|0|||
130727092|NCT02883049|470625436|FG012|Induction|MRD negative|0|||
130727093|NCT02883049|470625437|FG013|Induction|MRD negative|0|||
130727094|NCT02883049|470625438|FG014|Induction|MRD negative|0|||
130727095|NCT02883049|470625439|FG015|Induction|MRD negative|0|||
130727096|NCT02883049|470625424|FG000|Induction|Identified as HR patients|165|||
130727097|NCT02883049|470625425|FG001|Induction|Identified as HR patients|0|||
130727098|NCT02883049|470625426|FG002|Induction|Identified as HR patients|0|||
130727099|NCT02883049|470625427|FG003|Induction|Identified as HR patients|0|||
130727100|NCT02883049|470625428|FG004|Induction|Identified as HR patients|0|||
130727101|NCT02883049|470625429|FG005|Induction|Identified as HR patients|0|||
130727102|NCT02883049|470625430|FG006|Induction|Identified as HR patients|0|||
130727103|NCT02883049|470625431|FG007|Induction|Identified as HR patients|0|||
130727104|NCT02883049|470625432|FG008|Induction|Identified as HR patients|0|||
130727105|NCT02883049|470625433|FG009|Induction|Identified as HR patients|0|||
130727106|NCT02883049|470625434|FG010|Induction|Identified as HR patients|0|||
130727107|NCT02883049|470625435|FG011|Induction|Identified as HR patients|0|||
130727108|NCT02883049|470625436|FG012|Induction|Identified as HR patients|0|||
130727109|NCT02883049|470625437|FG013|Induction|Identified as HR patients|0|||
130727110|NCT02883049|470625438|FG014|Induction|Identified as HR patients|0|||
130727111|NCT02883049|470625439|FG015|Induction|Identified as HR patients|0|||
130727112|NCT02883049|470625424|FG000|Induction|Developed SMN|0|||
131232215|NCT00384033|472476599|FG003|Overall Study|Lost to Follow-up|7|||
131232216|NCT00384033|472476596|FG000|Overall Study|Other|2|||
131232217|NCT00384033|472476597|FG001|Overall Study|Other|0|||
131232218|NCT00384033|472476598|FG002|Overall Study|Other|0|||
131232219|NCT00384033|472476599|FG003|Overall Study|Other|0|||
131232220|NCT00384033|472476596|FG000|Overall Study|Protocol Violation|5|||
131232221|NCT00384033|472476597|FG001|Overall Study|Protocol Violation|0|||
131232222|NCT00384033|472476598|FG002|Overall Study|Protocol Violation|5|||
131232223|NCT00384033|472476599|FG003|Overall Study|Protocol Violation|6|||
131232224|NCT00384033|472476596|FG000|Overall Study|Withdrawal by Subject|6|||
131232225|NCT00384033|472476597|FG001|Overall Study|Withdrawal by Subject|2|||
131232226|NCT00384033|472476598|FG002|Overall Study|Withdrawal by Subject|5|||
131232227|NCT00384033|472476599|FG003|Overall Study|Withdrawal by Subject|2|||
130727113|NCT02883049|470625425|FG001|Induction|Developed SMN|1|||
130727114|NCT02883049|470625426|FG002|Induction|Developed SMN|0|||
130727115|NCT02883049|470625427|FG003|Induction|Developed SMN|0|||
130727116|NCT02883049|470625428|FG004|Induction|Developed SMN|0|||
130727117|NCT02883049|470625429|FG005|Induction|Developed SMN|0|||
130727118|NCT02883049|470625430|FG006|Induction|Developed SMN|0|||
130727119|NCT02883049|470625431|FG007|Induction|Developed SMN|0|||
130727120|NCT02883049|470625432|FG008|Induction|Developed SMN|0|||
130727121|NCT02883049|470625433|FG009|Induction|Developed SMN|0|||
130727122|NCT02883049|470625434|FG010|Induction|Developed SMN|0|||
130727123|NCT02883049|470625435|FG011|Induction|Developed SMN|0|||
131079881|NCT00634842|471926245|FG001|Overall Study|Physician Decision|0|||
131079882|NCT00634842|471926244|FG000|Overall Study|Withdrawal by Subject|1|||
131079883|NCT00634842|471926245|FG001|Overall Study|Withdrawal by Subject|3|||
131079884|NCT00634842|471926244|FG000|Overall Study|Lack of time and intolerance to drug|0|||
131079885|NCT00634842|471926245|FG001|Overall Study|Lack of time and intolerance to drug|1|||
131079886|NCT00634842|471926244|FG000|Overall Study|Discontinued due to injection|0|||
131079887|NCT00634842|471926245|FG001|Overall Study|Discontinued due to injection|2|||
131079888|NCT00634842|471926244|FG000|Overall Study|No need of study drug to treat diabetes|0|||
131079889|NCT00634842|471926245|FG001|Overall Study|No need of study drug to treat diabetes|1|||
131079890|NCT00634842|471926244|FG000|Overall Study|No wish to keep taking Avandia|0|||
131079891|NCT00634842|471926245|FG001|Overall Study|No wish to keep taking Avandia|1|||
131079892|NCT00634842|471926244|FG000|Overall Study|Subject off study drug for too long|0|||
131079893|NCT00634842|471926245|FG001|Overall Study|Subject off study drug for too long|1|||
131079894|NCT00810342|471926248|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
131079895|NCT00810342|471926249|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
131079896|NCT00810342|471926248|FG000|Month 1 Follow-up|Pregnancy|1|||
131079897|NCT00810342|471926249|FG001|Month 1 Follow-up|Pregnancy|0|||
131079898|NCT00810342|471926248|FG000|6-month Follow-up|Lost to Follow-up|18|||
131079899|NCT00810342|471926249|FG001|6-month Follow-up|Lost to Follow-up|6|||
131079900|NCT00810342|471926248|FG000|6-month Follow-up|Pregnancy|6|||
131079901|NCT00810342|471926249|FG001|6-month Follow-up|Pregnancy|2|||
131079902|NCT00810342|471926248|FG000|12-month Followup|Pregnancy|9|||
131079903|NCT00810342|471926249|FG001|12-month Followup|Pregnancy|10|||
131079904|NCT00810342|471926248|FG000|12-month Followup|Lost to Follow-up|3|||
131079905|NCT00810342|471926249|FG001|12-month Followup|Lost to Follow-up|1|||
131079906|NCT04504630|471926251|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
131079907|NCT04504630|471926252|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
131079908|NCT04504630|471926251|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
131079909|NCT04504630|471926252|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
131079910|NCT00943787|471926273|FG000|Overall Study|Physician Decision|4|||
131079911|NCT00943787|471926273|FG000|Overall Study|Withdrawal by Subject|3|||
131079912|NCT01216072|471926274|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
131079913|NCT01216072|471926275|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
131079914|NCT01216072|471926274|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
131079915|NCT01216072|471926275|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
131140329|NCT00666926|472140100|FG006|Overall Study|Lack of Efficacy|0|||
131140330|NCT00666926|472140101|FG007|Overall Study|Lack of Efficacy|0|||
131140331|NCT00666926|472140102|FG008|Overall Study|Lack of Efficacy|0|||
131140332|NCT00666926|472140103|FG009|Overall Study|Lack of Efficacy|0|||
131140333|NCT00666926|472140104|FG010|Overall Study|Lack of Efficacy|0|||
131140334|NCT00666926|472140105|FG011|Overall Study|Lack of Efficacy|1|||
131140335|NCT00666926|472140106|FG012|Overall Study|Lack of Efficacy|0|||
131140336|NCT00666926|472140107|FG013|Overall Study|Lack of Efficacy|0|||
131140337|NCT00666926|472140108|FG014|Overall Study|Lack of Efficacy|0|||
131140338|NCT00666926|472140109|FG015|Overall Study|Lack of Efficacy|0|||
131140339|NCT00666926|472140094|FG000|Overall Study|Lost to Follow-up|0|||
131140340|NCT00666926|472140095|FG001|Overall Study|Lost to Follow-up|0|||
131140341|NCT00666926|472140096|FG002|Overall Study|Lost to Follow-up|0|||
131140342|NCT00666926|472140097|FG003|Overall Study|Lost to Follow-up|1|||
131140343|NCT00666926|472140098|FG004|Overall Study|Lost to Follow-up|0|||
131140344|NCT00666926|472140099|FG005|Overall Study|Lost to Follow-up|0|||
131140345|NCT00666926|472140100|FG006|Overall Study|Lost to Follow-up|0|||
131140346|NCT00666926|472140101|FG007|Overall Study|Lost to Follow-up|0|||
131140347|NCT00666926|472140102|FG008|Overall Study|Lost to Follow-up|0|||
131140348|NCT00666926|472140103|FG009|Overall Study|Lost to Follow-up|0|||
131140349|NCT00666926|472140104|FG010|Overall Study|Lost to Follow-up|0|||
131140350|NCT00666926|472140105|FG011|Overall Study|Lost to Follow-up|0|||
131140351|NCT00666926|472140106|FG012|Overall Study|Lost to Follow-up|0|||
131140352|NCT00666926|472140107|FG013|Overall Study|Lost to Follow-up|0|||
131140353|NCT00666926|472140108|FG014|Overall Study|Lost to Follow-up|0|||
131140354|NCT00666926|472140109|FG015|Overall Study|Lost to Follow-up|0|||
131140355|NCT00666926|472140094|FG000|Overall Study|Other|2|||
131140356|NCT00666926|472140095|FG001|Overall Study|Other|4|||
131140357|NCT00666926|472140096|FG002|Overall Study|Other|3|||
131140358|NCT00666926|472140097|FG003|Overall Study|Other|3|||
131140359|NCT00666926|472140098|FG004|Overall Study|Other|3|||
131140360|NCT00666926|472140099|FG005|Overall Study|Other|3|||
131140361|NCT00666926|472140100|FG006|Overall Study|Other|4|||
131140362|NCT00666926|472140101|FG007|Overall Study|Other|0|||
131140363|NCT00666926|472140102|FG008|Overall Study|Other|3|||
131140364|NCT00666926|472140103|FG009|Overall Study|Other|5|||
131232228|NCT00384033|472476596|FG000|Overall Study|Lack of Efficacy|7|||
131232229|NCT00384033|472476597|FG001|Overall Study|Lack of Efficacy|3|||
131232230|NCT00384033|472476598|FG002|Overall Study|Lack of Efficacy|3|||
131232231|NCT00384033|472476599|FG003|Overall Study|Lack of Efficacy|1|||
131232232|NCT00384033|472476596|FG000|Overall Study|Randomized but not treated|3|||
131232233|NCT00384033|472476597|FG001|Overall Study|Randomized but not treated|7|||
131232234|NCT00384033|472476598|FG002|Overall Study|Randomized but not treated|10|||
131232235|NCT00384033|472476599|FG003|Overall Study|Randomized but not treated|2|||
131232236|NCT01006707|472476600|FG000|Study Session 1|Lost to Follow-up|2|||
131232237|NCT01006707|472476601|FG001|Study Session 1|Lost to Follow-up|0|||
131232238|NCT01006707|472476602|FG002|Study Session 1|Lost to Follow-up|0|||
131232239|NCT01006707|472476600|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
131232240|NCT01006707|472476601|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
131232241|NCT01006707|472476602|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
131232242|NCT00290745|472476603|FG000|Overall Study|Withdrawal by Subject|4|||
131232243|NCT00290745|472476603|FG000|Overall Study|Physician Decision|2|||
131232244|NCT00290745|472476603|FG000|Overall Study|Surgery after 3 months for progression|3|||
131232245|NCT00290745|472476603|FG000|Overall Study|Baseline MRI not available|3|||
131232246|NCT02750306|472476604|FG000|Overall Study|Withdrawal by Subject|5|||
131232247|NCT02750306|472476605|FG001|Overall Study|Withdrawal by Subject|2|||
131232248|NCT02750306|472476604|FG000|Overall Study|Protocol Violation|1|||
131232249|NCT02750306|472476605|FG001|Overall Study|Protocol Violation|0|||
131232250|NCT02737306|472476606|FG000|Overall Study|Adverse Event|3|||
131232251|NCT02737306|472476607|FG001|Overall Study|Adverse Event|0|||
131232252|NCT02737306|472476606|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
131232253|NCT02737306|472476607|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
131232254|NCT03361423|472476608|FG000|Overall Study|Withdrawal by Subject|4|||
131232255|NCT03361423|472476609|FG001|Overall Study|Withdrawal by Subject|3|||
131232256|NCT03361423|472476608|FG000|Overall Study|Did not treat|19|||
131232257|NCT03361423|472476609|FG001|Overall Study|Did not treat|18|||
131232258|NCT03361423|472476608|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
131232259|NCT03361423|472476609|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
131232260|NCT03361423|472476608|FG000|Overall Study|Missing data|4|||
131232261|NCT03361423|472476609|FG001|Overall Study|Missing data|1|||
131232262|NCT01336894|472476610|FG000|Follow-up|Study terminated prematurely|2|||
131232263|NCT01336894|472476611|FG001|Follow-up|Study terminated prematurely|7|||
131232264|NCT05034731|472476612|FG000|Overall Study|Screen fail|1|||
131232265|NCT05034731|472476613|FG001|Overall Study|Screen fail|1|||
131232266|NCT00283686|472476615|FG000|Overall Study|Death|1|||
131232267|NCT00283686|472476616|FG001|Overall Study|Death|1|||
131232268|NCT00283686|472476617|FG002|Overall Study|Death|1|||
131232269|NCT00283686|472476618|FG003|Overall Study|Death|0|||
131232270|NCT00283686|472476615|FG000|Overall Study|Lost to Follow-up|21|||
131232271|NCT00283686|472476616|FG001|Overall Study|Lost to Follow-up|31|||
131232272|NCT00283686|472476617|FG002|Overall Study|Lost to Follow-up|26|||
131232273|NCT00283686|472476618|FG003|Overall Study|Lost to Follow-up|20|||
131232274|NCT00283686|472476615|FG000|Overall Study|Less than full participation|7|||
131232275|NCT00283686|472476616|FG001|Overall Study|Less than full participation|9|||
131232276|NCT00283686|472476617|FG002|Overall Study|Less than full participation|6|||
131232277|NCT00283686|472476618|FG003|Overall Study|Less than full participation|12|||
131232278|NCT02970669|472476619|FG000|Double-blind Period|Adverse Event|4|||
131232279|NCT02970669|472476620|FG001|Double-blind Period|Adverse Event|0|||
131232280|NCT02970669|472476619|FG000|Double-blind Period|Death|1|||
131232281|NCT02970669|472476620|FG001|Double-blind Period|Death|0|||
131232282|NCT02970669|472476619|FG000|Double-blind Period|Study terminated by sponsor|1|||
131232283|NCT02970669|472476620|FG001|Double-blind Period|Study terminated by sponsor|2|||
131232284|NCT02970669|472476619|FG000|Double-blind Period|Physician Decision|0|||
131232285|NCT02970669|472476620|FG001|Double-blind Period|Physician Decision|2|||
131232286|NCT02970669|472476619|FG000|Double-blind Period|Withdrawal by Subject|2|||
131232287|NCT02970669|472476620|FG001|Double-blind Period|Withdrawal by Subject|2|||
131232288|NCT02970669|472476619|FG000|Open-label Period|Withdrawal by Subject|2|||
131232289|NCT02970669|472476620|FG001|Open-label Period|Withdrawal by Subject|2|||
131232290|NCT02970669|472476619|FG000|Open-label Period|Adverse Event|1|||
131232291|NCT02970669|472476620|FG001|Open-label Period|Adverse Event|0|||
131232292|NCT02970669|472476619|FG000|Open-label Period|Physician Decision|1|||
131232293|NCT02970669|472476620|FG001|Open-label Period|Physician Decision|0|||
131232294|NCT03521999|472476621|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
131232295|NCT03521999|472476622|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
131232296|NCT03521999|472476621|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
131232297|NCT03521999|472476622|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
131232298|NCT03521999|472476621|FG000|Completed 3 Month Follow up|Death|0|||
131232299|NCT03521999|472476622|FG001|Completed 3 Month Follow up|Death|1|||
131232300|NCT03521999|472476621|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
131232301|NCT03521999|472476622|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
131232302|NCT00467584|472476627|FG000|Overall Study|Withdrawal by Subject|4|||
131232303|NCT00467584|472476628|FG001|Overall Study|Withdrawal by Subject|5|||
131232304|NCT00467584|472476629|FG002|Overall Study|Withdrawal by Subject|1|||
131232305|NCT01498484|472476633|FG000|Overall Study|Death|6|||
131232306|NCT01498484|472476634|FG001|Overall Study|Death|3|||
131232307|NCT01498484|472476635|FG002|Overall Study|Death|1|||
131232308|NCT01498484|472476636|FG003|Overall Study|Death|1|||
131232309|NCT01498484|472476637|FG004|Overall Study|Death|0|||
131232310|NCT01498484|472476638|FG005|Overall Study|Death|0|||
131232311|NCT01498484|472476639|FG006|Overall Study|Death|10|||
131232312|NCT01498484|472476640|FG007|Overall Study|Death|1|||
131232313|NCT01498484|472476641|FG008|Overall Study|Death|0|||
131232314|NCT01498484|472476633|FG000|Overall Study|Physician Decision|3|||
131232315|NCT01498484|472476634|FG001|Overall Study|Physician Decision|2|||
131232316|NCT01498484|472476635|FG002|Overall Study|Physician Decision|1|||
131232317|NCT01498484|472476636|FG003|Overall Study|Physician Decision|1|||
131232318|NCT01498484|472476637|FG004|Overall Study|Physician Decision|0|||
131232319|NCT01498484|472476638|FG005|Overall Study|Physician Decision|0|||
131232320|NCT01498484|472476639|FG006|Overall Study|Physician Decision|8|||
131232321|NCT01498484|472476640|FG007|Overall Study|Physician Decision|13|||
131232322|NCT01498484|472476641|FG008|Overall Study|Physician Decision|1|||
131232323|NCT01498484|472476633|FG000|Overall Study|Adverse Event|0|||
131232324|NCT01498484|472476634|FG001|Overall Study|Adverse Event|0|||
131232325|NCT01498484|472476635|FG002|Overall Study|Adverse Event|0|||
131232326|NCT01498484|472476636|FG003|Overall Study|Adverse Event|0|||
131232327|NCT01498484|472476637|FG004|Overall Study|Adverse Event|0|||
131232328|NCT01498484|472476638|FG005|Overall Study|Adverse Event|1|||
131232329|NCT01498484|472476639|FG006|Overall Study|Adverse Event|0|||
131232330|NCT01498484|472476640|FG007|Overall Study|Adverse Event|0|||
131232331|NCT01498484|472476641|FG008|Overall Study|Adverse Event|0|||
131232332|NCT01498484|472476633|FG000|Overall Study|Withdrawal by Subject|0|||
131232333|NCT01498484|472476634|FG001|Overall Study|Withdrawal by Subject|0|||
131232334|NCT01498484|472476635|FG002|Overall Study|Withdrawal by Subject|0|||
131232335|NCT01498484|472476636|FG003|Overall Study|Withdrawal by Subject|1|||
131232336|NCT01498484|472476637|FG004|Overall Study|Withdrawal by Subject|0|||
131232337|NCT01498484|472476638|FG005|Overall Study|Withdrawal by Subject|0|||
131232338|NCT01498484|472476639|FG006|Overall Study|Withdrawal by Subject|1|||
131232339|NCT01498484|472476640|FG007|Overall Study|Withdrawal by Subject|0|||
131232340|NCT01498484|472476641|FG008|Overall Study|Withdrawal by Subject|0|||
131232341|NCT01498484|472476633|FG000|Overall Study|Other|5|||
131232342|NCT01498484|472476634|FG001|Overall Study|Other|2|||
131232343|NCT01498484|472476635|FG002|Overall Study|Other|0|||
131232344|NCT01498484|472476636|FG003|Overall Study|Other|0|||
131232345|NCT01498484|472476637|FG004|Overall Study|Other|1|||
131232346|NCT01498484|472476638|FG005|Overall Study|Other|0|||
131232347|NCT01498484|472476639|FG006|Overall Study|Other|3|||
131232348|NCT01498484|472476640|FG007|Overall Study|Other|0|||
131232349|NCT01498484|472476641|FG008|Overall Study|Other|1|||
131232350|NCT00319956|472476642|FG000|Overall Study|Death|20|||
131232351|NCT00319956|472476643|FG001|Overall Study|Death|24|||
131232352|NCT00753714|472476645|FG000|Overall Study|Lack of Efficacy|21|||
131232353|NCT00753714|472476646|FG001|Overall Study|Lack of Efficacy|34|||
131232354|NCT00753714|472476645|FG000|Overall Study|Adverse Event|26|||
131232355|NCT00753714|472476646|FG001|Overall Study|Adverse Event|18|||
131232356|NCT00753714|472476645|FG000|Overall Study|Protocol Violation|1|||
131232357|NCT00753714|472476646|FG001|Overall Study|Protocol Violation|0|||
131232358|NCT00753714|472476645|FG000|Overall Study|Lost to Follow-up|0|||
131232359|NCT00753714|472476646|FG001|Overall Study|Lost to Follow-up|1|||
131232360|NCT00753714|472476645|FG000|Overall Study|Withdrawal by Subject|2|||
131232361|NCT00753714|472476646|FG001|Overall Study|Withdrawal by Subject|1|||
131232362|NCT00753714|472476645|FG000|Overall Study|Death|3|||
131232363|NCT00753714|472476646|FG001|Overall Study|Death|3|||
131232364|NCT00753714|472476645|FG000|Overall Study|Other|7|||
131232365|NCT00753714|472476646|FG001|Overall Study|Other|5|||
131232366|NCT02607800|472476647|FG000|Overall Study|Lost to Follow-up|7|||
131232367|NCT02607800|472476648|FG001|Overall Study|Lost to Follow-up|10|||
131232368|NCT02607800|472476647|FG000|Overall Study|Withdrew Consent|2|||
131232369|NCT02607800|472476648|FG001|Overall Study|Withdrew Consent|0|||
131232370|NCT02607800|472476647|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
131232371|NCT02607800|472476648|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
131232372|NCT02486796|472476649|FG000|Overall Study|Withdrawal by Subject|1|||
131232373|NCT02486796|472476650|FG001|Overall Study|Withdrawal by Subject|1|||
131232374|NCT02486796|472476649|FG000|Overall Study|Physician Decision|1|||
131232375|NCT02486796|472476650|FG001|Overall Study|Physician Decision|0|||
131232376|NCT01185288|472476651|FG000|Overall Study|Adverse Event|7|||
131232377|NCT01185288|472476652|FG001|Overall Study|Adverse Event|6|||
131232378|NCT01185288|472476651|FG000|Overall Study|Withdrawal by Subject|6|||
131232379|NCT01185288|472476652|FG001|Overall Study|Withdrawal by Subject|4|||
131232380|NCT01185288|472476651|FG000|Overall Study|Lost to Follow-up|2|||
131232381|NCT01185288|472476652|FG001|Overall Study|Lost to Follow-up|5|||
131232382|NCT01185288|472476651|FG000|Overall Study|Lack of Efficacy|2|||
131232383|NCT01185288|472476652|FG001|Overall Study|Lack of Efficacy|0|||
131232384|NCT01185288|472476651|FG000|Overall Study|Investigator discretion|1|||
131079916|NCT01216072|471926274|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
131079917|NCT01216072|471926275|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
131079918|NCT01216072|471926274|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
131079919|NCT01216072|471926275|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
131079920|NCT01216072|471926274|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
131079921|NCT01216072|471926275|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
131079922|NCT01216072|471926274|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
131079923|NCT01216072|471926275|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
131079924|NCT01216072|471926274|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
131079925|NCT01216072|471926275|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
131079926|NCT01216072|471926274|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
131079927|NCT01216072|471926275|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
131079928|NCT01216072|471926274|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
131079929|NCT01216072|471926275|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
131079930|NCT01216072|471926274|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
131079931|NCT01216072|471926275|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
131140365|NCT00666926|472140104|FG010|Overall Study|Other|3|||
131140366|NCT00666926|472140105|FG011|Overall Study|Other|26|||
131140367|NCT00666926|472140106|FG012|Overall Study|Other|3|||
131140368|NCT00666926|472140107|FG013|Overall Study|Other|2|||
131140369|NCT00666926|472140108|FG014|Overall Study|Other|4|||
131140370|NCT00666926|472140109|FG015|Overall Study|Other|4|||
131140371|NCT00666926|472140094|FG000|Overall Study|Withdrawal by Subject|0|||
131140372|NCT00666926|472140095|FG001|Overall Study|Withdrawal by Subject|0|||
131140373|NCT00666926|472140096|FG002|Overall Study|Withdrawal by Subject|0|||
131140374|NCT00666926|472140097|FG003|Overall Study|Withdrawal by Subject|0|||
131140375|NCT00666926|472140098|FG004|Overall Study|Withdrawal by Subject|0|||
131140376|NCT00666926|472140099|FG005|Overall Study|Withdrawal by Subject|0|||
131140377|NCT00666926|472140100|FG006|Overall Study|Withdrawal by Subject|0|||
131140378|NCT00666926|472140101|FG007|Overall Study|Withdrawal by Subject|1|||
131140379|NCT00666926|472140102|FG008|Overall Study|Withdrawal by Subject|0|||
131140380|NCT00666926|472140103|FG009|Overall Study|Withdrawal by Subject|3|||
131140381|NCT00666926|472140104|FG010|Overall Study|Withdrawal by Subject|0|||
131140382|NCT00666926|472140105|FG011|Overall Study|Withdrawal by Subject|3|||
131140383|NCT00666926|472140106|FG012|Overall Study|Withdrawal by Subject|0|||
131140384|NCT00666926|472140107|FG013|Overall Study|Withdrawal by Subject|1|||
131140385|NCT00666926|472140108|FG014|Overall Study|Withdrawal by Subject|3|||
131140386|NCT00666926|472140109|FG015|Overall Study|Withdrawal by Subject|3|||
131140387|NCT00666926|472140094|FG000|Overall Study|Death|0|||
131140388|NCT00666926|472140095|FG001|Overall Study|Death|0|||
131140389|NCT00666926|472140096|FG002|Overall Study|Death|0|||
131140390|NCT00666926|472140097|FG003|Overall Study|Death|0|||
131140391|NCT00666926|472140098|FG004|Overall Study|Death|0|||
131140392|NCT00666926|472140099|FG005|Overall Study|Death|0|||
131140393|NCT00666926|472140100|FG006|Overall Study|Death|0|||
131140394|NCT00666926|472140101|FG007|Overall Study|Death|0|||
131140395|NCT00666926|472140102|FG008|Overall Study|Death|0|||
131140396|NCT00666926|472140103|FG009|Overall Study|Death|0|||
131140397|NCT00666926|472140104|FG010|Overall Study|Death|0|||
131140398|NCT00666926|472140105|FG011|Overall Study|Death|1|||
131140399|NCT00666926|472140106|FG012|Overall Study|Death|0|||
131140400|NCT00666926|472140107|FG013|Overall Study|Death|0|||
131140401|NCT00666926|472140108|FG014|Overall Study|Death|0|||
131140402|NCT00666926|472140109|FG015|Overall Study|Death|0|||
131140403|NCT02883244|472140110|FG000|Overall Study|Lost to Follow-up|0|||
131140404|NCT02883244|472140111|FG001|Overall Study|Lost to Follow-up|1|||
131140405|NCT00880256|472140112|FG000|Overall Study|Lost to Follow-up|28|||
131140406|NCT04871711|472140113|FG000|Overall Study|Withdrawal by Subject|11|||
131140407|NCT04871711|472140114|FG001|Overall Study|Withdrawal by Subject|5|||
131140408|NCT04871711|472140113|FG000|Overall Study|Lack of Efficacy|5|||
131140409|NCT04871711|472140114|FG001|Overall Study|Lack of Efficacy|7|||
131140410|NCT04871711|472140113|FG000|Overall Study|Adverse Event|2|||
131140411|NCT04871711|472140114|FG001|Overall Study|Adverse Event|6|||
131140412|NCT04871711|472140113|FG000|Overall Study|Various reasons|2|||
131140413|NCT04871711|472140114|FG001|Overall Study|Various reasons|1|||
131140414|NCT04871711|472140113|FG000|Overall Study|Lost to Follow-up|0|||
131140415|NCT04871711|472140114|FG001|Overall Study|Lost to Follow-up|2|||
131140416|NCT01469000|472140115|FG000|Overall Study|Withdrawal by Subject|16|||
131140417|NCT01469000|472140116|FG001|Overall Study|Withdrawal by Subject|3|||
131232385|NCT01185288|472476652|FG001|Overall Study|Investigator discretion|0|||
131232386|NCT01185288|472476651|FG000|Overall Study|Did not meet inclusion criteria|1|||
131140418|NCT01469000|472140115|FG000|Overall Study|Sponsor Decision|4|||
131140419|NCT01469000|472140116|FG001|Overall Study|Sponsor Decision|1|||
131140420|NCT02183519|472140123|FG000|Overall Study|computer error|3|||
131140421|NCT02183519|472140124|FG001|Overall Study|computer error|0|||
131140422|NCT02183519|472140123|FG000|Overall Study|Did not respond to cough inducter|0|||
131232387|NCT01185288|472476652|FG001|Overall Study|Did not meet inclusion criteria|0|||
131232388|NCT01185288|472476651|FG000|Overall Study|Noncompliance|0|||
131232389|NCT01185288|472476652|FG001|Overall Study|Noncompliance|1|||
131232390|NCT00278512|472476653|FG000|Overall Study|Death|1|||
131232391|NCT00278512|472476654|FG001|Overall Study|Death|0|||
131232392|NCT01202747|472476655|FG000|Overall Study|Withdrawal by Subject|1|||
131232393|NCT01620177|472476656|FG000|Overall Study|Failure at Screening Visit|43|||
131232394|NCT01620177|472476656|FG000|Overall Study|Withdrawal by Subject|26|||
131232395|NCT01620177|472476656|FG000|Overall Study|Lost to Follow-up|7|||
131232396|NCT01620177|472476656|FG000|Overall Study|Physician Decision|2|||
131232397|NCT01620177|472476656|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
131232398|NCT02292238|472476660|FG000|Overall Study|Protocol Violation|1|||
131232399|NCT02292238|472476661|FG001|Overall Study|Protocol Violation|2|||
131232400|NCT02292238|472476660|FG000|Overall Study|Withdrawal by Subject|2|||
131232401|NCT02292238|472476661|FG001|Overall Study|Withdrawal by Subject|1|||
131232402|NCT02292238|472476660|FG000|Overall Study|Lost to Follow-up|1|||
131232403|NCT02292238|472476661|FG001|Overall Study|Lost to Follow-up|0|||
131232404|NCT02292238|472476660|FG000|Overall Study|Physician Decision|0|||
131232405|NCT02292238|472476661|FG001|Overall Study|Physician Decision|1|||
131232406|NCT01789320|472476662|FG000|Overall Study|Re-enrolled into study|1|||
131232407|NCT01789320|472476662|FG000|Overall Study|Lost to Follow-up|1|||
131232408|NCT01626885|472476669|FG000|Overall Study|Adverse Event|8|||
131232409|NCT01626885|472476669|FG000|Overall Study|Withdrawal by Subject|4|||
131232410|NCT01533428|472476672|FG000|Overall Study|Adverse Event|0|||
131232411|NCT01533428|472476673|FG001|Overall Study|Adverse Event|1|||
131232412|NCT01533428|472476672|FG000|Overall Study|Lost to Follow-up|2|||
131232413|NCT01533428|472476673|FG001|Overall Study|Lost to Follow-up|1|||
131232414|NCT01533428|472476672|FG000|Overall Study|Withdrawal by Subject|7|||
131232415|NCT01533428|472476673|FG001|Overall Study|Withdrawal by Subject|6|||
131232416|NCT01364870|472476674|FG000|Overall Study|Withdrawal by Subject|13|||
131232417|NCT01364870|472476675|FG001|Overall Study|Withdrawal by Subject|24|||
131232418|NCT01364870|472476676|FG002|Overall Study|Withdrawal by Subject|10|||
131232419|NCT01364870|472476674|FG000|Overall Study|Adverse Event|8|||
131232420|NCT01364870|472476675|FG001|Overall Study|Adverse Event|6|||
131232421|NCT01364870|472476676|FG002|Overall Study|Adverse Event|4|||
131232422|NCT01364870|472476674|FG000|Overall Study|Protocol Violation|1|||
131232423|NCT01364870|472476675|FG001|Overall Study|Protocol Violation|0|||
131232424|NCT01364870|472476676|FG002|Overall Study|Protocol Violation|0|||
131232425|NCT02666430|472476677|FG000|Period 1|Lost to Follow-up|1|||
131232426|NCT02666430|472476678|FG001|Period 1|Lost to Follow-up|0|||
131232427|NCT02666430|472476677|FG000|Period 1|Adverse Event|0|||
131232428|NCT02666430|472476678|FG001|Period 1|Adverse Event|1|||
131232429|NCT02666430|472476677|FG000|Period 2|Withdrawal by Subject|1|||
131232430|NCT02666430|472476678|FG001|Period 2|Withdrawal by Subject|4|||
130780222|NCT01719380|470821450|FG003|Overall Study|Physician Decision|0|||
130780223|NCT01719380|470821451|FG004|Overall Study|Physician Decision|0|||
131079932|NCT01777490|471926276|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
131079933|NCT01777490|471926277|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
131079934|NCT01777490|471926278|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
131079935|NCT01777490|471926279|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
131079936|NCT02818998|471926282|FG000|Overall Study|Adverse Event|3|||
131079937|NCT02818998|471926283|FG001|Overall Study|Adverse Event|2|||
131079938|NCT02818998|471926284|FG002|Overall Study|Adverse Event|1|||
131079939|NCT02818998|471926282|FG000|Overall Study|Lost to Follow-up|4|||
131079940|NCT02818998|471926283|FG001|Overall Study|Lost to Follow-up|1|||
131079941|NCT02818998|471926284|FG002|Overall Study|Lost to Follow-up|2|||
131079942|NCT02818998|471926282|FG000|Overall Study|Withdrawal by sponsor|0|||
131079943|NCT02818998|471926283|FG001|Overall Study|Withdrawal by sponsor|1|||
131079944|NCT02818998|471926284|FG002|Overall Study|Withdrawal by sponsor|1|||
131079945|NCT02818998|471926282|FG000|Overall Study|Death|3|||
131079946|NCT02818998|471926283|FG001|Overall Study|Death|6|||
131232431|NCT02666430|472476677|FG000|Period 3|Lost to Follow-up|1|||
131232432|NCT02666430|472476678|FG001|Period 3|Lost to Follow-up|0|||
131232433|NCT03828461|472476679|FG000|Overall Study|Lost to Follow-up|1|||
131232434|NCT03828461|472476679|FG000|Overall Study|Withdrawal by Subject|3|||
131232435|NCT00576199|472476680|FG000|Overall Study|Adverse Event|12|||
131232436|NCT00576199|472476680|FG000|Overall Study|Insufficient Therapeutic Response|14|||
131232437|NCT00576199|472476680|FG000|Overall Study|Refused Treatment|2|||
131232438|NCT00576199|472476680|FG000|Overall Study|Reason Unspecified|2|||
131232439|NCT04317053|472476682|FG000|Overall Study|Withdrawn (screen failure)|4|||
131232440|NCT04317053|472476683|FG001|Overall Study|Withdrawn (screen failure)|2|||
131232441|NCT01628120|472478340|FG000|Overall Study|Withdrawal by Subject|7|||
131232442|NCT01628120|472478340|FG000|Overall Study|Adverse Event|12|||
130780224|NCT01719380|470821452|FG005|Overall Study|Physician Decision|0|||
131232443|NCT01628120|472478340|FG000|Overall Study|Lost to Follow-up|1|||
131232444|NCT01628120|472478340|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
131232445|NCT01628120|472478340|FG000|Overall Study|Non-compliant with Study Procedures|1|||
131232446|NCT01628120|472478340|FG000|Overall Study|Not Treated|3|||
131232447|NCT01628120|472478340|FG000|Overall Study|Sponsor Decision|5|||
131232448|NCT01628120|472478340|FG000|Overall Study|Switched Dialysis Method|2|||
131232449|NCT01628120|472478340|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
131232450|NCT01628120|472478340|FG000|Overall Study|Moved or Relocated|5|||
131232451|NCT01628120|472478340|FG000|Overall Study|Kidney Transplant|2|||
131232452|NCT01628120|472478340|FG000|Overall Study|Use of Standard of Care|1|||
131232453|NCT01075763|472478345|FG000|Overall Study|Lost to Follow-up|2|||
131232454|NCT01075763|472478346|FG001|Overall Study|Lost to Follow-up|1|||
131232455|NCT01075763|472478345|FG000|Overall Study|Lack of Efficacy|0|||
131232456|NCT01075763|472478346|FG001|Overall Study|Lack of Efficacy|1|||
131232457|NCT01075763|472478345|FG000|Overall Study|Withdrawal by Subject|2|||
131232458|NCT01075763|472478346|FG001|Overall Study|Withdrawal by Subject|2|||
131232459|NCT00586521|472478347|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
131232460|NCT03731182|472478354|FG000|Overall Study|Lost to Follow-up|2|||
131232461|NCT03731182|472478355|FG001|Overall Study|Lost to Follow-up|0|||
131232462|NCT03731182|472478354|FG000|Overall Study|Physician Decision|1|||
131232463|NCT03731182|472478355|FG001|Overall Study|Physician Decision|0|||
131232464|NCT03731182|472478354|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
131232465|NCT03731182|472478355|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
131232466|NCT00582036|472478356|FG000|Overall Study|Withdrawal by Subject|0|||
131232467|NCT00582036|472478357|FG001|Overall Study|Withdrawal by Subject|1|||
131232468|NCT04161144|472478358|FG000|Overall Study|Withdrawal by Subject|0|||
131232469|NCT04161144|472478359|FG001|Overall Study|Withdrawal by Subject|1|||
131232470|NCT04161144|472478358|FG000|Overall Study|Protocol Violation|1|||
131232471|NCT04161144|472478359|FG001|Overall Study|Protocol Violation|0|||
131232472|NCT02207621|472478362|FG000|Overall Study|Adverse Event|71|||
131232473|NCT02207621|472478363|FG001|Overall Study|Adverse Event|15|||
131232474|NCT02207621|472478364|FG002|Overall Study|Adverse Event|132|||
131232475|NCT02207621|472478362|FG000|Overall Study|Withdrawal by Subject|9|||
131079947|NCT02818998|471926284|FG002|Overall Study|Death|8|||
131079948|NCT02818998|471926282|FG000|Overall Study|Withdrawal by Subject|7|||
131079949|NCT02818998|471926283|FG001|Overall Study|Withdrawal by Subject|6|||
131079950|NCT02818998|471926284|FG002|Overall Study|Withdrawal by Subject|6|||
131079951|NCT02818998|471926282|FG000|Overall Study|Physician Decision|1|||
131079952|NCT02818998|471926283|FG001|Overall Study|Physician Decision|0|||
131079953|NCT02818998|471926284|FG002|Overall Study|Physician Decision|0|||
131079954|NCT00632021|471926288|FG000|Overall Study|Withdrawal/death|4|||
131079955|NCT00632021|471926289|FG001|Overall Study|Withdrawal/death|7|||
131079956|NCT00952848|471926292|FG000|Overall Study|Withdrawal by Subject|4|||
131079957|NCT00857233|471926295|FG000|Overall Study|Adverse Event|24|||
131079958|NCT00857233|471926295|FG000|Overall Study|Lack of Efficacy|1|||
131079959|NCT00857233|471926295|FG000|Overall Study|Non-compliance|1|||
131079960|NCT00857233|471926295|FG000|Overall Study|Withdrawal of Consent|9|||
131079961|NCT00857233|471926295|FG000|Overall Study|Lost to Follow-up|4|||
131079962|NCT00857233|471926295|FG000|Overall Study|Nursing Home Placement|14|||
131079963|NCT00857233|471926295|FG000|Overall Study|Other Reasons|2|||
131079964|NCT05043883|471926296|FG000|Overall Study|Minimum required measurements could not be taken|4|||
131079965|NCT01587118|471926297|FG000|Overall Study|Adverse Event|3|||
131079966|NCT01587118|471926297|FG000|Overall Study|Lost to Follow-up|2|||
131079967|NCT01587118|471926297|FG000|Overall Study|Relocation|1|||
131079968|NCT01587118|471926297|FG000|Overall Study|nonresponse|1|||
131079969|NCT00537329|471926298|FG000|Overall Study|Death|10|||
131079970|NCT00537329|471926298|FG000|Overall Study|Adverse Event|3|||
131079971|NCT00537329|471926298|FG000|Overall Study|Lack of Efficacy|2|||
131079972|NCT00537329|471926298|FG000|Overall Study|Lost to Follow-up|6|||
131079973|NCT00537329|471926298|FG000|Overall Study|Withdrawal by Subject|4|||
131079974|NCT00537329|471926298|FG000|Overall Study|Other|1|||
131079975|NCT02287233|471926299|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
131079976|NCT02287233|471926300|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
131079977|NCT02287233|471926301|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
131079978|NCT02287233|471926299|FG000|Overall Study|Adverse Event Related to Progression|0|||
131079979|NCT02287233|471926300|FG001|Overall Study|Adverse Event Related to Progression|2|||
131079980|NCT02287233|471926301|FG002|Overall Study|Adverse Event Related to Progression|8|||
131079981|NCT02287233|471926299|FG000|Overall Study|Physician Decision|1|||
131079982|NCT02287233|471926300|FG001|Overall Study|Physician Decision|2|||
131079983|NCT02287233|471926301|FG002|Overall Study|Physician Decision|4|||
131079984|NCT02287233|471926299|FG000|Overall Study|Progressive Disease with Death|0|||
131079985|NCT02287233|471926300|FG001|Overall Study|Progressive Disease with Death|0|||
131079986|NCT02287233|471926301|FG002|Overall Study|Progressive Disease with Death|10|||
131079987|NCT02287233|471926299|FG000|Overall Study|Progressive Disease Without Death|2|||
131079988|NCT02287233|471926300|FG001|Overall Study|Progressive Disease Without Death|3|||
131079989|NCT02287233|471926301|FG002|Overall Study|Progressive Disease Without Death|20|||
131232476|NCT02207621|472478363|FG001|Overall Study|Withdrawal by Subject|9|||
130727124|NCT02883049|470625436|FG012|Induction|Developed SMN|0|||
131079990|NCT02287233|471926299|FG000|Overall Study|Withdrawal by Subject|1|||
131079991|NCT02287233|471926300|FG001|Overall Study|Withdrawal by Subject|1|||
131232477|NCT02207621|472478364|FG002|Overall Study|Withdrawal by Subject|13|||
131232478|NCT02207621|472478362|FG000|Overall Study|Non-Compliant|3|||
131232479|NCT02207621|472478363|FG001|Overall Study|Non-Compliant|3|||
131232480|NCT02207621|472478364|FG002|Overall Study|Non-Compliant|1|||
131232481|NCT02207621|472478362|FG000|Overall Study|Lost to Follow-up|1|||
131232482|NCT02207621|472478363|FG001|Overall Study|Lost to Follow-up|0|||
131232483|NCT02207621|472478364|FG002|Overall Study|Lost to Follow-up|3|||
131232484|NCT02207621|472478362|FG000|Overall Study|Lack of Efficacy|10|||
131232485|NCT02207621|472478363|FG001|Overall Study|Lack of Efficacy|2|||
131232486|NCT02207621|472478364|FG002|Overall Study|Lack of Efficacy|4|||
131232487|NCT02207621|472478362|FG000|Overall Study|Disallowed Concurrent Medication|2|||
130727125|NCT02883049|470625437|FG013|Induction|Developed SMN|0|||
130727126|NCT02883049|470625438|FG014|Induction|Developed SMN|0|||
130727127|NCT02883049|470625439|FG015|Induction|Developed SMN|0|||
131079992|NCT02287233|471926301|FG002|Overall Study|Withdrawal by Subject|7|||
131079993|NCT02287233|471926299|FG000|Overall Study|Other|3|||
131079994|NCT02287233|471926300|FG001|Overall Study|Other|0|||
131079995|NCT02287233|471926301|FG002|Overall Study|Other|15|||
131079996|NCT02287233|471926299|FG000|Overall Study|Did Not Receive Treatment|0|||
131079997|NCT02287233|471926300|FG001|Overall Study|Did Not Receive Treatment|0|||
131079998|NCT02287233|471926301|FG002|Overall Study|Did Not Receive Treatment|2|||
131079999|NCT00085566|471926302|FG000|Overall Study|Adverse Event|0|||
131080000|NCT00085566|471926303|FG001|Overall Study|Adverse Event|0|||
131080001|NCT00085566|471926304|FG002|Overall Study|Adverse Event|10|||
131080002|NCT00085566|471926302|FG000|Overall Study|Patient Not treated|0|||
131080003|NCT00085566|471926303|FG001|Overall Study|Patient Not treated|0|||
131080004|NCT00085566|471926304|FG002|Overall Study|Patient Not treated|3|||
131080005|NCT00085566|471926302|FG000|Overall Study|Clinical progression|0|||
131080006|NCT00085566|471926303|FG001|Overall Study|Clinical progression|0|||
131080007|NCT00085566|471926304|FG002|Overall Study|Clinical progression|1|||
131080008|NCT03174782|471926305|FG000|Overall Study|Protocol Violation|1|||
131080009|NCT03174782|471926306|FG001|Overall Study|Protocol Violation|0|||
131080010|NCT03174782|471926305|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
131080011|NCT03174782|471926306|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
131080012|NCT03178045|471926307|FG000|Overall Study|Withdrawal by Subject|5|||
131080013|NCT03178045|471926308|FG001|Overall Study|Withdrawal by Subject|7|||
131080014|NCT03178045|471926307|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
131080015|NCT03178045|471926308|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
131080016|NCT03178045|471926307|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
131080017|NCT03178045|471926308|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
131080018|NCT03432390|471926311|FG000|Apnea Period|Protocol Violation|2|||
131080019|NCT03432390|471926312|FG001|Apnea Period|Protocol Violation|2|||
131080020|NCT02058836|471926314|FG000|Overall Study|Withdrawal by Subject|1|||
131080021|NCT02058836|471926315|FG001|Overall Study|Withdrawal by Subject|1|||
131080022|NCT00267098|471926316|FG000|Overall Study|Death|0|||
131080023|NCT00267098|471926317|FG001|Overall Study|Death|0|||
131080024|NCT00267098|471926318|FG002|Overall Study|Death|57|||
131080025|NCT00267098|471926319|FG003|Overall Study|Death|66|||
131080026|NCT00267098|471926320|FG004|Overall Study|Death|14|||
131080027|NCT00267098|471926321|FG005|Overall Study|Death|23|||
131080028|NCT00267098|471926322|FG006|Overall Study|Death|28|||
131080029|NCT00267098|471926323|FG007|Overall Study|Death|9|||
131140423|NCT02183519|472140124|FG001|Overall Study|Did not respond to cough inducter|3|||
131140424|NCT00695565|472140125|FG000|Overall Study|Lost to Follow-up|4|||
131140425|NCT00695565|472140126|FG001|Overall Study|Lost to Follow-up|4|||
131140426|NCT00695565|472140125|FG000|Overall Study|Adverse Event|3|||
131140427|NCT00695565|472140126|FG001|Overall Study|Adverse Event|1|||
131140428|NCT00695565|472140125|FG000|Overall Study|Protocol Violation|3|||
131140429|NCT00695565|472140126|FG001|Overall Study|Protocol Violation|1|||
131140430|NCT00695565|472140125|FG000|Overall Study|Withdrawal by Subject|1|||
131140431|NCT00695565|472140126|FG001|Overall Study|Withdrawal by Subject|1|||
131140432|NCT00695565|472140125|FG000|Overall Study|Lack of Efficacy|1|||
131140433|NCT00695565|472140126|FG001|Overall Study|Lack of Efficacy|1|||
131140434|NCT00695565|472140125|FG000|Overall Study|Subject did not follow instructions|1|||
131140435|NCT00695565|472140126|FG001|Overall Study|Subject did not follow instructions|1|||
131140436|NCT01462266|472140127|FG000|Overall Study|Adverse Event|7|||
131140437|NCT01462266|472140128|FG001|Overall Study|Adverse Event|6|||
131080030|NCT00267098|471926316|FG000|Overall Study|Lost to Follow-up|0|||
131080031|NCT00267098|471926317|FG001|Overall Study|Lost to Follow-up|0|||
131080032|NCT00267098|471926318|FG002|Overall Study|Lost to Follow-up|6|||
131080033|NCT00267098|471926319|FG003|Overall Study|Lost to Follow-up|5|||
131080034|NCT00267098|471926320|FG004|Overall Study|Lost to Follow-up|2|||
131080035|NCT00267098|471926321|FG005|Overall Study|Lost to Follow-up|3|||
131080036|NCT00267098|471926322|FG006|Overall Study|Lost to Follow-up|1|||
131080037|NCT00267098|471926323|FG007|Overall Study|Lost to Follow-up|1|||
131080038|NCT00267098|471926316|FG000|Overall Study|Withdrawal by Subject|8|||
131140438|NCT01462266|472140127|FG000|Overall Study|Death|2|||
131140439|NCT01462266|472140128|FG001|Overall Study|Death|1|||
131232488|NCT02207621|472478363|FG001|Overall Study|Disallowed Concurrent Medication|5|||
131232489|NCT02207621|472478364|FG002|Overall Study|Disallowed Concurrent Medication|2|||
130727128|NCT02883049|470625424|FG000|Induction|Enrolled onto another COG study|72|||
130727129|NCT02883049|470625425|FG001|Induction|Enrolled onto another COG study|0|||
130727130|NCT02883049|470625426|FG002|Induction|Enrolled onto another COG study|0|||
130727131|NCT02883049|470625427|FG003|Induction|Enrolled onto another COG study|0|||
130727132|NCT02883049|470625428|FG004|Induction|Enrolled onto another COG study|0|||
130727133|NCT02883049|470625429|FG005|Induction|Enrolled onto another COG study|0|||
130727134|NCT02883049|470625430|FG006|Induction|Enrolled onto another COG study|0|||
130727135|NCT02883049|470625431|FG007|Induction|Enrolled onto another COG study|0|||
130727136|NCT02883049|470625432|FG008|Induction|Enrolled onto another COG study|0|||
130727137|NCT02883049|470625433|FG009|Induction|Enrolled onto another COG study|0|||
130727138|NCT02883049|470625434|FG010|Induction|Enrolled onto another COG study|0|||
130727139|NCT02883049|470625435|FG011|Induction|Enrolled onto another COG study|0|||
131080039|NCT00267098|471926317|FG001|Overall Study|Withdrawal by Subject|0|||
131080040|NCT00267098|471926318|FG002|Overall Study|Withdrawal by Subject|24|||
131080041|NCT00267098|471926319|FG003|Overall Study|Withdrawal by Subject|21|||
131080042|NCT00267098|471926320|FG004|Overall Study|Withdrawal by Subject|12|||
131080043|NCT00267098|471926321|FG005|Overall Study|Withdrawal by Subject|9|||
131080044|NCT00267098|471926322|FG006|Overall Study|Withdrawal by Subject|12|||
131080045|NCT00267098|471926323|FG007|Overall Study|Withdrawal by Subject|5|||
131080046|NCT00267098|471926316|FG000|Overall Study|Physician Decision|5|||
131080047|NCT00267098|471926317|FG001|Overall Study|Physician Decision|0|||
131080048|NCT00267098|471926318|FG002|Overall Study|Physician Decision|7|||
131080049|NCT00267098|471926319|FG003|Overall Study|Physician Decision|11|||
131080050|NCT00267098|471926320|FG004|Overall Study|Physician Decision|5|||
131080051|NCT00267098|471926321|FG005|Overall Study|Physician Decision|4|||
131080052|NCT00267098|471926322|FG006|Overall Study|Physician Decision|3|||
131080053|NCT00267098|471926323|FG007|Overall Study|Physician Decision|0|||
131080054|NCT00267098|471926316|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
131080055|NCT00267098|471926317|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131080056|NCT00267098|471926318|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131080057|NCT00267098|471926319|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131080058|NCT00267098|471926320|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
131080059|NCT00267098|471926321|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131080060|NCT00267098|471926322|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131080061|NCT00267098|471926323|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131080062|NCT00267098|471926316|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131080063|NCT00267098|471926317|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
131080064|NCT00267098|471926318|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131080065|NCT00267098|471926319|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131080066|NCT00267098|471926320|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131080067|NCT00267098|471926321|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131080068|NCT00267098|471926322|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131080069|NCT00267098|471926323|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
131080070|NCT00267098|471926316|FG000|Overall Study|Site closure|0|||
131080071|NCT00267098|471926317|FG001|Overall Study|Site closure|0|||
131140440|NCT01462266|472140127|FG000|Overall Study|Lack of Efficacy|0|||
131140441|NCT01462266|472140128|FG001|Overall Study|Lack of Efficacy|2|||
131140442|NCT01462266|472140127|FG000|Overall Study|Lost to Follow-up|4|||
131140443|NCT01462266|472140128|FG001|Overall Study|Lost to Follow-up|3|||
131140444|NCT01462266|472140127|FG000|Overall Study|Non-compliance with study drug|3|||
131140445|NCT01462266|472140128|FG001|Overall Study|Non-compliance with study drug|0|||
131140446|NCT01462266|472140127|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
131140447|NCT01462266|472140128|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
131140448|NCT01462266|472140127|FG000|Overall Study|Physician Decision|2|||
131140449|NCT01462266|472140128|FG001|Overall Study|Physician Decision|5|||
131140450|NCT01462266|472140127|FG000|Overall Study|Protocol Violation|1|||
131140451|NCT01462266|472140128|FG001|Overall Study|Protocol Violation|3|||
131140452|NCT01462266|472140127|FG000|Overall Study|Withdrawal by Subject|7|||
131140453|NCT01462266|472140128|FG001|Overall Study|Withdrawal by Subject|2|||
131140454|NCT01462266|472140127|FG000|Overall Study|Screen failure|1|||
131140455|NCT01462266|472140128|FG001|Overall Study|Screen failure|1|||
131140456|NCT01106846|472140129|FG000|Overall Study|Change in surgical procedure|0|||
131140457|NCT01106846|472140130|FG001|Overall Study|Change in surgical procedure|1|||
131140458|NCT02419508|472140141|FG000|Overall Study|Adverse Event|9|||
131140459|NCT02419508|472140142|FG001|Overall Study|Adverse Event|3|||
131140460|NCT02419508|472140141|FG000|Overall Study|Withdrawal by Subject|1|||
131140461|NCT02419508|472140142|FG001|Overall Study|Withdrawal by Subject|0|||
131140462|NCT02419508|472140141|FG000|Overall Study|Other - Reason not specified|0|||
131140463|NCT02419508|472140142|FG001|Overall Study|Other - Reason not specified|1|||
131140464|NCT03110900|472140143|FG000|Overall Study|Sponsor withdrew|1|||
131140465|NCT03110900|472140144|FG001|Overall Study|Sponsor withdrew|1|||
131080072|NCT00267098|471926318|FG002|Overall Study|Site closure|0|||
131140466|NCT03344003|472140149|FG000|Overall Study|Switched to alternative treatment|1|||
131140467|NCT03344003|472140150|FG001|Overall Study|Switched to alternative treatment|0|||
131232490|NCT02207621|472478362|FG000|Overall Study|Physician Decision|1|||
131232491|NCT02207621|472478363|FG001|Overall Study|Physician Decision|2|||
131232492|NCT02207621|472478364|FG002|Overall Study|Physician Decision|2|||
131232493|NCT02207621|472478362|FG000|Overall Study|Protocol Violation|4|||
131232494|NCT02207621|472478363|FG001|Overall Study|Protocol Violation|10|||
131232495|NCT02207621|472478364|FG002|Overall Study|Protocol Violation|6|||
131232496|NCT02207621|472478362|FG000|Overall Study|Death|2|||
131232497|NCT02207621|472478363|FG001|Overall Study|Death|0|||
131232498|NCT02207621|472478364|FG002|Overall Study|Death|0|||
131232499|NCT02207621|472478362|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
131232500|NCT02207621|472478363|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
131232501|NCT02207621|472478364|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
131232502|NCT01090765|472478367|FG000|Overall Study|Patient withdrew consent|0|||
131232503|NCT01090765|472478368|FG001|Overall Study|Patient withdrew consent|0|||
130727140|NCT02883049|470625436|FG012|Induction|Enrolled onto another COG study|0|||
131080073|NCT00267098|471926319|FG003|Overall Study|Site closure|1|||
131080074|NCT00267098|471926320|FG004|Overall Study|Site closure|0|||
131080075|NCT00267098|471926321|FG005|Overall Study|Site closure|1|||
131080076|NCT00267098|471926322|FG006|Overall Study|Site closure|1|||
131080077|NCT00267098|471926323|FG007|Overall Study|Site closure|0|||
131080078|NCT00267098|471926316|FG000|Overall Study|Explanted Medtronic device|0|||
131080079|NCT00267098|471926317|FG001|Overall Study|Explanted Medtronic device|0|||
131080080|NCT00267098|471926318|FG002|Overall Study|Explanted Medtronic device|0|||
131080081|NCT00267098|471926319|FG003|Overall Study|Explanted Medtronic device|1|||
131080082|NCT00267098|471926320|FG004|Overall Study|Explanted Medtronic device|0|||
131080083|NCT00267098|471926321|FG005|Overall Study|Explanted Medtronic device|0|||
131080084|NCT00267098|471926322|FG006|Overall Study|Explanted Medtronic device|0|||
131080085|NCT00267098|471926323|FG007|Overall Study|Explanted Medtronic device|0|||
131080086|NCT00267098|471926316|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131080087|NCT00267098|471926317|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131080088|NCT00267098|471926318|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131080089|NCT00267098|471926319|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131080090|NCT00267098|471926320|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
131080091|NCT00267098|471926321|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131080092|NCT00267098|471926322|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131080093|NCT00267098|471926323|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
131080094|NCT00267098|471926316|FG000|Overall Study|Subject listed for heart transplant|0|||
131080095|NCT00267098|471926317|FG001|Overall Study|Subject listed for heart transplant|0|||
131080096|NCT00267098|471926318|FG002|Overall Study|Subject listed for heart transplant|0|||
131080097|NCT00267098|471926319|FG003|Overall Study|Subject listed for heart transplant|0|||
131080098|NCT00267098|471926320|FG004|Overall Study|Subject listed for heart transplant|0|||
131080099|NCT00267098|471926321|FG005|Overall Study|Subject listed for heart transplant|0|||
131080100|NCT00267098|471926322|FG006|Overall Study|Subject listed for heart transplant|1|||
131080101|NCT00267098|471926323|FG007|Overall Study|Subject listed for heart transplant|0|||
131080102|NCT00267098|471926316|FG000|Overall Study|Sponsor withdrew subject|0|||
131080103|NCT00267098|471926317|FG001|Overall Study|Sponsor withdrew subject|0|||
131080104|NCT00267098|471926318|FG002|Overall Study|Sponsor withdrew subject|0|||
131080105|NCT00267098|471926319|FG003|Overall Study|Sponsor withdrew subject|1|||
131080106|NCT00267098|471926320|FG004|Overall Study|Sponsor withdrew subject|0|||
131080107|NCT00267098|471926321|FG005|Overall Study|Sponsor withdrew subject|0|||
131080108|NCT00267098|471926322|FG006|Overall Study|Sponsor withdrew subject|0|||
131080109|NCT00267098|471926323|FG007|Overall Study|Sponsor withdrew subject|0|||
131080110|NCT00547534|471926329|FG000|Overall Study|Adverse Event|7|||
131080111|NCT00547534|471926329|FG000|Overall Study|Disease Progression|4|||
131080112|NCT02689453|471926333|FG000|Overall Study|Progressive disease|0|||
131080113|NCT02689453|471926334|FG001|Overall Study|Progressive disease|1|||
131080114|NCT02689453|471926335|FG002|Overall Study|Progressive disease|1|||
131080115|NCT02688530|471926336|FG000|Overall Study|Withdrawal by Subject|0|||
131080116|NCT02688530|471926337|FG001|Overall Study|Withdrawal by Subject|1|||
131080117|NCT02688530|471926338|FG002|Overall Study|Withdrawal by Subject|0|||
131080118|NCT02688530|471926339|FG003|Overall Study|Withdrawal by Subject|0|||
130727141|NCT02883049|470625437|FG013|Induction|Enrolled onto another COG study|0|||
130727142|NCT02883049|470625438|FG014|Induction|Enrolled onto another COG study|0|||
131080119|NCT02688530|471926336|FG000|Overall Study|Lost to Follow-up|0|||
131080120|NCT02688530|471926337|FG001|Overall Study|Lost to Follow-up|0|||
131080121|NCT02688530|471926338|FG002|Overall Study|Lost to Follow-up|2|||
131080122|NCT02688530|471926339|FG003|Overall Study|Lost to Follow-up|0|||
131080123|NCT01658020|471926340|FG000|Overall Study|Adverse Event|3|||
131080124|NCT01658020|471926341|FG001|Overall Study|Adverse Event|3|||
131080125|NCT01658020|471926340|FG000|Overall Study|Lost to Follow-up|1|||
131080126|NCT01658020|471926341|FG001|Overall Study|Lost to Follow-up|0|||
131080127|NCT01658020|471926340|FG000|Overall Study|Withdrawal by Subject|4|||
131080128|NCT01658020|471926341|FG001|Overall Study|Withdrawal by Subject|5|||
131232504|NCT01090765|472478369|FG002|Overall Study|Patient withdrew consent|0|||
131080129|NCT01658020|471926340|FG000|Overall Study|Protocol Violation|0|||
131080130|NCT01658020|471926341|FG001|Overall Study|Protocol Violation|1|||
131140468|NCT03344003|472140149|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
131140469|NCT03344003|472140150|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
131140470|NCT01583179|472141742|FG000|Overall Study|Screen failure|1|||
131140471|NCT01583179|472141743|FG001|Overall Study|Screen failure|2|||
131140472|NCT01613326|472141749|FG000|Overall Study|Adverse Event|7|||
131140473|NCT01613326|472141750|FG001|Overall Study|Adverse Event|5|||
131140474|NCT01613326|472141749|FG000|Overall Study|Withdrawal by Subject|3|||
131140475|NCT01613326|472141750|FG001|Overall Study|Withdrawal by Subject|4|||
131140476|NCT01613326|472141749|FG000|Overall Study|Abnormal test procedure result(s)|2|||
131140477|NCT01613326|472141750|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131140478|NCT01613326|472141749|FG000|Overall Study|inability to use device|1|||
131140479|NCT01613326|472141750|FG001|Overall Study|inability to use device|0|||
131140480|NCT01613326|472141749|FG000|Overall Study|Lack of Efficacy|0|||
131140481|NCT01613326|472141750|FG001|Overall Study|Lack of Efficacy|1|||
131140482|NCT01613326|472141749|FG000|Overall Study|Lost to Follow-up|0|||
131140483|NCT01613326|472141750|FG001|Overall Study|Lost to Follow-up|1|||
131140484|NCT01613326|472141749|FG000|Overall Study|Administrative|0|||
131140485|NCT01613326|472141750|FG001|Overall Study|Administrative|2|||
131140486|NCT01613326|472141749|FG000|Overall Study|Protocol Violation|0|||
131140487|NCT01613326|472141750|FG001|Overall Study|Protocol Violation|1|||
131140488|NCT03980938|472141751|FG000|Treatment Period 1|Study Terminated|1|||
131140489|NCT03980938|472141752|FG001|Treatment Period 1|Study Terminated|1|||
131140490|NCT03980938|472141751|FG000|Treatment Period 2|Study Terminated|2|||
131140491|NCT03980938|472141752|FG001|Treatment Period 2|Study Terminated|2|||
131140492|NCT00840827|472141753|FG000|Overall Study|Adverse Event|1|||
131140493|NCT00840827|472141753|FG000|Overall Study|Lack of Efficacy|4|||
131140494|NCT00840827|472141753|FG000|Overall Study|Physician Decision|1|||
131140495|NCT01445535|472141754|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
131140496|NCT01445535|472141755|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
131140497|NCT01445535|472141756|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
131140498|NCT01445535|472141757|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
131140499|NCT01445535|472141754|FG000|Overall Study|Disease progression|1|||
131140500|NCT01445535|472141755|FG001|Overall Study|Disease progression|0|||
131140501|NCT01445535|472141756|FG002|Overall Study|Disease progression|1|||
131140502|NCT01445535|472141757|FG003|Overall Study|Disease progression|0|||
131140503|NCT01445535|472141754|FG000|Overall Study|PI discretion|0|||
131140504|NCT01445535|472141755|FG001|Overall Study|PI discretion|0|||
131140505|NCT01445535|472141756|FG002|Overall Study|PI discretion|0|||
131140506|NCT01445535|472141757|FG003|Overall Study|PI discretion|1|||
131140507|NCT00420511|472141760|FG000|Overall Study|Adverse Event|1|||
131140508|NCT00420511|472141761|FG001|Overall Study|Adverse Event|1|||
131140509|NCT00420511|472141760|FG000|Overall Study|Lost to Follow-up|1|||
131140510|NCT00420511|472141761|FG001|Overall Study|Lost to Follow-up|0|||
131140511|NCT01337973|472141762|FG000|Overall Study|Lost to Follow-up|2|||
131140512|NCT01337973|472141763|FG001|Overall Study|Lost to Follow-up|4|||
131140513|NCT01337973|472141764|FG002|Overall Study|Lost to Follow-up|3|||
131140514|NCT01337973|472141762|FG000|Overall Study|Death|1|||
131140515|NCT01337973|472141763|FG001|Overall Study|Death|2|||
131140516|NCT01337973|472141764|FG002|Overall Study|Death|1|||
131140517|NCT01337973|472141762|FG000|Overall Study|Withdrawal by Subject|10|||
131140518|NCT01337973|472141763|FG001|Overall Study|Withdrawal by Subject|8|||
131140519|NCT01337973|472141764|FG002|Overall Study|Withdrawal by Subject|4|||
131140520|NCT01337973|472141762|FG000|Overall Study|missing data on primary outcome|3|||
131140521|NCT01337973|472141763|FG001|Overall Study|missing data on primary outcome|1|||
131140522|NCT01337973|472141764|FG002|Overall Study|missing data on primary outcome|3|||
131140523|NCT02624492|472141765|FG000|Overall Study|Adverse Event|2|||
131140524|NCT02624492|472141766|FG001|Overall Study|Adverse Event|2|||
131140525|NCT02624492|472141767|FG002|Overall Study|Adverse Event|2|||
131140526|NCT02624492|472141765|FG000|Overall Study|Progressive disease|0|||
131232505|NCT01090765|472478370|FG003|Overall Study|Patient withdrew consent|0|||
131232506|NCT01090765|472478371|FG004|Overall Study|Patient withdrew consent|1|||
131140527|NCT02624492|472141766|FG001|Overall Study|Progressive disease|2|||
131140528|NCT02624492|472141767|FG002|Overall Study|Progressive disease|3|||
131140529|NCT03555266|472141773|FG000|Overall Study|Protocol Violation|6|||
131140530|NCT03555266|472141774|FG001|Overall Study|Protocol Violation|4|||
131140531|NCT02167945|472141775|FG000|Overall Study|Adverse Event|16|||
131140532|NCT02167945|472141775|FG000|Overall Study|Withdrew Consent|42|||
131140533|NCT02167945|472141775|FG000|Overall Study|Lost to Follow-up|122|||
131140534|NCT02167945|472141775|FG000|Overall Study|COVID-19 logistical restrictions|6|||
131140535|NCT02167945|472141775|FG000|Overall Study|Other, not specified|63|||
131140536|NCT02239263|472141776|FG000|Overall Study|Protocol Violation|6|||
131140537|NCT01058096|472141778|FG000|Double-blind Treatment Phase|Adverse Event|11|||
131140538|NCT01058096|472141779|FG001|Double-blind Treatment Phase|Adverse Event|15|||
131140539|NCT01058096|472141778|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
131140540|NCT01058096|472141779|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
131140541|NCT01058096|472141778|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
131140542|NCT01058096|472141779|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
131140543|NCT01058096|472141778|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
131140544|NCT01058096|472141779|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
131140545|NCT01058096|472141778|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
131140546|NCT01058096|472141779|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
131140547|NCT01058096|472141778|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
131140548|NCT01058096|472141779|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
131140549|NCT04276207|472141780|FG000|Period 1|Withdrawal by Subject|0|||
131140550|NCT04276207|472141781|FG001|Period 1|Withdrawal by Subject|1|||
131140551|NCT02769624|472141782|FG000|Overall Study|Lost to Follow-up|0|||
131140552|NCT02769624|472141783|FG001|Overall Study|Lost to Follow-up|1|||
131140553|NCT04451330|472141784|FG000|Overall Study|Adverse Event|1|||
131140554|NCT04451330|472141785|FG001|Overall Study|Adverse Event|2|||
131140555|NCT04451330|472141784|FG000|Overall Study|Lost to Follow-up|5|||
131140556|NCT04451330|472141785|FG001|Overall Study|Lost to Follow-up|0|||
131140557|NCT04451330|472141784|FG000|Overall Study|Withdrawal by Subject|3|||
131140558|NCT04451330|472141785|FG001|Overall Study|Withdrawal by Subject|1|||
131140559|NCT04451330|472141784|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131140560|NCT04451330|472141785|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131140561|NCT04451330|472141784|FG000|Overall Study|Other than specified|0|||
131140562|NCT04451330|472141785|FG001|Overall Study|Other than specified|1|||
131140563|NCT05099640|472141786|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
131140564|NCT05099640|472141787|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
131140565|NCT05099640|472141788|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
131140566|NCT05099640|472141786|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
131140567|NCT05099640|472141787|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
131140568|NCT05099640|472141788|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
131140569|NCT05099640|472141786|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
131140570|NCT05099640|472141787|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
131140571|NCT05099640|472141788|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
131140572|NCT05099640|472141786|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
131140573|NCT05099640|472141787|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
131140574|NCT05099640|472141788|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
131140575|NCT05099640|472141786|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
131140576|NCT05099640|472141787|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
131140577|NCT05099640|472141788|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
131140578|NCT05099640|472141786|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
131140579|NCT05099640|472141787|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
131140580|NCT05099640|472141788|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
131140581|NCT00179959|472141789|FG000|Overall Study|Lost to Follow-up|3|||
131140582|NCT00179959|472141790|FG001|Overall Study|Lost to Follow-up|1|||
131140583|NCT00179959|472141789|FG000|Overall Study|Withdrawal by Subject|3|||
131140584|NCT00179959|472141790|FG001|Overall Study|Withdrawal by Subject|2|||
131140585|NCT03261531|472141791|FG000|Overall Study|Withdrawal by Subject|4|||
131140586|NCT00820755|472141792|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
131140587|NCT00820755|472141793|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
131140588|NCT00820755|472141794|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
131140589|NCT00820755|472141792|FG000|Period 1: Combination Therapy Phase|Death|28|||
131140590|NCT00820755|472141793|FG001|Period 1: Combination Therapy Phase|Death|0|||
131140591|NCT00820755|472141794|FG002|Period 1: Combination Therapy Phase|Death|0|||
131140592|NCT00820755|472141792|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
131140593|NCT00820755|472141793|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
131140594|NCT00820755|472141794|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
131140595|NCT00820755|472141792|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
131140596|NCT00820755|472141793|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
131140597|NCT00820755|472141794|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
131232507|NCT01090765|472478372|FG005|Overall Study|Patient withdrew consent|1|||
131232508|NCT01090765|472478367|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
131140598|NCT00820755|472141792|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
131140599|NCT00820755|472141793|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
131140600|NCT00820755|472141794|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
131140601|NCT00820755|472141792|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
131140602|NCT00820755|472141793|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
131140603|NCT00820755|472141794|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
131140604|NCT00820755|472141792|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
131140605|NCT00820755|472141793|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
131140606|NCT00820755|472141794|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
131140607|NCT00820755|472141792|FG000|Period 1: Combination Therapy Phase|Other|11|||
131140608|NCT00820755|472141793|FG001|Period 1: Combination Therapy Phase|Other|0|||
131080131|NCT04206085|471926342|FG000|Overall Study|Lost to Follow-up|0|||
131080132|NCT04206085|471926343|FG001|Overall Study|Lost to Follow-up|1|||
131080133|NCT04206085|471926344|FG002|Overall Study|Lost to Follow-up|0|||
131080134|NCT04206085|471926342|FG000|Overall Study|Lost to Follow-up|0|||
131080135|NCT04206085|471926343|FG001|Overall Study|Lost to Follow-up|0|||
131080136|NCT04206085|471926344|FG002|Overall Study|Lost to Follow-up|1|||
131080137|NCT00087555|471926351|FG000|Overall Study|Adverse Event|3|||
131080138|NCT00087555|471926352|FG001|Overall Study|Adverse Event|6|||
131080139|NCT00087555|471926353|FG002|Overall Study|Adverse Event|14|||
131080140|NCT00087555|471926351|FG000|Overall Study|Lost to Follow-up|0|||
131080141|NCT00087555|471926352|FG001|Overall Study|Lost to Follow-up|1|||
131080142|NCT00087555|471926353|FG002|Overall Study|Lost to Follow-up|1|||
131080143|NCT00087555|471926351|FG000|Overall Study|Non - Compliance|1|||
131080144|NCT00087555|471926352|FG001|Overall Study|Non - Compliance|0|||
131080145|NCT00087555|471926353|FG002|Overall Study|Non - Compliance|0|||
131080146|NCT00087555|471926351|FG000|Overall Study|Protocol Violation|0|||
131080147|NCT00087555|471926352|FG001|Overall Study|Protocol Violation|0|||
131080148|NCT00087555|471926353|FG002|Overall Study|Protocol Violation|2|||
131080149|NCT00087555|471926351|FG000|Overall Study|Screen Failure|1|||
131080150|NCT00087555|471926352|FG001|Overall Study|Screen Failure|1|||
131080151|NCT00087555|471926353|FG002|Overall Study|Screen Failure|0|||
131080152|NCT00087555|471926351|FG000|Overall Study|Pregnancy|0|||
131080153|NCT00087555|471926352|FG001|Overall Study|Pregnancy|1|||
131080154|NCT00087555|471926353|FG002|Overall Study|Pregnancy|1|||
131080155|NCT00087555|471926351|FG000|Overall Study|Withdrawal by Subject|3|||
131080156|NCT00087555|471926352|FG001|Overall Study|Withdrawal by Subject|2|||
131080157|NCT00087555|471926353|FG002|Overall Study|Withdrawal by Subject|1|||
131080158|NCT00087555|471926351|FG000|Overall Study|Lack of Efficacy|2|||
131080159|NCT00087555|471926352|FG001|Overall Study|Lack of Efficacy|0|||
131080160|NCT00087555|471926353|FG002|Overall Study|Lack of Efficacy|1|||
131080161|NCT00087555|471926351|FG000|Overall Study|Non Compliance|0|||
131080162|NCT00087555|471926352|FG001|Overall Study|Non Compliance|0|||
131080163|NCT00087555|471926353|FG002|Overall Study|Non Compliance|1|||
131080164|NCT00087555|471926351|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
131080165|NCT00087555|471926352|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
131080166|NCT00087555|471926353|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
131080167|NCT00087555|471926351|FG000|Overall Study|Patient wanted to go back on Med|1|||
131080168|NCT00087555|471926352|FG001|Overall Study|Patient wanted to go back on Med|0|||
131080169|NCT00087555|471926353|FG002|Overall Study|Patient wanted to go back on Med|0|||
131080170|NCT03845023|471926362|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
131080171|NCT03845023|471926363|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
131080172|NCT03845023|471926364|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
131080173|NCT03845023|471926365|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
131080174|NCT03845023|471926362|FG000|Follow-Up (14 Days)|Adverse Event|0|||
131080175|NCT03845023|471926363|FG001|Follow-Up (14 Days)|Adverse Event|0|||
131080176|NCT03845023|471926364|FG002|Follow-Up (14 Days)|Adverse Event|1|||
131140609|NCT00820755|472141794|FG002|Period 1: Combination Therapy Phase|Other|0|||
131140610|NCT00820755|472141792|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
131140611|NCT00820755|472141793|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
131140612|NCT00820755|472141794|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
131140613|NCT03604445|472141795|FG000|Overall Study|Death|0|||
131140614|NCT03604445|472141796|FG001|Overall Study|Death|0|||
131140615|NCT03604445|472141797|FG002|Overall Study|Death|0|||
131140616|NCT03604445|472141798|FG003|Overall Study|Death|0|||
131140617|NCT03604445|472141799|FG004|Overall Study|Death|0|||
131140618|NCT03604445|472141800|FG005|Overall Study|Death|0|||
131140619|NCT03604445|472141801|FG006|Overall Study|Death|0|||
131140620|NCT03604445|472141802|FG007|Overall Study|Death|0|||
131140621|NCT03604445|472141803|FG008|Overall Study|Death|1|||
131140622|NCT03604445|472141795|FG000|Overall Study|Withdrawal by Subject|0|||
131140623|NCT03604445|472141796|FG001|Overall Study|Withdrawal by Subject|0|||
131140624|NCT03604445|472141797|FG002|Overall Study|Withdrawal by Subject|0|||
131140625|NCT03604445|472141798|FG003|Overall Study|Withdrawal by Subject|0|||
131140626|NCT03604445|472141799|FG004|Overall Study|Withdrawal by Subject|0|||
131140627|NCT03604445|472141800|FG005|Overall Study|Withdrawal by Subject|0|||
131080177|NCT03845023|471926365|FG003|Follow-Up (14 Days)|Adverse Event|1|||
131080178|NCT00715117|471926366|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
131080179|NCT00715117|471926367|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
131140628|NCT03604445|472141801|FG006|Overall Study|Withdrawal by Subject|1|||
131140629|NCT03604445|472141802|FG007|Overall Study|Withdrawal by Subject|0|||
131140630|NCT03604445|472141803|FG008|Overall Study|Withdrawal by Subject|0|||
131140631|NCT03604445|472141795|FG000|Overall Study|Missing visit|0|||
131140632|NCT03604445|472141796|FG001|Overall Study|Missing visit|0|||
131140633|NCT03604445|472141797|FG002|Overall Study|Missing visit|0|||
131140634|NCT03604445|472141798|FG003|Overall Study|Missing visit|0|||
131232509|NCT01090765|472478368|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
131232510|NCT01090765|472478369|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
131232511|NCT01090765|472478370|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
131232512|NCT01090765|472478371|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
131232513|NCT01090765|472478372|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
131232514|NCT01090765|472478367|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
131232515|NCT01090765|472478368|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
131232516|NCT01090765|472478369|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
131232517|NCT01090765|472478370|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
131232518|NCT01090765|472478371|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
131232519|NCT01090765|472478372|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
131232520|NCT00421174|472478373|FG000|Overall Study|Withdrawal by Subject|0|||
131232521|NCT00421174|472478374|FG001|Overall Study|Withdrawal by Subject|1|||
131232522|NCT00421174|472478373|FG000|Overall Study|Ineligible due to infection|2|||
131232523|NCT00421174|472478374|FG001|Overall Study|Ineligible due to infection|0|||
131140635|NCT03604445|472141799|FG004|Overall Study|Missing visit|0|||
131140636|NCT03604445|472141800|FG005|Overall Study|Missing visit|1|||
131140637|NCT03604445|472141801|FG006|Overall Study|Missing visit|0|||
131140638|NCT03604445|472141802|FG007|Overall Study|Missing visit|1|||
131140639|NCT03604445|472141803|FG008|Overall Study|Missing visit|0|||
131140640|NCT03604445|472141795|FG000|Overall Study|Adverse Event|0|||
131140641|NCT03604445|472141796|FG001|Overall Study|Adverse Event|0|||
131140642|NCT03604445|472141797|FG002|Overall Study|Adverse Event|0|||
131140643|NCT03604445|472141798|FG003|Overall Study|Adverse Event|1|||
131140644|NCT03604445|472141799|FG004|Overall Study|Adverse Event|0|||
131140645|NCT03604445|472141800|FG005|Overall Study|Adverse Event|0|||
131140646|NCT03604445|472141801|FG006|Overall Study|Adverse Event|0|||
131140647|NCT03604445|472141802|FG007|Overall Study|Adverse Event|0|||
131140648|NCT03604445|472141803|FG008|Overall Study|Adverse Event|1|||
131140649|NCT01014585|472141808|FG000|Overall Study|Adverse Event|0|||
131140650|NCT01014585|472141809|FG001|Overall Study|Adverse Event|2|||
131140651|NCT01014585|472141810|FG002|Overall Study|Adverse Event|0|||
131140652|NCT01014585|472141811|FG003|Overall Study|Adverse Event|3|||
131140653|NCT01014585|472141808|FG000|Overall Study|Withdrawal by Subject|2|||
131140654|NCT01014585|472141809|FG001|Overall Study|Withdrawal by Subject|0|||
131140655|NCT01014585|472141810|FG002|Overall Study|Withdrawal by Subject|1|||
131140656|NCT01014585|472141811|FG003|Overall Study|Withdrawal by Subject|3|||
131140657|NCT01014585|472141808|FG000|Overall Study|Lost to Follow-up|0|||
131140658|NCT01014585|472141809|FG001|Overall Study|Lost to Follow-up|0|||
131140659|NCT01014585|472141810|FG002|Overall Study|Lost to Follow-up|0|||
131140660|NCT01014585|472141811|FG003|Overall Study|Lost to Follow-up|2|||
131140661|NCT01014585|472141808|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
131140662|NCT01014585|472141809|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
131140663|NCT01014585|472141810|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
131140664|NCT01014585|472141811|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
131232524|NCT02396381|472478375|FG000|Overall Study|Adverse Event|3|||
131232525|NCT02396381|472478376|FG001|Overall Study|Adverse Event|2|||
131232526|NCT02396381|472478375|FG000|Overall Study|Withdrawal by Subject|33|||
131232527|NCT02396381|472478376|FG001|Overall Study|Withdrawal by Subject|24|||
131080190|NCT03912532|471926370|FG000|Overall Study|Adverse Event|3|||
131080191|NCT03912532|471926371|FG001|Overall Study|Adverse Event|3|||
131080192|NCT03912532|471926372|FG002|Overall Study|Adverse Event|2|||
131080193|NCT03912532|471926373|FG003|Overall Study|Adverse Event|2|||
131080194|NCT03912532|471926370|FG000|Overall Study|Lost to Follow-up|3|||
131140665|NCT00773279|472141815|FG000|Period 1|Adverse Event|2|||
131140666|NCT00773279|472141816|FG001|Period 1|Adverse Event|1|||
131140667|NCT00773279|472141815|FG000|Period 1|Lack of Efficacy|0|||
131140668|NCT00773279|472141816|FG001|Period 1|Lack of Efficacy|2|||
131140669|NCT00773279|472141815|FG000|Period 1|Unclassified|5|||
131140670|NCT00773279|472141816|FG001|Period 1|Unclassified|1|||
131232528|NCT02396381|472478375|FG000|Overall Study|Lost to Follow-up|49|||
131232529|NCT02396381|472478376|FG001|Overall Study|Lost to Follow-up|31|||
131232530|NCT02396381|472478375|FG000|Overall Study|Protocol Violation|1|||
131232531|NCT02396381|472478376|FG001|Overall Study|Protocol Violation|0|||
131140671|NCT00773279|472141815|FG000|Period 2|Adverse Event|0|||
131140672|NCT00773279|472141816|FG001|Period 2|Adverse Event|1|||
131140673|NCT00773279|472141815|FG000|Period 2|Lack of Efficacy|1|||
131080195|NCT03912532|471926371|FG001|Overall Study|Lost to Follow-up|2|||
131080196|NCT03912532|471926372|FG002|Overall Study|Lost to Follow-up|1|||
131080197|NCT03912532|471926373|FG003|Overall Study|Lost to Follow-up|2|||
131140674|NCT00773279|472141816|FG001|Period 2|Lack of Efficacy|0|||
131232532|NCT02396381|472478375|FG000|Overall Study|Site terminated by sponsor|7|||
131232533|NCT02396381|472478376|FG001|Overall Study|Site terminated by sponsor|8|||
131232534|NCT02396381|472478375|FG000|Overall Study|Physician Decision|5|||
131232535|NCT02396381|472478376|FG001|Overall Study|Physician Decision|5|||
131232536|NCT02396381|472478375|FG000|Overall Study|Pregnancy|2|||
131232537|NCT02396381|472478376|FG001|Overall Study|Pregnancy|0|||
131232538|NCT02396381|472478375|FG000|Overall Study|Non-compliance with study procedures|1|||
131232539|NCT02396381|472478376|FG001|Overall Study|Non-compliance with study procedures|0|||
131232540|NCT02396381|472478375|FG000|Overall Study|Moved out of town/state|1|||
131232541|NCT02396381|472478376|FG001|Overall Study|Moved out of town/state|3|||
131232542|NCT02396381|472478375|FG000|Overall Study|Could not complete visit|1|||
131232543|NCT02396381|472478376|FG001|Overall Study|Could not complete visit|0|||
131232544|NCT02396381|472478375|FG000|Overall Study|Possible conflict of interest|1|||
131232545|NCT02396381|472478376|FG001|Overall Study|Possible conflict of interest|0|||
131232546|NCT02396381|472478375|FG000|Overall Study|Randomization/Screening Error|3|||
131232547|NCT02396381|472478376|FG001|Overall Study|Randomization/Screening Error|1|||
131232548|NCT00356200|472478378|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
131232549|NCT00356200|472478379|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
131232550|NCT00356200|472478378|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
131232551|NCT00356200|472478379|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
131232552|NCT01000337|472478383|FG000|Overall Study|Lost to Follow-up|4|||
131232553|NCT01000337|472478384|FG001|Overall Study|Lost to Follow-up|3|||
131232554|NCT02173704|472478385|FG000|Overall Study|Adverse Event|1|||
131232555|NCT02173704|472478386|FG001|Overall Study|Adverse Event|0|||
131232556|NCT02173704|472478385|FG000|Overall Study|Lost to Follow-up|1|||
131232557|NCT02173704|472478386|FG001|Overall Study|Lost to Follow-up|0|||
131232558|NCT02173704|472478385|FG000|Overall Study|Other|1|||
131232559|NCT02173704|472478386|FG001|Overall Study|Other|0|||
131080198|NCT03912532|471926370|FG000|Overall Study|Withdrawal by Subject|1|||
131080199|NCT03912532|471926371|FG001|Overall Study|Withdrawal by Subject|1|||
131080200|NCT03912532|471926372|FG002|Overall Study|Withdrawal by Subject|2|||
131080201|NCT03912532|471926373|FG003|Overall Study|Withdrawal by Subject|0|||
131080202|NCT03912532|471926370|FG000|Overall Study|Physician Decision|1|||
131080203|NCT03912532|471926371|FG001|Overall Study|Physician Decision|0|||
131080204|NCT03912532|471926372|FG002|Overall Study|Physician Decision|0|||
131080205|NCT03912532|471926373|FG003|Overall Study|Physician Decision|3|||
131080206|NCT03912532|471926370|FG000|Overall Study|Other|0|||
131080207|NCT03912532|471926371|FG001|Overall Study|Other|1|||
131080208|NCT03912532|471926372|FG002|Overall Study|Other|1|||
131080209|NCT03912532|471926373|FG003|Overall Study|Other|0|||
131080210|NCT00815919|471926377|FG000|Overall Study|Unrelated Fungal Infection|1|||
131080211|NCT00815919|471926377|FG000|Overall Study|AML Relapse|1|||
131080212|NCT00815919|471926377|FG000|Overall Study|Lack of Efficacy|2|||
131080213|NCT00826228|471928413|FG000|Overall Study|Withdrawal by Subject|1|||
131080214|NCT00307047|471928414|FG000|Overall Study|Lost to Follow-up|35|||
131232560|NCT02173704|472478385|FG000|Overall Study|Protocol Violation|1|||
131232561|NCT02173704|472478386|FG001|Overall Study|Protocol Violation|0|||
131232562|NCT02173704|472478385|FG000|Overall Study|Withdrawal by Subject|9|||
131232563|NCT02173704|472478386|FG001|Overall Study|Withdrawal by Subject|4|||
131232564|NCT00419926|472478387|FG000|Overall Study|Withdrawal by Subject|7|||
131232565|NCT00419926|472478388|FG001|Overall Study|Withdrawal by Subject|3|||
131232566|NCT00419926|472478387|FG000|Overall Study|Administrative Problem|4|||
131232567|NCT00419926|472478388|FG001|Overall Study|Administrative Problem|4|||
131232568|NCT00419926|472478387|FG000|Overall Study|Lost to Follow-up|1|||
131232569|NCT00419926|472478388|FG001|Overall Study|Lost to Follow-up|2|||
131232570|NCT00419926|472478387|FG000|Overall Study|Death|2|||
131232571|NCT00419926|472478388|FG001|Overall Study|Death|1|||
131232572|NCT03937466|472478389|FG000|Overall Study|not eligbile after the 2-week diary|9|||
131232573|NCT03937466|472478389|FG000|Overall Study|never returned their diary|6|||
131232574|NCT03937466|472478389|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
131232575|NCT03937466|472478389|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
131232576|NCT00622908|472478390|FG000|Overall Study|Protocol Violation|1|||
131232577|NCT00622908|472478391|FG001|Overall Study|Protocol Violation|0|||
131232578|NCT00622908|472478390|FG000|Overall Study|Adverse Event|0|||
131232579|NCT00622908|472478391|FG001|Overall Study|Adverse Event|1|||
131232580|NCT00622908|472478390|FG000|Overall Study|Lack of Efficacy|1|||
131232581|NCT00622908|472478391|FG001|Overall Study|Lack of Efficacy|7|||
131232582|NCT00622908|472478390|FG000|Overall Study|Lost to Follow-up|1|||
131232583|NCT00622908|472478391|FG001|Overall Study|Lost to Follow-up|0|||
131232584|NCT00622908|472478390|FG000|Overall Study|Refusal|0|||
131232585|NCT00622908|472478391|FG001|Overall Study|Refusal|1|||
131080215|NCT00307047|471928415|FG001|Overall Study|Lost to Follow-up|24|||
131080216|NCT00307047|471928414|FG000|Overall Study|Withdrawal by Subject|6|||
131080217|NCT00307047|471928415|FG001|Overall Study|Withdrawal by Subject|6|||
131080218|NCT00307047|471928414|FG000|Overall Study|Physician Decision|1|||
131080219|NCT00307047|471928415|FG001|Overall Study|Physician Decision|2|||
131232586|NCT00622908|472478390|FG000|Overall Study|Termination by study sponser|0|||
131232587|NCT00622908|472478391|FG001|Overall Study|Termination by study sponser|1|||
131080220|NCT00307047|471928414|FG000|Overall Study|Lost to follow-up for other reasons|0|||
131080221|NCT00307047|471928415|FG001|Overall Study|Lost to follow-up for other reasons|1|||
131080222|NCT00307047|471928414|FG000|Overall Study|All death, all MI, all Revascularization|27|||
131080223|NCT00307047|471928415|FG001|Overall Study|All death, all MI, all Revascularization|16|||
131080224|NCT00903760|471928416|FG000|Overall Study|Disease Progression/Death|8|||
131080225|NCT00903760|471928417|FG001|Overall Study|Disease Progression/Death|6|||
131080226|NCT00903760|471928416|FG000|Overall Study|Stem Cell Transplant|8|||
131080227|NCT00903760|471928417|FG001|Overall Study|Stem Cell Transplant|4|||
131080228|NCT00903760|471928416|FG000|Overall Study|Physician Decision|1|||
131080229|NCT00903760|471928417|FG001|Overall Study|Physician Decision|2|||
131080230|NCT00903760|471928416|FG000|Overall Study|Death|0|||
131080231|NCT00903760|471928417|FG001|Overall Study|Death|1|||
131080232|NCT00903760|471928416|FG000|Overall Study|Lost to Follow-up|1|||
131080233|NCT00903760|471928417|FG001|Overall Study|Lost to Follow-up|0|||
131080234|NCT00903760|471928416|FG000|Overall Study|Withdrawal by Subject|1|||
131080235|NCT00903760|471928417|FG001|Overall Study|Withdrawal by Subject|2|||
131080236|NCT00903760|471928416|FG000|Overall Study|Off treatment for long period|0|||
131080237|NCT00903760|471928417|FG001|Overall Study|Off treatment for long period|1|||
131080238|NCT02825251|471928419|FG000|Overall Study|Adverse Event|0|||
131080239|NCT02825251|471928420|FG001|Overall Study|Adverse Event|1|||
131080240|NCT02825251|471928419|FG000|Overall Study|Lost to Follow-up|0|||
131080241|NCT02825251|471928420|FG001|Overall Study|Lost to Follow-up|1|||
131080242|NCT02825251|471928419|FG000|Overall Study|Withdrawal by Subject|1|||
131080243|NCT02825251|471928420|FG001|Overall Study|Withdrawal by Subject|4|||
131080244|NCT02825251|471928419|FG000|Overall Study|Unclassified|2|||
131080245|NCT02825251|471928420|FG001|Overall Study|Unclassified|0|||
131080246|NCT00487825|471928421|FG000|Overall Study|Adverse Event|2|||
131080247|NCT00487825|471928422|FG001|Overall Study|Adverse Event|2|||
131080248|NCT00487825|471928421|FG000|Overall Study|Lack of Efficacy|1|||
131080249|NCT00487825|471928422|FG001|Overall Study|Lack of Efficacy|1|||
131080250|NCT00487825|471928421|FG000|Overall Study|Other|3|||
131080251|NCT00487825|471928422|FG001|Overall Study|Other|2|||
131080252|NCT02104505|471928423|FG000|First Intervention (14 Days)|Adverse Event|2|||
131080253|NCT02104505|471928424|FG001|First Intervention (14 Days)|Adverse Event|0|||
131080254|NCT02104505|471928423|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
131080255|NCT02104505|471928424|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
131080256|NCT02104505|471928423|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
131080257|NCT02104505|471928424|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
131080258|NCT02104505|471928423|FG000|First Intervention (14 Days)|exclusionary condition|0|||
131080259|NCT02104505|471928424|FG001|First Intervention (14 Days)|exclusionary condition|1|||
131080260|NCT02104505|471928423|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
131080261|NCT02104505|471928424|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
131080262|NCT02104505|471928423|FG000|Second Intervention (14 Days)|Adverse Event|2|||
131080263|NCT02104505|471928424|FG001|Second Intervention (14 Days)|Adverse Event|0|||
131080264|NCT01639742|471928425|FG000|Overall Study|Study Ongoing|17|||
131080265|NCT01639742|471928425|FG000|Overall Study|Lost to Follow-up|1|||
131080266|NCT01190644|471928426|FG000|Overall Study|Death|2|||
131080267|NCT01190644|471928426|FG000|Overall Study|Disease progression|1|||
131080268|NCT02366143|471928427|FG000|Overall Study|Death|307|||
131080269|NCT02366143|471928428|FG001|Overall Study|Death|278|||
131080270|NCT02366143|471928429|FG002|Overall Study|Death|280|||
131080271|NCT02366143|471928427|FG000|Overall Study|Lost to Follow-up|2|||
131080272|NCT02366143|471928428|FG001|Overall Study|Lost to Follow-up|4|||
131080273|NCT02366143|471928429|FG002|Overall Study|Lost to Follow-up|2|||
131080274|NCT02366143|471928427|FG000|Overall Study|Physician Decision|1|||
131080275|NCT02366143|471928428|FG001|Overall Study|Physician Decision|2|||
131080276|NCT02366143|471928429|FG002|Overall Study|Physician Decision|1|||
131080277|NCT02366143|471928427|FG000|Overall Study|Protocol Violation|0|||
131080278|NCT02366143|471928428|FG001|Overall Study|Protocol Violation|0|||
131080279|NCT02366143|471928429|FG002|Overall Study|Protocol Violation|2|||
131080280|NCT02366143|471928427|FG000|Overall Study|Withdrawal by Subject|16|||
131080281|NCT02366143|471928428|FG001|Overall Study|Withdrawal by Subject|17|||
131080282|NCT02366143|471928429|FG002|Overall Study|Withdrawal by Subject|22|||
131080283|NCT02366143|471928427|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
131080284|NCT02366143|471928428|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
131080285|NCT02366143|471928429|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
131080286|NCT02366143|471928427|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
131080287|NCT02366143|471928428|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
131080288|NCT02366143|471928429|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
131080289|NCT02366143|471928427|FG000|Overall Study|Randomization Error|1|||
131080290|NCT02366143|471928428|FG001|Overall Study|Randomization Error|0|||
131080291|NCT02366143|471928429|FG002|Overall Study|Randomization Error|0|||
131080292|NCT02366143|471928427|FG000|Overall Study|PI Move and Site Closure|1|||
131080293|NCT02366143|471928428|FG001|Overall Study|PI Move and Site Closure|0|||
131080294|NCT02366143|471928429|FG002|Overall Study|PI Move and Site Closure|1|||
131140675|NCT00773279|472141815|FG000|Period 2|Protocol Violation|0|||
131140676|NCT00773279|472141816|FG001|Period 2|Protocol Violation|3|||
131140677|NCT00773279|472141815|FG000|Period 2|Unclassified|2|||
131140678|NCT00773279|472141816|FG001|Period 2|Unclassified|2|||
131140679|NCT04178772|472141817|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
131140680|NCT04178772|472141817|FG000|Overall Study|study terminated early due to COVID-19|7|||
131080295|NCT02366143|471928427|FG000|Overall Study|Study Terminated By Sponsor|0|||
131080296|NCT02366143|471928428|FG001|Overall Study|Study Terminated By Sponsor|0|||
131140681|NCT02817087|472141820|FG000|Overall Study|Withdrawal by Subject|2|||
131140682|NCT02817087|472141821|FG001|Overall Study|Withdrawal by Subject|0|||
131140683|NCT02041962|472141822|FG000|Overall Study|Lost Aetna Coverage|43|||
131140684|NCT02041962|472141823|FG001|Overall Study|Lost Aetna Coverage|40|||
131140685|NCT02041962|472141822|FG000|Overall Study|Death|1|||
131140686|NCT02041962|472141823|FG001|Overall Study|Death|1|||
131080297|NCT02366143|471928429|FG002|Overall Study|Study Terminated By Sponsor|2|||
131080298|NCT02366143|471928427|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
131080299|NCT02366143|471928428|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
131080300|NCT02366143|471928429|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
131080301|NCT02366143|471928427|FG000|Overall Study|Patient moved to roll-over study|1|||
131080302|NCT02366143|471928428|FG001|Overall Study|Patient moved to roll-over study|19|||
131080303|NCT02366143|471928429|FG002|Overall Study|Patient moved to roll-over study|28|||
131080304|NCT02366143|471928427|FG000|Overall Study|Patient moved to commercial stock|0|||
131080305|NCT02366143|471928428|FG001|Overall Study|Patient moved to commercial stock|0|||
131080306|NCT02366143|471928429|FG002|Overall Study|Patient moved to commercial stock|1|||
131080307|NCT02366143|471928427|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
131080308|NCT02366143|471928428|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
131080309|NCT02366143|471928429|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
131080310|NCT02366143|471928427|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
131080311|NCT02366143|471928428|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
131080312|NCT02366143|471928429|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
131080313|NCT02366143|471928427|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
131080314|NCT02366143|471928428|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
131080315|NCT02366143|471928429|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
131080316|NCT02366143|471928427|FG000|Overall Study|Requester's instructions|1|||
131080317|NCT02366143|471928428|FG001|Overall Study|Requester's instructions|1|||
131080318|NCT02366143|471928429|FG002|Overall Study|Requester's instructions|1|||
131080319|NCT02366143|471928427|FG000|Overall Study|Uneligible|0|||
131080320|NCT02366143|471928428|FG001|Overall Study|Uneligible|1|||
131080321|NCT02366143|471928429|FG002|Overall Study|Uneligible|0|||
131080322|NCT02366143|471928427|FG000|Overall Study|Post Trial Migration|0|||
131080323|NCT02366143|471928428|FG001|Overall Study|Post Trial Migration|1|||
131080324|NCT02366143|471928429|FG002|Overall Study|Post Trial Migration|0|||
131080325|NCT02366143|471928427|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
131080326|NCT02366143|471928428|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
131080327|NCT02366143|471928429|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
131080328|NCT02366143|471928427|FG000|Overall Study|Patient switched to PTAP|0|||
131080329|NCT02366143|471928428|FG001|Overall Study|Patient switched to PTAP|1|||
131080330|NCT02366143|471928429|FG002|Overall Study|Patient switched to PTAP|0|||
131080331|NCT02366143|471928427|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
131080332|NCT02366143|471928428|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
131080333|NCT02366143|471928429|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
131080334|NCT04411186|471928430|FG000|Overall Study|Withdrawn due to protocol violation|0|||
131080335|NCT04411186|471928431|FG001|Overall Study|Withdrawn due to protocol violation|1|||
131080336|NCT01053247|471928432|FG000|Overall Study|Withdrawal by Subject|9|||
131080337|NCT01053247|471928433|FG001|Overall Study|Withdrawal by Subject|4|||
131080338|NCT01053247|471928434|FG002|Overall Study|Withdrawal by Subject|15|||
131080339|NCT01053247|471928432|FG000|Overall Study|Lack of Efficacy|1|||
131080340|NCT01053247|471928433|FG001|Overall Study|Lack of Efficacy|0|||
131080341|NCT01053247|471928434|FG002|Overall Study|Lack of Efficacy|1|||
131080342|NCT01053247|471928432|FG000|Overall Study|Protocol Violation|2|||
131140687|NCT02041962|472141822|FG000|Overall Study|Lost to Follow-up|37|||
131140688|NCT02041962|472141823|FG001|Overall Study|Lost to Follow-up|32|||
131140689|NCT02041962|472141822|FG000|Overall Study|Withdrawal by Subject|0|||
131140690|NCT02041962|472141823|FG001|Overall Study|Withdrawal by Subject|11|||
131140691|NCT01225562|472141826|FG000|Overall Study|Withdrawal by Subject|52|||
131140692|NCT01225562|472141827|FG001|Overall Study|Withdrawal by Subject|50|||
131140693|NCT01225562|472141828|FG002|Overall Study|Withdrawal by Subject|52|||
131140694|NCT01225562|472141826|FG000|Overall Study|Lost to Follow-up|3|||
131140695|NCT01225562|472141827|FG001|Overall Study|Lost to Follow-up|6|||
131140696|NCT01225562|472141828|FG002|Overall Study|Lost to Follow-up|1|||
131140697|NCT01162421|472141832|FG000|Overall Study|Did not receive study drug|2|||
131080343|NCT01053247|471928433|FG001|Overall Study|Protocol Violation|1|||
131080344|NCT01053247|471928434|FG002|Overall Study|Protocol Violation|2|||
131080345|NCT01053247|471928432|FG000|Overall Study|Lost to Follow-up|8|||
131080346|NCT01053247|471928433|FG001|Overall Study|Lost to Follow-up|5|||
131080347|NCT01053247|471928434|FG002|Overall Study|Lost to Follow-up|7|||
131080348|NCT01053247|471928432|FG000|Overall Study|Adverse Event|0|||
131080349|NCT01053247|471928433|FG001|Overall Study|Adverse Event|9|||
131080350|NCT01053247|471928434|FG002|Overall Study|Adverse Event|3|||
131080351|NCT00701909|471928435|FG000|Overall Study|Withdrawal by Subject|0|||
131080352|NCT00701909|471928436|FG001|Overall Study|Withdrawal by Subject|1|||
131080353|NCT01385748|471928437|FG000|Overall Study|Withdrawal by Subject|7|||
131080354|NCT01385748|471928438|FG001|Overall Study|Withdrawal by Subject|4|||
131080355|NCT01385748|471928439|FG002|Overall Study|Withdrawal by Subject|5|||
131080356|NCT01385748|471928437|FG000|Overall Study|Noncompliance|3|||
131080357|NCT01385748|471928438|FG001|Overall Study|Noncompliance|1|||
131080358|NCT01385748|471928439|FG002|Overall Study|Noncompliance|6|||
131080359|NCT01385748|471928437|FG000|Overall Study|Other|1|||
131080360|NCT01385748|471928438|FG001|Overall Study|Other|7|||
131080361|NCT01385748|471928439|FG002|Overall Study|Other|1|||
131080362|NCT01385748|471928437|FG000|Overall Study|Adverse Event|4|||
131080363|NCT01385748|471928438|FG001|Overall Study|Adverse Event|2|||
131080364|NCT01385748|471928439|FG002|Overall Study|Adverse Event|1|||
131080365|NCT00174447|471928443|FG000|Overall Study|Adverse Event|19|||
131080366|NCT00174447|471928443|FG000|Overall Study|Withdrawal by Subject|15|||
131080367|NCT00174447|471928443|FG000|Overall Study|Protocol Violation|1|||
131080368|NCT00174447|471928443|FG000|Overall Study|Lack of Efficacy|1|||
131080369|NCT00174447|471928443|FG000|Overall Study|Administrative reason/Other|2|||
131080370|NCT01437423|471928446|FG000|Overall Study|Lost to Follow-up|12|||
131080371|NCT01437423|471928446|FG000|Overall Study|Off label usage|3|||
131080372|NCT00633945|471928447|FG000|Overall Study|Physician Decision|2|||
131080373|NCT01271504|471928448|FG000|Overall Study|Death|7|||
131080374|NCT01271504|471928449|FG001|Overall Study|Death|6|||
131080375|NCT01271504|471928450|FG002|Overall Study|Death|32|||
131080376|NCT01271504|471928451|FG003|Overall Study|Death|32|||
131080377|NCT01271504|471928448|FG000|Overall Study|Lost to Follow-up|0|||
131080378|NCT01271504|471928449|FG001|Overall Study|Lost to Follow-up|1|||
131080379|NCT01271504|471928450|FG002|Overall Study|Lost to Follow-up|3|||
131080380|NCT01271504|471928451|FG003|Overall Study|Lost to Follow-up|1|||
131080381|NCT01271504|471928448|FG000|Overall Study|Protocol Violation|0|||
131080382|NCT01271504|471928449|FG001|Overall Study|Protocol Violation|0|||
131080383|NCT01271504|471928450|FG002|Overall Study|Protocol Violation|0|||
131080384|NCT01271504|471928451|FG003|Overall Study|Protocol Violation|2|||
131080385|NCT01271504|471928448|FG000|Overall Study|Administrative Reasons|0|||
131080386|NCT01271504|471928449|FG001|Overall Study|Administrative Reasons|0|||
131080387|NCT01271504|471928450|FG002|Overall Study|Administrative Reasons|6|||
131080388|NCT01271504|471928451|FG003|Overall Study|Administrative Reasons|5|||
131080389|NCT01271504|471928448|FG000|Overall Study|Withdrawal by Subject|0|||
131080390|NCT01271504|471928449|FG001|Overall Study|Withdrawal by Subject|0|||
131080391|NCT01271504|471928450|FG002|Overall Study|Withdrawal by Subject|1|||
131080392|NCT01271504|471928451|FG003|Overall Study|Withdrawal by Subject|3|||
131080393|NCT01271504|471928448|FG000|Overall Study|Other|0|||
131080394|NCT01271504|471928449|FG001|Overall Study|Other|1|||
131080395|NCT01271504|471928450|FG002|Overall Study|Other|2|||
131140698|NCT01162421|472141833|FG001|Overall Study|Did not receive study drug|1|||
131140699|NCT01162421|472141832|FG000|Overall Study|Adverse Event|2|||
131140700|NCT01162421|472141833|FG001|Overall Study|Adverse Event|5|||
131140701|NCT01162421|472141832|FG000|Overall Study|Lost to Follow-up|0|||
131140702|NCT01162421|472141833|FG001|Overall Study|Lost to Follow-up|2|||
131140703|NCT01162421|472141832|FG000|Overall Study|Lack of Efficacy|2|||
131140704|NCT01162421|472141833|FG001|Overall Study|Lack of Efficacy|2|||
131140705|NCT01162421|472141832|FG000|Overall Study|Other|2|||
131140706|NCT01162421|472141833|FG001|Overall Study|Other|3|||
131140707|NCT01107444|472141835|FG000|Overall Study|Withdrawal by Subject|8|||
131140708|NCT01107444|472141836|FG001|Overall Study|Withdrawal by Subject|12|||
131140709|NCT01107444|472141835|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
131140710|NCT01107444|472141836|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
131080396|NCT01271504|471928451|FG003|Overall Study|Other|0|||
131080397|NCT03865953|471928452|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
131080398|NCT03865953|471928453|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
131080399|NCT03865953|471928452|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
131080400|NCT03865953|471928453|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
131080401|NCT03865953|471928452|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
131080402|NCT03865953|471928453|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
131080403|NCT02229578|471928454|FG000|Overall Study|Withdrawal by Subject|1|||
131080404|NCT02229578|471928455|FG001|Overall Study|Withdrawal by Subject|3|||
131080405|NCT02229578|471928454|FG000|Overall Study|Protocol Violation|2|||
131080406|NCT02229578|471928455|FG001|Overall Study|Protocol Violation|0|||
131080407|NCT02706951|471928457|FG000|Period 1|Adverse Event|1|||
131080408|NCT02706951|471928458|FG001|Period 1|Adverse Event|5|||
131080409|NCT02706951|471928459|FG002|Period 1|Adverse Event|3|||
131232588|NCT00113490|472478392|FG000|Overall Study|Withdrawal by Subject|1|||
131232589|NCT00113490|472478393|FG001|Overall Study|Withdrawal by Subject|3|||
131232590|NCT00113490|472478392|FG000|Overall Study|Lost to Follow-up|1|||
131232591|NCT00113490|472478393|FG001|Overall Study|Lost to Follow-up|0|||
131232592|NCT02162758|472478394|FG000|Overall Study|Study termination|0|||
131232593|NCT02162758|472478395|FG001|Overall Study|Study termination|1|||
131232594|NCT04471935|472478396|FG000|Overall Study|Withdrawal by Subject|1|||
131232595|NCT04471935|472478396|FG000|Overall Study|Deemed ineligible to participate|1|||
131232596|NCT03019965|472478399|FG000|Overall Study|Withdrawal by Subject|1|||
131232597|NCT03019965|472478400|FG001|Overall Study|Withdrawal by Subject|0|||
131232598|NCT03019965|472478399|FG000|Overall Study|Protocol Violation|1|||
131232599|NCT03019965|472478400|FG001|Overall Study|Protocol Violation|3|||
131232600|NCT03019965|472478399|FG000|Overall Study|viral or fungal infection|3|||
131232601|NCT03019965|472478400|FG001|Overall Study|viral or fungal infection|4|||
131232602|NCT03019965|472478399|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
131232603|NCT03019965|472478400|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
131232604|NCT03019965|472478399|FG000|Overall Study|Physician Decision|1|||
131232605|NCT03019965|472478400|FG001|Overall Study|Physician Decision|1|||
131232606|NCT01659567|472478401|FG000|Overall Study|Lack of Efficacy|22|||
131232607|NCT01659567|472478401|FG000|Overall Study|Switched to Pegferon|6|||
131232608|NCT01659567|472478401|FG000|Overall Study|Adverse Event|12|||
131232609|NCT01659567|472478401|FG000|Overall Study|Good result at early stage of treatment|5|||
131080410|NCT02706951|471928460|FG003|Period 1|Adverse Event|0|||
131080411|NCT02706951|471928461|FG004|Period 1|Adverse Event|0|||
131080412|NCT02706951|471928457|FG000|Period 1|Withdrawal by Subject|10|||
131080413|NCT02706951|471928458|FG001|Period 1|Withdrawal by Subject|6|||
131080414|NCT02706951|471928459|FG002|Period 1|Withdrawal by Subject|6|||
131080415|NCT02706951|471928460|FG003|Period 1|Withdrawal by Subject|0|||
131080416|NCT02706951|471928461|FG004|Period 1|Withdrawal by Subject|0|||
131080417|NCT02706951|471928457|FG000|Period 1|Lost to Follow-up|0|||
131080418|NCT02706951|471928458|FG001|Period 1|Lost to Follow-up|4|||
131080419|NCT02706951|471928459|FG002|Period 1|Lost to Follow-up|1|||
131080420|NCT02706951|471928460|FG003|Period 1|Lost to Follow-up|0|||
131080421|NCT02706951|471928461|FG004|Period 1|Lost to Follow-up|0|||
131080422|NCT02706951|471928457|FG000|Period 1|Other|2|||
131080423|NCT02706951|471928458|FG001|Period 1|Other|1|||
131080424|NCT02706951|471928459|FG002|Period 1|Other|0|||
131080425|NCT02706951|471928460|FG003|Period 1|Other|0|||
131080426|NCT02706951|471928461|FG004|Period 1|Other|0|||
131080427|NCT02706951|471928457|FG000|Period 2|Adverse Event|0|||
131080428|NCT02706951|471928458|FG001|Period 2|Adverse Event|0|||
131080429|NCT02706951|471928459|FG002|Period 2|Adverse Event|0|||
131080430|NCT02706951|471928460|FG003|Period 2|Adverse Event|25|||
131080431|NCT02706951|471928461|FG004|Period 2|Adverse Event|34|||
131080432|NCT02706951|471928457|FG000|Period 2|Withdrawal by Subject|0|||
131080433|NCT02706951|471928458|FG001|Period 2|Withdrawal by Subject|0|||
131080434|NCT02706951|471928459|FG002|Period 2|Withdrawal by Subject|0|||
131080435|NCT02706951|471928460|FG003|Period 2|Withdrawal by Subject|38|||
131080436|NCT02706951|471928461|FG004|Period 2|Withdrawal by Subject|44|||
131080437|NCT02706951|471928457|FG000|Period 2|Lost to Follow-up|0|||
131080438|NCT02706951|471928458|FG001|Period 2|Lost to Follow-up|0|||
131080439|NCT02706951|471928459|FG002|Period 2|Lost to Follow-up|0|||
131080440|NCT02706951|471928460|FG003|Period 2|Lost to Follow-up|17|||
131080441|NCT02706951|471928461|FG004|Period 2|Lost to Follow-up|9|||
131080442|NCT02706951|471928457|FG000|Period 2|COVID-19 Related|0|||
131080443|NCT02706951|471928458|FG001|Period 2|COVID-19 Related|0|||
131080444|NCT02706951|471928459|FG002|Period 2|COVID-19 Related|0|||
131080445|NCT02706951|471928460|FG003|Period 2|COVID-19 Related|1|||
131080446|NCT02706951|471928461|FG004|Period 2|COVID-19 Related|2|||
131080447|NCT02706951|471928457|FG000|Period 2|Other|0|||
131080448|NCT02706951|471928458|FG001|Period 2|Other|0|||
131080449|NCT02706951|471928459|FG002|Period 2|Other|0|||
131080450|NCT02706951|471928460|FG003|Period 2|Other|37|||
131080451|NCT02706951|471928461|FG004|Period 2|Other|31|||
131080452|NCT04294667|471928463|FG000|Overall Study|Lack of Efficacy|4|||
131080453|NCT04294667|471928464|FG001|Overall Study|Lack of Efficacy|4|||
131080454|NCT04294667|471928463|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
131080455|NCT04294667|471928464|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
131080456|NCT04294667|471928463|FG000|Overall Study|Patient has a Renal Flare|1|||
131080457|NCT04294667|471928464|FG001|Overall Study|Patient has a Renal Flare|0|||
131080458|NCT04294667|471928463|FG000|Overall Study|SLE Worsening|0|||
131080459|NCT04294667|471928464|FG001|Overall Study|SLE Worsening|1|||
131080460|NCT04294667|471928463|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
131080461|NCT04294667|471928464|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
131080462|NCT04294667|471928463|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
131080463|NCT04294667|471928464|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
131080464|NCT04294667|471928463|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
131232610|NCT01659567|472478401|FG000|Overall Study|Withdrawal by Subject|64|||
131232611|NCT01659567|472478401|FG000|Overall Study|Progression of the main disease|1|||
131232612|NCT01659567|472478401|FG000|Overall Study|Other|13|||
131080465|NCT04294667|471928464|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
131080466|NCT04294667|471928463|FG000|Overall Study|Subject Moved to Another State|0|||
131140711|NCT00091832|472141838|FG000|Overall Study|Physician Decision|1|||
131140712|NCT00091832|472141839|FG001|Overall Study|Physician Decision|0|||
131140713|NCT00091832|472141840|FG002|Overall Study|Physician Decision|0|||
131140714|NCT00091832|472141841|FG003|Overall Study|Physician Decision|0|||
131140715|NCT00091832|472141842|FG004|Overall Study|Physician Decision|0|||
131140716|NCT00091832|472141843|FG005|Overall Study|Physician Decision|0|||
131140717|NCT00091832|472141838|FG000|Overall Study|Adverse Event|0|||
131140718|NCT00091832|472141839|FG001|Overall Study|Adverse Event|0|||
131140719|NCT00091832|472141840|FG002|Overall Study|Adverse Event|0|||
131140720|NCT00091832|472141841|FG003|Overall Study|Adverse Event|1|||
131140721|NCT00091832|472141842|FG004|Overall Study|Adverse Event|3|||
131140722|NCT00091832|472141843|FG005|Overall Study|Adverse Event|0|||
131140723|NCT00091832|472141838|FG000|Overall Study|Withdrawal by Subject|4|||
131140724|NCT00091832|472141839|FG001|Overall Study|Withdrawal by Subject|5|||
131140725|NCT00091832|472141840|FG002|Overall Study|Withdrawal by Subject|0|||
131140726|NCT00091832|472141841|FG003|Overall Study|Withdrawal by Subject|1|||
131140727|NCT00091832|472141842|FG004|Overall Study|Withdrawal by Subject|3|||
131140728|NCT00091832|472141843|FG005|Overall Study|Withdrawal by Subject|1|||
131140729|NCT00091832|472141838|FG000|Overall Study|Death|6|||
131140730|NCT00091832|472141839|FG001|Overall Study|Death|4|||
131140731|NCT00091832|472141840|FG002|Overall Study|Death|5|||
131140732|NCT00091832|472141841|FG003|Overall Study|Death|8|||
131140733|NCT00091832|472141842|FG004|Overall Study|Death|5|||
131140734|NCT00091832|472141843|FG005|Overall Study|Death|6|||
131140735|NCT00091832|472141838|FG000|Overall Study|Disease Progression|2|||
131140736|NCT00091832|472141839|FG001|Overall Study|Disease Progression|0|||
131140737|NCT00091832|472141840|FG002|Overall Study|Disease Progression|0|||
131140738|NCT00091832|472141841|FG003|Overall Study|Disease Progression|1|||
131140739|NCT00091832|472141842|FG004|Overall Study|Disease Progression|1|||
131140740|NCT00091832|472141843|FG005|Overall Study|Disease Progression|2|||
131140741|NCT00091832|472141838|FG000|Overall Study|Ineligibility Determined|0|||
131140742|NCT00091832|472141839|FG001|Overall Study|Ineligibility Determined|0|||
131140743|NCT00091832|472141840|FG002|Overall Study|Ineligibility Determined|1|||
131140744|NCT00091832|472141841|FG003|Overall Study|Ineligibility Determined|0|||
131140745|NCT00091832|472141842|FG004|Overall Study|Ineligibility Determined|1|||
131140746|NCT00091832|472141843|FG005|Overall Study|Ineligibility Determined|0|||
131140747|NCT00091832|472141838|FG000|Overall Study|Lost to Follow-up|1|||
131140748|NCT00091832|472141839|FG001|Overall Study|Lost to Follow-up|0|||
131140749|NCT00091832|472141840|FG002|Overall Study|Lost to Follow-up|3|||
131140750|NCT00091832|472141841|FG003|Overall Study|Lost to Follow-up|3|||
131140751|NCT00091832|472141842|FG004|Overall Study|Lost to Follow-up|2|||
131140752|NCT00091832|472141843|FG005|Overall Study|Lost to Follow-up|1|||
131140753|NCT00091832|472141838|FG000|Overall Study|Noncompliance|0|||
131140754|NCT00091832|472141839|FG001|Overall Study|Noncompliance|1|||
131140755|NCT00091832|472141840|FG002|Overall Study|Noncompliance|0|||
131140756|NCT00091832|472141841|FG003|Overall Study|Noncompliance|0|||
131140757|NCT00091832|472141842|FG004|Overall Study|Noncompliance|0|||
131140758|NCT00091832|472141843|FG005|Overall Study|Noncompliance|0|||
131140759|NCT00091832|472141838|FG000|Overall Study|Other|0|||
131140760|NCT00091832|472141839|FG001|Overall Study|Other|1|||
131140761|NCT00091832|472141840|FG002|Overall Study|Other|2|||
131140762|NCT00091832|472141841|FG003|Overall Study|Other|0|||
131140763|NCT00091832|472141842|FG004|Overall Study|Other|0|||
131140764|NCT00091832|472141843|FG005|Overall Study|Other|0|||
131140765|NCT00091832|472141838|FG000|Overall Study|Protocol Violation|0|||
131140766|NCT00091832|472141839|FG001|Overall Study|Protocol Violation|0|||
131140767|NCT00091832|472141840|FG002|Overall Study|Protocol Violation|1|||
131140768|NCT00091832|472141841|FG003|Overall Study|Protocol Violation|0|||
131140769|NCT00091832|472141842|FG004|Overall Study|Protocol Violation|0|||
131140770|NCT00091832|472141843|FG005|Overall Study|Protocol Violation|1|||
131140771|NCT00464178|472141844|FG000|Overall Study|Protocol Violation|1|||
131140772|NCT00464178|472141844|FG000|Overall Study|Withdrawal by Subject|1|||
131140773|NCT01557166|472141847|FG000|Overall Study|Adverse Event|20|||
131140774|NCT01557166|472141848|FG001|Overall Study|Adverse Event|6|||
131140775|NCT01557166|472141847|FG000|Overall Study|Lack of Efficacy|2|||
131140776|NCT01557166|472141848|FG001|Overall Study|Lack of Efficacy|1|||
131140777|NCT01557166|472141847|FG000|Overall Study|Protocol Violation|8|||
131140778|NCT01557166|472141848|FG001|Overall Study|Protocol Violation|5|||
131140779|NCT01557166|472141847|FG000|Overall Study|Withdrawn consent|12|||
131140780|NCT01557166|472141848|FG001|Overall Study|Withdrawn consent|20|||
131140781|NCT01557166|472141847|FG000|Overall Study|Target dose not tolerated|1|||
131140782|NCT01557166|472141848|FG001|Overall Study|Target dose not tolerated|0|||
131140783|NCT01557166|472141847|FG000|Overall Study|Psychiatric disorder|1|||
131140784|NCT01557166|472141848|FG001|Overall Study|Psychiatric disorder|0|||
131140785|NCT01557166|472141847|FG000|Overall Study|Unclassified|2|||
131232613|NCT03213210|472478402|FG000|Overall Study|Lost to Follow-up|2|||
131232614|NCT03213210|472478402|FG000|Overall Study|Study termination|3|||
131232615|NCT01325207|472478410|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
131232616|NCT01325207|472478411|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
131232617|NCT01325207|472478412|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
131232618|NCT01325207|472478413|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
131232619|NCT01325207|472478414|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
131232620|NCT01325207|472478415|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
131232621|NCT01325207|472478410|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
131232622|NCT01325207|472478411|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
131232623|NCT01325207|472478412|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
131232624|NCT01325207|472478413|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
131232625|NCT01325207|472478414|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
131232626|NCT01325207|472478415|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
131232627|NCT01325207|472478410|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
131232628|NCT01325207|472478411|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
131232629|NCT01325207|472478412|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
131232630|NCT01325207|472478413|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
131232631|NCT01325207|472478414|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
131232632|NCT01325207|472478415|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
131232633|NCT01325207|472478410|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
131232634|NCT01325207|472478411|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
131232635|NCT01325207|472478412|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
131232636|NCT01325207|472478413|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
131232637|NCT01325207|472478414|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
131232638|NCT01325207|472478415|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
131232639|NCT01325207|472478410|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
131232640|NCT01325207|472478411|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
131232641|NCT01325207|472478412|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
131232642|NCT01325207|472478413|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
131232643|NCT01325207|472478414|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
131232644|NCT01325207|472478415|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
131232645|NCT01325207|472478410|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
131232646|NCT01325207|472478411|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
131232647|NCT01325207|472478412|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
131232648|NCT01325207|472478413|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
131232649|NCT01325207|472478414|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
131232650|NCT01325207|472478415|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
131232651|NCT01325207|472478410|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
131232652|NCT01325207|472478411|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
131232653|NCT01325207|472478412|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
131232654|NCT01325207|472478413|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
131232655|NCT01325207|472478414|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
131232656|NCT01325207|472478415|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
131232657|NCT00708422|472478416|FG000|Overall Study|Adverse Event|3|||
131232658|NCT00708422|472478417|FG001|Overall Study|Adverse Event|1|||
131232659|NCT00708422|472478416|FG000|Overall Study|Withdrawal by Subject|1|||
131232660|NCT00708422|472478417|FG001|Overall Study|Withdrawal by Subject|0|||
131232661|NCT01254409|472478418|FG000|Overall Study|Adverse Event|0|||
131232662|NCT01254409|472478419|FG001|Overall Study|Adverse Event|1|||
131232663|NCT01254409|472478420|FG002|Overall Study|Adverse Event|0|||
131232664|NCT01254409|472478421|FG003|Overall Study|Adverse Event|0|||
131232665|NCT00299156|472478424|FG000|Period 2 (Randomized)|Screen Failure|0|||
131232666|NCT00299156|472478425|FG001|Period 2 (Randomized)|Screen Failure|1|||
131232667|NCT00299156|472478426|FG002|Period 2 (Randomized)|Screen Failure|0|||
131232668|NCT01166568|472478436|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
131232669|NCT01166568|472478437|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
131232670|NCT01166568|472478438|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
131232671|NCT01166568|472478436|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
131232672|NCT01166568|472478437|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
131232673|NCT01166568|472478438|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
131232674|NCT01166568|472478436|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
131232675|NCT01166568|472478437|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
131232676|NCT01166568|472478438|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
131232677|NCT03335371|472478439|FG000|Overall Study|Lost to Follow-up|0|||
131232678|NCT03335371|472478440|FG001|Overall Study|Lost to Follow-up|0|||
130727143|NCT02883049|470625439|FG015|Induction|Enrolled onto another COG study|0|||
130780225|NCT01719380|470821453|FG006|Overall Study|Physician Decision|0|||
131080467|NCT04294667|471928464|FG001|Overall Study|Subject Moved to Another State|1|||
131080468|NCT04294667|471928463|FG000|Overall Study|Adverse event, serious fatal|0|||
131080469|NCT04294667|471928464|FG001|Overall Study|Adverse event, serious fatal|1|||
131080470|NCT04294667|471928463|FG000|Overall Study|Adverse event, non-fatal|3|||
131080471|NCT04294667|471928464|FG001|Overall Study|Adverse event, non-fatal|4|||
131080472|NCT02599688|471928467|FG000|Overall Study|Lack of Efficacy|1|||
131080473|NCT02599688|471928467|FG000|Overall Study|Withdrawal by Subject|1|||
131080474|NCT02599688|471928467|FG000|Overall Study|Termination by Sponsor|2|||
131080475|NCT01841697|471928468|FG000|Overall Study|Death|0|||
131080476|NCT01841697|471928469|FG001|Overall Study|Death|1|||
131080477|NCT01841697|471928468|FG000|Overall Study|Lost to Follow-up|4|||
131080478|NCT01841697|471928469|FG001|Overall Study|Lost to Follow-up|1|||
131080479|NCT01841697|471928468|FG000|Overall Study|Withdrawal by Subject|16|||
131080480|NCT01841697|471928469|FG001|Overall Study|Withdrawal by Subject|16|||
131080481|NCT00756457|471928470|FG000|Overall Study|Lost to Follow-up|1|||
131080482|NCT00756457|471928471|FG001|Overall Study|Lost to Follow-up|2|||
131080483|NCT00458393|471928474|FG000|Overall Study|Withdrawal by Subject|67|||
131080484|NCT00458393|471928475|FG001|Overall Study|Withdrawal by Subject|80|||
131080485|NCT00458393|471928474|FG000|Overall Study|Physician Decision|31|||
131080486|NCT00458393|471928475|FG001|Overall Study|Physician Decision|22|||
131080487|NCT00458393|471928474|FG000|Overall Study|Relocated|77|||
131080488|NCT00458393|471928475|FG001|Overall Study|Relocated|81|||
131080489|NCT00458393|471928474|FG000|Overall Study|Lost to Follow-up|115|||
131080490|NCT00458393|471928475|FG001|Overall Study|Lost to Follow-up|92|||
131080491|NCT00458393|471928474|FG000|Overall Study|Sites marked other on the form.|19|||
131080492|NCT00458393|471928475|FG001|Overall Study|Sites marked other on the form.|20|||
131080493|NCT02049515|471928476|FG000|Overall Study|Adverse Event|46|||
131080494|NCT02049515|471928477|FG001|Overall Study|Adverse Event|2|||
131080495|NCT02049515|471928476|FG000|Overall Study|Protocol-specified Disease Progression|23|||
131140786|NCT01557166|472141848|FG001|Overall Study|Unclassified|5|||
131140787|NCT00946309|472141849|FG000|Overall Study|Protocol Violation|1|||
131140788|NCT00946309|472141850|FG001|Overall Study|Protocol Violation|0|||
131140789|NCT00946309|472141849|FG000|Overall Study|Lost to Follow-up|0|||
131140790|NCT00946309|472141850|FG001|Overall Study|Lost to Follow-up|1|||
131140791|NCT00946309|472141849|FG000|Overall Study|Procedure cancelled/discontinued|0|||
131140792|NCT00946309|472141850|FG001|Overall Study|Procedure cancelled/discontinued|3|||
131140793|NCT01465659|472141852|FG000|Completed 1 Cycle of Treatment|Death|0|||
131140794|NCT01465659|472141853|FG001|Completed 1 Cycle of Treatment|Death|1|||
131140795|NCT01465659|472141854|FG002|Completed 1 Cycle of Treatment|Death|0|||
131140796|NCT01465659|472141855|FG003|Completed 1 Cycle of Treatment|Death|0|||
131140797|NCT01465659|472141852|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
131140798|NCT01465659|472141853|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
131140799|NCT01465659|472141854|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
131140800|NCT01465659|472141855|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
131140801|NCT01465659|472141852|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
131140802|NCT01465659|472141853|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
131140803|NCT01465659|472141854|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
131140804|NCT01465659|472141855|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
131140805|NCT01465659|472141852|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
131140806|NCT01465659|472141853|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
131140807|NCT01465659|472141854|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
131140808|NCT01465659|472141855|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
131140809|NCT01465659|472141852|FG000|Completed Follow for 1 Year|Death|6|||
131140810|NCT01465659|472141853|FG001|Completed Follow for 1 Year|Death|3|||
131140811|NCT01465659|472141854|FG002|Completed Follow for 1 Year|Death|2|||
131140812|NCT01465659|472141855|FG003|Completed Follow for 1 Year|Death|4|||
131140813|NCT02445586|472141858|FG000|Overall Study|Death|14|||
131140814|NCT02445586|472141858|FG000|Overall Study|Withdrawal by Subject|13|||
131140815|NCT02445586|472141858|FG000|Overall Study|Disease Progression|10|||
131140816|NCT02445586|472141858|FG000|Overall Study|Protocol Violation|1|||
131140817|NCT02445586|472141858|FG000|Overall Study|Medical Condition|1|||
131140818|NCT00428597|472141861|FG000|Overall Study|Randomized but not treated|3|||
131140819|NCT00428597|472141862|FG001|Overall Study|Randomized but not treated|3|||
131140820|NCT00428597|472141861|FG000|Overall Study|Objective Progression or Relapse|19|||
131140821|NCT00428597|472141862|FG001|Overall Study|Objective Progression or Relapse|47|||
131140822|NCT00428597|472141861|FG000|Overall Study|Study Terminated by Sponsor|41|||
131140823|NCT00428597|472141862|FG001|Overall Study|Study Terminated by Sponsor|16|||
131140824|NCT00428597|472141861|FG000|Overall Study|Adverse Event|15|||
131140825|NCT00428597|472141862|FG001|Overall Study|Adverse Event|7|||
131140826|NCT00428597|472141861|FG000|Overall Study|Global Deterioration of Health Status|1|||
131140827|NCT00428597|472141862|FG001|Overall Study|Global Deterioration of Health Status|5|||
131140828|NCT00428597|472141861|FG000|Overall Study|Protocol Violation|2|||
131140829|NCT00428597|472141862|FG001|Overall Study|Protocol Violation|1|||
131232679|NCT03335371|472478441|FG002|Overall Study|Lost to Follow-up|0|||
131232680|NCT03335371|472478442|FG003|Overall Study|Lost to Follow-up|0|||
131232681|NCT03335371|472478443|FG004|Overall Study|Lost to Follow-up|1|||
131232682|NCT03335371|472478439|FG000|Overall Study|Withdrawal by Subject|0|||
131232683|NCT03335371|472478440|FG001|Overall Study|Withdrawal by Subject|0|||
131232684|NCT03335371|472478441|FG002|Overall Study|Withdrawal by Subject|0|||
131232685|NCT03335371|472478442|FG003|Overall Study|Withdrawal by Subject|0|||
131232686|NCT03335371|472478443|FG004|Overall Study|Withdrawal by Subject|1|||
131232687|NCT03335371|472478439|FG000|Overall Study|Randomization Error|0|||
131232688|NCT03335371|472478440|FG001|Overall Study|Randomization Error|0|||
131232689|NCT03335371|472478441|FG002|Overall Study|Randomization Error|1|||
131232690|NCT03335371|472478442|FG003|Overall Study|Randomization Error|0|||
131232691|NCT03335371|472478443|FG004|Overall Study|Randomization Error|0|||
131232692|NCT00684671|472478444|FG000|Overall Study|Adverse Event|1|||
131232693|NCT00684671|472478445|FG001|Overall Study|Adverse Event|0|||
131232694|NCT00684671|472478446|FG002|Overall Study|Adverse Event|0|||
131232695|NCT00684671|472478444|FG000|Overall Study|Lost to Follow-up|1|||
131232696|NCT00684671|472478445|FG001|Overall Study|Lost to Follow-up|0|||
131232697|NCT00684671|472478446|FG002|Overall Study|Lost to Follow-up|0|||
131232698|NCT00684671|472478444|FG000|Overall Study|Alcoholic dependance|1|||
131232699|NCT00684671|472478445|FG001|Overall Study|Alcoholic dependance|0|||
131232700|NCT00684671|472478446|FG002|Overall Study|Alcoholic dependance|0|||
131232701|NCT01725451|472478447|FG000|Period 1|Withdrawal by Subject|1|||
131232702|NCT01725451|472478448|FG001|Period 1|Withdrawal by Subject|0|||
131232703|NCT01725451|472478449|FG002|Period 1|Withdrawal by Subject|0|||
131232704|NCT01725451|472478450|FG003|Period 1|Withdrawal by Subject|0|||
131232705|NCT01725451|472478447|FG000|Washout From Period 3|Protocol Violation|0|||
131232706|NCT01725451|472478448|FG001|Washout From Period 3|Protocol Violation|0|||
131232707|NCT01725451|472478449|FG002|Washout From Period 3|Protocol Violation|1|||
131232708|NCT01725451|472478450|FG003|Washout From Period 3|Protocol Violation|0|||
131232709|NCT01725451|472478447|FG000|Washout From Period 3|Adverse Event|0|||
131232710|NCT01725451|472478448|FG001|Washout From Period 3|Adverse Event|1|||
131232711|NCT01725451|472478449|FG002|Washout From Period 3|Adverse Event|0|||
131232712|NCT01725451|472478450|FG003|Washout From Period 3|Adverse Event|0|||
131232713|NCT01725451|472478447|FG000|Period 4|Adverse Event|0|||
131232714|NCT01725451|472478448|FG001|Period 4|Adverse Event|0|||
131232715|NCT01725451|472478449|FG002|Period 4|Adverse Event|1|||
131232716|NCT01725451|472478450|FG003|Period 4|Adverse Event|0|||
131232717|NCT01564758|472478451|FG000|Overall Study|Death|8|||
131232718|NCT01564758|472478451|FG000|Overall Study|Adverse Event|3|||
131232719|NCT01564758|472478451|FG000|Overall Study|Other|3|||
131232720|NCT00249821|472478452|FG000|Overall Study|Technical problem|0|||
131232721|NCT00249821|472478453|FG001|Overall Study|Technical problem|1|||
131232722|NCT02482571|472478454|FG000|Overall Study|Adverse Event|1|||
131232723|NCT02482571|472478454|FG000|Overall Study|Scanner or Respiract failure|3|||
131232724|NCT02482571|472478454|FG000|Overall Study|Withdrawal by Subject|4|||
131232725|NCT01446913|472478455|FG000|Overall Study|Significant illness|1|||
131232726|NCT01446913|472478456|FG001|Overall Study|Significant illness|1|||
131232727|NCT01446913|472478457|FG002|Overall Study|Significant illness|1|||
131232728|NCT01446913|472478455|FG000|Overall Study|Withdrawal by Subject|5|||
131232729|NCT01446913|472478456|FG001|Overall Study|Withdrawal by Subject|3|||
131232730|NCT01446913|472478457|FG002|Overall Study|Withdrawal by Subject|5|||
131232731|NCT01446913|472478455|FG000|Overall Study|Physician Decision|0|||
131232732|NCT01446913|472478456|FG001|Overall Study|Physician Decision|0|||
131232733|NCT01446913|472478457|FG002|Overall Study|Physician Decision|2|||
131232734|NCT01446913|472478455|FG000|Overall Study|Lost to Follow-up|3|||
131232735|NCT01446913|472478456|FG001|Overall Study|Lost to Follow-up|5|||
131232736|NCT01446913|472478457|FG002|Overall Study|Lost to Follow-up|3|||
131232737|NCT02789111|472478460|FG000|Overall Study|Withdrawal by Subject|1|||
131232738|NCT02789111|472478461|FG001|Overall Study|Withdrawal by Subject|4|||
131232739|NCT00673790|472478465|FG000|Overall Study|Adverse Event|23|||
131232740|NCT00673790|472478466|FG001|Overall Study|Adverse Event|14|||
131232741|NCT00673790|472478467|FG002|Overall Study|Adverse Event|2|||
131232742|NCT00673790|472478465|FG000|Overall Study|Lack of Efficacy|2|||
131232743|NCT00673790|472478466|FG001|Overall Study|Lack of Efficacy|2|||
131232744|NCT00673790|472478467|FG002|Overall Study|Lack of Efficacy|2|||
131232745|NCT00673790|472478465|FG000|Overall Study|Protocol Violation|6|||
131232746|NCT00673790|472478466|FG001|Overall Study|Protocol Violation|9|||
131232747|NCT00673790|472478467|FG002|Overall Study|Protocol Violation|1|||
131232748|NCT00673790|472478465|FG000|Overall Study|Withdrawal by Subject|7|||
131232749|NCT00673790|472478466|FG001|Overall Study|Withdrawal by Subject|4|||
131232750|NCT00673790|472478467|FG002|Overall Study|Withdrawal by Subject|1|||
131232751|NCT00673790|472478465|FG000|Overall Study|Lost to Follow-up|6|||
131232752|NCT00673790|472478466|FG001|Overall Study|Lost to Follow-up|6|||
131232753|NCT00673790|472478467|FG002|Overall Study|Lost to Follow-up|5|||
131232754|NCT00673790|472478465|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
131232755|NCT00673790|472478466|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
131232756|NCT00673790|472478467|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
131232757|NCT00673790|472478465|FG000|Overall Study|Poor compliance|1|||
131232758|NCT00673790|472478466|FG001|Overall Study|Poor compliance|0|||
131232759|NCT00673790|472478467|FG002|Overall Study|Poor compliance|0|||
131232760|NCT00673790|472478465|FG000|Overall Study|Participated in two Nebivolol studies|0|||
131232761|NCT00673790|472478466|FG001|Overall Study|Participated in two Nebivolol studies|0|||
131232762|NCT00673790|472478467|FG002|Overall Study|Participated in two Nebivolol studies|1|||
131232763|NCT00673790|472478465|FG000|Overall Study|Unconfirmed pregnancy|0|||
131232764|NCT00673790|472478466|FG001|Overall Study|Unconfirmed pregnancy|1|||
131232765|NCT00673790|472478467|FG002|Overall Study|Unconfirmed pregnancy|0|||
131232766|NCT00673790|472478465|FG000|Overall Study|Randomization criteria not met|0|||
131232767|NCT00673790|472478466|FG001|Overall Study|Randomization criteria not met|1|||
131232768|NCT00673790|472478467|FG002|Overall Study|Randomization criteria not met|0|||
131232769|NCT00717756|472478468|FG000|Overall Study|Withdrawal by Subject|1|||
131232770|NCT00601484|472478472|FG000|Overall Study|Adverse Event|0|||
131232771|NCT00601484|472478473|FG001|Overall Study|Adverse Event|1|||
131232772|NCT00601484|472478472|FG000|Overall Study|Lost to Follow-up|4|||
131232773|NCT00601484|472478473|FG001|Overall Study|Lost to Follow-up|3|||
131232774|NCT00601484|472478472|FG000|Overall Study|Lack of Efficacy|0|||
131232775|NCT00601484|472478473|FG001|Overall Study|Lack of Efficacy|2|||
131232776|NCT00601484|472478472|FG000|Overall Study|Withdrawal by Subject|1|||
131232777|NCT00601484|472478473|FG001|Overall Study|Withdrawal by Subject|1|||
131232778|NCT00601484|472478472|FG000|Overall Study|Randomized, but not treated|0|||
131232779|NCT00601484|472478473|FG001|Overall Study|Randomized, but not treated|1|||
131232780|NCT00745251|472478474|FG000|Overall Study|Adverse Event|1|||
131232781|NCT00745251|472478475|FG001|Overall Study|Adverse Event|2|||
131232782|NCT00745251|472478474|FG000|Overall Study|Withdrawal by Subject|1|||
131232783|NCT00745251|472478475|FG001|Overall Study|Withdrawal by Subject|1|||
131232784|NCT02928848|472478476|FG000|Arm 2|Withdrawal by Subject|1|||
131232785|NCT02928848|472478477|FG001|Arm 2|Withdrawal by Subject|0|||
131232786|NCT01200394|472478478|FG000|Overall Study|Adverse Event|0|||
131232787|NCT01200394|472478479|FG001|Overall Study|Adverse Event|14|||
131232788|NCT01200394|472478478|FG000|Overall Study|Death|1|||
131232789|NCT01200394|472478479|FG001|Overall Study|Death|0|||
131232790|NCT01200394|472478478|FG000|Overall Study|Lost to Follow-up|0|||
131232791|NCT01200394|472478479|FG001|Overall Study|Lost to Follow-up|1|||
131232792|NCT01200394|472478478|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
131232793|NCT01200394|472478479|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
131232794|NCT01200394|472478478|FG000|Overall Study|Protocol Violation|0|||
131232795|NCT01200394|472478479|FG001|Overall Study|Protocol Violation|3|||
131232796|NCT01200394|472478478|FG000|Overall Study|Withdrawal by Subject|0|||
131232797|NCT01200394|472478479|FG001|Overall Study|Withdrawal by Subject|5|||
131232798|NCT01200394|472478478|FG000|Overall Study|Other|0|||
131232799|NCT01200394|472478479|FG001|Overall Study|Other|1|||
131232800|NCT02729896|472478480|FG000|Overall Study|Death|0|||
131232801|NCT02729896|472478481|FG001|Overall Study|Death|2|||
131232802|NCT02729896|472478482|FG002|Overall Study|Death|13|||
131232803|NCT02729896|472478480|FG000|Overall Study|Lost to Follow-up|0|||
131232804|NCT02729896|472478481|FG001|Overall Study|Lost to Follow-up|2|||
131232805|NCT02729896|472478482|FG002|Overall Study|Lost to Follow-up|3|||
131232806|NCT02729896|472478480|FG000|Overall Study|Other|0|||
131232807|NCT02729896|472478481|FG001|Overall Study|Other|2|||
131232808|NCT02729896|472478482|FG002|Overall Study|Other|0|||
131232809|NCT02729896|472478480|FG000|Overall Study|Physician Decision|1|||
131232810|NCT02729896|472478481|FG001|Overall Study|Physician Decision|2|||
131232811|NCT02729896|472478482|FG002|Overall Study|Physician Decision|3|||
131232812|NCT02729896|472478480|FG000|Overall Study|Progressive Disease|0|||
131232813|NCT02729896|472478481|FG001|Overall Study|Progressive Disease|1|||
131232814|NCT02729896|472478482|FG002|Overall Study|Progressive Disease|0|||
131232815|NCT02729896|472478480|FG000|Overall Study|Withdrawal by Subject|1|||
131232816|NCT02729896|472478481|FG001|Overall Study|Withdrawal by Subject|0|||
131232817|NCT02729896|472478482|FG002|Overall Study|Withdrawal by Subject|3|||
131232818|NCT00582309|472478483|FG000|Overall Study|Protocol Violation|0|||
131232819|NCT00582309|472478484|FG001|Overall Study|Protocol Violation|0|||
131232820|NCT00582309|472478485|FG002|Overall Study|Protocol Violation|2|||
131232821|NCT01463683|472478489|FG000|Overall Study|Adverse Event|2|||
131232822|NCT01463683|472478490|FG001|Overall Study|Adverse Event|0|||
131232823|NCT01463683|472478491|FG002|Overall Study|Adverse Event|0|||
131232824|NCT01463683|472478489|FG000|Overall Study|Lost to Follow-up|10|||
131232825|NCT01463683|472478490|FG001|Overall Study|Lost to Follow-up|9|||
131232826|NCT01463683|472478491|FG002|Overall Study|Lost to Follow-up|7|||
131232827|NCT01463683|472478489|FG000|Overall Study|Physician Decision|0|||
131232828|NCT01463683|472478490|FG001|Overall Study|Physician Decision|3|||
131232829|NCT01463683|472478491|FG002|Overall Study|Physician Decision|1|||
131232830|NCT01463683|472478489|FG000|Overall Study|Pregnancy|2|||
131232831|NCT01463683|472478490|FG001|Overall Study|Pregnancy|2|||
131232832|NCT01463683|472478491|FG002|Overall Study|Pregnancy|1|||
131232833|NCT01463683|472478489|FG000|Overall Study|Withdrawal by Subject|5|||
131232834|NCT01463683|472478490|FG001|Overall Study|Withdrawal by Subject|17|||
131232835|NCT01463683|472478491|FG002|Overall Study|Withdrawal by Subject|2|||
131232836|NCT01618305|472478493|FG000|Overall Study|Death|0|||
131232837|NCT01618305|472478494|FG001|Overall Study|Death|1|||
131232838|NCT01618305|472478493|FG000|Overall Study|Lost to Follow-up|11|||
131232839|NCT01618305|472478494|FG001|Overall Study|Lost to Follow-up|7|||
131232840|NCT01618305|472478493|FG000|Overall Study|Protocol Violation|1|||
131232841|NCT01618305|472478494|FG001|Overall Study|Protocol Violation|0|||
131232842|NCT01618305|472478493|FG000|Overall Study|Withdrawal by Subject|3|||
131232843|NCT01618305|472478494|FG001|Overall Study|Withdrawal by Subject|2|||
131232844|NCT04345471|472478498|FG000|Overall Study|Adverse Event|8|||
131232845|NCT04345471|472478499|FG001|Overall Study|Adverse Event|5|||
131232846|NCT04345471|472478500|FG002|Overall Study|Adverse Event|6|||
131232847|NCT04345471|472478498|FG000|Overall Study|Lack of Efficacy|1|||
131232848|NCT04345471|472478499|FG001|Overall Study|Lack of Efficacy|1|||
131232849|NCT04345471|472478500|FG002|Overall Study|Lack of Efficacy|0|||
131232850|NCT04345471|472478498|FG000|Overall Study|Protocol Violation|0|||
131232851|NCT04345471|472478499|FG001|Overall Study|Protocol Violation|1|||
131232852|NCT04345471|472478500|FG002|Overall Study|Protocol Violation|2|||
131232853|NCT04345471|472478498|FG000|Overall Study|Withdrawal by Subject|10|||
131232854|NCT04345471|472478499|FG001|Overall Study|Withdrawal by Subject|5|||
131232855|NCT04345471|472478500|FG002|Overall Study|Withdrawal by Subject|10|||
131232856|NCT03896490|472478535|FG000|Overall Study|Withdrawal by Subject|1|||
131232857|NCT03896490|472478536|FG001|Overall Study|Withdrawal by Subject|1|||
131232858|NCT00003782|472478537|FG000|Overall Study|No follow up data|30|||
131232859|NCT00003782|472478538|FG001|Overall Study|No follow up data|31|||
131232860|NCT00003782|472478539|FG002|Overall Study|No follow up data|26|||
131232861|NCT01890707|472478540|FG000|Overall Study|Lost to Follow-up|1|||
131232862|NCT01890707|472478541|FG001|Overall Study|Lost to Follow-up|1|||
131232863|NCT01326026|472478543|FG000|Overall Study|Adverse Event|4|||
131232864|NCT01326026|472478544|FG001|Overall Study|Adverse Event|3|||
131232865|NCT01326026|472478543|FG000|Overall Study|Withdrawal Criteria|5|||
131232866|NCT01326026|472478544|FG001|Overall Study|Withdrawal Criteria|7|||
131232867|NCT01326026|472478543|FG000|Overall Study|Other|3|||
131232868|NCT01326026|472478544|FG001|Overall Study|Other|3|||
131232869|NCT00992407|472480468|FG000|Overall Study|Protocol Violation|2|||
131232870|NCT00992407|472480469|FG001|Overall Study|Protocol Violation|1|||
131232871|NCT00992407|472480468|FG000|Overall Study|Lost to Follow-up|3|||
131232872|NCT00992407|472480469|FG001|Overall Study|Lost to Follow-up|3|||
131232873|NCT00992407|472480468|FG000|Overall Study|Adverse Event|3|||
131232874|NCT00992407|472480469|FG001|Overall Study|Adverse Event|2|||
131232875|NCT00992407|472480468|FG000|Overall Study|protocol Violation & Adverse events|2|||
131232876|NCT00992407|472480469|FG001|Overall Study|protocol Violation & Adverse events|4|||
131232877|NCT00992407|472480468|FG000|Overall Study|Other|2|||
131232878|NCT00992407|472480469|FG001|Overall Study|Other|0|||
131232879|NCT00992407|472480468|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
131232880|NCT00992407|472480469|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
131232881|NCT00992407|472480468|FG000|Overall Study|Study medication not administered|17|||
131232882|NCT00992407|472480469|FG001|Overall Study|Study medication not administered|13|||
131232883|NCT00635778|472480472|FG000|Overall Study|Adverse Event|1|||
131232884|NCT00635778|472480473|FG001|Overall Study|Adverse Event|0|||
131232885|NCT00635778|472480474|FG002|Overall Study|Adverse Event|0|||
131232886|NCT00635778|472480475|FG003|Overall Study|Adverse Event|3|||
131232887|NCT00635778|472480476|FG004|Overall Study|Adverse Event|3|||
131232888|NCT00635778|472480477|FG005|Overall Study|Adverse Event|6|||
131232889|NCT00635778|472480478|FG006|Overall Study|Adverse Event|1|||
131232890|NCT00635778|472480472|FG000|Overall Study|Withdrawal by Subject|0|||
131232891|NCT00635778|472480473|FG001|Overall Study|Withdrawal by Subject|0|||
131232892|NCT00635778|472480474|FG002|Overall Study|Withdrawal by Subject|0|||
131232893|NCT00635778|472480475|FG003|Overall Study|Withdrawal by Subject|1|||
131232894|NCT00635778|472480476|FG004|Overall Study|Withdrawal by Subject|0|||
131232895|NCT00635778|472480477|FG005|Overall Study|Withdrawal by Subject|1|||
131232896|NCT00635778|472480478|FG006|Overall Study|Withdrawal by Subject|1|||
131232897|NCT00635778|472480472|FG000|Overall Study|Progressive disease|0|||
131232898|NCT00635778|472480473|FG001|Overall Study|Progressive disease|3|||
131232899|NCT00635778|472480474|FG002|Overall Study|Progressive disease|3|||
130727144|NCT02883049|470625424|FG000|Induction|Incomplete induction data|17|||
130727145|NCT02883049|470625425|FG001|Induction|Incomplete induction data|0|||
130727146|NCT02883049|470625426|FG002|Induction|Incomplete induction data|0|||
130727147|NCT02883049|470625427|FG003|Induction|Incomplete induction data|0|||
130727148|NCT02883049|470625428|FG004|Induction|Incomplete induction data|0|||
130727149|NCT02883049|470625429|FG005|Induction|Incomplete induction data|0|||
130727150|NCT02883049|470625430|FG006|Induction|Incomplete induction data|0|||
130727151|NCT02883049|470625431|FG007|Induction|Incomplete induction data|0|||
131232900|NCT00635778|472480475|FG003|Overall Study|Progressive disease|4|||
131232901|NCT00635778|472480476|FG004|Overall Study|Progressive disease|5|||
131232902|NCT00635778|472480477|FG005|Overall Study|Progressive disease|14|||
131232903|NCT00635778|472480478|FG006|Overall Study|Progressive disease|4|||
131232904|NCT00812253|472480479|FG000|Overall Study|Withdrawal by Subject|3|||
131232905|NCT00812253|472480480|FG001|Overall Study|Withdrawal by Subject|2|||
131232906|NCT00812253|472480479|FG000|Overall Study|Protocol Violation|1|||
131232907|NCT00812253|472480480|FG001|Overall Study|Protocol Violation|1|||
131232908|NCT00812253|472480479|FG000|Overall Study|Lost to Follow-up|2|||
131232909|NCT00812253|472480480|FG001|Overall Study|Lost to Follow-up|0|||
131232910|NCT01884025|472480481|FG000|Overall Study|Lost to Follow-up|3|||
131232911|NCT01884025|472480482|FG001|Overall Study|Lost to Follow-up|4|||
131232912|NCT02918162|472480483|FG000|Overall Study|Withdrawal by Subject|1|||
131232913|NCT02918162|472480483|FG000|Overall Study|Omental Disease|1|||
131232914|NCT00395226|472480484|FG000|Overall Study|Adverse Event|4|||
131232915|NCT00395226|472480485|FG001|Overall Study|Adverse Event|3|||
131232916|NCT00395226|472480484|FG000|Overall Study|Withdrawal by Subject|0|||
131232917|NCT00395226|472480485|FG001|Overall Study|Withdrawal by Subject|1|||
131232918|NCT00395226|472480484|FG000|Overall Study|Lost to Follow-up|0|||
131232919|NCT00395226|472480485|FG001|Overall Study|Lost to Follow-up|1|||
131232920|NCT02374918|472480486|FG000|Overall Study|Protocol Violation|2|||
131232921|NCT02374918|472480487|FG001|Overall Study|Protocol Violation|0|||
131232922|NCT02374918|472480488|FG002|Overall Study|Protocol Violation|2|||
131232923|NCT02374918|472480489|FG003|Overall Study|Protocol Violation|1|||
131232924|NCT02374918|472480486|FG000|Overall Study|Withdrawal by Subject|1|||
131232925|NCT02374918|472480487|FG001|Overall Study|Withdrawal by Subject|1|||
131232926|NCT02374918|472480488|FG002|Overall Study|Withdrawal by Subject|1|||
131232927|NCT02374918|472480489|FG003|Overall Study|Withdrawal by Subject|0|||
131232928|NCT02374918|472480486|FG000|Overall Study|Lack of Efficacy|0|||
131232929|NCT02374918|472480487|FG001|Overall Study|Lack of Efficacy|0|||
131232930|NCT02374918|472480488|FG002|Overall Study|Lack of Efficacy|1|||
131232931|NCT02374918|472480489|FG003|Overall Study|Lack of Efficacy|1|||
130727152|NCT02883049|470625432|FG008|Induction|Incomplete induction data|0|||
130727153|NCT02883049|470625433|FG009|Induction|Incomplete induction data|0|||
130727154|NCT02883049|470625434|FG010|Induction|Incomplete induction data|0|||
130727155|NCT02883049|470625435|FG011|Induction|Incomplete induction data|0|||
130727156|NCT02883049|470625436|FG012|Induction|Incomplete induction data|0|||
130727157|NCT02883049|470625437|FG013|Induction|Incomplete induction data|0|||
130727158|NCT02883049|470625438|FG014|Induction|Incomplete induction data|0|||
130727159|NCT02883049|470625439|FG015|Induction|Incomplete induction data|0|||
131232932|NCT01180244|472480490|FG000|Overall Study|Lack of Efficacy|0|||
131232933|NCT01180244|472480491|FG001|Overall Study|Lack of Efficacy|7|||
131232934|NCT01180244|472480490|FG000|Overall Study|Physician Decision|3|||
131232935|NCT01180244|472480491|FG001|Overall Study|Physician Decision|0|||
131232936|NCT01180244|472480490|FG000|Overall Study|Adverse Event|1|||
131232937|NCT01180244|472480491|FG001|Overall Study|Adverse Event|0|||
131232938|NCT01180244|472480490|FG000|Overall Study|Withdrawal by Subject|0|||
131232939|NCT01180244|472480491|FG001|Overall Study|Withdrawal by Subject|1|||
131232940|NCT01180244|472480490|FG000|Overall Study|Protocol Violation|1|||
131232941|NCT01180244|472480491|FG001|Overall Study|Protocol Violation|0|||
131232942|NCT01180244|472480490|FG000|Overall Study|Lost to Follow-up|1|||
131232943|NCT01180244|472480491|FG001|Overall Study|Lost to Follow-up|0|||
131232944|NCT00729859|472480492|FG000|Overall Study|Adverse Event|0|||
131232945|NCT00729859|472480493|FG001|Overall Study|Adverse Event|1|||
131232946|NCT00729859|472480494|FG002|Overall Study|Adverse Event|0|||
131232947|NCT00729859|472480492|FG000|Overall Study|Withdrawal by Subject|0|||
131232948|NCT00729859|472480493|FG001|Overall Study|Withdrawal by Subject|1|||
131232949|NCT00729859|472480494|FG002|Overall Study|Withdrawal by Subject|0|||
131232950|NCT02623829|472480497|FG000|Overall Study|Lost to Follow-up|1|||
131232951|NCT02623829|472480498|FG001|Overall Study|Lost to Follow-up|1|||
131232952|NCT03349333|472480499|FG000|Overall Study|Progression of Disease|36|||
131232953|NCT03349333|472480499|FG000|Overall Study|Adverse Event|11|||
131232954|NCT03349333|472480499|FG000|Overall Study|Other|6|||
131232955|NCT03349333|472480499|FG000|Overall Study|Withdrawal by Subject|5|||
131232956|NCT03349333|472480499|FG000|Overall Study|Conditions interfere with participation|2|||
131232957|NCT03349333|472480499|FG000|Overall Study|Physician Decision|2|||
131232958|NCT03349333|472480499|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
131232959|NCT03349333|472480499|FG000|Overall Study|Patients in treatment less than 24 month|8|||
131232960|NCT00783796|472480500|FG000|Overall Study|Did not receive any stent|4|||
131232961|NCT00783796|472480500|FG000|Overall Study|Received non-XIENCE V stent|1|||
130727160|NCT02883049|470625424|FG000|Post Induction|Adverse Event|0|||
130727161|NCT02883049|470625425|FG001|Post Induction|Adverse Event|0|||
130727162|NCT02883049|470625426|FG002|Post Induction|Adverse Event|0|||
130727163|NCT02883049|470625427|FG003|Post Induction|Adverse Event|7|||
130727164|NCT02883049|470625428|FG004|Post Induction|Adverse Event|8|||
130727165|NCT02883049|470625429|FG005|Post Induction|Adverse Event|3|||
130727166|NCT02883049|470625430|FG006|Post Induction|Adverse Event|4|||
130780226|NCT01719380|470821454|FG007|Overall Study|Physician Decision|0|||
131232962|NCT00783796|472480500|FG000|Overall Study|Received commercial XIENCE V stent|1|||
131232963|NCT03267264|472480502|FG000|Overall Study|Withdrawal by Subject|1|||
131232964|NCT03267264|472480503|FG001|Overall Study|Withdrawal by Subject|0|||
131232965|NCT03267264|472480504|FG002|Overall Study|Withdrawal by Subject|2|||
131232966|NCT03267264|472480505|FG003|Overall Study|Withdrawal by Subject|4|||
131232967|NCT01766921|472480506|FG000|Overall Study|Administrative Reason|5|||
130727167|NCT02883049|470625431|FG007|Post Induction|Adverse Event|5|||
131232968|NCT01766921|472480507|FG001|Overall Study|Administrative Reason|5|||
131232969|NCT01766921|472480506|FG000|Overall Study|Death|1|||
131232970|NCT01766921|472480507|FG001|Overall Study|Death|1|||
131232971|NCT01766921|472480506|FG000|Overall Study|Lost to Follow-up|1|||
131232972|NCT01766921|472480507|FG001|Overall Study|Lost to Follow-up|3|||
131232973|NCT01766921|472480506|FG000|Overall Study|Unclassified|2|||
131232974|NCT01766921|472480507|FG001|Overall Study|Unclassified|2|||
131232975|NCT01766921|472480506|FG000|Overall Study|Protocol Violation|1|||
131232976|NCT01766921|472480507|FG001|Overall Study|Protocol Violation|1|||
131232977|NCT01766921|472480506|FG000|Overall Study|Withdrawal by Subject|14|||
131232978|NCT01766921|472480507|FG001|Overall Study|Withdrawal by Subject|5|||
131232979|NCT01915732|472480508|FG000|Overall Study|Withdrawal by Subject|18|||
131232980|NCT01915732|472480509|FG001|Overall Study|Withdrawal by Subject|18|||
131232981|NCT01915732|472480508|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
131232982|NCT01915732|472480509|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
131232983|NCT01915732|472480508|FG000|Overall Study|Adverse Event|12|||
131232984|NCT01915732|472480509|FG001|Overall Study|Adverse Event|4|||
131232985|NCT01915732|472480508|FG000|Overall Study|Protocol Violation|5|||
131232986|NCT01915732|472480509|FG001|Overall Study|Protocol Violation|5|||
131232987|NCT01915732|472480508|FG000|Overall Study|Lack of Efficacy|6|||
131232988|NCT01915732|472480509|FG001|Overall Study|Lack of Efficacy|11|||
131232989|NCT01915732|472480508|FG000|Overall Study|Lost to Follow-up|22|||
131232990|NCT01915732|472480509|FG001|Overall Study|Lost to Follow-up|26|||
131232991|NCT01915732|472480508|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
131232992|NCT01915732|472480509|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
131232993|NCT01915732|472480508|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
131232994|NCT01915732|472480509|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
131232995|NCT01915732|472480508|FG000|Overall Study|Drug Release Error|1|||
131232996|NCT01915732|472480509|FG001|Overall Study|Drug Release Error|0|||
131232997|NCT01915732|472480508|FG000|Overall Study|Recovered|1|||
131232998|NCT01915732|472480509|FG001|Overall Study|Recovered|0|||
131232999|NCT01915732|472480508|FG000|Overall Study|Pregnancy|1|||
131233000|NCT01915732|472480509|FG001|Overall Study|Pregnancy|0|||
131233001|NCT01915732|472480508|FG000|Overall Study|Poor Perceived Efficacy|1|||
131233002|NCT01915732|472480509|FG001|Overall Study|Poor Perceived Efficacy|0|||
131233003|NCT01915732|472480508|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
131233004|NCT01915732|472480509|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
131233005|NCT01915732|472480508|FG000|Overall Study|Got Well|0|||
131080496|NCT02049515|471928477|FG001|Overall Study|Protocol-specified Disease Progression|2|||
131080497|NCT02049515|471928476|FG000|Overall Study|Death|6|||
131233006|NCT01915732|472480509|FG001|Overall Study|Got Well|1|||
131233007|NCT01915732|472480508|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
131233008|NCT01915732|472480509|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
131233009|NCT01915732|472480508|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
131233010|NCT01915732|472480509|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
131233011|NCT01915732|472480508|FG000|Overall Study|Job Transfer|0|||
131233012|NCT01915732|472480509|FG001|Overall Study|Job Transfer|1|||
131233013|NCT01915732|472480508|FG000|Overall Study|Improper Facial Procedure|0|||
131233014|NCT01915732|472480509|FG001|Overall Study|Improper Facial Procedure|1|||
131233015|NCT01915732|472480508|FG000|Overall Study|Poor Conscious Effect|0|||
131233016|NCT01915732|472480509|FG001|Overall Study|Poor Conscious Effect|1|||
131233017|NCT01654380|472480518|FG000|Part B, Period 1|Physician Decision|0|||
131233018|NCT01654380|472480519|FG001|Part B, Period 1|Physician Decision|0|||
131233019|NCT01654380|472480520|FG002|Part B, Period 1|Physician Decision|1|||
131233020|NCT01654380|472480521|FG003|Part B, Period 1|Physician Decision|0|||
130727168|NCT02883049|470625432|FG008|Post Induction|Adverse Event|6|||
130727169|NCT02883049|470625433|FG009|Post Induction|Adverse Event|7|||
130727170|NCT02883049|470625434|FG010|Post Induction|Adverse Event|2|||
130727171|NCT02883049|470625435|FG011|Post Induction|Adverse Event|2|||
130727172|NCT02883049|470625436|FG012|Post Induction|Adverse Event|0|||
130727173|NCT02883049|470625437|FG013|Post Induction|Adverse Event|0|||
130727174|NCT02883049|470625438|FG014|Post Induction|Adverse Event|5|||
130727175|NCT02883049|470625439|FG015|Post Induction|Adverse Event|2|||
131233021|NCT02015793|472480530|FG000|Overall Study|Adverse Event|3|||
130727176|NCT02883049|470625424|FG000|Post Induction|Death|0|||
130727177|NCT02883049|470625425|FG001|Post Induction|Death|0|||
131233022|NCT02015793|472480531|FG001|Overall Study|Adverse Event|3|||
131233023|NCT02015793|472480530|FG000|Overall Study|Withdrawal by Subject|1|||
130727178|NCT02883049|470625426|FG002|Post Induction|Death|0|||
131080498|NCT02049515|471928477|FG001|Overall Study|Death|0|||
131233024|NCT02015793|472480531|FG001|Overall Study|Withdrawal by Subject|1|||
131233025|NCT00437281|472480532|FG000|Overall Study|Adverse Event|0|||
131233026|NCT00437281|472480533|FG001|Overall Study|Adverse Event|0|||
131233027|NCT00437281|472480534|FG002|Overall Study|Adverse Event|0|||
131233028|NCT00437281|472480535|FG003|Overall Study|Adverse Event|1|||
130727179|NCT02883049|470625427|FG003|Post Induction|Death|9|||
131233029|NCT00437281|472480536|FG004|Overall Study|Adverse Event|0|||
130727180|NCT02883049|470625428|FG004|Post Induction|Death|9|||
130727181|NCT02883049|470625429|FG005|Post Induction|Death|0|||
131080499|NCT02049515|471928476|FG000|Overall Study|Physician Decision|5|||
131080500|NCT02049515|471928477|FG001|Overall Study|Physician Decision|1|||
131080501|NCT02049515|471928476|FG000|Overall Study|Withdrawal by Subject|3|||
131080502|NCT02049515|471928477|FG001|Overall Study|Withdrawal by Subject|0|||
131080503|NCT02049515|471928476|FG000|Overall Study|Termination of the Study by Sponsor|2|||
131080504|NCT02049515|471928477|FG001|Overall Study|Termination of the Study by Sponsor|0|||
131080505|NCT02049515|471928476|FG000|Overall Study|Protocol Violation|1|||
131080506|NCT02049515|471928477|FG001|Overall Study|Protocol Violation|1|||
131080507|NCT02049515|471928476|FG000|Overall Study|Clinical Deterioration|1|||
131080508|NCT02049515|471928477|FG001|Overall Study|Clinical Deterioration|0|||
131080509|NCT02049515|471928476|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
131233030|NCT00437281|472480537|FG005|Overall Study|Adverse Event|1|||
131233031|NCT00437281|472480538|FG006|Overall Study|Adverse Event|0|||
131233032|NCT00437281|472480539|FG007|Overall Study|Adverse Event|0|||
131233033|NCT00437281|472480540|FG008|Overall Study|Adverse Event|0|||
131233034|NCT00437281|472480541|FG009|Overall Study|Adverse Event|1|||
131233035|NCT00437281|472480542|FG010|Overall Study|Adverse Event|0|||
131233036|NCT00437281|472480543|FG011|Overall Study|Adverse Event|0|||
131233037|NCT00437281|472480544|FG012|Overall Study|Adverse Event|0|||
131233038|NCT00437281|472480545|FG013|Overall Study|Adverse Event|1|||
131233039|NCT00437281|472480546|FG014|Overall Study|Adverse Event|1|||
131233040|NCT00437281|472480547|FG015|Overall Study|Adverse Event|0|||
131233041|NCT00437281|472480548|FG016|Overall Study|Adverse Event|0|||
131233042|NCT00437281|472480549|FG017|Overall Study|Adverse Event|0|||
131233043|NCT00437281|472480550|FG018|Overall Study|Adverse Event|1|||
131233044|NCT00437281|472480551|FG019|Overall Study|Adverse Event|0|||
131233045|NCT00437281|472480532|FG000|Overall Study|Lost to Follow-up|0|||
131233046|NCT00437281|472480533|FG001|Overall Study|Lost to Follow-up|0|||
131233047|NCT00437281|472480534|FG002|Overall Study|Lost to Follow-up|0|||
131233048|NCT00437281|472480535|FG003|Overall Study|Lost to Follow-up|0|||
131233049|NCT00437281|472480536|FG004|Overall Study|Lost to Follow-up|0|||
131233050|NCT00437281|472480537|FG005|Overall Study|Lost to Follow-up|0|||
131233051|NCT00437281|472480538|FG006|Overall Study|Lost to Follow-up|0|||
131233052|NCT00437281|472480539|FG007|Overall Study|Lost to Follow-up|0|||
131233053|NCT00437281|472480540|FG008|Overall Study|Lost to Follow-up|0|||
131233054|NCT00437281|472480541|FG009|Overall Study|Lost to Follow-up|0|||
131233055|NCT00437281|472480542|FG010|Overall Study|Lost to Follow-up|0|||
131233056|NCT00437281|472480543|FG011|Overall Study|Lost to Follow-up|0|||
131233057|NCT00437281|472480544|FG012|Overall Study|Lost to Follow-up|0|||
131080510|NCT02049515|471928477|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
131233058|NCT00437281|472480545|FG013|Overall Study|Lost to Follow-up|0|||
131233059|NCT00437281|472480546|FG014|Overall Study|Lost to Follow-up|0|||
131080511|NCT02049515|471928476|FG000|Overall Study|Treatment Interruption >42 Days|1|||
131080512|NCT02049515|471928477|FG001|Overall Study|Treatment Interruption >42 Days|0|||
131080513|NCT02049515|471928476|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
131080514|NCT02049515|471928477|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
131080515|NCT00224029|471928479|FG000|Overall Study|Lost to Follow-up|1|||
131080516|NCT00224029|471928479|FG000|Overall Study|Withdrawal by Subject|4|||
131080517|NCT00224029|471928479|FG000|Overall Study|Other|1|||
131080518|NCT01390441|471928480|FG000|Treatment Period|Protocol Violation|0|||
131080519|NCT01390441|471928481|FG001|Treatment Period|Protocol Violation|1|||
131080520|NCT01390441|471928482|FG002|Treatment Period|Protocol Violation|0|||
131080521|NCT01390441|471928483|FG003|Treatment Period|Protocol Violation|0|||
131080522|NCT01390441|471928484|FG004|Treatment Period|Protocol Violation|0|||
131080523|NCT01390441|471928480|FG000|Treatment Period|Physician Decision|0|||
131080524|NCT01390441|471928481|FG001|Treatment Period|Physician Decision|0|||
131080525|NCT01390441|471928482|FG002|Treatment Period|Physician Decision|0|||
131080526|NCT01390441|471928483|FG003|Treatment Period|Physician Decision|1|||
131080527|NCT01390441|471928484|FG004|Treatment Period|Physician Decision|0|||
131080528|NCT01390441|471928480|FG000|Treatment Period|Lack of Efficacy|0|||
131233060|NCT00437281|472480547|FG015|Overall Study|Lost to Follow-up|0|||
131080529|NCT01390441|471928481|FG001|Treatment Period|Lack of Efficacy|0|||
131080530|NCT01390441|471928482|FG002|Treatment Period|Lack of Efficacy|0|||
131080531|NCT01390441|471928483|FG003|Treatment Period|Lack of Efficacy|0|||
131080532|NCT01390441|471928484|FG004|Treatment Period|Lack of Efficacy|1|||
131080533|NCT01390441|471928480|FG000|Treatment Period|Unknown due to early stopping of study|0|||
131080534|NCT01390441|471928481|FG001|Treatment Period|Unknown due to early stopping of study|0|||
131080535|NCT01390441|471928482|FG002|Treatment Period|Unknown due to early stopping of study|8|||
131233061|NCT00437281|472480548|FG016|Overall Study|Lost to Follow-up|0|||
131233062|NCT00437281|472480549|FG017|Overall Study|Lost to Follow-up|0|||
131233063|NCT00437281|472480550|FG018|Overall Study|Lost to Follow-up|0|||
131080536|NCT01390441|471928483|FG003|Treatment Period|Unknown due to early stopping of study|11|||
131080537|NCT01390441|471928484|FG004|Treatment Period|Unknown due to early stopping of study|7|||
131233064|NCT00437281|472480551|FG019|Overall Study|Lost to Follow-up|1|||
131080538|NCT01390441|471928480|FG000|Treatment Period|Adverse Event|0|||
131080539|NCT01390441|471928481|FG001|Treatment Period|Adverse Event|0|||
131233065|NCT00947427|472480552|FG000|Overall Study|Withdrawal by Subject|1|||
131233066|NCT00947427|472480553|FG001|Overall Study|Withdrawal by Subject|3|||
131140830|NCT00428597|472141861|FG000|Overall Study|Withdrawal by Subject|2|||
131140831|NCT00428597|472141862|FG001|Overall Study|Withdrawal by Subject|1|||
131140832|NCT00428597|472141861|FG000|Overall Study|Other|1|||
131140833|NCT00428597|472141862|FG001|Overall Study|Other|1|||
131140834|NCT00428597|472141861|FG000|Overall Study|Lost to Follow-up|0|||
131140835|NCT00428597|472141862|FG001|Overall Study|Lost to Follow-up|1|||
131140836|NCT00428597|472141861|FG000|Overall Study|Pregnancy|1|||
131140837|NCT00428597|472141862|FG001|Overall Study|Pregnancy|0|||
131140838|NCT00428597|472141861|FG000|Overall Study|Death|1|||
131140839|NCT00428597|472141862|FG001|Overall Study|Death|3|||
131140840|NCT00686647|472141870|FG000|Overall Study|Lost to Follow-up|1|||
131140841|NCT00686647|472141870|FG000|Overall Study|Death|1|||
131140842|NCT05501119|472141874|FG000|Overall Study|Withdrawal by Subject|2|||
131080540|NCT01390441|471928482|FG002|Treatment Period|Adverse Event|1|||
131080541|NCT01390441|471928483|FG003|Treatment Period|Adverse Event|1|||
131080542|NCT01390441|471928484|FG004|Treatment Period|Adverse Event|2|||
131080543|NCT01390441|471928480|FG000|Treatment Period|Withdrawal by Subject|0|||
131080544|NCT01390441|471928481|FG001|Treatment Period|Withdrawal by Subject|0|||
131080545|NCT01390441|471928482|FG002|Treatment Period|Withdrawal by Subject|1|||
131080546|NCT01390441|471928483|FG003|Treatment Period|Withdrawal by Subject|0|||
131080547|NCT01390441|471928484|FG004|Treatment Period|Withdrawal by Subject|1|||
131080548|NCT01390441|471928480|FG000|Treatment Period|Lost to Follow-up|1|||
131080549|NCT01390441|471928481|FG001|Treatment Period|Lost to Follow-up|0|||
131080550|NCT01390441|471928482|FG002|Treatment Period|Lost to Follow-up|0|||
131080551|NCT01390441|471928483|FG003|Treatment Period|Lost to Follow-up|0|||
131080552|NCT01390441|471928484|FG004|Treatment Period|Lost to Follow-up|0|||
131080553|NCT01390441|471928480|FG000|Extension Period|Protocol Violation|3|||
131140843|NCT05501119|472141874|FG000|Overall Study|Lost to Follow-up|5|||
131140844|NCT01725750|472141875|FG000|Overall Study|Adverse Event|1|||
131140845|NCT01725750|472141876|FG001|Overall Study|Adverse Event|0|||
131140846|NCT01725750|472141875|FG000|Overall Study|Lost to Follow-up|1|||
131140847|NCT01725750|472141876|FG001|Overall Study|Lost to Follow-up|1|||
131140848|NCT01725750|472141875|FG000|Overall Study|Withdrawal by Subject|0|||
131140849|NCT01725750|472141876|FG001|Overall Study|Withdrawal by Subject|9|||
131140850|NCT02542072|472141877|FG000|First Intervention (1 Month)|Adverse Event|1|||
131140851|NCT02542072|472141878|FG001|First Intervention (1 Month)|Adverse Event|1|||
131140852|NCT02542072|472141877|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
131140853|NCT02542072|472141878|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
131140854|NCT02542072|472141877|FG000|First Intervention (1 Month)|Lens discomfort|1|||
131140855|NCT02542072|472141878|FG001|First Intervention (1 Month)|Lens discomfort|2|||
131140856|NCT02542072|472141877|FG000|First Intervention (1 Month)|Protocol Violation|1|||
131140857|NCT02542072|472141878|FG001|First Intervention (1 Month)|Protocol Violation|0|||
131140858|NCT02542072|472141877|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
131140859|NCT02542072|472141878|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
131140860|NCT02542072|472141877|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
131140861|NCT02542072|472141878|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
131140862|NCT00654498|472141879|FG000|Overall Study|Not Treated|1|||
131140863|NCT00654498|472141880|FG001|Overall Study|Not Treated|0|||
131140864|NCT00654498|472141879|FG000|Overall Study|Adverse Event|6|||
131140865|NCT00654498|472141880|FG001|Overall Study|Adverse Event|1|||
131140866|NCT00654498|472141879|FG000|Overall Study|Protocol Violation|1|||
131140867|NCT00654498|472141880|FG001|Overall Study|Protocol Violation|1|||
131140868|NCT00654498|472141879|FG000|Overall Study|Lost to Follow-up|1|||
131140869|NCT00654498|472141880|FG001|Overall Study|Lost to Follow-up|5|||
131140870|NCT00654498|472141879|FG000|Overall Study|Withdrawal by Subject|1|||
131140871|NCT00654498|472141880|FG001|Overall Study|Withdrawal by Subject|0|||
131140872|NCT00654498|472141879|FG000|Overall Study|Other reason not defined above|4|||
131140873|NCT00654498|472141880|FG001|Overall Study|Other reason not defined above|5|||
131140874|NCT01356589|472141884|FG000|Overall Study|Enrolled, but not treated|3|||
131140875|NCT01356589|472141884|FG000|Overall Study|Dose data not recorded|2|||
131140876|NCT01738971|472141893|FG000|Overall Study|Lost to Follow-up|19|||
131140877|NCT01738971|472141894|FG001|Overall Study|Lost to Follow-up|30|||
131140878|NCT01738971|472141895|FG002|Overall Study|Lost to Follow-up|17|||
131233067|NCT00947427|472480552|FG000|Overall Study|Protocol Violation|0|||
131080554|NCT01390441|471928481|FG001|Extension Period|Protocol Violation|1|||
131080555|NCT01390441|471928482|FG002|Extension Period|Protocol Violation|0|||
131080556|NCT01390441|471928483|FG003|Extension Period|Protocol Violation|1|||
131080557|NCT01390441|471928484|FG004|Extension Period|Protocol Violation|0|||
131080558|NCT01407276|471928485|FG000|Overall Study|Withdrawal by Subject|0|||
131080559|NCT01407276|471928486|FG001|Overall Study|Withdrawal by Subject|0|||
131080560|NCT01407276|471928487|FG002|Overall Study|Withdrawal by Subject|0|||
131140879|NCT01031446|472141896|FG000|Overall Study|Disease Progression|38|||
131080561|NCT01407276|471928488|FG003|Overall Study|Withdrawal by Subject|0|||
131140880|NCT01031446|472141896|FG000|Overall Study|Adverse Event|9|||
131140881|NCT01031446|472141896|FG000|Overall Study|Physician Decision|4|||
131140882|NCT01031446|472141896|FG000|Overall Study|Withdrawal by Subject|3|||
131140883|NCT01031446|472141896|FG000|Overall Study|Still on treatment|1|||
131140884|NCT02447848|472141897|FG000|Overall Study|Patient discharged|3|||
131140885|NCT02447848|472141897|FG000|Overall Study|Lack of Efficacy|4|||
131140886|NCT02447848|472141897|FG000|Overall Study|Withdrawal by Subject|4|||
131140887|NCT03631706|472141898|FG000|Overall Study|Randomized, not treated|1|||
131140888|NCT03631706|472141899|FG001|Overall Study|Randomized, not treated|0|||
131140889|NCT00865020|472141905|FG000|Overall Study|Withdrawal by Subject|22|||
131140890|NCT00865020|472141906|FG001|Overall Study|Withdrawal by Subject|16|||
131140891|NCT00865020|472141905|FG000|Overall Study|Adverse Event|9|||
131140892|NCT00865020|472141906|FG001|Overall Study|Adverse Event|14|||
131140893|NCT00865020|472141905|FG000|Overall Study|Abnormal test procedure result(s)|6|||
131140894|NCT00865020|472141906|FG001|Overall Study|Abnormal test procedure result(s)|8|||
131140895|NCT00865020|472141905|FG000|Overall Study|Lost to Follow-up|6|||
131140896|NCT00865020|472141906|FG001|Overall Study|Lost to Follow-up|4|||
131140897|NCT00865020|472141905|FG000|Overall Study|Protocol deviation|4|||
131140898|NCT00865020|472141906|FG001|Overall Study|Protocol deviation|1|||
131140899|NCT00865020|472141905|FG000|Overall Study|Administrative problems|0|||
131140900|NCT00865020|472141906|FG001|Overall Study|Administrative problems|2|||
131140901|NCT00865020|472141905|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131140902|NCT00865020|472141906|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131140903|NCT00865020|472141905|FG000|Overall Study|Death|0|||
131140904|NCT00865020|472141906|FG001|Overall Study|Death|1|||
131140905|NCT00865020|472141905|FG000|Overall Study|Randomized but discontinued|2|||
131140906|NCT00865020|472141906|FG001|Overall Study|Randomized but discontinued|4|||
131140907|NCT03641560|472141907|FG000|Overall Study|Withdrawal by Subject|6|||
131140908|NCT03641560|472141907|FG000|Overall Study|Progressive disease|40|||
131140909|NCT03641560|472141907|FG000|Overall Study|Death|6|||
131140910|NCT05847686|472143721|FG000|Overall Study|Withdrawal by Subject|3|||
131140911|NCT06272370|472143722|FG000|Overall Study|Lost to Follow-up|0|||
131140912|NCT06272370|472143723|FG001|Overall Study|Lost to Follow-up|3|||
131140913|NCT06272370|472143724|FG002|Overall Study|Lost to Follow-up|1|||
131140914|NCT06272370|472143725|FG003|Overall Study|Lost to Follow-up|1|||
131140915|NCT05888103|472143727|FG000|Overall Study|Participant decision|3|||
131140916|NCT05888103|472143728|FG001|Overall Study|Participant decision|3|||
131140917|NCT00352534|472143729|FG000|Initial Staging|Ineligible|8|||
131140918|NCT00352534|472143730|FG001|Initial Staging|Ineligible|9|||
131140919|NCT00352534|472143731|FG002|Initial Staging|Ineligible|0|||
131140920|NCT00352534|472143732|FG003|Initial Staging|Ineligible|0|||
131140921|NCT00352534|472143733|FG004|Initial Staging|Ineligible|0|||
131140922|NCT00352534|472143734|FG005|Initial Staging|Ineligible|0|||
131140923|NCT00352534|472143735|FG006|Initial Staging|Ineligible|0|||
131140924|NCT00352534|472143729|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
131140925|NCT00352534|472143730|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
131140926|NCT00352534|472143731|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
131140927|NCT00352534|472143732|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
131140928|NCT00352534|472143733|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
131140929|NCT00352534|472143734|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
131140930|NCT00352534|472143735|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
131140931|NCT00352534|472143729|FG000|Final Risk Group Assignment|Physician Decision|0|||
131140932|NCT00352534|472143730|FG001|Final Risk Group Assignment|Physician Decision|0|||
131140933|NCT00352534|472143731|FG002|Final Risk Group Assignment|Physician Decision|0|||
131140934|NCT00352534|472143732|FG003|Final Risk Group Assignment|Physician Decision|0|||
131140935|NCT00352534|472143733|FG004|Final Risk Group Assignment|Physician Decision|0|||
131140936|NCT00352534|472143734|FG005|Final Risk Group Assignment|Physician Decision|8|||
131140937|NCT00352534|472143735|FG006|Final Risk Group Assignment|Physician Decision|0|||
131140938|NCT00352534|472143729|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
131140939|NCT00352534|472143730|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
131140940|NCT00352534|472143731|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
131140941|NCT00352534|472143732|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
131140942|NCT00352534|472143733|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
131140943|NCT00352534|472143734|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
131140944|NCT00352534|472143735|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
131140945|NCT00352534|472143729|FG000|Final Risk Group Assignment|Ineligible|0|||
131140946|NCT00352534|472143730|FG001|Final Risk Group Assignment|Ineligible|0|||
131140947|NCT00352534|472143731|FG002|Final Risk Group Assignment|Ineligible|3|||
131140948|NCT00352534|472143732|FG003|Final Risk Group Assignment|Ineligible|1|||
131140949|NCT00352534|472143733|FG004|Final Risk Group Assignment|Ineligible|0|||
131140950|NCT00352534|472143734|FG005|Final Risk Group Assignment|Ineligible|13|||
131140951|NCT00352534|472143735|FG006|Final Risk Group Assignment|Ineligible|0|||
131140952|NCT00352534|472143729|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131140953|NCT00352534|472143730|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131140954|NCT00352534|472143731|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131140955|NCT00352534|472143732|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131140956|NCT00352534|472143733|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131140957|NCT00352534|472143734|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
131233068|NCT00947427|472480553|FG001|Overall Study|Protocol Violation|1|||
131233069|NCT00601354|472480554|FG000|Overall Study|Lost to Follow-up|4|||
131233070|NCT00601354|472480555|FG001|Overall Study|Lost to Follow-up|5|||
131233071|NCT01862328|472480558|FG000|Overall Study|Progressive Disease|3|||
131233072|NCT01862328|472480559|FG001|Overall Study|Progressive Disease|11|||
131233073|NCT01862328|472480560|FG002|Overall Study|Progressive Disease|5|||
131233074|NCT01862328|472480561|FG003|Overall Study|Progressive Disease|6|||
131233075|NCT01862328|472480562|FG004|Overall Study|Progressive Disease|7|||
131233076|NCT01862328|472480563|FG005|Overall Study|Progressive Disease|4|||
131233077|NCT01862328|472480564|FG006|Overall Study|Progressive Disease|3|||
131233078|NCT01862328|472480558|FG000|Overall Study|Adverse Event|0|||
131233079|NCT01862328|472480559|FG001|Overall Study|Adverse Event|4|||
131233080|NCT01862328|472480560|FG002|Overall Study|Adverse Event|0|||
131233081|NCT01862328|472480561|FG003|Overall Study|Adverse Event|1|||
131233082|NCT01862328|472480562|FG004|Overall Study|Adverse Event|0|||
131233083|NCT01862328|472480563|FG005|Overall Study|Adverse Event|2|||
131233084|NCT01862328|472480564|FG006|Overall Study|Adverse Event|4|||
131233085|NCT01862328|472480558|FG000|Overall Study|Other|0|||
131233086|NCT01862328|472480559|FG001|Overall Study|Other|2|||
131233087|NCT01862328|472480560|FG002|Overall Study|Other|1|||
131233088|NCT01862328|472480561|FG003|Overall Study|Other|0|||
131233089|NCT01862328|472480562|FG004|Overall Study|Other|4|||
131233090|NCT01862328|472480563|FG005|Overall Study|Other|0|||
131233091|NCT01862328|472480564|FG006|Overall Study|Other|1|||
131233092|NCT01862328|472480558|FG000|Overall Study|Withdrawal by Subject|1|||
131233093|NCT01862328|472480559|FG001|Overall Study|Withdrawal by Subject|1|||
131233094|NCT01862328|472480560|FG002|Overall Study|Withdrawal by Subject|0|||
131233095|NCT01862328|472480561|FG003|Overall Study|Withdrawal by Subject|0|||
131233096|NCT01862328|472480562|FG004|Overall Study|Withdrawal by Subject|1|||
131233097|NCT01862328|472480563|FG005|Overall Study|Withdrawal by Subject|1|||
131233098|NCT01862328|472480564|FG006|Overall Study|Withdrawal by Subject|1|||
131233099|NCT01862328|472480558|FG000|Overall Study|Symptomatic Deterioration|0|||
131233100|NCT01862328|472480559|FG001|Overall Study|Symptomatic Deterioration|0|||
131233101|NCT01862328|472480560|FG002|Overall Study|Symptomatic Deterioration|0|||
131080562|NCT01407276|471928489|FG004|Overall Study|Withdrawal by Subject|0|||
131080563|NCT01407276|471928490|FG005|Overall Study|Withdrawal by Subject|0|||
131080564|NCT01407276|471928491|FG006|Overall Study|Withdrawal by Subject|0|||
131233102|NCT01862328|472480561|FG003|Overall Study|Symptomatic Deterioration|0|||
131233103|NCT01862328|472480562|FG004|Overall Study|Symptomatic Deterioration|0|||
131233104|NCT01862328|472480563|FG005|Overall Study|Symptomatic Deterioration|0|||
131233105|NCT01862328|472480564|FG006|Overall Study|Symptomatic Deterioration|1|||
131233106|NCT01411995|472480565|FG000|Overall Study|Failed IUD insertion|0|||
131233107|NCT01411995|472480566|FG001|Overall Study|Failed IUD insertion|1|||
131233108|NCT00936975|472480567|FG000|Overall Study|Withdrawal by Subject|1|||
131233109|NCT00936975|472480567|FG000|Overall Study|Disease progression|3|||
131233110|NCT00936975|472480567|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
131233111|NCT01656889|472480568|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
131233112|NCT01656889|472480569|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
131233113|NCT01656889|472480568|FG000|Treatment Period, 12 Weeks|Death|0|||
131233114|NCT01656889|472480569|FG001|Treatment Period, 12 Weeks|Death|1|||
131233115|NCT01656889|472480568|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
131233116|NCT01656889|472480569|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
131233117|NCT01656889|472480568|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
131233118|NCT01656889|472480569|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
131233119|NCT01656889|472480568|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
131233120|NCT01656889|472480569|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
131233121|NCT01656889|472480568|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
131233122|NCT01656889|472480569|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
131233123|NCT01656889|472480568|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
131233124|NCT01656889|472480569|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
131233125|NCT01656889|472480568|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
131233126|NCT01656889|472480569|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
131233127|NCT01656889|472480568|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
131233128|NCT01656889|472480569|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
131233129|NCT01656889|472480568|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
131233130|NCT01656889|472480569|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
131233131|NCT02974153|472480570|FG000|Overall Study|Adverse Event|6|||
130727182|NCT02883049|470625430|FG006|Post Induction|Death|1|||
130727183|NCT02883049|470625431|FG007|Post Induction|Death|6|||
130727184|NCT02883049|470625432|FG008|Post Induction|Death|5|||
131080565|NCT01407276|471928492|FG007|Overall Study|Withdrawal by Subject|1|||
131080566|NCT02635386|471928493|FG000|Overall Study|Pregnancy|2|||
131233132|NCT02974153|472480571|FG001|Overall Study|Adverse Event|0|||
130727185|NCT02883049|470625433|FG009|Post Induction|Death|3|||
131080567|NCT02635386|471928494|FG001|Overall Study|Pregnancy|0|||
131233133|NCT02974153|472480572|FG002|Overall Study|Adverse Event|1|||
131233134|NCT02974153|472480570|FG000|Overall Study|Lack of Efficacy|6|||
131233135|NCT02974153|472480571|FG001|Overall Study|Lack of Efficacy|5|||
130727186|NCT02883049|470625434|FG010|Post Induction|Death|1|||
130727187|NCT02883049|470625435|FG011|Post Induction|Death|0|||
131080568|NCT02635386|471928495|FG002|Overall Study|Pregnancy|0|||
131080569|NCT02635386|471928496|FG003|Overall Study|Pregnancy|0|||
131080570|NCT02635386|471928497|FG004|Overall Study|Pregnancy|2|||
131080571|NCT02635386|471928493|FG000|Overall Study|Withdrawal by Subject|1|||
131080572|NCT02635386|471928494|FG001|Overall Study|Withdrawal by Subject|1|||
131080573|NCT02635386|471928495|FG002|Overall Study|Withdrawal by Subject|0|||
131080574|NCT02635386|471928496|FG003|Overall Study|Withdrawal by Subject|1|||
131080575|NCT02635386|471928497|FG004|Overall Study|Withdrawal by Subject|0|||
131080576|NCT02635386|471928493|FG000|Overall Study|Physician Decision|0|||
131080577|NCT02635386|471928494|FG001|Overall Study|Physician Decision|1|||
131080578|NCT02635386|471928495|FG002|Overall Study|Physician Decision|0|||
131080579|NCT02635386|471928496|FG003|Overall Study|Physician Decision|0|||
131080580|NCT02635386|471928497|FG004|Overall Study|Physician Decision|0|||
131080581|NCT02635386|471928493|FG000|Overall Study|Moved Out of State|0|||
131080582|NCT02635386|471928494|FG001|Overall Study|Moved Out of State|1|||
131080583|NCT02635386|471928495|FG002|Overall Study|Moved Out of State|0|||
131080584|NCT02635386|471928496|FG003|Overall Study|Moved Out of State|0|||
131080585|NCT02635386|471928497|FG004|Overall Study|Moved Out of State|0|||
131080586|NCT02635386|471928493|FG000|Overall Study|Noncompliant|0|||
131080587|NCT02635386|471928494|FG001|Overall Study|Noncompliant|2|||
131080588|NCT02635386|471928495|FG002|Overall Study|Noncompliant|1|||
131080589|NCT02635386|471928496|FG003|Overall Study|Noncompliant|1|||
131080590|NCT02635386|471928497|FG004|Overall Study|Noncompliant|1|||
131080591|NCT02635386|471928493|FG000|Overall Study|side effects|0|||
131080592|NCT02635386|471928494|FG001|Overall Study|side effects|0|||
131080593|NCT02635386|471928495|FG002|Overall Study|side effects|1|||
131080594|NCT02635386|471928496|FG003|Overall Study|side effects|4|||
131080595|NCT02635386|471928497|FG004|Overall Study|side effects|6|||
131080596|NCT02635386|471928493|FG000|Overall Study|needed other major surgery|0|||
131080597|NCT02635386|471928494|FG001|Overall Study|needed other major surgery|1|||
131080598|NCT02635386|471928495|FG002|Overall Study|needed other major surgery|0|||
131080599|NCT02635386|471928496|FG003|Overall Study|needed other major surgery|0|||
131080600|NCT02635386|471928497|FG004|Overall Study|needed other major surgery|0|||
131080601|NCT02635386|471928493|FG000|Overall Study|Other medical problems not drug related|0|||
131080602|NCT02635386|471928494|FG001|Overall Study|Other medical problems not drug related|0|||
131080603|NCT02635386|471928495|FG002|Overall Study|Other medical problems not drug related|0|||
131080604|NCT02635386|471928496|FG003|Overall Study|Other medical problems not drug related|1|||
131140958|NCT00352534|472143735|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
131140959|NCT00352534|472143729|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131140960|NCT00352534|472143730|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131140961|NCT00352534|472143731|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131140962|NCT00352534|472143732|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131140963|NCT00352534|472143733|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131140964|NCT00352534|472143734|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
131140965|NCT00352534|472143735|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
131140966|NCT00352534|472143729|FG000|Final Risk Group Assignment|Death|0|||
131140967|NCT00352534|472143730|FG001|Final Risk Group Assignment|Death|0|||
131140968|NCT00352534|472143731|FG002|Final Risk Group Assignment|Death|0|||
131140969|NCT00352534|472143732|FG003|Final Risk Group Assignment|Death|0|||
130727188|NCT02883049|470625436|FG012|Post Induction|Death|1|||
130727189|NCT02883049|470625437|FG013|Post Induction|Death|1|||
130727190|NCT02883049|470625438|FG014|Post Induction|Death|10|||
130727191|NCT02883049|470625439|FG015|Post Induction|Death|2|||
131080605|NCT02635386|471928497|FG004|Overall Study|Other medical problems not drug related|0|||
131080606|NCT00778921|471928501|FG000|Overall Study|Adverse Event|9|||
131080607|NCT00778921|471928502|FG001|Overall Study|Adverse Event|10|||
131080608|NCT00778921|471928503|FG002|Overall Study|Adverse Event|14|||
131080609|NCT00778921|471928501|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
131080610|NCT00778921|471928502|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
131080611|NCT00778921|471928503|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
131080612|NCT00778921|471928501|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
131140970|NCT00352534|472143733|FG004|Final Risk Group Assignment|Death|0|||
131140971|NCT00352534|472143734|FG005|Final Risk Group Assignment|Death|2|||
130727192|NCT02883049|470625424|FG000|Post Induction|Lost to Follow-up|0|||
131080613|NCT00778921|471928502|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
131080614|NCT00778921|471928503|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
131080615|NCT00778921|471928501|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
131080616|NCT00778921|471928502|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
131080617|NCT00778921|471928503|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
131140972|NCT00352534|472143735|FG006|Final Risk Group Assignment|Death|0|||
131080618|NCT00778921|471928501|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
131080619|NCT00778921|471928502|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
131080620|NCT00778921|471928503|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
131233136|NCT02974153|472480572|FG002|Overall Study|Lack of Efficacy|10|||
131233137|NCT02974153|472480570|FG000|Overall Study|Lost to Follow-up|9|||
131233138|NCT02974153|472480571|FG001|Overall Study|Lost to Follow-up|10|||
131233139|NCT02974153|472480572|FG002|Overall Study|Lost to Follow-up|17|||
131233140|NCT02974153|472480570|FG000|Overall Study|Physician Decision|0|||
131233141|NCT02974153|472480571|FG001|Overall Study|Physician Decision|2|||
131233142|NCT02974153|472480572|FG002|Overall Study|Physician Decision|1|||
130727193|NCT02883049|470625425|FG001|Post Induction|Lost to Follow-up|0|||
130727194|NCT02883049|470625426|FG002|Post Induction|Lost to Follow-up|0|||
130727195|NCT02883049|470625427|FG003|Post Induction|Lost to Follow-up|0|||
130727196|NCT02883049|470625428|FG004|Post Induction|Lost to Follow-up|1|||
131233143|NCT02974153|472480570|FG000|Overall Study|Withdrawal by Subject|9|||
131233144|NCT02974153|472480571|FG001|Overall Study|Withdrawal by Subject|16|||
131233145|NCT02974153|472480572|FG002|Overall Study|Withdrawal by Subject|11|||
131233146|NCT02974153|472480570|FG000|Overall Study|Study Burden|8|||
131233147|NCT02974153|472480571|FG001|Overall Study|Study Burden|7|||
131233148|NCT02974153|472480572|FG002|Overall Study|Study Burden|3|||
131233149|NCT02974153|472480570|FG000|Overall Study|Other|14|||
131233150|NCT02974153|472480571|FG001|Overall Study|Other|8|||
131233151|NCT02974153|472480572|FG002|Overall Study|Other|7|||
131233152|NCT02521948|472480573|FG000|Overall Study|Adverse Event|2|||
131233153|NCT02521948|472480573|FG000|Overall Study|Death|4|||
131233154|NCT02521948|472480573|FG000|Overall Study|Lost to Follow-up|1|||
131233155|NCT02521948|472480573|FG000|Overall Study|Did not attend one or both follow-ups|6|||
131233156|NCT02427607|472480574|FG000|Overall Study|Withdrawal by Subject|1|||
131233157|NCT00423800|472480575|FG000|Overall Study|Protocol Violation|0|||
131233158|NCT00423800|472480576|FG001|Overall Study|Protocol Violation|1|||
131233159|NCT04000009|472480577|FG000|Overall Study|Adverse Event|13|||
131233160|NCT04000009|472480577|FG000|Overall Study|Lack of Efficacy|7|||
131233161|NCT04000009|472480577|FG000|Overall Study|Lost to Follow-up|8|||
131233162|NCT04000009|472480577|FG000|Overall Study|Noncompliance with study drug|4|||
131233163|NCT04000009|472480577|FG000|Overall Study|Physician Decision|1|||
131233164|NCT04000009|472480577|FG000|Overall Study|Use of prohibited medication|3|||
131233165|NCT04000009|472480577|FG000|Overall Study|Pregnancy|1|||
131233166|NCT04000009|472480577|FG000|Overall Study|Withdrawal by Subject|22|||
131233167|NCT04000009|472480577|FG000|Overall Study|Study terminated by sponsor|98|||
131233168|NCT04000009|472480577|FG000|Overall Study|Not further specified|8|||
131233169|NCT00679783|472480579|FG000|Overall Study|Adverse Event|0|||
131233170|NCT00679783|472480580|FG001|Overall Study|Adverse Event|0|||
131233171|NCT00679783|472480581|FG002|Overall Study|Adverse Event|0|||
131233172|NCT00679783|472480582|FG003|Overall Study|Adverse Event|3|||
131233173|NCT00679783|472480583|FG004|Overall Study|Adverse Event|0|||
131233174|NCT00679783|472480584|FG005|Overall Study|Adverse Event|0|||
131233175|NCT00679783|472480585|FG006|Overall Study|Adverse Event|1|||
131233176|NCT00679783|472480579|FG000|Overall Study|Lack of Efficacy|0|||
131233177|NCT00679783|472480580|FG001|Overall Study|Lack of Efficacy|1|||
131233178|NCT00679783|472480581|FG002|Overall Study|Lack of Efficacy|0|||
131233179|NCT00679783|472480582|FG003|Overall Study|Lack of Efficacy|2|||
131233180|NCT00679783|472480583|FG004|Overall Study|Lack of Efficacy|0|||
131233181|NCT00679783|472480584|FG005|Overall Study|Lack of Efficacy|0|||
131233182|NCT00679783|472480585|FG006|Overall Study|Lack of Efficacy|0|||
131233183|NCT00679783|472480579|FG000|Overall Study|Withdrawal by Subject|0|||
131233184|NCT00679783|472480580|FG001|Overall Study|Withdrawal by Subject|0|||
131233185|NCT00679783|472480581|FG002|Overall Study|Withdrawal by Subject|1|||
131233186|NCT00679783|472480582|FG003|Overall Study|Withdrawal by Subject|1|||
131233187|NCT00679783|472480583|FG004|Overall Study|Withdrawal by Subject|0|||
131233188|NCT00679783|472480584|FG005|Overall Study|Withdrawal by Subject|0|||
131233189|NCT00679783|472480585|FG006|Overall Study|Withdrawal by Subject|0|||
130727197|NCT02883049|470625429|FG005|Post Induction|Lost to Follow-up|1|||
131080621|NCT00778921|471928501|FG000|Overall Study|Patient withdrew request|3|||
131080622|NCT00778921|471928502|FG001|Overall Study|Patient withdrew request|1|||
131080623|NCT00778921|471928503|FG002|Overall Study|Patient withdrew request|6|||
131080624|NCT00778921|471928501|FG000|Overall Study|Lost to Follow-up|0|||
131080625|NCT00778921|471928502|FG001|Overall Study|Lost to Follow-up|2|||
131080626|NCT00778921|471928503|FG002|Overall Study|Lost to Follow-up|1|||
131080627|NCT00778921|471928501|FG000|Overall Study|Administrative Problems|1|||
131080628|NCT00778921|471928502|FG001|Overall Study|Administrative Problems|2|||
131080629|NCT00778921|471928503|FG002|Overall Study|Administrative Problems|0|||
131080630|NCT00778921|471928501|FG000|Overall Study|Protocol Violation|3|||
131233190|NCT00679783|472480579|FG000|Overall Study|Not Captured|0|||
131233191|NCT00679783|472480580|FG001|Overall Study|Not Captured|0|||
131233192|NCT00679783|472480581|FG002|Overall Study|Not Captured|0|||
131233193|NCT00679783|472480582|FG003|Overall Study|Not Captured|5|||
131233194|NCT00679783|472480583|FG004|Overall Study|Not Captured|0|||
131233195|NCT00679783|472480584|FG005|Overall Study|Not Captured|0|||
131233196|NCT00679783|472480585|FG006|Overall Study|Not Captured|0|||
131233197|NCT00679783|472480579|FG000|Overall Study|Ongoing at data cut-off|2|||
131233198|NCT00679783|472480580|FG001|Overall Study|Ongoing at data cut-off|2|||
131233199|NCT00679783|472480581|FG002|Overall Study|Ongoing at data cut-off|0|||
131080631|NCT00778921|471928502|FG001|Overall Study|Protocol Violation|0|||
131080632|NCT00778921|471928503|FG002|Overall Study|Protocol Violation|2|||
131080633|NCT00778921|471928501|FG000|Overall Study|Not treated|0|||
131080634|NCT00778921|471928502|FG001|Overall Study|Not treated|2|||
131080635|NCT00778921|471928503|FG002|Overall Study|Not treated|2|||
131080636|NCT04805073|471928504|FG000|Overall Study|study personnel not available|2|||
131080637|NCT04805073|471928505|FG001|Overall Study|study personnel not available|0|||
131080638|NCT04805073|471928504|FG000|Overall Study|spinal anesthesia failure|0|||
131080639|NCT04805073|471928505|FG001|Overall Study|spinal anesthesia failure|1|||
131080640|NCT04805073|471928504|FG000|Overall Study|Lost to Follow-up|0|||
131080641|NCT04805073|471928505|FG001|Overall Study|Lost to Follow-up|2|||
131080642|NCT01163474|471928506|FG000|Overall Study|Withdrawal by Subject|1|||
131080643|NCT01163474|471928506|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
131080644|NCT01163474|471928506|FG000|Overall Study|Lost to Follow-up|3|||
131080645|NCT01078922|471928514|FG000|Overall Study|Adverse Event|1|||
131080646|NCT02706847|471928517|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
131080647|NCT02706847|471928518|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
131080648|NCT02706847|471928519|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
131080649|NCT02706847|471928520|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
131080650|NCT02706847|471928517|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
131080651|NCT02706847|471928518|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
131080652|NCT02706847|471928519|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
131080653|NCT02706847|471928520|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
131080654|NCT02706847|471928517|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
131080655|NCT02706847|471928518|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
131080656|NCT02706847|471928519|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
131080657|NCT02706847|471928520|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
131080658|NCT02706847|471928517|FG000|Period 1: Day 1 to Week 12|Other|4|||
131080659|NCT02706847|471928518|FG001|Period 1: Day 1 to Week 12|Other|4|||
131080660|NCT02706847|471928519|FG002|Period 1: Day 1 to Week 12|Other|2|||
131080661|NCT02706847|471928520|FG003|Period 1: Day 1 to Week 12|Other|2|||
131080662|NCT02706847|471928517|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
131080663|NCT02706847|471928518|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
131080664|NCT02706847|471928519|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
131080665|NCT02706847|471928520|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
131080666|NCT02706847|471928517|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
131080667|NCT02706847|471928518|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
131080668|NCT02706847|471928519|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
131080669|NCT02706847|471928520|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
131080670|NCT02706847|471928517|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
131080671|NCT02706847|471928518|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
131080672|NCT02706847|471928519|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
131080673|NCT02706847|471928520|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
131080674|NCT02706847|471928517|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
131080675|NCT02706847|471928518|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
131080676|NCT02706847|471928519|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
131080677|NCT02706847|471928520|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
131080678|NCT02706847|471928517|FG000|Period 1: Week 12 to Week 24|Other|1|||
131080679|NCT02706847|471928518|FG001|Period 1: Week 12 to Week 24|Other|0|||
131080680|NCT02706847|471928519|FG002|Period 1: Week 12 to Week 24|Other|1|||
131080681|NCT02706847|471928520|FG003|Period 1: Week 12 to Week 24|Other|4|||
131080682|NCT02706847|471928517|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
131080683|NCT02706847|471928518|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
131080684|NCT02706847|471928519|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
131080685|NCT02706847|471928520|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
131080686|NCT02706847|471928517|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
131080687|NCT02706847|471928518|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
131080688|NCT02706847|471928519|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
131080689|NCT02706847|471928520|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
131080690|NCT02706847|471928517|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
131080691|NCT02706847|471928518|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
131080692|NCT02706847|471928519|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
131080693|NCT02706847|471928520|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
131080694|NCT02706847|471928517|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
131140973|NCT01602341|472143736|FG000|Overall Study|Adverse Event|0|||
131140974|NCT01602341|472143737|FG001|Overall Study|Adverse Event|1|||
131140975|NCT04439279|472143738|FG000|Overall Study|Adverse Event|7|||
131080695|NCT02706847|471928518|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
131080696|NCT02706847|471928519|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
131080697|NCT02706847|471928520|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
131080698|NCT02706847|471928517|FG000|Period 2: Week 24 to Week 260|Other|8|||
131080699|NCT02706847|471928518|FG001|Period 2: Week 24 to Week 260|Other|5|||
131140976|NCT04439279|472143738|FG000|Overall Study|Death|4|||
131080700|NCT02706847|471928519|FG002|Period 2: Week 24 to Week 260|Other|15|||
131080701|NCT02706847|471928520|FG003|Period 2: Week 24 to Week 260|Other|15|||
131080702|NCT01174264|471928523|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
131080703|NCT01174264|471928524|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
131080704|NCT01174264|471928525|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
131080705|NCT01174264|471928523|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
131080706|NCT01174264|471928524|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
131080707|NCT01174264|471928525|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
131233200|NCT00679783|472480582|FG003|Overall Study|Ongoing at data cut-off|9|||
131233201|NCT00679783|472480583|FG004|Overall Study|Ongoing at data cut-off|1|||
131233202|NCT00679783|472480584|FG005|Overall Study|Ongoing at data cut-off|0|||
131233203|NCT00679783|472480585|FG006|Overall Study|Ongoing at data cut-off|0|||
131233204|NCT01754259|472480588|FG000|Overall Study|Withdrawal by Subject|2|||
131233205|NCT01754259|472480589|FG001|Overall Study|Withdrawal by Subject|4|||
131233206|NCT01754259|472480588|FG000|Overall Study|Adverse Event|3|||
131233207|NCT01754259|472480589|FG001|Overall Study|Adverse Event|1|||
131233208|NCT01754259|472480588|FG000|Overall Study|Lost to Follow-up|0|||
131233209|NCT01754259|472480589|FG001|Overall Study|Lost to Follow-up|1|||
131233210|NCT00814320|472480590|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
131233211|NCT00814320|472480591|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
131233212|NCT00814320|472480590|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
131233213|NCT00814320|472480591|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
131233214|NCT00814320|472480590|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
131233215|NCT00814320|472480591|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
131233216|NCT00814320|472480590|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
131233217|NCT00814320|472480591|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
131233218|NCT00814320|472480590|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
131233219|NCT00814320|472480591|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
131233220|NCT00814320|472480590|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
131233221|NCT00814320|472480591|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
131233222|NCT00814320|472480590|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
131233223|NCT00814320|472480591|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
131233224|NCT00814320|472480590|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
131233225|NCT00814320|472480591|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
131233226|NCT00814320|472480590|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
131233227|NCT00814320|472480591|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
131233228|NCT00814320|472480590|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
131233229|NCT00814320|472480591|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
131233230|NCT00491504|472480592|FG000|Overall Study|Adverse Event|0|||
131233231|NCT00491504|472480593|FG001|Overall Study|Adverse Event|1|||
131233232|NCT00491504|472480594|FG002|Overall Study|Adverse Event|0|||
131233233|NCT00491504|472480595|FG003|Overall Study|Adverse Event|0|||
131233234|NCT00491504|472480592|FG000|Overall Study|Withdrawal by Subject|0|||
131233235|NCT00491504|472480593|FG001|Overall Study|Withdrawal by Subject|0|||
131233236|NCT00491504|472480594|FG002|Overall Study|Withdrawal by Subject|1|||
131233237|NCT00491504|472480595|FG003|Overall Study|Withdrawal by Subject|2|||
131233238|NCT00491504|472480592|FG000|Overall Study|Protocol Violation|0|||
131233239|NCT00491504|472480593|FG001|Overall Study|Protocol Violation|0|||
131233240|NCT00491504|472480594|FG002|Overall Study|Protocol Violation|3|||
131233241|NCT00491504|472480595|FG003|Overall Study|Protocol Violation|2|||
131233242|NCT00619385|472480596|FG000|Overall Study|Adverse Event|0|||
131233243|NCT00619385|472480597|FG001|Overall Study|Adverse Event|0|||
131233244|NCT00619385|472480598|FG002|Overall Study|Adverse Event|3|||
131233245|NCT00619385|472480596|FG000|Overall Study|Other|1|||
131233246|NCT00619385|472480597|FG001|Overall Study|Other|2|||
131233247|NCT00619385|472480598|FG002|Overall Study|Other|1|||
131233248|NCT02041702|472480601|FG000|Overall Study|Lost to Follow-up|1|||
131233249|NCT02041702|472480602|FG001|Overall Study|Lost to Follow-up|6|||
131233250|NCT02041702|472480601|FG000|Overall Study|Death|4|||
131233251|NCT02041702|472480602|FG001|Overall Study|Death|0|||
131233252|NCT02041702|472480601|FG000|Overall Study|Withdrawal by Subject|4|||
131233253|NCT02041702|472480602|FG001|Overall Study|Withdrawal by Subject|3|||
131233254|NCT02041702|472480601|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
131233255|NCT02041702|472480602|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
131233256|NCT02041702|472480601|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
131233257|NCT02041702|472480602|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
131233258|NCT01488578|472480603|FG000|Overall Study|Protocol Violation|1836|||
131233259|NCT03271528|472480604|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
131233260|NCT03271528|472480605|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
131233261|NCT03271528|472480604|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
131233262|NCT03271528|472480605|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
131233263|NCT03271528|472480604|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
131140977|NCT04439279|472143738|FG000|Overall Study|Disease progression|17|||
131140978|NCT04439279|472143738|FG000|Overall Study|Complicating disease|3|||
131140979|NCT04439279|472143738|FG000|Overall Study|Withdrawal by Subject|2|||
131140980|NCT04439279|472143738|FG000|Overall Study|Ineligible|1|||
131140981|NCT04439279|472143738|FG000|Overall Study|Treatment still ongoing|1|||
131140982|NCT03521791|472143739|FG000|Overall Study|Protocol Violation|7|||
131140983|NCT03521791|472143740|FG001|Overall Study|Protocol Violation|17|||
131140984|NCT02090855|472143741|FG000|Overall Study|no evaluable Standard of Truth results|2|||
131140985|NCT00680836|472143743|FG000|Overall Study|Withdrawal by Subject|3|||
131140986|NCT00680836|472143744|FG001|Overall Study|Withdrawal by Subject|0|||
131140987|NCT00680836|472143743|FG000|Overall Study|Lost to Follow-up|3|||
131140988|NCT00680836|472143744|FG001|Overall Study|Lost to Follow-up|1|||
131140989|NCT00680836|472143743|FG000|Overall Study|Physician Decision|2|||
131140990|NCT00680836|472143744|FG001|Overall Study|Physician Decision|1|||
131140991|NCT03038308|472143745|FG000|Overall Study|Surgical resection|1|||
131140992|NCT03038308|472143745|FG000|Overall Study|Withdrawal by Subject|2|||
131140993|NCT03038308|472143745|FG000|Overall Study|Lost to Follow-up|1|||
131140994|NCT01777763|472143757|FG000|Overall Study|Adverse Event|2|||
131140995|NCT01777763|472143758|FG001|Overall Study|Adverse Event|32|||
131140996|NCT01777763|472143757|FG000|Overall Study|Protocol Violation|1|||
131140997|NCT01777763|472143758|FG001|Overall Study|Protocol Violation|7|||
131140998|NCT01777763|472143757|FG000|Overall Study|Withdrawal by Subject|0|||
131140999|NCT01777763|472143758|FG001|Overall Study|Withdrawal by Subject|2|||
131141000|NCT01777763|472143757|FG000|Overall Study|Treatment Failure|1|||
131141001|NCT01777763|472143758|FG001|Overall Study|Treatment Failure|6|||
131141002|NCT05512949|472143767|FG000|Overall Study|Lost to Follow-up|4|||
131141003|NCT05512949|472143768|FG001|Overall Study|Lost to Follow-up|6|||
131233264|NCT03271528|472480605|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
131233265|NCT03271528|472480604|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
131233266|NCT03271528|472480605|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
131141004|NCT05512949|472143769|FG002|Overall Study|Lost to Follow-up|2|||
131141005|NCT05512949|472143767|FG000|Overall Study|Protocol Violation|0|||
131141006|NCT05512949|472143768|FG001|Overall Study|Protocol Violation|0|||
131141007|NCT05512949|472143769|FG002|Overall Study|Protocol Violation|1|||
131141008|NCT05512949|472143767|FG000|Overall Study|Withdrawal by Subject|1|||
131141009|NCT05512949|472143768|FG001|Overall Study|Withdrawal by Subject|1|||
131141010|NCT05512949|472143769|FG002|Overall Study|Withdrawal by Subject|2|||
131141011|NCT05512949|472143767|FG000|Overall Study|Completion status unknown|1|||
131141012|NCT05512949|472143768|FG001|Overall Study|Completion status unknown|3|||
131141013|NCT05512949|472143769|FG002|Overall Study|Completion status unknown|0|||
131141014|NCT01246206|472143770|FG000|Overall Study|Patient did not receive study regiments.|1|||
131141015|NCT04660643|472143771|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
131141016|NCT04660643|472143772|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
131141017|NCT04660643|472143773|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
131141018|NCT04660643|472143771|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
131141019|NCT04660643|472143772|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
131141020|NCT04660643|472143773|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
131233267|NCT03271528|472480604|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
131233268|NCT03271528|472480605|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
131233269|NCT03271528|472480604|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
131233270|NCT03271528|472480605|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
131233271|NCT03271528|472480604|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
131233272|NCT03271528|472480605|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
131233273|NCT00306384|472480606|FG000|Overall Study|Adverse Event|103|||
131233274|NCT00306384|472480607|FG001|Overall Study|Adverse Event|87|||
131233275|NCT00306384|472480608|FG002|Overall Study|Adverse Event|40|||
131233276|NCT00306384|472480606|FG000|Overall Study|Major protocol deviation|43|||
131233277|NCT00306384|472480607|FG001|Overall Study|Major protocol deviation|51|||
131233278|NCT00306384|472480608|FG002|Overall Study|Major protocol deviation|18|||
131233279|NCT00306384|472480606|FG000|Overall Study|Lost to Follow-up|57|||
131141021|NCT04660643|472143771|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
131141022|NCT04660643|472143772|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
131141023|NCT04660643|472143773|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
131233280|NCT00306384|472480607|FG001|Overall Study|Lost to Follow-up|41|||
131233281|NCT00306384|472480608|FG002|Overall Study|Lost to Follow-up|35|||
131141024|NCT04660643|472143771|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
131141025|NCT04660643|472143772|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
131141026|NCT04660643|472143773|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
131141027|NCT04660643|472143771|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
131141028|NCT04660643|472143772|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
131141029|NCT04660643|472143773|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
131141030|NCT04660643|472143771|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
130727198|NCT02883049|470625430|FG006|Post Induction|Lost to Follow-up|0|||
130727199|NCT02883049|470625431|FG007|Post Induction|Lost to Follow-up|0|||
130727200|NCT02883049|470625432|FG008|Post Induction|Lost to Follow-up|3|||
130727201|NCT02883049|470625433|FG009|Post Induction|Lost to Follow-up|0|||
130727202|NCT02883049|470625434|FG010|Post Induction|Lost to Follow-up|1|||
131080708|NCT01174264|471928523|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
131080709|NCT01174264|471928524|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
131080710|NCT01174264|471928525|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
131080711|NCT02353871|471928526|FG000|Overall Study|Protocol deviation|0|||
131080712|NCT02353871|471928527|FG001|Overall Study|Protocol deviation|1|||
131080713|NCT02353871|471928526|FG000|Overall Study|Consent withdrawn|1|||
131080714|NCT02353871|471928527|FG001|Overall Study|Consent withdrawn|8|||
131080715|NCT02353871|471928526|FG000|Overall Study|Lost to Follow-up|2|||
131080716|NCT02353871|471928527|FG001|Overall Study|Lost to Follow-up|0|||
131080717|NCT00115336|471928528|FG000|Overall Study|Hospital discharge before study drug|0|||
131080718|NCT00115336|471928529|FG001|Overall Study|Hospital discharge before study drug|1|||
131080719|NCT04905849|471928545|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
131080720|NCT04905849|471928546|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
131080721|NCT04913948|471928549|FG000|Overall Study|Withdrawal by Subject|2|||
131080722|NCT04913948|471928549|FG000|Overall Study|Sample processing issues|1|||
131080723|NCT04913948|471928549|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
131080724|NCT04199052|471928550|FG000|Overall Study|Lost to Follow-up|11|||
131080725|NCT04199052|471928551|FG001|Overall Study|Lost to Follow-up|18|||
131141031|NCT04660643|472143772|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
131141032|NCT04660643|472143773|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
131141033|NCT04660643|472143771|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
131141034|NCT04660643|472143772|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
131141035|NCT04660643|472143773|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
131141036|NCT04660643|472143771|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
131141037|NCT04660643|472143772|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
131141038|NCT04660643|472143773|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
131141039|NCT04660643|472143771|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
131141040|NCT04660643|472143772|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
131141041|NCT04660643|472143773|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
131141042|NCT04660643|472143771|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
131141043|NCT04660643|472143772|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
131141044|NCT04660643|472143773|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
131141045|NCT04660643|472143771|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
131141046|NCT04660643|472143772|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
131141047|NCT04660643|472143773|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
131141048|NCT04660643|472143771|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
131141049|NCT04660643|472143772|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
131141050|NCT04660643|472143773|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
131141051|NCT04660643|472143771|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
131141052|NCT04660643|472143772|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
131141053|NCT04660643|472143773|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
131141054|NCT04660643|472143771|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
131141055|NCT04660643|472143772|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
131141056|NCT04660643|472143773|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
131141057|NCT04660643|472143771|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
131141058|NCT04660643|472143772|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
131141059|NCT04660643|472143773|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
131141060|NCT04660643|472143771|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
131141061|NCT04660643|472143772|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
131141062|NCT04660643|472143773|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
131141063|NCT03988907|472143774|FG000|Overall Study|Unable to complete visit|0|||
131141064|NCT03988907|472143775|FG001|Overall Study|Unable to complete visit|1|||
131141065|NCT02810964|472143776|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
131141066|NCT02810964|472143777|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
131141067|NCT02810964|472143776|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
131141068|NCT02810964|472143777|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
131141069|NCT02810964|472143776|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
131141070|NCT02810964|472143777|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
130727203|NCT02883049|470625435|FG011|Post Induction|Lost to Follow-up|0|||
130727204|NCT02883049|470625436|FG012|Post Induction|Lost to Follow-up|0|||
131141071|NCT02810964|472143776|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
131141072|NCT02810964|472143777|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
131141073|NCT01171820|472143779|FG000|Overall Study|Death|3|||
131141074|NCT01171820|472143780|FG001|Overall Study|Death|3|||
131080736|NCT00699842|471928554|FG000|Overall Study|Death|0|||
131080737|NCT00699842|471928555|FG001|Overall Study|Death|1|||
131080738|NCT00699842|471928556|FG002|Overall Study|Death|0|||
131080739|NCT03522389|471928557|FG000|Overall Study|Lost to Follow-up|1|||
131080740|NCT03522389|471928558|FG001|Overall Study|Lost to Follow-up|1|||
131080741|NCT03522389|471928559|FG002|Overall Study|Lost to Follow-up|2|||
131080742|NCT03522389|471928557|FG000|Overall Study|had herniated nucleus pulposus|0|||
131080743|NCT03522389|471928558|FG001|Overall Study|had herniated nucleus pulposus|1|||
131080744|NCT03522389|471928559|FG002|Overall Study|had herniated nucleus pulposus|0|||
131080745|NCT03522389|471928557|FG000|Overall Study|go to work in other province|1|||
131080746|NCT03522389|471928558|FG001|Overall Study|go to work in other province|0|||
131080747|NCT03522389|471928559|FG002|Overall Study|go to work in other province|0|||
131080748|NCT04750577|471928560|FG000|Overall Study|Adverse Event|2|||
131080749|NCT04750577|471928561|FG001|Overall Study|Adverse Event|10|||
131080750|NCT04750577|471928562|FG002|Overall Study|Adverse Event|8|||
131080751|NCT04750577|471928563|FG003|Overall Study|Adverse Event|1|||
131080752|NCT04750577|471928560|FG000|Overall Study|Change of residence|0|||
131080753|NCT04750577|471928561|FG001|Overall Study|Change of residence|0|||
131080754|NCT04750577|471928562|FG002|Overall Study|Change of residence|1|||
131080755|NCT04750577|471928563|FG003|Overall Study|Change of residence|0|||
131080756|NCT04750577|471928560|FG000|Overall Study|Burden of study procedures|0|||
131080757|NCT04750577|471928561|FG001|Overall Study|Burden of study procedures|2|||
131080758|NCT04750577|471928562|FG002|Overall Study|Burden of study procedures|2|||
131080759|NCT04750577|471928563|FG003|Overall Study|Burden of study procedures|0|||
131080760|NCT04750577|471928560|FG000|Overall Study|Prematurely discontinued|0|||
131080761|NCT04750577|471928561|FG001|Overall Study|Prematurely discontinued|0|||
131080762|NCT04750577|471928562|FG002|Overall Study|Prematurely discontinued|0|||
131080763|NCT04750577|471928563|FG003|Overall Study|Prematurely discontinued|2|||
131080764|NCT04750577|471928560|FG000|Overall Study|Protocol deviation|1|||
131080765|NCT04750577|471928561|FG001|Overall Study|Protocol deviation|1|||
131080766|NCT04750577|471928562|FG002|Overall Study|Protocol deviation|1|||
131080767|NCT04750577|471928563|FG003|Overall Study|Protocol deviation|1|||
131080768|NCT04750577|471928560|FG000|Overall Study|Other than listed|3|||
131080769|NCT04750577|471928561|FG001|Overall Study|Other than listed|2|||
131080770|NCT04750577|471928562|FG002|Overall Study|Other than listed|2|||
131080771|NCT04750577|471928563|FG003|Overall Study|Other than listed|1|||
131080772|NCT04750577|471928560|FG000|Overall Study|Not treated|0|||
131080773|NCT04750577|471928561|FG001|Overall Study|Not treated|0|||
131080774|NCT04750577|471928562|FG002|Overall Study|Not treated|0|||
131080775|NCT04750577|471928563|FG003|Overall Study|Not treated|2|||
131080776|NCT04599907|471928566|FG000|Overall Study|Withdrawal by Subject|1|||
131080777|NCT04599907|471928567|FG001|Overall Study|Withdrawal by Subject|7|||
131080778|NCT04599907|471928568|FG002|Overall Study|Withdrawal by Subject|6|||
131080779|NCT04599907|471928566|FG000|Overall Study|Lost to Follow-up|0|||
131080780|NCT04599907|471928567|FG001|Overall Study|Lost to Follow-up|1|||
131080781|NCT04599907|471928568|FG002|Overall Study|Lost to Follow-up|0|||
131080782|NCT01466790|471928569|FG000|Overall Study|Adverse Event|1|||
131080783|NCT01466790|471928570|FG001|Overall Study|Adverse Event|0|||
131080784|NCT01466790|471928571|FG002|Overall Study|Adverse Event|0|||
131080785|NCT01466790|471928572|FG003|Overall Study|Adverse Event|0|||
131080786|NCT01466790|471928573|FG004|Overall Study|Adverse Event|2|||
131080787|NCT01466790|471928574|FG005|Overall Study|Adverse Event|0|||
131080788|NCT01466790|471928575|FG006|Overall Study|Adverse Event|0|||
131141075|NCT01171820|472143779|FG000|Overall Study|Lost to Follow-up|0|||
131141076|NCT01171820|472143780|FG001|Overall Study|Lost to Follow-up|1|||
131141077|NCT01171820|472143779|FG000|Overall Study|Withdrawal by Subject|2|||
131141078|NCT01171820|472143780|FG001|Overall Study|Withdrawal by Subject|0|||
131141079|NCT01171820|472143779|FG000|Overall Study|Physician Decision|0|||
131141080|NCT01171820|472143780|FG001|Overall Study|Physician Decision|1|||
131141081|NCT01171820|472143779|FG000|Overall Study|1-Year Missed Visit|1|||
131141082|NCT01171820|472143780|FG001|Overall Study|1-Year Missed Visit|1|||
131141083|NCT03969875|472143781|FG000|Overall Study|did not receive allocated intervention|3|||
131141084|NCT03969875|472143782|FG001|Overall Study|did not receive allocated intervention|3|||
131141085|NCT03969875|472143783|FG002|Overall Study|did not receive allocated intervention|4|||
131141086|NCT03969875|472143781|FG000|Overall Study|Protocol Violation|4|||
131141087|NCT03969875|472143782|FG001|Overall Study|Protocol Violation|2|||
131141088|NCT03969875|472143783|FG002|Overall Study|Protocol Violation|2|||
131141089|NCT00568555|472143786|FG000|Overall Study|Withdrawal by Subject|1|||
131141090|NCT00568555|472143787|FG001|Overall Study|Withdrawal by Subject|1|||
131141091|NCT01307033|472143788|FG000|8-week Double-blind Period|Adverse Event|2|||
131141092|NCT01307033|472143789|FG001|8-week Double-blind Period|Adverse Event|0|||
131141093|NCT01307033|472143790|FG002|8-week Double-blind Period|Adverse Event|0|||
131141094|NCT01307033|472143791|FG003|8-week Double-blind Period|Adverse Event|0|||
131233282|NCT00306384|472480606|FG000|Overall Study|Voluntary withdrawal|199|||
131233283|NCT00306384|472480607|FG001|Overall Study|Voluntary withdrawal|187|||
131233284|NCT00306384|472480608|FG002|Overall Study|Voluntary withdrawal|91|||
131233285|NCT00306384|472480606|FG000|Overall Study|Study termination|1|||
131233286|NCT00306384|472480607|FG001|Overall Study|Study termination|0|||
131233287|NCT00306384|472480608|FG002|Overall Study|Study termination|1|||
131233288|NCT00306384|472480606|FG000|Overall Study|Pregnancy|3|||
131233289|NCT00306384|472480607|FG001|Overall Study|Pregnancy|1|||
131233290|NCT00306384|472480608|FG002|Overall Study|Pregnancy|1|||
131233291|NCT00306384|472480606|FG000|Overall Study|Lack of Efficacy|26|||
131233292|NCT00306384|472480607|FG001|Overall Study|Lack of Efficacy|40|||
131233293|NCT00306384|472480608|FG002|Overall Study|Lack of Efficacy|38|||
131233294|NCT00306384|472480606|FG000|Overall Study|Investigator discretion|28|||
131233295|NCT00306384|472480607|FG001|Overall Study|Investigator discretion|31|||
131233296|NCT00306384|472480608|FG002|Overall Study|Investigator discretion|21|||
131233297|NCT00306384|472480606|FG000|Overall Study|Other|80|||
131233298|NCT00306384|472480607|FG001|Overall Study|Other|70|||
131233299|NCT00306384|472480608|FG002|Overall Study|Other|32|||
131233300|NCT00306384|472480606|FG000|Overall Study|Site closure|2|||
131233301|NCT00306384|472480607|FG001|Overall Study|Site closure|0|||
131233302|NCT00306384|472480608|FG002|Overall Study|Site closure|0|||
131233303|NCT01873859|472480611|FG000|Overall Study|Withdrawal by Subject|0|||
131233304|NCT01873859|472480612|FG001|Overall Study|Withdrawal by Subject|4|||
131233305|NCT03977584|472480613|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
131233306|NCT03977584|472480614|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
131233307|NCT03977584|472480615|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
131233308|NCT03504852|472480619|FG000|Overall Study|Withdrawal of informed consent|2|||
131233309|NCT03504852|472480620|FG001|Overall Study|Withdrawal of informed consent|1|||
131233310|NCT03504852|472480621|FG002|Overall Study|Withdrawal of informed consent|0|||
131233311|NCT03504852|472480619|FG000|Overall Study|Withdrawal by Subject|5|||
131233312|NCT03504852|472480620|FG001|Overall Study|Withdrawal by Subject|5|||
131233313|NCT03504852|472480621|FG002|Overall Study|Withdrawal by Subject|1|||
131233314|NCT03504852|472480619|FG000|Overall Study|Lost to Follow-up|4|||
131233315|NCT03504852|472480620|FG001|Overall Study|Lost to Follow-up|1|||
131233316|NCT03504852|472480621|FG002|Overall Study|Lost to Follow-up|0|||
131233317|NCT03504852|472480619|FG000|Overall Study|New therapy for study indication|1|||
131233318|NCT03504852|472480620|FG001|Overall Study|New therapy for study indication|0|||
131233319|NCT03504852|472480621|FG002|Overall Study|New therapy for study indication|0|||
131233320|NCT03504852|472480619|FG000|Overall Study|Lack of Efficacy|1|||
131233321|NCT03504852|472480620|FG001|Overall Study|Lack of Efficacy|2|||
131233322|NCT03504852|472480621|FG002|Overall Study|Lack of Efficacy|0|||
131233323|NCT03504852|472480619|FG000|Overall Study|Death|0|||
131233324|NCT03504852|472480620|FG001|Overall Study|Death|1|||
131233325|NCT03504852|472480621|FG002|Overall Study|Death|0|||
131233326|NCT03504852|472480619|FG000|Overall Study|Adverse Event|4|||
131233327|NCT03504852|472480620|FG001|Overall Study|Adverse Event|8|||
131233328|NCT03504852|472480621|FG002|Overall Study|Adverse Event|2|||
131233329|NCT01066052|472480622|FG000|Overall Study|Enrolled But Not Treated|3|||
131233330|NCT01066052|472480623|FG001|Overall Study|Enrolled But Not Treated|0|||
131233331|NCT03850509|472480624|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
131233332|NCT03850509|472480625|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
131233333|NCT00969332|472480626|FG000|Overall Study|Physician Decision|8|||
131233334|NCT00969332|472480626|FG000|Overall Study|Withdrawal by Subject|3|||
131080789|NCT01466790|471928576|FG007|Overall Study|Adverse Event|0|||
131080790|NCT01466790|471928569|FG000|Overall Study|Lost to Follow-up|2|||
131080791|NCT01466790|471928570|FG001|Overall Study|Lost to Follow-up|0|||
131080792|NCT01466790|471928571|FG002|Overall Study|Lost to Follow-up|0|||
131080793|NCT01466790|471928572|FG003|Overall Study|Lost to Follow-up|0|||
131080794|NCT01466790|471928573|FG004|Overall Study|Lost to Follow-up|0|||
131080795|NCT01466790|471928574|FG005|Overall Study|Lost to Follow-up|0|||
131080796|NCT01466790|471928575|FG006|Overall Study|Lost to Follow-up|0|||
131080797|NCT01466790|471928576|FG007|Overall Study|Lost to Follow-up|0|||
131080798|NCT01466790|471928569|FG000|Overall Study|Withdrawal by Subject|1|||
131233335|NCT01835145|472480630|FG000|Overall Study|Ineligible prior to treatment|1|||
131233336|NCT01835145|472480631|FG001|Overall Study|Ineligible prior to treatment|0|||
131233337|NCT01565083|472480632|FG000|Overall Study|Withdrawal by Subject|6|||
131233338|NCT01565083|472480633|FG001|Overall Study|Withdrawal by Subject|4|||
131233339|NCT01565083|472480632|FG000|Overall Study|Lost to Follow-up|2|||
131233340|NCT01565083|472480633|FG001|Overall Study|Lost to Follow-up|7|||
131233341|NCT01565083|472480632|FG000|Overall Study|Death|22|||
131233342|NCT01565083|472480633|FG001|Overall Study|Death|23|||
131233343|NCT01565083|472480632|FG000|Overall Study|Other|3|||
130727205|NCT02883049|470625437|FG013|Post Induction|Lost to Follow-up|0|||
131080799|NCT01466790|471928570|FG001|Overall Study|Withdrawal by Subject|1|||
131080800|NCT01466790|471928571|FG002|Overall Study|Withdrawal by Subject|0|||
131233344|NCT01565083|472480633|FG001|Overall Study|Other|5|||
131233345|NCT02708277|472480634|FG000|Overall Study|Lost to Follow-up|7|||
131233346|NCT02708277|472480635|FG001|Overall Study|Lost to Follow-up|4|||
131080801|NCT01466790|471928572|FG003|Overall Study|Withdrawal by Subject|0|||
131080802|NCT01466790|471928573|FG004|Overall Study|Withdrawal by Subject|1|||
131080803|NCT01466790|471928574|FG005|Overall Study|Withdrawal by Subject|0|||
131080804|NCT01466790|471928575|FG006|Overall Study|Withdrawal by Subject|1|||
131080805|NCT01466790|471928576|FG007|Overall Study|Withdrawal by Subject|1|||
131080806|NCT01251887|471928578|FG000|Overall Study|Scheduling conflict|1|||
131080807|NCT01251887|471928579|FG001|Overall Study|Scheduling conflict|2|||
131080808|NCT01251887|471928580|FG002|Overall Study|Scheduling conflict|2|||
131080809|NCT01251887|471928578|FG000|Overall Study|Physician Decision|0|||
131080810|NCT01251887|471928579|FG001|Overall Study|Physician Decision|1|||
131080811|NCT01251887|471928580|FG002|Overall Study|Physician Decision|0|||
131080812|NCT03668223|471928581|FG000|Overall Study|Death|10|||
131080813|NCT03668223|471928582|FG001|Overall Study|Death|5|||
131080814|NCT03668223|471928581|FG000|Overall Study|Lost to Follow-up|12|||
131080815|NCT03668223|471928582|FG001|Overall Study|Lost to Follow-up|12|||
131080816|NCT03668223|471928581|FG000|Overall Study|Withdrawal by Subject|8|||
131080817|NCT03668223|471928582|FG001|Overall Study|Withdrawal by Subject|3|||
131080818|NCT01103232|471928583|FG000|Overall Study|Withdrawal by Subject|1|||
131080819|NCT01103232|471928584|FG001|Overall Study|Withdrawal by Subject|1|||
131080820|NCT01103232|471928583|FG000|Overall Study|Protocol Violation|0|||
131080821|NCT01103232|471928584|FG001|Overall Study|Protocol Violation|1|||
131080822|NCT05347485|471928585|FG000|Overall Study|Death|14|||
131080823|NCT05347485|471928585|FG000|Overall Study|Lost to Follow-up|2|||
131080824|NCT05347485|471928585|FG000|Overall Study|Withdrawal by Subject|13|||
131080825|NCT05347485|471928585|FG000|Overall Study|Progressive Disease|1|||
131080826|NCT05347485|471928585|FG000|Overall Study|Study Terminated by Sponsor|49|||
131080827|NCT05347485|471928585|FG000|Overall Study|Other|1|||
131080828|NCT05347485|471928585|FG000|Overall Study|Enrolled (consented) but not treated|4|||
131080829|NCT05347485|471928585|FG000|Overall Study|Disease Relapse|2|||
131080830|NCT04650698|471930093|FG000|Overall Study|Protocol Violation|2|||
131080831|NCT04650698|471930094|FG001|Overall Study|Protocol Violation|1|||
131080832|NCT04650698|471930093|FG000|Overall Study|Withdrawal by Subject|0|||
131080833|NCT04650698|471930094|FG001|Overall Study|Withdrawal by Subject|1|||
131080834|NCT03778294|471930095|FG000|Overall Study|Death|1|||
131080835|NCT03778294|471930095|FG000|Overall Study|Issues with insurance|1|||
131080836|NCT03778294|471930095|FG000|Overall Study|disease progression before treatment|2|||
131080837|NCT03023722|471930104|FG000|Overall Study|No follow-up assessment|4|||
131080838|NCT00589303|471930109|FG000|Overall Study|Withdrawal by Subject|2|||
131080839|NCT00589303|471930110|FG001|Overall Study|Withdrawal by Subject|1|||
131080840|NCT04836559|471930113|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
131080841|NCT04836559|471930114|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
131080842|NCT04836559|471930115|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
131080843|NCT04836559|471930116|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
131080844|NCT04836559|471930117|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
131080845|NCT04836559|471930118|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
131080846|NCT04836559|471930119|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
131080847|NCT04836559|471930120|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
131080848|NCT04836559|471930113|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131080849|NCT04836559|471930114|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
131080850|NCT04836559|471930115|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
131080851|NCT04836559|471930116|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
131080852|NCT04836559|471930117|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131080853|NCT04836559|471930118|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131080854|NCT04836559|471930119|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131080855|NCT04836559|471930120|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
131080856|NCT04836559|471930113|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
131080857|NCT04836559|471930114|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131080858|NCT04836559|471930115|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131080859|NCT04836559|471930116|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131080860|NCT04836559|471930117|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131080861|NCT04836559|471930118|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131080862|NCT04836559|471930119|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131080863|NCT04836559|471930120|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
131080864|NCT04836559|471930113|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
131080865|NCT04836559|471930114|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
131080866|NCT04836559|471930115|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
131080867|NCT04836559|471930116|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
131080868|NCT04836559|471930117|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
131080869|NCT04836559|471930118|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
131080870|NCT04836559|471930119|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
131080871|NCT04836559|471930120|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
131080872|NCT04836559|471930113|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131080873|NCT04836559|471930114|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131080874|NCT04836559|471930115|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131080875|NCT04836559|471930116|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
131080876|NCT04836559|471930117|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131080877|NCT04836559|471930118|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131080878|NCT04836559|471930119|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131080879|NCT04836559|471930120|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
131080880|NCT04836559|471930113|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
131080881|NCT04836559|471930114|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
131080882|NCT04836559|471930115|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
131080883|NCT04836559|471930116|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
131080884|NCT04836559|471930117|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
131080885|NCT04836559|471930118|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
131080886|NCT04836559|471930119|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
131080887|NCT04836559|471930120|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
131080888|NCT04836559|471930113|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
131080889|NCT04836559|471930114|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
131080890|NCT04836559|471930115|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
131080891|NCT04836559|471930116|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
131080892|NCT04836559|471930117|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
131080893|NCT04836559|471930118|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
131080894|NCT04836559|471930119|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
131080895|NCT04836559|471930120|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
131080896|NCT04836559|471930113|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
131080897|NCT04836559|471930114|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
131080898|NCT04836559|471930115|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
131080899|NCT04836559|471930116|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
131080900|NCT04836559|471930117|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
131080901|NCT04836559|471930118|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
131080902|NCT04836559|471930119|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
131080903|NCT04836559|471930120|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
131080904|NCT04836559|471930113|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131080905|NCT04836559|471930114|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131080906|NCT04836559|471930115|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131080907|NCT04836559|471930116|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131080908|NCT04836559|471930117|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131080909|NCT04836559|471930118|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131080910|NCT04836559|471930119|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
131080911|NCT04836559|471930120|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
131080912|NCT00730015|471930121|FG000|Overall Study|Adverse Event|11|||
131080913|NCT00730015|471930122|FG001|Overall Study|Adverse Event|10|||
131080914|NCT00730015|471930123|FG002|Overall Study|Adverse Event|8|||
131080915|NCT00730015|471930121|FG000|Overall Study|Protocol Violation|2|||
131080916|NCT00730015|471930122|FG001|Overall Study|Protocol Violation|6|||
131080917|NCT00730015|471930123|FG002|Overall Study|Protocol Violation|4|||
131080918|NCT00730015|471930121|FG000|Overall Study|Withdrawal by Subject|12|||
131080919|NCT00730015|471930122|FG001|Overall Study|Withdrawal by Subject|12|||
131080920|NCT00730015|471930123|FG002|Overall Study|Withdrawal by Subject|8|||
131080921|NCT00730015|471930121|FG000|Overall Study|Lost to Follow-up|4|||
131141095|NCT01307033|472143788|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
131141096|NCT01307033|472143789|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
131141097|NCT01307033|472143790|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
131141098|NCT01307033|472143791|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
131141099|NCT01307033|472143788|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
131080922|NCT00730015|471930122|FG001|Overall Study|Lost to Follow-up|10|||
131080923|NCT00730015|471930123|FG002|Overall Study|Lost to Follow-up|3|||
131080924|NCT00730015|471930121|FG000|Overall Study|Lack of Efficacy|1|||
131080925|NCT00730015|471930122|FG001|Overall Study|Lack of Efficacy|2|||
131080926|NCT00730015|471930123|FG002|Overall Study|Lack of Efficacy|8|||
131080927|NCT00730015|471930121|FG000|Overall Study|Other Reason|1|||
131080928|NCT00730015|471930122|FG001|Overall Study|Other Reason|0|||
131080929|NCT00730015|471930123|FG002|Overall Study|Other Reason|1|||
131141100|NCT01307033|472143789|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
131080930|NCT02370251|471930124|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
131080931|NCT02370251|471930124|FG000|Overall Study|Death|4|||
131080932|NCT00013611|471930125|FG000|Overall Study|Lost to Follow-up|91|||
131080933|NCT00013611|471930126|FG001|Overall Study|Lost to Follow-up|100|||
131080934|NCT01150045|471930127|FG000|Overall Study|Protocol Violation|0|||
131080935|NCT01150045|471930128|FG001|Overall Study|Protocol Violation|1|||
131080936|NCT01150045|471930129|FG002|Overall Study|Protocol Violation|0|||
131080937|NCT01150045|471930130|FG003|Overall Study|Protocol Violation|1|||
131080938|NCT01663506|471930132|FG000|Overall Study|Lack of Efficacy|3|||
131080939|NCT01663506|471930132|FG000|Overall Study|Consent Withdrawal by Subject|1|||
131080940|NCT01663506|471930132|FG000|Overall Study|Lost to Follow-up|1|||
131080941|NCT01663506|471930132|FG000|Overall Study|Adverse Event|1|||
131080942|NCT01663506|471930132|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
131080943|NCT02094898|471930138|FG000|Overall Study|Clinical Worsening|2|||
131080944|NCT02094898|471930138|FG000|Overall Study|Adverse Event|2|||
131080945|NCT02094898|471930138|FG000|Overall Study|Lack of Efficacy|1|||
131080946|NCT01432626|471930139|FG000|Overall Study|LV function recovered|2|||
131080947|NCT01432626|471930139|FG000|Overall Study|Withdrawal by Subject|2|||
131080948|NCT01432626|471930139|FG000|Overall Study|Only 1 image competed|2|||
131080949|NCT01432626|471930139|FG000|Overall Study|Imaging agent not available|1|||
131080950|NCT05382039|471930140|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
131080951|NCT05382039|471930141|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
131080952|NCT05382039|471930142|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
131080953|NCT05382039|471930140|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
131080954|NCT05382039|471930141|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
131080955|NCT05382039|471930142|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
131080956|NCT05382039|471930140|FG000|Overall Study|waiting for confirmation|0|||
131080957|NCT05382039|471930141|FG001|Overall Study|waiting for confirmation|0|||
131080958|NCT05382039|471930142|FG002|Overall Study|waiting for confirmation|1|||
131080959|NCT01234883|471930143|FG000|Overall Study|Early treatment release|8|||
131080960|NCT01234883|471930144|FG001|Overall Study|Early treatment release|10|||
131080961|NCT01234883|471930143|FG000|Overall Study|Parent/guardian withdrew consent|1|||
131080962|NCT01234883|471930144|FG001|Overall Study|Parent/guardian withdrew consent|2|||
131080963|NCT01234883|471930143|FG000|Overall Study|Technical difficulties with IV infusion|0|||
131080964|NCT01234883|471930144|FG001|Overall Study|Technical difficulties with IV infusion|1|||
131080965|NCT01234883|471930143|FG000|Overall Study|Inclusion/exclusion failure|1|||
131080966|NCT01234883|471930144|FG001|Overall Study|Inclusion/exclusion failure|0|||
131080967|NCT04351269|471930145|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
131080968|NCT04351269|471930146|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
131080969|NCT04351269|471930147|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
131080970|NCT04351269|471930145|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
131080971|NCT04351269|471930146|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
131080972|NCT04351269|471930147|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
131080973|NCT04351269|471930145|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
131080974|NCT04351269|471930146|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
131080975|NCT04351269|471930147|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
131080976|NCT04351269|471930145|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
131080977|NCT04351269|471930146|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
131080978|NCT04351269|471930147|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
131080979|NCT04351269|471930145|FG000|Overall Study|Lost to Follow-up|1|||
131080980|NCT04351269|471930146|FG001|Overall Study|Lost to Follow-up|3|||
131080981|NCT04351269|471930147|FG002|Overall Study|Lost to Follow-up|0|||
131080982|NCT03210519|471930148|FG000|Overall Study|Adverse Event|2|||
131080983|NCT03210519|471930149|FG001|Overall Study|Adverse Event|0|||
131080984|NCT02270671|471930152|FG000|Overall Study|Withdrawal by Subject|1|||
131080985|NCT02270671|471930153|FG001|Overall Study|Withdrawal by Subject|1|||
131080986|NCT02270671|471930152|FG000|Overall Study|Protocol Violation|0|||
131080987|NCT02270671|471930153|FG001|Overall Study|Protocol Violation|1|||
131080988|NCT02270671|471930152|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
131080989|NCT02270671|471930153|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
131080990|NCT02270671|471930152|FG000|Overall Study|Lost to Follow-up|2|||
131080991|NCT02270671|471930153|FG001|Overall Study|Lost to Follow-up|1|||
131080992|NCT05878873|471930163|FG000|Overall Study|Lost to Follow-up|2|||
131080993|NCT05878873|471930164|FG001|Overall Study|Lost to Follow-up|0|||
131080994|NCT00882115|471930166|FG000|Overall Study|Withdrawal by Subject|3|||
131080995|NCT00882115|471930166|FG000|Overall Study|did not respond to DEP challe|6|||
131080996|NCT02552147|471930167|FG000|First Intervention (7 Days)|Protocol Violation|1|||
131080997|NCT02552147|471930168|FG001|First Intervention (7 Days)|Protocol Violation|0|||
131233347|NCT01058421|472480636|FG000|1 Month Outcomes|Death|10|||
131233348|NCT01058421|472480637|FG001|1 Month Outcomes|Death|6|||
131233349|NCT01058421|472480636|FG000|1 Month Outcomes|Lost to Follow-up|8|||
131080998|NCT02552147|471930167|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
131080999|NCT02552147|471930168|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
131081000|NCT01547598|471930169|FG000|Overall Study|Withdrew consent|1|||
131081001|NCT01547598|471930170|FG001|Overall Study|Withdrew consent|1|||
131081002|NCT01547598|471930169|FG000|Overall Study|Lost to Follow-up|1|||
131081003|NCT01547598|471930170|FG001|Overall Study|Lost to Follow-up|1|||
131081004|NCT01547598|471930169|FG000|Overall Study|Adverse Event|1|||
131081005|NCT01547598|471930170|FG001|Overall Study|Adverse Event|1|||
131081006|NCT01547598|471930169|FG000|Overall Study|Protocol Violation|1|||
131081007|NCT01547598|471930170|FG001|Overall Study|Protocol Violation|1|||
131081008|NCT01547598|471930169|FG000|Overall Study|Other Miscellaneous Reasons|2|||
131081009|NCT01547598|471930170|FG001|Overall Study|Other Miscellaneous Reasons|1|||
131081010|NCT02229227|471930171|FG000|Overall Study|Adverse Event|14|||
131081011|NCT02229227|471930172|FG001|Overall Study|Adverse Event|9|||
131081012|NCT02229227|471930171|FG000|Overall Study|Lack of Efficacy|3|||
131081013|NCT02229227|471930172|FG001|Overall Study|Lack of Efficacy|3|||
131081014|NCT02229227|471930171|FG000|Overall Study|Protocol Violation|6|||
131081015|NCT02229227|471930172|FG001|Overall Study|Protocol Violation|8|||
131081016|NCT02229227|471930171|FG000|Overall Study|Protocol defined stopping criteria|1|||
131081017|NCT02229227|471930172|FG001|Overall Study|Protocol defined stopping criteria|3|||
131081018|NCT02229227|471930171|FG000|Overall Study|Lost to Follow-up|3|||
131081019|NCT02229227|471930172|FG001|Overall Study|Lost to Follow-up|3|||
131081020|NCT02229227|471930171|FG000|Overall Study|Study terminated by sponsor|11|||
131081021|NCT02229227|471930172|FG001|Overall Study|Study terminated by sponsor|11|||
131081022|NCT02229227|471930171|FG000|Overall Study|Withdrawal by Subject|8|||
131081023|NCT02229227|471930172|FG001|Overall Study|Withdrawal by Subject|12|||
131081024|NCT02229227|471930171|FG000|Overall Study|Other|0|||
131081025|NCT02229227|471930172|FG001|Overall Study|Other|1|||
131081026|NCT02229227|471930171|FG000|Overall Study|Physician Decision|5|||
131081027|NCT02229227|471930172|FG001|Overall Study|Physician Decision|12|||
131081028|NCT04071301|471930173|FG000|Overall Study|Withdrawal by Subject|6|||
131081029|NCT04071301|471930173|FG000|Overall Study|Death|1|||
131081030|NCT02125279|471930174|FG000|Overall Study|Lack of Efficacy|2|||
131081031|NCT02125279|471930174|FG000|Overall Study|Withdrawal by Subject|6|||
131081032|NCT02125279|471930174|FG000|Overall Study|Protocol Violation|1|||
131081033|NCT02125279|471930174|FG000|Overall Study|Lost to Follow-up|4|||
131081034|NCT01850589|471930180|FG000|Overall Study|Withdrawal by Subject|8|||
131081035|NCT01850589|471930181|FG001|Overall Study|Withdrawal by Subject|0|||
131081036|NCT04468230|471930186|FG000|Overall Study|Adverse Event|2|||
131081037|NCT01790295|471930189|FG000|Overall Study|Adverse Event|1|||
131081038|NCT01790295|471930189|FG000|Overall Study|Death|4|||
131081039|NCT01790295|471930189|FG000|Overall Study|Lack of Efficacy|2|||
131081040|NCT01790295|471930189|FG000|Overall Study|Study closure|4|||
131081041|NCT03721705|471930190|FG000|Overall Study|Adverse Event|2|||
131081042|NCT03721705|471930191|FG001|Overall Study|Adverse Event|0|||
131081043|NCT03721705|471930190|FG000|Overall Study|Withdrawal by Subject|4|||
131081044|NCT03721705|471930191|FG001|Overall Study|Withdrawal by Subject|10|||
131081045|NCT03721705|471930190|FG000|Overall Study|No Suitable Study Partner|1|||
131081046|NCT03721705|471930191|FG001|Overall Study|No Suitable Study Partner|0|||
131081047|NCT03721705|471930190|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
131081048|NCT03721705|471930191|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
131081049|NCT03721705|471930190|FG000|Overall Study|Death|0|||
131081050|NCT03721705|471930191|FG001|Overall Study|Death|1|||
131081051|NCT03721172|471930194|FG000|Placebo-controlled Phase|Adverse Event|7|||
131081052|NCT03721172|471930195|FG001|Placebo-controlled Phase|Adverse Event|7|||
131081053|NCT03721172|471930196|FG002|Placebo-controlled Phase|Adverse Event|0|||
131081054|NCT03721172|471930194|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
131081055|NCT03721172|471930195|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
131081056|NCT03721172|471930196|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
131081057|NCT03721172|471930194|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
131081058|NCT03721172|471930195|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
131081059|NCT03721172|471930196|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
131081060|NCT03721172|471930194|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
131081061|NCT03721172|471930195|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
131081062|NCT03721172|471930196|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
131081063|NCT03721172|471930194|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
131081064|NCT03721172|471930195|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
131081065|NCT03721172|471930196|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
131081066|NCT03721172|471930194|FG000|Placebo-controlled Phase|Other|3|||
131081067|NCT03721172|471930195|FG001|Placebo-controlled Phase|Other|0|||
131081068|NCT03721172|471930196|FG002|Placebo-controlled Phase|Other|0|||
131081069|NCT03721172|471930194|FG000|Apremilast Extension Phase|Adverse Event|0|||
131081070|NCT03721172|471930195|FG001|Apremilast Extension Phase|Adverse Event|0|||
131081071|NCT03721172|471930196|FG002|Apremilast Extension Phase|Adverse Event|10|||
131081072|NCT03721172|471930194|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
131081073|NCT03721172|471930195|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
131141101|NCT01307033|472143790|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
131141102|NCT01307033|472143791|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
131141103|NCT01307033|472143788|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
131141104|NCT01307033|472143789|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
131141105|NCT01307033|472143790|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
131141106|NCT01307033|472143791|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
131141107|NCT01307033|472143788|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
131141108|NCT01307033|472143789|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
131141109|NCT01307033|472143790|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
131141110|NCT01307033|472143791|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
131141111|NCT01307033|472143788|FG000|44-week Open-label Extension|Adverse Event|0|||
131233350|NCT01058421|472480637|FG001|1 Month Outcomes|Lost to Follow-up|7|||
131081074|NCT03721172|471930196|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
131081075|NCT03721172|471930194|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
131081076|NCT03721172|471930195|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
131081077|NCT03721172|471930196|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
131081078|NCT03721172|471930194|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
131081079|NCT03721172|471930195|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
131081080|NCT03721172|471930196|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
131081081|NCT03721172|471930194|FG000|Apremilast Extension Phase|Protocol Violation|0|||
131081082|NCT03721172|471930195|FG001|Apremilast Extension Phase|Protocol Violation|0|||
131081083|NCT03721172|471930196|FG002|Apremilast Extension Phase|Protocol Violation|1|||
131081084|NCT03721172|471930194|FG000|Apremilast Extension Phase|Physician Decision|0|||
131081085|NCT03721172|471930195|FG001|Apremilast Extension Phase|Physician Decision|0|||
131081086|NCT03721172|471930196|FG002|Apremilast Extension Phase|Physician Decision|1|||
131081087|NCT03721172|471930194|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
131081088|NCT03721172|471930195|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
131081089|NCT03721172|471930196|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
131081090|NCT03721172|471930194|FG000|Apremilast Extension Phase|Other|0|||
131081091|NCT03721172|471930195|FG001|Apremilast Extension Phase|Other|0|||
131081092|NCT03721172|471930196|FG002|Apremilast Extension Phase|Other|3|||
131081093|NCT03721172|471930194|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
131081094|NCT03721172|471930195|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
131081095|NCT03721172|471930196|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
131081096|NCT00420784|471930197|FG000|Overall Study|Adverse Event|11|||
131081097|NCT00420784|471930198|FG001|Overall Study|Adverse Event|29|||
131081098|NCT00420784|471930199|FG002|Overall Study|Adverse Event|10|||
131081099|NCT00420784|471930200|FG003|Overall Study|Adverse Event|5|||
131081100|NCT00420784|471930197|FG000|Overall Study|Withdrawal by Subject|0|||
131081101|NCT00420784|471930198|FG001|Overall Study|Withdrawal by Subject|1|||
131081102|NCT00420784|471930199|FG002|Overall Study|Withdrawal by Subject|0|||
131081103|NCT00420784|471930200|FG003|Overall Study|Withdrawal by Subject|0|||
131081104|NCT00420784|471930197|FG000|Overall Study|Lost to Follow-up|0|||
131081105|NCT00420784|471930198|FG001|Overall Study|Lost to Follow-up|0|||
131081106|NCT00420784|471930199|FG002|Overall Study|Lost to Follow-up|2|||
131081107|NCT00420784|471930200|FG003|Overall Study|Lost to Follow-up|1|||
131081108|NCT00420784|471930197|FG000|Overall Study|Virologic Stopping Rule|17|||
131233351|NCT01058421|472480636|FG000|1 Month Outcomes|Remained in Hospital|5|||
131233352|NCT01058421|472480637|FG001|1 Month Outcomes|Remained in Hospital|12|||
131233353|NCT01058421|472480636|FG000|1 Month Outcomes|Remained in Other Facility|16|||
131233354|NCT01058421|472480637|FG001|1 Month Outcomes|Remained in Other Facility|17|||
131233355|NCT01058421|472480636|FG000|3 Month Outcomes|Death|3|||
131233356|NCT01058421|472480637|FG001|3 Month Outcomes|Death|5|||
131233357|NCT01058421|472480636|FG000|3 Month Outcomes|Lost to Follow-up|12|||
131233358|NCT01058421|472480637|FG001|3 Month Outcomes|Lost to Follow-up|11|||
131233359|NCT01058421|472480636|FG000|3 Month Outcomes|Remained in Hospital|0|||
131233360|NCT01058421|472480637|FG001|3 Month Outcomes|Remained in Hospital|2|||
131233361|NCT01058421|472480636|FG000|3 Month Outcomes|Remained in Other Facility|5|||
131233362|NCT01058421|472480637|FG001|3 Month Outcomes|Remained in Other Facility|8|||
131233363|NCT01058421|472480636|FG000|6 Month Outcomes|Death|2|||
131233364|NCT01058421|472480637|FG001|6 Month Outcomes|Death|2|||
131233365|NCT01058421|472480636|FG000|6 Month Outcomes|Lost to Follow-up|16|||
131233366|NCT01058421|472480637|FG001|6 Month Outcomes|Lost to Follow-up|21|||
131233367|NCT01058421|472480636|FG000|6 Month Outcomes|Remained in Other Facility|1|||
130727206|NCT02883049|470625438|FG014|Post Induction|Lost to Follow-up|0|||
130727207|NCT02883049|470625439|FG015|Post Induction|Lost to Follow-up|0|||
130727208|NCT02883049|470625424|FG000|Post Induction|Physician Decision|0|||
131081109|NCT00420784|471930198|FG001|Overall Study|Virologic Stopping Rule|26|||
131233368|NCT01058421|472480637|FG001|6 Month Outcomes|Remained in Other Facility|3|||
130727209|NCT02883049|470625425|FG001|Post Induction|Physician Decision|0|||
131141112|NCT01307033|472143789|FG001|44-week Open-label Extension|Adverse Event|0|||
131081110|NCT00420784|471930199|FG002|Overall Study|Virologic Stopping Rule|41|||
131081111|NCT00420784|471930200|FG003|Overall Study|Virologic Stopping Rule|67|||
131081112|NCT00420784|471930197|FG000|Overall Study|Other|1|||
131081113|NCT00420784|471930198|FG001|Overall Study|Other|2|||
131081114|NCT00420784|471930199|FG002|Overall Study|Other|0|||
131081115|NCT00420784|471930200|FG003|Overall Study|Other|5|||
131081116|NCT00822770|471930203|FG000|Overall Study|Not treated|1|||
131081117|NCT00822770|471930204|FG001|Overall Study|Not treated|0|||
131081118|NCT00822770|471930203|FG000|Overall Study|Complication/Incomplete treatment|1|||
131081119|NCT00822770|471930204|FG001|Overall Study|Complication/Incomplete treatment|0|||
131081120|NCT00822770|471930203|FG000|Overall Study|Death|1|||
131081121|NCT00822770|471930204|FG001|Overall Study|Death|1|||
131081122|NCT02402322|471930205|FG000|Pretreatment|Withdrawal by Subject|3|||
131081123|NCT02402322|471930206|FG001|Pretreatment|Withdrawal by Subject|1|||
131081124|NCT02402322|471930207|FG002|Pretreatment|Withdrawal by Subject|1|||
131081125|NCT02402322|471930205|FG000|Follow-up|Withdrawal by Subject|6|||
131081126|NCT02402322|471930206|FG001|Follow-up|Withdrawal by Subject|3|||
131081127|NCT02402322|471930207|FG002|Follow-up|Withdrawal by Subject|24|||
131081128|NCT04593823|471930208|FG000|Overall Study|Withdrawal by Subject|1|||
131081129|NCT04593823|471930209|FG001|Overall Study|Withdrawal by Subject|1|||
131081130|NCT04593823|471930208|FG000|Overall Study|Lost to Follow-up|0|||
131081131|NCT04593823|471930209|FG001|Overall Study|Lost to Follow-up|1|||
131081132|NCT02472145|471930210|FG000|Overall Study|Death|10|||
131081133|NCT02472145|471930211|FG001|Overall Study|Death|101|||
131081134|NCT02472145|471930212|FG002|Overall Study|Death|99|||
131081135|NCT02472145|471930210|FG000|Overall Study|Lost to Follow-up|0|||
131081136|NCT02472145|471930211|FG001|Overall Study|Lost to Follow-up|1|||
131081137|NCT02472145|471930212|FG002|Overall Study|Lost to Follow-up|0|||
131081138|NCT02472145|471930210|FG000|Overall Study|Withdrawal by Subject|0|||
131081139|NCT02472145|471930211|FG001|Overall Study|Withdrawal by Subject|9|||
131081140|NCT02472145|471930212|FG002|Overall Study|Withdrawal by Subject|13|||
131081141|NCT02472145|471930210|FG000|Overall Study|Sponsor decision|0|||
131081142|NCT02472145|471930211|FG001|Overall Study|Sponsor decision|3|||
131081143|NCT02472145|471930212|FG002|Overall Study|Sponsor decision|2|||
131081144|NCT02472145|471930210|FG000|Overall Study|Other|0|||
131081145|NCT02472145|471930211|FG001|Overall Study|Other|45|||
131141113|NCT01307033|472143790|FG002|44-week Open-label Extension|Adverse Event|2|||
131141114|NCT01307033|472143791|FG003|44-week Open-label Extension|Adverse Event|1|||
131141115|NCT01307033|472143788|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
131141116|NCT01307033|472143789|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
131141117|NCT01307033|472143790|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
131141118|NCT01307033|472143791|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
131141119|NCT01307033|472143788|FG000|44-week Open-label Extension|Physician Decision|0|||
131141120|NCT01307033|472143789|FG001|44-week Open-label Extension|Physician Decision|0|||
131141121|NCT01307033|472143790|FG002|44-week Open-label Extension|Physician Decision|1|||
131141122|NCT01307033|472143791|FG003|44-week Open-label Extension|Physician Decision|0|||
131141123|NCT01307033|472143788|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
131141124|NCT01307033|472143789|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
131141125|NCT01307033|472143790|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
131141126|NCT01307033|472143791|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
131141127|NCT01307033|472143788|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
131141128|NCT01307033|472143789|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
131233369|NCT01960816|472480638|FG000|Overall Study|Lost to Follow-up|1|||
131233370|NCT01118728|472480639|FG000|Overall Study|Adverse Event|17|||
131233371|NCT01118728|472480639|FG000|Overall Study|Lack of Efficacy|27|||
131233372|NCT01118728|472480639|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
131141129|NCT01307033|472143790|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
131141130|NCT01307033|472143791|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
131141131|NCT01307033|472143788|FG000|44-week Open-label Extension|Death|0|||
131141132|NCT01307033|472143789|FG001|44-week Open-label Extension|Death|0|||
131141133|NCT01307033|472143790|FG002|44-week Open-label Extension|Death|0|||
131233373|NCT01118728|472480639|FG000|Overall Study|Withdrawal by Subject|3|||
131233374|NCT01118728|472480639|FG000|Overall Study|Lost to Follow-up|4|||
131233375|NCT00385541|472480640|FG000|Overall Study|severe pain, clinician requested unblind|0|||
131233376|NCT00385541|472480641|FG001|Overall Study|severe pain, clinician requested unblind|1|||
131233377|NCT00929708|472480642|FG000|Overall Study|Protocol Violation|2|||
131233378|NCT00929708|472480643|FG001|Overall Study|Protocol Violation|1|||
131081146|NCT02472145|471930212|FG002|Overall Study|Other|43|||
131081147|NCT01296555|471930213|FG000|Overall Study|Adverse Event|0|||
131081148|NCT01296555|471930214|FG001|Overall Study|Adverse Event|0|||
131081149|NCT01296555|471930215|FG002|Overall Study|Adverse Event|1|||
131081150|NCT01296555|471930216|FG003|Overall Study|Adverse Event|1|||
131081151|NCT01296555|471930217|FG004|Overall Study|Adverse Event|2|||
131081152|NCT01296555|471930218|FG005|Overall Study|Adverse Event|4|||
131081153|NCT01296555|471930219|FG006|Overall Study|Adverse Event|1|||
131081154|NCT01296555|471930220|FG007|Overall Study|Adverse Event|4|||
131233379|NCT00929708|472480644|FG002|Overall Study|Protocol Violation|1|||
131233380|NCT00929708|472480645|FG003|Overall Study|Protocol Violation|1|||
131233381|NCT00929708|472480646|FG004|Overall Study|Protocol Violation|1|||
131233382|NCT00929708|472480642|FG000|Overall Study|Withdrawal by Subject|2|||
131233383|NCT00929708|472480643|FG001|Overall Study|Withdrawal by Subject|0|||
131233384|NCT00929708|472480644|FG002|Overall Study|Withdrawal by Subject|0|||
131233385|NCT00929708|472480645|FG003|Overall Study|Withdrawal by Subject|2|||
131233386|NCT00929708|472480646|FG004|Overall Study|Withdrawal by Subject|1|||
131233387|NCT00929708|472480642|FG000|Overall Study|Adverse Event|0|||
131233388|NCT00929708|472480643|FG001|Overall Study|Adverse Event|0|||
131233389|NCT00929708|472480644|FG002|Overall Study|Adverse Event|0|||
131233390|NCT00929708|472480645|FG003|Overall Study|Adverse Event|0|||
131233391|NCT00929708|472480646|FG004|Overall Study|Adverse Event|3|||
131233392|NCT00929708|472480642|FG000|Overall Study|Physician Decision|0|||
131233393|NCT00929708|472480643|FG001|Overall Study|Physician Decision|2|||
131233394|NCT00929708|472480644|FG002|Overall Study|Physician Decision|2|||
131233395|NCT00929708|472480645|FG003|Overall Study|Physician Decision|2|||
131233396|NCT00929708|472480646|FG004|Overall Study|Physician Decision|1|||
131233397|NCT00929708|472480642|FG000|Overall Study|Lost to Follow-up|0|||
131233398|NCT00929708|472480643|FG001|Overall Study|Lost to Follow-up|0|||
131233399|NCT00929708|472480644|FG002|Overall Study|Lost to Follow-up|0|||
131233400|NCT00929708|472480645|FG003|Overall Study|Lost to Follow-up|1|||
131233401|NCT00929708|472480646|FG004|Overall Study|Lost to Follow-up|0|||
131233402|NCT01893138|472480647|FG000|Double-Blind Period|Withdrawal by Subject|1|||
131233403|NCT01893138|472480648|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131233404|NCT01893138|472480647|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
131233405|NCT01893138|472480648|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
131081155|NCT01296555|471930221|FG008|Overall Study|Adverse Event|3|||
131081156|NCT01296555|471930222|FG009|Overall Study|Adverse Event|1|||
131081157|NCT01296555|471930223|FG010|Overall Study|Adverse Event|0|||
131081158|NCT01296555|471930224|FG011|Overall Study|Adverse Event|4|||
131081159|NCT01296555|471930225|FG012|Overall Study|Adverse Event|1|||
131081160|NCT01296555|471930226|FG013|Overall Study|Adverse Event|4|||
131081161|NCT01296555|471930227|FG014|Overall Study|Adverse Event|0|||
131081162|NCT01296555|471930228|FG015|Overall Study|Adverse Event|0|||
131081163|NCT01296555|471930229|FG016|Overall Study|Adverse Event|0|||
131081164|NCT01296555|471930230|FG017|Overall Study|Adverse Event|0|||
131081165|NCT01296555|471930231|FG018|Overall Study|Adverse Event|0|||
131081166|NCT01296555|471930232|FG019|Overall Study|Adverse Event|1|||
131081167|NCT01296555|471930233|FG020|Overall Study|Adverse Event|0|||
131081168|NCT01296555|471930234|FG021|Overall Study|Adverse Event|0|||
131081169|NCT01296555|471930235|FG022|Overall Study|Adverse Event|0|||
131081170|NCT01296555|471930236|FG023|Overall Study|Adverse Event|0|||
131081171|NCT01296555|471930237|FG024|Overall Study|Adverse Event|0|||
131081172|NCT01296555|471930238|FG025|Overall Study|Adverse Event|0|||
131081173|NCT01296555|471930239|FG026|Overall Study|Adverse Event|0|||
131081174|NCT01296555|471930240|FG027|Overall Study|Adverse Event|0|||
131081175|NCT01296555|471930241|FG028|Overall Study|Adverse Event|0|||
131081176|NCT01296555|471930213|FG000|Overall Study|Reason Not Specified|0|||
131081177|NCT01296555|471930214|FG001|Overall Study|Reason Not Specified|0|||
131081178|NCT01296555|471930215|FG002|Overall Study|Reason Not Specified|0|||
131081179|NCT01296555|471930216|FG003|Overall Study|Reason Not Specified|0|||
131081180|NCT01296555|471930217|FG004|Overall Study|Reason Not Specified|0|||
131081181|NCT01296555|471930218|FG005|Overall Study|Reason Not Specified|0|||
131081182|NCT01296555|471930219|FG006|Overall Study|Reason Not Specified|0|||
131081183|NCT01296555|471930220|FG007|Overall Study|Reason Not Specified|0|||
131081184|NCT01296555|471930221|FG008|Overall Study|Reason Not Specified|0|||
131081185|NCT01296555|471930222|FG009|Overall Study|Reason Not Specified|0|||
131081186|NCT01296555|471930223|FG010|Overall Study|Reason Not Specified|0|||
131081187|NCT01296555|471930224|FG011|Overall Study|Reason Not Specified|0|||
131081188|NCT01296555|471930225|FG012|Overall Study|Reason Not Specified|0|||
131233406|NCT01893138|472480647|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
131233407|NCT01893138|472480648|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
130727210|NCT02883049|470625426|FG002|Post Induction|Physician Decision|0|||
130727211|NCT02883049|470625427|FG003|Post Induction|Physician Decision|27|||
131081189|NCT01296555|471930226|FG013|Overall Study|Reason Not Specified|1|||
131081190|NCT01296555|471930227|FG014|Overall Study|Reason Not Specified|2|||
131081191|NCT01296555|471930228|FG015|Overall Study|Reason Not Specified|3|||
131081192|NCT01296555|471930229|FG016|Overall Study|Reason Not Specified|7|||
131081193|NCT01296555|471930230|FG017|Overall Study|Reason Not Specified|4|||
131081194|NCT01296555|471930231|FG018|Overall Study|Reason Not Specified|3|||
131233408|NCT01893138|472480647|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
131233409|NCT01893138|472480648|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
130727212|NCT02883049|470625428|FG004|Post Induction|Physician Decision|27|||
131233410|NCT01893138|472480647|FG000|Open Label - Unblinded Period|Adverse Event|1|||
131233411|NCT01893138|472480648|FG001|Open Label - Unblinded Period|Adverse Event|0|||
131233412|NCT03329027|472482436|FG000|Overall Study|Lost to Follow-up|1|||
131233413|NCT03329027|472482437|FG001|Overall Study|Lost to Follow-up|0|||
131081195|NCT01296555|471930232|FG019|Overall Study|Reason Not Specified|7|||
131081196|NCT01296555|471930233|FG020|Overall Study|Reason Not Specified|11|||
131081197|NCT01296555|471930234|FG021|Overall Study|Reason Not Specified|5|||
131081198|NCT01296555|471930235|FG022|Overall Study|Reason Not Specified|5|||
131081199|NCT01296555|471930236|FG023|Overall Study|Reason Not Specified|7|||
131081200|NCT01296555|471930237|FG024|Overall Study|Reason Not Specified|2|||
131081201|NCT01296555|471930238|FG025|Overall Study|Reason Not Specified|2|||
131081202|NCT01296555|471930239|FG026|Overall Study|Reason Not Specified|19|||
131081203|NCT01296555|471930240|FG027|Overall Study|Reason Not Specified|11|||
131081204|NCT01296555|471930241|FG028|Overall Study|Reason Not Specified|9|||
131081205|NCT01296555|471930213|FG000|Overall Study|Physician Decision|0|||
131081206|NCT01296555|471930214|FG001|Overall Study|Physician Decision|0|||
131081207|NCT01296555|471930215|FG002|Overall Study|Physician Decision|0|||
131081208|NCT01296555|471930216|FG003|Overall Study|Physician Decision|0|||
131081209|NCT01296555|471930217|FG004|Overall Study|Physician Decision|1|||
131081210|NCT01296555|471930218|FG005|Overall Study|Physician Decision|0|||
131081211|NCT01296555|471930219|FG006|Overall Study|Physician Decision|0|||
131081212|NCT01296555|471930220|FG007|Overall Study|Physician Decision|0|||
131081213|NCT01296555|471930221|FG008|Overall Study|Physician Decision|0|||
131081214|NCT01296555|471930222|FG009|Overall Study|Physician Decision|0|||
131081215|NCT01296555|471930223|FG010|Overall Study|Physician Decision|0|||
131081216|NCT01296555|471930224|FG011|Overall Study|Physician Decision|0|||
131081217|NCT01296555|471930225|FG012|Overall Study|Physician Decision|0|||
131081218|NCT01296555|471930226|FG013|Overall Study|Physician Decision|1|||
131233414|NCT03329027|472482438|FG002|Overall Study|Lost to Follow-up|1|||
131233415|NCT03329027|472482436|FG000|Overall Study|Protocol Violation|9|||
131081219|NCT01296555|471930227|FG014|Overall Study|Physician Decision|0|||
131081220|NCT01296555|471930228|FG015|Overall Study|Physician Decision|0|||
131081221|NCT01296555|471930229|FG016|Overall Study|Physician Decision|0|||
131081222|NCT01296555|471930230|FG017|Overall Study|Physician Decision|0|||
131081223|NCT01296555|471930231|FG018|Overall Study|Physician Decision|0|||
131081224|NCT01296555|471930232|FG019|Overall Study|Physician Decision|1|||
131081225|NCT01296555|471930233|FG020|Overall Study|Physician Decision|0|||
131081226|NCT01296555|471930234|FG021|Overall Study|Physician Decision|0|||
131081227|NCT01296555|471930235|FG022|Overall Study|Physician Decision|0|||
131081228|NCT01296555|471930236|FG023|Overall Study|Physician Decision|0|||
131081229|NCT01296555|471930237|FG024|Overall Study|Physician Decision|0|||
131081230|NCT01296555|471930238|FG025|Overall Study|Physician Decision|0|||
131081231|NCT01296555|471930239|FG026|Overall Study|Physician Decision|0|||
131081232|NCT01296555|471930240|FG027|Overall Study|Physician Decision|0|||
131081233|NCT01296555|471930241|FG028|Overall Study|Physician Decision|0|||
131081234|NCT01296555|471930213|FG000|Overall Study|Progressive Disease|6|||
131081235|NCT01296555|471930214|FG001|Overall Study|Progressive Disease|3|||
131081236|NCT01296555|471930215|FG002|Overall Study|Progressive Disease|3|||
131081237|NCT01296555|471930216|FG003|Overall Study|Progressive Disease|7|||
131081238|NCT01296555|471930217|FG004|Overall Study|Progressive Disease|6|||
131081239|NCT01296555|471930218|FG005|Overall Study|Progressive Disease|16|||
131081240|NCT01296555|471930219|FG006|Overall Study|Progressive Disease|16|||
131081241|NCT01296555|471930220|FG007|Overall Study|Progressive Disease|8|||
131233416|NCT03329027|472482437|FG001|Overall Study|Protocol Violation|5|||
131233417|NCT03329027|472482438|FG002|Overall Study|Protocol Violation|7|||
131233418|NCT02761980|472482444|FG000|Overall Study|Adverse Event|4|||
131233419|NCT02761980|472482445|FG001|Overall Study|Adverse Event|6|||
131233420|NCT02761980|472482446|FG002|Overall Study|Adverse Event|5|||
131233421|NCT02761980|472482447|FG003|Overall Study|Adverse Event|6|||
131233422|NCT02761980|472482444|FG000|Overall Study|Withdrawal by Subject|0|||
131233423|NCT02761980|472482445|FG001|Overall Study|Withdrawal by Subject|1|||
131233424|NCT02761980|472482446|FG002|Overall Study|Withdrawal by Subject|0|||
131233425|NCT02761980|472482447|FG003|Overall Study|Withdrawal by Subject|0|||
131233426|NCT02761980|472482444|FG000|Overall Study|Other|0|||
131233427|NCT02761980|472482445|FG001|Overall Study|Other|0|||
131233428|NCT02761980|472482446|FG002|Overall Study|Other|1|||
131233429|NCT02761980|472482447|FG003|Overall Study|Other|0|||
131233430|NCT01052116|472482448|FG000|Overall Study|Lost to Follow-up|11|||
131233431|NCT01052116|472482449|FG001|Overall Study|Lost to Follow-up|17|||
131233432|NCT01052116|472482448|FG000|Overall Study|Withdrawal by Subject|3|||
131233433|NCT01052116|472482449|FG001|Overall Study|Withdrawal by Subject|6|||
131233434|NCT01052116|472482448|FG000|Overall Study|Spirometry not performed|0|||
131233435|NCT01052116|472482449|FG001|Overall Study|Spirometry not performed|4|||
131233436|NCT01768858|472482450|FG000|Overall Study|Lost to Follow-up|9|||
131081242|NCT01296555|471930221|FG008|Overall Study|Progressive Disease|7|||
131081243|NCT01296555|471930222|FG009|Overall Study|Progressive Disease|18|||
131081244|NCT01296555|471930223|FG010|Overall Study|Progressive Disease|7|||
131081245|NCT01296555|471930224|FG011|Overall Study|Progressive Disease|14|||
131081246|NCT01296555|471930225|FG012|Overall Study|Progressive Disease|5|||
131081247|NCT01296555|471930226|FG013|Overall Study|Progressive Disease|12|||
131081248|NCT01296555|471930227|FG014|Overall Study|Progressive Disease|1|||
131081249|NCT01296555|471930228|FG015|Overall Study|Progressive Disease|1|||
131081250|NCT01296555|471930229|FG016|Overall Study|Progressive Disease|0|||
131081251|NCT01296555|471930230|FG017|Overall Study|Progressive Disease|0|||
131081252|NCT01296555|471930231|FG018|Overall Study|Progressive Disease|0|||
131081253|NCT01296555|471930232|FG019|Overall Study|Progressive Disease|1|||
131081254|NCT01296555|471930233|FG020|Overall Study|Progressive Disease|0|||
131081255|NCT01296555|471930234|FG021|Overall Study|Progressive Disease|0|||
131081256|NCT01296555|471930235|FG022|Overall Study|Progressive Disease|0|||
131081257|NCT01296555|471930236|FG023|Overall Study|Progressive Disease|0|||
131081258|NCT01296555|471930237|FG024|Overall Study|Progressive Disease|1|||
131081259|NCT01296555|471930238|FG025|Overall Study|Progressive Disease|0|||
131081260|NCT01296555|471930239|FG026|Overall Study|Progressive Disease|5|||
131081261|NCT01296555|471930240|FG027|Overall Study|Progressive Disease|1|||
131081262|NCT01296555|471930241|FG028|Overall Study|Progressive Disease|0|||
131081263|NCT01296555|471930213|FG000|Overall Study|Protocol Violation|0|||
131081264|NCT01296555|471930214|FG001|Overall Study|Protocol Violation|0|||
131081265|NCT01296555|471930215|FG002|Overall Study|Protocol Violation|0|||
131081266|NCT01296555|471930216|FG003|Overall Study|Protocol Violation|0|||
131081267|NCT01296555|471930217|FG004|Overall Study|Protocol Violation|0|||
131081268|NCT01296555|471930218|FG005|Overall Study|Protocol Violation|0|||
131081269|NCT01296555|471930219|FG006|Overall Study|Protocol Violation|0|||
131081270|NCT01296555|471930220|FG007|Overall Study|Protocol Violation|0|||
131081271|NCT01296555|471930221|FG008|Overall Study|Protocol Violation|0|||
131081272|NCT01296555|471930222|FG009|Overall Study|Protocol Violation|0|||
131081273|NCT01296555|471930223|FG010|Overall Study|Protocol Violation|0|||
131081274|NCT01296555|471930224|FG011|Overall Study|Protocol Violation|0|||
131081275|NCT01296555|471930225|FG012|Overall Study|Protocol Violation|0|||
131081276|NCT01296555|471930226|FG013|Overall Study|Protocol Violation|1|||
131081277|NCT01296555|471930227|FG014|Overall Study|Protocol Violation|0|||
131081278|NCT01296555|471930228|FG015|Overall Study|Protocol Violation|0|||
131081279|NCT01296555|471930229|FG016|Overall Study|Protocol Violation|0|||
131081280|NCT01296555|471930230|FG017|Overall Study|Protocol Violation|0|||
131081281|NCT01296555|471930231|FG018|Overall Study|Protocol Violation|0|||
131081282|NCT01296555|471930232|FG019|Overall Study|Protocol Violation|0|||
131081283|NCT01296555|471930233|FG020|Overall Study|Protocol Violation|0|||
131081284|NCT01296555|471930234|FG021|Overall Study|Protocol Violation|0|||
131081285|NCT01296555|471930235|FG022|Overall Study|Protocol Violation|0|||
131081286|NCT01296555|471930236|FG023|Overall Study|Protocol Violation|0|||
131081287|NCT01296555|471930237|FG024|Overall Study|Protocol Violation|0|||
131081288|NCT01296555|471930238|FG025|Overall Study|Protocol Violation|0|||
131081289|NCT01296555|471930239|FG026|Overall Study|Protocol Violation|0|||
131081290|NCT01296555|471930240|FG027|Overall Study|Protocol Violation|0|||
131081291|NCT01296555|471930241|FG028|Overall Study|Protocol Violation|0|||
131081292|NCT01296555|471930213|FG000|Overall Study|Study Terminated By Sponsor|0|||
131081293|NCT01296555|471930214|FG001|Overall Study|Study Terminated By Sponsor|0|||
131081294|NCT01296555|471930215|FG002|Overall Study|Study Terminated By Sponsor|0|||
131081295|NCT01296555|471930216|FG003|Overall Study|Study Terminated By Sponsor|0|||
131081296|NCT01296555|471930217|FG004|Overall Study|Study Terminated By Sponsor|0|||
131081297|NCT01296555|471930218|FG005|Overall Study|Study Terminated By Sponsor|0|||
131081298|NCT01296555|471930219|FG006|Overall Study|Study Terminated By Sponsor|0|||
131081299|NCT01296555|471930220|FG007|Overall Study|Study Terminated By Sponsor|0|||
131081300|NCT01296555|471930221|FG008|Overall Study|Study Terminated By Sponsor|0|||
131081301|NCT01296555|471930222|FG009|Overall Study|Study Terminated By Sponsor|0|||
131081302|NCT01296555|471930223|FG010|Overall Study|Study Terminated By Sponsor|0|||
131081303|NCT01296555|471930224|FG011|Overall Study|Study Terminated By Sponsor|0|||
131081304|NCT01296555|471930225|FG012|Overall Study|Study Terminated By Sponsor|0|||
131081305|NCT01296555|471930226|FG013|Overall Study|Study Terminated By Sponsor|0|||
131081306|NCT01296555|471930227|FG014|Overall Study|Study Terminated By Sponsor|0|||
131081307|NCT01296555|471930228|FG015|Overall Study|Study Terminated By Sponsor|0|||
131081308|NCT01296555|471930229|FG016|Overall Study|Study Terminated By Sponsor|0|||
131081309|NCT01296555|471930230|FG017|Overall Study|Study Terminated By Sponsor|0|||
131081310|NCT01296555|471930231|FG018|Overall Study|Study Terminated By Sponsor|0|||
131081311|NCT01296555|471930232|FG019|Overall Study|Study Terminated By Sponsor|0|||
131081312|NCT01296555|471930233|FG020|Overall Study|Study Terminated By Sponsor|0|||
131081313|NCT01296555|471930234|FG021|Overall Study|Study Terminated By Sponsor|0|||
131081314|NCT01296555|471930235|FG022|Overall Study|Study Terminated By Sponsor|0|||
131081315|NCT01296555|471930236|FG023|Overall Study|Study Terminated By Sponsor|0|||
131081316|NCT01296555|471930237|FG024|Overall Study|Study Terminated By Sponsor|0|||
131081317|NCT01296555|471930238|FG025|Overall Study|Study Terminated By Sponsor|1|||
131081318|NCT01296555|471930239|FG026|Overall Study|Study Terminated By Sponsor|0|||
131081319|NCT01296555|471930240|FG027|Overall Study|Study Terminated By Sponsor|0|||
131081320|NCT01296555|471930241|FG028|Overall Study|Study Terminated By Sponsor|0|||
131081321|NCT01296555|471930213|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131233437|NCT01768858|472482450|FG000|Overall Study|Lack of Efficacy|8|||
131081322|NCT01296555|471930214|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081323|NCT01296555|471930215|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081324|NCT01296555|471930216|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081325|NCT01296555|471930217|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081326|NCT01296555|471930218|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081327|NCT01296555|471930219|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131233438|NCT01768858|472482450|FG000|Overall Study|Serious Adverse Event|1|||
131081328|NCT01296555|471930220|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081329|NCT01296555|471930221|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081330|NCT01296555|471930222|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081331|NCT01296555|471930223|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081332|NCT01296555|471930224|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081333|NCT01296555|471930225|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081334|NCT01296555|471930226|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081335|NCT01296555|471930227|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081336|NCT01296555|471930228|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081337|NCT01296555|471930229|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081338|NCT01296555|471930230|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081339|NCT01296555|471930231|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081340|NCT01296555|471930232|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
131081341|NCT01296555|471930233|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081342|NCT01296555|471930234|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081343|NCT01296555|471930235|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081344|NCT01296555|471930236|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081345|NCT01296555|471930237|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081346|NCT01296555|471930238|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081347|NCT01296555|471930239|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081348|NCT01296555|471930240|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081349|NCT01296555|471930241|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
131081350|NCT01296555|471930213|FG000|Overall Study|Death|0|||
131081351|NCT01296555|471930214|FG001|Overall Study|Death|0|||
131081352|NCT01296555|471930215|FG002|Overall Study|Death|0|||
131081353|NCT01296555|471930216|FG003|Overall Study|Death|2|||
131081354|NCT01296555|471930217|FG004|Overall Study|Death|1|||
131081355|NCT01296555|471930218|FG005|Overall Study|Death|0|||
131081356|NCT01296555|471930219|FG006|Overall Study|Death|2|||
131081357|NCT01296555|471930220|FG007|Overall Study|Death|0|||
131081358|NCT01296555|471930221|FG008|Overall Study|Death|0|||
131081359|NCT01296555|471930222|FG009|Overall Study|Death|1|||
131081360|NCT01296555|471930223|FG010|Overall Study|Death|0|||
131081361|NCT01296555|471930224|FG011|Overall Study|Death|1|||
131081362|NCT01296555|471930225|FG012|Overall Study|Death|0|||
131081363|NCT01296555|471930226|FG013|Overall Study|Death|2|||
131081364|NCT01296555|471930227|FG014|Overall Study|Death|27|||
131081365|NCT01296555|471930228|FG015|Overall Study|Death|15|||
131081366|NCT01296555|471930229|FG016|Overall Study|Death|11|||
131081367|NCT01296555|471930230|FG017|Overall Study|Death|11|||
131081368|NCT01296555|471930231|FG018|Overall Study|Death|17|||
131081369|NCT01296555|471930232|FG019|Overall Study|Death|12|||
131081370|NCT01296555|471930233|FG020|Overall Study|Death|13|||
131081371|NCT01296555|471930234|FG021|Overall Study|Death|12|||
131081372|NCT01296555|471930235|FG022|Overall Study|Death|12|||
131081373|NCT01296555|471930236|FG023|Overall Study|Death|13|||
131081374|NCT01296555|471930237|FG024|Overall Study|Death|7|||
131081375|NCT01296555|471930238|FG025|Overall Study|Death|7|||
131081376|NCT01296555|471930239|FG026|Overall Study|Death|35|||
131081377|NCT01296555|471930240|FG027|Overall Study|Death|92|||
131081378|NCT01296555|471930241|FG028|Overall Study|Death|44|||
131081379|NCT01296555|471930213|FG000|Overall Study|Lost to Follow-up|0|||
131081380|NCT01296555|471930214|FG001|Overall Study|Lost to Follow-up|0|||
131081381|NCT01296555|471930215|FG002|Overall Study|Lost to Follow-up|0|||
131081382|NCT01296555|471930216|FG003|Overall Study|Lost to Follow-up|0|||
131081383|NCT01296555|471930217|FG004|Overall Study|Lost to Follow-up|0|||
131081384|NCT01296555|471930218|FG005|Overall Study|Lost to Follow-up|0|||
131081385|NCT01296555|471930219|FG006|Overall Study|Lost to Follow-up|0|||
131081386|NCT01296555|471930220|FG007|Overall Study|Lost to Follow-up|0|||
131081387|NCT01296555|471930221|FG008|Overall Study|Lost to Follow-up|0|||
131081388|NCT01296555|471930222|FG009|Overall Study|Lost to Follow-up|0|||
131081389|NCT01296555|471930223|FG010|Overall Study|Lost to Follow-up|0|||
131081390|NCT01296555|471930224|FG011|Overall Study|Lost to Follow-up|0|||
131081391|NCT01296555|471930225|FG012|Overall Study|Lost to Follow-up|0|||
131081392|NCT01296555|471930226|FG013|Overall Study|Lost to Follow-up|0|||
131081393|NCT01296555|471930227|FG014|Overall Study|Lost to Follow-up|2|||
131081394|NCT01296555|471930228|FG015|Overall Study|Lost to Follow-up|1|||
131081395|NCT01296555|471930229|FG016|Overall Study|Lost to Follow-up|0|||
131081396|NCT01296555|471930230|FG017|Overall Study|Lost to Follow-up|2|||
131081397|NCT01296555|471930231|FG018|Overall Study|Lost to Follow-up|0|||
131081398|NCT01296555|471930232|FG019|Overall Study|Lost to Follow-up|2|||
131081399|NCT01296555|471930233|FG020|Overall Study|Lost to Follow-up|3|||
131081400|NCT01296555|471930234|FG021|Overall Study|Lost to Follow-up|2|||
131081401|NCT01296555|471930235|FG022|Overall Study|Lost to Follow-up|0|||
131081402|NCT01296555|471930236|FG023|Overall Study|Lost to Follow-up|0|||
130727213|NCT02883049|470625429|FG005|Post Induction|Physician Decision|23|||
131081403|NCT01296555|471930237|FG024|Overall Study|Lost to Follow-up|0|||
131081404|NCT01296555|471930238|FG025|Overall Study|Lost to Follow-up|0|||
131081405|NCT01296555|471930239|FG026|Overall Study|Lost to Follow-up|3|||
131081406|NCT01296555|471930240|FG027|Overall Study|Lost to Follow-up|13|||
131081407|NCT01296555|471930241|FG028|Overall Study|Lost to Follow-up|5|||
131081408|NCT01296555|471930213|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131081409|NCT01296555|471930214|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131081410|NCT01296555|471930215|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131081411|NCT01296555|471930216|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131081412|NCT01296555|471930217|FG004|Overall Study|Non-Compliance With Study Drug|0|||
131081413|NCT01296555|471930218|FG005|Overall Study|Non-Compliance With Study Drug|0|||
131081414|NCT01296555|471930219|FG006|Overall Study|Non-Compliance With Study Drug|0|||
131081415|NCT01296555|471930220|FG007|Overall Study|Non-Compliance With Study Drug|1|||
131081416|NCT01296555|471930221|FG008|Overall Study|Non-Compliance With Study Drug|0|||
131081417|NCT01296555|471930222|FG009|Overall Study|Non-Compliance With Study Drug|0|||
131081418|NCT01296555|471930223|FG010|Overall Study|Non-Compliance With Study Drug|0|||
131081419|NCT01296555|471930224|FG011|Overall Study|Non-Compliance With Study Drug|0|||
131081420|NCT01296555|471930225|FG012|Overall Study|Non-Compliance With Study Drug|0|||
131081421|NCT01296555|471930226|FG013|Overall Study|Non-Compliance With Study Drug|0|||
131081422|NCT01296555|471930227|FG014|Overall Study|Non-Compliance With Study Drug|0|||
131081423|NCT01296555|471930228|FG015|Overall Study|Non-Compliance With Study Drug|0|||
131081424|NCT01296555|471930229|FG016|Overall Study|Non-Compliance With Study Drug|0|||
131081425|NCT01296555|471930230|FG017|Overall Study|Non-Compliance With Study Drug|0|||
131081426|NCT01296555|471930231|FG018|Overall Study|Non-Compliance With Study Drug|0|||
131081427|NCT01296555|471930232|FG019|Overall Study|Non-Compliance With Study Drug|0|||
131081428|NCT01296555|471930233|FG020|Overall Study|Non-Compliance With Study Drug|0|||
131081429|NCT01296555|471930234|FG021|Overall Study|Non-Compliance With Study Drug|0|||
131081430|NCT01296555|471930235|FG022|Overall Study|Non-Compliance With Study Drug|0|||
131081431|NCT01296555|471930236|FG023|Overall Study|Non-Compliance With Study Drug|0|||
131081432|NCT01296555|471930237|FG024|Overall Study|Non-Compliance With Study Drug|0|||
131081433|NCT01296555|471930238|FG025|Overall Study|Non-Compliance With Study Drug|0|||
131081434|NCT01296555|471930239|FG026|Overall Study|Non-Compliance With Study Drug|0|||
131081435|NCT01296555|471930240|FG027|Overall Study|Non-Compliance With Study Drug|0|||
131081436|NCT01296555|471930241|FG028|Overall Study|Non-Compliance With Study Drug|0|||
131081437|NCT01296555|471930213|FG000|Overall Study|Withdrawal by Subject|0|||
131081438|NCT01296555|471930214|FG001|Overall Study|Withdrawal by Subject|0|||
131081439|NCT01296555|471930215|FG002|Overall Study|Withdrawal by Subject|0|||
131081440|NCT01296555|471930216|FG003|Overall Study|Withdrawal by Subject|0|||
131081441|NCT01296555|471930217|FG004|Overall Study|Withdrawal by Subject|1|||
131081442|NCT01296555|471930218|FG005|Overall Study|Withdrawal by Subject|0|||
131081443|NCT01296555|471930219|FG006|Overall Study|Withdrawal by Subject|1|||
131081444|NCT01296555|471930220|FG007|Overall Study|Withdrawal by Subject|0|||
131081445|NCT01296555|471930221|FG008|Overall Study|Withdrawal by Subject|0|||
131081446|NCT01296555|471930222|FG009|Overall Study|Withdrawal by Subject|0|||
131081447|NCT01296555|471930223|FG010|Overall Study|Withdrawal by Subject|1|||
131081448|NCT01296555|471930224|FG011|Overall Study|Withdrawal by Subject|1|||
131081449|NCT01296555|471930225|FG012|Overall Study|Withdrawal by Subject|0|||
131081450|NCT01296555|471930226|FG013|Overall Study|Withdrawal by Subject|0|||
131081451|NCT01296555|471930227|FG014|Overall Study|Withdrawal by Subject|3|||
131081452|NCT01296555|471930228|FG015|Overall Study|Withdrawal by Subject|0|||
131081453|NCT01296555|471930229|FG016|Overall Study|Withdrawal by Subject|2|||
131081454|NCT01296555|471930230|FG017|Overall Study|Withdrawal by Subject|1|||
131081455|NCT01296555|471930231|FG018|Overall Study|Withdrawal by Subject|0|||
131081456|NCT01296555|471930232|FG019|Overall Study|Withdrawal by Subject|1|||
131081457|NCT01296555|471930233|FG020|Overall Study|Withdrawal by Subject|1|||
131081458|NCT01296555|471930234|FG021|Overall Study|Withdrawal by Subject|1|||
131081459|NCT01296555|471930235|FG022|Overall Study|Withdrawal by Subject|3|||
131081460|NCT01296555|471930236|FG023|Overall Study|Withdrawal by Subject|0|||
131141134|NCT01307033|472143791|FG003|44-week Open-label Extension|Death|1|||
131141135|NCT01231555|472143792|FG000|Overall Study|Study terminated|8|||
131141136|NCT01231555|472143793|FG001|Overall Study|Study terminated|5|||
131141137|NCT01231555|472143794|FG002|Overall Study|Study terminated|8|||
131141138|NCT01231555|472143792|FG000|Overall Study|Withdrawal by Subject|0|||
131141139|NCT01231555|472143793|FG001|Overall Study|Withdrawal by Subject|2|||
131141140|NCT01231555|472143794|FG002|Overall Study|Withdrawal by Subject|0|||
131233439|NCT01768858|472482450|FG000|Overall Study|Participant moved to Germany|1|||
131233440|NCT01768858|472482450|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
131141141|NCT00947531|472143795|FG000|Overall Study|Withdrawal by Subject|10|||
131141142|NCT00947531|472143796|FG001|Overall Study|Withdrawal by Subject|7|||
131141143|NCT00947531|472143795|FG000|Overall Study|Administrative Reason|0|||
131141144|NCT00947531|472143796|FG001|Overall Study|Administrative Reason|1|||
131081461|NCT01296555|471930237|FG024|Overall Study|Withdrawal by Subject|0|||
131081462|NCT01296555|471930238|FG025|Overall Study|Withdrawal by Subject|0|||
131081463|NCT01296555|471930239|FG026|Overall Study|Withdrawal by Subject|8|||
131081464|NCT01296555|471930240|FG027|Overall Study|Withdrawal by Subject|4|||
131141145|NCT00947531|472143795|FG000|Overall Study|Adverse Event|2|||
131141146|NCT00947531|472143796|FG001|Overall Study|Adverse Event|2|||
131081465|NCT01296555|471930241|FG028|Overall Study|Withdrawal by Subject|2|||
131081466|NCT01101061|471930242|FG000|Overall Study|Adverse Event|0|||
131081467|NCT01101061|471930243|FG001|Overall Study|Adverse Event|0|||
131081468|NCT01101061|471930244|FG002|Overall Study|Adverse Event|1|||
131081469|NCT01101061|471930245|FG003|Overall Study|Adverse Event|0|||
131081470|NCT01101061|471930246|FG004|Overall Study|Adverse Event|0|||
131081471|NCT01101061|471930247|FG005|Overall Study|Adverse Event|0|||
131081472|NCT03000348|471930252|FG000|Overall Study|Adverse Event|1|||
131081473|NCT03000348|471930253|FG001|Overall Study|Adverse Event|1|||
131081474|NCT03000348|471930254|FG002|Overall Study|Adverse Event|1|||
131081475|NCT03000348|471930255|FG003|Overall Study|Adverse Event|1|||
131081476|NCT03000348|471930256|FG004|Overall Study|Adverse Event|1|||
131081477|NCT03000348|471930257|FG005|Overall Study|Adverse Event|1|||
131081478|NCT03000348|471930252|FG000|Overall Study|Lost to Follow-up|0|||
131081479|NCT03000348|471930253|FG001|Overall Study|Lost to Follow-up|0|||
131081480|NCT03000348|471930254|FG002|Overall Study|Lost to Follow-up|1|||
131081481|NCT03000348|471930255|FG003|Overall Study|Lost to Follow-up|0|||
131081482|NCT03000348|471930256|FG004|Overall Study|Lost to Follow-up|0|||
131081483|NCT03000348|471930257|FG005|Overall Study|Lost to Follow-up|0|||
131081484|NCT03000348|471930252|FG000|Overall Study|Withdrawal by Subject|0|||
131081485|NCT03000348|471930253|FG001|Overall Study|Withdrawal by Subject|1|||
131081486|NCT03000348|471930254|FG002|Overall Study|Withdrawal by Subject|0|||
131081487|NCT03000348|471930255|FG003|Overall Study|Withdrawal by Subject|0|||
131081488|NCT03000348|471930256|FG004|Overall Study|Withdrawal by Subject|0|||
131081489|NCT03000348|471930257|FG005|Overall Study|Withdrawal by Subject|0|||
131081490|NCT03000348|471930252|FG000|Overall Study|Consent|0|||
131081491|NCT03000348|471930253|FG001|Overall Study|Consent|0|||
131081492|NCT03000348|471930254|FG002|Overall Study|Consent|0|||
131081493|NCT03000348|471930255|FG003|Overall Study|Consent|0|||
131081494|NCT03000348|471930256|FG004|Overall Study|Consent|1|||
131081495|NCT03000348|471930257|FG005|Overall Study|Consent|0|||
131081496|NCT03000348|471930252|FG000|Overall Study|Failure to expectorate sputum|1|||
131081497|NCT03000348|471930253|FG001|Overall Study|Failure to expectorate sputum|0|||
131081498|NCT03000348|471930254|FG002|Overall Study|Failure to expectorate sputum|1|||
131081499|NCT03000348|471930255|FG003|Overall Study|Failure to expectorate sputum|0|||
131081500|NCT03000348|471930256|FG004|Overall Study|Failure to expectorate sputum|1|||
131081501|NCT03000348|471930257|FG005|Overall Study|Failure to expectorate sputum|0|||
131081502|NCT03000348|471930252|FG000|Overall Study|No gram negative|1|||
131081503|NCT03000348|471930253|FG001|Overall Study|No gram negative|2|||
131081504|NCT03000348|471930254|FG002|Overall Study|No gram negative|1|||
131081505|NCT03000348|471930255|FG003|Overall Study|No gram negative|1|||
131081506|NCT03000348|471930256|FG004|Overall Study|No gram negative|1|||
131081507|NCT03000348|471930257|FG005|Overall Study|No gram negative|1|||
131081508|NCT03000348|471930252|FG000|Overall Study|Patient had no transport|0|||
131081509|NCT03000348|471930253|FG001|Overall Study|Patient had no transport|0|||
131081510|NCT03000348|471930254|FG002|Overall Study|Patient had no transport|0|||
131081511|NCT03000348|471930255|FG003|Overall Study|Patient had no transport|1|||
131081512|NCT03000348|471930256|FG004|Overall Study|Patient had no transport|0|||
131081513|NCT03000348|471930257|FG005|Overall Study|Patient had no transport|0|||
131081514|NCT03000348|471930252|FG000|Overall Study|Dosing|0|||
131081515|NCT03000348|471930253|FG001|Overall Study|Dosing|0|||
131081516|NCT03000348|471930254|FG002|Overall Study|Dosing|0|||
131081517|NCT03000348|471930255|FG003|Overall Study|Dosing|0|||
131081518|NCT03000348|471930256|FG004|Overall Study|Dosing|1|||
131081519|NCT03000348|471930257|FG005|Overall Study|Dosing|0|||
131081520|NCT04042077|471930258|FG000|Overall Study|Adverse Event|0|||
131081521|NCT04042077|471930259|FG001|Overall Study|Adverse Event|1|||
131141147|NCT00947531|472143795|FG000|Overall Study|Lack of Efficacy|1|||
131141148|NCT00947531|472143796|FG001|Overall Study|Lack of Efficacy|0|||
131141149|NCT00947531|472143795|FG000|Overall Study|Other|1|||
131141150|NCT00947531|472143796|FG001|Overall Study|Other|1|||
131141151|NCT01773421|472143798|FG000|Treatment Phase|Other|0|||
131081522|NCT04042077|471930258|FG000|Overall Study|Death|2|||
131081523|NCT04042077|471930259|FG001|Overall Study|Death|1|||
131081524|NCT04042077|471930258|FG000|Overall Study|Physician Decision|2|||
131081525|NCT04042077|471930259|FG001|Overall Study|Physician Decision|0|||
131081526|NCT04042077|471930258|FG000|Overall Study|Withdrawal by Subject|3|||
131141152|NCT01773421|472143799|FG001|Treatment Phase|Other|0|||
131141153|NCT01773421|472143800|FG002|Treatment Phase|Other|2|||
131141154|NCT01773421|472143801|FG003|Treatment Phase|Other|0|||
131233441|NCT01768858|472482450|FG000|Overall Study|Exanthema|1|||
131233442|NCT01768858|472482450|FG000|Overall Study|Withdrawal by Subject|1|||
131081527|NCT04042077|471930259|FG001|Overall Study|Withdrawal by Subject|2|||
131081528|NCT04042077|471930258|FG000|Overall Study|Lack of Efficacy|0|||
131081529|NCT04042077|471930259|FG001|Overall Study|Lack of Efficacy|1|||
131081530|NCT00745498|471930261|FG000|Overall Study|Lost to Follow-up|1|||
131081531|NCT00745498|471930262|FG001|Overall Study|Lost to Follow-up|1|||
131081532|NCT00745498|471930263|FG002|Overall Study|Lost to Follow-up|3|||
131141155|NCT01773421|472143802|FG004|Treatment Phase|Other|0|||
131141156|NCT01773421|472143803|FG005|Treatment Phase|Other|0|||
131141157|NCT01773421|472143804|FG006|Treatment Phase|Other|0|||
131081533|NCT00745498|471930261|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
131081534|NCT00745498|471930262|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
131081535|NCT00745498|471930263|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
131081536|NCT00745498|471930261|FG000|Overall Study|Non-PDR related VH|0|||
131081537|NCT00745498|471930262|FG001|Overall Study|Non-PDR related VH|1|||
131233443|NCT02742090|472482451|FG000|Overall Study|Adverse Event|10|||
131081538|NCT00745498|471930263|FG002|Overall Study|Non-PDR related VH|1|||
131081539|NCT00745498|471930261|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
131081540|NCT00745498|471930262|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
131081541|NCT00745498|471930263|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
131081542|NCT02031536|471930267|FG000|Overall Study|ineligible|1|||
131081543|NCT02031536|471930268|FG001|Overall Study|ineligible|0|||
131081544|NCT01191008|471930269|FG000|Overall Study|Protocol Violation|7|||
131081545|NCT01191008|471930269|FG000|Overall Study|Lost to Follow-up|8|||
131081546|NCT03733899|471930277|FG000|Period 1|Protocol Violation|0|||
131081547|NCT03733899|471930278|FG001|Period 1|Protocol Violation|0|||
131081548|NCT03733899|471930279|FG002|Period 1|Protocol Violation|0|||
131081549|NCT03733899|471930280|FG003|Period 1|Protocol Violation|0|||
131081550|NCT03733899|471930281|FG004|Period 1|Protocol Violation|0|||
131081551|NCT03733899|471930282|FG005|Period 1|Protocol Violation|1|||
131081552|NCT03733899|471930277|FG000|Period 2|Unscuccessful Treatment|0|||
131081553|NCT03733899|471930278|FG001|Period 2|Unscuccessful Treatment|1|||
131081554|NCT03733899|471930279|FG002|Period 2|Unscuccessful Treatment|0|||
131081555|NCT03733899|471930280|FG003|Period 2|Unscuccessful Treatment|0|||
131081556|NCT03733899|471930281|FG004|Period 2|Unscuccessful Treatment|0|||
131081557|NCT03733899|471930282|FG005|Period 2|Unscuccessful Treatment|0|||
131081558|NCT03733899|471930277|FG000|Period 3|Withdrawal by Subject|1|||
131081559|NCT03733899|471930278|FG001|Period 3|Withdrawal by Subject|0|||
131081560|NCT03733899|471930279|FG002|Period 3|Withdrawal by Subject|0|||
131081561|NCT03733899|471930280|FG003|Period 3|Withdrawal by Subject|0|||
131081562|NCT03733899|471930281|FG004|Period 3|Withdrawal by Subject|0|||
131081563|NCT03733899|471930282|FG005|Period 3|Withdrawal by Subject|0|||
131081564|NCT02035696|471932136|FG000|Overall Study|Lost to Follow-up|0|||
131081565|NCT02035696|471932137|FG001|Overall Study|Lost to Follow-up|3|||
131081566|NCT02035696|471932138|FG002|Overall Study|Lost to Follow-up|1|||
131081567|NCT02035696|471932139|FG003|Overall Study|Lost to Follow-up|2|||
131141158|NCT01773421|472143798|FG000|Treatment Phase|Adverse Event|0|||
131141159|NCT01773421|472143799|FG001|Treatment Phase|Adverse Event|0|||
131141160|NCT01773421|472143800|FG002|Treatment Phase|Adverse Event|3|||
131141161|NCT01773421|472143801|FG003|Treatment Phase|Adverse Event|1|||
131141162|NCT01773421|472143802|FG004|Treatment Phase|Adverse Event|0|||
131141163|NCT01773421|472143803|FG005|Treatment Phase|Adverse Event|0|||
131141164|NCT01773421|472143804|FG006|Treatment Phase|Adverse Event|0|||
131141165|NCT01773421|472143798|FG000|Treatment Phase|Withdrawal by Subject|0|||
131141166|NCT01773421|472143799|FG001|Treatment Phase|Withdrawal by Subject|0|||
131141167|NCT01773421|472143800|FG002|Treatment Phase|Withdrawal by Subject|1|||
131141168|NCT01773421|472143801|FG003|Treatment Phase|Withdrawal by Subject|1|||
131141169|NCT01773421|472143802|FG004|Treatment Phase|Withdrawal by Subject|0|||
131141170|NCT01773421|472143803|FG005|Treatment Phase|Withdrawal by Subject|0|||
131141171|NCT01773421|472143804|FG006|Treatment Phase|Withdrawal by Subject|0|||
131141172|NCT01773421|472143798|FG000|Extension Phase|Other|0|||
131141173|NCT01773421|472143799|FG001|Extension Phase|Other|0|||
131141174|NCT01773421|472143800|FG002|Extension Phase|Other|0|||
131141175|NCT01773421|472143801|FG003|Extension Phase|Other|0|||
131141176|NCT01773421|472143802|FG004|Extension Phase|Other|1|||
131141177|NCT01773421|472143803|FG005|Extension Phase|Other|2|||
131141178|NCT01773421|472143804|FG006|Extension Phase|Other|0|||
131233444|NCT02742090|472482451|FG000|Overall Study|Death|3|||
131233445|NCT02742090|472482451|FG000|Overall Study|Disease Progression|25|||
131233446|NCT02742090|472482451|FG000|Overall Study|Investigator's Decision|1|||
131233447|NCT02742090|472482451|FG000|Overall Study|Lost to Follow-up|1|||
131233448|NCT02742090|472482451|FG000|Overall Study|Non-compliance with Study|1|||
131233449|NCT02742090|472482451|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
131233450|NCT02742090|472482451|FG000|Overall Study|Withdrawal by Subject|4|||
131233451|NCT02742090|472482451|FG000|Overall Study|Reason Not Specified|1|||
130727214|NCT02883049|470625430|FG006|Post Induction|Physician Decision|30|||
131081568|NCT02035696|471932136|FG000|Overall Study|Withdrawal by Subject|3|||
131233452|NCT00836927|472482454|FG000|Overall Study|Progressive disease|2|||
131081569|NCT02035696|471932137|FG001|Overall Study|Withdrawal by Subject|0|||
131081570|NCT02035696|471932138|FG002|Overall Study|Withdrawal by Subject|2|||
131081571|NCT02035696|471932139|FG003|Overall Study|Withdrawal by Subject|1|||
131081572|NCT01090011|471932140|FG000|Overall Study|Progressive disease|128|||
131141179|NCT01773421|472143798|FG000|Extension Phase|Adverse Event|0|||
131141180|NCT01773421|472143799|FG001|Extension Phase|Adverse Event|0|||
131141181|NCT01773421|472143800|FG002|Extension Phase|Adverse Event|0|||
131141182|NCT01773421|472143801|FG003|Extension Phase|Adverse Event|0|||
131141183|NCT01773421|472143802|FG004|Extension Phase|Adverse Event|2|||
131141184|NCT01773421|472143803|FG005|Extension Phase|Adverse Event|0|||
131141185|NCT01773421|472143804|FG006|Extension Phase|Adverse Event|0|||
131141186|NCT03502330|472143805|FG000|Overall Study|Adverse Event|2|||
131141187|NCT03502330|472143806|FG001|Overall Study|Adverse Event|1|||
131141188|NCT03502330|472143807|FG002|Overall Study|Adverse Event|0|||
131141189|NCT03502330|472143808|FG003|Overall Study|Adverse Event|0|||
131141190|NCT03502330|472143809|FG004|Overall Study|Adverse Event|1|||
131141191|NCT03502330|472143810|FG005|Overall Study|Adverse Event|0|||
131141192|NCT03502330|472143811|FG006|Overall Study|Adverse Event|1|||
131141193|NCT03502330|472143812|FG007|Overall Study|Adverse Event|1|||
131141194|NCT03502330|472143813|FG008|Overall Study|Adverse Event|0|||
130780227|NCT01719380|470821455|FG008|Overall Study|Physician Decision|1|||
131081573|NCT01090011|471932140|FG000|Overall Study|Adverse Event|32|||
131081574|NCT01090011|471932140|FG000|Overall Study|Protocol Violation|1|||
131081575|NCT01090011|471932140|FG000|Overall Study|Refusal to start/continue medication|5|||
131081576|NCT01090011|471932140|FG000|Overall Study|Other reason not defined above|5|||
131081577|NCT00379769|471932141|FG000|Main Study|Death|57|||
131081578|NCT00379769|471932142|FG001|Main Study|Death|67|||
131081579|NCT00379769|471932143|FG002|Main Study|Death|54|||
131081580|NCT00379769|471932144|FG003|Main Study|Death|72|||
131081581|NCT00379769|471932145|FG004|Main Study|Death|0|||
131081582|NCT00379769|471932146|FG005|Main Study|Death|0|||
131081583|NCT00379769|471932141|FG000|Main Study|Adverse Event|5|||
131081584|NCT00379769|471932142|FG001|Main Study|Adverse Event|8|||
131081585|NCT00379769|471932143|FG002|Main Study|Adverse Event|10|||
131081586|NCT00379769|471932144|FG003|Main Study|Adverse Event|11|||
131081587|NCT00379769|471932145|FG004|Main Study|Adverse Event|0|||
131081588|NCT00379769|471932146|FG005|Main Study|Adverse Event|0|||
131081589|NCT00379769|471932141|FG000|Main Study|Lost to Follow-up|29|||
131081590|NCT00379769|471932142|FG001|Main Study|Lost to Follow-up|29|||
131081591|NCT00379769|471932143|FG002|Main Study|Lost to Follow-up|25|||
131081592|NCT00379769|471932144|FG003|Main Study|Lost to Follow-up|26|||
131081593|NCT00379769|471932145|FG004|Main Study|Lost to Follow-up|0|||
131081594|NCT00379769|471932146|FG005|Main Study|Lost to Follow-up|0|||
131081595|NCT00379769|471932141|FG000|Main Study|Withdrawal by Subject|46|||
131081596|NCT00379769|471932142|FG001|Main Study|Withdrawal by Subject|56|||
131081597|NCT00379769|471932143|FG002|Main Study|Withdrawal by Subject|72|||
131081598|NCT00379769|471932144|FG003|Main Study|Withdrawal by Subject|70|||
131081599|NCT00379769|471932145|FG004|Main Study|Withdrawal by Subject|0|||
131081600|NCT00379769|471932146|FG005|Main Study|Withdrawal by Subject|0|||
131081601|NCT00379769|471932141|FG000|Main Study|Moved to survival status follow-up only|27|||
131081602|NCT00379769|471932142|FG001|Main Study|Moved to survival status follow-up only|25|||
131081603|NCT00379769|471932143|FG002|Main Study|Moved to survival status follow-up only|32|||
131081604|NCT00379769|471932144|FG003|Main Study|Moved to survival status follow-up only|36|||
131081605|NCT00379769|471932145|FG004|Main Study|Moved to survival status follow-up only|0|||
131081606|NCT00379769|471932146|FG005|Main Study|Moved to survival status follow-up only|0|||
131081607|NCT00379769|471932141|FG000|Main Study|Participant moved|3|||
131081608|NCT00379769|471932142|FG001|Main Study|Participant moved|2|||
131081609|NCT00379769|471932143|FG002|Main Study|Participant moved|3|||
131081610|NCT00379769|471932144|FG003|Main Study|Participant moved|3|||
131081611|NCT00379769|471932145|FG004|Main Study|Participant moved|0|||
131081612|NCT00379769|471932146|FG005|Main Study|Participant moved|0|||
131081613|NCT00379769|471932141|FG000|Main Study|Poor compliance|3|||
131081614|NCT00379769|471932142|FG001|Main Study|Poor compliance|2|||
131081615|NCT00379769|471932143|FG002|Main Study|Poor compliance|2|||
131081616|NCT00379769|471932144|FG003|Main Study|Poor compliance|1|||
131081617|NCT00379769|471932145|FG004|Main Study|Poor compliance|0|||
131081618|NCT00379769|471932146|FG005|Main Study|Poor compliance|0|||
131081619|NCT00379769|471932141|FG000|Main Study|Prohibited glucose lowering medication|0|||
131081620|NCT00379769|471932142|FG001|Main Study|Prohibited glucose lowering medication|3|||
131081621|NCT00379769|471932143|FG002|Main Study|Prohibited glucose lowering medication|0|||
131081622|NCT00379769|471932144|FG003|Main Study|Prohibited glucose lowering medication|1|||
131081623|NCT00379769|471932145|FG004|Main Study|Prohibited glucose lowering medication|0|||
131081624|NCT00379769|471932146|FG005|Main Study|Prohibited glucose lowering medication|0|||
131081625|NCT00379769|471932141|FG000|Main Study|Site closed|4|||
131081626|NCT00379769|471932142|FG001|Main Study|Site closed|4|||
131081627|NCT00379769|471932143|FG002|Main Study|Site closed|4|||
131081628|NCT00379769|471932144|FG003|Main Study|Site closed|8|||
131081629|NCT00379769|471932145|FG004|Main Study|Site closed|0|||
131081630|NCT00379769|471932146|FG005|Main Study|Site closed|0|||
131081631|NCT00379769|471932141|FG000|Main Study|Entry criteria violation|0|||
131233453|NCT00836927|472482455|FG001|Overall Study|Progressive disease|0|||
131081632|NCT00379769|471932142|FG001|Main Study|Entry criteria violation|0|||
131081633|NCT00379769|471932143|FG002|Main Study|Entry criteria violation|1|||
131081634|NCT00379769|471932144|FG003|Main Study|Entry criteria violation|1|||
131081635|NCT00379769|471932145|FG004|Main Study|Entry criteria violation|0|||
131141195|NCT03502330|472143805|FG000|Overall Study|Lack of Efficacy|1|||
131081636|NCT00379769|471932146|FG005|Main Study|Entry criteria violation|0|||
131081637|NCT00379769|471932141|FG000|Main Study|Participant did not take study drug|0|||
131141196|NCT03502330|472143806|FG001|Overall Study|Lack of Efficacy|5|||
131141197|NCT03502330|472143807|FG002|Overall Study|Lack of Efficacy|3|||
131141198|NCT03502330|472143808|FG003|Overall Study|Lack of Efficacy|5|||
131141199|NCT03502330|472143809|FG004|Overall Study|Lack of Efficacy|1|||
131141200|NCT03502330|472143810|FG005|Overall Study|Lack of Efficacy|5|||
131141201|NCT03502330|472143811|FG006|Overall Study|Lack of Efficacy|5|||
131141202|NCT03502330|472143812|FG007|Overall Study|Lack of Efficacy|6|||
131141203|NCT03502330|472143813|FG008|Overall Study|Lack of Efficacy|0|||
131141204|NCT03502330|472143805|FG000|Overall Study|Physician Decision|0|||
131141205|NCT03502330|472143806|FG001|Overall Study|Physician Decision|0|||
131141206|NCT03502330|472143807|FG002|Overall Study|Physician Decision|0|||
131141207|NCT03502330|472143808|FG003|Overall Study|Physician Decision|0|||
131141208|NCT03502330|472143809|FG004|Overall Study|Physician Decision|1|||
131141209|NCT03502330|472143810|FG005|Overall Study|Physician Decision|0|||
131081638|NCT00379769|471932142|FG001|Main Study|Participant did not take study drug|0|||
131081639|NCT00379769|471932143|FG002|Main Study|Participant did not take study drug|1|||
131081640|NCT00379769|471932144|FG003|Main Study|Participant did not take study drug|0|||
131081641|NCT00379769|471932145|FG004|Main Study|Participant did not take study drug|0|||
131081642|NCT00379769|471932146|FG005|Main Study|Participant did not take study drug|0|||
131081643|NCT00379769|471932141|FG000|Main Study|Physician Decision|2|||
131081644|NCT00379769|471932142|FG001|Main Study|Physician Decision|2|||
131081645|NCT00379769|471932143|FG002|Main Study|Physician Decision|1|||
131081646|NCT00379769|471932144|FG003|Main Study|Physician Decision|1|||
131081647|NCT00379769|471932145|FG004|Main Study|Physician Decision|0|||
131081648|NCT00379769|471932146|FG005|Main Study|Physician Decision|0|||
131081649|NCT00379769|471932141|FG000|Main Study|Participant completed study at visit 27|1|||
131081650|NCT00379769|471932142|FG001|Main Study|Participant completed study at visit 27|0|||
131081651|NCT00379769|471932143|FG002|Main Study|Participant completed study at visit 27|0|||
131081652|NCT00379769|471932144|FG003|Main Study|Participant completed study at visit 27|0|||
131081653|NCT00379769|471932145|FG004|Main Study|Participant completed study at visit 27|0|||
131081654|NCT00379769|471932146|FG005|Main Study|Participant completed study at visit 27|0|||
131081655|NCT00379769|471932141|FG000|Main Study|Personal reasons|1|||
131081656|NCT00379769|471932142|FG001|Main Study|Personal reasons|0|||
131081657|NCT00379769|471932143|FG002|Main Study|Personal reasons|0|||
131081658|NCT00379769|471932144|FG003|Main Study|Personal reasons|0|||
131081659|NCT00379769|471932145|FG004|Main Study|Personal reasons|0|||
131081660|NCT00379769|471932146|FG005|Main Study|Personal reasons|0|||
131081661|NCT00379769|471932141|FG000|Main Study|Risk of heart failure|0|||
131081662|NCT00379769|471932142|FG001|Main Study|Risk of heart failure|1|||
131081663|NCT00379769|471932143|FG002|Main Study|Risk of heart failure|0|||
131081664|NCT00379769|471932144|FG003|Main Study|Risk of heart failure|0|||
131081665|NCT00379769|471932145|FG004|Main Study|Risk of heart failure|0|||
131081666|NCT00379769|471932146|FG005|Main Study|Risk of heart failure|0|||
131081667|NCT00379769|471932141|FG000|Main Study|Investigator refused to log temperature|0|||
131081668|NCT00379769|471932142|FG001|Main Study|Investigator refused to log temperature|0|||
131081669|NCT00379769|471932143|FG002|Main Study|Investigator refused to log temperature|1|||
131081670|NCT00379769|471932144|FG003|Main Study|Investigator refused to log temperature|0|||
131081671|NCT00379769|471932145|FG004|Main Study|Investigator refused to log temperature|0|||
131081672|NCT00379769|471932146|FG005|Main Study|Investigator refused to log temperature|0|||
131081673|NCT00379769|471932141|FG000|Main Study|Reason unspecified|0|||
131081674|NCT00379769|471932142|FG001|Main Study|Reason unspecified|0|||
131081675|NCT00379769|471932143|FG002|Main Study|Reason unspecified|1|||
131081676|NCT00379769|471932144|FG003|Main Study|Reason unspecified|0|||
131081677|NCT00379769|471932145|FG004|Main Study|Reason unspecified|0|||
131081678|NCT00379769|471932146|FG005|Main Study|Reason unspecified|0|||
131081679|NCT00379769|471932141|FG000|Observational Follow-up|Death|0|||
131081680|NCT00379769|471932142|FG001|Observational Follow-up|Death|0|||
131081681|NCT00379769|471932143|FG002|Observational Follow-up|Death|0|||
131081682|NCT00379769|471932144|FG003|Observational Follow-up|Death|0|||
131081683|NCT00379769|471932145|FG004|Observational Follow-up|Death|78|||
131081684|NCT00379769|471932146|FG005|Observational Follow-up|Death|70|||
131081685|NCT00379769|471932141|FG000|Observational Follow-up|Adverse Event|0|||
131141210|NCT03502330|472143811|FG006|Overall Study|Physician Decision|0|||
131141211|NCT03502330|472143812|FG007|Overall Study|Physician Decision|0|||
131141212|NCT03502330|472143813|FG008|Overall Study|Physician Decision|0|||
131141213|NCT03502330|472143805|FG000|Overall Study|Withdrawal by Subject|0|||
131141214|NCT03502330|472143806|FG001|Overall Study|Withdrawal by Subject|0|||
131233454|NCT00836927|472482456|FG002|Overall Study|Progressive disease|0|||
131081686|NCT00379769|471932142|FG001|Observational Follow-up|Adverse Event|0|||
131081687|NCT00379769|471932143|FG002|Observational Follow-up|Adverse Event|0|||
131081688|NCT00379769|471932144|FG003|Observational Follow-up|Adverse Event|0|||
131081689|NCT00379769|471932145|FG004|Observational Follow-up|Adverse Event|1|||
131081690|NCT00379769|471932146|FG005|Observational Follow-up|Adverse Event|0|||
131081691|NCT00379769|471932141|FG000|Observational Follow-up|Lost to Follow-up|0|||
131081692|NCT00379769|471932142|FG001|Observational Follow-up|Lost to Follow-up|0|||
131141215|NCT03502330|472143807|FG002|Overall Study|Withdrawal by Subject|0|||
131141216|NCT03502330|472143808|FG003|Overall Study|Withdrawal by Subject|0|||
131141217|NCT03502330|472143809|FG004|Overall Study|Withdrawal by Subject|0|||
131141218|NCT03502330|472143810|FG005|Overall Study|Withdrawal by Subject|1|||
131081693|NCT00379769|471932143|FG002|Observational Follow-up|Lost to Follow-up|0|||
131081694|NCT00379769|471932144|FG003|Observational Follow-up|Lost to Follow-up|0|||
131081695|NCT00379769|471932145|FG004|Observational Follow-up|Lost to Follow-up|25|||
131081696|NCT00379769|471932146|FG005|Observational Follow-up|Lost to Follow-up|27|||
131081697|NCT00379769|471932141|FG000|Observational Follow-up|Withdrawal by Subject|0|||
131081698|NCT00379769|471932142|FG001|Observational Follow-up|Withdrawal by Subject|0|||
131081699|NCT00379769|471932143|FG002|Observational Follow-up|Withdrawal by Subject|0|||
131081700|NCT00379769|471932144|FG003|Observational Follow-up|Withdrawal by Subject|0|||
131081701|NCT00379769|471932145|FG004|Observational Follow-up|Withdrawal by Subject|12|||
131081702|NCT00379769|471932146|FG005|Observational Follow-up|Withdrawal by Subject|12|||
131081703|NCT00379769|471932141|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
131081704|NCT00379769|471932142|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
131081705|NCT00379769|471932143|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
131081706|NCT00379769|471932144|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
131081707|NCT00379769|471932145|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
131081708|NCT00379769|471932146|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
131081709|NCT00379769|471932141|FG000|Observational Follow-up|Physician Decision|0|||
131081710|NCT00379769|471932142|FG001|Observational Follow-up|Physician Decision|0|||
131081711|NCT00379769|471932143|FG002|Observational Follow-up|Physician Decision|0|||
131081712|NCT00379769|471932144|FG003|Observational Follow-up|Physician Decision|0|||
131081713|NCT00379769|471932145|FG004|Observational Follow-up|Physician Decision|8|||
131081714|NCT00379769|471932146|FG005|Observational Follow-up|Physician Decision|8|||
131081715|NCT00379769|471932141|FG000|Observational Follow-up|Site Closed Early|0|||
131081716|NCT00379769|471932142|FG001|Observational Follow-up|Site Closed Early|0|||
131081717|NCT00379769|471932143|FG002|Observational Follow-up|Site Closed Early|0|||
131081718|NCT00379769|471932144|FG003|Observational Follow-up|Site Closed Early|0|||
131081719|NCT00379769|471932145|FG004|Observational Follow-up|Site Closed Early|6|||
131081720|NCT00379769|471932146|FG005|Observational Follow-up|Site Closed Early|7|||
131081721|NCT00379769|471932141|FG000|Observational Follow-up|Participant Moved|0|||
131081722|NCT00379769|471932142|FG001|Observational Follow-up|Participant Moved|0|||
131081723|NCT00379769|471932143|FG002|Observational Follow-up|Participant Moved|0|||
131081724|NCT00379769|471932144|FG003|Observational Follow-up|Participant Moved|0|||
131081725|NCT00379769|471932145|FG004|Observational Follow-up|Participant Moved|0|||
131081726|NCT00379769|471932146|FG005|Observational Follow-up|Participant Moved|1|||
131081727|NCT00379769|471932141|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
131081728|NCT00379769|471932142|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
131081729|NCT00379769|471932143|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
131081730|NCT00379769|471932144|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
131081731|NCT00379769|471932145|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
131081732|NCT00379769|471932146|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
131081733|NCT01689363|471932154|FG000|Overall Study|Protocol Violation|0|||
131081734|NCT01689363|471932155|FG001|Overall Study|Protocol Violation|1|||
131081735|NCT01689363|471932156|FG002|Overall Study|Protocol Violation|0|||
131081736|NCT01689363|471932157|FG003|Overall Study|Protocol Violation|0|||
131081737|NCT01689363|471932158|FG004|Overall Study|Protocol Violation|0|||
131081738|NCT01689363|471932159|FG005|Overall Study|Protocol Violation|0|||
131081739|NCT01689363|471932160|FG006|Overall Study|Protocol Violation|0|||
131081740|NCT01689363|471932161|FG007|Overall Study|Protocol Violation|0|||
131081741|NCT02859064|471932162|FG000|Overall Study|Progressive Disease|3|||
131081742|NCT02859064|471932162|FG000|Overall Study|Physician Decision|1|||
131081743|NCT02859064|471932162|FG000|Overall Study|Withdrawal by Subject|1|||
131081744|NCT02859064|471932162|FG000|Overall Study|Death|1|||
131081745|NCT00321685|471932163|FG000|Overall Study|Adverse Event|18|||
131081746|NCT00321685|471932163|FG000|Overall Study|Death|2|||
131081747|NCT00321685|471932163|FG000|Overall Study|Withdrawal by Subject|8|||
131081748|NCT00321685|471932163|FG000|Overall Study|Alternative therapy|1|||
131081749|NCT00321685|471932163|FG000|Overall Study|Complicating disese|1|||
131081750|NCT00321685|471932163|FG000|Overall Study|Other|5|||
131081751|NCT00321685|471932163|FG000|Overall Study|Not start protocol therapy|2|||
131081752|NCT00321685|471932163|FG000|Overall Study|Ineligible|2|||
131081753|NCT00127842|471932164|FG000|Overall Study|Adverse Event|15|||
131081754|NCT00127842|471932164|FG000|Overall Study|Withdrawal by Subject|3|||
131081755|NCT00127842|471932164|FG000|Overall Study|Lost to Follow-up|1|||
131081756|NCT00127842|471932164|FG000|Overall Study|Lack of Efficacy|12|||
131081757|NCT00127842|471932164|FG000|Overall Study|Noncompliance|2|||
131081758|NCT00127842|471932164|FG000|Overall Study|Protocol Violation|1|||
131081759|NCT00127842|471932164|FG000|Overall Study|Other|5|||
131081760|NCT01638390|471932167|FG000|Overall Study|screening failures|21|||
131081761|NCT01536587|471932168|FG000|Overall Study|Adverse Event|2|||
131081762|NCT02354651|471932169|FG000|Overall Study|Withdrawal by Subject|2|||
131081763|NCT02354651|471932169|FG000|Overall Study|Physician Decision|1|||
131081764|NCT01377389|471932170|FG000|Overall Study|Withdrawal by Subject|1|||
131081765|NCT01377389|471932170|FG000|Overall Study|Screen failure|2|||
131081766|NCT03382561|471932171|FG000|Overall Study|Disease progression|47|||
131081767|NCT03382561|471932172|FG001|Overall Study|Disease progression|6|||
131081768|NCT03382561|471932171|FG000|Overall Study|Adverse Event|10|||
131081769|NCT03382561|471932172|FG001|Overall Study|Adverse Event|2|||
131081770|NCT03382561|471932171|FG000|Overall Study|Death|8|||
131081771|NCT03382561|471932172|FG001|Overall Study|Death|3|||
131081772|NCT03382561|471932171|FG000|Overall Study|Withdrawal by Subject|6|||
131081773|NCT03382561|471932172|FG001|Overall Study|Withdrawal by Subject|5|||
131081774|NCT03382561|471932171|FG000|Overall Study|Alternative therapy|2|||
131081775|NCT03382561|471932172|FG001|Overall Study|Alternative therapy|8|||
131081776|NCT03382561|471932171|FG000|Overall Study|Never started treatment|3|||
131081777|NCT03382561|471932172|FG001|Overall Study|Never started treatment|6|||
131081778|NCT03382561|471932171|FG000|Overall Study|Lack of Efficacy|0|||
131081779|NCT03382561|471932172|FG001|Overall Study|Lack of Efficacy|1|||
131081780|NCT03382561|471932171|FG000|Overall Study|Physician Decision|0|||
131081781|NCT03382561|471932172|FG001|Overall Study|Physician Decision|1|||
131081782|NCT03382561|471932171|FG000|Overall Study|Other complicating disease|0|||
131081783|NCT03382561|471932172|FG001|Overall Study|Other complicating disease|1|||
131081784|NCT01131104|471932173|FG000|Overall Study|Withdrawal by Subject|3|||
131081785|NCT01131104|471932173|FG000|Overall Study|Physician Decision|4|||
131081786|NCT01131104|471932173|FG000|Overall Study|Information Not Available|5|||
131081787|NCT01131104|471932173|FG000|Overall Study|No Information on Index Date of Onset|1|||
131081788|NCT01245140|471932174|FG000|Overall Study|Adverse Event|1|||
131081789|NCT01245140|471932175|FG001|Overall Study|Adverse Event|3|||
131081790|NCT01245140|471932174|FG000|Overall Study|Lack of Efficacy|2|||
131081791|NCT01245140|471932175|FG001|Overall Study|Lack of Efficacy|4|||
131081792|NCT01245140|471932174|FG000|Overall Study|Protocol Violation|0|||
131081793|NCT01245140|471932175|FG001|Overall Study|Protocol Violation|1|||
131081794|NCT01245140|471932174|FG000|Overall Study|Withdrawal by Subject|0|||
131081795|NCT01245140|471932175|FG001|Overall Study|Withdrawal by Subject|1|||
131081796|NCT01245140|471932174|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
131081797|NCT01245140|471932175|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
131081798|NCT00334542|471932176|FG000|Overall Study|Adverse Event|3|||
131081799|NCT00334542|471932176|FG000|Overall Study|Withdrawal by Subject|1|||
131081800|NCT00334542|471932176|FG000|Overall Study|New cancer diagnosis|1|||
131081801|NCT01080326|471932179|FG000|Overall Study|Patient deterioration prior to procedure|3|||
131081802|NCT01080326|471932179|FG000|Overall Study|Surgeon decision|1|||
131081803|NCT01318876|471932180|FG000|Day 8 Survey|email address invalid|96|||
131081804|NCT01318876|471932180|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
131081805|NCT01318876|471932180|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
131081806|NCT00723125|471932182|FG000|Overall Study|Met Dx|1|||
131081807|NCT00723125|471932183|FG001|Overall Study|Met Dx|0|||
131081808|NCT00723125|471932182|FG000|Overall Study|Withdrawal by Subject|15|||
131081809|NCT00723125|471932183|FG001|Overall Study|Withdrawal by Subject|6|||
131081810|NCT00723125|471932182|FG000|Overall Study|Adverse Event|2|||
131081811|NCT00723125|471932183|FG001|Overall Study|Adverse Event|0|||
131081812|NCT00965497|471932185|FG000|Overall Study|Physician Decision|1|||
131081813|NCT00246090|471932190|FG000|Overall Study|Adverse Event|25|||
131081814|NCT00246090|471932190|FG000|Overall Study|Withdrawal by Subject|7|||
131081815|NCT00246090|471932190|FG000|Overall Study|Progressive Disease|212|||
131081816|NCT00246090|471932190|FG000|Overall Study|Clinical Progression|30|||
131081817|NCT00246090|471932190|FG000|Overall Study|Physician Decision|11|||
131081818|NCT00246090|471932190|FG000|Overall Study|Not Otherwise Specified|10|||
131081819|NCT01827046|471932194|FG000|Overall Study|Lost to Follow-up|1|||
131081820|NCT01827046|471932195|FG001|Overall Study|Lost to Follow-up|5|||
131081821|NCT01827046|471932194|FG000|Overall Study|Withdrawal by Subject|0|||
131081822|NCT01827046|471932195|FG001|Overall Study|Withdrawal by Subject|4|||
131081823|NCT02734004|471932196|FG000|Overall Study|Death|36|||
131081824|NCT02734004|471932197|FG001|Overall Study|Death|24|||
131081825|NCT02734004|471932198|FG002|Overall Study|Death|26|||
131081826|NCT02734004|471932199|FG003|Overall Study|Death|35|||
131081827|NCT02734004|471932200|FG004|Overall Study|Death|13|||
131081828|NCT02734004|471932201|FG005|Overall Study|Death|17|||
131081829|NCT02734004|471932202|FG006|Overall Study|Death|20|||
131081830|NCT02734004|471932196|FG000|Overall Study|Lost to Follow-up|1|||
131081831|NCT02734004|471932197|FG001|Overall Study|Lost to Follow-up|1|||
131081832|NCT02734004|471932198|FG002|Overall Study|Lost to Follow-up|0|||
131081833|NCT02734004|471932199|FG003|Overall Study|Lost to Follow-up|0|||
131081834|NCT02734004|471932200|FG004|Overall Study|Lost to Follow-up|1|||
131081835|NCT02734004|471932201|FG005|Overall Study|Lost to Follow-up|0|||
131141219|NCT03502330|472143811|FG006|Overall Study|Withdrawal by Subject|0|||
131081836|NCT02734004|471932202|FG006|Overall Study|Lost to Follow-up|0|||
131081837|NCT02734004|471932196|FG000|Overall Study|Withdrawal by Subject|3|||
131081838|NCT02734004|471932197|FG001|Overall Study|Withdrawal by Subject|1|||
131081839|NCT02734004|471932198|FG002|Overall Study|Withdrawal by Subject|1|||
131081840|NCT02734004|471932199|FG003|Overall Study|Withdrawal by Subject|1|||
131081841|NCT02734004|471932200|FG004|Overall Study|Withdrawal by Subject|3|||
131081842|NCT02734004|471932201|FG005|Overall Study|Withdrawal by Subject|0|||
131081843|NCT02734004|471932202|FG006|Overall Study|Withdrawal by Subject|2|||
131081844|NCT02734004|471932196|FG000|Overall Study|Other|0|||
131141220|NCT03502330|472143812|FG007|Overall Study|Withdrawal by Subject|1|||
131081845|NCT02734004|471932197|FG001|Overall Study|Other|8|||
131081846|NCT02734004|471932198|FG002|Overall Study|Other|7|||
131081847|NCT02734004|471932199|FG003|Overall Study|Other|4|||
131081848|NCT02734004|471932200|FG004|Overall Study|Other|34|||
131081849|NCT02734004|471932201|FG005|Overall Study|Other|14|||
131081850|NCT02734004|471932202|FG006|Overall Study|Other|10|||
131081851|NCT01294436|471932203|FG000|Overall Study|Adverse Event|10|||
131081852|NCT01294436|471932204|FG001|Overall Study|Adverse Event|17|||
131081853|NCT01294436|471932203|FG000|Overall Study|Withdrawal by Subject|11|||
131081854|NCT01294436|471932204|FG001|Overall Study|Withdrawal by Subject|28|||
131081855|NCT01294436|471932203|FG000|Overall Study|subject no longer meets study criteria|5|||
131081856|NCT01294436|471932204|FG001|Overall Study|subject no longer meets study criteria|20|||
131081857|NCT01294436|471932203|FG000|Overall Study|poor/non-compliance|2|||
131081858|NCT01294436|471932204|FG001|Overall Study|poor/non-compliance|5|||
131081859|NCT01018732|471932207|FG000|Overall Study|Lost to Follow-up|0|||
131081860|NCT01018732|471932208|FG001|Overall Study|Lost to Follow-up|0|||
131081861|NCT01018732|471932209|FG002|Overall Study|Lost to Follow-up|3|||
131081862|NCT01018732|471932207|FG000|Overall Study|Protocol Violation|1|||
131081863|NCT01018732|471932208|FG001|Overall Study|Protocol Violation|1|||
131081864|NCT01018732|471932209|FG002|Overall Study|Protocol Violation|0|||
131081865|NCT01018732|471932207|FG000|Overall Study|Inappropriate Enrollment|0|||
131081866|NCT01018732|471932208|FG001|Overall Study|Inappropriate Enrollment|1|||
131081867|NCT01018732|471932209|FG002|Overall Study|Inappropriate Enrollment|0|||
131081868|NCT01018732|471932207|FG000|Overall Study|Unable to Classify|0|||
131081869|NCT01018732|471932208|FG001|Overall Study|Unable to Classify|0|||
131081870|NCT01018732|471932209|FG002|Overall Study|Unable to Classify|1|||
131081871|NCT00585078|471932210|FG000|Overall Study|Withdrawal by Subject|4|||
131081872|NCT00585078|471932210|FG000|Overall Study|Poor performance status|1|||
131081873|NCT00585078|471932210|FG000|Overall Study|Disease Progression|24|||
131081874|NCT00585078|471932210|FG000|Overall Study|Adverse Event|10|||
131081875|NCT00585078|471932210|FG000|Overall Study|Death|1|||
131081876|NCT01536171|471932211|FG000|Overall Study|Withdrawal by Subject|1|||
131081877|NCT02781311|471932214|FG000|Overall Study|Adverse Event|2|||
131081878|NCT02781311|471932215|FG001|Overall Study|Adverse Event|6|||
131081879|NCT02781311|471932216|FG002|Overall Study|Adverse Event|1|||
131081880|NCT02781311|471932214|FG000|Overall Study|Withdrawal of Consent|11|||
131081881|NCT02781311|471932215|FG001|Overall Study|Withdrawal of Consent|12|||
131081882|NCT02781311|471932216|FG002|Overall Study|Withdrawal of Consent|2|||
131081883|NCT02781311|471932214|FG000|Overall Study|Lost to Follow-up|11|||
131081884|NCT02781311|471932215|FG001|Overall Study|Lost to Follow-up|8|||
131081885|NCT02781311|471932216|FG002|Overall Study|Lost to Follow-up|1|||
131081886|NCT02781311|471932214|FG000|Overall Study|Non-Compliance with Study Drug|2|||
131081887|NCT02781311|471932215|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131081888|NCT02781311|471932216|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131081889|NCT01056263|471932219|FG000|Overall Study|Adverse Event|12|||
131081890|NCT01056263|471932219|FG000|Overall Study|Death|1|||
131081891|NCT01056263|471932219|FG000|Overall Study|Withdrawal by Subject|1|||
131081892|NCT01056263|471932219|FG000|Overall Study|Lack of Efficacy|29|||
131081893|NCT01056263|471932219|FG000|Overall Study|Progressive disease|2|||
131081894|NCT01056263|471932219|FG000|Overall Study|Neoplasm progression|1|||
131081895|NCT01056263|471932219|FG000|Overall Study|Objective progression or relapse|1|||
131081896|NCT01056263|471932219|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
131081897|NCT00838929|471932220|FG000|Overall Study|Protocol Violation|0|||
131081898|NCT00838929|471932221|FG001|Overall Study|Protocol Violation|1|||
131141221|NCT03502330|472143813|FG008|Overall Study|Withdrawal by Subject|0|||
131141222|NCT03502330|472143805|FG000|Overall Study|Death|0|||
131141223|NCT03502330|472143806|FG001|Overall Study|Death|0|||
131081899|NCT00838929|471932222|FG002|Overall Study|Protocol Violation|0|||
131081900|NCT00838929|471932220|FG000|Overall Study|Disease progression|0|||
131081901|NCT00838929|471932221|FG001|Overall Study|Disease progression|2|||
131081902|NCT00838929|471932222|FG002|Overall Study|Disease progression|1|||
131081903|NCT01068210|471932229|FG000|Overall Study|Lost to Follow-up|1|||
131081904|NCT01068210|471932230|FG001|Overall Study|Lost to Follow-up|2|||
131081905|NCT01068210|471932231|FG002|Overall Study|Lost to Follow-up|2|||
131081906|NCT01068210|471932232|FG003|Overall Study|Lost to Follow-up|1|||
131081907|NCT01068210|471932229|FG000|Overall Study|Second cancer|0|||
131081908|NCT01068210|471932230|FG001|Overall Study|Second cancer|1|||
131081909|NCT01068210|471932231|FG002|Overall Study|Second cancer|0|||
131081910|NCT01068210|471932232|FG003|Overall Study|Second cancer|0|||
131081911|NCT01068210|471932229|FG000|Overall Study|Disease progression|0|||
131081912|NCT01068210|471932230|FG001|Overall Study|Disease progression|0|||
131081913|NCT01068210|471932231|FG002|Overall Study|Disease progression|0|||
131081914|NCT01068210|471932232|FG003|Overall Study|Disease progression|2|||
131081915|NCT05990387|471932233|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
131081916|NCT05990387|471932234|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
131081917|NCT02257918|471932235|FG000|Overall Study|Lost to Follow-up|4|||
131081918|NCT02257918|471932236|FG001|Overall Study|Lost to Follow-up|1|||
131141224|NCT03502330|472143807|FG002|Overall Study|Death|0|||
131141225|NCT03502330|472143808|FG003|Overall Study|Death|0|||
131081919|NCT02257918|471932237|FG002|Overall Study|Lost to Follow-up|0|||
131081920|NCT02257918|471932235|FG000|Overall Study|Withdrawal by Subject|0|||
131081921|NCT02257918|471932236|FG001|Overall Study|Withdrawal by Subject|0|||
131081922|NCT02257918|471932237|FG002|Overall Study|Withdrawal by Subject|1|||
131081923|NCT02257918|471932235|FG000|Overall Study|Pregnancy|0|||
131081924|NCT02257918|471932236|FG001|Overall Study|Pregnancy|0|||
131081925|NCT02257918|471932237|FG002|Overall Study|Pregnancy|1|||
131081926|NCT01806389|471932239|FG000|Overall Study|Withdrawal by Subject|4|||
131081927|NCT03371823|471932246|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
131081928|NCT03371823|471932247|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
131081929|NCT01263054|471932251|FG000|Overall Study|Death|1|||
131081930|NCT01263054|471932252|FG001|Overall Study|Death|0|||
131081931|NCT01263054|471932251|FG000|Overall Study|Lost to Follow-up|2|||
131081932|NCT01263054|471932252|FG001|Overall Study|Lost to Follow-up|2|||
131081933|NCT01263054|471932251|FG000|Overall Study|Withdrawal by Subject|1|||
131081934|NCT01263054|471932252|FG001|Overall Study|Withdrawal by Subject|3|||
131081935|NCT01263054|471932251|FG000|Overall Study|Qualification Violation|1|||
131081936|NCT01263054|471932252|FG001|Overall Study|Qualification Violation|0|||
131081937|NCT01263054|471932251|FG000|Overall Study|Other|0|||
131081938|NCT01263054|471932252|FG001|Overall Study|Other|1|||
131081939|NCT00936598|471932253|FG000|Overall Study|Withdrawal by Subject|1|||
131081940|NCT00936598|471932254|FG001|Overall Study|Withdrawal by Subject|0|||
131081941|NCT00936598|471932253|FG000|Overall Study|Ineligible after consent|1|||
131081942|NCT00936598|471932254|FG001|Overall Study|Ineligible after consent|0|||
131081943|NCT01310699|471932255|FG000|Overall Study|Patients did not complete tandem.|4|||
131081944|NCT01310699|471932256|FG001|Overall Study|Patients did not complete tandem.|6|||
131081945|NCT00926575|471932257|FG000|Overall Study|Adverse Event|1|||
131081946|NCT00926575|471932258|FG001|Overall Study|Adverse Event|1|||
131081947|NCT00926575|471932257|FG000|Overall Study|Death|4|||
131081948|NCT00926575|471932258|FG001|Overall Study|Death|4|||
131081949|NCT00926575|471932257|FG000|Overall Study|Lost to Follow-up|1|||
131081950|NCT00926575|471932258|FG001|Overall Study|Lost to Follow-up|1|||
131081951|NCT00926575|471932257|FG000|Overall Study|Physician Decision|1|||
131081952|NCT00926575|471932258|FG001|Overall Study|Physician Decision|2|||
131081953|NCT00926575|471932257|FG000|Overall Study|Protocol Violation|1|||
131081954|NCT00926575|471932258|FG001|Overall Study|Protocol Violation|0|||
131081955|NCT00926575|471932257|FG000|Overall Study|Withdrawal by Subject|8|||
131081956|NCT00926575|471932258|FG001|Overall Study|Withdrawal by Subject|9|||
131081957|NCT02201901|471932261|FG000|Overall Study|Randomized but never treated|0|||
131081958|NCT02201901|471932262|FG001|Overall Study|Randomized but never treated|1|||
131141226|NCT03502330|472143809|FG004|Overall Study|Death|0|||
131141227|NCT03502330|472143810|FG005|Overall Study|Death|0|||
131141228|NCT03502330|472143811|FG006|Overall Study|Death|2|||
131141229|NCT03502330|472143812|FG007|Overall Study|Death|0|||
131141230|NCT03502330|472143813|FG008|Overall Study|Death|0|||
131141231|NCT02804763|472143816|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
131141232|NCT02804763|472143817|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
131141233|NCT02804763|472143818|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
131141234|NCT02804763|472143819|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
131141235|NCT02804763|472143816|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
131141236|NCT02804763|472143817|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
131141237|NCT02804763|472143818|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
131141238|NCT02804763|472143819|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
131141239|NCT02804763|472143816|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
131141240|NCT02804763|472143817|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
131141241|NCT02804763|472143818|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
131141242|NCT02804763|472143819|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
131141243|NCT02804763|472143816|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
131141244|NCT02804763|472143817|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
131141245|NCT02804763|472143818|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
131141246|NCT02804763|472143819|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
131081959|NCT02201901|471932263|FG002|Overall Study|Randomized but never treated|0|||
131081960|NCT02201901|471932261|FG000|Overall Study|Lack of Efficacy|7|||
131081961|NCT02201901|471932262|FG001|Overall Study|Lack of Efficacy|1|||
131081962|NCT02201901|471932263|FG002|Overall Study|Lack of Efficacy|6|||
131081963|NCT02201901|471932261|FG000|Overall Study|Death|3|||
131081964|NCT02201901|471932262|FG001|Overall Study|Death|3|||
131081965|NCT02201901|471932263|FG002|Overall Study|Death|3|||
131081966|NCT02201901|471932261|FG000|Overall Study|Lost to Follow-up|2|||
131081967|NCT02201901|471932262|FG001|Overall Study|Lost to Follow-up|3|||
131081968|NCT02201901|471932263|FG002|Overall Study|Lost to Follow-up|2|||
131081969|NCT02201901|471932261|FG000|Overall Study|Withdrew Consent|2|||
131141247|NCT02804763|472143816|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
131141248|NCT02804763|472143817|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
131233455|NCT00836927|472482457|FG003|Overall Study|Progressive disease|1|||
131081970|NCT02201901|471932262|FG001|Overall Study|Withdrew Consent|0|||
131141249|NCT02804763|472143818|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
131141250|NCT02804763|472143819|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
131141251|NCT02804763|472143816|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
131141252|NCT02804763|472143817|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
131141253|NCT02804763|472143818|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
131141254|NCT02804763|472143819|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
131141255|NCT00860158|472143820|FG000|Overall Study|Study Terminated|1|||
131141256|NCT00669617|472143822|FG000|Period 1|Withdrawal by Subject|0|||
131141257|NCT00669617|472143823|FG001|Period 1|Withdrawal by Subject|0|||
131141258|NCT00669617|472143824|FG002|Period 1|Withdrawal by Subject|1|||
131141259|NCT00669617|472143825|FG003|Period 1|Withdrawal by Subject|0|||
131141260|NCT00669617|472143826|FG004|Period 1|Withdrawal by Subject|0|||
131141261|NCT00669617|472143822|FG000|Period 1|Protocol Deviation|0|||
131141262|NCT00669617|472143823|FG001|Period 1|Protocol Deviation|0|||
131141263|NCT00669617|472143824|FG002|Period 1|Protocol Deviation|0|||
131141264|NCT00669617|472143825|FG003|Period 1|Protocol Deviation|0|||
131141265|NCT00669617|472143826|FG004|Period 1|Protocol Deviation|1|||
131141266|NCT00669617|472143822|FG000|Period 3|Lost to Follow-up|1|||
131141267|NCT00669617|472143823|FG001|Period 3|Lost to Follow-up|0|||
131141268|NCT00669617|472143824|FG002|Period 3|Lost to Follow-up|0|||
131141269|NCT00669617|472143825|FG003|Period 3|Lost to Follow-up|0|||
131141270|NCT00669617|472143826|FG004|Period 3|Lost to Follow-up|0|||
131141271|NCT05499520|472143827|FG000|Overall Study|Lost to Follow-up|0|||
131141272|NCT05499520|472143828|FG001|Overall Study|Lost to Follow-up|0|||
131141273|NCT05499520|472143829|FG002|Overall Study|Lost to Follow-up|38|||
131141274|NCT05499520|472143830|FG003|Overall Study|Lost to Follow-up|41|||
131141275|NCT05499520|472143831|FG004|Overall Study|Lost to Follow-up|46|||
131141276|NCT05499520|472143832|FG005|Overall Study|Lost to Follow-up|0|||
131141277|NCT05499520|472143833|FG006|Overall Study|Lost to Follow-up|31|||
131141278|NCT05499520|472143834|FG007|Overall Study|Lost to Follow-up|45|||
131141279|NCT05499520|472143835|FG008|Overall Study|Lost to Follow-up|42|||
131141280|NCT05499520|472143836|FG009|Overall Study|Lost to Follow-up|0|||
131141281|NCT05499520|472143837|FG010|Overall Study|Lost to Follow-up|0|||
131141282|NCT05499520|472143838|FG011|Overall Study|Lost to Follow-up|37|||
131141283|NCT05499520|472143839|FG012|Overall Study|Lost to Follow-up|53|||
131081971|NCT02201901|471932263|FG002|Overall Study|Withdrew Consent|2|||
131081972|NCT02201901|471932261|FG000|Overall Study|Adverse Event|1|||
131081973|NCT02201901|471932262|FG001|Overall Study|Adverse Event|1|||
131081974|NCT02201901|471932263|FG002|Overall Study|Adverse Event|0|||
131081975|NCT02242643|471932264|FG000|Overall Study|Protocol Violation|1|||
131081976|NCT02242643|471932265|FG001|Overall Study|Protocol Violation|2|||
131081977|NCT02242643|471932264|FG000|Overall Study|Withdrawal by Subject|15|||
131081978|NCT02242643|471932265|FG001|Overall Study|Withdrawal by Subject|10|||
131081979|NCT02242643|471932264|FG000|Overall Study|Migrated/moved from study area|1|||
131081980|NCT02242643|471932265|FG001|Overall Study|Migrated/moved from study area|3|||
131081981|NCT02242643|471932264|FG000|Overall Study|Lost to Follow-up|54|||
131081982|NCT02242643|471932265|FG001|Overall Study|Lost to Follow-up|61|||
131081983|NCT02242643|471932264|FG000|Overall Study|Child placed in foster care by family|0|||
131081984|NCT02242643|471932265|FG001|Overall Study|Child placed in foster care by family|1|||
131081985|NCT02242643|471932264|FG000|Overall Study|Non-compliance|1|||
131081986|NCT02242643|471932265|FG001|Overall Study|Non-compliance|0|||
131081987|NCT02242643|471932264|FG000|Overall Study|Consent withdrawal by parent|1|||
131141284|NCT05499520|472143840|FG013|Overall Study|Lost to Follow-up|49|||
131141285|NCT05499520|472143841|FG014|Overall Study|Lost to Follow-up|0|||
131141286|NCT05499520|472143842|FG015|Overall Study|Lost to Follow-up|36|||
131141287|NCT05499520|472143843|FG016|Overall Study|Lost to Follow-up|58|||
131141288|NCT05499520|472143844|FG017|Overall Study|Lost to Follow-up|53|||
131141289|NCT02494596|472143845|FG000|Overall Study|Insufficient Therapeutic Response|3|||
131141290|NCT02494596|472143846|FG001|Overall Study|Insufficient Therapeutic Response|3|||
131081988|NCT02242643|471932265|FG001|Overall Study|Consent withdrawal by parent|0|||
131081989|NCT02242643|471932264|FG000|Overall Study|Protocol requirements not followed|1|||
131081990|NCT02242643|471932265|FG001|Overall Study|Protocol requirements not followed|0|||
131081991|NCT02242643|471932264|FG000|Overall Study|Language barrier|1|||
131081992|NCT02242643|471932265|FG001|Overall Study|Language barrier|0|||
131081993|NCT02242643|471932264|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
131141291|NCT02494596|472143847|FG002|Overall Study|Insufficient Therapeutic Response|1|||
131141292|NCT02494596|472143845|FG000|Overall Study|Adverse Event|0|||
131141293|NCT02494596|472143846|FG001|Overall Study|Adverse Event|1|||
131141294|NCT02494596|472143847|FG002|Overall Study|Adverse Event|0|||
131141295|NCT02494596|472143845|FG000|Overall Study|Refused Treatment|0|||
131141296|NCT02494596|472143846|FG001|Overall Study|Refused Treatment|1|||
131141297|NCT02494596|472143847|FG002|Overall Study|Refused Treatment|0|||
131141298|NCT00584194|472143848|FG000|Overall Study|Other|135|||
131141299|NCT00559273|472143850|FG000|Correction Period (20 Weeks)|Death|3|||
131141300|NCT00559273|472143851|FG001|Correction Period (20 Weeks)|Death|4|||
131141301|NCT00559273|472143850|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
131081994|NCT02242643|471932265|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
131081995|NCT02633397|471932273|FG000|Overall Study|Adverse Event|8|||
131081996|NCT02633397|471932274|FG001|Overall Study|Adverse Event|8|||
131081997|NCT02633397|471932273|FG000|Overall Study|Study Burden|4|||
131081998|NCT02633397|471932274|FG001|Overall Study|Study Burden|1|||
131081999|NCT02633397|471932273|FG000|Overall Study|Treatment interruption|2|||
131082000|NCT02633397|471932274|FG001|Overall Study|Treatment interruption|5|||
131082001|NCT02633397|471932273|FG000|Overall Study|Death|2|||
131082002|NCT02633397|471932274|FG001|Overall Study|Death|2|||
131082003|NCT02633397|471932273|FG000|Overall Study|Physician Decision|0|||
131082004|NCT02633397|471932274|FG001|Overall Study|Physician Decision|1|||
131082005|NCT03595878|471932275|FG000|Overall Study|Death|2|||
131082006|NCT03595878|471932276|FG001|Overall Study|Death|1|||
131082007|NCT03595878|471932277|FG002|Overall Study|Death|0|||
131082008|NCT03595878|471932275|FG000|Overall Study|Disease progression|2|||
131082009|NCT03595878|471932276|FG001|Overall Study|Disease progression|1|||
131082010|NCT03595878|471932277|FG002|Overall Study|Disease progression|2|||
131082011|NCT03494985|471932278|FG000|Overall Study|Adverse Event|3|||
131082012|NCT03494985|471932279|FG001|Overall Study|Adverse Event|2|||
131082013|NCT03494985|471932280|FG002|Overall Study|Adverse Event|3|||
131082014|NCT03494985|471932281|FG003|Overall Study|Adverse Event|0|||
131082015|NCT03494985|471932278|FG000|Overall Study|Other (Withdrawal of consent)|2|||
131082016|NCT03494985|471932279|FG001|Overall Study|Other (Withdrawal of consent)|3|||
131082017|NCT03494985|471932280|FG002|Overall Study|Other (Withdrawal of consent)|2|||
131082018|NCT03494985|471932281|FG003|Overall Study|Other (Withdrawal of consent)|5|||
131082019|NCT03494985|471932278|FG000|Overall Study|Other (Not specified)|0|||
131082020|NCT03494985|471932279|FG001|Overall Study|Other (Not specified)|1|||
131082021|NCT03494985|471932280|FG002|Overall Study|Other (Not specified)|1|||
131082022|NCT03494985|471932281|FG003|Overall Study|Other (Not specified)|0|||
131082023|NCT03036124|471932282|FG000|Overall Study|Lost to Follow-up|0|||
131082024|NCT03036124|471932283|FG001|Overall Study|Lost to Follow-up|2|||
131082025|NCT03036124|471932282|FG000|Overall Study|Withdrawal by Subject|5|||
131082026|NCT03036124|471932283|FG001|Overall Study|Withdrawal by Subject|4|||
131082027|NCT02282059|471932284|FG000|Overall Study|Other|15|||
131082028|NCT02282059|471932285|FG001|Overall Study|Other|3|||
131082029|NCT02282059|471932284|FG000|Overall Study|Participant refused further follow-up|8|||
131082030|NCT02282059|471932285|FG001|Overall Study|Participant refused further follow-up|4|||
131082031|NCT02282059|471932284|FG000|Overall Study|Lost to Follow-up|19|||
131082032|NCT02282059|471932285|FG001|Overall Study|Lost to Follow-up|3|||
131082033|NCT02282059|471932284|FG000|Overall Study|Death|40|||
131082034|NCT02282059|471932285|FG001|Overall Study|Death|8|||
131082035|NCT05093504|471932286|FG000|Overall Study|Death|0|||
131082036|NCT05093504|471932287|FG001|Overall Study|Death|1|||
131082037|NCT02394925|471932288|FG000|Overall Study|Adverse Event|1|||
131082038|NCT02394925|471932288|FG000|Overall Study|Lens Discomfort|3|||
131082039|NCT02394925|471932288|FG000|Overall Study|Lens handling difficulities|5|||
131082040|NCT02394925|471932288|FG000|Overall Study|Lost to Follow-up|9|||
131082041|NCT02394925|471932288|FG000|Overall Study|Protocol Violation|5|||
131082042|NCT02394925|471932288|FG000|Overall Study|No longer meet eligibility criteria|1|||
131082043|NCT02394925|471932288|FG000|Overall Study|Unsatisfactory Visual Response|5|||
131082044|NCT04886518|471932298|FG000|Overall Study|Noncompliance with study drug|1|||
131082045|NCT04886518|471932299|FG001|Overall Study|Noncompliance with study drug|0|||
131082046|NCT04886518|471932300|FG002|Overall Study|Noncompliance with study drug|0|||
131082047|NCT04886518|471932298|FG000|Overall Study|Adverse Event|0|||
130727215|NCT02883049|470625431|FG007|Post Induction|Physician Decision|56|||
130727216|NCT02883049|470625432|FG008|Post Induction|Physician Decision|85|||
131082048|NCT04886518|471932299|FG001|Overall Study|Adverse Event|1|||
131082049|NCT04886518|471932300|FG002|Overall Study|Adverse Event|0|||
131082050|NCT04886518|471932298|FG000|Overall Study|Withdrawal by Subject|1|||
131082051|NCT04886518|471932299|FG001|Overall Study|Withdrawal by Subject|0|||
131082052|NCT04886518|471932300|FG002|Overall Study|Withdrawal by Subject|0|||
131082053|NCT00966264|471933964|FG000|Overall Study|Lost to Follow-up|4|||
131082054|NCT00966264|471933965|FG001|Overall Study|Lost to Follow-up|3|||
131082055|NCT01867047|471933966|FG000|Overall Study|Lost to Follow-up|3|||
131082056|NCT01867047|471933967|FG001|Overall Study|Lost to Follow-up|3|||
131082057|NCT01867047|471933966|FG000|Overall Study|Withdrawal by Subject|2|||
131082058|NCT01867047|471933967|FG001|Overall Study|Withdrawal by Subject|0|||
131082059|NCT01867047|471933966|FG000|Overall Study|Physician Decision|2|||
131082060|NCT01867047|471933967|FG001|Overall Study|Physician Decision|0|||
131082061|NCT01867047|471933966|FG000|Overall Study|surgery not indicated in protocol|1|||
131082062|NCT01867047|471933967|FG001|Overall Study|surgery not indicated in protocol|2|||
131082063|NCT04596995|471933968|FG000|Overall Study|Lack of Efficacy|8|||
131082064|NCT04596995|471933968|FG000|Overall Study|Lost to Follow-up|3|||
131082065|NCT04596995|471933968|FG000|Overall Study|Withdrawal by Subject|12|||
131082066|NCT04596995|471933968|FG000|Overall Study|Sponsor decision|3|||
131082067|NCT04596995|471933968|FG000|Overall Study|Enrolled in managed access program|3|||
131082068|NCT00590564|471933970|FG000|Overall Study|Withdrawal by Subject|4|||
131082069|NCT00590564|471933970|FG000|Overall Study|Lost to Follow-up|6|||
131082070|NCT00590564|471933970|FG000|Overall Study|Protocol Violation|1|||
131233456|NCT00836927|472482458|FG004|Overall Study|Progressive disease|1|||
131082071|NCT00590564|471933970|FG000|Overall Study|Patient Found to be Ineligible|1|||
131082072|NCT00590564|471933970|FG000|Overall Study|Patient Non-compliance|6|||
131082073|NCT01434680|471933971|FG000|Overall Study|Withdrawal by Subject|1|||
131082074|NCT01434680|471933972|FG001|Overall Study|Withdrawal by Subject|0|||
131082075|NCT01434680|471933973|FG002|Overall Study|Withdrawal by Subject|2|||
131082076|NCT01434680|471933974|FG003|Overall Study|Withdrawal by Subject|0|||
131082077|NCT01434680|471933971|FG000|Overall Study|Lost to Follow-up|1|||
131082078|NCT01434680|471933972|FG001|Overall Study|Lost to Follow-up|1|||
131082079|NCT01434680|471933973|FG002|Overall Study|Lost to Follow-up|0|||
131082080|NCT01434680|471933974|FG003|Overall Study|Lost to Follow-up|0|||
131082081|NCT01434680|471933971|FG000|Overall Study|Protocol Violation|1|||
131082082|NCT01434680|471933972|FG001|Overall Study|Protocol Violation|1|||
131082083|NCT01434680|471933973|FG002|Overall Study|Protocol Violation|0|||
131082084|NCT01434680|471933974|FG003|Overall Study|Protocol Violation|0|||
131082085|NCT03020069|471933978|FG000|Overall Study|Lost to Follow-up|0|||
131082086|NCT03020069|471933979|FG001|Overall Study|Lost to Follow-up|1|||
131082087|NCT05765435|471933985|FG000|Overall Study|Lost to Follow-up|0|||
131082088|NCT05765435|471933986|FG001|Overall Study|Lost to Follow-up|1|||
131082089|NCT05765435|471933987|FG002|Overall Study|Lost to Follow-up|0|||
131082090|NCT05765435|471933985|FG000|Overall Study|Withdrawal by Subject|0|||
131082091|NCT05765435|471933986|FG001|Overall Study|Withdrawal by Subject|0|||
131082092|NCT05765435|471933987|FG002|Overall Study|Withdrawal by Subject|1|||
131082093|NCT01907906|471933993|FG000|Overall Study|Withdrawal by Subject|1|||
131082094|NCT01907906|471933994|FG001|Overall Study|Withdrawal by Subject|0|||
131082095|NCT01907906|471933993|FG000|Overall Study|Physician Decision|3|||
131082096|NCT01907906|471933994|FG001|Overall Study|Physician Decision|1|||
131082097|NCT02786004|471933995|FG000|Overall Study|Withdrawal by Subject|0|||
131082098|NCT02786004|471933996|FG001|Overall Study|Withdrawal by Subject|1|||
131082099|NCT00126659|471934000|FG000|Overall Study|Adverse Event|0|||
131082100|NCT00126659|471934001|FG001|Overall Study|Adverse Event|0|||
131082101|NCT00126659|471934002|FG002|Overall Study|Adverse Event|2|||
131082102|NCT02367352|471934003|FG000|Overall Study|Progressive disease|7|||
131082103|NCT02367352|471934004|FG001|Overall Study|Progressive disease|0|||
131082104|NCT02367352|471934005|FG002|Overall Study|Progressive disease|0|||
131082105|NCT02367352|471934003|FG000|Overall Study|Participant Received Alternative Therapy|1|||
131082106|NCT02367352|471934004|FG001|Overall Study|Participant Received Alternative Therapy|0|||
131082107|NCT02367352|471934005|FG002|Overall Study|Participant Received Alternative Therapy|0|||
131082108|NCT02367352|471934003|FG000|Overall Study|Adverse Event|1|||
131082109|NCT02367352|471934004|FG001|Overall Study|Adverse Event|0|||
131233457|NCT00836927|472482454|FG000|Overall Study|Withdrawal by Subject|1|||
131233458|NCT00836927|472482455|FG001|Overall Study|Withdrawal by Subject|0|||
131233459|NCT00836927|472482456|FG002|Overall Study|Withdrawal by Subject|0|||
131233460|NCT00836927|472482457|FG003|Overall Study|Withdrawal by Subject|0|||
131233461|NCT00836927|472482458|FG004|Overall Study|Withdrawal by Subject|0|||
130727217|NCT02883049|470625433|FG009|Post Induction|Physician Decision|12|||
130727218|NCT02883049|470625434|FG010|Post Induction|Physician Decision|5|||
131233462|NCT02192905|472482464|FG000|Overall Study|Lost to Follow-up|1|||
131082110|NCT02367352|471934005|FG002|Overall Study|Adverse Event|0|||
131082111|NCT01013961|471934006|FG000|Overall Study|Adverse Event|2|||
131082112|NCT01013961|471934007|FG001|Overall Study|Adverse Event|2|||
131082113|NCT01013961|471934006|FG000|Overall Study|Withdrawal by Subject|1|||
131082114|NCT01013961|471934007|FG001|Overall Study|Withdrawal by Subject|0|||
131082115|NCT01013961|471934006|FG000|Overall Study|Physician Decision|0|||
131082116|NCT01013961|471934007|FG001|Overall Study|Physician Decision|1|||
131082117|NCT01375751|471934012|FG000|Overall Study|Other|0|||
131082118|NCT01375751|471934013|FG001|Overall Study|Other|1|||
131082119|NCT01375751|471934014|FG002|Overall Study|Other|0|||
131233463|NCT04820842|472482466|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
131233464|NCT04820842|472482467|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
131233465|NCT04820842|472482468|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
131233466|NCT04820842|472482469|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
131082120|NCT02980523|471934015|FG000|Overall Study|Lost to Follow-up|1|||
131082121|NCT02980523|471934016|FG001|Overall Study|Lost to Follow-up|4|||
131082122|NCT02980523|471934017|FG002|Overall Study|Lost to Follow-up|1|||
131082123|NCT02980523|471934018|FG003|Overall Study|Lost to Follow-up|2|||
131233467|NCT04820842|472482470|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
131082124|NCT02980523|471934019|FG004|Overall Study|Lost to Follow-up|1|||
131082125|NCT02980523|471934015|FG000|Overall Study|Excluded from analysis|1|||
131082126|NCT02980523|471934016|FG001|Overall Study|Excluded from analysis|3|||
131082127|NCT02980523|471934017|FG002|Overall Study|Excluded from analysis|1|||
131082128|NCT02980523|471934018|FG003|Overall Study|Excluded from analysis|1|||
131082129|NCT02980523|471934019|FG004|Overall Study|Excluded from analysis|1|||
131082130|NCT02980523|471934015|FG000|Overall Study|Lack of Efficacy|1|||
131082131|NCT02980523|471934016|FG001|Overall Study|Lack of Efficacy|4|||
131082132|NCT02980523|471934017|FG002|Overall Study|Lack of Efficacy|4|||
131082133|NCT02980523|471934018|FG003|Overall Study|Lack of Efficacy|5|||
131082134|NCT02980523|471934019|FG004|Overall Study|Lack of Efficacy|8|||
131082135|NCT02980523|471934015|FG000|Overall Study|Did not receive intervention|0|||
131082136|NCT02980523|471934016|FG001|Overall Study|Did not receive intervention|0|||
131082137|NCT02980523|471934017|FG002|Overall Study|Did not receive intervention|0|||
131082138|NCT02980523|471934018|FG003|Overall Study|Did not receive intervention|1|||
131082139|NCT02980523|471934019|FG004|Overall Study|Did not receive intervention|0|||
131082140|NCT02375347|471934020|FG000|Overall Study|Protocol Violation|1|||
131082141|NCT00559377|471934021|FG000|Overall Study|Withdrawal by Subject|9|||
131082142|NCT00940875|471934022|FG000|Treatment Phase|Adverse Event|9|||
131082143|NCT00940875|471934023|FG001|Treatment Phase|Adverse Event|3|||
131082144|NCT00940875|471934022|FG000|Treatment Phase|Death|3|||
131082145|NCT00940875|471934023|FG001|Treatment Phase|Death|5|||
131082146|NCT00940875|471934022|FG000|Treatment Phase|Lack of Efficacy|1|||
131082147|NCT00940875|471934023|FG001|Treatment Phase|Lack of Efficacy|0|||
131082148|NCT00940875|471934022|FG000|Treatment Phase|Withdrawal by Subject|3|||
131082149|NCT00940875|471934023|FG001|Treatment Phase|Withdrawal by Subject|0|||
131082150|NCT00940875|471934022|FG000|Treatment Phase|Disease progression|9|||
131082151|NCT00940875|471934023|FG001|Treatment Phase|Disease progression|11|||
131082152|NCT00940875|471934022|FG000|Treatment Phase|Physician Decision|1|||
131082153|NCT00940875|471934023|FG001|Treatment Phase|Physician Decision|0|||
131082154|NCT00940875|471934022|FG000|Post-Study Treatment|Death|0|||
131082155|NCT00940875|471934023|FG001|Post-Study Treatment|Death|1|||
131082156|NCT00940875|471934022|FG000|Post-Study Treatment|Disease Progression|0|||
131082157|NCT00940875|471934023|FG001|Post-Study Treatment|Disease Progression|2|||
131082158|NCT00490945|471934024|FG000|Overall Study|Adverse Event|0|||
131082159|NCT00490945|471934025|FG001|Overall Study|Adverse Event|1|||
131082160|NCT00490945|471934026|FG002|Overall Study|Adverse Event|0|||
131082161|NCT00490945|471934027|FG003|Overall Study|Adverse Event|0|||
131082162|NCT00490945|471934028|FG004|Overall Study|Adverse Event|0|||
131082163|NCT02879383|471934037|FG000|First 24 Weeks|Physician Decision|0|||
131082164|NCT02879383|471934038|FG001|First 24 Weeks|Physician Decision|1|||
131082165|NCT02879383|471934039|FG002|First 24 Weeks|Physician Decision|0|||
131082166|NCT02879383|471934040|FG003|First 24 Weeks|Physician Decision|0|||
131082167|NCT05186311|471934041|FG000|Part A: Serum|Withdrawal by Subject|1|||
131082168|NCT02417441|471934050|FG000|Overall Study|Inconclusive due to missing data|52|||
131082169|NCT02417441|471934051|FG001|Overall Study|Inconclusive due to missing data|19|||
131082170|NCT00983853|471934052|FG000|Overall Study|Lost to Follow-up|1|||
131082171|NCT00983853|471934053|FG001|Overall Study|Lost to Follow-up|1|||
131082172|NCT00983853|471934054|FG002|Overall Study|Lost to Follow-up|2|||
131082173|NCT00983853|471934055|FG003|Overall Study|Lost to Follow-up|2|||
131082174|NCT00983853|471934056|FG004|Overall Study|Lost to Follow-up|2|||
131082175|NCT00983853|471934057|FG005|Overall Study|Lost to Follow-up|1|||
131082176|NCT00983853|471934052|FG000|Overall Study|Withdrawal by Subject|0|||
131082177|NCT00983853|471934053|FG001|Overall Study|Withdrawal by Subject|0|||
131082178|NCT00983853|471934054|FG002|Overall Study|Withdrawal by Subject|1|||
131082179|NCT00983853|471934055|FG003|Overall Study|Withdrawal by Subject|0|||
131082180|NCT00983853|471934056|FG004|Overall Study|Withdrawal by Subject|1|||
131082181|NCT00983853|471934057|FG005|Overall Study|Withdrawal by Subject|0|||
131082182|NCT00983853|471934052|FG000|Overall Study|Unable to come to study follow-up visits|0|||
131082183|NCT00983853|471934053|FG001|Overall Study|Unable to come to study follow-up visits|1|||
131082184|NCT00983853|471934054|FG002|Overall Study|Unable to come to study follow-up visits|0|||
131082185|NCT00983853|471934055|FG003|Overall Study|Unable to come to study follow-up visits|0|||
131082186|NCT00983853|471934056|FG004|Overall Study|Unable to come to study follow-up visits|0|||
131082187|NCT00983853|471934057|FG005|Overall Study|Unable to come to study follow-up visits|0|||
131082188|NCT03603639|471934058|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
131082189|NCT03603639|471934059|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
131082190|NCT03603639|471934060|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
131082191|NCT03603639|471934061|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
131082192|NCT03603639|471934062|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
131082193|NCT03603639|471934063|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
131082194|NCT03603639|471934058|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
131082195|NCT03603639|471934059|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
131082196|NCT03603639|471934060|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
131082197|NCT03603639|471934061|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
131082198|NCT03603639|471934062|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
131082199|NCT03603639|471934063|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
131082200|NCT02947100|471934072|FG000|Overall Study|study terminated early|3|||
131082201|NCT02947100|471934072|FG000|Overall Study|did not meet inclusion criteria|1|||
131082202|NCT00742326|471934075|FG000|Overall Study|Physician Decision|0|||
131082203|NCT00742326|471934076|FG001|Overall Study|Physician Decision|1|||
131082204|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
131082205|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
131082206|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
131082207|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
131082208|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
131082209|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
131082210|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
131082211|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
131082212|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
131082213|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
131082214|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
131082215|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
131082216|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
131082217|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
131082218|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
131082219|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
131082220|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
131082221|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
131082222|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Missing|2|||
131082223|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Missing|1|||
131082224|NCT00443209|471934078|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
131082225|NCT00443209|471934079|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
131082226|NCT00443209|471934078|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
131082227|NCT00443209|471934079|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
131082228|NCT00443209|471934078|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
131082229|NCT00443209|471934079|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
131082230|NCT00443209|471934078|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
131082231|NCT00443209|471934079|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
131082232|NCT00443209|471934078|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
131082233|NCT00443209|471934079|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
131082234|NCT00443209|471934078|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
131082235|NCT00443209|471934079|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
131082236|NCT00443209|471934078|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
131082237|NCT00443209|471934079|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
131082238|NCT00409409|471934080|FG000|Overall Study|Adverse Event|7|||
131082239|NCT00409409|471934081|FG001|Overall Study|Adverse Event|2|||
131082240|NCT00409409|471934080|FG000|Overall Study|Withdrawal by Subject|1|||
131082241|NCT00409409|471934081|FG001|Overall Study|Withdrawal by Subject|1|||
131082242|NCT00409409|471934080|FG000|Overall Study|Any other reason not above-mentioned|0|||
131082243|NCT00409409|471934081|FG001|Overall Study|Any other reason not above-mentioned|1|||
131082244|NCT03635086|471934082|FG000|Overall Study|Withdrawal of consent|0|||
131082245|NCT03635086|471934083|FG001|Overall Study|Withdrawal of consent|0|||
131082246|NCT03635086|471934084|FG002|Overall Study|Withdrawal of consent|1|||
131082247|NCT03635086|471934085|FG003|Overall Study|Withdrawal of consent|0|||
131082248|NCT03635086|471934086|FG004|Overall Study|Withdrawal of consent|0|||
131082249|NCT03635086|471934082|FG000|Overall Study|Adverse Event|0|||
131082250|NCT03635086|471934083|FG001|Overall Study|Adverse Event|1|||
131082251|NCT03635086|471934084|FG002|Overall Study|Adverse Event|0|||
131082252|NCT03635086|471934085|FG003|Overall Study|Adverse Event|0|||
131082253|NCT03635086|471934086|FG004|Overall Study|Adverse Event|0|||
131082254|NCT03635086|471934082|FG000|Overall Study|Lost to Follow-up|1|||
131082255|NCT03635086|471934083|FG001|Overall Study|Lost to Follow-up|0|||
131082256|NCT03635086|471934084|FG002|Overall Study|Lost to Follow-up|0|||
131082257|NCT03635086|471934085|FG003|Overall Study|Lost to Follow-up|0|||
131082258|NCT03635086|471934086|FG004|Overall Study|Lost to Follow-up|0|||
131082259|NCT02196077|471934087|FG000|Overall Study|Adverse Event|4|||
131082260|NCT02196077|471934087|FG000|Overall Study|Lack of Efficacy|1|||
131082261|NCT02196077|471934087|FG000|Overall Study|Withdrawal by Subject|14|||
131082262|NCT02196077|471934087|FG000|Overall Study|Physician Decision|1|||
131082263|NCT02196077|471934087|FG000|Overall Study|Lost to Follow-up|3|||
131082264|NCT02196077|471934087|FG000|Overall Study|Protocol Violation|24|||
131082265|NCT00478205|471934092|FG000|Overall Study|Adverse Event|182|||
131082266|NCT00478205|471934093|FG001|Overall Study|Adverse Event|39|||
131082267|NCT00478205|471934092|FG000|Overall Study|Medication Non-compliance|9|||
131082268|NCT00478205|471934093|FG001|Overall Study|Medication Non-compliance|4|||
131082269|NCT00478205|471934092|FG000|Overall Study|Protocol Violation|15|||
131082270|NCT00478205|471934093|FG001|Overall Study|Protocol Violation|5|||
131082271|NCT00478205|471934092|FG000|Overall Study|Request of Investigator or Sponsor|4|||
131082272|NCT00478205|471934093|FG001|Overall Study|Request of Investigator or Sponsor|5|||
131082273|NCT00478205|471934092|FG000|Overall Study|Withdrawal by Subject|61|||
131082274|NCT00478205|471934093|FG001|Overall Study|Withdrawal by Subject|22|||
131082275|NCT00478205|471934092|FG000|Overall Study|Lack of Efficacy|1|||
131082276|NCT00478205|471934093|FG001|Overall Study|Lack of Efficacy|0|||
131082277|NCT00478205|471934092|FG000|Overall Study|Other|24|||
131082278|NCT00478205|471934093|FG001|Overall Study|Other|12|||
131082279|NCT00825305|471934104|FG000|Overall Study|Adverse Event|1|||
131082280|NCT00825305|471934105|FG001|Overall Study|Adverse Event|1|||
130727219|NCT02883049|470625435|FG011|Post Induction|Physician Decision|14|||
131082281|NCT00825305|471934104|FG000|Overall Study|Withdrawal by Subject|6|||
131082282|NCT00825305|471934105|FG001|Overall Study|Withdrawal by Subject|12|||
131082283|NCT00825305|471934104|FG000|Overall Study|Inappropriate inclusion|1|||
131082284|NCT00825305|471934105|FG001|Overall Study|Inappropriate inclusion|0|||
131082285|NCT00825305|471934104|FG000|Overall Study|Protocol Violation|9|||
131082286|NCT00825305|471934105|FG001|Overall Study|Protocol Violation|9|||
131082287|NCT00825305|471934104|FG000|Overall Study|Can not be classified|0|||
131082288|NCT00825305|471934105|FG001|Overall Study|Can not be classified|1|||
131082289|NCT00003477|471934108|FG000|Overall Study|Not evalauable|4|||
131082290|NCT01236352|471934109|FG000|Overall Study|Death|0|||
131082291|NCT01236352|471934110|FG001|Overall Study|Death|0|||
131082292|NCT01236352|471934111|FG002|Overall Study|Death|0|||
131082293|NCT01236352|471934112|FG003|Overall Study|Death|0|||
131082294|NCT01236352|471934113|FG004|Overall Study|Death|0|||
131082295|NCT01236352|471934114|FG005|Overall Study|Death|0|||
131082296|NCT01236352|471934115|FG006|Overall Study|Death|0|||
131082297|NCT01236352|471934116|FG007|Overall Study|Death|1|||
131082298|NCT01236352|471934117|FG008|Overall Study|Death|0|||
131082299|NCT01236352|471934118|FG009|Overall Study|Death|0|||
131082300|NCT01236352|471934119|FG010|Overall Study|Death|0|||
131082301|NCT01236352|471934109|FG000|Overall Study|Withdrawal by Subject|0|||
131082302|NCT01236352|471934110|FG001|Overall Study|Withdrawal by Subject|0|||
131082303|NCT01236352|471934111|FG002|Overall Study|Withdrawal by Subject|0|||
131082304|NCT01236352|471934112|FG003|Overall Study|Withdrawal by Subject|0|||
131082305|NCT01236352|471934113|FG004|Overall Study|Withdrawal by Subject|0|||
131082306|NCT01236352|471934114|FG005|Overall Study|Withdrawal by Subject|0|||
131082307|NCT01236352|471934115|FG006|Overall Study|Withdrawal by Subject|0|||
131082308|NCT01236352|471934116|FG007|Overall Study|Withdrawal by Subject|0|||
131082309|NCT01236352|471934117|FG008|Overall Study|Withdrawal by Subject|0|||
131082310|NCT01236352|471934118|FG009|Overall Study|Withdrawal by Subject|2|||
131082311|NCT01236352|471934119|FG010|Overall Study|Withdrawal by Subject|1|||
131082312|NCT01236352|471934109|FG000|Overall Study|Adverse Event|0|||
131082313|NCT01236352|471934110|FG001|Overall Study|Adverse Event|0|||
131082314|NCT01236352|471934111|FG002|Overall Study|Adverse Event|0|||
131082315|NCT01236352|471934112|FG003|Overall Study|Adverse Event|0|||
131082316|NCT01236352|471934113|FG004|Overall Study|Adverse Event|0|||
131082317|NCT01236352|471934114|FG005|Overall Study|Adverse Event|0|||
131082318|NCT01236352|471934115|FG006|Overall Study|Adverse Event|2|||
131082319|NCT01236352|471934116|FG007|Overall Study|Adverse Event|0|||
131082320|NCT01236352|471934117|FG008|Overall Study|Adverse Event|0|||
131082321|NCT01236352|471934118|FG009|Overall Study|Adverse Event|4|||
131082322|NCT01236352|471934119|FG010|Overall Study|Adverse Event|1|||
131082323|NCT01236352|471934109|FG000|Overall Study|Study drug toxicity|0|||
131082324|NCT01236352|471934110|FG001|Overall Study|Study drug toxicity|0|||
131082325|NCT01236352|471934111|FG002|Overall Study|Study drug toxicity|0|||
131082326|NCT01236352|471934112|FG003|Overall Study|Study drug toxicity|0|||
131082327|NCT01236352|471934113|FG004|Overall Study|Study drug toxicity|0|||
131082328|NCT01236352|471934114|FG005|Overall Study|Study drug toxicity|1|||
131082329|NCT01236352|471934115|FG006|Overall Study|Study drug toxicity|1|||
131082330|NCT01236352|471934116|FG007|Overall Study|Study drug toxicity|0|||
131141302|NCT00559273|472143851|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
131141303|NCT00559273|472143850|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
131141304|NCT00559273|472143851|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
131141305|NCT00559273|472143850|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
131141306|NCT00559273|472143851|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
131141307|NCT00559273|472143850|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
131141308|NCT00559273|472143851|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
131141309|NCT00559273|472143850|FG000|Evaluation Period (8 Weeks)|Death|1|||
131141310|NCT00559273|472143851|FG001|Evaluation Period (8 Weeks)|Death|3|||
131141311|NCT00559273|472143850|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
131141312|NCT00559273|472143851|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
131141313|NCT00559273|472143850|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
131141314|NCT00559273|472143851|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
131141315|NCT00559273|472143850|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
131141316|NCT00559273|472143851|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
131082331|NCT01236352|471934117|FG008|Overall Study|Study drug toxicity|0|||
131082332|NCT01236352|471934118|FG009|Overall Study|Study drug toxicity|2|||
131082333|NCT01236352|471934119|FG010|Overall Study|Study drug toxicity|2|||
131082334|NCT01236352|471934109|FG000|Overall Study|Disease progression|1|||
131082335|NCT01236352|471934110|FG001|Overall Study|Disease progression|2|||
131082336|NCT01236352|471934111|FG002|Overall Study|Disease progression|1|||
131082337|NCT01236352|471934112|FG003|Overall Study|Disease progression|2|||
131082338|NCT01236352|471934113|FG004|Overall Study|Disease progression|2|||
131082339|NCT01236352|471934114|FG005|Overall Study|Disease progression|2|||
131082340|NCT01236352|471934115|FG006|Overall Study|Disease progression|1|||
131141317|NCT00395967|472143853|FG000|Treatment Period|Failed Mobilization|1|||
131141318|NCT00395967|472143853|FG000|Follow-up Period|Death|1|||
131082341|NCT01236352|471934116|FG007|Overall Study|Disease progression|3|||
131082342|NCT01236352|471934117|FG008|Overall Study|Disease progression|2|||
131082343|NCT01236352|471934118|FG009|Overall Study|Disease progression|2|||
131082344|NCT01236352|471934119|FG010|Overall Study|Disease progression|2|||
131082345|NCT01236352|471934109|FG000|Overall Study|Poor/Non-compliance|1|||
131082346|NCT01236352|471934110|FG001|Overall Study|Poor/Non-compliance|0|||
131082347|NCT01236352|471934111|FG002|Overall Study|Poor/Non-compliance|0|||
131082348|NCT01236352|471934112|FG003|Overall Study|Poor/Non-compliance|0|||
131082349|NCT01236352|471934113|FG004|Overall Study|Poor/Non-compliance|0|||
131082350|NCT01236352|471934114|FG005|Overall Study|Poor/Non-compliance|0|||
131082351|NCT01236352|471934115|FG006|Overall Study|Poor/Non-compliance|0|||
131082352|NCT01236352|471934116|FG007|Overall Study|Poor/Non-compliance|0|||
131082353|NCT01236352|471934117|FG008|Overall Study|Poor/Non-compliance|0|||
131082354|NCT01236352|471934118|FG009|Overall Study|Poor/Non-compliance|0|||
131082355|NCT01236352|471934119|FG010|Overall Study|Poor/Non-compliance|0|||
131082356|NCT01236352|471934109|FG000|Overall Study|Maximum clinical benefit|1|||
131082357|NCT01236352|471934110|FG001|Overall Study|Maximum clinical benefit|1|||
131082358|NCT01236352|471934111|FG002|Overall Study|Maximum clinical benefit|1|||
131082359|NCT01236352|471934112|FG003|Overall Study|Maximum clinical benefit|0|||
131082360|NCT01236352|471934113|FG004|Overall Study|Maximum clinical benefit|2|||
131082361|NCT01236352|471934114|FG005|Overall Study|Maximum clinical benefit|0|||
131082362|NCT01236352|471934115|FG006|Overall Study|Maximum clinical benefit|3|||
131082363|NCT01236352|471934116|FG007|Overall Study|Maximum clinical benefit|1|||
131082364|NCT01236352|471934117|FG008|Overall Study|Maximum clinical benefit|1|||
131082365|NCT01236352|471934118|FG009|Overall Study|Maximum clinical benefit|4|||
131082366|NCT01236352|471934119|FG010|Overall Study|Maximum clinical benefit|2|||
131082367|NCT01236352|471934109|FG000|Overall Study|Subject request to discontinue treatment|0|||
131082368|NCT01236352|471934110|FG001|Overall Study|Subject request to discontinue treatment|0|||
131082369|NCT01236352|471934111|FG002|Overall Study|Subject request to discontinue treatment|1|||
131082370|NCT01236352|471934112|FG003|Overall Study|Subject request to discontinue treatment|1|||
131082371|NCT01236352|471934113|FG004|Overall Study|Subject request to discontinue treatment|0|||
131082372|NCT01236352|471934114|FG005|Overall Study|Subject request to discontinue treatment|1|||
131082373|NCT01236352|471934115|FG006|Overall Study|Subject request to discontinue treatment|0|||
131082374|NCT01236352|471934116|FG007|Overall Study|Subject request to discontinue treatment|0|||
131082375|NCT01236352|471934117|FG008|Overall Study|Subject request to discontinue treatment|0|||
131082376|NCT01236352|471934118|FG009|Overall Study|Subject request to discontinue treatment|1|||
131082377|NCT01236352|471934119|FG010|Overall Study|Subject request to discontinue treatment|4|||
131082378|NCT01236352|471934109|FG000|Overall Study|Subject to receive drug via EAP|1|||
131082379|NCT01236352|471934110|FG001|Overall Study|Subject to receive drug via EAP|1|||
131082380|NCT01236352|471934111|FG002|Overall Study|Subject to receive drug via EAP|1|||
131082381|NCT01236352|471934112|FG003|Overall Study|Subject to receive drug via EAP|0|||
131082382|NCT01236352|471934113|FG004|Overall Study|Subject to receive drug via EAP|0|||
131082383|NCT01236352|471934114|FG005|Overall Study|Subject to receive drug via EAP|0|||
131082384|NCT01236352|471934115|FG006|Overall Study|Subject to receive drug via EAP|0|||
131082385|NCT01236352|471934116|FG007|Overall Study|Subject to receive drug via EAP|2|||
131082386|NCT01236352|471934117|FG008|Overall Study|Subject to receive drug via EAP|0|||
131082387|NCT01236352|471934118|FG009|Overall Study|Subject to receive drug via EAP|4|||
131082388|NCT01236352|471934119|FG010|Overall Study|Subject to receive drug via EAP|0|||
131082389|NCT01236352|471934109|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
131082390|NCT01236352|471934110|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
131082391|NCT01236352|471934111|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
131082392|NCT01236352|471934112|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
131082393|NCT01236352|471934113|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
131082394|NCT01236352|471934114|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
131082395|NCT01236352|471934115|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
131082396|NCT01236352|471934116|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
131082397|NCT01236352|471934117|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
131082398|NCT01236352|471934118|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
131082399|NCT01236352|471934119|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
131082400|NCT01236352|471934109|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131082401|NCT01236352|471934110|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131082402|NCT01236352|471934111|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131082403|NCT01236352|471934112|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131082404|NCT01236352|471934113|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131082405|NCT01236352|471934114|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131082406|NCT01236352|471934115|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131082407|NCT01236352|471934116|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131082408|NCT01236352|471934117|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131082409|NCT01236352|471934118|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
131082410|NCT01236352|471934119|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
131082411|NCT01236352|471934109|FG000|Overall Study|Lack of response to drug|0|||
131082412|NCT01236352|471934110|FG001|Overall Study|Lack of response to drug|0|||
131082413|NCT01236352|471934111|FG002|Overall Study|Lack of response to drug|0|||
131082414|NCT01236352|471934112|FG003|Overall Study|Lack of response to drug|0|||
131082415|NCT01236352|471934113|FG004|Overall Study|Lack of response to drug|0|||
131082416|NCT01236352|471934114|FG005|Overall Study|Lack of response to drug|0|||
131082417|NCT01236352|471934115|FG006|Overall Study|Lack of response to drug|0|||
131082418|NCT01236352|471934116|FG007|Overall Study|Lack of response to drug|0|||
131082419|NCT01236352|471934117|FG008|Overall Study|Lack of response to drug|0|||
131082420|NCT01236352|471934118|FG009|Overall Study|Lack of response to drug|1|||
131082421|NCT01236352|471934119|FG010|Overall Study|Lack of response to drug|1|||
131082422|NCT01236352|471934109|FG000|Overall Study|Patient transferred to IST|0|||
131082423|NCT01236352|471934110|FG001|Overall Study|Patient transferred to IST|0|||
131082424|NCT01236352|471934111|FG002|Overall Study|Patient transferred to IST|0|||
131082425|NCT01236352|471934112|FG003|Overall Study|Patient transferred to IST|0|||
131082426|NCT01236352|471934113|FG004|Overall Study|Patient transferred to IST|0|||
131082427|NCT01236352|471934114|FG005|Overall Study|Patient transferred to IST|0|||
131082428|NCT01236352|471934115|FG006|Overall Study|Patient transferred to IST|0|||
131082429|NCT01236352|471934116|FG007|Overall Study|Patient transferred to IST|0|||
131082430|NCT01236352|471934117|FG008|Overall Study|Patient transferred to IST|0|||
131082431|NCT01236352|471934118|FG009|Overall Study|Patient transferred to IST|2|||
131082432|NCT01236352|471934119|FG010|Overall Study|Patient transferred to IST|6|||
131082433|NCT01575873|471934120|FG000|Overall Study|Withdrawal by Subject|15|||
131082434|NCT01575873|471934121|FG001|Overall Study|Withdrawal by Subject|20|||
131082435|NCT01575873|471934122|FG002|Overall Study|Withdrawal by Subject|34|||
131082436|NCT01575873|471934123|FG003|Overall Study|Withdrawal by Subject|34|||
131082437|NCT01575873|471934120|FG000|Overall Study|Adverse Event|7|||
131082438|NCT01575873|471934121|FG001|Overall Study|Adverse Event|7|||
131082439|NCT01575873|471934122|FG002|Overall Study|Adverse Event|9|||
131082440|NCT01575873|471934123|FG003|Overall Study|Adverse Event|12|||
131082441|NCT01575873|471934120|FG000|Overall Study|Lost to Follow-up|1|||
131082442|NCT01575873|471934121|FG001|Overall Study|Lost to Follow-up|3|||
131082443|NCT01575873|471934122|FG002|Overall Study|Lost to Follow-up|13|||
131082444|NCT01575873|471934123|FG003|Overall Study|Lost to Follow-up|5|||
131082445|NCT01575873|471934120|FG000|Overall Study|Death|3|||
131082446|NCT01575873|471934121|FG001|Overall Study|Death|2|||
131082447|NCT01575873|471934122|FG002|Overall Study|Death|8|||
131082448|NCT01575873|471934123|FG003|Overall Study|Death|9|||
131082449|NCT01575873|471934120|FG000|Overall Study|Noncompliance|1|||
131082450|NCT01575873|471934121|FG001|Overall Study|Noncompliance|2|||
131082451|NCT01575873|471934122|FG002|Overall Study|Noncompliance|4|||
131082452|NCT01575873|471934123|FG003|Overall Study|Noncompliance|3|||
131082453|NCT01575873|471934120|FG000|Overall Study|Administrative decision|1|||
131082454|NCT01575873|471934121|FG001|Overall Study|Administrative decision|1|||
131082455|NCT01575873|471934122|FG002|Overall Study|Administrative decision|1|||
131082456|NCT01575873|471934123|FG003|Overall Study|Administrative decision|0|||
131082457|NCT01575873|471934120|FG000|Overall Study|Protocol deviation|0|||
131082458|NCT01575873|471934121|FG001|Overall Study|Protocol deviation|1|||
131082459|NCT01575873|471934122|FG002|Overall Study|Protocol deviation|0|||
131082460|NCT01575873|471934123|FG003|Overall Study|Protocol deviation|1|||
131082461|NCT01575873|471934120|FG000|Overall Study|Requirement for Alternative Therapy|0|||
131082462|NCT01575873|471934121|FG001|Overall Study|Requirement for Alternative Therapy|0|||
131082463|NCT01575873|471934122|FG002|Overall Study|Requirement for Alternative Therapy|1|||
131082464|NCT01575873|471934123|FG003|Overall Study|Requirement for Alternative Therapy|1|||
131082465|NCT01575873|471934120|FG000|Overall Study|Other|0|||
131082466|NCT01575873|471934121|FG001|Overall Study|Other|0|||
131082467|NCT01575873|471934122|FG002|Overall Study|Other|4|||
131082468|NCT01575873|471934123|FG003|Overall Study|Other|2|||
131082469|NCT01850030|471934124|FG000|Overall Study|Adverse Event|64|||
131141319|NCT00395967|472143853|FG000|Follow-up Period|Lost to Follow-up|1|||
131141320|NCT03118947|472143854|FG000|Overall Study|Adverse Event|7|||
131141321|NCT03118947|472143854|FG000|Overall Study|Death|3|||
131141322|NCT03118947|472143854|FG000|Overall Study|Lack of Efficacy|4|||
131141323|NCT03118947|472143854|FG000|Overall Study|Non-compliance with study drug|1|||
131141324|NCT03118947|472143854|FG000|Overall Study|Protocol Violation|2|||
131141325|NCT03118947|472143854|FG000|Overall Study|Withdrawal by Subject|3|||
131141326|NCT03118947|472143854|FG000|Overall Study|Withdrawal by caregiver|3|||
131141327|NCT03118947|472143854|FG000|Overall Study|Change in patient's living situation|4|||
131082470|NCT01850030|471934125|FG001|Overall Study|Adverse Event|82|||
131082471|NCT01850030|471934124|FG000|Overall Study|Lack of Efficacy|3|||
131082472|NCT01850030|471934125|FG001|Overall Study|Lack of Efficacy|1|||
131082473|NCT01850030|471934124|FG000|Overall Study|Lost to Follow-up|5|||
131082474|NCT01850030|471934125|FG001|Overall Study|Lost to Follow-up|5|||
131082475|NCT01850030|471934124|FG000|Overall Study|Withdrawal by Subject|3|||
131082476|NCT01850030|471934125|FG001|Overall Study|Withdrawal by Subject|4|||
131082477|NCT01850030|471934124|FG000|Overall Study|Protocol Violation|24|||
131082478|NCT01850030|471934125|FG001|Overall Study|Protocol Violation|28|||
131141328|NCT03118947|472143854|FG000|Overall Study|Lost to Follow-up|2|||
131141329|NCT00189462|472143857|FG000|Overall Study|Lack of Efficacy|5|||
131082479|NCT01850030|471934124|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
131082480|NCT01850030|471934125|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
131082481|NCT02638103|471934126|FG000|Overall Study|Adverse Event|13|||
131082482|NCT02638103|471934127|FG001|Overall Study|Adverse Event|12|||
131082483|NCT02638103|471934128|FG002|Overall Study|Adverse Event|19|||
131082484|NCT02638103|471934129|FG003|Overall Study|Adverse Event|12|||
131082485|NCT02638103|471934126|FG000|Overall Study|Withdrawal by Subject|43|||
131082486|NCT02638103|471934127|FG001|Overall Study|Withdrawal by Subject|53|||
131082487|NCT02638103|471934128|FG002|Overall Study|Withdrawal by Subject|30|||
131082488|NCT02638103|471934129|FG003|Overall Study|Withdrawal by Subject|61|||
131082489|NCT02638103|471934126|FG000|Overall Study|Protocol Violation|1|||
131082490|NCT02638103|471934127|FG001|Overall Study|Protocol Violation|2|||
131082491|NCT02638103|471934128|FG002|Overall Study|Protocol Violation|1|||
131082492|NCT02638103|471934129|FG003|Overall Study|Protocol Violation|4|||
131082493|NCT02638103|471934126|FG000|Overall Study|Pregnancy|2|||
131082494|NCT02638103|471934127|FG001|Overall Study|Pregnancy|3|||
131082495|NCT02638103|471934128|FG002|Overall Study|Pregnancy|0|||
131082496|NCT02638103|471934129|FG003|Overall Study|Pregnancy|1|||
131082497|NCT02638103|471934126|FG000|Overall Study|Non-compliance to Study Procedures|2|||
131082498|NCT02638103|471934127|FG001|Overall Study|Non-compliance to Study Procedures|1|||
131082499|NCT02638103|471934128|FG002|Overall Study|Non-compliance to Study Procedures|1|||
131082500|NCT02638103|471934129|FG003|Overall Study|Non-compliance to Study Procedures|1|||
131082501|NCT02638103|471934126|FG000|Overall Study|Lost to Follow-up|26|||
131082502|NCT02638103|471934127|FG001|Overall Study|Lost to Follow-up|33|||
131082503|NCT02638103|471934128|FG002|Overall Study|Lost to Follow-up|20|||
131082504|NCT02638103|471934129|FG003|Overall Study|Lost to Follow-up|37|||
131082505|NCT02638103|471934126|FG000|Overall Study|Lack of Efficacy|14|||
131082506|NCT02638103|471934127|FG001|Overall Study|Lack of Efficacy|10|||
131082507|NCT02638103|471934128|FG002|Overall Study|Lack of Efficacy|12|||
131082508|NCT02638103|471934129|FG003|Overall Study|Lack of Efficacy|22|||
131082509|NCT02638103|471934126|FG000|Overall Study|Other than specified|5|||
131082510|NCT02638103|471934127|FG001|Overall Study|Other than specified|4|||
131082511|NCT02638103|471934128|FG002|Overall Study|Other than specified|2|||
131082512|NCT02638103|471934129|FG003|Overall Study|Other than specified|4|||
131082513|NCT02165826|471934138|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
131082514|NCT02165826|471934139|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
131082515|NCT02165826|471934140|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
131082516|NCT02165826|471934138|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
131082517|NCT02165826|471934139|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
131082518|NCT02165826|471934140|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
131082519|NCT02165826|471934138|FG000|Main Treatment Period|Lost to Follow-up|4|||
131082520|NCT02165826|471934139|FG001|Main Treatment Period|Lost to Follow-up|2|||
131082521|NCT02165826|471934140|FG002|Main Treatment Period|Lost to Follow-up|1|||
131082522|NCT02165826|471934138|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
131082523|NCT02165826|471934139|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
131082524|NCT02165826|471934140|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
131082525|NCT02165826|471934138|FG000|Main Treatment Period|Lack of Efficacy|2|||
131082526|NCT02165826|471934139|FG001|Main Treatment Period|Lack of Efficacy|0|||
131082527|NCT02165826|471934140|FG002|Main Treatment Period|Lack of Efficacy|0|||
131082528|NCT02165826|471934138|FG000|Main Treatment Period|Reason Not Specified|8|||
131082529|NCT02165826|471934139|FG001|Main Treatment Period|Reason Not Specified|5|||
131082530|NCT02165826|471934140|FG002|Main Treatment Period|Reason Not Specified|16|||
131082531|NCT02165826|471934138|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
131082532|NCT02165826|471934139|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
131082533|NCT02165826|471934140|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
131233468|NCT04820842|472482471|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
131082534|NCT02165826|471934138|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
131082535|NCT02165826|471934139|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
131082536|NCT02165826|471934140|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
131082537|NCT02165826|471934138|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
131082538|NCT02165826|471934139|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
131082539|NCT02165826|471934140|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
131082540|NCT02165826|471934138|FG000|Down-Titration Period|Reason Not Specified|1|||
131082541|NCT02165826|471934139|FG001|Down-Titration Period|Reason Not Specified|0|||
131082542|NCT02165826|471934140|FG002|Down-Titration Period|Reason Not Specified|2|||
131082543|NCT01439867|471936130|FG000|Overall Study|Non-compliance|0|||
131082544|NCT01439867|471936131|FG001|Overall Study|Non-compliance|1|||
131082545|NCT01439867|471936130|FG000|Overall Study|Withdrawal by Subject|1|||
131082546|NCT01439867|471936131|FG001|Overall Study|Withdrawal by Subject|2|||
131082547|NCT01439867|471936130|FG000|Overall Study|Administrative Decision|4|||
131082548|NCT01439867|471936131|FG001|Overall Study|Administrative Decision|5|||
131082549|NCT01439867|471936130|FG000|Overall Study|Protocol-specified Criteria|1|||
131082550|NCT01439867|471936131|FG001|Overall Study|Protocol-specified Criteria|0|||
131082551|NCT00863512|471936132|FG000|Overall Study|Adverse Event|2|||
131082552|NCT00863512|471936133|FG001|Overall Study|Adverse Event|0|||
131082553|NCT00863512|471936132|FG000|Overall Study|Withdrawal by Subject|11|||
131082554|NCT00863512|471936133|FG001|Overall Study|Withdrawal by Subject|0|||
131082555|NCT00863512|471936132|FG000|Overall Study|Physician Decision|1|||
131082556|NCT00863512|471936133|FG001|Overall Study|Physician Decision|0|||
131082557|NCT02037477|471936134|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
131082558|NCT02037477|471936135|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
131082559|NCT02037477|471936136|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
131082560|NCT02037477|471936137|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
131082561|NCT04978350|471936138|FG000|Overall Study|Lost to Follow-up|6|||
131082562|NCT00983749|471936141|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
131082563|NCT00983749|471936142|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
131082564|NCT01952847|471936143|FG000|Overall Study|Ineligible|1|||
131082565|NCT01952847|471936144|FG001|Overall Study|Ineligible|0|||
131082566|NCT01952847|471936145|FG002|Overall Study|Ineligible|0|||
131082567|NCT01952847|471936146|FG003|Overall Study|Ineligible|0|||
131082568|NCT01952847|471936143|FG000|Overall Study|Lack of Insurance Coverage|0|||
131082569|NCT01952847|471936144|FG001|Overall Study|Lack of Insurance Coverage|1|||
131082570|NCT01952847|471936145|FG002|Overall Study|Lack of Insurance Coverage|0|||
131082571|NCT01952847|471936146|FG003|Overall Study|Lack of Insurance Coverage|0|||
131082572|NCT01952847|471936143|FG000|Overall Study|Withdrawal by Subject|1|||
131082573|NCT01952847|471936144|FG001|Overall Study|Withdrawal by Subject|1|||
131082574|NCT01952847|471936145|FG002|Overall Study|Withdrawal by Subject|0|||
131082575|NCT01952847|471936146|FG003|Overall Study|Withdrawal by Subject|1|||
131082576|NCT00781937|471936150|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
131082577|NCT00781937|471936151|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
131082578|NCT00781937|471936150|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
131082579|NCT00781937|471936151|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
131082580|NCT00781937|471936150|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
131082581|NCT00781937|471936151|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
131082582|NCT00781937|471936150|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
131082583|NCT00781937|471936151|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
131082584|NCT00781937|471936150|FG000|Main Trial Period Through Week 56|Unclassified|10|||
131082585|NCT00781937|471936151|FG001|Main Trial Period Through Week 56|Unclassified|15|||
131082586|NCT00781937|471936150|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
131082587|NCT00781937|471936151|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
131082588|NCT00781937|471936150|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
131082589|NCT00781937|471936151|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
131082590|NCT04698915|471936152|FG000|Overall Study|Adverse Event|2|||
131082591|NCT04698915|471936153|FG001|Overall Study|Adverse Event|0|||
131082592|NCT04698915|471936152|FG000|Overall Study|Death|23|||
131082593|NCT04698915|471936153|FG001|Overall Study|Death|20|||
131082594|NCT04698915|471936152|FG000|Overall Study|Physician Decision|1|||
131082595|NCT04698915|471936153|FG001|Overall Study|Physician Decision|1|||
131082596|NCT04698915|471936152|FG000|Overall Study|Lost to Follow-up|1|||
131082597|NCT04698915|471936153|FG001|Overall Study|Lost to Follow-up|0|||
131082598|NCT04698915|471936152|FG000|Overall Study|Study Terminated by Sponsor|55|||
131082599|NCT04698915|471936153|FG001|Overall Study|Study Terminated by Sponsor|60|||
131082600|NCT04698915|471936152|FG000|Overall Study|Withdrawal by Subject|2|||
131082601|NCT04698915|471936153|FG001|Overall Study|Withdrawal by Subject|3|||
131082602|NCT03520075|471936154|FG000|Phase 1 (Dose Escalation)|Death|2|||
131082603|NCT03520075|471936155|FG001|Phase 1 (Dose Escalation)|Death|2|||
131082604|NCT03520075|471936156|FG002|Phase 1 (Dose Escalation)|Death|3|||
131082605|NCT03520075|471936157|FG003|Phase 1 (Dose Escalation)|Death|2|||
131082606|NCT03520075|471936158|FG004|Phase 1 (Dose Escalation)|Death|6|||
131082607|NCT03520075|471936159|FG005|Phase 1 (Dose Escalation)|Death|5|||
131082608|NCT03520075|471936160|FG006|Phase 1 (Dose Escalation)|Death|3|||
131082609|NCT03520075|471936161|FG007|Phase 1 (Dose Escalation)|Death|2|||
131082610|NCT03520075|471936162|FG008|Phase 1 (Dose Escalation)|Death|3|||
131082611|NCT03520075|471936163|FG009|Phase 1 (Dose Escalation)|Death|1|||
131082612|NCT03520075|471936164|FG010|Phase 1 (Dose Escalation)|Death|5|||
131082613|NCT03520075|471936165|FG011|Phase 1 (Dose Escalation)|Death|7|||
131233469|NCT04820842|472482472|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
131082614|NCT03520075|471936166|FG012|Phase 1 (Dose Escalation)|Death|11|||
131082615|NCT03520075|471936167|FG013|Phase 1 (Dose Escalation)|Death|0|||
131082616|NCT03520075|471936168|FG014|Phase 1 (Dose Escalation)|Death|0|||
131082617|NCT03520075|471936169|FG015|Phase 1 (Dose Escalation)|Death|0|||
131082618|NCT03520075|471936170|FG016|Phase 1 (Dose Escalation)|Death|0|||
131082619|NCT03520075|471936171|FG017|Phase 1 (Dose Escalation)|Death|0|||
131082620|NCT03520075|471936172|FG018|Phase 1 (Dose Escalation)|Death|0|||
131082621|NCT03520075|471936154|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
131082622|NCT03520075|471936155|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082623|NCT03520075|471936156|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082624|NCT03520075|471936157|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
131082625|NCT03520075|471936158|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
131082626|NCT03520075|471936159|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
131082627|NCT03520075|471936160|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082628|NCT03520075|471936161|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
131082629|NCT03520075|471936162|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082630|NCT03520075|471936163|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
131082631|NCT03520075|471936164|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082632|NCT03520075|471936165|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082633|NCT03520075|471936166|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
131082634|NCT03520075|471936167|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082635|NCT03520075|471936168|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082636|NCT03520075|471936169|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082637|NCT03520075|471936170|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082638|NCT03520075|471936171|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082639|NCT03520075|471936172|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
131082640|NCT03520075|471936154|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082641|NCT03520075|471936155|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
131082642|NCT03520075|471936156|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082643|NCT03520075|471936157|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
131082644|NCT03520075|471936158|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
131082645|NCT03520075|471936159|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082646|NCT03520075|471936160|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082647|NCT03520075|471936161|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082648|NCT03520075|471936162|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082649|NCT03520075|471936163|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082650|NCT03520075|471936164|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
131082651|NCT03520075|471936165|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082652|NCT03520075|471936166|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
131082653|NCT03520075|471936167|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082654|NCT03520075|471936168|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082655|NCT03520075|471936169|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082656|NCT03520075|471936170|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082657|NCT03520075|471936171|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082658|NCT03520075|471936172|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
131082659|NCT03520075|471936154|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082660|NCT03520075|471936155|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082661|NCT03520075|471936156|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082662|NCT03520075|471936157|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082663|NCT03520075|471936158|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082664|NCT03520075|471936159|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082665|NCT03520075|471936160|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082666|NCT03520075|471936161|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082667|NCT03520075|471936162|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082668|NCT03520075|471936163|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
131082669|NCT03520075|471936164|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082670|NCT03520075|471936165|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082671|NCT03520075|471936166|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
131082672|NCT03520075|471936167|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082673|NCT03520075|471936168|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082674|NCT03520075|471936169|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082675|NCT03520075|471936170|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082676|NCT03520075|471936171|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082677|NCT03520075|471936172|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
131082678|NCT03520075|471936154|FG000|Phase 2 (Dose Expansion)|Death|0|||
131082679|NCT03520075|471936155|FG001|Phase 2 (Dose Expansion)|Death|0|||
131082680|NCT03520075|471936156|FG002|Phase 2 (Dose Expansion)|Death|0|||
131082681|NCT03520075|471936157|FG003|Phase 2 (Dose Expansion)|Death|0|||
131082682|NCT03520075|471936158|FG004|Phase 2 (Dose Expansion)|Death|0|||
131082683|NCT03520075|471936159|FG005|Phase 2 (Dose Expansion)|Death|0|||
131082684|NCT03520075|471936160|FG006|Phase 2 (Dose Expansion)|Death|0|||
131082685|NCT03520075|471936161|FG007|Phase 2 (Dose Expansion)|Death|0|||
131082686|NCT03520075|471936162|FG008|Phase 2 (Dose Expansion)|Death|0|||
131082687|NCT03520075|471936163|FG009|Phase 2 (Dose Expansion)|Death|0|||
131082688|NCT03520075|471936164|FG010|Phase 2 (Dose Expansion)|Death|0|||
131082689|NCT03520075|471936165|FG011|Phase 2 (Dose Expansion)|Death|0|||
131082690|NCT03520075|471936166|FG012|Phase 2 (Dose Expansion)|Death|0|||
131082691|NCT03520075|471936167|FG013|Phase 2 (Dose Expansion)|Death|20|||
131082692|NCT03520075|471936168|FG014|Phase 2 (Dose Expansion)|Death|13|||
131082693|NCT03520075|471936169|FG015|Phase 2 (Dose Expansion)|Death|9|||
131082694|NCT03520075|471936170|FG016|Phase 2 (Dose Expansion)|Death|5|||
131082695|NCT03520075|471936171|FG017|Phase 2 (Dose Expansion)|Death|14|||
131082696|NCT03520075|471936172|FG018|Phase 2 (Dose Expansion)|Death|12|||
131082697|NCT03520075|471936154|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082698|NCT03520075|471936155|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082699|NCT03520075|471936156|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082700|NCT03520075|471936157|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082701|NCT03520075|471936158|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082702|NCT03520075|471936159|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082703|NCT03520075|471936160|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082704|NCT03520075|471936161|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082705|NCT03520075|471936162|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082706|NCT03520075|471936163|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082707|NCT03520075|471936164|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082708|NCT03520075|471936165|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082709|NCT03520075|471936166|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082710|NCT03520075|471936167|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
131082711|NCT03520075|471936168|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
131082712|NCT03520075|471936169|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
131082713|NCT03520075|471936170|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
131082714|NCT03520075|471936171|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
131082715|NCT03520075|471936172|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
131082716|NCT03520075|471936154|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082717|NCT03520075|471936155|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082718|NCT03520075|471936156|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082719|NCT03520075|471936157|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082720|NCT03520075|471936158|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082721|NCT03520075|471936159|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082722|NCT03520075|471936160|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082723|NCT03520075|471936161|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082724|NCT03520075|471936162|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082725|NCT03520075|471936163|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082726|NCT03520075|471936164|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082727|NCT03520075|471936165|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082728|NCT03520075|471936166|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082729|NCT03520075|471936167|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082730|NCT03520075|471936168|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
131082731|NCT03520075|471936169|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
131082732|NCT03520075|471936170|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082733|NCT03520075|471936171|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
131082734|NCT03520075|471936172|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
131082735|NCT03520075|471936154|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082736|NCT03520075|471936155|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082737|NCT03520075|471936156|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082738|NCT03520075|471936157|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082739|NCT03520075|471936158|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082740|NCT03520075|471936159|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082741|NCT03520075|471936160|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082742|NCT03520075|471936161|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082743|NCT03520075|471936162|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082744|NCT03520075|471936163|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082745|NCT03520075|471936164|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082746|NCT03520075|471936165|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082747|NCT03520075|471936166|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082748|NCT03520075|471936167|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
131082749|NCT03520075|471936168|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082750|NCT03520075|471936169|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082751|NCT03520075|471936170|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
131082752|NCT03520075|471936171|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
131082753|NCT03520075|471936172|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
131082754|NCT02577003|471936175|FG000|Overall Study|Adverse Event|2|||
131082755|NCT02577003|471936176|FG001|Overall Study|Adverse Event|4|||
131082756|NCT02577003|471936175|FG000|Overall Study|Withdrawal by Subject|0|||
131082757|NCT02577003|471936176|FG001|Overall Study|Withdrawal by Subject|1|||
131082758|NCT00203047|471936178|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
131082759|NCT00203047|471936179|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
131082760|NCT00203047|471936178|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
131082761|NCT00203047|471936179|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
131082762|NCT00203047|471936178|FG000|Overall Study|Withdrawal by Subject|13|||
131082763|NCT00203047|471936179|FG001|Overall Study|Withdrawal by Subject|47|||
131082764|NCT00203047|471936178|FG000|Overall Study|Teva requested participant withdrawal|1|||
131082765|NCT00203047|471936179|FG001|Overall Study|Teva requested participant withdrawal|1|||
131082766|NCT00203047|471936178|FG000|Overall Study|Physician Decision|8|||
131082767|NCT00203047|471936179|FG001|Overall Study|Physician Decision|7|||
131082768|NCT00203047|471936178|FG000|Overall Study|Non-compliance|4|||
131082769|NCT00203047|471936179|FG001|Overall Study|Non-compliance|8|||
131082770|NCT00203047|471936178|FG000|Overall Study|Protocol Violation|1|||
131082771|NCT00203047|471936179|FG001|Overall Study|Protocol Violation|0|||
131082772|NCT00203047|471936178|FG000|Overall Study|Lost to Follow-up|11|||
131082773|NCT00203047|471936179|FG001|Overall Study|Lost to Follow-up|5|||
131082774|NCT00203047|471936178|FG000|Overall Study|Adverse Event|8|||
131082775|NCT00203047|471936179|FG001|Overall Study|Adverse Event|18|||
131082776|NCT00203047|471936178|FG000|Overall Study|Death|1|||
131082777|NCT00203047|471936179|FG001|Overall Study|Death|2|||
131082778|NCT00203047|471936178|FG000|Overall Study|Pregnancy|3|||
131082779|NCT00203047|471936179|FG001|Overall Study|Pregnancy|0|||
131082780|NCT00203047|471936178|FG000|Overall Study|Other|5|||
131082781|NCT00203047|471936179|FG001|Overall Study|Other|5|||
131082782|NCT00340704|471936182|FG000|PK Study|Adverse Event|0|||
131082783|NCT00340704|471936183|FG001|PK Study|Adverse Event|1|||
131082784|NCT00340704|471936184|FG002|PK Study|Adverse Event|0|||
131082785|NCT00340704|471936185|FG003|PK Study|Adverse Event|0|||
131082786|NCT00340704|471936186|FG004|PK Study|Adverse Event|0|||
131082787|NCT00340704|471936187|FG005|PK Study|Adverse Event|0|||
131082788|NCT00340704|471936188|FG006|PK Study|Adverse Event|0|||
131082789|NCT00340704|471936189|FG007|PK Study|Adverse Event|0|||
131082790|NCT00340704|471936190|FG008|PK Study|Adverse Event|0|||
131082791|NCT00340704|471936182|FG000|PK Study|Not treated|0|||
131082792|NCT00340704|471936183|FG001|PK Study|Not treated|0|||
131082793|NCT00340704|471936184|FG002|PK Study|Not treated|1|||
131082794|NCT00340704|471936185|FG003|PK Study|Not treated|0|||
131082795|NCT00340704|471936186|FG004|PK Study|Not treated|0|||
131082796|NCT00340704|471936187|FG005|PK Study|Not treated|0|||
131082797|NCT00340704|471936188|FG006|PK Study|Not treated|0|||
131082798|NCT00340704|471936189|FG007|PK Study|Not treated|0|||
131082799|NCT00340704|471936190|FG008|PK Study|Not treated|0|||
131082800|NCT00340704|471936182|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
131082801|NCT00340704|471936183|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
131082802|NCT00340704|471936184|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
131082803|NCT00340704|471936185|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
131082804|NCT00340704|471936186|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
131082805|NCT00340704|471936187|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
131082806|NCT00340704|471936188|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
131082807|NCT00340704|471936189|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
131082808|NCT00340704|471936190|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
131082809|NCT00340704|471936182|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131082810|NCT00340704|471936183|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131082811|NCT00340704|471936184|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131082812|NCT00340704|471936185|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131082813|NCT00340704|471936186|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131082814|NCT00340704|471936187|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
131082815|NCT00340704|471936188|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131082816|NCT00340704|471936189|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131082817|NCT00340704|471936190|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
131082818|NCT00340704|471936182|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131082819|NCT00340704|471936183|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131082820|NCT00340704|471936184|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131082821|NCT00340704|471936185|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131082822|NCT00340704|471936186|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
131082823|NCT00340704|471936187|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
131082824|NCT00340704|471936188|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131082825|NCT00340704|471936189|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131082826|NCT00340704|471936190|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
131082827|NCT00340704|471936182|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
131082828|NCT00340704|471936183|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
131141330|NCT00189462|472143858|FG001|Overall Study|Lack of Efficacy|1|||
131141331|NCT00189462|472143857|FG000|Overall Study|Lost to Follow-up|18|||
131141332|NCT00189462|472143858|FG001|Overall Study|Lost to Follow-up|20|||
131141333|NCT00448708|472143859|FG000|Overall Study|Death|21|||
131141334|NCT00448708|472143860|FG001|Overall Study|Death|17|||
131141335|NCT00448708|472143859|FG000|Overall Study|Withdrawal by Subject|8|||
131141336|NCT00448708|472143860|FG001|Overall Study|Withdrawal by Subject|4|||
131141337|NCT00448708|472143859|FG000|Overall Study|Lost to Follow-up|6|||
131141338|NCT00448708|472143860|FG001|Overall Study|Lost to Follow-up|8|||
131082829|NCT00340704|471936184|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
131082830|NCT00340704|471936185|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
131082831|NCT00340704|471936186|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
131082832|NCT00340704|471936187|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
131082833|NCT00340704|471936188|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
131082834|NCT00340704|471936189|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
131082835|NCT00340704|471936190|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
131082836|NCT00121667|471936191|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
131082837|NCT00121667|471936192|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
131082838|NCT00121667|471936193|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
131082839|NCT00121667|471936194|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
131082840|NCT00121667|471936191|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
131082841|NCT00121667|471936192|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
131082842|NCT00121667|471936193|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
131082843|NCT00121667|471936194|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
131082844|NCT00121667|471936191|FG000|Short Term (ST) Period|Adverse Event|5|||
131082845|NCT00121667|471936192|FG001|Short Term (ST) Period|Adverse Event|6|||
131082846|NCT00121667|471936193|FG002|Short Term (ST) Period|Adverse Event|5|||
131082847|NCT00121667|471936194|FG003|Short Term (ST) Period|Adverse Event|3|||
131082848|NCT00121667|471936191|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
131082849|NCT00121667|471936192|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
131082850|NCT00121667|471936193|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
131082851|NCT00121667|471936194|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
131082852|NCT00121667|471936191|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
131082853|NCT00121667|471936192|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
131141339|NCT00448708|472143859|FG000|Overall Study|not listed|0|||
131141340|NCT00448708|472143860|FG001|Overall Study|not listed|2|||
131141341|NCT02400255|472143862|FG000|Overall Study|Relapse|4|||
131141342|NCT02400255|472143863|FG001|Overall Study|Relapse|1|||
131141343|NCT02400255|472143864|FG002|Overall Study|Relapse|1|||
131141344|NCT02400255|472143865|FG003|Overall Study|Relapse|2|||
131141345|NCT02400255|472143862|FG000|Overall Study|Adverse Event|6|||
131141346|NCT02400255|472143863|FG001|Overall Study|Adverse Event|3|||
131141347|NCT02400255|472143864|FG002|Overall Study|Adverse Event|0|||
131141348|NCT02400255|472143865|FG003|Overall Study|Adverse Event|0|||
131141349|NCT02400255|472143862|FG000|Overall Study|Physician Decision|6|||
131233470|NCT04820842|472482466|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
131233471|NCT04820842|472482467|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
131082854|NCT00121667|471936193|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
131082855|NCT00121667|471936194|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
131082856|NCT00121667|471936191|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
131082857|NCT00121667|471936192|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
131082858|NCT00121667|471936193|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
131082859|NCT00121667|471936194|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
131082860|NCT00121667|471936191|FG000|Short Term (ST) Period|Other Reason|3|||
131082861|NCT00121667|471936192|FG001|Short Term (ST) Period|Other Reason|0|||
131082862|NCT00121667|471936193|FG002|Short Term (ST) Period|Other Reason|0|||
131082863|NCT00121667|471936194|FG003|Short Term (ST) Period|Other Reason|0|||
131082864|NCT00121667|471936191|FG000|Short Term (ST) Period|Death|0|||
131082865|NCT00121667|471936192|FG001|Short Term (ST) Period|Death|0|||
131082866|NCT00121667|471936193|FG002|Short Term (ST) Period|Death|0|||
131082867|NCT00121667|471936194|FG003|Short Term (ST) Period|Death|1|||
131082868|NCT00121667|471936191|FG000|Short Term (ST) Period|Pregnancy|0|||
131082869|NCT00121667|471936192|FG001|Short Term (ST) Period|Pregnancy|0|||
131082870|NCT00121667|471936193|FG002|Short Term (ST) Period|Pregnancy|0|||
131082871|NCT00121667|471936194|FG003|Short Term (ST) Period|Pregnancy|1|||
131082872|NCT00121667|471936191|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
131082873|NCT00121667|471936192|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
131082874|NCT00121667|471936193|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
131082875|NCT00121667|471936194|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
131082876|NCT00121667|471936191|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
131082877|NCT00121667|471936192|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
131082878|NCT00121667|471936193|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
131082879|NCT00121667|471936194|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
131141350|NCT02400255|472143863|FG001|Overall Study|Physician Decision|0|||
131141351|NCT02400255|472143864|FG002|Overall Study|Physician Decision|0|||
131141352|NCT02400255|472143865|FG003|Overall Study|Physician Decision|0|||
131141353|NCT02400255|472143862|FG000|Overall Study|Loss of insurance|1|||
131141354|NCT02400255|472143863|FG001|Overall Study|Loss of insurance|0|||
131082880|NCT00121667|471936191|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
131082881|NCT00121667|471936192|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
131082882|NCT00121667|471936193|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
131082883|NCT00121667|471936194|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
131082884|NCT00121667|471936191|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
131082885|NCT00121667|471936192|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
131082886|NCT00121667|471936193|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
131082887|NCT00121667|471936194|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
131082888|NCT00121667|471936191|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
131082889|NCT00121667|471936192|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
131082890|NCT00121667|471936193|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
131082891|NCT00121667|471936194|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
131082892|NCT00121667|471936191|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
131082893|NCT00121667|471936192|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
131082894|NCT00121667|471936193|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
131082895|NCT00121667|471936194|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
131082896|NCT00121667|471936191|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
131082897|NCT00121667|471936192|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
131082898|NCT00121667|471936193|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
131082899|NCT00121667|471936194|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
131082900|NCT00121667|471936191|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
131082901|NCT00121667|471936192|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
131082902|NCT00121667|471936193|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
131082903|NCT00121667|471936194|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
131082904|NCT00121667|471936191|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
131082905|NCT00121667|471936192|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
131082906|NCT00121667|471936193|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
131082907|NCT00121667|471936194|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
131082908|NCT01453023|471936195|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
131082909|NCT01453023|471936196|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
131082910|NCT01453023|471936195|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
131082911|NCT01453023|471936196|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
131082912|NCT01453023|471936195|FG000|Treatment Period 2|Protocol Violation|0|||
131082913|NCT01453023|471936196|FG001|Treatment Period 2|Protocol Violation|1|||
131082914|NCT03016598|471936207|FG000|Overall Study|Lost to Follow-up|0|||
131082915|NCT03016598|471936208|FG001|Overall Study|Lost to Follow-up|2|||
131082916|NCT01628692|471936209|FG000|Overall Study|Lack of Efficacy|4|||
131082917|NCT01628692|471936210|FG001|Overall Study|Lack of Efficacy|4|||
131082918|NCT01628692|471936211|FG002|Overall Study|Lack of Efficacy|5|||
131082919|NCT01628692|471936212|FG003|Overall Study|Lack of Efficacy|1|||
131082920|NCT01628692|471936213|FG004|Overall Study|Lack of Efficacy|4|||
131082921|NCT01628692|471936214|FG005|Overall Study|Lack of Efficacy|7|||
131082922|NCT01628692|471936209|FG000|Overall Study|Adverse Event|2|||
131082923|NCT01628692|471936210|FG001|Overall Study|Adverse Event|0|||
131082924|NCT01628692|471936211|FG002|Overall Study|Adverse Event|2|||
131082925|NCT01628692|471936212|FG003|Overall Study|Adverse Event|0|||
131082926|NCT01628692|471936213|FG004|Overall Study|Adverse Event|0|||
131141355|NCT02400255|472143864|FG002|Overall Study|Loss of insurance|0|||
131141356|NCT02400255|472143865|FG003|Overall Study|Loss of insurance|0|||
131141357|NCT01961544|472143866|FG000|Overall Study|Protocol Violation|1|||
131141358|NCT01961544|472143866|FG000|Overall Study|Withdrawal by Subject|7|||
131141359|NCT01961544|472143866|FG000|Overall Study|Adverse Event|1|||
131082927|NCT01628692|471936214|FG005|Overall Study|Adverse Event|0|||
131141360|NCT01961544|472143866|FG000|Overall Study|Physician Decision|2|||
131141361|NCT01961544|472143866|FG000|Overall Study|Poor Tolerance|1|||
131141362|NCT01961544|472143866|FG000|Overall Study|Aggravation of Steral Pain|1|||
131141363|NCT03665285|472143867|FG000|Overall Study|Started New Anticancer Treatment|1|||
131141364|NCT03665285|472143868|FG001|Overall Study|Started New Anticancer Treatment|1|||
131141365|NCT03665285|472143869|FG002|Overall Study|Started New Anticancer Treatment|2|||
131082928|NCT01628692|471936209|FG000|Overall Study|Withdrawal by Subject|0|||
131082929|NCT01628692|471936210|FG001|Overall Study|Withdrawal by Subject|1|||
131082930|NCT01628692|471936211|FG002|Overall Study|Withdrawal by Subject|1|||
131082931|NCT01628692|471936212|FG003|Overall Study|Withdrawal by Subject|0|||
131082932|NCT01628692|471936213|FG004|Overall Study|Withdrawal by Subject|0|||
131082933|NCT01628692|471936214|FG005|Overall Study|Withdrawal by Subject|0|||
131082934|NCT01628692|471936209|FG000|Overall Study|Death|0|||
131141366|NCT03665285|472143870|FG003|Overall Study|Started New Anticancer Treatment|4|||
131141367|NCT03665285|472143871|FG004|Overall Study|Started New Anticancer Treatment|1|||
131141368|NCT03665285|472143872|FG005|Overall Study|Started New Anticancer Treatment|1|||
131141369|NCT03665285|472143873|FG006|Overall Study|Started New Anticancer Treatment|2|||
130727220|NCT02883049|470625436|FG012|Post Induction|Physician Decision|1|||
131082935|NCT01628692|471936210|FG001|Overall Study|Death|1|||
131082936|NCT01628692|471936211|FG002|Overall Study|Death|0|||
131082937|NCT01628692|471936212|FG003|Overall Study|Death|0|||
131082938|NCT01628692|471936213|FG004|Overall Study|Death|0|||
131082939|NCT01628692|471936214|FG005|Overall Study|Death|0|||
131082940|NCT01628692|471936209|FG000|Overall Study|Poor compliance/noncompliance|1|||
131082941|NCT01628692|471936210|FG001|Overall Study|Poor compliance/noncompliance|0|||
131082942|NCT01628692|471936211|FG002|Overall Study|Poor compliance/noncompliance|0|||
131082943|NCT01628692|471936212|FG003|Overall Study|Poor compliance/noncompliance|0|||
131082944|NCT01628692|471936213|FG004|Overall Study|Poor compliance/noncompliance|0|||
131082945|NCT01628692|471936214|FG005|Overall Study|Poor compliance/noncompliance|0|||
131082946|NCT01628692|471936209|FG000|Overall Study|Administrative reason by sponsor|0|||
131082947|NCT01628692|471936210|FG001|Overall Study|Administrative reason by sponsor|0|||
131082948|NCT01628692|471936211|FG002|Overall Study|Administrative reason by sponsor|0|||
131082949|NCT01628692|471936212|FG003|Overall Study|Administrative reason by sponsor|0|||
131082950|NCT01628692|471936213|FG004|Overall Study|Administrative reason by sponsor|0|||
131082951|NCT01628692|471936214|FG005|Overall Study|Administrative reason by sponsor|1|||
131082952|NCT01628692|471936209|FG000|Overall Study|Completed 12 Week only|0|||
131082953|NCT01628692|471936210|FG001|Overall Study|Completed 12 Week only|0|||
131082954|NCT01628692|471936211|FG002|Overall Study|Completed 12 Week only|0|||
131082955|NCT01628692|471936212|FG003|Overall Study|Completed 12 Week only|0|||
131082956|NCT01628692|471936213|FG004|Overall Study|Completed 12 Week only|0|||
131082957|NCT01628692|471936214|FG005|Overall Study|Completed 12 Week only|1|||
131082958|NCT03513068|471936218|FG000|Overall Study|Death|1|||
131082959|NCT03513068|471936219|FG001|Overall Study|Death|0|||
131082960|NCT03513068|471936218|FG000|Overall Study|Withdrawal by Subject|4|||
131082961|NCT03513068|471936219|FG001|Overall Study|Withdrawal by Subject|6|||
131082962|NCT01012947|471936220|FG000|Overall Study|Lost to Follow-up|131|||
131082963|NCT01012947|471936221|FG001|Overall Study|Lost to Follow-up|135|||
131082964|NCT01012947|471936222|FG002|Overall Study|Lost to Follow-up|130|||
131082965|NCT01012947|471936223|FG003|Overall Study|Lost to Follow-up|118|||
131082966|NCT01012947|471936224|FG004|Overall Study|Lost to Follow-up|142|||
131082967|NCT04016272|471936227|FG000|Overall Study|Withdrawal by Subject|1|||
131082968|NCT04016272|471936228|FG001|Overall Study|Withdrawal by Subject|2|||
131082969|NCT04547023|471936229|FG000|Overall Study|Did Not Receive Intervention|3|||
131082970|NCT04547023|471936230|FG001|Overall Study|Did Not Receive Intervention|2|||
131082971|NCT04547023|471936229|FG000|Overall Study|Lost to Follow-up|1|||
131082972|NCT04547023|471936230|FG001|Overall Study|Lost to Follow-up|1|||
131082973|NCT01262092|471936231|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
131082974|NCT01262092|471936232|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
131082975|NCT01262092|471936231|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
131082976|NCT01262092|471936232|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
131082977|NCT01262092|471936231|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
131082978|NCT01262092|471936232|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
131082979|NCT01262092|471936231|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
131082980|NCT01262092|471936232|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
131082981|NCT03784820|471936233|FG000|Overall Study|Lost to Follow-up|5|||
131082982|NCT03784820|471936234|FG001|Overall Study|Lost to Follow-up|5|||
131082983|NCT03784820|471936235|FG002|Overall Study|Lost to Follow-up|3|||
131082984|NCT03784820|471936236|FG003|Overall Study|Lost to Follow-up|3|||
131082985|NCT04147858|471936237|FG000|Overall Study|Adverse Event|6|||
131082986|NCT04147858|471936238|FG001|Overall Study|Adverse Event|6|||
131082987|NCT04147858|471936239|FG002|Overall Study|Adverse Event|6|||
131082988|NCT04147858|471936237|FG000|Overall Study|Lack of Efficacy|3|||
131082989|NCT04147858|471936238|FG001|Overall Study|Lack of Efficacy|3|||
131082990|NCT04147858|471936239|FG002|Overall Study|Lack of Efficacy|1|||
131082991|NCT04147858|471936237|FG000|Overall Study|Lost to Follow-up|1|||
131082992|NCT04147858|471936238|FG001|Overall Study|Lost to Follow-up|6|||
131082993|NCT04147858|471936239|FG002|Overall Study|Lost to Follow-up|2|||
131082994|NCT04147858|471936237|FG000|Overall Study|Withdrawal by Subject|3|||
131082995|NCT04147858|471936238|FG001|Overall Study|Withdrawal by Subject|4|||
131082996|NCT04147858|471936239|FG002|Overall Study|Withdrawal by Subject|10|||
131082997|NCT04147858|471936237|FG000|Overall Study|Subject Noncompliance, Other|4|||
131082998|NCT04147858|471936238|FG001|Overall Study|Subject Noncompliance, Other|3|||
131082999|NCT04147858|471936239|FG002|Overall Study|Subject Noncompliance, Other|1|||
131083000|NCT00658606|471936242|FG000|Overall Study|Adverse Event|2|||
131083001|NCT00658606|471936243|FG001|Overall Study|Adverse Event|1|||
131083002|NCT00658606|471936242|FG000|Overall Study|Lack of Efficacy|6|||
131083003|NCT00658606|471936243|FG001|Overall Study|Lack of Efficacy|3|||
131083004|NCT00658606|471936242|FG000|Overall Study|Lost to Follow-up|1|||
131083005|NCT00658606|471936243|FG001|Overall Study|Lost to Follow-up|0|||
131141370|NCT03665285|472143874|FG007|Overall Study|Started New Anticancer Treatment|15|||
131083006|NCT00658606|471936242|FG000|Overall Study|Withdrawal by Subject|7|||
131083007|NCT00658606|471936243|FG001|Overall Study|Withdrawal by Subject|16|||
131083008|NCT00658606|471936242|FG000|Overall Study|Lack of Compliance|0|||
131083009|NCT00658606|471936243|FG001|Overall Study|Lack of Compliance|3|||
131083010|NCT00365547|471936248|FG000|Overall Study|Insurance did not cover Avastin|1|||
131083011|NCT00365547|471936248|FG000|Overall Study|Screen failure|1|||
131083012|NCT00365547|471936248|FG000|Overall Study|Withdrawal by Subject|1|||
131083013|NCT03170518|471936249|FG000|Overall Study|Lost to Follow-up|4|||
131083014|NCT03170518|471936250|FG001|Overall Study|Lost to Follow-up|1|||
131083015|NCT03170518|471936251|FG002|Overall Study|Lost to Follow-up|0|||
131083016|NCT03170518|471936249|FG000|Overall Study|Physician Decision|1|||
131083017|NCT03170518|471936250|FG001|Overall Study|Physician Decision|0|||
131083018|NCT03170518|471936251|FG002|Overall Study|Physician Decision|0|||
131141371|NCT03665285|472143875|FG008|Overall Study|Started New Anticancer Treatment|1|||
131141372|NCT03665285|472143867|FG000|Overall Study|Disease Progression|0|||
131141373|NCT03665285|472143868|FG001|Overall Study|Disease Progression|0|||
131141374|NCT03665285|472143869|FG002|Overall Study|Disease Progression|3|||
131141375|NCT03665285|472143870|FG003|Overall Study|Disease Progression|1|||
131141376|NCT03665285|472143871|FG004|Overall Study|Disease Progression|0|||
131141377|NCT03665285|472143872|FG005|Overall Study|Disease Progression|0|||
131141378|NCT03665285|472143873|FG006|Overall Study|Disease Progression|0|||
131141379|NCT03665285|472143874|FG007|Overall Study|Disease Progression|7|||
131141380|NCT03665285|472143875|FG008|Overall Study|Disease Progression|1|||
131083019|NCT03170518|471936249|FG000|Overall Study|Withdrawal by Subject|4|||
131083020|NCT03170518|471936250|FG001|Overall Study|Withdrawal by Subject|5|||
131083021|NCT03170518|471936251|FG002|Overall Study|Withdrawal by Subject|2|||
131083022|NCT03170518|471936249|FG000|Overall Study|Site terminated by sponsor|0|||
131083023|NCT03170518|471936250|FG001|Overall Study|Site terminated by sponsor|1|||
131083024|NCT03170518|471936251|FG002|Overall Study|Site terminated by sponsor|0|||
131083025|NCT03170518|471936249|FG000|Overall Study|Non-compliance with study drug|1|||
131083026|NCT03170518|471936250|FG001|Overall Study|Non-compliance with study drug|0|||
131083027|NCT03170518|471936251|FG002|Overall Study|Non-compliance with study drug|1|||
131083028|NCT03170518|471936249|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131083029|NCT03170518|471936250|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131083030|NCT03170518|471936251|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131083031|NCT04428476|471936252|FG000|Overall Study|Withdrawal by Subject|1|||
131083032|NCT04428476|471936252|FG000|Overall Study|Still on treatment|12|||
131083033|NCT00546078|471936253|FG000|Overall Study|Lost to Follow-up|1|||
131083034|NCT00546078|471936254|FG001|Overall Study|Lost to Follow-up|3|||
131083035|NCT00546078|471936253|FG000|Overall Study|Withdrawal by Subject|2|||
131083036|NCT00546078|471936254|FG001|Overall Study|Withdrawal by Subject|3|||
131083037|NCT00546078|471936253|FG000|Overall Study|Other reason|1|||
131083038|NCT00546078|471936254|FG001|Overall Study|Other reason|1|||
131083039|NCT03023423|471936257|FG000|Overall Study|Death|5|||
131083040|NCT03023423|471936258|FG001|Overall Study|Death|12|||
131083041|NCT03023423|471936259|FG002|Overall Study|Death|20|||
131083042|NCT03023423|471936257|FG000|Overall Study|Other|0|||
131083043|NCT03023423|471936258|FG001|Overall Study|Other|2|||
131083044|NCT03023423|471936259|FG002|Overall Study|Other|2|||
131083045|NCT03023423|471936257|FG000|Overall Study|Ongoing|2|||
131083046|NCT03023423|471936258|FG001|Overall Study|Ongoing|32|||
131083047|NCT03023423|471936259|FG002|Overall Study|Ongoing|24|||
131083048|NCT03512197|471936260|FG000|Overall Study|Guardian decision|1|||
131083049|NCT03512197|471936261|FG001|Overall Study|Guardian decision|1|||
131083050|NCT03512197|471936260|FG000|Overall Study|Lack of Efficacy|19|||
131083051|NCT03512197|471936261|FG001|Overall Study|Lack of Efficacy|11|||
131083052|NCT03512197|471936260|FG000|Overall Study|New Therapy for Study Indication|16|||
131083053|NCT03512197|471936261|FG001|Overall Study|New Therapy for Study Indication|16|||
131083054|NCT03512197|471936260|FG000|Overall Study|Physician Decision|60|||
131083055|NCT03512197|471936261|FG001|Overall Study|Physician Decision|60|||
131083056|NCT03512197|471936260|FG000|Overall Study|Protocol Violation|0|||
131083057|NCT03512197|471936261|FG001|Overall Study|Protocol Violation|2|||
131083058|NCT03512197|471936260|FG000|Overall Study|Terminated by Sponsored|46|||
131083059|NCT03512197|471936261|FG001|Overall Study|Terminated by Sponsored|50|||
131141381|NCT03665285|472143867|FG000|Overall Study|Hospice|0|||
131141382|NCT03665285|472143868|FG001|Overall Study|Hospice|0|||
131141383|NCT03665285|472143869|FG002|Overall Study|Hospice|0|||
131141384|NCT03665285|472143870|FG003|Overall Study|Hospice|0|||
131083060|NCT03512197|471936260|FG000|Overall Study|Subject Decision|15|||
131083061|NCT03512197|471936261|FG001|Overall Study|Subject Decision|12|||
131083062|NCT03512197|471936260|FG000|Overall Study|Withdrawal of informed consent|20|||
131083063|NCT03512197|471936261|FG001|Overall Study|Withdrawal of informed consent|14|||
131083064|NCT03512197|471936260|FG000|Overall Study|Adverse Event|30|||
131083065|NCT03512197|471936261|FG001|Overall Study|Adverse Event|34|||
131083066|NCT03512197|471936260|FG000|Overall Study|Death|14|||
131083067|NCT03512197|471936261|FG001|Overall Study|Death|9|||
131083068|NCT03512197|471936260|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
131141385|NCT03665285|472143871|FG004|Overall Study|Hospice|0|||
131141386|NCT03665285|472143872|FG005|Overall Study|Hospice|0|||
131141387|NCT03665285|472143873|FG006|Overall Study|Hospice|0|||
131141388|NCT03665285|472143874|FG007|Overall Study|Hospice|2|||
131141389|NCT03665285|472143875|FG008|Overall Study|Hospice|0|||
131141390|NCT03665285|472143867|FG000|Overall Study|Withdrawal by Subject|0|||
131083069|NCT03512197|471936261|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
131083070|NCT03512197|471936260|FG000|Overall Study|Missing|3|||
131083071|NCT03512197|471936261|FG001|Overall Study|Missing|13|||
131083072|NCT03842436|471936262|FG000|Overall Study|Lost to Follow-up|1|||
131083073|NCT00490698|471936266|FG000|Overall Study|Withdrawal by Subject|1|||
131083074|NCT00490698|471936266|FG000|Overall Study|Disease Progression|7|||
131083075|NCT00490698|471936266|FG000|Overall Study|Physician Decision|2|||
131083076|NCT03358238|471936267|FG000|Overall Study|Withdrawal by Subject|0|||
131083077|NCT03358238|471936268|FG001|Overall Study|Withdrawal by Subject|1|||
131083078|NCT01431950|471936271|FG000|Overall Study|Study Site Closed/Terminated|7|||
131083079|NCT01431950|471936272|FG001|Overall Study|Study Site Closed/Terminated|3|||
131083080|NCT01431950|471936271|FG000|Overall Study|Withdrawal by Subject|4|||
131083081|NCT01431950|471936272|FG001|Overall Study|Withdrawal by Subject|3|||
131083082|NCT01431950|471936271|FG000|Overall Study|Protocol Violation|2|||
131083083|NCT01431950|471936272|FG001|Overall Study|Protocol Violation|3|||
131083084|NCT01431950|471936271|FG000|Overall Study|Adverse Event|2|||
131083085|NCT01431950|471936272|FG001|Overall Study|Adverse Event|2|||
131083086|NCT01431950|471936271|FG000|Overall Study|Physician Decision|2|||
131083087|NCT01431950|471936272|FG001|Overall Study|Physician Decision|1|||
131083088|NCT01431950|471936271|FG000|Overall Study|Lack of Efficacy|2|||
131083089|NCT01431950|471936272|FG001|Overall Study|Lack of Efficacy|1|||
131083090|NCT01431950|471936271|FG000|Overall Study|Lost to Follow-up|0|||
131083091|NCT01431950|471936272|FG001|Overall Study|Lost to Follow-up|1|||
131083092|NCT01431950|471936271|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131083093|NCT01431950|471936272|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131083094|NCT00583947|471936273|FG000|Cross-over Period|Adverse Event|2|||
131083095|NCT00583947|471936274|FG001|Cross-over Period|Adverse Event|0|||
131083096|NCT00583947|471936273|FG000|Cross-over Period|Withdrawal by Subject|2|||
131083097|NCT00583947|471936274|FG001|Cross-over Period|Withdrawal by Subject|0|||
131083098|NCT00583947|471936273|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
131083099|NCT00583947|471936274|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
131233472|NCT04820842|472482468|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
131233473|NCT04820842|472482469|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131233474|NCT04820842|472482470|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131083100|NCT00583947|471936273|FG000|Cross-over Period|Other|1|||
131083101|NCT00583947|471936274|FG001|Cross-over Period|Other|1|||
131083102|NCT01740154|471936276|FG000|Overall Study|Adverse Event|1|||
131083103|NCT05226130|471936277|FG000|Overall Study|Lost to Follow-up|0|||
131083104|NCT05226130|471936278|FG001|Overall Study|Lost to Follow-up|1|||
131083105|NCT05226130|471936277|FG000|Overall Study|Not treatment adherent|0|||
131083106|NCT05226130|471936278|FG001|Overall Study|Not treatment adherent|2|||
131083107|NCT03358472|471936279|FG000|Overall Study|Death|6|||
131083108|NCT03358472|471936280|FG001|Overall Study|Death|3|||
131083109|NCT03358472|471936281|FG002|Overall Study|Death|10|||
131083110|NCT03358472|471936279|FG000|Overall Study|Physician Decision|0|||
131083111|NCT03358472|471936280|FG001|Overall Study|Physician Decision|1|||
131083112|NCT03358472|471936281|FG002|Overall Study|Physician Decision|0|||
131083113|NCT03358472|471936279|FG000|Overall Study|Withdrawal by Subject|0|||
131083114|NCT03358472|471936280|FG001|Overall Study|Withdrawal by Subject|0|||
131083115|NCT03358472|471936281|FG002|Overall Study|Withdrawal by Subject|1|||
131083116|NCT03358472|471936279|FG000|Overall Study|On-going at clinical cut off date|9|||
131083117|NCT03358472|471936280|FG001|Overall Study|On-going at clinical cut off date|6|||
131233475|NCT04820842|472482471|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130727221|NCT02883049|470625437|FG013|Post Induction|Physician Decision|11|||
131083118|NCT03358472|471936281|FG002|Overall Study|On-going at clinical cut off date|5|||
131083119|NCT02520310|471936282|FG000|At 6 Months Clinical Follow-up|Death|1|||
131083120|NCT02520310|471936282|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
131083121|NCT02520310|471936282|FG000|AT 3 Year Clinical Follow-up|Death|2|||
131083122|NCT02520310|471936282|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
131083123|NCT02520310|471936282|FG000|AT 4 Year Clinical Follow-up|Death|1|||
131083124|NCT02520310|471936282|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
131083125|NCT04535544|471936283|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
131083126|NCT04535544|471936284|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
131083127|NCT04535544|471936285|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
131083128|NCT04535544|471936286|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
131083129|NCT04535544|471936283|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
131083130|NCT04535544|471936284|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
131083131|NCT04535544|471936285|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
131083132|NCT04535544|471936286|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
131083133|NCT04535544|471936283|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
131083134|NCT04535544|471936284|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
131083135|NCT04535544|471936285|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
131083136|NCT04535544|471936286|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
131083137|NCT04535544|471936283|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
131083138|NCT04535544|471936284|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
131083139|NCT04535544|471936285|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
131083140|NCT04535544|471936286|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
131083141|NCT04535544|471936283|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
131083142|NCT04535544|471936284|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
131083143|NCT04535544|471936285|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
131083144|NCT04535544|471936286|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
131083145|NCT04535544|471936283|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
131083146|NCT04535544|471936284|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
131083147|NCT04535544|471936285|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
131083148|NCT04535544|471936286|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
131083149|NCT04535544|471936283|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
131083150|NCT04535544|471936284|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
131083151|NCT04535544|471936285|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
131083152|NCT04535544|471936286|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
131083153|NCT04535544|471936283|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
131083154|NCT04535544|471936284|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
131083155|NCT04535544|471936285|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
131083156|NCT04535544|471936286|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
131083157|NCT01124838|471936289|FG000|Overall Study|Miscellaneous|4|||
131083158|NCT01124838|471936290|FG001|Overall Study|Miscellaneous|2|||
131083159|NCT01124838|471936289|FG000|Overall Study|Adverse Event|7|||
131083160|NCT01124838|471936290|FG001|Overall Study|Adverse Event|11|||
131083161|NCT01124838|471936289|FG000|Overall Study|Lack of Efficacy|2|||
131083162|NCT01124838|471936290|FG001|Overall Study|Lack of Efficacy|0|||
131083163|NCT01124838|471936289|FG000|Overall Study|Withdrawal by Subject|3|||
131083164|NCT01124838|471936290|FG001|Overall Study|Withdrawal by Subject|2|||
131083165|NCT01124838|471936289|FG000|Overall Study|Lost to Follow-up|2|||
131083166|NCT01124838|471936290|FG001|Overall Study|Lost to Follow-up|0|||
131083167|NCT02726945|471936291|FG000|Overall Study|Withdrawal by Subject|0|||
131083168|NCT02726945|471936292|FG001|Overall Study|Withdrawal by Subject|0|||
131083169|NCT02726945|471936293|FG002|Overall Study|Withdrawal by Subject|1|||
131083170|NCT02726945|471936291|FG000|Overall Study|Elected to have total knee replacement|0|||
131083171|NCT02726945|471936292|FG001|Overall Study|Elected to have total knee replacement|1|||
131083172|NCT02726945|471936293|FG002|Overall Study|Elected to have total knee replacement|0|||
131083173|NCT05992922|471936294|FG000|Overall Study|Adverse Event|6|||
131083174|NCT05992922|471936295|FG001|Overall Study|Adverse Event|0|||
131083175|NCT05992922|471936294|FG000|Overall Study|Sponsor Termination of Study|14|||
131083176|NCT05992922|471936295|FG001|Overall Study|Sponsor Termination of Study|20|||
131083177|NCT01246999|471937878|FG000|Overall Study|Lost to Follow-up|0|||
131083178|NCT01246999|471937879|FG001|Overall Study|Lost to Follow-up|1|||
131083179|NCT01246999|471937880|FG002|Overall Study|Lost to Follow-up|0|||
131083180|NCT01246999|471937881|FG003|Overall Study|Lost to Follow-up|0|||
131083181|NCT01246999|471937878|FG000|Overall Study|Withdrawal by Subject|0|||
131083182|NCT01246999|471937879|FG001|Overall Study|Withdrawal by Subject|0|||
131083183|NCT01246999|471937880|FG002|Overall Study|Withdrawal by Subject|0|||
131083184|NCT01246999|471937881|FG003|Overall Study|Withdrawal by Subject|2|||
131083185|NCT02172911|471937895|FG000|Overall Study|Serious Adverse Event|0|||
131083186|NCT02172911|471937896|FG001|Overall Study|Serious Adverse Event|1|||
131083187|NCT02172911|471937895|FG000|Overall Study|Progression of Disease|0|||
131083188|NCT02172911|471937896|FG001|Overall Study|Progression of Disease|1|||
131083189|NCT02172911|471937895|FG000|Overall Study|Loss of insurance coverage|1|||
131083190|NCT02172911|471937896|FG001|Overall Study|Loss of insurance coverage|0|||
131141391|NCT03665285|472143868|FG001|Overall Study|Withdrawal by Subject|0|||
131141392|NCT03665285|472143869|FG002|Overall Study|Withdrawal by Subject|0|||
131141393|NCT03665285|472143870|FG003|Overall Study|Withdrawal by Subject|0|||
131141394|NCT03665285|472143871|FG004|Overall Study|Withdrawal by Subject|1|||
131141395|NCT03665285|472143872|FG005|Overall Study|Withdrawal by Subject|0|||
131141396|NCT03665285|472143873|FG006|Overall Study|Withdrawal by Subject|0|||
131141397|NCT03665285|472143874|FG007|Overall Study|Withdrawal by Subject|2|||
131141398|NCT03665285|472143875|FG008|Overall Study|Withdrawal by Subject|0|||
131141399|NCT03665285|472143867|FG000|Overall Study|Physician Decision|0|||
130727222|NCT02883049|470625438|FG014|Post Induction|Physician Decision|19|||
131083191|NCT00129935|471937897|FG000|Overall Study|Adverse Event|18|||
131083192|NCT00129935|471937898|FG001|Overall Study|Adverse Event|56|||
131083193|NCT00129935|471937897|FG000|Overall Study|Death|1|||
131083194|NCT00129935|471937898|FG001|Overall Study|Death|1|||
131083195|NCT00129935|471937897|FG000|Overall Study|Withdrawal by Subject|7|||
131083196|NCT00129935|471937898|FG001|Overall Study|Withdrawal by Subject|20|||
131141400|NCT03665285|472143868|FG001|Overall Study|Physician Decision|0|||
131141401|NCT03665285|472143869|FG002|Overall Study|Physician Decision|0|||
131083197|NCT00129935|471937897|FG000|Overall Study|Protocol Violation|0|||
131083198|NCT00129935|471937898|FG001|Overall Study|Protocol Violation|4|||
131083199|NCT00129935|471937897|FG000|Overall Study|Physician Decision|3|||
131083200|NCT00129935|471937898|FG001|Overall Study|Physician Decision|4|||
131083201|NCT00129935|471937897|FG000|Overall Study|Recurrence|1|||
131083202|NCT00129935|471937898|FG001|Overall Study|Recurrence|3|||
131083203|NCT00129935|471937897|FG000|Overall Study|Second primary|0|||
131083204|NCT00129935|471937898|FG001|Overall Study|Second primary|1|||
131083205|NCT00129935|471937897|FG000|Overall Study|Other|3|||
131083206|NCT00129935|471937898|FG001|Overall Study|Other|2|||
131083207|NCT00129935|471937897|FG000|Overall Study|Crossed to the other arm|2|||
131083208|NCT00129935|471937898|FG001|Overall Study|Crossed to the other arm|1|||
131083209|NCT00129935|471937897|FG000|Overall Study|Incorrect study treatment|1|||
131083210|NCT00129935|471937898|FG001|Overall Study|Incorrect study treatment|0|||
131083211|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
131083212|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
131083213|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
131083214|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Death|4|||
131083215|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Death|2|||
131083216|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Death|3|||
131083217|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
131083218|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
131083219|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
131083220|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
131083221|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
131083222|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
131083223|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
131083224|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
131083225|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
131083226|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
131083227|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
131083228|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
131083229|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
131083230|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
131083231|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
131083232|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
131083233|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
131083234|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
131083235|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
131083236|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
131083237|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
131083238|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
131083239|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
131083240|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
131083241|NCT02783573|471937899|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
131083242|NCT02783573|471937900|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
131083243|NCT02783573|471937901|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
131083244|NCT02783573|471937899|FG000|Delayed-Start Period|Sponsor Decision|0|||
131083245|NCT02783573|471937900|FG001|Delayed-Start Period|Sponsor Decision|17|||
131083246|NCT02783573|471937901|FG002|Delayed-Start Period|Sponsor Decision|12|||
131083247|NCT00725712|471937909|FG000|Overall Study|Withdrawal by Subject|2|||
131083248|NCT00725712|471937910|FG001|Overall Study|Withdrawal by Subject|1|||
131083249|NCT00725712|471937909|FG000|Overall Study|Protocol Violation|1|||
131083250|NCT00725712|471937910|FG001|Overall Study|Protocol Violation|0|||
131141402|NCT03665285|472143870|FG003|Overall Study|Physician Decision|0|||
131141403|NCT03665285|472143871|FG004|Overall Study|Physician Decision|0|||
131141404|NCT03665285|472143872|FG005|Overall Study|Physician Decision|0|||
131141405|NCT03665285|472143873|FG006|Overall Study|Physician Decision|0|||
131141406|NCT03665285|472143874|FG007|Overall Study|Physician Decision|2|||
131141407|NCT03665285|472143875|FG008|Overall Study|Physician Decision|0|||
131141408|NCT00354601|472143876|FG000|Overall Study|Protocol Violation|1|||
131083251|NCT00725712|471937909|FG000|Overall Study|Progressive disease|37|||
131083252|NCT00725712|471937910|FG001|Overall Study|Progressive disease|16|||
131083253|NCT00725712|471937909|FG000|Overall Study|Clinical progression not based on RECIST|0|||
131083254|NCT00725712|471937910|FG001|Overall Study|Clinical progression not based on RECIST|3|||
131083255|NCT00725712|471937909|FG000|Overall Study|Adverse Event|5|||
131083256|NCT00725712|471937910|FG001|Overall Study|Adverse Event|5|||
131083257|NCT00725712|471937909|FG000|Overall Study|Death|2|||
131083258|NCT00725712|471937910|FG001|Overall Study|Death|0|||
131083259|NCT00725712|471937909|FG000|Overall Study|Other: Death|1|||
131141409|NCT00354601|472143876|FG000|Overall Study|progression|1|||
131141410|NCT03603652|472143877|FG000|Overall Study|Death|2|||
131083260|NCT00725712|471937910|FG001|Overall Study|Other: Death|0|||
131083261|NCT00725712|471937909|FG000|Overall Study|Hospitalized, unable to continue|0|||
131083262|NCT00725712|471937910|FG001|Overall Study|Hospitalized, unable to continue|1|||
131083263|NCT02056626|471937911|FG000|Overall Study|patient did not follow directions|3|||
131083264|NCT02056626|471937912|FG001|Overall Study|patient did not follow directions|1|||
131083265|NCT02056626|471937913|FG002|Overall Study|patient did not follow directions|0|||
131083266|NCT02056626|471937914|FG003|Overall Study|patient did not follow directions|0|||
131083267|NCT02635360|471937915|FG000|Overall Study|Adverse Event|0|||
131083268|NCT02635360|471937916|FG001|Overall Study|Adverse Event|3|||
131083269|NCT02635360|471937915|FG000|Overall Study|Withdrawal by Subject|2|||
131083270|NCT02635360|471937916|FG001|Overall Study|Withdrawal by Subject|0|||
131083271|NCT02635360|471937915|FG000|Overall Study|Non-Compliance|3|||
131083272|NCT02635360|471937916|FG001|Overall Study|Non-Compliance|1|||
131083273|NCT02635360|471937915|FG000|Overall Study|Disease Progression|0|||
131083274|NCT02635360|471937916|FG001|Overall Study|Disease Progression|2|||
131083275|NCT02635360|471937915|FG000|Overall Study|Lost to Follow-up|1|||
131083276|NCT02635360|471937916|FG001|Overall Study|Lost to Follow-up|1|||
131083277|NCT01454739|471937920|FG000|Overall Study|Protocol Violation|2|||
131083278|NCT01454739|471937921|FG001|Overall Study|Protocol Violation|3|||
131083279|NCT01454739|471937920|FG000|Overall Study|Withdrawal by Subject|2|||
131083280|NCT01454739|471937921|FG001|Overall Study|Withdrawal by Subject|6|||
131083281|NCT01454739|471937920|FG000|Overall Study|Other|3|||
131083282|NCT01454739|471937921|FG001|Overall Study|Other|5|||
131083283|NCT01454739|471937920|FG000|Overall Study|Physician Decision|0|||
131083284|NCT01454739|471937921|FG001|Overall Study|Physician Decision|5|||
131083285|NCT01454739|471937920|FG000|Overall Study|Lost to Follow-up|0|||
131083286|NCT01454739|471937921|FG001|Overall Study|Lost to Follow-up|1|||
131083287|NCT01454739|471937920|FG000|Overall Study|Adverse Event|0|||
131083288|NCT01454739|471937921|FG001|Overall Study|Adverse Event|1|||
131083289|NCT01784523|471937924|FG000|Overall Study|Study closed early|7|||
131083290|NCT01784523|471937925|FG001|Overall Study|Study closed early|4|||
131083291|NCT04340947|471937926|FG000|7-day Washout Period|Lost to Follow-up|5|||
131083292|NCT04340947|471937927|FG001|7-day Washout Period|Lost to Follow-up|4|||
131083293|NCT01124097|471937931|FG000|Overall Study|Withdrawal by Subject|4|||
131083294|NCT01124097|471937932|FG001|Overall Study|Withdrawal by Subject|3|||
131083295|NCT01124097|471937933|FG002|Overall Study|Withdrawal by Subject|2|||
131083296|NCT01124097|471937934|FG003|Overall Study|Withdrawal by Subject|3|||
131083297|NCT01124097|471937931|FG000|Overall Study|Lack of Efficacy|2|||
131083298|NCT01124097|471937932|FG001|Overall Study|Lack of Efficacy|3|||
131083299|NCT01124097|471937933|FG002|Overall Study|Lack of Efficacy|1|||
131083300|NCT01124097|471937934|FG003|Overall Study|Lack of Efficacy|3|||
131083301|NCT01124097|471937931|FG000|Overall Study|Adverse Event|24|||
131083302|NCT01124097|471937932|FG001|Overall Study|Adverse Event|15|||
131083303|NCT01124097|471937933|FG002|Overall Study|Adverse Event|15|||
131083304|NCT01124097|471937934|FG003|Overall Study|Adverse Event|7|||
131083305|NCT01124097|471937931|FG000|Overall Study|Protocol Violation|2|||
131083306|NCT01124097|471937932|FG001|Overall Study|Protocol Violation|0|||
131141411|NCT03213366|472143882|FG000|Overall Study|Lost to Follow-up|9|||
131141412|NCT03213366|472143883|FG001|Overall Study|Lost to Follow-up|4|||
131141413|NCT02532855|472143884|FG000|Overall Study|Lost to Follow-up|4|||
131141414|NCT02532855|472143885|FG001|Overall Study|Lost to Follow-up|3|||
131141415|NCT02532855|472143884|FG000|Overall Study|Withdrawal by Subject|4|||
131141416|NCT02532855|472143885|FG001|Overall Study|Withdrawal by Subject|8|||
131141417|NCT01727258|472143886|FG000|Overall Study|Adverse Event|0|||
131141418|NCT01727258|472143887|FG001|Overall Study|Adverse Event|2|||
131141419|NCT01727258|472143888|FG002|Overall Study|Adverse Event|0|||
131141420|NCT01727258|472143886|FG000|Overall Study|Noncompliance with Study Drug|0|||
131141421|NCT01727258|472143887|FG001|Overall Study|Noncompliance with Study Drug|0|||
131141422|NCT01727258|472143888|FG002|Overall Study|Noncompliance with Study Drug|1|||
131141423|NCT01727258|472143886|FG000|Overall Study|Withdrawal by Subject|1|||
131141424|NCT01727258|472143887|FG001|Overall Study|Withdrawal by Subject|1|||
131141425|NCT01727258|472143888|FG002|Overall Study|Withdrawal by Subject|0|||
130727223|NCT02883049|470625439|FG015|Post Induction|Physician Decision|5|||
130727224|NCT02883049|470625424|FG000|Post Induction|Protocol Violation|0|||
131083307|NCT01124097|471937933|FG002|Overall Study|Protocol Violation|2|||
131083308|NCT01124097|471937934|FG003|Overall Study|Protocol Violation|1|||
131083309|NCT01124097|471937931|FG000|Overall Study|Physician Decision|2|||
131083310|NCT01124097|471937932|FG001|Overall Study|Physician Decision|1|||
131083311|NCT01124097|471937933|FG002|Overall Study|Physician Decision|0|||
131083312|NCT01124097|471937934|FG003|Overall Study|Physician Decision|0|||
131083313|NCT01677299|471937935|FG000|Overall Study|Adverse Event|0|||
131083314|NCT01677299|471937936|FG001|Overall Study|Adverse Event|2|||
131083315|NCT01677299|471937937|FG002|Overall Study|Adverse Event|1|||
131083316|NCT01677299|471937938|FG003|Overall Study|Adverse Event|0|||
131083317|NCT01677299|471937935|FG000|Overall Study|Withdrawal by Subject|0|||
131083318|NCT01677299|471937936|FG001|Overall Study|Withdrawal by Subject|1|||
131141426|NCT01727258|472143886|FG000|Overall Study|Lost to Follow-up|1|||
131141427|NCT01727258|472143887|FG001|Overall Study|Lost to Follow-up|0|||
131141428|NCT01727258|472143888|FG002|Overall Study|Lost to Follow-up|0|||
131083319|NCT01677299|471937937|FG002|Overall Study|Withdrawal by Subject|0|||
131083320|NCT01677299|471937938|FG003|Overall Study|Withdrawal by Subject|1|||
131083321|NCT00193479|471937939|FG000|Induction Chemotherapy|Adverse Event|2|||
131083322|NCT00193479|471937939|FG000|Induction Chemotherapy|Disease Progression|1|||
131083323|NCT00193479|471937939|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
131083324|NCT00193479|471937939|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
131083325|NCT03334253|471937941|FG000|Overall Study|Withdrawal by Subject|1|||
131083326|NCT03334253|471937942|FG001|Overall Study|Withdrawal by Subject|0|||
131083327|NCT03334253|471937941|FG000|Overall Study|Lost to Follow-up|4|||
131083328|NCT03334253|471937942|FG001|Overall Study|Lost to Follow-up|3|||
131083329|NCT03334253|471937941|FG000|Overall Study|Moved residence|2|||
131083330|NCT03334253|471937942|FG001|Overall Study|Moved residence|2|||
131083331|NCT00872001|471937943|FG000|Overall Study|Adverse Event|34|||
131083332|NCT00872001|471937944|FG001|Overall Study|Adverse Event|23|||
131083333|NCT00872001|471937943|FG000|Overall Study|Protocol Defined Clinical Event|5|||
131083334|NCT00872001|471937944|FG001|Overall Study|Protocol Defined Clinical Event|7|||
131083335|NCT00872001|471937943|FG000|Overall Study|Lost to Follow-up|13|||
131083336|NCT00872001|471937944|FG001|Overall Study|Lost to Follow-up|12|||
131083337|NCT00872001|471937943|FG000|Overall Study|Withdrawal by Subject|18|||
131083338|NCT00872001|471937944|FG001|Overall Study|Withdrawal by Subject|30|||
131083339|NCT00872001|471937943|FG000|Overall Study|Protocol Violation|5|||
131083340|NCT00872001|471937944|FG001|Overall Study|Protocol Violation|8|||
131083341|NCT00872001|471937943|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
131083342|NCT00872001|471937944|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
131083343|NCT00872001|471937943|FG000|Overall Study|Administrative|23|||
131083344|NCT00872001|471937944|FG001|Overall Study|Administrative|15|||
131083345|NCT02030002|471937945|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
131083346|NCT02030002|471937945|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
131083347|NCT02030002|471937945|FG000|Follow-up|Lost to Follow-up|2|||
131083348|NCT02413593|471937955|FG000|Overall Study|Lost to Follow-up|3|||
131083349|NCT02413593|471937955|FG000|Overall Study|Adverse Event|1|||
131083350|NCT01807182|471937956|FG000|Overall Study|Death|1|||
131083351|NCT01807182|471937956|FG000|Overall Study|New therapy|1|||
131083352|NCT01807182|471937956|FG000|Overall Study|Moved to hospice care|1|||
131083353|NCT00150618|471937958|FG000|Overall Study|Adverse Event|2|||
131083354|NCT00150618|471937959|FG001|Overall Study|Adverse Event|2|||
131083355|NCT00150618|471937960|FG002|Overall Study|Adverse Event|6|||
131083356|NCT00150618|471937961|FG003|Overall Study|Adverse Event|9|||
131083357|NCT00150618|471937962|FG004|Overall Study|Adverse Event|5|||
131083358|NCT00150618|471937958|FG000|Overall Study|Withdrawal by Subject|6|||
131083359|NCT00150618|471937959|FG001|Overall Study|Withdrawal by Subject|8|||
131083360|NCT00150618|471937960|FG002|Overall Study|Withdrawal by Subject|8|||
131083361|NCT00150618|471937961|FG003|Overall Study|Withdrawal by Subject|4|||
131083362|NCT00150618|471937962|FG004|Overall Study|Withdrawal by Subject|5|||
131083363|NCT00150618|471937958|FG000|Overall Study|Lost to Follow-up|4|||
131083364|NCT00150618|471937959|FG001|Overall Study|Lost to Follow-up|1|||
131083365|NCT00150618|471937960|FG002|Overall Study|Lost to Follow-up|5|||
131083366|NCT00150618|471937961|FG003|Overall Study|Lost to Follow-up|8|||
131083367|NCT00150618|471937962|FG004|Overall Study|Lost to Follow-up|4|||
131083368|NCT00150618|471937958|FG000|Overall Study|Protocol Violation|1|||
131083369|NCT00150618|471937959|FG001|Overall Study|Protocol Violation|0|||
131083370|NCT00150618|471937960|FG002|Overall Study|Protocol Violation|0|||
131083371|NCT00150618|471937961|FG003|Overall Study|Protocol Violation|0|||
131083372|NCT00150618|471937962|FG004|Overall Study|Protocol Violation|1|||
131083373|NCT00150618|471937958|FG000|Overall Study|Lack of Efficacy|1|||
131083374|NCT00150618|471937959|FG001|Overall Study|Lack of Efficacy|4|||
131083375|NCT00150618|471937960|FG002|Overall Study|Lack of Efficacy|7|||
131083376|NCT00150618|471937961|FG003|Overall Study|Lack of Efficacy|4|||
131083377|NCT00150618|471937962|FG004|Overall Study|Lack of Efficacy|6|||
131083378|NCT00150618|471937958|FG000|Overall Study|No study meds|0|||
131083379|NCT00150618|471937959|FG001|Overall Study|No study meds|0|||
131083380|NCT00150618|471937960|FG002|Overall Study|No study meds|0|||
131083381|NCT00150618|471937961|FG003|Overall Study|No study meds|0|||
131141429|NCT01960855|472143889|FG000|Overall Study|Subject noncompliant|1|||
131141430|NCT01960855|472143890|FG001|Overall Study|Subject noncompliant|0|||
131141431|NCT01960855|472143891|FG002|Overall Study|Subject noncompliant|0|||
131141432|NCT01960855|472143892|FG003|Overall Study|Subject noncompliant|0|||
131141433|NCT01960855|472143893|FG004|Overall Study|Subject noncompliant|0|||
131083382|NCT00150618|471937962|FG004|Overall Study|No study meds|2|||
131083383|NCT00150618|471937958|FG000|Overall Study|Physician Decision|0|||
131083384|NCT00150618|471937959|FG001|Overall Study|Physician Decision|2|||
131083385|NCT00150618|471937960|FG002|Overall Study|Physician Decision|0|||
131083386|NCT00150618|471937961|FG003|Overall Study|Physician Decision|0|||
131083387|NCT00150618|471937962|FG004|Overall Study|Physician Decision|1|||
131083388|NCT00150618|471937958|FG000|Overall Study|Lack of compliance|2|||
131083389|NCT00150618|471937959|FG001|Overall Study|Lack of compliance|1|||
131141434|NCT01960855|472143889|FG000|Overall Study|Adverse Event|2|||
131233476|NCT04820842|472482472|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131233477|NCT04820842|472482466|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131233478|NCT04820842|472482467|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
131233479|NCT04820842|472482468|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131233480|NCT04820842|472482469|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131233481|NCT04820842|472482470|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131233482|NCT04820842|472482471|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131233483|NCT04820842|472482472|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
131233484|NCT04820842|472482466|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131233485|NCT04820842|472482467|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131233486|NCT04820842|472482468|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131233487|NCT04820842|472482469|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
131233488|NCT04820842|472482470|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131233489|NCT04820842|472482471|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
131233490|NCT04820842|472482472|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
131233491|NCT02688400|472482477|FG000|Overall Study|Protocol Violation|2|||
131233492|NCT02688400|472482478|FG001|Overall Study|Protocol Violation|5|||
131233493|NCT02688400|472482477|FG000|Overall Study|Lack of Efficacy|7|||
131083390|NCT00150618|471937960|FG002|Overall Study|Lack of compliance|1|||
131083391|NCT00150618|471937961|FG003|Overall Study|Lack of compliance|0|||
131083392|NCT00150618|471937962|FG004|Overall Study|Lack of compliance|1|||
131083393|NCT00150618|471937958|FG000|Overall Study|Abnormal ECG|1|||
131083394|NCT00150618|471937959|FG001|Overall Study|Abnormal ECG|0|||
131083395|NCT00150618|471937960|FG002|Overall Study|Abnormal ECG|0|||
131083396|NCT00150618|471937961|FG003|Overall Study|Abnormal ECG|0|||
131083397|NCT00150618|471937962|FG004|Overall Study|Abnormal ECG|0|||
131083398|NCT00150618|471937958|FG000|Overall Study|Sponsor's decision|0|||
131083399|NCT00150618|471937959|FG001|Overall Study|Sponsor's decision|0|||
131083400|NCT00150618|471937960|FG002|Overall Study|Sponsor's decision|0|||
131083401|NCT00150618|471937961|FG003|Overall Study|Sponsor's decision|1|||
131083402|NCT00150618|471937962|FG004|Overall Study|Sponsor's decision|0|||
131083403|NCT01791413|471937964|FG000|Overall Study|Lost to Follow-up|5|||
131083404|NCT01791413|471937965|FG001|Overall Study|Lost to Follow-up|1|||
131083405|NCT00250432|471937967|FG000|Overall Study|Adverse Event|25|||
131083406|NCT00250432|471937968|FG001|Overall Study|Adverse Event|29|||
131083407|NCT00250432|471937967|FG000|Overall Study|Lack of Efficacy|2|||
131083408|NCT00250432|471937968|FG001|Overall Study|Lack of Efficacy|1|||
131083409|NCT00250432|471937967|FG000|Overall Study|Lost to Follow-up|6|||
131083410|NCT00250432|471937968|FG001|Overall Study|Lost to Follow-up|5|||
131083411|NCT00250432|471937967|FG000|Overall Study|Patient Moved|0|||
131083412|NCT00250432|471937968|FG001|Overall Study|Patient Moved|1|||
131083413|NCT00250432|471937967|FG000|Overall Study|Protocol Violation|0|||
131083414|NCT00250432|471937968|FG001|Overall Study|Protocol Violation|3|||
131083415|NCT00250432|471937967|FG000|Overall Study|Withdrawal by Subject|6|||
131083416|NCT00250432|471937968|FG001|Overall Study|Withdrawal by Subject|2|||
131083417|NCT00250432|471937967|FG000|Overall Study|Pt died out of posttherapy report period|6|||
131083418|NCT00250432|471937968|FG001|Overall Study|Pt died out of posttherapy report period|5|||
131083419|NCT00250432|471937967|FG000|Overall Study|Pt was considered untreatable|0|||
131083420|NCT00250432|471937968|FG001|Overall Study|Pt was considered untreatable|1|||
131083421|NCT04946942|471937969|FG000|Overall Study|Lost to Follow-up|6|||
131083422|NCT04946942|471937970|FG001|Overall Study|Lost to Follow-up|2|||
131083423|NCT04946942|471937971|FG002|Overall Study|Lost to Follow-up|0|||
131083424|NCT04907357|471937972|FG000|Overall Study|Death|0|||
131083425|NCT04907357|471937973|FG001|Overall Study|Death|1|||
131083426|NCT04907357|471937972|FG000|Overall Study|Lost to Follow-up|9|||
131083427|NCT04907357|471937973|FG001|Overall Study|Lost to Follow-up|18|||
131083428|NCT04907357|471937972|FG000|Overall Study|Physician Decision|1|||
131083429|NCT04907357|471937973|FG001|Overall Study|Physician Decision|0|||
131083430|NCT04907357|471937972|FG000|Overall Study|Withdrawal by Subject|0|||
131083431|NCT04907357|471937973|FG001|Overall Study|Withdrawal by Subject|1|||
131083432|NCT04907357|471937972|FG000|Overall Study|Unable to attend visits|1|||
131083433|NCT04907357|471937973|FG001|Overall Study|Unable to attend visits|0|||
131083434|NCT04907357|471937972|FG000|Overall Study|Incarcerated|1|||
131083435|NCT04907357|471937973|FG001|Overall Study|Incarcerated|1|||
131083436|NCT04277507|471937974|FG000|Overall Study|Lost to Follow-up|17|||
131083437|NCT04277507|471937974|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
131083438|NCT04277507|471937974|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
131083439|NCT04277507|471937974|FG000|Overall Study|Withdrawal by Subject|3|||
131083440|NCT04277507|471937974|FG000|Overall Study|Death due to COVID-19|1|||
131083441|NCT04277507|471937974|FG000|Overall Study|Data missing for full evaluation|5|||
131083442|NCT00738283|471937980|FG000|Overall Study|Death|1|||
131083443|NCT00738283|471937980|FG000|Overall Study|Transfer to another facility|2|||
131083444|NCT00738283|471937980|FG000|Overall Study|Discharge home prior to end of study|1|||
131083445|NCT00486252|471937981|FG000|Overall Study|Adverse Event|7|||
131083446|NCT00486252|471937981|FG000|Overall Study|Lack of Efficacy|9|||
131083447|NCT00486252|471937981|FG000|Overall Study|Lost to Follow-up|24|||
131083448|NCT00486252|471937981|FG000|Overall Study|Other|18|||
131083449|NCT01261247|471937984|FG000|Overall Study|Ineligible|2|||
131083450|NCT01210651|471937985|FG000|Overall Study|Lost to Follow-up|1|||
131083451|NCT01210651|471937986|FG001|Overall Study|Lost to Follow-up|1|||
131083452|NCT01210651|471937985|FG000|Overall Study|schedule conflicts|1|||
131083453|NCT01210651|471937986|FG001|Overall Study|schedule conflicts|5|||
131083454|NCT01210651|471937985|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
131083455|NCT01210651|471937986|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
131083456|NCT01210651|471937985|FG000|Overall Study|Withdrawal by Subject|1|||
131083457|NCT01210651|471937986|FG001|Overall Study|Withdrawal by Subject|1|||
131083458|NCT01210651|471937985|FG000|Overall Study|Injury outside study|2|||
131083459|NCT01210651|471937986|FG001|Overall Study|Injury outside study|0|||
131083460|NCT02559310|471937987|FG000|Overall Study|Death|4|||
131083461|NCT02559310|471937988|FG001|Overall Study|Death|3|||
131083462|NCT02559310|471937987|FG000|Overall Study|Lost to Follow-up|5|||
131083463|NCT02559310|471937988|FG001|Overall Study|Lost to Follow-up|3|||
131083464|NCT02559310|471937987|FG000|Overall Study|Physician Decision|2|||
131083465|NCT02559310|471937988|FG001|Overall Study|Physician Decision|1|||
131083466|NCT02559310|471937987|FG000|Overall Study|Withdrawal by Subject|13|||
131083467|NCT02559310|471937988|FG001|Overall Study|Withdrawal by Subject|9|||
131083468|NCT02559310|471937987|FG000|Overall Study|Sponsor Decision|0|||
131083469|NCT02559310|471937988|FG001|Overall Study|Sponsor Decision|1|||
131083470|NCT02559310|471937987|FG000|Overall Study|Randomized but not treated|3|||
131083471|NCT02559310|471937988|FG001|Overall Study|Randomized but not treated|2|||
131083472|NCT02592707|471937989|FG000|Overall Study|Consent Withdrawn|0|||
131083473|NCT02592707|471937990|FG001|Overall Study|Consent Withdrawn|1|||
131083474|NCT02592707|471937991|FG002|Overall Study|Consent Withdrawn|2|||
131083475|NCT02592707|471937992|FG003|Overall Study|Consent Withdrawn|0|||
131083476|NCT02592707|471937989|FG000|Overall Study|Death|1|||
131083477|NCT02592707|471937990|FG001|Overall Study|Death|0|||
131083478|NCT02592707|471937991|FG002|Overall Study|Death|0|||
131083479|NCT02592707|471937992|FG003|Overall Study|Death|0|||
131083480|NCT02592707|471937989|FG000|Overall Study|Progressive Disease|4|||
131083481|NCT02592707|471937990|FG001|Overall Study|Progressive Disease|4|||
131083482|NCT02592707|471937991|FG002|Overall Study|Progressive Disease|3|||
131083483|NCT02592707|471937992|FG003|Overall Study|Progressive Disease|3|||
131083484|NCT02592707|471937989|FG000|Overall Study|Other|0|||
131083485|NCT02592707|471937990|FG001|Overall Study|Other|0|||
131083486|NCT02592707|471937991|FG002|Overall Study|Other|1|||
131083487|NCT02592707|471937992|FG003|Overall Study|Other|2|||
131083488|NCT02592707|471937989|FG000|Overall Study|Never entered LTFU period|1|||
131083489|NCT02592707|471937990|FG001|Overall Study|Never entered LTFU period|0|||
131083490|NCT02592707|471937991|FG002|Overall Study|Never entered LTFU period|0|||
131083491|NCT02592707|471937992|FG003|Overall Study|Never entered LTFU period|2|||
131083492|NCT00469859|471937993|FG000|Overall Study|Inevaluable|0|||
131083493|NCT00469859|471937994|FG001|Overall Study|Inevaluable|2|||
131083494|NCT04124471|471937995|FG000|Overall Study|screen failure|1|||
131083495|NCT04855734|471937996|FG000|Overall Study|Lost to Follow-up|2|||
131083496|NCT04855734|471937997|FG001|Overall Study|Lost to Follow-up|2|||
131083497|NCT01340014|471937998|FG000|Period 1, First 7 Days|Adverse Event|1|||
131083498|NCT01340014|471937999|FG001|Period 1, First 7 Days|Adverse Event|0|||
131083499|NCT01340014|471937998|FG000|Period 1, First 7 Days|Personal Reasons|1|||
131083500|NCT01340014|471937999|FG001|Period 1, First 7 Days|Personal Reasons|0|||
131083501|NCT01340014|471937998|FG000|Period 2, Second 7 Days|Adverse Event|0|||
131141435|NCT01960855|472143890|FG001|Overall Study|Adverse Event|0|||
131141436|NCT01960855|472143891|FG002|Overall Study|Adverse Event|6|||
131141437|NCT01960855|472143892|FG003|Overall Study|Adverse Event|2|||
131141438|NCT01960855|472143893|FG004|Overall Study|Adverse Event|2|||
131141439|NCT01960855|472143889|FG000|Overall Study|Lack of Efficacy|1|||
131141440|NCT01960855|472143890|FG001|Overall Study|Lack of Efficacy|1|||
131141441|NCT01960855|472143891|FG002|Overall Study|Lack of Efficacy|0|||
131141442|NCT01960855|472143892|FG003|Overall Study|Lack of Efficacy|0|||
131141443|NCT01960855|472143893|FG004|Overall Study|Lack of Efficacy|0|||
131141444|NCT01960855|472143889|FG000|Overall Study|Other|2|||
131083502|NCT01340014|471937999|FG001|Period 2, Second 7 Days|Adverse Event|1|||
131083503|NCT05131477|471938005|FG000|PART 1|Withdrawal by Subject|2|||
131083504|NCT05131477|471938006|FG001|PART 1|Withdrawal by Subject|9|||
131083505|NCT05131477|471938007|FG002|PART 1|Withdrawal by Subject|6|||
131083506|NCT05131477|471938008|FG003|PART 1|Withdrawal by Subject|2|||
131083507|NCT05131477|471938009|FG004|PART 1|Withdrawal by Subject|8|||
131083508|NCT05131477|471938010|FG005|PART 1|Withdrawal by Subject|0|||
131141445|NCT01960855|472143890|FG001|Overall Study|Other|1|||
131141446|NCT01960855|472143891|FG002|Overall Study|Other|1|||
131141447|NCT01960855|472143892|FG003|Overall Study|Other|1|||
131141448|NCT01960855|472143893|FG004|Overall Study|Other|0|||
131141449|NCT01960855|472143889|FG000|Overall Study|Consent withdrawn by subject|3|||
131141450|NCT01960855|472143890|FG001|Overall Study|Consent withdrawn by subject|1|||
131141451|NCT01960855|472143891|FG002|Overall Study|Consent withdrawn by subject|2|||
131141452|NCT01960855|472143892|FG003|Overall Study|Consent withdrawn by subject|1|||
131141453|NCT01960855|472143893|FG004|Overall Study|Consent withdrawn by subject|1|||
131141454|NCT01960855|472143889|FG000|Overall Study|Lost to Follow-up|2|||
131233494|NCT02688400|472482478|FG001|Overall Study|Lack of Efficacy|7|||
131233495|NCT02688400|472482477|FG000|Overall Study|Adverse Event|21|||
131233496|NCT02688400|472482478|FG001|Overall Study|Adverse Event|12|||
131233497|NCT02688400|472482477|FG000|Overall Study|Withdrawal by Subject|15|||
131233498|NCT02688400|472482478|FG001|Overall Study|Withdrawal by Subject|13|||
131233499|NCT02688400|472482477|FG000|Overall Study|No study medication intake|1|||
131233500|NCT02688400|472482478|FG001|Overall Study|No study medication intake|4|||
131233501|NCT02688400|472482477|FG000|Overall Study|Lost to Follow-up|0|||
131233502|NCT02688400|472482478|FG001|Overall Study|Lost to Follow-up|3|||
131233503|NCT02006706|472482480|FG000|Overall Study|Lost to Follow-up|1|||
131233504|NCT00958256|472482482|FG000|Overall Study|Adverse Event|3|||
131233505|NCT03036579|472482483|FG000|2 Years|Lost to Follow-up|1|||
131233506|NCT03036579|472482484|FG001|2 Years|Lost to Follow-up|0|||
131083509|NCT05131477|471938011|FG006|PART 1|Withdrawal by Subject|0|||
131233507|NCT03036579|472482483|FG000|3 Years|Lost to Follow-up|0|||
131233508|NCT03036579|472482484|FG001|3 Years|Lost to Follow-up|1|||
131233509|NCT02848599|472482485|FG000|Overall Study|Protocol Violation|7|||
131233510|NCT02848599|472482486|FG001|Overall Study|Protocol Violation|9|||
131233511|NCT01290263|472482494|FG000|Overall Study|Adverse Event|0|||
131233512|NCT01290263|472482495|FG001|Overall Study|Adverse Event|0|||
131233513|NCT01290263|472482496|FG002|Overall Study|Adverse Event|0|||
131233514|NCT01290263|472482497|FG003|Overall Study|Adverse Event|1|||
131233515|NCT01290263|472482498|FG004|Overall Study|Adverse Event|1|||
131233516|NCT01290263|472482494|FG000|Overall Study|Lack of Efficacy|8|||
131233517|NCT01290263|472482495|FG001|Overall Study|Lack of Efficacy|2|||
131233518|NCT01290263|472482496|FG002|Overall Study|Lack of Efficacy|7|||
131233519|NCT01290263|472482497|FG003|Overall Study|Lack of Efficacy|24|||
131233520|NCT01290263|472482498|FG004|Overall Study|Lack of Efficacy|33|||
131233521|NCT01290263|472482494|FG000|Overall Study|Withdrawal by Subject|3|||
131233522|NCT01290263|472482495|FG001|Overall Study|Withdrawal by Subject|1|||
131233523|NCT01290263|472482496|FG002|Overall Study|Withdrawal by Subject|0|||
131233524|NCT01290263|472482497|FG003|Overall Study|Withdrawal by Subject|1|||
131233525|NCT01290263|472482498|FG004|Overall Study|Withdrawal by Subject|2|||
131233526|NCT01290263|472482494|FG000|Overall Study|Participant Non-Compliance|0|||
131233527|NCT01290263|472482495|FG001|Overall Study|Participant Non-Compliance|0|||
131233528|NCT01290263|472482496|FG002|Overall Study|Participant Non-Compliance|0|||
131233529|NCT01290263|472482497|FG003|Overall Study|Participant Non-Compliance|1|||
131233530|NCT01290263|472482498|FG004|Overall Study|Participant Non-Compliance|1|||
130727225|NCT02883049|470625425|FG001|Post Induction|Protocol Violation|0|||
131083510|NCT05131477|471938012|FG007|PART 1|Withdrawal by Subject|0|||
131083511|NCT05131477|471938013|FG008|PART 1|Withdrawal by Subject|0|||
131083512|NCT05131477|471938014|FG009|PART 1|Withdrawal by Subject|0|||
131083513|NCT05131477|471938015|FG010|PART 1|Withdrawal by Subject|0|||
131083514|NCT05131477|471938016|FG011|PART 1|Withdrawal by Subject|0|||
131083515|NCT05131477|471938017|FG012|PART 1|Withdrawal by Subject|0|||
131083516|NCT05131477|471938018|FG013|PART 1|Withdrawal by Subject|0|||
131083517|NCT05131477|471938005|FG000|PART 1|Physician Decision|1|||
131083518|NCT05131477|471938006|FG001|PART 1|Physician Decision|0|||
131083519|NCT05131477|471938007|FG002|PART 1|Physician Decision|0|||
131083520|NCT05131477|471938008|FG003|PART 1|Physician Decision|0|||
131083521|NCT05131477|471938009|FG004|PART 1|Physician Decision|0|||
131083522|NCT05131477|471938010|FG005|PART 1|Physician Decision|0|||
131083523|NCT05131477|471938011|FG006|PART 1|Physician Decision|0|||
131083524|NCT05131477|471938012|FG007|PART 1|Physician Decision|0|||
131083525|NCT05131477|471938013|FG008|PART 1|Physician Decision|0|||
131083526|NCT05131477|471938014|FG009|PART 1|Physician Decision|0|||
130727226|NCT02883049|470625426|FG002|Post Induction|Protocol Violation|0|||
131083527|NCT05131477|471938015|FG010|PART 1|Physician Decision|0|||
130727227|NCT02883049|470625427|FG003|Post Induction|Protocol Violation|0|||
131083528|NCT05131477|471938016|FG011|PART 1|Physician Decision|0|||
131083529|NCT05131477|471938017|FG012|PART 1|Physician Decision|0|||
131141455|NCT01960855|472143890|FG001|Overall Study|Lost to Follow-up|1|||
131141456|NCT01960855|472143891|FG002|Overall Study|Lost to Follow-up|0|||
131083530|NCT05131477|471938018|FG013|PART 1|Physician Decision|0|||
131141457|NCT01960855|472143892|FG003|Overall Study|Lost to Follow-up|0|||
131233531|NCT03738332|472482499|FG000|Overall Study|Withdrawal by Subject|1|||
131233532|NCT02336737|472482500|FG000|Overall Study|Withdrawal by Subject|5|||
131233533|NCT02336737|472482500|FG000|Overall Study|Physician Decision|8|||
131233534|NCT02132247|472482501|FG000|Overall Study|Protocol Violation|1|||
131233535|NCT02132247|472482502|FG001|Overall Study|Protocol Violation|0|||
131233536|NCT02227862|472482506|FG000|Overall Study|Protocol Violation|7|||
131233537|NCT02227862|472482507|FG001|Overall Study|Protocol Violation|9|||
131233538|NCT02227862|472482506|FG000|Overall Study|Other|0|||
131233539|NCT02227862|472482507|FG001|Overall Study|Other|2|||
131233540|NCT02227862|472482506|FG000|Overall Study|Adverse Event|4|||
131233541|NCT02227862|472482507|FG001|Overall Study|Adverse Event|3|||
131233542|NCT02227862|472482506|FG000|Overall Study|Withdrawal by Subject|7|||
131233543|NCT02227862|472482507|FG001|Overall Study|Withdrawal by Subject|6|||
131083531|NCT05131477|471938005|FG000|PART 1|Adverse Event|3|||
131083532|NCT05131477|471938006|FG001|PART 1|Adverse Event|5|||
131083533|NCT05131477|471938007|FG002|PART 1|Adverse Event|1|||
131083534|NCT05131477|471938008|FG003|PART 1|Adverse Event|6|||
131083535|NCT05131477|471938009|FG004|PART 1|Adverse Event|4|||
131083536|NCT05131477|471938010|FG005|PART 1|Adverse Event|0|||
131083537|NCT05131477|471938011|FG006|PART 1|Adverse Event|0|||
131083538|NCT05131477|471938012|FG007|PART 1|Adverse Event|0|||
131083539|NCT05131477|471938013|FG008|PART 1|Adverse Event|0|||
131083540|NCT05131477|471938014|FG009|PART 1|Adverse Event|0|||
131083541|NCT05131477|471938015|FG010|PART 1|Adverse Event|0|||
131083542|NCT05131477|471938016|FG011|PART 1|Adverse Event|0|||
131083543|NCT05131477|471938017|FG012|PART 1|Adverse Event|0|||
131083544|NCT05131477|471938018|FG013|PART 1|Adverse Event|0|||
131083545|NCT05131477|471938005|FG000|PART 1|unclassified|1|||
131083546|NCT05131477|471938006|FG001|PART 1|unclassified|1|||
131083547|NCT05131477|471938007|FG002|PART 1|unclassified|0|||
131083548|NCT05131477|471938008|FG003|PART 1|unclassified|0|||
130780228|NCT01719380|470821456|FG009|Overall Study|Physician Decision|1|||
130780229|NCT01719380|470821447|FG000|Overall Study|Lack of Efficacy|2|||
130780230|NCT01719380|470821448|FG001|Overall Study|Lack of Efficacy|6|||
130780231|NCT01719380|470821449|FG002|Overall Study|Lack of Efficacy|5|||
130780232|NCT01719380|470821450|FG003|Overall Study|Lack of Efficacy|6|||
130780233|NCT01719380|470821451|FG004|Overall Study|Lack of Efficacy|3|||
130780234|NCT01719380|470821452|FG005|Overall Study|Lack of Efficacy|7|||
130780235|NCT01719380|470821453|FG006|Overall Study|Lack of Efficacy|10|||
131233544|NCT02227862|472482506|FG000|Overall Study|Lost to Follow-up|1|||
131233545|NCT02227862|472482507|FG001|Overall Study|Lost to Follow-up|2|||
130780236|NCT01719380|470821454|FG007|Overall Study|Lack of Efficacy|6|||
130780237|NCT01719380|470821455|FG008|Overall Study|Lack of Efficacy|39|||
130780238|NCT01719380|470821456|FG009|Overall Study|Lack of Efficacy|42|||
130780239|NCT01719380|470821447|FG000|Overall Study|Progressive Disease|0|||
130780240|NCT01719380|470821448|FG001|Overall Study|Progressive Disease|0|||
130780241|NCT01719380|470821449|FG002|Overall Study|Progressive Disease|0|||
130780242|NCT01719380|470821450|FG003|Overall Study|Progressive Disease|0|||
130780243|NCT01719380|470821451|FG004|Overall Study|Progressive Disease|0|||
130780244|NCT01719380|470821452|FG005|Overall Study|Progressive Disease|0|||
130780245|NCT01719380|470821453|FG006|Overall Study|Progressive Disease|0|||
130780246|NCT01719380|470821454|FG007|Overall Study|Progressive Disease|0|||
130780247|NCT01719380|470821455|FG008|Overall Study|Progressive Disease|1|||
130780248|NCT01719380|470821456|FG009|Overall Study|Progressive Disease|0|||
130780249|NCT00321906|470821464|FG000|Overall Study|Adverse Event|36|||
130780250|NCT00321906|470821465|FG001|Overall Study|Adverse Event|44|||
130780251|NCT00321906|470821464|FG000|Overall Study|Death|9|||
130780252|NCT00321906|470821465|FG001|Overall Study|Death|6|||
130780253|NCT00321906|470821464|FG000|Overall Study|Lost to Follow-up|1|||
130780254|NCT00321906|470821465|FG001|Overall Study|Lost to Follow-up|2|||
130780255|NCT00321906|470821464|FG000|Overall Study|Withdrawal by Subject|0|||
130780256|NCT00321906|470821465|FG001|Overall Study|Withdrawal by Subject|4|||
130780257|NCT00838097|470821468|FG000|Overall Study|Ineligibility determined|6|||
130780258|NCT00838097|470821468|FG000|Overall Study|Adverse Event|2|||
130780259|NCT00838097|470821468|FG000|Overall Study|Withdrawal by Subject|3|||
130780260|NCT00838097|470821468|FG000|Overall Study|Requirement for alternative therapy|2|||
130780261|NCT00838097|470821468|FG000|Overall Study|Physician Decision|4|||
130780262|NCT00838097|470821468|FG000|Overall Study|Lost to Follow-up|11|||
130780263|NCT00838097|470821468|FG000|Overall Study|Death|6|||
130780264|NCT00838097|470821468|FG000|Overall Study|Protocol-specified criteria|142|||
130780265|NCT00871234|470821469|FG000|Overall Study|Adverse Event|2|||
131083549|NCT05131477|471938009|FG004|PART 1|unclassified|4|||
131083550|NCT05131477|471938010|FG005|PART 1|unclassified|0|||
131083551|NCT05131477|471938011|FG006|PART 1|unclassified|0|||
131083552|NCT05131477|471938012|FG007|PART 1|unclassified|0|||
131083553|NCT05131477|471938013|FG008|PART 1|unclassified|0|||
131083554|NCT05131477|471938014|FG009|PART 1|unclassified|0|||
131083555|NCT05131477|471938015|FG010|PART 1|unclassified|0|||
131083556|NCT05131477|471938016|FG011|PART 1|unclassified|0|||
131083557|NCT05131477|471938017|FG012|PART 1|unclassified|0|||
131083558|NCT05131477|471938018|FG013|PART 1|unclassified|0|||
130780266|NCT00871234|470821469|FG000|Overall Study|Lost to Follow-up|3|||
130780267|NCT03380377|470821472|FG000|Overall Study|Physician Decision|1|||
131083559|NCT05131477|471938005|FG000|PART 1|Randomized and not treated|0|||
130780268|NCT03380377|470821472|FG000|Overall Study|Withdrawal by Subject|1|||
131083560|NCT05131477|471938006|FG001|PART 1|Randomized and not treated|0|||
131083561|NCT05131477|471938007|FG002|PART 1|Randomized and not treated|0|||
131083562|NCT05131477|471938008|FG003|PART 1|Randomized and not treated|1|||
131083563|NCT05131477|471938009|FG004|PART 1|Randomized and not treated|1|||
131233546|NCT02204371|472482510|FG000|Overall Study|Adverse Event|1|||
131233547|NCT00368966|472482513|FG000|Infant Series|Withdrawal by Subject|11|||
131083564|NCT05131477|471938010|FG005|PART 1|Randomized and not treated|0|||
131083565|NCT05131477|471938011|FG006|PART 1|Randomized and not treated|0|||
131083566|NCT05131477|471938012|FG007|PART 1|Randomized and not treated|0|||
131083567|NCT05131477|471938013|FG008|PART 1|Randomized and not treated|0|||
131083568|NCT05131477|471938014|FG009|PART 1|Randomized and not treated|0|||
131083569|NCT05131477|471938015|FG010|PART 1|Randomized and not treated|0|||
131083570|NCT05131477|471938016|FG011|PART 1|Randomized and not treated|0|||
131083571|NCT05131477|471938017|FG012|PART 1|Randomized and not treated|0|||
131083572|NCT05131477|471938018|FG013|PART 1|Randomized and not treated|0|||
131083573|NCT05131477|471938005|FG000|PART 1|Protocol Violation|2|||
131083574|NCT05131477|471938006|FG001|PART 1|Protocol Violation|0|||
131083575|NCT05131477|471938007|FG002|PART 1|Protocol Violation|0|||
131083576|NCT05131477|471938008|FG003|PART 1|Protocol Violation|1|||
131083577|NCT05131477|471938009|FG004|PART 1|Protocol Violation|0|||
131083578|NCT05131477|471938010|FG005|PART 1|Protocol Violation|0|||
131083579|NCT05131477|471938011|FG006|PART 1|Protocol Violation|0|||
131083580|NCT05131477|471938012|FG007|PART 1|Protocol Violation|0|||
131083581|NCT05131477|471938013|FG008|PART 1|Protocol Violation|0|||
131083582|NCT05131477|471938014|FG009|PART 1|Protocol Violation|0|||
131083583|NCT05131477|471938015|FG010|PART 1|Protocol Violation|0|||
131083584|NCT05131477|471938016|FG011|PART 1|Protocol Violation|0|||
131083585|NCT05131477|471938017|FG012|PART 1|Protocol Violation|0|||
131083586|NCT05131477|471938018|FG013|PART 1|Protocol Violation|0|||
131083587|NCT05131477|471938005|FG000|PART 1|Lack of Efficacy|0|||
131083588|NCT05131477|471938006|FG001|PART 1|Lack of Efficacy|1|||
131083589|NCT05131477|471938007|FG002|PART 1|Lack of Efficacy|1|||
131083590|NCT05131477|471938008|FG003|PART 1|Lack of Efficacy|2|||
131083591|NCT05131477|471938009|FG004|PART 1|Lack of Efficacy|5|||
131083592|NCT05131477|471938010|FG005|PART 1|Lack of Efficacy|0|||
131083593|NCT05131477|471938011|FG006|PART 1|Lack of Efficacy|0|||
131141458|NCT01960855|472143893|FG004|Overall Study|Lost to Follow-up|2|||
131141459|NCT02058147|472143894|FG000|Overall Study|Randomized but not treated|0|||
131141460|NCT02058147|472143895|FG001|Overall Study|Randomized but not treated|0|||
131141461|NCT02058147|472143896|FG002|Overall Study|Randomized but not treated|1|||
131141462|NCT02058147|472143894|FG000|Overall Study|Adverse Event|12|||
131141463|NCT02058147|472143895|FG001|Overall Study|Adverse Event|9|||
131141464|NCT02058147|472143896|FG002|Overall Study|Adverse Event|21|||
131141465|NCT02058147|472143894|FG000|Overall Study|Lack of Efficacy|1|||
131141466|NCT02058147|472143895|FG001|Overall Study|Lack of Efficacy|0|||
131141467|NCT02058147|472143896|FG002|Overall Study|Lack of Efficacy|3|||
131141468|NCT02058147|472143894|FG000|Overall Study|Poor compliance to protocol|8|||
131141469|NCT02058147|472143895|FG001|Overall Study|Poor compliance to protocol|9|||
131141470|NCT02058147|472143896|FG002|Overall Study|Poor compliance to protocol|4|||
131141471|NCT02058147|472143894|FG000|Overall Study|Other than specified|8|||
131141472|NCT02058147|472143895|FG001|Overall Study|Other than specified|9|||
131141473|NCT02058147|472143896|FG002|Overall Study|Other than specified|0|||
131141474|NCT00713219|472143903|FG000|Overall Study|Death|1|||
131141475|NCT00713219|472143903|FG000|Overall Study|Protocol Violation|1|||
131141476|NCT00508391|472143904|FG000|First Treatment|Withdrawal by Subject|6|||
131141477|NCT00508391|472143905|FG001|First Treatment|Withdrawal by Subject|3|||
131141478|NCT00508391|472143904|FG000|Second Treatment|Withdrawal by Subject|2|||
131141479|NCT00508391|472143905|FG001|Second Treatment|Withdrawal by Subject|0|||
131141480|NCT00802360|472143906|FG000|Overall Study|Stimulation failure|4|||
131141481|NCT00802360|472143907|FG001|Overall Study|Stimulation failure|0|||
131141482|NCT00802360|472143908|FG002|Overall Study|Stimulation failure|3|||
131141483|NCT00802360|472143909|FG003|Overall Study|Stimulation failure|3|||
131141484|NCT00802360|472143906|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
131141485|NCT00802360|472143907|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
131141486|NCT00802360|472143908|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
131141487|NCT00802360|472143909|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
131141488|NCT00802360|472143906|FG000|Overall Study|Cycle cancelled|0|||
131141489|NCT00802360|472143907|FG001|Overall Study|Cycle cancelled|1|||
131141490|NCT00802360|472143908|FG002|Overall Study|Cycle cancelled|1|||
131141491|NCT00802360|472143909|FG003|Overall Study|Cycle cancelled|1|||
131141492|NCT00802360|472143906|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
131083594|NCT05131477|471938012|FG007|PART 1|Lack of Efficacy|0|||
131083595|NCT05131477|471938013|FG008|PART 1|Lack of Efficacy|0|||
131083596|NCT05131477|471938014|FG009|PART 1|Lack of Efficacy|0|||
131083597|NCT05131477|471938015|FG010|PART 1|Lack of Efficacy|0|||
131083598|NCT05131477|471938016|FG011|PART 1|Lack of Efficacy|0|||
131141493|NCT00802360|472143907|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
131141494|NCT00802360|472143908|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
131141495|NCT00802360|472143909|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
131083599|NCT05131477|471938017|FG012|PART 1|Lack of Efficacy|0|||
131083600|NCT05131477|471938018|FG013|PART 1|Lack of Efficacy|0|||
131083601|NCT05131477|471938005|FG000|PART 2|Withdrawal by Subject|0|||
131083602|NCT05131477|471938006|FG001|PART 2|Withdrawal by Subject|0|||
131083603|NCT05131477|471938007|FG002|PART 2|Withdrawal by Subject|0|||
131083604|NCT05131477|471938008|FG003|PART 2|Withdrawal by Subject|0|||
131141496|NCT00802360|472143906|FG000|Overall Study|No positive serum pregnancy|17|||
131083605|NCT05131477|471938009|FG004|PART 2|Withdrawal by Subject|0|||
131083606|NCT05131477|471938010|FG005|PART 2|Withdrawal by Subject|0|||
131083607|NCT05131477|471938011|FG006|PART 2|Withdrawal by Subject|2|||
131083608|NCT05131477|471938012|FG007|PART 2|Withdrawal by Subject|0|||
131083609|NCT05131477|471938013|FG008|PART 2|Withdrawal by Subject|0|||
131083610|NCT05131477|471938014|FG009|PART 2|Withdrawal by Subject|0|||
131083611|NCT05131477|471938015|FG010|PART 2|Withdrawal by Subject|2|||
131083612|NCT05131477|471938016|FG011|PART 2|Withdrawal by Subject|0|||
131083613|NCT05131477|471938017|FG012|PART 2|Withdrawal by Subject|2|||
131083614|NCT05131477|471938018|FG013|PART 2|Withdrawal by Subject|2|||
131083615|NCT05131477|471938005|FG000|PART 2|Other|0|||
131083616|NCT05131477|471938006|FG001|PART 2|Other|0|||
131083617|NCT05131477|471938007|FG002|PART 2|Other|0|||
131083618|NCT05131477|471938008|FG003|PART 2|Other|0|||
131083619|NCT05131477|471938009|FG004|PART 2|Other|0|||
131083620|NCT05131477|471938010|FG005|PART 2|Other|0|||
131083621|NCT05131477|471938011|FG006|PART 2|Other|0|||
131083622|NCT05131477|471938012|FG007|PART 2|Other|0|||
131083623|NCT05131477|471938013|FG008|PART 2|Other|1|||
131083624|NCT05131477|471938014|FG009|PART 2|Other|1|||
131083625|NCT05131477|471938015|FG010|PART 2|Other|0|||
131083626|NCT05131477|471938016|FG011|PART 2|Other|0|||
131083627|NCT05131477|471938017|FG012|PART 2|Other|1|||
131083628|NCT05131477|471938018|FG013|PART 2|Other|0|||
131083629|NCT05131477|471938005|FG000|PART 2|Lack of Efficacy|0|||
131083630|NCT05131477|471938006|FG001|PART 2|Lack of Efficacy|0|||
131083631|NCT05131477|471938007|FG002|PART 2|Lack of Efficacy|0|||
131083632|NCT05131477|471938008|FG003|PART 2|Lack of Efficacy|0|||
131083633|NCT05131477|471938009|FG004|PART 2|Lack of Efficacy|0|||
131083634|NCT05131477|471938010|FG005|PART 2|Lack of Efficacy|1|||
131083635|NCT05131477|471938011|FG006|PART 2|Lack of Efficacy|1|||
131083636|NCT05131477|471938012|FG007|PART 2|Lack of Efficacy|0|||
131083637|NCT05131477|471938013|FG008|PART 2|Lack of Efficacy|3|||
131083638|NCT05131477|471938014|FG009|PART 2|Lack of Efficacy|0|||
131083639|NCT05131477|471938015|FG010|PART 2|Lack of Efficacy|1|||
131083640|NCT05131477|471938016|FG011|PART 2|Lack of Efficacy|0|||
131083641|NCT05131477|471938017|FG012|PART 2|Lack of Efficacy|2|||
131083642|NCT05131477|471938018|FG013|PART 2|Lack of Efficacy|0|||
131083643|NCT05131477|471938005|FG000|PART 2|Unclassified|0|||
131083644|NCT05131477|471938006|FG001|PART 2|Unclassified|0|||
131083645|NCT05131477|471938007|FG002|PART 2|Unclassified|0|||
131083646|NCT05131477|471938008|FG003|PART 2|Unclassified|0|||
131083647|NCT05131477|471938009|FG004|PART 2|Unclassified|0|||
131083648|NCT05131477|471938010|FG005|PART 2|Unclassified|0|||
131083649|NCT05131477|471938011|FG006|PART 2|Unclassified|0|||
131083650|NCT05131477|471938012|FG007|PART 2|Unclassified|0|||
131083651|NCT05131477|471938013|FG008|PART 2|Unclassified|0|||
131083652|NCT05131477|471938014|FG009|PART 2|Unclassified|0|||
131083653|NCT05131477|471938015|FG010|PART 2|Unclassified|1|||
131083654|NCT05131477|471938016|FG011|PART 2|Unclassified|0|||
131083655|NCT05131477|471938017|FG012|PART 2|Unclassified|0|||
131083656|NCT05131477|471938018|FG013|PART 2|Unclassified|0|||
131083657|NCT05131477|471938005|FG000|PART 2|Re-randomized and not treated|0|||
131083658|NCT05131477|471938006|FG001|PART 2|Re-randomized and not treated|0|||
131083659|NCT05131477|471938007|FG002|PART 2|Re-randomized and not treated|0|||
131083660|NCT05131477|471938008|FG003|PART 2|Re-randomized and not treated|0|||
131083661|NCT05131477|471938009|FG004|PART 2|Re-randomized and not treated|0|||
131083662|NCT05131477|471938010|FG005|PART 2|Re-randomized and not treated|0|||
131083663|NCT05131477|471938011|FG006|PART 2|Re-randomized and not treated|0|||
131083664|NCT05131477|471938012|FG007|PART 2|Re-randomized and not treated|1|||
131083665|NCT05131477|471938013|FG008|PART 2|Re-randomized and not treated|0|||
131083666|NCT05131477|471938014|FG009|PART 2|Re-randomized and not treated|0|||
131083667|NCT05131477|471938015|FG010|PART 2|Re-randomized and not treated|1|||
131083668|NCT05131477|471938016|FG011|PART 2|Re-randomized and not treated|0|||
131083669|NCT05131477|471938017|FG012|PART 2|Re-randomized and not treated|1|||
131083670|NCT05131477|471938018|FG013|PART 2|Re-randomized and not treated|1|||
131083671|NCT02194829|471938019|FG000|Overall Study|Adverse Event|2|||
131083672|NCT02194829|471938020|FG001|Overall Study|Adverse Event|2|||
131083673|NCT02194829|471938019|FG000|Overall Study|Death|0|||
131083674|NCT02194829|471938020|FG001|Overall Study|Death|1|||
131083675|NCT02194829|471938019|FG000|Overall Study|Disease progression|0|||
131083676|NCT02194829|471938020|FG001|Overall Study|Disease progression|1|||
131083677|NCT02194829|471938019|FG000|Overall Study|Withdrawal by Subject|0|||
131083678|NCT02194829|471938020|FG001|Overall Study|Withdrawal by Subject|1|||
131083679|NCT02194829|471938019|FG000|Overall Study|Never started protocol therapy|0|||
131083680|NCT02194829|471938020|FG001|Overall Study|Never started protocol therapy|1|||
131083681|NCT05101993|471938025|FG000|Overall Study|Withdrawal by Subject|1|||
131083682|NCT04577573|471938026|FG000|Overall Study|Technical - invalid protocol|0|||
131083683|NCT04577573|471938027|FG001|Overall Study|Technical - invalid protocol|2|||
131083684|NCT04577573|471938028|FG002|Overall Study|Technical - invalid protocol|0|||
131083685|NCT04297618|471938029|FG000|Overall Study|Adverse Event|1|||
131083686|NCT04297618|471938029|FG000|Overall Study|Withdrawal by Subject|1|||
131083687|NCT06719986|471938030|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
131233548|NCT00368966|472482514|FG001|Infant Series|Withdrawal by Subject|6|||
131233549|NCT00368966|472482513|FG000|Infant Series|Protocol Violation|2|||
131233550|NCT00368966|472482514|FG001|Infant Series|Protocol Violation|1|||
131233551|NCT00368966|472482513|FG000|Infant Series|Lost to Follow-up|2|||
131233552|NCT00368966|472482514|FG001|Infant Series|Lost to Follow-up|0|||
131233553|NCT00368966|472482513|FG000|Infant Series|Randomization error|0|||
131233554|NCT00368966|472482514|FG001|Infant Series|Randomization error|1|||
131233555|NCT00368966|472482513|FG000|Infant Series|Failed to meet eligibility criteria|0|||
131233556|NCT00368966|472482514|FG001|Infant Series|Failed to meet eligibility criteria|1|||
131233557|NCT00368966|472482513|FG000|Infant Series|Adverse Event|0|||
131233558|NCT00368966|472482514|FG001|Infant Series|Adverse Event|1|||
131233559|NCT00368966|472482513|FG000|Infant Series|Failed to return|1|||
131083688|NCT06719986|471938031|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
131083689|NCT06719986|471938032|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
131083690|NCT06719986|471938030|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
131083691|NCT06719986|471938031|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
131083692|NCT06719986|471938032|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
131083693|NCT02737826|471939864|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
131083694|NCT02737826|471939865|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
131083695|NCT02737826|471939866|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
131083696|NCT00581893|471939867|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
131083697|NCT00581893|471939868|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
131083698|NCT00233480|471939869|FG000|Overall Study|Underwent status II heart transplant|0|||
131083699|NCT00233480|471939870|FG001|Overall Study|Underwent status II heart transplant|1|||
131083700|NCT02797522|471939871|FG000|Overall Study|Study Terminated by Sponsor|0|||
131083701|NCT02797522|471939872|FG001|Overall Study|Study Terminated by Sponsor|0|||
131083702|NCT02797522|471939873|FG002|Overall Study|Study Terminated by Sponsor|0|||
131083703|NCT02797522|471939874|FG003|Overall Study|Study Terminated by Sponsor|0|||
131083704|NCT02797522|471939875|FG004|Overall Study|Study Terminated by Sponsor|0|||
131083705|NCT02797522|471939876|FG005|Overall Study|Study Terminated by Sponsor|0|||
131083706|NCT02797522|471939877|FG006|Overall Study|Study Terminated by Sponsor|0|||
131083707|NCT02797522|471939878|FG007|Overall Study|Study Terminated by Sponsor|4|||
131083708|NCT02797522|471939879|FG008|Overall Study|Study Terminated by Sponsor|2|||
131083709|NCT02797522|471939880|FG009|Overall Study|Study Terminated by Sponsor|4|||
131083710|NCT02797522|471939881|FG010|Overall Study|Study Terminated by Sponsor|1|||
131083711|NCT00132678|471939884|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
131083712|NCT00132678|471939885|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
131083713|NCT00132678|471939886|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
131083714|NCT00132678|471939884|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
131083715|NCT00132678|471939885|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
131083716|NCT00132678|471939886|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
131083717|NCT00132678|471939884|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
131083718|NCT00132678|471939885|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
131083719|NCT00132678|471939886|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
131083720|NCT00132678|471939884|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
131083721|NCT00132678|471939885|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
131083722|NCT00132678|471939886|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
131083723|NCT00132678|471939884|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
131083724|NCT00132678|471939885|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
131083725|NCT00132678|471939886|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
131083726|NCT00132678|471939884|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
131083727|NCT00132678|471939885|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
131083728|NCT00132678|471939886|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
131083729|NCT00132678|471939884|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
131083730|NCT00132678|471939885|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
131083731|NCT00132678|471939886|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
131083732|NCT00132678|471939884|FG000|Period III (Open-Label Stabilization)|Death|2|||
131083733|NCT00132678|471939885|FG001|Period III (Open-Label Stabilization)|Death|0|||
131083734|NCT00132678|471939886|FG002|Period III (Open-Label Stabilization)|Death|0|||
131083735|NCT00132678|471939884|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
131083736|NCT00132678|471939885|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
131083737|NCT00132678|471939886|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
131083738|NCT00132678|471939884|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
131083739|NCT00132678|471939885|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
131083740|NCT00132678|471939886|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
131083741|NCT00132678|471939884|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
131083742|NCT00132678|471939885|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
131233560|NCT00368966|472482514|FG001|Infant Series|Failed to return|0|||
131233561|NCT00368966|472482513|FG000|After Infant|Failed to return|3|||
131083743|NCT00132678|471939886|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
131083744|NCT00132678|471939884|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
131083745|NCT00132678|471939885|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
131083746|NCT00132678|471939886|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
131083747|NCT00132678|471939884|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
131083748|NCT00132678|471939885|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
131083749|NCT00132678|471939886|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
131083750|NCT00132678|471939884|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
131083751|NCT00132678|471939885|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
131083752|NCT00132678|471939886|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
131083753|NCT00132678|471939884|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
131083754|NCT00132678|471939885|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
131083755|NCT00132678|471939886|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
131083756|NCT00132678|471939884|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
131083757|NCT00132678|471939885|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
131083758|NCT00132678|471939886|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
131083759|NCT00132678|471939884|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
131083760|NCT00132678|471939885|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
131083761|NCT00132678|471939886|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
131083762|NCT00132678|471939884|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
131083763|NCT00132678|471939885|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
131083764|NCT00132678|471939886|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
131083765|NCT00132678|471939884|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
131083766|NCT00132678|471939885|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
131083767|NCT00132678|471939886|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
131083768|NCT00132678|471939884|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
131083769|NCT00132678|471939885|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
131083770|NCT00132678|471939886|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
131083771|NCT00132678|471939884|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
131083772|NCT00132678|471939885|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
131083773|NCT00132678|471939886|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
131083774|NCT00132678|471939884|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
131083775|NCT00132678|471939885|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
131083776|NCT00132678|471939886|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
131083777|NCT00132678|471939884|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
131083778|NCT00132678|471939885|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
131083779|NCT00132678|471939886|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
131083780|NCT01367847|471939887|FG000|Overall Study|Withdrawal by Subject|2|||
131083781|NCT01367847|471939888|FG001|Overall Study|Withdrawal by Subject|2|||
131083782|NCT01606319|471939889|FG000|Overall Study|Lost to Follow-up|17|||
131083783|NCT01606319|471939890|FG001|Overall Study|Lost to Follow-up|14|||
131083784|NCT01606319|471939889|FG000|Overall Study|Withdrawal by Subject|9|||
131083785|NCT01606319|471939890|FG001|Overall Study|Withdrawal by Subject|12|||
131083786|NCT01606319|471939889|FG000|Overall Study|Physician Decision|1|||
131083787|NCT01606319|471939890|FG001|Overall Study|Physician Decision|2|||
131083788|NCT01606319|471939889|FG000|Overall Study|Lack of Efficacy|6|||
131083789|NCT01606319|471939890|FG001|Overall Study|Lack of Efficacy|8|||
131083790|NCT01606319|471939889|FG000|Overall Study|Adverse Event|1|||
131083791|NCT01606319|471939890|FG001|Overall Study|Adverse Event|4|||
131083792|NCT01594827|471939891|FG000|Overall Study|Adverse Event|1|||
131083793|NCT01594827|471939892|FG001|Overall Study|Adverse Event|0|||
131083794|NCT01594827|471939891|FG000|Overall Study|Physician Decision|3|||
131083795|NCT01594827|471939892|FG001|Overall Study|Physician Decision|0|||
131083796|NCT01821937|471939894|FG000|Overall Study|Adverse Event|0|||
131083797|NCT01821937|471939895|FG001|Overall Study|Adverse Event|3|||
131083798|NCT02406248|471939901|FG000|Overall Study|Death|7|||
131083799|NCT02406248|471939901|FG000|Overall Study|Withdrawal by Subject|2|||
131083800|NCT03482752|471939905|FG000|Overall Study|Withdrawal by Subject|2|||
131083801|NCT03482752|471939905|FG000|Overall Study|Lost to Follow-up|1|||
131083802|NCT03482752|471939905|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
131083803|NCT01080300|471939906|FG000|Overall Study|Adverse Event|49|||
131083804|NCT01080300|471939907|FG001|Overall Study|Adverse Event|35|||
131083805|NCT01080300|471939906|FG000|Overall Study|Lack of Efficacy|12|||
131083806|NCT01080300|471939907|FG001|Overall Study|Lack of Efficacy|15|||
131083807|NCT01080300|471939906|FG000|Overall Study|Protocol Violation|7|||
131083808|NCT01080300|471939907|FG001|Overall Study|Protocol Violation|13|||
131083809|NCT01080300|471939906|FG000|Overall Study|Lost to Follow-up|10|||
131083810|NCT01080300|471939907|FG001|Overall Study|Lost to Follow-up|6|||
131083811|NCT01080300|471939906|FG000|Overall Study|Death|0|||
131083812|NCT01080300|471939907|FG001|Overall Study|Death|1|||
131083813|NCT01080300|471939906|FG000|Overall Study|Withdrawal by Subject|12|||
131083814|NCT01080300|471939907|FG001|Overall Study|Withdrawal by Subject|28|||
131083815|NCT01080300|471939906|FG000|Overall Study|Reasons not specified|4|||
131083816|NCT01080300|471939907|FG001|Overall Study|Reasons not specified|6|||
131083817|NCT04210843|471939909|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
131083818|NCT04210843|471939910|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
131083819|NCT04210843|471939909|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
131083820|NCT04210843|471939910|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
131083821|NCT04210843|471939909|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
131083822|NCT04210843|471939910|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
131083823|NCT04210843|471939909|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
131083824|NCT04210843|471939910|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
131083825|NCT04210843|471939909|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
131083826|NCT04210843|471939910|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
131083827|NCT04210843|471939909|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
131083828|NCT04210843|471939910|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
131083829|NCT04210843|471939909|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
131083830|NCT04210843|471939910|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
131083831|NCT04210843|471939909|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
131083832|NCT04210843|471939910|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
131083833|NCT04210843|471939909|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
131083834|NCT04210843|471939910|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
131083835|NCT04210843|471939909|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
131083836|NCT04210843|471939910|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
131083837|NCT04210843|471939909|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
131083838|NCT04210843|471939910|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
131083839|NCT04210843|471939909|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
131083840|NCT04210843|471939910|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
131083841|NCT04210843|471939909|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
131083842|NCT04210843|471939910|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
131083843|NCT04210843|471939909|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
131083844|NCT04210843|471939910|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
131083845|NCT04210843|471939909|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
131083846|NCT04210843|471939910|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
131083847|NCT04210843|471939909|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
131083848|NCT04210843|471939910|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
131083849|NCT04210843|471939909|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
131083850|NCT04210843|471939910|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
131083851|NCT04210843|471939909|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
131083852|NCT04210843|471939910|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
131083853|NCT04210843|471939909|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
131083854|NCT04210843|471939910|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
131083855|NCT04210843|471939909|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
131083856|NCT04210843|471939910|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
131083857|NCT04210843|471939909|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
131083858|NCT04210843|471939910|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
131083859|NCT04210843|471939909|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
131083860|NCT04210843|471939910|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
131083861|NCT04210843|471939909|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
131083862|NCT04210843|471939910|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
131083863|NCT04210843|471939909|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
131083864|NCT04210843|471939910|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
131083865|NCT01776008|471939911|FG000|Overall Study|ineligible|2|||
131083866|NCT02353468|471939913|FG000|Overall Study|Study terminated|3|||
131083867|NCT02493946|471939914|FG000|DB Period|Withdrawal by Subject|8|||
131083868|NCT02493946|471939915|FG001|DB Period|Withdrawal by Subject|5|||
131083869|NCT02493946|471939916|FG002|DB Period|Withdrawal by Subject|0|||
131083870|NCT02493946|471939914|FG000|Open Label Period|Withdrawal by Subject|0|||
131083871|NCT02493946|471939915|FG001|Open Label Period|Withdrawal by Subject|0|||
131083872|NCT02493946|471939916|FG002|Open Label Period|Withdrawal by Subject|74|||
131083873|NCT02493946|471939914|FG000|Open Label Period|Adverse Event|0|||
131083874|NCT02493946|471939915|FG001|Open Label Period|Adverse Event|0|||
131083875|NCT02493946|471939916|FG002|Open Label Period|Adverse Event|4|||
131083876|NCT02493946|471939914|FG000|Open Label Period|Lost to Follow-up|0|||
131083877|NCT02493946|471939915|FG001|Open Label Period|Lost to Follow-up|0|||
131083878|NCT02493946|471939916|FG002|Open Label Period|Lost to Follow-up|1|||
131083879|NCT02493946|471939914|FG000|Open Label Period|Investigator decision, non-compliance|0|||
131083880|NCT02493946|471939915|FG001|Open Label Period|Investigator decision, non-compliance|0|||
130727228|NCT02883049|470625428|FG004|Post Induction|Protocol Violation|0|||
131083881|NCT02493946|471939916|FG002|Open Label Period|Investigator decision, non-compliance|2|||
131083882|NCT02493946|471939914|FG000|Open Label Period|Investigator decision, non-availability|0|||
131083883|NCT02493946|471939915|FG001|Open Label Period|Investigator decision, non-availability|0|||
131083884|NCT02493946|471939916|FG002|Open Label Period|Investigator decision, non-availability|1|||
131083885|NCT02493946|471939914|FG000|Open Label Period|Pregnancy|0|||
131083886|NCT02493946|471939915|FG001|Open Label Period|Pregnancy|0|||
131083887|NCT02493946|471939916|FG002|Open Label Period|Pregnancy|3|||
131083888|NCT02493946|471939914|FG000|Open Label Period|Site error|0|||
131083889|NCT02493946|471939915|FG001|Open Label Period|Site error|0|||
131083890|NCT02493946|471939916|FG002|Open Label Period|Site error|1|||
131083891|NCT00848484|471939917|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
131083892|NCT00848484|471939918|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
131083893|NCT00848484|471939917|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
131083894|NCT00848484|471939918|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
131083895|NCT00848484|471939917|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
131083896|NCT00848484|471939918|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
131083897|NCT00848484|471939917|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
131083898|NCT00848484|471939918|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
131083899|NCT00848484|471939917|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
131083900|NCT00848484|471939918|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
131083901|NCT03017742|471939925|FG000|Overall Study|Protocol Violation|36|||
131083902|NCT03017742|471939925|FG000|Overall Study|Withdrawal by Subject|37|||
131083903|NCT00762476|471939927|FG000|Overall Study|Adverse Event|7|||
131083904|NCT00762476|471939928|FG001|Overall Study|Adverse Event|1|||
131083905|NCT00762476|471939927|FG000|Overall Study|Lost to Follow-up|2|||
131083906|NCT00762476|471939928|FG001|Overall Study|Lost to Follow-up|0|||
131083907|NCT00762476|471939927|FG000|Overall Study|Protocol Violation|5|||
131083908|NCT00762476|471939928|FG001|Overall Study|Protocol Violation|6|||
131083909|NCT00762476|471939927|FG000|Overall Study|Physician Decision|2|||
131083910|NCT00762476|471939928|FG001|Overall Study|Physician Decision|14|||
131083911|NCT00762476|471939927|FG000|Overall Study|Withdrawal by Subject|6|||
131083912|NCT00762476|471939928|FG001|Overall Study|Withdrawal by Subject|12|||
131083913|NCT00762476|471939927|FG000|Overall Study|antibiotic use|0|||
131083914|NCT00762476|471939928|FG001|Overall Study|antibiotic use|1|||
131083915|NCT00762476|471939927|FG000|Overall Study|non-compliance with study visits|0|||
131083916|NCT00762476|471939928|FG001|Overall Study|non-compliance with study visits|2|||
131083917|NCT00762476|471939927|FG000|Overall Study|Seasonal allergies|1|||
131083918|NCT00762476|471939928|FG001|Overall Study|Seasonal allergies|0|||
131083919|NCT02878603|471939929|FG000|Overall Study|Lost to Follow-up|4|||
131083920|NCT02878603|471939930|FG001|Overall Study|Lost to Follow-up|1|||
131083921|NCT02878603|471939929|FG000|Overall Study|Withdrawal by Subject|1|||
131083922|NCT02878603|471939930|FG001|Overall Study|Withdrawal by Subject|1|||
131083923|NCT02878603|471939929|FG000|Overall Study|Death|1|||
131083924|NCT02878603|471939930|FG001|Overall Study|Death|0|||
131083925|NCT02878603|471939929|FG000|Overall Study|Physician Decision|0|||
131083926|NCT02878603|471939930|FG001|Overall Study|Physician Decision|3|||
131083927|NCT04674189|471939931|FG000|Overall Study|Adverse Event|0|||
131083928|NCT04674189|471939932|FG001|Overall Study|Adverse Event|0|||
131083929|NCT04674189|471939933|FG002|Overall Study|Adverse Event|1|||
131083930|NCT04674189|471939931|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
131083931|NCT04674189|471939932|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
131141497|NCT00802360|472143907|FG001|Overall Study|No positive serum pregnancy|20|||
131141498|NCT00802360|472143908|FG002|Overall Study|No positive serum pregnancy|14|||
131141499|NCT00802360|472143909|FG003|Overall Study|No positive serum pregnancy|10|||
131141500|NCT00802360|472143906|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
131141501|NCT00802360|472143907|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
131141502|NCT00802360|472143908|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
131141503|NCT00802360|472143909|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
131141504|NCT00802360|472143906|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
131141505|NCT00802360|472143907|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
131141506|NCT00802360|472143908|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
131141507|NCT00802360|472143909|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
131141508|NCT00802360|472143906|FG000|Overall Study|Other|2|||
131141509|NCT00802360|472143907|FG001|Overall Study|Other|3|||
131083932|NCT04674189|471939933|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
131083933|NCT04674189|471939931|FG000|Overall Study|Physician Decision|1|||
131083934|NCT04674189|471939932|FG001|Overall Study|Physician Decision|0|||
131083935|NCT04674189|471939933|FG002|Overall Study|Physician Decision|0|||
131083936|NCT04674189|471939931|FG000|Overall Study|Withdrawal by Participant|83|||
131083937|NCT04674189|471939932|FG001|Overall Study|Withdrawal by Participant|71|||
131083938|NCT04674189|471939933|FG002|Overall Study|Withdrawal by Participant|142|||
131083939|NCT04674189|471939931|FG000|Overall Study|Lost to Follow-up|55|||
131083940|NCT04674189|471939932|FG001|Overall Study|Lost to Follow-up|53|||
131083941|NCT04674189|471939933|FG002|Overall Study|Lost to Follow-up|44|||
131083942|NCT04674189|471939931|FG000|Overall Study|Miscellaneous|27|||
131083943|NCT04674189|471939932|FG001|Overall Study|Miscellaneous|23|||
131083944|NCT04674189|471939933|FG002|Overall Study|Miscellaneous|207|||
131083945|NCT04674189|471939931|FG000|Overall Study|Did Not Receive Treatment|3|||
131083946|NCT04674189|471939932|FG001|Overall Study|Did Not Receive Treatment|1|||
131083947|NCT04674189|471939933|FG002|Overall Study|Did Not Receive Treatment|2|||
131083948|NCT02838134|471939934|FG000|Overall Study|Lost to Follow-up|1|||
131083949|NCT02838134|471939935|FG001|Overall Study|Lost to Follow-up|2|||
131083950|NCT02838134|471939934|FG000|Overall Study|logistic problems|1|||
131083951|NCT02838134|471939935|FG001|Overall Study|logistic problems|1|||
131083952|NCT01564277|471939936|FG000|Overall Study|Protocol Violation|0|||
131083953|NCT01564277|471939937|FG001|Overall Study|Protocol Violation|1|||
131083954|NCT01564277|471939936|FG000|Overall Study|Physician Decision|1|||
131083955|NCT01564277|471939937|FG001|Overall Study|Physician Decision|0|||
131083956|NCT01637077|471939938|FG000|Overall Study|Cancel|1|||
131083957|NCT01637077|471939939|FG001|Overall Study|Cancel|1|||
131083958|NCT01637077|471939938|FG000|Overall Study|Withdrawal by Subject|1|||
131083959|NCT01637077|471939939|FG001|Overall Study|Withdrawal by Subject|0|||
131083960|NCT01637077|471939938|FG000|Overall Study|No cycle 1 questionnaire data|2|||
131083961|NCT01637077|471939939|FG001|Overall Study|No cycle 1 questionnaire data|0|||
131083962|NCT02595372|471939940|FG000|Overall Study|Adverse Event|6|||
131083963|NCT02595372|471939940|FG000|Overall Study|Physician Decision|2|||
131083964|NCT02595372|471939940|FG000|Overall Study|Disease Progression|1|||
131083965|NCT00794924|471939941|FG000|Overall Study|Lost to Follow-up|6|||
131083966|NCT00794924|471939942|FG001|Overall Study|Lost to Follow-up|8|||
131083967|NCT00794924|471939941|FG000|Overall Study|Withdrawal by Subject|48|||
131083968|NCT00794924|471939942|FG001|Overall Study|Withdrawal by Subject|60|||
131083969|NCT00794924|471939941|FG000|Overall Study|Adverse Event|6|||
131083970|NCT00794924|471939942|FG001|Overall Study|Adverse Event|2|||
131083971|NCT01594970|471939943|FG000|Overall Study|Non-Adverse Event Related|4|||
131083972|NCT01594970|471939944|FG001|Overall Study|Non-Adverse Event Related|5|||
131083973|NCT01594970|471939945|FG002|Overall Study|Non-Adverse Event Related|6|||
131083974|NCT01594970|471939943|FG000|Overall Study|Adverse Event|17|||
131083975|NCT01594970|471939944|FG001|Overall Study|Adverse Event|23|||
131083976|NCT01594970|471939945|FG002|Overall Study|Adverse Event|23|||
131083977|NCT01594970|471939943|FG000|Overall Study|Lost to Follow-up|54|||
131083978|NCT01594970|471939944|FG001|Overall Study|Lost to Follow-up|54|||
131083979|NCT01594970|471939945|FG002|Overall Study|Lost to Follow-up|37|||
131083980|NCT00953615|471939946|FG000|Overall Study|Adverse Event|1|||
131083981|NCT01969851|471939954|FG000|Overall Study|Adverse Event|0|||
131083982|NCT01969851|471939955|FG001|Overall Study|Adverse Event|0|||
131083983|NCT01969851|471939956|FG002|Overall Study|Adverse Event|3|||
131083984|NCT01969851|471939954|FG000|Overall Study|Lack of Efficacy|0|||
131083985|NCT01969851|471939955|FG001|Overall Study|Lack of Efficacy|3|||
131083986|NCT01969851|471939956|FG002|Overall Study|Lack of Efficacy|1|||
131083987|NCT01969851|471939954|FG000|Overall Study|Withdrawal by Subject|1|||
131083988|NCT01969851|471939955|FG001|Overall Study|Withdrawal by Subject|0|||
131083989|NCT01969851|471939956|FG002|Overall Study|Withdrawal by Subject|1|||
131083990|NCT01969851|471939954|FG000|Overall Study|No effective dose in Titration period|0|||
131083991|NCT01969851|471939955|FG001|Overall Study|No effective dose in Titration period|0|||
131083992|NCT01969851|471939956|FG002|Overall Study|No effective dose in Titration period|1|||
131083993|NCT01969851|471939954|FG000|Overall Study|Sponsor decision|0|||
131083994|NCT01969851|471939955|FG001|Overall Study|Sponsor decision|0|||
131083995|NCT01969851|471939956|FG002|Overall Study|Sponsor decision|1|||
131083996|NCT02389764|471939962|FG000|Overall Study|Lack of Efficacy|9|||
131083997|NCT02498236|471939963|FG000|Overall Study|Did not show for testing|1|||
131083998|NCT02498236|471939964|FG001|Overall Study|Did not show for testing|0|||
131083999|NCT02498236|471939965|FG002|Overall Study|Did not show for testing|0|||
131084000|NCT02498236|471939966|FG003|Overall Study|Did not show for testing|0|||
131084001|NCT02498236|471939967|FG004|Overall Study|Did not show for testing|0|||
131084002|NCT02498236|471939968|FG005|Overall Study|Did not show for testing|0|||
131084003|NCT02498236|471939969|FG006|Overall Study|Did not show for testing|0|||
131084004|NCT02498236|471939970|FG007|Overall Study|Did not show for testing|1|||
131084005|NCT02498236|471939963|FG000|Overall Study|Equipment failure|0|||
131084006|NCT02498236|471939964|FG001|Overall Study|Equipment failure|0|||
131084007|NCT02498236|471939965|FG002|Overall Study|Equipment failure|0|||
131084008|NCT02498236|471939966|FG003|Overall Study|Equipment failure|0|||
131084009|NCT02498236|471939967|FG004|Overall Study|Equipment failure|0|||
131084010|NCT02498236|471939968|FG005|Overall Study|Equipment failure|0|||
131084011|NCT02498236|471939969|FG006|Overall Study|Equipment failure|1|||
131084012|NCT02498236|471939970|FG007|Overall Study|Equipment failure|0|||
131084013|NCT02498236|471939963|FG000|Overall Study|Withdrawal by Subject|0|||
131084014|NCT02498236|471939964|FG001|Overall Study|Withdrawal by Subject|0|||
131084015|NCT02498236|471939965|FG002|Overall Study|Withdrawal by Subject|0|||
131084016|NCT02498236|471939966|FG003|Overall Study|Withdrawal by Subject|0|||
131084017|NCT02498236|471939967|FG004|Overall Study|Withdrawal by Subject|1|||
131084018|NCT02498236|471939968|FG005|Overall Study|Withdrawal by Subject|0|||
131084019|NCT02498236|471939969|FG006|Overall Study|Withdrawal by Subject|0|||
131084020|NCT02498236|471939970|FG007|Overall Study|Withdrawal by Subject|0|||
131084021|NCT02296892|471939971|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
131084022|NCT02296892|471939972|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
131084023|NCT02296892|471939973|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
131084024|NCT02296892|471939971|FG000|Overall Study|Lost to Follow-up|5|||
131084025|NCT02296892|471939972|FG001|Overall Study|Lost to Follow-up|0|||
131084026|NCT02296892|471939973|FG002|Overall Study|Lost to Follow-up|1|||
131084027|NCT01814072|471939974|FG000|Overall Study|Lost to Follow-up|2|||
131084028|NCT01814072|471939975|FG001|Overall Study|Lost to Follow-up|2|||
131084029|NCT01814072|471939976|FG002|Overall Study|Lost to Follow-up|2|||
131084030|NCT01814072|471939977|FG003|Overall Study|Lost to Follow-up|0|||
131084031|NCT01814072|471939978|FG004|Overall Study|Lost to Follow-up|2|||
131084032|NCT01814072|471939979|FG005|Overall Study|Lost to Follow-up|3|||
131084033|NCT01814072|471939980|FG006|Overall Study|Lost to Follow-up|3|||
131084034|NCT01814072|471939981|FG007|Overall Study|Lost to Follow-up|1|||
131084035|NCT01814072|471939982|FG008|Overall Study|Lost to Follow-up|2|||
131084036|NCT01814072|471939983|FG009|Overall Study|Lost to Follow-up|3|||
131084037|NCT01814072|471939984|FG010|Overall Study|Lost to Follow-up|1|||
131084038|NCT01814072|471939985|FG011|Overall Study|Lost to Follow-up|2|||
131084039|NCT01814072|471939986|FG012|Overall Study|Lost to Follow-up|2|||
131084040|NCT01814072|471939987|FG013|Overall Study|Lost to Follow-up|1|||
131084041|NCT01814072|471939988|FG014|Overall Study|Lost to Follow-up|2|||
131084042|NCT01814072|471939989|FG015|Overall Study|Lost to Follow-up|1|||
131084043|NCT01814072|471939990|FG016|Overall Study|Lost to Follow-up|3|||
131084044|NCT01814072|471939991|FG017|Overall Study|Lost to Follow-up|1|||
131084045|NCT01814072|471939992|FG018|Overall Study|Lost to Follow-up|3|||
131084046|NCT01814072|471939993|FG019|Overall Study|Lost to Follow-up|3|||
131084047|NCT01814072|471939994|FG020|Overall Study|Lost to Follow-up|2|||
131084048|NCT01814072|471939995|FG021|Overall Study|Lost to Follow-up|1|||
131084049|NCT01814072|471939996|FG022|Overall Study|Lost to Follow-up|3|||
131084050|NCT01814072|471939997|FG023|Overall Study|Lost to Follow-up|1|||
131084051|NCT01814072|471939998|FG024|Overall Study|Lost to Follow-up|4|||
131084052|NCT01814072|471939999|FG025|Overall Study|Lost to Follow-up|1|||
131084053|NCT01814072|471940000|FG026|Overall Study|Lost to Follow-up|1|||
131084054|NCT01814072|471940001|FG027|Overall Study|Lost to Follow-up|2|||
131084055|NCT01814072|471940002|FG028|Overall Study|Lost to Follow-up|3|||
131084056|NCT01814072|471940003|FG029|Overall Study|Lost to Follow-up|3|||
131084057|NCT01814072|471940004|FG030|Overall Study|Lost to Follow-up|2|||
131084058|NCT01814072|471940005|FG031|Overall Study|Lost to Follow-up|0|||
131084059|NCT01814072|471939974|FG000|Overall Study|Withdrawal by Subject|2|||
131084060|NCT01814072|471939975|FG001|Overall Study|Withdrawal by Subject|0|||
131084061|NCT01814072|471939976|FG002|Overall Study|Withdrawal by Subject|1|||
131084062|NCT01814072|471939977|FG003|Overall Study|Withdrawal by Subject|0|||
131084063|NCT01814072|471939978|FG004|Overall Study|Withdrawal by Subject|2|||
131084064|NCT01814072|471939979|FG005|Overall Study|Withdrawal by Subject|3|||
131084065|NCT01814072|471939980|FG006|Overall Study|Withdrawal by Subject|1|||
131084066|NCT01814072|471939981|FG007|Overall Study|Withdrawal by Subject|0|||
131084067|NCT01814072|471939982|FG008|Overall Study|Withdrawal by Subject|1|||
131084068|NCT01814072|471939983|FG009|Overall Study|Withdrawal by Subject|2|||
131084069|NCT01814072|471939984|FG010|Overall Study|Withdrawal by Subject|0|||
131084070|NCT01814072|471939985|FG011|Overall Study|Withdrawal by Subject|0|||
131084071|NCT01814072|471939986|FG012|Overall Study|Withdrawal by Subject|1|||
131084072|NCT01814072|471939987|FG013|Overall Study|Withdrawal by Subject|1|||
131084073|NCT01814072|471939988|FG014|Overall Study|Withdrawal by Subject|1|||
131084074|NCT01814072|471939989|FG015|Overall Study|Withdrawal by Subject|1|||
131084075|NCT01814072|471939990|FG016|Overall Study|Withdrawal by Subject|0|||
131084076|NCT01814072|471939991|FG017|Overall Study|Withdrawal by Subject|0|||
131084077|NCT01814072|471939992|FG018|Overall Study|Withdrawal by Subject|0|||
131084078|NCT01814072|471939993|FG019|Overall Study|Withdrawal by Subject|2|||
131084079|NCT01814072|471939994|FG020|Overall Study|Withdrawal by Subject|0|||
131084080|NCT01814072|471939995|FG021|Overall Study|Withdrawal by Subject|0|||
131084081|NCT01814072|471939996|FG022|Overall Study|Withdrawal by Subject|1|||
131084082|NCT01814072|471939997|FG023|Overall Study|Withdrawal by Subject|0|||
131084083|NCT01814072|471939998|FG024|Overall Study|Withdrawal by Subject|2|||
131084084|NCT01814072|471939999|FG025|Overall Study|Withdrawal by Subject|1|||
131084085|NCT01814072|471940000|FG026|Overall Study|Withdrawal by Subject|1|||
131084086|NCT01814072|471940001|FG027|Overall Study|Withdrawal by Subject|2|||
131084087|NCT01814072|471940002|FG028|Overall Study|Withdrawal by Subject|1|||
131084088|NCT01814072|471940003|FG029|Overall Study|Withdrawal by Subject|0|||
131084089|NCT01814072|471940004|FG030|Overall Study|Withdrawal by Subject|0|||
131084090|NCT01814072|471940005|FG031|Overall Study|Withdrawal by Subject|0|||
131084091|NCT00383123|471940006|FG000|Overall Study|Adverse Event|1|||
131084092|NCT00383123|471940007|FG001|Overall Study|Adverse Event|0|||
131084093|NCT00383123|471940006|FG000|Overall Study|Lost to Follow-up|68|||
131084094|NCT00383123|471940007|FG001|Overall Study|Lost to Follow-up|61|||
131084095|NCT00383123|471940006|FG000|Overall Study|Protocol Violation|5|||
131084096|NCT00383123|471940007|FG001|Overall Study|Protocol Violation|1|||
131084097|NCT00383123|471940006|FG000|Overall Study|Withdrawal by Subject|27|||
130727229|NCT02883049|470625429|FG005|Post Induction|Protocol Violation|0|||
131141510|NCT00802360|472143908|FG002|Overall Study|Other|6|||
131141511|NCT00802360|472143909|FG003|Overall Study|Other|3|||
131141512|NCT01481896|472143910|FG000|Overall Study|Lost to Follow-up|12|||
131141513|NCT01990261|472143911|FG000|Overall Study|Death Before Treatment Start|2|||
131084098|NCT00383123|471940007|FG001|Overall Study|Withdrawal by Subject|18|||
131084099|NCT00383123|471940006|FG000|Overall Study|Other reason|10|||
131084100|NCT00383123|471940007|FG001|Overall Study|Other reason|6|||
131084101|NCT03566979|471940008|FG000|Overall Study|Withdrawal by Subject|2|||
131084102|NCT03566979|471940009|FG001|Overall Study|Withdrawal by Subject|0|||
131084103|NCT03566979|471940010|FG002|Overall Study|Withdrawal by Subject|1|||
131084104|NCT03566979|471940011|FG003|Overall Study|Withdrawal by Subject|1|||
131084105|NCT03566979|471940008|FG000|Overall Study|Lost to Follow-up|2|||
131084106|NCT03566979|471940009|FG001|Overall Study|Lost to Follow-up|7|||
131084107|NCT03566979|471940010|FG002|Overall Study|Lost to Follow-up|9|||
131084108|NCT03566979|471940011|FG003|Overall Study|Lost to Follow-up|5|||
131084109|NCT03566979|471940008|FG000|Overall Study|Adverse Event|1|||
131084110|NCT03566979|471940009|FG001|Overall Study|Adverse Event|0|||
131084111|NCT03566979|471940010|FG002|Overall Study|Adverse Event|0|||
131084112|NCT03566979|471940011|FG003|Overall Study|Adverse Event|0|||
131084113|NCT01011868|471940014|FG000|After Week 18 Follow-up|Adverse Event|8|||
131084114|NCT01011868|471940015|FG001|After Week 18 Follow-up|Adverse Event|6|||
131084115|NCT01011868|471940016|FG002|After Week 18 Follow-up|Adverse Event|13|||
131084116|NCT01011868|471940014|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
131084117|NCT01011868|471940015|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
131084118|NCT01011868|471940016|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
131084119|NCT01011868|471940014|FG000|After Week 18 Follow-up|Protocol Violation|1|||
131084120|NCT01011868|471940015|FG001|After Week 18 Follow-up|Protocol Violation|1|||
131084121|NCT01011868|471940016|FG002|After Week 18 Follow-up|Protocol Violation|1|||
131084122|NCT01011868|471940014|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
131084123|NCT01011868|471940015|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
131084124|NCT01011868|471940016|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
131084125|NCT01011868|471940014|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
131084126|NCT01011868|471940015|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
131084127|NCT01011868|471940016|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
131084128|NCT01011868|471940014|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
131084129|NCT01011868|471940015|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
131084130|NCT01011868|471940016|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
131084131|NCT01011868|471940014|FG000|After Week 78 Follow-up|Adverse Event|14|||
131084132|NCT01011868|471940015|FG001|After Week 78 Follow-up|Adverse Event|18|||
131084133|NCT01011868|471940016|FG002|After Week 78 Follow-up|Adverse Event|21|||
131084134|NCT01011868|471940014|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
131084135|NCT01011868|471940015|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
131084136|NCT01011868|471940016|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
131084137|NCT01011868|471940014|FG000|After Week 78 Follow-up|Protocol Violation|9|||
131084138|NCT01011868|471940015|FG001|After Week 78 Follow-up|Protocol Violation|1|||
131084139|NCT01011868|471940016|FG002|After Week 78 Follow-up|Protocol Violation|2|||
131084140|NCT01011868|471940014|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
131084141|NCT01011868|471940015|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
131084142|NCT01011868|471940016|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
131141514|NCT01990261|472143911|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
131141515|NCT01990261|472143911|FG000|Overall Study|Death From other Causes|1|||
131084143|NCT01011868|471940014|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
131084144|NCT01011868|471940015|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
131084145|NCT01011868|471940016|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
131084146|NCT01011868|471940014|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
131084147|NCT01011868|471940015|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
131084148|NCT01011868|471940016|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
131084149|NCT02336425|471940017|FG000|Overall Study|Study terminated.|2|||
131084150|NCT02336425|471940018|FG001|Overall Study|Study terminated.|2|||
131141516|NCT01990261|472143911|FG000|Overall Study|Disease Progression (PD)|8|||
131141517|NCT01990261|472143911|FG000|Overall Study|PD Before Treatment Start|1|||
131084151|NCT02336425|471940019|FG002|Overall Study|Study terminated.|3|||
131084152|NCT02336425|471940020|FG003|Overall Study|Study terminated.|3|||
131084153|NCT00978562|471940021|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
131084154|NCT01782690|471940022|FG000|Overall Study|Not reported|7|||
131084155|NCT01782690|471940022|FG000|Overall Study|Toxicity of gemcitabine|1|||
131084156|NCT01782690|471940022|FG000|Overall Study|Toxicity of erlotinib|1|||
131084157|NCT01782690|471940022|FG000|Overall Study|Lost to Follow-up|31|||
131233562|NCT00368966|472482514|FG001|After Infant|Failed to return|1|||
131084158|NCT01782690|471940022|FG000|Overall Study|Withdrawal of informed consent|2|||
131084159|NCT01782690|471940022|FG000|Overall Study|Absent rash|9|||
131084160|NCT01782690|471940022|FG000|Overall Study|Physician Decision|13|||
131084161|NCT01782690|471940022|FG000|Overall Study|Patient's wish|21|||
131141518|NCT01990261|472143911|FG000|Overall Study|Dossier not Approved|1|||
131141519|NCT01990261|472143911|FG000|Overall Study|Lost to Follow-up|2|||
131084162|NCT01782690|471940022|FG000|Overall Study|Tumor progression|74|||
131084163|NCT01782690|471940022|FG000|Overall Study|Death|133|||
131084164|NCT01782690|471940022|FG000|Overall Study|Study completion unknown|7|||
131084165|NCT01948076|471940024|FG000|Overall Study|Withdrawal by Subject|0|||
131084166|NCT01948076|471940025|FG001|Overall Study|Withdrawal by Subject|1|||
131084167|NCT03732677|471940030|FG000|Overall Study|Terminated the study|154|||
131084168|NCT03732677|471940031|FG001|Overall Study|Terminated the study|197|||
131084169|NCT03732677|471940030|FG000|Overall Study|Continuing study off treatment|379|||
131084170|NCT03732677|471940031|FG001|Overall Study|Continuing study off treatment|333|||
131084171|NCT04013971|471940032|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
131084172|NCT04013971|471940033|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
131084173|NCT04013971|471940032|FG000|Overall Study|Missing biomechanical data|0|||
131084174|NCT04013971|471940033|FG001|Overall Study|Missing biomechanical data|1|||
131084175|NCT00344032|471940039|FG000|Overall Study|Adverse Event|0|||
131084176|NCT00344032|471940040|FG001|Overall Study|Adverse Event|1|||
131084177|NCT00344032|471940039|FG000|Overall Study|Withdrawal by Subject|6|||
131084178|NCT00344032|471940040|FG001|Overall Study|Withdrawal by Subject|2|||
131084179|NCT00344032|471940039|FG000|Overall Study|Lost to Follow-up|4|||
131084180|NCT00344032|471940040|FG001|Overall Study|Lost to Follow-up|6|||
131084181|NCT00344032|471940039|FG000|Overall Study|Physician Decision|4|||
131084182|NCT00344032|471940040|FG001|Overall Study|Physician Decision|1|||
131084183|NCT02065882|471940041|FG000|Part I: PK/PD|Screening failure|5|||
131084184|NCT02065882|471940041|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
131084185|NCT02065882|471940041|FG000|Part I: PK/PD|Adverse Event|1|||
131084186|NCT02065882|471940041|FG000|Part II: Clinical Efficacy|Screening failure|7|||
131084187|NCT02065882|471940041|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
131084188|NCT02065882|471940041|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
131084189|NCT02065882|471940041|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
131084190|NCT02065882|471940041|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
131084191|NCT02065882|471940041|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
131084192|NCT02600897|471940042|FG000|Overall Study|Death|1|||
131084193|NCT02600897|471940043|FG001|Overall Study|Death|2|||
131084194|NCT02600897|471940044|FG002|Overall Study|Death|1|||
131084195|NCT02600897|471940045|FG003|Overall Study|Death|2|||
131084196|NCT02600897|471940046|FG004|Overall Study|Death|3|||
131084197|NCT02600897|471940047|FG005|Overall Study|Death|2|||
131084198|NCT02600897|471940048|FG006|Overall Study|Death|10|||
131084199|NCT02600897|471940049|FG007|Overall Study|Death|7|||
131084200|NCT02600897|471940050|FG008|Overall Study|Death|20|||
131084201|NCT02600897|471940042|FG000|Overall Study|Lost to Follow-up|1|||
131084202|NCT02600897|471940043|FG001|Overall Study|Lost to Follow-up|0|||
131084203|NCT02600897|471940044|FG002|Overall Study|Lost to Follow-up|0|||
131084204|NCT02600897|471940045|FG003|Overall Study|Lost to Follow-up|0|||
131084205|NCT02600897|471940046|FG004|Overall Study|Lost to Follow-up|0|||
131084206|NCT02600897|471940047|FG005|Overall Study|Lost to Follow-up|0|||
131084207|NCT02600897|471940048|FG006|Overall Study|Lost to Follow-up|0|||
131084208|NCT02600897|471940049|FG007|Overall Study|Lost to Follow-up|1|||
131084209|NCT02600897|471940050|FG008|Overall Study|Lost to Follow-up|0|||
131084210|NCT02600897|471940042|FG000|Overall Study|Withdrawal by Subject|0|||
131084211|NCT02600897|471940043|FG001|Overall Study|Withdrawal by Subject|0|||
131084212|NCT02600897|471940044|FG002|Overall Study|Withdrawal by Subject|0|||
131084213|NCT02600897|471940045|FG003|Overall Study|Withdrawal by Subject|0|||
131084214|NCT02600897|471940046|FG004|Overall Study|Withdrawal by Subject|0|||
131084215|NCT02600897|471940047|FG005|Overall Study|Withdrawal by Subject|0|||
131084216|NCT02600897|471940048|FG006|Overall Study|Withdrawal by Subject|0|||
131084217|NCT02600897|471940049|FG007|Overall Study|Withdrawal by Subject|4|||
131084218|NCT02600897|471940050|FG008|Overall Study|Withdrawal by Subject|2|||
131084219|NCT02600897|471940042|FG000|Overall Study|Reason Not Specified|0|||
131084220|NCT02600897|471940043|FG001|Overall Study|Reason Not Specified|0|||
131084221|NCT02600897|471940044|FG002|Overall Study|Reason Not Specified|0|||
131084222|NCT02600897|471940045|FG003|Overall Study|Reason Not Specified|0|||
131084223|NCT02600897|471940046|FG004|Overall Study|Reason Not Specified|0|||
131084224|NCT02600897|471940047|FG005|Overall Study|Reason Not Specified|0|||
131084225|NCT02600897|471940048|FG006|Overall Study|Reason Not Specified|0|||
131084226|NCT02600897|471940049|FG007|Overall Study|Reason Not Specified|0|||
131084227|NCT02600897|471940050|FG008|Overall Study|Reason Not Specified|1|||
131084228|NCT06840769|471940051|FG000|Overall Study|Withdrawal by Subject|1|||
131084229|NCT06840769|471940052|FG001|Overall Study|Withdrawal by Subject|0|||
131084230|NCT06840769|471940053|FG002|Overall Study|Withdrawal by Subject|0|||
131084231|NCT06840769|471940054|FG003|Overall Study|Withdrawal by Subject|0|||
131084232|NCT06840769|471940055|FG004|Overall Study|Withdrawal by Subject|0|||
131084233|NCT04949802|471942211|FG000|Overall Study|Lost to Follow-up|3|||
131084234|NCT02473965|471942212|FG000|Overall Study|Adverse Event|6|||
131084235|NCT02473965|471942213|FG001|Overall Study|Adverse Event|4|||
131084236|NCT02473965|471942212|FG000|Overall Study|MG worsening|4|||
131084237|NCT02473965|471942213|FG001|Overall Study|MG worsening|1|||
131084238|NCT02473965|471942212|FG000|Overall Study|Withdrawal by Subject|2|||
131084239|NCT02473965|471942213|FG001|Overall Study|Withdrawal by Subject|3|||
131084240|NCT02473965|471942212|FG000|Overall Study|Physician Decision|0|||
131084241|NCT02473965|471942213|FG001|Overall Study|Physician Decision|2|||
131084242|NCT03192462|471942214|FG000|Overall Study|Death|13|||
131084243|NCT03192462|471942215|FG001|Overall Study|Death|11|||
131084244|NCT03192462|471942216|FG002|Overall Study|Death|9|||
131084245|NCT03192462|471942214|FG000|Overall Study|Lost to Follow-up|0|||
131084246|NCT03192462|471942215|FG001|Overall Study|Lost to Follow-up|1|||
131084247|NCT03192462|471942216|FG002|Overall Study|Lost to Follow-up|0|||
131084248|NCT03192462|471942214|FG000|Overall Study|On follow up|0|||
131084249|NCT03192462|471942215|FG001|Overall Study|On follow up|0|||
131084250|NCT03192462|471942216|FG002|Overall Study|On follow up|3|||
131084251|NCT03816761|471942217|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
131084252|NCT03816761|471942218|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
131084253|NCT03816761|471942219|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
131084254|NCT03816761|471942220|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
131084255|NCT03816761|471942221|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
131084256|NCT03816761|471942222|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
131084257|NCT03816761|471942217|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
131084258|NCT03816761|471942218|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
131084259|NCT03816761|471942219|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
131084260|NCT03816761|471942220|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
131084261|NCT03816761|471942221|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
131084262|NCT03816761|471942222|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
131084263|NCT02419417|471942223|FG000|Overall Study|Disease progression|5|||
131084264|NCT02419417|471942224|FG001|Overall Study|Disease progression|4|||
131084265|NCT02419417|471942225|FG002|Overall Study|Disease progression|13|||
131084266|NCT02419417|471942226|FG003|Overall Study|Disease progression|10|||
131084267|NCT02419417|471942227|FG004|Overall Study|Disease progression|10|||
131084268|NCT02419417|471942228|FG005|Overall Study|Disease progression|3|||
131084269|NCT02419417|471942229|FG006|Overall Study|Disease progression|4|||
131084270|NCT02419417|471942230|FG007|Overall Study|Disease progression|5|||
131084271|NCT02419417|471942231|FG008|Overall Study|Disease progression|13|||
131084272|NCT02419417|471942232|FG009|Overall Study|Disease progression|9|||
131084273|NCT02419417|471942233|FG010|Overall Study|Disease progression|0|||
131084274|NCT02419417|471942223|FG000|Overall Study|Study drug toxicity|0|||
131084275|NCT02419417|471942224|FG001|Overall Study|Study drug toxicity|0|||
131084276|NCT02419417|471942225|FG002|Overall Study|Study drug toxicity|0|||
131084277|NCT02419417|471942226|FG003|Overall Study|Study drug toxicity|0|||
131084278|NCT02419417|471942227|FG004|Overall Study|Study drug toxicity|1|||
131084279|NCT02419417|471942228|FG005|Overall Study|Study drug toxicity|0|||
131084280|NCT02419417|471942229|FG006|Overall Study|Study drug toxicity|0|||
131084281|NCT02419417|471942230|FG007|Overall Study|Study drug toxicity|0|||
131084282|NCT02419417|471942231|FG008|Overall Study|Study drug toxicity|0|||
131084283|NCT02419417|471942232|FG009|Overall Study|Study drug toxicity|0|||
131084284|NCT02419417|471942233|FG010|Overall Study|Study drug toxicity|0|||
131084285|NCT02419417|471942223|FG000|Overall Study|Adverse event unrelated to study drug|0|||
131141520|NCT04698629|472143914|FG000|Overall Study|Adverse Event|1|||
131141521|NCT00619502|472146446|FG000|Overall Study|Lost to Follow-up|8|||
131084286|NCT02419417|471942224|FG001|Overall Study|Adverse event unrelated to study drug|0|||
131084287|NCT02419417|471942225|FG002|Overall Study|Adverse event unrelated to study drug|0|||
131084288|NCT02419417|471942226|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131084289|NCT02419417|471942227|FG004|Overall Study|Adverse event unrelated to study drug|2|||
131084290|NCT02419417|471942228|FG005|Overall Study|Adverse event unrelated to study drug|1|||
131084291|NCT02419417|471942229|FG006|Overall Study|Adverse event unrelated to study drug|0|||
131084292|NCT02419417|471942230|FG007|Overall Study|Adverse event unrelated to study drug|1|||
131084293|NCT02419417|471942231|FG008|Overall Study|Adverse event unrelated to study drug|0|||
131084294|NCT02419417|471942232|FG009|Overall Study|Adverse event unrelated to study drug|0|||
131141522|NCT00619502|472146447|FG001|Overall Study|Lost to Follow-up|10|||
131141523|NCT01475734|472146448|FG000|Overall Study|Withdrawal by Subject|1|||
131141524|NCT01475734|472146449|FG001|Overall Study|Withdrawal by Subject|0|||
131141525|NCT01475734|472146448|FG000|Overall Study|Protocol Violation|1|||
131084295|NCT02419417|471942233|FG010|Overall Study|Adverse event unrelated to study drug|0|||
131141526|NCT01475734|472146449|FG001|Overall Study|Protocol Violation|0|||
131141527|NCT01475734|472146448|FG000|Overall Study|Physician Decision|0|||
131084296|NCT02419417|471942223|FG000|Overall Study|Participant request to discontinue|0|||
131084297|NCT02419417|471942224|FG001|Overall Study|Participant request to discontinue|0|||
131084298|NCT02419417|471942225|FG002|Overall Study|Participant request to discontinue|0|||
131084299|NCT02419417|471942226|FG003|Overall Study|Participant request to discontinue|0|||
131084300|NCT02419417|471942227|FG004|Overall Study|Participant request to discontinue|0|||
131084301|NCT02419417|471942228|FG005|Overall Study|Participant request to discontinue|0|||
131084302|NCT02419417|471942229|FG006|Overall Study|Participant request to discontinue|0|||
131084303|NCT02419417|471942230|FG007|Overall Study|Participant request to discontinue|0|||
131141528|NCT01475734|472146449|FG001|Overall Study|Physician Decision|1|||
131141529|NCT00771472|472146450|FG000|Overall Study|Physician Decision|2|||
131084304|NCT02419417|471942231|FG008|Overall Study|Participant request to discontinue|0|||
131084305|NCT02419417|471942232|FG009|Overall Study|Participant request to discontinue|1|||
131084306|NCT02419417|471942233|FG010|Overall Study|Participant request to discontinue|0|||
131084307|NCT02419417|471942223|FG000|Overall Study|Withdrawal by Subject|0|||
131084308|NCT02419417|471942224|FG001|Overall Study|Withdrawal by Subject|0|||
131084309|NCT02419417|471942225|FG002|Overall Study|Withdrawal by Subject|0|||
131084310|NCT02419417|471942226|FG003|Overall Study|Withdrawal by Subject|0|||
131084311|NCT02419417|471942227|FG004|Overall Study|Withdrawal by Subject|0|||
131084312|NCT02419417|471942228|FG005|Overall Study|Withdrawal by Subject|0|||
131084313|NCT02419417|471942229|FG006|Overall Study|Withdrawal by Subject|0|||
131084314|NCT02419417|471942230|FG007|Overall Study|Withdrawal by Subject|0|||
131084315|NCT02419417|471942231|FG008|Overall Study|Withdrawal by Subject|0|||
131084316|NCT02419417|471942232|FG009|Overall Study|Withdrawal by Subject|0|||
131084317|NCT02419417|471942233|FG010|Overall Study|Withdrawal by Subject|1|||
131084318|NCT01240551|471942234|FG000|Overall Study|Refused further treatment|3|||
131084319|NCT01240551|471942235|FG001|Overall Study|Refused further treatment|2|||
131084320|NCT01240551|471942234|FG000|Overall Study|Lost to Follow-up|1|||
131084321|NCT01240551|471942235|FG001|Overall Study|Lost to Follow-up|1|||
131084322|NCT00078377|471942236|FG000|Overall Study|Adverse Event|2|||
131084323|NCT00078377|471942237|FG001|Overall Study|Adverse Event|5|||
131084324|NCT00078377|471942238|FG002|Overall Study|Adverse Event|1|||
131084325|NCT00078377|471942236|FG000|Overall Study|Lack of Efficacy|2|||
131084326|NCT00078377|471942237|FG001|Overall Study|Lack of Efficacy|0|||
131084327|NCT00078377|471942238|FG002|Overall Study|Lack of Efficacy|2|||
131084328|NCT00078377|471942236|FG000|Overall Study|Lost to Follow-up|0|||
131084329|NCT00078377|471942237|FG001|Overall Study|Lost to Follow-up|1|||
131084330|NCT00078377|471942238|FG002|Overall Study|Lost to Follow-up|1|||
131084331|NCT00078377|471942236|FG000|Overall Study|Physician Decision|2|||
131084332|NCT00078377|471942237|FG001|Overall Study|Physician Decision|0|||
131084333|NCT00078377|471942238|FG002|Overall Study|Physician Decision|0|||
131084334|NCT00078377|471942236|FG000|Overall Study|Withdrawal by Subject|3|||
131084335|NCT00078377|471942237|FG001|Overall Study|Withdrawal by Subject|4|||
131084336|NCT00078377|471942238|FG002|Overall Study|Withdrawal by Subject|4|||
131084337|NCT00078377|471942236|FG000|Overall Study|Miscellaneous|2|||
131084338|NCT00078377|471942237|FG001|Overall Study|Miscellaneous|6|||
131084339|NCT00078377|471942238|FG002|Overall Study|Miscellaneous|1|||
131084340|NCT00953147|471942239|FG000|Overall Study|Adverse Event|8|||
131084341|NCT00953147|471942240|FG001|Overall Study|Adverse Event|16|||
131084342|NCT00953147|471942241|FG002|Overall Study|Adverse Event|6|||
131084343|NCT00953147|471942239|FG000|Overall Study|Protocol Violation|2|||
131084344|NCT00953147|471942240|FG001|Overall Study|Protocol Violation|8|||
131084345|NCT00953147|471942241|FG002|Overall Study|Protocol Violation|4|||
131084346|NCT00953147|471942239|FG000|Overall Study|Withdrawal by Subject|13|||
131084347|NCT00953147|471942240|FG001|Overall Study|Withdrawal by Subject|15|||
131084348|NCT00953147|471942241|FG002|Overall Study|Withdrawal by Subject|12|||
131084349|NCT00953147|471942239|FG000|Overall Study|Lost to Follow-up|8|||
131084350|NCT00953147|471942240|FG001|Overall Study|Lost to Follow-up|9|||
131084351|NCT00953147|471942241|FG002|Overall Study|Lost to Follow-up|4|||
131084352|NCT00953147|471942239|FG000|Overall Study|Physician Decision|2|||
131084353|NCT00953147|471942240|FG001|Overall Study|Physician Decision|7|||
131084354|NCT00953147|471942241|FG002|Overall Study|Physician Decision|3|||
131084355|NCT00953147|471942239|FG000|Overall Study|Other|4|||
131084356|NCT00953147|471942240|FG001|Overall Study|Other|11|||
131141530|NCT00771472|472146451|FG001|Overall Study|Physician Decision|3|||
131141531|NCT00771472|472146450|FG000|Overall Study|Progressive Disease|3|||
131141532|NCT00771472|472146451|FG001|Overall Study|Progressive Disease|1|||
131141533|NCT00771472|472146450|FG000|Overall Study|Protocol Violation|1|||
131141534|NCT00771472|472146451|FG001|Overall Study|Protocol Violation|0|||
131141535|NCT01097629|472146460|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
131141536|NCT01097629|472146461|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
131141537|NCT01097629|472146462|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
131084357|NCT00953147|471942241|FG002|Overall Study|Other|13|||
131084358|NCT01484431|471942242|FG000|Period 1: High Dose|Physician Decision|0|||
131084359|NCT01484431|471942243|FG001|Period 1: High Dose|Physician Decision|1|||
131084360|NCT01484431|471942244|FG002|Period 1: High Dose|Physician Decision|0|||
131084361|NCT01484431|471942242|FG000|Period 2|Death|0|||
131141538|NCT01097629|472146463|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131141539|NCT01097629|472146464|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131141540|NCT01097629|472146465|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131141541|NCT01097629|472146466|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131141542|NCT01097629|472146467|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131141543|NCT01097629|472146460|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
131084362|NCT01484431|471942243|FG001|Period 2|Death|1|||
131084363|NCT01484431|471942244|FG002|Period 2|Death|1|||
131084364|NCT01484431|471942242|FG000|Period 2|Physician Decision|0|||
131084365|NCT01484431|471942243|FG001|Period 2|Physician Decision|0|||
131084366|NCT01484431|471942244|FG002|Period 2|Physician Decision|1|||
131084367|NCT01484431|471942242|FG000|Period 2|Non-Compliance with Study Drug|1|||
131084368|NCT01484431|471942243|FG001|Period 2|Non-Compliance with Study Drug|0|||
131084369|NCT01484431|471942244|FG002|Period 2|Non-Compliance with Study Drug|0|||
131084370|NCT00475644|471942247|FG000|Overall Study|Protocol Violation|13|||
131084371|NCT01411241|471942248|FG000|Overall Study|Protocol Violation|0|||
131084372|NCT01411241|471942249|FG001|Overall Study|Protocol Violation|5|||
131084373|NCT01411241|471942248|FG000|Overall Study|Withdrawal by Subject|9|||
131084374|NCT01411241|471942249|FG001|Overall Study|Withdrawal by Subject|10|||
131084375|NCT01411241|471942248|FG000|Overall Study|Serious Adverse Event|0|||
131084376|NCT01411241|471942249|FG001|Overall Study|Serious Adverse Event|3|||
131084377|NCT01411241|471942248|FG000|Overall Study|Lost to Follow-up|2|||
131084378|NCT01411241|471942249|FG001|Overall Study|Lost to Follow-up|4|||
131084379|NCT02980042|471942252|FG000|Overall Study|Lost to Follow-up|5|||
131084380|NCT02980042|471942253|FG001|Overall Study|Lost to Follow-up|0|||
131084381|NCT02980042|471942252|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
131084382|NCT02980042|471942253|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
131084383|NCT01020877|471942258|FG000|Second Intervention|Withdrawal by Subject|1|||
131084384|NCT01020877|471942259|FG001|Second Intervention|Withdrawal by Subject|0|||
131084385|NCT00790400|471942260|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
131084386|NCT00790400|471942261|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
131084387|NCT00790400|471942260|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
131084388|NCT00790400|471942261|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
131084389|NCT00790400|471942260|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
131084390|NCT00790400|471942261|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
131084391|NCT00790400|471942260|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
131084392|NCT00790400|471942261|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
131084393|NCT00790400|471942260|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
131084394|NCT00790400|471942261|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
131084395|NCT00790400|471942260|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
131084396|NCT00790400|471942261|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
131084397|NCT00790400|471942260|FG000|Double-blind Period (Core Phase)|Death|1|||
131084398|NCT00790400|471942261|FG001|Double-blind Period (Core Phase)|Death|0|||
131084399|NCT00790400|471942260|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
131084400|NCT00790400|471942261|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
131084401|NCT00790400|471942260|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
131084402|NCT00790400|471942261|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
131084403|NCT00790400|471942260|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
131084404|NCT00790400|471942261|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
131084405|NCT00790400|471942260|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
131084406|NCT00790400|471942261|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
131084407|NCT00790400|471942260|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
131084408|NCT00790400|471942261|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
131084409|NCT00790400|471942260|FG000|Everolimus Period (Core or Extension)|Death|1|||
131084410|NCT00790400|471942261|FG001|Everolimus Period (Core or Extension)|Death|0|||
131084411|NCT00790400|471942260|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
131084412|NCT00790400|471942261|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
131084413|NCT00790400|471942260|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
131084414|NCT00790400|471942261|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
131084415|NCT00790400|471942260|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
131084416|NCT00790400|471942261|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
131084417|NCT00078338|471942263|FG000|Overall Study|Adverse Event|31|||
131084418|NCT00078338|471942264|FG001|Overall Study|Adverse Event|24|||
131084419|NCT00078338|471942263|FG000|Overall Study|Lost to Follow-up|17|||
131084420|NCT00078338|471942264|FG001|Overall Study|Lost to Follow-up|2|||
131084421|NCT00078338|471942263|FG000|Overall Study|Protocol Violation|2|||
131084422|NCT00078338|471942264|FG001|Overall Study|Protocol Violation|2|||
131084423|NCT00078338|471942263|FG000|Overall Study|Disease Progression|4|||
131141544|NCT01097629|472146461|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
131141545|NCT01097629|472146462|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
131141546|NCT01097629|472146463|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131141547|NCT01097629|472146464|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131141548|NCT01097629|472146465|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131084424|NCT00078338|471942264|FG001|Overall Study|Disease Progression|7|||
131084425|NCT00078338|471942263|FG000|Overall Study|Other|28|||
131084426|NCT00078338|471942264|FG001|Overall Study|Other|16|||
131084427|NCT00078338|471942263|FG000|Overall Study|Subjects randomized, but not treated|3|||
131084428|NCT00078338|471942264|FG001|Overall Study|Subjects randomized, but not treated|3|||
131084429|NCT00592293|471942265|FG000|Overall Study|Withdrawal by Subject|1|||
131084430|NCT04292470|471942266|FG000|Overall Study|Withdrawal by Subject|0|||
131084431|NCT04292470|471942267|FG001|Overall Study|Withdrawal by Subject|1|||
131084432|NCT02906020|471942281|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
131084433|NCT02906020|471942282|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
131084434|NCT02906020|471942283|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
131084435|NCT02906020|471942284|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
131084436|NCT02906020|471942285|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
131084437|NCT02906020|471942286|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
131084438|NCT02906020|471942287|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
131084439|NCT02906020|471942288|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
131084440|NCT02906020|471942289|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
131084441|NCT02906020|471942290|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
131084442|NCT02906020|471942291|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
131084443|NCT02906020|471942292|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
131084444|NCT02906020|471942293|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
131084445|NCT02906020|471942294|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
131084446|NCT02906020|471942295|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
131084447|NCT02906020|471942296|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
131084448|NCT02906020|471942281|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084449|NCT02906020|471942282|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084450|NCT02906020|471942283|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084451|NCT02906020|471942284|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084452|NCT02906020|471942285|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084453|NCT02906020|471942286|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084454|NCT02906020|471942287|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084455|NCT02906020|471942288|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084456|NCT02906020|471942289|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
131084457|NCT02906020|471942290|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
131084458|NCT02906020|471942291|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084459|NCT02906020|471942292|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084460|NCT02906020|471942293|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084461|NCT02906020|471942294|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084462|NCT02906020|471942295|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084463|NCT02906020|471942296|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
131084464|NCT02906020|471942281|FG000|Part 2: Double-blind Treatment Period|Other|0|||
131084465|NCT02906020|471942282|FG001|Part 2: Double-blind Treatment Period|Other|0|||
131084466|NCT02906020|471942283|FG002|Part 2: Double-blind Treatment Period|Other|0|||
131084467|NCT02906020|471942284|FG003|Part 2: Double-blind Treatment Period|Other|0|||
131084468|NCT02906020|471942285|FG004|Part 2: Double-blind Treatment Period|Other|0|||
131141549|NCT01097629|472146466|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131141550|NCT01097629|472146467|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131141551|NCT01097629|472146460|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
131141552|NCT01097629|472146461|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
131141553|NCT01097629|472146462|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
131141554|NCT01097629|472146463|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131141555|NCT01097629|472146464|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131141556|NCT01097629|472146465|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131141557|NCT01097629|472146466|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131141558|NCT01097629|472146467|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131141559|NCT01097629|472146460|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
131141560|NCT01097629|472146461|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
131141561|NCT01097629|472146462|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
131141562|NCT01097629|472146463|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131141563|NCT01097629|472146464|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131141564|NCT01097629|472146465|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131141565|NCT01097629|472146466|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131141566|NCT01097629|472146467|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131141567|NCT01097629|472146460|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
131141568|NCT01097629|472146461|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
131141569|NCT01097629|472146462|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
131141570|NCT01097629|472146463|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131141571|NCT01097629|472146464|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131141572|NCT01097629|472146465|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131141573|NCT01097629|472146466|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131141574|NCT01097629|472146467|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131141575|NCT01097629|472146460|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
131141576|NCT01097629|472146461|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
131141577|NCT01097629|472146462|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131233563|NCT00368966|472482513|FG000|After Infant|Adverse Event|1|||
131084469|NCT02906020|471942286|FG005|Part 2: Double-blind Treatment Period|Other|0|||
131084470|NCT02906020|471942287|FG006|Part 2: Double-blind Treatment Period|Other|0|||
131084471|NCT02906020|471942288|FG007|Part 2: Double-blind Treatment Period|Other|0|||
131084472|NCT02906020|471942289|FG008|Part 2: Double-blind Treatment Period|Other|6|||
131084473|NCT02906020|471942290|FG009|Part 2: Double-blind Treatment Period|Other|10|||
131084474|NCT02906020|471942291|FG010|Part 2: Double-blind Treatment Period|Other|0|||
131084475|NCT02906020|471942292|FG011|Part 2: Double-blind Treatment Period|Other|0|||
131084476|NCT02906020|471942293|FG012|Part 2: Double-blind Treatment Period|Other|0|||
131084477|NCT02906020|471942294|FG013|Part 2: Double-blind Treatment Period|Other|0|||
131084478|NCT02906020|471942295|FG014|Part 2: Double-blind Treatment Period|Other|0|||
131084479|NCT02906020|471942296|FG015|Part 2: Double-blind Treatment Period|Other|0|||
131084480|NCT02906020|471942281|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084481|NCT02906020|471942282|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084482|NCT02906020|471942283|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084483|NCT02906020|471942284|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084484|NCT02906020|471942285|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084485|NCT02906020|471942286|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084486|NCT02906020|471942287|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084487|NCT02906020|471942288|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084488|NCT02906020|471942289|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084489|NCT02906020|471942290|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084490|NCT02906020|471942291|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084491|NCT02906020|471942292|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084492|NCT02906020|471942293|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
131084493|NCT02906020|471942294|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
131084494|NCT02906020|471942295|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084495|NCT02906020|471942296|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
131084496|NCT02906020|471942281|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084497|NCT02906020|471942282|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084498|NCT02906020|471942283|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084499|NCT02906020|471942284|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084500|NCT02906020|471942285|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084501|NCT02906020|471942286|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084502|NCT02906020|471942287|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084503|NCT02906020|471942288|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084504|NCT02906020|471942289|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084505|NCT02906020|471942290|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084506|NCT02906020|471942291|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084507|NCT02906020|471942292|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084508|NCT02906020|471942293|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
131084509|NCT02906020|471942294|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
131084510|NCT02906020|471942295|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
131084511|NCT02906020|471942296|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
131084512|NCT02906020|471942281|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084513|NCT02906020|471942282|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084514|NCT02906020|471942283|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084515|NCT02906020|471942284|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084516|NCT02906020|471942285|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084517|NCT02906020|471942286|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084518|NCT02906020|471942287|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084519|NCT02906020|471942288|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084520|NCT02906020|471942289|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131233564|NCT00368966|472482514|FG001|After Infant|Adverse Event|2|||
131233565|NCT00368966|472482513|FG000|After Infant|Withdrawal by Subject|1|||
131084521|NCT02906020|471942290|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084522|NCT02906020|471942291|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084523|NCT02906020|471942292|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084524|NCT02906020|471942293|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
131084525|NCT02906020|471942294|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
131084526|NCT02906020|471942295|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084527|NCT02906020|471942296|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
131084528|NCT02906020|471942281|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084529|NCT02906020|471942282|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084530|NCT02906020|471942283|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084531|NCT02906020|471942284|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084532|NCT02906020|471942285|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084533|NCT02906020|471942286|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084534|NCT02906020|471942287|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084535|NCT02906020|471942288|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084536|NCT02906020|471942289|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084537|NCT02906020|471942290|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084538|NCT02906020|471942291|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084539|NCT02906020|471942292|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084540|NCT02906020|471942293|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
131084541|NCT02906020|471942294|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
131084542|NCT02906020|471942295|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084543|NCT02906020|471942296|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
131084544|NCT02906020|471942281|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084545|NCT02906020|471942282|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084546|NCT02906020|471942283|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084547|NCT02906020|471942284|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084548|NCT02906020|471942285|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084549|NCT02906020|471942286|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084550|NCT02906020|471942287|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084551|NCT02906020|471942288|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084552|NCT02906020|471942289|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084553|NCT02906020|471942290|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084554|NCT02906020|471942291|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084555|NCT02906020|471942292|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
131084556|NCT02906020|471942293|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
131084557|NCT02906020|471942294|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
131084558|NCT02906020|471942295|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
131084559|NCT02906020|471942296|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
131084560|NCT02906020|471942281|FG000|Part 2: Long-term Follow-up Period|Other|0|||
131084561|NCT02906020|471942282|FG001|Part 2: Long-term Follow-up Period|Other|0|||
131084562|NCT02906020|471942283|FG002|Part 2: Long-term Follow-up Period|Other|0|||
131084563|NCT02906020|471942284|FG003|Part 2: Long-term Follow-up Period|Other|0|||
131084564|NCT02906020|471942285|FG004|Part 2: Long-term Follow-up Period|Other|0|||
131084565|NCT02906020|471942286|FG005|Part 2: Long-term Follow-up Period|Other|0|||
131084566|NCT02906020|471942287|FG006|Part 2: Long-term Follow-up Period|Other|0|||
131084567|NCT02906020|471942288|FG007|Part 2: Long-term Follow-up Period|Other|0|||
131084568|NCT02906020|471942289|FG008|Part 2: Long-term Follow-up Period|Other|0|||
131084569|NCT02906020|471942290|FG009|Part 2: Long-term Follow-up Period|Other|0|||
131084570|NCT02906020|471942291|FG010|Part 2: Long-term Follow-up Period|Other|0|||
131084571|NCT02906020|471942292|FG011|Part 2: Long-term Follow-up Period|Other|0|||
131084572|NCT02906020|471942293|FG012|Part 2: Long-term Follow-up Period|Other|13|||
131084573|NCT02906020|471942294|FG013|Part 2: Long-term Follow-up Period|Other|8|||
131084574|NCT02906020|471942295|FG014|Part 2: Long-term Follow-up Period|Other|3|||
131084575|NCT02906020|471942296|FG015|Part 2: Long-term Follow-up Period|Other|2|||
131084576|NCT01375673|471942297|FG000|Overall Study|Withdrawal by Subject|0|||
131084577|NCT01375673|471942298|FG001|Overall Study|Withdrawal by Subject|1|||
131084578|NCT02179177|471942299|FG000|Overall Study|Lost to Follow-up|1|||
131084579|NCT02179177|471942300|FG001|Overall Study|Lost to Follow-up|1|||
131084580|NCT02179177|471942299|FG000|Overall Study|Withdrawal by Subject|1|||
131084581|NCT02179177|471942300|FG001|Overall Study|Withdrawal by Subject|1|||
131084582|NCT02153905|471942304|FG000|Overall Study|Death|1|||
131084583|NCT02153905|471942305|FG001|Overall Study|Death|0|||
131084584|NCT01516749|471942310|FG000|Active Therapy|Lost to Follow-up|1|||
131084585|NCT01516749|471942310|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
131084586|NCT00351377|471942311|FG000|Overall Study|Adverse Event|5|||
131084587|NCT00351377|471942311|FG000|Overall Study|Death|1|||
131084588|NCT00351377|471942311|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131084589|NCT01607879|471942312|FG000|Overall Study|Death|1|||
131084590|NCT01607879|471942313|FG001|Overall Study|Death|0|||
131084591|NCT03994731|471942314|FG000|Pegloticase + IMM Period|Death|2|||
131084592|NCT03994731|471942315|FG001|Pegloticase + IMM Period|Death|0|||
131084593|NCT03994731|471942314|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
131084594|NCT03994731|471942315|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
131141578|NCT01097629|472146463|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131141579|NCT01097629|472146464|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131084595|NCT03994731|471942314|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
131084596|NCT03994731|471942315|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
131084597|NCT00609947|471942320|FG000|Overall Study|Death|1|||
131084598|NCT00790205|471942321|FG000|Overall Study|Lost to Follow-up|61|||
131084599|NCT00790205|471942322|FG001|Overall Study|Lost to Follow-up|71|||
131141580|NCT01097629|472146465|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131084600|NCT00790205|471942321|FG000|Overall Study|Withdrawal by Subject|299|||
131084601|NCT00790205|471942322|FG001|Overall Study|Withdrawal by Subject|363|||
131084602|NCT01304498|471942323|FG000|Overall Study|Adverse Event|1|||
131084603|NCT01304498|471942324|FG001|Overall Study|Adverse Event|1|||
131084604|NCT01304498|471942323|FG000|Overall Study|Withdrawal by Subject|2|||
131084605|NCT01304498|471942324|FG001|Overall Study|Withdrawal by Subject|3|||
131084606|NCT01304498|471942323|FG000|Overall Study|Protocol Violation|1|||
131084607|NCT01304498|471942324|FG001|Overall Study|Protocol Violation|0|||
131084608|NCT01304498|471942323|FG000|Overall Study|Lost to Follow-up|2|||
131084609|NCT01304498|471942324|FG001|Overall Study|Lost to Follow-up|1|||
131084610|NCT02643628|471942325|FG000|Overall Study|Lost to Follow-up|1|||
131084611|NCT02643628|471942326|FG001|Overall Study|Lost to Follow-up|4|||
131084612|NCT02643628|471942325|FG000|Overall Study|Withdrawal by Subject|0|||
131084613|NCT02643628|471942326|FG001|Overall Study|Withdrawal by Subject|1|||
131084614|NCT02643628|471942325|FG000|Overall Study|Relocated out of state|0|||
131084615|NCT02643628|471942326|FG001|Overall Study|Relocated out of state|1|||
131233566|NCT00368966|472482514|FG001|After Infant|Withdrawal by Subject|1|||
131233567|NCT00368966|472482513|FG000|After Infant|Death|1|||
131084616|NCT01834586|471942335|FG000|Overall Study|Adverse Event|1|||
131084617|NCT01667549|471942336|FG000|Overall Study|Withdrawal by Subject|3|||
131084618|NCT01667549|471942337|FG001|Overall Study|Withdrawal by Subject|5|||
131084619|NCT01667549|471942338|FG002|Overall Study|Withdrawal by Subject|7|||
131084620|NCT01667549|471942339|FG003|Overall Study|Withdrawal by Subject|6|||
131084621|NCT01667549|471942340|FG004|Overall Study|Withdrawal by Subject|1|||
131084622|NCT02844777|471942341|FG000|Overall Study|Withdrawal by Subject|2|||
131084623|NCT02844777|471942342|FG001|Overall Study|Withdrawal by Subject|0|||
131084624|NCT02844777|471942343|FG002|Overall Study|Withdrawal by Subject|0|||
131084625|NCT04092452|471942344|FG000|Overall Study|Adverse Event|1|||
131084626|NCT04092452|471942345|FG001|Overall Study|Adverse Event|3|||
131084627|NCT04092452|471942346|FG002|Overall Study|Adverse Event|3|||
131084628|NCT04092452|471942347|FG003|Overall Study|Adverse Event|7|||
131084629|NCT04092452|471942344|FG000|Overall Study|Lack of Efficacy|1|||
131084630|NCT04092452|471942345|FG001|Overall Study|Lack of Efficacy|1|||
131084631|NCT04092452|471942346|FG002|Overall Study|Lack of Efficacy|1|||
131084632|NCT04092452|471942347|FG003|Overall Study|Lack of Efficacy|0|||
131084633|NCT04092452|471942344|FG000|Overall Study|Lost to Follow-up|4|||
131084634|NCT04092452|471942345|FG001|Overall Study|Lost to Follow-up|3|||
131084635|NCT04092452|471942346|FG002|Overall Study|Lost to Follow-up|5|||
131084636|NCT04092452|471942347|FG003|Overall Study|Lost to Follow-up|1|||
131084637|NCT04092452|471942344|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131084638|NCT04092452|471942345|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131084639|NCT04092452|471942346|FG002|Overall Study|Non-Compliance With Study Drug|1|||
131084640|NCT04092452|471942347|FG003|Overall Study|Non-Compliance With Study Drug|1|||
131084641|NCT04092452|471942344|FG000|Overall Study|Physician Decision|1|||
131084642|NCT04092452|471942345|FG001|Overall Study|Physician Decision|0|||
131084643|NCT04092452|471942346|FG002|Overall Study|Physician Decision|1|||
131084644|NCT04092452|471942347|FG003|Overall Study|Physician Decision|0|||
131084645|NCT04092452|471942344|FG000|Overall Study|Pregnancy|2|||
131084646|NCT04092452|471942345|FG001|Overall Study|Pregnancy|0|||
131084647|NCT04092452|471942346|FG002|Overall Study|Pregnancy|0|||
131084648|NCT04092452|471942347|FG003|Overall Study|Pregnancy|0|||
131084649|NCT04092452|471942344|FG000|Overall Study|Protocol Deviation|1|||
131084650|NCT04092452|471942345|FG001|Overall Study|Protocol Deviation|0|||
131084651|NCT04092452|471942346|FG002|Overall Study|Protocol Deviation|0|||
131084652|NCT04092452|471942347|FG003|Overall Study|Protocol Deviation|0|||
131084653|NCT04092452|471942344|FG000|Overall Study|Withdrawal by Subject|3|||
131084654|NCT04092452|471942345|FG001|Overall Study|Withdrawal by Subject|10|||
131084655|NCT04092452|471942346|FG002|Overall Study|Withdrawal by Subject|3|||
131084656|NCT04092452|471942347|FG003|Overall Study|Withdrawal by Subject|5|||
131084657|NCT04092452|471942344|FG000|Overall Study|Other|0|||
131084658|NCT04092452|471942345|FG001|Overall Study|Other|0|||
131084659|NCT04092452|471942346|FG002|Overall Study|Other|1|||
131084660|NCT04092452|471942347|FG003|Overall Study|Other|2|||
131084661|NCT02127125|471942348|FG000|Overall Study|Lost to Follow-up|0|||
131084662|NCT02127125|471942349|FG001|Overall Study|Lost to Follow-up|0|||
131084663|NCT02127125|471942350|FG002|Overall Study|Lost to Follow-up|0|||
131084664|NCT02127125|471942351|FG003|Overall Study|Lost to Follow-up|0|||
131084665|NCT02127125|471942352|FG004|Overall Study|Lost to Follow-up|2|||
131084666|NCT02127125|471942353|FG005|Overall Study|Lost to Follow-up|1|||
131233568|NCT00368966|472482514|FG001|After Infant|Death|0|||
131084667|NCT02127125|471942354|FG006|Overall Study|Lost to Follow-up|0|||
131233569|NCT00368966|472482513|FG000|After Infant|Lost to Follow-up|0|||
131084668|NCT02127125|471942355|FG007|Overall Study|Lost to Follow-up|0|||
131084669|NCT02127125|471942356|FG008|Overall Study|Lost to Follow-up|0|||
131084670|NCT02127125|471942348|FG000|Overall Study|Withdrawal by Subject|0|||
131084671|NCT02127125|471942349|FG001|Overall Study|Withdrawal by Subject|0|||
131084672|NCT02127125|471942350|FG002|Overall Study|Withdrawal by Subject|0|||
131084673|NCT02127125|471942351|FG003|Overall Study|Withdrawal by Subject|1|||
131233570|NCT00368966|472482514|FG001|After Infant|Lost to Follow-up|1|||
131084674|NCT02127125|471942352|FG004|Overall Study|Withdrawal by Subject|0|||
131084675|NCT02127125|471942353|FG005|Overall Study|Withdrawal by Subject|0|||
131084676|NCT02127125|471942354|FG006|Overall Study|Withdrawal by Subject|0|||
131084677|NCT02127125|471942355|FG007|Overall Study|Withdrawal by Subject|0|||
131084678|NCT02127125|471942356|FG008|Overall Study|Withdrawal by Subject|0|||
131084679|NCT02127125|471942348|FG000|Overall Study|Physician Decision|0|||
131084680|NCT02127125|471942349|FG001|Overall Study|Physician Decision|0|||
131084681|NCT02127125|471942350|FG002|Overall Study|Physician Decision|1|||
131084682|NCT02127125|471942351|FG003|Overall Study|Physician Decision|0|||
131084683|NCT02127125|471942352|FG004|Overall Study|Physician Decision|1|||
131084684|NCT02127125|471942353|FG005|Overall Study|Physician Decision|2|||
131084685|NCT02127125|471942354|FG006|Overall Study|Physician Decision|0|||
131084686|NCT02127125|471942355|FG007|Overall Study|Physician Decision|0|||
131084687|NCT02127125|471942356|FG008|Overall Study|Physician Decision|0|||
131084688|NCT02975102|471942358|FG000|Overall Study|Adverse Event|2|||
131084689|NCT02975102|471942359|FG001|Overall Study|Adverse Event|1|||
131084690|NCT01727505|471942360|FG000|First 24 Hours|Adverse Event|0|||
131084691|NCT01727505|471942361|FG001|First 24 Hours|Adverse Event|1|||
131084692|NCT01727505|471942360|FG000|Second 24 Hours|Missing data|0|||
131084693|NCT01727505|471942361|FG001|Second 24 Hours|Missing data|1|||
131084694|NCT01441635|471942365|FG000|Overall Study|Adverse Event|4|||
131084695|NCT01441635|471942366|FG001|Overall Study|Adverse Event|3|||
131084696|NCT01441635|471942367|FG002|Overall Study|Adverse Event|1|||
131084697|NCT01441635|471942368|FG003|Overall Study|Adverse Event|5|||
131084698|NCT01441635|471942369|FG004|Overall Study|Adverse Event|1|||
131084699|NCT01441635|471942370|FG005|Overall Study|Adverse Event|2|||
131084700|NCT01441635|471942371|FG006|Overall Study|Adverse Event|2|||
131084701|NCT01441635|471942372|FG007|Overall Study|Adverse Event|2|||
131084702|NCT01441635|471942373|FG008|Overall Study|Adverse Event|1|||
131084703|NCT01441635|471942374|FG009|Overall Study|Adverse Event|0|||
131084704|NCT01441635|471942365|FG000|Overall Study|Withdrawal by Subject|1|||
131084705|NCT01441635|471942366|FG001|Overall Study|Withdrawal by Subject|1|||
131084706|NCT01441635|471942367|FG002|Overall Study|Withdrawal by Subject|0|||
131084707|NCT01441635|471942368|FG003|Overall Study|Withdrawal by Subject|1|||
131084708|NCT01441635|471942369|FG004|Overall Study|Withdrawal by Subject|0|||
131084709|NCT01441635|471942370|FG005|Overall Study|Withdrawal by Subject|0|||
131084710|NCT01441635|471942371|FG006|Overall Study|Withdrawal by Subject|2|||
131084711|NCT01441635|471942372|FG007|Overall Study|Withdrawal by Subject|0|||
131084712|NCT01441635|471942373|FG008|Overall Study|Withdrawal by Subject|1|||
131084713|NCT01441635|471942374|FG009|Overall Study|Withdrawal by Subject|1|||
131084714|NCT01441635|471942365|FG000|Overall Study|Lost to Follow-up|0|||
131084715|NCT01441635|471942366|FG001|Overall Study|Lost to Follow-up|1|||
131084716|NCT01441635|471942367|FG002|Overall Study|Lost to Follow-up|1|||
131084717|NCT01441635|471942368|FG003|Overall Study|Lost to Follow-up|1|||
131084718|NCT01441635|471942369|FG004|Overall Study|Lost to Follow-up|1|||
131084719|NCT01441635|471942370|FG005|Overall Study|Lost to Follow-up|3|||
131084720|NCT01441635|471942371|FG006|Overall Study|Lost to Follow-up|1|||
131084721|NCT01441635|471942372|FG007|Overall Study|Lost to Follow-up|1|||
131084722|NCT01441635|471942373|FG008|Overall Study|Lost to Follow-up|0|||
131084723|NCT01441635|471942374|FG009|Overall Study|Lost to Follow-up|1|||
131084724|NCT01441635|471942365|FG000|Overall Study|Noncompliance|0|||
131084725|NCT01441635|471942366|FG001|Overall Study|Noncompliance|1|||
131141581|NCT01097629|472146466|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131141582|NCT01097629|472146467|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131141583|NCT01097629|472146460|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
131141584|NCT01097629|472146461|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
131141585|NCT01097629|472146462|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
131141586|NCT01097629|472146463|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131141587|NCT01097629|472146464|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131141588|NCT01097629|472146465|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131141589|NCT01097629|472146466|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131141590|NCT01097629|472146467|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131141591|NCT01097629|472146460|FG000|DB RO Phase|Withdrawal by Subject|0|||
131141592|NCT01097629|472146461|FG001|DB RO Phase|Withdrawal by Subject|0|||
131141593|NCT01097629|472146462|FG002|DB RO Phase|Withdrawal by Subject|0|||
131141594|NCT01097629|472146463|FG003|DB RO Phase|Withdrawal by Subject|0|||
131141595|NCT01097629|472146464|FG004|DB RO Phase|Withdrawal by Subject|0|||
131141596|NCT01097629|472146465|FG005|DB RO Phase|Withdrawal by Subject|0|||
131084726|NCT01441635|471942367|FG002|Overall Study|Noncompliance|0|||
131141597|NCT01097629|472146466|FG006|DB RO Phase|Withdrawal by Subject|0|||
131084727|NCT01441635|471942368|FG003|Overall Study|Noncompliance|0|||
131084728|NCT01441635|471942369|FG004|Overall Study|Noncompliance|0|||
131084729|NCT01441635|471942370|FG005|Overall Study|Noncompliance|0|||
131084730|NCT01441635|471942371|FG006|Overall Study|Noncompliance|1|||
131084731|NCT01441635|471942372|FG007|Overall Study|Noncompliance|0|||
131084732|NCT01441635|471942373|FG008|Overall Study|Noncompliance|0|||
131084733|NCT01441635|471942374|FG009|Overall Study|Noncompliance|0|||
131084734|NCT01441635|471942365|FG000|Overall Study|Surgery or Invasive Intervention|0|||
131084735|NCT01441635|471942366|FG001|Overall Study|Surgery or Invasive Intervention|0|||
131084736|NCT01441635|471942367|FG002|Overall Study|Surgery or Invasive Intervention|1|||
131084737|NCT01441635|471942368|FG003|Overall Study|Surgery or Invasive Intervention|0|||
131084738|NCT01441635|471942369|FG004|Overall Study|Surgery or Invasive Intervention|0|||
131084739|NCT01441635|471942370|FG005|Overall Study|Surgery or Invasive Intervention|0|||
131084740|NCT01441635|471942371|FG006|Overall Study|Surgery or Invasive Intervention|0|||
131084741|NCT01441635|471942372|FG007|Overall Study|Surgery or Invasive Intervention|0|||
131084742|NCT01441635|471942373|FG008|Overall Study|Surgery or Invasive Intervention|0|||
131084743|NCT01441635|471942374|FG009|Overall Study|Surgery or Invasive Intervention|0|||
131084744|NCT01441635|471942365|FG000|Overall Study|Received Exclusionary Medication|1|||
131084745|NCT01441635|471942366|FG001|Overall Study|Received Exclusionary Medication|0|||
131084746|NCT01441635|471942367|FG002|Overall Study|Received Exclusionary Medication|0|||
131084747|NCT01441635|471942368|FG003|Overall Study|Received Exclusionary Medication|0|||
131141598|NCT01097629|472146467|FG007|DB RO Phase|Withdrawal by Subject|1|||
131141599|NCT01097629|472146460|FG000|DB RO Phase|Protocol Violation|0|||
131141600|NCT01097629|472146461|FG001|DB RO Phase|Protocol Violation|0|||
131141601|NCT01097629|472146462|FG002|DB RO Phase|Protocol Violation|0|||
131233571|NCT00368966|472482513|FG000|Toddler Dose|Withdrawal by Subject|1|||
131233572|NCT00368966|472482514|FG001|Toddler Dose|Withdrawal by Subject|1|||
131233573|NCT00368966|472482513|FG000|Toddler Dose|Lost to Follow-up|0|||
131233574|NCT00368966|472482514|FG001|Toddler Dose|Lost to Follow-up|2|||
131233575|NCT02866175|472482515|FG000|Overall Study|Adverse Event|56|||
131233576|NCT02866175|472482516|FG001|Overall Study|Adverse Event|54|||
131233577|NCT02866175|472482515|FG000|Overall Study|Withdrawal by Subject|31|||
131233578|NCT02866175|472482516|FG001|Overall Study|Withdrawal by Subject|52|||
131233579|NCT02866175|472482515|FG000|Overall Study|Death|30|||
131233580|NCT02866175|472482516|FG001|Overall Study|Death|23|||
131233581|NCT02866175|472482515|FG000|Overall Study|Other|7|||
131233582|NCT02866175|472482516|FG001|Overall Study|Other|14|||
131233583|NCT02866175|472482515|FG000|Overall Study|Progressive disease|1|||
131233584|NCT02866175|472482516|FG001|Overall Study|Progressive disease|1|||
131233585|NCT02866175|472482515|FG000|Overall Study|Lost to Follow-up|2|||
131233586|NCT02866175|472482516|FG001|Overall Study|Lost to Follow-up|0|||
131233587|NCT02866175|472482515|FG000|Overall Study|Lack of Efficacy|0|||
131233588|NCT02866175|472482516|FG001|Overall Study|Lack of Efficacy|1|||
131233589|NCT02866175|472482515|FG000|Overall Study|Physician Decision|3|||
131233590|NCT02866175|472482516|FG001|Overall Study|Physician Decision|15|||
131233591|NCT02866175|472482515|FG000|Overall Study|Did not receive treatment|5|||
131233592|NCT02866175|472482516|FG001|Overall Study|Did not receive treatment|15|||
131233593|NCT00662025|472482518|FG000|Overall Study|Objective progression or relapse|51|||
131233594|NCT00662025|472482518|FG000|Overall Study|Adverse Event|7|||
131233595|NCT00662025|472482518|FG000|Overall Study|Withdrawal by Subject|1|||
131233596|NCT00662025|472482518|FG000|Overall Study|Results of other clinical study|2|||
131233597|NCT00662025|472482518|FG000|Overall Study|Target lesion cannot be evaluated|1|||
131233598|NCT00662025|472482518|FG000|Overall Study|Domestic circumstances|1|||
131233599|NCT00760383|472482519|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
131233600|NCT00760383|472482520|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
131233601|NCT00626925|472482521|FG000|Overall Study|Lost to Follow-up|1|||
131233602|NCT00626925|472482522|FG001|Overall Study|Lost to Follow-up|2|||
131233603|NCT00626925|472482521|FG000|Overall Study|relapse|1|||
131233604|NCT00626925|472482522|FG001|Overall Study|relapse|0|||
131233605|NCT00626925|472482521|FG000|Overall Study|Adverse effect|6|||
131233606|NCT00626925|472482522|FG001|Overall Study|Adverse effect|2|||
131233607|NCT00626925|472482521|FG000|Overall Study|Lack of Efficacy|1|||
131233608|NCT00626925|472482522|FG001|Overall Study|Lack of Efficacy|4|||
131141602|NCT01097629|472146463|FG003|DB RO Phase|Protocol Violation|1|||
131141603|NCT01097629|472146464|FG004|DB RO Phase|Protocol Violation|0|||
131141604|NCT01097629|472146465|FG005|DB RO Phase|Protocol Violation|1|||
131141605|NCT01097629|472146466|FG006|DB RO Phase|Protocol Violation|1|||
131141606|NCT01097629|472146467|FG007|DB RO Phase|Protocol Violation|0|||
131141607|NCT01097629|472146460|FG000|DB RO Phase|Lost to Follow-up|0|||
131141608|NCT01097629|472146461|FG001|DB RO Phase|Lost to Follow-up|0|||
131233609|NCT00626925|472482521|FG000|Overall Study|Time constraints|3|||
131233610|NCT00626925|472482522|FG001|Overall Study|Time constraints|1|||
131141609|NCT01097629|472146462|FG002|DB RO Phase|Lost to Follow-up|0|||
131141610|NCT01097629|472146463|FG003|DB RO Phase|Lost to Follow-up|0|||
131141611|NCT01097629|472146464|FG004|DB RO Phase|Lost to Follow-up|0|||
131141612|NCT01097629|472146465|FG005|DB RO Phase|Lost to Follow-up|0|||
131233611|NCT01215942|472482527|FG000|Treatment Period|Adverse Event|15|||
131233612|NCT01215942|472482528|FG001|Treatment Period|Adverse Event|26|||
131233613|NCT01215942|472482527|FG000|Treatment Period|Death|2|||
131233614|NCT01215942|472482528|FG001|Treatment Period|Death|4|||
131233615|NCT01215942|472482527|FG000|Treatment Period|Lack of Efficacy|23|||
131233616|NCT01215942|472482528|FG001|Treatment Period|Lack of Efficacy|62|||
131233617|NCT01215942|472482527|FG000|Treatment Period|Lost to Follow-up|3|||
131233618|NCT01215942|472482528|FG001|Treatment Period|Lost to Follow-up|4|||
131233619|NCT01215942|472482527|FG000|Treatment Period|Withdrawal by Subject|17|||
131084748|NCT01441635|471942369|FG004|Overall Study|Received Exclusionary Medication|0|||
131084749|NCT01441635|471942370|FG005|Overall Study|Received Exclusionary Medication|0|||
131084750|NCT01441635|471942371|FG006|Overall Study|Received Exclusionary Medication|0|||
131084751|NCT01441635|471942372|FG007|Overall Study|Received Exclusionary Medication|0|||
131084752|NCT01441635|471942373|FG008|Overall Study|Received Exclusionary Medication|0|||
131084753|NCT01441635|471942374|FG009|Overall Study|Received Exclusionary Medication|0|||
131084754|NCT01441635|471942365|FG000|Overall Study|Other|0|||
131084755|NCT01441635|471942366|FG001|Overall Study|Other|0|||
131084756|NCT01441635|471942367|FG002|Overall Study|Other|0|||
131084757|NCT01441635|471942368|FG003|Overall Study|Other|0|||
131084758|NCT01441635|471942369|FG004|Overall Study|Other|0|||
131084759|NCT01441635|471942370|FG005|Overall Study|Other|0|||
131084760|NCT01441635|471942371|FG006|Overall Study|Other|0|||
131084761|NCT01441635|471942372|FG007|Overall Study|Other|1|||
131084762|NCT01441635|471942373|FG008|Overall Study|Other|0|||
131084763|NCT01441635|471942374|FG009|Overall Study|Other|0|||
131084764|NCT01358331|471942375|FG000|Overall Study|Lost to Follow-up|0|||
131084765|NCT01358331|471942376|FG001|Overall Study|Lost to Follow-up|0|||
131084766|NCT01358331|471942377|FG002|Overall Study|Lost to Follow-up|0|||
131084767|NCT01358331|471942378|FG003|Overall Study|Lost to Follow-up|1|||
131084768|NCT01358331|471942379|FG004|Overall Study|Lost to Follow-up|0|||
131084769|NCT01358331|471942380|FG005|Overall Study|Lost to Follow-up|0|||
131084770|NCT01358331|471942375|FG000|Overall Study|Withdrawal by Subject|0|||
131084771|NCT01358331|471942376|FG001|Overall Study|Withdrawal by Subject|0|||
131084772|NCT01358331|471942377|FG002|Overall Study|Withdrawal by Subject|0|||
131084773|NCT01358331|471942378|FG003|Overall Study|Withdrawal by Subject|1|||
131084774|NCT01358331|471942379|FG004|Overall Study|Withdrawal by Subject|1|||
131084775|NCT01358331|471942380|FG005|Overall Study|Withdrawal by Subject|1|||
131084776|NCT01358331|471942375|FG000|Overall Study|Adverse Events|1|||
131084777|NCT01358331|471942376|FG001|Overall Study|Adverse Events|1|||
131084778|NCT01358331|471942377|FG002|Overall Study|Adverse Events|1|||
131084779|NCT01358331|471942378|FG003|Overall Study|Adverse Events|0|||
131084780|NCT01358331|471942379|FG004|Overall Study|Adverse Events|1|||
131084781|NCT01358331|471942380|FG005|Overall Study|Adverse Events|5|||
131233620|NCT01215942|472482528|FG001|Treatment Period|Withdrawal by Subject|40|||
131233621|NCT01215942|472482527|FG000|Treatment Period|Physician Decision|5|||
131233622|NCT01215942|472482528|FG001|Treatment Period|Physician Decision|5|||
131233623|NCT01215942|472482527|FG000|Treatment Period|Protocol Violation|0|||
131233624|NCT01215942|472482528|FG001|Treatment Period|Protocol Violation|1|||
131233625|NCT01215942|472482527|FG000|Treatment Period|Sponsor Decision|349|||
131233626|NCT01215942|472482528|FG001|Treatment Period|Sponsor Decision|530|||
131233627|NCT01215942|472482527|FG000|Post-Treatment Follow-Up Period|Death|0|||
131233628|NCT01215942|472482528|FG001|Post-Treatment Follow-Up Period|Death|1|||
131233629|NCT01215942|472482527|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
130780269|NCT02600923|470821475|FG000|Overall Study|Death|10|||
131141613|NCT01097629|472146466|FG006|DB RO Phase|Lost to Follow-up|2|||
131141614|NCT01097629|472146467|FG007|DB RO Phase|Lost to Follow-up|0|||
131141615|NCT02613208|472146468|FG000|Overall Study|Withdrawal by Subject|1|||
131141616|NCT02613208|472146468|FG000|Overall Study|Change of address|2|||
131141617|NCT02613208|472146468|FG000|Overall Study|Physician Decision|2|||
131141618|NCT02613208|472146468|FG000|Overall Study|Lost to Follow-up|5|||
131141619|NCT02613208|472146468|FG000|Overall Study|Death|37|||
131141620|NCT02472847|472146471|FG000|Overall Study|Withdrawal by Subject|1|||
131141621|NCT02472847|472146472|FG001|Overall Study|Withdrawal by Subject|5|||
131141622|NCT04656990|472146473|FG000|Baseline|pandemic|20|||
131141623|NCT04656990|472146474|FG001|Baseline|pandemic|24|||
131141624|NCT04656990|472146473|FG000|Follow Up Period|Lost to Follow-up|61|||
131141625|NCT04656990|472146474|FG001|Follow Up Period|Lost to Follow-up|73|||
131141626|NCT03244059|472146475|FG000|Specific Aim 1|Physician Decision|1|||
131141627|NCT03244059|472146476|FG001|Specific Aim 1|Physician Decision|0|||
131141628|NCT03244059|472146475|FG000|Specific Aim 2|Physician Decision|1|||
131084782|NCT01358331|471942375|FG000|Overall Study|Symptomatic Deterioration|0|||
131084783|NCT01358331|471942376|FG001|Overall Study|Symptomatic Deterioration|0|||
131084784|NCT01358331|471942377|FG002|Overall Study|Symptomatic Deterioration|0|||
131084785|NCT01358331|471942378|FG003|Overall Study|Symptomatic Deterioration|0|||
131084786|NCT01358331|471942379|FG004|Overall Study|Symptomatic Deterioration|1|||
131084787|NCT01358331|471942380|FG005|Overall Study|Symptomatic Deterioration|0|||
131141629|NCT03244059|472146476|FG001|Specific Aim 2|Physician Decision|0|||
131141630|NCT00623831|472146479|FG000|Overall Study|Withdrawal by Subject|1|||
131141631|NCT00623831|472146480|FG001|Overall Study|Withdrawal by Subject|0|||
131233630|NCT01215942|472482528|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
131084788|NCT01358331|471942375|FG000|Overall Study|Participants did not wish to continue|0|||
131084789|NCT01358331|471942376|FG001|Overall Study|Participants did not wish to continue|0|||
131084790|NCT01358331|471942377|FG002|Overall Study|Participants did not wish to continue|0|||
131084791|NCT01358331|471942378|FG003|Overall Study|Participants did not wish to continue|0|||
131141632|NCT00623831|472146479|FG000|Overall Study|Progressive Disease|0|||
131233631|NCT01215942|472482527|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
131233632|NCT01215942|472482528|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
131233633|NCT01215942|472482527|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
131233634|NCT01215942|472482528|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
131233635|NCT01215942|472482527|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
131233636|NCT01215942|472482528|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
131233637|NCT03305055|472482529|FG000|Overall Study|Withdrawal by Subject|0|||
131233638|NCT03305055|472482530|FG001|Overall Study|Withdrawal by Subject|1|||
131233639|NCT03305055|472482529|FG000|Overall Study|Adverse Event|1|||
131084792|NCT01358331|471942379|FG004|Overall Study|Participants did not wish to continue|1|||
131084793|NCT01358331|471942380|FG005|Overall Study|Participants did not wish to continue|0|||
131084794|NCT01358331|471942375|FG000|Overall Study|Progress of disease under investigation|1|||
131084795|NCT01358331|471942376|FG001|Overall Study|Progress of disease under investigation|2|||
131084796|NCT01358331|471942377|FG002|Overall Study|Progress of disease under investigation|3|||
131084797|NCT01358331|471942378|FG003|Overall Study|Progress of disease under investigation|1|||
131084798|NCT01358331|471942379|FG004|Overall Study|Progress of disease under investigation|3|||
131084799|NCT01358331|471942380|FG005|Overall Study|Progress of disease under investigation|0|||
131084800|NCT03274895|471942381|FG000|Overall Study|Lack of Efficacy|1|||
131084801|NCT03274895|471942382|FG001|Overall Study|Lack of Efficacy|0|||
131084802|NCT03274895|471942381|FG000|Overall Study|Adverse Event|8|||
131084803|NCT03274895|471942382|FG001|Overall Study|Adverse Event|7|||
131084804|NCT03274895|471942381|FG000|Overall Study|Lost to Follow-up|1|||
131084805|NCT03274895|471942382|FG001|Overall Study|Lost to Follow-up|0|||
131084806|NCT03274895|471942381|FG000|Overall Study|Diagnosis not confirmed|3|||
131084807|NCT03274895|471942382|FG001|Overall Study|Diagnosis not confirmed|4|||
131084808|NCT01299480|471942387|FG000|Overall Study|No longer willing to participate|19|||
131084809|NCT01299480|471942388|FG001|Overall Study|No longer willing to participate|17|||
131084810|NCT01299480|471942389|FG002|Overall Study|No longer willing to participate|14|||
131084811|NCT01299480|471942390|FG003|Overall Study|No longer willing to participate|13|||
131084812|NCT01299480|471942391|FG004|Overall Study|No longer willing to participate|10|||
131084813|NCT01299480|471942387|FG000|Overall Study|Protocol Violation|7|||
131084814|NCT01299480|471942388|FG001|Overall Study|Protocol Violation|5|||
131084815|NCT01299480|471942389|FG002|Overall Study|Protocol Violation|8|||
131084816|NCT01299480|471942390|FG003|Overall Study|Protocol Violation|1|||
131084817|NCT01299480|471942391|FG004|Overall Study|Protocol Violation|1|||
131084818|NCT01299480|471942387|FG000|Overall Study|Withdrawal by Subject|3|||
131084819|NCT01299480|471942388|FG001|Overall Study|Withdrawal by Subject|4|||
131084820|NCT01299480|471942389|FG002|Overall Study|Withdrawal by Subject|7|||
131084821|NCT01299480|471942390|FG003|Overall Study|Withdrawal by Subject|3|||
131084822|NCT01299480|471942391|FG004|Overall Study|Withdrawal by Subject|4|||
131084823|NCT01299480|471942387|FG000|Overall Study|Adverse Event|6|||
131084824|NCT01299480|471942388|FG001|Overall Study|Adverse Event|4|||
131084825|NCT01299480|471942389|FG002|Overall Study|Adverse Event|5|||
131084826|NCT01299480|471942390|FG003|Overall Study|Adverse Event|4|||
131084827|NCT01299480|471942391|FG004|Overall Study|Adverse Event|0|||
131084828|NCT01299480|471942387|FG000|Overall Study|Withdrawal due to pregnancy|0|||
131084829|NCT01299480|471942388|FG001|Overall Study|Withdrawal due to pregnancy|1|||
131084830|NCT01299480|471942389|FG002|Overall Study|Withdrawal due to pregnancy|1|||
131084831|NCT01299480|471942390|FG003|Overall Study|Withdrawal due to pregnancy|0|||
131084832|NCT01299480|471942391|FG004|Overall Study|Withdrawal due to pregnancy|0|||
131084833|NCT01299480|471942387|FG000|Overall Study|Physician Decision|1|||
131084834|NCT01299480|471942388|FG001|Overall Study|Physician Decision|1|||
131084835|NCT01299480|471942389|FG002|Overall Study|Physician Decision|0|||
131084836|NCT01299480|471942390|FG003|Overall Study|Physician Decision|2|||
131084837|NCT01299480|471942391|FG004|Overall Study|Physician Decision|0|||
131084838|NCT01299480|471942387|FG000|Overall Study|Lost to Follow-up|3|||
131084839|NCT01299480|471942388|FG001|Overall Study|Lost to Follow-up|1|||
131084840|NCT01299480|471942389|FG002|Overall Study|Lost to Follow-up|2|||
131084841|NCT01299480|471942390|FG003|Overall Study|Lost to Follow-up|1|||
131084842|NCT01299480|471942391|FG004|Overall Study|Lost to Follow-up|2|||
131084843|NCT01299480|471942387|FG000|Overall Study|Other|3|||
131084844|NCT01299480|471942388|FG001|Overall Study|Other|2|||
131084845|NCT01299480|471942389|FG002|Overall Study|Other|3|||
131084846|NCT01299480|471942390|FG003|Overall Study|Other|0|||
131084847|NCT01299480|471942391|FG004|Overall Study|Other|3|||
131084848|NCT01299480|471942387|FG000|Overall Study|Started, but not vaccinated|0|||
131084849|NCT01299480|471942388|FG001|Overall Study|Started, but not vaccinated|0|||
131084850|NCT01299480|471942389|FG002|Overall Study|Started, but not vaccinated|1|||
131084851|NCT01299480|471942390|FG003|Overall Study|Started, but not vaccinated|1|||
131084852|NCT01299480|471942391|FG004|Overall Study|Started, but not vaccinated|0|||
131084853|NCT00617929|471942405|FG000|Overall Study|Physician Decision|1|||
131084854|NCT04982575|471942406|FG000|Overall Study|Withdrawal by Subject|2|||
131084855|NCT04982575|471942407|FG001|Overall Study|Withdrawal by Subject|0|||
131084856|NCT04982575|471942408|FG002|Overall Study|Withdrawal by Subject|2|||
131084857|NCT01151423|471942409|FG000|Overall Study|Study terminated by Sponsor|9|||
131084858|NCT01151423|471942410|FG001|Overall Study|Study terminated by Sponsor|10|||
131084859|NCT01151423|471942409|FG000|Overall Study|Protocol Violation|0|||
131233640|NCT03305055|472482530|FG001|Overall Study|Adverse Event|1|||
131084860|NCT01151423|471942410|FG001|Overall Study|Protocol Violation|1|||
131084861|NCT01151423|471942409|FG000|Overall Study|Physician Decision|1|||
131084862|NCT01151423|471942410|FG001|Overall Study|Physician Decision|1|||
131084863|NCT01151423|471942409|FG000|Overall Study|Pregnancy|0|||
131084864|NCT01151423|471942410|FG001|Overall Study|Pregnancy|1|||
131084865|NCT01151423|471942409|FG000|Overall Study|Death|0|||
131084866|NCT01151423|471942410|FG001|Overall Study|Death|1|||
131084867|NCT01151423|471942409|FG000|Overall Study|Adverse Event|3|||
131084868|NCT01151423|471942410|FG001|Overall Study|Adverse Event|0|||
131084869|NCT01151423|471942409|FG000|Overall Study|Withdrawal by Subject|1|||
131084870|NCT01151423|471942410|FG001|Overall Study|Withdrawal by Subject|3|||
131084871|NCT01151423|471942409|FG000|Overall Study|Lost to Follow-up|1|||
131084872|NCT01151423|471942410|FG001|Overall Study|Lost to Follow-up|0|||
131084873|NCT01151423|471942409|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
131084874|NCT01151423|471942410|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
131084875|NCT01151423|471942409|FG000|Overall Study|Participated in other clinical trial|1|||
131141633|NCT00623831|472146480|FG001|Overall Study|Progressive Disease|1|||
131141634|NCT00282243|472146481|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
131141635|NCT00282243|472146481|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
131141636|NCT00282243|472146481|FG000|Extension Treatment Period|Adverse Event|15|||
131233641|NCT02540356|472482536|FG000|Overall Study|Terminated due to disease progression|1|||
131233642|NCT02540356|472482537|FG001|Overall Study|Terminated due to disease progression|0|||
131233643|NCT01513148|472482538|FG000|Overall Study|Protocol Violation|2|||
131233644|NCT01513148|472482539|FG001|Overall Study|Protocol Violation|2|||
131233645|NCT04652453|472482540|FG000|Overall Study|Death|8|||
131233646|NCT04652453|472482541|FG001|Overall Study|Death|2|||
130727230|NCT02883049|470625430|FG006|Post Induction|Protocol Violation|0|||
130727231|NCT02883049|470625431|FG007|Post Induction|Protocol Violation|1|||
130727232|NCT02883049|470625432|FG008|Post Induction|Protocol Violation|0|||
130727233|NCT02883049|470625433|FG009|Post Induction|Protocol Violation|0|||
130727234|NCT02883049|470625434|FG010|Post Induction|Protocol Violation|0|||
130727235|NCT02883049|470625435|FG011|Post Induction|Protocol Violation|0|||
131084876|NCT01151423|471942410|FG001|Overall Study|Participated in other clinical trial|0|||
131233647|NCT04652453|472482542|FG002|Overall Study|Death|0|||
131233648|NCT04652453|472482540|FG000|Overall Study|Hospice|5|||
131233649|NCT04652453|472482541|FG001|Overall Study|Hospice|5|||
131233650|NCT04652453|472482542|FG002|Overall Study|Hospice|0|||
131233651|NCT04652453|472482540|FG000|Overall Study|Withdrawal by Subject|2|||
131084877|NCT02568397|471944867|FG000|Period 2|Withdrawal by Subject|0|||
131084878|NCT02568397|471944868|FG001|Period 2|Withdrawal by Subject|1|||
131141637|NCT00282243|472146481|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
131141638|NCT00282243|472146481|FG000|Extension Treatment Period|Non-compliance|2|||
131141639|NCT00282243|472146481|FG000|Extension Treatment Period|Physician Decision|1|||
131141640|NCT01070329|472146482|FG000|Overall Study|Adverse Event|13|||
131141641|NCT01070329|472146483|FG001|Overall Study|Adverse Event|10|||
131141642|NCT01070329|472146482|FG000|Overall Study|Lost to Follow-up|22|||
131141643|NCT01070329|472146483|FG001|Overall Study|Lost to Follow-up|12|||
131141644|NCT01070329|472146482|FG000|Overall Study|Withdrawal by Subject|9|||
131141645|NCT01070329|472146483|FG001|Overall Study|Withdrawal by Subject|11|||
131141646|NCT01070329|472146482|FG000|Overall Study|Protocol Violation|3|||
131141647|NCT01070329|472146483|FG001|Overall Study|Protocol Violation|8|||
131141648|NCT01070329|472146482|FG000|Overall Study|Lack of Efficacy|2|||
131141649|NCT01070329|472146483|FG001|Overall Study|Lack of Efficacy|6|||
131141650|NCT01070329|472146482|FG000|Overall Study|Physician Decision|2|||
131141651|NCT01070329|472146483|FG001|Overall Study|Physician Decision|1|||
131141652|NCT01070329|472146482|FG000|Overall Study|Entry Criteria Not Met|1|||
131141653|NCT01070329|472146483|FG001|Overall Study|Entry Criteria Not Met|0|||
131141654|NCT01070329|472146482|FG000|Overall Study|Sponsor Decision|0|||
131141655|NCT01070329|472146483|FG001|Overall Study|Sponsor Decision|1|||
131141656|NCT02863848|472146486|FG000|Overall Study|Lost to Follow-up|1|||
131084879|NCT02568397|471944867|FG000|Period 2|Physician Decision|0|||
131084880|NCT02568397|471944868|FG001|Period 2|Physician Decision|1|||
131084881|NCT01317875|471944869|FG000|Overall Study|Other|0|||
131233652|NCT04652453|472482541|FG001|Overall Study|Withdrawal by Subject|0|||
130727236|NCT02883049|470625436|FG012|Post Induction|Protocol Violation|0|||
131084882|NCT01317875|471944870|FG001|Overall Study|Other|0|||
131084883|NCT01317875|471944871|FG002|Overall Study|Other|1|||
130727237|NCT02883049|470625437|FG013|Post Induction|Protocol Violation|0|||
131084884|NCT01317875|471944872|FG003|Overall Study|Other|0|||
131084885|NCT01317875|471944873|FG004|Overall Study|Other|0|||
131141657|NCT02863848|472146487|FG001|Overall Study|Lost to Follow-up|1|||
131141658|NCT02863848|472146486|FG000|Overall Study|Protocol Violation|1|||
131141659|NCT02863848|472146487|FG001|Overall Study|Protocol Violation|2|||
131233653|NCT04652453|472482542|FG002|Overall Study|Withdrawal by Subject|0|||
130727238|NCT02883049|470625438|FG014|Post Induction|Protocol Violation|0|||
131084886|NCT01317875|471944874|FG005|Overall Study|Other|0|||
131084887|NCT01317875|471944875|FG006|Overall Study|Other|0|||
131233654|NCT02978326|472482544|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
131233655|NCT02978326|472482545|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
131084888|NCT01317875|471944876|FG007|Overall Study|Other|0|||
131084889|NCT01317875|471944877|FG008|Overall Study|Other|0|||
131084890|NCT01317875|471944878|FG009|Overall Study|Other|0|||
131084891|NCT01317875|471944869|FG000|Overall Study|Noncompliance with study drug|0|||
131084892|NCT01317875|471944870|FG001|Overall Study|Noncompliance with study drug|0|||
131084893|NCT01317875|471944871|FG002|Overall Study|Noncompliance with study drug|1|||
131084894|NCT01317875|471944872|FG003|Overall Study|Noncompliance with study drug|0|||
131084895|NCT01317875|471944873|FG004|Overall Study|Noncompliance with study drug|0|||
131084896|NCT01317875|471944874|FG005|Overall Study|Noncompliance with study drug|0|||
131084897|NCT01317875|471944875|FG006|Overall Study|Noncompliance with study drug|0|||
131084898|NCT01317875|471944876|FG007|Overall Study|Noncompliance with study drug|0|||
131084899|NCT01317875|471944877|FG008|Overall Study|Noncompliance with study drug|0|||
131084900|NCT01317875|471944878|FG009|Overall Study|Noncompliance with study drug|0|||
131084901|NCT01317875|471944869|FG000|Overall Study|Progressive Disease|1|||
131084902|NCT01317875|471944870|FG001|Overall Study|Progressive Disease|0|||
131084903|NCT01317875|471944871|FG002|Overall Study|Progressive Disease|2|||
131084904|NCT01317875|471944872|FG003|Overall Study|Progressive Disease|0|||
131084905|NCT01317875|471944873|FG004|Overall Study|Progressive Disease|1|||
131084906|NCT01317875|471944874|FG005|Overall Study|Progressive Disease|0|||
131084907|NCT01317875|471944875|FG006|Overall Study|Progressive Disease|0|||
131084908|NCT01317875|471944876|FG007|Overall Study|Progressive Disease|1|||
131084909|NCT01317875|471944877|FG008|Overall Study|Progressive Disease|0|||
131084910|NCT01317875|471944878|FG009|Overall Study|Progressive Disease|0|||
131084911|NCT01317875|471944869|FG000|Overall Study|Withdrawal by Subject|0|||
131084912|NCT01317875|471944870|FG001|Overall Study|Withdrawal by Subject|0|||
131084913|NCT01317875|471944871|FG002|Overall Study|Withdrawal by Subject|0|||
131084914|NCT01317875|471944872|FG003|Overall Study|Withdrawal by Subject|0|||
131084915|NCT01317875|471944873|FG004|Overall Study|Withdrawal by Subject|1|||
131084916|NCT01317875|471944874|FG005|Overall Study|Withdrawal by Subject|0|||
131084917|NCT01317875|471944875|FG006|Overall Study|Withdrawal by Subject|0|||
131084918|NCT01317875|471944876|FG007|Overall Study|Withdrawal by Subject|3|||
131084919|NCT01317875|471944877|FG008|Overall Study|Withdrawal by Subject|0|||
131084920|NCT01317875|471944878|FG009|Overall Study|Withdrawal by Subject|0|||
131084921|NCT01317875|471944869|FG000|Overall Study|Physician Decision|0|||
131084922|NCT01317875|471944870|FG001|Overall Study|Physician Decision|1|||
131084923|NCT01317875|471944871|FG002|Overall Study|Physician Decision|1|||
131084924|NCT01317875|471944872|FG003|Overall Study|Physician Decision|0|||
131084925|NCT01317875|471944873|FG004|Overall Study|Physician Decision|2|||
131084926|NCT01317875|471944874|FG005|Overall Study|Physician Decision|0|||
131084927|NCT01317875|471944875|FG006|Overall Study|Physician Decision|0|||
131084928|NCT01317875|471944876|FG007|Overall Study|Physician Decision|2|||
131084929|NCT01317875|471944877|FG008|Overall Study|Physician Decision|0|||
131084930|NCT01317875|471944878|FG009|Overall Study|Physician Decision|0|||
131084931|NCT01317875|471944869|FG000|Overall Study|Death|0|||
131084932|NCT01317875|471944870|FG001|Overall Study|Death|0|||
131084933|NCT01317875|471944871|FG002|Overall Study|Death|2|||
131084934|NCT01317875|471944872|FG003|Overall Study|Death|1|||
131084935|NCT01317875|471944873|FG004|Overall Study|Death|0|||
131084936|NCT01317875|471944874|FG005|Overall Study|Death|1|||
131084937|NCT01317875|471944875|FG006|Overall Study|Death|0|||
131084938|NCT01317875|471944876|FG007|Overall Study|Death|4|||
131084939|NCT01317875|471944877|FG008|Overall Study|Death|0|||
131084940|NCT01317875|471944878|FG009|Overall Study|Death|0|||
131084941|NCT01317875|471944869|FG000|Overall Study|Adverse Event|2|||
131084942|NCT01317875|471944870|FG001|Overall Study|Adverse Event|1|||
131084943|NCT01317875|471944871|FG002|Overall Study|Adverse Event|2|||
131084944|NCT01317875|471944872|FG003|Overall Study|Adverse Event|1|||
131084945|NCT01317875|471944873|FG004|Overall Study|Adverse Event|5|||
131084946|NCT01317875|471944874|FG005|Overall Study|Adverse Event|1|||
131084947|NCT01317875|471944875|FG006|Overall Study|Adverse Event|2|||
131084948|NCT01317875|471944876|FG007|Overall Study|Adverse Event|5|||
131084949|NCT01317875|471944877|FG008|Overall Study|Adverse Event|0|||
131141660|NCT03588741|472146492|FG000|Overall Study|Withdrawal by Subject|1|||
131141661|NCT01254669|472146493|FG000|Overall Study|Withdrawal by Subject|0|||
131084950|NCT01317875|471944878|FG009|Overall Study|Adverse Event|0|||
131084951|NCT01200342|471944879|FG000|Overall Study|Disease Progression|1|||
131084952|NCT02514239|471944880|FG000|Overall Study|Refused to continue trial medication|0|||
131084953|NCT02514239|471944881|FG001|Overall Study|Refused to continue trial medication|0|||
131084954|NCT02514239|471944882|FG002|Overall Study|Refused to continue trial medication|0|||
131084955|NCT02514239|471944883|FG003|Overall Study|Refused to continue trial medication|0|||
131084956|NCT02514239|471944884|FG004|Overall Study|Refused to continue trial medication|0|||
131084957|NCT02514239|471944885|FG005|Overall Study|Refused to continue trial medication|0|||
131084958|NCT02514239|471944886|FG006|Overall Study|Refused to continue trial medication|0|||
131084959|NCT02514239|471944887|FG007|Overall Study|Refused to continue trial medication|0|||
131084960|NCT02514239|471944888|FG008|Overall Study|Refused to continue trial medication|0|||
131084961|NCT02514239|471944889|FG009|Overall Study|Refused to continue trial medication|1|||
131141662|NCT01254669|472146494|FG001|Overall Study|Withdrawal by Subject|1|||
131084962|NCT02514239|471944880|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
131084963|NCT02514239|471944881|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
131084964|NCT02514239|471944882|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
131084965|NCT02514239|471944883|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
131084966|NCT02514239|471944884|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
131084967|NCT02514239|471944885|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
131084968|NCT02514239|471944886|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
131084969|NCT02514239|471944887|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
131084970|NCT02514239|471944888|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
131084971|NCT02514239|471944889|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
131084972|NCT02514239|471944880|FG000|Overall Study|Not treated|0|||
131084973|NCT02514239|471944881|FG001|Overall Study|Not treated|1|||
131084974|NCT02514239|471944882|FG002|Overall Study|Not treated|0|||
131084975|NCT02514239|471944883|FG003|Overall Study|Not treated|0|||
131084976|NCT02514239|471944884|FG004|Overall Study|Not treated|0|||
131084977|NCT02514239|471944885|FG005|Overall Study|Not treated|0|||
131084978|NCT02514239|471944886|FG006|Overall Study|Not treated|0|||
131084979|NCT02514239|471944887|FG007|Overall Study|Not treated|0|||
131084980|NCT02514239|471944888|FG008|Overall Study|Not treated|0|||
131084981|NCT02514239|471944889|FG009|Overall Study|Not treated|0|||
131084982|NCT02514239|471944880|FG000|Overall Study|Other Adverse Events|2|||
131084983|NCT02514239|471944881|FG001|Overall Study|Other Adverse Events|0|||
131084984|NCT02514239|471944882|FG002|Overall Study|Other Adverse Events|0|||
131084985|NCT02514239|471944883|FG003|Overall Study|Other Adverse Events|1|||
131084986|NCT02514239|471944884|FG004|Overall Study|Other Adverse Events|0|||
131084987|NCT02514239|471944885|FG005|Overall Study|Other Adverse Events|1|||
131084988|NCT02514239|471944886|FG006|Overall Study|Other Adverse Events|0|||
131084989|NCT02514239|471944887|FG007|Overall Study|Other Adverse Events|1|||
131084990|NCT02514239|471944888|FG008|Overall Study|Other Adverse Events|2|||
131084991|NCT02514239|471944889|FG009|Overall Study|Other Adverse Events|0|||
131084992|NCT02514239|471944880|FG000|Overall Study|Progressive disease|3|||
131084993|NCT02514239|471944881|FG001|Overall Study|Progressive disease|3|||
131084994|NCT02514239|471944882|FG002|Overall Study|Progressive disease|2|||
131084995|NCT02514239|471944883|FG003|Overall Study|Progressive disease|2|||
131084996|NCT02514239|471944884|FG004|Overall Study|Progressive disease|3|||
131084997|NCT02514239|471944885|FG005|Overall Study|Progressive disease|3|||
131084998|NCT02514239|471944886|FG006|Overall Study|Progressive disease|4|||
131084999|NCT02514239|471944887|FG007|Overall Study|Progressive disease|2|||
131085000|NCT02514239|471944888|FG008|Overall Study|Progressive disease|5|||
131085001|NCT02514239|471944889|FG009|Overall Study|Progressive disease|0|||
131085002|NCT02763215|471944890|FG000|Overall Study|Participants withdrew from study|3|||
131085003|NCT02763215|471944890|FG000|Overall Study|Missed visit|1|||
131085004|NCT02763215|471944890|FG000|Overall Study|Visit outside visit-window|1|||
131085005|NCT02763215|471944890|FG000|Overall Study|Death|1|||
131085006|NCT02763215|471944890|FG000|Overall Study|Lost to Follow-up|1|||
131085007|NCT01483144|471944891|FG000|Overall Study|Adverse Event|9|||
131141663|NCT01254669|472146493|FG000|Overall Study|time constraint|2|||
131141664|NCT01254669|472146494|FG001|Overall Study|time constraint|2|||
131141665|NCT01254669|472146493|FG000|Overall Study|called to clinic during intervention|1|||
131141666|NCT01254669|472146494|FG001|Overall Study|called to clinic during intervention|1|||
131141667|NCT02522767|472146495|FG000|Double-blind|Withdrawal by Subject|8|||
131141668|NCT02522767|472146496|FG001|Double-blind|Withdrawal by Subject|11|||
131141669|NCT02522767|472146495|FG000|Double-blind|Lost to Follow-up|1|||
131141670|NCT02522767|472146496|FG001|Double-blind|Lost to Follow-up|0|||
131141671|NCT02522767|472146495|FG000|Double-blind|Adverse Event|1|||
131141672|NCT02522767|472146496|FG001|Double-blind|Adverse Event|10|||
131141673|NCT02522767|472146495|FG000|Double-blind|Protocol Violation|0|||
131141674|NCT02522767|472146496|FG001|Double-blind|Protocol Violation|1|||
131141675|NCT02522767|472146495|FG000|Double-blind|Lack of Efficacy|0|||
131141676|NCT02522767|472146496|FG001|Double-blind|Lack of Efficacy|2|||
131085008|NCT01483144|471944892|FG001|Overall Study|Adverse Event|4|||
131141677|NCT02522767|472146495|FG000|Double-blind|Protocol Deviation|1|||
131085009|NCT01483144|471944893|FG002|Overall Study|Adverse Event|6|||
131085010|NCT01483144|471944891|FG000|Overall Study|Withdrawal by Subject|0|||
131085011|NCT01483144|471944892|FG001|Overall Study|Withdrawal by Subject|2|||
131085012|NCT01483144|471944893|FG002|Overall Study|Withdrawal by Subject|5|||
131085013|NCT01483144|471944891|FG000|Overall Study|Physician Decision|1|||
131085014|NCT01483144|471944892|FG001|Overall Study|Physician Decision|0|||
131085015|NCT01483144|471944893|FG002|Overall Study|Physician Decision|0|||
131085016|NCT01483144|471944891|FG000|Overall Study|Lost to Follow-up|2|||
131085017|NCT01483144|471944892|FG001|Overall Study|Lost to Follow-up|4|||
131141678|NCT02522767|472146496|FG001|Double-blind|Protocol Deviation|0|||
131141679|NCT02522767|472146495|FG000|Open-label|Withdrawal by Subject|2|||
131141680|NCT02522767|472146496|FG001|Open-label|Withdrawal by Subject|3|||
131141681|NCT02522767|472146495|FG000|Open-label|Lost to Follow-up|0|||
131141682|NCT02522767|472146496|FG001|Open-label|Lost to Follow-up|1|||
131141683|NCT02522767|472146495|FG000|Open-label|Adverse Event|2|||
131085018|NCT01483144|471944893|FG002|Overall Study|Lost to Follow-up|1|||
131141684|NCT02522767|472146496|FG001|Open-label|Adverse Event|1|||
131085019|NCT01483144|471944891|FG000|Overall Study|Protocol Violation|3|||
131085020|NCT01483144|471944892|FG001|Overall Study|Protocol Violation|3|||
131085021|NCT01483144|471944893|FG002|Overall Study|Protocol Violation|3|||
131085022|NCT03258723|471944896|FG000|Overall Study|COVID Interruption of study|54|||
131085023|NCT03258723|471944896|FG000|Overall Study|Lost to Follow-up|8|||
131085024|NCT01107899|471944900|FG000|Overall Study|Physician Decision|5|||
131085025|NCT01107899|471944901|FG001|Overall Study|Physician Decision|0|||
131085026|NCT01107899|471944902|FG002|Overall Study|Physician Decision|3|||
131085027|NCT01107899|471944900|FG000|Overall Study|Withdrawal by Subject|0|||
131085028|NCT01107899|471944901|FG001|Overall Study|Withdrawal by Subject|0|||
131085029|NCT01107899|471944902|FG002|Overall Study|Withdrawal by Subject|1|||
131085030|NCT00974259|471944903|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
131085031|NCT00974259|471944904|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
131085032|NCT00944229|471944907|FG000|Overall Study|Withdrawal by Subject|11|||
131085033|NCT00944229|471944907|FG000|Overall Study|Physician Decision|14|||
131085034|NCT01810939|471944912|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
131085035|NCT01810939|471944913|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
131085036|NCT01810939|471944914|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
131085037|NCT01810939|471944912|FG000|Part A Treatment Period|Protocol Violation|2|||
131085038|NCT01810939|471944913|FG001|Part A Treatment Period|Protocol Violation|0|||
131085039|NCT01810939|471944914|FG002|Part A Treatment Period|Protocol Violation|0|||
131085040|NCT01810939|471944912|FG000|Part A Treatment Period|Adverse Event|10|||
131085041|NCT01810939|471944913|FG001|Part A Treatment Period|Adverse Event|0|||
131085042|NCT01810939|471944914|FG002|Part A Treatment Period|Adverse Event|0|||
131085043|NCT01810939|471944912|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
131085044|NCT01810939|471944913|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
131141685|NCT02522767|472146495|FG000|Open-label|Lack of Efficacy|1|||
131141686|NCT02522767|472146496|FG001|Open-label|Lack of Efficacy|1|||
131141687|NCT02522767|472146495|FG000|Open-label|Protocol Violation|0|||
131085045|NCT01810939|471944914|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
131085046|NCT01810939|471944912|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
131085047|NCT01810939|471944913|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
131085048|NCT01810939|471944914|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
131085049|NCT01810939|471944912|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
131085050|NCT01810939|471944913|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
131085051|NCT01810939|471944914|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
131085052|NCT01810939|471944912|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
131085053|NCT01810939|471944913|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
131085054|NCT01810939|471944914|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
131085055|NCT01810939|471944912|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
131085056|NCT01810939|471944913|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
131085057|NCT01810939|471944914|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
131085058|NCT01810939|471944912|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
131085059|NCT01810939|471944913|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
131085060|NCT01810939|471944914|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
131085061|NCT01810939|471944912|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
131085062|NCT01810939|471944913|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
131085063|NCT01810939|471944914|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
131085064|NCT01810939|471944912|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
131085065|NCT01810939|471944913|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
131085066|NCT01810939|471944914|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
131085067|NCT01810939|471944912|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
131085068|NCT01810939|471944913|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
131085069|NCT01810939|471944914|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
131085070|NCT01810939|471944912|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
131233656|NCT02978326|472482546|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
131233657|NCT02978326|472482544|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
131085071|NCT01810939|471944913|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
131141688|NCT02522767|472146496|FG001|Open-label|Protocol Violation|1|||
131141689|NCT00548548|472146497|FG000|Overall Study|Death|345|||
131141690|NCT00548548|472146498|FG001|Overall Study|Death|348|||
131141691|NCT00548548|472146497|FG000|Overall Study|Lost to Follow-up|17|||
131141692|NCT00548548|472146498|FG001|Overall Study|Lost to Follow-up|18|||
131085072|NCT01810939|471944914|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
131085073|NCT01810939|471944912|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
131085074|NCT01810939|471944913|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
131141693|NCT01705691|472146499|FG000|Overall Study|Death|1|||
131141694|NCT01705691|472146500|FG001|Overall Study|Death|2|||
131141695|NCT01705691|472146499|FG000|Overall Study|Withdrawal by Subject|1|||
131141696|NCT01705691|472146500|FG001|Overall Study|Withdrawal by Subject|2|||
131233658|NCT02978326|472482545|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
131233659|NCT02978326|472482546|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
131233660|NCT02978326|472482544|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
131233661|NCT02978326|472482545|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
131233662|NCT02978326|472482546|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
131233663|NCT02978326|472482544|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
131233664|NCT02978326|472482545|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
131233665|NCT02978326|472482546|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
131233666|NCT01937364|472482549|FG000|Overall Study|Adverse Event|2|||
131085075|NCT01810939|471944914|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
131085076|NCT01810939|471944912|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
131085077|NCT01810939|471944913|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
131085078|NCT01810939|471944914|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
131085079|NCT01810939|471944912|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
131085080|NCT01810939|471944913|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
131085081|NCT01810939|471944914|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
131085082|NCT01810939|471944912|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
131085083|NCT01810939|471944913|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
131085084|NCT01810939|471944914|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
131085085|NCT00079339|471944921|FG000|Overall Study|Adverse Event|1|||
131085086|NCT00079339|471944922|FG001|Overall Study|Adverse Event|7|||
131085087|NCT00079339|471944923|FG002|Overall Study|Adverse Event|2|||
131085088|NCT00079339|471944921|FG000|Overall Study|Death|1|||
131085089|NCT00079339|471944922|FG001|Overall Study|Death|0|||
131085090|NCT00079339|471944923|FG002|Overall Study|Death|0|||
131085091|NCT00079339|471944921|FG000|Overall Study|Non-compliance|0|||
131085092|NCT00079339|471944922|FG001|Overall Study|Non-compliance|0|||
131085093|NCT00079339|471944923|FG002|Overall Study|Non-compliance|1|||
131085094|NCT00079339|471944921|FG000|Overall Study|Withdrawal by Subject|0|||
131085095|NCT00079339|471944922|FG001|Overall Study|Withdrawal by Subject|4|||
131085096|NCT00079339|471944923|FG002|Overall Study|Withdrawal by Subject|1|||
131085097|NCT00079339|471944921|FG000|Overall Study|Disease progression|3|||
131085098|NCT00079339|471944922|FG001|Overall Study|Disease progression|28|||
131085099|NCT00079339|471944923|FG002|Overall Study|Disease progression|2|||
131085100|NCT00520845|471944924|FG000|Overall Study|Death|3|||
131085101|NCT00520845|471944924|FG000|Overall Study|Adverse Event|4|||
131085102|NCT00520845|471944924|FG000|Overall Study|Disease Progression, relapse|13|||
131085103|NCT00520845|471944924|FG000|Overall Study|Withdrawal by Subject|1|||
131085104|NCT00520845|471944924|FG000|Overall Study|Alternative Therapy|1|||
131085105|NCT03274453|471944925|FG000|Overall Study|Lost to Follow-up|2|||
131085106|NCT03274453|471944926|FG001|Overall Study|Lost to Follow-up|5|||
131085107|NCT03274453|471944927|FG002|Overall Study|Lost to Follow-up|4|||
131085108|NCT03274453|471944928|FG003|Overall Study|Lost to Follow-up|1|||
131085109|NCT03274453|471944925|FG000|Overall Study|Physician Decision|2|||
131085110|NCT03274453|471944926|FG001|Overall Study|Physician Decision|0|||
131085111|NCT03274453|471944927|FG002|Overall Study|Physician Decision|0|||
131085112|NCT03274453|471944928|FG003|Overall Study|Physician Decision|3|||
131085113|NCT03274453|471944925|FG000|Overall Study|Surgery Cancelled|0|||
131085114|NCT03274453|471944926|FG001|Overall Study|Surgery Cancelled|1|||
131085115|NCT03274453|471944927|FG002|Overall Study|Surgery Cancelled|0|||
131085116|NCT03274453|471944928|FG003|Overall Study|Surgery Cancelled|0|||
131085117|NCT00945672|471944931|FG000|Overall Study|Withdrawal by Subject|0|||
131085118|NCT00945672|471944932|FG001|Overall Study|Withdrawal by Subject|0|||
131141697|NCT01705691|472146499|FG000|Overall Study|Lost to Follow-up|1|||
131141698|NCT01705691|472146500|FG001|Overall Study|Lost to Follow-up|1|||
131141699|NCT01705691|472146499|FG000|Overall Study|Other|0|||
131141700|NCT01705691|472146500|FG001|Overall Study|Other|1|||
131141701|NCT02913313|472146501|FG000|Overall Study|DISEASE PROGRESSION|1|||
131141702|NCT02913313|472146502|FG001|Overall Study|DISEASE PROGRESSION|2|||
131141703|NCT02913313|472146503|FG002|Overall Study|DISEASE PROGRESSION|2|||
131141704|NCT02913313|472146504|FG003|Overall Study|DISEASE PROGRESSION|4|||
131141705|NCT02913313|472146505|FG004|Overall Study|DISEASE PROGRESSION|6|||
131141706|NCT02913313|472146506|FG005|Overall Study|DISEASE PROGRESSION|4|||
131141707|NCT02913313|472146507|FG006|Overall Study|DISEASE PROGRESSION|19|||
131141708|NCT02913313|472146508|FG007|Overall Study|DISEASE PROGRESSION|3|||
131085119|NCT00945672|471944933|FG002|Overall Study|Withdrawal by Subject|0|||
131085120|NCT00945672|471944934|FG003|Overall Study|Withdrawal by Subject|1|||
131085121|NCT03845140|471944937|FG000|Overall Study|Participant travelled outside study area|0|||
131085122|NCT03845140|471944938|FG001|Overall Study|Participant travelled outside study area|1|||
131085123|NCT03845140|471944939|FG002|Overall Study|Participant travelled outside study area|0|||
131141709|NCT02913313|472146509|FG008|Overall Study|DISEASE PROGRESSION|4|||
131141710|NCT02913313|472146510|FG009|Overall Study|DISEASE PROGRESSION|4|||
131141711|NCT02913313|472146511|FG010|Overall Study|DISEASE PROGRESSION|11|||
131085124|NCT03845140|471944940|FG003|Overall Study|Participant travelled outside study area|0|||
131141712|NCT02913313|472146512|FG011|Overall Study|DISEASE PROGRESSION|5|||
131141713|NCT02913313|472146513|FG012|Overall Study|DISEASE PROGRESSION|14|||
131233667|NCT01937364|472482550|FG001|Overall Study|Adverse Event|1|||
131085125|NCT03845140|471944941|FG004|Overall Study|Participant travelled outside study area|0|||
131085126|NCT03845140|471944942|FG005|Overall Study|Participant travelled outside study area|0|||
131085127|NCT01592045|471944943|FG000|Overall Study|Disease Progression|1|||
131085128|NCT01592045|471944944|FG001|Overall Study|Disease Progression|1|||
131085129|NCT01592045|471944943|FG000|Overall Study|Adverse Event|1|||
131085130|NCT01592045|471944944|FG001|Overall Study|Adverse Event|1|||
131085131|NCT01592045|471944943|FG000|Overall Study|Withdrawal by Subject|1|||
131233668|NCT04104646|472482552|FG000|Overall Study|Withdrawal by Subject|1|||
131233669|NCT04104646|472482553|FG001|Overall Study|Withdrawal by Subject|1|||
131233670|NCT04104646|472482552|FG000|Overall Study|Lost to Follow-up|1|||
131233671|NCT04104646|472482553|FG001|Overall Study|Lost to Follow-up|0|||
131233672|NCT04104646|472482552|FG000|Overall Study|Physician Decision|2|||
131233673|NCT04104646|472482553|FG001|Overall Study|Physician Decision|0|||
131233674|NCT02277769|472482554|FG000|Overall Study|Protocol Violation|3|||
131233675|NCT02277769|472482555|FG001|Overall Study|Protocol Violation|3|||
131233676|NCT02277769|472482556|FG002|Overall Study|Protocol Violation|5|||
131233677|NCT02277769|472482554|FG000|Overall Study|Lack of Efficacy|17|||
131233678|NCT02277769|472482555|FG001|Overall Study|Lack of Efficacy|0|||
131233679|NCT02277769|472482556|FG002|Overall Study|Lack of Efficacy|4|||
131233680|NCT02277769|472482554|FG000|Overall Study|Adverse Event|14|||
131233681|NCT02277769|472482555|FG001|Overall Study|Adverse Event|2|||
131233682|NCT02277769|472482556|FG002|Overall Study|Adverse Event|4|||
131233683|NCT02277769|472482554|FG000|Overall Study|Other than specified above|12|||
131233684|NCT02277769|472482555|FG001|Overall Study|Other than specified above|8|||
131233685|NCT02277769|472482556|FG002|Overall Study|Other than specified above|5|||
130727239|NCT02883049|470625439|FG015|Post Induction|Protocol Violation|0|||
131085132|NCT01592045|471944944|FG001|Overall Study|Withdrawal by Subject|0|||
131233686|NCT00203307|472482557|FG000|First Intervention|Adverse Event|2|||
131085133|NCT01592045|471944943|FG000|Overall Study|Moved out of country|2|||
131085134|NCT01592045|471944944|FG001|Overall Study|Moved out of country|0|||
131085135|NCT01681992|471944947|FG000|Overall Study|Adverse Event|3|||
131085136|NCT01681992|471944948|FG001|Overall Study|Adverse Event|2|||
131085137|NCT01681992|471944949|FG002|Overall Study|Adverse Event|3|||
131085138|NCT01681992|471944947|FG000|Overall Study|Lost to Follow-up|36|||
131085139|NCT01681992|471944948|FG001|Overall Study|Lost to Follow-up|38|||
131085140|NCT01681992|471944949|FG002|Overall Study|Lost to Follow-up|53|||
131085141|NCT01681992|471944947|FG000|Overall Study|As Per Sponsor Decision|0|||
131085142|NCT01681992|471944948|FG001|Overall Study|As Per Sponsor Decision|0|||
131085143|NCT01681992|471944949|FG002|Overall Study|As Per Sponsor Decision|1|||
131085144|NCT01681992|471944947|FG000|Overall Study|Protocol Violation|0|||
131085145|NCT01681992|471944948|FG001|Overall Study|Protocol Violation|0|||
131085146|NCT01681992|471944949|FG002|Overall Study|Protocol Violation|1|||
131085147|NCT01681992|471944947|FG000|Overall Study|Withdrawal by Subject|27|||
131085148|NCT01681992|471944948|FG001|Overall Study|Withdrawal by Subject|30|||
131085149|NCT01681992|471944949|FG002|Overall Study|Withdrawal by Subject|25|||
131085150|NCT01661205|471944954|FG000|Overall Study|Physician Decision|2|||
131085151|NCT03111095|471944957|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
131085152|NCT03111095|471944958|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
131085153|NCT03111095|471944957|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
131085154|NCT03111095|471944958|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
131085155|NCT00504075|471944959|FG000|Overall Study|Adverse Event|1|||
131085156|NCT00504075|471944959|FG000|Overall Study|Lost to Follow-up|5|||
131085157|NCT00504075|471944959|FG000|Overall Study|Withdrawal by Subject|1|||
131085158|NCT00504075|471944959|FG000|Overall Study|Required other therapeutic intervention|1|||
131085159|NCT03812029|471944966|FG000|Overall Study|Protocol Violation|1|||
131085160|NCT03812029|471944967|FG001|Overall Study|Protocol Violation|0|||
131085161|NCT03812029|471944968|FG002|Overall Study|Protocol Violation|0|||
131085162|NCT03812029|471944969|FG003|Overall Study|Protocol Violation|1|||
131085163|NCT03812029|471944970|FG004|Overall Study|Protocol Violation|0|||
131085164|NCT03812029|471944966|FG000|Overall Study|Withdrawal by Subject|1|||
131233687|NCT00203307|472482558|FG001|First Intervention|Adverse Event|0|||
131233688|NCT03730103|472482559|FG000|Overall Study|Did not meet inclusion criteria|0|||
131233689|NCT03730103|472482560|FG001|Overall Study|Did not meet inclusion criteria|5|||
131085165|NCT03812029|471944967|FG001|Overall Study|Withdrawal by Subject|0|||
131085166|NCT03812029|471944968|FG002|Overall Study|Withdrawal by Subject|0|||
131085167|NCT03812029|471944969|FG003|Overall Study|Withdrawal by Subject|2|||
131085168|NCT03812029|471944970|FG004|Overall Study|Withdrawal by Subject|2|||
131085169|NCT03812029|471944966|FG000|Overall Study|Stopping rules|0|||
131085170|NCT03812029|471944967|FG001|Overall Study|Stopping rules|1|||
131085171|NCT03812029|471944968|FG002|Overall Study|Stopping rules|0|||
131085172|NCT03812029|471944969|FG003|Overall Study|Stopping rules|0|||
131085173|NCT03812029|471944970|FG004|Overall Study|Stopping rules|0|||
131085174|NCT03812029|471944966|FG000|Overall Study|Adverse Event|0|||
131233690|NCT02308111|472482561|FG000|Overall Study|Adverse Event|31|||
131233691|NCT02308111|472482562|FG001|Overall Study|Adverse Event|19|||
131233692|NCT02308111|472482561|FG000|Overall Study|Death|9|||
131233693|NCT02308111|472482562|FG001|Overall Study|Death|6|||
131233694|NCT02308111|472482561|FG000|Overall Study|Lost to Follow-up|2|||
131085175|NCT03812029|471944967|FG001|Overall Study|Adverse Event|9|||
131085176|NCT03812029|471944968|FG002|Overall Study|Adverse Event|0|||
131085177|NCT03812029|471944969|FG003|Overall Study|Adverse Event|3|||
131085178|NCT03812029|471944970|FG004|Overall Study|Adverse Event|5|||
131085179|NCT03812029|471944966|FG000|Overall Study|Lost to Follow-up|0|||
131085180|NCT03812029|471944967|FG001|Overall Study|Lost to Follow-up|0|||
131085181|NCT03812029|471944968|FG002|Overall Study|Lost to Follow-up|0|||
131085182|NCT03812029|471944969|FG003|Overall Study|Lost to Follow-up|0|||
131085183|NCT03812029|471944970|FG004|Overall Study|Lost to Follow-up|3|||
131085184|NCT03149042|471944971|FG000|Overall Study|Invasive FFR not performed|21|||
131085185|NCT03149042|471944971|FG000|Overall Study|Poor CT Image Quality|1|||
131085186|NCT03149042|471944971|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
131085187|NCT00732992|471944980|FG000|Overall Study|Adverse Event|1|||
131085188|NCT00732992|471944981|FG001|Overall Study|Adverse Event|1|||
131085189|NCT00732992|471944980|FG000|Overall Study|Objective Progression or Relapse|3|||
131085190|NCT00732992|471944981|FG001|Overall Study|Objective Progression or Relapse|5|||
131085191|NCT00732992|471944980|FG000|Overall Study|Global Deterioration of Health Status|1|||
131085192|NCT00732992|471944981|FG001|Overall Study|Global Deterioration of Health Status|0|||
131085193|NCT00732992|471944980|FG000|Overall Study|Withdrawal by Subject|1|||
131085194|NCT00732992|471944981|FG001|Overall Study|Withdrawal by Subject|0|||
131085195|NCT02344342|471944982|FG000|Overall Study|Industry partner dropped out|11|||
131085196|NCT02344342|471944983|FG001|Overall Study|Industry partner dropped out|9|||
131085197|NCT02344342|471944984|FG002|Overall Study|Industry partner dropped out|14|||
131085198|NCT02344342|471944985|FG003|Overall Study|Industry partner dropped out|10|||
131085199|NCT03690427|471944989|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
131085200|NCT03690427|471944990|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
131085201|NCT02609672|471944995|FG000|Overall Study|Lost to Follow-up|3|||
131085202|NCT02609672|471944996|FG001|Overall Study|Lost to Follow-up|1|||
131085203|NCT02956837|471944997|FG000|Overall Study|Serious Adverse Events|0|||
131085204|NCT02956837|471944998|FG001|Overall Study|Serious Adverse Events|1|||
131085205|NCT02956837|471944999|FG002|Overall Study|Serious Adverse Events|0|||
131085206|NCT02956837|471945000|FG003|Overall Study|Serious Adverse Events|0|||
131085207|NCT02956837|471944997|FG000|Overall Study|Withdrawal by Subject|0|||
131085208|NCT02956837|471944998|FG001|Overall Study|Withdrawal by Subject|1|||
131085209|NCT02956837|471944999|FG002|Overall Study|Withdrawal by Subject|0|||
131085210|NCT02956837|471945000|FG003|Overall Study|Withdrawal by Subject|3|||
131085211|NCT02956837|471944997|FG000|Overall Study|Lost to Follow-up|0|||
131085212|NCT02956837|471944998|FG001|Overall Study|Lost to Follow-up|1|||
131085213|NCT02956837|471944999|FG002|Overall Study|Lost to Follow-up|2|||
131085214|NCT02956837|471945000|FG003|Overall Study|Lost to Follow-up|0|||
131085215|NCT02597712|471945001|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
131085216|NCT02597712|471945002|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
131085217|NCT02597712|471945001|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
131085218|NCT02597712|471945002|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
131085219|NCT02597712|471945001|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
131085220|NCT02597712|471945002|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
131085221|NCT02637323|471945003|FG000|Overall Study|Lost to Follow-up|2|||
131085222|NCT02637323|471945004|FG001|Overall Study|Lost to Follow-up|0|||
131085223|NCT02637323|471945003|FG000|Overall Study|Protocol Violation|0|||
131085224|NCT02637323|471945004|FG001|Overall Study|Protocol Violation|1|||
131085225|NCT01825577|471945005|FG000|Overall Study|Physician Decision|2|||
131085226|NCT01825577|471945005|FG000|Overall Study|Withdrawal by Subject|1|||
131085227|NCT01825577|471945005|FG000|Overall Study|Withdrawn by family members|2|||
131085228|NCT01825577|471945005|FG000|Overall Study|Lack of Efficacy|3|||
131085229|NCT00358644|471945006|FG000|Overall Study|Progressive Disease|21|||
131085230|NCT00358644|471945006|FG000|Overall Study|Adverse Event|7|||
131085231|NCT00358644|471945006|FG000|Overall Study|Death|11|||
131085232|NCT00358644|471945006|FG000|Overall Study|Withdrawal by Subject|4|||
131085233|NCT00358644|471945006|FG000|Overall Study|Physician Decision|6|||
131085234|NCT00358644|471945006|FG000|Overall Study|Patient not eligible for study|1|||
131085235|NCT00513708|471945007|FG000|Overall Study|Lost to Follow-up|4|||
131085236|NCT00513708|471945008|FG001|Overall Study|Lost to Follow-up|4|||
131085237|NCT00513708|471945009|FG002|Overall Study|Lost to Follow-up|4|||
131085238|NCT03327831|471945010|FG000|Overall Study|Lost to Follow-up|2|||
131085239|NCT01162486|471945011|FG000|Overall Study|low ANC|1|||
131085240|NCT01162486|471945012|FG001|Overall Study|low ANC|0|||
131085241|NCT01162486|471945013|FG002|Overall Study|low ANC|0|||
131085242|NCT01162486|471945014|FG003|Overall Study|low ANC|0|||
131085243|NCT01162486|471945015|FG004|Overall Study|low ANC|0|||
131085244|NCT01162486|471945011|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
131085245|NCT01162486|471945012|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
131085246|NCT01162486|471945013|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
131085247|NCT01162486|471945014|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
131085248|NCT01162486|471945015|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
131085249|NCT01162486|471945011|FG000|Overall Study|elevated LFTs|0|||
131085250|NCT01162486|471945012|FG001|Overall Study|elevated LFTs|0|||
131085251|NCT01162486|471945013|FG002|Overall Study|elevated LFTs|1|||
131085252|NCT01162486|471945014|FG003|Overall Study|elevated LFTs|0|||
131085253|NCT01162486|471945015|FG004|Overall Study|elevated LFTs|0|||
131085254|NCT01162486|471945011|FG000|Overall Study|Pregnancy|0|||
131085255|NCT01162486|471945012|FG001|Overall Study|Pregnancy|0|||
131085256|NCT01162486|471945013|FG002|Overall Study|Pregnancy|0|||
131085257|NCT01162486|471945014|FG003|Overall Study|Pregnancy|1|||
131085258|NCT01162486|471945015|FG004|Overall Study|Pregnancy|0|||
131085259|NCT03332784|471945018|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085260|NCT03332784|471945019|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
131085261|NCT03332784|471945020|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085262|NCT03332784|471945021|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085263|NCT03332784|471945022|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085264|NCT03332784|471945023|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085265|NCT03332784|471945024|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085266|NCT03332784|471945025|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085267|NCT03332784|471945026|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085268|NCT03332784|471945027|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085269|NCT03332784|471945028|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085270|NCT03332784|471945029|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085271|NCT03332784|471945030|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085272|NCT03332784|471945031|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085273|NCT03332784|471945032|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
131085274|NCT03332784|471945033|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085275|NCT03332784|471945034|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085276|NCT03332784|471945035|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085277|NCT03332784|471945036|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085278|NCT03332784|471945037|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
131085279|NCT00401258|471945038|FG000|Overall Study|Adverse Event|7|||
131085280|NCT01430468|471945039|FG000|Overall Study|Physician Decision|2|||
131085281|NCT01430468|471945040|FG001|Overall Study|Physician Decision|1|||
131085282|NCT01430468|471945039|FG000|Overall Study|Withdrawal by Subject|5|||
131085283|NCT01430468|471945040|FG001|Overall Study|Withdrawal by Subject|5|||
131085284|NCT00760747|471945045|FG000|Study Period II|Adverse Event|3|||
131085285|NCT00760747|471945046|FG001|Study Period II|Adverse Event|4|||
131085286|NCT00760747|471945045|FG000|Study Period II|Lack of Efficacy|0|||
131085287|NCT00760747|471945046|FG001|Study Period II|Lack of Efficacy|6|||
131085288|NCT00760747|471945045|FG000|Study Period II|Parent/Caregiver Decision|3|||
131085289|NCT00760747|471945046|FG001|Study Period II|Parent/Caregiver Decision|0|||
131085290|NCT00760747|471945045|FG000|Study Period II|Protocol Violation|6|||
131085291|NCT00760747|471945046|FG001|Study Period II|Protocol Violation|3|||
131085292|NCT00760747|471945045|FG000|Study Period II|Withdrawal by Subject|1|||
131085293|NCT00760747|471945046|FG001|Study Period II|Withdrawal by Subject|0|||
131085294|NCT00760747|471945045|FG000|Study Period II|No drug administered|0|||
131085295|NCT00760747|471945046|FG001|Study Period II|No drug administered|1|||
131085296|NCT00760747|471945045|FG000|Study Period III|Adverse Event|1|||
131085297|NCT00760747|471945046|FG001|Study Period III|Adverse Event|0|||
131085298|NCT00760747|471945045|FG000|Study Period III|Lack of Efficacy|1|||
131085299|NCT00760747|471945046|FG001|Study Period III|Lack of Efficacy|0|||
131085300|NCT00760747|471945045|FG000|Study Period III|Parent/Caregiver Decision|0|||
131085301|NCT00760747|471945046|FG001|Study Period III|Parent/Caregiver Decision|1|||
131085302|NCT00760747|471945045|FG000|Study Period III|Protocol Violation|1|||
131085303|NCT00760747|471945046|FG001|Study Period III|Protocol Violation|1|||
131085304|NCT00760747|471945045|FG000|Study Period III|Physician Decision|0|||
131085305|NCT00760747|471945046|FG001|Study Period III|Physician Decision|1|||
131085306|NCT01443923|471945047|FG000|Overall Study|Adverse Event|1|||
131085307|NCT01443923|471945048|FG001|Overall Study|Adverse Event|0|||
131085308|NCT00108745|471945049|FG000|Overall Study|Withdrawal by Subject|19|||
131085309|NCT00108745|471945050|FG001|Overall Study|Withdrawal by Subject|12|||
131085310|NCT00108745|471945051|FG002|Overall Study|Withdrawal by Subject|12|||
131085311|NCT00108745|471945049|FG000|Overall Study|Never Treated|8|||
131085312|NCT00108745|471945050|FG001|Overall Study|Never Treated|10|||
131085313|NCT00108745|471945051|FG002|Overall Study|Never Treated|12|||
131085314|NCT00108745|471945049|FG000|Overall Study|Ineligible|7|||
131085315|NCT00108745|471945050|FG001|Overall Study|Ineligible|13|||
131085316|NCT00108745|471945051|FG002|Overall Study|Ineligible|13|||
131085317|NCT01889069|471945052|FG000|Overall Study|Death|18|||
131085318|NCT01889069|471945052|FG000|Overall Study|Progression of Disease|14|||
131085319|NCT01889069|471945052|FG000|Overall Study|Lost to Follow-up|6|||
131085320|NCT01889069|471945052|FG000|Overall Study|Other|4|||
131085321|NCT01889069|471945052|FG000|Overall Study|Consent Withdrawal|3|||
131085322|NCT01426347|471945054|FG000|Overall Study|Lost to Follow-up|0|||
131085323|NCT01426347|471945055|FG001|Overall Study|Lost to Follow-up|3|||
131085324|NCT01426347|471945054|FG000|Overall Study|Protocol Violation|2|||
131085325|NCT01426347|471945055|FG001|Overall Study|Protocol Violation|0|||
131085326|NCT01426347|471945054|FG000|Overall Study|Withdrawal by Subject|5|||
131085327|NCT01426347|471945055|FG001|Overall Study|Withdrawal by Subject|0|||
131085328|NCT00455741|471945056|FG000|Overall Study|Physician Decision|0|||
131085329|NCT00455741|471945057|FG001|Overall Study|Physician Decision|1|||
131085330|NCT01245374|471945062|FG000|Overall Study|Protocol Violation|1|||
131085331|NCT01245374|471945062|FG000|Overall Study|Withdrawal by Subject|3|||
131085332|NCT00935532|471945063|FG000|Overall Study|Adverse Event|11|||
131085333|NCT00935532|471945064|FG001|Overall Study|Adverse Event|6|||
131085334|NCT00935532|471945063|FG000|Overall Study|Death|1|||
131085335|NCT00935532|471945064|FG001|Overall Study|Death|0|||
131085336|NCT00935532|471945063|FG000|Overall Study|Lost to Follow-up|1|||
131085337|NCT00935532|471945064|FG001|Overall Study|Lost to Follow-up|0|||
131085338|NCT00935532|471945063|FG000|Overall Study|Physician Decision|1|||
131085339|NCT00935532|471945064|FG001|Overall Study|Physician Decision|2|||
131085340|NCT00935532|471945063|FG000|Overall Study|Protocol Violation|2|||
131085341|NCT00935532|471945064|FG001|Overall Study|Protocol Violation|1|||
131085342|NCT00935532|471945063|FG000|Overall Study|Subject Decision|2|||
131085343|NCT00935532|471945064|FG001|Overall Study|Subject Decision|1|||
131085344|NCT00935532|471945063|FG000|Overall Study|Sponsor Decision|0|||
131085345|NCT00935532|471945064|FG001|Overall Study|Sponsor Decision|1|||
131085346|NCT00935532|471945063|FG000|Overall Study|Loss Glucose Control|4|||
131085347|NCT00935532|471945064|FG001|Overall Study|Loss Glucose Control|0|||
131085348|NCT04954326|471945065|FG000|Overall Study|Protocol Violation|0|||
131085349|NCT04954326|471945066|FG001|Overall Study|Protocol Violation|1|||
131085350|NCT04954326|471945065|FG000|Overall Study|Death|0|||
131085351|NCT04954326|471945066|FG001|Overall Study|Death|2|||
131085352|NCT04954326|471945065|FG000|Overall Study|Physician Decision|0|||
131085353|NCT04954326|471945066|FG001|Overall Study|Physician Decision|1|||
131085354|NCT00475228|471945067|FG000|Overall Study|Lost to Follow-up|17|||
131085355|NCT00475228|471945068|FG001|Overall Study|Lost to Follow-up|17|||
131085356|NCT01183390|471947530|FG000|First Intervention|Adverse Event|0|||
131085357|NCT01183390|471947531|FG001|First Intervention|Adverse Event|1|||
131085358|NCT02358668|471947532|FG000|Overall Study|Adverse Event|2|||
131085359|NCT02358668|471947533|FG001|Overall Study|Adverse Event|0|||
131085360|NCT02358668|471947534|FG002|Overall Study|Adverse Event|0|||
131085361|NCT02358668|471947532|FG000|Overall Study|Withdrawal by Subject|0|||
131085362|NCT02358668|471947533|FG001|Overall Study|Withdrawal by Subject|1|||
131085363|NCT02358668|471947534|FG002|Overall Study|Withdrawal by Subject|0|||
131085364|NCT01730950|471947537|FG000|Overall Study|Protocol Violation|6|||
131085365|NCT01730950|471947538|FG001|Overall Study|Protocol Violation|6|||
131085366|NCT01381575|471947539|FG000|Overall Study|Serious Adverse Event|1|||
131085367|NCT01381575|471947540|FG001|Overall Study|Serious Adverse Event|0|||
131085368|NCT01381575|471947541|FG002|Overall Study|Serious Adverse Event|0|||
131085369|NCT01381575|471947539|FG000|Overall Study|Non-Serious Adverse Event|0|||
131085370|NCT01381575|471947540|FG001|Overall Study|Non-Serious Adverse Event|0|||
131085371|NCT01381575|471947541|FG002|Overall Study|Non-Serious Adverse Event|1|||
131085372|NCT01381575|471947539|FG000|Overall Study|Protocol Violation|0|||
131085373|NCT01381575|471947540|FG001|Overall Study|Protocol Violation|1|||
131085374|NCT01381575|471947541|FG002|Overall Study|Protocol Violation|1|||
131085375|NCT01381575|471947539|FG000|Overall Study|Withdrawal by Subject|15|||
131085376|NCT01381575|471947540|FG001|Overall Study|Withdrawal by Subject|9|||
131085377|NCT01381575|471947541|FG002|Overall Study|Withdrawal by Subject|7|||
131085378|NCT01381575|471947539|FG000|Overall Study|Migrated/moved from study area|2|||
131085379|NCT01381575|471947540|FG001|Overall Study|Migrated/moved from study area|12|||
131085380|NCT01381575|471947541|FG002|Overall Study|Migrated/moved from study area|2|||
131085381|NCT01381575|471947539|FG000|Overall Study|Lost to Follow-up|8|||
131085382|NCT01381575|471947540|FG001|Overall Study|Lost to Follow-up|17|||
131085383|NCT01381575|471947541|FG002|Overall Study|Lost to Follow-up|9|||
131085384|NCT01443403|471947542|FG000|Overall Study|Adverse Event|1|||
131085385|NCT01443403|471947543|FG001|Overall Study|Adverse Event|1|||
131085386|NCT01443403|471947544|FG002|Overall Study|Adverse Event|4|||
131085387|NCT01443403|471947545|FG003|Overall Study|Adverse Event|5|||
131085388|NCT01443403|471947542|FG000|Overall Study|Withdrawal by Subject|0|||
131085389|NCT01443403|471947543|FG001|Overall Study|Withdrawal by Subject|1|||
131085390|NCT01443403|471947544|FG002|Overall Study|Withdrawal by Subject|2|||
131085391|NCT01443403|471947545|FG003|Overall Study|Withdrawal by Subject|1|||
131085392|NCT01443403|471947542|FG000|Overall Study|Lost to Follow-up|0|||
131085393|NCT01443403|471947543|FG001|Overall Study|Lost to Follow-up|0|||
131085394|NCT01443403|471947544|FG002|Overall Study|Lost to Follow-up|0|||
131085395|NCT01443403|471947545|FG003|Overall Study|Lost to Follow-up|1|||
131085396|NCT01443403|471947542|FG000|Overall Study|Protocol Violation|2|||
131085397|NCT01443403|471947543|FG001|Overall Study|Protocol Violation|1|||
131085398|NCT01443403|471947544|FG002|Overall Study|Protocol Violation|1|||
131085399|NCT01443403|471947545|FG003|Overall Study|Protocol Violation|1|||
131085400|NCT01443403|471947542|FG000|Overall Study|Use of Prohibited Treatment|2|||
131085401|NCT01443403|471947543|FG001|Overall Study|Use of Prohibited Treatment|3|||
131085402|NCT01443403|471947544|FG002|Overall Study|Use of Prohibited Treatment|0|||
131085403|NCT01443403|471947545|FG003|Overall Study|Use of Prohibited Treatment|0|||
131085404|NCT01443403|471947542|FG000|Overall Study|Other - Miscellaneous|1|||
131085405|NCT01443403|471947543|FG001|Overall Study|Other - Miscellaneous|0|||
131141714|NCT02913313|472146514|FG013|Overall Study|DISEASE PROGRESSION|3|||
131141715|NCT02913313|472146501|FG000|Overall Study|Not Reported|0|||
131141716|NCT02913313|472146502|FG001|Overall Study|Not Reported|0|||
131141717|NCT02913313|472146503|FG002|Overall Study|Not Reported|0|||
131141718|NCT02913313|472146504|FG003|Overall Study|Not Reported|0|||
131141719|NCT02913313|472146505|FG004|Overall Study|Not Reported|1|||
131141720|NCT02913313|472146506|FG005|Overall Study|Not Reported|0|||
131141721|NCT02913313|472146507|FG006|Overall Study|Not Reported|0|||
131141722|NCT02913313|472146508|FG007|Overall Study|Not Reported|0|||
131141723|NCT02913313|472146509|FG008|Overall Study|Not Reported|0|||
131141724|NCT02913313|472146510|FG009|Overall Study|Not Reported|0|||
131141725|NCT02913313|472146511|FG010|Overall Study|Not Reported|4|||
131141726|NCT02913313|472146512|FG011|Overall Study|Not Reported|0|||
131141727|NCT02913313|472146513|FG012|Overall Study|Not Reported|0|||
131141728|NCT02913313|472146514|FG013|Overall Study|Not Reported|0|||
131141729|NCT02913313|472146501|FG000|Overall Study|Other reasons|0|||
131141730|NCT02913313|472146502|FG001|Overall Study|Other reasons|0|||
131141731|NCT02913313|472146503|FG002|Overall Study|Other reasons|0|||
131141732|NCT02913313|472146504|FG003|Overall Study|Other reasons|0|||
131141733|NCT02913313|472146505|FG004|Overall Study|Other reasons|1|||
131141734|NCT02913313|472146506|FG005|Overall Study|Other reasons|0|||
131141735|NCT02913313|472146507|FG006|Overall Study|Other reasons|0|||
131141736|NCT02913313|472146508|FG007|Overall Study|Other reasons|0|||
131141737|NCT02913313|472146509|FG008|Overall Study|Other reasons|0|||
131141738|NCT02913313|472146510|FG009|Overall Study|Other reasons|0|||
131141739|NCT02913313|472146511|FG010|Overall Study|Other reasons|1|||
131141740|NCT02913313|472146512|FG011|Overall Study|Other reasons|0|||
131141741|NCT02913313|472146513|FG012|Overall Study|Other reasons|0|||
131141742|NCT02913313|472146514|FG013|Overall Study|Other reasons|0|||
131085406|NCT01443403|471947544|FG002|Overall Study|Other - Miscellaneous|0|||
131085407|NCT01443403|471947545|FG003|Overall Study|Other - Miscellaneous|1|||
131233695|NCT02308111|472482562|FG001|Overall Study|Lost to Follow-up|7|||
131233696|NCT02308111|472482561|FG000|Overall Study|Physician Decision|6|||
131233697|NCT02308111|472482562|FG001|Overall Study|Physician Decision|17|||
131233698|NCT02308111|472482561|FG000|Overall Study|Protocol Violation|0|||
131085408|NCT00474526|471947546|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
131085409|NCT00474526|471947547|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
131085410|NCT00474526|471947548|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
131085411|NCT00474526|471947549|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
131085412|NCT00474526|471947550|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
131085413|NCT00474526|471947551|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
131085414|NCT00474526|471947552|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
131085415|NCT00474526|471947553|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
131085416|NCT00474526|471947554|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
131085417|NCT00474526|471947555|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
131085418|NCT00474526|471947556|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
131085419|NCT00474526|471947557|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
131085420|NCT00474526|471947558|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
131085421|NCT00474526|471947559|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
131085422|NCT00474526|471947560|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
131085423|NCT00474526|471947561|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
131085424|NCT00474526|471947562|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
131085425|NCT00474526|471947546|FG000|Overall Study|Adverse Event|2|||
131085426|NCT00474526|471947547|FG001|Overall Study|Adverse Event|0|||
131085427|NCT00474526|471947548|FG002|Overall Study|Adverse Event|2|||
131085428|NCT00474526|471947549|FG003|Overall Study|Adverse Event|4|||
131085429|NCT00474526|471947550|FG004|Overall Study|Adverse Event|2|||
131141743|NCT02913313|472146501|FG000|Overall Study|Withdrawal by Subject|0|||
131141744|NCT02913313|472146502|FG001|Overall Study|Withdrawal by Subject|0|||
131141745|NCT02913313|472146503|FG002|Overall Study|Withdrawal by Subject|1|||
131141746|NCT02913313|472146504|FG003|Overall Study|Withdrawal by Subject|0|||
131141747|NCT02913313|472146505|FG004|Overall Study|Withdrawal by Subject|0|||
131141748|NCT02913313|472146506|FG005|Overall Study|Withdrawal by Subject|0|||
131141749|NCT02913313|472146507|FG006|Overall Study|Withdrawal by Subject|1|||
131141750|NCT02913313|472146508|FG007|Overall Study|Withdrawal by Subject|1|||
131141751|NCT02913313|472146509|FG008|Overall Study|Withdrawal by Subject|0|||
131141752|NCT02913313|472146510|FG009|Overall Study|Withdrawal by Subject|0|||
131141753|NCT02913313|472146511|FG010|Overall Study|Withdrawal by Subject|1|||
131141754|NCT02913313|472146512|FG011|Overall Study|Withdrawal by Subject|0|||
131141755|NCT02913313|472146513|FG012|Overall Study|Withdrawal by Subject|0|||
131141756|NCT02913313|472146514|FG013|Overall Study|Withdrawal by Subject|0|||
131141757|NCT02913313|472146501|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131233699|NCT02308111|472482562|FG001|Overall Study|Protocol Violation|1|||
131085430|NCT00474526|471947551|FG005|Overall Study|Adverse Event|1|||
131085431|NCT00474526|471947552|FG006|Overall Study|Adverse Event|1|||
131085432|NCT00474526|471947553|FG007|Overall Study|Adverse Event|0|||
131233700|NCT02308111|472482561|FG000|Overall Study|Withdrawal by Subject|28|||
131233701|NCT02308111|472482562|FG001|Overall Study|Withdrawal by Subject|38|||
131085433|NCT00474526|471947554|FG008|Overall Study|Adverse Event|0|||
131085434|NCT00474526|471947555|FG009|Overall Study|Adverse Event|0|||
131085435|NCT00474526|471947556|FG010|Overall Study|Adverse Event|0|||
131085436|NCT00474526|471947557|FG011|Overall Study|Adverse Event|0|||
131085437|NCT00474526|471947558|FG012|Overall Study|Adverse Event|0|||
131085438|NCT00474526|471947559|FG013|Overall Study|Adverse Event|0|||
131085439|NCT00474526|471947560|FG014|Overall Study|Adverse Event|1|||
131085440|NCT00474526|471947561|FG015|Overall Study|Adverse Event|1|||
131085441|NCT00474526|471947562|FG016|Overall Study|Adverse Event|0|||
131085442|NCT00474526|471947546|FG000|Overall Study|Death|0|||
131085443|NCT00474526|471947547|FG001|Overall Study|Death|0|||
131085444|NCT00474526|471947548|FG002|Overall Study|Death|0|||
131085445|NCT00474526|471947549|FG003|Overall Study|Death|0|||
131085446|NCT00474526|471947550|FG004|Overall Study|Death|0|||
131085447|NCT00474526|471947551|FG005|Overall Study|Death|0|||
131085448|NCT00474526|471947552|FG006|Overall Study|Death|0|||
131085449|NCT00474526|471947553|FG007|Overall Study|Death|0|||
131085450|NCT00474526|471947554|FG008|Overall Study|Death|0|||
131085451|NCT00474526|471947555|FG009|Overall Study|Death|0|||
131085452|NCT00474526|471947556|FG010|Overall Study|Death|0|||
131085453|NCT00474526|471947557|FG011|Overall Study|Death|0|||
131085454|NCT00474526|471947558|FG012|Overall Study|Death|0|||
131085455|NCT00474526|471947559|FG013|Overall Study|Death|3|||
131085456|NCT00474526|471947560|FG014|Overall Study|Death|0|||
131141758|NCT02913313|472146502|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131141759|NCT02913313|472146503|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131141760|NCT02913313|472146504|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131141761|NCT02913313|472146505|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131141762|NCT02913313|472146506|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131141763|NCT02913313|472146507|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131141764|NCT02913313|472146508|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131141765|NCT02913313|472146509|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131141766|NCT02913313|472146510|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131141767|NCT02913313|472146511|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
131141768|NCT02913313|472146512|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
131141769|NCT02913313|472146513|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
131141770|NCT02913313|472146514|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
131141771|NCT02913313|472146501|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
131141772|NCT02913313|472146502|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
131141773|NCT02913313|472146503|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
131141774|NCT02913313|472146504|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
131141775|NCT02913313|472146505|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
131141776|NCT02913313|472146506|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
131141777|NCT02913313|472146507|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
131141778|NCT02913313|472146508|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
131141779|NCT02913313|472146509|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
131141780|NCT02913313|472146510|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
131141781|NCT02913313|472146511|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
131141782|NCT02913313|472146512|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
131141783|NCT02913313|472146513|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
131141784|NCT02913313|472146514|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
131141785|NCT04088409|472146515|FG000|Part A|Withdrawal by Subject|2|||
131141786|NCT04088409|472146516|FG001|Part A|Withdrawal by Subject|1|||
131141787|NCT04088409|472146515|FG000|Part A|Did Not Meet Randomization Criteria|2|||
131141788|NCT04088409|472146516|FG001|Part A|Did Not Meet Randomization Criteria|0|||
131141789|NCT04088409|472146515|FG000|Part A|Lack of Efficacy|9|||
131141790|NCT04088409|472146516|FG001|Part A|Lack of Efficacy|0|||
131141791|NCT04088409|472146515|FG000|Part A|Lost to Follow-up|1|||
131141792|NCT04088409|472146516|FG001|Part A|Lost to Follow-up|0|||
131141793|NCT04088409|472146515|FG000|Part A|Adverse Event|1|||
131141794|NCT04088409|472146516|FG001|Part A|Adverse Event|0|||
131141795|NCT04088409|472146515|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
131141796|NCT04088409|472146516|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
131141797|NCT04088409|472146515|FG000|Part B|Ongoing Treatment|10|||
131085457|NCT00474526|471947561|FG015|Overall Study|Death|0|||
131141798|NCT04088409|472146516|FG001|Part B|Ongoing Treatment|0|||
131085458|NCT00474526|471947562|FG016|Overall Study|Death|0|||
131141799|NCT04233229|472146517|FG000|Overall Study|Withdrawal by Subject|0|||
131141800|NCT04233229|472146518|FG001|Overall Study|Withdrawal by Subject|1|||
131141801|NCT04233229|472146517|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
131085459|NCT00474526|471947546|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085460|NCT00474526|471947547|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
131085461|NCT00474526|471947548|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085462|NCT00474526|471947549|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
131085463|NCT00474526|471947550|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
131085464|NCT00474526|471947551|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085465|NCT00474526|471947552|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131141802|NCT04233229|472146518|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
131085466|NCT00474526|471947553|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085467|NCT00474526|471947554|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085468|NCT00474526|471947555|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085469|NCT00474526|471947556|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085470|NCT00474526|471947557|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085471|NCT00474526|471947558|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085472|NCT00474526|471947559|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
131085473|NCT00474526|471947560|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
131085474|NCT00474526|471947561|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085475|NCT00474526|471947562|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
131085476|NCT00474526|471947546|FG000|Overall Study|Lost to Follow-up|8|||
131085477|NCT00474526|471947547|FG001|Overall Study|Lost to Follow-up|6|||
131085478|NCT00474526|471947548|FG002|Overall Study|Lost to Follow-up|13|||
131085479|NCT00474526|471947549|FG003|Overall Study|Lost to Follow-up|29|||
131085480|NCT00474526|471947550|FG004|Overall Study|Lost to Follow-up|11|||
131085481|NCT00474526|471947551|FG005|Overall Study|Lost to Follow-up|5|||
131085482|NCT00474526|471947552|FG006|Overall Study|Lost to Follow-up|8|||
131085483|NCT00474526|471947553|FG007|Overall Study|Lost to Follow-up|1|||
131085484|NCT00474526|471947554|FG008|Overall Study|Lost to Follow-up|0|||
131085485|NCT00474526|471947555|FG009|Overall Study|Lost to Follow-up|6|||
131085486|NCT00474526|471947556|FG010|Overall Study|Lost to Follow-up|2|||
131085487|NCT00474526|471947557|FG011|Overall Study|Lost to Follow-up|4|||
131085488|NCT00474526|471947558|FG012|Overall Study|Lost to Follow-up|6|||
131085489|NCT00474526|471947559|FG013|Overall Study|Lost to Follow-up|74|||
131085490|NCT00474526|471947560|FG014|Overall Study|Lost to Follow-up|29|||
131085491|NCT00474526|471947561|FG015|Overall Study|Lost to Follow-up|4|||
131085492|NCT00474526|471947562|FG016|Overall Study|Lost to Follow-up|5|||
131085493|NCT00474526|471947546|FG000|Overall Study|Protocol Violation|2|||
131085494|NCT00474526|471947547|FG001|Overall Study|Protocol Violation|6|||
131085495|NCT00474526|471947548|FG002|Overall Study|Protocol Violation|4|||
131085496|NCT00474526|471947549|FG003|Overall Study|Protocol Violation|12|||
131085497|NCT00474526|471947550|FG004|Overall Study|Protocol Violation|3|||
131085498|NCT00474526|471947551|FG005|Overall Study|Protocol Violation|1|||
131085499|NCT00474526|471947552|FG006|Overall Study|Protocol Violation|3|||
131085500|NCT00474526|471947553|FG007|Overall Study|Protocol Violation|0|||
131141803|NCT04233229|472146517|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
131141804|NCT04233229|472146518|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
131141805|NCT00841763|472146519|FG000|Overall Study|Withdrawal by Subject|60|||
131141806|NCT00841763|472146520|FG001|Overall Study|Withdrawal by Subject|17|||
131141807|NCT00841763|472146521|FG002|Overall Study|Withdrawal by Subject|4|||
131141808|NCT00841763|472146522|FG003|Overall Study|Withdrawal by Subject|1|||
131141809|NCT00841763|472146519|FG000|Overall Study|Adverse Event|9|||
131141810|NCT00841763|472146520|FG001|Overall Study|Adverse Event|10|||
131141811|NCT00841763|472146521|FG002|Overall Study|Adverse Event|3|||
131141812|NCT00841763|472146522|FG003|Overall Study|Adverse Event|2|||
131141813|NCT00841763|472146519|FG000|Overall Study|Lost to Follow-up|63|||
131141814|NCT00841763|472146520|FG001|Overall Study|Lost to Follow-up|25|||
131141815|NCT00841763|472146521|FG002|Overall Study|Lost to Follow-up|0|||
131141816|NCT00841763|472146522|FG003|Overall Study|Lost to Follow-up|0|||
131141817|NCT00841763|472146519|FG000|Overall Study|Protocol Violation|20|||
131141818|NCT00841763|472146520|FG001|Overall Study|Protocol Violation|3|||
131141819|NCT00841763|472146521|FG002|Overall Study|Protocol Violation|1|||
131141820|NCT00841763|472146522|FG003|Overall Study|Protocol Violation|0|||
131141821|NCT00841763|472146519|FG000|Overall Study|Administrative Reasons|3|||
131141822|NCT00841763|472146520|FG001|Overall Study|Administrative Reasons|1|||
131141823|NCT00841763|472146521|FG002|Overall Study|Administrative Reasons|0|||
131085501|NCT00474526|471947554|FG008|Overall Study|Protocol Violation|0|||
131085502|NCT00474526|471947555|FG009|Overall Study|Protocol Violation|4|||
131141824|NCT00841763|472146522|FG003|Overall Study|Administrative Reasons|0|||
131141825|NCT00841763|472146519|FG000|Overall Study|Unable to Classify|7|||
131141826|NCT00841763|472146520|FG001|Overall Study|Unable to Classify|1|||
131233702|NCT02308111|472482561|FG000|Overall Study|Study Terminated by Sponsor|72|||
131233703|NCT02308111|472482562|FG001|Overall Study|Study Terminated by Sponsor|61|||
131085503|NCT00474526|471947556|FG010|Overall Study|Protocol Violation|2|||
131141827|NCT00841763|472146521|FG002|Overall Study|Unable to Classify|0|||
131141828|NCT00841763|472146522|FG003|Overall Study|Unable to Classify|0|||
131233704|NCT02308111|472482561|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
131141829|NCT00648167|472146523|FG000|Overall Study|Adverse Event|6|||
131233705|NCT02308111|472482562|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
131233706|NCT02308111|472482561|FG000|Overall Study|Site Closure|3|||
130780270|NCT02600923|470821475|FG000|Overall Study|Adverse Event|3|||
131085504|NCT00474526|471947557|FG011|Overall Study|Protocol Violation|2|||
131085505|NCT00474526|471947558|FG012|Overall Study|Protocol Violation|4|||
131085506|NCT00474526|471947559|FG013|Overall Study|Protocol Violation|19|||
131085507|NCT00474526|471947560|FG014|Overall Study|Protocol Violation|9|||
131085508|NCT00474526|471947561|FG015|Overall Study|Protocol Violation|6|||
131085509|NCT00474526|471947562|FG016|Overall Study|Protocol Violation|2|||
131085510|NCT00474526|471947546|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
131085511|NCT00474526|471947547|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
131085512|NCT00474526|471947548|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
131085513|NCT00474526|471947549|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
131085514|NCT00474526|471947550|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
131085515|NCT00474526|471947551|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
131085516|NCT00474526|471947552|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
131085517|NCT00474526|471947553|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
131085518|NCT00474526|471947554|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
131085519|NCT00474526|471947555|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
131085520|NCT00474526|471947556|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
131085521|NCT00474526|471947557|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
131085522|NCT00474526|471947558|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
131085523|NCT00474526|471947559|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
131085524|NCT00474526|471947560|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
131085525|NCT00474526|471947561|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
131085526|NCT00474526|471947562|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
131085527|NCT00474526|471947546|FG000|Overall Study|Withdrawal by Subject|9|||
131085528|NCT00474526|471947547|FG001|Overall Study|Withdrawal by Subject|24|||
131085529|NCT00474526|471947548|FG002|Overall Study|Withdrawal by Subject|21|||
131085530|NCT00474526|471947549|FG003|Overall Study|Withdrawal by Subject|52|||
131085531|NCT00474526|471947550|FG004|Overall Study|Withdrawal by Subject|38|||
131085532|NCT00474526|471947551|FG005|Overall Study|Withdrawal by Subject|6|||
131085533|NCT00474526|471947552|FG006|Overall Study|Withdrawal by Subject|12|||
131085534|NCT00474526|471947553|FG007|Overall Study|Withdrawal by Subject|4|||
131085535|NCT00474526|471947554|FG008|Overall Study|Withdrawal by Subject|4|||
131085536|NCT00474526|471947555|FG009|Overall Study|Withdrawal by Subject|13|||
131085537|NCT00474526|471947556|FG010|Overall Study|Withdrawal by Subject|5|||
131085538|NCT00474526|471947557|FG011|Overall Study|Withdrawal by Subject|4|||
131085539|NCT00474526|471947558|FG012|Overall Study|Withdrawal by Subject|4|||
131085540|NCT00474526|471947559|FG013|Overall Study|Withdrawal by Subject|37|||
131085541|NCT00474526|471947560|FG014|Overall Study|Withdrawal by Subject|22|||
131085542|NCT00474526|471947561|FG015|Overall Study|Withdrawal by Subject|1|||
131085543|NCT00474526|471947562|FG016|Overall Study|Withdrawal by Subject|1|||
131085544|NCT04546217|471947565|FG000|Overall Study|Withdrawal by Subject|2|||
131085545|NCT04546217|471947566|FG001|Overall Study|Withdrawal by Subject|0|||
131085546|NCT04546217|471947565|FG000|Overall Study|Uncontrolled hypertension|1|||
131085547|NCT04546217|471947566|FG001|Overall Study|Uncontrolled hypertension|0|||
131085548|NCT02550938|471947567|FG000|Overall Study|Lost to Follow-up|8|||
131085549|NCT02550938|471947568|FG001|Overall Study|Lost to Follow-up|7|||
131085550|NCT02550938|471947569|FG002|Overall Study|Lost to Follow-up|12|||
131085551|NCT02550938|471947570|FG003|Overall Study|Lost to Follow-up|11|||
131085552|NCT01251770|471947571|FG000|Overall Study|Protocol Violation|13|||
131085553|NCT01251770|471947572|FG001|Overall Study|Protocol Violation|7|||
131085554|NCT01888874|471947576|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
131085555|NCT01888874|471947577|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
131085556|NCT01888874|471947578|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
131085557|NCT01888874|471947579|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
131085558|NCT01888874|471947580|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
131085559|NCT01888874|471947581|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
131085560|NCT01888874|471947582|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
131085561|NCT01888874|471947576|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
131085562|NCT01888874|471947577|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
131085563|NCT01888874|471947578|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
131085564|NCT01888874|471947579|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
131085565|NCT01888874|471947580|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
131085566|NCT01888874|471947581|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
131085567|NCT01888874|471947582|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
131085568|NCT01888874|471947576|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131085569|NCT01888874|471947577|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131085570|NCT01888874|471947578|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131085571|NCT01888874|471947579|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131085572|NCT01888874|471947580|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
131085573|NCT01888874|471947581|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
130727240|NCT02883049|470625424|FG000|Post Induction|Withdrawal by Subject|0|||
130727241|NCT02883049|470625425|FG001|Post Induction|Withdrawal by Subject|0|||
131085574|NCT01888874|471947582|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
131085575|NCT01888874|471947576|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
131085576|NCT01888874|471947577|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
131085577|NCT01888874|471947578|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
131085578|NCT01888874|471947579|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
131085579|NCT01888874|471947580|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
131085580|NCT01888874|471947581|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
131085581|NCT01888874|471947582|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
131085582|NCT01888874|471947576|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131085583|NCT01888874|471947577|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131085584|NCT01888874|471947578|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131085585|NCT01888874|471947579|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131085586|NCT01888874|471947580|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
131085587|NCT01888874|471947581|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131085588|NCT01888874|471947582|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131085589|NCT01888874|471947576|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131085590|NCT01888874|471947577|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
131085591|NCT01888874|471947578|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131085592|NCT01888874|471947579|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131085593|NCT01888874|471947580|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131085594|NCT01888874|471947581|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131085595|NCT01888874|471947582|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
131085596|NCT01888874|471947576|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
131085597|NCT01888874|471947577|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
131085598|NCT01888874|471947578|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
131085599|NCT01888874|471947579|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
131085600|NCT01888874|471947580|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
131085601|NCT01888874|471947581|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
131085602|NCT01888874|471947582|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
131085603|NCT01888874|471947576|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
131085604|NCT01888874|471947577|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
131085605|NCT01888874|471947578|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
131085606|NCT01888874|471947579|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131085607|NCT01888874|471947580|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
131085608|NCT01888874|471947581|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131085609|NCT01888874|471947582|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131085610|NCT01888874|471947576|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131085611|NCT01888874|471947577|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131085612|NCT01888874|471947578|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131085613|NCT01888874|471947579|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131085614|NCT01888874|471947580|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
131085615|NCT01888874|471947581|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131085616|NCT01888874|471947582|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
131085617|NCT01888874|471947576|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
131085618|NCT01888874|471947577|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
131085619|NCT01888874|471947578|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
131085620|NCT01888874|471947579|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
131085621|NCT01888874|471947580|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
131085622|NCT01888874|471947581|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
131085623|NCT01888874|471947582|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
131085624|NCT01888874|471947576|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131085625|NCT01888874|471947577|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131085626|NCT01888874|471947578|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
131085627|NCT01888874|471947579|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131085628|NCT01888874|471947580|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131085629|NCT01888874|471947581|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131085630|NCT01888874|471947582|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
131085631|NCT01888874|471947576|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
131085632|NCT01888874|471947577|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
131085633|NCT01888874|471947578|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
131085634|NCT01888874|471947579|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
131085635|NCT01888874|471947580|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
131085636|NCT01888874|471947581|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
131085637|NCT01888874|471947582|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
131085638|NCT01888874|471947576|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
131085639|NCT01888874|471947577|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
131085640|NCT01888874|471947578|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
131085641|NCT01888874|471947579|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
131085642|NCT01888874|471947580|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
131085643|NCT01888874|471947581|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
131085644|NCT01888874|471947582|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
131085645|NCT00953771|471947586|FG000|Overall Study|Death|1|||
131085646|NCT00953771|471947587|FG001|Overall Study|Death|0|||
131085647|NCT00884650|471947588|FG000|Overall Study|Did not return complete pain diaries|7|||
131085648|NCT00884650|471947589|FG001|Overall Study|Did not return complete pain diaries|7|||
131085649|NCT00884650|471947588|FG000|Overall Study|Admitted Post-Op|1|||
131085650|NCT00884650|471947589|FG001|Overall Study|Admitted Post-Op|0|||
131085651|NCT00884650|471947588|FG000|Overall Study|Femoral Stress Fracture|1|||
131085652|NCT00884650|471947589|FG001|Overall Study|Femoral Stress Fracture|0|||
131085653|NCT00884650|471947588|FG000|Overall Study|Pain Pump Complication|0|||
131085654|NCT00884650|471947589|FG001|Overall Study|Pain Pump Complication|1|||
131085655|NCT00979953|471947590|FG000|Overall Study|Adverse Event|5|||
131085656|NCT00979953|471947591|FG001|Overall Study|Adverse Event|2|||
131085657|NCT00979953|471947592|FG002|Overall Study|Adverse Event|17|||
131085658|NCT00979953|471947593|FG003|Overall Study|Adverse Event|4|||
131085659|NCT00979953|471947590|FG000|Overall Study|Lack of Efficacy|1|||
131085660|NCT00979953|471947591|FG001|Overall Study|Lack of Efficacy|2|||
131085661|NCT00979953|471947592|FG002|Overall Study|Lack of Efficacy|0|||
131085662|NCT00979953|471947593|FG003|Overall Study|Lack of Efficacy|0|||
131085663|NCT00979953|471947590|FG000|Overall Study|Lost to Follow-up|1|||
131085664|NCT00979953|471947591|FG001|Overall Study|Lost to Follow-up|1|||
131085665|NCT00979953|471947592|FG002|Overall Study|Lost to Follow-up|1|||
131085666|NCT00979953|471947593|FG003|Overall Study|Lost to Follow-up|0|||
131085667|NCT00979953|471947590|FG000|Overall Study|Withdrawal by Subject|0|||
131085668|NCT00979953|471947591|FG001|Overall Study|Withdrawal by Subject|0|||
131085669|NCT00979953|471947592|FG002|Overall Study|Withdrawal by Subject|2|||
131085670|NCT00979953|471947593|FG003|Overall Study|Withdrawal by Subject|1|||
131085671|NCT00979953|471947590|FG000|Overall Study|Protocol Violation|1|||
131085672|NCT00979953|471947591|FG001|Overall Study|Protocol Violation|0|||
131085673|NCT00979953|471947592|FG002|Overall Study|Protocol Violation|2|||
131085674|NCT00979953|471947593|FG003|Overall Study|Protocol Violation|2|||
131085675|NCT04052425|471947596|FG000|24-Week Double-blind Period|Adverse Event|0|||
131085676|NCT04052425|471947597|FG001|24-Week Double-blind Period|Adverse Event|1|||
131085677|NCT04052425|471947598|FG002|24-Week Double-blind Period|Adverse Event|0|||
131085678|NCT04052425|471947599|FG003|24-Week Double-blind Period|Adverse Event|0|||
131085679|NCT04052425|471947596|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
131085680|NCT04052425|471947597|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
131085681|NCT04052425|471947598|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
131085682|NCT04052425|471947599|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
131085683|NCT04052425|471947596|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
131085684|NCT04052425|471947597|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
131085685|NCT04052425|471947598|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
131085686|NCT04052425|471947599|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
131085687|NCT04052425|471947596|FG000|24-Week Double-blind Period|Physician Decision|1|||
131085688|NCT04052425|471947597|FG001|24-Week Double-blind Period|Physician Decision|0|||
131085689|NCT04052425|471947598|FG002|24-Week Double-blind Period|Physician Decision|0|||
131085690|NCT04052425|471947599|FG003|24-Week Double-blind Period|Physician Decision|0|||
131085691|NCT04052425|471947596|FG000|24-Week Double-blind Period|Protocol Violation|1|||
131085692|NCT04052425|471947597|FG001|24-Week Double-blind Period|Protocol Violation|0|||
131085693|NCT04052425|471947598|FG002|24-Week Double-blind Period|Protocol Violation|0|||
131085694|NCT04052425|471947599|FG003|24-Week Double-blind Period|Protocol Violation|0|||
131085695|NCT04052425|471947596|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
131085696|NCT04052425|471947597|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
131085697|NCT04052425|471947598|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
131085698|NCT04052425|471947599|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
131085699|NCT04052425|471947596|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
131085700|NCT04052425|471947597|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
131085701|NCT04052425|471947598|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
131085702|NCT04052425|471947599|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
131085703|NCT04052425|471947596|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
131085704|NCT04052425|471947597|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
131085705|NCT04052425|471947598|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
131085706|NCT04052425|471947599|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
131085707|NCT04052425|471947596|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
131085708|NCT04052425|471947597|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
131085709|NCT04052425|471947598|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
131085710|NCT04052425|471947599|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
131085711|NCT04052425|471947596|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
131085712|NCT04052425|471947597|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
131085713|NCT04052425|471947598|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
131085714|NCT04052425|471947599|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
131085715|NCT04052425|471947596|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
131085716|NCT04052425|471947597|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
131085717|NCT04052425|471947598|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
131085718|NCT04052425|471947599|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
131085719|NCT04052425|471947596|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
131085720|NCT04052425|471947597|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
131085721|NCT04052425|471947598|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
131085722|NCT04052425|471947599|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
131085723|NCT04052425|471947596|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
131085724|NCT04052425|471947597|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
131085725|NCT04052425|471947598|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
131085726|NCT04052425|471947599|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
131085727|NCT04052425|471947596|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
131085728|NCT04052425|471947597|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
131085729|NCT04052425|471947598|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
131085730|NCT04052425|471947599|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
131085731|NCT04334278|471947600|FG000|Overall Study|Lost to Follow-up|0|||
131085732|NCT04334278|471947601|FG001|Overall Study|Lost to Follow-up|3|||
131085733|NCT04334278|471947600|FG000|Overall Study|Withdrawal by Subject|4|||
131085734|NCT04334278|471947601|FG001|Overall Study|Withdrawal by Subject|2|||
131085735|NCT04829747|471947604|FG000|Overall Study|Protocol Violation|1|||
131085736|NCT02615509|471947605|FG000|Overall Study|Lost to Follow-up|134|||
131085737|NCT02615509|471947605|FG000|Overall Study|Death|4|||
131085738|NCT02615509|471947605|FG000|Overall Study|Withdrawal by Subject|8|||
131085739|NCT00425607|471947606|FG000|Overall Study|Death|1|||
131085740|NCT00425607|471947606|FG000|Overall Study|Withdrawal by Subject|1|||
131085741|NCT02563548|471947607|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
131085742|NCT02563548|471947608|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
131085743|NCT02563548|471947609|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
131085744|NCT02563548|471947610|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
131085745|NCT02563548|471947611|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
131085746|NCT02563548|471947612|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
131085747|NCT02563548|471947607|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
131085748|NCT02563548|471947608|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
131085749|NCT02563548|471947609|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
131085750|NCT02563548|471947610|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
131085751|NCT02563548|471947611|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
131085752|NCT02563548|471947612|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
131085753|NCT02563548|471947607|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
131085754|NCT02563548|471947608|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
131085755|NCT02563548|471947609|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
131085756|NCT02563548|471947610|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
131085757|NCT02563548|471947611|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
131085758|NCT02563548|471947612|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
131085759|NCT02563548|471947607|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
131085760|NCT02563548|471947608|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
131085761|NCT02563548|471947609|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
131085762|NCT02563548|471947610|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
131085763|NCT02563548|471947611|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
131085764|NCT02563548|471947612|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
131085765|NCT02563548|471947607|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
131085766|NCT02563548|471947608|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
131085767|NCT02563548|471947609|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
131085768|NCT02563548|471947610|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
131085769|NCT02563548|471947611|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
131085770|NCT02563548|471947612|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
131085771|NCT02563548|471947607|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
131085772|NCT02563548|471947608|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
131085773|NCT02563548|471947609|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
131085774|NCT02563548|471947610|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
131085775|NCT02563548|471947611|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
131085776|NCT02563548|471947612|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
131085777|NCT02563548|471947607|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
131085778|NCT02563548|471947608|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
131085779|NCT02563548|471947609|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
131085780|NCT02563548|471947610|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
131085781|NCT02563548|471947611|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
131085782|NCT02563548|471947612|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
131085783|NCT02563548|471947607|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
131233707|NCT02308111|472482562|FG001|Overall Study|Site Closure|3|||
131085784|NCT02563548|471947608|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
131085785|NCT02563548|471947609|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
131085786|NCT02563548|471947610|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
131085787|NCT02563548|471947611|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
131085788|NCT02563548|471947612|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
131085789|NCT02563548|471947607|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
131085790|NCT02563548|471947608|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
131085791|NCT02563548|471947609|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
131085792|NCT02563548|471947610|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
131085793|NCT02563548|471947611|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
131085794|NCT02563548|471947612|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
131085795|NCT02563548|471947607|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
131085796|NCT02563548|471947608|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
131085797|NCT02563548|471947609|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
131085798|NCT02563548|471947610|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
131085799|NCT02563548|471947611|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
131085800|NCT02563548|471947612|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
131085801|NCT02563548|471947607|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
131085802|NCT02563548|471947608|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
131085803|NCT02563548|471947609|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
131085804|NCT02563548|471947610|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
131085805|NCT02563548|471947611|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
131085806|NCT02563548|471947612|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
131085807|NCT02563548|471947607|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
131085808|NCT02563548|471947608|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
131085809|NCT02563548|471947609|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
131085810|NCT02563548|471947610|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
131085811|NCT02563548|471947611|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
131085812|NCT02563548|471947612|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
131085813|NCT01732549|471947615|FG000|Overall Study|Adverse Event|13|||
131085814|NCT01732549|471947616|FG001|Overall Study|Adverse Event|3|||
131085815|NCT01732549|471947615|FG000|Overall Study|Consent withdrawn|13|||
131085816|NCT01732549|471947616|FG001|Overall Study|Consent withdrawn|6|||
131085817|NCT01732549|471947615|FG000|Overall Study|Disease progression|37|||
131085818|NCT01732549|471947616|FG001|Overall Study|Disease progression|50|||
131085819|NCT01732549|471947615|FG000|Overall Study|Other|8|||
131085820|NCT01732549|471947616|FG001|Overall Study|Other|14|||
131085821|NCT00447590|471947619|FG000|Overall Study|Withdrawal by Subject|26|||
131085822|NCT00447590|471947619|FG000|Overall Study|Lost to Follow-up|24|||
131085823|NCT00447590|471947619|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
131085824|NCT01967069|471947620|FG000|Overall Study|Adverse Event|2|||
131085825|NCT01967069|471947621|FG001|Overall Study|Adverse Event|2|||
131085826|NCT01967069|471947620|FG000|Overall Study|Lost to Follow-up|5|||
131085827|NCT01967069|471947621|FG001|Overall Study|Lost to Follow-up|2|||
131085828|NCT01967069|471947620|FG000|Overall Study|Withdrawal by Subject|1|||
131085829|NCT01967069|471947621|FG001|Overall Study|Withdrawal by Subject|3|||
131085830|NCT01967069|471947620|FG000|Overall Study|Lack of Efficacy|0|||
131085831|NCT01967069|471947621|FG001|Overall Study|Lack of Efficacy|1|||
131085832|NCT04245345|471947628|FG000|Overall Study|Death|1|||
131141830|NCT00648167|472146523|FG000|Overall Study|unable to swallow tablets|1|||
131141831|NCT00927368|472146524|FG000|Overall Study|enrollment in another study|1|||
131141832|NCT00927368|472146525|FG001|Overall Study|enrollment in another study|1|||
131085833|NCT04245345|471947628|FG000|Overall Study|Exited prior to implant|5|||
131085834|NCT04245345|471947628|FG000|Overall Study|Exited prior to 1-month|9|||
131085835|NCT04245345|471947628|FG000|Overall Study|Missed 1-month visit|3|||
131085836|NCT04245345|471947628|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
131085837|NCT04245345|471947628|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
131141833|NCT00927368|472146526|FG002|Overall Study|enrollment in another study|2|||
131085838|NCT03933462|471947631|FG000|Overall Study|Adverse Event|2|||
131085839|NCT03933462|471947632|FG001|Overall Study|Adverse Event|0|||
131085840|NCT03355209|471947638|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
131085841|NCT03355209|471947639|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
131085842|NCT03355209|471947640|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
131085843|NCT03355209|471947641|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
131085844|NCT03355209|471947642|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
131085845|NCT03355209|471947643|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
131085846|NCT03355209|471947638|FG000|Part 1: Double-Blind Period|Death|0|||
131085847|NCT03355209|471947639|FG001|Part 1: Double-Blind Period|Death|0|||
131085848|NCT03355209|471947640|FG002|Part 1: Double-Blind Period|Death|1|||
131085849|NCT03355209|471947641|FG003|Part 1: Double-Blind Period|Death|0|||
131141834|NCT00927368|472146524|FG000|Overall Study|Lost to Follow-up|4|||
131141835|NCT00927368|472146525|FG001|Overall Study|Lost to Follow-up|0|||
131085850|NCT03355209|471947642|FG004|Part 1: Double-Blind Period|Death|0|||
131085851|NCT03355209|471947643|FG005|Part 1: Double-Blind Period|Death|0|||
131085852|NCT03355209|471947638|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
131085853|NCT03355209|471947639|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
131085854|NCT03355209|471947640|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
131085855|NCT03355209|471947641|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
131085856|NCT03355209|471947642|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
131085857|NCT03355209|471947643|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
131085858|NCT03355209|471947638|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
131085859|NCT03355209|471947639|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
131085860|NCT03355209|471947640|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
131085861|NCT03355209|471947641|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
131085862|NCT03355209|471947642|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
131085863|NCT03355209|471947643|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
131085864|NCT03355209|471947638|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
131085865|NCT03355209|471947639|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
131085866|NCT03355209|471947640|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
131085867|NCT03355209|471947641|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
131085868|NCT03355209|471947642|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
131085869|NCT03355209|471947643|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
131085870|NCT03355209|471947638|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
131085871|NCT03355209|471947639|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
131085872|NCT03355209|471947640|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
131085873|NCT03355209|471947641|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
131085874|NCT03355209|471947642|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
131085875|NCT03355209|471947643|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
131085876|NCT03355209|471947638|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
131085877|NCT03355209|471947639|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
131085878|NCT03355209|471947640|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
131085879|NCT03355209|471947641|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
131085880|NCT03355209|471947642|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
131085881|NCT03355209|471947643|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
131085882|NCT03355209|471947638|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
131085883|NCT03355209|471947639|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
131085884|NCT03355209|471947640|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
131085885|NCT03355209|471947641|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
131085886|NCT03355209|471947642|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
131085887|NCT03355209|471947643|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
131085888|NCT03355209|471947638|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
131085889|NCT03355209|471947639|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
131085890|NCT03355209|471947640|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
131085891|NCT03355209|471947641|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131085892|NCT03355209|471947642|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
131085893|NCT03355209|471947643|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131085894|NCT03355209|471947638|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
131085895|NCT03355209|471947639|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
131085896|NCT03355209|471947640|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
131085897|NCT03355209|471947641|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
131085898|NCT03355209|471947642|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
131085899|NCT03355209|471947643|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
131085900|NCT03355209|471947638|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
131085901|NCT03355209|471947639|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
131085902|NCT03355209|471947640|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
131085903|NCT03355209|471947641|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
131085904|NCT03355209|471947642|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
131141836|NCT00927368|472146526|FG002|Overall Study|Lost to Follow-up|0|||
131141837|NCT00927368|472146524|FG000|Overall Study|equipment failure|1|||
131141838|NCT00927368|472146525|FG001|Overall Study|equipment failure|0|||
131141839|NCT00927368|472146526|FG002|Overall Study|equipment failure|0|||
131141840|NCT00927368|472146524|FG000|Overall Study|ineligible post randomization|0|||
131141841|NCT00927368|472146525|FG001|Overall Study|ineligible post randomization|3|||
131141842|NCT00927368|472146526|FG002|Overall Study|ineligible post randomization|1|||
131141843|NCT00927368|472146524|FG000|Overall Study|cancellation of surgery|0|||
131141844|NCT00927368|472146525|FG001|Overall Study|cancellation of surgery|1|||
131085905|NCT03355209|471947643|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
131141845|NCT00927368|472146526|FG002|Overall Study|cancellation of surgery|2|||
131141846|NCT00331409|472146531|FG000|Overall Study|Lack of Efficacy|4|||
131085906|NCT00706654|471947644|FG000|Conversion Phase|Lost to Follow-up|4|||
131085907|NCT00706654|471947645|FG001|Conversion Phase|Lost to Follow-up|0|||
131085908|NCT00706654|471947646|FG002|Conversion Phase|Lost to Follow-up|0|||
131085909|NCT00706654|471947647|FG003|Conversion Phase|Lost to Follow-up|0|||
131085910|NCT00706654|471947644|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
131085911|NCT00706654|471947645|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
131085912|NCT00706654|471947646|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
131085913|NCT00706654|471947647|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
131085914|NCT00706654|471947644|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
131085915|NCT00706654|471947645|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
131085916|NCT00706654|471947646|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
131085917|NCT00706654|471947647|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
131085918|NCT00706654|471947644|FG000|Conversion Phase|Withdrawn by Investigator|14|||
131085919|NCT00706654|471947645|FG001|Conversion Phase|Withdrawn by Investigator|0|||
131085920|NCT00706654|471947646|FG002|Conversion Phase|Withdrawn by Investigator|0|||
131085921|NCT00706654|471947647|FG003|Conversion Phase|Withdrawn by Investigator|0|||
131085922|NCT00706654|471947644|FG000|Conversion Phase|Withdrew Consent|38|||
131085923|NCT00706654|471947645|FG001|Conversion Phase|Withdrew Consent|0|||
131085924|NCT00706654|471947646|FG002|Conversion Phase|Withdrew Consent|0|||
131085925|NCT00706654|471947647|FG003|Conversion Phase|Withdrew Consent|0|||
131085926|NCT00706654|471947644|FG000|Conversion Phase|Adverse Event|18|||
131085927|NCT00706654|471947645|FG001|Conversion Phase|Adverse Event|0|||
131085928|NCT00706654|471947646|FG002|Conversion Phase|Adverse Event|0|||
131085929|NCT00706654|471947647|FG003|Conversion Phase|Adverse Event|0|||
131085930|NCT00706654|471947644|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
131085931|NCT00706654|471947645|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
131085932|NCT00706654|471947646|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
131085933|NCT00706654|471947647|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
131085934|NCT00706654|471947644|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
131085935|NCT00706654|471947645|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
131141847|NCT01482910|472146532|FG000|Overall Study|Adverse Event|6|||
131141848|NCT01482910|472146533|FG001|Overall Study|Adverse Event|5|||
131141849|NCT01482910|472146532|FG000|Overall Study|Lost to Follow-up|0|||
131141850|NCT01482910|472146533|FG001|Overall Study|Lost to Follow-up|1|||
131141851|NCT01482910|472146532|FG000|Overall Study|Protocol Violation|1|||
131141852|NCT01482910|472146533|FG001|Overall Study|Protocol Violation|1|||
131141853|NCT01482910|472146532|FG000|Overall Study|Withdrawal by Subject|7|||
131141854|NCT01482910|472146533|FG001|Overall Study|Withdrawal by Subject|2|||
131141855|NCT01482910|472146532|FG000|Overall Study|Death|1|||
131141856|NCT01482910|472146533|FG001|Overall Study|Death|0|||
131141857|NCT00440726|472146535|FG000|Phase 1|Dose-Limiting Toxicity|0|||
131141858|NCT00440726|472146536|FG001|Phase 1|Dose-Limiting Toxicity|1|||
131141859|NCT00440726|472146537|FG002|Phase 1|Dose-Limiting Toxicity|0|||
131141860|NCT00440726|472146535|FG000|Phase 1|Physician Decision|1|||
131141861|NCT00440726|472146536|FG001|Phase 1|Physician Decision|0|||
131141862|NCT00440726|472146537|FG002|Phase 1|Physician Decision|0|||
131141863|NCT00440726|472146535|FG000|Phase 2|Death|0|||
131141864|NCT00440726|472146536|FG001|Phase 2|Death|0|||
131141865|NCT00440726|472146537|FG002|Phase 2|Death|1|||
131141866|NCT00440726|472146535|FG000|Phase 2|Adverse Event|0|||
131141867|NCT00440726|472146536|FG001|Phase 2|Adverse Event|0|||
131141868|NCT00440726|472146537|FG002|Phase 2|Adverse Event|1|||
131141869|NCT02614079|472146540|FG000|Overall Study|Withdrawal by Subject|1|||
131141870|NCT03370770|472146541|FG000|Overall Study|Patient was followed in another hospital center|1|||
131141871|NCT03370770|472146541|FG000|Overall Study|Progressive Disease|98|||
131141872|NCT03370770|472146541|FG000|Overall Study|Adverse Event|2|||
131141873|NCT03370770|472146541|FG000|Overall Study|Death|5|||
131141874|NCT00234039|472146542|FG000|Overall Study|Adverse Event|2|||
131141875|NCT00234039|472146542|FG000|Overall Study|Progression/relapse|34|||
131141876|NCT00234039|472146542|FG000|Overall Study|Other - Not Protocol Specified|3|||
131141877|NCT00234039|472146542|FG000|Overall Study|Ineligible|9|||
131233708|NCT02308111|472482561|FG000|Overall Study|Non-compliance with Study Drug|3|||
131085936|NCT00706654|471947646|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
131141878|NCT00234039|472146542|FG000|Overall Study|No Protocol Treatment Received|2|||
131141879|NCT03683394|472146545|FG000|Overall Study|Withdrawal by Subject|4|||
131141880|NCT03683394|472146546|FG001|Overall Study|Withdrawal by Subject|8|||
131141881|NCT03683394|472146545|FG000|Overall Study|Lost to Follow-up|7|||
131141882|NCT03683394|472146546|FG001|Overall Study|Lost to Follow-up|0|||
131085937|NCT00706654|471947647|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
131085938|NCT00706654|471947644|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
131085939|NCT00706654|471947645|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
131085940|NCT00706654|471947646|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
131085941|NCT00706654|471947647|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
131141883|NCT03683394|472146545|FG000|Overall Study|Death|3|||
131141884|NCT03683394|472146546|FG001|Overall Study|Death|1|||
131141885|NCT00110019|472146547|FG000|Overall Study|Lack of Efficacy|253|||
131141886|NCT00110019|472146548|FG001|Overall Study|Lack of Efficacy|285|||
131085942|NCT00706654|471947644|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
131085943|NCT00706654|471947645|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
131085944|NCT00706654|471947646|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
131085945|NCT00706654|471947647|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
131085946|NCT00706654|471947644|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
131085947|NCT00706654|471947645|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
131085948|NCT00706654|471947646|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
131085949|NCT00706654|471947647|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
131085950|NCT00706654|471947644|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
131085951|NCT00706654|471947645|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
131085952|NCT00706654|471947646|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
131085953|NCT00706654|471947647|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
131085954|NCT00706654|471947644|FG000|Oral Stabilization Phase|Withdrew consent|55|||
131085955|NCT00706654|471947645|FG001|Oral Stabilization Phase|Withdrew consent|0|||
131141887|NCT00110019|472146547|FG000|Overall Study|Adverse Event|61|||
131085956|NCT00706654|471947646|FG002|Oral Stabilization Phase|Withdrew consent|0|||
131085957|NCT00706654|471947647|FG003|Oral Stabilization Phase|Withdrew consent|0|||
131085958|NCT00706654|471947644|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
131085959|NCT00706654|471947645|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
131085960|NCT00706654|471947646|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
131085961|NCT00706654|471947647|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
131085962|NCT00706654|471947644|FG000|Oral Stabilization Phase|Adverse Event|21|||
131085963|NCT00706654|471947645|FG001|Oral Stabilization Phase|Adverse Event|0|||
131085964|NCT00706654|471947646|FG002|Oral Stabilization Phase|Adverse Event|0|||
131085965|NCT00706654|471947647|FG003|Oral Stabilization Phase|Adverse Event|0|||
131085966|NCT00706654|471947644|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
131085967|NCT00706654|471947645|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131085968|NCT00706654|471947646|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131085969|NCT00706654|471947647|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
131085970|NCT00706654|471947644|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
131085971|NCT00706654|471947645|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131085972|NCT00706654|471947646|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131085973|NCT00706654|471947647|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
131085974|NCT00706654|471947644|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
131085975|NCT00706654|471947645|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
131085976|NCT00706654|471947646|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
131085977|NCT00706654|471947647|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
131085978|NCT00706654|471947644|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
131085979|NCT00706654|471947645|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
131085980|NCT00706654|471947646|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
131085981|NCT00706654|471947647|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
131085982|NCT00706654|471947644|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
131085983|NCT00706654|471947645|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
131085984|NCT00706654|471947646|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
131085985|NCT00706654|471947647|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
131085986|NCT00706654|471947644|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
131085987|NCT00706654|471947645|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
131085988|NCT00706654|471947646|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
131085989|NCT00706654|471947647|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
131085990|NCT00706654|471947644|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
131141888|NCT00110019|472146548|FG001|Overall Study|Adverse Event|40|||
131141889|NCT00110019|472146547|FG000|Overall Study|Death|13|||
131141890|NCT00110019|472146548|FG001|Overall Study|Death|15|||
131141891|NCT00110019|472146547|FG000|Overall Study|Withdrawal by Subject|21|||
131141892|NCT00110019|472146548|FG001|Overall Study|Withdrawal by Subject|9|||
131141893|NCT00110019|472146547|FG000|Overall Study|alternative therapy|5|||
131141894|NCT00110019|472146548|FG001|Overall Study|alternative therapy|1|||
131141895|NCT00110019|472146547|FG000|Overall Study|complicating disease|1|||
131141896|NCT00110019|472146548|FG001|Overall Study|complicating disease|1|||
131141897|NCT00110019|472146547|FG000|Overall Study|symptom deterioration|13|||
131141898|NCT00110019|472146548|FG001|Overall Study|symptom deterioration|16|||
131085991|NCT00706654|471947645|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
131085992|NCT00706654|471947646|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
131085993|NCT00706654|471947647|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
131085994|NCT00706654|471947644|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
131085995|NCT00706654|471947645|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
131085996|NCT00706654|471947646|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
131085997|NCT00706654|471947647|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
131085998|NCT00706654|471947644|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
131085999|NCT00706654|471947645|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
131141899|NCT00110019|472146547|FG000|Overall Study|Not start protocol therapy|17|||
131141900|NCT00110019|472146548|FG001|Overall Study|Not start protocol therapy|16|||
131141901|NCT00110019|472146547|FG000|Overall Study|other reasons|22|||
131141902|NCT00110019|472146548|FG001|Overall Study|other reasons|30|||
131141903|NCT04303000|472146551|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
131141904|NCT04303000|472146552|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
131141905|NCT04303000|472146553|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
131086000|NCT00706654|471947646|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
131086001|NCT00706654|471947647|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
131086002|NCT00706654|471947644|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
131086003|NCT00706654|471947645|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
131086004|NCT00706654|471947646|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
131086005|NCT00706654|471947647|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
131086006|NCT00368875|471947653|FG000|Overall Study|Adverse Event|0|||
131086007|NCT00368875|471947654|FG001|Overall Study|Adverse Event|12|||
131086008|NCT00368875|471947653|FG000|Overall Study|Progressive disease|3|||
131086009|NCT00368875|471947654|FG001|Overall Study|Progressive disease|27|||
131086010|NCT00368875|471947653|FG000|Overall Study|Withdrawal by Subject|2|||
131141906|NCT04426695|472146554|FG000|Overall Study|Death|2|||
131141907|NCT04426695|472146555|FG001|Overall Study|Death|0|||
131141908|NCT04426695|472146556|FG002|Overall Study|Death|1|||
131141909|NCT04426695|472146557|FG003|Overall Study|Death|27|||
131141910|NCT04426695|472146558|FG004|Overall Study|Death|25|||
131141911|NCT04426695|472146559|FG005|Overall Study|Death|21|||
131086011|NCT00368875|471947654|FG001|Overall Study|Withdrawal by Subject|6|||
131086012|NCT00368875|471947653|FG000|Overall Study|Other Reason|0|||
131141912|NCT04426695|472146560|FG006|Overall Study|Death|42|||
131141913|NCT04426695|472146561|FG007|Overall Study|Death|23|||
131141914|NCT04426695|472146562|FG008|Overall Study|Death|37|||
131141915|NCT04426695|472146563|FG009|Overall Study|Death|14|||
131141916|NCT04426695|472146564|FG010|Overall Study|Death|8|||
131141917|NCT04426695|472146565|FG011|Overall Study|Death|7|||
131141918|NCT04426695|472146566|FG012|Overall Study|Death|13|||
131141919|NCT04426695|472146567|FG013|Overall Study|Death|25|||
131141920|NCT04426695|472146568|FG014|Overall Study|Death|19|||
131141921|NCT04426695|472146569|FG015|Overall Study|Death|7|||
131141922|NCT04426695|472146570|FG016|Overall Study|Death|8|||
131141923|NCT04426695|472146571|FG017|Overall Study|Death|4|||
131141924|NCT04426695|472146554|FG000|Overall Study|Lost to Follow-up|2|||
131141925|NCT04426695|472146555|FG001|Overall Study|Lost to Follow-up|4|||
131141926|NCT04426695|472146556|FG002|Overall Study|Lost to Follow-up|1|||
131141927|NCT04426695|472146557|FG003|Overall Study|Lost to Follow-up|19|||
131141928|NCT04426695|472146558|FG004|Overall Study|Lost to Follow-up|10|||
131141929|NCT04426695|472146559|FG005|Overall Study|Lost to Follow-up|14|||
131141930|NCT04426695|472146560|FG006|Overall Study|Lost to Follow-up|5|||
131141931|NCT04426695|472146561|FG007|Overall Study|Lost to Follow-up|14|||
131141932|NCT04426695|472146562|FG008|Overall Study|Lost to Follow-up|10|||
131141933|NCT04426695|472146563|FG009|Overall Study|Lost to Follow-up|11|||
131141934|NCT04426695|472146564|FG010|Overall Study|Lost to Follow-up|12|||
131141935|NCT04426695|472146565|FG011|Overall Study|Lost to Follow-up|6|||
131141936|NCT04426695|472146566|FG012|Overall Study|Lost to Follow-up|2|||
131141937|NCT04426695|472146567|FG013|Overall Study|Lost to Follow-up|2|||
131141938|NCT04426695|472146568|FG014|Overall Study|Lost to Follow-up|2|||
131141939|NCT04426695|472146569|FG015|Overall Study|Lost to Follow-up|0|||
131141940|NCT04426695|472146570|FG016|Overall Study|Lost to Follow-up|0|||
131141941|NCT04426695|472146571|FG017|Overall Study|Lost to Follow-up|0|||
131141942|NCT04426695|472146554|FG000|Overall Study|Participant Decision|1|||
131141943|NCT04426695|472146555|FG001|Overall Study|Participant Decision|2|||
131141944|NCT04426695|472146556|FG002|Overall Study|Participant Decision|2|||
131141945|NCT04426695|472146557|FG003|Overall Study|Participant Decision|12|||
131141946|NCT04426695|472146558|FG004|Overall Study|Participant Decision|18|||
131141947|NCT04426695|472146559|FG005|Overall Study|Participant Decision|22|||
131141948|NCT04426695|472146560|FG006|Overall Study|Participant Decision|13|||
131141949|NCT04426695|472146561|FG007|Overall Study|Participant Decision|13|||
131141950|NCT04426695|472146562|FG008|Overall Study|Participant Decision|10|||
131233709|NCT02308111|472482562|FG001|Overall Study|Non-compliance with Study Drug|1|||
131141951|NCT04426695|472146563|FG009|Overall Study|Participant Decision|15|||
131141952|NCT04426695|472146564|FG010|Overall Study|Participant Decision|16|||
131141953|NCT04426695|472146565|FG011|Overall Study|Participant Decision|17|||
131141954|NCT04426695|472146566|FG012|Overall Study|Participant Decision|2|||
131141955|NCT04426695|472146567|FG013|Overall Study|Participant Decision|1|||
131141956|NCT04426695|472146568|FG014|Overall Study|Participant Decision|2|||
131141957|NCT04426695|472146569|FG015|Overall Study|Participant Decision|0|||
131141958|NCT04426695|472146570|FG016|Overall Study|Participant Decision|0|||
131086013|NCT00368875|471947654|FG001|Overall Study|Other Reason|2|||
131086014|NCT00368875|471947653|FG000|Overall Study|Alternative Therapy|1|||
131141959|NCT04426695|472146571|FG017|Overall Study|Participant Decision|0|||
131141960|NCT04426695|472146554|FG000|Overall Study|Adverse Event|0|||
131086015|NCT00368875|471947654|FG001|Overall Study|Alternative Therapy|1|||
131086016|NCT01305239|471947655|FG000|Overall Study|Adverse Event|22|||
131086017|NCT01305239|471947655|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
131086018|NCT03229486|471947656|FG000|Overall Study|Protocol Violation|0|||
131086019|NCT03229486|471947657|FG001|Overall Study|Protocol Violation|1|||
131086020|NCT00844597|471947662|FG000|Overall Study|Adverse Event|0|||
131086021|NCT00844597|471947663|FG001|Overall Study|Adverse Event|0|||
131086022|NCT00844597|471947664|FG002|Overall Study|Adverse Event|0|||
131086023|NCT00844597|471947665|FG003|Overall Study|Adverse Event|1|||
131086024|NCT00844597|471947666|FG004|Overall Study|Adverse Event|0|||
131086025|NCT00844597|471947667|FG005|Overall Study|Adverse Event|0|||
131086026|NCT04160988|471947668|FG000|Overall Study|poor image quality|28|||
131086027|NCT02670122|471947669|FG000|Overall Study|Lost to Follow-up|4|||
131086028|NCT02762903|471947675|FG000|Overall Study|Lost to Follow-up|0|||
131086029|NCT02762903|471947676|FG001|Overall Study|Lost to Follow-up|1|||
131086030|NCT01228175|471947677|FG000|Overall Study|Lost to Follow-up|64|||
131086031|NCT01228175|471947678|FG001|Overall Study|Lost to Follow-up|50|||
131086032|NCT01228175|471947677|FG000|Overall Study|Withdrawal by Subject|1|||
131086033|NCT01228175|471947678|FG001|Overall Study|Withdrawal by Subject|2|||
131086034|NCT01228175|471947677|FG000|Overall Study|Physician Decision|1|||
131086035|NCT01228175|471947678|FG001|Overall Study|Physician Decision|1|||
131086036|NCT00243074|471947679|FG000|Overall Study|Ineligible|6|||
131086037|NCT00243074|471947679|FG000|Overall Study|Adverse Event|6|||
131086038|NCT00243074|471947679|FG000|Overall Study|Withdrawal by Subject|2|||
131086039|NCT00243074|471947679|FG000|Overall Study|Lack of Efficacy|36|||
131086040|NCT00243074|471947679|FG000|Overall Study|Death|2|||
131086041|NCT00243074|471947679|FG000|Overall Study|not protocol specified|1|||
131086042|NCT00243074|471947679|FG000|Overall Study|Did not receive any treatment|1|||
131086043|NCT03041792|471947680|FG000|Overall Study|Adverse Event|4|||
131086044|NCT03041792|471947681|FG001|Overall Study|Adverse Event|0|||
131086045|NCT03041792|471947680|FG000|Overall Study|Death in the family|0|||
131086046|NCT03041792|471947681|FG001|Overall Study|Death in the family|2|||
131086047|NCT03041792|471947680|FG000|Overall Study|Randomized but not treated|0|||
131086048|NCT03041792|471947681|FG001|Overall Study|Randomized but not treated|1|||
131086049|NCT04978090|471947684|FG000|Overall Study|unable to adequately fit device|2|||
131086050|NCT02227992|471947687|FG000|Overall Study|Lost to Follow-up|1|||
131086051|NCT02227992|471947688|FG001|Overall Study|Lost to Follow-up|1|||
131086052|NCT00996606|471947689|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
131141961|NCT04426695|472146555|FG001|Overall Study|Adverse Event|0|||
131141962|NCT04426695|472146556|FG002|Overall Study|Adverse Event|0|||
131141963|NCT04426695|472146557|FG003|Overall Study|Adverse Event|0|||
131141964|NCT04426695|472146558|FG004|Overall Study|Adverse Event|0|||
131141965|NCT04426695|472146559|FG005|Overall Study|Adverse Event|0|||
131141966|NCT04426695|472146560|FG006|Overall Study|Adverse Event|0|||
131141967|NCT04426695|472146561|FG007|Overall Study|Adverse Event|1|||
131141968|NCT04426695|472146562|FG008|Overall Study|Adverse Event|0|||
131141969|NCT04426695|472146563|FG009|Overall Study|Adverse Event|0|||
131141970|NCT04426695|472146564|FG010|Overall Study|Adverse Event|1|||
131141971|NCT04426695|472146565|FG011|Overall Study|Adverse Event|1|||
131233710|NCT02308111|472482561|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
131233711|NCT02308111|472482562|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
131233712|NCT02308111|472482561|FG000|Overall Study|Liver Transplant|3|||
131233713|NCT02308111|472482562|FG001|Overall Study|Liver Transplant|3|||
131233714|NCT02308111|472482561|FG000|Overall Study|Liver Transplant Waitlist|2|||
131233715|NCT02308111|472482562|FG001|Overall Study|Liver Transplant Waitlist|2|||
131233716|NCT02308111|472482561|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
131233717|NCT02308111|472482562|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
131233718|NCT01309919|472482585|FG000|Overall Study|Did not receive a postpartum IUD|17|||
131233719|NCT01309919|472482586|FG001|Overall Study|Did not receive a postpartum IUD|48|||
131233720|NCT00319449|472482587|FG000|Overall Study|Subject did not wish to continue|1|||
131233721|NCT00319449|472482588|FG001|Overall Study|Subject did not wish to continue|0|||
131233722|NCT00319449|472482587|FG000|Overall Study|Noncompliance with the protocol|1|||
131233723|NCT00319449|472482588|FG001|Overall Study|Noncompliance with the protocol|0|||
131233724|NCT02102490|472482589|FG000|Overall Study|Death|6|||
131086053|NCT00996606|471947689|FG000|Overall Study|Insufficient Therapeutic Response|2|||
131086054|NCT00996606|471947689|FG000|Overall Study|Protocol Violation|1|||
131086055|NCT00996606|471947689|FG000|Overall Study|Withdrawal by Subject|3|||
131086056|NCT00632502|471947691|FG000|Overall Study|Adverse Event|0|||
131086057|NCT00632502|471947692|FG001|Overall Study|Adverse Event|1|||
131086058|NCT00632502|471947691|FG000|Overall Study|Randomized not treated|3|||
131086059|NCT00632502|471947692|FG001|Overall Study|Randomized not treated|0|||
131141972|NCT04426695|472146566|FG012|Overall Study|Adverse Event|0|||
131141973|NCT04426695|472146567|FG013|Overall Study|Adverse Event|0|||
131141974|NCT04426695|472146568|FG014|Overall Study|Adverse Event|0|||
131141975|NCT04426695|472146569|FG015|Overall Study|Adverse Event|0|||
131086060|NCT03075527|471947693|FG000|Overall Study|Death|1|||
131233725|NCT02102490|472482589|FG000|Overall Study|Lost to Follow-up|1|||
131086061|NCT03075527|471947693|FG000|Overall Study|Withdrawal by Subject|1|||
131086062|NCT03075527|471947693|FG000|Overall Study|Physician Decision|3|||
131086063|NCT03075527|471947693|FG000|Overall Study|Progression/Relapse|14|||
131086064|NCT00681668|471947694|FG000|Overall Study|Protocol Violation|1|||
131086065|NCT00681668|471947694|FG000|Overall Study|Withdrawal by Subject|1|||
131086066|NCT02209181|471947695|FG000|Overall Study|Adverse Event|1|||
131086067|NCT02209181|471947696|FG001|Overall Study|Adverse Event|0|||
131086068|NCT02209181|471947697|FG002|Overall Study|Adverse Event|1|||
131086069|NCT02209181|471947698|FG003|Overall Study|Adverse Event|0|||
131086070|NCT02209181|471947695|FG000|Overall Study|Withdrawal by Subject|0|||
131086071|NCT02209181|471947696|FG001|Overall Study|Withdrawal by Subject|1|||
131086072|NCT02209181|471947697|FG002|Overall Study|Withdrawal by Subject|0|||
131086073|NCT02209181|471947698|FG003|Overall Study|Withdrawal by Subject|0|||
131086074|NCT04641962|471947704|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
131086075|NCT04641962|471947705|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
131086076|NCT04641962|471947706|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
131086077|NCT04641962|471947707|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
131086078|NCT04641962|471947708|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
131086079|NCT04641962|471947704|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
131086080|NCT04641962|471947705|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
131086081|NCT04641962|471947706|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
131086082|NCT04641962|471947707|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
131086083|NCT04641962|471947708|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
131086084|NCT04641962|471947704|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
131086085|NCT04641962|471947705|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
131086086|NCT04641962|471947706|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
131086087|NCT04641962|471947707|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
131086088|NCT04641962|471947708|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
131086089|NCT04641962|471947704|FG000|DBT Period: Up to 52 Weeks|Death|1|||
131086090|NCT04641962|471947705|FG001|DBT Period: Up to 52 Weeks|Death|0|||
131086091|NCT04641962|471947706|FG002|DBT Period: Up to 52 Weeks|Death|0|||
131086092|NCT04641962|471947707|FG003|DBT Period: Up to 52 Weeks|Death|0|||
131086093|NCT04641962|471947708|FG004|DBT Period: Up to 52 Weeks|Death|0|||
131086094|NCT04641962|471947704|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
131086095|NCT04641962|471947705|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
131086096|NCT04641962|471947706|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
131086097|NCT04641962|471947707|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
131086098|NCT04641962|471947708|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
131086099|NCT04641962|471947704|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
131086100|NCT04641962|471947705|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
131086101|NCT04641962|471947706|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
131086102|NCT04641962|471947707|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
131086103|NCT04641962|471947708|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
131086104|NCT04641962|471947704|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
131086105|NCT04641962|471947705|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
131086106|NCT04641962|471947706|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
131086107|NCT04641962|471947707|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
131086108|NCT04641962|471947708|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
131086109|NCT00862836|471947709|FG000|Overall Study|Withdrawal by Subject|1|||
131086110|NCT06926673|471947710|FG000|Overall Study|Lost to Follow-up|0|||
131086111|NCT06926673|471947711|FG001|Overall Study|Lost to Follow-up|0|||
131086112|NCT06926673|471947712|FG002|Overall Study|Lost to Follow-up|0|||
131086113|NCT06926673|471947713|FG003|Overall Study|Lost to Follow-up|1|||
131086114|NCT06926673|471947714|FG004|Overall Study|Lost to Follow-up|0|||
131086115|NCT06926673|471947715|FG005|Overall Study|Lost to Follow-up|0|||
131086116|NCT06926673|471947716|FG006|Overall Study|Lost to Follow-up|0|||
131141976|NCT04426695|472146570|FG016|Overall Study|Adverse Event|0|||
131141977|NCT04426695|472146571|FG017|Overall Study|Adverse Event|0|||
131141978|NCT04426695|472146554|FG000|Overall Study|Sponsor Request|0|||
131141979|NCT04426695|472146555|FG001|Overall Study|Sponsor Request|0|||
131141980|NCT04426695|472146556|FG002|Overall Study|Sponsor Request|0|||
131141981|NCT04426695|472146557|FG003|Overall Study|Sponsor Request|0|||
131141982|NCT04426695|472146558|FG004|Overall Study|Sponsor Request|0|||
131141983|NCT04426695|472146559|FG005|Overall Study|Sponsor Request|0|||
131141984|NCT04426695|472146560|FG006|Overall Study|Sponsor Request|1|||
131141985|NCT04426695|472146561|FG007|Overall Study|Sponsor Request|0|||
131141986|NCT04426695|472146562|FG008|Overall Study|Sponsor Request|0|||
131141987|NCT04426695|472146563|FG009|Overall Study|Sponsor Request|0|||
131141988|NCT04426695|472146564|FG010|Overall Study|Sponsor Request|0|||
131141989|NCT04426695|472146565|FG011|Overall Study|Sponsor Request|0|||
131141990|NCT04426695|472146566|FG012|Overall Study|Sponsor Request|0|||
131141991|NCT04426695|472146567|FG013|Overall Study|Sponsor Request|0|||
131141992|NCT04426695|472146568|FG014|Overall Study|Sponsor Request|0|||
131141993|NCT04426695|472146569|FG015|Overall Study|Sponsor Request|0|||
131141994|NCT04426695|472146570|FG016|Overall Study|Sponsor Request|0|||
131141995|NCT04426695|472146571|FG017|Overall Study|Sponsor Request|0|||
131086117|NCT06926673|471947710|FG000|Overall Study|Physician Decision|0|||
131141996|NCT04426695|472146554|FG000|Overall Study|Physician Decision|0|||
131141997|NCT04426695|472146555|FG001|Overall Study|Physician Decision|0|||
131141998|NCT04426695|472146556|FG002|Overall Study|Physician Decision|0|||
131141999|NCT04426695|472146557|FG003|Overall Study|Physician Decision|0|||
131142000|NCT04426695|472146558|FG004|Overall Study|Physician Decision|0|||
131142001|NCT04426695|472146559|FG005|Overall Study|Physician Decision|0|||
131233726|NCT01346410|472482590|FG000|Overall Study|Death|1|||
131233727|NCT00979628|472482591|FG000|Overall Study|received regimen < 24 hours|7|||
131233728|NCT00979628|472482592|FG001|Overall Study|received regimen < 24 hours|6|||
131233729|NCT00979628|472482593|FG002|Overall Study|received regimen < 24 hours|5|||
131233730|NCT00979628|472482591|FG000|Overall Study|received steroids|1|||
131233731|NCT00979628|472482592|FG001|Overall Study|received steroids|1|||
131233732|NCT00979628|472482593|FG002|Overall Study|received steroids|0|||
131233733|NCT00979628|472482591|FG000|Overall Study|transferred to ICU|1|||
131233734|NCT00979628|472482592|FG001|Overall Study|transferred to ICU|2|||
131233735|NCT00979628|472482593|FG002|Overall Study|transferred to ICU|1|||
131233736|NCT01736553|472482598|FG000|Overall Study|Death|12|||
131233737|NCT01736553|472482599|FG001|Overall Study|Death|0|||
131233738|NCT01736553|472482598|FG000|Overall Study|Withdrawal by Subject|5|||
131086118|NCT06926673|471947711|FG001|Overall Study|Physician Decision|0|||
131086119|NCT06926673|471947712|FG002|Overall Study|Physician Decision|0|||
131086120|NCT06926673|471947713|FG003|Overall Study|Physician Decision|0|||
131086121|NCT06926673|471947714|FG004|Overall Study|Physician Decision|0|||
131086122|NCT06926673|471947715|FG005|Overall Study|Physician Decision|0|||
131086123|NCT06926673|471947716|FG006|Overall Study|Physician Decision|1|||
131086124|NCT06926673|471947710|FG000|Overall Study|Withdrawal by Subject|0|||
131086125|NCT06926673|471947711|FG001|Overall Study|Withdrawal by Subject|3|||
131086126|NCT06926673|471947712|FG002|Overall Study|Withdrawal by Subject|2|||
131233739|NCT01736553|472482599|FG001|Overall Study|Withdrawal by Subject|2|||
131233740|NCT01736553|472482598|FG000|Overall Study|Lost to Follow-up|2|||
131233741|NCT01736553|472482599|FG001|Overall Study|Lost to Follow-up|2|||
131233742|NCT02154529|472482600|FG000|Overall Study|Death|1|||
131233743|NCT02154529|472482601|FG001|Overall Study|Death|1|||
131233744|NCT02154529|472482602|FG002|Overall Study|Death|5|||
131233745|NCT02154529|472482603|FG003|Overall Study|Death|1|||
131233746|NCT02154529|472482600|FG000|Overall Study|Termination of study by sponsor|2|||
131233747|NCT02154529|472482601|FG001|Overall Study|Termination of study by sponsor|2|||
131233748|NCT02154529|472482602|FG002|Overall Study|Termination of study by sponsor|3|||
131233749|NCT02154529|472482603|FG003|Overall Study|Termination of study by sponsor|1|||
131233750|NCT02154529|472482600|FG000|Overall Study|Lost to Follow-up|1|||
131233751|NCT02154529|472482601|FG001|Overall Study|Lost to Follow-up|0|||
131233752|NCT02154529|472482602|FG002|Overall Study|Lost to Follow-up|0|||
131233753|NCT02154529|472482603|FG003|Overall Study|Lost to Follow-up|0|||
131233754|NCT00458302|472484494|FG000|Overall Study|Adverse Event|4|||
131086127|NCT06926673|471947713|FG003|Overall Study|Withdrawal by Subject|1|||
131086128|NCT06926673|471947714|FG004|Overall Study|Withdrawal by Subject|0|||
131086129|NCT06926673|471947715|FG005|Overall Study|Withdrawal by Subject|2|||
131086130|NCT06926673|471947716|FG006|Overall Study|Withdrawal by Subject|0|||
131086131|NCT04057573|471949491|FG000|24-Week Double-Blind Period|Adverse Event|2|||
131086132|NCT04057573|471949492|FG001|24-Week Double-Blind Period|Adverse Event|0|||
131086133|NCT04057573|471949493|FG002|24-Week Double-Blind Period|Adverse Event|0|||
131086134|NCT04057573|471949494|FG003|24-Week Double-Blind Period|Adverse Event|0|||
131086135|NCT04057573|471949491|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
131086136|NCT04057573|471949492|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
131086137|NCT04057573|471949493|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
131086138|NCT04057573|471949494|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
131086139|NCT04057573|471949491|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
131142002|NCT04426695|472146560|FG006|Overall Study|Physician Decision|0|||
131142003|NCT04426695|472146561|FG007|Overall Study|Physician Decision|0|||
131142004|NCT04426695|472146562|FG008|Overall Study|Physician Decision|0|||
131142005|NCT04426695|472146563|FG009|Overall Study|Physician Decision|1|||
131142006|NCT04426695|472146564|FG010|Overall Study|Physician Decision|0|||
131233755|NCT00458302|472484495|FG001|Overall Study|Adverse Event|14|||
131233756|NCT00458302|472484494|FG000|Overall Study|Pregnancy|2|||
131233757|NCT00458302|472484495|FG001|Overall Study|Pregnancy|1|||
131233758|NCT00458302|472484494|FG000|Overall Study|Protocol Violation|0|||
131142007|NCT04426695|472146565|FG011|Overall Study|Physician Decision|0|||
131086140|NCT04057573|471949492|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
131086141|NCT04057573|471949493|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
131142008|NCT04426695|472146566|FG012|Overall Study|Physician Decision|1|||
131233759|NCT00458302|472484495|FG001|Overall Study|Protocol Violation|2|||
131233760|NCT00458302|472484494|FG000|Overall Study|Withdrawal by Subject|6|||
131233761|NCT00458302|472484495|FG001|Overall Study|Withdrawal by Subject|4|||
131233762|NCT00458302|472484494|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
131233763|NCT00458302|472484495|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
131233764|NCT00458302|472484494|FG000|Overall Study|Study Termination By Sponsor|1|||
131233765|NCT00458302|472484495|FG001|Overall Study|Study Termination By Sponsor|0|||
131086142|NCT04057573|471949494|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
131086143|NCT04057573|471949491|FG000|24-Week Double-Blind Period|Physician Decision|1|||
131086144|NCT04057573|471949492|FG001|24-Week Double-Blind Period|Physician Decision|0|||
131086145|NCT04057573|471949493|FG002|24-Week Double-Blind Period|Physician Decision|0|||
131086146|NCT04057573|471949494|FG003|24-Week Double-Blind Period|Physician Decision|0|||
131086147|NCT04057573|471949491|FG000|24-Week Double-Blind Period|Pregnancy|1|||
131086148|NCT04057573|471949492|FG001|24-Week Double-Blind Period|Pregnancy|0|||
131086149|NCT04057573|471949493|FG002|24-Week Double-Blind Period|Pregnancy|0|||
131086150|NCT04057573|471949494|FG003|24-Week Double-Blind Period|Pregnancy|0|||
131086151|NCT04057573|471949491|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
131086152|NCT04057573|471949492|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
131086153|NCT04057573|471949493|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
131086154|NCT04057573|471949494|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
131086155|NCT04057573|471949491|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
131086156|NCT04057573|471949492|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
131086157|NCT04057573|471949493|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
131086158|NCT04057573|471949494|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
131086159|NCT04057573|471949491|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
131086160|NCT04057573|471949492|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
131086161|NCT04057573|471949493|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
131086162|NCT04057573|471949494|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
131086163|NCT04057573|471949491|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
131086164|NCT04057573|471949492|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
131086165|NCT04057573|471949493|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
131142009|NCT04426695|472146567|FG013|Overall Study|Physician Decision|0|||
131142010|NCT04426695|472146568|FG014|Overall Study|Physician Decision|0|||
131142011|NCT04426695|472146569|FG015|Overall Study|Physician Decision|0|||
131142012|NCT04426695|472146570|FG016|Overall Study|Physician Decision|0|||
131142013|NCT04426695|472146571|FG017|Overall Study|Physician Decision|0|||
131142014|NCT04426695|472146554|FG000|Overall Study|Randomized but Never Treated|3|||
131142015|NCT04426695|472146555|FG001|Overall Study|Randomized but Never Treated|1|||
131142016|NCT04426695|472146556|FG002|Overall Study|Randomized but Never Treated|0|||
131142017|NCT04426695|472146557|FG003|Overall Study|Randomized but Never Treated|4|||
131142018|NCT04426695|472146558|FG004|Overall Study|Randomized but Never Treated|5|||
131142019|NCT04426695|472146559|FG005|Overall Study|Randomized but Never Treated|5|||
131142020|NCT04426695|472146560|FG006|Overall Study|Randomized but Never Treated|4|||
131142021|NCT04426695|472146561|FG007|Overall Study|Randomized but Never Treated|6|||
131142022|NCT04426695|472146562|FG008|Overall Study|Randomized but Never Treated|6|||
131142023|NCT04426695|472146563|FG009|Overall Study|Randomized but Never Treated|3|||
131142024|NCT04426695|472146564|FG010|Overall Study|Randomized but Never Treated|3|||
131142025|NCT04426695|472146565|FG011|Overall Study|Randomized but Never Treated|6|||
131142026|NCT04426695|472146566|FG012|Overall Study|Randomized but Never Treated|1|||
131233766|NCT00458302|472484494|FG000|Overall Study|Lost to Follow-up|2|||
131233767|NCT00458302|472484495|FG001|Overall Study|Lost to Follow-up|0|||
131233768|NCT00458302|472484494|FG000|Overall Study|Other|4|||
131233769|NCT00458302|472484495|FG001|Overall Study|Other|2|||
131233770|NCT02178709|472484497|FG000|Overall Study|Adverse Event|5|||
131233771|NCT02178709|472484497|FG000|Overall Study|Death|2|||
131233772|NCT02178709|472484497|FG000|Overall Study|Withdrawal by Subject|2|||
131233773|NCT02178709|472484497|FG000|Overall Study|Physician Decision|2|||
131233774|NCT02178709|472484497|FG000|Overall Study|Disease Progression|5|||
131233775|NCT02224456|472484498|FG000|Overall Study|Lack of Efficacy|1|||
131233776|NCT02224456|472484498|FG000|Overall Study|Lost to Follow-up|15|||
131233777|NCT02224456|472484498|FG000|Overall Study|Withdrawal by Subject|9|||
131233778|NCT02224456|472484498|FG000|Overall Study|Physician Decision|3|||
131233779|NCT02224456|472484498|FG000|Overall Study|Death|2|||
131233780|NCT02224456|472484498|FG000|Overall Study|Pregnancy|4|||
131233781|NCT02224456|472484498|FG000|Overall Study|Protocol Violation|1|||
131233782|NCT02224456|472484498|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
131233783|NCT02946385|472484499|FG000|Overall Study|Lost to Follow-up|0|||
131233784|NCT02946385|472484500|FG001|Overall Study|Lost to Follow-up|0|||
131086166|NCT04057573|471949494|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
131086167|NCT04057573|471949491|FG000|24-Week Double-Blind Period|Not Treated|1|||
131142027|NCT04426695|472146567|FG013|Overall Study|Randomized but Never Treated|2|||
131142028|NCT04426695|472146568|FG014|Overall Study|Randomized but Never Treated|0|||
131142029|NCT04426695|472146569|FG015|Overall Study|Randomized but Never Treated|0|||
131233785|NCT02946385|472484501|FG002|Overall Study|Lost to Follow-up|3|||
131233786|NCT02946385|472484502|FG003|Overall Study|Lost to Follow-up|0|||
131233787|NCT02946385|472484503|FG004|Overall Study|Lost to Follow-up|2|||
131233788|NCT02946385|472484504|FG005|Overall Study|Lost to Follow-up|1|||
131233789|NCT01379781|472484505|FG000|Overall Study|Lost to Follow-up|11|||
131233790|NCT01379781|472484506|FG001|Overall Study|Lost to Follow-up|8|||
131142030|NCT04426695|472146570|FG016|Overall Study|Randomized but Never Treated|0|||
131142031|NCT04426695|472146571|FG017|Overall Study|Randomized but Never Treated|0|||
131142032|NCT03653390|472146575|FG000|Overall Study|Lost to Follow-up|12|||
131142033|NCT03653390|472146576|FG001|Overall Study|Lost to Follow-up|8|||
131142034|NCT03653390|472146577|FG002|Overall Study|Lost to Follow-up|7|||
131142035|NCT03653390|472146575|FG000|Overall Study|Withdrawal by Subject|6|||
131142036|NCT03653390|472146576|FG001|Overall Study|Withdrawal by Subject|1|||
131142037|NCT03653390|472146577|FG002|Overall Study|Withdrawal by Subject|1|||
131142038|NCT03653390|472146575|FG000|Overall Study|Death|1|||
131142039|NCT03653390|472146576|FG001|Overall Study|Death|0|||
131142040|NCT03653390|472146577|FG002|Overall Study|Death|0|||
131142041|NCT03653390|472146575|FG000|Overall Study|Paper Survey Lost|1|||
131142042|NCT03653390|472146576|FG001|Overall Study|Paper Survey Lost|0|||
131142043|NCT03653390|472146577|FG002|Overall Study|Paper Survey Lost|0|||
131142044|NCT01109940|472146578|FG000|Overall Study|Administrative problems|2|||
131142045|NCT01109940|472146579|FG001|Overall Study|Administrative problems|0|||
131142046|NCT01109940|472146580|FG002|Overall Study|Administrative problems|0|||
131142047|NCT01109940|472146581|FG003|Overall Study|Administrative problems|0|||
131142048|NCT01109940|472146578|FG000|Overall Study|Serious Adverse Event|2|||
131142049|NCT01109940|472146579|FG001|Overall Study|Serious Adverse Event|1|||
131142050|NCT01109940|472146580|FG002|Overall Study|Serious Adverse Event|0|||
131142051|NCT01109940|472146581|FG003|Overall Study|Serious Adverse Event|0|||
131142052|NCT01109940|472146578|FG000|Overall Study|Lost to Follow-up|1|||
131142053|NCT01109940|472146579|FG001|Overall Study|Lost to Follow-up|0|||
131142054|NCT01109940|472146580|FG002|Overall Study|Lost to Follow-up|0|||
131142055|NCT01109940|472146581|FG003|Overall Study|Lost to Follow-up|0|||
131142056|NCT01109940|472146578|FG000|Overall Study|Patient withdrew consent|1|||
131142057|NCT01109940|472146579|FG001|Overall Study|Patient withdrew consent|1|||
131142058|NCT01109940|472146580|FG002|Overall Study|Patient withdrew consent|0|||
131142059|NCT01109940|472146581|FG003|Overall Study|Patient withdrew consent|0|||
131233791|NCT01644890|472484507|FG000|Overall Study|Adverse Event|7|||
131233792|NCT01644890|472484508|FG001|Overall Study|Adverse Event|20|||
131233793|NCT01644890|472484507|FG000|Overall Study|Death|1|||
131142060|NCT01109940|472146578|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131142061|NCT01109940|472146579|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131142062|NCT01109940|472146580|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
131142063|NCT01109940|472146581|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
131142064|NCT01262976|472146584|FG000|Up to Month 2|Serious Adverse Event|0|||
131142065|NCT01262976|472146585|FG001|Up to Month 2|Serious Adverse Event|0|||
131142066|NCT01262976|472146586|FG002|Up to Month 2|Serious Adverse Event|1|||
131142067|NCT01262976|472146587|FG003|Up to Month 2|Serious Adverse Event|0|||
131142068|NCT01262976|472146588|FG004|Up to Month 2|Serious Adverse Event|0|||
131142069|NCT01262976|472146589|FG005|Up to Month 2|Serious Adverse Event|0|||
131142070|NCT01262976|472146584|FG000|Up to Month 2|Withdrawal by Subject|1|||
131233794|NCT01644890|472484508|FG001|Overall Study|Death|3|||
131233795|NCT01644890|472484507|FG000|Overall Study|Physician Decision|3|||
131086168|NCT04057573|471949492|FG001|24-Week Double-Blind Period|Not Treated|0|||
131086169|NCT04057573|471949493|FG002|24-Week Double-Blind Period|Not Treated|0|||
131086170|NCT04057573|471949494|FG003|24-Week Double-Blind Period|Not Treated|0|||
131086171|NCT04057573|471949491|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
131086172|NCT04057573|471949492|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
131086173|NCT04057573|471949493|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
131086174|NCT04057573|471949494|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
131086175|NCT04057573|471949491|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
131086176|NCT04057573|471949492|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
131086177|NCT04057573|471949493|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
131086178|NCT04057573|471949494|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
131086179|NCT04057573|471949491|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
131086180|NCT04057573|471949492|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
131086181|NCT04057573|471949493|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
131086182|NCT04057573|471949494|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
131086183|NCT04057573|471949491|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
131142071|NCT01262976|472146585|FG001|Up to Month 2|Withdrawal by Subject|0|||
131142072|NCT01262976|472146586|FG002|Up to Month 2|Withdrawal by Subject|0|||
131142073|NCT01262976|472146587|FG003|Up to Month 2|Withdrawal by Subject|0|||
131142074|NCT01262976|472146588|FG004|Up to Month 2|Withdrawal by Subject|0|||
131142075|NCT01262976|472146589|FG005|Up to Month 2|Withdrawal by Subject|0|||
131142076|NCT01262976|472146584|FG000|Up to Month 2|Migrated/moved from study area|0|||
131142077|NCT01262976|472146585|FG001|Up to Month 2|Migrated/moved from study area|1|||
131086184|NCT04057573|471949492|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
131086185|NCT04057573|471949493|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
131142078|NCT01262976|472146586|FG002|Up to Month 2|Migrated/moved from study area|0|||
131233796|NCT01644890|472484508|FG001|Overall Study|Physician Decision|9|||
131233797|NCT01644890|472484507|FG000|Overall Study|Protocol Violation|6|||
131086186|NCT04057573|471949494|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
131086187|NCT04057573|471949491|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
131086188|NCT04057573|471949492|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
131086189|NCT04057573|471949493|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
131086190|NCT04057573|471949494|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
131086191|NCT00667459|471949497|FG000|Overall Study|Death|0|||
131086192|NCT00667459|471949498|FG001|Overall Study|Death|2|||
131086193|NCT00667459|471949497|FG000|Overall Study|Lost to Follow-up|8|||
131086194|NCT00667459|471949498|FG001|Overall Study|Lost to Follow-up|43|||
131086195|NCT02460575|471949503|FG000|Overall Study|Lost to Follow-up|1|||
131086196|NCT02460575|471949504|FG001|Overall Study|Lost to Follow-up|0|||
131086197|NCT04307940|471949505|FG000|Overall Study|Adverse Event|1|||
131086198|NCT04307940|471949506|FG001|Overall Study|Adverse Event|0|||
131086199|NCT04307940|471949507|FG002|Overall Study|Adverse Event|0|||
131086200|NCT04307940|471949505|FG000|Overall Study|Withdrawal by Subject|2|||
131086201|NCT04307940|471949506|FG001|Overall Study|Withdrawal by Subject|3|||
131086202|NCT04307940|471949507|FG002|Overall Study|Withdrawal by Subject|1|||
131086203|NCT04307940|471949505|FG000|Overall Study|Lost to Follow-up|2|||
131086204|NCT04307940|471949506|FG001|Overall Study|Lost to Follow-up|0|||
131086205|NCT04307940|471949507|FG002|Overall Study|Lost to Follow-up|1|||
131086206|NCT05543174|471949508|FG000|Overall Study|Ongoing|7|||
131086207|NCT04896008|471949509|FG000|Overall Study|Ongoing|70|||
131086208|NCT04896008|471949510|FG001|Overall Study|Ongoing|38|||
131086209|NCT04896008|471949509|FG000|Overall Study|Adverse Event|0|||
131086210|NCT04896008|471949510|FG001|Overall Study|Adverse Event|2|||
131086211|NCT04896008|471949509|FG000|Overall Study|Death|5|||
131086212|NCT04896008|471949510|FG001|Overall Study|Death|10|||
131086213|NCT04896008|471949509|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
131086214|NCT04896008|471949510|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
131086215|NCT04896008|471949509|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
131086216|NCT04896008|471949510|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
131086217|NCT04896008|471949509|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
131086218|NCT04896008|471949510|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
131086219|NCT04896008|471949509|FG000|Overall Study|Withdrawal by Subject|1|||
131086220|NCT04896008|471949510|FG001|Overall Study|Withdrawal by Subject|4|||
131086221|NCT04896008|471949509|FG000|Overall Study|Investigator Decision|2|||
131086222|NCT04896008|471949510|FG001|Overall Study|Investigator Decision|0|||
131086223|NCT04896008|471949509|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
131086224|NCT04896008|471949510|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
131086225|NCT01270828|471949511|FG000|Pregabalin CR SB|Reason Unspecified|0|||
131086226|NCT01270828|471949512|FG001|Pregabalin CR SB|Reason Unspecified|0|||
131086227|NCT01270828|471949513|FG002|Pregabalin CR SB|Reason Unspecified|8|||
131086228|NCT01270828|471949511|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
131086229|NCT01270828|471949512|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
131086230|NCT01270828|471949513|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
131086231|NCT01270828|471949511|FG000|Pregabalin CR SB|Related adverse event|0|||
131086232|NCT01270828|471949512|FG001|Pregabalin CR SB|Related adverse event|0|||
131086233|NCT01270828|471949513|FG002|Pregabalin CR SB|Related adverse event|46|||
131086234|NCT01270828|471949511|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
131086235|NCT01270828|471949512|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
131086236|NCT01270828|471949513|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
131086237|NCT01270828|471949511|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
131086238|NCT01270828|471949512|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
131086239|NCT01270828|471949513|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
131086240|NCT01270828|471949511|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
131086241|NCT01270828|471949512|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
131086242|NCT01270828|471949513|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
131086243|NCT01270828|471949511|FG000|Pregabalin CR SB|Unrelated AE|0|||
131086244|NCT01270828|471949512|FG001|Pregabalin CR SB|Unrelated AE|0|||
131086245|NCT01270828|471949513|FG002|Pregabalin CR SB|Unrelated AE|8|||
131086246|NCT01270828|471949511|FG000|Pregabalin CR SB|Protocol Violation|0|||
131142079|NCT01262976|472146587|FG003|Up to Month 2|Migrated/moved from study area|0|||
131142080|NCT01262976|472146588|FG004|Up to Month 2|Migrated/moved from study area|1|||
131142081|NCT01262976|472146589|FG005|Up to Month 2|Migrated/moved from study area|1|||
131142082|NCT01262976|472146584|FG000|Up to Month 2|Lost to Follow-up|1|||
131142083|NCT01262976|472146585|FG001|Up to Month 2|Lost to Follow-up|0|||
131086247|NCT01270828|471949512|FG001|Pregabalin CR SB|Protocol Violation|0|||
131086248|NCT01270828|471949513|FG002|Pregabalin CR SB|Protocol Violation|8|||
131086249|NCT01270828|471949511|FG000|Double Blind Phase|Death|0|||
131086250|NCT01270828|471949512|FG001|Double Blind Phase|Death|1|||
131086251|NCT01270828|471949513|FG002|Double Blind Phase|Death|0|||
131086252|NCT01270828|471949511|FG000|Double Blind Phase|Protocol Violation|0|||
131086253|NCT01270828|471949512|FG001|Double Blind Phase|Protocol Violation|1|||
131086254|NCT01270828|471949513|FG002|Double Blind Phase|Protocol Violation|0|||
131142084|NCT01262976|472146586|FG002|Up to Month 2|Lost to Follow-up|0|||
131142085|NCT01262976|472146587|FG003|Up to Month 2|Lost to Follow-up|1|||
131142086|NCT01262976|472146588|FG004|Up to Month 2|Lost to Follow-up|1|||
131142087|NCT01262976|472146589|FG005|Up to Month 2|Lost to Follow-up|1|||
131142088|NCT01262976|472146584|FG000|Up to Month 2|Other|1|||
131142089|NCT01262976|472146585|FG001|Up to Month 2|Other|0|||
131142090|NCT01262976|472146586|FG002|Up to Month 2|Other|0|||
131142091|NCT01262976|472146587|FG003|Up to Month 2|Other|1|||
131142092|NCT01262976|472146588|FG004|Up to Month 2|Other|0|||
131086255|NCT01270828|471949511|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
131086256|NCT01270828|471949512|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
131086257|NCT01270828|471949513|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
131086258|NCT01270828|471949511|FG000|Double Blind Phase|Reason Unspecified|7|||
131086259|NCT01270828|471949512|FG001|Double Blind Phase|Reason Unspecified|4|||
131086260|NCT01270828|471949513|FG002|Double Blind Phase|Reason Unspecified|0|||
131086261|NCT01270828|471949511|FG000|Double Blind Phase|Withdrawal by Subject|6|||
131086262|NCT01270828|471949512|FG001|Double Blind Phase|Withdrawal by Subject|15|||
131086263|NCT01270828|471949513|FG002|Double Blind Phase|Withdrawal by Subject|0|||
131086264|NCT01270828|471949511|FG000|Double Blind Phase|Lost to Follow-up|1|||
131086265|NCT01270828|471949512|FG001|Double Blind Phase|Lost to Follow-up|2|||
131086266|NCT01270828|471949513|FG002|Double Blind Phase|Lost to Follow-up|0|||
131086267|NCT01270828|471949511|FG000|Double Blind Phase|Lack of Efficacy|2|||
131086268|NCT01270828|471949512|FG001|Double Blind Phase|Lack of Efficacy|11|||
131086269|NCT01270828|471949513|FG002|Double Blind Phase|Lack of Efficacy|0|||
131086270|NCT01270828|471949511|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
131086271|NCT01270828|471949512|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
131086272|NCT01270828|471949513|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
131086273|NCT01270828|471949511|FG000|Double Blind Phase|Adverse event related to study drug|5|||
131086274|NCT01270828|471949512|FG001|Double Blind Phase|Adverse event related to study drug|7|||
131086275|NCT01270828|471949513|FG002|Double Blind Phase|Adverse event related to study drug|0|||
131086276|NCT02963090|471949516|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
131086277|NCT02963090|471949517|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
131086278|NCT00709228|471949521|FG000|Overall Study|Not treated|14|||
131086279|NCT00709228|471949521|FG000|Overall Study|Eligibility criteria not met|281|||
131086280|NCT00709228|471949521|FG000|Overall Study|Adverse events|2|||
131086281|NCT00709228|471949521|FG000|Overall Study|Discontinued treatment|14|||
131086282|NCT00709228|471949521|FG000|Overall Study|Did not enter follow-up|4|||
131086283|NCT00709228|471949521|FG000|Overall Study|Discontinued follow-up|5|||
131086284|NCT00709228|471949521|FG000|Overall Study|Disease progression|1|||
131086285|NCT00709228|471949521|FG000|Overall Study|Lost to Follow-up|6|||
131086286|NCT00709228|471949521|FG000|Overall Study|Non-compliance|5|||
131086287|NCT04497389|471949522|FG000|Overall Study|Withdrawal by Subject|1|||
131086288|NCT04497389|471949523|FG001|Overall Study|Withdrawal by Subject|0|||
131086289|NCT00789360|471949524|FG000|Overall Study|Protocol Violation|3|||
131086290|NCT00789360|471949525|FG001|Overall Study|Protocol Violation|1|||
131086291|NCT00022659|471949526|FG000|Overall Study|Ineligible: wrong primary|1|||
131086292|NCT00022659|471949526|FG000|Overall Study|Never treated|1|||
131086293|NCT03322540|471949528|FG000|Overall Study|Death|21|||
131086294|NCT03322540|471949529|FG001|Overall Study|Death|28|||
131086295|NCT03322540|471949528|FG000|Overall Study|Lost to Follow-up|0|||
131086296|NCT03322540|471949529|FG001|Overall Study|Lost to Follow-up|1|||
131086297|NCT03322540|471949528|FG000|Overall Study|Physician Decision|7|||
131086298|NCT03322540|471949529|FG001|Overall Study|Physician Decision|6|||
131086299|NCT03322540|471949528|FG000|Overall Study|Withdrawal by Subject|3|||
131142093|NCT01262976|472146589|FG005|Up to Month 2|Other|2|||
131142094|NCT01262976|472146584|FG000|Up to Month 7|Serious Adverse Event|0|||
131142095|NCT01262976|472146585|FG001|Up to Month 7|Serious Adverse Event|0|||
131142096|NCT01262976|472146586|FG002|Up to Month 7|Serious Adverse Event|2|||
131142097|NCT01262976|472146587|FG003|Up to Month 7|Serious Adverse Event|0|||
131142098|NCT01262976|472146588|FG004|Up to Month 7|Serious Adverse Event|0|||
131142099|NCT01262976|472146589|FG005|Up to Month 7|Serious Adverse Event|0|||
131142100|NCT01262976|472146584|FG000|Up to Month 7|Withdrawal by Subject|1|||
131086300|NCT03322540|471949529|FG001|Overall Study|Withdrawal by Subject|1|||
131086301|NCT03322540|471949528|FG000|Overall Study|Study terminated by sponsor|0|||
131086302|NCT03322540|471949529|FG001|Overall Study|Study terminated by sponsor|1|||
131086303|NCT00968526|471949530|FG000|Overall Study|Adverse Event|2|||
131086304|NCT00968526|471949531|FG001|Overall Study|Adverse Event|0|||
131086305|NCT00968526|471949530|FG000|Overall Study|Migrated/moved from study area|1|||
131086306|NCT00968526|471949531|FG001|Overall Study|Migrated/moved from study area|0|||
131086307|NCT03926195|471949535|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
131086308|NCT03926195|471949536|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
131142101|NCT01262976|472146585|FG001|Up to Month 7|Withdrawal by Subject|0|||
131142102|NCT01262976|472146586|FG002|Up to Month 7|Withdrawal by Subject|0|||
131142103|NCT01262976|472146587|FG003|Up to Month 7|Withdrawal by Subject|0|||
131142104|NCT01262976|472146588|FG004|Up to Month 7|Withdrawal by Subject|0|||
131086309|NCT03926195|471949535|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
131086310|NCT03926195|471949536|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
131086311|NCT03926195|471949535|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
131086312|NCT03926195|471949536|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
131086313|NCT03926195|471949535|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
131086314|NCT03926195|471949536|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
131086315|NCT03926195|471949535|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
131086316|NCT03926195|471949536|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
131086317|NCT03926195|471949535|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
131086318|NCT03926195|471949536|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
131086319|NCT03054337|471949537|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
131086320|NCT03054337|471949538|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
131086321|NCT03054337|471949539|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
131086322|NCT03054337|471949540|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
131086323|NCT03054337|471949541|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
131086324|NCT03054337|471949542|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
131086325|NCT03738475|471949544|FG000|Overall Study|Participant Non-Compliance|1|||
131086326|NCT03738475|471949545|FG001|Overall Study|Participant Non-Compliance|0|||
131086327|NCT00737477|471949546|FG000|Overall Study|Adverse Event|9|||
131086328|NCT00737477|471949546|FG000|Overall Study|Death|9|||
131086329|NCT00737477|471949546|FG000|Overall Study|Treatment Refusal|1|||
131086330|NCT00737477|471949546|FG000|Overall Study|Withdrawal by Subject|1|||
131086331|NCT00737477|471949546|FG000|Overall Study|Renal Transplantation|10|||
131086332|NCT00737477|471949546|FG000|Overall Study|Other|4|||
131086333|NCT00581477|471949547|FG000|Overall Study|Physician Decision|2|||
131086334|NCT03106753|471949548|FG000|Overall Study|Withdrawal by Subject|0|||
131086335|NCT03106753|471949549|FG001|Overall Study|Withdrawal by Subject|1|||
131086336|NCT01853475|471949556|FG000|Overall Study|Withdrawal by Subject|0|||
131086337|NCT01853475|471949557|FG001|Overall Study|Withdrawal by Subject|1|||
131086338|NCT01853475|471949558|FG002|Overall Study|Withdrawal by Subject|0|||
131086339|NCT01023958|471949563|FG000|Overall Study|Progressive disease|48|||
131086340|NCT01023958|471949563|FG000|Overall Study|Other adverse event|1|||
131086341|NCT01023958|471949563|FG000|Overall Study|Refused to continue medication|1|||
131086342|NCT02159040|471949564|FG000|Overall Study|Death|1|||
131086343|NCT03080493|471949565|FG000|Overall Study|Did not provide NRS pain results|1|||
131086344|NCT03080493|471949566|FG001|Overall Study|Did not provide NRS pain results|0|||
131086345|NCT03080493|471949565|FG000|Overall Study|Adverse Event|0|||
131086346|NCT03080493|471949566|FG001|Overall Study|Adverse Event|1|||
131086347|NCT03080493|471949565|FG000|Overall Study|Randomization error (parity group)|0|||
131086348|NCT03080493|471949566|FG001|Overall Study|Randomization error (parity group)|1|||
131086349|NCT00755417|471949567|FG000|Overall Study|Adverse Event|28|||
131086350|NCT00755417|471949568|FG001|Overall Study|Adverse Event|20|||
131086351|NCT00755417|471949569|FG002|Overall Study|Adverse Event|7|||
131086352|NCT00755417|471949567|FG000|Overall Study|Lack of Efficacy|8|||
131086353|NCT00755417|471949568|FG001|Overall Study|Lack of Efficacy|4|||
131142105|NCT01262976|472146589|FG005|Up to Month 7|Withdrawal by Subject|0|||
131142106|NCT01262976|472146584|FG000|Up to Month 7|Migrated/moved from study area|0|||
131142107|NCT01262976|472146585|FG001|Up to Month 7|Migrated/moved from study area|0|||
131142108|NCT01262976|472146586|FG002|Up to Month 7|Migrated/moved from study area|1|||
131142109|NCT01262976|472146587|FG003|Up to Month 7|Migrated/moved from study area|3|||
131142110|NCT01262976|472146588|FG004|Up to Month 7|Migrated/moved from study area|1|||
131142111|NCT01262976|472146589|FG005|Up to Month 7|Migrated/moved from study area|1|||
131142112|NCT01262976|472146584|FG000|Up to Month 7|Lost to Follow-up|1|||
131142113|NCT01262976|472146585|FG001|Up to Month 7|Lost to Follow-up|0|||
131142114|NCT01262976|472146586|FG002|Up to Month 7|Lost to Follow-up|1|||
131142115|NCT01262976|472146587|FG003|Up to Month 7|Lost to Follow-up|3|||
131142116|NCT01262976|472146588|FG004|Up to Month 7|Lost to Follow-up|1|||
131142117|NCT01262976|472146589|FG005|Up to Month 7|Lost to Follow-up|3|||
131142118|NCT01262976|472146584|FG000|Up to Month 7|Other|3|||
131142119|NCT01262976|472146585|FG001|Up to Month 7|Other|0|||
131233798|NCT01644890|472484508|FG001|Overall Study|Protocol Violation|7|||
131086354|NCT00755417|471949569|FG002|Overall Study|Lack of Efficacy|9|||
131233799|NCT01644890|472484507|FG000|Overall Study|Withdrawal by Subject|19|||
131086355|NCT00755417|471949567|FG000|Overall Study|Protocol Violation|2|||
131142120|NCT01262976|472146586|FG002|Up to Month 7|Other|2|||
131142121|NCT01262976|472146587|FG003|Up to Month 7|Other|0|||
131142122|NCT01262976|472146588|FG004|Up to Month 7|Other|0|||
131142123|NCT01262976|472146589|FG005|Up to Month 7|Other|0|||
131142124|NCT01262976|472146584|FG000|Up to Year 1|Serious Adverse Event|0|||
131233800|NCT01644890|472484508|FG001|Overall Study|Withdrawal by Subject|27|||
131086356|NCT00755417|471949568|FG001|Overall Study|Protocol Violation|1|||
131086357|NCT00755417|471949569|FG002|Overall Study|Protocol Violation|1|||
131086358|NCT00755417|471949567|FG000|Overall Study|Lost to Follow-up|3|||
131086359|NCT00755417|471949568|FG001|Overall Study|Lost to Follow-up|0|||
131233801|NCT01644890|472484507|FG000|Overall Study|Progression Disease|160|||
131086360|NCT00755417|471949569|FG002|Overall Study|Lost to Follow-up|1|||
131086361|NCT00755417|471949567|FG000|Overall Study|Withdrawal by Subject|12|||
131086362|NCT00755417|471949568|FG001|Overall Study|Withdrawal by Subject|12|||
131086363|NCT00755417|471949569|FG002|Overall Study|Withdrawal by Subject|12|||
131086364|NCT00755417|471949567|FG000|Overall Study|Not specified or missing data|9|||
131086365|NCT00755417|471949568|FG001|Overall Study|Not specified or missing data|18|||
131086366|NCT00755417|471949569|FG002|Overall Study|Not specified or missing data|12|||
131086367|NCT02362503|471949571|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
131086368|NCT02362503|471949572|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
131086369|NCT02362503|471949573|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
131086370|NCT02362503|471949571|FG000|Double-blind Period-Up to 8 Days|Death|1|||
131086371|NCT02362503|471949572|FG001|Double-blind Period-Up to 8 Days|Death|0|||
131086372|NCT02362503|471949573|FG002|Double-blind Period-Up to 8 Days|Death|0|||
131086373|NCT02362503|471949571|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
131086374|NCT02362503|471949572|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
131086375|NCT02362503|471949573|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
131086376|NCT02362503|471949571|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
131086377|NCT02362503|471949572|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
131086378|NCT02362503|471949573|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
131086379|NCT02362503|471949571|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
131086380|NCT02362503|471949572|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
131086381|NCT02362503|471949573|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
131086382|NCT02362503|471949571|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
131086383|NCT02362503|471949572|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
131086384|NCT02362503|471949573|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
131086385|NCT02362503|471949571|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
131086386|NCT02362503|471949572|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
131086387|NCT02362503|471949573|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
131086388|NCT02362503|471949571|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
131086389|NCT02362503|471949572|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
131086390|NCT02362503|471949573|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
131086391|NCT02362503|471949571|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
131086392|NCT02362503|471949572|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
131086393|NCT02362503|471949573|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
131086394|NCT02362503|471949571|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
131086395|NCT02362503|471949572|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
131086396|NCT02362503|471949573|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
131086397|NCT02362503|471949571|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
131086398|NCT02362503|471949572|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
131086399|NCT02362503|471949573|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
131086400|NCT02362503|471949571|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
131086401|NCT02362503|471949572|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
131086402|NCT02362503|471949573|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
131086403|NCT02362503|471949571|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
131086404|NCT02362503|471949572|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
131086405|NCT02362503|471949573|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
131086406|NCT02362503|471949571|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
131086407|NCT02362503|471949572|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
131086408|NCT02362503|471949573|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
131086409|NCT02803593|471949574|FG000|Overall Study|Lost to Follow-up|17|||
131086410|NCT02803593|471949575|FG001|Overall Study|Lost to Follow-up|35|||
131086411|NCT05143138|471949576|FG000|Overall Study|Death|5|||
131086412|NCT05143138|471949577|FG001|Overall Study|Death|35|||
131086413|NCT05143138|471949578|FG002|Overall Study|Death|1|||
131086414|NCT05143138|471949576|FG000|Overall Study|Lost to Follow-up|2|||
131086415|NCT05143138|471949577|FG001|Overall Study|Lost to Follow-up|4|||
131086416|NCT05143138|471949578|FG002|Overall Study|Lost to Follow-up|0|||
131086417|NCT05143138|471949576|FG000|Overall Study|withdrawal|1|||
131086418|NCT05143138|471949577|FG001|Overall Study|withdrawal|1|||
131086419|NCT05143138|471949578|FG002|Overall Study|withdrawal|0|||
131086420|NCT03004404|471949581|FG000|Period 2|Adverse Event|0|||
131086421|NCT03004404|471949582|FG001|Period 2|Adverse Event|0|||
131086422|NCT03004404|471949583|FG002|Period 2|Adverse Event|0|||
131233802|NCT01644890|472484508|FG001|Overall Study|Progression Disease|131|||
131233803|NCT01644890|472484507|FG000|Overall Study|Clinical Progression|6|||
131233804|NCT01644890|472484508|FG001|Overall Study|Clinical Progression|6|||
131086423|NCT03004404|471949584|FG003|Period 2|Adverse Event|0|||
131086424|NCT03004404|471949585|FG004|Period 2|Adverse Event|0|||
131086425|NCT03004404|471949586|FG005|Period 2|Adverse Event|0|||
131086426|NCT03004404|471949587|FG006|Period 2|Adverse Event|0|||
131086427|NCT03004404|471949588|FG007|Period 2|Adverse Event|0|||
131086428|NCT03004404|471949589|FG008|Period 2|Adverse Event|1|||
131233805|NCT01644890|472484507|FG000|Overall Study|> 28 days since last dose of study drug|6|||
131142125|NCT01262976|472146585|FG001|Up to Year 1|Serious Adverse Event|0|||
131086429|NCT03004404|471949590|FG009|Period 2|Adverse Event|0|||
131086430|NCT03004404|471949591|FG010|Period 2|Adverse Event|0|||
131086431|NCT03004404|471949592|FG011|Period 2|Adverse Event|0|||
131086432|NCT03004404|471949593|FG012|Period 2|Adverse Event|0|||
131086433|NCT03004404|471949594|FG013|Period 2|Adverse Event|0|||
131086434|NCT03004404|471949595|FG014|Period 2|Adverse Event|0|||
131086435|NCT03004404|471949596|FG015|Period 2|Adverse Event|1|||
131086436|NCT01099917|471949597|FG000|Overall Study|Adverse Event|3|||
131086437|NCT01099917|471949597|FG000|Overall Study|Not Treated|24|||
131086438|NCT00422734|471949603|FG000|Overall Study|Physician Decision|1|||
131086439|NCT00422734|471949604|FG001|Overall Study|Physician Decision|1|||
131086440|NCT00422734|471949603|FG000|Overall Study|Protocol Violation|1|||
131086441|NCT00422734|471949604|FG001|Overall Study|Protocol Violation|6|||
131086442|NCT00422734|471949603|FG000|Overall Study|Withdrawal by Subject|12|||
131086443|NCT00422734|471949604|FG001|Overall Study|Withdrawal by Subject|8|||
131086444|NCT00422734|471949603|FG000|Overall Study|Adverse Event|0|||
131086445|NCT00422734|471949604|FG001|Overall Study|Adverse Event|3|||
131086446|NCT00422734|471949603|FG000|Overall Study|Partner Decision|0|||
131086447|NCT00422734|471949604|FG001|Overall Study|Partner Decision|3|||
131086448|NCT02567708|471949605|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
131086449|NCT02567708|471949606|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
131086450|NCT02567708|471949605|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
131086451|NCT02567708|471949606|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
131086452|NCT02567708|471949605|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
131086453|NCT02567708|471949606|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
131086454|NCT02567708|471949605|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
131086455|NCT02567708|471949606|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
131086456|NCT04148651|471949607|FG000|Overall Study|Lost to Follow-up|2|||
131086457|NCT05262751|471949608|FG000|Washout Period 2|Adverse Event|1|||
131086458|NCT05262751|471949609|FG001|Washout Period 2|Adverse Event|0|||
131086459|NCT05262751|471949610|FG002|Washout Period 2|Adverse Event|0|||
131086460|NCT05262751|471949611|FG003|Washout Period 2|Adverse Event|0|||
131086461|NCT05262751|471949612|FG004|Washout Period 2|Adverse Event|0|||
131086462|NCT05262751|471949613|FG005|Washout Period 2|Adverse Event|0|||
131086463|NCT05262751|471949608|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
131142126|NCT01262976|472146586|FG002|Up to Year 1|Serious Adverse Event|2|||
131142127|NCT01262976|472146587|FG003|Up to Year 1|Serious Adverse Event|0|||
131142128|NCT01262976|472146588|FG004|Up to Year 1|Serious Adverse Event|0|||
131142129|NCT01262976|472146589|FG005|Up to Year 1|Serious Adverse Event|0|||
131142130|NCT01262976|472146584|FG000|Up to Year 1|Withdrawal by Subject|1|||
131142131|NCT01262976|472146585|FG001|Up to Year 1|Withdrawal by Subject|0|||
131142132|NCT01262976|472146586|FG002|Up to Year 1|Withdrawal by Subject|0|||
131142133|NCT01262976|472146587|FG003|Up to Year 1|Withdrawal by Subject|0|||
131142134|NCT01262976|472146588|FG004|Up to Year 1|Withdrawal by Subject|0|||
131142135|NCT01262976|472146589|FG005|Up to Year 1|Withdrawal by Subject|0|||
131142136|NCT01262976|472146584|FG000|Up to Year 1|Migrated/moved from study area|1|||
131142137|NCT01262976|472146585|FG001|Up to Year 1|Migrated/moved from study area|0|||
131142138|NCT01262976|472146586|FG002|Up to Year 1|Migrated/moved from study area|0|||
131142139|NCT01262976|472146587|FG003|Up to Year 1|Migrated/moved from study area|3|||
131142140|NCT01262976|472146588|FG004|Up to Year 1|Migrated/moved from study area|3|||
131142141|NCT01262976|472146589|FG005|Up to Year 1|Migrated/moved from study area|2|||
131142142|NCT01262976|472146584|FG000|Up to Year 1|Lost to Follow-up|4|||
131142143|NCT01262976|472146585|FG001|Up to Year 1|Lost to Follow-up|0|||
131142144|NCT01262976|472146586|FG002|Up to Year 1|Lost to Follow-up|0|||
131142145|NCT01262976|472146587|FG003|Up to Year 1|Lost to Follow-up|1|||
131142146|NCT01262976|472146588|FG004|Up to Year 1|Lost to Follow-up|6|||
131142147|NCT01262976|472146589|FG005|Up to Year 1|Lost to Follow-up|5|||
131142148|NCT01262976|472146584|FG000|Up to Year 1|Other|3|||
131142149|NCT01262976|472146585|FG001|Up to Year 1|Other|1|||
131086464|NCT05262751|471949609|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
131233806|NCT01644890|472484508|FG001|Overall Study|> 28 days since last dose of study drug|3|||
131086465|NCT05262751|471949610|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
131086466|NCT05262751|471949611|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
131142150|NCT01262976|472146586|FG002|Up to Year 1|Other|0|||
131142151|NCT01262976|472146587|FG003|Up to Year 1|Other|0|||
131142152|NCT01262976|472146588|FG004|Up to Year 1|Other|2|||
131142153|NCT01262976|472146589|FG005|Up to Year 1|Other|1|||
131233807|NCT01644890|472484507|FG000|Overall Study|Other|8|||
131086467|NCT05262751|471949612|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
131086468|NCT05262751|471949613|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
131086469|NCT01001390|471949614|FG000|Overall Study|Failure to wear AFO device|2|||
131086470|NCT01001390|471949615|FG001|Overall Study|Failure to wear AFO device|0|||
131142154|NCT01262976|472146584|FG000|Up to Year 1|Subjects with unknown completion status|0|||
131142155|NCT01262976|472146585|FG001|Up to Year 1|Subjects with unknown completion status|0|||
131086471|NCT01151215|471949616|FG000|Overall Study|Worsening of condition under study|1|||
131086472|NCT01151215|471949617|FG001|Overall Study|Worsening of condition under study|1|||
131086473|NCT01151215|471949618|FG002|Overall Study|Worsening of condition under study|1|||
131086474|NCT01151215|471949616|FG000|Overall Study|Death|16|||
131086475|NCT01151215|471949617|FG001|Overall Study|Death|20|||
131086476|NCT01151215|471949618|FG002|Overall Study|Death|11|||
131086477|NCT01151215|471949616|FG000|Overall Study|Lost to Follow-up|0|||
131086478|NCT01151215|471949617|FG001|Overall Study|Lost to Follow-up|0|||
131086479|NCT01151215|471949618|FG002|Overall Study|Lost to Follow-up|3|||
131086480|NCT01151215|471949616|FG000|Overall Study|Withdrawal by Subject|3|||
131086481|NCT01151215|471949617|FG001|Overall Study|Withdrawal by Subject|1|||
131086482|NCT01151215|471949618|FG002|Overall Study|Withdrawal by Subject|2|||
131086483|NCT01151215|471949616|FG000|Overall Study|Disease progression|0|||
131086484|NCT01151215|471949617|FG001|Overall Study|Disease progression|1|||
131086485|NCT01151215|471949618|FG002|Overall Study|Disease progression|1|||
131086486|NCT01151215|471949616|FG000|Overall Study|Safety as judged by the investigator|0|||
131086487|NCT01151215|471949617|FG001|Overall Study|Safety as judged by the investigator|0|||
131086488|NCT01151215|471949618|FG002|Overall Study|Safety as judged by the investigator|1|||
131086489|NCT01721954|471949619|FG000|Overall Study|Death|58|||
131086490|NCT01721954|471949620|FG001|Overall Study|Death|64|||
131086491|NCT01721954|471949619|FG000|Overall Study|Withdrawal by Subject|8|||
131086492|NCT01721954|471949620|FG001|Overall Study|Withdrawal by Subject|4|||
131086493|NCT01721954|471949619|FG000|Overall Study|Adverse Event|2|||
131086494|NCT01721954|471949620|FG001|Overall Study|Adverse Event|0|||
131086495|NCT01721954|471949619|FG000|Overall Study|Lost to Follow-up|2|||
131086496|NCT01721954|471949620|FG001|Overall Study|Lost to Follow-up|1|||
131086497|NCT03392168|471949621|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
131086498|NCT03392168|471949622|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
131086499|NCT03392168|471949623|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
131086500|NCT03392168|471949624|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
131086501|NCT03392168|471949621|FG000|Period 2: Cohort 2|Other|0|||
131086502|NCT03392168|471949622|FG001|Period 2: Cohort 2|Other|1|||
131086503|NCT03392168|471949623|FG002|Period 2: Cohort 2|Other|0|||
131086504|NCT03392168|471949624|FG003|Period 2: Cohort 2|Other|0|||
131086505|NCT01154140|471949632|FG000|Overall Study|Death|71|||
131086506|NCT01154140|471949633|FG001|Overall Study|Death|81|||
131086507|NCT01154140|471949632|FG000|Overall Study|Lost to Follow-up|4|||
131086508|NCT01154140|471949633|FG001|Overall Study|Lost to Follow-up|5|||
131086509|NCT01154140|471949632|FG000|Overall Study|Withdrawal by Subject|12|||
131086510|NCT01154140|471949633|FG001|Overall Study|Withdrawal by Subject|13|||
131086511|NCT01154140|471949632|FG000|Overall Study|Other|3|||
131086512|NCT01154140|471949633|FG001|Overall Study|Other|1|||
131086513|NCT01154140|471949632|FG000|Overall Study|Randomized but not treated|1|||
131086514|NCT01154140|471949633|FG001|Overall Study|Randomized but not treated|2|||
131086515|NCT02992691|471949635|FG000|Overall Study|Adverse Event|2|||
131086516|NCT02992691|471949635|FG000|Overall Study|Withdrawal by Subject|1|||
131086517|NCT04276051|471949636|FG000|Overall Study|Lost to Follow-up|0|||
131086518|NCT04276051|471949637|FG001|Overall Study|Lost to Follow-up|1|||
131086519|NCT04276051|471949636|FG000|Overall Study|Physician Decision|0|||
131086520|NCT04276051|471949637|FG001|Overall Study|Physician Decision|1|||
131086521|NCT04276051|471949636|FG000|Overall Study|Withdrawal by Subject|1|||
131086522|NCT04276051|471949637|FG001|Overall Study|Withdrawal by Subject|1|||
131086523|NCT00392925|471949638|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
131086524|NCT00392925|471949639|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
131086525|NCT00392925|471949640|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
131086526|NCT00392925|471949641|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
131086527|NCT00392925|471949638|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
131086528|NCT00392925|471949639|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
131086529|NCT00392925|471949640|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
131086530|NCT00392925|471949641|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
131086531|NCT00392925|471949638|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
131086532|NCT00392925|471949639|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
131086533|NCT00392925|471949640|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
131086534|NCT00392925|471949641|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
131086535|NCT00392925|471949638|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
131086536|NCT00392925|471949639|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
131086537|NCT00392925|471949640|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
131086538|NCT00392925|471949641|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
131086539|NCT00392925|471949638|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
131086540|NCT00392925|471949639|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
131086541|NCT00392925|471949640|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
131086542|NCT00392925|471949641|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
131086543|NCT00392925|471949638|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
131233808|NCT01644890|472484508|FG001|Overall Study|Other|9|||
131086544|NCT00392925|471949639|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
131086545|NCT00392925|471949640|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
131086546|NCT00392925|471949641|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
131086547|NCT00392925|471949638|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
131086548|NCT00392925|471949639|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
131086549|NCT00392925|471949640|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
131086550|NCT00392925|471949641|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
131086551|NCT00392925|471949638|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
131086552|NCT00392925|471949639|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
131086553|NCT00392925|471949640|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
131086554|NCT00392925|471949641|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
131086555|NCT00392925|471949638|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
131086556|NCT00392925|471949639|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
131086557|NCT00392925|471949640|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
131086558|NCT00392925|471949641|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
131086559|NCT01461005|471949645|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
131086560|NCT00664534|471949646|FG000|Overall Study|Adverse Event|2|||
131086561|NCT00664534|471949647|FG001|Overall Study|Adverse Event|3|||
131086562|NCT00664534|471949646|FG000|Overall Study|Lost to Follow-up|6|||
131086563|NCT00664534|471949647|FG001|Overall Study|Lost to Follow-up|10|||
131086564|NCT00664534|471949646|FG000|Overall Study|Protocol Violation|10|||
131086565|NCT00664534|471949647|FG001|Overall Study|Protocol Violation|8|||
131086566|NCT00664534|471949646|FG000|Overall Study|Withdrawal by Subject|7|||
131086567|NCT00664534|471949647|FG001|Overall Study|Withdrawal by Subject|6|||
131086568|NCT00664534|471949646|FG000|Overall Study|Physician Decision|8|||
131086569|NCT00664534|471949647|FG001|Overall Study|Physician Decision|0|||
131086570|NCT00664534|471949646|FG000|Overall Study|Sponsor decision|8|||
131086571|NCT00664534|471949647|FG001|Overall Study|Sponsor decision|6|||
131086572|NCT02579772|471949648|FG000|Overall Study|Withdrawal by Subject|0|||
131086573|NCT02579772|471949649|FG001|Overall Study|Withdrawal by Subject|1|||
131086574|NCT02579772|471949648|FG000|Overall Study|Usage of additional antioxidants|1|||
131086575|NCT02579772|471949649|FG001|Overall Study|Usage of additional antioxidants|0|||
131086576|NCT02579772|471949648|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
131086577|NCT02579772|471949649|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
131086578|NCT04147195|471949650|FG000|Overall Study|Adverse Event|0|||
131086579|NCT04147195|471949651|FG001|Overall Study|Adverse Event|3|||
131086580|NCT04147195|471949650|FG000|Overall Study|Study Terminated by Sponsor|4|||
131086581|NCT04147195|471949651|FG001|Overall Study|Study Terminated by Sponsor|2|||
131086582|NCT04147195|471949650|FG000|Overall Study|Withdrawal by Subject|0|||
131086583|NCT04147195|471949651|FG001|Overall Study|Withdrawal by Subject|1|||
131086584|NCT05823012|471949652|FG000|Titration Period|Adverse Event|1|||
131086585|NCT05823012|471949652|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
131086586|NCT05823012|471949652|FG000|Maintenance Period|Adverse Event|1|||
131086587|NCT05823012|471949652|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
131086588|NCT05823012|471949652|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
131086589|NCT01920477|471951544|FG000|Overall Study|Adverse Event|0|||
131086590|NCT01920477|471951545|FG001|Overall Study|Adverse Event|1|||
131086591|NCT01920477|471951544|FG000|Overall Study|Lack of Efficacy|1|||
131086592|NCT01920477|471951545|FG001|Overall Study|Lack of Efficacy|0|||
131086593|NCT01920477|471951544|FG000|Overall Study|Study closed/terminated|14|||
131086594|NCT01920477|471951545|FG001|Overall Study|Study closed/terminated|15|||
131086595|NCT01920477|471951544|FG000|Overall Study|Withdrawal by Subject|0|||
131142156|NCT01262976|472146586|FG002|Up to Year 1|Subjects with unknown completion status|1|||
131142157|NCT01262976|472146587|FG003|Up to Year 1|Subjects with unknown completion status|0|||
131142158|NCT01262976|472146588|FG004|Up to Year 1|Subjects with unknown completion status|0|||
131142159|NCT01262976|472146589|FG005|Up to Year 1|Subjects with unknown completion status|1|||
131142160|NCT01262976|472146584|FG000|Up to Year 2|Serious Adverse Event|0|||
131142161|NCT01262976|472146585|FG001|Up to Year 2|Serious Adverse Event|0|||
131142162|NCT01262976|472146586|FG002|Up to Year 2|Serious Adverse Event|2|||
131142163|NCT01262976|472146587|FG003|Up to Year 2|Serious Adverse Event|0|||
131142164|NCT01262976|472146588|FG004|Up to Year 2|Serious Adverse Event|0|||
131086596|NCT01920477|471951545|FG001|Overall Study|Withdrawal by Subject|1|||
131086597|NCT01681277|471951548|FG000|Overall Study|Adverse Event|1|||
131086598|NCT01681277|471951549|FG001|Overall Study|Adverse Event|0|||
131233809|NCT01060670|472484511|FG000|Run In|screen failure|0|||
131233810|NCT01060670|472484512|FG001|Run In|screen failure|238|||
131086599|NCT01681277|471951550|FG002|Overall Study|Adverse Event|0|||
131086600|NCT01681277|471951551|FG003|Overall Study|Adverse Event|0|||
131086601|NCT01681277|471951552|FG004|Overall Study|Adverse Event|0|||
131086602|NCT02271984|471951558|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131086603|NCT02271984|471951559|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131142165|NCT01262976|472146589|FG005|Up to Year 2|Serious Adverse Event|0|||
131086604|NCT02271984|471951560|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131086605|NCT02271984|471951561|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131086606|NCT02271984|471951562|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131086607|NCT02271984|471951563|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
131086608|NCT02271984|471951564|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131086609|NCT02271984|471951565|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
131086610|NCT02271984|471951566|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131086611|NCT02271984|471951567|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131086612|NCT02271984|471951568|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131086613|NCT02271984|471951569|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
131086614|NCT02521363|471951570|FG000|Overall Study|Withdrawal by Subject|1|||
131086615|NCT02521363|471951571|FG001|Overall Study|Withdrawal by Subject|2|||
131086616|NCT03374488|471951572|FG000|Overall Study|Death|13|||
131086617|NCT03374488|471951573|FG001|Overall Study|Death|13|||
131086618|NCT03374488|471951572|FG000|Overall Study|Withdrawal by Subject|3|||
131086619|NCT03374488|471951573|FG001|Overall Study|Withdrawal by Subject|1|||
131086620|NCT03374488|471951572|FG000|Overall Study|Physician Decision|3|||
131086621|NCT03374488|471951573|FG001|Overall Study|Physician Decision|0|||
131086622|NCT03104075|471951574|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
131086623|NCT03104075|471951575|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
131086624|NCT04024462|471951576|FG000|Overall Study|Withdrawal by Subject|6|||
131086625|NCT04024462|471951577|FG001|Overall Study|Withdrawal by Subject|7|||
131086626|NCT04024462|471951576|FG000|Overall Study|Progressive Disease|0|||
131086627|NCT04024462|471951577|FG001|Overall Study|Progressive Disease|1|||
131086628|NCT04024462|471951576|FG000|Overall Study|Adverse Event|0|||
131086629|NCT04024462|471951577|FG001|Overall Study|Adverse Event|1|||
131086630|NCT04024462|471951576|FG000|Overall Study|Death|0|||
131086631|NCT04024462|471951577|FG001|Overall Study|Death|1|||
131086632|NCT04024462|471951576|FG000|Overall Study|Lost to Follow-up|1|||
131086633|NCT04024462|471951577|FG001|Overall Study|Lost to Follow-up|0|||
131086634|NCT04024462|471951576|FG000|Overall Study|Ongoing in the Study|94|||
131086635|NCT04024462|471951577|FG001|Overall Study|Ongoing in the Study|89|||
131086636|NCT02870972|471951584|FG000|Overall Study|Adverse Event|1|||
131086637|NCT02870972|471951585|FG001|Overall Study|Adverse Event|0|||
131086638|NCT02870972|471951586|FG002|Overall Study|Adverse Event|0|||
131086639|NCT02870972|471951587|FG003|Overall Study|Adverse Event|0|||
131086640|NCT02870972|471951588|FG004|Overall Study|Adverse Event|0|||
131086641|NCT04400487|471951591|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
131086642|NCT04400487|471951591|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
131086643|NCT04400487|471951591|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
131086644|NCT03559062|471951592|FG000|Overall Study|Other|0|||
131086645|NCT03559062|471951593|FG001|Overall Study|Other|1|||
131086646|NCT03559062|471951594|FG002|Overall Study|Other|0|||
131086647|NCT03445533|471951595|FG000|Overall Study|Progressive Disease|48|||
131086648|NCT03445533|471951596|FG001|Overall Study|Progressive Disease|81|||
131086649|NCT03445533|471951595|FG000|Overall Study|Adverse Event|60|||
131086650|NCT03445533|471951596|FG001|Overall Study|Adverse Event|64|||
131086651|NCT03445533|471951595|FG000|Overall Study|Death|9|||
131086652|NCT03445533|471951596|FG001|Overall Study|Death|19|||
131086653|NCT03445533|471951595|FG000|Overall Study|Miscellaneous|0|||
131086654|NCT03445533|471951596|FG001|Overall Study|Miscellaneous|16|||
131086655|NCT03445533|471951595|FG000|Overall Study|Withdrawal by Subject|3|||
131086656|NCT03445533|471951596|FG001|Overall Study|Withdrawal by Subject|4|||
131086657|NCT03445533|471951595|FG000|Overall Study|Physician Decision|1|||
131086658|NCT03445533|471951596|FG001|Overall Study|Physician Decision|3|||
131086659|NCT03445533|471951595|FG000|Overall Study|Sponsor Decision|0|||
131086660|NCT03445533|471951596|FG001|Overall Study|Sponsor Decision|1|||
131086661|NCT03445533|471951595|FG000|Overall Study|Lost to Follow-up|0|||
131086662|NCT03445533|471951596|FG001|Overall Study|Lost to Follow-up|1|||
131086663|NCT03445533|471951595|FG000|Overall Study|Never Received any Study Treatment|7|||
131142166|NCT01262976|472146584|FG000|Up to Year 2|Withdrawal by Subject|1|||
131142167|NCT01262976|472146585|FG001|Up to Year 2|Withdrawal by Subject|0|||
131142168|NCT01262976|472146586|FG002|Up to Year 2|Withdrawal by Subject|0|||
131142169|NCT01262976|472146587|FG003|Up to Year 2|Withdrawal by Subject|0|||
131086664|NCT03445533|471951596|FG001|Overall Study|Never Received any Study Treatment|4|||
131086665|NCT02493062|471951597|FG000|Overall Study|Physician Decision|12|||
131086666|NCT01327612|471951599|FG000|Overall Study|Withdrawal by Subject|0|||
131086667|NCT01327612|471951600|FG001|Overall Study|Withdrawal by Subject|0|||
131086668|NCT01327612|471951601|FG002|Overall Study|Withdrawal by Subject|0|||
131086669|NCT01327612|471951602|FG003|Overall Study|Withdrawal by Subject|0|||
131086670|NCT01327612|471951603|FG004|Overall Study|Withdrawal by Subject|0|||
131086671|NCT01327612|471951604|FG005|Overall Study|Withdrawal by Subject|1|||
131086672|NCT01327612|471951605|FG006|Overall Study|Withdrawal by Subject|0|||
131142170|NCT01262976|472146588|FG004|Up to Year 2|Withdrawal by Subject|0|||
131086673|NCT01327612|471951599|FG000|Overall Study|Disease Progression|1|||
131142171|NCT01262976|472146589|FG005|Up to Year 2|Withdrawal by Subject|0|||
131086674|NCT01327612|471951600|FG001|Overall Study|Disease Progression|1|||
131086675|NCT01327612|471951601|FG002|Overall Study|Disease Progression|1|||
131086676|NCT01327612|471951602|FG003|Overall Study|Disease Progression|0|||
131086677|NCT01327612|471951603|FG004|Overall Study|Disease Progression|1|||
131086678|NCT01327612|471951604|FG005|Overall Study|Disease Progression|2|||
131086679|NCT01327612|471951605|FG006|Overall Study|Disease Progression|2|||
131086680|NCT01327612|471951599|FG000|Overall Study|Administrative Decision|0|||
131086681|NCT01327612|471951600|FG001|Overall Study|Administrative Decision|0|||
131086682|NCT01327612|471951601|FG002|Overall Study|Administrative Decision|0|||
131086683|NCT01327612|471951602|FG003|Overall Study|Administrative Decision|1|||
131086684|NCT01327612|471951603|FG004|Overall Study|Administrative Decision|0|||
131086685|NCT01327612|471951604|FG005|Overall Study|Administrative Decision|0|||
131086686|NCT01327612|471951605|FG006|Overall Study|Administrative Decision|0|||
131086687|NCT01327612|471951599|FG000|Overall Study|Death|0|||
131086688|NCT01327612|471951600|FG001|Overall Study|Death|0|||
131086689|NCT01327612|471951601|FG002|Overall Study|Death|0|||
131086690|NCT01327612|471951602|FG003|Overall Study|Death|0|||
131086691|NCT01327612|471951603|FG004|Overall Study|Death|1|||
131086692|NCT01327612|471951604|FG005|Overall Study|Death|0|||
131086693|NCT01327612|471951605|FG006|Overall Study|Death|0|||
131086694|NCT00426127|471951606|FG000|Overall Study|Adverse Event|1|||
131086695|NCT00426127|471951606|FG000|Overall Study|Removed due to disease progression|1|||
131086696|NCT05569421|471951607|FG000|Overall Study|Withdrawal by Subject|1|||
131086697|NCT05569421|471951608|FG001|Overall Study|Withdrawal by Subject|0|||
131086698|NCT05569421|471951609|FG002|Overall Study|Withdrawal by Subject|0|||
131086699|NCT01689857|471951610|FG000|Overall Study|Lost to Follow-up|5|||
131086700|NCT01689857|471951611|FG001|Overall Study|Lost to Follow-up|2|||
131086701|NCT01730378|471951613|FG000|Overall Study|Lost to Follow-up|1|||
131086702|NCT01730378|471951614|FG001|Overall Study|Lost to Follow-up|0|||
131086703|NCT00874731|471951615|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
131086704|NCT00874731|471951616|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
131086705|NCT00874731|471951617|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
131086706|NCT00874731|471951615|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
131086707|NCT00874731|471951616|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
131086708|NCT00874731|471951617|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
131086709|NCT00874731|471951615|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
131086710|NCT00874731|471951616|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
131086711|NCT00874731|471951617|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
131086712|NCT00955708|471951618|FG000|Overall Study|Death|269|||
131086713|NCT00955708|471951618|FG000|Overall Study|Lost to Follow-up|72|||
131086714|NCT00955708|471951618|FG000|Overall Study|Physician Decision|36|||
131086715|NCT00955708|471951618|FG000|Overall Study|Protocol Violation|134|||
131086716|NCT00955708|471951618|FG000|Overall Study|Registry Conclusion|186|||
131086717|NCT00955708|471951618|FG000|Overall Study|Product removed from service|94|||
131086718|NCT00955708|471951618|FG000|Overall Study|Patient Refused to participate further|116|||
131086719|NCT00955708|471951618|FG000|Overall Study|Closure of study location|60|||
131086720|NCT00955708|471951618|FG000|Overall Study|Patient changed care provider/moved|91|||
131086721|NCT05105087|471951619|FG000|Overall Study|Withdrawal by Subject|2|||
131086722|NCT05105087|471951619|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
131086723|NCT01016262|471951620|FG000|Double-blind Phase|Adverse Event|0|||
131086724|NCT01016262|471951621|FG001|Double-blind Phase|Adverse Event|0|||
131086725|NCT01016262|471951622|FG002|Double-blind Phase|Adverse Event|1|||
131086726|NCT01016262|471951623|FG003|Double-blind Phase|Adverse Event|0|||
131086727|NCT01016262|471951624|FG004|Double-blind Phase|Adverse Event|0|||
131086728|NCT01016262|471951625|FG005|Double-blind Phase|Adverse Event|0|||
131142172|NCT01262976|472146584|FG000|Up to Year 2|Migrated/moved from study area|0|||
131142173|NCT01262976|472146585|FG001|Up to Year 2|Migrated/moved from study area|0|||
131142174|NCT01262976|472146586|FG002|Up to Year 2|Migrated/moved from study area|0|||
131142175|NCT01262976|472146587|FG003|Up to Year 2|Migrated/moved from study area|2|||
131142176|NCT01262976|472146588|FG004|Up to Year 2|Migrated/moved from study area|1|||
131142177|NCT01262976|472146589|FG005|Up to Year 2|Migrated/moved from study area|2|||
131142178|NCT01262976|472146584|FG000|Up to Year 2|Lost to Follow-up|1|||
131142179|NCT01262976|472146585|FG001|Up to Year 2|Lost to Follow-up|1|||
131142180|NCT01262976|472146586|FG002|Up to Year 2|Lost to Follow-up|2|||
131142181|NCT01262976|472146587|FG003|Up to Year 2|Lost to Follow-up|2|||
131086729|NCT01016262|471951620|FG000|Double-blind Phase|Lack of Efficacy|1|||
131086730|NCT01016262|471951621|FG001|Double-blind Phase|Lack of Efficacy|0|||
131086731|NCT01016262|471951622|FG002|Double-blind Phase|Lack of Efficacy|5|||
131086732|NCT01016262|471951623|FG003|Double-blind Phase|Lack of Efficacy|0|||
131086733|NCT01016262|471951624|FG004|Double-blind Phase|Lack of Efficacy|0|||
131086734|NCT01016262|471951625|FG005|Double-blind Phase|Lack of Efficacy|0|||
131086735|NCT01016262|471951620|FG000|Double-blind Phase|Disease Progression|0|||
131086736|NCT01016262|471951621|FG001|Double-blind Phase|Disease Progression|1|||
131086737|NCT01016262|471951622|FG002|Double-blind Phase|Disease Progression|2|||
131086738|NCT01016262|471951623|FG003|Double-blind Phase|Disease Progression|0|||
131142182|NCT01262976|472146588|FG004|Up to Year 2|Lost to Follow-up|3|||
131142183|NCT01262976|472146589|FG005|Up to Year 2|Lost to Follow-up|3|||
131086739|NCT01016262|471951624|FG004|Double-blind Phase|Disease Progression|0|||
131086740|NCT01016262|471951625|FG005|Double-blind Phase|Disease Progression|0|||
131086741|NCT01016262|471951620|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
131086742|NCT01016262|471951621|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
131086743|NCT01016262|471951622|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
131086744|NCT01016262|471951623|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
131086745|NCT01016262|471951624|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
131086746|NCT01016262|471951625|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
131086747|NCT01016262|471951620|FG000|Open-Label Phase|Adverse Event|0|||
131086748|NCT01016262|471951621|FG001|Open-Label Phase|Adverse Event|0|||
131086749|NCT01016262|471951622|FG002|Open-Label Phase|Adverse Event|0|||
131086750|NCT01016262|471951623|FG003|Open-Label Phase|Adverse Event|1|||
131086751|NCT01016262|471951624|FG004|Open-Label Phase|Adverse Event|0|||
131086752|NCT01016262|471951625|FG005|Open-Label Phase|Adverse Event|0|||
131086753|NCT01016262|471951620|FG000|Open-Label Phase|Lost to Follow-up|0|||
131086754|NCT01016262|471951621|FG001|Open-Label Phase|Lost to Follow-up|0|||
131086755|NCT01016262|471951622|FG002|Open-Label Phase|Lost to Follow-up|0|||
131086756|NCT01016262|471951623|FG003|Open-Label Phase|Lost to Follow-up|0|||
131086757|NCT01016262|471951624|FG004|Open-Label Phase|Lost to Follow-up|1|||
131086758|NCT01016262|471951625|FG005|Open-Label Phase|Lost to Follow-up|0|||
131086759|NCT01016262|471951620|FG000|Open-Label Phase|Lack of Efficacy|0|||
131086760|NCT01016262|471951621|FG001|Open-Label Phase|Lack of Efficacy|0|||
131086761|NCT01016262|471951622|FG002|Open-Label Phase|Lack of Efficacy|0|||
131086762|NCT01016262|471951623|FG003|Open-Label Phase|Lack of Efficacy|1|||
131086763|NCT01016262|471951624|FG004|Open-Label Phase|Lack of Efficacy|0|||
131086764|NCT01016262|471951625|FG005|Open-Label Phase|Lack of Efficacy|0|||
131086765|NCT01016262|471951620|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
131086766|NCT01016262|471951621|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
131086767|NCT01016262|471951622|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
131086768|NCT01016262|471951623|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
131086769|NCT01016262|471951624|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
131086770|NCT01016262|471951625|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
131086771|NCT01736540|471951628|FG000|Overall Study|Did not complete scan within 45 days|2|||
131086772|NCT01736540|471951628|FG000|Overall Study|Death|1|||
131086773|NCT01736540|471951628|FG000|Overall Study|Abnormal test procedure|1|||
131086774|NCT01736540|471951628|FG000|Overall Study|Withdrawal by Subject|5|||
131086775|NCT01736540|471951628|FG000|Overall Study|Protocol Violation|1|||
131086776|NCT01736540|471951628|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
131086777|NCT01736540|471951628|FG000|Overall Study|No show for MRI appointment|1|||
131086778|NCT01736540|471951628|FG000|Overall Study|Unable to make MRI appointment|3|||
131086779|NCT00479882|471951629|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
131086780|NCT00479882|471951630|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
131086781|NCT00479882|471951631|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
131086782|NCT00479882|471951632|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
131086783|NCT00479882|471951629|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
131086784|NCT00479882|471951630|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
131086785|NCT00479882|471951631|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
131086786|NCT00479882|471951632|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
131086787|NCT00479882|471951629|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
131086788|NCT00479882|471951630|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
131086789|NCT00479882|471951631|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
131086790|NCT00479882|471951632|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
131086791|NCT00479882|471951629|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
131086792|NCT00479882|471951630|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
131086793|NCT00479882|471951631|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
131086794|NCT00479882|471951632|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
131086795|NCT00479882|471951629|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
131086796|NCT00479882|471951630|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
131142184|NCT01262976|472146584|FG000|Up to Year 2|Subjects with unknown completion status|0|||
131142185|NCT01262976|472146585|FG001|Up to Year 2|Subjects with unknown completion status|0|||
131142186|NCT01262976|472146586|FG002|Up to Year 2|Subjects with unknown completion status|1|||
131142187|NCT01262976|472146587|FG003|Up to Year 2|Subjects with unknown completion status|0|||
131142188|NCT01262976|472146588|FG004|Up to Year 2|Subjects with unknown completion status|0|||
131086797|NCT00479882|471951631|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
131086798|NCT00479882|471951632|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
131086799|NCT00479882|471951629|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
131142189|NCT01262976|472146589|FG005|Up to Year 2|Subjects with unknown completion status|0|||
131086800|NCT00479882|471951630|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
131086801|NCT00479882|471951631|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
131142190|NCT01262976|472146584|FG000|Up to Year 2|Other|3|||
131086802|NCT00479882|471951632|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
131086803|NCT00479882|471951629|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
131086804|NCT00479882|471951630|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
131086805|NCT00479882|471951631|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
131086806|NCT00479882|471951632|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
131086807|NCT00479882|471951629|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
131086808|NCT00479882|471951630|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
131086809|NCT00479882|471951631|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
131086810|NCT00479882|471951632|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
131086811|NCT00479882|471951629|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
131086812|NCT00479882|471951630|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
131086813|NCT00479882|471951631|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
131086814|NCT00479882|471951632|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
131086815|NCT00479882|471951629|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
131086816|NCT00479882|471951630|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
131086817|NCT00479882|471951631|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
131086818|NCT00479882|471951632|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
131086819|NCT00479882|471951629|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
131086820|NCT00479882|471951630|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
131086821|NCT00479882|471951631|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
131086822|NCT00479882|471951632|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
131086823|NCT00479882|471951629|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
131086824|NCT00479882|471951630|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
131086825|NCT00479882|471951631|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
131086826|NCT00479882|471951632|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
131086827|NCT00479882|471951629|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
131086828|NCT00479882|471951630|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
131086829|NCT00479882|471951631|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
131086830|NCT00479882|471951632|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
131086831|NCT00479882|471951629|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
131086832|NCT00479882|471951630|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
131086833|NCT00479882|471951631|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
131086834|NCT00479882|471951632|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
131086835|NCT01132820|471951633|FG000|Overall Study|Ineligible: wrong cell type|1|||
131086836|NCT01132820|471951633|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
131086837|NCT01132820|471951633|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
131086838|NCT01132820|471951633|FG000|Overall Study|Never treated|1|||
131086839|NCT01132820|471951633|FG000|Overall Study|Inadequate data|1|||
131086840|NCT01370655|471951636|FG000|Period 1|Adverse Event|2|||
131086841|NCT01370655|471951637|FG001|Period 1|Adverse Event|0|||
131086842|NCT01370655|471951638|FG002|Period 1|Adverse Event|0|||
131086843|NCT01370655|471951639|FG003|Period 1|Adverse Event|0|||
131086844|NCT01370655|471951640|FG004|Period 1|Adverse Event|0|||
131086845|NCT01370655|471951641|FG005|Period 1|Adverse Event|0|||
131086846|NCT01370655|471951642|FG006|Period 1|Adverse Event|1|||
131086847|NCT01370655|471951643|FG007|Period 1|Adverse Event|0|||
131086848|NCT01370655|471951644|FG008|Period 1|Adverse Event|0|||
131086849|NCT01370655|471951645|FG009|Period 1|Adverse Event|0|||
131086850|NCT01370655|471951646|FG010|Period 1|Adverse Event|0|||
131086851|NCT01370655|471951647|FG011|Period 1|Adverse Event|0|||
131086852|NCT01370655|471951636|FG000|Period 2|Adverse Event|0|||
131086853|NCT01370655|471951637|FG001|Period 2|Adverse Event|0|||
131086854|NCT01370655|471951638|FG002|Period 2|Adverse Event|1|||
131086855|NCT01370655|471951639|FG003|Period 2|Adverse Event|0|||
131086856|NCT01370655|471951640|FG004|Period 2|Adverse Event|1|||
131086857|NCT01370655|471951641|FG005|Period 2|Adverse Event|0|||
131086858|NCT01370655|471951642|FG006|Period 2|Adverse Event|0|||
131142191|NCT01262976|472146585|FG001|Up to Year 2|Other|0|||
131142192|NCT01262976|472146586|FG002|Up to Year 2|Other|0|||
131142193|NCT01262976|472146587|FG003|Up to Year 2|Other|0|||
131142194|NCT01262976|472146588|FG004|Up to Year 2|Other|0|||
131142195|NCT01262976|472146589|FG005|Up to Year 2|Other|0|||
131142196|NCT01262976|472146584|FG000|Up to Year 3|Serious Adverse Event|0|||
131142197|NCT01262976|472146585|FG001|Up to Year 3|Serious Adverse Event|0|||
131142198|NCT01262976|472146586|FG002|Up to Year 3|Serious Adverse Event|2|||
131142199|NCT01262976|472146587|FG003|Up to Year 3|Serious Adverse Event|0|||
131142200|NCT01262976|472146588|FG004|Up to Year 3|Serious Adverse Event|0|||
131142201|NCT01262976|472146589|FG005|Up to Year 3|Serious Adverse Event|0|||
131142202|NCT01262976|472146584|FG000|Up to Year 3|Withdrawal by Subject|1|||
131142203|NCT01262976|472146585|FG001|Up to Year 3|Withdrawal by Subject|0|||
131142204|NCT01262976|472146586|FG002|Up to Year 3|Withdrawal by Subject|0|||
131142205|NCT01262976|472146587|FG003|Up to Year 3|Withdrawal by Subject|0|||
131142206|NCT01262976|472146588|FG004|Up to Year 3|Withdrawal by Subject|0|||
131233811|NCT04849988|472484515|FG000|Overall Study|Lack of Efficacy|3|||
131086859|NCT01370655|471951643|FG007|Period 2|Adverse Event|1|||
131086860|NCT01370655|471951644|FG008|Period 2|Adverse Event|0|||
131086861|NCT01370655|471951645|FG009|Period 2|Adverse Event|0|||
131086862|NCT01370655|471951646|FG010|Period 2|Adverse Event|0|||
131086863|NCT01370655|471951647|FG011|Period 2|Adverse Event|0|||
131086864|NCT01370655|471951636|FG000|Period 2|met protocol specified stopping criteria|0|||
131086865|NCT01370655|471951637|FG001|Period 2|met protocol specified stopping criteria|0|||
131086866|NCT01370655|471951638|FG002|Period 2|met protocol specified stopping criteria|1|||
131086867|NCT01370655|471951639|FG003|Period 2|met protocol specified stopping criteria|0|||
131086868|NCT01370655|471951640|FG004|Period 2|met protocol specified stopping criteria|0|||
131086869|NCT01370655|471951641|FG005|Period 2|met protocol specified stopping criteria|0|||
131086870|NCT01370655|471951642|FG006|Period 2|met protocol specified stopping criteria|1|||
131086871|NCT01370655|471951643|FG007|Period 2|met protocol specified stopping criteria|0|||
131086872|NCT01370655|471951644|FG008|Period 2|met protocol specified stopping criteria|1|||
131086873|NCT01370655|471951645|FG009|Period 2|met protocol specified stopping criteria|0|||
131086874|NCT01370655|471951646|FG010|Period 2|met protocol specified stopping criteria|1|||
131086875|NCT01370655|471951647|FG011|Period 2|met protocol specified stopping criteria|0|||
131086876|NCT01370655|471951636|FG000|Period 2|Withdrawal by Subject|0|||
131086877|NCT01370655|471951637|FG001|Period 2|Withdrawal by Subject|0|||
131086878|NCT01370655|471951638|FG002|Period 2|Withdrawal by Subject|0|||
131086879|NCT01370655|471951639|FG003|Period 2|Withdrawal by Subject|0|||
131086880|NCT01370655|471951640|FG004|Period 2|Withdrawal by Subject|0|||
131086881|NCT01370655|471951641|FG005|Period 2|Withdrawal by Subject|0|||
131086882|NCT01370655|471951642|FG006|Period 2|Withdrawal by Subject|0|||
131086883|NCT01370655|471951643|FG007|Period 2|Withdrawal by Subject|0|||
131086884|NCT01370655|471951644|FG008|Period 2|Withdrawal by Subject|1|||
131086885|NCT01370655|471951645|FG009|Period 2|Withdrawal by Subject|0|||
131086886|NCT01370655|471951646|FG010|Period 2|Withdrawal by Subject|0|||
131086887|NCT01370655|471951647|FG011|Period 2|Withdrawal by Subject|0|||
131086888|NCT05000216|471951649|FG000|Stage 1|Lost to Follow-up|0|||
131086889|NCT05000216|471951650|FG001|Stage 1|Lost to Follow-up|0|||
131086890|NCT05000216|471951651|FG002|Stage 1|Lost to Follow-up|0|||
131086891|NCT05000216|471951652|FG003|Stage 1|Lost to Follow-up|0|||
131086892|NCT05000216|471951653|FG004|Stage 1|Lost to Follow-up|0|||
131086893|NCT05000216|471951654|FG005|Stage 1|Lost to Follow-up|0|||
131086894|NCT05000216|471951655|FG006|Stage 1|Lost to Follow-up|1|||
131086895|NCT05000216|471951656|FG007|Stage 1|Lost to Follow-up|1|||
131086896|NCT05000216|471951657|FG008|Stage 1|Lost to Follow-up|0|||
131086897|NCT05000216|471951658|FG009|Stage 1|Lost to Follow-up|2|||
131086898|NCT05000216|471951659|FG010|Stage 1|Lost to Follow-up|3|||
131086899|NCT05000216|471951660|FG011|Stage 1|Lost to Follow-up|0|||
131086900|NCT05000216|471951661|FG012|Stage 1|Lost to Follow-up|0|||
131086901|NCT05000216|471951662|FG013|Stage 1|Lost to Follow-up|0|||
131086902|NCT05000216|471951663|FG014|Stage 1|Lost to Follow-up|0|||
131086903|NCT05000216|471951664|FG015|Stage 1|Lost to Follow-up|0|||
131086904|NCT05000216|471951665|FG016|Stage 1|Lost to Follow-up|0|||
131086905|NCT05000216|471951666|FG017|Stage 1|Lost to Follow-up|0|||
131086906|NCT05000216|471951667|FG018|Stage 1|Lost to Follow-up|0|||
131086907|NCT05000216|471951668|FG019|Stage 1|Lost to Follow-up|0|||
131086908|NCT05000216|471951669|FG020|Stage 1|Lost to Follow-up|0|||
131086909|NCT05000216|471951670|FG021|Stage 1|Lost to Follow-up|0|||
131086910|NCT05000216|471951649|FG000|Stage 1|Physician Decision|0|||
131086911|NCT05000216|471951650|FG001|Stage 1|Physician Decision|0|||
131086912|NCT05000216|471951651|FG002|Stage 1|Physician Decision|0|||
131086913|NCT05000216|471951652|FG003|Stage 1|Physician Decision|0|||
131086914|NCT05000216|471951653|FG004|Stage 1|Physician Decision|0|||
131086915|NCT05000216|471951654|FG005|Stage 1|Physician Decision|0|||
131086916|NCT05000216|471951655|FG006|Stage 1|Physician Decision|0|||
131086917|NCT05000216|471951656|FG007|Stage 1|Physician Decision|1|||
131086918|NCT05000216|471951657|FG008|Stage 1|Physician Decision|1|||
131086919|NCT05000216|471951658|FG009|Stage 1|Physician Decision|0|||
131086920|NCT05000216|471951659|FG010|Stage 1|Physician Decision|0|||
131086921|NCT05000216|471951660|FG011|Stage 1|Physician Decision|0|||
131086922|NCT05000216|471951661|FG012|Stage 1|Physician Decision|0|||
131086923|NCT05000216|471951662|FG013|Stage 1|Physician Decision|0|||
131086924|NCT05000216|471951663|FG014|Stage 1|Physician Decision|0|||
131086925|NCT05000216|471951664|FG015|Stage 1|Physician Decision|0|||
131233812|NCT04849988|472484516|FG001|Overall Study|Lack of Efficacy|4|||
131233813|NCT04849988|472484517|FG002|Overall Study|Lack of Efficacy|1|||
131086926|NCT05000216|471951665|FG016|Stage 1|Physician Decision|0|||
131086927|NCT05000216|471951666|FG017|Stage 1|Physician Decision|0|||
131086928|NCT05000216|471951667|FG018|Stage 1|Physician Decision|0|||
131086929|NCT05000216|471951668|FG019|Stage 1|Physician Decision|0|||
131086930|NCT05000216|471951669|FG020|Stage 1|Physician Decision|0|||
131086931|NCT05000216|471951670|FG021|Stage 1|Physician Decision|0|||
131086932|NCT05000216|471951649|FG000|Stage 1|Withdrawal by Subject|0|||
131086933|NCT05000216|471951650|FG001|Stage 1|Withdrawal by Subject|1|||
131086934|NCT05000216|471951651|FG002|Stage 1|Withdrawal by Subject|0|||
131086935|NCT05000216|471951652|FG003|Stage 1|Withdrawal by Subject|0|||
131086936|NCT05000216|471951653|FG004|Stage 1|Withdrawal by Subject|0|||
131086937|NCT05000216|471951654|FG005|Stage 1|Withdrawal by Subject|0|||
131086938|NCT05000216|471951655|FG006|Stage 1|Withdrawal by Subject|0|||
131086939|NCT05000216|471951656|FG007|Stage 1|Withdrawal by Subject|0|||
131086940|NCT05000216|471951657|FG008|Stage 1|Withdrawal by Subject|0|||
131086941|NCT05000216|471951658|FG009|Stage 1|Withdrawal by Subject|3|||
131086942|NCT05000216|471951659|FG010|Stage 1|Withdrawal by Subject|10|||
131086943|NCT05000216|471951660|FG011|Stage 1|Withdrawal by Subject|0|||
131086944|NCT05000216|471951661|FG012|Stage 1|Withdrawal by Subject|0|||
131086945|NCT05000216|471951662|FG013|Stage 1|Withdrawal by Subject|0|||
131086946|NCT05000216|471951663|FG014|Stage 1|Withdrawal by Subject|0|||
131086947|NCT05000216|471951664|FG015|Stage 1|Withdrawal by Subject|0|||
131086948|NCT05000216|471951665|FG016|Stage 1|Withdrawal by Subject|0|||
131086949|NCT05000216|471951666|FG017|Stage 1|Withdrawal by Subject|0|||
131086950|NCT05000216|471951667|FG018|Stage 1|Withdrawal by Subject|0|||
131086951|NCT05000216|471951668|FG019|Stage 1|Withdrawal by Subject|0|||
131086952|NCT05000216|471951669|FG020|Stage 1|Withdrawal by Subject|0|||
131086953|NCT05000216|471951670|FG021|Stage 1|Withdrawal by Subject|0|||
131086954|NCT05000216|471951649|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
131086955|NCT05000216|471951650|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
131086956|NCT05000216|471951651|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
131086957|NCT05000216|471951652|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
131086958|NCT05000216|471951653|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
131086959|NCT05000216|471951654|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
131086960|NCT05000216|471951655|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
131086961|NCT05000216|471951656|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
131086962|NCT05000216|471951657|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
131086963|NCT05000216|471951658|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
131142207|NCT01262976|472146589|FG005|Up to Year 3|Withdrawal by Subject|0|||
131142208|NCT01262976|472146584|FG000|Up to Year 3|Migrated/moved from study area|0|||
131142209|NCT01262976|472146585|FG001|Up to Year 3|Migrated/moved from study area|0|||
131142210|NCT01262976|472146586|FG002|Up to Year 3|Migrated/moved from study area|0|||
131142211|NCT01262976|472146587|FG003|Up to Year 3|Migrated/moved from study area|2|||
131142212|NCT01262976|472146588|FG004|Up to Year 3|Migrated/moved from study area|1|||
131142213|NCT01262976|472146589|FG005|Up to Year 3|Migrated/moved from study area|1|||
131142214|NCT01262976|472146584|FG000|Up to Year 3|Lost to Follow-up|2|||
131142215|NCT01262976|472146585|FG001|Up to Year 3|Lost to Follow-up|2|||
131233814|NCT04849988|472484518|FG003|Overall Study|Lack of Efficacy|4|||
131233815|NCT04849988|472484515|FG000|Overall Study|Other reasons|1|||
131233816|NCT04849988|472484516|FG001|Overall Study|Other reasons|2|||
131233817|NCT04849988|472484517|FG002|Overall Study|Other reasons|2|||
131233818|NCT04849988|472484518|FG003|Overall Study|Other reasons|1|||
131233819|NCT00056160|472484525|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
131233820|NCT00056160|472484526|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
131233821|NCT00056160|472484525|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
131233822|NCT00056160|472484526|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
131233823|NCT00056160|472484525|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
131233824|NCT00056160|472484526|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
131233825|NCT00056160|472484525|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
131233826|NCT00056160|472484526|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
131233827|NCT00056160|472484525|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
131233828|NCT00056160|472484526|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
131233829|NCT00056160|472484525|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
131233830|NCT00056160|472484526|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
131233831|NCT00056160|472484525|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
131233832|NCT00056160|472484526|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
131233833|NCT00056160|472484525|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
131233834|NCT00056160|472484526|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
131233835|NCT00056160|472484525|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
131233836|NCT00056160|472484526|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
131233837|NCT00056160|472484525|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
131233838|NCT00056160|472484526|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
131233839|NCT00056160|472484525|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
131233840|NCT00056160|472484526|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
131233841|NCT00056160|472484525|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
131233842|NCT00056160|472484526|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
131233843|NCT00056160|472484525|FG000|Final Follow-up|Transferred into expanded access study.|3|||
130727242|NCT02883049|470625426|FG002|Post Induction|Withdrawal by Subject|0|||
130727243|NCT02883049|470625427|FG003|Post Induction|Withdrawal by Subject|5|||
131086964|NCT05000216|471951659|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
131086965|NCT05000216|471951660|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
131086966|NCT05000216|471951661|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
131142216|NCT01262976|472146586|FG002|Up to Year 3|Lost to Follow-up|4|||
131142217|NCT01262976|472146587|FG003|Up to Year 3|Lost to Follow-up|3|||
131233844|NCT00056160|472484526|FG001|Final Follow-up|Transferred into expanded access study.|0|||
131086967|NCT05000216|471951662|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
131086968|NCT05000216|471951663|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
131086969|NCT05000216|471951664|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
131086970|NCT05000216|471951665|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
131086971|NCT05000216|471951666|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
131086972|NCT05000216|471951667|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
131086973|NCT05000216|471951668|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
131086974|NCT05000216|471951669|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
131086975|NCT05000216|471951670|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
131086976|NCT05000216|471951649|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086977|NCT05000216|471951650|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086978|NCT05000216|471951651|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086979|NCT05000216|471951652|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086980|NCT05000216|471951653|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086981|NCT05000216|471951654|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086982|NCT05000216|471951655|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086983|NCT05000216|471951656|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086984|NCT05000216|471951657|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
131086985|NCT05000216|471951658|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086986|NCT05000216|471951659|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086987|NCT05000216|471951660|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086988|NCT05000216|471951661|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086989|NCT05000216|471951662|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086990|NCT05000216|471951663|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086991|NCT05000216|471951664|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086992|NCT05000216|471951665|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086993|NCT05000216|471951666|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086994|NCT05000216|471951667|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086995|NCT05000216|471951668|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086996|NCT05000216|471951669|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086997|NCT05000216|471951670|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
131086998|NCT05000216|471951649|FG000|Stage 1|Other|0|||
131086999|NCT05000216|471951650|FG001|Stage 1|Other|0|||
131087000|NCT05000216|471951651|FG002|Stage 1|Other|0|||
131087001|NCT05000216|471951652|FG003|Stage 1|Other|0|||
131087002|NCT05000216|471951653|FG004|Stage 1|Other|1|||
131087003|NCT05000216|471951654|FG005|Stage 1|Other|0|||
131087004|NCT05000216|471951655|FG006|Stage 1|Other|0|||
131087005|NCT05000216|471951656|FG007|Stage 1|Other|2|||
131087006|NCT05000216|471951657|FG008|Stage 1|Other|0|||
131087007|NCT05000216|471951658|FG009|Stage 1|Other|0|||
131087008|NCT05000216|471951659|FG010|Stage 1|Other|1|||
131087009|NCT05000216|471951660|FG011|Stage 1|Other|1|||
131087010|NCT05000216|471951661|FG012|Stage 1|Other|0|||
131087011|NCT05000216|471951662|FG013|Stage 1|Other|0|||
131087012|NCT05000216|471951663|FG014|Stage 1|Other|0|||
131087013|NCT05000216|471951664|FG015|Stage 1|Other|0|||
131087014|NCT05000216|471951665|FG016|Stage 1|Other|0|||
131087015|NCT05000216|471951666|FG017|Stage 1|Other|0|||
131087016|NCT05000216|471951667|FG018|Stage 1|Other|0|||
131087017|NCT05000216|471951668|FG019|Stage 1|Other|0|||
131087018|NCT05000216|471951669|FG020|Stage 1|Other|0|||
131087019|NCT05000216|471951670|FG021|Stage 1|Other|0|||
131087020|NCT05000216|471951649|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
131087021|NCT05000216|471951650|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
131142218|NCT01262976|472146588|FG004|Up to Year 3|Lost to Follow-up|1|||
131142219|NCT01262976|472146589|FG005|Up to Year 3|Lost to Follow-up|3|||
131142220|NCT01262976|472146584|FG000|Up to Year 3|Subjects with unknown completion status|0|||
131142221|NCT01262976|472146585|FG001|Up to Year 3|Subjects with unknown completion status|0|||
131142222|NCT01262976|472146586|FG002|Up to Year 3|Subjects with unknown completion status|1|||
131142223|NCT01262976|472146587|FG003|Up to Year 3|Subjects with unknown completion status|0|||
131142224|NCT01262976|472146588|FG004|Up to Year 3|Subjects with unknown completion status|0|||
131142225|NCT01262976|472146589|FG005|Up to Year 3|Subjects with unknown completion status|0|||
131142226|NCT01262976|472146584|FG000|Up to Year 3|Other|3|||
131142227|NCT01262976|472146585|FG001|Up to Year 3|Other|0|||
131142228|NCT01262976|472146586|FG002|Up to Year 3|Other|0|||
131142229|NCT01262976|472146587|FG003|Up to Year 3|Other|0|||
131142230|NCT01262976|472146588|FG004|Up to Year 3|Other|0|||
131142231|NCT01262976|472146589|FG005|Up to Year 3|Other|0|||
131142232|NCT01552681|472146590|FG000|Overall Study|Withdrawal by Subject|4|||
131087022|NCT05000216|471951651|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
131087023|NCT05000216|471951652|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
131087024|NCT05000216|471951653|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
131142233|NCT01552681|472146591|FG001|Overall Study|Withdrawal by Subject|0|||
131142234|NCT01552681|472146590|FG000|Overall Study|Physician Decision|1|||
131142235|NCT01552681|472146591|FG001|Overall Study|Physician Decision|0|||
131142236|NCT01552681|472146590|FG000|Overall Study|Subject moved away|0|||
131142237|NCT01552681|472146591|FG001|Overall Study|Subject moved away|1|||
131233845|NCT00056160|472484525|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
131233846|NCT00056160|472484526|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
131233847|NCT00056160|472484525|FG000|Final Follow-up|Adverse Event|1|||
131233848|NCT00056160|472484526|FG001|Final Follow-up|Adverse Event|0|||
131233849|NCT02146430|472484527|FG000|Overall Study|Protocol Violation|5|||
131233850|NCT02146430|472484528|FG001|Overall Study|Protocol Violation|4|||
131233851|NCT02146430|472484529|FG002|Overall Study|Protocol Violation|8|||
131233852|NCT02146430|472484530|FG003|Overall Study|Protocol Violation|6|||
131233853|NCT02146430|472484527|FG000|Overall Study|Lack of Efficacy|13|||
131233854|NCT02146430|472484528|FG001|Overall Study|Lack of Efficacy|11|||
131233855|NCT02146430|472484529|FG002|Overall Study|Lack of Efficacy|8|||
131233856|NCT02146430|472484530|FG003|Overall Study|Lack of Efficacy|5|||
131087025|NCT05000216|471951654|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
131087026|NCT05000216|471951655|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
131087027|NCT05000216|471951656|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
131087028|NCT05000216|471951657|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
131087029|NCT05000216|471951658|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
131087030|NCT05000216|471951659|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
131087031|NCT05000216|471951660|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
131087032|NCT05000216|471951661|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
131087033|NCT05000216|471951662|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
131087034|NCT05000216|471951663|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
131087035|NCT05000216|471951664|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
131087036|NCT05000216|471951665|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
131087037|NCT05000216|471951666|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
131087038|NCT05000216|471951667|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
131087039|NCT05000216|471951668|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
131087040|NCT05000216|471951669|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
130727244|NCT02883049|470625428|FG004|Post Induction|Withdrawal by Subject|2|||
130727245|NCT02883049|470625429|FG005|Post Induction|Withdrawal by Subject|1|||
131087041|NCT05000216|471951670|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
131087042|NCT05000216|471951649|FG000|Stage 2|Lost to Follow-up|0|||
131087043|NCT05000216|471951650|FG001|Stage 2|Lost to Follow-up|0|||
131087044|NCT05000216|471951651|FG002|Stage 2|Lost to Follow-up|0|||
131087045|NCT05000216|471951652|FG003|Stage 2|Lost to Follow-up|0|||
131087046|NCT05000216|471951653|FG004|Stage 2|Lost to Follow-up|0|||
131087047|NCT05000216|471951654|FG005|Stage 2|Lost to Follow-up|0|||
131087048|NCT05000216|471951655|FG006|Stage 2|Lost to Follow-up|0|||
131087049|NCT05000216|471951656|FG007|Stage 2|Lost to Follow-up|0|||
131087050|NCT05000216|471951657|FG008|Stage 2|Lost to Follow-up|0|||
131087051|NCT05000216|471951658|FG009|Stage 2|Lost to Follow-up|0|||
131087052|NCT05000216|471951659|FG010|Stage 2|Lost to Follow-up|0|||
131087053|NCT05000216|471951660|FG011|Stage 2|Lost to Follow-up|0|||
131087054|NCT05000216|471951661|FG012|Stage 2|Lost to Follow-up|0|||
131087055|NCT05000216|471951662|FG013|Stage 2|Lost to Follow-up|0|||
131087056|NCT05000216|471951663|FG014|Stage 2|Lost to Follow-up|0|||
131087057|NCT05000216|471951664|FG015|Stage 2|Lost to Follow-up|0|||
131087058|NCT05000216|471951665|FG016|Stage 2|Lost to Follow-up|4|||
131087059|NCT05000216|471951666|FG017|Stage 2|Lost to Follow-up|0|||
131087060|NCT05000216|471951667|FG018|Stage 2|Lost to Follow-up|0|||
131087061|NCT05000216|471951668|FG019|Stage 2|Lost to Follow-up|0|||
131087062|NCT05000216|471951669|FG020|Stage 2|Lost to Follow-up|0|||
131087063|NCT05000216|471951670|FG021|Stage 2|Lost to Follow-up|0|||
131087064|NCT05000216|471951649|FG000|Stage 2|Physician Decision|0|||
131087065|NCT05000216|471951650|FG001|Stage 2|Physician Decision|0|||
130727246|NCT02883049|470625430|FG006|Post Induction|Withdrawal by Subject|0|||
130727247|NCT02883049|470625431|FG007|Post Induction|Withdrawal by Subject|0|||
130727248|NCT02883049|470625432|FG008|Post Induction|Withdrawal by Subject|2|||
130727249|NCT02883049|470625433|FG009|Post Induction|Withdrawal by Subject|0|||
131087066|NCT05000216|471951651|FG002|Stage 2|Physician Decision|0|||
131087067|NCT05000216|471951652|FG003|Stage 2|Physician Decision|0|||
131087068|NCT05000216|471951653|FG004|Stage 2|Physician Decision|0|||
131087069|NCT05000216|471951654|FG005|Stage 2|Physician Decision|0|||
131087070|NCT05000216|471951655|FG006|Stage 2|Physician Decision|0|||
131087071|NCT05000216|471951656|FG007|Stage 2|Physician Decision|0|||
131087072|NCT05000216|471951657|FG008|Stage 2|Physician Decision|0|||
131087073|NCT05000216|471951658|FG009|Stage 2|Physician Decision|0|||
131087074|NCT05000216|471951659|FG010|Stage 2|Physician Decision|0|||
131087075|NCT05000216|471951660|FG011|Stage 2|Physician Decision|0|||
131087076|NCT05000216|471951661|FG012|Stage 2|Physician Decision|1|||
131233857|NCT02146430|472484527|FG000|Overall Study|Adverse Event|20|||
131087077|NCT05000216|471951662|FG013|Stage 2|Physician Decision|0|||
131087078|NCT05000216|471951663|FG014|Stage 2|Physician Decision|0|||
131087079|NCT05000216|471951664|FG015|Stage 2|Physician Decision|0|||
131233858|NCT02146430|472484528|FG001|Overall Study|Adverse Event|40|||
131087080|NCT05000216|471951665|FG016|Stage 2|Physician Decision|0|||
131087081|NCT05000216|471951666|FG017|Stage 2|Physician Decision|0|||
131087082|NCT05000216|471951667|FG018|Stage 2|Physician Decision|0|||
131087083|NCT05000216|471951668|FG019|Stage 2|Physician Decision|0|||
131142238|NCT02690194|472146592|FG000|Overall Study|Withdrawal by Subject|1|||
131142239|NCT02690194|472146593|FG001|Overall Study|Withdrawal by Subject|4|||
131142240|NCT02690194|472146594|FG002|Overall Study|Withdrawal by Subject|0|||
131142241|NCT01987908|472146596|FG000|Placebo Lead-in Period|Adverse Event|2|||
131142242|NCT01987908|472146597|FG001|Placebo Lead-in Period|Adverse Event|0|||
131142243|NCT01987908|472146598|FG002|Placebo Lead-in Period|Adverse Event|0|||
131142244|NCT01987908|472146596|FG000|Placebo Lead-in Period|Physician Decision|2|||
131142245|NCT01987908|472146597|FG001|Placebo Lead-in Period|Physician Decision|0|||
131142246|NCT01987908|472146598|FG002|Placebo Lead-in Period|Physician Decision|0|||
131142247|NCT01987908|472146596|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
131142248|NCT01987908|472146597|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
131142249|NCT01987908|472146598|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
131142250|NCT01987908|472146596|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
131142251|NCT01987908|472146597|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
131142252|NCT01987908|472146598|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
131142253|NCT01987908|472146596|FG000|Treatment Period|Adverse Event|0|||
131142254|NCT01987908|472146597|FG001|Treatment Period|Adverse Event|1|||
131142255|NCT01987908|472146598|FG002|Treatment Period|Adverse Event|1|||
131142256|NCT01987908|472146596|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
131142257|NCT01987908|472146597|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
131142258|NCT01987908|472146598|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
131142259|NCT01987908|472146596|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
131142260|NCT01987908|472146597|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
131142261|NCT01987908|472146598|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
131142262|NCT01262625|472146599|FG000|Overall Study|Administrative Error|1|||
131142263|NCT01262625|472146600|FG001|Overall Study|Administrative Error|1|||
131142264|NCT01262625|472146599|FG000|Overall Study|Site Closed|1|||
131142265|NCT01262625|472146600|FG001|Overall Study|Site Closed|0|||
131142266|NCT02789657|472146601|FG000|Overall Study|Withdrawal by Subject|2|||
131142267|NCT02789657|472146602|FG001|Overall Study|Withdrawal by Subject|0|||
131142268|NCT02789657|472146603|FG002|Overall Study|Withdrawal by Subject|0|||
130727250|NCT02883049|470625434|FG010|Post Induction|Withdrawal by Subject|1|||
130727251|NCT02883049|470625435|FG011|Post Induction|Withdrawal by Subject|1|||
130727252|NCT02883049|470625436|FG012|Post Induction|Withdrawal by Subject|0|||
130727253|NCT02883049|470625437|FG013|Post Induction|Withdrawal by Subject|0|||
130727254|NCT02883049|470625438|FG014|Post Induction|Withdrawal by Subject|1|||
130727255|NCT02883049|470625439|FG015|Post Induction|Withdrawal by Subject|0|||
130727256|NCT02883049|470625424|FG000|Post Induction|Ineligible|0|||
131087084|NCT05000216|471951669|FG020|Stage 2|Physician Decision|0|||
131087085|NCT05000216|471951670|FG021|Stage 2|Physician Decision|0|||
131087086|NCT05000216|471951649|FG000|Stage 2|Withdrawal by Subject|0|||
131087087|NCT05000216|471951650|FG001|Stage 2|Withdrawal by Subject|0|||
131087088|NCT05000216|471951651|FG002|Stage 2|Withdrawal by Subject|0|||
131087089|NCT05000216|471951652|FG003|Stage 2|Withdrawal by Subject|0|||
131087090|NCT05000216|471951653|FG004|Stage 2|Withdrawal by Subject|0|||
131087091|NCT05000216|471951654|FG005|Stage 2|Withdrawal by Subject|0|||
131087092|NCT05000216|471951655|FG006|Stage 2|Withdrawal by Subject|0|||
131087093|NCT05000216|471951656|FG007|Stage 2|Withdrawal by Subject|0|||
131087094|NCT05000216|471951657|FG008|Stage 2|Withdrawal by Subject|0|||
131087095|NCT05000216|471951658|FG009|Stage 2|Withdrawal by Subject|0|||
131087096|NCT05000216|471951659|FG010|Stage 2|Withdrawal by Subject|0|||
131087097|NCT05000216|471951660|FG011|Stage 2|Withdrawal by Subject|0|||
131087098|NCT05000216|471951661|FG012|Stage 2|Withdrawal by Subject|0|||
131087099|NCT05000216|471951662|FG013|Stage 2|Withdrawal by Subject|0|||
131087100|NCT05000216|471951663|FG014|Stage 2|Withdrawal by Subject|2|||
131087101|NCT05000216|471951664|FG015|Stage 2|Withdrawal by Subject|0|||
131087102|NCT05000216|471951665|FG016|Stage 2|Withdrawal by Subject|9|||
131087103|NCT05000216|471951666|FG017|Stage 2|Withdrawal by Subject|0|||
131087104|NCT05000216|471951667|FG018|Stage 2|Withdrawal by Subject|0|||
131087105|NCT05000216|471951668|FG019|Stage 2|Withdrawal by Subject|0|||
131087106|NCT05000216|471951669|FG020|Stage 2|Withdrawal by Subject|0|||
131087107|NCT05000216|471951670|FG021|Stage 2|Withdrawal by Subject|0|||
131087108|NCT05000216|471951649|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
131233859|NCT02146430|472484529|FG002|Overall Study|Adverse Event|32|||
131233860|NCT02146430|472484530|FG003|Overall Study|Adverse Event|49|||
130727257|NCT02883049|470625425|FG001|Post Induction|Ineligible|0|||
131087109|NCT05000216|471951650|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
131087110|NCT05000216|471951651|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
131087111|NCT05000216|471951652|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
131087112|NCT05000216|471951653|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
131087113|NCT05000216|471951654|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
131087114|NCT05000216|471951655|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
131142269|NCT02789657|472146604|FG003|Overall Study|Withdrawal by Subject|0|||
131142270|NCT03882424|472146605|FG000|Overall Study|Lost to Follow-up|3|||
131142271|NCT03882424|472146606|FG001|Overall Study|Lost to Follow-up|0|||
131142272|NCT03882424|472146607|FG002|Overall Study|Lost to Follow-up|0|||
131087115|NCT05000216|471951656|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
131087116|NCT05000216|471951657|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
131087117|NCT05000216|471951658|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
131087118|NCT05000216|471951659|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
131087119|NCT05000216|471951660|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
131087120|NCT05000216|471951661|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
131087121|NCT05000216|471951662|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
131087122|NCT05000216|471951663|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
131087123|NCT05000216|471951664|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
131087124|NCT05000216|471951665|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
131087125|NCT05000216|471951666|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
131142273|NCT03882424|472146605|FG000|Overall Study|schedule conflict|1|||
131142274|NCT03882424|472146606|FG001|Overall Study|schedule conflict|0|||
131142275|NCT03882424|472146607|FG002|Overall Study|schedule conflict|0|||
131142276|NCT00236080|472146608|FG000|Overall Study|Adverse Event|0|||
131142277|NCT00236080|472146609|FG001|Overall Study|Adverse Event|0|||
131142278|NCT00236080|472146610|FG002|Overall Study|Adverse Event|3|||
131142279|NCT00236080|472146611|FG003|Overall Study|Adverse Event|1|||
131142280|NCT00236080|472146612|FG004|Overall Study|Adverse Event|0|||
131142281|NCT00236080|472146608|FG000|Overall Study|Lost to Follow-up|0|||
131142282|NCT00236080|472146609|FG001|Overall Study|Lost to Follow-up|1|||
131142283|NCT00236080|472146610|FG002|Overall Study|Lost to Follow-up|0|||
131142284|NCT00236080|472146611|FG003|Overall Study|Lost to Follow-up|0|||
131142285|NCT00236080|472146612|FG004|Overall Study|Lost to Follow-up|0|||
131142286|NCT00236080|472146608|FG000|Overall Study|Physician Decision|1|||
131142287|NCT00236080|472146609|FG001|Overall Study|Physician Decision|0|||
131142288|NCT00236080|472146610|FG002|Overall Study|Physician Decision|1|||
131142289|NCT00236080|472146611|FG003|Overall Study|Physician Decision|1|||
131142290|NCT00236080|472146612|FG004|Overall Study|Physician Decision|1|||
131142291|NCT00236080|472146608|FG000|Overall Study|Withdrawal by Subject|1|||
131142292|NCT00236080|472146609|FG001|Overall Study|Withdrawal by Subject|0|||
131142293|NCT00236080|472146610|FG002|Overall Study|Withdrawal by Subject|0|||
131142294|NCT00236080|472146611|FG003|Overall Study|Withdrawal by Subject|0|||
131142295|NCT00236080|472146612|FG004|Overall Study|Withdrawal by Subject|0|||
131142296|NCT00236080|472146608|FG000|Overall Study|Miscellaneous|0|||
131142297|NCT00236080|472146609|FG001|Overall Study|Miscellaneous|0|||
131142298|NCT00236080|472146610|FG002|Overall Study|Miscellaneous|1|||
131142299|NCT00236080|472146611|FG003|Overall Study|Miscellaneous|0|||
131142300|NCT00236080|472146612|FG004|Overall Study|Miscellaneous|0|||
131142301|NCT01214044|472146613|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
131142302|NCT01214044|472146613|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
131142303|NCT01214044|472146613|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
131142304|NCT01214044|472146613|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
131142305|NCT01214044|472146613|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
131142306|NCT01214044|472146613|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
131142307|NCT02772757|472146617|FG000|Overall Study|Withdrawal by Subject|1|||
131142308|NCT02772757|472146618|FG001|Overall Study|Withdrawal by Subject|0|||
131142309|NCT02772757|472146619|FG002|Overall Study|Withdrawal by Subject|1|||
131142310|NCT02772757|472146617|FG000|Overall Study|Protocol Violation|0|||
131142311|NCT02772757|472146618|FG001|Overall Study|Protocol Violation|0|||
131142312|NCT02772757|472146619|FG002|Overall Study|Protocol Violation|1|||
131142313|NCT02772757|472146617|FG000|Overall Study|Physician Decision|0|||
131142314|NCT02772757|472146618|FG001|Overall Study|Physician Decision|3|||
131142315|NCT02772757|472146619|FG002|Overall Study|Physician Decision|3|||
131142316|NCT04698525|472146620|FG000|Overall Study|Lost to Follow-up|1|||
131142317|NCT04698525|472146621|FG001|Overall Study|Lost to Follow-up|2|||
131142318|NCT04698525|472146620|FG000|Overall Study|Three suffered of Covid-19|2|||
131142319|NCT04698525|472146621|FG001|Overall Study|Three suffered of Covid-19|1|||
131142320|NCT01360645|472146624|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
131142321|NCT01360645|472146625|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
131142322|NCT01360645|472146626|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
131233861|NCT02146430|472484527|FG000|Overall Study|Reason missing or not reported|2|||
131233862|NCT02146430|472484528|FG001|Overall Study|Reason missing or not reported|3|||
131233863|NCT02146430|472484529|FG002|Overall Study|Reason missing or not reported|4|||
131233864|NCT02146430|472484530|FG003|Overall Study|Reason missing or not reported|5|||
131233865|NCT02146430|472484527|FG000|Overall Study|Withdrawal by Subject|27|||
131142323|NCT01360645|472146627|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
131142324|NCT01360645|472146624|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
131233866|NCT02146430|472484528|FG001|Overall Study|Withdrawal by Subject|29|||
131233867|NCT02146430|472484529|FG002|Overall Study|Withdrawal by Subject|30|||
131087126|NCT05000216|471951667|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
131087127|NCT05000216|471951668|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
131142325|NCT01360645|472146625|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
131142326|NCT01360645|472146626|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
131142327|NCT01360645|472146627|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
131087128|NCT05000216|471951669|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
131087129|NCT05000216|471951670|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
131087130|NCT05000216|471951649|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087131|NCT05000216|471951650|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087132|NCT05000216|471951651|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087133|NCT05000216|471951652|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087134|NCT05000216|471951653|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087135|NCT05000216|471951654|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087136|NCT05000216|471951655|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087137|NCT05000216|471951656|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087138|NCT05000216|471951657|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087139|NCT05000216|471951658|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087140|NCT05000216|471951659|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087141|NCT05000216|471951660|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087142|NCT05000216|471951661|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087143|NCT05000216|471951662|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087144|NCT05000216|471951663|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
131087145|NCT05000216|471951664|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087146|NCT05000216|471951665|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
131087147|NCT05000216|471951666|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087148|NCT05000216|471951667|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087149|NCT05000216|471951668|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087150|NCT05000216|471951669|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087151|NCT05000216|471951670|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
131087152|NCT05000216|471951649|FG000|Stage 2|Other reason|0|||
131087153|NCT05000216|471951650|FG001|Stage 2|Other reason|0|||
131087154|NCT05000216|471951651|FG002|Stage 2|Other reason|0|||
131087155|NCT05000216|471951652|FG003|Stage 2|Other reason|0|||
131087156|NCT05000216|471951653|FG004|Stage 2|Other reason|0|||
131087157|NCT05000216|471951654|FG005|Stage 2|Other reason|0|||
131087158|NCT05000216|471951655|FG006|Stage 2|Other reason|0|||
131087159|NCT05000216|471951656|FG007|Stage 2|Other reason|0|||
131087160|NCT05000216|471951657|FG008|Stage 2|Other reason|0|||
131087161|NCT05000216|471951658|FG009|Stage 2|Other reason|0|||
131087162|NCT05000216|471951659|FG010|Stage 2|Other reason|0|||
131087163|NCT05000216|471951660|FG011|Stage 2|Other reason|0|||
131087164|NCT05000216|471951661|FG012|Stage 2|Other reason|0|||
131087165|NCT05000216|471951662|FG013|Stage 2|Other reason|0|||
131087166|NCT05000216|471951663|FG014|Stage 2|Other reason|0|||
131087167|NCT05000216|471951664|FG015|Stage 2|Other reason|0|||
131087168|NCT05000216|471951665|FG016|Stage 2|Other reason|1|||
131087169|NCT05000216|471951666|FG017|Stage 2|Other reason|0|||
131087170|NCT05000216|471951667|FG018|Stage 2|Other reason|0|||
131087171|NCT05000216|471951668|FG019|Stage 2|Other reason|0|||
131087172|NCT05000216|471951669|FG020|Stage 2|Other reason|0|||
131087173|NCT05000216|471951670|FG021|Stage 2|Other reason|0|||
131087174|NCT05000216|471951649|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
131087175|NCT05000216|471951650|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
131087176|NCT05000216|471951651|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
131087177|NCT05000216|471951652|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
131087178|NCT05000216|471951653|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
131087179|NCT05000216|471951654|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
131087180|NCT05000216|471951655|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
131087181|NCT05000216|471951656|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
131087182|NCT05000216|471951657|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
131087183|NCT05000216|471951658|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
131087184|NCT05000216|471951659|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
131087185|NCT05000216|471951660|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
131087186|NCT05000216|471951661|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
131087187|NCT05000216|471951662|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
131087188|NCT05000216|471951663|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
131087189|NCT05000216|471951664|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
131087190|NCT05000216|471951665|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
131087191|NCT05000216|471951666|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
131087192|NCT05000216|471951667|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
131087193|NCT05000216|471951668|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
131087194|NCT05000216|471951669|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
131087195|NCT05000216|471951670|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
131087196|NCT05000216|471951649|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087197|NCT05000216|471951650|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087198|NCT05000216|471951651|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087199|NCT05000216|471951652|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087200|NCT05000216|471951653|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087201|NCT05000216|471951654|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087202|NCT05000216|471951655|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087203|NCT05000216|471951656|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087204|NCT05000216|471951657|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087205|NCT05000216|471951658|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087206|NCT05000216|471951659|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087207|NCT05000216|471951660|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087208|NCT05000216|471951661|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087209|NCT05000216|471951662|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087210|NCT05000216|471951663|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087211|NCT05000216|471951664|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
131087212|NCT05000216|471951665|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087213|NCT05000216|471951666|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087214|NCT05000216|471951667|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087215|NCT05000216|471951668|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087216|NCT05000216|471951669|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087217|NCT05000216|471951670|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
131087218|NCT05000216|471951649|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087219|NCT05000216|471951650|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087220|NCT05000216|471951651|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087221|NCT05000216|471951652|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087222|NCT05000216|471951653|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087223|NCT05000216|471951654|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087224|NCT05000216|471951655|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087225|NCT05000216|471951656|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087226|NCT05000216|471951657|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087227|NCT05000216|471951658|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087228|NCT05000216|471951659|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087229|NCT05000216|471951660|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087230|NCT05000216|471951661|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087231|NCT05000216|471951662|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
131087232|NCT05000216|471951663|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087233|NCT05000216|471951664|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
131087234|NCT05000216|471951665|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087235|NCT05000216|471951666|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087236|NCT05000216|471951667|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
131087237|NCT05000216|471951668|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087238|NCT05000216|471951669|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087239|NCT05000216|471951670|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
131087240|NCT02057575|471951672|FG000|Overall Study|Adverse Event|0|||
131087241|NCT02057575|471951673|FG001|Overall Study|Adverse Event|2|||
131087242|NCT02057575|471951674|FG002|Overall Study|Adverse Event|0|||
131087243|NCT02057575|471951675|FG003|Overall Study|Adverse Event|1|||
131087244|NCT02057575|471951672|FG000|Overall Study|Withdrawal by Subject|1|||
131087245|NCT02057575|471951673|FG001|Overall Study|Withdrawal by Subject|0|||
131087246|NCT02057575|471951674|FG002|Overall Study|Withdrawal by Subject|0|||
131087247|NCT02057575|471951675|FG003|Overall Study|Withdrawal by Subject|0|||
131087248|NCT02057575|471951672|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
131087249|NCT02057575|471951673|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
131087250|NCT02057575|471951674|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
131087251|NCT02057575|471951675|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
131087252|NCT02057575|471951672|FG000|Overall Study|Protocol Violation|0|||
131087253|NCT02057575|471951673|FG001|Overall Study|Protocol Violation|1|||
131087254|NCT02057575|471951674|FG002|Overall Study|Protocol Violation|0|||
131087255|NCT02057575|471951675|FG003|Overall Study|Protocol Violation|0|||
131087256|NCT00332462|471951676|FG000|Overall Study|Adverse Event|5|||
131087257|NCT00332462|471951676|FG000|Overall Study|Abnormal Lab Value|1|||
131087258|NCT00332462|471951676|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131087259|NCT00332462|471951676|FG000|Overall Study|no longer requires study drug|1|||
131087260|NCT00332462|471951676|FG000|Overall Study|Death|3|||
131087261|NCT00332462|471951676|FG000|Overall Study|Graft Loss|2|||
131087262|NCT01643044|471951677|FG000|Overall Study|Lost to Follow-up|1|||
131087263|NCT01643044|471951678|FG001|Overall Study|Lost to Follow-up|1|||
131233868|NCT02146430|472484530|FG003|Overall Study|Withdrawal by Subject|34|||
131233869|NCT01893905|472484531|FG000|Overall Study|Withdrawal by Subject|1|||
131087264|NCT01643044|471951677|FG000|Overall Study|Miscarried baby|2|||
131087265|NCT01643044|471951678|FG001|Overall Study|Miscarried baby|2|||
131087266|NCT01643044|471951677|FG000|Overall Study|Delivered outside of hospital|1|||
131087267|NCT01643044|471951678|FG001|Overall Study|Delivered outside of hospital|2|||
131087268|NCT01735175|471951679|FG000|Overall Study|Withdrawal by Subject|9|||
131087269|NCT01735175|471951680|FG001|Overall Study|Withdrawal by Subject|2|||
131087270|NCT01735175|471951679|FG000|Overall Study|Lost to Follow-up|4|||
131087271|NCT01735175|471951680|FG001|Overall Study|Lost to Follow-up|2|||
131087272|NCT01735175|471951679|FG000|Overall Study|Death|3|||
131233870|NCT01893905|472484532|FG001|Overall Study|Withdrawal by Subject|0|||
131087273|NCT01735175|471951680|FG001|Overall Study|Death|2|||
131087274|NCT01735175|471951679|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
131087275|NCT01735175|471951680|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
131142328|NCT01360645|472146624|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
131142329|NCT01360645|472146625|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
131142330|NCT01360645|472146626|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
131142331|NCT01360645|472146627|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
131142332|NCT01360645|472146624|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
131142333|NCT01360645|472146625|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
131142334|NCT01360645|472146626|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
131142335|NCT01360645|472146627|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
131142336|NCT01360645|472146624|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
131142337|NCT01360645|472146625|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
131142338|NCT01360645|472146626|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
131142339|NCT01360645|472146627|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
131142340|NCT01360645|472146624|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
131142341|NCT01360645|472146625|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
131142342|NCT01360645|472146626|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
131142343|NCT01360645|472146627|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
131142344|NCT01360645|472146624|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
131142345|NCT01360645|472146625|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
131142346|NCT01360645|472146626|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
131142347|NCT01360645|472146627|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
131142348|NCT01360645|472146624|FG000|Phase B (6 Weeks)|Adverse Event|0|||
131142349|NCT01360645|472146625|FG001|Phase B (6 Weeks)|Adverse Event|6|||
131142350|NCT01360645|472146626|FG002|Phase B (6 Weeks)|Adverse Event|0|||
131142351|NCT01360645|472146627|FG003|Phase B (6 Weeks)|Adverse Event|0|||
131142352|NCT01360645|472146624|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
131142353|NCT01360645|472146625|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
131142354|NCT01360645|472146626|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
131142355|NCT01360645|472146627|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
131142356|NCT01360645|472146624|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
131142357|NCT01360645|472146625|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
131142358|NCT01360645|472146626|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
131142359|NCT01360645|472146627|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
131142360|NCT01360645|472146624|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
131142361|NCT01360645|472146625|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
131142362|NCT01360645|472146626|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
131142363|NCT01360645|472146627|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
131233871|NCT01893905|472484531|FG000|Overall Study|Adverse Event|9|||
131233872|NCT01893905|472484532|FG001|Overall Study|Adverse Event|3|||
131233873|NCT01893905|472484531|FG000|Overall Study|Lack of Efficacy|5|||
131233874|NCT01893905|472484532|FG001|Overall Study|Lack of Efficacy|7|||
131233875|NCT01893905|472484531|FG000|Overall Study|Lost to Follow-up|1|||
131233876|NCT01893905|472484532|FG001|Overall Study|Lost to Follow-up|0|||
131233877|NCT01893905|472484531|FG000|Overall Study|Protocol Violation|6|||
131233878|NCT01893905|472484532|FG001|Overall Study|Protocol Violation|1|||
131233879|NCT01893905|472484531|FG000|Overall Study|Lack of adherence to treatment|2|||
131233880|NCT01893905|472484532|FG001|Overall Study|Lack of adherence to treatment|0|||
131087276|NCT00659880|471951681|FG000|Overall Study|Lost to Follow-up|5|||
131087277|NCT01031628|471951682|FG000|Overall Study|Study terminated early|0|||
131087278|NCT01031628|471951683|FG001|Overall Study|Study terminated early|1|||
131087279|NCT01031628|471951684|FG002|Overall Study|Study terminated early|3|||
131087280|NCT01031628|471951685|FG003|Overall Study|Study terminated early|0|||
131087281|NCT02195479|471951689|FG000|Overall Study|Lost to Follow-up|18|||
131087282|NCT02195479|471951690|FG001|Overall Study|Lost to Follow-up|15|||
131087283|NCT02195479|471951689|FG000|Overall Study|Death|217|||
131087284|NCT02195479|471951690|FG001|Overall Study|Death|171|||
131087285|NCT02195479|471951689|FG000|Overall Study|Physician Decision|1|||
131233881|NCT01893905|472484531|FG000|Overall Study|Other reason|1|||
131087286|NCT02195479|471951690|FG001|Overall Study|Physician Decision|0|||
131087287|NCT02195479|471951689|FG000|Overall Study|Withdrawal by Subject|30|||
131087288|NCT02195479|471951690|FG001|Overall Study|Withdrawal by Subject|30|||
131142364|NCT01360645|472146624|FG000|Phase A+|Lost to Follow-up|0|||
131142365|NCT01360645|472146625|FG001|Phase A+|Lost to Follow-up|0|||
131142366|NCT01360645|472146626|FG002|Phase A+|Lost to Follow-up|0|||
131233882|NCT01893905|472484532|FG001|Overall Study|Other reason|3|||
131142367|NCT01360645|472146627|FG003|Phase A+|Lost to Follow-up|7|||
131233883|NCT03312530|472484533|FG000|Overall Study|Death|5|||
131142368|NCT01360645|472146624|FG000|Phase A+|Adverse Event|0|||
131233884|NCT03312530|472484534|FG001|Overall Study|Death|5|||
131087289|NCT02195479|471951689|FG000|Overall Study|Other|3|||
131087290|NCT02195479|471951690|FG001|Overall Study|Other|4|||
131142369|NCT01360645|472146625|FG001|Phase A+|Adverse Event|0|||
131142370|NCT01360645|472146626|FG002|Phase A+|Adverse Event|0|||
131142371|NCT01360645|472146627|FG003|Phase A+|Adverse Event|2|||
131233885|NCT03312530|472484535|FG002|Overall Study|Death|4|||
131233886|NCT03312530|472484536|FG003|Overall Study|Death|10|||
131087291|NCT02195479|471951689|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
131087292|NCT02195479|471951690|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
131087293|NCT03443414|471951691|FG000|Overall Study|Adverse Event|6|||
131087294|NCT03443414|471951692|FG001|Overall Study|Adverse Event|0|||
131087295|NCT03443414|471951693|FG002|Overall Study|Adverse Event|4|||
131087296|NCT03443414|471951694|FG003|Overall Study|Adverse Event|2|||
131087297|NCT03443414|471951695|FG004|Overall Study|Adverse Event|3|||
131087298|NCT03443414|471951691|FG000|Overall Study|Withdrawal by Subject|3|||
131087299|NCT03443414|471951692|FG001|Overall Study|Withdrawal by Subject|2|||
131087300|NCT03443414|471951693|FG002|Overall Study|Withdrawal by Subject|2|||
131087301|NCT03443414|471951694|FG003|Overall Study|Withdrawal by Subject|2|||
131087302|NCT03443414|471951695|FG004|Overall Study|Withdrawal by Subject|1|||
131087303|NCT03443414|471951691|FG000|Overall Study|Death|0|||
131087304|NCT03443414|471951692|FG001|Overall Study|Death|1|||
131087305|NCT03443414|471951693|FG002|Overall Study|Death|0|||
131087306|NCT03443414|471951694|FG003|Overall Study|Death|1|||
131087307|NCT03443414|471951695|FG004|Overall Study|Death|0|||
131087308|NCT03443414|471951691|FG000|Overall Study|Reason not specified|2|||
131087309|NCT03443414|471951692|FG001|Overall Study|Reason not specified|0|||
131087310|NCT03443414|471951693|FG002|Overall Study|Reason not specified|0|||
131087311|NCT03443414|471951694|FG003|Overall Study|Reason not specified|0|||
131087312|NCT03443414|471951695|FG004|Overall Study|Reason not specified|1|||
131087313|NCT03325777|471951698|FG000|Overall Study|Lost to Follow-up|9|||
131087314|NCT03325777|471951699|FG001|Overall Study|Lost to Follow-up|12|||
131087315|NCT02522728|471951702|FG000|Overall Study|Withdrawal by Subject|6|||
131087316|NCT02522728|471951703|FG001|Overall Study|Withdrawal by Subject|6|||
131087317|NCT02522728|471951702|FG000|Overall Study|Death|4|||
131087318|NCT02522728|471951703|FG001|Overall Study|Death|3|||
131087319|NCT02522728|471951702|FG000|Overall Study|Adverse Event|2|||
131087320|NCT02522728|471951703|FG001|Overall Study|Adverse Event|1|||
131087321|NCT02522728|471951702|FG000|Overall Study|Did not receive randomized study device|0|||
131087322|NCT02522728|471951703|FG001|Overall Study|Did not receive randomized study device|1|||
131087323|NCT01266161|471951710|FG000|Overall Study|Ineligible|1|||
131087324|NCT01266161|471951711|FG001|Overall Study|Ineligible|0|||
131087325|NCT01266161|471951710|FG000|Overall Study|Lack of Efficacy|0|||
131087326|NCT01266161|471951711|FG001|Overall Study|Lack of Efficacy|1|||
131087327|NCT01266161|471951710|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
131087328|NCT01266161|471951711|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
131087329|NCT02990468|471951712|FG000|Phase 2: MTD|Change in treatment|0|||
131087330|NCT02990468|471951713|FG001|Phase 2: MTD|Change in treatment|0|||
131087331|NCT02990468|471951714|FG002|Phase 2: MTD|Change in treatment|1|||
131087332|NCT01436305|471951716|FG000|Overall Study|Death|1|||
131087333|NCT01436305|471951717|FG001|Overall Study|Death|0|||
131087334|NCT01436305|471951718|FG002|Overall Study|Death|0|||
131087335|NCT01436305|471951716|FG000|Overall Study|Lost to Follow-up|0|||
131087336|NCT01436305|471951717|FG001|Overall Study|Lost to Follow-up|1|||
131087337|NCT01436305|471951718|FG002|Overall Study|Lost to Follow-up|0|||
131087338|NCT01436305|471951716|FG000|Overall Study|Withdrawal by Subject|1|||
131087339|NCT01436305|471951717|FG001|Overall Study|Withdrawal by Subject|3|||
131087340|NCT01436305|471951718|FG002|Overall Study|Withdrawal by Subject|0|||
131087341|NCT01485120|471951719|FG000|Overall Study|Withdrawal by Subject|2|||
131087342|NCT01081886|471951720|FG000|Overall Study|Study termination|11|||
131087343|NCT01081886|471951721|FG001|Overall Study|Study termination|13|||
131087344|NCT03128671|471951724|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
131087345|NCT03128671|471951725|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
131087346|NCT03128671|471951724|FG000|Allocation|Death|1|||
131087347|NCT03128671|471951725|FG001|Allocation|Death|0|||
131087348|NCT03128671|471951724|FG000|Allocation|Withdrawal by Subject|4|||
131087349|NCT03128671|471951725|FG001|Allocation|Withdrawal by Subject|0|||
131087350|NCT03128671|471951724|FG000|Intervention|Withdrawal by Subject|11|||
131087351|NCT03128671|471951725|FG001|Intervention|Withdrawal by Subject|10|||
131087352|NCT03128671|471951724|FG000|Intervention|Palliative/hospice care initiated|9|||
131233887|NCT03312530|472484537|FG004|Overall Study|Death|8|||
131233888|NCT03312530|472484533|FG000|Overall Study|Lost to Follow-up|0|||
131233889|NCT03312530|472484534|FG001|Overall Study|Lost to Follow-up|0|||
130727258|NCT02883049|470625426|FG002|Post Induction|Ineligible|2|||
131087353|NCT03128671|471951725|FG001|Intervention|Palliative/hospice care initiated|10|||
131087354|NCT03128671|471951724|FG000|Intervention|Death|13|||
131087355|NCT03128671|471951725|FG001|Intervention|Death|11|||
131087356|NCT03128671|471951724|FG000|Intervention|Interrupted by hurricane|1|||
131087357|NCT03128671|471951725|FG001|Intervention|Interrupted by hurricane|0|||
131087358|NCT03128671|471951724|FG000|Intervention|Physician Decision|2|||
131087359|NCT03128671|471951725|FG001|Intervention|Physician Decision|3|||
131087360|NCT04463680|471951726|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
131087361|NCT04463680|471951726|FG000|Overall Study|Not eligible due to implant duration of use|1|||
131087362|NCT04463680|471951726|FG000|Overall Study|Withdrawal by Subject|3|||
131087363|NCT05239598|471951729|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
131087364|NCT05239598|471951730|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
131087365|NCT05239598|471951729|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
131087366|NCT05239598|471951730|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
131087367|NCT02614183|471951735|FG000|Double Blind Treatment Phase|Adverse Event|10|||
131087368|NCT02614183|471951736|FG001|Double Blind Treatment Phase|Adverse Event|9|||
131087369|NCT02614183|471951737|FG002|Double Blind Treatment Phase|Adverse Event|7|||
131087370|NCT02614183|471951735|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
131087371|NCT02614183|471951736|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
131087372|NCT02614183|471951737|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
131087373|NCT02614183|471951735|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
131087374|NCT02614183|471951736|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
131087375|NCT02614183|471951737|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
131087376|NCT02614183|471951735|FG000|Double Blind Treatment Phase|Physician Decision|7|||
131087377|NCT02614183|471951736|FG001|Double Blind Treatment Phase|Physician Decision|3|||
131087378|NCT02614183|471951737|FG002|Double Blind Treatment Phase|Physician Decision|2|||
131087379|NCT02614183|471951735|FG000|Double Blind Treatment Phase|Pregnancy|2|||
131087380|NCT02614183|471951736|FG001|Double Blind Treatment Phase|Pregnancy|1|||
131087381|NCT02614183|471951737|FG002|Double Blind Treatment Phase|Pregnancy|3|||
131087382|NCT02614183|471951735|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
131087383|NCT02614183|471951736|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
131087384|NCT02614183|471951737|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
131087385|NCT02614183|471951735|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
131087386|NCT02614183|471951736|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
131087387|NCT02614183|471951737|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
131087388|NCT02614183|471951735|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
131087389|NCT02614183|471951736|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
131087390|NCT02614183|471951737|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
131087391|NCT02614183|471951735|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
131087392|NCT02614183|471951736|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
131087393|NCT02614183|471951737|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
131087394|NCT02614183|471951735|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
131087395|NCT02614183|471951736|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
131087396|NCT02614183|471951737|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
131087397|NCT02614183|471951735|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
131087398|NCT02614183|471951736|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
131087399|NCT02614183|471951737|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
131087400|NCT02614183|471951735|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
131087401|NCT02614183|471951736|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
131087402|NCT02614183|471951737|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
131087403|NCT04991753|471953033|FG000|Overall Study|Withdrawal by Subject|0|||
131087404|NCT04991753|471953034|FG001|Overall Study|Withdrawal by Subject|1|||
131087405|NCT02113124|471953035|FG000|Overall Study|Unable to retrieve blood sample|1|||
131087406|NCT02113124|471953036|FG001|Overall Study|Unable to retrieve blood sample|1|||
131087407|NCT03299049|471953037|FG000|Overall Study|On-going|486|||
131087408|NCT03299049|471953038|FG001|Overall Study|On-going|481|||
131087409|NCT03299049|471953037|FG000|Overall Study|Withdrawal by Subject|6|||
131087410|NCT03299049|471953038|FG001|Overall Study|Withdrawal by Subject|21|||
131087411|NCT03299049|471953037|FG000|Overall Study|Physician Decision|5|||
131087412|NCT03299049|471953038|FG001|Overall Study|Physician Decision|1|||
131087413|NCT03299049|471953037|FG000|Overall Study|Lost to Follow-up|2|||
131087414|NCT03299049|471953038|FG001|Overall Study|Lost to Follow-up|0|||
131087415|NCT03299049|471953037|FG000|Overall Study|Pregnancy|1|||
131087416|NCT03299049|471953038|FG001|Overall Study|Pregnancy|3|||
131087417|NCT03299049|471953037|FG000|Overall Study|Protocol Violation|1|||
131087418|NCT03299049|471953038|FG001|Overall Study|Protocol Violation|1|||
131087419|NCT03299049|471953037|FG000|Overall Study|Lack of Efficacy|9|||
131087420|NCT03299049|471953038|FG001|Overall Study|Lack of Efficacy|3|||
131087421|NCT03299049|471953037|FG000|Overall Study|Adverse Event|12|||
131087422|NCT03299049|471953038|FG001|Overall Study|Adverse Event|13|||
131087423|NCT01901419|471953039|FG000|Overall Study|Protocol Violation|2|||
131087424|NCT01901419|471953040|FG001|Overall Study|Protocol Violation|6|||
131087425|NCT01901419|471953039|FG000|Overall Study|unavailable researchers|6|||
131087426|NCT01901419|471953040|FG001|Overall Study|unavailable researchers|3|||
131087427|NCT01667926|471953041|FG000|Overall Study|Withdrawal by Subject|1|||
131087428|NCT01667926|471953042|FG001|Overall Study|Withdrawal by Subject|2|||
131087429|NCT01667926|471953043|FG002|Overall Study|Withdrawal by Subject|2|||
131087430|NCT01667926|471953041|FG000|Overall Study|Physician Decision|0|||
131087431|NCT01667926|471953042|FG001|Overall Study|Physician Decision|0|||
131087432|NCT01667926|471953043|FG002|Overall Study|Physician Decision|1|||
131087433|NCT01667926|471953041|FG000|Overall Study|Time committment|0|||
131087434|NCT01667926|471953042|FG001|Overall Study|Time committment|0|||
131087435|NCT01667926|471953043|FG002|Overall Study|Time committment|2|||
131087436|NCT01667926|471953041|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
131087437|NCT01667926|471953042|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
131142372|NCT01360645|472146624|FG000|Phase A+|Met Withdrawal Criteria|0|||
131142373|NCT01360645|472146625|FG001|Phase A+|Met Withdrawal Criteria|0|||
131142374|NCT01360645|472146626|FG002|Phase A+|Met Withdrawal Criteria|0|||
131142375|NCT01360645|472146627|FG003|Phase A+|Met Withdrawal Criteria|4|||
131142376|NCT01360645|472146624|FG000|Phase A+|Physician Decision|0|||
131142377|NCT01360645|472146625|FG001|Phase A+|Physician Decision|0|||
131142378|NCT01360645|472146626|FG002|Phase A+|Physician Decision|0|||
131142379|NCT01360645|472146627|FG003|Phase A+|Physician Decision|2|||
131142380|NCT01360645|472146624|FG000|Phase A+|Withdrawal by Subject|0|||
131142381|NCT01360645|472146625|FG001|Phase A+|Withdrawal by Subject|0|||
131142382|NCT01360645|472146626|FG002|Phase A+|Withdrawal by Subject|0|||
131142383|NCT01360645|472146627|FG003|Phase A+|Withdrawal by Subject|5|||
131142384|NCT01360645|472146624|FG000|Phase A+|Protocol Deviation|0|||
131142385|NCT01360645|472146625|FG001|Phase A+|Protocol Deviation|0|||
131142386|NCT01360645|472146626|FG002|Phase A+|Protocol Deviation|0|||
131142387|NCT01360645|472146627|FG003|Phase A+|Protocol Deviation|4|||
131142388|NCT02251912|472146628|FG000|Overall Study|Withdrawal by Subject|2|||
131142389|NCT02251912|472146629|FG001|Overall Study|Withdrawal by Subject|3|||
131142390|NCT02251912|472146628|FG000|Overall Study|Adverse Event|0|||
131142391|NCT02251912|472146629|FG001|Overall Study|Adverse Event|2|||
131142392|NCT01818726|472146630|FG000|Overall Study|Administrative reasons|5|||
131142393|NCT01818726|472146631|FG001|Overall Study|Administrative reasons|1|||
131142394|NCT01818726|472146630|FG000|Overall Study|Withdrawal by Subject|0|||
131142395|NCT01818726|472146631|FG001|Overall Study|Withdrawal by Subject|1|||
131142396|NCT01818726|472146630|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
131087438|NCT01667926|471953043|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
131087439|NCT01667926|471953041|FG000|Overall Study|Lost to Follow-up|1|||
131087440|NCT01667926|471953042|FG001|Overall Study|Lost to Follow-up|2|||
131087441|NCT01667926|471953043|FG002|Overall Study|Lost to Follow-up|1|||
131087442|NCT01667926|471953041|FG000|Overall Study|Side effects|3|||
131087443|NCT01667926|471953042|FG001|Overall Study|Side effects|0|||
131087444|NCT01667926|471953043|FG002|Overall Study|Side effects|0|||
131087445|NCT02412735|471953044|FG000|Overall Study|Adverse Event|0|||
131087446|NCT02412735|471953045|FG001|Overall Study|Adverse Event|1|||
131087447|NCT02412735|471953046|FG002|Overall Study|Adverse Event|2|||
131087448|NCT02412735|471953044|FG000|Overall Study|Withdrawal by Subject|23|||
131087449|NCT02412735|471953045|FG001|Overall Study|Withdrawal by Subject|27|||
131087450|NCT02412735|471953046|FG002|Overall Study|Withdrawal by Subject|22|||
131087451|NCT02412735|471953044|FG000|Overall Study|Investigator Decision|3|||
131087452|NCT02412735|471953045|FG001|Overall Study|Investigator Decision|3|||
131087453|NCT02412735|471953046|FG002|Overall Study|Investigator Decision|2|||
131087454|NCT02412735|471953044|FG000|Overall Study|Lost to Follow-up|17|||
131087455|NCT02412735|471953045|FG001|Overall Study|Lost to Follow-up|11|||
131087456|NCT02412735|471953046|FG002|Overall Study|Lost to Follow-up|18|||
131087457|NCT02412735|471953044|FG000|Overall Study|Reason not Specified|3|||
131087458|NCT02412735|471953045|FG001|Overall Study|Reason not Specified|2|||
131087459|NCT02412735|471953046|FG002|Overall Study|Reason not Specified|2|||
131087460|NCT04043143|471953047|FG000|Overall Study|Lost to Follow-up|5|||
131087461|NCT04043143|471953048|FG001|Overall Study|Lost to Follow-up|5|||
131087462|NCT04043143|471953047|FG000|Overall Study|screen failure|1|||
131087463|NCT04043143|471953048|FG001|Overall Study|screen failure|0|||
131087464|NCT03480932|471953049|FG000|Overall Study|Death|1|||
131087465|NCT03480932|471953050|FG001|Overall Study|Death|1|||
131087466|NCT03480932|471953051|FG002|Overall Study|Death|0|||
131087467|NCT03480932|471953049|FG000|Overall Study|Lost to Follow-up|0|||
131087468|NCT03480932|471953050|FG001|Overall Study|Lost to Follow-up|2|||
131087469|NCT03480932|471953051|FG002|Overall Study|Lost to Follow-up|3|||
131087470|NCT03480932|471953049|FG000|Overall Study|Incarcerated|2|||
131142397|NCT01818726|472146631|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
131142398|NCT03336502|472146632|FG000|Overall Study|Physician Decision|0|||
131142399|NCT03336502|472146633|FG001|Overall Study|Physician Decision|1|||
131142400|NCT03336502|472146632|FG000|Overall Study|Prohibited Drugs|1|||
131142401|NCT03336502|472146633|FG001|Overall Study|Prohibited Drugs|1|||
131142402|NCT03336502|472146632|FG000|Overall Study|Death|1|||
131142403|NCT03336502|472146633|FG001|Overall Study|Death|2|||
131142404|NCT03336502|472146632|FG000|Overall Study|Adverse Event|2|||
131142405|NCT03336502|472146633|FG001|Overall Study|Adverse Event|5|||
131087471|NCT03480932|471953050|FG001|Overall Study|Incarcerated|2|||
131142406|NCT00480857|472146634|FG000|Overall Study|Lack of Efficacy|2|||
131087472|NCT03480932|471953051|FG002|Overall Study|Incarcerated|2|||
131087473|NCT04624243|471953052|FG000|Overall Study|Death|0|||
131087474|NCT04624243|471953053|FG001|Overall Study|Death|1|||
131087475|NCT04624243|471953054|FG002|Overall Study|Death|0|||
131087476|NCT04624243|471953055|FG003|Overall Study|Death|0|||
131087477|NCT04624243|471953056|FG004|Overall Study|Death|0|||
131087478|NCT04624243|471953052|FG000|Overall Study|Lost to Follow-up|2|||
131087479|NCT04624243|471953053|FG001|Overall Study|Lost to Follow-up|3|||
131142407|NCT00611247|472146635|FG000|Overall Study|Death|1|||
131142408|NCT00611247|472146636|FG001|Overall Study|Death|5|||
131142409|NCT00611247|472146635|FG000|Overall Study|Lack of Efficacy|1|||
131142410|NCT00611247|472146636|FG001|Overall Study|Lack of Efficacy|16|||
131142411|NCT01948830|472146637|FG000|Overall Study|Physician Decision|1|||
131142412|NCT01948830|472146638|FG001|Overall Study|Physician Decision|3|||
131142413|NCT01948830|472146637|FG000|Overall Study|Protocol deviation|1|||
131142414|NCT01948830|472146638|FG001|Overall Study|Protocol deviation|2|||
131142415|NCT01948830|472146637|FG000|Overall Study|Lost to Follow-up|5|||
131142416|NCT01948830|472146638|FG001|Overall Study|Lost to Follow-up|4|||
131142417|NCT01948830|472146637|FG000|Overall Study|Withdrawal by Subject|14|||
131142418|NCT01948830|472146638|FG001|Overall Study|Withdrawal by Subject|17|||
131142419|NCT01948830|472146637|FG000|Overall Study|Adverse Event|9|||
131142420|NCT01948830|472146638|FG001|Overall Study|Adverse Event|2|||
131142421|NCT01948830|472146637|FG000|Overall Study|Death|3|||
131142422|NCT01948830|472146638|FG001|Overall Study|Death|4|||
131142423|NCT01890421|472146639|FG000|Overall Study|Adverse Event|1|||
131142424|NCT01890421|472146639|FG000|Overall Study|Other reason|10|||
131142425|NCT01133171|472146640|FG000|Overall Study|Withdrawal by Subject|1|||
131142426|NCT01133171|472146641|FG001|Overall Study|Withdrawal by Subject|2|||
131142427|NCT01133171|472146642|FG002|Overall Study|Withdrawal by Subject|0|||
131142428|NCT02526550|472146643|FG000|Overall Study|Lost to Follow-up|1|||
131142429|NCT03969888|472146646|FG000|Overall Study|Never Received Study Drug|0|||
131142430|NCT03969888|472146647|FG001|Overall Study|Never Received Study Drug|0|||
131142431|NCT03969888|472146648|FG002|Overall Study|Never Received Study Drug|1|||
131142432|NCT03969888|472146649|FG003|Overall Study|Never Received Study Drug|0|||
131142433|NCT03969888|472146650|FG004|Overall Study|Never Received Study Drug|0|||
131142434|NCT03969888|472146651|FG005|Overall Study|Never Received Study Drug|0|||
131142435|NCT03969888|472146652|FG006|Overall Study|Never Received Study Drug|1|||
131142436|NCT03969888|472146653|FG007|Overall Study|Never Received Study Drug|0|||
131142437|NCT03969888|472146646|FG000|Overall Study|Reason Not Specified|0|||
131142438|NCT03969888|472146647|FG001|Overall Study|Reason Not Specified|0|||
131142439|NCT03969888|472146648|FG002|Overall Study|Reason Not Specified|0|||
131142440|NCT03969888|472146649|FG003|Overall Study|Reason Not Specified|0|||
131142441|NCT03969888|472146650|FG004|Overall Study|Reason Not Specified|0|||
131142442|NCT03969888|472146651|FG005|Overall Study|Reason Not Specified|0|||
131142443|NCT03969888|472146652|FG006|Overall Study|Reason Not Specified|0|||
131142444|NCT03969888|472146653|FG007|Overall Study|Reason Not Specified|1|||
131142445|NCT01446419|472146663|FG000|Overall Study|Death|1|||
131142446|NCT01446419|472146664|FG001|Overall Study|Death|0|||
131142447|NCT01446419|472146663|FG000|Overall Study|Withdrawal by Subject|1|||
131142448|NCT01446419|472146664|FG001|Overall Study|Withdrawal by Subject|1|||
131142449|NCT01446419|472146663|FG000|Overall Study|Terminated per protocol|3|||
131142450|NCT01446419|472146664|FG001|Overall Study|Terminated per protocol|0|||
131142451|NCT02867761|472146667|FG000|Overall Study|Participant withdrawn by investigator|0|||
131142452|NCT02867761|472146668|FG001|Overall Study|Participant withdrawn by investigator|1|||
131142453|NCT02867761|472146667|FG000|Overall Study|Lost to Follow-up|25|||
131142454|NCT02867761|472146668|FG001|Overall Study|Lost to Follow-up|18|||
131142455|NCT02867761|472146667|FG000|Overall Study|Unable to complete protocol|3|||
131142456|NCT02867761|472146668|FG001|Overall Study|Unable to complete protocol|7|||
131142457|NCT04506294|472146669|FG000|Overall Study|Lost to Follow-up|70|||
131142458|NCT04506294|472146670|FG001|Overall Study|Lost to Follow-up|20|||
131142459|NCT04506294|472146669|FG000|Overall Study|Withdrawal by Subject|16|||
131142460|NCT04506294|472146670|FG001|Overall Study|Withdrawal by Subject|2|||
131142461|NCT01931059|472146671|FG000|Day 1|Pregnancy|0|||
131142462|NCT01931059|472146672|FG001|Day 1|Pregnancy|1|||
131142463|NCT01931059|472146671|FG000|Day3|Lost to Follow-up|1|||
131142464|NCT01931059|472146672|FG001|Day3|Lost to Follow-up|0|||
131142465|NCT00769119|472146673|FG000|Overall Study|Voluntary discontinuation|0|||
131142466|NCT00769119|472146674|FG001|Overall Study|Voluntary discontinuation|2|||
131142467|NCT00769119|472146673|FG000|Overall Study|Adverse Event|1|||
131142468|NCT00769119|472146674|FG001|Overall Study|Adverse Event|1|||
131142469|NCT00769119|472146673|FG000|Overall Study|Disallowed medication|1|||
131142470|NCT00769119|472146674|FG001|Overall Study|Disallowed medication|0|||
131142471|NCT01961115|472146678|FG000|Overall Study|Disease Progression|1|||
131142472|NCT01961115|472146679|FG001|Overall Study|Disease Progression|0|||
131233890|NCT03312530|472484535|FG002|Overall Study|Lost to Follow-up|0|||
131142473|NCT01961115|472146680|FG002|Overall Study|Disease Progression|3|||
131142474|NCT01961115|472146678|FG000|Overall Study|Adverse Event|1|||
131142475|NCT01961115|472146679|FG001|Overall Study|Adverse Event|0|||
131142476|NCT01961115|472146680|FG002|Overall Study|Adverse Event|1|||
131142477|NCT00578643|472146681|FG000|Overall Study|Death|1|||
131142478|NCT00578643|472146681|FG000|Overall Study|Lost to Follow-up|1|||
131142479|NCT03828487|472146682|FG000|Overall Study|Physician Decision|1|||
131142480|NCT01445678|472146684|FG000|Overall Study|Adverse Event|12|||
131142481|NCT01445678|472146685|FG001|Overall Study|Adverse Event|8|||
131142482|NCT01445678|472146684|FG000|Overall Study|Lack of Efficacy|0|||
131142483|NCT01445678|472146685|FG001|Overall Study|Lack of Efficacy|2|||
131142484|NCT01445678|472146684|FG000|Overall Study|Lost to Follow-up|8|||
131142485|NCT01445678|472146685|FG001|Overall Study|Lost to Follow-up|5|||
131142486|NCT01445678|472146684|FG000|Overall Study|Protocol Violation|1|||
131142487|NCT01445678|472146685|FG001|Overall Study|Protocol Violation|1|||
131142488|NCT01445678|472146684|FG000|Overall Study|Withdrawal by Subject|9|||
131087480|NCT04624243|471953054|FG002|Overall Study|Lost to Follow-up|7|||
131087481|NCT04624243|471953055|FG003|Overall Study|Lost to Follow-up|1|||
131087482|NCT04624243|471953056|FG004|Overall Study|Lost to Follow-up|3|||
131087483|NCT04624243|471953052|FG000|Overall Study|Physician Decision|3|||
131087484|NCT04624243|471953053|FG001|Overall Study|Physician Decision|8|||
131087485|NCT04624243|471953054|FG002|Overall Study|Physician Decision|15|||
131087486|NCT04624243|471953055|FG003|Overall Study|Physician Decision|2|||
131087487|NCT04624243|471953056|FG004|Overall Study|Physician Decision|11|||
131087488|NCT04624243|471953052|FG000|Overall Study|Withdrawal by Subject|19|||
131087489|NCT04624243|471953053|FG001|Overall Study|Withdrawal by Subject|44|||
131087490|NCT04624243|471953054|FG002|Overall Study|Withdrawal by Subject|40|||
131087491|NCT04624243|471953055|FG003|Overall Study|Withdrawal by Subject|21|||
131087492|NCT04624243|471953056|FG004|Overall Study|Withdrawal by Subject|39|||
131087493|NCT04624243|471953052|FG000|Overall Study|Miscellaneous|3|||
131087494|NCT04624243|471953053|FG001|Overall Study|Miscellaneous|12|||
131087495|NCT04624243|471953054|FG002|Overall Study|Miscellaneous|9|||
131087496|NCT04624243|471953055|FG003|Overall Study|Miscellaneous|4|||
131087497|NCT04624243|471953056|FG004|Overall Study|Miscellaneous|6|||
131087498|NCT01939353|471953057|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
131087499|NCT01939353|471953057|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
131087500|NCT01939353|471953057|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
131087501|NCT01939353|471953057|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
131087502|NCT01939353|471953057|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
131087503|NCT05048238|471953065|FG000|Overall Study|Withdrawal by Subject|1|||
131087504|NCT01886287|471953066|FG000|Overall Study|Radiographic disease progression|1|||
131087505|NCT01886287|471953066|FG000|Overall Study|Clinical progression due to disease|1|||
131087506|NCT01602510|471953071|FG000|Open Label Phase|Adverse Event|46|||
131087507|NCT01602510|471953072|FG001|Open Label Phase|Adverse Event|0|||
131087508|NCT01602510|471953073|FG002|Open Label Phase|Adverse Event|0|||
131087509|NCT01602510|471953071|FG000|Open Label Phase|Lack of Efficacy|22|||
131087510|NCT01602510|471953072|FG001|Open Label Phase|Lack of Efficacy|0|||
131087511|NCT01602510|471953073|FG002|Open Label Phase|Lack of Efficacy|0|||
131087512|NCT01602510|471953071|FG000|Open Label Phase|Protocol Violation|15|||
131087513|NCT01602510|471953072|FG001|Open Label Phase|Protocol Violation|0|||
131087514|NCT01602510|471953073|FG002|Open Label Phase|Protocol Violation|0|||
131087515|NCT01602510|471953071|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
131087516|NCT01602510|471953072|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
131087517|NCT01602510|471953073|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
131087518|NCT01602510|471953071|FG000|Open Label Phase|Lost to Follow-up|22|||
131087519|NCT01602510|471953072|FG001|Open Label Phase|Lost to Follow-up|0|||
131087520|NCT01602510|471953073|FG002|Open Label Phase|Lost to Follow-up|0|||
131087521|NCT01602510|471953071|FG000|Open Label Phase|Physician Decision|19|||
131087522|NCT01602510|471953072|FG001|Open Label Phase|Physician Decision|0|||
131087523|NCT01602510|471953073|FG002|Open Label Phase|Physician Decision|0|||
131087524|NCT01602510|471953071|FG000|Open Label Phase|Withdrawal by Subject|57|||
131142489|NCT01445678|472146685|FG001|Overall Study|Withdrawal by Subject|5|||
131142490|NCT02307370|472146686|FG000|Overall Study|Death|5|||
131142491|NCT02307370|472146686|FG000|Overall Study|Lost to Follow-up|1|||
131142492|NCT02307370|472146686|FG000|Overall Study|Withdrawal by Subject|1|||
131142493|NCT02307370|472146686|FG000|Overall Study|Declined Addendum ICF|6|||
131142494|NCT02307370|472146686|FG000|Overall Study|No response during telephone contact|5|||
131142495|NCT02307370|472146686|FG000|Overall Study|Protocol Violation|1|||
131142496|NCT05900115|472148511|FG000|Overall Study|Lost to Follow-up|129|||
131142497|NCT05900115|472148512|FG001|Overall Study|Lost to Follow-up|98|||
131142498|NCT00388947|472148515|FG000|Overall Study|Protocol Violation|47|||
131142499|NCT04187092|472148516|FG000|Overall Study|Lost to Follow-up|1|||
131142500|NCT04187092|472148517|FG001|Overall Study|Lost to Follow-up|1|||
131142501|NCT04187092|472148516|FG000|Overall Study|Withdrawal by Subject|1|||
131142502|NCT04187092|472148517|FG001|Overall Study|Withdrawal by Subject|1|||
131142503|NCT04187092|472148516|FG000|Overall Study|Adverse Event|0|||
131142504|NCT04187092|472148517|FG001|Overall Study|Adverse Event|1|||
131142505|NCT00544869|472148519|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
131087525|NCT01602510|471953072|FG001|Open Label Phase|Withdrawal by Subject|0|||
131087526|NCT01602510|471953073|FG002|Open Label Phase|Withdrawal by Subject|0|||
131087527|NCT01602510|471953071|FG000|Randomized Phase|Adverse Event|0|||
131087528|NCT01602510|471953072|FG001|Randomized Phase|Adverse Event|2|||
131087529|NCT01602510|471953073|FG002|Randomized Phase|Adverse Event|6|||
131087530|NCT01602510|471953071|FG000|Randomized Phase|Lack of Efficacy|0|||
131087531|NCT01602510|471953072|FG001|Randomized Phase|Lack of Efficacy|4|||
131087532|NCT01602510|471953073|FG002|Randomized Phase|Lack of Efficacy|4|||
131087533|NCT01602510|471953071|FG000|Randomized Phase|Protocol Violation|0|||
131087534|NCT01602510|471953072|FG001|Randomized Phase|Protocol Violation|3|||
131087535|NCT01602510|471953073|FG002|Randomized Phase|Protocol Violation|3|||
131142506|NCT00544869|472148520|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
131142507|NCT00544869|472148521|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
131142508|NCT00544869|472148519|FG000|Overall Study|Adverse Event|6|||
131087536|NCT01602510|471953071|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
131087537|NCT01602510|471953072|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
131087538|NCT01602510|471953073|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
131087539|NCT01602510|471953071|FG000|Randomized Phase|Lost to Follow-up|0|||
131087540|NCT01602510|471953072|FG001|Randomized Phase|Lost to Follow-up|1|||
131087541|NCT01602510|471953073|FG002|Randomized Phase|Lost to Follow-up|3|||
131087542|NCT01602510|471953071|FG000|Randomized Phase|Physician Decision|0|||
131087543|NCT01602510|471953072|FG001|Randomized Phase|Physician Decision|0|||
131087544|NCT01602510|471953073|FG002|Randomized Phase|Physician Decision|2|||
131087545|NCT01602510|471953071|FG000|Randomized Phase|Withdrawal by Subject|0|||
131087546|NCT01602510|471953072|FG001|Randomized Phase|Withdrawal by Subject|6|||
131087547|NCT01602510|471953073|FG002|Randomized Phase|Withdrawal by Subject|7|||
131087548|NCT03519204|471953074|FG000|Overall Study|Lost to Follow-up|3|||
131087549|NCT03519204|471953075|FG001|Overall Study|Lost to Follow-up|8|||
131087550|NCT03519204|471953074|FG000|Overall Study|Withdrawal by Subject|9|||
131087551|NCT03519204|471953075|FG001|Overall Study|Withdrawal by Subject|7|||
131087552|NCT03519204|471953074|FG000|Overall Study|Other Miscellaneous Reasons|1|||
131087553|NCT03519204|471953075|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131087554|NCT00600613|471953080|FG000|Overall Study|Protocol Deviation|1|||
131087555|NCT01509547|471953085|FG000|Overall Study|Lost to Follow-up|24|||
131087556|NCT01509547|471953086|FG001|Overall Study|Lost to Follow-up|14|||
131087557|NCT01509547|471953085|FG000|Overall Study|Withdrawal by Subject|11|||
131087558|NCT01509547|471953086|FG001|Overall Study|Withdrawal by Subject|24|||
131087559|NCT01509547|471953085|FG000|Overall Study|Physician Decision|0|||
131087560|NCT01509547|471953086|FG001|Overall Study|Physician Decision|1|||
131087561|NCT00402051|471953089|FG000|Overall Study|Progressive Disease|13|||
131087562|NCT00402051|471953090|FG001|Overall Study|Progressive Disease|20|||
131087563|NCT00402051|471953089|FG000|Overall Study|Adverse Event|11|||
131087564|NCT00402051|471953090|FG001|Overall Study|Adverse Event|4|||
131087565|NCT00402051|471953089|FG000|Overall Study|Physician Decision|7|||
131087566|NCT00402051|471953090|FG001|Overall Study|Physician Decision|3|||
131087567|NCT00402051|471953089|FG000|Overall Study|Withdrawal by Subject|3|||
131087568|NCT00402051|471953090|FG001|Overall Study|Withdrawal by Subject|3|||
131087569|NCT00402051|471953089|FG000|Overall Study|Death - Related to Study Drug|1|||
131087570|NCT00402051|471953090|FG001|Overall Study|Death - Related to Study Drug|2|||
131087571|NCT00402051|471953089|FG000|Overall Study|Death Due to Study Disease|2|||
131087572|NCT00402051|471953090|FG001|Overall Study|Death Due to Study Disease|1|||
131087573|NCT00402051|471953089|FG000|Overall Study|Death Due to Adverse Event|0|||
131087574|NCT00402051|471953090|FG001|Overall Study|Death Due to Adverse Event|2|||
131087575|NCT00402051|471953089|FG000|Overall Study|Lost to Follow-up|1|||
131087576|NCT00402051|471953090|FG001|Overall Study|Lost to Follow-up|0|||
131087577|NCT02514551|471953091|FG000|Overall Study|Lost to Follow-up|0|||
131087578|NCT02514551|471953092|FG001|Overall Study|Lost to Follow-up|1|||
131087579|NCT02514551|471953091|FG000|Overall Study|Participant Never Treated|0|||
131087580|NCT02514551|471953092|FG001|Overall Study|Participant Never Treated|2|||
131087581|NCT00570908|471953107|FG000|Overall Study|Adverse Event|5|||
131087582|NCT00570908|471953107|FG000|Overall Study|Withdrawal by Subject|2|||
131087583|NCT01213524|471953108|FG000|Baseline|Withdrawal by Subject|5|||
131087584|NCT01213524|471953108|FG000|Baseline|high breath alcohol levels|1|||
131087585|NCT01213524|471953108|FG000|Baseline|Physician Decision|1|||
131087586|NCT01213524|471953108|FG000|Session 2|Withdrawal by Subject|5|||
131087587|NCT01213524|471953108|FG000|Session 3|Withdrawal by Subject|4|||
131087588|NCT01213524|471953108|FG000|Session 4|Physician Decision|1|||
131087589|NCT01213524|471953108|FG000|Session 4|Withdrawal by Subject|2|||
131087590|NCT05415748|471953117|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
131087591|NCT05415748|471953118|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
131087592|NCT05415748|471953119|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
131087593|NCT05415748|471953120|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
131087594|NCT05415748|471953117|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
131087595|NCT05415748|471953118|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
131087596|NCT05415748|471953119|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
131087597|NCT05415748|471953120|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
131087598|NCT00281320|471953123|FG000|Overall Study|Adverse Event|12|||
131087599|NCT00281320|471953124|FG001|Overall Study|Adverse Event|9|||
131087600|NCT00281320|471953123|FG000|Overall Study|Lack of Efficacy|4|||
131233891|NCT03312530|472484536|FG003|Overall Study|Lost to Follow-up|1|||
131087601|NCT00281320|471953124|FG001|Overall Study|Lack of Efficacy|3|||
131087602|NCT00281320|471953123|FG000|Overall Study|Withdrawal by Subject|5|||
131087603|NCT00281320|471953124|FG001|Overall Study|Withdrawal by Subject|6|||
131087604|NCT00281320|471953123|FG000|Overall Study|Lost to Follow-up|1|||
131087605|NCT00281320|471953124|FG001|Overall Study|Lost to Follow-up|2|||
131087606|NCT00281320|471953123|FG000|Overall Study|Other|3|||
131087607|NCT00281320|471953124|FG001|Overall Study|Other|1|||
131087608|NCT01447576|471953135|FG000|Overall Study|Lost to Follow-up|52|||
131087609|NCT01447576|471953135|FG000|Overall Study|Adverse Event|127|||
131087610|NCT01447576|471953135|FG000|Overall Study|Participant met withdrawal criteria|40|||
131087611|NCT01447576|471953135|FG000|Overall Study|Withdrawal by Subject|100|||
131087612|NCT01447576|471953135|FG000|Overall Study|Protocol deviation|83|||
131087613|NCT01447576|471953135|FG000|Overall Study|Lack of Efficacy|68|||
131087614|NCT01447576|471953135|FG000|Overall Study|Physician Decision|6|||
131087615|NCT00975676|471953136|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
131087616|NCT00975676|471953137|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
131087617|NCT02548078|471953138|FG000|Overall Study|Serious adverse event/Adverse event|1|||
131087618|NCT02548078|471953139|FG001|Overall Study|Serious adverse event/Adverse event|0|||
131087619|NCT02548078|471953138|FG000|Overall Study|Moved from study area|3|||
131087620|NCT02548078|471953139|FG001|Overall Study|Moved from study area|3|||
131087621|NCT02548078|471953138|FG000|Overall Study|Lost to Follow-up|1|||
131087622|NCT02548078|471953139|FG001|Overall Study|Lost to Follow-up|3|||
131087623|NCT02998476|471953145|FG000|Overall Study|Lost to Follow-up|1|||
131087624|NCT02998476|471953146|FG001|Overall Study|Lost to Follow-up|0|||
131087625|NCT02998476|471953145|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
131087626|NCT02998476|471953146|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
131087627|NCT02998476|471953145|FG000|Overall Study|Withdrawal by Subject|1|||
131087628|NCT02998476|471953146|FG001|Overall Study|Withdrawal by Subject|2|||
131087629|NCT02998476|471953145|FG000|Overall Study|Death|45|||
131087630|NCT02998476|471953146|FG001|Overall Study|Death|2|||
131087631|NCT02998476|471953145|FG000|Overall Study|Other|6|||
131087632|NCT02998476|471953146|FG001|Overall Study|Other|1|||
131087633|NCT03277352|471953147|FG000|Overall Study|Study Terminated By Sponsor|2|||
131087634|NCT03277352|471953147|FG000|Overall Study|Withdrawal by Subject|4|||
131087635|NCT03277352|471953147|FG000|Overall Study|Death|4|||
131087636|NCT01435772|471953148|FG000|Overall Study|Adverse Event|1|||
131087637|NCT01435772|471953149|FG001|Overall Study|Adverse Event|0|||
131233892|NCT03312530|472484537|FG004|Overall Study|Lost to Follow-up|0|||
131233893|NCT03312530|472484533|FG000|Overall Study|Participant in another sponsor study.|0|||
131233894|NCT03312530|472484534|FG001|Overall Study|Participant in another sponsor study.|0|||
131233895|NCT03312530|472484535|FG002|Overall Study|Participant in another sponsor study.|0|||
131233896|NCT03312530|472484536|FG003|Overall Study|Participant in another sponsor study.|1|||
131233897|NCT03312530|472484537|FG004|Overall Study|Participant in another sponsor study.|0|||
131233898|NCT03312530|472484533|FG000|Overall Study|Study terminated by sponsor|1|||
131233899|NCT03312530|472484534|FG001|Overall Study|Study terminated by sponsor|0|||
131087638|NCT01435772|471953150|FG002|Overall Study|Adverse Event|2|||
131087639|NCT01435772|471953148|FG000|Overall Study|Withdrawal by Subject|0|||
131087640|NCT01435772|471953149|FG001|Overall Study|Withdrawal by Subject|1|||
131087641|NCT01435772|471953150|FG002|Overall Study|Withdrawal by Subject|3|||
131087642|NCT01435772|471953148|FG000|Overall Study|Other - study termination|2|||
131087643|NCT01435772|471953149|FG001|Overall Study|Other - study termination|2|||
131087644|NCT01435772|471953150|FG002|Overall Study|Other - study termination|10|||
131087645|NCT03238963|471953151|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
131087646|NCT03238963|471953152|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
131087647|NCT03238963|471953151|FG000|Overall Study|Withdrawal by Subject|1|||
131087648|NCT03238963|471953152|FG001|Overall Study|Withdrawal by Subject|1|||
131087649|NCT03238963|471953151|FG000|Overall Study|Lost to Follow-up|1|||
131087650|NCT03238963|471953152|FG001|Overall Study|Lost to Follow-up|0|||
131087651|NCT03238963|471953151|FG000|Overall Study|Protocol Violation|1|||
131087652|NCT03238963|471953152|FG001|Overall Study|Protocol Violation|1|||
131087653|NCT03238963|471953151|FG000|Overall Study|Adverse Event|1|||
131087654|NCT03238963|471953152|FG001|Overall Study|Adverse Event|0|||
131087655|NCT01424813|471953155|FG000|Overall Study|Withdrawal by Subject|3|||
131087656|NCT01424813|471953156|FG001|Overall Study|Withdrawal by Subject|0|||
131087657|NCT01424813|471953155|FG000|Overall Study|Protocol Violation|1|||
131087658|NCT01424813|471953156|FG001|Overall Study|Protocol Violation|0|||
131087659|NCT01424813|471953155|FG000|Overall Study|Other|1|||
131087660|NCT01424813|471953156|FG001|Overall Study|Other|2|||
131087661|NCT03838731|471955059|FG000|Overall Study|Pregnancy|0|||
131087662|NCT03838731|471955060|FG001|Overall Study|Pregnancy|1|||
131087663|NCT03838731|471955059|FG000|Overall Study|Withdrawal of consent|1|||
131087664|NCT03838731|471955060|FG001|Overall Study|Withdrawal of consent|0|||
131087665|NCT01088984|471955063|FG000|Phase 1|Death|2|||
131087666|NCT01088984|471955064|FG001|Phase 1|Death|1|||
131087667|NCT01088984|471955063|FG000|Phase 1|Disease Progression|2|||
131087668|NCT01088984|471955064|FG001|Phase 1|Disease Progression|4|||
131087669|NCT01088984|471955063|FG000|Phase 1|Other|1|||
131087670|NCT01088984|471955064|FG001|Phase 1|Other|1|||
131087671|NCT01088984|471955063|FG000|Phase 2|Death|0|||
131087672|NCT01088984|471955064|FG001|Phase 2|Death|5|||
131087673|NCT01088984|471955063|FG000|Phase 2|Withdrawal by Subject|0|||
131087674|NCT01088984|471955064|FG001|Phase 2|Withdrawal by Subject|1|||
131087675|NCT01088984|471955063|FG000|Phase 2|DIsease Progression|0|||
131087676|NCT01088984|471955064|FG001|Phase 2|DIsease Progression|25|||
131087677|NCT01088984|471955063|FG000|Phase 2|Other|0|||
131087678|NCT01088984|471955064|FG001|Phase 2|Other|1|||
131087679|NCT04707664|471955065|FG000|Overall Study|Adverse Event|2|||
131087680|NCT04707664|471955066|FG001|Overall Study|Adverse Event|0|||
131087681|NCT04707664|471955065|FG000|Overall Study|Death|1|||
131087682|NCT04707664|471955066|FG001|Overall Study|Death|2|||
131087683|NCT04707664|471955065|FG000|Overall Study|Withdrawal by Subject|13|||
131087684|NCT04707664|471955066|FG001|Overall Study|Withdrawal by Subject|21|||
131087685|NCT04707664|471955065|FG000|Overall Study|Lost to Follow-up|11|||
131087686|NCT04707664|471955066|FG001|Overall Study|Lost to Follow-up|13|||
131087687|NCT04707664|471955065|FG000|Overall Study|Not treated|2|||
131087688|NCT04707664|471955066|FG001|Overall Study|Not treated|0|||
131087689|NCT00699153|471955067|FG000|Overall Study|Lost to Follow-up|1|||
131087690|NCT00699153|471955068|FG001|Overall Study|Lost to Follow-up|0|||
131087691|NCT00699153|471955067|FG000|Overall Study|Adverse Event|0|||
131087692|NCT00699153|471955068|FG001|Overall Study|Adverse Event|2|||
131087693|NCT00699153|471955067|FG000|Overall Study|Protocol Violation|1|||
131087694|NCT00699153|471955068|FG001|Overall Study|Protocol Violation|0|||
131087695|NCT00699153|471955067|FG000|Overall Study|Travel Problem|1|||
131087696|NCT00699153|471955068|FG001|Overall Study|Travel Problem|0|||
131087697|NCT01006980|471955072|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
131087698|NCT01006980|471955073|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
131087699|NCT01006980|471955072|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
131087700|NCT01006980|471955073|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
131087701|NCT01006980|471955072|FG000|Vemurafenib and Dacarbazine|Death|13|||
131087702|NCT01006980|471955073|FG001|Vemurafenib and Dacarbazine|Death|12|||
131087703|NCT01006980|471955072|FG000|Vemurafenib and Dacarbazine|Progression|257|||
131087704|NCT01006980|471955073|FG001|Vemurafenib and Dacarbazine|Progression|218|||
131087705|NCT01006980|471955072|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
131087706|NCT01006980|471955073|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
131087707|NCT01006980|471955072|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
131087708|NCT01006980|471955073|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
131087709|NCT01006980|471955072|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
131087710|NCT01006980|471955073|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
131087711|NCT01006980|471955072|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
131087712|NCT01006980|471955073|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
131087713|NCT01006980|471955072|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
131087714|NCT01006980|471955073|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
131087715|NCT01006980|471955072|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
131087716|NCT01006980|471955073|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
131087717|NCT01006980|471955072|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
131087718|NCT01006980|471955073|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
131087719|NCT01006980|471955072|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
131087720|NCT01006980|471955073|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
131087721|NCT01006980|471955072|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
131087722|NCT01006980|471955073|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
131087723|NCT02706405|471955082|FG000|Overall Study|Death|3|||
131087724|NCT02706405|471955083|FG001|Overall Study|Death|2|||
131087725|NCT02706405|471955084|FG002|Overall Study|Death|0|||
131087726|NCT02706405|471955085|FG003|Overall Study|Death|1|||
131087727|NCT02706405|471955086|FG004|Overall Study|Death|0|||
131087728|NCT02706405|471955087|FG005|Overall Study|Death|0|||
131087729|NCT02706405|471955088|FG006|Overall Study|Death|3|||
131087730|NCT02706405|471955089|FG007|Overall Study|Death|4|||
131087731|NCT02706405|471955082|FG000|Overall Study|Disease progression|0|||
131087732|NCT02706405|471955083|FG001|Overall Study|Disease progression|0|||
131087733|NCT02706405|471955084|FG002|Overall Study|Disease progression|0|||
131087734|NCT02706405|471955085|FG003|Overall Study|Disease progression|0|||
131087735|NCT02706405|471955086|FG004|Overall Study|Disease progression|0|||
131087736|NCT02706405|471955087|FG005|Overall Study|Disease progression|0|||
131087737|NCT02706405|471955088|FG006|Overall Study|Disease progression|0|||
131087738|NCT02706405|471955089|FG007|Overall Study|Disease progression|1|||
131087739|NCT02706405|471955082|FG000|Overall Study|Pt moved to new therapy|0|||
131087740|NCT02706405|471955083|FG001|Overall Study|Pt moved to new therapy|0|||
131087741|NCT02706405|471955084|FG002|Overall Study|Pt moved to new therapy|0|||
131087742|NCT02706405|471955085|FG003|Overall Study|Pt moved to new therapy|0|||
131087743|NCT02706405|471955086|FG004|Overall Study|Pt moved to new therapy|0|||
131087744|NCT02706405|471955087|FG005|Overall Study|Pt moved to new therapy|1|||
131142509|NCT00544869|472148520|FG001|Overall Study|Adverse Event|1|||
131142510|NCT00544869|472148521|FG002|Overall Study|Adverse Event|0|||
131142511|NCT00544869|472148519|FG000|Overall Study|Lack of Efficacy|1|||
131142512|NCT00544869|472148520|FG001|Overall Study|Lack of Efficacy|1|||
131142513|NCT00544869|472148521|FG002|Overall Study|Lack of Efficacy|0|||
131142514|NCT00544869|472148519|FG000|Overall Study|Physician Decision|2|||
131087745|NCT02706405|471955088|FG006|Overall Study|Pt moved to new therapy|0|||
131087746|NCT02706405|471955089|FG007|Overall Study|Pt moved to new therapy|1|||
131087747|NCT02706405|471955082|FG000|Overall Study|Physician Decision|1|||
131087748|NCT02706405|471955083|FG001|Overall Study|Physician Decision|0|||
131087749|NCT02706405|471955084|FG002|Overall Study|Physician Decision|0|||
131087750|NCT02706405|471955085|FG003|Overall Study|Physician Decision|0|||
131142515|NCT00544869|472148520|FG001|Overall Study|Physician Decision|0|||
131233900|NCT03312530|472484535|FG002|Overall Study|Study terminated by sponsor|2|||
131233901|NCT03312530|472484536|FG003|Overall Study|Study terminated by sponsor|3|||
131233902|NCT03312530|472484537|FG004|Overall Study|Study terminated by sponsor|7|||
131233903|NCT03312530|472484533|FG000|Overall Study|Withdrawal by Subject|0|||
131233904|NCT03312530|472484534|FG001|Overall Study|Withdrawal by Subject|1|||
131233905|NCT03312530|472484535|FG002|Overall Study|Withdrawal by Subject|0|||
131233906|NCT03312530|472484536|FG003|Overall Study|Withdrawal by Subject|0|||
131233907|NCT03312530|472484537|FG004|Overall Study|Withdrawal by Subject|0|||
131233908|NCT03312530|472484533|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
131233909|NCT03312530|472484534|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
131233910|NCT03312530|472484535|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
131233911|NCT03312530|472484536|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
131233912|NCT03312530|472484537|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
131233913|NCT03093324|472484538|FG000|Overall Study|Adverse Event|4|||
131233914|NCT03093324|472484539|FG001|Overall Study|Adverse Event|15|||
131233915|NCT03093324|472484538|FG000|Overall Study|Lost to Follow-up|1|||
131233916|NCT03093324|472484539|FG001|Overall Study|Lost to Follow-up|0|||
131233917|NCT03093324|472484538|FG000|Overall Study|Protocol Deviation|2|||
131233918|NCT03093324|472484539|FG001|Overall Study|Protocol Deviation|2|||
131233919|NCT03093324|472484538|FG000|Overall Study|Withdrawal by Subject|2|||
131233920|NCT03093324|472484539|FG001|Overall Study|Withdrawal by Subject|2|||
131233921|NCT00614055|472484543|FG000|Overall Study|Adverse Event|1|||
131233922|NCT00614055|472484544|FG001|Overall Study|Adverse Event|0|||
131233923|NCT00614055|472484545|FG002|Overall Study|Adverse Event|0|||
131233924|NCT00614055|472484543|FG000|Overall Study|Protocol Violation|2|||
131233925|NCT00614055|472484544|FG001|Overall Study|Protocol Violation|2|||
131233926|NCT00614055|472484545|FG002|Overall Study|Protocol Violation|1|||
131233927|NCT00614055|472484543|FG000|Overall Study|Lack of Efficacy|0|||
131233928|NCT00614055|472484544|FG001|Overall Study|Lack of Efficacy|0|||
131233929|NCT00614055|472484545|FG002|Overall Study|Lack of Efficacy|2|||
131233930|NCT00614055|472484543|FG000|Overall Study|Unclassified|1|||
131233931|NCT00614055|472484544|FG001|Overall Study|Unclassified|4|||
131233932|NCT00614055|472484545|FG002|Overall Study|Unclassified|2|||
131233933|NCT04583579|472484547|FG000|Overall Study|Lost to Follow-up|4|||
131233934|NCT01691859|472484548|FG000|Overall Study|Adverse Event|19|||
131233935|NCT01691859|472484548|FG000|Overall Study|Lack of Efficacy|11|||
131233936|NCT01691859|472484548|FG000|Overall Study|Protocol Violation|4|||
131233937|NCT01691859|472484548|FG000|Overall Study|Product commercially available|221|||
131233938|NCT01691859|472484548|FG000|Overall Study|Study closed/terminated|50|||
131233939|NCT01691859|472484548|FG000|Overall Study|Lost to Follow-up|5|||
131233940|NCT01691859|472484548|FG000|Overall Study|Physician Decision|6|||
131233941|NCT01691859|472484548|FG000|Overall Study|Withdrawal by Subject|31|||
131233942|NCT01296932|472484549|FG000|Overall Study|Dose limiting toxicity|0|||
131233943|NCT01296932|472484550|FG001|Overall Study|Dose limiting toxicity|0|||
131233944|NCT01296932|472484551|FG002|Overall Study|Dose limiting toxicity|0|||
131087751|NCT02706405|471955086|FG004|Overall Study|Physician Decision|0|||
131087752|NCT02706405|471955087|FG005|Overall Study|Physician Decision|0|||
131087753|NCT02706405|471955088|FG006|Overall Study|Physician Decision|0|||
131087754|NCT02706405|471955089|FG007|Overall Study|Physician Decision|0|||
131087755|NCT01228318|471955090|FG000|Overall Study|Clinic no show to receive intervention|1|||
131087756|NCT01228318|471955091|FG001|Overall Study|Clinic no show to receive intervention|0|||
131087757|NCT01228318|471955090|FG000|Overall Study|Unable to contact|2|||
131087758|NCT01228318|471955091|FG001|Overall Study|Unable to contact|5|||
131087759|NCT01228318|471955090|FG000|Overall Study|Moved|0|||
131087760|NCT01228318|471955091|FG001|Overall Study|Moved|2|||
131087761|NCT01228318|471955090|FG000|Overall Study|Incarcerated|1|||
131087762|NCT01228318|471955091|FG001|Overall Study|Incarcerated|0|||
131233945|NCT01296932|472484552|FG003|Overall Study|Dose limiting toxicity|0|||
131233946|NCT01296932|472484553|FG004|Overall Study|Dose limiting toxicity|0|||
131233947|NCT01296932|472484554|FG005|Overall Study|Dose limiting toxicity|0|||
131233948|NCT01296932|472484555|FG006|Overall Study|Dose limiting toxicity|1|||
131233949|NCT01296932|472484556|FG007|Overall Study|Dose limiting toxicity|0|||
131233950|NCT01296932|472484557|FG008|Overall Study|Dose limiting toxicity|1|||
131087763|NCT01182441|471955092|FG000|Overall Study|Patient Still in Follow-up|152|||
131087764|NCT01182441|471955093|FG001|Overall Study|Patient Still in Follow-up|72|||
131233951|NCT01296932|472484549|FG000|Overall Study|Progressive disease|2|||
131233952|NCT01296932|472484550|FG001|Overall Study|Progressive disease|0|||
131233953|NCT01296932|472484551|FG002|Overall Study|Progressive disease|1|||
131233954|NCT01296932|472484552|FG003|Overall Study|Progressive disease|1|||
131087765|NCT01182441|471955092|FG000|Overall Study|Death|37|||
131087766|NCT01182441|471955093|FG001|Overall Study|Death|25|||
130727259|NCT02883049|470625427|FG003|Post Induction|Ineligible|0|||
131087767|NCT01182441|471955092|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
131087768|NCT01182441|471955093|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
131087769|NCT01182441|471955092|FG000|Overall Study|Lost to Follow-up|5|||
131142516|NCT00544869|472148521|FG002|Overall Study|Physician Decision|0|||
131142517|NCT00925600|472148526|FG000|Overall Study|Withdrawal by Subject|16|||
131142518|NCT00925600|472148527|FG001|Overall Study|Withdrawal by Subject|14|||
131142519|NCT00925600|472148526|FG000|Overall Study|Death|4|||
131142520|NCT00925600|472148527|FG001|Overall Study|Death|3|||
131142521|NCT00925600|472148526|FG000|Overall Study|Lost to Follow-up|2|||
131142522|NCT00925600|472148527|FG001|Overall Study|Lost to Follow-up|2|||
131142523|NCT00925600|472148526|FG000|Overall Study|Disease Progression|1|||
131142524|NCT00925600|472148527|FG001|Overall Study|Disease Progression|3|||
131142525|NCT00925600|472148526|FG000|Overall Study|Administrative Decision|1|||
131142526|NCT00925600|472148527|FG001|Overall Study|Administrative Decision|1|||
131142527|NCT00925600|472148526|FG000|Overall Study|Noncompliance|2|||
131142528|NCT00925600|472148527|FG001|Overall Study|Noncompliance|0|||
131142529|NCT00925600|472148526|FG000|Overall Study|Ineligibility Determined|2|||
131087770|NCT01182441|471955093|FG001|Overall Study|Lost to Follow-up|8|||
131142530|NCT00925600|472148527|FG001|Overall Study|Ineligibility Determined|0|||
131142531|NCT00925600|472148526|FG000|Overall Study|Protocol Deviation|0|||
131142532|NCT00925600|472148527|FG001|Overall Study|Protocol Deviation|1|||
131142533|NCT00925600|472148526|FG000|Overall Study|Requirement for Alternative Therapy|0|||
131142534|NCT00925600|472148527|FG001|Overall Study|Requirement for Alternative Therapy|1|||
131142535|NCT00925600|472148526|FG000|Overall Study|Other|3|||
131142536|NCT00925600|472148527|FG001|Overall Study|Other|1|||
131142537|NCT00925600|472148526|FG000|Overall Study|Adverse Event|1|||
131142538|NCT00925600|472148527|FG001|Overall Study|Adverse Event|2|||
131142539|NCT01974817|472148530|FG000|Overall Study|Death|4|||
131142540|NCT01974817|472148530|FG000|Overall Study|Lost to Follow-up|2|||
131142541|NCT01974817|472148530|FG000|Overall Study|Protocol Violation|2|||
131142542|NCT01891643|472148531|FG000|Overall Study|Adverse event unrelated to study drug|2|||
131142543|NCT01891643|472148532|FG001|Overall Study|Adverse event unrelated to study drug|5|||
131142544|NCT01891643|472148531|FG000|Overall Study|Disease Progression|4|||
131142545|NCT01891643|472148532|FG001|Overall Study|Disease Progression|3|||
131142546|NCT01891643|472148531|FG000|Overall Study|Study Drug Toxicity|3|||
131142547|NCT01891643|472148532|FG001|Overall Study|Study Drug Toxicity|0|||
131142548|NCT01891643|472148531|FG000|Overall Study|Maximum Clinical Benefit|0|||
131142549|NCT01891643|472148532|FG001|Overall Study|Maximum Clinical Benefit|1|||
131142550|NCT01891643|472148531|FG000|Overall Study|Poor/Non-compliance|0|||
131142551|NCT01891643|472148532|FG001|Overall Study|Poor/Non-compliance|1|||
131142552|NCT01891643|472148531|FG000|Overall Study|Participant request to discontinue|1|||
131142553|NCT01891643|472148532|FG001|Overall Study|Participant request to discontinue|0|||
131142554|NCT02965716|472148533|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
131142555|NCT02965716|472148534|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
131142556|NCT02965716|472148533|FG000|Overall Study|Progression/Relapse|8|||
131087771|NCT01182441|471955092|FG000|Overall Study|Withdrawal by Subject|6|||
131087772|NCT01182441|471955093|FG001|Overall Study|Withdrawal by Subject|13|||
131087773|NCT01182441|471955092|FG000|Overall Study|Implant Not Attempted|4|||
131087774|NCT01182441|471955093|FG001|Overall Study|Implant Not Attempted|0|||
131087775|NCT01182441|471955092|FG000|Overall Study|Adverse Event|2|||
131087776|NCT01182441|471955093|FG001|Overall Study|Adverse Event|0|||
131087777|NCT01182441|471955092|FG000|Overall Study|Physician Decision|1|||
131087778|NCT01182441|471955093|FG001|Overall Study|Physician Decision|1|||
131087779|NCT00603525|471955094|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
131087780|NCT00603525|471955095|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
131087781|NCT00603525|471955096|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131087782|NCT00603525|471955094|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
131087783|NCT00603525|471955095|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131087784|NCT00603525|471955096|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131087785|NCT00603525|471955094|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
131087786|NCT00603525|471955095|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
131087787|NCT00603525|471955096|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131087788|NCT00603525|471955094|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131087789|NCT00603525|471955095|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
131087790|NCT00603525|471955096|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131087791|NCT00603525|471955094|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
131087792|NCT00603525|471955095|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
131087793|NCT00603525|471955096|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131142557|NCT02965716|472148534|FG001|Overall Study|Progression/Relapse|16|||
131142558|NCT02965716|472148533|FG000|Overall Study|Death|1|||
131142559|NCT02965716|472148534|FG001|Overall Study|Death|0|||
131142560|NCT02965716|472148533|FG000|Overall Study|Not Protocol Specified|1|||
131142561|NCT02965716|472148534|FG001|Overall Study|Not Protocol Specified|3|||
131142562|NCT04047797|472148535|FG000|Overall Study|Progressive Disease|1|||
131142563|NCT03523351|472148536|FG000|Overall Study|Death|13|||
131142564|NCT03523351|472148537|FG001|Overall Study|Death|11|||
131142565|NCT03523351|472148536|FG000|Overall Study|Lost to Follow-up|2|||
131142566|NCT03523351|472148537|FG001|Overall Study|Lost to Follow-up|3|||
131142567|NCT03523351|472148536|FG000|Overall Study|Withdrawal by Subject|4|||
131087794|NCT00603525|471955094|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
131087795|NCT00603525|471955095|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
131087796|NCT00603525|471955096|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
131087797|NCT00603525|471955094|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
131087798|NCT00603525|471955095|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
131087799|NCT00603525|471955096|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
131087800|NCT00603525|471955094|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
131087801|NCT00603525|471955095|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
131087802|NCT00603525|471955096|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
131087803|NCT00603525|471955094|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
131087804|NCT00603525|471955095|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
131087805|NCT00603525|471955096|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
131087806|NCT00603525|471955094|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
131087807|NCT00603525|471955095|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
131087808|NCT00603525|471955096|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
131087809|NCT00603525|471955094|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
131087810|NCT00603525|471955095|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
131087811|NCT00603525|471955096|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
131087812|NCT00603525|471955094|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
131087813|NCT00603525|471955095|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
131087814|NCT00603525|471955096|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
131087815|NCT00603525|471955094|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
131087816|NCT00603525|471955095|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
131087817|NCT00603525|471955096|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
131087818|NCT00603525|471955094|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
131087819|NCT00603525|471955095|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
131087820|NCT00603525|471955096|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
131087821|NCT00603525|471955094|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
131087822|NCT00603525|471955095|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
131087823|NCT00603525|471955096|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
131087824|NCT04703192|471955100|FG000|Overall Study|Withdrawal by Subject|2|||
131087825|NCT04703192|471955101|FG001|Overall Study|Withdrawal by Subject|0|||
131087826|NCT04703192|471955100|FG000|Overall Study|Death|3|||
131087827|NCT04703192|471955101|FG001|Overall Study|Death|1|||
131087828|NCT04703192|471955100|FG000|Overall Study|Adverse Event|13|||
131087829|NCT04703192|471955101|FG001|Overall Study|Adverse Event|2|||
131087830|NCT04703192|471955100|FG000|Overall Study|Progressive or Relapsed Disease|46|||
131087831|NCT04703192|471955101|FG001|Overall Study|Progressive or Relapsed Disease|7|||
131087832|NCT04703192|471955100|FG000|Overall Study|Clinical Progression|19|||
131087833|NCT04703192|471955101|FG001|Overall Study|Clinical Progression|8|||
131087834|NCT04703192|471955100|FG000|Overall Study|Lost to Follow-up|1|||
131087835|NCT04703192|471955101|FG001|Overall Study|Lost to Follow-up|0|||
131087836|NCT04703192|471955100|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
131087837|NCT04703192|471955101|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
131087838|NCT04703192|471955100|FG000|Overall Study|Other|5|||
131087839|NCT04703192|471955101|FG001|Overall Study|Other|1|||
131087840|NCT01923662|471955102|FG000|Overall Study|Withdrawal by Subject|1|||
131087841|NCT01294397|471955103|FG000|Overall Study|Withdrawal by Subject|1|||
131087842|NCT01294397|471955103|FG000|Overall Study|Administrative Decision|1|||
131087843|NCT00678301|471955104|FG000|Overall Study|Non-compliance with study procedures|0|||
131087844|NCT00678301|471955105|FG001|Overall Study|Non-compliance with study procedures|1|||
131233955|NCT01296932|472484553|FG004|Overall Study|Progressive disease|2|||
131233956|NCT01296932|472484554|FG005|Overall Study|Progressive disease|3|||
131233957|NCT01296932|472484555|FG006|Overall Study|Progressive disease|1|||
131233958|NCT01296932|472484556|FG007|Overall Study|Progressive disease|0|||
131233959|NCT01296932|472484557|FG008|Overall Study|Progressive disease|0|||
131087845|NCT00678301|471955104|FG000|Overall Study|Adverse Event|1|||
131233960|NCT01296932|472484549|FG000|Overall Study|Withdrawal by Subject|0|||
131233961|NCT01296932|472484550|FG001|Overall Study|Withdrawal by Subject|0|||
131087846|NCT00678301|471955105|FG001|Overall Study|Adverse Event|0|||
131087847|NCT00678301|471955104|FG000|Overall Study|Withdrawal by Subject|4|||
131087848|NCT00678301|471955105|FG001|Overall Study|Withdrawal by Subject|0|||
131087849|NCT00678301|471955104|FG000|Overall Study|Lost to Follow-up|3|||
131087850|NCT00678301|471955105|FG001|Overall Study|Lost to Follow-up|1|||
131087851|NCT03596762|471955116|FG000|Overall Study|Protocol Violation|0|||
131087852|NCT03596762|471955117|FG001|Overall Study|Protocol Violation|0|||
131087853|NCT03596762|471955118|FG002|Overall Study|Protocol Violation|0|||
131087854|NCT03596762|471955119|FG003|Overall Study|Protocol Violation|0|||
131087855|NCT03596762|471955120|FG004|Overall Study|Protocol Violation|1|||
131087856|NCT03596762|471955116|FG000|Overall Study|Adverse Event|2|||
131233962|NCT01296932|472484551|FG002|Overall Study|Withdrawal by Subject|1|||
131233963|NCT01296932|472484552|FG003|Overall Study|Withdrawal by Subject|1|||
131233964|NCT01296932|472484553|FG004|Overall Study|Withdrawal by Subject|0|||
131233965|NCT01296932|472484554|FG005|Overall Study|Withdrawal by Subject|0|||
131233966|NCT01296932|472484555|FG006|Overall Study|Withdrawal by Subject|3|||
131233967|NCT01296932|472484556|FG007|Overall Study|Withdrawal by Subject|0|||
131233968|NCT01296932|472484557|FG008|Overall Study|Withdrawal by Subject|0|||
131233969|NCT01296932|472484549|FG000|Overall Study|Adverse Event|1|||
131233970|NCT01296932|472484550|FG001|Overall Study|Adverse Event|1|||
131233971|NCT01296932|472484551|FG002|Overall Study|Adverse Event|1|||
131233972|NCT01296932|472484552|FG003|Overall Study|Adverse Event|2|||
131233973|NCT01296932|472484553|FG004|Overall Study|Adverse Event|1|||
131233974|NCT01296932|472484554|FG005|Overall Study|Adverse Event|0|||
131233975|NCT01296932|472484555|FG006|Overall Study|Adverse Event|0|||
131233976|NCT01296932|472484556|FG007|Overall Study|Adverse Event|0|||
131233977|NCT01296932|472484557|FG008|Overall Study|Adverse Event|1|||
131233978|NCT01296932|472484549|FG000|Overall Study|Investigator decision|0|||
131233979|NCT01296932|472484550|FG001|Overall Study|Investigator decision|1|||
131233980|NCT01296932|472484551|FG002|Overall Study|Investigator decision|0|||
131233981|NCT01296932|472484552|FG003|Overall Study|Investigator decision|1|||
131233982|NCT01296932|472484553|FG004|Overall Study|Investigator decision|0|||
131233983|NCT01296932|472484554|FG005|Overall Study|Investigator decision|0|||
131233984|NCT01296932|472484555|FG006|Overall Study|Investigator decision|1|||
131233985|NCT01296932|472484556|FG007|Overall Study|Investigator decision|0|||
131233986|NCT01296932|472484557|FG008|Overall Study|Investigator decision|1|||
131233987|NCT01296932|472484549|FG000|Overall Study|No clinical benefit anymore|0|||
131233988|NCT01296932|472484550|FG001|Overall Study|No clinical benefit anymore|1|||
131233989|NCT01296932|472484551|FG002|Overall Study|No clinical benefit anymore|0|||
131233990|NCT01296932|472484552|FG003|Overall Study|No clinical benefit anymore|0|||
131233991|NCT01296932|472484553|FG004|Overall Study|No clinical benefit anymore|0|||
131233992|NCT01296932|472484554|FG005|Overall Study|No clinical benefit anymore|0|||
131233993|NCT01296932|472484555|FG006|Overall Study|No clinical benefit anymore|0|||
131233994|NCT01296932|472484556|FG007|Overall Study|No clinical benefit anymore|0|||
131233995|NCT01296932|472484557|FG008|Overall Study|No clinical benefit anymore|0|||
131233996|NCT01296932|472484549|FG000|Overall Study|Physician Decision|0|||
131233997|NCT01296932|472484550|FG001|Overall Study|Physician Decision|0|||
131233998|NCT01296932|472484551|FG002|Overall Study|Physician Decision|1|||
131233999|NCT01296932|472484552|FG003|Overall Study|Physician Decision|0|||
131234000|NCT01296932|472484553|FG004|Overall Study|Physician Decision|0|||
131234001|NCT01296932|472484554|FG005|Overall Study|Physician Decision|0|||
131234002|NCT01296932|472484555|FG006|Overall Study|Physician Decision|0|||
131234003|NCT01296932|472484556|FG007|Overall Study|Physician Decision|0|||
131234004|NCT01296932|472484557|FG008|Overall Study|Physician Decision|0|||
131234005|NCT01296932|472484549|FG000|Overall Study|IV problems, administration not possible|0|||
131234006|NCT01296932|472484550|FG001|Overall Study|IV problems, administration not possible|0|||
131234007|NCT01296932|472484551|FG002|Overall Study|IV problems, administration not possible|1|||
131234008|NCT01296932|472484552|FG003|Overall Study|IV problems, administration not possible|0|||
131234009|NCT01296932|472484553|FG004|Overall Study|IV problems, administration not possible|0|||
131234010|NCT01296932|472484554|FG005|Overall Study|IV problems, administration not possible|0|||
131234011|NCT01296932|472484555|FG006|Overall Study|IV problems, administration not possible|0|||
131234012|NCT01296932|472484556|FG007|Overall Study|IV problems, administration not possible|0|||
131234013|NCT01296932|472484557|FG008|Overall Study|IV problems, administration not possible|0|||
131234014|NCT01296932|472484549|FG000|Overall Study|per protocol|0|||
131234015|NCT01296932|472484550|FG001|Overall Study|per protocol|0|||
131234016|NCT01296932|472484551|FG002|Overall Study|per protocol|1|||
131234017|NCT01296932|472484552|FG003|Overall Study|per protocol|1|||
131234018|NCT01296932|472484553|FG004|Overall Study|per protocol|0|||
131234019|NCT01296932|472484554|FG005|Overall Study|per protocol|0|||
131234020|NCT01296932|472484555|FG006|Overall Study|per protocol|0|||
131234021|NCT01296932|472484556|FG007|Overall Study|per protocol|0|||
131234022|NCT01296932|472484557|FG008|Overall Study|per protocol|0|||
131234023|NCT01296932|472484549|FG000|Overall Study|Low benefit and too many side effects|0|||
131087857|NCT03596762|471955117|FG001|Overall Study|Adverse Event|0|||
131087858|NCT03596762|471955118|FG002|Overall Study|Adverse Event|1|||
131087859|NCT03596762|471955119|FG003|Overall Study|Adverse Event|0|||
131234024|NCT01296932|472484550|FG001|Overall Study|Low benefit and too many side effects|0|||
131234025|NCT01296932|472484551|FG002|Overall Study|Low benefit and too many side effects|0|||
131234026|NCT01296932|472484552|FG003|Overall Study|Low benefit and too many side effects|0|||
131234027|NCT01296932|472484553|FG004|Overall Study|Low benefit and too many side effects|0|||
131087860|NCT03596762|471955120|FG004|Overall Study|Adverse Event|5|||
131087861|NCT03596762|471955116|FG000|Overall Study|Withdrawal by Subject|2|||
131087862|NCT03596762|471955117|FG001|Overall Study|Withdrawal by Subject|1|||
131234028|NCT01296932|472484554|FG005|Overall Study|Low benefit and too many side effects|0|||
131234029|NCT01296932|472484555|FG006|Overall Study|Low benefit and too many side effects|0|||
131234030|NCT01296932|472484556|FG007|Overall Study|Low benefit and too many side effects|1|||
131234031|NCT01296932|472484557|FG008|Overall Study|Low benefit and too many side effects|0|||
131234032|NCT01296932|472484549|FG000|Overall Study|No adequate treatment response|0|||
131087863|NCT03596762|471955118|FG002|Overall Study|Withdrawal by Subject|0|||
131087864|NCT03596762|471955119|FG003|Overall Study|Withdrawal by Subject|1|||
131087865|NCT03596762|471955120|FG004|Overall Study|Withdrawal by Subject|1|||
131087866|NCT01263509|471955121|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
131087867|NCT01263509|471955122|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
131087868|NCT01263509|471955123|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
131087869|NCT01263509|471955124|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
131087870|NCT01263509|471955121|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
131087871|NCT01263509|471955122|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
131087872|NCT01263509|471955123|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
131087873|NCT01263509|471955124|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131087874|NCT01263509|471955121|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131087875|NCT01263509|471955122|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
131087876|NCT01263509|471955123|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131087877|NCT01263509|471955124|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131087878|NCT01263509|471955121|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
131087879|NCT01263509|471955122|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
131087880|NCT01263509|471955123|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131087881|NCT01263509|471955124|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
131087882|NCT01263509|471955121|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
131087883|NCT01263509|471955122|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
131087884|NCT01263509|471955123|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
131087885|NCT01263509|471955124|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
131087886|NCT05071053|471955125|FG000|Overall Study|Progressive disease|30|||
131087887|NCT05071053|471955125|FG000|Overall Study|Adverse Event|5|||
131087888|NCT01261000|471955128|FG000|Overall Study|Screen failure|1|||
131087889|NCT01572740|471955129|FG000|Overall Study|Adverse Event|1|||
131087890|NCT01572740|471955130|FG001|Overall Study|Adverse Event|1|||
131087891|NCT01572740|471955129|FG000|Overall Study|Withdrawal by Subject|1|||
131087892|NCT01572740|471955130|FG001|Overall Study|Withdrawal by Subject|1|||
131087893|NCT01572740|471955129|FG000|Overall Study|unclassified|4|||
131087894|NCT01572740|471955130|FG001|Overall Study|unclassified|3|||
131087895|NCT01289210|471955131|FG000|Overall Study|Adverse Event|1|||
131087896|NCT01818531|471955132|FG000|Overall Study|Withdrawn for case delay after block|1|||
131087897|NCT01818531|471955133|FG001|Overall Study|Withdrawn for case delay after block|0|||
131087898|NCT01818531|471955132|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
131087899|NCT01818531|471955133|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
131087900|NCT01818531|471955132|FG000|Overall Study|Withdrawn for failure to place block|0|||
131087901|NCT01818531|471955133|FG001|Overall Study|Withdrawn for failure to place block|1|||
131087902|NCT00477490|471955136|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
131087903|NCT00477490|471955137|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
131087904|NCT00477490|471955138|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
131087905|NCT00477490|471955139|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
131087906|NCT00477490|471955140|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
131087907|NCT00477490|471955141|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
131087908|NCT00477490|471955142|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
131087909|NCT00477490|471955143|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
131087910|NCT00477490|471955144|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
131087911|NCT00477490|471955136|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
131087912|NCT00477490|471955137|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131087913|NCT00477490|471955138|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131087914|NCT00477490|471955139|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
131087915|NCT00477490|471955140|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
131087916|NCT00477490|471955141|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131087917|NCT00477490|471955142|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131087918|NCT00477490|471955143|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131087919|NCT00477490|471955144|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
131087920|NCT00477490|471955136|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
131087921|NCT00477490|471955137|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
131087922|NCT00477490|471955138|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
131087923|NCT00477490|471955139|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
131087924|NCT00477490|471955140|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
131087925|NCT00477490|471955141|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
131087926|NCT00477490|471955142|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
131087927|NCT00477490|471955143|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
131087928|NCT00477490|471955144|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
131087929|NCT00477490|471955136|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
131087930|NCT00477490|471955137|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
131087931|NCT00477490|471955138|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
131087932|NCT00477490|471955139|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
131234033|NCT01296932|472484550|FG001|Overall Study|No adequate treatment response|0|||
131234034|NCT01296932|472484551|FG002|Overall Study|No adequate treatment response|0|||
131234035|NCT01296932|472484552|FG003|Overall Study|No adequate treatment response|0|||
131234036|NCT01296932|472484553|FG004|Overall Study|No adequate treatment response|0|||
131234037|NCT01296932|472484554|FG005|Overall Study|No adequate treatment response|0|||
131087933|NCT00477490|471955140|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
131087934|NCT00477490|471955141|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
131087935|NCT00477490|471955142|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
131087936|NCT00477490|471955143|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
131087937|NCT00477490|471955144|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
131087938|NCT00477490|471955136|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
131087939|NCT00477490|471955137|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
131087940|NCT00477490|471955138|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
131087941|NCT00477490|471955139|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
131087942|NCT00477490|471955140|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
131087943|NCT00477490|471955141|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
131087944|NCT00477490|471955142|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
131087945|NCT00477490|471955143|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
131087946|NCT00477490|471955144|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
131087947|NCT00477490|471955136|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
131087948|NCT00477490|471955137|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
131087949|NCT00477490|471955138|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
131087950|NCT00477490|471955139|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
131087951|NCT00477490|471955140|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
131087952|NCT00477490|471955141|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
131087953|NCT00477490|471955142|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
131087954|NCT00477490|471955143|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
131087955|NCT00477490|471955144|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
131087956|NCT00477490|471955136|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
131087957|NCT00477490|471955137|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
131087958|NCT00477490|471955138|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
131087959|NCT00477490|471955139|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
131087960|NCT00477490|471955140|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
131087961|NCT00477490|471955141|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
131087962|NCT00477490|471955142|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
131087963|NCT00477490|471955143|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
131087964|NCT00477490|471955144|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
131087965|NCT00477490|471955136|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
131087966|NCT00477490|471955137|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
131087967|NCT00477490|471955138|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
131087968|NCT00477490|471955139|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
131087969|NCT00477490|471955140|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
131087970|NCT00477490|471955141|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
131087971|NCT00477490|471955142|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
131087972|NCT00477490|471955143|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
131087973|NCT00477490|471955144|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
131087974|NCT00477490|471955136|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
131087975|NCT00477490|471955137|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
131087976|NCT00477490|471955138|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
131087977|NCT00477490|471955139|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
131087978|NCT00477490|471955140|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
131087979|NCT00477490|471955141|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
131087980|NCT00477490|471955142|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
131087981|NCT00477490|471955143|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
131087982|NCT00477490|471955144|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
131087983|NCT00477490|471955136|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
131087984|NCT00477490|471955137|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
131087985|NCT00477490|471955138|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
131087986|NCT00477490|471955139|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
131087987|NCT00477490|471955140|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
131087988|NCT00477490|471955141|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
131087989|NCT00477490|471955142|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
131087990|NCT00477490|471955143|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
131087991|NCT00477490|471955144|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
131087992|NCT00477490|471955136|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131087993|NCT00477490|471955137|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131234038|NCT01296932|472484555|FG006|Overall Study|No adequate treatment response|0|||
131234039|NCT01296932|472484556|FG007|Overall Study|No adequate treatment response|1|||
131234040|NCT01296932|472484557|FG008|Overall Study|No adequate treatment response|0|||
131087994|NCT00477490|471955138|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131087995|NCT00477490|471955139|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131087996|NCT00477490|471955140|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
131087997|NCT00477490|471955141|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131087998|NCT00477490|471955142|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
131087999|NCT00477490|471955143|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
131088000|NCT00477490|471955144|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
131088001|NCT00477490|471955136|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131088002|NCT00477490|471955137|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
131088003|NCT00477490|471955138|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131088004|NCT00477490|471955139|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131088005|NCT00477490|471955140|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131088006|NCT00477490|471955141|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131088007|NCT00477490|471955142|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131088008|NCT00477490|471955143|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131088009|NCT00477490|471955144|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
131088010|NCT00477490|471955136|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
131088011|NCT00477490|471955137|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
131088012|NCT00477490|471955138|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
131088013|NCT00477490|471955139|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
131088014|NCT00477490|471955140|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
131088015|NCT00477490|471955141|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
131088016|NCT00477490|471955142|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
131088017|NCT00477490|471955143|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
131088018|NCT00477490|471955144|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
131088019|NCT00477490|471955136|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131088020|NCT00477490|471955137|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
131088021|NCT00477490|471955138|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
131088022|NCT00477490|471955139|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131088023|NCT00477490|471955140|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
131088024|NCT00477490|471955141|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131088025|NCT00477490|471955142|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131088026|NCT00477490|471955143|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131088027|NCT00477490|471955144|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
131088028|NCT00669877|471955145|FG000|Overall Study|Disease Progression/Death|4|||
131088029|NCT01110408|471955146|FG000|Overall Study|Protocol Violation|1|||
131088030|NCT01110408|471955147|FG001|Overall Study|Protocol Violation|0|||
131088031|NCT01646177|471955148|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
131088032|NCT01646177|471955149|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
131088033|NCT01646177|471955150|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
131088034|NCT01646177|471955151|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
131088035|NCT01646177|471955152|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131088036|NCT01646177|471955153|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131088037|NCT01646177|471955154|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131088038|NCT01646177|471955155|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131088039|NCT01646177|471955156|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131088040|NCT01646177|471955157|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131088041|NCT01646177|471955158|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131088042|NCT01646177|471955159|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
131088043|NCT01646177|471955148|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
131088044|NCT01646177|471955149|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
131234041|NCT01296932|472484549|FG000|Overall Study|Dosage already reduced, AE still present|0|||
131234042|NCT01296932|472484550|FG001|Overall Study|Dosage already reduced, AE still present|0|||
131234043|NCT01296932|472484551|FG002|Overall Study|Dosage already reduced, AE still present|0|||
131234044|NCT01296932|472484552|FG003|Overall Study|Dosage already reduced, AE still present|0|||
131234045|NCT01296932|472484553|FG004|Overall Study|Dosage already reduced, AE still present|0|||
131234046|NCT01296932|472484554|FG005|Overall Study|Dosage already reduced, AE still present|0|||
131234047|NCT01296932|472484555|FG006|Overall Study|Dosage already reduced, AE still present|0|||
131234048|NCT01296932|472484556|FG007|Overall Study|Dosage already reduced, AE still present|0|||
131234049|NCT01296932|472484557|FG008|Overall Study|Dosage already reduced, AE still present|1|||
131234050|NCT05431153|472484558|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131234051|NCT05431153|472484559|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131234052|NCT05431153|472484560|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131234053|NCT05431153|472484561|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131088045|NCT01646177|471955150|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
131234054|NCT05431153|472484562|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
131234055|NCT05431153|472484563|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131234056|NCT02352337|472484564|FG000|Overall Study|Patients never treated|4|||
131234057|NCT02352337|472484565|FG001|Overall Study|Patients never treated|1|||
131234058|NCT02352337|472484566|FG002|Overall Study|Patients never treated|2|||
131234059|NCT02458638|472484569|FG000|Overall Study|Death|309|||
131234060|NCT02458638|472484569|FG000|Overall Study|End of Cohort/End of Study|67|||
131234061|NCT02458638|472484569|FG000|Overall Study|Lost to Follow-up|31|||
131234062|NCT02458638|472484569|FG000|Overall Study|Other Reasons|4|||
131234063|NCT02458638|472484569|FG000|Overall Study|Physician Decision|1|||
131234064|NCT02458638|472484569|FG000|Overall Study|Withdrawal by Subject|47|||
131234065|NCT01829464|472484578|FG000|Overall Study|Adverse Event|1|||
131234066|NCT01829464|472484579|FG001|Overall Study|Adverse Event|0|||
131234067|NCT01829464|472484580|FG002|Overall Study|Adverse Event|0|||
131234068|NCT01829464|472484578|FG000|Overall Study|Lost to Follow-up|0|||
131234069|NCT01829464|472484579|FG001|Overall Study|Lost to Follow-up|0|||
131234070|NCT01829464|472484580|FG002|Overall Study|Lost to Follow-up|1|||
131234071|NCT01829464|472484578|FG000|Overall Study|Withdrawal by Subject|2|||
131234072|NCT01829464|472484579|FG001|Overall Study|Withdrawal by Subject|0|||
131234073|NCT01829464|472484580|FG002|Overall Study|Withdrawal by Subject|0|||
131234074|NCT01829464|472484578|FG000|Overall Study|Study terminated by sponsor|25|||
131234075|NCT01829464|472484579|FG001|Overall Study|Study terminated by sponsor|28|||
131234076|NCT01829464|472484580|FG002|Overall Study|Study terminated by sponsor|25|||
131234077|NCT01829464|472484578|FG000|Overall Study|Lack of Efficacy|0|||
131234078|NCT01829464|472484579|FG001|Overall Study|Lack of Efficacy|1|||
130727260|NCT02883049|470625428|FG004|Post Induction|Ineligible|0|||
130727261|NCT02883049|470625429|FG005|Post Induction|Ineligible|0|||
130727262|NCT02883049|470625430|FG006|Post Induction|Ineligible|1|||
131234079|NCT01829464|472484580|FG002|Overall Study|Lack of Efficacy|0|||
131234080|NCT04700449|472484583|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
131234081|NCT04700449|472484584|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
131234082|NCT04700449|472484585|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
131234083|NCT04700449|472484586|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
131234084|NCT04700449|472484583|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
131234085|NCT04700449|472484584|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
131234086|NCT04700449|472484585|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
131088046|NCT01646177|471955151|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
131088047|NCT01646177|471955152|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131088048|NCT01646177|471955153|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131088049|NCT01646177|471955154|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131088050|NCT01646177|471955155|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131088051|NCT01646177|471955156|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131088052|NCT01646177|471955157|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131088053|NCT01646177|471955158|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131088054|NCT01646177|471955159|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
131088055|NCT01646177|471955148|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
131088056|NCT01646177|471955149|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
131088057|NCT01646177|471955150|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
131088058|NCT01646177|471955151|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
131088059|NCT01646177|471955152|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131088060|NCT01646177|471955153|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131088061|NCT01646177|471955154|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131088062|NCT01646177|471955155|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131088063|NCT01646177|471955156|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131088064|NCT01646177|471955157|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131088065|NCT01646177|471955158|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131088066|NCT01646177|471955159|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
131088067|NCT01646177|471955148|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
131088068|NCT01646177|471955149|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
131088069|NCT01646177|471955150|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
131234087|NCT04700449|472484586|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
131234088|NCT04700449|472484583|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
131234089|NCT04700449|472484584|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
131234090|NCT04700449|472484585|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
131234091|NCT04700449|472484586|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
131234092|NCT04700449|472484583|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
131234093|NCT04700449|472484584|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
131234094|NCT04700449|472484585|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
131234095|NCT04700449|472484586|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
131234096|NCT04700449|472484583|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
130727263|NCT02883049|470625431|FG007|Post Induction|Ineligible|0|||
131088070|NCT01646177|471955151|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
131088071|NCT01646177|471955152|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131088072|NCT01646177|471955153|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131088073|NCT01646177|471955154|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131088074|NCT01646177|471955155|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131088075|NCT01646177|471955156|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131088076|NCT01646177|471955157|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131088077|NCT01646177|471955158|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131088078|NCT01646177|471955159|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
131088079|NCT01646177|471955148|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131088080|NCT01646177|471955149|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131088081|NCT01646177|471955150|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
131088082|NCT01646177|471955151|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
131088083|NCT01646177|471955152|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131088084|NCT01646177|471955153|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131088085|NCT01646177|471955154|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131088086|NCT01646177|471955155|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131088087|NCT01646177|471955156|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131088088|NCT01646177|471955157|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131088089|NCT01646177|471955158|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131088090|NCT01646177|471955159|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
131088091|NCT01646177|471955148|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
131088092|NCT01646177|471955149|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
131088093|NCT01646177|471955150|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
131088094|NCT01646177|471955151|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131088095|NCT01646177|471955152|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131088096|NCT01646177|471955153|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131088097|NCT01646177|471955154|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131088098|NCT01646177|471955155|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131088099|NCT01646177|471955156|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131088100|NCT01646177|471955157|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131088101|NCT01646177|471955158|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131088102|NCT01646177|471955159|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
131088103|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131088104|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131088105|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131088106|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131088107|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
131088108|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
131088109|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
131088110|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
131088111|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131088112|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131088113|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131088114|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
131088115|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131088116|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131088117|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131088118|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131088119|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
131088120|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
131088121|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
131088122|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
131088123|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131088124|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131088125|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131088126|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
131088127|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131088128|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131088129|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131088130|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131088131|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
131088132|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
131088133|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
131088134|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
131088135|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131088136|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131088137|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131088138|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
131088139|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131088140|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131088141|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131234097|NCT04700449|472484584|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
131234098|NCT04700449|472484585|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
131234099|NCT04700449|472484586|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
131088142|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131088143|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
131088144|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
131088145|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
131088146|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
131088147|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131088148|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131088149|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131088150|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
131088151|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131088152|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131088153|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131088154|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131088155|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
131088156|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
131088157|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
131088158|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
131088159|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131088160|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131088161|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131088162|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
131088163|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131088164|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131088165|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131088166|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131088167|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
131088168|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
131088169|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131088170|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
131088171|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131088172|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131088173|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131088174|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
131088175|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131088176|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131088177|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131088178|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131088179|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
131088180|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
131088181|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
131088182|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
131088183|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131088184|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131088185|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131088186|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
131088187|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
131088188|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
131088189|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
131088190|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
131088191|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
131088192|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
131088193|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
131234100|NCT04700449|472484583|FG000|Stage 1: Double-Blind Period|Other|0|||
131088194|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
131088195|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
131088196|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
131088197|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
131088198|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
131088199|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131088200|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131088201|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131088202|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131088203|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
131088204|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
131088205|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
131088206|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
131088207|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131088208|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131088209|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131088210|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
131088211|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088212|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088213|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088214|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088215|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088216|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088217|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088218|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
131088219|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088220|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088221|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088222|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
131088223|NCT01646177|471955148|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131088224|NCT01646177|471955149|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131088225|NCT01646177|471955150|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131088226|NCT01646177|471955151|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131088227|NCT01646177|471955152|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131088228|NCT01646177|471955153|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
131088229|NCT01646177|471955154|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
131088230|NCT01646177|471955155|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
131088231|NCT01646177|471955156|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131088232|NCT01646177|471955157|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131088233|NCT01646177|471955158|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131088234|NCT01646177|471955159|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
131088235|NCT01646177|471955148|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131088236|NCT01646177|471955149|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131088237|NCT01646177|471955150|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131088238|NCT01646177|471955151|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131088239|NCT01646177|471955152|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131088240|NCT01646177|471955153|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131088241|NCT01646177|471955154|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131088242|NCT01646177|471955155|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
131088243|NCT01646177|471955156|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
131088244|NCT01646177|471955157|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
131088245|NCT01646177|471955158|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
131088246|NCT01646177|471955159|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
131088247|NCT01646177|471955148|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131088248|NCT01646177|471955149|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131088249|NCT01646177|471955150|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131088250|NCT01646177|471955151|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131088251|NCT01646177|471955152|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131088252|NCT01646177|471955153|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131088253|NCT01646177|471955154|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131088254|NCT01646177|471955155|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
131088255|NCT01646177|471955156|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
130780271|NCT02600923|470821475|FG000|Overall Study|Global deterioration of health status|2|||
131088256|NCT01646177|471955157|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
131088257|NCT01646177|471955158|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
131088258|NCT01646177|471955159|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
131088259|NCT01646177|471955148|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131088260|NCT01646177|471955149|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131088261|NCT01646177|471955150|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131088262|NCT01646177|471955151|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131088263|NCT01646177|471955152|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131088264|NCT01646177|471955153|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131088265|NCT01646177|471955154|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131088266|NCT01646177|471955155|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
131088267|NCT01646177|471955156|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
131088268|NCT01646177|471955157|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
131088269|NCT01646177|471955158|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
131088270|NCT01646177|471955159|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
131088271|NCT01646177|471955148|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131088272|NCT01646177|471955149|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131088273|NCT01646177|471955150|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131088274|NCT01646177|471955151|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131088275|NCT01646177|471955152|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131088276|NCT01646177|471955153|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131088277|NCT01646177|471955154|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131088278|NCT01646177|471955155|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
131088279|NCT01646177|471955156|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
131088280|NCT01646177|471955157|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
131088281|NCT01646177|471955158|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
131088282|NCT01646177|471955159|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
131088283|NCT01646177|471955148|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131088284|NCT01646177|471955149|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131088285|NCT01646177|471955150|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131088286|NCT01646177|471955151|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131088287|NCT01646177|471955152|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131088288|NCT01646177|471955153|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131088289|NCT01646177|471955154|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131088290|NCT01646177|471955155|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
131088291|NCT01646177|471955156|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
131088292|NCT01646177|471955157|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
131088293|NCT01646177|471955158|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
131088294|NCT01646177|471955159|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
131088295|NCT01646177|471955148|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131088296|NCT01646177|471955149|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131088297|NCT01646177|471955150|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131088298|NCT01646177|471955151|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131088299|NCT01646177|471955152|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131088300|NCT01646177|471955153|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131088301|NCT01646177|471955154|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131088302|NCT01646177|471955155|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
131088303|NCT01646177|471955156|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
131088304|NCT01646177|471955157|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
131088305|NCT01646177|471955158|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
131088306|NCT01646177|471955159|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
131088307|NCT01646177|471955148|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131088308|NCT01646177|471955149|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131088309|NCT01646177|471955150|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131088310|NCT01646177|471955151|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131088311|NCT01646177|471955152|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131088312|NCT01646177|471955153|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131088313|NCT01646177|471955154|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131088314|NCT01646177|471955155|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131088315|NCT01646177|471955156|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
131088316|NCT01646177|471955157|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
131088317|NCT01646177|471955158|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
131088318|NCT01646177|471955159|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
131088319|NCT01646177|471955148|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131088320|NCT01646177|471955149|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131234101|NCT04700449|472484584|FG001|Stage 1: Double-Blind Period|Other|0|||
131234102|NCT04700449|472484585|FG002|Stage 1: Double-Blind Period|Other|1|||
131234103|NCT04700449|472484586|FG003|Stage 1: Double-Blind Period|Other|0|||
131234104|NCT04700449|472484583|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
131234105|NCT04700449|472484584|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
131234106|NCT04700449|472484585|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
131234107|NCT04700449|472484586|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
131234108|NCT04700449|472484583|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
131234109|NCT04700449|472484584|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
131088321|NCT01646177|471955150|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131088322|NCT01646177|471955151|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131088323|NCT01646177|471955152|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131088324|NCT01646177|471955153|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131088325|NCT01646177|471955154|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131088326|NCT01646177|471955155|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131088327|NCT01646177|471955156|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
131088328|NCT01646177|471955157|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
131088329|NCT01646177|471955158|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
131088330|NCT01646177|471955159|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
131088331|NCT01646177|471955148|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131088332|NCT01646177|471955149|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131088333|NCT01646177|471955150|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131088334|NCT01646177|471955151|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131088335|NCT01646177|471955152|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131088336|NCT01646177|471955153|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131088337|NCT01646177|471955154|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131088338|NCT01646177|471955155|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131088339|NCT01646177|471955156|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
131088340|NCT01646177|471955157|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
131088341|NCT01646177|471955158|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
131088342|NCT01646177|471955159|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
131088343|NCT01646177|471955148|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131088344|NCT01646177|471955149|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131088345|NCT01646177|471955150|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131088346|NCT01646177|471955151|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131088347|NCT01646177|471955152|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131088348|NCT01646177|471955153|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131088349|NCT01646177|471955154|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131088350|NCT01646177|471955155|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131088351|NCT01646177|471955156|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131088352|NCT01646177|471955157|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
131088353|NCT01646177|471955158|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
131088354|NCT01646177|471955159|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
131088355|NCT02920970|471955160|FG000|First Intervention|Protocol Violation|0|||
131142568|NCT03523351|472148537|FG001|Overall Study|Withdrawal by Subject|0|||
131142569|NCT03523351|472148536|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
131142570|NCT03523351|472148537|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
131142571|NCT02327260|472148544|FG000|Overall Study|Lost to Follow-up|2|||
131142572|NCT02327260|472148545|FG001|Overall Study|Lost to Follow-up|3|||
131142573|NCT02327260|472148546|FG002|Overall Study|Lost to Follow-up|2|||
131142574|NCT02327260|472148544|FG000|Overall Study|invalid phone number|1|||
131142575|NCT02327260|472148545|FG001|Overall Study|invalid phone number|1|||
131142576|NCT02327260|472148546|FG002|Overall Study|invalid phone number|0|||
131142577|NCT02327260|472148544|FG000|Overall Study|non-adherence to protocol|2|||
131142578|NCT02327260|472148545|FG001|Overall Study|non-adherence to protocol|0|||
131142579|NCT02327260|472148546|FG002|Overall Study|non-adherence to protocol|0|||
131142580|NCT02327260|472148544|FG000|Overall Study|cognitive concerns|1|||
131142581|NCT02327260|472148545|FG001|Overall Study|cognitive concerns|0|||
131142582|NCT02327260|472148546|FG002|Overall Study|cognitive concerns|0|||
131142583|NCT01400932|472148547|FG000|Overall Study|Adverse Event|10|||
131142584|NCT01400932|472148548|FG001|Overall Study|Adverse Event|5|||
131142585|NCT01400932|472148547|FG000|Overall Study|Lack of Efficacy|0|||
131142586|NCT01400932|472148548|FG001|Overall Study|Lack of Efficacy|3|||
131142587|NCT01400932|472148547|FG000|Overall Study|Withdrawal by Subject|2|||
131142588|NCT01400932|472148548|FG001|Overall Study|Withdrawal by Subject|6|||
131142589|NCT01400932|472148547|FG000|Overall Study|Lost to Follow-up|1|||
131142590|NCT01400932|472148548|FG001|Overall Study|Lost to Follow-up|0|||
131142591|NCT01400932|472148547|FG000|Overall Study|Protocol Deviation|0|||
131142592|NCT01400932|472148548|FG001|Overall Study|Protocol Deviation|1|||
131234110|NCT04700449|472484585|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
131088356|NCT02920970|471955161|FG001|First Intervention|Protocol Violation|1|||
131088357|NCT02920970|471955160|FG000|First Intervention|Adverse Event|0|||
130780272|NCT02600923|470821475|FG000|Overall Study|Insufficient clinical response|6|||
131088358|NCT02920970|471955161|FG001|First Intervention|Adverse Event|1|||
131088359|NCT02920970|471955160|FG000|Second Intervention|Poor Lens Fit|1|||
131088360|NCT02920970|471955161|FG001|Second Intervention|Poor Lens Fit|0|||
131088361|NCT01711853|471955164|FG000|Overall Study|Not treated|3|||
131088362|NCT01427725|471955167|FG000|Overall Study|Lost to Follow-up|17|||
131088363|NCT01427725|471955167|FG000|Overall Study|Protocol Violation|1|||
131088364|NCT01427725|471955167|FG000|Overall Study|Drug not administered|1|||
131088365|NCT01427725|471955167|FG000|Overall Study|Failure to visit|7|||
131088366|NCT01427725|471955167|FG000|Overall Study|Adverse Event|46|||
131088367|NCT01427725|471955167|FG000|Overall Study|Failure to visit after administration|40|||
131088368|NCT01427725|471955167|FG000|Overall Study|Patient's rejection|27|||
131088369|NCT01427725|471955167|FG000|Overall Study|Transfer to a different hospital|17|||
131088370|NCT01427725|471955167|FG000|Overall Study|Lack of Efficacy|8|||
131088371|NCT01427725|471955167|FG000|Overall Study|Death|7|||
131088372|NCT01427725|471955167|FG000|Overall Study|Symptom improvement|6|||
131088373|NCT01427725|471955167|FG000|Overall Study|AE and Patient's rejection|5|||
131088374|NCT01427725|471955167|FG000|Overall Study|Physician Decision|5|||
131088375|NCT01427725|471955167|FG000|Overall Study|Exacerbation of underlying disease|5|||
131088376|NCT01427725|471955167|FG000|Overall Study|Oral feeding difficulty|5|||
131088377|NCT01427725|471955167|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
131088378|NCT01427725|471955167|FG000|Overall Study|Forgetting prescription|1|||
131088379|NCT01427725|471955167|FG000|Overall Study|Other|2|||
131088380|NCT01374568|471955169|FG000|Overall Study|Lab unable to analyze BTM|0|||
131088381|NCT01374568|471955170|FG001|Overall Study|Lab unable to analyze BTM|2|||
131088382|NCT01912404|471955171|FG000|Overall Study|Due to personal reasons|1|||
131088383|NCT01912404|471955172|FG001|Overall Study|Due to personal reasons|0|||
131088384|NCT02269423|471955177|FG000|Overall Study|Discontinued due to change in residence|0|||
131088385|NCT02269423|471955178|FG001|Overall Study|Discontinued due to change in residence|1|||
131088386|NCT02269423|471955179|FG002|Overall Study|Discontinued due to change in residence|0|||
131088387|NCT02269423|471955180|FG003|Overall Study|Discontinued due to change in residence|1|||
131088388|NCT00755105|471955183|FG000|Overall Study|Withdrawal by Subject|9|||
131088389|NCT00755105|471955184|FG001|Overall Study|Withdrawal by Subject|11|||
131088390|NCT00755105|471955185|FG002|Overall Study|Withdrawal by Subject|4|||
131088391|NCT01281839|471955187|FG000|Overall Study|Lost to Follow-up|6|||
131088392|NCT01281839|471955188|FG001|Overall Study|Lost to Follow-up|3|||
131088393|NCT01281839|471955187|FG000|Overall Study|Withdrawal by Subject|4|||
131088394|NCT01281839|471955188|FG001|Overall Study|Withdrawal by Subject|10|||
131088395|NCT01281839|471955187|FG000|Overall Study|Reason not specified|0|||
131088396|NCT01281839|471955188|FG001|Overall Study|Reason not specified|1|||
131088397|NCT01277887|471955189|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
131088398|NCT01277887|471955190|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
131088399|NCT01277887|471955189|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
131088400|NCT01277887|471955190|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
131088401|NCT01277887|471955189|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
131088402|NCT01277887|471955190|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
131088403|NCT00415051|471955191|FG000|Overall Study|Protocol Violation|1|||
131088404|NCT01518153|471955196|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
131088405|NCT01518153|471955197|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
131088406|NCT01518153|471955198|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
131088407|NCT01518153|471955196|FG000|Stem Cell Transplant|Death|2|||
131088408|NCT01518153|471955197|FG001|Stem Cell Transplant|Death|0|||
131088409|NCT01518153|471955198|FG002|Stem Cell Transplant|Death|0|||
131088410|NCT01518153|471955196|FG000|Stem Cell Transplant|Secondary graft failure|1|||
131088411|NCT01518153|471955197|FG001|Stem Cell Transplant|Secondary graft failure|0|||
131088412|NCT01518153|471955198|FG002|Stem Cell Transplant|Secondary graft failure|0|||
131142593|NCT01400932|472148547|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131142594|NCT01400932|472148548|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
131142595|NCT01276821|472148549|FG000|Overall Study|Protocol Violation|0|||
131142596|NCT01276821|472148550|FG001|Overall Study|Protocol Violation|1|||
131142597|NCT00270894|472148551|FG000|Overall Study|Adverse Event|1|||
131142598|NCT00270894|472148551|FG000|Overall Study|Withdrawal by Subject|1|||
131142599|NCT01748071|472148552|FG000|Overall Study|Adverse Event|2|||
131088413|NCT01518153|471955196|FG000|Stem Cell Transplant|Adverse Event|1|||
131088414|NCT01518153|471955197|FG001|Stem Cell Transplant|Adverse Event|0|||
131142600|NCT01748071|472148553|FG001|Overall Study|Adverse Event|2|||
131142601|NCT01748071|472148554|FG002|Overall Study|Adverse Event|0|||
131142602|NCT00605267|472148555|FG000|Overall Study|Adverse Event|0|||
131142603|NCT00605267|472148556|FG001|Overall Study|Adverse Event|1|||
131142604|NCT00605267|472148555|FG000|Overall Study|Lack of Efficacy|1|||
131142605|NCT00605267|472148556|FG001|Overall Study|Lack of Efficacy|5|||
131142606|NCT00605267|472148555|FG000|Overall Study|Withdrawal by Subject|2|||
131142607|NCT00605267|472148556|FG001|Overall Study|Withdrawal by Subject|3|||
131234111|NCT04700449|472484586|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
131234112|NCT04700449|472484583|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
131234113|NCT04700449|472484584|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
131234114|NCT04700449|472484585|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
131234115|NCT04700449|472484586|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
131234116|NCT04700449|472484583|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
131234117|NCT04700449|472484584|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
131234118|NCT04700449|472484585|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
131234119|NCT04700449|472484586|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
131234120|NCT04700449|472484583|FG000|Stage 2 Sub-study 1|Other|1|||
131088415|NCT01518153|471955198|FG002|Stem Cell Transplant|Adverse Event|0|||
131088416|NCT01518153|471955196|FG000|Donor Lymphocyte Infusion|Death|0|||
131088417|NCT01518153|471955197|FG001|Donor Lymphocyte Infusion|Death|2|||
131088418|NCT01518153|471955198|FG002|Donor Lymphocyte Infusion|Death|1|||
131088419|NCT01754753|471955199|FG000|Overall Study|Study close|43|||
131088420|NCT01754753|471955200|FG001|Overall Study|Study close|44|||
131088421|NCT01754753|471955199|FG000|Overall Study|Lost to Follow-up|9|||
131088422|NCT01754753|471955200|FG001|Overall Study|Lost to Follow-up|5|||
131088423|NCT00856245|471955202|FG000|Overall Study|Was not transplanted|5|||
131088424|NCT01250509|471955203|FG000|Overall Study|Lost to Follow-up|5|||
131088425|NCT01250509|471955204|FG001|Overall Study|Lost to Follow-up|2|||
131088426|NCT01371708|471955210|FG000|Overall Study|Insufficient clinical response|3|||
131088427|NCT01371708|471955211|FG001|Overall Study|Insufficient clinical response|2|||
131088428|NCT01371708|471955212|FG002|Overall Study|Insufficient clinical response|0|||
131088429|NCT01371708|471955210|FG000|Overall Study|Lost to Follow-up|5|||
131088430|NCT01371708|471955211|FG001|Overall Study|Lost to Follow-up|9|||
131088431|NCT01371708|471955212|FG002|Overall Study|Lost to Follow-up|7|||
131088432|NCT01371708|471955210|FG000|Overall Study|Protocol Violation|2|||
131088433|NCT01371708|471955211|FG001|Overall Study|Protocol Violation|1|||
131088434|NCT01371708|471955212|FG002|Overall Study|Protocol Violation|2|||
131088435|NCT01371708|471955210|FG000|Overall Study|No longer willing to participate|7|||
131088436|NCT01371708|471955211|FG001|Overall Study|No longer willing to participate|7|||
131088437|NCT01371708|471955212|FG002|Overall Study|No longer willing to participate|13|||
131088438|NCT01371708|471955210|FG000|Overall Study|Medication error/not related to AE|0|||
131088439|NCT01371708|471955211|FG001|Overall Study|Medication error/not related to AE|1|||
131088440|NCT01371708|471955212|FG002|Overall Study|Medication error/not related to AE|0|||
131088441|NCT01371708|471955210|FG000|Overall Study|Other|3|||
131088442|NCT01371708|471955211|FG001|Overall Study|Other|2|||
131088443|NCT01371708|471955212|FG002|Overall Study|Other|4|||
131088444|NCT01371708|471955210|FG000|Overall Study|Adverse Event|5|||
131088445|NCT01371708|471955211|FG001|Overall Study|Adverse Event|8|||
131088446|NCT01371708|471955212|FG002|Overall Study|Adverse Event|12|||
131088447|NCT01371708|471955210|FG000|Overall Study|Started but did not receive treatment|1|||
131088448|NCT01371708|471955211|FG001|Overall Study|Started but did not receive treatment|0|||
131088449|NCT01371708|471955212|FG002|Overall Study|Started but did not receive treatment|1|||
131088450|NCT02819024|471955213|FG000|Overall Study|Withdrawal by Subject|1|||
131088451|NCT00792948|471955214|FG000|Overall Study|Adverse Event|6|||
131088452|NCT00792948|471955214|FG000|Overall Study|Death|4|||
131088453|NCT00792948|471955214|FG000|Overall Study|Withdrawal by Subject|3|||
131088454|NCT00792948|471955214|FG000|Overall Study|Ineligible|2|||
131088455|NCT00792948|471955214|FG000|Overall Study|Insurance denial - not treated|1|||
131088456|NCT00792948|471955214|FG000|Overall Study|Physician Decision|11|||
131088457|NCT00792948|471955214|FG000|Overall Study|Protocol Violation|1|||
131088458|NCT03832595|471955219|FG000|Overall Study|Death|142|||
131088459|NCT03832595|471955220|FG001|Overall Study|Death|130|||
131088460|NCT03832595|471955219|FG000|Overall Study|Medical management without dialysis|37|||
131088461|NCT03832595|471955220|FG001|Overall Study|Medical management without dialysis|1|||
131234121|NCT04700449|472484584|FG001|Stage 2 Sub-study 1|Other|2|||
131234122|NCT04700449|472484585|FG002|Stage 2 Sub-study 1|Other|0|||
131234123|NCT04700449|472484586|FG003|Stage 2 Sub-study 1|Other|0|||
131234124|NCT04700449|472484583|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
131234125|NCT04700449|472484584|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
131234126|NCT04700449|472484585|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
131088462|NCT02397447|471955221|FG000|Overall Study|Lost to Follow-up|2|||
131088463|NCT02397447|471955222|FG001|Overall Study|Lost to Follow-up|2|||
131088466|NCT03939689|471960349|FG000|Overall Study|Radiographic progression|14|||
131088467|NCT03939689|471960350|FG001|Overall Study|Radiographic progression|17|||
131088468|NCT03939689|471960349|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
131088469|NCT03939689|471960350|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
131088470|NCT03939689|471960349|FG000|Overall Study|Adverse Event|1|||
131234127|NCT04700449|472484586|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
131088471|NCT03939689|471960350|FG001|Overall Study|Adverse Event|8|||
131234128|NCT04700449|472484583|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
131234129|NCT04700449|472484584|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
131234130|NCT04700449|472484585|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
131088472|NCT03939689|471960349|FG000|Overall Study|Unequivocal clinical progression|2|||
131088473|NCT03939689|471960350|FG001|Overall Study|Unequivocal clinical progression|5|||
131088474|NCT03939689|471960349|FG000|Overall Study|Other|1|||
131088475|NCT03939689|471960350|FG001|Overall Study|Other|4|||
131088476|NCT03939689|471960349|FG000|Overall Study|Death|0|||
131088477|NCT03939689|471960350|FG001|Overall Study|Death|3|||
131088478|NCT03939689|471960349|FG000|Overall Study|Participant decision|0|||
131088479|NCT03939689|471960350|FG001|Overall Study|Participant decision|3|||
131088480|NCT03939689|471960349|FG000|Overall Study|Withdrawal of consent|2|||
131088481|NCT03939689|471960350|FG001|Overall Study|Withdrawal of consent|1|||
131088482|NCT03939689|471960349|FG000|Overall Study|Investigator decision|1|||
131088483|NCT03939689|471960350|FG001|Overall Study|Investigator decision|0|||
131088534|NCT02964013|471960367|FG000|Overall Study|Death|58|||
131088535|NCT02964013|471960368|FG001|Overall Study|Death|239|||
131088536|NCT02964013|471960369|FG002|Overall Study|Death|38|||
131088537|NCT02964013|471960370|FG003|Overall Study|Death|10|||
131088538|NCT02964013|471960371|FG004|Overall Study|Death|33|||
131088539|NCT02964013|471960367|FG000|Overall Study|Lost to Follow-up|1|||
131088540|NCT02964013|471960368|FG001|Overall Study|Lost to Follow-up|4|||
131088541|NCT02964013|471960369|FG002|Overall Study|Lost to Follow-up|2|||
131088542|NCT02964013|471960370|FG003|Overall Study|Lost to Follow-up|0|||
131088543|NCT02964013|471960371|FG004|Overall Study|Lost to Follow-up|0|||
131088544|NCT02964013|471960367|FG000|Overall Study|Physician Decision|0|||
131088545|NCT02964013|471960368|FG001|Overall Study|Physician Decision|1|||
131088546|NCT02964013|471960369|FG002|Overall Study|Physician Decision|0|||
131088547|NCT02964013|471960370|FG003|Overall Study|Physician Decision|0|||
131088548|NCT02964013|471960371|FG004|Overall Study|Physician Decision|0|||
131088549|NCT02964013|471960367|FG000|Overall Study|Sponsor Decision|3|||
131088550|NCT02964013|471960368|FG001|Overall Study|Sponsor Decision|22|||
131088551|NCT02964013|471960369|FG002|Overall Study|Sponsor Decision|11|||
131088552|NCT02964013|471960370|FG003|Overall Study|Sponsor Decision|0|||
131088553|NCT02964013|471960371|FG004|Overall Study|Sponsor Decision|7|||
131088554|NCT02964013|471960367|FG000|Overall Study|Withdrawal by Subject|6|||
131088555|NCT02964013|471960368|FG001|Overall Study|Withdrawal by Subject|27|||
131088556|NCT02964013|471960369|FG002|Overall Study|Withdrawal by Subject|9|||
131088557|NCT02964013|471960370|FG003|Overall Study|Withdrawal by Subject|0|||
131088558|NCT02964013|471960371|FG004|Overall Study|Withdrawal by Subject|0|||
131088559|NCT02964013|471960367|FG000|Overall Study|Not Treated|0|||
131088560|NCT02964013|471960368|FG001|Overall Study|Not Treated|2|||
131088561|NCT02964013|471960369|FG002|Overall Study|Not Treated|0|||
131088562|NCT02964013|471960370|FG003|Overall Study|Not Treated|1|||
131088563|NCT02964013|471960371|FG004|Overall Study|Not Treated|0|||
131088648|NCT04079868|471960389|FG000|Overall Study|Lost to Follow-up|100|||
131088649|NCT04079868|471960390|FG001|Overall Study|Lost to Follow-up|200|||
131088650|NCT04079868|471960389|FG000|Overall Study|Physician Decision|100|||
131088651|NCT04079868|471960390|FG001|Overall Study|Physician Decision|0|||
131088655|NCT05620108|471960398|FG000|Overall Study|Physician Decision|1|||
131088656|NCT05620108|471960399|FG001|Overall Study|Physician Decision|2|||
131142608|NCT02939131|472148557|FG000|Overall Study|Unable to get to clinic|6|||
131142609|NCT02939131|472148558|FG001|Overall Study|Unable to get to clinic|4|||
131142610|NCT02939131|472148557|FG000|Overall Study|Lost to Follow-up|2|||
131142611|NCT02939131|472148558|FG001|Overall Study|Lost to Follow-up|4|||
131142612|NCT02939131|472148557|FG000|Overall Study|severe debilitation|1|||
131142613|NCT02939131|472148558|FG001|Overall Study|severe debilitation|0|||
131142614|NCT02939131|472148557|FG000|Overall Study|Other|0|||
131142615|NCT02939131|472148558|FG001|Overall Study|Other|1|||
131142616|NCT02939131|472148557|FG000|Overall Study|not willing to adhere to protocol|2|||
131142617|NCT02939131|472148558|FG001|Overall Study|not willing to adhere to protocol|0|||
131142618|NCT00793793|472148559|FG000|Overall Study|Adverse Event|0|||
131142619|NCT00793793|472148560|FG001|Overall Study|Adverse Event|0|||
131142620|NCT00793793|472148561|FG002|Overall Study|Adverse Event|1|||
131142621|NCT00793793|472148562|FG003|Overall Study|Adverse Event|1|||
131142622|NCT00793793|472148563|FG004|Overall Study|Adverse Event|0|||
131142623|NCT00793793|472148564|FG005|Overall Study|Adverse Event|1|||
131142624|NCT00793793|472148565|FG006|Overall Study|Adverse Event|2|||
131142625|NCT00793793|472148566|FG007|Overall Study|Adverse Event|0|||
131142626|NCT00793793|472148567|FG008|Overall Study|Adverse Event|0|||
131142627|NCT00793793|472148568|FG009|Overall Study|Adverse Event|0|||
131142628|NCT00793793|472148569|FG010|Overall Study|Adverse Event|0|||
131142629|NCT00793793|472148570|FG011|Overall Study|Adverse Event|2|||
131142630|NCT00793793|472148559|FG000|Overall Study|Protocol Violation|0|||
131142631|NCT00793793|472148560|FG001|Overall Study|Protocol Violation|0|||
131142632|NCT00793793|472148561|FG002|Overall Study|Protocol Violation|0|||
131142633|NCT00793793|472148562|FG003|Overall Study|Protocol Violation|1|||
131142634|NCT00793793|472148563|FG004|Overall Study|Protocol Violation|0|||
131142635|NCT00793793|472148564|FG005|Overall Study|Protocol Violation|0|||
131142636|NCT00793793|472148565|FG006|Overall Study|Protocol Violation|0|||
131142637|NCT00793793|472148566|FG007|Overall Study|Protocol Violation|0|||
131142638|NCT00793793|472148567|FG008|Overall Study|Protocol Violation|0|||
131142639|NCT00793793|472148568|FG009|Overall Study|Protocol Violation|0|||
131142640|NCT00793793|472148569|FG010|Overall Study|Protocol Violation|0|||
131142641|NCT00793793|472148570|FG011|Overall Study|Protocol Violation|0|||
131088760|NCT04201288|471960436|FG000|Overall Study|Death|1|||
131088761|NCT04201288|471960437|FG001|Overall Study|Death|1|||
131088762|NCT04201288|471960436|FG000|Overall Study|Lost to Follow-up|5|||
131088763|NCT04201288|471960437|FG001|Overall Study|Lost to Follow-up|3|||
131088764|NCT04201288|471960436|FG000|Overall Study|Withdrawal by Subject|1|||
131088765|NCT04201288|471960437|FG001|Overall Study|Withdrawal by Subject|0|||
131088766|NCT02038842|471960438|FG000|Overall Study|Withdrawal by Subject|2|||
131088767|NCT02038842|471960439|FG001|Overall Study|Withdrawal by Subject|2|||
131088768|NCT02038842|471960440|FG002|Overall Study|Withdrawal by Subject|0|||
131088769|NCT02038842|471960441|FG003|Overall Study|Withdrawal by Subject|0|||
131088770|NCT02038842|471960438|FG000|Overall Study|Participant decision|0|||
131088771|NCT02038842|471960439|FG001|Overall Study|Participant decision|0|||
131088772|NCT02038842|471960440|FG002|Overall Study|Participant decision|2|||
131088773|NCT02038842|471960441|FG003|Overall Study|Participant decision|1|||
131088774|NCT02038842|471960438|FG000|Overall Study|Adverse Event|0|||
131088775|NCT02038842|471960439|FG001|Overall Study|Adverse Event|0|||
131088776|NCT02038842|471960440|FG002|Overall Study|Adverse Event|3|||
131088777|NCT02038842|471960441|FG003|Overall Study|Adverse Event|1|||
131088778|NCT02038842|471960438|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
131088779|NCT02038842|471960439|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
131088780|NCT02038842|471960440|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
131088781|NCT02038842|471960441|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
131088782|NCT03412773|471960442|FG000|Overall Study|Lost to Follow-up|0|||
131088783|NCT03412773|471960443|FG001|Overall Study|Lost to Follow-up|7|||
131088784|NCT03412773|471960444|FG002|Overall Study|Lost to Follow-up|6|||
131088785|NCT03412773|471960442|FG000|Overall Study|Withdrawal by Subject|0|||
131088786|NCT03412773|471960443|FG001|Overall Study|Withdrawal by Subject|15|||
131088787|NCT03412773|471960444|FG002|Overall Study|Withdrawal by Subject|19|||
131088788|NCT03412773|471960442|FG000|Overall Study|Study Closed By Sponsor|3|||
131088789|NCT03412773|471960443|FG001|Overall Study|Study Closed By Sponsor|46|||
131088790|NCT03412773|471960444|FG002|Overall Study|Study Closed By Sponsor|33|||
131088791|NCT03412773|471960442|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
131088792|NCT03412773|471960443|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
131088793|NCT03412773|471960444|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
131088794|NCT03412773|471960442|FG000|Overall Study|Death|7|||
131088795|NCT03412773|471960443|FG001|Overall Study|Death|259|||
131088796|NCT03412773|471960444|FG002|Overall Study|Death|273|||
131088797|NCT03412773|471960442|FG000|Overall Study|Physician Decision|0|||
131088798|NCT03412773|471960443|FG001|Overall Study|Physician Decision|0|||
131088799|NCT03412773|471960444|FG002|Overall Study|Physician Decision|1|||
130727264|NCT02883049|470625432|FG008|Post Induction|Ineligible|0|||
130727265|NCT02883049|470625433|FG009|Post Induction|Ineligible|0|||
131142642|NCT00793793|472148559|FG000|Overall Study|Lost to Follow-up|0|||
131142643|NCT00793793|472148560|FG001|Overall Study|Lost to Follow-up|0|||
131142644|NCT00793793|472148561|FG002|Overall Study|Lost to Follow-up|1|||
131142645|NCT00793793|472148562|FG003|Overall Study|Lost to Follow-up|0|||
131142646|NCT00793793|472148563|FG004|Overall Study|Lost to Follow-up|0|||
131142647|NCT00793793|472148564|FG005|Overall Study|Lost to Follow-up|0|||
131142648|NCT00793793|472148565|FG006|Overall Study|Lost to Follow-up|0|||
131142649|NCT00793793|472148566|FG007|Overall Study|Lost to Follow-up|0|||
131142650|NCT00793793|472148567|FG008|Overall Study|Lost to Follow-up|1|||
131142651|NCT00793793|472148568|FG009|Overall Study|Lost to Follow-up|3|||
131234131|NCT04700449|472484586|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
131234132|NCT04700449|472484583|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
131234133|NCT04700449|472484584|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
131234134|NCT04700449|472484585|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
131234135|NCT04700449|472484586|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
131234136|NCT04700449|472484583|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
131234137|NCT04700449|472484584|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
131234138|NCT04700449|472484585|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
131234139|NCT04700449|472484586|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
131234140|NCT04700449|472484583|FG000|Stage 2 Sub-study 2|Other|0|||
131234141|NCT04700449|472484584|FG001|Stage 2 Sub-study 2|Other|0|||
131234142|NCT04700449|472484585|FG002|Stage 2 Sub-study 2|Other|0|||
131234143|NCT04700449|472484586|FG003|Stage 2 Sub-study 2|Other|5|||
131234144|NCT02228382|472484587|FG000|Overall Study|Death|5|||
131234145|NCT02228382|472484588|FG001|Overall Study|Death|7|||
131234146|NCT02228382|472484589|FG002|Overall Study|Death|5|||
131234147|NCT02228382|472484590|FG003|Overall Study|Death|0|||
131234148|NCT02228382|472484591|FG004|Overall Study|Death|2|||
131234149|NCT02228382|472484587|FG000|Overall Study|Participant refused further follow-up|0|||
131234150|NCT02228382|472484588|FG001|Overall Study|Participant refused further follow-up|0|||
131234151|NCT02228382|472484589|FG002|Overall Study|Participant refused further follow-up|1|||
131234152|NCT02228382|472484590|FG003|Overall Study|Participant refused further follow-up|0|||
131234153|NCT02228382|472484591|FG004|Overall Study|Participant refused further follow-up|0|||
131234154|NCT02228382|472484587|FG000|Overall Study|Study terminated by sponsor|3|||
131234155|NCT02228382|472484588|FG001|Overall Study|Study terminated by sponsor|5|||
131234156|NCT02228382|472484589|FG002|Overall Study|Study terminated by sponsor|7|||
131234157|NCT02228382|472484590|FG003|Overall Study|Study terminated by sponsor|0|||
131234158|NCT02228382|472484591|FG004|Overall Study|Study terminated by sponsor|0|||
131234159|NCT02228382|472484587|FG000|Overall Study|Lost to Follow-up|0|||
131234160|NCT02228382|472484588|FG001|Overall Study|Lost to Follow-up|0|||
131234161|NCT02228382|472484589|FG002|Overall Study|Lost to Follow-up|3|||
131234162|NCT02228382|472484590|FG003|Overall Study|Lost to Follow-up|1|||
131234163|NCT02228382|472484591|FG004|Overall Study|Lost to Follow-up|0|||
131234164|NCT02228382|472484587|FG000|Overall Study|Withdrawal by Subject|0|||
131234165|NCT02228382|472484588|FG001|Overall Study|Withdrawal by Subject|3|||
131234166|NCT02228382|472484589|FG002|Overall Study|Withdrawal by Subject|2|||
131234167|NCT02228382|472484590|FG003|Overall Study|Withdrawal by Subject|1|||
131234168|NCT02228382|472484591|FG004|Overall Study|Withdrawal by Subject|0|||
131234169|NCT02228382|472484587|FG000|Overall Study|Other|2|||
131234170|NCT02228382|472484588|FG001|Overall Study|Other|3|||
131234171|NCT02228382|472484589|FG002|Overall Study|Other|3|||
131234172|NCT02228382|472484590|FG003|Overall Study|Other|0|||
131234173|NCT02228382|472484591|FG004|Overall Study|Other|0|||
131142652|NCT00793793|472148569|FG010|Overall Study|Lost to Follow-up|1|||
131142653|NCT00793793|472148570|FG011|Overall Study|Lost to Follow-up|0|||
131142654|NCT00793793|472148559|FG000|Overall Study|Withdrawal by Subject|0|||
131142655|NCT00793793|472148560|FG001|Overall Study|Withdrawal by Subject|0|||
131142656|NCT00793793|472148561|FG002|Overall Study|Withdrawal by Subject|0|||
131142657|NCT00793793|472148562|FG003|Overall Study|Withdrawal by Subject|0|||
131142658|NCT00793793|472148563|FG004|Overall Study|Withdrawal by Subject|1|||
131142659|NCT00793793|472148564|FG005|Overall Study|Withdrawal by Subject|0|||
131142660|NCT00793793|472148565|FG006|Overall Study|Withdrawal by Subject|0|||
131142661|NCT00793793|472148566|FG007|Overall Study|Withdrawal by Subject|0|||
131142662|NCT00793793|472148567|FG008|Overall Study|Withdrawal by Subject|1|||
131142663|NCT00793793|472148568|FG009|Overall Study|Withdrawal by Subject|0|||
131142664|NCT00793793|472148569|FG010|Overall Study|Withdrawal by Subject|0|||
131142665|NCT00793793|472148570|FG011|Overall Study|Withdrawal by Subject|0|||
131142666|NCT00793793|472148559|FG000|Overall Study|reason not specified|0|||
131142667|NCT00793793|472148560|FG001|Overall Study|reason not specified|1|||
131142668|NCT00793793|472148561|FG002|Overall Study|reason not specified|0|||
131142669|NCT00793793|472148562|FG003|Overall Study|reason not specified|1|||
131142670|NCT00793793|472148563|FG004|Overall Study|reason not specified|1|||
131142671|NCT00793793|472148564|FG005|Overall Study|reason not specified|1|||
131142672|NCT00793793|472148565|FG006|Overall Study|reason not specified|2|||
131142673|NCT00793793|472148566|FG007|Overall Study|reason not specified|0|||
131142674|NCT00793793|472148567|FG008|Overall Study|reason not specified|7|||
131142675|NCT00793793|472148568|FG009|Overall Study|reason not specified|6|||
131142676|NCT00793793|472148569|FG010|Overall Study|reason not specified|2|||
131142677|NCT00793793|472148570|FG011|Overall Study|reason not specified|4|||
131142678|NCT00950170|472148571|FG000|Overall Study|Parent/Legal Guardian Request|1|||
131142679|NCT00950170|472148571|FG000|Overall Study|Adverse Event|2|||
131142680|NCT00950170|472148571|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
131142681|NCT04173741|472148572|FG000|Overall Study|IVC measurement cannot be done|1|||
131142682|NCT04173741|472148573|FG001|Overall Study|IVC measurement cannot be done|1|||
131142683|NCT02631538|472148574|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
131142684|NCT02631538|472148575|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
131142685|NCT02631538|472148576|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
131142686|NCT02631538|472148577|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
131142687|NCT02631538|472148574|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
131142688|NCT02631538|472148575|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
131142689|NCT02631538|472148576|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
131142690|NCT02631538|472148577|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
131142691|NCT02631538|472148574|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
131142692|NCT02631538|472148575|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
131142693|NCT02631538|472148576|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
131142694|NCT02631538|472148577|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
131142695|NCT02631538|472148574|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
131142696|NCT02631538|472148575|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
131142697|NCT02631538|472148576|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
131142698|NCT02631538|472148577|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
131142699|NCT02631538|472148574|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
131142700|NCT02631538|472148575|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
131142701|NCT02631538|472148576|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
131142702|NCT02631538|472148577|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
131142703|NCT02631538|472148574|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
131142704|NCT02631538|472148575|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
131142705|NCT02631538|472148576|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
131142706|NCT02631538|472148577|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
131142707|NCT00849667|472148581|FG000|Overall Study|Withdrawal by Subject|16|||
131142708|NCT00849667|472148582|FG001|Overall Study|Withdrawal by Subject|33|||
131142709|NCT00849667|472148583|FG002|Overall Study|Withdrawal by Subject|35|||
131142710|NCT00849667|472148581|FG000|Overall Study|Lost to Follow-up|8|||
131142711|NCT00849667|472148582|FG001|Overall Study|Lost to Follow-up|8|||
131142712|NCT00849667|472148583|FG002|Overall Study|Lost to Follow-up|8|||
131142713|NCT00849667|472148581|FG000|Overall Study|Adverse Event|1|||
131142714|NCT00849667|472148582|FG001|Overall Study|Adverse Event|2|||
131142715|NCT00849667|472148583|FG002|Overall Study|Adverse Event|0|||
131142716|NCT00849667|472148581|FG000|Overall Study|Other|18|||
131142717|NCT00849667|472148582|FG001|Overall Study|Other|19|||
131142718|NCT00849667|472148583|FG002|Overall Study|Other|18|||
131142719|NCT00849667|472148581|FG000|Overall Study|Progressive disease|119|||
131142720|NCT00849667|472148582|FG001|Overall Study|Progressive disease|100|||
131142721|NCT00849667|472148583|FG002|Overall Study|Progressive disease|112|||
131142722|NCT00849667|472148581|FG000|Overall Study|Sponsor decision|208|||
131142723|NCT00849667|472148582|FG001|Overall Study|Sponsor decision|204|||
131142724|NCT00849667|472148583|FG002|Overall Study|Sponsor decision|190|||
131142725|NCT00849667|472148581|FG000|Overall Study|Investigator discretion|0|||
131142726|NCT00849667|472148582|FG001|Overall Study|Investigator discretion|0|||
131142727|NCT00849667|472148583|FG002|Overall Study|Investigator discretion|1|||
131142728|NCT00510276|472148589|FG000|Acute Double-Blind Phase|Adverse Event|21|||
131142729|NCT00510276|472148590|FG001|Acute Double-Blind Phase|Adverse Event|6|||
131142730|NCT00510276|472148589|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
131142731|NCT00510276|472148590|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
131142732|NCT00510276|472148589|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
131142733|NCT00510276|472148590|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
131142734|NCT00510276|472148589|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
131142735|NCT00510276|472148590|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
131142736|NCT00510276|472148589|FG000|Acute Double-Blind Phase|Physician Decision|0|||
131142737|NCT00510276|472148590|FG001|Acute Double-Blind Phase|Physician Decision|3|||
131142738|NCT00510276|472148589|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
131142739|NCT00510276|472148590|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
131142740|NCT00510276|472148589|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
131142741|NCT00510276|472148590|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
131142742|NCT00510276|472148589|FG000|Acute Double-Blind Phase|Subject Decision|26|||
131142743|NCT00510276|472148590|FG001|Acute Double-Blind Phase|Subject Decision|28|||
131142744|NCT00510276|472148589|FG000|Extension Open-Label Phase|Adverse Event|9|||
131142745|NCT00510276|472148590|FG001|Extension Open-Label Phase|Adverse Event|18|||
131142746|NCT00510276|472148589|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
131142747|NCT00510276|472148590|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
131142748|NCT00510276|472148589|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
131142749|NCT00510276|472148590|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
131142750|NCT00510276|472148589|FG000|Extension Open-Label Phase|Physician Decision|2|||
131142751|NCT00510276|472148590|FG001|Extension Open-Label Phase|Physician Decision|3|||
131142752|NCT00510276|472148589|FG000|Extension Open-Label Phase|Protocol Violation|0|||
131142753|NCT00510276|472148590|FG001|Extension Open-Label Phase|Protocol Violation|1|||
131142754|NCT00510276|472148589|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
131142755|NCT00510276|472148590|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
131142756|NCT00510276|472148589|FG000|Extension Open-Label Phase|Subject Decision|7|||
131142757|NCT00510276|472148590|FG001|Extension Open-Label Phase|Subject Decision|9|||
131142758|NCT03486392|472148593|FG000|Overall Study|Lost to Follow-up|0|||
131142759|NCT03486392|472148594|FG001|Overall Study|Lost to Follow-up|0|||
131142760|NCT03486392|472148595|FG002|Overall Study|Lost to Follow-up|8|||
131142761|NCT03486392|472148596|FG003|Overall Study|Lost to Follow-up|5|||
131142762|NCT03486392|472148597|FG004|Overall Study|Lost to Follow-up|2|||
131142763|NCT03486392|472148593|FG000|Overall Study|Withdrawal by Subject|3|||
131142764|NCT03486392|472148594|FG001|Overall Study|Withdrawal by Subject|0|||
131142765|NCT03486392|472148595|FG002|Overall Study|Withdrawal by Subject|6|||
131142766|NCT03486392|472148596|FG003|Overall Study|Withdrawal by Subject|4|||
131142767|NCT03486392|472148597|FG004|Overall Study|Withdrawal by Subject|1|||
131142768|NCT03486392|472148593|FG000|Overall Study|Death|0|||
131142769|NCT03486392|472148594|FG001|Overall Study|Death|0|||
131142770|NCT03486392|472148595|FG002|Overall Study|Death|0|||
131142771|NCT03486392|472148596|FG003|Overall Study|Death|0|||
131142772|NCT03486392|472148597|FG004|Overall Study|Death|1|||
131142773|NCT00441792|472148600|FG000|Overall Study|Lost to Follow-up|0|||
131142774|NCT00441792|472148601|FG001|Overall Study|Lost to Follow-up|2|||
131142775|NCT00888355|472148608|FG000|Overall Study|Adverse Event|10|||
131142776|NCT00888355|472148609|FG001|Overall Study|Adverse Event|0|||
131142777|NCT00888355|472148610|FG002|Overall Study|Adverse Event|3|||
131142778|NCT00888355|472148611|FG003|Overall Study|Adverse Event|3|||
131142779|NCT00888355|472148608|FG000|Overall Study|Lack of Efficacy|9|||
131142780|NCT00888355|472148609|FG001|Overall Study|Lack of Efficacy|2|||
131142781|NCT00888355|472148610|FG002|Overall Study|Lack of Efficacy|5|||
131142782|NCT00888355|472148611|FG003|Overall Study|Lack of Efficacy|2|||
131142783|NCT00888355|472148608|FG000|Overall Study|Lost to Follow-up|0|||
131142784|NCT00888355|472148609|FG001|Overall Study|Lost to Follow-up|2|||
131234174|NCT02324465|472484592|FG000|Overall Study|device failure|0|||
131234175|NCT02324465|472484593|FG001|Overall Study|device failure|1|||
131142785|NCT00888355|472148610|FG002|Overall Study|Lost to Follow-up|2|||
131142786|NCT00888355|472148611|FG003|Overall Study|Lost to Follow-up|0|||
131142787|NCT00888355|472148608|FG000|Overall Study|Protocol Violation|3|||
131142788|NCT00888355|472148609|FG001|Overall Study|Protocol Violation|2|||
131142789|NCT00888355|472148610|FG002|Overall Study|Protocol Violation|1|||
131142790|NCT00888355|472148611|FG003|Overall Study|Protocol Violation|2|||
131142791|NCT00888355|472148608|FG000|Overall Study|Withdrawal by Subject|0|||
131142792|NCT00888355|472148609|FG001|Overall Study|Withdrawal by Subject|3|||
131142793|NCT00888355|472148610|FG002|Overall Study|Withdrawal by Subject|1|||
131142794|NCT00888355|472148611|FG003|Overall Study|Withdrawal by Subject|3|||
131142795|NCT01551693|472148613|FG000|Overall Study|Disease Progression|1|||
131142796|NCT01551693|472148614|FG001|Overall Study|Disease Progression|0|||
131142797|NCT01551693|472148613|FG000|Overall Study|Adverse Event|0|||
131142798|NCT01551693|472148614|FG001|Overall Study|Adverse Event|1|||
131234176|NCT02655237|472484596|FG000|Overall Study|Adverse Event|10|||
131088940|NCT05332912|471960483|FG000|Overall Study|Withdrawal by Subject|0|||
131088941|NCT05332912|471960484|FG001|Overall Study|Withdrawal by Subject|1|||
131088942|NCT05332912|471960485|FG002|Overall Study|Withdrawal by Subject|2|||
131088943|NCT05332912|471960486|FG003|Overall Study|Withdrawal by Subject|0|||
131088944|NCT05332912|471960483|FG000|Overall Study|Lost to Follow-up|0|||
131088945|NCT05332912|471960484|FG001|Overall Study|Lost to Follow-up|0|||
131088946|NCT05332912|471960485|FG002|Overall Study|Lost to Follow-up|1|||
131088947|NCT05332912|471960486|FG003|Overall Study|Lost to Follow-up|0|||
131142799|NCT01551693|472148613|FG000|Overall Study|Withdrawal by Subject|0|||
131142800|NCT01551693|472148614|FG001|Overall Study|Withdrawal by Subject|1|||
131142801|NCT00130286|472148615|FG000|Overall Study|Withdrawal by Subject|0|||
131234177|NCT02655237|472484597|FG001|Overall Study|Adverse Event|7|||
131234178|NCT02655237|472484596|FG000|Overall Study|Protocol Deviation|2|||
131234179|NCT02655237|472484597|FG001|Overall Study|Protocol Deviation|0|||
131234180|NCT02655237|472484596|FG000|Overall Study|Withdrawal by Participant|1|||
131234181|NCT02655237|472484597|FG001|Overall Study|Withdrawal by Participant|2|||
131234182|NCT02655237|472484596|FG000|Overall Study|Lack of Efficacy|0|||
131234183|NCT02655237|472484597|FG001|Overall Study|Lack of Efficacy|1|||
131234184|NCT02655237|472484596|FG000|Overall Study|Recovery Leading to Surgery|2|||
131234185|NCT02655237|472484597|FG001|Overall Study|Recovery Leading to Surgery|1|||
131234186|NCT02655237|472484596|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
131234187|NCT02655237|472484597|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
131234188|NCT02655237|472484596|FG000|Overall Study|Randomized but Not Treated|1|||
131234189|NCT02655237|472484597|FG001|Overall Study|Randomized but Not Treated|0|||
131234190|NCT03679741|472484598|FG000|Period 1|No longer meet eligibility criteria|1|||
131234191|NCT03679741|472484599|FG001|Period 1|No longer meet eligibility criteria|0|||
131234192|NCT03679741|472484598|FG000|Period 1|Lost to Follow-up|0|||
131142802|NCT00130286|472148616|FG001|Overall Study|Withdrawal by Subject|1|||
131234193|NCT03679741|472484599|FG001|Period 1|Lost to Follow-up|1|||
131234194|NCT03679741|472484598|FG000|Period 1|Adverse Event|1|||
131234195|NCT03679741|472484599|FG001|Period 1|Adverse Event|1|||
131234196|NCT03679741|472484598|FG000|Period 1|Withdrawal by Subject|0|||
131234197|NCT03679741|472484599|FG001|Period 1|Withdrawal by Subject|1|||
131234198|NCT03679741|472484598|FG000|Period 2|Adverse Event|2|||
131234199|NCT03679741|472484599|FG001|Period 2|Adverse Event|1|||
131234200|NCT03679741|472484598|FG000|Period 2|Withdrawal by Subject|1|||
131234201|NCT03679741|472484599|FG001|Period 2|Withdrawal by Subject|1|||
131234202|NCT00520741|472484600|FG000|Overall Study|Adverse Event|16|||
131234203|NCT00520741|472484601|FG001|Overall Study|Adverse Event|56|||
131234204|NCT00520741|472484600|FG000|Overall Study|Lack of Efficacy|11|||
131234205|NCT00520741|472484601|FG001|Overall Study|Lack of Efficacy|30|||
131234206|NCT00520741|472484600|FG000|Overall Study|Withdrawal by Subject|0|||
131234207|NCT00520741|472484601|FG001|Overall Study|Withdrawal by Subject|11|||
131234208|NCT00520741|472484600|FG000|Overall Study|Protocol Violation|2|||
131234209|NCT00520741|472484601|FG001|Overall Study|Protocol Violation|15|||
131234210|NCT00520741|472484600|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
131234211|NCT00520741|472484601|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
131234212|NCT00520741|472484600|FG000|Overall Study|Lost to Follow-up|4|||
131234213|NCT00520741|472484601|FG001|Overall Study|Lost to Follow-up|4|||
131234214|NCT00520741|472484600|FG000|Overall Study|Other reasons for premature termination|0|||
131234215|NCT00520741|472484601|FG001|Overall Study|Other reasons for premature termination|6|||
131234216|NCT02750761|472484602|FG000|Overall Study|Lost to Follow-up|0|||
131234217|NCT02750761|472484603|FG001|Overall Study|Lost to Follow-up|0|||
131234218|NCT02750761|472484604|FG002|Overall Study|Lost to Follow-up|1|||
131234219|NCT02750761|472484605|FG003|Overall Study|Lost to Follow-up|0|||
131234220|NCT02750761|472484606|FG004|Overall Study|Lost to Follow-up|0|||
131234221|NCT02750761|472484607|FG005|Overall Study|Lost to Follow-up|0|||
131234222|NCT01860976|472484608|FG000|Blinded Treatment|Adverse Event|1|||
131234223|NCT01860976|472484609|FG001|Blinded Treatment|Adverse Event|3|||
131234224|NCT01860976|472484608|FG000|Blinded Treatment|Lack of Efficacy|5|||
131234225|NCT01860976|472484609|FG001|Blinded Treatment|Lack of Efficacy|12|||
131234226|NCT01860976|472484608|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
131234227|NCT01860976|472484609|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
131234228|NCT01860976|472484608|FG000|Blinded Treatment|Withdrawal by Subject|3|||
131234229|NCT01860976|472484609|FG001|Blinded Treatment|Withdrawal by Subject|5|||
131234230|NCT01860976|472484608|FG000|Blinded Treatment|Subject no longer met criteria|1|||
131234231|NCT01860976|472484609|FG001|Blinded Treatment|Subject no longer met criteria|0|||
131234232|NCT01860976|472484608|FG000|Blinded Treatment|Entered Open-Label in error|0|||
131234233|NCT01860976|472484609|FG001|Blinded Treatment|Entered Open-Label in error|1|||
131142803|NCT00130286|472148617|FG002|Overall Study|Withdrawal by Subject|2|||
131142804|NCT00130286|472148618|FG003|Overall Study|Withdrawal by Subject|2|||
131142805|NCT00130286|472148615|FG000|Overall Study|Adverse Event|0|||
131142806|NCT00130286|472148616|FG001|Overall Study|Adverse Event|0|||
131142807|NCT00130286|472148617|FG002|Overall Study|Adverse Event|2|||
131142808|NCT00130286|472148618|FG003|Overall Study|Adverse Event|0|||
131142809|NCT00130286|472148615|FG000|Overall Study|Missing lab specimens|0|||
131142810|NCT00130286|472148616|FG001|Overall Study|Missing lab specimens|2|||
131142811|NCT00130286|472148617|FG002|Overall Study|Missing lab specimens|0|||
131142812|NCT00130286|472148618|FG003|Overall Study|Missing lab specimens|0|||
131234234|NCT01860976|472484608|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
131234235|NCT01860976|472484609|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
131234236|NCT01860976|472484608|FG000|Open-Label|Adverse Event|2|||
131234237|NCT01860976|472484609|FG001|Open-Label|Adverse Event|4|||
131142813|NCT02154425|472148623|FG000|Screening Period|Adverse Event|1|||
131142814|NCT02908516|472148630|FG000|Overall Study|Study Terminated|3|||
131142815|NCT02908516|472148631|FG001|Overall Study|Study Terminated|3|||
131142816|NCT00565617|472148634|FG000|Overall Study|Withdrawal by Subject|1|||
131234238|NCT01860976|472484608|FG000|Open-Label|Lack of Efficacy|16|||
131234239|NCT01860976|472484609|FG001|Open-Label|Lack of Efficacy|8|||
131234240|NCT01860976|472484608|FG000|Open-Label|Lost to Follow-up|1|||
131234241|NCT01860976|472484609|FG001|Open-Label|Lost to Follow-up|2|||
131234242|NCT01860976|472484608|FG000|Open-Label|Subject request discontinue treatment|4|||
131234243|NCT01860976|472484609|FG001|Open-Label|Subject request discontinue treatment|3|||
131234244|NCT01860976|472484608|FG000|Open-Label|Withdrawal by Subject|4|||
131234245|NCT01860976|472484609|FG001|Open-Label|Withdrawal by Subject|1|||
131234246|NCT01860976|472484608|FG000|Open-Label|Other Reasons|1|||
131234247|NCT01860976|472484609|FG001|Open-Label|Other Reasons|1|||
131234248|NCT01860976|472484608|FG000|Long Term Extension|Adverse Event|4|||
131234249|NCT01860976|472484609|FG001|Long Term Extension|Adverse Event|0|||
131234250|NCT01860976|472484608|FG000|Long Term Extension|Lack of Efficacy|2|||
131234251|NCT01860976|472484609|FG001|Long Term Extension|Lack of Efficacy|0|||
131234252|NCT01860976|472484608|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
131234253|NCT01860976|472484609|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
131234254|NCT01860976|472484608|FG000|Long Term Extension|Lost to Follow-up|2|||
131234255|NCT01860976|472484609|FG001|Long Term Extension|Lost to Follow-up|0|||
131234256|NCT01860976|472484608|FG000|Long Term Extension|subject withdrew consent|7|||
131234257|NCT01860976|472484609|FG001|Long Term Extension|subject withdrew consent|0|||
131234258|NCT01612000|472484611|FG000|Overall Study|Lost to Follow-up|6|||
131234259|NCT01612000|472484612|FG001|Overall Study|Lost to Follow-up|4|||
131234260|NCT01612000|472484613|FG002|Overall Study|Lost to Follow-up|4|||
131234261|NCT01612000|472484614|FG003|Overall Study|Lost to Follow-up|8|||
131234262|NCT01612000|472484611|FG000|Overall Study|Physician Decision|0|||
131234263|NCT01612000|472484612|FG001|Overall Study|Physician Decision|0|||
131234264|NCT01612000|472484613|FG002|Overall Study|Physician Decision|1|||
131234265|NCT01612000|472484614|FG003|Overall Study|Physician Decision|0|||
131234266|NCT01612000|472484611|FG000|Overall Study|Withdrawal by Subject|3|||
131234267|NCT01612000|472484612|FG001|Overall Study|Withdrawal by Subject|1|||
131234268|NCT01612000|472484613|FG002|Overall Study|Withdrawal by Subject|2|||
131234269|NCT01612000|472484614|FG003|Overall Study|Withdrawal by Subject|2|||
131234270|NCT02354586|472484618|FG000|Overall Study|Death|230|||
131234271|NCT02354586|472484618|FG000|Overall Study|Withdrawal by Subject|59|||
131234272|NCT02354586|472484618|FG000|Overall Study|Lost to Follow-up|11|||
131234273|NCT02354586|472484618|FG000|Overall Study|Sponsor decision|51|||
131234274|NCT02354586|472484618|FG000|Overall Study|Site closure|2|||
131234275|NCT02354586|472484618|FG000|Overall Study|Intercurrent illness|1|||
131234276|NCT02354586|472484618|FG000|Overall Study|Protocol Violation|3|||
131234277|NCT02354586|472484618|FG000|Overall Study|Physician Decision|13|||
131234278|NCT02354586|472484618|FG000|Overall Study|Lack of Efficacy|86|||
131234279|NCT02354586|472484618|FG000|Overall Study|Adverse Event|7|||
131234280|NCT00634907|472484620|FG000|Overall Study|Withdrawal by Subject|3|||
131234281|NCT00634907|472484621|FG001|Overall Study|Withdrawal by Subject|0|||
131234282|NCT00634907|472484620|FG000|Overall Study|Physician Decision|3|||
131234283|NCT00634907|472484621|FG001|Overall Study|Physician Decision|9|||
131234284|NCT00634907|472484620|FG000|Overall Study|Withdrawal by Subject|11|||
131234285|NCT00634907|472484621|FG001|Overall Study|Withdrawal by Subject|8|||
131234286|NCT02419313|472484627|FG000|First Intervention|Lost to Follow-up|2|||
131234287|NCT02419313|472484628|FG001|First Intervention|Lost to Follow-up|0|||
131234288|NCT02419313|472484627|FG000|Second Intervention|Lost to Follow-up|1|||
131234289|NCT02419313|472484628|FG001|Second Intervention|Lost to Follow-up|0|||
131234290|NCT00620763|472484629|FG000|Period: First Intervention|Withdrawal by Subject|0|||
131234291|NCT00620763|472484630|FG001|Period: First Intervention|Withdrawal by Subject|2|||
131234292|NCT00620763|472484629|FG000|Period: First Intervention|Protocol Violation|0|||
131234293|NCT00620763|472484630|FG001|Period: First Intervention|Protocol Violation|3|||
131234294|NCT00620763|472484629|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
131234295|NCT00620763|472484630|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
131234296|NCT01694485|472484634|FG000|Overall Study|Withdrawal by Subject|20|||
131234297|NCT01694485|472484635|FG001|Overall Study|Withdrawal by Subject|6|||
131234298|NCT01694485|472484636|FG002|Overall Study|Withdrawal by Subject|7|||
131234299|NCT01694485|472484637|FG003|Overall Study|Withdrawal by Subject|25|||
131089004|NCT02942004|471960509|FG000|Overall Study|Withdrawal by Subject|0|||
131089005|NCT02942004|471960510|FG001|Overall Study|Withdrawal by Subject|2|||
131089006|NCT02942004|471960511|FG002|Overall Study|Withdrawal by Subject|3|||
131089007|NCT02942004|471960509|FG000|Overall Study|Lost to Follow-up|1|||
131089008|NCT02942004|471960510|FG001|Overall Study|Lost to Follow-up|1|||
131089009|NCT02942004|471960511|FG002|Overall Study|Lost to Follow-up|2|||
131089010|NCT02942004|471960509|FG000|Overall Study|Randomized but not dosed|3|||
131089011|NCT02942004|471960510|FG001|Overall Study|Randomized but not dosed|9|||
131089012|NCT02942004|471960511|FG002|Overall Study|Randomized but not dosed|4|||
131089013|NCT04517669|471960512|FG000|Overall Study|Lost to Follow-up|2|||
131089014|NCT04517669|471960512|FG000|Overall Study|Withdrawal by Subject|3|||
131089015|NCT04517669|471960512|FG000|Overall Study|Drug withdrawn|44|||
131089016|NCT04517669|471960512|FG000|Overall Study|Other|1|||
131089017|NCT04517669|471960512|FG000|Overall Study|Eligibility criteria not met|4|||
131089018|NCT04517669|471960512|FG000|Overall Study|Did not receive treatment|3|||
131142817|NCT01078805|472148637|FG000|Overall Study|Clinically significant abnormal lab|5|||
131142818|NCT01078805|472148637|FG000|Overall Study|Death|134|||
131142819|NCT01078805|472148637|FG000|Overall Study|Lost to Follow-up|676|||
130727266|NCT02883049|470625434|FG010|Post Induction|Ineligible|1|||
130727267|NCT02883049|470625435|FG011|Post Induction|Ineligible|0|||
130727268|NCT02883049|470625436|FG012|Post Induction|Ineligible|0|||
130727269|NCT02883049|470625437|FG013|Post Induction|Ineligible|0|||
130727270|NCT02883049|470625438|FG014|Post Induction|Ineligible|0|||
130727271|NCT02883049|470625439|FG015|Post Induction|Ineligible|1|||
130727272|NCT02883049|470625424|FG000|Post Induction|Refusal of further protocol therapy|0|||
131142820|NCT01078805|472148637|FG000|Overall Study|Physician Decision|169|||
131142821|NCT01078805|472148637|FG000|Overall Study|Serious adverse event|26|||
131142822|NCT01078805|472148637|FG000|Overall Study|Sponsor decision|46|||
131142823|NCT01078805|472148637|FG000|Overall Study|Withdrawal by Subject|739|||
131142824|NCT01078805|472148637|FG000|Overall Study|Other|173|||
131142825|NCT01078805|472148637|FG000|Overall Study|Didn't take study drug|82|||
131142826|NCT01609842|472148638|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
131142827|NCT01609842|472148639|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
131142828|NCT02474329|472148647|FG000|Overall Study|Withdraw or did not contribute data.|13|||
131142829|NCT00880750|472150423|FG000|First Intervention|Adverse Event|1|||
131142830|NCT00880750|472150424|FG001|First Intervention|Adverse Event|0|||
131142831|NCT00880750|472150423|FG000|First Intervention|Unable to collect urine|4|||
130727273|NCT02883049|470625425|FG001|Post Induction|Refusal of further protocol therapy|0|||
131142832|NCT00880750|472150424|FG001|First Intervention|Unable to collect urine|0|||
131142833|NCT00880750|472150423|FG000|First Intervention|Non-compliance with meals|0|||
131142834|NCT00880750|472150424|FG001|First Intervention|Non-compliance with meals|1|||
131142835|NCT00880750|472150423|FG000|First Intervention|Withdrawal by Subject|2|||
131142836|NCT00880750|472150424|FG001|First Intervention|Withdrawal by Subject|0|||
131142837|NCT00880750|472150423|FG000|First Intervention|Lost to Follow-up|2|||
131142838|NCT00880750|472150424|FG001|First Intervention|Lost to Follow-up|0|||
131142839|NCT00880750|472150423|FG000|Second Intervention|Withdrawal by Subject|2|||
131142840|NCT00880750|472150424|FG001|Second Intervention|Withdrawal by Subject|2|||
131142841|NCT00880750|472150423|FG000|Second Intervention|Protocol Violation|1|||
131142842|NCT00880750|472150424|FG001|Second Intervention|Protocol Violation|0|||
131142843|NCT00880750|472150423|FG000|Second Intervention|Unable to collect urine|1|||
131142844|NCT00880750|472150424|FG001|Second Intervention|Unable to collect urine|0|||
131142845|NCT00483327|472150428|FG000|Overall Study|Adverse Event|1|||
131142846|NCT00483327|472150428|FG000|Overall Study|Withdrawal by Subject|3|||
131142847|NCT00483327|472150428|FG000|Overall Study|Lost to Follow-up|4|||
131142848|NCT00483327|472150428|FG000|Overall Study|Patient Non Compliance|2|||
131142849|NCT00670007|472150429|FG000|Overall Study|Drug abuse|1|||
131142850|NCT00670007|472150429|FG000|Overall Study|Lung transplant|1|||
131142851|NCT00670007|472150429|FG000|Overall Study|Travel/Vacation|1|||
131142852|NCT00670007|472150429|FG000|Overall Study|Adverse event, serious fatal|1|||
131142853|NCT00670007|472150429|FG000|Overall Study|Adverse Event|1|||
131142854|NCT00670007|472150429|FG000|Overall Study|Withdrawal by Subject|4|||
131142855|NCT00618722|472150430|FG000|Overall Study|Refusal of Treatment|0|||
131142856|NCT00618722|472150431|FG001|Overall Study|Refusal of Treatment|0|||
131142857|NCT00618722|472150432|FG002|Overall Study|Refusal of Treatment|1|||
131142858|NCT00618722|472150433|FG003|Overall Study|Refusal of Treatment|0|||
131142859|NCT00618722|472150430|FG000|Overall Study|Patient Request|1|||
131142860|NCT00618722|472150431|FG001|Overall Study|Patient Request|1|||
131142861|NCT00618722|472150432|FG002|Overall Study|Patient Request|1|||
131142862|NCT00618722|472150433|FG003|Overall Study|Patient Request|1|||
131142863|NCT00618722|472150430|FG000|Overall Study|Inability to Complete Study Procedure|0|||
131142864|NCT00618722|472150431|FG001|Overall Study|Inability to Complete Study Procedure|1|||
131142865|NCT00618722|472150432|FG002|Overall Study|Inability to Complete Study Procedure|0|||
131142866|NCT00618722|472150433|FG003|Overall Study|Inability to Complete Study Procedure|0|||
131142867|NCT00618722|472150430|FG000|Overall Study|Lost to Follow-up|2|||
131142868|NCT00618722|472150431|FG001|Overall Study|Lost to Follow-up|0|||
131142869|NCT00618722|472150432|FG002|Overall Study|Lost to Follow-up|0|||
131142870|NCT00618722|472150433|FG003|Overall Study|Lost to Follow-up|2|||
131142871|NCT00618722|472150430|FG000|Overall Study|Miscellaneous Reasons|0|||
131142872|NCT00618722|472150431|FG001|Overall Study|Miscellaneous Reasons|0|||
131142873|NCT00618722|472150432|FG002|Overall Study|Miscellaneous Reasons|1|||
131142874|NCT00618722|472150433|FG003|Overall Study|Miscellaneous Reasons|1|||
131142875|NCT00200057|472150436|FG000|Overall Study|Lack of Efficacy|3|||
131142876|NCT00200057|472150436|FG000|Overall Study|Exited due to terminal illness of PI|2|||
131142877|NCT00200057|472150436|FG000|Overall Study|Withdrawal by Subject|1|||
131142878|NCT00200057|472150436|FG000|Overall Study|Change in medical condition|1|||
131142879|NCT00200057|472150436|FG000|Overall Study|Infection|1|||
131142880|NCT00200057|472150436|FG000|Overall Study|Death|1|||
131142881|NCT01059448|472150437|FG000|Overall Study|Adverse Event|1|||
131142882|NCT01059448|472150438|FG001|Overall Study|Adverse Event|3|||
131142883|NCT01059448|472150439|FG002|Overall Study|Adverse Event|0|||
131142884|NCT01059448|472150440|FG003|Overall Study|Adverse Event|1|||
131142885|NCT01059448|472150437|FG000|Overall Study|Withdrawal by Subject|2|||
130727274|NCT02883049|470625426|FG002|Post Induction|Refusal of further protocol therapy|0|||
130727275|NCT02883049|470625427|FG003|Post Induction|Refusal of further protocol therapy|11|||
130727276|NCT02883049|470625428|FG004|Post Induction|Refusal of further protocol therapy|15|||
130727277|NCT02883049|470625429|FG005|Post Induction|Refusal of further protocol therapy|9|||
130727278|NCT02883049|470625430|FG006|Post Induction|Refusal of further protocol therapy|13|||
130727279|NCT02883049|470625431|FG007|Post Induction|Refusal of further protocol therapy|5|||
130727280|NCT02883049|470625432|FG008|Post Induction|Refusal of further protocol therapy|21|||
130727281|NCT02883049|470625433|FG009|Post Induction|Refusal of further protocol therapy|7|||
130727282|NCT02883049|470625434|FG010|Post Induction|Refusal of further protocol therapy|0|||
130727283|NCT02883049|470625435|FG011|Post Induction|Refusal of further protocol therapy|7|||
130727284|NCT02883049|470625436|FG012|Post Induction|Refusal of further protocol therapy|3|||
130727285|NCT02883049|470625437|FG013|Post Induction|Refusal of further protocol therapy|0|||
130727286|NCT02883049|470625438|FG014|Post Induction|Refusal of further protocol therapy|4|||
130727287|NCT02883049|470625439|FG015|Post Induction|Refusal of further protocol therapy|1|||
130727288|NCT02883049|470625424|FG000|Post Induction|Inevaluable|0|||
131089080|NCT06133348|471960526|FG000|Overall Study|Death|3|||
131089081|NCT06133348|471960526|FG000|Overall Study|Lost to Follow-up|1|||
131089082|NCT06133348|471960526|FG000|Overall Study|Physician Decision|1|||
131089083|NCT06133348|471960526|FG000|Overall Study|Withdrawal by Subject|5|||
130727289|NCT02883049|470625425|FG001|Post Induction|Inevaluable|0|||
130727290|NCT02883049|470625426|FG002|Post Induction|Inevaluable|0|||
131234300|NCT01694485|472484638|FG004|Overall Study|Withdrawal by Subject|18|||
131089136|NCT04638660|471960553|FG000|Overall Study|Withdrawal by Subject|2|||
131089137|NCT04638660|471960554|FG001|Overall Study|Withdrawal by Subject|0|||
131089138|NCT04638660|471960553|FG000|Overall Study|Lost to Follow-up|1|||
131089139|NCT04638660|471960554|FG001|Overall Study|Lost to Follow-up|0|||
131089140|NCT04481373|471960555|FG000|Overall Study|Protocol Violation|1|||
131089141|NCT04481373|471960556|FG001|Overall Study|Protocol Violation|0|||
131089142|NCT04481373|471960555|FG000|Overall Study|Viral load in hospital not over 1000|2|||
131089143|NCT04481373|471960556|FG001|Overall Study|Viral load in hospital not over 1000|1|||
131089144|NCT04481373|471960555|FG000|Overall Study|Death before hospital discharge|1|||
131089145|NCT04481373|471960556|FG001|Overall Study|Death before hospital discharge|0|||
131089178|NCT03199469|471960574|FG000|Overall Study|Randomized, not treated|0|||
131089179|NCT03199469|471960575|FG001|Overall Study|Randomized, not treated|3|||
131089180|NCT03199469|471960574|FG000|Overall Study|Withdrawal by Subject|1|||
131089181|NCT03199469|471960575|FG001|Overall Study|Withdrawal by Subject|0|||
131089182|NCT03199469|471960574|FG000|Overall Study|Death|1|||
131089183|NCT03199469|471960575|FG001|Overall Study|Death|3|||
131089184|NCT03199469|471960574|FG000|Overall Study|Ongoing|5|||
131089185|NCT03199469|471960575|FG001|Overall Study|Ongoing|14|||
131089186|NCT03842228|471960578|FG000|Overall Study|Adverse Event|1|||
131089187|NCT03842228|471960579|FG001|Overall Study|Adverse Event|1|||
131089188|NCT03842228|471960580|FG002|Overall Study|Adverse Event|1|||
131089189|NCT03842228|471960581|FG003|Overall Study|Adverse Event|0|||
131089190|NCT03842228|471960582|FG004|Overall Study|Adverse Event|0|||
131089191|NCT03842228|471960583|FG005|Overall Study|Adverse Event|0|||
131089192|NCT03842228|471960584|FG006|Overall Study|Adverse Event|0|||
131089193|NCT03842228|471960578|FG000|Overall Study|Death|0|||
131234301|NCT01694485|472484634|FG000|Overall Study|Sponsor Decision|3|||
131089194|NCT03842228|471960579|FG001|Overall Study|Death|1|||
131089195|NCT03842228|471960580|FG002|Overall Study|Death|0|||
131089196|NCT03842228|471960581|FG003|Overall Study|Death|0|||
131089197|NCT03842228|471960582|FG004|Overall Study|Death|0|||
131089198|NCT03842228|471960583|FG005|Overall Study|Death|0|||
131089199|NCT03842228|471960584|FG006|Overall Study|Death|0|||
131089200|NCT03842228|471960578|FG000|Overall Study|Withdrawal by Subject|0|||
131089201|NCT03842228|471960579|FG001|Overall Study|Withdrawal by Subject|0|||
131089202|NCT03842228|471960580|FG002|Overall Study|Withdrawal by Subject|2|||
131089203|NCT03842228|471960581|FG003|Overall Study|Withdrawal by Subject|1|||
131089204|NCT03842228|471960582|FG004|Overall Study|Withdrawal by Subject|0|||
131089205|NCT03842228|471960583|FG005|Overall Study|Withdrawal by Subject|0|||
131089206|NCT03842228|471960584|FG006|Overall Study|Withdrawal by Subject|2|||
131089207|NCT03842228|471960578|FG000|Overall Study|Progression|8|||
131089208|NCT03842228|471960579|FG001|Overall Study|Progression|1|||
131089209|NCT03842228|471960580|FG002|Overall Study|Progression|7|||
131089210|NCT03842228|471960581|FG003|Overall Study|Progression|5|||
131089211|NCT03842228|471960582|FG004|Overall Study|Progression|4|||
131089212|NCT03842228|471960583|FG005|Overall Study|Progression|2|||
131089213|NCT03842228|471960584|FG006|Overall Study|Progression|3|||
131142886|NCT01059448|472150438|FG001|Overall Study|Withdrawal by Subject|0|||
131142887|NCT01059448|472150439|FG002|Overall Study|Withdrawal by Subject|2|||
131142888|NCT01059448|472150440|FG003|Overall Study|Withdrawal by Subject|4|||
131142889|NCT01059448|472150437|FG000|Overall Study|Disease Progression|2|||
131142890|NCT01059448|472150438|FG001|Overall Study|Disease Progression|1|||
131142891|NCT01059448|472150439|FG002|Overall Study|Disease Progression|4|||
131142892|NCT01059448|472150440|FG003|Overall Study|Disease Progression|2|||
131142893|NCT01059448|472150437|FG000|Overall Study|Administrative Decision|43|||
131142894|NCT01059448|472150438|FG001|Overall Study|Administrative Decision|49|||
131142895|NCT01059448|472150439|FG002|Overall Study|Administrative Decision|45|||
131234302|NCT01694485|472484635|FG001|Overall Study|Sponsor Decision|0|||
131234303|NCT01694485|472484636|FG002|Overall Study|Sponsor Decision|0|||
131234304|NCT01694485|472484637|FG003|Overall Study|Sponsor Decision|2|||
131234305|NCT01694485|472484638|FG004|Overall Study|Sponsor Decision|0|||
131234306|NCT01694485|472484634|FG000|Overall Study|Lost to Follow-up|9|||
130727291|NCT02883049|470625427|FG003|Post Induction|Inevaluable|1|||
130727292|NCT02883049|470625428|FG004|Post Induction|Inevaluable|1|||
130727293|NCT02883049|470625429|FG005|Post Induction|Inevaluable|2|||
130727294|NCT02883049|470625430|FG006|Post Induction|Inevaluable|7|||
130727295|NCT02883049|470625431|FG007|Post Induction|Inevaluable|6|||
130727296|NCT02883049|470625432|FG008|Post Induction|Inevaluable|4|||
130727297|NCT02883049|470625433|FG009|Post Induction|Inevaluable|4|||
130727298|NCT02883049|470625434|FG010|Post Induction|Inevaluable|1|||
130727299|NCT02883049|470625435|FG011|Post Induction|Inevaluable|1|||
130727300|NCT02883049|470625436|FG012|Post Induction|Inevaluable|2|||
130727301|NCT02883049|470625437|FG013|Post Induction|Inevaluable|0|||
130727302|NCT02883049|470625438|FG014|Post Induction|Inevaluable|0|||
130727303|NCT02883049|470625439|FG015|Post Induction|Inevaluable|1|||
130727304|NCT02883049|470625424|FG000|Post Induction|Moved to another non-COG institution|0|||
130727305|NCT02883049|470625425|FG001|Post Induction|Moved to another non-COG institution|0|||
130727306|NCT02883049|470625426|FG002|Post Induction|Moved to another non-COG institution|0|||
130727307|NCT02883049|470625427|FG003|Post Induction|Moved to another non-COG institution|0|||
130727308|NCT02883049|470625428|FG004|Post Induction|Moved to another non-COG institution|0|||
130727309|NCT02883049|470625429|FG005|Post Induction|Moved to another non-COG institution|0|||
130727310|NCT02883049|470625430|FG006|Post Induction|Moved to another non-COG institution|0|||
130727311|NCT02883049|470625431|FG007|Post Induction|Moved to another non-COG institution|2|||
130727312|NCT02883049|470625432|FG008|Post Induction|Moved to another non-COG institution|2|||
131142896|NCT01059448|472150440|FG003|Overall Study|Administrative Decision|46|||
131142897|NCT01059448|472150437|FG000|Overall Study|Lost to Follow-up|0|||
130727313|NCT02883049|470625433|FG009|Post Induction|Moved to another non-COG institution|0|||
131142898|NCT01059448|472150438|FG001|Overall Study|Lost to Follow-up|0|||
131089250|NCT04868539|471960604|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
131089251|NCT04868539|471960605|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
131089267|NCT03651700|471960612|FG000|Overall Study|Withdrawal by Subject|1|||
131089268|NCT03651700|471960613|FG001|Overall Study|Withdrawal by Subject|0|||
131089269|NCT04916730|471960619|FG000|Overall Study|Withdrawal by Subject|4|||
131089270|NCT04916730|471960620|FG001|Overall Study|Withdrawal by Subject|2|||
131089271|NCT04916730|471960619|FG000|Overall Study|Lost to Follow-up|0|||
131089272|NCT04916730|471960620|FG001|Overall Study|Lost to Follow-up|2|||
131089273|NCT04916730|471960619|FG000|Overall Study|Physician Decision|1|||
131089274|NCT04916730|471960620|FG001|Overall Study|Physician Decision|0|||
131089308|NCT05479734|471960629|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
131089309|NCT05479734|471960630|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
131089310|NCT05479734|471960629|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
131089311|NCT05479734|471960630|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
131089312|NCT05479734|471960629|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
131089313|NCT05479734|471960630|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
131089314|NCT05479734|471960629|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
131089315|NCT05479734|471960630|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
131089316|NCT03945825|471960631|FG000|Overall Study|Enrolled but treatment not administered|0|||
131089317|NCT03945825|471960632|FG001|Overall Study|Enrolled but treatment not administered|0|||
131089318|NCT03945825|471960633|FG002|Overall Study|Enrolled but treatment not administered|0|||
131089319|NCT03945825|471960634|FG003|Overall Study|Enrolled but treatment not administered|0|||
131089320|NCT03945825|471960635|FG004|Overall Study|Enrolled but treatment not administered|1|||
131089321|NCT03945825|471960636|FG005|Overall Study|Enrolled but treatment not administered|0|||
131089322|NCT03945825|471960631|FG000|Overall Study|Lost to Follow-up|1|||
131089323|NCT03945825|471960632|FG001|Overall Study|Lost to Follow-up|5|||
131089324|NCT03945825|471960633|FG002|Overall Study|Lost to Follow-up|0|||
131142899|NCT01059448|472150439|FG002|Overall Study|Lost to Follow-up|2|||
131142900|NCT01059448|472150440|FG003|Overall Study|Lost to Follow-up|0|||
131142901|NCT01059448|472150437|FG000|Overall Study|Death|0|||
131142902|NCT01059448|472150438|FG001|Overall Study|Death|1|||
131142903|NCT01059448|472150439|FG002|Overall Study|Death|0|||
131142904|NCT01059448|472150440|FG003|Overall Study|Death|0|||
131142905|NCT01059448|472150437|FG000|Overall Study|Other|1|||
131142906|NCT01059448|472150438|FG001|Overall Study|Other|1|||
131142907|NCT01059448|472150439|FG002|Overall Study|Other|0|||
131142908|NCT01059448|472150440|FG003|Overall Study|Other|1|||
131089325|NCT03945825|471960634|FG003|Overall Study|Lost to Follow-up|1|||
131089326|NCT03945825|471960635|FG004|Overall Study|Lost to Follow-up|2|||
131089327|NCT03945825|471960636|FG005|Overall Study|Lost to Follow-up|2|||
131089328|NCT03945825|471960631|FG000|Overall Study|Withdrawal by Subject|1|||
131089329|NCT03945825|471960632|FG001|Overall Study|Withdrawal by Subject|0|||
131089330|NCT03945825|471960633|FG002|Overall Study|Withdrawal by Subject|1|||
131089331|NCT03945825|471960634|FG003|Overall Study|Withdrawal by Subject|1|||
131089332|NCT03945825|471960635|FG004|Overall Study|Withdrawal by Subject|0|||
131089333|NCT03945825|471960636|FG005|Overall Study|Withdrawal by Subject|1|||
131089334|NCT03083665|471960638|FG000|Double-Blind Period|Adverse Event|5|||
131089335|NCT03083665|471960639|FG001|Double-Blind Period|Adverse Event|4|||
131089336|NCT03083665|471960640|FG002|Double-Blind Period|Adverse Event|5|||
131089337|NCT03083665|471960641|FG003|Double-Blind Period|Adverse Event|0|||
131089338|NCT03083665|471960642|FG004|Double-Blind Period|Adverse Event|0|||
131089339|NCT03083665|471960643|FG005|Double-Blind Period|Adverse Event|0|||
131089340|NCT03083665|471960638|FG000|Double-Blind Period|Lack of Efficacy|0|||
131089341|NCT03083665|471960639|FG001|Double-Blind Period|Lack of Efficacy|0|||
131089342|NCT03083665|471960640|FG002|Double-Blind Period|Lack of Efficacy|1|||
131089343|NCT03083665|471960641|FG003|Double-Blind Period|Lack of Efficacy|0|||
131089344|NCT03083665|471960642|FG004|Double-Blind Period|Lack of Efficacy|0|||
131089345|NCT03083665|471960643|FG005|Double-Blind Period|Lack of Efficacy|0|||
131089346|NCT03083665|471960638|FG000|Double-Blind Period|Protocol Violation|1|||
131089347|NCT03083665|471960639|FG001|Double-Blind Period|Protocol Violation|0|||
131089348|NCT03083665|471960640|FG002|Double-Blind Period|Protocol Violation|1|||
131089349|NCT03083665|471960641|FG003|Double-Blind Period|Protocol Violation|0|||
131089350|NCT03083665|471960642|FG004|Double-Blind Period|Protocol Violation|0|||
131089351|NCT03083665|471960643|FG005|Double-Blind Period|Protocol Violation|0|||
131089352|NCT03083665|471960638|FG000|Double-Blind Period|Lost to Follow-up|1|||
131089353|NCT03083665|471960639|FG001|Double-Blind Period|Lost to Follow-up|0|||
131089354|NCT03083665|471960640|FG002|Double-Blind Period|Lost to Follow-up|1|||
131089355|NCT03083665|471960641|FG003|Double-Blind Period|Lost to Follow-up|0|||
131089356|NCT03083665|471960642|FG004|Double-Blind Period|Lost to Follow-up|0|||
131142909|NCT00778830|472150441|FG000|Overall Study|Ongoing at data cut-off|0|||
131142910|NCT00778830|472150442|FG001|Overall Study|Ongoing at data cut-off|1|||
131142911|NCT02591615|472150443|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
131142912|NCT02591615|472150444|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
131234307|NCT01694485|472484635|FG001|Overall Study|Lost to Follow-up|1|||
131234308|NCT01694485|472484636|FG002|Overall Study|Lost to Follow-up|6|||
131234309|NCT01694485|472484637|FG003|Overall Study|Lost to Follow-up|10|||
131089357|NCT03083665|471960643|FG005|Double-Blind Period|Lost to Follow-up|0|||
131089358|NCT03083665|471960638|FG000|Double-Blind Period|Withdrawal by Subject|3|||
131089359|NCT03083665|471960639|FG001|Double-Blind Period|Withdrawal by Subject|0|||
131089360|NCT03083665|471960640|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131089361|NCT03083665|471960641|FG003|Double-Blind Period|Withdrawal by Subject|0|||
131234310|NCT01694485|472484638|FG004|Overall Study|Lost to Follow-up|7|||
131234311|NCT01694485|472484634|FG000|Overall Study|Death|1|||
131234312|NCT01694485|472484635|FG001|Overall Study|Death|0|||
131089362|NCT03083665|471960642|FG004|Double-Blind Period|Withdrawal by Subject|0|||
131089363|NCT03083665|471960643|FG005|Double-Blind Period|Withdrawal by Subject|0|||
131089364|NCT03083665|471960638|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
131089365|NCT03083665|471960639|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
131142913|NCT02591615|472150445|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
131142914|NCT02591615|472150446|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
131142915|NCT02591615|472150443|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
131142916|NCT02591615|472150444|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
131142917|NCT02591615|472150445|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
131234313|NCT01694485|472484636|FG002|Overall Study|Death|0|||
131089366|NCT03083665|471960640|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
131089367|NCT03083665|471960641|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
131089368|NCT03083665|471960642|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
131089369|NCT03083665|471960643|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
131089370|NCT03083665|471960638|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
131089371|NCT03083665|471960639|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
131089372|NCT03083665|471960640|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
131089373|NCT03083665|471960641|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
131089374|NCT03083665|471960642|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
131089375|NCT03083665|471960643|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
131089376|NCT03083665|471960638|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
131089377|NCT03083665|471960639|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
131089378|NCT03083665|471960640|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
131089379|NCT03083665|471960641|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
131089380|NCT03083665|471960642|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
131089381|NCT03083665|471960643|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
131089382|NCT03083665|471960638|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
131089383|NCT03083665|471960639|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
131089384|NCT03083665|471960640|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
131089385|NCT03083665|471960641|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
131089386|NCT03083665|471960642|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
131089387|NCT03083665|471960643|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
131089388|NCT03083665|471960638|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
131089389|NCT03083665|471960639|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
131089390|NCT03083665|471960640|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
131089391|NCT03083665|471960641|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
131089392|NCT03083665|471960642|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
131089393|NCT03083665|471960643|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
131089394|NCT03083665|471960638|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
131089395|NCT03083665|471960639|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
131089396|NCT03083665|471960640|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
131089397|NCT03083665|471960641|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
131089398|NCT03083665|471960642|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
131089399|NCT03083665|471960643|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
131089400|NCT03083665|471960638|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
131089401|NCT03083665|471960639|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
131089402|NCT03083665|471960640|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
131089403|NCT03083665|471960641|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
131089404|NCT03083665|471960642|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
131089405|NCT03083665|471960643|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
131089406|NCT03083665|471960638|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
131142918|NCT02591615|472150446|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
131142919|NCT02591615|472150443|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
131142920|NCT02591615|472150444|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
131142921|NCT02591615|472150445|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
131142922|NCT02591615|472150446|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
131142923|NCT02591615|472150443|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
131142924|NCT02591615|472150444|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
131142925|NCT02591615|472150445|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
131142926|NCT02591615|472150446|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
131142927|NCT02591615|472150443|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
131142928|NCT02591615|472150444|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
131142929|NCT02591615|472150445|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
131142930|NCT02591615|472150446|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
131142931|NCT02591615|472150443|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
131142932|NCT02591615|472150444|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
131142933|NCT02591615|472150445|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
131142934|NCT02591615|472150446|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
131142935|NCT02591615|472150443|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
131142936|NCT02591615|472150444|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
131142937|NCT02591615|472150445|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
131142938|NCT02591615|472150446|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
131142939|NCT02591615|472150443|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
131234314|NCT01694485|472484637|FG003|Overall Study|Death|1|||
131089407|NCT03083665|471960639|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
131089408|NCT03083665|471960640|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
131089409|NCT03083665|471960641|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
131089410|NCT03083665|471960642|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
131089411|NCT03083665|471960643|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
131089412|NCT03083665|471960638|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
131089413|NCT03083665|471960639|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
131089414|NCT03083665|471960640|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
131089415|NCT03083665|471960641|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
131089416|NCT03083665|471960642|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
131089417|NCT03083665|471960643|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
131089421|NCT02519348|471960649|FG000|Overall Study|Death|31|||
131089422|NCT02519348|471960650|FG001|Overall Study|Death|74|||
131089423|NCT02519348|471960651|FG002|Overall Study|Death|47|||
131089424|NCT02519348|471960652|FG003|Overall Study|Death|54|||
131089425|NCT02519348|471960653|FG004|Overall Study|Death|63|||
131089426|NCT02519348|471960654|FG005|Overall Study|Death|18|||
131089427|NCT02519348|471960655|FG006|Overall Study|Death|2|||
131089428|NCT02519348|471960656|FG007|Overall Study|Death|5|||
131089429|NCT02519348|471960657|FG008|Overall Study|Death|5|||
131089430|NCT02519348|471960649|FG000|Overall Study|Withdrawal by Subject|4|||
131089431|NCT02519348|471960650|FG001|Overall Study|Withdrawal by Subject|7|||
131089432|NCT02519348|471960651|FG002|Overall Study|Withdrawal by Subject|4|||
131089433|NCT02519348|471960652|FG003|Overall Study|Withdrawal by Subject|3|||
131089434|NCT02519348|471960653|FG004|Overall Study|Withdrawal by Subject|3|||
131089435|NCT02519348|471960654|FG005|Overall Study|Withdrawal by Subject|2|||
131089436|NCT02519348|471960655|FG006|Overall Study|Withdrawal by Subject|0|||
131089437|NCT02519348|471960656|FG007|Overall Study|Withdrawal by Subject|0|||
131089438|NCT02519348|471960657|FG008|Overall Study|Withdrawal by Subject|1|||
131089439|NCT02519348|471960649|FG000|Overall Study|Lost to Follow-up|0|||
131089440|NCT02519348|471960650|FG001|Overall Study|Lost to Follow-up|0|||
131089441|NCT02519348|471960651|FG002|Overall Study|Lost to Follow-up|1|||
131089442|NCT02519348|471960652|FG003|Overall Study|Lost to Follow-up|0|||
131089443|NCT02519348|471960653|FG004|Overall Study|Lost to Follow-up|2|||
131089444|NCT02519348|471960654|FG005|Overall Study|Lost to Follow-up|1|||
131089445|NCT02519348|471960655|FG006|Overall Study|Lost to Follow-up|1|||
131089446|NCT02519348|471960656|FG007|Overall Study|Lost to Follow-up|0|||
131089447|NCT02519348|471960657|FG008|Overall Study|Lost to Follow-up|0|||
131089448|NCT02519348|471960649|FG000|Overall Study|Other|0|||
131089449|NCT02519348|471960650|FG001|Overall Study|Other|3|||
131089450|NCT02519348|471960651|FG002|Overall Study|Other|0|||
131089451|NCT02519348|471960652|FG003|Overall Study|Other|0|||
131089452|NCT02519348|471960653|FG004|Overall Study|Other|1|||
131089453|NCT02519348|471960654|FG005|Overall Study|Other|0|||
131089454|NCT02519348|471960655|FG006|Overall Study|Other|0|||
131089455|NCT02519348|471960656|FG007|Overall Study|Other|0|||
131089456|NCT02519348|471960657|FG008|Overall Study|Other|0|||
131089457|NCT02519348|471960649|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
131089458|NCT02519348|471960650|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
131089459|NCT02519348|471960651|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
131089460|NCT02519348|471960652|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
131089461|NCT02519348|471960653|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
131089462|NCT02519348|471960654|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
131089463|NCT02519348|471960655|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
131089464|NCT02519348|471960656|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
131234315|NCT01694485|472484638|FG004|Overall Study|Death|0|||
130780273|NCT02600923|470821475|FG000|Overall Study|Lost to Follow-up|1|||
131089465|NCT02519348|471960657|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
131089508|NCT06285240|471960663|FG000|Overall Study|Withdrawal by Subject|2|||
131089509|NCT06285240|471960664|FG001|Overall Study|Withdrawal by Subject|0|||
131089510|NCT06285240|471960665|FG002|Overall Study|Withdrawal by Subject|0|||
131089511|NCT06285240|471960666|FG003|Overall Study|Withdrawal by Subject|0|||
131089512|NCT06285240|471960663|FG000|Overall Study|Serious Adverse Event|0|||
131089513|NCT06285240|471960664|FG001|Overall Study|Serious Adverse Event|0|||
131089514|NCT06285240|471960665|FG002|Overall Study|Serious Adverse Event|1|||
131089515|NCT06285240|471960666|FG003|Overall Study|Serious Adverse Event|0|||
130727314|NCT02883049|470625434|FG010|Post Induction|Moved to another non-COG institution|0|||
130727315|NCT02883049|470625435|FG011|Post Induction|Moved to another non-COG institution|1|||
130727316|NCT02883049|470625436|FG012|Post Induction|Moved to another non-COG institution|0|||
130727317|NCT02883049|470625437|FG013|Post Induction|Moved to another non-COG institution|0|||
130727318|NCT02883049|470625438|FG014|Post Induction|Moved to another non-COG institution|0|||
130727319|NCT02883049|470625439|FG015|Post Induction|Moved to another non-COG institution|0|||
130727320|NCT02883049|470625424|FG000|Post Induction|Randomization closed|0|||
130727321|NCT02883049|470625425|FG001|Post Induction|Randomization closed|0|||
131234316|NCT01595009|472484639|FG000|Core|Patients completed per protocol|85|||
131234317|NCT01595009|472484640|FG001|Core|Patients completed per protocol|44|||
131234318|NCT01595009|472484641|FG002|Core|Patients completed per protocol|0|||
131234319|NCT01595009|472484642|FG003|Core|Patients completed per protocol|0|||
131234320|NCT01595009|472484639|FG000|Core|Adverse Event|19|||
131234321|NCT01595009|472484640|FG001|Core|Adverse Event|23|||
131234322|NCT01595009|472484641|FG002|Core|Adverse Event|0|||
131234323|NCT01595009|472484642|FG003|Core|Adverse Event|0|||
131234324|NCT01595009|472484639|FG000|Core|Disease progression|14|||
131234325|NCT01595009|472484640|FG001|Core|Disease progression|26|||
131234326|NCT01595009|472484641|FG002|Core|Disease progression|0|||
131234327|NCT01595009|472484642|FG003|Core|Disease progression|0|||
131234328|NCT01595009|472484639|FG000|Core|Withdrawal by Subject|4|||
131234329|NCT01595009|472484640|FG001|Core|Withdrawal by Subject|17|||
131234330|NCT01595009|472484641|FG002|Core|Withdrawal by Subject|0|||
131089548|NCT04428151|471960671|FG000|Overall Study|Death|100|||
131089549|NCT04428151|471960672|FG001|Overall Study|Death|86|||
131089550|NCT04428151|471960673|FG002|Overall Study|Death|57|||
131089551|NCT04428151|471960671|FG000|Overall Study|Lost to Follow-up|1|||
131089552|NCT04428151|471960672|FG001|Overall Study|Lost to Follow-up|1|||
131089553|NCT04428151|471960673|FG002|Overall Study|Lost to Follow-up|0|||
131089554|NCT04428151|471960671|FG000|Overall Study|Withdrawal by Subject|2|||
131089555|NCT04428151|471960672|FG001|Overall Study|Withdrawal by Subject|2|||
131089556|NCT04428151|471960673|FG002|Overall Study|Withdrawal by Subject|3|||
131089557|NCT04428151|471960671|FG000|Overall Study|Participant Ongoing in Study|41|||
131089558|NCT04428151|471960672|FG001|Overall Study|Participant Ongoing in Study|53|||
131089559|NCT04428151|471960673|FG002|Overall Study|Participant Ongoing in Study|28|||
131234331|NCT01595009|472484642|FG003|Core|Withdrawal by Subject|0|||
131234332|NCT01595009|472484639|FG000|Core|Death|3|||
131234333|NCT01595009|472484640|FG001|Core|Death|6|||
131234334|NCT01595009|472484641|FG002|Core|Death|0|||
131234335|NCT01595009|472484642|FG003|Core|Death|0|||
131234336|NCT01595009|472484639|FG000|Core|Lost to Follow-up|1|||
131234337|NCT01595009|472484640|FG001|Core|Lost to Follow-up|2|||
131234338|NCT01595009|472484641|FG002|Core|Lost to Follow-up|0|||
131234339|NCT01595009|472484642|FG003|Core|Lost to Follow-up|0|||
131234340|NCT01595009|472484639|FG000|Core|Protocol deviation|0|||
131234341|NCT01595009|472484640|FG001|Core|Protocol deviation|1|||
131234342|NCT01595009|472484641|FG002|Core|Protocol deviation|0|||
131234343|NCT01595009|472484642|FG003|Core|Protocol deviation|0|||
131089578|NCT04844879|471960690|FG000|Overall Study|Death|1|||
131089579|NCT04844879|471960690|FG000|Overall Study|Withdrawal by Subject|1|||
131089580|NCT04844879|471960690|FG000|Overall Study|Adverse Event|1|||
131089581|NCT06152224|471960693|FG000|Overall Study|Withdrawal by Subject|1|||
131089582|NCT06152224|471960694|FG001|Overall Study|Withdrawal by Subject|0|||
131089583|NCT06152224|471960693|FG000|Overall Study|Lost to Follow-up|0|||
131234344|NCT01595009|472484639|FG000|Core|Administrative problems|0|||
131234345|NCT01595009|472484640|FG001|Core|Administrative problems|1|||
131234346|NCT01595009|472484641|FG002|Core|Administrative problems|0|||
131234347|NCT01595009|472484642|FG003|Core|Administrative problems|0|||
131234348|NCT01595009|472484639|FG000|Extension|Administrative problems|0|||
131234349|NCT01595009|472484640|FG001|Extension|Administrative problems|0|||
131089584|NCT06152224|471960694|FG001|Overall Study|Lost to Follow-up|1|||
131089585|NCT06152224|471960693|FG000|Overall Study|On Follow Up|18|||
131089586|NCT06152224|471960694|FG001|Overall Study|On Follow Up|18|||
131089640|NCT04201262|471960719|FG000|Primary Treatment Period|Adverse Event|1|||
131089641|NCT04201262|471960720|FG001|Primary Treatment Period|Adverse Event|2|||
131234350|NCT01595009|472484641|FG002|Extension|Administrative problems|0|||
130727322|NCT02883049|470625426|FG002|Post Induction|Randomization closed|0|||
130727323|NCT02883049|470625427|FG003|Post Induction|Randomization closed|0|||
131089642|NCT04201262|471960719|FG000|Primary Treatment Period|Physician Decision|1|||
131089643|NCT04201262|471960720|FG001|Primary Treatment Period|Physician Decision|1|||
131089644|NCT04201262|471960719|FG000|Long-term Extension Period|Death|1|||
131089645|NCT04201262|471960720|FG001|Long-term Extension Period|Death|0|||
131234351|NCT01595009|472484642|FG003|Extension|Administrative problems|1|||
131089656|NCT03307785|471960724|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
131089657|NCT03307785|471960725|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
130727324|NCT02883049|470625428|FG004|Post Induction|Randomization closed|0|||
130727325|NCT02883049|470625429|FG005|Post Induction|Randomization closed|0|||
130727326|NCT02883049|470625430|FG006|Post Induction|Randomization closed|0|||
130727327|NCT02883049|470625431|FG007|Post Induction|Randomization closed|20|||
131089658|NCT03307785|471960726|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
131089659|NCT03307785|471960727|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
131089660|NCT03307785|471960728|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
131089661|NCT03307785|471960729|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
131089662|NCT03307785|471960730|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
131089663|NCT03307785|471960731|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
131089664|NCT03307785|471960732|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
131089665|NCT03307785|471960733|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
131089666|NCT03307785|471960734|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
131089667|NCT03307785|471960724|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
131089668|NCT03307785|471960725|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
131089669|NCT03307785|471960726|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130780274|NCT02600923|470821475|FG000|Overall Study|Withdrawal by Subject|5|||
130780275|NCT02600923|470821475|FG000|Overall Study|Objective progression or relapse|50|||
130780276|NCT02600923|470821475|FG000|Overall Study|Study terminated by Sponsor|53|||
131089670|NCT03307785|471960727|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131089671|NCT03307785|471960728|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131089672|NCT03307785|471960729|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131089673|NCT03307785|471960730|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131089674|NCT03307785|471960731|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131089675|NCT03307785|471960732|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131089676|NCT03307785|471960733|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131089677|NCT03307785|471960734|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
131089678|NCT03307785|471960724|FG000|Part A: Up to 28.5 Months|Death|4|||
131089679|NCT03307785|471960725|FG001|Part A: Up to 28.5 Months|Death|4|||
131089680|NCT03307785|471960726|FG002|Part A: Up to 28.5 Months|Death|0|||
131089681|NCT03307785|471960727|FG003|Part A: Up to 28.5 Months|Death|0|||
131089682|NCT03307785|471960728|FG004|Part A: Up to 28.5 Months|Death|0|||
131089683|NCT03307785|471960729|FG005|Part A: Up to 28.5 Months|Death|0|||
131089684|NCT03307785|471960730|FG006|Part A: Up to 28.5 Months|Death|0|||
131089685|NCT03307785|471960731|FG007|Part A: Up to 28.5 Months|Death|0|||
131089686|NCT03307785|471960732|FG008|Part A: Up to 28.5 Months|Death|0|||
131089687|NCT03307785|471960733|FG009|Part A: Up to 28.5 Months|Death|0|||
131089688|NCT03307785|471960734|FG010|Part A: Up to 28.5 Months|Death|0|||
131089689|NCT03307785|471960724|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
131089690|NCT03307785|471960725|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
131089691|NCT03307785|471960726|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
131089692|NCT03307785|471960727|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
131089693|NCT03307785|471960728|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
131089694|NCT03307785|471960729|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
131089695|NCT03307785|471960730|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
131089696|NCT03307785|471960731|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
131089697|NCT03307785|471960732|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
131089698|NCT03307785|471960733|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
131089699|NCT03307785|471960734|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
131089700|NCT03307785|471960724|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
130727328|NCT02883049|470625432|FG008|Post Induction|Randomization closed|0|||
130727329|NCT02883049|470625433|FG009|Post Induction|Randomization closed|0|||
130727330|NCT02883049|470625434|FG010|Post Induction|Randomization closed|0|||
130727331|NCT02883049|470625435|FG011|Post Induction|Randomization closed|0|||
130727332|NCT02883049|470625436|FG012|Post Induction|Randomization closed|0|||
130727333|NCT02883049|470625437|FG013|Post Induction|Randomization closed|0|||
130780277|NCT02600923|470821475|FG000|Overall Study|Not treated|1|||
131089701|NCT03307785|471960725|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
131089702|NCT03307785|471960726|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
131089703|NCT03307785|471960727|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
131089704|NCT03307785|471960728|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
131089705|NCT03307785|471960729|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
131089706|NCT03307785|471960730|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
131089707|NCT03307785|471960731|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
131089708|NCT03307785|471960732|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
131089709|NCT03307785|471960733|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
131089710|NCT03307785|471960734|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
131089711|NCT03307785|471960724|FG000|Part B: Up to Approx. 66 Months|Death|0|||
131089712|NCT03307785|471960725|FG001|Part B: Up to Approx. 66 Months|Death|0|||
131089713|NCT03307785|471960726|FG002|Part B: Up to Approx. 66 Months|Death|7|||
131089714|NCT03307785|471960727|FG003|Part B: Up to Approx. 66 Months|Death|0|||
131089715|NCT03307785|471960728|FG004|Part B: Up to Approx. 66 Months|Death|0|||
131089716|NCT03307785|471960729|FG005|Part B: Up to Approx. 66 Months|Death|0|||
131089717|NCT03307785|471960730|FG006|Part B: Up to Approx. 66 Months|Death|0|||
131089718|NCT03307785|471960731|FG007|Part B: Up to Approx. 66 Months|Death|0|||
131089719|NCT03307785|471960732|FG008|Part B: Up to Approx. 66 Months|Death|0|||
131089720|NCT03307785|471960733|FG009|Part B: Up to Approx. 66 Months|Death|0|||
131089721|NCT03307785|471960734|FG010|Part B: Up to Approx. 66 Months|Death|0|||
131089722|NCT03307785|471960724|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131089723|NCT03307785|471960725|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131089724|NCT03307785|471960726|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
131089725|NCT03307785|471960727|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131089726|NCT03307785|471960728|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131089727|NCT03307785|471960729|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131089728|NCT03307785|471960730|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131089729|NCT03307785|471960731|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131089730|NCT03307785|471960732|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131089731|NCT03307785|471960733|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131089732|NCT03307785|471960734|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
131089733|NCT03307785|471960724|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131089734|NCT03307785|471960725|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131142940|NCT02591615|472150444|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
131142941|NCT02591615|472150445|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
131142942|NCT02591615|472150446|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
131142943|NCT02591615|472150443|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
131142944|NCT02591615|472150444|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
131142945|NCT02591615|472150445|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
131142946|NCT02591615|472150446|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
131142947|NCT02591615|472150443|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
131142948|NCT02591615|472150444|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
131142949|NCT02591615|472150445|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
131142950|NCT02591615|472150446|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
131142951|NCT02591615|472150443|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
131142952|NCT02591615|472150444|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
131142953|NCT02591615|472150445|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
131142954|NCT02591615|472150446|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
131142955|NCT02591615|472150443|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
131142956|NCT02591615|472150444|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
131142957|NCT02591615|472150445|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
131142958|NCT02591615|472150446|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
131142959|NCT02591615|472150443|FG000|Maintenance MK-3475|Adverse Event|0|||
131142960|NCT02591615|472150444|FG001|Maintenance MK-3475|Adverse Event|3|||
131142961|NCT02591615|472150445|FG002|Maintenance MK-3475|Adverse Event|1|||
131142962|NCT02591615|472150446|FG003|Maintenance MK-3475|Adverse Event|2|||
131142963|NCT02591615|472150443|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
131142964|NCT02591615|472150444|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
131142965|NCT02591615|472150445|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
131142966|NCT02591615|472150446|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
131142967|NCT02591615|472150443|FG000|Maintenance MK-3475|Death|0|||
131142968|NCT02591615|472150444|FG001|Maintenance MK-3475|Death|1|||
131142969|NCT02591615|472150445|FG002|Maintenance MK-3475|Death|1|||
131142970|NCT02591615|472150446|FG003|Maintenance MK-3475|Death|0|||
131142971|NCT02591615|472150443|FG000|Maintenance MK-3475|Physician discretion|0|||
131142972|NCT02591615|472150444|FG001|Maintenance MK-3475|Physician discretion|0|||
131142973|NCT02591615|472150445|FG002|Maintenance MK-3475|Physician discretion|1|||
131142974|NCT02591615|472150446|FG003|Maintenance MK-3475|Physician discretion|0|||
131142975|NCT02591615|472150443|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
131142976|NCT02591615|472150444|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
131142977|NCT02591615|472150445|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
131142978|NCT02591615|472150446|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
131142979|NCT02591615|472150443|FG000|Maintenance MK-3475|In active treatment|2|||
131142980|NCT02591615|472150444|FG001|Maintenance MK-3475|In active treatment|0|||
131142981|NCT02591615|472150445|FG002|Maintenance MK-3475|In active treatment|0|||
131089735|NCT03307785|471960726|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
131089736|NCT03307785|471960727|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131089737|NCT03307785|471960728|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131142982|NCT02591615|472150446|FG003|Maintenance MK-3475|In active treatment|1|||
131142983|NCT04188197|472150447|FG000|Overall Study|Lost to Follow-up|4|||
131142984|NCT04188197|472150448|FG001|Overall Study|Lost to Follow-up|1|||
131142985|NCT04188197|472150447|FG000|Overall Study|Withdrawal by Subject|1|||
131089738|NCT03307785|471960729|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131089739|NCT03307785|471960730|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131089740|NCT03307785|471960731|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131089741|NCT03307785|471960732|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131089742|NCT03307785|471960733|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131089743|NCT03307785|471960734|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
131089744|NCT03307785|471960724|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131089745|NCT03307785|471960725|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131089746|NCT03307785|471960726|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
131089747|NCT03307785|471960727|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131089748|NCT03307785|471960728|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131089749|NCT03307785|471960729|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131089750|NCT03307785|471960730|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131089751|NCT03307785|471960731|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131089752|NCT03307785|471960732|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131089753|NCT03307785|471960733|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131089754|NCT03307785|471960734|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
131089755|NCT03307785|471960724|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131089756|NCT03307785|471960725|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131089757|NCT03307785|471960726|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131089758|NCT03307785|471960727|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
131089759|NCT03307785|471960728|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
131089760|NCT03307785|471960729|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131089761|NCT03307785|471960730|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131089762|NCT03307785|471960731|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131089763|NCT03307785|471960732|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131089764|NCT03307785|471960733|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130727334|NCT02883049|470625438|FG014|Post Induction|Randomization closed|0|||
130727335|NCT02883049|470625439|FG015|Post Induction|Randomization closed|0|||
131089765|NCT03307785|471960734|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
131089766|NCT03307785|471960724|FG000|Part C: Up to Approx. 60 Months|Death|0|||
131089767|NCT03307785|471960725|FG001|Part C: Up to Approx. 60 Months|Death|0|||
131142986|NCT04188197|472150448|FG001|Overall Study|Withdrawal by Subject|1|||
131142987|NCT04188197|472150447|FG000|Overall Study|Pregnancy|0|||
131142988|NCT04188197|472150448|FG001|Overall Study|Pregnancy|1|||
131142989|NCT00132041|472150454|FG000|Baseline|Ineligible|6|||
131142990|NCT00132041|472150454|FG000|3 Months Post Ablation|Transplant|1|||
131142991|NCT00132041|472150454|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
131142992|NCT00132041|472150454|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
131142993|NCT00132041|472150454|FG000|6 Months Post Ablation|Death|2|||
131142994|NCT00132041|472150454|FG000|6 Months Post Ablation|Transplant|6|||
131142995|NCT00132041|472150454|FG000|9 Months Post Ablation|Death|1|||
131142996|NCT00132041|472150454|FG000|9 Months Post Ablation|Transplant|1|||
131142997|NCT00132041|472150454|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
131142998|NCT00132041|472150454|FG000|12 Months Post Ablation|Death|1|||
131142999|NCT00132041|472150454|FG000|12 Months Post Ablation|Transplant|1|||
131143000|NCT00132041|472150454|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
131143001|NCT00132041|472150454|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
131143002|NCT00132041|472150454|FG000|15 Months Post Ablation|Death|1|||
131143003|NCT00132041|472150454|FG000|15 Months Post Ablation|Transplant|5|||
131143004|NCT00132041|472150454|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
131143005|NCT00132041|472150454|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
131143006|NCT00132041|472150454|FG000|18 Months Post Ablation|Transplant|1|||
131143007|NCT00132041|472150454|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
131143008|NCT00132041|472150454|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
131143009|NCT03609619|472150455|FG000|Overall Study|Adverse Event|1|||
131143010|NCT03609619|472150456|FG001|Overall Study|Adverse Event|0|||
131143011|NCT03609619|472150455|FG000|Overall Study|Lack of Efficacy|1|||
131143012|NCT03609619|472150456|FG001|Overall Study|Lack of Efficacy|2|||
131143013|NCT03609619|472150455|FG000|Overall Study|Protocol Violation|5|||
131143014|NCT03609619|472150456|FG001|Overall Study|Protocol Violation|0|||
131143015|NCT03609619|472150455|FG000|Overall Study|Withdrawal by Subject|2|||
131143016|NCT03609619|472150456|FG001|Overall Study|Withdrawal by Subject|3|||
131143017|NCT03609619|472150455|FG000|Overall Study|Lost to Follow-up|1|||
131143018|NCT03609619|472150456|FG001|Overall Study|Lost to Follow-up|1|||
131143019|NCT00956943|472150457|FG000|Overall Study|Lost to Follow-up|9|||
131143020|NCT00956943|472150458|FG001|Overall Study|Lost to Follow-up|10|||
131143021|NCT02663895|472150459|FG000|Overall Study|Adverse Event|3|||
131143022|NCT02663895|472150459|FG000|Overall Study|Physician Decision|2|||
131143023|NCT02663895|472150459|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
131143024|NCT02663895|472150459|FG000|Overall Study|Withdrawal by Subject|1|||
131089768|NCT03307785|471960726|FG002|Part C: Up to Approx. 60 Months|Death|0|||
131089769|NCT03307785|471960727|FG003|Part C: Up to Approx. 60 Months|Death|2|||
131089770|NCT03307785|471960728|FG004|Part C: Up to Approx. 60 Months|Death|5|||
131089771|NCT03307785|471960729|FG005|Part C: Up to Approx. 60 Months|Death|0|||
131089772|NCT03307785|471960730|FG006|Part C: Up to Approx. 60 Months|Death|0|||
131089773|NCT03307785|471960731|FG007|Part C: Up to Approx. 60 Months|Death|0|||
131089774|NCT03307785|471960732|FG008|Part C: Up to Approx. 60 Months|Death|0|||
131089775|NCT03307785|471960733|FG009|Part C: Up to Approx. 60 Months|Death|0|||
131089776|NCT03307785|471960734|FG010|Part C: Up to Approx. 60 Months|Death|0|||
131089777|NCT03307785|471960724|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131089778|NCT03307785|471960725|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131089779|NCT03307785|471960726|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131089780|NCT03307785|471960727|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
131089781|NCT03307785|471960728|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131089782|NCT03307785|471960729|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131089783|NCT03307785|471960730|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131089784|NCT03307785|471960731|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131089785|NCT03307785|471960732|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131089786|NCT03307785|471960733|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131089787|NCT03307785|471960734|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
131089788|NCT03307785|471960724|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131089789|NCT03307785|471960725|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131089790|NCT03307785|471960726|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131089791|NCT03307785|471960727|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131089792|NCT03307785|471960728|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
131089793|NCT03307785|471960729|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131089794|NCT03307785|471960730|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131089795|NCT03307785|471960731|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131089796|NCT03307785|471960732|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131089797|NCT03307785|471960733|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131089798|NCT03307785|471960734|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
131089799|NCT03307785|471960724|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131089800|NCT03307785|471960725|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131089801|NCT03307785|471960726|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131089802|NCT03307785|471960727|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131089803|NCT03307785|471960728|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131089804|NCT03307785|471960729|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
131089805|NCT03307785|471960730|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131089806|NCT03307785|471960731|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131089807|NCT03307785|471960732|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131089808|NCT03307785|471960733|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131089809|NCT03307785|471960734|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
131089810|NCT03307785|471960724|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
131089811|NCT03307785|471960725|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
131089812|NCT03307785|471960726|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
131089813|NCT03307785|471960727|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
131089814|NCT03307785|471960728|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
131089815|NCT03307785|471960729|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
131089816|NCT03307785|471960730|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
131089817|NCT03307785|471960731|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
131089818|NCT03307785|471960732|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
131089819|NCT03307785|471960733|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
131089820|NCT03307785|471960734|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
131089821|NCT03307785|471960724|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131089822|NCT03307785|471960725|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131089823|NCT03307785|471960726|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131089824|NCT03307785|471960727|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131089825|NCT03307785|471960728|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131089826|NCT03307785|471960729|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
131089827|NCT03307785|471960730|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131089828|NCT03307785|471960731|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131089829|NCT03307785|471960732|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131089830|NCT03307785|471960733|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131089831|NCT03307785|471960734|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
131089832|NCT03307785|471960724|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131089833|NCT03307785|471960725|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130727336|NCT02883049|470625424|FG000|Post Induction|MRD negative|0|||
131089834|NCT03307785|471960726|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131089835|NCT03307785|471960727|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131089836|NCT03307785|471960728|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131089837|NCT03307785|471960729|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
131089838|NCT03307785|471960730|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131089839|NCT03307785|471960731|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131089840|NCT03307785|471960732|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131089841|NCT03307785|471960733|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131089842|NCT03307785|471960734|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
131089843|NCT03307785|471960724|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131089844|NCT03307785|471960725|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131089845|NCT03307785|471960726|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131089846|NCT03307785|471960727|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131089847|NCT03307785|471960728|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131089848|NCT03307785|471960729|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
131089849|NCT03307785|471960730|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131089850|NCT03307785|471960731|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131089851|NCT03307785|471960732|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131089852|NCT03307785|471960733|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131089853|NCT03307785|471960734|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
131089854|NCT03307785|471960724|FG000|Part E: Up to 4.4 Months|Death|0|||
131089855|NCT03307785|471960725|FG001|Part E: Up to 4.4 Months|Death|0|||
131089856|NCT03307785|471960726|FG002|Part E: Up to 4.4 Months|Death|0|||
131089857|NCT03307785|471960727|FG003|Part E: Up to 4.4 Months|Death|0|||
131089858|NCT03307785|471960728|FG004|Part E: Up to 4.4 Months|Death|0|||
131089859|NCT03307785|471960729|FG005|Part E: Up to 4.4 Months|Death|0|||
131089860|NCT03307785|471960730|FG006|Part E: Up to 4.4 Months|Death|1|||
131089861|NCT03307785|471960731|FG007|Part E: Up to 4.4 Months|Death|0|||
131089862|NCT03307785|471960732|FG008|Part E: Up to 4.4 Months|Death|0|||
131089863|NCT03307785|471960733|FG009|Part E: Up to 4.4 Months|Death|0|||
131089864|NCT03307785|471960734|FG010|Part E: Up to 4.4 Months|Death|0|||
131089865|NCT03307785|471960724|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
131089866|NCT03307785|471960725|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
131089867|NCT03307785|471960726|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
131089868|NCT03307785|471960727|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
131089869|NCT03307785|471960728|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
131089870|NCT03307785|471960729|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
131089871|NCT03307785|471960730|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
131089872|NCT03307785|471960731|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
131089873|NCT03307785|471960732|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
131089874|NCT03307785|471960733|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
131089875|NCT03307785|471960734|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
131089876|NCT03307785|471960724|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
131089877|NCT03307785|471960725|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
131089878|NCT03307785|471960726|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
131089879|NCT03307785|471960727|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
131089880|NCT03307785|471960728|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
131089881|NCT03307785|471960729|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
131089882|NCT03307785|471960730|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
131089883|NCT03307785|471960731|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
131089884|NCT03307785|471960732|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
131089885|NCT03307785|471960733|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
131143025|NCT02911688|472150463|FG000|Washout|Lost to Follow-up|1|||
131143026|NCT02911688|472150464|FG001|Washout|Lost to Follow-up|1|||
131143027|NCT02911688|472150463|FG000|Washout|Withdrawal by Subject|0|||
131143028|NCT02911688|472150464|FG001|Washout|Withdrawal by Subject|1|||
131143029|NCT00809328|472150465|FG000|Overall Study|Lack of Efficacy|18|||
131143030|NCT00809328|472150465|FG000|Overall Study|Adverse Event|6|||
131143031|NCT00809328|472150465|FG000|Overall Study|Protocol Violation|3|||
131143032|NCT00809328|472150465|FG000|Overall Study|Withdrawal by Subject|2|||
131143033|NCT00066690|472150468|FG000|Overall Study|Adverse Event|145|||
131143034|NCT00066690|472150469|FG001|Overall Study|Adverse Event|58|||
131143035|NCT00066690|472150470|FG002|Overall Study|Adverse Event|126|||
131143036|NCT00066690|472150468|FG000|Overall Study|Death|3|||
131089886|NCT03307785|471960734|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
131143037|NCT00066690|472150469|FG001|Overall Study|Death|0|||
131143038|NCT00066690|472150470|FG002|Overall Study|Death|2|||
131143039|NCT00066690|472150468|FG000|Overall Study|Lack of Efficacy|114|||
131143040|NCT00066690|472150469|FG001|Overall Study|Lack of Efficacy|110|||
131089907|NCT03217747|471960741|FG000|Overall Study|Adverse Event|0|||
131089908|NCT03217747|471960742|FG001|Overall Study|Adverse Event|1|||
131089909|NCT03217747|471960743|FG002|Overall Study|Adverse Event|0|||
131089910|NCT03217747|471960744|FG003|Overall Study|Adverse Event|0|||
131089911|NCT03217747|471960745|FG004|Overall Study|Adverse Event|0|||
131089912|NCT03217747|471960746|FG005|Overall Study|Adverse Event|0|||
131089913|NCT03217747|471960747|FG006|Overall Study|Adverse Event|0|||
131089914|NCT03217747|471960748|FG007|Overall Study|Adverse Event|0|||
131089915|NCT03217747|471960749|FG008|Overall Study|Adverse Event|0|||
131089916|NCT03217747|471960750|FG009|Overall Study|Adverse Event|0|||
131089917|NCT03217747|471960751|FG010|Overall Study|Adverse Event|0|||
131089918|NCT03217747|471960752|FG011|Overall Study|Adverse Event|0|||
131089919|NCT03217747|471960753|FG012|Overall Study|Adverse Event|1|||
131089920|NCT03217747|471960754|FG013|Overall Study|Adverse Event|1|||
131089921|NCT03217747|471960741|FG000|Overall Study|Death|0|||
131089922|NCT03217747|471960742|FG001|Overall Study|Death|0|||
131089923|NCT03217747|471960743|FG002|Overall Study|Death|0|||
131089924|NCT03217747|471960744|FG003|Overall Study|Death|0|||
131089925|NCT03217747|471960745|FG004|Overall Study|Death|0|||
131089926|NCT03217747|471960746|FG005|Overall Study|Death|0|||
131089927|NCT03217747|471960747|FG006|Overall Study|Death|0|||
131089928|NCT03217747|471960748|FG007|Overall Study|Death|0|||
131089929|NCT03217747|471960749|FG008|Overall Study|Death|1|||
131089930|NCT03217747|471960750|FG009|Overall Study|Death|0|||
131089931|NCT03217747|471960751|FG010|Overall Study|Death|0|||
131089932|NCT03217747|471960752|FG011|Overall Study|Death|0|||
131089933|NCT03217747|471960753|FG012|Overall Study|Death|0|||
131089934|NCT03217747|471960754|FG013|Overall Study|Death|0|||
131089935|NCT03217747|471960741|FG000|Overall Study|Lack of Efficacy|12|||
131089936|NCT03217747|471960742|FG001|Overall Study|Lack of Efficacy|6|||
131089937|NCT03217747|471960743|FG002|Overall Study|Lack of Efficacy|15|||
131089938|NCT03217747|471960744|FG003|Overall Study|Lack of Efficacy|11|||
131089939|NCT03217747|471960745|FG004|Overall Study|Lack of Efficacy|3|||
131089940|NCT03217747|471960746|FG005|Overall Study|Lack of Efficacy|14|||
131089941|NCT03217747|471960747|FG006|Overall Study|Lack of Efficacy|10|||
131143041|NCT00066690|472150470|FG002|Overall Study|Lack of Efficacy|76|||
131143042|NCT00066690|472150468|FG000|Overall Study|Lost to Follow-up|40|||
131143043|NCT00066690|472150469|FG001|Overall Study|Lost to Follow-up|21|||
131089942|NCT03217747|471960748|FG007|Overall Study|Lack of Efficacy|4|||
131089943|NCT03217747|471960749|FG008|Overall Study|Lack of Efficacy|2|||
131089944|NCT03217747|471960750|FG009|Overall Study|Lack of Efficacy|7|||
131089945|NCT03217747|471960751|FG010|Overall Study|Lack of Efficacy|3|||
131089946|NCT03217747|471960752|FG011|Overall Study|Lack of Efficacy|1|||
131089947|NCT03217747|471960753|FG012|Overall Study|Lack of Efficacy|3|||
131089948|NCT03217747|471960754|FG013|Overall Study|Lack of Efficacy|1|||
131089949|NCT03217747|471960741|FG000|Overall Study|Withdrawal by Subject|2|||
130727337|NCT02883049|470625425|FG001|Post Induction|MRD negative|0|||
131089950|NCT03217747|471960742|FG001|Overall Study|Withdrawal by Subject|1|||
131089951|NCT03217747|471960743|FG002|Overall Study|Withdrawal by Subject|1|||
131089952|NCT03217747|471960744|FG003|Overall Study|Withdrawal by Subject|1|||
131089953|NCT03217747|471960745|FG004|Overall Study|Withdrawal by Subject|1|||
131089954|NCT03217747|471960746|FG005|Overall Study|Withdrawal by Subject|2|||
131089955|NCT03217747|471960747|FG006|Overall Study|Withdrawal by Subject|1|||
131089956|NCT03217747|471960748|FG007|Overall Study|Withdrawal by Subject|0|||
131089957|NCT03217747|471960749|FG008|Overall Study|Withdrawal by Subject|0|||
131089958|NCT03217747|471960750|FG009|Overall Study|Withdrawal by Subject|0|||
131143044|NCT00066690|472150470|FG002|Overall Study|Lost to Follow-up|29|||
131089959|NCT03217747|471960751|FG010|Overall Study|Withdrawal by Subject|0|||
131089960|NCT03217747|471960752|FG011|Overall Study|Withdrawal by Subject|1|||
131089961|NCT03217747|471960753|FG012|Overall Study|Withdrawal by Subject|0|||
131089962|NCT03217747|471960754|FG013|Overall Study|Withdrawal by Subject|1|||
130727338|NCT02883049|470625426|FG002|Post Induction|MRD negative|0|||
131089963|NCT03217747|471960741|FG000|Overall Study|Toxicity and progression|1|||
131089964|NCT03217747|471960742|FG001|Overall Study|Toxicity and progression|0|||
131089965|NCT03217747|471960743|FG002|Overall Study|Toxicity and progression|0|||
131089966|NCT03217747|471960744|FG003|Overall Study|Toxicity and progression|0|||
131089967|NCT03217747|471960745|FG004|Overall Study|Toxicity and progression|0|||
131089968|NCT03217747|471960746|FG005|Overall Study|Toxicity and progression|0|||
131089969|NCT03217747|471960747|FG006|Overall Study|Toxicity and progression|0|||
131089970|NCT03217747|471960748|FG007|Overall Study|Toxicity and progression|0|||
131089971|NCT03217747|471960749|FG008|Overall Study|Toxicity and progression|0|||
131089972|NCT03217747|471960750|FG009|Overall Study|Toxicity and progression|0|||
131089973|NCT03217747|471960751|FG010|Overall Study|Toxicity and progression|0|||
131089974|NCT03217747|471960752|FG011|Overall Study|Toxicity and progression|0|||
131089975|NCT03217747|471960753|FG012|Overall Study|Toxicity and progression|0|||
131089976|NCT03217747|471960754|FG013|Overall Study|Toxicity and progression|0|||
131089977|NCT03217747|471960741|FG000|Overall Study|Removal of sole target lesion|1|||
131089978|NCT03217747|471960742|FG001|Overall Study|Removal of sole target lesion|0|||
131089979|NCT03217747|471960743|FG002|Overall Study|Removal of sole target lesion|0|||
131089980|NCT03217747|471960744|FG003|Overall Study|Removal of sole target lesion|0|||
131089981|NCT03217747|471960745|FG004|Overall Study|Removal of sole target lesion|0|||
131089982|NCT03217747|471960746|FG005|Overall Study|Removal of sole target lesion|0|||
131089983|NCT03217747|471960747|FG006|Overall Study|Removal of sole target lesion|0|||
131089984|NCT03217747|471960748|FG007|Overall Study|Removal of sole target lesion|0|||
131089985|NCT03217747|471960749|FG008|Overall Study|Removal of sole target lesion|0|||
131089986|NCT03217747|471960750|FG009|Overall Study|Removal of sole target lesion|0|||
131089987|NCT03217747|471960751|FG010|Overall Study|Removal of sole target lesion|0|||
131089988|NCT03217747|471960752|FG011|Overall Study|Removal of sole target lesion|0|||
131089989|NCT03217747|471960753|FG012|Overall Study|Removal of sole target lesion|0|||
131089990|NCT03217747|471960754|FG013|Overall Study|Removal of sole target lesion|0|||
131089991|NCT03217747|471960741|FG000|Overall Study|Stroke|0|||
131089992|NCT03217747|471960742|FG001|Overall Study|Stroke|0|||
131089993|NCT03217747|471960743|FG002|Overall Study|Stroke|0|||
131089994|NCT03217747|471960744|FG003|Overall Study|Stroke|0|||
131089995|NCT03217747|471960745|FG004|Overall Study|Stroke|0|||
131089996|NCT03217747|471960746|FG005|Overall Study|Stroke|1|||
131089997|NCT03217747|471960747|FG006|Overall Study|Stroke|0|||
131089998|NCT03217747|471960748|FG007|Overall Study|Stroke|0|||
131089999|NCT03217747|471960749|FG008|Overall Study|Stroke|0|||
131090000|NCT03217747|471960750|FG009|Overall Study|Stroke|0|||
131090001|NCT03217747|471960751|FG010|Overall Study|Stroke|0|||
131090002|NCT03217747|471960752|FG011|Overall Study|Stroke|1|||
131090003|NCT03217747|471960753|FG012|Overall Study|Stroke|0|||
131090004|NCT03217747|471960754|FG013|Overall Study|Stroke|0|||
131090005|NCT04103892|471960755|FG000|Overall Study|Adverse Event|0|||
131090006|NCT04103892|471960756|FG001|Overall Study|Adverse Event|0|||
131090007|NCT04103892|471960757|FG002|Overall Study|Adverse Event|0|||
131090008|NCT04103892|471960758|FG003|Overall Study|Adverse Event|3|||
131090009|NCT04103892|471960755|FG000|Overall Study|Lost to Follow-up|0|||
131090010|NCT04103892|471960756|FG001|Overall Study|Lost to Follow-up|0|||
131090011|NCT04103892|471960757|FG002|Overall Study|Lost to Follow-up|2|||
131090012|NCT04103892|471960758|FG003|Overall Study|Lost to Follow-up|0|||
131090013|NCT04103892|471960755|FG000|Overall Study|Protocol Violation|0|||
131090014|NCT04103892|471960756|FG001|Overall Study|Protocol Violation|0|||
131090015|NCT04103892|471960757|FG002|Overall Study|Protocol Violation|1|||
131090016|NCT04103892|471960758|FG003|Overall Study|Protocol Violation|1|||
131090017|NCT04103892|471960755|FG000|Overall Study|Withdrawal by Subject|1|||
131090018|NCT04103892|471960756|FG001|Overall Study|Withdrawal by Subject|0|||
131090019|NCT04103892|471960757|FG002|Overall Study|Withdrawal by Subject|2|||
130727339|NCT02883049|470625427|FG003|Post Induction|MRD negative|0|||
130727340|NCT02883049|470625428|FG004|Post Induction|MRD negative|0|||
131090020|NCT04103892|471960758|FG003|Overall Study|Withdrawal by Subject|5|||
131090021|NCT04103892|471960755|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
131090022|NCT04103892|471960756|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
131090023|NCT04103892|471960757|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
131090024|NCT04103892|471960758|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
130727341|NCT02883049|470625429|FG005|Post Induction|MRD negative|0|||
130727342|NCT02883049|470625430|FG006|Post Induction|MRD negative|0|||
131143045|NCT00066690|472150468|FG000|Overall Study|Withdrawal by Subject|50|||
131143046|NCT00066690|472150469|FG001|Overall Study|Withdrawal by Subject|55|||
131143047|NCT00066690|472150470|FG002|Overall Study|Withdrawal by Subject|49|||
131143048|NCT00066690|472150468|FG000|Overall Study|Treatment Ongoing|246|||
131143049|NCT00066690|472150469|FG001|Overall Study|Treatment Ongoing|278|||
130727343|NCT02883049|470625431|FG007|Post Induction|MRD negative|11|||
130727344|NCT02883049|470625432|FG008|Post Induction|MRD negative|0|||
130727345|NCT02883049|470625433|FG009|Post Induction|MRD negative|0|||
130727346|NCT02883049|470625434|FG010|Post Induction|MRD negative|0|||
130727347|NCT02883049|470625435|FG011|Post Induction|MRD negative|0|||
130727348|NCT02883049|470625436|FG012|Post Induction|MRD negative|0|||
130727349|NCT02883049|470625437|FG013|Post Induction|MRD negative|0|||
131143050|NCT00066690|472150470|FG002|Overall Study|Treatment Ongoing|282|||
131234352|NCT01595009|472484639|FG000|Extension|Patients completed per protocol|0|||
130727350|NCT02883049|470625438|FG014|Post Induction|MRD negative|0|||
130727351|NCT02883049|470625439|FG015|Post Induction|MRD negative|0|||
131234353|NCT01595009|472484640|FG001|Extension|Patients completed per protocol|0|||
131234354|NCT01595009|472484641|FG002|Extension|Patients completed per protocol|0|||
131234355|NCT01595009|472484642|FG003|Extension|Patients completed per protocol|2|||
131143051|NCT03706365|472150474|FG000|Overall Study|Lost to Follow-up|7|||
131143052|NCT03706365|472150475|FG001|Overall Study|Lost to Follow-up|0|||
131143053|NCT03706365|472150474|FG000|Overall Study|Withdrawal by Subject|17|||
131143054|NCT03706365|472150475|FG001|Overall Study|Withdrawal by Subject|15|||
131143055|NCT03706365|472150474|FG000|Overall Study|On Study Treatment|51|||
131143056|NCT03706365|472150475|FG001|Overall Study|On Study Treatment|51|||
131143057|NCT03116113|472150476|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131090241|NCT05217641|471960793|FG000|Overall Study|Lost to Follow-up|1|||
131090242|NCT05217641|471960794|FG001|Overall Study|Lost to Follow-up|1|||
131090243|NCT05217641|471960795|FG002|Overall Study|Lost to Follow-up|0|||
131090244|NCT05217641|471960796|FG003|Overall Study|Lost to Follow-up|1|||
131090245|NCT05217641|471960797|FG004|Overall Study|Lost to Follow-up|1|||
131090246|NCT05217641|471960798|FG005|Overall Study|Lost to Follow-up|0|||
131090247|NCT05217641|471960793|FG000|Overall Study|Withdrawal by Subject|0|||
131090248|NCT05217641|471960794|FG001|Overall Study|Withdrawal by Subject|0|||
131090249|NCT05217641|471960795|FG002|Overall Study|Withdrawal by Subject|0|||
131090250|NCT05217641|471960796|FG003|Overall Study|Withdrawal by Subject|3|||
131090251|NCT05217641|471960797|FG004|Overall Study|Withdrawal by Subject|1|||
131090252|NCT05217641|471960798|FG005|Overall Study|Withdrawal by Subject|0|||
131090253|NCT05217641|471960793|FG000|Overall Study|Other: participant did not specify reason|0|||
131090254|NCT05217641|471960794|FG001|Overall Study|Other: participant did not specify reason|0|||
131090255|NCT05217641|471960795|FG002|Overall Study|Other: participant did not specify reason|0|||
131090256|NCT05217641|471960796|FG003|Overall Study|Other: participant did not specify reason|0|||
131090257|NCT05217641|471960797|FG004|Overall Study|Other: participant did not specify reason|1|||
131090258|NCT05217641|471960798|FG005|Overall Study|Other: participant did not specify reason|0|||
131090259|NCT05217641|471960793|FG000|Overall Study|Extended Follow up|1|||
131090260|NCT05217641|471960794|FG001|Overall Study|Extended Follow up|1|||
131090261|NCT05217641|471960795|FG002|Overall Study|Extended Follow up|0|||
131090262|NCT05217641|471960796|FG003|Overall Study|Extended Follow up|0|||
131090263|NCT05217641|471960797|FG004|Overall Study|Extended Follow up|1|||
131090264|NCT05217641|471960798|FG005|Overall Study|Extended Follow up|0|||
131143058|NCT03116113|472150477|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131143059|NCT03116113|472150478|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131143060|NCT03116113|472150479|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131143061|NCT03116113|472150480|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131143062|NCT03116113|472150481|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131143063|NCT03116113|472150482|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
131143064|NCT03116113|472150483|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
131143065|NCT03116113|472150484|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
131090351|NCT02367040|471962559|FG000|Overall Study|Lost to Follow-up|1|||
131090352|NCT02367040|471962560|FG001|Overall Study|Lost to Follow-up|1|||
131090353|NCT02367040|471962559|FG000|Overall Study|Lack of Efficacy|1|||
131090354|NCT02367040|471962560|FG001|Overall Study|Lack of Efficacy|0|||
131090355|NCT02367040|471962559|FG000|Overall Study|Additional primary malignancy|1|||
131090356|NCT02367040|471962560|FG001|Overall Study|Additional primary malignancy|1|||
131090357|NCT02367040|471962559|FG000|Overall Study|AE not associated with clinical disease progression|117|||
131090358|NCT02367040|471962560|FG001|Overall Study|AE not associated with clinical disease progression|12|||
131090359|NCT02367040|471962559|FG000|Overall Study|AE associated with clinical disease progression|1|||
131090360|NCT02367040|471962560|FG001|Overall Study|AE associated with clinical disease progression|4|||
131090361|NCT02367040|471962559|FG000|Overall Study|Physician Decision|2|||
131090362|NCT02367040|471962560|FG001|Overall Study|Physician Decision|8|||
131090363|NCT02367040|471962559|FG000|Overall Study|Non-compliance to study drug|1|||
131090364|NCT02367040|471962560|FG001|Overall Study|Non-compliance to study drug|0|||
131090365|NCT02367040|471962559|FG000|Overall Study|Failure to meet continuation criteria|1|||
131090366|NCT02367040|471962560|FG001|Overall Study|Failure to meet continuation criteria|0|||
131090367|NCT02367040|471962559|FG000|Overall Study|Switching to other therapy|2|||
131090368|NCT02367040|471962560|FG001|Overall Study|Switching to other therapy|0|||
131090369|NCT02367040|471962559|FG000|Overall Study|Withdrawal by Subject|51|||
131090370|NCT02367040|471962560|FG001|Overall Study|Withdrawal by Subject|16|||
131090371|NCT02367040|471962559|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
131090372|NCT02367040|471962560|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131090373|NCT02367040|471962559|FG000|Overall Study|Patient decision|40|||
131090374|NCT02367040|471962560|FG001|Overall Study|Patient decision|14|||
131090375|NCT02367040|471962559|FG000|Overall Study|Required procedure failed|1|||
131090376|NCT02367040|471962560|FG001|Overall Study|Required procedure failed|0|||
131090377|NCT02367040|471962559|FG000|Overall Study|Randomized by mistake with study treatment|1|||
131090378|NCT02367040|471962560|FG001|Overall Study|Randomized by mistake with study treatment|0|||
131090379|NCT02367040|471962559|FG000|Overall Study|Protocol Violation|1|||
131090380|NCT02367040|471962560|FG001|Overall Study|Protocol Violation|0|||
131090381|NCT02367040|471962559|FG000|Overall Study|Progressive disease - radiological progression|54|||
131090382|NCT02367040|471962560|FG001|Overall Study|Progressive disease - radiological progression|80|||
131090383|NCT02367040|471962559|FG000|Overall Study|Progressive disease - clinical progression|6|||
131090384|NCT02367040|471962560|FG001|Overall Study|Progressive disease - clinical progression|6|||
131090385|NCT02367040|471962559|FG000|Overall Study|Drug not administered|3|||
131090386|NCT02367040|471962560|FG001|Overall Study|Drug not administered|2|||
131090387|NCT02367040|471962559|FG000|Overall Study|Progressive disease|0|||
131090388|NCT02367040|471962560|FG001|Overall Study|Progressive disease|1|||
131090389|NCT02367040|471962559|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
131090390|NCT02367040|471962560|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
131090391|NCT02367040|471962559|FG000|Overall Study|Death|2|||
131090392|NCT02367040|471962560|FG001|Overall Study|Death|0|||
131090393|NCT02367040|471962559|FG000|Overall Study|Study terminated by sponsor|19|||
131090394|NCT02367040|471962560|FG001|Overall Study|Study terminated by sponsor|2|||
131090411|NCT02477618|471962566|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
131090412|NCT02477618|471962567|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
131090413|NCT02477618|471962566|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
131090414|NCT02477618|471962567|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
131090415|NCT02477618|471962566|FG000|Overall Study|Adverse Event|1|||
131090416|NCT02477618|471962567|FG001|Overall Study|Adverse Event|1|||
131143066|NCT02159807|472150485|FG000|Overall Study|Adverse Event|0|||
131090417|NCT02477618|471962566|FG000|Overall Study|Transferred Away from Study Site|1|||
131090418|NCT02477618|471962567|FG001|Overall Study|Transferred Away from Study Site|0|||
131090419|NCT02477618|471962566|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
131090420|NCT02477618|471962567|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
131090421|NCT01892722|471962568|FG000|Overall Study|Protocol deviation|0|||
131090422|NCT01892722|471962569|FG001|Overall Study|Protocol deviation|1|||
131090423|NCT01892722|471962568|FG000|Overall Study|Administrative problems|0|||
131143067|NCT02159807|472150486|FG001|Overall Study|Adverse Event|0|||
131143068|NCT02159807|472150487|FG002|Overall Study|Adverse Event|1|||
131234356|NCT01595009|472484639|FG000|Extension|Disease progression|0|||
131234357|NCT01595009|472484640|FG001|Extension|Disease progression|0|||
131234358|NCT01595009|472484641|FG002|Extension|Disease progression|4|||
130727352|NCT02883049|470625424|FG000|Post Induction|Developed SMN|0|||
130727353|NCT02883049|470625425|FG001|Post Induction|Developed SMN|0|||
130727354|NCT02883049|470625426|FG002|Post Induction|Developed SMN|0|||
130727355|NCT02883049|470625427|FG003|Post Induction|Developed SMN|0|||
130727356|NCT02883049|470625428|FG004|Post Induction|Developed SMN|1|||
130727357|NCT02883049|470625429|FG005|Post Induction|Developed SMN|0|||
130727358|NCT02883049|470625430|FG006|Post Induction|Developed SMN|1|||
130727359|NCT02883049|470625431|FG007|Post Induction|Developed SMN|0|||
130727360|NCT02883049|470625432|FG008|Post Induction|Developed SMN|0|||
130727361|NCT02883049|470625433|FG009|Post Induction|Developed SMN|0|||
130727362|NCT02883049|470625434|FG010|Post Induction|Developed SMN|1|||
130727363|NCT02883049|470625435|FG011|Post Induction|Developed SMN|1|||
130727364|NCT02883049|470625436|FG012|Post Induction|Developed SMN|0|||
130727365|NCT02883049|470625437|FG013|Post Induction|Developed SMN|0|||
130727366|NCT02883049|470625438|FG014|Post Induction|Developed SMN|1|||
130727367|NCT02883049|470625439|FG015|Post Induction|Developed SMN|0|||
130727368|NCT02883049|470625424|FG000|Post Induction|Enrolled onto another COG study|0|||
130727369|NCT02883049|470625425|FG001|Post Induction|Enrolled onto another COG study|0|||
130727370|NCT02883049|470625426|FG002|Post Induction|Enrolled onto another COG study|0|||
130727371|NCT02883049|470625427|FG003|Post Induction|Enrolled onto another COG study|1|||
130727372|NCT02883049|470625428|FG004|Post Induction|Enrolled onto another COG study|1|||
130727373|NCT02883049|470625429|FG005|Post Induction|Enrolled onto another COG study|0|||
130727374|NCT02883049|470625430|FG006|Post Induction|Enrolled onto another COG study|0|||
131090424|NCT01892722|471962569|FG001|Overall Study|Administrative problems|1|||
131090425|NCT01892722|471962568|FG000|Overall Study|Patient/guardian decision|0|||
131090426|NCT01892722|471962569|FG001|Overall Study|Patient/guardian decision|2|||
131090427|NCT01892722|471962568|FG000|Overall Study|Physician Decision|1|||
131090428|NCT01892722|471962569|FG001|Overall Study|Physician Decision|2|||
130727375|NCT02883049|470625431|FG007|Post Induction|Enrolled onto another COG study|4|||
131090429|NCT01892722|471962568|FG000|Overall Study|Adverse Event|3|||
131090430|NCT01892722|471962569|FG001|Overall Study|Adverse Event|2|||
131090431|NCT01892722|471962568|FG000|Overall Study|Lack of Efficacy|0|||
131143069|NCT02159807|472150485|FG000|Overall Study|No CSF|1|||
131143070|NCT02159807|472150486|FG001|Overall Study|No CSF|1|||
131143071|NCT02159807|472150487|FG002|Overall Study|No CSF|1|||
131143072|NCT02159807|472150485|FG000|Overall Study|elevated blood pressure|0|||
131143073|NCT02159807|472150486|FG001|Overall Study|elevated blood pressure|0|||
131143074|NCT02159807|472150487|FG002|Overall Study|elevated blood pressure|1|||
131143075|NCT05195528|472150489|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
131143076|NCT05195528|472150490|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
131143077|NCT05195528|472150491|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
131143078|NCT05195528|472150492|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
131143079|NCT05195528|472150493|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
131143080|NCT05195528|472150489|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
131143081|NCT05195528|472150490|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
131143082|NCT05195528|472150491|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
131143083|NCT05195528|472150492|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131143084|NCT05195528|472150493|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
131143085|NCT05195528|472150489|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131143086|NCT05195528|472150490|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
131143087|NCT05195528|472150491|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
131143088|NCT05195528|472150492|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131143089|NCT05195528|472150493|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131143090|NCT05195528|472150489|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
131143091|NCT05195528|472150490|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
131143092|NCT05195528|472150491|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
131143093|NCT05195528|472150492|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
131143094|NCT05195528|472150493|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
131234359|NCT01595009|472484642|FG003|Extension|Disease progression|7|||
131234360|NCT01595009|472484639|FG000|Extension|Adverse Event|0|||
130727376|NCT02883049|470625432|FG008|Post Induction|Enrolled onto another COG study|0|||
130727377|NCT02883049|470625433|FG009|Post Induction|Enrolled onto another COG study|0|||
130727378|NCT02883049|470625434|FG010|Post Induction|Enrolled onto another COG study|0|||
130727379|NCT02883049|470625435|FG011|Post Induction|Enrolled onto another COG study|2|||
130727380|NCT02883049|470625436|FG012|Post Induction|Enrolled onto another COG study|0|||
130727381|NCT02883049|470625437|FG013|Post Induction|Enrolled onto another COG study|1|||
131090432|NCT01892722|471962569|FG001|Overall Study|Lack of Efficacy|7|||
131090433|NCT01892722|471962568|FG000|Overall Study|Withdrawal by Subject|3|||
131090434|NCT01892722|471962569|FG001|Overall Study|Withdrawal by Subject|5|||
131143095|NCT05195528|472150489|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
131143096|NCT05195528|472150490|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
131143097|NCT05195528|472150491|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
131143098|NCT05195528|472150492|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
131143099|NCT05195528|472150493|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
131143100|NCT05195528|472150489|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
131143101|NCT05195528|472150490|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
131143102|NCT05195528|472150491|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
131143103|NCT05195528|472150492|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
131143104|NCT05195528|472150493|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
131143105|NCT05195528|472150489|FG000|Placebo-controlled Treatment Period|Other|0|||
131143106|NCT05195528|472150490|FG001|Placebo-controlled Treatment Period|Other|0|||
131143107|NCT05195528|472150491|FG002|Placebo-controlled Treatment Period|Other|1|||
131143108|NCT05195528|472150492|FG003|Placebo-controlled Treatment Period|Other|0|||
131143109|NCT05195528|472150493|FG004|Placebo-controlled Treatment Period|Other|0|||
131143110|NCT05195528|472150489|FG000|Extension Period|PTE or AE or SAE|0|||
131143111|NCT05195528|472150490|FG001|Extension Period|PTE or AE or SAE|4|||
131143112|NCT05195528|472150491|FG002|Extension Period|PTE or AE or SAE|5|||
131143113|NCT05195528|472150492|FG003|Extension Period|PTE or AE or SAE|4|||
131143114|NCT05195528|472150493|FG004|Extension Period|PTE or AE or SAE|4|||
131143115|NCT05195528|472150489|FG000|Extension Period|Protocol Violation|0|||
131143116|NCT05195528|472150490|FG001|Extension Period|Protocol Violation|2|||
131143117|NCT05195528|472150491|FG002|Extension Period|Protocol Violation|1|||
131090475|NCT03007420|471962575|FG000|Overall Study|Withdrawal by Subject|0|||
131090476|NCT03007420|471962576|FG001|Overall Study|Withdrawal by Subject|2|||
131090477|NCT03007420|471962575|FG000|Overall Study|Physician Decision|0|||
131090478|NCT03007420|471962576|FG001|Overall Study|Physician Decision|1|||
131143118|NCT05195528|472150492|FG003|Extension Period|Protocol Violation|0|||
131143119|NCT05195528|472150493|FG004|Extension Period|Protocol Violation|1|||
131143120|NCT05195528|472150489|FG000|Extension Period|Lost to Follow-up|0|||
131143121|NCT05195528|472150490|FG001|Extension Period|Lost to Follow-up|6|||
131143122|NCT05195528|472150491|FG002|Extension Period|Lost to Follow-up|13|||
131143123|NCT05195528|472150492|FG003|Extension Period|Lost to Follow-up|3|||
131143124|NCT05195528|472150493|FG004|Extension Period|Lost to Follow-up|7|||
131143125|NCT05195528|472150489|FG000|Extension Period|Withdrawal by Subject|0|||
131143126|NCT05195528|472150490|FG001|Extension Period|Withdrawal by Subject|12|||
131143127|NCT05195528|472150491|FG002|Extension Period|Withdrawal by Subject|9|||
131143128|NCT05195528|472150492|FG003|Extension Period|Withdrawal by Subject|6|||
131143129|NCT05195528|472150493|FG004|Extension Period|Withdrawal by Subject|5|||
131143130|NCT05195528|472150489|FG000|Extension Period|Lack of Efficacy|0|||
131143131|NCT05195528|472150490|FG001|Extension Period|Lack of Efficacy|3|||
131143132|NCT05195528|472150491|FG002|Extension Period|Lack of Efficacy|0|||
131143133|NCT05195528|472150492|FG003|Extension Period|Lack of Efficacy|0|||
131143134|NCT05195528|472150493|FG004|Extension Period|Lack of Efficacy|2|||
131143135|NCT05195528|472150489|FG000|Extension Period|Not Treated|0|||
131234361|NCT01595009|472484640|FG001|Extension|Adverse Event|0|||
131143136|NCT05195528|472150490|FG001|Extension Period|Not Treated|0|||
131234362|NCT01595009|472484641|FG002|Extension|Adverse Event|0|||
131234363|NCT01595009|472484642|FG003|Extension|Adverse Event|1|||
131234364|NCT02907203|472484643|FG000|Overall Study|Death|1|||
131143137|NCT05195528|472150491|FG002|Extension Period|Not Treated|2|||
131143138|NCT05195528|472150492|FG003|Extension Period|Not Treated|3|||
131143139|NCT05195528|472150493|FG004|Extension Period|Not Treated|0|||
131234365|NCT02907203|472484643|FG000|Overall Study|Lost to Follow-up|3|||
131143140|NCT05195528|472150489|FG000|Extension Period|Other|0|||
131143141|NCT05195528|472150490|FG001|Extension Period|Other|1|||
131143142|NCT05195528|472150491|FG002|Extension Period|Other|1|||
131143143|NCT05195528|472150492|FG003|Extension Period|Other|0|||
131143144|NCT05195528|472150493|FG004|Extension Period|Other|0|||
131143145|NCT01552902|472150494|FG000|Overall Study|Adverse Event|1|||
131143146|NCT01552902|472150495|FG001|Overall Study|Adverse Event|15|||
131143147|NCT01552902|472150496|FG002|Overall Study|Adverse Event|14|||
131143148|NCT01552902|472150494|FG000|Overall Study|Protocol Violation|3|||
131143149|NCT01552902|472150495|FG001|Overall Study|Protocol Violation|3|||
131143150|NCT01552902|472150496|FG002|Overall Study|Protocol Violation|3|||
131143151|NCT01552902|472150494|FG000|Overall Study|Lack of Efficacy|4|||
131143152|NCT01552902|472150495|FG001|Overall Study|Lack of Efficacy|3|||
131143153|NCT01552902|472150496|FG002|Overall Study|Lack of Efficacy|1|||
131143154|NCT01552902|472150494|FG000|Overall Study|Withdrawal by Subject|1|||
131143155|NCT01552902|472150495|FG001|Overall Study|Withdrawal by Subject|9|||
131143156|NCT01552902|472150496|FG002|Overall Study|Withdrawal by Subject|6|||
131143157|NCT01552902|472150494|FG000|Overall Study|Lost to Follow-up|1|||
131143158|NCT01552902|472150495|FG001|Overall Study|Lost to Follow-up|3|||
131143159|NCT01552902|472150496|FG002|Overall Study|Lost to Follow-up|6|||
131143160|NCT01552902|472150494|FG000|Overall Study|Other|3|||
131143161|NCT01552902|472150495|FG001|Overall Study|Other|4|||
131143162|NCT01552902|472150496|FG002|Overall Study|Other|3|||
131143163|NCT02487108|472150502|FG000|Overall Study|Adverse Event|1|||
131143164|NCT02487108|472150503|FG001|Overall Study|Adverse Event|6|||
131143165|NCT02487108|472150504|FG002|Overall Study|Adverse Event|12|||
131143166|NCT02487108|472150505|FG003|Overall Study|Adverse Event|6|||
131143167|NCT02487108|472150502|FG000|Overall Study|Withdrawal by Subject|8|||
131143168|NCT02487108|472150503|FG001|Overall Study|Withdrawal by Subject|5|||
131143169|NCT02487108|472150504|FG002|Overall Study|Withdrawal by Subject|5|||
131143170|NCT02487108|472150505|FG003|Overall Study|Withdrawal by Subject|0|||
131143171|NCT02487108|472150502|FG000|Overall Study|Non-compliance to study medication|3|||
131143172|NCT02487108|472150503|FG001|Overall Study|Non-compliance to study medication|2|||
131143173|NCT02487108|472150504|FG002|Overall Study|Non-compliance to study medication|5|||
131143174|NCT02487108|472150505|FG003|Overall Study|Non-compliance to study medication|4|||
131143175|NCT02487108|472150502|FG000|Overall Study|Protocol Violation|1|||
131143176|NCT02487108|472150503|FG001|Overall Study|Protocol Violation|1|||
131143177|NCT02487108|472150504|FG002|Overall Study|Protocol Violation|2|||
131143178|NCT02487108|472150505|FG003|Overall Study|Protocol Violation|0|||
131143179|NCT02487108|472150502|FG000|Overall Study|Non-compliance to study procedures|0|||
131143180|NCT02487108|472150503|FG001|Overall Study|Non-compliance to study procedures|0|||
131143181|NCT02487108|472150504|FG002|Overall Study|Non-compliance to study procedures|0|||
131143182|NCT02487108|472150505|FG003|Overall Study|Non-compliance to study procedures|1|||
131143183|NCT02487108|472150502|FG000|Overall Study|Other than specified|3|||
131143184|NCT02487108|472150503|FG001|Overall Study|Other than specified|2|||
131143185|NCT02487108|472150504|FG002|Overall Study|Other than specified|2|||
131143186|NCT02487108|472150505|FG003|Overall Study|Other than specified|0|||
131143187|NCT02720757|472150506|FG000|Overall Study|Other reason|5|||
131143188|NCT02720757|472150506|FG000|Overall Study|Loss of contact|4|||
131143189|NCT02720757|472150506|FG000|Overall Study|Informed consent withdrawal|1|||
131143190|NCT02720757|472150506|FG000|Overall Study|Patients wish to withdraw|2|||
131143191|NCT02720757|472150506|FG000|Overall Study|Missing|3|||
131143192|NCT02720757|472150506|FG000|Overall Study|General exclusion|3|||
131143193|NCT00883493|472150507|FG000|Overall Study|Adverse Event|11|||
131143194|NCT00883493|472150508|FG001|Overall Study|Adverse Event|12|||
131143195|NCT00883493|472150507|FG000|Overall Study|Lack of Efficacy|4|||
131143196|NCT00883493|472150508|FG001|Overall Study|Lack of Efficacy|3|||
131143197|NCT00883493|472150507|FG000|Overall Study|Lost to Follow-up|7|||
130727382|NCT02883049|470625438|FG014|Post Induction|Enrolled onto another COG study|0|||
130727383|NCT02883049|470625439|FG015|Post Induction|Enrolled onto another COG study|0|||
130727384|NCT02883049|470625424|FG000|Post Induction|Recurrent leukemia|0|||
130727385|NCT02883049|470625425|FG001|Post Induction|Recurrent leukemia|0|||
130727386|NCT02883049|470625426|FG002|Post Induction|Recurrent leukemia|0|||
130727387|NCT02883049|470625427|FG003|Post Induction|Recurrent leukemia|17|||
130727388|NCT02883049|470625428|FG004|Post Induction|Recurrent leukemia|12|||
130727389|NCT02883049|470625429|FG005|Post Induction|Recurrent leukemia|4|||
130727390|NCT02883049|470625430|FG006|Post Induction|Recurrent leukemia|1|||
130727391|NCT02883049|470625431|FG007|Post Induction|Recurrent leukemia|13|||
130727392|NCT02883049|470625432|FG008|Post Induction|Recurrent leukemia|27|||
130727393|NCT02883049|470625433|FG009|Post Induction|Recurrent leukemia|5|||
130727394|NCT02883049|470625434|FG010|Post Induction|Recurrent leukemia|3|||
130727395|NCT02883049|470625435|FG011|Post Induction|Recurrent leukemia|12|||
130727396|NCT02883049|470625436|FG012|Post Induction|Recurrent leukemia|1|||
130727397|NCT02883049|470625437|FG013|Post Induction|Recurrent leukemia|1|||
130727398|NCT02883049|470625438|FG014|Post Induction|Recurrent leukemia|9|||
130727399|NCT02883049|470625439|FG015|Post Induction|Recurrent leukemia|3|||
130727400|NCT02883049|470625424|FG000|Post Induction|Induction Failure|0|||
130727401|NCT02883049|470625425|FG001|Post Induction|Induction Failure|0|||
130727402|NCT02883049|470625426|FG002|Post Induction|Induction Failure|0|||
130727403|NCT02883049|470625427|FG003|Post Induction|Induction Failure|0|||
130727404|NCT02883049|470625428|FG004|Post Induction|Induction Failure|0|||
130727405|NCT02883049|470625429|FG005|Post Induction|Induction Failure|0|||
130727406|NCT02883049|470625430|FG006|Post Induction|Induction Failure|0|||
130727407|NCT02883049|470625431|FG007|Post Induction|Induction Failure|2|||
130727408|NCT02883049|470625432|FG008|Post Induction|Induction Failure|2|||
130727409|NCT02883049|470625433|FG009|Post Induction|Induction Failure|0|||
130727410|NCT02883049|470625434|FG010|Post Induction|Induction Failure|0|||
130727411|NCT02883049|470625435|FG011|Post Induction|Induction Failure|0|||
130727412|NCT02883049|470625436|FG012|Post Induction|Induction Failure|0|||
130727413|NCT02883049|470625437|FG013|Post Induction|Induction Failure|2|||
130727414|NCT02883049|470625438|FG014|Post Induction|Induction Failure|0|||
130727415|NCT02883049|470625439|FG015|Post Induction|Induction Failure|0|||
130727416|NCT01924754|470625445|FG000|Overall Study|Lost to Follow-up|1|||
130727417|NCT01924754|470625446|FG001|Overall Study|Lost to Follow-up|2|||
131143198|NCT00883493|472150508|FG001|Overall Study|Lost to Follow-up|6|||
131143199|NCT00883493|472150507|FG000|Overall Study|Withdrawal by Subject|11|||
131143200|NCT00883493|472150508|FG001|Overall Study|Withdrawal by Subject|20|||
131143201|NCT00883493|472150507|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
131143202|NCT00883493|472150508|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
131143203|NCT00883493|472150507|FG000|Overall Study|Study specific disc. criteria|2|||
131143204|NCT00883493|472150508|FG001|Overall Study|Study specific disc. criteria|0|||
131143205|NCT00883493|472150507|FG000|Overall Study|Other|5|||
131143206|NCT00883493|472150508|FG001|Overall Study|Other|3|||
131143207|NCT01731678|472150513|FG000|Overall Study|Withdrawal by Subject|3|||
131143208|NCT01731678|472150513|FG000|Overall Study|Did not meet inclusion criteria|1|||
131143209|NCT01731678|472150513|FG000|Overall Study|RMT too high, making TMS difficult|3|||
131143210|NCT02649634|472150515|FG000|Overall Study|Withdrawal by Subject|3|||
131143211|NCT02649634|472150516|FG001|Overall Study|Withdrawal by Subject|5|||
130727418|NCT01924754|470625447|FG002|Overall Study|Lost to Follow-up|1|||
130727419|NCT01924754|470625445|FG000|Overall Study|Pregnancy|0|||
130727420|NCT01924754|470625446|FG001|Overall Study|Pregnancy|1|||
130727421|NCT01924754|470625447|FG002|Overall Study|Pregnancy|2|||
130727422|NCT01392963|470625448|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
131143212|NCT02649634|472150515|FG000|Overall Study|Lost to Follow-up|0|||
131143213|NCT02649634|472150516|FG001|Overall Study|Lost to Follow-up|1|||
131234366|NCT02907203|472484643|FG000|Overall Study|Withdrawal by Subject|3|||
130727423|NCT01392963|470625449|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
130727424|NCT01392963|470625448|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
130727425|NCT01392963|470625449|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
130727426|NCT01392963|470625448|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
130727427|NCT01392963|470625449|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
130727428|NCT00369486|470625450|FG000|4-Week Visit|Missed visit|2|||
130727429|NCT00369486|470625451|FG001|4-Week Visit|Missed visit|2|||
130727430|NCT00369486|470625452|FG002|4-Week Visit|Missed visit|0|||
130727431|NCT00369486|470625453|FG003|4-Week Visit|Missed visit|2|||
130727432|NCT00369486|470625454|FG004|4-Week Visit|Missed visit|1|||
130727433|NCT00369486|470625450|FG000|4-Week Visit|Dropped|0|||
130727434|NCT00369486|470625451|FG001|4-Week Visit|Dropped|0|||
130727435|NCT00369486|470625452|FG002|4-Week Visit|Dropped|1|||
131090646|NCT02994069|471962597|FG000|Overall Study|Death|7|||
131090647|NCT02994069|471962598|FG001|Overall Study|Death|13|||
131090648|NCT02994069|471962597|FG000|Overall Study|Adverse Event|1|||
131090649|NCT02994069|471962598|FG001|Overall Study|Adverse Event|0|||
131090650|NCT02994069|471962597|FG000|Overall Study|Other|2|||
131090651|NCT02994069|471962598|FG001|Overall Study|Other|0|||
131090652|NCT02994069|471962597|FG000|Overall Study|still on follow up/treatment|5|||
131090653|NCT02994069|471962598|FG001|Overall Study|still on follow up/treatment|6|||
131090654|NCT05212168|471962599|FG000|Overall Study|Lost to Follow-up|0|||
131090655|NCT05212168|471962600|FG001|Overall Study|Lost to Follow-up|3|||
131090656|NCT05212168|471962599|FG000|Overall Study|Study terminated by sponsor|30|||
131090657|NCT05212168|471962600|FG001|Overall Study|Study terminated by sponsor|27|||
131090658|NCT05212168|471962599|FG000|Overall Study|Other|4|||
131090659|NCT05212168|471962600|FG001|Overall Study|Other|7|||
130727436|NCT00369486|470625453|FG003|4-Week Visit|Dropped|0|||
131143214|NCT01318122|472150517|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131143215|NCT01318122|472150518|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
131143216|NCT01318122|472150519|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
131143217|NCT01318122|472150520|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
131143218|NCT01318122|472150517|FG000|Enrolled - Long-Term Extension Study|Other|1|||
131143219|NCT01318122|472150518|FG001|Enrolled - Long-Term Extension Study|Other|0|||
131143220|NCT01318122|472150519|FG002|Enrolled - Long-Term Extension Study|Other|0|||
131143221|NCT01318122|472150520|FG003|Enrolled - Long-Term Extension Study|Other|0|||
131143222|NCT01318122|472150517|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
131143223|NCT01318122|472150518|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
131143224|NCT01318122|472150519|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
131234367|NCT02907203|472484643|FG000|Overall Study|Surgical bypass|1|||
131234368|NCT04956666|472484644|FG000|Overall Study|Adverse Event|18|||
131143225|NCT01318122|472150520|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
131143226|NCT01318122|472150517|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
131143227|NCT01318122|472150518|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131234369|NCT04956666|472484644|FG000|Overall Study|Physician Decision|5|||
131234370|NCT00329602|472484648|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
131234371|NCT00329602|472484649|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
130727437|NCT00369486|470625454|FG004|4-Week Visit|Dropped|0|||
130727438|NCT00369486|470625450|FG000|8-Week Visit|Missed visit|0|||
130727439|NCT00369486|470625451|FG001|8-Week Visit|Missed visit|1|||
130727440|NCT00369486|470625452|FG002|8-Week Visit|Missed visit|0|||
130727441|NCT00369486|470625453|FG003|8-Week Visit|Missed visit|0|||
130727442|NCT00369486|470625454|FG004|8-Week Visit|Missed visit|1|||
131143228|NCT01318122|472150519|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131143229|NCT01318122|472150520|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
131143230|NCT01318122|472150517|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130727443|NCT00369486|470625450|FG000|8-Week Visit|Dropped|0|||
130727444|NCT00369486|470625451|FG001|8-Week Visit|Dropped|0|||
130727445|NCT00369486|470625452|FG002|8-Week Visit|Dropped|0|||
130727446|NCT00369486|470625453|FG003|8-Week Visit|Dropped|1|||
131090753|NCT03524092|471962631|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
131090754|NCT03524092|471962632|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
131090755|NCT03524092|471962633|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
131090756|NCT03524092|471962634|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
131090757|NCT03524092|471962635|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
131090758|NCT03524092|471962636|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
131090759|NCT03524092|471962631|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
131090760|NCT03524092|471962632|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
131090761|NCT03524092|471962633|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
131090762|NCT03524092|471962634|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
131090763|NCT03524092|471962635|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
131090764|NCT03524092|471962636|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
131090765|NCT03524092|471962631|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
131090766|NCT03524092|471962632|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
131090767|NCT03524092|471962633|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
131090768|NCT03524092|471962634|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
131090769|NCT03524092|471962635|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
131090770|NCT03524092|471962636|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
131090771|NCT03524092|471962631|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
131090772|NCT03524092|471962632|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
131090773|NCT03524092|471962633|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
131090774|NCT03524092|471962634|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
131090775|NCT03524092|471962635|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
131090776|NCT03524092|471962636|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
131090777|NCT03524092|471962631|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
131090778|NCT03524092|471962632|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
131090779|NCT03524092|471962633|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
131090780|NCT03524092|471962634|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
131090781|NCT03524092|471962635|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
131090782|NCT03524092|471962636|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
131090783|NCT03524092|471962631|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
131090784|NCT03524092|471962632|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
131090785|NCT03524092|471962633|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
131090786|NCT03524092|471962634|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
131090787|NCT03524092|471962635|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
131090788|NCT03524092|471962636|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
131090789|NCT03524092|471962631|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
131143231|NCT01318122|472150518|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
131143232|NCT01318122|472150519|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
131143233|NCT01318122|472150520|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
131143234|NCT01318122|472150517|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131143235|NCT01318122|472150518|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
131143236|NCT01318122|472150519|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
131143237|NCT01318122|472150520|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
131143238|NCT01486199|472150521|FG000|Two Year Period Between Study Days|Physician Decision|1|||
131143239|NCT01486199|472150522|FG001|Two Year Period Between Study Days|Physician Decision|0|||
131143240|NCT02471716|472150524|FG000|Overall Study|Withdrawal by Subject|0|||
131143241|NCT02471716|472150525|FG001|Overall Study|Withdrawal by Subject|1|||
131143242|NCT02471716|472150526|FG002|Overall Study|Withdrawal by Subject|0|||
131090790|NCT03524092|471962632|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
131143243|NCT02471716|472150527|FG003|Overall Study|Withdrawal by Subject|2|||
131143244|NCT02471716|472150528|FG004|Overall Study|Withdrawal by Subject|5|||
131143245|NCT02471716|472150524|FG000|Overall Study|Study Terminiated by sponsor|0|||
131143246|NCT02471716|472150525|FG001|Overall Study|Study Terminiated by sponsor|0|||
131143247|NCT02471716|472150526|FG002|Overall Study|Study Terminiated by sponsor|0|||
131143248|NCT02471716|472150527|FG003|Overall Study|Study Terminiated by sponsor|1|||
131143249|NCT02471716|472150528|FG004|Overall Study|Study Terminiated by sponsor|0|||
131143250|NCT02471716|472150524|FG000|Overall Study|Lost to Follow-up|0|||
131143251|NCT02471716|472150525|FG001|Overall Study|Lost to Follow-up|0|||
131143252|NCT02471716|472150526|FG002|Overall Study|Lost to Follow-up|0|||
131090791|NCT03524092|471962633|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
131090792|NCT03524092|471962634|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
131090793|NCT03524092|471962635|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
131090794|NCT03524092|471962636|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
131090795|NCT03524092|471962631|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
131090796|NCT03524092|471962632|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
131090797|NCT03524092|471962633|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
131090798|NCT03524092|471962634|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
131090799|NCT03524092|471962635|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
131090800|NCT03524092|471962636|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
131090801|NCT03524092|471962631|FG000|Loss of Response Rescue Period|Adverse Event|0|||
131090802|NCT03524092|471962632|FG001|Loss of Response Rescue Period|Adverse Event|0|||
131090803|NCT03524092|471962633|FG002|Loss of Response Rescue Period|Adverse Event|0|||
131090804|NCT03524092|471962634|FG003|Loss of Response Rescue Period|Adverse Event|2|||
131090805|NCT03524092|471962635|FG004|Loss of Response Rescue Period|Adverse Event|0|||
131090806|NCT03524092|471962636|FG005|Loss of Response Rescue Period|Adverse Event|0|||
131090807|NCT03524092|471962631|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
131090808|NCT03524092|471962632|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
131090809|NCT03524092|471962633|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
131090810|NCT03524092|471962634|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
131090811|NCT03524092|471962635|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
131090812|NCT03524092|471962636|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
131090813|NCT03524092|471962631|FG000|Loss of Response Rescue Period|Pregnancy|0|||
131090814|NCT03524092|471962632|FG001|Loss of Response Rescue Period|Pregnancy|0|||
131090815|NCT03524092|471962633|FG002|Loss of Response Rescue Period|Pregnancy|0|||
131090816|NCT03524092|471962634|FG003|Loss of Response Rescue Period|Pregnancy|1|||
131090817|NCT03524092|471962635|FG004|Loss of Response Rescue Period|Pregnancy|0|||
131090818|NCT03524092|471962636|FG005|Loss of Response Rescue Period|Pregnancy|0|||
131090819|NCT03524092|471962631|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
131090820|NCT03524092|471962632|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
131090821|NCT03524092|471962633|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
131090822|NCT03524092|471962634|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
130780278|NCT00792909|470821476|FG000|Overall Study|Withdrawal by Subject|0|||
130780279|NCT00792909|470821477|FG001|Overall Study|Withdrawal by Subject|1|||
131090823|NCT03524092|471962635|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
131090824|NCT03524092|471962636|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
131090825|NCT03524092|471962631|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
131090826|NCT03524092|471962632|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
131090827|NCT03524092|471962633|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
131090828|NCT03524092|471962634|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
131090829|NCT03524092|471962635|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
131090830|NCT03524092|471962636|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
131090831|NCT03524092|471962631|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
131090832|NCT03524092|471962632|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
131090833|NCT03524092|471962633|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
131090834|NCT03524092|471962634|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
131090835|NCT03524092|471962635|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
131090836|NCT03524092|471962636|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
131090837|NCT03524092|471962631|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
131090838|NCT03524092|471962632|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
131090839|NCT03524092|471962633|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
131090840|NCT03524092|471962634|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
131090841|NCT03524092|471962635|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
131090842|NCT03524092|471962636|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
131090843|NCT03524092|471962631|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
131090844|NCT03524092|471962632|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
131090845|NCT03524092|471962633|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
131090846|NCT03524092|471962634|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
131090847|NCT03524092|471962635|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
131090848|NCT03524092|471962636|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
131090849|NCT03524092|471962631|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
131090850|NCT03524092|471962632|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
131090851|NCT03524092|471962633|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
131090852|NCT03524092|471962634|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
131090853|NCT03524092|471962635|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
130727447|NCT00369486|470625454|FG004|8-Week Visit|Dropped|0|||
130727448|NCT00369486|470625450|FG000|17-Week Visit|Missed visit|0|||
130727449|NCT00369486|470625451|FG001|17-Week Visit|Missed visit|0|||
130727450|NCT00369486|470625452|FG002|17-Week Visit|Missed visit|1|||
131090854|NCT03524092|471962636|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
131090855|NCT03524092|471962631|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
131143253|NCT02471716|472150527|FG003|Overall Study|Lost to Follow-up|3|||
131143254|NCT02471716|472150528|FG004|Overall Study|Lost to Follow-up|2|||
131143255|NCT02471716|472150524|FG000|Overall Study|Death|0|||
131143256|NCT02471716|472150525|FG001|Overall Study|Death|0|||
131143257|NCT02471716|472150526|FG002|Overall Study|Death|0|||
131143258|NCT02471716|472150527|FG003|Overall Study|Death|1|||
131143259|NCT02471716|472150528|FG004|Overall Study|Death|0|||
131143260|NCT02471716|472150524|FG000|Overall Study|Other|0|||
131090856|NCT03524092|471962632|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
131090857|NCT03524092|471962633|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
131090858|NCT03524092|471962634|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
131090859|NCT03524092|471962635|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
131090860|NCT03524092|471962636|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
131090861|NCT03524092|471962631|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
131090862|NCT03524092|471962632|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
131090863|NCT03524092|471962633|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
131090864|NCT03524092|471962634|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
131090865|NCT03524092|471962635|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
131090866|NCT03524092|471962636|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
131090867|NCT03524092|471962631|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
131090868|NCT03524092|471962632|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
131090869|NCT03524092|471962633|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
131090870|NCT03524092|471962634|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
131090871|NCT03524092|471962635|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
131090872|NCT03524092|471962636|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
131090873|NCT03524092|471962631|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
131090874|NCT03524092|471962632|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
131090875|NCT03524092|471962633|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
131090876|NCT03524092|471962634|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
131090877|NCT03524092|471962635|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
131090878|NCT03524092|471962636|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
131090879|NCT03524092|471962631|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
131090880|NCT03524092|471962632|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
131090881|NCT03524092|471962633|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
131090882|NCT03524092|471962634|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
131090883|NCT03524092|471962635|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
131090884|NCT03524092|471962636|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
131090885|NCT03524092|471962631|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
131090886|NCT03524092|471962632|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
131090887|NCT03524092|471962633|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
131090888|NCT03524092|471962634|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
131090889|NCT03524092|471962635|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
131090890|NCT03524092|471962636|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
131090891|NCT04303780|471962637|FG000|Overall Study|Death|104|||
131090892|NCT04303780|471962638|FG001|Overall Study|Death|85|||
131090893|NCT04303780|471962637|FG000|Overall Study|Lost to Follow-up|5|||
131143261|NCT02471716|472150525|FG001|Overall Study|Other|0|||
131143262|NCT02471716|472150526|FG002|Overall Study|Other|0|||
131143263|NCT02471716|472150527|FG003|Overall Study|Other|8|||
131143264|NCT02471716|472150528|FG004|Overall Study|Other|9|||
131143265|NCT02211261|472150534|FG000|Overall Study|Withdrawal by Subject|0|||
131143266|NCT02211261|472150535|FG001|Overall Study|Withdrawal by Subject|0|||
131143267|NCT02211261|472150536|FG002|Overall Study|Withdrawal by Subject|1|||
131143268|NCT02211261|472150537|FG003|Overall Study|Withdrawal by Subject|0|||
130727451|NCT00369486|470625453|FG003|17-Week Visit|Missed visit|1|||
130727452|NCT00369486|470625454|FG004|17-Week Visit|Missed visit|1|||
131143269|NCT02211261|472150538|FG004|Overall Study|Withdrawal by Subject|2|||
130727453|NCT00369486|470625450|FG000|34-Week Visit|Dropped|0|||
131090894|NCT04303780|471962638|FG001|Overall Study|Lost to Follow-up|2|||
131143270|NCT02211261|472150539|FG005|Overall Study|Withdrawal by Subject|0|||
131143271|NCT02211261|472150540|FG006|Overall Study|Withdrawal by Subject|0|||
130727454|NCT00369486|470625451|FG001|34-Week Visit|Dropped|1|||
130727455|NCT00369486|470625452|FG002|34-Week Visit|Dropped|1|||
131090895|NCT04303780|471962637|FG000|Overall Study|Withdrawal by Subject|12|||
131090896|NCT04303780|471962638|FG001|Overall Study|Withdrawal by Subject|39|||
131090897|NCT04303780|471962637|FG000|Overall Study|Ongoing in study|50|||
131090898|NCT04303780|471962638|FG001|Overall Study|Ongoing in study|45|||
131091030|NCT07149155|471962669|FG000|Overall Study|Lost to Follow-up|10|||
131091031|NCT03345576|471962670|FG000|Overall Study|Withdrawal by Subject|2|||
131091032|NCT03345576|471962671|FG001|Overall Study|Withdrawal by Subject|2|||
131234372|NCT00329602|472484650|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
131091033|NCT03345576|471962670|FG000|Overall Study|Adverse Event|1|||
131091034|NCT03345576|471962671|FG001|Overall Study|Adverse Event|0|||
131143272|NCT02211261|472150541|FG007|Overall Study|Withdrawal by Subject|0|||
131143273|NCT02211261|472150542|FG008|Overall Study|Withdrawal by Subject|0|||
131143274|NCT02211261|472150543|FG009|Overall Study|Withdrawal by Subject|0|||
131143275|NCT02211261|472150544|FG010|Overall Study|Withdrawal by Subject|0|||
131143276|NCT02211261|472150534|FG000|Overall Study|Other|0|||
131143277|NCT02211261|472150535|FG001|Overall Study|Other|0|||
131143278|NCT02211261|472150536|FG002|Overall Study|Other|0|||
131143279|NCT02211261|472150537|FG003|Overall Study|Other|0|||
131143280|NCT02211261|472150538|FG004|Overall Study|Other|0|||
131143281|NCT02211261|472150539|FG005|Overall Study|Other|1|||
131143282|NCT02211261|472150540|FG006|Overall Study|Other|0|||
131143283|NCT02211261|472150541|FG007|Overall Study|Other|0|||
131143284|NCT02211261|472150542|FG008|Overall Study|Other|0|||
131143285|NCT02211261|472150543|FG009|Overall Study|Other|2|||
131143286|NCT02211261|472150544|FG010|Overall Study|Other|0|||
131143287|NCT02211261|472150534|FG000|Overall Study|Lost to Follow-up|0|||
131143288|NCT02211261|472150535|FG001|Overall Study|Lost to Follow-up|0|||
131143289|NCT02211261|472150536|FG002|Overall Study|Lost to Follow-up|0|||
131143290|NCT02211261|472150537|FG003|Overall Study|Lost to Follow-up|0|||
131143291|NCT02211261|472150538|FG004|Overall Study|Lost to Follow-up|0|||
131143292|NCT02211261|472150539|FG005|Overall Study|Lost to Follow-up|0|||
131143293|NCT02211261|472150540|FG006|Overall Study|Lost to Follow-up|0|||
131143294|NCT02211261|472150541|FG007|Overall Study|Lost to Follow-up|1|||
131143295|NCT02211261|472150542|FG008|Overall Study|Lost to Follow-up|0|||
131143296|NCT02211261|472150543|FG009|Overall Study|Lost to Follow-up|0|||
131143297|NCT02211261|472150544|FG010|Overall Study|Lost to Follow-up|0|||
131143298|NCT01737931|472150545|FG000|Overall Study|Withdrawal by Subject|0|||
131143299|NCT01737931|472150546|FG001|Overall Study|Withdrawal by Subject|1|||
131143300|NCT01737931|472150547|FG002|Overall Study|Withdrawal by Subject|1|||
131143301|NCT01737931|472150545|FG000|Overall Study|Physician Decision|0|||
131143302|NCT01737931|472150546|FG001|Overall Study|Physician Decision|1|||
131143303|NCT01737931|472150547|FG002|Overall Study|Physician Decision|0|||
131143304|NCT04897867|472150548|FG000|Overall Study|Withdrawal of Consent|1|||
131143305|NCT04897867|472150548|FG000|Overall Study|Pregnancy|1|||
131143306|NCT04897867|472150548|FG000|Overall Study|Lost to Follow-up|7|||
131143307|NCT04897867|472150548|FG000|Overall Study|Reason not Specified|2|||
131143308|NCT03183128|472150551|FG000|Overall Study|Adverse Event|1|||
131143309|NCT03183128|472150552|FG001|Overall Study|Adverse Event|2|||
131143310|NCT03183128|472150551|FG000|Overall Study|Withdrawal by Subject|1|||
131143311|NCT03183128|472150552|FG001|Overall Study|Withdrawal by Subject|8|||
131143312|NCT03183128|472150551|FG000|Overall Study|Protocol Violation|2|||
131143313|NCT03183128|472150552|FG001|Overall Study|Protocol Violation|0|||
131143314|NCT03183128|472150551|FG000|Overall Study|Lack of Efficacy|4|||
131143315|NCT03183128|472150552|FG001|Overall Study|Lack of Efficacy|27|||
131143316|NCT03183128|472150551|FG000|Overall Study|Lost to Follow-up|1|||
131143317|NCT03183128|472150552|FG001|Overall Study|Lost to Follow-up|0|||
131143318|NCT03183128|472150551|FG000|Overall Study|Death|2|||
131143319|NCT03183128|472150552|FG001|Overall Study|Death|0|||
131143320|NCT03183128|472150551|FG000|Overall Study|Physician Decision|1|||
131143321|NCT03183128|472150552|FG001|Overall Study|Physician Decision|0|||
131143322|NCT01171612|472150553|FG000|Overall Study|Lost to Follow-up|51|||
131143323|NCT00243659|472150554|FG000|Overall Study|Withdrawal by Subject|1|||
131143324|NCT00243659|472150555|FG001|Overall Study|Withdrawal by Subject|1|||
131143325|NCT00243659|472150554|FG000|Overall Study|Protocol Violation|1|||
131143326|NCT00243659|472150555|FG001|Overall Study|Protocol Violation|2|||
131091069|NCT02304705|471964620|FG000|Overall Study|Withdrawal by Subject|2|||
131091070|NCT02304705|471964621|FG001|Overall Study|Withdrawal by Subject|0|||
131091071|NCT02304705|471964620|FG000|Overall Study|Physician Decision|2|||
131091072|NCT02304705|471964621|FG001|Overall Study|Physician Decision|4|||
131091073|NCT02304705|471964620|FG000|Overall Study|Death|0|||
131091074|NCT02304705|471964621|FG001|Overall Study|Death|1|||
131091075|NCT02304705|471964620|FG000|Overall Study|Lost to Follow-up|0|||
131091076|NCT02304705|471964621|FG001|Overall Study|Lost to Follow-up|2|||
131091077|NCT01195948|471964622|FG000|Overall Study|Lost to Follow-up|0|||
131091078|NCT01195948|471964623|FG001|Overall Study|Lost to Follow-up|1|||
131091079|NCT01195948|471964624|FG002|Overall Study|Lost to Follow-up|2|||
131091080|NCT00770029|471964625|FG000|Overall Study|Lost to Follow-up|2|||
131091081|NCT00770029|471964626|FG001|Overall Study|Lost to Follow-up|0|||
131091082|NCT00770029|471964625|FG000|Overall Study|Withdrawal by Subject|3|||
131091083|NCT00770029|471964626|FG001|Overall Study|Withdrawal by Subject|3|||
131091084|NCT00770029|471964625|FG000|Overall Study|Adverse Event|1|||
131091085|NCT00770029|471964626|FG001|Overall Study|Adverse Event|0|||
131091086|NCT02124811|471964627|FG000|Overall Study|Early termination|2|||
131091087|NCT02124811|471964628|FG001|Overall Study|Early termination|2|||
131091088|NCT02124811|471964627|FG000|Overall Study|Withdrawal by Subject|1|||
131091089|NCT02124811|471964628|FG001|Overall Study|Withdrawal by Subject|0|||
131091090|NCT01757197|471964631|FG000|Overall Study|Death|2|||
131091091|NCT01174446|471964634|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
131091092|NCT01174446|471964635|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
131091093|NCT01174446|471964636|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
131091094|NCT01174446|471964637|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
131091095|NCT01174446|471964634|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
131091096|NCT01174446|471964635|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
131091097|NCT01174446|471964636|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
131091098|NCT01174446|471964637|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
131091099|NCT01174446|471964634|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
131091100|NCT01174446|471964635|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
131091101|NCT01174446|471964636|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
131091102|NCT01174446|471964637|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
131091103|NCT01174446|471964634|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
131091104|NCT01174446|471964635|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
131091105|NCT01174446|471964636|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
131091106|NCT01174446|471964637|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
131091107|NCT00847626|471964638|FG000|Overall Study|Adverse Event|10|||
131091108|NCT00847626|471964639|FG001|Overall Study|Adverse Event|10|||
131091109|NCT00847626|471964640|FG002|Overall Study|Adverse Event|6|||
131091110|NCT00847626|471964641|FG003|Overall Study|Adverse Event|19|||
131091111|NCT00847626|471964642|FG004|Overall Study|Adverse Event|11|||
131091112|NCT00847626|471964643|FG005|Overall Study|Adverse Event|22|||
131091113|NCT00847626|471964644|FG006|Overall Study|Adverse Event|4|||
131091114|NCT00847626|471964645|FG007|Overall Study|Adverse Event|6|||
131091115|NCT00847626|471964646|FG008|Overall Study|Adverse Event|3|||
131091116|NCT00847626|471964647|FG009|Overall Study|Adverse Event|6|||
131091117|NCT00847626|471964648|FG010|Overall Study|Adverse Event|6|||
131091118|NCT00847626|471964638|FG000|Overall Study|Protocol Violation|2|||
131091119|NCT00847626|471964639|FG001|Overall Study|Protocol Violation|1|||
131091120|NCT00847626|471964640|FG002|Overall Study|Protocol Violation|2|||
131091121|NCT00847626|471964641|FG003|Overall Study|Protocol Violation|1|||
131091122|NCT00847626|471964642|FG004|Overall Study|Protocol Violation|1|||
131091123|NCT00847626|471964643|FG005|Overall Study|Protocol Violation|1|||
131091124|NCT00847626|471964644|FG006|Overall Study|Protocol Violation|1|||
131091125|NCT00847626|471964645|FG007|Overall Study|Protocol Violation|1|||
131091126|NCT00847626|471964646|FG008|Overall Study|Protocol Violation|0|||
131091127|NCT00847626|471964647|FG009|Overall Study|Protocol Violation|1|||
131091128|NCT00847626|471964648|FG010|Overall Study|Protocol Violation|1|||
131143327|NCT03310970|472150556|FG000|Overall Study|Withdrawal by Subject|0|||
131143328|NCT03310970|472150557|FG001|Overall Study|Withdrawal by Subject|1|||
131091129|NCT00847626|471964638|FG000|Overall Study|Lost to Follow-up|0|||
131091130|NCT00847626|471964639|FG001|Overall Study|Lost to Follow-up|1|||
131091131|NCT00847626|471964640|FG002|Overall Study|Lost to Follow-up|1|||
131091132|NCT00847626|471964641|FG003|Overall Study|Lost to Follow-up|1|||
131091133|NCT00847626|471964642|FG004|Overall Study|Lost to Follow-up|0|||
131091134|NCT00847626|471964643|FG005|Overall Study|Lost to Follow-up|3|||
131091135|NCT00847626|471964644|FG006|Overall Study|Lost to Follow-up|1|||
131091136|NCT00847626|471964645|FG007|Overall Study|Lost to Follow-up|3|||
131091137|NCT00847626|471964646|FG008|Overall Study|Lost to Follow-up|1|||
131091138|NCT00847626|471964647|FG009|Overall Study|Lost to Follow-up|0|||
131091139|NCT00847626|471964648|FG010|Overall Study|Lost to Follow-up|1|||
131091140|NCT00847626|471964638|FG000|Overall Study|Withdrawal by Subject|5|||
131091141|NCT00847626|471964639|FG001|Overall Study|Withdrawal by Subject|5|||
131091142|NCT00847626|471964640|FG002|Overall Study|Withdrawal by Subject|3|||
131091143|NCT00847626|471964641|FG003|Overall Study|Withdrawal by Subject|8|||
131091144|NCT00847626|471964642|FG004|Overall Study|Withdrawal by Subject|12|||
131091145|NCT00847626|471964643|FG005|Overall Study|Withdrawal by Subject|9|||
131091146|NCT00847626|471964644|FG006|Overall Study|Withdrawal by Subject|8|||
131091147|NCT00847626|471964645|FG007|Overall Study|Withdrawal by Subject|4|||
131091148|NCT00847626|471964646|FG008|Overall Study|Withdrawal by Subject|4|||
131091149|NCT00847626|471964647|FG009|Overall Study|Withdrawal by Subject|5|||
131091150|NCT00847626|471964648|FG010|Overall Study|Withdrawal by Subject|2|||
131091151|NCT00847626|471964638|FG000|Overall Study|Lack of Efficacy|3|||
131091152|NCT00847626|471964639|FG001|Overall Study|Lack of Efficacy|1|||
131091153|NCT00847626|471964640|FG002|Overall Study|Lack of Efficacy|0|||
131091154|NCT00847626|471964641|FG003|Overall Study|Lack of Efficacy|1|||
131091155|NCT00847626|471964642|FG004|Overall Study|Lack of Efficacy|2|||
131091156|NCT00847626|471964643|FG005|Overall Study|Lack of Efficacy|0|||
131091157|NCT00847626|471964644|FG006|Overall Study|Lack of Efficacy|6|||
131091158|NCT00847626|471964645|FG007|Overall Study|Lack of Efficacy|2|||
131091159|NCT00847626|471964646|FG008|Overall Study|Lack of Efficacy|5|||
131091160|NCT00847626|471964647|FG009|Overall Study|Lack of Efficacy|1|||
131091161|NCT00847626|471964648|FG010|Overall Study|Lack of Efficacy|7|||
131091162|NCT00847626|471964638|FG000|Overall Study|Other|1|||
131091163|NCT00847626|471964639|FG001|Overall Study|Other|5|||
131091164|NCT00847626|471964640|FG002|Overall Study|Other|4|||
131091165|NCT00847626|471964641|FG003|Overall Study|Other|1|||
131091166|NCT00847626|471964642|FG004|Overall Study|Other|2|||
131091167|NCT00847626|471964643|FG005|Overall Study|Other|2|||
131091168|NCT00847626|471964644|FG006|Overall Study|Other|2|||
131091169|NCT00847626|471964645|FG007|Overall Study|Other|3|||
131091170|NCT00847626|471964646|FG008|Overall Study|Other|1|||
131091171|NCT00847626|471964647|FG009|Overall Study|Other|1|||
131091172|NCT00847626|471964648|FG010|Overall Study|Other|3|||
131091173|NCT03057847|471964649|FG000|Overall Study|Lost to Follow-up|16|||
131091174|NCT01706705|471964651|FG000|Overall Study|Death|1|||
131091175|NCT01706705|471964651|FG000|Overall Study|Lack of Efficacy|13|||
131091176|NCT01706705|471964651|FG000|Overall Study|Non-clinical|6|||
131091177|NCT05627258|471964652|FG000|Overall Study|Lost to Follow-up|1|||
131091178|NCT05627258|471964653|FG001|Overall Study|Lost to Follow-up|0|||
131091179|NCT05627258|471964654|FG002|Overall Study|Lost to Follow-up|0|||
131091180|NCT05627258|471964655|FG003|Overall Study|Lost to Follow-up|0|||
131091181|NCT05627258|471964656|FG004|Overall Study|Lost to Follow-up|0|||
131091182|NCT05627258|471964657|FG005|Overall Study|Lost to Follow-up|0|||
131091183|NCT05627258|471964652|FG000|Overall Study|Withdrawal by Subject|0|||
131091184|NCT05627258|471964653|FG001|Overall Study|Withdrawal by Subject|0|||
131091185|NCT05627258|471964654|FG002|Overall Study|Withdrawal by Subject|0|||
131091186|NCT05627258|471964655|FG003|Overall Study|Withdrawal by Subject|0|||
131091187|NCT05627258|471964656|FG004|Overall Study|Withdrawal by Subject|2|||
131091188|NCT05627258|471964657|FG005|Overall Study|Withdrawal by Subject|0|||
131091189|NCT05627258|471964652|FG000|Overall Study|Enrolled, but product not administered|1|||
131091190|NCT05627258|471964653|FG001|Overall Study|Enrolled, but product not administered|0|||
131091191|NCT05627258|471964654|FG002|Overall Study|Enrolled, but product not administered|0|||
131091192|NCT05627258|471964655|FG003|Overall Study|Enrolled, but product not administered|0|||
131091193|NCT05627258|471964656|FG004|Overall Study|Enrolled, but product not administered|0|||
131091194|NCT05627258|471964657|FG005|Overall Study|Enrolled, but product not administered|0|||
131091195|NCT05627258|471964652|FG000|Overall Study|Other subject illness/injury|1|||
131091196|NCT05627258|471964653|FG001|Overall Study|Other subject illness/injury|0|||
131091197|NCT05627258|471964654|FG002|Overall Study|Other subject illness/injury|0|||
131091198|NCT05627258|471964655|FG003|Overall Study|Other subject illness/injury|0|||
131091199|NCT05627258|471964656|FG004|Overall Study|Other subject illness/injury|0|||
131091200|NCT05627258|471964657|FG005|Overall Study|Other subject illness/injury|0|||
131091201|NCT05627258|471964652|FG000|Overall Study|Subject moved from area|0|||
131091202|NCT05627258|471964653|FG001|Overall Study|Subject moved from area|0|||
131091203|NCT05627258|471964654|FG002|Overall Study|Subject moved from area|1|||
131091204|NCT05627258|471964655|FG003|Overall Study|Subject moved from area|0|||
131091205|NCT05627258|471964656|FG004|Overall Study|Subject moved from area|0|||
131091206|NCT05627258|471964657|FG005|Overall Study|Subject moved from area|0|||
131091207|NCT02138786|471964658|FG000|Overall Study|Adverse Event|0|||
131091208|NCT02138786|471964659|FG001|Overall Study|Adverse Event|2|||
131091209|NCT02138786|471964660|FG002|Overall Study|Adverse Event|1|||
131091210|NCT02138786|471964658|FG000|Overall Study|Death|1|||
131091211|NCT02138786|471964659|FG001|Overall Study|Death|7|||
131091212|NCT02138786|471964660|FG002|Overall Study|Death|2|||
131091213|NCT02138786|471964658|FG000|Overall Study|Disease Progression|1|||
131091214|NCT02138786|471964659|FG001|Overall Study|Disease Progression|1|||
131091215|NCT02138786|471964660|FG002|Overall Study|Disease Progression|3|||
131091216|NCT02138786|471964658|FG000|Overall Study|Withdrawal by Subject|1|||
131091217|NCT02138786|471964659|FG001|Overall Study|Withdrawal by Subject|2|||
131091218|NCT02138786|471964660|FG002|Overall Study|Withdrawal by Subject|0|||
131091219|NCT02138786|471964658|FG000|Overall Study|Patient's Wish|0|||
131091220|NCT02138786|471964659|FG001|Overall Study|Patient's Wish|2|||
131091221|NCT02138786|471964660|FG002|Overall Study|Patient's Wish|0|||
131091222|NCT02138786|471964658|FG000|Overall Study|Sponsor Terminated Study|0|||
131091223|NCT02138786|471964659|FG001|Overall Study|Sponsor Terminated Study|1|||
131091224|NCT02138786|471964660|FG002|Overall Study|Sponsor Terminated Study|1|||
131091225|NCT02138786|471964658|FG000|Overall Study|Non-Compliance|0|||
131091226|NCT02138786|471964659|FG001|Overall Study|Non-Compliance|0|||
131091227|NCT02138786|471964660|FG002|Overall Study|Non-Compliance|1|||
131091228|NCT02088957|471964661|FG000|Overall Study|Lack of Efficacy|1|||
131091229|NCT02088957|471964662|FG001|Overall Study|Lack of Efficacy|0|||
131091230|NCT01199068|471964663|FG000|Overall Study|Unacceptable toxicity|0|||
131091231|NCT01199068|471964664|FG001|Overall Study|Unacceptable toxicity|0|||
131091232|NCT01199068|471964665|FG002|Overall Study|Unacceptable toxicity|2|||
131091233|NCT01199068|471964663|FG000|Overall Study|Progressive disease|3|||
131091234|NCT01199068|471964664|FG001|Overall Study|Progressive disease|3|||
131091235|NCT01199068|471964665|FG002|Overall Study|Progressive disease|6|||
131091236|NCT01199068|471964663|FG000|Overall Study|Withdrawal by Subject|0|||
131091237|NCT01199068|471964664|FG001|Overall Study|Withdrawal by Subject|0|||
131091238|NCT01199068|471964665|FG002|Overall Study|Withdrawal by Subject|1|||
131091239|NCT03338296|471964666|FG000|Overall Study|Adverse Event|0|||
131091240|NCT03338296|471964667|FG001|Overall Study|Adverse Event|1|||
131091241|NCT03338296|471964666|FG000|Overall Study|Withdrawal by Subject|14|||
131143329|NCT00705263|472150558|FG000|Overall Study|Withdrawal by Subject|2|||
131143330|NCT01752023|472150559|FG000|Overall Study|Physician Decision|2|||
131091242|NCT03338296|471964667|FG001|Overall Study|Withdrawal by Subject|13|||
131091243|NCT03338296|471964666|FG000|Overall Study|Lost to Follow-up|10|||
131091244|NCT03338296|471964667|FG001|Overall Study|Lost to Follow-up|10|||
131091245|NCT03338296|471964666|FG000|Overall Study|Study Terminated by Sponsor|77|||
131091246|NCT03338296|471964667|FG001|Overall Study|Study Terminated by Sponsor|76|||
131091247|NCT03338296|471964666|FG000|Overall Study|Other|2|||
131091248|NCT03338296|471964667|FG001|Overall Study|Other|7|||
131091249|NCT03338296|471964666|FG000|Overall Study|Missing|0|||
131143331|NCT01752023|472150560|FG001|Overall Study|Physician Decision|1|||
131143332|NCT02440581|472150561|FG000|Overall Study|Death|0|||
131143333|NCT02440581|472150562|FG001|Overall Study|Death|0|||
131143334|NCT02440581|472150563|FG002|Overall Study|Death|7|||
131143335|NCT02440581|472150564|FG003|Overall Study|Death|5|||
131143336|NCT02440581|472150561|FG000|Overall Study|Transplanted|1|||
131143337|NCT02440581|472150562|FG001|Overall Study|Transplanted|0|||
131143338|NCT02440581|472150563|FG002|Overall Study|Transplanted|3|||
131143339|NCT02440581|472150564|FG003|Overall Study|Transplanted|2|||
131143340|NCT02440581|472150561|FG000|Overall Study|Withdrawal by Subject|4|||
131143341|NCT02440581|472150562|FG001|Overall Study|Withdrawal by Subject|11|||
131143342|NCT02440581|472150563|FG002|Overall Study|Withdrawal by Subject|3|||
131143343|NCT02440581|472150564|FG003|Overall Study|Withdrawal by Subject|7|||
131234373|NCT00329602|472484648|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
131234374|NCT00329602|472484649|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
131234375|NCT00329602|472484650|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
131234376|NCT00329602|472484648|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
131234377|NCT00329602|472484649|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
131234378|NCT00329602|472484650|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
131234379|NCT00329602|472484648|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
131234380|NCT00329602|472484649|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
131234381|NCT00329602|472484650|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
131234382|NCT00329602|472484648|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
131234383|NCT00329602|472484649|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
131234384|NCT00329602|472484650|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
131234385|NCT00329602|472484648|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
131234386|NCT00329602|472484649|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
131234387|NCT00329602|472484650|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
131234388|NCT00455533|472484651|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
131234389|NCT00455533|472484652|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
131091250|NCT03338296|471964667|FG001|Overall Study|Missing|1|||
131091251|NCT02687035|471964672|FG000|Overall Study|Withdrawal by Subject|1|||
131091252|NCT02687035|471964672|FG000|Overall Study|Death|87|||
131091253|NCT02687035|471964672|FG000|Overall Study|Lost to Follow-up|1|||
131091254|NCT02687035|471964672|FG000|Overall Study|Missed Visit|87|||
131091255|NCT02687035|471964672|FG000|Overall Study|Did not receive Study Device|8|||
131091256|NCT00667394|471964673|FG000|Overall Study|Adverse Event|3|||
131091257|NCT00667394|471964674|FG001|Overall Study|Adverse Event|0|||
131143344|NCT03430986|472150565|FG000|24-week Control Period|Adverse Event|1|||
131234390|NCT00455533|472484653|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
131091258|NCT00667394|471964673|FG000|Overall Study|Progressive disease|1|||
131091259|NCT00667394|471964674|FG001|Overall Study|Progressive disease|0|||
131143345|NCT03430986|472150566|FG001|24-week Control Period|Adverse Event|0|||
131143346|NCT03430986|472150565|FG000|24-week Control Period|Lost to Follow-up|2|||
131091260|NCT04076943|471964676|FG000|Overall Study|Withdrawal by Subject|12|||
131091261|NCT04076943|471964676|FG000|Overall Study|Adverse Event|1|||
131091262|NCT04076943|471964676|FG000|Overall Study|Progressive Disease|2|||
131091263|NCT04076943|471964676|FG000|Overall Study|Death|13|||
131091264|NCT04076943|471964676|FG000|Overall Study|Other than specified|6|||
131091265|NCT02224703|471964682|FG000|Overall Study|Adverse Event|0|||
131091266|NCT02224703|471964683|FG001|Overall Study|Adverse Event|5|||
131091267|NCT02224703|471964684|FG002|Overall Study|Adverse Event|0|||
131091268|NCT02224703|471964682|FG000|Overall Study|Withdrawn by investigator|1|||
131091269|NCT02224703|471964683|FG001|Overall Study|Withdrawn by investigator|0|||
131091270|NCT02224703|471964684|FG002|Overall Study|Withdrawn by investigator|0|||
131091271|NCT02224703|471964682|FG000|Overall Study|Advised by medical monitor|1|||
131091272|NCT02224703|471964683|FG001|Overall Study|Advised by medical monitor|0|||
131091273|NCT02224703|471964684|FG002|Overall Study|Advised by medical monitor|0|||
131091274|NCT02224703|471964682|FG000|Overall Study|Withdrawn by parent/guardian|0|||
131091275|NCT02224703|471964683|FG001|Overall Study|Withdrawn by parent/guardian|1|||
131091276|NCT02224703|471964684|FG002|Overall Study|Withdrawn by parent/guardian|0|||
131091277|NCT02224703|471964682|FG000|Overall Study|Lack of Efficacy|1|||
131143347|NCT03430986|472150566|FG001|24-week Control Period|Lost to Follow-up|2|||
131091278|NCT02224703|471964683|FG001|Overall Study|Lack of Efficacy|0|||
131091279|NCT02224703|471964684|FG002|Overall Study|Lack of Efficacy|0|||
131091280|NCT02922023|471964685|FG000|Overall Study|Lost to Follow-up|2|||
131091281|NCT02922023|471964686|FG001|Overall Study|Lost to Follow-up|0|||
131091282|NCT02593123|471964687|FG000|Overall Study|Physician Decision|2|||
131091283|NCT02593123|471964688|FG001|Overall Study|Physician Decision|1|||
131091284|NCT02593123|471964687|FG000|Overall Study|Relapse|1|||
131091285|NCT02593123|471964688|FG001|Overall Study|Relapse|1|||
131091286|NCT00504777|471964689|FG000|Overall Study|Adverse Event|1|||
131091287|NCT01465763|471964690|FG000|Overall Study|Withdrawal by Subject|4|||
131091288|NCT01465763|471964691|FG001|Overall Study|Withdrawal by Subject|0|||
131091289|NCT01465763|471964692|FG002|Overall Study|Withdrawal by Subject|1|||
131091290|NCT01465763|471964690|FG000|Overall Study|Insufficient Clinical Response|11|||
131091291|NCT01465763|471964691|FG001|Overall Study|Insufficient Clinical Response|0|||
131091292|NCT01465763|471964692|FG002|Overall Study|Insufficient Clinical Response|1|||
131091293|NCT01465763|471964690|FG000|Overall Study|Adverse Event|9|||
131091294|NCT01465763|471964691|FG001|Overall Study|Adverse Event|0|||
131091295|NCT01465763|471964692|FG002|Overall Study|Adverse Event|1|||
131091296|NCT01465763|471964690|FG000|Overall Study|Other|2|||
131091297|NCT01465763|471964691|FG001|Overall Study|Other|0|||
131091298|NCT01465763|471964692|FG002|Overall Study|Other|0|||
131091299|NCT01465763|471964690|FG000|Overall Study|Protocol Violation|4|||
131091300|NCT01465763|471964691|FG001|Overall Study|Protocol Violation|1|||
131091301|NCT01465763|471964692|FG002|Overall Study|Protocol Violation|1|||
131091302|NCT01465763|471964690|FG000|Overall Study|Death|1|||
131091303|NCT01465763|471964691|FG001|Overall Study|Death|0|||
131091304|NCT01465763|471964692|FG002|Overall Study|Death|0|||
131091305|NCT03538938|471964693|FG000|Overall Study|Death|0|||
131091306|NCT03538938|471964694|FG001|Overall Study|Death|0|||
131091307|NCT03538938|471964695|FG002|Overall Study|Death|2|||
131091308|NCT03538938|471964696|FG003|Overall Study|Death|0|||
131091309|NCT03538938|471964697|FG004|Overall Study|Death|0|||
131091310|NCT03538938|471964698|FG005|Overall Study|Death|1|||
131091311|NCT03538938|471964699|FG006|Overall Study|Death|0|||
131091312|NCT03538938|471964700|FG007|Overall Study|Death|1|||
131091313|NCT03538938|471964701|FG008|Overall Study|Death|1|||
131091314|NCT03538938|471964702|FG009|Overall Study|Death|1|||
131091315|NCT03538938|471964703|FG010|Overall Study|Death|0|||
131091316|NCT03538938|471964704|FG011|Overall Study|Death|0|||
131091317|NCT03538938|471964705|FG012|Overall Study|Death|1|||
131091318|NCT03538938|471964706|FG013|Overall Study|Death|1|||
131091319|NCT03538938|471964707|FG014|Overall Study|Death|0|||
131091320|NCT03538938|471964708|FG015|Overall Study|Death|1|||
131091321|NCT03538938|471964693|FG000|Overall Study|Withdrawal by Subject|4|||
131091322|NCT03538938|471964694|FG001|Overall Study|Withdrawal by Subject|6|||
131091323|NCT03538938|471964695|FG002|Overall Study|Withdrawal by Subject|5|||
131091324|NCT03538938|471964696|FG003|Overall Study|Withdrawal by Subject|3|||
131091325|NCT03538938|471964697|FG004|Overall Study|Withdrawal by Subject|0|||
131091326|NCT03538938|471964698|FG005|Overall Study|Withdrawal by Subject|0|||
131091327|NCT03538938|471964699|FG006|Overall Study|Withdrawal by Subject|3|||
131091328|NCT03538938|471964700|FG007|Overall Study|Withdrawal by Subject|1|||
131091329|NCT03538938|471964701|FG008|Overall Study|Withdrawal by Subject|5|||
131091330|NCT03538938|471964702|FG009|Overall Study|Withdrawal by Subject|1|||
131091331|NCT03538938|471964703|FG010|Overall Study|Withdrawal by Subject|2|||
131091332|NCT03538938|471964704|FG011|Overall Study|Withdrawal by Subject|1|||
131091333|NCT03538938|471964705|FG012|Overall Study|Withdrawal by Subject|3|||
131091334|NCT03538938|471964706|FG013|Overall Study|Withdrawal by Subject|0|||
131091335|NCT03538938|471964707|FG014|Overall Study|Withdrawal by Subject|2|||
131091336|NCT03538938|471964708|FG015|Overall Study|Withdrawal by Subject|4|||
131091337|NCT03538938|471964693|FG000|Overall Study|Incarcerated|0|||
131091338|NCT03538938|471964694|FG001|Overall Study|Incarcerated|0|||
131091339|NCT03538938|471964695|FG002|Overall Study|Incarcerated|0|||
130727456|NCT00369486|470625453|FG003|34-Week Visit|Dropped|3|||
130727457|NCT00369486|470625454|FG004|34-Week Visit|Dropped|3|||
130727458|NCT00402116|470625455|FG000|Overall Study|Jaw infection after surgery-other|1|||
130727459|NCT00402116|470625456|FG001|Overall Study|Jaw infection after surgery-other|0|||
130727460|NCT00402116|470625457|FG002|Overall Study|Jaw infection after surgery-other|0|||
130727461|NCT00402116|470625455|FG000|Overall Study|Withdrawal by Subject|1|||
131091340|NCT03538938|471964696|FG003|Overall Study|Incarcerated|0|||
131091341|NCT03538938|471964697|FG004|Overall Study|Incarcerated|0|||
131091342|NCT03538938|471964698|FG005|Overall Study|Incarcerated|0|||
131091343|NCT03538938|471964699|FG006|Overall Study|Incarcerated|0|||
131091344|NCT03538938|471964700|FG007|Overall Study|Incarcerated|0|||
131091345|NCT03538938|471964701|FG008|Overall Study|Incarcerated|0|||
131091346|NCT03538938|471964702|FG009|Overall Study|Incarcerated|0|||
131091347|NCT03538938|471964703|FG010|Overall Study|Incarcerated|0|||
131091348|NCT03538938|471964704|FG011|Overall Study|Incarcerated|1|||
131091349|NCT03538938|471964705|FG012|Overall Study|Incarcerated|0|||
131091350|NCT03538938|471964706|FG013|Overall Study|Incarcerated|0|||
131091351|NCT03538938|471964707|FG014|Overall Study|Incarcerated|0|||
131091352|NCT03538938|471964708|FG015|Overall Study|Incarcerated|0|||
131091353|NCT03995316|471964709|FG000|Overall Study|Lost to Follow-up|10|||
131091354|NCT03995316|471964710|FG001|Overall Study|Lost to Follow-up|3|||
131091355|NCT01361594|471964711|FG000|Overall Study|Withdrawal by Subject|1|||
131091356|NCT01361594|471964712|FG001|Overall Study|Withdrawal by Subject|2|||
131091357|NCT00203268|471964720|FG000|Early Treatment|only treated one headache|2|||
131091358|NCT00203268|471964720|FG000|Early Treatment|Lost to Follow-up|1|||
131091359|NCT00203268|471964720|FG000|Early Treatment|Withdrawal by Subject|1|||
131091360|NCT00839956|471964722|FG000|Overall Study|Adverse Event|2|||
131091361|NCT00839956|471964722|FG000|Overall Study|Lack of Efficacy|6|||
131091362|NCT00839956|471964722|FG000|Overall Study|Physician Decision|1|||
131091363|NCT00839956|471964722|FG000|Overall Study|Withdrawal by Subject|3|||
131091364|NCT02807883|471964723|FG000|Overall Study|Withdrawal by Subject|2|||
131091365|NCT01399918|471964727|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
131091366|NCT03197766|471964732|FG000|Overall Study|Withdrawal by Subject|2|||
131091367|NCT03197766|471964733|FG001|Overall Study|Withdrawal by Subject|0|||
131091368|NCT00972322|471964735|FG000|Overall Study|Adverse Event|2|||
131091369|NCT00972322|471964736|FG001|Overall Study|Adverse Event|1|||
131091370|NCT00972322|471964735|FG000|Overall Study|Positive drug screen|0|||
131091371|NCT00972322|471964736|FG001|Overall Study|Positive drug screen|1|||
131091372|NCT00972322|471964735|FG000|Overall Study|Lost to Follow-up|0|||
131091373|NCT00972322|471964736|FG001|Overall Study|Lost to Follow-up|1|||
131091374|NCT00972322|471964735|FG000|Overall Study|Consistently high glucose values|1|||
131091375|NCT00972322|471964736|FG001|Overall Study|Consistently high glucose values|0|||
131091376|NCT00277095|471964739|FG000|Overall Study|Death|2|||
131091377|NCT00277095|471964739|FG000|Overall Study|Explanted|7|||
131091378|NCT00277095|471964739|FG000|Overall Study|Lost to Follow-up|2|||
131091379|NCT00277095|471964739|FG000|Overall Study|Missed Follow-up|9|||
131091380|NCT00277095|471964739|FG000|Overall Study|Physician Decision|1|||
131091381|NCT05140915|471964741|FG000|Overall Study|Lost to Follow-up|2|||
131091382|NCT05140915|471964742|FG001|Overall Study|Lost to Follow-up|1|||
131091383|NCT04520659|471964743|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
131091384|NCT04520659|471964744|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
131091385|NCT04520659|471964745|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
131091386|NCT04520659|471964746|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
130727462|NCT00402116|470625456|FG001|Overall Study|Withdrawal by Subject|0|||
130727463|NCT00402116|470625457|FG002|Overall Study|Withdrawal by Subject|5|||
130727464|NCT00402116|470625455|FG000|Overall Study|Treatment completed per protocol|1|||
130727465|NCT00402116|470625456|FG001|Overall Study|Treatment completed per protocol|1|||
130727466|NCT00402116|470625457|FG002|Overall Study|Treatment completed per protocol|2|||
130727467|NCT00402116|470625455|FG000|Overall Study|other complicating disease|0|||
131091387|NCT04879849|471964751|FG000|Overall Study|Lost to Follow-up|0|||
131091388|NCT04879849|471964752|FG001|Overall Study|Lost to Follow-up|0|||
131091389|NCT04879849|471964753|FG002|Overall Study|Lost to Follow-up|0|||
131091390|NCT04879849|471964754|FG003|Overall Study|Lost to Follow-up|1|||
131091391|NCT04879849|471964755|FG004|Overall Study|Lost to Follow-up|0|||
131091392|NCT04879849|471964756|FG005|Overall Study|Lost to Follow-up|0|||
131091393|NCT04879849|471964757|FG006|Overall Study|Lost to Follow-up|0|||
131091394|NCT04879849|471964758|FG007|Overall Study|Lost to Follow-up|0|||
131091395|NCT04879849|471964751|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
131091396|NCT04879849|471964752|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
131091397|NCT04879849|471964753|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
131091398|NCT04879849|471964754|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
131091399|NCT04879849|471964755|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
131091400|NCT04879849|471964756|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
130727468|NCT00402116|470625456|FG001|Overall Study|other complicating disease|0|||
131091401|NCT04879849|471964757|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
131091402|NCT04879849|471964758|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
131091403|NCT04879849|471964751|FG000|Overall Study|Withdrawal by Subject|0|||
131091404|NCT04879849|471964752|FG001|Overall Study|Withdrawal by Subject|0|||
131091405|NCT04879849|471964753|FG002|Overall Study|Withdrawal by Subject|0|||
131091406|NCT04879849|471964754|FG003|Overall Study|Withdrawal by Subject|0|||
131091407|NCT04879849|471964755|FG004|Overall Study|Withdrawal by Subject|2|||
131091408|NCT04879849|471964756|FG005|Overall Study|Withdrawal by Subject|0|||
131091409|NCT04879849|471964757|FG006|Overall Study|Withdrawal by Subject|1|||
131091410|NCT04879849|471964758|FG007|Overall Study|Withdrawal by Subject|0|||
131091411|NCT04879849|471964751|FG000|Overall Study|Progressive Disease|0|||
131091412|NCT04879849|471964752|FG001|Overall Study|Progressive Disease|0|||
131091413|NCT04879849|471964753|FG002|Overall Study|Progressive Disease|1|||
131091414|NCT04879849|471964754|FG003|Overall Study|Progressive Disease|0|||
131091415|NCT04879849|471964755|FG004|Overall Study|Progressive Disease|0|||
131091416|NCT04879849|471964756|FG005|Overall Study|Progressive Disease|0|||
131091417|NCT04879849|471964757|FG006|Overall Study|Progressive Disease|0|||
131091418|NCT04879849|471964758|FG007|Overall Study|Progressive Disease|0|||
131091419|NCT04879849|471964751|FG000|Overall Study|Death|0|||
131091420|NCT04879849|471964752|FG001|Overall Study|Death|0|||
131091421|NCT04879849|471964753|FG002|Overall Study|Death|1|||
131091422|NCT04879849|471964754|FG003|Overall Study|Death|1|||
131091423|NCT04879849|471964755|FG004|Overall Study|Death|1|||
131091424|NCT04879849|471964756|FG005|Overall Study|Death|2|||
131091425|NCT04879849|471964757|FG006|Overall Study|Death|1|||
131091426|NCT04879849|471964758|FG007|Overall Study|Death|2|||
131091427|NCT04879849|471964751|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
131091428|NCT04879849|471964752|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
131091429|NCT04879849|471964753|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
131091430|NCT04879849|471964754|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
131091431|NCT04879849|471964755|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
131091432|NCT04879849|471964756|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
131091433|NCT04879849|471964757|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
131091434|NCT04879849|471964758|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
131091435|NCT04879849|471964751|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131091436|NCT04879849|471964752|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131091437|NCT04879849|471964753|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131091438|NCT04879849|471964754|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131091439|NCT04879849|471964755|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131091440|NCT04879849|471964756|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131091441|NCT04879849|471964757|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
131091442|NCT04879849|471964758|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
131091443|NCT04879849|471964751|FG000|Overall Study|Reason Not Specified|1|||
131091444|NCT04879849|471964752|FG001|Overall Study|Reason Not Specified|0|||
131091445|NCT04879849|471964753|FG002|Overall Study|Reason Not Specified|0|||
131091446|NCT04879849|471964754|FG003|Overall Study|Reason Not Specified|0|||
131091447|NCT04879849|471964755|FG004|Overall Study|Reason Not Specified|0|||
131091448|NCT04879849|471964756|FG005|Overall Study|Reason Not Specified|0|||
131091449|NCT04879849|471964757|FG006|Overall Study|Reason Not Specified|0|||
131091450|NCT04879849|471964758|FG007|Overall Study|Reason Not Specified|0|||
131091451|NCT03361865|471964759|FG000|Overall Study|Death|17|||
131091452|NCT03361865|471964760|FG001|Overall Study|Death|18|||
131091453|NCT03361865|471964759|FG000|Overall Study|Physician Decision|1|||
131091454|NCT03361865|471964760|FG001|Overall Study|Physician Decision|9|||
131091455|NCT03361865|471964759|FG000|Overall Study|Withdrawal by Subject|1|||
131091456|NCT03361865|471964760|FG001|Overall Study|Withdrawal by Subject|0|||
131091457|NCT03852719|471964761|FG000|Overall Study|Withdrawal of consent|8|||
131091458|NCT03852719|471964762|FG001|Overall Study|Withdrawal of consent|8|||
131091459|NCT03852719|471964763|FG002|Overall Study|Withdrawal of consent|9|||
131091460|NCT03852719|471964761|FG000|Overall Study|Physician Decision|5|||
131091461|NCT03852719|471964762|FG001|Overall Study|Physician Decision|4|||
131091462|NCT03852719|471964763|FG002|Overall Study|Physician Decision|1|||
131091463|NCT03852719|471964761|FG000|Overall Study|Pregnancy|2|||
131091464|NCT03852719|471964762|FG001|Overall Study|Pregnancy|1|||
131091465|NCT03852719|471964763|FG002|Overall Study|Pregnancy|0|||
131091466|NCT03852719|471964761|FG000|Overall Study|Death|1|||
131091467|NCT03852719|471964762|FG001|Overall Study|Death|0|||
131091468|NCT03852719|471964763|FG002|Overall Study|Death|0|||
131143348|NCT03430986|472150565|FG000|24-week Control Period|Withdrawal by Participant|5|||
131143349|NCT03430986|472150566|FG001|24-week Control Period|Withdrawal by Participant|0|||
131143350|NCT03430986|472150565|FG000|24-week Control Period|Protocol Deviation|0|||
131091469|NCT03852719|471964761|FG000|Overall Study|Reason not Specified|3|||
131091470|NCT03852719|471964762|FG001|Overall Study|Reason not Specified|3|||
131091471|NCT03852719|471964763|FG002|Overall Study|Reason not Specified|5|||
131091472|NCT03852719|471964761|FG000|Overall Study|Adverse Event|2|||
131091473|NCT03852719|471964762|FG001|Overall Study|Adverse Event|1|||
131091474|NCT03852719|471964763|FG002|Overall Study|Adverse Event|4|||
131091475|NCT03852719|471964761|FG000|Overall Study|Progressive disease|1|||
131091476|NCT03852719|471964762|FG001|Overall Study|Progressive disease|4|||
131091477|NCT03852719|471964763|FG002|Overall Study|Progressive disease|1|||
131091478|NCT03852719|471964761|FG000|Overall Study|Lost to Follow-up|1|||
131091479|NCT03852719|471964762|FG001|Overall Study|Lost to Follow-up|0|||
131091480|NCT03852719|471964763|FG002|Overall Study|Lost to Follow-up|0|||
131091481|NCT05543187|471964766|FG000|Overall Study|Ongoing|3|||
131091482|NCT05543187|471964767|FG001|Overall Study|Ongoing|2|||
131091483|NCT03810235|471964768|FG000|Overall Study|Withdrawal by Subject|2|||
131091484|NCT03810235|471964769|FG001|Overall Study|Withdrawal by Subject|0|||
131091485|NCT04777864|471964770|FG000|Overall Study|Lost to Follow-up|8|||
131091486|NCT04777864|471964771|FG001|Overall Study|Lost to Follow-up|19|||
131091487|NCT01647542|471964773|FG000|Overall Study|Major Protocol Deviation|1|||
131091488|NCT01647542|471964774|FG001|Overall Study|Major Protocol Deviation|0|||
131091489|NCT01647542|471964775|FG002|Overall Study|Major Protocol Deviation|0|||
131091490|NCT01647542|471964773|FG000|Overall Study|Adverse Event|4|||
131091491|NCT01647542|471964774|FG001|Overall Study|Adverse Event|5|||
131091492|NCT01647542|471964775|FG002|Overall Study|Adverse Event|4|||
131091493|NCT01647542|471964773|FG000|Overall Study|Lost to Follow-up|0|||
131091494|NCT01647542|471964774|FG001|Overall Study|Lost to Follow-up|2|||
131091495|NCT01647542|471964775|FG002|Overall Study|Lost to Follow-up|2|||
131091496|NCT01647542|471964773|FG000|Overall Study|Withdrawal by Subject|6|||
131091497|NCT01647542|471964774|FG001|Overall Study|Withdrawal by Subject|4|||
131091498|NCT01647542|471964775|FG002|Overall Study|Withdrawal by Subject|0|||
131091499|NCT01647542|471964773|FG000|Overall Study|Study Termination|64|||
131091500|NCT01647542|471964774|FG001|Overall Study|Study Termination|61|||
131091501|NCT01647542|471964775|FG002|Overall Study|Study Termination|65|||
131091502|NCT01647542|471964773|FG000|Overall Study|Lack of Efficacy|1|||
131091503|NCT01647542|471964774|FG001|Overall Study|Lack of Efficacy|1|||
131091504|NCT01647542|471964775|FG002|Overall Study|Lack of Efficacy|0|||
131091505|NCT01647542|471964773|FG000|Overall Study|Death|0|||
131091506|NCT01647542|471964774|FG001|Overall Study|Death|0|||
131091507|NCT01647542|471964775|FG002|Overall Study|Death|1|||
131091508|NCT03086655|471964776|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
131091509|NCT03086655|471964777|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
131091510|NCT03086655|471964776|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
131091511|NCT03086655|471964777|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
131091512|NCT03086655|471964776|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
131091513|NCT03086655|471964777|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
131091514|NCT03086655|471964776|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
131091515|NCT03086655|471964777|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
131091516|NCT03086655|471964776|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
131091517|NCT03086655|471964777|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
131091518|NCT03086655|471964776|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
131091519|NCT03086655|471964777|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
131091520|NCT03086655|471964776|FG000|12 Month Follow-up = Final Assessment|Death|0|||
131091521|NCT03086655|471964777|FG001|12 Month Follow-up = Final Assessment|Death|1|||
131091522|NCT05576662|471964778|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
131091523|NCT05576662|471964779|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
131091524|NCT05576662|471964778|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
131091525|NCT05576662|471964779|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
131091526|NCT05576662|471964778|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
131091527|NCT05576662|471964779|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
130727469|NCT00402116|470625457|FG002|Overall Study|other complicating disease|2|||
130727470|NCT00402116|470625455|FG000|Overall Study|Disease Progression|0|||
131091528|NCT05576662|471964778|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
131091529|NCT05576662|471964779|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
130727471|NCT00402116|470625456|FG001|Overall Study|Disease Progression|4|||
130727472|NCT00402116|470625457|FG002|Overall Study|Disease Progression|38|||
130727473|NCT00402116|470625455|FG000|Overall Study|mistaken thrombocytopenia|0|||
130727474|NCT00402116|470625456|FG001|Overall Study|mistaken thrombocytopenia|0|||
131091530|NCT03008005|471964780|FG000|Overall Study|Physician Decision|1|||
131091531|NCT03008005|471964781|FG001|Overall Study|Physician Decision|0|||
131091532|NCT03008005|471964782|FG002|Overall Study|Physician Decision|0|||
131091533|NCT03008005|471964780|FG000|Overall Study|Withdrawal by Subject|1|||
131091534|NCT03008005|471964781|FG001|Overall Study|Withdrawal by Subject|0|||
131091535|NCT03008005|471964782|FG002|Overall Study|Withdrawal by Subject|0|||
131091536|NCT03008005|471964780|FG000|Overall Study|Ineligible|0|||
131091537|NCT03008005|471964781|FG001|Overall Study|Ineligible|1|||
131091538|NCT03008005|471964782|FG002|Overall Study|Ineligible|0|||
131091539|NCT01040169|471964795|FG000|Overall Study|Lost to Follow-up|3|||
131091540|NCT01040169|471964796|FG001|Overall Study|Lost to Follow-up|8|||
131091541|NCT00350727|471964797|FG000|Phase I: Dose Escalation|Adverse Event|4|||
131091542|NCT00350727|471964798|FG001|Phase I: Dose Escalation|Adverse Event|0|||
131091543|NCT00350727|471964799|FG002|Phase I: Dose Escalation|Adverse Event|0|||
131091544|NCT00350727|471964797|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
131091545|NCT00350727|471964798|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
131091546|NCT00350727|471964799|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
131091547|NCT00350727|471964797|FG000|Phase I: Dose Escalation|Death|1|||
131091548|NCT00350727|471964798|FG001|Phase I: Dose Escalation|Death|0|||
131091549|NCT00350727|471964799|FG002|Phase I: Dose Escalation|Death|0|||
131091550|NCT00350727|471964797|FG000|Phase I: Dose Escalation|Physician Decision|1|||
131091551|NCT00350727|471964798|FG001|Phase I: Dose Escalation|Physician Decision|0|||
131091552|NCT00350727|471964799|FG002|Phase I: Dose Escalation|Physician Decision|0|||
131091553|NCT00350727|471964797|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
131091554|NCT00350727|471964798|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
131091555|NCT00350727|471964799|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
131091556|NCT00350727|471964797|FG000|Phase II|Disease Progression|0|||
131091557|NCT00350727|471964798|FG001|Phase II|Disease Progression|15|||
131091558|NCT00350727|471964799|FG002|Phase II|Disease Progression|16|||
131091559|NCT00350727|471964797|FG000|Phase II|Clinical Deterioration|0|||
131091560|NCT00350727|471964798|FG001|Phase II|Clinical Deterioration|1|||
131091561|NCT00350727|471964799|FG002|Phase II|Clinical Deterioration|0|||
131091562|NCT00350727|471964797|FG000|Phase II|Withdrawal by Subject|0|||
131091563|NCT00350727|471964798|FG001|Phase II|Withdrawal by Subject|2|||
131091564|NCT00350727|471964799|FG002|Phase II|Withdrawal by Subject|1|||
131091565|NCT00350727|471964797|FG000|Phase II|Adverse Event|0|||
131091566|NCT00350727|471964798|FG001|Phase II|Adverse Event|1|||
131091567|NCT00350727|471964799|FG002|Phase II|Adverse Event|1|||
131091568|NCT00350727|471964797|FG000|Phase II|Death|0|||
131091569|NCT00350727|471964798|FG001|Phase II|Death|0|||
131091570|NCT00350727|471964799|FG002|Phase II|Death|2|||
131091571|NCT00350727|471964797|FG000|Phase II|Sponsor Terminated Study|0|||
131091572|NCT00350727|471964798|FG001|Phase II|Sponsor Terminated Study|0|||
131091573|NCT00350727|471964799|FG002|Phase II|Sponsor Terminated Study|1|||
131091574|NCT00350727|471964797|FG000|Phase II|Enrolled in Rollover Study|0|||
131091575|NCT00350727|471964798|FG001|Phase II|Enrolled in Rollover Study|0|||
131091576|NCT00350727|471964799|FG002|Phase II|Enrolled in Rollover Study|1|||
131091577|NCT03633799|471964807|FG000|Overall Study|Adverse Event|349|||
131091578|NCT03633799|471964807|FG000|Overall Study|Withdrawal by Subject|288|||
131091579|NCT03633799|471964807|FG000|Overall Study|Lost to Follow-up|97|||
131091580|NCT03633799|471964807|FG000|Overall Study|Physician Decision|9|||
131091581|NCT03633799|471964807|FG000|Overall Study|Protocol Violation|4|||
131091582|NCT03633799|471964807|FG000|Overall Study|Pregnancy|20|||
131091583|NCT03633799|471964807|FG000|Overall Study|other|39|||
131091584|NCT03633799|471964807|FG000|Overall Study|ongoing within third year of study|106|||
131091585|NCT03633799|471964807|FG000|Overall Study|unsuccessful study drug placement|19|||
131091586|NCT03551691|471964808|FG000|Overall Study|Withdrawal by Subject|3|||
131091587|NCT03551691|471964809|FG001|Overall Study|Withdrawal by Subject|3|||
131091588|NCT03520712|471964810|FG000|Overall Study|Early termination of the study by Sponsor|2|||
131091589|NCT05855967|471964811|FG000|Overall Study|Withdrawal by Subject|7|||
131091590|NCT05855967|471964812|FG001|Overall Study|Withdrawal by Subject|5|||
131091591|NCT05855967|471964811|FG000|Overall Study|Lost to Follow-up|2|||
131091592|NCT05855967|471964812|FG001|Overall Study|Lost to Follow-up|1|||
131091593|NCT02446821|471964813|FG000|Overall Study|Adverse Event|28|||
131091594|NCT02446821|471964813|FG000|Overall Study|Withdrawal by Subject|6|||
131091595|NCT02446821|471964813|FG000|Overall Study|Lost to Follow-up|22|||
131091596|NCT02446821|471964813|FG000|Overall Study|other|9|||
131091597|NCT02446821|471964813|FG000|Overall Study|insertion failure|3|||
131091598|NCT04427280|471966704|FG000|Overall Study|Withdrawal by Subject|0|||
131091599|NCT04427280|471966705|FG001|Overall Study|Withdrawal by Subject|2|||
131091600|NCT04942366|471966713|FG000|Overall Study|Withdrawal by Subject|5|||
131091601|NCT04942366|471966714|FG001|Overall Study|Withdrawal by Subject|5|||
131091602|NCT04996004|471966715|FG000|Phase I|Death|1|||
131091603|NCT04996004|471966716|FG001|Phase I|Death|2|||
130727475|NCT00402116|470625457|FG002|Overall Study|mistaken thrombocytopenia|1|||
130727476|NCT00402116|470625455|FG000|Overall Study|decline related hyponatremia/tumor|0|||
131091604|NCT04996004|471966717|FG002|Phase I|Death|1|||
131091605|NCT04996004|471966718|FG003|Phase I|Death|0|||
131091606|NCT04996004|471966719|FG004|Phase I|Death|0|||
131091607|NCT04996004|471966720|FG005|Phase I|Death|0|||
131091608|NCT04996004|471966715|FG000|Phase I|Study terminated by sponsor|2|||
131091609|NCT04996004|471966716|FG001|Phase I|Study terminated by sponsor|1|||
131091610|NCT04996004|471966717|FG002|Phase I|Study terminated by sponsor|2|||
131091611|NCT04996004|471966718|FG003|Phase I|Study terminated by sponsor|0|||
131091612|NCT04996004|471966719|FG004|Phase I|Study terminated by sponsor|0|||
131091613|NCT04996004|471966720|FG005|Phase I|Study terminated by sponsor|0|||
131091614|NCT04996004|471966715|FG000|Phase II|Study terminated by sponsor|0|||
131091615|NCT04996004|471966716|FG001|Phase II|Study terminated by sponsor|0|||
131091616|NCT04996004|471966717|FG002|Phase II|Study terminated by sponsor|0|||
131091617|NCT04996004|471966718|FG003|Phase II|Study terminated by sponsor|20|||
131091618|NCT04996004|471966719|FG004|Phase II|Study terminated by sponsor|10|||
131091619|NCT04996004|471966720|FG005|Phase II|Study terminated by sponsor|10|||
131091620|NCT04996004|471966715|FG000|Phase II|Withdrawal by Subject|0|||
131091621|NCT04996004|471966716|FG001|Phase II|Withdrawal by Subject|0|||
131091622|NCT04996004|471966717|FG002|Phase II|Withdrawal by Subject|0|||
131091623|NCT04996004|471966718|FG003|Phase II|Withdrawal by Subject|0|||
131091624|NCT04996004|471966719|FG004|Phase II|Withdrawal by Subject|1|||
131091625|NCT04996004|471966720|FG005|Phase II|Withdrawal by Subject|2|||
131091626|NCT04996004|471966715|FG000|Phase II|Death|0|||
131091627|NCT04996004|471966716|FG001|Phase II|Death|0|||
131091628|NCT04996004|471966717|FG002|Phase II|Death|0|||
131091629|NCT04996004|471966718|FG003|Phase II|Death|12|||
131091630|NCT04996004|471966719|FG004|Phase II|Death|2|||
131091631|NCT04996004|471966720|FG005|Phase II|Death|9|||
131091632|NCT04996004|471966715|FG000|Phase II|Other|0|||
131091633|NCT04996004|471966716|FG001|Phase II|Other|0|||
131091634|NCT04996004|471966717|FG002|Phase II|Other|0|||
131091635|NCT04996004|471966718|FG003|Phase II|Other|0|||
131091636|NCT04996004|471966719|FG004|Phase II|Other|0|||
131091637|NCT04996004|471966720|FG005|Phase II|Other|1|||
131091638|NCT02942277|471966721|FG000|Year 1|Withdrawal by Subject|0|||
131091639|NCT02942277|471966722|FG001|Year 1|Withdrawal by Subject|0|||
131091640|NCT02942277|471966723|FG002|Year 1|Withdrawal by Subject|0|||
131091641|NCT02942277|471966724|FG003|Year 1|Withdrawal by Subject|0|||
131091642|NCT02942277|471966725|FG004|Year 1|Withdrawal by Subject|1|||
131091643|NCT02942277|471966726|FG005|Year 1|Withdrawal by Subject|3|||
131091644|NCT02942277|471966727|FG006|Year 1|Withdrawal by Subject|0|||
131091645|NCT02942277|471966728|FG007|Year 1|Withdrawal by Subject|1|||
131091646|NCT02942277|471966729|FG008|Year 1|Withdrawal by Subject|0|||
131091647|NCT02942277|471966730|FG009|Year 1|Withdrawal by Subject|0|||
131091648|NCT02942277|471966731|FG010|Year 1|Withdrawal by Subject|3|||
131091649|NCT02942277|471966721|FG000|Year 1|Travel|0|||
131091650|NCT02942277|471966722|FG001|Year 1|Travel|1|||
131091651|NCT02942277|471966723|FG002|Year 1|Travel|0|||
131091652|NCT02942277|471966724|FG003|Year 1|Travel|0|||
131091653|NCT02942277|471966725|FG004|Year 1|Travel|4|||
131091654|NCT02942277|471966726|FG005|Year 1|Travel|5|||
131091655|NCT02942277|471966727|FG006|Year 1|Travel|0|||
131091656|NCT02942277|471966728|FG007|Year 1|Travel|0|||
131091657|NCT02942277|471966729|FG008|Year 1|Travel|0|||
131091658|NCT02942277|471966730|FG009|Year 1|Travel|0|||
131091659|NCT02942277|471966731|FG010|Year 1|Travel|8|||
131091660|NCT02942277|471966721|FG000|Year 1|Joined Army|0|||
131091661|NCT02942277|471966722|FG001|Year 1|Joined Army|1|||
131143351|NCT03430986|472150566|FG001|24-week Control Period|Protocol Deviation|2|||
131143352|NCT03430986|472150565|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
131143353|NCT03430986|472150566|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
131143354|NCT03430986|472150565|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
131143355|NCT03430986|472150566|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
131143356|NCT03186989|472150567|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131143357|NCT03186989|472150568|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131143358|NCT03186989|472150569|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
131143359|NCT03186989|472150570|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
131234391|NCT00455533|472484651|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
131234392|NCT00455533|472484652|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
131234393|NCT00455533|472484653|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
131234394|NCT00455533|472484651|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
131234395|NCT00455533|472484652|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
131234396|NCT00455533|472484653|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
131234397|NCT00455533|472484651|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
131091662|NCT02942277|471966723|FG002|Year 1|Joined Army|0|||
131143360|NCT03186989|472150571|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
131143361|NCT03186989|472150572|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131091663|NCT02942277|471966724|FG003|Year 1|Joined Army|0|||
131091664|NCT02942277|471966725|FG004|Year 1|Joined Army|0|||
131091665|NCT02942277|471966726|FG005|Year 1|Joined Army|0|||
131091666|NCT02942277|471966727|FG006|Year 1|Joined Army|0|||
131091667|NCT02942277|471966728|FG007|Year 1|Joined Army|0|||
131091668|NCT02942277|471966729|FG008|Year 1|Joined Army|0|||
131091669|NCT02942277|471966730|FG009|Year 1|Joined Army|0|||
131091670|NCT02942277|471966731|FG010|Year 1|Joined Army|0|||
131091671|NCT02942277|471966721|FG000|Year 1|Subject met withdrawal criteria|0|||
131091672|NCT02942277|471966722|FG001|Year 1|Subject met withdrawal criteria|0|||
131091673|NCT02942277|471966723|FG002|Year 1|Subject met withdrawal criteria|0|||
131091674|NCT02942277|471966724|FG003|Year 1|Subject met withdrawal criteria|1|||
131091675|NCT02942277|471966725|FG004|Year 1|Subject met withdrawal criteria|0|||
131091676|NCT02942277|471966726|FG005|Year 1|Subject met withdrawal criteria|0|||
131091677|NCT02942277|471966727|FG006|Year 1|Subject met withdrawal criteria|0|||
131234398|NCT00455533|472484652|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
131234399|NCT00455533|472484653|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
131091678|NCT02942277|471966728|FG007|Year 1|Subject met withdrawal criteria|0|||
131091679|NCT02942277|471966729|FG008|Year 1|Subject met withdrawal criteria|0|||
131091680|NCT02942277|471966730|FG009|Year 1|Subject met withdrawal criteria|0|||
131091681|NCT02942277|471966731|FG010|Year 1|Subject met withdrawal criteria|0|||
131091682|NCT02942277|471966721|FG000|Year 1|Lost to Follow-up|0|||
131091683|NCT02942277|471966722|FG001|Year 1|Lost to Follow-up|0|||
131091684|NCT02942277|471966723|FG002|Year 1|Lost to Follow-up|0|||
131091685|NCT02942277|471966724|FG003|Year 1|Lost to Follow-up|0|||
131091686|NCT02942277|471966725|FG004|Year 1|Lost to Follow-up|1|||
131091687|NCT02942277|471966726|FG005|Year 1|Lost to Follow-up|0|||
131091688|NCT02942277|471966727|FG006|Year 1|Lost to Follow-up|0|||
131091689|NCT02942277|471966728|FG007|Year 1|Lost to Follow-up|0|||
131091690|NCT02942277|471966729|FG008|Year 1|Lost to Follow-up|0|||
131091691|NCT02942277|471966730|FG009|Year 1|Lost to Follow-up|0|||
131091692|NCT02942277|471966731|FG010|Year 1|Lost to Follow-up|2|||
131091693|NCT02942277|471966721|FG000|Year 1|Protocol Violation|0|||
131091694|NCT02942277|471966722|FG001|Year 1|Protocol Violation|0|||
131091695|NCT02942277|471966723|FG002|Year 1|Protocol Violation|0|||
131091696|NCT02942277|471966724|FG003|Year 1|Protocol Violation|0|||
131091697|NCT02942277|471966725|FG004|Year 1|Protocol Violation|1|||
131091698|NCT02942277|471966726|FG005|Year 1|Protocol Violation|1|||
131091699|NCT02942277|471966727|FG006|Year 1|Protocol Violation|0|||
131091700|NCT02942277|471966728|FG007|Year 1|Protocol Violation|0|||
131091701|NCT02942277|471966729|FG008|Year 1|Protocol Violation|0|||
131091702|NCT02942277|471966730|FG009|Year 1|Protocol Violation|0|||
131091703|NCT02942277|471966731|FG010|Year 1|Protocol Violation|2|||
131091704|NCT02942277|471966721|FG000|Year 1|Pregnancy|0|||
131091705|NCT02942277|471966722|FG001|Year 1|Pregnancy|0|||
131091706|NCT02942277|471966723|FG002|Year 1|Pregnancy|0|||
131091707|NCT02942277|471966724|FG003|Year 1|Pregnancy|0|||
131091708|NCT02942277|471966725|FG004|Year 1|Pregnancy|0|||
131091709|NCT02942277|471966726|FG005|Year 1|Pregnancy|1|||
131091710|NCT02942277|471966727|FG006|Year 1|Pregnancy|0|||
131091711|NCT02942277|471966728|FG007|Year 1|Pregnancy|0|||
131091712|NCT02942277|471966729|FG008|Year 1|Pregnancy|0|||
131091713|NCT02942277|471966730|FG009|Year 1|Pregnancy|0|||
131091714|NCT02942277|471966731|FG010|Year 1|Pregnancy|0|||
131091715|NCT02942277|471966721|FG000|Year 2|Lost to Follow-up|0|||
131091716|NCT02942277|471966722|FG001|Year 2|Lost to Follow-up|0|||
131091717|NCT02942277|471966723|FG002|Year 2|Lost to Follow-up|0|||
131091718|NCT02942277|471966724|FG003|Year 2|Lost to Follow-up|0|||
131091719|NCT02942277|471966725|FG004|Year 2|Lost to Follow-up|2|||
131091720|NCT02942277|471966726|FG005|Year 2|Lost to Follow-up|1|||
131091721|NCT02942277|471966727|FG006|Year 2|Lost to Follow-up|0|||
131091722|NCT02942277|471966728|FG007|Year 2|Lost to Follow-up|0|||
131091723|NCT02942277|471966729|FG008|Year 2|Lost to Follow-up|0|||
131091724|NCT02942277|471966730|FG009|Year 2|Lost to Follow-up|0|||
131091725|NCT02942277|471966731|FG010|Year 2|Lost to Follow-up|0|||
131091726|NCT02942277|471966721|FG000|Year 2|Did not rescreen|0|||
131091727|NCT02942277|471966722|FG001|Year 2|Did not rescreen|0|||
131091728|NCT02942277|471966723|FG002|Year 2|Did not rescreen|1|||
131091729|NCT02942277|471966724|FG003|Year 2|Did not rescreen|1|||
131091730|NCT02942277|471966725|FG004|Year 2|Did not rescreen|9|||
131091731|NCT02942277|471966726|FG005|Year 2|Did not rescreen|6|||
131234400|NCT00455533|472484651|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
131234401|NCT00455533|472484652|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
130727477|NCT00402116|470625456|FG001|Overall Study|decline related hyponatremia/tumor|0|||
130727478|NCT00402116|470625457|FG002|Overall Study|decline related hyponatremia/tumor|1|||
130727479|NCT00402116|470625455|FG000|Overall Study|Adverse Event|0|||
131091732|NCT02942277|471966727|FG006|Year 2|Did not rescreen|0|||
131091733|NCT02942277|471966728|FG007|Year 2|Did not rescreen|1|||
131091734|NCT02942277|471966729|FG008|Year 2|Did not rescreen|0|||
130727480|NCT00402116|470625456|FG001|Overall Study|Adverse Event|1|||
130727481|NCT00402116|470625457|FG002|Overall Study|Adverse Event|6|||
131091735|NCT02942277|471966730|FG009|Year 2|Did not rescreen|0|||
131091736|NCT02942277|471966731|FG010|Year 2|Did not rescreen|21|||
131091737|NCT02942277|471966721|FG000|Year 2|Met withdrawal criteria|0|||
131091738|NCT02942277|471966722|FG001|Year 2|Met withdrawal criteria|0|||
131091739|NCT02942277|471966723|FG002|Year 2|Met withdrawal criteria|0|||
131091740|NCT02942277|471966724|FG003|Year 2|Met withdrawal criteria|0|||
131091741|NCT02942277|471966725|FG004|Year 2|Met withdrawal criteria|1|||
131091742|NCT02942277|471966726|FG005|Year 2|Met withdrawal criteria|2|||
131091743|NCT02942277|471966727|FG006|Year 2|Met withdrawal criteria|0|||
131091744|NCT02942277|471966728|FG007|Year 2|Met withdrawal criteria|0|||
131091745|NCT02942277|471966729|FG008|Year 2|Met withdrawal criteria|0|||
131091746|NCT02942277|471966730|FG009|Year 2|Met withdrawal criteria|0|||
131091747|NCT02942277|471966731|FG010|Year 2|Met withdrawal criteria|1|||
131091748|NCT02942277|471966721|FG000|Year 2|Travel|0|||
131091749|NCT02942277|471966722|FG001|Year 2|Travel|1|||
131091750|NCT02942277|471966723|FG002|Year 2|Travel|0|||
131091751|NCT02942277|471966724|FG003|Year 2|Travel|0|||
131091752|NCT02942277|471966725|FG004|Year 2|Travel|0|||
131091753|NCT02942277|471966726|FG005|Year 2|Travel|1|||
131091754|NCT02942277|471966727|FG006|Year 2|Travel|0|||
131091755|NCT02942277|471966728|FG007|Year 2|Travel|0|||
131091756|NCT02942277|471966729|FG008|Year 2|Travel|0|||
131091757|NCT02942277|471966730|FG009|Year 2|Travel|1|||
131091758|NCT02942277|471966731|FG010|Year 2|Travel|3|||
131091759|NCT02942277|471966721|FG000|Year 2|Non-compliant|0|||
131091760|NCT02942277|471966722|FG001|Year 2|Non-compliant|0|||
131091761|NCT02942277|471966723|FG002|Year 2|Non-compliant|0|||
131091762|NCT02942277|471966724|FG003|Year 2|Non-compliant|0|||
131091763|NCT02942277|471966725|FG004|Year 2|Non-compliant|1|||
131091764|NCT02942277|471966726|FG005|Year 2|Non-compliant|1|||
131091765|NCT02942277|471966727|FG006|Year 2|Non-compliant|0|||
131091766|NCT02942277|471966728|FG007|Year 2|Non-compliant|0|||
131091767|NCT02942277|471966729|FG008|Year 2|Non-compliant|0|||
131091768|NCT02942277|471966730|FG009|Year 2|Non-compliant|0|||
131091769|NCT02942277|471966731|FG010|Year 2|Non-compliant|0|||
131091770|NCT02942277|471966721|FG000|Year 2|Withdrawal by Subject|0|||
131091771|NCT02942277|471966722|FG001|Year 2|Withdrawal by Subject|0|||
131091772|NCT02942277|471966723|FG002|Year 2|Withdrawal by Subject|0|||
131091773|NCT02942277|471966724|FG003|Year 2|Withdrawal by Subject|0|||
131091774|NCT02942277|471966725|FG004|Year 2|Withdrawal by Subject|0|||
131091775|NCT02942277|471966726|FG005|Year 2|Withdrawal by Subject|0|||
131091776|NCT02942277|471966727|FG006|Year 2|Withdrawal by Subject|1|||
131091777|NCT02942277|471966728|FG007|Year 2|Withdrawal by Subject|0|||
131091778|NCT02942277|471966729|FG008|Year 2|Withdrawal by Subject|0|||
131091779|NCT02942277|471966730|FG009|Year 2|Withdrawal by Subject|0|||
131091780|NCT02942277|471966731|FG010|Year 2|Withdrawal by Subject|0|||
131091781|NCT05577715|471966732|FG000|Overall Study|Withdrawal by Subject|1|||
131091782|NCT05577715|471966732|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
131091783|NCT05577715|471966732|FG000|Overall Study|Lost to Follow-up|1|||
131091784|NCT05577715|471966732|FG000|Overall Study|Death|6|||
131091785|NCT01736189|471966735|FG000|Overall Study|Violation of registration criteria|41|||
131091786|NCT01736189|471966735|FG000|Overall Study|Protocol Violation|4|||
131091787|NCT01736189|471966735|FG000|Overall Study|Criteria and protocol violations|1|||
131091788|NCT01077128|471966737|FG000|Overall Study|Adverse Event|8|||
131091789|NCT01077128|471966737|FG000|Overall Study|Lack of Efficacy|1|||
131091790|NCT01077128|471966737|FG000|Overall Study|Disease exacerbation|1|||
131091791|NCT01077128|471966737|FG000|Overall Study|Adverse event and consent withdrawal|1|||
131091792|NCT01077128|471966737|FG000|Overall Study|Adverse event and disease exacerbation|1|||
131091793|NCT01077128|471966737|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
131091794|NCT01077128|471966737|FG000|Overall Study|Other|54|||
131091795|NCT03809039|471966740|FG000|Part 1|Withdrawal by Subject|1|||
131091796|NCT03809039|471966741|FG001|Part 1|Withdrawal by Subject|0|||
131091797|NCT03809039|471966742|FG002|Part 1|Withdrawal by Subject|0|||
131091798|NCT03809039|471966743|FG003|Part 1|Withdrawal by Subject|1|||
131091799|NCT03809039|471966744|FG004|Part 1|Withdrawal by Subject|0|||
131091800|NCT03809039|471966745|FG005|Part 1|Withdrawal by Subject|0|||
131091801|NCT03809039|471966746|FG006|Part 1|Withdrawal by Subject|0|||
131091802|NCT03809039|471966747|FG007|Part 1|Withdrawal by Subject|0|||
131091803|NCT03809039|471966748|FG008|Part 1|Withdrawal by Subject|0|||
131091804|NCT03809039|471966740|FG000|Part 3|Withdrawn by study termination|0|||
131091805|NCT03809039|471966741|FG001|Part 3|Withdrawn by study termination|0|||
131091806|NCT03809039|471966742|FG002|Part 3|Withdrawn by study termination|0|||
131091807|NCT03809039|471966743|FG003|Part 3|Withdrawn by study termination|0|||
131091808|NCT03809039|471966744|FG004|Part 3|Withdrawn by study termination|0|||
131091809|NCT03809039|471966745|FG005|Part 3|Withdrawn by study termination|0|||
131091810|NCT03809039|471966746|FG006|Part 3|Withdrawn by study termination|0|||
131091811|NCT03809039|471966747|FG007|Part 3|Withdrawn by study termination|2|||
131143362|NCT03186989|472150573|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131143363|NCT03186989|472150574|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130727482|NCT04778904|470625458|FG000|Overall Study|Protocol Violation|1|||
130727483|NCT04778904|470625459|FG001|Overall Study|Protocol Violation|0|||
131091812|NCT03809039|471966748|FG008|Part 3|Withdrawn by study termination|6|||
131091813|NCT01250925|471966751|FG000|Overall Study|Lost to Follow-up|1|||
131143364|NCT03186989|472150575|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131143365|NCT03186989|472150576|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
131091814|NCT01250925|471966752|FG001|Overall Study|Lost to Follow-up|1|||
131091815|NCT01250925|471966753|FG002|Overall Study|Lost to Follow-up|0|||
131091816|NCT01250925|471966751|FG000|Overall Study|Withdrawal by Subject|2|||
131091817|NCT01250925|471966752|FG001|Overall Study|Withdrawal by Subject|0|||
131091818|NCT01250925|471966753|FG002|Overall Study|Withdrawal by Subject|0|||
131143366|NCT03186989|472150577|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130727484|NCT04778904|470625460|FG002|Overall Study|Protocol Violation|0|||
131091819|NCT01250925|471966751|FG000|Overall Study|Protocol Violation|2|||
131091820|NCT01250925|471966752|FG001|Overall Study|Protocol Violation|0|||
131091821|NCT01250925|471966753|FG002|Overall Study|Protocol Violation|0|||
131091822|NCT01250925|471966751|FG000|Overall Study|Physician Decision|0|||
131091823|NCT01250925|471966752|FG001|Overall Study|Physician Decision|2|||
131091824|NCT01250925|471966753|FG002|Overall Study|Physician Decision|1|||
131091825|NCT01250925|471966751|FG000|Overall Study|Adverse Event|0|||
131091826|NCT01250925|471966752|FG001|Overall Study|Adverse Event|0|||
131091827|NCT01250925|471966753|FG002|Overall Study|Adverse Event|1|||
131091828|NCT04421950|471966754|FG000|Overall Study|Dropped or lost to follow up|4|||
131091829|NCT04421950|471966755|FG001|Overall Study|Dropped or lost to follow up|2|||
131091830|NCT01252355|471966756|FG000|Overall Study|Adverse Event|9|||
131091831|NCT01252355|471966757|FG001|Overall Study|Adverse Event|17|||
131091832|NCT01252355|471966758|FG002|Overall Study|Adverse Event|22|||
131091833|NCT01252355|471966756|FG000|Overall Study|Lack of Efficacy|6|||
131091834|NCT01252355|471966757|FG001|Overall Study|Lack of Efficacy|4|||
131091835|NCT01252355|471966758|FG002|Overall Study|Lack of Efficacy|2|||
131091836|NCT01252355|471966756|FG000|Overall Study|Lost to Follow-up|0|||
131091837|NCT01252355|471966757|FG001|Overall Study|Lost to Follow-up|0|||
131091838|NCT01252355|471966758|FG002|Overall Study|Lost to Follow-up|1|||
131091839|NCT01252355|471966756|FG000|Overall Study|Poor Compliance to Protocol|1|||
131091840|NCT01252355|471966757|FG001|Overall Study|Poor Compliance to Protocol|1|||
131091841|NCT01252355|471966758|FG002|Overall Study|Poor Compliance to Protocol|1|||
131091842|NCT01252355|471966756|FG000|Overall Study|Progressive Disease|2|||
131091843|NCT01252355|471966757|FG001|Overall Study|Progressive Disease|0|||
131091844|NCT01252355|471966758|FG002|Overall Study|Progressive Disease|0|||
131091845|NCT01252355|471966756|FG000|Overall Study|Sponsor Early Termination of Study|149|||
131091846|NCT01252355|471966757|FG001|Overall Study|Sponsor Early Termination of Study|149|||
131091847|NCT01252355|471966758|FG002|Overall Study|Sponsor Early Termination of Study|146|||
131091848|NCT01252355|471966756|FG000|Overall Study|Randomized but not Treated|2|||
131091849|NCT01252355|471966757|FG001|Overall Study|Randomized but not Treated|0|||
131091850|NCT01252355|471966758|FG002|Overall Study|Randomized but not Treated|0|||
131091851|NCT01252355|471966756|FG000|Overall Study|Other Than Above|8|||
131091852|NCT01252355|471966757|FG001|Overall Study|Other Than Above|7|||
131091853|NCT01252355|471966758|FG002|Overall Study|Other Than Above|7|||
131091854|NCT00335140|471966759|FG000|Overall Study|Ineligible|1|||
131091855|NCT04546425|471966760|FG000|Overall Study|Protocol Violation|1|||
131091856|NCT04546425|471966761|FG001|Overall Study|Protocol Violation|1|||
131091857|NCT04546425|471966762|FG002|Overall Study|Protocol Violation|0|||
131091858|NCT04546425|471966763|FG003|Overall Study|Protocol Violation|0|||
131091859|NCT04546425|471966760|FG000|Overall Study|Adverse Event|3|||
131091860|NCT04546425|471966761|FG001|Overall Study|Adverse Event|0|||
131091861|NCT04546425|471966762|FG002|Overall Study|Adverse Event|0|||
131091862|NCT04546425|471966763|FG003|Overall Study|Adverse Event|0|||
131091863|NCT04546425|471966760|FG000|Overall Study|Lost to Follow-up|5|||
131091864|NCT04546425|471966761|FG001|Overall Study|Lost to Follow-up|4|||
131091865|NCT04546425|471966762|FG002|Overall Study|Lost to Follow-up|0|||
131091866|NCT04546425|471966763|FG003|Overall Study|Lost to Follow-up|0|||
131091867|NCT04546425|471966760|FG000|Overall Study|No Longer met eligibility criteria|3|||
131091868|NCT04546425|471966761|FG001|Overall Study|No Longer met eligibility criteria|3|||
131091869|NCT04546425|471966762|FG002|Overall Study|No Longer met eligibility criteria|1|||
131091870|NCT04546425|471966763|FG003|Overall Study|No Longer met eligibility criteria|1|||
131091871|NCT04546425|471966760|FG000|Overall Study|Withdrawal by parent/guardian|6|||
131091872|NCT04546425|471966761|FG001|Overall Study|Withdrawal by parent/guardian|5|||
131091873|NCT04546425|471966762|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131091874|NCT04546425|471966763|FG003|Overall Study|Withdrawal by parent/guardian|1|||
131091875|NCT01725126|471966764|FG000|Overall Study|Protocol Violation|0|||
131091876|NCT01725126|471966765|FG001|Overall Study|Protocol Violation|1|||
131091877|NCT01725126|471966766|FG002|Overall Study|Protocol Violation|0|||
131091878|NCT01725126|471966767|FG003|Overall Study|Protocol Violation|0|||
131091879|NCT01725126|471966768|FG004|Overall Study|Protocol Violation|0|||
131091880|NCT01725126|471966769|FG005|Overall Study|Protocol Violation|0|||
131091881|NCT01725126|471966764|FG000|Overall Study|Withdrawal by Subject|0|||
131091882|NCT01725126|471966765|FG001|Overall Study|Withdrawal by Subject|0|||
131091883|NCT01725126|471966766|FG002|Overall Study|Withdrawal by Subject|0|||
131091884|NCT01725126|471966767|FG003|Overall Study|Withdrawal by Subject|1|||
131091885|NCT01725126|471966768|FG004|Overall Study|Withdrawal by Subject|0|||
131091886|NCT01725126|471966769|FG005|Overall Study|Withdrawal by Subject|0|||
131091887|NCT00677534|471966770|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
131091888|NCT00677534|471966770|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
131091889|NCT00677534|471966770|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
131091890|NCT00863681|471966777|FG000|Overall Study|Other|2|||
131091891|NCT00863681|471966778|FG001|Overall Study|Other|0|||
131091892|NCT00863681|471966779|FG002|Overall Study|Other|0|||
131091893|NCT00863681|471966777|FG000|Overall Study|Missing|1|||
131091894|NCT00863681|471966778|FG001|Overall Study|Missing|0|||
131091895|NCT00863681|471966779|FG002|Overall Study|Missing|0|||
131091896|NCT00863681|471966777|FG000|Overall Study|Death|40|||
131091897|NCT00863681|471966778|FG001|Overall Study|Death|23|||
131091898|NCT00863681|471966779|FG002|Overall Study|Death|6|||
131091899|NCT00863681|471966777|FG000|Overall Study|Withdrawal by Subject|12|||
131091900|NCT00863681|471966778|FG001|Overall Study|Withdrawal by Subject|5|||
131091901|NCT00863681|471966779|FG002|Overall Study|Withdrawal by Subject|2|||
131091902|NCT00863681|471966777|FG000|Overall Study|Protocol Violation|2|||
131234402|NCT00455533|472484653|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
131091903|NCT00863681|471966778|FG001|Overall Study|Protocol Violation|0|||
131091904|NCT00863681|471966779|FG002|Overall Study|Protocol Violation|0|||
131091905|NCT00863681|471966777|FG000|Overall Study|Lost to Follow-up|3|||
131091906|NCT00863681|471966778|FG001|Overall Study|Lost to Follow-up|0|||
131091907|NCT00863681|471966779|FG002|Overall Study|Lost to Follow-up|3|||
131091908|NCT00863681|471966777|FG000|Overall Study|Adverse Event|28|||
131091909|NCT00863681|471966778|FG001|Overall Study|Adverse Event|10|||
131091910|NCT00863681|471966779|FG002|Overall Study|Adverse Event|6|||
131091911|NCT00863681|471966777|FG000|Overall Study|Lack of Efficacy|2|||
131091912|NCT00863681|471966778|FG001|Overall Study|Lack of Efficacy|2|||
131091913|NCT00863681|471966779|FG002|Overall Study|Lack of Efficacy|1|||
131091914|NCT00863681|471966777|FG000|Overall Study|Non-compliance with study drug|1|||
131091915|NCT00863681|471966778|FG001|Overall Study|Non-compliance with study drug|3|||
131091916|NCT00863681|471966779|FG002|Overall Study|Non-compliance with study drug|0|||
131091917|NCT03031496|471966780|FG000|Period 1|Adverse Event|2|||
131091918|NCT03031496|471966781|FG001|Period 1|Adverse Event|0|||
131091919|NCT03031496|471966780|FG000|Period 1|Withdrawal by Subject|0|||
131091920|NCT03031496|471966781|FG001|Period 1|Withdrawal by Subject|2|||
131091921|NCT02979249|471966783|FG000|Overall Study|Lost to Follow-up|2|||
131091922|NCT02979249|471966783|FG000|Overall Study|Withdrawal by Subject|4|||
131091923|NCT01125046|471966784|FG000|First 6 Months of Treatment|Death|1|||
131091924|NCT01125046|471966784|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
131091925|NCT01125046|471966784|FG000|First 6 Months of Treatment|Non-compliance|1|||
131091926|NCT01125046|471966784|FG000|First 6 Months of Treatment|Surgery|1|||
131091927|NCT01125046|471966784|FG000|First 6 Months of Treatment|Progressive Disease|7|||
131091928|NCT01125046|471966784|FG000|First 6 Months of Treatment|Adverse Event|2|||
131091929|NCT01125046|471966784|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
131091930|NCT01125046|471966784|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
131091931|NCT01125046|471966784|FG000|Follow-up/Data Cut Off Point|Death|29|||
131091932|NCT01125046|471966784|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
131091933|NCT01685229|471966786|FG000|Overall Study|Subjects missing Study Exit form|3|||
131091934|NCT01685229|471966787|FG001|Overall Study|Subjects missing Study Exit form|1|||
131091935|NCT01685229|471966786|FG000|Overall Study|Lost to Follow-up|16|||
131091936|NCT01685229|471966787|FG001|Overall Study|Lost to Follow-up|10|||
131091937|NCT01685229|471966786|FG000|Overall Study|Withdrawal by Subject|6|||
131091938|NCT01685229|471966787|FG001|Overall Study|Withdrawal by Subject|5|||
131091939|NCT01685229|471966786|FG000|Overall Study|Death|1|||
131091940|NCT01685229|471966787|FG001|Overall Study|Death|0|||
131091941|NCT00895895|471966788|FG000|Period 1|Adverse Event|7|||
131091942|NCT00895895|471966789|FG001|Period 1|Adverse Event|6|||
131091943|NCT00895895|471966790|FG002|Period 1|Adverse Event|4|||
131091944|NCT00895895|471966791|FG003|Period 1|Adverse Event|6|||
131091945|NCT00895895|471966792|FG004|Period 1|Adverse Event|7|||
131091946|NCT00895895|471966788|FG000|Period 1|Death|0|||
131091947|NCT00895895|471966789|FG001|Period 1|Death|0|||
131091948|NCT00895895|471966790|FG002|Period 1|Death|0|||
131091949|NCT00895895|471966791|FG003|Period 1|Death|0|||
131091950|NCT00895895|471966792|FG004|Period 1|Death|1|||
131091951|NCT00895895|471966788|FG000|Period 1|discontinued by sponsor|2|||
131091952|NCT00895895|471966789|FG001|Period 1|discontinued by sponsor|1|||
131091953|NCT00895895|471966790|FG002|Period 1|discontinued by sponsor|2|||
131091954|NCT00895895|471966791|FG003|Period 1|discontinued by sponsor|1|||
131091955|NCT00895895|471966792|FG004|Period 1|discontinued by sponsor|1|||
131091956|NCT00895895|471966788|FG000|Period 1|failed to return|0|||
131091957|NCT00895895|471966789|FG001|Period 1|failed to return|0|||
131091958|NCT00895895|471966790|FG002|Period 1|failed to return|1|||
131091959|NCT00895895|471966791|FG003|Period 1|failed to return|0|||
130727485|NCT04778904|470625461|FG003|Overall Study|Protocol Violation|0|||
130727486|NCT04778904|470625458|FG000|Overall Study|Withdrawal by Subject|0|||
131091960|NCT00895895|471966792|FG004|Period 1|failed to return|1|||
131091961|NCT00895895|471966788|FG000|Period 1|investigator request|0|||
131091962|NCT00895895|471966789|FG001|Period 1|investigator request|1|||
131143367|NCT03186989|472150567|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131143368|NCT03186989|472150568|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130727487|NCT04778904|470625459|FG001|Overall Study|Withdrawal by Subject|0|||
131091963|NCT00895895|471966790|FG002|Period 1|investigator request|0|||
131091964|NCT00895895|471966791|FG003|Period 1|investigator request|0|||
131091965|NCT00895895|471966792|FG004|Period 1|investigator request|0|||
131091966|NCT00895895|471966788|FG000|Period 1|Lost to Follow-up|2|||
131143369|NCT03186989|472150569|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131091967|NCT00895895|471966789|FG001|Period 1|Lost to Follow-up|1|||
131091968|NCT00895895|471966790|FG002|Period 1|Lost to Follow-up|3|||
131143370|NCT03186989|472150570|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130727488|NCT04778904|470625460|FG002|Overall Study|Withdrawal by Subject|1|||
130727489|NCT04778904|470625461|FG003|Overall Study|Withdrawal by Subject|0|||
130727490|NCT05048329|470625468|FG000|Overall Study|Withdrawal by Subject|1|||
131091969|NCT00895895|471966791|FG003|Period 1|Lost to Follow-up|2|||
131091970|NCT00895895|471966792|FG004|Period 1|Lost to Follow-up|3|||
131091971|NCT00895895|471966788|FG000|Period 1|Other|1|||
131091972|NCT00895895|471966789|FG001|Period 1|Other|2|||
131091973|NCT00895895|471966790|FG002|Period 1|Other|1|||
131091974|NCT00895895|471966791|FG003|Period 1|Other|1|||
131091975|NCT00895895|471966792|FG004|Period 1|Other|1|||
131091976|NCT00895895|471966788|FG000|Period 1|Protocol Violation|0|||
131091977|NCT00895895|471966789|FG001|Period 1|Protocol Violation|1|||
131091978|NCT00895895|471966790|FG002|Period 1|Protocol Violation|0|||
131091979|NCT00895895|471966791|FG003|Period 1|Protocol Violation|0|||
131091980|NCT00895895|471966792|FG004|Period 1|Protocol Violation|0|||
131091981|NCT00895895|471966788|FG000|Period 1|Withdrawal by Subject|6|||
131091982|NCT00895895|471966789|FG001|Period 1|Withdrawal by Subject|6|||
131091983|NCT00895895|471966790|FG002|Period 1|Withdrawal by Subject|8|||
131091984|NCT00895895|471966791|FG003|Period 1|Withdrawal by Subject|2|||
131091985|NCT00895895|471966792|FG004|Period 1|Withdrawal by Subject|4|||
131091986|NCT00895895|471966788|FG000|Period 1|unsatisfactory response-efficacy|2|||
131091987|NCT00895895|471966789|FG001|Period 1|unsatisfactory response-efficacy|0|||
131091988|NCT00895895|471966790|FG002|Period 1|unsatisfactory response-efficacy|0|||
131091989|NCT00895895|471966791|FG003|Period 1|unsatisfactory response-efficacy|0|||
131091990|NCT00895895|471966792|FG004|Period 1|unsatisfactory response-efficacy|0|||
131091991|NCT00895895|471966788|FG000|Period 1|randomized and not treated|1|||
131091992|NCT00895895|471966789|FG001|Period 1|randomized and not treated|3|||
131091993|NCT00895895|471966790|FG002|Period 1|randomized and not treated|1|||
131091994|NCT00895895|471966791|FG003|Period 1|randomized and not treated|1|||
131091995|NCT00895895|471966792|FG004|Period 1|randomized and not treated|2|||
131091996|NCT00895895|471966788|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
131091997|NCT00895895|471966789|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
131091998|NCT00895895|471966790|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
131091999|NCT00895895|471966791|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
131092000|NCT00895895|471966792|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
131092001|NCT00895895|471966788|FG000|After Period 1, Prior to Period 2|Other|0|||
131092002|NCT00895895|471966789|FG001|After Period 1, Prior to Period 2|Other|0|||
131092003|NCT00895895|471966790|FG002|After Period 1, Prior to Period 2|Other|1|||
131092004|NCT00895895|471966791|FG003|After Period 1, Prior to Period 2|Other|0|||
131092005|NCT00895895|471966792|FG004|After Period 1, Prior to Period 2|Other|0|||
131092006|NCT00895895|471966788|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
131092007|NCT00895895|471966789|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
131092008|NCT00895895|471966790|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
131092009|NCT00895895|471966791|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
131092010|NCT00895895|471966792|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
131092011|NCT00895895|471966788|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
131092012|NCT00895895|471966789|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
131092013|NCT00895895|471966790|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
131092014|NCT00895895|471966791|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
131092015|NCT00895895|471966792|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
131092016|NCT00895895|471966788|FG000|Period 2|Adverse Event|3|||
131092017|NCT00895895|471966789|FG001|Period 2|Adverse Event|3|||
131092018|NCT00895895|471966790|FG002|Period 2|Adverse Event|5|||
131092019|NCT00895895|471966791|FG003|Period 2|Adverse Event|2|||
131092020|NCT00895895|471966792|FG004|Period 2|Adverse Event|5|||
131092021|NCT00895895|471966788|FG000|Period 2|Death|0|||
131092022|NCT00895895|471966789|FG001|Period 2|Death|0|||
131092023|NCT00895895|471966790|FG002|Period 2|Death|1|||
131092024|NCT00895895|471966791|FG003|Period 2|Death|0|||
131092025|NCT00895895|471966792|FG004|Period 2|Death|0|||
131092026|NCT00895895|471966788|FG000|Period 2|discontinued by sponsor|44|||
131092027|NCT00895895|471966789|FG001|Period 2|discontinued by sponsor|44|||
131092028|NCT00895895|471966790|FG002|Period 2|discontinued by sponsor|38|||
131092029|NCT00895895|471966791|FG003|Period 2|discontinued by sponsor|46|||
131092030|NCT00895895|471966792|FG004|Period 2|discontinued by sponsor|37|||
131143371|NCT03186989|472150571|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131143372|NCT03186989|472150572|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
131143373|NCT03186989|472150573|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131143374|NCT03186989|472150574|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131092031|NCT00895895|471966788|FG000|Period 2|failed to return|2|||
131092032|NCT00895895|471966789|FG001|Period 2|failed to return|0|||
131092033|NCT00895895|471966790|FG002|Period 2|failed to return|0|||
131092034|NCT00895895|471966791|FG003|Period 2|failed to return|0|||
131092035|NCT00895895|471966792|FG004|Period 2|failed to return|0|||
131092036|NCT00895895|471966788|FG000|Period 2|investigator request|2|||
131092037|NCT00895895|471966789|FG001|Period 2|investigator request|0|||
131092038|NCT00895895|471966790|FG002|Period 2|investigator request|0|||
131092039|NCT00895895|471966791|FG003|Period 2|investigator request|0|||
131092040|NCT00895895|471966792|FG004|Period 2|investigator request|0|||
131143375|NCT03186989|472150575|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131092041|NCT00895895|471966788|FG000|Period 2|Lost to Follow-up|1|||
131092042|NCT00895895|471966789|FG001|Period 2|Lost to Follow-up|2|||
131092043|NCT00895895|471966790|FG002|Period 2|Lost to Follow-up|1|||
131092044|NCT00895895|471966791|FG003|Period 2|Lost to Follow-up|1|||
131234403|NCT00455533|472484651|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
131234404|NCT00455533|472484652|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
131234405|NCT00455533|472484653|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
131234406|NCT00455533|472484651|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
131234407|NCT00455533|472484652|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
131234408|NCT00455533|472484653|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
131234409|NCT00455533|472484651|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
131234410|NCT00455533|472484652|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
131234411|NCT00455533|472484653|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
131234412|NCT00455533|472484651|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
131234413|NCT00455533|472484652|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
131234414|NCT00455533|472484653|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
131234415|NCT00455533|472484651|FG000|Period Two: Randomized Period|Death|0|||
131234416|NCT00455533|472484652|FG001|Period Two: Randomized Period|Death|0|||
131234417|NCT00455533|472484653|FG002|Period Two: Randomized Period|Death|3|||
131234418|NCT00455533|472484651|FG000|Period Two: Randomized Period|Disease Progression|0|||
131234419|NCT00455533|472484652|FG001|Period Two: Randomized Period|Disease Progression|1|||
131234420|NCT00455533|472484653|FG002|Period Two: Randomized Period|Disease Progression|1|||
131234421|NCT00455533|472484651|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
131234422|NCT00455533|472484652|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
131234423|NCT00455533|472484653|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
131234424|NCT00455533|472484651|FG000|Period Two: Randomized Period|Other - need reasons|0|||
131234425|NCT00455533|472484652|FG001|Period Two: Randomized Period|Other - need reasons|1|||
131234426|NCT00455533|472484653|FG002|Period Two: Randomized Period|Other - need reasons|0|||
131234427|NCT00455533|472484651|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
131234428|NCT00455533|472484652|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
131234429|NCT00455533|472484653|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
131234430|NCT00455533|472484651|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
131234431|NCT00455533|472484652|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
131234432|NCT00455533|472484653|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
131234433|NCT02576990|472484658|FG000|Overall Study|Death|29|||
131234434|NCT02576990|472484659|FG001|Overall Study|Death|18|||
131234435|NCT02576990|472484658|FG000|Overall Study|Physician Decision|1|||
131234436|NCT02576990|472484659|FG001|Overall Study|Physician Decision|0|||
131234437|NCT02576990|472484658|FG000|Overall Study|Screen failure|2|||
131234438|NCT02576990|472484659|FG001|Overall Study|Screen failure|0|||
131234439|NCT02576990|472484658|FG000|Overall Study|Sponsor's decision|24|||
131234440|NCT02576990|472484659|FG001|Overall Study|Sponsor's decision|4|||
131234441|NCT02576990|472484658|FG000|Overall Study|Withdrawal by Subject|0|||
131234442|NCT02576990|472484659|FG001|Overall Study|Withdrawal by Subject|2|||
131234443|NCT02415959|472484660|FG000|Overall Study|Adverse Event|0|||
131234444|NCT02415959|472484661|FG001|Overall Study|Adverse Event|1|||
131092045|NCT00895895|471966792|FG004|Period 2|Lost to Follow-up|0|||
131092046|NCT00895895|471966788|FG000|Period 2|Other|1|||
131092047|NCT00895895|471966789|FG001|Period 2|Other|1|||
131092048|NCT00895895|471966790|FG002|Period 2|Other|3|||
131092049|NCT00895895|471966791|FG003|Period 2|Other|1|||
131092050|NCT00895895|471966792|FG004|Period 2|Other|1|||
131092051|NCT00895895|471966788|FG000|Period 2|Protocol Violation|1|||
131092052|NCT00895895|471966789|FG001|Period 2|Protocol Violation|0|||
131092053|NCT00895895|471966790|FG002|Period 2|Protocol Violation|1|||
131092054|NCT00895895|471966791|FG003|Period 2|Protocol Violation|1|||
131092055|NCT00895895|471966792|FG004|Period 2|Protocol Violation|1|||
131092056|NCT00895895|471966788|FG000|Period 2|Withdrawal by Subject|0|||
131234445|NCT02415959|472484662|FG002|Overall Study|Adverse Event|0|||
131092057|NCT00895895|471966789|FG001|Period 2|Withdrawal by Subject|2|||
131092058|NCT00895895|471966790|FG002|Period 2|Withdrawal by Subject|0|||
131092059|NCT00895895|471966791|FG003|Period 2|Withdrawal by Subject|3|||
131092060|NCT00895895|471966792|FG004|Period 2|Withdrawal by Subject|5|||
131092061|NCT00895895|471966788|FG000|Period 2|unsatisfactory response-efficacy|2|||
131092062|NCT00895895|471966789|FG001|Period 2|unsatisfactory response-efficacy|1|||
131092063|NCT00895895|471966790|FG002|Period 2|unsatisfactory response-efficacy|0|||
131092064|NCT00895895|471966791|FG003|Period 2|unsatisfactory response-efficacy|0|||
131092065|NCT00895895|471966792|FG004|Period 2|unsatisfactory response-efficacy|0|||
131234446|NCT02415959|472484663|FG003|Overall Study|Adverse Event|0|||
131234447|NCT02415959|472484664|FG004|Overall Study|Adverse Event|0|||
131092066|NCT00820170|471966795|FG000|Overall Study|Adverse Event|0|||
131092067|NCT00820170|471966796|FG001|Overall Study|Adverse Event|0|||
131092068|NCT00820170|471966797|FG002|Overall Study|Adverse Event|0|||
131092069|NCT00820170|471966798|FG003|Overall Study|Adverse Event|0|||
131092070|NCT00820170|471966799|FG004|Overall Study|Adverse Event|2|||
131092071|NCT00820170|471966795|FG000|Overall Study|Progressive Disease|0|||
131234448|NCT02415959|472484660|FG000|Overall Study|Protocol Violation|0|||
131092072|NCT00820170|471966796|FG001|Overall Study|Progressive Disease|0|||
131092073|NCT00820170|471966797|FG002|Overall Study|Progressive Disease|0|||
131092074|NCT00820170|471966798|FG003|Overall Study|Progressive Disease|0|||
131092075|NCT00820170|471966799|FG004|Overall Study|Progressive Disease|2|||
131092076|NCT00780559|471966800|FG000|Overall Study|Lost to Follow-up|2|||
131092077|NCT00780559|471966801|FG001|Overall Study|Lost to Follow-up|7|||
131092078|NCT00780559|471966800|FG000|Overall Study|Death|1|||
131092079|NCT00780559|471966801|FG001|Overall Study|Death|0|||
131092080|NCT03682185|471966807|FG000|Overall Study|Lost to Follow-up|4|||
131092081|NCT03682185|471966808|FG001|Overall Study|Lost to Follow-up|7|||
131092082|NCT03682185|471966809|FG002|Overall Study|Lost to Follow-up|4|||
131092083|NCT03682185|471966810|FG003|Overall Study|Lost to Follow-up|7|||
131092084|NCT03682185|471966811|FG004|Overall Study|Lost to Follow-up|1|||
131234449|NCT02415959|472484661|FG001|Overall Study|Protocol Violation|0|||
131234450|NCT02415959|472484662|FG002|Overall Study|Protocol Violation|0|||
131234451|NCT02415959|472484663|FG003|Overall Study|Protocol Violation|1|||
131234452|NCT02415959|472484664|FG004|Overall Study|Protocol Violation|0|||
131234453|NCT00911859|472484665|FG000|Treatment Period|Adverse Event|3|||
131092085|NCT03682185|471966807|FG000|Overall Study|Withdrawal by Subject|7|||
131092086|NCT03682185|471966808|FG001|Overall Study|Withdrawal by Subject|3|||
131092087|NCT03682185|471966809|FG002|Overall Study|Withdrawal by Subject|7|||
131092088|NCT03682185|471966810|FG003|Overall Study|Withdrawal by Subject|3|||
131092089|NCT03682185|471966811|FG004|Overall Study|Withdrawal by Subject|0|||
131092090|NCT04908631|471966812|FG000|Overall Study|Lost to Follow-up|1|||
131092091|NCT04908631|471966812|FG000|Overall Study|Physician Decision|1|||
131092092|NCT04908631|471966812|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
131092093|NCT02284009|471966813|FG000|Overall Study|Adverse Event|3|||
131092094|NCT02284009|471966814|FG001|Overall Study|Adverse Event|0|||
131092095|NCT02284009|471966813|FG000|Overall Study|Lost to Follow-up|1|||
131092096|NCT02284009|471966814|FG001|Overall Study|Lost to Follow-up|3|||
131092097|NCT02284009|471966813|FG000|Overall Study|Physician Decision|0|||
131092098|NCT02284009|471966814|FG001|Overall Study|Physician Decision|2|||
131092099|NCT02284009|471966813|FG000|Overall Study|Withdrawal by Subject|2|||
131092100|NCT02284009|471966814|FG001|Overall Study|Withdrawal by Subject|5|||
131092101|NCT04047862|471966827|FG000|Overall Study|Death|0|||
131092102|NCT04047862|471966828|FG001|Overall Study|Death|0|||
131092103|NCT04047862|471966829|FG002|Overall Study|Death|4|||
131092104|NCT04047862|471966830|FG003|Overall Study|Death|7|||
131092105|NCT04047862|471966831|FG004|Overall Study|Death|2|||
131092106|NCT04047862|471966832|FG005|Overall Study|Death|4|||
131092107|NCT04047862|471966833|FG006|Overall Study|Death|3|||
131092108|NCT04047862|471966834|FG007|Overall Study|Death|24|||
131092109|NCT04047862|471966835|FG008|Overall Study|Death|24|||
131092110|NCT04047862|471966836|FG009|Overall Study|Death|22|||
131092111|NCT04047862|471966837|FG010|Overall Study|Death|35|||
131092112|NCT04047862|471966838|FG011|Overall Study|Death|18|||
131092113|NCT04047862|471966839|FG012|Overall Study|Death|14|||
131092114|NCT04047862|471966840|FG013|Overall Study|Death|6|||
131092115|NCT04047862|471966841|FG014|Overall Study|Death|19|||
131092116|NCT04047862|471966842|FG015|Overall Study|Death|42|||
131092117|NCT04047862|471966843|FG016|Overall Study|Death|9|||
131092118|NCT04047862|471966844|FG017|Overall Study|Death|8|||
131092119|NCT04047862|471966845|FG018|Overall Study|Death|10|||
131092120|NCT04047862|471966827|FG000|Overall Study|Withdrawal by Subject|0|||
131092121|NCT04047862|471966828|FG001|Overall Study|Withdrawal by Subject|0|||
131092122|NCT04047862|471966829|FG002|Overall Study|Withdrawal by Subject|0|||
131092123|NCT04047862|471966830|FG003|Overall Study|Withdrawal by Subject|5|||
131092124|NCT04047862|471966831|FG004|Overall Study|Withdrawal by Subject|2|||
131092125|NCT04047862|471966832|FG005|Overall Study|Withdrawal by Subject|0|||
131092126|NCT04047862|471966833|FG006|Overall Study|Withdrawal by Subject|1|||
131092127|NCT04047862|471966834|FG007|Overall Study|Withdrawal by Subject|0|||
131092128|NCT04047862|471966835|FG008|Overall Study|Withdrawal by Subject|4|||
131092129|NCT04047862|471966836|FG009|Overall Study|Withdrawal by Subject|4|||
131092130|NCT04047862|471966837|FG010|Overall Study|Withdrawal by Subject|4|||
131092131|NCT04047862|471966838|FG011|Overall Study|Withdrawal by Subject|2|||
131092132|NCT04047862|471966839|FG012|Overall Study|Withdrawal by Subject|3|||
131092133|NCT04047862|471966840|FG013|Overall Study|Withdrawal by Subject|0|||
131092134|NCT04047862|471966841|FG014|Overall Study|Withdrawal by Subject|9|||
131092135|NCT04047862|471966842|FG015|Overall Study|Withdrawal by Subject|5|||
131092136|NCT04047862|471966843|FG016|Overall Study|Withdrawal by Subject|1|||
131092137|NCT04047862|471966844|FG017|Overall Study|Withdrawal by Subject|3|||
131092138|NCT04047862|471966845|FG018|Overall Study|Withdrawal by Subject|1|||
131092139|NCT04047862|471966827|FG000|Overall Study|Lost to Follow-up|0|||
131092140|NCT04047862|471966828|FG001|Overall Study|Lost to Follow-up|0|||
131092141|NCT04047862|471966829|FG002|Overall Study|Lost to Follow-up|1|||
131092142|NCT04047862|471966830|FG003|Overall Study|Lost to Follow-up|0|||
131092143|NCT04047862|471966831|FG004|Overall Study|Lost to Follow-up|0|||
131092144|NCT04047862|471966832|FG005|Overall Study|Lost to Follow-up|0|||
131234454|NCT00911859|472484666|FG001|Treatment Period|Adverse Event|3|||
131092145|NCT04047862|471966833|FG006|Overall Study|Lost to Follow-up|0|||
131092146|NCT04047862|471966834|FG007|Overall Study|Lost to Follow-up|1|||
131092147|NCT04047862|471966835|FG008|Overall Study|Lost to Follow-up|0|||
131092148|NCT04047862|471966836|FG009|Overall Study|Lost to Follow-up|1|||
131092149|NCT04047862|471966837|FG010|Overall Study|Lost to Follow-up|0|||
131092150|NCT04047862|471966838|FG011|Overall Study|Lost to Follow-up|3|||
131092151|NCT04047862|471966839|FG012|Overall Study|Lost to Follow-up|0|||
131092152|NCT04047862|471966840|FG013|Overall Study|Lost to Follow-up|0|||
131092153|NCT04047862|471966841|FG014|Overall Study|Lost to Follow-up|2|||
131092154|NCT04047862|471966842|FG015|Overall Study|Lost to Follow-up|2|||
131092155|NCT04047862|471966843|FG016|Overall Study|Lost to Follow-up|1|||
131092156|NCT04047862|471966844|FG017|Overall Study|Lost to Follow-up|0|||
131092157|NCT04047862|471966845|FG018|Overall Study|Lost to Follow-up|0|||
131092158|NCT04047862|471966827|FG000|Overall Study|Physician Decision|0|||
131092159|NCT04047862|471966828|FG001|Overall Study|Physician Decision|0|||
131092160|NCT04047862|471966829|FG002|Overall Study|Physician Decision|0|||
131092161|NCT04047862|471966830|FG003|Overall Study|Physician Decision|1|||
131092162|NCT04047862|471966831|FG004|Overall Study|Physician Decision|0|||
131092163|NCT04047862|471966832|FG005|Overall Study|Physician Decision|0|||
131092164|NCT04047862|471966833|FG006|Overall Study|Physician Decision|0|||
131092165|NCT04047862|471966834|FG007|Overall Study|Physician Decision|0|||
131092166|NCT04047862|471966835|FG008|Overall Study|Physician Decision|0|||
131092167|NCT04047862|471966836|FG009|Overall Study|Physician Decision|0|||
131092168|NCT04047862|471966837|FG010|Overall Study|Physician Decision|0|||
131092169|NCT04047862|471966838|FG011|Overall Study|Physician Decision|0|||
131092170|NCT04047862|471966839|FG012|Overall Study|Physician Decision|0|||
131143376|NCT03186989|472150576|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131143377|NCT03186989|472150577|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
131143378|NCT03186989|472150567|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131143379|NCT03186989|472150568|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131143380|NCT03186989|472150569|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131143381|NCT03186989|472150570|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131143382|NCT03186989|472150571|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131143383|NCT03186989|472150572|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131143384|NCT03186989|472150573|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
131143385|NCT03186989|472150574|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131143386|NCT03186989|472150575|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131143387|NCT03186989|472150576|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131143388|NCT03186989|472150577|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
131143389|NCT03186989|472150567|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131143390|NCT03186989|472150568|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131143391|NCT03186989|472150569|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131143392|NCT03186989|472150570|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131143393|NCT03186989|472150571|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131143394|NCT03186989|472150572|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
131143395|NCT03186989|472150573|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
131143396|NCT03186989|472150574|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131143397|NCT03186989|472150575|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
131143398|NCT03186989|472150576|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131143399|NCT03186989|472150577|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
131143400|NCT01583374|472150583|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
131143401|NCT01583374|472150584|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
131143402|NCT01583374|472150585|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
131143403|NCT01583374|472150586|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131143404|NCT01583374|472150587|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131143405|NCT01583374|472150588|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131143406|NCT01583374|472150589|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131143407|NCT01583374|472150590|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131143408|NCT01583374|472150591|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
131143409|NCT01583374|472150583|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
131143410|NCT01583374|472150584|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
131092171|NCT04047862|471966840|FG013|Overall Study|Physician Decision|0|||
131092172|NCT04047862|471966841|FG014|Overall Study|Physician Decision|1|||
131092173|NCT04047862|471966842|FG015|Overall Study|Physician Decision|0|||
131092174|NCT04047862|471966843|FG016|Overall Study|Physician Decision|1|||
131092175|NCT04047862|471966844|FG017|Overall Study|Physician Decision|0|||
131092176|NCT04047862|471966845|FG018|Overall Study|Physician Decision|0|||
131143411|NCT01583374|472150585|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
131092177|NCT04047862|471966827|FG000|Overall Study|Completed all Assessments|1|||
131092178|NCT04047862|471966828|FG001|Overall Study|Completed all Assessments|3|||
131092179|NCT04047862|471966829|FG002|Overall Study|Completed all Assessments|1|||
131234455|NCT00911859|472484667|FG002|Treatment Period|Adverse Event|7|||
131234456|NCT00911859|472484665|FG000|Treatment Period|Death|1|||
131234457|NCT00911859|472484666|FG001|Treatment Period|Death|3|||
131234458|NCT00911859|472484667|FG002|Treatment Period|Death|5|||
131234459|NCT00911859|472484665|FG000|Treatment Period|Lack of Efficacy|1|||
131234460|NCT00911859|472484666|FG001|Treatment Period|Lack of Efficacy|7|||
131092180|NCT04047862|471966830|FG003|Overall Study|Completed all Assessments|3|||
131092181|NCT04047862|471966831|FG004|Overall Study|Completed all Assessments|2|||
131092182|NCT04047862|471966832|FG005|Overall Study|Completed all Assessments|5|||
131092183|NCT04047862|471966833|FG006|Overall Study|Completed all Assessments|7|||
131092184|NCT04047862|471966834|FG007|Overall Study|Completed all Assessments|0|||
131092185|NCT04047862|471966835|FG008|Overall Study|Completed all Assessments|0|||
131092186|NCT04047862|471966836|FG009|Overall Study|Completed all Assessments|0|||
131092187|NCT04047862|471966837|FG010|Overall Study|Completed all Assessments|0|||
131092188|NCT04047862|471966838|FG011|Overall Study|Completed all Assessments|0|||
131092189|NCT04047862|471966839|FG012|Overall Study|Completed all Assessments|0|||
131092190|NCT04047862|471966840|FG013|Overall Study|Completed all Assessments|0|||
131092191|NCT04047862|471966841|FG014|Overall Study|Completed all Assessments|0|||
131092192|NCT04047862|471966842|FG015|Overall Study|Completed all Assessments|0|||
131092193|NCT04047862|471966843|FG016|Overall Study|Completed all Assessments|0|||
131092194|NCT04047862|471966844|FG017|Overall Study|Completed all Assessments|0|||
131234461|NCT00911859|472484667|FG002|Treatment Period|Lack of Efficacy|5|||
131234462|NCT00911859|472484665|FG000|Treatment Period|Physician Decision|3|||
131234463|NCT00911859|472484666|FG001|Treatment Period|Physician Decision|3|||
131234464|NCT00911859|472484667|FG002|Treatment Period|Physician Decision|3|||
131234465|NCT00911859|472484665|FG000|Treatment Period|Withdrawal by Subject|0|||
131234466|NCT00911859|472484666|FG001|Treatment Period|Withdrawal by Subject|4|||
131234467|NCT00911859|472484667|FG002|Treatment Period|Withdrawal by Subject|5|||
131234468|NCT00911859|472484665|FG000|Treatment Period|Did not receive study treatment|0|||
131234469|NCT00911859|472484666|FG001|Treatment Period|Did not receive study treatment|1|||
131234470|NCT00911859|472484667|FG002|Treatment Period|Did not receive study treatment|0|||
131234471|NCT00911859|472484665|FG000|Maintainance Period|Lack of Efficacy|0|||
131234472|NCT00911859|472484666|FG001|Maintainance Period|Lack of Efficacy|0|||
131234473|NCT00911859|472484667|FG002|Maintainance Period|Lack of Efficacy|9|||
131234474|NCT00911859|472484665|FG000|Maintainance Period|Physician Decision|0|||
131234475|NCT00911859|472484666|FG001|Maintainance Period|Physician Decision|0|||
131234476|NCT00911859|472484667|FG002|Maintainance Period|Physician Decision|9|||
131234477|NCT00911859|472484665|FG000|Maintainance Period|Withdrawal by Subject|0|||
131234478|NCT00911859|472484666|FG001|Maintainance Period|Withdrawal by Subject|0|||
131234479|NCT00911859|472484667|FG002|Maintainance Period|Withdrawal by Subject|3|||
131234480|NCT00911859|472484665|FG000|Follow-up Period|Death|5|||
131234481|NCT00911859|472484666|FG001|Follow-up Period|Death|8|||
131234482|NCT00911859|472484667|FG002|Follow-up Period|Death|10|||
131234483|NCT00911859|472484665|FG000|Follow-up Period|Lost to Follow-up|1|||
131234484|NCT00911859|472484666|FG001|Follow-up Period|Lost to Follow-up|1|||
131234485|NCT00911859|472484667|FG002|Follow-up Period|Lost to Follow-up|0|||
131234486|NCT00911859|472484665|FG000|Follow-up Period|Withdrawal by Subject|0|||
131234487|NCT00911859|472484666|FG001|Follow-up Period|Withdrawal by Subject|4|||
131234488|NCT00911859|472484667|FG002|Follow-up Period|Withdrawal by Subject|4|||
131234489|NCT00911859|472484665|FG000|Follow-up Period|Study terminated by sponsor|5|||
131234490|NCT00911859|472484666|FG001|Follow-up Period|Study terminated by sponsor|33|||
131234491|NCT00911859|472484667|FG002|Follow-up Period|Study terminated by sponsor|27|||
131234492|NCT01048333|472484670|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
131234493|NCT01048333|472484671|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
131234494|NCT01048333|472484672|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
131234495|NCT01048333|472484673|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
131234496|NCT01048333|472484674|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
131234497|NCT01048333|472484675|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
131234498|NCT02456909|472484676|FG000|Overall Study|Did not receive allocated intervention|24|||
131234499|NCT02456909|472484677|FG001|Overall Study|Did not receive allocated intervention|26|||
131234500|NCT02456909|472484676|FG000|Overall Study|Did not complete the primary outcome|0|||
131234501|NCT02456909|472484677|FG001|Overall Study|Did not complete the primary outcome|1|||
131234502|NCT01497938|472484680|FG000|Overall Study|Adverse Event|0|||
131234503|NCT01497938|472484681|FG001|Overall Study|Adverse Event|1|||
131234504|NCT01497938|472484680|FG000|Overall Study|Physician Decision|0|||
131092195|NCT04047862|471966845|FG018|Overall Study|Completed all Assessments|0|||
131092196|NCT04047862|471966827|FG000|Overall Study|Sponsor Decision|0|||
131092197|NCT04047862|471966828|FG001|Overall Study|Sponsor Decision|0|||
131092198|NCT04047862|471966829|FG002|Overall Study|Sponsor Decision|0|||
131234505|NCT01497938|472484681|FG001|Overall Study|Physician Decision|1|||
131234506|NCT01497938|472484680|FG000|Overall Study|Withdrawal by Subject|4|||
131234507|NCT01497938|472484681|FG001|Overall Study|Withdrawal by Subject|0|||
131234508|NCT01497938|472484680|FG000|Overall Study|Device Violation|1|||
131234509|NCT01497938|472484681|FG001|Overall Study|Device Violation|0|||
131234510|NCT05200858|472484682|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
131234511|NCT05200858|472484683|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
131092199|NCT04047862|471966830|FG003|Overall Study|Sponsor Decision|0|||
131092200|NCT04047862|471966831|FG004|Overall Study|Sponsor Decision|0|||
131092201|NCT04047862|471966832|FG005|Overall Study|Sponsor Decision|0|||
131092202|NCT04047862|471966833|FG006|Overall Study|Sponsor Decision|0|||
131092203|NCT04047862|471966834|FG007|Overall Study|Sponsor Decision|13|||
131092204|NCT04047862|471966835|FG008|Overall Study|Sponsor Decision|10|||
131092205|NCT04047862|471966836|FG009|Overall Study|Sponsor Decision|18|||
131092206|NCT04047862|471966837|FG010|Overall Study|Sponsor Decision|3|||
131092207|NCT04047862|471966838|FG011|Overall Study|Sponsor Decision|3|||
131092208|NCT04047862|471966839|FG012|Overall Study|Sponsor Decision|4|||
131092209|NCT04047862|471966840|FG013|Overall Study|Sponsor Decision|0|||
131092210|NCT04047862|471966841|FG014|Overall Study|Sponsor Decision|7|||
131092211|NCT04047862|471966842|FG015|Overall Study|Sponsor Decision|8|||
131092212|NCT04047862|471966843|FG016|Overall Study|Sponsor Decision|9|||
131092213|NCT04047862|471966844|FG017|Overall Study|Sponsor Decision|7|||
131092214|NCT04047862|471966845|FG018|Overall Study|Sponsor Decision|8|||
131092215|NCT04047862|471966827|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092216|NCT04047862|471966828|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092217|NCT04047862|471966829|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092218|NCT04047862|471966830|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092219|NCT04047862|471966831|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092220|NCT04047862|471966832|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092221|NCT04047862|471966833|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092222|NCT04047862|471966834|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
131092223|NCT04047862|471966835|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
131092224|NCT04047862|471966836|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092225|NCT04047862|471966837|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
131092226|NCT04047862|471966838|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092227|NCT04047862|471966839|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092228|NCT04047862|471966840|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
131092229|NCT04047862|471966841|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
131092230|NCT04047862|471966842|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
131092231|NCT04047862|471966843|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
131092232|NCT04047862|471966844|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
131092233|NCT04047862|471966845|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
131092234|NCT04047862|471966827|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092235|NCT04047862|471966828|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092236|NCT04047862|471966829|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092237|NCT04047862|471966830|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092238|NCT04047862|471966831|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092239|NCT04047862|471966832|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092240|NCT04047862|471966833|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092241|NCT04047862|471966834|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092242|NCT04047862|471966835|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092243|NCT04047862|471966836|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092244|NCT04047862|471966837|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092245|NCT04047862|471966838|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092246|NCT04047862|471966839|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092247|NCT04047862|471966840|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092248|NCT04047862|471966841|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092249|NCT04047862|471966842|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
131092250|NCT04047862|471966843|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092251|NCT04047862|471966844|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
131092252|NCT04047862|471966845|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
131092253|NCT04047862|471966827|FG000|Overall Study|Other|0|||
131092254|NCT04047862|471966828|FG001|Overall Study|Other|0|||
131143412|NCT01583374|472150586|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131143413|NCT01583374|472150587|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131143414|NCT01583374|472150588|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131143415|NCT01583374|472150589|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131143416|NCT01583374|472150590|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130727491|NCT05048329|470625468|FG000|Overall Study|Screenfail|1|||
131092255|NCT04047862|471966829|FG002|Overall Study|Other|0|||
131092256|NCT04047862|471966830|FG003|Overall Study|Other|0|||
131092257|NCT04047862|471966831|FG004|Overall Study|Other|0|||
131143417|NCT01583374|472150591|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
131143418|NCT01583374|472150583|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
131092258|NCT04047862|471966832|FG005|Overall Study|Other|0|||
131092259|NCT04047862|471966833|FG006|Overall Study|Other|0|||
131092260|NCT04047862|471966834|FG007|Overall Study|Other|0|||
131092261|NCT04047862|471966835|FG008|Overall Study|Other|0|||
131092262|NCT04047862|471966836|FG009|Overall Study|Other|0|||
131092263|NCT04047862|471966837|FG010|Overall Study|Other|0|||
131092264|NCT04047862|471966838|FG011|Overall Study|Other|0|||
131092265|NCT04047862|471966839|FG012|Overall Study|Other|0|||
131092266|NCT04047862|471966840|FG013|Overall Study|Other|0|||
131092267|NCT04047862|471966841|FG014|Overall Study|Other|2|||
131092268|NCT04047862|471966842|FG015|Overall Study|Other|1|||
131092269|NCT04047862|471966843|FG016|Overall Study|Other|1|||
131092270|NCT04047862|471966844|FG017|Overall Study|Other|1|||
131092271|NCT04047862|471966845|FG018|Overall Study|Other|0|||
131092272|NCT01876082|471968375|FG000|Overall Study|Withdrawal by Subject|0|||
131092273|NCT01876082|471968376|FG001|Overall Study|Withdrawal by Subject|2|||
131092274|NCT01876082|471968375|FG000|Overall Study|Protocol Violation|1|||
131092275|NCT01876082|471968376|FG001|Overall Study|Protocol Violation|0|||
131092276|NCT01876082|471968375|FG000|Overall Study|Adverse Event|1|||
131092277|NCT01876082|471968376|FG001|Overall Study|Adverse Event|1|||
131092278|NCT01876082|471968375|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
131092279|NCT01876082|471968376|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
131092280|NCT00626197|471968383|FG000|Overall Study|Did not cooperate|2|||
131092281|NCT00626197|471968384|FG001|Overall Study|Did not cooperate|6|||
131092282|NCT00626197|471968385|FG002|Overall Study|Did not cooperate|1|||
131092283|NCT00626197|471968383|FG000|Overall Study|Failure to return|6|||
131143419|NCT01583374|472150584|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
131143420|NCT01583374|472150585|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131143421|NCT01583374|472150586|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131143422|NCT01583374|472150587|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131143423|NCT01583374|472150588|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131143424|NCT01583374|472150589|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131143425|NCT01583374|472150590|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131143426|NCT01583374|472150591|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
131143427|NCT01583374|472150583|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
131143428|NCT01583374|472150584|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
131143429|NCT01583374|472150585|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
131143430|NCT01583374|472150586|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131143431|NCT01583374|472150587|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131092284|NCT00626197|471968384|FG001|Overall Study|Failure to return|5|||
131092285|NCT00626197|471968385|FG002|Overall Study|Failure to return|6|||
131092286|NCT00626197|471968383|FG000|Overall Study|Adverse event, serious fatal|3|||
131092287|NCT00626197|471968384|FG001|Overall Study|Adverse event, serious fatal|6|||
131092288|NCT00626197|471968385|FG002|Overall Study|Adverse event, serious fatal|6|||
131092289|NCT00626197|471968383|FG000|Overall Study|Adverse Event|1|||
131092290|NCT00626197|471968384|FG001|Overall Study|Adverse Event|1|||
131092291|NCT00626197|471968385|FG002|Overall Study|Adverse Event|2|||
131092292|NCT00626197|471968383|FG000|Overall Study|Withdrawal by Subject|17|||
131092293|NCT00626197|471968384|FG001|Overall Study|Withdrawal by Subject|17|||
131092294|NCT00626197|471968385|FG002|Overall Study|Withdrawal by Subject|7|||
131092295|NCT00626197|471968383|FG000|Overall Study|Administrative reasons|15|||
131092296|NCT00626197|471968384|FG001|Overall Study|Administrative reasons|19|||
131092297|NCT00626197|471968385|FG002|Overall Study|Administrative reasons|55|||
131143432|NCT01583374|472150588|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131092298|NCT04833127|471968386|FG000|Overall Study|Lost to Follow-up|1|||
131143433|NCT01583374|472150589|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131143434|NCT01583374|472150590|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131143435|NCT01583374|472150591|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
131143436|NCT01583374|472150583|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
131143437|NCT01583374|472150584|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
131143438|NCT01583374|472150585|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131143439|NCT01583374|472150586|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131234512|NCT05200858|472484684|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
131092299|NCT04833127|471968387|FG001|Overall Study|Lost to Follow-up|1|||
131092300|NCT05282121|471968390|FG000|Overall Study|Adverse Event|1|||
131092301|NCT05282121|471968391|FG001|Overall Study|Adverse Event|1|||
131092302|NCT05282121|471968392|FG002|Overall Study|Adverse Event|4|||
131092303|NCT05282121|471968393|FG003|Overall Study|Adverse Event|1|||
131092304|NCT05282121|471968390|FG000|Overall Study|Study Terminated by Sponsor|1|||
131092305|NCT05282121|471968391|FG001|Overall Study|Study Terminated by Sponsor|2|||
131092306|NCT05282121|471968392|FG002|Overall Study|Study Terminated by Sponsor|2|||
131092307|NCT05282121|471968393|FG003|Overall Study|Study Terminated by Sponsor|2|||
131092308|NCT05282121|471968390|FG000|Overall Study|Other than listed|0|||
131092309|NCT05282121|471968391|FG001|Overall Study|Other than listed|0|||
131092310|NCT05282121|471968392|FG002|Overall Study|Other than listed|1|||
131092311|NCT05282121|471968393|FG003|Overall Study|Other than listed|0|||
131092312|NCT05282121|471968390|FG000|Overall Study|No reason available|0|||
131092313|NCT05282121|471968391|FG001|Overall Study|No reason available|0|||
131092314|NCT05282121|471968392|FG002|Overall Study|No reason available|1|||
131092315|NCT05282121|471968393|FG003|Overall Study|No reason available|0|||
131092316|NCT00461981|471968397|FG000|Overall Study|Lost to Follow-up|9|||
131092317|NCT00461981|471968398|FG001|Overall Study|Lost to Follow-up|6|||
131092318|NCT00461981|471968397|FG000|Overall Study|Withdrawal by Subject|2|||
131092319|NCT00461981|471968398|FG001|Overall Study|Withdrawal by Subject|3|||
131092320|NCT03301155|471968402|FG000|Overall Study|Сompliance with exclusion criteria|8|||
131092321|NCT03301155|471968403|FG001|Overall Study|Сompliance with exclusion criteria|7|||
131092322|NCT00731133|471968406|FG000|Overall Study|Withdrawal by Subject|10|||
131092323|NCT03510455|471968407|FG000|Overall Study|Physician Decision|1|||
131092324|NCT00384189|471968408|FG000|Overall Study|Reason Not Specified|50|||
131092325|NCT00384189|471968409|FG001|Overall Study|Reason Not Specified|57|||
131092326|NCT00384189|471968410|FG002|Overall Study|Reason Not Specified|58|||
131092327|NCT00384189|471968411|FG003|Overall Study|Reason Not Specified|40|||
131092328|NCT04958642|471968412|FG000|Overall Study|Transferred to OLEX program|3|||
131092329|NCT04958642|471968413|FG001|Overall Study|Transferred to OLEX program|0|||
131092330|NCT04958642|471968414|FG002|Overall Study|Transferred to OLEX program|5|||
131092331|NCT04958642|471968412|FG000|Overall Study|Death|0|||
131092332|NCT04958642|471968413|FG001|Overall Study|Death|0|||
131092333|NCT04958642|471968414|FG002|Overall Study|Death|1|||
131092334|NCT04958642|471968412|FG000|Overall Study|Withdrawal by Subject|4|||
131092335|NCT04958642|471968413|FG001|Overall Study|Withdrawal by Subject|9|||
131092336|NCT04958642|471968414|FG002|Overall Study|Withdrawal by Subject|13|||
131092337|NCT04958642|471968412|FG000|Overall Study|Investigator's Decision|0|||
131092338|NCT04958642|471968413|FG001|Overall Study|Investigator's Decision|0|||
131092339|NCT04958642|471968414|FG002|Overall Study|Investigator's Decision|1|||
131092340|NCT04958642|471968412|FG000|Overall Study|Adverse Event|1|||
131092341|NCT04958642|471968413|FG001|Overall Study|Adverse Event|0|||
131092342|NCT04958642|471968414|FG002|Overall Study|Adverse Event|1|||
131092343|NCT04958642|471968412|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
131092344|NCT04958642|471968413|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
131092345|NCT04958642|471968414|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
131092346|NCT04958642|471968412|FG000|Overall Study|Lost to Follow-up|1|||
131092347|NCT04958642|471968413|FG001|Overall Study|Lost to Follow-up|0|||
131092348|NCT04958642|471968414|FG002|Overall Study|Lost to Follow-up|0|||
131092349|NCT04958642|471968412|FG000|Overall Study|Transferred to EAP following study termination|0|||
131092350|NCT04958642|471968413|FG001|Overall Study|Transferred to EAP following study termination|0|||
131092351|NCT04958642|471968414|FG002|Overall Study|Transferred to EAP following study termination|1|||
131092352|NCT04958642|471968412|FG000|Overall Study|Transferred to Expanded Access Program|1|||
131092353|NCT04958642|471968413|FG001|Overall Study|Transferred to Expanded Access Program|0|||
131092354|NCT04958642|471968414|FG002|Overall Study|Transferred to Expanded Access Program|0|||
131092355|NCT00608868|471968415|FG000|Overall Study|Withdrawal by Subject|7|||
131092356|NCT00608868|471968415|FG000|Overall Study|Protocol Violation|3|||
131092357|NCT00608868|471968415|FG000|Overall Study|Lost to Follow-up|2|||
131092358|NCT00608868|471968415|FG000|Overall Study|Adverse Event|1|||
131092359|NCT00608868|471968415|FG000|Overall Study|Physician Decision|2|||
131092360|NCT02476175|471968419|FG000|Overall Study|Adverse Event|2|||
131092361|NCT03868787|471968429|FG000|Overall Study|Withdrawal by Subject|2|||
131092362|NCT03868787|471968430|FG001|Overall Study|Withdrawal by Subject|1|||
131092363|NCT01399697|471968441|FG000|Overall Study|Adverse Event|13|||
131092364|NCT01399697|471968442|FG001|Overall Study|Adverse Event|3|||
131092365|NCT01399697|471968443|FG002|Overall Study|Adverse Event|1|||
131092366|NCT01399697|471968441|FG000|Overall Study|Lost to Follow-up|2|||
131143440|NCT01583374|472150587|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131143441|NCT01583374|472150588|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131092367|NCT01399697|471968442|FG001|Overall Study|Lost to Follow-up|0|||
131092368|NCT01399697|471968443|FG002|Overall Study|Lost to Follow-up|0|||
131092369|NCT01399697|471968441|FG000|Overall Study|Withdrawal by Subject|8|||
131092370|NCT01399697|471968442|FG001|Overall Study|Withdrawal by Subject|0|||
131092371|NCT01399697|471968443|FG002|Overall Study|Withdrawal by Subject|0|||
131092372|NCT01399697|471968441|FG000|Overall Study|Investigator Decisión|1|||
131092373|NCT01399697|471968442|FG001|Overall Study|Investigator Decisión|0|||
131092374|NCT01399697|471968443|FG002|Overall Study|Investigator Decisión|2|||
131092375|NCT01399697|471968441|FG000|Overall Study|Lack of Efficacy|9|||
131092376|NCT01399697|471968442|FG001|Overall Study|Lack of Efficacy|0|||
131092377|NCT01399697|471968443|FG002|Overall Study|Lack of Efficacy|1|||
131092378|NCT01399697|471968441|FG000|Overall Study|Protocol Violation|2|||
131092379|NCT01399697|471968442|FG001|Overall Study|Protocol Violation|0|||
131143442|NCT01583374|472150589|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131092380|NCT01399697|471968443|FG002|Overall Study|Protocol Violation|0|||
131092381|NCT01399697|471968441|FG000|Overall Study|Non-Compliant|1|||
131092382|NCT01399697|471968442|FG001|Overall Study|Non-Compliant|0|||
131143443|NCT01583374|472150590|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131143444|NCT01583374|472150591|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
131143445|NCT01583374|472150583|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131143446|NCT01583374|472150584|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131092383|NCT01399697|471968443|FG002|Overall Study|Non-Compliant|0|||
131092384|NCT01399697|471968441|FG000|Overall Study|Inclusion Error|2|||
131092385|NCT01399697|471968442|FG001|Overall Study|Inclusion Error|0|||
131092386|NCT01399697|471968443|FG002|Overall Study|Inclusion Error|0|||
131092387|NCT01399697|471968441|FG000|Overall Study|Positive result for hepatitis B|1|||
131092388|NCT01399697|471968442|FG001|Overall Study|Positive result for hepatitis B|0|||
131092389|NCT01399697|471968443|FG002|Overall Study|Positive result for hepatitis B|0|||
131092390|NCT01399697|471968441|FG000|Overall Study|Clinical RA remission|1|||
131092391|NCT01399697|471968442|FG001|Overall Study|Clinical RA remission|0|||
131092392|NCT01399697|471968443|FG002|Overall Study|Clinical RA remission|0|||
131092393|NCT01399697|471968441|FG000|Overall Study|Sponsor Decision|1|||
131092394|NCT01399697|471968442|FG001|Overall Study|Sponsor Decision|0|||
131092395|NCT01399697|471968443|FG002|Overall Study|Sponsor Decision|0|||
131092396|NCT02766777|471968448|FG000|Overall Study|Adverse Event|12|||
131092397|NCT02766777|471968448|FG000|Overall Study|Lost to Follow-up|16|||
131092398|NCT02766777|471968448|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131092399|NCT02766777|471968448|FG000|Overall Study|Protocol Violation|1|||
131092400|NCT02766777|471968448|FG000|Overall Study|Withdrawal by Subject|4|||
131092401|NCT02964325|471968449|FG000|Overall Study|Lost to Follow-up|3|||
131092402|NCT02964325|471968450|FG001|Overall Study|Lost to Follow-up|3|||
131092403|NCT02964325|471968449|FG000|Overall Study|Physician Decision|5|||
131092404|NCT02964325|471968450|FG001|Overall Study|Physician Decision|4|||
131092405|NCT02964325|471968449|FG000|Overall Study|Death|1|||
131092406|NCT02964325|471968450|FG001|Overall Study|Death|3|||
131092407|NCT02964325|471968449|FG000|Overall Study|Withdrawal by Subject|2|||
131092408|NCT02964325|471968450|FG001|Overall Study|Withdrawal by Subject|1|||
131092409|NCT02964325|471968449|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
131092410|NCT02964325|471968450|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
131092411|NCT02510040|471968451|FG000|Overall Study|Deemed no longer eligible|18|||
131092412|NCT02510040|471968452|FG001|Overall Study|Deemed no longer eligible|3|||
131092413|NCT02510040|471968453|FG002|Overall Study|Deemed no longer eligible|1|||
131092414|NCT00967005|471968461|FG000|Overall Study|Lost to Follow-up|7|||
131092415|NCT00967005|471968462|FG001|Overall Study|Lost to Follow-up|10|||
131092416|NCT01371825|471968465|FG000|Overall Study|Death|4|||
131092417|NCT03019640|471968466|FG000|Overall Study|Screen Failures|4|||
131092418|NCT03019640|471968466|FG000|Overall Study|Adverse Event|3|||
131092419|NCT03019640|471968466|FG000|Overall Study|Participant Relapsed|1|||
131092420|NCT00534495|471968472|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
131092421|NCT00534495|471968473|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
131092422|NCT00534495|471968474|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
131092423|NCT00534495|471968472|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
131092424|NCT00534495|471968473|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
131092425|NCT00534495|471968474|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
131092426|NCT00534495|471968472|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
131092427|NCT00534495|471968473|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
131092428|NCT00534495|471968474|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
131092429|NCT00534495|471968472|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
131092430|NCT00534495|471968473|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
131092431|NCT00534495|471968474|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
131092432|NCT00534495|471968472|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
131092433|NCT00534495|471968473|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
131143447|NCT01583374|472150585|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
131143448|NCT01583374|472150586|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131143449|NCT01583374|472150587|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131143450|NCT01583374|472150588|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131092434|NCT00534495|471968474|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
131092435|NCT00534495|471968472|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
131092436|NCT00534495|471968473|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
131092437|NCT00534495|471968474|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
131092438|NCT00534495|471968472|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
131143451|NCT01583374|472150589|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131092439|NCT00534495|471968473|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
131092440|NCT00534495|471968474|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
131092441|NCT00534495|471968472|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
131092442|NCT00534495|471968473|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
131143452|NCT01583374|472150590|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131092443|NCT00534495|471968474|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
131092444|NCT00534495|471968472|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
131092445|NCT00534495|471968473|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
131092446|NCT00534495|471968474|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
131092447|NCT01162863|471968475|FG000|Overall Study|Lack of Efficacy|1|||
131092448|NCT01162863|471968476|FG001|Overall Study|Lack of Efficacy|0|||
131092449|NCT01162863|471968477|FG002|Overall Study|Lack of Efficacy|0|||
131092450|NCT01162863|471968475|FG000|Overall Study|Adverse Event|0|||
131092451|NCT01162863|471968476|FG001|Overall Study|Adverse Event|1|||
131092452|NCT01162863|471968477|FG002|Overall Study|Adverse Event|0|||
131092453|NCT00588692|471968478|FG000|Overall Study|Withdrawal by Subject|4|||
131092454|NCT00588692|471968479|FG001|Overall Study|Withdrawal by Subject|2|||
131092455|NCT00588692|471968478|FG000|Overall Study|Hip Surgery|0|||
131092456|NCT00588692|471968479|FG001|Overall Study|Hip Surgery|1|||
131092457|NCT00588692|471968478|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
131092458|NCT00588692|471968479|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
131092459|NCT00588692|471968478|FG000|Overall Study|Cancer|1|||
131092460|NCT00588692|471968479|FG001|Overall Study|Cancer|0|||
131092461|NCT00588692|471968478|FG000|Overall Study|Death|1|||
131092462|NCT00588692|471968479|FG001|Overall Study|Death|0|||
131092463|NCT03552523|471968480|FG000|Overall Study|Withdrawal by Subject|1|||
131092464|NCT03552523|471968481|FG001|Overall Study|Withdrawal by Subject|1|||
131092465|NCT04462289|471968482|FG000|Overall Study|Lost to Follow-up|4|||
131092466|NCT04462289|471968483|FG001|Overall Study|Lost to Follow-up|5|||
131092467|NCT04462289|471968482|FG000|Overall Study|Death|0|||
131092468|NCT04462289|471968483|FG001|Overall Study|Death|3|||
131092469|NCT04462289|471968482|FG000|Overall Study|Withdrawal by Subject|1|||
131092470|NCT04462289|471968483|FG001|Overall Study|Withdrawal by Subject|3|||
131092471|NCT03686423|471968484|FG000|Overall Study|Withdrawal by Subject|9|||
131092472|NCT03686423|471968484|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
131092473|NCT01077518|471968485|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
131092474|NCT01077518|471968486|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
131092475|NCT01077518|471968487|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
131092476|NCT01077518|471968485|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
131092477|NCT01077518|471968486|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
131092478|NCT01077518|471968487|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
131092479|NCT01077518|471968485|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
131092480|NCT01077518|471968486|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
131092481|NCT01077518|471968487|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
131092482|NCT01077518|471968485|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
131092483|NCT01077518|471968486|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
131092484|NCT01077518|471968487|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
131092485|NCT01077518|471968485|FG000|Optional Ofa Phase|Physician Decision|0|||
131092486|NCT01077518|471968486|FG001|Optional Ofa Phase|Physician Decision|0|||
131092487|NCT01077518|471968487|FG002|Optional Ofa Phase|Physician Decision|1|||
131092488|NCT01077518|471968485|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
131092489|NCT01077518|471968486|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
131092490|NCT01077518|471968487|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
131092491|NCT01077518|471968485|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
131092492|NCT01077518|471968486|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
131092493|NCT01077518|471968487|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
131092494|NCT02387970|471968488|FG000|Overall Study|Did not complete 1-year follow up|1|||
131092495|NCT02387970|471968489|FG001|Overall Study|Did not complete 1-year follow up|2|||
131092496|NCT01436253|471968494|FG000|Overall Study|Lost to Follow-up|182|||
131092497|NCT01436253|471968494|FG000|Overall Study|Not meeting all eligibility criteria|117|||
131143453|NCT01583374|472150591|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
131143454|NCT01583374|472150583|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
131143455|NCT01583374|472150584|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
131143456|NCT01583374|472150585|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
131143457|NCT01583374|472150586|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
131143458|NCT01583374|472150587|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
131092498|NCT01495598|471968496|FG000|Overall Study|Death during follow up period|2|||
131092499|NCT01495598|471968496|FG000|Overall Study|Death on study|1|||
131092500|NCT01495598|471968496|FG000|Overall Study|Lost to Follow-up|3|||
131092501|NCT01495598|471968496|FG000|Overall Study|Physician Decision|8|||
131092502|NCT02671500|471968499|FG000|Overall Study|Lack of Efficacy|12|||
131092503|NCT02671500|471968499|FG000|Overall Study|Lost to Follow-up|2|||
131092504|NCT05511038|471968501|FG000|Overall|Withdrawal by Subject|5|||
131092505|NCT05511038|471968502|FG001|Overall|Withdrawal by Subject|3|||
131092506|NCT05511038|471968501|FG000|Overall|Screen Failure|20|||
131092507|NCT05511038|471968502|FG001|Overall|Screen Failure|1|||
131092508|NCT05511038|471968501|FG000|Overall|Physician Decision|3|||
131143459|NCT01583374|472150588|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
131092509|NCT05511038|471968502|FG001|Overall|Physician Decision|0|||
131092510|NCT05511038|471968501|FG000|Overall|Lost to Follow-up|3|||
131092511|NCT05511038|471968502|FG001|Overall|Lost to Follow-up|0|||
131092512|NCT05511038|471968501|FG000|Overall|Death|1|||
131092513|NCT05511038|471968502|FG001|Overall|Death|0|||
131092514|NCT05511038|471968501|FG000|Screening|Withdrawal by Subject|1|||
131092515|NCT05511038|471968502|FG001|Screening|Withdrawal by Subject|0|||
131092516|NCT05511038|471968501|FG000|Screening|Lost to Follow Up (1 participant)|1|||
131092517|NCT05511038|471968502|FG001|Screening|Lost to Follow Up (1 participant)|0|||
131092518|NCT05511038|471968501|FG000|Screening|Screen Failure|3|||
131092519|NCT05511038|471968502|FG001|Screening|Screen Failure|0|||
131092520|NCT05511038|471968501|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
131092521|NCT05511038|471968502|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
131092522|NCT05511038|471968501|FG000|Treatment|Withdrawal by Subject|5|||
131092523|NCT05511038|471968502|FG001|Treatment|Withdrawal by Subject|3|||
131092524|NCT05511038|471968501|FG000|Treatment|Physician Decision|4|||
131092525|NCT05511038|471968502|FG001|Treatment|Physician Decision|0|||
131092526|NCT05511038|471968501|FG000|Treatment|Lost to Follow-up|2|||
131092527|NCT05511038|471968502|FG001|Treatment|Lost to Follow-up|0|||
131092528|NCT05511038|471968501|FG000|Treatment|Death|1|||
131092529|NCT05511038|471968502|FG001|Treatment|Death|0|||
131092530|NCT05511038|471968501|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
131092531|NCT05511038|471968502|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
131092532|NCT05511038|471968501|FG000|Treatment|Refuse by subject|1|||
131092533|NCT05511038|471968502|FG001|Treatment|Refuse by subject|0|||
131092534|NCT05511038|471968501|FG000|Treatment|Subject did not go to the site for visit|1|||
131092535|NCT05511038|471968502|FG001|Treatment|Subject did not go to the site for visit|0|||
131092536|NCT04485611|471968503|FG000|Prehabilitation|Physician Decision|1|||
131092537|NCT05292586|471968506|FG000|Overall Study|Withdrawal by Subject|3|||
131092538|NCT05292586|471968507|FG001|Overall Study|Withdrawal by Subject|10|||
131092539|NCT05292586|471968506|FG000|Overall Study|Randomization error|3|||
131092540|NCT05292586|471968507|FG001|Overall Study|Randomization error|7|||
131092541|NCT05292586|471968506|FG000|Overall Study|Adverse Event|3|||
131092542|NCT05292586|471968507|FG001|Overall Study|Adverse Event|0|||
131092543|NCT05292586|471968506|FG000|Overall Study|Lost to Follow-up|0|||
131092544|NCT05292586|471968507|FG001|Overall Study|Lost to Follow-up|1|||
131092545|NCT05292586|471968506|FG000|Overall Study|Patient refused treatment|1|||
131092546|NCT05292586|471968507|FG001|Overall Study|Patient refused treatment|0|||
131092547|NCT05292586|471968506|FG000|Overall Study|Patient could not travel to the study site|1|||
131092548|NCT05292586|471968507|FG001|Overall Study|Patient could not travel to the study site|0|||
131092549|NCT05292586|471968506|FG000|Overall Study|Technical issues with the masterscope|0|||
131092550|NCT05292586|471968507|FG001|Overall Study|Technical issues with the masterscope|3|||
131092551|NCT05292586|471968506|FG000|Overall Study|Patient moved to a different state|0|||
131092552|NCT05292586|471968507|FG001|Overall Study|Patient moved to a different state|1|||
131092553|NCT04531982|471968508|FG000|Overall Study|Withdrawal by Subject|10|||
131092554|NCT04531982|471968509|FG001|Overall Study|Withdrawal by Subject|11|||
131092555|NCT04531982|471968508|FG000|Overall Study|Adverse Event|6|||
131092556|NCT04531982|471968509|FG001|Overall Study|Adverse Event|14|||
131092557|NCT04531982|471968508|FG000|Overall Study|Protocol Violation|6|||
131092558|NCT04531982|471968509|FG001|Overall Study|Protocol Violation|9|||
131092559|NCT04531982|471968508|FG000|Overall Study|Non-compliance with study drug|3|||
131092560|NCT04531982|471968509|FG001|Overall Study|Non-compliance with study drug|2|||
131092561|NCT04531982|471968508|FG000|Overall Study|Use of prohibited medication|2|||
131092562|NCT04531982|471968509|FG001|Overall Study|Use of prohibited medication|0|||
131143460|NCT01583374|472150589|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
131143461|NCT01583374|472150590|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
131143462|NCT01583374|472150591|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
131143463|NCT01583374|472150583|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131143464|NCT01583374|472150584|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131092563|NCT04531982|471968508|FG000|Overall Study|Lost to Follow-up|0|||
131092564|NCT04531982|471968509|FG001|Overall Study|Lost to Follow-up|1|||
131092565|NCT04531982|471968508|FG000|Overall Study|Geopolitical conflict|2|||
131092566|NCT04531982|471968509|FG001|Overall Study|Geopolitical conflict|0|||
131092567|NCT04531982|471968508|FG000|Overall Study|Lack of Efficacy|3|||
131092568|NCT04531982|471968509|FG001|Overall Study|Lack of Efficacy|1|||
131092569|NCT03841526|471968510|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
131092570|NCT03841526|471968511|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
131092571|NCT03841526|471968512|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
131092572|NCT03841526|471968513|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
131092573|NCT03841526|471968514|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
131092574|NCT03841526|471968515|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
131092575|NCT03841526|471968510|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
131092576|NCT03841526|471968511|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
131092577|NCT03841526|471968512|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
131143465|NCT01583374|472150585|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131092578|NCT03841526|471968513|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
131092579|NCT03841526|471968514|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
131092580|NCT03841526|471968515|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
131092581|NCT03841526|471968510|FG000|Outpatient Phase Treatment|Physician Decision|0|||
131092582|NCT03841526|471968511|FG001|Outpatient Phase Treatment|Physician Decision|1|||
131092583|NCT03841526|471968512|FG002|Outpatient Phase Treatment|Physician Decision|0|||
131092584|NCT03841526|471968513|FG003|Outpatient Phase Treatment|Physician Decision|0|||
131092585|NCT03841526|471968514|FG004|Outpatient Phase Treatment|Physician Decision|0|||
131092586|NCT03841526|471968515|FG005|Outpatient Phase Treatment|Physician Decision|0|||
131092587|NCT03841526|471968510|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
131092588|NCT03841526|471968511|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
131092589|NCT03841526|471968512|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
131092590|NCT03841526|471968513|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
131092591|NCT03841526|471968514|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
131092592|NCT03841526|471968515|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
131092593|NCT03829501|471969930|FG000|Overall Study|Withdrawal of Consent|2|||
131092594|NCT03829501|471969931|FG001|Overall Study|Withdrawal of Consent|0|||
131092595|NCT03829501|471969932|FG002|Overall Study|Withdrawal of Consent|3|||
131092596|NCT03829501|471969933|FG003|Overall Study|Withdrawal of Consent|0|||
131092597|NCT03829501|471969934|FG004|Overall Study|Withdrawal of Consent|1|||
131092598|NCT03829501|471969935|FG005|Overall Study|Withdrawal of Consent|1|||
131092599|NCT03829501|471969936|FG006|Overall Study|Withdrawal of Consent|0|||
131092600|NCT03829501|471969937|FG007|Overall Study|Withdrawal of Consent|10|||
131092601|NCT03829501|471969938|FG008|Overall Study|Withdrawal of Consent|10|||
131092602|NCT03829501|471969939|FG009|Overall Study|Withdrawal of Consent|3|||
131092603|NCT03829501|471969940|FG010|Overall Study|Withdrawal of Consent|4|||
131092604|NCT03829501|471969941|FG011|Overall Study|Withdrawal of Consent|4|||
131092605|NCT03829501|471969942|FG012|Overall Study|Withdrawal of Consent|4|||
131092606|NCT03829501|471969943|FG013|Overall Study|Withdrawal of Consent|0|||
131092607|NCT03829501|471969944|FG014|Overall Study|Withdrawal of Consent|3|||
131092608|NCT03829501|471969945|FG015|Overall Study|Withdrawal of Consent|0|||
131092609|NCT03829501|471969946|FG016|Overall Study|Withdrawal of Consent|1|||
131092610|NCT03829501|471969947|FG017|Overall Study|Withdrawal of Consent|1|||
131092611|NCT03829501|471969948|FG018|Overall Study|Withdrawal of Consent|0|||
131092612|NCT03829501|471969949|FG019|Overall Study|Withdrawal of Consent|0|||
131092613|NCT03829501|471969950|FG020|Overall Study|Withdrawal of Consent|3|||
131092614|NCT03829501|471969951|FG021|Overall Study|Withdrawal of Consent|0|||
131092615|NCT03829501|471969952|FG022|Overall Study|Withdrawal of Consent|1|||
131092616|NCT03829501|471969930|FG000|Overall Study|PD|0|||
131092617|NCT03829501|471969931|FG001|Overall Study|PD|0|||
131092618|NCT03829501|471969932|FG002|Overall Study|PD|0|||
131092619|NCT03829501|471969933|FG003|Overall Study|PD|2|||
131092620|NCT03829501|471969934|FG004|Overall Study|PD|0|||
131092621|NCT03829501|471969935|FG005|Overall Study|PD|0|||
131092622|NCT03829501|471969936|FG006|Overall Study|PD|0|||
131092623|NCT03829501|471969937|FG007|Overall Study|PD|0|||
131092624|NCT03829501|471969938|FG008|Overall Study|PD|0|||
131092625|NCT03829501|471969939|FG009|Overall Study|PD|0|||
131092626|NCT03829501|471969940|FG010|Overall Study|PD|0|||
131092627|NCT03829501|471969941|FG011|Overall Study|PD|0|||
131092628|NCT03829501|471969942|FG012|Overall Study|PD|0|||
131092629|NCT03829501|471969943|FG013|Overall Study|PD|0|||
131092630|NCT03829501|471969944|FG014|Overall Study|PD|0|||
131092631|NCT03829501|471969945|FG015|Overall Study|PD|1|||
131092632|NCT03829501|471969946|FG016|Overall Study|PD|0|||
131092633|NCT03829501|471969947|FG017|Overall Study|PD|0|||
131092634|NCT03829501|471969948|FG018|Overall Study|PD|0|||
131092635|NCT03829501|471969949|FG019|Overall Study|PD|0|||
131092636|NCT03829501|471969950|FG020|Overall Study|PD|1|||
131092637|NCT03829501|471969951|FG021|Overall Study|PD|0|||
131092638|NCT03829501|471969952|FG022|Overall Study|PD|0|||
131092639|NCT03829501|471969930|FG000|Overall Study|Study Terminated by Sponsor|0|||
131092640|NCT03829501|471969931|FG001|Overall Study|Study Terminated by Sponsor|0|||
131092641|NCT03829501|471969932|FG002|Overall Study|Study Terminated by Sponsor|0|||
131092642|NCT03829501|471969933|FG003|Overall Study|Study Terminated by Sponsor|0|||
131092643|NCT03829501|471969934|FG004|Overall Study|Study Terminated by Sponsor|0|||
131092644|NCT03829501|471969935|FG005|Overall Study|Study Terminated by Sponsor|0|||
131092645|NCT03829501|471969936|FG006|Overall Study|Study Terminated by Sponsor|0|||
131092646|NCT03829501|471969937|FG007|Overall Study|Study Terminated by Sponsor|3|||
131092647|NCT03829501|471969938|FG008|Overall Study|Study Terminated by Sponsor|1|||
131092648|NCT03829501|471969939|FG009|Overall Study|Study Terminated by Sponsor|0|||
131092649|NCT03829501|471969940|FG010|Overall Study|Study Terminated by Sponsor|0|||
131092650|NCT03829501|471969941|FG011|Overall Study|Study Terminated by Sponsor|0|||
131092651|NCT03829501|471969942|FG012|Overall Study|Study Terminated by Sponsor|0|||
131092652|NCT03829501|471969943|FG013|Overall Study|Study Terminated by Sponsor|0|||
131092653|NCT03829501|471969944|FG014|Overall Study|Study Terminated by Sponsor|3|||
131092654|NCT03829501|471969945|FG015|Overall Study|Study Terminated by Sponsor|2|||
131092655|NCT03829501|471969946|FG016|Overall Study|Study Terminated by Sponsor|2|||
131092656|NCT03829501|471969947|FG017|Overall Study|Study Terminated by Sponsor|0|||
131234513|NCT05200858|472484685|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
131092657|NCT03829501|471969948|FG018|Overall Study|Study Terminated by Sponsor|0|||
131092658|NCT03829501|471969949|FG019|Overall Study|Study Terminated by Sponsor|0|||
131234514|NCT00313703|472486347|FG000|Overall Study|Lost to Follow-up|11|||
131092659|NCT03829501|471969950|FG020|Overall Study|Study Terminated by Sponsor|1|||
131092660|NCT03829501|471969951|FG021|Overall Study|Study Terminated by Sponsor|0|||
131092661|NCT03829501|471969952|FG022|Overall Study|Study Terminated by Sponsor|3|||
131092662|NCT03829501|471969930|FG000|Overall Study|Lost to Follow Up|0|||
131092663|NCT03829501|471969931|FG001|Overall Study|Lost to Follow Up|0|||
131092664|NCT03829501|471969932|FG002|Overall Study|Lost to Follow Up|0|||
131092665|NCT03829501|471969933|FG003|Overall Study|Lost to Follow Up|0|||
131092666|NCT03829501|471969934|FG004|Overall Study|Lost to Follow Up|1|||
131092667|NCT03829501|471969935|FG005|Overall Study|Lost to Follow Up|0|||
131092668|NCT03829501|471969936|FG006|Overall Study|Lost to Follow Up|0|||
131092669|NCT03829501|471969937|FG007|Overall Study|Lost to Follow Up|2|||
131092670|NCT03829501|471969938|FG008|Overall Study|Lost to Follow Up|2|||
131092671|NCT03829501|471969939|FG009|Overall Study|Lost to Follow Up|0|||
131092672|NCT03829501|471969940|FG010|Overall Study|Lost to Follow Up|2|||
131092673|NCT03829501|471969941|FG011|Overall Study|Lost to Follow Up|1|||
131092674|NCT03829501|471969942|FG012|Overall Study|Lost to Follow Up|0|||
131092675|NCT03829501|471969943|FG013|Overall Study|Lost to Follow Up|1|||
131092676|NCT03829501|471969944|FG014|Overall Study|Lost to Follow Up|1|||
131092677|NCT03829501|471969945|FG015|Overall Study|Lost to Follow Up|0|||
131092678|NCT03829501|471969946|FG016|Overall Study|Lost to Follow Up|0|||
131092679|NCT03829501|471969947|FG017|Overall Study|Lost to Follow Up|0|||
131092680|NCT03829501|471969948|FG018|Overall Study|Lost to Follow Up|0|||
131092681|NCT03829501|471969949|FG019|Overall Study|Lost to Follow Up|0|||
131092682|NCT03829501|471969950|FG020|Overall Study|Lost to Follow Up|0|||
131092683|NCT03829501|471969951|FG021|Overall Study|Lost to Follow Up|0|||
131092684|NCT03829501|471969952|FG022|Overall Study|Lost to Follow Up|1|||
131092685|NCT03829501|471969930|FG000|Overall Study|Death|2|||
131092686|NCT03829501|471969931|FG001|Overall Study|Death|4|||
131092687|NCT03829501|471969932|FG002|Overall Study|Death|5|||
131092688|NCT03829501|471969933|FG003|Overall Study|Death|6|||
131092689|NCT03829501|471969934|FG004|Overall Study|Death|5|||
131092690|NCT03829501|471969935|FG005|Overall Study|Death|4|||
131092691|NCT03829501|471969936|FG006|Overall Study|Death|5|||
131092692|NCT03829501|471969937|FG007|Overall Study|Death|24|||
131092693|NCT03829501|471969938|FG008|Overall Study|Death|22|||
131092694|NCT03829501|471969939|FG009|Overall Study|Death|6|||
131092695|NCT03829501|471969940|FG010|Overall Study|Death|3|||
131092696|NCT03829501|471969941|FG011|Overall Study|Death|10|||
131092697|NCT03829501|471969942|FG012|Overall Study|Death|10|||
131092698|NCT03829501|471969943|FG013|Overall Study|Death|5|||
131092699|NCT03829501|471969944|FG014|Overall Study|Death|7|||
131092700|NCT03829501|471969945|FG015|Overall Study|Death|2|||
131143466|NCT01583374|472150586|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131143467|NCT01583374|472150587|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131143468|NCT01583374|472150588|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131143469|NCT01583374|472150589|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131143470|NCT01583374|472150590|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
131143471|NCT01583374|472150591|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
131143472|NCT01583374|472150583|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
131143473|NCT01583374|472150584|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
131143474|NCT01583374|472150585|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
131143475|NCT01583374|472150586|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
131143476|NCT01583374|472150587|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
131143477|NCT01583374|472150588|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
131143478|NCT01583374|472150589|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
131143479|NCT01583374|472150590|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
131092701|NCT03829501|471969946|FG016|Overall Study|Death|2|||
131092702|NCT03829501|471969947|FG017|Overall Study|Death|1|||
131092703|NCT03829501|471969948|FG018|Overall Study|Death|1|||
131234515|NCT00313703|472486348|FG001|Overall Study|Lost to Follow-up|2|||
131234516|NCT00313703|472486349|FG002|Overall Study|Lost to Follow-up|5|||
131234517|NCT00313703|472486350|FG003|Overall Study|Lost to Follow-up|12|||
131234518|NCT00101582|472486351|FG000|Overall Study|Ineligibility determined|0|||
131092704|NCT03829501|471969949|FG019|Overall Study|Death|1|||
131092705|NCT03829501|471969950|FG020|Overall Study|Death|1|||
131092706|NCT03829501|471969951|FG021|Overall Study|Death|2|||
131092707|NCT03829501|471969952|FG022|Overall Study|Death|3|||
131092708|NCT03829501|471969930|FG000|Overall Study|Miscellaneous|0|||
131092709|NCT03829501|471969931|FG001|Overall Study|Miscellaneous|0|||
131092710|NCT03829501|471969932|FG002|Overall Study|Miscellaneous|1|||
131092711|NCT03829501|471969933|FG003|Overall Study|Miscellaneous|0|||
131092712|NCT03829501|471969934|FG004|Overall Study|Miscellaneous|0|||
131092713|NCT03829501|471969935|FG005|Overall Study|Miscellaneous|0|||
131092714|NCT03829501|471969936|FG006|Overall Study|Miscellaneous|0|||
131092715|NCT03829501|471969937|FG007|Overall Study|Miscellaneous|1|||
131092716|NCT03829501|471969938|FG008|Overall Study|Miscellaneous|0|||
131143480|NCT01583374|472150591|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
131143481|NCT01583374|472150583|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
131143482|NCT01583374|472150584|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
131143483|NCT01583374|472150585|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
131143484|NCT01583374|472150586|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
131143485|NCT01583374|472150587|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
131143486|NCT01583374|472150588|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
131143487|NCT01583374|472150589|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
131143488|NCT01583374|472150590|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
131143489|NCT01583374|472150591|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
131143490|NCT01583374|472150583|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131143491|NCT01583374|472150584|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
131143492|NCT01583374|472150585|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
131143493|NCT01583374|472150586|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131143494|NCT01583374|472150587|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
131143495|NCT01583374|472150588|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131143496|NCT01583374|472150589|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131143497|NCT01583374|472150590|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131143498|NCT01583374|472150591|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
131143499|NCT01583374|472150583|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131143500|NCT01583374|472150584|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131143501|NCT01583374|472150585|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
131143502|NCT01583374|472150586|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131143503|NCT01583374|472150587|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
131143504|NCT01583374|472150588|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
131143505|NCT01583374|472150589|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131143506|NCT01583374|472150590|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131143507|NCT01583374|472150591|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
131143508|NCT01583374|472150583|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
131143509|NCT01583374|472150584|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
131143510|NCT01583374|472150585|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
131143511|NCT01583374|472150586|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
131143512|NCT01583374|472150587|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
131143513|NCT01583374|472150588|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
131143514|NCT01583374|472150589|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
131143515|NCT01583374|472150590|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
131143516|NCT01583374|472150591|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
131143517|NCT01583374|472150583|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
131143518|NCT01583374|472150584|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
131143519|NCT01583374|472150585|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
131143520|NCT01583374|472150586|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
131143521|NCT01583374|472150587|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
131143522|NCT01583374|472150588|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
131143523|NCT01583374|472150589|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
131143524|NCT01583374|472150590|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
131143525|NCT01583374|472150591|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
131143526|NCT01583374|472150583|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131143527|NCT01583374|472150584|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131143528|NCT01583374|472150585|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131143529|NCT01583374|472150586|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131143530|NCT01583374|472150587|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
131143531|NCT01583374|472150588|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131143532|NCT01583374|472150589|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
131143533|NCT01583374|472150590|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
131143534|NCT01583374|472150591|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
131234519|NCT00101582|472486352|FG001|Overall Study|Ineligibility determined|1|||
131234520|NCT00101582|472486351|FG000|Overall Study|Adverse Event|1|||
131234521|NCT00101582|472486352|FG001|Overall Study|Adverse Event|4|||
131234522|NCT00101582|472486351|FG000|Overall Study|Withdrawal by Subject|6|||
131234523|NCT00101582|472486352|FG001|Overall Study|Withdrawal by Subject|4|||
131234524|NCT00101582|472486351|FG000|Overall Study|Physician Decision|1|||
131234525|NCT00101582|472486352|FG001|Overall Study|Physician Decision|0|||
131234526|NCT00101582|472486351|FG000|Overall Study|Death|3|||
131234527|NCT00101582|472486352|FG001|Overall Study|Death|5|||
131234528|NCT00101582|472486351|FG000|Overall Study|Other|0|||
131234529|NCT00101582|472486352|FG001|Overall Study|Other|1|||
131234530|NCT00278200|472486354|FG000|Overall Study|Death|1|||
131092717|NCT03829501|471969939|FG009|Overall Study|Miscellaneous|0|||
131092718|NCT03829501|471969940|FG010|Overall Study|Miscellaneous|0|||
131092719|NCT03829501|471969941|FG011|Overall Study|Miscellaneous|0|||
131092720|NCT03829501|471969942|FG012|Overall Study|Miscellaneous|0|||
131092721|NCT03829501|471969943|FG013|Overall Study|Miscellaneous|0|||
131092722|NCT03829501|471969944|FG014|Overall Study|Miscellaneous|0|||
131092723|NCT03829501|471969945|FG015|Overall Study|Miscellaneous|0|||
131092724|NCT03829501|471969946|FG016|Overall Study|Miscellaneous|0|||
131092725|NCT03829501|471969947|FG017|Overall Study|Miscellaneous|0|||
131092726|NCT03829501|471969948|FG018|Overall Study|Miscellaneous|0|||
131092727|NCT03829501|471969949|FG019|Overall Study|Miscellaneous|0|||
131092728|NCT03829501|471969950|FG020|Overall Study|Miscellaneous|0|||
131092729|NCT03829501|471969951|FG021|Overall Study|Miscellaneous|0|||
131092730|NCT03829501|471969952|FG022|Overall Study|Miscellaneous|1|||
131092731|NCT04165031|471969953|FG000|Overall Study|Adverse Event|1|||
131092732|NCT04165031|471969954|FG001|Overall Study|Adverse Event|1|||
131092733|NCT04165031|471969955|FG002|Overall Study|Adverse Event|0|||
131092734|NCT04165031|471969956|FG003|Overall Study|Adverse Event|0|||
131092735|NCT04165031|471969957|FG004|Overall Study|Adverse Event|0|||
131092736|NCT04165031|471969958|FG005|Overall Study|Adverse Event|0|||
131092737|NCT04165031|471969953|FG000|Overall Study|Withdrawal by Subject|0|||
131092738|NCT04165031|471969954|FG001|Overall Study|Withdrawal by Subject|0|||
131092739|NCT04165031|471969955|FG002|Overall Study|Withdrawal by Subject|1|||
131092740|NCT04165031|471969956|FG003|Overall Study|Withdrawal by Subject|0|||
131092741|NCT04165031|471969957|FG004|Overall Study|Withdrawal by Subject|0|||
131092742|NCT04165031|471969958|FG005|Overall Study|Withdrawal by Subject|0|||
131092743|NCT01332630|471969959|FG000|Overall Study|Withdrawal by Subject|3|||
131092744|NCT03140280|471969960|FG000|Overall Study|Physician Decision|5|||
131092745|NCT00663702|471969969|FG000|Overall Study|Adverse Event|8|||
131092746|NCT00663702|471969970|FG001|Overall Study|Adverse Event|4|||
131092747|NCT00663702|471969969|FG000|Overall Study|Withdrawal by Subject|3|||
131092748|NCT00663702|471969970|FG001|Overall Study|Withdrawal by Subject|1|||
131092749|NCT00663702|471969969|FG000|Overall Study|Pregnancy|0|||
131092750|NCT00663702|471969970|FG001|Overall Study|Pregnancy|1|||
131092751|NCT00663702|471969969|FG000|Overall Study|Lost to Follow-up|3|||
131092752|NCT00663702|471969970|FG001|Overall Study|Lost to Follow-up|0|||
131092753|NCT00663702|471969969|FG000|Overall Study|Death|1|||
131092754|NCT00663702|471969970|FG001|Overall Study|Death|1|||
131092755|NCT00663702|471969969|FG000|Overall Study|Lack of Efficacy|3|||
131092756|NCT00663702|471969970|FG001|Overall Study|Lack of Efficacy|3|||
131092757|NCT01498887|471969971|FG000|Overall Study|Administrative problems|1|||
131092758|NCT01498887|471969972|FG001|Overall Study|Administrative problems|0|||
131092759|NCT01498887|471969971|FG000|Overall Study|Lost to Follow-up|1|||
131092760|NCT01498887|471969972|FG001|Overall Study|Lost to Follow-up|1|||
131092761|NCT01498887|471969971|FG000|Overall Study|Withdrawal by Subject|1|||
131092762|NCT01498887|471969972|FG001|Overall Study|Withdrawal by Subject|0|||
131092763|NCT01498887|471969971|FG000|Overall Study|Protocol Violation|1|||
131092764|NCT01498887|471969972|FG001|Overall Study|Protocol Violation|3|||
131092765|NCT01498887|471969971|FG000|Overall Study|Lack of Efficacy|5|||
131143535|NCT01583374|472150583|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
131143536|NCT01583374|472150584|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
131143537|NCT01583374|472150585|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
131143538|NCT01583374|472150586|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
131143539|NCT01583374|472150587|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
131143540|NCT01583374|472150588|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
131143541|NCT01583374|472150589|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
131143542|NCT01583374|472150590|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
131092766|NCT01498887|471969972|FG001|Overall Study|Lack of Efficacy|3|||
131092767|NCT01498887|471969971|FG000|Overall Study|Abnormal result from test procedure|1|||
131092768|NCT01498887|471969972|FG001|Overall Study|Abnormal result from test procedure|1|||
131092769|NCT01498887|471969971|FG000|Overall Study|Abnormal laboratory value|2|||
131092770|NCT01498887|471969972|FG001|Overall Study|Abnormal laboratory value|2|||
131092771|NCT01498887|471969971|FG000|Overall Study|Adverse Event|4|||
131092772|NCT01498887|471969972|FG001|Overall Study|Adverse Event|1|||
131092773|NCT00667225|471969975|FG000|Overall Study|Subject had no more lesions to treat.|1|||
131092774|NCT00667225|471969976|FG001|Overall Study|Subject had no more lesions to treat.|0|||
131092775|NCT00667225|471969975|FG000|Overall Study|Lost to Follow-up|0|||
131143543|NCT01583374|472150591|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
131092776|NCT00667225|471969976|FG001|Overall Study|Lost to Follow-up|1|||
131092777|NCT04313608|471969979|FG000|Overall Study|Death|12|||
131092778|NCT04313608|471969980|FG001|Overall Study|Death|3|||
131092779|NCT02440425|471969981|FG000|Overall Study|Death likely due to disease progression|1|||
131092780|NCT02440425|471969981|FG000|Overall Study|Withdrawal by Subject|2|||
131092781|NCT02440425|471969981|FG000|Overall Study|Adverse Event|1|||
131092782|NCT02440425|471969981|FG000|Overall Study|Adverse Event/Ineligible|1|||
131092783|NCT00214019|471969982|FG000|Overall Study|Lost to Follow-up|11|||
131092784|NCT00214019|471969982|FG000|Overall Study|Withdrawal by Subject|2|||
131092785|NCT00214019|471969982|FG000|Overall Study|Screen Failed prior to randomization|17|||
131092786|NCT03635099|471969985|FG000|Period 1|Adverse Event|1|||
131092787|NCT03635099|471969986|FG001|Period 1|Adverse Event|0|||
131092788|NCT03635099|471969987|FG002|Period 1|Adverse Event|0|||
131092789|NCT03635099|471969988|FG003|Period 1|Adverse Event|1|||
131092790|NCT03635099|471969989|FG004|Period 1|Adverse Event|0|||
131143544|NCT01583374|472150583|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
131143545|NCT01583374|472150584|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
131143546|NCT01583374|472150585|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
131143547|NCT01583374|472150586|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
131143548|NCT01583374|472150587|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
131143549|NCT01583374|472150588|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
131143550|NCT01583374|472150589|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
131143551|NCT01583374|472150590|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
131143552|NCT01583374|472150591|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
131143553|NCT01583374|472150583|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
131143554|NCT01583374|472150584|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
131234531|NCT00278200|472486355|FG001|Overall Study|Death|3|||
131234532|NCT00278200|472486354|FG000|Overall Study|Physician Decision|0|||
131234533|NCT00278200|472486355|FG001|Overall Study|Physician Decision|1|||
131143555|NCT01583374|472150585|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
131143556|NCT01583374|472150586|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
131143557|NCT01583374|472150587|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
131143558|NCT01583374|472150588|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
131143559|NCT01583374|472150589|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
131143560|NCT01583374|472150590|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
131143561|NCT01583374|472150591|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
131143562|NCT01583374|472150583|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
131143563|NCT01583374|472150584|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
131143564|NCT01583374|472150585|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
131143565|NCT01583374|472150586|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
131143566|NCT01583374|472150587|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
131143567|NCT01583374|472150588|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
131143568|NCT01583374|472150589|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
131143569|NCT01583374|472150590|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
131143570|NCT01583374|472150591|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
131143571|NCT01292057|472150592|FG000|Overall Study|Protocol Violation|1|||
131143572|NCT01292057|472150593|FG001|Overall Study|Protocol Violation|1|||
131143573|NCT01292057|472150592|FG000|Overall Study|Lost to Follow-up|1|||
131143574|NCT01292057|472150593|FG001|Overall Study|Lost to Follow-up|1|||
131143575|NCT01506882|472150598|FG000|Overall Study|Lack of Efficacy|4|||
131143576|NCT01506882|472150599|FG001|Overall Study|Lack of Efficacy|3|||
131143577|NCT01506882|472150598|FG000|Overall Study|Lost to Follow-up|1|||
131143578|NCT01506882|472150599|FG001|Overall Study|Lost to Follow-up|0|||
131143579|NCT01506882|472150598|FG000|Overall Study|Withdrawal by Subject|9|||
131143580|NCT01506882|472150599|FG001|Overall Study|Withdrawal by Subject|3|||
131143581|NCT01506882|472150598|FG000|Overall Study|SAE, non-fatal|2|||
131143582|NCT01506882|472150599|FG001|Overall Study|SAE, non-fatal|0|||
131143583|NCT01506882|472150598|FG000|Overall Study|AE, non-serious non-fatal|3|||
131143584|NCT01506882|472150599|FG001|Overall Study|AE, non-serious non-fatal|1|||
131143585|NCT01506882|472150598|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
131234534|NCT03519256|472486363|FG000|Overall Study|Disease recurrence|4|||
131234535|NCT03519256|472486364|FG001|Overall Study|Disease recurrence|4|||
131234536|NCT03519256|472486365|FG002|Overall Study|Disease recurrence|5|||
131234537|NCT03519256|472486366|FG003|Overall Study|Disease recurrence|2|||
131234538|NCT03519256|472486363|FG000|Overall Study|Study drug toxicity|0|||
131234539|NCT03519256|472486364|FG001|Overall Study|Study drug toxicity|2|||
131092791|NCT03635099|471969990|FG005|Period 1|Adverse Event|0|||
131092792|NCT03635099|471969991|FG006|Period 1|Adverse Event|0|||
131092793|NCT03635099|471969992|FG007|Period 1|Adverse Event|0|||
131143586|NCT01506882|472150599|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
131234540|NCT03519256|472486365|FG002|Overall Study|Study drug toxicity|5|||
131234541|NCT03519256|472486366|FG003|Overall Study|Study drug toxicity|2|||
131092794|NCT03635099|471969985|FG000|Period 1|Protocol Violation|0|||
131092795|NCT03635099|471969986|FG001|Period 1|Protocol Violation|0|||
131092796|NCT03635099|471969987|FG002|Period 1|Protocol Violation|1|||
131092797|NCT03635099|471969988|FG003|Period 1|Protocol Violation|0|||
131092798|NCT03635099|471969989|FG004|Period 1|Protocol Violation|0|||
131143587|NCT01506882|472150598|FG000|Overall Study|Other Reason|2|||
131143588|NCT01506882|472150599|FG001|Overall Study|Other Reason|0|||
131143589|NCT00821678|472150604|FG000|Overall Study|Withdrawal by Subject|8|||
131234542|NCT03519256|472486363|FG000|Overall Study|Adverse event unrelated to study drug|0|||
131234543|NCT03519256|472486364|FG001|Overall Study|Adverse event unrelated to study drug|1|||
131092799|NCT03635099|471969990|FG005|Period 1|Protocol Violation|0|||
131092800|NCT03635099|471969991|FG006|Period 1|Protocol Violation|0|||
131092801|NCT03635099|471969992|FG007|Period 1|Protocol Violation|0|||
131092802|NCT03635099|471969985|FG000|Period 1|Lost to Follow-up|0|||
131092803|NCT03635099|471969986|FG001|Period 1|Lost to Follow-up|0|||
131092804|NCT03635099|471969987|FG002|Period 1|Lost to Follow-up|1|||
131092805|NCT03635099|471969988|FG003|Period 1|Lost to Follow-up|2|||
131092806|NCT03635099|471969989|FG004|Period 1|Lost to Follow-up|1|||
131092807|NCT03635099|471969990|FG005|Period 1|Lost to Follow-up|0|||
131092808|NCT03635099|471969991|FG006|Period 1|Lost to Follow-up|1|||
131092809|NCT03635099|471969992|FG007|Period 1|Lost to Follow-up|2|||
131092810|NCT03635099|471969985|FG000|Period 1|Withdrawal by Subject|3|||
131092811|NCT03635099|471969986|FG001|Period 1|Withdrawal by Subject|3|||
131092812|NCT03635099|471969987|FG002|Period 1|Withdrawal by Subject|5|||
131092813|NCT03635099|471969988|FG003|Period 1|Withdrawal by Subject|2|||
131092814|NCT03635099|471969989|FG004|Period 1|Withdrawal by Subject|2|||
131092815|NCT03635099|471969990|FG005|Period 1|Withdrawal by Subject|0|||
131092816|NCT03635099|471969991|FG006|Period 1|Withdrawal by Subject|3|||
131092817|NCT03635099|471969992|FG007|Period 1|Withdrawal by Subject|0|||
131092818|NCT03635099|471969985|FG000|Period 1|History of suicidal ideation|0|||
131092819|NCT03635099|471969986|FG001|Period 1|History of suicidal ideation|0|||
131092820|NCT03635099|471969987|FG002|Period 1|History of suicidal ideation|1|||
131092821|NCT03635099|471969988|FG003|Period 1|History of suicidal ideation|0|||
131092822|NCT03635099|471969989|FG004|Period 1|History of suicidal ideation|0|||
131092823|NCT03635099|471969990|FG005|Period 1|History of suicidal ideation|0|||
131092824|NCT03635099|471969991|FG006|Period 1|History of suicidal ideation|0|||
131092825|NCT03635099|471969992|FG007|Period 1|History of suicidal ideation|0|||
131092826|NCT03635099|471969985|FG000|Period 1|pursue other treatment options|0|||
131092827|NCT03635099|471969986|FG001|Period 1|pursue other treatment options|0|||
131092828|NCT03635099|471969987|FG002|Period 1|pursue other treatment options|0|||
131092829|NCT03635099|471969988|FG003|Period 1|pursue other treatment options|0|||
131092830|NCT03635099|471969989|FG004|Period 1|pursue other treatment options|0|||
131092831|NCT03635099|471969990|FG005|Period 1|pursue other treatment options|1|||
131092832|NCT03635099|471969991|FG006|Period 1|pursue other treatment options|0|||
131092833|NCT03635099|471969992|FG007|Period 1|pursue other treatment options|0|||
131092834|NCT03635099|471969985|FG000|Not Eligible for Period 2|Pregnancy|0|||
131092835|NCT03635099|471969986|FG001|Not Eligible for Period 2|Pregnancy|0|||
131092836|NCT03635099|471969987|FG002|Not Eligible for Period 2|Pregnancy|0|||
131092837|NCT03635099|471969988|FG003|Not Eligible for Period 2|Pregnancy|1|||
131092838|NCT03635099|471969989|FG004|Not Eligible for Period 2|Pregnancy|0|||
131092839|NCT03635099|471969990|FG005|Not Eligible for Period 2|Pregnancy|0|||
131092840|NCT03635099|471969991|FG006|Not Eligible for Period 2|Pregnancy|0|||
131092841|NCT03635099|471969992|FG007|Not Eligible for Period 2|Pregnancy|0|||
131092842|NCT03635099|471969985|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
131092843|NCT03635099|471969986|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
131092844|NCT03635099|471969987|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
131092845|NCT03635099|471969988|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
131092846|NCT03635099|471969989|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
131092847|NCT03635099|471969990|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
131092848|NCT03635099|471969991|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
131143590|NCT00821678|472150605|FG001|Overall Study|Withdrawal by Subject|0|||
131143591|NCT00821678|472150604|FG000|Overall Study|Lost to Follow-up|13|||
131143592|NCT00821678|472150605|FG001|Overall Study|Lost to Follow-up|12|||
131143593|NCT00821678|472150604|FG000|Overall Study|Death|0|||
131143594|NCT00821678|472150605|FG001|Overall Study|Death|2|||
131092849|NCT03635099|471969992|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
131092850|NCT03635099|471969985|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
131092851|NCT03635099|471969986|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
131092852|NCT03635099|471969987|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
131092853|NCT03635099|471969988|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
131092854|NCT03635099|471969989|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
131092855|NCT03635099|471969990|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
131092856|NCT03635099|471969991|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
131092857|NCT03635099|471969992|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
131092858|NCT03635099|471969985|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
131092859|NCT03635099|471969986|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
131092860|NCT03635099|471969987|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
131092861|NCT03635099|471969988|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
131092862|NCT03635099|471969989|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
131092863|NCT03635099|471969990|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
131092864|NCT03635099|471969991|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
131092865|NCT03635099|471969992|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
131092866|NCT03635099|471969985|FG000|Period 2|Adverse Event|0|||
131092867|NCT03635099|471969986|FG001|Period 2|Adverse Event|0|||
131092868|NCT03635099|471969987|FG002|Period 2|Adverse Event|1|||
131092869|NCT03635099|471969988|FG003|Period 2|Adverse Event|0|||
131092870|NCT03635099|471969989|FG004|Period 2|Adverse Event|1|||
131092871|NCT03635099|471969990|FG005|Period 2|Adverse Event|0|||
131092872|NCT03635099|471969991|FG006|Period 2|Adverse Event|0|||
131092873|NCT03635099|471969992|FG007|Period 2|Adverse Event|0|||
131092874|NCT03635099|471969985|FG000|Period 2|Lost to Follow-up|0|||
131092875|NCT03635099|471969986|FG001|Period 2|Lost to Follow-up|0|||
131092876|NCT03635099|471969987|FG002|Period 2|Lost to Follow-up|1|||
131092877|NCT03635099|471969988|FG003|Period 2|Lost to Follow-up|0|||
131092878|NCT03635099|471969989|FG004|Period 2|Lost to Follow-up|4|||
131092879|NCT03635099|471969990|FG005|Period 2|Lost to Follow-up|0|||
131092880|NCT03635099|471969991|FG006|Period 2|Lost to Follow-up|0|||
131092881|NCT03635099|471969992|FG007|Period 2|Lost to Follow-up|0|||
131092882|NCT03635099|471969985|FG000|Period 2|Withdrawal by Subject|0|||
131092883|NCT03635099|471969986|FG001|Period 2|Withdrawal by Subject|0|||
131092884|NCT03635099|471969987|FG002|Period 2|Withdrawal by Subject|7|||
131092885|NCT03635099|471969988|FG003|Period 2|Withdrawal by Subject|4|||
131092886|NCT03635099|471969989|FG004|Period 2|Withdrawal by Subject|7|||
131092887|NCT03635099|471969990|FG005|Period 2|Withdrawal by Subject|0|||
131092888|NCT03635099|471969991|FG006|Period 2|Withdrawal by Subject|0|||
131092889|NCT03635099|471969992|FG007|Period 2|Withdrawal by Subject|0|||
131092890|NCT01068665|471969993|FG000|Overall Study|Adverse Event|5|||
131092891|NCT01068665|471969994|FG001|Overall Study|Adverse Event|4|||
131092892|NCT01068665|471969993|FG000|Overall Study|Lack of Efficacy|0|||
131092893|NCT01068665|471969994|FG001|Overall Study|Lack of Efficacy|2|||
131092894|NCT01068665|471969993|FG000|Overall Study|Protocol Violation|5|||
131092895|NCT01068665|471969994|FG001|Overall Study|Protocol Violation|2|||
131092896|NCT01068665|471969993|FG000|Overall Study|Withdrawal Criteria|3|||
131092897|NCT01068665|471969994|FG001|Overall Study|Withdrawal Criteria|9|||
131092898|NCT01068665|471969993|FG000|Overall Study|Other|17|||
131092899|NCT01068665|471969994|FG001|Overall Study|Other|12|||
131092900|NCT02807272|471969996|FG000|Overall Study|Death|9|||
131092901|NCT02807272|471969997|FG001|Overall Study|Death|5|||
131092902|NCT02807272|471969998|FG002|Overall Study|Death|2|||
131092903|NCT02807272|471969999|FG003|Overall Study|Death|0|||
131092904|NCT02807272|471970000|FG004|Overall Study|Death|1|||
131092905|NCT02807272|471969996|FG000|Overall Study|Lost to Follow-up|1|||
131092906|NCT02807272|471969997|FG001|Overall Study|Lost to Follow-up|0|||
131092907|NCT02807272|471969998|FG002|Overall Study|Lost to Follow-up|0|||
131092908|NCT02807272|471969999|FG003|Overall Study|Lost to Follow-up|0|||
131092909|NCT02807272|471970000|FG004|Overall Study|Lost to Follow-up|0|||
131092910|NCT02807272|471969996|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
131092911|NCT02807272|471969997|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
131092912|NCT02807272|471969998|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
131092913|NCT02807272|471969999|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
131092914|NCT02807272|471970000|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
131092915|NCT02807272|471969996|FG000|Overall Study|Protocol-defined Disease Progression|0|||
131092916|NCT02807272|471969997|FG001|Overall Study|Protocol-defined Disease Progression|1|||
131092917|NCT02807272|471969998|FG002|Overall Study|Protocol-defined Disease Progression|0|||
131092918|NCT02807272|471969999|FG003|Overall Study|Protocol-defined Disease Progression|0|||
131092919|NCT02807272|471970000|FG004|Overall Study|Protocol-defined Disease Progression|1|||
131092920|NCT02807272|471969996|FG000|Overall Study|Study Terminated by Sponsor|1|||
131092921|NCT02807272|471969997|FG001|Overall Study|Study Terminated by Sponsor|0|||
131092922|NCT02807272|471969998|FG002|Overall Study|Study Terminated by Sponsor|0|||
131092923|NCT02807272|471969999|FG003|Overall Study|Study Terminated by Sponsor|1|||
131092924|NCT02807272|471970000|FG004|Overall Study|Study Terminated by Sponsor|0|||
131092925|NCT02807272|471969996|FG000|Overall Study|Other|1|||
131092926|NCT02807272|471969997|FG001|Overall Study|Other|0|||
131092927|NCT02807272|471969998|FG002|Overall Study|Other|0|||
131092928|NCT02807272|471969999|FG003|Overall Study|Other|0|||
131092929|NCT02807272|471970000|FG004|Overall Study|Other|1|||
131092930|NCT04191616|471970002|FG000|Pre-assignment Period|Did not receive study treatment|2|||
131092931|NCT04191616|471970002|FG000|Treatment Period|Death|37|||
131092932|NCT04191616|471970002|FG000|Treatment Period|Sponsor decision|11|||
131092933|NCT04191616|471970002|FG000|Treatment Period|Withdrawal by Subject|4|||
131092934|NCT01038427|471970003|FG000|Overall Study|Lost to follow up|1|||
131092935|NCT01038427|471970004|FG001|Overall Study|Lost to follow up|1|||
131092936|NCT01038427|471970005|FG002|Overall Study|Lost to follow up|0|||
131092937|NCT01038427|471970003|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
131092938|NCT01038427|471970004|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
131092939|NCT01038427|471970005|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
131092940|NCT01038427|471970003|FG000|Overall Study|Withdrew consent|0|||
131092941|NCT01038427|471970004|FG001|Overall Study|Withdrew consent|0|||
131092942|NCT01038427|471970005|FG002|Overall Study|Withdrew consent|1|||
131092943|NCT01038427|471970003|FG000|Overall Study|Adverse Event|2|||
131092944|NCT01038427|471970004|FG001|Overall Study|Adverse Event|2|||
131234544|NCT03519256|472486365|FG002|Overall Study|Adverse event unrelated to study drug|1|||
131234545|NCT03519256|472486366|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131234546|NCT03519256|472486363|FG000|Overall Study|Participant request to discontinue study treatment|0|||
131092945|NCT01038427|471970005|FG002|Overall Study|Adverse Event|1|||
131092946|NCT01038427|471970003|FG000|Overall Study|Enrolled in error|0|||
131092947|NCT01038427|471970004|FG001|Overall Study|Enrolled in error|1|||
131092948|NCT01038427|471970005|FG002|Overall Study|Enrolled in error|1|||
131092949|NCT01038427|471970003|FG000|Overall Study|Other|0|||
131092950|NCT01038427|471970004|FG001|Overall Study|Other|2|||
131092951|NCT01038427|471970005|FG002|Overall Study|Other|0|||
131092952|NCT04230122|471970006|FG000|Overall Study|Lost to Follow-up|1|||
131092953|NCT04230122|471970007|FG001|Overall Study|Lost to Follow-up|0|||
131092954|NCT00604708|471970008|FG000|Overall Study|Withdrawal by Subject|9|||
131092955|NCT00604708|471970009|FG001|Overall Study|Withdrawal by Subject|10|||
131092956|NCT00604708|471970008|FG000|Overall Study|Protocol Violation|2|||
131092957|NCT00604708|471970009|FG001|Overall Study|Protocol Violation|8|||
131092958|NCT00604708|471970008|FG000|Overall Study|Lost to Follow-up|5|||
131092959|NCT00604708|471970009|FG001|Overall Study|Lost to Follow-up|5|||
131092960|NCT00604708|471970008|FG000|Overall Study|administrative reasons|9|||
131092961|NCT00604708|471970009|FG001|Overall Study|administrative reasons|11|||
131092962|NCT00604708|471970008|FG000|Overall Study|Adverse Event|6|||
131092963|NCT00604708|471970009|FG001|Overall Study|Adverse Event|6|||
131092964|NCT02180243|471970010|FG000|Overall Study|Withdrawal by Subject|12|||
131092965|NCT02180243|471970011|FG001|Overall Study|Withdrawal by Subject|12|||
131092966|NCT02180243|471970010|FG000|Overall Study|Lost to Follow-up|12|||
131092967|NCT02180243|471970011|FG001|Overall Study|Lost to Follow-up|2|||
131092968|NCT02202785|471970012|FG000|Overall Study|Study Terminated by Sponsor|1|||
131092969|NCT02202785|471970013|FG001|Overall Study|Study Terminated by Sponsor|6|||
131092970|NCT02202785|471970014|FG002|Overall Study|Study Terminated by Sponsor|4|||
131092971|NCT02202785|471970012|FG000|Overall Study|Withdrawal by Subject|0|||
131092972|NCT02202785|471970013|FG001|Overall Study|Withdrawal by Subject|1|||
131092973|NCT02202785|471970014|FG002|Overall Study|Withdrawal by Subject|0|||
131092974|NCT02202785|471970012|FG000|Overall Study|Lost to Follow-up|0|||
131092975|NCT02202785|471970013|FG001|Overall Study|Lost to Follow-up|1|||
131092976|NCT02202785|471970014|FG002|Overall Study|Lost to Follow-up|0|||
131092977|NCT02202785|471970012|FG000|Overall Study|Reason not Specified|10|||
131092978|NCT02202785|471970013|FG001|Overall Study|Reason not Specified|7|||
131092979|NCT02202785|471970014|FG002|Overall Study|Reason not Specified|13|||
131092980|NCT01137578|471970015|FG000|Overall Study|Participant requested to Discontinue|3|||
131092981|NCT01137578|471970016|FG001|Overall Study|Participant requested to Discontinue|0|||
131092982|NCT01137578|471970017|FG002|Overall Study|Participant requested to Discontinue|0|||
131092983|NCT01137578|471970015|FG000|Overall Study|Withdrawal by Subject|1|||
131092984|NCT01137578|471970016|FG001|Overall Study|Withdrawal by Subject|0|||
131092985|NCT01137578|471970017|FG002|Overall Study|Withdrawal by Subject|0|||
131092986|NCT01137578|471970015|FG000|Overall Study|Other|12|||
131092987|NCT01137578|471970016|FG001|Overall Study|Other|2|||
131092988|NCT01137578|471970017|FG002|Overall Study|Other|6|||
131092989|NCT04145700|471970018|FG000|Overall Study|Withdrawal by Subject|8|||
131092990|NCT04145700|471970019|FG001|Overall Study|Withdrawal by Subject|3|||
131092991|NCT00818779|471970022|FG000|Overall Study|Protocol Violation|1|||
131092992|NCT00818779|471970023|FG001|Overall Study|Protocol Violation|0|||
131092993|NCT00818779|471970022|FG000|Overall Study|Lost to Follow-up|1|||
131092994|NCT00818779|471970023|FG001|Overall Study|Lost to Follow-up|0|||
131092995|NCT00818779|471970022|FG000|Overall Study|Adverse Event|4|||
131092996|NCT00818779|471970023|FG001|Overall Study|Adverse Event|1|||
131092997|NCT04978493|471970024|FG000|Overall Study|No reason available|0|||
131092998|NCT04978493|471970025|FG001|Overall Study|No reason available|1|||
131092999|NCT04978493|471970024|FG000|Overall Study|Adverse Event|1|||
131093000|NCT04978493|471970025|FG001|Overall Study|Adverse Event|0|||
131093001|NCT01327846|471970028|FG000|Core Phase|Subject decision (vital status: missing)|1|||
131093002|NCT01327846|471970029|FG001|Core Phase|Subject decision (vital status: missing)|2|||
131093003|NCT01327846|471970030|FG002|Core Phase|Subject decision (vital status: missing)|2|||
131093004|NCT01327846|471970031|FG003|Core Phase|Subject decision (vital status: missing)|1|||
131093005|NCT01327846|471970028|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
131093006|NCT01327846|471970029|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
131093007|NCT01327846|471970030|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
131093008|NCT01327846|471970031|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
131093009|NCT01327846|471970028|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
131093010|NCT01327846|471970029|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
131093011|NCT01327846|471970030|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
131093012|NCT01327846|471970031|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
131093013|NCT01327846|471970028|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
131093014|NCT01327846|471970029|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
131093015|NCT01327846|471970030|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
131093016|NCT01327846|471970031|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
131093017|NCT01327846|471970028|FG000|Core Phase|Lost to Follow-up|3|||
131093018|NCT01327846|471970029|FG001|Core Phase|Lost to Follow-up|3|||
131093019|NCT01327846|471970030|FG002|Core Phase|Lost to Follow-up|4|||
131093020|NCT01327846|471970031|FG003|Core Phase|Lost to Follow-up|5|||
131093021|NCT01327846|471970028|FG000|Extension Phase|Study terminated by sponsor|1073|||
131093022|NCT01327846|471970029|FG001|Extension Phase|Study terminated by sponsor|1124|||
131093023|NCT01327846|471970030|FG002|Extension Phase|Study terminated by sponsor|1067|||
131093024|NCT01327846|471970031|FG003|Extension Phase|Study terminated by sponsor|1660|||
131093025|NCT01327846|471970028|FG000|Extension Phase|Withdrawal by Subject|20|||
131093026|NCT01327846|471970029|FG001|Extension Phase|Withdrawal by Subject|13|||
131093027|NCT01327846|471970030|FG002|Extension Phase|Withdrawal by Subject|19|||
131093028|NCT01327846|471970031|FG003|Extension Phase|Withdrawal by Subject|37|||
131093029|NCT01327846|471970028|FG000|Extension Phase|Lost to Follow-up|4|||
131093030|NCT01327846|471970029|FG001|Extension Phase|Lost to Follow-up|3|||
131093031|NCT01327846|471970030|FG002|Extension Phase|Lost to Follow-up|4|||
131093032|NCT01327846|471970031|FG003|Extension Phase|Lost to Follow-up|7|||
131093033|NCT01327846|471970028|FG000|Extension Phase|Technical Problems|2|||
131093034|NCT01327846|471970029|FG001|Extension Phase|Technical Problems|4|||
131093035|NCT01327846|471970030|FG002|Extension Phase|Technical Problems|2|||
131093036|NCT01327846|471970031|FG003|Extension Phase|Technical Problems|2|||
131093037|NCT01840410|471970032|FG000|Overall Study|Physician Decision|1|||
131093038|NCT01840410|471970033|FG001|Overall Study|Physician Decision|2|||
131093039|NCT01840410|471970032|FG000|Overall Study|Pregnancy|1|||
131093040|NCT01840410|471970033|FG001|Overall Study|Pregnancy|0|||
131093041|NCT01840410|471970032|FG000|Overall Study|Protocol deviation|1|||
131093042|NCT01840410|471970033|FG001|Overall Study|Protocol deviation|0|||
131093043|NCT01840410|471970032|FG000|Overall Study|Lost to Follow-up|1|||
131093044|NCT01840410|471970033|FG001|Overall Study|Lost to Follow-up|0|||
131093045|NCT01840410|471970032|FG000|Overall Study|Withdrawal by Subject|2|||
131093046|NCT01840410|471970033|FG001|Overall Study|Withdrawal by Subject|1|||
131093047|NCT01840410|471970032|FG000|Overall Study|Adverse Event|1|||
131093048|NCT01840410|471970033|FG001|Overall Study|Adverse Event|1|||
131093049|NCT00594880|471970034|FG000|Overall Study|Withdrawal by Subject|1|||
131093050|NCT00594880|471970035|FG001|Overall Study|Withdrawal by Subject|1|||
131093051|NCT00594880|471970034|FG000|Overall Study|Lost to Follow-up|1|||
131093052|NCT00594880|471970035|FG001|Overall Study|Lost to Follow-up|0|||
131093053|NCT00694109|471970036|FG000|Overall Study|Physician Decision|3|||
131093054|NCT00694109|471970036|FG000|Overall Study|Adverse Event|74|||
131093055|NCT00694109|471970036|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
131093056|NCT00694109|471970036|FG000|Overall Study|Lack of Efficacy|2|||
131093057|NCT00694109|471970036|FG000|Overall Study|Withdrawal by Subject|13|||
131093058|NCT00694109|471970036|FG000|Overall Study|Pregnancy|1|||
131093059|NCT00694109|471970036|FG000|Overall Study|Enrolled but not treated|1|||
131093060|NCT00694109|471970036|FG000|Overall Study|Other|2|||
131093061|NCT00694109|471970036|FG000|Overall Study|Consented but no additional treatment|3|||
131093062|NCT01254747|471970037|FG000|Overall Study|Unacceptable subjective vision|0|||
131093063|NCT01254747|471970038|FG001|Overall Study|Unacceptable subjective vision|0|||
131093064|NCT01254747|471970039|FG002|Overall Study|Unacceptable subjective vision|0|||
131093065|NCT01254747|471970040|FG003|Overall Study|Unacceptable subjective vision|2|||
131093066|NCT01254747|471970037|FG000|Overall Study|Difficult removal handling|0|||
131093067|NCT01254747|471970038|FG001|Overall Study|Difficult removal handling|0|||
131093068|NCT01254747|471970039|FG002|Overall Study|Difficult removal handling|1|||
131093069|NCT01254747|471970040|FG003|Overall Study|Difficult removal handling|0|||
131093070|NCT01254747|471970037|FG000|Overall Study|Symptoms and problems|0|||
131093071|NCT01254747|471970038|FG001|Overall Study|Symptoms and problems|2|||
131093072|NCT01254747|471970039|FG002|Overall Study|Symptoms and problems|1|||
131093073|NCT01254747|471970040|FG003|Overall Study|Symptoms and problems|0|||
131093074|NCT01254747|471970037|FG000|Overall Study|Lost to Follow-up|0|||
131093075|NCT01254747|471970038|FG001|Overall Study|Lost to Follow-up|0|||
131093076|NCT01254747|471970039|FG002|Overall Study|Lost to Follow-up|1|||
131093077|NCT01254747|471970040|FG003|Overall Study|Lost to Follow-up|0|||
131093078|NCT01254747|471970037|FG000|Overall Study|Biomicroscopy|0|||
131093079|NCT01254747|471970038|FG001|Overall Study|Biomicroscopy|0|||
131093080|NCT01254747|471970039|FG002|Overall Study|Biomicroscopy|1|||
131093081|NCT01254747|471970040|FG003|Overall Study|Biomicroscopy|0|||
131093082|NCT01254747|471970037|FG000|Overall Study|Discomfort|0|||
131093083|NCT01254747|471970038|FG001|Overall Study|Discomfort|4|||
131093084|NCT01254747|471970039|FG002|Overall Study|Discomfort|0|||
131093085|NCT01254747|471970040|FG003|Overall Study|Discomfort|0|||
131093086|NCT00846807|471970041|FG000|Overall Study|Adverse Event|270|||
131093087|NCT00846807|471970041|FG000|Overall Study|Lost to Follow-up|94|||
131093088|NCT00846807|471970041|FG000|Overall Study|Withdrawal by Subject|56|||
131093089|NCT00846807|471970041|FG000|Overall Study|Non compliant with European label|7|||
131093090|NCT00846807|471970041|FG000|Overall Study|Switch to other anticoagulants|89|||
131093091|NCT00846807|471970041|FG000|Overall Study|No prescription after hospital discharge|56|||
131093092|NCT00846807|471970041|FG000|Overall Study|Other|60|||
131093093|NCT00245960|471970042|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
131093094|NCT00245960|471970043|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
131093095|NCT00245960|471970042|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
131093096|NCT00245960|471970043|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
131093097|NCT00245960|471970042|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
130727492|NCT03772717|470625469|FG000|Overall Study|Withdrawal by Subject|2|||
131093098|NCT00245960|471970043|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
131093099|NCT00245960|471970042|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
131093100|NCT00245960|471970043|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
131093101|NCT00245960|471970042|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
131093102|NCT00245960|471970043|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
131093103|NCT00245960|471970042|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
131093104|NCT00245960|471970043|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
131093105|NCT00245960|471970042|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
131093106|NCT00245960|471970043|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
131093107|NCT00245960|471970042|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
131093108|NCT00245960|471970043|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
131093109|NCT00245960|471970042|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
131093110|NCT00245960|471970043|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
131093111|NCT00245960|471970042|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
131093112|NCT00245960|471970043|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
131093113|NCT00245960|471970042|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
131093114|NCT00245960|471970043|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
131093115|NCT00245960|471970042|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
131093116|NCT00245960|471970043|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
131093117|NCT00737698|471970044|FG000|Overall Study|Withdrawal by Subject|6|||
131093118|NCT00737698|471970045|FG001|Overall Study|Withdrawal by Subject|5|||
131093119|NCT00737698|471970046|FG002|Overall Study|Withdrawal by Subject|3|||
131093120|NCT00737698|471970044|FG000|Overall Study|Death|0|||
131093121|NCT00737698|471970045|FG001|Overall Study|Death|0|||
131093122|NCT00737698|471970046|FG002|Overall Study|Death|1|||
131093123|NCT01067846|471970047|FG000|Overall Study|Lost to Follow-up|17|||
131093124|NCT01067846|471970048|FG001|Overall Study|Lost to Follow-up|19|||
131093125|NCT01067846|471970047|FG000|Overall Study|Withdrawal by Subject|1|||
131093126|NCT01067846|471970048|FG001|Overall Study|Withdrawal by Subject|0|||
131143595|NCT00376961|472152432|FG000|Initial Registration|Adverse Event|1|||
131143596|NCT00376961|472152433|FG001|Initial Registration|Adverse Event|0|||
131143597|NCT00376961|472152432|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
131143598|NCT00376961|472152433|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
131143599|NCT00376961|472152432|FG000|Initial Registration|Progression/relapse|1|||
131143600|NCT00376961|472152433|FG001|Initial Registration|Progression/relapse|0|||
131143601|NCT00376961|472152432|FG000|Initial Registration|Ineligible|3|||
131143602|NCT00376961|472152433|FG001|Initial Registration|Ineligible|0|||
131143603|NCT00376961|472152432|FG000|Maintenance|Adverse Event|0|||
131143604|NCT00376961|472152433|FG001|Maintenance|Adverse Event|1|||
131143605|NCT00376961|472152432|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
131143606|NCT00376961|472152433|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
131143607|NCT00376961|472152432|FG000|Maintenance|Progression/relapse|0|||
131143608|NCT00376961|472152433|FG001|Maintenance|Progression/relapse|18|||
131143609|NCT00376961|472152432|FG000|Maintenance|Ineligible|0|||
131143610|NCT00376961|472152433|FG001|Maintenance|Ineligible|3|||
131143611|NCT02107703|472152435|FG000|Overall Study|Withdrawal by Subject|46|||
131143612|NCT02107703|472152436|FG001|Overall Study|Withdrawal by Subject|21|||
131143613|NCT02107703|472152435|FG000|Overall Study|Lost to Follow-up|20|||
131143614|NCT02107703|472152436|FG001|Overall Study|Lost to Follow-up|9|||
131143615|NCT02107703|472152435|FG000|Overall Study|On study treatment/follow up|48|||
131143616|NCT02107703|472152436|FG001|Overall Study|On study treatment/follow up|5|||
131143617|NCT06441877|472152439|FG000|Overall Study|Withdrawal by Subject|0|||
130727493|NCT04138043|470625470|FG000|Overall Study|Withdrawal by Subject|0|||
131093127|NCT01067846|471970047|FG000|Overall Study|participation in other tx study|1|||
131093128|NCT01067846|471970048|FG001|Overall Study|participation in other tx study|0|||
131093129|NCT02817906|471970049|FG000|Overall Study|Adverse Event|3|||
131093130|NCT02817906|471970050|FG001|Overall Study|Adverse Event|0|||
131093131|NCT02817906|471970049|FG000|Overall Study|Lack of Efficacy|1|||
131093132|NCT02817906|471970050|FG001|Overall Study|Lack of Efficacy|0|||
131093133|NCT02817906|471970049|FG000|Overall Study|Protocol Violation|1|||
131143618|NCT06441877|472152440|FG001|Overall Study|Withdrawal by Subject|2|||
131143619|NCT06441877|472152441|FG002|Overall Study|Withdrawal by Subject|0|||
131143620|NCT06441877|472152442|FG003|Overall Study|Withdrawal by Subject|0|||
131143621|NCT02367521|472152443|FG000|Overall Study|severe headache after intervention|2|||
131143622|NCT02367521|472152444|FG001|Overall Study|severe headache after intervention|0|||
130727494|NCT04138043|470625471|FG001|Overall Study|Withdrawal by Subject|1|||
131093134|NCT02817906|471970050|FG001|Overall Study|Protocol Violation|1|||
131093135|NCT02817906|471970049|FG000|Overall Study|Study Terminated by Sponsor|2|||
131093136|NCT02817906|471970050|FG001|Overall Study|Study Terminated by Sponsor|2|||
131143623|NCT02367521|472152443|FG000|Overall Study|unable to find transportation|2|||
131143624|NCT02367521|472152444|FG001|Overall Study|unable to find transportation|0|||
131143625|NCT00600171|472152445|FG000|Overall Study|Adverse Event|0|||
131143626|NCT00600171|472152446|FG001|Overall Study|Adverse Event|1|||
131143627|NCT00600171|472152447|FG002|Overall Study|Adverse Event|0|||
131143628|NCT00600171|472152448|FG003|Overall Study|Adverse Event|0|||
131143629|NCT00600171|472152449|FG004|Overall Study|Adverse Event|1|||
131143630|NCT00600171|472152450|FG005|Overall Study|Adverse Event|0|||
131143631|NCT00600171|472152445|FG000|Overall Study|Lack of Efficacy|9|||
131143632|NCT00600171|472152446|FG001|Overall Study|Lack of Efficacy|12|||
131143633|NCT00600171|472152447|FG002|Overall Study|Lack of Efficacy|3|||
130727495|NCT02856802|470625472|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
131093137|NCT02817906|471970049|FG000|Overall Study|Withdrawal by Subject|7|||
131093138|NCT02817906|471970050|FG001|Overall Study|Withdrawal by Subject|0|||
131093139|NCT02817906|471970049|FG000|Overall Study|Other|2|||
131093140|NCT02817906|471970050|FG001|Overall Study|Other|2|||
131093141|NCT02833077|471970051|FG000|Overall Study|Adverse Event|1|||
131093142|NCT02833077|471970052|FG001|Overall Study|Adverse Event|2|||
131093143|NCT02833077|471970051|FG000|Overall Study|Lost to Follow-up|10|||
131093144|NCT02833077|471970052|FG001|Overall Study|Lost to Follow-up|1|||
131093145|NCT02833077|471970051|FG000|Overall Study|Personal Reasons|6|||
131093146|NCT02833077|471970052|FG001|Overall Study|Personal Reasons|4|||
131093147|NCT02833077|471970051|FG000|Overall Study|Protocol Deviation|0|||
131093148|NCT02833077|471970052|FG001|Overall Study|Protocol Deviation|1|||
131093149|NCT04608773|471970053|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
131093150|NCT04608773|471970054|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
131093151|NCT04608773|471970053|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
131093152|NCT04608773|471970054|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
131093153|NCT04608773|471970053|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
131093154|NCT04608773|471970054|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
131093155|NCT04608773|471970053|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
131093156|NCT04608773|471970054|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
131093157|NCT04608773|471970053|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
131093158|NCT04608773|471970054|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
131143634|NCT00600171|472152448|FG003|Overall Study|Lack of Efficacy|5|||
131143635|NCT00600171|472152449|FG004|Overall Study|Lack of Efficacy|4|||
131143636|NCT00600171|472152450|FG005|Overall Study|Lack of Efficacy|0|||
131143637|NCT00600171|472152445|FG000|Overall Study|Protocol Violation|1|||
131143638|NCT00600171|472152446|FG001|Overall Study|Protocol Violation|2|||
131143639|NCT00600171|472152447|FG002|Overall Study|Protocol Violation|0|||
131143640|NCT00600171|472152448|FG003|Overall Study|Protocol Violation|1|||
131143641|NCT00600171|472152449|FG004|Overall Study|Protocol Violation|0|||
131143642|NCT00600171|472152450|FG005|Overall Study|Protocol Violation|0|||
131143643|NCT00600171|472152445|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
131143644|NCT00600171|472152446|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131143645|NCT00600171|472152447|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
131143646|NCT00600171|472152448|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
131143647|NCT00600171|472152449|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
131143648|NCT00600171|472152450|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
131143649|NCT00600171|472152445|FG000|Overall Study|Withdrawal by Subject|3|||
131143650|NCT00600171|472152446|FG001|Overall Study|Withdrawal by Subject|0|||
131143651|NCT00600171|472152447|FG002|Overall Study|Withdrawal by Subject|0|||
131143652|NCT00600171|472152448|FG003|Overall Study|Withdrawal by Subject|1|||
131143653|NCT00600171|472152449|FG004|Overall Study|Withdrawal by Subject|1|||
131143654|NCT00600171|472152450|FG005|Overall Study|Withdrawal by Subject|1|||
131143655|NCT00600171|472152445|FG000|Overall Study|Physician Decision|0|||
131143656|NCT00600171|472152446|FG001|Overall Study|Physician Decision|1|||
131143657|NCT00600171|472152447|FG002|Overall Study|Physician Decision|0|||
131143658|NCT00600171|472152448|FG003|Overall Study|Physician Decision|1|||
131143659|NCT00600171|472152449|FG004|Overall Study|Physician Decision|0|||
131093159|NCT00316017|471970055|FG000|Overall Study|Protocol Violation|11|||
131143660|NCT00600171|472152450|FG005|Overall Study|Physician Decision|2|||
131143661|NCT00600171|472152445|FG000|Overall Study|Lost to Follow-up|0|||
131143662|NCT00600171|472152446|FG001|Overall Study|Lost to Follow-up|0|||
131143663|NCT00600171|472152447|FG002|Overall Study|Lost to Follow-up|0|||
131143664|NCT00600171|472152448|FG003|Overall Study|Lost to Follow-up|1|||
131143665|NCT00600171|472152449|FG004|Overall Study|Lost to Follow-up|0|||
131143666|NCT00600171|472152450|FG005|Overall Study|Lost to Follow-up|0|||
131143667|NCT00542191|472152454|FG000|Overall Study|Death|3|||
131093160|NCT00316017|471970056|FG001|Overall Study|Protocol Violation|13|||
131093161|NCT00316017|471970057|FG002|Overall Study|Protocol Violation|19|||
131093162|NCT01217437|471970058|FG000|Overall Study|Adverse Event|0|||
131093163|NCT01217437|471970059|FG001|Overall Study|Adverse Event|8|||
131143668|NCT00469612|472152455|FG000|Overall Study|Study terminated before data collected|2|||
131143669|NCT00469612|472152456|FG001|Overall Study|Study terminated before data collected|0|||
131093164|NCT01217437|471970058|FG000|Overall Study|Death|5|||
131143670|NCT01084551|472152457|FG000|Overall Study|Adverse Event|2|||
131093165|NCT01217437|471970059|FG001|Overall Study|Death|0|||
131093166|NCT01217437|471970058|FG000|Overall Study|Lack of Efficacy|29|||
131093167|NCT01217437|471970059|FG001|Overall Study|Lack of Efficacy|25|||
131093168|NCT01217437|471970058|FG000|Overall Study|Physician Decision|8|||
131093169|NCT01217437|471970059|FG001|Overall Study|Physician Decision|5|||
131093170|NCT01217437|471970058|FG000|Overall Study|Withdrawal by Subject|0|||
131093171|NCT01217437|471970059|FG001|Overall Study|Withdrawal by Subject|2|||
131093172|NCT01217437|471970058|FG000|Overall Study|Ineligible|1|||
131093173|NCT01217437|471970059|FG001|Overall Study|Ineligible|1|||
131093174|NCT06748729|471970062|FG000|Overall Study|Withdrawal by Subject|1|||
131093175|NCT01123070|471971025|FG000|Part B Double Blind Period|Protocol Violation|0|||
131093176|NCT01123070|471971026|FG001|Part B Double Blind Period|Protocol Violation|0|||
131093177|NCT01123070|471971027|FG002|Part B Double Blind Period|Protocol Violation|0|||
131093178|NCT01123070|471971028|FG003|Part B Double Blind Period|Protocol Violation|1|||
131093179|NCT01123070|471971025|FG000|Part B Double Blind Period|Adverse Event|0|||
131093180|NCT01123070|471971026|FG001|Part B Double Blind Period|Adverse Event|0|||
131093181|NCT01123070|471971027|FG002|Part B Double Blind Period|Adverse Event|2|||
131093182|NCT01123070|471971028|FG003|Part B Double Blind Period|Adverse Event|0|||
131093183|NCT01123070|471971025|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
131093184|NCT01123070|471971026|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
131093185|NCT01123070|471971027|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
131093186|NCT01123070|471971028|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
131093187|NCT03284229|471971029|FG000|Overall Study|Lost to Follow-up|3|||
131093188|NCT01977677|471971036|FG000|Overall Study|Unrelated Adverse Event|0|||
131093189|NCT01977677|471971037|FG001|Overall Study|Unrelated Adverse Event|0|||
131093190|NCT01977677|471971038|FG002|Overall Study|Unrelated Adverse Event|1|||
131093191|NCT02993406|471971039|FG000|Overall Study|Withdrawal by Subject|170|||
131093192|NCT02993406|471971040|FG001|Overall Study|Withdrawal by Subject|196|||
131093193|NCT02993406|471971039|FG000|Overall Study|Physician Decision|3|||
131093194|NCT02993406|471971040|FG001|Overall Study|Physician Decision|5|||
131093195|NCT02993406|471971039|FG000|Overall Study|Lost to Follow-up|12|||
131093196|NCT02993406|471971040|FG001|Overall Study|Lost to Follow-up|13|||
131093197|NCT02993406|471971039|FG000|Overall Study|Unclassifiable Response|105|||
131093198|NCT02993406|471971040|FG001|Overall Study|Unclassifiable Response|139|||
131093199|NCT02993406|471971039|FG000|Overall Study|Administrative decision|1|||
131093200|NCT02993406|471971040|FG001|Overall Study|Administrative decision|0|||
131093201|NCT02993406|471971039|FG000|Overall Study|Sponsor decision|4|||
131093202|NCT02993406|471971040|FG001|Overall Study|Sponsor decision|5|||
131093203|NCT02248818|471971041|FG000|Screening|Protocol Violation|0|||
131093204|NCT02248818|471971042|FG001|Screening|Protocol Violation|0|||
131093205|NCT02248818|471971043|FG002|Screening|Protocol Violation|0|||
131093206|NCT02248818|471971044|FG003|Screening|Protocol Violation|0|||
131093207|NCT02248818|471971045|FG004|Screening|Protocol Violation|0|||
131093208|NCT02248818|471971046|FG005|Screening|Protocol Violation|0|||
131093209|NCT02248818|471971047|FG006|Screening|Protocol Violation|0|||
131093210|NCT02248818|471971048|FG007|Screening|Protocol Violation|0|||
131093211|NCT02248818|471971049|FG008|Screening|Protocol Violation|7|||
131093212|NCT02248818|471971041|FG000|Screening|Study fully enrolled|0|||
131093213|NCT02248818|471971042|FG001|Screening|Study fully enrolled|0|||
131093214|NCT02248818|471971043|FG002|Screening|Study fully enrolled|0|||
131093215|NCT02248818|471971044|FG003|Screening|Study fully enrolled|0|||
131093216|NCT02248818|471971045|FG004|Screening|Study fully enrolled|0|||
131093217|NCT02248818|471971046|FG005|Screening|Study fully enrolled|0|||
131093218|NCT02248818|471971047|FG006|Screening|Study fully enrolled|0|||
131093219|NCT02248818|471971048|FG007|Screening|Study fully enrolled|0|||
131093220|NCT02248818|471971049|FG008|Screening|Study fully enrolled|14|||
131093221|NCT02248818|471971041|FG000|Screening|Physician Decision|0|||
131093222|NCT02248818|471971042|FG001|Screening|Physician Decision|0|||
131093223|NCT02248818|471971043|FG002|Screening|Physician Decision|0|||
131093224|NCT02248818|471971044|FG003|Screening|Physician Decision|0|||
131093225|NCT02248818|471971045|FG004|Screening|Physician Decision|0|||
131093226|NCT02248818|471971046|FG005|Screening|Physician Decision|0|||
131093227|NCT02248818|471971047|FG006|Screening|Physician Decision|0|||
131093228|NCT02248818|471971048|FG007|Screening|Physician Decision|0|||
131093229|NCT02248818|471971049|FG008|Screening|Physician Decision|73|||
131093230|NCT02248818|471971041|FG000|Screening|Withdrawal by Subject|0|||
131093231|NCT02248818|471971042|FG001|Screening|Withdrawal by Subject|0|||
131093232|NCT02248818|471971043|FG002|Screening|Withdrawal by Subject|0|||
131093233|NCT02248818|471971044|FG003|Screening|Withdrawal by Subject|0|||
131093234|NCT02248818|471971045|FG004|Screening|Withdrawal by Subject|0|||
131093235|NCT02248818|471971046|FG005|Screening|Withdrawal by Subject|0|||
131093236|NCT02248818|471971047|FG006|Screening|Withdrawal by Subject|0|||
131093237|NCT02248818|471971048|FG007|Screening|Withdrawal by Subject|0|||
131093238|NCT02248818|471971049|FG008|Screening|Withdrawal by Subject|6|||
131093239|NCT02248818|471971041|FG000|Screening|Lost to Follow-up|0|||
131093240|NCT02248818|471971042|FG001|Screening|Lost to Follow-up|0|||
131093241|NCT02248818|471971043|FG002|Screening|Lost to Follow-up|0|||
131093242|NCT02248818|471971044|FG003|Screening|Lost to Follow-up|0|||
131093243|NCT02248818|471971045|FG004|Screening|Lost to Follow-up|0|||
131093244|NCT02248818|471971046|FG005|Screening|Lost to Follow-up|0|||
131093245|NCT02248818|471971047|FG006|Screening|Lost to Follow-up|0|||
131093246|NCT02248818|471971048|FG007|Screening|Lost to Follow-up|0|||
131093247|NCT02248818|471971049|FG008|Screening|Lost to Follow-up|7|||
131093248|NCT02248818|471971041|FG000|Randomised Study|Administrative - randomization error|0|||
131093249|NCT02248818|471971042|FG001|Randomised Study|Administrative - randomization error|0|||
131093250|NCT02248818|471971043|FG002|Randomised Study|Administrative - randomization error|0|||
131093251|NCT02248818|471971044|FG003|Randomised Study|Administrative - randomization error|0|||
131093252|NCT02248818|471971045|FG004|Randomised Study|Administrative - randomization error|0|||
131093253|NCT02248818|471971046|FG005|Randomised Study|Administrative - randomization error|8|||
131093254|NCT02248818|471971047|FG006|Randomised Study|Administrative - randomization error|0|||
131093255|NCT02248818|471971048|FG007|Randomised Study|Administrative - randomization error|0|||
131093256|NCT02248818|471971049|FG008|Randomised Study|Administrative - randomization error|0|||
131093257|NCT05262517|471971050|FG000|Overall Study|Randomized but not treated|5|||
131093258|NCT05262517|471971051|FG001|Overall Study|Randomized but not treated|11|||
131093259|NCT04325282|471971052|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
131093260|NCT04325282|471971053|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
131093261|NCT04325282|471971052|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
131093262|NCT04325282|471971053|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
131093263|NCT01283152|471971057|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
131093264|NCT01283152|471971058|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
131093265|NCT01283152|471971057|FG000|Overall Study|Refused HESA|1|||
131093266|NCT01283152|471971058|FG001|Overall Study|Refused HESA|0|||
131093267|NCT02643303|471971061|FG000|Overall Study|Progressive Disease|4|||
131093268|NCT02643303|471971062|FG001|Overall Study|Progressive Disease|4|||
131093269|NCT02643303|471971063|FG002|Overall Study|Progressive Disease|1|||
131093270|NCT02643303|471971064|FG003|Overall Study|Progressive Disease|12|||
131093271|NCT02643303|471971065|FG004|Overall Study|Progressive Disease|6|||
131093272|NCT02643303|471971066|FG005|Overall Study|Progressive Disease|4|||
131093273|NCT02643303|471971067|FG006|Overall Study|Progressive Disease|8|||
131093274|NCT02643303|471971068|FG007|Overall Study|Progressive Disease|2|||
131093275|NCT02643303|471971069|FG008|Overall Study|Progressive Disease|6|||
131093276|NCT02643303|471971061|FG000|Overall Study|Adverse Event|0|||
131093277|NCT02643303|471971062|FG001|Overall Study|Adverse Event|1|||
131093278|NCT02643303|471971063|FG002|Overall Study|Adverse Event|0|||
131093279|NCT02643303|471971064|FG003|Overall Study|Adverse Event|0|||
131093280|NCT02643303|471971065|FG004|Overall Study|Adverse Event|1|||
131093281|NCT02643303|471971066|FG005|Overall Study|Adverse Event|0|||
131093282|NCT02643303|471971067|FG006|Overall Study|Adverse Event|0|||
131093283|NCT02643303|471971068|FG007|Overall Study|Adverse Event|0|||
131093284|NCT02643303|471971069|FG008|Overall Study|Adverse Event|0|||
131093285|NCT02643303|471971061|FG000|Overall Study|Withdrawal by Subject|0|||
131093286|NCT02643303|471971062|FG001|Overall Study|Withdrawal by Subject|0|||
131093287|NCT02643303|471971063|FG002|Overall Study|Withdrawal by Subject|0|||
131093288|NCT02643303|471971064|FG003|Overall Study|Withdrawal by Subject|1|||
131093289|NCT02643303|471971065|FG004|Overall Study|Withdrawal by Subject|0|||
131093290|NCT02643303|471971066|FG005|Overall Study|Withdrawal by Subject|0|||
131093291|NCT02643303|471971067|FG006|Overall Study|Withdrawal by Subject|1|||
131093292|NCT02643303|471971068|FG007|Overall Study|Withdrawal by Subject|1|||
131093293|NCT02643303|471971069|FG008|Overall Study|Withdrawal by Subject|1|||
131093294|NCT04552899|471971076|FG000|Overall Study|Adverse Event|4|||
131093295|NCT04552899|471971077|FG001|Overall Study|Adverse Event|3|||
131093296|NCT04552899|471971076|FG000|Overall Study|Death|4|||
131093297|NCT04552899|471971077|FG001|Overall Study|Death|4|||
131093298|NCT04552899|471971076|FG000|Overall Study|Lost to Follow-up|8|||
131093299|NCT04552899|471971077|FG001|Overall Study|Lost to Follow-up|13|||
131093300|NCT04552899|471971076|FG000|Overall Study|Lung Transplant|4|||
131093301|NCT04552899|471971077|FG001|Overall Study|Lung Transplant|3|||
131093302|NCT04552899|471971076|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
131093303|NCT04552899|471971077|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
131093304|NCT04552899|471971076|FG000|Overall Study|Physician Decision|3|||
131093305|NCT04552899|471971077|FG001|Overall Study|Physician Decision|4|||
131093306|NCT04552899|471971076|FG000|Overall Study|Study Terminated By Sponsor|237|||
131093307|NCT04552899|471971077|FG001|Overall Study|Study Terminated By Sponsor|239|||
131093308|NCT04552899|471971076|FG000|Overall Study|Withdrawal by Subject|15|||
131093309|NCT04552899|471971077|FG001|Overall Study|Withdrawal by Subject|17|||
131093310|NCT01499303|471971078|FG000|Overall Study|Ongoing|2|||
131093311|NCT01499303|471971079|FG001|Overall Study|Ongoing|1|||
131093312|NCT01499303|471971078|FG000|Overall Study|Withdrawal by Subject|0|||
131093313|NCT01499303|471971079|FG001|Overall Study|Withdrawal by Subject|1|||
131093314|NCT01499303|471971078|FG000|Overall Study|Adverse Event|1|||
131093315|NCT01499303|471971079|FG001|Overall Study|Adverse Event|4|||
131093316|NCT01499303|471971078|FG000|Overall Study|Other|0|||
131093317|NCT01499303|471971079|FG001|Overall Study|Other|1|||
131093318|NCT02383940|471971088|FG000|Overall Study|Adverse Event|1|||
131093319|NCT02383940|471971089|FG001|Overall Study|Adverse Event|0|||
131093320|NCT02383940|471971088|FG000|Overall Study|Lost to Follow-up|2|||
131093321|NCT02383940|471971089|FG001|Overall Study|Lost to Follow-up|2|||
131093322|NCT02383940|471971088|FG000|Overall Study|Physician Decision|2|||
131093323|NCT02383940|471971089|FG001|Overall Study|Physician Decision|0|||
131093324|NCT02383940|471971088|FG000|Overall Study|Withdrawal by Subject|1|||
131093325|NCT02383940|471971089|FG001|Overall Study|Withdrawal by Subject|1|||
131093326|NCT02383940|471971088|FG000|Overall Study|Randomized but not treated|2|||
131093327|NCT02383940|471971089|FG001|Overall Study|Randomized but not treated|0|||
131093328|NCT02383940|471971088|FG000|Overall Study|Other than specified above|1|||
131093329|NCT02383940|471971089|FG001|Overall Study|Other than specified above|0|||
131093330|NCT04308590|471971090|FG000|Overall Study|Adverse Event|12|||
131093331|NCT04308590|471971091|FG001|Overall Study|Adverse Event|2|||
131093332|NCT04308590|471971090|FG000|Overall Study|Withdrawal by Subject|10|||
131093333|NCT04308590|471971091|FG001|Overall Study|Withdrawal by Subject|4|||
131093334|NCT04308590|471971090|FG000|Overall Study|Death|1|||
131093335|NCT04308590|471971091|FG001|Overall Study|Death|0|||
131093336|NCT04308590|471971090|FG000|Overall Study|Lost to Follow-up|1|||
131093337|NCT04308590|471971091|FG001|Overall Study|Lost to Follow-up|1|||
131093338|NCT04308590|471971090|FG000|Overall Study|Physician Decision|1|||
131093339|NCT04308590|471971091|FG001|Overall Study|Physician Decision|0|||
131093340|NCT04308590|471971090|FG000|Overall Study|Subject does not want to continue with Pi|0|||
131093341|NCT04308590|471971091|FG001|Overall Study|Subject does not want to continue with Pi|1|||
131093342|NCT01401153|471971092|FG000|First Test Day|Learning disabilities; illness|1|||
131093343|NCT01401153|471971093|FG001|First Test Day|Learning disabilities; illness|10|||
131093344|NCT01401153|471971092|FG000|Second Test Day|illness|0|||
131093345|NCT01401153|471971093|FG001|Second Test Day|illness|5|||
131093346|NCT04343976|471971094|FG000|Overall Study|Withdrawal by Subject|0|||
131093347|NCT04343976|471971095|FG001|Overall Study|Withdrawal by Subject|1|||
131093348|NCT04187326|471971096|FG000|Overall Study|Lost to Follow-up|2|||
131093349|NCT04187326|471971097|FG001|Overall Study|Lost to Follow-up|1|||
131093350|NCT04187326|471971096|FG000|Overall Study|Computer error- task was only partially completed.|0|||
131093351|NCT04187326|471971097|FG001|Overall Study|Computer error- task was only partially completed.|1|||
131093352|NCT05235269|471971101|FG000|Overall Study|Adverse Event|1|||
131093353|NCT05235269|471971101|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
131093354|NCT05235269|471971101|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
131093355|NCT00798434|471971102|FG000|Double-Blind|Adverse Event|22|||
131093356|NCT00798434|471971103|FG001|Double-Blind|Adverse Event|46|||
131093357|NCT00798434|471971102|FG000|Double-Blind|Death|0|||
131093358|NCT00798434|471971103|FG001|Double-Blind|Death|1|||
131093359|NCT00798434|471971102|FG000|Double-Blind|Lost to Follow-up|1|||
131093360|NCT00798434|471971103|FG001|Double-Blind|Lost to Follow-up|0|||
131093361|NCT00798434|471971102|FG000|Double-Blind|Lack of Efficacy|8|||
131093362|NCT00798434|471971103|FG001|Double-Blind|Lack of Efficacy|12|||
131093363|NCT00798434|471971102|FG000|Double-Blind|Withdrawal by Subject|17|||
131093364|NCT00798434|471971103|FG001|Double-Blind|Withdrawal by Subject|14|||
131093365|NCT00798434|471971102|FG000|Double-Blind|Protocol Violation|1|||
131093366|NCT00798434|471971103|FG001|Double-Blind|Protocol Violation|4|||
131093367|NCT00798434|471971102|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
131093368|NCT00798434|471971103|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
131093369|NCT00798434|471971102|FG000|Double-Blind|Other|1|||
131093370|NCT00798434|471971103|FG001|Double-Blind|Other|0|||
131093371|NCT00798434|471971102|FG000|Double-Blind|Not Treated|3|||
131093372|NCT00798434|471971103|FG001|Double-Blind|Not Treated|6|||
131093373|NCT00798434|471971102|FG000|Open-Label|Adverse Event|33|||
131093374|NCT00798434|471971103|FG001|Open-Label|Adverse Event|11|||
131093375|NCT00798434|471971102|FG000|Open-Label|Lack of Efficacy|5|||
131093376|NCT00798434|471971103|FG001|Open-Label|Lack of Efficacy|11|||
130727496|NCT02856802|470625473|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
130727497|NCT02856802|470625472|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
130727498|NCT02856802|470625473|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
130727499|NCT02856802|470625472|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
130727500|NCT02856802|470625473|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
131093377|NCT00798434|471971102|FG000|Open-Label|Withdrawal by Subject|2|||
131093378|NCT00798434|471971103|FG001|Open-Label|Withdrawal by Subject|7|||
131093379|NCT00798434|471971102|FG000|Open-Label|Protocol Violation|1|||
131093380|NCT00798434|471971103|FG001|Open-Label|Protocol Violation|0|||
131093381|NCT00798434|471971102|FG000|Open-Label|Other|1|||
131093382|NCT00798434|471971103|FG001|Open-Label|Other|2|||
131093383|NCT00798434|471971102|FG000|Open-Label|Not Treated|0|||
131093384|NCT00798434|471971103|FG001|Open-Label|Not Treated|1|||
131093385|NCT03898167|471971104|FG000|Overall Study|Terminated phone call early|7|||
131093386|NCT03898167|471971105|FG001|Overall Study|Terminated phone call early|0|||
131093387|NCT03898167|471971106|FG002|Overall Study|Terminated phone call early|0|||
131093388|NCT03898167|471971104|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
131093389|NCT03898167|471971105|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
130727501|NCT02856802|470625472|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
131143671|NCT01084551|472152458|FG001|Overall Study|Adverse Event|9|||
131143672|NCT01084551|472152459|FG002|Overall Study|Adverse Event|4|||
131143673|NCT01084551|472152457|FG000|Overall Study|Lack of Efficacy|2|||
131143674|NCT01084551|472152458|FG001|Overall Study|Lack of Efficacy|0|||
131143675|NCT01084551|472152459|FG002|Overall Study|Lack of Efficacy|1|||
131143676|NCT01084551|472152457|FG000|Overall Study|Withdrawal by Subject|2|||
131143677|NCT01084551|472152458|FG001|Overall Study|Withdrawal by Subject|1|||
131143678|NCT01084551|472152459|FG002|Overall Study|Withdrawal by Subject|0|||
131143679|NCT01084551|472152457|FG000|Overall Study|Protocol Violation|2|||
131143680|NCT01084551|472152458|FG001|Overall Study|Protocol Violation|4|||
131143681|NCT01084551|472152459|FG002|Overall Study|Protocol Violation|0|||
131143682|NCT01084551|472152457|FG000|Overall Study|Lost to Follow-up|0|||
131143683|NCT01084551|472152458|FG001|Overall Study|Lost to Follow-up|0|||
131143684|NCT01084551|472152459|FG002|Overall Study|Lost to Follow-up|3|||
131143685|NCT01084551|472152457|FG000|Overall Study|Physician Decision|1|||
131143686|NCT01084551|472152458|FG001|Overall Study|Physician Decision|0|||
131143687|NCT01084551|472152459|FG002|Overall Study|Physician Decision|0|||
131143688|NCT00463476|472152462|FG000|Overall Study|Withdrawal by Subject|1|||
131143689|NCT00463476|472152463|FG001|Overall Study|Withdrawal by Subject|2|||
131143690|NCT00463476|472152462|FG000|Overall Study|Lost to Follow-up|1|||
131143691|NCT00463476|472152463|FG001|Overall Study|Lost to Follow-up|1|||
131143692|NCT00988247|472152464|FG000|Overall Study|Adverse Event|17|||
131143693|NCT00988247|472152465|FG001|Overall Study|Adverse Event|3|||
131143694|NCT00988247|472152464|FG000|Overall Study|Withdrawal by Subject|44|||
131143695|NCT00988247|472152465|FG001|Overall Study|Withdrawal by Subject|13|||
131143696|NCT00988247|472152464|FG000|Overall Study|Pregnancy|1|||
131143697|NCT00988247|472152465|FG001|Overall Study|Pregnancy|2|||
131143698|NCT00988247|472152464|FG000|Overall Study|Lost to Follow-up|11|||
131143699|NCT00988247|472152465|FG001|Overall Study|Lost to Follow-up|2|||
131143700|NCT00988247|472152464|FG000|Overall Study|Protocol Violation|4|||
131143701|NCT00988247|472152465|FG001|Overall Study|Protocol Violation|5|||
131143702|NCT00988247|472152464|FG000|Overall Study|Sponsor requested withdrawal|3|||
131143703|NCT00988247|472152465|FG001|Overall Study|Sponsor requested withdrawal|1|||
131143704|NCT00988247|472152464|FG000|Overall Study|Other|3|||
131143705|NCT00988247|472152465|FG001|Overall Study|Other|0|||
131143706|NCT02661594|472152466|FG000|Overall Study|Protocol Violation|1|||
131143707|NCT02661594|472152467|FG001|Overall Study|Protocol Violation|0|||
131143708|NCT02661594|472152468|FG002|Overall Study|Protocol Violation|1|||
131143709|NCT02661594|472152469|FG003|Overall Study|Protocol Violation|0|||
131143710|NCT00289913|472152470|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143711|NCT00289913|472152471|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
131143712|NCT00289913|472152472|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143713|NCT00289913|472152473|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143714|NCT00289913|472152474|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143715|NCT00289913|472152470|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
131143716|NCT00289913|472152471|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
131143717|NCT00289913|472152472|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
131143718|NCT00289913|472152473|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
131143719|NCT00289913|472152474|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
131143720|NCT00289913|472152470|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
131143721|NCT00289913|472152471|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
131143722|NCT00289913|472152472|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131143723|NCT00289913|472152473|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
131143724|NCT00289913|472152474|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
131143725|NCT00289913|472152470|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
131143726|NCT00289913|472152471|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
131143727|NCT00289913|472152472|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
131143728|NCT00289913|472152473|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
131143729|NCT00289913|472152474|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
131143730|NCT00289913|472152470|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143731|NCT00289913|472152471|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143732|NCT00289913|472152472|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143733|NCT00289913|472152473|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
131143734|NCT00289913|472152474|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143735|NCT00289913|472152470|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
131143736|NCT00289913|472152471|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
131143737|NCT00289913|472152472|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130727502|NCT02856802|470625473|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
131143738|NCT00289913|472152473|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130727503|NCT02856802|470625472|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
131093390|NCT03898167|471971106|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
131093391|NCT05177354|471971107|FG000|Implant to 30-day Visit|Physician Decision|1|||
131093392|NCT05177354|471971107|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
131093393|NCT05177354|471971107|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
131093394|NCT05177354|471971107|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
131093395|NCT03548220|471971109|FG000|Overall Study|Lost to Follow-up|1|||
131093396|NCT03548220|471971110|FG001|Overall Study|Lost to Follow-up|0|||
131093397|NCT03548220|471971111|FG002|Overall Study|Lost to Follow-up|0|||
131093398|NCT03548220|471971112|FG003|Overall Study|Lost to Follow-up|0|||
131093399|NCT02906007|471971113|FG000|Overall Study|Physician Decision|0|||
131093400|NCT02906007|471971114|FG001|Overall Study|Physician Decision|0|||
131093401|NCT02906007|471971115|FG002|Overall Study|Physician Decision|1|||
131093402|NCT02906007|471971113|FG000|Overall Study|Died|1|||
131093403|NCT02906007|471971114|FG001|Overall Study|Died|0|||
131093404|NCT02906007|471971115|FG002|Overall Study|Died|0|||
131093405|NCT03570892|471971116|FG000|Overall Study|Death|51|||
131093406|NCT03570892|471971117|FG001|Overall Study|Death|45|||
131093407|NCT03570892|471971116|FG000|Overall Study|Subject decision|5|||
131093408|NCT03570892|471971117|FG001|Overall Study|Subject decision|3|||
131093409|NCT03570892|471971116|FG000|Overall Study|Protocol Violation|1|||
131093410|NCT03570892|471971117|FG001|Overall Study|Protocol Violation|4|||
131093411|NCT03570892|471971116|FG000|Overall Study|Physician Decision|0|||
131093412|NCT03570892|471971117|FG001|Overall Study|Physician Decision|2|||
131093413|NCT01901432|471972399|FG000|Overall Study|Adverse Event|0|||
131093414|NCT01901432|471972400|FG001|Overall Study|Adverse Event|1|||
131093415|NCT01901432|471972401|FG002|Overall Study|Adverse Event|1|||
131093416|NCT01901432|471972402|FG003|Overall Study|Adverse Event|0|||
131093417|NCT01901432|471972403|FG004|Overall Study|Adverse Event|1|||
131093418|NCT01901432|471972399|FG000|Overall Study|Withdrawal by Subject|0|||
131093419|NCT01901432|471972400|FG001|Overall Study|Withdrawal by Subject|0|||
131093420|NCT01901432|471972401|FG002|Overall Study|Withdrawal by Subject|1|||
131093421|NCT01901432|471972402|FG003|Overall Study|Withdrawal by Subject|0|||
131093422|NCT01901432|471972403|FG004|Overall Study|Withdrawal by Subject|5|||
131093423|NCT01901432|471972399|FG000|Overall Study|Physician Decision|0|||
131093424|NCT01901432|471972400|FG001|Overall Study|Physician Decision|0|||
131093425|NCT01901432|471972401|FG002|Overall Study|Physician Decision|0|||
131093426|NCT01901432|471972402|FG003|Overall Study|Physician Decision|0|||
131093427|NCT01901432|471972403|FG004|Overall Study|Physician Decision|2|||
131093428|NCT01901432|471972399|FG000|Overall Study|Patient decision to stop study drug|0|||
131093429|NCT01901432|471972400|FG001|Overall Study|Patient decision to stop study drug|0|||
131093430|NCT01901432|471972401|FG002|Overall Study|Patient decision to stop study drug|0|||
131093431|NCT01901432|471972402|FG003|Overall Study|Patient decision to stop study drug|0|||
131093432|NCT01901432|471972403|FG004|Overall Study|Patient decision to stop study drug|1|||
131093433|NCT00379288|471972404|FG000|Overall Study|Adverse Event|5|||
131093434|NCT00379288|471972405|FG001|Overall Study|Adverse Event|6|||
131093435|NCT00379288|471972406|FG002|Overall Study|Adverse Event|2|||
131093436|NCT00379288|471972407|FG003|Overall Study|Adverse Event|0|||
131234547|NCT03519256|472486364|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131234548|NCT03519256|472486365|FG002|Overall Study|Participant request to discontinue study treatment|0|||
131093437|NCT00379288|471972404|FG000|Overall Study|Treatment Failure|0|||
131093438|NCT00379288|471972405|FG001|Overall Study|Treatment Failure|1|||
131093439|NCT00379288|471972406|FG002|Overall Study|Treatment Failure|0|||
131093440|NCT00379288|471972407|FG003|Overall Study|Treatment Failure|1|||
131093441|NCT00379288|471972404|FG000|Overall Study|Lost to Follow-up|3|||
131093442|NCT00379288|471972405|FG001|Overall Study|Lost to Follow-up|3|||
131093443|NCT00379288|471972406|FG002|Overall Study|Lost to Follow-up|2|||
131093444|NCT00379288|471972407|FG003|Overall Study|Lost to Follow-up|0|||
131093445|NCT00379288|471972404|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
131093446|NCT00379288|471972405|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
131234549|NCT03519256|472486366|FG003|Overall Study|Participant request to discontinue study treatment|2|||
131234550|NCT03519256|472486363|FG000|Overall Study|Other reasons|0|||
131234551|NCT03519256|472486364|FG001|Overall Study|Other reasons|0|||
131234552|NCT03519256|472486365|FG002|Overall Study|Other reasons|2|||
131093447|NCT00379288|471972406|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
131093448|NCT00379288|471972407|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
131093449|NCT00379288|471972404|FG000|Overall Study|Subject withdrew-related to study drug|1|||
131093450|NCT00379288|471972405|FG001|Overall Study|Subject withdrew-related to study drug|0|||
131234553|NCT03519256|472486366|FG003|Overall Study|Other reasons|0|||
131093451|NCT00379288|471972406|FG002|Overall Study|Subject withdrew-related to study drug|0|||
131093452|NCT00379288|471972407|FG003|Overall Study|Subject withdrew-related to study drug|1|||
131093453|NCT00379288|471972404|FG000|Overall Study|Noncompliance with protocol|8|||
131093454|NCT00379288|471972405|FG001|Overall Study|Noncompliance with protocol|6|||
131093455|NCT00379288|471972406|FG002|Overall Study|Noncompliance with protocol|2|||
131093456|NCT00379288|471972407|FG003|Overall Study|Noncompliance with protocol|1|||
131093457|NCT00379288|471972404|FG000|Overall Study|Did not meet protocol eligibility|0|||
131093458|NCT00379288|471972405|FG001|Overall Study|Did not meet protocol eligibility|1|||
131093459|NCT00379288|471972406|FG002|Overall Study|Did not meet protocol eligibility|0|||
131093460|NCT00379288|471972407|FG003|Overall Study|Did not meet protocol eligibility|2|||
131093461|NCT00379288|471972404|FG000|Overall Study|Administrative|2|||
131093462|NCT00379288|471972405|FG001|Overall Study|Administrative|2|||
131093463|NCT00379288|471972406|FG002|Overall Study|Administrative|0|||
131093464|NCT00379288|471972407|FG003|Overall Study|Administrative|1|||
131093465|NCT00515671|471972418|FG000|Overall Study|Lost to Follow-up|13|||
131093466|NCT00515671|471972419|FG001|Overall Study|Lost to Follow-up|10|||
131093467|NCT00515671|471972418|FG000|Overall Study|Withdrawal by Subject|3|||
131093468|NCT00515671|471972419|FG001|Overall Study|Withdrawal by Subject|5|||
131093469|NCT00515671|471972418|FG000|Overall Study|incarcerated|1|||
131093470|NCT00515671|471972419|FG001|Overall Study|incarcerated|2|||
131093471|NCT00288639|471972422|FG000|Overall Study|Adverse Event|5|||
131093472|NCT00288639|471972422|FG000|Overall Study|Lack of Efficacy|4|||
131093473|NCT00288639|471972422|FG000|Overall Study|Withdrawal by Subject|2|||
131093474|NCT00288639|471972422|FG000|Overall Study|Other|1|||
131093475|NCT01014208|471972431|FG000|Overall Study|Lost to Follow-up|2|||
131093476|NCT01014208|471972432|FG001|Overall Study|Lost to Follow-up|5|||
131093477|NCT01014208|471972431|FG000|Overall Study|Participant Withdrew Consent|12|||
131093478|NCT01014208|471972432|FG001|Overall Study|Participant Withdrew Consent|12|||
131093479|NCT01014208|471972431|FG000|Overall Study|Did Not Receive Study Drug|2|||
131093480|NCT01014208|471972432|FG001|Overall Study|Did Not Receive Study Drug|0|||
131093481|NCT01014208|471972431|FG000|Overall Study|Study Closed/terminated|78|||
131093482|NCT01014208|471972432|FG001|Overall Study|Study Closed/terminated|83|||
131093483|NCT00527787|471972440|FG000|Overall Study|Adverse Event|14|||
131093484|NCT00527787|471972441|FG001|Overall Study|Adverse Event|24|||
131093485|NCT00527787|471972440|FG000|Overall Study|Withdrawal by Subject|13|||
131093486|NCT00527787|471972441|FG001|Overall Study|Withdrawal by Subject|25|||
131093487|NCT00527787|471972440|FG000|Overall Study|Lost to Follow-up|5|||
131093488|NCT00527787|471972441|FG001|Overall Study|Lost to Follow-up|2|||
131093489|NCT00527787|471972440|FG000|Overall Study|Duodenal Ulcer|1|||
131093490|NCT00527787|471972441|FG001|Overall Study|Duodenal Ulcer|10|||
131093491|NCT00527787|471972440|FG000|Overall Study|misc|5|||
131093492|NCT00527787|471972441|FG001|Overall Study|misc|2|||
131093493|NCT04939701|471972442|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
131093494|NCT04939701|471972443|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
131093495|NCT04939701|471972444|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
131093496|NCT04939701|471972442|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
131093497|NCT04939701|471972443|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
131093498|NCT04939701|471972444|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
131093499|NCT04939701|471972442|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
131093500|NCT04939701|471972443|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
131093501|NCT04939701|471972444|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
131093502|NCT04939701|471972442|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
131093503|NCT04939701|471972443|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
131093504|NCT04939701|471972444|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
131093505|NCT04939701|471972442|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
131093506|NCT04939701|471972443|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
131093507|NCT04939701|471972444|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
131093508|NCT04939701|471972442|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
131093509|NCT04939701|471972443|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
131093510|NCT04939701|471972444|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
131093511|NCT04939701|471972442|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
131093512|NCT04939701|471972443|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
131093513|NCT04939701|471972444|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
131093514|NCT02672852|471972446|FG000|Part A1|Disease Worsening|1|||
131093515|NCT02672852|471972447|FG001|Part A1|Disease Worsening|0|||
131093516|NCT02672852|471972448|FG002|Part A1|Disease Worsening|0|||
131093517|NCT02672852|471972449|FG003|Part A1|Disease Worsening|0|||
131093518|NCT02672852|471972450|FG004|Part A1|Disease Worsening|0|||
131093519|NCT02672852|471972451|FG005|Part A1|Disease Worsening|0|||
131143739|NCT00289913|472152474|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
131093520|NCT02672852|471972452|FG006|Part A1|Disease Worsening|0|||
131143740|NCT00289913|472152470|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
131093521|NCT02672852|471972446|FG000|Part A1|Adverse Event|0|||
131093522|NCT02672852|471972447|FG001|Part A1|Adverse Event|1|||
131143741|NCT00289913|472152471|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
131093523|NCT02672852|471972448|FG002|Part A1|Adverse Event|0|||
131093524|NCT02672852|471972449|FG003|Part A1|Adverse Event|0|||
131093525|NCT02672852|471972450|FG004|Part A1|Adverse Event|0|||
131093526|NCT02672852|471972451|FG005|Part A1|Adverse Event|0|||
131093527|NCT02672852|471972452|FG006|Part A1|Adverse Event|0|||
131093528|NCT02672852|471972446|FG000|Part A1|Lost to Follow-up|1|||
131093529|NCT02672852|471972447|FG001|Part A1|Lost to Follow-up|2|||
131093530|NCT02672852|471972448|FG002|Part A1|Lost to Follow-up|0|||
131093531|NCT02672852|471972449|FG003|Part A1|Lost to Follow-up|0|||
131093532|NCT02672852|471972450|FG004|Part A1|Lost to Follow-up|0|||
131093533|NCT02672852|471972451|FG005|Part A1|Lost to Follow-up|0|||
131093534|NCT02672852|471972452|FG006|Part A1|Lost to Follow-up|0|||
131093535|NCT02672852|471972446|FG000|Part A1|Withdrawal by Subject|1|||
131093536|NCT02672852|471972447|FG001|Part A1|Withdrawal by Subject|1|||
131093537|NCT02672852|471972448|FG002|Part A1|Withdrawal by Subject|0|||
131093538|NCT02672852|471972449|FG003|Part A1|Withdrawal by Subject|0|||
131093539|NCT02672852|471972450|FG004|Part A1|Withdrawal by Subject|0|||
131093540|NCT02672852|471972451|FG005|Part A1|Withdrawal by Subject|0|||
131093541|NCT02672852|471972452|FG006|Part A1|Withdrawal by Subject|0|||
131093542|NCT02672852|471972446|FG000|Part A2|Disease worsening|0|||
131093543|NCT02672852|471972447|FG001|Part A2|Disease worsening|0|||
131093544|NCT02672852|471972448|FG002|Part A2|Disease worsening|1|||
131093545|NCT02672852|471972449|FG003|Part A2|Disease worsening|0|||
131093546|NCT02672852|471972450|FG004|Part A2|Disease worsening|0|||
131093547|NCT02672852|471972451|FG005|Part A2|Disease worsening|0|||
131093548|NCT02672852|471972452|FG006|Part A2|Disease worsening|0|||
131093549|NCT02672852|471972446|FG000|Part A2|Adverse Event|0|||
131093550|NCT02672852|471972447|FG001|Part A2|Adverse Event|0|||
131093551|NCT02672852|471972448|FG002|Part A2|Adverse Event|3|||
131093552|NCT02672852|471972449|FG003|Part A2|Adverse Event|0|||
131093553|NCT02672852|471972450|FG004|Part A2|Adverse Event|0|||
131093554|NCT02672852|471972451|FG005|Part A2|Adverse Event|0|||
131093555|NCT02672852|471972452|FG006|Part A2|Adverse Event|0|||
131093556|NCT02672852|471972446|FG000|Part A2|Lost to Follow-up|0|||
131093557|NCT02672852|471972447|FG001|Part A2|Lost to Follow-up|0|||
131093558|NCT02672852|471972448|FG002|Part A2|Lost to Follow-up|2|||
131093559|NCT02672852|471972449|FG003|Part A2|Lost to Follow-up|0|||
131093560|NCT02672852|471972450|FG004|Part A2|Lost to Follow-up|0|||
131093561|NCT02672852|471972451|FG005|Part A2|Lost to Follow-up|0|||
131093562|NCT02672852|471972452|FG006|Part A2|Lost to Follow-up|0|||
131093563|NCT02672852|471972446|FG000|Part A2|Withdrawal by Subject|0|||
131093564|NCT02672852|471972447|FG001|Part A2|Withdrawal by Subject|0|||
131093565|NCT02672852|471972448|FG002|Part A2|Withdrawal by Subject|1|||
131093566|NCT02672852|471972449|FG003|Part A2|Withdrawal by Subject|0|||
131093567|NCT02672852|471972450|FG004|Part A2|Withdrawal by Subject|0|||
131093568|NCT02672852|471972451|FG005|Part A2|Withdrawal by Subject|0|||
131093569|NCT02672852|471972452|FG006|Part A2|Withdrawal by Subject|0|||
131093570|NCT02672852|471972446|FG000|Part A2|Other|0|||
131093571|NCT02672852|471972447|FG001|Part A2|Other|0|||
131093572|NCT02672852|471972448|FG002|Part A2|Other|3|||
131093573|NCT02672852|471972449|FG003|Part A2|Other|0|||
131093574|NCT02672852|471972450|FG004|Part A2|Other|0|||
131093575|NCT02672852|471972451|FG005|Part A2|Other|0|||
131093576|NCT02672852|471972452|FG006|Part A2|Other|0|||
131093577|NCT02672852|471972446|FG000|Part A2|Not entered in Part B|0|||
131093578|NCT02672852|471972447|FG001|Part A2|Not entered in Part B|0|||
131093579|NCT02672852|471972448|FG002|Part A2|Not entered in Part B|0|||
131093580|NCT02672852|471972449|FG003|Part A2|Not entered in Part B|4|||
131093581|NCT02672852|471972450|FG004|Part A2|Not entered in Part B|0|||
131093582|NCT02672852|471972451|FG005|Part A2|Not entered in Part B|0|||
131093583|NCT02672852|471972452|FG006|Part A2|Not entered in Part B|0|||
131093584|NCT02672852|471972446|FG000|Part B|Disease worsening|0|||
131093585|NCT02672852|471972447|FG001|Part B|Disease worsening|0|||
131093586|NCT02672852|471972448|FG002|Part B|Disease worsening|0|||
131093587|NCT02672852|471972449|FG003|Part B|Disease worsening|0|||
131093588|NCT02672852|471972450|FG004|Part B|Disease worsening|1|||
131093589|NCT02672852|471972451|FG005|Part B|Disease worsening|0|||
131093590|NCT02672852|471972452|FG006|Part B|Disease worsening|1|||
131093591|NCT02672852|471972446|FG000|Part B|Worsening pre-existing condition|0|||
131093592|NCT02672852|471972447|FG001|Part B|Worsening pre-existing condition|0|||
131093593|NCT02672852|471972448|FG002|Part B|Worsening pre-existing condition|0|||
131093594|NCT02672852|471972449|FG003|Part B|Worsening pre-existing condition|0|||
131093595|NCT02672852|471972450|FG004|Part B|Worsening pre-existing condition|0|||
131093596|NCT02672852|471972451|FG005|Part B|Worsening pre-existing condition|1|||
131093597|NCT02672852|471972452|FG006|Part B|Worsening pre-existing condition|0|||
131093598|NCT02672852|471972446|FG000|Part B|Other adverse event|0|||
131093599|NCT02672852|471972447|FG001|Part B|Other adverse event|0|||
131093600|NCT02672852|471972448|FG002|Part B|Other adverse event|0|||
131093601|NCT02672852|471972449|FG003|Part B|Other adverse event|0|||
131093602|NCT02672852|471972450|FG004|Part B|Other adverse event|3|||
131093603|NCT02672852|471972451|FG005|Part B|Other adverse event|5|||
131093604|NCT02672852|471972452|FG006|Part B|Other adverse event|1|||
131093605|NCT02672852|471972446|FG000|Part B|Lost to Follow-up|0|||
131093606|NCT02672852|471972447|FG001|Part B|Lost to Follow-up|0|||
131093607|NCT02672852|471972448|FG002|Part B|Lost to Follow-up|0|||
131093608|NCT02672852|471972449|FG003|Part B|Lost to Follow-up|0|||
131093609|NCT02672852|471972450|FG004|Part B|Lost to Follow-up|3|||
131093610|NCT02672852|471972451|FG005|Part B|Lost to Follow-up|4|||
131093611|NCT02672852|471972452|FG006|Part B|Lost to Follow-up|1|||
131093612|NCT02672852|471972446|FG000|Part B|Withdrawal by Subject|0|||
131093613|NCT02672852|471972447|FG001|Part B|Withdrawal by Subject|0|||
131093614|NCT02672852|471972448|FG002|Part B|Withdrawal by Subject|0|||
131093615|NCT02672852|471972449|FG003|Part B|Withdrawal by Subject|0|||
131093616|NCT02672852|471972450|FG004|Part B|Withdrawal by Subject|5|||
131093617|NCT02672852|471972451|FG005|Part B|Withdrawal by Subject|0|||
131093618|NCT02672852|471972452|FG006|Part B|Withdrawal by Subject|7|||
131093619|NCT02672852|471972446|FG000|Part B|Other|0|||
131093620|NCT02672852|471972447|FG001|Part B|Other|0|||
131093621|NCT02672852|471972448|FG002|Part B|Other|0|||
131093622|NCT02672852|471972449|FG003|Part B|Other|0|||
131093623|NCT02672852|471972450|FG004|Part B|Other|4|||
131093624|NCT02672852|471972451|FG005|Part B|Other|1|||
131093625|NCT02672852|471972452|FG006|Part B|Other|2|||
131093626|NCT03853551|471972453|FG000|Overall Study|Death|2|||
131093627|NCT03853551|471972453|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
131093628|NCT00702962|471972454|FG000|Overall Study|Progressive disease|0|||
131093629|NCT00702962|471972455|FG001|Overall Study|Progressive disease|1|||
131093630|NCT00702962|471972454|FG000|Overall Study|Hospitalized for other health disorder|1|||
131093631|NCT00702962|471972455|FG001|Overall Study|Hospitalized for other health disorder|0|||
131093632|NCT02175641|471972456|FG000|Overall Study|Death|3|||
131093633|NCT02175641|471972457|FG001|Overall Study|Death|4|||
131093634|NCT02175641|471972456|FG000|Overall Study|Lost to Follow-up|4|||
131093635|NCT02175641|471972457|FG001|Overall Study|Lost to Follow-up|4|||
131143742|NCT00289913|472152472|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
131143743|NCT00289913|472152473|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
131143744|NCT00289913|472152474|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
131143745|NCT00289913|472152470|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
131143746|NCT00289913|472152471|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
131143747|NCT00289913|472152472|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
131143748|NCT00289913|472152473|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
131143749|NCT00289913|472152474|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
131143750|NCT00289913|472152470|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
131143751|NCT00289913|472152471|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131143752|NCT00289913|472152472|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
131143753|NCT00289913|472152473|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131143754|NCT00289913|472152474|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131143755|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143756|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143757|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
131143758|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143759|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143760|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
131143761|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
131143762|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
131143763|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
131143764|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
131143765|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
131143766|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
131143767|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
131143768|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
131143769|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
131143770|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
131143771|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
131143772|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
131143773|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131143774|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131143775|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
131143776|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143777|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
131143778|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143779|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143780|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
131143781|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
131234554|NCT03519256|472486363|FG000|Overall Study|Disease progression|6|||
131093636|NCT02175641|471972456|FG000|Overall Study|Withdrawal by Subject|7|||
131093637|NCT02175641|471972457|FG001|Overall Study|Withdrawal by Subject|4|||
131093638|NCT02175641|471972456|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
131093639|NCT02175641|471972457|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
131093640|NCT02175641|471972456|FG000|Overall Study|Developed Contraindicated Condition|8|||
131093641|NCT02175641|471972457|FG001|Overall Study|Developed Contraindicated Condition|0|||
131093642|NCT01923467|471972459|FG000|Overall Study|Lost to Follow-up|62|||
131093643|NCT01923467|471972459|FG000|Overall Study|Subject non-interest|479|||
131093644|NCT01876901|471972460|FG000|Overall Study|Protocol Violation|10|||
131093645|NCT01876901|471972461|FG001|Overall Study|Protocol Violation|2|||
131093646|NCT01876901|471972460|FG000|Overall Study|No or other surgical intervention|7|||
131093647|NCT01876901|471972461|FG001|Overall Study|No or other surgical intervention|5|||
131093648|NCT02242097|471972462|FG000|Ibrutinib Treatment|Adverse Event|16|||
131093649|NCT02242097|471972462|FG000|Ibrutinib Treatment|Physician Decision|1|||
131093650|NCT02242097|471972462|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
131093651|NCT02242097|471972462|FG000|Ibrutinib Treatment|Death|1|||
131093652|NCT02242097|471972462|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
131093653|NCT02242097|471972462|FG000|Post Therapy Follow Up|Death|3|||
131093654|NCT02242097|471972462|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
131093655|NCT01598662|471972464|FG000|Overall Study|Lost to Follow-up|10|||
131093656|NCT01598662|471972465|FG001|Overall Study|Lost to Follow-up|17|||
131093657|NCT01598662|471972464|FG000|Overall Study|Physician Decision|1|||
131093658|NCT01598662|471972465|FG001|Overall Study|Physician Decision|2|||
131093659|NCT01598662|471972464|FG000|Overall Study|IUD expelled before month 6|0|||
131093660|NCT01598662|471972465|FG001|Overall Study|IUD expelled before month 6|2|||
131093661|NCT02574845|471972466|FG000|Overall Study|Consent withdrawn further participation|0|||
131093662|NCT02574845|471972467|FG001|Overall Study|Consent withdrawn further participation|0|||
131093663|NCT02574845|471972468|FG002|Overall Study|Consent withdrawn further participation|0|||
131093664|NCT02574845|471972469|FG003|Overall Study|Consent withdrawn further participation|0|||
131093665|NCT02574845|471972470|FG004|Overall Study|Consent withdrawn further participation|1|||
131093666|NCT02574845|471972471|FG005|Overall Study|Consent withdrawn further participation|0|||
131093667|NCT02574845|471972466|FG000|Overall Study|Adverse Event|0|||
131093668|NCT02574845|471972467|FG001|Overall Study|Adverse Event|1|||
131093669|NCT02574845|471972468|FG002|Overall Study|Adverse Event|0|||
131093670|NCT02574845|471972469|FG003|Overall Study|Adverse Event|0|||
131093671|NCT02574845|471972470|FG004|Overall Study|Adverse Event|0|||
131093672|NCT02574845|471972471|FG005|Overall Study|Adverse Event|1|||
131093673|NCT03435692|471972473|FG000|Overall Study|Lack of Efficacy|2|||
131093674|NCT03435692|471972474|FG001|Overall Study|Lack of Efficacy|2|||
131093675|NCT03435692|471972475|FG002|Overall Study|Lack of Efficacy|0|||
131093676|NCT02781090|471972476|FG000|3-Month Follow-Up|Missed Visit|20|||
131093677|NCT02781090|471972477|FG001|3-Month Follow-Up|Missed Visit|20|||
131093678|NCT02781090|471972476|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
131093679|NCT02781090|471972477|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
131093680|NCT02781090|471972476|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
131093681|NCT02781090|471972477|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
131093682|NCT02781090|471972476|FG000|3-Month Follow-Up|Death|1|||
131093683|NCT02781090|471972477|FG001|3-Month Follow-Up|Death|0|||
131093684|NCT02781090|471972476|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
131093685|NCT02781090|471972477|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
131093686|NCT02781090|471972476|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
131093687|NCT02781090|471972477|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
131093688|NCT02781090|471972476|FG000|6-Month Follow-Up|Death|0|||
131093689|NCT02781090|471972477|FG001|6-Month Follow-Up|Death|1|||
131093690|NCT01145898|471972478|FG000|3-year Treatment|medication change by treating physician|3|||
131093691|NCT01145898|471972479|FG001|3-year Treatment|medication change by treating physician|16|||
131093692|NCT01712061|471972480|FG000|Overall Study|Adverse Event|4|||
131093693|NCT01712061|471972481|FG001|Overall Study|Adverse Event|9|||
131093694|NCT01712061|471972482|FG002|Overall Study|Adverse Event|5|||
131093695|NCT01712061|471972480|FG000|Overall Study|Death|0|||
131093696|NCT01712061|471972481|FG001|Overall Study|Death|0|||
131093697|NCT01712061|471972482|FG002|Overall Study|Death|1|||
131093698|NCT01712061|471972480|FG000|Overall Study|Lost to Follow-up|1|||
131093699|NCT01712061|471972481|FG001|Overall Study|Lost to Follow-up|0|||
131093700|NCT01712061|471972482|FG002|Overall Study|Lost to Follow-up|1|||
131093701|NCT01712061|471972480|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
131093702|NCT01712061|471972481|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
131093703|NCT01712061|471972482|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
131093704|NCT01712061|471972480|FG000|Overall Study|Medication Error Without Associated AE|0|||
131093705|NCT01712061|471972481|FG001|Overall Study|Medication Error Without Associated AE|1|||
131093706|NCT01712061|471972482|FG002|Overall Study|Medication Error Without Associated AE|0|||
131093707|NCT01712061|471972480|FG000|Overall Study|Withdrawal by Subject|1|||
131093708|NCT01712061|471972481|FG001|Overall Study|Withdrawal by Subject|7|||
131093709|NCT01712061|471972482|FG002|Overall Study|Withdrawal by Subject|1|||
131093710|NCT01712061|471972480|FG000|Overall Study|Other|0|||
131093711|NCT01712061|471972481|FG001|Overall Study|Other|3|||
131143782|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
131143783|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
131143784|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
131143785|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
131143786|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
131093712|NCT01712061|471972482|FG002|Overall Study|Other|0|||
131093713|NCT00879775|471972483|FG000|Overall Study|Lost to Follow-up|2|||
131093714|NCT00879775|471972484|FG001|Overall Study|Lost to Follow-up|1|||
131093715|NCT02683785|471972487|FG000|Overall Study|Withdrawal by Subject|1|||
131093716|NCT02683785|471972488|FG001|Overall Study|Withdrawal by Subject|1|||
131093717|NCT02683785|471972487|FG000|Overall Study|Lost to Follow-up|0|||
131093718|NCT02683785|471972488|FG001|Overall Study|Lost to Follow-up|1|||
131093719|NCT02683785|471972487|FG000|Overall Study|Adverse Event|0|||
131093720|NCT02683785|471972488|FG001|Overall Study|Adverse Event|2|||
131093721|NCT01195623|471972489|FG000|Overall Study|Lost to Follow-up|35|||
131093722|NCT01195623|471972490|FG001|Overall Study|Lost to Follow-up|37|||
131093723|NCT01677767|471972496|FG000|Overall Study|Adverse Event|1|||
131093724|NCT01677767|471972496|FG000|Overall Study|Death|4|||
131093725|NCT01677767|471972496|FG000|Overall Study|Protocol Violation|4|||
131093726|NCT01677767|471972496|FG000|Overall Study|Withdrawal by Subject|10|||
131093727|NCT01677767|471972496|FG000|Overall Study|Non-compliance by the participants|3|||
131093728|NCT00842244|471972497|FG000|Overall Study|Death|3|||
131093729|NCT00842244|471972497|FG000|Overall Study|Withdrawal by Subject|1|||
131093730|NCT00842244|471972497|FG000|Overall Study|Other|17|||
131093731|NCT02233803|471972502|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
131093732|NCT02233803|471972503|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
131093733|NCT02233803|471972502|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
131093734|NCT02233803|471972503|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
131093735|NCT02233803|471972502|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
131093736|NCT02233803|471972503|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
131093737|NCT02233803|471972502|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
131093738|NCT02233803|471972503|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
131093739|NCT02233803|471972502|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
131093740|NCT02233803|471972503|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
131093741|NCT02233803|471972502|FG000|Washout Period (4-Wks)|Physician Decision|1|||
131093742|NCT02233803|471972503|FG001|Washout Period (4-Wks)|Physician Decision|0|||
131093743|NCT02233803|471972502|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
131093744|NCT02233803|471972503|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
131093745|NCT02233803|471972502|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
131093746|NCT02233803|471972503|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
131093747|NCT02233803|471972502|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
131093748|NCT02233803|471972503|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
131093749|NCT00757627|471972504|FG000|Overall Study|Adverse Event|15|||
131143787|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
131143788|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
131143789|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
131143790|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
131143791|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
131143792|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
131143793|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
131143794|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
131143795|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
131143796|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
131143797|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
131143798|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
131143799|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
131143800|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
131143801|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
131143802|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
131143803|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
131143804|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
131143805|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
131143806|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
131143807|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
131143808|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
131143809|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
131093750|NCT00757627|471972504|FG000|Overall Study|Lack of Efficacy|10|||
131093751|NCT00757627|471972504|FG000|Overall Study|Lost to Follow-up|28|||
131143810|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
131093752|NCT00757627|471972504|FG000|Overall Study|Withdrawal by Subject|27|||
131093753|NCT00757627|471972504|FG000|Overall Study|Other|1|||
131093754|NCT03846453|471972505|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
131093755|NCT03846453|471972506|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
131093756|NCT03846453|471972507|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
131093757|NCT03846453|471972505|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
131093758|NCT03846453|471972506|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
131093759|NCT03846453|471972507|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
131143811|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
131143812|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
131093760|NCT03846453|471972505|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
131093761|NCT03846453|471972506|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
131093762|NCT03846453|471972507|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
131093763|NCT03846453|471972505|FG000|Placebo Run-in (14 Days)|Other|2|||
131093764|NCT03846453|471972506|FG001|Placebo Run-in (14 Days)|Other|0|||
131093765|NCT03846453|471972507|FG002|Placebo Run-in (14 Days)|Other|0|||
131093766|NCT03846453|471972505|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
131093767|NCT03846453|471972506|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
131093768|NCT03846453|471972507|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
131093769|NCT03846453|471972505|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
131093770|NCT03846453|471972506|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
131093771|NCT03846453|471972507|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
131093772|NCT03846453|471972505|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
131093773|NCT03846453|471972506|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
131093774|NCT03846453|471972507|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
131093775|NCT03846453|471972505|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
131093776|NCT03846453|471972506|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
131093777|NCT03846453|471972507|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
131093778|NCT03846453|471972505|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
131093779|NCT03846453|471972506|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
131093780|NCT03846453|471972507|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
131093781|NCT00635661|471972508|FG000|Overall Study|Withdrawal by Subject|4|||
131093782|NCT00468143|471972511|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
131093783|NCT00468143|471972512|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
131093784|NCT00468143|471972511|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
131093785|NCT00468143|471972512|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
131093786|NCT01606670|471972513|FG000|Overall Study|Adverse Event|6|||
131093787|NCT01606670|471972513|FG000|Overall Study|Lack of Efficacy|2|||
131093788|NCT01606670|471972513|FG000|Overall Study|Lost to Follow-up|3|||
131093789|NCT01606670|471972513|FG000|Overall Study|Withdrawal by Subject|3|||
131093790|NCT01606670|471972513|FG000|Overall Study|Other Reason|2|||
131093791|NCT01559129|471972517|FG000|Treatment Phase|Adverse Event|0|||
131093792|NCT01559129|471972518|FG001|Treatment Phase|Adverse Event|2|||
131093793|NCT01559129|471972517|FG000|Treatment Phase|Progressive Disease|1|||
131093794|NCT01559129|471972518|FG001|Treatment Phase|Progressive Disease|1|||
131093795|NCT01559129|471972517|FG000|Treatment Phase|Lack of Efficacy|0|||
131093796|NCT01559129|471972518|FG001|Treatment Phase|Lack of Efficacy|1|||
131093797|NCT01559129|471972517|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
131093798|NCT01559129|471972518|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
131093799|NCT01559129|471972517|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
131093800|NCT01559129|471972518|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
131093801|NCT01559129|471972517|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
131093802|NCT01559129|471972518|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
131093803|NCT01559129|471972517|FG000|Open-label Extension Period|Adverse Event|1|||
131093804|NCT01559129|471972518|FG001|Open-label Extension Period|Adverse Event|0|||
131093805|NCT01559129|471972517|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
131093806|NCT01559129|471972518|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
131093807|NCT00368927|471972519|FG000|Overall Study|Lost to Follow-up|2|||
131093808|NCT00368927|471972520|FG001|Overall Study|Lost to Follow-up|0|||
131093809|NCT00368927|471972519|FG000|Overall Study|Adverse Event|1|||
131093810|NCT00368927|471972520|FG001|Overall Study|Adverse Event|1|||
131143813|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
131143814|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
131143815|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
131143816|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
131143817|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
131143818|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
131143819|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
131143820|NCT00289913|472152470|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
131093811|NCT00368927|471972519|FG000|Overall Study|Withdrawal by Subject|1|||
131093812|NCT00368927|471972520|FG001|Overall Study|Withdrawal by Subject|2|||
131093813|NCT00368927|471972519|FG000|Overall Study|Physician Decision|1|||
131093814|NCT00368927|471972520|FG001|Overall Study|Physician Decision|0|||
131093815|NCT03525392|471972521|FG000|Overall Study|Adverse Event|1|||
131093816|NCT03525392|471972522|FG001|Overall Study|Adverse Event|0|||
131093817|NCT03525392|471972523|FG002|Overall Study|Adverse Event|2|||
131093818|NCT03525392|471972524|FG003|Overall Study|Adverse Event|0|||
131093819|NCT03525392|471972525|FG004|Overall Study|Adverse Event|0|||
131093820|NCT03525392|471972521|FG000|Overall Study|Progressive disease|0|||
131093821|NCT03525392|471972522|FG001|Overall Study|Progressive disease|1|||
131093822|NCT03525392|471972523|FG002|Overall Study|Progressive disease|1|||
131093823|NCT03525392|471972524|FG003|Overall Study|Progressive disease|3|||
131093824|NCT03525392|471972525|FG004|Overall Study|Progressive disease|1|||
131093825|NCT01946529|471972532|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
131093826|NCT01946529|471972533|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
131093827|NCT01946529|471972534|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
131093828|NCT01946529|471972532|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
131093829|NCT01946529|471972533|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
131093830|NCT01946529|471972534|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
131093831|NCT06655558|471972535|FG000|Overall Study|Protocol Violation|1|||
131093832|NCT03578887|471972536|FG000|Overall Study|Withdrawal by Subject|7|||
131093833|NCT03578887|471972537|FG001|Overall Study|Withdrawal by Subject|2|||
131093834|NCT03578887|471972538|FG002|Overall Study|Withdrawal by Subject|1|||
131093835|NCT03578887|471972536|FG000|Overall Study|Lost to Follow-up|13|||
131093836|NCT03578887|471972537|FG001|Overall Study|Lost to Follow-up|1|||
131093837|NCT03578887|471972538|FG002|Overall Study|Lost to Follow-up|4|||
131093838|NCT03578887|471972536|FG000|Overall Study|Physician Decision|0|||
131093839|NCT03578887|471972537|FG001|Overall Study|Physician Decision|1|||
131093840|NCT03578887|471972538|FG002|Overall Study|Physician Decision|1|||
131093841|NCT00387426|471974092|FG000|Overall Study|Lack of Response|7|||
131093842|NCT00387426|471974092|FG000|Overall Study|Toxicities|4|||
131093843|NCT00387426|471974092|FG000|Overall Study|Disease Progression|3|||
131093844|NCT00747227|471974099|FG000|Overall Study|Death|3|||
131093845|NCT00747227|471974100|FG001|Overall Study|Death|1|||
131093846|NCT00747227|471974099|FG000|Overall Study|Withdrawal by Subject|1|||
131093847|NCT00747227|471974100|FG001|Overall Study|Withdrawal by Subject|0|||
131093848|NCT00747227|471974099|FG000|Overall Study|Lost to Follow-up|1|||
131093849|NCT00747227|471974100|FG001|Overall Study|Lost to Follow-up|2|||
131093850|NCT00747227|471974099|FG000|Overall Study|Illness|1|||
131093851|NCT00747227|471974100|FG001|Overall Study|Illness|1|||
131093852|NCT03554629|471974101|FG000|Overall Study|Inadequate data|6|||
131093853|NCT00918879|471974102|FG000|Overall Study|Withdrawal by Subject|4|||
131093854|NCT00918879|471974103|FG001|Overall Study|Withdrawal by Subject|4|||
131093855|NCT00918879|471974102|FG000|Overall Study|Lost to Follow-up|1|||
131093856|NCT00918879|471974103|FG001|Overall Study|Lost to Follow-up|1|||
131093857|NCT00918879|471974102|FG000|Overall Study|Severe non-compliance to protocol|1|||
131093858|NCT00918879|471974103|FG001|Overall Study|Severe non-compliance to protocol|1|||
131093859|NCT00357110|471974104|FG000|Overall Study|Early study termination|5|||
131093860|NCT00357110|471974105|FG001|Overall Study|Early study termination|5|||
131093861|NCT01008553|471974106|FG000|Period 1 (Titration Period)|Physician Decision|2|||
131093862|NCT01008553|471974107|FG001|Period 1 (Titration Period)|Physician Decision|0|||
131093863|NCT01008553|471974108|FG002|Period 1 (Titration Period)|Physician Decision|0|||
131093864|NCT01008553|471974106|FG000|Period 1 (Titration Period)|Adverse Event|33|||
131093865|NCT01008553|471974107|FG001|Period 1 (Titration Period)|Adverse Event|0|||
131093866|NCT01008553|471974108|FG002|Period 1 (Titration Period)|Adverse Event|0|||
131093867|NCT01008553|471974106|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
131093868|NCT01008553|471974107|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
131093869|NCT01008553|471974108|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
131093870|NCT01008553|471974106|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
131093871|NCT01008553|471974107|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
131093872|NCT01008553|471974108|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
131093873|NCT01008553|471974106|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
131093874|NCT01008553|471974107|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
131093875|NCT01008553|471974108|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
131093876|NCT01008553|471974106|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
131093877|NCT01008553|471974107|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
131093878|NCT01008553|471974108|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
131093879|NCT01008553|471974106|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
131234555|NCT03519256|472486364|FG001|Overall Study|Disease progression|3|||
131234556|NCT03519256|472486365|FG002|Overall Study|Disease progression|2|||
131234557|NCT03519256|472486366|FG003|Overall Study|Disease progression|1|||
131234558|NCT03519256|472486363|FG000|Overall Study|Lost to Follow-up|0|||
131234559|NCT03519256|472486364|FG001|Overall Study|Lost to Follow-up|1|||
131093880|NCT01008553|471974107|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
131093881|NCT01008553|471974108|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
131093882|NCT01008553|471974106|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
131093883|NCT01008553|471974107|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
131093884|NCT01008553|471974108|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
131093885|NCT01008553|471974106|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
131234560|NCT03519256|472486365|FG002|Overall Study|Lost to Follow-up|0|||
131234561|NCT03519256|472486366|FG003|Overall Study|Lost to Follow-up|0|||
130727504|NCT02856802|470625473|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
131093886|NCT01008553|471974107|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
131093887|NCT01008553|471974108|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
131093888|NCT01008553|471974106|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
131093889|NCT01008553|471974107|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
131093890|NCT01008553|471974108|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
131093891|NCT01008553|471974106|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
131093892|NCT01008553|471974107|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
131093893|NCT01008553|471974108|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
131093894|NCT01008553|471974106|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
131093895|NCT01008553|471974107|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
131093896|NCT01008553|471974108|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
131093897|NCT01008553|471974106|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
131093898|NCT01008553|471974107|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
131093899|NCT01008553|471974108|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
131093900|NCT01008553|471974106|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
131093901|NCT01008553|471974107|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
131093902|NCT01008553|471974108|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
131093903|NCT01008410|471974110|FG000|Overall Study|Adverse Event|13|||
131093904|NCT01008410|471974111|FG001|Overall Study|Adverse Event|7|||
131093905|NCT01008410|471974110|FG000|Overall Study|Withdrawal by Subject|6|||
131093906|NCT01008410|471974111|FG001|Overall Study|Withdrawal by Subject|2|||
131093907|NCT01008410|471974110|FG000|Overall Study|Lost to Follow-up|1|||
131093908|NCT01008410|471974111|FG001|Overall Study|Lost to Follow-up|0|||
131093909|NCT01008410|471974110|FG000|Overall Study|Noncompliance|1|||
131093910|NCT01008410|471974111|FG001|Overall Study|Noncompliance|0|||
131093911|NCT01008410|471974110|FG000|Overall Study|Low Cortisol|2|||
131093912|NCT01008410|471974111|FG001|Overall Study|Low Cortisol|0|||
131093913|NCT01008410|471974110|FG000|Overall Study|Lack of Efficacy|2|||
131093914|NCT01008410|471974111|FG001|Overall Study|Lack of Efficacy|6|||
131093915|NCT01008410|471974110|FG000|Overall Study|Met Exclusion Criterion|0|||
131093916|NCT01008410|471974111|FG001|Overall Study|Met Exclusion Criterion|1|||
131093917|NCT03056300|471974114|FG000|Overall Study|Surgical reason per study protocol|3|||
131093918|NCT03563157|471974115|FG000|Overall Study|Progressive Disease|2|||
131093919|NCT05602727|471974118|FG000|Overall Study|Physician Decision|0|||
131093920|NCT05602727|471974119|FG001|Overall Study|Physician Decision|1|||
131093921|NCT05602727|471974120|FG002|Overall Study|Physician Decision|0|||
131093922|NCT05602727|471974118|FG000|Overall Study|Randomized by mistake without study medication|1|||
131093923|NCT05602727|471974119|FG001|Overall Study|Randomized by mistake without study medication|0|||
131093924|NCT05602727|471974120|FG002|Overall Study|Randomized by mistake without study medication|0|||
131093925|NCT05602727|471974118|FG000|Overall Study|Study termination by Sponsor|18|||
131093926|NCT05602727|471974119|FG001|Overall Study|Study termination by Sponsor|15|||
131093927|NCT05602727|471974120|FG002|Overall Study|Study termination by Sponsor|19|||
131093928|NCT05602727|471974118|FG000|Overall Study|Withdrawal by Subject|2|||
131093929|NCT05602727|471974119|FG001|Overall Study|Withdrawal by Subject|1|||
131093930|NCT05602727|471974120|FG002|Overall Study|Withdrawal by Subject|1|||
131093931|NCT05602727|471974118|FG000|Overall Study|Various reasons|1|||
131093932|NCT05602727|471974119|FG001|Overall Study|Various reasons|6|||
131093933|NCT05602727|471974120|FG002|Overall Study|Various reasons|1|||
131093934|NCT02187159|471974121|FG000|Overall Study|Protocol Violation|4|||
131093935|NCT02187159|471974122|FG001|Overall Study|Protocol Violation|6|||
131093936|NCT02187159|471974123|FG002|Overall Study|Protocol Violation|3|||
131093937|NCT02187159|471974124|FG003|Overall Study|Protocol Violation|4|||
131093938|NCT02187159|471974121|FG000|Overall Study|Lack of Efficacy|10|||
131093939|NCT02187159|471974122|FG001|Overall Study|Lack of Efficacy|5|||
131093940|NCT02187159|471974123|FG002|Overall Study|Lack of Efficacy|4|||
131093941|NCT02187159|471974124|FG003|Overall Study|Lack of Efficacy|7|||
131093942|NCT02187159|471974121|FG000|Overall Study|Adverse Event|28|||
131093943|NCT02187159|471974122|FG001|Overall Study|Adverse Event|33|||
131093944|NCT02187159|471974123|FG002|Overall Study|Adverse Event|42|||
131093945|NCT02187159|471974124|FG003|Overall Study|Adverse Event|50|||
131093946|NCT02187159|471974121|FG000|Overall Study|Withdrawal by Subject|24|||
131093947|NCT02187159|471974122|FG001|Overall Study|Withdrawal by Subject|28|||
131093948|NCT02187159|471974123|FG002|Overall Study|Withdrawal by Subject|25|||
131093949|NCT02187159|471974124|FG003|Overall Study|Withdrawal by Subject|26|||
131093950|NCT02187159|471974121|FG000|Overall Study|Other|3|||
130780280|NCT00792909|470821478|FG002|Overall Study|Withdrawal by Subject|0|||
131093951|NCT02187159|471974122|FG001|Overall Study|Other|7|||
131093952|NCT02187159|471974123|FG002|Overall Study|Other|3|||
131093953|NCT02187159|471974124|FG003|Overall Study|Other|9|||
131093954|NCT04020185|471974125|FG000|Overall Study|Death|0|||
131093955|NCT04020185|471974126|FG001|Overall Study|Death|0|||
131093956|NCT04020185|471974127|FG002|Overall Study|Death|1|||
131093957|NCT04020185|471974128|FG003|Overall Study|Death|2|||
130727505|NCT02856802|470625472|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
130727506|NCT02856802|470625473|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
130727507|NCT03092219|470625474|FG000|Overall Study|Protocol Violation|7|||
130727508|NCT03092219|470625475|FG001|Overall Study|Protocol Violation|4|||
130727509|NCT00459355|470625484|FG000|Overall Study|Subject no longer met inc criteria|20|||
131093958|NCT04020185|471974129|FG004|Overall Study|Death|1|||
131093959|NCT04020185|471974130|FG005|Overall Study|Death|0|||
131093960|NCT04020185|471974131|FG006|Overall Study|Death|1|||
131093961|NCT04020185|471974132|FG007|Overall Study|Death|0|||
131093962|NCT04020185|471974125|FG000|Overall Study|Consent withdrawn|1|||
131093963|NCT04020185|471974126|FG001|Overall Study|Consent withdrawn|0|||
131093964|NCT04020185|471974127|FG002|Overall Study|Consent withdrawn|0|||
131093965|NCT04020185|471974128|FG003|Overall Study|Consent withdrawn|0|||
131093966|NCT04020185|471974129|FG004|Overall Study|Consent withdrawn|2|||
131093967|NCT04020185|471974130|FG005|Overall Study|Consent withdrawn|0|||
131093968|NCT04020185|471974131|FG006|Overall Study|Consent withdrawn|1|||
131093969|NCT04020185|471974132|FG007|Overall Study|Consent withdrawn|1|||
131093970|NCT04020185|471974125|FG000|Overall Study|Patient in hospice|0|||
131093971|NCT04020185|471974126|FG001|Overall Study|Patient in hospice|1|||
131093972|NCT04020185|471974127|FG002|Overall Study|Patient in hospice|0|||
131093973|NCT04020185|471974128|FG003|Overall Study|Patient in hospice|0|||
131093974|NCT04020185|471974129|FG004|Overall Study|Patient in hospice|0|||
131093975|NCT04020185|471974130|FG005|Overall Study|Patient in hospice|0|||
131093976|NCT04020185|471974131|FG006|Overall Study|Patient in hospice|0|||
131093977|NCT04020185|471974132|FG007|Overall Study|Patient in hospice|0|||
131093978|NCT04020185|471974125|FG000|Overall Study|Continuing on expanded access|0|||
131093979|NCT04020185|471974126|FG001|Overall Study|Continuing on expanded access|0|||
131093980|NCT04020185|471974127|FG002|Overall Study|Continuing on expanded access|0|||
131093981|NCT04020185|471974128|FG003|Overall Study|Continuing on expanded access|0|||
131093982|NCT04020185|471974129|FG004|Overall Study|Continuing on expanded access|0|||
131093983|NCT04020185|471974130|FG005|Overall Study|Continuing on expanded access|0|||
131093984|NCT04020185|471974131|FG006|Overall Study|Continuing on expanded access|1|||
131093985|NCT04020185|471974132|FG007|Overall Study|Continuing on expanded access|1|||
131093986|NCT00567567|471974133|FG000|Overall Study|Adverse Event|0|||
131093987|NCT00567567|471974134|FG001|Overall Study|Adverse Event|2|||
131093988|NCT00567567|471974135|FG002|Overall Study|Adverse Event|5|||
131093989|NCT00567567|471974133|FG000|Overall Study|Death|8|||
131093990|NCT00567567|471974134|FG001|Overall Study|Death|1|||
131093991|NCT00567567|471974135|FG002|Overall Study|Death|5|||
131093992|NCT00567567|471974133|FG000|Overall Study|Lack of Efficacy|16|||
131093993|NCT00567567|471974134|FG001|Overall Study|Lack of Efficacy|17|||
131093994|NCT00567567|471974135|FG002|Overall Study|Lack of Efficacy|48|||
131093995|NCT00567567|471974133|FG000|Overall Study|Lost to Follow-up|0|||
131093996|NCT00567567|471974134|FG001|Overall Study|Lost to Follow-up|0|||
131093997|NCT00567567|471974135|FG002|Overall Study|Lost to Follow-up|1|||
131093998|NCT00567567|471974133|FG000|Overall Study|Physician Decision|16|||
131093999|NCT00567567|471974134|FG001|Overall Study|Physician Decision|18|||
131094000|NCT00567567|471974135|FG002|Overall Study|Physician Decision|84|||
131094001|NCT00567567|471974133|FG000|Overall Study|Withdrawal by Subject|0|||
131094002|NCT00567567|471974134|FG001|Overall Study|Withdrawal by Subject|0|||
131094003|NCT00567567|471974135|FG002|Overall Study|Withdrawal by Subject|2|||
131094004|NCT00567567|471974133|FG000|Overall Study|Ineligible|4|||
131094005|NCT00567567|471974134|FG001|Overall Study|Ineligible|0|||
131094006|NCT00567567|471974135|FG002|Overall Study|Ineligible|9|||
131094007|NCT00567567|471974133|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
131094008|NCT00567567|471974134|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
131094009|NCT00567567|471974135|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
131094010|NCT00567567|471974133|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
130727510|NCT00459355|470625485|FG001|Overall Study|Subject no longer met inc criteria|18|||
131094011|NCT00567567|471974134|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
130727511|NCT00287586|470625486|FG000|Overall Study|Withdrew Consent|19|||
130727512|NCT00287586|470625487|FG001|Overall Study|Withdrew Consent|30|||
130727513|NCT00287586|470625486|FG000|Overall Study|Lost to Follow-up|5|||
130780281|NCT00128661|470821481|FG000|Overall Study|Adverse Event|14|||
131094012|NCT00567567|471974135|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
131094013|NCT00567567|471974133|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
131094014|NCT00567567|471974134|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
131094015|NCT00567567|471974135|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
130727514|NCT00287586|470625487|FG001|Overall Study|Lost to Follow-up|4|||
131094016|NCT03433677|471974136|FG000|Period 1|Protocol Violation|1|||
131094017|NCT03433677|471974137|FG001|Period 1|Protocol Violation|0|||
131094018|NCT03433677|471974136|FG000|Period 2|Withdrawal by Subject|1|||
131094019|NCT03433677|471974137|FG001|Period 2|Withdrawal by Subject|1|||
131094020|NCT03330405|471974138|FG000|Overall Study|Other|1|||
131094021|NCT03330405|471974139|FG001|Overall Study|Other|3|||
131094022|NCT03330405|471974140|FG002|Overall Study|Other|1|||
130727515|NCT00287586|470625486|FG000|Overall Study|Death|2|||
130780282|NCT00128661|470821482|FG001|Overall Study|Adverse Event|11|||
130727516|NCT00287586|470625487|FG001|Overall Study|Death|3|||
130727517|NCT00287586|470625486|FG000|Overall Study|Elevated Hematocrit|3|||
130727518|NCT00287586|470625487|FG001|Overall Study|Elevated Hematocrit|0|||
130727519|NCT00287586|470625486|FG000|Overall Study|Rash|3|||
130727520|NCT00287586|470625487|FG001|Overall Study|Rash|0|||
130727521|NCT00287586|470625486|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
131094023|NCT03330405|471974141|FG003|Overall Study|Other|0|||
131094024|NCT03330405|471974142|FG004|Overall Study|Other|2|||
131094025|NCT03330405|471974143|FG005|Overall Study|Other|0|||
131094026|NCT03330405|471974144|FG006|Overall Study|Other|1|||
131094027|NCT03330405|471974145|FG007|Overall Study|Other|0|||
131094028|NCT03330405|471974146|FG008|Overall Study|Other|0|||
131094029|NCT03330405|471974147|FG009|Overall Study|Other|0|||
131094030|NCT03330405|471974148|FG010|Overall Study|Other|0|||
131094031|NCT03330405|471974138|FG000|Overall Study|Progressive disease|8|||
131094032|NCT03330405|471974139|FG001|Overall Study|Progressive disease|27|||
131094033|NCT03330405|471974140|FG002|Overall Study|Progressive disease|4|||
131094034|NCT03330405|471974141|FG003|Overall Study|Progressive disease|18|||
131094035|NCT03330405|471974142|FG004|Overall Study|Progressive disease|16|||
131094036|NCT03330405|471974143|FG005|Overall Study|Progressive disease|14|||
131094037|NCT03330405|471974144|FG006|Overall Study|Progressive disease|7|||
131094038|NCT03330405|471974145|FG007|Overall Study|Progressive disease|29|||
131094039|NCT03330405|471974146|FG008|Overall Study|Progressive disease|9|||
131094040|NCT03330405|471974147|FG009|Overall Study|Progressive disease|11|||
131094041|NCT03330405|471974148|FG010|Overall Study|Progressive disease|5|||
131094042|NCT03330405|471974138|FG000|Overall Study|Withdrawal by Subject|1|||
131094043|NCT03330405|471974139|FG001|Overall Study|Withdrawal by Subject|4|||
131094044|NCT03330405|471974140|FG002|Overall Study|Withdrawal by Subject|0|||
131094045|NCT03330405|471974141|FG003|Overall Study|Withdrawal by Subject|1|||
131094046|NCT03330405|471974142|FG004|Overall Study|Withdrawal by Subject|1|||
131094047|NCT03330405|471974143|FG005|Overall Study|Withdrawal by Subject|1|||
131094048|NCT03330405|471974144|FG006|Overall Study|Withdrawal by Subject|0|||
131094049|NCT03330405|471974145|FG007|Overall Study|Withdrawal by Subject|2|||
131094050|NCT03330405|471974146|FG008|Overall Study|Withdrawal by Subject|2|||
131094051|NCT03330405|471974147|FG009|Overall Study|Withdrawal by Subject|1|||
131094052|NCT03330405|471974148|FG010|Overall Study|Withdrawal by Subject|1|||
131094053|NCT03330405|471974138|FG000|Overall Study|Global deterioration of health status|2|||
131094054|NCT03330405|471974139|FG001|Overall Study|Global deterioration of health status|3|||
131094055|NCT03330405|471974140|FG002|Overall Study|Global deterioration of health status|0|||
131094056|NCT03330405|471974141|FG003|Overall Study|Global deterioration of health status|2|||
131094057|NCT03330405|471974142|FG004|Overall Study|Global deterioration of health status|3|||
131094058|NCT03330405|471974143|FG005|Overall Study|Global deterioration of health status|3|||
131094059|NCT03330405|471974144|FG006|Overall Study|Global deterioration of health status|0|||
131094060|NCT03330405|471974145|FG007|Overall Study|Global deterioration of health status|2|||
131094061|NCT03330405|471974146|FG008|Overall Study|Global deterioration of health status|8|||
131094062|NCT03330405|471974147|FG009|Overall Study|Global deterioration of health status|4|||
131094063|NCT03330405|471974148|FG010|Overall Study|Global deterioration of health status|1|||
131094064|NCT03330405|471974138|FG000|Overall Study|Adverse Event|0|||
131094065|NCT03330405|471974139|FG001|Overall Study|Adverse Event|1|||
131094066|NCT03330405|471974140|FG002|Overall Study|Adverse Event|0|||
131094067|NCT03330405|471974141|FG003|Overall Study|Adverse Event|1|||
131094068|NCT03330405|471974142|FG004|Overall Study|Adverse Event|1|||
131094069|NCT03330405|471974143|FG005|Overall Study|Adverse Event|1|||
131094070|NCT03330405|471974144|FG006|Overall Study|Adverse Event|3|||
131094071|NCT03330405|471974145|FG007|Overall Study|Adverse Event|4|||
131094072|NCT03330405|471974146|FG008|Overall Study|Adverse Event|2|||
131094073|NCT03330405|471974147|FG009|Overall Study|Adverse Event|2|||
131094074|NCT03330405|471974148|FG010|Overall Study|Adverse Event|2|||
131094075|NCT03330405|471974138|FG000|Overall Study|Death|0|||
131094076|NCT03330405|471974139|FG001|Overall Study|Death|4|||
131094077|NCT03330405|471974140|FG002|Overall Study|Death|0|||
131094078|NCT03330405|471974141|FG003|Overall Study|Death|0|||
131094079|NCT03330405|471974142|FG004|Overall Study|Death|0|||
131094080|NCT03330405|471974143|FG005|Overall Study|Death|1|||
131094081|NCT03330405|471974144|FG006|Overall Study|Death|0|||
131094082|NCT03330405|471974145|FG007|Overall Study|Death|2|||
131094083|NCT03330405|471974146|FG008|Overall Study|Death|0|||
131094084|NCT03330405|471974147|FG009|Overall Study|Death|0|||
131094085|NCT03330405|471974148|FG010|Overall Study|Death|0|||
131094086|NCT03330405|471974138|FG000|Overall Study|Physician Decision|0|||
131094087|NCT03330405|471974139|FG001|Overall Study|Physician Decision|0|||
131094088|NCT03330405|471974140|FG002|Overall Study|Physician Decision|0|||
131094089|NCT03330405|471974141|FG003|Overall Study|Physician Decision|0|||
131094090|NCT03330405|471974142|FG004|Overall Study|Physician Decision|0|||
131094091|NCT03330405|471974143|FG005|Overall Study|Physician Decision|0|||
131094092|NCT03330405|471974144|FG006|Overall Study|Physician Decision|0|||
131094093|NCT03330405|471974145|FG007|Overall Study|Physician Decision|1|||
131094094|NCT03330405|471974146|FG008|Overall Study|Physician Decision|0|||
130727522|NCT00287586|470625487|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
131143821|NCT00289913|472152471|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
131143822|NCT00289913|472152472|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
131143823|NCT00289913|472152473|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
131143824|NCT00289913|472152474|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
131143825|NCT00289913|472152470|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143826|NCT00289913|472152471|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
131143827|NCT00289913|472152472|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143828|NCT00289913|472152473|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143829|NCT00289913|472152474|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
131143830|NCT00289913|472152470|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
131143831|NCT00289913|472152471|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
131143832|NCT00289913|472152472|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
131143833|NCT00289913|472152473|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
131143834|NCT00289913|472152474|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
131234562|NCT04828161|472486367|FG000|Overall Study|Withdrawal by Subject|0|||
131234563|NCT04828161|472486368|FG001|Overall Study|Withdrawal by Subject|3|||
131234564|NCT04828161|472486369|FG002|Overall Study|Withdrawal by Subject|3|||
131234565|NCT04828161|472486370|FG003|Overall Study|Withdrawal by Subject|4|||
131234566|NCT04828161|472486367|FG000|Overall Study|Lost to Follow-up|1|||
131234567|NCT04828161|472486368|FG001|Overall Study|Lost to Follow-up|4|||
131234568|NCT04828161|472486369|FG002|Overall Study|Lost to Follow-up|2|||
131094095|NCT03330405|471974147|FG009|Overall Study|Physician Decision|0|||
131094096|NCT03330405|471974148|FG010|Overall Study|Physician Decision|0|||
131094097|NCT03889704|471974149|FG000|Overall Study|Study terminated due to pandemic|1|||
131094098|NCT03482466|471974150|FG000|Overall Study|Protocol Violation|2|||
131094099|NCT04335591|471974151|FG000|Overall Study|Adverse Event|5|||
131094100|NCT04335591|471974152|FG001|Overall Study|Adverse Event|2|||
131094101|NCT04335591|471974153|FG002|Overall Study|Adverse Event|3|||
131094102|NCT04335591|471974154|FG003|Overall Study|Adverse Event|2|||
131094103|NCT04335591|471974151|FG000|Overall Study|Protocol Violation|1|||
131094104|NCT04335591|471974152|FG001|Overall Study|Protocol Violation|0|||
131094105|NCT04335591|471974153|FG002|Overall Study|Protocol Violation|0|||
131094106|NCT04335591|471974154|FG003|Overall Study|Protocol Violation|0|||
131094107|NCT04335591|471974151|FG000|Overall Study|Withdrawal by Subject|8|||
131094108|NCT04335591|471974152|FG001|Overall Study|Withdrawal by Subject|4|||
131094109|NCT04335591|471974153|FG002|Overall Study|Withdrawal by Subject|4|||
131094110|NCT04335591|471974154|FG003|Overall Study|Withdrawal by Subject|5|||
131094111|NCT04335591|471974151|FG000|Overall Study|Subject planning pregnancy|0|||
131094112|NCT04335591|471974152|FG001|Overall Study|Subject planning pregnancy|1|||
131094113|NCT04335591|471974153|FG002|Overall Study|Subject planning pregnancy|0|||
131094114|NCT04335591|471974154|FG003|Overall Study|Subject planning pregnancy|0|||
131094115|NCT04335591|471974151|FG000|Overall Study|Ukrainian Russian war conflict|4|||
131094116|NCT04335591|471974152|FG001|Overall Study|Ukrainian Russian war conflict|5|||
131094117|NCT04335591|471974153|FG002|Overall Study|Ukrainian Russian war conflict|2|||
131094118|NCT04335591|471974154|FG003|Overall Study|Ukrainian Russian war conflict|0|||
131094119|NCT03268603|471974155|FG000|Overall Study|Withdrawal by Subject|6|||
131094120|NCT03268603|471974155|FG000|Overall Study|Physician Decision|1|||
131094121|NCT03268603|471974155|FG000|Overall Study|Withdrawn due to disease progression|2|||
131094122|NCT02060370|471974156|FG000|Overall Study|Physician Decision|1|||
131094123|NCT00356408|471974157|FG000|Overall Study|Adverse Event|9|||
131094124|NCT00356408|471974157|FG000|Overall Study|Lack of Efficacy|36|||
131094125|NCT00356408|471974157|FG000|Overall Study|Lost to Follow-up|2|||
131094126|NCT00356408|471974157|FG000|Overall Study|Withdrawal by Subject|6|||
131094127|NCT00356408|471974157|FG000|Overall Study|Other: Principal investigator discretion|3|||
131094128|NCT00356408|471974157|FG000|Overall Study|Other: Sponsor request|1|||
131094129|NCT00356408|471974157|FG000|Overall Study|Other: Azathioprine stopped|1|||
131094130|NCT00356408|471974157|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
131094131|NCT00356408|471974157|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
131094132|NCT05487586|471974159|FG000|Overall Study|Death|22|||
131234569|NCT04828161|472486370|FG003|Overall Study|Lost to Follow-up|2|||
131234570|NCT04828161|472486367|FG000|Overall Study|Other|2|||
131094133|NCT05487586|471974159|FG000|Overall Study|Physician Decision|1|||
131094134|NCT05487586|471974159|FG000|Overall Study|Transfer to another hospital|4|||
131094135|NCT05487586|471974159|FG000|Overall Study|Other|1|||
131094136|NCT01493427|471974160|FG000|Overall Study|Adverse Event|10|||
131094137|NCT01493427|471974160|FG000|Overall Study|Personal Reasons|4|||
131094138|NCT01493427|471974160|FG000|Overall Study|Lost to Follow-up|2|||
131094139|NCT01493427|471974160|FG000|Overall Study|Inability to Follow Instructions|2|||
131094140|NCT01493427|471974160|FG000|Overall Study|Other|2|||
131234571|NCT04828161|472486368|FG001|Overall Study|Other|0|||
131234572|NCT04828161|472486369|FG002|Overall Study|Other|2|||
131094141|NCT00565773|471974161|FG000|Overall Study|Withdrawal by Subject|1|||
131094142|NCT00565773|471974161|FG000|Overall Study|Physician Decision|1|||
131094143|NCT04798781|471974162|FG000|Overall Study|Withdrawal by Subject|1|||
131094144|NCT05775991|471974163|FG000|Overall Study|Withdrawal by Subject|0|||
131094145|NCT05775991|471974164|FG001|Overall Study|Withdrawal by Subject|0|||
131094146|NCT05775991|471974165|FG002|Overall Study|Withdrawal by Subject|2|||
131094147|NCT03921723|471974168|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
131094148|NCT03921723|471974168|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
131094149|NCT01461811|471974169|FG000|Overall Study|Adverse Event|2|||
131094150|NCT01461811|471974170|FG001|Overall Study|Adverse Event|1|||
131094151|NCT01461811|471974169|FG000|Overall Study|Subject decision unrelated to an AE|1|||
131094152|NCT01461811|471974170|FG001|Overall Study|Subject decision unrelated to an AE|1|||
131094153|NCT01461811|471974169|FG000|Overall Study|Noncompliance|1|||
131094154|NCT01461811|471974170|FG001|Overall Study|Noncompliance|1|||
131094155|NCT03015129|471974171|FG000|Overall Study|Death|2|||
131094156|NCT03015129|471974172|FG001|Overall Study|Death|2|||
131094157|NCT03015129|471974171|FG000|Overall Study|Lost to Follow-up|0|||
131094158|NCT03015129|471974172|FG001|Overall Study|Lost to Follow-up|1|||
131094159|NCT03015129|471974171|FG000|Overall Study|Progression of disease|38|||
131094160|NCT03015129|471974172|FG001|Overall Study|Progression of disease|33|||
131094161|NCT03015129|471974171|FG000|Overall Study|Adverse Event|0|||
131094162|NCT03015129|471974172|FG001|Overall Study|Adverse Event|4|||
131094163|NCT00406692|471974178|FG000|Overall Study|Withdrawal by Subject|4|||
131094164|NCT00406692|471974178|FG000|Overall Study|Physician Decision|1|||
131094165|NCT00406692|471974178|FG000|Overall Study|Adverse Event|1|||
131094166|NCT00406692|471974178|FG000|Overall Study|Lack of Efficacy|1|||
131094167|NCT00821587|471974179|FG000|Overall Study|Physician Decision|0|||
131094168|NCT00821587|471974180|FG001|Overall Study|Physician Decision|1|||
131094169|NCT00643617|471974183|FG000|Overall Study|Death|6|||
131094170|NCT00643617|471974184|FG001|Overall Study|Death|9|||
131094171|NCT00643617|471974183|FG000|Overall Study|Lost to Follow-up|42|||
131094172|NCT00643617|471974184|FG001|Overall Study|Lost to Follow-up|51|||
131094173|NCT04958200|471974191|FG000|Overall Study|Withdrawal by Subject|0|||
131094174|NCT04958200|471974192|FG001|Overall Study|Withdrawal by Subject|2|||
131094175|NCT04958200|471974191|FG000|Overall Study|Lost to Follow-up|3|||
131094176|NCT04958200|471974192|FG001|Overall Study|Lost to Follow-up|2|||
131094177|NCT04531098|471974193|FG000|Stage I|Adverse Event|0|||
131094178|NCT04531098|471974194|FG001|Stage I|Adverse Event|0|||
131094179|NCT04531098|471974195|FG002|Stage I|Adverse Event|3|||
131094180|NCT04531098|471974193|FG000|Stage I|Protocol Violation|0|||
131094181|NCT04531098|471974194|FG001|Stage I|Protocol Violation|0|||
131094182|NCT04531098|471974195|FG002|Stage I|Protocol Violation|5|||
131094183|NCT04531098|471974193|FG000|Stage I|Withdrawal by Subject|0|||
131094184|NCT04531098|471974194|FG001|Stage I|Withdrawal by Subject|5|||
131094185|NCT04531098|471974195|FG002|Stage I|Withdrawal by Subject|10|||
131094186|NCT04531098|471974193|FG000|Stage II|Adverse Event|1|||
131094187|NCT04531098|471974194|FG001|Stage II|Adverse Event|2|||
131094188|NCT04531098|471974195|FG002|Stage II|Adverse Event|0|||
131094189|NCT04531098|471974193|FG000|Stage II|Protocol Violation|1|||
131094190|NCT04531098|471974194|FG001|Stage II|Protocol Violation|2|||
131094191|NCT04531098|471974195|FG002|Stage II|Protocol Violation|0|||
131094192|NCT04531098|471974193|FG000|Stage II|Withdrawal by Subject|3|||
131094193|NCT04531098|471974194|FG001|Stage II|Withdrawal by Subject|1|||
131094194|NCT04531098|471974195|FG002|Stage II|Withdrawal by Subject|0|||
131094195|NCT04531098|471974193|FG000|Stage II|Moved from study area|8|||
131094196|NCT04531098|471974194|FG001|Stage II|Moved from study area|5|||
131094197|NCT04531098|471974195|FG002|Stage II|Moved from study area|0|||
131094198|NCT02628028|471974196|FG000|Dosing Period|Withdrawal by Subject|0|||
131094199|NCT02628028|471974197|FG001|Dosing Period|Withdrawal by Subject|0|||
131094200|NCT02628028|471974198|FG002|Dosing Period|Withdrawal by Subject|1|||
131094201|NCT02628028|471974199|FG003|Dosing Period|Withdrawal by Subject|0|||
131094202|NCT02628028|471974200|FG004|Dosing Period|Withdrawal by Subject|2|||
131094203|NCT02628028|471974201|FG005|Dosing Period|Withdrawal by Subject|4|||
131094204|NCT02628028|471974202|FG006|Dosing Period|Withdrawal by Subject|1|||
131094205|NCT02628028|471974203|FG007|Dosing Period|Withdrawal by Subject|1|||
131094206|NCT02628028|471974196|FG000|Dosing Period|Adverse Event|0|||
131094207|NCT02628028|471974197|FG001|Dosing Period|Adverse Event|0|||
131094208|NCT02628028|471974198|FG002|Dosing Period|Adverse Event|0|||
131094209|NCT02628028|471974199|FG003|Dosing Period|Adverse Event|0|||
131094210|NCT02628028|471974200|FG004|Dosing Period|Adverse Event|2|||
131094211|NCT02628028|471974201|FG005|Dosing Period|Adverse Event|1|||
131094212|NCT02628028|471974202|FG006|Dosing Period|Adverse Event|3|||
131094213|NCT02628028|471974203|FG007|Dosing Period|Adverse Event|2|||
131094214|NCT02628028|471974196|FG000|Dosing Period|Death|0|||
131234573|NCT04828161|472486370|FG003|Overall Study|Other|0|||
131094215|NCT02628028|471974197|FG001|Dosing Period|Death|0|||
131094216|NCT02628028|471974198|FG002|Dosing Period|Death|0|||
131094217|NCT02628028|471974199|FG003|Dosing Period|Death|0|||
131094218|NCT02628028|471974200|FG004|Dosing Period|Death|0|||
131094219|NCT02628028|471974201|FG005|Dosing Period|Death|0|||
131094220|NCT02628028|471974202|FG006|Dosing Period|Death|0|||
131094221|NCT02628028|471974203|FG007|Dosing Period|Death|1|||
131094222|NCT02628028|471974196|FG000|Dosing Period|Lack of Efficacy|0|||
131094223|NCT02628028|471974197|FG001|Dosing Period|Lack of Efficacy|0|||
131094224|NCT02628028|471974198|FG002|Dosing Period|Lack of Efficacy|0|||
131094225|NCT02628028|471974199|FG003|Dosing Period|Lack of Efficacy|0|||
131094226|NCT02628028|471974200|FG004|Dosing Period|Lack of Efficacy|3|||
131094227|NCT02628028|471974201|FG005|Dosing Period|Lack of Efficacy|0|||
131094228|NCT02628028|471974202|FG006|Dosing Period|Lack of Efficacy|1|||
131094229|NCT02628028|471974203|FG007|Dosing Period|Lack of Efficacy|0|||
131094230|NCT02628028|471974196|FG000|Dosing Period|Study Terminated by Sponsor|0|||
131094231|NCT02628028|471974197|FG001|Dosing Period|Study Terminated by Sponsor|0|||
131094232|NCT02628028|471974198|FG002|Dosing Period|Study Terminated by Sponsor|0|||
131094233|NCT02628028|471974199|FG003|Dosing Period|Study Terminated by Sponsor|0|||
131094234|NCT02628028|471974200|FG004|Dosing Period|Study Terminated by Sponsor|7|||
131094235|NCT02628028|471974201|FG005|Dosing Period|Study Terminated by Sponsor|6|||
131094236|NCT02628028|471974202|FG006|Dosing Period|Study Terminated by Sponsor|7|||
131094237|NCT02628028|471974203|FG007|Dosing Period|Study Terminated by Sponsor|7|||
131094238|NCT02628028|471974196|FG000|Dosing Period|Physician Decision|0|||
131094239|NCT02628028|471974197|FG001|Dosing Period|Physician Decision|0|||
131094240|NCT02628028|471974198|FG002|Dosing Period|Physician Decision|0|||
131094241|NCT02628028|471974199|FG003|Dosing Period|Physician Decision|0|||
131094242|NCT02628028|471974200|FG004|Dosing Period|Physician Decision|0|||
131094243|NCT02628028|471974201|FG005|Dosing Period|Physician Decision|1|||
131094244|NCT02628028|471974202|FG006|Dosing Period|Physician Decision|0|||
131094245|NCT02628028|471974203|FG007|Dosing Period|Physician Decision|0|||
131094246|NCT02628028|471974196|FG000|Dosing Period|Site Terminated by Sponsor|0|||
131094247|NCT02628028|471974197|FG001|Dosing Period|Site Terminated by Sponsor|0|||
131094248|NCT02628028|471974198|FG002|Dosing Period|Site Terminated by Sponsor|0|||
131094249|NCT02628028|471974199|FG003|Dosing Period|Site Terminated by Sponsor|0|||
131094250|NCT02628028|471974200|FG004|Dosing Period|Site Terminated by Sponsor|0|||
131094251|NCT02628028|471974201|FG005|Dosing Period|Site Terminated by Sponsor|1|||
131094252|NCT02628028|471974202|FG006|Dosing Period|Site Terminated by Sponsor|1|||
131094253|NCT02628028|471974203|FG007|Dosing Period|Site Terminated by Sponsor|0|||
131094254|NCT02628028|471974196|FG000|Dosing Period|Lost to Follow-up|0|||
131094255|NCT02628028|471974197|FG001|Dosing Period|Lost to Follow-up|0|||
131094256|NCT02628028|471974198|FG002|Dosing Period|Lost to Follow-up|0|||
131094257|NCT02628028|471974199|FG003|Dosing Period|Lost to Follow-up|0|||
131094258|NCT02628028|471974200|FG004|Dosing Period|Lost to Follow-up|0|||
131094259|NCT02628028|471974201|FG005|Dosing Period|Lost to Follow-up|0|||
131094260|NCT02628028|471974202|FG006|Dosing Period|Lost to Follow-up|1|||
131094261|NCT02628028|471974203|FG007|Dosing Period|Lost to Follow-up|0|||
131094262|NCT02628028|471974196|FG000|Dosing Period|Other|0|||
131094263|NCT02628028|471974197|FG001|Dosing Period|Other|0|||
131094264|NCT02628028|471974198|FG002|Dosing Period|Other|0|||
131094265|NCT02628028|471974199|FG003|Dosing Period|Other|0|||
131094266|NCT02628028|471974200|FG004|Dosing Period|Other|2|||
131094267|NCT02628028|471974201|FG005|Dosing Period|Other|1|||
131094268|NCT02628028|471974202|FG006|Dosing Period|Other|2|||
131094269|NCT02628028|471974203|FG007|Dosing Period|Other|4|||
131094270|NCT02628028|471974196|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
131094271|NCT02628028|471974197|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
131143835|NCT00289913|472152470|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131143836|NCT00289913|472152471|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131143837|NCT00289913|472152472|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131143838|NCT00289913|472152473|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
131143839|NCT00289913|472152474|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
131143840|NCT00289913|472152470|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143841|NCT00289913|472152471|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143842|NCT00289913|472152472|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143843|NCT00289913|472152473|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
131143844|NCT00289913|472152474|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
131143845|NCT00289913|472152470|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
131094272|NCT02628028|471974198|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
131094273|NCT02628028|471974199|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
131094274|NCT02628028|471974200|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
131094275|NCT02628028|471974201|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
131094276|NCT02628028|471974202|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
131094277|NCT02628028|471974203|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
131094278|NCT02628028|471974196|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131094279|NCT02628028|471974197|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131094280|NCT02628028|471974198|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131094281|NCT02628028|471974199|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131094282|NCT02628028|471974200|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131094283|NCT02628028|471974201|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
131094284|NCT02628028|471974202|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
131094285|NCT02628028|471974203|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
131094286|NCT02628028|471974196|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
131094287|NCT02628028|471974197|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
131094288|NCT02628028|471974198|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
131094289|NCT02628028|471974199|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
131094290|NCT02628028|471974200|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
131094291|NCT02628028|471974201|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
131094292|NCT02628028|471974202|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
131094293|NCT02628028|471974203|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
131094294|NCT02628028|471974196|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
131094295|NCT02628028|471974197|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
131094296|NCT02628028|471974198|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
131094297|NCT02628028|471974199|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
131094298|NCT02628028|471974200|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
131094299|NCT02628028|471974201|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
131094300|NCT02628028|471974202|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
131094301|NCT02628028|471974203|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
131094302|NCT02628028|471974196|FG000|Long-term Extension (LTE) Period|Other|0|||
131094303|NCT02628028|471974197|FG001|Long-term Extension (LTE) Period|Other|0|||
131094304|NCT02628028|471974198|FG002|Long-term Extension (LTE) Period|Other|0|||
131094305|NCT02628028|471974199|FG003|Long-term Extension (LTE) Period|Other|0|||
131094306|NCT02628028|471974200|FG004|Long-term Extension (LTE) Period|Other|0|||
131094307|NCT02628028|471974201|FG005|Long-term Extension (LTE) Period|Other|3|||
131094308|NCT02628028|471974202|FG006|Long-term Extension (LTE) Period|Other|4|||
131094309|NCT02628028|471974203|FG007|Long-term Extension (LTE) Period|Other|3|||
131094310|NCT02145468|471974204|FG000|Overall Study|Withdrawal by Subject|5|||
131094311|NCT02145468|471974205|FG001|Overall Study|Withdrawal by Subject|8|||
131094312|NCT00623805|471974207|FG000|Overall Study|Adverse Event|9|||
131094313|NCT00623805|471974208|FG001|Overall Study|Adverse Event|6|||
131094314|NCT00623805|471974207|FG000|Overall Study|Death|2|||
131094315|NCT00623805|471974208|FG001|Overall Study|Death|0|||
131094316|NCT00623805|471974207|FG000|Overall Study|Lack of Efficacy|3|||
131094317|NCT00623805|471974208|FG001|Overall Study|Lack of Efficacy|7|||
131094318|NCT00623805|471974207|FG000|Overall Study|Lost to Follow-up|2|||
131094319|NCT00623805|471974208|FG001|Overall Study|Lost to Follow-up|2|||
131094320|NCT00623805|471974207|FG000|Overall Study|Protocol Violation|1|||
131094321|NCT00623805|471974208|FG001|Overall Study|Protocol Violation|1|||
131094322|NCT00623805|471974207|FG000|Overall Study|Reason not Specified|3|||
131094323|NCT00623805|471974208|FG001|Overall Study|Reason not Specified|6|||
131094324|NCT02336451|471974227|FG000|Overall Study|Adverse Event|1|||
131094325|NCT02336451|471974228|FG001|Overall Study|Adverse Event|2|||
131094326|NCT02336451|471974229|FG002|Overall Study|Adverse Event|0|||
131094327|NCT02336451|471974230|FG003|Overall Study|Adverse Event|6|||
131094328|NCT02336451|471974231|FG004|Overall Study|Adverse Event|4|||
131094329|NCT02336451|471974227|FG000|Overall Study|Death|6|||
131094330|NCT02336451|471974228|FG001|Overall Study|Death|2|||
131094331|NCT02336451|471974229|FG002|Overall Study|Death|3|||
131094332|NCT02336451|471974230|FG003|Overall Study|Death|6|||
131094333|NCT02336451|471974231|FG004|Overall Study|Death|6|||
131094334|NCT02336451|471974227|FG000|Overall Study|Physician Decision|9|||
131094335|NCT02336451|471974228|FG001|Overall Study|Physician Decision|6|||
131094336|NCT02336451|471974229|FG002|Overall Study|Physician Decision|7|||
131094337|NCT02336451|471974230|FG003|Overall Study|Physician Decision|16|||
131094338|NCT02336451|471974231|FG004|Overall Study|Physician Decision|3|||
131094339|NCT02336451|471974227|FG000|Overall Study|Progressive disease|23|||
131094340|NCT02336451|471974228|FG001|Overall Study|Progressive disease|26|||
131094341|NCT02336451|471974229|FG002|Overall Study|Progressive disease|2|||
131094342|NCT02336451|471974230|FG003|Overall Study|Progressive disease|14|||
131094343|NCT02336451|471974231|FG004|Overall Study|Progressive disease|4|||
131094344|NCT02336451|471974227|FG000|Overall Study|Protocol Violation|1|||
131143846|NCT00289913|472152471|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
131094345|NCT02336451|471974228|FG001|Overall Study|Protocol Violation|0|||
131094346|NCT02336451|471974229|FG002|Overall Study|Protocol Violation|0|||
131094347|NCT02336451|471974230|FG003|Overall Study|Protocol Violation|0|||
131094348|NCT02336451|471974231|FG004|Overall Study|Protocol Violation|0|||
131094349|NCT02336451|471974227|FG000|Overall Study|Patient/guardian decision|2|||
131094350|NCT02336451|471974228|FG001|Overall Study|Patient/guardian decision|4|||
131094351|NCT02336451|471974229|FG002|Overall Study|Patient/guardian decision|0|||
131094352|NCT02336451|471974230|FG003|Overall Study|Patient/guardian decision|2|||
131094353|NCT02336451|471974231|FG004|Overall Study|Patient/guardian decision|1|||
131094354|NCT04998812|471974238|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
131094355|NCT04998812|471974239|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
131094356|NCT04998812|471974238|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
131094357|NCT04998812|471974239|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
131094358|NCT04998812|471974238|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
131094359|NCT04998812|471974239|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
131143847|NCT00289913|472152472|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
131143848|NCT00289913|472152473|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
131143849|NCT00289913|472152474|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
131143850|NCT00289913|472152470|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
131143851|NCT00289913|472152471|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
131094360|NCT04998812|471974238|FG000|Vaccination Period|Ongoing in study|23|||
131094361|NCT04998812|471974239|FG001|Vaccination Period|Ongoing in study|23|||
131094362|NCT04893460|471974248|FG000|Overall Study|Lost to Follow-up|18|||
131094363|NCT05718466|471976291|FG000|Overall Study|Withdrawal by Subject|1|||
131094364|NCT05718466|471976292|FG001|Overall Study|Withdrawal by Subject|2|||
131094365|NCT05718466|471976291|FG000|Overall Study|Death|0|||
131094366|NCT05718466|471976292|FG001|Overall Study|Death|1|||
131094367|NCT01099215|471976293|FG000|Overall Study|Withdrawal by Subject|1|||
131094368|NCT01099215|471976294|FG001|Overall Study|Withdrawal by Subject|0|||
131094369|NCT01099215|471976293|FG000|Overall Study|Adverse Event|0|||
131094370|NCT01099215|471976294|FG001|Overall Study|Adverse Event|1|||
131094371|NCT01253135|471976296|FG000|Original Protocol|Protocol Amendment|15|||
131094372|NCT01253135|471976296|FG000|Amended Protocol|Non-compliance|1|||
131094373|NCT00833261|471976303|FG000|Overall Study|Withdrawal by Subject|4|||
131094374|NCT03248882|471976304|FG000|Overall Study|Adverse Event|3|||
131094375|NCT03248882|471976305|FG001|Overall Study|Adverse Event|3|||
131094376|NCT03248882|471976306|FG002|Overall Study|Adverse Event|2|||
131094377|NCT03248882|471976307|FG003|Overall Study|Adverse Event|6|||
131094378|NCT03248882|471976308|FG004|Overall Study|Adverse Event|9|||
131094379|NCT03248882|471976304|FG000|Overall Study|Lost to Follow-up|0|||
131094380|NCT03248882|471976305|FG001|Overall Study|Lost to Follow-up|0|||
131094381|NCT03248882|471976306|FG002|Overall Study|Lost to Follow-up|0|||
131094382|NCT03248882|471976307|FG003|Overall Study|Lost to Follow-up|0|||
131094383|NCT03248882|471976308|FG004|Overall Study|Lost to Follow-up|1|||
131094384|NCT03248882|471976304|FG000|Overall Study|Protocol Violation|2|||
131094385|NCT03248882|471976305|FG001|Overall Study|Protocol Violation|0|||
131094386|NCT03248882|471976306|FG002|Overall Study|Protocol Violation|2|||
131094387|NCT03248882|471976307|FG003|Overall Study|Protocol Violation|0|||
131094388|NCT03248882|471976308|FG004|Overall Study|Protocol Violation|1|||
131094389|NCT03248882|471976304|FG000|Overall Study|Withdrawal by Subject|2|||
131094390|NCT03248882|471976305|FG001|Overall Study|Withdrawal by Subject|2|||
131094391|NCT03248882|471976306|FG002|Overall Study|Withdrawal by Subject|3|||
131094392|NCT03248882|471976307|FG003|Overall Study|Withdrawal by Subject|4|||
131094393|NCT03248882|471976308|FG004|Overall Study|Withdrawal by Subject|2|||
131094394|NCT01156376|471976311|FG000|Overall Study|Adverse Event|1|||
131094395|NCT01156376|471976312|FG001|Overall Study|Adverse Event|0|||
131094396|NCT01156376|471976313|FG002|Overall Study|Adverse Event|1|||
131143852|NCT00289913|472152472|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
131143853|NCT00289913|472152473|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
131143854|NCT00289913|472152474|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
131143855|NCT00289913|472152470|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
131143856|NCT00289913|472152471|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
131143857|NCT00289913|472152472|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
131143858|NCT00289913|472152473|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
131143859|NCT00289913|472152474|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
131143860|NCT00289913|472152470|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131143861|NCT00289913|472152471|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
131143862|NCT00289913|472152472|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131143863|NCT00289913|472152473|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131143864|NCT00289913|472152474|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
131143865|NCT01169779|472152479|FG000|Overall Study|Adverse Event|3|||
131143866|NCT01169779|472152480|FG001|Overall Study|Adverse Event|11|||
131143867|NCT01169779|472152479|FG000|Overall Study|Lack of Efficacy|1|||
131143868|NCT01169779|472152480|FG001|Overall Study|Lack of Efficacy|0|||
131143869|NCT01169779|472152479|FG000|Overall Study|Protocol Violation|1|||
131143870|NCT01169779|472152480|FG001|Overall Study|Protocol Violation|1|||
131143871|NCT01169779|472152479|FG000|Overall Study|Withdrawal by Subject|3|||
131234574|NCT04828161|472486367|FG000|Overall Study|Death|0|||
131094397|NCT01156376|471976311|FG000|Overall Study|Withdrawal by Subject|0|||
131094398|NCT01156376|471976312|FG001|Overall Study|Withdrawal by Subject|0|||
131234575|NCT04828161|472486368|FG001|Overall Study|Death|0|||
131094399|NCT01156376|471976313|FG002|Overall Study|Withdrawal by Subject|3|||
131094400|NCT01075958|471976314|FG000|Overall Study|Blood sample could not be obtained|44|||
131094401|NCT03733314|471976315|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
131094402|NCT03733314|471976316|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
131094403|NCT03733314|471976315|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
131094404|NCT03733314|471976316|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
131094405|NCT03733314|471976315|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
131234576|NCT04828161|472486369|FG002|Overall Study|Death|0|||
131234577|NCT04828161|472486370|FG003|Overall Study|Death|2|||
131234578|NCT00135707|472486375|FG000|Overall Study|Lost to Follow-up|94|||
131234579|NCT00135707|472486376|FG001|Overall Study|Lost to Follow-up|89|||
131234580|NCT00135707|472486375|FG000|Overall Study|Withdrawal by Subject|0|||
131234581|NCT00135707|472486376|FG001|Overall Study|Withdrawal by Subject|1|||
130727523|NCT00287586|470625486|FG000|Overall Study|Stroke|2|||
130727524|NCT00287586|470625487|FG001|Overall Study|Stroke|0|||
131094406|NCT03733314|471976316|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
131094407|NCT03733314|471976315|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
131094408|NCT03733314|471976316|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
131094409|NCT03733314|471976315|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
131094410|NCT03733314|471976316|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
131094411|NCT03733314|471976315|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
131094412|NCT03733314|471976316|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
131094413|NCT01240915|471976317|FG000|Overall Study|Adverse Event|0|||
131094414|NCT01240915|471976318|FG001|Overall Study|Adverse Event|0|||
131094415|NCT01240915|471976319|FG002|Overall Study|Adverse Event|0|||
131094416|NCT01240915|471976320|FG003|Overall Study|Adverse Event|1|||
131094417|NCT01240915|471976321|FG004|Overall Study|Adverse Event|0|||
131094418|NCT01240915|471976322|FG005|Overall Study|Adverse Event|2|||
131094419|NCT01240915|471976323|FG006|Overall Study|Adverse Event|0|||
131094420|NCT01240915|471976324|FG007|Overall Study|Adverse Event|0|||
131094421|NCT01240915|471976325|FG008|Overall Study|Adverse Event|1|||
131094422|NCT01240915|471976317|FG000|Overall Study|Lost to Follow-up|0|||
131094423|NCT01240915|471976318|FG001|Overall Study|Lost to Follow-up|0|||
131094424|NCT01240915|471976319|FG002|Overall Study|Lost to Follow-up|0|||
131094425|NCT01240915|471976320|FG003|Overall Study|Lost to Follow-up|0|||
131094426|NCT01240915|471976321|FG004|Overall Study|Lost to Follow-up|1|||
131094427|NCT01240915|471976322|FG005|Overall Study|Lost to Follow-up|1|||
131094428|NCT01240915|471976323|FG006|Overall Study|Lost to Follow-up|0|||
131094429|NCT01240915|471976324|FG007|Overall Study|Lost to Follow-up|1|||
131094430|NCT01240915|471976325|FG008|Overall Study|Lost to Follow-up|1|||
131094431|NCT01240915|471976317|FG000|Overall Study|Withdrawal by Subject|2|||
131094432|NCT01240915|471976318|FG001|Overall Study|Withdrawal by Subject|1|||
131094433|NCT01240915|471976319|FG002|Overall Study|Withdrawal by Subject|0|||
131094434|NCT01240915|471976320|FG003|Overall Study|Withdrawal by Subject|2|||
131094435|NCT01240915|471976321|FG004|Overall Study|Withdrawal by Subject|0|||
131094436|NCT01240915|471976322|FG005|Overall Study|Withdrawal by Subject|4|||
131094437|NCT01240915|471976323|FG006|Overall Study|Withdrawal by Subject|2|||
131094438|NCT01240915|471976324|FG007|Overall Study|Withdrawal by Subject|3|||
131094439|NCT01240915|471976325|FG008|Overall Study|Withdrawal by Subject|3|||
131094440|NCT01240915|471976317|FG000|Overall Study|Other|0|||
131094441|NCT01240915|471976318|FG001|Overall Study|Other|0|||
131094442|NCT01240915|471976319|FG002|Overall Study|Other|0|||
131094443|NCT01240915|471976320|FG003|Overall Study|Other|0|||
131094444|NCT01240915|471976321|FG004|Overall Study|Other|2|||
131094445|NCT01240915|471976322|FG005|Overall Study|Other|0|||
131094446|NCT01240915|471976323|FG006|Overall Study|Other|0|||
131094447|NCT01240915|471976324|FG007|Overall Study|Other|0|||
131094448|NCT01240915|471976325|FG008|Overall Study|Other|0|||
131094449|NCT01240915|471976317|FG000|Overall Study|Insufficient Clinical Response|0|||
131094450|NCT01240915|471976318|FG001|Overall Study|Insufficient Clinical Response|0|||
131094451|NCT01240915|471976319|FG002|Overall Study|Insufficient Clinical Response|0|||
131094452|NCT01240915|471976320|FG003|Overall Study|Insufficient Clinical Response|0|||
131094453|NCT01240915|471976321|FG004|Overall Study|Insufficient Clinical Response|1|||
131094454|NCT01240915|471976322|FG005|Overall Study|Insufficient Clinical Response|3|||
131094455|NCT01240915|471976323|FG006|Overall Study|Insufficient Clinical Response|6|||
131094456|NCT01240915|471976324|FG007|Overall Study|Insufficient Clinical Response|0|||
131094457|NCT01240915|471976325|FG008|Overall Study|Insufficient Clinical Response|3|||
131094458|NCT04514510|471976326|FG000|Overall Study|Lost to Follow-up|0|||
131094459|NCT04514510|471976327|FG001|Overall Study|Lost to Follow-up|1|||
131094460|NCT04514510|471976326|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
131094461|NCT04514510|471976327|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
131094462|NCT04488770|471976328|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131234582|NCT00135707|472486375|FG000|Overall Study|Institutional review board request|1|||
131234583|NCT00135707|472486376|FG001|Overall Study|Institutional review board request|0|||
130727525|NCT00287586|470625486|FG000|Overall Study|Myocardial Infarction|1|||
130727526|NCT00287586|470625487|FG001|Overall Study|Myocardial Infarction|0|||
130727527|NCT00287586|470625486|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
131094463|NCT04488770|471976329|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131094464|NCT04488770|471976330|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131094465|NCT04488770|471976331|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
131094466|NCT04488770|471976332|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131094467|NCT04488770|471976333|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131094468|NCT04488770|471976334|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131094469|NCT04488770|471976335|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131094470|NCT04488770|471976336|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131094471|NCT04488770|471976337|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131094472|NCT04488770|471976338|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131143872|NCT01169779|472152480|FG001|Overall Study|Withdrawal by Subject|2|||
131143873|NCT01169779|472152479|FG000|Overall Study|Familial and personal reasons|3|||
131143874|NCT01169779|472152480|FG001|Overall Study|Familial and personal reasons|3|||
131143875|NCT01279057|472152482|FG000|Overall Study|Adverse Event|1|||
131143876|NCT01279057|472152483|FG001|Overall Study|Adverse Event|0|||
131143877|NCT01279057|472152484|FG002|Overall Study|Adverse Event|1|||
131143878|NCT01279057|472152482|FG000|Overall Study|Insufficient therapeutic response|0|||
131143879|NCT01279057|472152483|FG001|Overall Study|Insufficient therapeutic response|0|||
131234584|NCT03093454|472486377|FG000|Overall Study|Withdrawal by Subject|1|||
131234585|NCT03093454|472486378|FG001|Overall Study|Withdrawal by Subject|1|||
131234586|NCT03093454|472486377|FG000|Overall Study|Scheduling conflict|3|||
131234587|NCT03093454|472486378|FG001|Overall Study|Scheduling conflict|1|||
131234588|NCT03093454|472486377|FG000|Overall Study|Physician Decision|2|||
131234589|NCT03093454|472486378|FG001|Overall Study|Physician Decision|1|||
131234590|NCT04540497|472486382|FG000|Overall Study|Adverse Event|0|||
131234591|NCT04540497|472486383|FG001|Overall Study|Adverse Event|2|||
131234592|NCT04540497|472486382|FG000|Overall Study|Lost to Follow-up|1|||
131234593|NCT04540497|472486383|FG001|Overall Study|Lost to Follow-up|0|||
131234594|NCT04540497|472486382|FG000|Overall Study|Withdrawal by Subject|1|||
131234595|NCT04540497|472486383|FG001|Overall Study|Withdrawal by Subject|1|||
131234596|NCT04540497|472486382|FG000|Overall Study|Miscellaneous|2|||
131234597|NCT04540497|472486383|FG001|Overall Study|Miscellaneous|1|||
131234598|NCT02524379|472486384|FG000|Overall Study|Death|1|||
131234599|NCT01521559|472486385|FG000|Overall Study|Adverse Event|0|||
131234600|NCT01521559|472486386|FG001|Overall Study|Adverse Event|4|||
131234601|NCT01521559|472486385|FG000|Overall Study|Death|1|||
131234602|NCT01521559|472486386|FG001|Overall Study|Death|0|||
131234603|NCT01521559|472486385|FG000|Overall Study|Withdrawal by Subject|9|||
131234604|NCT01521559|472486386|FG001|Overall Study|Withdrawal by Subject|11|||
131234605|NCT01521559|472486385|FG000|Overall Study|Lost to Follow-up|3|||
131234606|NCT01521559|472486386|FG001|Overall Study|Lost to Follow-up|1|||
131234607|NCT01521559|472486385|FG000|Overall Study|Protocol Violation|1|||
131234608|NCT01521559|472486386|FG001|Overall Study|Protocol Violation|0|||
131234609|NCT01521559|472486385|FG000|Overall Study|Other|1|||
131234610|NCT01521559|472486386|FG001|Overall Study|Other|2|||
131234611|NCT00275002|472486388|FG000|Overall Study|Death|1|||
131094473|NCT04488770|471976339|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131094474|NCT04488770|471976340|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
131094475|NCT04488770|471976328|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
131094476|NCT04488770|471976329|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094477|NCT04488770|471976330|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094478|NCT04488770|471976331|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094479|NCT04488770|471976332|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094480|NCT04488770|471976333|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094481|NCT04488770|471976334|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094482|NCT04488770|471976335|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094483|NCT04488770|471976336|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094484|NCT04488770|471976337|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094485|NCT04488770|471976338|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094486|NCT04488770|471976339|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094487|NCT04488770|471976340|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
131094488|NCT04488770|471976328|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131094489|NCT04488770|471976329|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131143880|NCT01279057|472152484|FG002|Overall Study|Insufficient therapeutic response|1|||
131143881|NCT01279057|472152482|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
131143882|NCT01279057|472152483|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
131234612|NCT00275002|472486389|FG001|Overall Study|Death|0|||
130727528|NCT00287586|470625487|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
131094490|NCT04488770|471976330|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131143883|NCT01279057|472152484|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
131143884|NCT01279057|472152482|FG000|Overall Study|Withdrew consent|2|||
131143885|NCT01279057|472152483|FG001|Overall Study|Withdrew consent|0|||
131234613|NCT00275002|472486388|FG000|Overall Study|Disease progression|21|||
131234614|NCT00275002|472486389|FG001|Overall Study|Disease progression|15|||
131234615|NCT00275002|472486388|FG000|Overall Study|Adverse Event|0|||
131234616|NCT00275002|472486389|FG001|Overall Study|Adverse Event|1|||
131234617|NCT00576381|472486399|FG000|Overall Study|Reoperation|3|||
131234618|NCT00576381|472486399|FG000|Overall Study|Adverse Event|4|||
131234619|NCT01031537|472486400|FG000|Overall Study|medical reasons not related to study|3|||
131143886|NCT01279057|472152484|FG002|Overall Study|Withdrew consent|1|||
131143887|NCT01279057|472152482|FG000|Overall Study|Pregnancy|0|||
131143888|NCT01279057|472152483|FG001|Overall Study|Pregnancy|1|||
131143889|NCT01279057|472152484|FG002|Overall Study|Pregnancy|0|||
131143890|NCT01279057|472152482|FG000|Overall Study|Other|3|||
131143891|NCT01279057|472152483|FG001|Overall Study|Other|3|||
131143892|NCT01279057|472152484|FG002|Overall Study|Other|0|||
131143893|NCT01427309|472152486|FG000|Overall Study|Lost to Follow-up|130|||
131143894|NCT01427309|472152487|FG001|Overall Study|Lost to Follow-up|145|||
131143895|NCT01427309|472152488|FG002|Overall Study|Lost to Follow-up|122|||
131143896|NCT01427309|472152489|FG003|Overall Study|Lost to Follow-up|135|||
130727529|NCT00287586|470625486|FG000|Overall Study|Cognitive Impairment|1|||
131094491|NCT04488770|471976331|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131094492|NCT04488770|471976332|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131094493|NCT04488770|471976333|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
131094494|NCT04488770|471976334|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
131094495|NCT04488770|471976335|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131094496|NCT04488770|471976336|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131094497|NCT04488770|471976337|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131094498|NCT04488770|471976338|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131094499|NCT04488770|471976339|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131094500|NCT04488770|471976340|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
131094501|NCT04488770|471976328|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094502|NCT04488770|471976329|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094503|NCT04488770|471976330|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094504|NCT04488770|471976331|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094505|NCT04488770|471976332|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
131094506|NCT04488770|471976333|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094507|NCT04488770|471976334|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094508|NCT04488770|471976335|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094509|NCT04488770|471976336|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094510|NCT04488770|471976337|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094511|NCT04488770|471976338|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094512|NCT04488770|471976339|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094513|NCT04488770|471976340|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
131094514|NCT01867333|471976341|FG000|Overall Study|Withdrawal by Subject|1|||
130727530|NCT00287586|470625487|FG001|Overall Study|Cognitive Impairment|0|||
130727531|NCT00287586|470625486|FG000|Overall Study|Pancreatic Cancer|1|||
130727532|NCT00287586|470625487|FG001|Overall Study|Pancreatic Cancer|3|||
130727533|NCT00287586|470625486|FG000|Overall Study|Sleep Apnea|1|||
131094515|NCT01867333|471976342|FG001|Overall Study|Withdrawal by Subject|0|||
131094516|NCT01867333|471976341|FG000|Overall Study|Adverse Event|1|||
131094517|NCT01867333|471976342|FG001|Overall Study|Adverse Event|0|||
131094518|NCT01867333|471976341|FG000|Overall Study|Participant choice|1|||
131094519|NCT01867333|471976342|FG001|Overall Study|Participant choice|2|||
131094520|NCT01867333|471976341|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
131094521|NCT01867333|471976342|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
131094522|NCT01867333|471976341|FG000|Overall Study|Death|0|||
131094523|NCT01867333|471976342|FG001|Overall Study|Death|1|||
131094524|NCT01867333|471976341|FG000|Overall Study|Physician Decision|3|||
131094525|NCT01867333|471976342|FG001|Overall Study|Physician Decision|2|||
131094526|NCT01867333|471976341|FG000|Overall Study|Switched to alternative treatment|1|||
131094527|NCT01867333|471976342|FG001|Overall Study|Switched to alternative treatment|0|||
131094528|NCT02636725|471976345|FG000|Overall Study|Adverse Event|1|||
131094529|NCT05330676|471976348|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
131094530|NCT05330676|471976349|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
131094531|NCT03653208|471976350|FG000|Overall Study|Withdrawal by Subject|0|||
131094532|NCT03653208|471976351|FG001|Overall Study|Withdrawal by Subject|0|||
131094533|NCT03653208|471976352|FG002|Overall Study|Withdrawal by Subject|0|||
131094534|NCT03653208|471976353|FG003|Overall Study|Withdrawal by Subject|0|||
131094535|NCT03653208|471976354|FG004|Overall Study|Withdrawal by Subject|1|||
131143897|NCT01427309|472152486|FG000|Overall Study|Protocol Violation|42|||
130727534|NCT00287586|470625487|FG001|Overall Study|Sleep Apnea|0|||
130727535|NCT00287586|470625486|FG000|Overall Study|Shoulder Pain|1|||
130727536|NCT00287586|470625487|FG001|Overall Study|Shoulder Pain|0|||
131143898|NCT01427309|472152487|FG001|Overall Study|Protocol Violation|69|||
130727537|NCT00287586|470625486|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
130727538|NCT00287586|470625487|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
130727539|NCT00287586|470625486|FG000|Overall Study|Nonadherence|1|||
131094536|NCT03653208|471976355|FG005|Overall Study|Withdrawal by Subject|0|||
131094537|NCT03653208|471976356|FG006|Overall Study|Withdrawal by Subject|0|||
131143899|NCT01427309|472152488|FG002|Overall Study|Protocol Violation|125|||
131094538|NCT03653208|471976357|FG007|Overall Study|Withdrawal by Subject|1|||
131094539|NCT03653208|471976358|FG008|Overall Study|Withdrawal by Subject|1|||
131094540|NCT01696045|471976361|FG000|Overall Study|Study drug toxicity|1|||
131094541|NCT01696045|471976362|FG001|Overall Study|Study drug toxicity|5|||
131094542|NCT01696045|471976361|FG000|Overall Study|Disease progression|2|||
131094543|NCT01696045|471976362|FG001|Overall Study|Disease progression|2|||
131094544|NCT00573859|471976363|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
131094545|NCT00573859|471976363|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
131094546|NCT00864253|471976372|FG000|Overall Study|Adverse Event|56|||
131094547|NCT00864253|471976373|FG001|Overall Study|Adverse Event|11|||
131094548|NCT00864253|471976372|FG000|Overall Study|Unrelated Adverse Event|3|||
131094549|NCT00864253|471976373|FG001|Overall Study|Unrelated Adverse Event|1|||
131094550|NCT00864253|471976372|FG000|Overall Study|Physician Decision|11|||
131094551|NCT00864253|471976373|FG001|Overall Study|Physician Decision|15|||
131094552|NCT00864253|471976372|FG000|Overall Study|Protocol Violation|0|||
131094553|NCT00864253|471976373|FG001|Overall Study|Protocol Violation|2|||
131094554|NCT00864253|471976372|FG000|Overall Study|Lost to Follow-up|1|||
131094555|NCT00864253|471976373|FG001|Overall Study|Lost to Follow-up|1|||
131094556|NCT00864253|471976372|FG000|Overall Study|Withdrawal by Subject|18|||
131094557|NCT00864253|471976373|FG001|Overall Study|Withdrawal by Subject|18|||
131094558|NCT00864253|471976372|FG000|Overall Study|Death|1|||
131094559|NCT00864253|471976373|FG001|Overall Study|Death|0|||
131094560|NCT00864253|471976372|FG000|Overall Study|Ongoing|2|||
131094561|NCT00864253|471976373|FG001|Overall Study|Ongoing|3|||
131094562|NCT00864253|471976372|FG000|Overall Study|Untreated|7|||
131094563|NCT00864253|471976373|FG001|Overall Study|Untreated|7|||
131094564|NCT01896726|471976374|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
131094565|NCT01896726|471976374|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
131094566|NCT01128114|471976375|FG000|Overall Study|Treatment Withdrawn|6|||
131094567|NCT01128114|471976375|FG000|Overall Study|Screening Failed|2|||
131094568|NCT01111240|471976376|FG000|Overall Study|Adverse Event|190|||
131094569|NCT01111240|471976376|FG000|Overall Study|Lack of Efficacy|545|||
131094570|NCT01111240|471976376|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
131094571|NCT01111240|471976376|FG000|Overall Study|Other|312|||
131094572|NCT00208325|471976377|FG000|Overall Study|Death|18|||
131094573|NCT00208325|471976378|FG001|Overall Study|Death|19|||
131094574|NCT00208325|471976379|FG002|Overall Study|Death|7|||
131094575|NCT00208325|471976380|FG003|Overall Study|Death|5|||
131094576|NCT00208325|471976377|FG000|Overall Study|Withdrawal by Subject|0|||
131094577|NCT00208325|471976378|FG001|Overall Study|Withdrawal by Subject|1|||
131094578|NCT00208325|471976379|FG002|Overall Study|Withdrawal by Subject|0|||
131094579|NCT00208325|471976380|FG003|Overall Study|Withdrawal by Subject|0|||
131094580|NCT00208325|471976377|FG000|Overall Study|Revision|4|||
131094581|NCT00208325|471976378|FG001|Overall Study|Revision|1|||
131094582|NCT00208325|471976379|FG002|Overall Study|Revision|0|||
131094583|NCT00208325|471976380|FG003|Overall Study|Revision|4|||
131094584|NCT00208325|471976377|FG000|Overall Study|Lost to Follow-up|1|||
131094585|NCT00208325|471976378|FG001|Overall Study|Lost to Follow-up|0|||
131094586|NCT00208325|471976379|FG002|Overall Study|Lost to Follow-up|2|||
131094587|NCT00208325|471976380|FG003|Overall Study|Lost to Follow-up|0|||
131094588|NCT00208325|471976377|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
131143900|NCT01427309|472152489|FG003|Overall Study|Protocol Violation|124|||
131143901|NCT01427309|472152486|FG000|Overall Study|Adverse Event|0|||
131143902|NCT01427309|472152487|FG001|Overall Study|Adverse Event|0|||
131143903|NCT01427309|472152488|FG002|Overall Study|Adverse Event|3|||
131143904|NCT01427309|472152489|FG003|Overall Study|Adverse Event|1|||
131143905|NCT01427309|472152486|FG000|Overall Study|Serious adverse event|52|||
131143906|NCT01427309|472152487|FG001|Overall Study|Serious adverse event|45|||
131234620|NCT01031537|472486400|FG000|Overall Study|Lack of Efficacy|1|||
131234621|NCT01031537|472486400|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
131094589|NCT00208325|471976378|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
131094590|NCT00208325|471976379|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
131094591|NCT00208325|471976380|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
131094592|NCT00208325|471976377|FG000|Overall Study|Does not wish to Continue in Study|5|||
131143907|NCT01427309|472152488|FG002|Overall Study|Serious adverse event|50|||
131234622|NCT01031537|472486400|FG000|Overall Study|moved, met exclusion criteria|10|||
131234623|NCT01031537|472486400|FG000|Overall Study|Withdrawal by Subject|5|||
131143908|NCT01427309|472152489|FG003|Overall Study|Serious adverse event|61|||
131234624|NCT01031537|472486400|FG000|Overall Study|PI removal, no longer met eligibility|12|||
131094593|NCT00208325|471976378|FG001|Overall Study|Does not wish to Continue in Study|8|||
131094594|NCT00208325|471976379|FG002|Overall Study|Does not wish to Continue in Study|3|||
131094595|NCT00208325|471976380|FG003|Overall Study|Does not wish to Continue in Study|2|||
131094596|NCT00208325|471976377|FG000|Overall Study|Other|2|||
131094597|NCT00208325|471976378|FG001|Overall Study|Other|1|||
131094598|NCT00208325|471976379|FG002|Overall Study|Other|1|||
131094599|NCT00208325|471976380|FG003|Overall Study|Other|0|||
131094600|NCT00208325|471976377|FG000|Overall Study|Mis-Randomized|17|||
131094601|NCT00208325|471976378|FG001|Overall Study|Mis-Randomized|20|||
131094602|NCT00208325|471976379|FG002|Overall Study|Mis-Randomized|0|||
131143909|NCT01427309|472152486|FG000|Overall Study|Withdrawal by Subject|148|||
131143910|NCT01427309|472152487|FG001|Overall Study|Withdrawal by Subject|148|||
131143911|NCT01427309|472152488|FG002|Overall Study|Withdrawal by Subject|61|||
131143912|NCT01427309|472152489|FG003|Overall Study|Withdrawal by Subject|55|||
131143913|NCT03502187|472152492|FG000|Overall Study|Withdrawal by Subject|4|||
131143914|NCT03502187|472152493|FG001|Overall Study|Withdrawal by Subject|3|||
131143915|NCT03502187|472152494|FG002|Overall Study|Withdrawal by Subject|3|||
131143916|NCT03502187|472152492|FG000|Overall Study|Lost to Follow-up|5|||
131094603|NCT00208325|471976380|FG003|Overall Study|Mis-Randomized|0|||
131143917|NCT03502187|472152493|FG001|Overall Study|Lost to Follow-up|4|||
131094604|NCT02206061|471976381|FG000|Overall Study|Withdrawal by Subject|4|||
131094605|NCT02206061|471976382|FG001|Overall Study|Withdrawal by Subject|7|||
131094606|NCT02206061|471976383|FG002|Overall Study|Withdrawal by Subject|1|||
131094607|NCT02206061|471976381|FG000|Overall Study|Lost to Follow-up|14|||
131094608|NCT02206061|471976382|FG001|Overall Study|Lost to Follow-up|7|||
131094609|NCT02206061|471976383|FG002|Overall Study|Lost to Follow-up|20|||
131094610|NCT01607476|471976384|FG000|Overall Study|Withdrawal by Subject|1|||
131094611|NCT01607476|471976385|FG001|Overall Study|Withdrawal by Subject|0|||
131094612|NCT01607476|471976386|FG002|Overall Study|Withdrawal by Subject|1|||
131094613|NCT01607476|471976384|FG000|Overall Study|Lost to Follow-up|0|||
131094614|NCT01607476|471976385|FG001|Overall Study|Lost to Follow-up|0|||
131094615|NCT01607476|471976386|FG002|Overall Study|Lost to Follow-up|2|||
131094616|NCT04445987|471976387|FG000|Overall Study|Adverse Event|0|||
131094617|NCT04445987|471976388|FG001|Overall Study|Adverse Event|0|||
131094618|NCT04445987|471976389|FG002|Overall Study|Adverse Event|1|||
131094619|NCT04445987|471976390|FG003|Overall Study|Adverse Event|0|||
131094620|NCT04445987|471976391|FG004|Overall Study|Adverse Event|4|||
131094621|NCT04445987|471976392|FG005|Overall Study|Adverse Event|0|||
131094622|NCT04445987|471976387|FG000|Overall Study|Lost to Follow-up|4|||
131094623|NCT04445987|471976388|FG001|Overall Study|Lost to Follow-up|3|||
131094624|NCT04445987|471976389|FG002|Overall Study|Lost to Follow-up|1|||
131094625|NCT04445987|471976390|FG003|Overall Study|Lost to Follow-up|1|||
131094626|NCT04445987|471976391|FG004|Overall Study|Lost to Follow-up|29|||
131094627|NCT04445987|471976392|FG005|Overall Study|Lost to Follow-up|0|||
131094628|NCT04445987|471976387|FG000|Overall Study|Physician Decision|0|||
131094629|NCT04445987|471976388|FG001|Overall Study|Physician Decision|0|||
131094630|NCT04445987|471976389|FG002|Overall Study|Physician Decision|0|||
131094631|NCT04445987|471976390|FG003|Overall Study|Physician Decision|0|||
131094632|NCT04445987|471976391|FG004|Overall Study|Physician Decision|1|||
131094633|NCT04445987|471976392|FG005|Overall Study|Physician Decision|0|||
131094634|NCT04445987|471976387|FG000|Overall Study|Protocol Violation|1|||
131094635|NCT04445987|471976388|FG001|Overall Study|Protocol Violation|0|||
131094636|NCT04445987|471976389|FG002|Overall Study|Protocol Violation|0|||
131094637|NCT04445987|471976390|FG003|Overall Study|Protocol Violation|0|||
131094638|NCT04445987|471976391|FG004|Overall Study|Protocol Violation|2|||
131094639|NCT04445987|471976392|FG005|Overall Study|Protocol Violation|0|||
131094640|NCT04445987|471976387|FG000|Overall Study|Withdrawal by Subject|4|||
131094641|NCT04445987|471976388|FG001|Overall Study|Withdrawal by Subject|0|||
131094642|NCT04445987|471976389|FG002|Overall Study|Withdrawal by Subject|1|||
131094643|NCT04445987|471976390|FG003|Overall Study|Withdrawal by Subject|0|||
131094644|NCT04445987|471976391|FG004|Overall Study|Withdrawal by Subject|18|||
131094645|NCT04445987|471976392|FG005|Overall Study|Withdrawal by Subject|1|||
131094646|NCT04445987|471976387|FG000|Overall Study|Other reason|0|||
131143918|NCT03502187|472152494|FG002|Overall Study|Lost to Follow-up|5|||
131143919|NCT00214461|472152495|FG000|Overall Study|Adverse Event|0|||
131143920|NCT00214461|472152496|FG001|Overall Study|Adverse Event|0|||
131143921|NCT00214461|472152497|FG002|Overall Study|Adverse Event|1|||
131143922|NCT00214461|472152498|FG003|Overall Study|Adverse Event|1|||
131143923|NCT00214461|472152495|FG000|Overall Study|Withdrawal by Subject|0|||
131234625|NCT01506947|472486404|FG000|Overall Study|Lost to Follow-up|7|||
131234626|NCT01506947|472486404|FG000|Overall Study|Adverse Event|5|||
131143924|NCT00214461|472152496|FG001|Overall Study|Withdrawal by Subject|0|||
131143925|NCT00214461|472152497|FG002|Overall Study|Withdrawal by Subject|1|||
131143926|NCT00214461|472152498|FG003|Overall Study|Withdrawal by Subject|0|||
130727540|NCT00287586|470625487|FG001|Overall Study|Nonadherence|1|||
130727541|NCT00287586|470625486|FG000|Overall Study|Enrolled in Another Study|1|||
131094647|NCT04445987|471976388|FG001|Overall Study|Other reason|0|||
131094648|NCT04445987|471976389|FG002|Overall Study|Other reason|1|||
131143927|NCT02908100|472152500|FG000|Overall Study|Adverse Event|7|||
131143928|NCT02908100|472152501|FG001|Overall Study|Adverse Event|6|||
131234627|NCT01506947|472486404|FG000|Overall Study|Death|1|||
131094649|NCT04445987|471976390|FG003|Overall Study|Other reason|0|||
131094650|NCT04445987|471976391|FG004|Overall Study|Other reason|2|||
131094651|NCT04445987|471976392|FG005|Overall Study|Other reason|0|||
131094652|NCT01114880|471976393|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
131094653|NCT01114880|471976394|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
131094654|NCT01114880|471976393|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
131094655|NCT01114880|471976394|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
131094656|NCT01114880|471976393|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
131094657|NCT01114880|471976394|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
131094658|NCT01114880|471976393|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
131094659|NCT01114880|471976394|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
131094660|NCT01114880|471976393|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
131094661|NCT01114880|471976394|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
131094662|NCT01114880|471976393|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
131094663|NCT01114880|471976394|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
131094664|NCT04157400|471976400|FG000|Overall Study|Withdrawal by Subject|1|||
131094665|NCT04157400|471976400|FG000|Overall Study|Lost to Follow-up|3|||
131094666|NCT04655027|471976401|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
131094667|NCT04655027|471976402|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
131094668|NCT03519997|471976405|FG000|Overall Study|Adverse Event|4|||
131094669|NCT03519997|471976405|FG000|Overall Study|Withdrawal by Subject|2|||
131094670|NCT03519997|471976405|FG000|Overall Study|Protocol Violation|1|||
131094671|NCT05543707|471976406|FG000|Overall Study|Study drug non-compliance/|5|||
130727542|NCT00287586|470625487|FG001|Overall Study|Enrolled in Another Study|0|||
130727543|NCT00287586|470625486|FG000|Overall Study|Major Depression|0|||
130727544|NCT00287586|470625487|FG001|Overall Study|Major Depression|2|||
131094672|NCT05543707|471976407|FG001|Overall Study|Study drug non-compliance/|0|||
130727545|NCT00287586|470625486|FG000|Overall Study|Lung Cancer|0|||
131094673|NCT05543707|471976406|FG000|Overall Study|Withdrawal by Subject|1|||
131094674|NCT05543707|471976407|FG001|Overall Study|Withdrawal by Subject|1|||
131094675|NCT05543707|471976406|FG000|Overall Study|Adverse Event|1|||
131094676|NCT05543707|471976407|FG001|Overall Study|Adverse Event|0|||
131094677|NCT05543707|471976406|FG000|Overall Study|concurrent illness|0|||
131094678|NCT05543707|471976407|FG001|Overall Study|concurrent illness|1|||
131094679|NCT05543707|471976406|FG000|Overall Study|Pregnancy|1|||
131094680|NCT05543707|471976407|FG001|Overall Study|Pregnancy|1|||
131094681|NCT00186888|471976408|FG000|Overall Study|Toxicity|0|||
131094682|NCT00186888|471976409|FG001|Overall Study|Toxicity|1|||
131094683|NCT00186888|471976410|FG002|Overall Study|Toxicity|0|||
131094684|NCT00186888|471976408|FG000|Overall Study|Relapse or progression of disease|4|||
131094685|NCT00186888|471976409|FG001|Overall Study|Relapse or progression of disease|2|||
131094686|NCT00186888|471976410|FG002|Overall Study|Relapse or progression of disease|0|||
131094687|NCT03006848|471976411|FG000|Overall Study|Adverse Event|1|||
131094688|NCT03006848|471976411|FG000|Overall Study|Physician Decision|1|||
131094689|NCT03006848|471976411|FG000|Overall Study|Lack of Efficacy|16|||
131094690|NCT04372121|471976415|FG000|Overall Study|Lost to Follow-up|0|||
131094691|NCT04372121|471976416|FG001|Overall Study|Lost to Follow-up|0|||
131094692|NCT04372121|471976417|FG002|Overall Study|Lost to Follow-up|0|||
131094693|NCT04372121|471976418|FG003|Overall Study|Lost to Follow-up|1|||
131094694|NCT04372121|471976415|FG000|Overall Study|Protocol Violation|0|||
131094695|NCT04372121|471976416|FG001|Overall Study|Protocol Violation|0|||
131094696|NCT04372121|471976417|FG002|Overall Study|Protocol Violation|1|||
131094697|NCT04372121|471976418|FG003|Overall Study|Protocol Violation|0|||
131094698|NCT04372121|471976415|FG000|Overall Study|Withdrawal by Subject|3|||
131094699|NCT04372121|471976416|FG001|Overall Study|Withdrawal by Subject|1|||
131094700|NCT04372121|471976417|FG002|Overall Study|Withdrawal by Subject|0|||
131143929|NCT02908100|472152502|FG002|Overall Study|Adverse Event|9|||
131143930|NCT02908100|472152500|FG000|Overall Study|Death|2|||
131143931|NCT02908100|472152501|FG001|Overall Study|Death|0|||
131143932|NCT02908100|472152502|FG002|Overall Study|Death|0|||
131143933|NCT02908100|472152500|FG000|Overall Study|Lack of Efficacy|2|||
131143934|NCT02908100|472152501|FG001|Overall Study|Lack of Efficacy|3|||
131143935|NCT02908100|472152502|FG002|Overall Study|Lack of Efficacy|3|||
131143936|NCT02908100|472152500|FG000|Overall Study|Lost to Follow-up|0|||
131143937|NCT02908100|472152501|FG001|Overall Study|Lost to Follow-up|1|||
131143938|NCT02908100|472152502|FG002|Overall Study|Lost to Follow-up|2|||
131143939|NCT02908100|472152500|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131143940|NCT02908100|472152501|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130727546|NCT00287586|470625487|FG001|Overall Study|Lung Cancer|2|||
131094701|NCT04372121|471976418|FG003|Overall Study|Withdrawal by Subject|0|||
131094702|NCT04372121|471976415|FG000|Overall Study|Study termination|6|||
131094703|NCT04372121|471976416|FG001|Overall Study|Study termination|5|||
131094704|NCT04372121|471976417|FG002|Overall Study|Study termination|1|||
131094705|NCT04372121|471976418|FG003|Overall Study|Study termination|1|||
131094706|NCT04372121|471976415|FG000|Overall Study|Hysterectomy planned|1|||
131094707|NCT04372121|471976416|FG001|Overall Study|Hysterectomy planned|0|||
131094708|NCT04372121|471976417|FG002|Overall Study|Hysterectomy planned|0|||
131094709|NCT04372121|471976418|FG003|Overall Study|Hysterectomy planned|0|||
131094710|NCT02344290|471976419|FG000|Overall Study|Withdrawal by Subject|315|||
131094711|NCT02344290|471976420|FG001|Overall Study|Withdrawal by Subject|324|||
131094712|NCT02344290|471976419|FG000|Overall Study|Lost to Follow-up|258|||
131143941|NCT02908100|472152502|FG002|Overall Study|Non-Compliance With Study Drug|2|||
131143942|NCT02908100|472152500|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
131143943|NCT02908100|472152501|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
131094713|NCT02344290|471976420|FG001|Overall Study|Lost to Follow-up|249|||
131094714|NCT02344290|471976419|FG000|Overall Study|Unable to get to clinic|69|||
131094715|NCT02344290|471976420|FG001|Overall Study|Unable to get to clinic|60|||
131094716|NCT02344290|471976419|FG000|Overall Study|Physician Decision|25|||
131094717|NCT02344290|471976420|FG001|Overall Study|Physician Decision|25|||
131094718|NCT02344290|471976419|FG000|Overall Study|Site Closure|15|||
131094719|NCT02344290|471976420|FG001|Overall Study|Site Closure|19|||
131094720|NCT02344290|471976419|FG000|Overall Study|Other|5|||
131094721|NCT02344290|471976420|FG001|Overall Study|Other|3|||
131094722|NCT03826030|471976421|FG000|Overall Study|Withdrawal by Subject|2|||
131094723|NCT03826030|471976422|FG001|Overall Study|Withdrawal by Subject|0|||
131094724|NCT03826030|471976423|FG002|Overall Study|Withdrawal by Subject|1|||
131094725|NCT03826030|471976421|FG000|Overall Study|Lost to Follow-up|1|||
131094726|NCT03826030|471976422|FG001|Overall Study|Lost to Follow-up|1|||
131094727|NCT03826030|471976423|FG002|Overall Study|Lost to Follow-up|1|||
131094728|NCT03826030|471976421|FG000|Overall Study|Too busy to return for visits|1|||
131094729|NCT03826030|471976422|FG001|Overall Study|Too busy to return for visits|0|||
131094730|NCT03826030|471976423|FG002|Overall Study|Too busy to return for visits|0|||
131094731|NCT03820947|471976428|FG000|Overall Study|Physician Decision|0|||
131094732|NCT03820947|471976429|FG001|Overall Study|Physician Decision|1|||
131094733|NCT03820947|471976430|FG002|Overall Study|Physician Decision|1|||
131094734|NCT03820947|471976431|FG003|Overall Study|Physician Decision|0|||
131094735|NCT03820947|471976432|FG004|Overall Study|Physician Decision|3|||
131094736|NCT03820947|471976428|FG000|Overall Study|Withdrawal by Subject|6|||
131094737|NCT03820947|471976429|FG001|Overall Study|Withdrawal by Subject|10|||
131094738|NCT03820947|471976430|FG002|Overall Study|Withdrawal by Subject|3|||
131094739|NCT03820947|471976431|FG003|Overall Study|Withdrawal by Subject|8|||
131094740|NCT03820947|471976432|FG004|Overall Study|Withdrawal by Subject|5|||
131094741|NCT03820947|471976428|FG000|Overall Study|Procedure Not Attempted|0|||
131094742|NCT03820947|471976429|FG001|Overall Study|Procedure Not Attempted|2|||
131094743|NCT03820947|471976430|FG002|Overall Study|Procedure Not Attempted|1|||
131094744|NCT03820947|471976431|FG003|Overall Study|Procedure Not Attempted|0|||
131094745|NCT03820947|471976432|FG004|Overall Study|Procedure Not Attempted|0|||
131094746|NCT03820947|471976428|FG000|Overall Study|Other Exit|1|||
131094747|NCT03820947|471976429|FG001|Overall Study|Other Exit|3|||
131094748|NCT03820947|471976430|FG002|Overall Study|Other Exit|3|||
131094749|NCT03820947|471976431|FG003|Overall Study|Other Exit|3|||
131094750|NCT03820947|471976432|FG004|Overall Study|Other Exit|0|||
131094751|NCT03820947|471976428|FG000|Overall Study|Follow-up Not Done|10|||
131094752|NCT03820947|471976429|FG001|Overall Study|Follow-up Not Done|13|||
131094753|NCT03820947|471976430|FG002|Overall Study|Follow-up Not Done|2|||
131094754|NCT03820947|471976431|FG003|Overall Study|Follow-up Not Done|3|||
131094755|NCT03820947|471976432|FG004|Overall Study|Follow-up Not Done|12|||
131094756|NCT03820947|471976428|FG000|Overall Study|Death|0|||
131094757|NCT03820947|471976429|FG001|Overall Study|Death|0|||
131094758|NCT03820947|471976430|FG002|Overall Study|Death|0|||
131094759|NCT03820947|471976431|FG003|Overall Study|Death|0|||
131094760|NCT03820947|471976432|FG004|Overall Study|Death|9|||
131094761|NCT03820947|471976428|FG000|Overall Study|Lost to Follow-up|4|||
131094762|NCT03820947|471976429|FG001|Overall Study|Lost to Follow-up|6|||
131094763|NCT03820947|471976430|FG002|Overall Study|Lost to Follow-up|0|||
131094764|NCT03820947|471976431|FG003|Overall Study|Lost to Follow-up|0|||
131094765|NCT03820947|471976432|FG004|Overall Study|Lost to Follow-up|9|||
131094766|NCT04500769|471978674|FG000|Overall Study|Withdrawal by Subject|5|||
131094767|NCT01967147|471978675|FG000|Overall Study|Adverse Event|5|||
131094768|NCT01967147|471978676|FG001|Overall Study|Adverse Event|2|||
131094769|NCT01967147|471978675|FG000|Overall Study|Lack of Efficacy|1|||
131094770|NCT01967147|471978676|FG001|Overall Study|Lack of Efficacy|4|||
131094771|NCT01967147|471978675|FG000|Overall Study|Lost to Follow-up|1|||
131094772|NCT01967147|471978676|FG001|Overall Study|Lost to Follow-up|2|||
131094773|NCT01967147|471978675|FG000|Overall Study|Withdrawal by Subject|2|||
131094774|NCT01967147|471978676|FG001|Overall Study|Withdrawal by Subject|4|||
131094775|NCT01967147|471978675|FG000|Overall Study|Non-compliance with Study Drug|0|||
131094776|NCT01967147|471978676|FG001|Overall Study|Non-compliance with Study Drug|3|||
131094777|NCT01967147|471978675|FG000|Overall Study|Other|4|||
131094778|NCT01967147|471978676|FG001|Overall Study|Other|5|||
131094779|NCT02218606|471978677|FG000|Overall Study|Adverse Event|1|||
131094780|NCT02218606|471978678|FG001|Overall Study|Adverse Event|1|||
131094781|NCT02218606|471978677|FG000|Overall Study|Death|15|||
131094782|NCT02218606|471978678|FG001|Overall Study|Death|28|||
131094783|NCT02218606|471978677|FG000|Overall Study|Physician Decision|0|||
131094784|NCT02218606|471978678|FG001|Overall Study|Physician Decision|1|||
131094785|NCT02218606|471978677|FG000|Overall Study|Withdrawal by Subject|4|||
131094786|NCT02218606|471978678|FG001|Overall Study|Withdrawal by Subject|0|||
131094787|NCT02218606|471978677|FG000|Overall Study|Noncompliance|1|||
131094788|NCT02218606|471978678|FG001|Overall Study|Noncompliance|0|||
131094789|NCT02218606|471978677|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
131094790|NCT02218606|471978678|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
131094791|NCT02218606|471978677|FG000|Overall Study|Other|2|||
130727547|NCT00287586|470625486|FG000|Overall Study|Elevated IPSS Score|0|||
130727548|NCT00287586|470625487|FG001|Overall Study|Elevated IPSS Score|1|||
130727549|NCT00287586|470625486|FG000|Overall Study|Retroperitoneal Cancer|0|||
130727550|NCT00287586|470625487|FG001|Overall Study|Retroperitoneal Cancer|1|||
131094792|NCT02218606|471978678|FG001|Overall Study|Other|1|||
131094793|NCT02218606|471978677|FG000|Overall Study|Never started treatment|0|||
131094794|NCT02218606|471978678|FG001|Overall Study|Never started treatment|1|||
131094795|NCT03203473|471978679|FG000|Induction Phase|Never started primary treatment|2|||
131094796|NCT03203473|471978680|FG001|Induction Phase|Never started primary treatment|0|||
131094797|NCT03203473|471978681|FG002|Induction Phase|Never started primary treatment|0|||
131094798|NCT03203473|471978679|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
131094799|NCT03203473|471978680|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
131094800|NCT03203473|471978681|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
131094801|NCT03203473|471978679|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
131094802|NCT03203473|471978680|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
131094803|NCT03203473|471978681|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
131094804|NCT03203473|471978679|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
131094805|NCT03203473|471978680|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
131094806|NCT03203473|471978681|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
131094807|NCT03203473|471978679|FG000|Arm Allocation Phase|started salvage therapy|0|||
131094808|NCT03203473|471978680|FG001|Arm Allocation Phase|started salvage therapy|5|||
131094809|NCT03203473|471978681|FG002|Arm Allocation Phase|started salvage therapy|0|||
131094810|NCT03203473|471978679|FG000|Arm Allocation Phase|Disease progression|0|||
131094811|NCT03203473|471978680|FG001|Arm Allocation Phase|Disease progression|0|||
131094812|NCT03203473|471978681|FG002|Arm Allocation Phase|Disease progression|37|||
131094813|NCT03203473|471978679|FG000|Arm Allocation Phase|Adverse Event|0|||
131094814|NCT03203473|471978680|FG001|Arm Allocation Phase|Adverse Event|0|||
131094815|NCT03203473|471978681|FG002|Arm Allocation Phase|Adverse Event|11|||
131094816|NCT03203473|471978679|FG000|Arm Allocation Phase|Physician Decision|0|||
131094817|NCT03203473|471978680|FG001|Arm Allocation Phase|Physician Decision|0|||
131094818|NCT03203473|471978681|FG002|Arm Allocation Phase|Physician Decision|3|||
131094819|NCT03203473|471978679|FG000|Arm Allocation Phase|Death|0|||
131094820|NCT03203473|471978680|FG001|Arm Allocation Phase|Death|0|||
131094821|NCT03203473|471978681|FG002|Arm Allocation Phase|Death|1|||
131094822|NCT03203473|471978679|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
131094823|NCT03203473|471978680|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
131094824|NCT03203473|471978681|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
131094825|NCT03203473|471978679|FG000|Arm Allocation Phase|Intercurrent illness|0|||
131094826|NCT03203473|471978680|FG001|Arm Allocation Phase|Intercurrent illness|0|||
131094827|NCT03203473|471978681|FG002|Arm Allocation Phase|Intercurrent illness|1|||
131094828|NCT03203473|471978679|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
131094829|NCT03203473|471978680|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
131094830|NCT03203473|471978681|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
131094831|NCT00890695|471978682|FG000|Overall Study|Protocol Violation|1|||
131094832|NCT00890695|471978683|FG001|Overall Study|Protocol Violation|0|||
131094833|NCT01255631|471978688|FG000|Overall Study|poor enrollment, no data analyzed|9|||
131094834|NCT01255631|471978689|FG001|Overall Study|poor enrollment, no data analyzed|6|||
131094835|NCT01531673|471978699|FG000|Overall Study|Non-Compliance|0|||
131094836|NCT01531673|471978700|FG001|Overall Study|Non-Compliance|0|||
131094837|NCT01531673|471978701|FG002|Overall Study|Non-Compliance|0|||
131094838|NCT01531673|471978702|FG003|Overall Study|Non-Compliance|0|||
131143944|NCT02908100|472152502|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
131143945|NCT02908100|472152500|FG000|Overall Study|Physician Decision|0|||
131143946|NCT02908100|472152501|FG001|Overall Study|Physician Decision|1|||
131143947|NCT02908100|472152502|FG002|Overall Study|Physician Decision|0|||
130727551|NCT00287586|470625486|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
130727552|NCT00287586|470625487|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
131094839|NCT01531673|471978703|FG004|Overall Study|Non-Compliance|0|||
131094840|NCT01531673|471978704|FG005|Overall Study|Non-Compliance|1|||
131094841|NCT01531673|471978705|FG006|Overall Study|Non-Compliance|0|||
131094842|NCT01531673|471978706|FG007|Overall Study|Non-Compliance|0|||
131094843|NCT01531673|471978707|FG008|Overall Study|Non-Compliance|0|||
131094844|NCT01531673|471978708|FG009|Overall Study|Non-Compliance|0|||
131094845|NCT01531673|471978709|FG010|Overall Study|Non-Compliance|0|||
131094846|NCT01531673|471978710|FG011|Overall Study|Non-Compliance|0|||
131094847|NCT01531673|471978711|FG012|Overall Study|Non-Compliance|0|||
131094848|NCT01531673|471978699|FG000|Overall Study|Adverse Event|0|||
131094849|NCT01531673|471978700|FG001|Overall Study|Adverse Event|1|||
131094850|NCT01531673|471978701|FG002|Overall Study|Adverse Event|0|||
131094851|NCT01531673|471978702|FG003|Overall Study|Adverse Event|0|||
131094852|NCT01531673|471978703|FG004|Overall Study|Adverse Event|0|||
131094853|NCT01531673|471978704|FG005|Overall Study|Adverse Event|0|||
131094854|NCT01531673|471978705|FG006|Overall Study|Adverse Event|0|||
131094855|NCT01531673|471978706|FG007|Overall Study|Adverse Event|0|||
130727553|NCT00287586|470625486|FG000|Overall Study|Mood Swings and Irritability|0|||
131094856|NCT01531673|471978707|FG008|Overall Study|Adverse Event|0|||
131094857|NCT01531673|471978708|FG009|Overall Study|Adverse Event|0|||
131094858|NCT01531673|471978709|FG010|Overall Study|Adverse Event|0|||
131094859|NCT01531673|471978710|FG011|Overall Study|Adverse Event|0|||
131094860|NCT01531673|471978711|FG012|Overall Study|Adverse Event|0|||
131094861|NCT01531673|471978699|FG000|Overall Study|Lost to Follow-up|0|||
131094862|NCT01531673|471978700|FG001|Overall Study|Lost to Follow-up|0|||
131094863|NCT01531673|471978701|FG002|Overall Study|Lost to Follow-up|0|||
131094864|NCT01531673|471978702|FG003|Overall Study|Lost to Follow-up|0|||
131094865|NCT01531673|471978703|FG004|Overall Study|Lost to Follow-up|1|||
131094866|NCT01531673|471978704|FG005|Overall Study|Lost to Follow-up|0|||
131094867|NCT01531673|471978705|FG006|Overall Study|Lost to Follow-up|0|||
131094868|NCT01531673|471978706|FG007|Overall Study|Lost to Follow-up|0|||
131094869|NCT01531673|471978707|FG008|Overall Study|Lost to Follow-up|0|||
131094870|NCT01531673|471978708|FG009|Overall Study|Lost to Follow-up|0|||
131094871|NCT01531673|471978709|FG010|Overall Study|Lost to Follow-up|0|||
131094872|NCT01531673|471978710|FG011|Overall Study|Lost to Follow-up|0|||
131094873|NCT01531673|471978711|FG012|Overall Study|Lost to Follow-up|0|||
131094874|NCT01531673|471978699|FG000|Overall Study|Other|0|||
131094875|NCT01531673|471978700|FG001|Overall Study|Other|0|||
131094876|NCT01531673|471978701|FG002|Overall Study|Other|0|||
131094877|NCT01531673|471978702|FG003|Overall Study|Other|1|||
131094878|NCT01531673|471978703|FG004|Overall Study|Other|0|||
131094879|NCT01531673|471978704|FG005|Overall Study|Other|0|||
131094880|NCT01531673|471978705|FG006|Overall Study|Other|0|||
131094881|NCT01531673|471978706|FG007|Overall Study|Other|0|||
131094882|NCT01531673|471978707|FG008|Overall Study|Other|0|||
131094883|NCT01531673|471978708|FG009|Overall Study|Other|1|||
131094884|NCT01531673|471978709|FG010|Overall Study|Other|0|||
131094885|NCT01531673|471978710|FG011|Overall Study|Other|0|||
131094886|NCT01531673|471978711|FG012|Overall Study|Other|0|||
131094887|NCT00568178|471978712|FG000|Double Blind Base Study|Adverse Event|0|||
131094888|NCT00568178|471978713|FG001|Double Blind Base Study|Adverse Event|2|||
131094889|NCT00568178|471978714|FG002|Double Blind Base Study|Adverse Event|1|||
131094890|NCT00568178|471978715|FG003|Double Blind Base Study|Adverse Event|2|||
131094891|NCT00568178|471978716|FG004|Double Blind Base Study|Adverse Event|0|||
131094892|NCT00568178|471978717|FG005|Double Blind Base Study|Adverse Event|0|||
131094893|NCT00568178|471978712|FG000|Double Blind Base Study|Lost to Follow-up|1|||
131094894|NCT00568178|471978713|FG001|Double Blind Base Study|Lost to Follow-up|0|||
131094895|NCT00568178|471978714|FG002|Double Blind Base Study|Lost to Follow-up|0|||
131094896|NCT00568178|471978715|FG003|Double Blind Base Study|Lost to Follow-up|1|||
131094897|NCT00568178|471978716|FG004|Double Blind Base Study|Lost to Follow-up|0|||
131094898|NCT00568178|471978717|FG005|Double Blind Base Study|Lost to Follow-up|0|||
131094899|NCT00568178|471978712|FG000|Double Blind Base Study|Physician Decision|1|||
131094900|NCT00568178|471978713|FG001|Double Blind Base Study|Physician Decision|1|||
131094901|NCT00568178|471978714|FG002|Double Blind Base Study|Physician Decision|0|||
131094902|NCT00568178|471978715|FG003|Double Blind Base Study|Physician Decision|1|||
131094903|NCT00568178|471978716|FG004|Double Blind Base Study|Physician Decision|0|||
131094904|NCT00568178|471978717|FG005|Double Blind Base Study|Physician Decision|0|||
131094905|NCT00568178|471978712|FG000|Double Blind Base Study|Protocol Violation|3|||
131094906|NCT00568178|471978713|FG001|Double Blind Base Study|Protocol Violation|2|||
131094907|NCT00568178|471978714|FG002|Double Blind Base Study|Protocol Violation|0|||
131094908|NCT00568178|471978715|FG003|Double Blind Base Study|Protocol Violation|0|||
131094909|NCT00568178|471978716|FG004|Double Blind Base Study|Protocol Violation|0|||
131094910|NCT00568178|471978717|FG005|Double Blind Base Study|Protocol Violation|0|||
131094911|NCT00568178|471978712|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
131094912|NCT00568178|471978713|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
131143948|NCT02908100|472152500|FG000|Overall Study|Pregnancy|1|||
131143949|NCT02908100|472152501|FG001|Overall Study|Pregnancy|2|||
131143950|NCT02908100|472152502|FG002|Overall Study|Pregnancy|0|||
131143951|NCT02908100|472152500|FG000|Overall Study|Withdrawal by Subject|8|||
131143952|NCT02908100|472152501|FG001|Overall Study|Withdrawal by Subject|7|||
131094913|NCT00568178|471978714|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
131094914|NCT00568178|471978715|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
131143953|NCT02908100|472152502|FG002|Overall Study|Withdrawal by Subject|5|||
131094915|NCT00568178|471978716|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
131094916|NCT00568178|471978717|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
131094917|NCT00568178|471978712|FG000|Double Blind Base Study|Progressive Disease|0|||
131143954|NCT02908100|472152500|FG000|Overall Study|Randomised in Error|1|||
130780283|NCT00128661|470821481|FG000|Overall Study|Lost to Follow-up|10|||
131094918|NCT00568178|471978713|FG001|Double Blind Base Study|Progressive Disease|0|||
131094919|NCT00568178|471978714|FG002|Double Blind Base Study|Progressive Disease|0|||
131094920|NCT00568178|471978715|FG003|Double Blind Base Study|Progressive Disease|1|||
131094921|NCT00568178|471978716|FG004|Double Blind Base Study|Progressive Disease|0|||
131094922|NCT00568178|471978717|FG005|Double Blind Base Study|Progressive Disease|0|||
131094923|NCT00568178|471978712|FG000|Open Label Extension|Adverse Event|0|||
131094924|NCT00568178|471978713|FG001|Open Label Extension|Adverse Event|0|||
130727554|NCT00287586|470625487|FG001|Overall Study|Mood Swings and Irritability|1|||
130727555|NCT00287586|470625486|FG000|Overall Study|Bradycardia|0|||
130727556|NCT00287586|470625487|FG001|Overall Study|Bradycardia|1|||
130727557|NCT00287586|470625486|FG000|Overall Study|Itchy Swollen Eyes|0|||
130727558|NCT00287586|470625487|FG001|Overall Study|Itchy Swollen Eyes|1|||
130727559|NCT00287586|470625486|FG000|Overall Study|Recurrent Melanoma|0|||
131094925|NCT00568178|471978714|FG002|Open Label Extension|Adverse Event|0|||
131094926|NCT00568178|471978715|FG003|Open Label Extension|Adverse Event|0|||
131094927|NCT00568178|471978716|FG004|Open Label Extension|Adverse Event|11|||
131094928|NCT00568178|471978717|FG005|Open Label Extension|Adverse Event|8|||
131094929|NCT00568178|471978712|FG000|Open Label Extension|Protocol Violation|0|||
131094930|NCT00568178|471978713|FG001|Open Label Extension|Protocol Violation|0|||
131094931|NCT00568178|471978714|FG002|Open Label Extension|Protocol Violation|0|||
131094932|NCT00568178|471978715|FG003|Open Label Extension|Protocol Violation|0|||
131094933|NCT00568178|471978716|FG004|Open Label Extension|Protocol Violation|1|||
131094934|NCT00568178|471978717|FG005|Open Label Extension|Protocol Violation|0|||
131094935|NCT00568178|471978712|FG000|Open Label Extension|Lost to Follow-up|0|||
131094936|NCT00568178|471978713|FG001|Open Label Extension|Lost to Follow-up|0|||
131094937|NCT00568178|471978714|FG002|Open Label Extension|Lost to Follow-up|0|||
131094938|NCT00568178|471978715|FG003|Open Label Extension|Lost to Follow-up|0|||
131094939|NCT00568178|471978716|FG004|Open Label Extension|Lost to Follow-up|6|||
131094940|NCT00568178|471978717|FG005|Open Label Extension|Lost to Follow-up|11|||
131094941|NCT00568178|471978712|FG000|Open Label Extension|Physician Decision|0|||
131094942|NCT00568178|471978713|FG001|Open Label Extension|Physician Decision|0|||
131094943|NCT00568178|471978714|FG002|Open Label Extension|Physician Decision|0|||
131094944|NCT00568178|471978715|FG003|Open Label Extension|Physician Decision|0|||
131094945|NCT00568178|471978716|FG004|Open Label Extension|Physician Decision|9|||
131094946|NCT00568178|471978717|FG005|Open Label Extension|Physician Decision|8|||
131094947|NCT00568178|471978712|FG000|Open Label Extension|Pregnancy|0|||
131094948|NCT00568178|471978713|FG001|Open Label Extension|Pregnancy|0|||
131094949|NCT00568178|471978714|FG002|Open Label Extension|Pregnancy|0|||
131094950|NCT00568178|471978715|FG003|Open Label Extension|Pregnancy|0|||
131094951|NCT00568178|471978716|FG004|Open Label Extension|Pregnancy|0|||
131094952|NCT00568178|471978717|FG005|Open Label Extension|Pregnancy|1|||
131094953|NCT00568178|471978712|FG000|Open Label Extension|Progressive Disease|0|||
131094954|NCT00568178|471978713|FG001|Open Label Extension|Progressive Disease|0|||
131094955|NCT00568178|471978714|FG002|Open Label Extension|Progressive Disease|0|||
131094956|NCT00568178|471978715|FG003|Open Label Extension|Progressive Disease|0|||
131094957|NCT00568178|471978716|FG004|Open Label Extension|Progressive Disease|3|||
131094958|NCT00568178|471978717|FG005|Open Label Extension|Progressive Disease|1|||
131094959|NCT00568178|471978712|FG000|Open Label Extension|Termination of Trial|0|||
131094960|NCT00568178|471978713|FG001|Open Label Extension|Termination of Trial|0|||
131094961|NCT00568178|471978714|FG002|Open Label Extension|Termination of Trial|0|||
131094962|NCT00568178|471978715|FG003|Open Label Extension|Termination of Trial|0|||
131094963|NCT00568178|471978716|FG004|Open Label Extension|Termination of Trial|45|||
131094964|NCT00568178|471978717|FG005|Open Label Extension|Termination of Trial|47|||
131094965|NCT00568178|471978712|FG000|Open Label Extension|Withdrawal by Subject|0|||
131094966|NCT00568178|471978713|FG001|Open Label Extension|Withdrawal by Subject|0|||
131094967|NCT00568178|471978714|FG002|Open Label Extension|Withdrawal by Subject|0|||
131094968|NCT00568178|471978715|FG003|Open Label Extension|Withdrawal by Subject|0|||
131094969|NCT00568178|471978716|FG004|Open Label Extension|Withdrawal by Subject|4|||
131094970|NCT00568178|471978717|FG005|Open Label Extension|Withdrawal by Subject|4|||
131094971|NCT02815579|471978718|FG000|Overall Study|Non-payment of loan down-payment|16|||
131094972|NCT02815579|471978719|FG001|Overall Study|Non-payment of loan down-payment|0|||
131094973|NCT02815579|471978718|FG000|Overall Study|Withdrawal by Subject|7|||
131094974|NCT02815579|471978719|FG001|Overall Study|Withdrawal by Subject|1|||
131094975|NCT02815579|471978718|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
131094976|NCT02815579|471978719|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
131094977|NCT02815579|471978718|FG000|Overall Study|Lost to Follow-up|7|||
131094978|NCT02815579|471978719|FG001|Overall Study|Lost to Follow-up|4|||
131094979|NCT02815579|471978718|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
131094980|NCT02815579|471978719|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
131094981|NCT02815579|471978718|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
131094982|NCT02815579|471978719|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
131094983|NCT02815579|471978718|FG000|Overall Study|Death|5|||
131094984|NCT02815579|471978719|FG001|Overall Study|Death|4|||
131143955|NCT02908100|472152501|FG001|Overall Study|Randomised in Error|0|||
130727560|NCT00287586|470625487|FG001|Overall Study|Recurrent Melanoma|1|||
130727561|NCT03743415|470625489|FG000|Overall Study|Death|5|||
130727562|NCT03743415|470625490|FG001|Overall Study|Death|3|||
130727563|NCT03743415|470625491|FG002|Overall Study|Death|1|||
130727564|NCT03743415|470625492|FG003|Overall Study|Death|4|||
131094985|NCT02815579|471978718|FG000|Overall Study|Imprisoned|0|||
131094986|NCT02815579|471978719|FG001|Overall Study|Imprisoned|2|||
131094987|NCT02815579|471978718|FG000|Overall Study|Did not meet enrollment criteria|0|||
131143956|NCT02908100|472152502|FG002|Overall Study|Randomised in Error|0|||
131143957|NCT00400400|472152503|FG000|Overall Study|Adverse Event|9|||
131143958|NCT00400400|472152504|FG001|Overall Study|Adverse Event|8|||
131143959|NCT00400400|472152503|FG000|Overall Study|Protocol Violation|2|||
131143960|NCT00400400|472152504|FG001|Overall Study|Protocol Violation|0|||
131143961|NCT00400400|472152503|FG000|Overall Study|Withdrawal by Subject|1|||
131143962|NCT00400400|472152504|FG001|Overall Study|Withdrawal by Subject|3|||
131143963|NCT00400400|472152503|FG000|Overall Study|Administrative Problem|1|||
131143964|NCT00400400|472152504|FG001|Overall Study|Administrative Problem|0|||
131143965|NCT00400400|472152503|FG000|Overall Study|Lost to Follow-up|0|||
131143966|NCT00400400|472152504|FG001|Overall Study|Lost to Follow-up|1|||
131143967|NCT00400400|472152503|FG000|Overall Study|Did not receive study drug|1|||
131143968|NCT00400400|472152504|FG001|Overall Study|Did not receive study drug|3|||
131143969|NCT01688050|472152505|FG000|Overall Study|Death|7|||
131143970|NCT01688050|472152505|FG000|Overall Study|Conversion to open repair|1|||
131143971|NCT01688050|472152505|FG000|Overall Study|Lost to Follow-up|13|||
131143972|NCT01688050|472152505|FG000|Overall Study|Withdrawal by Subject|10|||
131143973|NCT00330187|472152518|FG000|Overall Study|Lost to Follow-up|12|||
131143974|NCT00330187|472152519|FG001|Overall Study|Lost to Follow-up|13|||
131143975|NCT00330187|472152520|FG002|Overall Study|Lost to Follow-up|14|||
131143976|NCT00330187|472152521|FG003|Overall Study|Lost to Follow-up|10|||
131143977|NCT00330187|472152518|FG000|Overall Study|Withdrawal by Subject|8|||
131143978|NCT00330187|472152519|FG001|Overall Study|Withdrawal by Subject|5|||
131143979|NCT00330187|472152520|FG002|Overall Study|Withdrawal by Subject|4|||
131094988|NCT02815579|471978719|FG001|Overall Study|Did not meet enrollment criteria|1|||
131094989|NCT00264303|471978720|FG000|Overall Study|Adverse Event|4|||
131094990|NCT00264303|471978721|FG001|Overall Study|Adverse Event|3|||
131094991|NCT00264303|471978720|FG000|Overall Study|Lack of Efficacy|10|||
131094992|NCT00264303|471978721|FG001|Overall Study|Lack of Efficacy|13|||
131094993|NCT00264303|471978720|FG000|Overall Study|Lost to Follow-up|3|||
131094994|NCT00264303|471978721|FG001|Overall Study|Lost to Follow-up|3|||
131094995|NCT00264303|471978720|FG000|Overall Study|Withdrawal by Subject|2|||
131094996|NCT00264303|471978721|FG001|Overall Study|Withdrawal by Subject|3|||
131094997|NCT00264303|471978720|FG000|Overall Study|Various reasons listed in study report|6|||
131094998|NCT00264303|471978721|FG001|Overall Study|Various reasons listed in study report|7|||
131094999|NCT02389452|471978722|FG000|Overall Study|Lost to Follow-up|13|||
131095000|NCT02389452|471978722|FG000|Overall Study|Adverse Event|1|||
131095001|NCT02389452|471978722|FG000|Overall Study|Withdrawal by Subject|5|||
131095002|NCT02389452|471978722|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
131095003|NCT02311673|471978723|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
131095004|NCT02311673|471978724|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
131095005|NCT02311673|471978725|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
131095006|NCT02311673|471978726|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
131095007|NCT00414908|471978737|FG000|Overall Study|Protocol Violation|1|||
131095008|NCT00414908|471978738|FG001|Overall Study|Protocol Violation|1|||
131095009|NCT01076153|471978739|FG000|Overall Study|Symptoms improved/resolved|10|||
131095010|NCT01076153|471978739|FG000|Overall Study|Adverse Event|1|||
131095011|NCT00818168|471978740|FG000|Overall Study|Lack of Efficacy|18|||
131095012|NCT00818168|471978740|FG000|Overall Study|Pregnancy|2|||
131095013|NCT00818168|471978740|FG000|Overall Study|Withdrawal by Subject|16|||
131095014|NCT00818168|471978740|FG000|Overall Study|Lost to Follow-up|7|||
131095015|NCT00818168|471978740|FG000|Overall Study|Adverse Event|19|||
131095016|NCT00818168|471978740|FG000|Overall Study|Reason for Non-completion Not reported|6|||
131095017|NCT00818168|471978740|FG000|Overall Study|Participant Moved|2|||
131095018|NCT02040259|471978743|FG000|Overall Study|Death|280|||
131095019|NCT02040259|471978743|FG000|Overall Study|Lost to Follow-up|76|||
131095020|NCT02040259|471978743|FG000|Overall Study|Assessment not completed|3|||
131095021|NCT02040259|471978743|FG000|Overall Study|Withdrawal by Subject|4|||
131095022|NCT04476251|471978744|FG000|Overall Study|Not treated|1|||
131143980|NCT00330187|472152521|FG003|Overall Study|Withdrawal by Subject|4|||
131143981|NCT03258814|472152522|FG000|Overall Study|Early Termination|4|||
131143982|NCT03258814|472152523|FG001|Overall Study|Early Termination|3|||
131143983|NCT03258814|472152524|FG002|Overall Study|Early Termination|10|||
131143984|NCT01413958|472152525|FG000|Overall Study|Lost to Follow-up|0|||
131143985|NCT01413958|472152526|FG001|Overall Study|Lost to Follow-up|1|||
131143986|NCT01900002|472152527|FG000|Overall Study|Withdrawal by Subject|2|||
131143987|NCT01900002|472152527|FG000|Overall Study|ineligible for Y-90|4|||
130727565|NCT03743415|470625493|FG004|Overall Study|Death|0|||
131095023|NCT00316602|471978755|FG000|Overall Study|Withdrawal by Subject|3|||
131095024|NCT00316602|471978756|FG001|Overall Study|Withdrawal by Subject|2|||
131095025|NCT00316602|471978755|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
131095026|NCT00316602|471978756|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
131095027|NCT00316602|471978755|FG000|Overall Study|Adverse Event|1|||
131143988|NCT01573910|472152534|FG000|Overall Study|Adverse Event|4|||
131143989|NCT01573910|472152535|FG001|Overall Study|Adverse Event|4|||
131143990|NCT01573910|472152534|FG000|Overall Study|Lost to Follow-up|2|||
131234628|NCT01506947|472486404|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
131234629|NCT01700621|472486405|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
131234630|NCT01700621|472486406|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
131234631|NCT01700621|472486405|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
131095028|NCT00316602|471978756|FG001|Overall Study|Adverse Event|0|||
131095029|NCT00316602|471978755|FG000|Overall Study|Other|3|||
131095030|NCT00316602|471978756|FG001|Overall Study|Other|6|||
131095031|NCT01142232|471978757|FG000|Overall Study|Adverse Event|1|||
131095032|NCT01142232|471978758|FG001|Overall Study|Adverse Event|2|||
131095033|NCT01142232|471978759|FG002|Overall Study|Adverse Event|1|||
131095034|NCT01142232|471978760|FG003|Overall Study|Adverse Event|0|||
131095035|NCT01142232|471978761|FG004|Overall Study|Adverse Event|4|||
131095036|NCT01142232|471978757|FG000|Overall Study|Death|0|||
131095037|NCT01142232|471978758|FG001|Overall Study|Death|0|||
131095038|NCT01142232|471978759|FG002|Overall Study|Death|0|||
131095039|NCT01142232|471978760|FG003|Overall Study|Death|0|||
131095040|NCT01142232|471978761|FG004|Overall Study|Death|1|||
131095041|NCT01142232|471978757|FG000|Overall Study|Disease Progression|2|||
131095042|NCT01142232|471978758|FG001|Overall Study|Disease Progression|0|||
131095043|NCT01142232|471978759|FG002|Overall Study|Disease Progression|1|||
131095044|NCT01142232|471978760|FG003|Overall Study|Disease Progression|2|||
131095045|NCT01142232|471978761|FG004|Overall Study|Disease Progression|12|||
131095046|NCT01142232|471978757|FG000|Overall Study|Withdrawal by Subject|0|||
131095047|NCT01142232|471978758|FG001|Overall Study|Withdrawal by Subject|0|||
131095048|NCT01142232|471978759|FG002|Overall Study|Withdrawal by Subject|0|||
131095049|NCT01142232|471978760|FG003|Overall Study|Withdrawal by Subject|1|||
131095050|NCT01142232|471978761|FG004|Overall Study|Withdrawal by Subject|3|||
131095051|NCT01142232|471978757|FG000|Overall Study|Physician Decision|0|||
131095052|NCT01142232|471978758|FG001|Overall Study|Physician Decision|1|||
131095053|NCT01142232|471978759|FG002|Overall Study|Physician Decision|0|||
131095054|NCT01142232|471978760|FG003|Overall Study|Physician Decision|2|||
131095055|NCT01142232|471978761|FG004|Overall Study|Physician Decision|10|||
131095056|NCT01142232|471978757|FG000|Overall Study|Alternative Therapy|0|||
131095057|NCT01142232|471978758|FG001|Overall Study|Alternative Therapy|1|||
131095058|NCT01142232|471978759|FG002|Overall Study|Alternative Therapy|1|||
131095059|NCT01142232|471978760|FG003|Overall Study|Alternative Therapy|0|||
131095060|NCT01142232|471978761|FG004|Overall Study|Alternative Therapy|1|||
131095061|NCT01142232|471978757|FG000|Overall Study|Off Trt for other complicating disease|0|||
131095062|NCT01142232|471978758|FG001|Overall Study|Off Trt for other complicating disease|0|||
131095063|NCT01142232|471978759|FG002|Overall Study|Off Trt for other complicating disease|0|||
131095064|NCT01142232|471978760|FG003|Overall Study|Off Trt for other complicating disease|0|||
131095065|NCT01142232|471978761|FG004|Overall Study|Off Trt for other complicating disease|1|||
131095066|NCT01142232|471978757|FG000|Overall Study|Noncompliance|0|||
131095067|NCT01142232|471978758|FG001|Overall Study|Noncompliance|0|||
131095068|NCT01142232|471978759|FG002|Overall Study|Noncompliance|0|||
131095069|NCT01142232|471978760|FG003|Overall Study|Noncompliance|0|||
131095070|NCT01142232|471978761|FG004|Overall Study|Noncompliance|2|||
131095071|NCT00626990|471978764|FG000|Overall Study|Lack of Efficacy|6|||
131095072|NCT00626990|471978765|FG001|Overall Study|Lack of Efficacy|7|||
131095073|NCT00626990|471978766|FG002|Overall Study|Lack of Efficacy|49|||
131095074|NCT00626990|471978767|FG003|Overall Study|Lack of Efficacy|40|||
131095075|NCT00626990|471978764|FG000|Overall Study|Adverse Event|1|||
131095076|NCT00626990|471978765|FG001|Overall Study|Adverse Event|7|||
131095077|NCT00626990|471978766|FG002|Overall Study|Adverse Event|14|||
131095078|NCT00626990|471978767|FG003|Overall Study|Adverse Event|28|||
131095079|NCT00626990|471978764|FG000|Overall Study|Death|0|||
131095080|NCT00626990|471978765|FG001|Overall Study|Death|1|||
131095081|NCT00626990|471978766|FG002|Overall Study|Death|0|||
131095082|NCT00626990|471978767|FG003|Overall Study|Death|0|||
131095083|NCT00626990|471978764|FG000|Overall Study|Withdrawal by Subject|3|||
131095084|NCT00626990|471978765|FG001|Overall Study|Withdrawal by Subject|1|||
131095085|NCT00626990|471978766|FG002|Overall Study|Withdrawal by Subject|5|||
131095086|NCT00626990|471978767|FG003|Overall Study|Withdrawal by Subject|11|||
131095087|NCT00626990|471978764|FG000|Overall Study|Protocol Violation|0|||
131234632|NCT01700621|472486406|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
131234633|NCT01700621|472486405|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
131234634|NCT01700621|472486406|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
131234635|NCT02166697|472486407|FG000|Overall Study|Protocol Violation|347|||
131095088|NCT00626990|471978765|FG001|Overall Study|Protocol Violation|1|||
131095089|NCT00626990|471978766|FG002|Overall Study|Protocol Violation|1|||
131095090|NCT00626990|471978767|FG003|Overall Study|Protocol Violation|0|||
131095091|NCT00626990|471978764|FG000|Overall Study|Various different reasons/missing|4|||
131095092|NCT00626990|471978765|FG001|Overall Study|Various different reasons/missing|8|||
131095093|NCT00626990|471978766|FG002|Overall Study|Various different reasons/missing|8|||
131095094|NCT00626990|471978767|FG003|Overall Study|Various different reasons/missing|16|||
131095095|NCT04138576|471978772|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
131095096|NCT00297427|471978773|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
131095097|NCT00297427|471978774|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
131095098|NCT00297427|471978773|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
131095099|NCT00297427|471978774|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
131095100|NCT00297427|471978773|FG000|Phase 1: Initial Intervention|Death|0|||
131095101|NCT00297427|471978774|FG001|Phase 1: Initial Intervention|Death|1|||
131095102|NCT00297427|471978773|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
131095103|NCT00297427|471978774|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
131095104|NCT00297427|471978773|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
131095105|NCT00297427|471978774|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
131095106|NCT00297427|471978773|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
131095107|NCT00297427|471978774|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
131095108|NCT00297427|471978773|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
131095109|NCT00297427|471978774|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
131095110|NCT00297427|471978773|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
131095111|NCT00297427|471978774|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
131095112|NCT02787044|471978777|FG000|Overall Study|Lost to Follow-up|15|||
131095113|NCT02787044|471978778|FG001|Overall Study|Lost to Follow-up|19|||
131095114|NCT02591953|471978780|FG000|Overall Study|Lost to Follow-up|6|||
131095115|NCT02591953|471978781|FG001|Overall Study|Lost to Follow-up|6|||
131095116|NCT01517295|471978784|FG000|Overall Study|Physician Decision|1|||
131095117|NCT01517295|471978785|FG001|Overall Study|Physician Decision|0|||
131095118|NCT02182947|471978786|FG000|Overall Study|Withdrawal by Subject|7|||
131095119|NCT02182947|471978786|FG000|Overall Study|Lost to Follow-up|3|||
131095120|NCT02182947|471978786|FG000|Overall Study|Failed screening activities|8|||
131095121|NCT01656200|471978787|FG000|Overall Study|Withdrawal by Subject|1|||
131095122|NCT02003222|471978801|FG000|Induction|Never started treatment|0|||
131095123|NCT02003222|471978802|FG001|Induction|Never started treatment|0|||
131095124|NCT02003222|471978803|FG002|Induction|Never started treatment|0|||
131095125|NCT02003222|471978804|FG003|Induction|Never started treatment|0|||
131095126|NCT02003222|471978805|FG004|Induction|Never started treatment|8|||
131095127|NCT02003222|471978801|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
131095128|NCT02003222|471978802|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
131095129|NCT02003222|471978803|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
131095130|NCT02003222|471978804|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
131095131|NCT02003222|471978805|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
131095132|NCT02003222|471978801|FG000|Induction|Adverse Event|0|||
131095133|NCT02003222|471978802|FG001|Induction|Adverse Event|0|||
131095134|NCT02003222|471978803|FG002|Induction|Adverse Event|0|||
131095135|NCT02003222|471978804|FG003|Induction|Adverse Event|0|||
130727566|NCT03743415|470625494|FG005|Overall Study|Death|0|||
130727567|NCT03743415|470625495|FG006|Overall Study|Death|0|||
130727568|NCT03743415|470625496|FG007|Overall Study|Death|0|||
130727569|NCT03743415|470625497|FG008|Overall Study|Death|1|||
130727570|NCT03743415|470625498|FG009|Overall Study|Death|0|||
130727571|NCT03743415|470625489|FG000|Overall Study|Withdrawal by Subject|1|||
130727572|NCT03743415|470625490|FG001|Overall Study|Withdrawal by Subject|0|||
130727573|NCT03743415|470625491|FG002|Overall Study|Withdrawal by Subject|4|||
130727574|NCT03743415|470625492|FG003|Overall Study|Withdrawal by Subject|5|||
130727575|NCT03743415|470625493|FG004|Overall Study|Withdrawal by Subject|5|||
131095136|NCT02003222|471978805|FG004|Induction|Adverse Event|13|||
131095137|NCT02003222|471978801|FG000|Induction|Alternative therapy|0|||
131095138|NCT02003222|471978802|FG001|Induction|Alternative therapy|0|||
131095139|NCT02003222|471978803|FG002|Induction|Alternative therapy|0|||
131095140|NCT02003222|471978804|FG003|Induction|Alternative therapy|0|||
131095141|NCT02003222|471978805|FG004|Induction|Alternative therapy|12|||
131095142|NCT02003222|471978801|FG000|Induction|Disease progression|0|||
131095143|NCT02003222|471978802|FG001|Induction|Disease progression|0|||
131095144|NCT02003222|471978803|FG002|Induction|Disease progression|0|||
131095145|NCT02003222|471978804|FG003|Induction|Disease progression|0|||
131095146|NCT02003222|471978805|FG004|Induction|Disease progression|22|||
131095147|NCT02003222|471978801|FG000|Induction|Death|0|||
131095148|NCT02003222|471978802|FG001|Induction|Death|0|||
130727576|NCT03743415|470625494|FG005|Overall Study|Withdrawal by Subject|2|||
130727577|NCT03743415|470625495|FG006|Overall Study|Withdrawal by Subject|2|||
130727578|NCT03743415|470625496|FG007|Overall Study|Withdrawal by Subject|5|||
131095149|NCT02003222|471978803|FG002|Induction|Death|0|||
131095150|NCT02003222|471978804|FG003|Induction|Death|0|||
131095151|NCT02003222|471978805|FG004|Induction|Death|3|||
131095152|NCT02003222|471978801|FG000|Induction|Withdrawal by Subject|0|||
131095153|NCT02003222|471978802|FG001|Induction|Withdrawal by Subject|0|||
131095154|NCT02003222|471978803|FG002|Induction|Withdrawal by Subject|0|||
131095155|NCT02003222|471978804|FG003|Induction|Withdrawal by Subject|0|||
131095156|NCT02003222|471978805|FG004|Induction|Withdrawal by Subject|8|||
131095157|NCT02003222|471978801|FG000|Induction|Other reasons|0|||
131095158|NCT02003222|471978802|FG001|Induction|Other reasons|0|||
131095159|NCT02003222|471978803|FG002|Induction|Other reasons|0|||
131095160|NCT02003222|471978804|FG003|Induction|Other reasons|0|||
131095161|NCT02003222|471978805|FG004|Induction|Other reasons|22|||
131095162|NCT02003222|471978801|FG000|Intensification|Never started treatment|0|||
131095163|NCT02003222|471978802|FG001|Intensification|Never started treatment|0|||
131095164|NCT02003222|471978803|FG002|Intensification|Never started treatment|0|||
131095165|NCT02003222|471978804|FG003|Intensification|Never started treatment|0|||
131095166|NCT02003222|471978805|FG004|Intensification|Never started treatment|2|||
131095167|NCT02003222|471978801|FG000|Intensification|Adverse Event|0|||
131095168|NCT02003222|471978802|FG001|Intensification|Adverse Event|0|||
131095169|NCT02003222|471978803|FG002|Intensification|Adverse Event|0|||
131095170|NCT02003222|471978804|FG003|Intensification|Adverse Event|0|||
131095171|NCT02003222|471978805|FG004|Intensification|Adverse Event|6|||
131095172|NCT02003222|471978801|FG000|Intensification|Alternative therapy|0|||
131095173|NCT02003222|471978802|FG001|Intensification|Alternative therapy|0|||
131095174|NCT02003222|471978803|FG002|Intensification|Alternative therapy|0|||
131095175|NCT02003222|471978804|FG003|Intensification|Alternative therapy|0|||
131095176|NCT02003222|471978805|FG004|Intensification|Alternative therapy|8|||
131095177|NCT02003222|471978801|FG000|Intensification|Disease progression|0|||
131095178|NCT02003222|471978802|FG001|Intensification|Disease progression|0|||
131095179|NCT02003222|471978803|FG002|Intensification|Disease progression|0|||
131095180|NCT02003222|471978804|FG003|Intensification|Disease progression|0|||
131095181|NCT02003222|471978805|FG004|Intensification|Disease progression|18|||
131095182|NCT02003222|471978801|FG000|Intensification|Withdrawal by Subject|0|||
131095183|NCT02003222|471978802|FG001|Intensification|Withdrawal by Subject|0|||
131095184|NCT02003222|471978803|FG002|Intensification|Withdrawal by Subject|0|||
131095185|NCT02003222|471978804|FG003|Intensification|Withdrawal by Subject|0|||
131095186|NCT02003222|471978805|FG004|Intensification|Withdrawal by Subject|5|||
131095187|NCT02003222|471978801|FG000|Intensification|Other reasons|0|||
131095188|NCT02003222|471978802|FG001|Intensification|Other reasons|0|||
131095189|NCT02003222|471978803|FG002|Intensification|Other reasons|0|||
131095190|NCT02003222|471978804|FG003|Intensification|Other reasons|0|||
131095191|NCT02003222|471978805|FG004|Intensification|Other reasons|8|||
131095192|NCT01365481|471978806|FG000|Overall Study|Adverse Event|6|||
131095193|NCT01365481|471978807|FG001|Overall Study|Adverse Event|9|||
131095194|NCT01365481|471978808|FG002|Overall Study|Adverse Event|0|||
131095195|NCT01365481|471978809|FG003|Overall Study|Adverse Event|2|||
131095196|NCT01365481|471978806|FG000|Overall Study|Withdrawal by Subject|0|||
131095197|NCT01365481|471978807|FG001|Overall Study|Withdrawal by Subject|2|||
131095198|NCT01365481|471978808|FG002|Overall Study|Withdrawal by Subject|1|||
131095199|NCT01365481|471978809|FG003|Overall Study|Withdrawal by Subject|1|||
131095200|NCT01365481|471978806|FG000|Overall Study|Lost to Follow-up|1|||
131095201|NCT01365481|471978807|FG001|Overall Study|Lost to Follow-up|1|||
131095202|NCT01365481|471978808|FG002|Overall Study|Lost to Follow-up|2|||
131095203|NCT01365481|471978809|FG003|Overall Study|Lost to Follow-up|3|||
131095204|NCT01365481|471978806|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131095205|NCT01365481|471978807|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131095206|NCT01365481|471978808|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131095207|NCT01365481|471978809|FG003|Overall Study|Abnormal laboratory value(s)|0|||
131095208|NCT01365481|471978806|FG000|Overall Study|Administrative problems|0|||
131095209|NCT01365481|471978807|FG001|Overall Study|Administrative problems|1|||
131095210|NCT01365481|471978808|FG002|Overall Study|Administrative problems|0|||
131095211|NCT01365481|471978809|FG003|Overall Study|Administrative problems|0|||
131095212|NCT01365481|471978806|FG000|Overall Study|Protocol deviation|0|||
131095213|NCT01365481|471978807|FG001|Overall Study|Protocol deviation|1|||
131095214|NCT01365481|471978808|FG002|Overall Study|Protocol deviation|0|||
131095215|NCT01365481|471978809|FG003|Overall Study|Protocol deviation|1|||
131095216|NCT01365481|471978806|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131095217|NCT01365481|471978807|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131095218|NCT01365481|471978808|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
131095219|NCT01365481|471978809|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
131095220|NCT01696955|471978812|FG000|Main Study|Protocol Violation|1|||
131095221|NCT01696955|471978813|FG001|Main Study|Protocol Violation|0|||
131095222|NCT01696955|471978812|FG000|Main Study|Withdrawal by Subject|1|||
131095223|NCT01696955|471978813|FG001|Main Study|Withdrawal by Subject|1|||
131095224|NCT03192475|471978814|FG000|Overall Study|Death|0|||
131095225|NCT03192475|471978815|FG001|Overall Study|Death|1|||
131095226|NCT03192475|471978814|FG000|Overall Study|Lost to Follow-up|13|||
131095227|NCT03192475|471978815|FG001|Overall Study|Lost to Follow-up|8|||
131095228|NCT01641159|471978816|FG000|Overall Study|Lost to Follow-up|2|||
131095229|NCT01641159|471978817|FG001|Overall Study|Lost to Follow-up|1|||
131095230|NCT01641159|471978816|FG000|Overall Study|Withdrawal by Subject|0|||
131095231|NCT01641159|471978817|FG001|Overall Study|Withdrawal by Subject|1|||
131095232|NCT00436605|471978818|FG000|Overall Study|Protocol Violation|3|||
131095233|NCT03284203|471978825|FG000|Overall Study|Lost to Follow-up|3|||
131095234|NCT02229851|471978826|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
131095235|NCT02229851|471978827|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
131143991|NCT01573910|472152535|FG001|Overall Study|Lost to Follow-up|1|||
131095236|NCT02229851|471978828|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
131095237|NCT02229851|471978829|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
131095238|NCT02229851|471978830|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
131095239|NCT02229851|471978831|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
131095240|NCT02229851|471978832|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
131095241|NCT02229851|471978826|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131095242|NCT02229851|471978827|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
131095243|NCT02229851|471978828|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131095244|NCT02229851|471978829|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131095245|NCT02229851|471978830|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131095246|NCT02229851|471978831|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131095247|NCT02229851|471978832|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
131095248|NCT02229851|471978826|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
131095249|NCT02229851|471978827|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
131095250|NCT02229851|471978828|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
131095251|NCT02229851|471978829|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
131095252|NCT02229851|471978830|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
131095253|NCT02229851|471978831|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
131095254|NCT02229851|471978832|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
131095255|NCT02229851|471978826|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131095256|NCT02229851|471978827|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131095257|NCT02229851|471978828|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
131095258|NCT02229851|471978829|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131095259|NCT02229851|471978830|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131095260|NCT02229851|471978831|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131095261|NCT02229851|471978832|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
131095262|NCT02229851|471978826|FG000|Main Phase (Double-blind Phase)|Death|1|||
131095263|NCT02229851|471978827|FG001|Main Phase (Double-blind Phase)|Death|1|||
131095264|NCT02229851|471978828|FG002|Main Phase (Double-blind Phase)|Death|0|||
131095265|NCT02229851|471978829|FG003|Main Phase (Double-blind Phase)|Death|0|||
131095266|NCT02229851|471978830|FG004|Main Phase (Double-blind Phase)|Death|0|||
131095267|NCT02229851|471978831|FG005|Main Phase (Double-blind Phase)|Death|0|||
131095268|NCT02229851|471978832|FG006|Main Phase (Double-blind Phase)|Death|0|||
131095269|NCT02229851|471978826|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
131095270|NCT02229851|471978827|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
131095271|NCT02229851|471978828|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
131095272|NCT02229851|471978829|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
131095273|NCT02229851|471978830|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
131095274|NCT02229851|471978831|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
131095275|NCT02229851|471978832|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
131095276|NCT02229851|471978826|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
131095277|NCT02229851|471978827|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
131095278|NCT02229851|471978828|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
131095279|NCT02229851|471978829|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
131095280|NCT02229851|471978830|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
131095281|NCT02229851|471978831|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
131095282|NCT02229851|471978832|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
131095283|NCT02229851|471978826|FG000|Extension Phase (Open-label Phase)|Death|0|||
131095284|NCT02229851|471978827|FG001|Extension Phase (Open-label Phase)|Death|0|||
131095285|NCT02229851|471978828|FG002|Extension Phase (Open-label Phase)|Death|0|||
131095286|NCT02229851|471978829|FG003|Extension Phase (Open-label Phase)|Death|1|||
131095287|NCT02229851|471978830|FG004|Extension Phase (Open-label Phase)|Death|0|||
131095288|NCT02229851|471978831|FG005|Extension Phase (Open-label Phase)|Death|1|||
131095289|NCT02229851|471978832|FG006|Extension Phase (Open-label Phase)|Death|1|||
131095290|NCT03541200|471978833|FG000|Overall Study|Adverse Event|19|||
131095291|NCT03541200|471978833|FG000|Overall Study|Death|1|||
131095292|NCT03541200|471978833|FG000|Overall Study|Lost to Follow-up|10|||
131143992|NCT01573910|472152534|FG000|Overall Study|Withdrawal by Subject|0|||
131143993|NCT01573910|472152535|FG001|Overall Study|Withdrawal by Subject|1|||
131143994|NCT01573910|472152534|FG000|Overall Study|Protocol Violation|3|||
131143995|NCT01573910|472152535|FG001|Overall Study|Protocol Violation|0|||
131143996|NCT01573910|472152534|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
131095293|NCT03541200|471978833|FG000|Overall Study|Physician Decision|1|||
131095294|NCT03541200|471978833|FG000|Overall Study|Protocol Violation|51|||
131095295|NCT03541200|471978833|FG000|Overall Study|Withdrawal by Subject|23|||
131095296|NCT03541200|471978833|FG000|Overall Study|other|8|||
131095297|NCT00831129|471978834|FG000|Overall Study|Adverse Event|0|||
131095298|NCT00831129|471978835|FG001|Overall Study|Adverse Event|1|||
131143997|NCT01573910|472152535|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
131095299|NCT00831129|471978834|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
131143998|NCT00364182|472152538|FG000|First Intervention|Secondary prophylaxis|1|||
131143999|NCT00364182|472152539|FG001|First Intervention|Secondary prophylaxis|0|||
131144000|NCT00364182|472152540|FG002|First Intervention|Secondary prophylaxis|0|||
131144001|NCT00364182|472152538|FG000|First Intervention|Withdrawal by Subject|2|||
131144002|NCT00364182|472152539|FG001|First Intervention|Withdrawal by Subject|0|||
131144003|NCT00364182|472152540|FG002|First Intervention|Withdrawal by Subject|0|||
131144004|NCT00364182|472152538|FG000|Second Intervention|non-compliance|0|||
131144005|NCT00364182|472152539|FG001|Second Intervention|non-compliance|1|||
131144006|NCT00364182|472152540|FG002|Second Intervention|non-compliance|1|||
131144007|NCT00364182|472152538|FG000|Second Intervention|Protocol Violation|0|||
131144008|NCT00364182|472152539|FG001|Second Intervention|Protocol Violation|1|||
131144009|NCT00364182|472152540|FG002|Second Intervention|Protocol Violation|0|||
131144010|NCT00364182|472152538|FG000|Second Intervention|Adverse Event|0|||
131144011|NCT00364182|472152539|FG001|Second Intervention|Adverse Event|0|||
131144012|NCT00364182|472152540|FG002|Second Intervention|Adverse Event|1|||
131144013|NCT00364182|472152538|FG000|Third Intervention|non-compliance|0|||
131144014|NCT00364182|472152539|FG001|Third Intervention|non-compliance|1|||
131144015|NCT00364182|472152540|FG002|Third Intervention|non-compliance|0|||
131144016|NCT00364182|472152538|FG000|Third Intervention|Lost to Follow-up|0|||
131144017|NCT00364182|472152539|FG001|Third Intervention|Lost to Follow-up|0|||
131144018|NCT00364182|472152540|FG002|Third Intervention|Lost to Follow-up|1|||
131144019|NCT02601573|472152548|FG000|Overall Study|Lost to Follow-up|0|||
131144020|NCT02601573|472152549|FG001|Overall Study|Lost to Follow-up|3|||
131144021|NCT02601573|472152550|FG002|Overall Study|Lost to Follow-up|1|||
131144022|NCT02601573|472152551|FG003|Overall Study|Lost to Follow-up|0|||
131144023|NCT02601573|472152552|FG004|Overall Study|Lost to Follow-up|2|||
131144024|NCT02601573|472152548|FG000|Overall Study|Withdrawal by Subject|0|||
131144025|NCT02601573|472152549|FG001|Overall Study|Withdrawal by Subject|1|||
131144026|NCT02601573|472152550|FG002|Overall Study|Withdrawal by Subject|0|||
131144027|NCT02601573|472152551|FG003|Overall Study|Withdrawal by Subject|1|||
131144028|NCT02601573|472152552|FG004|Overall Study|Withdrawal by Subject|0|||
131144029|NCT00974220|472152553|FG000|Treatment Period 1|Adverse Event|2|||
131095300|NCT00831129|471978835|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
131095301|NCT01283516|471978837|FG000|Overall Study|Adverse Event|0|||
131095302|NCT01283516|471978838|FG001|Overall Study|Adverse Event|0|||
131095303|NCT01283516|471978839|FG002|Overall Study|Adverse Event|0|||
131095304|NCT01283516|471978840|FG003|Overall Study|Adverse Event|0|||
131095305|NCT01283516|471978841|FG004|Overall Study|Adverse Event|0|||
131095306|NCT01283516|471978842|FG005|Overall Study|Adverse Event|0|||
131095307|NCT01283516|471978843|FG006|Overall Study|Adverse Event|2|||
131095308|NCT01283516|471978844|FG007|Overall Study|Adverse Event|0|||
131095309|NCT01283516|471978845|FG008|Overall Study|Adverse Event|28|||
131095310|NCT01283516|471978837|FG000|Overall Study|Death|0|||
131095311|NCT01283516|471978838|FG001|Overall Study|Death|0|||
131095312|NCT01283516|471978839|FG002|Overall Study|Death|0|||
131095313|NCT01283516|471978840|FG003|Overall Study|Death|0|||
131095314|NCT01283516|471978841|FG004|Overall Study|Death|0|||
131095315|NCT01283516|471978842|FG005|Overall Study|Death|1|||
131095316|NCT01283516|471978843|FG006|Overall Study|Death|0|||
131095317|NCT01283516|471978844|FG007|Overall Study|Death|1|||
131095318|NCT01283516|471978845|FG008|Overall Study|Death|12|||
131095319|NCT01283516|471978837|FG000|Overall Study|Disease Progression|2|||
131095320|NCT01283516|471978838|FG001|Overall Study|Disease Progression|2|||
131095321|NCT01283516|471978839|FG002|Overall Study|Disease Progression|3|||
131095322|NCT01283516|471978840|FG003|Overall Study|Disease Progression|3|||
131095323|NCT01283516|471978841|FG004|Overall Study|Disease Progression|13|||
131095324|NCT01283516|471978842|FG005|Overall Study|Disease Progression|8|||
131095325|NCT01283516|471978843|FG006|Overall Study|Disease Progression|6|||
131234636|NCT02720510|472486411|FG000|Overall Study|Study Terminated by the sponsor|2|||
131234637|NCT02720510|472486412|FG001|Overall Study|Study Terminated by the sponsor|0|||
131095326|NCT01283516|471978844|FG007|Overall Study|Disease Progression|3|||
131095327|NCT01283516|471978845|FG008|Overall Study|Disease Progression|139|||
131095328|NCT01283516|471978837|FG000|Overall Study|Withdrawal by Subject|0|||
131095329|NCT01283516|471978838|FG001|Overall Study|Withdrawal by Subject|0|||
131095330|NCT01283516|471978839|FG002|Overall Study|Withdrawal by Subject|0|||
131095331|NCT01283516|471978840|FG003|Overall Study|Withdrawal by Subject|0|||
131095332|NCT01283516|471978841|FG004|Overall Study|Withdrawal by Subject|1|||
131095333|NCT01283516|471978842|FG005|Overall Study|Withdrawal by Subject|0|||
131095334|NCT01283516|471978843|FG006|Overall Study|Withdrawal by Subject|1|||
131095335|NCT01283516|471978844|FG007|Overall Study|Withdrawal by Subject|0|||
131095336|NCT01283516|471978845|FG008|Overall Study|Withdrawal by Subject|36|||
131095337|NCT01283516|471978837|FG000|Overall Study|Administrative problems|0|||
131095338|NCT01283516|471978838|FG001|Overall Study|Administrative problems|0|||
131095339|NCT01283516|471978839|FG002|Overall Study|Administrative problems|0|||
131095340|NCT01283516|471978840|FG003|Overall Study|Administrative problems|0|||
131144030|NCT00974220|472152554|FG001|Treatment Period 1|Adverse Event|1|||
131144031|NCT00974220|472152553|FG000|Treatment Period 1|noncompliant subjects|0|||
131144032|NCT00974220|472152554|FG001|Treatment Period 1|noncompliant subjects|1|||
131144033|NCT02921425|472152555|FG000|Overall Study|Protocol Violation|9|||
131144034|NCT01227967|472152556|FG000|Overall Study|Protocol Violation|3|||
131144035|NCT01227967|472152557|FG001|Overall Study|Protocol Violation|1|||
131144036|NCT01227967|472152556|FG000|Overall Study|Death|0|||
131144037|NCT01227967|472152557|FG001|Overall Study|Death|1|||
131144038|NCT01227967|472152556|FG000|Overall Study|Lost to Follow-up|8|||
131144039|NCT01227967|472152557|FG001|Overall Study|Lost to Follow-up|3|||
131144040|NCT01227967|472152556|FG000|Overall Study|Withdrawal by Subject|4|||
131144041|NCT01227967|472152557|FG001|Overall Study|Withdrawal by Subject|3|||
131144042|NCT01227967|472152556|FG000|Overall Study|Physician Decision|0|||
131144043|NCT01227967|472152557|FG001|Overall Study|Physician Decision|1|||
131144044|NCT01227967|472152556|FG000|Overall Study|Never Started Treatment|0|||
131144045|NCT01227967|472152557|FG001|Overall Study|Never Started Treatment|4|||
131144046|NCT01227967|472152556|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
131144047|NCT01227967|472152557|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
131144048|NCT03403400|472152558|FG000|Overall Study|Lost to Follow-up|1|||
131144049|NCT03403400|472152559|FG001|Overall Study|Lost to Follow-up|0|||
131144050|NCT03403400|472152560|FG002|Overall Study|Lost to Follow-up|1|||
131144051|NCT03403400|472152558|FG000|Overall Study|Hospitalization|1|||
131144052|NCT03403400|472152559|FG001|Overall Study|Hospitalization|0|||
131144053|NCT03403400|472152560|FG002|Overall Study|Hospitalization|0|||
131144054|NCT03403400|472152558|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
131144055|NCT03403400|472152559|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
131144056|NCT03403400|472152560|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
131144057|NCT01763164|472152561|FG000|Treatment Phase|Participant/Guardian decision|26|||
131144058|NCT01763164|472152562|FG001|Treatment Phase|Participant/Guardian decision|14|||
131144059|NCT01763164|472152561|FG000|Treatment Phase|Protocol Violation|1|||
131144060|NCT01763164|472152562|FG001|Treatment Phase|Protocol Violation|1|||
131144061|NCT01763164|472152561|FG000|Treatment Phase|Progressive Disease|142|||
131144062|NCT01763164|472152562|FG001|Treatment Phase|Progressive Disease|76|||
131144063|NCT01763164|472152561|FG000|Treatment Phase|Physician Decision|24|||
131144064|NCT01763164|472152562|FG001|Treatment Phase|Physician Decision|13|||
131144065|NCT01763164|472152561|FG000|Treatment Phase|Death|10|||
131144066|NCT01763164|472152562|FG001|Treatment Phase|Death|1|||
131144067|NCT01763164|472152561|FG000|Treatment Phase|Adverse Event|66|||
131144068|NCT01763164|472152562|FG001|Treatment Phase|Adverse Event|8|||
131144069|NCT01763164|472152561|FG000|Treatment Phase|Randomized but not Treated|0|||
131144070|NCT01763164|472152562|FG001|Treatment Phase|Randomized but not Treated|19|||
131144071|NCT01763164|472152561|FG000|Treatment Phase|Other|0|||
131144072|NCT01763164|472152562|FG001|Treatment Phase|Other|1|||
131144073|NCT01763164|472152561|FG000|Follow up Phase|New therapy for study indication|12|||
131144074|NCT01763164|472152562|FG001|Follow up Phase|New therapy for study indication|3|||
131144075|NCT01763164|472152561|FG000|Follow up Phase|Death|21|||
131144076|NCT01763164|472152562|FG001|Follow up Phase|Death|4|||
131144077|NCT01763164|472152561|FG000|Follow up Phase|Subject/guardian decision|9|||
131144078|NCT01763164|472152562|FG001|Follow up Phase|Subject/guardian decision|2|||
131144079|NCT01763164|472152561|FG000|Follow up Phase|Progressive disease|127|||
131144080|NCT01763164|472152562|FG001|Follow up Phase|Progressive disease|62|||
131144081|NCT01763164|472152561|FG000|Follow up Phase|Physician Decision|10|||
131144082|NCT01763164|472152562|FG001|Follow up Phase|Physician Decision|3|||
131144083|NCT01763164|472152561|FG000|Follow up Phase|Lost to Follow-up|1|||
131144084|NCT01763164|472152562|FG001|Follow up Phase|Lost to Follow-up|0|||
131144085|NCT01763164|472152561|FG000|Follow up Phase|Adverse Event|17|||
131144086|NCT01763164|472152562|FG001|Follow up Phase|Adverse Event|1|||
131144087|NCT01384292|472152566|FG000|Part B|Severe non-compliance to protocol|1|||
131144088|NCT01384292|472152567|FG001|Part B|Severe non-compliance to protocol|0|||
131144089|NCT01384292|472152568|FG002|Part B|Severe non-compliance to protocol|0|||
131144090|NCT01273064|472152571|FG000|Overall Study|Adverse Event|5|||
131234638|NCT02720510|472486411|FG000|Overall Study|Adverse Event|0|||
131234639|NCT02720510|472486412|FG001|Overall Study|Adverse Event|1|||
131234640|NCT02720510|472486411|FG000|Overall Study|Physician Decision|1|||
131234641|NCT02720510|472486412|FG001|Overall Study|Physician Decision|2|||
131234642|NCT01618266|472486422|FG000|Overall Study|Lost to Follow-up|9|||
131234643|NCT01618266|472486422|FG000|Overall Study|Treatment satisfaction|10|||
131234644|NCT01618266|472486422|FG000|Overall Study|Other reasons|11|||
130727579|NCT03743415|470625497|FG008|Overall Study|Withdrawal by Subject|9|||
131144091|NCT01273064|472152572|FG001|Overall Study|Adverse Event|1|||
131144092|NCT01273064|472152573|FG002|Overall Study|Adverse Event|3|||
131144093|NCT01273064|472152574|FG003|Overall Study|Adverse Event|2|||
131144094|NCT01273064|472152575|FG004|Overall Study|Adverse Event|1|||
131144095|NCT01273064|472152571|FG000|Overall Study|Withdrawal by Subject|4|||
131144096|NCT01273064|472152572|FG001|Overall Study|Withdrawal by Subject|2|||
131144097|NCT01273064|472152573|FG002|Overall Study|Withdrawal by Subject|2|||
131144098|NCT01273064|472152574|FG003|Overall Study|Withdrawal by Subject|2|||
131234645|NCT01618266|472486422|FG000|Overall Study|Lack of Efficacy|23|||
130727580|NCT03743415|470625498|FG009|Overall Study|Withdrawal by Subject|10|||
130727581|NCT03743415|470625489|FG000|Overall Study|Lost to Follow-up|2|||
131144099|NCT01273064|472152575|FG004|Overall Study|Withdrawal by Subject|0|||
130727582|NCT03743415|470625490|FG001|Overall Study|Lost to Follow-up|0|||
131234646|NCT01618266|472486422|FG000|Overall Study|Protocol Violation|43|||
131144100|NCT01273064|472152571|FG000|Overall Study|Study Termination|13|||
131144101|NCT01273064|472152572|FG001|Overall Study|Study Termination|27|||
131144102|NCT01273064|472152573|FG002|Overall Study|Study Termination|26|||
131144103|NCT01273064|472152574|FG003|Overall Study|Study Termination|16|||
131144104|NCT01273064|472152575|FG004|Overall Study|Study Termination|8|||
131144105|NCT01273064|472152571|FG000|Overall Study|Lost to Follow-up|1|||
131144106|NCT01273064|472152572|FG001|Overall Study|Lost to Follow-up|0|||
131144107|NCT01273064|472152573|FG002|Overall Study|Lost to Follow-up|0|||
131144108|NCT01273064|472152574|FG003|Overall Study|Lost to Follow-up|0|||
131144109|NCT01273064|472152575|FG004|Overall Study|Lost to Follow-up|0|||
131144110|NCT01273064|472152571|FG000|Overall Study|Physician Decision|0|||
131144111|NCT01273064|472152572|FG001|Overall Study|Physician Decision|0|||
131144112|NCT01273064|472152573|FG002|Overall Study|Physician Decision|0|||
131144113|NCT01273064|472152574|FG003|Overall Study|Physician Decision|0|||
131144114|NCT01273064|472152575|FG004|Overall Study|Physician Decision|1|||
131144115|NCT04062214|472152576|FG000|Week 12|Death|1|||
131144116|NCT04062214|472152577|FG001|Week 12|Death|1|||
131144117|NCT04062214|472152576|FG000|Week 12|Withdrawal by Subject|14|||
131144118|NCT04062214|472152577|FG001|Week 12|Withdrawal by Subject|13|||
131144119|NCT04062214|472152576|FG000|Week 12|Lost to Follow-up|55|||
131144120|NCT04062214|472152577|FG001|Week 12|Lost to Follow-up|68|||
131144121|NCT04062214|472152576|FG000|Week 12|Intermittent missing|31|||
131144122|NCT04062214|472152577|FG001|Week 12|Intermittent missing|29|||
131144123|NCT04062214|472152576|FG000|Week 36|Withdrawal by Subject|4|||
131144124|NCT04062214|472152577|FG001|Week 36|Withdrawal by Subject|5|||
131144125|NCT04062214|472152576|FG000|Week 36|Lost to Follow-up|50|||
131144126|NCT04062214|472152577|FG001|Week 36|Lost to Follow-up|46|||
131144127|NCT04062214|472152576|FG000|Week 36|Death|0|||
131144128|NCT04062214|472152577|FG001|Week 36|Death|1|||
131144129|NCT00291551|472152578|FG000|Overall Study|Death|7|||
131144130|NCT00291551|472152578|FG000|Overall Study|Withdrawal by Subject|6|||
131144131|NCT04666038|472152579|FG000|Overall Study|Progressive Disease|2|||
131144132|NCT04666038|472152580|FG001|Overall Study|Progressive Disease|0|||
131144133|NCT04666038|472152579|FG000|Overall Study|Death|38|||
131144134|NCT04666038|472152580|FG001|Overall Study|Death|32|||
131144135|NCT04666038|472152579|FG000|Overall Study|Withdrawal by Subject|10|||
131144136|NCT04666038|472152580|FG001|Overall Study|Withdrawal by Subject|19|||
131144137|NCT04666038|472152579|FG000|Overall Study|Lost to Follow-up|0|||
131144138|NCT04666038|472152580|FG001|Overall Study|Lost to Follow-up|2|||
131144139|NCT04666038|472152579|FG000|Overall Study|On Study Treatment|46|||
131144140|NCT04666038|472152580|FG001|Overall Study|On Study Treatment|5|||
131144141|NCT04666038|472152579|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
131144142|NCT04666038|472152580|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
131234647|NCT02985151|472486423|FG000|Original Randomization|Withdrawal by Subject|0|||
131234648|NCT02985151|472486424|FG001|Original Randomization|Withdrawal by Subject|1|||
131234649|NCT03522948|472486433|FG000|Overall Study|Lost to Follow-up|1|||
131234650|NCT00084084|472486434|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
131234651|NCT00084084|472486434|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
131234652|NCT01802879|472486435|FG000|Overall Study|Administrative problems|2|||
131234653|NCT01802879|472486435|FG000|Overall Study|Disease progression|6|||
131144143|NCT01512264|472152583|FG000|Overall Study|Lost to Follow-up|0|||
131144144|NCT01512264|472152584|FG001|Overall Study|Lost to Follow-up|0|||
131144145|NCT01512264|472152585|FG002|Overall Study|Lost to Follow-up|0|||
131144146|NCT01512264|472152586|FG003|Overall Study|Lost to Follow-up|1|||
131144147|NCT01282229|472152595|FG000|Overall Study|Protocol Violation|2|||
131144148|NCT00996203|472152596|FG000|Overall Study|Adverse Event|3|||
131144149|NCT00996203|472152596|FG000|Overall Study|Lost to Follow-up|1|||
131234654|NCT01047345|472486442|FG000|Base Study|Adverse Event|3|||
131234655|NCT01047345|472486443|FG001|Base Study|Adverse Event|0|||
131234656|NCT01047345|472486444|FG002|Base Study|Adverse Event|0|||
131144150|NCT00996203|472152596|FG000|Overall Study|Lack of Efficacy|1|||
131144151|NCT00996203|472152596|FG000|Overall Study|Protocol Violation|2|||
131144152|NCT03686969|472152597|FG000|Overall Study|Study terminated|1|||
131144153|NCT03686969|472152598|FG001|Overall Study|Study terminated|0|||
131144154|NCT03094195|472152608|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
131234657|NCT01047345|472486442|FG000|Base Study|Lost to Follow-up|4|||
131234658|NCT01047345|472486443|FG001|Base Study|Lost to Follow-up|1|||
131234659|NCT01047345|472486444|FG002|Base Study|Lost to Follow-up|0|||
131234660|NCT01047345|472486442|FG000|Base Study|Protocol Violation|3|||
131234661|NCT01047345|472486443|FG001|Base Study|Protocol Violation|1|||
131234662|NCT01047345|472486444|FG002|Base Study|Protocol Violation|0|||
131234663|NCT01047345|472486442|FG000|Base Study|Withdrawal by Subject|12|||
131144155|NCT03094195|472152609|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
131144156|NCT03094195|472152610|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
131144157|NCT03094195|472152611|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131144158|NCT03094195|472152612|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131144159|NCT03094195|472152613|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131144160|NCT03094195|472152614|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131095341|NCT01283516|471978841|FG004|Overall Study|Administrative problems|0|||
131095342|NCT01283516|471978842|FG005|Overall Study|Administrative problems|1|||
131095343|NCT01283516|471978843|FG006|Overall Study|Administrative problems|1|||
131095344|NCT01283516|471978844|FG007|Overall Study|Administrative problems|1|||
131095345|NCT01283516|471978845|FG008|Overall Study|Administrative problems|39|||
131095346|NCT01283516|471978837|FG000|Overall Study|Lost to Follow-up|0|||
131095347|NCT01283516|471978838|FG001|Overall Study|Lost to Follow-up|0|||
131095348|NCT01283516|471978839|FG002|Overall Study|Lost to Follow-up|0|||
131095349|NCT01283516|471978840|FG003|Overall Study|Lost to Follow-up|0|||
131095350|NCT01283516|471978841|FG004|Overall Study|Lost to Follow-up|0|||
131095351|NCT01283516|471978842|FG005|Overall Study|Lost to Follow-up|0|||
131095352|NCT01283516|471978843|FG006|Overall Study|Lost to Follow-up|0|||
131095353|NCT01283516|471978844|FG007|Overall Study|Lost to Follow-up|0|||
131095354|NCT01283516|471978845|FG008|Overall Study|Lost to Follow-up|1|||
131095355|NCT01276379|471978846|FG000|Overall Study|Screening failure|40|||
131095356|NCT02001064|471978847|FG000|Overall Study|Withdrawal by Subject|2|||
131095357|NCT02001064|471978848|FG001|Overall Study|Withdrawal by Subject|1|||
131095358|NCT02108964|471978853|FG000|Overall Study|Progressive disease|15|||
131095359|NCT02108964|471978854|FG001|Overall Study|Progressive disease|31|||
131095360|NCT02108964|471978855|FG002|Overall Study|Progressive disease|54|||
131095361|NCT02108964|471978856|FG003|Overall Study|Progressive disease|7|||
131095362|NCT02108964|471978857|FG004|Overall Study|Progressive disease|20|||
131095363|NCT02108964|471978858|FG005|Overall Study|Progressive disease|4|||
131095364|NCT02108964|471978859|FG006|Overall Study|Progressive disease|6|||
131095365|NCT02108964|471978860|FG007|Overall Study|Progressive disease|33|||
131095366|NCT02108964|471978853|FG000|Overall Study|Physician Decision|1|||
131095367|NCT02108964|471978854|FG001|Overall Study|Physician Decision|5|||
131095368|NCT02108964|471978855|FG002|Overall Study|Physician Decision|7|||
131095369|NCT02108964|471978856|FG003|Overall Study|Physician Decision|1|||
131095370|NCT02108964|471978857|FG004|Overall Study|Physician Decision|2|||
131095371|NCT02108964|471978858|FG005|Overall Study|Physician Decision|1|||
131095372|NCT02108964|471978859|FG006|Overall Study|Physician Decision|1|||
131095373|NCT02108964|471978860|FG007|Overall Study|Physician Decision|3|||
131095374|NCT02108964|471978853|FG000|Overall Study|Adverse Event|0|||
131095375|NCT02108964|471978854|FG001|Overall Study|Adverse Event|0|||
131095376|NCT02108964|471978855|FG002|Overall Study|Adverse Event|4|||
131095377|NCT02108964|471978856|FG003|Overall Study|Adverse Event|0|||
131095378|NCT02108964|471978857|FG004|Overall Study|Adverse Event|1|||
131095379|NCT02108964|471978858|FG005|Overall Study|Adverse Event|0|||
131095380|NCT02108964|471978859|FG006|Overall Study|Adverse Event|3|||
131095381|NCT02108964|471978860|FG007|Overall Study|Adverse Event|2|||
131095382|NCT02108964|471978853|FG000|Overall Study|Death|1|||
131095383|NCT02108964|471978854|FG001|Overall Study|Death|1|||
131095384|NCT02108964|471978855|FG002|Overall Study|Death|4|||
131095385|NCT02108964|471978856|FG003|Overall Study|Death|0|||
131095386|NCT02108964|471978857|FG004|Overall Study|Death|3|||
131095387|NCT02108964|471978858|FG005|Overall Study|Death|0|||
131095388|NCT02108964|471978859|FG006|Overall Study|Death|0|||
131095389|NCT02108964|471978860|FG007|Overall Study|Death|2|||
131095390|NCT02108964|471978853|FG000|Overall Study|Subject/Guardian decision|0|||
131095391|NCT02108964|471978854|FG001|Overall Study|Subject/Guardian decision|1|||
131095392|NCT02108964|471978855|FG002|Overall Study|Subject/Guardian decision|4|||
131095393|NCT02108964|471978856|FG003|Overall Study|Subject/Guardian decision|0|||
131095394|NCT02108964|471978857|FG004|Overall Study|Subject/Guardian decision|2|||
131095395|NCT02108964|471978858|FG005|Overall Study|Subject/Guardian decision|0|||
131095396|NCT02108964|471978859|FG006|Overall Study|Subject/Guardian decision|1|||
131095397|NCT02108964|471978860|FG007|Overall Study|Subject/Guardian decision|2|||
130727583|NCT03743415|470625491|FG002|Overall Study|Lost to Follow-up|2|||
131095398|NCT02108964|471978853|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131095399|NCT02108964|471978854|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131095400|NCT02108964|471978855|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131095401|NCT02108964|471978856|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131095402|NCT02108964|471978857|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131095403|NCT02108964|471978858|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131095404|NCT02108964|471978859|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
131095405|NCT02108964|471978860|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
131095406|NCT00384397|471978861|FG000|Overall Study|Adverse Event|0|||
131095407|NCT00384397|471978862|FG001|Overall Study|Adverse Event|1|||
131095408|NCT00384397|471978863|FG002|Overall Study|Adverse Event|2|||
131095409|NCT00384397|471978861|FG000|Overall Study|Protocol Violation|7|||
131095410|NCT00384397|471978862|FG001|Overall Study|Protocol Violation|15|||
131095411|NCT00384397|471978863|FG002|Overall Study|Protocol Violation|13|||
131095412|NCT00384397|471978861|FG000|Overall Study|Lost to Follow-up|11|||
131095413|NCT00384397|471978862|FG001|Overall Study|Lost to Follow-up|13|||
131144161|NCT03094195|472152615|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
131144162|NCT03094195|472152608|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
131144163|NCT03094195|472152609|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
131144164|NCT03094195|472152610|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
131144165|NCT03094195|472152611|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131144166|NCT03094195|472152612|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131144167|NCT03094195|472152613|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131144168|NCT03094195|472152614|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131144169|NCT03094195|472152615|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
131144170|NCT03094195|472152608|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131144171|NCT03094195|472152609|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131144172|NCT03094195|472152610|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
131144173|NCT03094195|472152611|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131144174|NCT03094195|472152612|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131144175|NCT03094195|472152613|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131144176|NCT03094195|472152614|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131144177|NCT03094195|472152615|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
131144178|NCT03094195|472152608|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131144179|NCT03094195|472152609|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
131234664|NCT01047345|472486443|FG001|Base Study|Withdrawal by Subject|4|||
131234665|NCT01047345|472486444|FG002|Base Study|Withdrawal by Subject|0|||
131234666|NCT01047345|472486442|FG000|Extension|Withdrawal by Subject|0|||
131095414|NCT00384397|471978863|FG002|Overall Study|Lost to Follow-up|3|||
131095415|NCT00384397|471978861|FG000|Overall Study|Withdrawal by Subject|14|||
131095416|NCT00384397|471978862|FG001|Overall Study|Withdrawal by Subject|17|||
131095417|NCT00384397|471978863|FG002|Overall Study|Withdrawal by Subject|15|||
131095418|NCT01214642|471978864|FG000|Overall Study|Progressive Disease|3|||
131095419|NCT01214642|471978865|FG001|Overall Study|Progressive Disease|2|||
131095420|NCT01214642|471978866|FG002|Overall Study|Progressive Disease|3|||
131095421|NCT01214642|471978867|FG003|Overall Study|Progressive Disease|5|||
131095422|NCT01214642|471978868|FG004|Overall Study|Progressive Disease|5|||
131095423|NCT01214642|471978869|FG005|Overall Study|Progressive Disease|3|||
131095424|NCT01214642|471978870|FG006|Overall Study|Progressive Disease|5|||
131095425|NCT01214642|471978871|FG007|Overall Study|Progressive Disease|3|||
131095426|NCT01214642|471978872|FG008|Overall Study|Progressive Disease|10|||
131095427|NCT01214642|471978873|FG009|Overall Study|Progressive Disease|2|||
131095428|NCT01214642|471978874|FG010|Overall Study|Progressive Disease|1|||
131095429|NCT01214642|471978875|FG011|Overall Study|Progressive Disease|4|||
131095430|NCT01214642|471978864|FG000|Overall Study|Adverse Event|0|||
131095431|NCT01214642|471978865|FG001|Overall Study|Adverse Event|1|||
131095432|NCT01214642|471978866|FG002|Overall Study|Adverse Event|0|||
131095433|NCT01214642|471978867|FG003|Overall Study|Adverse Event|0|||
131095434|NCT01214642|471978868|FG004|Overall Study|Adverse Event|0|||
131095435|NCT01214642|471978869|FG005|Overall Study|Adverse Event|0|||
131095436|NCT01214642|471978870|FG006|Overall Study|Adverse Event|1|||
131095437|NCT01214642|471978871|FG007|Overall Study|Adverse Event|0|||
131095438|NCT01214642|471978872|FG008|Overall Study|Adverse Event|0|||
131095439|NCT01214642|471978873|FG009|Overall Study|Adverse Event|1|||
131095440|NCT01214642|471978874|FG010|Overall Study|Adverse Event|1|||
131095441|NCT01214642|471978875|FG011|Overall Study|Adverse Event|0|||
131095442|NCT01214642|471978864|FG000|Overall Study|Death|0|||
131095443|NCT01214642|471978865|FG001|Overall Study|Death|0|||
131095444|NCT01214642|471978866|FG002|Overall Study|Death|1|||
131095445|NCT01214642|471978867|FG003|Overall Study|Death|0|||
131095446|NCT01214642|471978868|FG004|Overall Study|Death|0|||
131095447|NCT01214642|471978869|FG005|Overall Study|Death|0|||
131095448|NCT01214642|471978870|FG006|Overall Study|Death|0|||
131095449|NCT01214642|471978871|FG007|Overall Study|Death|0|||
131095450|NCT01214642|471978872|FG008|Overall Study|Death|0|||
131095451|NCT01214642|471978873|FG009|Overall Study|Death|0|||
131095452|NCT01214642|471978874|FG010|Overall Study|Death|1|||
131095453|NCT01214642|471978875|FG011|Overall Study|Death|0|||
131095454|NCT01214642|471978864|FG000|Overall Study|Withdrawal by Subject|0|||
131095455|NCT01214642|471978865|FG001|Overall Study|Withdrawal by Subject|0|||
131095456|NCT01214642|471978866|FG002|Overall Study|Withdrawal by Subject|1|||
131234667|NCT01047345|472486443|FG001|Extension|Withdrawal by Subject|0|||
131234668|NCT01047345|472486444|FG002|Extension|Withdrawal by Subject|1|||
131095457|NCT01214642|471978867|FG003|Overall Study|Withdrawal by Subject|0|||
130727584|NCT03743415|470625492|FG003|Overall Study|Lost to Follow-up|1|||
131095458|NCT01214642|471978868|FG004|Overall Study|Withdrawal by Subject|0|||
131095459|NCT01214642|471978869|FG005|Overall Study|Withdrawal by Subject|0|||
131095460|NCT01214642|471978870|FG006|Overall Study|Withdrawal by Subject|0|||
131095461|NCT01214642|471978871|FG007|Overall Study|Withdrawal by Subject|0|||
131095462|NCT01214642|471978872|FG008|Overall Study|Withdrawal by Subject|3|||
131095463|NCT01214642|471978873|FG009|Overall Study|Withdrawal by Subject|1|||
131095464|NCT01214642|471978874|FG010|Overall Study|Withdrawal by Subject|1|||
131095465|NCT01214642|471978875|FG011|Overall Study|Withdrawal by Subject|0|||
131144180|NCT03094195|472152610|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
131144181|NCT03094195|472152611|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131144182|NCT03094195|472152612|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131144183|NCT03094195|472152613|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131144184|NCT03094195|472152614|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131144185|NCT03094195|472152615|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
131144186|NCT01988090|472152616|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
131144187|NCT01988090|472152617|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
131144188|NCT01988090|472152616|FG000|Start Treament After Randomization|Protocol Violation|0|||
131144189|NCT01988090|472152617|FG001|Start Treament After Randomization|Protocol Violation|1|||
131144190|NCT01988090|472152616|FG000|Complete Study After Start|Withdrawal by Subject|2|||
131144191|NCT01988090|472152617|FG001|Complete Study After Start|Withdrawal by Subject|0|||
131144192|NCT01988090|472152616|FG000|Complete Study After Start|Protocol Violation|1|||
131144193|NCT01988090|472152617|FG001|Complete Study After Start|Protocol Violation|1|||
131144194|NCT03887130|472152625|FG000|Overall Study|Progressive disease|23|||
131144195|NCT03887130|472152626|FG001|Overall Study|Progressive disease|14|||
131144196|NCT03887130|472152627|FG002|Overall Study|Progressive disease|7|||
131144197|NCT03887130|472152625|FG000|Overall Study|Protocol Violation|3|||
131144198|NCT03887130|472152626|FG001|Overall Study|Protocol Violation|1|||
131144199|NCT03887130|472152627|FG002|Overall Study|Protocol Violation|2|||
131144200|NCT03887130|472152625|FG000|Overall Study|Drug related toxicity|7|||
131144201|NCT03887130|472152626|FG001|Overall Study|Drug related toxicity|7|||
131144202|NCT03887130|472152627|FG002|Overall Study|Drug related toxicity|13|||
131144203|NCT03887130|472152625|FG000|Overall Study|Non drug related toxicity|3|||
131144204|NCT03887130|472152626|FG001|Overall Study|Non drug related toxicity|0|||
131144205|NCT03887130|472152627|FG002|Overall Study|Non drug related toxicity|0|||
131144206|NCT03887130|472152625|FG000|Overall Study|Death|2|||
131144207|NCT03887130|472152626|FG001|Overall Study|Death|2|||
131144208|NCT03887130|472152627|FG002|Overall Study|Death|1|||
131144209|NCT03887130|472152625|FG000|Overall Study|Withdrawal by Subject|7|||
131144210|NCT03887130|472152626|FG001|Overall Study|Withdrawal by Subject|6|||
131144211|NCT03887130|472152627|FG002|Overall Study|Withdrawal by Subject|11|||
131144212|NCT03887130|472152625|FG000|Overall Study|other reason|6|||
131144213|NCT03887130|472152626|FG001|Overall Study|other reason|20|||
131144214|NCT03887130|472152627|FG002|Overall Study|other reason|17|||
131144215|NCT01439945|472152628|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
131144216|NCT01439945|472152629|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
131144217|NCT01439945|472152630|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
131144218|NCT01439945|472152631|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
131144219|NCT01439945|472152628|FG000|Double-Blind Treatment Phase|Ineligible|1|||
131144220|NCT01439945|472152629|FG001|Double-Blind Treatment Phase|Ineligible|2|||
131144221|NCT01439945|472152630|FG002|Double-Blind Treatment Phase|Ineligible|0|||
131144222|NCT01439945|472152631|FG003|Double-Blind Treatment Phase|Ineligible|1|||
131144223|NCT04082663|472152632|FG000|Overall Study|Adverse Event|6|||
131144224|NCT04082663|472152632|FG000|Overall Study|Lost to Follow-up|1|||
131144225|NCT00432237|472154156|FG000|Overall Study|Adverse Event|0|||
131144226|NCT00432237|472154157|FG001|Overall Study|Adverse Event|0|||
131144227|NCT00432237|472154158|FG002|Overall Study|Adverse Event|0|||
131144228|NCT00432237|472154159|FG003|Overall Study|Adverse Event|1|||
131144229|NCT00432237|472154156|FG000|Overall Study|Lack of Efficacy|0|||
131144230|NCT00432237|472154157|FG001|Overall Study|Lack of Efficacy|0|||
131144231|NCT00432237|472154158|FG002|Overall Study|Lack of Efficacy|0|||
131144232|NCT00432237|472154159|FG003|Overall Study|Lack of Efficacy|1|||
131144233|NCT00432237|472154156|FG000|Overall Study|Lost to Follow-up|10|||
131144234|NCT00432237|472154157|FG001|Overall Study|Lost to Follow-up|10|||
131144235|NCT00432237|472154158|FG002|Overall Study|Lost to Follow-up|18|||
131144236|NCT00432237|472154159|FG003|Overall Study|Lost to Follow-up|18|||
131144237|NCT00432237|472154156|FG000|Overall Study|Physician Decision|1|||
131144238|NCT00432237|472154157|FG001|Overall Study|Physician Decision|3|||
131144239|NCT00432237|472154158|FG002|Overall Study|Physician Decision|2|||
131144240|NCT00432237|472154159|FG003|Overall Study|Physician Decision|1|||
131144241|NCT00432237|472154156|FG000|Overall Study|Pregnancy|0|||
131144242|NCT00432237|472154157|FG001|Overall Study|Pregnancy|1|||
131144243|NCT00432237|472154158|FG002|Overall Study|Pregnancy|0|||
131144244|NCT00432237|472154159|FG003|Overall Study|Pregnancy|0|||
131144245|NCT00432237|472154156|FG000|Overall Study|Protocol Violation|13|||
131144246|NCT00432237|472154157|FG001|Overall Study|Protocol Violation|10|||
131144247|NCT00432237|472154158|FG002|Overall Study|Protocol Violation|11|||
131234669|NCT01047345|472486442|FG000|Extension|Lost to Follow-up|0|||
131144248|NCT00432237|472154159|FG003|Overall Study|Protocol Violation|8|||
131144249|NCT00432237|472154156|FG000|Overall Study|Withdrawal by Subject|5|||
131144250|NCT00432237|472154157|FG001|Overall Study|Withdrawal by Subject|6|||
131144251|NCT00432237|472154158|FG002|Overall Study|Withdrawal by Subject|9|||
131144252|NCT00432237|472154159|FG003|Overall Study|Withdrawal by Subject|11|||
131234670|NCT01047345|472486443|FG001|Extension|Lost to Follow-up|0|||
131144253|NCT00432237|472154156|FG000|Overall Study|Lack of Qualifying Event|38|||
131095466|NCT01214642|471978864|FG000|Overall Study|Physician Decision|0|||
131095467|NCT01214642|471978865|FG001|Overall Study|Physician Decision|0|||
131095468|NCT01214642|471978866|FG002|Overall Study|Physician Decision|1|||
131095469|NCT01214642|471978867|FG003|Overall Study|Physician Decision|1|||
131095470|NCT01214642|471978868|FG004|Overall Study|Physician Decision|1|||
131095471|NCT01214642|471978869|FG005|Overall Study|Physician Decision|0|||
131095472|NCT01214642|471978870|FG006|Overall Study|Physician Decision|0|||
131095473|NCT01214642|471978871|FG007|Overall Study|Physician Decision|0|||
131095474|NCT01214642|471978872|FG008|Overall Study|Physician Decision|0|||
131095475|NCT01214642|471978873|FG009|Overall Study|Physician Decision|0|||
131095476|NCT01214642|471978874|FG010|Overall Study|Physician Decision|0|||
131095477|NCT01214642|471978875|FG011|Overall Study|Physician Decision|2|||
131095478|NCT01732822|471980701|FG000|Overall Study|Withdrawal by Subject|123|||
131095479|NCT01732822|471980702|FG001|Overall Study|Withdrawal by Subject|113|||
131095480|NCT02314780|471980703|FG000|Overall Study|organizational reasons|0|||
131095481|NCT02314780|471980704|FG001|Overall Study|organizational reasons|2|||
131095482|NCT02314780|471980705|FG002|Overall Study|organizational reasons|0|||
131095483|NCT02314780|471980703|FG000|Overall Study|Adverse Event|0|||
131095484|NCT02314780|471980704|FG001|Overall Study|Adverse Event|1|||
131095485|NCT02314780|471980705|FG002|Overall Study|Adverse Event|0|||
131095486|NCT00215137|471980709|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
131095487|NCT00215137|471980710|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
131095488|NCT00215137|471980711|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
131095489|NCT00215137|471980709|FG000|Randomization Period|Lost to Follow-up|0|||
131095490|NCT00215137|471980710|FG001|Randomization Period|Lost to Follow-up|1|||
131095491|NCT00215137|471980711|FG002|Randomization Period|Lost to Follow-up|0|||
131095492|NCT00215137|471980709|FG000|Randomization Period|Withdrawal by Subject|0|||
131095493|NCT00215137|471980710|FG001|Randomization Period|Withdrawal by Subject|1|||
131095494|NCT00215137|471980711|FG002|Randomization Period|Withdrawal by Subject|0|||
131095495|NCT03002220|471980713|FG000|Overall Study|Lack of Efficacy|2|||
131095496|NCT03002220|471980713|FG000|Overall Study|Withdrawal by Subject|3|||
131095497|NCT03002220|471980713|FG000|Overall Study|Adverse Event|2|||
131095498|NCT03002220|471980713|FG000|Overall Study|Disease progression|13|||
131095499|NCT03002220|471980713|FG000|Overall Study|Physician Decision|1|||
131095500|NCT01183260|471980716|FG000|Overall Study|Intraop screen failure|2|||
131095501|NCT01183260|471980717|FG001|Overall Study|Intraop screen failure|0|||
131095502|NCT01183260|471980716|FG000|Overall Study|Withdrawal by Subject|1|||
131095503|NCT01183260|471980717|FG001|Overall Study|Withdrawal by Subject|1|||
131095504|NCT01183260|471980716|FG000|Overall Study|Revised within 30 days|0|||
131095505|NCT01183260|471980717|FG001|Overall Study|Revised within 30 days|1|||
131095506|NCT01183260|471980716|FG000|Overall Study|Death|1|||
131095507|NCT01183260|471980717|FG001|Overall Study|Death|0|||
131095508|NCT00730275|471980718|FG000|Overall Study|Withdrawal by Subject|0|||
131095509|NCT00730275|471980719|FG001|Overall Study|Withdrawal by Subject|0|||
131095510|NCT00730275|471980720|FG002|Overall Study|Withdrawal by Subject|0|||
131095511|NCT00730275|471980721|FG003|Overall Study|Withdrawal by Subject|1|||
131095512|NCT03046121|471980726|FG000|Overall Study|Death|32|||
131095513|NCT03046121|471980727|FG001|Overall Study|Death|60|||
131095514|NCT03046121|471980726|FG000|Overall Study|Withdrawal by Subject|14|||
131095515|NCT03046121|471980727|FG001|Overall Study|Withdrawal by Subject|12|||
131095516|NCT00910039|471980728|FG000|Overall Study|Physician Decision|1|||
131095517|NCT04155047|471980731|FG000|Overall Study|Adverse Event|1|||
131095518|NCT04155047|471980732|FG001|Overall Study|Adverse Event|0|||
131095519|NCT04155047|471980731|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
131095520|NCT04155047|471980732|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
131095521|NCT03174431|471980740|FG000|Overall Study|Withdrawal by Subject|14|||
131095522|NCT03174431|471980741|FG001|Overall Study|Withdrawal by Subject|11|||
131095523|NCT03174431|471980740|FG000|Overall Study|alternative treatment|2|||
131095524|NCT03174431|471980741|FG001|Overall Study|alternative treatment|0|||
131144254|NCT00432237|472154157|FG001|Overall Study|Lack of Qualifying Event|71|||
131144255|NCT00432237|472154158|FG002|Overall Study|Lack of Qualifying Event|69|||
131095525|NCT03174431|471980740|FG000|Overall Study|Lost to Follow-up|1|||
131095526|NCT03174431|471980741|FG001|Overall Study|Lost to Follow-up|5|||
131095527|NCT03547739|471980742|FG000|Overall Study|Death|0|||
131144256|NCT00432237|472154159|FG003|Overall Study|Lack of Qualifying Event|84|||
131095528|NCT03547739|471980743|FG001|Overall Study|Death|1|||
131095529|NCT03547739|471980744|FG002|Overall Study|Death|5|||
131144257|NCT01354132|472154162|FG000|Randomization|Physician Decision|1|||
131144258|NCT01354132|472154163|FG001|Randomization|Physician Decision|0|||
131095530|NCT03547739|471980742|FG000|Overall Study|Adverse Event|24|||
131095531|NCT03547739|471980743|FG001|Overall Study|Adverse Event|11|||
131095532|NCT03547739|471980744|FG002|Overall Study|Adverse Event|13|||
131144259|NCT01354132|472154162|FG000|Randomization|Withdrawal by Subject|0|||
131095533|NCT03547739|471980742|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
131095534|NCT03547739|471980743|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
131144260|NCT01354132|472154163|FG001|Randomization|Withdrawal by Subject|1|||
131095535|NCT03547739|471980744|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
131095536|NCT03547739|471980742|FG000|Overall Study|Lost to Follow-up|80|||
131095537|NCT03547739|471980743|FG001|Overall Study|Lost to Follow-up|84|||
131095538|NCT03547739|471980744|FG002|Overall Study|Lost to Follow-up|116|||
131095539|NCT02075073|471980745|FG000|Overall Study|Withdrawal by Subject|0|||
131095540|NCT02075073|471980746|FG001|Overall Study|Withdrawal by Subject|1|||
131095541|NCT02075073|471980747|FG002|Overall Study|Withdrawal by Subject|0|||
131095542|NCT02797080|471980755|FG000|Overall Study|Lost to Follow-up|1|||
131095543|NCT02797080|471980755|FG000|Overall Study|Withdrawal by Subject|1|||
131095544|NCT04035499|471980758|FG000|Overall Study|Death|2|||
131095545|NCT04035499|471980758|FG000|Overall Study|Withdrawal by Subject|1|||
131095546|NCT00951015|471980759|FG000|Randomization Phase 96 Week|Adverse Event|1|||
131095547|NCT00951015|471980760|FG001|Randomization Phase 96 Week|Adverse Event|1|||
131095548|NCT00951015|471980761|FG002|Randomization Phase 96 Week|Adverse Event|2|||
131095549|NCT00951015|471980762|FG003|Randomization Phase 96 Week|Adverse Event|5|||
131095550|NCT00951015|471980763|FG004|Randomization Phase 96 Week|Adverse Event|0|||
131095551|NCT00951015|471980759|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
131095552|NCT00951015|471980760|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
131095553|NCT00951015|471980761|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
131095554|NCT00951015|471980762|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
131095555|NCT00951015|471980763|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
131095556|NCT00951015|471980759|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
131095557|NCT00951015|471980760|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
131095558|NCT00951015|471980761|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
131095559|NCT00951015|471980762|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
131095560|NCT00951015|471980763|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
131095561|NCT00951015|471980759|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
131095562|NCT00951015|471980760|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
131095563|NCT00951015|471980761|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
131095564|NCT00951015|471980762|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
131095565|NCT00951015|471980763|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
131095566|NCT00951015|471980759|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
131144261|NCT01354132|472154162|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
131144262|NCT01354132|472154163|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
131144263|NCT01354132|472154162|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
131144264|NCT01354132|472154163|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
131144265|NCT01354132|472154162|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
131144266|NCT01354132|472154163|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
131144267|NCT03617705|472154164|FG000|Overall Study|Withdrawal by Subject|2|||
131144268|NCT03617705|472154164|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
131144269|NCT03617705|472154164|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
131144270|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
131144271|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
131144272|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
131144273|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
131144274|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
131144275|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
131144276|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
131144277|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
131144278|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
131144279|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
131144280|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
131144281|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
131144282|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
131144283|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
131144284|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
131144285|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
131144286|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
131144287|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
131144288|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
131144289|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
131144290|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
131144291|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
131144292|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
131144293|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
131095567|NCT00951015|471980760|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
131095568|NCT00951015|471980761|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
131095569|NCT00951015|471980762|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
131095570|NCT00951015|471980763|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
131144294|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
131144295|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
131144296|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
131144297|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
131144298|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
131144299|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
131144300|NCT00849017|472154165|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
131144301|NCT00849017|472154166|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
131144302|NCT00849017|472154167|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
131144303|NCT00849017|472154165|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
131144304|NCT00849017|472154166|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
131144305|NCT00849017|472154167|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
131144306|NCT00849017|472154165|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
131144307|NCT00849017|472154166|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
131144308|NCT00849017|472154167|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
131144309|NCT00849017|472154165|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
131144310|NCT00849017|472154166|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
131144311|NCT00849017|472154167|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
131144312|NCT00849017|472154165|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
131144313|NCT00849017|472154166|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
131144314|NCT00849017|472154167|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
131144315|NCT00849017|472154165|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
131144316|NCT00849017|472154166|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
131144317|NCT00849017|472154167|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
131144318|NCT00849017|472154165|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
131144319|NCT00849017|472154166|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
131144320|NCT00849017|472154167|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
131144321|NCT00849017|472154165|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
131144322|NCT00849017|472154166|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
131144323|NCT00849017|472154167|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
131144324|NCT00849017|472154165|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
131144325|NCT00849017|472154166|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
131144326|NCT00849017|472154167|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
131144327|NCT01061008|472154168|FG000|Overall Study|Badiocephalic fistula failed|3|||
131144328|NCT01061008|472154169|FG001|Overall Study|Badiocephalic fistula failed|2|||
131144329|NCT01061008|472154168|FG000|Overall Study|Death|1|||
131144330|NCT01061008|472154169|FG001|Overall Study|Death|0|||
131144331|NCT01061008|472154168|FG000|Overall Study|Withdrawal by Subject|1|||
131144332|NCT01061008|472154169|FG001|Overall Study|Withdrawal by Subject|3|||
131144333|NCT01061008|472154168|FG000|Overall Study|Unable to exercise following surgery|1|||
131144334|NCT01061008|472154169|FG001|Overall Study|Unable to exercise following surgery|0|||
131144335|NCT01061008|472154168|FG000|Overall Study|Adverse Event|0|||
131144336|NCT01061008|472154169|FG001|Overall Study|Adverse Event|1|||
131144337|NCT02024971|472154170|FG000|Overall Study|Data Not Available|30|||
131144338|NCT02024971|472154170|FG000|Overall Study|Lost to Follow-up|6|||
131144339|NCT05254418|472154172|FG000|Overall Study|Adverse Event|2|||
131144340|NCT01323478|472154177|FG000|Overall Study|Adverse Event|7|||
131144341|NCT01323478|472154177|FG000|Overall Study|Lack of Efficacy|4|||
131144342|NCT01323478|472154177|FG000|Overall Study|Non-compliance With Study Product|3|||
131144343|NCT01323478|472154177|FG000|Overall Study|Protocol Violation|1|||
131144344|NCT01323478|472154177|FG000|Overall Study|Withdrawal of Consent|1|||
131234671|NCT01047345|472486444|FG002|Extension|Lost to Follow-up|5|||
131234672|NCT01816477|472486445|FG000|Overall Study|Withdrawal by Subject|13|||
131234673|NCT01816477|472486446|FG001|Overall Study|Withdrawal by Subject|1|||
131234674|NCT01816477|472486445|FG000|Overall Study|Unable to tolerate catheter placement|3|||
131234675|NCT01816477|472486446|FG001|Overall Study|Unable to tolerate catheter placement|0|||
131234676|NCT00819247|472486447|FG000|Overall Study|Adverse Event|0|||
131234677|NCT00819247|472486448|FG001|Overall Study|Adverse Event|5|||
131234678|NCT00819247|472486449|FG002|Overall Study|Adverse Event|3|||
131234679|NCT00819247|472486447|FG000|Overall Study|Insufficient testosterone response|5|||
131234680|NCT00819247|472486448|FG001|Overall Study|Insufficient testosterone response|8|||
131234681|NCT00819247|472486449|FG002|Overall Study|Insufficient testosterone response|10|||
131234682|NCT00819247|472486447|FG000|Overall Study|Withdrawal by Subject|1|||
130727585|NCT03743415|470625493|FG004|Overall Study|Lost to Follow-up|1|||
131234683|NCT00819247|472486448|FG001|Overall Study|Withdrawal by Subject|0|||
131234684|NCT00819247|472486449|FG002|Overall Study|Withdrawal by Subject|0|||
130727586|NCT03743415|470625494|FG005|Overall Study|Lost to Follow-up|0|||
131234685|NCT00819247|472486447|FG000|Overall Study|Protocol Violation|1|||
130727587|NCT03743415|470625495|FG006|Overall Study|Lost to Follow-up|1|||
130727588|NCT03743415|470625496|FG007|Overall Study|Lost to Follow-up|4|||
131144345|NCT01323478|472154177|FG000|Overall Study|Administrative or Other Reasons|8|||
131234686|NCT00819247|472486448|FG001|Overall Study|Protocol Violation|0|||
131234687|NCT00819247|472486449|FG002|Overall Study|Protocol Violation|1|||
131234688|NCT00819247|472486447|FG000|Overall Study|Mistakenly withdrawn|0|||
130727589|NCT03743415|470625497|FG008|Overall Study|Lost to Follow-up|13|||
131095571|NCT00951015|471980759|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
131095572|NCT00951015|471980760|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
131095573|NCT00951015|471980761|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
131095574|NCT00951015|471980762|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
131095575|NCT00951015|471980763|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
131095576|NCT00951015|471980759|FG000|Open-label Phase|Adverse Event|0|||
131095577|NCT00951015|471980760|FG001|Open-label Phase|Adverse Event|0|||
131095578|NCT00951015|471980761|FG002|Open-label Phase|Adverse Event|0|||
131095579|NCT00951015|471980762|FG003|Open-label Phase|Adverse Event|0|||
131095580|NCT00951015|471980763|FG004|Open-label Phase|Adverse Event|3|||
131095581|NCT00951015|471980759|FG000|Open-label Phase|Lack of Efficacy|0|||
131095582|NCT00951015|471980760|FG001|Open-label Phase|Lack of Efficacy|0|||
131095583|NCT00951015|471980761|FG002|Open-label Phase|Lack of Efficacy|0|||
131095584|NCT00951015|471980762|FG003|Open-label Phase|Lack of Efficacy|0|||
131095585|NCT00951015|471980763|FG004|Open-label Phase|Lack of Efficacy|1|||
131095586|NCT00951015|471980759|FG000|Open-label Phase|Protocol Violation|0|||
131095587|NCT00951015|471980760|FG001|Open-label Phase|Protocol Violation|0|||
131095588|NCT00951015|471980761|FG002|Open-label Phase|Protocol Violation|0|||
131095589|NCT00951015|471980762|FG003|Open-label Phase|Protocol Violation|0|||
131095590|NCT00951015|471980763|FG004|Open-label Phase|Protocol Violation|12|||
131095591|NCT00951015|471980759|FG000|Open-label Phase|Lost to Follow-up|0|||
131095592|NCT00951015|471980760|FG001|Open-label Phase|Lost to Follow-up|0|||
131095593|NCT00951015|471980761|FG002|Open-label Phase|Lost to Follow-up|0|||
131095594|NCT00951015|471980762|FG003|Open-label Phase|Lost to Follow-up|0|||
131095595|NCT00951015|471980763|FG004|Open-label Phase|Lost to Follow-up|12|||
131095596|NCT00951015|471980759|FG000|Open-label Phase|Withdrawal by Subject|0|||
131095597|NCT00951015|471980760|FG001|Open-label Phase|Withdrawal by Subject|0|||
131095598|NCT00951015|471980761|FG002|Open-label Phase|Withdrawal by Subject|0|||
131095599|NCT00951015|471980762|FG003|Open-label Phase|Withdrawal by Subject|0|||
131095600|NCT00951015|471980763|FG004|Open-label Phase|Withdrawal by Subject|14|||
131095601|NCT00951015|471980759|FG000|Open-label Phase|Physician Decision|0|||
131095602|NCT00951015|471980760|FG001|Open-label Phase|Physician Decision|0|||
131095603|NCT00951015|471980761|FG002|Open-label Phase|Physician Decision|0|||
131095604|NCT00951015|471980762|FG003|Open-label Phase|Physician Decision|0|||
131095605|NCT00951015|471980763|FG004|Open-label Phase|Physician Decision|8|||
131095606|NCT01208103|471980765|FG000|Overall Study|Adverse Event|1|||
131095607|NCT01208103|471980765|FG000|Overall Study|Withdrawal by Subject|1|||
131095608|NCT03819634|471980766|FG000|Overall Study|Physician Decision|2|||
131095609|NCT00299494|471980767|FG000|Overall Study|Withdrawal by Subject|0|||
131095610|NCT00299494|471980768|FG001|Overall Study|Withdrawal by Subject|0|||
131095611|NCT00299494|471980769|FG002|Overall Study|Withdrawal by Subject|0|||
131095612|NCT00299494|471980770|FG003|Overall Study|Withdrawal by Subject|3|||
131095613|NCT00299494|471980771|FG004|Overall Study|Withdrawal by Subject|1|||
131095614|NCT00299494|471980772|FG005|Overall Study|Withdrawal by Subject|4|||
131095615|NCT00299494|471980767|FG000|Overall Study|Physician Decision|0|||
131095616|NCT00299494|471980768|FG001|Overall Study|Physician Decision|0|||
131095617|NCT00299494|471980769|FG002|Overall Study|Physician Decision|0|||
131095618|NCT00299494|471980770|FG003|Overall Study|Physician Decision|0|||
131095619|NCT00299494|471980771|FG004|Overall Study|Physician Decision|1|||
131095620|NCT00299494|471980772|FG005|Overall Study|Physician Decision|0|||
131095621|NCT00299494|471980767|FG000|Overall Study|Death|3|||
131095622|NCT00299494|471980768|FG001|Overall Study|Death|1|||
131095623|NCT00299494|471980769|FG002|Overall Study|Death|4|||
131095624|NCT00299494|471980770|FG003|Overall Study|Death|6|||
131095625|NCT00299494|471980771|FG004|Overall Study|Death|18|||
131095626|NCT00299494|471980772|FG005|Overall Study|Death|19|||
131095627|NCT00299494|471980767|FG000|Overall Study|Lost to Follow-up|0|||
131095628|NCT00299494|471980768|FG001|Overall Study|Lost to Follow-up|0|||
131095629|NCT00299494|471980769|FG002|Overall Study|Lost to Follow-up|0|||
131095630|NCT00299494|471980770|FG003|Overall Study|Lost to Follow-up|0|||
131095631|NCT00299494|471980771|FG004|Overall Study|Lost to Follow-up|3|||
131095632|NCT00299494|471980772|FG005|Overall Study|Lost to Follow-up|1|||
131095633|NCT00299494|471980767|FG000|Overall Study|Other - Unspecified|0|||
131095634|NCT00299494|471980768|FG001|Overall Study|Other - Unspecified|0|||
131095635|NCT00299494|471980769|FG002|Overall Study|Other - Unspecified|0|||
131095636|NCT00299494|471980770|FG003|Overall Study|Other - Unspecified|0|||
131095637|NCT00299494|471980771|FG004|Overall Study|Other - Unspecified|3|||
131095638|NCT00299494|471980772|FG005|Overall Study|Other - Unspecified|1|||
131095639|NCT00299494|471980767|FG000|Overall Study|Other - site closure|0|||
131095640|NCT00299494|471980768|FG001|Overall Study|Other - site closure|0|||
131095641|NCT00299494|471980769|FG002|Overall Study|Other - site closure|0|||
131095642|NCT00299494|471980770|FG003|Overall Study|Other - site closure|1|||
131095643|NCT00299494|471980771|FG004|Overall Study|Other - site closure|1|||
131095644|NCT00299494|471980772|FG005|Overall Study|Other - site closure|1|||
131095645|NCT00416195|471980773|FG000|Overall Study|Adverse Event|1|||
130727590|NCT03743415|470625498|FG009|Overall Study|Lost to Follow-up|13|||
130727591|NCT02242045|470625499|FG000|Overall Study|Investigator's Discretion|1|||
131095646|NCT00416195|471980774|FG001|Overall Study|Adverse Event|2|||
130727592|NCT02242045|470625499|FG000|Overall Study|Progressive Disease|2|||
130727593|NCT02242045|470625499|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
130727594|NCT02242045|470625499|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
130727595|NCT02473523|470625500|FG000|Overall Study|Death|1|||
130727596|NCT02473523|470625500|FG000|Overall Study|Lost to Follow-up|1|||
130727597|NCT00976911|470625506|FG000|Overall Study|Withdrawal by Subject|4|||
131095647|NCT00416195|471980773|FG000|Overall Study|Protocol Violation|1|||
131095648|NCT00416195|471980774|FG001|Overall Study|Protocol Violation|1|||
131095649|NCT00416195|471980773|FG000|Overall Study|Other|0|||
131095650|NCT00416195|471980774|FG001|Overall Study|Other|1|||
131095651|NCT01417104|471980780|FG000|Overall Study|Withdrawal by Subject|5|||
131095652|NCT01417104|471980781|FG001|Overall Study|Withdrawal by Subject|1|||
131095653|NCT01417104|471980780|FG000|Overall Study|Failure to make contact|0|||
131095654|NCT01417104|471980781|FG001|Overall Study|Failure to make contact|1|||
131095655|NCT01417104|471980780|FG000|Overall Study|Adverse Event|1|||
131095656|NCT01417104|471980781|FG001|Overall Study|Adverse Event|0|||
131095657|NCT03361605|471980782|FG000|Overall Study|Analyzable data not available|3|||
131144346|NCT02411448|472154178|FG000|Overall Study|Withdrawal by Subject|1|||
131144347|NCT02411448|472154179|FG001|Overall Study|Withdrawal by Subject|14|||
131144348|NCT02411448|472154180|FG002|Overall Study|Withdrawal by Subject|9|||
131144349|NCT02411448|472154178|FG000|Overall Study|Other|0|||
131144350|NCT02411448|472154179|FG001|Overall Study|Other|2|||
131144351|NCT02411448|472154180|FG002|Overall Study|Other|0|||
131144352|NCT02411448|472154178|FG000|Overall Study|Did not receive study treatment|0|||
131144353|NCT02411448|472154179|FG001|Overall Study|Did not receive study treatment|3|||
131144354|NCT02411448|472154180|FG002|Overall Study|Did not receive study treatment|0|||
131144355|NCT02411448|472154178|FG000|Overall Study|Alive on study treatment|3|||
131144356|NCT02411448|472154179|FG001|Overall Study|Alive on study treatment|64|||
131144357|NCT02411448|472154180|FG002|Overall Study|Alive on study treatment|43|||
131144358|NCT02771522|472154183|FG000|Overall Study|Lost to Follow-up|3|||
131144359|NCT02771522|472154183|FG000|Overall Study|Withdrawal by Subject|2|||
131144360|NCT02771522|472154183|FG000|Overall Study|No white spot lesions|3|||
131144361|NCT05655377|472154186|FG000|Overall Study|Withdrawal by Subject|2|||
131144362|NCT01256177|472154187|FG000|Overall Study|Withdrawal by Subject|23|||
131144363|NCT01256177|472154188|FG001|Overall Study|Withdrawal by Subject|22|||
131144364|NCT01256177|472154187|FG000|Overall Study|Lost to Follow-up|2|||
131144365|NCT01256177|472154188|FG001|Overall Study|Lost to Follow-up|2|||
131144366|NCT01256177|472154187|FG000|Overall Study|Adverse Event|8|||
131144367|NCT01256177|472154188|FG001|Overall Study|Adverse Event|9|||
131144368|NCT01256177|472154187|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
131144369|NCT01256177|472154188|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
131144370|NCT01256177|472154187|FG000|Overall Study|Condition under Investigation Worsened|1|||
131144371|NCT01256177|472154188|FG001|Overall Study|Condition under Investigation Worsened|0|||
131144372|NCT01256177|472154187|FG000|Overall Study|Lack of Efficacy|11|||
131144373|NCT01256177|472154188|FG001|Overall Study|Lack of Efficacy|2|||
131144374|NCT01256177|472154187|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
131144375|NCT01256177|472154188|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
131144376|NCT03624946|472154192|FG000|Overall Study|Lost to Follow-up|0|||
131144377|NCT03624946|472154193|FG001|Overall Study|Lost to Follow-up|1|||
131144378|NCT00553462|472154194|FG000|Overall Study|Adverse Event|4|||
131144379|NCT00553462|472154194|FG000|Overall Study|Progression|4|||
131144380|NCT00553462|472154194|FG000|Overall Study|Withdrawal by Subject|5|||
131144381|NCT00553462|472154194|FG000|Overall Study|Physician Decision|1|||
131144382|NCT01869348|472154195|FG000|Overall Study|Withdrawal by Subject|1|||
131144383|NCT01869348|472154196|FG001|Overall Study|Withdrawal by Subject|1|||
131144384|NCT03075163|472154198|FG000|Overall Study|not eligible for treatment limb|138|||
131144385|NCT03075163|472154199|FG001|Overall Study|not eligible for treatment limb|138|||
131144386|NCT00110994|472154200|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
131144387|NCT00110994|472154201|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
131144388|NCT00110994|472154200|FG000|Double-blind (DB) Treatment|Death|1|||
131144389|NCT00110994|472154201|FG001|Double-blind (DB) Treatment|Death|0|||
131144390|NCT00110994|472154200|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
131144391|NCT00110994|472154201|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
131144392|NCT00110994|472154200|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
131144393|NCT00110994|472154201|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
131144394|NCT00110994|472154200|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
131144395|NCT00110994|472154201|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
131234689|NCT00819247|472486448|FG001|Overall Study|Mistakenly withdrawn|1|||
131234690|NCT00819247|472486449|FG002|Overall Study|Mistakenly withdrawn|0|||
131095658|NCT01305408|471980783|FG000|Overall Study|Adverse Event|10|||
131144396|NCT00110994|472154200|FG000|Double-blind (DB) Treatment|other reasons|2|||
131144397|NCT00110994|472154201|FG001|Double-blind (DB) Treatment|other reasons|3|||
131095659|NCT01305408|471980784|FG001|Overall Study|Adverse Event|7|||
131095660|NCT01305408|471980783|FG000|Overall Study|Lack of Efficacy|3|||
131095661|NCT01305408|471980784|FG001|Overall Study|Lack of Efficacy|4|||
131095662|NCT01305408|471980783|FG000|Overall Study|Withdrawal by Subject|9|||
131095663|NCT01305408|471980784|FG001|Overall Study|Withdrawal by Subject|9|||
131095664|NCT01305408|471980783|FG000|Overall Study|Protocol Violation|4|||
131095665|NCT01305408|471980784|FG001|Overall Study|Protocol Violation|6|||
131095666|NCT01305408|471980783|FG000|Overall Study|Lost to Follow-up|5|||
131095667|NCT01305408|471980784|FG001|Overall Study|Lost to Follow-up|3|||
131095668|NCT01305408|471980783|FG000|Overall Study|Noncompliance with study medication|0|||
131095669|NCT01305408|471980784|FG001|Overall Study|Noncompliance with study medication|1|||
131095670|NCT01305408|471980783|FG000|Overall Study|Noncompliance with study procedures|0|||
131095671|NCT01305408|471980784|FG001|Overall Study|Noncompliance with study procedures|1|||
131095672|NCT01305408|471980783|FG000|Overall Study|Other|1|||
131095673|NCT01305408|471980784|FG001|Overall Study|Other|0|||
131095674|NCT03101462|471980785|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
131095675|NCT03101462|471980786|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
131095676|NCT02530970|471980788|FG000|Overall Study|Adverse Event|8|||
131095677|NCT02530970|471980788|FG000|Overall Study|Lost to Follow-up|88|||
131095678|NCT02530970|471980788|FG000|Overall Study|Physician Decision|5|||
131095679|NCT02530970|471980788|FG000|Overall Study|Withdrawal by Subject|14|||
131095680|NCT02530970|471980788|FG000|Overall Study|Death|6|||
131095681|NCT02530970|471980788|FG000|Overall Study|Hospitalization|1|||
131095682|NCT02530970|471980788|FG000|Overall Study|Insurance|2|||
131095683|NCT02530970|471980788|FG000|Overall Study|Explant|2|||
131095684|NCT02530970|471980788|FG000|Overall Study|Change in Provider|5|||
131095685|NCT02530970|471980788|FG000|Overall Study|Relocation|3|||
131095686|NCT02770612|471980789|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
131095687|NCT00403767|471980792|FG000|Overall Study|Adverse Event|993|||
131095688|NCT00403767|471980793|FG001|Overall Study|Adverse Event|919|||
131095689|NCT00403767|471980792|FG000|Overall Study|Non-compliant with study medication|134|||
131095690|NCT00403767|471980793|FG001|Overall Study|Non-compliant with study medication|164|||
131095691|NCT00403767|471980792|FG000|Overall Study|Consent withdrawn|671|||
131095692|NCT00403767|471980793|FG001|Overall Study|Consent withdrawn|673|||
131095693|NCT00403767|471980792|FG000|Overall Study|Investigator dec./not protocol-related|191|||
131095694|NCT00403767|471980793|FG001|Overall Study|Investigator dec./not protocol-related|178|||
131095695|NCT00403767|471980792|FG000|Overall Study|Lost to Follow-up|6|||
131095696|NCT00403767|471980793|FG001|Overall Study|Lost to Follow-up|8|||
131095697|NCT00403767|471980792|FG000|Overall Study|Protocol Violation|142|||
131095698|NCT00403767|471980793|FG001|Overall Study|Protocol Violation|124|||
131095699|NCT00403767|471980792|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
131095700|NCT00403767|471980793|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
131095701|NCT00403767|471980792|FG000|Overall Study|Study terminated by sponsor|82|||
131095702|NCT00403767|471980793|FG001|Overall Study|Study terminated by sponsor|69|||
131095703|NCT00403767|471980792|FG000|Overall Study|Missing/incomplete data|1|||
131095704|NCT00403767|471980793|FG001|Overall Study|Missing/incomplete data|1|||
131095705|NCT01152814|471980805|FG000|Overall Study|Lost to Follow-up|2|||
131095706|NCT01877239|471980806|FG000|Overall Study|Adverse Event|4|||
131095707|NCT01877239|471980806|FG000|Overall Study|Disease Remission|1|||
131095708|NCT01877239|471980806|FG000|Overall Study|Withdrawal by Subject|4|||
131095709|NCT01877239|471980806|FG000|Overall Study|Other|2|||
131095710|NCT01877239|471980806|FG000|Overall Study|Lack of Efficacy|4|||
131095711|NCT01877239|471980806|FG000|Overall Study|Data not available|35|||
131095712|NCT01669577|471980807|FG000|Overall Study|Death|22|||
131095713|NCT01669577|471980807|FG000|Overall Study|Lost to Follow-up|78|||
131095714|NCT01669577|471980807|FG000|Overall Study|Physician Decision|34|||
131095715|NCT00444275|471980808|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
131144398|NCT00110994|472154200|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
131144399|NCT00110994|472154201|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
131144400|NCT00110994|472154200|FG000|Active Follow-up|Other reasons|0|||
131144401|NCT00110994|472154201|FG001|Active Follow-up|Other reasons|2|||
131144402|NCT00110994|472154200|FG000|Long Term Follow-up|Death|19|||
131144403|NCT00110994|472154201|FG001|Long Term Follow-up|Death|17|||
131144404|NCT01299727|472154204|FG000|Overall Study|Withdrawal by Subject|1|||
131095716|NCT00444275|471980809|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
131095717|NCT00444275|471980810|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
131095718|NCT00444275|471980811|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
131095719|NCT00444275|471980812|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
131095720|NCT00444275|471980808|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
131095721|NCT00444275|471980809|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
131095722|NCT00444275|471980810|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
131095723|NCT00444275|471980811|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
131095724|NCT00444275|471980812|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
131095725|NCT00444275|471980808|FG000|Maintenance Treatment Phase|Adverse Event|0|||
131095726|NCT00444275|471980809|FG001|Maintenance Treatment Phase|Adverse Event|0|||
131095727|NCT00444275|471980810|FG002|Maintenance Treatment Phase|Adverse Event|3|||
131095728|NCT00444275|471980811|FG003|Maintenance Treatment Phase|Adverse Event|2|||
131095729|NCT00444275|471980812|FG004|Maintenance Treatment Phase|Adverse Event|13|||
131095730|NCT00444275|471980808|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
131095731|NCT00444275|471980809|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
131095732|NCT00444275|471980810|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
131095733|NCT00444275|471980811|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
131095734|NCT00444275|471980812|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
131095735|NCT00444275|471980808|FG000|Maintenance Treatment Phase|Patient's wish|0|||
131095736|NCT00444275|471980809|FG001|Maintenance Treatment Phase|Patient's wish|0|||
131095737|NCT00444275|471980810|FG002|Maintenance Treatment Phase|Patient's wish|19|||
131095738|NCT00444275|471980811|FG003|Maintenance Treatment Phase|Patient's wish|9|||
131095739|NCT00444275|471980812|FG004|Maintenance Treatment Phase|Patient's wish|20|||
131095740|NCT00444275|471980808|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
131095741|NCT00444275|471980809|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
131095742|NCT00444275|471980810|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
131095743|NCT00444275|471980811|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
131095744|NCT00444275|471980812|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
131095745|NCT00444275|471980808|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
131095746|NCT00444275|471980809|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
131095747|NCT00444275|471980810|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
131095748|NCT00444275|471980811|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
131095749|NCT00444275|471980812|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
131095750|NCT01204710|471980813|FG000|Randomization Treatment|Lost to Follow-up|1|||
131095751|NCT01204710|471980814|FG001|Randomization Treatment|Lost to Follow-up|0|||
131095752|NCT01204710|471980813|FG000|Randomization Treatment|Withdrawal by Subject|6|||
131095753|NCT01204710|471980814|FG001|Randomization Treatment|Withdrawal by Subject|5|||
131095754|NCT01204710|471980813|FG000|Randomization Treatment|Physician Decision|3|||
131095755|NCT01204710|471980814|FG001|Randomization Treatment|Physician Decision|2|||
131095756|NCT01204710|471980813|FG000|Randomization Treatment|Entry criteria not met|0|||
131095757|NCT01204710|471980814|FG001|Randomization Treatment|Entry criteria not met|1|||
131095758|NCT01204710|471980813|FG000|Randomization Treatment|Adverse Event|4|||
131095759|NCT01204710|471980814|FG001|Randomization Treatment|Adverse Event|2|||
131095760|NCT01204710|471980813|FG000|Randomization Treatment|Sponsor Decision|0|||
131095761|NCT01204710|471980814|FG001|Randomization Treatment|Sponsor Decision|1|||
131095762|NCT01204710|471980813|FG000|Randomization Treatment|Worsening of General condition|0|||
131095763|NCT01204710|471980814|FG001|Randomization Treatment|Worsening of General condition|1|||
131095764|NCT01204710|471980813|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
131095765|NCT01204710|471980814|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
131095766|NCT01204710|471980813|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
131095767|NCT01204710|471980814|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
131095768|NCT01204710|471980813|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
131095769|NCT01204710|471980814|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
131095770|NCT01204710|471980813|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
131095771|NCT01204710|471980814|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
131095772|NCT00743431|471980815|FG000|Overall Study|Toxicity|6|||
131095773|NCT00743431|471980815|FG000|Overall Study|Tumor progression|56|||
131095774|NCT00743431|471980815|FG000|Overall Study|Withdrawal by Subject|13|||
131095775|NCT00743431|471980815|FG000|Overall Study|Death|9|||
131095776|NCT00743431|471980815|FG000|Overall Study|Reason for discontinuation not specified|29|||
131095777|NCT00743431|471980815|FG000|Overall Study|No documentation available|13|||
131095778|NCT03291288|471980816|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
131095779|NCT03291288|471980817|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
131095780|NCT03291288|471980816|FG000|Drug-drug Interaction Phase|Disease progression|1|||
131095781|NCT03291288|471980817|FG001|Drug-drug Interaction Phase|Disease progression|0|||
131095782|NCT03291288|471980816|FG000|Drug-drug Interaction Phase|Other|3|||
131095783|NCT03291288|471980817|FG001|Drug-drug Interaction Phase|Other|0|||
131095784|NCT03291288|471980816|FG000|Pexidartinib Only|Ongoing|0|||
131095785|NCT03291288|471980817|FG001|Pexidartinib Only|Ongoing|2|||
131095786|NCT04276415|471980818|FG000|Overall Study|Adverse Event|0|||
131144405|NCT01299727|472154205|FG001|Overall Study|Withdrawal by Subject|0|||
131144406|NCT01299727|472154206|FG002|Overall Study|Withdrawal by Subject|0|||
131144407|NCT01299727|472154204|FG000|Overall Study|Adverse Event|0|||
131144408|NCT01299727|472154205|FG001|Overall Study|Adverse Event|0|||
131095787|NCT04276415|471980819|FG001|Overall Study|Adverse Event|0|||
131095788|NCT04276415|471980820|FG002|Overall Study|Adverse Event|0|||
131095789|NCT04276415|471980821|FG003|Overall Study|Adverse Event|3|||
131095790|NCT04276415|471980822|FG004|Overall Study|Adverse Event|0|||
131095791|NCT04276415|471980823|FG005|Overall Study|Adverse Event|0|||
131095792|NCT04276415|471980818|FG000|Overall Study|Clinical progression|1|||
131095793|NCT04276415|471980819|FG001|Overall Study|Clinical progression|1|||
131144409|NCT01299727|472154206|FG002|Overall Study|Adverse Event|1|||
131144410|NCT01299727|472154204|FG000|Overall Study|Completed the Treatment Period|3|||
131234691|NCT00819247|472486447|FG000|Overall Study|Bad prostate-specific antigen response|3|||
130727598|NCT00976911|470625507|FG001|Overall Study|Withdrawal by Subject|6|||
130727599|NCT00976911|470625506|FG000|Overall Study|Death|138|||
131095794|NCT04276415|471980820|FG002|Overall Study|Clinical progression|0|||
131095795|NCT04276415|471980821|FG003|Overall Study|Clinical progression|0|||
131095796|NCT04276415|471980822|FG004|Overall Study|Clinical progression|1|||
131095797|NCT04276415|471980823|FG005|Overall Study|Clinical progression|0|||
131095798|NCT04276415|471980818|FG000|Overall Study|Other|0|||
131095799|NCT04276415|471980819|FG001|Overall Study|Other|0|||
131095800|NCT04276415|471980820|FG002|Overall Study|Other|0|||
131095801|NCT04276415|471980821|FG003|Overall Study|Other|1|||
131095802|NCT04276415|471980822|FG004|Overall Study|Other|0|||
131095803|NCT04276415|471980823|FG005|Overall Study|Other|0|||
131095804|NCT04276415|471980818|FG000|Overall Study|Physician Decision|0|||
131095805|NCT04276415|471980819|FG001|Overall Study|Physician Decision|0|||
131095806|NCT04276415|471980820|FG002|Overall Study|Physician Decision|1|||
131095807|NCT04276415|471980821|FG003|Overall Study|Physician Decision|3|||
131095808|NCT04276415|471980822|FG004|Overall Study|Physician Decision|2|||
131095809|NCT04276415|471980823|FG005|Overall Study|Physician Decision|0|||
131095810|NCT04276415|471980818|FG000|Overall Study|Progressive disease|3|||
131095811|NCT04276415|471980819|FG001|Overall Study|Progressive disease|3|||
131095812|NCT04276415|471980820|FG002|Overall Study|Progressive disease|4|||
131095813|NCT04276415|471980821|FG003|Overall Study|Progressive disease|5|||
131095814|NCT04276415|471980822|FG004|Overall Study|Progressive disease|1|||
131095815|NCT04276415|471980823|FG005|Overall Study|Progressive disease|2|||
131095816|NCT04276415|471980818|FG000|Overall Study|Withdrawal by patient|0|||
131095817|NCT04276415|471980819|FG001|Overall Study|Withdrawal by patient|0|||
131095818|NCT04276415|471980820|FG002|Overall Study|Withdrawal by patient|0|||
131095819|NCT04276415|471980821|FG003|Overall Study|Withdrawal by patient|1|||
131095820|NCT04276415|471980822|FG004|Overall Study|Withdrawal by patient|2|||
131095821|NCT04276415|471980823|FG005|Overall Study|Withdrawal by patient|0|||
131095822|NCT03309813|471980824|FG000|Main Randomized Study|Withdrawal by Subject|1|||
131095823|NCT03309813|471980825|FG001|Main Randomized Study|Withdrawal by Subject|0|||
131095824|NCT01989169|471980828|FG000|Period 2|Adverse Event|0|||
131095825|NCT01989169|471980829|FG001|Period 2|Adverse Event|1|||
131095826|NCT02406677|471980830|FG000|Overall Study|Death|16|||
131095827|NCT02406677|471980831|FG001|Overall Study|Death|8|||
131095828|NCT02406677|471980830|FG000|Overall Study|Discharged without P2Y12|1|||
131095829|NCT02406677|471980831|FG001|Overall Study|Discharged without P2Y12|3|||
131095830|NCT02406677|471980830|FG000|Overall Study|Discharged on prasugrel|283|||
131095831|NCT02406677|471980831|FG001|Overall Study|Discharged on prasugrel|587|||
131095832|NCT02406677|471980830|FG000|Overall Study|Withdrawal by Subject|1|||
131095833|NCT02406677|471980831|FG001|Overall Study|Withdrawal by Subject|0|||
131095834|NCT04531904|471980832|FG000|Overall Study|Lost to Follow-up|1|||
131095835|NCT04531904|471980832|FG000|Overall Study|Death|14|||
131095836|NCT00283244|471980833|FG000|Overall Study|Adverse Event|0|||
131095837|NCT00283244|471980834|FG001|Overall Study|Adverse Event|8|||
131095838|NCT00283244|471980835|FG002|Overall Study|Adverse Event|11|||
131095839|NCT00283244|471980833|FG000|Overall Study|Death|4|||
131095840|NCT00283244|471980834|FG001|Overall Study|Death|3|||
131095841|NCT00283244|471980835|FG002|Overall Study|Death|2|||
131095842|NCT00283244|471980833|FG000|Overall Study|Lack of Efficacy|8|||
131095843|NCT00283244|471980834|FG001|Overall Study|Lack of Efficacy|32|||
131095844|NCT00283244|471980835|FG002|Overall Study|Lack of Efficacy|26|||
131095845|NCT00283244|471980833|FG000|Overall Study|Withdrawal by Subject|1|||
131095846|NCT00283244|471980834|FG001|Overall Study|Withdrawal by Subject|2|||
131095847|NCT00283244|471980835|FG002|Overall Study|Withdrawal by Subject|2|||
131095848|NCT00283244|471980833|FG000|Overall Study|Physician Decision|0|||
131095849|NCT00283244|471980834|FG001|Overall Study|Physician Decision|0|||
131095850|NCT00283244|471980835|FG002|Overall Study|Physician Decision|1|||
131095851|NCT00283244|471980833|FG000|Overall Study|Medical illness (other complicating dz)|4|||
131095852|NCT00283244|471980834|FG001|Overall Study|Medical illness (other complicating dz)|3|||
131095853|NCT00283244|471980835|FG002|Overall Study|Medical illness (other complicating dz)|6|||
131095854|NCT00283244|471980833|FG000|Overall Study|Clinical deterioration|1|||
131095855|NCT00283244|471980834|FG001|Overall Study|Clinical deterioration|3|||
131095856|NCT00283244|471980835|FG002|Overall Study|Clinical deterioration|3|||
131095857|NCT00586612|471980836|FG000|Primary Phase|Protocol Violation|1|||
131095858|NCT00586612|471980837|FG001|Primary Phase|Protocol Violation|0|||
131095859|NCT00586612|471980836|FG000|Primary Phase|Lost to Follow-up|0|||
131095860|NCT00586612|471980837|FG001|Primary Phase|Lost to Follow-up|1|||
131095861|NCT00586612|471980836|FG000|Primary Phase|Withdrawal by Subject|0|||
131095862|NCT00586612|471980837|FG001|Primary Phase|Withdrawal by Subject|2|||
131095863|NCT00586612|471980836|FG000|Booster Phase|Lost to Follow-up|3|||
131095864|NCT00586612|471980837|FG001|Booster Phase|Lost to Follow-up|1|||
131095865|NCT01609062|471980838|FG000|Extension Phase|Terminated by Sponsor|14|||
131095866|NCT01609062|471980839|FG001|Extension Phase|Terminated by Sponsor|9|||
131095867|NCT01609062|471980838|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
131095868|NCT01609062|471980839|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
131095869|NCT01609062|471980838|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
131095870|NCT01609062|471980839|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
131095871|NCT02738853|471980840|FG000|Enrollment|Inclusion/Exclusion not met|21|||
131095872|NCT02738853|471980840|FG000|Enrollment|Withdrawal by Subject|3|||
131095873|NCT02738853|471980840|FG000|Enrollment|Subject treated with commercially available device|6|||
131095874|NCT02738853|471980840|FG000|Enrollment|Study Enrollment Closed|3|||
131095875|NCT02738853|471980840|FG000|Procedure|Death|1|||
131095876|NCT02738853|471980840|FG000|1 Month|Death|2|||
131095877|NCT02738853|471980840|FG000|6 Month|Death|4|||
131095878|NCT02738853|471980840|FG000|6 Month|Withdrawal by Subject|2|||
131095879|NCT02738853|471980840|FG000|1 Year|Death|6|||
131095880|NCT02738853|471980840|FG000|1 Year|Withdrawal by Subject|1|||
131095881|NCT02738853|471980840|FG000|2 Year|Death|2|||
131095882|NCT02738853|471980840|FG000|2 Year|Lost to Follow-up|1|||
131095883|NCT02738853|471980840|FG000|3 Year|Death|2|||
131095884|NCT02738853|471980840|FG000|3 Year|Withdrawal by Subject|1|||
131095885|NCT02738853|471980840|FG000|4 Year|Death|9|||
131095886|NCT02738853|471980840|FG000|5 Year|Lost to Follow-up|4|||
131095887|NCT02235311|471980841|FG000|Overall Study|Lost to Follow-up|0|||
131095888|NCT02235311|471980842|FG001|Overall Study|Lost to Follow-up|1|||
131095889|NCT02235311|471980841|FG000|Overall Study|Protocol Violation|0|||
131095890|NCT02235311|471980842|FG001|Overall Study|Protocol Violation|1|||
131095891|NCT00658788|471980843|FG000|Overall Study|Adverse Event|11|||
131095892|NCT00658788|471980843|FG000|Overall Study|Withdrawal by Subject|13|||
131095893|NCT00658788|471980843|FG000|Overall Study|Lost to Follow-up|18|||
131095894|NCT00658788|471980843|FG000|Overall Study|Treatment Discontinuation|32|||
131095895|NCT05384938|471980844|FG000|Overall Study|Withdrawal by Subject|8|||
131095896|NCT05384938|471980844|FG000|Overall Study|Lost to Follow-up|6|||
131095897|NCT05384938|471980844|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
131095898|NCT02626455|471980845|FG000|Overall Study|Other|1|||
131095899|NCT02626455|471980846|FG001|Overall Study|Other|1|||
131095900|NCT02626455|471980847|FG002|Overall Study|Other|0|||
131095901|NCT02626455|471980848|FG003|Overall Study|Other|0|||
131095902|NCT02626455|471980849|FG004|Overall Study|Other|0|||
131095903|NCT02626455|471980850|FG005|Overall Study|Other|17|||
131095904|NCT02626455|471980851|FG006|Overall Study|Other|23|||
131095905|NCT02626455|471980845|FG000|Overall Study|Withdrawal by Subject|1|||
131095906|NCT02626455|471980846|FG001|Overall Study|Withdrawal by Subject|0|||
131095907|NCT02626455|471980847|FG002|Overall Study|Withdrawal by Subject|0|||
131095908|NCT02626455|471980848|FG003|Overall Study|Withdrawal by Subject|0|||
131095909|NCT02626455|471980849|FG004|Overall Study|Withdrawal by Subject|0|||
131095910|NCT02626455|471980850|FG005|Overall Study|Withdrawal by Subject|10|||
131095911|NCT02626455|471980851|FG006|Overall Study|Withdrawal by Subject|6|||
131095912|NCT02626455|471980845|FG000|Overall Study|Physician Decision|0|||
131095913|NCT02626455|471980846|FG001|Overall Study|Physician Decision|2|||
131095914|NCT02626455|471980847|FG002|Overall Study|Physician Decision|2|||
131095915|NCT02626455|471980848|FG003|Overall Study|Physician Decision|2|||
131095916|NCT02626455|471980849|FG004|Overall Study|Physician Decision|1|||
131095917|NCT02626455|471980850|FG005|Overall Study|Physician Decision|10|||
131095918|NCT02626455|471980851|FG006|Overall Study|Physician Decision|3|||
131095919|NCT02626455|471980845|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131095920|NCT02626455|471980846|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131095921|NCT02626455|471980847|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131095922|NCT02626455|471980848|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131095923|NCT02626455|471980849|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131095924|NCT02626455|471980850|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
131095925|NCT02626455|471980851|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
131095926|NCT02626455|471980845|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131095927|NCT02626455|471980846|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131095928|NCT02626455|471980847|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131095929|NCT02626455|471980848|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131095930|NCT02626455|471980849|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131095931|NCT02626455|471980850|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
131095932|NCT02626455|471980851|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
131095933|NCT02626455|471980845|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
131095934|NCT02626455|471980846|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
131095935|NCT02626455|471980847|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
131095936|NCT02626455|471980848|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
131095937|NCT02626455|471980849|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
131095938|NCT02626455|471980850|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
131095939|NCT02626455|471980851|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
131095940|NCT02626455|471980845|FG000|Overall Study|Patient decision|0|||
131095941|NCT02626455|471980846|FG001|Overall Study|Patient decision|1|||
131095942|NCT02626455|471980847|FG002|Overall Study|Patient decision|0|||
131095943|NCT02626455|471980848|FG003|Overall Study|Patient decision|0|||
131095944|NCT02626455|471980849|FG004|Overall Study|Patient decision|1|||
130727600|NCT00976911|470625507|FG001|Overall Study|Death|126|||
130727601|NCT00976911|470625506|FG000|Overall Study|Adverse Event|0|||
130727602|NCT00976911|470625507|FG001|Overall Study|Adverse Event|1|||
130727603|NCT00976911|470625506|FG000|Overall Study|Protocol Violation|2|||
130727604|NCT00976911|470625507|FG001|Overall Study|Protocol Violation|0|||
130727605|NCT00976911|470625506|FG000|Overall Study|Other|8|||
131095945|NCT02626455|471980850|FG005|Overall Study|Patient decision|36|||
131095946|NCT02626455|471980851|FG006|Overall Study|Patient decision|22|||
131095947|NCT02626455|471980845|FG000|Overall Study|Protocol Violation|0|||
131095948|NCT02626455|471980846|FG001|Overall Study|Protocol Violation|0|||
131095949|NCT02626455|471980847|FG002|Overall Study|Protocol Violation|0|||
131095950|NCT02626455|471980848|FG003|Overall Study|Protocol Violation|0|||
131095951|NCT02626455|471980849|FG004|Overall Study|Protocol Violation|0|||
131095952|NCT02626455|471980850|FG005|Overall Study|Protocol Violation|0|||
131095953|NCT02626455|471980851|FG006|Overall Study|Protocol Violation|1|||
131095954|NCT02626455|471980845|FG000|Overall Study|Progressive disease - radiological progression|0|||
131095955|NCT02626455|471980846|FG001|Overall Study|Progressive disease - radiological progression|0|||
131095956|NCT02626455|471980847|FG002|Overall Study|Progressive disease - radiological progression|0|||
131095957|NCT02626455|471980848|FG003|Overall Study|Progressive disease - radiological progression|0|||
131095958|NCT02626455|471980849|FG004|Overall Study|Progressive disease - radiological progression|0|||
131095959|NCT02626455|471980850|FG005|Overall Study|Progressive disease - radiological progression|11|||
131095960|NCT02626455|471980851|FG006|Overall Study|Progressive disease - radiological progression|22|||
131095961|NCT02626455|471980845|FG000|Overall Study|Progressive disease - clinical progression|0|||
131095962|NCT02626455|471980846|FG001|Overall Study|Progressive disease - clinical progression|0|||
131095963|NCT02626455|471980847|FG002|Overall Study|Progressive disease - clinical progression|0|||
131095964|NCT02626455|471980848|FG003|Overall Study|Progressive disease - clinical progression|0|||
131095965|NCT02626455|471980849|FG004|Overall Study|Progressive disease - clinical progression|0|||
131095966|NCT02626455|471980850|FG005|Overall Study|Progressive disease - clinical progression|1|||
131095967|NCT02626455|471980851|FG006|Overall Study|Progressive disease - clinical progression|2|||
131095968|NCT02626455|471980845|FG000|Overall Study|Lost to Follow-up|0|||
131095969|NCT02626455|471980846|FG001|Overall Study|Lost to Follow-up|0|||
131095970|NCT02626455|471980847|FG002|Overall Study|Lost to Follow-up|0|||
131095971|NCT02626455|471980848|FG003|Overall Study|Lost to Follow-up|0|||
131095972|NCT02626455|471980849|FG004|Overall Study|Lost to Follow-up|0|||
131095973|NCT02626455|471980850|FG005|Overall Study|Lost to Follow-up|1|||
131095974|NCT02626455|471980851|FG006|Overall Study|Lost to Follow-up|0|||
131095975|NCT02626455|471980845|FG000|Overall Study|AE not associated with clinical disease progression|1|||
131095976|NCT02626455|471980846|FG001|Overall Study|AE not associated with clinical disease progression|1|||
131095977|NCT02626455|471980847|FG002|Overall Study|AE not associated with clinical disease progression|0|||
131095978|NCT02626455|471980848|FG003|Overall Study|AE not associated with clinical disease progression|2|||
131095979|NCT02626455|471980849|FG004|Overall Study|AE not associated with clinical disease progression|1|||
131095980|NCT02626455|471980850|FG005|Overall Study|AE not associated with clinical disease progression|65|||
131095981|NCT02626455|471980851|FG006|Overall Study|AE not associated with clinical disease progression|21|||
131095982|NCT02626455|471980845|FG000|Overall Study|AE associated with clinical disease progression|0|||
131095983|NCT02626455|471980846|FG001|Overall Study|AE associated with clinical disease progression|0|||
131095984|NCT02626455|471980847|FG002|Overall Study|AE associated with clinical disease progression|0|||
131095985|NCT02626455|471980848|FG003|Overall Study|AE associated with clinical disease progression|0|||
131095986|NCT02626455|471980849|FG004|Overall Study|AE associated with clinical disease progression|0|||
131095987|NCT02626455|471980850|FG005|Overall Study|AE associated with clinical disease progression|1|||
131095988|NCT02626455|471980851|FG006|Overall Study|AE associated with clinical disease progression|2|||
131095989|NCT02626455|471980845|FG000|Overall Study|Study intervention never administered|0|||
131095990|NCT02626455|471980846|FG001|Overall Study|Study intervention never administered|0|||
131095991|NCT02626455|471980847|FG002|Overall Study|Study intervention never administered|0|||
131095992|NCT02626455|471980848|FG003|Overall Study|Study intervention never administered|0|||
131095993|NCT02626455|471980849|FG004|Overall Study|Study intervention never administered|0|||
131095994|NCT02626455|471980850|FG005|Overall Study|Study intervention never administered|1|||
131095995|NCT02626455|471980851|FG006|Overall Study|Study intervention never administered|3|||
131095996|NCT00166712|471982307|FG000|Overall Study|Death|0|||
130727606|NCT00976911|470625507|FG001|Overall Study|Other|9|||
131095997|NCT00166712|471982308|FG001|Overall Study|Death|1|||
131095998|NCT00166712|471982307|FG000|Overall Study|Adverse Event|1|||
131095999|NCT00166712|471982308|FG001|Overall Study|Adverse Event|0|||
130727607|NCT00976911|470625506|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
131096000|NCT00166712|471982307|FG000|Overall Study|Withdrawal by Subject|1|||
131096001|NCT00166712|471982308|FG001|Overall Study|Withdrawal by Subject|2|||
131096002|NCT00166712|471982307|FG000|Overall Study|Physician Decision|0|||
131096003|NCT00166712|471982308|FG001|Overall Study|Physician Decision|2|||
130727608|NCT00976911|470625507|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
130727609|NCT02954991|470625508|FG000|Overall Study|Death|92|||
131096004|NCT03986944|471982309|FG000|Overall Study|Adverse Event|1|||
131096005|NCT03986944|471982310|FG001|Overall Study|Adverse Event|2|||
131096006|NCT03986944|471982311|FG002|Overall Study|Adverse Event|3|||
130727610|NCT02954991|470625509|FG001|Overall Study|Death|11|||
130727611|NCT02954991|470625510|FG002|Overall Study|Death|2|||
130727612|NCT02954991|470625508|FG000|Overall Study|Lost to Follow-up|3|||
130727613|NCT02954991|470625509|FG001|Overall Study|Lost to Follow-up|2|||
131096007|NCT03986944|471982309|FG000|Overall Study|Protocol Violation|0|||
131096008|NCT03986944|471982310|FG001|Overall Study|Protocol Violation|1|||
131096009|NCT03986944|471982311|FG002|Overall Study|Protocol Violation|1|||
131096010|NCT03986944|471982309|FG000|Overall Study|Withdrawal by Subject|3|||
131096011|NCT03986944|471982310|FG001|Overall Study|Withdrawal by Subject|5|||
131096012|NCT03986944|471982311|FG002|Overall Study|Withdrawal by Subject|5|||
131096013|NCT03986944|471982309|FG000|Overall Study|Study termination|10|||
131096014|NCT03986944|471982310|FG001|Overall Study|Study termination|10|||
131096015|NCT03986944|471982311|FG002|Overall Study|Study termination|10|||
131096016|NCT03986944|471982309|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
131096017|NCT03986944|471982310|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
131096018|NCT03986944|471982311|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
131096019|NCT03986944|471982309|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
131096020|NCT03986944|471982310|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
131096021|NCT03986944|471982311|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
131096022|NCT01015560|471982313|FG000|Overall Study|Adverse Event|1|||
131096023|NCT01015560|471982313|FG000|Overall Study|Not protocol specified|1|||
131096024|NCT01015560|471982313|FG000|Overall Study|Withdrawal by Subject|1|||
131096025|NCT00640133|471982314|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
131096026|NCT00640133|471982315|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
131096027|NCT00640133|471982314|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
131096028|NCT00640133|471982315|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
131096029|NCT00640133|471982314|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
131096030|NCT00640133|471982315|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
131096031|NCT00128102|471982318|FG000|Overall Study|Site Discontinued|3|||
131096032|NCT00128102|471982319|FG001|Overall Study|Site Discontinued|6|||
131096033|NCT00128102|471982318|FG000|Overall Study|Other|0|||
131096034|NCT00128102|471982319|FG001|Overall Study|Other|1|||
131096035|NCT00128102|471982318|FG000|Overall Study|Progressive Disease|255|||
131096036|NCT00128102|471982319|FG001|Overall Study|Progressive Disease|285|||
131096037|NCT00128102|471982318|FG000|Overall Study|Adverse Event|34|||
131096038|NCT00128102|471982319|FG001|Overall Study|Adverse Event|11|||
131144411|NCT01299727|472154205|FG001|Overall Study|Completed the Treatment Period|4|||
131144412|NCT01299727|472154206|FG002|Overall Study|Completed the Treatment Period|3|||
131144413|NCT00944034|472154210|FG000|Overall Study|Inappropriate enrollment|0|||
131144414|NCT00944034|472154211|FG001|Overall Study|Inappropriate enrollment|1|||
131144415|NCT00944034|472154212|FG002|Overall Study|Inappropriate enrollment|0|||
131144416|NCT00944034|472154213|FG003|Overall Study|Inappropriate enrollment|1|||
131144417|NCT00944034|472154214|FG004|Overall Study|Inappropriate enrollment|2|||
131144418|NCT00944034|472154215|FG005|Overall Study|Inappropriate enrollment|1|||
131144419|NCT00944034|472154216|FG006|Overall Study|Inappropriate enrollment|0|||
131144420|NCT00944034|472154217|FG007|Overall Study|Inappropriate enrollment|0|||
131144421|NCT00944034|472154218|FG008|Overall Study|Inappropriate enrollment|1|||
131144422|NCT00944034|472154219|FG009|Overall Study|Inappropriate enrollment|1|||
131144423|NCT00944034|472154220|FG010|Overall Study|Inappropriate enrollment|0|||
131144424|NCT00944034|472154221|FG011|Overall Study|Inappropriate enrollment|0|||
131144425|NCT00944034|472154210|FG000|Overall Study|Withdrawal by Subject|3|||
131144426|NCT00944034|472154211|FG001|Overall Study|Withdrawal by Subject|2|||
131144427|NCT00944034|472154212|FG002|Overall Study|Withdrawal by Subject|6|||
130727614|NCT02954991|470625510|FG002|Overall Study|Lost to Follow-up|0|||
131096039|NCT00128102|471982318|FG000|Overall Study|Death|12|||
131096040|NCT00128102|471982319|FG001|Overall Study|Death|13|||
131096041|NCT00128102|471982318|FG000|Overall Study|Physician Decision|3|||
131096042|NCT00128102|471982319|FG001|Overall Study|Physician Decision|3|||
131096043|NCT00128102|471982318|FG000|Overall Study|Withdrawal by Subject|19|||
131096044|NCT00128102|471982319|FG001|Overall Study|Withdrawal by Subject|11|||
131096045|NCT00128102|471982318|FG000|Overall Study|Protocol Violation|2|||
131096046|NCT00128102|471982319|FG001|Overall Study|Protocol Violation|2|||
131096047|NCT01202903|471982321|FG000|Overall Study|Administrative Probelms|1|||
131096048|NCT01202903|471982322|FG001|Overall Study|Administrative Probelms|4|||
131096049|NCT01202903|471982321|FG000|Overall Study|Protocol Violation|0|||
131096050|NCT01202903|471982322|FG001|Overall Study|Protocol Violation|1|||
131096051|NCT01202903|471982321|FG000|Overall Study|Death|1|||
131096052|NCT01202903|471982322|FG001|Overall Study|Death|0|||
131096053|NCT01202903|471982321|FG000|Overall Study|Lost to Follow-up|1|||
131096054|NCT01202903|471982322|FG001|Overall Study|Lost to Follow-up|1|||
130727615|NCT02954991|470625508|FG000|Overall Study|Withdrawal by Subject|9|||
131096055|NCT01202903|471982321|FG000|Overall Study|Lack of Efficacy|1|||
131096056|NCT01202903|471982322|FG001|Overall Study|Lack of Efficacy|3|||
131096057|NCT01202903|471982321|FG000|Overall Study|Adverse Event|3|||
131096058|NCT01202903|471982322|FG001|Overall Study|Adverse Event|3|||
131096059|NCT01202903|471982321|FG000|Overall Study|Withdrawal by Subject|4|||
131096060|NCT01202903|471982322|FG001|Overall Study|Withdrawal by Subject|4|||
131096061|NCT01302080|471982323|FG000|Overall Study|Withdrew Consent|92|||
131096062|NCT01302080|471982324|FG001|Overall Study|Withdrew Consent|39|||
131096063|NCT01302080|471982323|FG000|Overall Study|Patient/Family Moved|28|||
131096064|NCT01302080|471982324|FG001|Overall Study|Patient/Family Moved|3|||
131096065|NCT01302080|471982323|FG000|Overall Study|Lost to Follow-up|192|||
131096066|NCT01302080|471982324|FG001|Overall Study|Lost to Follow-up|93|||
131096067|NCT01302080|471982323|FG000|Overall Study|Death|1|||
131096068|NCT01302080|471982324|FG001|Overall Study|Death|0|||
131096069|NCT01302080|471982323|FG000|Overall Study|Other|52|||
131096070|NCT01302080|471982324|FG001|Overall Study|Other|8|||
131096071|NCT01302080|471982323|FG000|Overall Study|Reason Missing For Discontinuation|1|||
131096072|NCT01302080|471982324|FG001|Overall Study|Reason Missing For Discontinuation|0|||
131096073|NCT03339245|471982327|FG000|Overall Study|Adverse Event|1|||
131096074|NCT03339245|471982328|FG001|Overall Study|Adverse Event|1|||
131096075|NCT03339245|471982327|FG000|Overall Study|Withdrawal by Subject|1|||
131096076|NCT03339245|471982328|FG001|Overall Study|Withdrawal by Subject|0|||
131096077|NCT00837694|471982329|FG000|Overall Study|Lost to Follow-up|2|||
131096078|NCT00837694|471982330|FG001|Overall Study|Lost to Follow-up|0|||
131096079|NCT00837694|471982331|FG002|Overall Study|Lost to Follow-up|2|||
131096080|NCT00837694|471982332|FG003|Overall Study|Lost to Follow-up|1|||
131096081|NCT00837694|471982333|FG004|Overall Study|Lost to Follow-up|1|||
131096082|NCT00837694|471982334|FG005|Overall Study|Lost to Follow-up|1|||
131096083|NCT00306670|471982339|FG000|Overall Study|patients recruited; Genentech, the st|0|||
131096084|NCT00306670|471982340|FG001|Overall Study|patients recruited; Genentech, the st|2|||
131096085|NCT00833833|471982344|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
131096086|NCT00833833|471982345|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
131096087|NCT00833833|471982346|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
131096088|NCT00833833|471982347|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
131096089|NCT00833833|471982348|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
131096090|NCT00833833|471982349|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
131096091|NCT00833833|471982344|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
131096092|NCT00833833|471982345|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
131096093|NCT00833833|471982346|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
131096094|NCT00833833|471982347|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
131096095|NCT00833833|471982348|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
131096096|NCT00833833|471982349|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
131096097|NCT00833833|471982344|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
131096098|NCT00833833|471982345|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
131096099|NCT00833833|471982346|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
131096100|NCT00833833|471982347|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
131096101|NCT00833833|471982348|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
131096102|NCT00833833|471982349|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
131096103|NCT00833833|471982344|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
131096104|NCT00833833|471982345|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
131096105|NCT00833833|471982346|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
131096106|NCT00833833|471982347|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
131096107|NCT00833833|471982348|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
131096108|NCT00833833|471982349|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
131096109|NCT00833833|471982344|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
130727616|NCT02954991|470625509|FG001|Overall Study|Withdrawal by Subject|8|||
130727617|NCT02954991|470625510|FG002|Overall Study|Withdrawal by Subject|1|||
130727618|NCT02954991|470625508|FG000|Overall Study|Study Terminated by Sponsor|18|||
130727619|NCT02954991|470625509|FG001|Overall Study|Study Terminated by Sponsor|10|||
130727620|NCT02954991|470625510|FG002|Overall Study|Study Terminated by Sponsor|1|||
130727621|NCT02954991|470625508|FG000|Overall Study|Miscellaneous|2|||
130727622|NCT02954991|470625509|FG001|Overall Study|Miscellaneous|1|||
130727623|NCT02954991|470625510|FG002|Overall Study|Miscellaneous|1|||
130727624|NCT00576316|470625511|FG000|Overall Study|Adverse Event|9|||
130727625|NCT00576316|470625511|FG000|Overall Study|Withdrawal by Subject|2|||
131096110|NCT00833833|471982345|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131096111|NCT00833833|471982346|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
131096112|NCT00833833|471982347|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131096113|NCT00833833|471982348|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131096114|NCT00833833|471982349|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131096115|NCT00833833|471982344|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
131096116|NCT00833833|471982345|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
131096117|NCT00833833|471982346|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
131096118|NCT00833833|471982347|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
131096119|NCT00833833|471982348|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
131096120|NCT00833833|471982349|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
131096121|NCT00833833|471982344|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
131096122|NCT00833833|471982345|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
131096123|NCT00833833|471982346|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
131096124|NCT00833833|471982347|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
131096125|NCT00833833|471982348|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
131096126|NCT00833833|471982349|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
131096127|NCT00833833|471982344|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
131096128|NCT00833833|471982345|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
131096129|NCT00833833|471982346|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
131096130|NCT00833833|471982347|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
131096131|NCT00833833|471982348|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
131096132|NCT00833833|471982349|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
131096133|NCT00833833|471982344|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
131096134|NCT00833833|471982345|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
131096135|NCT00833833|471982346|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
131096136|NCT00833833|471982347|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
131096137|NCT00833833|471982348|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
131096138|NCT00833833|471982349|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
131096139|NCT00833833|471982344|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131096140|NCT00833833|471982345|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131096141|NCT00833833|471982346|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131096142|NCT00833833|471982347|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
131096143|NCT00833833|471982348|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
131096144|NCT00833833|471982349|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
131096145|NCT00833833|471982344|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
131096146|NCT00833833|471982345|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
131096147|NCT00833833|471982346|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
131096148|NCT00833833|471982347|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
131096149|NCT00833833|471982348|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
131096150|NCT00833833|471982349|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
131096151|NCT00833833|471982344|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
131096152|NCT00833833|471982345|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
131096153|NCT00833833|471982346|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
131096154|NCT00833833|471982347|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
131096155|NCT00833833|471982348|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
131096156|NCT00833833|471982349|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
131096157|NCT00833833|471982344|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
131096158|NCT00833833|471982345|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
131144428|NCT00944034|472154213|FG003|Overall Study|Withdrawal by Subject|2|||
131144429|NCT00944034|472154214|FG004|Overall Study|Withdrawal by Subject|5|||
131144430|NCT00944034|472154215|FG005|Overall Study|Withdrawal by Subject|8|||
131144431|NCT00944034|472154216|FG006|Overall Study|Withdrawal by Subject|2|||
131144432|NCT00944034|472154217|FG007|Overall Study|Withdrawal by Subject|2|||
131144433|NCT00944034|472154218|FG008|Overall Study|Withdrawal by Subject|3|||
131144434|NCT00944034|472154219|FG009|Overall Study|Withdrawal by Subject|4|||
131144435|NCT00944034|472154220|FG010|Overall Study|Withdrawal by Subject|0|||
131144436|NCT00944034|472154221|FG011|Overall Study|Withdrawal by Subject|4|||
131144437|NCT00944034|472154210|FG000|Overall Study|Lost to Follow-up|0|||
131144438|NCT00944034|472154211|FG001|Overall Study|Lost to Follow-up|4|||
131144439|NCT00944034|472154212|FG002|Overall Study|Lost to Follow-up|2|||
131144440|NCT00944034|472154213|FG003|Overall Study|Lost to Follow-up|0|||
131144441|NCT00944034|472154214|FG004|Overall Study|Lost to Follow-up|5|||
131144442|NCT00944034|472154215|FG005|Overall Study|Lost to Follow-up|7|||
131144443|NCT00944034|472154216|FG006|Overall Study|Lost to Follow-up|0|||
131144444|NCT00944034|472154217|FG007|Overall Study|Lost to Follow-up|1|||
131144445|NCT00944034|472154218|FG008|Overall Study|Lost to Follow-up|5|||
131144446|NCT00944034|472154219|FG009|Overall Study|Lost to Follow-up|1|||
131144447|NCT00944034|472154220|FG010|Overall Study|Lost to Follow-up|1|||
131144448|NCT00944034|472154221|FG011|Overall Study|Lost to Follow-up|0|||
131144449|NCT00944034|472154210|FG000|Overall Study|Death|0|||
131144450|NCT00944034|472154211|FG001|Overall Study|Death|0|||
131144451|NCT00944034|472154212|FG002|Overall Study|Death|1|||
131144452|NCT00944034|472154213|FG003|Overall Study|Death|0|||
131144453|NCT00944034|472154214|FG004|Overall Study|Death|0|||
131144454|NCT00944034|472154215|FG005|Overall Study|Death|0|||
131096159|NCT00833833|471982346|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
131096160|NCT00833833|471982347|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
131096161|NCT00833833|471982348|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
131144455|NCT00944034|472154216|FG006|Overall Study|Death|0|||
131144456|NCT00944034|472154217|FG007|Overall Study|Death|0|||
131096162|NCT00833833|471982349|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
131096163|NCT01994837|471982350|FG000|Overall Study|Progressive disease per protocol|23|||
131096164|NCT01994837|471982350|FG000|Overall Study|Adv event related to progressive disease|3|||
131096165|NCT01994837|471982350|FG000|Overall Study|Fatal progressive disease|2|||
131096166|NCT01994837|471982350|FG000|Overall Study|Adverse event not related to progression|1|||
131096167|NCT01994837|471982350|FG000|Overall Study|Chose palliative care|1|||
131096168|NCT01994837|471982350|FG000|Overall Study|Proceeded to transplant|1|||
131096169|NCT01994837|471982350|FG000|Overall Study|Removed from study due to no response|1|||
131096170|NCT01127893|471982351|FG000|Overall Study|Study Termination by the Sponsor|1|||
131096171|NCT00574873|471982352|FG000|Overall Study|Withdrawal by Subject|18|||
131096172|NCT00574873|471982353|FG001|Overall Study|Withdrawal by Subject|19|||
131096173|NCT00574873|471982352|FG000|Overall Study|Investigator request|18|||
131096174|NCT00574873|471982353|FG001|Overall Study|Investigator request|8|||
131096175|NCT00574873|471982352|FG000|Overall Study|Death|15|||
131096176|NCT00574873|471982353|FG001|Overall Study|Death|14|||
131096177|NCT00574873|471982352|FG000|Overall Study|Lost to Follow-up|14|||
131096178|NCT00574873|471982353|FG001|Overall Study|Lost to Follow-up|5|||
131096179|NCT00574873|471982352|FG000|Overall Study|Other|40|||
131096180|NCT00574873|471982353|FG001|Overall Study|Other|4|||
131096181|NCT00574873|471982352|FG000|Overall Study|Discontinuation of study by sponsor|5|||
131096182|NCT00574873|471982353|FG001|Overall Study|Discontinuation of study by sponsor|199|||
131096183|NCT00574873|471982352|FG000|Overall Study|Blank, site closed per local regulations|2|||
131096184|NCT00574873|471982353|FG001|Overall Study|Blank, site closed per local regulations|2|||
131096185|NCT00574873|471982352|FG000|Overall Study|Extension Study|126|||
131096186|NCT00574873|471982353|FG001|Overall Study|Extension Study|0|||
131096187|NCT03568318|471982356|FG000|Overall Study|Adverse Event|3|||
131096188|NCT03568318|471982357|FG001|Overall Study|Adverse Event|1|||
131096189|NCT03568318|471982358|FG002|Overall Study|Adverse Event|1|||
131096190|NCT03568318|471982359|FG003|Overall Study|Adverse Event|0|||
131096191|NCT03568318|471982360|FG004|Overall Study|Adverse Event|1|||
131096192|NCT03568318|471982361|FG005|Overall Study|Adverse Event|0|||
131096193|NCT03568318|471982356|FG000|Overall Study|Withdrawal by Subject|6|||
131096194|NCT03568318|471982357|FG001|Overall Study|Withdrawal by Subject|5|||
131096195|NCT03568318|471982358|FG002|Overall Study|Withdrawal by Subject|2|||
131096196|NCT03568318|471982359|FG003|Overall Study|Withdrawal by Subject|1|||
131096197|NCT03568318|471982360|FG004|Overall Study|Withdrawal by Subject|0|||
131096198|NCT03568318|471982361|FG005|Overall Study|Withdrawal by Subject|0|||
131096199|NCT03568318|471982356|FG000|Overall Study|Lost to Follow-up|3|||
131096200|NCT03568318|471982357|FG001|Overall Study|Lost to Follow-up|2|||
131096201|NCT03568318|471982358|FG002|Overall Study|Lost to Follow-up|2|||
131096202|NCT03568318|471982359|FG003|Overall Study|Lost to Follow-up|2|||
131096203|NCT03568318|471982360|FG004|Overall Study|Lost to Follow-up|1|||
131096204|NCT03568318|471982361|FG005|Overall Study|Lost to Follow-up|0|||
131096205|NCT03568318|471982356|FG000|Overall Study|Other|3|||
131096206|NCT03568318|471982357|FG001|Overall Study|Other|1|||
131096207|NCT03568318|471982358|FG002|Overall Study|Other|3|||
131096208|NCT03568318|471982359|FG003|Overall Study|Other|0|||
131096209|NCT03568318|471982360|FG004|Overall Study|Other|0|||
131096210|NCT03568318|471982361|FG005|Overall Study|Other|0|||
131096211|NCT03568318|471982356|FG000|Overall Study|Ongoing at Time of Analysis|5|||
131096212|NCT03568318|471982357|FG001|Overall Study|Ongoing at Time of Analysis|3|||
131096213|NCT03568318|471982358|FG002|Overall Study|Ongoing at Time of Analysis|2|||
131096214|NCT03568318|471982359|FG003|Overall Study|Ongoing at Time of Analysis|1|||
131096215|NCT03568318|471982360|FG004|Overall Study|Ongoing at Time of Analysis|0|||
131096216|NCT03568318|471982361|FG005|Overall Study|Ongoing at Time of Analysis|0|||
131096217|NCT01638429|471982364|FG000|Overall Study|Withdrawal by Subject|1|||
131096218|NCT03207451|471982365|FG000|Overall Study|scheduling conflict|1|||
131096219|NCT03207451|471982366|FG001|Overall Study|scheduling conflict|0|||
131096220|NCT03207451|471982367|FG002|Overall Study|scheduling conflict|2|||
131144457|NCT00944034|472154218|FG008|Overall Study|Death|0|||
131144458|NCT00944034|472154219|FG009|Overall Study|Death|0|||
131144459|NCT00944034|472154220|FG010|Overall Study|Death|0|||
131144460|NCT00944034|472154221|FG011|Overall Study|Death|0|||
131144461|NCT00944034|472154210|FG000|Overall Study|Protocol Violation|2|||
131144462|NCT00944034|472154211|FG001|Overall Study|Protocol Violation|0|||
131096221|NCT03207451|471982368|FG003|Overall Study|scheduling conflict|2|||
131096222|NCT03207451|471982365|FG000|Overall Study|Adverse Event|0|||
131096223|NCT03207451|471982366|FG001|Overall Study|Adverse Event|0|||
131144463|NCT00944034|472154212|FG002|Overall Study|Protocol Violation|0|||
131144464|NCT00944034|472154213|FG003|Overall Study|Protocol Violation|1|||
131144465|NCT00944034|472154214|FG004|Overall Study|Protocol Violation|2|||
131144466|NCT00944034|472154215|FG005|Overall Study|Protocol Violation|3|||
131096224|NCT03207451|471982367|FG002|Overall Study|Adverse Event|0|||
131096225|NCT03207451|471982368|FG003|Overall Study|Adverse Event|1|||
131096226|NCT01802567|471982370|FG000|Overall Study|Withdrawal by Subject|2|||
131096227|NCT01802567|471982370|FG000|Overall Study|Physician Decision|1|||
131096228|NCT01802567|471982370|FG000|Overall Study|Lack of Efficacy|7|||
131144467|NCT00944034|472154216|FG006|Overall Study|Protocol Violation|0|||
131144468|NCT00944034|472154217|FG007|Overall Study|Protocol Violation|1|||
131096229|NCT01802567|471982370|FG000|Overall Study|Consented but did not start therapy|7|||
131096230|NCT01802567|471982370|FG000|Overall Study|Protocol Violation|1|||
131096231|NCT03167359|471982371|FG000|Overall Study|Physician Decision|1|||
131096232|NCT03167359|471982371|FG000|Overall Study|Lost to Follow-up|1|||
131096233|NCT03339583|471982372|FG000|First Intervention (14 Days)|Adverse Event|1|||
131096234|NCT03339583|471982373|FG001|First Intervention (14 Days)|Adverse Event|0|||
131096235|NCT03339583|471982372|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
131096236|NCT03339583|471982373|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
131096237|NCT03339583|471982372|FG000|Second Intervention (14 Days)|Adverse Event|0|||
131096238|NCT03339583|471982373|FG001|Second Intervention (14 Days)|Adverse Event|1|||
131096239|NCT03339583|471982372|FG000|Follow-up (14 Days)|Physician Decision|6|||
131096240|NCT03339583|471982373|FG001|Follow-up (14 Days)|Physician Decision|3|||
131096241|NCT01896557|471982374|FG000|Clopidogrel Alone|Adverse Event|1|||
131096242|NCT01896557|471982375|FG001|Clopidogrel Alone|Adverse Event|0|||
131096243|NCT01896557|471982374|FG000|Clopidogrel + GI Protector|low adherence|1|||
131096244|NCT01896557|471982375|FG001|Clopidogrel + GI Protector|low adherence|1|||
131096245|NCT01896557|471982374|FG000|Clopidogrel + GI Protector|Reading error|1|||
131096246|NCT01896557|471982375|FG001|Clopidogrel + GI Protector|Reading error|3|||
131096247|NCT00734591|471982376|FG000|Screening for Prospective Period|Site did not participate|1604|||
131096248|NCT00734591|471982377|FG001|Screening for Prospective Period|Site did not participate|1488|||
131096249|NCT00734591|471982376|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
131096250|NCT00734591|471982377|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
131096251|NCT00734591|471982376|FG000|Prospective Period|Withdrawal by Subject|11|||
131096252|NCT00734591|471982377|FG001|Prospective Period|Withdrawal by Subject|9|||
131096253|NCT00734591|471982376|FG000|Prospective Period|Lost to Follow-up|37|||
131096254|NCT00734591|471982377|FG001|Prospective Period|Lost to Follow-up|33|||
131096255|NCT00734591|471982376|FG000|Prospective Period|Study Terminated|1|||
131096256|NCT00734591|471982377|FG001|Prospective Period|Study Terminated|0|||
131096257|NCT00734591|471982376|FG000|Prospective Period|Other|2|||
131096258|NCT00734591|471982377|FG001|Prospective Period|Other|2|||
131096259|NCT02236988|471982380|FG000|Overall Study|Lost to Follow-up|0|||
131144469|NCT00944034|472154218|FG008|Overall Study|Protocol Violation|1|||
131144470|NCT00944034|472154219|FG009|Overall Study|Protocol Violation|4|||
131144471|NCT00944034|472154220|FG010|Overall Study|Protocol Violation|0|||
131144472|NCT00944034|472154221|FG011|Overall Study|Protocol Violation|0|||
131144473|NCT00944034|472154210|FG000|Overall Study|Unable to classify|0|||
131144474|NCT00944034|472154211|FG001|Overall Study|Unable to classify|0|||
131144475|NCT00944034|472154212|FG002|Overall Study|Unable to classify|0|||
131144476|NCT00944034|472154213|FG003|Overall Study|Unable to classify|0|||
131144477|NCT00944034|472154214|FG004|Overall Study|Unable to classify|0|||
131144478|NCT00944034|472154215|FG005|Overall Study|Unable to classify|1|||
131144479|NCT00944034|472154216|FG006|Overall Study|Unable to classify|1|||
131144480|NCT00944034|472154217|FG007|Overall Study|Unable to classify|1|||
131144481|NCT00944034|472154218|FG008|Overall Study|Unable to classify|0|||
131144482|NCT00944034|472154219|FG009|Overall Study|Unable to classify|0|||
131144483|NCT00944034|472154220|FG010|Overall Study|Unable to classify|0|||
131144484|NCT00944034|472154221|FG011|Overall Study|Unable to classify|0|||
131144485|NCT00944034|472154210|FG000|Overall Study|Administrative reason|0|||
131144486|NCT00944034|472154211|FG001|Overall Study|Administrative reason|0|||
131144487|NCT00944034|472154212|FG002|Overall Study|Administrative reason|0|||
131144488|NCT00944034|472154213|FG003|Overall Study|Administrative reason|0|||
131144489|NCT00944034|472154214|FG004|Overall Study|Administrative reason|0|||
131144490|NCT00944034|472154215|FG005|Overall Study|Administrative reason|0|||
131144491|NCT00944034|472154216|FG006|Overall Study|Administrative reason|1|||
131144492|NCT00944034|472154217|FG007|Overall Study|Administrative reason|0|||
131144493|NCT00944034|472154218|FG008|Overall Study|Administrative reason|0|||
131144494|NCT00944034|472154219|FG009|Overall Study|Administrative reason|0|||
131144495|NCT00944034|472154220|FG010|Overall Study|Administrative reason|0|||
131144496|NCT00944034|472154221|FG011|Overall Study|Administrative reason|0|||
131144497|NCT01570244|472154224|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
131144498|NCT00531960|472154229|FG000|Overall Study|Adverse Event|5|||
131144499|NCT00531960|472154230|FG001|Overall Study|Adverse Event|4|||
131144500|NCT00531960|472154229|FG000|Overall Study|Death|3|||
131144501|NCT00531960|472154230|FG001|Overall Study|Death|2|||
131144502|NCT00531960|472154229|FG000|Overall Study|Lack of Efficacy|42|||
131144503|NCT00531960|472154230|FG001|Overall Study|Lack of Efficacy|41|||
131144504|NCT00531960|472154229|FG000|Overall Study|Violation of Selection Criteria|2|||
131144505|NCT00531960|472154230|FG001|Overall Study|Violation of Selection Criteria|0|||
131144506|NCT00531960|472154229|FG000|Overall Study|Refused Treatment|5|||
131096260|NCT02236988|471982381|FG001|Overall Study|Lost to Follow-up|0|||
131096261|NCT02236988|471982382|FG002|Overall Study|Lost to Follow-up|0|||
131096262|NCT02236988|471982383|FG003|Overall Study|Lost to Follow-up|1|||
131144507|NCT00531960|472154230|FG001|Overall Study|Refused Treatment|6|||
131144508|NCT00531960|472154229|FG000|Overall Study|Other|4|||
131144509|NCT00531960|472154230|FG001|Overall Study|Other|10|||
131144510|NCT01500057|472154231|FG000|Overall Study|Lost to Follow-up|6|||
131144511|NCT01500057|472154232|FG001|Overall Study|Lost to Follow-up|4|||
130727626|NCT00576316|470625511|FG000|Overall Study|Protocol Violation|9|||
130727627|NCT00425373|470625514|FG000|Overall Study|Adverse Event|2|||
130727628|NCT00425373|470625515|FG001|Overall Study|Adverse Event|2|||
130727629|NCT00425373|470625516|FG002|Overall Study|Adverse Event|0|||
130727630|NCT00425373|470625517|FG003|Overall Study|Adverse Event|1|||
130727631|NCT00425373|470625518|FG004|Overall Study|Adverse Event|4|||
130727632|NCT00425373|470625519|FG005|Overall Study|Adverse Event|6|||
131096263|NCT02236988|471982380|FG000|Overall Study|Unable to Comply with Study Visits|0|||
131096264|NCT02236988|471982381|FG001|Overall Study|Unable to Comply with Study Visits|0|||
131096265|NCT02236988|471982382|FG002|Overall Study|Unable to Comply with Study Visits|0|||
131096266|NCT02236988|471982383|FG003|Overall Study|Unable to Comply with Study Visits|2|||
131096267|NCT00939822|471982386|FG000|Overall Study|Lost to Follow-up|1|||
131096268|NCT00939822|471982387|FG001|Overall Study|Lost to Follow-up|0|||
131096269|NCT00939822|471982386|FG000|Overall Study|withdrew from study due to busy schedule|1|||
131096270|NCT00939822|471982387|FG001|Overall Study|withdrew from study due to busy schedule|1|||
131144512|NCT04134494|472154239|FG000|Overall Study|Lost to Follow-up|2|||
131144513|NCT00781365|472154240|FG000|Overall Study|Withdrawal by Subject|13|||
131144514|NCT00781365|472154241|FG001|Overall Study|Withdrawal by Subject|8|||
131144515|NCT00781365|472154240|FG000|Overall Study|Did Not Attend Visit|20|||
131144516|NCT00781365|472154241|FG001|Overall Study|Did Not Attend Visit|28|||
131144517|NCT00781365|472154240|FG000|Overall Study|Language barrier|1|||
131144518|NCT00781365|472154241|FG001|Overall Study|Language barrier|0|||
131144519|NCT01879410|472154242|FG000|Overall Study|Adverse Event|9|||
131144520|NCT01879410|472154243|FG001|Overall Study|Adverse Event|14|||
131144521|NCT01879410|472154242|FG000|Overall Study|Lack of Efficacy|4|||
131144522|NCT01879410|472154243|FG001|Overall Study|Lack of Efficacy|6|||
131144523|NCT01879410|472154242|FG000|Overall Study|Protocol Violation|1|||
131144524|NCT01879410|472154243|FG001|Overall Study|Protocol Violation|7|||
131144525|NCT01879410|472154242|FG000|Overall Study|Lost to Follow-up|2|||
131144526|NCT01879410|472154243|FG001|Overall Study|Lost to Follow-up|1|||
131144527|NCT01879410|472154242|FG000|Overall Study|Withdrawal by Subject|7|||
131144528|NCT01879410|472154243|FG001|Overall Study|Withdrawal by Subject|8|||
131144529|NCT01879410|472154242|FG000|Overall Study|Randomised in Error|1|||
131144530|NCT01879410|472154243|FG001|Overall Study|Randomised in Error|2|||
131144531|NCT01756456|472154251|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
131144532|NCT01756456|472154252|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
131144533|NCT01756456|472154253|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
131144534|NCT01756456|472154254|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
131144535|NCT01756456|472154255|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
131144536|NCT01756456|472154256|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
131144537|NCT01756456|472154251|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
131144538|NCT01756456|472154252|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
131144539|NCT01756456|472154253|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
131144540|NCT01756456|472154254|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
131144541|NCT01756456|472154255|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
131144542|NCT01756456|472154256|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
131144543|NCT01756456|472154251|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
131144544|NCT01756456|472154252|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
131144545|NCT01756456|472154253|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
131144546|NCT01756456|472154254|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
131144547|NCT01756456|472154255|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
131144548|NCT01756456|472154256|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
131144549|NCT01756456|472154251|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
131144550|NCT01756456|472154252|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
131144551|NCT01756456|472154253|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
131144552|NCT01756456|472154254|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
131144553|NCT01756456|472154255|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
131144554|NCT01756456|472154256|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
131144555|NCT01756456|472154251|FG000|Treatment Period: Phase I/II|Other causes|0|||
131144556|NCT01756456|472154252|FG001|Treatment Period: Phase I/II|Other causes|0|||
131144557|NCT01756456|472154253|FG002|Treatment Period: Phase I/II|Other causes|0|||
130727633|NCT00425373|470625520|FG006|Overall Study|Adverse Event|2|||
130727634|NCT00425373|470625521|FG007|Overall Study|Adverse Event|3|||
130727635|NCT00425373|470625522|FG008|Overall Study|Adverse Event|8|||
130727636|NCT00425373|470625514|FG000|Overall Study|Lost to Follow-up|0|||
130727637|NCT00425373|470625515|FG001|Overall Study|Lost to Follow-up|1|||
130727638|NCT00425373|470625516|FG002|Overall Study|Lost to Follow-up|0|||
131096271|NCT00939822|471982386|FG000|Overall Study|Mental health issues|0|||
131144558|NCT01756456|472154254|FG003|Treatment Period: Phase I/II|Other causes|1|||
131144559|NCT01756456|472154255|FG004|Treatment Period: Phase I/II|Other causes|2|||
131144560|NCT01756456|472154256|FG005|Treatment Period: Phase I/II|Other causes|2|||
131144561|NCT01756456|472154251|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
131144562|NCT01756456|472154252|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
131144563|NCT01756456|472154253|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
131144564|NCT01756456|472154254|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
131144565|NCT01756456|472154255|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
131144566|NCT01756456|472154256|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
131144567|NCT01756456|472154251|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
131144568|NCT01756456|472154252|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
131144569|NCT01756456|472154253|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
131144570|NCT01756456|472154254|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
131144571|NCT01756456|472154255|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
131144572|NCT01756456|472154256|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
131144573|NCT01756456|472154251|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
131144574|NCT01756456|472154252|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
131144575|NCT01756456|472154253|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
131144576|NCT01756456|472154254|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
131144577|NCT01756456|472154255|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
131144578|NCT01756456|472154256|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
131144579|NCT01756456|472154251|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
131144580|NCT01756456|472154252|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
131144581|NCT01756456|472154253|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
131144582|NCT01756456|472154254|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
131144583|NCT01756456|472154255|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
131144584|NCT01756456|472154256|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
131144585|NCT01756456|472154251|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
131144586|NCT01756456|472154252|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
131144587|NCT01756456|472154253|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
131144588|NCT01756456|472154254|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
131144589|NCT01756456|472154255|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
131144590|NCT01756456|472154256|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
131144591|NCT01756456|472154251|FG000|Follow Up Period Phase I/II|Other causes|0|||
131144592|NCT01756456|472154252|FG001|Follow Up Period Phase I/II|Other causes|0|||
131144593|NCT01756456|472154253|FG002|Follow Up Period Phase I/II|Other causes|0|||
131144594|NCT01756456|472154254|FG003|Follow Up Period Phase I/II|Other causes|1|||
131144595|NCT01756456|472154255|FG004|Follow Up Period Phase I/II|Other causes|3|||
131144596|NCT01756456|472154256|FG005|Follow Up Period Phase I/II|Other causes|5|||
130727639|NCT00425373|470625517|FG003|Overall Study|Lost to Follow-up|0|||
130727640|NCT00425373|470625518|FG004|Overall Study|Lost to Follow-up|1|||
131096272|NCT00939822|471982387|FG001|Overall Study|Mental health issues|2|||
131096273|NCT00958841|471982392|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131096274|NCT00958841|471982392|FG000|Overall Study|Abnormal test procedure result(s)|3|||
131096275|NCT00958841|471982392|FG000|Overall Study|Administrative problems|1|||
131096276|NCT00958841|471982392|FG000|Overall Study|Adverse Event|8|||
131096277|NCT00958841|471982392|FG000|Overall Study|New cancer therapy|5|||
131096278|NCT00958841|471982392|FG000|Overall Study|Withdrawal by Subject|1|||
131096279|NCT00958841|471982392|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
131096280|NCT00958841|471982392|FG000|Overall Study|Completed M6/did not enter extension|27|||
131096281|NCT00958841|471982392|FG000|Overall Study|Discontinued prior to M*|28|||
131096282|NCT03014011|471982394|FG000|First Intervention|Withdrawal by Subject|1|||
131096283|NCT03014011|471982395|FG001|First Intervention|Withdrawal by Subject|0|||
131096284|NCT03014011|471982394|FG000|Washout|Withdrawal by Subject|1|||
131096285|NCT03014011|471982395|FG001|Washout|Withdrawal by Subject|0|||
131096286|NCT02416453|471982396|FG000|Overall Study|Adverse Event|0|||
131096287|NCT02416453|471982397|FG001|Overall Study|Adverse Event|0|||
131096288|NCT02416453|471982398|FG002|Overall Study|Adverse Event|0|||
131096289|NCT02416453|471982399|FG003|Overall Study|Adverse Event|2|||
131096290|NCT02416453|471982400|FG004|Overall Study|Adverse Event|0|||
131096291|NCT02416453|471982401|FG005|Overall Study|Adverse Event|1|||
131096292|NCT02416453|471982402|FG006|Overall Study|Adverse Event|0|||
131096293|NCT02416453|471982403|FG007|Overall Study|Adverse Event|0|||
131144597|NCT02658812|472154259|FG000|Overall Study|Disease Progression|7|||
131096294|NCT02416453|471982404|FG008|Overall Study|Adverse Event|0|||
131096295|NCT02416453|471982405|FG009|Overall Study|Adverse Event|0|||
131096296|NCT02416453|471982406|FG010|Overall Study|Adverse Event|0|||
131096297|NCT02416453|471982396|FG000|Overall Study|Lost to Follow-up|1|||
131096298|NCT02416453|471982397|FG001|Overall Study|Lost to Follow-up|3|||
131096299|NCT02416453|471982398|FG002|Overall Study|Lost to Follow-up|0|||
131096300|NCT02416453|471982399|FG003|Overall Study|Lost to Follow-up|8|||
131096301|NCT02416453|471982400|FG004|Overall Study|Lost to Follow-up|0|||
131144598|NCT02658812|472154259|FG000|Overall Study|Unrelated to study treatment|1|||
130727641|NCT00425373|470625519|FG005|Overall Study|Lost to Follow-up|0|||
131096302|NCT02416453|471982401|FG005|Overall Study|Lost to Follow-up|5|||
131096303|NCT02416453|471982402|FG006|Overall Study|Lost to Follow-up|1|||
131144599|NCT02658812|472154259|FG000|Overall Study|Adverse Event|1|||
131144600|NCT02411747|472154260|FG000|Overall Study|Withdrawal by Subject|1|||
131234692|NCT00819247|472486448|FG001|Overall Study|Bad prostate-specific antigen response|2|||
131234693|NCT00819247|472486449|FG002|Overall Study|Bad prostate-specific antigen response|0|||
131234694|NCT00819247|472486447|FG000|Overall Study|Other|1|||
131234695|NCT00819247|472486448|FG001|Overall Study|Other|0|||
131096304|NCT02416453|471982403|FG007|Overall Study|Lost to Follow-up|3|||
131096305|NCT02416453|471982404|FG008|Overall Study|Lost to Follow-up|1|||
131096306|NCT02416453|471982405|FG009|Overall Study|Lost to Follow-up|0|||
131096307|NCT02416453|471982406|FG010|Overall Study|Lost to Follow-up|0|||
131096308|NCT02416453|471982396|FG000|Overall Study|Physician Decision|0|||
131096309|NCT02416453|471982397|FG001|Overall Study|Physician Decision|0|||
131096310|NCT02416453|471982398|FG002|Overall Study|Physician Decision|0|||
131096311|NCT02416453|471982399|FG003|Overall Study|Physician Decision|0|||
131096312|NCT02416453|471982400|FG004|Overall Study|Physician Decision|0|||
131096313|NCT02416453|471982401|FG005|Overall Study|Physician Decision|1|||
131096314|NCT02416453|471982402|FG006|Overall Study|Physician Decision|1|||
131096315|NCT02416453|471982403|FG007|Overall Study|Physician Decision|1|||
131096316|NCT02416453|471982404|FG008|Overall Study|Physician Decision|0|||
131096317|NCT02416453|471982405|FG009|Overall Study|Physician Decision|0|||
131096318|NCT02416453|471982406|FG010|Overall Study|Physician Decision|0|||
131096319|NCT02416453|471982396|FG000|Overall Study|Withdrawal by Subject|2|||
131096320|NCT02416453|471982397|FG001|Overall Study|Withdrawal by Subject|0|||
131096321|NCT02416453|471982398|FG002|Overall Study|Withdrawal by Subject|0|||
131096322|NCT02416453|471982399|FG003|Overall Study|Withdrawal by Subject|5|||
131096323|NCT02416453|471982400|FG004|Overall Study|Withdrawal by Subject|1|||
131096324|NCT02416453|471982401|FG005|Overall Study|Withdrawal by Subject|8|||
131096325|NCT02416453|471982402|FG006|Overall Study|Withdrawal by Subject|0|||
131096326|NCT02416453|471982403|FG007|Overall Study|Withdrawal by Subject|8|||
131096327|NCT02416453|471982404|FG008|Overall Study|Withdrawal by Subject|4|||
131096328|NCT02416453|471982405|FG009|Overall Study|Withdrawal by Subject|0|||
131096329|NCT02416453|471982406|FG010|Overall Study|Withdrawal by Subject|0|||
131096330|NCT02416453|471982396|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131096331|NCT02416453|471982397|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131096332|NCT02416453|471982398|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
131096333|NCT02416453|471982399|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131096334|NCT02416453|471982400|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131096335|NCT02416453|471982401|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131096336|NCT02416453|471982402|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131096337|NCT02416453|471982403|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131096338|NCT02416453|471982404|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131096339|NCT02416453|471982405|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131096340|NCT02416453|471982406|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
131096341|NCT02416453|471982396|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131096342|NCT02416453|471982397|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131096343|NCT02416453|471982398|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131096344|NCT02416453|471982399|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131096345|NCT02416453|471982400|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131096346|NCT02416453|471982401|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
131096347|NCT02416453|471982402|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131096348|NCT02416453|471982403|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131096349|NCT02416453|471982404|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131096350|NCT02416453|471982405|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131096351|NCT02416453|471982406|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
131096352|NCT00132873|471982419|FG000|Overall Study|Adverse Event|3|||
131234696|NCT00819247|472486449|FG002|Overall Study|Other|0|||
131234697|NCT00108732|472486450|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
131234698|NCT00108732|472486450|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
131096353|NCT00132873|471982419|FG000|Overall Study|Lost to Follow-up|1|||
131096354|NCT00132873|471982419|FG000|Overall Study|Lack of Efficacy|1|||
131096355|NCT00132873|471982419|FG000|Overall Study|Withdrawal by Subject|3|||
131096356|NCT00132873|471982419|FG000|Overall Study|Planned Pregnancy|1|||
131234699|NCT00108732|472486450|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
131234700|NCT00108732|472486450|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
131096357|NCT02045875|471982420|FG000|Overall Study|Lost to Follow-up|3|||
131096358|NCT02045875|471982421|FG001|Overall Study|Lost to Follow-up|0|||
131096359|NCT02045875|471982420|FG000|Overall Study|Withdrawal by Subject|4|||
131096360|NCT02045875|471982421|FG001|Overall Study|Withdrawal by Subject|3|||
131096361|NCT01803282|471982425|FG000|Overall Study|Progressive Disease|4|||
131096362|NCT01803282|471982426|FG001|Overall Study|Progressive Disease|3|||
131096363|NCT01803282|471982427|FG002|Overall Study|Progressive Disease|6|||
131096364|NCT01803282|471982428|FG003|Overall Study|Progressive Disease|22|||
131096365|NCT01803282|471982429|FG004|Overall Study|Progressive Disease|5|||
131234701|NCT00108732|472486450|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
131096366|NCT01803282|471982430|FG005|Overall Study|Progressive Disease|8|||
131096367|NCT01803282|471982431|FG006|Overall Study|Progressive Disease|23|||
131096368|NCT01803282|471982432|FG007|Overall Study|Progressive Disease|24|||
131096369|NCT01803282|471982433|FG008|Overall Study|Progressive Disease|3|||
131096370|NCT01803282|471982434|FG009|Overall Study|Progressive Disease|29|||
131096371|NCT01803282|471982435|FG010|Overall Study|Progressive Disease|6|||
131096372|NCT01803282|471982436|FG011|Overall Study|Progressive Disease|11|||
131096373|NCT01803282|471982425|FG000|Overall Study|Death|0|||
131096374|NCT01803282|471982426|FG001|Overall Study|Death|0|||
131096375|NCT01803282|471982427|FG002|Overall Study|Death|0|||
131096376|NCT01803282|471982428|FG003|Overall Study|Death|0|||
131096377|NCT01803282|471982429|FG004|Overall Study|Death|2|||
131096378|NCT01803282|471982430|FG005|Overall Study|Death|1|||
131096379|NCT01803282|471982431|FG006|Overall Study|Death|1|||
131096380|NCT01803282|471982432|FG007|Overall Study|Death|5|||
131096381|NCT01803282|471982433|FG008|Overall Study|Death|1|||
131096382|NCT01803282|471982434|FG009|Overall Study|Death|1|||
131096383|NCT01803282|471982435|FG010|Overall Study|Death|0|||
131096384|NCT01803282|471982436|FG011|Overall Study|Death|0|||
131096385|NCT01803282|471982425|FG000|Overall Study|Withdrew Consent|0|||
131096386|NCT01803282|471982426|FG001|Overall Study|Withdrew Consent|0|||
131096387|NCT01803282|471982427|FG002|Overall Study|Withdrew Consent|0|||
131096388|NCT01803282|471982428|FG003|Overall Study|Withdrew Consent|6|||
131096389|NCT01803282|471982429|FG004|Overall Study|Withdrew Consent|1|||
131096390|NCT01803282|471982430|FG005|Overall Study|Withdrew Consent|0|||
131096391|NCT01803282|471982431|FG006|Overall Study|Withdrew Consent|8|||
131096392|NCT01803282|471982432|FG007|Overall Study|Withdrew Consent|3|||
131096393|NCT01803282|471982433|FG008|Overall Study|Withdrew Consent|1|||
131096394|NCT01803282|471982434|FG009|Overall Study|Withdrew Consent|5|||
131096395|NCT01803282|471982435|FG010|Overall Study|Withdrew Consent|0|||
131096396|NCT01803282|471982436|FG011|Overall Study|Withdrew Consent|1|||
131096397|NCT01803282|471982425|FG000|Overall Study|Investigator's Discretion|0|||
131096398|NCT01803282|471982426|FG001|Overall Study|Investigator's Discretion|0|||
131096399|NCT01803282|471982427|FG002|Overall Study|Investigator's Discretion|0|||
131096400|NCT01803282|471982428|FG003|Overall Study|Investigator's Discretion|7|||
131096401|NCT01803282|471982429|FG004|Overall Study|Investigator's Discretion|2|||
131096402|NCT01803282|471982430|FG005|Overall Study|Investigator's Discretion|1|||
131234702|NCT00108732|472486450|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
131234703|NCT00108732|472486450|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
131234704|NCT02187042|472486451|FG000|Overall Study|Death|1|||
131096403|NCT01803282|471982431|FG006|Overall Study|Investigator's Discretion|7|||
131096404|NCT01803282|471982432|FG007|Overall Study|Investigator's Discretion|10|||
131096405|NCT01803282|471982433|FG008|Overall Study|Investigator's Discretion|6|||
131096406|NCT01803282|471982434|FG009|Overall Study|Investigator's Discretion|7|||
131096407|NCT01803282|471982435|FG010|Overall Study|Investigator's Discretion|1|||
131096408|NCT01803282|471982436|FG011|Overall Study|Investigator's Discretion|0|||
131096409|NCT01803282|471982425|FG000|Overall Study|Adverse Event|0|||
131096410|NCT01803282|471982426|FG001|Overall Study|Adverse Event|0|||
131096411|NCT01803282|471982427|FG002|Overall Study|Adverse Event|0|||
131096412|NCT01803282|471982428|FG003|Overall Study|Adverse Event|0|||
131096413|NCT01803282|471982429|FG004|Overall Study|Adverse Event|0|||
131096414|NCT01803282|471982430|FG005|Overall Study|Adverse Event|0|||
131096415|NCT01803282|471982431|FG006|Overall Study|Adverse Event|1|||
131096416|NCT01803282|471982432|FG007|Overall Study|Adverse Event|2|||
131096417|NCT01803282|471982433|FG008|Overall Study|Adverse Event|0|||
131096418|NCT01803282|471982434|FG009|Overall Study|Adverse Event|1|||
131096419|NCT01803282|471982435|FG010|Overall Study|Adverse Event|0|||
131096420|NCT01803282|471982436|FG011|Overall Study|Adverse Event|3|||
131096421|NCT01803282|471982425|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131096422|NCT01803282|471982426|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131096423|NCT01803282|471982427|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131096424|NCT01803282|471982428|FG003|Overall Study|Non-Compliance with Study Drug|1|||
131096425|NCT01803282|471982429|FG004|Overall Study|Non-Compliance with Study Drug|0|||
131096426|NCT01803282|471982430|FG005|Overall Study|Non-Compliance with Study Drug|0|||
131096427|NCT01803282|471982431|FG006|Overall Study|Non-Compliance with Study Drug|0|||
131096428|NCT01803282|471982432|FG007|Overall Study|Non-Compliance with Study Drug|0|||
131096429|NCT01803282|471982433|FG008|Overall Study|Non-Compliance with Study Drug|0|||
131096430|NCT01803282|471982434|FG009|Overall Study|Non-Compliance with Study Drug|0|||
131096431|NCT01803282|471982435|FG010|Overall Study|Non-Compliance with Study Drug|0|||
131096432|NCT01803282|471982436|FG011|Overall Study|Non-Compliance with Study Drug|0|||
131096433|NCT01803282|471982425|FG000|Overall Study|Unknown Reason|0|||
131096434|NCT01803282|471982426|FG001|Overall Study|Unknown Reason|0|||
131096435|NCT01803282|471982427|FG002|Overall Study|Unknown Reason|0|||
131096436|NCT01803282|471982428|FG003|Overall Study|Unknown Reason|0|||
131096437|NCT01803282|471982429|FG004|Overall Study|Unknown Reason|0|||
131096438|NCT01803282|471982430|FG005|Overall Study|Unknown Reason|0|||
131096439|NCT01803282|471982431|FG006|Overall Study|Unknown Reason|0|||
131096440|NCT01803282|471982432|FG007|Overall Study|Unknown Reason|1|||
131234705|NCT02187042|472486452|FG001|Overall Study|Death|1|||
131096441|NCT01803282|471982433|FG008|Overall Study|Unknown Reason|0|||
131096442|NCT01803282|471982434|FG009|Overall Study|Unknown Reason|0|||
131144601|NCT02411747|472154261|FG001|Overall Study|Withdrawal by Subject|0|||
131144602|NCT02411747|472154260|FG000|Overall Study|Protocol Violation|2|||
131144603|NCT02411747|472154261|FG001|Overall Study|Protocol Violation|4|||
131144604|NCT00848120|472154263|FG000|Overall Study|Adverse Event|1|||
131144605|NCT00560755|472154264|FG000|Overall Study|Protocol Violation|15|||
131144606|NCT00560755|472154264|FG000|Overall Study|Withdrawal by Subject|26|||
131144607|NCT00560755|472154264|FG000|Overall Study|Lost to Follow-up|9|||
131144608|NCT00560755|472154264|FG000|Overall Study|Adverse Event|8|||
131144609|NCT00560755|472154264|FG000|Overall Study|Physician Decision|2|||
131144610|NCT02116621|472154268|FG000|Baseline|Withdrawal by Subject|0|||
131144611|NCT02116621|472154269|FG001|Baseline|Withdrawal by Subject|4|||
131144612|NCT02116621|472154268|FG000|Three Month Follow-up|Death|1|||
131144613|NCT02116621|472154269|FG001|Three Month Follow-up|Death|1|||
131144614|NCT02116621|472154268|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
131144615|NCT02116621|472154269|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
131144616|NCT02116621|472154268|FG000|Three Month Follow-up|Lost to Follow-up|0|||
131144617|NCT02116621|472154269|FG001|Three Month Follow-up|Lost to Follow-up|1|||
131144618|NCT02116621|472154268|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
131144619|NCT02116621|472154269|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
131144620|NCT02116621|472154268|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
131144621|NCT02116621|472154269|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
131144622|NCT02116621|472154268|FG000|Six Month Follow-up|Lost to Follow-up|2|||
131144623|NCT02116621|472154269|FG001|Six Month Follow-up|Lost to Follow-up|1|||
131144624|NCT02116621|472154268|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
131144625|NCT02116621|472154269|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
131144626|NCT02116621|472154268|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
131144627|NCT02116621|472154269|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
131144628|NCT02116621|472154268|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
131144629|NCT02116621|472154269|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
131144630|NCT02116621|472154268|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
131144631|NCT02116621|472154269|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
131144632|NCT02116621|472154268|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
131144633|NCT02116621|472154269|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
131144634|NCT00961961|472154270|FG000|Phase I|Withdrawal by Subject|7|||
131144635|NCT00961961|472154271|FG001|Phase I|Withdrawal by Subject|0|||
131144636|NCT00961961|472154272|FG002|Phase I|Withdrawal by Subject|0|||
131144637|NCT00961961|472154273|FG003|Phase I|Withdrawal by Subject|0|||
131144638|NCT00961961|472154270|FG000|Phase I|Lost to Follow-up|10|||
131144639|NCT00961961|472154271|FG001|Phase I|Lost to Follow-up|0|||
131144640|NCT00961961|472154272|FG002|Phase I|Lost to Follow-up|0|||
131144641|NCT00961961|472154273|FG003|Phase I|Lost to Follow-up|0|||
131144642|NCT00961961|472154270|FG000|Phase I|Lack of Efficacy|94|||
131144643|NCT00961961|472154271|FG001|Phase I|Lack of Efficacy|0|||
131144644|NCT00961961|472154272|FG002|Phase I|Lack of Efficacy|0|||
131144645|NCT00961961|472154273|FG003|Phase I|Lack of Efficacy|0|||
131144646|NCT00961961|472154270|FG000|Phase I|Adverse Event|7|||
131144647|NCT00961961|472154271|FG001|Phase I|Adverse Event|0|||
131144648|NCT00961961|472154272|FG002|Phase I|Adverse Event|0|||
131144649|NCT00961961|472154273|FG003|Phase I|Adverse Event|0|||
131144650|NCT00961961|472154270|FG000|Phase I|Physician Decision|8|||
131144651|NCT00961961|472154271|FG001|Phase I|Physician Decision|0|||
131144652|NCT00961961|472154272|FG002|Phase I|Physician Decision|0|||
131144653|NCT00961961|472154273|FG003|Phase I|Physician Decision|0|||
131144654|NCT00961961|472154270|FG000|Phase II|Lost to Follow-up|0|||
131144655|NCT00961961|472154271|FG001|Phase II|Lost to Follow-up|0|||
131144656|NCT00961961|472154272|FG002|Phase II|Lost to Follow-up|10|||
131144657|NCT00961961|472154273|FG003|Phase II|Lost to Follow-up|7|||
131144658|NCT00961961|472154270|FG000|Phase II|Adverse Event|0|||
131144659|NCT00961961|472154271|FG001|Phase II|Adverse Event|0|||
131144660|NCT00961961|472154272|FG002|Phase II|Adverse Event|0|||
131144661|NCT00961961|472154273|FG003|Phase II|Adverse Event|1|||
131144662|NCT00961961|472154270|FG000|Phase II|Physician Decision|0|||
131144663|NCT00961961|472154271|FG001|Phase II|Physician Decision|0|||
131144664|NCT00961961|472154272|FG002|Phase II|Physician Decision|1|||
131144665|NCT00961961|472154273|FG003|Phase II|Physician Decision|0|||
131144666|NCT00961961|472154270|FG000|Phase II|Withdrawal by Subject|0|||
131144667|NCT00961961|472154271|FG001|Phase II|Withdrawal by Subject|0|||
131144668|NCT00961961|472154272|FG002|Phase II|Withdrawal by Subject|1|||
131144669|NCT00961961|472154273|FG003|Phase II|Withdrawal by Subject|0|||
131144670|NCT01412957|472154274|FG000|Overall Study|Withdrawal by Subject|6|||
131144671|NCT01412957|472154275|FG001|Overall Study|Withdrawal by Subject|22|||
131144672|NCT01412957|472154274|FG000|Overall Study|Lost to Follow-up|7|||
131144673|NCT01412957|472154275|FG001|Overall Study|Lost to Follow-up|2|||
131144674|NCT01412957|472154274|FG000|Overall Study|Death|136|||
131144675|NCT01412957|472154275|FG001|Overall Study|Death|133|||
131144676|NCT04722991|472154281|FG000|Overall Study|Adverse Event|12|||
131144677|NCT04722991|472154282|FG001|Overall Study|Adverse Event|4|||
131144678|NCT04722991|472154281|FG000|Overall Study|Death|2|||
131144679|NCT04722991|472154282|FG001|Overall Study|Death|0|||
131096443|NCT01803282|471982435|FG010|Overall Study|Unknown Reason|0|||
131096444|NCT01803282|471982436|FG011|Overall Study|Unknown Reason|0|||
131096445|NCT01803282|471982425|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
131096446|NCT01803282|471982426|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
131096447|NCT01803282|471982427|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
131096448|NCT01803282|471982428|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
131144680|NCT04722991|472154281|FG000|Overall Study|Lost to Follow-up|1|||
131144681|NCT04722991|472154282|FG001|Overall Study|Lost to Follow-up|1|||
131144682|NCT04722991|472154281|FG000|Overall Study|Withdrawal cirterion met|2|||
131144683|NCT04722991|472154282|FG001|Overall Study|Withdrawal cirterion met|2|||
131144684|NCT04722991|472154281|FG000|Overall Study|Other|1|||
131144685|NCT04722991|472154282|FG001|Overall Study|Other|0|||
131144686|NCT04722991|472154281|FG000|Overall Study|Non-compliance|0|||
131144687|NCT04722991|472154282|FG001|Overall Study|Non-compliance|1|||
131144688|NCT04722991|472154281|FG000|Overall Study|Withdrawal by Subject|0|||
131144689|NCT04722991|472154282|FG001|Overall Study|Withdrawal by Subject|1|||
131144690|NCT00413959|472154283|FG000|Overall Study|Pt had only one cycle.|1|||
131144691|NCT04343651|472154287|FG000|Overall Study|Physician Decision|2|||
131144692|NCT04343651|472154288|FG001|Overall Study|Physician Decision|1|||
131144693|NCT04343651|472154287|FG000|Overall Study|Lost to Follow-up|2|||
131144694|NCT04343651|472154288|FG001|Overall Study|Lost to Follow-up|1|||
131144695|NCT04343651|472154287|FG000|Overall Study|Protocol Violation|4|||
131144696|NCT04343651|472154288|FG001|Overall Study|Protocol Violation|6|||
131144697|NCT04343651|472154287|FG000|Overall Study|Missing|3|||
131144698|NCT04343651|472154288|FG001|Overall Study|Missing|9|||
131144699|NCT04343651|472154287|FG000|Overall Study|Withdrawal by Subject|0|||
131144700|NCT04343651|472154288|FG001|Overall Study|Withdrawal by Subject|4|||
131144701|NCT04343651|472154287|FG000|Overall Study|Death|0|||
131144702|NCT04343651|472154288|FG001|Overall Study|Death|1|||
131144703|NCT04343651|472154287|FG000|Overall Study|Did not start treatment|1|||
131144704|NCT04343651|472154288|FG001|Overall Study|Did not start treatment|1|||
131144705|NCT04343651|472154287|FG000|Overall Study|Patient did not complete visits 3-6|0|||
131144706|NCT04343651|472154288|FG001|Overall Study|Patient did not complete visits 3-6|1|||
131144707|NCT02246621|472154289|FG000|Overall Study|Withdrawal by Subject|28|||
131144708|NCT02246621|472154290|FG001|Overall Study|Withdrawal by Subject|16|||
131144709|NCT02246621|472154289|FG000|Overall Study|Lost to Follow-up|1|||
131144710|NCT02246621|472154290|FG001|Overall Study|Lost to Follow-up|0|||
131144711|NCT02246621|472154289|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
131144712|NCT02246621|472154290|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
131144713|NCT01459614|472154291|FG000|Overall Study|Adverse Event|1|||
131144714|NCT01459614|472154292|FG001|Overall Study|Adverse Event|0|||
131144715|NCT03283085|472154302|FG000|Overall Study|Adverse Event|18|||
131144716|NCT03283085|472154303|FG001|Overall Study|Adverse Event|3|||
131144717|NCT03283085|472154304|FG002|Overall Study|Adverse Event|13|||
131144718|NCT03283085|472154305|FG003|Overall Study|Adverse Event|0|||
131144719|NCT03283085|472154306|FG004|Overall Study|Adverse Event|0|||
131144720|NCT03283085|472154307|FG005|Overall Study|Adverse Event|5|||
131144721|NCT03283085|472154302|FG000|Overall Study|Death|0|||
131144722|NCT03283085|472154303|FG001|Overall Study|Death|0|||
131144723|NCT03283085|472154304|FG002|Overall Study|Death|3|||
131144724|NCT03283085|472154305|FG003|Overall Study|Death|1|||
131144725|NCT03283085|472154306|FG004|Overall Study|Death|0|||
131144726|NCT03283085|472154307|FG005|Overall Study|Death|0|||
131144727|NCT03283085|472154302|FG000|Overall Study|Withdrawal by Subject|42|||
131144728|NCT03283085|472154303|FG001|Overall Study|Withdrawal by Subject|21|||
131144729|NCT03283085|472154304|FG002|Overall Study|Withdrawal by Subject|66|||
131144730|NCT03283085|472154305|FG003|Overall Study|Withdrawal by Subject|3|||
131144731|NCT03283085|472154306|FG004|Overall Study|Withdrawal by Subject|3|||
131144732|NCT03283085|472154307|FG005|Overall Study|Withdrawal by Subject|5|||
131144733|NCT03283085|472154302|FG000|Overall Study|Physician Decision|14|||
131144734|NCT03283085|472154303|FG001|Overall Study|Physician Decision|8|||
131144735|NCT03283085|472154304|FG002|Overall Study|Physician Decision|19|||
131096449|NCT01803282|471982429|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
131144736|NCT03283085|472154305|FG003|Overall Study|Physician Decision|0|||
131144737|NCT03283085|472154306|FG004|Overall Study|Physician Decision|0|||
131144738|NCT03283085|472154307|FG005|Overall Study|Physician Decision|2|||
131144739|NCT03283085|472154302|FG000|Overall Study|Site Terminated by Sponsor|1|||
131144740|NCT03283085|472154303|FG001|Overall Study|Site Terminated by Sponsor|0|||
131096450|NCT01803282|471982430|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
131096451|NCT01803282|471982431|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
131144741|NCT03283085|472154304|FG002|Overall Study|Site Terminated by Sponsor|3|||
131144742|NCT03283085|472154305|FG003|Overall Study|Site Terminated by Sponsor|0|||
131096452|NCT01803282|471982432|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
131144743|NCT03283085|472154306|FG004|Overall Study|Site Terminated by Sponsor|0|||
131144744|NCT03283085|472154307|FG005|Overall Study|Site Terminated by Sponsor|0|||
131144745|NCT03283085|472154302|FG000|Overall Study|Lost to Follow-up|2|||
131144746|NCT03283085|472154303|FG001|Overall Study|Lost to Follow-up|0|||
131144747|NCT03283085|472154304|FG002|Overall Study|Lost to Follow-up|2|||
131096453|NCT01803282|471982433|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
131096454|NCT01803282|471982434|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
131096455|NCT01803282|471982435|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
131096456|NCT01803282|471982436|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
131096457|NCT01803282|471982425|FG000|Overall Study|Enrolled but Never Treated|0|||
131096458|NCT01803282|471982426|FG001|Overall Study|Enrolled but Never Treated|0|||
131096459|NCT01803282|471982427|FG002|Overall Study|Enrolled but Never Treated|0|||
131096460|NCT01803282|471982428|FG003|Overall Study|Enrolled but Never Treated|0|||
131096461|NCT01803282|471982429|FG004|Overall Study|Enrolled but Never Treated|1|||
131096462|NCT01803282|471982430|FG005|Overall Study|Enrolled but Never Treated|0|||
131096463|NCT01803282|471982431|FG006|Overall Study|Enrolled but Never Treated|1|||
131096464|NCT01803282|471982432|FG007|Overall Study|Enrolled but Never Treated|1|||
131096465|NCT01803282|471982433|FG008|Overall Study|Enrolled but Never Treated|0|||
131096466|NCT01803282|471982434|FG009|Overall Study|Enrolled but Never Treated|1|||
131096467|NCT01803282|471982435|FG010|Overall Study|Enrolled but Never Treated|0|||
131096468|NCT01803282|471982436|FG011|Overall Study|Enrolled but Never Treated|0|||
131096469|NCT01743989|471982437|FG000|Treatment Phase|Unstable MR4.0|0|||
131096470|NCT01743989|471982438|FG001|Treatment Phase|Unstable MR4.0|6|||
131096471|NCT01743989|471982439|FG002|Treatment Phase|Unstable MR4.0|263|||
131096472|NCT01743989|471982437|FG000|Treatment Phase|Adverse Event|0|||
131096473|NCT01743989|471982438|FG001|Treatment Phase|Adverse Event|4|||
131096474|NCT01743989|471982439|FG002|Treatment Phase|Adverse Event|67|||
131096475|NCT01743989|471982437|FG000|Treatment Phase|Withdrawal by Subject|1|||
131096476|NCT01743989|471982438|FG001|Treatment Phase|Withdrawal by Subject|3|||
131096477|NCT01743989|471982439|FG002|Treatment Phase|Withdrawal by Subject|28|||
131096478|NCT01743989|471982437|FG000|Treatment Phase|Death|0|||
131096479|NCT01743989|471982438|FG001|Treatment Phase|Death|1|||
131096480|NCT01743989|471982439|FG002|Treatment Phase|Death|3|||
131096481|NCT01743989|471982437|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
131096482|NCT01743989|471982438|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
131096483|NCT01743989|471982439|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
131096484|NCT01743989|471982437|FG000|Treatment Phase|Protocol deviation|0|||
131096485|NCT01743989|471982438|FG001|Treatment Phase|Protocol deviation|0|||
131096486|NCT01743989|471982439|FG002|Treatment Phase|Protocol deviation|3|||
131096487|NCT01743989|471982437|FG000|Treatment Phase|Pregnancy|0|||
131096488|NCT01743989|471982438|FG001|Treatment Phase|Pregnancy|0|||
131096489|NCT01743989|471982439|FG002|Treatment Phase|Pregnancy|2|||
131096490|NCT01743989|471982437|FG000|Treatment Phase|Lost to Follow-up|0|||
131096491|NCT01743989|471982438|FG001|Treatment Phase|Lost to Follow-up|0|||
131096492|NCT01743989|471982439|FG002|Treatment Phase|Lost to Follow-up|2|||
131096493|NCT01743989|471982437|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
131096494|NCT01743989|471982438|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
131096495|NCT01743989|471982439|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
131096496|NCT01743989|471982437|FG000|Treatment Phase|Administrative problems|0|||
131096497|NCT01743989|471982438|FG001|Treatment Phase|Administrative problems|0|||
131096498|NCT01743989|471982439|FG002|Treatment Phase|Administrative problems|1|||
131096499|NCT01743989|471982437|FG000|Treatment Phase|New cancer (CML) therapy|0|||
131096500|NCT01743989|471982438|FG001|Treatment Phase|New cancer (CML) therapy|1|||
131096501|NCT01743989|471982439|FG002|Treatment Phase|New cancer (CML) therapy|0|||
131096502|NCT01743989|471982437|FG000|Treatment Phase|Physician Decision|0|||
131096503|NCT01743989|471982438|FG001|Treatment Phase|Physician Decision|0|||
131096504|NCT01743989|471982439|FG002|Treatment Phase|Physician Decision|3|||
131096505|NCT01743989|471982437|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
131096506|NCT01743989|471982438|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
131096507|NCT01743989|471982439|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
131144748|NCT03283085|472154305|FG003|Overall Study|Lost to Follow-up|0|||
131144749|NCT03283085|472154306|FG004|Overall Study|Lost to Follow-up|0|||
131144750|NCT03283085|472154307|FG005|Overall Study|Lost to Follow-up|1|||
131144751|NCT03283085|472154302|FG000|Overall Study|Pregnancy|0|||
131144752|NCT03283085|472154303|FG001|Overall Study|Pregnancy|0|||
131144753|NCT03283085|472154304|FG002|Overall Study|Pregnancy|1|||
131144754|NCT03283085|472154305|FG003|Overall Study|Pregnancy|0|||
131096508|NCT01743989|471982437|FG000|Treatment Phase|Not randomized by mistake|0|||
131096509|NCT01743989|471982438|FG001|Treatment Phase|Not randomized by mistake|0|||
131096510|NCT01743989|471982439|FG002|Treatment Phase|Not randomized by mistake|1|||
131096511|NCT01743989|471982437|FG000|Treatment Phase|Included by mistake|0|||
131096512|NCT01743989|471982438|FG001|Treatment Phase|Included by mistake|0|||
131096513|NCT01743989|471982439|FG002|Treatment Phase|Included by mistake|1|||
131096514|NCT01743989|471982437|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
131096515|NCT01743989|471982438|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
131144755|NCT03283085|472154306|FG004|Overall Study|Pregnancy|0|||
131096516|NCT01743989|471982439|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
131096517|NCT01743989|471982437|FG000|TFR Phase|Adverse Event|0|||
131096518|NCT01743989|471982438|FG001|TFR Phase|Adverse Event|1|||
131144756|NCT03283085|472154307|FG005|Overall Study|Pregnancy|0|||
131144757|NCT03283085|472154302|FG000|Overall Study|Lack of Efficacy|12|||
131144758|NCT03283085|472154303|FG001|Overall Study|Lack of Efficacy|6|||
131096519|NCT01743989|471982439|FG002|TFR Phase|Adverse Event|0|||
131096520|NCT01743989|471982437|FG000|TFR Phase|Lost to Follow-up|0|||
131096521|NCT01743989|471982438|FG001|TFR Phase|Lost to Follow-up|2|||
131096522|NCT01743989|471982439|FG002|TFR Phase|Lost to Follow-up|0|||
131096523|NCT01743989|471982437|FG000|TFR Phase|Physician Decision|0|||
131096524|NCT01743989|471982438|FG001|TFR Phase|Physician Decision|1|||
131096525|NCT01743989|471982439|FG002|TFR Phase|Physician Decision|0|||
131096526|NCT01743989|471982437|FG000|TFR Phase|Logistical problems|0|||
131096527|NCT01743989|471982438|FG001|TFR Phase|Logistical problems|2|||
131096528|NCT01743989|471982439|FG002|TFR Phase|Logistical problems|0|||
131096529|NCT01743989|471982437|FG000|TFR Phase|Protocol deviation|0|||
131096530|NCT01743989|471982438|FG001|TFR Phase|Protocol deviation|1|||
131096531|NCT01743989|471982439|FG002|TFR Phase|Protocol deviation|0|||
131096532|NCT01743989|471982437|FG000|TFR Phase|Withdrawal by Subject|0|||
131096533|NCT01743989|471982438|FG001|TFR Phase|Withdrawal by Subject|2|||
131096534|NCT01743989|471982439|FG002|TFR Phase|Withdrawal by Subject|0|||
131096535|NCT01743989|471982437|FG000|Re-treatment Phase|Adverse Event|8|||
131096536|NCT01743989|471982438|FG001|Re-treatment Phase|Adverse Event|4|||
131096537|NCT01743989|471982439|FG002|Re-treatment Phase|Adverse Event|0|||
131096538|NCT01743989|471982437|FG000|Re-treatment Phase|Death|1|||
131096539|NCT01743989|471982438|FG001|Re-treatment Phase|Death|1|||
131096540|NCT01743989|471982439|FG002|Re-treatment Phase|Death|0|||
131096541|NCT01743989|471982437|FG000|Re-treatment Phase|Administrative problems|1|||
131096542|NCT01743989|471982438|FG001|Re-treatment Phase|Administrative problems|1|||
131096543|NCT01743989|471982439|FG002|Re-treatment Phase|Administrative problems|0|||
131096544|NCT01743989|471982437|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
131096545|NCT01743989|471982438|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
131096546|NCT01743989|471982439|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
131096547|NCT01743989|471982437|FG000|Re-treatment Phase|Unstable MR|1|||
131096548|NCT01743989|471982438|FG001|Re-treatment Phase|Unstable MR|0|||
131096549|NCT01743989|471982439|FG002|Re-treatment Phase|Unstable MR|0|||
131096550|NCT01743989|471982437|FG000|Re-treatment Phase|Physician Decision|0|||
131096551|NCT01743989|471982438|FG001|Re-treatment Phase|Physician Decision|1|||
131096552|NCT01743989|471982439|FG002|Re-treatment Phase|Physician Decision|0|||
131096553|NCT01743989|471982437|FG000|Re-treatment Phase|Lost to Follow-up|0|||
131096554|NCT01743989|471982438|FG001|Re-treatment Phase|Lost to Follow-up|1|||
131096555|NCT01743989|471982439|FG002|Re-treatment Phase|Lost to Follow-up|0|||
131096556|NCT00653523|471982444|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
131096557|NCT00653523|471982444|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
131096558|NCT00653523|471982444|FG000|Overall Study|Adverse Event|7|||
131096559|NCT00653523|471982444|FG000|Overall Study|Withdrawal by Subject|6|||
131096560|NCT00653523|471982444|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
131096561|NCT00653523|471982444|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
131096562|NCT02425904|471982445|FG000|Overall Study|Lost to Follow-up|1|||
131096563|NCT02425904|471982446|FG001|Overall Study|Lost to Follow-up|0|||
131144759|NCT03283085|472154304|FG002|Overall Study|Lack of Efficacy|24|||
131144760|NCT03283085|472154305|FG003|Overall Study|Lack of Efficacy|1|||
131144761|NCT03283085|472154306|FG004|Overall Study|Lack of Efficacy|1|||
131144762|NCT03283085|472154307|FG005|Overall Study|Lack of Efficacy|0|||
131144763|NCT03283085|472154302|FG000|Overall Study|Reason not Specified|0|||
131144764|NCT03283085|472154303|FG001|Overall Study|Reason not Specified|4|||
131096564|NCT02425904|471982445|FG000|Overall Study|Withdrawal by Subject|2|||
131096565|NCT02425904|471982446|FG001|Overall Study|Withdrawal by Subject|0|||
131096566|NCT02425904|471982445|FG000|Overall Study|Death|0|||
131096567|NCT02425904|471982446|FG001|Overall Study|Death|3|||
131096568|NCT03843554|471983859|FG000|Overall Study|Physician Decision|0|||
131096569|NCT03843554|471983860|FG001|Overall Study|Physician Decision|2|||
131096570|NCT04396366|471983863|FG000|Overall Study|Adverse Event|1|||
131144765|NCT03283085|472154304|FG002|Overall Study|Reason not Specified|8|||
131144766|NCT03283085|472154305|FG003|Overall Study|Reason not Specified|0|||
131144767|NCT03283085|472154306|FG004|Overall Study|Reason not Specified|0|||
131234706|NCT02187042|472486451|FG000|Overall Study|Toxicity|6|||
131234707|NCT02187042|472486452|FG001|Overall Study|Toxicity|5|||
131234708|NCT02187042|472486451|FG000|Overall Study|Participant choice|1|||
131096571|NCT04396366|471983864|FG001|Overall Study|Adverse Event|0|||
131096572|NCT00503139|471983867|FG000|Overall Study|Case Report Forms were not collected|4|||
131096573|NCT00503139|471983867|FG000|Overall Study|Protocol Violation|4|||
131096574|NCT02735577|471983868|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
131096575|NCT02735577|471983868|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
131096576|NCT02040584|471983872|FG000|Overall Study|Adverse Event|13|||
131234709|NCT02187042|472486452|FG001|Overall Study|Participant choice|0|||
130780284|NCT00128661|470821482|FG001|Overall Study|Lost to Follow-up|7|||
131096577|NCT02040584|471983873|FG001|Overall Study|Adverse Event|6|||
131096578|NCT02040584|471983872|FG000|Overall Study|Protocol Violation|9|||
131144768|NCT03283085|472154307|FG005|Overall Study|Reason not Specified|1|||
131144769|NCT03136107|472154308|FG000|Overall Study|Other (Not specified)|1|||
131096579|NCT02040584|471983873|FG001|Overall Study|Protocol Violation|11|||
131096580|NCT02040584|471983872|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131096581|NCT02040584|471983873|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
131096582|NCT02040584|471983872|FG000|Overall Study|Death|6|||
131096583|NCT02040584|471983873|FG001|Overall Study|Death|3|||
131096584|NCT02040584|471983872|FG000|Overall Study|Transplant rejection/retransplant|0|||
131096585|NCT02040584|471983873|FG001|Overall Study|Transplant rejection/retransplant|1|||
131096586|NCT02040584|471983872|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
131096587|NCT02040584|471983873|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
131096588|NCT00996476|471983874|FG000|Overall Study|Withdrawal by Subject|1|||
131096589|NCT00996476|471983875|FG001|Overall Study|Withdrawal by Subject|2|||
131096590|NCT00996476|471983876|FG002|Overall Study|Withdrawal by Subject|1|||
131096591|NCT00996476|471983877|FG003|Overall Study|Withdrawal by Subject|0|||
131096592|NCT00996476|471983878|FG004|Overall Study|Withdrawal by Subject|1|||
131096593|NCT00996476|471983874|FG000|Overall Study|Adverse Event|0|||
131096594|NCT00996476|471983875|FG001|Overall Study|Adverse Event|1|||
131096595|NCT00996476|471983876|FG002|Overall Study|Adverse Event|0|||
131096596|NCT00996476|471983877|FG003|Overall Study|Adverse Event|0|||
131096597|NCT00996476|471983878|FG004|Overall Study|Adverse Event|1|||
131096598|NCT05540717|471983879|FG000|Overall Study|Lost to Follow-up|2|||
131096599|NCT05540717|471983880|FG001|Overall Study|Lost to Follow-up|5|||
131096600|NCT05540717|471983879|FG000|Overall Study|Withdrawal by Subject|6|||
131096601|NCT05540717|471983880|FG001|Overall Study|Withdrawal by Subject|6|||
131096602|NCT05540717|471983879|FG000|Overall Study|Sponsor request|1|||
131096603|NCT05540717|471983880|FG001|Overall Study|Sponsor request|0|||
131096604|NCT05540717|471983879|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
131096605|NCT05540717|471983880|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
131096606|NCT05540717|471983879|FG000|Overall Study|Other|0|||
131096607|NCT05540717|471983880|FG001|Overall Study|Other|1|||
131096608|NCT01940939|471983881|FG000|Overall Study|Withdrawal by Subject|2|||
131096609|NCT01940939|471983882|FG001|Overall Study|Withdrawal by Subject|8|||
131096610|NCT01470001|471983883|FG000|Overall Study|Lost to Follow-up|1|||
131096611|NCT01470001|471983884|FG001|Overall Study|Lost to Follow-up|1|||
131096612|NCT01470001|471983883|FG000|Overall Study|Physician Decision|2|||
131096613|NCT01470001|471983884|FG001|Overall Study|Physician Decision|0|||
131096614|NCT01470001|471983883|FG000|Overall Study|Withdrawal by Subject|2|||
131096615|NCT01470001|471983884|FG001|Overall Study|Withdrawal by Subject|1|||
131096616|NCT01895101|471983885|FG000|Overall Study|OPCAB procedure|1|||
131096617|NCT01895101|471983886|FG001|Overall Study|OPCAB procedure|1|||
131096618|NCT01895101|471983887|FG002|Overall Study|OPCAB procedure|3|||
131096619|NCT01895101|471983885|FG000|Overall Study|Withdrawal by Subject|0|||
131096620|NCT01895101|471983886|FG001|Overall Study|Withdrawal by Subject|1|||
131096621|NCT01895101|471983887|FG002|Overall Study|Withdrawal by Subject|2|||
131096622|NCT01895101|471983885|FG000|Overall Study|another study, enrolled in other study|0|||
131096623|NCT01895101|471983886|FG001|Overall Study|another study, enrolled in other study|1|||
131096624|NCT01895101|471983887|FG002|Overall Study|another study, enrolled in other study|0|||
131096625|NCT01895101|471983885|FG000|Overall Study|Death|0|||
131096626|NCT01895101|471983886|FG001|Overall Study|Death|1|||
131096627|NCT01895101|471983887|FG002|Overall Study|Death|0|||
131096628|NCT01895101|471983885|FG000|Overall Study|coagulation disorder|0|||
131096629|NCT01895101|471983886|FG001|Overall Study|coagulation disorder|1|||
131096630|NCT01895101|471983887|FG002|Overall Study|coagulation disorder|0|||
131096631|NCT04032613|471983890|FG000|Overall Study|Did not complete post-program assessment|5|||
131096632|NCT04032613|471983891|FG001|Overall Study|Did not complete post-program assessment|2|||
131096633|NCT01659853|471983892|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
131096634|NCT01659853|471983893|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
131096635|NCT01659853|471983892|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
131096636|NCT01659853|471983893|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
131096637|NCT03053518|471983896|FG000|Overall Study|Withdrawal by Subject|3|||
131096638|NCT03053518|471983896|FG000|Overall Study|Lost to Follow-up|2|||
131096639|NCT03053518|471983896|FG000|Overall Study|Ineligible|5|||
131096640|NCT05560243|471983898|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
131096641|NCT01072630|471983899|FG000|Overall Study|Adverse Event|11|||
131096642|NCT01072630|471983900|FG001|Overall Study|Adverse Event|19|||
131096643|NCT01072630|471983901|FG002|Overall Study|Adverse Event|2|||
131144770|NCT02292771|472154312|FG000|Overall Study|Withdrawal by Subject|2|||
131144771|NCT02292771|472154313|FG001|Overall Study|Withdrawal by Subject|1|||
131144772|NCT02292771|472154312|FG000|Overall Study|Lost to Follow-up|2|||
131144773|NCT02292771|472154313|FG001|Overall Study|Lost to Follow-up|1|||
131144774|NCT04574999|472156274|FG000|Overall Study|Adverse Event|1|||
131144775|NCT04574999|472156275|FG001|Overall Study|Adverse Event|0|||
131144776|NCT04574999|472156274|FG000|Overall Study|Lack of Efficacy|2|||
131144777|NCT04574999|472156275|FG001|Overall Study|Lack of Efficacy|3|||
131144778|NCT04574999|472156274|FG000|Overall Study|Protocol Violation|1|||
131144779|NCT04574999|472156275|FG001|Overall Study|Protocol Violation|0|||
131144780|NCT04574999|472156274|FG000|Overall Study|Withdrawal by Subject|2|||
131144781|NCT04574999|472156275|FG001|Overall Study|Withdrawal by Subject|2|||
131144782|NCT04574999|472156274|FG000|Overall Study|Lost to Follow-up|1|||
131096644|NCT01072630|471983899|FG000|Overall Study|Lack of Efficacy|10|||
131096645|NCT01072630|471983900|FG001|Overall Study|Lack of Efficacy|10|||
131096646|NCT01072630|471983901|FG002|Overall Study|Lack of Efficacy|1|||
131096647|NCT01072630|471983899|FG000|Overall Study|Withdrawal by Subject|8|||
131096648|NCT01072630|471983900|FG001|Overall Study|Withdrawal by Subject|7|||
131096649|NCT01072630|471983901|FG002|Overall Study|Withdrawal by Subject|2|||
131096650|NCT01072630|471983899|FG000|Overall Study|Protocol Violation|10|||
131096651|NCT01072630|471983900|FG001|Overall Study|Protocol Violation|8|||
131096652|NCT01072630|471983901|FG002|Overall Study|Protocol Violation|4|||
131096653|NCT01072630|471983899|FG000|Overall Study|Lost to Follow-up|11|||
131096654|NCT01072630|471983900|FG001|Overall Study|Lost to Follow-up|11|||
131096655|NCT01072630|471983901|FG002|Overall Study|Lost to Follow-up|1|||
131096656|NCT01072630|471983899|FG000|Overall Study|Noncompliance with study medication|1|||
131096657|NCT01072630|471983900|FG001|Overall Study|Noncompliance with study medication|1|||
131096658|NCT01072630|471983901|FG002|Overall Study|Noncompliance with study medication|1|||
131096659|NCT01072630|471983899|FG000|Overall Study|Noncompliance with study procedures|1|||
131096660|NCT01072630|471983900|FG001|Overall Study|Noncompliance with study procedures|2|||
131096661|NCT01072630|471983901|FG002|Overall Study|Noncompliance with study procedures|1|||
131096662|NCT01072630|471983899|FG000|Overall Study|Other|3|||
131096663|NCT01072630|471983900|FG001|Overall Study|Other|2|||
131096664|NCT01072630|471983901|FG002|Overall Study|Other|1|||
131096665|NCT01232738|471983902|FG000|Overall Study|Death|3|||
131096666|NCT01232738|471983902|FG000|Overall Study|Physician Decision|2|||
131096667|NCT01232738|471983902|FG000|Overall Study|Lost to Follow-up|1|||
131096668|NCT01232738|471983902|FG000|Overall Study|Withdrawal by Subject|2|||
131096669|NCT01232738|471983902|FG000|Overall Study|Adverse Event|5|||
131096670|NCT00338962|471983903|FG000|Overall Study|Lost to Follow-up|3|||
131096671|NCT00338962|471983904|FG001|Overall Study|Lost to Follow-up|3|||
131096672|NCT00338962|471983905|FG002|Overall Study|Lost to Follow-up|2|||
131096673|NCT00338962|471983906|FG003|Overall Study|Lost to Follow-up|3|||
131096674|NCT00338962|471983903|FG000|Overall Study|Withdrawal by Subject|1|||
131096675|NCT00338962|471983904|FG001|Overall Study|Withdrawal by Subject|0|||
131096676|NCT00338962|471983905|FG002|Overall Study|Withdrawal by Subject|0|||
131096677|NCT00338962|471983906|FG003|Overall Study|Withdrawal by Subject|0|||
131096678|NCT00338962|471983903|FG000|Overall Study|No Transportation|2|||
131096679|NCT00338962|471983904|FG001|Overall Study|No Transportation|0|||
131096680|NCT00338962|471983905|FG002|Overall Study|No Transportation|0|||
131096681|NCT00338962|471983906|FG003|Overall Study|No Transportation|0|||
131096682|NCT00338962|471983903|FG000|Overall Study|Time Constraint|2|||
131096683|NCT00338962|471983904|FG001|Overall Study|Time Constraint|0|||
131096684|NCT00338962|471983905|FG002|Overall Study|Time Constraint|0|||
131096685|NCT00338962|471983906|FG003|Overall Study|Time Constraint|0|||
131096686|NCT00338962|471983903|FG000|Overall Study|Moved|0|||
131096687|NCT00338962|471983904|FG001|Overall Study|Moved|1|||
131096688|NCT00338962|471983905|FG002|Overall Study|Moved|0|||
131096689|NCT00338962|471983906|FG003|Overall Study|Moved|0|||
131096690|NCT00338962|471983903|FG000|Overall Study|Adverse Event|0|||
131096691|NCT00338962|471983904|FG001|Overall Study|Adverse Event|0|||
131144783|NCT04574999|472156275|FG001|Overall Study|Lost to Follow-up|0|||
130727642|NCT00425373|470625520|FG006|Overall Study|Lost to Follow-up|0|||
130727643|NCT00425373|470625521|FG007|Overall Study|Lost to Follow-up|0|||
131096692|NCT00338962|471983905|FG002|Overall Study|Adverse Event|2|||
131096693|NCT00338962|471983906|FG003|Overall Study|Adverse Event|0|||
131096694|NCT00338962|471983903|FG000|Overall Study|Poor Compliance|0|||
131096695|NCT00338962|471983904|FG001|Overall Study|Poor Compliance|0|||
131096696|NCT00338962|471983905|FG002|Overall Study|Poor Compliance|2|||
131096697|NCT00338962|471983906|FG003|Overall Study|Poor Compliance|0|||
131096698|NCT03214640|471983907|FG000|Overall Study|Protocol Violation|1|||
131096699|NCT03214640|471983908|FG001|Overall Study|Protocol Violation|2|||
131096700|NCT03214640|471983909|FG002|Overall Study|Protocol Violation|1|||
131096701|NCT03214640|471983910|FG003|Overall Study|Protocol Violation|4|||
131096702|NCT01253018|471983916|FG000|Overall Study|Lost to Follow-up|1|||
131096703|NCT01253018|471983917|FG001|Overall Study|Lost to Follow-up|1|||
131096704|NCT01253018|471983916|FG000|Overall Study|Robot Repair Issues|2|||
131096705|NCT01253018|471983917|FG001|Overall Study|Robot Repair Issues|0|||
131096706|NCT01253018|471983916|FG000|Overall Study|Withdrawal by Subject|1|||
131096707|NCT01253018|471983917|FG001|Overall Study|Withdrawal by Subject|1|||
131096708|NCT03449901|471983918|FG000|Overall Study|Progression|57|||
131096709|NCT03449901|471983919|FG001|Overall Study|Progression|12|||
131096710|NCT03449901|471983918|FG000|Overall Study|Adverse Event|3|||
131096711|NCT03449901|471983919|FG001|Overall Study|Adverse Event|0|||
131096712|NCT03449901|471983918|FG000|Overall Study|Death|6|||
131096713|NCT03449901|471983919|FG001|Overall Study|Death|2|||
131096714|NCT03449901|471983918|FG000|Overall Study|Withdrawal by Subject|12|||
131096715|NCT03449901|471983919|FG001|Overall Study|Withdrawal by Subject|1|||
131096716|NCT03449901|471983918|FG000|Overall Study|Physician Decision|1|||
131096717|NCT03449901|471983919|FG001|Overall Study|Physician Decision|0|||
131096718|NCT03449901|471983918|FG000|Overall Study|Patient elected for surgical intervention|1|||
131096719|NCT03449901|471983919|FG001|Overall Study|Patient elected for surgical intervention|0|||
131144784|NCT04574999|472156274|FG000|Overall Study|Personal problems|1|||
130727644|NCT00425373|470625522|FG008|Overall Study|Lost to Follow-up|0|||
130727645|NCT00425373|470625514|FG000|Overall Study|Protocol Violation|1|||
130727646|NCT00425373|470625515|FG001|Overall Study|Protocol Violation|0|||
130727647|NCT00425373|470625516|FG002|Overall Study|Protocol Violation|1|||
130727648|NCT00425373|470625517|FG003|Overall Study|Protocol Violation|0|||
130727649|NCT00425373|470625518|FG004|Overall Study|Protocol Violation|0|||
130727650|NCT00425373|470625519|FG005|Overall Study|Protocol Violation|0|||
130727651|NCT00425373|470625520|FG006|Overall Study|Protocol Violation|0|||
130727652|NCT00425373|470625521|FG007|Overall Study|Protocol Violation|5|||
130727653|NCT00425373|470625522|FG008|Overall Study|Protocol Violation|3|||
130727654|NCT00425373|470625514|FG000|Overall Study|Withdrawal by Subject|2|||
130727655|NCT00425373|470625515|FG001|Overall Study|Withdrawal by Subject|0|||
130727656|NCT00425373|470625516|FG002|Overall Study|Withdrawal by Subject|2|||
131096720|NCT03449901|471983918|FG000|Overall Study|Patient off for other complicating disease|1|||
131096721|NCT03449901|471983919|FG001|Overall Study|Patient off for other complicating disease|0|||
131096722|NCT03466073|471983920|FG000|Overall Study|Death|1|||
131096723|NCT03466073|471983921|FG001|Overall Study|Death|0|||
130727657|NCT00425373|470625517|FG003|Overall Study|Withdrawal by Subject|1|||
130727658|NCT00425373|470625518|FG004|Overall Study|Withdrawal by Subject|4|||
130727659|NCT00425373|470625519|FG005|Overall Study|Withdrawal by Subject|0|||
130727660|NCT00425373|470625520|FG006|Overall Study|Withdrawal by Subject|2|||
131096724|NCT03466073|471983922|FG002|Overall Study|Death|0|||
131096725|NCT03466073|471983923|FG003|Overall Study|Death|0|||
131096726|NCT03466073|471983924|FG004|Overall Study|Death|0|||
131096727|NCT03466073|471983925|FG005|Overall Study|Death|1|||
131096728|NCT00744757|471983926|FG000|Overall Study|Objective disease progression|7|||
131096729|NCT00744757|471983926|FG000|Overall Study|Physician Decision|5|||
131096730|NCT00744757|471983926|FG000|Overall Study|Withdrawal by Subject|1|||
131096731|NCT00744757|471983926|FG000|Overall Study|Death|6|||
131096732|NCT00744757|471983926|FG000|Overall Study|Adverse Event|2|||
130727661|NCT00425373|470625521|FG007|Overall Study|Withdrawal by Subject|2|||
131096733|NCT03682302|471983927|FG000|Overall Study|Lost to Follow-up|1|||
131096734|NCT03682302|471983928|FG001|Overall Study|Lost to Follow-up|2|||
131096735|NCT03682302|471983929|FG002|Overall Study|Lost to Follow-up|0|||
131096736|NCT03682302|471983930|FG003|Overall Study|Lost to Follow-up|1|||
131096737|NCT03682302|471983927|FG000|Overall Study|Study drug was not administered|0|||
131096738|NCT03682302|471983928|FG001|Overall Study|Study drug was not administered|0|||
131096739|NCT03682302|471983929|FG002|Overall Study|Study drug was not administered|1|||
131096740|NCT03682302|471983930|FG003|Overall Study|Study drug was not administered|1|||
131096741|NCT01585155|471983931|FG000|Overall Study|Adverse Event|1|||
131096742|NCT01585155|471983931|FG000|Overall Study|Lack of Efficacy|2|||
131096743|NCT01585155|471983931|FG000|Overall Study|Worsening ulcerative colitis|2|||
131096744|NCT03772587|471983936|FG000|Overall Study|COVID-19|0|||
131096745|NCT03772587|471983937|FG001|Overall Study|COVID-19|0|||
130727662|NCT00425373|470625522|FG008|Overall Study|Withdrawal by Subject|2|||
130727663|NCT00425373|470625514|FG000|Overall Study|Lack of Efficacy|0|||
130727664|NCT00425373|470625515|FG001|Overall Study|Lack of Efficacy|0|||
131096746|NCT03772587|471983938|FG002|Overall Study|COVID-19|1|||
131096747|NCT03772587|471983939|FG003|Overall Study|COVID-19|1|||
131096748|NCT03772587|471983940|FG004|Overall Study|COVID-19|0|||
131144785|NCT04574999|472156275|FG001|Overall Study|Personal problems|0|||
131144786|NCT04574999|472156274|FG000|Overall Study|Previous planned surgery|1|||
131144787|NCT04574999|472156275|FG001|Overall Study|Previous planned surgery|0|||
131144788|NCT00008385|472156278|FG000|Overall Study|Off treatment reasons not reported|79|||
131144789|NCT00008385|472156279|FG001|Overall Study|Off treatment reasons not reported|70|||
131144790|NCT00008385|472156278|FG000|Overall Study|Progressive disease|52|||
131144791|NCT00008385|472156279|FG001|Overall Study|Progressive disease|117|||
131144792|NCT00008385|472156278|FG000|Overall Study|Adverse Event|8|||
131144793|NCT00008385|472156279|FG001|Overall Study|Adverse Event|20|||
131144794|NCT00008385|472156278|FG000|Overall Study|Death|12|||
131144795|NCT00008385|472156279|FG001|Overall Study|Death|18|||
131144796|NCT00008385|472156278|FG000|Overall Study|Withdrawal by Subject|67|||
131144797|NCT00008385|472156279|FG001|Overall Study|Withdrawal by Subject|157|||
131144798|NCT00008385|472156278|FG000|Overall Study|Start non-protocol therapy|3|||
131144799|NCT00008385|472156279|FG001|Overall Study|Start non-protocol therapy|1|||
131144800|NCT00008385|472156278|FG000|Overall Study|Other complicating disease|17|||
131144801|NCT00008385|472156279|FG001|Overall Study|Other complicating disease|30|||
131144802|NCT00008385|472156278|FG000|Overall Study|Maximum dose reached|0|||
131144803|NCT00008385|472156279|FG001|Overall Study|Maximum dose reached|2|||
131144804|NCT00008385|472156278|FG000|Overall Study|Other|105|||
131144805|NCT00008385|472156279|FG001|Overall Study|Other|212|||
130727665|NCT00425373|470625516|FG002|Overall Study|Lack of Efficacy|0|||
130727666|NCT00425373|470625517|FG003|Overall Study|Lack of Efficacy|0|||
130727667|NCT00425373|470625518|FG004|Overall Study|Lack of Efficacy|1|||
131096749|NCT03772587|471983936|FG000|Overall Study|Withdrawal by Subject|1|||
131096750|NCT03772587|471983937|FG001|Overall Study|Withdrawal by Subject|0|||
131096751|NCT03772587|471983938|FG002|Overall Study|Withdrawal by Subject|0|||
131096752|NCT03772587|471983939|FG003|Overall Study|Withdrawal by Subject|0|||
131096753|NCT03772587|471983940|FG004|Overall Study|Withdrawal by Subject|0|||
131096754|NCT05260021|471983946|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
131096755|NCT05260021|471983947|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
131096756|NCT05260021|471983948|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
131096757|NCT05260021|471983946|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
131096758|NCT05260021|471983947|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
131096759|NCT05260021|471983948|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
131096760|NCT05260021|471983946|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
131096761|NCT05260021|471983947|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
131096762|NCT05260021|471983948|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
131096763|NCT05260021|471983946|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
131096764|NCT05260021|471983947|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
131096765|NCT05260021|471983948|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
131096766|NCT05260021|471983946|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
131096767|NCT05260021|471983947|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
131096768|NCT05260021|471983948|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
131096769|NCT03842358|471983949|FG000|Overall Study|Poor DOT probe contact with breast|2|||
131096770|NCT03842358|471983949|FG000|Overall Study|DOT system problem|1|||
131096771|NCT03842358|471983949|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
131096772|NCT03842358|471983949|FG000|Overall Study|No biopsy after physician review|4|||
131096773|NCT03842358|471983949|FG000|Overall Study|Patient withdrew|2|||
131096774|NCT01525238|471983950|FG000|Overall Study|Withdrawal by Subject|1|||
131096775|NCT01525238|471983951|FG001|Overall Study|Withdrawal by Subject|0|||
131096776|NCT01525238|471983952|FG002|Overall Study|Withdrawal by Subject|0|||
131096777|NCT04625413|471983953|FG000|Overall Study|Hospice|2|||
131096778|NCT04625413|471983953|FG000|Overall Study|Distress|1|||
131096779|NCT04625413|471983953|FG000|Overall Study|Not feeling well|1|||
131096780|NCT04679935|471983954|FG000|Overall Study|Death|0|||
131096781|NCT04679935|471983955|FG001|Overall Study|Death|1|||
131096782|NCT02993146|471983956|FG000|Overall Study|Withdrawal by Subject|0|||
131096783|NCT02993146|471983957|FG001|Overall Study|Withdrawal by Subject|0|||
131096784|NCT02993146|471983958|FG002|Overall Study|Withdrawal by Subject|1|||
131096785|NCT02993146|471983959|FG003|Overall Study|Withdrawal by Subject|1|||
131096786|NCT04362189|471983960|FG000|Overall Study|Lost to Follow-up|0|||
131096787|NCT04362189|471983961|FG001|Overall Study|Lost to Follow-up|1|||
131096788|NCT04362189|471983960|FG000|Overall Study|Withdrawal by Subject|1|||
131096789|NCT04362189|471983961|FG001|Overall Study|Withdrawal by Subject|0|||
131096790|NCT04362189|471983960|FG000|Overall Study|FDA Clinical Hold|7|||
131096791|NCT04362189|471983961|FG001|Overall Study|FDA Clinical Hold|2|||
131096792|NCT04362189|471983960|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
131096793|NCT04362189|471983961|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
131096794|NCT04362189|471983960|FG000|Overall Study|Adverse Event|0|||
131096795|NCT04362189|471983961|FG001|Overall Study|Adverse Event|2|||
131096796|NCT04362189|471983960|FG000|Overall Study|Death|4|||
131096797|NCT04362189|471983961|FG001|Overall Study|Death|1|||
131096798|NCT02111681|471983962|FG000|Overall Study|Death|5|||
131096799|NCT02111681|471983962|FG000|Overall Study|Lack of Efficacy|2|||
131096800|NCT02111681|471983962|FG000|Overall Study|Progression of disease|4|||
131096801|NCT01077271|471986300|FG000|Overall Study|Parental desire|8|||
131096802|NCT01077271|471986300|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
131096803|NCT01077271|471986300|FG000|Overall Study|Noncompliance|2|||
131096804|NCT01077271|471986300|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
131096805|NCT01077271|471986300|FG000|Overall Study|Changed doctors|2|||
131096806|NCT01077271|471986300|FG000|Overall Study|Parents thought too many injections|2|||
131096807|NCT01077271|471986300|FG000|Overall Study|End of RSV season nearly reached|1|||
131096808|NCT01077271|471986300|FG000|Overall Study|Mother unconvinced of the necessity|1|||
131096809|NCT03333876|471986301|FG000|Screening Period|Screen Failure|4|||
131096810|NCT03333876|471986301|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
131096811|NCT03333876|471986301|FG000|Mandibular Advancement|Adverse Event|2|||
131096812|NCT03333876|471986301|FG000|Mandibular Advancement|Product Damage|2|||
131096813|NCT00095498|471986302|FG000|Overall Study|Physician Decision|9|||
131096814|NCT00095498|471986303|FG001|Overall Study|Physician Decision|10|||
131096815|NCT00095498|471986304|FG002|Overall Study|Physician Decision|8|||
131096816|NCT00095498|471986302|FG000|Overall Study|Adverse Event|1|||
131096817|NCT00095498|471986303|FG001|Overall Study|Adverse Event|0|||
131096818|NCT00095498|471986304|FG002|Overall Study|Adverse Event|1|||
131096819|NCT00095498|471986302|FG000|Overall Study|Withdrawal by Subject|15|||
131096820|NCT00095498|471986303|FG001|Overall Study|Withdrawal by Subject|16|||
130727668|NCT00425373|470625519|FG005|Overall Study|Lack of Efficacy|3|||
131096821|NCT00095498|471986304|FG002|Overall Study|Withdrawal by Subject|15|||
131096822|NCT00095498|471986302|FG000|Overall Study|Disease progression|0|||
131096823|NCT00095498|471986303|FG001|Overall Study|Disease progression|1|||
131096824|NCT00095498|471986304|FG002|Overall Study|Disease progression|1|||
131096825|NCT00095498|471986302|FG000|Overall Study|Ineligibility determined|3|||
131096826|NCT00095498|471986303|FG001|Overall Study|Ineligibility determined|0|||
131096827|NCT00095498|471986304|FG002|Overall Study|Ineligibility determined|2|||
131096828|NCT00095498|471986302|FG000|Overall Study|Lost to Follow-up|1|||
131096829|NCT00095498|471986303|FG001|Overall Study|Lost to Follow-up|1|||
131096830|NCT00095498|471986304|FG002|Overall Study|Lost to Follow-up|2|||
131096831|NCT00095498|471986302|FG000|Overall Study|Noncompliance|1|||
131096832|NCT00095498|471986303|FG001|Overall Study|Noncompliance|0|||
131096833|NCT00095498|471986304|FG002|Overall Study|Noncompliance|1|||
131096834|NCT00095498|471986302|FG000|Overall Study|Other|6|||
131096835|NCT00095498|471986303|FG001|Overall Study|Other|7|||
131096836|NCT00095498|471986304|FG002|Overall Study|Other|6|||
131096837|NCT00095498|471986302|FG000|Overall Study|Protocol Violation|0|||
131096838|NCT00095498|471986303|FG001|Overall Study|Protocol Violation|0|||
131096839|NCT00095498|471986304|FG002|Overall Study|Protocol Violation|1|||
131096840|NCT00095498|471986302|FG000|Overall Study|Requirement for alternative therapy|1|||
131096841|NCT00095498|471986303|FG001|Overall Study|Requirement for alternative therapy|0|||
131096842|NCT00095498|471986304|FG002|Overall Study|Requirement for alternative therapy|2|||
131144806|NCT00008385|472156278|FG000|Overall Study|Not start protocol therapy|44|||
131144807|NCT00008385|472156279|FG001|Overall Study|Not start protocol therapy|175|||
131144808|NCT00582556|472156280|FG000|Overall Study|Withdrawal by Subject|0|||
131144809|NCT00582556|472156281|FG001|Overall Study|Withdrawal by Subject|1|||
131144810|NCT00582556|472156282|FG002|Overall Study|Withdrawal by Subject|1|||
131144811|NCT00582556|472156280|FG000|Overall Study|Physician Decision|0|||
131144812|NCT00582556|472156281|FG001|Overall Study|Physician Decision|0|||
131144813|NCT00582556|472156282|FG002|Overall Study|Physician Decision|1|||
131144814|NCT01993888|472156285|FG000|Overall Study|Death|1|||
131144815|NCT01993888|472156286|FG001|Overall Study|Death|1|||
131144816|NCT01993888|472156285|FG000|Overall Study|Lost to Follow-up|1|||
131144817|NCT01993888|472156286|FG001|Overall Study|Lost to Follow-up|1|||
131144818|NCT01993888|472156285|FG000|Overall Study|Withdrawal by Subject|0|||
131144819|NCT01993888|472156286|FG001|Overall Study|Withdrawal by Subject|1|||
131144820|NCT00832819|472156287|FG000|Overall Study|Adverse Event|0|||
131144821|NCT00832819|472156288|FG001|Overall Study|Adverse Event|1|||
131144822|NCT00832819|472156289|FG002|Overall Study|Adverse Event|0|||
131144823|NCT00832819|472156287|FG000|Overall Study|Protocol Violation|0|||
131144824|NCT00832819|472156288|FG001|Overall Study|Protocol Violation|0|||
131144825|NCT00832819|472156289|FG002|Overall Study|Protocol Violation|1|||
131144826|NCT00317044|472156290|FG000|Overall Study|Protocol Violation|28|||
131144827|NCT00317044|472156291|FG001|Overall Study|Protocol Violation|22|||
131144828|NCT00317044|472156292|FG002|Overall Study|Protocol Violation|20|||
131144829|NCT00317044|472156290|FG000|Overall Study|Adverse Event|4|||
131144830|NCT00317044|472156291|FG001|Overall Study|Adverse Event|7|||
131144831|NCT00317044|472156292|FG002|Overall Study|Adverse Event|4|||
131144832|NCT00317044|472156290|FG000|Overall Study|Withdrawal by Subject|10|||
131144833|NCT00317044|472156291|FG001|Overall Study|Withdrawal by Subject|7|||
131144834|NCT00317044|472156292|FG002|Overall Study|Withdrawal by Subject|12|||
131144835|NCT00317044|472156290|FG000|Overall Study|Lost to Follow-up|0|||
131144836|NCT00317044|472156291|FG001|Overall Study|Lost to Follow-up|2|||
131144837|NCT00317044|472156292|FG002|Overall Study|Lost to Follow-up|3|||
131144838|NCT00317044|472156290|FG000|Overall Study|Multiple Reasons|6|||
131144839|NCT00317044|472156291|FG001|Overall Study|Multiple Reasons|2|||
131144840|NCT00317044|472156292|FG002|Overall Study|Multiple Reasons|6|||
131144841|NCT05742984|472156293|FG000|Overall Study|Adverse Event|0|||
131144842|NCT05742984|472156294|FG001|Overall Study|Adverse Event|0|||
131144843|NCT05742984|472156295|FG002|Overall Study|Adverse Event|1|||
131144844|NCT05742984|472156296|FG003|Overall Study|Adverse Event|0|||
131144845|NCT05742984|472156297|FG004|Overall Study|Adverse Event|1|||
131144846|NCT05742984|472156298|FG005|Overall Study|Adverse Event|1|||
131144847|NCT05742984|472156293|FG000|Overall Study|Withdrawal by Subject|0|||
131144848|NCT05742984|472156294|FG001|Overall Study|Withdrawal by Subject|1|||
131144849|NCT05742984|472156295|FG002|Overall Study|Withdrawal by Subject|0|||
131096843|NCT05020327|471986305|FG000|Overall Study|Physician Decision|3|||
131096844|NCT05020327|471986306|FG001|Overall Study|Physician Decision|0|||
131144850|NCT05742984|472156296|FG003|Overall Study|Withdrawal by Subject|0|||
131144851|NCT05742984|472156297|FG004|Overall Study|Withdrawal by Subject|0|||
131144852|NCT05742984|472156298|FG005|Overall Study|Withdrawal by Subject|2|||
130780285|NCT00128661|470821481|FG000|Overall Study|Withdrawal by Subject|243|||
131144853|NCT00379340|472156299|FG000|Overall Study|Death|0|||
131144854|NCT00379340|472156300|FG001|Overall Study|Death|0|||
131144855|NCT00379340|472156301|FG002|Overall Study|Death|0|||
130780286|NCT00128661|470821482|FG001|Overall Study|Withdrawal by Subject|232|||
131144856|NCT00379340|472156302|FG003|Overall Study|Death|2|||
131096845|NCT05020327|471986307|FG002|Overall Study|Physician Decision|0|||
131096846|NCT05020327|471986305|FG000|Overall Study|Withdrawal by Subject|1|||
131096847|NCT05020327|471986306|FG001|Overall Study|Withdrawal by Subject|1|||
131144857|NCT00379340|472156303|FG004|Overall Study|Death|0|||
131144858|NCT00379340|472156299|FG000|Overall Study|Lack of Efficacy|6|||
131096848|NCT05020327|471986307|FG002|Overall Study|Withdrawal by Subject|0|||
131144859|NCT00379340|472156300|FG001|Overall Study|Lack of Efficacy|1|||
131144860|NCT00379340|472156301|FG002|Overall Study|Lack of Efficacy|0|||
131144861|NCT00379340|472156302|FG003|Overall Study|Lack of Efficacy|4|||
131144862|NCT00379340|472156303|FG004|Overall Study|Lack of Efficacy|3|||
130727669|NCT00425373|470625520|FG006|Overall Study|Lack of Efficacy|3|||
130727670|NCT00425373|470625521|FG007|Overall Study|Lack of Efficacy|0|||
131096849|NCT05020327|471986305|FG000|Overall Study|personal/cultural, ineligible|12|||
131096850|NCT05020327|471986306|FG001|Overall Study|personal/cultural, ineligible|0|||
131096851|NCT05020327|471986307|FG002|Overall Study|personal/cultural, ineligible|0|||
131096852|NCT04684394|471986308|FG000|Overall Study|Death|1|||
131096853|NCT04684394|471986309|FG001|Overall Study|Death|2|||
131096854|NCT04684394|471986308|FG000|Overall Study|Lost to Follow-up|1|||
131096855|NCT04684394|471986309|FG001|Overall Study|Lost to Follow-up|0|||
131144863|NCT00379340|472156299|FG000|Overall Study|Physician Decision|6|||
131144864|NCT00379340|472156300|FG001|Overall Study|Physician Decision|2|||
131144865|NCT00379340|472156301|FG002|Overall Study|Physician Decision|1|||
131144866|NCT00379340|472156302|FG003|Overall Study|Physician Decision|2|||
131144867|NCT00379340|472156303|FG004|Overall Study|Physician Decision|3|||
131144868|NCT00379340|472156299|FG000|Overall Study|Withdrawal by Subject|0|||
131144869|NCT00379340|472156300|FG001|Overall Study|Withdrawal by Subject|0|||
131144870|NCT00379340|472156301|FG002|Overall Study|Withdrawal by Subject|0|||
131144871|NCT00379340|472156302|FG003|Overall Study|Withdrawal by Subject|1|||
131144872|NCT00379340|472156303|FG004|Overall Study|Withdrawal by Subject|0|||
131144873|NCT00379340|472156299|FG000|Overall Study|Refusal of further protocol therapy|1|||
131144874|NCT00379340|472156300|FG001|Overall Study|Refusal of further protocol therapy|0|||
131144875|NCT00379340|472156301|FG002|Overall Study|Refusal of further protocol therapy|1|||
131144876|NCT00379340|472156302|FG003|Overall Study|Refusal of further protocol therapy|1|||
131144877|NCT00379340|472156303|FG004|Overall Study|Refusal of further protocol therapy|7|||
131144878|NCT00379340|472156299|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
131144879|NCT00379340|472156300|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
131144880|NCT00379340|472156301|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
131144881|NCT00379340|472156302|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
131144882|NCT00379340|472156303|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
131144883|NCT00379340|472156299|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
131144884|NCT00379340|472156300|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
131144885|NCT00379340|472156301|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
131144886|NCT00379340|472156302|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
131144887|NCT00379340|472156303|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
131144888|NCT02162862|472156307|FG000|Overall Study|Lost to Follow-up|0|||
131144889|NCT02162862|472156308|FG001|Overall Study|Lost to Follow-up|11|||
131144890|NCT02162862|472156309|FG002|Overall Study|Lost to Follow-up|0|||
130727671|NCT00425373|470625522|FG008|Overall Study|Lack of Efficacy|5|||
130727672|NCT01266031|470625524|FG000|Overall Study|Not treated|0|||
130727673|NCT01266031|470625525|FG001|Overall Study|Not treated|3|||
130727674|NCT01266031|470625526|FG002|Overall Study|Not treated|2|||
130727675|NCT01434810|470625527|FG000|Overall Study|Did not receive treatment|11|||
130727676|NCT01434810|470625528|FG001|Overall Study|Did not receive treatment|3|||
130727677|NCT01434810|470625527|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
130727678|NCT01434810|470625528|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
130727679|NCT04893018|470625530|FG000|Overall Study|Lost to Follow-up|1|||
130727680|NCT04893018|470625531|FG001|Overall Study|Lost to Follow-up|0|||
130727681|NCT04893018|470625530|FG000|Overall Study|Withdrawal by Subject|2|||
130727682|NCT04893018|470625531|FG001|Overall Study|Withdrawal by Subject|0|||
130727683|NCT04893018|470625530|FG000|Overall Study|Study Terminated|1|||
130727684|NCT04893018|470625531|FG001|Overall Study|Study Terminated|2|||
130727685|NCT02533180|470625535|FG000|Overall Study|Death|0|||
130727686|NCT02533180|470625536|FG001|Overall Study|Death|2|||
131096856|NCT04684394|471986308|FG000|Overall Study|Withdrawal by Subject|2|||
131096857|NCT04684394|471986309|FG001|Overall Study|Withdrawal by Subject|0|||
131096858|NCT04684394|471986308|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
131096859|NCT04684394|471986309|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
131096860|NCT00591370|471986311|FG000|Overall Study|Not Treated|2|||
131144891|NCT02162862|472156307|FG000|Overall Study|Subject did not feel the med was needed|0|||
131144892|NCT02162862|472156308|FG001|Overall Study|Subject did not feel the med was needed|0|||
131144893|NCT02162862|472156309|FG002|Overall Study|Subject did not feel the med was needed|4|||
131144894|NCT01703000|472156312|FG000|Overall Study|Death|1|||
131096861|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
131144895|NCT03822884|472156313|FG000|Overall Study|Withdrawal by Subject|0|||
131144896|NCT03822884|472156314|FG001|Overall Study|Withdrawal by Subject|0|||
131144897|NCT03822884|472156315|FG002|Overall Study|Withdrawal by Subject|0|||
131144898|NCT03822884|472156316|FG003|Overall Study|Withdrawal by Subject|0|||
131144899|NCT03822884|472156317|FG004|Overall Study|Withdrawal by Subject|1|||
131144900|NCT03822884|472156318|FG005|Overall Study|Withdrawal by Subject|0|||
131144901|NCT00603239|472156324|FG000|Overall Study|Adverse Event|4|||
130727687|NCT02533180|470625535|FG000|Overall Study|Lost to Follow-up|0|||
130727688|NCT02533180|470625536|FG001|Overall Study|Lost to Follow-up|1|||
130727689|NCT02533180|470625535|FG000|Overall Study|Physician Decision|0|||
130727690|NCT02533180|470625536|FG001|Overall Study|Physician Decision|1|||
130727691|NCT02533180|470625535|FG000|Overall Study|Withdrawal by Subject|2|||
131096862|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
131096863|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
131096864|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
131096865|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
131096866|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
131234710|NCT02187042|472486451|FG000|Overall Study|Doctor choice|1|||
131234711|NCT02187042|472486452|FG001|Overall Study|Doctor choice|0|||
131234712|NCT02187042|472486451|FG000|Overall Study|Progressive disease|4|||
131234713|NCT02187042|472486452|FG001|Overall Study|Progressive disease|8|||
131234714|NCT02116803|472486454|FG000|Overall Study|Adverse Event|2|||
131234715|NCT02116803|472486455|FG001|Overall Study|Adverse Event|1|||
131234716|NCT02116803|472486454|FG000|Overall Study|Physician Decision|1|||
131234717|NCT02116803|472486455|FG001|Overall Study|Physician Decision|0|||
131234718|NCT02116803|472486454|FG000|Overall Study|Progressive disease|4|||
131234719|NCT02116803|472486455|FG001|Overall Study|Progressive disease|0|||
131234720|NCT02116803|472486454|FG000|Overall Study|Study terminated by sponsor|2|||
131234721|NCT02116803|472486455|FG001|Overall Study|Study terminated by sponsor|1|||
131234722|NCT02116803|472486454|FG000|Overall Study|Death|1|||
131234723|NCT02116803|472486455|FG001|Overall Study|Death|0|||
131234724|NCT00282256|472486458|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
131234725|NCT00282256|472486458|FG000|Extension Treatment Period|Adverse Event|2|||
131234726|NCT00698685|472486459|FG000|Overall Study|Sister withdrew as donor|1|||
131234727|NCT00698685|472486459|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
131234728|NCT01457053|472486462|FG000|Overall Study|Unable to undergo selected treatment|1|||
131234729|NCT01457053|472486463|FG001|Overall Study|Unable to undergo selected treatment|1|||
131234730|NCT00429923|472486465|FG000|Overall Study|Adverse Event|0|||
131234731|NCT00429923|472486466|FG001|Overall Study|Adverse Event|2|||
131234732|NCT00429923|472486467|FG002|Overall Study|Adverse Event|3|||
131234733|NCT00429923|472486465|FG000|Overall Study|Lack of Efficacy|4|||
131234734|NCT00429923|472486466|FG001|Overall Study|Lack of Efficacy|1|||
131234735|NCT00429923|472486467|FG002|Overall Study|Lack of Efficacy|33|||
131234736|NCT00429923|472486465|FG000|Overall Study|Lost to Follow-up|0|||
131234737|NCT00429923|472486466|FG001|Overall Study|Lost to Follow-up|0|||
131234738|NCT00429923|472486467|FG002|Overall Study|Lost to Follow-up|2|||
131234739|NCT00429923|472486465|FG000|Overall Study|Withdrew Consent|1|||
130727692|NCT02533180|470625536|FG001|Overall Study|Withdrawal by Subject|5|||
130727693|NCT02533180|470625535|FG000|Overall Study|Screen Failure|37|||
130727694|NCT02533180|470625536|FG001|Overall Study|Screen Failure|0|||
130727695|NCT02533180|470625535|FG000|Overall Study|Protocol Deviation|0|||
130727696|NCT02533180|470625536|FG001|Overall Study|Protocol Deviation|1|||
131096867|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
131096868|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
131096869|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
131096870|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
131096871|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
131096872|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
131096873|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Death|1|||
131096874|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Death|2|||
131096875|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Death|2|||
131096876|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Death|0|||
131096877|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Death|0|||
131096878|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Death|0|||
131144902|NCT00603239|472156325|FG001|Overall Study|Adverse Event|1|||
131144903|NCT00603239|472156324|FG000|Overall Study|Entry criteria not met|0|||
131144904|NCT00603239|472156325|FG001|Overall Study|Entry criteria not met|1|||
131144905|NCT00603239|472156324|FG000|Overall Study|Loss of glucose control|3|||
131144906|NCT00603239|472156325|FG001|Overall Study|Loss of glucose control|0|||
131144907|NCT00603239|472156324|FG000|Overall Study|Lost to Follow-up|2|||
131144908|NCT00603239|472156325|FG001|Overall Study|Lost to Follow-up|1|||
131144909|NCT00603239|472156324|FG000|Overall Study|Physician Decision|2|||
131144910|NCT00603239|472156325|FG001|Overall Study|Physician Decision|0|||
131144911|NCT00603239|472156324|FG000|Overall Study|Protocol Violation|2|||
131144912|NCT00603239|472156325|FG001|Overall Study|Protocol Violation|0|||
131144913|NCT00603239|472156324|FG000|Overall Study|Subject decision|2|||
131144914|NCT00603239|472156325|FG001|Overall Study|Subject decision|1|||
131144915|NCT02357420|472156326|FG000|Overall Study|Adverse Event|3|||
130727697|NCT02533180|470625535|FG000|Overall Study|Non-compliance|0|||
131144916|NCT02357420|472156327|FG001|Overall Study|Adverse Event|3|||
131234740|NCT00429923|472486466|FG001|Overall Study|Withdrew Consent|0|||
131234741|NCT00429923|472486467|FG002|Overall Study|Withdrew Consent|1|||
131234742|NCT00429923|472486465|FG000|Overall Study|Early Termination|0|||
130727698|NCT02533180|470625536|FG001|Overall Study|Non-compliance|1|||
131234743|NCT00429923|472486466|FG001|Overall Study|Early Termination|1|||
131234744|NCT00429923|472486467|FG002|Overall Study|Early Termination|0|||
131234745|NCT03387098|472486468|FG000|Overall Study|progressive disease|1|||
131144917|NCT02357420|472156328|FG002|Overall Study|Adverse Event|8|||
131144918|NCT02357420|472156329|FG003|Overall Study|Adverse Event|9|||
131144919|NCT02357420|472156326|FG000|Overall Study|Investigator Decision|1|||
131144920|NCT02357420|472156327|FG001|Overall Study|Investigator Decision|0|||
131144921|NCT02357420|472156328|FG002|Overall Study|Investigator Decision|0|||
131144922|NCT02357420|472156329|FG003|Overall Study|Investigator Decision|0|||
131096879|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
131096880|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
131096881|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
131096882|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
131096883|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
131096884|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
131096885|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
131096886|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
131096887|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
131096888|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
131096889|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
131096890|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
131096891|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
131096892|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
131096893|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
131096894|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
131096895|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
131096896|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
131096897|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
131096898|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
131096899|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
131144923|NCT02357420|472156326|FG000|Overall Study|Prohibited Medication|1|||
131144924|NCT02357420|472156327|FG001|Overall Study|Prohibited Medication|1|||
131144925|NCT02357420|472156328|FG002|Overall Study|Prohibited Medication|0|||
131144926|NCT02357420|472156329|FG003|Overall Study|Prohibited Medication|0|||
131144927|NCT02357420|472156326|FG000|Overall Study|Protocol Non-compliance|0|||
131144928|NCT02357420|472156327|FG001|Overall Study|Protocol Non-compliance|0|||
131144929|NCT02357420|472156328|FG002|Overall Study|Protocol Non-compliance|0|||
131144930|NCT02357420|472156329|FG003|Overall Study|Protocol Non-compliance|1|||
131144931|NCT02357420|472156326|FG000|Overall Study|Withdrawn Consent|4|||
131144932|NCT02357420|472156327|FG001|Overall Study|Withdrawn Consent|8|||
131144933|NCT02357420|472156328|FG002|Overall Study|Withdrawn Consent|6|||
131144934|NCT02357420|472156329|FG003|Overall Study|Withdrawn Consent|6|||
131144935|NCT02357420|472156326|FG000|Overall Study|Lost to Follow-up|3|||
131144936|NCT02357420|472156327|FG001|Overall Study|Lost to Follow-up|0|||
131144937|NCT02357420|472156328|FG002|Overall Study|Lost to Follow-up|2|||
131144938|NCT02357420|472156329|FG003|Overall Study|Lost to Follow-up|3|||
131144939|NCT00928070|472156332|FG000|Overall Study|Lost to Follow-up|1|||
131144940|NCT00928070|472156333|FG001|Overall Study|Lost to Follow-up|2|||
131144941|NCT00928070|472156332|FG000|Overall Study|Withdrawal by Subject|10|||
131144942|NCT00928070|472156333|FG001|Overall Study|Withdrawal by Subject|3|||
131144943|NCT00928070|472156332|FG000|Overall Study|Adverse Event|14|||
131144944|NCT00928070|472156333|FG001|Overall Study|Adverse Event|26|||
131144945|NCT00928070|472156332|FG000|Overall Study|Lack of Efficacy|9|||
131144946|NCT00928070|472156333|FG001|Overall Study|Lack of Efficacy|5|||
131144947|NCT00928070|472156332|FG000|Overall Study|Did not meet entrance criteria|16|||
131144948|NCT00928070|472156333|FG001|Overall Study|Did not meet entrance criteria|9|||
131144949|NCT00928070|472156332|FG000|Overall Study|Protocol Violation|6|||
131144950|NCT00928070|472156333|FG001|Overall Study|Protocol Violation|5|||
131144951|NCT00928070|472156332|FG000|Overall Study|Randomized but not treated|2|||
131144952|NCT00928070|472156333|FG001|Overall Study|Randomized but not treated|2|||
131144953|NCT00928070|472156332|FG000|Overall Study|Other|5|||
131144954|NCT00928070|472156333|FG001|Overall Study|Other|5|||
131144955|NCT00191854|472156334|FG000|Overall Study|Death|26|||
131144956|NCT00191854|472156335|FG001|Overall Study|Death|23|||
131144957|NCT00191854|472156336|FG002|Overall Study|Death|29|||
131234746|NCT03387098|472486468|FG000|Overall Study|Withdrawal by Subject|2|||
131234747|NCT03387098|472486468|FG000|Overall Study|study terminated by sponsor|1|||
130727699|NCT00447876|470625537|FG000|Overall Study|Withdrawal by Subject|1|||
131234748|NCT02799602|472486472|FG000|Overall Study|Protocol Violation|1|||
130727700|NCT00447876|470625538|FG001|Overall Study|Withdrawal by Subject|4|||
130727701|NCT00447876|470625537|FG000|Overall Study|Lost to Follow-up|1|||
130727702|NCT00447876|470625538|FG001|Overall Study|Lost to Follow-up|0|||
131144958|NCT00191854|472156334|FG000|Overall Study|Lost to Follow-up|7|||
131144959|NCT00191854|472156335|FG001|Overall Study|Lost to Follow-up|5|||
131144960|NCT00191854|472156336|FG002|Overall Study|Lost to Follow-up|5|||
131234749|NCT02799602|472486473|FG001|Overall Study|Protocol Violation|0|||
131096900|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
131096901|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
131096902|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
131096903|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
131096904|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
131096905|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
131096906|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
131096907|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
131096908|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
131096909|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
131096910|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
131096911|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
131096912|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
131096913|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
131096914|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
131096915|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
131096916|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
131096917|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
131096918|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
131096919|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
131096920|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
131096921|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Site closure|0|||
131096922|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Site closure|0|||
131096923|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Site closure|1|||
131096924|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Site closure|0|||
131096925|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Site closure|0|||
131096926|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Site closure|0|||
131096927|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
131096928|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
131096929|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
131096930|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
131096931|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
131096932|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
131096933|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
131096934|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
131096935|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
131096936|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
131096937|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
131096938|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
131096939|NCT03439254|471986312|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
131096940|NCT03439254|471986313|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
131096941|NCT03439254|471986314|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
131096942|NCT03439254|471986315|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
131096943|NCT03439254|471986316|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
131096944|NCT03439254|471986317|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
131096945|NCT03439254|471986312|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
131096946|NCT03439254|471986313|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
131096947|NCT03439254|471986314|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
131096948|NCT03439254|471986315|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
131096949|NCT03439254|471986316|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
131096950|NCT03439254|471986317|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
131096951|NCT03439254|471986312|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
131096952|NCT03439254|471986313|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
131096953|NCT03439254|471986314|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
131096954|NCT03439254|471986315|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
131096955|NCT03439254|471986316|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
131096956|NCT03439254|471986317|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
131096957|NCT03439254|471986312|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
131096958|NCT03439254|471986313|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
131144961|NCT00191854|472156334|FG000|Overall Study|Withdrawal by Subject|4|||
131144962|NCT00191854|472156335|FG001|Overall Study|Withdrawal by Subject|2|||
131234750|NCT02799602|472486472|FG000|Overall Study|Physician Decision|5|||
131096959|NCT03439254|471986314|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
131096960|NCT03439254|471986315|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
131096961|NCT03439254|471986316|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
131096962|NCT03439254|471986317|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
131096963|NCT03439254|471986312|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
131096964|NCT03439254|471986313|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
131096965|NCT03439254|471986314|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
131096966|NCT03439254|471986315|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
131096967|NCT03439254|471986316|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
131096968|NCT03439254|471986317|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
131096969|NCT03439254|471986312|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
131096970|NCT03439254|471986313|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
131096971|NCT03439254|471986314|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
131096972|NCT03439254|471986315|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
131096973|NCT03439254|471986316|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
131096974|NCT03439254|471986317|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
131096975|NCT03439254|471986312|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
131096976|NCT03439254|471986313|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
131096977|NCT03439254|471986314|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
131096978|NCT03439254|471986315|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
131096979|NCT03439254|471986316|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
131096980|NCT03439254|471986317|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
131096981|NCT03439254|471986312|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
131096982|NCT03439254|471986313|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
131096983|NCT03439254|471986314|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
131096984|NCT03439254|471986315|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
131096985|NCT03439254|471986316|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
131096986|NCT03439254|471986317|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
131096987|NCT03439254|471986312|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
131096988|NCT03439254|471986313|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
131096989|NCT03439254|471986314|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
131096990|NCT03439254|471986315|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
131096991|NCT03439254|471986316|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
131096992|NCT03439254|471986317|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
131096993|NCT03439254|471986312|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
131096994|NCT03439254|471986313|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
131096995|NCT03439254|471986314|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
131096996|NCT03439254|471986315|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
131096997|NCT03439254|471986316|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
131096998|NCT03439254|471986317|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
131096999|NCT02075476|471986319|FG000|Overall Study|Death|2|||
131097000|NCT02075476|471986320|FG001|Overall Study|Death|2|||
131097001|NCT02075476|471986319|FG000|Overall Study|Lost to Follow-up|1|||
131097002|NCT02075476|471986320|FG001|Overall Study|Lost to Follow-up|3|||
131097003|NCT00095056|471986321|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
131097004|NCT00095056|471986322|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
131097005|NCT00095056|471986321|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
131097006|NCT00095056|471986322|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
131097007|NCT00095056|471986321|FG000|Phase A (Weeks 0-12)|Death|1|||
131097008|NCT00095056|471986322|FG001|Phase A (Weeks 0-12)|Death|0|||
131097009|NCT00095056|471986321|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
131097010|NCT00095056|471986322|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
131097011|NCT00095056|471986321|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
131097012|NCT00095056|471986322|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
131097013|NCT00095056|471986321|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
131097014|NCT00095056|471986322|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
131097015|NCT00095056|471986321|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
131097016|NCT00095056|471986322|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
131097017|NCT00095056|471986321|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
131097018|NCT00095056|471986322|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
131097019|NCT00095056|471986321|FG000|Phase B (Weeks 12-54)|Death|3|||
131234751|NCT02799602|472486473|FG001|Overall Study|Physician Decision|6|||
131234752|NCT02799602|472486472|FG000|Overall Study|Lost to Follow-up|4|||
131097020|NCT00095056|471986322|FG001|Phase B (Weeks 12-54)|Death|1|||
131097021|NCT00095056|471986321|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
131097022|NCT00095056|471986322|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
131234753|NCT02799602|472486473|FG001|Overall Study|Lost to Follow-up|2|||
131144963|NCT00191854|472156336|FG002|Overall Study|Withdrawal by Subject|3|||
131144964|NCT00191854|472156334|FG000|Overall Study|Sponsor Decision|0|||
131144965|NCT00191854|472156335|FG001|Overall Study|Sponsor Decision|0|||
131144966|NCT00191854|472156336|FG002|Overall Study|Sponsor Decision|1|||
131144967|NCT00191854|472156334|FG000|Overall Study|Screen Failure|0|||
131144968|NCT00191854|472156335|FG001|Overall Study|Screen Failure|0|||
131144969|NCT00191854|472156336|FG002|Overall Study|Screen Failure|1|||
131144970|NCT06118385|472156340|FG000|Overall Study|Protocol Violation|0|||
131144971|NCT06118385|472156341|FG001|Overall Study|Protocol Violation|0|||
131144972|NCT06118385|472156342|FG002|Overall Study|Protocol Violation|0|||
131144973|NCT06118385|472156343|FG003|Overall Study|Protocol Violation|0|||
131144974|NCT06118385|472156344|FG004|Overall Study|Protocol Violation|0|||
131144975|NCT06118385|472156345|FG005|Overall Study|Protocol Violation|0|||
131144976|NCT06118385|472156346|FG006|Overall Study|Protocol Violation|0|||
131144977|NCT06118385|472156347|FG007|Overall Study|Protocol Violation|0|||
131144978|NCT06118385|472156348|FG008|Overall Study|Protocol Violation|1|||
131144979|NCT06118385|472156349|FG009|Overall Study|Protocol Violation|0|||
131144980|NCT06118385|472156350|FG010|Overall Study|Protocol Violation|0|||
131144981|NCT06118385|472156351|FG011|Overall Study|Protocol Violation|0|||
131144982|NCT06118385|472156340|FG000|Overall Study|Out-of-range blood tests|0|||
131144983|NCT06118385|472156341|FG001|Overall Study|Out-of-range blood tests|0|||
131144984|NCT06118385|472156342|FG002|Overall Study|Out-of-range blood tests|0|||
131144985|NCT06118385|472156343|FG003|Overall Study|Out-of-range blood tests|0|||
131144986|NCT06118385|472156344|FG004|Overall Study|Out-of-range blood tests|0|||
131144987|NCT06118385|472156345|FG005|Overall Study|Out-of-range blood tests|0|||
131144988|NCT06118385|472156346|FG006|Overall Study|Out-of-range blood tests|0|||
131144989|NCT06118385|472156347|FG007|Overall Study|Out-of-range blood tests|0|||
131144990|NCT06118385|472156348|FG008|Overall Study|Out-of-range blood tests|1|||
131144991|NCT06118385|472156349|FG009|Overall Study|Out-of-range blood tests|0|||
131144992|NCT06118385|472156350|FG010|Overall Study|Out-of-range blood tests|0|||
131144993|NCT06118385|472156351|FG011|Overall Study|Out-of-range blood tests|0|||
131144994|NCT02388295|472156352|FG000|Dose Escalation Week 1|Adverse Event|1|||
131144995|NCT02388295|472156353|FG001|Dose Escalation Week 1|Adverse Event|2|||
131144996|NCT02388295|472156354|FG002|Dose Escalation Week 1|Adverse Event|1|||
131144997|NCT02388295|472156352|FG000|Dose Escalation Week 1|Determined not eligible|1|||
131144998|NCT02388295|472156353|FG001|Dose Escalation Week 1|Determined not eligible|1|||
131144999|NCT02388295|472156354|FG002|Dose Escalation Week 1|Determined not eligible|1|||
131145000|NCT02388295|472156352|FG000|Dose Escalation Week 2|Protocol Violation|0|||
131145001|NCT02388295|472156353|FG001|Dose Escalation Week 2|Protocol Violation|1|||
131145002|NCT02388295|472156354|FG002|Dose Escalation Week 2|Protocol Violation|0|||
131145003|NCT02388295|472156352|FG000|Dose Escalation Week 2|Determined not eligible|1|||
131145004|NCT02388295|472156353|FG001|Dose Escalation Week 2|Determined not eligible|1|||
131145005|NCT02388295|472156354|FG002|Dose Escalation Week 2|Determined not eligible|1|||
131145006|NCT02388295|472156352|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
131145007|NCT02388295|472156353|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
131145008|NCT02388295|472156354|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
131145009|NCT04258579|472156355|FG000|Overall Study|Withdrawal by Subject|7|||
131145010|NCT04258579|472156355|FG000|Overall Study|Lost to Follow-up|3|||
131145011|NCT04258579|472156355|FG000|Overall Study|Protocol Violation|2|||
131145012|NCT04258579|472156355|FG000|Overall Study|Adverse Event|1|||
131145013|NCT02076165|472156357|FG000|Overall Study|Lost to Follow-up|7|||
131145014|NCT02076165|472156358|FG001|Overall Study|Lost to Follow-up|5|||
131145015|NCT02076165|472156357|FG000|Overall Study|Refused follow-up assessment|1|||
131234754|NCT02799602|472486472|FG000|Overall Study|Additional primary malignancy|11|||
131097023|NCT00095056|471986321|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
131097024|NCT00095056|471986322|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
131097025|NCT02731690|471986328|FG000|Overall Study|Adverse Event|1|||
131097026|NCT02731690|471986328|FG000|Overall Study|Withdrawal by Subject|3|||
131097027|NCT02731690|471986328|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
131097028|NCT00923260|471986329|FG000|Overall Study|Lost to Follow-up|1|||
131097029|NCT00923260|471986330|FG001|Overall Study|Lost to Follow-up|1|||
131097030|NCT01262677|471986332|FG000|Overall Study|Does not meet entrance criteria|0|||
131097031|NCT01262677|471986333|FG001|Overall Study|Does not meet entrance criteria|2|||
131097032|NCT01262677|471986334|FG002|Overall Study|Does not meet entrance criteria|0|||
131097033|NCT01262677|471986332|FG000|Overall Study|Insufficient clinical response|0|||
131097034|NCT01262677|471986333|FG001|Overall Study|Insufficient clinical response|0|||
131145016|NCT02076165|472156358|FG001|Overall Study|Refused follow-up assessment|1|||
131145017|NCT03157531|472156362|FG000|Overall Study|Death|2|||
131145018|NCT03157531|472156362|FG000|Overall Study|Lost to Follow-up|4|||
131145019|NCT00331006|472156363|FG000|Screening Phase|Withdrawal by Subject|1|||
131145020|NCT00331006|472156363|FG000|Screening Phase|enrollment halted|1|||
131145021|NCT00331006|472156363|FG000|Screening Phase|Lost to Follow-up|1|||
131097035|NCT01262677|471986334|FG002|Overall Study|Insufficient clinical response|1|||
131145022|NCT00331006|472156363|FG000|Screening Phase|Ineligible for treatment phase|4|||
131145023|NCT00331006|472156363|FG000|Treatment Phase|Withdrawal by Subject|1|||
131145024|NCT00331006|472156363|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
130727703|NCT00447876|470625537|FG000|Overall Study|Deterioration of symptomology|1|||
130727704|NCT00447876|470625538|FG001|Overall Study|Deterioration of symptomology|0|||
130727705|NCT00005957|470625541|FG000|Overall Study|No treated|3|||
130727706|NCT00005957|470625542|FG001|Overall Study|No treated|9|||
130727707|NCT00005957|470625541|FG000|Overall Study|Crossover to the other arm|5|||
130727708|NCT00005957|470625542|FG001|Overall Study|Crossover to the other arm|19|||
130727709|NCT01609023|470625543|FG000|Overall Study|Lack of Efficacy|3|||
130727710|NCT01609023|470625543|FG000|Overall Study|Withdrawal by Subject|4|||
131097036|NCT01262677|471986332|FG000|Overall Study|Lost to Follow-up|1|||
131097037|NCT01262677|471986333|FG001|Overall Study|Lost to Follow-up|0|||
131097038|NCT01262677|471986334|FG002|Overall Study|Lost to Follow-up|2|||
131097039|NCT01262677|471986332|FG000|Overall Study|No longer willing to participate|3|||
131097040|NCT01262677|471986333|FG001|Overall Study|No longer willing to participate|3|||
131097041|NCT01262677|471986334|FG002|Overall Study|No longer willing to participate|2|||
131097042|NCT01262677|471986332|FG000|Overall Study|Reason not provided|2|||
131097043|NCT01262677|471986333|FG001|Overall Study|Reason not provided|1|||
131097044|NCT01262677|471986334|FG002|Overall Study|Reason not provided|3|||
131097045|NCT01262677|471986332|FG000|Overall Study|Protocol Violation|0|||
131097046|NCT01262677|471986333|FG001|Overall Study|Protocol Violation|1|||
131097047|NCT01262677|471986334|FG002|Overall Study|Protocol Violation|1|||
131097048|NCT01262677|471986332|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
131097049|NCT01262677|471986333|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
131097050|NCT01262677|471986334|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
131097051|NCT00201643|471986340|FG000|Overall Study|Withdrawal by Subject|5|||
131097052|NCT00201643|471986341|FG001|Overall Study|Withdrawal by Subject|4|||
131097053|NCT03446781|471986350|FG000|Overall Study|Lost to Follow-up|11|||
131097054|NCT03446781|471986351|FG001|Overall Study|Lost to Follow-up|5|||
131097055|NCT03446781|471986350|FG000|Overall Study|Withdrawal by Subject|9|||
131097056|NCT03446781|471986351|FG001|Overall Study|Withdrawal by Subject|7|||
131097057|NCT03446781|471986350|FG000|Overall Study|Adverse Event|8|||
131097058|NCT03446781|471986351|FG001|Overall Study|Adverse Event|2|||
131097059|NCT03446781|471986350|FG000|Overall Study|Protocol Violation|0|||
131097060|NCT03446781|471986351|FG001|Overall Study|Protocol Violation|3|||
131097061|NCT04410523|471986355|FG000|Overall Study|Study terminated by sponsor|1|||
131097062|NCT04410523|471986356|FG001|Overall Study|Study terminated by sponsor|3|||
131097063|NCT04410523|471986357|FG002|Overall Study|Study terminated by sponsor|2|||
131097064|NCT04410523|471986358|FG003|Overall Study|Study terminated by sponsor|6|||
131097065|NCT04410523|471986359|FG004|Overall Study|Study terminated by sponsor|3|||
131097066|NCT04410523|471986360|FG005|Overall Study|Study terminated by sponsor|4|||
131097067|NCT04410523|471986355|FG000|Overall Study|Adverse Event|1|||
131097068|NCT04410523|471986356|FG001|Overall Study|Adverse Event|0|||
131097069|NCT04410523|471986357|FG002|Overall Study|Adverse Event|0|||
131097070|NCT04410523|471986358|FG003|Overall Study|Adverse Event|0|||
131097071|NCT04410523|471986359|FG004|Overall Study|Adverse Event|0|||
131097072|NCT04410523|471986360|FG005|Overall Study|Adverse Event|2|||
131097073|NCT04410523|471986355|FG000|Overall Study|Lost to Follow-up|0|||
131097074|NCT04410523|471986356|FG001|Overall Study|Lost to Follow-up|1|||
131097075|NCT04410523|471986357|FG002|Overall Study|Lost to Follow-up|0|||
131097076|NCT04410523|471986358|FG003|Overall Study|Lost to Follow-up|0|||
131097077|NCT04410523|471986359|FG004|Overall Study|Lost to Follow-up|0|||
131097078|NCT04410523|471986360|FG005|Overall Study|Lost to Follow-up|0|||
131097079|NCT04410523|471986355|FG000|Overall Study|Physician Decision|0|||
131097080|NCT04410523|471986356|FG001|Overall Study|Physician Decision|1|||
131097081|NCT04410523|471986357|FG002|Overall Study|Physician Decision|0|||
131097082|NCT04410523|471986358|FG003|Overall Study|Physician Decision|0|||
131097083|NCT04410523|471986359|FG004|Overall Study|Physician Decision|0|||
131097084|NCT04410523|471986360|FG005|Overall Study|Physician Decision|0|||
131097085|NCT04410523|471986355|FG000|Overall Study|Pregnancy|0|||
131097086|NCT04410523|471986356|FG001|Overall Study|Pregnancy|0|||
131097087|NCT04410523|471986357|FG002|Overall Study|Pregnancy|0|||
131097088|NCT04410523|471986358|FG003|Overall Study|Pregnancy|0|||
131097089|NCT04410523|471986359|FG004|Overall Study|Pregnancy|0|||
131097090|NCT04410523|471986360|FG005|Overall Study|Pregnancy|1|||
131097091|NCT04410523|471986355|FG000|Overall Study|Protocol deviation|0|||
131097092|NCT04410523|471986356|FG001|Overall Study|Protocol deviation|0|||
131097093|NCT04410523|471986357|FG002|Overall Study|Protocol deviation|0|||
131097094|NCT04410523|471986358|FG003|Overall Study|Protocol deviation|0|||
131234755|NCT02799602|472486473|FG001|Overall Study|Additional primary malignancy|6|||
130727711|NCT01609023|470625543|FG000|Overall Study|Lost to Follow-up|8|||
131097095|NCT04410523|471986359|FG004|Overall Study|Protocol deviation|0|||
131097096|NCT04410523|471986360|FG005|Overall Study|Protocol deviation|2|||
131097097|NCT04410523|471986355|FG000|Overall Study|Subject decision|2|||
131097098|NCT04410523|471986356|FG001|Overall Study|Subject decision|0|||
131234756|NCT02799602|472486472|FG000|Overall Study|Non-compliance with study drug|14|||
131097099|NCT04410523|471986357|FG002|Overall Study|Subject decision|0|||
131097100|NCT04410523|471986358|FG003|Overall Study|Subject decision|1|||
131097101|NCT04410523|471986359|FG004|Overall Study|Subject decision|0|||
131097102|NCT04410523|471986360|FG005|Overall Study|Subject decision|1|||
131097103|NCT00370682|471986361|FG000|Overall Study|Moved from area|0|||
131097104|NCT00370682|471986362|FG001|Overall Study|Moved from area|2|||
131145025|NCT00331006|472156363|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
131097105|NCT00370682|471986363|FG002|Overall Study|Moved from area|0|||
131097106|NCT00370682|471986361|FG000|Overall Study|Lost to Follow-up|0|||
131097107|NCT00370682|471986362|FG001|Overall Study|Lost to Follow-up|1|||
131097108|NCT00370682|471986363|FG002|Overall Study|Lost to Follow-up|1|||
131097109|NCT03651622|471986364|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
131097110|NCT03651622|471986365|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
131097111|NCT03651622|471986366|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
131097112|NCT03651622|471986364|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
131097113|NCT03651622|471986365|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
131145026|NCT01950819|472156364|FG000|Overall Study|Graft Loss|35|||
131145027|NCT01950819|472156365|FG001|Overall Study|Graft Loss|30|||
131145028|NCT01950819|472156364|FG000|Overall Study|Death|29|||
131145029|NCT01950819|472156365|FG001|Overall Study|Death|34|||
131145030|NCT01950819|472156364|FG000|Overall Study|Subject / Gardian decision|54|||
131145031|NCT01950819|472156365|FG001|Overall Study|Subject / Gardian decision|51|||
131145032|NCT01950819|472156364|FG000|Overall Study|technical problems|2|||
131145033|NCT01950819|472156365|FG001|Overall Study|technical problems|0|||
131145034|NCT01950819|472156364|FG000|Overall Study|Pregnancy|0|||
131145035|NCT01950819|472156365|FG001|Overall Study|Pregnancy|2|||
131145036|NCT01950819|472156364|FG000|Overall Study|Lost to Follow-up|9|||
131145037|NCT01950819|472156365|FG001|Overall Study|Lost to Follow-up|17|||
131145038|NCT01838044|472156369|FG000|Overall Study|Adverse Event|4|||
131145039|NCT01838044|472156370|FG001|Overall Study|Adverse Event|6|||
131145040|NCT01838044|472156369|FG000|Overall Study|Protocol Violation|3|||
131145041|NCT01838044|472156370|FG001|Overall Study|Protocol Violation|3|||
131145042|NCT01838044|472156369|FG000|Overall Study|Withdrawal by Subject|0|||
131145043|NCT01838044|472156370|FG001|Overall Study|Withdrawal by Subject|2|||
131145044|NCT01838044|472156369|FG000|Overall Study|Insufficient clinical response|1|||
131145045|NCT01838044|472156370|FG001|Overall Study|Insufficient clinical response|2|||
131145046|NCT01838044|472156369|FG000|Overall Study|Medication error without associated AE|0|||
131145047|NCT01838044|472156370|FG001|Overall Study|Medication error without associated AE|1|||
131145048|NCT01838044|472156369|FG000|Overall Study|Lost to Follow-up|0|||
131145049|NCT01838044|472156370|FG001|Overall Study|Lost to Follow-up|2|||
131145050|NCT02928952|472156374|FG000|Overall Study|Lost to Follow-up|5|||
131145051|NCT02928952|472156375|FG001|Overall Study|Lost to Follow-up|5|||
131145052|NCT02928952|472156374|FG000|Overall Study|Withdrawal by Subject|5|||
131145053|NCT02928952|472156375|FG001|Overall Study|Withdrawal by Subject|1|||
131145054|NCT02928952|472156374|FG000|Overall Study|Physician Decision|0|||
131145055|NCT02928952|472156375|FG001|Overall Study|Physician Decision|1|||
131145056|NCT00723957|472156376|FG000|Overall Study|Adverse event unrelated to study drug|1|||
131145057|NCT00723957|472156377|FG001|Overall Study|Adverse event unrelated to study drug|4|||
131145058|NCT00723957|472156376|FG000|Overall Study|Death|3|||
131145059|NCT00723957|472156377|FG001|Overall Study|Death|4|||
131145060|NCT00723957|472156376|FG000|Overall Study|Disease progression|27|||
131145061|NCT00723957|472156377|FG001|Overall Study|Disease progression|25|||
131145062|NCT00723957|472156376|FG000|Overall Study|Maximum clinical benefit|4|||
131145063|NCT00723957|472156377|FG001|Overall Study|Maximum clinical benefit|5|||
131145064|NCT00723957|472156376|FG000|Overall Study|Investigator decision|1|||
131145065|NCT00723957|472156377|FG001|Overall Study|Investigator decision|1|||
131145066|NCT00723957|472156376|FG000|Overall Study|Study drug toxicity|4|||
131145067|NCT00723957|472156377|FG001|Overall Study|Study drug toxicity|6|||
131145068|NCT00723957|472156376|FG000|Overall Study|Withdrawal by Subject|7|||
131145069|NCT00723957|472156377|FG001|Overall Study|Withdrawal by Subject|5|||
131145070|NCT00723957|472156376|FG000|Overall Study|Reason not analyzed|1|||
131145071|NCT00723957|472156377|FG001|Overall Study|Reason not analyzed|0|||
131145072|NCT00723957|472156376|FG000|Overall Study|Never received treatment|3|||
131145073|NCT00723957|472156377|FG001|Overall Study|Never received treatment|3|||
131145074|NCT01850615|472156379|FG000|Overall Study|Protocol Violation|4|||
131145075|NCT01850615|472156380|FG001|Overall Study|Protocol Violation|1|||
131234757|NCT02799602|472486473|FG001|Overall Study|Non-compliance with study drug|12|||
131234758|NCT02799602|472486472|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
131234759|NCT02799602|472486473|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
131145076|NCT01850615|472156379|FG000|Overall Study|Adverse Event|2|||
131145077|NCT01850615|472156380|FG001|Overall Study|Adverse Event|1|||
131145078|NCT01850615|472156379|FG000|Overall Study|Withdrawal by Subject|3|||
131145079|NCT01850615|472156380|FG001|Overall Study|Withdrawal by Subject|1|||
131145080|NCT01850615|472156379|FG000|Overall Study|Lost to Follow-up|0|||
131234760|NCT02799602|472486472|FG000|Overall Study|Withdrawal by Subject|26|||
131097114|NCT03651622|471986366|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
131145081|NCT01850615|472156380|FG001|Overall Study|Lost to Follow-up|1|||
131145082|NCT01850615|472156379|FG000|Overall Study|Unclassified|0|||
131145083|NCT01850615|472156380|FG001|Overall Study|Unclassified|1|||
131145084|NCT00706628|472156381|FG000|Overall Study|Other Adverse Event|16|||
131145085|NCT00706628|472156382|FG001|Overall Study|Other Adverse Event|5|||
131145086|NCT00706628|472156383|FG002|Overall Study|Other Adverse Event|5|||
131145087|NCT00706628|472156384|FG003|Overall Study|Other Adverse Event|2|||
131145088|NCT00706628|472156381|FG000|Overall Study|Non compliant with protocol|0|||
131145089|NCT00706628|472156382|FG001|Overall Study|Non compliant with protocol|1|||
131145090|NCT00706628|472156383|FG002|Overall Study|Non compliant with protocol|0|||
131145091|NCT00706628|472156384|FG003|Overall Study|Non compliant with protocol|0|||
131145092|NCT00706628|472156381|FG000|Overall Study|Consent withdrawn|6|||
131145093|NCT00706628|472156382|FG001|Overall Study|Consent withdrawn|1|||
131145094|NCT00706628|472156383|FG002|Overall Study|Consent withdrawn|3|||
131145095|NCT00706628|472156384|FG003|Overall Study|Consent withdrawn|0|||
131145096|NCT00706628|472156381|FG000|Overall Study|Progressive disease|20|||
131145097|NCT00706628|472156382|FG001|Overall Study|Progressive disease|13|||
131145098|NCT00706628|472156383|FG002|Overall Study|Progressive disease|8|||
131145099|NCT00706628|472156384|FG003|Overall Study|Progressive disease|1|||
131145100|NCT00706628|472156381|FG000|Overall Study|Other than those stated above|4|||
131145101|NCT00706628|472156382|FG001|Overall Study|Other than those stated above|0|||
131145102|NCT00706628|472156383|FG002|Overall Study|Other than those stated above|0|||
131145103|NCT00706628|472156384|FG003|Overall Study|Other than those stated above|0|||
131145104|NCT00706628|472156381|FG000|Overall Study|Not treated|1|||
131145105|NCT00706628|472156382|FG001|Overall Study|Not treated|1|||
131145106|NCT00706628|472156383|FG002|Overall Study|Not treated|0|||
131145107|NCT00706628|472156384|FG003|Overall Study|Not treated|0|||
131145108|NCT02266433|472156389|FG000|Overall Study|Lost to Follow-up|54|||
131145109|NCT02266433|472156390|FG001|Overall Study|Lost to Follow-up|46|||
131145110|NCT02266433|472156389|FG000|Overall Study|Withdrawal by Subject|5|||
131145111|NCT02266433|472156390|FG001|Overall Study|Withdrawal by Subject|7|||
131145112|NCT04525703|472156394|FG000|Overall Study|Lost to Follow-up|6|||
131145113|NCT04525703|472156395|FG001|Overall Study|Lost to Follow-up|15|||
131097115|NCT03651622|471986364|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
131097116|NCT03651622|471986365|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
131145114|NCT04525703|472156396|FG002|Overall Study|Lost to Follow-up|8|||
131145115|NCT01285349|472156397|FG000|Overall Study|Lost to Follow-up|27|||
131145116|NCT01285349|472156398|FG001|Overall Study|Lost to Follow-up|20|||
131145117|NCT01285349|472156399|FG002|Overall Study|Lost to Follow-up|27|||
131145118|NCT00712348|472156400|FG000|Overall Study|Withdrawal by Subject|1|||
131145119|NCT01375764|472156405|FG000|Overall Study|Lost to Follow-up|0|||
131145120|NCT01375764|472156406|FG001|Overall Study|Lost to Follow-up|1|||
131145121|NCT01375764|472156407|FG002|Overall Study|Lost to Follow-up|0|||
131145122|NCT01375764|472156408|FG003|Overall Study|Lost to Follow-up|0|||
131145123|NCT01375764|472156409|FG004|Overall Study|Lost to Follow-up|0|||
131145124|NCT01375764|472156405|FG000|Overall Study|Withdrawal by Subject|2|||
131145125|NCT01375764|472156406|FG001|Overall Study|Withdrawal by Subject|0|||
131145126|NCT01375764|472156407|FG002|Overall Study|Withdrawal by Subject|0|||
131145127|NCT01375764|472156408|FG003|Overall Study|Withdrawal by Subject|0|||
131145128|NCT01375764|472156409|FG004|Overall Study|Withdrawal by Subject|1|||
131145129|NCT01375764|472156405|FG000|Overall Study|Other|0|||
131145130|NCT01375764|472156406|FG001|Overall Study|Other|0|||
131145131|NCT01375764|472156407|FG002|Overall Study|Other|0|||
131145132|NCT01375764|472156408|FG003|Overall Study|Other|1|||
131234761|NCT02799602|472486473|FG001|Overall Study|Withdrawal by Subject|40|||
130727712|NCT01609023|470625543|FG000|Overall Study|Toxicity|3|||
130727713|NCT01609023|470625543|FG000|Overall Study|Disease progression|10|||
131097117|NCT03651622|471986366|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
131097118|NCT03651622|471986364|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
131097119|NCT03651622|471986365|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
131097120|NCT03651622|471986366|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
131097121|NCT03651622|471986364|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
131097122|NCT03651622|471986365|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
131097123|NCT03651622|471986366|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
131097124|NCT01519089|471986367|FG000|Overall Study|Adverse Event|4|||
131097125|NCT01519089|471986368|FG001|Overall Study|Adverse Event|4|||
131097126|NCT01519089|471986367|FG000|Overall Study|Lack of Efficacy|0|||
131097127|NCT01519089|471986368|FG001|Overall Study|Lack of Efficacy|2|||
131097128|NCT01519089|471986367|FG000|Overall Study|Lost to Follow-up|1|||
131145133|NCT01375764|472156409|FG004|Overall Study|Other|0|||
131145134|NCT03595280|472156411|FG000|Overall Study|Lost to Follow-up|6|||
131145135|NCT03595280|472156412|FG001|Overall Study|Lost to Follow-up|9|||
131145136|NCT03595280|472156413|FG002|Overall Study|Lost to Follow-up|15|||
131145137|NCT01194440|472156414|FG000|Baseline (First Dose)|Reason not specified|4|||
131145138|NCT01194440|472156414|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
131145139|NCT01194440|472156414|FG000|Baseline (First Dose)|Change in therapy|1|||
131145140|NCT01194440|472156414|FG000|Baseline (First Dose)|Adverse Event|1|||
131234762|NCT02799602|472486472|FG000|Overall Study|Progressive disease - clinical progression|131|||
131145141|NCT01194440|472156414|FG000|6-months (2nd Dose)|Change in therapy|4|||
131145142|NCT00854828|472156415|FG000|Overall Study|Death|1|||
131145143|NCT00854828|472156416|FG001|Overall Study|Death|0|||
131145144|NCT00854828|472156417|FG002|Overall Study|Death|0|||
131145145|NCT00854828|472156418|FG003|Overall Study|Death|0|||
131234763|NCT02799602|472486473|FG001|Overall Study|Progressive disease - clinical progression|276|||
131145146|NCT00854828|472156415|FG000|Overall Study|Withdrawal by Subject|1|||
131145147|NCT00854828|472156416|FG001|Overall Study|Withdrawal by Subject|1|||
130727714|NCT01609023|470625543|FG000|Overall Study|Physician Decision|2|||
131097129|NCT01519089|471986368|FG001|Overall Study|Lost to Follow-up|0|||
131097130|NCT01519089|471986367|FG000|Overall Study|Withdrawal by Subject|0|||
131097131|NCT01519089|471986368|FG001|Overall Study|Withdrawal by Subject|2|||
131097132|NCT01519089|471986367|FG000|Overall Study|Other|2|||
131097133|NCT01519089|471986368|FG001|Overall Study|Other|6|||
131097134|NCT01519089|471986367|FG000|Overall Study|Not received study drug|0|||
131097135|NCT01519089|471986368|FG001|Overall Study|Not received study drug|1|||
131097136|NCT00127205|471986369|FG000|Overall Study|Adverse Event|228|||
131097137|NCT00127205|471986370|FG001|Overall Study|Adverse Event|387|||
131097138|NCT00127205|471986371|FG002|Overall Study|Adverse Event|273|||
131097139|NCT00127205|471986369|FG000|Overall Study|Death|8|||
131097140|NCT00127205|471986370|FG001|Overall Study|Death|6|||
131097141|NCT00127205|471986371|FG002|Overall Study|Death|5|||
131097142|NCT00127205|471986369|FG000|Overall Study|Withdrawal by Subject|318|||
131097143|NCT00127205|471986370|FG001|Overall Study|Withdrawal by Subject|310|||
131097144|NCT00127205|471986371|FG002|Overall Study|Withdrawal by Subject|172|||
131097145|NCT00127205|471986369|FG000|Overall Study|Other-non protocol specified|142|||
131097146|NCT00127205|471986370|FG001|Overall Study|Other-non protocol specified|129|||
131097147|NCT00127205|471986371|FG002|Overall Study|Other-non protocol specified|77|||
131097148|NCT00127205|471986369|FG000|Overall Study|Data not reported|6|||
131097149|NCT00127205|471986370|FG001|Overall Study|Data not reported|10|||
131097150|NCT00127205|471986371|FG002|Overall Study|Data not reported|1|||
131097151|NCT00127205|471986369|FG000|Overall Study|Progression|127|||
131097152|NCT00127205|471986370|FG001|Overall Study|Progression|131|||
131097153|NCT00127205|471986371|FG002|Overall Study|Progression|84|||
131097154|NCT03582943|471986374|FG000|Allocated to Groups|Withdrawal by Subject|1|||
131097155|NCT03582943|471986375|FG001|Allocated to Groups|Withdrawal by Subject|1|||
131097156|NCT03582943|471986374|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
131097157|NCT03582943|471986375|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
131097158|NCT03582943|471986374|FG000|Analyzed|Protocol Violation|4|||
131097159|NCT03582943|471986375|FG001|Analyzed|Protocol Violation|1|||
131097160|NCT02071290|471986376|FG000|Overall Study|Death|1|||
131097161|NCT02071290|471986377|FG001|Overall Study|Death|0|||
131097162|NCT02071290|471986376|FG000|Overall Study|Withdrawal by Subject|0|||
131097163|NCT02071290|471986377|FG001|Overall Study|Withdrawal by Subject|1|||
131097164|NCT02071290|471986376|FG000|Overall Study|Protocol Violation|3|||
131097165|NCT02071290|471986377|FG001|Overall Study|Protocol Violation|5|||
131097166|NCT02071290|471986376|FG000|Overall Study|Physician Decision|0|||
131097167|NCT02071290|471986377|FG001|Overall Study|Physician Decision|1|||
131097168|NCT05032872|471986384|FG000|Overall Study|Adverse Event|1|||
131097169|NCT05032872|471986385|FG001|Overall Study|Adverse Event|0|||
131097170|NCT05032872|471986384|FG000|Overall Study|Lost to Follow-up|2|||
131097171|NCT05032872|471986385|FG001|Overall Study|Lost to Follow-up|4|||
131097172|NCT05032872|471986384|FG000|Overall Study|Withdrawal by Subject|4|||
131097173|NCT05032872|471986385|FG001|Overall Study|Withdrawal by Subject|3|||
131097174|NCT05870228|471986386|FG000|Overall Study|Lost to Follow-up|2|||
131097175|NCT05870228|471986387|FG001|Overall Study|Lost to Follow-up|0|||
131097176|NCT05870228|471986386|FG000|Overall Study|Withdrawal by Subject|1|||
131097177|NCT05870228|471986387|FG001|Overall Study|Withdrawal by Subject|0|||
131097178|NCT00488475|471986388|FG000|Overall Study|Other|1754|||
131097179|NCT00798590|471986407|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
131097180|NCT00798590|471986408|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
131097181|NCT01280357|471986411|FG000|Overall Study|Excluded no internal monitoring|14|||
131097182|NCT01280357|471986411|FG000|Overall Study|IInsufficient data/No data supplied|12|||
131097183|NCT01259089|471986416|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
131097184|NCT01259089|471986417|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
131097185|NCT01259089|471986418|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
131097186|NCT01259089|471986419|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
131097187|NCT01259089|471986420|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
131097188|NCT01259089|471986421|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
131097189|NCT01259089|471986416|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
131097190|NCT01259089|471986417|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
131097191|NCT01259089|471986418|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
131097192|NCT01259089|471986419|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
131097193|NCT01259089|471986420|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
131097194|NCT01259089|471986421|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
131097195|NCT01259089|471986416|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
131097196|NCT01259089|471986417|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
131097197|NCT01259089|471986418|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
131097198|NCT01259089|471986419|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
131097199|NCT01259089|471986420|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
131097200|NCT01259089|471986421|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
131097201|NCT01259089|471986416|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
131097202|NCT01259089|471986417|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
131097203|NCT01259089|471986418|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
131097204|NCT01259089|471986419|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
131097205|NCT01259089|471986420|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
131097206|NCT01259089|471986421|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
131097207|NCT01259089|471986416|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
131097208|NCT01259089|471986417|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
131097209|NCT01259089|471986418|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
131097210|NCT01259089|471986419|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
131097211|NCT01259089|471986420|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
131097212|NCT01259089|471986421|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
131097213|NCT01259089|471986416|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
131097214|NCT01259089|471986417|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
131097215|NCT01259089|471986418|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
131097216|NCT01259089|471986419|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
131097217|NCT01259089|471986420|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
131097218|NCT01259089|471986421|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
131097219|NCT01259089|471986416|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
131097220|NCT01259089|471986417|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
131097221|NCT01259089|471986418|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
131097222|NCT01259089|471986419|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
131097223|NCT01259089|471986420|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
131097224|NCT01259089|471986421|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
131097225|NCT01259089|471986416|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
131097226|NCT01259089|471986417|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
131097227|NCT01259089|471986418|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
131097228|NCT01259089|471986419|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
131097229|NCT01259089|471986420|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
131097230|NCT01259089|471986421|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
131097231|NCT01259089|471986416|FG000|Survival Follow up for Two Years|Death|3|||
131097232|NCT01259089|471986417|FG001|Survival Follow up for Two Years|Death|2|||
131097233|NCT01259089|471986418|FG002|Survival Follow up for Two Years|Death|2|||
131097234|NCT01259089|471986419|FG003|Survival Follow up for Two Years|Death|3|||
131097235|NCT01259089|471986420|FG004|Survival Follow up for Two Years|Death|6|||
131097236|NCT01259089|471986421|FG005|Survival Follow up for Two Years|Death|13|||
131097237|NCT01259089|471986416|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
131097238|NCT01259089|471986417|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
131097239|NCT01259089|471986418|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
131097240|NCT01259089|471986419|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
131097241|NCT01259089|471986420|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
131097242|NCT01259089|471986421|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
131097243|NCT01259089|471986416|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
131097244|NCT01259089|471986417|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
131097245|NCT01259089|471986418|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
131097246|NCT01259089|471986419|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
131097247|NCT01259089|471986420|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
131097248|NCT01259089|471986421|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
131097249|NCT00886795|471986422|FG000|Overall Study|Lack of Efficacy|1|||
131097250|NCT02310100|471986423|FG000|Overall Study|Physician Decision|3|||
131097251|NCT02310100|471986423|FG000|Overall Study|Withdrawal by Subject|10|||
131097252|NCT02310100|471986423|FG000|Overall Study|Enrollment closure|1|||
131097253|NCT02310100|471986423|FG000|Overall Study|Unapproved ablation operator|1|||
131097254|NCT02310100|471986423|FG000|Overall Study|Visit compliance|1|||
131097255|NCT02310100|471986423|FG000|Overall Study|Lost to Follow-up|2|||
131097256|NCT00688870|471986426|FG000|Infant Series|Parent or legal guardian request|4|||
131097257|NCT00688870|471986427|FG001|Infant Series|Parent or legal guardian request|0|||
131097258|NCT01769326|471986438|FG000|Overall Study|Lost to Follow-up|1|||
131097259|NCT01769326|471986439|FG001|Overall Study|Lost to Follow-up|2|||
131145148|NCT00854828|472156417|FG002|Overall Study|Withdrawal by Subject|0|||
131145149|NCT00854828|472156418|FG003|Overall Study|Withdrawal by Subject|9|||
131145150|NCT00854828|472156415|FG000|Overall Study|Missed 24mo visit|1|||
131145151|NCT00854828|472156416|FG001|Overall Study|Missed 24mo visit|1|||
131145152|NCT00854828|472156417|FG002|Overall Study|Missed 24mo visit|8|||
131145153|NCT00854828|472156418|FG003|Overall Study|Missed 24mo visit|8|||
131145154|NCT04957290|472156420|FG000|Overall Study|Progressive disease|3|||
131145155|NCT04957290|472156421|FG001|Overall Study|Progressive disease|3|||
131145156|NCT04957290|472156422|FG002|Overall Study|Progressive disease|2|||
131145157|NCT04957290|472156423|FG003|Overall Study|Progressive disease|0|||
131145158|NCT04957290|472156424|FG004|Overall Study|Progressive disease|0|||
131097260|NCT01769326|471986440|FG002|Overall Study|Lost to Follow-up|0|||
131097261|NCT01769326|471986441|FG003|Overall Study|Lost to Follow-up|0|||
131097262|NCT01769326|471986438|FG000|Overall Study|unrelated injry|1|||
131097263|NCT01769326|471986439|FG001|Overall Study|unrelated injry|1|||
131097264|NCT01769326|471986440|FG002|Overall Study|unrelated injry|0|||
131097265|NCT01769326|471986441|FG003|Overall Study|unrelated injry|0|||
131097266|NCT01769326|471986438|FG000|Overall Study|got a job|0|||
131097267|NCT01769326|471986439|FG001|Overall Study|got a job|1|||
131097268|NCT01769326|471986440|FG002|Overall Study|got a job|0|||
131097269|NCT01769326|471986441|FG003|Overall Study|got a job|0|||
131097270|NCT01769326|471986438|FG000|Overall Study|Got sick and could not complete study|0|||
131097271|NCT01769326|471986439|FG001|Overall Study|Got sick and could not complete study|0|||
131097272|NCT01769326|471986440|FG002|Overall Study|Got sick and could not complete study|1|||
131097273|NCT01769326|471986441|FG003|Overall Study|Got sick and could not complete study|0|||
131097274|NCT01278173|471986442|FG000|Overall Study|Lack of Efficacy|13|||
131097275|NCT01278173|471986442|FG000|Overall Study|Adverse Event|8|||
131097276|NCT01278173|471986442|FG000|Overall Study|Administrative or other reason|4|||
131097277|NCT01278173|471986442|FG000|Overall Study|Protocol Violation|1|||
131097278|NCT01278173|471986442|FG000|Overall Study|Withdrawal by Subject|1|||
131097279|NCT04662931|471986444|FG000|Overall Study|Withdrawal by Subject|17|||
131097280|NCT04662931|471986444|FG000|Overall Study|Death|3|||
131097281|NCT04662931|471986444|FG000|Overall Study|Lost to Follow-up|3|||
131097282|NCT04662931|471986444|FG000|Overall Study|Guardian Decision|1|||
131097283|NCT01397422|471986446|FG000|Overall Study|Adverse Event|0|||
131097284|NCT01397422|471986447|FG001|Overall Study|Adverse Event|3|||
131097285|NCT01397422|471986448|FG002|Overall Study|Adverse Event|3|||
131097286|NCT01397422|471986449|FG003|Overall Study|Adverse Event|8|||
131097287|NCT01397422|471986446|FG000|Overall Study|Withdrawal by Subject|1|||
131097288|NCT01397422|471986447|FG001|Overall Study|Withdrawal by Subject|0|||
131097289|NCT01397422|471986448|FG002|Overall Study|Withdrawal by Subject|0|||
131097290|NCT01397422|471986449|FG003|Overall Study|Withdrawal by Subject|0|||
131097291|NCT01397422|471986446|FG000|Overall Study|Increased bradykinesia related to PD|1|||
131097292|NCT01397422|471986447|FG001|Overall Study|Increased bradykinesia related to PD|0|||
131097293|NCT01397422|471986448|FG002|Overall Study|Increased bradykinesia related to PD|0|||
131097294|NCT01397422|471986449|FG003|Overall Study|Increased bradykinesia related to PD|0|||
131097295|NCT05051462|471986450|FG000|Overall Study|Lost to Follow-up|1|||
131097296|NCT05051462|471986451|FG001|Overall Study|Lost to Follow-up|8|||
131097297|NCT05051462|471986450|FG000|Overall Study|Withdrawal by Subject|1|||
131097298|NCT05051462|471986451|FG001|Overall Study|Withdrawal by Subject|0|||
131097299|NCT05051462|471986450|FG000|Overall Study|Protocol Violation|0|||
131097300|NCT05051462|471986451|FG001|Overall Study|Protocol Violation|2|||
131097301|NCT05148962|471986452|FG000|Overall Study|Withdrawal by Subject|1|||
131097302|NCT05148962|471986453|FG001|Overall Study|Withdrawal by Subject|1|||
131097303|NCT05148962|471986454|FG002|Overall Study|Withdrawal by Subject|0|||
131097304|NCT05148962|471986455|FG003|Overall Study|Withdrawal by Subject|1|||
131097305|NCT05148962|471986456|FG004|Overall Study|Withdrawal by Subject|0|||
131097306|NCT05148962|471986452|FG000|Overall Study|Participant was early terminated per protocol|0|||
131097307|NCT05148962|471986453|FG001|Overall Study|Participant was early terminated per protocol|0|||
131097308|NCT05148962|471986454|FG002|Overall Study|Participant was early terminated per protocol|3|||
131097309|NCT05148962|471986455|FG003|Overall Study|Participant was early terminated per protocol|5|||
131097310|NCT05148962|471986456|FG004|Overall Study|Participant was early terminated per protocol|2|||
131097311|NCT05148962|471986452|FG000|Overall Study|Miscellaneous|0|||
131097312|NCT05148962|471986453|FG001|Overall Study|Miscellaneous|0|||
131097313|NCT05148962|471986454|FG002|Overall Study|Miscellaneous|0|||
131097314|NCT05148962|471986455|FG003|Overall Study|Miscellaneous|1|||
131097315|NCT05148962|471986456|FG004|Overall Study|Miscellaneous|0|||
131097316|NCT01200290|471986457|FG000|Treatment Period|Adverse Event|1|||
131097317|NCT01200290|471986457|FG000|Post-Treatment Follow-Up Period|Death|2|||
131097318|NCT01144377|471986458|FG000|52 Week Treatment Period|Adverse Event|0|||
131097319|NCT01144377|471986459|FG001|52 Week Treatment Period|Adverse Event|0|||
131097320|NCT01144377|471986460|FG002|52 Week Treatment Period|Adverse Event|3|||
131097321|NCT01144377|471986461|FG003|52 Week Treatment Period|Adverse Event|2|||
131097322|NCT01144377|471986462|FG004|52 Week Treatment Period|Adverse Event|1|||
131097323|NCT01144377|471986458|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
131097324|NCT01144377|471986459|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
131097325|NCT01144377|471986460|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
130727715|NCT01609023|470625543|FG000|Overall Study|Death|2|||
131097326|NCT01144377|471986461|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
131097327|NCT01144377|471986462|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
131097328|NCT01144377|471986458|FG000|52 Week Treatment Period|Protocol Violation|0|||
131097329|NCT01144377|471986459|FG001|52 Week Treatment Period|Protocol Violation|0|||
131097330|NCT01144377|471986460|FG002|52 Week Treatment Period|Protocol Violation|0|||
130727716|NCT01609023|470625543|FG000|Overall Study|Personal reasons|1|||
131097331|NCT01144377|471986461|FG003|52 Week Treatment Period|Protocol Violation|0|||
131097332|NCT01144377|471986462|FG004|52 Week Treatment Period|Protocol Violation|1|||
131097333|NCT01144377|471986458|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
131097334|NCT01144377|471986459|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
131097335|NCT01144377|471986460|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
131097336|NCT01144377|471986461|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
131097337|NCT01144377|471986462|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
131097338|NCT01144377|471986458|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
131097339|NCT01144377|471986459|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
131097340|NCT01144377|471986460|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
131097341|NCT01144377|471986461|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
131097342|NCT01144377|471986462|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
131097343|NCT01144377|471986458|FG000|52 Week Treatment Period|Sponsor Decision|0|||
131097344|NCT01144377|471986459|FG001|52 Week Treatment Period|Sponsor Decision|0|||
131097345|NCT01144377|471986460|FG002|52 Week Treatment Period|Sponsor Decision|0|||
131097346|NCT01144377|471986461|FG003|52 Week Treatment Period|Sponsor Decision|0|||
131097347|NCT01144377|471986462|FG004|52 Week Treatment Period|Sponsor Decision|1|||
131097348|NCT01144377|471986458|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
131097349|NCT01144377|471986459|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
131097350|NCT01144377|471986460|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
131097351|NCT01144377|471986461|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
131097352|NCT01144377|471986462|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
131145159|NCT04957290|472156425|FG005|Overall Study|Progressive disease|0|||
131145160|NCT04957290|472156420|FG000|Overall Study|Withdrawal by Subject|1|||
131145161|NCT04957290|472156421|FG001|Overall Study|Withdrawal by Subject|0|||
131145162|NCT04957290|472156422|FG002|Overall Study|Withdrawal by Subject|1|||
131145163|NCT04957290|472156423|FG003|Overall Study|Withdrawal by Subject|0|||
131145164|NCT04957290|472156424|FG004|Overall Study|Withdrawal by Subject|0|||
131145165|NCT04957290|472156425|FG005|Overall Study|Withdrawal by Subject|0|||
131145166|NCT04957290|472156420|FG000|Overall Study|Death|0|||
131145167|NCT04957290|472156421|FG001|Overall Study|Death|2|||
131145168|NCT04957290|472156422|FG002|Overall Study|Death|1|||
131145169|NCT04957290|472156423|FG003|Overall Study|Death|0|||
131145170|NCT04957290|472156424|FG004|Overall Study|Death|0|||
131145171|NCT04957290|472156425|FG005|Overall Study|Death|0|||
131145172|NCT04957290|472156420|FG000|Overall Study|non compliance with study drug|0|||
131145173|NCT04957290|472156421|FG001|Overall Study|non compliance with study drug|1|||
131145174|NCT04957290|472156422|FG002|Overall Study|non compliance with study drug|0|||
131145175|NCT04957290|472156423|FG003|Overall Study|non compliance with study drug|0|||
131145176|NCT04957290|472156424|FG004|Overall Study|non compliance with study drug|0|||
131145177|NCT04957290|472156425|FG005|Overall Study|non compliance with study drug|0|||
131145178|NCT04957290|472156420|FG000|Overall Study|none specified.|0|||
131145179|NCT04957290|472156421|FG001|Overall Study|none specified.|1|||
131145180|NCT04957290|472156422|FG002|Overall Study|none specified.|2|||
131145181|NCT04957290|472156423|FG003|Overall Study|none specified.|0|||
131145182|NCT04957290|472156424|FG004|Overall Study|none specified.|0|||
131145183|NCT04957290|472156425|FG005|Overall Study|none specified.|0|||
131145184|NCT04957290|472156420|FG000|Overall Study|unacceptable toxicity|0|||
131145185|NCT04957290|472156421|FG001|Overall Study|unacceptable toxicity|0|||
131145186|NCT04957290|472156422|FG002|Overall Study|unacceptable toxicity|1|||
131145187|NCT04957290|472156423|FG003|Overall Study|unacceptable toxicity|0|||
131145188|NCT04957290|472156424|FG004|Overall Study|unacceptable toxicity|0|||
131145189|NCT04957290|472156425|FG005|Overall Study|unacceptable toxicity|0|||
131145190|NCT04957290|472156420|FG000|Overall Study|Adverse Event|0|||
131145191|NCT04957290|472156421|FG001|Overall Study|Adverse Event|0|||
131145192|NCT04957290|472156422|FG002|Overall Study|Adverse Event|1|||
131145193|NCT04957290|472156423|FG003|Overall Study|Adverse Event|0|||
131145194|NCT04957290|472156424|FG004|Overall Study|Adverse Event|0|||
131145195|NCT04957290|472156425|FG005|Overall Study|Adverse Event|0|||
131145196|NCT04957290|472156420|FG000|Overall Study|study terminated by sponsor|0|||
131145197|NCT04957290|472156421|FG001|Overall Study|study terminated by sponsor|0|||
131145198|NCT04957290|472156422|FG002|Overall Study|study terminated by sponsor|2|||
131097353|NCT01144377|471986458|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
131097354|NCT01144377|471986459|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
131145199|NCT04957290|472156423|FG003|Overall Study|study terminated by sponsor|0|||
131145200|NCT04957290|472156424|FG004|Overall Study|study terminated by sponsor|0|||
131145201|NCT04957290|472156425|FG005|Overall Study|study terminated by sponsor|0|||
131145202|NCT00896532|472156426|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145203|NCT00896532|472156427|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131097355|NCT01144377|471986460|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
131145204|NCT00896532|472156428|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145205|NCT00896532|472156429|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
131145206|NCT00896532|472156430|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145207|NCT00896532|472156431|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
131145208|NCT00896532|472156432|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145209|NCT00896532|472156433|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145210|NCT00896532|472156434|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145211|NCT00896532|472156435|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145212|NCT00896532|472156436|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145213|NCT00896532|472156437|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145214|NCT00896532|472156438|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145215|NCT00896532|472156439|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145216|NCT00896532|472156440|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145217|NCT00896532|472156441|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145218|NCT00896532|472156442|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145219|NCT00896532|472156443|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145220|NCT00896532|472156444|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145221|NCT00896532|472156445|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145222|NCT00896532|472156446|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145223|NCT00896532|472156447|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145224|NCT00896532|472156448|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
131145225|NCT00896532|472156426|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
131145226|NCT00896532|472156427|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
131145227|NCT00896532|472156428|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
131145228|NCT00896532|472156429|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
131145229|NCT00896532|472156430|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
131145230|NCT00896532|472156431|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
131145231|NCT00896532|472156432|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
131145232|NCT00896532|472156433|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145233|NCT00896532|472156434|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145234|NCT00896532|472156435|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145235|NCT00896532|472156436|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145236|NCT00896532|472156437|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145237|NCT00896532|472156438|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145238|NCT00896532|472156439|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145239|NCT00896532|472156440|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145240|NCT00896532|472156441|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145241|NCT00896532|472156442|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145242|NCT00896532|472156443|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145243|NCT00896532|472156444|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145244|NCT00896532|472156445|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145245|NCT00896532|472156446|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145246|NCT00896532|472156447|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145247|NCT00896532|472156448|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
131145248|NCT00896532|472156426|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
131145249|NCT00896532|472156427|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
131145250|NCT00896532|472156428|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
131145251|NCT00896532|472156429|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
131145252|NCT00896532|472156430|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
131145253|NCT00896532|472156431|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
131145254|NCT00896532|472156432|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
131145255|NCT00896532|472156433|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
131145256|NCT00896532|472156434|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145257|NCT00896532|472156435|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145258|NCT00896532|472156436|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145259|NCT00896532|472156437|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145260|NCT00896532|472156438|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145261|NCT00896532|472156439|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145262|NCT00896532|472156440|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145263|NCT00896532|472156441|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145264|NCT00896532|472156442|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145265|NCT00896532|472156443|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145266|NCT00896532|472156444|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145267|NCT00896532|472156445|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131234764|NCT02799602|472486472|FG000|Overall Study|Progressive disease - radiological progression|90|||
130727717|NCT02952586|470625548|FG000|Lead-In Phase (7 Days)|Death|0|||
130727718|NCT02952586|470625549|FG001|Lead-In Phase (7 Days)|Death|1|||
130727719|NCT02952586|470625548|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
131097356|NCT01144377|471986461|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
131097357|NCT01144377|471986462|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
131097358|NCT01144377|471986458|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
131097359|NCT01144377|471986459|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
131097360|NCT01144377|471986460|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
131097361|NCT01144377|471986461|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
131097362|NCT01144377|471986462|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
131097363|NCT00151281|471986463|FG000|Overall Study|Not evaluable|3|||
131097364|NCT04150068|471986464|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
131097365|NCT04150068|471986465|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
131097366|NCT04150068|471986466|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
131097367|NCT04150068|471986464|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
131097368|NCT04150068|471986465|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
131097369|NCT04150068|471986466|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
131097370|NCT00836745|471987816|FG000|Overall Study|Death|2|||
131097371|NCT00836745|471987816|FG000|Overall Study|Lost to Follow-up|10|||
131097372|NCT00836745|471987816|FG000|Overall Study|Adverse Event|3|||
131097373|NCT00836745|471987816|FG000|Overall Study|Objective progression or relapse|4|||
131097374|NCT00836745|471987816|FG000|Overall Study|Other|2|||
131097375|NCT02898077|471987818|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
131097376|NCT02898077|471987819|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
131097377|NCT02898077|471987818|FG000|Overall Study|Lost to Follow-up|4|||
131097378|NCT02898077|471987819|FG001|Overall Study|Lost to Follow-up|3|||
131097379|NCT02898077|471987818|FG000|Overall Study|Physician Decision|0|||
131097380|NCT02898077|471987819|FG001|Overall Study|Physician Decision|2|||
131097381|NCT02898077|471987818|FG000|Overall Study|Sponsor Decision|32|||
131097382|NCT02898077|471987819|FG001|Overall Study|Sponsor Decision|13|||
131097383|NCT02898077|471987818|FG000|Overall Study|Withdrawal by Subject|6|||
131097384|NCT02898077|471987819|FG001|Overall Study|Withdrawal by Subject|3|||
131097385|NCT02898077|471987818|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
131097386|NCT02898077|471987819|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
131097387|NCT02898077|471987818|FG000|Overall Study|Ended extension period|3|||
131097388|NCT02898077|471987819|FG001|Overall Study|Ended extension period|0|||
131097389|NCT00621777|471987820|FG000|Open Phase|Adverse Event|20|||
131097390|NCT00621777|471987821|FG001|Open Phase|Adverse Event|0|||
131097391|NCT00621777|471987820|FG000|Open Phase|Did not abstain during open phase|56|||
131097392|NCT00621777|471987821|FG001|Open Phase|Did not abstain during open phase|0|||
131097393|NCT00621777|471987820|FG000|Open Phase|Withdrawal by Subject|17|||
131097394|NCT00621777|471987821|FG001|Open Phase|Withdrawal by Subject|0|||
131097395|NCT00621777|471987820|FG000|Open Phase|administrative|13|||
131097396|NCT00621777|471987821|FG001|Open Phase|administrative|0|||
131097397|NCT00621777|471987820|FG000|Open Phase|Lost to Follow-up|10|||
131097398|NCT00621777|471987821|FG001|Open Phase|Lost to Follow-up|0|||
131097399|NCT00621777|471987820|FG000|Randomized Phase|Adverse Event|3|||
131097400|NCT00621777|471987821|FG001|Randomized Phase|Adverse Event|3|||
131097401|NCT00621777|471987820|FG000|Randomized Phase|Lost to Follow-up|3|||
131097402|NCT00621777|471987821|FG001|Randomized Phase|Lost to Follow-up|3|||
131097403|NCT00621777|471987820|FG000|Randomized Phase|Withdrawal by Subject|1|||
131097404|NCT00621777|471987821|FG001|Randomized Phase|Withdrawal by Subject|9|||
131097405|NCT00621777|471987820|FG000|Randomized Phase|administrative|0|||
130727720|NCT02952586|470625549|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
130727721|NCT02952586|470625548|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
131097406|NCT00621777|471987821|FG001|Randomized Phase|administrative|3|||
131097407|NCT00621777|471987820|FG000|Randomized Phase|Death|0|||
131097408|NCT00621777|471987821|FG001|Randomized Phase|Death|1|||
131097409|NCT00490490|471987822|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
131097410|NCT00490490|471987822|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
131097411|NCT01239043|471987823|FG000|Overall Study|Protocol Violation|2|||
131097412|NCT01239043|471987824|FG001|Overall Study|Protocol Violation|1|||
131097413|NCT02121301|471987827|FG000|Overall Study|Protocol Violation|1|||
131097414|NCT02121301|471987828|FG001|Overall Study|Protocol Violation|4|||
131097415|NCT02121301|471987829|FG002|Overall Study|Protocol Violation|1|||
131097416|NCT00473265|471987830|FG000|Overall Study|Unrelated adverse event|5|||
131097417|NCT00473265|471987830|FG000|Overall Study|Off treatment early|15|||
131097418|NCT02663518|471987838|FG000|Part 1: Phase 1a Escalation|Death|0|||
131097419|NCT02663518|471987839|FG001|Part 1: Phase 1a Escalation|Death|0|||
131097420|NCT02663518|471987840|FG002|Part 1: Phase 1a Escalation|Death|1|||
131097421|NCT02663518|471987841|FG003|Part 1: Phase 1a Escalation|Death|0|||
131097422|NCT02663518|471987842|FG004|Part 1: Phase 1a Escalation|Death|0|||
131097423|NCT02663518|471987843|FG005|Part 1: Phase 1a Escalation|Death|0|||
131097424|NCT02663518|471987844|FG006|Part 1: Phase 1a Escalation|Death|0|||
131097425|NCT02663518|471987845|FG007|Part 1: Phase 1a Escalation|Death|0|||
131097426|NCT02663518|471987846|FG008|Part 1: Phase 1a Escalation|Death|0|||
131097427|NCT02663518|471987847|FG009|Part 1: Phase 1a Escalation|Death|0|||
131097428|NCT02663518|471987848|FG010|Part 1: Phase 1a Escalation|Death|0|||
131097429|NCT02663518|471987849|FG011|Part 1: Phase 1a Escalation|Death|0|||
131234765|NCT02799602|472486473|FG001|Overall Study|Progressive disease - radiological progression|133|||
131234766|NCT02799602|472486472|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
131234767|NCT02799602|472486473|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
131234768|NCT02799602|472486472|FG000|Overall Study|Death|9|||
131097430|NCT02663518|471987850|FG012|Part 1: Phase 1a Escalation|Death|0|||
131097431|NCT02663518|471987851|FG013|Part 1: Phase 1a Escalation|Death|0|||
131097432|NCT02663518|471987838|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097433|NCT02663518|471987839|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097434|NCT02663518|471987840|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
131097435|NCT02663518|471987841|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097436|NCT02663518|471987842|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097437|NCT02663518|471987843|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097438|NCT02663518|471987844|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097439|NCT02663518|471987845|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097440|NCT02663518|471987846|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097441|NCT02663518|471987847|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097442|NCT02663518|471987848|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097443|NCT02663518|471987849|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097444|NCT02663518|471987850|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097445|NCT02663518|471987851|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
131097446|NCT02663518|471987838|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
131097447|NCT02663518|471987839|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
131097448|NCT02663518|471987840|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
131097449|NCT02663518|471987841|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
131097450|NCT02663518|471987842|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131097451|NCT02663518|471987843|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131097452|NCT02663518|471987844|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131097453|NCT02663518|471987845|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131097454|NCT02663518|471987846|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131097455|NCT02663518|471987847|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131097456|NCT02663518|471987848|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131097457|NCT02663518|471987849|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131097458|NCT02663518|471987850|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131097459|NCT02663518|471987851|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
131097460|NCT02663518|471987838|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
131097461|NCT02663518|471987839|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097462|NCT02663518|471987840|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
131097463|NCT02663518|471987841|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
131097464|NCT02663518|471987842|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097465|NCT02663518|471987843|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097466|NCT02663518|471987844|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097467|NCT02663518|471987845|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097468|NCT02663518|471987846|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097469|NCT02663518|471987847|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097470|NCT02663518|471987848|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097471|NCT02663518|471987849|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097472|NCT02663518|471987850|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097473|NCT02663518|471987851|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
131097474|NCT02663518|471987838|FG000|Part 1: Phase 1a Escalation|Other|0|||
131097475|NCT02663518|471987839|FG001|Part 1: Phase 1a Escalation|Other|0|||
131097476|NCT02663518|471987840|FG002|Part 1: Phase 1a Escalation|Other|2|||
131097477|NCT02663518|471987841|FG003|Part 1: Phase 1a Escalation|Other|0|||
131097478|NCT02663518|471987842|FG004|Part 1: Phase 1a Escalation|Other|0|||
131097479|NCT02663518|471987843|FG005|Part 1: Phase 1a Escalation|Other|0|||
131097480|NCT02663518|471987844|FG006|Part 1: Phase 1a Escalation|Other|0|||
131097481|NCT02663518|471987845|FG007|Part 1: Phase 1a Escalation|Other|0|||
131097482|NCT02663518|471987846|FG008|Part 1: Phase 1a Escalation|Other|0|||
131097483|NCT02663518|471987847|FG009|Part 1: Phase 1a Escalation|Other|0|||
131097484|NCT02663518|471987848|FG010|Part 1: Phase 1a Escalation|Other|0|||
131097485|NCT02663518|471987849|FG011|Part 1: Phase 1a Escalation|Other|0|||
131097486|NCT02663518|471987850|FG012|Part 1: Phase 1a Escalation|Other|0|||
131234769|NCT02799602|472486473|FG001|Overall Study|Death|5|||
131097487|NCT02663518|471987851|FG013|Part 1: Phase 1a Escalation|Other|0|||
131234770|NCT02799602|472486472|FG000|Overall Study|Other|287|||
131097488|NCT02663518|471987838|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
131097489|NCT02663518|471987839|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
131097490|NCT02663518|471987840|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
131097491|NCT02663518|471987841|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
130727722|NCT02952586|470625549|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
131097492|NCT02663518|471987842|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
131097493|NCT02663518|471987843|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
131234771|NCT02799602|472486473|FG001|Overall Study|Other|118|||
131145268|NCT00896532|472156446|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145269|NCT00896532|472156447|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145270|NCT00896532|472156448|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
131145271|NCT00896532|472156426|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145272|NCT00896532|472156427|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145273|NCT00896532|472156428|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
131145274|NCT00896532|472156429|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145275|NCT00896532|472156430|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
131145276|NCT00896532|472156431|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145277|NCT00896532|472156432|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145278|NCT00896532|472156433|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145279|NCT00896532|472156434|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145280|NCT00896532|472156435|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145281|NCT00896532|472156436|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145282|NCT00896532|472156437|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145283|NCT00896532|472156438|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145284|NCT00896532|472156439|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145285|NCT00896532|472156440|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145286|NCT00896532|472156441|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145287|NCT00896532|472156442|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145288|NCT00896532|472156443|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145289|NCT00896532|472156444|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145290|NCT00896532|472156445|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145291|NCT00896532|472156446|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145292|NCT00896532|472156447|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145293|NCT00896532|472156448|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
131145294|NCT00896532|472156426|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
131145295|NCT00896532|472156427|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145296|NCT00896532|472156428|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145297|NCT00896532|472156429|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
131145298|NCT00896532|472156430|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145299|NCT00896532|472156431|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145300|NCT00896532|472156432|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145301|NCT00896532|472156433|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145302|NCT00896532|472156434|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145303|NCT00896532|472156435|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145304|NCT00896532|472156436|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145305|NCT00896532|472156437|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145306|NCT00896532|472156438|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145307|NCT00896532|472156439|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145308|NCT00896532|472156440|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145309|NCT00896532|472156441|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145310|NCT00896532|472156442|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145311|NCT00896532|472156443|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145312|NCT00896532|472156444|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145313|NCT00896532|472156445|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145314|NCT00896532|472156446|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145315|NCT00896532|472156447|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145316|NCT00896532|472156448|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
131145317|NCT00896532|472156426|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145318|NCT00896532|472156427|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145319|NCT00896532|472156428|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
131145320|NCT00896532|472156429|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145321|NCT00896532|472156430|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145322|NCT00896532|472156431|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145323|NCT00896532|472156432|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145324|NCT00896532|472156433|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145325|NCT00896532|472156434|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145326|NCT00896532|472156435|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145327|NCT00896532|472156436|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145328|NCT00896532|472156437|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145329|NCT00896532|472156438|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145330|NCT00896532|472156439|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130727723|NCT02952586|470625548|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
131097494|NCT02663518|471987844|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
131097495|NCT02663518|471987845|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
131097496|NCT02663518|471987846|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
131097497|NCT02663518|471987847|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
131097498|NCT02663518|471987848|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
131097499|NCT02663518|471987849|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
131097500|NCT02663518|471987850|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
131097501|NCT02663518|471987851|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
131097502|NCT02663518|471987838|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097503|NCT02663518|471987839|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097504|NCT02663518|471987840|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097505|NCT02663518|471987841|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097506|NCT02663518|471987842|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
131097507|NCT02663518|471987843|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097508|NCT02663518|471987844|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
131097509|NCT02663518|471987845|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
131097510|NCT02663518|471987846|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097511|NCT02663518|471987847|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097512|NCT02663518|471987848|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097513|NCT02663518|471987849|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097514|NCT02663518|471987850|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097515|NCT02663518|471987851|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
131097516|NCT02663518|471987838|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097517|NCT02663518|471987839|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097518|NCT02663518|471987840|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097519|NCT02663518|471987841|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097520|NCT02663518|471987842|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
131097521|NCT02663518|471987843|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097522|NCT02663518|471987844|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097523|NCT02663518|471987845|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097524|NCT02663518|471987846|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097525|NCT02663518|471987847|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097526|NCT02663518|471987848|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097527|NCT02663518|471987849|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097528|NCT02663518|471987850|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097529|NCT02663518|471987851|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
131097530|NCT02663518|471987838|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131097531|NCT02663518|471987839|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131097532|NCT02663518|471987840|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131097533|NCT02663518|471987841|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131097534|NCT02663518|471987842|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
131097535|NCT02663518|471987843|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
131097536|NCT02663518|471987844|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
131097537|NCT02663518|471987845|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
131097538|NCT02663518|471987846|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131097539|NCT02663518|471987847|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131097540|NCT02663518|471987848|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131097541|NCT02663518|471987849|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131097542|NCT02663518|471987850|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131097543|NCT02663518|471987851|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
131097544|NCT02663518|471987838|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
131097545|NCT02663518|471987839|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
131097546|NCT02663518|471987840|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
131097547|NCT02663518|471987841|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
131097548|NCT02663518|471987842|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
131097549|NCT02663518|471987843|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
131097550|NCT02663518|471987844|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
131097551|NCT02663518|471987845|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
131097552|NCT02663518|471987846|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
131097553|NCT02663518|471987847|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
131097554|NCT02663518|471987848|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
131097555|NCT02663518|471987849|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
131145331|NCT00896532|472156440|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145332|NCT00896532|472156441|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130727724|NCT02952586|470625549|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
131097556|NCT02663518|471987850|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
131097557|NCT02663518|471987851|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
131145333|NCT00896532|472156442|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145334|NCT00896532|472156443|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145335|NCT00896532|472156444|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145336|NCT00896532|472156445|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145337|NCT00896532|472156446|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145338|NCT00896532|472156447|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145339|NCT00896532|472156448|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
131145340|NCT00896532|472156426|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145341|NCT00896532|472156427|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145342|NCT00896532|472156428|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
130727725|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
130727726|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
130727727|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
130727728|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
130727729|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
130727730|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
130727731|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
130780287|NCT00128661|470821481|FG000|Overall Study|Other|7|||
131145343|NCT00896532|472156429|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145344|NCT00896532|472156430|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145345|NCT00896532|472156431|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145346|NCT00896532|472156432|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145347|NCT00896532|472156433|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145348|NCT00896532|472156434|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145349|NCT00896532|472156435|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145350|NCT00896532|472156436|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145351|NCT00896532|472156437|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145352|NCT00896532|472156438|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145353|NCT00896532|472156439|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145354|NCT00896532|472156440|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145355|NCT00896532|472156441|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145356|NCT00896532|472156442|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145357|NCT00896532|472156443|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145358|NCT00896532|472156444|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145359|NCT00896532|472156445|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145360|NCT00896532|472156446|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145361|NCT00896532|472156447|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145362|NCT00896532|472156448|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
131145363|NCT00896532|472156426|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145364|NCT00896532|472156427|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145365|NCT00896532|472156428|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145366|NCT00896532|472156429|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
131145367|NCT00896532|472156430|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145368|NCT00896532|472156431|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145369|NCT00896532|472156432|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145370|NCT00896532|472156433|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145371|NCT00896532|472156434|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145372|NCT00896532|472156435|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145373|NCT00896532|472156436|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145374|NCT00896532|472156437|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145375|NCT00896532|472156438|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145376|NCT00896532|472156439|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145377|NCT00896532|472156440|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145378|NCT00896532|472156441|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145379|NCT00896532|472156442|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145380|NCT00896532|472156443|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145381|NCT00896532|472156444|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145382|NCT00896532|472156445|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145383|NCT00896532|472156446|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145384|NCT00896532|472156447|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145385|NCT00896532|472156448|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
131145386|NCT00896532|472156426|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145387|NCT00896532|472156427|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
131145388|NCT00896532|472156428|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145389|NCT00896532|472156429|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
131145390|NCT00896532|472156430|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
131145391|NCT00896532|472156431|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145392|NCT00896532|472156432|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145393|NCT00896532|472156433|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145394|NCT00896532|472156434|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145395|NCT00896532|472156435|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145396|NCT00896532|472156436|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145397|NCT00896532|472156437|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145398|NCT00896532|472156438|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145399|NCT00896532|472156439|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145400|NCT00896532|472156440|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145401|NCT00896532|472156441|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145402|NCT00896532|472156442|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145403|NCT00896532|472156443|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145404|NCT00896532|472156444|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145405|NCT00896532|472156445|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145406|NCT00896532|472156446|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145407|NCT00896532|472156447|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145408|NCT00896532|472156448|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
131145409|NCT00896532|472156426|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145410|NCT00896532|472156427|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130727732|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
130727733|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
130727734|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
131145411|NCT00896532|472156428|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145412|NCT00896532|472156429|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145413|NCT00896532|472156430|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145414|NCT00896532|472156431|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145415|NCT00896532|472156432|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145416|NCT00896532|472156433|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145417|NCT00896532|472156434|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
131145418|NCT00896532|472156435|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145419|NCT00896532|472156436|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145420|NCT00896532|472156437|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145421|NCT00896532|472156438|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145422|NCT00896532|472156439|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145423|NCT00896532|472156440|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145424|NCT00896532|472156441|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145425|NCT00896532|472156442|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145426|NCT00896532|472156443|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145427|NCT00896532|472156444|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145428|NCT00896532|472156445|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145429|NCT00896532|472156446|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145430|NCT00896532|472156447|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145431|NCT00896532|472156448|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
131145432|NCT00896532|472156426|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145433|NCT00896532|472156427|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145434|NCT00896532|472156428|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145435|NCT00896532|472156429|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145436|NCT00896532|472156430|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145437|NCT00896532|472156431|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145438|NCT00896532|472156432|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145439|NCT00896532|472156433|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145440|NCT00896532|472156434|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145441|NCT00896532|472156435|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145442|NCT00896532|472156436|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145443|NCT00896532|472156437|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145444|NCT00896532|472156438|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
131145445|NCT00896532|472156439|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145446|NCT00896532|472156440|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130727735|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
131145447|NCT00896532|472156441|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145448|NCT00896532|472156442|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145449|NCT00896532|472156443|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145450|NCT00896532|472156444|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145451|NCT00896532|472156445|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145452|NCT00896532|472156446|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145453|NCT00896532|472156447|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145454|NCT00896532|472156448|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
131145455|NCT00896532|472156426|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145456|NCT00896532|472156427|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145457|NCT00896532|472156428|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145458|NCT00896532|472156429|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145459|NCT00896532|472156430|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145460|NCT00896532|472156431|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145461|NCT00896532|472156432|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145462|NCT00896532|472156433|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145463|NCT00896532|472156434|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145464|NCT00896532|472156435|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145465|NCT00896532|472156436|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
131145466|NCT00896532|472156437|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145467|NCT00896532|472156438|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
131145468|NCT00896532|472156439|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145469|NCT00896532|472156440|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145470|NCT00896532|472156441|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145471|NCT00896532|472156442|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145472|NCT00896532|472156443|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145473|NCT00896532|472156444|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145474|NCT00896532|472156445|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145475|NCT00896532|472156446|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145476|NCT00896532|472156447|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145477|NCT00896532|472156448|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
131145478|NCT00896532|472156426|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145479|NCT00896532|472156427|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145480|NCT00896532|472156428|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145481|NCT00896532|472156429|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145482|NCT00896532|472156430|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145483|NCT00896532|472156431|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145484|NCT00896532|472156432|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145485|NCT00896532|472156433|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145486|NCT00896532|472156434|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145487|NCT00896532|472156435|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145488|NCT00896532|472156436|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145489|NCT00896532|472156437|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145490|NCT00896532|472156438|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
131145491|NCT00896532|472156439|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
131145492|NCT00896532|472156440|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145493|NCT00896532|472156441|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130727736|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
130727737|NCT02952586|470625548|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
131145494|NCT00896532|472156442|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145495|NCT00896532|472156443|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145496|NCT00896532|472156444|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145497|NCT00896532|472156445|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145498|NCT00896532|472156446|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145499|NCT00896532|472156447|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145500|NCT00896532|472156448|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
131145501|NCT00896532|472156426|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
131145502|NCT00896532|472156427|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
131145503|NCT00896532|472156428|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
131145504|NCT00896532|472156429|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
131145505|NCT00896532|472156430|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
131145506|NCT00896532|472156431|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
130727738|NCT02952586|470625549|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
130727739|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Death|3|||
130727740|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Death|8|||
130727741|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
131145507|NCT00896532|472156432|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
131145508|NCT00896532|472156433|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
131145509|NCT00896532|472156434|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
131145510|NCT00896532|472156435|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
131145511|NCT00896532|472156436|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
131145512|NCT00896532|472156437|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
131145513|NCT00896532|472156438|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
131145514|NCT00896532|472156439|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
131145515|NCT00896532|472156440|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
131145516|NCT00896532|472156441|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
131145517|NCT00896532|472156442|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
131145518|NCT00896532|472156443|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
131145519|NCT00896532|472156444|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
131145520|NCT00896532|472156445|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
131145521|NCT00896532|472156446|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
131145522|NCT00896532|472156447|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
131145523|NCT00896532|472156448|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
131145524|NCT00896532|472156426|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145525|NCT00896532|472156427|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145526|NCT00896532|472156428|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145527|NCT00896532|472156429|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145528|NCT00896532|472156430|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145529|NCT00896532|472156431|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145530|NCT00896532|472156432|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145531|NCT00896532|472156433|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145532|NCT00896532|472156434|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145533|NCT00896532|472156435|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145534|NCT00896532|472156436|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145535|NCT00896532|472156437|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145536|NCT00896532|472156438|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145537|NCT00896532|472156439|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145538|NCT00896532|472156440|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145539|NCT00896532|472156441|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
131145540|NCT00896532|472156442|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
131145541|NCT00896532|472156443|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145542|NCT00896532|472156444|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145543|NCT00896532|472156445|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145544|NCT00896532|472156446|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145545|NCT00896532|472156447|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145546|NCT00896532|472156448|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
131145547|NCT00896532|472156426|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145548|NCT00896532|472156427|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145549|NCT00896532|472156428|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145550|NCT00896532|472156429|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145551|NCT00896532|472156430|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145552|NCT00896532|472156431|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145553|NCT00896532|472156432|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145554|NCT00896532|472156433|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145555|NCT00896532|472156434|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145556|NCT00896532|472156435|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145557|NCT00896532|472156436|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145558|NCT00896532|472156437|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145559|NCT00896532|472156438|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145560|NCT00896532|472156439|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145561|NCT00896532|472156440|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145562|NCT00896532|472156441|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
131145563|NCT00896532|472156442|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
131145564|NCT00896532|472156443|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
131145565|NCT00896532|472156444|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145566|NCT00896532|472156445|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145567|NCT00896532|472156446|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145568|NCT00896532|472156447|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145569|NCT00896532|472156448|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
131145570|NCT00896532|472156426|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145571|NCT00896532|472156427|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131097558|NCT02663518|471987838|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097559|NCT02663518|471987839|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097560|NCT02663518|471987840|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097561|NCT02663518|471987841|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097562|NCT02663518|471987842|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097563|NCT02663518|471987843|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097564|NCT02663518|471987844|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
131097565|NCT02663518|471987845|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097566|NCT02663518|471987846|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097567|NCT02663518|471987847|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097568|NCT02663518|471987848|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097569|NCT02663518|471987849|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097570|NCT02663518|471987850|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097571|NCT02663518|471987851|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
131097572|NCT02663518|471987838|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
131097573|NCT02663518|471987839|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
131097574|NCT02663518|471987840|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
131097575|NCT02663518|471987841|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
131097576|NCT02663518|471987842|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
131097577|NCT02663518|471987843|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
131097578|NCT02663518|471987844|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
131097579|NCT02663518|471987845|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
131097580|NCT02663518|471987846|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
131097581|NCT02663518|471987847|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
131097582|NCT02663518|471987848|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
131097583|NCT02663518|471987849|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
131097584|NCT02663518|471987850|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
131097585|NCT02663518|471987851|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
131097586|NCT02663518|471987838|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097587|NCT02663518|471987839|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097588|NCT02663518|471987840|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097589|NCT02663518|471987841|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097590|NCT02663518|471987842|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097591|NCT02663518|471987843|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097592|NCT02663518|471987844|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097593|NCT02663518|471987845|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097594|NCT02663518|471987846|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097595|NCT02663518|471987847|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097596|NCT02663518|471987848|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097597|NCT02663518|471987849|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097598|NCT02663518|471987850|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
131097599|NCT02663518|471987851|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
131097600|NCT02663518|471987838|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097601|NCT02663518|471987839|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097602|NCT02663518|471987840|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097603|NCT02663518|471987841|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097604|NCT02663518|471987842|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097605|NCT02663518|471987843|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097606|NCT02663518|471987844|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097607|NCT02663518|471987845|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097608|NCT02663518|471987846|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097609|NCT02663518|471987847|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097610|NCT02663518|471987848|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097611|NCT02663518|471987849|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
131097612|NCT02663518|471987850|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097613|NCT02663518|471987851|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
131097614|NCT02663518|471987838|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131097615|NCT02663518|471987839|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131097616|NCT02663518|471987840|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131097617|NCT02663518|471987841|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131097618|NCT02663518|471987842|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131145572|NCT00896532|472156428|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145573|NCT00896532|472156429|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131097619|NCT02663518|471987843|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131097620|NCT02663518|471987844|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131097621|NCT02663518|471987845|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131097622|NCT02663518|471987846|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131097623|NCT02663518|471987847|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
131097624|NCT02663518|471987848|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
131097625|NCT02663518|471987849|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
131097626|NCT02663518|471987850|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
131097627|NCT02663518|471987851|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
131097628|NCT02663518|471987838|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
131097629|NCT02663518|471987839|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
131097630|NCT02663518|471987840|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
131097631|NCT02663518|471987841|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
131097632|NCT02663518|471987842|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
131097633|NCT02663518|471987843|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
131097634|NCT02663518|471987844|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
131097635|NCT02663518|471987845|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
131097636|NCT02663518|471987846|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
131097637|NCT02663518|471987847|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
131097638|NCT02663518|471987848|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
131097639|NCT02663518|471987849|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
131097640|NCT02663518|471987850|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
131097641|NCT02663518|471987851|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
131097642|NCT02663518|471987838|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097643|NCT02663518|471987839|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097644|NCT02663518|471987840|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097645|NCT02663518|471987841|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097646|NCT02663518|471987842|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097647|NCT02663518|471987843|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097648|NCT02663518|471987844|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097649|NCT02663518|471987845|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097650|NCT02663518|471987846|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097651|NCT02663518|471987847|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097652|NCT02663518|471987848|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097653|NCT02663518|471987849|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097654|NCT02663518|471987850|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
131097655|NCT02663518|471987851|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
131097656|NCT03896152|471987857|FG000|Overall Study|Patient/guardian decision|1|||
131097657|NCT03896152|471987858|FG001|Overall Study|Patient/guardian decision|1|||
131097658|NCT03896152|471987857|FG000|Overall Study|Adverse Event|0|||
131097659|NCT03896152|471987858|FG001|Overall Study|Adverse Event|1|||
131097660|NCT03896152|471987857|FG000|Overall Study|Physician Decision|1|||
131097661|NCT03896152|471987858|FG001|Overall Study|Physician Decision|0|||
131097662|NCT03896152|471987857|FG000|Overall Study|Technical problems|1|||
131097663|NCT03896152|471987858|FG001|Overall Study|Technical problems|0|||
131097664|NCT00436852|471987859|FG000|Overall Study|Death|23|||
131097665|NCT00436852|471987860|FG001|Overall Study|Death|34|||
131097666|NCT00436852|471987859|FG000|Overall Study|Lack of Efficacy|9|||
131097667|NCT00436852|471987860|FG001|Overall Study|Lack of Efficacy|7|||
131097668|NCT00436852|471987859|FG000|Overall Study|Withdrawal by Subject|2|||
131097669|NCT00436852|471987860|FG001|Overall Study|Withdrawal by Subject|4|||
131097670|NCT00436852|471987859|FG000|Overall Study|Ineligible|1|||
131097671|NCT00436852|471987860|FG001|Overall Study|Ineligible|0|||
131097672|NCT00943852|471987861|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131097673|NCT00943852|471987862|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131097674|NCT00943852|471987863|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131097675|NCT00943852|471987864|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
131097676|NCT00943852|471987865|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131097677|NCT00943852|471987866|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131097678|NCT00943852|471987867|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131097679|NCT00943852|471987868|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131097680|NCT00943852|471987869|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131097681|NCT00943852|471987870|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
131145574|NCT00896532|472156430|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145575|NCT00896532|472156431|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145576|NCT00896532|472156432|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145577|NCT00896532|472156433|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145578|NCT00896532|472156434|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131097682|NCT00943852|471987861|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131097683|NCT00943852|471987862|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131097684|NCT00943852|471987863|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131097685|NCT00943852|471987864|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131097686|NCT00943852|471987865|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131097687|NCT00943852|471987866|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
131097688|NCT00943852|471987867|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131097689|NCT00943852|471987868|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131097690|NCT00943852|471987869|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131097691|NCT00943852|471987870|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
131097692|NCT00943852|471987861|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131097693|NCT00943852|471987862|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131097694|NCT00943852|471987863|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131097695|NCT00943852|471987864|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131234772|NCT02799602|472486472|FG000|Overall Study|Study drug never administered|0|||
131234773|NCT02799602|472486473|FG001|Overall Study|Study drug never administered|3|||
131234774|NCT02626949|472486474|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
131234775|NCT02626949|472486475|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
131234776|NCT02626949|472486474|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
131234777|NCT02626949|472486475|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
130727742|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
130727743|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
131097696|NCT00943852|471987865|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131097697|NCT00943852|471987866|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131097698|NCT00943852|471987867|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
131097699|NCT00943852|471987868|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131097700|NCT00943852|471987869|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131097701|NCT00943852|471987870|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
131097702|NCT00943852|471987861|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131097703|NCT00943852|471987862|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131097704|NCT00943852|471987863|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131097705|NCT00943852|471987864|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131097706|NCT00943852|471987865|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131097707|NCT00943852|471987866|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131097708|NCT00943852|471987867|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131097709|NCT00943852|471987868|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
131097710|NCT00943852|471987869|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131097711|NCT00943852|471987870|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
131097712|NCT00943852|471987861|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
131097713|NCT00943852|471987862|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131097714|NCT00943852|471987863|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
131097715|NCT00943852|471987864|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
131097716|NCT00943852|471987865|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131097717|NCT00943852|471987866|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131097718|NCT00943852|471987867|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
131097719|NCT00943852|471987868|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131097720|NCT00943852|471987869|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131097721|NCT00943852|471987870|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
131097722|NCT02141620|471987871|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
131097723|NCT02141620|471987872|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
131097724|NCT03377699|471987873|FG000|Overall Study|Withdrawal by Subject|2|||
131097725|NCT03377699|471987874|FG001|Overall Study|Withdrawal by Subject|9|||
131097726|NCT03377699|471987873|FG000|Overall Study|Lost to Follow-up|1|||
131097727|NCT03377699|471987874|FG001|Overall Study|Lost to Follow-up|1|||
131097728|NCT03377699|471987873|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
131097729|NCT03377699|471987874|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
131097730|NCT03377699|471987873|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
131097731|NCT03377699|471987874|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
131097732|NCT03377699|471987873|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
131097733|NCT03377699|471987874|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
131097734|NCT03377699|471987873|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
131097735|NCT03377699|471987874|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
131097736|NCT00307684|471987875|FG000|Open Label Phase|Lack of Efficacy|0|||
131097737|NCT00307684|471987876|FG001|Open Label Phase|Lack of Efficacy|0|||
131097738|NCT00307684|471987877|FG002|Open Label Phase|Lack of Efficacy|3|||
131097739|NCT00307684|471987875|FG000|Open Label Phase|Adverse Event|0|||
131097740|NCT00307684|471987876|FG001|Open Label Phase|Adverse Event|0|||
131097741|NCT00307684|471987877|FG002|Open Label Phase|Adverse Event|16|||
131097742|NCT00307684|471987875|FG000|Open Label Phase|Withdrawal by Subject|0|||
131097743|NCT00307684|471987876|FG001|Open Label Phase|Withdrawal by Subject|0|||
131097744|NCT00307684|471987877|FG002|Open Label Phase|Withdrawal by Subject|15|||
131097745|NCT00307684|471987875|FG000|Open Label Phase|Lost to Follow-up|0|||
131097746|NCT00307684|471987876|FG001|Open Label Phase|Lost to Follow-up|0|||
131097747|NCT00307684|471987877|FG002|Open Label Phase|Lost to Follow-up|11|||
131097748|NCT00307684|471987875|FG000|Open Label Phase|non compliance|0|||
131097749|NCT00307684|471987876|FG001|Open Label Phase|non compliance|0|||
131097750|NCT00307684|471987877|FG002|Open Label Phase|non compliance|5|||
131097751|NCT00307684|471987875|FG000|Open Label Phase|other|0|||
131097752|NCT00307684|471987876|FG001|Open Label Phase|other|0|||
131097753|NCT00307684|471987877|FG002|Open Label Phase|other|6|||
131097754|NCT00307684|471987875|FG000|Double Blind Phase|Lack of Efficacy|2|||
131097755|NCT00307684|471987876|FG001|Double Blind Phase|Lack of Efficacy|5|||
131097756|NCT00307684|471987877|FG002|Double Blind Phase|Lack of Efficacy|0|||
131097757|NCT02580305|471987881|FG000|Overall Study|Adverse Event|15|||
131097758|NCT02580305|471987882|FG001|Overall Study|Adverse Event|19|||
131097759|NCT02580305|471987883|FG002|Overall Study|Adverse Event|10|||
131097760|NCT02580305|471987881|FG000|Overall Study|Lack of Efficacy|5|||
131097761|NCT02580305|471987882|FG001|Overall Study|Lack of Efficacy|0|||
131097762|NCT02580305|471987883|FG002|Overall Study|Lack of Efficacy|2|||
131097763|NCT02580305|471987881|FG000|Overall Study|Protocol Violation|4|||
131097764|NCT02580305|471987882|FG001|Overall Study|Protocol Violation|9|||
131097765|NCT02580305|471987883|FG002|Overall Study|Protocol Violation|6|||
131097766|NCT02580305|471987881|FG000|Overall Study|Lost to Follow-up|4|||
131097767|NCT02580305|471987882|FG001|Overall Study|Lost to Follow-up|4|||
131097768|NCT02580305|471987883|FG002|Overall Study|Lost to Follow-up|2|||
131097769|NCT02580305|471987881|FG000|Overall Study|Withdrawal by Subject|11|||
131097770|NCT02580305|471987882|FG001|Overall Study|Withdrawal by Subject|9|||
131097771|NCT02580305|471987883|FG002|Overall Study|Withdrawal by Subject|7|||
131097772|NCT02580305|471987881|FG000|Overall Study|Randomized in error and never treated|4|||
131097773|NCT02580305|471987882|FG001|Overall Study|Randomized in error and never treated|8|||
131097774|NCT02580305|471987883|FG002|Overall Study|Randomized in error and never treated|5|||
131097775|NCT00224887|471987884|FG000|Overall Study|Pregnancy|6|||
131097776|NCT00224887|471987885|FG001|Overall Study|Pregnancy|6|||
131145579|NCT00896532|472156435|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145580|NCT00896532|472156436|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145581|NCT00896532|472156437|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145582|NCT00896532|472156438|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145583|NCT00896532|472156439|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145584|NCT00896532|472156440|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145585|NCT00896532|472156441|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145586|NCT00896532|472156442|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
131145587|NCT00896532|472156443|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145588|NCT00896532|472156444|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145589|NCT00896532|472156445|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145590|NCT00896532|472156446|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145591|NCT00896532|472156447|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145592|NCT00896532|472156448|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
131145593|NCT00896532|472156426|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
131145594|NCT00896532|472156427|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
131145595|NCT00896532|472156428|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
131145596|NCT00896532|472156429|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
131145597|NCT00896532|472156430|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
131145598|NCT00896532|472156431|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
131145599|NCT00896532|472156432|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
131145600|NCT00896532|472156433|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
131145601|NCT00896532|472156434|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
131145602|NCT00896532|472156435|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
130727744|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
130780288|NCT00128661|470821482|FG001|Overall Study|Other|8|||
131097777|NCT00941070|471987889|FG000|Overall Study|Patient non-compliant|1|||
131097778|NCT01163292|471987893|FG000|Overall Study|Lack of Efficacy|9|||
131097779|NCT01163292|471987894|FG001|Overall Study|Lack of Efficacy|0|||
131097780|NCT01163292|471987893|FG000|Overall Study|Adverse Event|6|||
131097781|NCT01163292|471987894|FG001|Overall Study|Adverse Event|0|||
131097782|NCT01163292|471987893|FG000|Overall Study|Initiation of biological therapy|0|||
131145603|NCT00896532|472156436|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
131145604|NCT00896532|472156437|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
131145605|NCT00896532|472156438|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
131145606|NCT00896532|472156439|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
131145607|NCT00896532|472156440|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
131145608|NCT00896532|472156441|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
131145609|NCT00896532|472156442|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
131145610|NCT00896532|472156443|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
131145611|NCT00896532|472156444|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
131145612|NCT00896532|472156445|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
131145613|NCT00896532|472156446|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
131145614|NCT00896532|472156447|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
131145615|NCT00896532|472156448|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
131145616|NCT00896532|472156426|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145617|NCT00896532|472156427|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145618|NCT00896532|472156428|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145619|NCT00896532|472156429|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145620|NCT00896532|472156430|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145621|NCT00896532|472156431|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145622|NCT00896532|472156432|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145623|NCT00896532|472156433|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145624|NCT00896532|472156434|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145625|NCT00896532|472156435|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145626|NCT00896532|472156436|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145627|NCT00896532|472156437|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145628|NCT00896532|472156438|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145629|NCT00896532|472156439|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145630|NCT00896532|472156440|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145631|NCT00896532|472156441|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145632|NCT00896532|472156442|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
131145633|NCT00896532|472156443|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145634|NCT00896532|472156444|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145635|NCT00896532|472156445|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145636|NCT00896532|472156446|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145637|NCT00896532|472156447|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145638|NCT00896532|472156448|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
131145639|NCT00896532|472156426|FG000|Months 48-72: Follow-on Phase|Death|0|||
131145640|NCT00896532|472156427|FG001|Months 48-72: Follow-on Phase|Death|0|||
131145641|NCT00896532|472156428|FG002|Months 48-72: Follow-on Phase|Death|0|||
131145642|NCT00896532|472156429|FG003|Months 48-72: Follow-on Phase|Death|0|||
131145643|NCT00896532|472156430|FG004|Months 48-72: Follow-on Phase|Death|0|||
131145644|NCT00896532|472156431|FG005|Months 48-72: Follow-on Phase|Death|0|||
131145645|NCT00896532|472156432|FG006|Months 48-72: Follow-on Phase|Death|0|||
131145646|NCT00896532|472156433|FG007|Months 48-72: Follow-on Phase|Death|0|||
131145647|NCT00896532|472156434|FG008|Months 48-72: Follow-on Phase|Death|0|||
131145648|NCT00896532|472156435|FG009|Months 48-72: Follow-on Phase|Death|0|||
131145649|NCT00896532|472156436|FG010|Months 48-72: Follow-on Phase|Death|0|||
131145650|NCT00896532|472156437|FG011|Months 48-72: Follow-on Phase|Death|0|||
131145651|NCT00896532|472156438|FG012|Months 48-72: Follow-on Phase|Death|0|||
131145652|NCT00896532|472156439|FG013|Months 48-72: Follow-on Phase|Death|0|||
131145653|NCT00896532|472156440|FG014|Months 48-72: Follow-on Phase|Death|0|||
131145654|NCT00896532|472156441|FG015|Months 48-72: Follow-on Phase|Death|0|||
131145655|NCT00896532|472156442|FG016|Months 48-72: Follow-on Phase|Death|0|||
131145656|NCT00896532|472156443|FG017|Months 48-72: Follow-on Phase|Death|0|||
131145657|NCT00896532|472156444|FG018|Months 48-72: Follow-on Phase|Death|1|||
131145658|NCT00896532|472156445|FG019|Months 48-72: Follow-on Phase|Death|0|||
131145659|NCT00896532|472156446|FG020|Months 48-72: Follow-on Phase|Death|0|||
131145660|NCT00896532|472156447|FG021|Months 48-72: Follow-on Phase|Death|0|||
131145661|NCT00896532|472156448|FG022|Months 48-72: Follow-on Phase|Death|0|||
131145662|NCT00896532|472156426|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145663|NCT00896532|472156427|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145664|NCT00896532|472156428|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145665|NCT00896532|472156429|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130727745|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
130727746|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
130727747|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
131097783|NCT01163292|471987894|FG001|Overall Study|Initiation of biological therapy|15|||
131097784|NCT01163292|471987893|FG000|Overall Study|Sufficient response to adalimumab|8|||
131097785|NCT01163292|471987894|FG001|Overall Study|Sufficient response to adalimumab|0|||
131097786|NCT01163292|471987893|FG000|Overall Study|Refusal to receive adalimumab|7|||
131097787|NCT01163292|471987894|FG001|Overall Study|Refusal to receive adalimumab|0|||
131097788|NCT01163292|471987893|FG000|Overall Study|Economic reasons|6|||
131097789|NCT01163292|471987894|FG001|Overall Study|Economic reasons|0|||
131097790|NCT01163292|471987893|FG000|Overall Study|No further visits|5|||
131097791|NCT01163292|471987894|FG001|Overall Study|No further visits|7|||
131097792|NCT02643472|471987895|FG000|Overall Study|Death|2|||
131097793|NCT02643472|471987896|FG001|Overall Study|Death|5|||
131097794|NCT02643472|471987895|FG000|Overall Study|Withdrawal by Subject|3|||
131097795|NCT02643472|471987896|FG001|Overall Study|Withdrawal by Subject|2|||
131097796|NCT02643472|471987895|FG000|Overall Study|Protocol Violation|0|||
131097797|NCT02643472|471987896|FG001|Overall Study|Protocol Violation|1|||
131097798|NCT02643472|471987895|FG000|Overall Study|Lost to Follow-up|22|||
131097799|NCT02643472|471987896|FG001|Overall Study|Lost to Follow-up|26|||
131097800|NCT01127763|471987899|FG000|Overall Study|Adverse Event|2|||
131097801|NCT01127763|471987899|FG000|Overall Study|Withdrawal by Subject|1|||
131097802|NCT01127763|471987899|FG000|Overall Study|Physician Decision|2|||
131097803|NCT00680992|471987904|FG000|Overall Study|Complete Resection (as per protocol)|25|||
131097804|NCT00680992|471987905|FG001|Overall Study|Complete Resection (as per protocol)|121|||
131097805|NCT00680992|471987906|FG002|Overall Study|Complete Resection (as per protocol)|0|||
131097806|NCT00680992|471987904|FG000|Overall Study|Administrative Decision|83|||
131097807|NCT00680992|471987905|FG001|Overall Study|Administrative Decision|42|||
131097808|NCT00680992|471987906|FG002|Overall Study|Administrative Decision|5|||
131097809|NCT00680992|471987904|FG000|Overall Study|End of Trial|32|||
131097810|NCT00680992|471987905|FG001|Overall Study|End of Trial|12|||
131097811|NCT00680992|471987906|FG002|Overall Study|End of Trial|3|||
131097812|NCT00680992|471987904|FG000|Overall Study|Withdrawal by Subject|33|||
131097813|NCT00680992|471987905|FG001|Overall Study|Withdrawal by Subject|11|||
131097814|NCT00680992|471987906|FG002|Overall Study|Withdrawal by Subject|1|||
131097815|NCT00680992|471987904|FG000|Overall Study|Adverse Event|21|||
131097816|NCT00680992|471987905|FG001|Overall Study|Adverse Event|19|||
131097817|NCT00680992|471987906|FG002|Overall Study|Adverse Event|1|||
131097818|NCT00680992|471987904|FG000|Overall Study|Other|19|||
131097819|NCT00680992|471987905|FG001|Overall Study|Other|14|||
131097820|NCT00680992|471987906|FG002|Overall Study|Other|1|||
131097821|NCT00680992|471987904|FG000|Overall Study|Disease Progression|21|||
131097822|NCT00680992|471987905|FG001|Overall Study|Disease Progression|9|||
131097823|NCT00680992|471987906|FG002|Overall Study|Disease Progression|0|||
131097824|NCT00680992|471987904|FG000|Overall Study|Lost to Follow-up|12|||
131097825|NCT00680992|471987905|FG001|Overall Study|Lost to Follow-up|14|||
131097826|NCT00680992|471987906|FG002|Overall Study|Lost to Follow-up|0|||
131097827|NCT00680992|471987904|FG000|Overall Study|Noncompliance|4|||
131097828|NCT00680992|471987905|FG001|Overall Study|Noncompliance|6|||
131097829|NCT00680992|471987906|FG002|Overall Study|Noncompliance|0|||
131097830|NCT00680992|471987904|FG000|Overall Study|Requirement for Alternative Therapy|8|||
131097831|NCT00680992|471987905|FG001|Overall Study|Requirement for Alternative Therapy|2|||
131097832|NCT00680992|471987906|FG002|Overall Study|Requirement for Alternative Therapy|0|||
131097833|NCT00680992|471987904|FG000|Overall Study|Pregnancy|5|||
131097834|NCT00680992|471987905|FG001|Overall Study|Pregnancy|0|||
131097835|NCT00680992|471987906|FG002|Overall Study|Pregnancy|1|||
131097836|NCT00680992|471987904|FG000|Overall Study|Death|5|||
131097837|NCT00680992|471987905|FG001|Overall Study|Death|1|||
131097838|NCT00680992|471987906|FG002|Overall Study|Death|0|||
131097839|NCT00680992|471987904|FG000|Overall Study|Ineligibility Determined|0|||
131097840|NCT00680992|471987905|FG001|Overall Study|Ineligibility Determined|1|||
131097841|NCT00680992|471987906|FG002|Overall Study|Ineligibility Determined|0|||
131097842|NCT06665919|471987908|FG000|Overall Study|Withdrawal by Subject|4|||
131097843|NCT06665919|471987909|FG001|Overall Study|Withdrawal by Subject|4|||
131097844|NCT06665919|471987910|FG002|Overall Study|Withdrawal by Subject|4|||
131097845|NCT06665919|471987908|FG000|Overall Study|Non-compliance to Treatment|4|||
131097846|NCT06665919|471987909|FG001|Overall Study|Non-compliance to Treatment|1|||
131097847|NCT06665919|471987910|FG002|Overall Study|Non-compliance to Treatment|6|||
131097848|NCT06665919|471987908|FG000|Overall Study|Lost to Follow-up|3|||
131097849|NCT06665919|471987909|FG001|Overall Study|Lost to Follow-up|0|||
131097850|NCT06665919|471987910|FG002|Overall Study|Lost to Follow-up|2|||
131097851|NCT06665919|471987908|FG000|Overall Study|Physician Decision|4|||
131145666|NCT00896532|472156430|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131097852|NCT06665919|471987909|FG001|Overall Study|Physician Decision|0|||
131097853|NCT06665919|471987910|FG002|Overall Study|Physician Decision|1|||
131097854|NCT00607724|471987911|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
131097855|NCT00607724|471987912|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
131097856|NCT00607724|471987913|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
131097857|NCT00607724|471987914|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
131097858|NCT00607724|471987915|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
131234778|NCT02626949|472486474|FG000|Enrolled|Lost to Follow-up|7|||
131234779|NCT02626949|472486475|FG001|Enrolled|Lost to Follow-up|6|||
131234780|NCT02626949|472486474|FG000|Enrolled|Withdrawal by Subject|3|||
131097859|NCT00607724|471987916|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
131097860|NCT00607724|471987917|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
131097861|NCT00607724|471987911|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
131097862|NCT00607724|471987912|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
131097863|NCT00607724|471987913|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
131097864|NCT00607724|471987914|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
131097865|NCT00607724|471987915|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
131097866|NCT00607724|471987916|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
131097867|NCT00607724|471987917|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
131097868|NCT00607724|471987911|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
131097869|NCT00607724|471987912|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
131097870|NCT00607724|471987913|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
131097871|NCT00607724|471987914|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
131097872|NCT00607724|471987915|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
131097873|NCT00607724|471987916|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
131097874|NCT00607724|471987917|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
131097875|NCT00607724|471987911|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
131145667|NCT00896532|472156431|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145668|NCT00896532|472156432|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145669|NCT00896532|472156433|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145670|NCT00896532|472156434|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145671|NCT00896532|472156435|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145672|NCT00896532|472156436|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145673|NCT00896532|472156437|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145674|NCT00896532|472156438|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145675|NCT00896532|472156439|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145676|NCT00896532|472156440|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145677|NCT00896532|472156441|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145678|NCT00896532|472156442|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145679|NCT00896532|472156443|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145680|NCT00896532|472156444|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145681|NCT00896532|472156445|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145682|NCT00896532|472156446|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145683|NCT00896532|472156447|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
131145684|NCT00896532|472156448|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
131145685|NCT00896532|472156426|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145686|NCT00896532|472156427|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145687|NCT00896532|472156428|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145688|NCT00896532|472156429|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145689|NCT00896532|472156430|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145690|NCT00896532|472156431|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145691|NCT00896532|472156432|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145692|NCT00896532|472156433|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145693|NCT00896532|472156434|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145694|NCT00896532|472156435|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145695|NCT00896532|472156436|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145696|NCT00896532|472156437|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145697|NCT00896532|472156438|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145698|NCT00896532|472156439|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145699|NCT00896532|472156440|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145700|NCT00896532|472156441|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145701|NCT00896532|472156442|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145702|NCT00896532|472156443|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145703|NCT00896532|472156444|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145704|NCT00896532|472156445|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145705|NCT00896532|472156446|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131234781|NCT02626949|472486475|FG001|Enrolled|Withdrawal by Subject|2|||
131234782|NCT03072459|472486477|FG000|Overall Study|Device revised/removed|1|||
131234783|NCT03072459|472486477|FG000|Overall Study|Subject not able to return|1|||
131097876|NCT00607724|471987912|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
131097877|NCT00607724|471987913|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
131097878|NCT00607724|471987914|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
131097879|NCT00607724|471987915|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
131097880|NCT00607724|471987916|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
131145706|NCT00896532|472156447|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
131145707|NCT00896532|472156448|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
131145708|NCT02149810|472156449|FG000|Overall Study|Physician Decision|1|||
131145709|NCT02149810|472156450|FG001|Overall Study|Physician Decision|2|||
131145710|NCT02149810|472156449|FG000|Overall Study|Lost to Follow-up|2|||
131145711|NCT02149810|472156450|FG001|Overall Study|Lost to Follow-up|1|||
131145712|NCT02149810|472156449|FG000|Overall Study|Withdrawal by Subject|5|||
131145713|NCT02149810|472156450|FG001|Overall Study|Withdrawal by Subject|1|||
131145714|NCT01176916|472156451|FG000|Overall Study|Adverse Event|61|||
131145715|NCT01176916|472156451|FG000|Overall Study|Death|1|||
131145716|NCT01176916|472156451|FG000|Overall Study|Lost to Follow-up|15|||
131145717|NCT01176916|472156451|FG000|Overall Study|Objective progression or relapse|17|||
131145718|NCT01176916|472156451|FG000|Overall Study|Protocol Violation|24|||
131145719|NCT01176916|472156451|FG000|Overall Study|Withdrawal by Subject|37|||
131145720|NCT01176916|472156451|FG000|Overall Study|Other|6|||
131145721|NCT01176916|472156451|FG000|Overall Study|Withdrawal prior to Treatment|6|||
131145722|NCT03158220|472156452|FG000|Overall Study|Screen Failure|0|||
131145723|NCT03158220|472156453|FG001|Overall Study|Screen Failure|1|||
131145724|NCT03158220|472156452|FG000|Overall Study|Withdrawal by Subject|8|||
131145725|NCT03158220|472156453|FG001|Overall Study|Withdrawal by Subject|9|||
131145726|NCT03158220|472156452|FG000|Overall Study|Status unknown|0|||
131145727|NCT03158220|472156453|FG001|Overall Study|Status unknown|1|||
131145728|NCT03158220|472156452|FG000|Overall Study|Lost to Follow-up|8|||
131145729|NCT03158220|472156453|FG001|Overall Study|Lost to Follow-up|5|||
131145730|NCT03158220|472156452|FG000|Overall Study|Physician Decision|1|||
131145731|NCT03158220|472156453|FG001|Overall Study|Physician Decision|0|||
131145732|NCT01015833|472156454|FG000|Overall Study|Death|1|||
131145733|NCT01015833|472156455|FG001|Overall Study|Death|0|||
131145734|NCT01015833|472156454|FG000|Overall Study|Withdrawal by Subject|3|||
131145735|NCT01015833|472156455|FG001|Overall Study|Withdrawal by Subject|2|||
131145736|NCT01015833|472156454|FG000|Overall Study|Adverse Event|0|||
131145737|NCT01015833|472156455|FG001|Overall Study|Adverse Event|1|||
131145738|NCT01015833|472156454|FG000|Overall Study|Physician Decision|2|||
131145739|NCT01015833|472156455|FG001|Overall Study|Physician Decision|0|||
131145740|NCT01015833|472156454|FG000|Overall Study|Symptomatic deterioration|0|||
131145741|NCT01015833|472156455|FG001|Overall Study|Symptomatic deterioration|1|||
131145742|NCT01015833|472156454|FG000|Overall Study|Other|5|||
131145743|NCT01015833|472156455|FG001|Overall Study|Other|1|||
131145744|NCT01015833|472156454|FG000|Overall Study|Motor Vehicle Accidents|1|||
131145745|NCT01015833|472156455|FG001|Overall Study|Motor Vehicle Accidents|0|||
131145746|NCT01015833|472156454|FG000|Overall Study|Did not start treatment|1|||
131145747|NCT01015833|472156455|FG001|Overall Study|Did not start treatment|0|||
131145748|NCT01671280|472156456|FG000|Overall Study|Withdrawal by Subject|2|||
131145749|NCT01959165|472156457|FG000|Overall Study|Adverse Event|0|||
131145750|NCT01959165|472156458|FG001|Overall Study|Adverse Event|0|||
131145751|NCT01959165|472156459|FG002|Overall Study|Adverse Event|0|||
131145752|NCT01959165|472156460|FG003|Overall Study|Adverse Event|1|||
131145753|NCT01959165|472156457|FG000|Overall Study|Lack of Efficacy|1|||
131145754|NCT01959165|472156458|FG001|Overall Study|Lack of Efficacy|0|||
131145755|NCT01959165|472156459|FG002|Overall Study|Lack of Efficacy|0|||
131145756|NCT01959165|472156460|FG003|Overall Study|Lack of Efficacy|0|||
131145757|NCT01959165|472156457|FG000|Overall Study|overdose|0|||
131145758|NCT01959165|472156458|FG001|Overall Study|overdose|0|||
131145759|NCT01959165|472156459|FG002|Overall Study|overdose|0|||
131145760|NCT01959165|472156460|FG003|Overall Study|overdose|1|||
131145761|NCT01959165|472156457|FG000|Overall Study|Welfare recipient|0|||
131145762|NCT01959165|472156458|FG001|Overall Study|Welfare recipient|1|||
131145763|NCT01959165|472156459|FG002|Overall Study|Welfare recipient|0|||
131145764|NCT01959165|472156460|FG003|Overall Study|Welfare recipient|0|||
131145765|NCT00927563|472156473|FG000|Overall Study|Lost to Follow-up|1|||
131145766|NCT00927563|472156473|FG000|Overall Study|Withdrawal by Subject|1|||
131145767|NCT02899156|472156477|FG000|Overall Study|Death|1|||
131145768|NCT02899156|472156478|FG001|Overall Study|Death|0|||
131145769|NCT02899156|472156477|FG000|Overall Study|Physician Decision|0|||
131145770|NCT02899156|472156478|FG001|Overall Study|Physician Decision|1|||
131145771|NCT01468987|472156481|FG000|Overall Study|Adverse Event|12|||
131145772|NCT01468987|472156482|FG001|Overall Study|Adverse Event|9|||
131145773|NCT01468987|472156481|FG000|Overall Study|Death|4|||
131145774|NCT01468987|472156482|FG001|Overall Study|Death|1|||
131145775|NCT01468987|472156481|FG000|Overall Study|Lost to Follow-up|10|||
131145776|NCT01468987|472156482|FG001|Overall Study|Lost to Follow-up|5|||
131145777|NCT01468987|472156481|FG000|Overall Study|Protocol Violation|8|||
131145778|NCT01468987|472156482|FG001|Overall Study|Protocol Violation|2|||
131145779|NCT01468987|472156481|FG000|Overall Study|Withdrawal by Subject|28|||
131145780|NCT01468987|472156482|FG001|Overall Study|Withdrawal by Subject|28|||
131145781|NCT01468987|472156481|FG000|Overall Study|Physician Decision|8|||
131145782|NCT01468987|472156482|FG001|Overall Study|Physician Decision|15|||
131145783|NCT01468987|472156481|FG000|Overall Study|Sponsor Decision|1|||
131145784|NCT01468987|472156482|FG001|Overall Study|Sponsor Decision|0|||
131145785|NCT00787787|472156483|FG000|Overall Study|Lack of Efficacy|4|||
131097881|NCT00607724|471987917|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
131097882|NCT00607724|471987911|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131097883|NCT00607724|471987912|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131097884|NCT00607724|471987913|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131097885|NCT00607724|471987914|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
131097886|NCT00607724|471987915|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131097887|NCT00607724|471987916|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131097888|NCT00607724|471987917|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
131097889|NCT03738423|471987918|FG000|Overall Study|Withdrawal by Subject|9|||
131097890|NCT03738423|471987919|FG001|Overall Study|Withdrawal by Subject|12|||
131097891|NCT03738423|471987920|FG002|Overall Study|Withdrawal by Subject|9|||
131097892|NCT03738423|471987921|FG003|Overall Study|Withdrawal by Subject|12|||
131097893|NCT03738423|471987922|FG004|Overall Study|Withdrawal by Subject|10|||
131097894|NCT03738423|471987918|FG000|Overall Study|Lack of Efficacy|3|||
131097895|NCT03738423|471987919|FG001|Overall Study|Lack of Efficacy|1|||
131097896|NCT03738423|471987920|FG002|Overall Study|Lack of Efficacy|1|||
131097897|NCT03738423|471987921|FG003|Overall Study|Lack of Efficacy|1|||
131097898|NCT03738423|471987922|FG004|Overall Study|Lack of Efficacy|2|||
131097899|NCT03738423|471987918|FG000|Overall Study|Lost to Follow-up|1|||
131097900|NCT03738423|471987919|FG001|Overall Study|Lost to Follow-up|0|||
131097901|NCT03738423|471987920|FG002|Overall Study|Lost to Follow-up|1|||
131097902|NCT03738423|471987921|FG003|Overall Study|Lost to Follow-up|1|||
131097903|NCT03738423|471987922|FG004|Overall Study|Lost to Follow-up|0|||
131097904|NCT03738423|471987918|FG000|Overall Study|Protocol Violation|1|||
131097905|NCT03738423|471987919|FG001|Overall Study|Protocol Violation|0|||
131097906|NCT03738423|471987920|FG002|Overall Study|Protocol Violation|0|||
131097907|NCT03738423|471987921|FG003|Overall Study|Protocol Violation|0|||
131097908|NCT03738423|471987922|FG004|Overall Study|Protocol Violation|1|||
131097909|NCT03738423|471987918|FG000|Overall Study|Physician Decision|0|||
131097910|NCT03738423|471987919|FG001|Overall Study|Physician Decision|0|||
131097911|NCT03738423|471987920|FG002|Overall Study|Physician Decision|1|||
131097912|NCT03738423|471987921|FG003|Overall Study|Physician Decision|0|||
131097913|NCT03738423|471987922|FG004|Overall Study|Physician Decision|1|||
130727748|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
130727749|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
130727750|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
130727751|NCT02952586|470625548|FG000|CRT for Cisplatin (63 Days)|Other|1|||
131097914|NCT03738423|471987918|FG000|Overall Study|Death|0|||
131097915|NCT03738423|471987919|FG001|Overall Study|Death|0|||
131097916|NCT03738423|471987920|FG002|Overall Study|Death|0|||
131097917|NCT03738423|471987921|FG003|Overall Study|Death|0|||
131097918|NCT03738423|471987922|FG004|Overall Study|Death|1|||
131097919|NCT03738423|471987918|FG000|Overall Study|Randomized but never treated|0|||
131097920|NCT03738423|471987919|FG001|Overall Study|Randomized but never treated|0|||
131097921|NCT03738423|471987920|FG002|Overall Study|Randomized but never treated|1|||
131097922|NCT03738423|471987921|FG003|Overall Study|Randomized but never treated|1|||
131097923|NCT03738423|471987922|FG004|Overall Study|Randomized but never treated|0|||
131145786|NCT00787787|472156483|FG000|Overall Study|Adverse Event|3|||
131145787|NCT05032950|472156485|FG000|Overall Study|Adverse Event|0|||
131145788|NCT05032950|472156486|FG001|Overall Study|Adverse Event|0|||
131145789|NCT05032950|472156487|FG002|Overall Study|Adverse Event|1|||
131145790|NCT05032950|472156488|FG003|Overall Study|Adverse Event|1|||
131145791|NCT05032950|472156489|FG004|Overall Study|Adverse Event|0|||
131145792|NCT05032950|472156490|FG005|Overall Study|Adverse Event|0|||
131145793|NCT02959814|472156492|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
131145794|NCT02959814|472156492|FG000|Overall Study|Excluded based on anatomical criteria|2|||
131145795|NCT02959814|472156492|FG000|Overall Study|Protocol Violation|7|||
131145796|NCT02959814|472156492|FG000|Overall Study|FFR not measured|2|||
131145797|NCT02959814|472156492|FG000|Overall Study|In-procedure QFR not computed|6|||
131145798|NCT02959814|472156492|FG000|Overall Study|Excluded by FFR core-lab|24|||
130727752|NCT02952586|470625549|FG001|CRT for Cisplatin (63 Days)|Other|1|||
130727753|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Death|5|||
130727754|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Death|8|||
131097924|NCT01133418|471987923|FG000|Overall Study|Lost to Follow-up|5|||
131097925|NCT01133418|471987924|FG001|Overall Study|Lost to Follow-up|6|||
131097926|NCT05316701|471987925|FG000|Overall Study|Adverse Event|0|||
131097927|NCT05316701|471987926|FG001|Overall Study|Adverse Event|1|||
131097928|NCT05316701|471987925|FG000|Overall Study|Death|3|||
131097929|NCT05316701|471987926|FG001|Overall Study|Death|9|||
131097930|NCT05316701|471987925|FG000|Overall Study|Lost to Follow-up|1|||
131145799|NCT01245673|472156495|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
131097931|NCT05316701|471987926|FG001|Overall Study|Lost to Follow-up|0|||
131097932|NCT05316701|471987925|FG000|Overall Study|Physician Decision|1|||
131097933|NCT05316701|471987926|FG001|Overall Study|Physician Decision|4|||
131145800|NCT02425098|472156497|FG000|Overall Study|Lost to Follow-up|7|||
131145801|NCT02425098|472156498|FG001|Overall Study|Lost to Follow-up|7|||
131097934|NCT05316701|471987925|FG000|Overall Study|Withdrawal by Subject|3|||
131234784|NCT02275364|472486478|FG000|Period 1|Withdrawal by Subject|1|||
131097935|NCT05316701|471987926|FG001|Overall Study|Withdrawal by Subject|5|||
131097936|NCT05316701|471987925|FG000|Overall Study|Progression/Relapse|14|||
131097937|NCT05316701|471987926|FG001|Overall Study|Progression/Relapse|9|||
131097938|NCT05316701|471987925|FG000|Overall Study|Received Standard of Care|1|||
131097939|NCT05316701|471987926|FG001|Overall Study|Received Standard of Care|0|||
131097940|NCT05316701|471987925|FG000|Overall Study|Ongoing|70|||
131097941|NCT05316701|471987926|FG001|Overall Study|Ongoing|64|||
131097942|NCT04696653|471987927|FG000|Overall Study|left organization|18|||
131097943|NCT04696653|471987927|FG000|Overall Study|Lost to Follow-up|3|||
131097944|NCT04349631|471987928|FG000|Overall Study|Lost to Follow-up|3|||
131097945|NCT04349631|471987928|FG000|Overall Study|Withdrawal by Subject|7|||
131097946|NCT01982448|471987929|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
131097947|NCT01982448|471987930|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
131097948|NCT01982448|471987929|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
131097949|NCT01982448|471987930|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
131097950|NCT01982448|471987929|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
131097951|NCT01982448|471987930|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
131097952|NCT01982448|471987929|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
131097953|NCT01982448|471987930|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
131097954|NCT01198756|471989468|FG000|Overall Study|Adverse Event|0|||
131097955|NCT01198756|471989469|FG001|Overall Study|Adverse Event|0|||
131097956|NCT01198756|471989470|FG002|Overall Study|Adverse Event|0|||
131097957|NCT01198756|471989471|FG003|Overall Study|Adverse Event|1|||
131097958|NCT01198756|471989468|FG000|Overall Study|Protocol Violation|0|||
131097959|NCT01198756|471989469|FG001|Overall Study|Protocol Violation|0|||
131097960|NCT01198756|471989470|FG002|Overall Study|Protocol Violation|0|||
131097961|NCT01198756|471989471|FG003|Overall Study|Protocol Violation|2|||
131097962|NCT01198756|471989468|FG000|Overall Study|Withdrawal by Subject|9|||
131097963|NCT01198756|471989469|FG001|Overall Study|Withdrawal by Subject|4|||
131097964|NCT01198756|471989470|FG002|Overall Study|Withdrawal by Subject|7|||
131097965|NCT01198756|471989471|FG003|Overall Study|Withdrawal by Subject|5|||
131097966|NCT01198756|471989468|FG000|Overall Study|Lost to Follow-up|29|||
131097967|NCT01198756|471989469|FG001|Overall Study|Lost to Follow-up|36|||
131097968|NCT01198756|471989470|FG002|Overall Study|Lost to Follow-up|23|||
131097969|NCT01198756|471989471|FG003|Overall Study|Lost to Follow-up|18|||
131097970|NCT00901186|471989475|FG000|Overall Study|Lack of Efficacy|0|||
131097971|NCT00901186|471989476|FG001|Overall Study|Lack of Efficacy|1|||
131097972|NCT00901186|471989475|FG000|Overall Study|Abnormal laboratory values|0|||
131097973|NCT00901186|471989476|FG001|Overall Study|Abnormal laboratory values|1|||
131097974|NCT00901186|471989475|FG000|Overall Study|Lost to Follow-up|2|||
131097975|NCT00901186|471989476|FG001|Overall Study|Lost to Follow-up|0|||
131097976|NCT00901186|471989475|FG000|Overall Study|Adverse Event|2|||
131097977|NCT00901186|471989476|FG001|Overall Study|Adverse Event|4|||
131097978|NCT00901186|471989475|FG000|Overall Study|Administration problems|0|||
131097979|NCT00901186|471989476|FG001|Overall Study|Administration problems|1|||
131097980|NCT00901186|471989475|FG000|Overall Study|Protocol deviations|5|||
131097981|NCT00901186|471989476|FG001|Overall Study|Protocol deviations|4|||
131097982|NCT00581555|471989479|FG000|Overall Study|Adverse Event|4|||
131097983|NCT00581555|471989480|FG001|Overall Study|Adverse Event|3|||
131097984|NCT00581555|471989479|FG000|Overall Study|Physician Decision|3|||
131097985|NCT00581555|471989480|FG001|Overall Study|Physician Decision|2|||
131097986|NCT00581555|471989479|FG000|Overall Study|Withdrawal by Subject|18|||
131097987|NCT00581555|471989480|FG001|Overall Study|Withdrawal by Subject|9|||
131097988|NCT00581555|471989479|FG000|Overall Study|Lost to Follow-up|2|||
131097989|NCT00581555|471989480|FG001|Overall Study|Lost to Follow-up|2|||
131097990|NCT00581555|471989479|FG000|Overall Study|Other reasons|16|||
131097991|NCT00581555|471989480|FG001|Overall Study|Other reasons|4|||
131097992|NCT05816330|471989481|FG000|Overall Study|Withdrawal by Subject|4|||
131097993|NCT05816330|471989482|FG001|Overall Study|Withdrawal by Subject|1|||
131097994|NCT03900416|471989483|FG000|Six Week Follow-up|Lost to Follow-up|1|||
131097995|NCT03900416|471989484|FG001|Six Week Follow-up|Lost to Follow-up|0|||
131097996|NCT03900416|471989483|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
131097997|NCT03900416|471989484|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
131097998|NCT03900416|471989483|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
131097999|NCT03900416|471989484|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
131098000|NCT03900416|471989483|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
131098001|NCT03900416|471989484|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
131098002|NCT03900416|471989483|FG000|Twelve Week Follow-up|Adverse Event|1|||
131098003|NCT03900416|471989484|FG001|Twelve Week Follow-up|Adverse Event|1|||
130727755|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
131098004|NCT03900416|471989483|FG000|Six Month Follow-up|Lost to Follow-up|4|||
131098005|NCT03900416|471989484|FG001|Six Month Follow-up|Lost to Follow-up|3|||
131098006|NCT03900416|471989483|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
131098007|NCT03900416|471989484|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
131098008|NCT00772330|471989485|FG000|Overall Study|Lost to Follow-up|3|||
131098009|NCT01353859|471989486|FG000|Overall Study|Adverse Event|3|||
131098010|NCT01353859|471989486|FG000|Overall Study|Lack of Efficacy|1|||
131098011|NCT00700427|471989487|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
131098012|NCT00700427|471989488|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
131098013|NCT00700427|471989489|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
131098014|NCT00700427|471989490|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
131098015|NCT00700427|471989491|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
131098016|NCT00700427|471989487|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
131098017|NCT00700427|471989488|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
131098018|NCT00700427|471989489|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
131098019|NCT00700427|471989490|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
131098020|NCT00700427|471989491|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
131098021|NCT00700427|471989487|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
131098022|NCT00700427|471989488|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
131098023|NCT00700427|471989489|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
131098024|NCT00700427|471989490|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
131098025|NCT00700427|471989491|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
131098026|NCT00700427|471989487|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
131098027|NCT00700427|471989488|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
131098028|NCT00700427|471989489|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
131098029|NCT00700427|471989490|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
131098030|NCT00700427|471989491|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
131098031|NCT00700427|471989487|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
131098032|NCT00700427|471989488|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
131098033|NCT00700427|471989489|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
131098034|NCT00700427|471989490|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
131098035|NCT00700427|471989491|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
131098036|NCT00700427|471989487|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
131098037|NCT00700427|471989488|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
131098038|NCT00700427|471989489|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
131098039|NCT00700427|471989490|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
131098040|NCT00700427|471989491|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
131098041|NCT00700427|471989487|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
131098042|NCT00700427|471989488|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
131098043|NCT00700427|471989489|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
131098044|NCT00700427|471989490|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
131098045|NCT00700427|471989491|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
131098046|NCT00700427|471989487|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
131098047|NCT00700427|471989488|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
131098048|NCT00700427|471989489|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
131098049|NCT00700427|471989490|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
131098050|NCT00700427|471989491|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
131098051|NCT00700427|471989487|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
131098052|NCT00700427|471989488|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
131098053|NCT00700427|471989489|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
131098054|NCT00700427|471989490|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
131098055|NCT00700427|471989491|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
131098056|NCT00700427|471989487|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
131098057|NCT00700427|471989488|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
131098058|NCT00700427|471989489|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
131098059|NCT00700427|471989490|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
131098060|NCT00700427|471989491|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
131098061|NCT00700427|471989487|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
131098062|NCT00700427|471989488|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
131098063|NCT00700427|471989489|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
131098064|NCT00700427|471989490|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
131098065|NCT00700427|471989491|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
131098066|NCT00700427|471989487|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
131098067|NCT00700427|471989488|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
131098068|NCT00700427|471989489|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
131098069|NCT00700427|471989490|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
131098070|NCT00700427|471989491|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
131098071|NCT00700427|471989487|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
131234785|NCT02275364|472486479|FG001|Period 1|Withdrawal by Subject|0|||
131234786|NCT02275364|472486478|FG000|Period 1|Other reason|1|||
131145802|NCT02425098|472156497|FG000|Overall Study|Withdrawal by Subject|4|||
131145803|NCT02425098|472156498|FG001|Overall Study|Withdrawal by Subject|8|||
131145804|NCT02425098|472156497|FG000|Overall Study|Pregnancy|2|||
131145805|NCT02425098|472156498|FG001|Overall Study|Pregnancy|0|||
131145806|NCT02425098|472156497|FG000|Overall Study|Reason not Specified|0|||
131145807|NCT02425098|472156498|FG001|Overall Study|Reason not Specified|1|||
131145808|NCT01929135|472156499|FG000|Overall Study|Lost to Follow-up|1|||
131145809|NCT01929135|472156500|FG001|Overall Study|Lost to Follow-up|1|||
131145810|NCT02078219|472156501|FG000|Overall Study|Other|2|||
131145811|NCT02078219|472156502|FG001|Overall Study|Other|2|||
131145812|NCT02078219|472156503|FG002|Overall Study|Other|3|||
131145813|NCT02078219|472156504|FG003|Overall Study|Other|0|||
131145814|NCT02078219|472156505|FG004|Overall Study|Other|1|||
131145815|NCT02078219|472156501|FG000|Overall Study|Withdrawal by Subject|0|||
131145816|NCT02078219|472156502|FG001|Overall Study|Withdrawal by Subject|1|||
131145817|NCT02078219|472156503|FG002|Overall Study|Withdrawal by Subject|0|||
131145818|NCT02078219|472156504|FG003|Overall Study|Withdrawal by Subject|1|||
131145819|NCT02078219|472156505|FG004|Overall Study|Withdrawal by Subject|1|||
131145820|NCT02078219|472156501|FG000|Overall Study|Protocol Violation|0|||
131145821|NCT02078219|472156502|FG001|Overall Study|Protocol Violation|0|||
131145822|NCT02078219|472156503|FG002|Overall Study|Protocol Violation|0|||
131145823|NCT02078219|472156504|FG003|Overall Study|Protocol Violation|1|||
131145824|NCT02078219|472156505|FG004|Overall Study|Protocol Violation|0|||
131145825|NCT02078219|472156501|FG000|Overall Study|Death|0|||
131145826|NCT02078219|472156502|FG001|Overall Study|Death|0|||
131145827|NCT02078219|472156503|FG002|Overall Study|Death|0|||
131145828|NCT02078219|472156504|FG003|Overall Study|Death|1|||
131145829|NCT02078219|472156505|FG004|Overall Study|Death|0|||
131145830|NCT02078219|472156501|FG000|Overall Study|Adverse Event|1|||
131145831|NCT02078219|472156502|FG001|Overall Study|Adverse Event|1|||
131145832|NCT02078219|472156503|FG002|Overall Study|Adverse Event|3|||
131145833|NCT02078219|472156504|FG003|Overall Study|Adverse Event|1|||
131145834|NCT02078219|472156505|FG004|Overall Study|Adverse Event|0|||
131145835|NCT01468311|472156506|FG000|Overall Study|mobilization failure|1|||
131145836|NCT01468311|472156506|FG000|Overall Study|Withdrawal by Subject|1|||
131145837|NCT00127127|472158389|FG000|Overall Study|Adverse Event|0|||
131098072|NCT00700427|471989488|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
131098073|NCT00700427|471989489|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
131098074|NCT00700427|471989490|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
131098075|NCT00700427|471989491|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
131098076|NCT00700427|471989487|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
131098077|NCT00700427|471989488|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
131098078|NCT00700427|471989489|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
131098079|NCT00700427|471989490|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
131098080|NCT00700427|471989491|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
131098081|NCT00700427|471989487|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
131098082|NCT00700427|471989488|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
131098083|NCT00700427|471989489|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
131098084|NCT00700427|471989490|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
131098085|NCT00700427|471989491|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
131098086|NCT00700427|471989487|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
131098087|NCT00700427|471989488|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
131098088|NCT00700427|471989489|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
131098089|NCT00700427|471989490|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
131098090|NCT00700427|471989491|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
131098091|NCT00700427|471989487|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
131098092|NCT00700427|471989488|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
131098093|NCT00700427|471989489|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
131098094|NCT00700427|471989490|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
131098095|NCT00700427|471989491|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
131098096|NCT00700427|471989487|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
131145838|NCT00127127|472158390|FG001|Overall Study|Adverse Event|2|||
131145839|NCT00127127|472158391|FG002|Overall Study|Adverse Event|0|||
131145840|NCT00127127|472158392|FG003|Overall Study|Adverse Event|1|||
131145841|NCT00127127|472158389|FG000|Overall Study|Lack of Efficacy|1|||
131145842|NCT00127127|472158390|FG001|Overall Study|Lack of Efficacy|3|||
131145843|NCT00127127|472158391|FG002|Overall Study|Lack of Efficacy|0|||
131145844|NCT00127127|472158392|FG003|Overall Study|Lack of Efficacy|2|||
131145845|NCT01805180|472158393|FG000|Lead-in Donor Phase|screen failure|1|||
131145846|NCT01805180|472158394|FG001|Lead-in Donor Phase|screen failure|0|||
131145847|NCT01805180|472158395|FG002|Lead-in Donor Phase|screen failure|0|||
131145848|NCT00398112|472158413|FG000|Overall Study|Adverse Event|4|||
131145849|NCT00398112|472158413|FG000|Overall Study|Disease progression|9|||
131145850|NCT00398112|472158413|FG000|Overall Study|Alternative treatment|1|||
131145851|NCT00398112|472158413|FG000|Overall Study|Withdrawal by Subject|3|||
131098097|NCT00700427|471989488|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
131098098|NCT00700427|471989489|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
131098099|NCT00700427|471989490|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
131098100|NCT00700427|471989491|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
131098101|NCT00700427|471989487|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
131098102|NCT00700427|471989488|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
131098103|NCT00700427|471989489|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
131098104|NCT00700427|471989490|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
131098105|NCT00700427|471989491|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
131098106|NCT00700427|471989487|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
131098107|NCT00700427|471989488|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
131098108|NCT00700427|471989489|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
131098109|NCT00700427|471989490|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
131098110|NCT00700427|471989491|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
131098111|NCT00700427|471989487|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
131098112|NCT00700427|471989488|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
131098113|NCT00700427|471989489|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
131098114|NCT00700427|471989490|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
131098115|NCT00700427|471989491|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
131098116|NCT00700427|471989487|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
131098117|NCT00700427|471989488|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
131098118|NCT00700427|471989489|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
131098119|NCT00700427|471989490|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
131098120|NCT00700427|471989491|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
131098121|NCT00700427|471989487|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
131098122|NCT00700427|471989488|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
131098123|NCT00700427|471989489|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
131098124|NCT00700427|471989490|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
131098125|NCT00700427|471989491|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
131098126|NCT00700427|471989487|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
131098127|NCT00700427|471989488|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
131098128|NCT00700427|471989489|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
131098129|NCT00700427|471989490|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
131098130|NCT00700427|471989491|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
131098131|NCT00700427|471989487|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
131098132|NCT00700427|471989488|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
131098133|NCT00700427|471989489|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
131098134|NCT00700427|471989490|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
131098135|NCT00700427|471989491|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
131098136|NCT00700427|471989487|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
131098137|NCT00700427|471989488|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
131098138|NCT00700427|471989489|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
131098139|NCT00700427|471989490|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
131098140|NCT00700427|471989491|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
131098141|NCT00700427|471989487|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
131098142|NCT00700427|471989488|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
131098143|NCT00700427|471989489|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
131098144|NCT00700427|471989490|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
131098145|NCT00700427|471989491|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
131098146|NCT00700427|471989487|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
131098147|NCT00700427|471989488|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
131098148|NCT00700427|471989489|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
131098149|NCT00700427|471989490|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
131098150|NCT00700427|471989491|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
131098151|NCT00700427|471989487|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
130727756|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
130727757|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
131098152|NCT00700427|471989488|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
131098153|NCT00700427|471989489|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
131098154|NCT00700427|471989490|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
131145852|NCT00398112|472158413|FG000|Overall Study|Death|1|||
131145853|NCT05148884|472158414|FG000|Overall Study|Withdrawal by Subject|3|||
131145854|NCT05148884|472158415|FG001|Overall Study|Withdrawal by Subject|0|||
131145855|NCT05148884|472158414|FG000|Overall Study|Deep brain stimulation operation|0|||
131234787|NCT02275364|472486479|FG001|Period 1|Other reason|0|||
131098155|NCT00700427|471989491|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
131098156|NCT00700427|471989487|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
131098157|NCT00700427|471989488|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
131098158|NCT00700427|471989489|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
131098159|NCT00700427|471989490|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
131098160|NCT00700427|471989491|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
131098161|NCT00700427|471989487|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
131098162|NCT00700427|471989488|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
131098163|NCT00700427|471989489|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
131098164|NCT00700427|471989490|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
131098165|NCT00700427|471989491|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
131098166|NCT00700427|471989487|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
131098167|NCT00700427|471989488|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
131098168|NCT00700427|471989489|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
131098169|NCT00700427|471989490|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
131098170|NCT00700427|471989491|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
131098171|NCT00700427|471989487|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
131098172|NCT00700427|471989488|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
131098173|NCT00700427|471989489|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
131098174|NCT00700427|471989490|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
131098175|NCT00700427|471989491|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
131098176|NCT00700427|471989487|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
131098177|NCT00700427|471989488|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
131098178|NCT00700427|471989489|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
131098179|NCT00700427|471989490|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
131098180|NCT00700427|471989491|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
131098181|NCT00700427|471989487|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
131098182|NCT00700427|471989488|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
131098183|NCT00700427|471989489|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
131098184|NCT00700427|471989490|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
131098185|NCT00700427|471989491|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
131098186|NCT00700427|471989487|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
131098187|NCT00700427|471989488|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
131098188|NCT00700427|471989489|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
131098189|NCT00700427|471989490|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
131098190|NCT00700427|471989491|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
131098191|NCT00700427|471989487|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
131098192|NCT00700427|471989488|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
131098193|NCT00700427|471989489|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
131098194|NCT00700427|471989490|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
131098195|NCT00700427|471989491|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
131098196|NCT00700427|471989487|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
131098197|NCT00700427|471989488|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
131098198|NCT00700427|471989489|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
131098199|NCT00700427|471989490|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
131098200|NCT00700427|471989491|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
131098201|NCT03231800|471989492|FG000|Overall Study|Lost to Follow-up|0|||
131098202|NCT03231800|471989493|FG001|Overall Study|Lost to Follow-up|2|||
131098203|NCT03231800|471989492|FG000|Overall Study|Protocol Violation|1|||
131098204|NCT03231800|471989493|FG001|Overall Study|Protocol Violation|1|||
131098205|NCT03231800|471989492|FG000|Overall Study|reason not provided|2|||
131098206|NCT03231800|471989493|FG001|Overall Study|reason not provided|0|||
131098207|NCT00859222|471989494|FG000|Overall Study|Adverse Event|2|||
131098208|NCT00859222|471989495|FG001|Overall Study|Adverse Event|3|||
131098209|NCT00859222|471989496|FG002|Overall Study|Adverse Event|6|||
131098210|NCT00859222|471989497|FG003|Overall Study|Adverse Event|24|||
131145856|NCT05148884|472158415|FG001|Overall Study|Deep brain stimulation operation|1|||
131098211|NCT00859222|471989498|FG004|Overall Study|Adverse Event|15|||
131098212|NCT00859222|471989494|FG000|Overall Study|DLT|1|||
131098213|NCT00859222|471989495|FG001|Overall Study|DLT|0|||
131098214|NCT00859222|471989496|FG002|Overall Study|DLT|0|||
131098215|NCT00859222|471989497|FG003|Overall Study|DLT|0|||
131098216|NCT00859222|471989498|FG004|Overall Study|DLT|0|||
131098217|NCT00400725|471989499|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
131098218|NCT00400725|471989500|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
131098219|NCT00400725|471989501|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
131098220|NCT00400725|471989499|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
131145857|NCT00365989|472158416|FG000|Overall Study|Withdrawal by Subject|1|||
131145858|NCT00365989|472158416|FG000|Overall Study|Non-compliance|1|||
131145859|NCT00851903|472158418|FG000|Overall Study|Withdrawal by Subject|2|||
131098221|NCT00400725|471989500|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
131098222|NCT00400725|471989501|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
131098223|NCT00400725|471989499|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
131098224|NCT00400725|471989500|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
131098225|NCT00400725|471989501|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
131098226|NCT00400725|471989499|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
131098227|NCT00400725|471989500|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
131098228|NCT00400725|471989501|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
131098229|NCT00400725|471989499|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
131098230|NCT00400725|471989500|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
131098231|NCT00400725|471989501|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
131098232|NCT00400725|471989499|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
131098233|NCT00400725|471989500|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
131098234|NCT00400725|471989501|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
131098235|NCT00400725|471989499|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
131098236|NCT00400725|471989500|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
131098237|NCT00400725|471989501|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
131098238|NCT00400725|471989499|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
131098239|NCT00400725|471989500|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
131098240|NCT00400725|471989501|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
131098241|NCT00400725|471989499|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
131098242|NCT00400725|471989500|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
131098243|NCT00400725|471989501|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
131098244|NCT04075994|471989502|FG000|Overall Study|Withdrawal by Subject|8|||
131098245|NCT04075994|471989503|FG001|Overall Study|Withdrawal by Subject|9|||
131098246|NCT04075994|471989502|FG000|Overall Study|Adverse Event|2|||
131098247|NCT04075994|471989503|FG001|Overall Study|Adverse Event|2|||
131098248|NCT04075994|471989502|FG000|Overall Study|Investigator withdrew|3|||
131098249|NCT04075994|471989503|FG001|Overall Study|Investigator withdrew|1|||
131098250|NCT01941719|471989508|FG000|Overall Study|Lost to Follow-up|20|||
131098251|NCT01941719|471989509|FG001|Overall Study|Lost to Follow-up|19|||
131098252|NCT00252577|471989510|FG000|Overall Study|Lost to Follow-up|20|||
131098253|NCT01744392|471989513|FG000|Overall Study|Physician Decision|1|||
131098254|NCT01416389|471989514|FG000|Overall Study|Lost to Follow-up|1|||
131098255|NCT01416389|471989515|FG001|Overall Study|Lost to Follow-up|0|||
131098256|NCT01416389|471989514|FG000|Overall Study|Started New Therapy|2|||
131098257|NCT01416389|471989515|FG001|Overall Study|Started New Therapy|0|||
131098258|NCT01125514|471989516|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
131098259|NCT01125514|471989516|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
131098260|NCT01125514|471989516|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
131098261|NCT01125514|471989516|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
131098262|NCT01125514|471989516|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
131098263|NCT01125514|471989516|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
131098264|NCT00858364|471989519|FG000|Overall Study|Administrative Decision|3|||
131098265|NCT00858364|471989520|FG001|Overall Study|Administrative Decision|2|||
131098266|NCT00858364|471989519|FG000|Overall Study|Adverse Event|5|||
131098267|NCT00858364|471989520|FG001|Overall Study|Adverse Event|2|||
131098268|NCT00858364|471989519|FG000|Overall Study|Withdrawal by Subject|44|||
131098269|NCT00858364|471989520|FG001|Overall Study|Withdrawal by Subject|118|||
131098270|NCT00858364|471989519|FG000|Overall Study|Ineligibility Determined|1|||
131098271|NCT00858364|471989520|FG001|Overall Study|Ineligibility Determined|10|||
131098272|NCT00858364|471989519|FG000|Overall Study|Lost to Follow-up|24|||
131098273|NCT00858364|471989520|FG001|Overall Study|Lost to Follow-up|54|||
131098274|NCT00858364|471989519|FG000|Overall Study|Noncompliance|3|||
131098275|NCT00858364|471989520|FG001|Overall Study|Noncompliance|4|||
131145860|NCT02318095|472158419|FG000|Overall Study|Adverse Event|1|||
131145861|NCT00686127|472158420|FG000|Overall Study|Withdrawal by Subject|14|||
131098276|NCT00858364|471989519|FG000|Overall Study|Protocol Deviation|0|||
131098277|NCT00858364|471989520|FG001|Overall Study|Protocol Deviation|2|||
131098278|NCT00858364|471989519|FG000|Overall Study|Other|9|||
131098279|NCT00858364|471989520|FG001|Overall Study|Other|17|||
131098280|NCT00858364|471989519|FG000|Overall Study|Missing|1|||
131098281|NCT00858364|471989520|FG001|Overall Study|Missing|1|||
131098282|NCT00858364|471989519|FG000|Overall Study|Still on-study|114|||
131098283|NCT00858364|471989520|FG001|Overall Study|Still on-study|247|||
131098284|NCT02755818|471989521|FG000|Overall Study|Withdrawal by Subject|0|||
131098285|NCT02755818|471989522|FG001|Overall Study|Withdrawal by Subject|0|||
131098286|NCT02755818|471989523|FG002|Overall Study|Withdrawal by Subject|0|||
131145862|NCT00686127|472158421|FG001|Overall Study|Withdrawal by Subject|6|||
131098287|NCT02755818|471989524|FG003|Overall Study|Withdrawal by Subject|2|||
131098288|NCT02755818|471989521|FG000|Overall Study|withdrawal by PI|0|||
131098289|NCT02755818|471989522|FG001|Overall Study|withdrawal by PI|0|||
131098290|NCT02755818|471989523|FG002|Overall Study|withdrawal by PI|1|||
131145863|NCT02300129|472158422|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
131098291|NCT02755818|471989524|FG003|Overall Study|withdrawal by PI|1|||
131098292|NCT02535091|471989532|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
131098293|NCT02535091|471989533|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
131098294|NCT02535091|471989534|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
131098295|NCT02535091|471989532|FG000|Overall Study|Withdrawal by Subject|14|||
131098296|NCT02535091|471989533|FG001|Overall Study|Withdrawal by Subject|5|||
131098297|NCT02535091|471989534|FG002|Overall Study|Withdrawal by Subject|121|||
131098298|NCT02535091|471989532|FG000|Overall Study|Adverse Event|9|||
131098299|NCT02535091|471989533|FG001|Overall Study|Adverse Event|4|||
131098300|NCT02535091|471989534|FG002|Overall Study|Adverse Event|170|||
131098301|NCT02535091|471989532|FG000|Overall Study|Other|4|||
131098302|NCT02535091|471989533|FG001|Overall Study|Other|3|||
131098303|NCT02535091|471989534|FG002|Overall Study|Other|81|||
131098304|NCT02535091|471989532|FG000|Overall Study|Lost to Follow-up|0|||
131098305|NCT02535091|471989533|FG001|Overall Study|Lost to Follow-up|1|||
131098306|NCT02535091|471989534|FG002|Overall Study|Lost to Follow-up|19|||
131098307|NCT02535091|471989532|FG000|Overall Study|Protocol Violation|0|||
131098308|NCT02535091|471989533|FG001|Overall Study|Protocol Violation|1|||
131098309|NCT02535091|471989534|FG002|Overall Study|Protocol Violation|11|||
131098310|NCT02535091|471989532|FG000|Overall Study|Pregnancy|0|||
131098311|NCT02535091|471989533|FG001|Overall Study|Pregnancy|0|||
131098312|NCT02535091|471989534|FG002|Overall Study|Pregnancy|7|||
131098313|NCT03223662|471989535|FG000|Overall Study|Physician Decision|1|||
131098314|NCT03223662|471989535|FG000|Overall Study|Study closure|1|||
131098315|NCT02217475|471989536|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
131098316|NCT02217475|471989537|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
131098317|NCT02217475|471989538|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
131098318|NCT02217475|471989536|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
131098319|NCT02217475|471989537|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
131098320|NCT02217475|471989538|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
131098321|NCT02217475|471989536|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
131098322|NCT02217475|471989537|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
131098323|NCT02217475|471989538|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
131098324|NCT02217475|471989536|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
131098325|NCT02217475|471989537|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
131098326|NCT02217475|471989538|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
131098327|NCT02217475|471989536|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
131098328|NCT02217475|471989537|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
131098329|NCT02217475|471989538|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
131098330|NCT02217475|471989536|FG000|Discontinued After Period 1|Adverse Event|1|||
131098331|NCT02217475|471989537|FG001|Discontinued After Period 1|Adverse Event|2|||
131098332|NCT02217475|471989538|FG002|Discontinued After Period 1|Adverse Event|0|||
131098333|NCT02217475|471989536|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
131098334|NCT02217475|471989537|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
131098335|NCT02217475|471989538|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
131098336|NCT02217475|471989536|FG000|Discontinued After Period 1|Physician Decision|0|||
131098337|NCT02217475|471989537|FG001|Discontinued After Period 1|Physician Decision|0|||
131098338|NCT02217475|471989538|FG002|Discontinued After Period 1|Physician Decision|1|||
131098339|NCT02217475|471989536|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
131098340|NCT02217475|471989537|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
131098341|NCT02217475|471989538|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
131098342|NCT02217475|471989536|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
131098343|NCT02217475|471989537|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
131098344|NCT02217475|471989538|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
131145864|NCT02300129|472158423|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
131145865|NCT02300129|472158424|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
131145866|NCT02300129|472158425|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
131145867|NCT02300129|472158422|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
131145868|NCT02300129|472158423|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
131145869|NCT02300129|472158424|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
131145870|NCT02300129|472158425|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
131145871|NCT02300129|472158422|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
131145872|NCT02300129|472158423|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
131145873|NCT02300129|472158424|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
131145874|NCT02300129|472158425|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
131098345|NCT02217475|471989536|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
131098346|NCT02217475|471989537|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
131098347|NCT02217475|471989538|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
131098348|NCT02217475|471989536|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
131145875|NCT00522392|472158428|FG000|Overall Study|Disease progression|0|||
131145876|NCT00522392|472158429|FG001|Overall Study|Disease progression|3|||
131234788|NCT00661999|472486480|FG000|Overall Study|Adverse Event|11|||
130727758|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
130727759|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
130727760|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
130727761|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
130727762|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
131098349|NCT02217475|471989537|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
131098350|NCT02217475|471989538|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
131098351|NCT02217475|471989536|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
131098352|NCT02217475|471989537|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
131098353|NCT02217475|471989538|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
131098354|NCT01215188|471989539|FG000|Overall Study|Lost to Follow-up|22|||
131098355|NCT01215188|471989540|FG001|Overall Study|Lost to Follow-up|22|||
131098356|NCT01215188|471989541|FG002|Overall Study|Lost to Follow-up|16|||
131098357|NCT01215188|471989539|FG000|Overall Study|Adverse Event|1|||
131098358|NCT01215188|471989540|FG001|Overall Study|Adverse Event|1|||
131098359|NCT01215188|471989541|FG002|Overall Study|Adverse Event|3|||
131098360|NCT01215188|471989539|FG000|Overall Study|Physician Decision|2|||
131098361|NCT01215188|471989540|FG001|Overall Study|Physician Decision|1|||
131098362|NCT01215188|471989541|FG002|Overall Study|Physician Decision|0|||
131098363|NCT01215188|471989539|FG000|Overall Study|Lack of Efficacy|0|||
131098364|NCT01215188|471989540|FG001|Overall Study|Lack of Efficacy|0|||
131098365|NCT01215188|471989541|FG002|Overall Study|Lack of Efficacy|1|||
131098366|NCT01215188|471989539|FG000|Overall Study|Protocol Violation|1|||
131098367|NCT01215188|471989540|FG001|Overall Study|Protocol Violation|1|||
131098368|NCT01215188|471989541|FG002|Overall Study|Protocol Violation|1|||
131098369|NCT01215188|471989539|FG000|Overall Study|Withdrawal by Subject|32|||
131098370|NCT01215188|471989540|FG001|Overall Study|Withdrawal by Subject|34|||
131098371|NCT01215188|471989541|FG002|Overall Study|Withdrawal by Subject|31|||
131098372|NCT01012414|471989542|FG000|Overall Study|Withdrawal by Subject|2|||
131098373|NCT01012414|471989542|FG000|Overall Study|Lost to Follow-up|1|||
131098374|NCT01012414|471989542|FG000|Overall Study|Trial was stopped before completed|7|||
131098375|NCT00506441|471989543|FG000|Period 1; Open-label Period|Adverse Event|21|||
131098376|NCT00506441|471989544|FG001|Period 1; Open-label Period|Adverse Event|0|||
131098377|NCT00506441|471989543|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
131098378|NCT00506441|471989544|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
131098379|NCT00506441|471989543|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
131098380|NCT00506441|471989544|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
131098381|NCT00506441|471989543|FG000|Period 1; Open-label Period|Physician Decision|5|||
131098382|NCT00506441|471989544|FG001|Period 1; Open-label Period|Physician Decision|0|||
131098383|NCT00506441|471989543|FG000|Period 1; Open-label Period|Protocol Violation|9|||
131098384|NCT00506441|471989544|FG001|Period 1; Open-label Period|Protocol Violation|0|||
131098385|NCT00506441|471989543|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
131098386|NCT00506441|471989544|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
131098387|NCT00506441|471989543|FG000|Period 1; Open-label Period|Other Reasons|13|||
131098388|NCT00506441|471989544|FG001|Period 1; Open-label Period|Other Reasons|0|||
131098389|NCT00506441|471989543|FG000|Period 2; Double-blind Period|Adverse Event|0|||
131098390|NCT00506441|471989544|FG001|Period 2; Double-blind Period|Adverse Event|1|||
131098391|NCT00506441|471989543|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
131098392|NCT00506441|471989544|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
131098393|NCT00506441|471989543|FG000|Period 2; Double-blind Period|Physician Decision|1|||
131098394|NCT00506441|471989544|FG001|Period 2; Double-blind Period|Physician Decision|1|||
131098395|NCT00506441|471989543|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
131098396|NCT00506441|471989544|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
131098397|NCT00506441|471989543|FG000|Period 2; Double-blind Period|Other Reason|1|||
131098398|NCT00506441|471989544|FG001|Period 2; Double-blind Period|Other Reason|1|||
131098399|NCT02601300|471989545|FG000|Induction Phase|Lack of Efficacy|2|||
131098400|NCT02601300|471989545|FG000|Induction Phase|Protocol Violation|1|||
131098401|NCT02601300|471989545|FG000|Extension Phase|Withdrawal by Subject|3|||
131098402|NCT02601300|471989545|FG000|Extension Phase|Adverse Event|4|||
131098403|NCT02601300|471989545|FG000|Extension Phase|Lack of Efficacy|10|||
130727763|NCT02952586|470625548|FG000|CRT for IMRT (63 Days)|Other|1|||
130727764|NCT02952586|470625549|FG001|CRT for IMRT (63 Days)|Other|0|||
131098404|NCT00528931|471989547|FG000|Overall Study|Lost to Follow-up|1|||
131098405|NCT00992225|471989548|FG000|Overall Study|Entry Criteria Not Met|8|||
131098406|NCT00992225|471989548|FG000|Overall Study|Adverse Event|2|||
131098407|NCT00291642|471989549|FG000|Overall Study|Adverse Event|1|||
131098408|NCT00291642|471989550|FG001|Overall Study|Adverse Event|0|||
131098409|NCT00291642|471989551|FG002|Overall Study|Adverse Event|1|||
131098410|NCT00291642|471989552|FG003|Overall Study|Adverse Event|0|||
131098411|NCT00291642|471989553|FG004|Overall Study|Adverse Event|1|||
131098412|NCT00291642|471989549|FG000|Overall Study|Patient missed visit|0|||
131098413|NCT00291642|471989550|FG001|Overall Study|Patient missed visit|0|||
131098414|NCT00291642|471989551|FG002|Overall Study|Patient missed visit|1|||
131098415|NCT00291642|471989552|FG003|Overall Study|Patient missed visit|0|||
131098416|NCT00291642|471989553|FG004|Overall Study|Patient missed visit|0|||
131098417|NCT00291642|471989549|FG000|Overall Study|Intake of prohibited medication|1|||
131098418|NCT00291642|471989550|FG001|Overall Study|Intake of prohibited medication|0|||
131098419|NCT00291642|471989551|FG002|Overall Study|Intake of prohibited medication|0|||
131098420|NCT00291642|471989552|FG003|Overall Study|Intake of prohibited medication|0|||
131098421|NCT00291642|471989553|FG004|Overall Study|Intake of prohibited medication|0|||
131098422|NCT02576587|471989558|FG000|Baseline|Equipment failure|0|||
131098423|NCT02576587|471989559|FG001|Baseline|Equipment failure|1|||
131098424|NCT02576587|471989558|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
131098425|NCT02576587|471989559|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
131098426|NCT02576587|471989558|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
131098427|NCT02576587|471989559|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
131098428|NCT02576587|471989558|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
131098429|NCT02576587|471989559|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
131098430|NCT00532493|471989560|FG000|Overall Study|Death|1|||
131098431|NCT00532493|471989561|FG001|Overall Study|Death|1|||
131098432|NCT00532493|471989560|FG000|Overall Study|Lost to Follow-up|10|||
131098433|NCT00532493|471989561|FG001|Overall Study|Lost to Follow-up|7|||
131098434|NCT00532493|471989560|FG000|Overall Study|Withdrawal by Subject|7|||
131098435|NCT00532493|471989561|FG001|Overall Study|Withdrawal by Subject|9|||
131098436|NCT00532493|471989560|FG000|Overall Study|Physician Decision|1|||
131098437|NCT00532493|471989561|FG001|Overall Study|Physician Decision|6|||
131098438|NCT00532493|471989560|FG000|Overall Study|Adverse Event|6|||
131145877|NCT00522392|472158428|FG000|Overall Study|Adverse Event|7|||
131145878|NCT00522392|472158429|FG001|Overall Study|Adverse Event|7|||
131145879|NCT00522392|472158428|FG000|Overall Study|Withdrawal by Subject|1|||
131145880|NCT00522392|472158429|FG001|Overall Study|Withdrawal by Subject|1|||
131145881|NCT00522392|472158428|FG000|Overall Study|Physician Decision|0|||
131098439|NCT00532493|471989561|FG001|Overall Study|Adverse Event|5|||
131098440|NCT00532493|471989560|FG000|Overall Study|Protocol Deviation|1|||
131098441|NCT00532493|471989561|FG001|Overall Study|Protocol Deviation|0|||
131098442|NCT00532493|471989560|FG000|Overall Study|Subject Moved Away|3|||
131098443|NCT00532493|471989561|FG001|Overall Study|Subject Moved Away|1|||
131098444|NCT00532493|471989560|FG000|Overall Study|Contraindicative Medication|1|||
131098445|NCT00532493|471989561|FG001|Overall Study|Contraindicative Medication|0|||
131098446|NCT01036438|471989562|FG000|Overall Study|Adverse Event|7|||
131098447|NCT01036438|471989563|FG001|Overall Study|Adverse Event|8|||
131098448|NCT01036438|471989562|FG000|Overall Study|Death|0|||
131098449|NCT01036438|471989563|FG001|Overall Study|Death|1|||
131098450|NCT01036438|471989562|FG000|Overall Study|No effect of study treatment|3|||
131098451|NCT01036438|471989563|FG001|Overall Study|No effect of study treatment|1|||
131145882|NCT00522392|472158429|FG001|Overall Study|Physician Decision|1|||
131145883|NCT00522392|472158428|FG000|Overall Study|Non-compliance|0|||
131145884|NCT00522392|472158429|FG001|Overall Study|Non-compliance|1|||
131145885|NCT00430755|472158430|FG000|Overall Study|Withdrawal by Subject|53|||
131145886|NCT00103012|472158431|FG000|Overall Study|Withdrawal by Subject|2|||
131145887|NCT00103012|472158432|FG001|Overall Study|Withdrawal by Subject|1|||
131145888|NCT00103012|472158433|FG002|Overall Study|Withdrawal by Subject|2|||
131145889|NCT00103012|472158431|FG000|Overall Study|Pregnancy|1|||
131145890|NCT00103012|472158432|FG001|Overall Study|Pregnancy|0|||
131145891|NCT00103012|472158433|FG002|Overall Study|Pregnancy|0|||
131145892|NCT00103012|472158431|FG000|Overall Study|Adverse Event|0|||
131145893|NCT00103012|472158432|FG001|Overall Study|Adverse Event|0|||
131098452|NCT00888927|471989564|FG000|Overall Study|Adverse Event|0|||
131098453|NCT00888927|471989565|FG001|Overall Study|Adverse Event|0|||
131098454|NCT00888927|471989566|FG002|Overall Study|Adverse Event|0|||
131098455|NCT00888927|471989567|FG003|Overall Study|Adverse Event|1|||
131145894|NCT00103012|472158433|FG002|Overall Study|Adverse Event|1|||
131145895|NCT00103012|472158431|FG000|Overall Study|Subject non-compliant with medications|0|||
131145896|NCT00103012|472158432|FG001|Overall Study|Subject non-compliant with medications|0|||
131145897|NCT00103012|472158433|FG002|Overall Study|Subject non-compliant with medications|1|||
131145898|NCT05211336|472158440|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
131145899|NCT05211336|472158441|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
131145900|NCT05211336|472158440|FG000|Overall Study|Progressive disease|0|||
131098456|NCT00888927|471989564|FG000|Overall Study|Withdrawal of consent|0|||
131098457|NCT00888927|471989565|FG001|Overall Study|Withdrawal of consent|0|||
131098458|NCT00888927|471989566|FG002|Overall Study|Withdrawal of consent|0|||
131098459|NCT00888927|471989567|FG003|Overall Study|Withdrawal of consent|1|||
131098460|NCT03459443|471989568|FG000|Overall Study|Lack of Efficacy|3|||
131098461|NCT03459443|471989568|FG000|Overall Study|Adverse Event|1|||
131098462|NCT03459443|471989568|FG000|Overall Study|Sponsor's decision to close the study|18|||
131098463|NCT03702231|471989569|FG000|Overall Study|Withdrawal by Subject|1|||
131145901|NCT05211336|472158441|FG001|Overall Study|Progressive disease|4|||
131145902|NCT05211336|472158440|FG000|Overall Study|Death due to myocardial infarction|0|||
131145903|NCT05211336|472158441|FG001|Overall Study|Death due to myocardial infarction|1|||
131145904|NCT05211336|472158440|FG000|Overall Study|Death due to unknown cause|0|||
131145905|NCT05211336|472158441|FG001|Overall Study|Death due to unknown cause|1|||
131098464|NCT03702231|471989570|FG001|Overall Study|Withdrawal by Subject|0|||
131098465|NCT03702231|471989571|FG002|Overall Study|Withdrawal by Subject|0|||
131098466|NCT03702231|471989569|FG000|Overall Study|Protocol Violation|0|||
131098467|NCT03702231|471989570|FG001|Overall Study|Protocol Violation|0|||
131098468|NCT03702231|471989571|FG002|Overall Study|Protocol Violation|1|||
131098469|NCT03702231|471989569|FG000|Overall Study|Change in CLL Treatment|0|||
131098470|NCT03702231|471989570|FG001|Overall Study|Change in CLL Treatment|0|||
131098471|NCT03702231|471989571|FG002|Overall Study|Change in CLL Treatment|1|||
131098472|NCT03702231|471989569|FG000|Overall Study|COVID Pandemic|1|||
131098473|NCT03702231|471989570|FG001|Overall Study|COVID Pandemic|4|||
131098474|NCT03702231|471989571|FG002|Overall Study|COVID Pandemic|1|||
131098475|NCT03702231|471989569|FG000|Overall Study|Non-compliance|0|||
131098476|NCT03702231|471989570|FG001|Overall Study|Non-compliance|0|||
131098477|NCT03702231|471989571|FG002|Overall Study|Non-compliance|1|||
131098478|NCT03590366|471989572|FG000|Overall Study|Adverse Event|0|||
131098479|NCT03590366|471989573|FG001|Overall Study|Adverse Event|3|||
131098480|NCT03590366|471989572|FG000|Overall Study|Lost to Follow-up|3|||
131098481|NCT03590366|471989573|FG001|Overall Study|Lost to Follow-up|3|||
131098482|NCT03590366|471989572|FG000|Overall Study|Withdrawal by Subject|0|||
131098483|NCT03590366|471989573|FG001|Overall Study|Withdrawal by Subject|2|||
131098484|NCT04927247|471989576|FG000|Overall Study|Other|2|||
131098485|NCT04927247|471989577|FG001|Overall Study|Other|1|||
131098486|NCT04927247|471989576|FG000|Overall Study|Physician Decision|0|||
131098487|NCT04927247|471989577|FG001|Overall Study|Physician Decision|1|||
131098488|NCT04927247|471989576|FG000|Overall Study|Adverse Event|1|||
131098489|NCT04927247|471989577|FG001|Overall Study|Adverse Event|0|||
131098490|NCT00513305|471989581|FG000|Overall Study|Adverse Event|6|||
131098491|NCT00513305|471989582|FG001|Overall Study|Adverse Event|2|||
131098492|NCT00513305|471989581|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
131098493|NCT00513305|471989582|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
131098494|NCT00513305|471989581|FG000|Overall Study|Lack of Efficacy|8|||
131098495|NCT00513305|471989582|FG001|Overall Study|Lack of Efficacy|13|||
131098496|NCT00513305|471989581|FG000|Overall Study|Withdrawal by Subject|1|||
131098497|NCT00513305|471989582|FG001|Overall Study|Withdrawal by Subject|2|||
131098498|NCT00513305|471989581|FG000|Overall Study|Disease progression|8|||
131098499|NCT00513305|471989582|FG001|Overall Study|Disease progression|5|||
131098500|NCT00513305|471989581|FG000|Overall Study|Eligible for stem cell transplant|1|||
131098501|NCT00513305|471989582|FG001|Overall Study|Eligible for stem cell transplant|0|||
131098502|NCT00513305|471989581|FG000|Overall Study|Hematologic counts did not recover|1|||
131098503|NCT00513305|471989582|FG001|Overall Study|Hematologic counts did not recover|0|||
131098504|NCT00513305|471989581|FG000|Overall Study|Physician Decision|1|||
131098505|NCT00513305|471989582|FG001|Overall Study|Physician Decision|0|||
131098506|NCT00513305|471989581|FG000|Overall Study|Persistent hypocellularity|0|||
131098507|NCT00513305|471989582|FG001|Overall Study|Persistent hypocellularity|1|||
131098508|NCT00513305|471989581|FG000|Overall Study|Sponsor Decision|0|||
131098509|NCT00513305|471989582|FG001|Overall Study|Sponsor Decision|2|||
131098510|NCT05597787|471989593|FG000|Overall Study|Withdrawal by Subject|0|||
131098511|NCT05597787|471989594|FG001|Overall Study|Withdrawal by Subject|0|||
131098512|NCT05597787|471989595|FG002|Overall Study|Withdrawal by Subject|1|||
131098513|NCT05453201|471989597|FG000|Overall Study|Withdrawal by Subject|1|||
131098514|NCT03798691|471989598|FG000|Overall Study|Lost to Follow-up|2|||
131098515|NCT03798691|471989599|FG001|Overall Study|Lost to Follow-up|2|||
131098516|NCT02489968|471989603|FG000|Open-label Treatment Period|Adverse Event|14|||
131098517|NCT02489968|471989604|FG001|Open-label Treatment Period|Adverse Event|7|||
131098518|NCT02489968|471989605|FG002|Open-label Treatment Period|Adverse Event|0|||
131098519|NCT02489968|471989606|FG003|Open-label Treatment Period|Adverse Event|0|||
131098520|NCT02489968|471989607|FG004|Open-label Treatment Period|Adverse Event|0|||
131098521|NCT02489968|471989608|FG005|Open-label Treatment Period|Adverse Event|0|||
131098522|NCT02489968|471989603|FG000|Open-label Treatment Period|Protocol Violation|2|||
131234789|NCT00661999|472486481|FG001|Overall Study|Adverse Event|5|||
131098523|NCT02489968|471989604|FG001|Open-label Treatment Period|Protocol Violation|2|||
131098524|NCT02489968|471989605|FG002|Open-label Treatment Period|Protocol Violation|0|||
131098525|NCT02489968|471989606|FG003|Open-label Treatment Period|Protocol Violation|0|||
131098526|NCT02489968|471989607|FG004|Open-label Treatment Period|Protocol Violation|0|||
131098527|NCT02489968|471989608|FG005|Open-label Treatment Period|Protocol Violation|0|||
131098528|NCT02489968|471989603|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
131098529|NCT02489968|471989604|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
131098530|NCT02489968|471989605|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
131098531|NCT02489968|471989606|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
131098532|NCT02489968|471989607|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
131098533|NCT02489968|471989608|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
131234790|NCT00661999|472486482|FG002|Overall Study|Adverse Event|8|||
130780289|NCT01261390|470821484|FG000|Overall Study|Significant Concurrent Illness|1|||
131098534|NCT02489968|471989603|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
131098535|NCT02489968|471989604|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
130780290|NCT01261390|470821485|FG001|Overall Study|Significant Concurrent Illness|0|||
131098536|NCT02489968|471989605|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
131098537|NCT02489968|471989606|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
131098538|NCT02489968|471989607|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
131098539|NCT02489968|471989608|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
131098540|NCT02489968|471989603|FG000|Open-label Treatment Period|Other than specified above|204|||
131098541|NCT02489968|471989604|FG001|Open-label Treatment Period|Other than specified above|189|||
131098542|NCT02489968|471989605|FG002|Open-label Treatment Period|Other than specified above|0|||
131098543|NCT02489968|471989606|FG003|Open-label Treatment Period|Other than specified above|0|||
131098544|NCT02489968|471989607|FG004|Open-label Treatment Period|Other than specified above|0|||
131098545|NCT02489968|471989608|FG005|Open-label Treatment Period|Other than specified above|0|||
131098546|NCT02489968|471989603|FG000|Double-blind Treatment Period|Adverse Event|0|||
131098547|NCT02489968|471989604|FG001|Double-blind Treatment Period|Adverse Event|0|||
131098548|NCT02489968|471989605|FG002|Double-blind Treatment Period|Adverse Event|2|||
131098549|NCT02489968|471989606|FG003|Double-blind Treatment Period|Adverse Event|6|||
131098550|NCT02489968|471989607|FG004|Double-blind Treatment Period|Adverse Event|4|||
131098551|NCT02489968|471989608|FG005|Double-blind Treatment Period|Adverse Event|5|||
131098552|NCT02489968|471989603|FG000|Double-blind Treatment Period|Protocol Violation|0|||
131098553|NCT02489968|471989604|FG001|Double-blind Treatment Period|Protocol Violation|0|||
131098554|NCT02489968|471989605|FG002|Double-blind Treatment Period|Protocol Violation|0|||
131098555|NCT02489968|471989606|FG003|Double-blind Treatment Period|Protocol Violation|0|||
131098556|NCT02489968|471989607|FG004|Double-blind Treatment Period|Protocol Violation|1|||
131098557|NCT02489968|471989608|FG005|Double-blind Treatment Period|Protocol Violation|1|||
131098558|NCT02489968|471989603|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
131098559|NCT02489968|471989604|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
131098560|NCT02489968|471989605|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131098561|NCT02489968|471989606|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
131098562|NCT02489968|471989607|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
131098563|NCT02489968|471989608|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
131098564|NCT02489968|471989603|FG000|Double-blind Treatment Period|Other than specified above|0|||
131098565|NCT02489968|471989604|FG001|Double-blind Treatment Period|Other than specified above|0|||
131098566|NCT02489968|471989605|FG002|Double-blind Treatment Period|Other than specified above|0|||
131098567|NCT02489968|471989606|FG003|Double-blind Treatment Period|Other than specified above|0|||
131098568|NCT02489968|471989607|FG004|Double-blind Treatment Period|Other than specified above|1|||
131098569|NCT02489968|471989608|FG005|Double-blind Treatment Period|Other than specified above|0|||
131098570|NCT01865747|471989610|FG000|Overall Study (ITT)|Adverse Event|32|||
131098571|NCT01865747|471989611|FG001|Overall Study (ITT)|Adverse Event|31|||
131098572|NCT01865747|471989610|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
131098573|NCT01865747|471989611|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
131098574|NCT01865747|471989610|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
131098575|NCT01865747|471989611|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
131098576|NCT01865747|471989610|FG000|Overall Study (ITT)|Protocol Violation|1|||
131098577|NCT01865747|471989611|FG001|Overall Study (ITT)|Protocol Violation|1|||
131098578|NCT01865747|471989610|FG000|Overall Study (ITT)|Physician Decision|5|||
131098579|NCT01865747|471989611|FG001|Overall Study (ITT)|Physician Decision|2|||
131098580|NCT01865747|471989610|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
131098581|NCT01865747|471989611|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
131098582|NCT01865747|471989610|FG000|Overall Study (ITT)|Sponsor Decision|0|||
131098583|NCT01865747|471989611|FG001|Overall Study (ITT)|Sponsor Decision|1|||
131098584|NCT01865747|471989610|FG000|Overall Study (ITT)|Progressive Disease|122|||
131098585|NCT01865747|471989611|FG001|Overall Study (ITT)|Progressive Disease|158|||
131098586|NCT01865747|471989610|FG000|Overall Study (ITT)|Reason Not Provided|0|||
131098587|NCT01865747|471989611|FG001|Overall Study (ITT)|Reason Not Provided|1|||
131098588|NCT01865747|471989610|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
131098589|NCT01865747|471989611|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
131098590|NCT01865747|471989610|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
131098591|NCT01865747|471989611|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
131098592|NCT01865747|471989610|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
131098593|NCT01865747|471989611|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
131098594|NCT01865747|471989610|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
131098595|NCT01865747|471989611|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
131098596|NCT01865747|471989610|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
131098597|NCT01865747|471989611|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
131098598|NCT01865747|471989610|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
131098599|NCT01865747|471989611|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
131098600|NCT01865747|471989610|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
131098601|NCT01865747|471989611|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
131098602|NCT01865747|471989610|FG000|Primary Intent to Treat (PITT)|Other|0|||
131098603|NCT01865747|471989611|FG001|Primary Intent to Treat (PITT)|Other|1|||
131098604|NCT02592876|471989612|FG000|Overall Study|Withdrawal by Subject|3|||
131098605|NCT02592876|471989613|FG001|Overall Study|Withdrawal by Subject|3|||
131098606|NCT02592876|471989612|FG000|Overall Study|Study Termination by Sponsor|32|||
131098607|NCT02592876|471989613|FG001|Overall Study|Study Termination by Sponsor|27|||
131098608|NCT02592876|471989612|FG000|Overall Study|Lost to Follow-up|0|||
131098609|NCT02592876|471989613|FG001|Overall Study|Lost to Follow-up|1|||
131098610|NCT02592876|471989612|FG000|Overall Study|Death|6|||
131098611|NCT02592876|471989613|FG001|Overall Study|Death|9|||
131098612|NCT00611975|471989618|FG000|Overall Study|Withdrawal by Subject|3|||
131098613|NCT00611975|471989619|FG001|Overall Study|Withdrawal by Subject|7|||
131098614|NCT00611975|471989618|FG000|Overall Study|Pregnancy|2|||
131098615|NCT00611975|471989619|FG001|Overall Study|Pregnancy|1|||
131098616|NCT03465904|471989620|FG000|Overall Study|Withdrawal by Subject|9|||
131098617|NCT03465904|471989621|FG001|Overall Study|Withdrawal by Subject|5|||
131098618|NCT03465904|471989620|FG000|Overall Study|Lost to Follow-up|11|||
131098619|NCT03465904|471989621|FG001|Overall Study|Lost to Follow-up|9|||
131098620|NCT03465904|471989620|FG000|Overall Study|Protocol Violation|20|||
131098621|NCT03465904|471989621|FG001|Overall Study|Protocol Violation|15|||
131098622|NCT01305200|471989623|FG000|Overall Study|Physician Decision|4|||
131098623|NCT01305200|471989624|FG001|Overall Study|Physician Decision|6|||
131098624|NCT01305200|471989625|FG002|Overall Study|Physician Decision|1|||
131098625|NCT01305200|471989623|FG000|Overall Study|Withdrawal by Subject|24|||
131098626|NCT01305200|471989624|FG001|Overall Study|Withdrawal by Subject|21|||
131098627|NCT01305200|471989625|FG002|Overall Study|Withdrawal by Subject|1|||
131098628|NCT01305200|471989623|FG000|Overall Study|Ineligible|1|||
131098629|NCT01305200|471989624|FG001|Overall Study|Ineligible|2|||
131098630|NCT01305200|471989625|FG002|Overall Study|Ineligible|1|||
131098631|NCT01305200|471989623|FG000|Overall Study|Death|0|||
131098632|NCT01305200|471989624|FG001|Overall Study|Death|2|||
131098633|NCT01305200|471989625|FG002|Overall Study|Death|0|||
131145906|NCT05211336|472158440|FG000|Overall Study|Worsening kidney function and quality of response|0|||
131145907|NCT05211336|472158441|FG001|Overall Study|Worsening kidney function and quality of response|1|||
131145908|NCT05019131|472158450|FG000|Overall Study|Lost to Follow-up|0|||
131145909|NCT05019131|472158451|FG001|Overall Study|Lost to Follow-up|3|||
131145910|NCT03575104|472158452|FG000|Overall Study|Adverse Event|4|||
131145911|NCT03575104|472158453|FG001|Overall Study|Adverse Event|3|||
131145912|NCT03575104|472158454|FG002|Overall Study|Adverse Event|4|||
131145913|NCT03575104|472158452|FG000|Overall Study|Withdrawal by Subject|13|||
131145914|NCT03575104|472158453|FG001|Overall Study|Withdrawal by Subject|16|||
131145915|NCT03575104|472158454|FG002|Overall Study|Withdrawal by Subject|11|||
131145916|NCT03575104|472158452|FG000|Overall Study|Other reasons|6|||
131145917|NCT03575104|472158453|FG001|Overall Study|Other reasons|8|||
131145918|NCT03575104|472158454|FG002|Overall Study|Other reasons|6|||
131145919|NCT03575104|472158452|FG000|Overall Study|Lost to Follow-up|1|||
131145920|NCT03575104|472158453|FG001|Overall Study|Lost to Follow-up|2|||
131145921|NCT03575104|472158454|FG002|Overall Study|Lost to Follow-up|1|||
131145922|NCT00332709|472158455|FG000|Overall Study|Adverse Event|11|||
131145923|NCT00332709|472158456|FG001|Overall Study|Adverse Event|14|||
131145924|NCT00332709|472158455|FG000|Overall Study|Withdrawal by Subject|2|||
131145925|NCT00332709|472158456|FG001|Overall Study|Withdrawal by Subject|3|||
131145926|NCT00332709|472158455|FG000|Overall Study|Lost to Follow-up|2|||
131145927|NCT00332709|472158456|FG001|Overall Study|Lost to Follow-up|0|||
131145928|NCT00332709|472158455|FG000|Overall Study|Administrative Problems|0|||
131145929|NCT00332709|472158456|FG001|Overall Study|Administrative Problems|3|||
131145930|NCT00332709|472158455|FG000|Overall Study|Abnormal test procedure result|1|||
131145931|NCT00332709|472158456|FG001|Overall Study|Abnormal test procedure result|0|||
131145932|NCT04684420|472158457|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131145933|NCT04684420|472158458|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
131145934|NCT04684420|472158459|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
131145935|NCT04684420|472158460|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
131145936|NCT04684420|472158457|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
131145937|NCT04684420|472158458|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
131145938|NCT04684420|472158459|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
131145939|NCT04684420|472158460|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
131145940|NCT03480802|472158463|FG000|Overall Study|Lost to Follow-up|5|||
131145941|NCT03480802|472158464|FG001|Overall Study|Lost to Follow-up|1|||
131145942|NCT03480802|472158463|FG000|Overall Study|Withdrawal by Subject|2|||
131145943|NCT03480802|472158464|FG001|Overall Study|Withdrawal by Subject|1|||
131145944|NCT03480802|472158463|FG000|Overall Study|Relocated|0|||
131145945|NCT03480802|472158464|FG001|Overall Study|Relocated|1|||
131145946|NCT01409928|472158465|FG000|Overall Study|Physician Decision|12|||
131145947|NCT03155997|472158468|FG000|Overall Study|Withdrawal by Subject|119|||
131145948|NCT03155997|472158469|FG001|Overall Study|Withdrawal by Subject|134|||
131145949|NCT03155997|472158468|FG000|Overall Study|Lost to Follow-up|12|||
131145950|NCT03155997|472158469|FG001|Overall Study|Lost to Follow-up|13|||
131145951|NCT03155997|472158468|FG000|Overall Study|Missing disposition data|0|||
131145952|NCT03155997|472158469|FG001|Overall Study|Missing disposition data|1|||
131145953|NCT03155997|472158468|FG000|Overall Study|On study treatment|2027|||
131145954|NCT03155997|472158469|FG001|Overall Study|On study treatment|2074|||
131145955|NCT04067518|472158470|FG000|Overall Study|Adverse Event|1|||
131145956|NCT04067518|472158471|FG001|Overall Study|Adverse Event|3|||
131145957|NCT04067518|472158470|FG000|Overall Study|Screen failures|0|||
131145958|NCT04067518|472158471|FG001|Overall Study|Screen failures|1|||
130727765|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Death|17|||
130727766|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Death|11|||
131145959|NCT04067518|472158470|FG000|Overall Study|Enrolled but not treated|0|||
131145960|NCT04067518|472158471|FG001|Overall Study|Enrolled but not treated|1|||
131145961|NCT01728779|472158472|FG000|Overall Study|Withdrawal by Subject|1|||
131145962|NCT00862251|472158473|FG000|Overall Study|Adverse Event|8|||
131145963|NCT00862251|472158474|FG001|Overall Study|Adverse Event|3|||
131145964|NCT00862251|472158475|FG002|Overall Study|Adverse Event|1|||
131145965|NCT00862251|472158473|FG000|Overall Study|Lost to Follow-up|0|||
131145966|NCT00862251|472158474|FG001|Overall Study|Lost to Follow-up|0|||
131145967|NCT00862251|472158475|FG002|Overall Study|Lost to Follow-up|1|||
131145968|NCT00862251|472158473|FG000|Overall Study|Protocol Violation|2|||
131145969|NCT00862251|472158474|FG001|Overall Study|Protocol Violation|0|||
131145970|NCT00862251|472158475|FG002|Overall Study|Protocol Violation|1|||
131145971|NCT00862251|472158473|FG000|Overall Study|Withdrawal by Subject|9|||
131145972|NCT00862251|472158474|FG001|Overall Study|Withdrawal by Subject|2|||
131145973|NCT00862251|472158475|FG002|Overall Study|Withdrawal by Subject|6|||
131145974|NCT00624520|472158476|FG000|Overall Study|Withdrawal by Subject|12|||
131145975|NCT00624520|472158477|FG001|Overall Study|Withdrawal by Subject|7|||
131145976|NCT00624520|472158476|FG000|Overall Study|Death|0|||
131145977|NCT00624520|472158477|FG001|Overall Study|Death|1|||
131145978|NCT01925209|472158478|FG000|Treatment Epoch|Physician Decision|1|||
131145979|NCT01925209|472158479|FG001|Treatment Epoch|Physician Decision|0|||
131145980|NCT01925209|472158480|FG002|Treatment Epoch|Physician Decision|0|||
131145981|NCT01925209|472158481|FG003|Treatment Epoch|Physician Decision|0|||
131145982|NCT01925209|472158478|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
131145983|NCT01925209|472158479|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
131145984|NCT01925209|472158480|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
131145985|NCT01925209|472158481|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
131145986|NCT01925209|472158478|FG000|Treatment Epoch|Death|1|||
131145987|NCT01925209|472158479|FG001|Treatment Epoch|Death|0|||
131145988|NCT01925209|472158480|FG002|Treatment Epoch|Death|0|||
131145989|NCT01925209|472158481|FG003|Treatment Epoch|Death|0|||
131145990|NCT01925209|472158478|FG000|Treatment Epoch|Protocol deviation|0|||
131145991|NCT01925209|472158479|FG001|Treatment Epoch|Protocol deviation|0|||
131145992|NCT01925209|472158480|FG002|Treatment Epoch|Protocol deviation|1|||
131145993|NCT01925209|472158481|FG003|Treatment Epoch|Protocol deviation|1|||
131145994|NCT01925209|472158478|FG000|Treatment Epoch|Withdrawal by Subject|4|||
131145995|NCT01925209|472158479|FG001|Treatment Epoch|Withdrawal by Subject|3|||
131145996|NCT01925209|472158480|FG002|Treatment Epoch|Withdrawal by Subject|3|||
131145997|NCT01925209|472158481|FG003|Treatment Epoch|Withdrawal by Subject|2|||
131145998|NCT01925209|472158478|FG000|Treatment Epoch|Adverse Event|3|||
131145999|NCT01925209|472158479|FG001|Treatment Epoch|Adverse Event|5|||
131146000|NCT01925209|472158480|FG002|Treatment Epoch|Adverse Event|3|||
131146001|NCT01925209|472158481|FG003|Treatment Epoch|Adverse Event|1|||
131146002|NCT01925209|472158478|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
131146003|NCT01925209|472158479|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
131146004|NCT01925209|472158480|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
131146005|NCT01925209|472158481|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
131146006|NCT01925209|472158478|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
131146007|NCT01925209|472158479|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
131146008|NCT01925209|472158480|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
131146009|NCT01925209|472158481|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
130727767|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
130727768|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
130727769|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
130727770|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
130727771|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
130727772|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
131146010|NCT01925209|472158478|FG000|Follow-up|Adverse Event|1|||
131146011|NCT01925209|472158479|FG001|Follow-up|Adverse Event|4|||
131146012|NCT01925209|472158480|FG002|Follow-up|Adverse Event|0|||
131146013|NCT01925209|472158481|FG003|Follow-up|Adverse Event|1|||
131146014|NCT01925209|472158478|FG000|Follow-up|Physician Decision|0|||
131146015|NCT01925209|472158479|FG001|Follow-up|Physician Decision|0|||
131146016|NCT01925209|472158480|FG002|Follow-up|Physician Decision|1|||
131146017|NCT01925209|472158481|FG003|Follow-up|Physician Decision|0|||
131146018|NCT01925209|472158478|FG000|Follow-up|Non-compliance with study treatment|0|||
131146019|NCT01925209|472158479|FG001|Follow-up|Non-compliance with study treatment|0|||
131146020|NCT01925209|472158480|FG002|Follow-up|Non-compliance with study treatment|0|||
131146021|NCT01925209|472158481|FG003|Follow-up|Non-compliance with study treatment|1|||
131146022|NCT01925209|472158478|FG000|Follow-up|Withdrawal by Subject|0|||
131146023|NCT01925209|472158479|FG001|Follow-up|Withdrawal by Subject|2|||
131146024|NCT01925209|472158480|FG002|Follow-up|Withdrawal by Subject|0|||
131146025|NCT01925209|472158481|FG003|Follow-up|Withdrawal by Subject|2|||
131146026|NCT02796755|472158482|FG000|Overall Study|Adverse Event|2|||
131146027|NCT02796755|472158483|FG001|Overall Study|Adverse Event|0|||
131146028|NCT00675025|472158484|FG000|Overall Study|Study Terminated by Sponsor|38|||
131146029|NCT00675025|472158485|FG001|Overall Study|Study Terminated by Sponsor|42|||
131146030|NCT00675025|472158484|FG000|Overall Study|Adverse Event|6|||
131146031|NCT00675025|472158485|FG001|Overall Study|Adverse Event|11|||
131146032|NCT00675025|472158484|FG000|Overall Study|Lost to Follow-up|6|||
131146033|NCT00675025|472158485|FG001|Overall Study|Lost to Follow-up|4|||
131146034|NCT00675025|472158484|FG000|Overall Study|Withdrawal by Subject|4|||
131146035|NCT00675025|472158485|FG001|Overall Study|Withdrawal by Subject|6|||
131146036|NCT04398732|472158489|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
131146037|NCT00556426|472158490|FG000|Overall Study|Withdrawal by Subject|3|||
131146038|NCT00556426|472158490|FG000|Overall Study|Death|6|||
131146039|NCT01596257|472158492|FG000|Overall Study|Inadequate Collection|23|||
131146040|NCT01596257|472158493|FG001|Overall Study|Inadequate Collection|19|||
131146041|NCT02054702|472158497|FG000|Overall Study|Lost to Follow-up|3|||
131146042|NCT02054702|472158498|FG001|Overall Study|Lost to Follow-up|5|||
131146043|NCT02054702|472158497|FG000|Overall Study|Adverse Event|3|||
131146044|NCT02054702|472158498|FG001|Overall Study|Adverse Event|1|||
131146045|NCT02054702|472158497|FG000|Overall Study|Met Withdrawal Criteria|4|||
131146046|NCT02054702|472158498|FG001|Overall Study|Met Withdrawal Criteria|1|||
131146047|NCT02054702|472158497|FG000|Overall Study|Physician Decision|0|||
131146048|NCT02054702|472158498|FG001|Overall Study|Physician Decision|1|||
131146049|NCT02054702|472158497|FG000|Overall Study|Withdrawal by Subject|14|||
131146050|NCT02054702|472158498|FG001|Overall Study|Withdrawal by Subject|4|||
131146051|NCT02347631|472158499|FG000|First Intervention (2 Months)|Adverse Event|1|||
131146052|NCT02347631|472158500|FG001|First Intervention (2 Months)|Adverse Event|1|||
131146053|NCT02347631|472158499|FG000|First Intervention (2 Months)|Pregnancy|1|||
130727773|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
130727774|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
130727775|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
131146054|NCT02347631|472158500|FG001|First Intervention (2 Months)|Pregnancy|0|||
131146055|NCT02347631|472158499|FG000|First Intervention (2 Months)|Moved out of area|0|||
131146056|NCT02347631|472158500|FG001|First Intervention (2 Months)|Moved out of area|2|||
131146057|NCT02347631|472158499|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
131146058|NCT02347631|472158500|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
131146059|NCT02347631|472158499|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
131146060|NCT02347631|472158500|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
131146061|NCT02347631|472158499|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
131146062|NCT02347631|472158500|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
131146063|NCT02347631|472158499|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
131146064|NCT02347631|472158500|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
131146065|NCT02347631|472158499|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
131146066|NCT02347631|472158500|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
131146067|NCT00934102|472158502|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
131146068|NCT00934102|472158503|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
130727776|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
130727777|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
131146069|NCT00934102|472158504|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
131146070|NCT02318784|472158505|FG000|Overall Study|Adverse Event|13|||
131146071|NCT02318784|472158505|FG000|Overall Study|Death|2|||
131146072|NCT02318784|472158505|FG000|Overall Study|Progressive Disease|37|||
130727778|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
130727779|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
130727780|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
130727781|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Other|2|||
131146073|NCT02318784|472158505|FG000|Overall Study|Withdrawal by Subject|10|||
131146074|NCT02304926|472158506|FG000|Overall Study|Lost to Follow-up|2|||
131146075|NCT02304926|472158507|FG001|Overall Study|Lost to Follow-up|1|||
131146076|NCT00792298|472158509|FG000|Treatment Period 1|Adverse Event|0|||
131146077|NCT00792298|472158510|FG001|Treatment Period 1|Adverse Event|1|||
131146078|NCT00792298|472158511|FG002|Treatment Period 1|Adverse Event|0|||
131146079|NCT00792298|472158512|FG003|Treatment Period 1|Adverse Event|1|||
131146080|NCT00792298|472158513|FG004|Treatment Period 1|Adverse Event|0|||
131146081|NCT00792298|472158514|FG005|Treatment Period 1|Adverse Event|1|||
131146082|NCT00792298|472158515|FG006|Treatment Period 1|Adverse Event|1|||
131146083|NCT00792298|472158516|FG007|Treatment Period 1|Adverse Event|0|||
131146084|NCT00792298|472158509|FG000|Treatment Period 1|Lack of Efficacy|0|||
131146085|NCT00792298|472158510|FG001|Treatment Period 1|Lack of Efficacy|0|||
131146086|NCT00792298|472158511|FG002|Treatment Period 1|Lack of Efficacy|1|||
131146087|NCT00792298|472158512|FG003|Treatment Period 1|Lack of Efficacy|0|||
130727782|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Other|1|||
130727783|NCT02952586|470625548|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
131146088|NCT00792298|472158513|FG004|Treatment Period 1|Lack of Efficacy|0|||
131146089|NCT00792298|472158514|FG005|Treatment Period 1|Lack of Efficacy|0|||
131146090|NCT00792298|472158515|FG006|Treatment Period 1|Lack of Efficacy|0|||
131146091|NCT00792298|472158516|FG007|Treatment Period 1|Lack of Efficacy|0|||
131146092|NCT00792298|472158509|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131146093|NCT00792298|472158510|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131146094|NCT00792298|472158511|FG002|Treatment Period 1|Withdrawal by Subject|1|||
131146095|NCT00792298|472158512|FG003|Treatment Period 1|Withdrawal by Subject|2|||
131146096|NCT00792298|472158513|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131146097|NCT00792298|472158514|FG005|Treatment Period 1|Withdrawal by Subject|2|||
131146098|NCT00792298|472158515|FG006|Treatment Period 1|Withdrawal by Subject|1|||
131146099|NCT00792298|472158516|FG007|Treatment Period 1|Withdrawal by Subject|0|||
131146100|NCT00792298|472158509|FG000|Treatment Period 1|Lost to Follow-up|0|||
131146101|NCT00792298|472158510|FG001|Treatment Period 1|Lost to Follow-up|0|||
131146102|NCT00792298|472158511|FG002|Treatment Period 1|Lost to Follow-up|0|||
131146103|NCT00792298|472158512|FG003|Treatment Period 1|Lost to Follow-up|0|||
131146104|NCT00792298|472158513|FG004|Treatment Period 1|Lost to Follow-up|0|||
131146105|NCT00792298|472158514|FG005|Treatment Period 1|Lost to Follow-up|0|||
131146106|NCT00792298|472158515|FG006|Treatment Period 1|Lost to Follow-up|1|||
131146107|NCT00792298|472158516|FG007|Treatment Period 1|Lost to Follow-up|0|||
131146108|NCT00792298|472158509|FG000|Treatment Period 1|Physician Decision|0|||
131146109|NCT00792298|472158510|FG001|Treatment Period 1|Physician Decision|0|||
131146110|NCT00792298|472158511|FG002|Treatment Period 1|Physician Decision|0|||
131146111|NCT00792298|472158512|FG003|Treatment Period 1|Physician Decision|1|||
131146112|NCT00792298|472158513|FG004|Treatment Period 1|Physician Decision|0|||
131146113|NCT00792298|472158514|FG005|Treatment Period 1|Physician Decision|0|||
131146114|NCT00792298|472158515|FG006|Treatment Period 1|Physician Decision|1|||
131146115|NCT00792298|472158516|FG007|Treatment Period 1|Physician Decision|0|||
131146116|NCT00792298|472158509|FG000|Treatment Period 1|Protocol Violation|0|||
131146117|NCT00792298|472158510|FG001|Treatment Period 1|Protocol Violation|0|||
131146118|NCT00792298|472158511|FG002|Treatment Period 1|Protocol Violation|0|||
131146119|NCT00792298|472158512|FG003|Treatment Period 1|Protocol Violation|0|||
131146120|NCT00792298|472158513|FG004|Treatment Period 1|Protocol Violation|0|||
131146121|NCT00792298|472158514|FG005|Treatment Period 1|Protocol Violation|0|||
131146122|NCT00792298|472158515|FG006|Treatment Period 1|Protocol Violation|0|||
131146123|NCT00792298|472158516|FG007|Treatment Period 1|Protocol Violation|1|||
131146124|NCT00792298|472158509|FG000|Washout|Adverse Event|0|||
131146125|NCT00792298|472158510|FG001|Washout|Adverse Event|0|||
131146126|NCT00792298|472158511|FG002|Washout|Adverse Event|0|||
131146127|NCT00792298|472158512|FG003|Washout|Adverse Event|0|||
131146128|NCT00792298|472158513|FG004|Washout|Adverse Event|0|||
131146129|NCT00792298|472158514|FG005|Washout|Adverse Event|1|||
131146130|NCT00792298|472158515|FG006|Washout|Adverse Event|0|||
131146131|NCT00792298|472158516|FG007|Washout|Adverse Event|0|||
131146132|NCT00792298|472158509|FG000|Washout|Withdrawal by Subject|0|||
131146133|NCT00792298|472158510|FG001|Washout|Withdrawal by Subject|0|||
131146134|NCT00792298|472158511|FG002|Washout|Withdrawal by Subject|1|||
131146135|NCT00792298|472158512|FG003|Washout|Withdrawal by Subject|0|||
131146136|NCT00792298|472158513|FG004|Washout|Withdrawal by Subject|0|||
131146137|NCT00792298|472158514|FG005|Washout|Withdrawal by Subject|1|||
131146138|NCT00792298|472158515|FG006|Washout|Withdrawal by Subject|0|||
131146139|NCT00792298|472158516|FG007|Washout|Withdrawal by Subject|0|||
131146140|NCT00792298|472158509|FG000|Treatment Period 2|Lack of Efficacy|0|||
131146141|NCT00792298|472158510|FG001|Treatment Period 2|Lack of Efficacy|0|||
131146142|NCT00792298|472158511|FG002|Treatment Period 2|Lack of Efficacy|0|||
131146143|NCT00792298|472158512|FG003|Treatment Period 2|Lack of Efficacy|0|||
131146144|NCT00792298|472158513|FG004|Treatment Period 2|Lack of Efficacy|1|||
131146145|NCT00792298|472158514|FG005|Treatment Period 2|Lack of Efficacy|0|||
131146146|NCT00792298|472158515|FG006|Treatment Period 2|Lack of Efficacy|0|||
131146147|NCT00792298|472158516|FG007|Treatment Period 2|Lack of Efficacy|0|||
131146148|NCT00792298|472158509|FG000|Treatment Period 2|Physician Decision|0|||
131146149|NCT00792298|472158510|FG001|Treatment Period 2|Physician Decision|0|||
130727784|NCT02952586|470625549|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
130727785|NCT02952586|470625548|FG000|Follow-Up Phase (90 Days)|Death|12|||
130727786|NCT02952586|470625549|FG001|Follow-Up Phase (90 Days)|Death|10|||
130727787|NCT02952586|470625548|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
131146150|NCT00792298|472158511|FG002|Treatment Period 2|Physician Decision|0|||
130727788|NCT02952586|470625549|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
130727789|NCT02952586|470625548|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
131146151|NCT00792298|472158512|FG003|Treatment Period 2|Physician Decision|0|||
131146152|NCT00792298|472158513|FG004|Treatment Period 2|Physician Decision|0|||
131146153|NCT00792298|472158514|FG005|Treatment Period 2|Physician Decision|0|||
131146154|NCT00792298|472158515|FG006|Treatment Period 2|Physician Decision|1|||
131146155|NCT00792298|472158516|FG007|Treatment Period 2|Physician Decision|0|||
131146156|NCT00792298|472158509|FG000|Treatment Period 2|Pregnancy|0|||
131146157|NCT00792298|472158510|FG001|Treatment Period 2|Pregnancy|0|||
130727790|NCT02952586|470625549|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
130727791|NCT02952586|470625548|FG000|Follow-Up Phase (90 Days)|Other|7|||
131146158|NCT00792298|472158511|FG002|Treatment Period 2|Pregnancy|1|||
131146159|NCT00792298|472158512|FG003|Treatment Period 2|Pregnancy|0|||
131146160|NCT00792298|472158513|FG004|Treatment Period 2|Pregnancy|0|||
131146161|NCT00792298|472158514|FG005|Treatment Period 2|Pregnancy|0|||
131146162|NCT00792298|472158515|FG006|Treatment Period 2|Pregnancy|0|||
131146163|NCT00792298|472158516|FG007|Treatment Period 2|Pregnancy|0|||
131146164|NCT00792298|472158509|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131146165|NCT00792298|472158510|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131146166|NCT00792298|472158511|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131146167|NCT00792298|472158512|FG003|Treatment Period 2|Withdrawal by Subject|2|||
131146168|NCT00792298|472158513|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131146169|NCT00792298|472158514|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131146170|NCT00792298|472158515|FG006|Treatment Period 2|Withdrawal by Subject|0|||
131146171|NCT00792298|472158516|FG007|Treatment Period 2|Withdrawal by Subject|2|||
131146172|NCT04007159|472158522|FG000|Induction Phase|(missed study visits)|16|||
131146173|NCT04007159|472158522|FG000|Induction Phase|Withdrawal by Subject|4|||
131146174|NCT04007159|472158522|FG000|Induction Phase|Adverse Event|2|||
131146175|NCT04007159|472158522|FG000|Challenge Phase|missed study visits|3|||
131146176|NCT00619957|472158524|FG000|Month 24 Double-Blind|Adverse Event|9|||
131146177|NCT00619957|472158525|FG001|Month 24 Double-Blind|Adverse Event|7|||
131146178|NCT00619957|472158524|FG000|Month 24 Double-Blind|Protocol Violation|1|||
131146179|NCT00619957|472158525|FG001|Month 24 Double-Blind|Protocol Violation|0|||
131146180|NCT00619957|472158524|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
131146181|NCT00619957|472158525|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
131146182|NCT00619957|472158524|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
131146183|NCT00619957|472158525|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
131146184|NCT00619957|472158524|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
131146185|NCT00619957|472158525|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
131146186|NCT00619957|472158524|FG000|Month 48 Open-Label|Adverse Event|4|||
131146187|NCT00619957|472158525|FG001|Month 48 Open-Label|Adverse Event|4|||
131146188|NCT00619957|472158524|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
131146189|NCT00619957|472158525|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
131146190|NCT00619957|472158524|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
131146191|NCT00619957|472158525|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
131146192|NCT02292212|472158526|FG000|ViE Phase|Withdrawal by Subject|1|||
131146193|NCT02292212|472158526|FG000|ViE Phase|Protocol Violation|2|||
131146194|NCT00772447|472158527|FG000|Overall Study|Withdrawal by Subject|9|||
131146195|NCT00772447|472158528|FG001|Overall Study|Withdrawal by Subject|5|||
131146196|NCT00772447|472158527|FG000|Overall Study|Physician Decision|4|||
131146197|NCT00772447|472158528|FG001|Overall Study|Physician Decision|8|||
131146198|NCT00772447|472158527|FG000|Overall Study|Lost to Follow-up|2|||
131146199|NCT00772447|472158528|FG001|Overall Study|Lost to Follow-up|4|||
131146200|NCT00772447|472158527|FG000|Overall Study|incorrect enrolment|3|||
131146201|NCT00772447|472158528|FG001|Overall Study|incorrect enrolment|4|||
131146202|NCT00772447|472158527|FG000|Overall Study|Protocol Violation|0|||
131146203|NCT00772447|472158528|FG001|Overall Study|Protocol Violation|1|||
131146204|NCT00772447|472158527|FG000|Overall Study|all others|2|||
131146205|NCT00772447|472158528|FG001|Overall Study|all others|2|||
131146206|NCT01957137|472158529|FG000|Randomized Portion|Adverse Event|1|||
131146207|NCT01957137|472158529|FG000|Randomized Portion|Withdrawal by Subject|1|||
131146208|NCT03529409|472158530|FG000|Randomized|Lost to Follow-up|0|||
131146209|NCT03529409|472158531|FG001|Randomized|Lost to Follow-up|0|||
131146210|NCT03529409|472158532|FG002|Randomized|Lost to Follow-up|4|||
131146211|NCT03529409|472158530|FG000|Randomized|Excluded|0|||
131146212|NCT03529409|472158531|FG001|Randomized|Excluded|0|||
131146213|NCT03529409|472158532|FG002|Randomized|Excluded|1|||
131146214|NCT03529409|472158530|FG000|Post-treatment Assessment|Death|1|||
131146215|NCT03529409|472158531|FG001|Post-treatment Assessment|Death|0|||
131146216|NCT03529409|472158532|FG002|Post-treatment Assessment|Death|0|||
131146217|NCT03529409|472158530|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
131146218|NCT03529409|472158531|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
131146219|NCT03529409|472158532|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
131146220|NCT03529409|472158530|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
131146221|NCT03529409|472158531|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
131146222|NCT03529409|472158532|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
131146223|NCT03529409|472158530|FG000|Follow-up Assessment|Death|1|||
131146224|NCT03529409|472158531|FG001|Follow-up Assessment|Death|0|||
131146225|NCT03529409|472158532|FG002|Follow-up Assessment|Death|0|||
131146226|NCT03529409|472158530|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
131146227|NCT03529409|472158531|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
131146228|NCT03529409|472158532|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
131146229|NCT01497262|472158533|FG000|Overall Study|Abnormal Lab Values|4|||
131146230|NCT01497262|472158533|FG000|Overall Study|Abnormal Test Procedure Result|1|||
131146231|NCT01497262|472158533|FG000|Overall Study|Physician Decision|1|||
131146232|NCT01497262|472158533|FG000|Overall Study|Withdrawal by Subject|2|||
131146233|NCT01497262|472158533|FG000|Overall Study|Adverse Event|2|||
131146234|NCT01497262|472158533|FG000|Overall Study|Protocol Violation|1|||
131146235|NCT02497001|472158536|FG000|Overall Study|Lost to Follow-up|10|||
131146236|NCT02497001|472158537|FG001|Overall Study|Lost to Follow-up|2|||
131146237|NCT02497001|472158538|FG002|Overall Study|Lost to Follow-up|0|||
131146238|NCT02497001|472158539|FG003|Overall Study|Lost to Follow-up|2|||
131146239|NCT02497001|472158536|FG000|Overall Study|Adverse Event|28|||
131146240|NCT02497001|472158537|FG001|Overall Study|Adverse Event|30|||
131146241|NCT02497001|472158538|FG002|Overall Study|Adverse Event|11|||
131146242|NCT02497001|472158539|FG003|Overall Study|Adverse Event|11|||
131146243|NCT02497001|472158536|FG000|Overall Study|Withdrawal by Subject|14|||
131146244|NCT02497001|472158537|FG001|Overall Study|Withdrawal by Subject|37|||
131146245|NCT02497001|472158538|FG002|Overall Study|Withdrawal by Subject|19|||
131146246|NCT02497001|472158539|FG003|Overall Study|Withdrawal by Subject|15|||
131146247|NCT02497001|472158536|FG000|Overall Study|Physician Decision|5|||
131146248|NCT02497001|472158537|FG001|Overall Study|Physician Decision|11|||
131146249|NCT02497001|472158538|FG002|Overall Study|Physician Decision|5|||
131146250|NCT02497001|472158539|FG003|Overall Study|Physician Decision|1|||
131146251|NCT02497001|472158536|FG000|Overall Study|subjects that were not treated|1|||
131146252|NCT02497001|472158537|FG001|Overall Study|subjects that were not treated|2|||
131146253|NCT02497001|472158538|FG002|Overall Study|subjects that were not treated|2|||
131146254|NCT02497001|472158539|FG003|Overall Study|subjects that were not treated|1|||
131146255|NCT02497001|472158536|FG000|Overall Study|Major Protocol Deviation|3|||
131146256|NCT02497001|472158537|FG001|Overall Study|Major Protocol Deviation|4|||
131146257|NCT02497001|472158538|FG002|Overall Study|Major Protocol Deviation|4|||
131146258|NCT02497001|472158539|FG003|Overall Study|Major Protocol Deviation|4|||
131146259|NCT02497001|472158536|FG000|Overall Study|Lack of Efficacy|10|||
131146260|NCT02497001|472158537|FG001|Overall Study|Lack of Efficacy|16|||
131146261|NCT02497001|472158538|FG002|Overall Study|Lack of Efficacy|6|||
131146262|NCT02497001|472158539|FG003|Overall Study|Lack of Efficacy|6|||
131146263|NCT02497001|472158536|FG000|Overall Study|Protocol Violation|3|||
131146264|NCT02497001|472158537|FG001|Overall Study|Protocol Violation|1|||
131146265|NCT02497001|472158538|FG002|Overall Study|Protocol Violation|3|||
131146266|NCT02497001|472158539|FG003|Overall Study|Protocol Violation|1|||
131146267|NCT01795547|472158540|FG000|Overall Study|Adverse Event|16|||
131146268|NCT01795547|472158541|FG001|Overall Study|Adverse Event|27|||
131146269|NCT01795547|472158540|FG000|Overall Study|Lack of Efficacy|8|||
131146270|NCT01795547|472158541|FG001|Overall Study|Lack of Efficacy|3|||
131146271|NCT01795547|472158540|FG000|Overall Study|Protocol Violation|6|||
131146272|NCT01795547|472158541|FG001|Overall Study|Protocol Violation|4|||
131146273|NCT01795547|472158540|FG000|Overall Study|Lost to Follow-up|2|||
131146274|NCT01795547|472158541|FG001|Overall Study|Lost to Follow-up|5|||
131146275|NCT01795547|472158540|FG000|Overall Study|Withdrawal of consent|7|||
131146276|NCT01795547|472158541|FG001|Overall Study|Withdrawal of consent|12|||
131146277|NCT01795547|472158540|FG000|Overall Study|Not Treated|4|||
131146278|NCT01795547|472158541|FG001|Overall Study|Not Treated|10|||
131146279|NCT01795547|472158540|FG000|Overall Study|Non-compliance with IMP|1|||
131146280|NCT01795547|472158541|FG001|Overall Study|Non-compliance with IMP|1|||
131146281|NCT01795547|472158540|FG000|Overall Study|Others|4|||
131146282|NCT01795547|472158541|FG001|Overall Study|Others|1|||
131146283|NCT01795547|472158540|FG000|Overall Study|Not stated|0|||
131146284|NCT01795547|472158541|FG001|Overall Study|Not stated|1|||
131146285|NCT03437447|472158543|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131146286|NCT03437447|472158544|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131146287|NCT03437447|472158545|FG002|Treatment Period 1|Withdrawal by Subject|1|||
131146288|NCT00484315|472158546|FG000|12-Month Clinical Follow-up|Death|6|||
131146289|NCT00484315|472158547|FG001|12-Month Clinical Follow-up|Death|2|||
131146290|NCT00484315|472158546|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
131146291|NCT00484315|472158547|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
131146292|NCT00484315|472158546|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
131146293|NCT00484315|472158547|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
131146294|NCT00484315|472158546|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
131146295|NCT00484315|472158547|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
131146296|NCT00484315|472158546|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
131146297|NCT00484315|472158547|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
131146298|NCT00484315|472158546|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
131146299|NCT00484315|472158547|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
131146300|NCT00484315|472158546|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
131146301|NCT00484315|472158547|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
131146302|NCT00943683|472158548|FG000|Overall Study|Adverse Event|3|||
131146303|NCT00943683|472158549|FG001|Overall Study|Adverse Event|3|||
131146304|NCT00943683|472158548|FG000|Overall Study|Lost to Follow-up|1|||
131146305|NCT00943683|472158549|FG001|Overall Study|Lost to Follow-up|1|||
131146306|NCT00943683|472158548|FG000|Overall Study|Protocol Violation|1|||
131146307|NCT00943683|472158549|FG001|Overall Study|Protocol Violation|2|||
131146308|NCT00943683|472158548|FG000|Overall Study|Withdrawal by Subject|1|||
131234791|NCT00661999|472486480|FG000|Overall Study|Death|8|||
131234792|NCT00661999|472486481|FG001|Overall Study|Death|6|||
131234793|NCT00661999|472486482|FG002|Overall Study|Death|3|||
131234794|NCT00661999|472486480|FG000|Overall Study|Other Reasons|5|||
131234795|NCT00661999|472486481|FG001|Overall Study|Other Reasons|12|||
131234796|NCT00661999|472486482|FG002|Overall Study|Other Reasons|23|||
131234797|NCT00661999|472486480|FG000|Overall Study|Withdrawal by Subject|30|||
131234798|NCT00661999|472486481|FG001|Overall Study|Withdrawal by Subject|23|||
131234799|NCT00661999|472486482|FG002|Overall Study|Withdrawal by Subject|14|||
131234800|NCT00661999|472486480|FG000|Overall Study|Alternative Treatment|1|||
131234801|NCT00661999|472486481|FG001|Overall Study|Alternative Treatment|0|||
131234802|NCT00661999|472486482|FG002|Overall Study|Alternative Treatment|0|||
131234803|NCT00661999|472486480|FG000|Overall Study|Other Medical Problems|4|||
131234804|NCT00661999|472486481|FG001|Overall Study|Other Medical Problems|4|||
131234805|NCT00661999|472486482|FG002|Overall Study|Other Medical Problems|9|||
131234806|NCT03595657|472486483|FG000|Overall Study|Adverse Event|14|||
131234807|NCT03595657|472486483|FG000|Overall Study|Death|1|||
131234808|NCT03595657|472486483|FG000|Overall Study|Lack of Efficacy|40|||
131234809|NCT03595657|472486483|FG000|Overall Study|Withdrawal by Subject|10|||
131234810|NCT03595657|472486483|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
131234811|NCT03595657|472486483|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
131234812|NCT00663871|472486484|FG000|Overall Study|Lost to Follow-up|5|||
131234813|NCT00663871|472486485|FG001|Overall Study|Lost to Follow-up|5|||
131234814|NCT00663871|472486484|FG000|Overall Study|Withdrawal by Subject|5|||
131234815|NCT00663871|472486485|FG001|Overall Study|Withdrawal by Subject|2|||
131234816|NCT02739984|472486488|FG000|Overall Study|Sponsor Decision|1|||
131234817|NCT02739984|472486489|FG001|Overall Study|Sponsor Decision|0|||
131234818|NCT02739984|472486488|FG000|Overall Study|Withdrawal by Subject|1|||
131234819|NCT02739984|472486489|FG001|Overall Study|Withdrawal by Subject|1|||
131234820|NCT02739984|472486488|FG000|Overall Study|Death|0|||
131234821|NCT02739984|472486489|FG001|Overall Study|Death|1|||
131234822|NCT02739984|472486488|FG000|Overall Study|Lost to Follow-up|3|||
131234823|NCT02739984|472486489|FG001|Overall Study|Lost to Follow-up|0|||
130727792|NCT02952586|470625549|FG001|Follow-Up Phase (90 Days)|Other|5|||
130727793|NCT02952586|470625548|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
130727794|NCT02952586|470625549|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
130727795|NCT02952586|470625548|FG000|LT Follow-up (up to 45 Months)|Death|51|||
130727796|NCT02952586|470625549|FG001|LT Follow-up (up to 45 Months)|Death|31|||
130727797|NCT02952586|470625548|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
130727798|NCT02952586|470625549|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
130727799|NCT02952586|470625548|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
131146309|NCT00943683|472158549|FG001|Overall Study|Withdrawal by Subject|0|||
131146310|NCT00943683|472158548|FG000|Overall Study|Patient Moved|1|||
131146311|NCT00943683|472158549|FG001|Overall Study|Patient Moved|0|||
131146312|NCT01551745|472158550|FG000|Overall Study|Withdrawal by Subject|1|||
131146313|NCT01551745|472158550|FG000|Overall Study|Disease Progression|2|||
131146314|NCT00749190|472158551|FG000|Overall Study|Adverse Event|0|||
131146315|NCT00749190|472158552|FG001|Overall Study|Adverse Event|2|||
131146316|NCT00749190|472158553|FG002|Overall Study|Adverse Event|0|||
131146317|NCT00749190|472158554|FG003|Overall Study|Adverse Event|4|||
131146318|NCT00749190|472158555|FG004|Overall Study|Adverse Event|0|||
131146319|NCT00749190|472158556|FG005|Overall Study|Adverse Event|3|||
131146320|NCT00749190|472158557|FG006|Overall Study|Adverse Event|0|||
131146321|NCT00749190|472158551|FG000|Overall Study|Lack of Efficacy|3|||
131146322|NCT00749190|472158552|FG001|Overall Study|Lack of Efficacy|1|||
131146323|NCT00749190|472158553|FG002|Overall Study|Lack of Efficacy|1|||
131146324|NCT00749190|472158554|FG003|Overall Study|Lack of Efficacy|0|||
131146325|NCT00749190|472158555|FG004|Overall Study|Lack of Efficacy|0|||
131146326|NCT00749190|472158556|FG005|Overall Study|Lack of Efficacy|1|||
131146327|NCT00749190|472158557|FG006|Overall Study|Lack of Efficacy|0|||
131146328|NCT00749190|472158551|FG000|Overall Study|Withdrawal by Subject|2|||
131146329|NCT00749190|472158552|FG001|Overall Study|Withdrawal by Subject|1|||
131146330|NCT00749190|472158553|FG002|Overall Study|Withdrawal by Subject|0|||
131146331|NCT00749190|472158554|FG003|Overall Study|Withdrawal by Subject|0|||
131146332|NCT00749190|472158555|FG004|Overall Study|Withdrawal by Subject|0|||
131146333|NCT00749190|472158556|FG005|Overall Study|Withdrawal by Subject|1|||
131146334|NCT00749190|472158557|FG006|Overall Study|Withdrawal by Subject|0|||
131146335|NCT00749190|472158551|FG000|Overall Study|Protocol Violation|0|||
131146336|NCT00749190|472158552|FG001|Overall Study|Protocol Violation|1|||
131234824|NCT00767325|472486490|FG000|Overall Study|Lack of Efficacy|2|||
131234825|NCT00767325|472486490|FG000|Overall Study|Adverse Event|7|||
131234826|NCT00767325|472486490|FG000|Overall Study|Lost to Follow-up|3|||
131234827|NCT00767325|472486490|FG000|Overall Study|No longer met study criteria|2|||
131234828|NCT00767325|472486490|FG000|Overall Study|Missed visit due to family reasons|1|||
131234829|NCT03538756|472486491|FG000|Long-Term Follow-up|Adverse Event|0|||
130727800|NCT02952586|470625549|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
131146337|NCT00749190|472158553|FG002|Overall Study|Protocol Violation|0|||
131234830|NCT03538756|472486492|FG001|Long-Term Follow-up|Adverse Event|0|||
131234831|NCT03538756|472486493|FG002|Long-Term Follow-up|Adverse Event|6|||
131146338|NCT00749190|472158554|FG003|Overall Study|Protocol Violation|0|||
131146339|NCT00749190|472158555|FG004|Overall Study|Protocol Violation|0|||
131146340|NCT00749190|472158556|FG005|Overall Study|Protocol Violation|0|||
131146341|NCT00749190|472158557|FG006|Overall Study|Protocol Violation|1|||
131146342|NCT00749190|472158551|FG000|Overall Study|Other reason not defined above|0|||
131146343|NCT00749190|472158552|FG001|Overall Study|Other reason not defined above|0|||
131146344|NCT00749190|472158553|FG002|Overall Study|Other reason not defined above|0|||
131146345|NCT00749190|472158554|FG003|Overall Study|Other reason not defined above|1|||
131146346|NCT00749190|472158555|FG004|Overall Study|Other reason not defined above|0|||
131146347|NCT00749190|472158556|FG005|Overall Study|Other reason not defined above|0|||
131146348|NCT00749190|472158557|FG006|Overall Study|Other reason not defined above|0|||
131146349|NCT00355121|472158558|FG000|Overall Study|Did not receive study vaccine|1|||
130727801|NCT02952586|470625548|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
130727802|NCT02952586|470625549|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
131146350|NCT00355121|472158559|FG001|Overall Study|Did not receive study vaccine|0|||
131146351|NCT00355121|472158560|FG002|Overall Study|Did not receive study vaccine|1|||
131146352|NCT00355121|472158558|FG000|Overall Study|Adverse Event|0|||
131146353|NCT00355121|472158559|FG001|Overall Study|Adverse Event|1|||
131146354|NCT00355121|472158560|FG002|Overall Study|Adverse Event|0|||
131146355|NCT00355121|472158558|FG000|Overall Study|Protocol Violation|7|||
131146356|NCT00355121|472158559|FG001|Overall Study|Protocol Violation|9|||
131146357|NCT00355121|472158560|FG002|Overall Study|Protocol Violation|1|||
131146358|NCT00355121|472158558|FG000|Overall Study|Lost to Follow-up|4|||
131146359|NCT00355121|472158559|FG001|Overall Study|Lost to Follow-up|7|||
131146360|NCT00355121|472158560|FG002|Overall Study|Lost to Follow-up|1|||
131146361|NCT00355121|472158558|FG000|Overall Study|Withdrawal by Subject|9|||
131146362|NCT00355121|472158559|FG001|Overall Study|Withdrawal by Subject|10|||
131146363|NCT00355121|472158560|FG002|Overall Study|Withdrawal by Subject|2|||
131146364|NCT00355121|472158558|FG000|Overall Study|Serious adverse events|0|||
131146365|NCT00355121|472158559|FG001|Overall Study|Serious adverse events|2|||
131146366|NCT00355121|472158560|FG002|Overall Study|Serious adverse events|0|||
131146367|NCT01565980|472158567|FG000|Overall Study|Death|1|||
131146368|NCT01565980|472158568|FG001|Overall Study|Death|0|||
131146369|NCT01565980|472158567|FG000|Overall Study|Lost to Follow-up|1|||
131146370|NCT01565980|472158568|FG001|Overall Study|Lost to Follow-up|0|||
131146371|NCT01565980|472158567|FG000|Overall Study|health complications|1|||
131146372|NCT01565980|472158568|FG001|Overall Study|health complications|1|||
131146373|NCT01565980|472158567|FG000|Overall Study|stopped medical treatment|1|||
131146374|NCT01565980|472158568|FG001|Overall Study|stopped medical treatment|0|||
131146375|NCT01565980|472158567|FG000|Overall Study|Withdrawal by Subject|0|||
131146376|NCT01565980|472158568|FG001|Overall Study|Withdrawal by Subject|3|||
131146377|NCT01817790|472158577|FG000|Overall Study|Adverse Event|0|||
131146378|NCT01817790|472158578|FG001|Overall Study|Adverse Event|2|||
131146379|NCT01817790|472158577|FG000|Overall Study|Lost to Follow-up|0|||
131146380|NCT01817790|472158578|FG001|Overall Study|Lost to Follow-up|1|||
131146381|NCT01817790|472158577|FG000|Overall Study|Protocol Violation|2|||
131146382|NCT01817790|472158578|FG001|Overall Study|Protocol Violation|1|||
131146383|NCT01817790|472158577|FG000|Overall Study|Withdrawal by Subject|1|||
131146384|NCT01817790|472158578|FG001|Overall Study|Withdrawal by Subject|3|||
131146385|NCT01817790|472158577|FG000|Overall Study|Other: Could not attend appointment|1|||
131146386|NCT01817790|472158578|FG001|Overall Study|Other: Could not attend appointment|1|||
130727803|NCT02910011|470625552|FG000|Overall Study|Physician Decision|2|||
130727804|NCT03280381|470625553|FG000|Overall Study|Physician Decision|0|||
130727805|NCT03280381|470625554|FG001|Overall Study|Physician Decision|2|||
130727806|NCT01822366|470625555|FG000|Overall Study|Lost to Follow-up|5|||
131146387|NCT01671345|472158579|FG000|Overall Study|Lost to Follow-up|10|||
131146388|NCT01671345|472158580|FG001|Overall Study|Lost to Follow-up|6|||
131146389|NCT01671345|472158579|FG000|Overall Study|visit with non-participating physician|3|||
131146390|NCT01671345|472158580|FG001|Overall Study|visit with non-participating physician|3|||
131146391|NCT03636906|472158581|FG000|Overall Study|Adverse Event|0|||
131146392|NCT03636906|472158582|FG001|Overall Study|Adverse Event|0|||
131146393|NCT03636906|472158583|FG002|Overall Study|Adverse Event|1|||
131146394|NCT03636906|472158581|FG000|Overall Study|Lost to Follow-up|1|||
131146395|NCT03636906|472158582|FG001|Overall Study|Lost to Follow-up|0|||
131146396|NCT03636906|472158583|FG002|Overall Study|Lost to Follow-up|0|||
131146397|NCT03636906|472158581|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
131146398|NCT03636906|472158582|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
130727807|NCT01822366|470625556|FG001|Overall Study|Lost to Follow-up|1|||
130727808|NCT01822366|470625557|FG002|Overall Study|Lost to Follow-up|5|||
130727809|NCT01822366|470625558|FG003|Overall Study|Lost to Follow-up|1|||
130727810|NCT01822366|470625555|FG000|Overall Study|Withdrawal by Subject|0|||
131146399|NCT03636906|472158583|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
131146400|NCT03636906|472158581|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
130727811|NCT01822366|470625556|FG001|Overall Study|Withdrawal by Subject|6|||
130727812|NCT01822366|470625557|FG002|Overall Study|Withdrawal by Subject|0|||
131234832|NCT03538756|472486491|FG000|Long-Term Follow-up|Death|0|||
130727813|NCT01822366|470625558|FG003|Overall Study|Withdrawal by Subject|6|||
130727814|NCT01822366|470625555|FG000|Overall Study|Partial Intervention Completion|0|||
131146401|NCT03636906|472158582|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
131146402|NCT03636906|472158583|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
131146403|NCT03636906|472158581|FG000|Overall Study|Other|0|||
131146404|NCT03636906|472158582|FG001|Overall Study|Other|0|||
131146405|NCT03636906|472158583|FG002|Overall Study|Other|1|||
131146406|NCT02689492|472160956|FG000|Overall Study|Lost to Follow-up|61|||
131146407|NCT02689492|472160956|FG000|Overall Study|Withdrawal by Subject|11|||
131146408|NCT02689492|472160956|FG000|Overall Study|Death|9|||
131146409|NCT02689492|472160956|FG000|Overall Study|Physician Decision|2|||
131146410|NCT02689492|472160956|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
131146411|NCT02689492|472160956|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
131146412|NCT02689492|472160956|FG000|Overall Study|Other than listed|1|||
131146413|NCT02029976|472160957|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
131146414|NCT02029976|472160958|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
131146415|NCT02029976|472160957|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
131146416|NCT02029976|472160958|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
131146417|NCT02029976|472160957|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
131146418|NCT02029976|472160958|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
131146419|NCT02029976|472160957|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
131146420|NCT02029976|472160958|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
131146421|NCT04025632|472160959|FG000|Overall Study|Adverse Event|1|||
131146422|NCT04025632|472160960|FG001|Overall Study|Adverse Event|1|||
131146423|NCT04025632|472160959|FG000|Overall Study|Withdrawal by Subject|1|||
131146424|NCT04025632|472160960|FG001|Overall Study|Withdrawal by Subject|1|||
131146425|NCT04025632|472160959|FG000|Overall Study|Study Terminated by Sponsor|10|||
131146426|NCT04025632|472160960|FG001|Overall Study|Study Terminated by Sponsor|9|||
131146427|NCT04025632|472160959|FG000|Overall Study|Physician Decision|3|||
131146428|NCT04025632|472160960|FG001|Overall Study|Physician Decision|1|||
131146429|NCT01793792|472160967|FG000|Overall Study|Death|5|||
131146430|NCT01793792|472160967|FG000|Overall Study|Lost to Follow-up|5|||
131146431|NCT01793792|472160967|FG000|Overall Study|Withdrawal by Subject|1|||
131146432|NCT01793792|472160967|FG000|Overall Study|Device Not Implanted|1|||
131146433|NCT01524991|472160968|FG000|Overall Study|Adverse Event|12|||
131146434|NCT01524991|472160968|FG000|Overall Study|Death|1|||
131146435|NCT01524991|472160968|FG000|Overall Study|Disease ProgressionDu|17|||
131146436|NCT01524991|472160968|FG000|Overall Study|Other complicating disease|1|||
131146437|NCT01524991|472160968|FG000|Overall Study|Withdrawal by Subject|2|||
131146438|NCT01524991|472160968|FG000|Overall Study|Symptomatic Deterioration|1|||
131146439|NCT01341457|472160972|FG000|Overall Study|Adverse Event|2|||
131146440|NCT01341457|472160973|FG001|Overall Study|Adverse Event|0|||
131146441|NCT01717638|472160980|FG000|Overall Study|Lost to Follow-up|0|||
131146442|NCT01717638|472160981|FG001|Overall Study|Lost to Follow-up|0|||
131146443|NCT01717638|472160982|FG002|Overall Study|Lost to Follow-up|0|||
131146444|NCT01717638|472160983|FG003|Overall Study|Lost to Follow-up|0|||
131146445|NCT01717638|472160984|FG004|Overall Study|Lost to Follow-up|0|||
131146446|NCT01717638|472160985|FG005|Overall Study|Lost to Follow-up|1|||
131146447|NCT01717638|472160986|FG006|Overall Study|Lost to Follow-up|0|||
131146448|NCT01717638|472160987|FG007|Overall Study|Lost to Follow-up|0|||
131146449|NCT01717638|472160988|FG008|Overall Study|Lost to Follow-up|0|||
131146450|NCT01717638|472160989|FG009|Overall Study|Lost to Follow-up|0|||
131146451|NCT01717638|472160990|FG010|Overall Study|Lost to Follow-up|0|||
131146452|NCT01717638|472160991|FG011|Overall Study|Lost to Follow-up|0|||
131146453|NCT01717638|472160992|FG012|Overall Study|Lost to Follow-up|0|||
131146454|NCT01717638|472160980|FG000|Overall Study|Father in hospital|0|||
131146455|NCT01717638|472160981|FG001|Overall Study|Father in hospital|0|||
131146456|NCT01717638|472160982|FG002|Overall Study|Father in hospital|0|||
131146457|NCT01717638|472160983|FG003|Overall Study|Father in hospital|0|||
131146458|NCT01717638|472160984|FG004|Overall Study|Father in hospital|0|||
131146459|NCT01717638|472160985|FG005|Overall Study|Father in hospital|0|||
131234833|NCT03538756|472486492|FG001|Long-Term Follow-up|Death|0|||
131146460|NCT01717638|472160986|FG006|Overall Study|Father in hospital|0|||
130727815|NCT01822366|470625556|FG001|Overall Study|Partial Intervention Completion|15|||
131146461|NCT01717638|472160987|FG007|Overall Study|Father in hospital|0|||
131146462|NCT01717638|472160988|FG008|Overall Study|Father in hospital|0|||
131146463|NCT01717638|472160989|FG009|Overall Study|Father in hospital|0|||
131146464|NCT01717638|472160990|FG010|Overall Study|Father in hospital|0|||
131146465|NCT01717638|472160991|FG011|Overall Study|Father in hospital|0|||
131146466|NCT01717638|472160992|FG012|Overall Study|Father in hospital|1|||
131146467|NCT01717638|472160980|FG000|Overall Study|Withdrawal by Subject|0|||
131146468|NCT01717638|472160981|FG001|Overall Study|Withdrawal by Subject|1|||
131146469|NCT01717638|472160982|FG002|Overall Study|Withdrawal by Subject|1|||
131146470|NCT01717638|472160983|FG003|Overall Study|Withdrawal by Subject|0|||
131146471|NCT01717638|472160984|FG004|Overall Study|Withdrawal by Subject|1|||
131234834|NCT03538756|472486493|FG002|Long-Term Follow-up|Death|1|||
131234835|NCT03538756|472486491|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
130727816|NCT01822366|470625557|FG002|Overall Study|Partial Intervention Completion|0|||
131146472|NCT01717638|472160985|FG005|Overall Study|Withdrawal by Subject|0|||
131146473|NCT01717638|472160986|FG006|Overall Study|Withdrawal by Subject|2|||
131146474|NCT01717638|472160987|FG007|Overall Study|Withdrawal by Subject|1|||
131146475|NCT01717638|472160988|FG008|Overall Study|Withdrawal by Subject|2|||
131146476|NCT01717638|472160989|FG009|Overall Study|Withdrawal by Subject|1|||
131146477|NCT01717638|472160990|FG010|Overall Study|Withdrawal by Subject|0|||
131146478|NCT01717638|472160991|FG011|Overall Study|Withdrawal by Subject|0|||
131146479|NCT01717638|472160992|FG012|Overall Study|Withdrawal by Subject|18|||
131146480|NCT00408005|472160994|FG000|Induction|Adverse Event|19|||
131146481|NCT00408005|472160995|FG001|Induction|Adverse Event|3|||
131146482|NCT00408005|472160996|FG002|Induction|Adverse Event|0|||
131146483|NCT00408005|472160997|FG003|Induction|Adverse Event|0|||
131146484|NCT00408005|472160998|FG004|Induction|Adverse Event|0|||
131146485|NCT00408005|472160999|FG005|Induction|Adverse Event|0|||
131146486|NCT00408005|472161000|FG006|Induction|Adverse Event|0|||
131146487|NCT00408005|472161001|FG007|Induction|Adverse Event|0|||
131146488|NCT00408005|472160994|FG000|Induction|Death|6|||
131146489|NCT00408005|472160995|FG001|Induction|Death|0|||
131146490|NCT00408005|472160996|FG002|Induction|Death|0|||
131146491|NCT00408005|472160997|FG003|Induction|Death|0|||
131146492|NCT00408005|472160998|FG004|Induction|Death|0|||
131146493|NCT00408005|472160999|FG005|Induction|Death|0|||
131146494|NCT00408005|472161000|FG006|Induction|Death|0|||
131146495|NCT00408005|472161001|FG007|Induction|Death|0|||
131146496|NCT00408005|472160994|FG000|Induction|Physician Decision|83|||
131146497|NCT00408005|472160995|FG001|Induction|Physician Decision|9|||
131146498|NCT00408005|472160996|FG002|Induction|Physician Decision|0|||
131146499|NCT00408005|472160997|FG003|Induction|Physician Decision|0|||
131146500|NCT00408005|472160998|FG004|Induction|Physician Decision|0|||
131146501|NCT00408005|472160999|FG005|Induction|Physician Decision|0|||
131146502|NCT00408005|472161000|FG006|Induction|Physician Decision|0|||
131146503|NCT00408005|472161001|FG007|Induction|Physician Decision|0|||
131146504|NCT00408005|472160994|FG000|Induction|Withdrawal by Subject|2|||
131146505|NCT00408005|472160995|FG001|Induction|Withdrawal by Subject|4|||
131146506|NCT00408005|472160996|FG002|Induction|Withdrawal by Subject|0|||
131146507|NCT00408005|472160997|FG003|Induction|Withdrawal by Subject|0|||
131146508|NCT00408005|472160998|FG004|Induction|Withdrawal by Subject|0|||
131146509|NCT00408005|472160999|FG005|Induction|Withdrawal by Subject|0|||
131146510|NCT00408005|472161000|FG006|Induction|Withdrawal by Subject|0|||
131146511|NCT00408005|472161001|FG007|Induction|Withdrawal by Subject|0|||
131146512|NCT00408005|472160994|FG000|Induction|Ineligible|33|||
131146513|NCT00408005|472160995|FG001|Induction|Ineligible|14|||
131146514|NCT00408005|472160996|FG002|Induction|Ineligible|0|||
131146515|NCT00408005|472160997|FG003|Induction|Ineligible|0|||
131146516|NCT00408005|472160998|FG004|Induction|Ineligible|0|||
131146517|NCT00408005|472160999|FG005|Induction|Ineligible|0|||
131146518|NCT00408005|472161000|FG006|Induction|Ineligible|0|||
131146519|NCT00408005|472161001|FG007|Induction|Ineligible|0|||
131146520|NCT00408005|472160994|FG000|Induction|Refusal of Further Protocol Therapy|225|||
131146521|NCT00408005|472160995|FG001|Induction|Refusal of Further Protocol Therapy|44|||
131146522|NCT00408005|472160996|FG002|Induction|Refusal of Further Protocol Therapy|0|||
131146523|NCT00408005|472160997|FG003|Induction|Refusal of Further Protocol Therapy|0|||
131146524|NCT00408005|472160998|FG004|Induction|Refusal of Further Protocol Therapy|0|||
131146525|NCT00408005|472160999|FG005|Induction|Refusal of Further Protocol Therapy|0|||
131146526|NCT00408005|472161000|FG006|Induction|Refusal of Further Protocol Therapy|0|||
131146527|NCT00408005|472161001|FG007|Induction|Refusal of Further Protocol Therapy|0|||
131146528|NCT00408005|472160994|FG000|Induction|Entered another COG therapeutic protocol|4|||
131146529|NCT00408005|472160995|FG001|Induction|Entered another COG therapeutic protocol|0|||
131146530|NCT00408005|472160996|FG002|Induction|Entered another COG therapeutic protocol|0|||
131146531|NCT00408005|472160997|FG003|Induction|Entered another COG therapeutic protocol|0|||
130727817|NCT01822366|470625558|FG003|Overall Study|Partial Intervention Completion|15|||
130727818|NCT00025259|470625559|FG000|Overall Study|Death|1|||
131146532|NCT00408005|472160998|FG004|Induction|Entered another COG therapeutic protocol|0|||
131146533|NCT00408005|472160999|FG005|Induction|Entered another COG therapeutic protocol|0|||
131146534|NCT00408005|472161000|FG006|Induction|Entered another COG therapeutic protocol|0|||
131146535|NCT00408005|472161001|FG007|Induction|Entered another COG therapeutic protocol|0|||
131146536|NCT00408005|472160994|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
131146537|NCT00408005|472160995|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
131146538|NCT00408005|472160996|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
130727819|NCT00025259|470625560|FG001|Overall Study|Death|3|||
131146539|NCT00408005|472160997|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
131146540|NCT00408005|472160998|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
131146541|NCT00408005|472160999|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
131146542|NCT00408005|472161000|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
131146543|NCT00408005|472161001|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
131146544|NCT00408005|472160994|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
131146545|NCT00408005|472160995|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
131146546|NCT00408005|472160996|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
131146547|NCT00408005|472160997|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
131146548|NCT00408005|472160998|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
131146549|NCT00408005|472160999|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
131146550|NCT00408005|472161000|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
131146551|NCT00408005|472161001|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
131146552|NCT00408005|472160994|FG000|Induction|Progressive Disease|0|||
131146553|NCT00408005|472160995|FG001|Induction|Progressive Disease|1|||
131146554|NCT00408005|472160996|FG002|Induction|Progressive Disease|0|||
131146555|NCT00408005|472160997|FG003|Induction|Progressive Disease|0|||
131146556|NCT00408005|472160998|FG004|Induction|Progressive Disease|0|||
131146557|NCT00408005|472160999|FG005|Induction|Progressive Disease|0|||
131146558|NCT00408005|472161000|FG006|Induction|Progressive Disease|0|||
131146559|NCT00408005|472161001|FG007|Induction|Progressive Disease|0|||
131146560|NCT00408005|472160994|FG000|Induction|Inevaluable|18|||
131146561|NCT00408005|472160995|FG001|Induction|Inevaluable|14|||
131146562|NCT00408005|472160996|FG002|Induction|Inevaluable|0|||
131146563|NCT00408005|472160997|FG003|Induction|Inevaluable|0|||
131146564|NCT00408005|472160998|FG004|Induction|Inevaluable|0|||
131146565|NCT00408005|472160999|FG005|Induction|Inevaluable|0|||
131146566|NCT00408005|472161000|FG006|Induction|Inevaluable|0|||
131146567|NCT00408005|472161001|FG007|Induction|Inevaluable|0|||
131146568|NCT00408005|472160994|FG000|Induction|Failed to Complete Randomization|3|||
131146569|NCT00408005|472160995|FG001|Induction|Failed to Complete Randomization|2|||
131146570|NCT00408005|472160996|FG002|Induction|Failed to Complete Randomization|0|||
131146571|NCT00408005|472160997|FG003|Induction|Failed to Complete Randomization|0|||
131146572|NCT00408005|472160998|FG004|Induction|Failed to Complete Randomization|0|||
131146573|NCT00408005|472160999|FG005|Induction|Failed to Complete Randomization|0|||
131146574|NCT00408005|472161000|FG006|Induction|Failed to Complete Randomization|0|||
131146575|NCT00408005|472161001|FG007|Induction|Failed to Complete Randomization|0|||
131146576|NCT00408005|472160994|FG000|Induction|Protocol Deviation|3|||
131146577|NCT00408005|472160995|FG001|Induction|Protocol Deviation|1|||
131146578|NCT00408005|472160996|FG002|Induction|Protocol Deviation|0|||
131146579|NCT00408005|472160997|FG003|Induction|Protocol Deviation|0|||
131146580|NCT00408005|472160998|FG004|Induction|Protocol Deviation|0|||
131146581|NCT00408005|472160999|FG005|Induction|Protocol Deviation|0|||
131146582|NCT00408005|472161000|FG006|Induction|Protocol Deviation|0|||
131146583|NCT00408005|472161001|FG007|Induction|Protocol Deviation|0|||
131146584|NCT00408005|472160994|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
131146585|NCT00408005|472160995|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
131146586|NCT00408005|472160996|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
131146587|NCT00408005|472160997|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
131146588|NCT00408005|472160998|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
131146589|NCT00408005|472160999|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
131146590|NCT00408005|472161000|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
131146591|NCT00408005|472161001|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
131146592|NCT00408005|472160994|FG000|Induction|Recurrent leukemia|1|||
131146593|NCT00408005|472160995|FG001|Induction|Recurrent leukemia|0|||
131146594|NCT00408005|472160996|FG002|Induction|Recurrent leukemia|0|||
131146595|NCT00408005|472160997|FG003|Induction|Recurrent leukemia|0|||
131146596|NCT00408005|472160998|FG004|Induction|Recurrent leukemia|0|||
131146597|NCT00408005|472160999|FG005|Induction|Recurrent leukemia|0|||
131146598|NCT00408005|472161000|FG006|Induction|Recurrent leukemia|0|||
131146599|NCT00408005|472161001|FG007|Induction|Recurrent leukemia|0|||
131146600|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
131146601|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
131146602|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
131146603|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
131146604|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
131146605|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
131146606|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
131146607|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
131146608|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
131146609|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
131146610|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
131146611|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
131146612|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
131146613|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
131146614|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
131146615|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
131146616|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131146617|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131146618|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
131146619|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131146620|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
131146621|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131146622|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131146623|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
131146624|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
131146625|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
131146626|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
131146627|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
131146628|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
131146629|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
131146630|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
131146631|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
131146632|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
131146633|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
131146634|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
131146635|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
131146636|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
131146637|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
131146638|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
131146639|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
131146640|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
131146641|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
131146642|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
131146643|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
131146644|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
131146645|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
131146646|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
131146647|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
131146648|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131146649|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131146650|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131146651|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131146652|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
131146653|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131146654|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131146655|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
131146656|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
131146657|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
131146658|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
131146659|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
131146660|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
131146661|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
131146662|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
131146663|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
131146664|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
131146665|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
131146666|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
131146667|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
131146668|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
131146669|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
131146670|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
131146671|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
131146672|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131146673|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131146674|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131146675|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131146676|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131146677|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
130727820|NCT00025259|470625561|FG002|Overall Study|Death|0|||
130727821|NCT00025259|470625562|FG003|Overall Study|Death|3|||
130727822|NCT00025259|470625563|FG004|Overall Study|Death|0|||
130727823|NCT00025259|470625564|FG005|Overall Study|Death|1|||
130727824|NCT00025259|470625565|FG006|Overall Study|Death|2|||
130727825|NCT00025259|470625559|FG000|Overall Study|Lack of Efficacy|2|||
130727826|NCT00025259|470625560|FG001|Overall Study|Lack of Efficacy|46|||
130727827|NCT00025259|470625561|FG002|Overall Study|Lack of Efficacy|60|||
130727828|NCT00025259|470625562|FG003|Overall Study|Lack of Efficacy|78|||
130727829|NCT00025259|470625563|FG004|Overall Study|Lack of Efficacy|11|||
131146678|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131146679|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
131146680|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
131146681|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
131146682|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
131146683|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
131146684|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
131146685|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
131146686|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
131146687|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
131146688|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131146689|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131146690|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131146691|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131146692|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
131146693|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
131146694|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131146695|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
131146696|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
131146697|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
131146698|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
131146699|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
131146700|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
131146701|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
131146702|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
131146703|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
131146704|NCT00408005|472160994|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
131146705|NCT00408005|472160995|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
131146706|NCT00408005|472160996|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
131146707|NCT00408005|472160997|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
131146708|NCT00408005|472160998|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
131146709|NCT00408005|472160999|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
131146710|NCT00408005|472161000|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
131146711|NCT00408005|472161001|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
131146712|NCT01848145|472161002|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
131146713|NCT01848145|472161002|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
131146714|NCT01848145|472161002|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
131146715|NCT01848145|472161002|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
131146716|NCT01848145|472161002|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
131146717|NCT01848145|472161002|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
131146718|NCT01848145|472161002|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
131146719|NCT03417440|472161014|FG000|Overall Study|Lost to Follow-up|0|||
131146720|NCT03417440|472161015|FG001|Overall Study|Lost to Follow-up|1|||
131146721|NCT03417440|472161016|FG002|Overall Study|Lost to Follow-up|0|||
131146722|NCT03417440|472161017|FG003|Overall Study|Lost to Follow-up|0|||
131146723|NCT03417440|472161018|FG004|Overall Study|Lost to Follow-up|1|||
131146724|NCT03417440|472161019|FG005|Overall Study|Lost to Follow-up|0|||
131146725|NCT03417440|472161020|FG006|Overall Study|Lost to Follow-up|0|||
131146726|NCT03417440|472161021|FG007|Overall Study|Lost to Follow-up|0|||
131146727|NCT03417440|472161014|FG000|Overall Study|Withdrawal by Subject|2|||
130727830|NCT00025259|470625564|FG005|Overall Study|Lack of Efficacy|30|||
130727831|NCT00025259|470625565|FG006|Overall Study|Lack of Efficacy|38|||
130727832|NCT00025259|470625559|FG000|Overall Study|Lost to Follow-up|2|||
130727833|NCT00025259|470625560|FG001|Overall Study|Lost to Follow-up|9|||
130727834|NCT00025259|470625561|FG002|Overall Study|Lost to Follow-up|13|||
130727835|NCT00025259|470625562|FG003|Overall Study|Lost to Follow-up|13|||
130727836|NCT00025259|470625563|FG004|Overall Study|Lost to Follow-up|1|||
130727837|NCT00025259|470625564|FG005|Overall Study|Lost to Follow-up|3|||
131146728|NCT03417440|472161015|FG001|Overall Study|Withdrawal by Subject|0|||
131146729|NCT03417440|472161016|FG002|Overall Study|Withdrawal by Subject|2|||
131146730|NCT03417440|472161017|FG003|Overall Study|Withdrawal by Subject|1|||
131146731|NCT03417440|472161018|FG004|Overall Study|Withdrawal by Subject|1|||
131146732|NCT03417440|472161019|FG005|Overall Study|Withdrawal by Subject|0|||
131146733|NCT03417440|472161020|FG006|Overall Study|Withdrawal by Subject|0|||
131146734|NCT03417440|472161021|FG007|Overall Study|Withdrawal by Subject|1|||
131146735|NCT03304522|472161022|FG000|Overall Study|Adverse Event|0|||
131146736|NCT03304522|472161023|FG001|Overall Study|Adverse Event|4|||
131146737|NCT03304522|472161022|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
131146738|NCT03304522|472161023|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
131146739|NCT03304522|472161022|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
131146740|NCT03304522|472161023|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
131146741|NCT03304522|472161022|FG000|Overall Study|Other|0|||
131146742|NCT03304522|472161023|FG001|Overall Study|Other|1|||
131146743|NCT02013544|472161026|FG000|Overall Study|Adverse Event|5|||
131146744|NCT02013544|472161027|FG001|Overall Study|Adverse Event|5|||
131146745|NCT02013544|472161026|FG000|Overall Study|Lost to Follow-up|2|||
131146746|NCT02013544|472161027|FG001|Overall Study|Lost to Follow-up|3|||
131146747|NCT02013544|472161026|FG000|Overall Study|Withdrawal by Subject|2|||
131146748|NCT02013544|472161027|FG001|Overall Study|Withdrawal by Subject|8|||
131146749|NCT02013544|472161026|FG000|Overall Study|Physician Decision|0|||
131146750|NCT02013544|472161027|FG001|Overall Study|Physician Decision|1|||
131146751|NCT02013544|472161026|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
131146752|NCT02013544|472161027|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
131146753|NCT00238264|472161028|FG000|Overall Study|Death|7|||
131146754|NCT00238264|472161028|FG000|Overall Study|Lost to Follow-up|18|||
131146755|NCT00238264|472161028|FG000|Overall Study|Withdrawal by Subject|4|||
131146756|NCT00238264|472161028|FG000|Overall Study|Ineligible|7|||
131146757|NCT00885365|472161031|FG000|4 Weeks ON Treatment|Adverse Event|2|||
131146758|NCT00885365|472161032|FG001|4 Weeks ON Treatment|Adverse Event|4|||
131146759|NCT00885365|472161031|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
131146760|NCT00885365|472161032|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
131146761|NCT00885365|472161031|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
131146762|NCT00885365|472161032|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
131146763|NCT02706938|472161033|FG000|First Period, 6 Weeks|Adverse Event|8|||
131146764|NCT02706938|472161034|FG001|First Period, 6 Weeks|Adverse Event|0|||
131146765|NCT02706938|472161033|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
131146766|NCT02706938|472161034|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
131146767|NCT02706938|472161033|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
131146768|NCT02706938|472161034|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
131146769|NCT02706938|472161033|FG000|Second Period, 6 Weeks|Adverse Event|0|||
131146770|NCT02706938|472161034|FG001|Second Period, 6 Weeks|Adverse Event|7|||
131146771|NCT02706938|472161033|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
131146772|NCT02706938|472161034|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
131146773|NCT03838484|472161035|FG000|Overall Study|Lost to Follow-up|0|||
131146774|NCT03838484|472161036|FG001|Overall Study|Lost to Follow-up|1|||
131146775|NCT03838484|472161037|FG002|Overall Study|Lost to Follow-up|0|||
131146776|NCT03838484|472161038|FG003|Overall Study|Lost to Follow-up|0|||
131146777|NCT02507349|472161039|FG000|Overall Study|Death|12|||
131146778|NCT02507349|472161040|FG001|Overall Study|Death|16|||
131146779|NCT02507349|472161039|FG000|Overall Study|Withdrawal by Subject|1|||
131146780|NCT02507349|472161040|FG001|Overall Study|Withdrawal by Subject|1|||
131146781|NCT02507349|472161039|FG000|Overall Study|Lost to Follow-up|174|||
131146782|NCT02507349|472161040|FG001|Overall Study|Lost to Follow-up|144|||
131146783|NCT00813995|472161041|FG000|Overall Study|Clinical adverse event|9|||
131146784|NCT00813995|472161042|FG001|Overall Study|Clinical adverse event|3|||
131146785|NCT00813995|472161041|FG000|Overall Study|Laboratory adverse event|0|||
131146786|NCT00813995|472161042|FG001|Overall Study|Laboratory adverse event|2|||
131146787|NCT00813995|472161041|FG000|Overall Study|Lack of Efficacy|1|||
131146788|NCT00813995|472161042|FG001|Overall Study|Lack of Efficacy|0|||
131146789|NCT00813995|472161041|FG000|Overall Study|Lost to Follow-up|4|||
131146790|NCT00813995|472161042|FG001|Overall Study|Lost to Follow-up|2|||
131146791|NCT00813995|472161041|FG000|Overall Study|Other reason|2|||
131146792|NCT00813995|472161042|FG001|Overall Study|Other reason|2|||
131146793|NCT00813995|472161041|FG000|Overall Study|Protocol Violation|3|||
131146794|NCT00813995|472161042|FG001|Overall Study|Protocol Violation|2|||
131146795|NCT00813995|472161041|FG000|Overall Study|Subject moved|4|||
131146796|NCT00813995|472161042|FG001|Overall Study|Subject moved|0|||
131146797|NCT00813995|472161041|FG000|Overall Study|Withdrawal by Subject|0|||
131146798|NCT00813995|472161042|FG001|Overall Study|Withdrawal by Subject|5|||
131146799|NCT00860470|472161051|FG000|Overall Study|Death|6|||
131146800|NCT00860470|472161052|FG001|Overall Study|Death|10|||
131146801|NCT00860470|472161051|FG000|Overall Study|Moved away|8|||
131146802|NCT00860470|472161052|FG001|Overall Study|Moved away|10|||
131146803|NCT00860470|472161051|FG000|Overall Study|Lost to Follow-up|34|||
131146804|NCT00860470|472161052|FG001|Overall Study|Lost to Follow-up|39|||
131146805|NCT02700984|472161054|FG000|Overall Study|Death|2|||
131146806|NCT02700984|472161055|FG001|Overall Study|Death|1|||
131146807|NCT02700984|472161054|FG000|Overall Study|Lost to Follow-up|2|||
131146808|NCT02700984|472161055|FG001|Overall Study|Lost to Follow-up|1|||
131146809|NCT02700984|472161054|FG000|Overall Study|Physician Decision|0|||
131146810|NCT02700984|472161055|FG001|Overall Study|Physician Decision|1|||
131146811|NCT02700984|472161054|FG000|Overall Study|Withdrawal by Subject|8|||
131146812|NCT02700984|472161055|FG001|Overall Study|Withdrawal by Subject|9|||
131146813|NCT02700984|472161054|FG000|Overall Study|Reason not specified|3|||
131146814|NCT02700984|472161055|FG001|Overall Study|Reason not specified|2|||
131146815|NCT00473876|472161064|FG000|Overall Study|Lost to Follow-up|3|||
131146816|NCT00473876|472161065|FG001|Overall Study|Lost to Follow-up|1|||
131146817|NCT00348140|472161067|FG000|Overall Study|Adverse Event|46|||
131146818|NCT00348140|472161068|FG001|Overall Study|Adverse Event|49|||
131146819|NCT00348140|472161069|FG002|Overall Study|Adverse Event|78|||
131146820|NCT00348140|472161067|FG000|Overall Study|Lost to Follow-up|4|||
131146821|NCT00348140|472161068|FG001|Overall Study|Lost to Follow-up|4|||
131146822|NCT00348140|472161069|FG002|Overall Study|Lost to Follow-up|4|||
131146823|NCT00348140|472161067|FG000|Overall Study|Protocol Violation|12|||
131146824|NCT00348140|472161068|FG001|Overall Study|Protocol Violation|13|||
131146825|NCT00348140|472161069|FG002|Overall Study|Protocol Violation|14|||
131146826|NCT00348140|472161067|FG000|Overall Study|Withdrawal by Subject|32|||
131146827|NCT00348140|472161068|FG001|Overall Study|Withdrawal by Subject|40|||
131146828|NCT00348140|472161069|FG002|Overall Study|Withdrawal by Subject|40|||
131146829|NCT00348140|472161067|FG000|Overall Study|Non-compliance|8|||
131146830|NCT00348140|472161068|FG001|Overall Study|Non-compliance|13|||
131146831|NCT00348140|472161069|FG002|Overall Study|Non-compliance|5|||
131146832|NCT00348140|472161067|FG000|Overall Study|Participant at risk due to study drug|2|||
131146833|NCT00348140|472161068|FG001|Overall Study|Participant at risk due to study drug|0|||
131146834|NCT00348140|472161069|FG002|Overall Study|Participant at risk due to study drug|0|||
131146835|NCT00348140|472161067|FG000|Overall Study|Conditional medication increased dose|1|||
131146836|NCT00348140|472161068|FG001|Overall Study|Conditional medication increased dose|0|||
131146837|NCT00348140|472161069|FG002|Overall Study|Conditional medication increased dose|0|||
131146838|NCT00348140|472161067|FG000|Overall Study|Caregiver related|4|||
131146839|NCT00348140|472161068|FG001|Overall Study|Caregiver related|7|||
131146840|NCT00348140|472161069|FG002|Overall Study|Caregiver related|3|||
131146841|NCT00348140|472161067|FG000|Overall Study|Participant hospitalised|3|||
131146842|NCT00348140|472161068|FG001|Overall Study|Participant hospitalised|0|||
131146843|NCT00348140|472161069|FG002|Overall Study|Participant hospitalised|0|||
131146844|NCT00348140|472161067|FG000|Overall Study|Efficacy related|1|||
131146845|NCT00348140|472161068|FG001|Overall Study|Efficacy related|1|||
131146846|NCT00348140|472161069|FG002|Overall Study|Efficacy related|0|||
131146847|NCT00348140|472161067|FG000|Overall Study|Administration related|3|||
131146848|NCT00348140|472161068|FG001|Overall Study|Administration related|1|||
131146849|NCT00348140|472161069|FG002|Overall Study|Administration related|1|||
131146850|NCT00348140|472161067|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
131146851|NCT00348140|472161068|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
131146852|NCT00348140|472161069|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
131146853|NCT00348140|472161067|FG000|Overall Study|Participant unwell|1|||
131146854|NCT00348140|472161068|FG001|Overall Study|Participant unwell|0|||
131146855|NCT00348140|472161069|FG002|Overall Study|Participant unwell|0|||
131146856|NCT00348140|472161067|FG000|Overall Study|Screen failure|1|||
131146857|NCT00348140|472161068|FG001|Overall Study|Screen failure|0|||
131146858|NCT00348140|472161069|FG002|Overall Study|Screen failure|0|||
131146859|NCT00348140|472161067|FG000|Overall Study|Investigator decided to discontinue|4|||
131146860|NCT00348140|472161068|FG001|Overall Study|Investigator decided to discontinue|1|||
131146861|NCT00348140|472161069|FG002|Overall Study|Investigator decided to discontinue|4|||
131146862|NCT00348140|472161067|FG000|Overall Study|Decided to discontinue on their own|1|||
131146863|NCT00348140|472161068|FG001|Overall Study|Decided to discontinue on their own|4|||
131146864|NCT00348140|472161069|FG002|Overall Study|Decided to discontinue on their own|1|||
131146865|NCT00348140|472161067|FG000|Overall Study|Use of prohibited drug|1|||
131146866|NCT00348140|472161068|FG001|Overall Study|Use of prohibited drug|0|||
131146867|NCT00348140|472161069|FG002|Overall Study|Use of prohibited drug|2|||
131146868|NCT00348140|472161067|FG000|Overall Study|Disease progression|1|||
131146869|NCT00348140|472161068|FG001|Overall Study|Disease progression|2|||
131146870|NCT00348140|472161069|FG002|Overall Study|Disease progression|5|||
131146871|NCT00348140|472161067|FG000|Overall Study|Increased risk of cardiac infarction|0|||
131234836|NCT03538756|472486492|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
130727838|NCT00025259|470625565|FG006|Overall Study|Lost to Follow-up|1|||
131146872|NCT00348140|472161068|FG001|Overall Study|Increased risk of cardiac infarction|1|||
131146873|NCT00348140|472161069|FG002|Overall Study|Increased risk of cardiac infarction|0|||
131146874|NCT00348140|472161067|FG000|Overall Study|Serious adverse event|0|||
131146875|NCT00348140|472161068|FG001|Overall Study|Serious adverse event|1|||
131146876|NCT00348140|472161069|FG002|Overall Study|Serious adverse event|0|||
131146877|NCT00348140|472161067|FG000|Overall Study|Abnormal ECG|0|||
131146878|NCT00348140|472161068|FG001|Overall Study|Abnormal ECG|1|||
131146879|NCT00348140|472161069|FG002|Overall Study|Abnormal ECG|3|||
131146880|NCT00348140|472161067|FG000|Overall Study|Participant died|0|||
131146881|NCT00348140|472161068|FG001|Overall Study|Participant died|1|||
131146882|NCT00348140|472161069|FG002|Overall Study|Participant died|0|||
131146883|NCT00348140|472161067|FG000|Overall Study|Exclusion criteria met|0|||
131146884|NCT00348140|472161068|FG001|Overall Study|Exclusion criteria met|0|||
131146885|NCT00348140|472161069|FG002|Overall Study|Exclusion criteria met|1|||
131146886|NCT00348140|472161067|FG000|Overall Study|Memory declined|0|||
131146887|NCT00348140|472161068|FG001|Overall Study|Memory declined|0|||
131146888|NCT00348140|472161069|FG002|Overall Study|Memory declined|1|||
131146889|NCT03371355|472161072|FG000|Overall Study|Investigator judgment|0|||
131146890|NCT03371355|472161073|FG001|Overall Study|Investigator judgment|0|||
131146891|NCT03371355|472161074|FG002|Overall Study|Investigator judgment|1|||
131146892|NCT03371355|472161075|FG003|Overall Study|Investigator judgment|1|||
131146893|NCT03371355|472161072|FG000|Overall Study|Voluntary withdrawal|1|||
131146894|NCT03371355|472161073|FG001|Overall Study|Voluntary withdrawal|0|||
131146895|NCT03371355|472161074|FG002|Overall Study|Voluntary withdrawal|1|||
131146896|NCT03371355|472161075|FG003|Overall Study|Voluntary withdrawal|2|||
131146897|NCT03371355|472161072|FG000|Overall Study|Adverse Event|0|||
131146898|NCT03371355|472161073|FG001|Overall Study|Adverse Event|1|||
131146899|NCT03371355|472161074|FG002|Overall Study|Adverse Event|2|||
131146900|NCT03371355|472161075|FG003|Overall Study|Adverse Event|3|||
131146901|NCT03371355|472161072|FG000|Overall Study|Reason not Specified|0|||
131146902|NCT03371355|472161073|FG001|Overall Study|Reason not Specified|1|||
131146903|NCT03371355|472161074|FG002|Overall Study|Reason not Specified|0|||
131146904|NCT03371355|472161075|FG003|Overall Study|Reason not Specified|1|||
131146905|NCT02868892|472161076|FG000|Overall Study|Investigator left site and no follow-up|6|||
131146906|NCT01662648|472161077|FG000|Overall Study|Death|1|||
131146907|NCT01662648|472161078|FG001|Overall Study|Death|3|||
131146908|NCT01662648|472161077|FG000|Overall Study|Adverse Event|40|||
131146909|NCT01662648|472161078|FG001|Overall Study|Adverse Event|37|||
131146910|NCT01662648|472161077|FG000|Overall Study|Lack of Efficacy|17|||
131146911|NCT01662648|472161078|FG001|Overall Study|Lack of Efficacy|16|||
131146912|NCT01662648|472161077|FG000|Overall Study|Participant ineligible to continue trial|1|||
131146913|NCT01662648|472161078|FG001|Overall Study|Participant ineligible to continue trial|1|||
131146914|NCT01662648|472161077|FG000|Overall Study|Lost to Follow-up|24|||
131146915|NCT01662648|472161078|FG001|Overall Study|Lost to Follow-up|36|||
131146916|NCT01662648|472161077|FG000|Overall Study|Withdrawal by Subject|36|||
131146917|NCT01662648|472161078|FG001|Overall Study|Withdrawal by Subject|53|||
131146918|NCT01662648|472161077|FG000|Overall Study|Participant non-compliant|16|||
131146919|NCT01662648|472161078|FG001|Overall Study|Participant non-compliant|20|||
131146920|NCT01662648|472161077|FG000|Overall Study|Other|8|||
131146921|NCT01662648|472161078|FG001|Overall Study|Other|11|||
131146922|NCT01662648|472161077|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
131146923|NCT01662648|472161078|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
131146924|NCT01662648|472161077|FG000|Overall Study|LOE and other reason unspecified|1|||
131146925|NCT01662648|472161078|FG001|Overall Study|LOE and other reason unspecified|0|||
131146926|NCT01662648|472161077|FG000|Overall Study|LOE and Participant non-compliant|0|||
131146927|NCT01662648|472161078|FG001|Overall Study|LOE and Participant non-compliant|1|||
131146928|NCT01791855|472161083|FG000|Overall Study|Adverse Event|0|||
131146929|NCT01791855|472161084|FG001|Overall Study|Adverse Event|0|||
131146930|NCT01791855|472161085|FG002|Overall Study|Adverse Event|0|||
131146931|NCT01791855|472161086|FG003|Overall Study|Adverse Event|1|||
131146932|NCT01791855|472161083|FG000|Overall Study|Randomized, not treated|0|||
131146933|NCT01791855|472161084|FG001|Overall Study|Randomized, not treated|1|||
131146934|NCT01791855|472161085|FG002|Overall Study|Randomized, not treated|0|||
131146935|NCT01791855|472161086|FG003|Overall Study|Randomized, not treated|0|||
131146936|NCT03898063|472161090|FG000|Overall Study|Withdrawal by Subject|10|||
131146937|NCT03898063|472161091|FG001|Overall Study|Withdrawal by Subject|8|||
131146938|NCT02949830|472161092|FG000|Overall Study|Adverse Event|1|||
131146939|NCT02949830|472161092|FG000|Overall Study|Withdrawal by Subject|1|||
131146940|NCT00054132|472161093|FG000|Overall Study|Not Treated|1|||
131146941|NCT01290887|472161094|FG000|Overall Study|Adverse Event|6|||
131146942|NCT01290887|472161095|FG001|Overall Study|Adverse Event|11|||
131146943|NCT01290887|472161094|FG000|Overall Study|Lack of Efficacy|4|||
131146944|NCT01290887|472161095|FG001|Overall Study|Lack of Efficacy|5|||
131146945|NCT01290887|472161094|FG000|Overall Study|Withdrawal by Subject|26|||
131146946|NCT01290887|472161095|FG001|Overall Study|Withdrawal by Subject|32|||
131146947|NCT01290887|472161094|FG000|Overall Study|Protocol Violation|2|||
131146948|NCT01290887|472161095|FG001|Overall Study|Protocol Violation|1|||
131146949|NCT01290887|472161094|FG000|Overall Study|Lost to Follow-up|4|||
131146950|NCT01290887|472161095|FG001|Overall Study|Lost to Follow-up|4|||
131146951|NCT01290887|472161094|FG000|Overall Study|Non-compliance to study procedures|0|||
131146952|NCT01290887|472161095|FG001|Overall Study|Non-compliance to study procedures|1|||
131146953|NCT01290887|472161094|FG000|Overall Study|Non-compliance to study medications|1|||
131146954|NCT01290887|472161095|FG001|Overall Study|Non-compliance to study medications|0|||
131146955|NCT01290887|472161094|FG000|Overall Study|Sponsor closure of study|420|||
131146956|NCT01290887|472161095|FG001|Overall Study|Sponsor closure of study|476|||
131146957|NCT01290887|472161094|FG000|Overall Study|Other|3|||
131146958|NCT01290887|472161095|FG001|Overall Study|Other|6|||
131146959|NCT02764541|472161098|FG000|Overall Study|Withdrawal by Subject|0|||
131146960|NCT02764541|472161099|FG001|Overall Study|Withdrawal by Subject|0|||
131146961|NCT02764541|472161100|FG002|Overall Study|Withdrawal by Subject|0|||
131146962|NCT02764541|472161101|FG003|Overall Study|Withdrawal by Subject|0|||
131146963|NCT02764541|472161102|FG004|Overall Study|Withdrawal by Subject|1|||
131146964|NCT02764541|472161103|FG005|Overall Study|Withdrawal by Subject|1|||
131146965|NCT02764541|472161104|FG006|Overall Study|Withdrawal by Subject|0|||
131146966|NCT02764541|472161105|FG007|Overall Study|Withdrawal by Subject|1|||
131146967|NCT02764541|472161098|FG000|Overall Study|Adverse Event|1|||
131146968|NCT02764541|472161099|FG001|Overall Study|Adverse Event|0|||
131146969|NCT02764541|472161100|FG002|Overall Study|Adverse Event|0|||
131146970|NCT02764541|472161101|FG003|Overall Study|Adverse Event|0|||
131146971|NCT02764541|472161102|FG004|Overall Study|Adverse Event|0|||
131146972|NCT02764541|472161103|FG005|Overall Study|Adverse Event|0|||
131146973|NCT02764541|472161104|FG006|Overall Study|Adverse Event|1|||
131146974|NCT02764541|472161105|FG007|Overall Study|Adverse Event|0|||
131146975|NCT02764541|472161098|FG000|Overall Study|Metastasis|1|||
131146976|NCT02764541|472161099|FG001|Overall Study|Metastasis|0|||
131146977|NCT02764541|472161100|FG002|Overall Study|Metastasis|0|||
131146978|NCT02764541|472161101|FG003|Overall Study|Metastasis|0|||
131146979|NCT02764541|472161102|FG004|Overall Study|Metastasis|0|||
131146980|NCT02764541|472161103|FG005|Overall Study|Metastasis|0|||
131146981|NCT02764541|472161104|FG006|Overall Study|Metastasis|0|||
131146982|NCT02764541|472161105|FG007|Overall Study|Metastasis|0|||
131146983|NCT02764541|472161098|FG000|Overall Study|Disease progression|1|||
131146984|NCT02764541|472161099|FG001|Overall Study|Disease progression|1|||
131146985|NCT02764541|472161100|FG002|Overall Study|Disease progression|0|||
131146986|NCT02764541|472161101|FG003|Overall Study|Disease progression|0|||
131146987|NCT02764541|472161102|FG004|Overall Study|Disease progression|0|||
131146988|NCT02764541|472161103|FG005|Overall Study|Disease progression|0|||
131146989|NCT02764541|472161104|FG006|Overall Study|Disease progression|0|||
131146990|NCT02764541|472161105|FG007|Overall Study|Disease progression|1|||
131146991|NCT02764541|472161098|FG000|Overall Study|Protocol Violation|0|||
131146992|NCT02764541|472161099|FG001|Overall Study|Protocol Violation|0|||
131146993|NCT02764541|472161100|FG002|Overall Study|Protocol Violation|0|||
131146994|NCT02764541|472161101|FG003|Overall Study|Protocol Violation|1|||
131146995|NCT02764541|472161102|FG004|Overall Study|Protocol Violation|0|||
131146996|NCT02764541|472161103|FG005|Overall Study|Protocol Violation|1|||
131146997|NCT02764541|472161104|FG006|Overall Study|Protocol Violation|0|||
131146998|NCT02764541|472161105|FG007|Overall Study|Protocol Violation|0|||
131146999|NCT02764541|472161098|FG000|Overall Study|Physician Decision|0|||
131147000|NCT02764541|472161099|FG001|Overall Study|Physician Decision|0|||
131147001|NCT02764541|472161100|FG002|Overall Study|Physician Decision|0|||
131147002|NCT02764541|472161101|FG003|Overall Study|Physician Decision|1|||
131147003|NCT02764541|472161102|FG004|Overall Study|Physician Decision|0|||
131147004|NCT02764541|472161103|FG005|Overall Study|Physician Decision|0|||
131147005|NCT02764541|472161104|FG006|Overall Study|Physician Decision|0|||
131147006|NCT02764541|472161105|FG007|Overall Study|Physician Decision|1|||
131147007|NCT02764541|472161098|FG000|Overall Study|Three Cycles completed before surgery|0|||
131147008|NCT02764541|472161099|FG001|Overall Study|Three Cycles completed before surgery|0|||
131147009|NCT02764541|472161100|FG002|Overall Study|Three Cycles completed before surgery|0|||
131147010|NCT02764541|472161101|FG003|Overall Study|Three Cycles completed before surgery|1|||
131147011|NCT02764541|472161102|FG004|Overall Study|Three Cycles completed before surgery|0|||
131147012|NCT02764541|472161103|FG005|Overall Study|Three Cycles completed before surgery|0|||
131147013|NCT02764541|472161104|FG006|Overall Study|Three Cycles completed before surgery|0|||
131147014|NCT02764541|472161105|FG007|Overall Study|Three Cycles completed before surgery|0|||
131147015|NCT02764541|472161098|FG000|Overall Study|Patient Compliance|0|||
131147016|NCT02764541|472161099|FG001|Overall Study|Patient Compliance|0|||
131147017|NCT02764541|472161100|FG002|Overall Study|Patient Compliance|1|||
131147018|NCT02764541|472161101|FG003|Overall Study|Patient Compliance|0|||
131147019|NCT02764541|472161102|FG004|Overall Study|Patient Compliance|0|||
131147020|NCT02764541|472161103|FG005|Overall Study|Patient Compliance|0|||
131147021|NCT02764541|472161104|FG006|Overall Study|Patient Compliance|0|||
131147022|NCT02764541|472161105|FG007|Overall Study|Patient Compliance|0|||
131147023|NCT02764541|472161098|FG000|Overall Study|Death|0|||
131147024|NCT02764541|472161099|FG001|Overall Study|Death|0|||
131147025|NCT02764541|472161100|FG002|Overall Study|Death|0|||
131147026|NCT02764541|472161101|FG003|Overall Study|Death|0|||
131147027|NCT02764541|472161102|FG004|Overall Study|Death|0|||
131147028|NCT02764541|472161103|FG005|Overall Study|Death|0|||
131147029|NCT02764541|472161104|FG006|Overall Study|Death|1|||
131147030|NCT02764541|472161105|FG007|Overall Study|Death|0|||
131147031|NCT02764541|472161098|FG000|Overall Study|Insurance reasons|0|||
131147032|NCT02764541|472161099|FG001|Overall Study|Insurance reasons|0|||
131147033|NCT02764541|472161100|FG002|Overall Study|Insurance reasons|0|||
131147034|NCT02764541|472161101|FG003|Overall Study|Insurance reasons|0|||
131147035|NCT02764541|472161102|FG004|Overall Study|Insurance reasons|0|||
131147036|NCT02764541|472161103|FG005|Overall Study|Insurance reasons|0|||
131147037|NCT02764541|472161104|FG006|Overall Study|Insurance reasons|1|||
131147038|NCT02764541|472161105|FG007|Overall Study|Insurance reasons|0|||
131147039|NCT02040142|472161111|FG000|Overall Study|Lost to Follow-up|5|||
131147040|NCT02040142|472161111|FG000|Overall Study|Death|17|||
131147041|NCT02040142|472161111|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
131147042|NCT02330419|472161112|FG000|Overall Study|Lost to Follow-up|3|||
131147043|NCT02330419|472161113|FG001|Overall Study|Lost to Follow-up|7|||
131147044|NCT01813890|472161116|FG000|Overall Study|Adverse Event|0|||
131147045|NCT01813890|472161117|FG001|Overall Study|Adverse Event|3|||
131147046|NCT01813890|472161118|FG002|Overall Study|Adverse Event|4|||
131147047|NCT01813890|472161116|FG000|Overall Study|Lack of Efficacy|9|||
131147048|NCT01813890|472161117|FG001|Overall Study|Lack of Efficacy|1|||
131147049|NCT01813890|472161118|FG002|Overall Study|Lack of Efficacy|2|||
131147050|NCT04439123|472161119|FG000|Overall Study|Adverse Event|11|||
131147051|NCT04439123|472161119|FG000|Overall Study|Death|1|||
131147052|NCT04439123|472161119|FG000|Overall Study|Disease progression|19|||
131147053|NCT04439123|472161119|FG000|Overall Study|Withdrawal by Subject|2|||
131147054|NCT04439123|472161119|FG000|Overall Study|Still on treatment|2|||
131147055|NCT03952559|472161120|FG000|Double Blind Treatment Period|Adverse Event|0|||
131147056|NCT03952559|472161121|FG001|Double Blind Treatment Period|Adverse Event|2|||
131147057|NCT03952559|472161122|FG002|Double Blind Treatment Period|Adverse Event|1|||
131147058|NCT03952559|472161123|FG003|Double Blind Treatment Period|Adverse Event|0|||
131147059|NCT03952559|472161124|FG004|Double Blind Treatment Period|Adverse Event|1|||
131147060|NCT03952559|472161120|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
131147061|NCT03952559|472161121|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
131147062|NCT03952559|472161122|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
131147063|NCT03952559|472161123|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
131147064|NCT03952559|472161124|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
131147065|NCT03952559|472161120|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
131147066|NCT03952559|472161121|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
131147067|NCT03952559|472161122|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
131147068|NCT03952559|472161123|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
131147069|NCT03952559|472161124|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
131147070|NCT03952559|472161120|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
131147071|NCT03952559|472161121|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
131147072|NCT03952559|472161122|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
131147073|NCT03952559|472161123|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
131147074|NCT03952559|472161124|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
131147075|NCT01870739|472161127|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
131147076|NCT01870739|472161128|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
131147077|NCT01870739|472161127|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
131147078|NCT01870739|472161128|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
131147079|NCT01870739|472161127|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
131147080|NCT01870739|472161128|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
131147081|NCT01870739|472161127|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
131147082|NCT01870739|472161128|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
131147083|NCT01870739|472161127|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
131147084|NCT01870739|472161128|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
131147085|NCT01870739|472161127|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
131147086|NCT01870739|472161128|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
131147087|NCT01870739|472161127|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
131147088|NCT01870739|472161128|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
131147089|NCT01986062|472161129|FG000|Overall Study|Lost to Follow-up|1|||
131147090|NCT01986062|472161130|FG001|Overall Study|Lost to Follow-up|0|||
131147091|NCT01986062|472161129|FG000|Overall Study|Withdrawal by Subject|0|||
131147092|NCT01986062|472161130|FG001|Overall Study|Withdrawal by Subject|1|||
131147093|NCT03538743|472161131|FG000|Overall Study|Adverse Event|0|||
131147094|NCT03538743|472161132|FG001|Overall Study|Adverse Event|0|||
131147095|NCT03538743|472161133|FG002|Overall Study|Adverse Event|1|||
131147096|NCT03538743|472161134|FG003|Overall Study|Adverse Event|1|||
131147097|NCT03538743|472161135|FG004|Overall Study|Adverse Event|0|||
131147098|NCT03538743|472161136|FG005|Overall Study|Adverse Event|0|||
131147099|NCT03538743|472161137|FG006|Overall Study|Adverse Event|0|||
131147100|NCT03538743|472161138|FG007|Overall Study|Adverse Event|0|||
131147101|NCT03538743|472161139|FG008|Overall Study|Adverse Event|0|||
131147102|NCT03538743|472161131|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
131147103|NCT03538743|472161132|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
131147104|NCT03538743|472161133|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
131147105|NCT03538743|472161134|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
131147106|NCT03538743|472161135|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
131147107|NCT03538743|472161136|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
131147108|NCT03538743|472161137|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
131147109|NCT03538743|472161138|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
131147110|NCT03538743|472161139|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
131147111|NCT03538743|472161131|FG000|Overall Study|Withdrawal by Subject|0|||
131147112|NCT03538743|472161132|FG001|Overall Study|Withdrawal by Subject|0|||
131147113|NCT03538743|472161133|FG002|Overall Study|Withdrawal by Subject|0|||
131147114|NCT03538743|472161134|FG003|Overall Study|Withdrawal by Subject|1|||
131147115|NCT03538743|472161135|FG004|Overall Study|Withdrawal by Subject|0|||
131147116|NCT03538743|472161136|FG005|Overall Study|Withdrawal by Subject|0|||
131147117|NCT03538743|472161137|FG006|Overall Study|Withdrawal by Subject|0|||
131147118|NCT03538743|472161138|FG007|Overall Study|Withdrawal by Subject|0|||
131147119|NCT03538743|472161139|FG008|Overall Study|Withdrawal by Subject|0|||
131147120|NCT04640766|472161140|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
131147121|NCT01827384|472161141|FG000|Overall Study|Switched to alternative treatment|0|||
131147122|NCT01827384|472161142|FG001|Overall Study|Switched to alternative treatment|0|||
131147123|NCT01827384|472161143|FG002|Overall Study|Switched to alternative treatment|0|||
131147124|NCT01827384|472161144|FG003|Overall Study|Switched to alternative treatment|0|||
131147125|NCT01827384|472161145|FG004|Overall Study|Switched to alternative treatment|0|||
131147126|NCT01827384|472161146|FG005|Overall Study|Switched to alternative treatment|0|||
131147127|NCT01827384|472161147|FG006|Overall Study|Switched to alternative treatment|0|||
131147128|NCT01827384|472161148|FG007|Overall Study|Switched to alternative treatment|0|||
131147129|NCT01827384|472161149|FG008|Overall Study|Switched to alternative treatment|0|||
131147130|NCT01827384|472161150|FG009|Overall Study|Switched to alternative treatment|0|||
131147131|NCT01827384|472161151|FG010|Overall Study|Switched to alternative treatment|0|||
131147132|NCT01827384|472161152|FG011|Overall Study|Switched to alternative treatment|0|||
131147133|NCT01827384|472161153|FG012|Overall Study|Switched to alternative treatment|0|||
131147134|NCT01827384|472161154|FG013|Overall Study|Switched to alternative treatment|2|||
131147135|NCT01827384|472161141|FG000|Overall Study|Disease progression before treatment|0|||
131147136|NCT01827384|472161142|FG001|Overall Study|Disease progression before treatment|0|||
131147137|NCT01827384|472161143|FG002|Overall Study|Disease progression before treatment|0|||
131147138|NCT01827384|472161144|FG003|Overall Study|Disease progression before treatment|0|||
131147139|NCT01827384|472161145|FG004|Overall Study|Disease progression before treatment|0|||
131147140|NCT01827384|472161146|FG005|Overall Study|Disease progression before treatment|0|||
131147141|NCT01827384|472161147|FG006|Overall Study|Disease progression before treatment|0|||
131147142|NCT01827384|472161148|FG007|Overall Study|Disease progression before treatment|0|||
131147143|NCT01827384|472161149|FG008|Overall Study|Disease progression before treatment|0|||
131147144|NCT01827384|472161150|FG009|Overall Study|Disease progression before treatment|0|||
131147145|NCT01827384|472161151|FG010|Overall Study|Disease progression before treatment|0|||
131147146|NCT01827384|472161152|FG011|Overall Study|Disease progression before treatment|0|||
131147147|NCT01827384|472161153|FG012|Overall Study|Disease progression before treatment|0|||
131147148|NCT01827384|472161154|FG013|Overall Study|Disease progression before treatment|4|||
131147149|NCT01827384|472161141|FG000|Overall Study|Ineligible|0|||
131147150|NCT01827384|472161142|FG001|Overall Study|Ineligible|0|||
131147151|NCT01827384|472161143|FG002|Overall Study|Ineligible|0|||
131147152|NCT01827384|472161144|FG003|Overall Study|Ineligible|0|||
131147153|NCT01827384|472161145|FG004|Overall Study|Ineligible|0|||
131147154|NCT01827384|472161146|FG005|Overall Study|Ineligible|0|||
131147155|NCT01827384|472161147|FG006|Overall Study|Ineligible|0|||
131147156|NCT01827384|472161148|FG007|Overall Study|Ineligible|0|||
131147157|NCT01827384|472161149|FG008|Overall Study|Ineligible|0|||
131147158|NCT01827384|472161150|FG009|Overall Study|Ineligible|0|||
131147159|NCT01827384|472161151|FG010|Overall Study|Ineligible|0|||
131147160|NCT01827384|472161152|FG011|Overall Study|Ineligible|0|||
131147161|NCT01827384|472161153|FG012|Overall Study|Ineligible|0|||
131147162|NCT01827384|472161154|FG013|Overall Study|Ineligible|19|||
131147163|NCT01827384|472161141|FG000|Overall Study|Participant died before treatment|0|||
131147164|NCT01827384|472161142|FG001|Overall Study|Participant died before treatment|0|||
131147165|NCT01827384|472161143|FG002|Overall Study|Participant died before treatment|0|||
131147166|NCT01827384|472161144|FG003|Overall Study|Participant died before treatment|0|||
131147167|NCT01827384|472161145|FG004|Overall Study|Participant died before treatment|0|||
131147168|NCT01827384|472161146|FG005|Overall Study|Participant died before treatment|0|||
131147169|NCT01827384|472161147|FG006|Overall Study|Participant died before treatment|0|||
131147170|NCT01827384|472161148|FG007|Overall Study|Participant died before treatment|0|||
131147171|NCT01827384|472161149|FG008|Overall Study|Participant died before treatment|0|||
131147172|NCT01827384|472161150|FG009|Overall Study|Participant died before treatment|0|||
131147173|NCT01827384|472161151|FG010|Overall Study|Participant died before treatment|0|||
131147174|NCT01827384|472161152|FG011|Overall Study|Participant died before treatment|0|||
131147175|NCT01827384|472161153|FG012|Overall Study|Participant died before treatment|0|||
131147176|NCT01827384|472161154|FG013|Overall Study|Participant died before treatment|5|||
131147177|NCT01827384|472161141|FG000|Overall Study|Insufficient tumor cells|0|||
131147178|NCT01827384|472161142|FG001|Overall Study|Insufficient tumor cells|0|||
131147179|NCT01827384|472161143|FG002|Overall Study|Insufficient tumor cells|0|||
131147180|NCT01827384|472161144|FG003|Overall Study|Insufficient tumor cells|0|||
131147181|NCT01827384|472161145|FG004|Overall Study|Insufficient tumor cells|0|||
131147182|NCT01827384|472161146|FG005|Overall Study|Insufficient tumor cells|0|||
131147183|NCT01827384|472161147|FG006|Overall Study|Insufficient tumor cells|0|||
131147184|NCT01827384|472161148|FG007|Overall Study|Insufficient tumor cells|0|||
131147185|NCT01827384|472161149|FG008|Overall Study|Insufficient tumor cells|0|||
131147186|NCT01827384|472161150|FG009|Overall Study|Insufficient tumor cells|0|||
131147187|NCT01827384|472161151|FG010|Overall Study|Insufficient tumor cells|0|||
131147188|NCT01827384|472161152|FG011|Overall Study|Insufficient tumor cells|0|||
131147189|NCT01827384|472161153|FG012|Overall Study|Insufficient tumor cells|0|||
131147190|NCT01827384|472161154|FG013|Overall Study|Insufficient tumor cells|13|||
131147191|NCT01827384|472161141|FG000|Overall Study|No actionable mutation|0|||
131147192|NCT01827384|472161142|FG001|Overall Study|No actionable mutation|0|||
131147193|NCT01827384|472161143|FG002|Overall Study|No actionable mutation|0|||
131147194|NCT01827384|472161144|FG003|Overall Study|No actionable mutation|0|||
131147195|NCT01827384|472161145|FG004|Overall Study|No actionable mutation|0|||
131147196|NCT01827384|472161146|FG005|Overall Study|No actionable mutation|0|||
131147197|NCT01827384|472161147|FG006|Overall Study|No actionable mutation|0|||
131147198|NCT01827384|472161148|FG007|Overall Study|No actionable mutation|0|||
131147199|NCT01827384|472161149|FG008|Overall Study|No actionable mutation|0|||
131147200|NCT01827384|472161150|FG009|Overall Study|No actionable mutation|0|||
131147201|NCT01827384|472161151|FG010|Overall Study|No actionable mutation|0|||
131147202|NCT01827384|472161152|FG011|Overall Study|No actionable mutation|0|||
131147203|NCT01827384|472161153|FG012|Overall Study|No actionable mutation|0|||
131147204|NCT01827384|472161154|FG013|Overall Study|No actionable mutation|73|||
131147205|NCT01827384|472161141|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
131147206|NCT01827384|472161142|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
131147207|NCT01827384|472161143|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
131147208|NCT01827384|472161144|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
131147209|NCT01827384|472161145|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
131147210|NCT01827384|472161146|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
131147211|NCT01827384|472161147|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
131147212|NCT01827384|472161148|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
131147213|NCT01827384|472161149|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
131147214|NCT01827384|472161150|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
131147215|NCT01827384|472161151|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
131147216|NCT01827384|472161152|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
131147217|NCT01827384|472161153|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
131147218|NCT01827384|472161154|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
131147219|NCT00630331|472161156|FG000|Overall Study|Death|2|||
131147220|NCT00630331|472161157|FG001|Overall Study|Death|1|||
131147221|NCT00630331|472161158|FG002|Overall Study|Death|1|||
131147222|NCT00630331|472161156|FG000|Overall Study|Adverse Event|1|||
131147223|NCT00630331|472161157|FG001|Overall Study|Adverse Event|0|||
131147224|NCT00630331|472161158|FG002|Overall Study|Adverse Event|0|||
131147225|NCT00630331|472161156|FG000|Overall Study|Withdrawal by Subject|12|||
131147226|NCT00630331|472161157|FG001|Overall Study|Withdrawal by Subject|7|||
131147227|NCT00630331|472161158|FG002|Overall Study|Withdrawal by Subject|5|||
131147228|NCT00630331|472161156|FG000|Overall Study|Lost to Follow-up|175|||
131147229|NCT00630331|472161157|FG001|Overall Study|Lost to Follow-up|143|||
131147230|NCT00630331|472161158|FG002|Overall Study|Lost to Follow-up|170|||
131147231|NCT00630331|472161156|FG000|Overall Study|Inappropriate enrollment|3|||
131147232|NCT00630331|472161157|FG001|Overall Study|Inappropriate enrollment|6|||
131147233|NCT00630331|472161158|FG002|Overall Study|Inappropriate enrollment|3|||
131147234|NCT00630331|472161156|FG000|Overall Study|Unable to classify|9|||
131147235|NCT00630331|472161157|FG001|Overall Study|Unable to classify|4|||
131147236|NCT00630331|472161158|FG002|Overall Study|Unable to classify|3|||
131147237|NCT00630331|472161156|FG000|Overall Study|Protocol Violation|4|||
131147238|NCT00630331|472161157|FG001|Overall Study|Protocol Violation|5|||
131147239|NCT00630331|472161158|FG002|Overall Study|Protocol Violation|6|||
131147240|NCT01955707|472161163|FG000|Overall Study|Adverse Event|1|||
131147241|NCT01955707|472161164|FG001|Overall Study|Adverse Event|2|||
131147242|NCT01955707|472161163|FG000|Overall Study|Lost to Follow-up|2|||
131147243|NCT01955707|472161164|FG001|Overall Study|Lost to Follow-up|1|||
131147244|NCT01955707|472161163|FG000|Overall Study|Withdrawal by Subject|0|||
131147245|NCT01955707|472161164|FG001|Overall Study|Withdrawal by Subject|3|||
131147246|NCT01955707|472161163|FG000|Overall Study|Death|13|||
131147247|NCT01955707|472161164|FG001|Overall Study|Death|14|||
131147248|NCT01955707|472161163|FG000|Overall Study|Other|4|||
131147249|NCT01955707|472161164|FG001|Overall Study|Other|2|||
131147250|NCT04280081|472161167|FG000|Overall Study|Adverse Event|4|||
131147251|NCT04280081|472161167|FG000|Overall Study|Death|2|||
131147252|NCT04280081|472161167|FG000|Overall Study|Progressive Disease|6|||
131147253|NCT03219164|472162876|FG000|Overall Study|Study Terminated by Sponsor|16|||
131147254|NCT03219164|472162877|FG001|Overall Study|Study Terminated by Sponsor|12|||
131147255|NCT03219164|472162876|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
131147256|NCT03219164|472162877|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
131147257|NCT03219164|472162876|FG000|Overall Study|Lost to Follow-up|1|||
131147258|NCT03219164|472162877|FG001|Overall Study|Lost to Follow-up|1|||
131147259|NCT03219164|472162876|FG000|Overall Study|Adverse Event|1|||
131147260|NCT03219164|472162877|FG001|Overall Study|Adverse Event|0|||
131147261|NCT03219164|472162876|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131147262|NCT03219164|472162877|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131147263|NCT03219164|472162876|FG000|Overall Study|Protocol Violation|0|||
131147264|NCT03219164|472162877|FG001|Overall Study|Protocol Violation|1|||
131147265|NCT03219164|472162876|FG000|Overall Study|Withdrew Assent|1|||
131147266|NCT03219164|472162877|FG001|Overall Study|Withdrew Assent|0|||
131147267|NCT02338843|472162878|FG000|Overall Study|Adverse Event|2|||
131147268|NCT02338843|472162879|FG001|Overall Study|Adverse Event|1|||
131147269|NCT02338843|472162878|FG000|Overall Study|Death|40|||
131147270|NCT02338843|472162879|FG001|Overall Study|Death|53|||
131147271|NCT02338843|472162878|FG000|Overall Study|Physician Decision|1|||
131147272|NCT02338843|472162879|FG001|Overall Study|Physician Decision|0|||
131147273|NCT02338843|472162878|FG000|Overall Study|Withdrawal by Subject|0|||
131147274|NCT02338843|472162879|FG001|Overall Study|Withdrawal by Subject|2|||
131147275|NCT02338843|472162878|FG000|Overall Study|Subject Recovered|0|||
131147276|NCT02338843|472162879|FG001|Overall Study|Subject Recovered|2|||
131147277|NCT02338843|472162878|FG000|Overall Study|Discontinued prior to randomizat|1|||
131147278|NCT02338843|472162879|FG001|Overall Study|Discontinued prior to randomizat|0|||
131147279|NCT00023322|472162880|FG000|Overall Study|Lost to Follow-up|1|||
131147280|NCT02185521|472162887|FG000|Overall Study|Withdrawal by Subject|1|||
131147281|NCT02185521|472162887|FG000|Overall Study|Protocol Violation|1|||
131147282|NCT03124459|472162890|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
131147283|NCT03124459|472162891|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
131147284|NCT03124459|472162892|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
131147285|NCT03124459|472162893|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
131147286|NCT03124459|472162894|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
131147287|NCT03124459|472162895|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
131147288|NCT03124459|472162890|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
131147289|NCT03124459|472162891|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
131147290|NCT03124459|472162892|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
131147291|NCT03124459|472162893|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
131147292|NCT03124459|472162894|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
131147293|NCT03124459|472162895|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
131147294|NCT03124459|472162890|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
131147295|NCT03124459|472162891|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
131147296|NCT03124459|472162892|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
131147297|NCT03124459|472162893|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
131147298|NCT03124459|472162894|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
131147299|NCT03124459|472162895|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
131147300|NCT03124459|472162890|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
131147301|NCT03124459|472162891|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
131147302|NCT03124459|472162892|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
131147303|NCT03124459|472162893|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
131147304|NCT03124459|472162894|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
131147305|NCT03124459|472162895|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
131147306|NCT03124459|472162890|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
131147307|NCT03124459|472162891|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
131147308|NCT03124459|472162892|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
131147309|NCT03124459|472162893|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
131147310|NCT03124459|472162894|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
131147311|NCT03124459|472162895|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
131147312|NCT03124459|472162890|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
131147313|NCT03124459|472162891|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
131147314|NCT03124459|472162892|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
131147315|NCT03124459|472162893|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
131147316|NCT03124459|472162894|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
131147317|NCT03124459|472162895|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
131147318|NCT00434967|472162898|FG000|Overall Study|Adverse Event|2|||
131147319|NCT00434967|472162899|FG001|Overall Study|Adverse Event|4|||
131147320|NCT00434967|472162900|FG002|Overall Study|Adverse Event|3|||
131147321|NCT00434967|472162901|FG003|Overall Study|Adverse Event|3|||
131147322|NCT00434967|472162898|FG000|Overall Study|Lost to Follow-up|0|||
131147323|NCT00434967|472162899|FG001|Overall Study|Lost to Follow-up|0|||
131147324|NCT00434967|472162900|FG002|Overall Study|Lost to Follow-up|1|||
131147325|NCT00434967|472162901|FG003|Overall Study|Lost to Follow-up|0|||
131147326|NCT00434967|472162898|FG000|Overall Study|Withdrawal by Subject|2|||
131147327|NCT00434967|472162899|FG001|Overall Study|Withdrawal by Subject|2|||
131147328|NCT00434967|472162900|FG002|Overall Study|Withdrawal by Subject|4|||
131147329|NCT00434967|472162901|FG003|Overall Study|Withdrawal by Subject|6|||
131147330|NCT00434967|472162898|FG000|Overall Study|Randomized in error|0|||
131147331|NCT00434967|472162899|FG001|Overall Study|Randomized in error|0|||
131147332|NCT00434967|472162900|FG002|Overall Study|Randomized in error|0|||
131147333|NCT00434967|472162901|FG003|Overall Study|Randomized in error|1|||
131147334|NCT00434967|472162898|FG000|Overall Study|Protocol Violation|0|||
131147335|NCT00434967|472162899|FG001|Overall Study|Protocol Violation|1|||
131147336|NCT00434967|472162900|FG002|Overall Study|Protocol Violation|0|||
131147337|NCT00434967|472162901|FG003|Overall Study|Protocol Violation|1|||
131147338|NCT00434967|472162898|FG000|Overall Study|Physician Decision|1|||
131147339|NCT00434967|472162899|FG001|Overall Study|Physician Decision|1|||
131147340|NCT00434967|472162900|FG002|Overall Study|Physician Decision|1|||
131147341|NCT00434967|472162901|FG003|Overall Study|Physician Decision|0|||
131147342|NCT00434967|472162898|FG000|Overall Study|Patient Disposition Challenges|2|||
131147343|NCT00434967|472162899|FG001|Overall Study|Patient Disposition Challenges|0|||
131147344|NCT00434967|472162900|FG002|Overall Study|Patient Disposition Challenges|0|||
131147345|NCT00434967|472162901|FG003|Overall Study|Patient Disposition Challenges|3|||
131147346|NCT00501228|472162902|FG000|Overall Study|Withdrawal by Subject|1|||
131147347|NCT03804684|472162903|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
131147348|NCT03804684|472162904|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
131147349|NCT01756274|472162908|FG000|Overall Study|Protocol Violation|2|||
131147350|NCT01756274|472162908|FG000|Overall Study|Laboratory error|1|||
131147351|NCT01147926|472162909|FG000|Overall Study|Subject Withdrew Consent|9|||
131147352|NCT01147926|472162910|FG001|Overall Study|Subject Withdrew Consent|10|||
131147353|NCT01147926|472162909|FG000|Overall Study|Adverse Event|7|||
131147354|NCT01147926|472162910|FG001|Overall Study|Adverse Event|6|||
131147355|NCT01147926|472162909|FG000|Overall Study|Subject Non-Compliant|5|||
131147356|NCT01147926|472162910|FG001|Overall Study|Subject Non-Compliant|4|||
131147357|NCT01147926|472162909|FG000|Overall Study|Principal investigator left hospital|1|||
131147358|NCT01147926|472162910|FG001|Overall Study|Principal investigator left hospital|3|||
131147359|NCT01147926|472162909|FG000|Overall Study|Selection criteria not met|3|||
131147360|NCT01147926|472162910|FG001|Overall Study|Selection criteria not met|1|||
131147361|NCT01147926|472162909|FG000|Overall Study|Lost to Follow-up|0|||
131147362|NCT01147926|472162910|FG001|Overall Study|Lost to Follow-up|2|||
131147363|NCT01147926|472162909|FG000|Overall Study|Sponsor's Decision|0|||
131147364|NCT01147926|472162910|FG001|Overall Study|Sponsor's Decision|1|||
131147365|NCT01147926|472162909|FG000|Overall Study|Lack of Efficacy|1|||
131147366|NCT01147926|472162910|FG001|Overall Study|Lack of Efficacy|0|||
131147367|NCT01147926|472162909|FG000|Overall Study|Too busy, no time for study|1|||
131147368|NCT01147926|472162910|FG001|Overall Study|Too busy, no time for study|0|||
131147369|NCT01147926|472162909|FG000|Overall Study|Went on holiday|0|||
131147370|NCT01147926|472162910|FG001|Overall Study|Went on holiday|1|||
131147371|NCT01147926|472162909|FG000|Overall Study|Colonoscopy result|0|||
131147372|NCT01147926|472162910|FG001|Overall Study|Colonoscopy result|1|||
131147373|NCT00486603|472162915|FG000|Overall Study|Withdrawal by Subject|1|||
131147374|NCT00486603|472162916|FG001|Overall Study|Withdrawal by Subject|0|||
131147375|NCT00486603|472162917|FG002|Overall Study|Withdrawal by Subject|0|||
131147376|NCT00486603|472162918|FG003|Overall Study|Withdrawal by Subject|0|||
131147377|NCT00486603|472162919|FG004|Overall Study|Withdrawal by Subject|0|||
131147378|NCT00486603|472162915|FG000|Overall Study|Physician Decision|0|||
131147379|NCT00486603|472162916|FG001|Overall Study|Physician Decision|1|||
131147380|NCT00486603|472162917|FG002|Overall Study|Physician Decision|0|||
131147381|NCT00486603|472162918|FG003|Overall Study|Physician Decision|0|||
131147382|NCT00486603|472162919|FG004|Overall Study|Physician Decision|0|||
131147383|NCT01670994|472162921|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
131147384|NCT01670994|472162922|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
131147385|NCT01670994|472162921|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
131147386|NCT01670994|472162922|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
131147387|NCT01670994|472162921|FG000|Overall Study|Patient experienced DLT|0|||
131147388|NCT01670994|472162922|FG001|Overall Study|Patient experienced DLT|1|||
131147389|NCT01295125|472162924|FG000|Overall Study|Study stopped prematurely|9|||
131147390|NCT01824979|472162926|FG000|Overall Study|Withdrawal by Subject|5|||
131147391|NCT01824979|472162927|FG001|Overall Study|Withdrawal by Subject|0|||
131147392|NCT01824979|472162926|FG000|Overall Study|Physician Decision|2|||
131147393|NCT01824979|472162927|FG001|Overall Study|Physician Decision|0|||
131147394|NCT01824979|472162926|FG000|Overall Study|Protocol Violation|6|||
131147395|NCT01824979|472162927|FG001|Overall Study|Protocol Violation|13|||
131147396|NCT04336163|472162932|FG000|Overall Study|Lost to Follow-up|55|||
131147397|NCT04336163|472162933|FG001|Overall Study|Lost to Follow-up|0|||
131147398|NCT02978222|472162937|FG000|Overall Study|Withdrawal by Subject|2|||
131147399|NCT02978222|472162938|FG001|Overall Study|Withdrawal by Subject|2|||
131147400|NCT02978222|472162937|FG000|Overall Study|Physician Decision|2|||
131147401|NCT02978222|472162938|FG001|Overall Study|Physician Decision|0|||
131147402|NCT02978222|472162937|FG000|Overall Study|Adverse Event|0|||
131147403|NCT02978222|472162938|FG001|Overall Study|Adverse Event|1|||
131147404|NCT02978222|472162937|FG000|Overall Study|Death|1|||
131147405|NCT02978222|472162938|FG001|Overall Study|Death|0|||
131147406|NCT02978222|472162937|FG000|Overall Study|Disease Progression|32|||
131147407|NCT02978222|472162938|FG001|Overall Study|Disease Progression|32|||
131147408|NCT02978222|472162937|FG000|Overall Study|Early Study Termination|24|||
131147409|NCT02978222|472162938|FG001|Overall Study|Early Study Termination|21|||
131147410|NCT01686568|472162939|FG000|Main Study|Withdrawal by Subject|1|||
131147411|NCT01686568|472162940|FG001|Main Study|Withdrawal by Subject|3|||
131147412|NCT01686568|472162939|FG000|Main Study|Noncompliance with protocol|0|||
131147413|NCT01686568|472162940|FG001|Main Study|Noncompliance with protocol|1|||
131147414|NCT01686568|472162939|FG000|Main Study|Liver enzymes above range of exclusion|1|||
131147415|NCT01686568|472162940|FG001|Main Study|Liver enzymes above range of exclusion|0|||
131147416|NCT01686568|472162939|FG000|Sub-Study|Not consented for sub-study|2|||
131147417|NCT01686568|472162940|FG001|Sub-Study|Not consented for sub-study|2|||
131147418|NCT01614964|472162943|FG000|Overall Study|Withdrawal by Subject|2|||
131147419|NCT01614964|472162944|FG001|Overall Study|Withdrawal by Subject|0|||
131147420|NCT01614964|472162943|FG000|Overall Study|Lost to Follow-up|3|||
131147421|NCT01614964|472162944|FG001|Overall Study|Lost to Follow-up|0|||
131147422|NCT00888238|472162945|FG000|Washout Period After Period 2|Adverse Event|0|||
131147423|NCT00888238|472162946|FG001|Washout Period After Period 2|Adverse Event|0|||
131147424|NCT00888238|472162947|FG002|Washout Period After Period 2|Adverse Event|1|||
131147425|NCT01032629|472162948|FG000|Overall Study|Closed Site|21|||
131147426|NCT01032629|472162949|FG001|Overall Study|Closed Site|18|||
131147427|NCT01032629|472162950|FG002|Overall Study|Closed Site|16|||
131147428|NCT01032629|472162948|FG000|Overall Study|Withdrawal by Subject|50|||
131147429|NCT01032629|472162949|FG001|Overall Study|Withdrawal by Subject|36|||
131147430|NCT01032629|472162950|FG002|Overall Study|Withdrawal by Subject|35|||
131147431|NCT01032629|472162948|FG000|Overall Study|Lost to Follow-up|74|||
131147432|NCT01032629|472162949|FG001|Overall Study|Lost to Follow-up|47|||
131147433|NCT01032629|472162950|FG002|Overall Study|Lost to Follow-up|37|||
131147434|NCT03751111|472162954|FG000|Overall Study|Lack of Efficacy|9|||
131147435|NCT03751111|472162955|FG001|Overall Study|Lack of Efficacy|30|||
131147436|NCT03751111|472162954|FG000|Overall Study|Adverse Event|3|||
131147437|NCT03751111|472162955|FG001|Overall Study|Adverse Event|2|||
131147438|NCT00868790|472162956|FG000|Period 1|Adverse Event|1|||
131147439|NCT00868790|472162957|FG001|Period 1|Adverse Event|0|||
131147440|NCT00868790|472162958|FG002|Period 1|Adverse Event|0|||
131147441|NCT00868790|472162959|FG003|Period 1|Adverse Event|0|||
131147442|NCT00868790|472162960|FG004|Period 1|Adverse Event|0|||
131147443|NCT00868790|472162961|FG005|Period 1|Adverse Event|0|||
131147444|NCT00868790|472162962|FG006|Period 1|Adverse Event|0|||
131147445|NCT00868790|472162963|FG007|Period 1|Adverse Event|3|||
131147446|NCT00868790|472162964|FG008|Period 1|Adverse Event|1|||
131147447|NCT00868790|472162965|FG009|Period 1|Adverse Event|0|||
131147448|NCT00868790|472162966|FG010|Period 1|Adverse Event|0|||
131147449|NCT00868790|472162967|FG011|Period 1|Adverse Event|0|||
131147450|NCT00868790|472162968|FG012|Period 1|Adverse Event|0|||
131147451|NCT00868790|472162969|FG013|Period 1|Adverse Event|1|||
131147452|NCT00868790|472162956|FG000|Period 1|Protocol Violation|1|||
131147453|NCT00868790|472162957|FG001|Period 1|Protocol Violation|0|||
131147454|NCT00868790|472162958|FG002|Period 1|Protocol Violation|0|||
131147455|NCT00868790|472162959|FG003|Period 1|Protocol Violation|0|||
131147456|NCT00868790|472162960|FG004|Period 1|Protocol Violation|0|||
131147457|NCT00868790|472162961|FG005|Period 1|Protocol Violation|0|||
131147458|NCT00868790|472162962|FG006|Period 1|Protocol Violation|0|||
131147459|NCT00868790|472162963|FG007|Period 1|Protocol Violation|0|||
131147460|NCT00868790|472162964|FG008|Period 1|Protocol Violation|0|||
131147461|NCT00868790|472162965|FG009|Period 1|Protocol Violation|0|||
131147462|NCT00868790|472162966|FG010|Period 1|Protocol Violation|0|||
131147463|NCT00868790|472162967|FG011|Period 1|Protocol Violation|0|||
131147464|NCT00868790|472162968|FG012|Period 1|Protocol Violation|0|||
131147465|NCT00868790|472162969|FG013|Period 1|Protocol Violation|0|||
131147466|NCT00868790|472162956|FG000|Period 1|Withdrawal by Subject|0|||
131147467|NCT00868790|472162957|FG001|Period 1|Withdrawal by Subject|1|||
131147468|NCT00868790|472162958|FG002|Period 1|Withdrawal by Subject|0|||
131147469|NCT00868790|472162959|FG003|Period 1|Withdrawal by Subject|0|||
131147470|NCT00868790|472162960|FG004|Period 1|Withdrawal by Subject|0|||
131147471|NCT00868790|472162961|FG005|Period 1|Withdrawal by Subject|0|||
131147472|NCT00868790|472162962|FG006|Period 1|Withdrawal by Subject|0|||
131147473|NCT00868790|472162963|FG007|Period 1|Withdrawal by Subject|0|||
131147474|NCT00868790|472162964|FG008|Period 1|Withdrawal by Subject|0|||
131147475|NCT00868790|472162965|FG009|Period 1|Withdrawal by Subject|0|||
131147476|NCT00868790|472162966|FG010|Period 1|Withdrawal by Subject|0|||
131147477|NCT00868790|472162967|FG011|Period 1|Withdrawal by Subject|0|||
131147478|NCT00868790|472162968|FG012|Period 1|Withdrawal by Subject|0|||
131147479|NCT00868790|472162969|FG013|Period 1|Withdrawal by Subject|1|||
131147480|NCT00868790|472162956|FG000|Period 1|Abnormal Triglycerides|0|||
131147481|NCT00868790|472162957|FG001|Period 1|Abnormal Triglycerides|0|||
131147482|NCT00868790|472162958|FG002|Period 1|Abnormal Triglycerides|0|||
131147483|NCT00868790|472162959|FG003|Period 1|Abnormal Triglycerides|0|||
131147484|NCT00868790|472162960|FG004|Period 1|Abnormal Triglycerides|1|||
131147485|NCT00868790|472162961|FG005|Period 1|Abnormal Triglycerides|0|||
131147486|NCT00868790|472162962|FG006|Period 1|Abnormal Triglycerides|0|||
131147487|NCT00868790|472162963|FG007|Period 1|Abnormal Triglycerides|0|||
131147488|NCT00868790|472162964|FG008|Period 1|Abnormal Triglycerides|0|||
131147489|NCT00868790|472162965|FG009|Period 1|Abnormal Triglycerides|0|||
131147490|NCT00868790|472162966|FG010|Period 1|Abnormal Triglycerides|0|||
131147491|NCT00868790|472162967|FG011|Period 1|Abnormal Triglycerides|0|||
131147492|NCT00868790|472162968|FG012|Period 1|Abnormal Triglycerides|0|||
131147493|NCT00868790|472162969|FG013|Period 1|Abnormal Triglycerides|0|||
131147494|NCT00868790|472162956|FG000|Period 1|Lost to Follow-up|0|||
131147495|NCT00868790|472162957|FG001|Period 1|Lost to Follow-up|0|||
131147496|NCT00868790|472162958|FG002|Period 1|Lost to Follow-up|0|||
131147497|NCT00868790|472162959|FG003|Period 1|Lost to Follow-up|0|||
131147498|NCT00868790|472162960|FG004|Period 1|Lost to Follow-up|0|||
131147499|NCT00868790|472162961|FG005|Period 1|Lost to Follow-up|1|||
131147500|NCT00868790|472162962|FG006|Period 1|Lost to Follow-up|0|||
131147501|NCT00868790|472162963|FG007|Period 1|Lost to Follow-up|0|||
131147502|NCT00868790|472162964|FG008|Period 1|Lost to Follow-up|0|||
131147503|NCT00868790|472162965|FG009|Period 1|Lost to Follow-up|0|||
131147504|NCT00868790|472162966|FG010|Period 1|Lost to Follow-up|0|||
131147505|NCT00868790|472162967|FG011|Period 1|Lost to Follow-up|0|||
131147506|NCT00868790|472162968|FG012|Period 1|Lost to Follow-up|0|||
131147507|NCT00868790|472162969|FG013|Period 1|Lost to Follow-up|0|||
131147508|NCT00868790|472162956|FG000|Period 2|Adverse Event|0|||
131147509|NCT00868790|472162957|FG001|Period 2|Adverse Event|0|||
131147510|NCT00868790|472162958|FG002|Period 2|Adverse Event|0|||
131147511|NCT00868790|472162959|FG003|Period 2|Adverse Event|0|||
131147512|NCT00868790|472162960|FG004|Period 2|Adverse Event|0|||
131147513|NCT00868790|472162961|FG005|Period 2|Adverse Event|0|||
131147514|NCT00868790|472162962|FG006|Period 2|Adverse Event|0|||
131147515|NCT00868790|472162963|FG007|Period 2|Adverse Event|0|||
131147516|NCT00868790|472162964|FG008|Period 2|Adverse Event|1|||
131147517|NCT00868790|472162965|FG009|Period 2|Adverse Event|0|||
131147518|NCT00868790|472162966|FG010|Period 2|Adverse Event|0|||
131147519|NCT00868790|472162967|FG011|Period 2|Adverse Event|0|||
131147520|NCT00868790|472162968|FG012|Period 2|Adverse Event|0|||
131147521|NCT00868790|472162969|FG013|Period 2|Adverse Event|0|||
131147522|NCT00868790|472162956|FG000|Period 2|Lost to Follow-up|0|||
131147523|NCT00868790|472162957|FG001|Period 2|Lost to Follow-up|1|||
131147524|NCT00868790|472162958|FG002|Period 2|Lost to Follow-up|0|||
131147525|NCT00868790|472162959|FG003|Period 2|Lost to Follow-up|0|||
131147526|NCT00868790|472162960|FG004|Period 2|Lost to Follow-up|0|||
131147527|NCT00868790|472162961|FG005|Period 2|Lost to Follow-up|1|||
131147528|NCT00868790|472162962|FG006|Period 2|Lost to Follow-up|0|||
131147529|NCT00868790|472162963|FG007|Period 2|Lost to Follow-up|0|||
131147530|NCT00868790|472162964|FG008|Period 2|Lost to Follow-up|0|||
131147531|NCT00868790|472162965|FG009|Period 2|Lost to Follow-up|0|||
131147532|NCT00868790|472162966|FG010|Period 2|Lost to Follow-up|0|||
131147533|NCT00868790|472162967|FG011|Period 2|Lost to Follow-up|0|||
131147534|NCT00868790|472162968|FG012|Period 2|Lost to Follow-up|0|||
131147535|NCT00868790|472162969|FG013|Period 2|Lost to Follow-up|0|||
131147536|NCT00868790|472162956|FG000|Period 2|Withdrawal by Subject|0|||
131147537|NCT00868790|472162957|FG001|Period 2|Withdrawal by Subject|0|||
131147538|NCT00868790|472162958|FG002|Period 2|Withdrawal by Subject|0|||
131147539|NCT00868790|472162959|FG003|Period 2|Withdrawal by Subject|0|||
131147540|NCT00868790|472162960|FG004|Period 2|Withdrawal by Subject|0|||
131147541|NCT00868790|472162961|FG005|Period 2|Withdrawal by Subject|0|||
131147542|NCT00868790|472162962|FG006|Period 2|Withdrawal by Subject|0|||
131147543|NCT00868790|472162963|FG007|Period 2|Withdrawal by Subject|0|||
131147544|NCT00868790|472162964|FG008|Period 2|Withdrawal by Subject|1|||
131147545|NCT00868790|472162965|FG009|Period 2|Withdrawal by Subject|0|||
131147546|NCT00868790|472162966|FG010|Period 2|Withdrawal by Subject|0|||
131147547|NCT00868790|472162967|FG011|Period 2|Withdrawal by Subject|0|||
131147548|NCT00868790|472162968|FG012|Period 2|Withdrawal by Subject|0|||
131147549|NCT00868790|472162969|FG013|Period 2|Withdrawal by Subject|1|||
131147550|NCT00868790|472162956|FG000|Period 3|Adverse Event|0|||
131147551|NCT00868790|472162957|FG001|Period 3|Adverse Event|0|||
131147552|NCT00868790|472162958|FG002|Period 3|Adverse Event|0|||
131147553|NCT00868790|472162959|FG003|Period 3|Adverse Event|0|||
131147554|NCT00868790|472162960|FG004|Period 3|Adverse Event|0|||
131147555|NCT00868790|472162961|FG005|Period 3|Adverse Event|0|||
131147556|NCT00868790|472162962|FG006|Period 3|Adverse Event|0|||
131147557|NCT00868790|472162963|FG007|Period 3|Adverse Event|0|||
131147558|NCT00868790|472162964|FG008|Period 3|Adverse Event|0|||
131147559|NCT00868790|472162965|FG009|Period 3|Adverse Event|1|||
131147560|NCT00868790|472162966|FG010|Period 3|Adverse Event|0|||
131147561|NCT00868790|472162967|FG011|Period 3|Adverse Event|0|||
131147562|NCT00868790|472162968|FG012|Period 3|Adverse Event|0|||
131147563|NCT00868790|472162969|FG013|Period 3|Adverse Event|0|||
131147564|NCT00868790|472162956|FG000|Period 3|Protocol Violation|0|||
131147565|NCT00868790|472162957|FG001|Period 3|Protocol Violation|0|||
131147566|NCT00868790|472162958|FG002|Period 3|Protocol Violation|0|||
131147567|NCT00868790|472162959|FG003|Period 3|Protocol Violation|0|||
131147568|NCT00868790|472162960|FG004|Period 3|Protocol Violation|0|||
131147569|NCT00868790|472162961|FG005|Period 3|Protocol Violation|0|||
131147570|NCT00868790|472162962|FG006|Period 3|Protocol Violation|0|||
131147571|NCT00868790|472162963|FG007|Period 3|Protocol Violation|0|||
131147572|NCT00868790|472162964|FG008|Period 3|Protocol Violation|0|||
131147573|NCT00868790|472162965|FG009|Period 3|Protocol Violation|0|||
131147574|NCT00868790|472162966|FG010|Period 3|Protocol Violation|1|||
131147575|NCT00868790|472162967|FG011|Period 3|Protocol Violation|0|||
131147576|NCT00868790|472162968|FG012|Period 3|Protocol Violation|0|||
131147577|NCT00868790|472162969|FG013|Period 3|Protocol Violation|0|||
131147578|NCT00868790|472162956|FG000|Period 3|Study Terminated by Sponsor|0|||
131147579|NCT00868790|472162957|FG001|Period 3|Study Terminated by Sponsor|0|||
131147580|NCT00868790|472162958|FG002|Period 3|Study Terminated by Sponsor|0|||
131147581|NCT00868790|472162959|FG003|Period 3|Study Terminated by Sponsor|1|||
131147582|NCT00868790|472162960|FG004|Period 3|Study Terminated by Sponsor|0|||
131147583|NCT00868790|472162961|FG005|Period 3|Study Terminated by Sponsor|0|||
131147584|NCT00868790|472162962|FG006|Period 3|Study Terminated by Sponsor|0|||
131147585|NCT00868790|472162963|FG007|Period 3|Study Terminated by Sponsor|0|||
131147586|NCT00868790|472162964|FG008|Period 3|Study Terminated by Sponsor|0|||
131147587|NCT00868790|472162965|FG009|Period 3|Study Terminated by Sponsor|0|||
131147588|NCT00868790|472162966|FG010|Period 3|Study Terminated by Sponsor|0|||
131147589|NCT00868790|472162967|FG011|Period 3|Study Terminated by Sponsor|0|||
131147590|NCT00868790|472162968|FG012|Period 3|Study Terminated by Sponsor|0|||
131147591|NCT00868790|472162969|FG013|Period 3|Study Terminated by Sponsor|0|||
131147592|NCT00868790|472162956|FG000|Period 4|Adverse Event|0|||
131147593|NCT00868790|472162957|FG001|Period 4|Adverse Event|0|||
131147594|NCT00868790|472162958|FG002|Period 4|Adverse Event|0|||
131147595|NCT00868790|472162959|FG003|Period 4|Adverse Event|0|||
131147596|NCT00868790|472162960|FG004|Period 4|Adverse Event|0|||
131147597|NCT00868790|472162961|FG005|Period 4|Adverse Event|0|||
131147598|NCT00868790|472162962|FG006|Period 4|Adverse Event|0|||
131147599|NCT00868790|472162963|FG007|Period 4|Adverse Event|1|||
131147600|NCT00868790|472162964|FG008|Period 4|Adverse Event|0|||
131147601|NCT00868790|472162965|FG009|Period 4|Adverse Event|0|||
131147602|NCT00868790|472162966|FG010|Period 4|Adverse Event|1|||
131147603|NCT00868790|472162967|FG011|Period 4|Adverse Event|0|||
131147604|NCT00868790|472162968|FG012|Period 4|Adverse Event|1|||
131147605|NCT00868790|472162969|FG013|Period 4|Adverse Event|0|||
131147606|NCT00868790|472162956|FG000|Period 4|Lost to Follow-up|0|||
131147607|NCT00868790|472162957|FG001|Period 4|Lost to Follow-up|0|||
131147608|NCT00868790|472162958|FG002|Period 4|Lost to Follow-up|0|||
131147609|NCT00868790|472162959|FG003|Period 4|Lost to Follow-up|0|||
131147610|NCT00868790|472162960|FG004|Period 4|Lost to Follow-up|0|||
131147611|NCT00868790|472162961|FG005|Period 4|Lost to Follow-up|0|||
131147612|NCT00868790|472162962|FG006|Period 4|Lost to Follow-up|0|||
131147613|NCT00868790|472162963|FG007|Period 4|Lost to Follow-up|1|||
131147614|NCT00868790|472162964|FG008|Period 4|Lost to Follow-up|0|||
131147615|NCT00868790|472162965|FG009|Period 4|Lost to Follow-up|0|||
131147616|NCT00868790|472162966|FG010|Period 4|Lost to Follow-up|0|||
131147617|NCT00868790|472162967|FG011|Period 4|Lost to Follow-up|0|||
131147618|NCT00868790|472162968|FG012|Period 4|Lost to Follow-up|0|||
131147619|NCT00868790|472162969|FG013|Period 4|Lost to Follow-up|0|||
131147620|NCT00868790|472162956|FG000|Period 4|Study Terminated by Sponsor|2|||
131147621|NCT00868790|472162957|FG001|Period 4|Study Terminated by Sponsor|0|||
130727839|NCT00025259|470625559|FG000|Overall Study|Physician Decision|12|||
130727840|NCT00025259|470625560|FG001|Overall Study|Physician Decision|1|||
130727841|NCT00025259|470625561|FG002|Overall Study|Physician Decision|0|||
130727842|NCT00025259|470625562|FG003|Overall Study|Physician Decision|5|||
130727843|NCT00025259|470625563|FG004|Overall Study|Physician Decision|4|||
130727844|NCT00025259|470625564|FG005|Overall Study|Physician Decision|2|||
130727845|NCT00025259|470625565|FG006|Overall Study|Physician Decision|1|||
130727846|NCT00025259|470625559|FG000|Overall Study|Protocol Violation|3|||
130727847|NCT00025259|470625560|FG001|Overall Study|Protocol Violation|2|||
130727848|NCT00025259|470625561|FG002|Overall Study|Protocol Violation|2|||
130727849|NCT00025259|470625562|FG003|Overall Study|Protocol Violation|1|||
130727850|NCT00025259|470625563|FG004|Overall Study|Protocol Violation|2|||
130727851|NCT00025259|470625564|FG005|Overall Study|Protocol Violation|1|||
131147622|NCT00868790|472162958|FG002|Period 4|Study Terminated by Sponsor|0|||
131147623|NCT00868790|472162959|FG003|Period 4|Study Terminated by Sponsor|0|||
131147624|NCT00868790|472162960|FG004|Period 4|Study Terminated by Sponsor|0|||
131147625|NCT00868790|472162961|FG005|Period 4|Study Terminated by Sponsor|0|||
131147626|NCT00868790|472162962|FG006|Period 4|Study Terminated by Sponsor|0|||
131147627|NCT00868790|472162963|FG007|Period 4|Study Terminated by Sponsor|1|||
131147628|NCT00868790|472162964|FG008|Period 4|Study Terminated by Sponsor|2|||
131147629|NCT00868790|472162965|FG009|Period 4|Study Terminated by Sponsor|0|||
131147630|NCT00868790|472162966|FG010|Period 4|Study Terminated by Sponsor|2|||
131147631|NCT00868790|472162967|FG011|Period 4|Study Terminated by Sponsor|1|||
131147632|NCT00868790|472162968|FG012|Period 4|Study Terminated by Sponsor|0|||
131147633|NCT00868790|472162969|FG013|Period 4|Study Terminated by Sponsor|1|||
131147634|NCT00868790|472162956|FG000|Period 4|Abnormal ALT/AST|0|||
131147635|NCT00868790|472162957|FG001|Period 4|Abnormal ALT/AST|0|||
131147636|NCT00868790|472162958|FG002|Period 4|Abnormal ALT/AST|1|||
131147637|NCT00868790|472162959|FG003|Period 4|Abnormal ALT/AST|0|||
131147638|NCT00868790|472162960|FG004|Period 4|Abnormal ALT/AST|0|||
131147639|NCT00868790|472162961|FG005|Period 4|Abnormal ALT/AST|0|||
131147640|NCT00868790|472162962|FG006|Period 4|Abnormal ALT/AST|0|||
131147641|NCT00868790|472162963|FG007|Period 4|Abnormal ALT/AST|0|||
131147642|NCT00868790|472162964|FG008|Period 4|Abnormal ALT/AST|0|||
131147643|NCT00868790|472162965|FG009|Period 4|Abnormal ALT/AST|0|||
131147644|NCT00868790|472162966|FG010|Period 4|Abnormal ALT/AST|0|||
131147645|NCT00868790|472162967|FG011|Period 4|Abnormal ALT/AST|0|||
131147646|NCT00868790|472162968|FG012|Period 4|Abnormal ALT/AST|0|||
131147647|NCT00868790|472162969|FG013|Period 4|Abnormal ALT/AST|0|||
131147648|NCT00868790|472162956|FG000|Post-study|Withdrawal by Subject|0|||
131147649|NCT00868790|472162957|FG001|Post-study|Withdrawal by Subject|0|||
131147650|NCT00868790|472162958|FG002|Post-study|Withdrawal by Subject|0|||
131147651|NCT00868790|472162959|FG003|Post-study|Withdrawal by Subject|0|||
131147652|NCT00868790|472162960|FG004|Post-study|Withdrawal by Subject|1|||
131147653|NCT00868790|472162961|FG005|Post-study|Withdrawal by Subject|0|||
131147654|NCT00868790|472162962|FG006|Post-study|Withdrawal by Subject|0|||
131147655|NCT00868790|472162963|FG007|Post-study|Withdrawal by Subject|0|||
131147656|NCT00868790|472162964|FG008|Post-study|Withdrawal by Subject|0|||
131147657|NCT00868790|472162965|FG009|Post-study|Withdrawal by Subject|0|||
131147658|NCT00868790|472162966|FG010|Post-study|Withdrawal by Subject|0|||
131147659|NCT00868790|472162967|FG011|Post-study|Withdrawal by Subject|0|||
131147660|NCT00868790|472162968|FG012|Post-study|Withdrawal by Subject|0|||
131147661|NCT00868790|472162969|FG013|Post-study|Withdrawal by Subject|0|||
131147662|NCT00868790|472162956|FG000|Post-study|Excluded Medication|0|||
131147663|NCT00868790|472162957|FG001|Post-study|Excluded Medication|0|||
131147664|NCT00868790|472162958|FG002|Post-study|Excluded Medication|0|||
131147665|NCT00868790|472162959|FG003|Post-study|Excluded Medication|0|||
131147666|NCT00868790|472162960|FG004|Post-study|Excluded Medication|0|||
131147667|NCT00868790|472162961|FG005|Post-study|Excluded Medication|0|||
131147668|NCT00868790|472162962|FG006|Post-study|Excluded Medication|0|||
131147669|NCT00868790|472162963|FG007|Post-study|Excluded Medication|2|||
131147670|NCT00868790|472162964|FG008|Post-study|Excluded Medication|0|||
131147671|NCT00868790|472162965|FG009|Post-study|Excluded Medication|1|||
131147672|NCT00868790|472162966|FG010|Post-study|Excluded Medication|0|||
131147673|NCT00868790|472162967|FG011|Post-study|Excluded Medication|0|||
131147674|NCT00868790|472162968|FG012|Post-study|Excluded Medication|0|||
131147675|NCT00868790|472162969|FG013|Post-study|Excluded Medication|0|||
131147676|NCT03377634|472162973|FG000|Study Period|Adverse Event|1|||
131147677|NCT03377634|472162974|FG001|Study Period|Adverse Event|0|||
131147678|NCT03377634|472162973|FG000|Study Period|Withdrawal by Subject|1|||
131147679|NCT03377634|472162974|FG001|Study Period|Withdrawal by Subject|0|||
131147680|NCT01264939|472162975|FG000|Overall Study|Adverse Event|1|||
131147681|NCT01264939|472162976|FG001|Overall Study|Adverse Event|3|||
131147682|NCT01264939|472162975|FG000|Overall Study|Lost to Follow-up|0|||
131147683|NCT01264939|472162976|FG001|Overall Study|Lost to Follow-up|3|||
131147684|NCT01264939|472162975|FG000|Overall Study|Physician Decision|1|||
131147685|NCT01264939|472162976|FG001|Overall Study|Physician Decision|1|||
131147686|NCT01264939|472162975|FG000|Overall Study|Patient/Guardian Decision|8|||
131147687|NCT01264939|472162976|FG001|Overall Study|Patient/Guardian Decision|10|||
131147688|NCT01264939|472162975|FG000|Overall Study|Disease Progression|8|||
131147689|NCT01264939|472162976|FG001|Overall Study|Disease Progression|11|||
131147690|NCT00737529|472162984|FG000|Overall Study|Disease Progression|95|||
131147691|NCT00737529|472162984|FG000|Overall Study|Adverse Event|24|||
131147692|NCT00737529|472162984|FG000|Overall Study|Withdrawal by Subject|5|||
131147693|NCT00737529|472162984|FG000|Overall Study|Death|4|||
131147694|NCT00737529|472162984|FG000|Overall Study|Protocol Violation|1|||
131147695|NCT00737529|472162984|FG000|Overall Study|Other|4|||
131147696|NCT01145560|472162985|FG000|Overall Study|Withdrawal by Subject|2|||
131147697|NCT01145560|472162986|FG001|Overall Study|Withdrawal by Subject|1|||
131147698|NCT01145560|472162987|FG002|Overall Study|Withdrawal by Subject|0|||
131147699|NCT01145560|472162985|FG000|Overall Study|Lost to Follow-up|1|||
131147700|NCT01145560|472162986|FG001|Overall Study|Lost to Follow-up|1|||
131147701|NCT01145560|472162987|FG002|Overall Study|Lost to Follow-up|1|||
131147702|NCT01145560|472162985|FG000|Overall Study|No study drug by 24h after organ failure|1|||
131147703|NCT01145560|472162986|FG001|Overall Study|No study drug by 24h after organ failure|0|||
131147704|NCT01145560|472162987|FG002|Overall Study|No study drug by 24h after organ failure|0|||
131147705|NCT01145560|472162985|FG000|Overall Study|Accidental unblinding of study treatment|0|||
131147706|NCT01145560|472162986|FG001|Overall Study|Accidental unblinding of study treatment|1|||
131147707|NCT01145560|472162987|FG002|Overall Study|Accidental unblinding of study treatment|0|||
131147708|NCT01145560|472162985|FG000|Overall Study|False insurance information|0|||
131147709|NCT01145560|472162986|FG001|Overall Study|False insurance information|1|||
131147710|NCT01145560|472162987|FG002|Overall Study|False insurance information|0|||
131147711|NCT01145560|472162985|FG000|Overall Study|Withdrawal of therapy|0|||
131147712|NCT01145560|472162986|FG001|Overall Study|Withdrawal of therapy|0|||
131147713|NCT01145560|472162987|FG002|Overall Study|Withdrawal of therapy|1|||
131147714|NCT03040024|472162988|FG000|Overall Study|Adverse Event|0|||
131147715|NCT03040024|472162989|FG001|Overall Study|Adverse Event|1|||
131147716|NCT03040024|472162990|FG002|Overall Study|Adverse Event|0|||
131147717|NCT03040024|472162988|FG000|Overall Study|Death|0|||
131147718|NCT03040024|472162989|FG001|Overall Study|Death|1|||
131147719|NCT03040024|472162990|FG002|Overall Study|Death|0|||
131147720|NCT03040024|472162988|FG000|Overall Study|Physician Decision|0|||
131147721|NCT03040024|472162989|FG001|Overall Study|Physician Decision|0|||
131147722|NCT03040024|472162990|FG002|Overall Study|Physician Decision|1|||
131147723|NCT01526148|472162999|FG000|Overall Study|Adverse Event|6|||
131147724|NCT01526148|472163000|FG001|Overall Study|Adverse Event|5|||
131147725|NCT01526148|472162999|FG000|Overall Study|Lost to Follow-up|3|||
131147726|NCT01526148|472163000|FG001|Overall Study|Lost to Follow-up|6|||
131147727|NCT01526148|472162999|FG000|Overall Study|Withdrawal by Subject|2|||
131147728|NCT01526148|472163000|FG001|Overall Study|Withdrawal by Subject|0|||
131147729|NCT01526148|472162999|FG000|Overall Study|Unstable Medical Condition|1|||
131147730|NCT01526148|472163000|FG001|Overall Study|Unstable Medical Condition|0|||
131147731|NCT01526148|472162999|FG000|Overall Study|Unable to discontinue concomitant med|1|||
131147732|NCT01526148|472163000|FG001|Overall Study|Unable to discontinue concomitant med|0|||
131147733|NCT01526148|472162999|FG000|Overall Study|Moved out of state|1|||
131147734|NCT01526148|472163000|FG001|Overall Study|Moved out of state|0|||
131147735|NCT01526148|472162999|FG000|Overall Study|Incarcerated|0|||
131147736|NCT01526148|472163000|FG001|Overall Study|Incarcerated|2|||
131147737|NCT01173653|472163001|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
131147738|NCT01173653|472163002|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
131147739|NCT02452762|472163003|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
131147740|NCT02452762|472163004|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
131147741|NCT02452762|472163003|FG000|Overall Study|Withdrawal by Subject|1|||
131147742|NCT02452762|472163004|FG001|Overall Study|Withdrawal by Subject|0|||
131147743|NCT01818297|472163005|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
131147744|NCT01818297|472163006|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
131147745|NCT01818297|472163005|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
131147746|NCT01818297|472163006|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
131147747|NCT01818297|472163005|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
131147748|NCT01818297|472163006|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
131147749|NCT00584870|472163007|FG000|Overall Study|Adverse Event|4|||
131147750|NCT00584870|472163008|FG001|Overall Study|Adverse Event|3|||
131147751|NCT00584870|472163009|FG002|Overall Study|Adverse Event|2|||
131147752|NCT00584870|472163007|FG000|Overall Study|Lost to Follow-up|4|||
131147753|NCT00584870|472163008|FG001|Overall Study|Lost to Follow-up|1|||
131147754|NCT00584870|472163009|FG002|Overall Study|Lost to Follow-up|1|||
131147755|NCT00584870|472163007|FG000|Overall Study|Lack of Efficacy|7|||
131147756|NCT00584870|472163008|FG001|Overall Study|Lack of Efficacy|14|||
131147757|NCT00584870|472163009|FG002|Overall Study|Lack of Efficacy|8|||
131147758|NCT00584870|472163007|FG000|Overall Study|Withdrawal by Subject|10|||
131147759|NCT00584870|472163008|FG001|Overall Study|Withdrawal by Subject|5|||
131147760|NCT00584870|472163009|FG002|Overall Study|Withdrawal by Subject|3|||
131147761|NCT00584870|472163007|FG000|Overall Study|Protocol Violation|1|||
131147762|NCT00584870|472163008|FG001|Overall Study|Protocol Violation|1|||
131147763|NCT00584870|472163009|FG002|Overall Study|Protocol Violation|2|||
131147764|NCT00584870|472163007|FG000|Overall Study|Did not met entrance criteria|1|||
131147765|NCT00584870|472163008|FG001|Overall Study|Did not met entrance criteria|0|||
131147766|NCT00584870|472163009|FG002|Overall Study|Did not met entrance criteria|0|||
131147767|NCT00584870|472163007|FG000|Overall Study|Other|2|||
131147768|NCT00584870|472163008|FG001|Overall Study|Other|0|||
131147769|NCT00584870|472163009|FG002|Overall Study|Other|0|||
131147770|NCT00584870|472163007|FG000|Overall Study|Randomized but not treated|0|||
131147771|NCT00584870|472163008|FG001|Overall Study|Randomized but not treated|1|||
131147772|NCT00584870|472163009|FG002|Overall Study|Randomized but not treated|2|||
131147773|NCT02675075|472163010|FG000|Overall Study|Lost to Follow-up|3|||
131147774|NCT02675075|472163011|FG001|Overall Study|Lost to Follow-up|0|||
131147775|NCT00675597|472163012|FG000|Overall Study|Withdrawal by Subject|3|||
131147776|NCT00631137|472163013|FG000|Overall Study|Withdrawal by Subject|1|||
131147777|NCT00631137|472163014|FG001|Overall Study|Withdrawal by Subject|0|||
131147778|NCT03682120|472163015|FG000|Overall Study|Lost to Follow-up|11|||
131147779|NCT03682120|472163016|FG001|Overall Study|Lost to Follow-up|4|||
131147780|NCT03682120|472163017|FG002|Overall Study|Lost to Follow-up|5|||
131147781|NCT03682120|472163018|FG003|Overall Study|Lost to Follow-up|2|||
131147782|NCT03682120|472163015|FG000|Overall Study|Physician Decision|1|||
131147783|NCT03682120|472163016|FG001|Overall Study|Physician Decision|0|||
131147784|NCT03682120|472163017|FG002|Overall Study|Physician Decision|0|||
131147785|NCT03682120|472163018|FG003|Overall Study|Physician Decision|0|||
131147786|NCT03682120|472163015|FG000|Overall Study|Withdrawal by Subject|1|||
131147787|NCT03682120|472163016|FG001|Overall Study|Withdrawal by Subject|2|||
131147788|NCT03682120|472163017|FG002|Overall Study|Withdrawal by Subject|3|||
131147789|NCT03682120|472163018|FG003|Overall Study|Withdrawal by Subject|0|||
131147790|NCT03682120|472163015|FG000|Overall Study|Death|0|||
131147791|NCT03682120|472163016|FG001|Overall Study|Death|1|||
131147792|NCT03682120|472163017|FG002|Overall Study|Death|0|||
131147793|NCT03682120|472163018|FG003|Overall Study|Death|0|||
131147794|NCT03682120|472163015|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
131147795|NCT03682120|472163016|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
131147796|NCT03682120|472163017|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
131147797|NCT03682120|472163018|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
131147798|NCT03308188|472163019|FG000|Overall Study|Withdrawal by Subject|0|||
131147799|NCT03308188|472163020|FG001|Overall Study|Withdrawal by Subject|3|||
131147800|NCT03308188|472163019|FG000|Overall Study|Death|0|||
131147801|NCT03308188|472163020|FG001|Overall Study|Death|1|||
131147802|NCT01628926|472163023|FG000|Overall Study|Adverse Event|13|||
131147803|NCT01628926|472163024|FG001|Overall Study|Adverse Event|11|||
131147804|NCT01628926|472163025|FG002|Overall Study|Adverse Event|9|||
131147805|NCT01628926|472163023|FG000|Overall Study|Lack of Efficacy|2|||
131147806|NCT01628926|472163024|FG001|Overall Study|Lack of Efficacy|1|||
131147807|NCT01628926|472163025|FG002|Overall Study|Lack of Efficacy|5|||
131147808|NCT01628926|472163023|FG000|Overall Study|Withdrawal by Subject|6|||
131147809|NCT01628926|472163024|FG001|Overall Study|Withdrawal by Subject|4|||
131147810|NCT01628926|472163025|FG002|Overall Study|Withdrawal by Subject|2|||
131147811|NCT01628926|472163023|FG000|Overall Study|Protocol Violation|0|||
131147812|NCT01628926|472163024|FG001|Overall Study|Protocol Violation|1|||
131147813|NCT01628926|472163025|FG002|Overall Study|Protocol Violation|0|||
131147814|NCT01628926|472163023|FG000|Overall Study|Discontinuation criteria|3|||
131147815|NCT01628926|472163024|FG001|Overall Study|Discontinuation criteria|4|||
131147816|NCT01628926|472163025|FG002|Overall Study|Discontinuation criteria|0|||
131147817|NCT01628926|472163023|FG000|Overall Study|Physician Decision|2|||
131147818|NCT01628926|472163024|FG001|Overall Study|Physician Decision|2|||
131147819|NCT01628926|472163025|FG002|Overall Study|Physician Decision|1|||
131147820|NCT00151892|472163030|FG000|Overall Study|Lack of Efficacy|50|||
131147821|NCT00151892|472163031|FG001|Overall Study|Lack of Efficacy|57|||
131147822|NCT00151892|472163030|FG000|Overall Study|Patient request|10|||
131147823|NCT00151892|472163031|FG001|Overall Study|Patient request|7|||
131147824|NCT00151892|472163030|FG000|Overall Study|Lost to Follow-up|5|||
131147825|NCT00151892|472163031|FG001|Overall Study|Lost to Follow-up|10|||
131147826|NCT00151892|472163030|FG000|Overall Study|Adverse Event|6|||
131147827|NCT00151892|472163031|FG001|Overall Study|Adverse Event|3|||
131147828|NCT00151892|472163030|FG000|Overall Study|Protocol Violation|3|||
131147829|NCT00151892|472163031|FG001|Overall Study|Protocol Violation|3|||
131147830|NCT00151892|472163030|FG000|Overall Study|Non-compliance|0|||
131147831|NCT00151892|472163031|FG001|Overall Study|Non-compliance|1|||
131147832|NCT00151892|472163030|FG000|Overall Study|Pregnancy|0|||
131147833|NCT00151892|472163031|FG001|Overall Study|Pregnancy|1|||
131147834|NCT00151892|472163030|FG000|Overall Study|Did not return for a visit|1|||
131147835|NCT00151892|472163031|FG001|Overall Study|Did not return for a visit|0|||
131147836|NCT00151892|472163030|FG000|Overall Study|Used prohibited corticosteroids|1|||
131147837|NCT00151892|472163031|FG001|Overall Study|Used prohibited corticosteroids|0|||
131147838|NCT00151892|472163030|FG000|Overall Study|Lack of study medication at center|0|||
131147839|NCT00151892|472163031|FG001|Overall Study|Lack of study medication at center|1|||
131147840|NCT02901431|472163032|FG000|PK Part|Adverse Event|0|||
131147841|NCT02901431|472163033|FG001|PK Part|Adverse Event|1|||
131147842|NCT02901431|472163034|FG002|PK Part|Adverse Event|0|||
131147843|NCT02901431|472163035|FG003|PK Part|Adverse Event|0|||
131147844|NCT02901431|472163036|FG004|PK Part|Adverse Event|0|||
131147845|NCT02901431|472163037|FG005|PK Part|Adverse Event|0|||
131147846|NCT02901431|472163038|FG006|PK Part|Adverse Event|0|||
131147847|NCT02901431|472163039|FG007|PK Part|Adverse Event|0|||
131147848|NCT02901431|472163040|FG008|PK Part|Adverse Event|0|||
131147849|NCT02901431|472163041|FG009|PK Part|Adverse Event|0|||
131147850|NCT02901431|472163042|FG010|PK Part|Adverse Event|0|||
131147851|NCT02901431|472163043|FG011|PK Part|Adverse Event|0|||
131147852|NCT02901431|472163044|FG012|PK Part|Adverse Event|0|||
131147853|NCT02901431|472163032|FG000|PK Part|Lost to Follow-up|0|||
131147854|NCT02901431|472163033|FG001|PK Part|Lost to Follow-up|0|||
131147855|NCT02901431|472163034|FG002|PK Part|Lost to Follow-up|1|||
131147856|NCT02901431|472163035|FG003|PK Part|Lost to Follow-up|0|||
131147857|NCT02901431|472163036|FG004|PK Part|Lost to Follow-up|0|||
131147858|NCT02901431|472163037|FG005|PK Part|Lost to Follow-up|0|||
131147859|NCT02901431|472163038|FG006|PK Part|Lost to Follow-up|0|||
131147860|NCT02901431|472163039|FG007|PK Part|Lost to Follow-up|0|||
131147861|NCT02901431|472163040|FG008|PK Part|Lost to Follow-up|0|||
131147862|NCT02901431|472163041|FG009|PK Part|Lost to Follow-up|0|||
131147863|NCT02901431|472163042|FG010|PK Part|Lost to Follow-up|0|||
131147864|NCT02901431|472163043|FG011|PK Part|Lost to Follow-up|0|||
131147865|NCT02901431|472163044|FG012|PK Part|Lost to Follow-up|0|||
131147866|NCT02901431|472163032|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
131147867|NCT02901431|472163033|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147868|NCT02901431|472163034|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147869|NCT02901431|472163035|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147870|NCT02901431|472163036|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147871|NCT02901431|472163037|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147872|NCT02901431|472163038|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147873|NCT02901431|472163039|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147874|NCT02901431|472163040|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147875|NCT02901431|472163041|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147876|NCT02901431|472163042|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147877|NCT02901431|472163043|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147878|NCT02901431|472163044|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
131147879|NCT02901431|472163032|FG000|PK Part|Pending dose confirmation|0|||
131147880|NCT02901431|472163033|FG001|PK Part|Pending dose confirmation|1|||
131147881|NCT02901431|472163034|FG002|PK Part|Pending dose confirmation|0|||
131147882|NCT02901431|472163035|FG003|PK Part|Pending dose confirmation|0|||
131147883|NCT02901431|472163036|FG004|PK Part|Pending dose confirmation|0|||
131147884|NCT02901431|472163037|FG005|PK Part|Pending dose confirmation|0|||
131147885|NCT02901431|472163038|FG006|PK Part|Pending dose confirmation|0|||
131147886|NCT02901431|472163039|FG007|PK Part|Pending dose confirmation|0|||
131147887|NCT02901431|472163040|FG008|PK Part|Pending dose confirmation|0|||
131147888|NCT02901431|472163041|FG009|PK Part|Pending dose confirmation|0|||
131147889|NCT02901431|472163042|FG010|PK Part|Pending dose confirmation|0|||
131147890|NCT02901431|472163043|FG011|PK Part|Pending dose confirmation|0|||
131147891|NCT02901431|472163044|FG012|PK Part|Pending dose confirmation|0|||
131147892|NCT02901431|472163032|FG000|PK Part|8 weeks of treatment ran out|2|||
131147893|NCT02901431|472163033|FG001|PK Part|8 weeks of treatment ran out|0|||
131147894|NCT02901431|472163034|FG002|PK Part|8 weeks of treatment ran out|0|||
131147895|NCT02901431|472163035|FG003|PK Part|8 weeks of treatment ran out|0|||
131147896|NCT02901431|472163036|FG004|PK Part|8 weeks of treatment ran out|0|||
131147897|NCT02901431|472163037|FG005|PK Part|8 weeks of treatment ran out|0|||
131147898|NCT02901431|472163038|FG006|PK Part|8 weeks of treatment ran out|0|||
131147899|NCT02901431|472163039|FG007|PK Part|8 weeks of treatment ran out|0|||
131147900|NCT02901431|472163040|FG008|PK Part|8 weeks of treatment ran out|0|||
131147901|NCT02901431|472163041|FG009|PK Part|8 weeks of treatment ran out|0|||
131147902|NCT02901431|472163042|FG010|PK Part|8 weeks of treatment ran out|0|||
131147903|NCT02901431|472163043|FG011|PK Part|8 weeks of treatment ran out|0|||
131147904|NCT02901431|472163044|FG012|PK Part|8 weeks of treatment ran out|0|||
131147905|NCT02901431|472163032|FG000|PK Part|Stopped treatment after 8 weeks|1|||
131147906|NCT02901431|472163033|FG001|PK Part|Stopped treatment after 8 weeks|0|||
131147907|NCT02901431|472163034|FG002|PK Part|Stopped treatment after 8 weeks|1|||
131147908|NCT02901431|472163035|FG003|PK Part|Stopped treatment after 8 weeks|0|||
131147909|NCT02901431|472163036|FG004|PK Part|Stopped treatment after 8 weeks|0|||
131147910|NCT02901431|472163037|FG005|PK Part|Stopped treatment after 8 weeks|0|||
131147911|NCT02901431|472163038|FG006|PK Part|Stopped treatment after 8 weeks|0|||
131147912|NCT02901431|472163039|FG007|PK Part|Stopped treatment after 8 weeks|0|||
131147913|NCT02901431|472163040|FG008|PK Part|Stopped treatment after 8 weeks|0|||
131147914|NCT02901431|472163041|FG009|PK Part|Stopped treatment after 8 weeks|0|||
131147915|NCT02901431|472163042|FG010|PK Part|Stopped treatment after 8 weeks|0|||
131147916|NCT02901431|472163043|FG011|PK Part|Stopped treatment after 8 weeks|0|||
131147917|NCT02901431|472163044|FG012|PK Part|Stopped treatment after 8 weeks|0|||
131147918|NCT02901431|472163032|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
131147919|NCT02901431|472163033|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147920|NCT02901431|472163034|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
131147921|NCT02901431|472163035|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147922|NCT02901431|472163036|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147923|NCT02901431|472163037|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147924|NCT02901431|472163038|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147925|NCT02901431|472163039|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147926|NCT02901431|472163040|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147927|NCT02901431|472163041|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147928|NCT02901431|472163042|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147929|NCT02901431|472163043|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147930|NCT02901431|472163044|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
131147931|NCT02901431|472163032|FG000|PK Part|Discontinued per Sponsor|0|||
131147932|NCT02901431|472163033|FG001|PK Part|Discontinued per Sponsor|3|||
131147933|NCT02901431|472163034|FG002|PK Part|Discontinued per Sponsor|0|||
131147934|NCT02901431|472163035|FG003|PK Part|Discontinued per Sponsor|0|||
131147935|NCT02901431|472163036|FG004|PK Part|Discontinued per Sponsor|0|||
131147936|NCT02901431|472163037|FG005|PK Part|Discontinued per Sponsor|0|||
131147937|NCT02901431|472163038|FG006|PK Part|Discontinued per Sponsor|0|||
131147938|NCT02901431|472163039|FG007|PK Part|Discontinued per Sponsor|0|||
131147939|NCT02901431|472163040|FG008|PK Part|Discontinued per Sponsor|0|||
131147940|NCT02901431|472163041|FG009|PK Part|Discontinued per Sponsor|0|||
131147941|NCT02901431|472163042|FG010|PK Part|Discontinued per Sponsor|0|||
131147942|NCT02901431|472163043|FG011|PK Part|Discontinued per Sponsor|0|||
131147943|NCT02901431|472163044|FG012|PK Part|Discontinued per Sponsor|0|||
131147944|NCT02901431|472163032|FG000|PK Part|Withdrawal by Subject|1|||
131147945|NCT02901431|472163033|FG001|PK Part|Withdrawal by Subject|1|||
131147946|NCT02901431|472163034|FG002|PK Part|Withdrawal by Subject|3|||
131147947|NCT02901431|472163035|FG003|PK Part|Withdrawal by Subject|0|||
131147948|NCT02901431|472163036|FG004|PK Part|Withdrawal by Subject|0|||
131147949|NCT02901431|472163037|FG005|PK Part|Withdrawal by Subject|0|||
131147950|NCT02901431|472163038|FG006|PK Part|Withdrawal by Subject|0|||
131147951|NCT02901431|472163039|FG007|PK Part|Withdrawal by Subject|0|||
131147952|NCT02901431|472163040|FG008|PK Part|Withdrawal by Subject|0|||
131147953|NCT02901431|472163041|FG009|PK Part|Withdrawal by Subject|0|||
131147954|NCT02901431|472163042|FG010|PK Part|Withdrawal by Subject|0|||
131147955|NCT02901431|472163043|FG011|PK Part|Withdrawal by Subject|0|||
131147956|NCT02901431|472163044|FG012|PK Part|Withdrawal by Subject|0|||
131147957|NCT02901431|472163032|FG000|Main Treatment Part|Adverse Event|0|||
131147958|NCT02901431|472163033|FG001|Main Treatment Part|Adverse Event|0|||
131147959|NCT02901431|472163034|FG002|Main Treatment Part|Adverse Event|0|||
131147960|NCT02901431|472163035|FG003|Main Treatment Part|Adverse Event|3|||
131147961|NCT02901431|472163036|FG004|Main Treatment Part|Adverse Event|3|||
131147962|NCT02901431|472163037|FG005|Main Treatment Part|Adverse Event|4|||
131147963|NCT02901431|472163038|FG006|Main Treatment Part|Adverse Event|1|||
131147964|NCT02901431|472163039|FG007|Main Treatment Part|Adverse Event|0|||
131147965|NCT02901431|472163040|FG008|Main Treatment Part|Adverse Event|0|||
131147966|NCT02901431|472163041|FG009|Main Treatment Part|Adverse Event|0|||
131147967|NCT02901431|472163042|FG010|Main Treatment Part|Adverse Event|0|||
131147968|NCT02901431|472163043|FG011|Main Treatment Part|Adverse Event|0|||
131147969|NCT02901431|472163044|FG012|Main Treatment Part|Adverse Event|0|||
131147970|NCT02901431|472163032|FG000|Main Treatment Part|Lack of Efficacy|0|||
131147971|NCT02901431|472163033|FG001|Main Treatment Part|Lack of Efficacy|0|||
131147972|NCT02901431|472163034|FG002|Main Treatment Part|Lack of Efficacy|0|||
131147973|NCT02901431|472163035|FG003|Main Treatment Part|Lack of Efficacy|1|||
131147974|NCT02901431|472163036|FG004|Main Treatment Part|Lack of Efficacy|0|||
131147975|NCT02901431|472163037|FG005|Main Treatment Part|Lack of Efficacy|0|||
131147976|NCT02901431|472163038|FG006|Main Treatment Part|Lack of Efficacy|0|||
131147977|NCT02901431|472163039|FG007|Main Treatment Part|Lack of Efficacy|0|||
131147978|NCT02901431|472163040|FG008|Main Treatment Part|Lack of Efficacy|0|||
131147979|NCT02901431|472163041|FG009|Main Treatment Part|Lack of Efficacy|0|||
131147980|NCT02901431|472163042|FG010|Main Treatment Part|Lack of Efficacy|0|||
131147981|NCT02901431|472163043|FG011|Main Treatment Part|Lack of Efficacy|0|||
131147982|NCT02901431|472163044|FG012|Main Treatment Part|Lack of Efficacy|0|||
131147983|NCT02901431|472163032|FG000|Main Treatment Part|Lost to Follow-up|0|||
131147984|NCT02901431|472163033|FG001|Main Treatment Part|Lost to Follow-up|0|||
131147985|NCT02901431|472163034|FG002|Main Treatment Part|Lost to Follow-up|0|||
131147986|NCT02901431|472163035|FG003|Main Treatment Part|Lost to Follow-up|3|||
131147987|NCT02901431|472163036|FG004|Main Treatment Part|Lost to Follow-up|1|||
131147988|NCT02901431|472163037|FG005|Main Treatment Part|Lost to Follow-up|2|||
131147989|NCT02901431|472163038|FG006|Main Treatment Part|Lost to Follow-up|3|||
131147990|NCT02901431|472163039|FG007|Main Treatment Part|Lost to Follow-up|0|||
131147991|NCT02901431|472163040|FG008|Main Treatment Part|Lost to Follow-up|0|||
131147992|NCT02901431|472163041|FG009|Main Treatment Part|Lost to Follow-up|0|||
131147993|NCT02901431|472163042|FG010|Main Treatment Part|Lost to Follow-up|0|||
131147994|NCT02901431|472163043|FG011|Main Treatment Part|Lost to Follow-up|0|||
131147995|NCT02901431|472163044|FG012|Main Treatment Part|Lost to Follow-up|0|||
131147996|NCT02901431|472163032|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
131147997|NCT02901431|472163033|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
131147998|NCT02901431|472163034|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
131147999|NCT02901431|472163035|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
131148000|NCT02901431|472163036|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
131148001|NCT02901431|472163037|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
131148002|NCT02901431|472163038|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
131148003|NCT02901431|472163039|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
131148004|NCT02901431|472163040|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
131148005|NCT02901431|472163041|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
131148006|NCT02901431|472163042|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
131148007|NCT02901431|472163043|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
131148008|NCT02901431|472163044|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
131148009|NCT02901431|472163032|FG000|Main Treatment Part|Physician Decision|0|||
131148010|NCT02901431|472163033|FG001|Main Treatment Part|Physician Decision|0|||
131148011|NCT02901431|472163034|FG002|Main Treatment Part|Physician Decision|0|||
131148012|NCT02901431|472163035|FG003|Main Treatment Part|Physician Decision|1|||
131148013|NCT02901431|472163036|FG004|Main Treatment Part|Physician Decision|0|||
131148014|NCT02901431|472163037|FG005|Main Treatment Part|Physician Decision|0|||
131148015|NCT02901431|472163038|FG006|Main Treatment Part|Physician Decision|1|||
131148016|NCT02901431|472163039|FG007|Main Treatment Part|Physician Decision|0|||
131234837|NCT03538756|472486493|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
131148017|NCT02901431|472163040|FG008|Main Treatment Part|Physician Decision|0|||
131148018|NCT02901431|472163041|FG009|Main Treatment Part|Physician Decision|0|||
131148019|NCT02901431|472163042|FG010|Main Treatment Part|Physician Decision|0|||
131148020|NCT02901431|472163043|FG011|Main Treatment Part|Physician Decision|0|||
131148021|NCT02901431|472163044|FG012|Main Treatment Part|Physician Decision|0|||
131148022|NCT02901431|472163032|FG000|Main Treatment Part|Withdrawal by Subject|0|||
131148023|NCT02901431|472163033|FG001|Main Treatment Part|Withdrawal by Subject|0|||
131148024|NCT02901431|472163034|FG002|Main Treatment Part|Withdrawal by Subject|0|||
131148025|NCT02901431|472163035|FG003|Main Treatment Part|Withdrawal by Subject|18|||
131148026|NCT02901431|472163036|FG004|Main Treatment Part|Withdrawal by Subject|3|||
131148027|NCT02901431|472163037|FG005|Main Treatment Part|Withdrawal by Subject|5|||
131148028|NCT02901431|472163038|FG006|Main Treatment Part|Withdrawal by Subject|6|||
131148029|NCT02901431|472163039|FG007|Main Treatment Part|Withdrawal by Subject|0|||
131148030|NCT02901431|472163040|FG008|Main Treatment Part|Withdrawal by Subject|0|||
131148031|NCT02901431|472163041|FG009|Main Treatment Part|Withdrawal by Subject|0|||
131148032|NCT02901431|472163042|FG010|Main Treatment Part|Withdrawal by Subject|0|||
131148033|NCT02901431|472163043|FG011|Main Treatment Part|Withdrawal by Subject|0|||
131148034|NCT02901431|472163044|FG012|Main Treatment Part|Withdrawal by Subject|0|||
131148035|NCT02901431|472163032|FG000|Open Label Part|Adverse Event|0|||
131148036|NCT02901431|472163033|FG001|Open Label Part|Adverse Event|0|||
131148037|NCT02901431|472163034|FG002|Open Label Part|Adverse Event|0|||
131148038|NCT02901431|472163035|FG003|Open Label Part|Adverse Event|0|||
131148039|NCT02901431|472163036|FG004|Open Label Part|Adverse Event|0|||
131148040|NCT02901431|472163037|FG005|Open Label Part|Adverse Event|0|||
131148041|NCT02901431|472163038|FG006|Open Label Part|Adverse Event|0|||
131148042|NCT02901431|472163039|FG007|Open Label Part|Adverse Event|0|||
131148043|NCT02901431|472163040|FG008|Open Label Part|Adverse Event|4|||
131148044|NCT02901431|472163041|FG009|Open Label Part|Adverse Event|4|||
131148045|NCT02901431|472163042|FG010|Open Label Part|Adverse Event|0|||
131148046|NCT02901431|472163043|FG011|Open Label Part|Adverse Event|4|||
131148047|NCT02901431|472163044|FG012|Open Label Part|Adverse Event|1|||
130780291|NCT01261390|470821486|FG002|Overall Study|Significant Concurrent Illness|1|||
130780292|NCT01261390|470821487|FG003|Overall Study|Significant Concurrent Illness|0|||
130780293|NCT01261390|470821484|FG000|Overall Study|Dissatisfaction with Treatment|2|||
130780294|NCT01261390|470821485|FG001|Overall Study|Dissatisfaction with Treatment|1|||
130780295|NCT01261390|470821486|FG002|Overall Study|Dissatisfaction with Treatment|1|||
130780296|NCT01261390|470821487|FG003|Overall Study|Dissatisfaction with Treatment|2|||
130780297|NCT01261390|470821484|FG000|Overall Study|Relocation|0|||
130780298|NCT01261390|470821485|FG001|Overall Study|Relocation|1|||
130780299|NCT01261390|470821486|FG002|Overall Study|Relocation|0|||
130780300|NCT01261390|470821487|FG003|Overall Study|Relocation|0|||
130780301|NCT01261390|470821484|FG000|Overall Study|Loss of Interest in the Study|3|||
130780302|NCT01261390|470821485|FG001|Overall Study|Loss of Interest in the Study|1|||
130780303|NCT01261390|470821486|FG002|Overall Study|Loss of Interest in the Study|0|||
130780304|NCT01261390|470821487|FG003|Overall Study|Loss of Interest in the Study|0|||
130780305|NCT01261390|470821484|FG000|Overall Study|Lost to Follow-up|1|||
131148048|NCT02901431|472163032|FG000|Open Label Part|Lost to Follow-up|0|||
131148049|NCT02901431|472163033|FG001|Open Label Part|Lost to Follow-up|0|||
131148050|NCT02901431|472163034|FG002|Open Label Part|Lost to Follow-up|0|||
131148051|NCT02901431|472163035|FG003|Open Label Part|Lost to Follow-up|0|||
131148052|NCT02901431|472163036|FG004|Open Label Part|Lost to Follow-up|0|||
131148053|NCT02901431|472163037|FG005|Open Label Part|Lost to Follow-up|0|||
131148054|NCT02901431|472163038|FG006|Open Label Part|Lost to Follow-up|0|||
131148055|NCT02901431|472163039|FG007|Open Label Part|Lost to Follow-up|0|||
131148056|NCT02901431|472163040|FG008|Open Label Part|Lost to Follow-up|2|||
131148057|NCT02901431|472163041|FG009|Open Label Part|Lost to Follow-up|2|||
131148058|NCT02901431|472163042|FG010|Open Label Part|Lost to Follow-up|1|||
131148059|NCT02901431|472163043|FG011|Open Label Part|Lost to Follow-up|1|||
131148060|NCT02901431|472163044|FG012|Open Label Part|Lost to Follow-up|1|||
131148061|NCT02901431|472163032|FG000|Open Label Part|Physician Decision|0|||
131148062|NCT02901431|472163033|FG001|Open Label Part|Physician Decision|0|||
131148063|NCT02901431|472163034|FG002|Open Label Part|Physician Decision|0|||
131148064|NCT02901431|472163035|FG003|Open Label Part|Physician Decision|0|||
131148065|NCT02901431|472163036|FG004|Open Label Part|Physician Decision|0|||
131148066|NCT02901431|472163037|FG005|Open Label Part|Physician Decision|0|||
131148067|NCT02901431|472163038|FG006|Open Label Part|Physician Decision|0|||
131148068|NCT02901431|472163039|FG007|Open Label Part|Physician Decision|0|||
131148069|NCT02901431|472163040|FG008|Open Label Part|Physician Decision|1|||
131148070|NCT02901431|472163041|FG009|Open Label Part|Physician Decision|1|||
131148071|NCT02901431|472163042|FG010|Open Label Part|Physician Decision|0|||
130780306|NCT01261390|470821485|FG001|Overall Study|Lost to Follow-up|6|||
130780307|NCT01261390|470821486|FG002|Overall Study|Lost to Follow-up|5|||
130780308|NCT01261390|470821487|FG003|Overall Study|Lost to Follow-up|6|||
131148072|NCT02901431|472163043|FG011|Open Label Part|Physician Decision|0|||
131148073|NCT02901431|472163044|FG012|Open Label Part|Physician Decision|0|||
131148074|NCT02901431|472163032|FG000|Open Label Part|Study Terminated By Sponsor|0|||
131148075|NCT02901431|472163033|FG001|Open Label Part|Study Terminated By Sponsor|0|||
131148076|NCT02901431|472163034|FG002|Open Label Part|Study Terminated By Sponsor|0|||
131148077|NCT02901431|472163035|FG003|Open Label Part|Study Terminated By Sponsor|0|||
131148078|NCT02901431|472163036|FG004|Open Label Part|Study Terminated By Sponsor|0|||
131148079|NCT02901431|472163037|FG005|Open Label Part|Study Terminated By Sponsor|0|||
131148080|NCT02901431|472163038|FG006|Open Label Part|Study Terminated By Sponsor|0|||
131148081|NCT02901431|472163039|FG007|Open Label Part|Study Terminated By Sponsor|0|||
131148082|NCT02901431|472163040|FG008|Open Label Part|Study Terminated By Sponsor|35|||
131148083|NCT02901431|472163041|FG009|Open Label Part|Study Terminated By Sponsor|12|||
131148084|NCT02901431|472163042|FG010|Open Label Part|Study Terminated By Sponsor|21|||
131148085|NCT02901431|472163043|FG011|Open Label Part|Study Terminated By Sponsor|31|||
131148086|NCT02901431|472163044|FG012|Open Label Part|Study Terminated By Sponsor|0|||
131148087|NCT02901431|472163032|FG000|Open Label Part|Withdrawal by Subject|0|||
131148088|NCT02901431|472163033|FG001|Open Label Part|Withdrawal by Subject|0|||
131148089|NCT02901431|472163034|FG002|Open Label Part|Withdrawal by Subject|0|||
131148090|NCT02901431|472163035|FG003|Open Label Part|Withdrawal by Subject|0|||
131148091|NCT02901431|472163036|FG004|Open Label Part|Withdrawal by Subject|0|||
131148092|NCT02901431|472163037|FG005|Open Label Part|Withdrawal by Subject|0|||
131148093|NCT02901431|472163038|FG006|Open Label Part|Withdrawal by Subject|0|||
131148094|NCT02901431|472163039|FG007|Open Label Part|Withdrawal by Subject|0|||
131148095|NCT02901431|472163040|FG008|Open Label Part|Withdrawal by Subject|6|||
131148096|NCT02901431|472163041|FG009|Open Label Part|Withdrawal by Subject|5|||
131148097|NCT02901431|472163042|FG010|Open Label Part|Withdrawal by Subject|7|||
131148098|NCT02901431|472163043|FG011|Open Label Part|Withdrawal by Subject|3|||
131148099|NCT02901431|472163044|FG012|Open Label Part|Withdrawal by Subject|1|||
131148100|NCT04672083|472163045|FG000|Overall Study|Lost to Follow-up|1|||
131148101|NCT04672083|472163046|FG001|Overall Study|Lost to Follow-up|0|||
131148102|NCT04672083|472163047|FG002|Overall Study|Lost to Follow-up|0|||
131148103|NCT04672083|472163048|FG003|Overall Study|Lost to Follow-up|0|||
131148104|NCT04672083|472163049|FG004|Overall Study|Lost to Follow-up|0|||
131148105|NCT02048904|472163050|FG000|Overall Study|Withdrawal by Subject|7|||
131148106|NCT02048904|472163050|FG000|Overall Study|Physician Decision|70|||
131148107|NCT04752384|472163051|FG000|Overall Study|Withdrawal by Subject|1|||
131148108|NCT04752384|472163051|FG000|Overall Study|Death|1|||
131148109|NCT04980391|472163059|FG000|Overall Study|Death|0|||
131148110|NCT04980391|472163060|FG001|Overall Study|Death|0|||
131148111|NCT04980391|472163061|FG002|Overall Study|Death|1|||
131148112|NCT04980391|472163062|FG003|Overall Study|Death|1|||
131148113|NCT04980391|472163059|FG000|Overall Study|Lost to Follow-up|3|||
131148114|NCT04980391|472163060|FG001|Overall Study|Lost to Follow-up|3|||
131148115|NCT04980391|472163061|FG002|Overall Study|Lost to Follow-up|2|||
131148116|NCT04980391|472163062|FG003|Overall Study|Lost to Follow-up|3|||
131148117|NCT04980391|472163059|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
131148118|NCT04980391|472163060|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
131148119|NCT04980391|472163061|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
131148120|NCT04980391|472163062|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
131148121|NCT04980391|472163059|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131148122|NCT04980391|472163060|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131148123|NCT04980391|472163061|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
131148124|NCT04980391|472163062|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131148125|NCT04980391|472163059|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
131148126|NCT04980391|472163060|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
131148127|NCT04980391|472163061|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
131148128|NCT04980391|472163062|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
131148129|NCT03690869|472163063|FG000|Overall Study|Adverse Event|0|||
131148130|NCT03690869|472163064|FG001|Overall Study|Adverse Event|0|||
131148131|NCT03690869|472163065|FG002|Overall Study|Adverse Event|0|||
131148132|NCT03690869|472163066|FG003|Overall Study|Adverse Event|1|||
131148133|NCT03690869|472163067|FG004|Overall Study|Adverse Event|0|||
131148134|NCT03690869|472163068|FG005|Overall Study|Adverse Event|0|||
131148135|NCT03690869|472163069|FG006|Overall Study|Adverse Event|0|||
131148136|NCT03690869|472163070|FG007|Overall Study|Adverse Event|1|||
131148137|NCT03690869|472163071|FG008|Overall Study|Adverse Event|0|||
131148138|NCT03690869|472163072|FG009|Overall Study|Adverse Event|1|||
131148139|NCT03690869|472163063|FG000|Overall Study|Death|1|||
131148140|NCT03690869|472163064|FG001|Overall Study|Death|1|||
131148141|NCT03690869|472163065|FG002|Overall Study|Death|1|||
130780309|NCT00977613|470821493|FG000|Overall Study|Lost to Follow-up|16|||
131148142|NCT03690869|472163066|FG003|Overall Study|Death|4|||
131148143|NCT03690869|472163067|FG004|Overall Study|Death|2|||
131148144|NCT03690869|472163068|FG005|Overall Study|Death|5|||
131148145|NCT03690869|472163069|FG006|Overall Study|Death|3|||
131148146|NCT03690869|472163070|FG007|Overall Study|Death|2|||
130780310|NCT01691378|470821497|FG000|Overall Study|Withdrawal by Subject|2|||
131148147|NCT03690869|472163071|FG008|Overall Study|Death|0|||
131148148|NCT03690869|472163072|FG009|Overall Study|Death|3|||
131148149|NCT03690869|472163063|FG000|Overall Study|Lost to Follow-up|0|||
131148150|NCT03690869|472163064|FG001|Overall Study|Lost to Follow-up|0|||
131148151|NCT03690869|472163065|FG002|Overall Study|Lost to Follow-up|1|||
131148152|NCT03690869|472163066|FG003|Overall Study|Lost to Follow-up|0|||
131148153|NCT03690869|472163067|FG004|Overall Study|Lost to Follow-up|0|||
131148154|NCT03690869|472163068|FG005|Overall Study|Lost to Follow-up|0|||
131148155|NCT03690869|472163069|FG006|Overall Study|Lost to Follow-up|0|||
131148156|NCT03690869|472163070|FG007|Overall Study|Lost to Follow-up|0|||
131148157|NCT03690869|472163071|FG008|Overall Study|Lost to Follow-up|0|||
131148158|NCT03690869|472163072|FG009|Overall Study|Lost to Follow-up|0|||
131148159|NCT03690869|472163063|FG000|Overall Study|Other Treatment|1|||
131148160|NCT03690869|472163064|FG001|Overall Study|Other Treatment|1|||
131148161|NCT03690869|472163065|FG002|Overall Study|Other Treatment|1|||
131148162|NCT03690869|472163066|FG003|Overall Study|Other Treatment|2|||
131148163|NCT03690869|472163067|FG004|Overall Study|Other Treatment|3|||
131148164|NCT03690869|472163068|FG005|Overall Study|Other Treatment|1|||
131148165|NCT03690869|472163069|FG006|Overall Study|Other Treatment|2|||
131148166|NCT03690869|472163070|FG007|Overall Study|Other Treatment|7|||
131148167|NCT03690869|472163071|FG008|Overall Study|Other Treatment|0|||
131148168|NCT03690869|472163072|FG009|Overall Study|Other Treatment|3|||
131148169|NCT03690869|472163063|FG000|Overall Study|Physician Decision|0|||
131148170|NCT03690869|472163064|FG001|Overall Study|Physician Decision|1|||
131148171|NCT03690869|472163065|FG002|Overall Study|Physician Decision|0|||
131148172|NCT03690869|472163066|FG003|Overall Study|Physician Decision|0|||
131148173|NCT03690869|472163067|FG004|Overall Study|Physician Decision|0|||
131148174|NCT03690869|472163068|FG005|Overall Study|Physician Decision|0|||
131148175|NCT03690869|472163069|FG006|Overall Study|Physician Decision|0|||
131148176|NCT03690869|472163070|FG007|Overall Study|Physician Decision|0|||
131148177|NCT03690869|472163071|FG008|Overall Study|Physician Decision|0|||
131148178|NCT03690869|472163072|FG009|Overall Study|Physician Decision|0|||
131148179|NCT03690869|472163063|FG000|Overall Study|Progressive Disease|1|||
131148180|NCT03690869|472163064|FG001|Overall Study|Progressive Disease|2|||
131148181|NCT03690869|472163065|FG002|Overall Study|Progressive Disease|0|||
131148182|NCT03690869|472163066|FG003|Overall Study|Progressive Disease|1|||
131148183|NCT03690869|472163067|FG004|Overall Study|Progressive Disease|0|||
131148184|NCT03690869|472163068|FG005|Overall Study|Progressive Disease|0|||
131148185|NCT03690869|472163069|FG006|Overall Study|Progressive Disease|0|||
131148186|NCT03690869|472163070|FG007|Overall Study|Progressive Disease|0|||
131148187|NCT03690869|472163071|FG008|Overall Study|Progressive Disease|1|||
131148188|NCT03690869|472163072|FG009|Overall Study|Progressive Disease|1|||
131148189|NCT03690869|472163063|FG000|Overall Study|Subject Decision|0|||
131148190|NCT03690869|472163064|FG001|Overall Study|Subject Decision|0|||
131148191|NCT03690869|472163065|FG002|Overall Study|Subject Decision|0|||
131148192|NCT03690869|472163066|FG003|Overall Study|Subject Decision|1|||
131148193|NCT03690869|472163067|FG004|Overall Study|Subject Decision|0|||
131148194|NCT03690869|472163068|FG005|Overall Study|Subject Decision|0|||
131148195|NCT03690869|472163069|FG006|Overall Study|Subject Decision|0|||
131148196|NCT03690869|472163070|FG007|Overall Study|Subject Decision|1|||
131148197|NCT03690869|472163071|FG008|Overall Study|Subject Decision|0|||
131148198|NCT03690869|472163072|FG009|Overall Study|Subject Decision|0|||
131148199|NCT02732951|472164527|FG000|Overall Study|Other than listed|1|||
131148200|NCT02732951|472164528|FG001|Overall Study|Other than listed|0|||
131148201|NCT02732951|472164527|FG000|Overall Study|Lost to Follow-up|0|||
131148202|NCT02732951|472164528|FG001|Overall Study|Lost to Follow-up|1|||
131148203|NCT02732951|472164527|FG000|Overall Study|Adverse Event|4|||
131148204|NCT02732951|472164528|FG001|Overall Study|Adverse Event|4|||
131148205|NCT02732951|472164527|FG000|Overall Study|Protocol Violation|0|||
131148206|NCT02732951|472164528|FG001|Overall Study|Protocol Violation|1|||
131148207|NCT01750918|472164529|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
131148208|NCT01750918|472164530|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
131148209|NCT01750918|472164531|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
131148210|NCT01750918|472164532|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
131148211|NCT01750918|472164533|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
131148212|NCT01750918|472164534|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
131148213|NCT01750918|472164535|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
131148214|NCT01750918|472164536|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
131148215|NCT01750918|472164529|FG000|Overall Study|Lost to Follow-up|0|||
131148216|NCT01750918|472164530|FG001|Overall Study|Lost to Follow-up|0|||
131148217|NCT01750918|472164531|FG002|Overall Study|Lost to Follow-up|2|||
131148218|NCT01750918|472164532|FG003|Overall Study|Lost to Follow-up|2|||
131148219|NCT01750918|472164533|FG004|Overall Study|Lost to Follow-up|0|||
131148220|NCT01750918|472164534|FG005|Overall Study|Lost to Follow-up|0|||
131148221|NCT01750918|472164535|FG006|Overall Study|Lost to Follow-up|0|||
131148222|NCT01750918|472164536|FG007|Overall Study|Lost to Follow-up|1|||
131148223|NCT01750918|472164529|FG000|Overall Study|Withdrawal by Subject|0|||
131148224|NCT01750918|472164530|FG001|Overall Study|Withdrawal by Subject|0|||
131148225|NCT01750918|472164531|FG002|Overall Study|Withdrawal by Subject|1|||
131148226|NCT01750918|472164532|FG003|Overall Study|Withdrawal by Subject|2|||
131148227|NCT01750918|472164533|FG004|Overall Study|Withdrawal by Subject|1|||
131148228|NCT01750918|472164534|FG005|Overall Study|Withdrawal by Subject|1|||
131148229|NCT01750918|472164535|FG006|Overall Study|Withdrawal by Subject|2|||
131148230|NCT01750918|472164536|FG007|Overall Study|Withdrawal by Subject|2|||
131148231|NCT04840667|472164541|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
131148232|NCT01609933|472164552|FG000|Overall Study|Adverse Event|1|||
131148233|NCT01609933|472164552|FG000|Overall Study|Withdrawal by Subject|3|||
131148234|NCT00224016|472164553|FG000|Titration Period|Withdrawal by Subject|0|||
131148235|NCT00224016|472164554|FG001|Titration Period|Withdrawal by Subject|1|||
131148236|NCT00224016|472164553|FG000|Titration Period|Lost to Follow-up|1|||
131148237|NCT00224016|472164554|FG001|Titration Period|Lost to Follow-up|0|||
131148238|NCT00224016|472164553|FG000|Maintenance Period|Withdrawal by Subject|2|||
131148239|NCT00224016|472164554|FG001|Maintenance Period|Withdrawal by Subject|0|||
131148240|NCT00224016|472164553|FG000|Maintenance Period|Lost to Follow-up|0|||
131148241|NCT00224016|472164554|FG001|Maintenance Period|Lost to Follow-up|1|||
131148242|NCT01252966|472164555|FG000|Overall Study|Lost to Follow-up|16|||
131148243|NCT01252966|472164556|FG001|Overall Study|Lost to Follow-up|10|||
131148244|NCT01252966|472164555|FG000|Overall Study|Withdrawal by Subject|7|||
131148245|NCT01252966|472164556|FG001|Overall Study|Withdrawal by Subject|3|||
131148246|NCT01903876|472164561|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
131234838|NCT03538756|472486491|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
131234839|NCT03538756|472486492|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
131234840|NCT03538756|472486493|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
131234841|NCT03538756|472486491|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
131148247|NCT01903876|472164562|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
131148248|NCT01903876|472164561|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
131148249|NCT01903876|472164562|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
131148250|NCT00496366|472164563|FG000|Overall Study|Death|1|||
131148251|NCT04317690|472164566|FG000|Overall Study|did not have complete information for primary outcome|0|||
131148252|NCT04317690|472164567|FG001|Overall Study|did not have complete information for primary outcome|4|||
131148253|NCT04317690|472164568|FG002|Overall Study|did not have complete information for primary outcome|0|||
131148254|NCT04317690|472164569|FG003|Overall Study|did not have complete information for primary outcome|2|||
131148255|NCT04317690|472164570|FG004|Overall Study|did not have complete information for primary outcome|0|||
131148256|NCT02612909|472164571|FG000|Phase 2|Withdrawal by Subject|2|||
131148257|NCT02612909|472164572|FG001|Phase 2|Withdrawal by Subject|5|||
131148258|NCT02612909|472164573|FG002|Phase 2|Withdrawal by Subject|0|||
131148259|NCT02612909|472164574|FG003|Phase 2|Withdrawal by Subject|0|||
131148260|NCT02612909|472164575|FG004|Phase 2|Withdrawal by Subject|0|||
131148261|NCT02612909|472164571|FG000|Phase 2|Pregnancy|0|||
131148262|NCT02612909|472164572|FG001|Phase 2|Pregnancy|0|||
131148263|NCT02612909|472164573|FG002|Phase 2|Pregnancy|1|||
131148264|NCT02612909|472164574|FG003|Phase 2|Pregnancy|0|||
131148265|NCT02612909|472164575|FG004|Phase 2|Pregnancy|0|||
131148266|NCT02612909|472164571|FG000|Phase 3|Withdrawal by Subject|0|||
131148267|NCT02612909|472164572|FG001|Phase 3|Withdrawal by Subject|0|||
131148268|NCT02612909|472164573|FG002|Phase 3|Withdrawal by Subject|0|||
131148269|NCT02612909|472164574|FG003|Phase 3|Withdrawal by Subject|1|||
131148270|NCT02612909|472164575|FG004|Phase 3|Withdrawal by Subject|0|||
131148271|NCT01901224|472164576|FG000|Overall Study|study was not funded and terminated|2|||
131148272|NCT03902080|472164577|FG000|Overall Study|Adverse Event|17|||
131148273|NCT03902080|472164578|FG001|Overall Study|Adverse Event|15|||
131148274|NCT03902080|472164577|FG000|Overall Study|Withdrawal by Subject|28|||
131148275|NCT03902080|472164578|FG001|Overall Study|Withdrawal by Subject|35|||
131148276|NCT03902080|472164577|FG000|Overall Study|Lost to Follow-up|6|||
131148277|NCT03902080|472164578|FG001|Overall Study|Lost to Follow-up|7|||
131148278|NCT03902080|472164577|FG000|Overall Study|Other|3|||
131148279|NCT03902080|472164578|FG001|Overall Study|Other|5|||
131148280|NCT03902080|472164577|FG000|Overall Study|Non compliance|4|||
131148281|NCT03902080|472164578|FG001|Overall Study|Non compliance|3|||
131148282|NCT03902080|472164577|FG000|Overall Study|Physician Decision|5|||
131148283|NCT03902080|472164578|FG001|Overall Study|Physician Decision|1|||
131148284|NCT03902080|472164577|FG000|Overall Study|Protocol Violation|3|||
131234842|NCT03538756|472486492|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
131234843|NCT03538756|472486493|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
131234844|NCT00752856|472486494|FG000|Overall Study|randomized but did not do viral kinetics|0|||
131234845|NCT00752856|472486495|FG001|Overall Study|randomized but did not do viral kinetics|1|||
131234846|NCT02260492|472486496|FG000|Overall Study|Adverse Event|6|||
131234847|NCT02260492|472486497|FG001|Overall Study|Adverse Event|1|||
131234848|NCT02260492|472486498|FG002|Overall Study|Adverse Event|2|||
131234849|NCT02260492|472486496|FG000|Overall Study|Death|0|||
131234850|NCT02260492|472486497|FG001|Overall Study|Death|1|||
131148285|NCT03902080|472164578|FG001|Overall Study|Protocol Violation|3|||
131148286|NCT03902080|472164577|FG000|Overall Study|Lack of Efficacy|1|||
131148287|NCT03902080|472164578|FG001|Overall Study|Lack of Efficacy|3|||
131148288|NCT03902080|472164577|FG000|Overall Study|Withdrawn prior to dosing|0|||
131148289|NCT03902080|472164578|FG001|Overall Study|Withdrawn prior to dosing|1|||
131148290|NCT00391976|472164579|FG000|Overall Study|Adverse Event|0|||
131148291|NCT00391976|472164580|FG001|Overall Study|Adverse Event|0|||
131148292|NCT00391976|472164581|FG002|Overall Study|Adverse Event|1|||
131148293|NCT00391976|472164579|FG000|Overall Study|Withdrawal of consent|0|||
131148294|NCT00391976|472164580|FG001|Overall Study|Withdrawal of consent|1|||
131148295|NCT00391976|472164581|FG002|Overall Study|Withdrawal of consent|1|||
131148296|NCT00391976|472164579|FG000|Overall Study|Lost to Follow-up|1|||
131148297|NCT00391976|472164580|FG001|Overall Study|Lost to Follow-up|2|||
131148298|NCT00391976|472164581|FG002|Overall Study|Lost to Follow-up|0|||
131148299|NCT00391976|472164579|FG000|Overall Study|Inappropriate enrollment|1|||
131148300|NCT00391976|472164580|FG001|Overall Study|Inappropriate enrollment|1|||
131148301|NCT00391976|472164581|FG002|Overall Study|Inappropriate enrollment|0|||
131148302|NCT00391976|472164579|FG000|Overall Study|Protocol deviation/violation|4|||
131148303|NCT00391976|472164580|FG001|Overall Study|Protocol deviation/violation|2|||
131148304|NCT00391976|472164581|FG002|Overall Study|Protocol deviation/violation|1|||
131148305|NCT00391976|472164579|FG000|Overall Study|Recurrence/no eradication of infection|21|||
131148306|NCT00391976|472164580|FG001|Overall Study|Recurrence/no eradication of infection|19|||
131148307|NCT00391976|472164581|FG002|Overall Study|Recurrence/no eradication of infection|0|||
131148308|NCT00391976|472164579|FG000|Overall Study|Unable to classify|0|||
131148309|NCT00391976|472164580|FG001|Overall Study|Unable to classify|0|||
131148310|NCT00391976|472164581|FG002|Overall Study|Unable to classify|1|||
131148311|NCT00391976|472164579|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
131148312|NCT00391976|472164580|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
131148313|NCT00391976|472164581|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
131148314|NCT01701258|472164586|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
131148315|NCT01701258|472164587|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
131148316|NCT01701258|472164588|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
131148317|NCT01701258|472164589|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
131148318|NCT01701258|472164590|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
131148319|NCT01701258|472164591|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
131148320|NCT01701258|472164592|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
131148321|NCT01701258|472164593|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
131148322|NCT01701258|472164594|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
131148323|NCT01701258|472164595|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
131148324|NCT01701258|472164596|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
131148325|NCT01701258|472164597|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
131148326|NCT01701258|472164598|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
131148327|NCT01701258|472164586|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
131148328|NCT01701258|472164587|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
131148329|NCT01701258|472164588|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
131148330|NCT01701258|472164589|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
131148331|NCT01701258|472164590|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
131148332|NCT01701258|472164591|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
131148333|NCT01701258|472164592|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
131148334|NCT01701258|472164593|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
131148335|NCT01701258|472164594|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
131148336|NCT01701258|472164595|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
131148337|NCT01701258|472164596|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
131148338|NCT01701258|472164597|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
131148339|NCT01701258|472164598|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
131148340|NCT01701258|472164586|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
131148341|NCT01701258|472164587|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
131148342|NCT01701258|472164588|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
131148343|NCT01701258|472164589|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
131148344|NCT01701258|472164590|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
131148345|NCT01701258|472164591|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
131148346|NCT01701258|472164592|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
131148347|NCT01701258|472164593|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
131148348|NCT01701258|472164594|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
131148349|NCT01701258|472164595|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
131148350|NCT01701258|472164596|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
131148351|NCT01701258|472164597|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
131148352|NCT01701258|472164598|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
131148353|NCT01701258|472164586|FG000|Assessment and Scheduling|Investigator Terminated|2|||
131148354|NCT01701258|472164587|FG001|Assessment and Scheduling|Investigator Terminated|0|||
131148355|NCT01701258|472164588|FG002|Assessment and Scheduling|Investigator Terminated|0|||
131148356|NCT01701258|472164589|FG003|Assessment and Scheduling|Investigator Terminated|0|||
131148357|NCT01701258|472164590|FG004|Assessment and Scheduling|Investigator Terminated|0|||
131148358|NCT01701258|472164591|FG005|Assessment and Scheduling|Investigator Terminated|0|||
131148359|NCT01701258|472164592|FG006|Assessment and Scheduling|Investigator Terminated|0|||
131148360|NCT01701258|472164593|FG007|Assessment and Scheduling|Investigator Terminated|0|||
131148361|NCT01701258|472164594|FG008|Assessment and Scheduling|Investigator Terminated|0|||
131148362|NCT01701258|472164595|FG009|Assessment and Scheduling|Investigator Terminated|0|||
131148363|NCT01701258|472164596|FG010|Assessment and Scheduling|Investigator Terminated|0|||
131148364|NCT01701258|472164597|FG011|Assessment and Scheduling|Investigator Terminated|0|||
131148365|NCT01701258|472164598|FG012|Assessment and Scheduling|Investigator Terminated|0|||
131148366|NCT03093402|472164599|FG000|Overall Study|Lost to Follow-up|1|||
131148367|NCT03093402|472164600|FG001|Overall Study|Lost to Follow-up|0|||
131148368|NCT03093402|472164601|FG002|Overall Study|Lost to Follow-up|0|||
131148369|NCT03093402|472164602|FG003|Overall Study|Lost to Follow-up|0|||
131148370|NCT03093402|472164599|FG000|Overall Study|Withdrawal by Subject|3|||
131148371|NCT03093402|472164600|FG001|Overall Study|Withdrawal by Subject|3|||
131148372|NCT03093402|472164601|FG002|Overall Study|Withdrawal by Subject|0|||
131148373|NCT03093402|472164602|FG003|Overall Study|Withdrawal by Subject|1|||
131148374|NCT03093402|472164599|FG000|Overall Study|Withdrew prior to dosing|2|||
131148375|NCT03093402|472164600|FG001|Overall Study|Withdrew prior to dosing|1|||
131148376|NCT03093402|472164601|FG002|Overall Study|Withdrew prior to dosing|2|||
131148377|NCT03093402|472164602|FG003|Overall Study|Withdrew prior to dosing|3|||
131148378|NCT03093402|472164599|FG000|Overall Study|Ineligible for study|1|||
131148379|NCT03093402|472164600|FG001|Overall Study|Ineligible for study|0|||
131148380|NCT03093402|472164601|FG002|Overall Study|Ineligible for study|0|||
131148381|NCT03093402|472164602|FG003|Overall Study|Ineligible for study|0|||
131148382|NCT03093402|472164599|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
131148383|NCT03093402|472164600|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
131148384|NCT03093402|472164601|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
131148385|NCT03093402|472164602|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
131148386|NCT02429856|472164605|FG000|Overall Study|Death|12|||
131148387|NCT02429856|472164606|FG001|Overall Study|Death|13|||
131148388|NCT02429856|472164605|FG000|Overall Study|Lost to Follow-up|6|||
131148389|NCT02429856|472164606|FG001|Overall Study|Lost to Follow-up|5|||
131148390|NCT02429856|472164605|FG000|Overall Study|Withdrawal by Subject|1|||
131148391|NCT02429856|472164606|FG001|Overall Study|Withdrawal by Subject|1|||
131148392|NCT00763009|472164609|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
131148393|NCT03514914|472164611|FG000|Overall Study|Death|3|||
131148394|NCT03514914|472164612|FG001|Overall Study|Death|3|||
131148395|NCT03514914|472164611|FG000|Overall Study|Lost to Follow-up|117|||
131148396|NCT03514914|472164612|FG001|Overall Study|Lost to Follow-up|89|||
131148397|NCT00891735|472164613|FG000|Overall Study|Adverse Event|2|||
131148398|NCT00891735|472164614|FG001|Overall Study|Adverse Event|0|||
131148399|NCT00891735|472164615|FG002|Overall Study|Adverse Event|2|||
131148400|NCT00891735|472164616|FG003|Overall Study|Adverse Event|0|||
131148401|NCT00891735|472164613|FG000|Overall Study|Death|8|||
131148402|NCT00891735|472164614|FG001|Overall Study|Death|5|||
131148403|NCT00891735|472164615|FG002|Overall Study|Death|4|||
131148404|NCT00891735|472164616|FG003|Overall Study|Death|5|||
131148405|NCT00891735|472164613|FG000|Overall Study|Lost to Follow-up|2|||
131148406|NCT00891735|472164614|FG001|Overall Study|Lost to Follow-up|2|||
131148407|NCT00891735|472164615|FG002|Overall Study|Lost to Follow-up|2|||
131148408|NCT00891735|472164616|FG003|Overall Study|Lost to Follow-up|2|||
131148409|NCT00891735|472164613|FG000|Overall Study|Physician's decision to withdraw patient|1|||
131148410|NCT00891735|472164614|FG001|Overall Study|Physician's decision to withdraw patient|0|||
131148411|NCT00891735|472164615|FG002|Overall Study|Physician's decision to withdraw patient|0|||
131148412|NCT00891735|472164616|FG003|Overall Study|Physician's decision to withdraw patient|0|||
131148413|NCT00891735|472164613|FG000|Overall Study|Patient's decision to withdraw|4|||
131148414|NCT00891735|472164614|FG001|Overall Study|Patient's decision to withdraw|9|||
131148415|NCT00891735|472164615|FG002|Overall Study|Patient's decision to withdraw|4|||
131148416|NCT00891735|472164616|FG003|Overall Study|Patient's decision to withdraw|8|||
131148417|NCT01651780|472164622|FG000|Overall Study|Physician decision: No 30-day visit|2|||
131148418|NCT01651780|472164623|FG001|Overall Study|Physician decision: No 30-day visit|1|||
131148419|NCT01651780|472164622|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
131148420|NCT01651780|472164623|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
131148421|NCT01651780|472164622|FG000|Overall Study|Withdrawal by Subject|2|||
131148422|NCT01651780|472164623|FG001|Overall Study|Withdrawal by Subject|0|||
131148423|NCT01651780|472164622|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
131148424|NCT01651780|472164623|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
131148425|NCT01651780|472164622|FG000|Overall Study|Lost to Follow-up|1|||
131148426|NCT01651780|472164623|FG001|Overall Study|Lost to Follow-up|2|||
131148427|NCT01651780|472164622|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
131148428|NCT01651780|472164623|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
131148429|NCT03029832|472164624|FG000|Overall Study|Safety Follow-Up Completed|2|||
130727852|NCT00025259|470625565|FG006|Overall Study|Protocol Violation|3|||
131148430|NCT03029832|472164625|FG001|Overall Study|Safety Follow-Up Completed|0|||
131148431|NCT03029832|472164624|FG000|Overall Study|Death due to Disease Progression|1|||
131148432|NCT03029832|472164625|FG001|Overall Study|Death due to Disease Progression|0|||
131148433|NCT03029832|472164624|FG000|Overall Study|Study Terminated By Sponsor|1|||
131148434|NCT03029832|472164625|FG001|Overall Study|Study Terminated By Sponsor|1|||
131148435|NCT01412229|472164626|FG000|Overall Study|Physician Decision|1|||
131148436|NCT01889602|472164629|FG000|First Intervention|Adverse Event|1|||
131148437|NCT01889602|472164630|FG001|First Intervention|Adverse Event|1|||
131148438|NCT01889602|472164631|FG002|First Intervention|Adverse Event|1|||
131148439|NCT01889602|472164629|FG000|First Intervention|Protocol Violation|0|||
131148440|NCT01889602|472164630|FG001|First Intervention|Protocol Violation|1|||
131148441|NCT01889602|472164631|FG002|First Intervention|Protocol Violation|1|||
131148442|NCT01889602|472164629|FG000|First Intervention|Study ending|0|||
131148443|NCT01889602|472164630|FG001|First Intervention|Study ending|1|||
131148444|NCT01889602|472164631|FG002|First Intervention|Study ending|0|||
131148445|NCT01889602|472164629|FG000|Second Intervention|Adverse Event|0|||
131148446|NCT01889602|472164630|FG001|Second Intervention|Adverse Event|0|||
131148447|NCT01889602|472164631|FG002|Second Intervention|Adverse Event|1|||
131148448|NCT01889602|472164629|FG000|Second Intervention|Study ending|1|||
131148449|NCT01889602|472164630|FG001|Second Intervention|Study ending|0|||
131148450|NCT01889602|472164631|FG002|Second Intervention|Study ending|0|||
131148451|NCT01889602|472164629|FG000|Second Intervention|Withdrawal by Subject|0|||
131148452|NCT01889602|472164630|FG001|Second Intervention|Withdrawal by Subject|0|||
131148453|NCT01889602|472164631|FG002|Second Intervention|Withdrawal by Subject|1|||
131148454|NCT01889602|472164629|FG000|Third Intervention|Protocol Violation|1|||
131148455|NCT01889602|472164630|FG001|Third Intervention|Protocol Violation|0|||
131148456|NCT01889602|472164631|FG002|Third Intervention|Protocol Violation|0|||
131148457|NCT01889602|472164629|FG000|Third Intervention|Withdrawal by Subject|2|||
131148458|NCT01889602|472164630|FG001|Third Intervention|Withdrawal by Subject|2|||
131148459|NCT01889602|472164631|FG002|Third Intervention|Withdrawal by Subject|0|||
131148460|NCT00404092|472164632|FG000|Overall Study|Death|1|||
131148461|NCT00404092|472164633|FG001|Overall Study|Death|0|||
131148462|NCT00404092|472164634|FG002|Overall Study|Death|0|||
131148463|NCT00404092|472164635|FG003|Overall Study|Death|0|||
131148464|NCT00404092|472164632|FG000|Overall Study|Adverse Event|0|||
131148465|NCT00404092|472164633|FG001|Overall Study|Adverse Event|0|||
131148466|NCT00404092|472164634|FG002|Overall Study|Adverse Event|1|||
131148467|NCT00404092|472164635|FG003|Overall Study|Adverse Event|0|||
131148468|NCT04223609|472164640|FG000|Overall Study|Adverse Event|0|||
131148469|NCT04223609|472164641|FG001|Overall Study|Adverse Event|1|||
131148470|NCT04223609|472164640|FG000|Overall Study|Missed last visit|0|||
131148471|NCT04223609|472164641|FG001|Overall Study|Missed last visit|1|||
131148472|NCT01275222|472164644|FG000|Phase l by Treatment|Adverse Event|1|||
131148473|NCT01275222|472164645|FG001|Phase l by Treatment|Adverse Event|4|||
131148474|NCT01275222|472164646|FG002|Phase l by Treatment|Adverse Event|2|||
131148475|NCT01275222|472164647|FG003|Phase l by Treatment|Adverse Event|3|||
131148476|NCT01275222|472164648|FG004|Phase l by Treatment|Adverse Event|0|||
131148477|NCT01275222|472164649|FG005|Phase l by Treatment|Adverse Event|0|||
131148478|NCT01275222|472164644|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
131148479|NCT01275222|472164645|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
131148480|NCT01275222|472164646|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
131148481|NCT01275222|472164647|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
131148482|NCT01275222|472164648|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
131148483|NCT01275222|472164649|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
131148484|NCT01275222|472164644|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
131148485|NCT01275222|472164645|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
131148486|NCT01275222|472164646|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
131148487|NCT01275222|472164647|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
131148488|NCT01275222|472164648|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
131148489|NCT01275222|472164649|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
131148490|NCT01275222|472164644|FG000|Phase l by Treatment|Disease progression|12|||
131148491|NCT01275222|472164645|FG001|Phase l by Treatment|Disease progression|8|||
131148492|NCT01275222|472164646|FG002|Phase l by Treatment|Disease progression|2|||
131148493|NCT01275222|472164647|FG003|Phase l by Treatment|Disease progression|5|||
131148494|NCT01275222|472164648|FG004|Phase l by Treatment|Disease progression|0|||
131148495|NCT01275222|472164649|FG005|Phase l by Treatment|Disease progression|0|||
131148496|NCT01275222|472164644|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
131148497|NCT01275222|472164645|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
131148498|NCT01275222|472164646|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
131148499|NCT01275222|472164647|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
131148500|NCT01275222|472164648|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
131148501|NCT01275222|472164649|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
131234851|NCT02260492|472486498|FG002|Overall Study|Death|0|||
131234852|NCT02260492|472486496|FG000|Overall Study|Lost to Follow-up|12|||
131148502|NCT01275222|472164644|FG000|Phase l by Treatment|Death|0|||
131148503|NCT01275222|472164645|FG001|Phase l by Treatment|Death|1|||
131148504|NCT01275222|472164646|FG002|Phase l by Treatment|Death|0|||
131148505|NCT01275222|472164647|FG003|Phase l by Treatment|Death|1|||
131148506|NCT01275222|472164648|FG004|Phase l by Treatment|Death|0|||
131148507|NCT01275222|472164649|FG005|Phase l by Treatment|Death|0|||
131148508|NCT01275222|472164644|FG000|Phase ll by Stratum|Adverse Event|0|||
131148509|NCT01275222|472164645|FG001|Phase ll by Stratum|Adverse Event|0|||
130727853|NCT00025259|470625559|FG000|Overall Study|Withdrawal by Subject|9|||
131148510|NCT01275222|472164646|FG002|Phase ll by Stratum|Adverse Event|0|||
131148511|NCT01275222|472164647|FG003|Phase ll by Stratum|Adverse Event|0|||
131148512|NCT01275222|472164648|FG004|Phase ll by Stratum|Adverse Event|2|||
131148513|NCT01275222|472164649|FG005|Phase ll by Stratum|Adverse Event|10|||
131148514|NCT01275222|472164644|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
131148515|NCT01275222|472164645|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
131148516|NCT01275222|472164646|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
131148517|NCT01275222|472164647|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
131148518|NCT01275222|472164648|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
131148519|NCT01275222|472164649|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
131148520|NCT01275222|472164644|FG000|Phase ll by Stratum|Disease progression|0|||
131148521|NCT01275222|472164645|FG001|Phase ll by Stratum|Disease progression|0|||
131148522|NCT01275222|472164646|FG002|Phase ll by Stratum|Disease progression|0|||
131148523|NCT01275222|472164647|FG003|Phase ll by Stratum|Disease progression|0|||
131148524|NCT01275222|472164648|FG004|Phase ll by Stratum|Disease progression|23|||
131148525|NCT01275222|472164649|FG005|Phase ll by Stratum|Disease progression|31|||
131148526|NCT01275222|472164644|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
131148527|NCT01275222|472164645|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
131148528|NCT01275222|472164646|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
131148529|NCT01275222|472164647|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
131148530|NCT01275222|472164648|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
131148531|NCT01275222|472164649|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
131148532|NCT01275222|472164644|FG000|Phase ll by Stratum|Death|0|||
131148533|NCT01275222|472164645|FG001|Phase ll by Stratum|Death|0|||
131148534|NCT01275222|472164646|FG002|Phase ll by Stratum|Death|0|||
131148535|NCT01275222|472164647|FG003|Phase ll by Stratum|Death|0|||
130727854|NCT00025259|470625560|FG001|Overall Study|Withdrawal by Subject|27|||
130727855|NCT00025259|470625561|FG002|Overall Study|Withdrawal by Subject|6|||
130727856|NCT00025259|470625562|FG003|Overall Study|Withdrawal by Subject|14|||
130727857|NCT00025259|470625563|FG004|Overall Study|Withdrawal by Subject|11|||
130727858|NCT00025259|470625564|FG005|Overall Study|Withdrawal by Subject|8|||
130727859|NCT00025259|470625565|FG006|Overall Study|Withdrawal by Subject|3|||
130727860|NCT00025259|470625559|FG000|Overall Study|Ineligible|14|||
130727861|NCT00025259|470625560|FG001|Overall Study|Ineligible|1|||
130727862|NCT00025259|470625561|FG002|Overall Study|Ineligible|0|||
131148536|NCT01275222|472164648|FG004|Phase ll by Stratum|Death|1|||
131148537|NCT01275222|472164649|FG005|Phase ll by Stratum|Death|1|||
131148538|NCT03440944|472164650|FG000|Overall Study|Physician Decision|1|||
131148539|NCT03440944|472164651|FG001|Overall Study|Physician Decision|0|||
130727863|NCT00025259|470625562|FG003|Overall Study|Ineligible|0|||
130727864|NCT00025259|470625563|FG004|Overall Study|Ineligible|6|||
130727865|NCT00025259|470625564|FG005|Overall Study|Ineligible|0|||
130727866|NCT00025259|470625565|FG006|Overall Study|Ineligible|1|||
130727867|NCT00025259|470625559|FG000|Overall Study|Randomization error|1|||
130727868|NCT00025259|470625560|FG001|Overall Study|Randomization error|0|||
130727869|NCT00025259|470625561|FG002|Overall Study|Randomization error|0|||
131148540|NCT03440944|472164650|FG000|Overall Study|No Acceptable Vasculature|0|||
131148541|NCT03440944|472164651|FG001|Overall Study|No Acceptable Vasculature|1|||
131148542|NCT00591734|472164652|FG000|Overall Study|Lack of Efficacy|35|||
131148543|NCT00591734|472164652|FG000|Overall Study|Adverse Event|5|||
131148544|NCT00591734|472164652|FG000|Overall Study|Physician Decision|5|||
131148545|NCT00591734|472164652|FG000|Overall Study|Intercurrent Illness|8|||
131148546|NCT01661790|472164653|FG000|Overall Study|Lost to Follow-up|0|||
131148547|NCT01661790|472164654|FG001|Overall Study|Lost to Follow-up|2|||
131148548|NCT00784758|472164655|FG000|Overall Study|Withdrawal by Subject|3|||
131148549|NCT00784758|472164656|FG001|Overall Study|Withdrawal by Subject|0|||
131148550|NCT00784758|472164655|FG000|Overall Study|Adverse Event|1|||
131148551|NCT00784758|472164656|FG001|Overall Study|Adverse Event|0|||
130727870|NCT00025259|470625562|FG003|Overall Study|Randomization error|0|||
130727871|NCT00025259|470625563|FG004|Overall Study|Randomization error|1|||
130727872|NCT00025259|470625564|FG005|Overall Study|Randomization error|7|||
130727873|NCT00025259|470625565|FG006|Overall Study|Randomization error|2|||
131148552|NCT00891202|472164657|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
131148553|NCT00891202|472164658|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
131148554|NCT00891202|472164659|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
131148555|NCT00891202|472164660|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
131148556|NCT00891202|472164657|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
131148557|NCT00891202|472164658|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
131148558|NCT00891202|472164659|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
131148559|NCT00891202|472164660|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
131148560|NCT00891202|472164657|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
131148561|NCT00891202|472164658|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
131148562|NCT00891202|472164659|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
130727874|NCT00025259|470625559|FG000|Overall Study|Adverse Event|1|||
130727875|NCT00025259|470625560|FG001|Overall Study|Adverse Event|0|||
130727876|NCT00025259|470625561|FG002|Overall Study|Adverse Event|0|||
130727877|NCT00025259|470625562|FG003|Overall Study|Adverse Event|0|||
130727878|NCT00025259|470625563|FG004|Overall Study|Adverse Event|0|||
130727879|NCT00025259|470625564|FG005|Overall Study|Adverse Event|0|||
130727880|NCT00025259|470625565|FG006|Overall Study|Adverse Event|0|||
130727881|NCT01449370|470625566|FG000|Overall Study|Disease Progression|5|||
130727882|NCT01449370|470625567|FG001|Overall Study|Disease Progression|4|||
130727883|NCT01449370|470625568|FG002|Overall Study|Disease Progression|8|||
130727884|NCT01449370|470625569|FG003|Overall Study|Disease Progression|3|||
130727885|NCT01449370|470625570|FG004|Overall Study|Disease Progression|3|||
130727886|NCT01449370|470625571|FG005|Overall Study|Disease Progression|3|||
130727887|NCT01449370|470625572|FG006|Overall Study|Disease Progression|3|||
130727888|NCT01449370|470625573|FG007|Overall Study|Disease Progression|2|||
130727889|NCT01449370|470625574|FG008|Overall Study|Disease Progression|9|||
130727890|NCT01449370|470625575|FG009|Overall Study|Disease Progression|1|||
130727891|NCT01449370|470625576|FG010|Overall Study|Disease Progression|3|||
130727892|NCT01449370|470625577|FG011|Overall Study|Disease Progression|3|||
130727893|NCT01449370|470625578|FG012|Overall Study|Disease Progression|2|||
130727894|NCT01449370|470625579|FG013|Overall Study|Disease Progression|8|||
130727895|NCT01449370|470625580|FG014|Overall Study|Disease Progression|3|||
130727896|NCT01449370|470625581|FG015|Overall Study|Disease Progression|1|||
130727897|NCT01449370|470625582|FG016|Overall Study|Disease Progression|4|||
130727898|NCT01449370|470625583|FG017|Overall Study|Disease Progression|3|||
130727899|NCT01449370|470625584|FG018|Overall Study|Disease Progression|1|||
130727900|NCT01449370|470625585|FG019|Overall Study|Disease Progression|2|||
130727901|NCT01449370|470625586|FG020|Overall Study|Disease Progression|5|||
130727902|NCT01449370|470625587|FG021|Overall Study|Disease Progression|2|||
130727903|NCT01449370|470625588|FG022|Overall Study|Disease Progression|3|||
130727904|NCT01449370|470625589|FG023|Overall Study|Disease Progression|7|||
130727905|NCT01449370|470625590|FG024|Overall Study|Disease Progression|3|||
130727906|NCT01449370|470625566|FG000|Overall Study|Adverse Event|1|||
130727907|NCT01449370|470625567|FG001|Overall Study|Adverse Event|2|||
130727908|NCT01449370|470625568|FG002|Overall Study|Adverse Event|0|||
130727909|NCT01449370|470625569|FG003|Overall Study|Adverse Event|1|||
130727910|NCT01449370|470625570|FG004|Overall Study|Adverse Event|0|||
130727911|NCT01449370|470625571|FG005|Overall Study|Adverse Event|0|||
130727912|NCT01449370|470625572|FG006|Overall Study|Adverse Event|0|||
130727913|NCT01449370|470625573|FG007|Overall Study|Adverse Event|0|||
130727914|NCT01449370|470625574|FG008|Overall Study|Adverse Event|1|||
130727915|NCT01449370|470625575|FG009|Overall Study|Adverse Event|1|||
130727916|NCT01449370|470625576|FG010|Overall Study|Adverse Event|0|||
130727917|NCT01449370|470625577|FG011|Overall Study|Adverse Event|0|||
130727918|NCT01449370|470625578|FG012|Overall Study|Adverse Event|0|||
130727919|NCT01449370|470625579|FG013|Overall Study|Adverse Event|2|||
130727920|NCT01449370|470625580|FG014|Overall Study|Adverse Event|0|||
130727921|NCT01449370|470625581|FG015|Overall Study|Adverse Event|1|||
130727922|NCT01449370|470625582|FG016|Overall Study|Adverse Event|0|||
130727923|NCT01449370|470625583|FG017|Overall Study|Adverse Event|0|||
130727924|NCT01449370|470625584|FG018|Overall Study|Adverse Event|1|||
130727925|NCT01449370|470625585|FG019|Overall Study|Adverse Event|1|||
130727926|NCT01449370|470625586|FG020|Overall Study|Adverse Event|0|||
130727927|NCT01449370|470625587|FG021|Overall Study|Adverse Event|1|||
130727928|NCT01449370|470625588|FG022|Overall Study|Adverse Event|0|||
130727929|NCT01449370|470625589|FG023|Overall Study|Adverse Event|1|||
130727930|NCT01449370|470625590|FG024|Overall Study|Adverse Event|3|||
130727931|NCT01449370|470625566|FG000|Overall Study|Participant Decision|0|||
130727932|NCT01449370|470625567|FG001|Overall Study|Participant Decision|0|||
130727933|NCT01449370|470625568|FG002|Overall Study|Participant Decision|0|||
130727934|NCT01449370|470625569|FG003|Overall Study|Participant Decision|0|||
130727935|NCT01449370|470625570|FG004|Overall Study|Participant Decision|0|||
130727936|NCT01449370|470625571|FG005|Overall Study|Participant Decision|0|||
130727937|NCT01449370|470625572|FG006|Overall Study|Participant Decision|0|||
130727938|NCT01449370|470625573|FG007|Overall Study|Participant Decision|1|||
130727939|NCT01449370|470625574|FG008|Overall Study|Participant Decision|1|||
130727940|NCT01449370|470625575|FG009|Overall Study|Participant Decision|0|||
130727941|NCT01449370|470625576|FG010|Overall Study|Participant Decision|0|||
130727942|NCT01449370|470625577|FG011|Overall Study|Participant Decision|0|||
130727943|NCT01449370|470625578|FG012|Overall Study|Participant Decision|1|||
130727944|NCT01449370|470625579|FG013|Overall Study|Participant Decision|1|||
130727945|NCT01449370|470625580|FG014|Overall Study|Participant Decision|0|||
130727946|NCT01449370|470625581|FG015|Overall Study|Participant Decision|1|||
130727947|NCT01449370|470625582|FG016|Overall Study|Participant Decision|3|||
130727948|NCT01449370|470625583|FG017|Overall Study|Participant Decision|0|||
130727949|NCT01449370|470625584|FG018|Overall Study|Participant Decision|1|||
130727950|NCT01449370|470625585|FG019|Overall Study|Participant Decision|0|||
130727951|NCT01449370|470625586|FG020|Overall Study|Participant Decision|0|||
130727952|NCT01449370|470625587|FG021|Overall Study|Participant Decision|1|||
130727953|NCT01449370|470625588|FG022|Overall Study|Participant Decision|0|||
130727954|NCT01449370|470625589|FG023|Overall Study|Participant Decision|0|||
130727955|NCT01449370|470625590|FG024|Overall Study|Participant Decision|1|||
131148563|NCT00891202|472164660|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
131148564|NCT00891202|472164657|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
131148565|NCT00891202|472164658|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
131148566|NCT00891202|472164659|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
131148567|NCT00891202|472164660|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
131148568|NCT01291017|472164663|FG000|Overall Study|Lost to Follow-up|2|||
131148569|NCT01291017|472164663|FG000|Overall Study|Withdrawal by Subject|3|||
131148570|NCT06119191|472164666|FG000|Overall Study|Adverse Event|0|||
131148571|NCT06119191|472164667|FG001|Overall Study|Adverse Event|1|||
131148572|NCT06119191|472164666|FG000|Overall Study|Protocol Violation|1|||
131148573|NCT06119191|472164667|FG001|Overall Study|Protocol Violation|0|||
131148574|NCT03896581|472167176|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
131148575|NCT03896581|472167177|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
131234853|NCT02260492|472486497|FG001|Overall Study|Lost to Follow-up|9|||
131234854|NCT02260492|472486498|FG002|Overall Study|Lost to Follow-up|0|||
131234855|NCT02260492|472486496|FG000|Overall Study|Physician Decision|2|||
131234856|NCT02260492|472486497|FG001|Overall Study|Physician Decision|0|||
131234857|NCT02260492|472486498|FG002|Overall Study|Physician Decision|1|||
131148576|NCT03896581|472167176|FG000|Overall Study|Withdrawal by Subject|4|||
131148577|NCT03896581|472167177|FG001|Overall Study|Withdrawal by Subject|1|||
131148578|NCT03896581|472167176|FG000|Overall Study|Lost to Follow-up|1|||
131148579|NCT03896581|472167177|FG001|Overall Study|Lost to Follow-up|0|||
131234858|NCT02260492|472486496|FG000|Overall Study|Withdrawal by Subject|3|||
131234859|NCT02260492|472486497|FG001|Overall Study|Withdrawal by Subject|2|||
131234860|NCT02260492|472486498|FG002|Overall Study|Withdrawal by Subject|2|||
131234861|NCT03131999|472486499|FG000|Overall Study|Withdrawal by Subject|0|||
131234862|NCT03131999|472486500|FG001|Overall Study|Withdrawal by Subject|1|||
131234863|NCT00996736|472486506|FG000|Overall Study|Death|1|||
131234864|NCT00996736|472486507|FG001|Overall Study|Death|1|||
131234865|NCT00996736|472486506|FG000|Overall Study|Lost to Follow-up|15|||
131234866|NCT00996736|472486507|FG001|Overall Study|Lost to Follow-up|14|||
131234867|NCT00996736|472486506|FG000|Overall Study|Visit not within 3-month window|5|||
131234868|NCT00996736|472486507|FG001|Overall Study|Visit not within 3-month window|3|||
131234869|NCT02688608|472486508|FG000|Overall Study|Lost to Follow-up|1|||
131234870|NCT00365352|472486509|FG000|Overall Study|Adverse Event|6|||
131234871|NCT00365352|472486510|FG001|Overall Study|Adverse Event|7|||
131234872|NCT00365352|472486511|FG002|Overall Study|Adverse Event|8|||
131234873|NCT00365352|472486509|FG000|Overall Study|Participant Withdrew Consent|8|||
131234874|NCT00365352|472486510|FG001|Overall Study|Participant Withdrew Consent|3|||
131234875|NCT00365352|472486511|FG002|Overall Study|Participant Withdrew Consent|4|||
131234876|NCT00365352|472486509|FG000|Overall Study|Lack of Efficacy|3|||
131234877|NCT00365352|472486510|FG001|Overall Study|Lack of Efficacy|0|||
131234878|NCT00365352|472486511|FG002|Overall Study|Lack of Efficacy|0|||
131234879|NCT00365352|472486509|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
131234880|NCT00365352|472486510|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
131234881|NCT00365352|472486511|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
131234882|NCT00365352|472486509|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
131234883|NCT00365352|472486510|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
131234884|NCT00365352|472486511|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
131234885|NCT00365352|472486509|FG000|Overall Study|Lost to Follow-up|1|||
131234886|NCT00365352|472486510|FG001|Overall Study|Lost to Follow-up|1|||
131234887|NCT00365352|472486511|FG002|Overall Study|Lost to Follow-up|0|||
131148580|NCT03896581|472167176|FG000|Overall Study|Lack of Efficacy|2|||
131148581|NCT03896581|472167177|FG001|Overall Study|Lack of Efficacy|1|||
131148582|NCT03896581|472167176|FG000|Overall Study|Adverse event, non-fatal|0|||
131148583|NCT03896581|472167177|FG001|Overall Study|Adverse event, non-fatal|2|||
131148584|NCT01431287|472167178|FG000|Overall Study|not treated|0|||
131148585|NCT01431287|472167179|FG001|Overall Study|not treated|0|||
131148586|NCT01431287|472167180|FG002|Overall Study|not treated|1|||
131148587|NCT01431287|472167181|FG003|Overall Study|not treated|0|||
131148588|NCT01431287|472167182|FG004|Overall Study|not treated|0|||
131234888|NCT00365352|472486509|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
131234889|NCT00365352|472486510|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
131234890|NCT00365352|472486511|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
131234891|NCT00409578|472486516|FG000|Overall Study|Adverse Event|27|||
131234892|NCT00409578|472486517|FG001|Overall Study|Adverse Event|37|||
131234893|NCT00409578|472486518|FG002|Overall Study|Adverse Event|25|||
131234894|NCT00409578|472486519|FG003|Overall Study|Adverse Event|33|||
130727956|NCT01449370|470625566|FG000|Overall Study|Lost to Follow-up|0|||
130727957|NCT01449370|470625567|FG001|Overall Study|Lost to Follow-up|0|||
131148589|NCT01431287|472167178|FG000|Overall Study|Adverse Event|59|||
131148590|NCT01431287|472167179|FG001|Overall Study|Adverse Event|57|||
131148591|NCT01431287|472167180|FG002|Overall Study|Adverse Event|53|||
131148592|NCT01431287|472167181|FG003|Overall Study|Adverse Event|33|||
131148593|NCT01431287|472167182|FG004|Overall Study|Adverse Event|41|||
131148594|NCT01431287|472167178|FG000|Overall Study|Non compliant with protocol|6|||
131148595|NCT01431287|472167179|FG001|Overall Study|Non compliant with protocol|6|||
131148596|NCT01431287|472167180|FG002|Overall Study|Non compliant with protocol|5|||
131148597|NCT01431287|472167181|FG003|Overall Study|Non compliant with protocol|6|||
131148598|NCT01431287|472167182|FG004|Overall Study|Non compliant with protocol|5|||
131148599|NCT01431287|472167178|FG000|Overall Study|Lost to Follow-up|0|||
131148600|NCT01431287|472167179|FG001|Overall Study|Lost to Follow-up|3|||
131148601|NCT01431287|472167180|FG002|Overall Study|Lost to Follow-up|2|||
131148602|NCT01431287|472167181|FG003|Overall Study|Lost to Follow-up|3|||
131148603|NCT01431287|472167182|FG004|Overall Study|Lost to Follow-up|1|||
131148604|NCT01431287|472167178|FG000|Overall Study|Consent withdrawn not due to AE|29|||
131148605|NCT01431287|472167179|FG001|Overall Study|Consent withdrawn not due to AE|30|||
131148606|NCT01431287|472167180|FG002|Overall Study|Consent withdrawn not due to AE|34|||
131148607|NCT01431287|472167181|FG003|Overall Study|Consent withdrawn not due to AE|19|||
131148608|NCT01431287|472167182|FG004|Overall Study|Consent withdrawn not due to AE|29|||
131148609|NCT01431287|472167178|FG000|Overall Study|not stated above|4|||
131148610|NCT01431287|472167179|FG001|Overall Study|not stated above|2|||
131148611|NCT01431287|472167180|FG002|Overall Study|not stated above|2|||
131148612|NCT01431287|472167181|FG003|Overall Study|not stated above|2|||
131148613|NCT01431287|472167182|FG004|Overall Study|not stated above|1|||
131148614|NCT02224664|472167184|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
131148615|NCT02224664|472167185|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
131148616|NCT02224664|472167186|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
131148617|NCT02224664|472167187|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
131148618|NCT02224664|472167188|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
131148619|NCT02224664|472167184|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
131148620|NCT02224664|472167185|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
131148621|NCT02224664|472167186|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
131148622|NCT02224664|472167187|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
131148623|NCT02224664|472167188|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
131148624|NCT02224664|472167184|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
131148625|NCT02224664|472167185|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
131148626|NCT02224664|472167186|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
131148627|NCT02224664|472167187|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
131148628|NCT02224664|472167188|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
131148629|NCT00110305|472167189|FG000|Overall Study|Adverse Event|46|||
131148630|NCT00110305|472167190|FG001|Overall Study|Adverse Event|13|||
131148631|NCT00110305|472167189|FG000|Overall Study|Sponsors Decision|1|||
131148632|NCT00110305|472167190|FG001|Overall Study|Sponsors Decision|0|||
131148633|NCT00110305|472167189|FG000|Overall Study|Subject Non-Compliant|9|||
131148634|NCT00110305|472167190|FG001|Overall Study|Subject Non-Compliant|2|||
131148635|NCT00110305|472167189|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
131148636|NCT00110305|472167190|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
131148637|NCT00110305|472167189|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
131148638|NCT00110305|472167190|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
131148639|NCT00110305|472167189|FG000|Overall Study|Protocol Violation|0|||
131148640|NCT00110305|472167190|FG001|Overall Study|Protocol Violation|1|||
131148641|NCT00110305|472167189|FG000|Overall Study|Withdrawal by Subject|7|||
131148642|NCT00110305|472167190|FG001|Overall Study|Withdrawal by Subject|7|||
131148643|NCT00110305|472167189|FG000|Overall Study|Lost to Follow-up|20|||
131148644|NCT00110305|472167190|FG001|Overall Study|Lost to Follow-up|3|||
131148645|NCT00110305|472167189|FG000|Overall Study|Other|8|||
131148646|NCT00110305|472167190|FG001|Overall Study|Other|2|||
131148647|NCT05047523|472167194|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
131148648|NCT05047523|472167195|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
131148649|NCT05047523|472167196|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
131148650|NCT05047523|472167197|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
131148651|NCT05047523|472167198|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
131148652|NCT05047523|472167199|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
131148653|NCT05047523|472167194|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131148654|NCT05047523|472167195|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
131148655|NCT05047523|472167196|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131148656|NCT05047523|472167197|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131148657|NCT05047523|472167198|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131148658|NCT05047523|472167199|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
131148659|NCT05047523|472167194|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
131148660|NCT05047523|472167195|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
131148661|NCT05047523|472167196|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
131148662|NCT05047523|472167197|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
131148663|NCT05047523|472167198|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
131148664|NCT05047523|472167199|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
131148665|NCT05047523|472167194|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
131148666|NCT05047523|472167195|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131148667|NCT05047523|472167196|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131148668|NCT05047523|472167197|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131148669|NCT05047523|472167198|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131148670|NCT05047523|472167199|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
131148671|NCT05047523|472167194|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
131148672|NCT05047523|472167195|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
131148673|NCT05047523|472167196|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
131148674|NCT05047523|472167197|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
131148675|NCT05047523|472167198|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
131148676|NCT05047523|472167199|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
131148677|NCT05047523|472167194|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
131148678|NCT05047523|472167195|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
131148679|NCT05047523|472167196|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
131148680|NCT05047523|472167197|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
131148681|NCT05047523|472167198|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
131148682|NCT05047523|472167199|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
131148683|NCT03658889|472167200|FG000|Overall Study|Protocol Violation|2|||
131148684|NCT03658889|472167201|FG001|Overall Study|Protocol Violation|0|||
131148685|NCT00206726|472167211|FG000|Overall Study|Delayed recovery of blood counts|1|||
131148686|NCT00206726|472167211|FG000|Overall Study|Progressive disease or relapsed disease|18|||
131148687|NCT00206726|472167211|FG000|Overall Study|Placed on new protocol|1|||
131148688|NCT00206726|472167211|FG000|Overall Study|Bone marrow transplant|1|||
131148689|NCT00206726|472167211|FG000|Overall Study|Adverse Event|17|||
131148690|NCT00206726|472167211|FG000|Overall Study|Death|4|||
131148691|NCT00206726|472167211|FG000|Overall Study|Protocol Violation|1|||
131148692|NCT00206726|472167211|FG000|Overall Study|Withdrawal by Subject|8|||
131148693|NCT01719757|472167213|FG000|Overall Study|Adverse Event|38|||
131148694|NCT01719757|472167213|FG000|Overall Study|Withdrawal by Subject|15|||
131148695|NCT01719757|472167213|FG000|Overall Study|Lost to Follow-up|20|||
131148696|NCT01719757|472167213|FG000|Overall Study|Protocol Violation|1|||
131148697|NCT01719757|472167213|FG000|Overall Study|well controlled pain|27|||
131148698|NCT02626338|472167214|FG000|Overall Study|Lack of Efficacy|3|||
131148699|NCT02626338|472167215|FG001|Overall Study|Lack of Efficacy|2|||
131148700|NCT02626338|472167216|FG002|Overall Study|Lack of Efficacy|0|||
131148701|NCT00450580|472167222|FG000|Overall Study|Adverse Event|5|||
131148702|NCT00450580|472167223|FG001|Overall Study|Adverse Event|7|||
131148703|NCT00450580|472167222|FG000|Overall Study|Lost to Follow-up|4|||
131148704|NCT00450580|472167223|FG001|Overall Study|Lost to Follow-up|5|||
131148705|NCT00450580|472167222|FG000|Overall Study|Withdrawal by Subject|2|||
131148706|NCT00450580|472167223|FG001|Overall Study|Withdrawal by Subject|2|||
131148707|NCT00450580|472167222|FG000|Overall Study|Protocol Violation|1|||
131148708|NCT00450580|472167223|FG001|Overall Study|Protocol Violation|1|||
131148709|NCT00450580|472167222|FG000|Overall Study|Protocol-defined virologic failure|1|||
131148710|NCT00450580|472167223|FG001|Overall Study|Protocol-defined virologic failure|0|||
131148711|NCT00450580|472167222|FG000|Overall Study|Could not comply with scheduled visits|1|||
131148712|NCT00450580|472167223|FG001|Overall Study|Could not comply with scheduled visits|0|||
131148713|NCT00450580|472167222|FG000|Overall Study|Patient went to Brazil|1|||
131148714|NCT00450580|472167223|FG001|Overall Study|Patient went to Brazil|0|||
131148715|NCT00450580|472167222|FG000|Overall Study|Patient could not swallow Norvir|1|||
131148716|NCT00450580|472167223|FG001|Overall Study|Patient could not swallow Norvir|0|||
131148717|NCT00450580|472167222|FG000|Overall Study|Withdrawal due to pregnancy|0|||
131148718|NCT00450580|472167223|FG001|Overall Study|Withdrawal due to pregnancy|1|||
130727958|NCT01449370|470625568|FG002|Overall Study|Lost to Follow-up|0|||
130727959|NCT01449370|470625569|FG003|Overall Study|Lost to Follow-up|0|||
130727960|NCT01449370|470625570|FG004|Overall Study|Lost to Follow-up|0|||
130727961|NCT01449370|470625571|FG005|Overall Study|Lost to Follow-up|0|||
130727962|NCT01449370|470625572|FG006|Overall Study|Lost to Follow-up|0|||
130727963|NCT01449370|470625573|FG007|Overall Study|Lost to Follow-up|0|||
131148719|NCT01154101|472167225|FG000|Overall Study|Adverse Event|0|||
131148720|NCT01154101|472167226|FG001|Overall Study|Adverse Event|2|||
131148721|NCT01154101|472167227|FG002|Overall Study|Adverse Event|1|||
131148722|NCT01154101|472167228|FG003|Overall Study|Adverse Event|1|||
131148723|NCT01154101|472167229|FG004|Overall Study|Adverse Event|0|||
131148724|NCT01154101|472167225|FG000|Overall Study|Lost to Follow-up|0|||
131148725|NCT01154101|472167226|FG001|Overall Study|Lost to Follow-up|1|||
131148726|NCT01154101|472167227|FG002|Overall Study|Lost to Follow-up|0|||
131148727|NCT01154101|472167228|FG003|Overall Study|Lost to Follow-up|1|||
131148728|NCT01154101|472167229|FG004|Overall Study|Lost to Follow-up|0|||
131148729|NCT01154101|472167225|FG000|Overall Study|Withdrawal by Subject|0|||
131148730|NCT01154101|472167226|FG001|Overall Study|Withdrawal by Subject|1|||
131148731|NCT01154101|472167227|FG002|Overall Study|Withdrawal by Subject|2|||
131148732|NCT01154101|472167228|FG003|Overall Study|Withdrawal by Subject|0|||
131148733|NCT01154101|472167229|FG004|Overall Study|Withdrawal by Subject|1|||
131148734|NCT00393718|472167230|FG000|Overall Study|Adverse Event|20|||
131148735|NCT00393718|472167231|FG001|Overall Study|Adverse Event|8|||
131148736|NCT00393718|472167230|FG000|Overall Study|Protocol Violation|1|||
131148737|NCT00393718|472167231|FG001|Overall Study|Protocol Violation|2|||
131148738|NCT00393718|472167230|FG000|Overall Study|Lack of Efficacy|10|||
131148739|NCT00393718|472167231|FG001|Overall Study|Lack of Efficacy|9|||
131148740|NCT00393718|472167230|FG000|Overall Study|Hypoglycaemia|3|||
131148741|NCT00393718|472167231|FG001|Overall Study|Hypoglycaemia|2|||
131148742|NCT00393718|472167230|FG000|Overall Study|Subject decision|5|||
131148743|NCT00393718|472167231|FG001|Overall Study|Subject decision|0|||
131148744|NCT00393718|472167230|FG000|Overall Study|Withdrawal of consent|2|||
131148745|NCT00393718|472167231|FG001|Overall Study|Withdrawal of consent|1|||
131148746|NCT00393718|472167230|FG000|Overall Study|Missed measurement|1|||
131148747|NCT00393718|472167231|FG001|Overall Study|Missed measurement|0|||
130727964|NCT01449370|470625574|FG008|Overall Study|Lost to Follow-up|0|||
130727965|NCT01449370|470625575|FG009|Overall Study|Lost to Follow-up|0|||
130727966|NCT01449370|470625576|FG010|Overall Study|Lost to Follow-up|0|||
130727967|NCT01449370|470625577|FG011|Overall Study|Lost to Follow-up|0|||
130727968|NCT01449370|470625578|FG012|Overall Study|Lost to Follow-up|0|||
130727969|NCT01449370|470625579|FG013|Overall Study|Lost to Follow-up|0|||
130727970|NCT01449370|470625580|FG014|Overall Study|Lost to Follow-up|0|||
130727971|NCT01449370|470625581|FG015|Overall Study|Lost to Follow-up|0|||
130727972|NCT01449370|470625582|FG016|Overall Study|Lost to Follow-up|0|||
130727973|NCT01449370|470625583|FG017|Overall Study|Lost to Follow-up|0|||
130727974|NCT01449370|470625584|FG018|Overall Study|Lost to Follow-up|0|||
130727975|NCT01449370|470625585|FG019|Overall Study|Lost to Follow-up|0|||
130727976|NCT01449370|470625586|FG020|Overall Study|Lost to Follow-up|1|||
130727977|NCT01449370|470625587|FG021|Overall Study|Lost to Follow-up|0|||
130727978|NCT01449370|470625588|FG022|Overall Study|Lost to Follow-up|0|||
130727979|NCT01449370|470625589|FG023|Overall Study|Lost to Follow-up|0|||
131148748|NCT00393718|472167230|FG000|Overall Study|Move|1|||
131148749|NCT00393718|472167231|FG001|Overall Study|Move|0|||
131148750|NCT04125680|472167233|FG000|Overall Study|Lost to Follow-up|15|||
131148751|NCT01562028|472167234|FG000|Overall Study|Withdrawal by Subject|1|||
131148752|NCT01562028|472167235|FG001|Overall Study|Withdrawal by Subject|1|||
131148753|NCT01562028|472167234|FG000|Overall Study|Lost to Follow-up|2|||
131148754|NCT01562028|472167235|FG001|Overall Study|Lost to Follow-up|1|||
131148755|NCT02360098|472167236|FG000|Overall Study|Physician Decision|7|||
131148756|NCT04938648|472167241|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
131148757|NCT04938648|472167242|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
131148758|NCT04938648|472167241|FG000|Overall Study|Patient too ill|0|||
131148759|NCT04938648|472167242|FG001|Overall Study|Patient too ill|1|||
131148760|NCT04938648|472167241|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
131148761|NCT04938648|472167242|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
131148762|NCT04938648|472167241|FG000|Overall Study|Patient did not have memory problems|1|||
131148763|NCT04938648|472167242|FG001|Overall Study|Patient did not have memory problems|1|||
131148764|NCT04938648|472167241|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
131148765|NCT04938648|472167242|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
131148766|NCT04938648|472167241|FG000|Overall Study|Care partner could not be reached|0|||
131148767|NCT04938648|472167242|FG001|Overall Study|Care partner could not be reached|1|||
131148768|NCT04938648|472167241|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
131148769|NCT04938648|472167242|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
131148770|NCT04938648|472167241|FG000|Overall Study|Withdrawal by Subject|2|||
131148771|NCT04938648|472167242|FG001|Overall Study|Withdrawal by Subject|1|||
131148772|NCT03293654|472167243|FG000|Overall Study|Lost to Follow-up|0|||
131148773|NCT03293654|472167244|FG001|Overall Study|Lost to Follow-up|1|||
131148774|NCT03293654|472167245|FG002|Overall Study|Lost to Follow-up|0|||
131148775|NCT01919307|472167246|FG000|Overall Study|Withdrawal by Subject|9|||
131148776|NCT05113940|472167248|FG000|Part A (18 Days)|Adverse Event|0|||
131148777|NCT05113940|472167249|FG001|Part A (18 Days)|Adverse Event|0|||
131148778|NCT05113940|472167250|FG002|Part A (18 Days)|Adverse Event|1|||
131234895|NCT00409578|472486516|FG000|Overall Study|Abnormal laboratory value(s)|2|||
130727980|NCT01449370|470625590|FG024|Overall Study|Lost to Follow-up|0|||
130727981|NCT01449370|470625566|FG000|Overall Study|Other|0|||
130727982|NCT01449370|470625567|FG001|Overall Study|Other|0|||
131148779|NCT05113940|472167251|FG003|Part A (18 Days)|Adverse Event|1|||
131148780|NCT05113940|472167252|FG004|Part A (18 Days)|Adverse Event|1|||
131148781|NCT05113940|472167253|FG005|Part A (18 Days)|Adverse Event|0|||
131234896|NCT00409578|472486517|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130727983|NCT01449370|470625568|FG002|Overall Study|Other|0|||
130727984|NCT01449370|470625569|FG003|Overall Study|Other|0|||
130727985|NCT01449370|470625570|FG004|Overall Study|Other|0|||
130727986|NCT01449370|470625571|FG005|Overall Study|Other|0|||
130727987|NCT01449370|470625572|FG006|Overall Study|Other|0|||
131148782|NCT05113940|472167254|FG006|Part A (18 Days)|Adverse Event|0|||
131148783|NCT05113940|472167255|FG007|Part A (18 Days)|Adverse Event|0|||
130727988|NCT01449370|470625573|FG007|Overall Study|Other|0|||
130727989|NCT01449370|470625574|FG008|Overall Study|Other|1|||
131148784|NCT05113940|472167256|FG008|Part A (18 Days)|Adverse Event|0|||
131148785|NCT05113940|472167257|FG009|Part A (18 Days)|Adverse Event|0|||
131148786|NCT05113940|472167258|FG010|Part A (18 Days)|Adverse Event|0|||
131148787|NCT05113940|472167259|FG011|Part A (18 Days)|Adverse Event|2|||
131148788|NCT05113940|472167260|FG012|Part A (18 Days)|Adverse Event|0|||
131148789|NCT05113940|472167261|FG013|Part A (18 Days)|Adverse Event|0|||
131148790|NCT05113940|472167262|FG014|Part A (18 Days)|Adverse Event|0|||
131148791|NCT05113940|472167248|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148792|NCT05113940|472167249|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148793|NCT05113940|472167250|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148794|NCT05113940|472167251|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148795|NCT05113940|472167252|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148796|NCT05113940|472167253|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148797|NCT05113940|472167254|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148798|NCT05113940|472167255|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148799|NCT05113940|472167256|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148800|NCT05113940|472167257|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148801|NCT05113940|472167258|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148802|NCT05113940|472167259|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148803|NCT05113940|472167260|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148804|NCT05113940|472167261|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
131148805|NCT05113940|472167262|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
131148806|NCT02542267|472167263|FG000|Overall Study|Withdrawal by Subject|10|||
131148807|NCT02542267|472167263|FG000|Overall Study|Physician Decision|6|||
131148808|NCT02542267|472167263|FG000|Overall Study|Lost to Follow-up|4|||
131148809|NCT02542267|472167263|FG000|Overall Study|Death|13|||
131148810|NCT02542267|472167263|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
131148811|NCT02542267|472167263|FG000|Overall Study|Other|9|||
131148812|NCT01355289|472167264|FG000|Core Study|Adverse Event, Non-Fatal|1|||
131148813|NCT01355289|472167265|FG001|Core Study|Adverse Event, Non-Fatal|0|||
131148814|NCT01355289|472167266|FG002|Core Study|Adverse Event, Non-Fatal|0|||
131148815|NCT01355289|472167267|FG003|Core Study|Adverse Event, Non-Fatal|0|||
131148816|NCT01355289|472167268|FG004|Core Study|Adverse Event, Non-Fatal|0|||
131148817|NCT01355289|472167264|FG000|Core Study|Inadequate Therapeutic Effect|0|||
131148818|NCT01355289|472167265|FG001|Core Study|Inadequate Therapeutic Effect|0|||
131148819|NCT01355289|472167266|FG002|Core Study|Inadequate Therapeutic Effect|0|||
131148820|NCT01355289|472167267|FG003|Core Study|Inadequate Therapeutic Effect|1|||
131148821|NCT01355289|472167268|FG004|Core Study|Inadequate Therapeutic Effect|0|||
131148822|NCT01355289|472167264|FG000|Core Study|Other|0|||
131148823|NCT01355289|472167265|FG001|Core Study|Other|0|||
131148824|NCT01355289|472167266|FG002|Core Study|Other|0|||
131148825|NCT01355289|472167267|FG003|Core Study|Other|1|||
131148826|NCT01355289|472167268|FG004|Core Study|Other|0|||
131148827|NCT01355289|472167264|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
131148828|NCT01355289|472167265|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
131148829|NCT01355289|472167266|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
131148830|NCT01355289|472167267|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
131148831|NCT01355289|472167268|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
131148832|NCT01355289|472167264|FG000|Open Label Extension|Lost to Follow-up|0|||
131148833|NCT01355289|472167265|FG001|Open Label Extension|Lost to Follow-up|0|||
131148834|NCT01355289|472167266|FG002|Open Label Extension|Lost to Follow-up|0|||
131148835|NCT01355289|472167267|FG003|Open Label Extension|Lost to Follow-up|0|||
131148836|NCT01355289|472167268|FG004|Open Label Extension|Lost to Follow-up|1|||
131148837|NCT01355289|472167264|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
131148838|NCT01355289|472167265|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
131148839|NCT01355289|472167266|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
131148840|NCT01355289|472167267|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
131148841|NCT01355289|472167268|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
131148842|NCT01355289|472167264|FG000|Open Label Extension|Other|0|||
131148843|NCT01355289|472167265|FG001|Open Label Extension|Other|0|||
131148844|NCT01355289|472167266|FG002|Open Label Extension|Other|0|||
131148845|NCT01355289|472167267|FG003|Open Label Extension|Other|0|||
131148846|NCT01355289|472167268|FG004|Open Label Extension|Other|3|||
131148847|NCT01085682|472167269|FG000|Overall Study|Withdrawal by Subject|25|||
131148848|NCT01085682|472167270|FG001|Overall Study|Withdrawal by Subject|25|||
131148849|NCT01451645|472167271|FG000|Overall Study|Protocol Violation|1|||
131148850|NCT01451645|472167272|FG001|Overall Study|Protocol Violation|0|||
131148851|NCT01451645|472167271|FG000|Overall Study|Adverse Event|0|||
131148852|NCT01451645|472167272|FG001|Overall Study|Adverse Event|3|||
131148853|NCT01451645|472167271|FG000|Overall Study|Withdrawal by Subject|4|||
131148854|NCT01451645|472167272|FG001|Overall Study|Withdrawal by Subject|2|||
131148855|NCT01451645|472167271|FG000|Overall Study|Lost to Follow-up|4|||
131148856|NCT01451645|472167272|FG001|Overall Study|Lost to Follow-up|3|||
131148857|NCT02207907|472167283|FG000|Overall Study|Lost to Follow-up|3|||
131148858|NCT02207907|472167284|FG001|Overall Study|Lost to Follow-up|1|||
131148859|NCT02207907|472167283|FG000|Overall Study|Withdrawal by Subject|5|||
131148860|NCT02207907|472167284|FG001|Overall Study|Withdrawal by Subject|6|||
131148861|NCT02207907|472167283|FG000|Overall Study|Did not meet study criteria|3|||
131148862|NCT02207907|472167284|FG001|Overall Study|Did not meet study criteria|0|||
131148863|NCT02207907|472167283|FG000|Overall Study|Pregnancy|0|||
131148864|NCT02207907|472167284|FG001|Overall Study|Pregnancy|1|||
131148865|NCT00158184|472167285|FG000|Overall Study|personal issues|3|||
130727990|NCT01449370|470625575|FG009|Overall Study|Other|1|||
130727991|NCT01449370|470625576|FG010|Overall Study|Other|0|||
130727992|NCT01449370|470625577|FG011|Overall Study|Other|0|||
130727993|NCT01449370|470625578|FG012|Overall Study|Other|0|||
130727994|NCT01449370|470625579|FG013|Overall Study|Other|0|||
130727995|NCT01449370|470625580|FG014|Overall Study|Other|0|||
130727996|NCT01449370|470625581|FG015|Overall Study|Other|0|||
131148866|NCT00158184|472167286|FG001|Overall Study|personal issues|1|||
131148867|NCT00158184|472167285|FG000|Overall Study|failed for follow unit/study rules|2|||
131148868|NCT00158184|472167286|FG001|Overall Study|failed for follow unit/study rules|0|||
130727997|NCT01449370|470625582|FG016|Overall Study|Other|0|||
131148869|NCT00158184|472167285|FG000|Overall Study|Adverse Event|1|||
131148870|NCT00158184|472167286|FG001|Overall Study|Adverse Event|1|||
131148871|NCT05340504|472167287|FG000|Overall Study|Withdrawal by Subject|1|||
131148872|NCT05340504|472167288|FG001|Overall Study|Withdrawal by Subject|0|||
131148873|NCT02620020|472167289|FG000|Overall Study|Adverse Event|8|||
131148874|NCT02620020|472167290|FG001|Overall Study|Adverse Event|4|||
131148875|NCT02620020|472167291|FG002|Overall Study|Adverse Event|3|||
131148876|NCT02620020|472167292|FG003|Overall Study|Adverse Event|5|||
131148877|NCT02620020|472167289|FG000|Overall Study|Lost to Follow-up|4|||
131148878|NCT02620020|472167290|FG001|Overall Study|Lost to Follow-up|8|||
131148879|NCT02620020|472167291|FG002|Overall Study|Lost to Follow-up|1|||
131148880|NCT02620020|472167292|FG003|Overall Study|Lost to Follow-up|4|||
131148881|NCT02620020|472167289|FG000|Overall Study|Physician Decision|7|||
131148882|NCT02620020|472167290|FG001|Overall Study|Physician Decision|4|||
131148883|NCT02620020|472167291|FG002|Overall Study|Physician Decision|3|||
131148884|NCT02620020|472167292|FG003|Overall Study|Physician Decision|4|||
131148885|NCT02620020|472167289|FG000|Overall Study|Protocol Violation|5|||
131148886|NCT02620020|472167290|FG001|Overall Study|Protocol Violation|2|||
131148887|NCT02620020|472167291|FG002|Overall Study|Protocol Violation|1|||
131148888|NCT02620020|472167292|FG003|Overall Study|Protocol Violation|1|||
131148889|NCT02620020|472167289|FG000|Overall Study|Withdrawal by Subject|20|||
131148890|NCT02620020|472167290|FG001|Overall Study|Withdrawal by Subject|16|||
131148891|NCT02620020|472167291|FG002|Overall Study|Withdrawal by Subject|17|||
131148892|NCT02620020|472167292|FG003|Overall Study|Withdrawal by Subject|12|||
131148893|NCT02620020|472167289|FG000|Overall Study|Death|0|||
131148894|NCT02620020|472167290|FG001|Overall Study|Death|1|||
131148895|NCT02620020|472167291|FG002|Overall Study|Death|0|||
131148896|NCT02620020|472167292|FG003|Overall Study|Death|0|||
131148897|NCT02393209|472167295|FG000|Overall Study|Study Terminated by Sponsor|1|||
131148898|NCT02393209|472167296|FG001|Overall Study|Study Terminated by Sponsor|1|||
131148899|NCT02393209|472167297|FG002|Overall Study|Study Terminated by Sponsor|0|||
131148900|NCT02393209|472167298|FG003|Overall Study|Study Terminated by Sponsor|0|||
131148901|NCT02393209|472167295|FG000|Overall Study|Withdrawal by Patient|1|||
131148902|NCT02393209|472167296|FG001|Overall Study|Withdrawal by Patient|0|||
131148903|NCT02393209|472167297|FG002|Overall Study|Withdrawal by Patient|0|||
131148904|NCT02393209|472167298|FG003|Overall Study|Withdrawal by Patient|0|||
131148905|NCT02393209|472167295|FG000|Overall Study|Death|2|||
131148906|NCT02393209|472167296|FG001|Overall Study|Death|2|||
131148907|NCT02393209|472167297|FG002|Overall Study|Death|0|||
131148908|NCT02393209|472167298|FG003|Overall Study|Death|0|||
131148909|NCT02393209|472167295|FG000|Overall Study|Death due to Disease Progression|2|||
131148910|NCT02393209|472167296|FG001|Overall Study|Death due to Disease Progression|2|||
131148911|NCT02393209|472167297|FG002|Overall Study|Death due to Disease Progression|0|||
131148912|NCT02393209|472167298|FG003|Overall Study|Death due to Disease Progression|0|||
130727998|NCT01449370|470625583|FG017|Overall Study|Other|0|||
130727999|NCT01449370|470625584|FG018|Overall Study|Other|0|||
131148913|NCT02393209|472167295|FG000|Overall Study|Death from Legionella Infection|0|||
131148914|NCT02393209|472167296|FG001|Overall Study|Death from Legionella Infection|1|||
131148915|NCT02393209|472167297|FG002|Overall Study|Death from Legionella Infection|0|||
131148916|NCT02393209|472167298|FG003|Overall Study|Death from Legionella Infection|0|||
131148917|NCT02393209|472167295|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
130728000|NCT01449370|470625585|FG019|Overall Study|Other|0|||
130728001|NCT01449370|470625586|FG020|Overall Study|Other|0|||
130728002|NCT01449370|470625587|FG021|Overall Study|Other|0|||
130728003|NCT01449370|470625588|FG022|Overall Study|Other|1|||
130728004|NCT01449370|470625589|FG023|Overall Study|Other|1|||
131148918|NCT02393209|472167296|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
131148919|NCT02393209|472167297|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
131148920|NCT02393209|472167298|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
131148921|NCT02393209|472167295|FG000|Overall Study|Lost to Follow-up|0|||
131148922|NCT02393209|472167296|FG001|Overall Study|Lost to Follow-up|1|||
131148923|NCT02393209|472167297|FG002|Overall Study|Lost to Follow-up|0|||
131148924|NCT02393209|472167298|FG003|Overall Study|Lost to Follow-up|0|||
131148925|NCT00755079|472167299|FG000|Overall Study|Lost to Follow-up|1|||
131148926|NCT00755079|472167300|FG001|Overall Study|Lost to Follow-up|3|||
131148927|NCT00755079|472167299|FG000|Overall Study|Adverse Event|0|||
131148928|NCT00755079|472167300|FG001|Overall Study|Adverse Event|1|||
131148929|NCT00755079|472167299|FG000|Overall Study|Withdrawal by Subject|0|||
131148930|NCT00755079|472167300|FG001|Overall Study|Withdrawal by Subject|2|||
131148931|NCT01709331|472167303|FG000|Overall Study|Adverse Event|1|||
131148932|NCT03896295|472167306|FG000|Overall Study|Adverse Event|0|||
131148933|NCT03896295|472167307|FG001|Overall Study|Adverse Event|1|||
131148934|NCT03896295|472167306|FG000|Overall Study|COVID-19|7|||
131148935|NCT03896295|472167307|FG001|Overall Study|COVID-19|29|||
131148936|NCT00700804|472167308|FG000|Overall Study|Withdrawal by Subject|1|||
131148937|NCT00700804|472167309|FG001|Overall Study|Withdrawal by Subject|2|||
131148938|NCT00700804|472167308|FG000|Overall Study|Protocol Violation|1|||
131148939|NCT00700804|472167309|FG001|Overall Study|Protocol Violation|1|||
131148940|NCT00700804|472167308|FG000|Overall Study|Loose Stools|1|||
131148941|NCT00700804|472167309|FG001|Overall Study|Loose Stools|1|||
131148942|NCT02500537|472167310|FG000|Overall Study|Death|2|||
131148943|NCT02500537|472167311|FG001|Overall Study|Death|0|||
131148944|NCT02500537|472167310|FG000|Overall Study|Lost to Follow-up|0|||
131148945|NCT02500537|472167311|FG001|Overall Study|Lost to Follow-up|1|||
131148946|NCT02500537|472167310|FG000|Overall Study|Withdrawal by Subject|1|||
131148947|NCT02500537|472167311|FG001|Overall Study|Withdrawal by Subject|0|||
131148948|NCT02875223|472167316|FG000|Overall Study|Other reasons|0|||
131148949|NCT02875223|472167317|FG001|Overall Study|Other reasons|0|||
131148950|NCT02875223|472167318|FG002|Overall Study|Other reasons|1|||
131148951|NCT02875223|472167319|FG003|Overall Study|Other reasons|0|||
131148952|NCT02875223|472167320|FG004|Overall Study|Other reasons|1|||
131148953|NCT02875223|472167321|FG005|Overall Study|Other reasons|2|||
131148954|NCT02875223|472167322|FG006|Overall Study|Other reasons|0|||
131148955|NCT02875223|472167323|FG007|Overall Study|Other reasons|2|||
131148956|NCT02875223|472167324|FG008|Overall Study|Other reasons|0|||
131148957|NCT02875223|472167325|FG009|Overall Study|Other reasons|0|||
131148958|NCT02875223|472167326|FG010|Overall Study|Other reasons|0|||
131148959|NCT02875223|472167327|FG011|Overall Study|Other reasons|0|||
131148960|NCT02875223|472167328|FG012|Overall Study|Other reasons|0|||
131148961|NCT02875223|472167316|FG000|Overall Study|Withdrawal by Subject|0|||
131148962|NCT02875223|472167317|FG001|Overall Study|Withdrawal by Subject|0|||
131148963|NCT02875223|472167318|FG002|Overall Study|Withdrawal by Subject|0|||
131148964|NCT02875223|472167319|FG003|Overall Study|Withdrawal by Subject|0|||
131148965|NCT02875223|472167320|FG004|Overall Study|Withdrawal by Subject|1|||
131148966|NCT02875223|472167321|FG005|Overall Study|Withdrawal by Subject|1|||
131148967|NCT02875223|472167322|FG006|Overall Study|Withdrawal by Subject|0|||
131148968|NCT02875223|472167323|FG007|Overall Study|Withdrawal by Subject|0|||
131148969|NCT02875223|472167324|FG008|Overall Study|Withdrawal by Subject|1|||
131148970|NCT02875223|472167325|FG009|Overall Study|Withdrawal by Subject|0|||
131148971|NCT02875223|472167326|FG010|Overall Study|Withdrawal by Subject|0|||
131148972|NCT02875223|472167327|FG011|Overall Study|Withdrawal by Subject|0|||
131148973|NCT02875223|472167328|FG012|Overall Study|Withdrawal by Subject|0|||
130780311|NCT01691378|470821498|FG001|Overall Study|Withdrawal by Subject|0|||
130780312|NCT01691378|470821497|FG000|Overall Study|Lost to Follow-up|5|||
131148974|NCT02875223|472167316|FG000|Overall Study|Progressive disease|0|||
131148975|NCT02875223|472167317|FG001|Overall Study|Progressive disease|0|||
131148976|NCT02875223|472167318|FG002|Overall Study|Progressive disease|1|||
131148977|NCT02875223|472167319|FG003|Overall Study|Progressive disease|0|||
131148978|NCT02875223|472167320|FG004|Overall Study|Progressive disease|0|||
131148979|NCT02875223|472167321|FG005|Overall Study|Progressive disease|0|||
131148980|NCT02875223|472167322|FG006|Overall Study|Progressive disease|0|||
131148981|NCT02875223|472167323|FG007|Overall Study|Progressive disease|0|||
131148982|NCT02875223|472167324|FG008|Overall Study|Progressive disease|0|||
131148983|NCT02875223|472167325|FG009|Overall Study|Progressive disease|12|||
131148984|NCT02875223|472167326|FG010|Overall Study|Progressive disease|2|||
131148985|NCT02875223|472167327|FG011|Overall Study|Progressive disease|3|||
131148986|NCT02875223|472167328|FG012|Overall Study|Progressive disease|6|||
131148987|NCT02875223|472167316|FG000|Overall Study|Death|4|||
131148988|NCT02875223|472167317|FG001|Overall Study|Death|4|||
131148989|NCT02875223|472167318|FG002|Overall Study|Death|3|||
131148990|NCT02875223|472167319|FG003|Overall Study|Death|4|||
131148991|NCT02875223|472167320|FG004|Overall Study|Death|2|||
131148992|NCT02875223|472167321|FG005|Overall Study|Death|3|||
131234897|NCT00409578|472486518|FG002|Overall Study|Abnormal laboratory value(s)|2|||
131234898|NCT00409578|472486519|FG003|Overall Study|Abnormal laboratory value(s)|4|||
131148993|NCT02875223|472167322|FG006|Overall Study|Death|5|||
131148994|NCT02875223|472167323|FG007|Overall Study|Death|7|||
131148995|NCT02875223|472167324|FG008|Overall Study|Death|3|||
131148996|NCT02875223|472167325|FG009|Overall Study|Death|2|||
131148997|NCT02875223|472167326|FG010|Overall Study|Death|0|||
131148998|NCT02875223|472167327|FG011|Overall Study|Death|0|||
131148999|NCT02875223|472167328|FG012|Overall Study|Death|0|||
131149000|NCT02875223|472167316|FG000|Overall Study|Lost to Follow-up|0|||
131149001|NCT02875223|472167317|FG001|Overall Study|Lost to Follow-up|1|||
130728005|NCT01449370|470625590|FG024|Overall Study|Other|0|||
130728006|NCT01449370|470625566|FG000|Overall Study|Medication Prohibited by Protocol|0|||
130728007|NCT01449370|470625567|FG001|Overall Study|Medication Prohibited by Protocol|0|||
131149002|NCT02875223|472167318|FG002|Overall Study|Lost to Follow-up|1|||
131149003|NCT02875223|472167319|FG003|Overall Study|Lost to Follow-up|0|||
131149004|NCT02875223|472167320|FG004|Overall Study|Lost to Follow-up|1|||
131149005|NCT02875223|472167321|FG005|Overall Study|Lost to Follow-up|0|||
131149006|NCT02875223|472167322|FG006|Overall Study|Lost to Follow-up|1|||
131149007|NCT02875223|472167323|FG007|Overall Study|Lost to Follow-up|1|||
131149008|NCT02875223|472167324|FG008|Overall Study|Lost to Follow-up|0|||
131149009|NCT02875223|472167325|FG009|Overall Study|Lost to Follow-up|0|||
131149010|NCT02875223|472167326|FG010|Overall Study|Lost to Follow-up|0|||
131149011|NCT02875223|472167327|FG011|Overall Study|Lost to Follow-up|0|||
131149012|NCT02875223|472167328|FG012|Overall Study|Lost to Follow-up|0|||
131149013|NCT01707992|472167331|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
131149014|NCT01707992|472167332|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
131149015|NCT01707992|472167333|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
131149016|NCT01707992|472167334|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
131149017|NCT01707992|472167335|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
131149018|NCT01707992|472167336|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
131149019|NCT01707992|472167331|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
131149020|NCT01707992|472167332|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
131149021|NCT01707992|472167333|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
131149022|NCT01707992|472167334|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
131149023|NCT01707992|472167335|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
131149024|NCT01707992|472167336|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
131149025|NCT01707992|472167331|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
131149026|NCT01707992|472167332|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
131149027|NCT01707992|472167333|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
131149028|NCT01707992|472167334|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
131149029|NCT01707992|472167335|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
131149030|NCT01707992|472167336|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
131149031|NCT01707992|472167331|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
131149032|NCT01707992|472167332|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
131149033|NCT01707992|472167333|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
131149034|NCT01707992|472167334|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
131149035|NCT01707992|472167335|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
131149036|NCT01707992|472167336|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
131149037|NCT01707992|472167331|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
131149038|NCT01707992|472167332|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
131149039|NCT01707992|472167333|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
131149040|NCT01707992|472167334|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
131149041|NCT01707992|472167335|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
131149042|NCT01707992|472167336|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
131149043|NCT01707992|472167331|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
131149044|NCT01707992|472167332|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
131149045|NCT01707992|472167333|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
131149046|NCT01707992|472167334|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
131149047|NCT01707992|472167335|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
131149048|NCT01707992|472167336|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
131149049|NCT01707992|472167331|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
131149050|NCT01707992|472167332|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
131149051|NCT01707992|472167333|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
131149052|NCT01707992|472167334|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
131149053|NCT01707992|472167335|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
131149054|NCT01707992|472167336|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
131149055|NCT01707992|472167331|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
131149056|NCT01707992|472167332|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
131149057|NCT01707992|472167333|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
131149058|NCT01707992|472167334|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
131149059|NCT01707992|472167335|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
130728008|NCT01449370|470625568|FG002|Overall Study|Medication Prohibited by Protocol|0|||
130728009|NCT01449370|470625569|FG003|Overall Study|Medication Prohibited by Protocol|0|||
130728010|NCT01449370|470625570|FG004|Overall Study|Medication Prohibited by Protocol|0|||
130728011|NCT01449370|470625571|FG005|Overall Study|Medication Prohibited by Protocol|0|||
130728012|NCT01449370|470625572|FG006|Overall Study|Medication Prohibited by Protocol|0|||
130728013|NCT01449370|470625573|FG007|Overall Study|Medication Prohibited by Protocol|0|||
131149060|NCT01707992|472167336|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
131149061|NCT01707992|472167331|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
131149062|NCT01707992|472167332|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
131149063|NCT01707992|472167333|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
131149064|NCT01707992|472167334|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
131149065|NCT01707992|472167335|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
131149066|NCT01707992|472167336|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
131149067|NCT01707992|472167331|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
131149068|NCT01707992|472167332|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
131149069|NCT01707992|472167333|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
131149070|NCT01707992|472167334|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
131149071|NCT01707992|472167335|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
131149072|NCT01707992|472167336|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
131149073|NCT01707992|472167331|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
131149074|NCT01707992|472167332|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
131149075|NCT01707992|472167333|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
131149076|NCT01707992|472167334|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
131149077|NCT01707992|472167335|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
131149078|NCT01707992|472167336|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
131149079|NCT01707992|472167331|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
131149080|NCT01707992|472167332|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
131149081|NCT01707992|472167333|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
131149082|NCT01707992|472167334|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
131149083|NCT01707992|472167335|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
131149084|NCT01707992|472167336|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
131149085|NCT01707992|472167331|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
131149086|NCT01707992|472167332|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
131149087|NCT01707992|472167333|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
131149088|NCT01707992|472167334|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
131149089|NCT01707992|472167335|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
131149090|NCT01707992|472167336|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
131149091|NCT01707992|472167331|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
131149092|NCT01707992|472167332|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
131149093|NCT01707992|472167333|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
130728014|NCT01449370|470625574|FG008|Overall Study|Medication Prohibited by Protocol|0|||
131149094|NCT01707992|472167334|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
131149095|NCT01707992|472167335|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
131149096|NCT01707992|472167336|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
131149097|NCT01707992|472167331|FG000|Active Treatment Phase (24 Months)|Death|0|||
131149098|NCT01707992|472167332|FG001|Active Treatment Phase (24 Months)|Death|0|||
131149099|NCT01707992|472167333|FG002|Active Treatment Phase (24 Months)|Death|0|||
131149100|NCT01707992|472167334|FG003|Active Treatment Phase (24 Months)|Death|2|||
131149101|NCT01707992|472167335|FG004|Active Treatment Phase (24 Months)|Death|0|||
131149102|NCT01707992|472167336|FG005|Active Treatment Phase (24 Months)|Death|0|||
131149103|NCT01707992|472167331|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
131149104|NCT01707992|472167332|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
131149105|NCT01707992|472167333|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
131149106|NCT01707992|472167334|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
131149107|NCT01707992|472167335|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
131149108|NCT01707992|472167336|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
131149109|NCT01707992|472167331|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
131149110|NCT01707992|472167332|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
131149111|NCT01707992|472167333|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
131149112|NCT01707992|472167334|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
131149113|NCT01707992|472167335|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
131149114|NCT01707992|472167336|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
131149115|NCT01707992|472167331|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
131149116|NCT01707992|472167332|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
131149117|NCT01707992|472167333|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
131149118|NCT01707992|472167334|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
131149119|NCT01707992|472167335|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
131234899|NCT00409578|472486516|FG000|Overall Study|Lack of Efficacy|0|||
130728015|NCT01449370|470625575|FG009|Overall Study|Medication Prohibited by Protocol|0|||
130728016|NCT01449370|470625576|FG010|Overall Study|Medication Prohibited by Protocol|0|||
131149120|NCT01707992|472167336|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
131149121|NCT01707992|472167331|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
131149122|NCT01707992|472167332|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
131149123|NCT01707992|472167333|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
131149124|NCT01707992|472167334|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
131149125|NCT01707992|472167335|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
131149126|NCT01707992|472167336|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
131149127|NCT02654002|472167338|FG000|Overall Study|Adverse Event|0|||
131149128|NCT02654002|472167339|FG001|Overall Study|Adverse Event|0|||
131149129|NCT02654002|472167340|FG002|Overall Study|Adverse Event|0|||
131149130|NCT02654002|472167341|FG003|Overall Study|Adverse Event|0|||
131149131|NCT02654002|472167342|FG004|Overall Study|Adverse Event|0|||
131149132|NCT02654002|472167343|FG005|Overall Study|Adverse Event|0|||
131149133|NCT02654002|472167344|FG006|Overall Study|Adverse Event|1|||
131149134|NCT02654002|472167345|FG007|Overall Study|Adverse Event|0|||
131149135|NCT02654002|472167346|FG008|Overall Study|Adverse Event|0|||
131149136|NCT02654002|472167338|FG000|Overall Study|Withdrew Consent|0|||
131149137|NCT02654002|472167339|FG001|Overall Study|Withdrew Consent|0|||
131149138|NCT02654002|472167340|FG002|Overall Study|Withdrew Consent|0|||
131149139|NCT02654002|472167341|FG003|Overall Study|Withdrew Consent|0|||
131149140|NCT02654002|472167342|FG004|Overall Study|Withdrew Consent|0|||
131149141|NCT02654002|472167343|FG005|Overall Study|Withdrew Consent|1|||
131149142|NCT02654002|472167344|FG006|Overall Study|Withdrew Consent|0|||
131149143|NCT02654002|472167345|FG007|Overall Study|Withdrew Consent|1|||
131149144|NCT02654002|472167346|FG008|Overall Study|Withdrew Consent|0|||
131149145|NCT03313050|472167348|FG000|Stage 2: 12 Months|Adverse Event|0|||
131149146|NCT03313050|472167349|FG001|Stage 2: 12 Months|Adverse Event|0|||
131149147|NCT03313050|472167350|FG002|Stage 2: 12 Months|Adverse Event|0|||
131149148|NCT03313050|472167351|FG003|Stage 2: 12 Months|Adverse Event|1|||
131149149|NCT03313050|472167348|FG000|Stage 2: 12 Months|Death|0|||
131149150|NCT03313050|472167349|FG001|Stage 2: 12 Months|Death|0|||
131149151|NCT03313050|472167350|FG002|Stage 2: 12 Months|Death|3|||
131149152|NCT03313050|472167351|FG003|Stage 2: 12 Months|Death|0|||
131149153|NCT03313050|472167348|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
131149154|NCT03313050|472167349|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
131149155|NCT03313050|472167350|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
131149156|NCT03313050|472167351|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
131149157|NCT03313050|472167348|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
131149158|NCT03313050|472167349|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
131149159|NCT03313050|472167350|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
131149160|NCT03313050|472167351|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
131149161|NCT03313050|472167348|FG000|Stage 2: 12 Months|Protocol deviation|0|||
131149162|NCT03313050|472167349|FG001|Stage 2: 12 Months|Protocol deviation|0|||
131149163|NCT03313050|472167350|FG002|Stage 2: 12 Months|Protocol deviation|7|||
131149164|NCT03313050|472167351|FG003|Stage 2: 12 Months|Protocol deviation|7|||
131149165|NCT03313050|472167348|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
131149166|NCT03313050|472167349|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
131149167|NCT03313050|472167350|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
131149168|NCT03313050|472167351|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
131149169|NCT03313050|472167348|FG000|Stage 2: 12 Months|Other|0|||
131149170|NCT03313050|472167349|FG001|Stage 2: 12 Months|Other|0|||
131149171|NCT03313050|472167350|FG002|Stage 2: 12 Months|Other|0|||
131149172|NCT03313050|472167351|FG003|Stage 2: 12 Months|Other|1|||
131149173|NCT04211337|472167352|FG000|Overall Study|On Treatment|175|||
131149174|NCT04211337|472167353|FG001|Overall Study|On Treatment|40|||
131149175|NCT04211337|472167352|FG000|Overall Study|Withdrawal by Subject|0|||
131149176|NCT04211337|472167353|FG001|Overall Study|Withdrawal by Subject|2|||
131149177|NCT02848833|472167362|FG000|Overall Study|subject who are duplicated|1|||
131149178|NCT02848833|472167362|FG000|Overall Study|have not taken the study drug|11|||
131149179|NCT02848833|472167362|FG000|Overall Study|follow-up failure|6|||
131149180|NCT02848833|472167362|FG000|Overall Study|Protocol Violation|119|||
131149181|NCT02847598|472167363|FG000|Overall Study|Adverse Event|0|||
131149182|NCT02847598|472167364|FG001|Overall Study|Adverse Event|0|||
131149183|NCT02847598|472167365|FG002|Overall Study|Adverse Event|0|||
131149184|NCT02847598|472167366|FG003|Overall Study|Adverse Event|0|||
131149185|NCT02847598|472167367|FG004|Overall Study|Adverse Event|0|||
131149186|NCT02847598|472167368|FG005|Overall Study|Adverse Event|0|||
131149187|NCT02847598|472167369|FG006|Overall Study|Adverse Event|0|||
131149188|NCT02847598|472167370|FG007|Overall Study|Adverse Event|1|||
131149189|NCT02847598|472167363|FG000|Overall Study|Consent withdrawn|2|||
131149190|NCT02847598|472167364|FG001|Overall Study|Consent withdrawn|0|||
131149191|NCT02847598|472167365|FG002|Overall Study|Consent withdrawn|0|||
131149192|NCT02847598|472167366|FG003|Overall Study|Consent withdrawn|4|||
131149193|NCT02847598|472167367|FG004|Overall Study|Consent withdrawn|3|||
131149194|NCT02847598|472167368|FG005|Overall Study|Consent withdrawn|2|||
131149195|NCT02847598|472167369|FG006|Overall Study|Consent withdrawn|1|||
131149196|NCT02847598|472167370|FG007|Overall Study|Consent withdrawn|3|||
131149197|NCT02847598|472167363|FG000|Overall Study|Death|3|||
131149198|NCT02847598|472167364|FG001|Overall Study|Death|0|||
131149199|NCT02847598|472167365|FG002|Overall Study|Death|0|||
131149200|NCT02847598|472167366|FG003|Overall Study|Death|0|||
131149201|NCT02847598|472167367|FG004|Overall Study|Death|0|||
131149202|NCT02847598|472167368|FG005|Overall Study|Death|0|||
131149203|NCT02847598|472167369|FG006|Overall Study|Death|0|||
131149204|NCT02847598|472167370|FG007|Overall Study|Death|0|||
131149205|NCT02847598|472167363|FG000|Overall Study|Lost to Follow-up|0|||
131149206|NCT02847598|472167364|FG001|Overall Study|Lost to Follow-up|0|||
131149207|NCT02847598|472167365|FG002|Overall Study|Lost to Follow-up|0|||
131149208|NCT02847598|472167366|FG003|Overall Study|Lost to Follow-up|0|||
131149209|NCT02847598|472167367|FG004|Overall Study|Lost to Follow-up|0|||
131149210|NCT02847598|472167368|FG005|Overall Study|Lost to Follow-up|1|||
131149211|NCT02847598|472167369|FG006|Overall Study|Lost to Follow-up|1|||
131149212|NCT02847598|472167370|FG007|Overall Study|Lost to Follow-up|0|||
131149213|NCT04167345|472167371|FG000|Overall Study|Other|1|||
131149214|NCT04167345|472167372|FG001|Overall Study|Other|1|||
131149215|NCT04167345|472167373|FG002|Overall Study|Other|0|||
131149216|NCT04167345|472167374|FG003|Overall Study|Other|0|||
131149217|NCT04167345|472167375|FG004|Overall Study|Other|0|||
131149218|NCT00960076|472169205|FG000|Overall Study|Adverse Event|1|||
131149219|NCT00960076|472169206|FG001|Overall Study|Adverse Event|7|||
131149220|NCT00960076|472169205|FG000|Overall Study|No longer met study criteria|1|||
131149221|NCT00960076|472169206|FG001|Overall Study|No longer met study criteria|5|||
131149222|NCT00960076|472169205|FG000|Overall Study|Withdrawal by Subject|1|||
131149223|NCT00960076|472169206|FG001|Overall Study|Withdrawal by Subject|2|||
131149224|NCT00960076|472169205|FG000|Overall Study|Lost to Follow-up|3|||
131149225|NCT00960076|472169206|FG001|Overall Study|Lost to Follow-up|3|||
131149226|NCT00960076|472169205|FG000|Overall Study|Severe non-compliance to protocol|1|||
131149227|NCT00960076|472169206|FG001|Overall Study|Severe non-compliance to protocol|2|||
131149228|NCT00960076|472169205|FG000|Overall Study|Hyperglycemia|1|||
131149229|NCT00960076|472169206|FG001|Overall Study|Hyperglycemia|5|||
131149230|NCT00960076|472169205|FG000|Overall Study|Did not attend the termination visit|0|||
131149231|NCT00960076|472169206|FG001|Overall Study|Did not attend the termination visit|1|||
131149232|NCT00500266|472169207|FG000|Overall Study|Death|3|||
131149233|NCT00500266|472169207|FG000|Overall Study|Lost to Follow-up|3|||
131149234|NCT00500266|472169207|FG000|Overall Study|Withdrawal by Subject|3|||
131149235|NCT00500266|472169207|FG000|Overall Study|Assigned, not treated|4|||
131149236|NCT03019549|472169208|FG000|Washout|DId not meet genotype criteria|11|||
131149237|NCT03019549|472169208|FG000|Period 2|Adverse Event|2|||
131149238|NCT03019549|472169208|FG000|Period 2|Physician Decision|2|||
131149239|NCT03019549|472169208|FG000|Period 2|Withdrawal by Subject|1|||
131149240|NCT03263806|472169211|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
131149241|NCT03263806|472169212|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
131149242|NCT03263806|472169211|FG000|Overall Study|Withdrawal by Subject|0|||
131149243|NCT03263806|472169212|FG001|Overall Study|Withdrawal by Subject|1|||
131149244|NCT03263806|472169211|FG000|Overall Study|Study Termination|5|||
131149245|NCT03263806|472169212|FG001|Overall Study|Study Termination|6|||
131149246|NCT03619213|472169217|FG000|Overall Study|Lost to Follow-up|2|||
131149247|NCT03619213|472169218|FG001|Overall Study|Lost to Follow-up|1|||
131149248|NCT03619213|472169217|FG000|Overall Study|Withdrawal by Subject|8|||
131149249|NCT03619213|472169218|FG001|Overall Study|Withdrawal by Subject|10|||
131149250|NCT02886702|472169222|FG000|Overall Study|Other|4|||
131149251|NCT02886702|472169223|FG001|Overall Study|Other|3|||
131149252|NCT02886702|472169224|FG002|Overall Study|Other|9|||
131149253|NCT02886702|472169222|FG000|Overall Study|Withdrawal by Subject|24|||
131149254|NCT02886702|472169223|FG001|Overall Study|Withdrawal by Subject|18|||
131149255|NCT02886702|472169224|FG002|Overall Study|Withdrawal by Subject|22|||
131149256|NCT02886702|472169222|FG000|Overall Study|Significant Worsening of Condition|0|||
131149257|NCT02886702|472169223|FG001|Overall Study|Significant Worsening of Condition|1|||
131149258|NCT02886702|472169224|FG002|Overall Study|Significant Worsening of Condition|0|||
131149259|NCT02886702|472169222|FG000|Overall Study|Protocol Violation|2|||
131149260|NCT02886702|472169223|FG001|Overall Study|Protocol Violation|2|||
131149261|NCT02886702|472169224|FG002|Overall Study|Protocol Violation|1|||
131149262|NCT02886702|472169222|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131234900|NCT00409578|472486517|FG001|Overall Study|Lack of Efficacy|0|||
131149263|NCT02886702|472169223|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131149264|NCT02886702|472169224|FG002|Overall Study|Non-Compliance With Study Drug|4|||
131149265|NCT02886702|472169222|FG000|Overall Study|Lost to Follow-up|11|||
131149266|NCT02886702|472169223|FG001|Overall Study|Lost to Follow-up|13|||
131149267|NCT02886702|472169224|FG002|Overall Study|Lost to Follow-up|8|||
131149268|NCT02886702|472169222|FG000|Overall Study|Lack of Efficacy|3|||
131149269|NCT02886702|472169223|FG001|Overall Study|Lack of Efficacy|4|||
131149270|NCT02886702|472169224|FG002|Overall Study|Lack of Efficacy|5|||
131234901|NCT00409578|472486518|FG002|Overall Study|Lack of Efficacy|0|||
131149271|NCT02886702|472169222|FG000|Overall Study|Adverse Event|4|||
131149272|NCT02886702|472169223|FG001|Overall Study|Adverse Event|9|||
131149273|NCT02886702|472169224|FG002|Overall Study|Adverse Event|3|||
131149274|NCT02886702|472169222|FG000|Overall Study|Administrative Reasons|0|||
131149275|NCT02886702|472169223|FG001|Overall Study|Administrative Reasons|0|||
131149276|NCT02886702|472169224|FG002|Overall Study|Administrative Reasons|1|||
131149277|NCT01262898|472169227|FG000|Overall Study|Protocol Violation|1|||
131149278|NCT01262898|472169228|FG001|Overall Study|Protocol Violation|1|||
131234902|NCT00409578|472486519|FG003|Overall Study|Lack of Efficacy|2|||
131149279|NCT01262898|472169229|FG002|Overall Study|Protocol Violation|0|||
131149280|NCT01262898|472169230|FG003|Overall Study|Protocol Violation|0|||
131149281|NCT01262898|472169227|FG000|Overall Study|Lost to Follow-up|1|||
131149282|NCT01262898|472169228|FG001|Overall Study|Lost to Follow-up|0|||
131149283|NCT01262898|472169229|FG002|Overall Study|Lost to Follow-up|0|||
131149284|NCT01262898|472169230|FG003|Overall Study|Lost to Follow-up|0|||
131149285|NCT01262898|472169227|FG000|Overall Study|Withdrawal by Subject|1|||
131149286|NCT01262898|472169228|FG001|Overall Study|Withdrawal by Subject|1|||
131149287|NCT01262898|472169229|FG002|Overall Study|Withdrawal by Subject|0|||
131149288|NCT01262898|472169230|FG003|Overall Study|Withdrawal by Subject|0|||
131149289|NCT02731742|472169231|FG000|Overall Study|Death|1|||
131149290|NCT02731742|472169232|FG001|Overall Study|Death|2|||
131149291|NCT02731742|472169233|FG002|Overall Study|Death|5|||
131149292|NCT02731742|472169234|FG003|Overall Study|Death|0|||
131149293|NCT02731742|472169231|FG000|Overall Study|Physician Decision|0|||
131149294|NCT02731742|472169232|FG001|Overall Study|Physician Decision|0|||
131149295|NCT02731742|472169233|FG002|Overall Study|Physician Decision|0|||
131149296|NCT02731742|472169234|FG003|Overall Study|Physician Decision|1|||
131149297|NCT02731742|472169231|FG000|Overall Study|Study Terminated by Sponsor|2|||
131149298|NCT02731742|472169232|FG001|Overall Study|Study Terminated by Sponsor|1|||
131149299|NCT02731742|472169233|FG002|Overall Study|Study Terminated by Sponsor|1|||
131149300|NCT02731742|472169234|FG003|Overall Study|Study Terminated by Sponsor|1|||
131149301|NCT00502840|472169235|FG000|Overall Study|Adverse Event|5|||
131149302|NCT00502840|472169235|FG000|Overall Study|Additional or changed therapy|48|||
131149303|NCT00502840|472169235|FG000|Overall Study|Lack of Efficacy|11|||
131149304|NCT00502840|472169235|FG000|Overall Study|Protocol Violation|4|||
131149305|NCT00502840|472169235|FG000|Overall Study|Withdrawal by Subject|5|||
131149306|NCT00502840|472169235|FG000|Overall Study|Lost to Follow-up|6|||
131149307|NCT00502840|472169235|FG000|Overall Study|Administrative problems|1|||
131149308|NCT00502840|472169235|FG000|Overall Study|Other|20|||
131149309|NCT01974323|472169236|FG000|Overall Study|Other Reasons|25|||
131149310|NCT01974323|472169237|FG001|Overall Study|Other Reasons|28|||
131149311|NCT01974323|472169236|FG000|Overall Study|Protocol Violation|2|||
131149312|NCT01974323|472169237|FG001|Overall Study|Protocol Violation|2|||
131149313|NCT01974323|472169236|FG000|Overall Study|Personal Reasons|15|||
131149314|NCT01974323|472169237|FG001|Overall Study|Personal Reasons|19|||
131149315|NCT01974323|472169236|FG000|Overall Study|Lost to Follow-up|45|||
131149316|NCT01974323|472169237|FG001|Overall Study|Lost to Follow-up|40|||
131149317|NCT01974323|472169236|FG000|Overall Study|Pregnancy|2|||
131149318|NCT01974323|472169237|FG001|Overall Study|Pregnancy|1|||
131149319|NCT01974323|472169236|FG000|Overall Study|Lack of Efficacy|1|||
131149320|NCT01974323|472169237|FG001|Overall Study|Lack of Efficacy|1|||
131149321|NCT01974323|472169236|FG000|Overall Study|Adverse Event|2|||
131149322|NCT01974323|472169237|FG001|Overall Study|Adverse Event|2|||
131149323|NCT00331760|472169238|FG000|Overall Study|Ineligible / no protocol treatment|15|||
131149324|NCT00331760|472169239|FG001|Overall Study|Ineligible / no protocol treatment|8|||
131149325|NCT00461175|472169240|FG000|Overall Study|Protocol Violation|522|||
131149326|NCT00461175|472169241|FG001|Overall Study|Protocol Violation|365|||
131149327|NCT03093155|472169243|FG000|Overall Study|Not Eligible|1|||
131149328|NCT03093155|472169244|FG001|Overall Study|Not Eligible|0|||
131149329|NCT03093155|472169243|FG000|Overall Study|Withdrawal by Subject|0|||
131149330|NCT03093155|472169244|FG001|Overall Study|Withdrawal by Subject|1|||
131149331|NCT00619229|472169245|FG000|Overall Study|Withdrawal by Subject|1|||
131149332|NCT00619229|472169246|FG001|Overall Study|Withdrawal by Subject|1|||
131149333|NCT00619229|472169245|FG000|Overall Study|Lost to Follow-up|1|||
131149334|NCT00619229|472169246|FG001|Overall Study|Lost to Follow-up|0|||
131149335|NCT00619229|472169245|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
131149336|NCT00619229|472169246|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
131149337|NCT00619229|472169245|FG000|Overall Study|Investigator planned Cataract Operation|1|||
131149338|NCT00619229|472169246|FG001|Overall Study|Investigator planned Cataract Operation|0|||
131149339|NCT01700829|472169247|FG000|Overall Study|Withdrawal by Subject|1|||
131149340|NCT01700829|472169248|FG001|Overall Study|Withdrawal by Subject|1|||
131149341|NCT02786901|472169249|FG000|Overall Study|Adverse Event|1|||
131149342|NCT02786901|472169250|FG001|Overall Study|Adverse Event|1|||
131149343|NCT02786901|472169251|FG002|Overall Study|Adverse Event|2|||
131234903|NCT00409578|472486516|FG000|Overall Study|Subject no longer requires study drug|0|||
131234904|NCT00409578|472486517|FG001|Overall Study|Subject no longer requires study drug|0|||
131149344|NCT02786901|472169249|FG000|Overall Study|Physician Decision|1|||
131149345|NCT02786901|472169250|FG001|Overall Study|Physician Decision|0|||
131149346|NCT02786901|472169251|FG002|Overall Study|Physician Decision|0|||
131149347|NCT02786901|472169249|FG000|Overall Study|Rescue Therapy Use|71|||
131149348|NCT02786901|472169250|FG001|Overall Study|Rescue Therapy Use|49|||
131149349|NCT02786901|472169251|FG002|Overall Study|Rescue Therapy Use|33|||
131149350|NCT02786901|472169249|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
131149351|NCT02786901|472169250|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
131149352|NCT02786901|472169251|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
131149353|NCT02786901|472169249|FG000|Overall Study|Disallowed medication|1|||
131149354|NCT02786901|472169250|FG001|Overall Study|Disallowed medication|1|||
131149355|NCT02786901|472169251|FG002|Overall Study|Disallowed medication|0|||
131149356|NCT02786901|472169249|FG000|Overall Study|Randomized in error|2|||
131149357|NCT02786901|472169250|FG001|Overall Study|Randomized in error|0|||
131149358|NCT02786901|472169251|FG002|Overall Study|Randomized in error|1|||
131149359|NCT03367871|472169252|FG000|Overall Study|Lost to Follow-up|1|||
131149360|NCT01075178|472169253|FG000|Subject Matching|eligible but not matched|130|||
131149361|NCT01075178|472169254|FG001|Subject Matching|eligible but not matched|403|||
131149362|NCT01075178|472169253|FG000|Subject Chart Review|died before chart review period|0|||
131149363|NCT01075178|472169254|FG001|Subject Chart Review|died before chart review period|2|||
131149364|NCT01075178|472169253|FG000|Subject Chart Review|no data collected due to site closure|3|||
131149365|NCT01075178|472169254|FG001|Subject Chart Review|no data collected due to site closure|4|||
131149366|NCT01075178|472169253|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
131149367|NCT01075178|472169254|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
131149368|NCT02983604|472169255|FG000|Overall Study|Enrolled but not Treated|0|||
131149369|NCT02983604|472169256|FG001|Overall Study|Enrolled but not Treated|0|||
131149370|NCT02983604|472169257|FG002|Overall Study|Enrolled but not Treated|1|||
131149371|NCT02983604|472169258|FG003|Overall Study|Enrolled but not Treated|0|||
131149372|NCT01111604|472169259|FG000|Overall Study|Lost to Follow-up|0|||
131149373|NCT01111604|472169260|FG001|Overall Study|Lost to Follow-up|0|||
131149374|NCT01111604|472169261|FG002|Overall Study|Lost to Follow-up|1|||
131149375|NCT01111604|472169259|FG000|Overall Study|Withdrew Consent|3|||
131149376|NCT01111604|472169260|FG001|Overall Study|Withdrew Consent|0|||
131149377|NCT01111604|472169261|FG002|Overall Study|Withdrew Consent|2|||
131149378|NCT01111604|472169259|FG000|Overall Study|Withdrawal by Subject|2|||
131149379|NCT01111604|472169260|FG001|Overall Study|Withdrawal by Subject|0|||
131149380|NCT01111604|472169261|FG002|Overall Study|Withdrawal by Subject|0|||
131149381|NCT01111604|472169259|FG000|Overall Study|Death|1|||
131149382|NCT01111604|472169260|FG001|Overall Study|Death|0|||
131149383|NCT01111604|472169261|FG002|Overall Study|Death|0|||
131149384|NCT01111604|472169259|FG000|Overall Study|Met Exclusion Criteria|2|||
131149385|NCT01111604|472169260|FG001|Overall Study|Met Exclusion Criteria|0|||
131149386|NCT01111604|472169261|FG002|Overall Study|Met Exclusion Criteria|0|||
131149387|NCT00607048|472169263|FG000|Overall Study|Adverse Event|0|||
131149388|NCT00607048|472169264|FG001|Overall Study|Adverse Event|1|||
131149389|NCT00607048|472169265|FG002|Overall Study|Adverse Event|0|||
131149390|NCT00607048|472169266|FG003|Overall Study|Adverse Event|0|||
131149391|NCT00607048|472169267|FG004|Overall Study|Adverse Event|4|||
131149392|NCT00607048|472169268|FG005|Overall Study|Adverse Event|0|||
131149393|NCT00607048|472169263|FG000|Overall Study|Global deterioration of health|1|||
131149394|NCT00607048|472169264|FG001|Overall Study|Global deterioration of health|0|||
131149395|NCT00607048|472169265|FG002|Overall Study|Global deterioration of health|0|||
131149396|NCT00607048|472169266|FG003|Overall Study|Global deterioration of health|0|||
131149397|NCT00607048|472169267|FG004|Overall Study|Global deterioration of health|0|||
131149398|NCT00607048|472169268|FG005|Overall Study|Global deterioration of health|0|||
131149399|NCT00607048|472169263|FG000|Overall Study|Objective disease progression - relapse|1|||
131149400|NCT00607048|472169264|FG001|Overall Study|Objective disease progression - relapse|2|||
131149401|NCT00607048|472169265|FG002|Overall Study|Objective disease progression - relapse|4|||
131149402|NCT00607048|472169266|FG003|Overall Study|Objective disease progression - relapse|2|||
131149403|NCT00607048|472169267|FG004|Overall Study|Objective disease progression - relapse|2|||
131149404|NCT00607048|472169268|FG005|Overall Study|Objective disease progression - relapse|2|||
131149405|NCT00607048|472169263|FG000|Overall Study|Withdrawal by Subject|0|||
131149406|NCT00607048|472169264|FG001|Overall Study|Withdrawal by Subject|0|||
131149407|NCT00607048|472169265|FG002|Overall Study|Withdrawal by Subject|0|||
131149408|NCT00607048|472169266|FG003|Overall Study|Withdrawal by Subject|1|||
131149409|NCT00607048|472169267|FG004|Overall Study|Withdrawal by Subject|0|||
131149410|NCT00607048|472169268|FG005|Overall Study|Withdrawal by Subject|2|||
131149411|NCT00607048|472169263|FG000|Overall Study|Other|1|||
131149412|NCT00607048|472169264|FG001|Overall Study|Other|1|||
131149413|NCT00607048|472169265|FG002|Overall Study|Other|0|||
131149414|NCT00607048|472169266|FG003|Overall Study|Other|0|||
131149415|NCT00607048|472169267|FG004|Overall Study|Other|0|||
131149416|NCT00607048|472169268|FG005|Overall Study|Other|1|||
131149417|NCT00316264|472169269|FG000|Overall Study|Lost to Follow-up|0|||
131149418|NCT00316264|472169270|FG001|Overall Study|Lost to Follow-up|1|||
131149419|NCT00316264|472169271|FG002|Overall Study|Lost to Follow-up|0|||
131149420|NCT00316264|472169269|FG000|Overall Study|Withdrawal of Consent|3|||
131149421|NCT00316264|472169270|FG001|Overall Study|Withdrawal of Consent|5|||
131149422|NCT00316264|472169271|FG002|Overall Study|Withdrawal of Consent|6|||
131149423|NCT00316264|472169269|FG000|Overall Study|Death|2|||
131149424|NCT00316264|472169270|FG001|Overall Study|Death|0|||
131149425|NCT00316264|472169271|FG002|Overall Study|Death|0|||
131149426|NCT00316264|472169269|FG000|Overall Study|Other|1|||
131149427|NCT00316264|472169270|FG001|Overall Study|Other|1|||
131149428|NCT00316264|472169271|FG002|Overall Study|Other|0|||
131149429|NCT03926143|472169274|FG000|Overall Study|Physician Decision|3|||
131149430|NCT03926143|472169274|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
131149431|NCT03926143|472169274|FG000|Overall Study|Adverse Event|2|||
131149432|NCT03926143|472169274|FG000|Overall Study|Progressive disease|3|||
131149433|NCT03545282|472169278|FG000|Overall Study|Lost to Follow-up|15|||
131149434|NCT03545282|472169279|FG001|Overall Study|Lost to Follow-up|10|||
131149435|NCT03545282|472169278|FG000|Overall Study|Withdrawal by Subject|2|||
131149436|NCT03545282|472169279|FG001|Overall Study|Withdrawal by Subject|2|||
131149437|NCT02582671|472169280|FG000|Overall Study|Failure to return|1|||
131149438|NCT02582671|472169280|FG000|Overall Study|Other, not specified|1|||
131149439|NCT01287104|472169285|FG000|Overall Study|Patient developed progressive disease|1|||
131149440|NCT01287104|472169286|FG001|Overall Study|Patient developed progressive disease|1|||
131149441|NCT01287104|472169287|FG002|Overall Study|Patient developed progressive disease|3|||
131149442|NCT01287104|472169288|FG003|Overall Study|Patient developed progressive disease|2|||
131149443|NCT01287104|472169285|FG000|Overall Study|Donor anaphylaxis|0|||
131149444|NCT01287104|472169286|FG001|Overall Study|Donor anaphylaxis|1|||
131149445|NCT01287104|472169287|FG002|Overall Study|Donor anaphylaxis|0|||
131149446|NCT01287104|472169288|FG003|Overall Study|Donor anaphylaxis|1|||
131149447|NCT01287104|472169285|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
131149448|NCT01287104|472169286|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
131149449|NCT01287104|472169287|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
131149450|NCT01287104|472169288|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
131149451|NCT01287104|472169285|FG000|Overall Study|Low donor chimerism|0|||
131149452|NCT01287104|472169286|FG001|Overall Study|Low donor chimerism|1|||
131149453|NCT01287104|472169287|FG002|Overall Study|Low donor chimerism|0|||
131149454|NCT01287104|472169288|FG003|Overall Study|Low donor chimerism|0|||
131149455|NCT01287104|472169285|FG000|Overall Study|NK cells did not meet release criteria|0|||
131149456|NCT01287104|472169286|FG001|Overall Study|NK cells did not meet release criteria|1|||
131149457|NCT01287104|472169287|FG002|Overall Study|NK cells did not meet release criteria|0|||
131149458|NCT01287104|472169288|FG003|Overall Study|NK cells did not meet release criteria|0|||
131149459|NCT03068715|472169289|FG000|Overall Study|No longer met inclusion criteria|1|||
131149460|NCT03068715|472169290|FG001|Overall Study|No longer met inclusion criteria|0|||
131149461|NCT01276288|472169291|FG000|Overall Study|Adverse Event|1|||
131149462|NCT01276288|472169292|FG001|Overall Study|Adverse Event|1|||
131149463|NCT01276288|472169293|FG002|Overall Study|Adverse Event|0|||
131149464|NCT01276288|472169294|FG003|Overall Study|Adverse Event|0|||
131149465|NCT01276288|472169291|FG000|Overall Study|not treated|1|||
131149466|NCT01276288|472169292|FG001|Overall Study|not treated|0|||
131149467|NCT01276288|472169293|FG002|Overall Study|not treated|0|||
131149468|NCT01276288|472169294|FG003|Overall Study|not treated|0|||
131149469|NCT03168867|472169295|FG000|Overall Study|Withdrawal by Subject|1|||
131149470|NCT03168867|472169296|FG001|Overall Study|Withdrawal by Subject|5|||
131149471|NCT04964258|472169297|FG000|Overall Study|Lost to Follow-up|1|||
131149472|NCT04964258|472169298|FG001|Overall Study|Lost to Follow-up|0|||
131149473|NCT04964258|472169299|FG002|Overall Study|Lost to Follow-up|0|||
131149474|NCT04964258|472169300|FG003|Overall Study|Lost to Follow-up|0|||
131149475|NCT04964258|472169301|FG004|Overall Study|Lost to Follow-up|0|||
131149476|NCT04964258|472169302|FG005|Overall Study|Lost to Follow-up|1|||
131149477|NCT04964258|472169303|FG006|Overall Study|Lost to Follow-up|0|||
131149478|NCT04964258|472169304|FG007|Overall Study|Lost to Follow-up|0|||
131149479|NCT04964258|472169305|FG008|Overall Study|Lost to Follow-up|0|||
131149480|NCT04964258|472169306|FG009|Overall Study|Lost to Follow-up|0|||
131149481|NCT04964258|472169307|FG010|Overall Study|Lost to Follow-up|0|||
131149482|NCT01307423|472169313|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
131149483|NCT01307423|472169314|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
131149484|NCT01307423|472169315|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
131149485|NCT01307423|472169316|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131149486|NCT01307423|472169317|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131149487|NCT01307423|472169318|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131149488|NCT01307423|472169319|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131149489|NCT01307423|472169320|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131149490|NCT01307423|472169321|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
131149491|NCT01307423|472169313|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
131149492|NCT01307423|472169314|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
131149493|NCT01307423|472169315|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
131149494|NCT01307423|472169316|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131149495|NCT01307423|472169317|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131149496|NCT01307423|472169318|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131149497|NCT01307423|472169319|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131149498|NCT01307423|472169320|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131149499|NCT01307423|472169321|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
131149500|NCT01307423|472169313|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
131149501|NCT01307423|472169314|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
131149502|NCT01307423|472169315|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
131149503|NCT01307423|472169316|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131149504|NCT01307423|472169317|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131149505|NCT01307423|472169318|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131149506|NCT01307423|472169319|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131149507|NCT01307423|472169320|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131149508|NCT01307423|472169321|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
131149509|NCT01307423|472169313|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131149510|NCT01307423|472169314|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131149511|NCT01307423|472169315|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
131149512|NCT01307423|472169316|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131149513|NCT01307423|472169317|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131149514|NCT01307423|472169318|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131149515|NCT01307423|472169319|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131149516|NCT01307423|472169320|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131149517|NCT01307423|472169321|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
131149518|NCT01307423|472169313|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
131149519|NCT01307423|472169314|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
131149520|NCT01307423|472169315|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
131149521|NCT01307423|472169316|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131149522|NCT01307423|472169317|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131149523|NCT01307423|472169318|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131149524|NCT01307423|472169319|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131149525|NCT01307423|472169320|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131149526|NCT01307423|472169321|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
131149527|NCT01307423|472169313|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
131149528|NCT01307423|472169314|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131149529|NCT01307423|472169315|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131149530|NCT01307423|472169316|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131149531|NCT01307423|472169317|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131149532|NCT01307423|472169318|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131149533|NCT01307423|472169319|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131149534|NCT01307423|472169320|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131149535|NCT01307423|472169321|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
131149536|NCT01307423|472169313|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
131149537|NCT01307423|472169314|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
131149538|NCT01307423|472169315|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131149539|NCT01307423|472169316|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131149540|NCT01307423|472169317|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131149541|NCT01307423|472169318|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131149542|NCT01307423|472169319|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131149543|NCT01307423|472169320|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131149544|NCT01307423|472169321|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
131149545|NCT01307423|472169313|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131149546|NCT01307423|472169314|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
131149547|NCT01307423|472169315|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
131149548|NCT01307423|472169316|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131149549|NCT01307423|472169317|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131149550|NCT01307423|472169318|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131149551|NCT01307423|472169319|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131149552|NCT01307423|472169320|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131149553|NCT01307423|472169321|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
131149554|NCT01307423|472169313|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
131149555|NCT01307423|472169314|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
131149556|NCT01307423|472169315|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
131149557|NCT01307423|472169316|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
131149558|NCT01307423|472169317|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
131149559|NCT01307423|472169318|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
131149560|NCT01307423|472169319|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
131149561|NCT01307423|472169320|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
131149562|NCT01307423|472169321|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
131149563|NCT01307423|472169313|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
131149564|NCT01307423|472169314|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
131149565|NCT01307423|472169315|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
131149566|NCT01307423|472169316|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
131149567|NCT01307423|472169317|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
131149568|NCT01307423|472169318|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
131149569|NCT01307423|472169319|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
131149570|NCT01307423|472169320|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
131149571|NCT01307423|472169321|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
131149572|NCT01307423|472169313|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131149573|NCT01307423|472169314|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131149574|NCT01307423|472169315|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131149575|NCT01307423|472169316|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131149576|NCT01307423|472169317|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131149577|NCT01307423|472169318|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
131149578|NCT01307423|472169319|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131149579|NCT01307423|472169320|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131149580|NCT01307423|472169321|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
131149581|NCT01307423|472169313|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
131149582|NCT01307423|472169314|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
131149583|NCT01307423|472169315|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
131149584|NCT01307423|472169316|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
131149585|NCT01307423|472169317|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
131149586|NCT01307423|472169318|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
131149587|NCT01307423|472169319|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
131149588|NCT01307423|472169320|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
131149589|NCT01307423|472169321|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
131149590|NCT01307423|472169313|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131149591|NCT01307423|472169314|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131149592|NCT01307423|472169315|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131149593|NCT01307423|472169316|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
131149594|NCT01307423|472169317|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131149595|NCT01307423|472169318|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131149596|NCT01307423|472169319|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131149597|NCT01307423|472169320|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131149598|NCT01307423|472169321|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
131149599|NCT01307423|472169313|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
131149600|NCT01307423|472169314|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
131149601|NCT01307423|472169315|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
131149602|NCT01307423|472169316|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
131149603|NCT01307423|472169317|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
131149604|NCT01307423|472169318|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
131149605|NCT01307423|472169319|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
131149606|NCT01307423|472169320|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
131149607|NCT01307423|472169321|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
131149608|NCT01307423|472169313|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131149609|NCT01307423|472169314|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131149610|NCT01307423|472169315|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131149611|NCT01307423|472169316|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131149612|NCT01307423|472169317|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131149613|NCT01307423|472169318|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
131149614|NCT01307423|472169319|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131149615|NCT01307423|472169320|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131149616|NCT01307423|472169321|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
131149617|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131149618|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
131149619|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
131149620|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131149621|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131149622|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131149623|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
131234905|NCT00409578|472486518|FG002|Overall Study|Subject no longer requires study drug|0|||
131149624|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
131149625|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
131149626|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131149627|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
131149628|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
131234906|NCT00409578|472486519|FG003|Overall Study|Subject no longer requires study drug|1|||
131234907|NCT00409578|472486516|FG000|Overall Study|Withdrawal by Subject|8|||
131234908|NCT00409578|472486517|FG001|Overall Study|Withdrawal by Subject|15|||
131234909|NCT00409578|472486518|FG002|Overall Study|Withdrawal by Subject|16|||
131149629|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131149630|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131149631|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131149632|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
131149633|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
131149634|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
131149635|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131149636|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131149637|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
131149638|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131149639|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131149640|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131149641|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131149642|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131149643|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
131149644|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131149645|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
131149646|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
131149647|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131149648|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131149649|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131149650|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
131149651|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
131149652|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
131149653|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131149654|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
131149655|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131149656|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131149657|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131149658|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131149659|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
131149660|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
131149661|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
131149662|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131149663|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
131149664|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
131149665|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131149666|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131149667|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131149668|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
131149669|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
131149670|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
131149671|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131149672|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
131149673|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
131149674|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131149675|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131149676|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131149677|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
131149678|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
131149679|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
131149680|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131149681|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
131149682|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
131149683|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131149684|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131149685|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131149686|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131149687|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131149688|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
131149689|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131149690|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
131149691|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
131149692|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130728017|NCT01449370|470625577|FG011|Overall Study|Medication Prohibited by Protocol|0|||
131149693|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131149694|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131149695|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
131149696|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
131149697|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
131149698|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131149699|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
131149700|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
131149701|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131149702|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131149703|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131149704|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
131149705|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
131149706|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
131149707|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131149708|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
131149709|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131149710|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131149711|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131149712|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131149713|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131149714|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
131149715|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
131149716|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131149717|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
131149718|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131149719|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131149720|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131149721|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131149722|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131149723|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131149724|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
131149725|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131149726|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
131149727|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131149728|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131149729|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131149730|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131149731|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131149732|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
131149733|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
131149734|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131149735|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
131149736|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
131149737|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131149738|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131149739|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131149740|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
131149741|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
131149742|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
131149743|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131149744|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131149745|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
131149746|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131149747|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131149748|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131149749|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131149750|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131149751|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
131149752|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131149753|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131149754|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131149755|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131149756|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131149757|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131149758|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131149759|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
131149760|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
131149761|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131234910|NCT00409578|472486519|FG003|Overall Study|Withdrawal by Subject|17|||
131149762|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
131149763|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
131149764|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131149765|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131149766|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131149767|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131149768|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
131149769|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
131149770|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131149771|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
131149772|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
131149773|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131149774|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131149775|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131149776|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131149777|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131149778|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
131149779|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131149780|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
131149781|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
131149782|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131149783|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131149784|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131149785|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131149786|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
131149787|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
131149788|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131149789|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
131149790|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131149791|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131149792|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131149793|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131149794|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131149795|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131149796|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
131149797|NCT01307423|472169313|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131149798|NCT01307423|472169314|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131149799|NCT01307423|472169315|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
131149800|NCT01307423|472169316|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131149801|NCT01307423|472169317|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131149802|NCT01307423|472169318|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
131149803|NCT01307423|472169319|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130728018|NCT01449370|470625578|FG012|Overall Study|Medication Prohibited by Protocol|0|||
131149804|NCT01307423|472169320|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
131149805|NCT01307423|472169321|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
131149806|NCT00481065|472169322|FG000|Overall Study|Adverse event or death|1|||
131149807|NCT00481065|472169323|FG001|Overall Study|Adverse event or death|1|||
131149808|NCT00481065|472169324|FG002|Overall Study|Adverse event or death|3|||
131149809|NCT00481065|472169325|FG003|Overall Study|Adverse event or death|0|||
131149810|NCT00481065|472169326|FG004|Overall Study|Adverse event or death|2|||
131149811|NCT00481065|472169327|FG005|Overall Study|Adverse event or death|0|||
131149812|NCT00481065|472169328|FG006|Overall Study|Adverse event or death|1|||
131149813|NCT00481065|472169329|FG007|Overall Study|Adverse event or death|1|||
131149814|NCT00481065|472169322|FG000|Overall Study|Withdrawal by Subject|11|||
131149815|NCT00481065|472169323|FG001|Overall Study|Withdrawal by Subject|12|||
131149816|NCT00481065|472169324|FG002|Overall Study|Withdrawal by Subject|7|||
131149817|NCT00481065|472169325|FG003|Overall Study|Withdrawal by Subject|11|||
131149818|NCT00481065|472169326|FG004|Overall Study|Withdrawal by Subject|13|||
131149819|NCT00481065|472169327|FG005|Overall Study|Withdrawal by Subject|12|||
131149820|NCT00481065|472169328|FG006|Overall Study|Withdrawal by Subject|9|||
131149821|NCT00481065|472169329|FG007|Overall Study|Withdrawal by Subject|10|||
131149822|NCT00481065|472169322|FG000|Overall Study|Lost to Follow-up|4|||
131149823|NCT00481065|472169323|FG001|Overall Study|Lost to Follow-up|2|||
131149824|NCT00481065|472169324|FG002|Overall Study|Lost to Follow-up|4|||
131149825|NCT00481065|472169325|FG003|Overall Study|Lost to Follow-up|3|||
130780313|NCT01691378|470821498|FG001|Overall Study|Lost to Follow-up|2|||
131149826|NCT00481065|472169326|FG004|Overall Study|Lost to Follow-up|3|||
131149827|NCT00481065|472169327|FG005|Overall Study|Lost to Follow-up|3|||
131149828|NCT00481065|472169328|FG006|Overall Study|Lost to Follow-up|2|||
131149829|NCT00481065|472169329|FG007|Overall Study|Lost to Follow-up|5|||
131149830|NCT00481065|472169322|FG000|Overall Study|Inappropriate enrollment|4|||
131149831|NCT00481065|472169323|FG001|Overall Study|Inappropriate enrollment|0|||
131149832|NCT00481065|472169324|FG002|Overall Study|Inappropriate enrollment|2|||
131149833|NCT00481065|472169325|FG003|Overall Study|Inappropriate enrollment|0|||
131149834|NCT00481065|472169326|FG004|Overall Study|Inappropriate enrollment|2|||
131149835|NCT00481065|472169327|FG005|Overall Study|Inappropriate enrollment|1|||
131149836|NCT00481065|472169328|FG006|Overall Study|Inappropriate enrollment|0|||
131149837|NCT00481065|472169329|FG007|Overall Study|Inappropriate enrollment|1|||
131149838|NCT00481065|472169322|FG000|Overall Study|Administrative reason|0|||
131149839|NCT00481065|472169323|FG001|Overall Study|Administrative reason|0|||
131149840|NCT00481065|472169324|FG002|Overall Study|Administrative reason|0|||
131149841|NCT00481065|472169325|FG003|Overall Study|Administrative reason|0|||
131149842|NCT00481065|472169326|FG004|Overall Study|Administrative reason|0|||
131149843|NCT00481065|472169327|FG005|Overall Study|Administrative reason|2|||
131149844|NCT00481065|472169328|FG006|Overall Study|Administrative reason|1|||
131149845|NCT00481065|472169329|FG007|Overall Study|Administrative reason|0|||
131149846|NCT00481065|472169322|FG000|Overall Study|Protocol Violation|2|||
131149847|NCT00481065|472169323|FG001|Overall Study|Protocol Violation|1|||
131149848|NCT00481065|472169324|FG002|Overall Study|Protocol Violation|1|||
131149849|NCT00481065|472169325|FG003|Overall Study|Protocol Violation|1|||
131149850|NCT00481065|472169326|FG004|Overall Study|Protocol Violation|2|||
131149851|NCT00481065|472169327|FG005|Overall Study|Protocol Violation|6|||
131149852|NCT00481065|472169328|FG006|Overall Study|Protocol Violation|3|||
131149853|NCT00481065|472169329|FG007|Overall Study|Protocol Violation|2|||
131149854|NCT00481065|472169322|FG000|Overall Study|Unable to classify|0|||
131149855|NCT00481065|472169323|FG001|Overall Study|Unable to classify|1|||
131149856|NCT00481065|472169324|FG002|Overall Study|Unable to classify|2|||
131149857|NCT00481065|472169325|FG003|Overall Study|Unable to classify|0|||
131149858|NCT00481065|472169326|FG004|Overall Study|Unable to classify|1|||
131149859|NCT00481065|472169327|FG005|Overall Study|Unable to classify|0|||
131149860|NCT00481065|472169328|FG006|Overall Study|Unable to classify|0|||
131149861|NCT00481065|472169329|FG007|Overall Study|Unable to classify|0|||
131149862|NCT01926626|472169330|FG000|Overall Study|Withdrawal by Subject|15|||
131149863|NCT01926626|472169330|FG000|Overall Study|Lost to Follow-up|7|||
131149864|NCT00924703|472169333|FG000|Overall Study|Withdrawal by Subject|11|||
131149865|NCT00924703|472169333|FG000|Overall Study|Physician Decision|5|||
131149866|NCT00924703|472169333|FG000|Overall Study|Lost to Follow-up|3|||
131149867|NCT00924703|472169333|FG000|Overall Study|Adverse Event|2|||
131149868|NCT00924703|472169333|FG000|Overall Study|Withdrawal by Sponsor|1|||
131149869|NCT00666562|472169334|FG000|Overall Study|Withdrawal by Subject|0|||
131149870|NCT00666562|472169335|FG001|Overall Study|Withdrawal by Subject|1|||
131149871|NCT00666562|472169336|FG002|Overall Study|Withdrawal by Subject|0|||
131149872|NCT00666562|472169334|FG000|Overall Study|Concomitant Medication|0|||
131149873|NCT00666562|472169335|FG001|Overall Study|Concomitant Medication|1|||
131149874|NCT00666562|472169336|FG002|Overall Study|Concomitant Medication|0|||
131149875|NCT02382133|472169337|FG000|Overall Study|Death|22|||
131149876|NCT02382133|472169337|FG000|Overall Study|transfer out of ICU|4|||
131149877|NCT02382133|472169337|FG000|Overall Study|Physician Decision|2|||
131149878|NCT02382133|472169337|FG000|Overall Study|arterial catheter loss|4|||
131149879|NCT02382133|472169337|FG000|Overall Study|pressure injury both sites|1|||
131149880|NCT00655928|472169338|FG000|Overall Study|Withdrawal by Subject|2|||
131149881|NCT00655928|472169339|FG001|Overall Study|Withdrawal by Subject|1|||
131149882|NCT00655928|472169338|FG000|Overall Study|Physician Decision|1|||
131149883|NCT00655928|472169339|FG001|Overall Study|Physician Decision|1|||
131149884|NCT04906707|472169340|FG000|Overall Study|Withdrawal by Subject|2|||
131149885|NCT04906707|472169341|FG001|Overall Study|Withdrawal by Subject|0|||
131149886|NCT04906707|472169340|FG000|Overall Study|Withdrawal due to PI decision|1|||
131149887|NCT04906707|472169341|FG001|Overall Study|Withdrawal due to PI decision|0|||
131149888|NCT04906707|472169340|FG000|Overall Study|Lost to Follow-up|0|||
131149889|NCT04906707|472169341|FG001|Overall Study|Lost to Follow-up|1|||
131149890|NCT01976806|472169342|FG000|Overall Study|Lost to Follow-up|1|||
131149891|NCT01976806|472169343|FG001|Overall Study|Lost to Follow-up|4|||
131149892|NCT01976806|472169342|FG000|Overall Study|Adverse Event|1|||
131149893|NCT01976806|472169343|FG001|Overall Study|Adverse Event|1|||
131149894|NCT01976806|472169342|FG000|Overall Study|Withdrawal by Subject|1|||
131149895|NCT01976806|472169343|FG001|Overall Study|Withdrawal by Subject|1|||
131149896|NCT01523873|472169351|FG000|Overall Study|Protocol Violation|422|||
131149897|NCT01587989|472169352|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
131149898|NCT01587989|472169353|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
131149899|NCT01587989|472169354|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
131149900|NCT01587989|472169352|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
131149901|NCT01587989|472169353|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
131149902|NCT01587989|472169354|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
131149903|NCT01587989|472169352|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
131149904|NCT01587989|472169353|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
131149905|NCT01587989|472169354|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
131149906|NCT01587989|472169352|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
131149907|NCT01587989|472169353|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
130728019|NCT01449370|470625579|FG013|Overall Study|Medication Prohibited by Protocol|0|||
130728020|NCT01449370|470625580|FG014|Overall Study|Medication Prohibited by Protocol|0|||
130728021|NCT01449370|470625581|FG015|Overall Study|Medication Prohibited by Protocol|0|||
130728022|NCT01449370|470625582|FG016|Overall Study|Medication Prohibited by Protocol|0|||
130728023|NCT01449370|470625583|FG017|Overall Study|Medication Prohibited by Protocol|0|||
131149908|NCT01587989|472169354|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
131149909|NCT01587989|472169352|FG000|Randomized Study Treatment|Screening failure|0|||
131149910|NCT01587989|472169353|FG001|Randomized Study Treatment|Screening failure|1|||
131149911|NCT01587989|472169354|FG002|Randomized Study Treatment|Screening failure|0|||
131149912|NCT01587989|472169352|FG000|Randomized Study Treatment|Physician Decision|0|||
131149913|NCT01587989|472169353|FG001|Randomized Study Treatment|Physician Decision|0|||
131149914|NCT01587989|472169354|FG002|Randomized Study Treatment|Physician Decision|1|||
131149915|NCT00998738|472169357|FG000|Overall Study|Uknown|1|||
131149916|NCT00684177|472169359|FG000|Overall Study|Adverse Event|4|||
131149917|NCT00684177|472169360|FG001|Overall Study|Adverse Event|3|||
131149918|NCT00684177|472169359|FG000|Overall Study|Lack of Efficacy|10|||
131149919|NCT00684177|472169360|FG001|Overall Study|Lack of Efficacy|15|||
131149920|NCT00684177|472169359|FG000|Overall Study|Protocol Violation|1|||
131149921|NCT00684177|472169360|FG001|Overall Study|Protocol Violation|0|||
131149922|NCT00684177|472169359|FG000|Overall Study|Lost to Follow-up|2|||
131149923|NCT00684177|472169360|FG001|Overall Study|Lost to Follow-up|1|||
131149924|NCT00684177|472169359|FG000|Overall Study|Physician Decision|2|||
131149925|NCT00684177|472169360|FG001|Overall Study|Physician Decision|0|||
131149926|NCT00684177|472169359|FG000|Overall Study|Withdrawal by Subject|1|||
131149927|NCT00684177|472169360|FG001|Overall Study|Withdrawal by Subject|2|||
131149928|NCT00684177|472169359|FG000|Overall Study|Other|1|||
131149929|NCT00684177|472169360|FG001|Overall Study|Other|2|||
131149930|NCT05630846|472171879|FG000|Overall Study|Death|1|||
131149931|NCT05630846|472171880|FG001|Overall Study|Death|0|||
131149932|NCT05630846|472171881|FG002|Overall Study|Death|0|||
131149933|NCT05630846|472171882|FG003|Overall Study|Death|0|||
131149934|NCT05630846|472171879|FG000|Overall Study|Withdrawal by Subject|3|||
131149935|NCT05630846|472171880|FG001|Overall Study|Withdrawal by Subject|3|||
131149936|NCT05630846|472171881|FG002|Overall Study|Withdrawal by Subject|4|||
131149937|NCT05630846|472171882|FG003|Overall Study|Withdrawal by Subject|1|||
131149938|NCT05630846|472171879|FG000|Overall Study|Lost to Follow-up|6|||
131149939|NCT05630846|472171880|FG001|Overall Study|Lost to Follow-up|5|||
131149940|NCT05630846|472171881|FG002|Overall Study|Lost to Follow-up|2|||
131149941|NCT05630846|472171882|FG003|Overall Study|Lost to Follow-up|5|||
131149942|NCT05630846|472171879|FG000|Overall Study|Other|1|||
131149943|NCT05630846|472171880|FG001|Overall Study|Other|0|||
131149944|NCT05630846|472171881|FG002|Overall Study|Other|0|||
131149945|NCT05630846|472171882|FG003|Overall Study|Other|0|||
131149946|NCT05556616|472171883|FG000|Overall Study|Withdrawal by Subject|1|||
131149947|NCT05556616|472171884|FG001|Overall Study|Withdrawal by Subject|0|||
131149948|NCT05556616|472171885|FG002|Overall Study|Withdrawal by Subject|0|||
131149949|NCT05556616|472171886|FG003|Overall Study|Withdrawal by Subject|0|||
131149950|NCT05556616|472171887|FG004|Overall Study|Withdrawal by Subject|0|||
131149951|NCT05556616|472171888|FG005|Overall Study|Withdrawal by Subject|0|||
131149952|NCT05556616|472171889|FG006|Overall Study|Withdrawal by Subject|0|||
131149953|NCT05556616|472171883|FG000|Overall Study|Death|0|||
131149954|NCT05556616|472171884|FG001|Overall Study|Death|0|||
131149955|NCT05556616|472171885|FG002|Overall Study|Death|2|||
131149956|NCT05556616|472171886|FG003|Overall Study|Death|1|||
131149957|NCT05556616|472171887|FG004|Overall Study|Death|0|||
131149958|NCT05556616|472171888|FG005|Overall Study|Death|0|||
131149959|NCT05556616|472171889|FG006|Overall Study|Death|0|||
131149960|NCT05556616|472171883|FG000|Overall Study|Study Terminated by Sponsor|0|||
131149961|NCT05556616|472171884|FG001|Overall Study|Study Terminated by Sponsor|3|||
131149962|NCT05556616|472171885|FG002|Overall Study|Study Terminated by Sponsor|0|||
131149963|NCT05556616|472171886|FG003|Overall Study|Study Terminated by Sponsor|0|||
131149964|NCT05556616|472171887|FG004|Overall Study|Study Terminated by Sponsor|0|||
131149965|NCT05556616|472171888|FG005|Overall Study|Study Terminated by Sponsor|0|||
130728024|NCT01449370|470625584|FG018|Overall Study|Medication Prohibited by Protocol|0|||
130728025|NCT01449370|470625585|FG019|Overall Study|Medication Prohibited by Protocol|0|||
130728026|NCT01449370|470625586|FG020|Overall Study|Medication Prohibited by Protocol|0|||
131149966|NCT05556616|472171889|FG006|Overall Study|Study Terminated by Sponsor|0|||
131149967|NCT02031679|472171890|FG000|Overall Study|Protocol Violation|0|||
131149968|NCT02031679|472171891|FG001|Overall Study|Protocol Violation|1|||
131149969|NCT02031679|472171890|FG000|Overall Study|Lack of Efficacy|0|||
131149970|NCT02031679|472171891|FG001|Overall Study|Lack of Efficacy|1|||
131149971|NCT01412879|472171892|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
131149972|NCT01412879|472171893|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
131149973|NCT01412879|472171894|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
131149974|NCT01412879|472171892|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
131149975|NCT01412879|472171893|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
130728027|NCT01449370|470625587|FG021|Overall Study|Medication Prohibited by Protocol|0|||
131149976|NCT01412879|472171894|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
131149977|NCT01412879|472171892|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
131149978|NCT01412879|472171893|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
131149979|NCT01412879|472171894|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
131149980|NCT01412879|472171892|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
131149981|NCT01412879|472171893|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
131149982|NCT01412879|472171894|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
131149983|NCT01412879|472171892|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
131149984|NCT01412879|472171893|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
131149985|NCT01412879|472171894|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
131149986|NCT02109029|472171895|FG000|Part B|Adverse Event|0|||
131149987|NCT02109029|472171896|FG001|Part B|Adverse Event|0|||
131149988|NCT02109029|472171897|FG002|Part B|Adverse Event|0|||
131149989|NCT02109029|472171898|FG003|Part B|Adverse Event|0|||
131149990|NCT02109029|472171899|FG004|Part B|Adverse Event|1|||
131149991|NCT02109029|472171900|FG005|Part B|Adverse Event|1|||
131149992|NCT01445171|472171901|FG000|Overall Study|Lost to Follow-up|11|||
131149993|NCT01445171|472171901|FG000|Overall Study|Withdrawal by Subject|16|||
131149994|NCT01445171|472171901|FG000|Overall Study|Death|51|||
131149995|NCT01445171|472171901|FG000|Overall Study|Subjects declined to return for followup|9|||
131149996|NCT01445171|472171901|FG000|Overall Study|Consented but did not receive device|8|||
131149997|NCT03195894|472171908|FG000|Overall Study|"An example is Started other treatment."|4|||
131149998|NCT03195894|472171909|FG001|Overall Study|"An example is Started other treatment."|5|||
131149999|NCT03195894|472171908|FG000|Overall Study|Withdrawal by Subject|15|||
131150000|NCT03195894|472171909|FG001|Overall Study|Withdrawal by Subject|4|||
131150001|NCT03195894|472171908|FG000|Overall Study|Lost to Follow-up|14|||
131150002|NCT03195894|472171909|FG001|Overall Study|Lost to Follow-up|19|||
131150003|NCT00162773|472171913|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
131150004|NCT02251743|472171914|FG000|Overall Study|Withdrawal by Subject|1|||
131150005|NCT02251743|472171915|FG001|Overall Study|Withdrawal by Subject|1|||
131150006|NCT02091440|472171918|FG000|Overall Study|Death|2|||
131150007|NCT00768222|472171919|FG000|Overall Study|Lost to Follow-up|1|||
131150008|NCT00768222|472171920|FG001|Overall Study|Lost to Follow-up|1|||
131150009|NCT00768222|472171919|FG000|Overall Study|Withdrawal by Subject|3|||
131150010|NCT00768222|472171920|FG001|Overall Study|Withdrawal by Subject|1|||
131150011|NCT00768222|472171919|FG000|Overall Study|Protocol Violation|0|||
131150012|NCT00768222|472171920|FG001|Overall Study|Protocol Violation|2|||
131150013|NCT00278629|472171927|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
131150014|NCT03323749|472171928|FG000|Double-blind Period|Lost to Follow-up|4|||
131150015|NCT03323749|472171929|FG001|Double-blind Period|Lost to Follow-up|5|||
131150016|NCT03323749|472171928|FG000|Double-blind Period|Adverse Event|3|||
131150017|NCT03323749|472171929|FG001|Double-blind Period|Adverse Event|1|||
131150018|NCT03323749|472171928|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
131150019|NCT03323749|472171929|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
131150020|NCT03323749|472171928|FG000|Open-Label Period|Adverse Event|3|||
131150021|NCT03323749|472171929|FG001|Open-Label Period|Adverse Event|10|||
131150022|NCT03323749|472171928|FG000|Open-Label Period|Withdrawal by Subject|7|||
131150023|NCT03323749|472171929|FG001|Open-Label Period|Withdrawal by Subject|5|||
131150024|NCT03263091|472171931|FG000|OL Component|Withdrawal by Subject|1|||
131150025|NCT03263091|472171932|FG001|OL Component|Withdrawal by Subject|1|||
131150026|NCT03263091|472171933|FG002|OL Component|Withdrawal by Subject|0|||
131150027|NCT03263091|472171934|FG003|OL Component|Withdrawal by Subject|0|||
131150028|NCT03263091|472171935|FG004|OL Component|Withdrawal by Subject|0|||
131150029|NCT03263091|472171936|FG005|OL Component|Withdrawal by Subject|0|||
131150030|NCT03263091|472171931|FG000|OL Component|Physician Decision|0|||
131150031|NCT03263091|472171932|FG001|OL Component|Physician Decision|1|||
131150032|NCT03263091|472171933|FG002|OL Component|Physician Decision|2|||
131150033|NCT03263091|472171934|FG003|OL Component|Physician Decision|0|||
131150034|NCT03263091|472171935|FG004|OL Component|Physician Decision|0|||
131150035|NCT03263091|472171936|FG005|OL Component|Physician Decision|0|||
131150036|NCT03263091|472171931|FG000|OL Component|Death|1|||
131150037|NCT03263091|472171932|FG001|OL Component|Death|0|||
131150038|NCT03263091|472171933|FG002|OL Component|Death|0|||
131150039|NCT03263091|472171934|FG003|OL Component|Death|0|||
131150040|NCT03263091|472171935|FG004|OL Component|Death|0|||
131150041|NCT03263091|472171936|FG005|OL Component|Death|0|||
131150042|NCT03263091|472171931|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
131150043|NCT03263091|472171932|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
131150044|NCT03263091|472171933|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
131150045|NCT03263091|472171934|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
131150046|NCT03263091|472171935|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
131150047|NCT03263091|472171936|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
131150048|NCT03263091|472171931|FG000|OL High-EPO Component|Physician Decision|0|||
131150049|NCT03263091|472171932|FG001|OL High-EPO Component|Physician Decision|0|||
131150050|NCT03263091|472171933|FG002|OL High-EPO Component|Physician Decision|0|||
131150051|NCT03263091|472171934|FG003|OL High-EPO Component|Physician Decision|1|||
131150052|NCT03263091|472171935|FG004|OL High-EPO Component|Physician Decision|0|||
131150053|NCT03263091|472171936|FG005|OL High-EPO Component|Physician Decision|0|||
131150054|NCT03263091|472171931|FG000|OL High-EPO Component|Death|0|||
131150055|NCT03263091|472171932|FG001|OL High-EPO Component|Death|0|||
131150056|NCT03263091|472171933|FG002|OL High-EPO Component|Death|0|||
131150057|NCT03263091|472171934|FG003|OL High-EPO Component|Death|3|||
131150058|NCT03263091|472171935|FG004|OL High-EPO Component|Death|0|||
131150059|NCT03263091|472171936|FG005|OL High-EPO Component|Death|0|||
131150060|NCT03263091|472171931|FG000|DB Component|Withdrawal by Subject|0|||
131150061|NCT03263091|472171932|FG001|DB Component|Withdrawal by Subject|0|||
131150062|NCT03263091|472171933|FG002|DB Component|Withdrawal by Subject|0|||
131150063|NCT03263091|472171934|FG003|DB Component|Withdrawal by Subject|0|||
131150064|NCT03263091|472171935|FG004|DB Component|Withdrawal by Subject|22|||
131150065|NCT03263091|472171936|FG005|DB Component|Withdrawal by Subject|8|||
131150066|NCT03263091|472171931|FG000|DB Component|Physician Decision|0|||
131150067|NCT03263091|472171932|FG001|DB Component|Physician Decision|0|||
131150068|NCT03263091|472171933|FG002|DB Component|Physician Decision|0|||
131150069|NCT03263091|472171934|FG003|DB Component|Physician Decision|0|||
131150070|NCT03263091|472171935|FG004|DB Component|Physician Decision|3|||
131150071|NCT03263091|472171936|FG005|DB Component|Physician Decision|1|||
131150072|NCT03263091|472171931|FG000|DB Component|Adverse Event|0|||
131150073|NCT03263091|472171932|FG001|DB Component|Adverse Event|0|||
131150074|NCT03263091|472171933|FG002|DB Component|Adverse Event|0|||
131150075|NCT03263091|472171934|FG003|DB Component|Adverse Event|0|||
131150076|NCT03263091|472171935|FG004|DB Component|Adverse Event|2|||
131150077|NCT03263091|472171936|FG005|DB Component|Adverse Event|1|||
131150078|NCT03263091|472171931|FG000|DB Component|Lost to Follow-up|0|||
131150079|NCT03263091|472171932|FG001|DB Component|Lost to Follow-up|0|||
131150080|NCT03263091|472171933|FG002|DB Component|Lost to Follow-up|0|||
131150081|NCT03263091|472171934|FG003|DB Component|Lost to Follow-up|0|||
131150082|NCT03263091|472171935|FG004|DB Component|Lost to Follow-up|2|||
131150083|NCT03263091|472171936|FG005|DB Component|Lost to Follow-up|1|||
131150084|NCT03263091|472171931|FG000|DB Component|Death|0|||
131150085|NCT03263091|472171932|FG001|DB Component|Death|0|||
131150086|NCT03263091|472171933|FG002|DB Component|Death|0|||
131150087|NCT03263091|472171934|FG003|DB Component|Death|0|||
131150088|NCT03263091|472171935|FG004|DB Component|Death|7|||
131150089|NCT03263091|472171936|FG005|DB Component|Death|4|||
131150090|NCT03263091|472171931|FG000|DB Component|Other than specified|0|||
131150091|NCT03263091|472171932|FG001|DB Component|Other than specified|0|||
131150092|NCT03263091|472171933|FG002|DB Component|Other than specified|0|||
131150093|NCT03263091|472171934|FG003|DB Component|Other than specified|0|||
131150094|NCT03263091|472171935|FG004|DB Component|Other than specified|8|||
131150095|NCT03263091|472171936|FG005|DB Component|Other than specified|6|||
131150096|NCT02468193|472171937|FG000|Overall Study|Adverse Event|4|||
131150097|NCT02468193|472171937|FG000|Overall Study|Subject/ Guardian decision|2|||
131150098|NCT00826748|472171938|FG000|Overall Study|Withdrawal by Subject|0|||
131150099|NCT00826748|472171939|FG001|Overall Study|Withdrawal by Subject|0|||
131150100|NCT00826748|472171940|FG002|Overall Study|Withdrawal by Subject|2|||
131150101|NCT00826748|472171938|FG000|Overall Study|Physician Decision|0|||
131150102|NCT00826748|472171939|FG001|Overall Study|Physician Decision|0|||
131150103|NCT00826748|472171940|FG002|Overall Study|Physician Decision|1|||
131150104|NCT00826748|472171938|FG000|Overall Study|Samples Did Not pass QC|0|||
131150105|NCT00826748|472171939|FG001|Overall Study|Samples Did Not pass QC|0|||
131150106|NCT00826748|472171940|FG002|Overall Study|Samples Did Not pass QC|1|||
131150107|NCT03312218|472171943|FG000|Overall Study|Never signed in to access the app|54|||
131150108|NCT03312218|472171944|FG001|Overall Study|Never signed in to access the app|58|||
131150109|NCT01887912|472171946|FG000|Overall Study|Serious adverse event|400|||
131150110|NCT01887912|472171947|FG001|Overall Study|Serious adverse event|198|||
131150111|NCT01887912|472171946|FG000|Overall Study|Other Adverse Event|34|||
131150112|NCT01887912|472171947|FG001|Overall Study|Other Adverse Event|15|||
131150113|NCT01887912|472171946|FG000|Overall Study|Protocol Violation|67|||
131150114|NCT01887912|472171947|FG001|Overall Study|Protocol Violation|37|||
131150115|NCT01887912|472171946|FG000|Overall Study|Lost to Follow-up|163|||
131150116|NCT01887912|472171947|FG001|Overall Study|Lost to Follow-up|74|||
131150117|NCT01887912|472171946|FG000|Overall Study|Withdrawal by Subject|606|||
131150118|NCT01887912|472171947|FG001|Overall Study|Withdrawal by Subject|349|||
131150119|NCT01887912|472171946|FG000|Overall Study|Other|122|||
131150120|NCT01887912|472171947|FG001|Overall Study|Other|58|||
131150121|NCT05067127|472171950|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
131150122|NCT05067127|472171951|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
131150123|NCT05067127|472171952|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
131150124|NCT05067127|472171953|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
131150125|NCT05067127|472171950|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
131150126|NCT05067127|472171951|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
131150127|NCT05067127|472171952|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
131150128|NCT05067127|472171953|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
131150129|NCT05067127|472171950|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
131150130|NCT05067127|472171951|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
131150131|NCT05067127|472171952|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
131150132|NCT05067127|472171953|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
131150133|NCT05067127|472171950|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
131150134|NCT05067127|472171951|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
131150135|NCT05067127|472171952|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
131150136|NCT05067127|472171953|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
131150137|NCT05067127|472171950|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
131150138|NCT05067127|472171951|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
131150139|NCT05067127|472171952|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
131150140|NCT05067127|472171953|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
131150141|NCT05067127|472171950|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
131150142|NCT05067127|472171951|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
131150143|NCT05067127|472171952|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
131150144|NCT05067127|472171953|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
131150145|NCT05067127|472171950|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
131150146|NCT05067127|472171951|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
131150147|NCT05067127|472171952|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
131150148|NCT05067127|472171953|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
131150149|NCT04462536|472171954|FG000|Overall Study|Withdrawal by Subject|3|||
131150150|NCT04462536|472171955|FG001|Overall Study|Withdrawal by Subject|9|||
131150151|NCT04462536|472171954|FG000|Overall Study|Lost to Follow-up|2|||
131150152|NCT04462536|472171955|FG001|Overall Study|Lost to Follow-up|4|||
131150153|NCT04439266|472171959|FG000|Overall Study|Ineligible|1|||
131150154|NCT04439266|472171959|FG000|Overall Study|Adverse Event|1|||
131150155|NCT04439266|472171959|FG000|Overall Study|Death|1|||
131150156|NCT04439266|472171959|FG000|Overall Study|Disease progression|1|||
131150157|NCT04439266|472171959|FG000|Overall Study|Still on treatment|1|||
131150158|NCT06161012|472171962|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
131150159|NCT06161012|472171963|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
131150160|NCT02601950|472171964|FG000|Overall Study|Participant enrolled in rollover study|0|||
131150161|NCT02601950|472171965|FG001|Overall Study|Participant enrolled in rollover study|0|||
131150162|NCT02601950|472171966|FG002|Overall Study|Participant enrolled in rollover study|1|||
131150163|NCT02601950|472171967|FG003|Overall Study|Participant enrolled in rollover study|0|||
131150164|NCT02601950|472171968|FG004|Overall Study|Participant enrolled in rollover study|1|||
131150165|NCT02601950|472171969|FG005|Overall Study|Participant enrolled in rollover study|1|||
131150166|NCT02601950|472171970|FG006|Overall Study|Participant enrolled in rollover study|1|||
131150167|NCT02601950|472171971|FG007|Overall Study|Participant enrolled in rollover study|0|||
131150168|NCT02601950|472171964|FG000|Overall Study|Disease progression - radiological|21|||
131150169|NCT02601950|472171965|FG001|Overall Study|Disease progression - radiological|26|||
131150170|NCT02601950|472171966|FG002|Overall Study|Disease progression - radiological|22|||
131150171|NCT02601950|472171967|FG003|Overall Study|Disease progression - radiological|11|||
131150172|NCT02601950|472171968|FG004|Overall Study|Disease progression - radiological|46|||
131150173|NCT02601950|472171969|FG005|Overall Study|Disease progression - radiological|52|||
131150174|NCT02601950|472171970|FG006|Overall Study|Disease progression - radiological|7|||
131150175|NCT02601950|472171971|FG007|Overall Study|Disease progression - radiological|5|||
131150176|NCT02601950|472171964|FG000|Overall Study|Disease progression - clinical|3|||
131150177|NCT02601950|472171965|FG001|Overall Study|Disease progression - clinical|5|||
131150178|NCT02601950|472171966|FG002|Overall Study|Disease progression - clinical|4|||
131150179|NCT02601950|472171967|FG003|Overall Study|Disease progression - clinical|2|||
131150180|NCT02601950|472171968|FG004|Overall Study|Disease progression - clinical|6|||
131150181|NCT02601950|472171969|FG005|Overall Study|Disease progression - clinical|6|||
131150182|NCT02601950|472171970|FG006|Overall Study|Disease progression - clinical|5|||
131150183|NCT02601950|472171971|FG007|Overall Study|Disease progression - clinical|1|||
131150184|NCT02601950|472171964|FG000|Overall Study|Death|6|||
131150185|NCT02601950|472171965|FG001|Overall Study|Death|0|||
131150186|NCT02601950|472171966|FG002|Overall Study|Death|3|||
131150187|NCT02601950|472171967|FG003|Overall Study|Death|1|||
131150188|NCT02601950|472171968|FG004|Overall Study|Death|4|||
131150189|NCT02601950|472171969|FG005|Overall Study|Death|1|||
131150190|NCT02601950|472171970|FG006|Overall Study|Death|0|||
131150191|NCT02601950|472171971|FG007|Overall Study|Death|0|||
131150192|NCT02601950|472171964|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131150193|NCT02601950|472171965|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131150194|NCT02601950|472171966|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131150195|NCT02601950|472171967|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131150196|NCT02601950|472171968|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131150197|NCT02601950|472171969|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
131150198|NCT02601950|472171970|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131150199|NCT02601950|472171971|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
131150200|NCT02601950|472171964|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
131150201|NCT02601950|472171965|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
131150202|NCT02601950|472171966|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
131150203|NCT02601950|472171967|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
131150204|NCT02601950|472171968|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
131150205|NCT02601950|472171969|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
131150206|NCT02601950|472171970|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
131150207|NCT02601950|472171971|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
131150208|NCT02601950|472171964|FG000|Overall Study|Non-compliance|0|||
131150209|NCT02601950|472171965|FG001|Overall Study|Non-compliance|1|||
131150210|NCT02601950|472171966|FG002|Overall Study|Non-compliance|0|||
131150211|NCT02601950|472171967|FG003|Overall Study|Non-compliance|0|||
131150212|NCT02601950|472171968|FG004|Overall Study|Non-compliance|0|||
131150213|NCT02601950|472171969|FG005|Overall Study|Non-compliance|1|||
131150214|NCT02601950|472171970|FG006|Overall Study|Non-compliance|1|||
131150215|NCT02601950|472171971|FG007|Overall Study|Non-compliance|0|||
131150216|NCT02601950|472171964|FG000|Overall Study|Participant refused further study treatment|0|||
131150217|NCT02601950|472171965|FG001|Overall Study|Participant refused further study treatment|1|||
131150218|NCT02601950|472171966|FG002|Overall Study|Participant refused further study treatment|1|||
131150219|NCT02601950|472171967|FG003|Overall Study|Participant refused further study treatment|0|||
131150220|NCT02601950|472171968|FG004|Overall Study|Participant refused further study treatment|2|||
131150221|NCT02601950|472171969|FG005|Overall Study|Participant refused further study treatment|2|||
131150222|NCT02601950|472171970|FG006|Overall Study|Participant refused further study treatment|2|||
131150223|NCT02601950|472171971|FG007|Overall Study|Participant refused further study treatment|1|||
131150224|NCT02601950|472171964|FG000|Overall Study|Investigator discretion|1|||
131150225|NCT02601950|472171965|FG001|Overall Study|Investigator discretion|0|||
131150226|NCT02601950|472171966|FG002|Overall Study|Investigator discretion|1|||
131150227|NCT02601950|472171967|FG003|Overall Study|Investigator discretion|0|||
131150228|NCT02601950|472171968|FG004|Overall Study|Investigator discretion|1|||
131150229|NCT02601950|472171969|FG005|Overall Study|Investigator discretion|1|||
131150230|NCT02601950|472171970|FG006|Overall Study|Investigator discretion|1|||
131150231|NCT02601950|472171971|FG007|Overall Study|Investigator discretion|0|||
131150232|NCT02601950|472171964|FG000|Overall Study|Other|0|||
131150233|NCT02601950|472171965|FG001|Overall Study|Other|0|||
131150234|NCT02601950|472171966|FG002|Overall Study|Other|0|||
131150235|NCT02601950|472171967|FG003|Overall Study|Other|0|||
131150236|NCT02601950|472171968|FG004|Overall Study|Other|2|||
131150237|NCT02601950|472171969|FG005|Overall Study|Other|2|||
131150238|NCT02601950|472171970|FG006|Overall Study|Other|1|||
131150239|NCT02601950|472171971|FG007|Overall Study|Other|0|||
131150240|NCT04889209|472171976|FG000|All Cohorts Except 15E|Adverse Event|0|||
131150241|NCT04889209|472171977|FG001|All Cohorts Except 15E|Adverse Event|0|||
131150242|NCT04889209|472171978|FG002|All Cohorts Except 15E|Adverse Event|0|||
131150243|NCT04889209|472171979|FG003|All Cohorts Except 15E|Adverse Event|0|||
131150244|NCT04889209|472171980|FG004|All Cohorts Except 15E|Adverse Event|0|||
131150245|NCT04889209|472171981|FG005|All Cohorts Except 15E|Adverse Event|0|||
131150246|NCT04889209|472171982|FG006|All Cohorts Except 15E|Adverse Event|1|||
131150247|NCT04889209|472171983|FG007|All Cohorts Except 15E|Adverse Event|0|||
131150248|NCT04889209|472171984|FG008|All Cohorts Except 15E|Adverse Event|0|||
131150249|NCT04889209|472171985|FG009|All Cohorts Except 15E|Adverse Event|0|||
131150250|NCT04889209|472171986|FG010|All Cohorts Except 15E|Adverse Event|0|||
131150251|NCT04889209|472171987|FG011|All Cohorts Except 15E|Adverse Event|0|||
131150252|NCT04889209|472171988|FG012|All Cohorts Except 15E|Adverse Event|0|||
131150253|NCT04889209|472171989|FG013|All Cohorts Except 15E|Adverse Event|0|||
131150254|NCT04889209|472171990|FG014|All Cohorts Except 15E|Adverse Event|0|||
131150255|NCT04889209|472171991|FG015|All Cohorts Except 15E|Adverse Event|0|||
131150256|NCT04889209|472171992|FG016|All Cohorts Except 15E|Adverse Event|0|||
131234911|NCT00409578|472486516|FG000|Overall Study|Lost to Follow-up|2|||
131234912|NCT00409578|472486517|FG001|Overall Study|Lost to Follow-up|0|||
131234913|NCT00409578|472486518|FG002|Overall Study|Lost to Follow-up|2|||
131234914|NCT00409578|472486519|FG003|Overall Study|Lost to Follow-up|2|||
131150257|NCT04889209|472171993|FG017|All Cohorts Except 15E|Adverse Event|0|||
131150258|NCT04889209|472171976|FG000|All Cohorts Except 15E|Death|0|||
131150259|NCT04889209|472171977|FG001|All Cohorts Except 15E|Death|1|||
131150260|NCT04889209|472171978|FG002|All Cohorts Except 15E|Death|0|||
131150261|NCT04889209|472171979|FG003|All Cohorts Except 15E|Death|0|||
131150262|NCT04889209|472171980|FG004|All Cohorts Except 15E|Death|0|||
131150263|NCT04889209|472171981|FG005|All Cohorts Except 15E|Death|0|||
131150264|NCT04889209|472171982|FG006|All Cohorts Except 15E|Death|0|||
131150265|NCT04889209|472171983|FG007|All Cohorts Except 15E|Death|0|||
131150266|NCT04889209|472171984|FG008|All Cohorts Except 15E|Death|0|||
131150267|NCT04889209|472171985|FG009|All Cohorts Except 15E|Death|0|||
131150268|NCT04889209|472171986|FG010|All Cohorts Except 15E|Death|0|||
131150269|NCT04889209|472171987|FG011|All Cohorts Except 15E|Death|0|||
131150270|NCT04889209|472171988|FG012|All Cohorts Except 15E|Death|0|||
131150271|NCT04889209|472171989|FG013|All Cohorts Except 15E|Death|0|||
131150272|NCT04889209|472171990|FG014|All Cohorts Except 15E|Death|0|||
131150273|NCT04889209|472171991|FG015|All Cohorts Except 15E|Death|0|||
131150274|NCT04889209|472171992|FG016|All Cohorts Except 15E|Death|0|||
131150275|NCT04889209|472171993|FG017|All Cohorts Except 15E|Death|0|||
131150276|NCT04889209|472171976|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
131150277|NCT04889209|472171977|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
131150278|NCT04889209|472171978|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
131150279|NCT04889209|472171979|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
131150280|NCT04889209|472171980|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
131150281|NCT04889209|472171981|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
131150282|NCT04889209|472171982|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
131150283|NCT04889209|472171983|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
131150284|NCT04889209|472171984|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
131150285|NCT04889209|472171985|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
131150286|NCT04889209|472171986|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
131150287|NCT04889209|472171987|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
131150288|NCT04889209|472171988|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
131150289|NCT04889209|472171989|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
131150290|NCT04889209|472171990|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
131150291|NCT04889209|472171991|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
131150292|NCT04889209|472171992|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
131150293|NCT04889209|472171993|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
131150294|NCT04889209|472171976|FG000|All Cohorts Except 15E|Physician Decision|0|||
131150295|NCT04889209|472171977|FG001|All Cohorts Except 15E|Physician Decision|0|||
131150296|NCT04889209|472171978|FG002|All Cohorts Except 15E|Physician Decision|0|||
131150297|NCT04889209|472171979|FG003|All Cohorts Except 15E|Physician Decision|0|||
131150298|NCT04889209|472171980|FG004|All Cohorts Except 15E|Physician Decision|1|||
131150299|NCT04889209|472171981|FG005|All Cohorts Except 15E|Physician Decision|0|||
131150300|NCT04889209|472171982|FG006|All Cohorts Except 15E|Physician Decision|0|||
131150301|NCT04889209|472171983|FG007|All Cohorts Except 15E|Physician Decision|1|||
131150302|NCT04889209|472171984|FG008|All Cohorts Except 15E|Physician Decision|0|||
131150303|NCT04889209|472171985|FG009|All Cohorts Except 15E|Physician Decision|1|||
131150304|NCT04889209|472171986|FG010|All Cohorts Except 15E|Physician Decision|0|||
131150305|NCT04889209|472171987|FG011|All Cohorts Except 15E|Physician Decision|1|||
131150306|NCT04889209|472171988|FG012|All Cohorts Except 15E|Physician Decision|1|||
131150307|NCT04889209|472171989|FG013|All Cohorts Except 15E|Physician Decision|0|||
131150308|NCT04889209|472171990|FG014|All Cohorts Except 15E|Physician Decision|0|||
131150309|NCT04889209|472171991|FG015|All Cohorts Except 15E|Physician Decision|0|||
131150310|NCT04889209|472171992|FG016|All Cohorts Except 15E|Physician Decision|0|||
131150311|NCT04889209|472171993|FG017|All Cohorts Except 15E|Physician Decision|0|||
131150312|NCT04889209|472171976|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
131150313|NCT04889209|472171977|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
131150314|NCT04889209|472171978|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
131150315|NCT04889209|472171979|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
131150316|NCT04889209|472171980|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
131234915|NCT00409578|472486516|FG000|Overall Study|Administrative problems|8|||
131150317|NCT04889209|472171981|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
131150318|NCT04889209|472171982|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
131150319|NCT04889209|472171983|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
131150320|NCT04889209|472171984|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
131234916|NCT00409578|472486517|FG001|Overall Study|Administrative problems|9|||
131234917|NCT00409578|472486518|FG002|Overall Study|Administrative problems|2|||
131234918|NCT00409578|472486519|FG003|Overall Study|Administrative problems|4|||
131234919|NCT00409578|472486516|FG000|Overall Study|Death|2|||
131150321|NCT04889209|472171985|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
131150322|NCT04889209|472171986|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
131150323|NCT04889209|472171987|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
131150324|NCT04889209|472171988|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
131150325|NCT04889209|472171989|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
131150326|NCT04889209|472171990|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
131150327|NCT04889209|472171991|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
131150328|NCT04889209|472171992|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
131150329|NCT04889209|472171993|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
131234920|NCT00409578|472486517|FG001|Overall Study|Death|4|||
131150330|NCT04889209|472171976|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
131150331|NCT04889209|472171977|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
131150332|NCT04889209|472171978|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150333|NCT04889209|472171979|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131234921|NCT00409578|472486518|FG002|Overall Study|Death|4|||
131150334|NCT04889209|472171980|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150335|NCT04889209|472171981|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
131150336|NCT04889209|472171982|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150337|NCT04889209|472171983|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
131150338|NCT04889209|472171984|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150339|NCT04889209|472171985|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
131150340|NCT04889209|472171986|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150341|NCT04889209|472171987|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150342|NCT04889209|472171988|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150343|NCT04889209|472171989|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150344|NCT04889209|472171990|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150345|NCT04889209|472171991|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150346|NCT04889209|472171992|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
131150347|NCT04889209|472171993|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
131150348|NCT04889209|472171976|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150349|NCT04889209|472171977|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150350|NCT04889209|472171978|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150351|NCT04889209|472171979|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
131150352|NCT04889209|472171980|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150353|NCT04889209|472171981|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150354|NCT04889209|472171982|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150355|NCT04889209|472171983|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150356|NCT04889209|472171984|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150357|NCT04889209|472171985|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150358|NCT04889209|472171986|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150359|NCT04889209|472171987|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150360|NCT04889209|472171988|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150361|NCT04889209|472171989|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150362|NCT04889209|472171990|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150363|NCT04889209|472171991|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150364|NCT04889209|472171992|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150365|NCT04889209|472171993|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
131150366|NCT04889209|472171976|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150367|NCT04889209|472171977|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150368|NCT04889209|472171978|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150369|NCT04889209|472171979|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150370|NCT04889209|472171980|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131150371|NCT04889209|472171981|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150372|NCT04889209|472171982|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131150373|NCT04889209|472171983|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131150374|NCT04889209|472171984|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150375|NCT04889209|472171985|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131150376|NCT04889209|472171986|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131150377|NCT04889209|472171987|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150378|NCT04889209|472171988|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131150379|NCT04889209|472171989|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150380|NCT04889209|472171990|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150381|NCT04889209|472171991|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150382|NCT04889209|472171992|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
131150383|NCT04889209|472171993|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
131150384|NCT04889209|472171976|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150385|NCT04889209|472171977|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150386|NCT04889209|472171978|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150387|NCT04889209|472171979|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150388|NCT04889209|472171980|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150389|NCT04889209|472171981|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150390|NCT04889209|472171982|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150391|NCT04889209|472171983|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150392|NCT04889209|472171984|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150393|NCT04889209|472171985|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150394|NCT04889209|472171986|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150395|NCT04889209|472171987|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150396|NCT04889209|472171988|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150397|NCT04889209|472171989|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150398|NCT04889209|472171990|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150399|NCT04889209|472171991|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150400|NCT04889209|472171992|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
131150401|NCT04889209|472171993|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
131150402|NCT04889209|472171976|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150403|NCT04889209|472171977|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150404|NCT04889209|472171978|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150405|NCT04889209|472171979|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150406|NCT04889209|472171980|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150407|NCT04889209|472171981|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150408|NCT04889209|472171982|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150409|NCT04889209|472171983|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150410|NCT04889209|472171984|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150411|NCT04889209|472171985|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150412|NCT04889209|472171986|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150413|NCT04889209|472171987|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150414|NCT04889209|472171988|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150415|NCT04889209|472171989|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150416|NCT04889209|472171990|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150417|NCT04889209|472171991|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150418|NCT04889209|472171992|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
131150419|NCT04889209|472171993|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
131150420|NCT04889209|472171976|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150421|NCT04889209|472171977|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150422|NCT04889209|472171978|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150423|NCT04889209|472171979|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150424|NCT04889209|472171980|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150425|NCT04889209|472171981|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150426|NCT04889209|472171982|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150427|NCT04889209|472171983|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150428|NCT04889209|472171984|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150429|NCT04889209|472171985|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150430|NCT04889209|472171986|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150431|NCT04889209|472171987|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150432|NCT04889209|472171988|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150433|NCT04889209|472171989|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150434|NCT04889209|472171990|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
131150435|NCT04889209|472171991|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150436|NCT04889209|472171992|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150437|NCT04889209|472171993|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
131150438|NCT01725165|472171996|FG000|Overall Study|Death|11|||
131150439|NCT01725165|472171997|FG001|Overall Study|Death|18|||
131150440|NCT03049449|472171998|FG000|Overall Study|Did not receive treatment.|0|||
131150441|NCT03049449|472171999|FG001|Overall Study|Did not receive treatment.|0|||
131150442|NCT03049449|472172000|FG002|Overall Study|Did not receive treatment.|0|||
131150443|NCT03049449|472172001|FG003|Overall Study|Did not receive treatment.|0|||
131150444|NCT03049449|472172002|FG004|Overall Study|Did not receive treatment.|0|||
131150445|NCT03049449|472172003|FG005|Overall Study|Did not receive treatment.|0|||
131150446|NCT03049449|472172004|FG006|Overall Study|Did not receive treatment.|0|||
131150447|NCT03049449|472172005|FG007|Overall Study|Did not receive treatment.|0|||
131150448|NCT03049449|472172006|FG008|Overall Study|Did not receive treatment.|1|||
131150449|NCT03049449|472172007|FG009|Overall Study|Did not receive treatment.|0|||
131150450|NCT03049449|472171998|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
131150451|NCT03049449|472171999|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
131150452|NCT03049449|472172000|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
131150453|NCT03049449|472172001|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
131150454|NCT03049449|472172002|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
131150455|NCT03049449|472172003|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
131150456|NCT03049449|472172004|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
131150457|NCT03049449|472172005|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
131150458|NCT03049449|472172006|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
131150459|NCT03049449|472172007|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
131150460|NCT03049449|472171998|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131150461|NCT03049449|472171999|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131150462|NCT03049449|472172000|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131150463|NCT03049449|472172001|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131150464|NCT03049449|472172002|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131150465|NCT03049449|472172003|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131150466|NCT03049449|472172004|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131150467|NCT03049449|472172005|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
131150468|NCT03049449|472172006|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
131150469|NCT03049449|472172007|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
131150470|NCT00442598|472172008|FG000|Overall Study|Adverse Event|1|||
131150471|NCT00442598|472172009|FG001|Overall Study|Adverse Event|0|||
131150472|NCT00442598|472172010|FG002|Overall Study|Adverse Event|0|||
131150473|NCT00442598|472172008|FG000|Overall Study|Tumor progression|3|||
131150474|NCT00442598|472172009|FG001|Overall Study|Tumor progression|4|||
131150475|NCT00442598|472172010|FG002|Overall Study|Tumor progression|0|||
131150476|NCT00442598|472172008|FG000|Overall Study|Clinical deterioration|1|||
131150477|NCT00442598|472172009|FG001|Overall Study|Clinical deterioration|2|||
131150478|NCT00442598|472172010|FG002|Overall Study|Clinical deterioration|0|||
131150479|NCT00442598|472172008|FG000|Overall Study|CA125 progression|0|||
131150480|NCT00442598|472172009|FG001|Overall Study|CA125 progression|1|||
131150481|NCT00442598|472172010|FG002|Overall Study|CA125 progression|0|||
131150482|NCT00442598|472172008|FG000|Overall Study|Reduced creatinine clearance|1|||
131150483|NCT00442598|472172009|FG001|Overall Study|Reduced creatinine clearance|0|||
131150484|NCT00442598|472172010|FG002|Overall Study|Reduced creatinine clearance|0|||
131150485|NCT00442598|472172008|FG000|Overall Study|Death|0|||
131150486|NCT00442598|472172009|FG001|Overall Study|Death|1|||
131150487|NCT00442598|472172010|FG002|Overall Study|Death|0|||
131150488|NCT01147497|472172011|FG000|Overall Study|failed insertion|2|||
130728028|NCT01449370|470625588|FG022|Overall Study|Medication Prohibited by Protocol|0|||
130728029|NCT01449370|470625589|FG023|Overall Study|Medication Prohibited by Protocol|1|||
130728030|NCT01449370|470625590|FG024|Overall Study|Medication Prohibited by Protocol|0|||
131150489|NCT01147497|472172012|FG001|Overall Study|failed insertion|0|||
131150490|NCT00355264|472172015|FG000|Extension (Variable Duration)|Adverse Event|1|||
131150491|NCT00355264|472172015|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
131150492|NCT01157117|472172016|FG000|Overall Study|Dosing Symptoms|0|||
131150493|NCT01157117|472172017|FG001|Overall Study|Dosing Symptoms|4|||
131150494|NCT01157117|472172018|FG002|Overall Study|Dosing Symptoms|0|||
131150495|NCT01157117|472172016|FG000|Overall Study|Withdrawal by Subject|4|||
131150496|NCT01157117|472172017|FG001|Overall Study|Withdrawal by Subject|1|||
131150497|NCT01157117|472172018|FG002|Overall Study|Withdrawal by Subject|1|||
131150498|NCT01157117|472172016|FG000|Overall Study|Lack of Efficacy|1|||
131150499|NCT01157117|472172017|FG001|Overall Study|Lack of Efficacy|1|||
131150500|NCT01157117|472172018|FG002|Overall Study|Lack of Efficacy|0|||
131150501|NCT01157117|472172016|FG000|Overall Study|Lost to Follow-up|0|||
131150502|NCT01157117|472172017|FG001|Overall Study|Lost to Follow-up|0|||
131150503|NCT01157117|472172018|FG002|Overall Study|Lost to Follow-up|1|||
131150504|NCT01157117|472172016|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
131150505|NCT01157117|472172017|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
131150506|NCT01157117|472172018|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
131150507|NCT00826514|472172019|FG000|Overall Study|Adverse Event|1|||
131150508|NCT00826514|472172020|FG001|Overall Study|Adverse Event|1|||
131150509|NCT00826514|472172019|FG000|Overall Study|Lack of Efficacy|0|||
131150510|NCT00826514|472172020|FG001|Overall Study|Lack of Efficacy|1|||
131150511|NCT00826514|472172019|FG000|Overall Study|Withdrawal by Subject|2|||
131150512|NCT00826514|472172020|FG001|Overall Study|Withdrawal by Subject|3|||
131150513|NCT03663166|472172021|FG000|Overall Study|Withdrawal by Subject|1|||
131150514|NCT02209506|472172027|FG000|Overall Study|Withdrawal by Subject|0|||
131150515|NCT02209506|472172028|FG001|Overall Study|Withdrawal by Subject|0|||
131150516|NCT02209506|472172029|FG002|Overall Study|Withdrawal by Subject|0|||
131150517|NCT02209506|472172030|FG003|Overall Study|Withdrawal by Subject|0|||
131150518|NCT02209506|472172031|FG004|Overall Study|Withdrawal by Subject|1|||
131150519|NCT00098787|472172032|FG000|Overall Study|Never started treatment|3|||
131234922|NCT00409578|472486519|FG003|Overall Study|Death|2|||
131234923|NCT00409578|472486516|FG000|Overall Study|Protocol Violation|3|||
130728031|NCT01449370|470625566|FG000|Overall Study|Death|0|||
131150520|NCT00098787|472172033|FG001|Overall Study|Never started treatment|2|||
131150521|NCT00098787|472172034|FG002|Overall Study|Never started treatment|1|||
131150522|NCT00098787|472172032|FG000|Overall Study|Ineligible|9|||
131150523|NCT00098787|472172033|FG001|Overall Study|Ineligible|7|||
131150524|NCT00098787|472172034|FG002|Overall Study|Ineligible|3|||
131150525|NCT00098787|472172032|FG000|Overall Study|Disease progression|28|||
131150526|NCT00098787|472172033|FG001|Overall Study|Disease progression|17|||
131150527|NCT00098787|472172034|FG002|Overall Study|Disease progression|23|||
131150528|NCT00098787|472172032|FG000|Overall Study|Adverse Event|8|||
131150529|NCT00098787|472172033|FG001|Overall Study|Adverse Event|17|||
131150530|NCT00098787|472172034|FG002|Overall Study|Adverse Event|8|||
131150531|NCT00098787|472172032|FG000|Overall Study|Death|6|||
131150532|NCT00098787|472172033|FG001|Overall Study|Death|1|||
131150533|NCT00098787|472172034|FG002|Overall Study|Death|0|||
131150534|NCT00098787|472172032|FG000|Overall Study|Withdrawal by Subject|4|||
131150535|NCT00098787|472172033|FG001|Overall Study|Withdrawal by Subject|12|||
131150536|NCT00098787|472172034|FG002|Overall Study|Withdrawal by Subject|6|||
131150537|NCT00098787|472172032|FG000|Overall Study|Alternative therapy|8|||
131150538|NCT00098787|472172033|FG001|Overall Study|Alternative therapy|13|||
131150539|NCT00098787|472172034|FG002|Overall Study|Alternative therapy|13|||
131150540|NCT00098787|472172032|FG000|Overall Study|Other|7|||
131150541|NCT00098787|472172033|FG001|Overall Study|Other|6|||
131150542|NCT00098787|472172034|FG002|Overall Study|Other|9|||
131150543|NCT02537678|472172037|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
131150544|NCT02537678|472172038|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
131150545|NCT02537678|472172037|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
131150546|NCT02537678|472172038|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
131150547|NCT02537678|472172037|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
131150548|NCT02537678|472172038|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
131150549|NCT02537678|472172037|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
131150550|NCT02537678|472172038|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
131150551|NCT02537678|472172037|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
131150552|NCT02537678|472172038|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
131150553|NCT02537678|472172037|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
131150554|NCT02537678|472172038|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
131150555|NCT02537678|472172037|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
131150556|NCT02537678|472172038|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
131150557|NCT01360996|472172039|FG000|Overall Study|Withdrawal by Subject|4|||
131150558|NCT01360996|472172040|FG001|Overall Study|Withdrawal by Subject|3|||
131150559|NCT01360996|472172041|FG002|Overall Study|Withdrawal by Subject|2|||
131150560|NCT01360996|472172039|FG000|Overall Study|Noncompliant|2|||
131150561|NCT01360996|472172040|FG001|Overall Study|Noncompliant|0|||
131150562|NCT01360996|472172041|FG002|Overall Study|Noncompliant|0|||
131150563|NCT04348851|472172042|FG000|Post-Test 1|Withdrawal by Subject|0|||
131150564|NCT04348851|472172043|FG001|Post-Test 1|Withdrawal by Subject|1|||
131150565|NCT04348851|472172044|FG002|Post-Test 1|Withdrawal by Subject|0|||
131150566|NCT04348851|472172045|FG003|Post-Test 1|Withdrawal by Subject|0|||
131150567|NCT04348851|472172042|FG000|Post-Test 1|Lost to Follow-up|0|||
131150568|NCT04348851|472172043|FG001|Post-Test 1|Lost to Follow-up|1|||
131150569|NCT04348851|472172044|FG002|Post-Test 1|Lost to Follow-up|0|||
131150570|NCT04348851|472172045|FG003|Post-Test 1|Lost to Follow-up|0|||
131150571|NCT04348851|472172042|FG000|Post-Test 2|Stroke survivor death|0|||
131150572|NCT04348851|472172043|FG001|Post-Test 2|Stroke survivor death|1|||
130728032|NCT01449370|470625567|FG001|Overall Study|Death|0|||
131150573|NCT04348851|472172044|FG002|Post-Test 2|Stroke survivor death|0|||
131150574|NCT04348851|472172045|FG003|Post-Test 2|Stroke survivor death|1|||
131150575|NCT02965378|472172046|FG000|Overall Study|Progression|16|||
131150576|NCT02965378|472172047|FG001|Overall Study|Progression|4|||
131150577|NCT02965378|472172046|FG000|Overall Study|Adverse Event|5|||
131150578|NCT02965378|472172047|FG001|Overall Study|Adverse Event|2|||
131150579|NCT02965378|472172046|FG000|Overall Study|Death|2|||
131150580|NCT02965378|472172047|FG001|Overall Study|Death|0|||
131150581|NCT02965378|472172046|FG000|Overall Study|Refusal|2|||
131150582|NCT02965378|472172047|FG001|Overall Study|Refusal|1|||
131150583|NCT02965378|472172046|FG000|Overall Study|Not protocol specified|0|||
131150584|NCT02965378|472172047|FG001|Overall Study|Not protocol specified|2|||
131150585|NCT00629083|472172048|FG000|Overall Study|Adverse Event|0|||
130728033|NCT01449370|470625568|FG002|Overall Study|Death|0|||
131150586|NCT00629083|472172049|FG001|Overall Study|Adverse Event|2|||
131150587|NCT00629083|472172048|FG000|Overall Study|Lack of Efficacy|3|||
131150588|NCT00629083|472172049|FG001|Overall Study|Lack of Efficacy|1|||
131150589|NCT00629083|472172048|FG000|Overall Study|Withdrawal by Subject|10|||
131150590|NCT00629083|472172049|FG001|Overall Study|Withdrawal by Subject|2|||
131150591|NCT00629083|472172048|FG000|Overall Study|Lost to Follow-up|12|||
131150592|NCT00629083|472172049|FG001|Overall Study|Lost to Follow-up|8|||
131150593|NCT00629083|472172048|FG000|Overall Study|Moved out of country/state|2|||
131150594|NCT00629083|472172049|FG001|Overall Study|Moved out of country/state|1|||
131150595|NCT00629083|472172048|FG000|Overall Study|Refused to return for 12 month visit|1|||
131150596|NCT00629083|472172049|FG001|Overall Study|Refused to return for 12 month visit|0|||
131150597|NCT02909153|472172050|FG000|Overall Study|Withdrawal by Subject|0|||
131150598|NCT02909153|472172051|FG001|Overall Study|Withdrawal by Subject|1|||
131150599|NCT02909153|472172052|FG002|Overall Study|Withdrawal by Subject|0|||
131150600|NCT02909153|472172053|FG003|Overall Study|Withdrawal by Subject|0|||
131150601|NCT02909153|472172054|FG004|Overall Study|Withdrawal by Subject|0|||
131150602|NCT01147809|472172057|FG000|Phase I (168 Days)|Adverse Event|0|||
131150603|NCT01147809|472172058|FG001|Phase I (168 Days)|Adverse Event|0|||
131150604|NCT01147809|472172059|FG002|Phase I (168 Days)|Adverse Event|0|||
131150605|NCT01147809|472172060|FG003|Phase I (168 Days)|Adverse Event|1|||
131150606|NCT01147809|472172061|FG004|Phase I (168 Days)|Adverse Event|0|||
131150607|NCT01147809|472172062|FG005|Phase I (168 Days)|Adverse Event|0|||
131150608|NCT01147809|472172057|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
131150609|NCT01147809|472172058|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
131150610|NCT01147809|472172059|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
131150611|NCT01147809|472172060|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
131150612|NCT01147809|472172061|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
131150613|NCT01147809|472172062|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
131150614|NCT01147809|472172057|FG000|Phase I (168 Days)|Physician Decision|0|||
131150615|NCT01147809|472172058|FG001|Phase I (168 Days)|Physician Decision|1|||
131150616|NCT01147809|472172059|FG002|Phase I (168 Days)|Physician Decision|2|||
131150617|NCT01147809|472172060|FG003|Phase I (168 Days)|Physician Decision|0|||
131150618|NCT01147809|472172061|FG004|Phase I (168 Days)|Physician Decision|0|||
131150619|NCT01147809|472172062|FG005|Phase I (168 Days)|Physician Decision|0|||
131150620|NCT01147809|472172057|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
131150621|NCT01147809|472172058|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
131150622|NCT01147809|472172059|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
131150623|NCT01147809|472172060|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
131150624|NCT01147809|472172061|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
131234924|NCT00409578|472486517|FG001|Overall Study|Protocol Violation|2|||
131150625|NCT01147809|472172062|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
131150626|NCT01147809|472172057|FG000|Phase II (168 Days)|Adverse Event|0|||
131150627|NCT01147809|472172058|FG001|Phase II (168 Days)|Adverse Event|0|||
131150628|NCT01147809|472172059|FG002|Phase II (168 Days)|Adverse Event|0|||
131150629|NCT01147809|472172060|FG003|Phase II (168 Days)|Adverse Event|0|||
131150630|NCT01147809|472172061|FG004|Phase II (168 Days)|Adverse Event|3|||
131150631|NCT01147809|472172062|FG005|Phase II (168 Days)|Adverse Event|6|||
131150632|NCT01147809|472172057|FG000|Phase II (168 Days)|Protocol Violation|0|||
131150633|NCT01147809|472172058|FG001|Phase II (168 Days)|Protocol Violation|0|||
131150634|NCT01147809|472172059|FG002|Phase II (168 Days)|Protocol Violation|0|||
131150635|NCT01147809|472172060|FG003|Phase II (168 Days)|Protocol Violation|0|||
131150636|NCT01147809|472172061|FG004|Phase II (168 Days)|Protocol Violation|0|||
131150637|NCT01147809|472172062|FG005|Phase II (168 Days)|Protocol Violation|1|||
131150638|NCT01147809|472172057|FG000|Phase II (168 Days)|Physician Decision|0|||
131150639|NCT01147809|472172058|FG001|Phase II (168 Days)|Physician Decision|0|||
131150640|NCT01147809|472172059|FG002|Phase II (168 Days)|Physician Decision|0|||
131150641|NCT01147809|472172060|FG003|Phase II (168 Days)|Physician Decision|0|||
131150642|NCT01147809|472172061|FG004|Phase II (168 Days)|Physician Decision|5|||
131150643|NCT01147809|472172062|FG005|Phase II (168 Days)|Physician Decision|11|||
131150644|NCT01147809|472172057|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
131150645|NCT01147809|472172058|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
131150646|NCT01147809|472172059|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
131150647|NCT01147809|472172060|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
131150648|NCT01147809|472172061|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
131150649|NCT01147809|472172062|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
131234925|NCT00409578|472486518|FG002|Overall Study|Protocol Violation|3|||
131234926|NCT00409578|472486519|FG003|Overall Study|Protocol Violation|1|||
131234927|NCT00409578|472486516|FG000|Overall Study|Missing|0|||
131234928|NCT00409578|472486517|FG001|Overall Study|Missing|1|||
131234929|NCT00409578|472486518|FG002|Overall Study|Missing|0|||
131234930|NCT00409578|472486519|FG003|Overall Study|Missing|1|||
131234931|NCT02109133|472486522|FG000|Overall Study|Lost to Follow-up|1|||
131234932|NCT02109133|472486523|FG001|Overall Study|Lost to Follow-up|0|||
131234933|NCT01691508|472488750|FG000|Overall Study|Adverse Event|3|||
131150650|NCT01147809|472172057|FG000|Phase II (168 Days)|Ongoing|0|||
131150651|NCT01147809|472172058|FG001|Phase II (168 Days)|Ongoing|0|||
131150652|NCT01147809|472172059|FG002|Phase II (168 Days)|Ongoing|0|||
131150653|NCT01147809|472172060|FG003|Phase II (168 Days)|Ongoing|0|||
131150654|NCT01147809|472172061|FG004|Phase II (168 Days)|Ongoing|1|||
131150655|NCT01147809|472172062|FG005|Phase II (168 Days)|Ongoing|0|||
131150656|NCT01499290|472172063|FG000|Overall Study|Withdrawal by Subject|22|||
131150657|NCT01499290|472172064|FG001|Overall Study|Withdrawal by Subject|15|||
131150658|NCT01499290|472172063|FG000|Overall Study|Not specified in study report|11|||
131150659|NCT01499290|472172064|FG001|Overall Study|Not specified in study report|5|||
131234934|NCT01691508|472488751|FG001|Overall Study|Adverse Event|3|||
131150660|NCT01499290|472172063|FG000|Overall Study|Condition improved/subject recovered|1|||
131150661|NCT01499290|472172064|FG001|Overall Study|Condition improved/subject recovered|0|||
131150662|NCT01499290|472172063|FG000|Overall Study|Lack of Efficacy|7|||
131150663|NCT01499290|472172064|FG001|Overall Study|Lack of Efficacy|8|||
131150664|NCT01499290|472172063|FG000|Overall Study|Adverse Event|14|||
131150665|NCT01499290|472172064|FG001|Overall Study|Adverse Event|7|||
131150666|NCT04052139|472172065|FG000|Overall Study|Lost to Follow-up|2|||
131150667|NCT04052139|472172066|FG001|Overall Study|Lost to Follow-up|0|||
131150668|NCT04052139|472172067|FG002|Overall Study|Lost to Follow-up|0|||
131150669|NCT04052139|472172065|FG000|Overall Study|Withdrawal by Subject|1|||
131150670|NCT04052139|472172066|FG001|Overall Study|Withdrawal by Subject|0|||
131150671|NCT04052139|472172067|FG002|Overall Study|Withdrawal by Subject|0|||
131150672|NCT03406962|472172068|FG000|Overall Study|Death|2|||
131150673|NCT03406962|472172068|FG000|Overall Study|Adverse Event|1|||
131150674|NCT00190775|472172069|FG000|Overall Study|Adverse Event|57|||
131150675|NCT00190775|472172070|FG001|Overall Study|Adverse Event|22|||
131150676|NCT00190775|472172069|FG000|Overall Study|Satisfactory Response|1|||
131150677|NCT00190775|472172070|FG001|Overall Study|Satisfactory Response|0|||
131150678|NCT00190775|472172069|FG000|Overall Study|Lack of Efficacy|28|||
131150679|NCT00190775|472172070|FG001|Overall Study|Lack of Efficacy|32|||
131150680|NCT00190775|472172069|FG000|Overall Study|Lost to Follow-up|31|||
131150681|NCT00190775|472172070|FG001|Overall Study|Lost to Follow-up|23|||
131150682|NCT00190775|472172069|FG000|Overall Study|Participant Moved|0|||
131150683|NCT00190775|472172070|FG001|Overall Study|Participant Moved|1|||
131150684|NCT00190775|472172069|FG000|Overall Study|Withdrawal by Subject|24|||
131150685|NCT00190775|472172070|FG001|Overall Study|Withdrawal by Subject|13|||
131150686|NCT00190775|472172069|FG000|Overall Study|Sponsor Decision|1|||
131150687|NCT00190775|472172070|FG001|Overall Study|Sponsor Decision|0|||
131150688|NCT00190775|472172069|FG000|Overall Study|Physician Decision|3|||
131150689|NCT00190775|472172070|FG001|Overall Study|Physician Decision|0|||
131150690|NCT00190775|472172069|FG000|Overall Study|Noncompliance|3|||
131150691|NCT00190775|472172070|FG001|Overall Study|Noncompliance|5|||
131150692|NCT00190775|472172069|FG000|Overall Study|Protocol Violation|0|||
131150693|NCT00190775|472172070|FG001|Overall Study|Protocol Violation|1|||
131150694|NCT00190775|472172069|FG000|Overall Study|Exclusion Criteria Met|1|||
131150695|NCT00190775|472172070|FG001|Overall Study|Exclusion Criteria Met|3|||
131150696|NCT00519077|472172071|FG000|Overall Study|Death|6|||
131150697|NCT00519077|472172071|FG000|Overall Study|Other|2|||
131150698|NCT01967225|472172072|FG000|Overall Study|Adverse Event|3|||
131150699|NCT01967225|472172073|FG001|Overall Study|Adverse Event|1|||
131150700|NCT01967225|472172072|FG000|Overall Study|Withdrawal by Subject|2|||
131150701|NCT01967225|472172073|FG001|Overall Study|Withdrawal by Subject|1|||
131150702|NCT01967225|472172072|FG000|Overall Study|Lack of Efficacy|1|||
131150703|NCT01967225|472172073|FG001|Overall Study|Lack of Efficacy|1|||
131150704|NCT01967225|472172072|FG000|Overall Study|Switching to other therapy|2|||
131150705|NCT01967225|472172073|FG001|Overall Study|Switching to other therapy|0|||
131150706|NCT01967225|472172072|FG000|Overall Study|Protocol driven decision point|1|||
131150707|NCT01967225|472172073|FG001|Overall Study|Protocol driven decision point|0|||
131150708|NCT01967225|472172072|FG000|Overall Study|Logistical difficulties|1|||
131150709|NCT01967225|472172073|FG001|Overall Study|Logistical difficulties|0|||
131150710|NCT01967225|472172072|FG000|Overall Study|Protocol Violation|2|||
131150711|NCT01967225|472172073|FG001|Overall Study|Protocol Violation|0|||
131150712|NCT00327444|472172074|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
131150713|NCT00327444|472172075|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
131150714|NCT00327444|472172074|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
131150715|NCT00327444|472172075|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
131150716|NCT00327444|472172074|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
131150717|NCT00327444|472172075|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
131150718|NCT00327444|472172074|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
131150719|NCT00327444|472172075|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
131150720|NCT00327444|472172074|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
131150721|NCT00327444|472172075|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
131150722|NCT00327444|472172074|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
131150723|NCT00327444|472172075|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
130728034|NCT01449370|470625569|FG003|Overall Study|Death|0|||
130728035|NCT01449370|470625570|FG004|Overall Study|Death|0|||
131150724|NCT00327444|472172074|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
131150725|NCT00327444|472172075|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
131150726|NCT00327444|472172074|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
131150727|NCT00327444|472172075|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
131150728|NCT04439344|472172076|FG000|Overall Study|Never started threapy|3|||
131150729|NCT04439344|472172076|FG000|Overall Study|Ineligible|3|||
131150730|NCT04439344|472172076|FG000|Overall Study|Adverse Event|13|||
131150731|NCT04439344|472172076|FG000|Overall Study|Death|2|||
131150732|NCT04439344|472172076|FG000|Overall Study|Disease progression|29|||
131150733|NCT04439344|472172076|FG000|Overall Study|Withdrawal by Subject|2|||
131150734|NCT04439344|472172076|FG000|Overall Study|Alternative therapy|1|||
131150735|NCT00552110|472172077|FG000|Overall Study|Serious or Life-Threatening AE|0|||
131150736|NCT00552110|472172078|FG001|Overall Study|Serious or Life-Threatening AE|0|||
131150737|NCT00552110|472172079|FG002|Overall Study|Serious or Life-Threatening AE|1|||
131234935|NCT01691508|472488750|FG000|Overall Study|Withdrawal by Subject|1|||
131234936|NCT01691508|472488751|FG001|Overall Study|Withdrawal by Subject|0|||
131234937|NCT00623103|472488760|FG000|Overall Study|Adverse Event|70|||
131234938|NCT00623103|472488761|FG001|Overall Study|Adverse Event|60|||
131234939|NCT00623103|472488760|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131150738|NCT00552110|472172080|FG003|Overall Study|Serious or Life-Threatening AE|0|||
131150739|NCT00552110|472172081|FG004|Overall Study|Serious or Life-Threatening AE|0|||
131150740|NCT00552110|472172077|FG000|Overall Study|Lack of Efficacy|1|||
131150741|NCT00552110|472172078|FG001|Overall Study|Lack of Efficacy|0|||
131150742|NCT00552110|472172079|FG002|Overall Study|Lack of Efficacy|0|||
131150743|NCT00552110|472172080|FG003|Overall Study|Lack of Efficacy|1|||
131150744|NCT00552110|472172081|FG004|Overall Study|Lack of Efficacy|4|||
131150745|NCT00552110|472172077|FG000|Overall Study|Withdrawal by Subject|0|||
131150746|NCT00552110|472172078|FG001|Overall Study|Withdrawal by Subject|2|||
131150747|NCT00552110|472172079|FG002|Overall Study|Withdrawal by Subject|0|||
131150748|NCT00552110|472172080|FG003|Overall Study|Withdrawal by Subject|3|||
131150749|NCT00552110|472172081|FG004|Overall Study|Withdrawal by Subject|2|||
131150750|NCT00552110|472172077|FG000|Overall Study|Lost to Follow-up|0|||
131150751|NCT00552110|472172078|FG001|Overall Study|Lost to Follow-up|0|||
131150752|NCT00552110|472172079|FG002|Overall Study|Lost to Follow-up|0|||
131150753|NCT00552110|472172080|FG003|Overall Study|Lost to Follow-up|1|||
131150754|NCT00552110|472172081|FG004|Overall Study|Lost to Follow-up|1|||
131150755|NCT00552110|472172077|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
131150756|NCT00552110|472172078|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
131150757|NCT00552110|472172079|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
131150758|NCT00552110|472172080|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
131150759|NCT00552110|472172081|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
131150760|NCT00552110|472172077|FG000|Overall Study|Withdrawn per Sponsor|0|||
131150761|NCT00552110|472172078|FG001|Overall Study|Withdrawn per Sponsor|1|||
131150762|NCT00552110|472172079|FG002|Overall Study|Withdrawn per Sponsor|0|||
131150763|NCT00552110|472172080|FG003|Overall Study|Withdrawn per Sponsor|0|||
131150764|NCT00552110|472172081|FG004|Overall Study|Withdrawn per Sponsor|1|||
131150765|NCT00552110|472172077|FG000|Overall Study|Use of Prohibited Medication|1|||
131150766|NCT00552110|472172078|FG001|Overall Study|Use of Prohibited Medication|1|||
131150767|NCT00552110|472172079|FG002|Overall Study|Use of Prohibited Medication|0|||
131150768|NCT00552110|472172080|FG003|Overall Study|Use of Prohibited Medication|0|||
131150769|NCT00552110|472172081|FG004|Overall Study|Use of Prohibited Medication|0|||
131150770|NCT00552110|472172077|FG000|Overall Study|Delay of Study due to Relabeling|0|||
131150771|NCT00552110|472172078|FG001|Overall Study|Delay of Study due to Relabeling|0|||
131150772|NCT00552110|472172079|FG002|Overall Study|Delay of Study due to Relabeling|0|||
131150773|NCT00552110|472172080|FG003|Overall Study|Delay of Study due to Relabeling|1|||
131150774|NCT00552110|472172081|FG004|Overall Study|Delay of Study due to Relabeling|0|||
131150775|NCT00552110|472172077|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
131150776|NCT00552110|472172078|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
131150777|NCT00552110|472172079|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
131150778|NCT00552110|472172080|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
131150779|NCT00552110|472172081|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
131150780|NCT00552110|472172077|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
131150781|NCT00552110|472172078|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
131150782|NCT00552110|472172079|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
131150783|NCT00552110|472172080|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
131150784|NCT00552110|472172081|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
131150785|NCT01672957|472172082|FG000|Overall Study|Protocol Violation|48|||
131150786|NCT01672957|472172082|FG000|Overall Study|Death|2|||
131150787|NCT01672957|472172082|FG000|Overall Study|ICF Signed After Transplantation|5|||
131150788|NCT01511445|472172083|FG000|Overall Study|Lost to Follow-up|3|||
131150789|NCT01511445|472172084|FG001|Overall Study|Lost to Follow-up|1|||
131150790|NCT01511445|472172083|FG000|Overall Study|Protocol Violation|1|||
131150791|NCT01511445|472172084|FG001|Overall Study|Protocol Violation|3|||
131234940|NCT00623103|472488761|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
131150792|NCT01511445|472172083|FG000|Overall Study|Protocol Violation|1|||
131150793|NCT01511445|472172084|FG001|Overall Study|Protocol Violation|0|||
131150794|NCT00332202|472172087|FG000|Overall Study|Adverse Event|72|||
131150795|NCT00332202|472172088|FG001|Overall Study|Adverse Event|28|||
131150796|NCT00332202|472172087|FG000|Overall Study|Lost to Follow-up|2|||
131150797|NCT00332202|472172088|FG001|Overall Study|Lost to Follow-up|1|||
131150798|NCT00332202|472172087|FG000|Overall Study|Physician Decision|6|||
131150799|NCT00332202|472172088|FG001|Overall Study|Physician Decision|8|||
131150800|NCT00332202|472172087|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
131150801|NCT00332202|472172088|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
131150802|NCT00332202|472172087|FG000|Overall Study|Protocol Violation|7|||
130728036|NCT01449370|470625571|FG005|Overall Study|Death|0|||
130728037|NCT01449370|470625572|FG006|Overall Study|Death|0|||
130728038|NCT01449370|470625573|FG007|Overall Study|Death|0|||
130728039|NCT01449370|470625574|FG008|Overall Study|Death|0|||
131150803|NCT00332202|472172088|FG001|Overall Study|Protocol Violation|2|||
131150804|NCT00332202|472172087|FG000|Overall Study|Sponsor Decision|1|||
131150805|NCT00332202|472172088|FG001|Overall Study|Sponsor Decision|2|||
131150806|NCT00332202|472172087|FG000|Overall Study|Withdrawal by Subject|36|||
131150807|NCT00332202|472172088|FG001|Overall Study|Withdrawal by Subject|17|||
131150808|NCT00332202|472172087|FG000|Overall Study|Progressive Disease|106|||
131150809|NCT00332202|472172088|FG001|Overall Study|Progressive Disease|60|||
131150810|NCT00332202|472172087|FG000|Overall Study|Death|5|||
131150811|NCT00332202|472172088|FG001|Overall Study|Death|2|||
131150812|NCT00490542|472172093|FG000|Overall Study|Lost to Follow-up|3|||
131150813|NCT00490542|472172094|FG001|Overall Study|Lost to Follow-up|0|||
131150814|NCT00490542|472172093|FG000|Overall Study|Adverse Event|3|||
131150815|NCT00490542|472172094|FG001|Overall Study|Adverse Event|3|||
131150816|NCT00490542|472172093|FG000|Overall Study|Lack of Efficacy|1|||
131150817|NCT00490542|472172094|FG001|Overall Study|Lack of Efficacy|1|||
131150818|NCT04696861|472172095|FG000|Overall Study|Death|1|||
131150819|NCT04696861|472172096|FG001|Overall Study|Death|0|||
131150820|NCT04696861|472172095|FG000|Overall Study|Lost to Follow-up|3|||
131150821|NCT04696861|472172096|FG001|Overall Study|Lost to Follow-up|0|||
131150822|NCT00818259|472172097|FG000|Part I|Withdrawal by Subject|1|||
131150823|NCT00818259|472172098|FG001|Part I|Withdrawal by Subject|0|||
131150824|NCT00818259|472172099|FG002|Part I|Withdrawal by Subject|0|||
131150825|NCT00818259|472172100|FG003|Part I|Withdrawal by Subject|0|||
131150826|NCT00818259|472172101|FG004|Part I|Withdrawal by Subject|0|||
131150827|NCT00818259|472172102|FG005|Part I|Withdrawal by Subject|0|||
131150828|NCT00818259|472172103|FG006|Part I|Withdrawal by Subject|0|||
131150829|NCT00818259|472172104|FG007|Part I|Withdrawal by Subject|0|||
131150830|NCT00818259|472172105|FG008|Part I|Withdrawal by Subject|0|||
131150831|NCT00818259|472172097|FG000|Part II|Physician Decision|0|||
131150832|NCT00818259|472172098|FG001|Part II|Physician Decision|0|||
131150833|NCT00818259|472172099|FG002|Part II|Physician Decision|1|||
131150834|NCT00818259|472172100|FG003|Part II|Physician Decision|0|||
131150835|NCT00818259|472172101|FG004|Part II|Physician Decision|0|||
131150836|NCT00818259|472172102|FG005|Part II|Physician Decision|0|||
131150837|NCT00818259|472172103|FG006|Part II|Physician Decision|0|||
131150838|NCT00818259|472172104|FG007|Part II|Physician Decision|0|||
131150839|NCT00818259|472172105|FG008|Part II|Physician Decision|0|||
131150840|NCT00818259|472172097|FG000|Part II|Lack of Efficacy|0|||
131150841|NCT00818259|472172098|FG001|Part II|Lack of Efficacy|0|||
131150842|NCT00818259|472172099|FG002|Part II|Lack of Efficacy|0|||
131150843|NCT00818259|472172100|FG003|Part II|Lack of Efficacy|1|||
131150844|NCT00818259|472172101|FG004|Part II|Lack of Efficacy|0|||
131150845|NCT00818259|472172102|FG005|Part II|Lack of Efficacy|0|||
131150846|NCT00818259|472172103|FG006|Part II|Lack of Efficacy|0|||
131150847|NCT00818259|472172104|FG007|Part II|Lack of Efficacy|0|||
131150848|NCT00818259|472172105|FG008|Part II|Lack of Efficacy|0|||
131150849|NCT00818259|472172097|FG000|Part II|Not Treated|0|||
131150850|NCT00818259|472172098|FG001|Part II|Not Treated|0|||
131150851|NCT00818259|472172099|FG002|Part II|Not Treated|0|||
131150852|NCT00818259|472172100|FG003|Part II|Not Treated|1|||
131150853|NCT00818259|472172101|FG004|Part II|Not Treated|0|||
131150854|NCT00818259|472172102|FG005|Part II|Not Treated|0|||
131150855|NCT00818259|472172103|FG006|Part II|Not Treated|0|||
131150856|NCT00818259|472172104|FG007|Part II|Not Treated|0|||
131150857|NCT00818259|472172105|FG008|Part II|Not Treated|0|||
131150858|NCT00818259|472172097|FG000|Part IV|Physician Decision|0|||
131150859|NCT00818259|472172098|FG001|Part IV|Physician Decision|0|||
131150860|NCT00818259|472172099|FG002|Part IV|Physician Decision|0|||
131150861|NCT00818259|472172100|FG003|Part IV|Physician Decision|0|||
131150862|NCT00818259|472172101|FG004|Part IV|Physician Decision|0|||
130728040|NCT01449370|470625575|FG009|Overall Study|Death|0|||
131150863|NCT00818259|472172102|FG005|Part IV|Physician Decision|1|||
131150864|NCT00818259|472172103|FG006|Part IV|Physician Decision|0|||
131150865|NCT00818259|472172104|FG007|Part IV|Physician Decision|0|||
131150866|NCT00818259|472172105|FG008|Part IV|Physician Decision|0|||
131150867|NCT00818259|472172097|FG000|Part V|Adverse Event|0|||
131150868|NCT00818259|472172098|FG001|Part V|Adverse Event|0|||
131150869|NCT00818259|472172099|FG002|Part V|Adverse Event|0|||
131150870|NCT00818259|472172100|FG003|Part V|Adverse Event|0|||
131150871|NCT00818259|472172101|FG004|Part V|Adverse Event|0|||
131150872|NCT00818259|472172102|FG005|Part V|Adverse Event|0|||
131150873|NCT00818259|472172103|FG006|Part V|Adverse Event|0|||
130728041|NCT01449370|470625576|FG010|Overall Study|Death|0|||
130728042|NCT01449370|470625577|FG011|Overall Study|Death|0|||
131150874|NCT00818259|472172104|FG007|Part V|Adverse Event|1|||
131150875|NCT00818259|472172105|FG008|Part V|Adverse Event|0|||
131150876|NCT01053429|472172111|FG000|Overall Study|Adverse Event|64|||
131150877|NCT01053429|472172111|FG000|Overall Study|Other|309|||
131150878|NCT00752986|472172112|FG000|Overall Study|Withdrawal by Subject|2|||
131150879|NCT00752986|472172113|FG001|Overall Study|Withdrawal by Subject|1|||
131150880|NCT00752986|472172114|FG002|Overall Study|Withdrawal by Subject|2|||
131150881|NCT00752986|472172112|FG000|Overall Study|Protocol Violation|3|||
131150882|NCT00752986|472172113|FG001|Overall Study|Protocol Violation|0|||
131150883|NCT00752986|472172114|FG002|Overall Study|Protocol Violation|0|||
131150884|NCT04375761|472173970|FG000|Overall Study|Death|1|||
131150885|NCT04375761|472173971|FG001|Overall Study|Death|2|||
131150886|NCT04375761|472173970|FG000|Overall Study|Lost to Follow-up|203|||
131150887|NCT04375761|472173971|FG001|Overall Study|Lost to Follow-up|380|||
131150888|NCT04375761|472173970|FG000|Overall Study|Withdrawal by Subject|47|||
131150889|NCT04375761|472173971|FG001|Overall Study|Withdrawal by Subject|98|||
131150890|NCT04375761|472173970|FG000|Overall Study|Noncompliance with study procedure|121|||
131150891|NCT04375761|472173971|FG001|Overall Study|Noncompliance with study procedure|251|||
131150892|NCT04375761|472173970|FG000|Overall Study|Reimbursement not enough|1|||
131150893|NCT04375761|472173971|FG001|Overall Study|Reimbursement not enough|2|||
131150894|NCT04375761|472173970|FG000|Overall Study|Unforeseen family circumstances|1|||
131150895|NCT04375761|472173971|FG001|Overall Study|Unforeseen family circumstances|3|||
131150896|NCT04375761|472173970|FG000|Overall Study|Test too painful|1|||
131150897|NCT04375761|472173971|FG001|Overall Study|Test too painful|1|||
131150898|NCT04375761|472173970|FG000|Overall Study|Moved|0|||
131150899|NCT04375761|472173971|FG001|Overall Study|Moved|2|||
131150900|NCT04375761|472173970|FG000|Overall Study|Nonresponsive|0|||
131150901|NCT04375761|472173971|FG001|Overall Study|Nonresponsive|5|||
131150902|NCT03797001|472173972|FG000|Overall Study|Withdrawn due to COVID19|4|||
131150903|NCT03797001|472173973|FG001|Overall Study|Withdrawn due to COVID19|0|||
131150904|NCT03797001|472173972|FG000|Overall Study|Withdrawal by Subject|7|||
131150905|NCT03797001|472173973|FG001|Overall Study|Withdrawal by Subject|6|||
131150906|NCT03797001|472173972|FG000|Overall Study|Adverse Event|0|||
131150907|NCT03797001|472173973|FG001|Overall Study|Adverse Event|1|||
131150908|NCT00075881|472173978|FG000|Overall Study|Lack of Efficacy|18|||
131150909|NCT00075881|472173978|FG000|Overall Study|Adverse Event|7|||
131150910|NCT00075881|472173978|FG000|Overall Study|Death|1|||
131150911|NCT00075881|472173978|FG000|Overall Study|Withdrawal by Subject|2|||
131150912|NCT00075881|472173978|FG000|Overall Study|Protocol Violation|4|||
131150913|NCT00075881|472173978|FG000|Overall Study|other complicating disease|3|||
131150914|NCT00075881|472173978|FG000|Overall Study|other|4|||
131150915|NCT00075881|472173978|FG000|Overall Study|missing data|2|||
131150916|NCT00075881|472173978|FG000|Overall Study|Ineligible|1|||
131150917|NCT00075881|472173978|FG000|Overall Study|never start protocol therapy|1|||
131150918|NCT04030195|472173979|FG000|Overall Study|Withdrawal by Subject|2|||
131150919|NCT04030195|472173980|FG001|Overall Study|Withdrawal by Subject|0|||
131150920|NCT04030195|472173981|FG002|Overall Study|Withdrawal by Subject|0|||
131150921|NCT00215150|472173983|FG000|Open Label Phase|Lost to Follow-up|7|||
131150922|NCT00215150|472173983|FG000|Open Label Phase|Withdrawal by Subject|1|||
131150923|NCT00215150|472173983|FG000|Open Label Phase|Did not complete a post base visit|13|||
131150924|NCT00215150|472173983|FG000|Open Label Phase|Did not meet randomization criteria|9|||
131150925|NCT00215150|472173983|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
131150926|NCT00215150|472173983|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
131150927|NCT00215150|472173983|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
131150928|NCT01028352|472173986|FG000|Overall Study|Ineligible due to baseline average pain|5|||
131150929|NCT01028352|472173986|FG000|Overall Study|Withdrawal by Subject|1|||
131150930|NCT00260208|472173988|FG000|Overall Study|Subject withdrew consent|11|||
131150931|NCT00260208|472173989|FG001|Overall Study|Subject withdrew consent|7|||
131150932|NCT00260208|472173988|FG000|Overall Study|Lost to Follow-up|6|||
131150933|NCT00260208|472173989|FG001|Overall Study|Lost to Follow-up|1|||
131150934|NCT00260208|472173988|FG000|Overall Study|Death|12|||
131150935|NCT00260208|472173989|FG001|Overall Study|Death|10|||
131150936|NCT00260208|472173988|FG000|Overall Study|Missing|18|||
131150937|NCT00260208|472173989|FG001|Overall Study|Missing|16|||
131150938|NCT03095703|472173996|FG000|Overall Study|Withdrawal by Subject|1|||
131150939|NCT02665689|472174010|FG000|Overall Study|Adverse Event|1|||
131150940|NCT02665689|472174011|FG001|Overall Study|Adverse Event|0|||
131150941|NCT02665689|472174010|FG000|Overall Study|Trial termination|1|||
131150942|NCT02665689|472174011|FG001|Overall Study|Trial termination|1|||
131150943|NCT02665689|472174010|FG000|Overall Study|Lost to Follow-up|0|||
131150944|NCT02665689|472174011|FG001|Overall Study|Lost to Follow-up|1|||
131150945|NCT00824564|472174012|FG000|Overall Study|Lost to Follow-up|5|||
131150946|NCT00824564|472174013|FG001|Overall Study|Lost to Follow-up|7|||
131150947|NCT00824564|472174012|FG000|Overall Study|Withdrawal by Subject|1|||
131234941|NCT00623103|472488760|FG000|Overall Study|Withdrawal by Subject|18|||
131234942|NCT00623103|472488761|FG001|Overall Study|Withdrawal by Subject|24|||
131150948|NCT00824564|472174013|FG001|Overall Study|Withdrawal by Subject|1|||
131150949|NCT00824564|472174012|FG000|Overall Study|Other|1|||
131150950|NCT00824564|472174013|FG001|Overall Study|Other|2|||
131150951|NCT00824564|472174012|FG000|Overall Study|Randomized, but not treated|1|||
131150952|NCT00824564|472174013|FG001|Overall Study|Randomized, but not treated|0|||
131150953|NCT00486902|472174014|FG000|Overall Study|Withdrawal by Subject|1|||
131150954|NCT00486902|472174015|FG001|Overall Study|Withdrawal by Subject|2|||
131150955|NCT00486902|472174014|FG000|Overall Study|decision for postpartum tubal ligation|3|||
131150956|NCT00486902|472174015|FG001|Overall Study|decision for postpartum tubal ligation|1|||
131150957|NCT00486902|472174014|FG000|Overall Study|spinal anesthetic protocal violation|1|||
131150958|NCT00486902|472174015|FG001|Overall Study|spinal anesthetic protocal violation|1|||
131150959|NCT00486902|472174014|FG000|Overall Study|Did not meet inclusion criteria|1|||
131150960|NCT00486902|472174015|FG001|Overall Study|Did not meet inclusion criteria|0|||
131150961|NCT00486902|472174014|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
131150962|NCT00486902|472174015|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
131150963|NCT01552057|472174026|FG000|Overall Study|Adverse Event|14|||
131150964|NCT01552057|472174027|FG001|Overall Study|Adverse Event|15|||
131150965|NCT01552057|472174026|FG000|Overall Study|Lack of Efficacy|8|||
131150966|NCT01552057|472174027|FG001|Overall Study|Lack of Efficacy|23|||
131150967|NCT01552057|472174026|FG000|Overall Study|Withdrawal by Subject|5|||
131150968|NCT01552057|472174027|FG001|Overall Study|Withdrawal by Subject|8|||
131150969|NCT01552057|472174026|FG000|Overall Study|Entry Criteria Not Met|2|||
131150970|NCT01552057|472174027|FG001|Overall Study|Entry Criteria Not Met|2|||
131150971|NCT01552057|472174026|FG000|Overall Study|Physician Decision|1|||
131150972|NCT01552057|472174027|FG001|Overall Study|Physician Decision|0|||
131150973|NCT00476086|472174028|FG000|Overall Study|Alternative therapy|1|||
131150974|NCT00476086|472174028|FG000|Overall Study|Progressive Disease|4|||
131150975|NCT02900092|472174029|FG000|Overall Study|Adverse Event|1|||
131150976|NCT00364793|472174031|FG000|Overall Study|Adverse Event|2|||
131150977|NCT00364793|472174032|FG001|Overall Study|Adverse Event|0|||
131150978|NCT00364793|472174033|FG002|Overall Study|Adverse Event|0|||
131150979|NCT00364793|472174034|FG003|Overall Study|Adverse Event|0|||
131150980|NCT00364793|472174031|FG000|Overall Study|Death|1|||
131150981|NCT00364793|472174032|FG001|Overall Study|Death|0|||
131150982|NCT00364793|472174033|FG002|Overall Study|Death|1|||
131150983|NCT00364793|472174034|FG003|Overall Study|Death|0|||
131150984|NCT00364793|472174031|FG000|Overall Study|Lack of Efficacy|3|||
131150985|NCT00364793|472174032|FG001|Overall Study|Lack of Efficacy|3|||
131150986|NCT00364793|472174033|FG002|Overall Study|Lack of Efficacy|1|||
131150987|NCT00364793|472174034|FG003|Overall Study|Lack of Efficacy|1|||
131150988|NCT00364793|472174031|FG000|Overall Study|Lost to Follow-up|1|||
131150989|NCT00364793|472174032|FG001|Overall Study|Lost to Follow-up|0|||
131150990|NCT00364793|472174033|FG002|Overall Study|Lost to Follow-up|2|||
131150991|NCT00364793|472174034|FG003|Overall Study|Lost to Follow-up|0|||
131150992|NCT00364793|472174031|FG000|Overall Study|Poor or non-compliance|1|||
131150993|NCT00364793|472174032|FG001|Overall Study|Poor or non-compliance|1|||
131150994|NCT00364793|472174033|FG002|Overall Study|Poor or non-compliance|0|||
131150995|NCT00364793|472174034|FG003|Overall Study|Poor or non-compliance|1|||
131150996|NCT00364793|472174031|FG000|Overall Study|No longer meets criteria|0|||
131150997|NCT00364793|472174032|FG001|Overall Study|No longer meets criteria|0|||
131150998|NCT00364793|472174033|FG002|Overall Study|No longer meets criteria|0|||
131150999|NCT00364793|472174034|FG003|Overall Study|No longer meets criteria|1|||
131151000|NCT00364793|472174031|FG000|Overall Study|Withdrawal by Subject|0|||
131151001|NCT00364793|472174032|FG001|Overall Study|Withdrawal by Subject|1|||
131151002|NCT00364793|472174033|FG002|Overall Study|Withdrawal by Subject|0|||
131151003|NCT00364793|472174034|FG003|Overall Study|Withdrawal by Subject|0|||
131151004|NCT05127486|472174035|FG000|Overall Study|Adverse Event|2|||
131151005|NCT05127486|472174036|FG001|Overall Study|Adverse Event|4|||
131151006|NCT05127486|472174035|FG000|Overall Study|Lack of Efficacy|1|||
131151007|NCT05127486|472174036|FG001|Overall Study|Lack of Efficacy|0|||
131151008|NCT05127486|472174035|FG000|Overall Study|Pregnancy|0|||
131151009|NCT05127486|472174036|FG001|Overall Study|Pregnancy|1|||
131151010|NCT05127486|472174035|FG000|Overall Study|Physician Decision|4|||
131151011|NCT05127486|472174036|FG001|Overall Study|Physician Decision|1|||
131151012|NCT05127486|472174035|FG000|Overall Study|Withdrawal by Subject|14|||
131151013|NCT05127486|472174036|FG001|Overall Study|Withdrawal by Subject|13|||
131151014|NCT05127486|472174035|FG000|Overall Study|Lost to Follow-up|5|||
131151015|NCT05127486|472174036|FG001|Overall Study|Lost to Follow-up|8|||
130728043|NCT01449370|470625578|FG012|Overall Study|Death|0|||
131151016|NCT01287754|472174039|FG000|Overall Study|Death|2|||
131151017|NCT01287754|472174040|FG001|Overall Study|Death|12|||
131151018|NCT01287754|472174039|FG000|Overall Study|Lost to Follow-up|1|||
131151019|NCT01287754|472174040|FG001|Overall Study|Lost to Follow-up|6|||
131151020|NCT01287754|472174039|FG000|Overall Study|Protocol Violation|0|||
131151021|NCT01287754|472174040|FG001|Overall Study|Protocol Violation|3|||
131151022|NCT04971226|472174051|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
131151023|NCT04971226|472174052|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
131151024|NCT04971226|472174053|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
131151025|NCT04971226|472174054|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
131151026|NCT04971226|472174051|FG000|Overall Study|Adverse Event|6|||
131151027|NCT04971226|472174052|FG001|Overall Study|Adverse Event|5|||
131151028|NCT04971226|472174053|FG002|Overall Study|Adverse Event|11|||
131151029|NCT04971226|472174054|FG003|Overall Study|Adverse Event|10|||
131151030|NCT04971226|472174051|FG000|Overall Study|Progressive disease|2|||
131151031|NCT04971226|472174052|FG001|Overall Study|Progressive disease|0|||
130728044|NCT01449370|470625579|FG013|Overall Study|Death|0|||
131151032|NCT04971226|472174053|FG002|Overall Study|Progressive disease|3|||
131151033|NCT04971226|472174054|FG003|Overall Study|Progressive disease|1|||
131151034|NCT04971226|472174051|FG000|Overall Study|Protocol Deviation|1|||
131151035|NCT04971226|472174052|FG001|Overall Study|Protocol Deviation|0|||
131151036|NCT04971226|472174053|FG002|Overall Study|Protocol Deviation|1|||
131151037|NCT04971226|472174054|FG003|Overall Study|Protocol Deviation|1|||
131151038|NCT04971226|472174051|FG000|Overall Study|Subject Decision|0|||
131151039|NCT04971226|472174052|FG001|Overall Study|Subject Decision|1|||
131151040|NCT04971226|472174053|FG002|Overall Study|Subject Decision|1|||
131151041|NCT04971226|472174054|FG003|Overall Study|Subject Decision|1|||
131151042|NCT04971226|472174051|FG000|Overall Study|Pregnancy|0|||
131151043|NCT04971226|472174052|FG001|Overall Study|Pregnancy|0|||
131151044|NCT04971226|472174053|FG002|Overall Study|Pregnancy|0|||
131151045|NCT04971226|472174054|FG003|Overall Study|Pregnancy|1|||
131151046|NCT04971226|472174051|FG000|Overall Study|Participants not treated|1|||
131151047|NCT04971226|472174052|FG001|Overall Study|Participants not treated|0|||
131151048|NCT04971226|472174053|FG002|Overall Study|Participants not treated|2|||
131151049|NCT04971226|472174054|FG003|Overall Study|Participants not treated|1|||
131151050|NCT00001337|472174056|FG000|Overall Study|Switched to alternate treatment|2|||
131151051|NCT00001337|472174057|FG001|Overall Study|Switched to alternate treatment|2|||
131151052|NCT00001337|472174058|FG002|Overall Study|Switched to alternate treatment|0|||
131151053|NCT00001337|472174056|FG000|Overall Study|Refused further treatment|2|||
131151054|NCT00001337|472174057|FG001|Overall Study|Refused further treatment|1|||
131151055|NCT00001337|472174058|FG002|Overall Study|Refused further treatment|0|||
131151056|NCT00001337|472174056|FG000|Overall Study|Began other Tx|1|||
131151057|NCT00001337|472174057|FG001|Overall Study|Began other Tx|0|||
131151058|NCT00001337|472174058|FG002|Overall Study|Began other Tx|0|||
131151059|NCT00001337|472174056|FG000|Overall Study|Physician Decision|3|||
131151060|NCT00001337|472174057|FG001|Overall Study|Physician Decision|1|||
131151061|NCT00001337|472174058|FG002|Overall Study|Physician Decision|0|||
131151062|NCT00001337|472174056|FG000|Overall Study|Doesn't have NHL|0|||
131151063|NCT00001337|472174057|FG001|Overall Study|Doesn't have NHL|1|||
131151064|NCT00001337|472174058|FG002|Overall Study|Doesn't have NHL|0|||
131151065|NCT00001337|472174056|FG000|Overall Study|Non protocol tx needed|3|||
131151066|NCT00001337|472174057|FG001|Overall Study|Non protocol tx needed|1|||
131151067|NCT00001337|472174058|FG002|Overall Study|Non protocol tx needed|0|||
131151068|NCT00001337|472174056|FG000|Overall Study|Protocol change|1|||
131151069|NCT00001337|472174057|FG001|Overall Study|Protocol change|0|||
131151070|NCT00001337|472174058|FG002|Overall Study|Protocol change|0|||
131151071|NCT00001337|472174056|FG000|Overall Study|2nd primary disease|0|||
131151072|NCT00001337|472174057|FG001|Overall Study|2nd primary disease|0|||
131151073|NCT00001337|472174058|FG002|Overall Study|2nd primary disease|1|||
131151074|NCT00001337|472174056|FG000|Overall Study|Death during follow up period|9|||
131151075|NCT00001337|472174057|FG001|Overall Study|Death during follow up period|4|||
131151076|NCT00001337|472174058|FG002|Overall Study|Death during follow up period|0|||
131151077|NCT00001337|472174056|FG000|Overall Study|Death on study|19|||
131151078|NCT00001337|472174057|FG001|Overall Study|Death on study|9|||
131151079|NCT00001337|472174058|FG002|Overall Study|Death on study|0|||
131151080|NCT00001337|472174056|FG000|Overall Study|Disease progression during follow-up period|3|||
131151081|NCT00001337|472174057|FG001|Overall Study|Disease progression during follow-up period|1|||
131151082|NCT00001337|472174058|FG002|Overall Study|Disease progression during follow-up period|0|||
131151083|NCT00001337|472174056|FG000|Overall Study|Disease progression on study|33|||
131151084|NCT00001337|472174057|FG001|Overall Study|Disease progression on study|41|||
131151085|NCT00001337|472174058|FG002|Overall Study|Disease progression on study|0|||
131151086|NCT00001337|472174056|FG000|Overall Study|Lost to further follow-up|10|||
131151087|NCT00001337|472174057|FG001|Overall Study|Lost to further follow-up|6|||
131151088|NCT00001337|472174058|FG002|Overall Study|Lost to further follow-up|0|||
131151089|NCT00001337|472174056|FG000|Overall Study|2nd malignancy|1|||
131151090|NCT00001337|472174057|FG001|Overall Study|2nd malignancy|0|||
131151091|NCT00001337|472174058|FG002|Overall Study|2nd malignancy|0|||
131151092|NCT00001337|472174056|FG000|Overall Study|Treatment for second lymphoma|0|||
131151093|NCT00001337|472174057|FG001|Overall Study|Treatment for second lymphoma|1|||
131151094|NCT00001337|472174058|FG002|Overall Study|Treatment for second lymphoma|0|||
131151095|NCT00001337|472174056|FG000|Overall Study|Transfer to transplant|0|||
131151096|NCT00001337|472174057|FG001|Overall Study|Transfer to transplant|1|||
131151097|NCT00001337|472174058|FG002|Overall Study|Transfer to transplant|0|||
131151098|NCT05817045|472174061|FG000|Overall Study|Protocol Violation|0|||
131151099|NCT05817045|472174062|FG001|Overall Study|Protocol Violation|3|||
131151100|NCT05817045|472174061|FG000|Overall Study|Withdrawal by Subject|10|||
131151101|NCT05817045|472174062|FG001|Overall Study|Withdrawal by Subject|7|||
131151102|NCT05817045|472174061|FG000|Overall Study|Physician Decision|3|||
131151103|NCT05817045|472174062|FG001|Overall Study|Physician Decision|0|||
131151104|NCT05817045|472174061|FG000|Overall Study|Lost to Follow-up|0|||
131151105|NCT05817045|472174062|FG001|Overall Study|Lost to Follow-up|1|||
131151106|NCT05817045|472174061|FG000|Overall Study|Device Deficiency|1|||
131151107|NCT05817045|472174062|FG001|Overall Study|Device Deficiency|0|||
131151108|NCT05817045|472174061|FG000|Overall Study|System Error|1|||
131151109|NCT05817045|472174062|FG001|Overall Study|System Error|0|||
131151110|NCT05590377|472174069|FG000|Overall Study|Death|1|||
131151111|NCT05590377|472174070|FG001|Overall Study|Death|1|||
131151112|NCT05590377|472174071|FG002|Overall Study|Death|2|||
131151113|NCT05590377|472174072|FG003|Overall Study|Death|0|||
131151114|NCT05590377|472174073|FG004|Overall Study|Death|0|||
131151115|NCT05590377|472174069|FG000|Overall Study|Study Terminated by Sponsor|1|||
131151116|NCT05590377|472174070|FG001|Overall Study|Study Terminated by Sponsor|5|||
131151117|NCT05590377|472174071|FG002|Overall Study|Study Terminated by Sponsor|4|||
130728045|NCT01449370|470625580|FG014|Overall Study|Death|0|||
131151118|NCT05590377|472174072|FG003|Overall Study|Study Terminated by Sponsor|0|||
131151119|NCT05590377|472174073|FG004|Overall Study|Study Terminated by Sponsor|0|||
131151120|NCT05590377|472174069|FG000|Overall Study|Withdrawal by Subject|1|||
131151121|NCT05590377|472174070|FG001|Overall Study|Withdrawal by Subject|0|||
131151122|NCT05590377|472174071|FG002|Overall Study|Withdrawal by Subject|0|||
131151123|NCT05590377|472174072|FG003|Overall Study|Withdrawal by Subject|0|||
131151124|NCT05590377|472174073|FG004|Overall Study|Withdrawal by Subject|0|||
131151125|NCT02688647|472174074|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
131151126|NCT02688647|472174075|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
131151127|NCT02688647|472174074|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
131151128|NCT02688647|472174075|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
131151129|NCT02688647|472174074|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
131151130|NCT02688647|472174075|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
131151131|NCT02688647|472174074|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
131151132|NCT02688647|472174075|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
131151133|NCT02688647|472174074|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
131151134|NCT02688647|472174075|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
131151135|NCT02688647|472174074|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
131151136|NCT02688647|472174075|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
131151137|NCT02688647|472174074|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
131151138|NCT02688647|472174075|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
131151139|NCT00382967|472174076|FG000|Overall Study|Protocol Violation|1|||
131151140|NCT00382967|472174077|FG001|Overall Study|Protocol Violation|1|||
131151141|NCT00828464|472174078|FG000|Overall Study|Withdrawal by Subject|1|||
131151142|NCT00474240|472174079|FG000|Overall Study|Withdrawal by Subject|1|||
131151143|NCT00474240|472174080|FG001|Overall Study|Withdrawal by Subject|1|||
131151144|NCT00474240|472174081|FG002|Overall Study|Withdrawal by Subject|0|||
131151145|NCT00474240|472174082|FG003|Overall Study|Withdrawal by Subject|2|||
131151146|NCT00474240|472174083|FG004|Overall Study|Withdrawal by Subject|3|||
131151147|NCT00474240|472174084|FG005|Overall Study|Withdrawal by Subject|1|||
131151148|NCT00474240|472174079|FG000|Overall Study|Adverse Event|0|||
131151149|NCT00474240|472174080|FG001|Overall Study|Adverse Event|0|||
131151150|NCT00474240|472174081|FG002|Overall Study|Adverse Event|9|||
131151151|NCT00474240|472174082|FG003|Overall Study|Adverse Event|14|||
131151152|NCT00474240|472174083|FG004|Overall Study|Adverse Event|5|||
131151153|NCT00474240|472174084|FG005|Overall Study|Adverse Event|16|||
131151154|NCT00474240|472174079|FG000|Overall Study|Removed due to lab value|0|||
131151155|NCT00474240|472174080|FG001|Overall Study|Removed due to lab value|0|||
131151156|NCT00474240|472174081|FG002|Overall Study|Removed due to lab value|0|||
131151157|NCT00474240|472174082|FG003|Overall Study|Removed due to lab value|0|||
131151158|NCT00474240|472174083|FG004|Overall Study|Removed due to lab value|0|||
131151159|NCT00474240|472174084|FG005|Overall Study|Removed due to lab value|1|||
131151160|NCT04026568|472174090|FG000|Overall Study|study terminated|0|||
131151161|NCT04026568|472174091|FG001|Overall Study|study terminated|1|||
131151162|NCT02197377|472174092|FG000|Overall Study|Insertion Failure|0|||
131151163|NCT02197377|472174093|FG001|Overall Study|Insertion Failure|3|||
131151164|NCT01773473|472174094|FG000|Overall Study|Adverse Event|3|||
131151165|NCT01773473|472174095|FG001|Overall Study|Adverse Event|2|||
131151166|NCT01773473|472174094|FG000|Overall Study|Protocol Violation|0|||
131151167|NCT01773473|472174095|FG001|Overall Study|Protocol Violation|4|||
131151168|NCT01773473|472174094|FG000|Overall Study|Physician Decision|3|||
131151169|NCT01773473|472174095|FG001|Overall Study|Physician Decision|5|||
131151170|NCT01773473|472174094|FG000|Overall Study|Sponsor Decision|2|||
131151171|NCT01773473|472174095|FG001|Overall Study|Sponsor Decision|0|||
131151172|NCT01773473|472174094|FG000|Overall Study|Lack of Efficacy|0|||
131151173|NCT01773473|472174095|FG001|Overall Study|Lack of Efficacy|1|||
131151174|NCT01773473|472174094|FG000|Overall Study|Non-Compliance with study drug|1|||
131151175|NCT01773473|472174095|FG001|Overall Study|Non-Compliance with study drug|4|||
131151176|NCT01773473|472174094|FG000|Overall Study|Withdrawal by Subject|5|||
131151177|NCT01773473|472174095|FG001|Overall Study|Withdrawal by Subject|3|||
131151178|NCT01773473|472174094|FG000|Overall Study|Lost to Follow-up|2|||
131151179|NCT01773473|472174095|FG001|Overall Study|Lost to Follow-up|0|||
131151180|NCT02561156|472174096|FG000|Part 2|Adverse Event|0|||
131151181|NCT02561156|472174097|FG001|Part 2|Adverse Event|0|||
131151182|NCT02561156|472174098|FG002|Part 2|Adverse Event|0|||
130728046|NCT01449370|470625581|FG015|Overall Study|Death|0|||
130728047|NCT01449370|470625582|FG016|Overall Study|Death|0|||
130728048|NCT01449370|470625583|FG017|Overall Study|Death|0|||
130728049|NCT01449370|470625584|FG018|Overall Study|Death|0|||
130728050|NCT01449370|470625585|FG019|Overall Study|Death|0|||
130728051|NCT01449370|470625586|FG020|Overall Study|Death|0|||
130728052|NCT01449370|470625587|FG021|Overall Study|Death|0|||
130728053|NCT01449370|470625588|FG022|Overall Study|Death|0|||
130728054|NCT01449370|470625589|FG023|Overall Study|Death|0|||
130728055|NCT01449370|470625590|FG024|Overall Study|Death|1|||
130728056|NCT02290223|470625591|FG000|6 Months|Lost to Follow-up|9|||
130728057|NCT02290223|470625592|FG001|6 Months|Lost to Follow-up|6|||
130728058|NCT02290223|470625591|FG000|6 Months|Withdrawal by Subject|5|||
130728059|NCT02290223|470625592|FG001|6 Months|Withdrawal by Subject|0|||
130728060|NCT02290223|470625591|FG000|6 Months|deceased (not related to study)|2|||
130728061|NCT02290223|470625592|FG001|6 Months|deceased (not related to study)|0|||
130728062|NCT02290223|470625591|FG000|12 Months|Lost to Follow-up|16|||
130728063|NCT02290223|470625592|FG001|12 Months|Lost to Follow-up|10|||
130728064|NCT02290223|470625591|FG000|12 Months|Refusal|0|||
131151183|NCT02561156|472174099|FG003|Part 2|Adverse Event|0|||
131151184|NCT02561156|472174100|FG004|Part 2|Adverse Event|0|||
131151185|NCT02561156|472174101|FG005|Part 2|Adverse Event|0|||
131151186|NCT02561156|472174102|FG006|Part 2|Adverse Event|0|||
131151187|NCT02561156|472174103|FG007|Part 2|Adverse Event|0|||
131151188|NCT02561156|472174104|FG008|Part 2|Adverse Event|0|||
131151189|NCT02561156|472174105|FG009|Part 2|Adverse Event|0|||
131151190|NCT02561156|472174106|FG010|Part 2|Adverse Event|0|||
131151191|NCT02561156|472174107|FG011|Part 2|Adverse Event|1|||
131151192|NCT02561156|472174108|FG012|Part 2|Adverse Event|0|||
131151193|NCT01071070|472174109|FG000|Overall Study|Adverse Event|0|||
131151194|NCT01071070|472174110|FG001|Overall Study|Adverse Event|3|||
131151195|NCT01071070|472174109|FG000|Overall Study|Withdrawal by Subject|1|||
131151196|NCT01071070|472174110|FG001|Overall Study|Withdrawal by Subject|0|||
131151197|NCT01071070|472174109|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
131151198|NCT01071070|472174110|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
131151199|NCT01071070|472174109|FG000|Overall Study|Hypercalcemia|1|||
131151200|NCT01071070|472174110|FG001|Overall Study|Hypercalcemia|0|||
131151201|NCT02203149|472174116|FG000|Part 1|Adverse Event|0|||
131151202|NCT02203149|472174117|FG001|Part 1|Adverse Event|1|||
131151203|NCT02203149|472174118|FG002|Part 1|Adverse Event|0|||
131151204|NCT02203149|472174119|FG003|Part 1|Adverse Event|0|||
131151205|NCT02203149|472174120|FG004|Part 1|Adverse Event|0|||
131151206|NCT02203149|472174116|FG000|Part 2|Death|0|||
131151207|NCT02203149|472174117|FG001|Part 2|Death|0|||
131151208|NCT02203149|472174118|FG002|Part 2|Death|1|||
131151209|NCT02203149|472174119|FG003|Part 2|Death|1|||
131151210|NCT02203149|472174120|FG004|Part 2|Death|0|||
131151211|NCT02203149|472174116|FG000|Part 2|Withdrawal by Subject|0|||
131151212|NCT02203149|472174117|FG001|Part 2|Withdrawal by Subject|0|||
131151213|NCT02203149|472174118|FG002|Part 2|Withdrawal by Subject|0|||
131151214|NCT02203149|472174119|FG003|Part 2|Withdrawal by Subject|1|||
131151215|NCT02203149|472174120|FG004|Part 2|Withdrawal by Subject|0|||
131151216|NCT02203149|472174116|FG000|Part 2|Adverse Event|0|||
131151217|NCT02203149|472174117|FG001|Part 2|Adverse Event|0|||
131151218|NCT02203149|472174118|FG002|Part 2|Adverse Event|0|||
131151219|NCT02203149|472174119|FG003|Part 2|Adverse Event|1|||
131151220|NCT02203149|472174120|FG004|Part 2|Adverse Event|1|||
131151221|NCT01454076|472174122|FG000|Overall Study|Other|2|||
131151222|NCT01454076|472174123|FG001|Overall Study|Other|0|||
131151223|NCT01454076|472174124|FG002|Overall Study|Other|0|||
131151224|NCT01454076|472174125|FG003|Overall Study|Other|1|||
131151225|NCT01454076|472174126|FG004|Overall Study|Other|2|||
131151226|NCT01454076|472174122|FG000|Overall Study|Withdrawal by Subject|3|||
131151227|NCT01454076|472174123|FG001|Overall Study|Withdrawal by Subject|4|||
131151228|NCT01454076|472174124|FG002|Overall Study|Withdrawal by Subject|2|||
131151229|NCT01454076|472174125|FG003|Overall Study|Withdrawal by Subject|1|||
131151230|NCT01454076|472174126|FG004|Overall Study|Withdrawal by Subject|2|||
131151231|NCT01454076|472174122|FG000|Overall Study|Adverse Event|8|||
131151232|NCT01454076|472174123|FG001|Overall Study|Adverse Event|2|||
131151233|NCT01454076|472174124|FG002|Overall Study|Adverse Event|7|||
130728065|NCT02290223|470625592|FG001|12 Months|Refusal|1|||
131151234|NCT01454076|472174125|FG003|Overall Study|Adverse Event|0|||
131151235|NCT01454076|472174126|FG004|Overall Study|Adverse Event|2|||
131151236|NCT01478958|472174127|FG000|Overall Study|Withdrawal by Subject|1|||
130728066|NCT00534404|470625593|FG000|Overall Study|Death|0|||
130728067|NCT00534404|470625594|FG001|Overall Study|Death|0|||
131151237|NCT01478958|472174128|FG001|Overall Study|Withdrawal by Subject|1|||
131151238|NCT01478958|472174129|FG002|Overall Study|Withdrawal by Subject|1|||
131151239|NCT01478958|472174127|FG000|Overall Study|Weight loss|1|||
130728068|NCT00534404|470625595|FG002|Overall Study|Death|2|||
130728069|NCT00534404|470625593|FG000|Overall Study|Withdrawal by Subject|8|||
131151240|NCT01478958|472174128|FG001|Overall Study|Weight loss|0|||
131151241|NCT01478958|472174129|FG002|Overall Study|Weight loss|0|||
131151242|NCT01478958|472174127|FG000|Overall Study|Re-located|0|||
131151243|NCT01478958|472174128|FG001|Overall Study|Re-located|1|||
131151244|NCT01478958|472174129|FG002|Overall Study|Re-located|0|||
131151245|NCT01478958|472174127|FG000|Overall Study|Unable to comply|0|||
131151246|NCT01478958|472174128|FG001|Overall Study|Unable to comply|0|||
131151247|NCT01478958|472174129|FG002|Overall Study|Unable to comply|2|||
131151248|NCT04373460|472174138|FG000|Overall Study|Did not receive tranfusion|18|||
131151249|NCT04373460|472174139|FG001|Overall Study|Did not receive tranfusion|26|||
131151250|NCT00642642|472174140|FG000|Treatment & Follow Up|Adverse Event|2|||
131151251|NCT00642642|472174140|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
131151252|NCT00642642|472174140|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
131151253|NCT02337387|472174143|FG000|Overall Study|Adverse Event|0|||
131151254|NCT02337387|472174144|FG001|Overall Study|Adverse Event|1|||
131151255|NCT02337387|472174145|FG002|Overall Study|Adverse Event|0|||
131151256|NCT02337387|472174146|FG003|Overall Study|Adverse Event|0|||
131151257|NCT02337387|472174143|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
131151258|NCT02337387|472174144|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
131151259|NCT02337387|472174145|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
131151260|NCT02337387|472174146|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
131151261|NCT01856114|472174147|FG000|Overall Study|Withdrawal by Subject|1|||
131151262|NCT01856114|472174148|FG001|Overall Study|Withdrawal by Subject|0|||
131151263|NCT01856114|472174147|FG000|Overall Study|Adverse Event|1|||
131151264|NCT01856114|472174148|FG001|Overall Study|Adverse Event|0|||
131151265|NCT02272790|472174149|FG000|Overall Study|Physician Decision|0|||
131151266|NCT02272790|472174150|FG001|Overall Study|Physician Decision|1|||
131151267|NCT02272790|472174151|FG002|Overall Study|Physician Decision|0|||
131151268|NCT02272790|472174152|FG003|Overall Study|Physician Decision|0|||
131151269|NCT02272790|472174153|FG004|Overall Study|Physician Decision|0|||
131151270|NCT02272790|472174154|FG005|Overall Study|Physician Decision|0|||
131151271|NCT01237951|472174155|FG000|Overall Study|Death|1|||
131151272|NCT00275561|472174156|FG000|Overall Study|Withdrawal by Subject|0|||
131151273|NCT00275561|472174157|FG001|Overall Study|Withdrawal by Subject|1|||
131151274|NCT00275561|472174156|FG000|Overall Study|Travel|1|||
131151275|NCT00275561|472174157|FG001|Overall Study|Travel|1|||
131151276|NCT00275561|472174156|FG000|Overall Study|Scheduling|1|||
131151277|NCT00275561|472174157|FG001|Overall Study|Scheduling|2|||
131151278|NCT00275561|472174156|FG000|Overall Study|Family Issues|0|||
131151279|NCT00275561|472174157|FG001|Overall Study|Family Issues|2|||
131151280|NCT02660580|472176569|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
131151281|NCT02660580|472176570|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
131151282|NCT02660580|472176571|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
131151283|NCT02660580|472176572|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
131151284|NCT02660580|472176573|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
131151285|NCT02660580|472176569|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
131151286|NCT02660580|472176570|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
131151287|NCT02660580|472176571|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
131151288|NCT02660580|472176572|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
131151289|NCT02660580|472176573|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
131151290|NCT02660580|472176569|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
131151291|NCT02660580|472176570|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
131151292|NCT02660580|472176571|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
131151293|NCT02660580|472176572|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
131151294|NCT02660580|472176573|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
131151295|NCT02660580|472176569|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
131151296|NCT02660580|472176570|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
131151297|NCT02660580|472176571|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
131151298|NCT02660580|472176572|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
131151299|NCT02660580|472176573|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
131151300|NCT02660580|472176569|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
131151301|NCT02660580|472176570|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
131151302|NCT02660580|472176571|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
131151303|NCT02660580|472176572|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
131151304|NCT02660580|472176573|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
131151305|NCT02660580|472176569|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
131151306|NCT02660580|472176570|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
131151307|NCT02660580|472176571|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
131151308|NCT02660580|472176572|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
131151309|NCT02660580|472176573|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
131151310|NCT02660580|472176569|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
131151311|NCT02660580|472176570|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
131151312|NCT02660580|472176571|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
131151313|NCT02660580|472176572|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
131151314|NCT02660580|472176573|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
131151315|NCT02660580|472176569|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
131151316|NCT02660580|472176570|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
131151317|NCT02660580|472176571|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
131151318|NCT02660580|472176572|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
131151319|NCT02660580|472176573|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
131151320|NCT02660580|472176569|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
131151321|NCT02660580|472176570|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
131151322|NCT02660580|472176571|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
131151323|NCT02660580|472176572|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
131151324|NCT02660580|472176573|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
131151325|NCT02660580|472176569|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
131151326|NCT02660580|472176570|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
131151327|NCT02660580|472176571|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
131151328|NCT02660580|472176572|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
131151329|NCT02660580|472176573|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
131151330|NCT02660580|472176569|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
131151331|NCT02660580|472176570|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
131151332|NCT02660580|472176571|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
131151333|NCT02660580|472176572|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
131151334|NCT02660580|472176573|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
131151335|NCT02660580|472176569|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
131151336|NCT02660580|472176570|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
131151337|NCT02660580|472176571|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
131151338|NCT02660580|472176572|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
131151339|NCT02660580|472176573|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
131151340|NCT02660580|472176569|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
131151341|NCT02660580|472176570|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
131151342|NCT02660580|472176571|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
131151343|NCT02660580|472176572|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
131151344|NCT02660580|472176573|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
131151345|NCT00377962|472176574|FG000|Core Study: 0-12 Months|Adverse Event|18|||
131151346|NCT00377962|472176575|FG001|Core Study: 0-12 Months|Adverse Event|2|||
131151347|NCT00377962|472176574|FG000|Core Study: 0-12 Months|Death|3|||
131151348|NCT00377962|472176575|FG001|Core Study: 0-12 Months|Death|0|||
131151349|NCT00377962|472176574|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
131151350|NCT00377962|472176575|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
131151351|NCT00377962|472176574|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
131151352|NCT00377962|472176575|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
131151353|NCT00377962|472176574|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
131151354|NCT00377962|472176575|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
131151355|NCT00377962|472176574|FG000|Extension Study: 12-24 Months|Death|1|||
131151356|NCT00377962|472176575|FG001|Extension Study: 12-24 Months|Death|1|||
131151357|NCT00377962|472176574|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
131151358|NCT00377962|472176575|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
131151359|NCT00377962|472176574|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
131151360|NCT00377962|472176575|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
131151361|NCT00377962|472176574|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
131151362|NCT00377962|472176575|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
131151363|NCT00742781|472176576|FG000|Overall Study|Withdrawal by Subject|3|||
131151364|NCT03539432|472176577|FG000|Overall Study|Lost to Follow-up|0|||
131151365|NCT03539432|472176578|FG001|Overall Study|Lost to Follow-up|1|||
131151366|NCT02443402|472176579|FG000|Overall Study|Withdrawal by Subject|3|||
131151367|NCT02443402|472176580|FG001|Overall Study|Withdrawal by Subject|1|||
131151368|NCT02443402|472176579|FG000|Overall Study|Screen Failure|1|||
131151369|NCT02443402|472176580|FG001|Overall Study|Screen Failure|2|||
131151370|NCT04178590|472176583|FG000|Overall Study|Pregnancy|1|||
131151371|NCT04178590|472176583|FG000|Overall Study|Lost to Follow-up|1|||
131151372|NCT01389245|472176584|FG000|Overall Study|Protocol Violation|10|||
131151373|NCT01389245|472176584|FG000|Overall Study|Lost to Follow-up|3|||
131151374|NCT01389245|472176584|FG000|Overall Study|Withdrawal by Subject|2|||
131234943|NCT00623103|472488760|FG000|Overall Study|Lost to Follow-up|4|||
131234944|NCT00623103|472488761|FG001|Overall Study|Lost to Follow-up|1|||
131234945|NCT00623103|472488760|FG000|Overall Study|Administrative problems|2|||
131234946|NCT00623103|472488761|FG001|Overall Study|Administrative problems|4|||
131234947|NCT00623103|472488760|FG000|Overall Study|Death|11|||
131234948|NCT00623103|472488761|FG001|Overall Study|Death|11|||
131234949|NCT00623103|472488760|FG000|Overall Study|Protocol deviation|2|||
131234950|NCT00623103|472488761|FG001|Overall Study|Protocol deviation|1|||
131234951|NCT00625807|472488764|FG000|Overall Study|schedule conflict|2|||
131151375|NCT02292849|472176585|FG000|Overall Study|Lost to Follow-up|0|||
131151376|NCT02292849|472176586|FG001|Overall Study|Lost to Follow-up|2|||
131151377|NCT02292849|472176587|FG002|Overall Study|Lost to Follow-up|2|||
131151378|NCT02292849|472176585|FG000|Overall Study|Physician Decision|4|||
131151379|NCT02292849|472176586|FG001|Overall Study|Physician Decision|0|||
131151380|NCT02292849|472176587|FG002|Overall Study|Physician Decision|0|||
131151381|NCT02725788|472176592|FG000|Overall Study|Lost to Follow-up|1|||
131151382|NCT02725788|472176593|FG001|Overall Study|Lost to Follow-up|1|||
131151383|NCT02725788|472176592|FG000|Overall Study|Protocol Violation|0|||
131151384|NCT02725788|472176593|FG001|Overall Study|Protocol Violation|1|||
131151385|NCT02599402|472176594|FG000|Overall Study|Disease progression|153|||
131151386|NCT02599402|472176594|FG000|Overall Study|Study drug toxicity|201|||
131151387|NCT02599402|472176594|FG000|Overall Study|Death|26|||
131151388|NCT02599402|472176594|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
131151389|NCT02599402|472176594|FG000|Overall Study|Participant request to discontinue study treatment|13|||
131151390|NCT02599402|472176594|FG000|Overall Study|Participant withdrew consent|5|||
131151391|NCT02599402|472176594|FG000|Overall Study|Lost to Follow-up|1|||
131151392|NCT02599402|472176594|FG000|Overall Study|Maximum Clinical Benefit|7|||
131151393|NCT02599402|472176594|FG000|Overall Study|Poor/non-compliance|1|||
131151394|NCT02599402|472176594|FG000|Overall Study|Pregnancy|1|||
131151395|NCT02599402|472176594|FG000|Overall Study|Participant no longer met study criteria|7|||
131151396|NCT02599402|472176594|FG000|Overall Study|Other Reasons|95|||
131151397|NCT00809133|472176595|FG000|Overall Study|Progressive disease|2|||
131151398|NCT00809133|472176596|FG001|Overall Study|Progressive disease|5|||
131151399|NCT00809133|472176597|FG002|Overall Study|Progressive disease|5|||
131151400|NCT00809133|472176598|FG003|Overall Study|Progressive disease|3|||
131151401|NCT00809133|472176599|FG004|Overall Study|Progressive disease|4|||
131151402|NCT00809133|472176600|FG005|Overall Study|Progressive disease|1|||
131151403|NCT00809133|472176601|FG006|Overall Study|Progressive disease|3|||
131151404|NCT00809133|472176602|FG007|Overall Study|Progressive disease|3|||
131151405|NCT00809133|472176603|FG008|Overall Study|Progressive disease|3|||
131151406|NCT00809133|472176604|FG009|Overall Study|Progressive disease|9|||
131151407|NCT00809133|472176605|FG010|Overall Study|Progressive disease|5|||
131151408|NCT00809133|472176606|FG011|Overall Study|Progressive disease|7|||
131151409|NCT00809133|472176607|FG012|Overall Study|Progressive disease|5|||
131151410|NCT00809133|472176608|FG013|Overall Study|Progressive disease|4|||
131151411|NCT00809133|472176595|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131151412|NCT00809133|472176596|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131151413|NCT00809133|472176597|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131151414|NCT00809133|472176598|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131151415|NCT00809133|472176599|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131151416|NCT00809133|472176600|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
131151417|NCT00809133|472176601|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
131151418|NCT00809133|472176602|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
131151419|NCT00809133|472176603|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131151420|NCT00809133|472176604|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131151421|NCT00809133|472176605|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131151422|NCT00809133|472176606|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131151423|NCT00809133|472176607|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
131151424|NCT00809133|472176608|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
131151425|NCT00809133|472176595|FG000|Overall Study|Other adverse event|1|||
131151426|NCT00809133|472176596|FG001|Overall Study|Other adverse event|1|||
131151427|NCT00809133|472176597|FG002|Overall Study|Other adverse event|1|||
131151428|NCT00809133|472176598|FG003|Overall Study|Other adverse event|0|||
131151429|NCT00809133|472176599|FG004|Overall Study|Other adverse event|0|||
131151430|NCT00809133|472176600|FG005|Overall Study|Other adverse event|3|||
131151431|NCT00809133|472176601|FG006|Overall Study|Other adverse event|2|||
131151432|NCT00809133|472176602|FG007|Overall Study|Other adverse event|4|||
131151433|NCT00809133|472176603|FG008|Overall Study|Other adverse event|0|||
131151434|NCT00809133|472176604|FG009|Overall Study|Other adverse event|0|||
131151435|NCT00809133|472176605|FG010|Overall Study|Other adverse event|1|||
131151436|NCT00809133|472176606|FG011|Overall Study|Other adverse event|1|||
131151437|NCT00809133|472176607|FG012|Overall Study|Other adverse event|0|||
131151438|NCT00809133|472176608|FG013|Overall Study|Other adverse event|1|||
131151439|NCT00809133|472176595|FG000|Overall Study|Lost to Follow-up|0|||
131151440|NCT00809133|472176596|FG001|Overall Study|Lost to Follow-up|0|||
131151441|NCT00809133|472176597|FG002|Overall Study|Lost to Follow-up|0|||
131151442|NCT00809133|472176598|FG003|Overall Study|Lost to Follow-up|0|||
131151443|NCT00809133|472176599|FG004|Overall Study|Lost to Follow-up|0|||
131151444|NCT00809133|472176600|FG005|Overall Study|Lost to Follow-up|1|||
131151445|NCT00809133|472176601|FG006|Overall Study|Lost to Follow-up|0|||
131151446|NCT00809133|472176602|FG007|Overall Study|Lost to Follow-up|0|||
131151447|NCT00809133|472176603|FG008|Overall Study|Lost to Follow-up|0|||
131151448|NCT00809133|472176604|FG009|Overall Study|Lost to Follow-up|0|||
131151449|NCT00809133|472176605|FG010|Overall Study|Lost to Follow-up|0|||
131151450|NCT00809133|472176606|FG011|Overall Study|Lost to Follow-up|0|||
131151451|NCT00809133|472176607|FG012|Overall Study|Lost to Follow-up|0|||
131151452|NCT00809133|472176608|FG013|Overall Study|Lost to Follow-up|0|||
131151453|NCT00809133|472176595|FG000|Overall Study|Consent withdrawn|0|||
131151454|NCT00809133|472176596|FG001|Overall Study|Consent withdrawn|0|||
131151455|NCT00809133|472176597|FG002|Overall Study|Consent withdrawn|0|||
131151456|NCT00809133|472176598|FG003|Overall Study|Consent withdrawn|0|||
131151457|NCT00809133|472176599|FG004|Overall Study|Consent withdrawn|1|||
131151458|NCT00809133|472176600|FG005|Overall Study|Consent withdrawn|0|||
131151459|NCT00809133|472176601|FG006|Overall Study|Consent withdrawn|0|||
131151460|NCT00809133|472176602|FG007|Overall Study|Consent withdrawn|0|||
131151461|NCT00809133|472176603|FG008|Overall Study|Consent withdrawn|0|||
131151462|NCT00809133|472176604|FG009|Overall Study|Consent withdrawn|0|||
131151463|NCT00809133|472176605|FG010|Overall Study|Consent withdrawn|0|||
131151464|NCT00809133|472176606|FG011|Overall Study|Consent withdrawn|0|||
131151465|NCT00809133|472176607|FG012|Overall Study|Consent withdrawn|0|||
131151466|NCT00809133|472176608|FG013|Overall Study|Consent withdrawn|0|||
131151467|NCT00809133|472176595|FG000|Overall Study|Other not mentioned above|0|||
131151468|NCT00809133|472176596|FG001|Overall Study|Other not mentioned above|1|||
131151469|NCT00809133|472176597|FG002|Overall Study|Other not mentioned above|0|||
131151470|NCT00809133|472176598|FG003|Overall Study|Other not mentioned above|0|||
131151471|NCT00809133|472176599|FG004|Overall Study|Other not mentioned above|0|||
131151472|NCT00809133|472176600|FG005|Overall Study|Other not mentioned above|1|||
131151473|NCT00809133|472176601|FG006|Overall Study|Other not mentioned above|0|||
131151474|NCT00809133|472176602|FG007|Overall Study|Other not mentioned above|0|||
131151475|NCT00809133|472176603|FG008|Overall Study|Other not mentioned above|0|||
131151476|NCT00809133|472176604|FG009|Overall Study|Other not mentioned above|0|||
131151477|NCT00809133|472176605|FG010|Overall Study|Other not mentioned above|0|||
131151478|NCT00809133|472176606|FG011|Overall Study|Other not mentioned above|0|||
131151479|NCT00809133|472176607|FG012|Overall Study|Other not mentioned above|0|||
131151480|NCT00809133|472176608|FG013|Overall Study|Other not mentioned above|0|||
131151481|NCT00833092|472176609|FG000|Overall Study|Withdrawal by Subject|2|||
131151482|NCT00833092|472176610|FG001|Overall Study|Withdrawal by Subject|3|||
131151483|NCT00833092|472176609|FG000|Overall Study|Protocol Violation|2|||
131151484|NCT00833092|472176610|FG001|Overall Study|Protocol Violation|1|||
131151485|NCT00833092|472176609|FG000|Overall Study|Diarrhea|0|||
131151486|NCT00833092|472176610|FG001|Overall Study|Diarrhea|2|||
131151487|NCT00833092|472176609|FG000|Overall Study|constipation|0|||
131151488|NCT00833092|472176610|FG001|Overall Study|constipation|1|||
131151489|NCT00699192|472176611|FG000|Overall Study|Missing|1|||
131151490|NCT00699192|472176612|FG001|Overall Study|Missing|1|||
131151491|NCT00699192|472176613|FG002|Overall Study|Missing|1|||
131151492|NCT00699192|472176611|FG000|Overall Study|Adverse Event|9|||
131151493|NCT00699192|472176612|FG001|Overall Study|Adverse Event|4|||
131151494|NCT00699192|472176613|FG002|Overall Study|Adverse Event|3|||
131151495|NCT00699192|472176611|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131151496|NCT00699192|472176612|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131151497|NCT00699192|472176613|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131151498|NCT00699192|472176611|FG000|Overall Study|Lack of Efficacy|0|||
131151499|NCT00699192|472176612|FG001|Overall Study|Lack of Efficacy|0|||
131151500|NCT00699192|472176613|FG002|Overall Study|Lack of Efficacy|1|||
131151501|NCT00699192|472176611|FG000|Overall Study|Withdrawal by Subject|3|||
131151502|NCT00699192|472176612|FG001|Overall Study|Withdrawal by Subject|2|||
131151503|NCT00699192|472176613|FG002|Overall Study|Withdrawal by Subject|4|||
131151504|NCT00699192|472176611|FG000|Overall Study|Administrative problems|1|||
131151505|NCT00699192|472176612|FG001|Overall Study|Administrative problems|3|||
131151506|NCT00699192|472176613|FG002|Overall Study|Administrative problems|1|||
131151507|NCT00699192|472176611|FG000|Overall Study|Protocol Violation|2|||
131151508|NCT00699192|472176612|FG001|Overall Study|Protocol Violation|2|||
131151509|NCT00699192|472176613|FG002|Overall Study|Protocol Violation|0|||
131151510|NCT01025635|472176623|FG000|Overall Study|Withdrawal by Subject|6|||
131151511|NCT01025635|472176624|FG001|Overall Study|Withdrawal by Subject|7|||
131151512|NCT01025635|472176623|FG000|Overall Study|Protocol Violation|4|||
131151513|NCT01025635|472176624|FG001|Overall Study|Protocol Violation|2|||
131151514|NCT01025635|472176623|FG000|Overall Study|Lack of Efficacy|0|||
131151515|NCT01025635|472176624|FG001|Overall Study|Lack of Efficacy|1|||
131234952|NCT00625807|472488765|FG001|Overall Study|schedule conflict|8|||
131234953|NCT02224391|472488766|FG000|Overall Study|Lost to Follow-up|26|||
131234954|NCT02224391|472488767|FG001|Overall Study|Lost to Follow-up|19|||
131234955|NCT02224391|472488766|FG000|Overall Study|Withdrawal by Subject|6|||
131151516|NCT01025635|472176623|FG000|Overall Study|Lost to Follow-up|9|||
131151517|NCT01025635|472176624|FG001|Overall Study|Lost to Follow-up|13|||
131151518|NCT01025635|472176623|FG000|Overall Study|Reason not known|4|||
131151519|NCT01025635|472176624|FG001|Overall Study|Reason not known|2|||
131151520|NCT00727402|472176625|FG000|Overall Study|Physician Decision|116|||
131151521|NCT00929240|472176626|FG000|Initial Treatment Phase|Adverse Event|31|||
131151522|NCT00929240|472176627|FG001|Initial Treatment Phase|Adverse Event|0|||
131151523|NCT00929240|472176628|FG002|Initial Treatment Phase|Adverse Event|0|||
131151524|NCT00929240|472176626|FG000|Initial Treatment Phase|Disease progression|41|||
131151525|NCT00929240|472176627|FG001|Initial Treatment Phase|Disease progression|0|||
131151526|NCT00929240|472176628|FG002|Initial Treatment Phase|Disease progression|0|||
131151527|NCT00929240|472176626|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
131151528|NCT00929240|472176627|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
131151529|NCT00929240|472176628|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
131151530|NCT00929240|472176626|FG000|Initial Treatment Phase|Protocol Violation|5|||
131151531|NCT00929240|472176627|FG001|Initial Treatment Phase|Protocol Violation|0|||
131151532|NCT00929240|472176628|FG002|Initial Treatment Phase|Protocol Violation|0|||
131151533|NCT00929240|472176626|FG000|Initial Treatment Phase|Death|2|||
131151534|NCT00929240|472176627|FG001|Initial Treatment Phase|Death|0|||
131151535|NCT00929240|472176628|FG002|Initial Treatment Phase|Death|0|||
131151536|NCT00929240|472176626|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
131151537|NCT00929240|472176627|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
131151538|NCT00929240|472176628|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
131151539|NCT00929240|472176626|FG000|Initial Treatment Phase|Physician Decision|4|||
131151540|NCT00929240|472176627|FG001|Initial Treatment Phase|Physician Decision|0|||
131151541|NCT00929240|472176628|FG002|Initial Treatment Phase|Physician Decision|0|||
131151542|NCT00929240|472176626|FG000|Maintenance Phase|Disease progression|0|||
131151543|NCT00929240|472176627|FG001|Maintenance Phase|Disease progression|73|||
131151544|NCT00929240|472176628|FG002|Maintenance Phase|Disease progression|60|||
131151545|NCT00929240|472176626|FG000|Maintenance Phase|Adverse Event|0|||
131151546|NCT00929240|472176627|FG001|Maintenance Phase|Adverse Event|9|||
131151547|NCT00929240|472176628|FG002|Maintenance Phase|Adverse Event|12|||
131151548|NCT00929240|472176626|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131151549|NCT00929240|472176627|FG001|Maintenance Phase|Withdrawal by Subject|2|||
131151550|NCT00929240|472176628|FG002|Maintenance Phase|Withdrawal by Subject|6|||
131151551|NCT00929240|472176626|FG000|Maintenance Phase|Protocol Violation|0|||
131151552|NCT00929240|472176627|FG001|Maintenance Phase|Protocol Violation|1|||
131151553|NCT00929240|472176628|FG002|Maintenance Phase|Protocol Violation|0|||
131151554|NCT00929240|472176626|FG000|Maintenance Phase|Health authority/Study termination|0|||
131151555|NCT00929240|472176627|FG001|Maintenance Phase|Health authority/Study termination|1|||
131151556|NCT00929240|472176628|FG002|Maintenance Phase|Health authority/Study termination|2|||
131151557|NCT00929240|472176626|FG000|Maintenance Phase|Physician Decision|0|||
131151558|NCT00929240|472176627|FG001|Maintenance Phase|Physician Decision|2|||
131151559|NCT00929240|472176628|FG002|Maintenance Phase|Physician Decision|1|||
131151560|NCT00929240|472176626|FG000|Maintenance Phase|Change of treatment|0|||
131151561|NCT00929240|472176627|FG001|Maintenance Phase|Change of treatment|4|||
131151562|NCT00929240|472176628|FG002|Maintenance Phase|Change of treatment|0|||
131151563|NCT00929240|472176626|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
131151564|NCT00929240|472176627|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
131151565|NCT00929240|472176628|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
131151566|NCT00929240|472176626|FG000|Maintenance Phase|Participant not treated|0|||
131151567|NCT00929240|472176627|FG001|Maintenance Phase|Participant not treated|2|||
131151568|NCT00929240|472176628|FG002|Maintenance Phase|Participant not treated|0|||
131151569|NCT05292755|472176629|FG000|Overall Study|Lost to Follow-up|5|||
131151570|NCT05292755|472176630|FG001|Overall Study|Lost to Follow-up|9|||
131151571|NCT03401749|472176631|FG000|Overall Study|Lost to Follow-up|20|||
131151572|NCT03401749|472176632|FG001|Overall Study|Lost to Follow-up|16|||
131151573|NCT03401749|472176633|FG002|Overall Study|Lost to Follow-up|26|||
131151574|NCT01193686|472176634|FG000|Overall Study|Withdrawal by Subject|4|||
131151575|NCT01193686|472176635|FG001|Overall Study|Withdrawal by Subject|1|||
131151576|NCT01193686|472176634|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
131151577|NCT01193686|472176635|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
131151578|NCT00432809|472176636|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
131151579|NCT00432809|472176637|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
130728070|NCT00534404|470625594|FG001|Overall Study|Withdrawal by Subject|2|||
130728071|NCT00534404|470625595|FG002|Overall Study|Withdrawal by Subject|38|||
130728072|NCT00534404|470625593|FG000|Overall Study|Removed by study staff|2|||
130728073|NCT00534404|470625594|FG001|Overall Study|Removed by study staff|3|||
130728074|NCT00534404|470625595|FG002|Overall Study|Removed by study staff|1|||
130728075|NCT00534404|470625593|FG000|Overall Study|Lost to Follow-up|170|||
130728076|NCT00534404|470625594|FG001|Overall Study|Lost to Follow-up|138|||
130728077|NCT00534404|470625595|FG002|Overall Study|Lost to Follow-up|201|||
131151580|NCT00432809|472176638|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
131151581|NCT00432809|472176636|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
131151582|NCT00432809|472176637|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
131151583|NCT00432809|472176638|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
131151584|NCT03075839|472176639|FG000|Overall Study|Lost to Follow-up|4|||
131151585|NCT04433117|472176640|FG000|Overall Study|Withdrawal by Subject|1|||
131151586|NCT04433117|472176641|FG001|Overall Study|Withdrawal by Subject|0|||
131151587|NCT00707577|472176642|FG000|Overall Study|Withdrawal by Subject|3|||
131151588|NCT00707577|472176643|FG001|Overall Study|Withdrawal by Subject|2|||
130728078|NCT03371459|470625599|FG000|Washout|Lost to Follow-up|0|||
130728079|NCT03371459|470625600|FG001|Washout|Lost to Follow-up|1|||
130728080|NCT03597464|470625603|FG000|Overall Study|Withdrawal by Subject|4|||
130728081|NCT03597464|470625604|FG001|Overall Study|Withdrawal by Subject|5|||
131151589|NCT00707577|472176642|FG000|Overall Study|Lost to Follow-up|34|||
131151590|NCT00707577|472176643|FG001|Overall Study|Lost to Follow-up|25|||
131151591|NCT00707577|472176642|FG000|Overall Study|Left employment|13|||
131151592|NCT00707577|472176643|FG001|Overall Study|Left employment|10|||
131151593|NCT00707577|472176642|FG000|Overall Study|Pregnancy|4|||
131151594|NCT00707577|472176643|FG001|Overall Study|Pregnancy|1|||
131151595|NCT03853694|472176644|FG000|Overall Study|Protocol Violation|3|||
131151596|NCT03853694|472176645|FG001|Overall Study|Protocol Violation|5|||
131151597|NCT03853694|472176646|FG002|Overall Study|Protocol Violation|3|||
131151598|NCT03853694|472176644|FG000|Overall Study|Delivered early|0|||
131151599|NCT03853694|472176645|FG001|Overall Study|Delivered early|1|||
131151600|NCT03853694|472176646|FG002|Overall Study|Delivered early|0|||
131151601|NCT03853694|472176644|FG000|Overall Study|not suitable to proceed|0|||
131151602|NCT03853694|472176645|FG001|Overall Study|not suitable to proceed|1|||
131151603|NCT03853694|472176646|FG002|Overall Study|not suitable to proceed|0|||
131151604|NCT03853694|472176644|FG000|Overall Study|difficult surgery|0|||
131151605|NCT03853694|472176645|FG001|Overall Study|difficult surgery|0|||
131151606|NCT03853694|472176646|FG002|Overall Study|difficult surgery|1|||
131151607|NCT03853694|472176644|FG000|Overall Study|Lost to Follow-up|0|||
131151608|NCT03853694|472176645|FG001|Overall Study|Lost to Follow-up|1|||
131151609|NCT03853694|472176646|FG002|Overall Study|Lost to Follow-up|0|||
131151610|NCT03853694|472176644|FG000|Overall Study|Withdrawal by Subject|0|||
131151611|NCT03853694|472176645|FG001|Overall Study|Withdrawal by Subject|1|||
131151612|NCT03853694|472176646|FG002|Overall Study|Withdrawal by Subject|0|||
131151613|NCT05089708|472176647|FG000|Overall Study|Lost to Follow-up|9|||
131151614|NCT05089708|472176648|FG001|Overall Study|Lost to Follow-up|7|||
131151615|NCT05089708|472176647|FG000|Overall Study|Withdrawal by Subject|3|||
131151616|NCT05089708|472176648|FG001|Overall Study|Withdrawal by Subject|1|||
131151617|NCT05089708|472176647|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
131151618|NCT05089708|472176648|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
131151619|NCT05089708|472176647|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
131151620|NCT05089708|472176648|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
131151621|NCT02209766|472176650|FG000|Overall Study|Withdrawal by Subject|0|||
131151622|NCT02209766|472176651|FG001|Overall Study|Withdrawal by Subject|0|||
131151623|NCT02209766|472176652|FG002|Overall Study|Withdrawal by Subject|0|||
131151624|NCT02209766|472176653|FG003|Overall Study|Withdrawal by Subject|1|||
131151625|NCT02209766|472176654|FG004|Overall Study|Withdrawal by Subject|0|||
131151626|NCT00805207|472176655|FG000|Overall Study|Protocol Violation|0|||
131151627|NCT00805207|472176656|FG001|Overall Study|Protocol Violation|0|||
131151628|NCT00805207|472176657|FG002|Overall Study|Protocol Violation|1|||
131151629|NCT00805207|472176658|FG003|Overall Study|Protocol Violation|0|||
131151630|NCT00805207|472176659|FG004|Overall Study|Protocol Violation|0|||
131151631|NCT00805207|472176660|FG005|Overall Study|Protocol Violation|0|||
131151632|NCT00805207|472176661|FG006|Overall Study|Protocol Violation|0|||
131151633|NCT00805207|472176662|FG007|Overall Study|Protocol Violation|0|||
131151634|NCT00805207|472176663|FG008|Overall Study|Protocol Violation|0|||
131151635|NCT00805207|472176655|FG000|Overall Study|Physician Decision|0|||
131151636|NCT00805207|472176656|FG001|Overall Study|Physician Decision|1|||
131151637|NCT00805207|472176657|FG002|Overall Study|Physician Decision|0|||
131151638|NCT00805207|472176658|FG003|Overall Study|Physician Decision|0|||
131151639|NCT00805207|472176659|FG004|Overall Study|Physician Decision|0|||
131151640|NCT00805207|472176660|FG005|Overall Study|Physician Decision|1|||
131151641|NCT00805207|472176661|FG006|Overall Study|Physician Decision|0|||
131151642|NCT00805207|472176662|FG007|Overall Study|Physician Decision|0|||
131151643|NCT00805207|472176663|FG008|Overall Study|Physician Decision|0|||
131151644|NCT00805207|472176655|FG000|Overall Study|Withdrawal by Subject|0|||
131151645|NCT00805207|472176656|FG001|Overall Study|Withdrawal by Subject|1|||
131151646|NCT00805207|472176657|FG002|Overall Study|Withdrawal by Subject|0|||
131151647|NCT00805207|472176658|FG003|Overall Study|Withdrawal by Subject|0|||
131151648|NCT00805207|472176659|FG004|Overall Study|Withdrawal by Subject|1|||
131151649|NCT00805207|472176660|FG005|Overall Study|Withdrawal by Subject|2|||
131151650|NCT00805207|472176661|FG006|Overall Study|Withdrawal by Subject|0|||
131151651|NCT00805207|472176662|FG007|Overall Study|Withdrawal by Subject|0|||
131151652|NCT00805207|472176663|FG008|Overall Study|Withdrawal by Subject|0|||
131151653|NCT00064701|472176664|FG000|One Year Post-transplant|Did not receive study drug|7|||
131151654|NCT00064701|472176665|FG001|One Year Post-transplant|Did not receive study drug|12|||
131151655|NCT00064701|472176666|FG002|One Year Post-transplant|Did not receive study drug|11|||
131151656|NCT00064701|472176664|FG000|One Year Post-transplant|Adverse Event|23|||
131151657|NCT00064701|472176665|FG001|One Year Post-transplant|Adverse Event|19|||
131151658|NCT00064701|472176666|FG002|One Year Post-transplant|Adverse Event|37|||
131151659|NCT00064701|472176664|FG000|One Year Post-transplant|Rejection|0|||
131151660|NCT00064701|472176665|FG001|One Year Post-transplant|Rejection|1|||
131151661|NCT00064701|472176666|FG002|One Year Post-transplant|Rejection|16|||
131151662|NCT00064701|472176664|FG000|One Year Post-transplant|Non-compliance|4|||
131151663|NCT00064701|472176665|FG001|One Year Post-transplant|Non-compliance|2|||
131151664|NCT00064701|472176666|FG002|One Year Post-transplant|Non-compliance|5|||
131151665|NCT00064701|472176664|FG000|One Year Post-transplant|Graft Failure|3|||
131151666|NCT00064701|472176665|FG001|One Year Post-transplant|Graft Failure|2|||
131151667|NCT00064701|472176666|FG002|One Year Post-transplant|Graft Failure|1|||
131151668|NCT00064701|472176664|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
131151669|NCT00064701|472176665|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
131151670|NCT00064701|472176666|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
131151671|NCT00064701|472176664|FG000|One Year Post-transplant|Lost to Follow-up|1|||
131151672|NCT00064701|472176665|FG001|One Year Post-transplant|Lost to Follow-up|0|||
131151673|NCT00064701|472176666|FG002|One Year Post-transplant|Lost to Follow-up|0|||
131151674|NCT00064701|472176664|FG000|One Year Post-transplant|Converted to rapamycin|1|||
131151675|NCT00064701|472176665|FG001|One Year Post-transplant|Converted to rapamycin|0|||
131151676|NCT00064701|472176666|FG002|One Year Post-transplant|Converted to rapamycin|0|||
131151677|NCT00064701|472176664|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
131151678|NCT00064701|472176665|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
131151679|NCT00064701|472176666|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
131151680|NCT00064701|472176664|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
131151681|NCT00064701|472176665|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
131151682|NCT00064701|472176666|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
131151683|NCT00064701|472176664|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
131151684|NCT00064701|472176665|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
131151685|NCT00064701|472176666|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
131151686|NCT00064701|472176664|FG000|One Year Post-transplant|Poor absorption|0|||
131151687|NCT00064701|472176665|FG001|One Year Post-transplant|Poor absorption|1|||
131151688|NCT00064701|472176666|FG002|One Year Post-transplant|Poor absorption|0|||
131151689|NCT00064701|472176664|FG000|One Year Post-transplant|Pancreas transplant|0|||
131151690|NCT00064701|472176665|FG001|One Year Post-transplant|Pancreas transplant|0|||
131151691|NCT00064701|472176666|FG002|One Year Post-transplant|Pancreas transplant|1|||
131151692|NCT00064701|472176664|FG000|Clinical Continuation Phase|Adverse Event|12|||
131151693|NCT00064701|472176665|FG001|Clinical Continuation Phase|Adverse Event|21|||
131151694|NCT00064701|472176666|FG002|Clinical Continuation Phase|Adverse Event|14|||
131151695|NCT00064701|472176664|FG000|Clinical Continuation Phase|Non-compliance|8|||
131151696|NCT00064701|472176665|FG001|Clinical Continuation Phase|Non-compliance|6|||
131151697|NCT00064701|472176666|FG002|Clinical Continuation Phase|Non-compliance|7|||
131151698|NCT00064701|472176664|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
131151699|NCT00064701|472176665|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
131151700|NCT00064701|472176666|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
131151701|NCT00064701|472176664|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
131151702|NCT00064701|472176665|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
131151703|NCT00064701|472176666|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
131151704|NCT00064701|472176664|FG000|Clinical Continuation Phase|Graft Failure|5|||
131151705|NCT00064701|472176665|FG001|Clinical Continuation Phase|Graft Failure|5|||
131151706|NCT00064701|472176666|FG002|Clinical Continuation Phase|Graft Failure|2|||
131151707|NCT00064701|472176664|FG000|Clinical Continuation Phase|Rejection|1|||
131151708|NCT00064701|472176665|FG001|Clinical Continuation Phase|Rejection|2|||
131151709|NCT00064701|472176666|FG002|Clinical Continuation Phase|Rejection|2|||
131151710|NCT00064701|472176664|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
131151711|NCT00064701|472176665|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
131151712|NCT00064701|472176666|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
131151713|NCT00064701|472176664|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
131151714|NCT00064701|472176665|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
131151715|NCT00064701|472176666|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
131151716|NCT00064701|472176664|FG000|Clinical Continuation Phase|Physician Decision|1|||
131151717|NCT00064701|472176665|FG001|Clinical Continuation Phase|Physician Decision|3|||
131151718|NCT00064701|472176666|FG002|Clinical Continuation Phase|Physician Decision|0|||
131151719|NCT00064701|472176664|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
131151720|NCT00064701|472176665|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
131151721|NCT00064701|472176666|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
131151722|NCT00064701|472176664|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
131151723|NCT00064701|472176665|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
130728082|NCT03597464|470625603|FG000|Overall Study|Lost to Follow-up|3|||
131151724|NCT00064701|472176666|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
131151725|NCT00064701|472176664|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
131151726|NCT00064701|472176665|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
131151727|NCT00064701|472176666|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
131151728|NCT00064701|472176664|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
131151729|NCT00064701|472176665|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
131151730|NCT00064701|472176666|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
131151731|NCT00064701|472176664|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
131151732|NCT00064701|472176665|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
131151733|NCT00064701|472176666|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
131151734|NCT00064701|472176664|FG000|Clinical Continuation Phase|Patient opted out|0|||
131151735|NCT00064701|472176665|FG001|Clinical Continuation Phase|Patient opted out|0|||
131151736|NCT00064701|472176666|FG002|Clinical Continuation Phase|Patient opted out|1|||
131151737|NCT01491945|472176668|FG000|Overall Study|Death|30|||
131151738|NCT01491945|472176668|FG000|Overall Study|Withdrwan/LTF|16|||
131151739|NCT01491945|472176668|FG000|Overall Study|Conversion|4|||
131151740|NCT01491945|472176668|FG000|Overall Study|Missed Visit|1|||
131151741|NCT05681715|472176669|FG000|Training Period (6-weeks)|Adverse Event|3|||
131151742|NCT05681715|472176670|FG001|Training Period (6-weeks)|Adverse Event|0|||
131151743|NCT05681715|472176671|FG002|Training Period (6-weeks)|Adverse Event|0|||
131151744|NCT05681715|472176669|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
131151745|NCT05681715|472176670|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
131151746|NCT05681715|472176671|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
131151747|NCT05681715|472176669|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
131151748|NCT05681715|472176670|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
131151749|NCT05681715|472176671|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
131151750|NCT05681715|472176669|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
131151751|NCT05681715|472176670|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
131151752|NCT05681715|472176671|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
131151753|NCT05681715|472176669|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
131151754|NCT05681715|472176670|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
131151755|NCT05681715|472176671|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
131151756|NCT05681715|472176669|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
131151757|NCT05681715|472176670|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
131151758|NCT05681715|472176671|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
131151759|NCT05681715|472176669|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
131151760|NCT05681715|472176670|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
131151761|NCT05681715|472176671|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
131151762|NCT05681715|472176669|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
131151763|NCT05681715|472176670|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
131151764|NCT05681715|472176671|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
131151765|NCT03770403|472176672|FG000|Overall Study|Adverse Event|8|||
131151766|NCT03770403|472176672|FG000|Overall Study|Death|5|||
131151767|NCT03770403|472176672|FG000|Overall Study|Physician Decision|1|||
131151768|NCT03770403|472176672|FG000|Overall Study|Sponsor decision|1|||
131151769|NCT03770403|472176672|FG000|Overall Study|Study terminated by Sponsor|1|||
131151770|NCT03770403|472176672|FG000|Overall Study|Withdrawal by Subject|13|||
131151771|NCT03770403|472176672|FG000|Overall Study|Other|88|||
131151772|NCT02305563|472176678|FG000|Treatment Period|Disease progression|0|||
131151773|NCT02305563|472176679|FG001|Treatment Period|Disease progression|0|||
131151774|NCT02305563|472176680|FG002|Treatment Period|Disease progression|15|||
131151775|NCT02305563|472176681|FG003|Treatment Period|Disease progression|6|||
131151776|NCT02305563|472176682|FG004|Treatment Period|Disease progression|6|||
131151777|NCT02305563|472176678|FG000|Treatment Period|Study drug toxicity|0|||
131151778|NCT02305563|472176679|FG001|Treatment Period|Study drug toxicity|0|||
131151779|NCT02305563|472176680|FG002|Treatment Period|Study drug toxicity|0|||
131151780|NCT02305563|472176681|FG003|Treatment Period|Study drug toxicity|1|||
131151781|NCT02305563|472176682|FG004|Treatment Period|Study drug toxicity|2|||
131151782|NCT02305563|472176678|FG000|Treatment Period|Death|0|||
131151783|NCT02305563|472176679|FG001|Treatment Period|Death|0|||
131151784|NCT02305563|472176680|FG002|Treatment Period|Death|1|||
131151785|NCT02305563|472176681|FG003|Treatment Period|Death|2|||
131151786|NCT02305563|472176682|FG004|Treatment Period|Death|1|||
131151787|NCT02305563|472176678|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
131151788|NCT02305563|472176679|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
131151789|NCT02305563|472176680|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
131151790|NCT02305563|472176681|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
131151791|NCT02305563|472176682|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
131151792|NCT02305563|472176678|FG000|Treatment Period|Participant request to stop therapy|0|||
131151793|NCT02305563|472176679|FG001|Treatment Period|Participant request to stop therapy|2|||
131151794|NCT02305563|472176680|FG002|Treatment Period|Participant request to stop therapy|0|||
131151795|NCT02305563|472176681|FG003|Treatment Period|Participant request to stop therapy|1|||
131151796|NCT02305563|472176682|FG004|Treatment Period|Participant request to stop therapy|0|||
131151797|NCT02305563|472176678|FG000|Treatment Period|Participant withdrew consent|0|||
131151798|NCT02305563|472176679|FG001|Treatment Period|Participant withdrew consent|0|||
131151799|NCT02305563|472176680|FG002|Treatment Period|Participant withdrew consent|1|||
131151800|NCT02305563|472176681|FG003|Treatment Period|Participant withdrew consent|1|||
131151801|NCT02305563|472176682|FG004|Treatment Period|Participant withdrew consent|1|||
131151802|NCT02305563|472176678|FG000|Treatment Period|Maximum clinical benefit|0|||
131151803|NCT02305563|472176679|FG001|Treatment Period|Maximum clinical benefit|0|||
131151804|NCT02305563|472176680|FG002|Treatment Period|Maximum clinical benefit|0|||
131151805|NCT02305563|472176681|FG003|Treatment Period|Maximum clinical benefit|0|||
131151806|NCT02305563|472176682|FG004|Treatment Period|Maximum clinical benefit|1|||
131151807|NCT02305563|472176678|FG000|Treatment Period|Poor/non-compliance|0|||
131151808|NCT02305563|472176679|FG001|Treatment Period|Poor/non-compliance|0|||
131151809|NCT02305563|472176680|FG002|Treatment Period|Poor/non-compliance|0|||
131151810|NCT02305563|472176681|FG003|Treatment Period|Poor/non-compliance|0|||
131151811|NCT02305563|472176682|FG004|Treatment Period|Poor/non-compliance|1|||
131151812|NCT02305563|472176678|FG000|Treatment Period|Administrative reason by Sponsor|0|||
131151813|NCT02305563|472176679|FG001|Treatment Period|Administrative reason by Sponsor|0|||
131151814|NCT02305563|472176680|FG002|Treatment Period|Administrative reason by Sponsor|0|||
131151815|NCT02305563|472176681|FG003|Treatment Period|Administrative reason by Sponsor|0|||
131151816|NCT02305563|472176682|FG004|Treatment Period|Administrative reason by Sponsor|1|||
131151817|NCT02305563|472176678|FG000|Treatment Period|other reason|2|||
131151818|NCT02305563|472176679|FG001|Treatment Period|other reason|0|||
131151819|NCT02305563|472176680|FG002|Treatment Period|other reason|2|||
131151820|NCT02305563|472176681|FG003|Treatment Period|other reason|2|||
131151821|NCT02305563|472176682|FG004|Treatment Period|other reason|1|||
131151822|NCT02305563|472176678|FG000|Treatment Period|Randomized but not treated|0|||
131151823|NCT02305563|472176679|FG001|Treatment Period|Randomized but not treated|0|||
131151824|NCT02305563|472176680|FG002|Treatment Period|Randomized but not treated|0|||
131151825|NCT02305563|472176681|FG003|Treatment Period|Randomized but not treated|0|||
131151826|NCT02305563|472176682|FG004|Treatment Period|Randomized but not treated|2|||
131151827|NCT02305563|472176678|FG000|Treatment Period|added ULO, then disease progression|0|||
131151828|NCT02305563|472176679|FG001|Treatment Period|added ULO, then disease progression|0|||
131151829|NCT02305563|472176680|FG002|Treatment Period|added ULO, then disease progression|0|||
131151830|NCT02305563|472176681|FG003|Treatment Period|added ULO, then disease progression|0|||
131151831|NCT02305563|472176682|FG004|Treatment Period|added ULO, then disease progression|4|||
131151832|NCT02305563|472176678|FG000|Treatment Period|added ULO; then other reason|0|||
130728083|NCT03597464|470625604|FG001|Overall Study|Lost to Follow-up|1|||
130728084|NCT03597464|470625603|FG000|Overall Study|Pregnancy|3|||
130728085|NCT03597464|470625604|FG001|Overall Study|Pregnancy|1|||
130728086|NCT03597464|470625603|FG000|Overall Study|Lack of Efficacy|2|||
130728087|NCT03597464|470625604|FG001|Overall Study|Lack of Efficacy|0|||
131151833|NCT02305563|472176679|FG001|Treatment Period|added ULO; then other reason|0|||
131151834|NCT02305563|472176680|FG002|Treatment Period|added ULO; then other reason|0|||
131151835|NCT02305563|472176681|FG003|Treatment Period|added ULO; then other reason|0|||
131151836|NCT02305563|472176682|FG004|Treatment Period|added ULO; then other reason|1|||
131151837|NCT02305563|472176678|FG000|Treatment Period|added ULO, then request to stop|0|||
131151838|NCT02305563|472176679|FG001|Treatment Period|added ULO, then request to stop|0|||
131151839|NCT02305563|472176680|FG002|Treatment Period|added ULO, then request to stop|0|||
131151840|NCT02305563|472176681|FG003|Treatment Period|added ULO, then request to stop|0|||
131151841|NCT02305563|472176682|FG004|Treatment Period|added ULO, then request to stop|1|||
131151842|NCT02305563|472176678|FG000|Follow-up Period|Death|0|||
131151843|NCT02305563|472176679|FG001|Follow-up Period|Death|0|||
131151844|NCT02305563|472176680|FG002|Follow-up Period|Death|5|||
131151845|NCT02305563|472176681|FG003|Follow-up Period|Death|4|||
131151846|NCT02305563|472176682|FG004|Follow-up Period|Death|7|||
131151847|NCT02305563|472176678|FG000|Follow-up Period|Participant withdrew consent|0|||
131151848|NCT02305563|472176679|FG001|Follow-up Period|Participant withdrew consent|0|||
131151849|NCT02305563|472176680|FG002|Follow-up Period|Participant withdrew consent|2|||
131151850|NCT02305563|472176681|FG003|Follow-up Period|Participant withdrew consent|1|||
131151851|NCT02305563|472176682|FG004|Follow-up Period|Participant withdrew consent|0|||
131151852|NCT02305563|472176678|FG000|Follow-up Period|other reason|0|||
131151853|NCT02305563|472176679|FG001|Follow-up Period|other reason|0|||
131151854|NCT02305563|472176680|FG002|Follow-up Period|other reason|0|||
131151855|NCT02305563|472176681|FG003|Follow-up Period|other reason|0|||
131151856|NCT02305563|472176682|FG004|Follow-up Period|other reason|1|||
131151857|NCT02305563|472176678|FG000|Follow-up Period|Followup no longer required per protocol|3|||
131151858|NCT02305563|472176679|FG001|Follow-up Period|Followup no longer required per protocol|3|||
131151859|NCT02305563|472176680|FG002|Follow-up Period|Followup no longer required per protocol|4|||
131151860|NCT02305563|472176681|FG003|Follow-up Period|Followup no longer required per protocol|1|||
131151861|NCT02305563|472176682|FG004|Follow-up Period|Followup no longer required per protocol|4|||
131151862|NCT02700451|472176685|FG000|Overall Study|Protocol Violation|2|||
130728088|NCT03597464|470625603|FG000|Overall Study|Physician Decision|2|||
131151863|NCT02700451|472176686|FG001|Overall Study|Protocol Violation|2|||
131151864|NCT02700451|472176687|FG002|Overall Study|Protocol Violation|3|||
130728089|NCT03597464|470625604|FG001|Overall Study|Physician Decision|2|||
130728090|NCT03597464|470625603|FG000|Overall Study|Protocol Violation|1|||
131151865|NCT02700451|472176685|FG000|Overall Study|Discontinued intervention|14|||
131234956|NCT02224391|472488767|FG001|Overall Study|Withdrawal by Subject|5|||
131234957|NCT01974895|472488768|FG000|Overall Study|Protocol Violation|1|||
131151866|NCT02700451|472176686|FG001|Overall Study|Discontinued intervention|15|||
131151867|NCT02700451|472176687|FG002|Overall Study|Discontinued intervention|14|||
131151868|NCT00454207|472176688|FG000|Overall Study|Adverse Event|3|||
131151869|NCT00454207|472176689|FG001|Overall Study|Adverse Event|1|||
131151870|NCT00454207|472176688|FG000|Overall Study|Lack of Efficacy|1|||
131151871|NCT00454207|472176689|FG001|Overall Study|Lack of Efficacy|0|||
131151872|NCT00454207|472176688|FG000|Overall Study|Protocol Violation|0|||
131151873|NCT00454207|472176689|FG001|Overall Study|Protocol Violation|1|||
131151874|NCT00981526|472176692|FG000|Overall Study|Withdrawal by Subject|0|||
131151875|NCT00981526|472176693|FG001|Overall Study|Withdrawal by Subject|2|||
131151876|NCT00981526|472176692|FG000|Overall Study|Physician Decision|4|||
131151877|NCT00981526|472176693|FG001|Overall Study|Physician Decision|4|||
131151878|NCT01564784|472176694|FG000|Overall Study|Other|1|||
131151879|NCT01564784|472176695|FG001|Overall Study|Other|0|||
131151880|NCT01564784|472176694|FG000|Overall Study|Subject refused further follow-up|1|||
131151881|NCT01564784|472176695|FG001|Overall Study|Subject refused further follow-up|6|||
131151882|NCT01564784|472176694|FG000|Overall Study|Lost to Follow-up|1|||
131151883|NCT01564784|472176695|FG001|Overall Study|Lost to Follow-up|1|||
131151884|NCT01564784|472176694|FG000|Overall Study|Death|131|||
131151885|NCT01564784|472176695|FG001|Overall Study|Death|126|||
131151886|NCT03871491|472176696|FG000|Overall Study|Withdrawal by Subject|14|||
131151887|NCT03871491|472176697|FG001|Overall Study|Withdrawal by Subject|14|||
131151888|NCT03871491|472176698|FG002|Overall Study|Withdrawal by Subject|14|||
131151889|NCT03871491|472176699|FG003|Overall Study|Withdrawal by Subject|14|||
131151890|NCT03871491|472176696|FG000|Overall Study|Physician Decision|0|||
131151891|NCT03871491|472176697|FG001|Overall Study|Physician Decision|0|||
131151892|NCT03871491|472176698|FG002|Overall Study|Physician Decision|1|||
131151893|NCT03871491|472176699|FG003|Overall Study|Physician Decision|1|||
131151894|NCT03871491|472176696|FG000|Overall Study|Lost to Follow-up|50|||
131151895|NCT03871491|472176697|FG001|Overall Study|Lost to Follow-up|15|||
131151896|NCT03871491|472176698|FG002|Overall Study|Lost to Follow-up|36|||
131151897|NCT03871491|472176699|FG003|Overall Study|Lost to Follow-up|11|||
131151898|NCT05202808|472176700|FG000|Overall Study|Lost to Follow-up|3|||
131151899|NCT05202808|472176701|FG001|Overall Study|Lost to Follow-up|1|||
131151900|NCT04439331|472176702|FG000|Overall Study|Never Start Protocol Therapy|2|||
131151901|NCT04439331|472176702|FG000|Overall Study|Ineligible|2|||
131151902|NCT04439331|472176702|FG000|Overall Study|Mutation Status Not Confirmed|1|||
131151903|NCT04439331|472176702|FG000|Overall Study|Adverse Event|1|||
131151904|NCT04439331|472176702|FG000|Overall Study|Death|1|||
131151905|NCT04439331|472176702|FG000|Overall Study|Disease Progression|20|||
131151906|NCT04439331|472176702|FG000|Overall Study|Withdrawal by Subject|6|||
131151907|NCT04439331|472176702|FG000|Overall Study|Physician Decision|1|||
131151908|NCT04439331|472176702|FG000|Overall Study|Other Complicating Disease|1|||
131151909|NCT02495948|472176703|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
131151910|NCT02495948|472176704|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
131151911|NCT02495948|472176703|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
131151912|NCT02495948|472176704|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
131151913|NCT02747004|472176706|FG000|Overall Study|Withdrawal by Subject|8|||
131151914|NCT02747004|472176707|FG001|Overall Study|Withdrawal by Subject|5|||
131151915|NCT02747004|472176708|FG002|Overall Study|Withdrawal by Subject|4|||
131151916|NCT02747004|472176706|FG000|Overall Study|Lost to Follow-up|1|||
131151917|NCT02747004|472176707|FG001|Overall Study|Lost to Follow-up|2|||
131151918|NCT02747004|472176708|FG002|Overall Study|Lost to Follow-up|2|||
131151919|NCT02747004|472176706|FG000|Overall Study|on study treatment/follow-up|48|||
131151920|NCT02747004|472176707|FG001|Overall Study|on study treatment/follow-up|42|||
131151921|NCT02747004|472176708|FG002|Overall Study|on study treatment/follow-up|41|||
131151922|NCT01444300|472176709|FG000|Overall Study|Adverse Event|4|||
131151923|NCT01444300|472176710|FG001|Overall Study|Adverse Event|0|||
131151924|NCT02370121|472176714|FG000|Overall Study|Lost to Follow-up|1|||
131151925|NCT02370121|472176715|FG001|Overall Study|Lost to Follow-up|1|||
131151926|NCT04429022|472176717|FG000|Overall Study|Protocol Violation|18|||
131151927|NCT04429022|472176718|FG001|Overall Study|Protocol Violation|1|||
131151928|NCT01769105|472176719|FG000|First Intervention|Protocol Violation|2|||
131151929|NCT01769105|472176720|FG001|First Intervention|Protocol Violation|2|||
131151930|NCT01769105|472176719|FG000|Cross-over|Lost to Follow-up|5|||
131151931|NCT01769105|472176720|FG001|Cross-over|Lost to Follow-up|0|||
131151932|NCT00963807|472176721|FG000|Overall Study|Physician Decision|2|||
131151933|NCT00963807|472176721|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
131151934|NCT00963807|472176721|FG000|Overall Study|Disease progression|15|||
131151935|NCT00045032|472176723|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
131151936|NCT00045032|472176724|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
131151937|NCT00045032|472176725|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
131151938|NCT00045032|472176723|FG000|Overall Study|Death|22|||
131151939|NCT00045032|472176724|FG001|Overall Study|Death|24|||
131151940|NCT00045032|472176725|FG002|Overall Study|Death|17|||
131151941|NCT00045032|472176723|FG000|Overall Study|Insufficient Therapeutic Response|542|||
131151942|NCT00045032|472176724|FG001|Overall Study|Insufficient Therapeutic Response|437|||
131151943|NCT00045032|472176725|FG002|Overall Study|Insufficient Therapeutic Response|445|||
131151944|NCT00045032|472176723|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
131151945|NCT00045032|472176724|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
131151946|NCT00045032|472176725|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
131151947|NCT00045032|472176723|FG000|Overall Study|Other Protocol Violation|2|||
131151948|NCT00045032|472176724|FG001|Overall Study|Other Protocol Violation|0|||
131151949|NCT00045032|472176725|FG002|Overall Study|Other Protocol Violation|1|||
131151950|NCT00045032|472176723|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
131151951|NCT00045032|472176724|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
131151952|NCT00045032|472176725|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
131151953|NCT00045032|472176723|FG000|Overall Study|Failure to Return|57|||
131151954|NCT00045032|472176724|FG001|Overall Study|Failure to Return|62|||
131151955|NCT00045032|472176725|FG002|Overall Study|Failure to Return|61|||
131151956|NCT00045032|472176723|FG000|Overall Study|Other|93|||
131151957|NCT00045032|472176724|FG001|Overall Study|Other|84|||
131151958|NCT00045032|472176725|FG002|Overall Study|Other|105|||
131151959|NCT00473694|472178686|FG000|Overall Study|Adverse Event|0|||
131151960|NCT00473694|472178687|FG001|Overall Study|Adverse Event|1|||
131151961|NCT00473694|472178688|FG002|Overall Study|Adverse Event|0|||
131151962|NCT00473694|472178689|FG003|Overall Study|Adverse Event|0|||
131151963|NCT00473694|472178686|FG000|Overall Study|Participants did not receive treatment|11|||
131151964|NCT00473694|472178687|FG001|Overall Study|Participants did not receive treatment|3|||
131151965|NCT00473694|472178688|FG002|Overall Study|Participants did not receive treatment|5|||
131151966|NCT00473694|472178689|FG003|Overall Study|Participants did not receive treatment|6|||
131151967|NCT00473694|472178686|FG000|Overall Study|Lost to Follow-up|0|||
131151968|NCT00473694|472178687|FG001|Overall Study|Lost to Follow-up|0|||
131151969|NCT00473694|472178688|FG002|Overall Study|Lost to Follow-up|0|||
131151970|NCT00473694|472178689|FG003|Overall Study|Lost to Follow-up|1|||
131151971|NCT00506389|472178697|FG000|In-treatment Period|Other|3|||
131151972|NCT00506389|472178698|FG001|In-treatment Period|Other|3|||
131151973|NCT00506389|472178699|FG002|In-treatment Period|Other|4|||
131151974|NCT00506389|472178697|FG000|In-treatment Period|Lost to Follow-up|0|||
131151975|NCT00506389|472178698|FG001|In-treatment Period|Lost to Follow-up|0|||
131151976|NCT00506389|472178699|FG002|In-treatment Period|Lost to Follow-up|1|||
131151977|NCT00506389|472178697|FG000|In-treatment Period|Lack of compliance|1|||
131151978|NCT00506389|472178698|FG001|In-treatment Period|Lack of compliance|0|||
131151979|NCT00506389|472178699|FG002|In-treatment Period|Lack of compliance|0|||
131151980|NCT00506389|472178697|FG000|In-treatment Period|Reasons not related to trial|4|||
131151981|NCT00506389|472178698|FG001|In-treatment Period|Reasons not related to trial|1|||
131151982|NCT00506389|472178699|FG002|In-treatment Period|Reasons not related to trial|0|||
131151983|NCT00506389|472178697|FG000|In-treatment Period|Withdrawal by Subject|3|||
131151984|NCT00506389|472178698|FG001|In-treatment Period|Withdrawal by Subject|3|||
131151985|NCT00506389|472178699|FG002|In-treatment Period|Withdrawal by Subject|4|||
131151986|NCT00506389|472178697|FG000|In-treatment Period|Lack of Efficacy|0|||
131151987|NCT00506389|472178698|FG001|In-treatment Period|Lack of Efficacy|2|||
131151988|NCT00506389|472178699|FG002|In-treatment Period|Lack of Efficacy|0|||
131151989|NCT00506389|472178697|FG000|In-treatment Period|Adverse Event|11|||
131151990|NCT00506389|472178698|FG001|In-treatment Period|Adverse Event|5|||
131234958|NCT01974895|472488769|FG001|Overall Study|Protocol Violation|0|||
131234959|NCT01974895|472488768|FG000|Overall Study|Lost to Follow-up|4|||
131234960|NCT01974895|472488769|FG001|Overall Study|Lost to Follow-up|6|||
131234961|NCT01974895|472488768|FG000|Overall Study|Withdrawal by Subject|0|||
131234962|NCT01974895|472488769|FG001|Overall Study|Withdrawal by Subject|1|||
131234963|NCT01974895|472488768|FG000|Overall Study|Other (Missed Visit)|1|||
131234964|NCT01974895|472488769|FG001|Overall Study|Other (Missed Visit)|0|||
131234965|NCT01974895|472488768|FG000|Overall Study|Other (Reason unknown)|9|||
131234966|NCT01974895|472488769|FG001|Overall Study|Other (Reason unknown)|8|||
131234967|NCT01984242|472488770|FG000|Overall Study|Death|52|||
131234968|NCT01984242|472488771|FG001|Overall Study|Death|50|||
131151991|NCT00506389|472178699|FG002|In-treatment Period|Adverse Event|2|||
131151992|NCT00506389|472178697|FG000|In-treatment Period|Randomized but not treated|4|||
131151993|NCT00506389|472178698|FG001|In-treatment Period|Randomized but not treated|1|||
131151994|NCT00506389|472178699|FG002|In-treatment Period|Randomized but not treated|1|||
131151995|NCT05224258|472178700|FG000|Overall Study|Withdrawal by Subject|1|||
131151996|NCT05224258|472178701|FG001|Overall Study|Withdrawal by Subject|1|||
131151997|NCT05224258|472178700|FG000|Overall Study|Physician Decision|1|||
131151998|NCT05224258|472178701|FG001|Overall Study|Physician Decision|1|||
131151999|NCT05224258|472178700|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131152000|NCT05224258|472178701|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131152001|NCT05224258|472178700|FG000|Overall Study|Study Product No Longer in Use|1|||
131152002|NCT05224258|472178701|FG001|Overall Study|Study Product No Longer in Use|0|||
131152003|NCT05224258|472178700|FG000|Overall Study|Adverse Event|0|||
131234969|NCT01984242|472488772|FG002|Overall Study|Death|52|||
131234970|NCT01984242|472488770|FG000|Overall Study|Withdrawal by Subject|5|||
131234971|NCT01984242|472488771|FG001|Overall Study|Withdrawal by Subject|3|||
131152004|NCT05224258|472178701|FG001|Overall Study|Adverse Event|1|||
131152005|NCT05224258|472178700|FG000|Overall Study|Protocol Deviation|0|||
131152006|NCT05224258|472178701|FG001|Overall Study|Protocol Deviation|1|||
131152007|NCT01381094|472178702|FG000|Overall Study|Adverse Event|1|||
131152008|NCT01381094|472178703|FG001|Overall Study|Adverse Event|2|||
131152009|NCT01381094|472178704|FG002|Overall Study|Adverse Event|0|||
131152010|NCT01381094|472178705|FG003|Overall Study|Adverse Event|1|||
131152011|NCT01381094|472178706|FG004|Overall Study|Adverse Event|0|||
131152012|NCT01381094|472178702|FG000|Overall Study|Lost to Follow-up|0|||
131152013|NCT01381094|472178703|FG001|Overall Study|Lost to Follow-up|0|||
131152014|NCT01381094|472178704|FG002|Overall Study|Lost to Follow-up|0|||
131152015|NCT01381094|472178705|FG003|Overall Study|Lost to Follow-up|0|||
131152016|NCT01381094|472178706|FG004|Overall Study|Lost to Follow-up|1|||
131152017|NCT01381094|472178702|FG000|Overall Study|Withdrawal of informed consent|0|||
131152018|NCT01381094|472178703|FG001|Overall Study|Withdrawal of informed consent|1|||
131152019|NCT01381094|472178704|FG002|Overall Study|Withdrawal of informed consent|0|||
131152020|NCT01381094|472178705|FG003|Overall Study|Withdrawal of informed consent|0|||
131152021|NCT01381094|472178706|FG004|Overall Study|Withdrawal of informed consent|0|||
131152022|NCT01381094|472178702|FG000|Overall Study|Participant given Aranesp injection|1|||
131152023|NCT01381094|472178703|FG001|Overall Study|Participant given Aranesp injection|0|||
131152024|NCT01381094|472178704|FG002|Overall Study|Participant given Aranesp injection|0|||
131152025|NCT01381094|472178705|FG003|Overall Study|Participant given Aranesp injection|0|||
131152026|NCT01381094|472178706|FG004|Overall Study|Participant given Aranesp injection|0|||
131152027|NCT01934504|472178709|FG000|Overall Study|Protocol Deviation|0|||
131152028|NCT01934504|472178710|FG001|Overall Study|Protocol Deviation|0|||
131152029|NCT01934504|472178711|FG002|Overall Study|Protocol Deviation|0|||
131152030|NCT01934504|472178712|FG003|Overall Study|Protocol Deviation|2|||
131152031|NCT01934504|472178709|FG000|Overall Study|Study Terminated by Sponsor|1|||
131152032|NCT01934504|472178710|FG001|Overall Study|Study Terminated by Sponsor|0|||
131152033|NCT01934504|472178711|FG002|Overall Study|Study Terminated by Sponsor|5|||
131152034|NCT01934504|472178712|FG003|Overall Study|Study Terminated by Sponsor|5|||
131152035|NCT00541307|472178713|FG000|Overall Study|Death|5|||
131152036|NCT00541307|472178713|FG000|Overall Study|Physician Decision|3|||
131152037|NCT00541307|472178713|FG000|Overall Study|Withdrawal by Subject|6|||
131152038|NCT00541307|472178713|FG000|Overall Study|Lost to Follow-up|4|||
131152039|NCT00541307|472178713|FG000|Overall Study|Subject returned early (outside window)|1|||
131152040|NCT00541307|472178713|FG000|Overall Study|Surgical Bypass|5|||
131152041|NCT03615222|472178718|FG000|Overall Study|Ineligible|26|||
131152042|NCT03615222|472178718|FG000|Overall Study|Withdrawal by Subject|7|||
131152043|NCT03615222|472178718|FG000|Overall Study|Death|1|||
131152044|NCT03895203|472178719|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
131152045|NCT03895203|472178720|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
131152046|NCT03895203|472178721|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
131152047|NCT03895203|472178722|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
131152048|NCT03895203|472178723|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
131152049|NCT03895203|472178724|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
131152050|NCT03895203|472178719|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
131152051|NCT03895203|472178720|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
131152052|NCT03895203|472178721|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
131152053|NCT03895203|472178722|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
131152054|NCT03895203|472178723|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
131152055|NCT03895203|472178724|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
131152056|NCT03895203|472178719|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
131152057|NCT03895203|472178720|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
131152058|NCT03895203|472178721|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
131152059|NCT03895203|472178722|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
131152060|NCT03895203|472178723|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
131152061|NCT03895203|472178724|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
131152062|NCT03895203|472178719|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
131152063|NCT03895203|472178720|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
131152064|NCT03895203|472178721|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
131152065|NCT03895203|472178722|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
131152066|NCT03895203|472178723|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
131152067|NCT03895203|472178724|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
131234972|NCT01984242|472488772|FG002|Overall Study|Withdrawal by Subject|10|||
131152068|NCT03895203|472178719|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
131152069|NCT03895203|472178720|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
131152070|NCT03895203|472178721|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
131152071|NCT03895203|472178722|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
131152072|NCT03895203|472178723|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
131152073|NCT03895203|472178724|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
131152074|NCT03895203|472178719|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
131152075|NCT03895203|472178720|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
131152076|NCT03895203|472178721|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
131152077|NCT03895203|472178722|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
131152078|NCT03895203|472178723|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
131152079|NCT03895203|472178724|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
131152080|NCT03895203|472178719|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
131152081|NCT03895203|472178720|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
131152082|NCT03895203|472178721|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
131152083|NCT03895203|472178722|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
131152084|NCT03895203|472178723|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
131152085|NCT03895203|472178724|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
131152086|NCT03895203|472178719|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
131152087|NCT03895203|472178720|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
131152088|NCT03895203|472178721|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
131152089|NCT03895203|472178722|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
131152090|NCT03895203|472178723|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
131152091|NCT03895203|472178724|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
131152092|NCT03895203|472178719|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
131152093|NCT03895203|472178720|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
131152094|NCT03895203|472178721|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
131152095|NCT03895203|472178722|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
131152096|NCT03895203|472178723|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
131152097|NCT03895203|472178724|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
131152098|NCT03895203|472178719|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
131152099|NCT03895203|472178720|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
131152100|NCT03895203|472178721|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
131152101|NCT03895203|472178722|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
131152102|NCT03895203|472178723|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
131152103|NCT03895203|472178724|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
131152104|NCT03895203|472178719|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
131152105|NCT03895203|472178720|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
131152106|NCT03895203|472178721|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
131152107|NCT03895203|472178722|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
131152108|NCT03895203|472178723|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
131152109|NCT03895203|472178724|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
131152110|NCT03895203|472178719|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
131152111|NCT03895203|472178720|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
131152112|NCT03895203|472178721|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
131152113|NCT03895203|472178722|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
131152114|NCT03895203|472178723|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
131152115|NCT03895203|472178724|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
131152116|NCT03895203|472178719|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
131152117|NCT03895203|472178720|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
131152118|NCT03895203|472178721|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
131152119|NCT03895203|472178722|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
131152120|NCT03895203|472178723|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
131152121|NCT03895203|472178724|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
131152122|NCT03895203|472178719|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
131152123|NCT03895203|472178720|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
131152124|NCT03895203|472178721|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
131152125|NCT03895203|472178722|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
131152126|NCT03895203|472178723|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
131152127|NCT03895203|472178724|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
131152128|NCT00996840|472178725|FG000|Overall Study|Adverse Event|0|||
131152129|NCT00996840|472178726|FG001|Overall Study|Adverse Event|1|||
131152130|NCT00996840|472178727|FG002|Overall Study|Adverse Event|0|||
131152131|NCT00996840|472178728|FG003|Overall Study|Adverse Event|0|||
131152132|NCT00996840|472178729|FG004|Overall Study|Adverse Event|0|||
130728091|NCT03597464|470625604|FG001|Overall Study|Protocol Violation|1|||
130728092|NCT03597464|470625603|FG000|Overall Study|Adverse Event|0|||
130728093|NCT03597464|470625604|FG001|Overall Study|Adverse Event|2|||
130728094|NCT03597464|470625603|FG000|Overall Study|Death|0|||
130728095|NCT03597464|470625604|FG001|Overall Study|Death|3|||
130728096|NCT02542605|470625607|FG000|Part B: Challenge Phase|Sponsor decision|1|||
131152133|NCT00996840|472178725|FG000|Overall Study|Physician Decision|0|||
131152134|NCT00996840|472178726|FG001|Overall Study|Physician Decision|0|||
131152135|NCT00996840|472178727|FG002|Overall Study|Physician Decision|1|||
131152136|NCT00996840|472178728|FG003|Overall Study|Physician Decision|1|||
131152137|NCT00996840|472178729|FG004|Overall Study|Physician Decision|2|||
131152138|NCT00996840|472178725|FG000|Overall Study|Withdrawal by Subject|1|||
131152139|NCT00996840|472178726|FG001|Overall Study|Withdrawal by Subject|1|||
131152140|NCT00996840|472178727|FG002|Overall Study|Withdrawal by Subject|0|||
131152141|NCT00996840|472178728|FG003|Overall Study|Withdrawal by Subject|0|||
131152142|NCT00996840|472178729|FG004|Overall Study|Withdrawal by Subject|0|||
131152143|NCT00886938|472178730|FG000|Overall Study|Adverse Event|1|||
131152144|NCT00886938|472178730|FG000|Overall Study|Withdrawal by Subject|1|||
131152145|NCT00363415|472178731|FG000|Overall Study|Progressive Disease|196|||
131152146|NCT00363415|472178732|FG001|Overall Study|Progressive Disease|107|||
131152147|NCT00363415|472178731|FG000|Overall Study|Sponsor Decision|67|||
131152148|NCT00363415|472178732|FG001|Overall Study|Sponsor Decision|31|||
131152149|NCT00363415|472178731|FG000|Overall Study|Death|32|||
131152150|NCT00363415|472178732|FG001|Overall Study|Death|29|||
131152151|NCT00363415|472178731|FG000|Overall Study|Adverse Event|24|||
131152152|NCT00363415|472178732|FG001|Overall Study|Adverse Event|15|||
131152153|NCT00363415|472178731|FG000|Overall Study|Physician Decision|18|||
131152154|NCT00363415|472178732|FG001|Overall Study|Physician Decision|35|||
131152155|NCT00363415|472178731|FG000|Overall Study|Entry Criteria Not Met|11|||
131152156|NCT00363415|472178732|FG001|Overall Study|Entry Criteria Not Met|10|||
131152157|NCT00363415|472178731|FG000|Overall Study|Withdrawal by Subject|9|||
131152158|NCT00363415|472178732|FG001|Overall Study|Withdrawal by Subject|15|||
131152159|NCT00363415|472178731|FG000|Overall Study|Lost to Follow-up|3|||
131152160|NCT00363415|472178732|FG001|Overall Study|Lost to Follow-up|3|||
131152161|NCT00363415|472178731|FG000|Overall Study|Protocol Violation|1|||
131152162|NCT00363415|472178732|FG001|Overall Study|Protocol Violation|4|||
131152163|NCT05027802|472178735|FG000|Overall Study|Adverse Event|2|||
131152164|NCT05027802|472178735|FG000|Overall Study|Withdrawal by Subject|18|||
131152165|NCT05027802|472178735|FG000|Overall Study|Death|2|||
131152166|NCT05027802|472178735|FG000|Overall Study|Other|1|||
131152167|NCT03872180|472178738|FG000|Overall Study|Adverse Event|4|||
131152168|NCT03872180|472178738|FG000|Overall Study|Lack of Efficacy|2|||
131152169|NCT01506141|472178739|FG000|Overall Study|Adverse Event|0|||
131152170|NCT01506141|472178740|FG001|Overall Study|Adverse Event|2|||
131152171|NCT01506141|472178739|FG000|Overall Study|Participation Terminated by Investigator|1|||
131152172|NCT01506141|472178740|FG001|Overall Study|Participation Terminated by Investigator|1|||
131152173|NCT01506141|472178739|FG000|Overall Study|Site Terminated by Sponsor|2|||
131152174|NCT01506141|472178740|FG001|Overall Study|Site Terminated by Sponsor|0|||
131152175|NCT01506141|472178739|FG000|Overall Study|Reason Not Specified|4|||
131152176|NCT01506141|472178740|FG001|Overall Study|Reason Not Specified|2|||
131152177|NCT04607408|472178741|FG000|Overall Study|Lost to Follow-up|0|||
131152178|NCT04607408|472178742|FG001|Overall Study|Lost to Follow-up|0|||
131152179|NCT04607408|472178743|FG002|Overall Study|Lost to Follow-up|0|||
131152180|NCT04607408|472178744|FG003|Overall Study|Lost to Follow-up|1|||
131152181|NCT04607408|472178745|FG004|Overall Study|Lost to Follow-up|0|||
131152182|NCT04607408|472178741|FG000|Overall Study|Withdrawal by Subject|0|||
131152183|NCT04607408|472178742|FG001|Overall Study|Withdrawal by Subject|1|||
131152184|NCT04607408|472178743|FG002|Overall Study|Withdrawal by Subject|0|||
131152185|NCT04607408|472178744|FG003|Overall Study|Withdrawal by Subject|1|||
131152186|NCT04607408|472178745|FG004|Overall Study|Withdrawal by Subject|0|||
131152187|NCT04919564|472178748|FG000|Overall Study|Lost to Follow-up|1|||
131152188|NCT04919564|472178749|FG001|Overall Study|Lost to Follow-up|0|||
131152189|NCT04919564|472178748|FG000|Overall Study|Physician Decision|1|||
131152190|NCT04919564|472178749|FG001|Overall Study|Physician Decision|1|||
131152191|NCT01241786|472178750|FG000|Overall Study|Lack of Efficacy|5|||
131152192|NCT01051739|472178755|FG000|Overall Study|Death|3|||
131152193|NCT01051739|472178756|FG001|Overall Study|Death|3|||
131152194|NCT01051739|472178755|FG000|Overall Study|Withdrawal by Subject|25|||
131152195|NCT01051739|472178756|FG001|Overall Study|Withdrawal by Subject|10|||
131152196|NCT02499952|472178757|FG000|Overall Study|Lost to Follow-up|1|||
131152197|NCT02499952|472178757|FG000|Overall Study|Death|9|||
131152198|NCT01440101|472178758|FG000|Overall Study|Adverse Event|2|||
131152199|NCT01440101|472178759|FG001|Overall Study|Adverse Event|0|||
131152200|NCT01440101|472178760|FG002|Overall Study|Adverse Event|0|||
131152201|NCT01440101|472178758|FG000|Overall Study|Withdrawal by Subject|0|||
131152202|NCT01440101|472178759|FG001|Overall Study|Withdrawal by Subject|3|||
131152203|NCT01440101|472178760|FG002|Overall Study|Withdrawal by Subject|1|||
131152204|NCT01440101|472178758|FG000|Overall Study|Other|0|||
131152205|NCT01440101|472178759|FG001|Overall Study|Other|1|||
131152206|NCT01440101|472178760|FG002|Overall Study|Other|0|||
131152207|NCT00636818|472178764|FG000|Overall Study|Adverse Event|1|||
131152208|NCT00636818|472178764|FG000|Overall Study|Lost to Follow-up|2|||
131152209|NCT00636818|472178764|FG000|Overall Study|Entry Criteria Exclusion|3|||
131152210|NCT00636818|472178764|FG000|Overall Study|Protocol Violation|1|||
131152211|NCT00636818|472178764|FG000|Overall Study|Withdrawal by Subject|4|||
130728097|NCT02542605|470625608|FG001|Part B: Challenge Phase|Sponsor decision|0|||
130728098|NCT02542605|470625609|FG002|Part B: Challenge Phase|Sponsor decision|0|||
130728099|NCT02542605|470625607|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
130728100|NCT02542605|470625608|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
130728101|NCT02542605|470625609|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
130728102|NCT02682927|470625610|FG000|Overall Study|Adverse Event|0|||
130728103|NCT02682927|470625611|FG001|Overall Study|Adverse Event|0|||
130728104|NCT02682927|470625612|FG002|Overall Study|Adverse Event|5|||
131152212|NCT00074958|472178765|FG000|Overall Study|Adverse Event|1|||
131152213|NCT02115308|472178771|FG000|Overall Study|Safety Screening|2|||
131152214|NCT02115308|472178772|FG001|Overall Study|Safety Screening|2|||
131152215|NCT01658514|472178780|FG000|Overall Study|Protocol Violation|1|||
131152216|NCT01658514|472178781|FG001|Overall Study|Protocol Violation|0|||
131152217|NCT01658514|472178782|FG002|Overall Study|Protocol Violation|2|||
131152218|NCT02344576|472178786|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
131152219|NCT02344576|472178787|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
131152220|NCT02344576|472178788|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
131152221|NCT02344576|472178789|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
131152222|NCT02344576|472178786|FG000|1-Month Follow-Up|Death|13|||
131152223|NCT02344576|472178787|FG001|1-Month Follow-Up|Death|8|||
131152224|NCT02344576|472178788|FG002|1-Month Follow-Up|Death|0|||
131152225|NCT02344576|472178789|FG003|1-Month Follow-Up|Death|0|||
131152226|NCT02344576|472178786|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
131152227|NCT02344576|472178787|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
131152228|NCT02344576|472178788|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
131152229|NCT02344576|472178789|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
131152230|NCT02344576|472178786|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
131152231|NCT02344576|472178787|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
131152232|NCT02344576|472178788|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
131152233|NCT02344576|472178789|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
131152234|NCT02344576|472178786|FG000|6-Month Follow-Up|Death|14|||
131152235|NCT02344576|472178787|FG001|6-Month Follow-Up|Death|14|||
131152236|NCT02344576|472178788|FG002|6-Month Follow-Up|Death|0|||
131152237|NCT02344576|472178789|FG003|6-Month Follow-Up|Death|0|||
131152238|NCT02344576|472178786|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
131152239|NCT02344576|472178787|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
131152240|NCT02344576|472178788|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
131152241|NCT02344576|472178789|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
131152242|NCT02344576|472178786|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
131152243|NCT02344576|472178787|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
131152244|NCT02344576|472178788|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
131152245|NCT02344576|472178789|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
131152246|NCT04325503|472178804|FG000|Overall Study|Withdrawal by Subject|1|||
131152247|NCT04325503|472178804|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
131152248|NCT03832387|472178805|FG000|Overall Study|Protocol Violation|2|||
131152249|NCT03832387|472178806|FG001|Overall Study|Protocol Violation|6|||
131152250|NCT03832387|472178805|FG000|Overall Study|EXCLUSION CRITERIA|3|||
131152251|NCT03832387|472178806|FG001|Overall Study|EXCLUSION CRITERIA|1|||
131152252|NCT00144170|472178807|FG000|Overall Study|Adverse Event|84|||
131152253|NCT00144170|472178808|FG001|Overall Study|Adverse Event|41|||
131152254|NCT00144170|472178807|FG000|Overall Study|Protocol Violation|23|||
131152255|NCT00144170|472178808|FG001|Overall Study|Protocol Violation|16|||
131152256|NCT00144170|472178807|FG000|Overall Study|Lost to Follow-up|5|||
131152257|NCT00144170|472178808|FG001|Overall Study|Lost to Follow-up|10|||
131152258|NCT00144170|472178807|FG000|Overall Study|Withdrawal by Subject|29|||
131152259|NCT00144170|472178808|FG001|Overall Study|Withdrawal by Subject|13|||
131152260|NCT00144170|472178807|FG000|Overall Study|Other reason not defined above|211|||
131152261|NCT00144170|472178808|FG001|Overall Study|Other reason not defined above|316|||
131152262|NCT00702143|472178809|FG000|Overall Study|Lost to Follow-up|0|||
131152263|NCT00702143|472178810|FG001|Overall Study|Lost to Follow-up|0|||
131152264|NCT00702143|472178811|FG002|Overall Study|Lost to Follow-up|1|||
130728105|NCT02682927|470625613|FG003|Overall Study|Adverse Event|1|||
130728106|NCT02682927|470625614|FG004|Overall Study|Adverse Event|0|||
130728107|NCT02682927|470625615|FG005|Overall Study|Adverse Event|2|||
131152265|NCT04996797|472178816|FG000|Overall Study|Adverse Event|0|||
131152266|NCT04996797|472178817|FG001|Overall Study|Adverse Event|2|||
131152267|NCT04996797|472178818|FG002|Overall Study|Adverse Event|0|||
130728108|NCT02682927|470625610|FG000|Overall Study|Death|0|||
130728109|NCT02682927|470625611|FG001|Overall Study|Death|0|||
131152268|NCT04996797|472178819|FG003|Overall Study|Adverse Event|1|||
131152269|NCT04996797|472178816|FG000|Overall Study|Lack of Efficacy|0|||
130728110|NCT02682927|470625612|FG002|Overall Study|Death|0|||
131152270|NCT04996797|472178817|FG001|Overall Study|Lack of Efficacy|2|||
131152271|NCT04996797|472178818|FG002|Overall Study|Lack of Efficacy|0|||
131152272|NCT04996797|472178819|FG003|Overall Study|Lack of Efficacy|0|||
131152273|NCT04996797|472178816|FG000|Overall Study|Prohibited Medication|0|||
131152274|NCT04996797|472178817|FG001|Overall Study|Prohibited Medication|1|||
131152275|NCT04996797|472178818|FG002|Overall Study|Prohibited Medication|0|||
131152276|NCT04996797|472178819|FG003|Overall Study|Prohibited Medication|0|||
131152277|NCT04996797|472178816|FG000|Overall Study|Ongoing|68|||
131152278|NCT04996797|472178817|FG001|Overall Study|Ongoing|60|||
131152279|NCT04996797|472178818|FG002|Overall Study|Ongoing|22|||
131152280|NCT04996797|472178819|FG003|Overall Study|Ongoing|20|||
131152281|NCT04996797|472178816|FG000|Overall Study|Withdrawal by Subject|0|||
131152282|NCT04996797|472178817|FG001|Overall Study|Withdrawal by Subject|2|||
131152283|NCT04996797|472178818|FG002|Overall Study|Withdrawal by Subject|0|||
131152284|NCT04996797|472178819|FG003|Overall Study|Withdrawal by Subject|0|||
130728111|NCT02682927|470625613|FG003|Overall Study|Death|1|||
131152285|NCT02793544|472178820|FG000|Overall Study|Death|10|||
131152286|NCT02793544|472178821|FG001|Overall Study|Death|8|||
131152287|NCT02793544|472178820|FG000|Overall Study|Lost to Follow-up|2|||
131152288|NCT02793544|472178821|FG001|Overall Study|Lost to Follow-up|0|||
131152289|NCT02793544|472178820|FG000|Overall Study|Withdrawal by Subject|1|||
131152290|NCT02793544|472178821|FG001|Overall Study|Withdrawal by Subject|0|||
131152291|NCT06218251|472178824|FG000|Overall Study|Lost to Follow-up|4|||
131152292|NCT05087030|472178825|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
131152293|NCT05087030|472178826|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
131152294|NCT05087030|472178827|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
131152295|NCT05087030|472178828|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
131152296|NCT05087030|472178829|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
131152297|NCT05087030|472178825|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
131152298|NCT05087030|472178826|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
131152299|NCT05087030|472178827|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
131152300|NCT05087030|472178828|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
131152301|NCT05087030|472178829|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
131152302|NCT05087030|472178825|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
131152303|NCT05087030|472178826|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
131152304|NCT05087030|472178827|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
131152305|NCT05087030|472178828|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
131152306|NCT05087030|472178829|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
131152307|NCT05087030|472178825|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
131152308|NCT05087030|472178826|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
131152309|NCT05087030|472178827|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
131152310|NCT05087030|472178828|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
131152311|NCT05087030|472178829|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
131152312|NCT05087030|472178825|FG000|Main Period (Week 0 to Week 52)|Death|0|||
131152313|NCT05087030|472178826|FG001|Main Period (Week 0 to Week 52)|Death|1|||
131152314|NCT05087030|472178827|FG002|Main Period (Week 0 to Week 52)|Death|0|||
131152315|NCT05087030|472178828|FG003|Main Period (Week 0 to Week 52)|Death|0|||
131152316|NCT05087030|472178829|FG004|Main Period (Week 0 to Week 52)|Death|0|||
131152317|NCT05087030|472178825|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
131152318|NCT05087030|472178826|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
131152319|NCT05087030|472178827|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
131152320|NCT05087030|472178828|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
131152321|NCT05087030|472178829|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
131152322|NCT05087030|472178825|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
131152323|NCT05087030|472178826|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
131152324|NCT05087030|472178827|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
131152325|NCT05087030|472178828|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
131152326|NCT05087030|472178829|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
131152327|NCT05087030|472178825|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
131152328|NCT05087030|472178826|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
131152329|NCT05087030|472178827|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
131152330|NCT05087030|472178828|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
131152331|NCT05087030|472178829|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
131152332|NCT05087030|472178825|FG000|Main Period (Week 0 to Week 52)|Other|1|||
131152333|NCT05087030|472178826|FG001|Main Period (Week 0 to Week 52)|Other|2|||
131152334|NCT05087030|472178827|FG002|Main Period (Week 0 to Week 52)|Other|0|||
131152335|NCT05087030|472178828|FG003|Main Period (Week 0 to Week 52)|Other|0|||
131234973|NCT01984242|472488770|FG000|Overall Study|Physician Decision|0|||
130728112|NCT02682927|470625614|FG004|Overall Study|Death|0|||
130728113|NCT02682927|470625615|FG005|Overall Study|Death|0|||
131152336|NCT05087030|472178829|FG004|Main Period (Week 0 to Week 52)|Other|0|||
131152337|NCT05087030|472178825|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
131152338|NCT05087030|472178826|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
131152339|NCT05087030|472178827|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
131152340|NCT05087030|472178828|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130728114|NCT02682927|470625610|FG000|Overall Study|Lack of Efficacy|1|||
131152341|NCT05087030|472178829|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
131152342|NCT04826900|472178830|FG000|Overall Study|Family factor|1|||
131152343|NCT04826900|472178831|FG001|Overall Study|Family factor|1|||
131152344|NCT00609622|472178832|FG000|Overall Study|Adverse Event|14|||
131152345|NCT00609622|472178833|FG001|Overall Study|Adverse Event|10|||
131152346|NCT00609622|472178832|FG000|Overall Study|Withdrawal by Subject|4|||
131152347|NCT00609622|472178833|FG001|Overall Study|Withdrawal by Subject|20|||
131152348|NCT00609622|472178832|FG000|Overall Study|Death|1|||
131152349|NCT00609622|472178833|FG001|Overall Study|Death|4|||
131152350|NCT00609622|472178832|FG000|Overall Study|Protocol Violation|1|||
131152351|NCT00609622|472178833|FG001|Overall Study|Protocol Violation|1|||
131152352|NCT00609622|472178832|FG000|Overall Study|Objective progression or relapse|47|||
131152353|NCT00609622|472178833|FG001|Overall Study|Objective progression or relapse|41|||
131152354|NCT00609622|472178832|FG000|Overall Study|Study terminated by sponsor|16|||
131152355|NCT00609622|472178833|FG001|Overall Study|Study terminated by sponsor|3|||
131152356|NCT00609622|472178832|FG000|Overall Study|Other|7|||
131152357|NCT00609622|472178833|FG001|Overall Study|Other|14|||
131152358|NCT00609622|472178832|FG000|Overall Study|Global deterioration of health status|6|||
131152359|NCT00609622|472178833|FG001|Overall Study|Global deterioration of health status|2|||
131152360|NCT00686543|472178834|FG000|Overall Study|Adverse Event|9|||
131152361|NCT00686543|472178835|FG001|Overall Study|Adverse Event|1|||
131152362|NCT00686543|472178836|FG002|Overall Study|Adverse Event|3|||
131152363|NCT00686543|472178837|FG003|Overall Study|Adverse Event|2|||
131152364|NCT00686543|472178834|FG000|Overall Study|Withdrawal by Subject|2|||
131152365|NCT00686543|472178835|FG001|Overall Study|Withdrawal by Subject|0|||
131152366|NCT00686543|472178836|FG002|Overall Study|Withdrawal by Subject|0|||
131152367|NCT00686543|472178837|FG003|Overall Study|Withdrawal by Subject|0|||
131152368|NCT00686543|472178834|FG000|Overall Study|Protocol Violation|3|||
131152369|NCT00686543|472178835|FG001|Overall Study|Protocol Violation|0|||
131152370|NCT00686543|472178836|FG002|Overall Study|Protocol Violation|2|||
131152371|NCT00686543|472178837|FG003|Overall Study|Protocol Violation|1|||
131152372|NCT03929250|472178838|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
131152373|NCT03929250|472178839|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
131152374|NCT02582658|472178847|FG000|Overall Study|Failure to Return|10|||
131152375|NCT02582658|472178847|FG000|Overall Study|Insufficient Virological Response|2|||
131152376|NCT02582658|472178847|FG000|Overall Study|Withdrawn Consent|1|||
131152377|NCT02582658|472178847|FG000|Overall Study|Death|1|||
131152378|NCT02582658|472178847|FG000|Overall Study|Not further specified|11|||
131152379|NCT01024244|472180300|FG000|Overall Study|Adverse Event|1|||
131152380|NCT01024244|472180301|FG001|Overall Study|Adverse Event|2|||
131152381|NCT01024244|472180302|FG002|Overall Study|Adverse Event|0|||
131152382|NCT01024244|472180303|FG003|Overall Study|Adverse Event|1|||
131152383|NCT01024244|472180304|FG004|Overall Study|Adverse Event|2|||
131152384|NCT01024244|472180300|FG000|Overall Study|Entry Criteria Not Met|0|||
131152385|NCT01024244|472180301|FG001|Overall Study|Entry Criteria Not Met|1|||
131152386|NCT01024244|472180302|FG002|Overall Study|Entry Criteria Not Met|0|||
131152387|NCT01024244|472180303|FG003|Overall Study|Entry Criteria Not Met|0|||
131152388|NCT01024244|472180304|FG004|Overall Study|Entry Criteria Not Met|0|||
131152389|NCT01024244|472180300|FG000|Overall Study|Lack of Efficacy|1|||
131152390|NCT01024244|472180301|FG001|Overall Study|Lack of Efficacy|0|||
131152391|NCT01024244|472180302|FG002|Overall Study|Lack of Efficacy|0|||
130728115|NCT02682927|470625611|FG001|Overall Study|Lack of Efficacy|0|||
130728116|NCT02682927|470625612|FG002|Overall Study|Lack of Efficacy|0|||
130728117|NCT02682927|470625613|FG003|Overall Study|Lack of Efficacy|1|||
130728118|NCT02682927|470625614|FG004|Overall Study|Lack of Efficacy|0|||
130728119|NCT02682927|470625615|FG005|Overall Study|Lack of Efficacy|0|||
130728120|NCT02682927|470625610|FG000|Overall Study|Other|0|||
130728121|NCT02682927|470625611|FG001|Overall Study|Other|0|||
130728122|NCT02682927|470625612|FG002|Overall Study|Other|0|||
130728123|NCT02682927|470625613|FG003|Overall Study|Other|2|||
130728124|NCT02682927|470625614|FG004|Overall Study|Other|0|||
130728125|NCT02682927|470625615|FG005|Overall Study|Other|0|||
131152392|NCT01024244|472180303|FG003|Overall Study|Lack of Efficacy|0|||
131152393|NCT01024244|472180304|FG004|Overall Study|Lack of Efficacy|0|||
131152394|NCT01024244|472180300|FG000|Overall Study|Protocol Violation|1|||
131234974|NCT01984242|472488771|FG001|Overall Study|Physician Decision|0|||
131234975|NCT01984242|472488772|FG002|Overall Study|Physician Decision|1|||
130728126|NCT02682927|470625610|FG000|Overall Study|Withdrawal by Subject|2|||
130728127|NCT02682927|470625611|FG001|Overall Study|Withdrawal by Subject|0|||
130728128|NCT02682927|470625612|FG002|Overall Study|Withdrawal by Subject|1|||
131152395|NCT01024244|472180301|FG001|Overall Study|Protocol Violation|0|||
131152396|NCT01024244|472180302|FG002|Overall Study|Protocol Violation|0|||
131152397|NCT01024244|472180303|FG003|Overall Study|Protocol Violation|0|||
130728129|NCT02682927|470625613|FG003|Overall Study|Withdrawal by Subject|0|||
131152398|NCT01024244|472180304|FG004|Overall Study|Protocol Violation|2|||
131152399|NCT01024244|472180300|FG000|Overall Study|Sponsor Decision|14|||
131152400|NCT01024244|472180301|FG001|Overall Study|Sponsor Decision|7|||
131152401|NCT01024244|472180302|FG002|Overall Study|Sponsor Decision|14|||
131234976|NCT01984242|472488770|FG000|Overall Study|Lost to Follow-up|4|||
131152402|NCT01024244|472180303|FG003|Overall Study|Sponsor Decision|12|||
131152403|NCT01024244|472180304|FG004|Overall Study|Sponsor Decision|10|||
131152404|NCT01024244|472180300|FG000|Overall Study|Withdrawal by Subject|0|||
131152405|NCT01024244|472180301|FG001|Overall Study|Withdrawal by Subject|1|||
131152406|NCT01024244|472180302|FG002|Overall Study|Withdrawal by Subject|0|||
131152407|NCT01024244|472180303|FG003|Overall Study|Withdrawal by Subject|0|||
131152408|NCT01024244|472180304|FG004|Overall Study|Withdrawal by Subject|0|||
131152409|NCT04645797|472180314|FG000|Overall Study|Disease Progression|3|||
131152410|NCT04645797|472180315|FG001|Overall Study|Disease Progression|3|||
131152411|NCT04645797|472180316|FG002|Overall Study|Disease Progression|1|||
131152412|NCT04645797|472180317|FG003|Overall Study|Disease Progression|0|||
131152413|NCT04645797|472180318|FG004|Overall Study|Disease Progression|0|||
131152414|NCT04645797|472180319|FG005|Overall Study|Disease Progression|0|||
131152415|NCT04645797|472180320|FG006|Overall Study|Disease Progression|0|||
131152416|NCT04645797|472180314|FG000|Overall Study|Death|3|||
131152417|NCT04645797|472180315|FG001|Overall Study|Death|1|||
131152418|NCT04645797|472180316|FG002|Overall Study|Death|0|||
131152419|NCT04645797|472180317|FG003|Overall Study|Death|0|||
131152420|NCT04645797|472180318|FG004|Overall Study|Death|0|||
131152421|NCT04645797|472180319|FG005|Overall Study|Death|0|||
131152422|NCT04645797|472180320|FG006|Overall Study|Death|0|||
131152423|NCT00733902|472180322|FG000|Overall Study|Death|0|||
131152424|NCT00733902|472180323|FG001|Overall Study|Death|0|||
131152425|NCT00733902|472180324|FG002|Overall Study|Death|0|||
131152426|NCT00733902|472180325|FG003|Overall Study|Death|1|||
131152427|NCT00733902|472180322|FG000|Overall Study|Adverse Event|3|||
131152428|NCT00733902|472180323|FG001|Overall Study|Adverse Event|4|||
131152429|NCT00733902|472180324|FG002|Overall Study|Adverse Event|7|||
131152430|NCT00733902|472180325|FG003|Overall Study|Adverse Event|11|||
131152431|NCT00733902|472180322|FG000|Overall Study|Lack of Efficacy|56|||
131152432|NCT00733902|472180323|FG001|Overall Study|Lack of Efficacy|21|||
131152433|NCT00733902|472180324|FG002|Overall Study|Lack of Efficacy|34|||
131152434|NCT00733902|472180325|FG003|Overall Study|Lack of Efficacy|23|||
131152435|NCT00733902|472180322|FG000|Overall Study|Protocol Violation|4|||
131152436|NCT00733902|472180323|FG001|Overall Study|Protocol Violation|6|||
131152437|NCT00733902|472180324|FG002|Overall Study|Protocol Violation|3|||
131152438|NCT00733902|472180325|FG003|Overall Study|Protocol Violation|3|||
131152439|NCT00733902|472180322|FG000|Overall Study|Withdrawal by Subject|10|||
131152440|NCT00733902|472180323|FG001|Overall Study|Withdrawal by Subject|5|||
131152441|NCT00733902|472180324|FG002|Overall Study|Withdrawal by Subject|4|||
131152442|NCT00733902|472180325|FG003|Overall Study|Withdrawal by Subject|16|||
131152443|NCT00733902|472180322|FG000|Overall Study|Entered extension study|89|||
131152444|NCT00733902|472180323|FG001|Overall Study|Entered extension study|124|||
131152445|NCT00733902|472180324|FG002|Overall Study|Entered extension study|111|||
131152446|NCT00733902|472180325|FG003|Overall Study|Entered extension study|109|||
131152447|NCT00733902|472180322|FG000|Overall Study|Randomized but not treated|2|||
131152448|NCT00733902|472180323|FG001|Overall Study|Randomized but not treated|2|||
131152449|NCT00733902|472180324|FG002|Overall Study|Randomized but not treated|2|||
131152450|NCT00733902|472180325|FG003|Overall Study|Randomized but not treated|1|||
131152451|NCT00049127|472180326|FG000|Overall Study|Withdrawal by Subject|0|||
131152452|NCT00049127|472180327|FG001|Overall Study|Withdrawal by Subject|0|||
131152453|NCT00049127|472180328|FG002|Overall Study|Withdrawal by Subject|1|||
131152454|NCT00049127|472180329|FG003|Overall Study|Withdrawal by Subject|0|||
131152455|NCT00049127|472180330|FG004|Overall Study|Withdrawal by Subject|0|||
131152456|NCT02582515|472180331|FG000|Overall Study|Withdrawal by Subject|0|||
131152457|NCT02582515|472180332|FG001|Overall Study|Withdrawal by Subject|1|||
131152458|NCT00775021|472180333|FG000|First Intervention|Lost to Follow-up|1|||
131152459|NCT00775021|472180334|FG001|First Intervention|Lost to Follow-up|0|||
131152460|NCT00775021|472180333|FG000|Second Intervention|Adverse Event|0|||
131152461|NCT00775021|472180334|FG001|Second Intervention|Adverse Event|1|||
131152462|NCT00870688|472180335|FG000|Overall Study|Lost to Follow-up|2|||
131152463|NCT00870688|472180335|FG000|Overall Study|Death, Unrelated|1|||
131152464|NCT00870688|472180335|FG000|Overall Study|Granules in the Stools|1|||
131234977|NCT01984242|472488771|FG001|Overall Study|Lost to Follow-up|0|||
131152465|NCT04927312|472180342|FG000|Overall Study|Adverse Event|1|||
131152466|NCT04927312|472180342|FG000|Overall Study|Death|1|||
131152467|NCT04927312|472180342|FG000|Overall Study|Withdrawal by Subject|1|||
131152468|NCT04927312|472180342|FG000|Overall Study|Other|1|||
131152469|NCT01122927|472180348|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
131152470|NCT01122927|472180349|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
131152471|NCT01122927|472180348|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
131152472|NCT01122927|472180349|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
131152473|NCT01122927|472180348|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
131152474|NCT01122927|472180349|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
131152475|NCT01122927|472180348|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
131152476|NCT01122927|472180349|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
131152477|NCT01122927|472180348|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
131152478|NCT01122927|472180349|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
131152479|NCT01122927|472180348|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
131152480|NCT01122927|472180349|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
131152481|NCT01122927|472180348|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
131152482|NCT01122927|472180349|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
131152483|NCT01122927|472180348|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
131152484|NCT01122927|472180349|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
131152485|NCT01122927|472180348|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
131152486|NCT01122927|472180349|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
131152487|NCT01122927|472180348|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
131152488|NCT01122927|472180349|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
131152489|NCT01122927|472180348|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
131152490|NCT01122927|472180349|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
131152491|NCT01122927|472180348|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
131152492|NCT01122927|472180349|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
131152493|NCT00684814|472180352|FG000|Washout Period of 7 Days|Adverse Event|1|||
131152494|NCT00684814|472180353|FG001|Washout Period of 7 Days|Adverse Event|2|||
131152495|NCT00684814|472180352|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
131152496|NCT00684814|472180353|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
131152497|NCT00684814|472180352|FG000|Second Intervention|Adverse Event|1|||
131234978|NCT01984242|472488772|FG002|Overall Study|Lost to Follow-up|3|||
131234979|NCT01984242|472488770|FG000|Overall Study|Sponsor Decision|1|||
131234980|NCT01984242|472488771|FG001|Overall Study|Sponsor Decision|0|||
131234981|NCT01984242|472488772|FG002|Overall Study|Sponsor Decision|0|||
131234982|NCT01984242|472488770|FG000|Overall Study|Non-Compliance|1|||
131234983|NCT01984242|472488771|FG001|Overall Study|Non-Compliance|0|||
131234984|NCT01984242|472488772|FG002|Overall Study|Non-Compliance|0|||
131234985|NCT01984242|472488770|FG000|Overall Study|Study terminated by Sponsor|38|||
131234986|NCT01984242|472488771|FG001|Overall Study|Study terminated by Sponsor|50|||
131234987|NCT01984242|472488772|FG002|Overall Study|Study terminated by Sponsor|34|||
131234988|NCT01984242|472488770|FG000|Overall Study|Disease Progression|0|||
131234989|NCT01984242|472488771|FG001|Overall Study|Disease Progression|0|||
131234990|NCT01984242|472488772|FG002|Overall Study|Disease Progression|1|||
131234991|NCT04543136|472488775|FG000|Overall Study|Withdrawal by Subject|0|||
131234992|NCT04543136|472488776|FG001|Overall Study|Withdrawal by Subject|1|||
131234993|NCT04543136|472488777|FG002|Overall Study|Withdrawal by Subject|0|||
131234994|NCT04543136|472488778|FG003|Overall Study|Withdrawal by Subject|1|||
131234995|NCT04543136|472488779|FG004|Overall Study|Withdrawal by Subject|0|||
131234996|NCT04543136|472488780|FG005|Overall Study|Withdrawal by Subject|0|||
131234997|NCT00536575|472488781|FG000|Overall Study|Withdrawal by Subject|1|||
131234998|NCT00536575|472488781|FG000|Overall Study|Death|1|||
131234999|NCT04117607|472488785|FG000|Overall Study|Early Termination|0|||
131235000|NCT04117607|472488786|FG001|Overall Study|Early Termination|1|||
131235001|NCT04117607|472488787|FG002|Overall Study|Early Termination|0|||
131235002|NCT04117607|472488788|FG003|Overall Study|Early Termination|0|||
131235003|NCT04117607|472488789|FG004|Overall Study|Early Termination|0|||
131235004|NCT04117607|472488790|FG005|Overall Study|Early Termination|0|||
131235005|NCT04117607|472488791|FG006|Overall Study|Early Termination|1|||
131235006|NCT04117607|472488792|FG007|Overall Study|Early Termination|0|||
131235007|NCT04117607|472488793|FG008|Overall Study|Early Termination|0|||
131235008|NCT04117607|472488794|FG009|Overall Study|Early Termination|0|||
131235009|NCT04117607|472488795|FG010|Overall Study|Early Termination|0|||
131235010|NCT04117607|472488796|FG011|Overall Study|Early Termination|0|||
131235011|NCT04117607|472488797|FG012|Overall Study|Early Termination|0|||
131235012|NCT04117607|472488798|FG013|Overall Study|Early Termination|0|||
131235013|NCT01626079|472488801|FG000|Overall Study|Death|167|||
131235014|NCT01626079|472488802|FG001|Overall Study|Death|192|||
131152498|NCT00684814|472180353|FG001|Second Intervention|Adverse Event|0|||
131152499|NCT01676961|472180356|FG000|Overall Study|Death|3|||
131152500|NCT01676961|472180356|FG000|Overall Study|Lost to Follow-up|1|||
131152501|NCT01676961|472180356|FG000|Overall Study|Withdrawal by Subject|1|||
131152502|NCT00768560|472180357|FG000|Intervention Set 1|Adverse Event|0|||
131152503|NCT00768560|472180358|FG001|Intervention Set 1|Adverse Event|1|||
131152504|NCT00768560|472180359|FG002|Intervention Set 1|Adverse Event|0|||
131152505|NCT00768560|472180360|FG003|Intervention Set 1|Adverse Event|0|||
131152506|NCT00768560|472180361|FG004|Intervention Set 1|Adverse Event|0|||
131235015|NCT01626079|472488803|FG002|Overall Study|Death|39|||
131235016|NCT01626079|472488801|FG000|Overall Study|Withdrawal by Subject|23|||
131235017|NCT01626079|472488802|FG001|Overall Study|Withdrawal by Subject|37|||
131235018|NCT01626079|472488803|FG002|Overall Study|Withdrawal by Subject|5|||
131235019|NCT01626079|472488801|FG000|Overall Study|Lost to Follow-up|7|||
131152507|NCT00768560|472180362|FG005|Intervention Set 1|Adverse Event|0|||
131152508|NCT00117312|472180363|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
131152509|NCT00117312|472180364|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
131152510|NCT00117312|472180365|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
131235020|NCT01626079|472488802|FG001|Overall Study|Lost to Follow-up|4|||
131235021|NCT01626079|472488803|FG002|Overall Study|Lost to Follow-up|2|||
131152511|NCT00117312|472180366|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
131152512|NCT00117312|472180363|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
131152513|NCT00117312|472180364|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
131152514|NCT00117312|472180365|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
131152515|NCT00117312|472180366|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
131152516|NCT00117312|472180363|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
131152517|NCT00117312|472180364|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
131152518|NCT00117312|472180365|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
131152519|NCT00117312|472180366|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
131152520|NCT00117312|472180363|FG000|Overall Study|Other|0|||
131152521|NCT00117312|472180364|FG001|Overall Study|Other|1|||
131152522|NCT00117312|472180365|FG002|Overall Study|Other|3|||
131152523|NCT00117312|472180366|FG003|Overall Study|Other|1|||
131152524|NCT00117312|472180363|FG000|Overall Study|Patient choice|0|||
131152525|NCT00117312|472180364|FG001|Overall Study|Patient choice|0|||
131152526|NCT00117312|472180365|FG002|Overall Study|Patient choice|2|||
131152527|NCT00117312|472180366|FG003|Overall Study|Patient choice|1|||
131152528|NCT00117312|472180363|FG000|Overall Study|Adverse Event|0|||
131152529|NCT00117312|472180364|FG001|Overall Study|Adverse Event|2|||
131152530|NCT00117312|472180365|FG002|Overall Study|Adverse Event|0|||
131152531|NCT00117312|472180366|FG003|Overall Study|Adverse Event|0|||
131152532|NCT00117312|472180363|FG000|Overall Study|Protocol Violation|0|||
131152533|NCT00117312|472180364|FG001|Overall Study|Protocol Violation|1|||
131152534|NCT00117312|472180365|FG002|Overall Study|Protocol Violation|3|||
131152535|NCT00117312|472180366|FG003|Overall Study|Protocol Violation|0|||
131152536|NCT00117312|472180363|FG000|Overall Study|PSA decrease <=50%|0|||
131152537|NCT00117312|472180364|FG001|Overall Study|PSA decrease <=50%|2|||
131152538|NCT00117312|472180365|FG002|Overall Study|PSA decrease <=50%|2|||
131152539|NCT00117312|472180366|FG003|Overall Study|PSA decrease <=50%|4|||
131152540|NCT00117312|472180363|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
131152541|NCT00117312|472180364|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
131152542|NCT00117312|472180365|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
131152543|NCT00117312|472180366|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
131152544|NCT00117312|472180363|FG000|Overall Study|Hepatic abnormality|0|||
131152545|NCT00117312|472180364|FG001|Overall Study|Hepatic abnormality|1|||
131152546|NCT00117312|472180365|FG002|Overall Study|Hepatic abnormality|0|||
131152547|NCT00117312|472180366|FG003|Overall Study|Hepatic abnormality|1|||
131152548|NCT00117312|472180363|FG000|Overall Study|Withdrawal by Subject|0|||
131152549|NCT00117312|472180364|FG001|Overall Study|Withdrawal by Subject|2|||
131152550|NCT00117312|472180365|FG002|Overall Study|Withdrawal by Subject|0|||
131152551|NCT00117312|472180366|FG003|Overall Study|Withdrawal by Subject|0|||
131152552|NCT00195650|472180367|FG000|Overall Study|Adverse Event|194|||
131152553|NCT00195650|472180367|FG000|Overall Study|Lack of Efficacy|99|||
131152554|NCT00195650|472180367|FG000|Overall Study|Withdrawal by Subject|67|||
131152555|NCT00195650|472180367|FG000|Overall Study|Lost to Follow-up|44|||
131152556|NCT00195650|472180367|FG000|Overall Study|Death|23|||
131152557|NCT00195650|472180367|FG000|Overall Study|Protocol Violation|15|||
131152558|NCT00195650|472180367|FG000|Overall Study|Administrative reasons|83|||
131152559|NCT01128387|472180368|FG000|Overall Study|Physician Decision|0|||
131152560|NCT01128387|472180369|FG001|Overall Study|Physician Decision|1|||
131152561|NCT01535235|472180370|FG000|Overall Study|Adverse Event|1|||
131152562|NCT01535235|472180371|FG001|Overall Study|Adverse Event|0|||
131152563|NCT00858832|472180373|FG000|Overall Study|became ineligible: delivered vaginally|1|||
131152564|NCT00858832|472180374|FG001|Overall Study|became ineligible: delivered vaginally|0|||
131152565|NCT00858832|472180373|FG000|Overall Study|Adverse Event|0|||
131152566|NCT00858832|472180374|FG001|Overall Study|Adverse Event|1|||
131152567|NCT02371629|472180377|FG000|Overall Study|Patient decision|14|||
131152568|NCT02371629|472180378|FG001|Overall Study|Patient decision|10|||
131152569|NCT02371629|472180377|FG000|Overall Study|Adverse Event|8|||
131152570|NCT02371629|472180378|FG001|Overall Study|Adverse Event|8|||
131152571|NCT02371629|472180377|FG000|Overall Study|Physician Decision|2|||
131152572|NCT02371629|472180378|FG001|Overall Study|Physician Decision|3|||
131152573|NCT02371629|472180377|FG000|Overall Study|Death|1|||
131152574|NCT02371629|472180378|FG001|Overall Study|Death|1|||
131152575|NCT02371629|472180377|FG000|Overall Study|Noncompliance with study treatment|1|||
131152576|NCT02371629|472180378|FG001|Overall Study|Noncompliance with study treatment|0|||
131152577|NCT02371629|472180377|FG000|Overall Study|Lack of Efficacy|0|||
131152578|NCT02371629|472180378|FG001|Overall Study|Lack of Efficacy|2|||
131152579|NCT02371629|472180377|FG000|Overall Study|Protocol deviation|0|||
131152580|NCT02371629|472180378|FG001|Overall Study|Protocol deviation|1|||
131152581|NCT01794780|472180379|FG000|Overall Study|Adverse Event|0|||
131152582|NCT01794780|472180380|FG001|Overall Study|Adverse Event|1|||
131152583|NCT01794780|472180381|FG002|Overall Study|Adverse Event|2|||
131152584|NCT01794780|472180382|FG003|Overall Study|Adverse Event|0|||
131152585|NCT01794780|472180383|FG004|Overall Study|Adverse Event|0|||
131152586|NCT01794780|472180384|FG005|Overall Study|Adverse Event|0|||
131152587|NCT01794780|472180385|FG006|Overall Study|Adverse Event|0|||
131152588|NCT01794780|472180386|FG007|Overall Study|Adverse Event|0|||
131152589|NCT01794780|472180379|FG000|Overall Study|Death|0|||
131152590|NCT01794780|472180380|FG001|Overall Study|Death|2|||
131152591|NCT01794780|472180381|FG002|Overall Study|Death|14|||
131152592|NCT01794780|472180382|FG003|Overall Study|Death|1|||
131152593|NCT01794780|472180383|FG004|Overall Study|Death|0|||
131152594|NCT01794780|472180384|FG005|Overall Study|Death|9|||
131152595|NCT01794780|472180385|FG006|Overall Study|Death|4|||
131152596|NCT01794780|472180386|FG007|Overall Study|Death|0|||
131152597|NCT01794780|472180379|FG000|Overall Study|Lost to Follow-up|10|||
131152598|NCT01794780|472180380|FG001|Overall Study|Lost to Follow-up|64|||
131152599|NCT01794780|472180381|FG002|Overall Study|Lost to Follow-up|165|||
131152600|NCT01794780|472180382|FG003|Overall Study|Lost to Follow-up|53|||
131152601|NCT01794780|472180383|FG004|Overall Study|Lost to Follow-up|2|||
131152602|NCT01794780|472180384|FG005|Overall Study|Lost to Follow-up|99|||
131152603|NCT01794780|472180385|FG006|Overall Study|Lost to Follow-up|30|||
131152604|NCT01794780|472180386|FG007|Overall Study|Lost to Follow-up|5|||
131152605|NCT01794780|472180379|FG000|Overall Study|Withdrew informed consent|7|||
131152606|NCT01794780|472180380|FG001|Overall Study|Withdrew informed consent|17|||
131152607|NCT01794780|472180381|FG002|Overall Study|Withdrew informed consent|36|||
131152608|NCT01794780|472180382|FG003|Overall Study|Withdrew informed consent|9|||
131152609|NCT01794780|472180383|FG004|Overall Study|Withdrew informed consent|0|||
131152610|NCT01794780|472180384|FG005|Overall Study|Withdrew informed consent|48|||
131152611|NCT01794780|472180385|FG006|Overall Study|Withdrew informed consent|4|||
131152612|NCT01794780|472180386|FG007|Overall Study|Withdrew informed consent|3|||
131152613|NCT01794780|472180379|FG000|Overall Study|Other|0|||
131152614|NCT01794780|472180380|FG001|Overall Study|Other|12|||
131152615|NCT01794780|472180381|FG002|Overall Study|Other|25|||
131152616|NCT01794780|472180382|FG003|Overall Study|Other|20|||
131152617|NCT01794780|472180383|FG004|Overall Study|Other|1|||
131152618|NCT01794780|472180384|FG005|Overall Study|Other|24|||
131152619|NCT01794780|472180385|FG006|Overall Study|Other|4|||
131152620|NCT01794780|472180386|FG007|Overall Study|Other|1|||
131152621|NCT00201851|472180387|FG000|Overall Study|Lost to Follow-up|2|||
131152622|NCT00201851|472180388|FG001|Overall Study|Lost to Follow-up|1|||
131152623|NCT00201851|472180389|FG002|Overall Study|Lost to Follow-up|0|||
131152624|NCT00201851|472180387|FG000|Overall Study|Ineligible post enrollment|6|||
131152625|NCT00201851|472180388|FG001|Overall Study|Ineligible post enrollment|1|||
131152626|NCT00201851|472180389|FG002|Overall Study|Ineligible post enrollment|1|||
131152627|NCT00749203|472180393|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
131152628|NCT00749203|472180394|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
131152629|NCT00749203|472180393|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
131152630|NCT00749203|472180394|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
131152631|NCT00749203|472180393|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
131152632|NCT00749203|472180394|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
131152633|NCT00749203|472180393|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
131152634|NCT00749203|472180394|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
131152635|NCT00749203|472180393|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
131152636|NCT00749203|472180394|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
131152637|NCT00749203|472180393|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
131152638|NCT00749203|472180394|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
131152639|NCT02853760|472180395|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
131152640|NCT02853760|472180396|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
131152641|NCT02853760|472180397|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
131152642|NCT02853760|472180398|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
131152643|NCT02853760|472180399|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
131152644|NCT02853760|472180400|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
131152645|NCT01243268|472180401|FG000|Overall Study|Lost to Follow-up|4|||
131152646|NCT01243268|472180401|FG000|Overall Study|Protocol Violation|51|||
131152647|NCT01243268|472180401|FG000|Overall Study|Deviation with contract date|7|||
131152648|NCT01243268|472180401|FG000|Overall Study|Duplicate subject|2|||
131152649|NCT00957853|472180402|FG000|Overall Study|Withdrawal by Subject|1|||
131152650|NCT00957853|472180403|FG001|Overall Study|Withdrawal by Subject|0|||
131152651|NCT00957853|472180404|FG002|Overall Study|Withdrawal by Subject|0|||
131152652|NCT00004980|472180405|FG000|Overall Study|Withdrawal by Subject|1|||
131152653|NCT00004980|472180406|FG001|Overall Study|Withdrawal by Subject|0|||
131152654|NCT00004980|472180405|FG000|Overall Study|memory difficulties|1|||
131152655|NCT00004980|472180406|FG001|Overall Study|memory difficulties|1|||
131152656|NCT00004980|472180405|FG000|Overall Study|Physician Decision|0|||
131152657|NCT00004980|472180406|FG001|Overall Study|Physician Decision|1|||
131152658|NCT03577990|472180407|FG000|Overall Study|Lost to Follow-up|4|||
131152659|NCT03577990|472180408|FG001|Overall Study|Lost to Follow-up|6|||
131152660|NCT03577990|472180407|FG000|Overall Study|Withdrawal by Subject|4|||
131152661|NCT03577990|472180408|FG001|Overall Study|Withdrawal by Subject|7|||
131152662|NCT03372941|472180409|FG000|Overall Study|Lost to Follow-up|2|||
131152663|NCT03372941|472180410|FG001|Overall Study|Lost to Follow-up|4|||
131152664|NCT00741819|472180411|FG000|Overall Study|Adverse Event|3|||
131152665|NCT00741819|472180411|FG000|Overall Study|Withdrawal by Subject|3|||
131152666|NCT00741819|472180411|FG000|Overall Study|Death|1|||
130728130|NCT02682927|470625614|FG004|Overall Study|Withdrawal by Subject|1|||
130728131|NCT02682927|470625615|FG005|Overall Study|Withdrawal by Subject|1|||
130728132|NCT05314816|470625617|FG000|Overall Study|Lost to Follow-up|5|||
130728133|NCT05314816|470625618|FG001|Overall Study|Lost to Follow-up|0|||
130728134|NCT05314816|470625619|FG002|Overall Study|Lost to Follow-up|1|||
130728135|NCT05314816|470625617|FG000|Overall Study|Protocol Violation|13|||
131152667|NCT00741819|472180411|FG000|Overall Study|Disease progression|1|||
131152668|NCT01126580|472180412|FG000|Overall Study|Adverse Event|14|||
130728136|NCT05314816|470625618|FG001|Overall Study|Protocol Violation|8|||
130728137|NCT05314816|470625619|FG002|Overall Study|Protocol Violation|0|||
130728138|NCT04981717|470627395|FG000|Overall Study|Protocol Violation|0|||
130728139|NCT04981717|470627396|FG001|Overall Study|Protocol Violation|3|||
131152669|NCT01126580|472180413|FG001|Overall Study|Adverse Event|8|||
131152670|NCT01126580|472180414|FG002|Overall Study|Adverse Event|12|||
131152671|NCT01126580|472180412|FG000|Overall Study|Withdrawal by Subject|11|||
131152672|NCT01126580|472180413|FG001|Overall Study|Withdrawal by Subject|19|||
131152673|NCT01126580|472180414|FG002|Overall Study|Withdrawal by Subject|14|||
131152674|NCT01126580|472180412|FG000|Overall Study|Sponsor Decision|5|||
131152675|NCT01126580|472180413|FG001|Overall Study|Sponsor Decision|4|||
131152676|NCT01126580|472180414|FG002|Overall Study|Sponsor Decision|7|||
131152677|NCT01126580|472180412|FG000|Overall Study|Physician Decision|1|||
131152678|NCT01126580|472180413|FG001|Overall Study|Physician Decision|1|||
131152679|NCT01126580|472180414|FG002|Overall Study|Physician Decision|2|||
131152680|NCT01126580|472180412|FG000|Overall Study|Entry Criteria Not Met|1|||
131152681|NCT01126580|472180413|FG001|Overall Study|Entry Criteria Not Met|1|||
131152682|NCT01126580|472180414|FG002|Overall Study|Entry Criteria Not Met|2|||
131152683|NCT01126580|472180412|FG000|Overall Study|Lack of Efficacy|2|||
131152684|NCT01126580|472180413|FG001|Overall Study|Lack of Efficacy|3|||
131152685|NCT01126580|472180414|FG002|Overall Study|Lack of Efficacy|4|||
131152686|NCT01126580|472180412|FG000|Overall Study|Protocol Violation|0|||
131152687|NCT01126580|472180413|FG001|Overall Study|Protocol Violation|1|||
131152688|NCT01126580|472180414|FG002|Overall Study|Protocol Violation|2|||
131152689|NCT01126580|472180412|FG000|Overall Study|Lost to Follow-up|15|||
131152690|NCT01126580|472180413|FG001|Overall Study|Lost to Follow-up|13|||
131152691|NCT01126580|472180414|FG002|Overall Study|Lost to Follow-up|9|||
131152692|NCT01126580|472180412|FG000|Overall Study|Treatment Non-compliance|0|||
131152693|NCT01126580|472180413|FG001|Overall Study|Treatment Non-compliance|2|||
131152694|NCT01126580|472180414|FG002|Overall Study|Treatment Non-compliance|3|||
131152695|NCT01708057|472180415|FG000|Overall Study|Withdrawal due to study termination.|1|||
131152696|NCT01708057|472180416|FG001|Overall Study|Withdrawal due to study termination.|1|||
131152697|NCT01708057|472180417|FG002|Overall Study|Withdrawal due to study termination.|1|||
131152698|NCT00538681|472180418|FG000|Overall Study|Progressive Disease|7|||
131152699|NCT00538681|472180419|FG001|Overall Study|Progressive Disease|0|||
131152700|NCT00538681|472180420|FG002|Overall Study|Progressive Disease|1|||
131152701|NCT00538681|472180421|FG003|Overall Study|Progressive Disease|0|||
131152702|NCT00538681|472180418|FG000|Overall Study|Sponsor Decision|1|||
131152703|NCT00538681|472180419|FG001|Overall Study|Sponsor Decision|3|||
131152704|NCT00538681|472180420|FG002|Overall Study|Sponsor Decision|8|||
131152705|NCT00538681|472180421|FG003|Overall Study|Sponsor Decision|9|||
131152706|NCT00538681|472180418|FG000|Overall Study|Adverse Event|1|||
131152707|NCT00538681|472180419|FG001|Overall Study|Adverse Event|1|||
131152708|NCT00538681|472180420|FG002|Overall Study|Adverse Event|1|||
131152709|NCT00538681|472180421|FG003|Overall Study|Adverse Event|0|||
131152710|NCT00538681|472180418|FG000|Overall Study|Death|0|||
131152711|NCT00538681|472180419|FG001|Overall Study|Death|0|||
131152712|NCT00538681|472180420|FG002|Overall Study|Death|1|||
131152713|NCT00538681|472180421|FG003|Overall Study|Death|1|||
131152714|NCT00538681|472180418|FG000|Overall Study|Investigator Decision|0|||
131152715|NCT00538681|472180419|FG001|Overall Study|Investigator Decision|0|||
131152716|NCT00538681|472180420|FG002|Overall Study|Investigator Decision|0|||
131152717|NCT00538681|472180421|FG003|Overall Study|Investigator Decision|1|||
131152718|NCT02970929|472180422|FG000|Overall Study|Adverse Event|18|||
131235022|NCT01626079|472488801|FG000|Overall Study|Missed Visits|1|||
131152719|NCT02970929|472180422|FG000|Overall Study|Lack of Efficacy|8|||
131152720|NCT02970929|472180422|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
131152721|NCT02970929|472180422|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
131152722|NCT02970929|472180422|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
131152723|NCT02970929|472180422|FG000|Overall Study|LOST TO FOLLOWUP|6|||
131152724|NCT02970929|472180422|FG000|Overall Study|MOVED OUT OF STATE|1|||
131152725|NCT02970929|472180422|FG000|Overall Study|Withdrawal by Subject|16|||
131152726|NCT05369806|472180425|FG000|Overall Study|Lost to Follow-up|1|||
131152727|NCT04321343|472180428|FG000|Overall Study|Adverse Event|0|||
131152728|NCT04321343|472180429|FG001|Overall Study|Adverse Event|0|||
131152729|NCT04321343|472180430|FG002|Overall Study|Adverse Event|1|||
130728140|NCT04981717|470627395|FG000|Overall Study|Adverse Event|1|||
130728141|NCT04981717|470627396|FG001|Overall Study|Adverse Event|3|||
130728142|NCT04981717|470627395|FG000|Overall Study|Pregnancy|1|||
131152730|NCT04321343|472180431|FG003|Overall Study|Adverse Event|0|||
131152731|NCT04321343|472180428|FG000|Overall Study|Death|0|||
131152732|NCT04321343|472180429|FG001|Overall Study|Death|0|||
131152733|NCT04321343|472180430|FG002|Overall Study|Death|0|||
131152734|NCT04321343|472180431|FG003|Overall Study|Death|1|||
131152735|NCT04321343|472180428|FG000|Overall Study|Pregnancy|1|||
131152736|NCT04321343|472180429|FG001|Overall Study|Pregnancy|0|||
131152737|NCT04321343|472180430|FG002|Overall Study|Pregnancy|0|||
131152738|NCT04321343|472180431|FG003|Overall Study|Pregnancy|0|||
131152739|NCT04321343|472180428|FG000|Overall Study|Protocol Violation|1|||
131152740|NCT04321343|472180429|FG001|Overall Study|Protocol Violation|1|||
131152741|NCT04321343|472180430|FG002|Overall Study|Protocol Violation|1|||
131152742|NCT04321343|472180431|FG003|Overall Study|Protocol Violation|1|||
131152743|NCT04321343|472180428|FG000|Overall Study|Withdrawal by Subject|0|||
131152744|NCT04321343|472180429|FG001|Overall Study|Withdrawal by Subject|6|||
131152745|NCT04321343|472180430|FG002|Overall Study|Withdrawal by Subject|0|||
131152746|NCT04321343|472180431|FG003|Overall Study|Withdrawal by Subject|2|||
131152747|NCT04321343|472180428|FG000|Overall Study|Lost to Follow-up|2|||
131152748|NCT04321343|472180429|FG001|Overall Study|Lost to Follow-up|2|||
131152749|NCT04321343|472180430|FG002|Overall Study|Lost to Follow-up|1|||
131152750|NCT04321343|472180431|FG003|Overall Study|Lost to Follow-up|3|||
131152751|NCT01331161|472180432|FG000|Overall Study|Physician Decision|1|||
131152752|NCT01331161|472180433|FG001|Overall Study|Physician Decision|0|||
131152753|NCT01331161|472180432|FG000|Overall Study|Lost to Follow-up|0|||
131152754|NCT01331161|472180433|FG001|Overall Study|Lost to Follow-up|1|||
131152755|NCT01331161|472180432|FG000|Overall Study|Pregnancy|0|||
131152756|NCT01331161|472180433|FG001|Overall Study|Pregnancy|1|||
131152757|NCT01097044|472180434|FG000|Overall Study|Withdrawal by Subject|4|||
131152758|NCT01097044|472180435|FG001|Overall Study|Withdrawal by Subject|4|||
131152759|NCT01097044|472180434|FG000|Overall Study|Lost to Follow-up|1|||
131152760|NCT01097044|472180435|FG001|Overall Study|Lost to Follow-up|0|||
131152761|NCT01097044|472180434|FG000|Overall Study|Withdrawal by Sponsor|0|||
131152762|NCT01097044|472180435|FG001|Overall Study|Withdrawal by Sponsor|1|||
131152763|NCT04194944|472180436|FG000|Overall Study|Lost to Follow-up|3|||
131152764|NCT04194944|472180437|FG001|Overall Study|Lost to Follow-up|0|||
131152765|NCT04194944|472180436|FG000|Overall Study|Withdrawal by Subject|2|||
131152766|NCT04194944|472180437|FG001|Overall Study|Withdrawal by Subject|2|||
131152767|NCT04194944|472180436|FG000|Overall Study|On Treatment|93|||
130728143|NCT04981717|470627396|FG001|Overall Study|Pregnancy|0|||
130728144|NCT04981717|470627395|FG000|Overall Study|Physician Decision|1|||
130728145|NCT04981717|470627396|FG001|Overall Study|Physician Decision|0|||
130728146|NCT04981717|470627395|FG000|Overall Study|Sponsor Request|157|||
130728147|NCT04981717|470627396|FG001|Overall Study|Sponsor Request|172|||
130728148|NCT04981717|470627395|FG000|Overall Study|Lost to Follow-up|4|||
130728149|NCT04981717|470627396|FG001|Overall Study|Lost to Follow-up|5|||
130728150|NCT04981717|470627395|FG000|Overall Study|Withdrawal by Subject|50|||
130728151|NCT04981717|470627396|FG001|Overall Study|Withdrawal by Subject|37|||
130728152|NCT02207634|470627397|FG000|Overall Study|Withdrawal by Subject|21|||
130728153|NCT02207634|470627398|FG001|Overall Study|Withdrawal by Subject|31|||
130728154|NCT02207634|470627397|FG000|Overall Study|Lost to Follow-up|1|||
130728155|NCT02207634|470627398|FG001|Overall Study|Lost to Follow-up|0|||
130728156|NCT00887289|470627399|FG000|Overall Study|Lack of Efficacy|14|||
130728157|NCT00887289|470627399|FG000|Overall Study|Adverse Event|27|||
130728158|NCT00887289|470627399|FG000|Overall Study|Withdrawal by Subject|26|||
130728159|NCT00887289|470627399|FG000|Overall Study|Lost to Follow-up|8|||
130728160|NCT00887289|470627399|FG000|Overall Study|Other|20|||
130728161|NCT00591773|470627400|FG000|Overall Study|Adverse Event|9|||
130728162|NCT00591773|470627401|FG001|Overall Study|Adverse Event|9|||
131152768|NCT04194944|472180437|FG001|Overall Study|On Treatment|30|||
131152769|NCT02581995|472180440|FG000|Overall Study|Unspecified other|3|||
131152770|NCT02581995|472180440|FG000|Overall Study|Adverse Event|6|||
131152771|NCT02581995|472180440|FG000|Overall Study|Lost to Follow-up|5|||
131152772|NCT02581995|472180440|FG000|Overall Study|Withdrawal by participant|12|||
131152773|NCT02581995|472180440|FG000|Overall Study|Physician Decision|1|||
131152774|NCT02581995|472180440|FG000|Overall Study|Death|4|||
131152775|NCT00686205|472182028|FG000|Overall Study|Protocol Violation|127|||
131152776|NCT00686205|472182029|FG001|Overall Study|Protocol Violation|0|||
131152777|NCT00686205|472182028|FG000|Overall Study|Withdrawal by Subject|2|||
130728163|NCT00591773|470627402|FG002|Overall Study|Adverse Event|6|||
130728164|NCT00591773|470627400|FG000|Overall Study|Protocol Violation|2|||
130728165|NCT00591773|470627401|FG001|Overall Study|Protocol Violation|3|||
131152778|NCT00686205|472182029|FG001|Overall Study|Withdrawal by Subject|0|||
131152779|NCT00686205|472182028|FG000|Overall Study|Specimen handling procedure altered|5878|||
131152780|NCT00686205|472182029|FG001|Overall Study|Specimen handling procedure altered|0|||
131152781|NCT00686205|472182028|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
131152782|NCT00686205|472182029|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
131152783|NCT00265941|472182030|FG000|Overall Study|Protocol Violation|22|||
131152784|NCT00265941|472182031|FG001|Overall Study|Protocol Violation|25|||
131152785|NCT00265941|472182030|FG000|Overall Study|Lost to Follow-up|1|||
131152786|NCT00265941|472182031|FG001|Overall Study|Lost to Follow-up|1|||
131152787|NCT03816995|472182034|FG000|Overall Study|Withdrawal by Subject|3|||
131152788|NCT03816995|472182035|FG001|Overall Study|Withdrawal by Subject|1|||
131152789|NCT03816995|472182034|FG000|Overall Study|Cancelled Surgery|8|||
131152790|NCT03816995|472182035|FG001|Overall Study|Cancelled Surgery|12|||
131152791|NCT03816995|472182034|FG000|Overall Study|No wound protector used|11|||
131152792|NCT03816995|472182035|FG001|Overall Study|No wound protector used|17|||
131152793|NCT03816995|472182034|FG000|Overall Study|Protocol Violation|2|||
131152794|NCT03816995|472182035|FG001|Overall Study|Protocol Violation|3|||
130728166|NCT00591773|470627402|FG002|Overall Study|Protocol Violation|0|||
130728167|NCT00591773|470627400|FG000|Overall Study|Lost to Follow-up|1|||
130728168|NCT00591773|470627401|FG001|Overall Study|Lost to Follow-up|4|||
130728169|NCT00591773|470627402|FG002|Overall Study|Lost to Follow-up|1|||
131152795|NCT01324830|472182037|FG000|Overall Study|Progressive Disease|3|||
131152796|NCT01324830|472182038|FG001|Overall Study|Progressive Disease|2|||
131152797|NCT01324830|472182039|FG002|Overall Study|Progressive Disease|3|||
131152798|NCT01324830|472182040|FG003|Overall Study|Progressive Disease|3|||
131152799|NCT01324830|472182041|FG004|Overall Study|Progressive Disease|6|||
131152800|NCT01324830|472182042|FG005|Overall Study|Progressive Disease|6|||
131152801|NCT01324830|472182043|FG006|Overall Study|Progressive Disease|3|||
131152802|NCT01324830|472182044|FG007|Overall Study|Progressive Disease|3|||
131152803|NCT01324830|472182045|FG008|Overall Study|Progressive Disease|3|||
131152804|NCT01324830|472182046|FG009|Overall Study|Progressive Disease|6|||
131152805|NCT01324830|472182047|FG010|Overall Study|Progressive Disease|2|||
131152806|NCT01324830|472182048|FG011|Overall Study|Progressive Disease|1|||
131152807|NCT01324830|472182049|FG012|Overall Study|Progressive Disease|1|||
131152808|NCT01324830|472182050|FG013|Overall Study|Progressive Disease|1|||
131152809|NCT01324830|472182051|FG014|Overall Study|Progressive Disease|1|||
131152810|NCT01324830|472182052|FG015|Overall Study|Progressive Disease|3|||
131152811|NCT01324830|472182053|FG016|Overall Study|Progressive Disease|2|||
131152812|NCT01324830|472182054|FG017|Overall Study|Progressive Disease|3|||
131152813|NCT01324830|472182055|FG018|Overall Study|Progressive Disease|4|||
131152814|NCT01324830|472182037|FG000|Overall Study|Dose limiting toxicity|0|||
131152815|NCT01324830|472182038|FG001|Overall Study|Dose limiting toxicity|0|||
131152816|NCT01324830|472182039|FG002|Overall Study|Dose limiting toxicity|0|||
131152817|NCT01324830|472182040|FG003|Overall Study|Dose limiting toxicity|0|||
131152818|NCT01324830|472182041|FG004|Overall Study|Dose limiting toxicity|1|||
131152819|NCT01324830|472182042|FG005|Overall Study|Dose limiting toxicity|0|||
131152820|NCT01324830|472182043|FG006|Overall Study|Dose limiting toxicity|0|||
131152821|NCT01324830|472182044|FG007|Overall Study|Dose limiting toxicity|0|||
131152822|NCT01324830|472182045|FG008|Overall Study|Dose limiting toxicity|0|||
131152823|NCT01324830|472182046|FG009|Overall Study|Dose limiting toxicity|0|||
131152824|NCT01324830|472182047|FG010|Overall Study|Dose limiting toxicity|0|||
131152825|NCT01324830|472182048|FG011|Overall Study|Dose limiting toxicity|0|||
131152826|NCT01324830|472182049|FG012|Overall Study|Dose limiting toxicity|0|||
131152827|NCT01324830|472182050|FG013|Overall Study|Dose limiting toxicity|0|||
131152828|NCT01324830|472182051|FG014|Overall Study|Dose limiting toxicity|0|||
131152829|NCT01324830|472182052|FG015|Overall Study|Dose limiting toxicity|0|||
131152830|NCT01324830|472182053|FG016|Overall Study|Dose limiting toxicity|1|||
131152831|NCT01324830|472182054|FG017|Overall Study|Dose limiting toxicity|1|||
131152832|NCT01324830|472182055|FG018|Overall Study|Dose limiting toxicity|1|||
131152833|NCT01324830|472182037|FG000|Overall Study|Reason not mentioned above|0|||
131152834|NCT01324830|472182038|FG001|Overall Study|Reason not mentioned above|0|||
131152835|NCT01324830|472182039|FG002|Overall Study|Reason not mentioned above|0|||
131152836|NCT01324830|472182040|FG003|Overall Study|Reason not mentioned above|0|||
131152837|NCT01324830|472182041|FG004|Overall Study|Reason not mentioned above|0|||
131152838|NCT01324830|472182042|FG005|Overall Study|Reason not mentioned above|0|||
131152839|NCT01324830|472182043|FG006|Overall Study|Reason not mentioned above|0|||
131152840|NCT01324830|472182044|FG007|Overall Study|Reason not mentioned above|0|||
131152841|NCT01324830|472182045|FG008|Overall Study|Reason not mentioned above|0|||
131152842|NCT01324830|472182046|FG009|Overall Study|Reason not mentioned above|0|||
130728170|NCT00591773|470627400|FG000|Overall Study|Withdrawal by Subject|2|||
131152843|NCT01324830|472182047|FG010|Overall Study|Reason not mentioned above|0|||
131152844|NCT01324830|472182048|FG011|Overall Study|Reason not mentioned above|0|||
131152845|NCT01324830|472182049|FG012|Overall Study|Reason not mentioned above|0|||
131152846|NCT01324830|472182050|FG013|Overall Study|Reason not mentioned above|0|||
131152847|NCT01324830|472182051|FG014|Overall Study|Reason not mentioned above|0|||
131152848|NCT01324830|472182052|FG015|Overall Study|Reason not mentioned above|0|||
130728171|NCT00591773|470627401|FG001|Overall Study|Withdrawal by Subject|5|||
131152849|NCT01324830|472182053|FG016|Overall Study|Reason not mentioned above|0|||
131152850|NCT01324830|472182054|FG017|Overall Study|Reason not mentioned above|1|||
131152851|NCT01324830|472182055|FG018|Overall Study|Reason not mentioned above|0|||
131152852|NCT01324830|472182037|FG000|Overall Study|Adverse Event, serious fatal|0|||
131152853|NCT01324830|472182038|FG001|Overall Study|Adverse Event, serious fatal|1|||
131152854|NCT01324830|472182039|FG002|Overall Study|Adverse Event, serious fatal|0|||
131152855|NCT01324830|472182040|FG003|Overall Study|Adverse Event, serious fatal|0|||
131152856|NCT01324830|472182041|FG004|Overall Study|Adverse Event, serious fatal|0|||
131152857|NCT01324830|472182042|FG005|Overall Study|Adverse Event, serious fatal|0|||
131152858|NCT01324830|472182043|FG006|Overall Study|Adverse Event, serious fatal|0|||
131152859|NCT01324830|472182044|FG007|Overall Study|Adverse Event, serious fatal|0|||
131152860|NCT01324830|472182045|FG008|Overall Study|Adverse Event, serious fatal|0|||
131152861|NCT01324830|472182046|FG009|Overall Study|Adverse Event, serious fatal|0|||
131152862|NCT01324830|472182047|FG010|Overall Study|Adverse Event, serious fatal|0|||
131152863|NCT01324830|472182048|FG011|Overall Study|Adverse Event, serious fatal|0|||
131152864|NCT01324830|472182049|FG012|Overall Study|Adverse Event, serious fatal|0|||
131152865|NCT01324830|472182050|FG013|Overall Study|Adverse Event, serious fatal|0|||
131152866|NCT01324830|472182051|FG014|Overall Study|Adverse Event, serious fatal|0|||
131152867|NCT01324830|472182052|FG015|Overall Study|Adverse Event, serious fatal|0|||
131152868|NCT01324830|472182053|FG016|Overall Study|Adverse Event, serious fatal|0|||
131152869|NCT01324830|472182054|FG017|Overall Study|Adverse Event, serious fatal|0|||
131152870|NCT01324830|472182055|FG018|Overall Study|Adverse Event, serious fatal|0|||
131152871|NCT01324830|472182037|FG000|Overall Study|Adverse Event, non-fatal|0|||
131152872|NCT01324830|472182038|FG001|Overall Study|Adverse Event, non-fatal|0|||
131152873|NCT01324830|472182039|FG002|Overall Study|Adverse Event, non-fatal|0|||
131152874|NCT01324830|472182040|FG003|Overall Study|Adverse Event, non-fatal|0|||
131152875|NCT01324830|472182041|FG004|Overall Study|Adverse Event, non-fatal|0|||
131152876|NCT01324830|472182042|FG005|Overall Study|Adverse Event, non-fatal|0|||
131152877|NCT01324830|472182043|FG006|Overall Study|Adverse Event, non-fatal|0|||
131152878|NCT01324830|472182044|FG007|Overall Study|Adverse Event, non-fatal|0|||
131152879|NCT01324830|472182045|FG008|Overall Study|Adverse Event, non-fatal|2|||
131152880|NCT01324830|472182046|FG009|Overall Study|Adverse Event, non-fatal|0|||
131152881|NCT01324830|472182047|FG010|Overall Study|Adverse Event, non-fatal|1|||
131152882|NCT01324830|472182048|FG011|Overall Study|Adverse Event, non-fatal|0|||
131152883|NCT01324830|472182049|FG012|Overall Study|Adverse Event, non-fatal|0|||
131152884|NCT01324830|472182050|FG013|Overall Study|Adverse Event, non-fatal|0|||
131152885|NCT01324830|472182051|FG014|Overall Study|Adverse Event, non-fatal|0|||
131152886|NCT01324830|472182052|FG015|Overall Study|Adverse Event, non-fatal|0|||
131152887|NCT01324830|472182053|FG016|Overall Study|Adverse Event, non-fatal|0|||
131152888|NCT01324830|472182054|FG017|Overall Study|Adverse Event, non-fatal|1|||
131152889|NCT01324830|472182055|FG018|Overall Study|Adverse Event, non-fatal|0|||
131152890|NCT01324830|472182037|FG000|Overall Study|Withdrawal by Subject|0|||
131152891|NCT01324830|472182038|FG001|Overall Study|Withdrawal by Subject|0|||
131152892|NCT01324830|472182039|FG002|Overall Study|Withdrawal by Subject|0|||
131152893|NCT01324830|472182040|FG003|Overall Study|Withdrawal by Subject|0|||
131152894|NCT01324830|472182041|FG004|Overall Study|Withdrawal by Subject|0|||
131152895|NCT01324830|472182042|FG005|Overall Study|Withdrawal by Subject|1|||
131152896|NCT01324830|472182043|FG006|Overall Study|Withdrawal by Subject|0|||
131152897|NCT01324830|472182044|FG007|Overall Study|Withdrawal by Subject|0|||
131152898|NCT01324830|472182045|FG008|Overall Study|Withdrawal by Subject|0|||
131152899|NCT01324830|472182046|FG009|Overall Study|Withdrawal by Subject|0|||
131152900|NCT01324830|472182047|FG010|Overall Study|Withdrawal by Subject|1|||
131152901|NCT01324830|472182048|FG011|Overall Study|Withdrawal by Subject|0|||
131152902|NCT01324830|472182049|FG012|Overall Study|Withdrawal by Subject|0|||
131152903|NCT01324830|472182050|FG013|Overall Study|Withdrawal by Subject|0|||
131152904|NCT01324830|472182051|FG014|Overall Study|Withdrawal by Subject|0|||
131152905|NCT01324830|472182052|FG015|Overall Study|Withdrawal by Subject|0|||
131152906|NCT01324830|472182053|FG016|Overall Study|Withdrawal by Subject|0|||
131152907|NCT01324830|472182054|FG017|Overall Study|Withdrawal by Subject|0|||
131152908|NCT01324830|472182055|FG018|Overall Study|Withdrawal by Subject|1|||
131152909|NCT01485614|472182056|FG000|Randomization|Not Treated|1|||
131152910|NCT01485614|472182057|FG001|Randomization|Not Treated|0|||
131152911|NCT01485614|472182058|FG002|Randomization|Not Treated|0|||
131152912|NCT01485614|472182059|FG003|Randomization|Not Treated|0|||
131235023|NCT01626079|472488802|FG001|Overall Study|Missed Visits|4|||
131235024|NCT01626079|472488803|FG002|Overall Study|Missed Visits|6|||
130728172|NCT00591773|470627402|FG002|Overall Study|Withdrawal by Subject|3|||
130728173|NCT00591773|470627400|FG000|Overall Study|Lack of Efficacy|1|||
131152913|NCT01485614|472182056|FG000|Weeks 0-20|Lost to Follow-up|2|||
131152914|NCT01485614|472182057|FG001|Weeks 0-20|Lost to Follow-up|0|||
131152915|NCT01485614|472182058|FG002|Weeks 0-20|Lost to Follow-up|0|||
131152916|NCT01485614|472182059|FG003|Weeks 0-20|Lost to Follow-up|0|||
131152917|NCT01485614|472182056|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
131152918|NCT01485614|472182057|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
131152919|NCT01485614|472182058|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
131152920|NCT01485614|472182059|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
131152921|NCT01485614|472182056|FG000|Weeks 0-20|Withdrawal by Subject|3|||
131152922|NCT01485614|472182057|FG001|Weeks 0-20|Withdrawal by Subject|2|||
131152923|NCT01485614|472182058|FG002|Weeks 0-20|Withdrawal by Subject|1|||
131235025|NCT00814463|472488804|FG000|Overall Study|Lost to Follow-up|1|||
131235026|NCT02430870|472488806|FG000|Part 2|Voluntary Withdrawal|0|||
131235027|NCT02430870|472488807|FG001|Part 2|Voluntary Withdrawal|0|||
131152924|NCT01485614|472182059|FG003|Weeks 0-20|Withdrawal by Subject|0|||
131152925|NCT01485614|472182056|FG000|Weeks 20-54|Lost to Follow-up|4|||
131152926|NCT01485614|472182057|FG001|Weeks 20-54|Lost to Follow-up|3|||
131235028|NCT02430870|472488808|FG002|Part 2|Voluntary Withdrawal|0|||
131152927|NCT01485614|472182058|FG002|Weeks 20-54|Lost to Follow-up|1|||
131152928|NCT01485614|472182059|FG003|Weeks 20-54|Lost to Follow-up|0|||
131152929|NCT01485614|472182056|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
131152930|NCT01485614|472182057|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
131152931|NCT01485614|472182058|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
131152932|NCT01485614|472182059|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
131152933|NCT01485614|472182056|FG000|Weeks 20-54|Withdrawal by Subject|5|||
131152934|NCT01485614|472182057|FG001|Weeks 20-54|Withdrawal by Subject|3|||
131152935|NCT01485614|472182058|FG002|Weeks 20-54|Withdrawal by Subject|0|||
131152936|NCT01485614|472182059|FG003|Weeks 20-54|Withdrawal by Subject|0|||
131152937|NCT02210780|472182060|FG000|Overall Study|Adverse Event|0|||
131152938|NCT02210780|472182061|FG001|Overall Study|Adverse Event|5|||
131152939|NCT02210780|472182060|FG000|Overall Study|Lost to Follow-up|2|||
131152940|NCT02210780|472182061|FG001|Overall Study|Lost to Follow-up|1|||
130728174|NCT00591773|470627401|FG001|Overall Study|Lack of Efficacy|2|||
130728175|NCT00591773|470627402|FG002|Overall Study|Lack of Efficacy|2|||
130728176|NCT00591773|470627400|FG000|Overall Study|Other|1|||
130728177|NCT00591773|470627401|FG001|Overall Study|Other|1|||
131152941|NCT02210780|472182060|FG000|Overall Study|Withdrawal by Subject|1|||
131152942|NCT02210780|472182061|FG001|Overall Study|Withdrawal by Subject|1|||
131152943|NCT02210780|472182060|FG000|Overall Study|Physician Decision|1|||
131152944|NCT02210780|472182061|FG001|Overall Study|Physician Decision|0|||
131152945|NCT02210780|472182060|FG000|Overall Study|Protocol Violation|1|||
131152946|NCT02210780|472182061|FG001|Overall Study|Protocol Violation|0|||
130728178|NCT00591773|470627402|FG002|Overall Study|Other|4|||
130728179|NCT02047734|470627403|FG000|Overall Study|Adverse Event|18|||
130728180|NCT02047734|470627404|FG001|Overall Study|Adverse Event|13|||
130728181|NCT02047734|470627405|FG002|Overall Study|Adverse Event|13|||
130728182|NCT02047734|470627403|FG000|Overall Study|Lack of Efficacy|4|||
130728183|NCT02047734|470627404|FG001|Overall Study|Lack of Efficacy|5|||
130728184|NCT02047734|470627405|FG002|Overall Study|Lack of Efficacy|1|||
130728185|NCT02047734|470627403|FG000|Overall Study|Protocol Violation|3|||
130728186|NCT02047734|470627404|FG001|Overall Study|Protocol Violation|1|||
130728187|NCT02047734|470627405|FG002|Overall Study|Protocol Violation|1|||
130728188|NCT02047734|470627403|FG000|Overall Study|Lost to Follow-up|1|||
130728189|NCT02047734|470627404|FG001|Overall Study|Lost to Follow-up|4|||
130728190|NCT02047734|470627405|FG002|Overall Study|Lost to Follow-up|0|||
130728191|NCT02047734|470627403|FG000|Overall Study|Death|0|||
130728192|NCT02047734|470627404|FG001|Overall Study|Death|1|||
130728193|NCT02047734|470627405|FG002|Overall Study|Death|0|||
130728194|NCT02047734|470627403|FG000|Overall Study|Withdrawal by Subject|30|||
130728195|NCT02047734|470627404|FG001|Overall Study|Withdrawal by Subject|31|||
130728196|NCT02047734|470627405|FG002|Overall Study|Withdrawal by Subject|19|||
130728197|NCT02047734|470627403|FG000|Overall Study|Physician Decision|7|||
130728198|NCT02047734|470627404|FG001|Overall Study|Physician Decision|6|||
130728199|NCT02047734|470627405|FG002|Overall Study|Physician Decision|5|||
130728200|NCT02047734|470627403|FG000|Overall Study|Miscellaneous|2|||
130728201|NCT02047734|470627404|FG001|Overall Study|Miscellaneous|4|||
130728202|NCT02047734|470627405|FG002|Overall Study|Miscellaneous|6|||
130728203|NCT02047734|470627403|FG000|Overall Study|Did Not Receive Study Drug|2|||
130728204|NCT02047734|470627404|FG001|Overall Study|Did Not Receive Study Drug|4|||
130728205|NCT02047734|470627405|FG002|Overall Study|Did Not Receive Study Drug|1|||
130728206|NCT00799825|470627408|FG000|Overall Study|Adverse Event|1|||
130728207|NCT00799825|470627408|FG000|Overall Study|Withdrawal by Subject|6|||
130728208|NCT00799825|470627408|FG000|Overall Study|Lost to Follow-up|38|||
130728209|NCT00799825|470627408|FG000|Overall Study|Pregnancy|3|||
130728210|NCT02439970|470627409|FG000|Overall Study|Study Terminated|2|||
130728211|NCT02439970|470627410|FG001|Overall Study|Study Terminated|3|||
130728212|NCT00492778|470627411|FG000|Overall Study|Ineligible by Pathology Review|8|||
130728213|NCT00492778|470627412|FG001|Overall Study|Ineligible by Pathology Review|1|||
131152947|NCT02210780|472182060|FG000|Overall Study|Other than specified above|0|||
131152948|NCT02210780|472182061|FG001|Overall Study|Other than specified above|1|||
131152949|NCT00942409|472182062|FG000|Overall Study|Lack of Efficacy|1|||
131152950|NCT00942409|472182062|FG000|Overall Study|study drug unavailable|2|||
130728214|NCT01371539|470627413|FG000|Period One: One Week|Lost to Follow-up|0|||
130728215|NCT01371539|470627414|FG001|Period One: One Week|Lost to Follow-up|1|||
130728216|NCT01371539|470627413|FG000|Period Two: One Week|Lost to Follow-up|0|||
131152951|NCT01486264|472182069|FG000|Overall Study|Death|1|||
131152952|NCT01486264|472182070|FG001|Overall Study|Death|1|||
131152953|NCT01486264|472182069|FG000|Overall Study|Adverse Event|3|||
131152954|NCT01486264|472182070|FG001|Overall Study|Adverse Event|3|||
130728217|NCT01371539|470627414|FG001|Period Two: One Week|Lost to Follow-up|1|||
130728218|NCT01371539|470627413|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
131152955|NCT01486264|472182069|FG000|Overall Study|Lack of Efficacy|6|||
131152956|NCT01486264|472182070|FG001|Overall Study|Lack of Efficacy|10|||
131152957|NCT01486264|472182069|FG000|Overall Study|Withdrawal by Subject|7|||
131152958|NCT01486264|472182070|FG001|Overall Study|Withdrawal by Subject|18|||
131152959|NCT01486264|472182069|FG000|Overall Study|Physician Decision|1|||
131152960|NCT01486264|472182070|FG001|Overall Study|Physician Decision|1|||
131152961|NCT01486264|472182069|FG000|Overall Study|Protocol Violation|3|||
131152962|NCT01486264|472182070|FG001|Overall Study|Protocol Violation|0|||
130728219|NCT01371539|470627414|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
130728220|NCT01371539|470627413|FG000|Period Two: One Week|Time/job conflict|0|||
130728221|NCT01371539|470627414|FG001|Period Two: One Week|Time/job conflict|1|||
130728222|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
130728223|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
131152963|NCT01486264|472182069|FG000|Overall Study|Lost to Follow-up|3|||
131152964|NCT01486264|472182070|FG001|Overall Study|Lost to Follow-up|2|||
131152965|NCT01486264|472182069|FG000|Overall Study|Other|5|||
131152966|NCT01486264|472182070|FG001|Overall Study|Other|11|||
131152967|NCT01486264|472182069|FG000|Overall Study|Not treated|0|||
131152968|NCT01486264|472182070|FG001|Overall Study|Not treated|1|||
131152969|NCT03812510|472182071|FG000|Overall Study|Lost to Follow-up|39|||
131152970|NCT03812510|472182071|FG000|Overall Study|Withdrawal by Subject|42|||
131152971|NCT03812510|472182071|FG000|Overall Study|Physician Decision|2|||
131152972|NCT03812510|472182071|FG000|Overall Study|Study Terminated by Sponsor|9|||
131152973|NCT03812510|472182071|FG000|Overall Study|Did Not Start Study Medication|55|||
131152974|NCT03812510|472182071|FG000|Overall Study|Adverse Event|5|||
131152975|NCT02635204|472182072|FG000|Overall Study|Adverse Event|1|||
131152976|NCT02635204|472182073|FG001|Overall Study|Adverse Event|0|||
131152977|NCT02635204|472182072|FG000|Overall Study|Lost to Follow-up|1|||
131152978|NCT02635204|472182073|FG001|Overall Study|Lost to Follow-up|1|||
131152979|NCT00389207|472182074|FG000|Overall Study|Adverse Event|26|||
131152980|NCT00389207|472182075|FG001|Overall Study|Adverse Event|32|||
131152981|NCT00389207|472182076|FG002|Overall Study|Adverse Event|10|||
131152982|NCT00389207|472182074|FG000|Overall Study|Protocol Violation|3|||
131152983|NCT00389207|472182075|FG001|Overall Study|Protocol Violation|1|||
131152984|NCT00389207|472182076|FG002|Overall Study|Protocol Violation|4|||
131152985|NCT00389207|472182074|FG000|Overall Study|Lost to Follow-up|12|||
131152986|NCT00389207|472182075|FG001|Overall Study|Lost to Follow-up|9|||
131152987|NCT00389207|472182076|FG002|Overall Study|Lost to Follow-up|7|||
131152988|NCT00389207|472182074|FG000|Overall Study|Withdrawal by Subject|5|||
131152989|NCT00389207|472182075|FG001|Overall Study|Withdrawal by Subject|7|||
131152990|NCT00389207|472182076|FG002|Overall Study|Withdrawal by Subject|11|||
131152991|NCT00389207|472182074|FG000|Overall Study|Other|17|||
131152992|NCT00389207|472182075|FG001|Overall Study|Other|23|||
131152993|NCT00389207|472182076|FG002|Overall Study|Other|9|||
131152994|NCT03527043|472182077|FG000|Overall Study|Withdrawal by Subject|1|||
131152995|NCT03527043|472182078|FG001|Overall Study|Withdrawal by Subject|0|||
131152996|NCT02120417|472182079|FG000|Overall Study|Death|5|||
131152997|NCT02120417|472182080|FG001|Overall Study|Death|1|||
131152998|NCT02120417|472182079|FG000|Overall Study|Adverse Event|3|||
131152999|NCT02120417|472182080|FG001|Overall Study|Adverse Event|9|||
131153000|NCT02120417|472182079|FG000|Overall Study|Participant decision|4|||
131153001|NCT02120417|472182080|FG001|Overall Study|Participant decision|4|||
131153002|NCT02120417|472182079|FG000|Overall Study|Disease progression|41|||
131153003|NCT02120417|472182080|FG001|Overall Study|Disease progression|45|||
131153004|NCT02120417|472182079|FG000|Overall Study|Noncompliance with study treatment|0|||
131153005|NCT02120417|472182080|FG001|Overall Study|Noncompliance with study treatment|2|||
131153006|NCT02120417|472182079|FG000|Overall Study|Physician Decision|2|||
131153007|NCT02120417|472182080|FG001|Overall Study|Physician Decision|3|||
131153008|NCT02120417|472182079|FG000|Overall Study|Other unspecified|5|||
131153009|NCT02120417|472182080|FG001|Overall Study|Other unspecified|4|||
131153010|NCT02286102|472182081|FG000|Overall Study|Screen Failure|1|||
131153011|NCT02286102|472182082|FG001|Overall Study|Screen Failure|1|||
131153012|NCT02469246|472182083|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
131153013|NCT02469246|472182084|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
131153014|NCT02469246|472182083|FG000|Double-Blind Phase|Adverse Event|12|||
130728224|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
130728225|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130728226|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
131153015|NCT02469246|472182084|FG001|Double-Blind Phase|Adverse Event|9|||
131153016|NCT02469246|472182083|FG000|Double-Blind Phase|Death|2|||
131153017|NCT02469246|472182084|FG001|Double-Blind Phase|Death|0|||
130728227|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
130728228|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
131153018|NCT02469246|472182083|FG000|Double-Blind Phase|Lack of Efficacy|2|||
131153019|NCT02469246|472182084|FG001|Double-Blind Phase|Lack of Efficacy|1|||
131153020|NCT02469246|472182083|FG000|Double-Blind Phase|Investigator's Discretion|8|||
131153021|NCT02469246|472182084|FG001|Double-Blind Phase|Investigator's Discretion|8|||
131153022|NCT02469246|472182083|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
131153023|NCT02469246|472182084|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
131153024|NCT02469246|472182083|FG000|Double-Blind Phase|Protocol Violation|1|||
131153025|NCT02469246|472182084|FG001|Double-Blind Phase|Protocol Violation|1|||
131153026|NCT02469246|472182083|FG000|Double-Blind Phase|Withdrew Consent|25|||
131153027|NCT02469246|472182084|FG001|Double-Blind Phase|Withdrew Consent|25|||
131153028|NCT02469246|472182083|FG000|Double-Blind Phase|Lost to Follow-up|9|||
131153029|NCT02469246|472182084|FG001|Double-Blind Phase|Lost to Follow-up|5|||
131153030|NCT03293680|472182085|FG000|Overall Study|Death|1|||
131153031|NCT03293680|472182085|FG000|Overall Study|Did not meet inclusion criteria|8|||
131153032|NCT02690701|472182088|FG000|Treatment Period 1|Adverse Event|2|||
131153033|NCT02690701|472182089|FG001|Treatment Period 1|Adverse Event|2|||
131153034|NCT02690701|472182088|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131153035|NCT02690701|472182089|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131153036|NCT02690701|472182088|FG000|Treatment Period 2|Adverse Event|2|||
131153037|NCT02690701|472182089|FG001|Treatment Period 2|Adverse Event|0|||
131153038|NCT02690701|472182088|FG000|Treatment Period 2|Lack of Efficacy|1|||
131153039|NCT02690701|472182089|FG001|Treatment Period 2|Lack of Efficacy|0|||
131153040|NCT02690701|472182088|FG000|Treatment Period 2|Lost to Follow-up|0|||
131153041|NCT02690701|472182089|FG001|Treatment Period 2|Lost to Follow-up|2|||
131153042|NCT02690701|472182088|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131153043|NCT02690701|472182089|FG001|Treatment Period 2|Withdrawal by Subject|2|||
131153044|NCT02690701|472182088|FG000|Treatment Period 2|Protocol Violation|0|||
131153045|NCT02690701|472182089|FG001|Treatment Period 2|Protocol Violation|1|||
131153046|NCT01642212|472182090|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
131153047|NCT01642212|472182091|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
131153048|NCT01642212|472182092|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
131153049|NCT01642212|472182093|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
131153050|NCT01642212|472182094|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
131153051|NCT01642212|472182090|FG000|Double-blind Treatment|Other|0|||
131153052|NCT01642212|472182091|FG001|Double-blind Treatment|Other|2|||
131153053|NCT01642212|472182092|FG002|Double-blind Treatment|Other|1|||
131153054|NCT01642212|472182093|FG003|Double-blind Treatment|Other|0|||
131153055|NCT01642212|472182094|FG004|Double-blind Treatment|Other|0|||
131153056|NCT01642212|472182090|FG000|Double-blind Treatment|Non-compliance|0|||
131153057|NCT01642212|472182091|FG001|Double-blind Treatment|Non-compliance|1|||
131153058|NCT01642212|472182092|FG002|Double-blind Treatment|Non-compliance|0|||
131153059|NCT01642212|472182093|FG003|Double-blind Treatment|Non-compliance|0|||
131153060|NCT01642212|472182094|FG004|Double-blind Treatment|Non-compliance|0|||
131153061|NCT01642212|472182090|FG000|Double-blind Treatment|Adverse Event|0|||
131153062|NCT01642212|472182091|FG001|Double-blind Treatment|Adverse Event|0|||
131153063|NCT01642212|472182092|FG002|Double-blind Treatment|Adverse Event|1|||
131153064|NCT01642212|472182093|FG003|Double-blind Treatment|Adverse Event|0|||
131153065|NCT01642212|472182094|FG004|Double-blind Treatment|Adverse Event|0|||
131153066|NCT01642212|472182090|FG000|Open-label Extension|Adverse Event|0|||
131153067|NCT01642212|472182091|FG001|Open-label Extension|Adverse Event|0|||
131153068|NCT01642212|472182092|FG002|Open-label Extension|Adverse Event|0|||
131153069|NCT01642212|472182093|FG003|Open-label Extension|Adverse Event|3|||
131153070|NCT01642212|472182094|FG004|Open-label Extension|Adverse Event|0|||
131153071|NCT01642212|472182090|FG000|Open-label Extension|Sponsor Decision|0|||
131153072|NCT01642212|472182091|FG001|Open-label Extension|Sponsor Decision|0|||
131153073|NCT01642212|472182092|FG002|Open-label Extension|Sponsor Decision|0|||
131153074|NCT01642212|472182093|FG003|Open-label Extension|Sponsor Decision|7|||
131153075|NCT01642212|472182094|FG004|Open-label Extension|Sponsor Decision|4|||
131153076|NCT01642212|472182090|FG000|Open-label Extension|Consent Withdrawn|0|||
131153077|NCT01642212|472182091|FG001|Open-label Extension|Consent Withdrawn|0|||
131153078|NCT01642212|472182092|FG002|Open-label Extension|Consent Withdrawn|0|||
131153079|NCT01642212|472182093|FG003|Open-label Extension|Consent Withdrawn|0|||
131153080|NCT01642212|472182094|FG004|Open-label Extension|Consent Withdrawn|2|||
131153081|NCT01642212|472182090|FG000|Open-label Extension|Lost to Follow-up|0|||
131153082|NCT01642212|472182091|FG001|Open-label Extension|Lost to Follow-up|0|||
131153083|NCT01642212|472182092|FG002|Open-label Extension|Lost to Follow-up|0|||
131153084|NCT01642212|472182093|FG003|Open-label Extension|Lost to Follow-up|0|||
131153085|NCT01642212|472182094|FG004|Open-label Extension|Lost to Follow-up|1|||
131153086|NCT01642212|472182090|FG000|Open-label Extension|Other|0|||
131153087|NCT01642212|472182091|FG001|Open-label Extension|Other|0|||
131153088|NCT01642212|472182092|FG002|Open-label Extension|Other|0|||
131153089|NCT01642212|472182093|FG003|Open-label Extension|Other|0|||
131153090|NCT01642212|472182094|FG004|Open-label Extension|Other|1|||
131153091|NCT00100048|472182095|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
131153092|NCT00100048|472182096|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
131153093|NCT00100048|472182097|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
131153094|NCT00100048|472182098|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
131153095|NCT00100048|472182099|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
131153096|NCT00100048|472182100|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
130728229|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
130728230|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130728231|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
131153097|NCT00100048|472182095|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
131153098|NCT00100048|472182096|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
131153099|NCT00100048|472182097|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
131153100|NCT00100048|472182098|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
131153101|NCT00100048|472182099|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
131153102|NCT00100048|472182100|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
131153103|NCT00100048|472182095|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
131153104|NCT00100048|472182096|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
131153105|NCT00100048|472182097|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
131153106|NCT00100048|472182098|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
131153107|NCT00100048|472182099|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
131153108|NCT00100048|472182100|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
131153109|NCT00100048|472182095|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
131153110|NCT00100048|472182096|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
131153111|NCT00100048|472182097|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
131153112|NCT00100048|472182098|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
131153113|NCT00100048|472182099|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
131153114|NCT00100048|472182100|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
131153115|NCT00100048|472182095|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
131153116|NCT00100048|472182096|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
131153117|NCT00100048|472182097|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
131153118|NCT00100048|472182098|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
131153119|NCT00100048|472182099|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
131153120|NCT00100048|472182100|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
131153121|NCT00100048|472182095|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
131153122|NCT00100048|472182096|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
131153123|NCT00100048|472182097|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
131153124|NCT00100048|472182098|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
131153125|NCT00100048|472182099|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
131153126|NCT00100048|472182100|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
131153127|NCT00100048|472182095|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
131153128|NCT00100048|472182096|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
131153129|NCT00100048|472182097|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
131153130|NCT00100048|472182098|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
131153131|NCT00100048|472182099|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
131153132|NCT00100048|472182100|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
131153133|NCT00100048|472182095|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
131153134|NCT00100048|472182096|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
131153135|NCT00100048|472182097|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
131153136|NCT00100048|472182098|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
131153137|NCT00100048|472182099|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
131153138|NCT00100048|472182100|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
131153139|NCT01624142|472182102|FG000|Overall Study|Withdrawal by Subject|14|||
131153140|NCT01624142|472182103|FG001|Overall Study|Withdrawal by Subject|4|||
131153141|NCT01624142|472182102|FG000|Overall Study|Death|3|||
131153142|NCT01624142|472182103|FG001|Overall Study|Death|6|||
131153143|NCT01624142|472182102|FG000|Overall Study|Study Closure|12|||
131153144|NCT01624142|472182103|FG001|Overall Study|Study Closure|6|||
131153145|NCT01624142|472182102|FG000|Overall Study|Lost to Follow-up|2|||
131153146|NCT01624142|472182103|FG001|Overall Study|Lost to Follow-up|0|||
131153147|NCT01624142|472182102|FG000|Overall Study|Other|1|||
131153148|NCT01624142|472182103|FG001|Overall Study|Other|0|||
131153149|NCT01822561|472182104|FG000|Overall Study|Withdrawal by Subject|2|||
131153150|NCT02597062|472182107|FG000|Overall Study|Ineligible|1|||
131153151|NCT00947349|472182113|FG000|Triple Treatment Combination Period|Adverse Event|0|||
131153152|NCT00947349|472182114|FG001|Triple Treatment Combination Period|Adverse Event|1|||
131153153|NCT00947349|472182115|FG002|Triple Treatment Combination Period|Adverse Event|0|||
131153154|NCT00947349|472182116|FG003|Triple Treatment Combination Period|Adverse Event|0|||
130728232|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130728233|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130728234|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130728235|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
131153155|NCT00947349|472182113|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
131153156|NCT00947349|472182114|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
131153157|NCT00947349|472182115|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
131153158|NCT00947349|472182116|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
131153159|NCT00947349|472182113|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
131153160|NCT00947349|472182114|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
130728236|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
131153161|NCT00947349|472182115|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
131153162|NCT00947349|472182116|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
131153163|NCT00947349|472182113|FG000|Overall Study Standard of Care|Other|0|||
131153164|NCT00947349|472182114|FG001|Overall Study Standard of Care|Other|0|||
131153165|NCT00947349|472182115|FG002|Overall Study Standard of Care|Other|0|||
131153166|NCT00947349|472182116|FG003|Overall Study Standard of Care|Other|1|||
131153167|NCT01697345|472182117|FG000|Overall Study|Withdrawal by Subject|1|||
131153168|NCT00140855|472182118|FG000|Overall Study|Progressive disease|2|||
131153169|NCT05262764|472182128|FG000|Overall Study|Case report form not collected|9|||
131153170|NCT05262764|472182128|FG000|Overall Study|No patient visits after entry|23|||
131153171|NCT05262764|472182128|FG000|Overall Study|Registration rule not followed|2|||
131153172|NCT05262764|472182128|FG000|Overall Study|Patient of non-chronic heart failure|1|||
131153173|NCT01392183|472182129|FG000|First Drug Administration|Adverse Event|3|||
131153174|NCT01392183|472182130|FG001|First Drug Administration|Adverse Event|2|||
131153175|NCT01392183|472182129|FG000|First Drug Administration|Death|1|||
130780314|NCT00808067|470821501|FG000|Overall Study|Major/minor bleed|30|||
130780315|NCT00808067|470821502|FG001|Overall Study|Major/minor bleed|44|||
130780316|NCT00808067|470821501|FG000|Overall Study|Outcome event - other|33|||
130780317|NCT00808067|470821502|FG001|Overall Study|Outcome event - other|25|||
130780318|NCT00808067|470821501|FG000|Overall Study|Adverse Event|111|||
130780319|NCT00808067|470821502|FG001|Overall Study|Adverse Event|121|||
130780320|NCT00808067|470821501|FG000|Overall Study|Hospitalization (not including surgery)|18|||
130780321|NCT00808067|470821502|FG001|Overall Study|Hospitalization (not including surgery)|17|||
130780322|NCT00808067|470821501|FG000|Overall Study|Hospitalization due to surgery|37|||
130780323|NCT00808067|470821502|FG001|Overall Study|Hospitalization due to surgery|40|||
130780324|NCT00808067|470821501|FG000|Overall Study|Reduced creatinine clearance|53|||
131153176|NCT01392183|472182130|FG001|First Drug Administration|Death|0|||
131153177|NCT01392183|472182129|FG000|First Drug Administration|Withdrawal by Subject|10|||
131153178|NCT01392183|472182130|FG001|First Drug Administration|Withdrawal by Subject|17|||
131153179|NCT03430310|472182131|FG000|Overall Study|Protocol Violation|2|||
131153180|NCT03430310|472182132|FG001|Overall Study|Protocol Violation|0|||
131153181|NCT03430310|472182131|FG000|Overall Study|Withdrawal by Subject|3|||
131153182|NCT03430310|472182132|FG001|Overall Study|Withdrawal by Subject|2|||
131153183|NCT03430310|472182131|FG000|Overall Study|COVID shutdown March 2020|0|||
131153184|NCT03430310|472182132|FG001|Overall Study|COVID shutdown March 2020|1|||
131153185|NCT02770807|472182138|FG000|Overall Study|Adverse Event|3|||
131153186|NCT02770807|472182139|FG001|Overall Study|Adverse Event|3|||
131153187|NCT02770807|472182140|FG002|Overall Study|Adverse Event|1|||
131153188|NCT02770807|472182138|FG000|Overall Study|Withdrawal by Subject|7|||
131153189|NCT02770807|472182139|FG001|Overall Study|Withdrawal by Subject|3|||
131153190|NCT02770807|472182140|FG002|Overall Study|Withdrawal by Subject|4|||
131153191|NCT02770807|472182138|FG000|Overall Study|Other|0|||
131153192|NCT02770807|472182139|FG001|Overall Study|Other|1|||
131153193|NCT02770807|472182140|FG002|Overall Study|Other|0|||
131153194|NCT02770807|472182138|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
131153195|NCT02770807|472182139|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
131153196|NCT02770807|472182140|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
131153197|NCT02770807|472182138|FG000|Overall Study|Physician Decision|0|||
131153198|NCT02770807|472182139|FG001|Overall Study|Physician Decision|0|||
131153199|NCT02770807|472182140|FG002|Overall Study|Physician Decision|1|||
131153200|NCT03277196|472182141|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
131153201|NCT03277196|472182141|FG000|Overall Study|Lost to Follow-up|3|||
131153202|NCT03277196|472182141|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
131153203|NCT03277196|472182141|FG000|Overall Study|Other|2|||
131153204|NCT01056107|472184029|FG000|Overall Study|Withdrawal by Subject|0|||
131153205|NCT01056107|472184030|FG001|Overall Study|Withdrawal by Subject|1|||
131153206|NCT01056107|472184031|FG002|Overall Study|Withdrawal by Subject|3|||
131153207|NCT01056107|472184032|FG003|Overall Study|Withdrawal by Subject|0|||
131153208|NCT02017444|472184033|FG000|Overall Study|Physician Decision|1|||
131153209|NCT02017444|472184034|FG001|Overall Study|Physician Decision|0|||
131153210|NCT02017444|472184033|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
131153211|NCT02017444|472184034|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
131153212|NCT00374556|472184035|FG000|Overall Study|Lost to Follow-up|1|||
131153213|NCT00374556|472184036|FG001|Overall Study|Lost to Follow-up|0|||
131153214|NCT00374556|472184035|FG000|Overall Study|Removed at baseline due to medical cond|0|||
131153215|NCT00374556|472184036|FG001|Overall Study|Removed at baseline due to medical cond|1|||
131153216|NCT03874234|472184043|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153217|NCT03874234|472184044|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153218|NCT03874234|472184045|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153219|NCT03874234|472184046|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
131153220|NCT03874234|472184047|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153221|NCT03874234|472184048|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153222|NCT03874234|472184049|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153223|NCT03874234|472184050|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153224|NCT03874234|472184051|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153225|NCT03874234|472184052|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153226|NCT03874234|472184053|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153227|NCT03874234|472184054|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153228|NCT03874234|472184055|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
131153229|NCT03874234|472184043|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
131153230|NCT03874234|472184044|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153231|NCT03874234|472184045|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153232|NCT03874234|472184046|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153233|NCT03874234|472184047|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153234|NCT03874234|472184048|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153235|NCT03874234|472184049|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153236|NCT03874234|472184050|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153237|NCT03874234|472184051|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153238|NCT03874234|472184052|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153239|NCT03874234|472184053|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153240|NCT03874234|472184054|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153241|NCT03874234|472184055|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
131153242|NCT03874234|472184043|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153243|NCT03874234|472184044|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153244|NCT03874234|472184045|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153245|NCT03874234|472184046|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
131235029|NCT02430870|472488809|FG003|Part 2|Voluntary Withdrawal|0|||
131235030|NCT02430870|472488810|FG004|Part 2|Voluntary Withdrawal|0|||
131235031|NCT02430870|472488811|FG005|Part 2|Voluntary Withdrawal|0|||
131235032|NCT02430870|472488812|FG006|Part 2|Voluntary Withdrawal|1|||
131235033|NCT02430870|472488813|FG007|Part 2|Voluntary Withdrawal|0|||
131235034|NCT02430870|472488806|FG000|Part 2|Other Reason Not Specified|0|||
131235035|NCT02430870|472488807|FG001|Part 2|Other Reason Not Specified|0|||
131235036|NCT02430870|472488808|FG002|Part 2|Other Reason Not Specified|0|||
131235037|NCT02430870|472488809|FG003|Part 2|Other Reason Not Specified|0|||
131235038|NCT02430870|472488810|FG004|Part 2|Other Reason Not Specified|0|||
131235039|NCT02430870|472488811|FG005|Part 2|Other Reason Not Specified|0|||
131235040|NCT02430870|472488812|FG006|Part 2|Other Reason Not Specified|0|||
131235041|NCT02430870|472488813|FG007|Part 2|Other Reason Not Specified|1|||
131235042|NCT03982433|472488814|FG000|Overall Study|Lost to Follow-up|1|||
131235043|NCT00865709|472488815|FG000|Treatment|Adverse Event|9|||
131235044|NCT00865709|472488816|FG001|Treatment|Adverse Event|6|||
131235045|NCT00865709|472488815|FG000|Treatment|Withdrawal by Subject|10|||
131235046|NCT00865709|472488816|FG001|Treatment|Withdrawal by Subject|7|||
131235047|NCT00865709|472488815|FG000|Treatment|Physician Decision|3|||
131235048|NCT00865709|472488816|FG001|Treatment|Physician Decision|2|||
131235049|NCT00865709|472488815|FG000|Treatment|Surgery|8|||
131235050|NCT00865709|472488816|FG001|Treatment|Surgery|3|||
131235051|NCT01265784|472488819|FG000|Overall Study|Lost to Follow-up|5|||
131235052|NCT01265784|472488820|FG001|Overall Study|Lost to Follow-up|3|||
131235053|NCT01265784|472488821|FG002|Overall Study|Lost to Follow-up|2|||
131235054|NCT01265784|472488819|FG000|Overall Study|Withdrawal by Subject|0|||
131235055|NCT01265784|472488820|FG001|Overall Study|Withdrawal by Subject|5|||
131235056|NCT01265784|472488821|FG002|Overall Study|Withdrawal by Subject|0|||
131235057|NCT01265784|472488819|FG000|Overall Study|Physician Decision|1|||
131235058|NCT01265784|472488820|FG001|Overall Study|Physician Decision|0|||
131235059|NCT01265784|472488821|FG002|Overall Study|Physician Decision|1|||
131235060|NCT01265784|472488819|FG000|Overall Study|Adverse Event|1|||
131235061|NCT01265784|472488820|FG001|Overall Study|Adverse Event|0|||
131153246|NCT03874234|472184047|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153247|NCT03874234|472184048|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131235062|NCT01265784|472488821|FG002|Overall Study|Adverse Event|0|||
131235063|NCT01265784|472488819|FG000|Overall Study|Death|3|||
131235064|NCT01265784|472488820|FG001|Overall Study|Death|0|||
131235065|NCT01265784|472488821|FG002|Overall Study|Death|0|||
131235066|NCT01265784|472488819|FG000|Overall Study|Protocol Violation|2|||
131235067|NCT01265784|472488820|FG001|Overall Study|Protocol Violation|0|||
131235068|NCT01265784|472488821|FG002|Overall Study|Protocol Violation|0|||
131235069|NCT01265784|472488819|FG000|Overall Study|Incorrectly Randomized|0|||
131235070|NCT01265784|472488820|FG001|Overall Study|Incorrectly Randomized|0|||
131235071|NCT01265784|472488821|FG002|Overall Study|Incorrectly Randomized|1|||
131235072|NCT00984295|472488824|FG000|Overall Study|Lost to Follow-up|31|||
131235073|NCT00984295|472488825|FG001|Overall Study|Lost to Follow-up|12|||
131235074|NCT00984295|472488826|FG002|Overall Study|Lost to Follow-up|13|||
131235075|NCT00984295|472488824|FG000|Overall Study|Protocol Violation|2|||
131235076|NCT00984295|472488825|FG001|Overall Study|Protocol Violation|1|||
131235077|NCT00984295|472488826|FG002|Overall Study|Protocol Violation|4|||
131235078|NCT00984295|472488824|FG000|Overall Study|Withdrawal by Subject|18|||
131235079|NCT00984295|472488825|FG001|Overall Study|Withdrawal by Subject|9|||
131153248|NCT03874234|472184049|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153249|NCT03874234|472184050|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153250|NCT03874234|472184051|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153251|NCT03874234|472184052|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153252|NCT03874234|472184053|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153253|NCT03874234|472184054|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153254|NCT03874234|472184055|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
131153255|NCT03874234|472184043|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153256|NCT03874234|472184044|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153257|NCT03874234|472184045|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153258|NCT03874234|472184046|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153259|NCT03874234|472184047|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
131153260|NCT03874234|472184048|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153261|NCT03874234|472184049|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153262|NCT03874234|472184050|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153263|NCT03874234|472184051|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153264|NCT03874234|472184052|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153265|NCT03874234|472184053|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153266|NCT03874234|472184054|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153267|NCT03874234|472184055|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
131153268|NCT03874234|472184043|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153269|NCT03874234|472184044|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153270|NCT03874234|472184045|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153271|NCT03874234|472184046|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153272|NCT03874234|472184047|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153273|NCT03874234|472184048|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153274|NCT03874234|472184049|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153275|NCT03874234|472184050|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
131153276|NCT03874234|472184051|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153277|NCT03874234|472184052|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153278|NCT03874234|472184053|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153279|NCT03874234|472184054|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153280|NCT03874234|472184055|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
131153281|NCT03874234|472184043|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153282|NCT03874234|472184044|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153283|NCT03874234|472184045|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153284|NCT03874234|472184046|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153285|NCT03874234|472184047|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
131153286|NCT03874234|472184048|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
131153287|NCT03874234|472184049|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153288|NCT03874234|472184050|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153289|NCT03874234|472184051|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153290|NCT03874234|472184052|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153291|NCT03874234|472184053|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153292|NCT03874234|472184054|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153293|NCT03874234|472184055|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
131153294|NCT03874234|472184043|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153295|NCT03874234|472184044|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153296|NCT03874234|472184045|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153297|NCT03874234|472184046|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153298|NCT03874234|472184047|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153299|NCT03874234|472184048|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153300|NCT03874234|472184049|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
131153301|NCT03874234|472184050|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153302|NCT03874234|472184051|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153303|NCT03874234|472184052|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153304|NCT03874234|472184053|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153305|NCT03874234|472184054|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153306|NCT03874234|472184055|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
131153307|NCT03874234|472184043|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153308|NCT03874234|472184044|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153309|NCT03874234|472184045|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153310|NCT03874234|472184046|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153311|NCT03874234|472184047|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
131153312|NCT03874234|472184048|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153313|NCT03874234|472184049|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153314|NCT03874234|472184050|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153315|NCT03874234|472184051|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130728237|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
130728238|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
130728239|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
130728240|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
130728241|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
130728242|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
131153316|NCT03874234|472184052|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153317|NCT03874234|472184053|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153318|NCT03874234|472184054|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153319|NCT03874234|472184055|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
131153320|NCT01821963|472184059|FG000|Overall Study|Adverse Event|1|||
131153321|NCT00783289|472184060|FG000|Overall Study|Protocol Violation|0|||
131153322|NCT00783289|472184061|FG001|Overall Study|Protocol Violation|1|||
131153323|NCT00783289|472184062|FG002|Overall Study|Protocol Violation|0|||
131153324|NCT00783289|472184063|FG003|Overall Study|Protocol Violation|0|||
131153325|NCT01896232|472184064|FG000|Overall Study|Death|6|||
131153326|NCT01896232|472184065|FG001|Overall Study|Death|10|||
131153327|NCT01896232|472184064|FG000|Overall Study|Withdrawal by Subject|32|||
131153328|NCT01896232|472184065|FG001|Overall Study|Withdrawal by Subject|31|||
131153329|NCT01896232|472184064|FG000|Overall Study|Sponsor Decision|2|||
131153330|NCT01896232|472184065|FG001|Overall Study|Sponsor Decision|0|||
131153331|NCT01896232|472184064|FG000|Overall Study|Lost to Follow-up|9|||
131153332|NCT01896232|472184065|FG001|Overall Study|Lost to Follow-up|12|||
131153333|NCT01217606|472184068|FG000|Initial Treatment Phase|Other Reasons|0|||
131153334|NCT01217606|472184069|FG001|Initial Treatment Phase|Other Reasons|2|||
131153335|NCT01217606|472184068|FG000|Initial Treatment Phase|Protocol Violation|3|||
131153336|NCT01217606|472184069|FG001|Initial Treatment Phase|Protocol Violation|2|||
131153337|NCT01217606|472184068|FG000|Initial Treatment Phase|Personal Reasons|0|||
131153338|NCT01217606|472184069|FG001|Initial Treatment Phase|Personal Reasons|2|||
131153339|NCT01217606|472184068|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
131153340|NCT01217606|472184069|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
131153341|NCT01217606|472184068|FG000|Initial Treatment Phase|Adverse Event|10|||
131153342|NCT01217606|472184069|FG001|Initial Treatment Phase|Adverse Event|6|||
131153343|NCT01217606|472184068|FG000|9-Month Masked Extension|Adverse Event|3|||
131153344|NCT01217606|472184069|FG001|9-Month Masked Extension|Adverse Event|6|||
131153345|NCT01217606|472184068|FG000|9-Month Masked Extension|Other Reasons|4|||
131153346|NCT01217606|472184069|FG001|9-Month Masked Extension|Other Reasons|4|||
131153347|NCT01217606|472184068|FG000|9-Month Masked Extension|Personal Reasons|2|||
131153348|NCT01217606|472184069|FG001|9-Month Masked Extension|Personal Reasons|1|||
131153349|NCT01217606|472184068|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
131153350|NCT01217606|472184069|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
131153351|NCT01217606|472184068|FG000|9-Month Masked Extension|Pregnancy|1|||
131153352|NCT01217606|472184069|FG001|9-Month Masked Extension|Pregnancy|0|||
131153353|NCT01217606|472184068|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
131153354|NCT01217606|472184069|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
131153355|NCT04419506|472184072|FG000|Overall Study|Adverse Event|0|||
131153356|NCT04419506|472184073|FG001|Overall Study|Adverse Event|10|||
131153357|NCT04419506|472184074|FG002|Overall Study|Adverse Event|0|||
131153358|NCT04419506|472184075|FG003|Overall Study|Adverse Event|3|||
131153359|NCT04419506|472184072|FG000|Overall Study|Withdrawal by Subject|0|||
131153360|NCT04419506|472184073|FG001|Overall Study|Withdrawal by Subject|0|||
131153361|NCT04419506|472184074|FG002|Overall Study|Withdrawal by Subject|0|||
131153362|NCT04419506|472184075|FG003|Overall Study|Withdrawal by Subject|1|||
131153363|NCT04419506|472184072|FG000|Overall Study|poor-compliance|0|||
131153364|NCT04419506|472184073|FG001|Overall Study|poor-compliance|0|||
131153365|NCT04419506|472184074|FG002|Overall Study|poor-compliance|0|||
131153366|NCT04419506|472184075|FG003|Overall Study|poor-compliance|1|||
131153367|NCT03976401|472184082|FG000|Overall Study|Adverse Event|2|||
131153368|NCT03976401|472184083|FG001|Overall Study|Adverse Event|0|||
131153369|NCT03976401|472184084|FG002|Overall Study|Adverse Event|4|||
131153370|NCT03976401|472184085|FG003|Overall Study|Adverse Event|1|||
131153371|NCT03976401|472184086|FG004|Overall Study|Adverse Event|1|||
131153372|NCT03976401|472184087|FG005|Overall Study|Adverse Event|0|||
131153373|NCT03976401|472184082|FG000|Overall Study|Withdrawal by Subject|0|||
131153374|NCT03976401|472184083|FG001|Overall Study|Withdrawal by Subject|1|||
131153375|NCT03976401|472184084|FG002|Overall Study|Withdrawal by Subject|0|||
131153376|NCT03976401|472184085|FG003|Overall Study|Withdrawal by Subject|0|||
131153377|NCT03976401|472184086|FG004|Overall Study|Withdrawal by Subject|0|||
131153378|NCT03976401|472184087|FG005|Overall Study|Withdrawal by Subject|1|||
131153379|NCT03976401|472184082|FG000|Overall Study|Physician Decision|0|||
131153380|NCT03976401|472184083|FG001|Overall Study|Physician Decision|0|||
131235080|NCT00984295|472488826|FG002|Overall Study|Withdrawal by Subject|12|||
130728243|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
131153381|NCT03976401|472184084|FG002|Overall Study|Physician Decision|1|||
131153382|NCT03976401|472184085|FG003|Overall Study|Physician Decision|0|||
131153383|NCT03976401|472184086|FG004|Overall Study|Physician Decision|0|||
131153384|NCT03976401|472184087|FG005|Overall Study|Physician Decision|0|||
131153385|NCT03976401|472184082|FG000|Overall Study|Lost to Follow-up|1|||
131153386|NCT03976401|472184083|FG001|Overall Study|Lost to Follow-up|2|||
131153387|NCT03976401|472184084|FG002|Overall Study|Lost to Follow-up|0|||
131153388|NCT03976401|472184085|FG003|Overall Study|Lost to Follow-up|0|||
131153389|NCT03976401|472184086|FG004|Overall Study|Lost to Follow-up|0|||
131153390|NCT03976401|472184087|FG005|Overall Study|Lost to Follow-up|0|||
131153391|NCT03976401|472184082|FG000|Overall Study|Protocol Violation|0|||
131153392|NCT03976401|472184083|FG001|Overall Study|Protocol Violation|1|||
131153393|NCT03976401|472184084|FG002|Overall Study|Protocol Violation|0|||
131153394|NCT03976401|472184085|FG003|Overall Study|Protocol Violation|0|||
131153395|NCT03976401|472184086|FG004|Overall Study|Protocol Violation|0|||
131153396|NCT03976401|472184087|FG005|Overall Study|Protocol Violation|0|||
131153397|NCT03976401|472184082|FG000|Overall Study|Withdrew Consent|0|||
131153398|NCT03976401|472184083|FG001|Overall Study|Withdrew Consent|0|||
131153399|NCT03976401|472184084|FG002|Overall Study|Withdrew Consent|0|||
131153400|NCT03976401|472184085|FG003|Overall Study|Withdrew Consent|1|||
131153401|NCT03976401|472184086|FG004|Overall Study|Withdrew Consent|0|||
131153402|NCT03976401|472184087|FG005|Overall Study|Withdrew Consent|0|||
131153403|NCT00817414|472184089|FG000|Overall Study|Adverse Event|1|||
131153404|NCT00817414|472184090|FG001|Overall Study|Adverse Event|1|||
131153405|NCT00817414|472184091|FG002|Overall Study|Adverse Event|1|||
131153406|NCT00817414|472184092|FG003|Overall Study|Adverse Event|0|||
131153407|NCT00817414|472184093|FG004|Overall Study|Adverse Event|0|||
131153408|NCT00817414|472184089|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
131153409|NCT00817414|472184090|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
131153410|NCT00817414|472184091|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
131153411|NCT00817414|472184092|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
131153412|NCT00817414|472184093|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
131153413|NCT00817414|472184089|FG000|Overall Study|Withdrawal by Subject|1|||
131153414|NCT00817414|472184090|FG001|Overall Study|Withdrawal by Subject|1|||
131153415|NCT00817414|472184091|FG002|Overall Study|Withdrawal by Subject|0|||
131153416|NCT00817414|472184092|FG003|Overall Study|Withdrawal by Subject|0|||
131153417|NCT00817414|472184093|FG004|Overall Study|Withdrawal by Subject|0|||
131153418|NCT00817414|472184089|FG000|Overall Study|Lost to Follow-up|0|||
131153419|NCT00817414|472184090|FG001|Overall Study|Lost to Follow-up|0|||
131153420|NCT00817414|472184091|FG002|Overall Study|Lost to Follow-up|1|||
131153421|NCT00817414|472184092|FG003|Overall Study|Lost to Follow-up|1|||
131153422|NCT00817414|472184093|FG004|Overall Study|Lost to Follow-up|1|||
131153423|NCT00817414|472184089|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
131153424|NCT00817414|472184090|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
131153425|NCT00817414|472184091|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
131153426|NCT00817414|472184092|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
131153427|NCT00817414|472184093|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
131153428|NCT00817414|472184089|FG000|Overall Study|Protocol Violation|0|||
131153429|NCT00817414|472184090|FG001|Overall Study|Protocol Violation|0|||
131153430|NCT00817414|472184091|FG002|Overall Study|Protocol Violation|0|||
131153431|NCT00817414|472184092|FG003|Overall Study|Protocol Violation|0|||
131153432|NCT00817414|472184093|FG004|Overall Study|Protocol Violation|1|||
131153433|NCT01503021|472184094|FG000|Overall Study|Adverse Event|7|||
131153434|NCT01503021|472184095|FG001|Overall Study|Adverse Event|6|||
131153435|NCT01503021|472184094|FG000|Overall Study|Death|0|||
131153436|NCT01503021|472184095|FG001|Overall Study|Death|2|||
131153437|NCT01503021|472184094|FG000|Overall Study|Lost to Follow-up|2|||
131153438|NCT01503021|472184095|FG001|Overall Study|Lost to Follow-up|0|||
131153439|NCT01503021|472184094|FG000|Overall Study|Physician Decision|3|||
131153440|NCT01503021|472184095|FG001|Overall Study|Physician Decision|0|||
131153441|NCT01503021|472184094|FG000|Overall Study|Protocol Violation|1|||
131153442|NCT01503021|472184095|FG001|Overall Study|Protocol Violation|3|||
131153443|NCT01503021|472184094|FG000|Overall Study|Withdrawal by Subject|9|||
131153444|NCT01503021|472184095|FG001|Overall Study|Withdrawal by Subject|8|||
131153445|NCT01503021|472184094|FG000|Overall Study|Moved, received transplant, etc.|5|||
131153446|NCT01503021|472184095|FG001|Overall Study|Moved, received transplant, etc.|7|||
131153447|NCT00097539|472184096|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
131153448|NCT00097539|472184097|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
131153449|NCT00097539|472184098|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
131153450|NCT00097539|472184099|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
131153451|NCT00097539|472184100|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
131153452|NCT00097539|472184101|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
131153453|NCT00097539|472184102|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
131153454|NCT00097539|472184096|FG000|Overall Study|Withdrawal by Subject|925|||
131153455|NCT00097539|472184097|FG001|Overall Study|Withdrawal by Subject|323|||
131153456|NCT00097539|472184098|FG002|Overall Study|Withdrawal by Subject|346|||
131153457|NCT00097539|472184099|FG003|Overall Study|Withdrawal by Subject|217|||
131153458|NCT00097539|472184100|FG004|Overall Study|Withdrawal by Subject|68|||
131153459|NCT00097539|472184101|FG005|Overall Study|Withdrawal by Subject|229|||
131153460|NCT00097539|472184102|FG006|Overall Study|Withdrawal by Subject|3|||
131153461|NCT00097539|472184096|FG000|Overall Study|Participant Non-compliant|2140|||
131153462|NCT00097539|472184097|FG001|Overall Study|Participant Non-compliant|567|||
131153463|NCT00097539|472184098|FG002|Overall Study|Participant Non-compliant|1067|||
131153464|NCT00097539|472184099|FG003|Overall Study|Participant Non-compliant|353|||
131153465|NCT00097539|472184100|FG004|Overall Study|Participant Non-compliant|136|||
131153466|NCT00097539|472184101|FG005|Overall Study|Participant Non-compliant|543|||
131153467|NCT00097539|472184102|FG006|Overall Study|Participant Non-compliant|18|||
131153468|NCT00097539|472184096|FG000|Overall Study|Lack of Efficacy|249|||
131153469|NCT00097539|472184097|FG001|Overall Study|Lack of Efficacy|122|||
131153470|NCT00097539|472184098|FG002|Overall Study|Lack of Efficacy|202|||
131153471|NCT00097539|472184099|FG003|Overall Study|Lack of Efficacy|105|||
131153472|NCT00097539|472184100|FG004|Overall Study|Lack of Efficacy|45|||
131153473|NCT00097539|472184101|FG005|Overall Study|Lack of Efficacy|228|||
131153474|NCT00097539|472184102|FG006|Overall Study|Lack of Efficacy|5|||
131153475|NCT00097539|472184096|FG000|Overall Study|Adverse Event|78|||
131153476|NCT00097539|472184097|FG001|Overall Study|Adverse Event|133|||
131153477|NCT00097539|472184098|FG002|Overall Study|Adverse Event|37|||
131153478|NCT00097539|472184099|FG003|Overall Study|Adverse Event|27|||
131153479|NCT00097539|472184100|FG004|Overall Study|Adverse Event|30|||
131153480|NCT00097539|472184101|FG005|Overall Study|Adverse Event|59|||
131153481|NCT00097539|472184102|FG006|Overall Study|Adverse Event|1|||
131153482|NCT00097539|472184096|FG000|Overall Study|Death|2|||
131153483|NCT00097539|472184097|FG001|Overall Study|Death|7|||
131153484|NCT00097539|472184098|FG002|Overall Study|Death|0|||
131153485|NCT00097539|472184099|FG003|Overall Study|Death|0|||
131153486|NCT00097539|472184100|FG004|Overall Study|Death|1|||
131153487|NCT00097539|472184101|FG005|Overall Study|Death|3|||
131153488|NCT00097539|472184102|FG006|Overall Study|Death|0|||
131153489|NCT00097539|472184096|FG000|Overall Study|Reasons Other Than Above|3602|||
131153490|NCT00097539|472184097|FG001|Overall Study|Reasons Other Than Above|1382|||
131153491|NCT00097539|472184098|FG002|Overall Study|Reasons Other Than Above|1757|||
131153492|NCT00097539|472184099|FG003|Overall Study|Reasons Other Than Above|692|||
131153493|NCT00097539|472184100|FG004|Overall Study|Reasons Other Than Above|361|||
131153494|NCT00097539|472184101|FG005|Overall Study|Reasons Other Than Above|1244|||
131235081|NCT00984295|472488824|FG000|Overall Study|CAE - discontinued test vaccine|0|||
131235082|NCT00984295|472488825|FG001|Overall Study|CAE - discontinued test vaccine|1|||
131235083|NCT00984295|472488826|FG002|Overall Study|CAE - discontinued test vaccine|3|||
131235084|NCT00984295|472488824|FG000|Overall Study|Missed one or more blood samplings|3|||
131235085|NCT00984295|472488825|FG001|Overall Study|Missed one or more blood samplings|7|||
131235086|NCT00984295|472488826|FG002|Overall Study|Missed one or more blood samplings|2|||
131235087|NCT00984295|472488824|FG000|Overall Study|Incomplete safety follow-up|11|||
131235088|NCT00984295|472488825|FG001|Overall Study|Incomplete safety follow-up|2|||
131235089|NCT00984295|472488826|FG002|Overall Study|Incomplete safety follow-up|3|||
131235090|NCT04799158|472488827|FG000|Run-In Period|Adverse Event|6|||
131235091|NCT04799158|472488828|FG001|Run-In Period|Adverse Event|0|||
131235092|NCT04799158|472488829|FG002|Run-In Period|Adverse Event|0|||
131235093|NCT04799158|472488830|FG003|Run-In Period|Adverse Event|0|||
131235094|NCT04799158|472488831|FG004|Run-In Period|Adverse Event|0|||
131235095|NCT04799158|472488827|FG000|Run-In Period|Lost to Follow-up|4|||
131235096|NCT04799158|472488828|FG001|Run-In Period|Lost to Follow-up|0|||
131235097|NCT04799158|472488829|FG002|Run-In Period|Lost to Follow-up|0|||
131235098|NCT04799158|472488830|FG003|Run-In Period|Lost to Follow-up|0|||
131235099|NCT04799158|472488831|FG004|Run-In Period|Lost to Follow-up|0|||
131235100|NCT04799158|472488827|FG000|Run-In Period|Significant Protocol Deviation|1|||
131235101|NCT04799158|472488828|FG001|Run-In Period|Significant Protocol Deviation|0|||
131235102|NCT04799158|472488829|FG002|Run-In Period|Significant Protocol Deviation|0|||
131235103|NCT04799158|472488830|FG003|Run-In Period|Significant Protocol Deviation|0|||
131235104|NCT04799158|472488831|FG004|Run-In Period|Significant Protocol Deviation|0|||
131235105|NCT04799158|472488827|FG000|Run-In Period|Withdrawal by Subject|11|||
131235106|NCT04799158|472488828|FG001|Run-In Period|Withdrawal by Subject|0|||
131235107|NCT04799158|472488829|FG002|Run-In Period|Withdrawal by Subject|0|||
131153495|NCT00097539|472184102|FG006|Overall Study|Reasons Other Than Above|34|||
131153496|NCT00097539|472184096|FG000|Overall Study|Reason not Specified|111|||
131153497|NCT00097539|472184097|FG001|Overall Study|Reason not Specified|49|||
131153498|NCT00097539|472184098|FG002|Overall Study|Reason not Specified|53|||
131235108|NCT04799158|472488830|FG003|Run-In Period|Withdrawal by Subject|0|||
131235109|NCT04799158|472488831|FG004|Run-In Period|Withdrawal by Subject|0|||
131235110|NCT04799158|472488827|FG000|Run-In Period|Miscellaneous|3|||
131235111|NCT04799158|472488828|FG001|Run-In Period|Miscellaneous|0|||
131153499|NCT00097539|472184099|FG003|Overall Study|Reason not Specified|21|||
131235112|NCT04799158|472488829|FG002|Run-In Period|Miscellaneous|0|||
131153500|NCT00097539|472184100|FG004|Overall Study|Reason not Specified|11|||
131153501|NCT00097539|472184101|FG005|Overall Study|Reason not Specified|40|||
131153502|NCT00097539|472184102|FG006|Overall Study|Reason not Specified|2|||
131153503|NCT02966314|472184103|FG000|Overall Study|Lost to Follow-up|1|||
131153504|NCT02966314|472184104|FG001|Overall Study|Lost to Follow-up|0|||
131153505|NCT03941548|472184105|FG000|Overall Study|Adverse Event|0|||
131153506|NCT03941548|472184106|FG001|Overall Study|Adverse Event|1|||
130728244|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
130728245|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130728246|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130728247|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
130728248|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
130728249|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
131153507|NCT03941548|472184105|FG000|Overall Study|Lost to Follow-up|0|||
131153508|NCT03941548|472184106|FG001|Overall Study|Lost to Follow-up|1|||
131153509|NCT03941548|472184105|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
131153510|NCT03941548|472184106|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
131153511|NCT01242111|472184109|FG000|Overall Study|Adverse Event|1|||
131153512|NCT01242111|472184109|FG000|Overall Study|Withdrawal by Subject|1|||
131153513|NCT01242111|472184109|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
131153514|NCT02015819|472184110|FG000|Overall Study|Rickham catheter was misaligned|0|||
131153515|NCT02015819|472184111|FG001|Overall Study|Rickham catheter was misaligned|0|||
131153516|NCT02015819|472184112|FG002|Overall Study|Rickham catheter was misaligned|0|||
131153517|NCT02015819|472184113|FG003|Overall Study|Rickham catheter was misaligned|1|||
131153518|NCT02945657|472184114|FG000|Overall Study|Adverse Event|1|||
131153519|NCT02945657|472184114|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
131153520|NCT03584009|472184121|FG000|Overall Study|Death|25|||
131153521|NCT03584009|472184122|FG001|Overall Study|Death|18|||
131153522|NCT03584009|472184121|FG000|Overall Study|Lost to Follow-up|0|||
131153523|NCT03584009|472184122|FG001|Overall Study|Lost to Follow-up|1|||
131153524|NCT03584009|472184121|FG000|Overall Study|Physician Decision|1|||
131153525|NCT03584009|472184122|FG001|Overall Study|Physician Decision|1|||
131153526|NCT03584009|472184121|FG000|Overall Study|Study Terminated by Sponsor|22|||
131153527|NCT03584009|472184122|FG001|Overall Study|Study Terminated by Sponsor|30|||
131153528|NCT03584009|472184121|FG000|Overall Study|Withdrawal by Subject|3|||
131153529|NCT03584009|472184122|FG001|Overall Study|Withdrawal by Subject|2|||
131153530|NCT00446030|472184123|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
131153531|NCT00446030|472184124|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
131153532|NCT00446030|472184123|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
131153533|NCT00446030|472184124|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
131153534|NCT00446030|472184123|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
131153535|NCT00446030|472184124|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
131153536|NCT00446030|472184123|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
131153537|NCT00446030|472184124|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
131153538|NCT00446030|472184123|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
131153539|NCT00446030|472184124|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
131153540|NCT00446030|472184123|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
131153541|NCT00446030|472184124|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
131153542|NCT00446030|472184123|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
131153543|NCT00446030|472184124|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
131153544|NCT00446030|472184123|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
131235113|NCT04799158|472488830|FG003|Run-In Period|Miscellaneous|0|||
131235114|NCT04799158|472488831|FG004|Run-In Period|Miscellaneous|0|||
131235115|NCT04799158|472488827|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
131235116|NCT04799158|472488828|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
131235117|NCT04799158|472488829|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
131235118|NCT04799158|472488830|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
131235119|NCT04799158|472488831|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
131235120|NCT04799158|472488827|FG000|On-Demand Treatment Period|Adverse Event|0|||
131235121|NCT04799158|472488828|FG001|On-Demand Treatment Period|Adverse Event|1|||
131235122|NCT04799158|472488829|FG002|On-Demand Treatment Period|Adverse Event|0|||
131235123|NCT04799158|472488830|FG003|On-Demand Treatment Period|Adverse Event|0|||
131235124|NCT04799158|472488831|FG004|On-Demand Treatment Period|Adverse Event|1|||
131235125|NCT04799158|472488827|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
131235126|NCT04799158|472488828|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
131235127|NCT04799158|472488829|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
131235128|NCT04799158|472488830|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
131235129|NCT04799158|472488831|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
131235130|NCT04799158|472488827|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
131235131|NCT04799158|472488828|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
131235132|NCT04799158|472488829|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
130728250|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
131153545|NCT00446030|472184124|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
131153546|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
131153547|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
131153548|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
131153549|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
131153550|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
131153551|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
131153552|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
131153553|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
131153554|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
131153555|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
131153556|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
131153557|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
131153558|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
131153559|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
131153560|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
131153561|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
131153562|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
131153563|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
131153564|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
131153565|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
131153566|NCT00446030|472184123|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
131153567|NCT00446030|472184124|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
131153568|NCT02886715|472184125|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131153569|NCT02886715|472184126|FG001|Overall Study|Non-Compliance With Study Drug|2|||
131153570|NCT02886715|472184127|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131153571|NCT02886715|472184125|FG000|Overall Study|Adverse Event|4|||
131153572|NCT02886715|472184126|FG001|Overall Study|Adverse Event|2|||
131153573|NCT02886715|472184127|FG002|Overall Study|Adverse Event|0|||
131153574|NCT02886715|472184125|FG000|Overall Study|Lack of Efficacy|0|||
131153575|NCT02886715|472184126|FG001|Overall Study|Lack of Efficacy|2|||
131153576|NCT02886715|472184127|FG002|Overall Study|Lack of Efficacy|1|||
131153577|NCT02886715|472184125|FG000|Overall Study|Lost to Follow-up|29|||
131153578|NCT02886715|472184126|FG001|Overall Study|Lost to Follow-up|26|||
131153579|NCT02886715|472184127|FG002|Overall Study|Lost to Follow-up|10|||
131153580|NCT02886715|472184125|FG000|Overall Study|Pregnancy|1|||
131153581|NCT02886715|472184126|FG001|Overall Study|Pregnancy|1|||
131153582|NCT02886715|472184127|FG002|Overall Study|Pregnancy|1|||
131153583|NCT02886715|472184125|FG000|Overall Study|Protocol Violation|3|||
131153584|NCT02886715|472184126|FG001|Overall Study|Protocol Violation|2|||
131153585|NCT02886715|472184127|FG002|Overall Study|Protocol Violation|1|||
131153586|NCT02886715|472184125|FG000|Overall Study|Withdrawal by Subject|20|||
131153587|NCT02886715|472184126|FG001|Overall Study|Withdrawal by Subject|18|||
131153588|NCT02886715|472184127|FG002|Overall Study|Withdrawal by Subject|5|||
131153589|NCT02886715|472184125|FG000|Overall Study|missing|7|||
131153590|NCT02886715|472184126|FG001|Overall Study|missing|2|||
131153591|NCT02886715|472184127|FG002|Overall Study|missing|2|||
131153592|NCT00222105|472184128|FG000|Overall Study|Removed due to wrong diagnosis|1|||
131153593|NCT00222105|472184128|FG000|Overall Study|Withdrawal by Subject|1|||
131153594|NCT00222105|472184128|FG000|Overall Study|Adverse Event|8|||
131153595|NCT00222105|472184128|FG000|Overall Study|Treatment delays|2|||
131153596|NCT00222105|472184128|FG000|Overall Study|Death|2|||
131153597|NCT00503399|472184129|FG000|Overall Study|Death|2|||
131153598|NCT00503399|472184130|FG001|Overall Study|Death|1|||
131153599|NCT00503399|472184129|FG000|Overall Study|Protocol Violation|1|||
131153600|NCT00503399|472184130|FG001|Overall Study|Protocol Violation|0|||
131153601|NCT00503399|472184129|FG000|Overall Study|Withdrawal by Subject|4|||
131153602|NCT00503399|472184130|FG001|Overall Study|Withdrawal by Subject|2|||
131153603|NCT00503399|472184129|FG000|Overall Study|Adverse Event|0|||
131153604|NCT00503399|472184130|FG001|Overall Study|Adverse Event|3|||
131153605|NCT00503399|472184129|FG000|Overall Study|Lost to Follow-up|0|||
131153606|NCT00503399|472184130|FG001|Overall Study|Lost to Follow-up|2|||
131153607|NCT01120626|472184133|FG000|Overall Study|Withdrawal by Subject|1|||
131153608|NCT01120626|472184134|FG001|Overall Study|Withdrawal by Subject|0|||
131153609|NCT00488631|472184151|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
131153610|NCT00488631|472184152|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
131153611|NCT00488631|472184153|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
131153612|NCT00488631|472184154|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
131153613|NCT00488631|472184155|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
131153614|NCT00488631|472184156|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
131153615|NCT00488631|472184157|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
131153616|NCT00488631|472184158|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
131153617|NCT00488631|472184159|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
131153618|NCT00488631|472184160|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
131153619|NCT00488631|472184151|FG000|Double Blind Period (Week 0-54)|Death|0|||
130728251|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
131153620|NCT00488631|472184152|FG001|Double Blind Period (Week 0-54)|Death|0|||
131153621|NCT00488631|472184153|FG002|Double Blind Period (Week 0-54)|Death|0|||
131153622|NCT00488631|472184154|FG003|Double Blind Period (Week 0-54)|Death|0|||
131153623|NCT00488631|472184155|FG004|Double Blind Period (Week 0-54)|Death|0|||
131153624|NCT00488631|472184156|FG005|Double Blind Period (Week 0-54)|Death|1|||
131153625|NCT00488631|472184157|FG006|Double Blind Period (Week 0-54)|Death|0|||
131153626|NCT00488631|472184158|FG007|Double Blind Period (Week 0-54)|Death|0|||
131153627|NCT00488631|472184159|FG008|Double Blind Period (Week 0-54)|Death|0|||
131153628|NCT00488631|472184160|FG009|Double Blind Period (Week 0-54)|Death|0|||
131153629|NCT00488631|472184151|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
131153630|NCT00488631|472184152|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
131153631|NCT00488631|472184153|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
131153632|NCT00488631|472184154|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
131153633|NCT00488631|472184155|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
131153634|NCT00488631|472184156|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
131153635|NCT00488631|472184157|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
131153636|NCT00488631|472184158|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
131153637|NCT00488631|472184159|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
131153638|NCT00488631|472184160|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
131153639|NCT00488631|472184151|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
131153640|NCT00488631|472184152|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
131153641|NCT00488631|472184153|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
131153642|NCT00488631|472184154|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
131153643|NCT00488631|472184155|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
131153644|NCT00488631|472184156|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
131153645|NCT00488631|472184157|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
131153646|NCT00488631|472184158|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
131153647|NCT00488631|472184159|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
131153648|NCT00488631|472184160|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
131153649|NCT00488631|472184151|FG000|Double Blind Period (Week 0-54)|Other|6|||
131153650|NCT00488631|472184152|FG001|Double Blind Period (Week 0-54)|Other|12|||
131153651|NCT00488631|472184153|FG002|Double Blind Period (Week 0-54)|Other|10|||
131153652|NCT00488631|472184154|FG003|Double Blind Period (Week 0-54)|Other|11|||
131153653|NCT00488631|472184155|FG004|Double Blind Period (Week 0-54)|Other|14|||
131153654|NCT00488631|472184156|FG005|Double Blind Period (Week 0-54)|Other|34|||
131153655|NCT00488631|472184157|FG006|Double Blind Period (Week 0-54)|Other|0|||
131153656|NCT00488631|472184158|FG007|Double Blind Period (Week 0-54)|Other|0|||
131153657|NCT00488631|472184159|FG008|Double Blind Period (Week 0-54)|Other|0|||
131153658|NCT00488631|472184160|FG009|Double Blind Period (Week 0-54)|Other|0|||
131153659|NCT00488631|472184151|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131153660|NCT00488631|472184152|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131153661|NCT00488631|472184153|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131153662|NCT00488631|472184154|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131153663|NCT00488631|472184155|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131153664|NCT00488631|472184156|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131153665|NCT00488631|472184157|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
131153666|NCT00488631|472184158|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
131153667|NCT00488631|472184159|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
131153668|NCT00488631|472184160|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
131153669|NCT00488631|472184151|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
131153670|NCT00488631|472184152|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
131153671|NCT00488631|472184153|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
131153672|NCT00488631|472184154|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
131153673|NCT00488631|472184155|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
131153674|NCT00488631|472184156|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
131153675|NCT00488631|472184157|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
131153676|NCT00488631|472184158|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
131153677|NCT00488631|472184159|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
131153678|NCT00488631|472184160|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
131153679|NCT00488631|472184151|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131153680|NCT00488631|472184152|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131153681|NCT00488631|472184153|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131153682|NCT00488631|472184154|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131153683|NCT00488631|472184155|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131153684|NCT00488631|472184156|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
131235133|NCT04799158|472488830|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
131153685|NCT00488631|472184157|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
131153686|NCT00488631|472184158|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
131153687|NCT00488631|472184159|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
131153688|NCT00488631|472184160|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
131153689|NCT00488631|472184151|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131153690|NCT00488631|472184152|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131153691|NCT00488631|472184153|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131153692|NCT00488631|472184154|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131153693|NCT00488631|472184155|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131153694|NCT00488631|472184156|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131153695|NCT00488631|472184157|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
131153696|NCT00488631|472184158|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131153697|NCT00488631|472184159|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
131153698|NCT00488631|472184160|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
131153699|NCT00488631|472184151|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131153700|NCT00488631|472184152|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131153701|NCT00488631|472184153|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131153702|NCT00488631|472184154|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131153703|NCT00488631|472184155|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131153704|NCT00488631|472184156|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131153705|NCT00488631|472184157|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
131153706|NCT00488631|472184158|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
131153707|NCT00488631|472184159|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
131153708|NCT00488631|472184160|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
131153709|NCT01073943|472184168|FG000|Overall Study|Withdrawal by Subject|8|||
131153710|NCT01073943|472184169|FG001|Overall Study|Withdrawal by Subject|2|||
131153711|NCT01073943|472184168|FG000|Overall Study|Protocol Violation|2|||
131153712|NCT01073943|472184169|FG001|Overall Study|Protocol Violation|1|||
131153713|NCT01073943|472184168|FG000|Overall Study|Adverse Event|1|||
131153714|NCT01073943|472184169|FG001|Overall Study|Adverse Event|1|||
131153715|NCT01073943|472184168|FG000|Overall Study|Lost to Follow-up|0|||
131153716|NCT01073943|472184169|FG001|Overall Study|Lost to Follow-up|2|||
131153717|NCT01073943|472184168|FG000|Overall Study|Power outage; colonoscopy not done|1|||
131153718|NCT01073943|472184169|FG001|Overall Study|Power outage; colonoscopy not done|0|||
131153719|NCT01073943|472184168|FG000|Overall Study|Subject forgot|0|||
131153720|NCT01073943|472184169|FG001|Overall Study|Subject forgot|1|||
131153721|NCT01073943|472184168|FG000|Overall Study|Unable to return for follow-up|0|||
131153722|NCT01073943|472184169|FG001|Overall Study|Unable to return for follow-up|1|||
131153723|NCT01073943|472184168|FG000|Overall Study|Could not tolerate prep|1|||
131153724|NCT01073943|472184169|FG001|Overall Study|Could not tolerate prep|0|||
131153725|NCT00824421|472184171|FG000|Overall Study|Adverse Event|6|||
131153726|NCT00824421|472184172|FG001|Overall Study|Adverse Event|6|||
131153727|NCT00824421|472184173|FG002|Overall Study|Adverse Event|6|||
131153728|NCT00824421|472184171|FG000|Overall Study|Death|0|||
131153729|NCT00824421|472184172|FG001|Overall Study|Death|1|||
131153730|NCT00824421|472184173|FG002|Overall Study|Death|0|||
131153731|NCT00824421|472184171|FG000|Overall Study|Lack of Efficacy|5|||
131153732|NCT00824421|472184172|FG001|Overall Study|Lack of Efficacy|7|||
131153733|NCT00824421|472184173|FG002|Overall Study|Lack of Efficacy|4|||
131153734|NCT00824421|472184171|FG000|Overall Study|Lost to Follow-up|2|||
131153735|NCT00824421|472184172|FG001|Overall Study|Lost to Follow-up|3|||
131153736|NCT00824421|472184173|FG002|Overall Study|Lost to Follow-up|0|||
131153737|NCT00824421|472184171|FG000|Overall Study|Pregnancy|1|||
131153738|NCT00824421|472184172|FG001|Overall Study|Pregnancy|0|||
131153739|NCT00824421|472184173|FG002|Overall Study|Pregnancy|1|||
131153740|NCT00824421|472184171|FG000|Overall Study|Withdrawal by Subject|2|||
131153741|NCT00824421|472184172|FG001|Overall Study|Withdrawal by Subject|3|||
131153742|NCT00824421|472184173|FG002|Overall Study|Withdrawal by Subject|3|||
131153743|NCT00824421|472184171|FG000|Overall Study|Randomized but not Treated|1|||
131153744|NCT00824421|472184172|FG001|Overall Study|Randomized but not Treated|1|||
131153745|NCT00824421|472184173|FG002|Overall Study|Randomized but not Treated|0|||
131153746|NCT00824421|472184171|FG000|Overall Study|Other|0|||
131153747|NCT00824421|472184172|FG001|Overall Study|Other|1|||
131153748|NCT00824421|472184173|FG002|Overall Study|Other|0|||
131153749|NCT03830281|472184175|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
131153750|NCT03830281|472184176|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
131153751|NCT03830281|472184175|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
131153752|NCT03830281|472184176|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
131153753|NCT03830281|472184175|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
131153754|NCT03830281|472184176|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
131153755|NCT03830281|472184175|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
131153756|NCT03830281|472184176|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
131153757|NCT03830281|472184175|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
131153758|NCT03830281|472184176|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
131153759|NCT03830281|472184175|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
131153760|NCT03830281|472184176|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
131153761|NCT03830281|472184175|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
131153762|NCT03830281|472184176|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
131153763|NCT03830281|472184175|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
131153764|NCT03830281|472184176|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
131153765|NCT03830281|472184175|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
131153766|NCT03830281|472184176|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
131153767|NCT00594399|472184177|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
131153768|NCT00594399|472184178|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
131153769|NCT00594399|472184179|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
131153770|NCT00594399|472184177|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
131153771|NCT00594399|472184178|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
131153772|NCT00594399|472184179|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
131153773|NCT00594399|472184177|FG000|Initial 3 Month Counseling|Personal issues|2|||
131153774|NCT00594399|472184178|FG001|Initial 3 Month Counseling|Personal issues|0|||
131153775|NCT00594399|472184179|FG002|Initial 3 Month Counseling|Personal issues|0|||
131153776|NCT00594399|472184177|FG000|Initial 3 Month Counseling|Too busy|7|||
131153777|NCT00594399|472184178|FG001|Initial 3 Month Counseling|Too busy|1|||
131153778|NCT00594399|472184179|FG002|Initial 3 Month Counseling|Too busy|0|||
131153779|NCT00594399|472184177|FG000|Initial 3 Month Counseling|Pain|2|||
131153780|NCT00594399|472184178|FG001|Initial 3 Month Counseling|Pain|0|||
131153781|NCT00594399|472184179|FG002|Initial 3 Month Counseling|Pain|0|||
131153782|NCT00594399|472184177|FG000|Initial 3 Month Counseling|Moved|1|||
131153783|NCT00594399|472184178|FG001|Initial 3 Month Counseling|Moved|0|||
131153784|NCT00594399|472184179|FG002|Initial 3 Month Counseling|Moved|0|||
131153785|NCT00594399|472184177|FG000|Initial 3 Month Counseling|Family illness|1|||
131153786|NCT00594399|472184178|FG001|Initial 3 Month Counseling|Family illness|0|||
131153787|NCT00594399|472184179|FG002|Initial 3 Month Counseling|Family illness|0|||
131153788|NCT00594399|472184177|FG000|Rerandomization Arm 1 Only|Death|2|||
131153789|NCT00594399|472184178|FG001|Rerandomization Arm 1 Only|Death|1|||
131153790|NCT00594399|472184179|FG002|Rerandomization Arm 1 Only|Death|0|||
131153791|NCT00594399|472184177|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
131153792|NCT00594399|472184178|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
131153793|NCT00594399|472184179|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
131153794|NCT00659438|472184181|FG000|Overall Study|Withdrawal by Subject|2|||
131153795|NCT00659438|472184182|FG001|Overall Study|Withdrawal by Subject|2|||
131153796|NCT00659438|472184181|FG000|Overall Study|Death|11|||
131153797|NCT00659438|472184182|FG001|Overall Study|Death|6|||
131153798|NCT00659438|472184181|FG000|Overall Study|Lost to Follow-up|1|||
131153799|NCT00659438|472184182|FG001|Overall Study|Lost to Follow-up|0|||
131153800|NCT03192904|472184183|FG000|Overall Study|Physician Decision|3|||
131153801|NCT03192904|472184184|FG001|Overall Study|Physician Decision|1|||
131153802|NCT03192904|472184183|FG000|Overall Study|Lost to Follow-up|0|||
130728252|NCT03713632|470627415|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
130728253|NCT03713632|470627416|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
130728254|NCT03713632|470627417|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
130728255|NCT03713632|470627418|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
131153803|NCT03192904|472184184|FG001|Overall Study|Lost to Follow-up|1|||
131153804|NCT01309737|472184185|FG000|Week 0 to 16|Death|1|||
131153805|NCT01309737|472184186|FG001|Week 0 to 16|Death|0|||
131153806|NCT01309737|472184187|FG002|Week 0 to 16|Death|1|||
131153807|NCT01309737|472184188|FG003|Week 0 to 16|Death|0|||
131153808|NCT01309737|472184189|FG004|Week 0 to 16|Death|0|||
131153809|NCT01309737|472184185|FG000|Week 0 to 16|Adverse Event|11|||
131153810|NCT01309737|472184186|FG001|Week 0 to 16|Adverse Event|10|||
131153811|NCT01309737|472184187|FG002|Week 0 to 16|Adverse Event|5|||
131153812|NCT01309737|472184188|FG003|Week 0 to 16|Adverse Event|0|||
131153813|NCT01309737|472184189|FG004|Week 0 to 16|Adverse Event|0|||
131153814|NCT01309737|472184185|FG000|Week 0 to 16|Lack of Efficacy|15|||
131153815|NCT01309737|472184186|FG001|Week 0 to 16|Lack of Efficacy|2|||
131153816|NCT01309737|472184187|FG002|Week 0 to 16|Lack of Efficacy|24|||
131153817|NCT01309737|472184188|FG003|Week 0 to 16|Lack of Efficacy|0|||
130728256|NCT03713632|470627419|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
131153818|NCT01309737|472184189|FG004|Week 0 to 16|Lack of Efficacy|0|||
131153819|NCT01309737|472184185|FG000|Week 0 to 16|Lost to Follow-up|7|||
131153820|NCT01309737|472184186|FG001|Week 0 to 16|Lost to Follow-up|8|||
131153821|NCT01309737|472184187|FG002|Week 0 to 16|Lost to Follow-up|3|||
131153822|NCT01309737|472184188|FG003|Week 0 to 16|Lost to Follow-up|0|||
131153823|NCT01309737|472184189|FG004|Week 0 to 16|Lost to Follow-up|0|||
131153824|NCT01309737|472184185|FG000|Week 0 to 16|Withdrawal by Subject|7|||
131153825|NCT01309737|472184186|FG001|Week 0 to 16|Withdrawal by Subject|6|||
131153826|NCT01309737|472184187|FG002|Week 0 to 16|Withdrawal by Subject|7|||
131153827|NCT01309737|472184188|FG003|Week 0 to 16|Withdrawal by Subject|0|||
131153828|NCT01309737|472184189|FG004|Week 0 to 16|Withdrawal by Subject|0|||
131153829|NCT01309737|472184185|FG000|Week 0 to 16|Other|10|||
131153830|NCT01309737|472184186|FG001|Week 0 to 16|Other|14|||
131153831|NCT01309737|472184187|FG002|Week 0 to 16|Other|4|||
131153832|NCT01309737|472184188|FG003|Week 0 to 16|Other|0|||
131153833|NCT01309737|472184189|FG004|Week 0 to 16|Other|0|||
131153834|NCT01309737|472184185|FG000|Week 0 to 16|Randomized, but not treated|1|||
131153835|NCT01309737|472184186|FG001|Week 0 to 16|Randomized, but not treated|0|||
131153836|NCT01309737|472184187|FG002|Week 0 to 16|Randomized, but not treated|0|||
131153837|NCT01309737|472184188|FG003|Week 0 to 16|Randomized, but not treated|0|||
131153838|NCT01309737|472184189|FG004|Week 0 to 16|Randomized, but not treated|0|||
131153839|NCT01309737|472184185|FG000|Week 16 to 52|Death|0|||
131153840|NCT01309737|472184186|FG001|Week 16 to 52|Death|0|||
131153841|NCT01309737|472184187|FG002|Week 16 to 52|Death|0|||
131153842|NCT01309737|472184188|FG003|Week 16 to 52|Death|0|||
131153843|NCT01309737|472184189|FG004|Week 16 to 52|Death|1|||
131153844|NCT01309737|472184185|FG000|Week 16 to 52|Adverse Event|7|||
131153845|NCT01309737|472184186|FG001|Week 16 to 52|Adverse Event|7|||
131153846|NCT01309737|472184187|FG002|Week 16 to 52|Adverse Event|0|||
131153847|NCT01309737|472184188|FG003|Week 16 to 52|Adverse Event|6|||
131153848|NCT01309737|472184189|FG004|Week 16 to 52|Adverse Event|5|||
131153849|NCT01309737|472184185|FG000|Week 16 to 52|Lack of Efficacy|107|||
131153850|NCT01309737|472184186|FG001|Week 16 to 52|Lack of Efficacy|76|||
131153851|NCT01309737|472184187|FG002|Week 16 to 52|Lack of Efficacy|0|||
131153852|NCT01309737|472184188|FG003|Week 16 to 52|Lack of Efficacy|25|||
131153853|NCT01309737|472184189|FG004|Week 16 to 52|Lack of Efficacy|21|||
131153854|NCT01309737|472184185|FG000|Week 16 to 52|Lost to Follow-up|4|||
131153855|NCT01309737|472184186|FG001|Week 16 to 52|Lost to Follow-up|2|||
131153856|NCT01309737|472184187|FG002|Week 16 to 52|Lost to Follow-up|0|||
131153857|NCT01309737|472184188|FG003|Week 16 to 52|Lost to Follow-up|1|||
131153858|NCT01309737|472184189|FG004|Week 16 to 52|Lost to Follow-up|4|||
131153859|NCT01309737|472184185|FG000|Week 16 to 52|Withdrawal by Subject|5|||
131153860|NCT01309737|472184186|FG001|Week 16 to 52|Withdrawal by Subject|6|||
131153861|NCT01309737|472184187|FG002|Week 16 to 52|Withdrawal by Subject|0|||
131153862|NCT01309737|472184188|FG003|Week 16 to 52|Withdrawal by Subject|0|||
131153863|NCT01309737|472184189|FG004|Week 16 to 52|Withdrawal by Subject|2|||
131153864|NCT01309737|472184185|FG000|Week 16 to 52|Other|10|||
131153865|NCT01309737|472184186|FG001|Week 16 to 52|Other|12|||
131153866|NCT01309737|472184187|FG002|Week 16 to 52|Other|0|||
131153867|NCT01309737|472184188|FG003|Week 16 to 52|Other|2|||
131153868|NCT01309737|472184189|FG004|Week 16 to 52|Other|0|||
131153869|NCT01442181|472184190|FG000|Overall Study|patient refused surgery|1|||
131153870|NCT01442181|472184191|FG001|Overall Study|patient refused surgery|0|||
131153871|NCT01442181|472184190|FG000|Overall Study|no insurance for surgery|1|||
131153872|NCT01442181|472184191|FG001|Overall Study|no insurance for surgery|0|||
131153873|NCT01442181|472184190|FG000|Overall Study|low ejection factor|0|||
131153874|NCT01442181|472184191|FG001|Overall Study|low ejection factor|1|||
131153875|NCT01442181|472184190|FG000|Overall Study|Lost to Follow-up|1|||
131153876|NCT01442181|472184191|FG001|Overall Study|Lost to Follow-up|1|||
131153877|NCT01442181|472184190|FG000|Overall Study|patient in an additional study|1|||
131153878|NCT01442181|472184191|FG001|Overall Study|patient in an additional study|0|||
131153879|NCT01442181|472184190|FG000|Overall Study|atrial fibrillation not noted|0|||
131153880|NCT01442181|472184191|FG001|Overall Study|atrial fibrillation not noted|1|||
131153881|NCT00709202|472184192|FG000|Overall Study|Withdrawal by Subject|6|||
131153882|NCT00709202|472184193|FG001|Overall Study|Withdrawal by Subject|6|||
131153883|NCT03133767|472184195|FG000|Overall Study|Lost to Follow-up|38|||
131153884|NCT03133767|472184196|FG001|Overall Study|Lost to Follow-up|24|||
131153885|NCT03133767|472184195|FG000|Overall Study|Protocol Violation|0|||
131153886|NCT03133767|472184196|FG001|Overall Study|Protocol Violation|1|||
131153887|NCT02240706|472184199|FG000|Overall Study|Lack of Efficacy|2|||
131153888|NCT02240706|472184200|FG001|Overall Study|Lack of Efficacy|2|||
131153889|NCT02240706|472184201|FG002|Overall Study|Lack of Efficacy|2|||
131153890|NCT02240706|472184202|FG003|Overall Study|Lack of Efficacy|2|||
131153891|NCT02240706|472184203|FG004|Overall Study|Lack of Efficacy|5|||
131153892|NCT02240706|472184204|FG005|Overall Study|Lack of Efficacy|0|||
131153893|NCT02240706|472184205|FG006|Overall Study|Lack of Efficacy|0|||
131153894|NCT02240706|472184199|FG000|Overall Study|Adverse Event|1|||
131153895|NCT02240706|472184200|FG001|Overall Study|Adverse Event|0|||
131153896|NCT02240706|472184201|FG002|Overall Study|Adverse Event|1|||
131153897|NCT02240706|472184202|FG003|Overall Study|Adverse Event|0|||
131153898|NCT02240706|472184203|FG004|Overall Study|Adverse Event|2|||
131153899|NCT02240706|472184204|FG005|Overall Study|Adverse Event|0|||
131153900|NCT02240706|472184205|FG006|Overall Study|Adverse Event|0|||
131153901|NCT02240706|472184199|FG000|Overall Study|Progressive disease|0|||
131153902|NCT02240706|472184200|FG001|Overall Study|Progressive disease|0|||
131153903|NCT02240706|472184201|FG002|Overall Study|Progressive disease|0|||
131153904|NCT02240706|472184202|FG003|Overall Study|Progressive disease|0|||
131153905|NCT02240706|472184203|FG004|Overall Study|Progressive disease|1|||
131153906|NCT02240706|472184204|FG005|Overall Study|Progressive disease|0|||
131153907|NCT02240706|472184205|FG006|Overall Study|Progressive disease|0|||
131153908|NCT02240706|472184199|FG000|Overall Study|Dose limiting toxicity|0|||
131153909|NCT02240706|472184200|FG001|Overall Study|Dose limiting toxicity|0|||
131153910|NCT02240706|472184201|FG002|Overall Study|Dose limiting toxicity|0|||
131153911|NCT02240706|472184202|FG003|Overall Study|Dose limiting toxicity|0|||
131153912|NCT02240706|472184203|FG004|Overall Study|Dose limiting toxicity|1|||
131153913|NCT02240706|472184204|FG005|Overall Study|Dose limiting toxicity|0|||
131153914|NCT02240706|472184205|FG006|Overall Study|Dose limiting toxicity|0|||
131153915|NCT02240706|472184199|FG000|Overall Study|Refused to continue taking medication|0|||
131153916|NCT02240706|472184200|FG001|Overall Study|Refused to continue taking medication|1|||
131153917|NCT02240706|472184201|FG002|Overall Study|Refused to continue taking medication|3|||
131153918|NCT02240706|472184202|FG003|Overall Study|Refused to continue taking medication|1|||
131153919|NCT02240706|472184203|FG004|Overall Study|Refused to continue taking medication|2|||
131153920|NCT02240706|472184204|FG005|Overall Study|Refused to continue taking medication|0|||
131153921|NCT02240706|472184205|FG006|Overall Study|Refused to continue taking medication|0|||
131153922|NCT02240706|472184199|FG000|Overall Study|Insurance billing concerns|0|||
131153923|NCT02240706|472184200|FG001|Overall Study|Insurance billing concerns|0|||
131153924|NCT02240706|472184201|FG002|Overall Study|Insurance billing concerns|0|||
131153925|NCT02240706|472184202|FG003|Overall Study|Insurance billing concerns|1|||
131153926|NCT02240706|472184203|FG004|Overall Study|Insurance billing concerns|0|||
131153927|NCT02240706|472184204|FG005|Overall Study|Insurance billing concerns|0|||
131153928|NCT02240706|472184205|FG006|Overall Study|Insurance billing concerns|0|||
131153929|NCT03934684|472184206|FG000|Overall Study|Participants continuing in study|11|||
131153930|NCT03934684|472184207|FG001|Overall Study|Participants continuing in study|4|||
131153931|NCT03934684|472184206|FG000|Overall Study|Discontinuation of carfilzomib|20|||
131153932|NCT03934684|472184207|FG001|Overall Study|Discontinuation of carfilzomib|30|||
131153933|NCT03934684|472184206|FG000|Overall Study|Death|2|||
131153934|NCT03934684|472184207|FG001|Overall Study|Death|2|||
131153935|NCT03934684|472184206|FG000|Overall Study|Lost to Follow-up|2|||
131153936|NCT03934684|472184207|FG001|Overall Study|Lost to Follow-up|5|||
131153937|NCT03934684|472184206|FG000|Overall Study|Withdrawal by Subject|7|||
131153938|NCT03934684|472184207|FG001|Overall Study|Withdrawal by Subject|8|||
131153939|NCT01731002|472184208|FG000|Overall Study|Adverse Event|0|||
131153940|NCT01731002|472184209|FG001|Overall Study|Adverse Event|2|||
131153941|NCT01731002|472184210|FG002|Overall Study|Adverse Event|2|||
131153942|NCT01731002|472184208|FG000|Overall Study|Non-Compliant|0|||
131153943|NCT01731002|472184209|FG001|Overall Study|Non-Compliant|1|||
131153944|NCT01731002|472184210|FG002|Overall Study|Non-Compliant|0|||
131153945|NCT01731002|472184208|FG000|Overall Study|Lost to Follow-up|1|||
131153946|NCT01731002|472184209|FG001|Overall Study|Lost to Follow-up|0|||
131153947|NCT01731002|472184210|FG002|Overall Study|Lost to Follow-up|0|||
131153948|NCT01731002|472184208|FG000|Overall Study|Test Agent Discontinuation|0|||
131153949|NCT01731002|472184209|FG001|Overall Study|Test Agent Discontinuation|1|||
131153950|NCT01731002|472184210|FG002|Overall Study|Test Agent Discontinuation|0|||
131153951|NCT01731002|472184208|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
131153952|NCT01731002|472184209|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
131153953|NCT01731002|472184210|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
131153954|NCT01731002|472184208|FG000|Overall Study|Elevated IOP|1|||
131153955|NCT01731002|472184209|FG001|Overall Study|Elevated IOP|0|||
131153956|NCT01731002|472184210|FG002|Overall Study|Elevated IOP|0|||
131153957|NCT01731002|472184208|FG000|Overall Study|Inappropriate use of study medications|0|||
131153958|NCT01731002|472184209|FG001|Overall Study|Inappropriate use of study medications|0|||
131153959|NCT01731002|472184210|FG002|Overall Study|Inappropriate use of study medications|1|||
131153960|NCT03476239|472184211|FG000|Overall Study|Withdrawal by Subject|10|||
131153961|NCT03476239|472184211|FG000|Overall Study|Death|80|||
131153962|NCT03476239|472184211|FG000|Overall Study|Lost to Follow-up|8|||
131153963|NCT01446809|472184215|FG000|Overall Study|Adverse Event|0|||
131153964|NCT01446809|472184216|FG001|Overall Study|Adverse Event|0|||
131153965|NCT01446809|472184217|FG002|Overall Study|Adverse Event|1|||
131153966|NCT01446809|472184215|FG000|Overall Study|Failure to complete study procedures|0|||
131153967|NCT01446809|472184216|FG001|Overall Study|Failure to complete study procedures|0|||
131153968|NCT01446809|472184217|FG002|Overall Study|Failure to complete study procedures|1|||
131153969|NCT00785577|472184218|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
131153970|NCT00785577|472184219|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
131153971|NCT00785577|472184220|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
131153972|NCT00785577|472184221|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
131153973|NCT00785577|472184222|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
131153974|NCT00785577|472184218|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
131153975|NCT00785577|472184219|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
131153976|NCT00785577|472184220|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
131153977|NCT00785577|472184221|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
131153978|NCT00785577|472184222|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
131153979|NCT00785577|472184218|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
131153980|NCT00785577|472184219|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
131153981|NCT00785577|472184220|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
131153982|NCT00785577|472184221|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
131153983|NCT00785577|472184222|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
131153984|NCT00785577|472184218|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
131153985|NCT00785577|472184219|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
131153986|NCT00785577|472184220|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
131153987|NCT00785577|472184221|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
131153988|NCT00785577|472184222|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
131153989|NCT00785577|472184218|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
131153990|NCT00785577|472184219|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
131153991|NCT00785577|472184220|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
131153992|NCT00785577|472184221|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
131153993|NCT00785577|472184222|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
131153994|NCT00785577|472184218|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
131153995|NCT00785577|472184219|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
131153996|NCT00785577|472184220|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
131153997|NCT00785577|472184221|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
131153998|NCT00785577|472184222|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
131153999|NCT00785577|472184218|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
131154000|NCT00785577|472184219|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
131154001|NCT00785577|472184220|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
131154002|NCT00785577|472184221|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
131154003|NCT00785577|472184222|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
131154004|NCT00785577|472184218|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
131154005|NCT00785577|472184219|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
131154006|NCT00785577|472184220|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
131154007|NCT00785577|472184221|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
131154008|NCT00785577|472184222|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
131154009|NCT00785577|472184218|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
131154010|NCT00785577|472184219|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
130780325|NCT00808067|470821502|FG001|Overall Study|Reduced creatinine clearance|55|||
130780326|NCT00808067|470821501|FG000|Overall Study|Elevated LFT results|7|||
130780327|NCT00808067|470821502|FG001|Overall Study|Elevated LFT results|3|||
130780328|NCT00808067|470821501|FG000|Overall Study|Patient refused to take study medication|65|||
130780329|NCT00808067|470821502|FG001|Overall Study|Patient refused to take study medication|76|||
130780330|NCT00808067|470821501|FG000|Overall Study|Missing|1|||
130780331|NCT00808067|470821502|FG001|Overall Study|Missing|0|||
130780332|NCT00808067|470821501|FG000|Overall Study|Death|1|||
130780333|NCT00808067|470821502|FG001|Overall Study|Death|1|||
130780334|NCT00808067|470821501|FG000|Overall Study|Procedure|6|||
130780335|NCT00808067|470821502|FG001|Overall Study|Procedure|7|||
130780336|NCT00808067|470821501|FG000|Overall Study|Withdrawal by Subject|21|||
130780337|NCT00808067|470821502|FG001|Overall Study|Withdrawal by Subject|25|||
130780338|NCT00808067|470821501|FG000|Overall Study|Site closed|4|||
130780339|NCT00808067|470821502|FG001|Overall Study|Site closed|3|||
130780340|NCT00808067|470821501|FG000|Overall Study|Physician Decision|47|||
130780341|NCT00808067|470821502|FG001|Overall Study|Physician Decision|38|||
130780342|NCT00808067|470821501|FG000|Overall Study|Protocol Violation|3|||
130780343|NCT00808067|470821502|FG001|Overall Study|Protocol Violation|11|||
130780344|NCT00808067|470821501|FG000|Overall Study|Patient elected|7|||
130780345|NCT00808067|470821502|FG001|Overall Study|Patient elected|9|||
130780346|NCT00808067|470821501|FG000|Overall Study|Site closed for cause|19|||
130780347|NCT00808067|470821502|FG001|Overall Study|Site closed for cause|19|||
130780348|NCT00808067|470821501|FG000|Overall Study|Other reason not defined above|5|||
130780349|NCT00808067|470821502|FG001|Overall Study|Other reason not defined above|5|||
130780350|NCT00808067|470821501|FG000|Overall Study|Excluded from analysis|13|||
130780351|NCT00808067|470821502|FG001|Overall Study|Excluded from analysis|19|||
130780352|NCT02532283|470821505|FG000|Overall Study|Adverse Event|0|||
130780353|NCT02532283|470821506|FG001|Overall Study|Adverse Event|1|||
130780354|NCT02532283|470821505|FG000|Overall Study|Death|1|||
130780355|NCT02532283|470821506|FG001|Overall Study|Death|0|||
130780356|NCT02532283|470821505|FG000|Overall Study|Lost to Follow-up|0|||
131154011|NCT00785577|472184220|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
131154012|NCT00785577|472184221|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
131154013|NCT00785577|472184222|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
131154014|NCT00785577|472184218|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
131235134|NCT04799158|472488831|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
131154015|NCT00785577|472184219|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
130780357|NCT02532283|470821506|FG001|Overall Study|Lost to Follow-up|1|||
130780358|NCT02532283|470821505|FG000|Overall Study|Withdrawal by Subject|8|||
130780359|NCT02532283|470821506|FG001|Overall Study|Withdrawal by Subject|3|||
130780360|NCT00490971|470821507|FG000|Acute/Continuation|Adverse Event|62|||
131154016|NCT00785577|472184220|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
131154017|NCT00785577|472184221|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
131154018|NCT00785577|472184222|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
131154019|NCT01682044|472184223|FG000|Overall Study|Death|1|||
131154020|NCT01682044|472184223|FG000|Overall Study|Progression|3|||
131154021|NCT03972488|472184224|FG000|Overall Study|Progressive disease|42|||
131154022|NCT03972488|472184225|FG001|Overall Study|Progressive disease|44|||
131154023|NCT03972488|472184224|FG000|Overall Study|Physician Decision|13|||
131154024|NCT03972488|472184225|FG001|Overall Study|Physician Decision|7|||
131154025|NCT03972488|472184224|FG000|Overall Study|Adverse Event|8|||
131154026|NCT03972488|472184225|FG001|Overall Study|Adverse Event|1|||
131154027|NCT03972488|472184224|FG000|Overall Study|Death|4|||
131154028|NCT03972488|472184225|FG001|Overall Study|Death|4|||
131154029|NCT03972488|472184224|FG000|Overall Study|Withdrawal by Subject|3|||
131154030|NCT03972488|472184225|FG001|Overall Study|Withdrawal by Subject|4|||
131154031|NCT03972488|472184224|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
131154032|NCT03972488|472184225|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
131154033|NCT01826214|472185630|FG000|Overall Study|Adverse Event|7|||
131154034|NCT01826214|472185631|FG001|Overall Study|Adverse Event|6|||
131154035|NCT01826214|472185630|FG000|Overall Study|Death|3|||
131154036|NCT01826214|472185631|FG001|Overall Study|Death|1|||
131154037|NCT01826214|472185630|FG000|Overall Study|Lost to Follow-up|1|||
131154038|NCT01826214|472185631|FG001|Overall Study|Lost to Follow-up|0|||
131154039|NCT01826214|472185630|FG000|Overall Study|Physician Decision|0|||
130728257|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
130728258|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
130728259|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
130728260|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
130728261|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
131154040|NCT01826214|472185631|FG001|Overall Study|Physician Decision|2|||
131154041|NCT01826214|472185630|FG000|Overall Study|Progressive disease|22|||
131154042|NCT01826214|472185631|FG001|Overall Study|Progressive disease|21|||
131154043|NCT01826214|472185630|FG000|Overall Study|Study terminated by Sponsor|0|||
131154044|NCT01826214|472185631|FG001|Overall Study|Study terminated by Sponsor|1|||
131154045|NCT01826214|472185630|FG000|Overall Study|Subject/guardian decision|2|||
131154046|NCT01826214|472185631|FG001|Overall Study|Subject/guardian decision|3|||
131154047|NCT01614457|472185639|FG000|Overall Study|Non-Compliance|1|||
131154048|NCT01614457|472185640|FG001|Overall Study|Non-Compliance|0|||
131154049|NCT01614457|472185639|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
131154050|NCT01614457|472185640|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
131154051|NCT01756157|472185648|FG000|First Intervention Period|Withdrawal by Subject|1|||
131154052|NCT01756157|472185649|FG001|First Intervention Period|Withdrawal by Subject|0|||
131154053|NCT01756157|472185648|FG000|First Intervention Period|Lost to Follow-up|0|||
131154054|NCT01756157|472185649|FG001|First Intervention Period|Lost to Follow-up|2|||
131154055|NCT02799381|472185652|FG000|Overall Study|Withdrew consent|3|||
131154056|NCT02799381|472185653|FG001|Overall Study|Withdrew consent|2|||
131154057|NCT02799381|472185652|FG000|Overall Study|Adverse Event|0|||
131154058|NCT02799381|472185653|FG001|Overall Study|Adverse Event|1|||
131154059|NCT02799381|472185652|FG000|Overall Study|Participant did not take any study drug|1|||
131154060|NCT02799381|472185653|FG001|Overall Study|Participant did not take any study drug|0|||
131154061|NCT03368859|472185654|FG000|Overall Study|Withdrew Consent|5|||
131154062|NCT03368859|472185655|FG001|Overall Study|Withdrew Consent|4|||
131154063|NCT03368859|472185654|FG000|Overall Study|Death|12|||
131154064|NCT03368859|472185655|FG001|Overall Study|Death|6|||
131154065|NCT03368859|472185654|FG000|Overall Study|Study terminated by Sponsor|18|||
131154066|NCT03368859|472185655|FG001|Overall Study|Study terminated by Sponsor|23|||
131154067|NCT03368859|472185654|FG000|Overall Study|Other|1|||
131154068|NCT03368859|472185655|FG001|Overall Study|Other|1|||
131154069|NCT03952130|472185656|FG000|Overall Study|Adverse Event|0|||
131154070|NCT03952130|472185657|FG001|Overall Study|Adverse Event|1|||
131154071|NCT03952130|472185656|FG000|Overall Study|Lost to Follow-up|1|||
131154072|NCT03952130|472185657|FG001|Overall Study|Lost to Follow-up|0|||
131154073|NCT03952130|472185656|FG000|Overall Study|Withdrawal by Subject|1|||
131154074|NCT03952130|472185657|FG001|Overall Study|Withdrawal by Subject|5|||
131154075|NCT01713348|472185658|FG000|Overall Study|Withdrawal by Subject|3|||
131154076|NCT01713348|472185659|FG001|Overall Study|Withdrawal by Subject|2|||
131154077|NCT01713348|472185660|FG002|Overall Study|Withdrawal by Subject|2|||
131154078|NCT01713348|472185661|FG003|Overall Study|Withdrawal by Subject|0|||
131154079|NCT01713348|472185658|FG000|Overall Study|Lost to Follow-up|1|||
131154080|NCT01713348|472185659|FG001|Overall Study|Lost to Follow-up|0|||
131154081|NCT01713348|472185660|FG002|Overall Study|Lost to Follow-up|0|||
131154082|NCT01713348|472185661|FG003|Overall Study|Lost to Follow-up|0|||
131154083|NCT05882890|472185664|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
131154084|NCT00613314|472185665|FG000|Overall Study|Adverse Event|5|||
131154085|NCT00613314|472185665|FG000|Overall Study|Protocol Violation|14|||
131154086|NCT00613314|472185665|FG000|Overall Study|Lost to Follow-up|46|||
131154087|NCT00613314|472185665|FG000|Overall Study|Other reason not defined above|90|||
131154088|NCT01584024|472185666|FG000|Overall Study|Lost to Follow-up|10|||
131154089|NCT01584024|472185666|FG000|Overall Study|Withdrawal by Subject|3|||
131154090|NCT01845025|472185667|FG000|Overall Study|Adverse Event|6|||
131154091|NCT01845025|472185668|FG001|Overall Study|Adverse Event|3|||
131154092|NCT01845025|472185667|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131154093|NCT01845025|472185668|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131154094|NCT01845025|472185667|FG000|Overall Study|Withdrawal by Subject|48|||
130728262|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
131154095|NCT01845025|472185668|FG001|Overall Study|Withdrawal by Subject|44|||
131154096|NCT01845025|472185667|FG000|Overall Study|Lost to Follow-up|13|||
131154097|NCT01845025|472185668|FG001|Overall Study|Lost to Follow-up|13|||
131154098|NCT01845025|472185667|FG000|Overall Study|Administrative problems|8|||
131154099|NCT01845025|472185668|FG001|Overall Study|Administrative problems|8|||
131154100|NCT01845025|472185667|FG000|Overall Study|Death|2|||
131154101|NCT01845025|472185668|FG001|Overall Study|Death|0|||
131154102|NCT01845025|472185667|FG000|Overall Study|Protocol deviation|3|||
131154103|NCT01845025|472185668|FG001|Overall Study|Protocol deviation|6|||
131154104|NCT01845025|472185667|FG000|Overall Study|Missing|1|||
131154105|NCT01845025|472185668|FG001|Overall Study|Missing|1|||
131154106|NCT01929083|472185669|FG000|Intervention 1|Lost to Follow-up|2|||
131154107|NCT01929083|472185670|FG001|Intervention 1|Lost to Follow-up|0|||
131154108|NCT01929083|472185669|FG000|Intervention 1|Nonadherent to study medications|1|||
131154109|NCT01929083|472185670|FG001|Intervention 1|Nonadherent to study medications|0|||
131154110|NCT01929083|472185669|FG000|Intervention 2|Adverse Event|0|||
131154111|NCT01929083|472185670|FG001|Intervention 2|Adverse Event|1|||
131154112|NCT00087438|472185680|FG000|Overall Study|Ineligible / No protocol treatment|4|||
131154113|NCT00466505|472185681|FG000|Overall Study|disease progression|13|||
131154114|NCT00466505|472185681|FG000|Overall Study|Adverse Event|4|||
131154115|NCT00811252|472185682|FG000|Overall Study|Adverse Event|6|||
131154116|NCT00811252|472185683|FG001|Overall Study|Adverse Event|10|||
131154117|NCT00811252|472185684|FG002|Overall Study|Adverse Event|15|||
131154118|NCT00811252|472185682|FG000|Overall Study|Lack of Efficacy|7|||
131154119|NCT00811252|472185683|FG001|Overall Study|Lack of Efficacy|2|||
131154120|NCT00811252|472185684|FG002|Overall Study|Lack of Efficacy|0|||
131154121|NCT00811252|472185682|FG000|Overall Study|Protocol Violation|3|||
131154122|NCT00811252|472185683|FG001|Overall Study|Protocol Violation|3|||
131154123|NCT00811252|472185684|FG002|Overall Study|Protocol Violation|2|||
131154124|NCT00811252|472185682|FG000|Overall Study|Withdrawal of Consent|1|||
131154125|NCT00811252|472185683|FG001|Overall Study|Withdrawal of Consent|2|||
131154126|NCT00811252|472185684|FG002|Overall Study|Withdrawal of Consent|2|||
131154127|NCT00811252|472185682|FG000|Overall Study|Lost to Follow-up|0|||
131154128|NCT00811252|472185683|FG001|Overall Study|Lost to Follow-up|0|||
131154129|NCT00811252|472185684|FG002|Overall Study|Lost to Follow-up|2|||
131154130|NCT00811252|472185682|FG000|Overall Study|Administrative or Other Reasons|0|||
131154131|NCT00811252|472185683|FG001|Overall Study|Administrative or Other Reasons|3|||
131154132|NCT00811252|472185684|FG002|Overall Study|Administrative or Other Reasons|2|||
131154133|NCT00813748|472185685|FG000|Skin Test Substudy|Physician Decision|0|||
131154134|NCT00813748|472185686|FG001|Skin Test Substudy|Physician Decision|1|||
131154135|NCT00283387|472185687|FG000|First Intervention|Subject non-compliant|1|||
131154136|NCT00283387|472185688|FG001|First Intervention|Subject non-compliant|1|||
131154137|NCT00283387|472185687|FG000|First Intervention|Withdrawal by Subject|0|||
131154138|NCT00283387|472185688|FG001|First Intervention|Withdrawal by Subject|1|||
131154139|NCT01931865|472185689|FG000|Overall Study|Lost to Follow-up|2|||
131154140|NCT01931865|472185689|FG000|Overall Study|Withdrawal by Subject|2|||
131154141|NCT00728416|472185693|FG000|Overall Study|Adverse Event|1|||
130728263|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
130728264|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
130728265|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
130728266|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
130728267|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
130728268|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
130728269|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
131154142|NCT00728416|472185694|FG001|Overall Study|Adverse Event|1|||
131154143|NCT00728416|472185693|FG000|Overall Study|Treatment Failure|0|||
131154144|NCT00728416|472185694|FG001|Overall Study|Treatment Failure|1|||
131154145|NCT00728416|472185693|FG000|Overall Study|Withdrawal by Subject|1|||
131154146|NCT00728416|472185694|FG001|Overall Study|Withdrawal by Subject|0|||
131154147|NCT00356915|472185697|FG000|Overall Study|Non compliance|1|||
131154148|NCT00356915|472185698|FG001|Overall Study|Non compliance|2|||
131154149|NCT00356915|472185699|FG002|Overall Study|Non compliance|1|||
131154150|NCT00356915|472185697|FG000|Overall Study|Protocol Violation|2|||
131154151|NCT00356915|472185698|FG001|Overall Study|Protocol Violation|3|||
131154152|NCT00356915|472185699|FG002|Overall Study|Protocol Violation|2|||
131154153|NCT00356915|472185697|FG000|Overall Study|Withdrawal by Subject|14|||
130728270|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
130728271|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
130728272|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
130728273|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
130728274|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
130728275|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
130728276|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
130728277|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
130728278|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
130728279|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130728280|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130728281|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
130728282|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
130728283|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130728284|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130728285|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130728286|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130728287|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Death|0|||
131154154|NCT00356915|472185698|FG001|Overall Study|Withdrawal by Subject|14|||
131154155|NCT00356915|472185699|FG002|Overall Study|Withdrawal by Subject|10|||
131154156|NCT00356915|472185697|FG000|Overall Study|Lack of Efficacy|0|||
131154157|NCT00356915|472185698|FG001|Overall Study|Lack of Efficacy|0|||
131154158|NCT00356915|472185699|FG002|Overall Study|Lack of Efficacy|3|||
131154159|NCT00356915|472185697|FG000|Overall Study|Lost to Follow-up|27|||
131154160|NCT00356915|472185698|FG001|Overall Study|Lost to Follow-up|34|||
131154161|NCT00356915|472185699|FG002|Overall Study|Lost to Follow-up|14|||
131154162|NCT00356915|472185697|FG000|Overall Study|Administrative Decision|0|||
131154163|NCT00356915|472185698|FG001|Overall Study|Administrative Decision|0|||
131154164|NCT00356915|472185699|FG002|Overall Study|Administrative Decision|1|||
131154165|NCT00356915|472185697|FG000|Overall Study|Physician Decision|0|||
131154166|NCT00356915|472185698|FG001|Overall Study|Physician Decision|2|||
131154167|NCT00356915|472185699|FG002|Overall Study|Physician Decision|0|||
131154168|NCT00356915|472185697|FG000|Overall Study|Adverse Event|21|||
131154169|NCT00356915|472185698|FG001|Overall Study|Adverse Event|31|||
131154170|NCT00356915|472185699|FG002|Overall Study|Adverse Event|8|||
131154171|NCT00356915|472185697|FG000|Overall Study|Miscellaneous reasons|11|||
131154172|NCT00356915|472185698|FG001|Overall Study|Miscellaneous reasons|8|||
131154173|NCT00356915|472185699|FG002|Overall Study|Miscellaneous reasons|3|||
131154174|NCT00509106|472185700|FG000|Overall Study|Adverse Event|3|||
131154175|NCT00509106|472185701|FG001|Overall Study|Adverse Event|2|||
131154176|NCT00509106|472185700|FG000|Overall Study|Noncompliance|0|||
131154177|NCT00509106|472185701|FG001|Overall Study|Noncompliance|1|||
131154178|NCT00509106|472185700|FG000|Overall Study|At the request of sponsor/investigator|1|||
131154179|NCT00509106|472185701|FG001|Overall Study|At the request of sponsor/investigator|2|||
131154180|NCT00509106|472185700|FG000|Overall Study|Withdrew consent|4|||
131154181|NCT00509106|472185701|FG001|Overall Study|Withdrew consent|8|||
131154182|NCT00509106|472185700|FG000|Overall Study|Lost to Follow-up|16|||
131154183|NCT00509106|472185701|FG001|Overall Study|Lost to Follow-up|10|||
131154184|NCT00509106|472185700|FG000|Overall Study|Other|1|||
131154185|NCT00509106|472185701|FG001|Overall Study|Other|0|||
131154186|NCT00509106|472185700|FG000|Overall Study|Death|6|||
131154187|NCT00509106|472185701|FG001|Overall Study|Death|6|||
130728288|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Death|1|||
130728289|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Death|0|||
130728290|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Death|0|||
130728291|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Death|0|||
130728292|NCT03713632|470627415|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130728293|NCT03713632|470627416|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
130728294|NCT03713632|470627417|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130728295|NCT03713632|470627418|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130728296|NCT03713632|470627419|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130728297|NCT01098474|470627420|FG000|Active Phase|Other|0|||
130728298|NCT01098474|470627421|FG001|Active Phase|Other|0|||
130728299|NCT01098474|470627422|FG002|Active Phase|Other|3|||
130728300|NCT01098474|470627423|FG003|Active Phase|Other|0|||
131154188|NCT00927485|472185702|FG000|Overall Study|Adverse Event|4|||
131154189|NCT00927485|472185703|FG001|Overall Study|Adverse Event|2|||
131154190|NCT00927485|472185702|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
131154191|NCT00927485|472185703|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
130728301|NCT01098474|470627424|FG004|Active Phase|Other|0|||
130728302|NCT01098474|470627425|FG005|Active Phase|Other|0|||
131154192|NCT01985321|472185704|FG000|Overall Study|Protocol Violation|4|||
131154193|NCT01985321|472185705|FG001|Overall Study|Protocol Violation|3|||
131154194|NCT01985321|472185704|FG000|Overall Study|Withdrawal by Subject|1|||
131154195|NCT01985321|472185705|FG001|Overall Study|Withdrawal by Subject|0|||
130728303|NCT01098474|470627420|FG000|Active Phase|Withdrawal by Subject|1|||
130728304|NCT01098474|470627421|FG001|Active Phase|Withdrawal by Subject|1|||
130728305|NCT01098474|470627422|FG002|Active Phase|Withdrawal by Subject|2|||
131154196|NCT01985321|472185704|FG000|Overall Study|Lost to Follow-up|5|||
131154197|NCT01985321|472185705|FG001|Overall Study|Lost to Follow-up|2|||
131154198|NCT01985321|472185704|FG000|Overall Study|Subject treated wrong type of sore|1|||
131154199|NCT01985321|472185705|FG001|Overall Study|Subject treated wrong type of sore|0|||
131154200|NCT02201940|472185707|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
131154201|NCT02201940|472185708|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
131154202|NCT02201940|472185707|FG000|Overall Study|Lack of Efficacy|2|||
131154203|NCT02201940|472185708|FG001|Overall Study|Lack of Efficacy|113|||
130728306|NCT01098474|470627423|FG003|Active Phase|Withdrawal by Subject|0|||
130728307|NCT01098474|470627424|FG004|Active Phase|Withdrawal by Subject|0|||
130728308|NCT01098474|470627425|FG005|Active Phase|Withdrawal by Subject|0|||
130728309|NCT01098474|470627420|FG000|Active Phase|Lost to Follow-up|1|||
130728310|NCT01098474|470627421|FG001|Active Phase|Lost to Follow-up|0|||
130728311|NCT01098474|470627422|FG002|Active Phase|Lost to Follow-up|0|||
130728312|NCT01098474|470627423|FG003|Active Phase|Lost to Follow-up|0|||
130728313|NCT01098474|470627424|FG004|Active Phase|Lost to Follow-up|0|||
130728314|NCT01098474|470627425|FG005|Active Phase|Lost to Follow-up|0|||
131154204|NCT02201940|472185707|FG000|Overall Study|Lost to Follow-up|5|||
131154205|NCT02201940|472185708|FG001|Overall Study|Lost to Follow-up|0|||
131154206|NCT02201940|472185707|FG000|Overall Study|Withdrew Consent|2|||
131154207|NCT02201940|472185708|FG001|Overall Study|Withdrew Consent|1|||
131154208|NCT02201940|472185707|FG000|Overall Study|Investigator's Discretion|1|||
131154209|NCT02201940|472185708|FG001|Overall Study|Investigator's Discretion|1|||
131154210|NCT02201940|472185707|FG000|Overall Study|Death|1|||
131154211|NCT02201940|472185708|FG001|Overall Study|Death|0|||
131154212|NCT02201940|472185707|FG000|Overall Study|Adverse Event|0|||
131154213|NCT02201940|472185708|FG001|Overall Study|Adverse Event|1|||
131154214|NCT03953118|472185709|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
131154215|NCT03953118|472185710|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
131154216|NCT02604264|472185712|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
131154217|NCT02604264|472185713|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
131154218|NCT00424398|472185714|FG000|Overall Study|Withdrawal by Subject|2|||
131154219|NCT00424398|472185715|FG001|Overall Study|Withdrawal by Subject|1|||
131154220|NCT00424398|472185716|FG002|Overall Study|Withdrawal by Subject|0|||
131154221|NCT00424398|472185714|FG000|Overall Study|Subject met exclusion criteria|1|||
131154222|NCT00424398|472185715|FG001|Overall Study|Subject met exclusion criteria|0|||
131154223|NCT00424398|472185716|FG002|Overall Study|Subject met exclusion criteria|0|||
131154224|NCT01023789|472185717|FG000|3 - Year Visit|Death|29|||
131154225|NCT01023789|472185717|FG000|3 - Year Visit|Withdrawal of consent|1|||
131154226|NCT01023789|472185717|FG000|3 - Year Visit|Lost to Follow-up|13|||
131154227|NCT02034123|472185722|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154228|NCT02034123|472185723|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154229|NCT02034123|472185724|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154230|NCT02034123|472185725|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154231|NCT02034123|472185726|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
131154232|NCT02034123|472185727|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154233|NCT02034123|472185728|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154234|NCT02034123|472185729|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
131154235|NCT02034123|472185730|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
131154236|NCT02034123|472185731|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154237|NCT02034123|472185732|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154238|NCT02034123|472185733|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154239|NCT02034123|472185734|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154240|NCT02034123|472185735|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154241|NCT02034123|472185736|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154242|NCT02034123|472185737|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154243|NCT02034123|472185738|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130728315|NCT01098474|470627420|FG000|Follow Up Phase|Travelled out of study area|0|||
130728316|NCT01098474|470627421|FG001|Follow Up Phase|Travelled out of study area|0|||
130728317|NCT01098474|470627422|FG002|Follow Up Phase|Travelled out of study area|0|||
130728318|NCT01098474|470627423|FG003|Follow Up Phase|Travelled out of study area|0|||
130728319|NCT01098474|470627424|FG004|Follow Up Phase|Travelled out of study area|1|||
130728320|NCT01098474|470627425|FG005|Follow Up Phase|Travelled out of study area|0|||
130780361|NCT00490971|470821508|FG001|Acute/Continuation|Adverse Event|13|||
131154244|NCT02034123|472185739|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
131154245|NCT02034123|472185722|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154246|NCT02034123|472185723|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130728321|NCT01098474|470627420|FG000|Follow Up Phase|Other|0|||
131154247|NCT02034123|472185724|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154248|NCT02034123|472185725|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
131154249|NCT02034123|472185726|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154250|NCT02034123|472185727|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154251|NCT02034123|472185728|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154252|NCT02034123|472185729|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154253|NCT02034123|472185730|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154254|NCT02034123|472185731|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154255|NCT02034123|472185732|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154256|NCT02034123|472185733|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154257|NCT02034123|472185734|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154258|NCT02034123|472185735|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154259|NCT02034123|472185736|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154260|NCT02034123|472185737|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154261|NCT02034123|472185738|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154262|NCT02034123|472185739|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
131154263|NCT02034123|472185722|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154264|NCT02034123|472185723|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154265|NCT02034123|472185724|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154266|NCT02034123|472185725|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154267|NCT02034123|472185726|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154268|NCT02034123|472185727|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154269|NCT02034123|472185728|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154270|NCT02034123|472185729|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154271|NCT02034123|472185730|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
131154272|NCT02034123|472185731|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154273|NCT02034123|472185732|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154274|NCT02034123|472185733|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154275|NCT02034123|472185734|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154276|NCT02034123|472185735|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154277|NCT02034123|472185736|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154278|NCT02034123|472185737|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154279|NCT02034123|472185738|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154280|NCT02034123|472185739|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
131154281|NCT02034123|472185722|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154282|NCT02034123|472185723|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154283|NCT02034123|472185724|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154284|NCT02034123|472185725|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
131154285|NCT02034123|472185726|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
131154286|NCT02034123|472185727|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154287|NCT02034123|472185728|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154288|NCT02034123|472185729|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154289|NCT02034123|472185730|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154290|NCT02034123|472185731|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154291|NCT02034123|472185732|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154292|NCT02034123|472185733|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154293|NCT02034123|472185734|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154294|NCT02034123|472185735|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154295|NCT02034123|472185736|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154296|NCT02034123|472185737|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154297|NCT02034123|472185738|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154298|NCT02034123|472185739|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
131154299|NCT00246259|472185740|FG000|Overall Study|Other|3|||
131154300|NCT00246259|472185741|FG001|Overall Study|Other|3|||
131154301|NCT00246259|472185740|FG000|Overall Study|Not stable by Week 18|2|||
131154302|NCT00246259|472185741|FG001|Overall Study|Not stable by Week 18|1|||
131154303|NCT00246259|472185740|FG000|Overall Study|Participant non-compliant|4|||
131154304|NCT00246259|472185741|FG001|Overall Study|Participant non-compliant|9|||
131154305|NCT00246259|472185740|FG000|Overall Study|Lack of Efficacy|2|||
131154306|NCT00246259|472185741|FG001|Overall Study|Lack of Efficacy|2|||
131154307|NCT00246259|472185740|FG000|Overall Study|Investigator withdrew participant|2|||
131154308|NCT00246259|472185741|FG001|Overall Study|Investigator withdrew participant|0|||
131235135|NCT04799158|472488827|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
131235136|NCT04799158|472488828|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
130728322|NCT01098474|470627421|FG001|Follow Up Phase|Other|0|||
130728323|NCT01098474|470627422|FG002|Follow Up Phase|Other|0|||
130728324|NCT01098474|470627423|FG003|Follow Up Phase|Other|0|||
130728325|NCT01098474|470627424|FG004|Follow Up Phase|Other|0|||
130728326|NCT01098474|470627425|FG005|Follow Up Phase|Other|4|||
130728327|NCT01098474|470627420|FG000|Follow Up Phase|Withdrawal by Subject|0|||
130728328|NCT01098474|470627421|FG001|Follow Up Phase|Withdrawal by Subject|0|||
130728329|NCT01098474|470627422|FG002|Follow Up Phase|Withdrawal by Subject|0|||
130728330|NCT01098474|470627423|FG003|Follow Up Phase|Withdrawal by Subject|2|||
130728331|NCT01098474|470627424|FG004|Follow Up Phase|Withdrawal by Subject|0|||
130728332|NCT01098474|470627425|FG005|Follow Up Phase|Withdrawal by Subject|1|||
130728333|NCT01098474|470627420|FG000|Follow Up Phase|Lost to Follow-up|0|||
130728334|NCT01098474|470627421|FG001|Follow Up Phase|Lost to Follow-up|0|||
130728335|NCT01098474|470627422|FG002|Follow Up Phase|Lost to Follow-up|0|||
130728336|NCT01098474|470627423|FG003|Follow Up Phase|Lost to Follow-up|0|||
130728337|NCT01098474|470627424|FG004|Follow Up Phase|Lost to Follow-up|1|||
130728338|NCT01098474|470627425|FG005|Follow Up Phase|Lost to Follow-up|0|||
130728339|NCT02165735|470627428|FG000|Overall Study|Lost to Follow-up|12|||
131154309|NCT00246259|472185740|FG000|Overall Study|Adverse Event|5|||
131154310|NCT00246259|472185741|FG001|Overall Study|Adverse Event|0|||
131154311|NCT00246259|472185740|FG000|Overall Study|Lost to Follow-up|3|||
131154312|NCT00246259|472185741|FG001|Overall Study|Lost to Follow-up|4|||
131154313|NCT00246259|472185740|FG000|Overall Study|Withdrawal by Subject|5|||
131154314|NCT00246259|472185741|FG001|Overall Study|Withdrawal by Subject|1|||
131154315|NCT00246259|472185740|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
131154316|NCT00246259|472185741|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
131154317|NCT00613626|472185743|FG000|Overall Study|Ineligible|0|||
131154318|NCT00613626|472185744|FG001|Overall Study|Ineligible|1|||
131154319|NCT00613626|472185745|FG002|Overall Study|Ineligible|0|||
131154320|NCT02333227|472185746|FG000|Overall Study|Lost to Follow-up|137|||
131154321|NCT02333227|472185747|FG001|Overall Study|Lost to Follow-up|106|||
131154322|NCT02333227|472185746|FG000|Overall Study|Pregnancy Interrupted|42|||
131154323|NCT02333227|472185747|FG001|Overall Study|Pregnancy Interrupted|89|||
131154324|NCT02333227|472185746|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
131154325|NCT02333227|472185747|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
131154326|NCT01299025|472185748|FG000|Overall Study|Withdrawal by Subject|2|||
131154327|NCT01299025|472185749|FG001|Overall Study|Withdrawal by Subject|1|||
131154328|NCT01299025|472185748|FG000|Overall Study|Lost to Follow-up|1|||
131154329|NCT01299025|472185749|FG001|Overall Study|Lost to Follow-up|0|||
131154330|NCT01624194|472185750|FG000|Overall Study|Lost to Follow-up|1|||
131154331|NCT01624194|472185751|FG001|Overall Study|Lost to Follow-up|0|||
131154332|NCT01624194|472185750|FG000|Overall Study|Withdrawal by Subject|1|||
131154333|NCT01624194|472185751|FG001|Overall Study|Withdrawal by Subject|0|||
131154334|NCT01076179|472185752|FG000|Overall Study|Withdrawal by Subject|1|||
131154335|NCT05480514|472185753|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
131154336|NCT05480514|472185754|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
131154337|NCT05480514|472185753|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
131154338|NCT05480514|472185754|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
131154339|NCT05480514|472185753|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
131154340|NCT05480514|472185754|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
131154341|NCT05480514|472185753|FG000|Period 1|Covid-19 Related|1|||
131154342|NCT05480514|472185754|FG001|Period 1|Covid-19 Related|0|||
131154343|NCT05480514|472185753|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
131154344|NCT05480514|472185754|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
131154345|NCT04091217|472185755|FG000|Overall Study|Lost to Follow-up|2|||
131154346|NCT05662332|472185756|FG000|Overall Study|Death|3|||
131154347|NCT05662332|472185757|FG001|Overall Study|Death|3|||
131154348|NCT05662332|472185756|FG000|Overall Study|Lost to Follow-up|3|||
131154349|NCT05662332|472185757|FG001|Overall Study|Lost to Follow-up|8|||
130728340|NCT02165735|470627429|FG001|Overall Study|Lost to Follow-up|10|||
130728341|NCT02165735|470627428|FG000|Overall Study|Withdrawal by Subject|3|||
130728342|NCT02165735|470627429|FG001|Overall Study|Withdrawal by Subject|0|||
130728343|NCT02165735|470627428|FG000|Overall Study|Participant indicated lack of time|1|||
130728344|NCT02165735|470627429|FG001|Overall Study|Participant indicated lack of time|3|||
130728345|NCT02165735|470627428|FG000|Overall Study|Protocol Violation|0|||
130728346|NCT02165735|470627429|FG001|Overall Study|Protocol Violation|1|||
130728347|NCT00101283|470627432|FG000|Overall Study|Withdrawal by Subject|0|||
130728348|NCT00101283|470627433|FG001|Overall Study|Withdrawal by Subject|1|||
130728349|NCT00101283|470627432|FG000|Overall Study|Insurance Refusal|0|||
130728350|NCT00101283|470627433|FG001|Overall Study|Insurance Refusal|1|||
131154350|NCT05662332|472185756|FG000|Overall Study|Physician Decision|1|||
131235137|NCT04799158|472488829|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
131154351|NCT05662332|472185757|FG001|Overall Study|Physician Decision|2|||
131154352|NCT05662332|472185756|FG000|Overall Study|Protocol Deviation|2|||
131154353|NCT05662332|472185757|FG001|Overall Study|Protocol Deviation|1|||
131154354|NCT05662332|472185756|FG000|Overall Study|Withdrawal by Subject|14|||
131154355|NCT05662332|472185757|FG001|Overall Study|Withdrawal by Subject|14|||
131154356|NCT05662332|472185756|FG000|Overall Study|Assigned Treatment by Mistake|5|||
131154357|NCT05662332|472185757|FG001|Overall Study|Assigned Treatment by Mistake|7|||
131154358|NCT05662332|472185756|FG000|Overall Study|Non-compliance with study drug|4|||
131154359|NCT05662332|472185757|FG001|Overall Study|Non-compliance with study drug|1|||
131154360|NCT05662332|472185756|FG000|Overall Study|Due to Bariatric surgery|1|||
131154361|NCT05662332|472185757|FG001|Overall Study|Due to Bariatric surgery|0|||
131154362|NCT05662332|472185756|FG000|Overall Study|Subject Moving out of State|0|||
131154363|NCT05662332|472185757|FG001|Overall Study|Subject Moving out of State|1|||
131154364|NCT05662332|472185756|FG000|Overall Study|Subject Missed the Schedule|1|||
131154365|NCT05662332|472185757|FG001|Overall Study|Subject Missed the Schedule|0|||
131154366|NCT05662332|472185756|FG000|Overall Study|The Patient Moved to Another City|1|||
131154367|NCT05662332|472185757|FG001|Overall Study|The Patient Moved to Another City|0|||
131154368|NCT04885257|472185758|FG000|Overall Study|Withdrawal by Subject|1|||
131154369|NCT04885257|472185759|FG001|Overall Study|Withdrawal by Subject|0|||
131154370|NCT00256295|472185760|FG000|Overall Study|Withdrawal by Subject|3|||
131154371|NCT00256295|472185760|FG000|Overall Study|Death|1|||
131154372|NCT01659151|472185772|FG000|Overall Study|Inadequate TIL growth|1|||
131154373|NCT01901328|472185773|FG000|Overall Study|Lost to Follow-up|1|||
131154374|NCT01901328|472185774|FG001|Overall Study|Lost to Follow-up|0|||
131154375|NCT01901328|472185773|FG000|Overall Study|Physician Decision|0|||
131154376|NCT01901328|472185774|FG001|Overall Study|Physician Decision|1|||
131154377|NCT01901328|472185773|FG000|Overall Study|Protocol Violation|1|||
131154378|NCT01901328|472185774|FG001|Overall Study|Protocol Violation|1|||
131154379|NCT01901328|472185773|FG000|Overall Study|Study Terminated by Sponsor|19|||
131154380|NCT01901328|472185774|FG001|Overall Study|Study Terminated by Sponsor|16|||
131154381|NCT01901328|472185773|FG000|Overall Study|Withdrawal by Subject|1|||
131154382|NCT01901328|472185774|FG001|Overall Study|Withdrawal by Subject|2|||
131154383|NCT01901328|472185773|FG000|Overall Study|Lack of Efficacy|0|||
131154384|NCT01901328|472185774|FG001|Overall Study|Lack of Efficacy|1|||
131154385|NCT04865731|472185775|FG000|Overall Study|Physician Decision|2|||
131154386|NCT04865731|472185776|FG001|Overall Study|Physician Decision|1|||
131154387|NCT04865731|472185775|FG000|Overall Study|Adverse Event|1|||
130728351|NCT00101283|470627432|FG000|Overall Study|Prostate Cancer Recurrence|0|||
130728352|NCT00101283|470627433|FG001|Overall Study|Prostate Cancer Recurrence|1|||
130728353|NCT00398866|470627435|FG000|Overall Study|Adverse Event|1|||
130728354|NCT00398866|470627436|FG001|Overall Study|Adverse Event|0|||
130728355|NCT00398866|470627437|FG002|Overall Study|Adverse Event|0|||
130728356|NCT00398866|470627435|FG000|Overall Study|Lack of Efficacy|0|||
130728357|NCT00398866|470627436|FG001|Overall Study|Lack of Efficacy|0|||
130728358|NCT00398866|470627437|FG002|Overall Study|Lack of Efficacy|1|||
130728359|NCT00398866|470627435|FG000|Overall Study|Lost to Follow-up|7|||
130728360|NCT00398866|470627436|FG001|Overall Study|Lost to Follow-up|6|||
130728361|NCT00398866|470627437|FG002|Overall Study|Lost to Follow-up|4|||
130728362|NCT00398866|470627435|FG000|Overall Study|Withdrawal by Subject|5|||
130728363|NCT00398866|470627436|FG001|Overall Study|Withdrawal by Subject|1|||
130728364|NCT00398866|470627437|FG002|Overall Study|Withdrawal by Subject|2|||
130728365|NCT00398866|470627435|FG000|Overall Study|Unable to complete requirements of study|1|||
130728366|NCT00398866|470627436|FG001|Overall Study|Unable to complete requirements of study|1|||
130728367|NCT00398866|470627437|FG002|Overall Study|Unable to complete requirements of study|1|||
130728368|NCT04841577|470627442|FG000|Overall Study|Adverse Event|5|||
130728369|NCT04841577|470627443|FG001|Overall Study|Adverse Event|10|||
130728370|NCT04841577|470627442|FG000|Overall Study|Lost to Follow-up|8|||
130728371|NCT04841577|470627443|FG001|Overall Study|Lost to Follow-up|7|||
130728372|NCT04841577|470627442|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
130728373|NCT04841577|470627443|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
130728374|NCT04841577|470627442|FG000|Overall Study|Other|0|||
130728375|NCT04841577|470627443|FG001|Overall Study|Other|1|||
130728376|NCT00182325|470627444|FG000|Overall Study|Lost to Follow-up|7|||
130728377|NCT00182325|470627445|FG001|Overall Study|Lost to Follow-up|7|||
130728378|NCT00182325|470627444|FG000|Overall Study|Miscarriage|5|||
130728379|NCT00182325|470627445|FG001|Overall Study|Miscarriage|3|||
130728380|NCT00182325|470627444|FG000|Overall Study|Did not complete survey|22|||
130728381|NCT00182325|470627445|FG001|Overall Study|Did not complete survey|43|||
130728382|NCT01420965|470627450|FG000|Overall Study|Withdrawal by Subject|1|||
130728383|NCT01420965|470627451|FG001|Overall Study|Withdrawal by Subject|0|||
131154388|NCT04865731|472185776|FG001|Overall Study|Adverse Event|0|||
131154389|NCT04865731|472185775|FG000|Overall Study|Withdrawal by Subject|0|||
131154390|NCT04865731|472185776|FG001|Overall Study|Withdrawal by Subject|1|||
131154391|NCT01672892|472186827|FG000|Overall Study|Protocol Violation|7|||
131154392|NCT01672892|472186828|FG001|Overall Study|Protocol Violation|3|||
131154393|NCT00942162|472186841|FG000|Overall Study|Death|45|||
131154394|NCT00942162|472186842|FG001|Overall Study|Death|35|||
131154395|NCT00942162|472186843|FG002|Overall Study|Death|0|||
131154396|NCT00942162|472186841|FG000|Overall Study|Withdrawal by Subject|7|||
131154397|NCT00942162|472186842|FG001|Overall Study|Withdrawal by Subject|2|||
131154398|NCT00942162|472186843|FG002|Overall Study|Withdrawal by Subject|0|||
131154399|NCT00942162|472186841|FG000|Overall Study|Lost to Follow-up|4|||
130728384|NCT01420965|470627452|FG002|Overall Study|Withdrawal by Subject|0|||
130728385|NCT01420965|470627450|FG000|Overall Study|Adverse Event|0|||
130728386|NCT01420965|470627451|FG001|Overall Study|Adverse Event|1|||
130728387|NCT01420965|470627452|FG002|Overall Study|Adverse Event|0|||
130728388|NCT00339144|470627457|FG000|Overall Study|Disease progression|5|||
130728389|NCT00339144|470627458|FG001|Overall Study|Disease progression|2|||
131154400|NCT00942162|472186842|FG001|Overall Study|Lost to Follow-up|0|||
131154401|NCT00942162|472186843|FG002|Overall Study|Lost to Follow-up|0|||
131154402|NCT00942162|472186841|FG000|Overall Study|Other|14|||
131154403|NCT00942162|472186842|FG001|Overall Study|Other|13|||
131154404|NCT00942162|472186843|FG002|Overall Study|Other|2|||
131154405|NCT01006356|472186844|FG000|Overall Study|Adverse Event|6|||
131154406|NCT01006356|472186844|FG000|Overall Study|Physician Decision|1|||
131154407|NCT01006356|472186844|FG000|Overall Study|Paticipants did not cooperate|6|||
131154408|NCT01006356|472186844|FG000|Overall Study|Withdrawal by Subject|1|||
131154409|NCT01006356|472186844|FG000|Overall Study|Choice by participants|2|||
131154410|NCT01006356|472186844|FG000|Overall Study|Protocol Violation|3|||
131154411|NCT01006356|472186844|FG000|Overall Study|Other|23|||
131154412|NCT02424539|472186852|FG000|Overall Study|Adverse Event|0|||
131154413|NCT02424539|472186853|FG001|Overall Study|Adverse Event|0|||
131154414|NCT02424539|472186854|FG002|Overall Study|Adverse Event|1|||
131154415|NCT02424539|472186852|FG000|Overall Study|Physician Decision|0|||
131154416|NCT02424539|472186853|FG001|Overall Study|Physician Decision|0|||
131154417|NCT02424539|472186854|FG002|Overall Study|Physician Decision|1|||
131154418|NCT02424539|472186852|FG000|Overall Study|Withdrawal by Subject|3|||
131154419|NCT02424539|472186853|FG001|Overall Study|Withdrawal by Subject|1|||
131154420|NCT02424539|472186854|FG002|Overall Study|Withdrawal by Subject|0|||
131154421|NCT02424539|472186852|FG000|Overall Study|Other: Reached stopping criteria|11|||
131154422|NCT02424539|472186853|FG001|Overall Study|Other: Reached stopping criteria|7|||
131154423|NCT02424539|472186854|FG002|Overall Study|Other: Reached stopping criteria|6|||
131154424|NCT04893265|472186855|FG000|Overall Study|Withdrawal by Subject|2|||
131154425|NCT04893265|472186856|FG001|Overall Study|Withdrawal by Subject|5|||
131154426|NCT04893265|472186855|FG000|Overall Study|Lost to Follow-up|0|||
131154427|NCT04893265|472186856|FG001|Overall Study|Lost to Follow-up|4|||
131154428|NCT03090191|472186861|FG000|Overall Study|Adverse Event|90|||
131154429|NCT03090191|472186862|FG001|Overall Study|Adverse Event|72|||
131154430|NCT03090191|472186861|FG000|Overall Study|Death|365|||
131154431|NCT03090191|472186862|FG001|Overall Study|Death|358|||
131154432|NCT03090191|472186861|FG000|Overall Study|Lost to Follow-up|382|||
131154433|NCT03090191|472186862|FG001|Overall Study|Lost to Follow-up|394|||
131154434|NCT03090191|472186861|FG000|Overall Study|Physician Decision|77|||
131154435|NCT03090191|472186862|FG001|Overall Study|Physician Decision|66|||
131154436|NCT03090191|472186861|FG000|Overall Study|Protocol Violation|43|||
131154437|NCT03090191|472186862|FG001|Overall Study|Protocol Violation|52|||
131154438|NCT03090191|472186861|FG000|Overall Study|Withdrawal by Subject|2160|||
131154439|NCT03090191|472186862|FG001|Overall Study|Withdrawal by Subject|2133|||
131154440|NCT03090191|472186861|FG000|Overall Study|Site terminated|7|||
131154441|NCT03090191|472186862|FG001|Overall Study|Site terminated|8|||
130728390|NCT00339144|470627459|FG002|Overall Study|Disease progression|2|||
130728391|NCT00339144|470627457|FG000|Overall Study|Study drug toxicity|3|||
130728392|NCT00339144|470627458|FG001|Overall Study|Study drug toxicity|1|||
131154442|NCT03090191|472186861|FG000|Overall Study|Other|66|||
131154443|NCT03090191|472186862|FG001|Overall Study|Other|60|||
131154444|NCT03090191|472186861|FG000|Overall Study|Withdrawn before any study vaccination|43|||
131154445|NCT03090191|472186862|FG001|Overall Study|Withdrawn before any study vaccination|52|||
131154446|NCT04723537|472186864|FG000|Overall Study|Withdrawal by Subject|3|||
131154447|NCT04723537|472186865|FG001|Overall Study|Withdrawal by Subject|0|||
131154448|NCT04723537|472186866|FG002|Overall Study|Withdrawal by Subject|0|||
131154449|NCT04723537|472186864|FG000|Overall Study|Physician Decision|0|||
131154450|NCT04723537|472186865|FG001|Overall Study|Physician Decision|0|||
131154451|NCT04723537|472186866|FG002|Overall Study|Physician Decision|1|||
131154452|NCT04723537|472186864|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
131154453|NCT04723537|472186865|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
131154454|NCT04723537|472186866|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
131154455|NCT02432807|472186867|FG000|Overall Study|Adverse Event|0|||
131154456|NCT02432807|472186868|FG001|Overall Study|Adverse Event|2|||
131154457|NCT02432807|472186867|FG000|Overall Study|Lost to Follow-up|1|||
131154458|NCT02432807|472186868|FG001|Overall Study|Lost to Follow-up|0|||
131154459|NCT02432807|472186867|FG000|Overall Study|Withdrawal by Subject|1|||
131154460|NCT02432807|472186868|FG001|Overall Study|Withdrawal by Subject|1|||
131154461|NCT02432807|472186867|FG000|Overall Study|Other|1|||
131154462|NCT02432807|472186868|FG001|Overall Study|Other|1|||
131154463|NCT01021007|472186872|FG000|Overall Study|Lost to Follow-up|1|||
131154464|NCT01021007|472186873|FG001|Overall Study|Lost to Follow-up|1|||
131154465|NCT01021007|472186872|FG000|Overall Study|Adverse Event|1|||
131154466|NCT01021007|472186873|FG001|Overall Study|Adverse Event|3|||
130728393|NCT00339144|470627459|FG002|Overall Study|Study drug toxicity|1|||
131154467|NCT01244737|472186883|FG000|Overall Study|Physician Decision|2|||
131154468|NCT01244737|472186884|FG001|Overall Study|Physician Decision|18|||
131154469|NCT01244737|472186885|FG002|Overall Study|Physician Decision|5|||
131154470|NCT01244737|472186883|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
131154471|NCT01244737|472186884|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
131154472|NCT01244737|472186885|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
131154473|NCT01244737|472186883|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
131154474|NCT01244737|472186884|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
131154475|NCT01244737|472186885|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
131154476|NCT01244737|472186883|FG000|Overall Study|MIB immunopathology results not available|3|||
131154477|NCT01244737|472186884|FG001|Overall Study|MIB immunopathology results not available|2|||
131154478|NCT01244737|472186885|FG002|Overall Study|MIB immunopathology results not available|0|||
131154479|NCT01244737|472186883|FG000|Overall Study|PET data failure|0|||
131154480|NCT01244737|472186884|FG001|Overall Study|PET data failure|1|||
131154481|NCT01244737|472186885|FG002|Overall Study|PET data failure|0|||
131154482|NCT01244737|472186883|FG000|Overall Study|Withdrawal by Subject|0|||
131154483|NCT01244737|472186884|FG001|Overall Study|Withdrawal by Subject|0|||
131154484|NCT01244737|472186885|FG002|Overall Study|Withdrawal by Subject|1|||
131154485|NCT00730236|472186886|FG000|Overall Study|Adverse Event|4|||
131154486|NCT00730236|472186886|FG000|Overall Study|Withdrawal by Subject|1|||
131154487|NCT00730236|472186886|FG000|Overall Study|Non-compliance|1|||
131154488|NCT01772134|472186891|FG000|Overall Study|Adverse Event|6|||
131235138|NCT04799158|472488830|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
131154489|NCT01772134|472186892|FG001|Overall Study|Adverse Event|5|||
131154490|NCT01772134|472186893|FG002|Overall Study|Adverse Event|10|||
131154491|NCT01772134|472186891|FG000|Overall Study|Withdrew Consent|3|||
131154492|NCT01772134|472186892|FG001|Overall Study|Withdrew Consent|1|||
131154493|NCT01772134|472186893|FG002|Overall Study|Withdrew Consent|5|||
131154494|NCT01772134|472186891|FG000|Overall Study|Lost to Follow-up|2|||
131154495|NCT01772134|472186892|FG001|Overall Study|Lost to Follow-up|0|||
131154496|NCT01772134|472186893|FG002|Overall Study|Lost to Follow-up|0|||
131154497|NCT01772134|472186891|FG000|Overall Study|Protocol Deviation|4|||
131154498|NCT01772134|472186892|FG001|Overall Study|Protocol Deviation|3|||
131154499|NCT01772134|472186893|FG002|Overall Study|Protocol Deviation|3|||
131154500|NCT01772134|472186891|FG000|Overall Study|Lack of Efficacy|11|||
131154501|NCT01772134|472186892|FG001|Overall Study|Lack of Efficacy|5|||
131154502|NCT01772134|472186893|FG002|Overall Study|Lack of Efficacy|3|||
131154503|NCT01772134|472186891|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
131154504|NCT01772134|472186892|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
131154505|NCT01772134|472186893|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
131154506|NCT01772134|472186891|FG000|Overall Study|Randomized Study Medication Not Received|2|||
131154507|NCT01772134|472186892|FG001|Overall Study|Randomized Study Medication Not Received|0|||
131154508|NCT01772134|472186893|FG002|Overall Study|Randomized Study Medication Not Received|1|||
131154509|NCT03486314|472186898|FG000|Part A|Adverse Event|1|||
131154510|NCT03486314|472186899|FG001|Part A|Adverse Event|0|||
131154511|NCT03486314|472186900|FG002|Part A|Adverse Event|0|||
131154512|NCT03486314|472186898|FG000|Part A|Symptomatic Deterioration|2|||
131154513|NCT03486314|472186899|FG001|Part A|Symptomatic Deterioration|0|||
131154514|NCT03486314|472186900|FG002|Part A|Symptomatic Deterioration|0|||
131154515|NCT04003610|472186902|FG000|Overall Study|Lost to Follow-up|0|||
131154516|NCT04003610|472186903|FG001|Overall Study|Lost to Follow-up|1|||
131154517|NCT04003610|472186904|FG002|Overall Study|Lost to Follow-up|0|||
131154518|NCT04003610|472186902|FG000|Overall Study|Death|0|||
131154519|NCT04003610|472186903|FG001|Overall Study|Death|0|||
131154520|NCT04003610|472186904|FG002|Overall Study|Death|3|||
131154521|NCT04003610|472186902|FG000|Overall Study|Study Terminated by Sponsor|0|||
131154522|NCT04003610|472186903|FG001|Overall Study|Study Terminated by Sponsor|0|||
131154523|NCT04003610|472186904|FG002|Overall Study|Study Terminated by Sponsor|3|||
131154524|NCT03301857|472186905|FG000|Overall Study|Death|0|||
131154525|NCT03301857|472186906|FG001|Overall Study|Death|2|||
131154526|NCT03301857|472186905|FG000|Overall Study|Lost to Follow-up|4|||
131154527|NCT03301857|472186906|FG001|Overall Study|Lost to Follow-up|2|||
131154528|NCT03301857|472186905|FG000|Overall Study|Decision by Sponsor|6|||
131235139|NCT04799158|472488831|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
131235140|NCT04799158|472488827|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
131154529|NCT03301857|472186906|FG001|Overall Study|Decision by Sponsor|0|||
131154530|NCT03301857|472186905|FG000|Overall Study|Withdrawal by Subject|12|||
131154531|NCT03301857|472186906|FG001|Overall Study|Withdrawal by Subject|4|||
131154532|NCT00855439|472186911|FG000|Overall Study|Withdrawal by Subject|2|||
131235141|NCT04799158|472488828|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
131154533|NCT00855439|472186912|FG001|Overall Study|Withdrawal by Subject|0|||
131154534|NCT00855439|472186911|FG000|Overall Study|Pregnancy|1|||
131154535|NCT00855439|472186912|FG001|Overall Study|Pregnancy|0|||
131154536|NCT05502289|472186913|FG000|Period 1|Out Of Window|1|||
131154537|NCT05502289|472186914|FG001|Period 1|Out Of Window|0|||
131154538|NCT03022461|472186927|FG000|Overall Study|Death|3|||
131154539|NCT00816036|472186928|FG000|Overall Study|Death|47|||
131154540|NCT00816036|472186929|FG001|Overall Study|Death|28|||
131154541|NCT00816036|472186928|FG000|Overall Study|Lost to Follow-up|75|||
131154542|NCT00816036|472186929|FG001|Overall Study|Lost to Follow-up|57|||
131154543|NCT00816036|472186928|FG000|Overall Study|Withdrawal by Subject|54|||
131154544|NCT00816036|472186929|FG001|Overall Study|Withdrawal by Subject|23|||
131154545|NCT03212261|472186930|FG000|Overall Study|Became ineligible d/t tech|2|||
131154546|NCT03212261|472186930|FG000|Overall Study|Tech Trouble- No first study visit|1|||
131154547|NCT03212261|472186930|FG000|Overall Study|Lost to Follow-up|7|||
131154548|NCT03212261|472186930|FG000|Overall Study|Family Emergency|1|||
131154549|NCT03212261|472186930|FG000|Overall Study|Too busy/ No time|5|||
131154550|NCT00628355|472186933|FG000|Overall Study|Withdrawal by Subject|1|||
131154551|NCT00628355|472186934|FG001|Overall Study|Withdrawal by Subject|1|||
131154552|NCT03542682|472186935|FG000|Overall Study|COVID-19 Protocol|0|||
131154553|NCT03542682|472186936|FG001|Overall Study|COVID-19 Protocol|1|||
131154554|NCT03232073|472186940|FG000|Overall Study|Death|1|||
131154555|NCT03232073|472186941|FG001|Overall Study|Death|0|||
131154556|NCT03232073|472186940|FG000|Overall Study|Adverse Event|7|||
131154557|NCT03232073|472186941|FG001|Overall Study|Adverse Event|12|||
131154558|NCT03232073|472186940|FG000|Overall Study|Lost to Follow-up|6|||
131154559|NCT03232073|472186941|FG001|Overall Study|Lost to Follow-up|6|||
131154560|NCT03232073|472186940|FG000|Overall Study|Lack of Efficacy|10|||
131154561|NCT03232073|472186941|FG001|Overall Study|Lack of Efficacy|8|||
131154562|NCT03232073|472186940|FG000|Overall Study|Physician Decision|9|||
131154563|NCT03232073|472186941|FG001|Overall Study|Physician Decision|2|||
131154564|NCT03232073|472186940|FG000|Overall Study|Withdrawal by Subject|54|||
131154565|NCT03232073|472186941|FG001|Overall Study|Withdrawal by Subject|39|||
131154566|NCT04909463|472188963|FG000|Overall Study|Withdrawal by Subject|0|||
130728394|NCT00339144|470627457|FG000|Overall Study|Participant's request to discontinuation|1|||
130728395|NCT00339144|470627458|FG001|Overall Study|Participant's request to discontinuation|0|||
130728396|NCT00339144|470627459|FG002|Overall Study|Participant's request to discontinuation|1|||
131154567|NCT04909463|472188964|FG001|Overall Study|Withdrawal by Subject|1|||
131154568|NCT04909463|472188965|FG002|Overall Study|Withdrawal by Subject|0|||
131154569|NCT04909463|472188966|FG003|Overall Study|Withdrawal by Subject|0|||
131154570|NCT04909463|472188963|FG000|Overall Study|Lost to Follow-up|2|||
131154571|NCT04909463|472188964|FG001|Overall Study|Lost to Follow-up|1|||
131154572|NCT04909463|472188965|FG002|Overall Study|Lost to Follow-up|1|||
131154573|NCT04909463|472188966|FG003|Overall Study|Lost to Follow-up|0|||
131154574|NCT00853632|472188967|FG000|Overall Study|Death|88|||
131154575|NCT00853632|472188967|FG000|Overall Study|Withdrawal by Subject|45|||
131154576|NCT00853632|472188967|FG000|Overall Study|Lost to Follow-up|30|||
131154577|NCT00853632|472188967|FG000|Overall Study|Reoperation/Explant|17|||
131154578|NCT00853632|472188967|FG000|Overall Study|Exit with other reason|22|||
131154579|NCT00886821|472188968|FG000|Stage 2|Adverse Event|0|||
131154580|NCT00886821|472188969|FG001|Stage 2|Adverse Event|0|||
131154581|NCT00886821|472188970|FG002|Stage 2|Adverse Event|0|||
131154582|NCT00886821|472188971|FG003|Stage 2|Adverse Event|0|||
131154583|NCT00886821|472188972|FG004|Stage 2|Adverse Event|0|||
131154584|NCT00886821|472188973|FG005|Stage 2|Adverse Event|0|||
131154585|NCT00886821|472188974|FG006|Stage 2|Adverse Event|0|||
131154586|NCT00886821|472188975|FG007|Stage 2|Adverse Event|0|||
131154587|NCT00886821|472188976|FG008|Stage 2|Adverse Event|0|||
131154588|NCT00886821|472188977|FG009|Stage 2|Adverse Event|0|||
131154589|NCT00886821|472188978|FG010|Stage 2|Adverse Event|0|||
131154590|NCT00886821|472188979|FG011|Stage 2|Adverse Event|1|||
131154591|NCT00886821|472188980|FG012|Stage 2|Adverse Event|3|||
131154592|NCT00886821|472188981|FG013|Stage 2|Adverse Event|0|||
131154593|NCT00886821|472188968|FG000|Stage 2|Lost to Follow-up|0|||
131154594|NCT00886821|472188969|FG001|Stage 2|Lost to Follow-up|0|||
131154595|NCT00886821|472188970|FG002|Stage 2|Lost to Follow-up|0|||
131154596|NCT00886821|472188971|FG003|Stage 2|Lost to Follow-up|0|||
131154597|NCT00886821|472188972|FG004|Stage 2|Lost to Follow-up|0|||
131154598|NCT00886821|472188973|FG005|Stage 2|Lost to Follow-up|0|||
131154599|NCT00886821|472188974|FG006|Stage 2|Lost to Follow-up|0|||
130728397|NCT01890434|470627460|FG000|Overall Study|Adverse Event|8|||
130728398|NCT01890434|470627460|FG000|Overall Study|PCI at external hospital|1|||
131154600|NCT00886821|472188975|FG007|Stage 2|Lost to Follow-up|0|||
131154601|NCT00886821|472188976|FG008|Stage 2|Lost to Follow-up|0|||
131154602|NCT00886821|472188977|FG009|Stage 2|Lost to Follow-up|0|||
131154603|NCT00886821|472188978|FG010|Stage 2|Lost to Follow-up|0|||
131154604|NCT00886821|472188979|FG011|Stage 2|Lost to Follow-up|0|||
131154605|NCT00886821|472188980|FG012|Stage 2|Lost to Follow-up|2|||
131154606|NCT00886821|472188981|FG013|Stage 2|Lost to Follow-up|1|||
131154607|NCT00914628|472188982|FG000|Overall Study|Death|35|||
131154608|NCT00914628|472188983|FG001|Overall Study|Death|17|||
131154609|NCT00914628|472188982|FG000|Overall Study|Medical decision|4|||
131154610|NCT00914628|472188983|FG001|Overall Study|Medical decision|0|||
131154611|NCT00914628|472188982|FG000|Overall Study|Protocol Violation|1|||
131154612|NCT00914628|472188983|FG001|Overall Study|Protocol Violation|0|||
131154613|NCT00914628|472188982|FG000|Overall Study|Lack of Efficacy|1|||
131154614|NCT00914628|472188983|FG001|Overall Study|Lack of Efficacy|0|||
131154615|NCT00914628|472188982|FG000|Overall Study|non-randomized|1|||
131154616|NCT00914628|472188983|FG001|Overall Study|non-randomized|0|||
131154617|NCT00914628|472188982|FG000|Overall Study|Relapse|1|||
131154618|NCT00914628|472188983|FG001|Overall Study|Relapse|2|||
131154619|NCT00914628|472188982|FG000|Overall Study|Study terminated by Sponsor|14|||
131154620|NCT00914628|472188983|FG001|Overall Study|Study terminated by Sponsor|8|||
131154621|NCT00914628|472188982|FG000|Overall Study|Patients who did not receive a single dose|7|||
131154622|NCT00914628|472188983|FG001|Overall Study|Patients who did not receive a single dose|1|||
131154623|NCT03311126|472188984|FG000|Induction|Death|1|||
131154624|NCT03311126|472188984|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
131154625|NCT02579603|472188985|FG000|Overall Study|Not treated|1|||
131154626|NCT02579603|472188986|FG001|Overall Study|Not treated|0|||
131154627|NCT02579603|472188985|FG000|Overall Study|Adverse Event|2|||
131154628|NCT02579603|472188986|FG001|Overall Study|Adverse Event|2|||
131154629|NCT02579603|472188985|FG000|Overall Study|Other than stated|1|||
131154630|NCT02579603|472188986|FG001|Overall Study|Other than stated|0|||
131154631|NCT00469079|472188987|FG000|Overall Study|Lack of Efficacy|3|||
131154632|NCT00469079|472188988|FG001|Overall Study|Lack of Efficacy|8|||
131154633|NCT00469079|472188989|FG002|Overall Study|Lack of Efficacy|5|||
131154634|NCT00469079|472188987|FG000|Overall Study|Adverse Event|1|||
131154635|NCT00469079|472188988|FG001|Overall Study|Adverse Event|3|||
131154636|NCT00469079|472188989|FG002|Overall Study|Adverse Event|2|||
131154637|NCT00469079|472188987|FG000|Overall Study|Lost to Follow-up|4|||
131154638|NCT00469079|472188988|FG001|Overall Study|Lost to Follow-up|8|||
131154639|NCT00469079|472188989|FG002|Overall Study|Lost to Follow-up|10|||
131154640|NCT00469079|472188987|FG000|Overall Study|Withdrawal by Subject|1|||
131154641|NCT00469079|472188988|FG001|Overall Study|Withdrawal by Subject|2|||
131154642|NCT00469079|472188989|FG002|Overall Study|Withdrawal by Subject|2|||
131154643|NCT00469079|472188987|FG000|Overall Study|Ineligible|0|||
131154644|NCT00469079|472188988|FG001|Overall Study|Ineligible|1|||
131154645|NCT00469079|472188989|FG002|Overall Study|Ineligible|0|||
131154646|NCT02698410|472188990|FG000|Overall Study|Adverse Event|2|||
131154647|NCT02698410|472188990|FG000|Overall Study|Withdrawal by Subject|1|||
131154648|NCT02698410|472188990|FG000|Overall Study|Other|1|||
131154649|NCT04331899|472188995|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
131154650|NCT04331899|472188996|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
131154651|NCT00719810|472188999|FG000|Overall Study|Adverse Event|0|||
131154652|NCT00719810|472189000|FG001|Overall Study|Adverse Event|2|||
131154653|NCT00719810|472189001|FG002|Overall Study|Adverse Event|3|||
131154654|NCT00719810|472188999|FG000|Overall Study|Lost to Follow-up|2|||
131154655|NCT00719810|472189000|FG001|Overall Study|Lost to Follow-up|0|||
131154656|NCT00719810|472189001|FG002|Overall Study|Lost to Follow-up|3|||
131154657|NCT00719810|472188999|FG000|Overall Study|Physician Decision|0|||
131154658|NCT00719810|472189000|FG001|Overall Study|Physician Decision|1|||
131154659|NCT00719810|472189001|FG002|Overall Study|Physician Decision|0|||
131154660|NCT00719810|472188999|FG000|Overall Study|Withdrawal by Subject|1|||
131154661|NCT00719810|472189000|FG001|Overall Study|Withdrawal by Subject|1|||
131154662|NCT00719810|472189001|FG002|Overall Study|Withdrawal by Subject|2|||
131154663|NCT00573131|472189004|FG000|Overall Study|Withdrawal by Subject|10|||
131154664|NCT00573131|472189005|FG001|Overall Study|Withdrawal by Subject|8|||
131154665|NCT00893789|472189006|FG000|Overall Study|Withdrawal by Subject|3|||
131154666|NCT00893789|472189007|FG001|Overall Study|Withdrawal by Subject|1|||
131154667|NCT00893789|472189008|FG002|Overall Study|Withdrawal by Subject|3|||
131154668|NCT00893789|472189009|FG003|Overall Study|Withdrawal by Subject|1|||
131154669|NCT00893789|472189006|FG000|Overall Study|Noncompliance With Study Drug|1|||
131154670|NCT00893789|472189007|FG001|Overall Study|Noncompliance With Study Drug|0|||
131154671|NCT00893789|472189008|FG002|Overall Study|Noncompliance With Study Drug|1|||
131154672|NCT00893789|472189009|FG003|Overall Study|Noncompliance With Study Drug|2|||
131154673|NCT00893789|472189006|FG000|Overall Study|Noncompliance With Study Procedures|1|||
131154674|NCT00893789|472189007|FG001|Overall Study|Noncompliance With Study Procedures|0|||
131154675|NCT00893789|472189008|FG002|Overall Study|Noncompliance With Study Procedures|0|||
131154676|NCT00893789|472189009|FG003|Overall Study|Noncompliance With Study Procedures|0|||
131154677|NCT00893789|472189006|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
131154678|NCT00893789|472189007|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
131154679|NCT00893789|472189008|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
131154680|NCT00893789|472189009|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
131235142|NCT04799158|472488829|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
131154681|NCT00893789|472189006|FG000|Overall Study|Adverse Event|0|||
131154682|NCT00893789|472189007|FG001|Overall Study|Adverse Event|2|||
131154683|NCT00893789|472189008|FG002|Overall Study|Adverse Event|1|||
131154684|NCT00893789|472189009|FG003|Overall Study|Adverse Event|5|||
131154685|NCT00893789|472189006|FG000|Overall Study|Protocol Violation|0|||
131154686|NCT00893789|472189007|FG001|Overall Study|Protocol Violation|1|||
131154687|NCT00893789|472189008|FG002|Overall Study|Protocol Violation|1|||
131154688|NCT00893789|472189009|FG003|Overall Study|Protocol Violation|4|||
131154689|NCT00893789|472189006|FG000|Overall Study|Lost to Follow-up|0|||
131154690|NCT00893789|472189007|FG001|Overall Study|Lost to Follow-up|0|||
131154691|NCT00893789|472189008|FG002|Overall Study|Lost to Follow-up|0|||
130728399|NCT01890434|470627460|FG000|Overall Study|Assessment discrepancy|1|||
130728400|NCT01890434|470627460|FG000|Overall Study|CRC didn't contact participant for FU|1|||
130728401|NCT01890434|470627460|FG000|Overall Study|Could not get whole set of images|1|||
130728402|NCT01890434|470627460|FG000|Overall Study|Decline to return for GSPECT|1|||
130728403|NCT01890434|470627460|FG000|Overall Study|GSPECT at rest was not done|1|||
130728404|NCT01890434|470627460|FG000|Overall Study|Participant didn't complete MRI|1|||
130728405|NCT01890434|470627460|FG000|Overall Study|Uncontactable by phone|1|||
130728406|NCT01890434|470627460|FG000|Overall Study|Moved out of position|1|||
130728407|NCT01890434|470627460|FG000|Overall Study|Unable to contact|1|||
130728408|NCT01890434|470627460|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
130728409|NCT01141205|470627461|FG000|Overall Study|Physician Decision|1|||
131154692|NCT00893789|472189009|FG003|Overall Study|Lost to Follow-up|1|||
131154693|NCT02024464|472189010|FG000|Overall Study|Discontinued|5|||
131154694|NCT02024464|472189011|FG001|Overall Study|Discontinued|4|||
131154695|NCT02024464|472189010|FG000|Overall Study|Missed Visits|1|||
131154696|NCT02024464|472189011|FG001|Overall Study|Missed Visits|0|||
131154697|NCT02024464|472189010|FG000|Overall Study|Lost to Follow-up|4|||
131154698|NCT02024464|472189011|FG001|Overall Study|Lost to Follow-up|7|||
131154699|NCT05408858|472189016|FG000|Overall Study|no longer met eligibility criteria|1|||
131154700|NCT02037919|472189020|FG000|Overall Study|Lost to Follow-up|30|||
131154701|NCT02037919|472189021|FG001|Overall Study|Lost to Follow-up|45|||
131154702|NCT01973283|472189022|FG000|Overall Study|Lost to Follow-up|4|||
131154703|NCT03717922|472189030|FG000|Overall Study|Lost to Follow-up|2|||
131154704|NCT03717922|472189031|FG001|Overall Study|Lost to Follow-up|2|||
131154705|NCT01697215|472189042|FG000|Overall Study|Physician Decision|5|||
131154706|NCT01697215|472189042|FG000|Overall Study|Malfunction|9|||
131154707|NCT01697215|472189042|FG000|Overall Study|CXR not available|9|||
131154708|NCT00900796|472189045|FG000|Phase 1|Lacked sufficient information|4|||
131154709|NCT00900796|472189045|FG000|Phase 1|Missing information at Week 16|7|||
131154710|NCT00900796|472189045|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
131154711|NCT00900796|472189045|FG000|Phase 2|Lost to Follow-up|5|||
131154712|NCT01829048|472189050|FG000|Overall Study|Withdrawal by Subject|0|||
131154713|NCT01829048|472189051|FG001|Overall Study|Withdrawal by Subject|0|||
131154714|NCT01829048|472189052|FG002|Overall Study|Withdrawal by Subject|0|||
131154715|NCT01829048|472189053|FG003|Overall Study|Withdrawal by Subject|2|||
131154716|NCT01829048|472189054|FG004|Overall Study|Withdrawal by Subject|0|||
131154717|NCT01121406|472189055|FG000|Overall Study|Progressive disease RECIST|44|||
131154718|NCT01121406|472189056|FG001|Overall Study|Progressive disease RECIST|28|||
131154719|NCT01121406|472189055|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
131154720|NCT01121406|472189056|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
131154721|NCT01121406|472189055|FG000|Overall Study|Other AE|3|||
131154722|NCT01121406|472189056|FG001|Overall Study|Other AE|10|||
131154723|NCT01121406|472189055|FG000|Overall Study|Non-compliant with protocol|0|||
131154724|NCT01121406|472189056|FG001|Overall Study|Non-compliant with protocol|2|||
131154725|NCT01121406|472189055|FG000|Overall Study|Lost to Follow-up|0|||
131154726|NCT01121406|472189056|FG001|Overall Study|Lost to Follow-up|1|||
131154727|NCT01121406|472189055|FG000|Overall Study|Refused continuation of study med.|1|||
131154728|NCT01121406|472189056|FG001|Overall Study|Refused continuation of study med.|2|||
131154729|NCT01121406|472189055|FG000|Overall Study|Reason other than specified above|2|||
131154730|NCT01121406|472189056|FG001|Overall Study|Reason other than specified above|6|||
131154731|NCT01121406|472189055|FG000|Overall Study|Not treated|1|||
131154732|NCT01121406|472189056|FG001|Overall Study|Not treated|0|||
131154733|NCT02504541|472189058|FG000|Overall Study|Adverse Event|4|||
130728410|NCT01141205|470627462|FG001|Overall Study|Physician Decision|1|||
130728411|NCT01141205|470627461|FG000|Overall Study|Lost to Follow-up|1|||
131154734|NCT02504541|472189058|FG000|Overall Study|Withdrawal by Subject|4|||
131154735|NCT02504541|472189058|FG000|Overall Study|Lost to Follow-up|1|||
131154736|NCT02504541|472189058|FG000|Overall Study|Met Stopping Criteria|1|||
131154737|NCT02504541|472189058|FG000|Overall Study|Protocol Violation|2|||
131154738|NCT02504541|472189058|FG000|Overall Study|Termination by Sponsor|1|||
131154739|NCT02504541|472189058|FG000|Overall Study|Other|2|||
131154740|NCT02504541|472189058|FG000|Overall Study|Multiple|5|||
131154741|NCT01531725|472189059|FG000|Overall Study|Protocol Violation|5|||
131154742|NCT00500071|472189060|FG000|Screening and Washout Phase|Protocol Violation|1|||
131154743|NCT00500071|472189060|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
131154744|NCT00500071|472189060|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
131154745|NCT00500071|472189060|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
131154746|NCT00500071|472189060|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
131154747|NCT00500071|472189060|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
131154748|NCT00500071|472189060|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
131154749|NCT00472303|472189061|FG000|Titration Phase|Adverse Event|22|||
130728412|NCT01141205|470627462|FG001|Overall Study|Lost to Follow-up|0|||
130728413|NCT01141205|470627461|FG000|Overall Study|Withdrawal by Subject|1|||
130728414|NCT01141205|470627462|FG001|Overall Study|Withdrawal by Subject|1|||
131154750|NCT00472303|472189062|FG001|Titration Phase|Adverse Event|12|||
131154751|NCT00472303|472189063|FG002|Titration Phase|Adverse Event|0|||
130728415|NCT02257385|470627464|FG000|Overall Study|Adverse Event|12|||
130728416|NCT02257385|470627465|FG001|Overall Study|Adverse Event|8|||
131154752|NCT00472303|472189061|FG000|Titration Phase|Death|4|||
131154753|NCT00472303|472189062|FG001|Titration Phase|Death|2|||
131154754|NCT00472303|472189063|FG002|Titration Phase|Death|0|||
131154755|NCT00472303|472189061|FG000|Titration Phase|Lack of Efficacy|10|||
131154756|NCT00472303|472189062|FG001|Titration Phase|Lack of Efficacy|0|||
131154757|NCT00472303|472189063|FG002|Titration Phase|Lack of Efficacy|0|||
131154758|NCT00472303|472189061|FG000|Titration Phase|Withdrawal by Subject|16|||
131154759|NCT00472303|472189062|FG001|Titration Phase|Withdrawal by Subject|13|||
131154760|NCT00472303|472189063|FG002|Titration Phase|Withdrawal by Subject|0|||
131154761|NCT00472303|472189061|FG000|Titration Phase|Trial Medication non-compliant|4|||
131154762|NCT00472303|472189062|FG001|Titration Phase|Trial Medication non-compliant|1|||
131154763|NCT00472303|472189063|FG002|Titration Phase|Trial Medication non-compliant|0|||
131154764|NCT00472303|472189061|FG000|Titration Phase|Other|3|||
131154765|NCT00472303|472189062|FG001|Titration Phase|Other|1|||
131154766|NCT00472303|472189063|FG002|Titration Phase|Other|0|||
131154767|NCT00472303|472189061|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
131154768|NCT00472303|472189062|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
131154769|NCT00472303|472189063|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
131154770|NCT00472303|472189061|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
131154771|NCT00472303|472189062|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
131154772|NCT00472303|472189063|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
131154773|NCT00472303|472189061|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
131154774|NCT00472303|472189062|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
131154775|NCT00472303|472189063|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
131154776|NCT00472303|472189061|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
131154777|NCT00472303|472189062|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
131154778|NCT00472303|472189063|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
131154779|NCT00472303|472189061|FG000|Discontinuations After Titration Phase|Other|5|||
131154780|NCT00472303|472189062|FG001|Discontinuations After Titration Phase|Other|0|||
131154781|NCT00472303|472189063|FG002|Discontinuations After Titration Phase|Other|0|||
131154782|NCT00472303|472189061|FG000|Maintenance Phase|Adverse Event|5|||
131154783|NCT00472303|472189062|FG001|Maintenance Phase|Adverse Event|6|||
131154784|NCT00472303|472189063|FG002|Maintenance Phase|Adverse Event|6|||
131154785|NCT00472303|472189061|FG000|Maintenance Phase|Death|3|||
131154786|NCT00472303|472189062|FG001|Maintenance Phase|Death|0|||
131154787|NCT00472303|472189063|FG002|Maintenance Phase|Death|2|||
131154788|NCT00472303|472189061|FG000|Maintenance Phase|Lack of Efficacy|2|||
131154789|NCT00472303|472189062|FG001|Maintenance Phase|Lack of Efficacy|2|||
131154790|NCT00472303|472189063|FG002|Maintenance Phase|Lack of Efficacy|4|||
131154791|NCT00472303|472189061|FG000|Maintenance Phase|Withdrawal by Subject|6|||
131154792|NCT00472303|472189062|FG001|Maintenance Phase|Withdrawal by Subject|7|||
131154793|NCT00472303|472189063|FG002|Maintenance Phase|Withdrawal by Subject|3|||
131154794|NCT00472303|472189061|FG000|Maintenance Phase|Trial medication non-compliant|0|||
131154795|NCT00472303|472189062|FG001|Maintenance Phase|Trial medication non-compliant|0|||
131154796|NCT00472303|472189063|FG002|Maintenance Phase|Trial medication non-compliant|1|||
131154797|NCT00472303|472189061|FG000|Maintenance Phase|Resolution of pain|0|||
131154798|NCT00472303|472189062|FG001|Maintenance Phase|Resolution of pain|0|||
131154799|NCT00472303|472189063|FG002|Maintenance Phase|Resolution of pain|1|||
131154800|NCT00472303|472189061|FG000|Maintenance Phase|Other|1|||
131154801|NCT00472303|472189062|FG001|Maintenance Phase|Other|1|||
131154802|NCT00472303|472189063|FG002|Maintenance Phase|Other|0|||
131154803|NCT03182738|472189072|FG000|Overall Study|Lost to Follow-up|9|||
131154804|NCT03182738|472189073|FG001|Overall Study|Lost to Follow-up|3|||
131154805|NCT03182738|472189072|FG000|Overall Study|Pregnancy|0|||
131154806|NCT03182738|472189073|FG001|Overall Study|Pregnancy|1|||
131154807|NCT03182738|472189072|FG000|Overall Study|Withdrawal by Subject|0|||
131154808|NCT03182738|472189073|FG001|Overall Study|Withdrawal by Subject|1|||
130728417|NCT02257385|470627464|FG000|Overall Study|Lack of Efficacy|1|||
131154809|NCT02835495|472189084|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
131154810|NCT02835495|472189085|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
131154811|NCT02835495|472189084|FG000|Overall Study|Declined in-person follow-up visit|4|||
131154812|NCT02835495|472189085|FG001|Overall Study|Declined in-person follow-up visit|2|||
131154813|NCT03459040|472189086|FG000|Overall Study|Death|8|||
131154814|NCT03459040|472189086|FG000|Overall Study|Withdrawal by Subject|1|||
131154815|NCT00986349|472189087|FG000|Overall Study|Unsuccessful implant procedure|3|||
131154816|NCT00986349|472189087|FG000|Overall Study|Adverse Event|2|||
131154817|NCT00986349|472189087|FG000|Overall Study|Physician Decision|1|||
131154818|NCT00986349|472189087|FG000|Overall Study|device migration|1|||
131154819|NCT02299934|472189088|FG000|Overall Study|Termination of study|13|||
131154820|NCT00561353|472189089|FG000|Overall Study|Subject reached a virologic endpoint|2|||
131154821|NCT00561353|472189090|FG001|Overall Study|Subject reached a virologic endpoint|1|||
130728418|NCT02257385|470627465|FG001|Overall Study|Lack of Efficacy|2|||
131154822|NCT00561353|472189091|FG002|Overall Study|Subject reached a virologic endpoint|1|||
131154823|NCT00561353|472189092|FG003|Overall Study|Subject reached a virologic endpoint|4|||
131154824|NCT00561353|472189093|FG004|Overall Study|Subject reached a virologic endpoint|1|||
131154825|NCT00561353|472189094|FG005|Overall Study|Subject reached a virologic endpoint|3|||
131154826|NCT00561353|472189095|FG006|Overall Study|Subject reached a virologic endpoint|4|||
131154827|NCT00561353|472189096|FG007|Overall Study|Subject reached a virologic endpoint|4|||
131154828|NCT00561353|472189097|FG008|Overall Study|Subject reached a virologic endpoint|5|||
131154829|NCT00561353|472189098|FG009|Overall Study|Subject reached a virologic endpoint|0|||
131154830|NCT00561353|472189089|FG000|Overall Study|Subject ineligible to continue the trial|0|||
131154831|NCT00561353|472189090|FG001|Overall Study|Subject ineligible to continue the trial|0|||
131154832|NCT00561353|472189091|FG002|Overall Study|Subject ineligible to continue the trial|0|||
131154833|NCT00561353|472189092|FG003|Overall Study|Subject ineligible to continue the trial|0|||
131154834|NCT00561353|472189093|FG004|Overall Study|Subject ineligible to continue the trial|0|||
131154835|NCT00561353|472189094|FG005|Overall Study|Subject ineligible to continue the trial|1|||
131154836|NCT00561353|472189095|FG006|Overall Study|Subject ineligible to continue the trial|1|||
131154837|NCT00561353|472189096|FG007|Overall Study|Subject ineligible to continue the trial|0|||
131154838|NCT00561353|472189097|FG008|Overall Study|Subject ineligible to continue the trial|2|||
131154839|NCT00561353|472189098|FG009|Overall Study|Subject ineligible to continue the trial|1|||
131154840|NCT00561353|472189089|FG000|Overall Study|Other|1|||
131154841|NCT00561353|472189090|FG001|Overall Study|Other|0|||
131154842|NCT00561353|472189091|FG002|Overall Study|Other|1|||
131154843|NCT00561353|472189092|FG003|Overall Study|Other|0|||
131154844|NCT00561353|472189093|FG004|Overall Study|Other|0|||
131154845|NCT00561353|472189094|FG005|Overall Study|Other|2|||
131154846|NCT00561353|472189095|FG006|Overall Study|Other|0|||
131154847|NCT00561353|472189096|FG007|Overall Study|Other|0|||
131154848|NCT00561353|472189097|FG008|Overall Study|Other|0|||
131154849|NCT00561353|472189098|FG009|Overall Study|Other|0|||
131154850|NCT00561353|472189089|FG000|Overall Study|Adverse Event|0|||
131154851|NCT00561353|472189090|FG001|Overall Study|Adverse Event|0|||
131154852|NCT00561353|472189091|FG002|Overall Study|Adverse Event|0|||
131154853|NCT00561353|472189092|FG003|Overall Study|Adverse Event|2|||
131154854|NCT00561353|472189093|FG004|Overall Study|Adverse Event|0|||
131154855|NCT00561353|472189094|FG005|Overall Study|Adverse Event|0|||
131154856|NCT00561353|472189095|FG006|Overall Study|Adverse Event|1|||
131154857|NCT00561353|472189096|FG007|Overall Study|Adverse Event|0|||
131154858|NCT00561353|472189097|FG008|Overall Study|Adverse Event|0|||
131154859|NCT00561353|472189098|FG009|Overall Study|Adverse Event|1|||
131154860|NCT00561353|472189089|FG000|Overall Study|Lost to Follow-up|2|||
131154861|NCT00561353|472189090|FG001|Overall Study|Lost to Follow-up|0|||
131154862|NCT00561353|472189091|FG002|Overall Study|Lost to Follow-up|1|||
131154863|NCT00561353|472189092|FG003|Overall Study|Lost to Follow-up|0|||
131154864|NCT00561353|472189093|FG004|Overall Study|Lost to Follow-up|0|||
131154865|NCT00561353|472189094|FG005|Overall Study|Lost to Follow-up|0|||
131154866|NCT00561353|472189095|FG006|Overall Study|Lost to Follow-up|0|||
131154867|NCT00561353|472189096|FG007|Overall Study|Lost to Follow-up|0|||
131154868|NCT00561353|472189097|FG008|Overall Study|Lost to Follow-up|0|||
131154869|NCT00561353|472189098|FG009|Overall Study|Lost to Follow-up|0|||
131154870|NCT00561353|472189089|FG000|Overall Study|Withdrawal by Subject|0|||
131154871|NCT00561353|472189090|FG001|Overall Study|Withdrawal by Subject|2|||
131154872|NCT00561353|472189091|FG002|Overall Study|Withdrawal by Subject|0|||
131154873|NCT00561353|472189092|FG003|Overall Study|Withdrawal by Subject|0|||
131154874|NCT00561353|472189093|FG004|Overall Study|Withdrawal by Subject|0|||
131154875|NCT00561353|472189094|FG005|Overall Study|Withdrawal by Subject|0|||
131154876|NCT00561353|472189095|FG006|Overall Study|Withdrawal by Subject|0|||
131154877|NCT00561353|472189096|FG007|Overall Study|Withdrawal by Subject|0|||
131154878|NCT00561353|472189097|FG008|Overall Study|Withdrawal by Subject|0|||
131154879|NCT00561353|472189098|FG009|Overall Study|Withdrawal by Subject|0|||
131154880|NCT01273818|472189099|FG000|Overall Study|Physician Decision|13|||
131154881|NCT01273818|472189100|FG001|Overall Study|Physician Decision|2|||
131154882|NCT01273818|472189101|FG002|Overall Study|Physician Decision|9|||
131154883|NCT03815175|472189102|FG000|Overall Study|Subject Lost to Follow-up|6|||
131154884|NCT03815175|472189102|FG000|Overall Study|Subject Withdrew Consent|48|||
131154885|NCT03815175|472189102|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
131154886|NCT03815175|472189102|FG000|Overall Study|Death|86|||
131154887|NCT03815175|472189102|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
131154888|NCT03815175|472189102|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
131154889|NCT03815175|472189102|FG000|Overall Study|Other Status Change Reason|1|||
131154890|NCT03815175|472189102|FG000|Overall Study|Missed Visit|12|||
131154891|NCT00457639|472189103|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
131154892|NCT00457639|472189104|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
131235143|NCT04799158|472488830|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
131154893|NCT00457639|472189103|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
131154894|NCT00457639|472189104|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
131154895|NCT00457639|472189103|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
131154896|NCT00457639|472189104|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
131154897|NCT02117687|472189105|FG000|Overall Study|Lost to Follow-up|0|||
131154898|NCT02117687|472189106|FG001|Overall Study|Lost to Follow-up|1|||
131154899|NCT02117687|472189105|FG000|Overall Study|Adverse Event|0|||
131154900|NCT02117687|472189106|FG001|Overall Study|Adverse Event|2|||
131154901|NCT02117687|472189105|FG000|Overall Study|Other Reasons|1|||
131154902|NCT02117687|472189106|FG001|Overall Study|Other Reasons|1|||
131235144|NCT04799158|472488831|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
131235145|NCT04799158|472488827|FG000|On-Demand Treatment Period|Miscellaneous|0|||
131235146|NCT04799158|472488828|FG001|On-Demand Treatment Period|Miscellaneous|0|||
131235147|NCT04799158|472488829|FG002|On-Demand Treatment Period|Miscellaneous|0|||
131235148|NCT04799158|472488830|FG003|On-Demand Treatment Period|Miscellaneous|0|||
131235149|NCT04799158|472488831|FG004|On-Demand Treatment Period|Miscellaneous|1|||
131235150|NCT03922477|472488834|FG000|Overall Study|Death|9|||
131235151|NCT03922477|472488834|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
131235152|NCT03922477|472488834|FG000|Overall Study|Physician Decision|1|||
131235153|NCT03922477|472488834|FG000|Overall Study|Withdrawal by Subject|2|||
131235154|NCT00662129|472488840|FG000|Overall Study|Protocol Violation|1|||
130728419|NCT02257385|470627464|FG000|Overall Study|Protocol Violation|5|||
130728420|NCT02257385|470627465|FG001|Overall Study|Protocol Violation|7|||
130728421|NCT02257385|470627464|FG000|Overall Study|Lost to Follow-up|0|||
131235155|NCT00662129|472488840|FG000|Overall Study|Cancel prior to beginning treatment|1|||
131235156|NCT00662129|472488840|FG000|Overall Study|Ineligible|1|||
131235157|NCT00918567|472488843|FG000|Overall Study|Lack of Efficacy|3|||
131235158|NCT00918567|472488844|FG001|Overall Study|Lack of Efficacy|1|||
131235159|NCT00918567|472488843|FG000|Overall Study|Withdrawal by Subject|1|||
131235160|NCT00918567|472488844|FG001|Overall Study|Withdrawal by Subject|1|||
131235161|NCT00918567|472488843|FG000|Overall Study|Adverse Event|1|||
131235162|NCT00918567|472488844|FG001|Overall Study|Adverse Event|0|||
131235163|NCT02153736|472488849|FG000|Overall Study|Lost to Follow-up|1|||
131235164|NCT02153736|472488850|FG001|Overall Study|Lost to Follow-up|0|||
131235165|NCT02153736|472488849|FG000|Overall Study|Medical status change made ineligible|1|||
131235166|NCT02153736|472488850|FG001|Overall Study|Medical status change made ineligible|0|||
131235167|NCT02153736|472488849|FG000|Overall Study|Death|0|||
131235168|NCT02153736|472488850|FG001|Overall Study|Death|1|||
131235169|NCT02153736|472488849|FG000|Overall Study|Withdrawal by Subject|0|||
131235170|NCT02153736|472488850|FG001|Overall Study|Withdrawal by Subject|1|||
131235171|NCT02568384|472488855|FG000|Overall Study|Mobile devices incompatible with App|2|||
131235172|NCT01485536|472488856|FG000|Overall Study|Withdrawal by Subject|3|||
131235173|NCT01485536|472488856|FG000|Overall Study|Adverse Event|1|||
131235174|NCT00796510|472488857|FG000|Overall Study|Death|1|||
131235175|NCT00796510|472488858|FG001|Overall Study|Death|0|||
131235176|NCT00796510|472488857|FG000|Overall Study|Study Terminated|2|||
131235177|NCT00796510|472488858|FG001|Overall Study|Study Terminated|0|||
131235178|NCT00720122|472488866|FG000|Overall Study|Lost to Follow-up|1|||
131235179|NCT00720122|472488866|FG000|Overall Study|Physician Decision|1|||
131235180|NCT00720122|472488866|FG000|Overall Study|Withdrawal by Subject|7|||
131235181|NCT02579096|472488867|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
131235182|NCT02579096|472488868|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
131235183|NCT02579096|472488867|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
131235184|NCT02579096|472488868|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
131235185|NCT02579096|472488867|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
131235186|NCT02579096|472488868|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
131235187|NCT02579096|472488867|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
131235188|NCT02579096|472488868|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
131235189|NCT02579096|472488867|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
131235190|NCT02579096|472488868|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
131235191|NCT02579096|472488867|FG000|Phase 2, Weeks 25 - 48|Death|2|||
131235192|NCT02579096|472488868|FG001|Phase 2, Weeks 25 - 48|Death|4|||
131235193|NCT02579096|472488867|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
131235194|NCT02579096|472488868|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
131235195|NCT02579096|472488867|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
131235196|NCT02579096|472488868|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
131235197|NCT02579096|472488867|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
131235198|NCT02579096|472488868|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
131235199|NCT02579096|472488867|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
131235200|NCT02579096|472488868|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
131235201|NCT02579096|472488867|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
131235202|NCT02579096|472488868|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
131235203|NCT02579096|472488867|FG000|Phase 3, Weeks 49 - 72|Death|3|||
131235204|NCT02579096|472488868|FG001|Phase 3, Weeks 49 - 72|Death|2|||
131235205|NCT02579096|472488867|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
131235206|NCT02579096|472488868|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
130728422|NCT02257385|470627465|FG001|Overall Study|Lost to Follow-up|1|||
130780362|NCT00490971|470821509|FG002|Acute/Continuation|Adverse Event|0|||
131154903|NCT03528681|472190784|FG000|Open-Label Phase|Physician Decision|2|||
131154904|NCT03528681|472190785|FG001|Open-Label Phase|Physician Decision|0|||
131154905|NCT03528681|472190786|FG002|Open-Label Phase|Physician Decision|0|||
131154906|NCT03528681|472190787|FG003|Open-Label Phase|Physician Decision|0|||
131154907|NCT03528681|472190784|FG000|Open-Label Phase|Withdrawal by Subject|8|||
131154908|NCT03528681|472190785|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131154909|NCT03528681|472190786|FG002|Open-Label Phase|Withdrawal by Subject|0|||
131154910|NCT03528681|472190787|FG003|Open-Label Phase|Withdrawal by Subject|0|||
131154911|NCT03528681|472190784|FG000|Open-Label Phase|(Not collected)|4|||
131154912|NCT03528681|472190785|FG001|Open-Label Phase|(Not collected)|0|||
131154913|NCT03528681|472190786|FG002|Open-Label Phase|(Not collected)|0|||
131154914|NCT03528681|472190787|FG003|Open-Label Phase|(Not collected)|0|||
131154915|NCT03528681|472190784|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
131154916|NCT03528681|472190785|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
131154917|NCT03528681|472190786|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
131154918|NCT03528681|472190787|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
131154919|NCT03528681|472190784|FG000|Randomized Treatment Phase|Physician Decision|0|||
131154920|NCT03528681|472190785|FG001|Randomized Treatment Phase|Physician Decision|5|||
131154921|NCT03528681|472190786|FG002|Randomized Treatment Phase|Physician Decision|1|||
131154922|NCT03528681|472190787|FG003|Randomized Treatment Phase|Physician Decision|2|||
131154923|NCT03528681|472190784|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
131154924|NCT03528681|472190785|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
131154925|NCT03528681|472190786|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
131154926|NCT03528681|472190787|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
131154927|NCT03528681|472190784|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
131154928|NCT03528681|472190785|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
131154929|NCT03528681|472190786|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
131154930|NCT03528681|472190787|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
131154931|NCT03528681|472190784|FG000|Randomized Treatment Phase|(Not collected)|0|||
131154932|NCT03528681|472190785|FG001|Randomized Treatment Phase|(Not collected)|4|||
131154933|NCT03528681|472190786|FG002|Randomized Treatment Phase|(Not collected)|6|||
131154934|NCT03528681|472190787|FG003|Randomized Treatment Phase|(Not collected)|5|||
131154935|NCT00955110|472190788|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
131154936|NCT00955110|472190788|FG000|Treatment Phase|Adverse Event|2|||
131154937|NCT00955110|472190788|FG000|Treatment Phase|Administrative reasons|2|||
131154938|NCT00955110|472190788|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
131154939|NCT00955110|472190788|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
131154940|NCT01416181|472190798|FG000|Part 1|Other|10|||
131154941|NCT01416181|472190799|FG001|Part 1|Other|24|||
131154942|NCT01416181|472190798|FG000|Part 1|Death|0|||
131154943|NCT01416181|472190799|FG001|Part 1|Death|1|||
131154944|NCT01416181|472190798|FG000|Part 1|Investigator Decision|7|||
131154945|NCT01416181|472190799|FG001|Part 1|Investigator Decision|6|||
131154946|NCT01416181|472190798|FG000|Part 1|Withdrawal by Subject|74|||
131154947|NCT01416181|472190799|FG001|Part 1|Withdrawal by Subject|48|||
131154948|NCT01416181|472190798|FG000|Part 1|Lack of Efficacy|16|||
131154949|NCT01416181|472190799|FG001|Part 1|Lack of Efficacy|8|||
131154950|NCT01416181|472190798|FG000|Part 1|Lost to Follow-up|1|||
131154951|NCT01416181|472190799|FG001|Part 1|Lost to Follow-up|1|||
131154952|NCT01416181|472190798|FG000|Part 1|Adverse Event|15|||
131154953|NCT01416181|472190799|FG001|Part 1|Adverse Event|18|||
131154954|NCT01416181|472190798|FG000|Part 1|Ongoing in Follow-Up|14|||
131154955|NCT01416181|472190799|FG001|Part 1|Ongoing in Follow-Up|8|||
131154956|NCT01416181|472190798|FG000|Part 2|Adverse Event|11|||
131154957|NCT01416181|472190799|FG001|Part 2|Adverse Event|4|||
131154958|NCT01416181|472190798|FG000|Part 2|Other|234|||
131154959|NCT01416181|472190799|FG001|Part 2|Other|267|||
131154960|NCT01416181|472190798|FG000|Part 2|Investigator Decision|6|||
131154961|NCT01416181|472190799|FG001|Part 2|Investigator Decision|7|||
131154962|NCT01416181|472190798|FG000|Part 2|Withdrawal by Subject|14|||
131154963|NCT01416181|472190799|FG001|Part 2|Withdrawal by Subject|5|||
131154964|NCT01416181|472190798|FG000|Part 2|Lack of Efficacy|4|||
131154965|NCT01416181|472190799|FG001|Part 2|Lack of Efficacy|1|||
131154966|NCT01416181|472190798|FG000|Part 2|Lost to Follow-up|2|||
131154967|NCT01416181|472190799|FG001|Part 2|Lost to Follow-up|2|||
131154968|NCT02981472|472190800|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
131154969|NCT02981472|472190801|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
131154970|NCT02981472|472190800|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
131154971|NCT02981472|472190801|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
131154972|NCT02981472|472190800|FG000|Treatment Period|Adverse Event|6|||
131154973|NCT02981472|472190801|FG001|Treatment Period|Adverse Event|1|||
131154974|NCT02981472|472190800|FG000|Treatment Period|Participant withdrew consent|1|||
131154975|NCT02981472|472190801|FG001|Treatment Period|Participant withdrew consent|0|||
131154976|NCT02981472|472190800|FG000|Treatment Period|Lost to Follow-up|0|||
131154977|NCT02981472|472190801|FG001|Treatment Period|Lost to Follow-up|1|||
131154978|NCT00621023|472190803|FG000|Overall Study|Death|5|||
131154979|NCT00621023|472190803|FG000|Overall Study|Follow up discontinued|1|||
131154980|NCT04430348|472190814|FG000|Overall Study|Death|3|||
131154981|NCT04430348|472190815|FG001|Overall Study|Death|2|||
131154982|NCT04430348|472190816|FG002|Overall Study|Death|2|||
131154983|NCT04430348|472190817|FG003|Overall Study|Death|2|||
131154984|NCT04430348|472190818|FG004|Overall Study|Death|2|||
131154985|NCT04430348|472190819|FG005|Overall Study|Death|3|||
131154986|NCT04430348|472190814|FG000|Overall Study|Lost to Follow-up|0|||
131154987|NCT04430348|472190815|FG001|Overall Study|Lost to Follow-up|0|||
131154988|NCT04430348|472190816|FG002|Overall Study|Lost to Follow-up|0|||
131154989|NCT04430348|472190817|FG003|Overall Study|Lost to Follow-up|1|||
131154990|NCT04430348|472190818|FG004|Overall Study|Lost to Follow-up|0|||
131154991|NCT04430348|472190819|FG005|Overall Study|Lost to Follow-up|0|||
131154992|NCT04430348|472190814|FG000|Overall Study|Adverse Event|0|||
131154993|NCT04430348|472190815|FG001|Overall Study|Adverse Event|0|||
131154994|NCT04430348|472190816|FG002|Overall Study|Adverse Event|0|||
131154995|NCT04430348|472190817|FG003|Overall Study|Adverse Event|0|||
131154996|NCT04430348|472190818|FG004|Overall Study|Adverse Event|0|||
131154997|NCT04430348|472190819|FG005|Overall Study|Adverse Event|1|||
131154998|NCT04430348|472190814|FG000|Overall Study|Withdrawal by Subject|0|||
131154999|NCT04430348|472190815|FG001|Overall Study|Withdrawal by Subject|1|||
131155000|NCT04430348|472190816|FG002|Overall Study|Withdrawal by Subject|0|||
131155001|NCT04430348|472190817|FG003|Overall Study|Withdrawal by Subject|0|||
131155002|NCT04430348|472190818|FG004|Overall Study|Withdrawal by Subject|0|||
131155003|NCT04430348|472190819|FG005|Overall Study|Withdrawal by Subject|1|||
131155004|NCT04430348|472190814|FG000|Overall Study|Study Terminated by Sponsor|0|||
131155005|NCT04430348|472190815|FG001|Overall Study|Study Terminated by Sponsor|0|||
131155006|NCT04430348|472190816|FG002|Overall Study|Study Terminated by Sponsor|2|||
131155007|NCT04430348|472190817|FG003|Overall Study|Study Terminated by Sponsor|0|||
131155008|NCT04430348|472190818|FG004|Overall Study|Study Terminated by Sponsor|1|||
131155009|NCT04430348|472190819|FG005|Overall Study|Study Terminated by Sponsor|1|||
131155010|NCT02559505|472190820|FG000|Overall Study|Lost to Follow-up|23|||
131155011|NCT02559505|472190821|FG001|Overall Study|Lost to Follow-up|20|||
131155012|NCT02559505|472190820|FG000|Overall Study|Withdrawal by Subject|4|||
131155013|NCT02559505|472190821|FG001|Overall Study|Withdrawal by Subject|2|||
131155014|NCT00698516|472190822|FG000|Overall Study|Study Termination|2|||
131155015|NCT00698516|472190822|FG000|Overall Study|Withdrawal by Subject|3|||
131155016|NCT02586805|472190829|FG000|Overall Study|Withdrawal by Subject|3|||
131155017|NCT02586805|472190830|FG001|Overall Study|Withdrawal by Subject|1|||
131155018|NCT02586805|472190831|FG002|Overall Study|Withdrawal by Subject|1|||
131155019|NCT02586805|472190832|FG003|Overall Study|Withdrawal by Subject|2|||
131155020|NCT02586805|472190829|FG000|Overall Study|Adverse Event|2|||
131155021|NCT02586805|472190830|FG001|Overall Study|Adverse Event|0|||
131155022|NCT02586805|472190831|FG002|Overall Study|Adverse Event|1|||
130728423|NCT02257385|470627464|FG000|Overall Study|Withdrawal by Subject|4|||
130728424|NCT02257385|470627465|FG001|Overall Study|Withdrawal by Subject|4|||
130728425|NCT05199090|470627466|FG000|Overall Study|Adverse Event|1|||
130728426|NCT05199090|470627467|FG001|Overall Study|Adverse Event|4|||
130728427|NCT05199090|470627468|FG002|Overall Study|Adverse Event|0|||
131155023|NCT02586805|472190832|FG003|Overall Study|Adverse Event|0|||
131155024|NCT02586805|472190829|FG000|Overall Study|Lost to Follow-up|0|||
131155025|NCT02586805|472190830|FG001|Overall Study|Lost to Follow-up|0|||
131155026|NCT02586805|472190831|FG002|Overall Study|Lost to Follow-up|1|||
131155027|NCT02586805|472190832|FG003|Overall Study|Lost to Follow-up|0|||
131155028|NCT02586805|472190829|FG000|Overall Study|Physician Decision|1|||
131155029|NCT02586805|472190830|FG001|Overall Study|Physician Decision|0|||
131155030|NCT02586805|472190831|FG002|Overall Study|Physician Decision|0|||
131155031|NCT02586805|472190832|FG003|Overall Study|Physician Decision|0|||
131155032|NCT01859403|472190833|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
131155033|NCT01859403|472190834|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
131155034|NCT01859403|472190833|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
130728428|NCT05199090|470627469|FG003|Overall Study|Adverse Event|0|||
130728429|NCT05199090|470627470|FG004|Overall Study|Adverse Event|0|||
130780363|NCT00490971|470821510|FG003|Acute/Continuation|Adverse Event|0|||
131155035|NCT01859403|472190834|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
131155036|NCT01859403|472190833|FG000|Primary Endpoint Measure|Physician Decision|0|||
131155037|NCT01859403|472190834|FG001|Primary Endpoint Measure|Physician Decision|1|||
131155038|NCT01859403|472190833|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
131155039|NCT01859403|472190834|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
131155040|NCT00504257|472190835|FG000|Overall Study|Withdrawal by Subject|2|||
131155041|NCT00504257|472190835|FG000|Overall Study|ineligible histology|2|||
131155042|NCT02750410|472190836|FG000|Double-Blind Treatment Period|Adverse Event|2|||
130728430|NCT05199090|470627471|FG005|Overall Study|Adverse Event|0|||
130728431|NCT05199090|470627466|FG000|Overall Study|Lost to Follow-up|1|||
130728432|NCT05199090|470627467|FG001|Overall Study|Lost to Follow-up|0|||
131155043|NCT02750410|472190837|FG001|Double-Blind Treatment Period|Adverse Event|2|||
131155044|NCT02750410|472190836|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131155045|NCT02750410|472190837|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130728433|NCT05199090|470627468|FG002|Overall Study|Lost to Follow-up|1|||
130728434|NCT05199090|470627469|FG003|Overall Study|Lost to Follow-up|4|||
130728435|NCT05199090|470627470|FG004|Overall Study|Lost to Follow-up|0|||
130728436|NCT05199090|470627471|FG005|Overall Study|Lost to Follow-up|5|||
130728437|NCT05199090|470627466|FG000|Overall Study|Physician Decision|0|||
130728438|NCT05199090|470627467|FG001|Overall Study|Physician Decision|0|||
130728439|NCT05199090|470627468|FG002|Overall Study|Physician Decision|0|||
130728440|NCT05199090|470627469|FG003|Overall Study|Physician Decision|0|||
130728441|NCT05199090|470627470|FG004|Overall Study|Physician Decision|0|||
130728442|NCT05199090|470627471|FG005|Overall Study|Physician Decision|1|||
130728443|NCT05199090|470627466|FG000|Overall Study|Study terminated by sponsor|0|||
130728444|NCT05199090|470627467|FG001|Overall Study|Study terminated by sponsor|6|||
130728445|NCT05199090|470627468|FG002|Overall Study|Study terminated by sponsor|0|||
130728446|NCT05199090|470627469|FG003|Overall Study|Study terminated by sponsor|0|||
130728447|NCT05199090|470627470|FG004|Overall Study|Study terminated by sponsor|0|||
130728448|NCT05199090|470627471|FG005|Overall Study|Study terminated by sponsor|5|||
130728449|NCT05199090|470627466|FG000|Overall Study|Subject decision|0|||
130728450|NCT05199090|470627467|FG001|Overall Study|Subject decision|4|||
130728451|NCT05199090|470627468|FG002|Overall Study|Subject decision|0|||
130728452|NCT05199090|470627469|FG003|Overall Study|Subject decision|2|||
130728453|NCT05199090|470627470|FG004|Overall Study|Subject decision|5|||
130728454|NCT05199090|470627471|FG005|Overall Study|Subject decision|2|||
130728455|NCT03276078|470627473|FG000|Overall Study|Adverse Event|1|||
130728456|NCT02552732|470627474|FG000|Overall Study|Lost to Follow-up|2|||
130728457|NCT02552732|470627474|FG000|Overall Study|Physician Decision|1|||
130728458|NCT02552732|470627474|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
130728459|NCT02552732|470627474|FG000|Overall Study|Withdrawal by Subject|6|||
130728460|NCT04988087|470627477|FG000|Overall Study|Adverse Event|4|||
130728461|NCT04988087|470627478|FG001|Overall Study|Adverse Event|0|||
130728462|NCT04988087|470627479|FG002|Overall Study|Adverse Event|0|||
130728463|NCT04988087|470627480|FG003|Overall Study|Adverse Event|0|||
130728464|NCT04988087|470627477|FG000|Overall Study|Withdrawal by Subject|1|||
130728465|NCT04988087|470627478|FG001|Overall Study|Withdrawal by Subject|1|||
130728466|NCT04988087|470627479|FG002|Overall Study|Withdrawal by Subject|0|||
130728467|NCT04988087|470627480|FG003|Overall Study|Withdrawal by Subject|0|||
130728468|NCT04988087|470627477|FG000|Overall Study|Technical problems|7|||
130728469|NCT04988087|470627478|FG001|Overall Study|Technical problems|9|||
130728470|NCT04988087|470627479|FG002|Overall Study|Technical problems|1|||
130728471|NCT04988087|470627480|FG003|Overall Study|Technical problems|2|||
131155046|NCT02750410|472190836|FG000|Open-Label Extension Period|Adverse Event|5|||
131155047|NCT02750410|472190837|FG001|Open-Label Extension Period|Adverse Event|3|||
131155048|NCT02750410|472190836|FG000|Open-Label Extension Period|Protocol Violation|0|||
131155049|NCT02750410|472190837|FG001|Open-Label Extension Period|Protocol Violation|1|||
131155050|NCT02750410|472190836|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
131155051|NCT02750410|472190837|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
131155052|NCT02317510|472190838|FG000|Overall Study|Adverse Event|0|||
131155053|NCT02317510|472190839|FG001|Overall Study|Adverse Event|1|||
131155054|NCT01238120|472190840|FG000|Overall Study|Withdrawal by Subject|4|||
131155055|NCT01238120|472190841|FG001|Overall Study|Withdrawal by Subject|1|||
131155056|NCT01238120|472190842|FG002|Overall Study|Withdrawal by Subject|2|||
131155057|NCT01238120|472190843|FG003|Overall Study|Withdrawal by Subject|5|||
131155058|NCT01238120|472190840|FG000|Overall Study|Lost to Follow-up|2|||
131155059|NCT01238120|472190841|FG001|Overall Study|Lost to Follow-up|0|||
131155060|NCT01238120|472190842|FG002|Overall Study|Lost to Follow-up|1|||
131155061|NCT01238120|472190843|FG003|Overall Study|Lost to Follow-up|1|||
131155062|NCT01238120|472190840|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
131155063|NCT01238120|472190841|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
131155064|NCT01238120|472190842|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
131155065|NCT01238120|472190843|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
131155066|NCT03596164|472190845|FG000|Overall Study|Adverse Event|0|||
131155067|NCT03596164|472190846|FG001|Overall Study|Adverse Event|1|||
131155068|NCT03596164|472190845|FG000|Overall Study|Death|1|||
131155069|NCT03596164|472190846|FG001|Overall Study|Death|0|||
131155070|NCT04112914|472190847|FG000|Overall Study|Lost to Follow-up|13|||
131155071|NCT04112914|472190848|FG001|Overall Study|Lost to Follow-up|9|||
130728472|NCT02800642|470627484|FG000|Overall Study|Death|3|||
131155072|NCT04112914|472190847|FG000|Overall Study|Withdrawal by Subject|1|||
131155073|NCT04112914|472190848|FG001|Overall Study|Withdrawal by Subject|0|||
131155074|NCT03427073|472190849|FG000|Overall Study|Disease Progression|1|||
131155075|NCT03427073|472190850|FG001|Overall Study|Disease Progression|1|||
131155076|NCT03427073|472190851|FG002|Overall Study|Disease Progression|1|||
130728473|NCT02800642|470627484|FG000|Overall Study|Other|10|||
130728474|NCT02800642|470627484|FG000|Overall Study|Physician Decision|2|||
130728475|NCT02800642|470627484|FG000|Overall Study|Adverse Event|6|||
130728476|NCT02800642|470627484|FG000|Overall Study|Withdrawal by Subject|3|||
130728477|NCT02800642|470627484|FG000|Overall Study|Lost to Follow-up|1|||
130728478|NCT01004003|470627485|FG000|Overall Study|Progressive disease|2|||
130728479|NCT01004003|470627486|FG001|Overall Study|Progressive disease|1|||
131155077|NCT03427073|472190852|FG003|Overall Study|Disease Progression|3|||
131155078|NCT03427073|472190853|FG004|Overall Study|Disease Progression|3|||
131155079|NCT03427073|472190854|FG005|Overall Study|Disease Progression|4|||
131155080|NCT03427073|472190855|FG006|Overall Study|Disease Progression|2|||
131155081|NCT03427073|472190856|FG007|Overall Study|Disease Progression|3|||
131155082|NCT03427073|472190849|FG000|Overall Study|Physician Decision|0|||
131155083|NCT03427073|472190850|FG001|Overall Study|Physician Decision|0|||
131155084|NCT03427073|472190851|FG002|Overall Study|Physician Decision|0|||
131155085|NCT03427073|472190852|FG003|Overall Study|Physician Decision|0|||
131155086|NCT03427073|472190853|FG004|Overall Study|Physician Decision|0|||
131155087|NCT03427073|472190854|FG005|Overall Study|Physician Decision|0|||
131155088|NCT03427073|472190855|FG006|Overall Study|Physician Decision|1|||
131155089|NCT03427073|472190856|FG007|Overall Study|Physician Decision|1|||
131155090|NCT01486238|472190859|FG000|Overall Study|Death|0|||
131155091|NCT01486238|472190860|FG001|Overall Study|Death|2|||
131155092|NCT01486238|472190859|FG000|Overall Study|Withdrawal by Subject|2|||
131155093|NCT01486238|472190860|FG001|Overall Study|Withdrawal by Subject|1|||
131155094|NCT01486238|472190859|FG000|Overall Study|Lost to Follow-up|0|||
131155095|NCT01486238|472190860|FG001|Overall Study|Lost to Follow-up|3|||
131155096|NCT02318602|472190862|FG000|Overall Study|Adverse Event|0|||
131155097|NCT02318602|472190863|FG001|Overall Study|Adverse Event|1|||
131155098|NCT02318602|472190864|FG002|Overall Study|Adverse Event|1|||
131155099|NCT02318602|472190862|FG000|Overall Study|Withdrawal by Subject|0|||
131155100|NCT02318602|472190863|FG001|Overall Study|Withdrawal by Subject|3|||
131155101|NCT02318602|472190864|FG002|Overall Study|Withdrawal by Subject|0|||
131155102|NCT02318602|472190862|FG000|Overall Study|Death|1|||
131155103|NCT02318602|472190863|FG001|Overall Study|Death|0|||
131155104|NCT02318602|472190864|FG002|Overall Study|Death|0|||
131155105|NCT02318602|472190862|FG000|Overall Study|Guardian decision to withdraw|0|||
131155106|NCT02318602|472190863|FG001|Overall Study|Guardian decision to withdraw|0|||
131155107|NCT02318602|472190864|FG002|Overall Study|Guardian decision to withdraw|1|||
131155108|NCT00693706|472190865|FG000|Overall Study|Protocol Violation|0|||
131155109|NCT00693706|472190866|FG001|Overall Study|Protocol Violation|1|||
131155110|NCT01873950|472190867|FG000|Period 5|Withdrawal by Subject|0|||
131155111|NCT01873950|472190868|FG001|Period 5|Withdrawal by Subject|0|||
131155112|NCT01873950|472190869|FG002|Period 5|Withdrawal by Subject|0|||
131155113|NCT01873950|472190870|FG003|Period 5|Withdrawal by Subject|1|||
131155114|NCT01873950|472190871|FG004|Period 5|Withdrawal by Subject|0|||
131155115|NCT05421754|472190872|FG000|Overall Study|Technical issue with sensor|1|||
131155116|NCT02580058|472190873|FG000|Overall Study|Adverse Event|16|||
131155117|NCT02580058|472190874|FG001|Overall Study|Adverse Event|30|||
131155118|NCT02580058|472190875|FG002|Overall Study|Adverse Event|20|||
131155119|NCT02580058|472190873|FG000|Overall Study|Death|4|||
131155120|NCT02580058|472190874|FG001|Overall Study|Death|4|||
131155121|NCT02580058|472190875|FG002|Overall Study|Death|5|||
131155122|NCT02580058|472190873|FG000|Overall Study|Physician Decision|1|||
131155123|NCT02580058|472190874|FG001|Overall Study|Physician Decision|3|||
131155124|NCT02580058|472190875|FG002|Overall Study|Physician Decision|11|||
131155125|NCT02580058|472190873|FG000|Overall Study|Other|5|||
131155126|NCT02580058|472190874|FG001|Overall Study|Other|1|||
131155127|NCT02580058|472190875|FG002|Overall Study|Other|3|||
131155128|NCT02580058|472190873|FG000|Overall Study|Withdrawal by Subject|4|||
131155129|NCT02580058|472190874|FG001|Overall Study|Withdrawal by Subject|7|||
131155130|NCT02580058|472190875|FG002|Overall Study|Withdrawal by Subject|31|||
131155131|NCT02580058|472190873|FG000|Overall Study|Global Deterioration of Health Status|19|||
131155132|NCT02580058|472190874|FG001|Overall Study|Global Deterioration of Health Status|18|||
131155133|NCT02580058|472190875|FG002|Overall Study|Global Deterioration of Health Status|24|||
131155134|NCT02580058|472190873|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
131155135|NCT02580058|472190874|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131155136|NCT02580058|472190875|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
131155137|NCT02580058|472190873|FG000|Overall Study|Progressive Disease|137|||
131155138|NCT02580058|472190874|FG001|Overall Study|Progressive Disease|125|||
131155139|NCT02580058|472190875|FG002|Overall Study|Progressive Disease|94|||
131155140|NCT02580058|472190873|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131155141|NCT02580058|472190874|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131155142|NCT02580058|472190875|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131155143|NCT01193335|472190877|FG000|After Infant Series|Lost to Follow-up|1|||
131155144|NCT01193335|472190878|FG001|After Infant Series|Lost to Follow-up|2|||
131155145|NCT01193335|472190877|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
131155146|NCT01193335|472190878|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
131155147|NCT01193335|472190877|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
131155148|NCT01193335|472190878|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
131155149|NCT01193335|472190877|FG000|1-Year Follow-up|Lost to Follow-up|4|||
131155150|NCT01193335|472190878|FG001|1-Year Follow-up|Lost to Follow-up|0|||
131155151|NCT01193335|472190877|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
131155152|NCT01193335|472190878|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
131155153|NCT01193335|472190877|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
131155154|NCT01193335|472190878|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
131155155|NCT01733329|472190879|FG000|Overall Study|Protocol Violation|1|||
131155156|NCT01733329|472190880|FG001|Overall Study|Protocol Violation|1|||
131155157|NCT01733329|472190879|FG000|Overall Study|Uterine artery injury|1|||
131155158|NCT01733329|472190880|FG001|Overall Study|Uterine artery injury|0|||
131155159|NCT02388776|472190884|FG000|Overall Study|Death|1|||
131155160|NCT02388776|472190884|FG000|Overall Study|Lost to Follow-up|1|||
131155161|NCT03826914|472190885|FG000|Overall Study|Withdrawal by Subject|1|||
131155162|NCT03826914|472190886|FG001|Overall Study|Withdrawal by Subject|1|||
131155163|NCT04233424|472190895|FG000|Overall Study|Death|15|||
131155164|NCT04233424|472190896|FG001|Overall Study|Death|16|||
131155165|NCT04233424|472190895|FG000|Overall Study|Withdrawal by Subject|2|||
131155166|NCT04233424|472190896|FG001|Overall Study|Withdrawal by Subject|8|||
131155167|NCT04233424|472190895|FG000|Overall Study|Physician Decision|1|||
131155168|NCT04233424|472190896|FG001|Overall Study|Physician Decision|3|||
131155169|NCT04233424|472190895|FG000|Overall Study|Protocol Violation|3|||
131155170|NCT04233424|472190896|FG001|Overall Study|Protocol Violation|1|||
131155171|NCT04233424|472190895|FG000|Overall Study|Lost to Follow-up|1|||
131155172|NCT04233424|472190896|FG001|Overall Study|Lost to Follow-up|3|||
131155173|NCT04233424|472190895|FG000|Overall Study|subject refuse to visit site|2|||
131155174|NCT04233424|472190896|FG001|Overall Study|subject refuse to visit site|0|||
131155175|NCT03517436|472190897|FG000|Overall Study|Death|3|||
131155176|NCT03517436|472190897|FG000|Overall Study|Withdrawal by Subject|4|||
131155177|NCT03517436|472190897|FG000|Overall Study|Did not receive study valve.|1|||
131155178|NCT02698189|472190898|FG000|Overall Study|Physician Decision|3|||
131155179|NCT02698189|472190899|FG001|Overall Study|Physician Decision|0|||
131155180|NCT02698189|472190898|FG000|Overall Study|Progressive disease|0|||
131155181|NCT02698189|472190899|FG001|Overall Study|Progressive disease|5|||
131155182|NCT02698189|472190898|FG000|Overall Study|Study terminated by sponsor|0|||
131155183|NCT02698189|472190899|FG001|Overall Study|Study terminated by sponsor|1|||
131155184|NCT04375878|472190904|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
131155185|NCT04375878|472190905|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
131155186|NCT04375878|472190906|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
131155187|NCT04375878|472190907|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
131155188|NCT04375878|472190908|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
131155189|NCT04375878|472190909|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
131155190|NCT04375878|472190904|FG000|Crossover First and Second Interventions|Adverse Event|0|||
131155191|NCT04375878|472190905|FG001|Crossover First and Second Interventions|Adverse Event|0|||
131155192|NCT04375878|472190906|FG002|Crossover First and Second Interventions|Adverse Event|1|||
131155193|NCT04375878|472190907|FG003|Crossover First and Second Interventions|Adverse Event|0|||
131155194|NCT04375878|472190908|FG004|Crossover First and Second Interventions|Adverse Event|0|||
131155195|NCT04375878|472190909|FG005|Crossover First and Second Interventions|Adverse Event|0|||
131155196|NCT04375878|472190904|FG000|Extension Phase|Withdrawal by Subject|0|||
131155197|NCT04375878|472190905|FG001|Extension Phase|Withdrawal by Subject|0|||
131155198|NCT04375878|472190906|FG002|Extension Phase|Withdrawal by Subject|0|||
131155199|NCT04375878|472190907|FG003|Extension Phase|Withdrawal by Subject|0|||
131155200|NCT04375878|472190908|FG004|Extension Phase|Withdrawal by Subject|1|||
131155201|NCT04375878|472190909|FG005|Extension Phase|Withdrawal by Subject|0|||
131155202|NCT01254344|472190910|FG000|Overall Study|Adverse Event|2|||
131155203|NCT01254344|472190911|FG001|Overall Study|Adverse Event|5|||
131155204|NCT01254344|472190910|FG000|Overall Study|Physician Decision|7|||
131155205|NCT01254344|472190911|FG001|Overall Study|Physician Decision|4|||
131155206|NCT01254344|472190910|FG000|Overall Study|Protocol Violation|1|||
131155207|NCT01254344|472190911|FG001|Overall Study|Protocol Violation|4|||
131155208|NCT01254344|472190910|FG000|Overall Study|Withdrawal by Subject|3|||
131155209|NCT01254344|472190911|FG001|Overall Study|Withdrawal by Subject|6|||
131155210|NCT01982630|472190912|FG000|Overall Study|Adverse Event|2|||
131155211|NCT01982630|472190913|FG001|Overall Study|Adverse Event|0|||
131155212|NCT01982630|472190914|FG002|Overall Study|Adverse Event|1|||
131155213|NCT01982630|472190915|FG003|Overall Study|Adverse Event|0|||
131155214|NCT01982630|472190916|FG004|Overall Study|Adverse Event|1|||
131155215|NCT01982630|472190917|FG005|Overall Study|Adverse Event|2|||
131155216|NCT01982630|472190918|FG006|Overall Study|Adverse Event|1|||
131155217|NCT01982630|472190919|FG007|Overall Study|Adverse Event|0|||
131155218|NCT01982630|472190912|FG000|Overall Study|Physician Decision|1|||
131155219|NCT01982630|472190913|FG001|Overall Study|Physician Decision|0|||
131155220|NCT01982630|472190914|FG002|Overall Study|Physician Decision|2|||
131155221|NCT01982630|472190915|FG003|Overall Study|Physician Decision|1|||
131155222|NCT01982630|472190916|FG004|Overall Study|Physician Decision|2|||
131155223|NCT01982630|472190917|FG005|Overall Study|Physician Decision|0|||
131155224|NCT01982630|472190918|FG006|Overall Study|Physician Decision|0|||
131155225|NCT01982630|472190919|FG007|Overall Study|Physician Decision|0|||
131155226|NCT01982630|472190912|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131155227|NCT01982630|472190913|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131155228|NCT01982630|472190914|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
131155229|NCT01982630|472190915|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130728480|NCT01004003|470627487|FG002|Overall Study|Progressive disease|1|||
130728481|NCT01004003|470627488|FG003|Overall Study|Progressive disease|0|||
130728482|NCT01004003|470627489|FG004|Overall Study|Progressive disease|2|||
130728483|NCT01004003|470627490|FG005|Overall Study|Progressive disease|1|||
130728484|NCT01004003|470627491|FG006|Overall Study|Progressive disease|1|||
130728485|NCT01004003|470627492|FG007|Overall Study|Progressive disease|39|||
130728486|NCT01004003|470627493|FG008|Overall Study|Progressive disease|22|||
130728487|NCT01004003|470627485|FG000|Overall Study|Adverse Event|4|||
130728488|NCT01004003|470627486|FG001|Overall Study|Adverse Event|2|||
130728489|NCT01004003|470627487|FG002|Overall Study|Adverse Event|3|||
130728490|NCT01004003|470627488|FG003|Overall Study|Adverse Event|3|||
130728491|NCT01004003|470627489|FG004|Overall Study|Adverse Event|2|||
130728492|NCT01004003|470627490|FG005|Overall Study|Adverse Event|2|||
130728493|NCT01004003|470627491|FG006|Overall Study|Adverse Event|7|||
131155230|NCT01982630|472190916|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131155231|NCT01982630|472190917|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131155232|NCT01982630|472190918|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131155233|NCT01982630|472190919|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
131155234|NCT01982630|472190912|FG000|Overall Study|Withdrawal by Subject|0|||
131155235|NCT01982630|472190913|FG001|Overall Study|Withdrawal by Subject|0|||
131155236|NCT01982630|472190914|FG002|Overall Study|Withdrawal by Subject|0|||
131155237|NCT01982630|472190915|FG003|Overall Study|Withdrawal by Subject|0|||
131155238|NCT01982630|472190916|FG004|Overall Study|Withdrawal by Subject|0|||
131155239|NCT01982630|472190917|FG005|Overall Study|Withdrawal by Subject|1|||
131155240|NCT01982630|472190918|FG006|Overall Study|Withdrawal by Subject|0|||
131155241|NCT01982630|472190919|FG007|Overall Study|Withdrawal by Subject|0|||
131155242|NCT00820040|472190922|FG000|Overall Study|Death|1|||
131155243|NCT00820040|472190922|FG000|Overall Study|Sponsor terminated study|1|||
131155244|NCT00820040|472190922|FG000|Overall Study|Screen failure|1|||
131155245|NCT01259466|472190927|FG000|Overall Study|Withdrawal by Subject|1|||
131155246|NCT01259466|472190928|FG001|Overall Study|Withdrawal by Subject|9|||
131155247|NCT01824602|472190929|FG000|Overall Study|Withdrawal by Subject|0|||
131155248|NCT01824602|472190930|FG001|Overall Study|Withdrawal by Subject|0|||
131155249|NCT01824602|472190931|FG002|Overall Study|Withdrawal by Subject|1|||
131155250|NCT01824602|472190932|FG003|Overall Study|Withdrawal by Subject|2|||
131155251|NCT01824602|472190929|FG000|Overall Study|Patient non-compliance|0|||
131155252|NCT01824602|472190930|FG001|Overall Study|Patient non-compliance|0|||
131155253|NCT01824602|472190931|FG002|Overall Study|Patient non-compliance|1|||
131155254|NCT01824602|472190932|FG003|Overall Study|Patient non-compliance|0|||
131155255|NCT01824602|472190929|FG000|Overall Study|Adverse Event|1|||
131155256|NCT01824602|472190930|FG001|Overall Study|Adverse Event|0|||
131155257|NCT01824602|472190931|FG002|Overall Study|Adverse Event|2|||
131155258|NCT01824602|472190932|FG003|Overall Study|Adverse Event|2|||
131155259|NCT01824602|472190929|FG000|Overall Study|Treatment failure|0|||
131155260|NCT01824602|472190930|FG001|Overall Study|Treatment failure|0|||
131155261|NCT01824602|472190931|FG002|Overall Study|Treatment failure|0|||
131155262|NCT01824602|472190932|FG003|Overall Study|Treatment failure|1|||
131155263|NCT05300087|472190935|FG000|Overall Study|Withdrawal by Subject|0|||
131155264|NCT05300087|472190936|FG001|Overall Study|Withdrawal by Subject|1|||
131155265|NCT03248128|472190937|FG000|Overall Study|Lost to Follow-up|1|||
131155266|NCT03248128|472190938|FG001|Overall Study|Lost to Follow-up|0|||
131155267|NCT03248128|472190937|FG000|Overall Study|Withdrawal by Subject|16|||
131155268|NCT03248128|472190938|FG001|Overall Study|Withdrawal by Subject|14|||
131155269|NCT03248128|472190937|FG000|Overall Study|Site Closed|4|||
131155270|NCT03248128|472190938|FG001|Overall Study|Site Closed|3|||
131155271|NCT03248128|472190937|FG000|Overall Study|Randomized, but did not receive treatment|1|||
131155272|NCT03248128|472190938|FG001|Overall Study|Randomized, but did not receive treatment|3|||
131155273|NCT01914679|472190939|FG000|Overall Study|Lack of Efficacy|1|||
131155274|NCT01914679|472190939|FG000|Overall Study|Sponsor terminated study|4|||
131155275|NCT02722044|472190940|FG000|Overall Study|Adverse Event|2|||
131155276|NCT02722044|472190940|FG000|Overall Study|Physician Decision|1|||
131155277|NCT02722044|472190940|FG000|Overall Study|Withdrawal by Subject|1|||
131155278|NCT02722044|472190940|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
130728494|NCT01004003|470627492|FG007|Overall Study|Adverse Event|21|||
131155279|NCT00002850|472190942|FG000|Overall Study|Death|4|||
131155280|NCT00002850|472190943|FG001|Overall Study|Death|1|||
131155281|NCT00002850|472190944|FG002|Overall Study|Death|3|||
131155282|NCT00002850|472190942|FG000|Overall Study|Protocol Violation|1|||
131155283|NCT00002850|472190943|FG001|Overall Study|Protocol Violation|0|||
131155284|NCT00002850|472190944|FG002|Overall Study|Protocol Violation|1|||
131155285|NCT00002850|472190942|FG000|Overall Study|Withdrawal by Subject|0|||
131155286|NCT00002850|472190943|FG001|Overall Study|Withdrawal by Subject|1|||
131155287|NCT00002850|472190944|FG002|Overall Study|Withdrawal by Subject|0|||
130728495|NCT01004003|470627493|FG008|Overall Study|Adverse Event|6|||
130728496|NCT01004003|470627485|FG000|Overall Study|Refused to continue taking trial med.|0|||
130728497|NCT01004003|470627486|FG001|Overall Study|Refused to continue taking trial med.|0|||
130780364|NCT00490971|470821511|FG004|Acute/Continuation|Adverse Event|0|||
130728498|NCT01004003|470627487|FG002|Overall Study|Refused to continue taking trial med.|0|||
130728499|NCT01004003|470627488|FG003|Overall Study|Refused to continue taking trial med.|0|||
130728500|NCT01004003|470627489|FG004|Overall Study|Refused to continue taking trial med.|0|||
130728501|NCT01004003|470627490|FG005|Overall Study|Refused to continue taking trial med.|0|||
131155288|NCT00756002|472192287|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
131155289|NCT00756002|472192288|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
131155290|NCT00756002|472192287|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131155291|NCT00756002|472192288|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
131155292|NCT00756002|472192287|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
131155293|NCT00756002|472192288|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
131155294|NCT00756002|472192287|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
131155295|NCT00756002|472192288|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
131155296|NCT00756002|472192287|FG000|Double-Blind Treatment Period|Other|2|||
131155297|NCT00756002|472192288|FG001|Double-Blind Treatment Period|Other|2|||
131155298|NCT01126619|472192289|FG000|Overall Study|Not eligible for the study|2|||
131155299|NCT01126619|472192289|FG000|Overall Study|Investigator decision|4|||
131155300|NCT01126619|472192289|FG000|Overall Study|Serious adverse event|1|||
131155301|NCT01126619|472192289|FG000|Overall Study|Withdrawal by Subject|9|||
131155302|NCT01126619|472192289|FG000|Overall Study|Non-compliance|1|||
131155303|NCT00892437|472192298|FG000|Randomized Phase|Randomized but not treated|6|||
131155304|NCT00892437|472192299|FG001|Randomized Phase|Randomized but not treated|0|||
131155305|NCT00892437|472192298|FG000|Randomized Phase|Adverse Event|2|||
131155306|NCT00892437|472192299|FG001|Randomized Phase|Adverse Event|2|||
131155307|NCT00892437|472192298|FG000|Randomized Phase|Lost to Follow-up|1|||
131155308|NCT00892437|472192299|FG001|Randomized Phase|Lost to Follow-up|3|||
131155309|NCT00892437|472192298|FG000|Randomized Phase|Investigator's Discretion|1|||
131155310|NCT00892437|472192299|FG001|Randomized Phase|Investigator's Discretion|0|||
131155311|NCT00892437|472192298|FG000|Randomized Phase|Withdrew Consent|1|||
131155312|NCT00892437|472192299|FG001|Randomized Phase|Withdrew Consent|0|||
131155313|NCT00892437|472192298|FG000|Open-Label Extension Phase|Adverse Event|4|||
131155314|NCT00892437|472192299|FG001|Open-Label Extension Phase|Adverse Event|2|||
131155315|NCT00892437|472192298|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
131155316|NCT00892437|472192299|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
131155317|NCT00892437|472192298|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
131155318|NCT00892437|472192299|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
131155319|NCT00892437|472192298|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
131155320|NCT00892437|472192299|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
131155321|NCT00892437|472192298|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
131155322|NCT00892437|472192299|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
131155323|NCT03185130|472192300|FG000|Overall Study|Withdrawal by Subject|0|||
131155324|NCT03185130|472192301|FG001|Overall Study|Withdrawal by Subject|2|||
131155325|NCT01925703|472192302|FG000|Overall Study|Physician Decision|1|||
131155326|NCT01925703|472192302|FG000|Overall Study|Lost to Follow-up|2|||
131155327|NCT01925703|472192302|FG000|Overall Study|Discharge prior to full iron repletion|1|||
131155328|NCT02498652|472192310|FG000|Overall Study|Protocol Violation|0|||
131155329|NCT02498652|472192311|FG001|Overall Study|Protocol Violation|1|||
131155330|NCT02500550|472192316|FG000|Overall Study|Death|7|||
131155331|NCT04334148|472192317|FG000|Overall Study|positive nasal swab at baseline|0|||
131155332|NCT04334148|472192318|FG001|Overall Study|positive nasal swab at baseline|1|||
131155333|NCT00922935|472192319|FG000|Overall Study|Protocol Violation|0|||
131155334|NCT00922935|472192320|FG001|Overall Study|Protocol Violation|3|||
131155335|NCT00922935|472192321|FG002|Overall Study|Protocol Violation|0|||
131155336|NCT00922935|472192319|FG000|Overall Study|Physician Decision|1|||
131155337|NCT00922935|472192320|FG001|Overall Study|Physician Decision|1|||
131155338|NCT00922935|472192321|FG002|Overall Study|Physician Decision|0|||
131155339|NCT00922935|472192319|FG000|Overall Study|Lost to Follow-up|0|||
131155340|NCT00922935|472192320|FG001|Overall Study|Lost to Follow-up|1|||
131155341|NCT00922935|472192321|FG002|Overall Study|Lost to Follow-up|0|||
131155342|NCT00542828|472192322|FG000|Overall Study|Physician Decision|1|||
131155343|NCT00542828|472192322|FG000|Overall Study|Need for Prohibited Treatment|3|||
131155344|NCT00542828|472192322|FG000|Overall Study|Study Prematurely Discontinued|7|||
130728502|NCT01004003|470627491|FG006|Overall Study|Refused to continue taking trial med.|0|||
130728503|NCT01004003|470627492|FG007|Overall Study|Refused to continue taking trial med.|0|||
131155345|NCT00542828|472192322|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
131155346|NCT01499576|472192325|FG000|Overall Study|Physician Decision|12|||
131155347|NCT01499576|472192325|FG000|Overall Study|Withdrawal by Subject|9|||
131155348|NCT03228186|472192326|FG000|Overall Study|Patient never started treatment|1|||
131155349|NCT04283461|472192327|FG000|Overall Study|Enrolled in separate trial|0|||
131155350|NCT04283461|472192328|FG001|Overall Study|Enrolled in separate trial|0|||
131155351|NCT04283461|472192329|FG002|Overall Study|Enrolled in separate trial|8|||
131155352|NCT04283461|472192330|FG003|Overall Study|Enrolled in separate trial|13|||
131235207|NCT02579096|472488867|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
130728504|NCT01004003|470627493|FG008|Overall Study|Refused to continue taking trial med.|2|||
131155353|NCT04283461|472192331|FG004|Overall Study|Enrolled in separate trial|12|||
131155354|NCT04283461|472192332|FG005|Overall Study|Enrolled in separate trial|0|||
131155355|NCT04283461|472192333|FG006|Overall Study|Enrolled in separate trial|0|||
131155356|NCT04283461|472192334|FG007|Overall Study|Enrolled in separate trial|8|||
131155357|NCT04283461|472192335|FG008|Overall Study|Enrolled in separate trial|0|||
131155358|NCT04283461|472192336|FG009|Overall Study|Enrolled in separate trial|0|||
131155359|NCT04283461|472192337|FG010|Overall Study|Enrolled in separate trial|0|||
131155360|NCT04283461|472192338|FG011|Overall Study|Enrolled in separate trial|7|||
131155361|NCT04283461|472192339|FG012|Overall Study|Enrolled in separate trial|0|||
131155362|NCT04246047|472192340|FG000|Overall Study|Death|50|||
131155363|NCT04246047|472192341|FG001|Overall Study|Death|77|||
131155364|NCT04246047|472192340|FG000|Overall Study|Lost to Follow-up|1|||
131155365|NCT04246047|472192341|FG001|Overall Study|Lost to Follow-up|3|||
131155366|NCT04246047|472192340|FG000|Overall Study|Physician Decision|4|||
131155367|NCT04246047|472192341|FG001|Overall Study|Physician Decision|10|||
131155368|NCT04246047|472192340|FG000|Overall Study|Withdrawal by Subject|19|||
131155369|NCT04246047|472192341|FG001|Overall Study|Withdrawal by Subject|26|||
131155370|NCT04246047|472192340|FG000|Overall Study|Ongoing|169|||
131155371|NCT04246047|472192341|FG001|Overall Study|Ongoing|135|||
131155372|NCT05139030|472192345|FG000|Overall Study|Withdrawal by Subject|1|||
131155373|NCT05139030|472192346|FG001|Overall Study|Withdrawal by Subject|3|||
131155374|NCT05139030|472192345|FG000|Overall Study|Adverse Event|0|||
131155375|NCT05139030|472192346|FG001|Overall Study|Adverse Event|1|||
131155376|NCT05139030|472192345|FG000|Overall Study|Failure to meet continuation criteria|0|||
131155377|NCT05139030|472192346|FG001|Overall Study|Failure to meet continuation criteria|1|||
131155378|NCT02502864|472192354|FG000|Overall Study|Withdrawal by Subject|1|||
131155379|NCT03772327|472192355|FG000|Overall Study|Lost to Follow-up|3|||
131155380|NCT03772327|472192356|FG001|Overall Study|Lost to Follow-up|4|||
131155381|NCT03772327|472192355|FG000|Overall Study|Withdrawal by Subject|2|||
131155382|NCT03772327|472192356|FG001|Overall Study|Withdrawal by Subject|3|||
131155383|NCT00587223|472192360|FG000|Overall Study|Adverse Event|1|||
131155384|NCT00195351|472192361|FG000|Overall Study|Lost to Follow-up|9|||
131155385|NCT00195351|472192362|FG001|Overall Study|Lost to Follow-up|9|||
131155386|NCT00195351|472192361|FG000|Overall Study|Withdrawal by Subject|6|||
131155387|NCT00195351|472192362|FG001|Overall Study|Withdrawal by Subject|3|||
131155388|NCT00195351|472192361|FG000|Overall Study|Protocol Deviation|3|||
131155389|NCT00195351|472192362|FG001|Overall Study|Protocol Deviation|2|||
131155390|NCT00195351|472192361|FG000|Overall Study|Death|3|||
131155391|NCT00195351|472192362|FG001|Overall Study|Death|1|||
131155392|NCT00195351|472192361|FG000|Overall Study|Lack of Efficacy|0|||
131155393|NCT00195351|472192362|FG001|Overall Study|Lack of Efficacy|1|||
131155394|NCT02493751|472192363|FG000|Overall Study|Withdrawal by Subject|2|||
131155395|NCT02493751|472192364|FG001|Overall Study|Withdrawal by Subject|8|||
131155396|NCT02493751|472192363|FG000|Overall Study|Death|6|||
131155397|NCT02493751|472192364|FG001|Overall Study|Death|13|||
131155398|NCT02493751|472192363|FG000|Overall Study|Lost to Follow-up|2|||
131155399|NCT02493751|472192364|FG001|Overall Study|Lost to Follow-up|3|||
131155400|NCT02493751|472192363|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
131155401|NCT02493751|472192364|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
131155402|NCT02296840|472192367|FG000|Overall Study|Adverse Event|1|||
131155403|NCT02296840|472192368|FG001|Overall Study|Adverse Event|1|||
131155404|NCT02296840|472192367|FG000|Overall Study|Protocol Violation|2|||
131155405|NCT02296840|472192368|FG001|Overall Study|Protocol Violation|1|||
131155406|NCT02296840|472192367|FG000|Overall Study|Lost to Follow-up|6|||
131155407|NCT02296840|472192368|FG001|Overall Study|Lost to Follow-up|17|||
131155408|NCT00104871|472192369|FG000|Overall Study|Not evaluable|1|||
131155409|NCT00761215|472192372|FG000|Overall Study|Randomized but didn't receive drug|1|||
131155410|NCT00761215|472192373|FG001|Overall Study|Randomized but didn't receive drug|1|||
131155411|NCT00761215|472192374|FG002|Overall Study|Randomized but didn't receive drug|2|||
131155412|NCT00761215|472192372|FG000|Overall Study|Lost to Follow-up|6|||
131155413|NCT00761215|472192373|FG001|Overall Study|Lost to Follow-up|3|||
131155414|NCT00761215|472192374|FG002|Overall Study|Lost to Follow-up|6|||
131155415|NCT00761215|472192372|FG000|Overall Study|Withdrawal by Subject|1|||
131155416|NCT00761215|472192373|FG001|Overall Study|Withdrawal by Subject|0|||
131155417|NCT00761215|472192374|FG002|Overall Study|Withdrawal by Subject|0|||
131155418|NCT00761215|472192372|FG000|Overall Study|Bacteremia|1|||
131155419|NCT00761215|472192373|FG001|Overall Study|Bacteremia|0|||
131155420|NCT00761215|472192374|FG002|Overall Study|Bacteremia|0|||
131155421|NCT01450137|472192385|FG000|Up to Week 12|Adverse Event|2|||
131155422|NCT01450137|472192386|FG001|Up to Week 12|Adverse Event|1|||
131155423|NCT01450137|472192385|FG000|Up to Week 12|Withdrawal by Subject|0|||
131155424|NCT01450137|472192386|FG001|Up to Week 12|Withdrawal by Subject|2|||
131155425|NCT01450137|472192385|FG000|Week 12 to Study End|Death|0|||
131155426|NCT01450137|472192386|FG001|Week 12 to Study End|Death|1|||
131155427|NCT01450137|472192385|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
131155428|NCT01450137|472192386|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
131155429|NCT01687673|472192399|FG000|Overall Study|Physician Decision|1|||
131155430|NCT00618956|472192400|FG000|Overall Study|Adverse Event|10|||
131155431|NCT00618956|472192401|FG001|Overall Study|Adverse Event|34|||
131155432|NCT00618956|472192400|FG000|Overall Study|Lack of Efficacy|2|||
131155433|NCT00618956|472192401|FG001|Overall Study|Lack of Efficacy|1|||
131155434|NCT00618956|472192400|FG000|Overall Study|Withdrawal by Subject|5|||
131155435|NCT00618956|472192401|FG001|Overall Study|Withdrawal by Subject|7|||
131155436|NCT00618956|472192400|FG000|Overall Study|Lost to Follow-up|4|||
131155437|NCT00618956|472192401|FG001|Overall Study|Lost to Follow-up|5|||
131155438|NCT00618956|472192400|FG000|Overall Study|Protocol Violation|2|||
131155439|NCT00618956|472192401|FG001|Overall Study|Protocol Violation|2|||
131155440|NCT00618956|472192400|FG000|Overall Study|did not meet criteria, non-compliance|2|||
131155441|NCT00618956|472192401|FG001|Overall Study|did not meet criteria, non-compliance|1|||
131155442|NCT02006576|472192403|FG000|Overall Study|Withdrawal by Subject|4|||
131155443|NCT02006576|472192404|FG001|Overall Study|Withdrawal by Subject|6|||
131155444|NCT02006576|472192405|FG002|Overall Study|Withdrawal by Subject|2|||
131155445|NCT02006576|472192403|FG000|Overall Study|Death|0|||
131155446|NCT02006576|472192404|FG001|Overall Study|Death|0|||
131155447|NCT02006576|472192405|FG002|Overall Study|Death|1|||
131155448|NCT02006576|472192403|FG000|Overall Study|Lost to Follow-up|1|||
131155449|NCT02006576|472192404|FG001|Overall Study|Lost to Follow-up|0|||
131155450|NCT02006576|472192405|FG002|Overall Study|Lost to Follow-up|1|||
131155451|NCT02006576|472192403|FG000|Overall Study|Screen Failure, too sick, other|13|||
131155452|NCT02006576|472192404|FG001|Overall Study|Screen Failure, too sick, other|1|||
131155453|NCT02006576|472192405|FG002|Overall Study|Screen Failure, too sick, other|13|||
131155454|NCT03478683|472192406|FG000|Overall Study|Adverse Event|5|||
131155455|NCT03478683|472192407|FG001|Overall Study|Adverse Event|3|||
131155456|NCT03478683|472192406|FG000|Overall Study|Lost to Follow-up|0|||
131155457|NCT03478683|472192407|FG001|Overall Study|Lost to Follow-up|5|||
131155458|NCT03478683|472192406|FG000|Overall Study|Physician Decision|1|||
131155459|NCT03478683|472192407|FG001|Overall Study|Physician Decision|3|||
131155460|NCT03478683|472192406|FG000|Overall Study|Withdrawal by Subject|7|||
131155461|NCT03478683|472192407|FG001|Overall Study|Withdrawal by Subject|7|||
131155462|NCT02332915|472192414|FG000|Overall Study|Moved out of region|3|||
131155463|NCT02332915|472192415|FG001|Overall Study|Moved out of region|0|||
131155464|NCT02332915|472192414|FG000|Overall Study|Unrelated illness|1|||
131155465|NCT02332915|472192415|FG001|Overall Study|Unrelated illness|1|||
131155466|NCT02332915|472192414|FG000|Overall Study|Travel distance prohibitive|0|||
131155467|NCT02332915|472192415|FG001|Overall Study|Travel distance prohibitive|1|||
131155468|NCT02332915|472192414|FG000|Overall Study|did not meet inclusion criteria|2|||
131155469|NCT02332915|472192415|FG001|Overall Study|did not meet inclusion criteria|4|||
131155470|NCT05847881|472192419|FG000|Overall Study|Principal Investigator Decision|8|||
131155471|NCT05847881|472192419|FG000|Overall Study|Withdrawal by Subject|2|||
131155472|NCT01084252|472194200|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155473|NCT01084252|472194201|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155474|NCT01084252|472194202|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155475|NCT01084252|472194203|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155476|NCT01084252|472194204|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155477|NCT01084252|472194205|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155478|NCT01084252|472194206|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155479|NCT01084252|472194207|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155480|NCT01084252|472194208|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155481|NCT01084252|472194209|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155482|NCT01084252|472194210|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155483|NCT01084252|472194211|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155484|NCT01084252|472194212|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
131155485|NCT01084252|472194213|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
131155486|NCT04493619|472194215|FG000|Overall Study|Death|4|||
131155487|NCT04493619|472194216|FG001|Overall Study|Death|3|||
131155488|NCT04493619|472194217|FG002|Overall Study|Death|3|||
131155489|NCT04493619|472194218|FG003|Overall Study|Death|4|||
131155490|NCT04493619|472194215|FG000|Overall Study|Study discontinued early|10|||
131155491|NCT04493619|472194216|FG001|Overall Study|Study discontinued early|0|||
131155492|NCT04493619|472194217|FG002|Overall Study|Study discontinued early|4|||
131155493|NCT04493619|472194218|FG003|Overall Study|Study discontinued early|8|||
131155494|NCT04493619|472194215|FG000|Overall Study|Lost to Follow-up|0|||
131155495|NCT04493619|472194216|FG001|Overall Study|Lost to Follow-up|0|||
131155496|NCT04493619|472194217|FG002|Overall Study|Lost to Follow-up|0|||
131155497|NCT04493619|472194218|FG003|Overall Study|Lost to Follow-up|1|||
131155498|NCT02128490|472194221|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
131155499|NCT02128490|472194222|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
131155500|NCT02128490|472194223|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
131155501|NCT02128490|472194224|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
131155502|NCT02128490|472194225|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
131155503|NCT02128490|472194221|FG000|Overall Study|Major Protocol Deviation|1|||
131155504|NCT02128490|472194222|FG001|Overall Study|Major Protocol Deviation|2|||
131155505|NCT02128490|472194223|FG002|Overall Study|Major Protocol Deviation|0|||
131155506|NCT02128490|472194224|FG003|Overall Study|Major Protocol Deviation|2|||
131155507|NCT02128490|472194225|FG004|Overall Study|Major Protocol Deviation|2|||
131155508|NCT02128490|472194221|FG000|Overall Study|Lost to Follow-up|0|||
131155509|NCT02128490|472194222|FG001|Overall Study|Lost to Follow-up|0|||
131155510|NCT02128490|472194223|FG002|Overall Study|Lost to Follow-up|1|||
131155511|NCT02128490|472194224|FG003|Overall Study|Lost to Follow-up|1|||
131155512|NCT02128490|472194225|FG004|Overall Study|Lost to Follow-up|1|||
131155513|NCT02128490|472194221|FG000|Overall Study|Voluntary Withdrawal|3|||
131155514|NCT02128490|472194222|FG001|Overall Study|Voluntary Withdrawal|3|||
131155515|NCT02128490|472194223|FG002|Overall Study|Voluntary Withdrawal|1|||
131155516|NCT02128490|472194224|FG003|Overall Study|Voluntary Withdrawal|1|||
131155517|NCT02128490|472194225|FG004|Overall Study|Voluntary Withdrawal|2|||
131155518|NCT02128490|472194221|FG000|Overall Study|Lack of Efficacy|0|||
131155519|NCT02128490|472194222|FG001|Overall Study|Lack of Efficacy|1|||
131155520|NCT02128490|472194223|FG002|Overall Study|Lack of Efficacy|0|||
131155521|NCT02128490|472194224|FG003|Overall Study|Lack of Efficacy|0|||
131155522|NCT02128490|472194225|FG004|Overall Study|Lack of Efficacy|0|||
131155523|NCT02128490|472194221|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
131155524|NCT02128490|472194222|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
131155525|NCT02128490|472194223|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
131155526|NCT02128490|472194224|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
131155527|NCT02128490|472194225|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
131155528|NCT02128490|472194221|FG000|Overall Study|Other Miscellaneous Reasons|0|||
131155529|NCT02128490|472194222|FG001|Overall Study|Other Miscellaneous Reasons|0|||
131155530|NCT02128490|472194223|FG002|Overall Study|Other Miscellaneous Reasons|2|||
131155531|NCT02128490|472194224|FG003|Overall Study|Other Miscellaneous Reasons|1|||
131155532|NCT02128490|472194225|FG004|Overall Study|Other Miscellaneous Reasons|1|||
131155533|NCT02243176|472194226|FG000|Overall Study|Other reason|1|||
131155534|NCT02243176|472194227|FG001|Overall Study|Other reason|2|||
131155535|NCT02243176|472194226|FG000|Overall Study|protocol specified withdrawal critera|1|||
131155536|NCT02243176|472194227|FG001|Overall Study|protocol specified withdrawal critera|3|||
131155537|NCT02243176|472194226|FG000|Overall Study|Protocol Violation|2|||
131155538|NCT02243176|472194227|FG001|Overall Study|Protocol Violation|1|||
131155539|NCT02243176|472194226|FG000|Overall Study|Withdrawal by Subject|8|||
131155540|NCT02243176|472194227|FG001|Overall Study|Withdrawal by Subject|7|||
131155541|NCT02243176|472194226|FG000|Overall Study|Adverse Event|2|||
131155542|NCT02243176|472194227|FG001|Overall Study|Adverse Event|2|||
131155543|NCT02342171|472194231|FG000|Overall Study|Death|4|||
131155544|NCT02342171|472194232|FG001|Overall Study|Death|87|||
131155545|NCT02342171|472194231|FG000|Overall Study|Received favipiravir|10|||
131155546|NCT02342171|472194232|FG001|Overall Study|Received favipiravir|0|||
131155547|NCT02342171|472194231|FG000|Overall Study|Missing cycle treshold value|1|||
131155548|NCT02342171|472194232|FG001|Overall Study|Missing cycle treshold value|0|||
131155549|NCT02342171|472194231|FG000|Overall Study|Unknown outcome|0|||
131155550|NCT02342171|472194232|FG001|Overall Study|Unknown outcome|1|||
131155551|NCT02342171|472194231|FG000|Overall Study|Missing age data|0|||
131155552|NCT02342171|472194232|FG001|Overall Study|Missing age data|1|||
131155553|NCT03518840|472194235|FG000|Overall Study|Lost to Follow-up|6|||
131155554|NCT03704051|472194236|FG000|Overall Study|Withdrawal by Subject|4|||
131155555|NCT03704051|472194237|FG001|Overall Study|Withdrawal by Subject|0|||
131155556|NCT03715465|472194238|FG000|Overall Study|Withdrawal by Subject|1|||
131155557|NCT03715465|472194239|FG001|Overall Study|Withdrawal by Subject|2|||
131155558|NCT00430781|472194249|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
131155559|NCT00430781|472194250|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
131155560|NCT00430781|472194251|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
131155561|NCT00430781|472194249|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
131155562|NCT00430781|472194250|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
131155563|NCT00430781|472194251|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
131155564|NCT00430781|472194249|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
131155565|NCT00430781|472194250|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
131155566|NCT00430781|472194251|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
131155567|NCT00430781|472194249|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
131155568|NCT00430781|472194250|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
131155569|NCT00430781|472194251|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
131155570|NCT00430781|472194249|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
131155571|NCT00430781|472194250|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
131155572|NCT00430781|472194251|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
131155573|NCT00430781|472194249|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
131155574|NCT00430781|472194250|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
131155575|NCT00430781|472194251|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
131155576|NCT00430781|472194249|FG000|Interim Analysis; 11 February 2008|Death|0|||
131155577|NCT00430781|472194250|FG001|Interim Analysis; 11 February 2008|Death|1|||
131155578|NCT00430781|472194251|FG002|Interim Analysis; 11 February 2008|Death|0|||
131155579|NCT00430781|472194249|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
131155580|NCT00430781|472194250|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
131155581|NCT00430781|472194251|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
131155582|NCT00430781|472194249|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
131155583|NCT00430781|472194250|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
131155584|NCT00430781|472194251|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
131155585|NCT00430781|472194249|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
131155586|NCT00430781|472194250|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
131155587|NCT00430781|472194251|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
131155588|NCT00430781|472194249|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
131155589|NCT00430781|472194250|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
131155590|NCT00430781|472194251|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
131155591|NCT00430781|472194249|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
131155592|NCT00430781|472194250|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
131155593|NCT00430781|472194251|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
131155594|NCT00430781|472194249|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
131155595|NCT00430781|472194250|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
131155596|NCT00430781|472194251|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
131155597|NCT00430781|472194249|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
131155598|NCT00430781|472194250|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
131155599|NCT00430781|472194251|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
131155600|NCT00430781|472194249|FG000|Final Analysis; 31 July 2008|Other|0|||
131155601|NCT00430781|472194250|FG001|Final Analysis; 31 July 2008|Other|1|||
131155602|NCT00430781|472194251|FG002|Final Analysis; 31 July 2008|Other|0|||
131155603|NCT00430781|472194249|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
131155604|NCT00430781|472194250|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
131155605|NCT00430781|472194251|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
131155606|NCT00430781|472194249|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
131155607|NCT00430781|472194250|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
131155608|NCT00430781|472194251|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
131155609|NCT00430781|472194249|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
131155610|NCT00430781|472194250|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
131155611|NCT00430781|472194251|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
131155612|NCT00430781|472194249|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
131155613|NCT00430781|472194250|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
131155614|NCT00430781|472194251|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
131155615|NCT00430781|472194249|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
131155616|NCT00430781|472194250|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
131155617|NCT00430781|472194251|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
131155618|NCT00430781|472194249|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
131155619|NCT00430781|472194250|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
131155620|NCT00430781|472194251|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
131155621|NCT00430781|472194249|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
131155622|NCT00430781|472194250|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
131155623|NCT00430781|472194251|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
131155624|NCT02158533|472194252|FG000|Stage 1|Adverse Event|6|||
131155625|NCT02158533|472194253|FG001|Stage 1|Adverse Event|4|||
131155626|NCT02158533|472194254|FG002|Stage 1|Adverse Event|7|||
131155627|NCT02158533|472194255|FG003|Stage 1|Adverse Event|0|||
131155628|NCT02158533|472194256|FG004|Stage 1|Adverse Event|0|||
131155629|NCT02158533|472194257|FG005|Stage 1|Adverse Event|0|||
131155630|NCT02158533|472194252|FG000|Stage 1|Withdrawal by Subject|3|||
131155631|NCT02158533|472194253|FG001|Stage 1|Withdrawal by Subject|2|||
131155632|NCT02158533|472194254|FG002|Stage 1|Withdrawal by Subject|1|||
131155633|NCT02158533|472194255|FG003|Stage 1|Withdrawal by Subject|0|||
131155634|NCT02158533|472194256|FG004|Stage 1|Withdrawal by Subject|0|||
131155635|NCT02158533|472194257|FG005|Stage 1|Withdrawal by Subject|0|||
130728505|NCT01004003|470627485|FG000|Overall Study|Other|0|||
130728506|NCT01004003|470627486|FG001|Overall Study|Other|0|||
130728507|NCT01004003|470627487|FG002|Overall Study|Other|0|||
130728508|NCT01004003|470627488|FG003|Overall Study|Other|0|||
130728509|NCT01004003|470627489|FG004|Overall Study|Other|0|||
131155636|NCT02158533|472194252|FG000|Stage 1|Lack of Efficacy|1|||
131155637|NCT02158533|472194253|FG001|Stage 1|Lack of Efficacy|0|||
131155638|NCT02158533|472194254|FG002|Stage 1|Lack of Efficacy|0|||
131155639|NCT02158533|472194255|FG003|Stage 1|Lack of Efficacy|0|||
131155640|NCT02158533|472194256|FG004|Stage 1|Lack of Efficacy|0|||
131155641|NCT02158533|472194257|FG005|Stage 1|Lack of Efficacy|0|||
131155642|NCT02158533|472194252|FG000|Stage 1|Lost to Follow-up|3|||
131155643|NCT02158533|472194253|FG001|Stage 1|Lost to Follow-up|1|||
131155644|NCT02158533|472194254|FG002|Stage 1|Lost to Follow-up|0|||
130728510|NCT01004003|470627490|FG005|Overall Study|Other|1|||
131155645|NCT02158533|472194255|FG003|Stage 1|Lost to Follow-up|0|||
131155646|NCT02158533|472194256|FG004|Stage 1|Lost to Follow-up|0|||
131155647|NCT02158533|472194257|FG005|Stage 1|Lost to Follow-up|0|||
131155648|NCT02158533|472194252|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
131155649|NCT02158533|472194253|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
131155650|NCT02158533|472194254|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
131155651|NCT02158533|472194255|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
131155652|NCT02158533|472194256|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
131155653|NCT02158533|472194257|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
131155654|NCT02158533|472194252|FG000|Stage 1|Non-compliance with study visits|1|||
131155655|NCT02158533|472194253|FG001|Stage 1|Non-compliance with study visits|0|||
131155656|NCT02158533|472194254|FG002|Stage 1|Non-compliance with study visits|0|||
131155657|NCT02158533|472194255|FG003|Stage 1|Non-compliance with study visits|0|||
131155658|NCT02158533|472194256|FG004|Stage 1|Non-compliance with study visits|0|||
131155659|NCT02158533|472194257|FG005|Stage 1|Non-compliance with study visits|0|||
131155660|NCT02158533|472194252|FG000|Stage 2|Adverse Event|0|||
131155661|NCT02158533|472194253|FG001|Stage 2|Adverse Event|0|||
131155662|NCT02158533|472194254|FG002|Stage 2|Adverse Event|0|||
131155663|NCT02158533|472194255|FG003|Stage 2|Adverse Event|0|||
131155664|NCT02158533|472194256|FG004|Stage 2|Adverse Event|0|||
131155665|NCT02158533|472194257|FG005|Stage 2|Adverse Event|1|||
131155666|NCT02158533|472194252|FG000|Stage 2|Lack of Efficacy|0|||
131155667|NCT02158533|472194253|FG001|Stage 2|Lack of Efficacy|0|||
131155668|NCT02158533|472194254|FG002|Stage 2|Lack of Efficacy|0|||
131155669|NCT02158533|472194255|FG003|Stage 2|Lack of Efficacy|0|||
131155670|NCT02158533|472194256|FG004|Stage 2|Lack of Efficacy|1|||
131155671|NCT02158533|472194257|FG005|Stage 2|Lack of Efficacy|0|||
131155672|NCT02158533|472194252|FG000|Stage 2|Lost to Follow-up|0|||
131155673|NCT02158533|472194253|FG001|Stage 2|Lost to Follow-up|0|||
131155674|NCT02158533|472194254|FG002|Stage 2|Lost to Follow-up|0|||
131155675|NCT02158533|472194255|FG003|Stage 2|Lost to Follow-up|1|||
131155676|NCT02158533|472194256|FG004|Stage 2|Lost to Follow-up|1|||
131155677|NCT02158533|472194257|FG005|Stage 2|Lost to Follow-up|2|||
131155678|NCT02158533|472194252|FG000|Stage 2|Withdrawal by Subject|0|||
131155679|NCT02158533|472194253|FG001|Stage 2|Withdrawal by Subject|0|||
131155680|NCT02158533|472194254|FG002|Stage 2|Withdrawal by Subject|0|||
131155681|NCT02158533|472194255|FG003|Stage 2|Withdrawal by Subject|0|||
131155682|NCT02158533|472194256|FG004|Stage 2|Withdrawal by Subject|1|||
131155683|NCT02158533|472194257|FG005|Stage 2|Withdrawal by Subject|2|||
131155684|NCT02158533|472194252|FG000|Stage 2|Physician Decision|0|||
131155685|NCT02158533|472194253|FG001|Stage 2|Physician Decision|0|||
131155686|NCT02158533|472194254|FG002|Stage 2|Physician Decision|0|||
131155687|NCT02158533|472194255|FG003|Stage 2|Physician Decision|0|||
131155688|NCT02158533|472194256|FG004|Stage 2|Physician Decision|1|||
131155689|NCT02158533|472194257|FG005|Stage 2|Physician Decision|0|||
131155690|NCT02158533|472194252|FG000|Stage 2|Pregnancy|0|||
131155691|NCT02158533|472194253|FG001|Stage 2|Pregnancy|0|||
131155692|NCT02158533|472194254|FG002|Stage 2|Pregnancy|0|||
131155693|NCT02158533|472194255|FG003|Stage 2|Pregnancy|1|||
131155694|NCT02158533|472194256|FG004|Stage 2|Pregnancy|0|||
131155695|NCT02158533|472194257|FG005|Stage 2|Pregnancy|0|||
131155696|NCT02158533|472194252|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
131155697|NCT02158533|472194253|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
131155698|NCT02158533|472194254|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
131155699|NCT02158533|472194255|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
131155700|NCT02158533|472194256|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
131155701|NCT02158533|472194257|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
131155702|NCT02158533|472194252|FG000|Stage 2|Non-adherence with study visits|0|||
131155703|NCT02158533|472194253|FG001|Stage 2|Non-adherence with study visits|0|||
131155704|NCT02158533|472194254|FG002|Stage 2|Non-adherence with study visits|0|||
131155705|NCT02158533|472194255|FG003|Stage 2|Non-adherence with study visits|0|||
131155706|NCT02158533|472194256|FG004|Stage 2|Non-adherence with study visits|0|||
131155707|NCT02158533|472194257|FG005|Stage 2|Non-adherence with study visits|1|||
131155708|NCT04329949|472194260|FG000|Overall Study|Death|36|||
131155709|NCT04329949|472194260|FG000|Overall Study|Withdrawal by Subject|4|||
131155710|NCT04329949|472194260|FG000|Overall Study|Termination of study by sponsor|3|||
130728511|NCT01004003|470627491|FG006|Overall Study|Other|0|||
130728512|NCT01004003|470627492|FG007|Overall Study|Other|0|||
131155711|NCT01335971|472194265|FG000|Overall Study|Withdrawal by Subject|1|||
131155712|NCT01335971|472194266|FG001|Overall Study|Withdrawal by Subject|0|||
131155713|NCT01335971|472194267|FG002|Overall Study|Withdrawal by Subject|0|||
131155714|NCT01335971|472194265|FG000|Overall Study|Did not complete bronchoscopy|1|||
131155715|NCT01335971|472194266|FG001|Overall Study|Did not complete bronchoscopy|1|||
131155716|NCT01335971|472194267|FG002|Overall Study|Did not complete bronchoscopy|1|||
131155717|NCT00384956|472194268|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
131155718|NCT00917384|472194269|FG000|Overall Study|Lost to Follow-up|4|||
131155719|NCT00917384|472194270|FG001|Overall Study|Lost to Follow-up|2|||
131155720|NCT00917384|472194269|FG000|Overall Study|Withdrawal by Subject|10|||
131155721|NCT00917384|472194270|FG001|Overall Study|Withdrawal by Subject|2|||
131155722|NCT00149214|472194275|FG000|Overall Study|Adverse Event|12|||
130728513|NCT01004003|470627493|FG008|Overall Study|Other|0|||
130728514|NCT00315731|470627508|FG000|Overall Study|Lost to Follow-up|1|||
130728515|NCT00315731|470627508|FG000|Overall Study|Death|5|||
130728516|NCT05819203|470627509|FG000|Overall Study|Protocol Violation|1|||
130728517|NCT05819203|470627510|FG001|Overall Study|Protocol Violation|2|||
130728518|NCT05819203|470627509|FG000|Overall Study|Withdrawal by Subject|1|||
130728519|NCT05819203|470627510|FG001|Overall Study|Withdrawal by Subject|0|||
130728520|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
130728521|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
130728522|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728523|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728524|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728525|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728526|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728527|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728528|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728529|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130728530|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
130728531|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
130728532|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728533|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728534|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728535|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728536|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728537|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728538|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728539|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130728540|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728541|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
130728542|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728543|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728544|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728545|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728546|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728547|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728548|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728549|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130728550|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
130728551|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130728552|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130728553|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131155723|NCT00149214|472194276|FG001|Overall Study|Adverse Event|9|||
131155724|NCT00149214|472194275|FG000|Overall Study|Withdrawal by Subject|4|||
131155725|NCT00149214|472194276|FG001|Overall Study|Withdrawal by Subject|1|||
131155726|NCT00149214|472194275|FG000|Overall Study|Physician Decision|3|||
131155727|NCT00149214|472194276|FG001|Overall Study|Physician Decision|3|||
131155728|NCT00149214|472194275|FG000|Overall Study|Sponsor Decision|0|||
131155729|NCT00149214|472194276|FG001|Overall Study|Sponsor Decision|1|||
131155730|NCT00149214|472194275|FG000|Overall Study|Progressive Disease|7|||
131155731|NCT00149214|472194276|FG001|Overall Study|Progressive Disease|3|||
131155732|NCT01451515|472194277|FG000|Overall Study|Death|0|||
131155733|NCT01451515|472194278|FG001|Overall Study|Death|1|||
131155734|NCT01451515|472194279|FG002|Overall Study|Death|0|||
131155735|NCT01451515|472194277|FG000|Overall Study|Withdrawal by Subject|0|||
131155736|NCT01451515|472194278|FG001|Overall Study|Withdrawal by Subject|1|||
131235208|NCT02579096|472488868|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
130728554|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130728555|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130728556|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131235209|NCT02579096|472488867|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
131235210|NCT02579096|472488868|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
131235211|NCT02579096|472488867|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
130728557|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131155737|NCT01451515|472194279|FG002|Overall Study|Withdrawal by Subject|0|||
131155738|NCT01451515|472194277|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
131235212|NCT02579096|472488868|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
131155739|NCT01451515|472194278|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
131155740|NCT01451515|472194279|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
131155741|NCT01451515|472194277|FG000|Overall Study|Relapse (except CNS)|1|||
131155742|NCT01451515|472194278|FG001|Overall Study|Relapse (except CNS)|1|||
131155743|NCT01451515|472194279|FG002|Overall Study|Relapse (except CNS)|0|||
131155744|NCT00174941|472194280|FG000|Overall Study|Adverse Event|1|||
131155745|NCT00174941|472194281|FG001|Overall Study|Adverse Event|10|||
131155746|NCT00174941|472194282|FG002|Overall Study|Adverse Event|2|||
131155747|NCT00174941|472194283|FG003|Overall Study|Adverse Event|13|||
131155748|NCT00174941|472194280|FG000|Overall Study|Protocol Violation|0|||
131155749|NCT00174941|472194281|FG001|Overall Study|Protocol Violation|1|||
131155750|NCT00174941|472194282|FG002|Overall Study|Protocol Violation|0|||
131155751|NCT00174941|472194283|FG003|Overall Study|Protocol Violation|1|||
131155752|NCT00174941|472194280|FG000|Overall Study|Lost to Follow-up|0|||
131155753|NCT00174941|472194281|FG001|Overall Study|Lost to Follow-up|3|||
131155754|NCT00174941|472194282|FG002|Overall Study|Lost to Follow-up|2|||
131155755|NCT00174941|472194283|FG003|Overall Study|Lost to Follow-up|5|||
131155756|NCT00174941|472194280|FG000|Overall Study|Personal Reason(s)|0|||
131155757|NCT00174941|472194281|FG001|Overall Study|Personal Reason(s)|14|||
131155758|NCT00174941|472194282|FG002|Overall Study|Personal Reason(s)|8|||
131155759|NCT00174941|472194283|FG003|Overall Study|Personal Reason(s)|22|||
131155760|NCT00174941|472194280|FG000|Overall Study|Gout Flare|0|||
131155761|NCT00174941|472194281|FG001|Overall Study|Gout Flare|4|||
131155762|NCT00174941|472194282|FG002|Overall Study|Gout Flare|4|||
131155763|NCT00174941|472194283|FG003|Overall Study|Gout Flare|8|||
131155764|NCT00174941|472194280|FG000|Overall Study|Reason Not Specified|1|||
131155765|NCT00174941|472194281|FG001|Overall Study|Reason Not Specified|6|||
131155766|NCT00174941|472194282|FG002|Overall Study|Reason Not Specified|2|||
131155767|NCT00174941|472194283|FG003|Overall Study|Reason Not Specified|9|||
131155768|NCT01458340|472194284|FG000|Overall Study|Adverse Event|5|||
131155769|NCT01458340|472194285|FG001|Overall Study|Adverse Event|4|||
131155770|NCT01458340|472194286|FG002|Overall Study|Adverse Event|2|||
131155771|NCT01458340|472194284|FG000|Overall Study|Lost to Follow-up|3|||
131155772|NCT01458340|472194285|FG001|Overall Study|Lost to Follow-up|3|||
131155773|NCT01458340|472194286|FG002|Overall Study|Lost to Follow-up|10|||
131155774|NCT01458340|472194284|FG000|Overall Study|Miscellaneous|0|||
131155775|NCT01458340|472194285|FG001|Overall Study|Miscellaneous|1|||
131155776|NCT01458340|472194286|FG002|Overall Study|Miscellaneous|0|||
131155777|NCT01458340|472194284|FG000|Overall Study|Physician Decision|1|||
131155778|NCT01458340|472194285|FG001|Overall Study|Physician Decision|1|||
131155779|NCT01458340|472194286|FG002|Overall Study|Physician Decision|2|||
131155780|NCT01458340|472194284|FG000|Overall Study|Protocol Violation|6|||
131155781|NCT01458340|472194285|FG001|Overall Study|Protocol Violation|6|||
131155782|NCT01458340|472194286|FG002|Overall Study|Protocol Violation|5|||
131155783|NCT01458340|472194284|FG000|Overall Study|Withdrawal by Subject|12|||
131155784|NCT01458340|472194285|FG001|Overall Study|Withdrawal by Subject|6|||
131155785|NCT01458340|472194286|FG002|Overall Study|Withdrawal by Subject|4|||
131155786|NCT03126227|472194287|FG000|Overall Study|Adverse Event|43|||
131155787|NCT03126227|472194288|FG001|Overall Study|Adverse Event|4|||
131155788|NCT03126227|472194287|FG000|Overall Study|Death|0|||
131155789|NCT03126227|472194288|FG001|Overall Study|Death|1|||
131155790|NCT03126227|472194287|FG000|Overall Study|Lost to Follow-up|0|||
131155791|NCT03126227|472194288|FG001|Overall Study|Lost to Follow-up|1|||
131155792|NCT03126227|472194287|FG000|Overall Study|Physician Decision|2|||
131155793|NCT03126227|472194288|FG001|Overall Study|Physician Decision|0|||
131155794|NCT03126227|472194287|FG000|Overall Study|Protocol Violation|1|||
131155795|NCT03126227|472194288|FG001|Overall Study|Protocol Violation|0|||
131155796|NCT03126227|472194287|FG000|Overall Study|Withdrawal by Subject|19|||
131155797|NCT03126227|472194288|FG001|Overall Study|Withdrawal by Subject|3|||
131155798|NCT03126227|472194287|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
131155799|NCT03126227|472194288|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
131155800|NCT03126227|472194287|FG000|Overall Study|Lack of dosing compliance|2|||
131155801|NCT03126227|472194288|FG001|Overall Study|Lack of dosing compliance|0|||
131155802|NCT03126227|472194287|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
131155803|NCT03126227|472194288|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
131155804|NCT03126227|472194287|FG000|Overall Study|Scheduling conflict|1|||
131155805|NCT03126227|472194288|FG001|Overall Study|Scheduling conflict|0|||
131155806|NCT03351244|472194293|FG000|Overall Study|Adverse Event|7|||
131155807|NCT03351244|472194294|FG001|Overall Study|Adverse Event|11|||
131155808|NCT03351244|472194295|FG002|Overall Study|Adverse Event|12|||
131155809|NCT03351244|472194293|FG000|Overall Study|Investigator's decision|0|||
131155810|NCT03351244|472194294|FG001|Overall Study|Investigator's decision|0|||
131155811|NCT03351244|472194295|FG002|Overall Study|Investigator's decision|2|||
131155812|NCT03351244|472194293|FG000|Overall Study|System error|0|||
131155813|NCT03351244|472194294|FG001|Overall Study|System error|0|||
131155814|NCT03351244|472194295|FG002|Overall Study|System error|2|||
131155815|NCT03351244|472194293|FG000|Overall Study|COVID-19 restrictions|3|||
131155816|NCT03351244|472194294|FG001|Overall Study|COVID-19 restrictions|0|||
131155817|NCT03351244|472194295|FG002|Overall Study|COVID-19 restrictions|1|||
131155818|NCT03351244|472194293|FG000|Overall Study|Non-compliance|2|||
131155819|NCT03351244|472194294|FG001|Overall Study|Non-compliance|5|||
131155820|NCT03351244|472194295|FG002|Overall Study|Non-compliance|0|||
131155821|NCT03351244|472194293|FG000|Overall Study|Withdrawal by Subject|11|||
131155822|NCT03351244|472194294|FG001|Overall Study|Withdrawal by Subject|16|||
131155823|NCT03351244|472194295|FG002|Overall Study|Withdrawal by Subject|13|||
131155824|NCT03351244|472194293|FG000|Overall Study|Lost to Follow-up|2|||
131155825|NCT03351244|472194294|FG001|Overall Study|Lost to Follow-up|6|||
131155826|NCT03351244|472194295|FG002|Overall Study|Lost to Follow-up|4|||
131155827|NCT03351244|472194293|FG000|Overall Study|Protocol Violation|2|||
131155828|NCT03351244|472194294|FG001|Overall Study|Protocol Violation|2|||
131155829|NCT03351244|472194295|FG002|Overall Study|Protocol Violation|0|||
131155830|NCT04899271|472194296|FG000|Overall Study|Lost to Follow-up|1|||
131155831|NCT04899271|472194297|FG001|Overall Study|Lost to Follow-up|0|||
131155832|NCT04899271|472194296|FG000|Overall Study|Subject request/consent withdrawal|2|||
131155833|NCT04899271|472194297|FG001|Overall Study|Subject request/consent withdrawal|0|||
131155834|NCT03215277|472194299|FG000|Overall Study|Adverse Event|2|||
131155835|NCT03215277|472194300|FG001|Overall Study|Adverse Event|3|||
131155836|NCT03215277|472194299|FG000|Overall Study|Death|1|||
131155837|NCT03215277|472194300|FG001|Overall Study|Death|0|||
131155838|NCT03215277|472194299|FG000|Overall Study|Lost to Follow-up|0|||
131155839|NCT03215277|472194300|FG001|Overall Study|Lost to Follow-up|1|||
131155840|NCT03215277|472194299|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
131155841|NCT03215277|472194300|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
131155842|NCT04786210|472194303|FG000|Overall Study|Lost to Follow-up|2|||
131155843|NCT04786210|472194303|FG000|Overall Study|Withdrawal by Subject|4|||
131155844|NCT00095303|472194304|FG000|Main Study|Lost to Follow-up|91|||
131155845|NCT00095303|472194305|FG001|Main Study|Lost to Follow-up|87|||
131155846|NCT00095303|472194304|FG000|Follow Up Study|Lost to Follow-up|59|||
131155847|NCT00095303|472194305|FG001|Follow Up Study|Lost to Follow-up|58|||
131155848|NCT01364467|472194306|FG000|Overall Study|Lost to Follow-up|1|||
131155849|NCT01364467|472194307|FG001|Overall Study|Lost to Follow-up|2|||
131155850|NCT00845429|472194317|FG000|Overall Study|Protocol Violation|5|||
131155851|NCT00845429|472194318|FG001|Overall Study|Protocol Violation|4|||
131155852|NCT00845429|472194319|FG002|Overall Study|Protocol Violation|7|||
131155853|NCT00845429|472194317|FG000|Overall Study|Lost to Follow-up|7|||
131155854|NCT00845429|472194318|FG001|Overall Study|Lost to Follow-up|9|||
131155855|NCT00845429|472194319|FG002|Overall Study|Lost to Follow-up|10|||
131155856|NCT00845429|472194317|FG000|Overall Study|Withdrawal by Subject|2|||
131155857|NCT00845429|472194318|FG001|Overall Study|Withdrawal by Subject|2|||
131155858|NCT00845429|472194319|FG002|Overall Study|Withdrawal by Subject|2|||
131155859|NCT00845429|472194317|FG000|Overall Study|Serious adverse event|0|||
131155860|NCT00845429|472194318|FG001|Overall Study|Serious adverse event|0|||
131155861|NCT00845429|472194319|FG002|Overall Study|Serious adverse event|1|||
131155862|NCT00971321|472194322|FG000|Up to Month 7|Withdrawal by Subject|1|||
131155863|NCT00971321|472194323|FG001|Up to Month 7|Withdrawal by Subject|0|||
131155864|NCT00971321|472194322|FG000|Up to Month 7|Migrated/moved from study area|3|||
131155865|NCT00971321|472194323|FG001|Up to Month 7|Migrated/moved from study area|2|||
131155866|NCT00971321|472194322|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
131155867|NCT00971321|472194323|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
131155868|NCT00971321|472194322|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
131155869|NCT00971321|472194323|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
131155870|NCT00971321|472194322|FG000|Up to Month 11-12|Lost to Follow-up|1|||
131235213|NCT02579096|472488867|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
131235214|NCT02579096|472488868|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
131235215|NCT02579096|472488867|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
131155871|NCT00971321|472194323|FG001|Up to Month 11-12|Lost to Follow-up|0|||
131155872|NCT00519623|472194326|FG000|Overall Study|Adverse Event|1|||
131155873|NCT02485717|472194330|FG000|Overall Study|Lost to Follow-up|6|||
131155874|NCT02485717|472194331|FG001|Overall Study|Lost to Follow-up|0|||
131155875|NCT02485717|472194332|FG002|Overall Study|Lost to Follow-up|0|||
131155876|NCT02485717|472194330|FG000|Overall Study|Withdrawal by Subject|0|||
131155877|NCT02485717|472194331|FG001|Overall Study|Withdrawal by Subject|0|||
131155878|NCT02485717|472194332|FG002|Overall Study|Withdrawal by Subject|1|||
131155879|NCT02485717|472194330|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
131155880|NCT02485717|472194331|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
131155881|NCT02485717|472194332|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
131155882|NCT02485717|472194330|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
131155883|NCT02485717|472194331|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
131155884|NCT02485717|472194332|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
131155885|NCT01476787|472194333|FG000|Treatment|Progression|64|||
131155886|NCT01476787|472194334|FG001|Treatment|Progression|71|||
131155887|NCT01476787|472194333|FG000|Treatment|Toxicity|44|||
131155888|NCT01476787|472194334|FG001|Treatment|Toxicity|16|||
131155889|NCT01476787|472194333|FG000|Treatment|Death|0|||
131155890|NCT01476787|472194334|FG001|Treatment|Death|1|||
131155891|NCT01476787|472194333|FG000|Treatment|Withdrawal by Subject|3|||
131155892|NCT01476787|472194334|FG001|Treatment|Withdrawal by Subject|14|||
131155893|NCT01476787|472194333|FG000|Treatment|Major protocol violation|1|||
131155894|NCT01476787|472194334|FG001|Treatment|Major protocol violation|6|||
131155895|NCT01476787|472194333|FG000|Treatment|Other reasons|10|||
131155896|NCT01476787|472194334|FG001|Treatment|Other reasons|22|||
131155897|NCT01476787|472194333|FG000|Treatment|Concurrent illness|12|||
131155898|NCT01476787|472194334|FG001|Treatment|Concurrent illness|9|||
131155899|NCT01476787|472194333|FG000|Treatment|Insufficient response|15|||
131155900|NCT01476787|472194334|FG001|Treatment|Insufficient response|3|||
131155901|NCT01476787|472194333|FG000|Treatment|Voluntary treatment discontinuation|8|||
131155902|NCT01476787|472194334|FG001|Treatment|Voluntary treatment discontinuation|4|||
131155903|NCT01450540|472194335|FG000|Overall Study|Withdrawal by Subject|19|||
131155904|NCT01450540|472194336|FG001|Overall Study|Withdrawal by Subject|13|||
131155905|NCT01450540|472194335|FG000|Overall Study|protocol deviation|3|||
131155906|NCT01450540|472194336|FG001|Overall Study|protocol deviation|23|||
131155907|NCT01926886|472194337|FG000|Overall Study|Administrative/other|1|||
131155908|NCT01926886|472194338|FG001|Overall Study|Administrative/other|0|||
131155909|NCT01926886|472194337|FG000|Overall Study|Adverse event/intercurrent illness|4|||
131155910|NCT01926886|472194338|FG001|Overall Study|Adverse event/intercurrent illness|0|||
131155911|NCT01926886|472194337|FG000|Overall Study|Disease progression/recurrence|4|||
131155912|NCT01926886|472194338|FG001|Overall Study|Disease progression/recurrence|0|||
131155913|NCT01926886|472194337|FG000|Overall Study|Withdrawal by Subject|15|||
131155914|NCT01926886|472194338|FG001|Overall Study|Withdrawal by Subject|0|||
131155915|NCT01926886|472194337|FG000|Overall Study|Failure to return|3|||
131155916|NCT01926886|472194338|FG001|Overall Study|Failure to return|0|||
131155917|NCT01926886|472194337|FG000|Overall Study|Recurrence of disease|1|||
131155918|NCT01926886|472194338|FG001|Overall Study|Recurrence of disease|0|||
131155919|NCT01926886|472194337|FG000|Overall Study|Progression of disease|2|||
131155920|NCT01926886|472194338|FG001|Overall Study|Progression of disease|0|||
131155921|NCT01926886|472194337|FG000|Overall Study|Death|1|||
131155922|NCT01926886|472194338|FG001|Overall Study|Death|0|||
131155923|NCT01926886|472194337|FG000|Overall Study|Did not cooperate|1|||
131155924|NCT01926886|472194338|FG001|Overall Study|Did not cooperate|0|||
131155925|NCT01662999|472194347|FG000|Period 3|Withdrawal by Subject|0|||
131155926|NCT01662999|472194348|FG001|Period 3|Withdrawal by Subject|1|||
131155927|NCT01662999|472194349|FG002|Period 3|Withdrawal by Subject|0|||
131155928|NCT01662999|472194350|FG003|Period 3|Withdrawal by Subject|0|||
131155929|NCT01662999|472194351|FG004|Period 3|Withdrawal by Subject|0|||
131155930|NCT01662999|472194352|FG005|Period 3|Withdrawal by Subject|0|||
131155931|NCT02234622|472194353|FG000|Overall Study|Withdrawal by Subject|16|||
131155932|NCT02234622|472194354|FG001|Overall Study|Withdrawal by Subject|22|||
131155933|NCT02234622|472194353|FG000|Overall Study|Lost to Follow-up|27|||
131155934|NCT02234622|472194354|FG001|Overall Study|Lost to Follow-up|14|||
131155935|NCT04090164|472194355|FG000|Overall Study|incomplete data on file|245|||
131155936|NCT04090164|472194356|FG001|Overall Study|incomplete data on file|0|||
131155937|NCT01877655|472194361|FG000|Overall Study|Death|57|||
131155938|NCT01877655|472194362|FG001|Overall Study|Death|52|||
131155939|NCT01877655|472194361|FG000|Overall Study|Withdrawal by Subject|18|||
131155940|NCT01877655|472194362|FG001|Overall Study|Withdrawal by Subject|26|||
131155941|NCT01877655|472194361|FG000|Overall Study|Physician Decision|11|||
131155942|NCT01877655|472194362|FG001|Overall Study|Physician Decision|10|||
131155943|NCT01877655|472194361|FG000|Overall Study|Miscellaneous|4|||
131155944|NCT01877655|472194362|FG001|Overall Study|Miscellaneous|4|||
131155945|NCT01877655|472194361|FG000|Overall Study|Randomized but Never Received Drug|8|||
131155946|NCT01877655|472194362|FG001|Overall Study|Randomized but Never Received Drug|5|||
131155947|NCT03497689|472194363|FG000|Overall Study|Adverse Event|2|||
131155948|NCT03497689|472194363|FG000|Overall Study|Death|1|||
131155949|NCT03497689|472194363|FG000|Overall Study|Physician Decision|1|||
131155950|NCT03497689|472194363|FG000|Overall Study|Withdrawal by Subject|1|||
131235216|NCT02579096|472488868|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
131235217|NCT02097121|472488873|FG000|Overall Study|Other, not specified|4|||
130728558|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131235218|NCT02097121|472488874|FG001|Overall Study|Other, not specified|2|||
130728559|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
131155951|NCT03497689|472194363|FG000|Overall Study|Protocol Violation|2|||
131155952|NCT03191786|472194364|FG000|Overall Study|Death|236|||
131155953|NCT03191786|472194365|FG001|Overall Study|Death|127|||
131155954|NCT03191786|472194364|FG000|Overall Study|Lost to Follow-up|9|||
131155955|NCT03191786|472194365|FG001|Overall Study|Lost to Follow-up|3|||
131155956|NCT03191786|472194364|FG000|Overall Study|Physician Decision|1|||
131155957|NCT03191786|472194365|FG001|Overall Study|Physician Decision|0|||
131155958|NCT03191786|472194364|FG000|Overall Study|Moved to Post Trial Access Program|30|||
131155959|NCT03191786|472194365|FG001|Overall Study|Moved to Post Trial Access Program|5|||
131155960|NCT03191786|472194364|FG000|Overall Study|Withdrawal by Subject|26|||
131155961|NCT03191786|472194365|FG001|Overall Study|Withdrawal by Subject|16|||
131155962|NCT04513158|472194368|FG000|Overall Study|Screen Failure|1|||
131155963|NCT03439345|472196458|FG000|Overall Study|Lost to Follow-up|0|||
131155964|NCT03439345|472196459|FG001|Overall Study|Lost to Follow-up|1|||
131155965|NCT03439345|472196458|FG000|Overall Study|Consent withdrawn|0|||
131155966|NCT03439345|472196459|FG001|Overall Study|Consent withdrawn|1|||
131155967|NCT00875420|472196464|FG000|Overall Study|Adverse Event|0|||
131155968|NCT00875420|472196465|FG001|Overall Study|Adverse Event|1|||
131155969|NCT00875420|472196466|FG002|Overall Study|Adverse Event|1|||
131155970|NCT00875420|472196467|FG003|Overall Study|Adverse Event|0|||
131155971|NCT00875420|472196468|FG004|Overall Study|Adverse Event|0|||
131155972|NCT00875420|472196464|FG000|Overall Study|Inability to complete study procedures|1|||
131155973|NCT00875420|472196465|FG001|Overall Study|Inability to complete study procedures|0|||
131155974|NCT00875420|472196466|FG002|Overall Study|Inability to complete study procedures|1|||
131155975|NCT00875420|472196467|FG003|Overall Study|Inability to complete study procedures|1|||
131155976|NCT00875420|472196468|FG004|Overall Study|Inability to complete study procedures|1|||
131155977|NCT00875420|472196464|FG000|Overall Study|Lost to Follow-up|1|||
131155978|NCT00875420|472196465|FG001|Overall Study|Lost to Follow-up|0|||
131155979|NCT00875420|472196466|FG002|Overall Study|Lost to Follow-up|0|||
131155980|NCT00875420|472196467|FG003|Overall Study|Lost to Follow-up|0|||
131155981|NCT00875420|472196468|FG004|Overall Study|Lost to Follow-up|0|||
131155982|NCT00875420|472196464|FG000|Overall Study|Personal reason|0|||
131155983|NCT00875420|472196465|FG001|Overall Study|Personal reason|0|||
131155984|NCT00875420|472196466|FG002|Overall Study|Personal reason|0|||
131155985|NCT00875420|472196467|FG003|Overall Study|Personal reason|0|||
131155986|NCT00875420|472196468|FG004|Overall Study|Personal reason|1|||
131155987|NCT00875420|472196464|FG000|Overall Study|Prohibited medication|0|||
131155988|NCT00875420|472196465|FG001|Overall Study|Prohibited medication|0|||
131155989|NCT00875420|472196466|FG002|Overall Study|Prohibited medication|0|||
131155990|NCT00875420|472196467|FG003|Overall Study|Prohibited medication|1|||
131155991|NCT00875420|472196468|FG004|Overall Study|Prohibited medication|0|||
131155992|NCT00875420|472196464|FG000|Overall Study|Sponsor decision|0|||
131155993|NCT00875420|472196465|FG001|Overall Study|Sponsor decision|1|||
131155994|NCT00875420|472196466|FG002|Overall Study|Sponsor decision|0|||
131155995|NCT00875420|472196467|FG003|Overall Study|Sponsor decision|0|||
131155996|NCT00875420|472196468|FG004|Overall Study|Sponsor decision|0|||
131155997|NCT00875420|472196464|FG000|Overall Study|Withdrawal by Subject|0|||
131155998|NCT00875420|472196465|FG001|Overall Study|Withdrawal by Subject|0|||
131155999|NCT00875420|472196466|FG002|Overall Study|Withdrawal by Subject|1|||
131156000|NCT00875420|472196467|FG003|Overall Study|Withdrawal by Subject|0|||
131156001|NCT00875420|472196468|FG004|Overall Study|Withdrawal by Subject|0|||
131156002|NCT02517515|472196469|FG000|Overall Study|Adverse Event|0|||
131156003|NCT02517515|472196470|FG001|Overall Study|Adverse Event|1|||
131156004|NCT02517515|472196469|FG000|Overall Study|Withdrew Consent|0|||
131156005|NCT02517515|472196470|FG001|Overall Study|Withdrew Consent|1|||
131156006|NCT02517515|472196469|FG000|Overall Study|Lost to Follow-up|1|||
131156007|NCT02517515|472196470|FG001|Overall Study|Lost to Follow-up|0|||
131156008|NCT02517515|472196469|FG000|Overall Study|Other|1|||
131156009|NCT02517515|472196470|FG001|Overall Study|Other|0|||
131156010|NCT03716726|472196473|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
131156011|NCT03716726|472196474|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
131156012|NCT03716726|472196473|FG000|12 Months Followup|Lost to Follow-up|10|||
131156013|NCT03716726|472196474|FG001|12 Months Followup|Lost to Follow-up|17|||
131156014|NCT02786537|472196477|FG000|As Randomized|Adverse Event|0|||
131156015|NCT02786537|472196478|FG001|As Randomized|Adverse Event|11|||
131156016|NCT02786537|472196479|FG002|As Randomized|Adverse Event|0|||
131156017|NCT02786537|472196480|FG003|As Randomized|Adverse Event|4|||
131156018|NCT02786537|472196481|FG004|As Randomized|Adverse Event|6|||
131156019|NCT02786537|472196482|FG005|As Randomized|Adverse Event|2|||
131156020|NCT02786537|472196477|FG000|As Randomized|Lack of Efficacy|0|||
131156021|NCT02786537|472196478|FG001|As Randomized|Lack of Efficacy|0|||
131156022|NCT02786537|472196479|FG002|As Randomized|Lack of Efficacy|0|||
131156023|NCT02786537|472196480|FG003|As Randomized|Lack of Efficacy|1|||
131156024|NCT02786537|472196481|FG004|As Randomized|Lack of Efficacy|0|||
131156025|NCT02786537|472196482|FG005|As Randomized|Lack of Efficacy|0|||
131156026|NCT02786537|472196477|FG000|As Randomized|Withdrawal by Subject|1|||
131156027|NCT02786537|472196478|FG001|As Randomized|Withdrawal by Subject|2|||
131156028|NCT02786537|472196479|FG002|As Randomized|Withdrawal by Subject|0|||
131156029|NCT02786537|472196480|FG003|As Randomized|Withdrawal by Subject|1|||
131156030|NCT02786537|472196481|FG004|As Randomized|Withdrawal by Subject|1|||
131156031|NCT02786537|472196482|FG005|As Randomized|Withdrawal by Subject|0|||
131156032|NCT02786537|472196477|FG000|As Randomized|Death|0|||
131156033|NCT02786537|472196478|FG001|As Randomized|Death|2|||
131156034|NCT02786537|472196479|FG002|As Randomized|Death|0|||
131156035|NCT02786537|472196480|FG003|As Randomized|Death|3|||
131156036|NCT02786537|472196481|FG004|As Randomized|Death|1|||
131156037|NCT02786537|472196482|FG005|As Randomized|Death|0|||
131156038|NCT02786537|472196477|FG000|As Randomized|Non-compliance with study drug|1|||
131156039|NCT02786537|472196478|FG001|As Randomized|Non-compliance with study drug|11|||
131156040|NCT02786537|472196479|FG002|As Randomized|Non-compliance with study drug|0|||
131156041|NCT02786537|472196480|FG003|As Randomized|Non-compliance with study drug|1|||
131156042|NCT02786537|472196481|FG004|As Randomized|Non-compliance with study drug|0|||
131156043|NCT02786537|472196482|FG005|As Randomized|Non-compliance with study drug|1|||
131156044|NCT02786537|472196477|FG000|As Randomized|Lost to treatment follow-up|4|||
131156045|NCT02786537|472196478|FG001|As Randomized|Lost to treatment follow-up|32|||
131156046|NCT02786537|472196479|FG002|As Randomized|Lost to treatment follow-up|0|||
131156047|NCT02786537|472196480|FG003|As Randomized|Lost to treatment follow-up|24|||
131156048|NCT02786537|472196481|FG004|As Randomized|Lost to treatment follow-up|4|||
131156049|NCT02786537|472196482|FG005|As Randomized|Lost to treatment follow-up|4|||
131156050|NCT02786537|472196477|FG000|As Randomized|Incarceration|0|||
131156051|NCT02786537|472196478|FG001|As Randomized|Incarceration|1|||
131156052|NCT02786537|472196479|FG002|As Randomized|Incarceration|0|||
131156053|NCT02786537|472196480|FG003|As Randomized|Incarceration|0|||
131156054|NCT02786537|472196481|FG004|As Randomized|Incarceration|0|||
131156055|NCT02786537|472196482|FG005|As Randomized|Incarceration|0|||
131156056|NCT02786537|472196477|FG000|As Randomized|Opiate Dependency Relapse|0|||
131156057|NCT02786537|472196478|FG001|As Randomized|Opiate Dependency Relapse|1|||
131156058|NCT02786537|472196479|FG002|As Randomized|Opiate Dependency Relapse|0|||
131156059|NCT02786537|472196480|FG003|As Randomized|Opiate Dependency Relapse|0|||
131156060|NCT02786537|472196481|FG004|As Randomized|Opiate Dependency Relapse|0|||
131156061|NCT02786537|472196482|FG005|As Randomized|Opiate Dependency Relapse|0|||
131156062|NCT02786537|472196477|FG000|As Randomized|HCV drugs stolen from pt|0|||
131156063|NCT02786537|472196478|FG001|As Randomized|HCV drugs stolen from pt|1|||
131156064|NCT02786537|472196479|FG002|As Randomized|HCV drugs stolen from pt|0|||
131156065|NCT02786537|472196480|FG003|As Randomized|HCV drugs stolen from pt|0|||
131156066|NCT02786537|472196481|FG004|As Randomized|HCV drugs stolen from pt|0|||
131156067|NCT02786537|472196482|FG005|As Randomized|HCV drugs stolen from pt|0|||
131156068|NCT02786537|472196477|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
131156069|NCT02786537|472196478|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
131156070|NCT02786537|472196479|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
131156071|NCT02786537|472196480|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
131156072|NCT02786537|472196481|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
131156073|NCT02786537|472196482|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
131156074|NCT02786537|472196477|FG000|As Randomized|Subject lost insurance|0|||
131156075|NCT02786537|472196478|FG001|As Randomized|Subject lost insurance|0|||
131156076|NCT02786537|472196479|FG002|As Randomized|Subject lost insurance|0|||
131156077|NCT02786537|472196480|FG003|As Randomized|Subject lost insurance|1|||
131156078|NCT02786537|472196481|FG004|As Randomized|Subject lost insurance|0|||
131156079|NCT02786537|472196482|FG005|As Randomized|Subject lost insurance|0|||
131156080|NCT02786537|472196477|FG000|As Treated|Adverse Event|0|||
131156081|NCT02786537|472196478|FG001|As Treated|Adverse Event|11|||
131156082|NCT02786537|472196479|FG002|As Treated|Adverse Event|0|||
131156083|NCT02786537|472196480|FG003|As Treated|Adverse Event|4|||
131156084|NCT02786537|472196481|FG004|As Treated|Adverse Event|6|||
131156085|NCT02786537|472196482|FG005|As Treated|Adverse Event|2|||
131156086|NCT02786537|472196477|FG000|As Treated|Death|0|||
131156087|NCT02786537|472196478|FG001|As Treated|Death|2|||
131156088|NCT02786537|472196479|FG002|As Treated|Death|0|||
131156089|NCT02786537|472196480|FG003|As Treated|Death|3|||
131156090|NCT02786537|472196481|FG004|As Treated|Death|1|||
131156091|NCT02786537|472196482|FG005|As Treated|Death|0|||
131156092|NCT02786537|472196477|FG000|As Treated|Lack of Efficacy|0|||
131156093|NCT02786537|472196478|FG001|As Treated|Lack of Efficacy|0|||
131156094|NCT02786537|472196479|FG002|As Treated|Lack of Efficacy|0|||
131156095|NCT02786537|472196480|FG003|As Treated|Lack of Efficacy|1|||
131156096|NCT02786537|472196481|FG004|As Treated|Lack of Efficacy|0|||
131156097|NCT02786537|472196482|FG005|As Treated|Lack of Efficacy|0|||
131156098|NCT02786537|472196477|FG000|As Treated|Lost to Follow-up|4|||
131156099|NCT02786537|472196478|FG001|As Treated|Lost to Follow-up|32|||
131156100|NCT02786537|472196479|FG002|As Treated|Lost to Follow-up|0|||
131235219|NCT02097121|472488875|FG002|Overall Study|Other, not specified|3|||
131235220|NCT02097121|472488873|FG000|Overall Study|Lack of Efficacy|2|||
131235221|NCT02097121|472488874|FG001|Overall Study|Lack of Efficacy|1|||
131235222|NCT02097121|472488875|FG002|Overall Study|Lack of Efficacy|3|||
131235223|NCT02097121|472488873|FG000|Overall Study|Withdrawal by Subject|0|||
131235224|NCT02097121|472488874|FG001|Overall Study|Withdrawal by Subject|1|||
131156101|NCT02786537|472196480|FG003|As Treated|Lost to Follow-up|25|||
131156102|NCT02786537|472196481|FG004|As Treated|Lost to Follow-up|4|||
131156103|NCT02786537|472196482|FG005|As Treated|Lost to Follow-up|4|||
131156104|NCT02786537|472196477|FG000|As Treated|Non-compliance with study drug|1|||
131156105|NCT02786537|472196478|FG001|As Treated|Non-compliance with study drug|11|||
131156106|NCT02786537|472196479|FG002|As Treated|Non-compliance with study drug|0|||
131156107|NCT02786537|472196480|FG003|As Treated|Non-compliance with study drug|1|||
131156108|NCT02786537|472196481|FG004|As Treated|Non-compliance with study drug|0|||
131156109|NCT02786537|472196482|FG005|As Treated|Non-compliance with study drug|1|||
131156110|NCT02786537|472196477|FG000|As Treated|Lost insurance|0|||
131156111|NCT02786537|472196478|FG001|As Treated|Lost insurance|0|||
131156112|NCT02786537|472196479|FG002|As Treated|Lost insurance|0|||
131156113|NCT02786537|472196480|FG003|As Treated|Lost insurance|1|||
131156114|NCT02786537|472196481|FG004|As Treated|Lost insurance|0|||
131156115|NCT02786537|472196482|FG005|As Treated|Lost insurance|0|||
130728560|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
130728561|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
130728562|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728563|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728564|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728565|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728566|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728567|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728568|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728569|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130728570|NCT04784533|470627511|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
130728571|NCT04784533|470627512|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
130728572|NCT04784533|470627513|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728573|NCT04784533|470627514|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728574|NCT04784533|470627515|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728575|NCT04784533|470627516|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728576|NCT04784533|470627517|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728577|NCT04784533|470627518|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728578|NCT04784533|470627519|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728579|NCT04784533|470627520|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130728580|NCT04784533|470627511|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728581|NCT04784533|470627512|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728582|NCT04784533|470627513|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
130728583|NCT04784533|470627514|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728584|NCT04784533|470627515|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728585|NCT04784533|470627516|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728586|NCT04784533|470627517|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
131156116|NCT02786537|472196477|FG000|As Treated|Withdrawal by Subject|1|||
131156117|NCT02786537|472196478|FG001|As Treated|Withdrawal by Subject|2|||
131156118|NCT02786537|472196479|FG002|As Treated|Withdrawal by Subject|0|||
131156119|NCT02786537|472196480|FG003|As Treated|Withdrawal by Subject|0|||
131156120|NCT02786537|472196481|FG004|As Treated|Withdrawal by Subject|1|||
131156121|NCT02786537|472196482|FG005|As Treated|Withdrawal by Subject|0|||
131156122|NCT02786537|472196477|FG000|As Treated|Incarceration|0|||
131156123|NCT02786537|472196478|FG001|As Treated|Incarceration|1|||
131156124|NCT02786537|472196479|FG002|As Treated|Incarceration|0|||
131156125|NCT02786537|472196480|FG003|As Treated|Incarceration|0|||
131156126|NCT02786537|472196481|FG004|As Treated|Incarceration|0|||
131156127|NCT02786537|472196482|FG005|As Treated|Incarceration|0|||
131156128|NCT02786537|472196477|FG000|As Treated|Opiate dependency relapse|0|||
131156129|NCT02786537|472196478|FG001|As Treated|Opiate dependency relapse|1|||
131156130|NCT02786537|472196479|FG002|As Treated|Opiate dependency relapse|0|||
131156131|NCT02786537|472196480|FG003|As Treated|Opiate dependency relapse|0|||
131156132|NCT02786537|472196481|FG004|As Treated|Opiate dependency relapse|0|||
131156133|NCT02786537|472196482|FG005|As Treated|Opiate dependency relapse|0|||
131156134|NCT02786537|472196477|FG000|As Treated|Drugs stolen from patient|0|||
131156135|NCT02786537|472196478|FG001|As Treated|Drugs stolen from patient|1|||
131156136|NCT02786537|472196479|FG002|As Treated|Drugs stolen from patient|0|||
131156137|NCT02786537|472196480|FG003|As Treated|Drugs stolen from patient|0|||
131156138|NCT02786537|472196481|FG004|As Treated|Drugs stolen from patient|0|||
131156139|NCT02786537|472196482|FG005|As Treated|Drugs stolen from patient|0|||
131156140|NCT02786537|472196477|FG000|As Treated|Advised to stop tx after loss of meds|0|||
131156141|NCT02786537|472196478|FG001|As Treated|Advised to stop tx after loss of meds|1|||
131156142|NCT02786537|472196479|FG002|As Treated|Advised to stop tx after loss of meds|0|||
131156143|NCT02786537|472196480|FG003|As Treated|Advised to stop tx after loss of meds|0|||
130728587|NCT04784533|470627518|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728588|NCT04784533|470627519|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728589|NCT04784533|470627520|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130728590|NCT04784533|470627511|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728591|NCT04784533|470627512|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
131156144|NCT02786537|472196481|FG004|As Treated|Advised to stop tx after loss of meds|0|||
131156145|NCT02786537|472196482|FG005|As Treated|Advised to stop tx after loss of meds|0|||
131156146|NCT01981187|472196483|FG000|Overall Study|Participant/guardian decision|2|||
131156147|NCT01981187|472196483|FG000|Overall Study|Physician Decision|1|||
131156148|NCT01981187|472196483|FG000|Overall Study|Disease progression|2|||
131156149|NCT01981187|472196483|FG000|Overall Study|Adverse Event|7|||
131156150|NCT02638012|472196484|FG000|Overall Study|Lost to Follow-up|1|||
131156151|NCT00443560|472196488|FG000|Overall Study|No intrathecal dose|58|||
131156152|NCT00443560|472196489|FG001|Overall Study|No intrathecal dose|26|||
131156153|NCT00443560|472196488|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
131156154|NCT00443560|472196489|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
131156155|NCT01943539|472196494|FG000|Overall Study|Non-compliance with at-home intervention|4|||
131156156|NCT01943539|472196495|FG001|Overall Study|Non-compliance with at-home intervention|0|||
131156157|NCT01362322|472196496|FG000|Overall Study|Withdrawal by Subject|3|||
131156158|NCT01362322|472196497|FG001|Overall Study|Withdrawal by Subject|1|||
131156159|NCT01362322|472196496|FG000|Overall Study|Lost to Follow-up|2|||
131156160|NCT01362322|472196497|FG001|Overall Study|Lost to Follow-up|6|||
131156161|NCT01009463|472196498|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
131156162|NCT01009463|472196499|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131156163|NCT01009463|472196500|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131156164|NCT01009463|472196501|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131156165|NCT01009463|472196502|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
131156166|NCT01009463|472196498|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
131156167|NCT01009463|472196499|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
131156168|NCT01009463|472196500|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
131156169|NCT01009463|472196501|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
131156170|NCT01009463|472196502|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
131156171|NCT01009463|472196498|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
131156172|NCT01009463|472196499|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131156173|NCT01009463|472196500|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131156174|NCT01009463|472196501|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131156175|NCT01009463|472196502|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
131156176|NCT01009463|472196498|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
131156177|NCT01009463|472196499|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
131156178|NCT01009463|472196500|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
131156179|NCT01009463|472196501|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
131156180|NCT01009463|472196502|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
131156181|NCT01009463|472196498|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
131156182|NCT01009463|472196499|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131156183|NCT01009463|472196500|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131156184|NCT01009463|472196501|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131156185|NCT01009463|472196502|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
131156186|NCT01009463|472196498|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
131156187|NCT01009463|472196499|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
131156188|NCT01009463|472196500|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
131156189|NCT01009463|472196501|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
131156190|NCT01009463|472196502|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
131156191|NCT01009463|472196498|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131156192|NCT01009463|472196499|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
131156193|NCT01009463|472196500|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
131156194|NCT01009463|472196501|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
131156195|NCT01009463|472196502|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
131156196|NCT01009463|472196498|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
131156197|NCT01009463|472196499|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
131156198|NCT01009463|472196500|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
131156199|NCT01009463|472196501|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
131156200|NCT01009463|472196502|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
131156201|NCT01009463|472196498|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
131156202|NCT01009463|472196499|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
131156203|NCT01009463|472196500|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
131156204|NCT01009463|472196501|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
131156205|NCT01009463|472196502|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
131156206|NCT01009463|472196498|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
131156207|NCT01009463|472196499|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
131156208|NCT01009463|472196500|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
131156209|NCT01009463|472196501|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
131156210|NCT01009463|472196502|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
131156211|NCT01009463|472196498|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131156212|NCT01009463|472196499|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
131156213|NCT01009463|472196500|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131156214|NCT01009463|472196501|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
131156215|NCT01009463|472196502|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
131156216|NCT01009463|472196498|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131156217|NCT01009463|472196499|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
131156218|NCT01009463|472196500|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
131156219|NCT01009463|472196501|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
131156220|NCT01009463|472196502|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
131156221|NCT01009463|472196498|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
131156222|NCT01009463|472196499|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
131156223|NCT01009463|472196500|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
131156224|NCT01009463|472196501|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
131156225|NCT01009463|472196502|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
131156226|NCT02413255|472196503|FG000|Overall Study|Voluntary Withdrawal|0|||
131156227|NCT02413255|472196504|FG001|Overall Study|Voluntary Withdrawal|0|||
131156228|NCT02413255|472196505|FG002|Overall Study|Voluntary Withdrawal|0|||
131156229|NCT02413255|472196506|FG003|Overall Study|Voluntary Withdrawal|0|||
131156230|NCT02413255|472196507|FG004|Overall Study|Voluntary Withdrawal|0|||
131156231|NCT02413255|472196508|FG005|Overall Study|Voluntary Withdrawal|0|||
131156232|NCT02413255|472196509|FG006|Overall Study|Voluntary Withdrawal|0|||
131156233|NCT02413255|472196510|FG007|Overall Study|Voluntary Withdrawal|0|||
131156234|NCT02413255|472196511|FG008|Overall Study|Voluntary Withdrawal|0|||
131156235|NCT02413255|472196512|FG009|Overall Study|Voluntary Withdrawal|0|||
131156236|NCT02413255|472196513|FG010|Overall Study|Voluntary Withdrawal|0|||
131156237|NCT02413255|472196514|FG011|Overall Study|Voluntary Withdrawal|0|||
131156238|NCT02413255|472196515|FG012|Overall Study|Voluntary Withdrawal|0|||
131156239|NCT02413255|472196516|FG013|Overall Study|Voluntary Withdrawal|0|||
131156240|NCT02413255|472196517|FG014|Overall Study|Voluntary Withdrawal|1|||
131156241|NCT02413255|472196518|FG015|Overall Study|Voluntary Withdrawal|0|||
131156242|NCT02413255|472196519|FG016|Overall Study|Voluntary Withdrawal|0|||
131156243|NCT03199911|472196520|FG000|Overall Study|Lost to Follow-up|5|||
131156244|NCT03199911|472196521|FG001|Overall Study|Lost to Follow-up|5|||
131156245|NCT03199911|472196520|FG000|Overall Study|Did not proceed with surgery|2|||
131156246|NCT03199911|472196521|FG001|Overall Study|Did not proceed with surgery|1|||
131156247|NCT02333331|472196522|FG000|Overall Study|Adverse Event|1|||
131156248|NCT02333331|472196523|FG001|Overall Study|Adverse Event|0|||
131156249|NCT02333331|472196524|FG002|Overall Study|Adverse Event|4|||
131156250|NCT02333331|472196525|FG003|Overall Study|Adverse Event|1|||
131156251|NCT02333331|472196522|FG000|Overall Study|Death|0|||
131156252|NCT02333331|472196523|FG001|Overall Study|Death|0|||
131156253|NCT02333331|472196524|FG002|Overall Study|Death|2|||
131156254|NCT02333331|472196525|FG003|Overall Study|Death|0|||
131156255|NCT02333331|472196522|FG000|Overall Study|Lost to Follow-up|0|||
131156256|NCT02333331|472196523|FG001|Overall Study|Lost to Follow-up|0|||
131156257|NCT02333331|472196524|FG002|Overall Study|Lost to Follow-up|1|||
131156258|NCT02333331|472196525|FG003|Overall Study|Lost to Follow-up|0|||
131156259|NCT02333331|472196522|FG000|Overall Study|Physician Decision|0|||
131156260|NCT02333331|472196523|FG001|Overall Study|Physician Decision|1|||
131156261|NCT02333331|472196524|FG002|Overall Study|Physician Decision|0|||
131156262|NCT02333331|472196525|FG003|Overall Study|Physician Decision|0|||
131156263|NCT02333331|472196522|FG000|Overall Study|Protocol Deviation|0|||
131156264|NCT02333331|472196523|FG001|Overall Study|Protocol Deviation|3|||
131156265|NCT02333331|472196524|FG002|Overall Study|Protocol Deviation|2|||
131156266|NCT02333331|472196525|FG003|Overall Study|Protocol Deviation|1|||
131156267|NCT02333331|472196522|FG000|Overall Study|Patient/Guardian Decision|1|||
131156268|NCT02333331|472196523|FG001|Overall Study|Patient/Guardian Decision|2|||
131156269|NCT02333331|472196524|FG002|Overall Study|Patient/Guardian Decision|9|||
131156270|NCT02333331|472196525|FG003|Overall Study|Patient/Guardian Decision|1|||
131156271|NCT02413398|472196526|FG000|Overall Study|Lost to Follow-up|2|||
131156272|NCT02413398|472196527|FG001|Overall Study|Lost to Follow-up|4|||
131156273|NCT02413398|472196526|FG000|Overall Study|Withdrawal by Subject|1|||
131156274|NCT02413398|472196527|FG001|Overall Study|Withdrawal by Subject|1|||
131156275|NCT02413398|472196526|FG000|Overall Study|Other Eligibility criteria|1|||
131156276|NCT02413398|472196527|FG001|Overall Study|Other Eligibility criteria|2|||
131156277|NCT01494038|472196530|FG000|Overall Study|Protocol Violation|1|||
131156278|NCT01494038|472196531|FG001|Overall Study|Protocol Violation|1|||
131156279|NCT01494038|472196530|FG000|Overall Study|Lost to Follow-up|18|||
131156280|NCT01494038|472196531|FG001|Overall Study|Lost to Follow-up|20|||
131156281|NCT01494038|472196530|FG000|Overall Study|Withdrawal by Subject|44|||
131156282|NCT01494038|472196531|FG001|Overall Study|Withdrawal by Subject|34|||
131156283|NCT01494038|472196530|FG000|Overall Study|Not able to get to clinic|21|||
131156284|NCT01494038|472196531|FG001|Overall Study|Not able to get to clinic|15|||
131156285|NCT01494038|472196530|FG000|Overall Study|Not willing to adhere to reqs|2|||
131156286|NCT01494038|472196531|FG001|Overall Study|Not willing to adhere to reqs|9|||
131156287|NCT01494038|472196530|FG000|Overall Study|Death|2|||
131156288|NCT01494038|472196531|FG001|Overall Study|Death|4|||
131156289|NCT02874794|472196532|FG000|Overall Study|Physician Decision|3|||
131156290|NCT02874794|472196533|FG001|Overall Study|Physician Decision|2|||
131156291|NCT02874794|472196532|FG000|Overall Study|Withdrawal by Subject|2|||
131156292|NCT02874794|472196533|FG001|Overall Study|Withdrawal by Subject|8|||
131156293|NCT02874794|472196532|FG000|Overall Study|Death|2|||
131156294|NCT02874794|472196533|FG001|Overall Study|Death|1|||
131156295|NCT00537940|472196534|FG000|Overall Study|Adverse Event|20|||
131156296|NCT00537940|472196535|FG001|Overall Study|Adverse Event|19|||
131156297|NCT00537940|472196534|FG000|Overall Study|Lack of Efficacy|8|||
131156298|NCT00537940|472196535|FG001|Overall Study|Lack of Efficacy|16|||
131156299|NCT00537940|472196534|FG000|Overall Study|Lost to Follow-up|23|||
131156300|NCT00537940|472196535|FG001|Overall Study|Lost to Follow-up|29|||
131156301|NCT00537940|472196534|FG000|Overall Study|Withdrawal by Subject|113|||
131156302|NCT00537940|472196535|FG001|Overall Study|Withdrawal by Subject|95|||
131156303|NCT00537940|472196534|FG000|Overall Study|Protocol Violation|6|||
131156304|NCT00537940|472196535|FG001|Overall Study|Protocol Violation|4|||
130780365|NCT00490971|470821507|FG000|Acute/Continuation|Death|2|||
131156305|NCT00537940|472196534|FG000|Overall Study|Pregnancy|1|||
131156306|NCT00537940|472196535|FG001|Overall Study|Pregnancy|1|||
131156307|NCT00537940|472196534|FG000|Overall Study|Study terminated by sponsor|2|||
131156308|NCT00537940|472196535|FG001|Overall Study|Study terminated by sponsor|3|||
131156309|NCT00537940|472196534|FG000|Overall Study|Other|10|||
131156310|NCT00537940|472196535|FG001|Overall Study|Other|12|||
131156311|NCT05309668|472196537|FG000|Overall Study|Ongoing at data cut-off|14|||
131156312|NCT05309668|472196538|FG001|Overall Study|Ongoing at data cut-off|17|||
131156313|NCT05309668|472196539|FG002|Overall Study|Ongoing at data cut-off|4|||
131156314|NCT02401256|472196540|FG000|Overall Study|Adverse Event|5|||
131156315|NCT02401256|472196540|FG000|Overall Study|Withdrawal by Subject|12|||
131156316|NCT00345605|472196544|FG000|Arm 1|Adverse Event|0|||
131156317|NCT00345605|472196545|FG001|Arm 1|Adverse Event|1|||
131156318|NCT00345605|472196544|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
131156319|NCT00345605|472196545|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
131156320|NCT01389128|472196546|FG000|Overall Study|Fetal distress|1|||
131156321|NCT01389128|472196547|FG001|Overall Study|Fetal distress|0|||
131156322|NCT01389128|472196546|FG000|Overall Study|Cervix dilation stop|1|||
131156323|NCT01389128|472196547|FG001|Overall Study|Cervix dilation stop|2|||
131156324|NCT01389128|472196546|FG000|Overall Study|Rapid labor evolution|3|||
131156325|NCT01389128|472196547|FG001|Overall Study|Rapid labor evolution|2|||
131156326|NCT01389128|472196546|FG000|Overall Study|Intolerance to procedure|0|||
131156327|NCT01389128|472196547|FG001|Overall Study|Intolerance to procedure|2|||
131156328|NCT01059812|472196548|FG000|Overall Study|Adverse Event|9|||
131156329|NCT01059812|472196549|FG001|Overall Study|Adverse Event|5|||
131156330|NCT01059812|472196548|FG000|Overall Study|Lack of Efficacy|2|||
131156331|NCT01059812|472196549|FG001|Overall Study|Lack of Efficacy|2|||
131156332|NCT01059812|472196548|FG000|Overall Study|Protocol Violation|3|||
131156333|NCT01059812|472196549|FG001|Overall Study|Protocol Violation|1|||
131156334|NCT01059812|472196548|FG000|Overall Study|Withdrawal Criteria|9|||
131156335|NCT01059812|472196549|FG001|Overall Study|Withdrawal Criteria|4|||
131156336|NCT01059812|472196548|FG000|Overall Study|Unclassified|14|||
131156337|NCT01059812|472196549|FG001|Overall Study|Unclassified|4|||
131156338|NCT03180736|472196550|FG000|Overall Study|Adverse Event|3|||
131156339|NCT03180736|472196551|FG001|Overall Study|Adverse Event|4|||
131156340|NCT03180736|472196550|FG000|Overall Study|Death|10|||
131156341|NCT03180736|472196551|FG001|Overall Study|Death|7|||
131156342|NCT03180736|472196550|FG000|Overall Study|Withdrawal by Subject|5|||
131156343|NCT03180736|472196551|FG001|Overall Study|Withdrawal by Subject|12|||
131156344|NCT03180736|472196550|FG000|Overall Study|Lost to Follow-up|1|||
131156345|NCT03180736|472196551|FG001|Overall Study|Lost to Follow-up|0|||
131156346|NCT03180736|472196550|FG000|Overall Study|Lack of Efficacy|66|||
131156347|NCT03180736|472196551|FG001|Overall Study|Lack of Efficacy|87|||
131156348|NCT03180736|472196550|FG000|Overall Study|Physician Decision|4|||
131156349|NCT03180736|472196551|FG001|Overall Study|Physician Decision|7|||
131156350|NCT03180736|472196550|FG000|Overall Study|randomized but not treated|2|||
131156351|NCT03180736|472196551|FG001|Overall Study|randomized but not treated|3|||
131156352|NCT03230097|472196560|FG000|Overall Study|Adverse Event|2|||
131156353|NCT03230097|472196561|FG001|Overall Study|Adverse Event|1|||
131156354|NCT03230097|472196560|FG000|Overall Study|non-compliance|0|||
131156355|NCT03230097|472196561|FG001|Overall Study|non-compliance|1|||
131156356|NCT03230097|472196560|FG000|Overall Study|Lost to Follow-up|2|||
131156357|NCT03230097|472196561|FG001|Overall Study|Lost to Follow-up|4|||
131156358|NCT03230097|472196560|FG000|Overall Study|Withdrawal by Subject|7|||
131156359|NCT03230097|472196561|FG001|Overall Study|Withdrawal by Subject|3|||
131156360|NCT03230097|472196560|FG000|Overall Study|Trial termination|4|||
131156361|NCT03230097|472196561|FG001|Overall Study|Trial termination|5|||
131156362|NCT03230097|472196560|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
131156363|NCT03230097|472196561|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
130780366|NCT00490971|470821508|FG001|Acute/Continuation|Death|0|||
131156364|NCT03230097|472196560|FG000|Overall Study|outcome event|0|||
131156365|NCT03230097|472196561|FG001|Overall Study|outcome event|1|||
131156366|NCT03056287|472196562|FG000|Overall Study|Withdrawal by Subject|0|||
131156367|NCT03056287|472196563|FG001|Overall Study|Withdrawal by Subject|1|||
131156368|NCT03056287|472196564|FG002|Overall Study|Withdrawal by Subject|0|||
131156369|NCT03056287|472196565|FG003|Overall Study|Withdrawal by Subject|0|||
130780367|NCT00490971|470821509|FG002|Acute/Continuation|Death|0|||
130780368|NCT00490971|470821510|FG003|Acute/Continuation|Death|0|||
130780369|NCT00490971|470821511|FG004|Acute/Continuation|Death|0|||
130780370|NCT00490971|470821507|FG000|Acute/Continuation|Lack of Efficacy|106|||
130780371|NCT00490971|470821508|FG001|Acute/Continuation|Lack of Efficacy|12|||
130780372|NCT00490971|470821509|FG002|Acute/Continuation|Lack of Efficacy|0|||
130780373|NCT00490971|470821510|FG003|Acute/Continuation|Lack of Efficacy|0|||
130780374|NCT00490971|470821511|FG004|Acute/Continuation|Lack of Efficacy|0|||
130780375|NCT00490971|470821507|FG000|Acute/Continuation|Lost to Follow-up|23|||
130780376|NCT00490971|470821508|FG001|Acute/Continuation|Lost to Follow-up|7|||
130780377|NCT00490971|470821509|FG002|Acute/Continuation|Lost to Follow-up|0|||
130780378|NCT00490971|470821510|FG003|Acute/Continuation|Lost to Follow-up|0|||
130780379|NCT00490971|470821511|FG004|Acute/Continuation|Lost to Follow-up|0|||
130780380|NCT00490971|470821507|FG000|Acute/Continuation|Protocol Violation|10|||
130780381|NCT00490971|470821508|FG001|Acute/Continuation|Protocol Violation|2|||
130780382|NCT00490971|470821509|FG002|Acute/Continuation|Protocol Violation|0|||
130780383|NCT00490971|470821510|FG003|Acute/Continuation|Protocol Violation|0|||
130780384|NCT00490971|470821511|FG004|Acute/Continuation|Protocol Violation|0|||
130780385|NCT00490971|470821507|FG000|Acute/Continuation|Withdrawal by Subject|92|||
130780386|NCT00490971|470821508|FG001|Acute/Continuation|Withdrawal by Subject|24|||
130780387|NCT00490971|470821509|FG002|Acute/Continuation|Withdrawal by Subject|0|||
130780388|NCT00490971|470821510|FG003|Acute/Continuation|Withdrawal by Subject|0|||
130780389|NCT00490971|470821511|FG004|Acute/Continuation|Withdrawal by Subject|0|||
130780390|NCT00490971|470821507|FG000|Acute/Continuation|Other|11|||
130780391|NCT00490971|470821508|FG001|Acute/Continuation|Other|4|||
130780392|NCT00490971|470821509|FG002|Acute/Continuation|Other|0|||
130780393|NCT00490971|470821510|FG003|Acute/Continuation|Other|0|||
130780394|NCT00490971|470821511|FG004|Acute/Continuation|Other|0|||
130780395|NCT00490971|470821507|FG000|Maintenance|Adverse Event|0|||
130780396|NCT00490971|470821508|FG001|Maintenance|Adverse Event|0|||
130780397|NCT00490971|470821509|FG002|Maintenance|Adverse Event|4|||
130780398|NCT00490971|470821510|FG003|Maintenance|Adverse Event|5|||
130780399|NCT00490971|470821511|FG004|Maintenance|Adverse Event|7|||
130780400|NCT00490971|470821507|FG000|Maintenance|Death|0|||
130780401|NCT00490971|470821508|FG001|Maintenance|Death|0|||
130780402|NCT00490971|470821509|FG002|Maintenance|Death|0|||
130780403|NCT00490971|470821510|FG003|Maintenance|Death|2|||
130780404|NCT00490971|470821511|FG004|Maintenance|Death|0|||
130780405|NCT00490971|470821507|FG000|Maintenance|Lost to Follow-up|0|||
130780406|NCT00490971|470821508|FG001|Maintenance|Lost to Follow-up|0|||
130780407|NCT00490971|470821509|FG002|Maintenance|Lost to Follow-up|5|||
130780408|NCT00490971|470821510|FG003|Maintenance|Lost to Follow-up|8|||
130780409|NCT00490971|470821511|FG004|Maintenance|Lost to Follow-up|10|||
130780410|NCT00490971|470821507|FG000|Maintenance|Pregnancy|0|||
130780411|NCT00490971|470821508|FG001|Maintenance|Pregnancy|0|||
130780412|NCT00490971|470821509|FG002|Maintenance|Pregnancy|1|||
130780413|NCT00490971|470821510|FG003|Maintenance|Pregnancy|0|||
130780414|NCT00490971|470821511|FG004|Maintenance|Pregnancy|0|||
130780415|NCT00490971|470821507|FG000|Maintenance|Protocol Violation|0|||
130780416|NCT00490971|470821508|FG001|Maintenance|Protocol Violation|0|||
131156370|NCT03056287|472196562|FG000|Overall Study|move out of area|0|||
131156371|NCT03056287|472196563|FG001|Overall Study|move out of area|0|||
131156372|NCT03056287|472196564|FG002|Overall Study|move out of area|1|||
131156373|NCT03056287|472196565|FG003|Overall Study|move out of area|1|||
131156374|NCT00947154|472196566|FG000|Overall Study|Lost to Follow-up|1|||
131156375|NCT03794986|472196567|FG000|Overall Study|0 Sessions Attended|34|||
131156376|NCT03794986|472196568|FG001|Overall Study|0 Sessions Attended|37|||
131156377|NCT03794986|472196567|FG000|Overall Study|Withdrawal by Subject|4|||
131156378|NCT03794986|472196568|FG001|Overall Study|Withdrawal by Subject|6|||
131156379|NCT03794986|472196567|FG000|Overall Study|Protocol Violation|1|||
131156380|NCT03794986|472196568|FG001|Overall Study|Protocol Violation|0|||
131156381|NCT05309083|472196569|FG000|Overall Study|Withdrawal by Subject|2|||
131156382|NCT01165229|472196570|FG000|Overall Study|Serious Adverse Event|456|||
131156383|NCT01165229|472196571|FG001|Overall Study|Serious Adverse Event|487|||
131156384|NCT01165229|472196570|FG000|Overall Study|Non-Serious Adverse Event|47|||
131156385|NCT01165229|472196571|FG001|Overall Study|Non-Serious Adverse Event|15|||
131156386|NCT01165229|472196570|FG000|Overall Study|Protocol Violation|6|||
131156387|NCT01165229|472196571|FG001|Overall Study|Protocol Violation|8|||
131156388|NCT01165229|472196570|FG000|Overall Study|Withdrawal by Subject|387|||
130780417|NCT00490971|470821509|FG002|Maintenance|Protocol Violation|4|||
131156389|NCT01165229|472196571|FG001|Overall Study|Withdrawal by Subject|396|||
130780418|NCT00490971|470821510|FG003|Maintenance|Protocol Violation|1|||
130780419|NCT00490971|470821511|FG004|Maintenance|Protocol Violation|1|||
130780420|NCT00490971|470821507|FG000|Maintenance|Withdrawal by Subject|0|||
130780421|NCT00490971|470821508|FG001|Maintenance|Withdrawal by Subject|0|||
130780422|NCT00490971|470821509|FG002|Maintenance|Withdrawal by Subject|26|||
130780423|NCT00490971|470821510|FG003|Maintenance|Withdrawal by Subject|28|||
130780424|NCT00490971|470821511|FG004|Maintenance|Withdrawal by Subject|18|||
130780425|NCT00490971|470821507|FG000|Maintenance|Other|0|||
131156390|NCT01165229|472196570|FG000|Overall Study|Migrated/moved from study area|51|||
131156391|NCT01165229|472196571|FG001|Overall Study|Migrated/moved from study area|46|||
131156392|NCT01165229|472196570|FG000|Overall Study|Lost to Follow-up|123|||
131156393|NCT01165229|472196571|FG001|Overall Study|Lost to Follow-up|133|||
131156394|NCT01165229|472196570|FG000|Overall Study|Suspected HZ Episode|2|||
131156395|NCT01165229|472196571|FG001|Overall Study|Suspected HZ Episode|2|||
131156396|NCT01165229|472196570|FG000|Overall Study|No reason from the subject|108|||
131156397|NCT01165229|472196571|FG001|Overall Study|No reason from the subject|102|||
131156398|NCT01165229|472196570|FG000|Overall Study|Unknown completion status|0|||
131156399|NCT01165229|472196571|FG001|Overall Study|Unknown completion status|1|||
131156400|NCT00881205|472196575|FG000|Overall Study|Adverse Event|8|||
131156401|NCT00881205|472196576|FG001|Overall Study|Adverse Event|3|||
131156402|NCT00881205|472196575|FG000|Overall Study|Withdrawal by Subject|1|||
131156403|NCT00881205|472196576|FG001|Overall Study|Withdrawal by Subject|2|||
131156404|NCT00881205|472196575|FG000|Overall Study|Lost to Follow-up|0|||
131156405|NCT00881205|472196576|FG001|Overall Study|Lost to Follow-up|1|||
131156406|NCT00881205|472196575|FG000|Overall Study|Administrative problems|1|||
131156407|NCT00881205|472196576|FG001|Overall Study|Administrative problems|1|||
131156408|NCT00881205|472196575|FG000|Overall Study|Condition no longer requires drug|1|||
131156409|NCT00881205|472196576|FG001|Overall Study|Condition no longer requires drug|0|||
131156410|NCT00465569|472196577|FG000|Overall Study|persistent eczema during dose escalation|1|||
131156411|NCT00465569|472196578|FG001|Overall Study|persistent eczema during dose escalation|0|||
131156412|NCT00849212|472196579|FG000|Overall Study|Lack of Efficacy|1|||
131156413|NCT00849212|472196579|FG000|Overall Study|Withdrawal by Subject|3|||
131156414|NCT00849212|472196579|FG000|Overall Study|Adverse Event|2|||
131156415|NCT00849212|472196579|FG000|Overall Study|Miscellaneous|1|||
131156416|NCT01634243|472196580|FG000|Overall Study|Adverse Event|5|||
131156417|NCT01634243|472196581|FG001|Overall Study|Adverse Event|5|||
131156418|NCT01634243|472196580|FG000|Overall Study|Lack of Efficacy|1|||
131156419|NCT01634243|472196581|FG001|Overall Study|Lack of Efficacy|0|||
131156420|NCT02111369|472196589|FG000|Overall Study|Lost to Follow-up|2|||
131156421|NCT02111369|472196589|FG000|Overall Study|Withdrawal by Subject|1|||
131156422|NCT03240081|472196593|FG000|Overall Study|Withdrawal by Subject|0|||
131156423|NCT03240081|472196594|FG001|Overall Study|Withdrawal by Subject|2|||
131156424|NCT03240081|472196593|FG000|Overall Study|Lost to Follow-up|0|||
131156425|NCT03240081|472196594|FG001|Overall Study|Lost to Follow-up|1|||
131156426|NCT00883753|472196595|FG000|Overall Study|Adverse Event|37|||
131156427|NCT00883753|472196595|FG000|Overall Study|Death|2|||
131156428|NCT00883753|472196595|FG000|Overall Study|Insufficient therapeutic response|16|||
131156429|NCT00883753|472196595|FG000|Overall Study|Lost to Follow-up|4|||
131156430|NCT00883753|472196595|FG000|Overall Study|Violation of selection criteria at entry|7|||
131156431|NCT00883753|472196595|FG000|Overall Study|Protocol Violation|2|||
131156432|NCT00883753|472196595|FG000|Overall Study|Refused treatment|4|||
131156433|NCT00883753|472196595|FG000|Overall Study|Withdrew consent|10|||
131156434|NCT00883753|472196595|FG000|Overall Study|Investigator's decision|17|||
131156435|NCT00883753|472196595|FG000|Overall Study|Administrative/Other|8|||
131156436|NCT01480180|472196596|FG000|Main Phase|Withdrawal criteria|12|||
131156437|NCT01480180|472196597|FG001|Main Phase|Withdrawal criteria|1|||
131156438|NCT01480180|472196598|FG002|Main Phase|Withdrawal criteria|0|||
131156439|NCT01480180|472196599|FG003|Main Phase|Withdrawal criteria|0|||
131156440|NCT01480180|472196600|FG004|Main Phase|Withdrawal criteria|0|||
131156441|NCT01480180|472196601|FG005|Main Phase|Withdrawal criteria|0|||
131156442|NCT01480180|472196596|FG000|Main Phase|Lack of Efficacy|1|||
131156443|NCT01480180|472196597|FG001|Main Phase|Lack of Efficacy|0|||
131156444|NCT01480180|472196598|FG002|Main Phase|Lack of Efficacy|0|||
131156445|NCT01480180|472196599|FG003|Main Phase|Lack of Efficacy|0|||
131156446|NCT01480180|472196600|FG004|Main Phase|Lack of Efficacy|0|||
131156447|NCT01480180|472196601|FG005|Main Phase|Lack of Efficacy|0|||
131156448|NCT01480180|472196596|FG000|Main Phase|Non-compliance|3|||
131156449|NCT01480180|472196597|FG001|Main Phase|Non-compliance|0|||
131156450|NCT01480180|472196598|FG002|Main Phase|Non-compliance|0|||
131156451|NCT01480180|472196599|FG003|Main Phase|Non-compliance|0|||
131156452|NCT01480180|472196600|FG004|Main Phase|Non-compliance|0|||
131156453|NCT01480180|472196601|FG005|Main Phase|Non-compliance|0|||
131156454|NCT01480180|472196596|FG000|Main Phase|Unclassified|3|||
131156455|NCT01480180|472196597|FG001|Main Phase|Unclassified|0|||
131156456|NCT01480180|472196598|FG002|Main Phase|Unclassified|0|||
131156457|NCT01480180|472196599|FG003|Main Phase|Unclassified|0|||
131156458|NCT01480180|472196600|FG004|Main Phase|Unclassified|0|||
131156459|NCT01480180|472196601|FG005|Main Phase|Unclassified|0|||
131156460|NCT01480180|472196596|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
131156461|NCT01480180|472196597|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
131156462|NCT01480180|472196598|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
131235225|NCT02097121|472488875|FG002|Overall Study|Withdrawal by Subject|2|||
131156463|NCT01480180|472196599|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
131156464|NCT01480180|472196600|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
131156465|NCT01480180|472196601|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
131156466|NCT01480180|472196596|FG000|Extension Phase, Part 1|Unclassified|0|||
131156467|NCT01480180|472196597|FG001|Extension Phase, Part 1|Unclassified|0|||
131156468|NCT01480180|472196598|FG002|Extension Phase, Part 1|Unclassified|1|||
131156469|NCT01480180|472196599|FG003|Extension Phase, Part 1|Unclassified|0|||
131156470|NCT01480180|472196600|FG004|Extension Phase, Part 1|Unclassified|0|||
131156471|NCT01480180|472196601|FG005|Extension Phase, Part 1|Unclassified|0|||
131156472|NCT01480180|472196596|FG000|Extension Phase, Part 1|Adverse Event|0|||
131156473|NCT01480180|472196597|FG001|Extension Phase, Part 1|Adverse Event|0|||
131156474|NCT01480180|472196598|FG002|Extension Phase, Part 1|Adverse Event|4|||
131156475|NCT01480180|472196599|FG003|Extension Phase, Part 1|Adverse Event|1|||
131156476|NCT01480180|472196600|FG004|Extension Phase, Part 1|Adverse Event|0|||
131156477|NCT01480180|472196601|FG005|Extension Phase, Part 1|Adverse Event|0|||
131156478|NCT01480180|472196596|FG000|Extension Phase, Part 1|Change of treatment|0|||
131156479|NCT01480180|472196597|FG001|Extension Phase, Part 1|Change of treatment|0|||
131156480|NCT01480180|472196598|FG002|Extension Phase, Part 1|Change of treatment|0|||
131156481|NCT01480180|472196599|FG003|Extension Phase, Part 1|Change of treatment|9|||
131156482|NCT01480180|472196600|FG004|Extension Phase, Part 1|Change of treatment|0|||
131156483|NCT01480180|472196601|FG005|Extension Phase, Part 1|Change of treatment|0|||
131156484|NCT01480180|472196596|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
131156485|NCT01480180|472196597|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
131156486|NCT01480180|472196598|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
131156487|NCT01480180|472196599|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
131156488|NCT01480180|472196600|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
131156489|NCT01480180|472196601|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
131156490|NCT01480180|472196596|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
131156491|NCT01480180|472196597|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
131156492|NCT01480180|472196598|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
131156493|NCT01480180|472196599|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
131156494|NCT01480180|472196600|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
131156495|NCT01480180|472196601|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
131156496|NCT01480180|472196596|FG000|Extension Phase, Part 2|Unclassified|0|||
131156497|NCT01480180|472196597|FG001|Extension Phase, Part 2|Unclassified|0|||
131156498|NCT01480180|472196598|FG002|Extension Phase, Part 2|Unclassified|3|||
131156499|NCT01480180|472196599|FG003|Extension Phase, Part 2|Unclassified|1|||
131156500|NCT01480180|472196600|FG004|Extension Phase, Part 2|Unclassified|1|||
131156501|NCT01480180|472196601|FG005|Extension Phase, Part 2|Unclassified|0|||
131156502|NCT01919411|472196606|FG000|Overall Study|Lost to Follow-up|2|||
131156503|NCT01919411|472196607|FG001|Overall Study|Lost to Follow-up|4|||
131156504|NCT01919411|472196606|FG000|Overall Study|Physician Decision|1|||
131156505|NCT01919411|472196607|FG001|Overall Study|Physician Decision|0|||
131156506|NCT01919411|472196606|FG000|Overall Study|Protocol Violation|2|||
131156507|NCT01919411|472196607|FG001|Overall Study|Protocol Violation|1|||
131156508|NCT01650805|472196608|FG000|Overall Study|Withdrawal by Subject|1|||
131156509|NCT01650805|472196609|FG001|Overall Study|Withdrawal by Subject|0|||
131156510|NCT01887210|472196610|FG000|Overall Study|Withdrawal by Subject|1|||
131156511|NCT01887210|472196611|FG001|Overall Study|Withdrawal by Subject|3|||
131156512|NCT01887210|472196610|FG000|Overall Study|Lost to Follow-up|0|||
131156513|NCT01887210|472196611|FG001|Overall Study|Lost to Follow-up|1|||
131156514|NCT00840463|472196612|FG000|Overall Study|Adverse Event|1|||
131156515|NCT00840463|472196613|FG001|Overall Study|Adverse Event|0|||
131156516|NCT02452359|472196614|FG000|Overall Study|Adverse Event|1|||
131156517|NCT02452359|472196614|FG000|Overall Study|Lost to Follow-up|15|||
131156518|NCT02452359|472196614|FG000|Overall Study|Pregnancy|1|||
131156519|NCT02452359|472196614|FG000|Overall Study|Withdrawal by Subject|4|||
131156520|NCT02515669|472196619|FG000|228 Week Open-Label Phase|Other|0|||
131156521|NCT02515669|472196620|FG001|228 Week Open-Label Phase|Other|0|||
131156522|NCT02515669|472196621|FG002|228 Week Open-Label Phase|Other|1|||
131156523|NCT02515669|472196622|FG003|228 Week Open-Label Phase|Other|4|||
131156524|NCT02515669|472196619|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
131156525|NCT02515669|472196620|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
131156526|NCT02515669|472196621|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
131156527|NCT02515669|472196622|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
131156528|NCT02515669|472196619|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
131156529|NCT02515669|472196620|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
131156530|NCT02515669|472196621|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
131156531|NCT02515669|472196622|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
131156532|NCT02515669|472196619|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
131156533|NCT02515669|472196620|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
131156534|NCT02515669|472196621|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
131156535|NCT02515669|472196622|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
131156536|NCT02515669|472196619|FG000|228 Week Open-Label Phase|Missing|0|||
131156537|NCT02515669|472196620|FG001|228 Week Open-Label Phase|Missing|2|||
131156538|NCT02515669|472196621|FG002|228 Week Open-Label Phase|Missing|2|||
131156539|NCT02515669|472196622|FG003|228 Week Open-Label Phase|Missing|2|||
131156540|NCT03750838|472196623|FG000|Overall Study|Lost to Follow-up|10|||
131235226|NCT02097121|472488873|FG000|Overall Study|Adverse Event|0|||
131235227|NCT02097121|472488874|FG001|Overall Study|Adverse Event|1|||
131156541|NCT03750838|472196624|FG001|Overall Study|Lost to Follow-up|6|||
131156542|NCT00630032|472196628|FG000|Overall Study|Death|55|||
131156543|NCT00630032|472196629|FG001|Overall Study|Death|49|||
131156544|NCT00630032|472196628|FG000|Overall Study|Withdrawal by Subject|3|||
131156545|NCT00630032|472196629|FG001|Overall Study|Withdrawal by Subject|2|||
131156546|NCT00630032|472196628|FG000|Overall Study|Lost to Follow-up|18|||
131156547|NCT00630032|472196629|FG001|Overall Study|Lost to Follow-up|31|||
131156548|NCT00630032|472196628|FG000|Overall Study|Protocol Violation|1|||
131156549|NCT00630032|472196629|FG001|Overall Study|Protocol Violation|0|||
131156550|NCT00630032|472196628|FG000|Overall Study|Patient has moved|1|||
131156551|NCT00630032|472196629|FG001|Overall Study|Patient has moved|1|||
131156552|NCT00630032|472196628|FG000|Overall Study|Disease progression|1|||
131156553|NCT00630032|472196629|FG001|Overall Study|Disease progression|1|||
131156554|NCT00630032|472196628|FG000|Overall Study|End of monitoring in US centers|11|||
131156555|NCT00630032|472196629|FG001|Overall Study|End of monitoring in US centers|11|||
131156556|NCT05635838|472198146|FG000|16-Week DBVC Period|Adverse Event|2|||
131156557|NCT05635838|472198147|FG001|16-Week DBVC Period|Adverse Event|0|||
131156558|NCT05635838|472198148|FG002|16-Week DBVC Period|Adverse Event|0|||
131156559|NCT05635838|472198149|FG003|16-Week DBVC Period|Adverse Event|0|||
131156560|NCT05635838|472198146|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
131156561|NCT05635838|472198147|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
131156562|NCT05635838|472198148|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
131156563|NCT05635838|472198149|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
131156564|NCT05635838|472198146|FG000|16-Week DBVC Period|Physician Decision|0|||
131156565|NCT05635838|472198147|FG001|16-Week DBVC Period|Physician Decision|1|||
131156566|NCT05635838|472198148|FG002|16-Week DBVC Period|Physician Decision|0|||
131156567|NCT05635838|472198149|FG003|16-Week DBVC Period|Physician Decision|0|||
131156568|NCT05635838|472198146|FG000|16-Week DBVC Period|Protocol Violation|1|||
131156569|NCT05635838|472198147|FG001|16-Week DBVC Period|Protocol Violation|0|||
131156570|NCT05635838|472198148|FG002|16-Week DBVC Period|Protocol Violation|0|||
131156571|NCT05635838|472198149|FG003|16-Week DBVC Period|Protocol Violation|0|||
131156572|NCT05635838|472198146|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
131156573|NCT05635838|472198147|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
131156574|NCT05635838|472198148|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
131156575|NCT05635838|472198149|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
131156576|NCT05635838|472198146|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
131156577|NCT05635838|472198147|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
131156578|NCT05635838|472198148|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
131156579|NCT05635838|472198149|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
131156580|NCT05635838|472198146|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
131156581|NCT05635838|472198147|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
131156582|NCT05635838|472198148|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
131156583|NCT05635838|472198149|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
131156584|NCT05635838|472198146|FG000|16-Week OLE Period|Adverse Event|0|||
131156585|NCT05635838|472198147|FG001|16-Week OLE Period|Adverse Event|0|||
131156586|NCT05635838|472198148|FG002|16-Week OLE Period|Adverse Event|0|||
131156587|NCT05635838|472198149|FG003|16-Week OLE Period|Adverse Event|2|||
131156588|NCT05635838|472198146|FG000|16-Week OLE Period|Lost to Follow-up|0|||
131156589|NCT05635838|472198147|FG001|16-Week OLE Period|Lost to Follow-up|0|||
131156590|NCT05635838|472198148|FG002|16-Week OLE Period|Lost to Follow-up|1|||
131156591|NCT05635838|472198149|FG003|16-Week OLE Period|Lost to Follow-up|3|||
131156592|NCT05635838|472198146|FG000|16-Week OLE Period|Physician Decision|0|||
131156593|NCT05635838|472198147|FG001|16-Week OLE Period|Physician Decision|0|||
131156594|NCT05635838|472198148|FG002|16-Week OLE Period|Physician Decision|0|||
131156595|NCT05635838|472198149|FG003|16-Week OLE Period|Physician Decision|1|||
131156596|NCT05635838|472198146|FG000|16-Week OLE Period|Protocol Violation|0|||
131156597|NCT05635838|472198147|FG001|16-Week OLE Period|Protocol Violation|0|||
131156598|NCT05635838|472198148|FG002|16-Week OLE Period|Protocol Violation|1|||
131156599|NCT05635838|472198149|FG003|16-Week OLE Period|Protocol Violation|1|||
131156600|NCT05635838|472198146|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
131156601|NCT05635838|472198147|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
131156602|NCT05635838|472198148|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
131156603|NCT05635838|472198149|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
131156604|NCT05635838|472198146|FG000|16-Week OLE Period|Pregnancy|0|||
131156605|NCT05635838|472198147|FG001|16-Week OLE Period|Pregnancy|0|||
131156606|NCT05635838|472198148|FG002|16-Week OLE Period|Pregnancy|1|||
131156607|NCT05635838|472198149|FG003|16-Week OLE Period|Pregnancy|0|||
131156608|NCT05165394|472198152|FG000|Overall Study|Withdrawal by Subject|5|||
131235228|NCT02097121|472488875|FG002|Overall Study|Adverse Event|0|||
131156609|NCT05165394|472198153|FG001|Overall Study|Withdrawal by Subject|1|||
131156610|NCT05165394|472198152|FG000|Overall Study|Lost to Follow-up|1|||
131156611|NCT05165394|472198153|FG001|Overall Study|Lost to Follow-up|2|||
131156612|NCT05165394|472198152|FG000|Overall Study|Other Than Specified|0|||
131156613|NCT05165394|472198153|FG001|Overall Study|Other Than Specified|1|||
131156614|NCT00001259|472198154|FG000|Study 2|Adverse Event|0|||
131156615|NCT00001259|472198155|FG001|Study 2|Adverse Event|0|||
131156616|NCT00001259|472198156|FG002|Study 2|Adverse Event|0|||
131156617|NCT00001259|472198157|FG003|Study 2|Adverse Event|0|||
131156618|NCT00001259|472198158|FG004|Study 2|Adverse Event|2|||
131156619|NCT00001259|472198159|FG005|Study 2|Adverse Event|0|||
131156620|NCT00001259|472198160|FG006|Study 2|Adverse Event|0|||
131156621|NCT03705494|472198161|FG000|Overall Study|Lost to Follow-up|2|||
131156622|NCT03705494|472198162|FG001|Overall Study|Lost to Follow-up|1|||
131156623|NCT03705494|472198161|FG000|Overall Study|Withdrawal by Subject|5|||
131156624|NCT03705494|472198162|FG001|Overall Study|Withdrawal by Subject|2|||
131156625|NCT02629393|472198168|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
131156626|NCT02629393|472198168|FG000|Overall Study|Physician Decision|1|||
131156627|NCT02089737|472198170|FG000|Overall Study|Survey form not completed|5|||
131156628|NCT02089737|472198170|FG000|Overall Study|Not treated|1|||
131156629|NCT00440401|472198191|FG000|Overall Study|Adverse Event|2|||
131156630|NCT00440401|472198192|FG001|Overall Study|Adverse Event|1|||
131156631|NCT00440401|472198191|FG000|Overall Study|Other|2|||
131156632|NCT00440401|472198192|FG001|Overall Study|Other|5|||
131156633|NCT02286960|472198193|FG000|Overall Study|Lost to Follow-up|3|||
131156634|NCT02286960|472198194|FG001|Overall Study|Lost to Follow-up|3|||
131156635|NCT00091793|472198195|FG000|Overall Study|Adverse Event|1|||
131156636|NCT00091793|472198196|FG001|Overall Study|Adverse Event|2|||
131156637|NCT00091793|472198195|FG000|Overall Study|Withdrawal by Subject|10|||
131156638|NCT00091793|472198196|FG001|Overall Study|Withdrawal by Subject|15|||
131156639|NCT00091793|472198195|FG000|Overall Study|Ineligibility determined|2|||
131156640|NCT00091793|472198196|FG001|Overall Study|Ineligibility determined|0|||
131156641|NCT00091793|472198195|FG000|Overall Study|Lost to Follow-up|7|||
131156642|NCT00091793|472198196|FG001|Overall Study|Lost to Follow-up|5|||
131156643|NCT00091793|472198195|FG000|Overall Study|Noncompliance|2|||
131156644|NCT00091793|472198196|FG001|Overall Study|Noncompliance|0|||
131156645|NCT00091793|472198195|FG000|Overall Study|Other|2|||
131156646|NCT00091793|472198196|FG001|Overall Study|Other|0|||
131156647|NCT00550238|472198197|FG000|Overall Study|Adverse Event|88|||
131156648|NCT00550238|472198197|FG000|Overall Study|Death|34|||
131156649|NCT00550238|472198197|FG000|Overall Study|Disease progression|46|||
131156650|NCT00550238|472198197|FG000|Overall Study|Withdrawal by Subject|167|||
131156651|NCT00550238|472198197|FG000|Overall Study|Physician Decision|31|||
131156652|NCT00550238|472198197|FG000|Overall Study|Patient noncompliance|25|||
131156653|NCT00550238|472198197|FG000|Overall Study|Lost to Follow-up|13|||
131156654|NCT00550238|472198197|FG000|Overall Study|Sponsor decision|55|||
131156655|NCT00637728|472198198|FG000|Double-blind Phase|Adverse Event|1|||
131156656|NCT00637728|472198199|FG001|Double-blind Phase|Adverse Event|0|||
131156657|NCT00637728|472198200|FG002|Double-blind Phase|Adverse Event|0|||
131156658|NCT00637728|472198198|FG000|Double-blind Phase|Non-compliance|2|||
131156659|NCT00637728|472198199|FG001|Double-blind Phase|Non-compliance|0|||
131156660|NCT00637728|472198200|FG002|Double-blind Phase|Non-compliance|0|||
131156661|NCT00637728|472198198|FG000|Double-blind Phase|Study Discontinued|1|||
131156662|NCT00637728|472198199|FG001|Double-blind Phase|Study Discontinued|1|||
131156663|NCT00637728|472198200|FG002|Double-blind Phase|Study Discontinued|0|||
131156664|NCT02723630|472198201|FG000|Intervention Period 1|Adverse Event|1|||
131156665|NCT02723630|472198202|FG001|Intervention Period 1|Adverse Event|0|||
131156666|NCT02723630|472198203|FG002|Intervention Period 1|Adverse Event|0|||
131156667|NCT02723630|472198204|FG003|Intervention Period 1|Adverse Event|0|||
131156668|NCT02723630|472198205|FG004|Intervention Period 1|Adverse Event|0|||
131156669|NCT02723630|472198206|FG005|Intervention Period 1|Adverse Event|0|||
131156670|NCT02723630|472198201|FG000|Intervention Period 3|consumption of restricted item|0|||
131156671|NCT02723630|472198202|FG001|Intervention Period 3|consumption of restricted item|1|||
131156672|NCT02723630|472198203|FG002|Intervention Period 3|consumption of restricted item|0|||
131156673|NCT02723630|472198204|FG003|Intervention Period 3|consumption of restricted item|0|||
131156674|NCT02723630|472198205|FG004|Intervention Period 3|consumption of restricted item|0|||
131156675|NCT02723630|472198206|FG005|Intervention Period 3|consumption of restricted item|0|||
131156676|NCT00537745|472198207|FG000|Overall Study|Did not meet eligibility criteria|2|||
131156677|NCT00537745|472198207|FG000|Overall Study|Withdrawal by Subject|2|||
131235229|NCT02097121|472488873|FG000|Overall Study|Lost to Follow-up|1|||
131235230|NCT02097121|472488874|FG001|Overall Study|Lost to Follow-up|1|||
131156678|NCT00537745|472198207|FG000|Overall Study|Subject unable to provide Interlock info|1|||
131156679|NCT03047213|472198208|FG000|Overall Study|Withdrawal by Subject|2|||
131156680|NCT03047213|472198209|FG001|Overall Study|Withdrawal by Subject|0|||
131156681|NCT03047213|472198208|FG000|Overall Study|Adverse Event|2|||
131156682|NCT03047213|472198209|FG001|Overall Study|Adverse Event|0|||
131156683|NCT00482001|472198210|FG000|Overall Study|Protocol Violation|1|||
131156684|NCT00482001|472198211|FG001|Overall Study|Protocol Violation|1|||
131156685|NCT03700892|472198212|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
131156686|NCT03700892|472198213|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
131156687|NCT03700892|472198214|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
131156688|NCT00258154|472198220|FG000|Overall Study|Adverse Event|1|||
131156689|NCT00258154|472198221|FG001|Overall Study|Adverse Event|0|||
131156690|NCT00258154|472198220|FG000|Overall Study|Lost to Follow-up|0|||
131156691|NCT00258154|472198221|FG001|Overall Study|Lost to Follow-up|1|||
131156692|NCT00258154|472198220|FG000|Overall Study|Protocol Violation|2|||
131156693|NCT00258154|472198221|FG001|Overall Study|Protocol Violation|1|||
131156694|NCT00258154|472198220|FG000|Overall Study|Withdrawal by Subject|3|||
131156695|NCT00258154|472198221|FG001|Overall Study|Withdrawal by Subject|4|||
131156696|NCT00258154|472198220|FG000|Overall Study|Patient Moved|3|||
131156697|NCT00258154|472198221|FG001|Overall Study|Patient Moved|1|||
131156698|NCT01856673|472198226|FG000|Overall Study|Withdrawal by Subject|44|||
131156699|NCT01856673|472198227|FG001|Overall Study|Withdrawal by Subject|50|||
131156700|NCT01856673|472198228|FG002|Overall Study|Withdrawal by Subject|33|||
131156701|NCT01856673|472198226|FG000|Overall Study|Lost to Follow-up|31|||
131156702|NCT01856673|472198227|FG001|Overall Study|Lost to Follow-up|34|||
131156703|NCT01856673|472198228|FG002|Overall Study|Lost to Follow-up|0|||
131156704|NCT01856673|472198226|FG000|Overall Study|Unknown reasons|9|||
131156705|NCT01856673|472198227|FG001|Overall Study|Unknown reasons|0|||
131156706|NCT01856673|472198228|FG002|Overall Study|Unknown reasons|0|||
131156707|NCT01856673|472198226|FG000|Overall Study|Psychologist decision|1|||
131156708|NCT01856673|472198227|FG001|Overall Study|Psychologist decision|0|||
131156709|NCT01856673|472198228|FG002|Overall Study|Psychologist decision|0|||
131156710|NCT01856673|472198226|FG000|Overall Study|Paperwork errors|8|||
131156711|NCT01856673|472198227|FG001|Overall Study|Paperwork errors|0|||
131156712|NCT01856673|472198228|FG002|Overall Study|Paperwork errors|0|||
131156713|NCT01856673|472198226|FG000|Overall Study|Death|1|||
131156714|NCT01856673|472198227|FG001|Overall Study|Death|1|||
131156715|NCT01856673|472198228|FG002|Overall Study|Death|0|||
131156716|NCT01856673|472198226|FG000|Overall Study|Protocol Violation|1|||
131156717|NCT01856673|472198227|FG001|Overall Study|Protocol Violation|0|||
131156718|NCT01856673|472198228|FG002|Overall Study|Protocol Violation|1|||
131156719|NCT00184054|472198229|FG000|Overall Study|Adverse Event|1|||
131156720|NCT05121103|472198232|FG000|Overall Study|Progressive disease|2|||
131156721|NCT05121103|472198233|FG001|Overall Study|Progressive disease|1|||
131156722|NCT05121103|472198234|FG002|Overall Study|Progressive disease|6|||
131156723|NCT05121103|472198232|FG000|Overall Study|Physician Decision|2|||
131156724|NCT05121103|472198233|FG001|Overall Study|Physician Decision|1|||
131156725|NCT05121103|472198234|FG002|Overall Study|Physician Decision|0|||
131156726|NCT05121103|472198232|FG000|Overall Study|Withdrawal by Subject|0|||
131156727|NCT05121103|472198233|FG001|Overall Study|Withdrawal by Subject|1|||
131156728|NCT05121103|472198234|FG002|Overall Study|Withdrawal by Subject|0|||
131156729|NCT00814710|472198235|FG000|Overall Study|Adverse Event|1|||
131156730|NCT00814710|472198236|FG001|Overall Study|Adverse Event|0|||
131156731|NCT00814710|472198235|FG000|Overall Study|Lost to Follow-up|7|||
131156732|NCT00814710|472198236|FG001|Overall Study|Lost to Follow-up|3|||
131156733|NCT03443024|472198237|FG000|Overall Study|Adverse Event|2|||
131156734|NCT03443024|472198238|FG001|Overall Study|Adverse Event|4|||
131156735|NCT03443024|472198239|FG002|Overall Study|Adverse Event|3|||
131156736|NCT03443024|472198240|FG003|Overall Study|Adverse Event|1|||
131156737|NCT03443024|472198237|FG000|Overall Study|Lost to Follow-up|9|||
131156738|NCT03443024|472198238|FG001|Overall Study|Lost to Follow-up|9|||
131156739|NCT03443024|472198239|FG002|Overall Study|Lost to Follow-up|7|||
131156740|NCT03443024|472198240|FG003|Overall Study|Lost to Follow-up|5|||
131156741|NCT03443024|472198237|FG000|Overall Study|Withdrawal by Subject|8|||
131156742|NCT03443024|472198238|FG001|Overall Study|Withdrawal by Subject|15|||
131156743|NCT03443024|472198239|FG002|Overall Study|Withdrawal by Subject|9|||
131156744|NCT03443024|472198240|FG003|Overall Study|Withdrawal by Subject|23|||
131156745|NCT03443024|472198237|FG000|Overall Study|Physician Decision|1|||
131156746|NCT03443024|472198238|FG001|Overall Study|Physician Decision|2|||
131156747|NCT03443024|472198239|FG002|Overall Study|Physician Decision|0|||
131156748|NCT03443024|472198240|FG003|Overall Study|Physician Decision|1|||
131156749|NCT03443024|472198237|FG000|Overall Study|Sponsor Decision|1|||
131156750|NCT03443024|472198238|FG001|Overall Study|Sponsor Decision|1|||
131156751|NCT03443024|472198239|FG002|Overall Study|Sponsor Decision|0|||
131156752|NCT03443024|472198240|FG003|Overall Study|Sponsor Decision|0|||
131156753|NCT03443024|472198237|FG000|Overall Study|Protocol Deviation|0|||
131156754|NCT03443024|472198238|FG001|Overall Study|Protocol Deviation|0|||
131156755|NCT03443024|472198239|FG002|Overall Study|Protocol Deviation|0|||
131156756|NCT03443024|472198240|FG003|Overall Study|Protocol Deviation|2|||
131156757|NCT03885284|472198242|FG000|Overall Study|Disease Progression|1|||
131156758|NCT03885284|472198243|FG001|Overall Study|Disease Progression|3|||
131156759|NCT03885284|472198242|FG000|Overall Study|Physician Decision|0|||
131156760|NCT03885284|472198243|FG001|Overall Study|Physician Decision|1|||
131156761|NCT01591330|472198246|FG000|Period 1|Adverse Event|1|||
131156762|NCT01591330|472198247|FG001|Period 1|Adverse Event|0|||
131156763|NCT01591330|472198248|FG002|Period 1|Adverse Event|0|||
131156764|NCT01591330|472198249|FG003|Period 1|Adverse Event|0|||
131156765|NCT01591330|472198246|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
131156766|NCT01591330|472198247|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
131156767|NCT01591330|472198248|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
131156768|NCT01591330|472198249|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
131156769|NCT01591330|472198246|FG000|Period 2|Adverse Event|1|||
131156770|NCT01591330|472198247|FG001|Period 2|Adverse Event|0|||
131156771|NCT01591330|472198248|FG002|Period 2|Adverse Event|0|||
130780426|NCT00490971|470821508|FG001|Maintenance|Other|0|||
131156772|NCT01591330|472198249|FG003|Period 2|Adverse Event|0|||
131156773|NCT04800315|472198252|FG000|Randomization|Did not receive study treatment|1|||
131156774|NCT04800315|472198253|FG001|Randomization|Did not receive study treatment|0|||
131156775|NCT04800315|472198254|FG002|Randomization|Did not receive study treatment|0|||
131156776|NCT04800315|472198255|FG003|Randomization|Did not receive study treatment|0|||
131156777|NCT04800315|472198252|FG000|Treatment Period|Adverse Event|4|||
131156778|NCT04800315|472198253|FG001|Treatment Period|Adverse Event|2|||
131156779|NCT04800315|472198254|FG002|Treatment Period|Adverse Event|1|||
131156780|NCT04800315|472198255|FG003|Treatment Period|Adverse Event|2|||
131156781|NCT04800315|472198252|FG000|Treatment Period|Lack of Efficacy|1|||
131156782|NCT04800315|472198253|FG001|Treatment Period|Lack of Efficacy|0|||
131156783|NCT04800315|472198254|FG002|Treatment Period|Lack of Efficacy|0|||
131156784|NCT04800315|472198255|FG003|Treatment Period|Lack of Efficacy|3|||
131156785|NCT04800315|472198252|FG000|Treatment Period|Lost to Follow-up|0|||
131156786|NCT04800315|472198253|FG001|Treatment Period|Lost to Follow-up|1|||
131156787|NCT04800315|472198254|FG002|Treatment Period|Lost to Follow-up|2|||
131156788|NCT04800315|472198255|FG003|Treatment Period|Lost to Follow-up|2|||
131156789|NCT04800315|472198252|FG000|Treatment Period|Withdrawal by participant|0|||
131156790|NCT04800315|472198253|FG001|Treatment Period|Withdrawal by participant|0|||
131156791|NCT04800315|472198254|FG002|Treatment Period|Withdrawal by participant|0|||
131235231|NCT02097121|472488875|FG002|Overall Study|Lost to Follow-up|2|||
131235232|NCT03066999|472488876|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
130780427|NCT00490971|470821509|FG002|Maintenance|Other|11|||
130780428|NCT00490971|470821510|FG003|Maintenance|Other|9|||
130780429|NCT00490971|470821511|FG004|Maintenance|Other|3|||
130780430|NCT04888494|470821522|FG000|Overall Study|Lost to Follow-up|2|||
130780431|NCT04888494|470821523|FG001|Overall Study|Lost to Follow-up|3|||
130780432|NCT04888494|470821522|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
130780433|NCT04888494|470821523|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
130780434|NCT03430856|470821524|FG000|Overall Study|Adverse Event|0|||
130780435|NCT03430856|470821525|FG001|Overall Study|Adverse Event|1|||
130780436|NCT03430856|470821526|FG002|Overall Study|Adverse Event|0|||
130780437|NCT03430856|470821524|FG000|Overall Study|Rescue criteria|1|||
130780438|NCT03430856|470821525|FG001|Overall Study|Rescue criteria|1|||
130780439|NCT03430856|470821526|FG002|Overall Study|Rescue criteria|0|||
130780440|NCT03430856|470821524|FG000|Overall Study|Voluntary withdrawal of consent|1|||
130780441|NCT03430856|470821525|FG001|Overall Study|Voluntary withdrawal of consent|1|||
130780442|NCT03430856|470821526|FG002|Overall Study|Voluntary withdrawal of consent|1|||
130780443|NCT00565604|470821532|FG000|Overall Study|Failure to treat|2|||
130780444|NCT00565604|470821532|FG000|Overall Study|Lost to Follow-up|2|||
130780445|NCT01395810|470821533|FG000|Overall Study|Adverse Event|0|||
130780446|NCT01395810|470821534|FG001|Overall Study|Adverse Event|1|||
130780447|NCT01395810|470821535|FG002|Overall Study|Adverse Event|0|||
130780448|NCT01395810|470821536|FG003|Overall Study|Adverse Event|0|||
130780449|NCT01395810|470821533|FG000|Overall Study|Lack of Efficacy|0|||
130780450|NCT01395810|470821534|FG001|Overall Study|Lack of Efficacy|1|||
130780451|NCT01395810|470821535|FG002|Overall Study|Lack of Efficacy|0|||
130780452|NCT01395810|470821536|FG003|Overall Study|Lack of Efficacy|0|||
130780453|NCT01395810|470821533|FG000|Overall Study|Withdrawal criteria|0|||
130780454|NCT01395810|470821534|FG001|Overall Study|Withdrawal criteria|2|||
130780455|NCT01395810|470821535|FG002|Overall Study|Withdrawal criteria|0|||
130780456|NCT01395810|470821536|FG003|Overall Study|Withdrawal criteria|0|||
130780457|NCT01395810|470821533|FG000|Overall Study|Unclassified|2|||
130780458|NCT01395810|470821534|FG001|Overall Study|Unclassified|0|||
130780459|NCT01395810|470821535|FG002|Overall Study|Unclassified|0|||
130780460|NCT01395810|470821536|FG003|Overall Study|Unclassified|0|||
130780461|NCT05027815|470821537|FG000|Overall Study|Death|2|||
130780462|NCT05027815|470821538|FG001|Overall Study|Death|1|||
130780463|NCT03877224|470821543|FG000|Overall Study|Death|3|||
130780464|NCT03877224|470821544|FG001|Overall Study|Death|2|||
130780465|NCT03877224|470821543|FG000|Overall Study|Withdrawal by Subject|1|||
130780466|NCT03877224|470821544|FG001|Overall Study|Withdrawal by Subject|6|||
130780467|NCT03877224|470821543|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
130780468|NCT03877224|470821544|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
130780469|NCT04754542|470821545|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
130780470|NCT04754542|470821546|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
130780471|NCT02317991|470823080|FG000|Overall Study|Adverse Event|12|||
130780472|NCT02317991|470823080|FG000|Overall Study|Death|4|||
130780473|NCT02317991|470823080|FG000|Overall Study|Withdrawal by Subject|8|||
130780474|NCT02317991|470823080|FG000|Overall Study|Progressive Disease|41|||
131235233|NCT03066999|472488877|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
131235234|NCT00510510|472488878|FG000|Overall Study|Adverse Event|4|||
131235235|NCT00510510|472488879|FG001|Overall Study|Adverse Event|3|||
131156792|NCT04800315|472198255|FG003|Treatment Period|Withdrawal by participant|4|||
131156793|NCT04800315|472198252|FG000|Treatment Period|Other Reasons|0|||
131156794|NCT04800315|472198253|FG001|Treatment Period|Other Reasons|2|||
131156795|NCT04800315|472198254|FG002|Treatment Period|Other Reasons|0|||
131156796|NCT04800315|472198255|FG003|Treatment Period|Other Reasons|1|||
131156797|NCT00753922|472198256|FG000|Overall Study|Lost to Follow-up|155|||
131156798|NCT00753922|472198257|FG001|Overall Study|Lost to Follow-up|24|||
131156799|NCT00753922|472198258|FG002|Overall Study|Lost to Follow-up|28|||
131156800|NCT00753922|472198259|FG003|Overall Study|Lost to Follow-up|5|||
131156801|NCT00753922|472198256|FG000|Overall Study|Withdrawal by Subject|9|||
131156802|NCT00753922|472198257|FG001|Overall Study|Withdrawal by Subject|11|||
131156803|NCT00753922|472198258|FG002|Overall Study|Withdrawal by Subject|4|||
131156804|NCT00753922|472198259|FG003|Overall Study|Withdrawal by Subject|2|||
131156805|NCT00753922|472198256|FG000|Overall Study|Patient Non-compliance|55|||
131156806|NCT00753922|472198257|FG001|Overall Study|Patient Non-compliance|22|||
131156807|NCT00753922|472198258|FG002|Overall Study|Patient Non-compliance|14|||
131156808|NCT00753922|472198259|FG003|Overall Study|Patient Non-compliance|11|||
131156809|NCT00753922|472198256|FG000|Overall Study|Patients Not Completing Visit|11|||
131156810|NCT00753922|472198257|FG001|Overall Study|Patients Not Completing Visit|0|||
131156811|NCT00753922|472198258|FG002|Overall Study|Patients Not Completing Visit|1|||
131156812|NCT00753922|472198259|FG003|Overall Study|Patients Not Completing Visit|0|||
131156813|NCT00753922|472198256|FG000|Overall Study|Death|2|||
131156814|NCT00753922|472198257|FG001|Overall Study|Death|23|||
131156815|NCT00753922|472198258|FG002|Overall Study|Death|2|||
131156816|NCT00753922|472198259|FG003|Overall Study|Death|1|||
131156817|NCT00753922|472198256|FG000|Overall Study|Discontinuation Due to Explantation|14|||
131156818|NCT00753922|472198257|FG001|Overall Study|Discontinuation Due to Explantation|14|||
131156819|NCT00753922|472198258|FG002|Overall Study|Discontinuation Due to Explantation|14|||
131156820|NCT00753922|472198259|FG003|Overall Study|Discontinuation Due to Explantation|4|||
131156821|NCT02932267|472198260|FG000|Overall Study|Withdrawal by Subject|3|||
131156822|NCT02932267|472198260|FG000|Overall Study|Lost to Follow-up|4|||
131156823|NCT02932267|472198260|FG000|Overall Study|Pregnancy|1|||
131156824|NCT02453841|472198263|FG000|Overall Study|Protocol Violation|1|||
131156825|NCT02453841|472198263|FG000|Overall Study|Unable to obtain blood samples|2|||
131156826|NCT02190591|472198264|FG000|Overall Study|Withdrawal by Subject|1|||
131156827|NCT02190591|472198265|FG001|Overall Study|Withdrawal by Subject|8|||
131156828|NCT02190591|472198264|FG000|Overall Study|Protocol Violation|1|||
131156829|NCT02190591|472198265|FG001|Overall Study|Protocol Violation|0|||
131156830|NCT02190591|472198264|FG000|Overall Study|did not use peanut ball as instructed|0|||
131156831|NCT02190591|472198265|FG001|Overall Study|did not use peanut ball as instructed|2|||
131156832|NCT02190591|472198264|FG000|Overall Study|face presentation so she was ineligible|0|||
131156833|NCT02190591|472198265|FG001|Overall Study|face presentation so she was ineligible|1|||
131156834|NCT03851510|472198266|FG000|Overall Study|Screen Fail|1|||
131156835|NCT03851510|472198266|FG000|Overall Study|Adverse Event|1|||
131156836|NCT03851510|472198266|FG000|Overall Study|Withdrawal by Subject|1|||
131156837|NCT03598777|472198267|FG000|Overall Study|Study Terminated by Sponsor|3|||
131156838|NCT03598777|472198268|FG001|Overall Study|Study Terminated by Sponsor|0|||
131156839|NCT03598777|472198269|FG002|Overall Study|Study Terminated by Sponsor|0|||
131156840|NCT03598777|472198270|FG003|Overall Study|Study Terminated by Sponsor|0|||
131156841|NCT03598777|472198271|FG004|Overall Study|Study Terminated by Sponsor|15|||
131156842|NCT03598777|472198267|FG000|Overall Study|Withdrawal by Subject|1|||
131156843|NCT03598777|472198268|FG001|Overall Study|Withdrawal by Subject|1|||
131156844|NCT03598777|472198269|FG002|Overall Study|Withdrawal by Subject|0|||
131156845|NCT03598777|472198270|FG003|Overall Study|Withdrawal by Subject|0|||
131156846|NCT03598777|472198271|FG004|Overall Study|Withdrawal by Subject|0|||
131156847|NCT03598777|472198267|FG000|Overall Study|Adverse Event|1|||
131156848|NCT03598777|472198268|FG001|Overall Study|Adverse Event|0|||
131156849|NCT03598777|472198269|FG002|Overall Study|Adverse Event|0|||
131156850|NCT03598777|472198270|FG003|Overall Study|Adverse Event|0|||
131156851|NCT03598777|472198271|FG004|Overall Study|Adverse Event|0|||
131156852|NCT03598777|472198267|FG000|Overall Study|Lost to Follow-up|1|||
131156853|NCT03598777|472198268|FG001|Overall Study|Lost to Follow-up|0|||
131156854|NCT03598777|472198269|FG002|Overall Study|Lost to Follow-up|0|||
131156855|NCT03598777|472198270|FG003|Overall Study|Lost to Follow-up|0|||
131156856|NCT03598777|472198271|FG004|Overall Study|Lost to Follow-up|0|||
131156857|NCT00072189|472198272|FG000|Overall Study|Withdrawal by Subject|1|||
131235236|NCT00510510|472488880|FG002|Overall Study|Adverse Event|6|||
131156858|NCT00144300|472198273|FG000|Overall Study|Adverse Event|18|||
131156859|NCT00144300|472198274|FG001|Overall Study|Adverse Event|16|||
131156860|NCT00144300|472198273|FG000|Overall Study|Protocol Violation|1|||
131156861|NCT00144300|472198274|FG001|Overall Study|Protocol Violation|3|||
131156862|NCT00144300|472198273|FG000|Overall Study|Lost to Follow-up|3|||
131156863|NCT00144300|472198274|FG001|Overall Study|Lost to Follow-up|0|||
131156864|NCT00144300|472198273|FG000|Overall Study|Withdrawal by Subject|6|||
131156865|NCT00144300|472198274|FG001|Overall Study|Withdrawal by Subject|6|||
131156866|NCT00144300|472198273|FG000|Overall Study|Other reason (not specified)|1|||
131156867|NCT00144300|472198274|FG001|Overall Study|Other reason (not specified)|3|||
131156868|NCT01933672|472198275|FG000|Metformin Run-in Period|Adverse Event|1|||
131156869|NCT01933672|472198276|FG001|Metformin Run-in Period|Adverse Event|0|||
131156870|NCT01933672|472198277|FG002|Metformin Run-in Period|Adverse Event|0|||
130728592|NCT04784533|470627513|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728593|NCT04784533|470627514|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728594|NCT04784533|470627515|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728595|NCT04784533|470627516|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728596|NCT04784533|470627517|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728597|NCT04784533|470627518|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728598|NCT04784533|470627519|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
130728599|NCT04784533|470627520|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130728600|NCT04784533|470627511|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728601|NCT04784533|470627512|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728602|NCT04784533|470627513|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728603|NCT04784533|470627514|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728604|NCT04784533|470627515|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728605|NCT04784533|470627516|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728606|NCT04784533|470627517|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728607|NCT04784533|470627518|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130728608|NCT04784533|470627519|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
130728609|NCT04784533|470627520|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
130728610|NCT02185053|470627521|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
130728611|NCT02185053|470627522|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
130728612|NCT02185053|470627523|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
130728613|NCT02185053|470627521|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
131235237|NCT00510510|472488878|FG000|Overall Study|Lack of Efficacy|0|||
131235238|NCT00510510|472488879|FG001|Overall Study|Lack of Efficacy|1|||
131235239|NCT00510510|472488880|FG002|Overall Study|Lack of Efficacy|1|||
131235240|NCT00510510|472488878|FG000|Overall Study|Subjects no longer requires study drug|0|||
131235241|NCT00510510|472488879|FG001|Overall Study|Subjects no longer requires study drug|0|||
131235242|NCT00510510|472488880|FG002|Overall Study|Subjects no longer requires study drug|2|||
131235243|NCT00510510|472488878|FG000|Overall Study|Withdrawal by Subject|1|||
131235244|NCT00510510|472488879|FG001|Overall Study|Withdrawal by Subject|2|||
131235245|NCT00510510|472488880|FG002|Overall Study|Withdrawal by Subject|3|||
131235246|NCT00510510|472488878|FG000|Overall Study|Lost to Follow-up|0|||
131235247|NCT00510510|472488879|FG001|Overall Study|Lost to Follow-up|0|||
131235248|NCT00510510|472488880|FG002|Overall Study|Lost to Follow-up|1|||
131235249|NCT00510510|472488878|FG000|Overall Study|Protocol Violation|0|||
131235250|NCT00510510|472488879|FG001|Overall Study|Protocol Violation|3|||
131235251|NCT00510510|472488880|FG002|Overall Study|Protocol Violation|4|||
131235252|NCT01361126|472488881|FG000|Overall Study|Sponsor decision|0|||
131235253|NCT01361126|472488882|FG001|Overall Study|Sponsor decision|2|||
131235254|NCT04094870|472488884|FG000|Overall Study|Lost to Follow-up|1|||
131235255|NCT04094870|472488885|FG001|Overall Study|Lost to Follow-up|1|||
131235256|NCT03384745|472488886|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
131235257|NCT03384745|472488887|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
131235258|NCT03384745|472488888|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
131235259|NCT03384745|472488889|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
131235260|NCT03384745|472488890|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
131235261|NCT03384745|472488891|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
131235262|NCT03384745|472488886|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
131235263|NCT03384745|472488887|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
131235264|NCT03384745|472488888|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
131235265|NCT03384745|472488889|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
131235266|NCT03384745|472488890|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
131235267|NCT03384745|472488891|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
131235268|NCT03384745|472488886|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
131235269|NCT03384745|472488887|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
131235270|NCT03384745|472488888|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
131235271|NCT03384745|472488889|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
131235272|NCT03384745|472488890|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
131235273|NCT03384745|472488891|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
131235274|NCT03384745|472488886|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
131235275|NCT03384745|472488887|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
131235276|NCT03384745|472488888|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
131235277|NCT03384745|472488889|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
131235278|NCT03384745|472488890|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
131235279|NCT03384745|472488891|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
131235280|NCT03384745|472488886|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
131235281|NCT03384745|472488887|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
131235282|NCT03384745|472488888|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
131235283|NCT03384745|472488889|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
131156871|NCT01933672|472198278|FG003|Metformin Run-in Period|Adverse Event|0|||
131156872|NCT01933672|472198279|FG004|Metformin Run-in Period|Adverse Event|0|||
131156873|NCT01933672|472198280|FG005|Metformin Run-in Period|Adverse Event|0|||
131156874|NCT01933672|472198281|FG006|Metformin Run-in Period|Adverse Event|0|||
131156875|NCT01933672|472198275|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
131156876|NCT01933672|472198276|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131156877|NCT01933672|472198277|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131156878|NCT01933672|472198278|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131156879|NCT01933672|472198279|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131156880|NCT01933672|472198280|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131156881|NCT01933672|472198281|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
131156882|NCT01933672|472198275|FG000|Metformin Run-in Period|Other|5|||
131156883|NCT01933672|472198276|FG001|Metformin Run-in Period|Other|0|||
131156884|NCT01933672|472198277|FG002|Metformin Run-in Period|Other|0|||
131156885|NCT01933672|472198278|FG003|Metformin Run-in Period|Other|0|||
131156886|NCT01933672|472198279|FG004|Metformin Run-in Period|Other|0|||
131156887|NCT01933672|472198280|FG005|Metformin Run-in Period|Other|0|||
131156888|NCT01933672|472198281|FG006|Metformin Run-in Period|Other|0|||
131156889|NCT01933672|472198275|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156890|NCT01933672|472198276|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156891|NCT01933672|472198277|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156892|NCT01933672|472198278|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156893|NCT01933672|472198279|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
131156894|NCT01933672|472198280|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156895|NCT01933672|472198281|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156896|NCT01933672|472198275|FG000|First Intervention Period (12-16 Days)|Other|0|||
131156897|NCT01933672|472198276|FG001|First Intervention Period (12-16 Days)|Other|0|||
131156898|NCT01933672|472198277|FG002|First Intervention Period (12-16 Days)|Other|1|||
131156899|NCT01933672|472198278|FG003|First Intervention Period (12-16 Days)|Other|0|||
131156900|NCT01933672|472198279|FG004|First Intervention Period (12-16 Days)|Other|0|||
131156901|NCT01933672|472198280|FG005|First Intervention Period (12-16 Days)|Other|1|||
131156902|NCT01933672|472198281|FG006|First Intervention Period (12-16 Days)|Other|0|||
131156903|NCT01933672|472198275|FG000|Second Intervention Period (12-16 Days)|Other|0|||
131156904|NCT01933672|472198276|FG001|Second Intervention Period (12-16 Days)|Other|1|||
131156905|NCT01933672|472198277|FG002|Second Intervention Period (12-16 Days)|Other|1|||
131156906|NCT01933672|472198278|FG003|Second Intervention Period (12-16 Days)|Other|0|||
131156907|NCT01933672|472198279|FG004|Second Intervention Period (12-16 Days)|Other|0|||
131156908|NCT01933672|472198280|FG005|Second Intervention Period (12-16 Days)|Other|0|||
131156909|NCT01933672|472198281|FG006|Second Intervention Period (12-16 Days)|Other|0|||
131156910|NCT01933672|472198275|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156911|NCT01933672|472198276|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156912|NCT01933672|472198277|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156913|NCT01933672|472198278|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
131156914|NCT01933672|472198279|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156915|NCT01933672|472198280|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156916|NCT01933672|472198281|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
131156917|NCT01933672|472198275|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131156918|NCT01933672|472198276|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
131156919|NCT01933672|472198277|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131156920|NCT01933672|472198278|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131156921|NCT01933672|472198279|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131156922|NCT01933672|472198280|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131156923|NCT01933672|472198281|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
131156924|NCT02426086|472198285|FG000|Overall Study|Death|33|||
131156925|NCT02426086|472198286|FG001|Overall Study|Death|36|||
131156926|NCT02426086|472198285|FG000|Overall Study|Lost to Follow-up|2|||
131156927|NCT02426086|472198286|FG001|Overall Study|Lost to Follow-up|0|||
131156928|NCT02426086|472198285|FG000|Overall Study|Study Terminated by Sponsor|5|||
131156929|NCT02426086|472198286|FG001|Overall Study|Study Terminated by Sponsor|14|||
131156930|NCT02426086|472198285|FG000|Overall Study|Withdrawal by Subject|8|||
131156931|NCT02426086|472198286|FG001|Overall Study|Withdrawal by Subject|9|||
131156932|NCT00524303|472198287|FG000|Overall Study|Lost to Follow-up|6|||
131156933|NCT00524303|472198288|FG001|Overall Study|Lost to Follow-up|0|||
131156934|NCT00524303|472198289|FG002|Overall Study|Lost to Follow-up|3|||
131156935|NCT00524303|472198287|FG000|Overall Study|Protocol Violation|0|||
131156936|NCT00524303|472198288|FG001|Overall Study|Protocol Violation|1|||
131156937|NCT00524303|472198289|FG002|Overall Study|Protocol Violation|1|||
131156938|NCT00524303|472198287|FG000|Overall Study|Withdrawal by Subject|3|||
131156939|NCT00524303|472198288|FG001|Overall Study|Withdrawal by Subject|0|||
131156940|NCT00524303|472198289|FG002|Overall Study|Withdrawal by Subject|4|||
131156941|NCT00524303|472198287|FG000|Overall Study|Death|0|||
131156942|NCT00524303|472198288|FG001|Overall Study|Death|2|||
131156943|NCT00524303|472198289|FG002|Overall Study|Death|3|||
131156944|NCT00524303|472198287|FG000|Overall Study|Adverse Event|1|||
131156945|NCT00524303|472198288|FG001|Overall Study|Adverse Event|2|||
131156946|NCT00524303|472198289|FG002|Overall Study|Adverse Event|3|||
131156947|NCT00524303|472198287|FG000|Overall Study|Did not Complete Study Dosing|1|||
131156948|NCT00524303|472198288|FG001|Overall Study|Did not Complete Study Dosing|0|||
131156949|NCT00524303|472198289|FG002|Overall Study|Did not Complete Study Dosing|0|||
131156950|NCT00524303|472198287|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
131156951|NCT00524303|472198288|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
131156952|NCT00524303|472198289|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
131156953|NCT00524303|472198287|FG000|Overall Study|Disease Progression|0|||
131156954|NCT00524303|472198288|FG001|Overall Study|Disease Progression|4|||
131156955|NCT00524303|472198289|FG002|Overall Study|Disease Progression|1|||
131156956|NCT00524303|472198287|FG000|Overall Study|Disease Recurrence|0|||
131156957|NCT00524303|472198288|FG001|Overall Study|Disease Recurrence|1|||
131156958|NCT00524303|472198289|FG002|Overall Study|Disease Recurrence|0|||
131156959|NCT00524303|472198287|FG000|Overall Study|Sponsor Request|0|||
131156960|NCT00524303|472198288|FG001|Overall Study|Sponsor Request|0|||
131156961|NCT00524303|472198289|FG002|Overall Study|Sponsor Request|1|||
131156962|NCT00524303|472198287|FG000|Overall Study|Physician Decision|0|||
131156963|NCT00524303|472198288|FG001|Overall Study|Physician Decision|0|||
131156964|NCT00524303|472198289|FG002|Overall Study|Physician Decision|1|||
131156965|NCT00524303|472198287|FG000|Overall Study|Completed 5 years|0|||
131156966|NCT00524303|472198288|FG001|Overall Study|Completed 5 years|0|||
131156967|NCT00524303|472198289|FG002|Overall Study|Completed 5 years|1|||
131156968|NCT01769404|472198298|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
131156969|NCT01769404|472198299|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
131156970|NCT01769404|472198298|FG000|Treatment Period 1|Withdrawal by Subject|3|||
131156971|NCT01769404|472198299|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131156972|NCT01769404|472198298|FG000|Treatment Period 1|Sponsor decision|1|||
131156973|NCT01769404|472198299|FG001|Treatment Period 1|Sponsor decision|0|||
131156974|NCT01769404|472198298|FG000|Treatment Period 2|Sponsor decision|7|||
131156975|NCT01769404|472198299|FG001|Treatment Period 2|Sponsor decision|0|||
131156976|NCT00538733|472198300|FG000|Overall Study|Adverse Event|8|||
131156977|NCT00538733|472198300|FG000|Overall Study|Death|1|||
131156978|NCT00538733|472198300|FG000|Overall Study|declined to participate|2|||
131156979|NCT00538733|472198300|FG000|Overall Study|still on therapy|1|||
131156980|NCT00095121|472198303|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
131156981|NCT00095121|472198304|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
131156982|NCT00095121|472198303|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
131156983|NCT00095121|472198304|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
131156984|NCT03167619|472200313|FG000|Overall Study|Death|11|||
131156985|NCT03167619|472200314|FG001|Overall Study|Death|8|||
131156986|NCT03167619|472200313|FG000|Overall Study|Withdrawal by Subject|1|||
131156987|NCT03167619|472200314|FG001|Overall Study|Withdrawal by Subject|2|||
131156988|NCT03167619|472200313|FG000|Overall Study|Physician Decision|0|||
131156989|NCT03167619|472200314|FG001|Overall Study|Physician Decision|1|||
131156990|NCT02082184|472200315|FG000|Overall Study|Adverse Event|1|||
131156991|NCT02082184|472200316|FG001|Overall Study|Adverse Event|0|||
131156992|NCT02082184|472200315|FG000|Overall Study|Medical diagnosis|1|||
131156993|NCT02082184|472200316|FG001|Overall Study|Medical diagnosis|2|||
131156994|NCT02082184|472200315|FG000|Overall Study|Device associated symptoms|5|||
131156995|NCT02082184|472200316|FG001|Overall Study|Device associated symptoms|0|||
131156996|NCT02082184|472200315|FG000|Overall Study|Withdrawal by Subject|3|||
131156997|NCT02082184|472200316|FG001|Overall Study|Withdrawal by Subject|2|||
131156998|NCT02082184|472200315|FG000|Overall Study|Protocol Violation|0|||
131156999|NCT02082184|472200316|FG001|Overall Study|Protocol Violation|6|||
131157000|NCT02082184|472200315|FG000|Overall Study|Lost to Follow-up|0|||
131157001|NCT02082184|472200316|FG001|Overall Study|Lost to Follow-up|2|||
131157002|NCT02082184|472200315|FG000|Overall Study|Subject non-compliance|0|||
131157003|NCT02082184|472200316|FG001|Overall Study|Subject non-compliance|1|||
131157004|NCT01062399|472200319|FG000|Overall Study|Protocol Violation|0|||
131157005|NCT01062399|472200320|FG001|Overall Study|Protocol Violation|1|||
131157006|NCT01062399|472200321|FG002|Overall Study|Protocol Violation|0|||
131157007|NCT01062399|472200322|FG003|Overall Study|Protocol Violation|6|||
131157008|NCT01062399|472200323|FG004|Overall Study|Protocol Violation|4|||
131157009|NCT00077623|472200326|FG000|Overall Study|Adverse Event|1|||
131157010|NCT00077623|472200327|FG001|Overall Study|Adverse Event|0|||
131157011|NCT00077623|472200328|FG002|Overall Study|Adverse Event|1|||
131157012|NCT00077623|472200326|FG000|Overall Study|Withdrawal by Subject|2|||
131157013|NCT00077623|472200327|FG001|Overall Study|Withdrawal by Subject|10|||
131157014|NCT00077623|472200328|FG002|Overall Study|Withdrawal by Subject|1|||
131157015|NCT00077623|472200326|FG000|Overall Study|Other-Non safety reason|18|||
131157016|NCT00077623|472200327|FG001|Overall Study|Other-Non safety reason|15|||
131157017|NCT00077623|472200328|FG002|Overall Study|Other-Non safety reason|19|||
131157018|NCT00077623|472200326|FG000|Overall Study|Insufficient therapeutic response|2|||
131157019|NCT00077623|472200327|FG001|Overall Study|Insufficient therapeutic response|0|||
131157020|NCT00077623|472200328|FG002|Overall Study|Insufficient therapeutic response|0|||
131157021|NCT00077623|472200326|FG000|Overall Study|Death|12|||
131157022|NCT00077623|472200327|FG001|Overall Study|Death|18|||
131157023|NCT00077623|472200328|FG002|Overall Study|Death|11|||
131157024|NCT00077623|472200326|FG000|Overall Study|Failure to return|1|||
131157025|NCT00077623|472200327|FG001|Overall Study|Failure to return|0|||
131157026|NCT00077623|472200328|FG002|Overall Study|Failure to return|0|||
131157027|NCT02465034|472200329|FG000|Overall Study|Withdrawal by Subject|1|||
131157028|NCT02465034|472200330|FG001|Overall Study|Withdrawal by Subject|1|||
131157029|NCT02465034|472200329|FG000|Overall Study|Screen fail|2|||
131157030|NCT02465034|472200330|FG001|Overall Study|Screen fail|0|||
131157031|NCT02465034|472200329|FG000|Overall Study|Could not be scheduled for study visit|0|||
131157032|NCT02465034|472200330|FG001|Overall Study|Could not be scheduled for study visit|5|||
131157033|NCT05299892|472200335|FG000|Overall Study|Withdrawal by Subject|2|||
131157034|NCT02397655|472200336|FG000|Overall Study|data not completed|1301|||
131157035|NCT03334214|472200338|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
131157036|NCT03334214|472200339|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
131157037|NCT03334214|472200338|FG000|Overall Study|Withdrawal by Subject|0|||
131157038|NCT03334214|472200339|FG001|Overall Study|Withdrawal by Subject|1|||
131157039|NCT03334214|472200338|FG000|Overall Study|Other|1|||
131157040|NCT03334214|472200339|FG001|Overall Study|Other|0|||
131157041|NCT01588197|472200342|FG000|Overall Study|Lack of Efficacy|0|||
131157042|NCT01588197|472200343|FG001|Overall Study|Lack of Efficacy|1|||
131157043|NCT01588197|472200342|FG000|Overall Study|No MRI|1|||
131157044|NCT01588197|472200343|FG001|Overall Study|No MRI|0|||
131157045|NCT01937312|472200344|FG000|Overall Study|Adverse Event|10|||
131157046|NCT01937312|472200345|FG001|Overall Study|Adverse Event|1|||
131157047|NCT01937312|472200344|FG000|Overall Study|Lack of Efficacy|0|||
131157048|NCT01937312|472200345|FG001|Overall Study|Lack of Efficacy|1|||
131157049|NCT01937312|472200344|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
131157050|NCT01937312|472200345|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
131157051|NCT01025336|472200349|FG000|Overall Study|Protocol Violation|0|||
131157052|NCT01025336|472200350|FG001|Overall Study|Protocol Violation|0|||
131157053|NCT01025336|472200351|FG002|Overall Study|Protocol Violation|0|||
131157054|NCT01025336|472200352|FG003|Overall Study|Protocol Violation|2|||
131157055|NCT01025336|472200353|FG004|Overall Study|Protocol Violation|0|||
131157056|NCT00474253|472200354|FG000|Overall Study|Withdrew consent|2|||
131157057|NCT00474253|472200355|FG001|Overall Study|Withdrew consent|0|||
131157058|NCT00474253|472200354|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
131157059|NCT00474253|472200355|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
131157060|NCT00474253|472200354|FG000|Overall Study|Lost to Follow-up|1|||
131157061|NCT00474253|472200355|FG001|Overall Study|Lost to Follow-up|0|||
131157062|NCT00474253|472200354|FG000|Overall Study|Discharged prior to study completion|0|||
131157063|NCT00474253|472200355|FG001|Overall Study|Discharged prior to study completion|1|||
131157064|NCT03133481|472200356|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
131157065|NCT03133481|472200357|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
131157066|NCT00779038|472200368|FG000|Overall Study|Study Prematurely Terminated|13|||
131157067|NCT01184989|472200369|FG000|Overall Study|Adverse Event|11|||
131157068|NCT01184989|472200369|FG000|Overall Study|Withdrawal by Subject|1|||
131157069|NCT01570491|472200370|FG000|Overall Study|Lost to Follow-up|3|||
131157070|NCT01570491|472200371|FG001|Overall Study|Lost to Follow-up|1|||
131157071|NCT01570491|472200370|FG000|Overall Study|treatment: not given or discontinued|2|||
131157072|NCT01570491|472200371|FG001|Overall Study|treatment: not given or discontinued|0|||
131157073|NCT05370157|472200374|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
131157074|NCT05370157|472200375|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
131157075|NCT05370157|472200374|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
131157076|NCT05370157|472200375|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
131157077|NCT04407507|472200376|FG000|Overall Study|Withdrawal by Subject|0|||
131157078|NCT04407507|472200377|FG001|Overall Study|Withdrawal by Subject|1|||
131157079|NCT00754390|472200382|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
131157080|NCT00754390|472200382|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
131157081|NCT00754390|472200382|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
131157082|NCT00754390|472200382|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
131157083|NCT00847613|472200383|FG000|Overall Study|Ongoing at cut-off date|250|||
131157084|NCT00847613|472200384|FG001|Overall Study|Ongoing at cut-off date|265|||
131157085|NCT00847613|472200385|FG002|Overall Study|Ongoing at cut-off date|64|||
131157086|NCT00847613|472200386|FG003|Overall Study|Ongoing at cut-off date|64|||
131157087|NCT00847613|472200383|FG000|Overall Study|Death|1|||
131157088|NCT00847613|472200384|FG001|Overall Study|Death|1|||
131157089|NCT00847613|472200385|FG002|Overall Study|Death|0|||
131157090|NCT00847613|472200386|FG003|Overall Study|Death|0|||
131157091|NCT00847613|472200383|FG000|Overall Study|Adverse Event|36|||
131157092|NCT00847613|472200384|FG001|Overall Study|Adverse Event|26|||
131157093|NCT00847613|472200385|FG002|Overall Study|Adverse Event|5|||
131157094|NCT00847613|472200386|FG003|Overall Study|Adverse Event|6|||
131157095|NCT00847613|472200383|FG000|Overall Study|Lack of Efficacy|7|||
131157096|NCT00847613|472200384|FG001|Overall Study|Lack of Efficacy|3|||
131157097|NCT00847613|472200385|FG002|Overall Study|Lack of Efficacy|3|||
131157098|NCT00847613|472200386|FG003|Overall Study|Lack of Efficacy|1|||
131157099|NCT00847613|472200383|FG000|Overall Study|Study terminated by Sponsor|1|||
131157100|NCT00847613|472200384|FG001|Overall Study|Study terminated by Sponsor|0|||
131157101|NCT00847613|472200385|FG002|Overall Study|Study terminated by Sponsor|2|||
131157102|NCT00847613|472200386|FG003|Overall Study|Study terminated by Sponsor|1|||
131157103|NCT00847613|472200383|FG000|Overall Study|Lost to Follow-up|5|||
131157104|NCT00847613|472200384|FG001|Overall Study|Lost to Follow-up|0|||
131157105|NCT00847613|472200385|FG002|Overall Study|Lost to Follow-up|0|||
131157106|NCT00847613|472200386|FG003|Overall Study|Lost to Follow-up|3|||
131157107|NCT00847613|472200383|FG000|Overall Study|Protocol Violation|6|||
131157108|NCT00847613|472200384|FG001|Overall Study|Protocol Violation|6|||
131157109|NCT00847613|472200385|FG002|Overall Study|Protocol Violation|3|||
131157110|NCT00847613|472200386|FG003|Overall Study|Protocol Violation|1|||
131157111|NCT00847613|472200383|FG000|Overall Study|Pregnancy|1|||
131157112|NCT00847613|472200384|FG001|Overall Study|Pregnancy|1|||
131157113|NCT00847613|472200385|FG002|Overall Study|Pregnancy|0|||
131157114|NCT00847613|472200386|FG003|Overall Study|Pregnancy|0|||
131157115|NCT00847613|472200383|FG000|Overall Study|Site closure|1|||
131157116|NCT00847613|472200384|FG001|Overall Study|Site closure|0|||
131157117|NCT00847613|472200385|FG002|Overall Study|Site closure|0|||
131157118|NCT00847613|472200386|FG003|Overall Study|Site closure|1|||
131157119|NCT00847613|472200383|FG000|Overall Study|Withdrawal by Subject|8|||
131157120|NCT00847613|472200384|FG001|Overall Study|Withdrawal by Subject|11|||
131157121|NCT00847613|472200385|FG002|Overall Study|Withdrawal by Subject|2|||
131157122|NCT00847613|472200386|FG003|Overall Study|Withdrawal by Subject|2|||
131157123|NCT00847613|472200383|FG000|Overall Study|Participant moved|4|||
131157124|NCT00847613|472200384|FG001|Overall Study|Participant moved|1|||
131157125|NCT00847613|472200385|FG002|Overall Study|Participant moved|0|||
131157126|NCT00847613|472200386|FG003|Overall Study|Participant moved|0|||
131157127|NCT00847613|472200383|FG000|Overall Study|Sponsor request|0|||
131157128|NCT00847613|472200384|FG001|Overall Study|Sponsor request|1|||
131157129|NCT00847613|472200385|FG002|Overall Study|Sponsor request|0|||
131157130|NCT00847613|472200386|FG003|Overall Study|Sponsor request|0|||
131157131|NCT00847613|472200383|FG000|Overall Study|Randomized, but not treated|0|||
131157132|NCT00847613|472200384|FG001|Overall Study|Randomized, but not treated|3|||
131157133|NCT00847613|472200385|FG002|Overall Study|Randomized, but not treated|0|||
131157134|NCT00847613|472200386|FG003|Overall Study|Randomized, but not treated|0|||
131157135|NCT00847613|472200383|FG000|Overall Study|Other|1|||
131157136|NCT00847613|472200384|FG001|Overall Study|Other|1|||
131157137|NCT00847613|472200385|FG002|Overall Study|Other|2|||
131157138|NCT00847613|472200386|FG003|Overall Study|Other|0|||
131157139|NCT01009294|472200387|FG000|Overall Study|Study discontinued by Sponsor|6|||
131157140|NCT04332419|472200388|FG000|Overall Study|Withdrawal by Subject|1|||
131157141|NCT04222725|472200391|FG000|Overall Study|Adverse Event|0|||
131157142|NCT04222725|472200392|FG001|Overall Study|Adverse Event|1|||
131157143|NCT04222725|472200393|FG002|Overall Study|Adverse Event|0|||
131157144|NCT04222725|472200394|FG003|Overall Study|Adverse Event|0|||
131157145|NCT04925570|472200395|FG000|Overall Study|Protocol Violation|24|||
131157146|NCT04925570|472200396|FG001|Overall Study|Protocol Violation|30|||
131157147|NCT04925570|472200395|FG000|Overall Study|Withdrawal by Subject|0|||
131157148|NCT04925570|472200396|FG001|Overall Study|Withdrawal by Subject|2|||
131157149|NCT00658333|472200397|FG000|Overall Study|Adverse Event|2|||
131157150|NCT00658333|472200398|FG001|Overall Study|Adverse Event|1|||
131157151|NCT00828451|472200399|FG000|Overall Study|Death|2|||
131157152|NCT00828451|472200399|FG000|Overall Study|Lack of intravenous line|7|||
131157153|NCT00828451|472200399|FG000|Overall Study|Withdrawal by Subject|1|||
131157154|NCT00828451|472200399|FG000|Overall Study|Deterioration in clinical status|1|||
131157155|NCT00667277|472200402|FG000|Overall Study|Withdrawal by Subject|2|||
131157156|NCT00519532|472200403|FG000|Overall Study|Adverse Event|11|||
131235284|NCT03384745|472488890|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
131157157|NCT00519532|472200403|FG000|Overall Study|Withdrawal by Subject|5|||
131157158|NCT00519532|472200403|FG000|Overall Study|Lost to Follow-up|2|||
131157159|NCT03138564|472200404|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
131157160|NCT03138564|472200405|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
131157161|NCT03138564|472200404|FG000|Overall Study|Lost to Follow-up|16|||
131157162|NCT03138564|472200405|FG001|Overall Study|Lost to Follow-up|2|||
131157163|NCT03138564|472200404|FG000|Overall Study|Withdrawal by Subject|48|||
131157164|NCT03138564|472200405|FG001|Overall Study|Withdrawal by Subject|4|||
131157165|NCT03138564|472200404|FG000|Overall Study|No longer met eligibility criteria|2|||
131157166|NCT03138564|472200405|FG001|Overall Study|No longer met eligibility criteria|0|||
131157167|NCT03138564|472200404|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
131235285|NCT03384745|472488891|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
131235286|NCT03384745|472488886|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130780475|NCT00379834|470823081|FG000|Overall Study|Time constraints|2|||
130780476|NCT00327340|470823082|FG000|Overall Study|Withdrawal by Subject|1|||
130780477|NCT00327340|470823083|FG001|Overall Study|Withdrawal by Subject|5|||
130780478|NCT00327340|470823082|FG000|Overall Study|Physician Decision|1|||
130780479|NCT00327340|470823083|FG001|Overall Study|Physician Decision|1|||
130780480|NCT00327340|470823082|FG000|Overall Study|Disease Progression|10|||
130780481|NCT00327340|470823083|FG001|Overall Study|Disease Progression|19|||
130780482|NCT00327340|470823082|FG000|Overall Study|Symptomatic Disease|0|||
130780483|NCT00327340|470823083|FG001|Overall Study|Symptomatic Disease|2|||
130780484|NCT00327340|470823082|FG000|Overall Study|Adverse Event|3|||
130780485|NCT00327340|470823083|FG001|Overall Study|Adverse Event|3|||
130780486|NCT01716806|470823088|FG000|Overall Study|Patient withdrawal of consent|4|||
130780487|NCT01716806|470823089|FG001|Overall Study|Patient withdrawal of consent|2|||
130780488|NCT01716806|470823090|FG002|Overall Study|Patient withdrawal of consent|4|||
130780489|NCT01716806|470823091|FG003|Overall Study|Patient withdrawal of consent|3|||
130780490|NCT01716806|470823092|FG004|Overall Study|Patient withdrawal of consent|2|||
130780491|NCT01716806|470823093|FG005|Overall Study|Patient withdrawal of consent|0|||
130780492|NCT01716806|470823088|FG000|Overall Study|Lost to Follow-up|3|||
130780493|NCT01716806|470823089|FG001|Overall Study|Lost to Follow-up|3|||
130780494|NCT01716806|470823090|FG002|Overall Study|Lost to Follow-up|0|||
130780495|NCT01716806|470823091|FG003|Overall Study|Lost to Follow-up|2|||
130780496|NCT01716806|470823092|FG004|Overall Study|Lost to Follow-up|1|||
130780497|NCT01716806|470823093|FG005|Overall Study|Lost to Follow-up|0|||
130780498|NCT01716806|470823088|FG000|Overall Study|Death|13|||
130780499|NCT01716806|470823089|FG001|Overall Study|Death|9|||
130780500|NCT01716806|470823090|FG002|Overall Study|Death|12|||
130780501|NCT01716806|470823091|FG003|Overall Study|Death|4|||
130780502|NCT01716806|470823092|FG004|Overall Study|Death|10|||
130780503|NCT01716806|470823093|FG005|Overall Study|Death|5|||
130780504|NCT01716806|470823088|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130780505|NCT01716806|470823089|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130780506|NCT01716806|470823090|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130780507|NCT01716806|470823091|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130780508|NCT01716806|470823092|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
130780509|NCT01716806|470823093|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
130780510|NCT01716806|470823088|FG000|Overall Study|PI decision|0|||
130780511|NCT01716806|470823089|FG001|Overall Study|PI decision|0|||
130780512|NCT01716806|470823090|FG002|Overall Study|PI decision|0|||
130780513|NCT01716806|470823091|FG003|Overall Study|PI decision|0|||
130780514|NCT01716806|470823092|FG004|Overall Study|PI decision|1|||
130780515|NCT01716806|470823093|FG005|Overall Study|PI decision|0|||
130780516|NCT01716806|470823088|FG000|Overall Study|Change in performance status|1|||
130780517|NCT01716806|470823089|FG001|Overall Study|Change in performance status|0|||
130780518|NCT01716806|470823090|FG002|Overall Study|Change in performance status|0|||
130780519|NCT01716806|470823091|FG003|Overall Study|Change in performance status|0|||
130780520|NCT01716806|470823092|FG004|Overall Study|Change in performance status|0|||
130780521|NCT01716806|470823093|FG005|Overall Study|Change in performance status|0|||
130780522|NCT01716806|470823088|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
130780523|NCT01716806|470823089|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
130780524|NCT01716806|470823090|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
130780525|NCT01716806|470823091|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
130780526|NCT01716806|470823092|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
130780527|NCT01716806|470823093|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
130780528|NCT01716806|470823088|FG000|Overall Study|Sponsor direction|7|||
130780529|NCT01716806|470823089|FG001|Overall Study|Sponsor direction|8|||
130780530|NCT01716806|470823090|FG002|Overall Study|Sponsor direction|5|||
130780531|NCT01716806|470823091|FG003|Overall Study|Sponsor direction|12|||
130780532|NCT01716806|470823092|FG004|Overall Study|Sponsor direction|16|||
130780533|NCT01716806|470823093|FG005|Overall Study|Sponsor direction|1|||
130780534|NCT00956839|470823094|FG000|Overall Study|Lost to Follow-up|3|||
130780535|NCT00956839|470823095|FG001|Overall Study|Lost to Follow-up|0|||
130780536|NCT00956839|470823096|FG002|Overall Study|Lost to Follow-up|3|||
130780537|NCT01001429|470823097|FG000|Overall Study|surgery cancelled|0|||
130780538|NCT01001429|470823098|FG001|Overall Study|surgery cancelled|1|||
130780539|NCT03506438|470823101|FG000|Overall Study|Lost to Follow-up|8|||
130780540|NCT03506438|470823102|FG001|Overall Study|Lost to Follow-up|7|||
130780541|NCT03506438|470823103|FG002|Overall Study|Lost to Follow-up|8|||
131157168|NCT03138564|472200405|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
130780542|NCT03506438|470823104|FG003|Overall Study|Lost to Follow-up|7|||
130780543|NCT03506438|470823105|FG004|Overall Study|Lost to Follow-up|0|||
130780544|NCT03506438|470823106|FG005|Overall Study|Lost to Follow-up|0|||
130780545|NCT03527277|470823107|FG000|Overall Study|Withdrawal by Subject|5|||
130780546|NCT03527277|470823108|FG001|Overall Study|Withdrawal by Subject|0|||
131157169|NCT03138564|472200404|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
131157170|NCT03138564|472200405|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
131157171|NCT03138564|472200404|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
131157172|NCT03138564|472200405|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
131157173|NCT03138564|472200404|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
131157174|NCT03138564|472200405|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
131157175|NCT00624338|472200406|FG000|Overall Study|Adverse Event|14|||
131157176|NCT00624338|472200407|FG001|Overall Study|Adverse Event|14|||
131157177|NCT00624338|472200408|FG002|Overall Study|Adverse Event|18|||
131157178|NCT00624338|472200406|FG000|Overall Study|Lost to Follow-up|1|||
131157179|NCT00624338|472200407|FG001|Overall Study|Lost to Follow-up|0|||
131157180|NCT00624338|472200408|FG002|Overall Study|Lost to Follow-up|0|||
131157181|NCT00624338|472200406|FG000|Overall Study|Lack of Efficacy|11|||
131157182|NCT00624338|472200407|FG001|Overall Study|Lack of Efficacy|3|||
131157183|NCT00624338|472200408|FG002|Overall Study|Lack of Efficacy|14|||
131157184|NCT00624338|472200406|FG000|Overall Study|Protocol Violation|3|||
131157185|NCT00624338|472200407|FG001|Overall Study|Protocol Violation|3|||
131157186|NCT00624338|472200408|FG002|Overall Study|Protocol Violation|2|||
131157187|NCT00624338|472200406|FG000|Overall Study|Death|0|||
131157188|NCT00624338|472200407|FG001|Overall Study|Death|2|||
131157189|NCT00624338|472200408|FG002|Overall Study|Death|0|||
131157190|NCT00624338|472200406|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
131157191|NCT00624338|472200407|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
131157192|NCT00624338|472200408|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
131157193|NCT00624338|472200406|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
131157194|NCT00624338|472200407|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
131157195|NCT00624338|472200408|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
131157196|NCT00624338|472200406|FG000|Overall Study|Other|15|||
131157197|NCT00624338|472200407|FG001|Overall Study|Other|5|||
131157198|NCT00624338|472200408|FG002|Overall Study|Other|9|||
131157199|NCT00624338|472200406|FG000|Overall Study|Randomized but not treated|2|||
131157200|NCT00624338|472200407|FG001|Overall Study|Randomized but not treated|1|||
131157201|NCT00624338|472200408|FG002|Overall Study|Randomized but not treated|3|||
131157202|NCT01548638|472200409|FG000|Overall Study|Protocol Violation|3|||
131157203|NCT01548638|472200409|FG000|Overall Study|Withdrawal by Subject|1|||
131157204|NCT05593432|472200410|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
131157205|NCT05593432|472200411|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
131157206|NCT05593432|472200412|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
131157207|NCT05593432|472200413|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
131157208|NCT05593432|472200410|FG000|16-Week OLE Period|Lack of Efficacy|0|||
131157209|NCT05593432|472200411|FG001|16-Week OLE Period|Lack of Efficacy|0|||
131157210|NCT05593432|472200412|FG002|16-Week OLE Period|Lack of Efficacy|0|||
131157211|NCT05593432|472200413|FG003|16-Week OLE Period|Lack of Efficacy|1|||
131157212|NCT05593432|472200410|FG000|16-Week OLE Period|Lost to Follow-up|0|||
131157213|NCT05593432|472200411|FG001|16-Week OLE Period|Lost to Follow-up|0|||
131157214|NCT05593432|472200412|FG002|16-Week OLE Period|Lost to Follow-up|1|||
131157215|NCT05593432|472200413|FG003|16-Week OLE Period|Lost to Follow-up|2|||
131157216|NCT05593432|472200410|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
131157217|NCT05593432|472200411|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
131157218|NCT05593432|472200412|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
131157219|NCT05593432|472200413|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
131157220|NCT05897853|472200414|FG000|Overall Study|Lost to Follow-up|2|||
131157221|NCT05897853|472200415|FG001|Overall Study|Lost to Follow-up|0|||
131157222|NCT05897853|472200414|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
131157223|NCT05897853|472200415|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
131157224|NCT02609399|472200422|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
131157225|NCT02609399|472200423|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
131157226|NCT02609399|472200422|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
131157227|NCT02609399|472200423|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
131157228|NCT02609399|472200422|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
131157229|NCT02609399|472200423|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
131157230|NCT04458857|472200424|FG000|Overall Study|Adverse Event|0|||
131157231|NCT04458857|472200425|FG001|Overall Study|Adverse Event|1|||
131157232|NCT04458857|472200426|FG002|Overall Study|Adverse Event|0|||
131157233|NCT04458857|472200424|FG000|Overall Study|Withdrawal by Subject|2|||
131235287|NCT03384745|472488887|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
131235288|NCT03384745|472488888|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
131235289|NCT03384745|472488889|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
131157234|NCT04458857|472200425|FG001|Overall Study|Withdrawal by Subject|0|||
131157235|NCT04458857|472200426|FG002|Overall Study|Withdrawal by Subject|0|||
131157236|NCT04458857|472200424|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131157237|NCT04458857|472200425|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131157238|NCT04458857|472200426|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131157239|NCT04458857|472200424|FG000|Overall Study|Non-compliance with study drug|0|||
131157240|NCT04458857|472200425|FG001|Overall Study|Non-compliance with study drug|1|||
131157241|NCT04458857|472200426|FG002|Overall Study|Non-compliance with study drug|0|||
131157242|NCT04458857|472200424|FG000|Overall Study|Lost to Follow-up|4|||
131157243|NCT04458857|472200425|FG001|Overall Study|Lost to Follow-up|1|||
131157244|NCT04458857|472200426|FG002|Overall Study|Lost to Follow-up|0|||
131157245|NCT02986373|472200427|FG000|Overall Study|Adverse Event|4|||
131157246|NCT02986373|472200427|FG000|Overall Study|Lost to Follow-up|1|||
131157247|NCT02986373|472200427|FG000|Overall Study|Withdrawal by Subject|10|||
131157248|NCT02986373|472200427|FG000|Overall Study|Other|24|||
131157249|NCT01151137|472200430|FG000|Overall Study|Death|15|||
131157250|NCT01151137|472200431|FG001|Overall Study|Death|27|||
131157251|NCT01151137|472200430|FG000|Overall Study|Lost to Follow-up|1|||
131157252|NCT01151137|472200431|FG001|Overall Study|Lost to Follow-up|1|||
131157253|NCT03414359|472200432|FG000|Overall Study|Lack of Efficacy|1|||
131157254|NCT03414359|472200433|FG001|Overall Study|Lack of Efficacy|1|||
131157255|NCT03414359|472200432|FG000|Overall Study|Protocol Violation|0|||
131157256|NCT03414359|472200433|FG001|Overall Study|Protocol Violation|1|||
131157257|NCT02273973|472200436|FG000|Overall Study|Adverse Event|4|||
131157258|NCT02273973|472200437|FG001|Overall Study|Adverse Event|0|||
131157259|NCT02273973|472200436|FG000|Overall Study|Withdrawal by Subject|2|||
131157260|NCT02273973|472200437|FG001|Overall Study|Withdrawal by Subject|3|||
131157261|NCT02273973|472200436|FG000|Overall Study|Death|1|||
131157262|NCT02273973|472200437|FG001|Overall Study|Death|0|||
131157263|NCT02273973|472200436|FG000|Overall Study|Non-compliance|1|||
131157264|NCT02273973|472200437|FG001|Overall Study|Non-compliance|0|||
131157265|NCT02273973|472200436|FG000|Overall Study|Protocol Violation|1|||
131157266|NCT02273973|472200437|FG001|Overall Study|Protocol Violation|0|||
131157267|NCT02273973|472200436|FG000|Overall Study|Progression of disease|0|||
131157268|NCT02273973|472200437|FG001|Overall Study|Progression of disease|2|||
131157269|NCT02273973|472200436|FG000|Overall Study|Lost to Follow-up|0|||
131157270|NCT02273973|472200437|FG001|Overall Study|Lost to Follow-up|1|||
131157271|NCT02273973|472200436|FG000|Overall Study|Physician Decision|0|||
131157272|NCT02273973|472200437|FG001|Overall Study|Physician Decision|1|||
131157273|NCT02273973|472200436|FG000|Overall Study|Reason not specified|0|||
131157274|NCT02273973|472200437|FG001|Overall Study|Reason not specified|1|||
131157275|NCT01739595|472200439|FG000|Overall Study|Adverse Event|3|||
131157276|NCT01739595|472200440|FG001|Overall Study|Adverse Event|0|||
131157277|NCT01739595|472200441|FG002|Overall Study|Adverse Event|0|||
131157278|NCT01739595|472200439|FG000|Overall Study|Lost to Follow-up|2|||
131157279|NCT01739595|472200440|FG001|Overall Study|Lost to Follow-up|0|||
131157280|NCT01739595|472200441|FG002|Overall Study|Lost to Follow-up|0|||
131157281|NCT01739595|472200439|FG000|Overall Study|Withdrawal by Subject|2|||
131157282|NCT01739595|472200440|FG001|Overall Study|Withdrawal by Subject|1|||
131157283|NCT01739595|472200441|FG002|Overall Study|Withdrawal by Subject|2|||
131157284|NCT01739595|472200439|FG000|Overall Study|Eligibility issue|3|||
131157285|NCT01739595|472200440|FG001|Overall Study|Eligibility issue|0|||
131157286|NCT01739595|472200441|FG002|Overall Study|Eligibility issue|0|||
131157287|NCT01739595|472200439|FG000|Overall Study|Protocol Violation|1|||
131157288|NCT01739595|472200440|FG001|Overall Study|Protocol Violation|0|||
131157289|NCT01739595|472200441|FG002|Overall Study|Protocol Violation|0|||
131157290|NCT01739595|472200439|FG000|Overall Study|Lab assessment|1|||
131157291|NCT01739595|472200440|FG001|Overall Study|Lab assessment|0|||
131157292|NCT01739595|472200441|FG002|Overall Study|Lab assessment|0|||
131157293|NCT01739595|472200439|FG000|Overall Study|Drug discrepancy|1|||
131157294|NCT01739595|472200440|FG001|Overall Study|Drug discrepancy|0|||
130728614|NCT02185053|470627522|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130728615|NCT02185053|470627523|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130728616|NCT02185053|470627521|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
131157295|NCT01739595|472200441|FG002|Overall Study|Drug discrepancy|0|||
131157296|NCT00957372|472200442|FG000|PART I|Lost to Follow-up|0|||
131157297|NCT00957372|472200443|FG001|PART I|Lost to Follow-up|0|||
131157298|NCT00957372|472200444|FG002|PART I|Lost to Follow-up|1|||
131157299|NCT00957372|472200445|FG003|PART I|Lost to Follow-up|0|||
131157300|NCT00957372|472200442|FG000|PART II|Withdrawal by Subject|0|||
131157301|NCT00957372|472200443|FG001|PART II|Withdrawal by Subject|0|||
131157302|NCT00957372|472200444|FG002|PART II|Withdrawal by Subject|0|||
131157303|NCT00957372|472200445|FG003|PART II|Withdrawal by Subject|8|||
131157304|NCT00957372|472200442|FG000|PART II|Physician Decision|0|||
131157305|NCT00957372|472200443|FG001|PART II|Physician Decision|0|||
131157306|NCT00957372|472200444|FG002|PART II|Physician Decision|0|||
131157307|NCT00957372|472200445|FG003|PART II|Physician Decision|1|||
131157308|NCT00957372|472200442|FG000|PART II|Pregnancy|0|||
131157309|NCT00957372|472200443|FG001|PART II|Pregnancy|0|||
131157310|NCT00957372|472200444|FG002|PART II|Pregnancy|0|||
131157311|NCT00957372|472200445|FG003|PART II|Pregnancy|1|||
131157312|NCT00957372|472200442|FG000|PART II|Not Know|0|||
131157313|NCT00957372|472200443|FG001|PART II|Not Know|0|||
131157314|NCT00957372|472200444|FG002|PART II|Not Know|0|||
131157315|NCT00957372|472200445|FG003|PART II|Not Know|20|||
131157316|NCT00957372|472200442|FG000|PART II|Adverse Event|0|||
131157317|NCT00957372|472200443|FG001|PART II|Adverse Event|0|||
131157318|NCT00957372|472200444|FG002|PART II|Adverse Event|0|||
131157319|NCT00957372|472200445|FG003|PART II|Adverse Event|10|||
131157320|NCT00957372|472200442|FG000|PART II|Patient non-compliance|0|||
131157321|NCT00957372|472200443|FG001|PART II|Patient non-compliance|0|||
131157322|NCT00957372|472200444|FG002|PART II|Patient non-compliance|0|||
131157323|NCT00957372|472200445|FG003|PART II|Patient non-compliance|4|||
131157324|NCT01282814|472200446|FG000|First Intervention|Emesis During Dosing Interval|0|||
131157325|NCT01282814|472200447|FG001|First Intervention|Emesis During Dosing Interval|3|||
131157326|NCT01282814|472200446|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
131157327|NCT01282814|472200447|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
131157328|NCT02403206|472200448|FG000|Overall Study|Lost to Follow-up|4|||
131157329|NCT02403206|472200449|FG001|Overall Study|Lost to Follow-up|3|||
131157330|NCT02403206|472200448|FG000|Overall Study|Physician Decision|2|||
131157331|NCT02403206|472200449|FG001|Overall Study|Physician Decision|0|||
131157332|NCT02403206|472200448|FG000|Overall Study|Withdrawal by Subject|3|||
131157333|NCT02403206|472200449|FG001|Overall Study|Withdrawal by Subject|3|||
131157334|NCT02403206|472200448|FG000|Overall Study|Reason not given|2|||
131157335|NCT02403206|472200449|FG001|Overall Study|Reason not given|4|||
131157336|NCT01676116|472200452|FG000|Overall Study|Withdrawal criteria|2|||
131157337|NCT01676116|472200453|FG001|Overall Study|Withdrawal criteria|14|||
131157338|NCT01676116|472200452|FG000|Overall Study|Adverse Event|1|||
131157339|NCT01676116|472200453|FG001|Overall Study|Adverse Event|2|||
131157340|NCT01676116|472200452|FG000|Overall Study|Unclassified|4|||
131157341|NCT01676116|472200453|FG001|Overall Study|Unclassified|10|||
131157342|NCT01676116|472200452|FG000|Overall Study|Protocol Violation|9|||
131157343|NCT01676116|472200453|FG001|Overall Study|Protocol Violation|3|||
131157344|NCT01287117|472200454|FG000|Overall Study|Adverse Event|2|||
131157345|NCT01287117|472200455|FG001|Overall Study|Adverse Event|1|||
131157346|NCT01287117|472200456|FG002|Overall Study|Adverse Event|1|||
131157347|NCT01287117|472200457|FG003|Overall Study|Adverse Event|1|||
131157348|NCT01287117|472200454|FG000|Overall Study|Lost to Follow-up|1|||
131157349|NCT01287117|472200455|FG001|Overall Study|Lost to Follow-up|1|||
131157350|NCT01287117|472200456|FG002|Overall Study|Lost to Follow-up|0|||
131157351|NCT01287117|472200457|FG003|Overall Study|Lost to Follow-up|0|||
131157352|NCT01287117|472200454|FG000|Overall Study|Physician Decision|0|||
131157353|NCT01287117|472200455|FG001|Overall Study|Physician Decision|1|||
131157354|NCT01287117|472200456|FG002|Overall Study|Physician Decision|1|||
131157355|NCT01287117|472200457|FG003|Overall Study|Physician Decision|1|||
131157356|NCT01287117|472200454|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
131157357|NCT01287117|472200455|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
131157358|NCT01287117|472200456|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
131157359|NCT01287117|472200457|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
131157360|NCT01287117|472200454|FG000|Overall Study|Disease Progression|10|||
131157361|NCT01287117|472200455|FG001|Overall Study|Disease Progression|5|||
131157362|NCT01287117|472200456|FG002|Overall Study|Disease Progression|6|||
131157363|NCT01287117|472200457|FG003|Overall Study|Disease Progression|5|||
131157364|NCT00778999|472200464|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
131157365|NCT00778999|472200465|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
131157366|NCT00778999|472200464|FG000|Overall Study|Did not receive recFSH|14|||
131157367|NCT00778999|472200465|FG001|Overall Study|Did not receive recFSH|20|||
131157368|NCT02032524|472200466|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
131157369|NCT02032524|472200467|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
131157370|NCT02032524|472200468|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
131157371|NCT02032524|472200469|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
131157372|NCT02032524|472200470|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
131157373|NCT02032524|472200471|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
131157374|NCT02032524|472200466|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
131157375|NCT02032524|472200467|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
131157376|NCT02032524|472200468|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
131157377|NCT02032524|472200469|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
131157378|NCT02032524|472200470|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
131157379|NCT02032524|472200471|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
131157380|NCT02032524|472200466|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
131157381|NCT02032524|472200467|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
131157382|NCT02032524|472200468|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
131157383|NCT02032524|472200469|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
131157384|NCT02032524|472200470|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
131157385|NCT02032524|472200471|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
131157386|NCT02032524|472200466|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
131157387|NCT02032524|472200467|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
131157388|NCT02032524|472200468|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
131157389|NCT02032524|472200469|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
131157390|NCT02032524|472200470|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
131157391|NCT02032524|472200471|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
131157392|NCT02032524|472200466|FG000|Period 2: LTS13769 Study|Other|0|||
130780547|NCT03527277|470823107|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
130780548|NCT03527277|470823108|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
131157393|NCT02032524|472200467|FG001|Period 2: LTS13769 Study|Other|0|||
131157394|NCT02032524|472200468|FG002|Period 2: LTS13769 Study|Other|0|||
131157395|NCT02032524|472200469|FG003|Period 2: LTS13769 Study|Other|0|||
131157396|NCT02032524|472200470|FG004|Period 2: LTS13769 Study|Other|0|||
131157397|NCT02032524|472200471|FG005|Period 2: LTS13769 Study|Other|1|||
131157398|NCT02975349|472200472|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131157399|NCT02975349|472200473|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131157400|NCT02975349|472200474|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131157401|NCT02975349|472200475|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131157402|NCT02975349|472200476|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131157403|NCT02975349|472200477|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131157404|NCT02975349|472200478|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131157405|NCT02975349|472200472|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131157406|NCT02975349|472200473|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131157407|NCT02975349|472200474|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131157408|NCT02975349|472200475|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131157409|NCT02975349|472200476|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131157410|NCT02975349|472200477|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131157411|NCT02975349|472200478|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131157412|NCT02975349|472200472|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
131157413|NCT02975349|472200473|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
131157414|NCT02975349|472200474|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
131157415|NCT02975349|472200475|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
131157416|NCT02975349|472200476|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
131157417|NCT02975349|472200477|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
130780549|NCT03527277|470823107|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
130780550|NCT03527277|470823108|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
130780551|NCT03316586|470823111|FG000|Overall Study|Adverse Event|2|||
130780552|NCT03316586|470823111|FG000|Overall Study|Physician Decision|3|||
130780553|NCT03316586|470823111|FG000|Overall Study|Lack of Efficacy|10|||
130780554|NCT03316586|470823111|FG000|Overall Study|still on treatment|1|||
130780555|NCT03316586|470823111|FG000|Overall Study|Patient needed radiation therapy|1|||
130780556|NCT03316586|470823111|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
130780557|NCT03934216|470823114|FG000|Overall Study|Other Reasons|5|||
130780558|NCT03934216|470823115|FG001|Overall Study|Other Reasons|5|||
130780559|NCT03934216|470823114|FG000|Overall Study|Adverse Event|22|||
130780560|NCT03934216|470823115|FG001|Overall Study|Adverse Event|11|||
130780561|NCT03934216|470823114|FG000|Overall Study|Lack of Efficacy|8|||
130780562|NCT03934216|470823115|FG001|Overall Study|Lack of Efficacy|7|||
130780563|NCT03934216|470823114|FG000|Overall Study|Lost to Follow-up|2|||
130780564|NCT03934216|470823115|FG001|Overall Study|Lost to Follow-up|0|||
130780565|NCT03934216|470823114|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130780566|NCT03934216|470823115|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130780567|NCT03934216|470823114|FG000|Overall Study|Pregnancy|1|||
130780568|NCT03934216|470823115|FG001|Overall Study|Pregnancy|0|||
130780569|NCT03934216|470823114|FG000|Overall Study|Withdrawal by Subject|18|||
130780570|NCT03934216|470823115|FG001|Overall Study|Withdrawal by Subject|6|||
130780571|NCT03934216|470823114|FG000|Overall Study|Randomized but not treated|1|||
130780572|NCT03934216|470823115|FG001|Overall Study|Randomized but not treated|1|||
130780573|NCT01396083|470823118|FG000|Overall Study|Adverse Event|2|||
130780574|NCT01396083|470823119|FG001|Overall Study|Adverse Event|28|||
130780575|NCT01396083|470823118|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130780576|NCT01396083|470823119|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
130780577|NCT01396083|470823118|FG000|Overall Study|Consent withdrawn|4|||
130780578|NCT01396083|470823119|FG001|Overall Study|Consent withdrawn|5|||
130780579|NCT01396083|470823118|FG000|Overall Study|Protocol deviation(s)|0|||
130780580|NCT01396083|470823119|FG001|Overall Study|Protocol deviation(s)|1|||
130780581|NCT01396083|470823118|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130780582|NCT01396083|470823119|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130780583|NCT01396083|470823118|FG000|Overall Study|Administrative problems|1|||
130780584|NCT01396083|470823119|FG001|Overall Study|Administrative problems|0|||
130780585|NCT01396083|470823118|FG000|Overall Study|Lost to Follow-up|1|||
131157418|NCT02975349|472200478|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
131157419|NCT02975349|472200472|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
131157420|NCT02975349|472200473|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
130780586|NCT01396083|470823119|FG001|Overall Study|Lost to Follow-up|0|||
130780587|NCT02806713|470823120|FG000|Overall Study|Urethral injury during procedure|1|||
130780588|NCT02806713|470823121|FG001|Overall Study|Urethral injury during procedure|0|||
130780589|NCT02806713|470823120|FG000|Overall Study|cancelled surgery|1|||
130780590|NCT02806713|470823121|FG001|Overall Study|cancelled surgery|2|||
131157421|NCT02975349|472200474|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
131157422|NCT02975349|472200475|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
131157423|NCT02975349|472200476|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
131157424|NCT02975349|472200477|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
131157425|NCT02975349|472200478|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
131157426|NCT02975349|472200472|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
131157427|NCT02975349|472200473|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
131157428|NCT02975349|472200474|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
131157429|NCT02975349|472200475|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
131157430|NCT02975349|472200476|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
131157431|NCT02975349|472200477|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
131157432|NCT02975349|472200478|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
131157433|NCT02975349|472200472|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131157434|NCT02975349|472200473|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131157435|NCT02975349|472200474|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131157436|NCT02975349|472200475|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
131157437|NCT02975349|472200476|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131157438|NCT02975349|472200477|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131157439|NCT02975349|472200478|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
131157440|NCT02975349|472200472|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131157441|NCT02975349|472200473|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
131157442|NCT02975349|472200474|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131157443|NCT02975349|472200475|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131157444|NCT02975349|472200476|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131157445|NCT02975349|472200477|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131157446|NCT02975349|472200478|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
131157447|NCT02975349|472200472|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
131157448|NCT02975349|472200473|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
131157449|NCT02975349|472200474|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
131157450|NCT02975349|472200475|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
131157451|NCT02975349|472200476|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
131157452|NCT02975349|472200477|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
131157453|NCT02975349|472200478|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
131157454|NCT02975349|472200472|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131157455|NCT02975349|472200473|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131157456|NCT02975349|472200474|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131157457|NCT02975349|472200475|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131157458|NCT02975349|472200476|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
131157459|NCT02975349|472200477|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131157460|NCT02975349|472200478|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
131157461|NCT02975349|472200472|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
131157462|NCT02975349|472200473|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
131157463|NCT02975349|472200474|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
131157464|NCT02975349|472200475|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
131157465|NCT02975349|472200476|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
131157466|NCT02975349|472200477|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
131157467|NCT02975349|472200478|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
131157468|NCT02975349|472200472|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
131157469|NCT02975349|472200473|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
131157470|NCT02975349|472200474|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
131157471|NCT02975349|472200475|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
131157472|NCT02975349|472200476|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
131157473|NCT02975349|472200477|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
131157474|NCT02975349|472200478|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
131157475|NCT02975349|472200472|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
131157476|NCT02975349|472200473|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
131157477|NCT02975349|472200474|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
131157478|NCT02975349|472200475|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
131157479|NCT02975349|472200476|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
131157480|NCT02975349|472200477|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
131157481|NCT02975349|472200478|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
131157482|NCT02975349|472200472|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
131157483|NCT02975349|472200473|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
131157484|NCT02975349|472200474|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
131157485|NCT02975349|472200475|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
131157486|NCT02975349|472200476|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
131157487|NCT02975349|472200477|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
131157488|NCT02975349|472200478|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
131157489|NCT02975349|472200472|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
131157490|NCT02975349|472200473|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
131157491|NCT02975349|472200474|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
131157492|NCT02975349|472200475|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
131157493|NCT02975349|472200476|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
131157494|NCT02975349|472200477|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
131157495|NCT02975349|472200478|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
131157496|NCT02975349|472200472|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
131157497|NCT02975349|472200473|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
131157498|NCT02975349|472200474|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
131157499|NCT02975349|472200475|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
131157500|NCT02975349|472200476|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
131157501|NCT02975349|472200477|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
131157502|NCT02975349|472200478|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
131157503|NCT03567187|472200481|FG000|Overall Study|Lost to Follow-up|18|||
131157504|NCT02032875|472200484|FG000|Treatment Period|Adverse Event|1|||
131157505|NCT02032875|472200485|FG001|Treatment Period|Adverse Event|0|||
131157506|NCT02032875|472200484|FG000|Treatment Period|Liver transplant, No extension needed|0|||
131157507|NCT02032875|472200485|FG001|Treatment Period|Liver transplant, No extension needed|1|||
131157508|NCT02032875|472200484|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
131157509|NCT02032875|472200485|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
131157510|NCT02032875|472200484|FG000|Follow-up Period|Death|0|||
131157511|NCT02032875|472200485|FG001|Follow-up Period|Death|1|||
131157512|NCT02032875|472200484|FG000|Follow-up Period|Virologic Relapse|3|||
131157513|NCT02032875|472200485|FG001|Follow-up Period|Virologic Relapse|10|||
131157514|NCT04358458|472200486|FG000|Overall Study|Death|1|||
131157515|NCT04358458|472200487|FG001|Overall Study|Death|1|||
131157516|NCT04358458|472200488|FG002|Overall Study|Death|3|||
131157517|NCT04358458|472200489|FG003|Overall Study|Death|8|||
131157518|NCT04358458|472200490|FG004|Overall Study|Death|1|||
131157519|NCT04358458|472200491|FG005|Overall Study|Death|6|||
131157520|NCT04358458|472200492|FG006|Overall Study|Death|2|||
131157521|NCT04358458|472200493|FG007|Overall Study|Death|3|||
131157522|NCT04358458|472200486|FG000|Overall Study|Lost to Follow-up|0|||
131157523|NCT04358458|472200487|FG001|Overall Study|Lost to Follow-up|0|||
131157524|NCT04358458|472200488|FG002|Overall Study|Lost to Follow-up|0|||
131157525|NCT04358458|472200489|FG003|Overall Study|Lost to Follow-up|0|||
131157526|NCT04358458|472200490|FG004|Overall Study|Lost to Follow-up|0|||
131157527|NCT04358458|472200491|FG005|Overall Study|Lost to Follow-up|0|||
131157528|NCT04358458|472200492|FG006|Overall Study|Lost to Follow-up|0|||
131157529|NCT04358458|472200493|FG007|Overall Study|Lost to Follow-up|1|||
131157530|NCT04358458|472200486|FG000|Overall Study|Site is closing study participation|0|||
131157531|NCT04358458|472200487|FG001|Overall Study|Site is closing study participation|0|||
131157532|NCT04358458|472200488|FG002|Overall Study|Site is closing study participation|0|||
131157533|NCT04358458|472200489|FG003|Overall Study|Site is closing study participation|1|||
131157534|NCT04358458|472200490|FG004|Overall Study|Site is closing study participation|0|||
131157535|NCT04358458|472200491|FG005|Overall Study|Site is closing study participation|0|||
131157536|NCT04358458|472200492|FG006|Overall Study|Site is closing study participation|0|||
131157537|NCT04358458|472200493|FG007|Overall Study|Site is closing study participation|0|||
131157538|NCT04358458|472200486|FG000|Overall Study|Sponsor request|2|||
131157539|NCT04358458|472200487|FG001|Overall Study|Sponsor request|3|||
131157540|NCT04358458|472200488|FG002|Overall Study|Sponsor request|3|||
131157541|NCT04358458|472200489|FG003|Overall Study|Sponsor request|0|||
131157542|NCT04358458|472200490|FG004|Overall Study|Sponsor request|2|||
131157543|NCT04358458|472200491|FG005|Overall Study|Sponsor request|3|||
131157544|NCT04358458|472200492|FG006|Overall Study|Sponsor request|1|||
131157545|NCT04358458|472200493|FG007|Overall Study|Sponsor request|1|||
131157546|NCT04358458|472200486|FG000|Overall Study|Withdrawal by Subject|0|||
131157547|NCT04358458|472200487|FG001|Overall Study|Withdrawal by Subject|0|||
131157548|NCT04358458|472200488|FG002|Overall Study|Withdrawal by Subject|1|||
131157549|NCT04358458|472200489|FG003|Overall Study|Withdrawal by Subject|1|||
131157550|NCT04358458|472200490|FG004|Overall Study|Withdrawal by Subject|0|||
131157551|NCT04358458|472200491|FG005|Overall Study|Withdrawal by Subject|1|||
131157552|NCT04358458|472200492|FG006|Overall Study|Withdrawal by Subject|0|||
131157553|NCT04358458|472200493|FG007|Overall Study|Withdrawal by Subject|1|||
131157554|NCT01266148|472201797|FG000|Overall Study|Adverse Event|2|||
131157555|NCT01266148|472201798|FG001|Overall Study|Adverse Event|0|||
131157556|NCT01266148|472201797|FG000|Overall Study|Ongoing rejection|1|||
131157557|NCT01266148|472201798|FG001|Overall Study|Ongoing rejection|0|||
131157558|NCT01266148|472201797|FG000|Overall Study|2 2R rejections|1|||
131157559|NCT01266148|472201798|FG001|Overall Study|2 2R rejections|0|||
131157560|NCT01266148|472201797|FG000|Overall Study|Death|2|||
131157561|NCT01266148|472201798|FG001|Overall Study|Death|3|||
131157562|NCT01266148|472201797|FG000|Overall Study|missing mGFR value + AE|1|||
131157563|NCT01266148|472201798|FG001|Overall Study|missing mGFR value + AE|0|||
131157564|NCT01853228|472201799|FG000|Phase 1|Lack of Efficacy|8|||
131157565|NCT01853228|472201800|FG001|Phase 1|Lack of Efficacy|0|||
131157566|NCT01853228|472201799|FG000|Phase 1|Other|1|||
131157567|NCT01853228|472201800|FG001|Phase 1|Other|0|||
131157568|NCT01853228|472201799|FG000|Phase 2|Physician Decision|0|||
131157569|NCT01853228|472201800|FG001|Phase 2|Physician Decision|1|||
131157570|NCT01853228|472201799|FG000|Phase 2|Proceed To Transplant|0|||
131157571|NCT01853228|472201800|FG001|Phase 2|Proceed To Transplant|3|||
131157572|NCT01853228|472201799|FG000|Phase 2|Lack of Efficacy|0|||
131157573|NCT01853228|472201800|FG001|Phase 2|Lack of Efficacy|4|||
131157574|NCT01348919|472201802|FG000|Overall Study|Adverse Event|3|||
131157575|NCT01348919|472201803|FG001|Overall Study|Adverse Event|1|||
131157576|NCT01348919|472201804|FG002|Overall Study|Adverse Event|0|||
131157577|NCT01348919|472201802|FG000|Overall Study|Withdrawal by Subject|0|||
131157578|NCT01348919|472201803|FG001|Overall Study|Withdrawal by Subject|1|||
131157579|NCT01348919|472201804|FG002|Overall Study|Withdrawal by Subject|0|||
131157580|NCT01348919|472201802|FG000|Overall Study|Disease progression|0|||
131157581|NCT01348919|472201803|FG001|Overall Study|Disease progression|1|||
131157582|NCT01348919|472201804|FG002|Overall Study|Disease progression|1|||
131157583|NCT04426630|472201805|FG000|Overall Study|Death|4|||
131157584|NCT04426630|472201805|FG000|Overall Study|Lost to Follow-up|2|||
131157585|NCT04328623|472201817|FG000|Overall Study|Protocol Violation|0|||
131157586|NCT04328623|472201818|FG001|Overall Study|Protocol Violation|1|||
131157587|NCT00849693|472201819|FG000|Acute Treatment Phase|Adverse Event|12|||
131157588|NCT00849693|472201820|FG001|Acute Treatment Phase|Adverse Event|7|||
131157589|NCT00849693|472201821|FG002|Acute Treatment Phase|Adverse Event|6|||
131157590|NCT00849693|472201822|FG003|Acute Treatment Phase|Adverse Event|4|||
131157591|NCT00849693|472201819|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
131157592|NCT00849693|472201820|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
131157593|NCT00849693|472201821|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
131157594|NCT00849693|472201822|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
131157595|NCT00849693|472201819|FG000|Acute Treatment Phase|Protocol Violation|1|||
131157596|NCT00849693|472201820|FG001|Acute Treatment Phase|Protocol Violation|5|||
131157597|NCT00849693|472201821|FG002|Acute Treatment Phase|Protocol Violation|2|||
131157598|NCT00849693|472201822|FG003|Acute Treatment Phase|Protocol Violation|6|||
131157599|NCT00849693|472201819|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
131157600|NCT00849693|472201820|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
131157601|NCT00849693|472201821|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
131157602|NCT00849693|472201822|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
131157603|NCT00849693|472201819|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
131157604|NCT00849693|472201820|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
131157605|NCT00849693|472201821|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
131157606|NCT00849693|472201822|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
131157607|NCT00849693|472201819|FG000|Acute Treatment Phase|Physician Decision|2|||
131157608|NCT00849693|472201820|FG001|Acute Treatment Phase|Physician Decision|1|||
131157609|NCT00849693|472201821|FG002|Acute Treatment Phase|Physician Decision|2|||
131157610|NCT00849693|472201822|FG003|Acute Treatment Phase|Physician Decision|1|||
131157611|NCT00849693|472201819|FG000|Acute Treatment Phase|Sponsor decision|0|||
131157612|NCT00849693|472201820|FG001|Acute Treatment Phase|Sponsor decision|0|||
131157613|NCT00849693|472201821|FG002|Acute Treatment Phase|Sponsor decision|1|||
131157614|NCT00849693|472201822|FG003|Acute Treatment Phase|Sponsor decision|0|||
131157615|NCT00849693|472201819|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
131157616|NCT00849693|472201820|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
131157617|NCT00849693|472201821|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
131157618|NCT00849693|472201822|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
131157619|NCT00849693|472201819|FG000|Extension Phase|Adverse Event|4|||
131157620|NCT00849693|472201820|FG001|Extension Phase|Adverse Event|6|||
131157621|NCT00849693|472201821|FG002|Extension Phase|Adverse Event|3|||
131157622|NCT00849693|472201822|FG003|Extension Phase|Adverse Event|7|||
131157623|NCT00849693|472201819|FG000|Extension Phase|Lost to Follow-up|7|||
131157624|NCT00849693|472201820|FG001|Extension Phase|Lost to Follow-up|5|||
131157625|NCT00849693|472201821|FG002|Extension Phase|Lost to Follow-up|6|||
131157626|NCT00849693|472201822|FG003|Extension Phase|Lost to Follow-up|6|||
131157627|NCT00849693|472201819|FG000|Extension Phase|Protocol Violation|0|||
131157628|NCT00849693|472201820|FG001|Extension Phase|Protocol Violation|3|||
131157629|NCT00849693|472201821|FG002|Extension Phase|Protocol Violation|2|||
131157630|NCT00849693|472201822|FG003|Extension Phase|Protocol Violation|3|||
131157631|NCT00849693|472201819|FG000|Extension Phase|Withdrawal by Subject|6|||
131157632|NCT00849693|472201820|FG001|Extension Phase|Withdrawal by Subject|9|||
131157633|NCT00849693|472201821|FG002|Extension Phase|Withdrawal by Subject|10|||
131157634|NCT00849693|472201822|FG003|Extension Phase|Withdrawal by Subject|15|||
131157635|NCT00849693|472201819|FG000|Extension Phase|Parent or caregiver decision|9|||
131157636|NCT00849693|472201820|FG001|Extension Phase|Parent or caregiver decision|4|||
131157637|NCT00849693|472201821|FG002|Extension Phase|Parent or caregiver decision|10|||
131157638|NCT00849693|472201822|FG003|Extension Phase|Parent or caregiver decision|5|||
131157639|NCT00849693|472201819|FG000|Extension Phase|Physician Decision|1|||
131157640|NCT00849693|472201820|FG001|Extension Phase|Physician Decision|1|||
131157641|NCT00849693|472201821|FG002|Extension Phase|Physician Decision|2|||
131157642|NCT00849693|472201822|FG003|Extension Phase|Physician Decision|0|||
131157643|NCT00849693|472201819|FG000|Extension Phase|Sponsor decision|1|||
131157644|NCT00849693|472201820|FG001|Extension Phase|Sponsor decision|0|||
131157645|NCT00849693|472201821|FG002|Extension Phase|Sponsor decision|0|||
131157646|NCT00849693|472201822|FG003|Extension Phase|Sponsor decision|1|||
131157647|NCT00849693|472201819|FG000|Extension Phase|Lack of Efficacy|2|||
131157648|NCT00849693|472201820|FG001|Extension Phase|Lack of Efficacy|2|||
131157649|NCT00849693|472201821|FG002|Extension Phase|Lack of Efficacy|2|||
131157650|NCT00849693|472201822|FG003|Extension Phase|Lack of Efficacy|1|||
131157651|NCT00634543|472201823|FG000|Overall Study|Other|1|||
131157652|NCT00634543|472201824|FG001|Overall Study|Other|2|||
131157653|NCT00634543|472201823|FG000|Overall Study|Protocol Violation|3|||
131157654|NCT00634543|472201824|FG001|Overall Study|Protocol Violation|3|||
131157655|NCT00634543|472201823|FG000|Overall Study|Adverse Event|11|||
131157656|NCT00634543|472201824|FG001|Overall Study|Adverse Event|11|||
131157657|NCT00634543|472201823|FG000|Overall Study|Withdrawal by Subject|4|||
131157658|NCT00634543|472201824|FG001|Overall Study|Withdrawal by Subject|4|||
131157659|NCT00634543|472201823|FG000|Overall Study|Lost to Follow-up|0|||
131157660|NCT00634543|472201824|FG001|Overall Study|Lost to Follow-up|1|||
131157661|NCT02138110|472201827|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
131157662|NCT02138110|472201827|FG000|Overall Scaffold Implantation|Death|3|||
131157663|NCT00882713|472201830|FG000|Overall Study|Adverse Event|2|||
131157664|NCT00882713|472201830|FG000|Overall Study|Death|3|||
131157665|NCT00882713|472201830|FG000|Overall Study|Administrative reasons|4|||
131157666|NCT00882713|472201830|FG000|Overall Study|refused treatment/withdrew consent|4|||
131157667|NCT00882713|472201830|FG000|Overall Study|Blood transfusion|2|||
131157668|NCT00882713|472201830|FG000|Overall Study|Insufficient therapeutic response|3|||
131157669|NCT00882713|472201830|FG000|Overall Study|Failure to return|2|||
131157670|NCT00882713|472201830|FG000|Overall Study|Other - Reasons|2|||
131157671|NCT02760602|472201833|FG000|Overall Study|Withdrawal by Subject|1|||
131157672|NCT02760602|472201834|FG001|Overall Study|Withdrawal by Subject|0|||
131157673|NCT02760602|472201833|FG000|Overall Study|Terminated by sponsor|12|||
131157674|NCT02760602|472201834|FG001|Overall Study|Terminated by sponsor|13|||
131157675|NCT01736683|472201842|FG000|Overall Study|Disease Relapse|0|||
131157676|NCT01736683|472201843|FG001|Overall Study|Disease Relapse|0|||
131157677|NCT01736683|472201844|FG002|Overall Study|Disease Relapse|2|||
131157678|NCT01736683|472201845|FG003|Overall Study|Disease Relapse|1|||
131157679|NCT01736683|472201846|FG004|Overall Study|Disease Relapse|0|||
131157680|NCT01736683|472201842|FG000|Overall Study|Adverse Event|0|||
131157681|NCT01736683|472201843|FG001|Overall Study|Adverse Event|2|||
131157682|NCT01736683|472201844|FG002|Overall Study|Adverse Event|2|||
131157683|NCT01736683|472201845|FG003|Overall Study|Adverse Event|3|||
131157684|NCT01736683|472201846|FG004|Overall Study|Adverse Event|2|||
131157685|NCT01736683|472201842|FG000|Overall Study|Withdrawal by Subject|0|||
131157686|NCT01736683|472201843|FG001|Overall Study|Withdrawal by Subject|0|||
131157687|NCT01736683|472201844|FG002|Overall Study|Withdrawal by Subject|3|||
131157688|NCT01736683|472201845|FG003|Overall Study|Withdrawal by Subject|1|||
131157689|NCT01736683|472201846|FG004|Overall Study|Withdrawal by Subject|1|||
131157690|NCT01736683|472201842|FG000|Overall Study|Lack of Therapeutic Effect|7|||
130728617|NCT02185053|470627522|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
130728618|NCT02185053|470627523|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
130728619|NCT02185053|470627521|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
130728620|NCT02185053|470627522|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
130728621|NCT02185053|470627523|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
130728622|NCT02185053|470627521|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130728623|NCT02185053|470627522|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
130728624|NCT02185053|470627523|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130728625|NCT02185053|470627521|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
130728626|NCT02185053|470627522|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
130728627|NCT02185053|470627523|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
130780591|NCT00735709|470823122|FG000|Overall Study|Adverse Event|2|||
131157691|NCT01736683|472201843|FG001|Overall Study|Lack of Therapeutic Effect|4|||
131157692|NCT01736683|472201844|FG002|Overall Study|Lack of Therapeutic Effect|13|||
131157693|NCT01736683|472201845|FG003|Overall Study|Lack of Therapeutic Effect|20|||
131157694|NCT01736683|472201846|FG004|Overall Study|Lack of Therapeutic Effect|1|||
131157695|NCT01736683|472201842|FG000|Overall Study|Progressive Disease|0|||
131157696|NCT01736683|472201843|FG001|Overall Study|Progressive Disease|0|||
131157697|NCT01736683|472201844|FG002|Overall Study|Progressive Disease|0|||
131157698|NCT01736683|472201845|FG003|Overall Study|Progressive Disease|1|||
131157699|NCT01736683|472201846|FG004|Overall Study|Progressive Disease|0|||
131157700|NCT01736683|472201842|FG000|Overall Study|Other|0|||
131157701|NCT01736683|472201843|FG001|Overall Study|Other|0|||
131157702|NCT01736683|472201844|FG002|Overall Study|Other|1|||
131157703|NCT01736683|472201845|FG003|Overall Study|Other|9|||
131157704|NCT01736683|472201846|FG004|Overall Study|Other|1|||
131157705|NCT02046564|472201847|FG000|Overall Study|Adverse Event|6|||
131157706|NCT02046564|472201848|FG001|Overall Study|Adverse Event|3|||
131157707|NCT02046564|472201847|FG000|Overall Study|Physician Decision|0|||
131157708|NCT02046564|472201848|FG001|Overall Study|Physician Decision|1|||
131157709|NCT02046564|472201847|FG000|Overall Study|Protocol Violation|3|||
131157710|NCT02046564|472201848|FG001|Overall Study|Protocol Violation|1|||
131157711|NCT02046564|472201847|FG000|Overall Study|Withdrawal by Subject|4|||
131157712|NCT02046564|472201848|FG001|Overall Study|Withdrawal by Subject|10|||
131157713|NCT02046564|472201847|FG000|Overall Study|Subject met withdrawal criteria|2|||
131157714|NCT02046564|472201848|FG001|Overall Study|Subject met withdrawal criteria|5|||
131157715|NCT01260181|472201849|FG000|Overall Study|Decision of Investigator|1|||
131157716|NCT01844076|472201852|FG000|Overall Study|Adverse Event|1|||
131157717|NCT01844076|472201853|FG001|Overall Study|Adverse Event|0|||
131157718|NCT01844076|472201854|FG002|Overall Study|Adverse Event|0|||
131157719|NCT01844076|472201855|FG003|Overall Study|Adverse Event|0|||
131157720|NCT01844076|472201852|FG000|Overall Study|Withdrawal by Subject|1|||
131157721|NCT01844076|472201853|FG001|Overall Study|Withdrawal by Subject|0|||
131157722|NCT01844076|472201854|FG002|Overall Study|Withdrawal by Subject|0|||
131157723|NCT01844076|472201855|FG003|Overall Study|Withdrawal by Subject|0|||
131157724|NCT00635102|472201858|FG000|Overall Study|Withdrawal by Subject|7|||
131157725|NCT00635102|472201859|FG001|Overall Study|Withdrawal by Subject|8|||
131157726|NCT01938625|472201861|FG000|Overall Study|Withdrawal by Subject|0|||
131157727|NCT01938625|472201862|FG001|Overall Study|Withdrawal by Subject|1|||
131157728|NCT01938625|472201861|FG000|Overall Study|Adverse Event|0|||
131157729|NCT01938625|472201862|FG001|Overall Study|Adverse Event|1|||
131157730|NCT02088034|472201863|FG000|Overall Study|Lost to Follow-up|1|||
131157731|NCT02088034|472201864|FG001|Overall Study|Lost to Follow-up|1|||
131157732|NCT02088034|472201865|FG002|Overall Study|Lost to Follow-up|0|||
131157733|NCT02088034|472201863|FG000|Overall Study|Pregnancy|2|||
131157734|NCT02088034|472201864|FG001|Overall Study|Pregnancy|1|||
131157735|NCT02088034|472201865|FG002|Overall Study|Pregnancy|2|||
131157736|NCT00308620|472201866|FG000|Overall Study|Death|1|||
131157737|NCT00308620|472201867|FG001|Overall Study|Death|1|||
131157738|NCT00308620|472201868|FG002|Overall Study|Death|0|||
131157739|NCT00308620|472201866|FG000|Overall Study|Lost to Follow-up|0|||
131157740|NCT00308620|472201867|FG001|Overall Study|Lost to Follow-up|0|||
131157741|NCT00308620|472201868|FG002|Overall Study|Lost to Follow-up|1|||
131157742|NCT00593112|472201871|FG000|Overall Study|Scan Anxiety|3|||
131157743|NCT00593112|472201872|FG001|Overall Study|Scan Anxiety|0|||
131157744|NCT00593112|472201871|FG000|Overall Study|Abnormal Scan|1|||
131157745|NCT00593112|472201872|FG001|Overall Study|Abnormal Scan|0|||
131157746|NCT00593112|472201871|FG000|Overall Study|Unreadable Scan|1|||
131157747|NCT00593112|472201872|FG001|Overall Study|Unreadable Scan|0|||
131157748|NCT00593112|472201871|FG000|Overall Study|Withdrawal by Subject|5|||
131157749|NCT00593112|472201872|FG001|Overall Study|Withdrawal by Subject|0|||
131157750|NCT00467649|472201873|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
131157751|NCT00467649|472201874|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
131157752|NCT00467649|472201875|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
131157753|NCT00467649|472201876|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
131157754|NCT00467649|472201877|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
131157755|NCT00467649|472201878|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
131157756|NCT00467649|472201873|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
131157757|NCT00467649|472201874|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
131157758|NCT00467649|472201875|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
131157759|NCT00467649|472201876|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
131157760|NCT00467649|472201877|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
131157761|NCT00467649|472201878|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
131157762|NCT00467649|472201873|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
131157763|NCT00467649|472201874|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
131157764|NCT00467649|472201875|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
131157765|NCT00467649|472201876|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
131157766|NCT00467649|472201877|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
131157767|NCT00467649|472201878|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
131235290|NCT03384745|472488890|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
131235291|NCT03384745|472488891|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
131235292|NCT03384745|472488886|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
131235293|NCT03384745|472488887|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
131235294|NCT03384745|472488888|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
131235295|NCT03384745|472488889|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
131157768|NCT00467649|472201873|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
131157769|NCT00467649|472201874|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
131157770|NCT00467649|472201875|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
131157771|NCT00467649|472201876|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
131157772|NCT00467649|472201877|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
131157773|NCT00467649|472201878|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
131157774|NCT00467649|472201873|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
131157775|NCT00467649|472201874|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
131157776|NCT00467649|472201875|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
131157777|NCT00467649|472201876|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
131157778|NCT00467649|472201877|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
131157779|NCT00467649|472201878|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
131157780|NCT00467649|472201873|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
131157781|NCT00467649|472201874|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
131157782|NCT00467649|472201875|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
131157783|NCT00467649|472201876|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
131157784|NCT00467649|472201877|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
131157785|NCT00467649|472201878|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
131157786|NCT00467649|472201873|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
131157787|NCT00467649|472201874|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
131157788|NCT00467649|472201875|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
131157789|NCT00467649|472201876|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
131157790|NCT00467649|472201877|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
131157791|NCT00467649|472201878|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
131157792|NCT02436239|472201883|FG000|Open-Lable Treatment Period|Adverse Event|12|||
131157793|NCT02436239|472201884|FG001|Open-Lable Treatment Period|Adverse Event|3|||
131157794|NCT02436239|472201885|FG002|Open-Lable Treatment Period|Adverse Event|4|||
131157795|NCT02436239|472201886|FG003|Open-Lable Treatment Period|Adverse Event|2|||
131157796|NCT02436239|472201883|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
131157797|NCT02436239|472201884|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
131157798|NCT02436239|472201885|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
131157799|NCT02436239|472201886|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
131157800|NCT02436239|472201883|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
131157801|NCT02436239|472201884|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
131157802|NCT02436239|472201885|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
131157803|NCT02436239|472201886|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
131157804|NCT02436239|472201883|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
131157805|NCT02436239|472201884|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
131157806|NCT02436239|472201885|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
131157807|NCT02436239|472201886|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
131157808|NCT02436239|472201883|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
131157809|NCT02436239|472201884|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
131157810|NCT02436239|472201885|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
131157811|NCT02436239|472201886|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
131157812|NCT02436239|472201883|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
131157813|NCT02436239|472201884|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
131157814|NCT02436239|472201885|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
131157815|NCT02436239|472201886|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
131157816|NCT02436239|472201883|FG000|Open-Lable Treatment Period|Other Reason|1|||
131157817|NCT02436239|472201884|FG001|Open-Lable Treatment Period|Other Reason|1|||
131157818|NCT02436239|472201885|FG002|Open-Lable Treatment Period|Other Reason|0|||
131157819|NCT02436239|472201886|FG003|Open-Lable Treatment Period|Other Reason|0|||
131157820|NCT02436239|472201883|FG000|Down-Taper Period|Withdrawal by Subject|4|||
131157821|NCT02436239|472201884|FG001|Down-Taper Period|Withdrawal by Subject|4|||
131157822|NCT02436239|472201885|FG002|Down-Taper Period|Withdrawal by Subject|1|||
131157823|NCT02436239|472201886|FG003|Down-Taper Period|Withdrawal by Subject|2|||
131157824|NCT02782715|472201896|FG000|Overall Study|Withdrawal by Subject|1|||
131157825|NCT03368404|472201901|FG000|Overall Study|Adverse Event|2|||
131157826|NCT03368404|472201902|FG001|Overall Study|Adverse Event|1|||
131157827|NCT03368404|472201901|FG000|Overall Study|Withdrawal by Subject|1|||
131157828|NCT03368404|472201902|FG001|Overall Study|Withdrawal by Subject|1|||
131157829|NCT02983292|472201903|FG000|Overall Study|Participant unwell & cannot travel|2|||
131157830|NCT02983292|472201903|FG000|Overall Study|Lost to Follow-up|3|||
131157831|NCT02983292|472201903|FG000|Overall Study|Participant withdrew consent|2|||
131157832|NCT02983292|472201903|FG000|Overall Study|Revision|7|||
131157833|NCT02983292|472201903|FG000|Overall Study|Death|1|||
131157834|NCT02983292|472201903|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
131157835|NCT02983292|472201903|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
131157836|NCT02983292|472201903|FG000|Overall Study|Participant relocation|1|||
131157837|NCT04725682|472201904|FG000|Overall Study|Withdrawal by Subject|7|||
131157838|NCT04725682|472201905|FG001|Overall Study|Withdrawal by Subject|5|||
131157839|NCT04725682|472201904|FG000|Overall Study|Failed to comply with the requirements|2|||
131157840|NCT04725682|472201905|FG001|Overall Study|Failed to comply with the requirements|1|||
131157841|NCT04725682|472201904|FG000|Overall Study|Adverse Event|1|||
131157842|NCT04725682|472201905|FG001|Overall Study|Adverse Event|1|||
131157843|NCT04725682|472201904|FG000|Overall Study|Death|0|||
131157844|NCT04725682|472201905|FG001|Overall Study|Death|1|||
131157845|NCT01607892|472201908|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
131157846|NCT01607892|472201909|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
131157847|NCT01607892|472201910|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
131157848|NCT01607892|472201911|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
131157849|NCT01607892|472201912|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
131157850|NCT01607892|472201908|FG000|Overall Study|Death|4|||
131157851|NCT01607892|472201909|FG001|Overall Study|Death|2|||
131157852|NCT01607892|472201910|FG002|Overall Study|Death|8|||
131157853|NCT01607892|472201911|FG003|Overall Study|Death|10|||
131157854|NCT01607892|472201912|FG004|Overall Study|Death|3|||
131157855|NCT01607892|472201908|FG000|Overall Study|Investigator discretion|2|||
130728628|NCT02185053|470627521|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
130728629|NCT02185053|470627522|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
130728630|NCT02185053|470627523|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
130728631|NCT02185053|470627521|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
130728632|NCT02185053|470627522|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
130728633|NCT02185053|470627523|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
130728634|NCT02521376|470627524|FG000|Overall Study|Enrolled, But Not Treated|1|||
130728635|NCT02521376|470627525|FG001|Overall Study|Enrolled, But Not Treated|0|||
130728636|NCT02521376|470627526|FG002|Overall Study|Enrolled, But Not Treated|0|||
130728637|NCT02521376|470627527|FG003|Overall Study|Enrolled, But Not Treated|0|||
130728638|NCT00340678|470627537|FG000|Overall Study|Lost to Follow-up|1|||
130728639|NCT00340678|470627538|FG001|Overall Study|Lost to Follow-up|0|||
130728640|NCT00340678|470627539|FG002|Overall Study|Lost to Follow-up|0|||
130728641|NCT00340678|470627540|FG003|Overall Study|Lost to Follow-up|0|||
130728642|NCT03316547|470627543|FG000|Overall Study|Death|3|||
130728643|NCT03316547|470627544|FG001|Overall Study|Death|1|||
130728644|NCT03316547|470627543|FG000|Overall Study|Lost to Follow-up|6|||
130728645|NCT03316547|470627544|FG001|Overall Study|Lost to Follow-up|6|||
130728646|NCT03316547|470627543|FG000|Overall Study|Withdrawal by Subject|3|||
130728647|NCT03316547|470627544|FG001|Overall Study|Withdrawal by Subject|2|||
130728648|NCT03316547|470627543|FG000|Overall Study|Transfer to another hospital|6|||
130728649|NCT03316547|470627544|FG001|Overall Study|Transfer to another hospital|4|||
130728650|NCT00708227|470627545|FG000|Overall Study|Physician Decision|0|||
131157856|NCT01607892|472201909|FG001|Overall Study|Investigator discretion|4|||
131157857|NCT01607892|472201910|FG002|Overall Study|Investigator discretion|4|||
131157858|NCT01607892|472201911|FG003|Overall Study|Investigator discretion|8|||
131157859|NCT01607892|472201912|FG004|Overall Study|Investigator discretion|0|||
131157860|NCT01607892|472201908|FG000|Overall Study|Other treatments became available|1|||
131157861|NCT01607892|472201909|FG001|Overall Study|Other treatments became available|1|||
131157862|NCT01607892|472201910|FG002|Overall Study|Other treatments became available|0|||
131157863|NCT01607892|472201911|FG003|Overall Study|Other treatments became available|0|||
131157864|NCT01607892|472201912|FG004|Overall Study|Other treatments became available|2|||
131157865|NCT01607892|472201908|FG000|Overall Study|Intercurrent illness|1|||
131157866|NCT01607892|472201909|FG001|Overall Study|Intercurrent illness|0|||
131157867|NCT01607892|472201910|FG002|Overall Study|Intercurrent illness|0|||
131157868|NCT01607892|472201911|FG003|Overall Study|Intercurrent illness|3|||
131157869|NCT01607892|472201912|FG004|Overall Study|Intercurrent illness|0|||
131157870|NCT01607892|472201908|FG000|Overall Study|Non-Compliance with study procedures|0|||
131157871|NCT01607892|472201909|FG001|Overall Study|Non-Compliance with study procedures|0|||
131157872|NCT01607892|472201910|FG002|Overall Study|Non-Compliance with study procedures|1|||
131157873|NCT01607892|472201911|FG003|Overall Study|Non-Compliance with study procedures|0|||
131157874|NCT01607892|472201912|FG004|Overall Study|Non-Compliance with study procedures|0|||
131157875|NCT01607892|472201908|FG000|Overall Study|Consent withdrawn by participant|9|||
130728651|NCT00708227|470627546|FG001|Overall Study|Physician Decision|3|||
130728652|NCT00708227|470627547|FG002|Overall Study|Physician Decision|1|||
130728653|NCT00708227|470627548|FG003|Overall Study|Physician Decision|2|||
131157876|NCT01607892|472201909|FG001|Overall Study|Consent withdrawn by participant|4|||
131157877|NCT01607892|472201910|FG002|Overall Study|Consent withdrawn by participant|24|||
130728654|NCT00708227|470627545|FG000|Overall Study|Withdrawal by Subject|1|||
130728655|NCT00708227|470627546|FG001|Overall Study|Withdrawal by Subject|2|||
130728656|NCT00708227|470627547|FG002|Overall Study|Withdrawal by Subject|0|||
130728657|NCT00708227|470627548|FG003|Overall Study|Withdrawal by Subject|1|||
131157878|NCT01607892|472201911|FG003|Overall Study|Consent withdrawn by participant|14|||
131157879|NCT01607892|472201912|FG004|Overall Study|Consent withdrawn by participant|4|||
131157880|NCT01607892|472201908|FG000|Overall Study|Disease progression|38|||
131157881|NCT01607892|472201909|FG001|Overall Study|Disease progression|13|||
131157882|NCT01607892|472201910|FG002|Overall Study|Disease progression|37|||
131157883|NCT01607892|472201911|FG003|Overall Study|Disease progression|57|||
131157884|NCT01607892|472201912|FG004|Overall Study|Disease progression|9|||
131157885|NCT01607892|472201908|FG000|Overall Study|Incidence or severity of Adverse events|3|||
131157886|NCT01607892|472201909|FG001|Overall Study|Incidence or severity of Adverse events|3|||
131157887|NCT01607892|472201910|FG002|Overall Study|Incidence or severity of Adverse events|7|||
131157888|NCT01607892|472201911|FG003|Overall Study|Incidence or severity of Adverse events|2|||
131157889|NCT01607892|472201912|FG004|Overall Study|Incidence or severity of Adverse events|6|||
131157890|NCT03022422|472201913|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
131157891|NCT03022422|472201914|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
131157892|NCT03022422|472201915|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
131157893|NCT03022422|472201916|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
131157894|NCT03022422|472201917|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
131157895|NCT03022422|472201918|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
131157896|NCT01444391|472201919|FG000|Overall Study|Death|1|||
131157897|NCT02031146|472203616|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
131157898|NCT02031146|472203617|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
131157899|NCT02031146|472203618|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
131157900|NCT02031146|472203619|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
131157901|NCT02031146|472203620|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
131157902|NCT02031146|472203621|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
131157903|NCT02031146|472203622|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
131157904|NCT01582282|472203625|FG000|Overall Study|Adverse Event|1|||
131157905|NCT01582282|472203626|FG001|Overall Study|Adverse Event|1|||
131157906|NCT01582282|472203627|FG002|Overall Study|Adverse Event|0|||
131157907|NCT01582282|472203625|FG000|Overall Study|Lost to Follow-up|1|||
131157908|NCT01582282|472203626|FG001|Overall Study|Lost to Follow-up|0|||
131157909|NCT01582282|472203627|FG002|Overall Study|Lost to Follow-up|0|||
131157910|NCT01582282|472203625|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
131157911|NCT01582282|472203626|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
131157912|NCT01582282|472203627|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
131157913|NCT02495077|472203628|FG000|Overall Study|Adverse Event|0|||
131157914|NCT02495077|472203629|FG001|Overall Study|Adverse Event|1|||
131157915|NCT02495077|472203630|FG002|Overall Study|Adverse Event|1|||
131157916|NCT02495077|472203631|FG003|Overall Study|Adverse Event|0|||
131157917|NCT02495077|472203628|FG000|Overall Study|Death|3|||
131157918|NCT02495077|472203629|FG001|Overall Study|Death|5|||
131157919|NCT02495077|472203630|FG002|Overall Study|Death|0|||
131157920|NCT02495077|472203631|FG003|Overall Study|Death|0|||
131157921|NCT02495077|472203628|FG000|Overall Study|Lost to Follow-up|6|||
131157922|NCT02495077|472203629|FG001|Overall Study|Lost to Follow-up|4|||
131157923|NCT02495077|472203630|FG002|Overall Study|Lost to Follow-up|0|||
131157924|NCT02495077|472203631|FG003|Overall Study|Lost to Follow-up|0|||
131157925|NCT02495077|472203628|FG000|Overall Study|Physician Decision|2|||
131157926|NCT02495077|472203629|FG001|Overall Study|Physician Decision|1|||
131157927|NCT02495077|472203630|FG002|Overall Study|Physician Decision|4|||
131157928|NCT02495077|472203631|FG003|Overall Study|Physician Decision|0|||
131157929|NCT02495077|472203628|FG000|Overall Study|Protocol Violation|0|||
131157930|NCT02495077|472203629|FG001|Overall Study|Protocol Violation|1|||
131157931|NCT02495077|472203630|FG002|Overall Study|Protocol Violation|0|||
131157932|NCT02495077|472203631|FG003|Overall Study|Protocol Violation|0|||
131157933|NCT02495077|472203628|FG000|Overall Study|Screen Failure|0|||
131157934|NCT02495077|472203629|FG001|Overall Study|Screen Failure|0|||
131157935|NCT02495077|472203630|FG002|Overall Study|Screen Failure|0|||
131157936|NCT02495077|472203631|FG003|Overall Study|Screen Failure|48|||
131157937|NCT02495077|472203628|FG000|Overall Study|Withdrawal by Subject|7|||
131157938|NCT02495077|472203629|FG001|Overall Study|Withdrawal by Subject|7|||
131157939|NCT02495077|472203630|FG002|Overall Study|Withdrawal by Subject|7|||
131157940|NCT02495077|472203631|FG003|Overall Study|Withdrawal by Subject|0|||
131157941|NCT02495077|472203628|FG000|Overall Study|Covid-19 research restrictions|1|||
131157942|NCT02495077|472203629|FG001|Overall Study|Covid-19 research restrictions|0|||
131157943|NCT02495077|472203630|FG002|Overall Study|Covid-19 research restrictions|0|||
131157944|NCT02495077|472203631|FG003|Overall Study|Covid-19 research restrictions|0|||
131157945|NCT02495077|472203628|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
131157946|NCT02495077|472203629|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
131157947|NCT02495077|472203630|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
131157948|NCT02495077|472203631|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
131157949|NCT02495077|472203628|FG000|Overall Study|Incarcerated|0|||
131157950|NCT02495077|472203629|FG001|Overall Study|Incarcerated|1|||
131157951|NCT02495077|472203630|FG002|Overall Study|Incarcerated|0|||
131157952|NCT02495077|472203631|FG003|Overall Study|Incarcerated|0|||
131157953|NCT02495077|472203628|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
131157954|NCT02495077|472203629|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
131157955|NCT02495077|472203630|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
131157956|NCT02495077|472203631|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
131235296|NCT03384745|472488890|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
130728658|NCT04007991|470627549|FG000|Overall Study|Withdrawal by Subject|1|||
130728659|NCT04007991|470627550|FG001|Overall Study|Withdrawal by Subject|1|||
130728660|NCT04007991|470627549|FG000|Overall Study|Physician Decision|1|||
130728661|NCT04007991|470627550|FG001|Overall Study|Physician Decision|1|||
130728662|NCT04007991|470627549|FG000|Overall Study|Non-compliance with Study Drug|0|||
130728663|NCT04007991|470627550|FG001|Overall Study|Non-compliance with Study Drug|1|||
130728664|NCT04007991|470627549|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
130728665|NCT04007991|470627550|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
130728666|NCT04007991|470627549|FG000|Overall Study|Adverse event, non-fatal|5|||
130728667|NCT04007991|470627550|FG001|Overall Study|Adverse event, non-fatal|0|||
130728668|NCT04007991|470627549|FG000|Overall Study|Lost to Follow-up|2|||
130728669|NCT04007991|470627550|FG001|Overall Study|Lost to Follow-up|1|||
130728670|NCT01810302|470628595|FG000|Overall Study|Death|1|||
130728671|NCT01810302|470628596|FG001|Overall Study|Death|0|||
130728672|NCT01810302|470628595|FG000|Overall Study|Physician Decision|0|||
130728673|NCT01810302|470628596|FG001|Overall Study|Physician Decision|1|||
130728674|NCT02111603|470628613|FG000|Overall Study|Withdrawal by Subject|1|||
130728675|NCT03106987|470628614|FG000|Overall Study|Death|37|||
130728676|NCT03106987|470628615|FG001|Overall Study|Death|22|||
130728677|NCT03106987|470628616|FG002|Overall Study|Death|12|||
130728678|NCT03106987|470628617|FG003|Overall Study|Death|8|||
130728679|NCT03106987|470628614|FG000|Overall Study|Lost to Follow-up|2|||
130728680|NCT03106987|470628615|FG001|Overall Study|Lost to Follow-up|0|||
130728681|NCT03106987|470628616|FG002|Overall Study|Lost to Follow-up|2|||
131157957|NCT02495077|472203628|FG000|Overall Study|Timing of transplant and randomization|0|||
131157958|NCT02495077|472203629|FG001|Overall Study|Timing of transplant and randomization|0|||
131157959|NCT02495077|472203630|FG002|Overall Study|Timing of transplant and randomization|5|||
131157960|NCT02495077|472203631|FG003|Overall Study|Timing of transplant and randomization|0|||
131157961|NCT02742649|472203638|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
131157962|NCT02742649|472203639|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
131157963|NCT02742649|472203640|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
131157964|NCT02742649|472203641|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
131157965|NCT02742649|472203642|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
131157966|NCT02742649|472203638|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131157967|NCT02742649|472203639|FG001|Double-Blind Treatment Period|Adverse Event|1|||
131157968|NCT02742649|472203640|FG002|Double-Blind Treatment Period|Adverse Event|0|||
131157969|NCT02742649|472203641|FG003|Double-Blind Treatment Period|Adverse Event|0|||
131157970|NCT02742649|472203642|FG004|Double-Blind Treatment Period|Adverse Event|0|||
131157971|NCT02742649|472203638|FG000|Open-Label Period|Lost to Follow-up|0|||
131157972|NCT02742649|472203639|FG001|Open-Label Period|Lost to Follow-up|0|||
131157973|NCT02742649|472203640|FG002|Open-Label Period|Lost to Follow-up|0|||
131157974|NCT02742649|472203641|FG003|Open-Label Period|Lost to Follow-up|0|||
131157975|NCT02742649|472203642|FG004|Open-Label Period|Lost to Follow-up|1|||
131157976|NCT03937986|472203645|FG000|Overall Study|COVID-19 Pandemic|1|||
131157977|NCT00744055|472203651|FG000|Overall Study|Withdrawal by Subject|6|||
131157978|NCT00744055|472203652|FG001|Overall Study|Withdrawal by Subject|9|||
131157979|NCT00744055|472203651|FG000|Overall Study|Lack of Efficacy|0|||
131157980|NCT00744055|472203652|FG001|Overall Study|Lack of Efficacy|1|||
131157981|NCT00744055|472203651|FG000|Overall Study|Physician Decision|0|||
131235297|NCT03384745|472488891|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
131235298|NCT03384745|472488886|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
131235299|NCT03384745|472488887|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
131235300|NCT03384745|472488888|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
131235301|NCT03384745|472488889|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
131235302|NCT03384745|472488890|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
131235303|NCT03384745|472488891|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
131235304|NCT03384745|472488886|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
131235305|NCT03384745|472488887|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
131235306|NCT03384745|472488888|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
131235307|NCT03384745|472488889|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
131235308|NCT03384745|472488890|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
131235309|NCT03384745|472488891|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
131235310|NCT03384745|472488886|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
131235311|NCT03384745|472488887|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
131235312|NCT03384745|472488888|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130728682|NCT03106987|470628617|FG003|Overall Study|Lost to Follow-up|2|||
131235313|NCT03384745|472488889|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
131235314|NCT03384745|472488890|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
131235315|NCT03384745|472488891|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130728683|NCT03106987|470628614|FG000|Overall Study|Withdrawal by Subject|5|||
130728684|NCT03106987|470628615|FG001|Overall Study|Withdrawal by Subject|1|||
130728685|NCT03106987|470628616|FG002|Overall Study|Withdrawal by Subject|4|||
131157982|NCT00744055|472203652|FG001|Overall Study|Physician Decision|2|||
131157983|NCT00744055|472203651|FG000|Overall Study|Protocol Violation|1|||
131157984|NCT00744055|472203652|FG001|Overall Study|Protocol Violation|1|||
131157985|NCT00744055|472203651|FG000|Overall Study|Lost to Follow-up|0|||
131157986|NCT00744055|472203652|FG001|Overall Study|Lost to Follow-up|1|||
131157987|NCT02767570|472203655|FG000|Overall Study|Lost to Follow-up|3|||
131157988|NCT02767570|472203656|FG001|Overall Study|Lost to Follow-up|0|||
131157989|NCT02767570|472203655|FG000|Overall Study|COVID shutdown|2|||
131157990|NCT02767570|472203656|FG001|Overall Study|COVID shutdown|5|||
131157991|NCT02767570|472203655|FG000|Overall Study|Increased pain|2|||
131157992|NCT02767570|472203656|FG001|Overall Study|Increased pain|0|||
131157993|NCT02767570|472203655|FG000|Overall Study|Withdrawal by Subject|1|||
131157994|NCT02767570|472203656|FG001|Overall Study|Withdrawal by Subject|3|||
131157995|NCT02767570|472203655|FG000|Overall Study|Unrelated medical issue|1|||
131157996|NCT02767570|472203656|FG001|Overall Study|Unrelated medical issue|1|||
131157997|NCT02767570|472203655|FG000|Overall Study|Received intra-articular injection|0|||
131157998|NCT02767570|472203656|FG001|Overall Study|Received intra-articular injection|1|||
131157999|NCT00151411|472203657|FG000|Overall Study|Lost to Follow-up|15|||
131158000|NCT00151411|472203658|FG001|Overall Study|Lost to Follow-up|19|||
131158001|NCT00151411|472203657|FG000|Overall Study|Withdrawal by Subject|12|||
131158002|NCT00151411|472203658|FG001|Overall Study|Withdrawal by Subject|20|||
131158003|NCT00151411|472203657|FG000|Overall Study|Adverse Event|6|||
131158004|NCT00151411|472203658|FG001|Overall Study|Adverse Event|0|||
131158005|NCT00151411|472203657|FG000|Overall Study|Pregnancy|0|||
131158006|NCT00151411|472203658|FG001|Overall Study|Pregnancy|4|||
131158007|NCT00417612|472203659|FG000|Overall Study|Errant diagnosis|0|||
131158008|NCT00417612|472203660|FG001|Overall Study|Errant diagnosis|1|||
131158009|NCT00417612|472203659|FG000|Overall Study|Adverse Event|2|||
131158010|NCT00417612|472203660|FG001|Overall Study|Adverse Event|0|||
131158011|NCT00417612|472203659|FG000|Overall Study|Protocol Violation|0|||
131158012|NCT00417612|472203660|FG001|Overall Study|Protocol Violation|2|||
131158013|NCT00417612|472203659|FG000|Overall Study|Lost to Follow-up|1|||
131158014|NCT00417612|472203660|FG001|Overall Study|Lost to Follow-up|0|||
131158015|NCT01712438|472203663|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
131158016|NCT01712438|472203663|FG000|Overall Study|Ongoing ITI treatment|6|||
131158017|NCT01712438|472203663|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
131158018|NCT01712438|472203663|FG000|Overall Study|Prematurely Discontinued|25|||
131158019|NCT01157169|472203664|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
131158020|NCT01157169|472203665|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
131158021|NCT01157169|472203664|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
131158022|NCT01157169|472203665|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
131158023|NCT01123889|472203666|FG000|Overall Study|Lost to Follow-up|3|||
131158024|NCT01123889|472203667|FG001|Overall Study|Lost to Follow-up|1|||
131158025|NCT01330381|472203670|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
131158026|NCT01330381|472203671|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
131158027|NCT01330381|472203672|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
131158028|NCT01330381|472203670|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
131158029|NCT01330381|472203671|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
131158030|NCT01330381|472203672|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
131158031|NCT01330381|472203670|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
131158032|NCT01330381|472203671|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
131158033|NCT01330381|472203672|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
131158034|NCT01330381|472203670|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
131158035|NCT01330381|472203671|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
131158036|NCT01330381|472203672|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
130728686|NCT03106987|470628617|FG003|Overall Study|Withdrawal by Subject|1|||
131158037|NCT01330381|472203670|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
131158038|NCT01330381|472203671|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
131158039|NCT01330381|472203672|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
130728687|NCT02114385|470628619|FG000|Overall Study|Withdrawal by Subject|3|||
131158040|NCT01330381|472203670|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
131158041|NCT01330381|472203671|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
131158042|NCT01330381|472203672|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
131158043|NCT01330381|472203670|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
131158044|NCT01330381|472203671|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
131158045|NCT01330381|472203672|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
131158046|NCT01330381|472203670|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
131158047|NCT01330381|472203671|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
131158048|NCT01330381|472203672|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
131158049|NCT01330381|472203670|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
131158050|NCT01330381|472203671|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
131158051|NCT01330381|472203672|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
131158052|NCT01330381|472203670|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
131158053|NCT01330381|472203671|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
131158054|NCT01330381|472203672|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
131158055|NCT03846947|472203673|FG000|Overall Study|technical issues with imaging sequence|2|||
131158056|NCT00224107|472203674|FG000|Overall Study|Adverse Event|20|||
131158057|NCT00224107|472203675|FG001|Overall Study|Adverse Event|6|||
131158058|NCT00224107|472203674|FG000|Overall Study|Protocol Violation|2|||
131158059|NCT00224107|472203675|FG001|Overall Study|Protocol Violation|3|||
131158060|NCT00224107|472203674|FG000|Overall Study|Withdrawal by Subject|1|||
131158061|NCT00224107|472203675|FG001|Overall Study|Withdrawal by Subject|4|||
131158062|NCT00224107|472203674|FG000|Overall Study|Lack of Efficacy|2|||
131158063|NCT00224107|472203675|FG001|Overall Study|Lack of Efficacy|0|||
131158064|NCT00224107|472203674|FG000|Overall Study|Lost to Follow-up|4|||
131158065|NCT00224107|472203675|FG001|Overall Study|Lost to Follow-up|0|||
131158066|NCT00224107|472203674|FG000|Overall Study|Physician Decision|1|||
131158067|NCT00224107|472203675|FG001|Overall Study|Physician Decision|0|||
131158068|NCT00224107|472203674|FG000|Overall Study|Other|1|||
131158069|NCT00224107|472203675|FG001|Overall Study|Other|1|||
131158070|NCT00685178|472203676|FG000|Overall Study|Adverse Event|1|||
131158071|NCT00685178|472203677|FG001|Overall Study|Adverse Event|5|||
131158072|NCT00685178|472203678|FG002|Overall Study|Adverse Event|2|||
131158073|NCT00685178|472203679|FG003|Overall Study|Adverse Event|4|||
131158074|NCT00685178|472203676|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
131158075|NCT00685178|472203677|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
131158076|NCT00685178|472203678|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
131158077|NCT00685178|472203679|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
131158078|NCT00685178|472203676|FG000|Overall Study|voluntary study discharge|4|||
131158079|NCT00685178|472203677|FG001|Overall Study|voluntary study discharge|5|||
131158080|NCT00685178|472203678|FG002|Overall Study|voluntary study discharge|1|||
131158081|NCT00685178|472203679|FG003|Overall Study|voluntary study discharge|1|||
131158082|NCT00685178|472203676|FG000|Overall Study|incarcerated|1|||
131158083|NCT00685178|472203677|FG001|Overall Study|incarcerated|3|||
131158084|NCT00685178|472203678|FG002|Overall Study|incarcerated|7|||
131158085|NCT00685178|472203679|FG003|Overall Study|incarcerated|0|||
131158086|NCT00685178|472203676|FG000|Overall Study|administrative (disciplinary) discharge|0|||
131158087|NCT00685178|472203677|FG001|Overall Study|administrative (disciplinary) discharge|1|||
131158088|NCT00685178|472203678|FG002|Overall Study|administrative (disciplinary) discharge|0|||
131158089|NCT00685178|472203679|FG003|Overall Study|administrative (disciplinary) discharge|2|||
131158090|NCT00685178|472203676|FG000|Overall Study|Pregnancy|0|||
131158091|NCT00685178|472203677|FG001|Overall Study|Pregnancy|0|||
131158092|NCT00685178|472203678|FG002|Overall Study|Pregnancy|0|||
131158093|NCT00685178|472203679|FG003|Overall Study|Pregnancy|1|||
131158094|NCT01408537|472203682|FG000|Overall Study|Withdrawal by Subject|2|||
131158095|NCT01408537|472203682|FG000|Overall Study|Protocol Violation|3|||
131158096|NCT01408537|472203682|FG000|Overall Study|Lost to Follow-up|3|||
131158097|NCT00984659|472203686|FG000|2-week Run-in Period|Adverse Event|8|||
131158098|NCT00984659|472203687|FG001|2-week Run-in Period|Adverse Event|0|||
131158099|NCT00984659|472203688|FG002|2-week Run-in Period|Adverse Event|0|||
131158100|NCT00984659|472203689|FG003|2-week Run-in Period|Adverse Event|0|||
131158101|NCT00984659|472203686|FG000|2-week Run-in Period|Protocol Violation|5|||
131158102|NCT00984659|472203687|FG001|2-week Run-in Period|Protocol Violation|0|||
131158103|NCT00984659|472203688|FG002|2-week Run-in Period|Protocol Violation|0|||
131158104|NCT00984659|472203689|FG003|2-week Run-in Period|Protocol Violation|0|||
131158105|NCT00984659|472203686|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
131158106|NCT00984659|472203687|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
131158107|NCT00984659|472203688|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
131158108|NCT00984659|472203689|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
131158109|NCT00984659|472203686|FG000|2-week Run-in Period|Lost to Follow-up|3|||
131158110|NCT00984659|472203687|FG001|2-week Run-in Period|Lost to Follow-up|0|||
131158111|NCT00984659|472203688|FG002|2-week Run-in Period|Lost to Follow-up|0|||
131158112|NCT00984659|472203689|FG003|2-week Run-in Period|Lost to Follow-up|0|||
131158113|NCT00984659|472203686|FG000|2-week Run-in Period|Physician Decision|10|||
131158114|NCT00984659|472203687|FG001|2-week Run-in Period|Physician Decision|0|||
131158115|NCT00984659|472203688|FG002|2-week Run-in Period|Physician Decision|0|||
131158116|NCT00984659|472203689|FG003|2-week Run-in Period|Physician Decision|0|||
131158117|NCT00984659|472203686|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
131235316|NCT03384745|472488886|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
131235317|NCT03384745|472488887|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
130728688|NCT02114385|470628620|FG001|Overall Study|Withdrawal by Subject|2|||
131158118|NCT00984659|472203687|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
131158119|NCT00984659|472203688|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
131158120|NCT00984659|472203689|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
131158121|NCT00984659|472203686|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
131158122|NCT00984659|472203687|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
131158123|NCT00984659|472203688|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
131158124|NCT00984659|472203689|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
131158125|NCT00984659|472203686|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
131158126|NCT00984659|472203687|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
131158127|NCT00984659|472203688|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
131158128|NCT00984659|472203689|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
131158129|NCT00984659|472203686|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
131158130|NCT00984659|472203687|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
131158131|NCT00984659|472203688|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
131158132|NCT00984659|472203689|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
131158133|NCT00984659|472203686|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
131158134|NCT00984659|472203687|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
131158135|NCT00984659|472203688|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
131158136|NCT00984659|472203689|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
131158137|NCT00984659|472203686|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
131158138|NCT00984659|472203687|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
131158139|NCT00984659|472203688|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
131158140|NCT00984659|472203689|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
131158141|NCT00984659|472203686|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
131158142|NCT00984659|472203687|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
131158143|NCT00984659|472203688|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
131158144|NCT00984659|472203689|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
131158145|NCT03894540|472203693|FG000|Overall Study|Adverse Event|0|||
131158146|NCT03894540|472203694|FG001|Overall Study|Adverse Event|0|||
131158147|NCT03894540|472203695|FG002|Overall Study|Adverse Event|0|||
131158148|NCT03894540|472203696|FG003|Overall Study|Adverse Event|0|||
131158149|NCT03894540|472203697|FG004|Overall Study|Adverse Event|1|||
131158150|NCT03894540|472203698|FG005|Overall Study|Adverse Event|0|||
131158151|NCT03894540|472203693|FG000|Overall Study|Withdrawal by Subject|0|||
131158152|NCT03894540|472203694|FG001|Overall Study|Withdrawal by Subject|0|||
131158153|NCT03894540|472203695|FG002|Overall Study|Withdrawal by Subject|0|||
131158154|NCT03894540|472203696|FG003|Overall Study|Withdrawal by Subject|0|||
131158155|NCT03894540|472203697|FG004|Overall Study|Withdrawal by Subject|1|||
131158156|NCT03894540|472203698|FG005|Overall Study|Withdrawal by Subject|0|||
131158157|NCT03894540|472203693|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
131158158|NCT03894540|472203694|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
131158159|NCT03894540|472203695|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
131158160|NCT03894540|472203696|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
131158161|NCT03894540|472203697|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
131158162|NCT03894540|472203698|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
131158163|NCT03894540|472203693|FG000|Overall Study|Progressive Disease Clinical|1|||
131158164|NCT03894540|472203694|FG001|Overall Study|Progressive Disease Clinical|1|||
131158165|NCT03894540|472203695|FG002|Overall Study|Progressive Disease Clinical|0|||
131158166|NCT03894540|472203696|FG003|Overall Study|Progressive Disease Clinical|1|||
131158167|NCT03894540|472203697|FG004|Overall Study|Progressive Disease Clinical|5|||
131158168|NCT03894540|472203698|FG005|Overall Study|Progressive Disease Clinical|1|||
131158169|NCT03894540|472203693|FG000|Overall Study|Study termination by sponsor|0|||
131158170|NCT03894540|472203694|FG001|Overall Study|Study termination by sponsor|0|||
131158171|NCT03894540|472203695|FG002|Overall Study|Study termination by sponsor|0|||
131158172|NCT03894540|472203696|FG003|Overall Study|Study termination by sponsor|0|||
131158173|NCT03894540|472203697|FG004|Overall Study|Study termination by sponsor|2|||
131158174|NCT03894540|472203698|FG005|Overall Study|Study termination by sponsor|0|||
131158175|NCT03043365|472203699|FG000|Weeks 0 to Week 8|Adverse Event|1|||
131158176|NCT03043365|472203700|FG001|Weeks 0 to Week 8|Adverse Event|3|||
131158177|NCT03043365|472203699|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
131158178|NCT03043365|472203700|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
131158179|NCT03043365|472203699|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
131158180|NCT03043365|472203700|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
131158181|NCT05372315|472203701|FG000|Overall Study|Withdrawal by Subject|1|||
131158182|NCT05372315|472203702|FG001|Overall Study|Withdrawal by Subject|0|||
131158183|NCT01508676|472203705|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
131158184|NCT01508676|472203706|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
131235318|NCT03384745|472488888|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
131235319|NCT03384745|472488889|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
131235320|NCT03384745|472488890|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
131235321|NCT03384745|472488891|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
131235322|NCT02984683|472488894|FG000|Overall Study|Adverse Event|3|||
131235323|NCT02984683|472488895|FG001|Overall Study|Adverse Event|3|||
131158185|NCT01508676|472203705|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
131158186|NCT01508676|472203706|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
131158187|NCT01508676|472203705|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
131158188|NCT01508676|472203706|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
131158189|NCT01508676|472203705|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
131158190|NCT01508676|472203706|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
131158191|NCT01508676|472203705|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
131158192|NCT01508676|472203706|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
131158193|NCT02532543|472203708|FG000|Overall Study|Lost to Follow-up|0|||
131158194|NCT02532543|472203709|FG001|Overall Study|Lost to Follow-up|0|||
131158195|NCT02532543|472203710|FG002|Overall Study|Lost to Follow-up|1|||
131158196|NCT02532543|472203711|FG003|Overall Study|Lost to Follow-up|0|||
131158197|NCT00650585|472203712|FG000|Overall Study|Lost to Follow-up|505|||
131158198|NCT00650585|472203713|FG001|Overall Study|Lost to Follow-up|482|||
131158199|NCT00650585|472203712|FG000|Overall Study|No parental consent|935|||
131158200|NCT00650585|472203713|FG001|Overall Study|No parental consent|866|||
131158201|NCT00650585|472203712|FG000|Overall Study|Excluded/ruled ineligible|357|||
131158202|NCT00650585|472203713|FG001|Overall Study|Excluded/ruled ineligible|129|||
131158203|NCT00923091|472203719|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
131158204|NCT00923091|472203720|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
131158205|NCT00923091|472203721|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
131158206|NCT00923091|472203722|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
131158207|NCT00923091|472203723|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
131158208|NCT00923091|472203724|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
131158209|NCT00923091|472203725|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
131158210|NCT00923091|472203726|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
131158211|NCT00923091|472203727|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
131158212|NCT00923091|472203728|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
131158213|NCT00923091|472203729|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
131158214|NCT00923091|472203730|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
131158215|NCT00923091|472203731|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
131158216|NCT00923091|472203719|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
131158217|NCT00923091|472203720|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
131158218|NCT00923091|472203721|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
131158219|NCT00923091|472203722|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
131158220|NCT00923091|472203723|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
131158221|NCT00923091|472203724|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
131158222|NCT00923091|472203725|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
131158223|NCT00923091|472203726|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
131158224|NCT00923091|472203727|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
131158225|NCT00923091|472203728|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
131158226|NCT00923091|472203729|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
131158227|NCT00923091|472203730|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
131158228|NCT00923091|472203731|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
131158229|NCT00923091|472203719|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
131158230|NCT00923091|472203720|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
131158231|NCT00923091|472203721|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
131158232|NCT00923091|472203722|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
131158233|NCT00923091|472203723|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
131158234|NCT00923091|472203724|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
131158235|NCT00923091|472203725|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
131158236|NCT00923091|472203726|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
131158237|NCT00923091|472203727|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
131158238|NCT00923091|472203728|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
131158239|NCT00923091|472203729|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
131158240|NCT00923091|472203730|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
131158241|NCT00923091|472203731|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
131158242|NCT00923091|472203719|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158243|NCT00923091|472203720|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158244|NCT00923091|472203721|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158245|NCT00923091|472203722|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158246|NCT00923091|472203723|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158247|NCT00923091|472203724|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
131158248|NCT00923091|472203725|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158249|NCT00923091|472203726|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158250|NCT00923091|472203727|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131235324|NCT02984683|472488894|FG000|Overall Study|Withdrawal by Subject|1|||
131235325|NCT02984683|472488895|FG001|Overall Study|Withdrawal by Subject|0|||
131158251|NCT00923091|472203728|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158252|NCT00923091|472203729|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158253|NCT00923091|472203730|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158254|NCT00923091|472203731|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
131158255|NCT00923091|472203719|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131158256|NCT00923091|472203720|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
131158257|NCT00923091|472203721|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131158258|NCT00923091|472203722|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
131158259|NCT00923091|472203723|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131158260|NCT00923091|472203724|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
131158261|NCT00923091|472203725|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131158262|NCT00923091|472203726|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131158263|NCT00923091|472203727|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131158264|NCT00923091|472203728|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131158265|NCT00923091|472203729|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131158266|NCT00923091|472203730|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131158267|NCT00923091|472203731|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
131158268|NCT00923091|472203719|FG000|Period III (Single-Blind)|Adverse Event|5|||
131158269|NCT00923091|472203720|FG001|Period III (Single-Blind)|Adverse Event|0|||
131158270|NCT00923091|472203721|FG002|Period III (Single-Blind)|Adverse Event|0|||
131158271|NCT00923091|472203722|FG003|Period III (Single-Blind)|Adverse Event|0|||
131158272|NCT00923091|472203723|FG004|Period III (Single-Blind)|Adverse Event|0|||
131158273|NCT00923091|472203724|FG005|Period III (Single-Blind)|Adverse Event|0|||
131158274|NCT00923091|472203725|FG006|Period III (Single-Blind)|Adverse Event|0|||
131158275|NCT00923091|472203726|FG007|Period III (Single-Blind)|Adverse Event|0|||
131158276|NCT00923091|472203727|FG008|Period III (Single-Blind)|Adverse Event|0|||
131158277|NCT00923091|472203728|FG009|Period III (Single-Blind)|Adverse Event|0|||
131158278|NCT00923091|472203729|FG010|Period III (Single-Blind)|Adverse Event|0|||
131158279|NCT00923091|472203730|FG011|Period III (Single-Blind)|Adverse Event|0|||
131158280|NCT00923091|472203731|FG012|Period III (Single-Blind)|Adverse Event|0|||
131158281|NCT00923091|472203719|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
131158282|NCT00923091|472203720|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158283|NCT00923091|472203721|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158284|NCT00923091|472203722|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158285|NCT00923091|472203723|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158286|NCT00923091|472203724|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158287|NCT00923091|472203725|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158288|NCT00923091|472203726|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158289|NCT00923091|472203727|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158290|NCT00923091|472203728|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158291|NCT00923091|472203729|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158292|NCT00923091|472203730|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158293|NCT00923091|472203731|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
131158294|NCT00923091|472203719|FG000|Period III (Single-Blind)|Protocol Violation|3|||
131158295|NCT00923091|472203720|FG001|Period III (Single-Blind)|Protocol Violation|0|||
131158296|NCT00923091|472203721|FG002|Period III (Single-Blind)|Protocol Violation|0|||
131158297|NCT00923091|472203722|FG003|Period III (Single-Blind)|Protocol Violation|0|||
131158298|NCT00923091|472203723|FG004|Period III (Single-Blind)|Protocol Violation|0|||
131158299|NCT00923091|472203724|FG005|Period III (Single-Blind)|Protocol Violation|0|||
131158300|NCT00923091|472203725|FG006|Period III (Single-Blind)|Protocol Violation|0|||
131158301|NCT00923091|472203726|FG007|Period III (Single-Blind)|Protocol Violation|0|||
131158302|NCT00923091|472203727|FG008|Period III (Single-Blind)|Protocol Violation|0|||
131158303|NCT00923091|472203728|FG009|Period III (Single-Blind)|Protocol Violation|0|||
131158304|NCT00923091|472203729|FG010|Period III (Single-Blind)|Protocol Violation|0|||
131158305|NCT00923091|472203730|FG011|Period III (Single-Blind)|Protocol Violation|0|||
131158306|NCT00923091|472203731|FG012|Period III (Single-Blind)|Protocol Violation|0|||
131158307|NCT00923091|472203719|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
131158308|NCT00923091|472203720|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
131158309|NCT00923091|472203721|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
131158310|NCT00923091|472203722|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
131158311|NCT00923091|472203723|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
131158312|NCT00923091|472203724|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
131158313|NCT00923091|472203725|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
131158314|NCT00923091|472203726|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
131158315|NCT00923091|472203727|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
131158316|NCT00923091|472203728|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
131158317|NCT00923091|472203729|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
131158318|NCT00923091|472203730|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
131158319|NCT00923091|472203731|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
131158320|NCT00923091|472203719|FG000|Period IV (Double-Blind)|Adverse Event|2|||
130728689|NCT02114385|470628619|FG000|Overall Study|Lost to Follow-up|0|||
130728690|NCT02114385|470628620|FG001|Overall Study|Lost to Follow-up|6|||
130728691|NCT01174043|470628624|FG000|Overall Study|Disease progression|5|||
130728692|NCT01174043|470628624|FG000|Overall Study|Adverse Event|3|||
130728693|NCT01174043|470628624|FG000|Overall Study|Death|1|||
131158321|NCT00923091|472203720|FG001|Period IV (Double-Blind)|Adverse Event|0|||
131158322|NCT00923091|472203721|FG002|Period IV (Double-Blind)|Adverse Event|0|||
131158323|NCT00923091|472203722|FG003|Period IV (Double-Blind)|Adverse Event|0|||
131158324|NCT00923091|472203723|FG004|Period IV (Double-Blind)|Adverse Event|0|||
131158325|NCT00923091|472203724|FG005|Period IV (Double-Blind)|Adverse Event|0|||
131158326|NCT00923091|472203725|FG006|Period IV (Double-Blind)|Adverse Event|0|||
131158327|NCT00923091|472203726|FG007|Period IV (Double-Blind)|Adverse Event|0|||
131158328|NCT00923091|472203727|FG008|Period IV (Double-Blind)|Adverse Event|0|||
131158329|NCT00923091|472203728|FG009|Period IV (Double-Blind)|Adverse Event|0|||
131158330|NCT00923091|472203729|FG010|Period IV (Double-Blind)|Adverse Event|0|||
131158331|NCT00923091|472203730|FG011|Period IV (Double-Blind)|Adverse Event|0|||
131158332|NCT00923091|472203731|FG012|Period IV (Double-Blind)|Adverse Event|0|||
131158333|NCT00923091|472203719|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158334|NCT00923091|472203720|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
131158335|NCT00923091|472203721|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158336|NCT00923091|472203722|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158337|NCT00923091|472203723|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158338|NCT00923091|472203724|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158339|NCT00923091|472203725|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158340|NCT00923091|472203726|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158341|NCT00923091|472203727|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158342|NCT00923091|472203728|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158343|NCT00923091|472203729|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158344|NCT00923091|472203730|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158345|NCT00923091|472203731|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
131158346|NCT00923091|472203719|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
131158347|NCT00923091|472203720|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
131158348|NCT00923091|472203721|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
131158349|NCT00923091|472203722|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
131158350|NCT00923091|472203723|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
131158351|NCT00923091|472203724|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
131158352|NCT00923091|472203725|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
131158353|NCT00923091|472203726|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
131158354|NCT00923091|472203727|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
131158355|NCT00923091|472203728|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
131158356|NCT00923091|472203729|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
131158357|NCT00923091|472203730|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
131158358|NCT00923091|472203731|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
131158359|NCT00923091|472203719|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158360|NCT00923091|472203720|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158361|NCT00923091|472203721|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158362|NCT00923091|472203722|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158363|NCT00923091|472203723|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158364|NCT00923091|472203724|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158365|NCT00923091|472203725|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158366|NCT00923091|472203726|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158367|NCT00923091|472203727|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
131158368|NCT00923091|472203728|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158369|NCT00923091|472203729|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158370|NCT00923091|472203730|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
131158371|NCT00923091|472203731|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
131158372|NCT00923091|472203719|FG000|Period V (Double -Blind)|Protocol Violation|0|||
131158373|NCT00923091|472203720|FG001|Period V (Double -Blind)|Protocol Violation|0|||
131158374|NCT00923091|472203721|FG002|Period V (Double -Blind)|Protocol Violation|0|||
131158375|NCT00923091|472203722|FG003|Period V (Double -Blind)|Protocol Violation|0|||
131158376|NCT00923091|472203723|FG004|Period V (Double -Blind)|Protocol Violation|0|||
130728694|NCT01174043|470628624|FG000|Overall Study|Withdrawal by Subject|2|||
131158377|NCT00923091|472203724|FG005|Period V (Double -Blind)|Protocol Violation|0|||
131158378|NCT00923091|472203725|FG006|Period V (Double -Blind)|Protocol Violation|0|||
131158379|NCT00923091|472203726|FG007|Period V (Double -Blind)|Protocol Violation|0|||
131158380|NCT00923091|472203727|FG008|Period V (Double -Blind)|Protocol Violation|0|||
131158381|NCT00923091|472203728|FG009|Period V (Double -Blind)|Protocol Violation|0|||
131158382|NCT00923091|472203729|FG010|Period V (Double -Blind)|Protocol Violation|0|||
131158383|NCT00923091|472203730|FG011|Period V (Double -Blind)|Protocol Violation|0|||
130728695|NCT00582010|470628629|FG000|Overall Study|Death|0|||
130728696|NCT00582010|470628630|FG001|Overall Study|Death|1|||
130728697|NCT02681510|470628631|FG000|Overall Study|Withdrawal by Subject|1|||
131158384|NCT00923091|472203731|FG012|Period V (Double -Blind)|Protocol Violation|1|||
131158385|NCT00923091|472203719|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
131158386|NCT00923091|472203720|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
131158387|NCT00923091|472203721|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
131158388|NCT00923091|472203722|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
131158389|NCT00923091|472203723|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
131158390|NCT00923091|472203724|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
131158391|NCT00923091|472203725|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
131158392|NCT00923091|472203726|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
131158393|NCT00923091|472203727|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
131158394|NCT00923091|472203728|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
131158395|NCT00923091|472203729|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
131158396|NCT00923091|472203730|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
131158397|NCT00923091|472203731|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
131158398|NCT00923091|472203719|FG000|Period VI (Open-Label)|Adverse Event|17|||
131158399|NCT00923091|472203720|FG001|Period VI (Open-Label)|Adverse Event|0|||
131158400|NCT00923091|472203721|FG002|Period VI (Open-Label)|Adverse Event|4|||
131158401|NCT00923091|472203722|FG003|Period VI (Open-Label)|Adverse Event|1|||
131158402|NCT00923091|472203723|FG004|Period VI (Open-Label)|Adverse Event|1|||
131158403|NCT00923091|472203724|FG005|Period VI (Open-Label)|Adverse Event|0|||
131158404|NCT00923091|472203725|FG006|Period VI (Open-Label)|Adverse Event|0|||
131158405|NCT00923091|472203726|FG007|Period VI (Open-Label)|Adverse Event|0|||
131158406|NCT00923091|472203727|FG008|Period VI (Open-Label)|Adverse Event|0|||
131158407|NCT00923091|472203728|FG009|Period VI (Open-Label)|Adverse Event|0|||
131158408|NCT00923091|472203729|FG010|Period VI (Open-Label)|Adverse Event|0|||
131158409|NCT00923091|472203730|FG011|Period VI (Open-Label)|Adverse Event|0|||
131158410|NCT00923091|472203731|FG012|Period VI (Open-Label)|Adverse Event|0|||
131158411|NCT00923091|472203719|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
131158412|NCT00923091|472203720|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
131158413|NCT00923091|472203721|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
131158414|NCT00923091|472203722|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
131158415|NCT00923091|472203723|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
131158416|NCT00923091|472203724|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
131158417|NCT00923091|472203725|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
131158418|NCT00923091|472203726|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
131158419|NCT00923091|472203727|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
131158420|NCT00923091|472203728|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
131158421|NCT00923091|472203729|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
130728698|NCT02681510|470628631|FG000|Overall Study|Lost to Follow-up|9|||
130728699|NCT00741338|470628632|FG000|Overall Study|Adverse Event|0|||
130728700|NCT00741338|470628633|FG001|Overall Study|Adverse Event|1|||
130728701|NCT03066258|470628636|FG000|Overall Study|Death|1|||
130728702|NCT03066258|470628637|FG001|Overall Study|Death|0|||
130728703|NCT03066258|470628638|FG002|Overall Study|Death|0|||
130728704|NCT03066258|470628639|FG003|Overall Study|Death|0|||
130728705|NCT03066258|470628640|FG004|Overall Study|Death|1|||
130728706|NCT02784795|470628641|FG000|Overall Study|Progressive Disease|2|||
130728707|NCT02784795|470628642|FG001|Overall Study|Progressive Disease|1|||
131158422|NCT00923091|472203730|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
131158423|NCT00923091|472203731|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
131158424|NCT00923091|472203719|FG000|Period VI (Open-Label)|Protocol Violation|6|||
131158425|NCT00923091|472203720|FG001|Period VI (Open-Label)|Protocol Violation|1|||
131158426|NCT00923091|472203721|FG002|Period VI (Open-Label)|Protocol Violation|3|||
131158427|NCT00923091|472203722|FG003|Period VI (Open-Label)|Protocol Violation|1|||
131158428|NCT00923091|472203723|FG004|Period VI (Open-Label)|Protocol Violation|4|||
131158429|NCT00923091|472203724|FG005|Period VI (Open-Label)|Protocol Violation|0|||
130728708|NCT02784795|470628643|FG002|Overall Study|Progressive Disease|1|||
130728709|NCT02784795|470628644|FG003|Overall Study|Progressive Disease|0|||
131158430|NCT00923091|472203725|FG006|Period VI (Open-Label)|Protocol Violation|0|||
131158431|NCT00923091|472203726|FG007|Period VI (Open-Label)|Protocol Violation|0|||
131158432|NCT00923091|472203727|FG008|Period VI (Open-Label)|Protocol Violation|0|||
131158433|NCT00923091|472203728|FG009|Period VI (Open-Label)|Protocol Violation|0|||
131158434|NCT00923091|472203729|FG010|Period VI (Open-Label)|Protocol Violation|0|||
131158435|NCT00923091|472203730|FG011|Period VI (Open-Label)|Protocol Violation|0|||
131158436|NCT00923091|472203731|FG012|Period VI (Open-Label)|Protocol Violation|0|||
131158437|NCT00923091|472203719|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
131158438|NCT00923091|472203720|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
131158439|NCT00923091|472203721|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
131158440|NCT00923091|472203722|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
131158441|NCT00923091|472203723|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
131158442|NCT00923091|472203724|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
131158443|NCT00923091|472203725|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
131235326|NCT02984683|472488894|FG000|Overall Study|Disease progression|7|||
130728710|NCT02784795|470628645|FG004|Overall Study|Progressive Disease|2|||
130728711|NCT02784795|470628646|FG005|Overall Study|Progressive Disease|0|||
131158444|NCT00923091|472203726|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
131158445|NCT00923091|472203727|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
131158446|NCT00923091|472203728|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
131158447|NCT00923091|472203729|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
131158448|NCT00923091|472203730|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
131158449|NCT00923091|472203731|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
131158450|NCT00923091|472203719|FG000|Period VI (Open-Label)|Other Reason|0|||
131158451|NCT00923091|472203720|FG001|Period VI (Open-Label)|Other Reason|0|||
131158452|NCT00923091|472203721|FG002|Period VI (Open-Label)|Other Reason|0|||
131158453|NCT00923091|472203722|FG003|Period VI (Open-Label)|Other Reason|1|||
131158454|NCT00923091|472203723|FG004|Period VI (Open-Label)|Other Reason|1|||
131158455|NCT00923091|472203724|FG005|Period VI (Open-Label)|Other Reason|0|||
131158456|NCT00923091|472203725|FG006|Period VI (Open-Label)|Other Reason|0|||
131158457|NCT00923091|472203726|FG007|Period VI (Open-Label)|Other Reason|0|||
131158458|NCT00923091|472203727|FG008|Period VI (Open-Label)|Other Reason|0|||
131158459|NCT00923091|472203728|FG009|Period VI (Open-Label)|Other Reason|0|||
131158460|NCT00923091|472203729|FG010|Period VI (Open-Label)|Other Reason|0|||
131158461|NCT00923091|472203730|FG011|Period VI (Open-Label)|Other Reason|0|||
131158462|NCT00923091|472203731|FG012|Period VI (Open-Label)|Other Reason|0|||
131158463|NCT03633331|472203734|FG000|Overall Study|Withdrawal by Subject|1|||
131158464|NCT03233048|472203735|FG000|Overall Study|Withdrawal by Subject|1|||
131158465|NCT01396525|472203736|FG000|Overall Study|Withdrawal by Subject|8|||
131158466|NCT01396525|472203736|FG000|Overall Study|Death|14|||
131158467|NCT01396525|472203736|FG000|Overall Study|Lost to Follow-up|4|||
131158468|NCT03114969|472203737|FG000|Overall Study|Lost to Follow-up|0|||
131158469|NCT03114969|472203738|FG001|Overall Study|Lost to Follow-up|0|||
131158470|NCT03114969|472203739|FG002|Overall Study|Lost to Follow-up|3|||
131158471|NCT03114969|472203740|FG003|Overall Study|Lost to Follow-up|2|||
131158472|NCT03114969|472203741|FG004|Overall Study|Lost to Follow-up|0|||
131158473|NCT03114969|472203742|FG005|Overall Study|Lost to Follow-up|0|||
131158474|NCT03114969|472203743|FG006|Overall Study|Lost to Follow-up|0|||
131158475|NCT03114969|472203744|FG007|Overall Study|Lost to Follow-up|0|||
131158476|NCT03114969|472203745|FG008|Overall Study|Lost to Follow-up|0|||
131158477|NCT03114969|472203737|FG000|Overall Study|Adverse Event|0|||
131158478|NCT03114969|472203738|FG001|Overall Study|Adverse Event|0|||
131158479|NCT03114969|472203739|FG002|Overall Study|Adverse Event|1|||
131158480|NCT03114969|472203740|FG003|Overall Study|Adverse Event|0|||
131158481|NCT03114969|472203741|FG004|Overall Study|Adverse Event|0|||
131158482|NCT03114969|472203742|FG005|Overall Study|Adverse Event|1|||
131158483|NCT03114969|472203743|FG006|Overall Study|Adverse Event|1|||
131158484|NCT03114969|472203744|FG007|Overall Study|Adverse Event|0|||
131158485|NCT03114969|472203745|FG008|Overall Study|Adverse Event|2|||
131158486|NCT00949650|472203746|FG000|Overall Study|Progressive disease|188|||
131158487|NCT00949650|472203747|FG001|Overall Study|Progressive disease|19|||
131158488|NCT00949650|472203746|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
131158489|NCT00949650|472203747|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
131158490|NCT00949650|472203746|FG000|Overall Study|Other Adverse Event (AE)|28|||
131158491|NCT00949650|472203747|FG001|Overall Study|Other Adverse Event (AE)|17|||
131158492|NCT00949650|472203746|FG000|Overall Study|Protocol Violation|1|||
131158493|NCT00949650|472203747|FG001|Overall Study|Protocol Violation|4|||
131158494|NCT00949650|472203746|FG000|Overall Study|Refusal to continue medication|7|||
131158495|NCT00949650|472203747|FG001|Overall Study|Refusal to continue medication|11|||
131158496|NCT00949650|472203746|FG000|Overall Study|Not treated|1|||
131158497|NCT00949650|472203747|FG001|Overall Study|Not treated|4|||
131158498|NCT00949650|472203746|FG000|Overall Study|Other not specified above|5|||
131158499|NCT00949650|472203747|FG001|Overall Study|Other not specified above|0|||
131158500|NCT00450866|472203756|FG000|Overall Study|Adverse Event|0|||
131158501|NCT00450866|472203757|FG001|Overall Study|Adverse Event|1|||
131158502|NCT00450866|472203756|FG000|Overall Study|Withdrawal by Subject|5|||
131158503|NCT00450866|472203757|FG001|Overall Study|Withdrawal by Subject|2|||
131158504|NCT00450866|472203756|FG000|Overall Study|Death|1|||
131158505|NCT00450866|472203757|FG001|Overall Study|Death|0|||
131158506|NCT00450866|472203756|FG000|Overall Study|Physician Decision|1|||
131158507|NCT00450866|472203757|FG001|Overall Study|Physician Decision|0|||
131158508|NCT00995371|472203761|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
131158509|NCT00995371|472203762|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
131158510|NCT00964795|472203763|FG000|Overall Study|Withdrawal by Subject|79|||
131158511|NCT00964795|472203763|FG000|Overall Study|Adverse Event|12|||
131158512|NCT00964795|472203763|FG000|Overall Study|Death|14|||
131158513|NCT00964795|472203763|FG000|Overall Study|Lost to Follow-up|7|||
130780592|NCT00735709|470823123|FG001|Overall Study|Adverse Event|3|||
131158514|NCT00964795|472203763|FG000|Overall Study|Termination of Study by Sponsor|169|||
131158515|NCT00964795|472203763|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
131158516|NCT00964795|472203763|FG000|Overall Study|Other|23|||
131158517|NCT00586690|472203767|FG000|Overall Study|Death|2|||
131158518|NCT00586690|472203768|FG001|Overall Study|Death|0|||
131158519|NCT00586690|472203767|FG000|Overall Study|Disease Progression|10|||
131158520|NCT00586690|472203768|FG001|Overall Study|Disease Progression|0|||
131158521|NCT00586690|472203767|FG000|Overall Study|Adverse Event|1|||
131158522|NCT00586690|472203768|FG001|Overall Study|Adverse Event|0|||
131158523|NCT00586690|472203767|FG000|Overall Study|Lack of Efficacy|2|||
131158524|NCT00586690|472203768|FG001|Overall Study|Lack of Efficacy|0|||
131158525|NCT00586690|472203767|FG000|Overall Study|Lab can't accommodate|1|||
131158526|NCT00586690|472203768|FG001|Overall Study|Lab can't accommodate|0|||
131158527|NCT00857246|472203769|FG000|Induction Regimen|Adverse Event|1|||
131158528|NCT00857246|472203769|FG000|Induction Regimen|disease-related complications|1|||
131158529|NCT00857246|472203769|FG000|Induction Regimen|Withdrawal by Subject|1|||
131158530|NCT00857246|472203769|FG000|Surgery (Curative)|disease progression|6|||
131158531|NCT00857246|472203769|FG000|ChemoRT|Withdrawal by Subject|1|||
131158532|NCT00857246|472203769|FG000|ChemoRT|Adverse Event|2|||
131158533|NCT01524289|472203778|FG000|Overall Study|Lost to Follow-up|0|||
131158534|NCT01524289|472203779|FG001|Overall Study|Lost to Follow-up|1|||
131158535|NCT01524289|472203778|FG000|Overall Study|Physician Decision|1|||
131158536|NCT01524289|472203779|FG001|Overall Study|Physician Decision|0|||
131158537|NCT01524289|472203778|FG000|Overall Study|Protocol Violation|5|||
131158538|NCT01524289|472203779|FG001|Overall Study|Protocol Violation|1|||
130728712|NCT02784795|470628647|FG006|Overall Study|Progressive Disease|2|||
130728713|NCT02784795|470628648|FG007|Overall Study|Progressive Disease|0|||
130728714|NCT02784795|470628649|FG008|Overall Study|Progressive Disease|0|||
130728715|NCT02784795|470628650|FG009|Overall Study|Progressive Disease|0|||
130728716|NCT02784795|470628651|FG010|Overall Study|Progressive Disease|1|||
130728717|NCT02784795|470628652|FG011|Overall Study|Progressive Disease|0|||
130728718|NCT02784795|470628641|FG000|Overall Study|Adverse Event|1|||
130728719|NCT02784795|470628642|FG001|Overall Study|Adverse Event|0|||
130728720|NCT02784795|470628643|FG002|Overall Study|Adverse Event|0|||
130728721|NCT02784795|470628644|FG003|Overall Study|Adverse Event|1|||
130728722|NCT02784795|470628645|FG004|Overall Study|Adverse Event|0|||
130728723|NCT02784795|470628646|FG005|Overall Study|Adverse Event|0|||
130728724|NCT02784795|470628647|FG006|Overall Study|Adverse Event|1|||
130728725|NCT02784795|470628648|FG007|Overall Study|Adverse Event|0|||
130728726|NCT02784795|470628649|FG008|Overall Study|Adverse Event|0|||
131158539|NCT01524289|472203778|FG000|Overall Study|Withdrawal by Subject|11|||
131158540|NCT01524289|472203779|FG001|Overall Study|Withdrawal by Subject|7|||
131158541|NCT01524289|472203778|FG000|Overall Study|Adverse Event|12|||
131158542|NCT01524289|472203779|FG001|Overall Study|Adverse Event|5|||
131158543|NCT01524289|472203778|FG000|Overall Study|Did not take study medication|1|||
131158544|NCT01524289|472203779|FG001|Overall Study|Did not take study medication|0|||
131158545|NCT02104180|472203780|FG000|Overall Study|Protocol Violation|1|||
131158546|NCT02104180|472203781|FG001|Overall Study|Protocol Violation|0|||
131158547|NCT02704429|472203782|FG000|Part A: 24 Weeks|Adverse Event|3|||
131158548|NCT02704429|472203783|FG001|Part A: 24 Weeks|Adverse Event|0|||
131158549|NCT02704429|472203782|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
131158550|NCT02704429|472203783|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
131158551|NCT02209597|472203786|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
131158552|NCT02209597|472203786|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
131158553|NCT02209597|472203786|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
131158554|NCT02209597|472203786|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
131158555|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Adverse Event|37|||
131158556|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Adverse Event|0|||
131158557|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Adverse Event|0|||
131158558|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Adverse Event|0|||
131158559|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Death|2|||
131158560|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Death|0|||
131158561|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Death|0|||
131158562|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Death|0|||
131158563|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
131158564|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
131158565|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
131158566|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
131158567|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
131158568|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
131158569|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
131158570|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
131158571|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
131158572|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
131158573|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
131158574|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
131158575|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
131235327|NCT02984683|472488895|FG001|Overall Study|Disease progression|9|||
130728727|NCT02784795|470628650|FG009|Overall Study|Adverse Event|0|||
130728728|NCT02784795|470628651|FG010|Overall Study|Adverse Event|0|||
130728729|NCT02784795|470628652|FG011|Overall Study|Adverse Event|2|||
130728730|NCT02784795|470628641|FG000|Overall Study|Withdrawal by Subject|1|||
130728731|NCT02784795|470628642|FG001|Overall Study|Withdrawal by Subject|0|||
130728732|NCT02784795|470628643|FG002|Overall Study|Withdrawal by Subject|2|||
131158576|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
131158577|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
131158578|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
131158579|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Physician Decision|4|||
131158580|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Physician Decision|0|||
131158581|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Physician Decision|0|||
131158582|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Physician Decision|0|||
131158583|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Pregnancy|1|||
131158584|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Pregnancy|0|||
131158585|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Pregnancy|0|||
131158586|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Pregnancy|0|||
131158587|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
131158588|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
131158589|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
131158590|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
131158591|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
131158592|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
131158593|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
131158594|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
131158595|NCT01855789|472203788|FG000|1) Baseline up to Week 24|Other|4|||
131158596|NCT01855789|472203789|FG001|1) Baseline up to Week 24|Other|0|||
131158597|NCT01855789|472203790|FG002|1) Baseline up to Week 24|Other|0|||
131158598|NCT01855789|472203791|FG003|1) Baseline up to Week 24|Other|0|||
131158599|NCT01855789|472203788|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
131158600|NCT01855789|472203789|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
131158601|NCT01855789|472203790|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
131158602|NCT01855789|472203791|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
131158603|NCT01855789|472203788|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
131158604|NCT01855789|472203789|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
131158605|NCT01855789|472203790|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
131158606|NCT01855789|472203791|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
131158607|NCT01855789|472203788|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
131158608|NCT01855789|472203789|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
131158609|NCT01855789|472203790|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
131158610|NCT01855789|472203791|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
131158611|NCT01855789|472203788|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
131158612|NCT01855789|472203789|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
131158613|NCT01855789|472203790|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
131158614|NCT01855789|472203791|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
131158615|NCT01855789|472203788|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
131158616|NCT01855789|472203789|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
131158617|NCT01855789|472203790|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
131158618|NCT01855789|472203791|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
131158619|NCT01855789|472203788|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
131158620|NCT01855789|472203789|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
131158621|NCT01855789|472203790|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
131158622|NCT01855789|472203791|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
131158623|NCT01855789|472203788|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
131158624|NCT01855789|472203789|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
131158625|NCT01855789|472203790|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
131158626|NCT01855789|472203791|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
131158627|NCT01855789|472203788|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
131158628|NCT01855789|472203789|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
131158629|NCT01855789|472203790|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
131158630|NCT01855789|472203791|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
131158631|NCT01855789|472203788|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
131158632|NCT01855789|472203789|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
131158633|NCT01855789|472203790|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
131158634|NCT01855789|472203791|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
131158635|NCT01855789|472203788|FG000|2) Week 24 up to End of Study|Other|0|||
131158636|NCT01855789|472203789|FG001|2) Week 24 up to End of Study|Other|0|||
131158637|NCT01855789|472203790|FG002|2) Week 24 up to End of Study|Other|0|||
131158638|NCT01855789|472203791|FG003|2) Week 24 up to End of Study|Other|1|||
131158639|NCT03067311|472203792|FG000|Overall Study|Lost to Follow-up|1|||
131158640|NCT03067311|472203793|FG001|Overall Study|Lost to Follow-up|1|||
131158641|NCT03067311|472203792|FG000|Overall Study|Moved away|1|||
131158642|NCT03067311|472203793|FG001|Overall Study|Moved away|1|||
130780593|NCT00735709|470823124|FG002|Overall Study|Adverse Event|1|||
131158643|NCT00907738|472203794|FG000|Overall Study|Adverse Event|2|||
131158644|NCT00907738|472203795|FG001|Overall Study|Adverse Event|0|||
131158645|NCT00907738|472203796|FG002|Overall Study|Adverse Event|1|||
131158646|NCT00907738|472203797|FG003|Overall Study|Adverse Event|0|||
131158647|NCT00907738|472203798|FG004|Overall Study|Adverse Event|0|||
131158648|NCT00907738|472203794|FG000|Overall Study|not specified or withdrew consent|3|||
131158649|NCT00907738|472203795|FG001|Overall Study|not specified or withdrew consent|0|||
131158650|NCT00907738|472203796|FG002|Overall Study|not specified or withdrew consent|0|||
131158651|NCT00907738|472203797|FG003|Overall Study|not specified or withdrew consent|0|||
131158652|NCT00907738|472203798|FG004|Overall Study|not specified or withdrew consent|0|||
131158653|NCT00907738|472203794|FG000|Overall Study|Disease progression|8|||
131158654|NCT00907738|472203795|FG001|Overall Study|Disease progression|1|||
131158655|NCT00907738|472203796|FG002|Overall Study|Disease progression|6|||
131158656|NCT00907738|472203797|FG003|Overall Study|Disease progression|4|||
131158657|NCT00907738|472203798|FG004|Overall Study|Disease progression|2|||
131158658|NCT01089725|472203799|FG000|Overall Study|Adverse Event|1|||
131158659|NCT01089725|472203800|FG001|Overall Study|Adverse Event|1|||
131158660|NCT01089725|472203801|FG002|Overall Study|Adverse Event|0|||
131158661|NCT01089725|472203802|FG003|Overall Study|Adverse Event|0|||
131158662|NCT01089725|472203803|FG004|Overall Study|Adverse Event|2|||
131158663|NCT01089725|472203799|FG000|Overall Study|Lack of Efficacy|4|||
131158664|NCT01089725|472203800|FG001|Overall Study|Lack of Efficacy|3|||
131158665|NCT01089725|472203801|FG002|Overall Study|Lack of Efficacy|1|||
131158666|NCT01089725|472203802|FG003|Overall Study|Lack of Efficacy|0|||
131158667|NCT01089725|472203803|FG004|Overall Study|Lack of Efficacy|4|||
131158668|NCT01089725|472203799|FG000|Overall Study|Lost to Follow-up|2|||
131158669|NCT01089725|472203800|FG001|Overall Study|Lost to Follow-up|2|||
131158670|NCT01089725|472203801|FG002|Overall Study|Lost to Follow-up|0|||
131158671|NCT01089725|472203802|FG003|Overall Study|Lost to Follow-up|3|||
131158672|NCT01089725|472203803|FG004|Overall Study|Lost to Follow-up|0|||
131158673|NCT01089725|472203799|FG000|Overall Study|Protocol Violation|0|||
131158674|NCT01089725|472203800|FG001|Overall Study|Protocol Violation|0|||
131158675|NCT01089725|472203801|FG002|Overall Study|Protocol Violation|1|||
131158676|NCT01089725|472203802|FG003|Overall Study|Protocol Violation|1|||
131158677|NCT01089725|472203803|FG004|Overall Study|Protocol Violation|0|||
131158678|NCT01089725|472203799|FG000|Overall Study|Withdrawal by Subject|5|||
131158679|NCT01089725|472203800|FG001|Overall Study|Withdrawal by Subject|5|||
131158680|NCT01089725|472203801|FG002|Overall Study|Withdrawal by Subject|4|||
131158681|NCT01089725|472203802|FG003|Overall Study|Withdrawal by Subject|5|||
131158682|NCT01089725|472203803|FG004|Overall Study|Withdrawal by Subject|4|||
131158683|NCT01089725|472203799|FG000|Overall Study|Study Terminated by Sponsor|51|||
131158684|NCT01089725|472203800|FG001|Overall Study|Study Terminated by Sponsor|56|||
131158685|NCT01089725|472203801|FG002|Overall Study|Study Terminated by Sponsor|53|||
131158686|NCT01089725|472203802|FG003|Overall Study|Study Terminated by Sponsor|68|||
131158687|NCT01089725|472203803|FG004|Overall Study|Study Terminated by Sponsor|68|||
131158688|NCT01089725|472203799|FG000|Overall Study|Randomized, but not treated|0|||
131158689|NCT01089725|472203800|FG001|Overall Study|Randomized, but not treated|1|||
131158690|NCT01089725|472203801|FG002|Overall Study|Randomized, but not treated|2|||
131158691|NCT01089725|472203802|FG003|Overall Study|Randomized, but not treated|1|||
131158692|NCT01089725|472203803|FG004|Overall Study|Randomized, but not treated|2|||
131158693|NCT01089725|472203799|FG000|Overall Study|Other|3|||
131158694|NCT01089725|472203800|FG001|Overall Study|Other|0|||
131158695|NCT01089725|472203801|FG002|Overall Study|Other|0|||
131158696|NCT01089725|472203802|FG003|Overall Study|Other|1|||
131158697|NCT01089725|472203803|FG004|Overall Study|Other|0|||
131158698|NCT01486316|472205283|FG000|Overall Study|Device explanted with/without re-implant|3|||
131158699|NCT01486316|472205284|FG001|Overall Study|Device explanted with/without re-implant|2|||
131158700|NCT01486316|472205285|FG002|Overall Study|Device explanted with/without re-implant|0|||
131158701|NCT01486316|472205286|FG003|Overall Study|Device explanted with/without re-implant|2|||
131158702|NCT01486316|472205283|FG000|Overall Study|Not meeting eligibility criteria|0|||
131158703|NCT01486316|472205284|FG001|Overall Study|Not meeting eligibility criteria|0|||
131158704|NCT01486316|472205285|FG002|Overall Study|Not meeting eligibility criteria|1|||
131158705|NCT01486316|472205286|FG003|Overall Study|Not meeting eligibility criteria|0|||
131158706|NCT01486316|472205283|FG000|Overall Study|Withdrawal by Subject|1|||
131158707|NCT01486316|472205284|FG001|Overall Study|Withdrawal by Subject|0|||
131158708|NCT01486316|472205285|FG002|Overall Study|Withdrawal by Subject|3|||
131235328|NCT02742181|472488896|FG000|Overall Study|Physician Decision|1|||
131235329|NCT02742181|472488897|FG001|Overall Study|Physician Decision|0|||
131235330|NCT03008460|472488898|FG000|Overall Study|Protocol deviation|0|||
131235331|NCT03008460|472488899|FG001|Overall Study|Protocol deviation|2|||
131235332|NCT03008460|472488898|FG000|Overall Study|Study drug not dispensed|0|||
131235333|NCT03008460|472488899|FG001|Overall Study|Study drug not dispensed|1|||
131235334|NCT03008460|472488898|FG000|Overall Study|Adverse Event|0|||
131235335|NCT03008460|472488899|FG001|Overall Study|Adverse Event|1|||
131235336|NCT03008460|472488898|FG000|Overall Study|Withdrawal by Subject|5|||
131235337|NCT03008460|472488899|FG001|Overall Study|Withdrawal by Subject|6|||
131235338|NCT03008460|472488898|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
131158709|NCT01486316|472205286|FG003|Overall Study|Withdrawal by Subject|0|||
131158710|NCT01486316|472205283|FG000|Overall Study|Physician Decision|0|||
131235339|NCT03008460|472488899|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
131158711|NCT01486316|472205284|FG001|Overall Study|Physician Decision|0|||
131158712|NCT01486316|472205285|FG002|Overall Study|Physician Decision|1|||
131158713|NCT01486316|472205286|FG003|Overall Study|Physician Decision|0|||
131158714|NCT01486316|472205283|FG000|Overall Study|Death|0|||
131158715|NCT01486316|472205284|FG001|Overall Study|Death|1|||
131158716|NCT01486316|472205285|FG002|Overall Study|Death|0|||
131158717|NCT01486316|472205286|FG003|Overall Study|Death|0|||
131158718|NCT02114203|472205302|FG000|Overall Study|Adverse Event|0|||
131158719|NCT02114203|472205303|FG001|Overall Study|Adverse Event|1|||
131158720|NCT02114203|472205304|FG002|Overall Study|Adverse Event|0|||
131158721|NCT02114203|472205302|FG000|Overall Study|Withdrawal by Subject|0|||
131158722|NCT02114203|472205303|FG001|Overall Study|Withdrawal by Subject|1|||
131158723|NCT02114203|472205304|FG002|Overall Study|Withdrawal by Subject|0|||
131158724|NCT01518699|472205306|FG000|Period 2|Protocol Violation|1|||
131158725|NCT01518699|472205307|FG001|Period 2|Protocol Violation|1|||
131158726|NCT01518699|472205308|FG002|Period 2|Protocol Violation|0|||
131158727|NCT01518699|472205309|FG003|Period 2|Protocol Violation|0|||
131158728|NCT01518699|472205310|FG004|Period 2|Protocol Violation|0|||
131158729|NCT01518699|472205311|FG005|Period 2|Protocol Violation|0|||
131158730|NCT01518699|472205306|FG000|Period 2|Lost to Follow-up|0|||
131158731|NCT01518699|472205307|FG001|Period 2|Lost to Follow-up|1|||
131158732|NCT01518699|472205308|FG002|Period 2|Lost to Follow-up|0|||
131158733|NCT01518699|472205309|FG003|Period 2|Lost to Follow-up|0|||
131158734|NCT01518699|472205310|FG004|Period 2|Lost to Follow-up|0|||
131158735|NCT01518699|472205311|FG005|Period 2|Lost to Follow-up|0|||
131158736|NCT01518699|472205306|FG000|Period 2|Adverse Event|1|||
131158737|NCT01518699|472205307|FG001|Period 2|Adverse Event|0|||
131158738|NCT01518699|472205308|FG002|Period 2|Adverse Event|0|||
131158739|NCT01518699|472205309|FG003|Period 2|Adverse Event|0|||
131158740|NCT01518699|472205310|FG004|Period 2|Adverse Event|0|||
131158741|NCT01518699|472205311|FG005|Period 2|Adverse Event|0|||
131158742|NCT02839746|472205313|FG000|Overall Study|Not met selection criteria|12|||
131158743|NCT01978912|472205314|FG000|Overall Study|Adverse Event|0|||
131158744|NCT01978912|472205315|FG001|Overall Study|Adverse Event|1|||
131158745|NCT01978912|472205316|FG002|Overall Study|Adverse Event|0|||
131158746|NCT01978912|472205317|FG003|Overall Study|Adverse Event|0|||
131158747|NCT01978912|472205314|FG000|Overall Study|Lost to Follow-up|1|||
131158748|NCT01978912|472205315|FG001|Overall Study|Lost to Follow-up|1|||
131158749|NCT01978912|472205316|FG002|Overall Study|Lost to Follow-up|0|||
131158750|NCT01978912|472205317|FG003|Overall Study|Lost to Follow-up|1|||
131158751|NCT01978912|472205314|FG000|Overall Study|Withdrawal by Subject|1|||
131158752|NCT01978912|472205315|FG001|Overall Study|Withdrawal by Subject|0|||
131158753|NCT01978912|472205316|FG002|Overall Study|Withdrawal by Subject|2|||
131158754|NCT01978912|472205317|FG003|Overall Study|Withdrawal by Subject|2|||
131158755|NCT01978912|472205314|FG000|Overall Study|Lumbar Surgery|1|||
131158756|NCT01978912|472205315|FG001|Overall Study|Lumbar Surgery|0|||
131158757|NCT01978912|472205316|FG002|Overall Study|Lumbar Surgery|1|||
131158758|NCT01978912|472205317|FG003|Overall Study|Lumbar Surgery|0|||
131158759|NCT01978912|472205314|FG000|Overall Study|Intradiscal Steroid Injection|0|||
131158760|NCT01978912|472205315|FG001|Overall Study|Intradiscal Steroid Injection|1|||
130728733|NCT02784795|470628644|FG003|Overall Study|Withdrawal by Subject|1|||
131158761|NCT01978912|472205316|FG002|Overall Study|Intradiscal Steroid Injection|0|||
131158762|NCT01978912|472205317|FG003|Overall Study|Intradiscal Steroid Injection|0|||
131158763|NCT04220866|472205318|FG000|Overall Study|Death|4|||
131158764|NCT04220866|472205319|FG001|Overall Study|Death|5|||
131158765|NCT04220866|472205318|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
131158766|NCT04220866|472205319|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
131158767|NCT04220866|472205318|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
131158768|NCT04220866|472205319|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
131158769|NCT04220866|472205318|FG000|Overall Study|Withdrawal by Subject|0|||
131158770|NCT04220866|472205319|FG001|Overall Study|Withdrawal by Subject|1|||
131158771|NCT03515538|472205320|FG000|Overall Study|Lack of Efficacy|2|||
131158772|NCT03515538|472205321|FG001|Overall Study|Lack of Efficacy|0|||
131158773|NCT03515538|472205322|FG002|Overall Study|Lack of Efficacy|2|||
131158774|NCT03515538|472205323|FG003|Overall Study|Lack of Efficacy|0|||
131158775|NCT03515538|472205320|FG000|Overall Study|Death|0|||
131158776|NCT03515538|472205321|FG001|Overall Study|Death|0|||
131158777|NCT03515538|472205322|FG002|Overall Study|Death|1|||
131158778|NCT03515538|472205323|FG003|Overall Study|Death|0|||
131158779|NCT03515538|472205320|FG000|Overall Study|Protocol Violation|0|||
131158780|NCT03515538|472205321|FG001|Overall Study|Protocol Violation|0|||
131158781|NCT03515538|472205322|FG002|Overall Study|Protocol Violation|0|||
131158782|NCT03515538|472205323|FG003|Overall Study|Protocol Violation|1|||
131158783|NCT03515538|472205320|FG000|Overall Study|Screen failure (baseline dropout)|0|||
131158784|NCT03515538|472205321|FG001|Overall Study|Screen failure (baseline dropout)|1|||
131158785|NCT03515538|472205322|FG002|Overall Study|Screen failure (baseline dropout)|0|||
131158786|NCT03515538|472205323|FG003|Overall Study|Screen failure (baseline dropout)|0|||
131158787|NCT03515538|472205320|FG000|Overall Study|Withdrawal by Subject|2|||
131158788|NCT03515538|472205321|FG001|Overall Study|Withdrawal by Subject|2|||
131158789|NCT03515538|472205322|FG002|Overall Study|Withdrawal by Subject|1|||
131158790|NCT03515538|472205323|FG003|Overall Study|Withdrawal by Subject|3|||
131158791|NCT03515538|472205320|FG000|Overall Study|Physician Decision|1|||
131158792|NCT03515538|472205321|FG001|Overall Study|Physician Decision|0|||
131158793|NCT03515538|472205322|FG002|Overall Study|Physician Decision|0|||
131158794|NCT03515538|472205323|FG003|Overall Study|Physician Decision|1|||
131158795|NCT03842709|472205329|FG000|Overall Study|Withdrawal by Subject|3|||
131158796|NCT03842709|472205330|FG001|Overall Study|Withdrawal by Subject|3|||
131158797|NCT03842709|472205329|FG000|Overall Study|Lost to Follow-up|1|||
131158798|NCT03842709|472205330|FG001|Overall Study|Lost to Follow-up|0|||
131158799|NCT00641147|472205331|FG000|Completed 4 Months.|Physician Decision|1|||
131158800|NCT00641147|472205332|FG001|Completed 4 Months.|Physician Decision|0|||
131158801|NCT00641147|472205331|FG000|Completed 4 Months.|Adverse Event|1|||
131158802|NCT00641147|472205332|FG001|Completed 4 Months.|Adverse Event|0|||
131158803|NCT00641147|472205331|FG000|Completed 8 Months.|Physician Decision|2|||
131158804|NCT00641147|472205332|FG001|Completed 8 Months.|Physician Decision|1|||
131158805|NCT00641147|472205331|FG000|Completed 8 Months.|non compliance|1|||
131158806|NCT00641147|472205332|FG001|Completed 8 Months.|non compliance|0|||
131158807|NCT00641147|472205331|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
131158808|NCT00641147|472205332|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
131158809|NCT00641147|472205331|FG000|Completed 12 Months.|Physician Decision|1|||
131158810|NCT00641147|472205332|FG001|Completed 12 Months.|Physician Decision|1|||
131158811|NCT00641147|472205331|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
131158812|NCT00641147|472205332|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
131158813|NCT00641147|472205331|FG000|Completed 16 Months.|Physician Decision|1|||
131158814|NCT00641147|472205332|FG001|Completed 16 Months.|Physician Decision|0|||
131158815|NCT00641147|472205331|FG000|Completed 16 Months.|Lost to Follow-up|1|||
131158816|NCT00641147|472205332|FG001|Completed 16 Months.|Lost to Follow-up|0|||
131158817|NCT00791128|472205333|FG000|Overall Study|Adverse Event|4|||
131158818|NCT00791128|472205333|FG000|Overall Study|Device migration|2|||
131158819|NCT00791128|472205333|FG000|Overall Study|non-compliance by subject|2|||
131158820|NCT00791128|472205333|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
131158821|NCT01629667|472205334|FG000|Overall Study|Lost to Follow-up|0|||
131158822|NCT01629667|472205335|FG001|Overall Study|Lost to Follow-up|1|||
131158823|NCT01629667|472205336|FG002|Overall Study|Lost to Follow-up|1|||
131158824|NCT01629667|472205334|FG000|Overall Study|Withdrawal by Subject|31|||
131158825|NCT01629667|472205335|FG001|Overall Study|Withdrawal by Subject|20|||
131158826|NCT01629667|472205336|FG002|Overall Study|Withdrawal by Subject|28|||
131158827|NCT01629667|472205334|FG000|Overall Study|Death|1|||
131158828|NCT01629667|472205335|FG001|Overall Study|Death|5|||
131158829|NCT01629667|472205336|FG002|Overall Study|Death|3|||
131158830|NCT01629667|472205334|FG000|Overall Study|Randomized, not treated|2|||
131158831|NCT01629667|472205335|FG001|Overall Study|Randomized, not treated|1|||
131158832|NCT01629667|472205336|FG002|Overall Study|Randomized, not treated|0|||
131158833|NCT01629667|472205334|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
131158834|NCT01629667|472205335|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
131158835|NCT01629667|472205336|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
131158836|NCT01629667|472205334|FG000|Overall Study|Requiring lung transplant|2|||
131158837|NCT01629667|472205335|FG001|Overall Study|Requiring lung transplant|1|||
131158838|NCT01629667|472205336|FG002|Overall Study|Requiring lung transplant|3|||
131158839|NCT01629667|472205334|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
131158840|NCT01629667|472205335|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
131158841|NCT01629667|472205336|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
131158842|NCT01629667|472205334|FG000|Overall Study|Started other medicine|1|||
131158843|NCT01629667|472205335|FG001|Overall Study|Started other medicine|0|||
131158844|NCT01629667|472205336|FG002|Overall Study|Started other medicine|1|||
131158845|NCT01629667|472205334|FG000|Overall Study|Site error in safety follow-up|0|||
131158846|NCT01629667|472205335|FG001|Overall Study|Site error in safety follow-up|0|||
131158847|NCT01629667|472205336|FG002|Overall Study|Site error in safety follow-up|1|||
131158848|NCT01629667|472205334|FG000|Overall Study|Enrolled in another clinical study|0|||
131158849|NCT01629667|472205335|FG001|Overall Study|Enrolled in another clinical study|1|||
131158850|NCT01629667|472205336|FG002|Overall Study|Enrolled in another clinical study|0|||
131158851|NCT01629667|472205334|FG000|Overall Study|Code break|1|||
131158852|NCT01629667|472205335|FG001|Overall Study|Code break|0|||
131158853|NCT01629667|472205336|FG002|Overall Study|Code break|0|||
131158854|NCT00546351|472205337|FG000|Overall Study|Adverse Event|76|||
131158855|NCT00546351|472205337|FG000|Overall Study|Lack of Efficacy|15|||
131158856|NCT00546351|472205337|FG000|Overall Study|Withdrawal by Subject|109|||
131158857|NCT00546351|472205337|FG000|Overall Study|Lost to Follow-up|9|||
131158858|NCT00546351|472205337|FG000|Overall Study|Protocol Deviation|1|||
131158859|NCT00546351|472205337|FG000|Overall Study|Unsatisfactory compliance|9|||
131158860|NCT00546351|472205337|FG000|Overall Study|Other reasons for premature termination|17|||
131158861|NCT03952650|472205338|FG000|Overall Study|TRAVEL|0|||
131158862|NCT03952650|472205339|FG001|Overall Study|TRAVEL|4|||
131158863|NCT03952650|472205340|FG002|Overall Study|TRAVEL|0|||
131158864|NCT03952650|472205341|FG003|Overall Study|TRAVEL|4|||
131158865|NCT03952650|472205342|FG004|Overall Study|TRAVEL|0|||
131158866|NCT03952650|472205343|FG005|Overall Study|TRAVEL|3|||
131158867|NCT03952650|472205344|FG006|Overall Study|TRAVEL|2|||
131158868|NCT03952650|472205338|FG000|Overall Study|Withdrawal by Subject|0|||
131158869|NCT03952650|472205339|FG001|Overall Study|Withdrawal by Subject|2|||
131158870|NCT03952650|472205340|FG002|Overall Study|Withdrawal by Subject|0|||
131158871|NCT03952650|472205341|FG003|Overall Study|Withdrawal by Subject|3|||
131158872|NCT03952650|472205342|FG004|Overall Study|Withdrawal by Subject|0|||
131158873|NCT03952650|472205343|FG005|Overall Study|Withdrawal by Subject|1|||
131158874|NCT03952650|472205344|FG006|Overall Study|Withdrawal by Subject|1|||
131158875|NCT03952650|472205338|FG000|Overall Study|Lost to Follow-up|0|||
131158876|NCT03952650|472205339|FG001|Overall Study|Lost to Follow-up|1|||
131158877|NCT03952650|472205340|FG002|Overall Study|Lost to Follow-up|0|||
131158878|NCT03952650|472205341|FG003|Overall Study|Lost to Follow-up|0|||
131158879|NCT03952650|472205342|FG004|Overall Study|Lost to Follow-up|0|||
131158880|NCT03952650|472205343|FG005|Overall Study|Lost to Follow-up|1|||
131158881|NCT03952650|472205344|FG006|Overall Study|Lost to Follow-up|1|||
131158882|NCT03952650|472205338|FG000|Overall Study|Received wrong vaccine and travelled|0|||
131158883|NCT03952650|472205339|FG001|Overall Study|Received wrong vaccine and travelled|0|||
131158884|NCT03952650|472205340|FG002|Overall Study|Received wrong vaccine and travelled|0|||
131158885|NCT03952650|472205341|FG003|Overall Study|Received wrong vaccine and travelled|0|||
131158886|NCT03952650|472205342|FG004|Overall Study|Received wrong vaccine and travelled|0|||
131158887|NCT03952650|472205343|FG005|Overall Study|Received wrong vaccine and travelled|1|||
131158888|NCT03952650|472205344|FG006|Overall Study|Received wrong vaccine and travelled|0|||
131158889|NCT03952650|472205338|FG000|Overall Study|Unable to make study visit|0|||
131158890|NCT03952650|472205339|FG001|Overall Study|Unable to make study visit|0|||
131158891|NCT03952650|472205340|FG002|Overall Study|Unable to make study visit|0|||
130728734|NCT02784795|470628645|FG004|Overall Study|Withdrawal by Subject|3|||
130728735|NCT02784795|470628646|FG005|Overall Study|Withdrawal by Subject|0|||
130728736|NCT02784795|470628647|FG006|Overall Study|Withdrawal by Subject|0|||
130728737|NCT02784795|470628648|FG007|Overall Study|Withdrawal by Subject|1|||
130728738|NCT02784795|470628649|FG008|Overall Study|Withdrawal by Subject|0|||
130728739|NCT02784795|470628650|FG009|Overall Study|Withdrawal by Subject|0|||
130728740|NCT02784795|470628651|FG010|Overall Study|Withdrawal by Subject|0|||
130728741|NCT02784795|470628652|FG011|Overall Study|Withdrawal by Subject|2|||
130728742|NCT02784795|470628641|FG000|Overall Study|Death|0|||
130728743|NCT02784795|470628642|FG001|Overall Study|Death|0|||
130728744|NCT02784795|470628643|FG002|Overall Study|Death|0|||
130728745|NCT02784795|470628644|FG003|Overall Study|Death|0|||
130728746|NCT02784795|470628645|FG004|Overall Study|Death|1|||
130728747|NCT02784795|470628646|FG005|Overall Study|Death|0|||
130728748|NCT02784795|470628647|FG006|Overall Study|Death|0|||
130728749|NCT02784795|470628648|FG007|Overall Study|Death|0|||
130728750|NCT02784795|470628649|FG008|Overall Study|Death|0|||
130728751|NCT02784795|470628650|FG009|Overall Study|Death|0|||
130728752|NCT02784795|470628651|FG010|Overall Study|Death|0|||
130728753|NCT02784795|470628652|FG011|Overall Study|Death|0|||
130728754|NCT02784795|470628641|FG000|Overall Study|Physician Decision|0|||
130728755|NCT02784795|470628642|FG001|Overall Study|Physician Decision|0|||
131158892|NCT03952650|472205341|FG003|Overall Study|Unable to make study visit|0|||
131158893|NCT03952650|472205342|FG004|Overall Study|Unable to make study visit|0|||
131158894|NCT03952650|472205343|FG005|Overall Study|Unable to make study visit|1|||
131158895|NCT03952650|472205344|FG006|Overall Study|Unable to make study visit|0|||
131158896|NCT02424149|472205345|FG000|Overall Study|surgery cancelled|2|||
131158897|NCT02424149|472205346|FG001|Overall Study|surgery cancelled|0|||
131158898|NCT02424149|472205345|FG000|Overall Study|Withdrawal by Subject|0|||
131158899|NCT02424149|472205346|FG001|Overall Study|Withdrawal by Subject|1|||
131158900|NCT00592683|472205347|FG000|Overall Study|Found ineligible|0|||
131158901|NCT00592683|472205348|FG001|Overall Study|Found ineligible|1|||
131158902|NCT00592683|472205347|FG000|Overall Study|Withdrawal by Subject|1|||
131158903|NCT00592683|472205348|FG001|Overall Study|Withdrawal by Subject|0|||
131235340|NCT03008460|472488898|FG000|Overall Study|End of study visit outside permitted time window|0|||
131235341|NCT03008460|472488899|FG001|Overall Study|End of study visit outside permitted time window|1|||
130728756|NCT02784795|470628643|FG002|Overall Study|Physician Decision|0|||
130728757|NCT02784795|470628644|FG003|Overall Study|Physician Decision|0|||
130728758|NCT02784795|470628645|FG004|Overall Study|Physician Decision|0|||
130728759|NCT02784795|470628646|FG005|Overall Study|Physician Decision|0|||
131158904|NCT00592683|472205347|FG000|Overall Study|Adverse Event|0|||
131158905|NCT00592683|472205348|FG001|Overall Study|Adverse Event|2|||
131158906|NCT00592683|472205347|FG000|Overall Study|Protocol Violation|1|||
131235342|NCT03008460|472488898|FG000|Overall Study|Lost to Follow-up|1|||
131235343|NCT03008460|472488899|FG001|Overall Study|Lost to Follow-up|3|||
130728760|NCT02784795|470628647|FG006|Overall Study|Physician Decision|1|||
130728761|NCT02784795|470628648|FG007|Overall Study|Physician Decision|0|||
131158907|NCT00592683|472205348|FG001|Overall Study|Protocol Violation|0|||
131158908|NCT00592683|472205347|FG000|Overall Study|Study drug expired|1|||
131158909|NCT00592683|472205348|FG001|Overall Study|Study drug expired|0|||
130728762|NCT02784795|470628649|FG008|Overall Study|Physician Decision|0|||
131158910|NCT00592683|472205347|FG000|Overall Study|Other|1|||
131158911|NCT00592683|472205348|FG001|Overall Study|Other|0|||
131158912|NCT00592683|472205347|FG000|Overall Study|Lost to Follow-up|0|||
131158913|NCT00592683|472205348|FG001|Overall Study|Lost to Follow-up|1|||
131158914|NCT01357239|472205351|FG000|Stratum: All Patients|Adverse Event|0|||
131158915|NCT01357239|472205352|FG001|Stratum: All Patients|Adverse Event|0|||
131158916|NCT01357239|472205353|FG002|Stratum: All Patients|Adverse Event|1|||
131158917|NCT01357239|472205354|FG003|Stratum: All Patients|Adverse Event|1|||
131158918|NCT01357239|472205351|FG000|Stratum: All Patients|Subject withdrew consent|0|||
131158919|NCT01357239|472205352|FG001|Stratum: All Patients|Subject withdrew consent|0|||
131158920|NCT01357239|472205353|FG002|Stratum: All Patients|Subject withdrew consent|1|||
131158921|NCT01357239|472205354|FG003|Stratum: All Patients|Subject withdrew consent|1|||
131158922|NCT01357239|472205351|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
131158923|NCT01357239|472205352|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
131158924|NCT01357239|472205353|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
131158925|NCT01357239|472205354|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
131158926|NCT01357239|472205351|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
131158927|NCT01357239|472205352|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
131158928|NCT01357239|472205353|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
131158929|NCT01357239|472205354|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
131158930|NCT01357239|472205351|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
131158931|NCT01357239|472205352|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
131158932|NCT01357239|472205353|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
131158933|NCT01357239|472205354|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
131158934|NCT00545818|472205363|FG000|Overall Study|Protocol Violation|1|||
131158935|NCT00545818|472205364|FG001|Overall Study|Protocol Violation|0|||
131158936|NCT00545818|472205363|FG000|Overall Study|Adverse Event|1|||
131158937|NCT00545818|472205364|FG001|Overall Study|Adverse Event|1|||
131158938|NCT00545818|472205363|FG000|Overall Study|Lost to Follow-up|1|||
131158939|NCT00545818|472205364|FG001|Overall Study|Lost to Follow-up|6|||
131158940|NCT00609609|472205365|FG000|Overall Study|Withdrawal by Subject|2|||
131158941|NCT00609609|472205366|FG001|Overall Study|Withdrawal by Subject|0|||
131158942|NCT00609609|472205365|FG000|Overall Study|Progression|4|||
131158943|NCT00609609|472205366|FG001|Overall Study|Progression|2|||
131158944|NCT01050062|472205367|FG000|Overall Study|Adverse Event|75|||
131158945|NCT01050062|472205368|FG001|Overall Study|Adverse Event|22|||
131158946|NCT01050062|472205367|FG000|Overall Study|Lost to Follow-up|83|||
131158947|NCT01050062|472205368|FG001|Overall Study|Lost to Follow-up|35|||
131158948|NCT01050062|472205367|FG000|Overall Study|Lack of Efficacy|22|||
131158949|NCT01050062|472205368|FG001|Overall Study|Lack of Efficacy|35|||
131158950|NCT01050062|472205367|FG000|Overall Study|Physician Decision|74|||
131158951|NCT01050062|472205368|FG001|Overall Study|Physician Decision|9|||
131158952|NCT01050062|472205367|FG000|Overall Study|Others|17|||
131158953|NCT01050062|472205368|FG001|Overall Study|Others|11|||
131158954|NCT00670111|472205371|FG000|Enrollment to One Month|Testing Failure|0|||
131158955|NCT00670111|472205372|FG001|Enrollment to One Month|Testing Failure|0|||
131158956|NCT00670111|472205373|FG002|Enrollment to One Month|Testing Failure|13|||
131158957|NCT00670111|472205371|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
131158958|NCT00670111|472205372|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
131158959|NCT00670111|472205373|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
131158960|NCT00670111|472205371|FG000|Enrollment to One Month|Physician Decision|1|||
131158961|NCT00670111|472205372|FG001|Enrollment to One Month|Physician Decision|0|||
131158962|NCT00670111|472205373|FG002|Enrollment to One Month|Physician Decision|0|||
131158963|NCT03988751|472205374|FG000|Overall Study|Withdrawal by Subject|1|||
131158964|NCT03988751|472205375|FG001|Overall Study|Withdrawal by Subject|0|||
131158965|NCT03988751|472205374|FG000|Overall Study|Protocol Violation|0|||
131158966|NCT03988751|472205375|FG001|Overall Study|Protocol Violation|1|||
131158967|NCT02623361|472205378|FG000|Overall Study|Protocol Violation|0|||
131158968|NCT02623361|472205379|FG001|Overall Study|Protocol Violation|1|||
131158969|NCT02623361|472205378|FG000|Overall Study|Withdrawal by Subject|0|||
131158970|NCT02623361|472205379|FG001|Overall Study|Withdrawal by Subject|1|||
131158971|NCT00844883|472205380|FG000|Overall Study|Bridged to liver transplant|3|||
131158972|NCT00844883|472205380|FG000|Overall Study|Bridged to resection|1|||
131158973|NCT03000452|472205383|FG000|Treatment Period|Death|1|||
131158974|NCT03000452|472205383|FG000|Treatment Period|Progressive Disease (PD)|14|||
131158975|NCT03000452|472205383|FG000|Treatment Period|Physician Decision|1|||
131158976|NCT03000452|472205383|FG000|Treatment Period|Miscellaneous|2|||
131158977|NCT03000452|472205383|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
131158978|NCT03000452|472205383|FG000|Follow-Up Period|Death|3|||
131158979|NCT03000452|472205383|FG000|Follow-Up Period|Withdrawal by Subject|3|||
131158980|NCT00537823|472205386|FG000|Overall Study|Adverse Event|2|||
131158981|NCT00537823|472205387|FG001|Overall Study|Adverse Event|0|||
131158982|NCT03065530|472205388|FG000|Overall Study|Lack of Efficacy|1|||
131158983|NCT03065530|472205389|FG001|Overall Study|Lack of Efficacy|1|||
131158984|NCT03065530|472205390|FG002|Overall Study|Lack of Efficacy|0|||
131158985|NCT03065530|472205391|FG003|Overall Study|Lack of Efficacy|1|||
131158986|NCT03065530|472205388|FG000|Overall Study|Protocol Violation|1|||
131158987|NCT03065530|472205389|FG001|Overall Study|Protocol Violation|0|||
131158988|NCT03065530|472205390|FG002|Overall Study|Protocol Violation|1|||
131158989|NCT03065530|472205391|FG003|Overall Study|Protocol Violation|1|||
131158990|NCT03455543|472205392|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
131158991|NCT03455543|472205393|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
131158992|NCT03455543|472205394|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
131158993|NCT03455543|472205392|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
131158994|NCT03455543|472205393|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
131158995|NCT03455543|472205394|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
131158996|NCT03455543|472205392|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
131158997|NCT03455543|472205393|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
131158998|NCT03455543|472205394|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
131158999|NCT03455543|472205392|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
131159000|NCT03455543|472205393|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
131159001|NCT03455543|472205394|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
131159002|NCT03455543|472205392|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
131159003|NCT03455543|472205393|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
131159004|NCT03455543|472205394|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
131159005|NCT03455543|472205392|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
131159006|NCT03455543|472205393|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
131159007|NCT03455543|472205394|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
131159008|NCT03455543|472205392|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
131159009|NCT03455543|472205393|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
131159010|NCT03455543|472205394|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
131159011|NCT03455543|472205392|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
131159012|NCT03455543|472205393|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
131159013|NCT03455543|472205394|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
131159014|NCT03455543|472205392|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
131159015|NCT03455543|472205393|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
131159016|NCT03455543|472205394|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
131159017|NCT02873221|472205395|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
131159018|NCT02873221|472205396|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
131159019|NCT02873221|472205397|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
131159020|NCT02873221|472205395|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
131159021|NCT02873221|472205396|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
131159022|NCT02873221|472205397|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
131159023|NCT02873221|472205395|FG000|Treatment Period|Protocol Violation|2|||
131159024|NCT02873221|472205396|FG001|Treatment Period|Protocol Violation|5|||
131159025|NCT02873221|472205397|FG002|Treatment Period|Protocol Violation|8|||
131159026|NCT02873221|472205395|FG000|Treatment Period|Pregnancy|4|||
131159027|NCT02873221|472205396|FG001|Treatment Period|Pregnancy|6|||
131159028|NCT02873221|472205397|FG002|Treatment Period|Pregnancy|3|||
131159029|NCT02873221|472205395|FG000|Treatment Period|Lack of Qualifying Event|0|||
131159030|NCT02873221|472205396|FG001|Treatment Period|Lack of Qualifying Event|3|||
131159031|NCT02873221|472205397|FG002|Treatment Period|Lack of Qualifying Event|1|||
131159032|NCT02873221|472205395|FG000|Treatment Period|Withdrawal of Consent|52|||
131159033|NCT02873221|472205396|FG001|Treatment Period|Withdrawal of Consent|51|||
131159034|NCT02873221|472205397|FG002|Treatment Period|Withdrawal of Consent|41|||
131159035|NCT02873221|472205395|FG000|Treatment Period|Lack of Efficacy|0|||
131159036|NCT02873221|472205396|FG001|Treatment Period|Lack of Efficacy|17|||
131159037|NCT02873221|472205397|FG002|Treatment Period|Lack of Efficacy|12|||
131159038|NCT02873221|472205395|FG000|Treatment Period|Adverse Event|4|||
131159039|NCT02873221|472205396|FG001|Treatment Period|Adverse Event|9|||
131159040|NCT02873221|472205397|FG002|Treatment Period|Adverse Event|11|||
131159041|NCT02873221|472205395|FG000|Treatment Period|Lost to Follow-up|26|||
131159042|NCT02873221|472205396|FG001|Treatment Period|Lost to Follow-up|30|||
131159043|NCT02873221|472205397|FG002|Treatment Period|Lost to Follow-up|26|||
131159044|NCT02873221|472205395|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
131159045|NCT02873221|472205396|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
131159046|NCT02873221|472205397|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
131159047|NCT02873221|472205395|FG000|Safety Follow-up Period|Protocol Violation|0|||
131235344|NCT00634179|472488909|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
131235345|NCT02016300|472490881|FG000|Overall Study|Lost to Follow-up|0|||
131235346|NCT02016300|472490882|FG001|Overall Study|Lost to Follow-up|3|||
131235347|NCT02309099|472490883|FG000|Overall Study|Adverse Event|2|||
131159048|NCT02873221|472205396|FG001|Safety Follow-up Period|Protocol Violation|0|||
131159049|NCT02873221|472205397|FG002|Safety Follow-up Period|Protocol Violation|1|||
131235348|NCT02309099|472490884|FG001|Overall Study|Adverse Event|0|||
131235349|NCT06165744|472490885|FG000|Overall Study|Non device-related adverse event|1|||
131159050|NCT02873221|472205395|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
131159051|NCT02873221|472205396|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
131159052|NCT02873221|472205397|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
131159053|NCT02873221|472205395|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
131159054|NCT02873221|472205396|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
131159055|NCT02873221|472205397|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
131159056|NCT00852930|472205400|FG000|Overall Study|Withdrawal by Subject|1|||
131159057|NCT00852930|472205401|FG001|Overall Study|Withdrawal by Subject|1|||
131159058|NCT00852930|472205402|FG002|Overall Study|Withdrawal by Subject|1|||
131159059|NCT00852930|472205400|FG000|Overall Study|Physician Decision|0|||
131159060|NCT00852930|472205401|FG001|Overall Study|Physician Decision|0|||
131159061|NCT00852930|472205402|FG002|Overall Study|Physician Decision|1|||
131159062|NCT00479466|472205403|FG000|Overall Study|Adverse Event|5|||
131159063|NCT00479466|472205404|FG001|Overall Study|Adverse Event|1|||
131159064|NCT00479466|472205405|FG002|Overall Study|Adverse Event|0|||
131159065|NCT00479466|472205406|FG003|Overall Study|Adverse Event|1|||
131159066|NCT00479466|472205407|FG004|Overall Study|Adverse Event|2|||
131159067|NCT00479466|472205408|FG005|Overall Study|Adverse Event|0|||
131159068|NCT00479466|472205403|FG000|Overall Study|Hyperglycemia|0|||
131159069|NCT00479466|472205404|FG001|Overall Study|Hyperglycemia|0|||
131159070|NCT00479466|472205405|FG002|Overall Study|Hyperglycemia|0|||
130728763|NCT02784795|470628650|FG009|Overall Study|Physician Decision|0|||
131159071|NCT00479466|472205406|FG003|Overall Study|Hyperglycemia|0|||
131159072|NCT00479466|472205407|FG004|Overall Study|Hyperglycemia|0|||
131159073|NCT00479466|472205408|FG005|Overall Study|Hyperglycemia|1|||
131159074|NCT00479466|472205403|FG000|Overall Study|Lack of Efficacy|2|||
131159075|NCT00479466|472205404|FG001|Overall Study|Lack of Efficacy|0|||
131159076|NCT00479466|472205405|FG002|Overall Study|Lack of Efficacy|1|||
131159077|NCT00479466|472205406|FG003|Overall Study|Lack of Efficacy|0|||
131159078|NCT00479466|472205407|FG004|Overall Study|Lack of Efficacy|0|||
131159079|NCT00479466|472205408|FG005|Overall Study|Lack of Efficacy|0|||
131159080|NCT00479466|472205403|FG000|Overall Study|Lost to Follow-up|0|||
131159081|NCT00479466|472205404|FG001|Overall Study|Lost to Follow-up|1|||
131159082|NCT00479466|472205405|FG002|Overall Study|Lost to Follow-up|1|||
131159083|NCT00479466|472205406|FG003|Overall Study|Lost to Follow-up|0|||
131159084|NCT00479466|472205407|FG004|Overall Study|Lost to Follow-up|2|||
131159085|NCT00479466|472205408|FG005|Overall Study|Lost to Follow-up|2|||
131159086|NCT00479466|472205403|FG000|Overall Study|Physician Decision|2|||
131159087|NCT00479466|472205404|FG001|Overall Study|Physician Decision|1|||
131159088|NCT00479466|472205405|FG002|Overall Study|Physician Decision|1|||
131159089|NCT00479466|472205406|FG003|Overall Study|Physician Decision|0|||
131159090|NCT00479466|472205407|FG004|Overall Study|Physician Decision|0|||
131159091|NCT00479466|472205408|FG005|Overall Study|Physician Decision|0|||
131159092|NCT00479466|472205403|FG000|Overall Study|Pregnancy|0|||
131159093|NCT00479466|472205404|FG001|Overall Study|Pregnancy|0|||
131159094|NCT00479466|472205405|FG002|Overall Study|Pregnancy|0|||
131159095|NCT00479466|472205406|FG003|Overall Study|Pregnancy|0|||
131159096|NCT00479466|472205407|FG004|Overall Study|Pregnancy|1|||
131159097|NCT00479466|472205408|FG005|Overall Study|Pregnancy|0|||
131159098|NCT00479466|472205403|FG000|Overall Study|Protocol Violation|1|||
131159099|NCT00479466|472205404|FG001|Overall Study|Protocol Violation|0|||
131159100|NCT00479466|472205405|FG002|Overall Study|Protocol Violation|0|||
131159101|NCT00479466|472205406|FG003|Overall Study|Protocol Violation|0|||
131159102|NCT00479466|472205407|FG004|Overall Study|Protocol Violation|0|||
131159103|NCT00479466|472205408|FG005|Overall Study|Protocol Violation|0|||
131159104|NCT00479466|472205403|FG000|Overall Study|Withdrawal by Subject|3|||
131159105|NCT00479466|472205404|FG001|Overall Study|Withdrawal by Subject|5|||
131159106|NCT00479466|472205405|FG002|Overall Study|Withdrawal by Subject|0|||
131159107|NCT00479466|472205406|FG003|Overall Study|Withdrawal by Subject|2|||
131159108|NCT00479466|472205407|FG004|Overall Study|Withdrawal by Subject|3|||
131159109|NCT00479466|472205408|FG005|Overall Study|Withdrawal by Subject|1|||
131159110|NCT01325493|472205409|FG000|Overall Study|Protocol Violation|0|||
131159111|NCT01325493|472205410|FG001|Overall Study|Protocol Violation|1|||
130728764|NCT02784795|470628651|FG010|Overall Study|Physician Decision|0|||
131159112|NCT01325493|472205409|FG000|Overall Study|loss of neuromonitoring signals|0|||
131159113|NCT01325493|472205410|FG001|Overall Study|loss of neuromonitoring signals|2|||
131159114|NCT01325493|472205409|FG000|Overall Study|Allergy|1|||
131159115|NCT01325493|472205410|FG001|Overall Study|Allergy|0|||
130728765|NCT02784795|470628652|FG011|Overall Study|Physician Decision|0|||
130728766|NCT00626561|470628653|FG000|Overall Study|Withdrawal by Subject|2|||
131159116|NCT00234104|472205419|FG000|Overall Study|Adverse Event|4|||
131159117|NCT00234104|472205420|FG001|Overall Study|Adverse Event|0|||
131159118|NCT00234104|472205421|FG002|Overall Study|Adverse Event|3|||
130728767|NCT00626561|470628653|FG000|Overall Study|Disease Progression|2|||
131159119|NCT00234104|472205422|FG003|Overall Study|Adverse Event|5|||
131159120|NCT00234104|472205419|FG000|Overall Study|Protocol Violation|0|||
131159121|NCT00234104|472205420|FG001|Overall Study|Protocol Violation|0|||
131159122|NCT00234104|472205421|FG002|Overall Study|Protocol Violation|0|||
131159123|NCT00234104|472205422|FG003|Overall Study|Protocol Violation|1|||
131159124|NCT00234104|472205419|FG000|Overall Study|Physician Decision|0|||
131159125|NCT00234104|472205420|FG001|Overall Study|Physician Decision|1|||
131159126|NCT00234104|472205421|FG002|Overall Study|Physician Decision|2|||
131159127|NCT00234104|472205422|FG003|Overall Study|Physician Decision|2|||
131159128|NCT02052960|472205423|FG000|Overall Study|Adverse Event|19|||
131159129|NCT02052960|472205424|FG001|Overall Study|Adverse Event|17|||
131159130|NCT02052960|472205423|FG000|Overall Study|Protocol Violation|4|||
131159131|NCT02052960|472205424|FG001|Overall Study|Protocol Violation|3|||
131159132|NCT02052960|472205423|FG000|Overall Study|Withdrawal by Subject|6|||
131159133|NCT02052960|472205424|FG001|Overall Study|Withdrawal by Subject|11|||
131159134|NCT02052960|472205423|FG000|Overall Study|Other|25|||
131159135|NCT02052960|472205424|FG001|Overall Study|Other|15|||
131159136|NCT02460822|472205425|FG000|Overall Study|Withdrawal by Subject|1|||
131159137|NCT03849560|472205426|FG000|Overall Study|Withdrawal by Subject|1|||
131159138|NCT03849560|472205427|FG001|Overall Study|Withdrawal by Subject|0|||
131159139|NCT03849560|472205428|FG002|Overall Study|Withdrawal by Subject|0|||
131159140|NCT04045613|472205429|FG000|Overall Study|Adverse Event|2|||
131159141|NCT04045613|472205430|FG001|Overall Study|Adverse Event|2|||
131159142|NCT04045613|472205431|FG002|Overall Study|Adverse Event|1|||
131159143|NCT04045613|472205432|FG003|Overall Study|Adverse Event|1|||
131159144|NCT04045613|472205433|FG004|Overall Study|Adverse Event|0|||
131159145|NCT04045613|472205434|FG005|Overall Study|Adverse Event|0|||
131159146|NCT04045613|472205435|FG006|Overall Study|Adverse Event|1|||
131159147|NCT04045613|472205429|FG000|Overall Study|Withdrawal by Subject|0|||
131159148|NCT04045613|472205430|FG001|Overall Study|Withdrawal by Subject|5|||
131159149|NCT04045613|472205431|FG002|Overall Study|Withdrawal by Subject|0|||
131159150|NCT04045613|472205432|FG003|Overall Study|Withdrawal by Subject|0|||
131159151|NCT04045613|472205433|FG004|Overall Study|Withdrawal by Subject|0|||
131159152|NCT04045613|472205434|FG005|Overall Study|Withdrawal by Subject|1|||
131159153|NCT04045613|472205435|FG006|Overall Study|Withdrawal by Subject|0|||
131159154|NCT04045613|472205429|FG000|Overall Study|Physician Decision|2|||
131159155|NCT04045613|472205430|FG001|Overall Study|Physician Decision|0|||
131159156|NCT04045613|472205431|FG002|Overall Study|Physician Decision|0|||
131159157|NCT04045613|472205432|FG003|Overall Study|Physician Decision|0|||
131159158|NCT04045613|472205433|FG004|Overall Study|Physician Decision|1|||
131159159|NCT04045613|472205434|FG005|Overall Study|Physician Decision|0|||
131159160|NCT04045613|472205435|FG006|Overall Study|Physician Decision|0|||
131159161|NCT04045613|472205429|FG000|Overall Study|Death|3|||
131159162|NCT04045613|472205430|FG001|Overall Study|Death|0|||
131159163|NCT04045613|472205431|FG002|Overall Study|Death|0|||
131159164|NCT04045613|472205432|FG003|Overall Study|Death|0|||
130728768|NCT00595309|470628654|FG000|Overall Study|Lost to Follow-up|1|||
131159165|NCT04045613|472205433|FG004|Overall Study|Death|0|||
131159166|NCT04045613|472205434|FG005|Overall Study|Death|0|||
131159167|NCT04045613|472205435|FG006|Overall Study|Death|1|||
131159168|NCT04045613|472205429|FG000|Overall Study|Other reasons|0|||
131159169|NCT04045613|472205430|FG001|Overall Study|Other reasons|1|||
131159170|NCT04045613|472205431|FG002|Overall Study|Other reasons|0|||
131159171|NCT04045613|472205432|FG003|Overall Study|Other reasons|0|||
131159172|NCT04045613|472205433|FG004|Overall Study|Other reasons|0|||
131159173|NCT04045613|472205434|FG005|Overall Study|Other reasons|0|||
131159174|NCT04045613|472205435|FG006|Overall Study|Other reasons|1|||
131159175|NCT04045613|472205429|FG000|Overall Study|Progressive disease: Clinical progression|1|||
131159176|NCT04045613|472205430|FG001|Overall Study|Progressive disease: Clinical progression|0|||
131159177|NCT04045613|472205431|FG002|Overall Study|Progressive disease: Clinical progression|3|||
131159178|NCT04045613|472205432|FG003|Overall Study|Progressive disease: Clinical progression|1|||
131159179|NCT04045613|472205433|FG004|Overall Study|Progressive disease: Clinical progression|1|||
131159180|NCT04045613|472205434|FG005|Overall Study|Progressive disease: Clinical progression|3|||
131159181|NCT04045613|472205435|FG006|Overall Study|Progressive disease: Clinical progression|3|||
131159182|NCT04045613|472205429|FG000|Overall Study|Progressive disease: Radiological progression|24|||
131159183|NCT04045613|472205430|FG001|Overall Study|Progressive disease: Radiological progression|6|||
131159184|NCT04045613|472205431|FG002|Overall Study|Progressive disease: Radiological progression|8|||
131159185|NCT04045613|472205432|FG003|Overall Study|Progressive disease: Radiological progression|0|||
131159186|NCT04045613|472205433|FG004|Overall Study|Progressive disease: Radiological progression|6|||
130728769|NCT00595309|470628654|FG000|Overall Study|planned vaccination against yellow fever|1|||
130728770|NCT00595309|470628654|FG000|Overall Study|acute infection after V0|1|||
131159187|NCT04045613|472205434|FG005|Overall Study|Progressive disease: Radiological progression|6|||
131159188|NCT04045613|472205435|FG006|Overall Study|Progressive disease: Radiological progression|11|||
131159189|NCT01633060|472205436|FG000|Randomization Phase|Protocol deviation|1|||
131159190|NCT01633060|472205437|FG001|Randomization Phase|Protocol deviation|2|||
131159191|NCT01633060|472205436|FG000|Randomization Phase|Technical problem|0|||
131159192|NCT01633060|472205437|FG001|Randomization Phase|Technical problem|1|||
131159193|NCT01633060|472205436|FG000|Treatment Phase|Adverse Event|24|||
131159194|NCT01633060|472205437|FG001|Treatment Phase|Adverse Event|3|||
131159195|NCT01633060|472205436|FG000|Treatment Phase|Lost to Follow-up|1|||
131159196|NCT01633060|472205437|FG001|Treatment Phase|Lost to Follow-up|0|||
131159197|NCT01633060|472205436|FG000|Treatment Phase|Physician Decision|16|||
131159198|NCT01633060|472205437|FG001|Treatment Phase|Physician Decision|7|||
131159199|NCT01633060|472205436|FG000|Treatment Phase|Progressive Disease|210|||
131159200|NCT01633060|472205437|FG001|Treatment Phase|Progressive Disease|120|||
131159201|NCT01633060|472205436|FG000|Treatment Phase|Protocol Deviation|1|||
131159202|NCT01633060|472205437|FG001|Treatment Phase|Protocol Deviation|0|||
131159203|NCT01633060|472205436|FG000|Treatment Phase|Study Terminated by sponsor|7|||
131159204|NCT01633060|472205437|FG001|Treatment Phase|Study Terminated by sponsor|3|||
131159205|NCT01633060|472205436|FG000|Treatment Phase|Subject/guardian decision|25|||
131159206|NCT01633060|472205437|FG001|Treatment Phase|Subject/guardian decision|4|||
131159207|NCT01633060|472205436|FG000|Treatment Phase|Death|4|||
131159208|NCT01633060|472205437|FG001|Treatment Phase|Death|3|||
131159209|NCT01633060|472205436|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
131159210|NCT01633060|472205437|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
131159211|NCT01633060|472205436|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
131159212|NCT01633060|472205437|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
131159213|NCT01633060|472205436|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
131159214|NCT01633060|472205437|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
131159215|NCT01633060|472205436|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
131159216|NCT01633060|472205437|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
131159217|NCT01633060|472205436|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
131159218|NCT01633060|472205437|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
131159219|NCT01633060|472205436|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
131159220|NCT01633060|472205437|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
131159221|NCT01743027|472205438|FG000|Overall Study|Adverse Event|2|||
131159222|NCT01743027|472205439|FG001|Overall Study|Adverse Event|0|||
131159223|NCT01743027|472205440|FG002|Overall Study|Adverse Event|0|||
131159224|NCT01743027|472205441|FG003|Overall Study|Adverse Event|0|||
131159225|NCT01743027|472205438|FG000|Overall Study|Lost to Follow-up|0|||
131159226|NCT01743027|472205439|FG001|Overall Study|Lost to Follow-up|0|||
131159227|NCT01743027|472205440|FG002|Overall Study|Lost to Follow-up|2|||
131159228|NCT01743027|472205441|FG003|Overall Study|Lost to Follow-up|0|||
131159229|NCT01743027|472205438|FG000|Overall Study|Progressive Disease|1|||
131159230|NCT01743027|472205439|FG001|Overall Study|Progressive Disease|4|||
131159231|NCT01743027|472205440|FG002|Overall Study|Progressive Disease|3|||
131159232|NCT01743027|472205441|FG003|Overall Study|Progressive Disease|0|||
131159233|NCT01743027|472205438|FG000|Overall Study|Protocol Violation|1|||
131159234|NCT01743027|472205439|FG001|Overall Study|Protocol Violation|1|||
131159235|NCT01743027|472205440|FG002|Overall Study|Protocol Violation|1|||
131159236|NCT01743027|472205441|FG003|Overall Study|Protocol Violation|0|||
131159237|NCT01743027|472205438|FG000|Overall Study|Withdrawal by Subject|1|||
131159238|NCT01743027|472205439|FG001|Overall Study|Withdrawal by Subject|0|||
131159239|NCT01743027|472205440|FG002|Overall Study|Withdrawal by Subject|3|||
131159240|NCT01743027|472205441|FG003|Overall Study|Withdrawal by Subject|1|||
131159241|NCT02111811|472205444|FG000|Treatment Phase|Lost to Follow-up|22|||
131159242|NCT02111811|472205445|FG001|Treatment Phase|Lost to Follow-up|18|||
131159243|NCT02111811|472205444|FG000|Treatment Phase|Death|2|||
131159244|NCT02111811|472205445|FG001|Treatment Phase|Death|0|||
131159245|NCT02111811|472205444|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
131159246|NCT02111811|472205445|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
131159247|NCT02111811|472205444|FG000|Follow up Period (Aim 2)|Death|2|||
131159248|NCT02111811|472205445|FG001|Follow up Period (Aim 2)|Death|0|||
131159249|NCT00069121|472205447|FG000|Overall Study|Death|286|||
131159250|NCT00069121|472205448|FG001|Overall Study|Death|242|||
131159251|NCT00069121|472205447|FG000|Overall Study|Withdrawal by Subject|18|||
131159252|NCT00069121|472205448|FG001|Overall Study|Withdrawal by Subject|20|||
131159253|NCT00069121|472205447|FG000|Overall Study|Lost to Follow-up|63|||
131159254|NCT00069121|472205448|FG001|Overall Study|Lost to Follow-up|63|||
131159255|NCT00231478|472205454|FG000|Overall Study|Protocol Violation|3|||
131159256|NCT00231478|472205455|FG001|Overall Study|Protocol Violation|2|||
131159257|NCT00231478|472205454|FG000|Overall Study|Refused Treatment|1|||
131159258|NCT00231478|472205455|FG001|Overall Study|Refused Treatment|1|||
131159259|NCT00231478|472205454|FG000|Overall Study|Withdrawal by Subject|1|||
131159260|NCT00231478|472205455|FG001|Overall Study|Withdrawal by Subject|0|||
131159261|NCT00231478|472205454|FG000|Overall Study|Adverse Event|0|||
131159262|NCT00231478|472205455|FG001|Overall Study|Adverse Event|1|||
131159263|NCT00231478|472205454|FG000|Overall Study|Administrative|3|||
131159264|NCT00231478|472205455|FG001|Overall Study|Administrative|2|||
131159265|NCT00393458|472205467|FG000|Overall Study|Adverse Event|35|||
131159266|NCT00393458|472205468|FG001|Overall Study|Adverse Event|24|||
131159267|NCT00393458|472205469|FG002|Overall Study|Adverse Event|40|||
131159268|NCT00393458|472205470|FG003|Overall Study|Adverse Event|35|||
131159269|NCT00393458|472205467|FG000|Overall Study|Subject withdrew consent|27|||
131159270|NCT00393458|472205468|FG001|Overall Study|Subject withdrew consent|40|||
131159271|NCT00393458|472205469|FG002|Overall Study|Subject withdrew consent|33|||
131159272|NCT00393458|472205470|FG003|Overall Study|Subject withdrew consent|50|||
131159273|NCT00393458|472205467|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
131159274|NCT00393458|472205468|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
131159275|NCT00393458|472205469|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
131159276|NCT00393458|472205470|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
131159277|NCT00393458|472205467|FG000|Overall Study|Protocol deviation|11|||
131159278|NCT00393458|472205468|FG001|Overall Study|Protocol deviation|11|||
131159279|NCT00393458|472205469|FG002|Overall Study|Protocol deviation|11|||
131159280|NCT00393458|472205470|FG003|Overall Study|Protocol deviation|10|||
131159281|NCT00393458|472205467|FG000|Overall Study|Administrative problems|7|||
131159282|NCT00393458|472205468|FG001|Overall Study|Administrative problems|8|||
131159283|NCT00393458|472205469|FG002|Overall Study|Administrative problems|5|||
131159284|NCT00393458|472205470|FG003|Overall Study|Administrative problems|2|||
131159285|NCT00393458|472205467|FG000|Overall Study|Lost to Follow-up|5|||
131159286|NCT00393458|472205468|FG001|Overall Study|Lost to Follow-up|6|||
131159287|NCT00393458|472205469|FG002|Overall Study|Lost to Follow-up|5|||
131159288|NCT00393458|472205470|FG003|Overall Study|Lost to Follow-up|3|||
131159289|NCT00393458|472205467|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131159290|NCT00393458|472205468|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131159291|NCT00393458|472205469|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131159292|NCT00393458|472205470|FG003|Overall Study|Abnormal laboratory value(s)|0|||
131159293|NCT00393458|472205467|FG000|Overall Study|Death|1|||
131159294|NCT00393458|472205468|FG001|Overall Study|Death|1|||
131159295|NCT00393458|472205469|FG002|Overall Study|Death|5|||
131159296|NCT00393458|472205470|FG003|Overall Study|Death|5|||
131159297|NCT00393458|472205467|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131159298|NCT00393458|472205468|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131159299|NCT00393458|472205469|FG002|Overall Study|Abnormal test procedure result(s)|1|||
131159300|NCT00393458|472205470|FG003|Overall Study|Abnormal test procedure result(s)|2|||
131159301|NCT00393458|472205467|FG000|Overall Study|Subject no longer requires study drug|0|||
131159302|NCT00393458|472205468|FG001|Overall Study|Subject no longer requires study drug|1|||
131159303|NCT00393458|472205469|FG002|Overall Study|Subject no longer requires study drug|0|||
131159304|NCT00393458|472205470|FG003|Overall Study|Subject no longer requires study drug|0|||
131159305|NCT00104104|472205476|FG000|Overall Study|Adverse Event|8|||
131159306|NCT00104104|472205477|FG001|Overall Study|Adverse Event|8|||
131159307|NCT00104104|472205476|FG000|Overall Study|Abnormal laboratory value(s)|20|||
131159308|NCT00104104|472205477|FG001|Overall Study|Abnormal laboratory value(s)|14|||
131159309|NCT00104104|472205476|FG000|Overall Study|Lack of Efficacy|0|||
131159310|NCT00104104|472205477|FG001|Overall Study|Lack of Efficacy|3|||
131159311|NCT00104104|472205476|FG000|Overall Study|Condition no longer requires study drug|7|||
131159312|NCT00104104|472205477|FG001|Overall Study|Condition no longer requires study drug|4|||
131159313|NCT00104104|472205476|FG000|Overall Study|Protocol Violation|5|||
131159314|NCT00104104|472205477|FG001|Overall Study|Protocol Violation|2|||
131159315|NCT00104104|472205476|FG000|Overall Study|Withdrawal by Subject|11|||
131159316|NCT00104104|472205477|FG001|Overall Study|Withdrawal by Subject|15|||
131159317|NCT00104104|472205476|FG000|Overall Study|Lost to Follow-up|3|||
131159318|NCT00104104|472205477|FG001|Overall Study|Lost to Follow-up|7|||
131159319|NCT00104104|472205476|FG000|Overall Study|Administrative problems|12|||
131159320|NCT00104104|472205477|FG001|Overall Study|Administrative problems|13|||
131159321|NCT00104104|472205476|FG000|Overall Study|Death|9|||
131159322|NCT00104104|472205477|FG001|Overall Study|Death|6|||
131159323|NCT01821677|472205479|FG000|Overall Study|Adverse Event|4|||
131159324|NCT01821677|472205480|FG001|Overall Study|Adverse Event|6|||
131159325|NCT01821677|472205481|FG002|Overall Study|Adverse Event|5|||
131159326|NCT01821677|472205479|FG000|Overall Study|Physician Decision|1|||
131159327|NCT01821677|472205480|FG001|Overall Study|Physician Decision|4|||
131159328|NCT01821677|472205481|FG002|Overall Study|Physician Decision|1|||
131159329|NCT01821677|472205479|FG000|Overall Study|Non-compliance|0|||
131159330|NCT01821677|472205480|FG001|Overall Study|Non-compliance|1|||
131159331|NCT01821677|472205481|FG002|Overall Study|Non-compliance|2|||
131159332|NCT01821677|472205479|FG000|Overall Study|Lost to Follow-up|2|||
131159333|NCT01821677|472205480|FG001|Overall Study|Lost to Follow-up|1|||
131159334|NCT01821677|472205481|FG002|Overall Study|Lost to Follow-up|3|||
131159335|NCT01821677|472205479|FG000|Overall Study|Protocol Violation|0|||
131159336|NCT01821677|472205480|FG001|Overall Study|Protocol Violation|0|||
131159337|NCT01821677|472205481|FG002|Overall Study|Protocol Violation|2|||
131159338|NCT01821677|472205479|FG000|Overall Study|Withdrawal by Subject|7|||
131159339|NCT01821677|472205480|FG001|Overall Study|Withdrawal by Subject|3|||
131159340|NCT01821677|472205481|FG002|Overall Study|Withdrawal by Subject|2|||
130780594|NCT00735709|470823125|FG003|Overall Study|Adverse Event|5|||
130780595|NCT00735709|470823122|FG000|Overall Study|Lack of Efficacy|8|||
131159341|NCT01821677|472205479|FG000|Overall Study|Other|9|||
131159342|NCT01821677|472205480|FG001|Overall Study|Other|0|||
131159343|NCT01821677|472205481|FG002|Overall Study|Other|0|||
131159344|NCT01894516|472207031|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
131159345|NCT01894516|472207032|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
131159346|NCT01894516|472207033|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
131159347|NCT01894516|472207034|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
131159348|NCT01894516|472207031|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
131159349|NCT01894516|472207032|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131159350|NCT01894516|472207033|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131159351|NCT01894516|472207034|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
131159352|NCT01894516|472207031|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
131159353|NCT01894516|472207032|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
131159354|NCT01894516|472207033|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
131159355|NCT01894516|472207034|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
131159356|NCT01894516|472207031|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
131159357|NCT01894516|472207032|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
131159358|NCT01894516|472207033|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
131159359|NCT01894516|472207034|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
131159360|NCT01894516|472207031|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
131159361|NCT01894516|472207032|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
131159362|NCT01894516|472207033|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
131159363|NCT01894516|472207034|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
131159364|NCT01894516|472207031|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
131159365|NCT01894516|472207032|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
131159366|NCT01894516|472207033|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
131159367|NCT01894516|472207034|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
131159368|NCT01894516|472207031|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
131159369|NCT01894516|472207032|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
131159370|NCT01894516|472207033|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
131159371|NCT01894516|472207034|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
131159372|NCT01894516|472207031|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131159373|NCT01894516|472207032|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131159374|NCT01894516|472207033|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
131159375|NCT01894516|472207034|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
131159376|NCT03635190|472207035|FG000|Overall Study|Lost to Follow-up|4|||
131159377|NCT03635190|472207035|FG000|Overall Study|Death|3|||
131159378|NCT03635190|472207035|FG000|Overall Study|Withdrawal by Subject|1|||
131159379|NCT03635190|472207035|FG000|Overall Study|Patient moved and did not return for follow up|1|||
131159380|NCT03692910|472207036|FG000|Overall Study|Lost to Follow-up|4|||
131159381|NCT03692910|472207037|FG001|Overall Study|Lost to Follow-up|0|||
131159382|NCT03692910|472207038|FG002|Overall Study|Lost to Follow-up|0|||
131159383|NCT03692910|472207036|FG000|Overall Study|Withdrawal by Subject|2|||
131159384|NCT03692910|472207037|FG001|Overall Study|Withdrawal by Subject|0|||
131159385|NCT03692910|472207038|FG002|Overall Study|Withdrawal by Subject|0|||
131159386|NCT01981122|472207039|FG000|Overall Study|Withdrawal by Subject|0|||
131159387|NCT01981122|472207040|FG001|Overall Study|Withdrawal by Subject|2|||
131159388|NCT01981122|472207039|FG000|Overall Study|Protocol Violation|0|||
131159389|NCT01981122|472207040|FG001|Overall Study|Protocol Violation|1|||
131159390|NCT01981122|472207039|FG000|Overall Study|Lost to Follow-up|0|||
131159391|NCT01981122|472207040|FG001|Overall Study|Lost to Follow-up|1|||
131159392|NCT01981122|472207039|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
131159393|NCT01981122|472207040|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
131159394|NCT01981122|472207039|FG000|Overall Study|Death|14|||
131159395|NCT01981122|472207040|FG001|Overall Study|Death|15|||
131159396|NCT03216265|472207041|FG000|Overall Study|Adverse Event|2|||
131159397|NCT03216265|472207042|FG001|Overall Study|Adverse Event|0|||
131159398|NCT03216265|472207043|FG002|Overall Study|Adverse Event|2|||
131159399|NCT03216265|472207041|FG000|Overall Study|Lost to Follow-up|0|||
131159400|NCT03216265|472207042|FG001|Overall Study|Lost to Follow-up|1|||
131159401|NCT03216265|472207043|FG002|Overall Study|Lost to Follow-up|0|||
131159402|NCT03216265|472207041|FG000|Overall Study|Withdrawal by Subject|0|||
131159403|NCT03216265|472207042|FG001|Overall Study|Withdrawal by Subject|0|||
131159404|NCT03216265|472207043|FG002|Overall Study|Withdrawal by Subject|1|||
131159405|NCT01277289|472207045|FG000|Overall Study|fragile vein|1|||
131159406|NCT01277289|472207046|FG001|Overall Study|fragile vein|0|||
131159407|NCT01277289|472207045|FG000|Overall Study|Physician Decision|1|||
131159408|NCT01277289|472207046|FG001|Overall Study|Physician Decision|0|||
131235350|NCT05456529|472490886|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
131235351|NCT05456529|472490886|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
131235352|NCT05456529|472490886|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
131159409|NCT01277289|472207045|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
131159410|NCT01277289|472207046|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
131159411|NCT01277289|472207045|FG000|Overall Study|Protocol Violation|1|||
131159412|NCT01277289|472207046|FG001|Overall Study|Protocol Violation|1|||
131159413|NCT01277289|472207045|FG000|Overall Study|Adverse Event|2|||
131159414|NCT01277289|472207046|FG001|Overall Study|Adverse Event|1|||
131159415|NCT01277289|472207045|FG000|Overall Study|consent withdrawn|1|||
131159416|NCT01277289|472207046|FG001|Overall Study|consent withdrawn|1|||
131159417|NCT01277289|472207045|FG000|Overall Study|premature closure of the study|4|||
131159418|NCT01277289|472207046|FG001|Overall Study|premature closure of the study|2|||
131159419|NCT00092547|472207047|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
131159420|NCT00092547|472207048|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
131159421|NCT00092547|472207049|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
131159422|NCT00092547|472207047|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
131159423|NCT00092547|472207048|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
131159424|NCT00092547|472207049|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
131159425|NCT00092547|472207047|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
131159426|NCT00092547|472207048|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
131159427|NCT00092547|472207049|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
131159428|NCT00092547|472207047|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
131159429|NCT00092547|472207048|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
131159430|NCT00092547|472207049|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
131159431|NCT00092547|472207047|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
131159432|NCT00092547|472207048|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
131159433|NCT00092547|472207049|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
131159434|NCT00092547|472207047|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
131159435|NCT00092547|472207048|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
131159436|NCT00092547|472207049|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
131159437|NCT00092547|472207047|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
131159438|NCT00092547|472207048|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
131159439|NCT00092547|472207049|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
131159440|NCT00092547|472207047|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
131159441|NCT00092547|472207048|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
131159442|NCT00092547|472207049|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
131159443|NCT00092547|472207047|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
131159444|NCT00092547|472207048|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
131159445|NCT00092547|472207049|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
131159446|NCT00092547|472207047|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
131159447|NCT00092547|472207048|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
131159448|NCT00092547|472207049|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
131159449|NCT00092547|472207047|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
131159450|NCT00092547|472207048|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
131159451|NCT00092547|472207049|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
131159452|NCT00092547|472207047|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
131159453|NCT00092547|472207048|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
131159454|NCT00092547|472207049|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
131159455|NCT00092547|472207047|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
131159456|NCT00092547|472207048|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
131159457|NCT00092547|472207049|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
131159458|NCT00092547|472207047|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
131159459|NCT00092547|472207048|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
131159460|NCT00092547|472207049|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
131159461|NCT00092547|472207047|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
131159462|NCT00092547|472207048|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
131159463|NCT00092547|472207049|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
131159464|NCT00092547|472207047|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
131159465|NCT00092547|472207048|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
131159466|NCT00092547|472207049|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
131159467|NCT00092547|472207047|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
131159468|NCT00092547|472207048|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
131159469|NCT00092547|472207049|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
131159470|NCT00092547|472207047|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
131159471|NCT00092547|472207048|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
131159472|NCT00092547|472207049|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
131159473|NCT00092547|472207047|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
131159474|NCT00092547|472207048|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
131159475|NCT00092547|472207049|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
131159476|NCT00092547|472207047|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
131159477|NCT00092547|472207048|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
131159478|NCT00092547|472207049|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
131159479|NCT00092547|472207047|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
130728771|NCT00595309|470628654|FG000|Overall Study|personal reason|1|||
131159480|NCT00092547|472207048|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
131159481|NCT00092547|472207049|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
131159482|NCT01539837|472207050|FG000|Overall Study|reduce neutrophil level|0|||
131159483|NCT01539837|472207051|FG001|Overall Study|reduce neutrophil level|1|||
131159484|NCT01539837|472207052|FG002|Overall Study|reduce neutrophil level|1|||
131159485|NCT01539837|472207050|FG000|Overall Study|bad compliance|0|||
131159486|NCT01539837|472207051|FG001|Overall Study|bad compliance|0|||
131159487|NCT01539837|472207052|FG002|Overall Study|bad compliance|1|||
131159488|NCT01334125|472207063|FG000|Overall Study|Lost to Follow-up|3|||
131159489|NCT01334125|472207064|FG001|Overall Study|Lost to Follow-up|3|||
131159490|NCT00401973|472207067|FG000|Overall Study|Adverse Event|2|||
131159491|NCT00401973|472207068|FG001|Overall Study|Adverse Event|8|||
131159492|NCT00401973|472207069|FG002|Overall Study|Adverse Event|4|||
131159493|NCT00401973|472207067|FG000|Overall Study|Clinical Relapse|0|||
131159494|NCT00401973|472207068|FG001|Overall Study|Clinical Relapse|1|||
131159495|NCT00401973|472207069|FG002|Overall Study|Clinical Relapse|1|||
131159496|NCT00401973|472207067|FG000|Overall Study|Lack of Efficacy|0|||
131159497|NCT00401973|472207068|FG001|Overall Study|Lack of Efficacy|0|||
131159498|NCT00401973|472207069|FG002|Overall Study|Lack of Efficacy|3|||
131159499|NCT00401973|472207067|FG000|Overall Study|Lost to Follow-up|2|||
131159500|NCT00401973|472207068|FG001|Overall Study|Lost to Follow-up|2|||
131159501|NCT00401973|472207069|FG002|Overall Study|Lost to Follow-up|2|||
131159502|NCT00401973|472207067|FG000|Overall Study|Physician Decision|2|||
131159503|NCT00401973|472207068|FG001|Overall Study|Physician Decision|0|||
131159504|NCT00401973|472207069|FG002|Overall Study|Physician Decision|1|||
131159505|NCT00401973|472207067|FG000|Overall Study|Protocol Violation|1|||
131159506|NCT00401973|472207068|FG001|Overall Study|Protocol Violation|2|||
131159507|NCT00401973|472207069|FG002|Overall Study|Protocol Violation|3|||
131159508|NCT00401973|472207067|FG000|Overall Study|Sponsor Decision|0|||
131159509|NCT00401973|472207068|FG001|Overall Study|Sponsor Decision|1|||
131159510|NCT00401973|472207069|FG002|Overall Study|Sponsor Decision|0|||
131159511|NCT00401973|472207067|FG000|Overall Study|Withdrawal by Subject|4|||
131159512|NCT00401973|472207068|FG001|Overall Study|Withdrawal by Subject|12|||
131159513|NCT00401973|472207069|FG002|Overall Study|Withdrawal by Subject|9|||
131159514|NCT05523362|472207070|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
131159515|NCT05523362|472207070|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
131159516|NCT05523362|472207070|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
131159517|NCT05523362|472207070|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
131159518|NCT04075604|472207071|FG000|Overall Study|Adverse Event|0|||
131159519|NCT04075604|472207072|FG001|Overall Study|Adverse Event|0|||
131159520|NCT04075604|472207073|FG002|Overall Study|Adverse Event|3|||
131159521|NCT04075604|472207071|FG000|Overall Study|Participant request to discontinue study treatment|0|||
131159522|NCT04075604|472207072|FG001|Overall Study|Participant request to discontinue study treatment|0|||
131159523|NCT04075604|472207073|FG002|Overall Study|Participant request to discontinue study treatment|1|||
131159524|NCT04075604|472207071|FG000|Overall Study|Participant withdrew consent|0|||
131159525|NCT04075604|472207072|FG001|Overall Study|Participant withdrew consent|0|||
131159526|NCT04075604|472207073|FG002|Overall Study|Participant withdrew consent|1|||
131159527|NCT04075604|472207071|FG000|Overall Study|Other reasons|1|||
131159528|NCT04075604|472207072|FG001|Overall Study|Other reasons|0|||
131159529|NCT04075604|472207073|FG002|Overall Study|Other reasons|0|||
131159530|NCT04075604|472207071|FG000|Overall Study|Disease progression|0|||
131159531|NCT04075604|472207072|FG001|Overall Study|Disease progression|1|||
131159532|NCT04075604|472207073|FG002|Overall Study|Disease progression|0|||
131159533|NCT04075604|472207071|FG000|Overall Study|Study drug toxicity|0|||
131159534|NCT04075604|472207072|FG001|Overall Study|Study drug toxicity|5|||
131159535|NCT04075604|472207073|FG002|Overall Study|Study drug toxicity|1|||
131159536|NCT01650779|472207076|FG000|Overall Study|Withdrawal by Subject|1|||
131159537|NCT04329923|472207077|FG000|Overall Study|Withdrawal by Subject|1|||
131159538|NCT04329923|472207078|FG001|Overall Study|Withdrawal by Subject|4|||
131159539|NCT04329923|472207079|FG002|Overall Study|Withdrawal by Subject|1|||
131159540|NCT04329923|472207080|FG003|Overall Study|Withdrawal by Subject|1|||
131159541|NCT04329923|472207081|FG004|Overall Study|Withdrawal by Subject|1|||
131159542|NCT04329923|472207082|FG005|Overall Study|Withdrawal by Subject|1|||
131159543|NCT04329923|472207077|FG000|Overall Study|early termination of study|0|||
131159544|NCT04329923|472207078|FG001|Overall Study|early termination of study|0|||
131159545|NCT04329923|472207079|FG002|Overall Study|early termination of study|0|||
131159546|NCT04329923|472207080|FG003|Overall Study|early termination of study|0|||
131159547|NCT04329923|472207081|FG004|Overall Study|early termination of study|1|||
131159548|NCT04329923|472207082|FG005|Overall Study|early termination of study|2|||
131159549|NCT04329923|472207077|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
131159550|NCT04329923|472207078|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
131159551|NCT04329923|472207079|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
131159552|NCT04329923|472207080|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
131159553|NCT04329923|472207081|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
131159554|NCT04329923|472207082|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
131159555|NCT01272180|472207083|FG000|Overall Study|Adverse Event|0|||
131159556|NCT01272180|472207084|FG001|Overall Study|Adverse Event|0|||
131159557|NCT01272180|472207085|FG002|Overall Study|Adverse Event|1|||
131159558|NCT01272180|472207086|FG003|Overall Study|Adverse Event|0|||
131159559|NCT01272180|472207083|FG000|Overall Study|Withdrawal by Subject|2|||
131159560|NCT01272180|472207084|FG001|Overall Study|Withdrawal by Subject|6|||
131159561|NCT01272180|472207085|FG002|Overall Study|Withdrawal by Subject|3|||
131159562|NCT01272180|472207086|FG003|Overall Study|Withdrawal by Subject|2|||
131159563|NCT01272180|472207083|FG000|Overall Study|Lost to Follow-up|15|||
131159564|NCT01272180|472207084|FG001|Overall Study|Lost to Follow-up|14|||
131159565|NCT01272180|472207085|FG002|Overall Study|Lost to Follow-up|8|||
131159566|NCT01272180|472207086|FG003|Overall Study|Lost to Follow-up|10|||
131159567|NCT01272180|472207083|FG000|Overall Study|Inappropriate enrollment|0|||
131159568|NCT01272180|472207084|FG001|Overall Study|Inappropriate enrollment|0|||
131159569|NCT01272180|472207085|FG002|Overall Study|Inappropriate enrollment|1|||
131159570|NCT01272180|472207086|FG003|Overall Study|Inappropriate enrollment|1|||
131159571|NCT01272180|472207083|FG000|Overall Study|Protocol Violation|0|||
131159572|NCT01272180|472207084|FG001|Overall Study|Protocol Violation|1|||
131159573|NCT01272180|472207085|FG002|Overall Study|Protocol Violation|0|||
131159574|NCT01272180|472207086|FG003|Overall Study|Protocol Violation|1|||
131159575|NCT01183858|472207087|FG000|Overall Study|Death not related to Progressive Disease|5|||
131159576|NCT01183858|472207088|FG001|Overall Study|Death not related to Progressive Disease|6|||
131159577|NCT01183858|472207087|FG000|Overall Study|Adverse Event|14|||
131159578|NCT01183858|472207088|FG001|Overall Study|Adverse Event|11|||
131159579|NCT01183858|472207087|FG000|Overall Study|Investigator's Decision|0|||
131159580|NCT01183858|472207088|FG001|Overall Study|Investigator's Decision|3|||
131159581|NCT01183858|472207087|FG000|Overall Study|Insufficient Therapeutic Response|2|||
131159582|NCT01183858|472207088|FG001|Overall Study|Insufficient Therapeutic Response|0|||
131159583|NCT01183858|472207087|FG000|Overall Study|Refused Treatment|1|||
131159584|NCT01183858|472207088|FG001|Overall Study|Refused Treatment|4|||
131235353|NCT05456529|472490886|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
131235354|NCT05456529|472490886|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
131235355|NCT05456529|472490886|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
131235356|NCT05456529|472490886|FG000|44-week Long-term Safety Period|Physician Decision|2|||
131235357|NCT05456529|472490886|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
131235358|NCT05456529|472490886|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
131235359|NCT05456529|472490886|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
131235360|NCT05456529|472490886|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
131235361|NCT02518113|472490887|FG000|Overall Study|Adverse Event|1|||
131235362|NCT02518113|472490888|FG001|Overall Study|Adverse Event|0|||
131235363|NCT02518113|472490889|FG002|Overall Study|Adverse Event|1|||
131235364|NCT02518113|472490890|FG003|Overall Study|Adverse Event|0|||
131235365|NCT02518113|472490887|FG000|Overall Study|Death|1|||
131235366|NCT02518113|472490888|FG001|Overall Study|Death|2|||
131235367|NCT02518113|472490889|FG002|Overall Study|Death|0|||
131235368|NCT02518113|472490890|FG003|Overall Study|Death|0|||
131235369|NCT02518113|472490887|FG000|Overall Study|Physician Decision|0|||
131235370|NCT02518113|472490888|FG001|Overall Study|Physician Decision|1|||
131235371|NCT02518113|472490889|FG002|Overall Study|Physician Decision|0|||
131235372|NCT02518113|472490890|FG003|Overall Study|Physician Decision|0|||
131159585|NCT01183858|472207087|FG000|Overall Study|Withdrew Consent|4|||
131159586|NCT01183858|472207088|FG001|Overall Study|Withdrew Consent|4|||
131159587|NCT01183858|472207087|FG000|Overall Study|Discontinued Smoking|3|||
131159588|NCT01183858|472207088|FG001|Overall Study|Discontinued Smoking|1|||
131159589|NCT01183858|472207087|FG000|Overall Study|Protocol Violation|1|||
131159590|NCT01183858|472207088|FG001|Overall Study|Protocol Violation|0|||
131159591|NCT01183858|472207087|FG000|Overall Study|Administrative/Other|6|||
131159592|NCT01183858|472207088|FG001|Overall Study|Administrative/Other|6|||
131159593|NCT01183858|472207087|FG000|Overall Study|Progressive Disease|112|||
131159594|NCT01183858|472207088|FG001|Overall Study|Progressive Disease|115|||
131159595|NCT01183858|472207087|FG000|Overall Study|Death related to Progressive Disease|4|||
131159596|NCT01183858|472207088|FG001|Overall Study|Death related to Progressive Disease|5|||
131159597|NCT01183858|472207087|FG000|Overall Study|Lost to Follow-up|1|||
131159598|NCT01183858|472207088|FG001|Overall Study|Lost to Follow-up|1|||
131159599|NCT02441803|472207089|FG000|Overall Study|Physician Decision|0|||
131159600|NCT02441803|472207090|FG001|Overall Study|Physician Decision|2|||
131159601|NCT02441803|472207091|FG002|Overall Study|Physician Decision|2|||
131159602|NCT01512368|472207097|FG000|Overall Study|Protocol Violation|3|||
131159603|NCT00328198|472207098|FG000|Treatment|Adverse Event|21|||
131159604|NCT00328198|472207098|FG000|Treatment|Death|1|||
131159605|NCT00328198|472207098|FG000|Treatment|Physician Decision|5|||
131159606|NCT00328198|472207098|FG000|Treatment|Withdrawal by Subject|5|||
131159607|NCT00328198|472207098|FG000|Treatment|Evidence of disease progression|2|||
131235373|NCT02518113|472490887|FG000|Overall Study|Progressive Disease|1|||
131235374|NCT02518113|472490888|FG001|Overall Study|Progressive Disease|2|||
131235375|NCT02518113|472490889|FG002|Overall Study|Progressive Disease|3|||
131235376|NCT02518113|472490890|FG003|Overall Study|Progressive Disease|0|||
131235377|NCT00797108|472490891|FG000|Overall Study|Adverse Event|1|||
131159608|NCT00328198|472207098|FG000|Treatment|Non-compliance|1|||
131159609|NCT00328198|472207098|FG000|Treatment|Confirmed complete response, MRD -|3|||
131159610|NCT00328198|472207098|FG000|Follow-up|Lost to Follow-up|4|||
131159611|NCT00328198|472207098|FG000|Follow-up|Death|31|||
131159612|NCT02717546|472207100|FG000|Overall Study|Lost to Follow-up|12|||
131159613|NCT02614794|472207102|FG000|Overall Study|Death|258|||
131159614|NCT02614794|472207103|FG001|Overall Study|Death|151|||
131159615|NCT02614794|472207102|FG000|Overall Study|Study closure by Sponsor|119|||
131159616|NCT02614794|472207103|FG001|Overall Study|Study closure by Sponsor|45|||
131159617|NCT02614794|472207102|FG000|Overall Study|Withdrawal by Subject|24|||
131159618|NCT02614794|472207103|FG001|Overall Study|Withdrawal by Subject|5|||
131159619|NCT02614794|472207102|FG000|Overall Study|Lost to Follow-up|7|||
131159620|NCT02614794|472207103|FG001|Overall Study|Lost to Follow-up|0|||
131159621|NCT02614794|472207102|FG000|Overall Study|Physician Decision|1|||
131159622|NCT02614794|472207103|FG001|Overall Study|Physician Decision|1|||
131159623|NCT02614794|472207102|FG000|Overall Study|Hospital closure|1|||
131159624|NCT02614794|472207103|FG001|Overall Study|Hospital closure|0|||
131159625|NCT03396471|472207108|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
131159626|NCT03396471|472207108|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
131159627|NCT03396471|472207108|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
131159628|NCT03396471|472207108|FG000|Study Treatment - Up to 22 Months|Death|2|||
131159629|NCT03396471|472207108|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
131159630|NCT03396471|472207108|FG000|Follow up - Up to 2 Years|Death|9|||
131159631|NCT03396471|472207108|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
131159632|NCT03396471|472207108|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
131159633|NCT03396471|472207108|FG000|Follow up - Up to 2 Years|study terminated|1|||
131159634|NCT03396471|472207108|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
131159635|NCT03396471|472207108|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
131159636|NCT03237845|472207112|FG000|Overall Study|Adverse Event|0|||
131159637|NCT03237845|472207113|FG001|Overall Study|Adverse Event|1|||
131159638|NCT03237845|472207112|FG000|Overall Study|Lost to Follow-up|13|||
131159639|NCT03237845|472207113|FG001|Overall Study|Lost to Follow-up|10|||
131159640|NCT03237845|472207112|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
131159641|NCT03237845|472207113|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
131159642|NCT03237845|472207112|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
131159643|NCT03237845|472207113|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
131159644|NCT03237845|472207112|FG000|Overall Study|Physician Decision|1|||
131159645|NCT03237845|472207113|FG001|Overall Study|Physician Decision|2|||
131159646|NCT03237845|472207112|FG000|Overall Study|Pregnancy|1|||
131159647|NCT03237845|472207113|FG001|Overall Study|Pregnancy|0|||
131159648|NCT03237845|472207112|FG000|Overall Study|Protocol Deviation|0|||
131159649|NCT03237845|472207113|FG001|Overall Study|Protocol Deviation|1|||
131159650|NCT03237845|472207112|FG000|Overall Study|Technical Problems|8|||
131159651|NCT03237845|472207113|FG001|Overall Study|Technical Problems|1|||
131159652|NCT03237845|472207112|FG000|Overall Study|Withdrawal by Subject|3|||
131159653|NCT03237845|472207113|FG001|Overall Study|Withdrawal by Subject|3|||
131159654|NCT03237845|472207112|FG000|Overall Study|Other Reasons|4|||
131159655|NCT03237845|472207113|FG001|Overall Study|Other Reasons|0|||
131159656|NCT01645280|472207117|FG000|Overall Study|Death|0|||
131235378|NCT00797108|472490892|FG001|Overall Study|Adverse Event|0|||
131235379|NCT00797108|472490893|FG002|Overall Study|Adverse Event|3|||
131235380|NCT00797108|472490891|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
131235381|NCT00797108|472490892|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
131235382|NCT00797108|472490893|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
131235383|NCT00797108|472490891|FG000|Overall Study|Global Deterioration of Health Status|0|||
131235384|NCT00797108|472490892|FG001|Overall Study|Global Deterioration of Health Status|1|||
131235385|NCT00797108|472490893|FG002|Overall Study|Global Deterioration of Health Status|0|||
131235386|NCT00797108|472490891|FG000|Overall Study|Lack of Efficacy|1|||
131235387|NCT00797108|472490892|FG001|Overall Study|Lack of Efficacy|0|||
131235388|NCT00797108|472490893|FG002|Overall Study|Lack of Efficacy|1|||
131235389|NCT00797108|472490891|FG000|Overall Study|Other|0|||
131235390|NCT00797108|472490892|FG001|Overall Study|Other|0|||
131235391|NCT00797108|472490893|FG002|Overall Study|Other|2|||
131235392|NCT00797108|472490891|FG000|Overall Study|Randomized but not Treated|2|||
131235393|NCT00797108|472490892|FG001|Overall Study|Randomized but not Treated|0|||
131159657|NCT01645280|472207118|FG001|Overall Study|Death|1|||
131159658|NCT01645280|472207119|FG002|Overall Study|Death|0|||
131159659|NCT01645280|472207120|FG003|Overall Study|Death|0|||
131159660|NCT01645280|472207121|FG004|Overall Study|Death|0|||
131159661|NCT01645280|472207117|FG000|Overall Study|Withdrawal by Subject|4|||
131159662|NCT01645280|472207118|FG001|Overall Study|Withdrawal by Subject|0|||
131235394|NCT00797108|472490893|FG002|Overall Study|Randomized but not Treated|0|||
131235395|NCT02270736|472490894|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
131235396|NCT02270736|472490895|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
131235397|NCT02270736|472490896|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
131235398|NCT02270736|472490897|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
131159663|NCT01645280|472207119|FG002|Overall Study|Withdrawal by Subject|2|||
131159664|NCT01645280|472207120|FG003|Overall Study|Withdrawal by Subject|4|||
131159665|NCT01645280|472207121|FG004|Overall Study|Withdrawal by Subject|5|||
131159666|NCT01645280|472207117|FG000|Overall Study|Lost to Follow-up|0|||
131159667|NCT01645280|472207118|FG001|Overall Study|Lost to Follow-up|0|||
131159668|NCT01645280|472207119|FG002|Overall Study|Lost to Follow-up|0|||
131159669|NCT01645280|472207120|FG003|Overall Study|Lost to Follow-up|2|||
131159670|NCT01645280|472207121|FG004|Overall Study|Lost to Follow-up|1|||
131159671|NCT01645280|472207117|FG000|Overall Study|Other|1|||
131159672|NCT01645280|472207118|FG001|Overall Study|Other|1|||
131159673|NCT01645280|472207119|FG002|Overall Study|Other|2|||
131159674|NCT01645280|472207120|FG003|Overall Study|Other|0|||
131159675|NCT01645280|472207121|FG004|Overall Study|Other|0|||
131159676|NCT01645280|472207117|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
131159677|NCT01645280|472207118|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
131159678|NCT01645280|472207119|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
131159679|NCT01645280|472207120|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
131159680|NCT01645280|472207121|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
131159681|NCT00491530|472207133|FG000|Overall Study|Adverse Event|6|||
131159682|NCT00491530|472207134|FG001|Overall Study|Adverse Event|1|||
131159683|NCT00491530|472207135|FG002|Overall Study|Adverse Event|2|||
131159684|NCT00491530|472207133|FG000|Overall Study|Withdrawal by Subject|3|||
131159685|NCT00491530|472207134|FG001|Overall Study|Withdrawal by Subject|0|||
131159686|NCT00491530|472207135|FG002|Overall Study|Withdrawal by Subject|0|||
131159687|NCT00491530|472207133|FG000|Overall Study|Lost to Follow-up|3|||
131159688|NCT00491530|472207134|FG001|Overall Study|Lost to Follow-up|2|||
131159689|NCT00491530|472207135|FG002|Overall Study|Lost to Follow-up|2|||
131159690|NCT00491530|472207133|FG000|Overall Study|Lack of Efficacy|0|||
131159691|NCT00491530|472207134|FG001|Overall Study|Lack of Efficacy|1|||
131159692|NCT00491530|472207135|FG002|Overall Study|Lack of Efficacy|0|||
131159693|NCT00491530|472207133|FG000|Overall Study|Investigator Discretion|0|||
131159694|NCT00491530|472207134|FG001|Overall Study|Investigator Discretion|1|||
131159695|NCT00491530|472207135|FG002|Overall Study|Investigator Discretion|0|||
131159696|NCT00491530|472207133|FG000|Overall Study|Patient Request|0|||
131159697|NCT00491530|472207134|FG001|Overall Study|Patient Request|1|||
131159698|NCT00491530|472207135|FG002|Overall Study|Patient Request|0|||
131159699|NCT00491530|472207133|FG000|Overall Study|Use of Prohibited Medication|0|||
131159700|NCT00491530|472207134|FG001|Overall Study|Use of Prohibited Medication|0|||
131159701|NCT00491530|472207135|FG002|Overall Study|Use of Prohibited Medication|1|||
131159702|NCT02168946|472207136|FG000|Overall Study|Adverse Event|8|||
131159703|NCT02168946|472207137|FG001|Overall Study|Adverse Event|5|||
131159704|NCT02168946|472207136|FG000|Overall Study|Lost to Follow-up|3|||
131159705|NCT02168946|472207137|FG001|Overall Study|Lost to Follow-up|0|||
131159706|NCT02168946|472207136|FG000|Overall Study|Subject unable to come back for visits|1|||
131159707|NCT02168946|472207137|FG001|Overall Study|Subject unable to come back for visits|0|||
131159708|NCT00553787|472207139|FG000|Overall Study|Adverse Event|34|||
131159709|NCT00553787|472207140|FG001|Overall Study|Adverse Event|21|||
131159710|NCT00553787|472207141|FG002|Overall Study|Adverse Event|67|||
131159711|NCT00553787|472207139|FG000|Overall Study|Lost to Follow-up|132|||
131159712|NCT00553787|472207140|FG001|Overall Study|Lost to Follow-up|44|||
131159713|NCT00553787|472207141|FG002|Overall Study|Lost to Follow-up|78|||
131159714|NCT00553787|472207139|FG000|Overall Study|Withdrawal by Subject|151|||
131159715|NCT00553787|472207140|FG001|Overall Study|Withdrawal by Subject|40|||
131159716|NCT00553787|472207141|FG002|Overall Study|Withdrawal by Subject|83|||
131159717|NCT00553787|472207139|FG000|Overall Study|Lack of Efficacy|31|||
131235399|NCT02270736|472490898|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
131235400|NCT02270736|472490894|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
131235401|NCT02270736|472490895|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
131235402|NCT02270736|472490896|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
131159718|NCT00553787|472207140|FG001|Overall Study|Lack of Efficacy|1|||
131159719|NCT00553787|472207141|FG002|Overall Study|Lack of Efficacy|3|||
131159720|NCT00553787|472207139|FG000|Overall Study|Pregnancy|0|||
131159721|NCT00553787|472207140|FG001|Overall Study|Pregnancy|1|||
131159722|NCT00553787|472207141|FG002|Overall Study|Pregnancy|2|||
131159723|NCT00553787|472207139|FG000|Overall Study|non compliance|4|||
131159724|NCT00553787|472207140|FG001|Overall Study|non compliance|0|||
131159725|NCT00553787|472207141|FG002|Overall Study|non compliance|11|||
131159726|NCT00553787|472207139|FG000|Overall Study|Requirement for restricted medication|8|||
131159727|NCT00553787|472207140|FG001|Overall Study|Requirement for restricted medication|7|||
131159728|NCT00553787|472207141|FG002|Overall Study|Requirement for restricted medication|5|||
131159729|NCT00553787|472207139|FG000|Overall Study|Other|18|||
131159730|NCT00553787|472207140|FG001|Overall Study|Other|10|||
131159731|NCT00553787|472207141|FG002|Overall Study|Other|13|||
131159732|NCT05258058|472207160|FG000|Overall Study|Withdrawal by Subject|2|||
131159733|NCT04579393|472207161|FG000|Overall Study|Withdrawal by Subject|2|||
131159734|NCT04579393|472207162|FG001|Overall Study|Withdrawal by Subject|2|||
131159735|NCT04579393|472207161|FG000|Overall Study|Death|1|||
131159736|NCT04579393|472207162|FG001|Overall Study|Death|3|||
131159737|NCT02725177|472207170|FG000|Overall Study|Physician Decision|4|||
131159738|NCT02725177|472207170|FG000|Overall Study|Adverse Event|1|||
131159739|NCT00793585|472207171|FG000|Overall Study|Adverse Event|1|||
131159740|NCT00793585|472207172|FG001|Overall Study|Adverse Event|1|||
131159741|NCT00793585|472207171|FG000|Overall Study|Protocol Violation|1|||
131159742|NCT00793585|472207172|FG001|Overall Study|Protocol Violation|2|||
131159743|NCT00377299|472207173|FG000|Overall Study|Lost to Follow-up|14|||
131159744|NCT00377299|472207174|FG001|Overall Study|Lost to Follow-up|19|||
131159745|NCT00377299|472207173|FG000|Overall Study|Adverse Event|0|||
131159746|NCT00377299|472207174|FG001|Overall Study|Adverse Event|1|||
131159747|NCT00377299|472207173|FG000|Overall Study|Withdrawal by Subject|5|||
131159748|NCT00377299|472207174|FG001|Overall Study|Withdrawal by Subject|4|||
131159749|NCT00035815|472207178|FG000|Overall Study|Withdrawal by Subject|17|||
131159750|NCT00035815|472207179|FG001|Overall Study|Withdrawal by Subject|11|||
131159751|NCT02903511|472207186|FG000|Overall Study|Withdrawal by Subject|1|||
131159752|NCT02903511|472207187|FG001|Overall Study|Withdrawal by Subject|0|||
131159753|NCT02903511|472207186|FG000|Overall Study|Lost to Follow-up|3|||
131159754|NCT02903511|472207187|FG001|Overall Study|Lost to Follow-up|2|||
131159755|NCT05363293|472207192|FG000|Overall Study|Withdrawal by Subject|1|||
131159756|NCT05363293|472207193|FG001|Overall Study|Withdrawal by Subject|0|||
131159757|NCT05363293|472207194|FG002|Overall Study|Withdrawal by Subject|0|||
131159758|NCT05363293|472207195|FG003|Overall Study|Withdrawal by Subject|0|||
131159759|NCT05363293|472207196|FG004|Overall Study|Withdrawal by Subject|0|||
131159760|NCT05363293|472207197|FG005|Overall Study|Withdrawal by Subject|0|||
131159761|NCT05363293|472207198|FG006|Overall Study|Withdrawal by Subject|0|||
131159762|NCT05363293|472207199|FG007|Overall Study|Withdrawal by Subject|0|||
131159763|NCT05363293|472207200|FG008|Overall Study|Withdrawal by Subject|0|||
131159764|NCT05363293|472207201|FG009|Overall Study|Withdrawal by Subject|0|||
131159765|NCT02699515|472208877|FG000|Overall Study|Death|3|||
131159766|NCT02699515|472208878|FG001|Overall Study|Death|3|||
131159767|NCT02699515|472208879|FG002|Overall Study|Death|3|||
131159768|NCT02699515|472208880|FG003|Overall Study|Death|23|||
131159769|NCT02699515|472208881|FG004|Overall Study|Death|22|||
131159770|NCT02699515|472208882|FG005|Overall Study|Death|23|||
131159771|NCT02699515|472208883|FG006|Overall Study|Death|3|||
131159772|NCT02699515|472208884|FG007|Overall Study|Death|5|||
131159773|NCT02699515|472208877|FG000|Overall Study|Withdrawal by Subject|0|||
131159774|NCT02699515|472208878|FG001|Overall Study|Withdrawal by Subject|0|||
131159775|NCT02699515|472208879|FG002|Overall Study|Withdrawal by Subject|3|||
131159776|NCT02699515|472208880|FG003|Overall Study|Withdrawal by Subject|1|||
131159777|NCT02699515|472208881|FG004|Overall Study|Withdrawal by Subject|5|||
131159778|NCT02699515|472208882|FG005|Overall Study|Withdrawal by Subject|3|||
131159779|NCT02699515|472208883|FG006|Overall Study|Withdrawal by Subject|0|||
131159780|NCT02699515|472208884|FG007|Overall Study|Withdrawal by Subject|1|||
131159781|NCT02699515|472208877|FG000|Overall Study|Other|1|||
131159782|NCT02699515|472208878|FG001|Overall Study|Other|0|||
131159783|NCT02699515|472208879|FG002|Overall Study|Other|1|||
131159784|NCT02699515|472208880|FG003|Overall Study|Other|6|||
131159785|NCT02699515|472208881|FG004|Overall Study|Other|4|||
131159786|NCT02699515|472208882|FG005|Overall Study|Other|3|||
131159787|NCT02699515|472208883|FG006|Overall Study|Other|0|||
131159788|NCT02699515|472208884|FG007|Overall Study|Other|0|||
131159789|NCT00375934|472208886|FG000|Overall Study|Adverse Event|1|||
131159790|NCT00375934|472208887|FG001|Overall Study|Adverse Event|1|||
131159791|NCT00375934|472208886|FG000|Overall Study|Withdrawal by Subject|2|||
131159792|NCT00375934|472208887|FG001|Overall Study|Withdrawal by Subject|2|||
131235403|NCT02270736|472490897|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
131235404|NCT02270736|472490898|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
131235405|NCT02270736|472490894|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
131235406|NCT02270736|472490895|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
131235407|NCT02270736|472490896|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
131235408|NCT02270736|472490897|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
130780596|NCT00735709|470823123|FG001|Overall Study|Lack of Efficacy|4|||
131159793|NCT00375934|472208886|FG000|Overall Study|Lack of Efficacy|0|||
131159794|NCT00375934|472208887|FG001|Overall Study|Lack of Efficacy|2|||
131159795|NCT00375934|472208886|FG000|Overall Study|Physician Decision|0|||
131159796|NCT00375934|472208887|FG001|Overall Study|Physician Decision|1|||
131159797|NCT03191396|472208888|FG000|Overall Study|Lost to Follow-up|0|||
131159798|NCT03191396|472208889|FG001|Overall Study|Lost to Follow-up|3|||
131159799|NCT03191396|472208888|FG000|Overall Study|Withdrawal by Subject|3|||
131159800|NCT03191396|472208889|FG001|Overall Study|Withdrawal by Subject|2|||
131159801|NCT01300286|472208890|FG000|Overall Study|did not get dosed|1|||
131159802|NCT03060577|472208893|FG000|Overall Study|Withdrawal by Subject|25|||
131159803|NCT03060577|472208894|FG001|Overall Study|Withdrawal by Subject|5|||
131159804|NCT03060577|472208893|FG000|Overall Study|Physician Decision|4|||
131159805|NCT03060577|472208894|FG001|Overall Study|Physician Decision|3|||
131159806|NCT03060577|472208893|FG000|Overall Study|Lost to Follow-up|3|||
131159807|NCT03060577|472208894|FG001|Overall Study|Lost to Follow-up|0|||
131159808|NCT03060577|472208893|FG000|Overall Study|Death|7|||
131159809|NCT03060577|472208894|FG001|Overall Study|Death|1|||
131159810|NCT03060577|472208893|FG000|Overall Study|Adverse Event|9|||
131159811|NCT03060577|472208894|FG001|Overall Study|Adverse Event|1|||
131159812|NCT03060577|472208893|FG000|Overall Study|Inclusion/Exclusion|1|||
131159813|NCT03060577|472208894|FG001|Overall Study|Inclusion/Exclusion|0|||
131159814|NCT03060577|472208893|FG000|Overall Study|Other|8|||
131159815|NCT03060577|472208894|FG001|Overall Study|Other|2|||
131159816|NCT03666143|472208898|FG000|Overall Study|Death|158|||
131159817|NCT03666143|472208898|FG000|Overall Study|Sponsor Decision|31|||
131159818|NCT03666143|472208898|FG000|Overall Study|Withdrawal by Subject|11|||
131159819|NCT03666143|472208898|FG000|Overall Study|Lost to Follow-up|5|||
131159820|NCT03666143|472208898|FG000|Overall Study|Physician Decision|1|||
131159821|NCT03666143|472208898|FG000|Overall Study|Rolled into extension study|9|||
131159822|NCT03666143|472208898|FG000|Overall Study|Progressive Disease|1|||
131159823|NCT02747043|472208901|FG000|Overall Study|Other|1|||
131159824|NCT02747043|472208902|FG001|Overall Study|Other|1|||
131159825|NCT02747043|472208901|FG000|Overall Study|Adverse Event|3|||
131159826|NCT02747043|472208902|FG001|Overall Study|Adverse Event|1|||
131159827|NCT02747043|472208901|FG000|Overall Study|Withdrawal by Subject|1|||
131159828|NCT02747043|472208902|FG001|Overall Study|Withdrawal by Subject|1|||
131159829|NCT02747043|472208901|FG000|Overall Study|Physician Decision|1|||
131159830|NCT02747043|472208902|FG001|Overall Study|Physician Decision|1|||
131159831|NCT02747043|472208901|FG000|Overall Study|Protocol Violation|0|||
131159832|NCT02747043|472208902|FG001|Overall Study|Protocol Violation|1|||
131159833|NCT02747043|472208901|FG000|Overall Study|Disease progression|4|||
131159834|NCT02747043|472208902|FG001|Overall Study|Disease progression|0|||
131159835|NCT01295905|472208909|FG000|Overall Study|Did not meet inclusion criteria|1|||
131159836|NCT01295905|472208910|FG001|Overall Study|Did not meet inclusion criteria|0|||
131159837|NCT01295905|472208909|FG000|Overall Study|Met exclusion criteria|1|||
131159838|NCT01295905|472208910|FG001|Overall Study|Met exclusion criteria|0|||
131159839|NCT03707977|472208912|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
131159840|NCT03707977|472208913|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
131159841|NCT03707977|472208914|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
131159842|NCT03707977|472208912|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
131159843|NCT03707977|472208913|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
131159844|NCT03707977|472208914|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
131159845|NCT02640612|472208915|FG000|Overall Study|Adverse Event|6|||
131159846|NCT02640612|472208916|FG001|Overall Study|Adverse Event|7|||
131159847|NCT02640612|472208917|FG002|Overall Study|Adverse Event|2|||
131159848|NCT02640612|472208915|FG000|Overall Study|Death|1|||
131159849|NCT02640612|472208916|FG001|Overall Study|Death|0|||
131159850|NCT02640612|472208917|FG002|Overall Study|Death|0|||
131159851|NCT02640612|472208915|FG000|Overall Study|Withdrawal by Subject|10|||
131159852|NCT02640612|472208916|FG001|Overall Study|Withdrawal by Subject|3|||
131159853|NCT02640612|472208917|FG002|Overall Study|Withdrawal by Subject|3|||
131159854|NCT02640612|472208915|FG000|Overall Study|Lost to Follow-up|4|||
131159855|NCT02640612|472208916|FG001|Overall Study|Lost to Follow-up|1|||
131159856|NCT02640612|472208917|FG002|Overall Study|Lost to Follow-up|1|||
131159857|NCT02640612|472208915|FG000|Overall Study|Protocol Violation|0|||
131159858|NCT02640612|472208916|FG001|Overall Study|Protocol Violation|2|||
131159859|NCT02640612|472208917|FG002|Overall Study|Protocol Violation|0|||
131159860|NCT02640612|472208915|FG000|Overall Study|Lack of Efficacy|1|||
131159861|NCT02640612|472208916|FG001|Overall Study|Lack of Efficacy|1|||
131159862|NCT02640612|472208917|FG002|Overall Study|Lack of Efficacy|0|||
131159863|NCT01720667|472208918|FG000|Overall Study|Adverse Event|1|||
131159864|NCT01720667|472208919|FG001|Overall Study|Adverse Event|1|||
131159865|NCT01720667|472208918|FG000|Overall Study|Withdrawal by Subject|3|||
131159866|NCT01720667|472208919|FG001|Overall Study|Withdrawal by Subject|0|||
131159867|NCT03472534|472208920|FG000|Overall Study|Withdrawal by Subject|9|||
131159868|NCT03472534|472208920|FG000|Overall Study|Adverse Event|2|||
131159869|NCT01319929|472208924|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
131159870|NCT01319929|472208925|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
131159871|NCT01319929|472208924|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
131159872|NCT01319929|472208925|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
131159873|NCT01319929|472208924|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
131159874|NCT01319929|472208925|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
131159875|NCT01319929|472208924|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
131159876|NCT01319929|472208925|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
131159877|NCT01319929|472208924|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
131159878|NCT01319929|472208925|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
131159879|NCT01221233|472208926|FG000|Overall Study|Withdrawal by Subject|3|||
131159880|NCT01221233|472208927|FG001|Overall Study|Withdrawal by Subject|1|||
131159881|NCT02117050|472208929|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
131159882|NCT03865407|472208930|FG000|Overall Study|Adverse Event|1|||
131159883|NCT03865407|472208931|FG001|Overall Study|Adverse Event|0|||
131159884|NCT03865407|472208930|FG000|Overall Study|Withdrawal by Subject|1|||
131159885|NCT03865407|472208931|FG001|Overall Study|Withdrawal by Subject|0|||
131159886|NCT03865407|472208930|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
131159887|NCT03865407|472208931|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
131159888|NCT00546819|472208934|FG000|Overall Study|Adverse Event|2|||
131159889|NCT00546819|472208935|FG001|Overall Study|Adverse Event|3|||
131159890|NCT00546819|472208934|FG000|Overall Study|Lost to Follow-up|2|||
131159891|NCT00546819|472208935|FG001|Overall Study|Lost to Follow-up|1|||
131159892|NCT00546819|472208934|FG000|Overall Study|Withdrawal by Subject|4|||
131159893|NCT00546819|472208935|FG001|Overall Study|Withdrawal by Subject|2|||
131159894|NCT02859415|472208937|FG000|Overall Study|Physician Decision|1|||
131159895|NCT02859415|472208938|FG001|Overall Study|Physician Decision|0|||
131159896|NCT02859415|472208937|FG000|Overall Study|Off treatment due to cardiac event|0|||
131159897|NCT02859415|472208938|FG001|Overall Study|Off treatment due to cardiac event|1|||
131159898|NCT01174784|472208939|FG000|Overall Study|Screen fails|4|||
131159899|NCT04601272|472208943|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
131159900|NCT04601272|472208944|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
131159901|NCT04601272|472208945|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
131159902|NCT00414440|472208946|FG000|Core Period|Withdrawal by Subject|70|||
131159903|NCT00414440|472208947|FG001|Core Period|Withdrawal by Subject|32|||
131159904|NCT00414440|472208946|FG000|Extension Period|Lost to Follow-up|44|||
131159905|NCT00414440|472208947|FG001|Extension Period|Lost to Follow-up|52|||
131159906|NCT00414440|472208946|FG000|Extension Period|Did not consent to continue follow up|61|||
131159907|NCT00414440|472208947|FG001|Extension Period|Did not consent to continue follow up|54|||
131159908|NCT00414440|472208946|FG000|Extension Period|Other|1|||
131159909|NCT00414440|472208947|FG001|Extension Period|Other|1|||
131159910|NCT00414440|472208946|FG000|Extension Period|Administrative|16|||
131159911|NCT00414440|472208947|FG001|Extension Period|Administrative|16|||
131159912|NCT00414440|472208946|FG000|Extension Period|Death|1|||
131159913|NCT00414440|472208947|FG001|Extension Period|Death|2|||
131159914|NCT00414440|472208946|FG000|Extension Period|Withdrawal by Subject|9|||
131159915|NCT00414440|472208947|FG001|Extension Period|Withdrawal by Subject|7|||
131159916|NCT00414440|472208946|FG000|Extension Period|Not included in follow up period|18|||
131159917|NCT00414440|472208947|FG001|Extension Period|Not included in follow up period|8|||
131159918|NCT01971476|472208948|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
131159919|NCT01971476|472208949|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
131159920|NCT01971476|472208950|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
131159921|NCT01971476|472208948|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
131159922|NCT01971476|472208949|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
131159923|NCT01971476|472208950|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
131159924|NCT01971476|472208948|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
131159925|NCT01971476|472208949|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
131159926|NCT01971476|472208950|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
131159927|NCT02498821|472208951|FG000|Overall Study|Screen failure|3|||
131159928|NCT02498821|472208952|FG001|Overall Study|Screen failure|5|||
131159929|NCT01716169|472208953|FG000|Overall Study|Adverse Event|1|||
131159930|NCT01716169|472208953|FG000|Overall Study|Lost to Follow-up|1|||
131159931|NCT01716169|472208953|FG000|Overall Study|Withdrawal by Subject|1|||
131159932|NCT01716169|472208953|FG000|Overall Study|inconsistent dressing application|1|||
131159933|NCT01088412|472208954|FG000|Overall Study|Adverse Event|38|||
131159934|NCT01088412|472208955|FG001|Overall Study|Adverse Event|0|||
131159935|NCT01088412|472208956|FG002|Overall Study|Adverse Event|0|||
131159936|NCT01088412|472208954|FG000|Overall Study|Death|42|||
131159937|NCT01088412|472208955|FG001|Overall Study|Death|6|||
131159938|NCT01088412|472208956|FG002|Overall Study|Death|0|||
131159939|NCT01088412|472208954|FG000|Overall Study|Other Reason per Case Report Form|2089|||
131159940|NCT01088412|472208955|FG001|Overall Study|Other Reason per Case Report Form|103|||
130728772|NCT00704132|470628664|FG000|Overall Study|Clinical Adverse Experience|1|||
131159941|NCT01088412|472208956|FG002|Overall Study|Other Reason per Case Report Form|9|||
131159942|NCT01088412|472208954|FG000|Overall Study|Withdrawal by Subject|1761|||
130728773|NCT00704132|470628665|FG001|Overall Study|Clinical Adverse Experience|0|||
131159943|NCT01088412|472208955|FG001|Overall Study|Withdrawal by Subject|25|||
130728774|NCT00704132|470628664|FG000|Overall Study|Lack of Efficacy|0|||
131159944|NCT01088412|472208956|FG002|Overall Study|Withdrawal by Subject|1|||
131159945|NCT01088412|472208954|FG000|Overall Study|Received Another GH Product|79|||
131159946|NCT01088412|472208955|FG001|Overall Study|Received Another GH Product|0|||
131159947|NCT01088412|472208956|FG002|Overall Study|Received Another GH Product|0|||
131159948|NCT01088412|472208954|FG000|Overall Study|Participant Moved|601|||
131159949|NCT01088412|472208955|FG001|Overall Study|Participant Moved|21|||
131159950|NCT01088412|472208956|FG002|Overall Study|Participant Moved|2|||
131159951|NCT01088412|472208954|FG000|Overall Study|Physician Decision|1041|||
131159952|NCT01088412|472208955|FG001|Overall Study|Physician Decision|8|||
130728775|NCT00704132|470628665|FG001|Overall Study|Lack of Efficacy|1|||
130728776|NCT00704132|470628664|FG000|Overall Study|Withdrawal by Subject|0|||
130728777|NCT00704132|470628665|FG001|Overall Study|Withdrawal by Subject|1|||
130728778|NCT00442962|470628666|FG000|Overall Study|Pregnancy|1|||
130728779|NCT00442962|470628666|FG000|Overall Study|Lost to Follow-up|7|||
130728780|NCT03633825|470628667|FG000|Enrollment|Did not post on network|5066|||
130728781|NCT03633825|470628668|FG001|Enrollment|Did not post on network|5080|||
131159953|NCT01088412|472208956|FG002|Overall Study|Physician Decision|4|||
130728782|NCT03633825|470628667|FG000|Enrollment|Post not classified as crisis|13967|||
130728783|NCT03633825|470628668|FG001|Enrollment|Post not classified as crisis|13757|||
130728784|NCT03633825|470628667|FG000|Follow up|Lost to Follow-up|478|||
130728785|NCT03633825|470628668|FG001|Follow up|Lost to Follow-up|450|||
130728786|NCT00214383|470628669|FG000|Overall Study|Lost to Follow-up|16|||
130728787|NCT00214383|470628670|FG001|Overall Study|Lost to Follow-up|26|||
130728788|NCT00879411|470628671|FG000|Overall Study|lost to follow-up (non-AE)|162|||
130728789|NCT01267994|470628674|FG000|Overall Study|Adverse Event|2|||
130728790|NCT02655666|470628675|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
130728791|NCT03837743|470628676|FG000|Overall Study|Adverse Event|1|||
130728792|NCT03837743|470628676|FG000|Overall Study|Withdrawal by Subject|2|||
130728793|NCT01210612|470628680|FG000|Overall Study|Withdrawal by Subject|0|||
130728794|NCT01210612|470628681|FG001|Overall Study|Withdrawal by Subject|2|||
130728795|NCT00086281|470628684|FG000|Phase 1|Adverse Event|0|||
130728796|NCT00086281|470628685|FG001|Phase 1|Adverse Event|0|||
130728797|NCT00086281|470628686|FG002|Phase 1|Adverse Event|0|||
130728798|NCT00086281|470628687|FG003|Phase 1|Adverse Event|0|||
130728799|NCT00086281|470628688|FG004|Phase 1|Adverse Event|0|||
130728800|NCT00086281|470628689|FG005|Phase 1|Adverse Event|0|||
130728801|NCT00086281|470628690|FG006|Phase 1|Adverse Event|0|||
130728802|NCT00086281|470628691|FG007|Phase 1|Adverse Event|0|||
130728803|NCT00086281|470628692|FG008|Phase 1|Adverse Event|0|||
130728804|NCT00086281|470628693|FG009|Phase 1|Adverse Event|1|||
130728805|NCT00086281|470628694|FG010|Phase 1|Adverse Event|2|||
130728806|NCT00086281|470628695|FG011|Phase 1|Adverse Event|1|||
131159954|NCT01088412|472208954|FG000|Overall Study|Sponsor Decision|4467|||
131159955|NCT01088412|472208955|FG001|Overall Study|Sponsor Decision|79|||
131159956|NCT01088412|472208956|FG002|Overall Study|Sponsor Decision|23|||
131159957|NCT01088412|472208954|FG000|Overall Study|Third Party Required to Change Brand|487|||
131159958|NCT01088412|472208955|FG001|Overall Study|Third Party Required to Change Brand|0|||
131159959|NCT01088412|472208956|FG002|Overall Study|Third Party Required to Change Brand|0|||
131159960|NCT01088412|472208954|FG000|Overall Study|Lost to Follow-up|3052|||
131159961|NCT01088412|472208955|FG001|Overall Study|Lost to Follow-up|130|||
131159962|NCT01088412|472208956|FG002|Overall Study|Lost to Follow-up|11|||
131159963|NCT01088412|472208954|FG000|Overall Study|Study Summary Not Completed|4360|||
131159964|NCT01088412|472208955|FG001|Overall Study|Study Summary Not Completed|64|||
131159965|NCT01088412|472208956|FG002|Overall Study|Study Summary Not Completed|22|||
131159966|NCT02285010|472208957|FG000|Overall Study|not abdominal hysterectomy|2|||
131159967|NCT02285010|472208958|FG001|Overall Study|not abdominal hysterectomy|0|||
131159968|NCT02285010|472208957|FG000|Overall Study|Not spinal anesthesia|3|||
131159969|NCT02285010|472208958|FG001|Overall Study|Not spinal anesthesia|1|||
131159970|NCT01208181|472208962|FG000|Part 1|Withdrawal by Subject|11|||
131159971|NCT01208181|472208963|FG001|Part 1|Withdrawal by Subject|10|||
131159972|NCT01208181|472208964|FG002|Part 1|Withdrawal by Subject|0|||
131159973|NCT01208181|472208965|FG003|Part 1|Withdrawal by Subject|0|||
131159974|NCT01208181|472208966|FG004|Part 1|Withdrawal by Subject|0|||
131159975|NCT01208181|472208962|FG000|Part 1|Technical problem|5|||
131159976|NCT01208181|472208963|FG001|Part 1|Technical problem|0|||
131159977|NCT01208181|472208964|FG002|Part 1|Technical problem|0|||
131159978|NCT01208181|472208965|FG003|Part 1|Technical problem|0|||
131159979|NCT01208181|472208966|FG004|Part 1|Technical problem|0|||
131159980|NCT01208181|472208962|FG000|Part 1|Protocol Violation|10|||
131159981|NCT01208181|472208963|FG001|Part 1|Protocol Violation|5|||
131159982|NCT01208181|472208964|FG002|Part 1|Protocol Violation|0|||
131159983|NCT01208181|472208965|FG003|Part 1|Protocol Violation|0|||
130728807|NCT00086281|470628696|FG012|Phase 1|Adverse Event|1|||
130728808|NCT00086281|470628697|FG013|Phase 1|Adverse Event|1|||
130728809|NCT00086281|470628698|FG014|Phase 1|Adverse Event|2|||
131159984|NCT01208181|472208966|FG004|Part 1|Protocol Violation|0|||
131159985|NCT01208181|472208962|FG000|Part 1|Physician Decision|4|||
131159986|NCT01208181|472208963|FG001|Part 1|Physician Decision|0|||
131159987|NCT01208181|472208964|FG002|Part 1|Physician Decision|0|||
131159988|NCT01208181|472208965|FG003|Part 1|Physician Decision|0|||
131159989|NCT01208181|472208966|FG004|Part 1|Physician Decision|0|||
131159990|NCT01208181|472208962|FG000|Part 1|Non-compliance with study drug|1|||
131159991|NCT01208181|472208963|FG001|Part 1|Non-compliance with study drug|1|||
130728810|NCT00086281|470628684|FG000|Phase 1|Protocol Violation|0|||
130728811|NCT00086281|470628685|FG001|Phase 1|Protocol Violation|0|||
130728812|NCT00086281|470628686|FG002|Phase 1|Protocol Violation|0|||
130728813|NCT00086281|470628687|FG003|Phase 1|Protocol Violation|0|||
131159992|NCT01208181|472208964|FG002|Part 1|Non-compliance with study drug|0|||
131159993|NCT01208181|472208965|FG003|Part 1|Non-compliance with study drug|0|||
131159994|NCT01208181|472208966|FG004|Part 1|Non-compliance with study drug|0|||
130728814|NCT00086281|470628688|FG004|Phase 1|Protocol Violation|0|||
131159995|NCT01208181|472208962|FG000|Part 1|Lost to Follow-up|5|||
131159996|NCT01208181|472208963|FG001|Part 1|Lost to Follow-up|3|||
131159997|NCT01208181|472208964|FG002|Part 1|Lost to Follow-up|0|||
131159998|NCT01208181|472208965|FG003|Part 1|Lost to Follow-up|0|||
131159999|NCT01208181|472208966|FG004|Part 1|Lost to Follow-up|1|||
131160000|NCT01208181|472208962|FG000|Part 1|Lack of Efficacy|37|||
131160001|NCT01208181|472208963|FG001|Part 1|Lack of Efficacy|12|||
131160002|NCT01208181|472208964|FG002|Part 1|Lack of Efficacy|0|||
131160003|NCT01208181|472208965|FG003|Part 1|Lack of Efficacy|0|||
131160004|NCT01208181|472208966|FG004|Part 1|Lack of Efficacy|17|||
131160005|NCT01208181|472208962|FG000|Part 1|Adverse Event|26|||
131160006|NCT01208181|472208963|FG001|Part 1|Adverse Event|24|||
131160007|NCT01208181|472208964|FG002|Part 1|Adverse Event|0|||
131160008|NCT01208181|472208965|FG003|Part 1|Adverse Event|0|||
131160009|NCT01208181|472208966|FG004|Part 1|Adverse Event|4|||
131160010|NCT01208181|472208962|FG000|Part 2|Adverse Event|0|||
131160011|NCT01208181|472208963|FG001|Part 2|Adverse Event|0|||
131160012|NCT01208181|472208964|FG002|Part 2|Adverse Event|6|||
131160013|NCT01208181|472208965|FG003|Part 2|Adverse Event|7|||
131160014|NCT01208181|472208966|FG004|Part 2|Adverse Event|0|||
131160015|NCT01208181|472208962|FG000|Part 2|Withdrawal by Subject|0|||
131160016|NCT01208181|472208963|FG001|Part 2|Withdrawal by Subject|0|||
131160017|NCT01208181|472208964|FG002|Part 2|Withdrawal by Subject|1|||
131160018|NCT01208181|472208965|FG003|Part 2|Withdrawal by Subject|1|||
131160019|NCT01208181|472208966|FG004|Part 2|Withdrawal by Subject|0|||
131160020|NCT01208181|472208962|FG000|Part 2|Protocol Violation|0|||
131160021|NCT01208181|472208963|FG001|Part 2|Protocol Violation|0|||
131160022|NCT01208181|472208964|FG002|Part 2|Protocol Violation|1|||
131160023|NCT01208181|472208965|FG003|Part 2|Protocol Violation|0|||
131160024|NCT01208181|472208966|FG004|Part 2|Protocol Violation|0|||
131160025|NCT01208181|472208962|FG000|Part 2|Physician Decision|0|||
131160026|NCT01208181|472208963|FG001|Part 2|Physician Decision|0|||
131160027|NCT01208181|472208964|FG002|Part 2|Physician Decision|1|||
131160028|NCT01208181|472208965|FG003|Part 2|Physician Decision|2|||
131160029|NCT01208181|472208966|FG004|Part 2|Physician Decision|0|||
131160030|NCT01208181|472208962|FG000|Part 2|Non-compliance with study drug|0|||
131160031|NCT01208181|472208963|FG001|Part 2|Non-compliance with study drug|0|||
131160032|NCT01208181|472208964|FG002|Part 2|Non-compliance with study drug|1|||
131160033|NCT01208181|472208965|FG003|Part 2|Non-compliance with study drug|1|||
131160034|NCT01208181|472208966|FG004|Part 2|Non-compliance with study drug|0|||
131160035|NCT01208181|472208962|FG000|Part 2|Lost to Follow-up|0|||
131160036|NCT01208181|472208963|FG001|Part 2|Lost to Follow-up|0|||
131160037|NCT01208181|472208964|FG002|Part 2|Lost to Follow-up|1|||
131160038|NCT01208181|472208965|FG003|Part 2|Lost to Follow-up|2|||
131160039|NCT01208181|472208966|FG004|Part 2|Lost to Follow-up|0|||
131160040|NCT01208181|472208962|FG000|Part 2|Lack of Efficacy|0|||
131160041|NCT01208181|472208963|FG001|Part 2|Lack of Efficacy|0|||
131160042|NCT01208181|472208964|FG002|Part 2|Lack of Efficacy|5|||
131160043|NCT01208181|472208965|FG003|Part 2|Lack of Efficacy|7|||
131160044|NCT01208181|472208966|FG004|Part 2|Lack of Efficacy|0|||
131160045|NCT01457339|472208967|FG000|Period 3 (100 mg)|Adverse Event|0|||
131160046|NCT01457339|472208968|FG001|Period 3 (100 mg)|Adverse Event|1|||
131160047|NCT01457339|472208967|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
131160048|NCT01457339|472208968|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
131160049|NCT01457339|472208967|FG000|Period 6 (250 mg)|Family Emergency|1|||
131160050|NCT01457339|472208968|FG001|Period 6 (250 mg)|Family Emergency|0|||
131160051|NCT01457339|472208967|FG000|Period 6 (250 mg)|Personal appointment|0|||
131160052|NCT01457339|472208968|FG001|Period 6 (250 mg)|Personal appointment|1|||
131160053|NCT01478347|472208971|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
131160054|NCT01478347|472208971|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
131160055|NCT01478347|472208971|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
131160056|NCT00196937|472208972|FG000|Overall Study|Serious Adverse Event|1|||
131160057|NCT00196937|472208973|FG001|Overall Study|Serious Adverse Event|0|||
131160058|NCT00196937|472208974|FG002|Overall Study|Serious Adverse Event|0|||
131160059|NCT00196937|472208972|FG000|Overall Study|Non-serious adverse event|1|||
131160060|NCT00196937|472208973|FG001|Overall Study|Non-serious adverse event|1|||
131160061|NCT00196937|472208974|FG002|Overall Study|Non-serious adverse event|1|||
131160062|NCT00196937|472208972|FG000|Overall Study|Withdrawal by Subject|0|||
131160063|NCT00196937|472208973|FG001|Overall Study|Withdrawal by Subject|0|||
131160064|NCT00196937|472208974|FG002|Overall Study|Withdrawal by Subject|2|||
131160065|NCT00196937|472208972|FG000|Overall Study|Lost to Follow-up|4|||
131160066|NCT00196937|472208973|FG001|Overall Study|Lost to Follow-up|3|||
131160067|NCT00196937|472208974|FG002|Overall Study|Lost to Follow-up|3|||
131160068|NCT00196937|472208972|FG000|Overall Study|Other|3|||
131160069|NCT00196937|472208973|FG001|Overall Study|Other|1|||
131160070|NCT00196937|472208974|FG002|Overall Study|Other|1|||
131160071|NCT02335450|472208977|FG000|Overall Study|Pregnancy|1|||
131160072|NCT02973815|472208978|FG000|Post Intervention|Death|1|||
131160073|NCT02973815|472208979|FG001|Post Intervention|Death|0|||
131160074|NCT02973815|472208978|FG000|Post Intervention|Lost to Follow-up|7|||
131160075|NCT02973815|472208979|FG001|Post Intervention|Lost to Follow-up|24|||
131160076|NCT02973815|472208978|FG000|Follow-up|Lost to Follow-up|2|||
131160077|NCT02973815|472208979|FG001|Follow-up|Lost to Follow-up|0|||
131160078|NCT02613572|472208980|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
131160079|NCT02613572|472208981|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
131160080|NCT02613572|472208982|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
131160081|NCT02613572|472208980|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
131160082|NCT02613572|472208981|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
131160083|NCT02613572|472208982|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
131160084|NCT04542291|472208983|FG000|Overall Study|Adverse Event|1|||
131160085|NCT04542291|472208983|FG000|Overall Study|Physician Decision|2|||
131160086|NCT01056523|472208987|FG000|Overall Study|Death|1|||
131160087|NCT01056523|472208988|FG001|Overall Study|Death|0|||
131160088|NCT01056523|472208989|FG002|Overall Study|Death|2|||
131160089|NCT01056523|472208990|FG003|Overall Study|Death|3|||
131160090|NCT01056523|472208991|FG004|Overall Study|Death|0|||
131160091|NCT01056523|472208992|FG005|Overall Study|Death|0|||
131160092|NCT01056523|472208993|FG006|Overall Study|Death|1|||
131160093|NCT03429556|472208994|FG000|Overall Study|Lost to Follow-up|0|||
131160094|NCT03429556|472208995|FG001|Overall Study|Lost to Follow-up|1|||
131160095|NCT03429556|472208996|FG002|Overall Study|Lost to Follow-up|0|||
131160096|NCT03429556|472208997|FG003|Overall Study|Lost to Follow-up|0|||
131160097|NCT01863758|472209002|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
131160098|NCT01863758|472209002|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
131160099|NCT02369510|472209003|FG000|Overall Study|Spilled Medication|1|||
131160100|NCT02369510|472209004|FG001|Overall Study|Spilled Medication|2|||
131160101|NCT02369510|472209005|FG002|Overall Study|Spilled Medication|1|||
131160102|NCT02369510|472209003|FG000|Overall Study|Epidural Activation|1|||
131160103|NCT02369510|472209004|FG001|Overall Study|Epidural Activation|1|||
131160104|NCT02369510|472209005|FG002|Overall Study|Epidural Activation|5|||
131160105|NCT04952389|472209011|FG000|Overall Study|Withdrawal by Subject|8|||
131160106|NCT04952389|472209012|FG001|Overall Study|Withdrawal by Subject|4|||
130728815|NCT00086281|470628689|FG005|Phase 1|Protocol Violation|0|||
131160107|NCT02050048|472209013|FG000|Overall Study|Lost to Follow-up|0|||
131160108|NCT02050048|472209014|FG001|Overall Study|Lost to Follow-up|1|||
131160109|NCT02050048|472209013|FG000|Overall Study|Death|1|||
131160110|NCT02050048|472209014|FG001|Overall Study|Death|0|||
131160111|NCT02050048|472209013|FG000|Overall Study|Ineligible after ERCP|4|||
131160112|NCT02050048|472209014|FG001|Overall Study|Ineligible after ERCP|1|||
131160113|NCT04285723|472209020|FG000|Overall Study|Subject decision|1|||
131160114|NCT04285723|472209021|FG001|Overall Study|Subject decision|2|||
131160115|NCT04285723|472209020|FG000|Overall Study|Physician Decision|1|||
131160116|NCT04285723|472209021|FG001|Overall Study|Physician Decision|0|||
131160117|NCT04285723|472209020|FG000|Overall Study|No efficiency|1|||
131160118|NCT04285723|472209021|FG001|Overall Study|No efficiency|0|||
131160119|NCT01507246|472209022|FG000|Overall Study|Required different surgical procedures|2|||
131160120|NCT01507246|472209023|FG001|Overall Study|Required different surgical procedures|1|||
131160121|NCT00969618|472209029|FG000|Overall Study|Adverse Event|29|||
131160122|NCT00969618|472209029|FG000|Overall Study|Entry Criteria Not Met|3|||
131160123|NCT00969618|472209029|FG000|Overall Study|Lack of Efficacy|2|||
131160124|NCT00969618|472209029|FG000|Overall Study|Lost to Follow-up|7|||
131160125|NCT00969618|472209029|FG000|Overall Study|Physician Decision|1|||
131160126|NCT00969618|472209029|FG000|Overall Study|Protocol Violation|9|||
131160127|NCT00969618|472209029|FG000|Overall Study|Withdrawal by Subject|27|||
131160128|NCT02452970|472210881|FG000|Overall Study|Adverse Event|1|||
131160129|NCT03270085|472210884|FG000|Overall Study|Withdrawal by Subject|1|||
131160130|NCT03270085|472210885|FG001|Overall Study|Withdrawal by Subject|0|||
131160131|NCT02400346|472210886|FG000|Overall Study|Adverse Event|24|||
131160132|NCT02400346|472210886|FG000|Overall Study|Lack of Efficacy|9|||
131160133|NCT02400346|472210886|FG000|Overall Study|Non-compliance with IMP|1|||
131160134|NCT02400346|472210886|FG000|Overall Study|Withdrawal by Subject|7|||
131160135|NCT02400346|472210886|FG000|Overall Study|Administrative or other reason(s)|2|||
131160136|NCT02400346|472210886|FG000|Overall Study|Lost to Follow-up|1|||
130728816|NCT00086281|470628690|FG006|Phase 1|Protocol Violation|0|||
130728817|NCT00086281|470628691|FG007|Phase 1|Protocol Violation|0|||
131160137|NCT01283581|472210888|FG000|Overall Study|Lost to Follow-up|8|||
131160138|NCT01283581|472210889|FG001|Overall Study|Lost to Follow-up|6|||
131160139|NCT01283581|472210890|FG002|Overall Study|Lost to Follow-up|8|||
131160140|NCT01283581|472210888|FG000|Overall Study|Withdrawal by Subject|2|||
131160141|NCT01283581|472210889|FG001|Overall Study|Withdrawal by Subject|5|||
131160142|NCT01283581|472210890|FG002|Overall Study|Withdrawal by Subject|2|||
131160143|NCT01283581|472210888|FG000|Overall Study|Adverse Event|1|||
131160144|NCT01283581|472210889|FG001|Overall Study|Adverse Event|1|||
131160145|NCT01283581|472210890|FG002|Overall Study|Adverse Event|4|||
131160146|NCT01283581|472210888|FG000|Overall Study|Physician Decision|0|||
131160147|NCT01283581|472210889|FG001|Overall Study|Physician Decision|1|||
131160148|NCT01283581|472210890|FG002|Overall Study|Physician Decision|2|||
131160149|NCT01283581|472210888|FG000|Overall Study|Protocol Violation|0|||
130728818|NCT00086281|470628692|FG008|Phase 1|Protocol Violation|0|||
131160150|NCT01283581|472210889|FG001|Overall Study|Protocol Violation|1|||
131160151|NCT01283581|472210890|FG002|Overall Study|Protocol Violation|2|||
131160152|NCT01283581|472210888|FG000|Overall Study|Noncompliance|1|||
131160153|NCT01283581|472210889|FG001|Overall Study|Noncompliance|0|||
131160154|NCT01283581|472210890|FG002|Overall Study|Noncompliance|0|||
131160155|NCT01283581|472210888|FG000|Overall Study|Investigator unblinded|0|||
131160156|NCT01283581|472210889|FG001|Overall Study|Investigator unblinded|0|||
131160157|NCT01283581|472210890|FG002|Overall Study|Investigator unblinded|1|||
131160158|NCT01283581|472210888|FG000|Overall Study|"Early termination"|0|||
131160159|NCT01283581|472210889|FG001|Overall Study|"Early termination"|0|||
131160160|NCT01283581|472210890|FG002|Overall Study|"Early termination"|1|||
131160161|NCT00486226|472210891|FG000|Overall Study|Death|3|||
131160162|NCT00486226|472210891|FG000|Overall Study|Adverse Event|1|||
131160163|NCT00486226|472210891|FG000|Overall Study|Withdrawal by Subject|1|||
131160164|NCT00486226|472210891|FG000|Overall Study|Lost to Follow-up|8|||
131160165|NCT01259492|472210892|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
131160166|NCT01259492|472210893|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
131160167|NCT01259492|472210894|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
131160168|NCT01259492|472210895|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
131160169|NCT01259492|472210892|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
131160170|NCT01259492|472210893|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
131160171|NCT01259492|472210894|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
131160172|NCT01259492|472210895|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
131160173|NCT01259492|472210892|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
131160174|NCT01259492|472210893|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
131160175|NCT01259492|472210894|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
131160176|NCT01259492|472210895|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
131160177|NCT01259492|472210892|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
131160178|NCT01259492|472210893|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
131160179|NCT01259492|472210894|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
131160180|NCT01259492|472210895|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
131160181|NCT01259492|472210892|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
131160182|NCT01259492|472210893|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
131160183|NCT01259492|472210894|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
131160184|NCT01259492|472210895|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
131160185|NCT01259492|472210892|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
131160186|NCT01259492|472210893|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
131160187|NCT01259492|472210894|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
131160188|NCT01259492|472210895|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
131160189|NCT01259492|472210892|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
131160190|NCT01259492|472210893|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
131160191|NCT01259492|472210894|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
131160192|NCT01259492|472210895|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
131160193|NCT01259492|472210892|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
131160194|NCT01259492|472210893|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
131160195|NCT01259492|472210894|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
131160196|NCT01259492|472210895|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
131160197|NCT01259492|472210892|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
131160198|NCT01259492|472210893|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
131160199|NCT01259492|472210894|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
131160200|NCT01259492|472210895|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
131160201|NCT01259492|472210892|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
131160202|NCT01259492|472210893|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
131160203|NCT01259492|472210894|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
131160204|NCT01259492|472210895|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
131160205|NCT01259492|472210892|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
131160206|NCT01259492|472210893|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
131160207|NCT01259492|472210894|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
131160208|NCT01259492|472210895|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
131160209|NCT01259492|472210892|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
131160210|NCT01259492|472210893|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
131160211|NCT01259492|472210894|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
131160212|NCT01259492|472210895|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
131160213|NCT01259492|472210892|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
131160214|NCT01259492|472210893|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
131160215|NCT01259492|472210894|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
131160216|NCT01259492|472210895|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
131160217|NCT01259492|472210892|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
131160218|NCT01259492|472210893|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
131160219|NCT01259492|472210894|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
131160220|NCT01259492|472210895|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
131160221|NCT01259492|472210892|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
131160222|NCT01259492|472210893|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
131160223|NCT01259492|472210894|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
131160224|NCT01259492|472210895|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
131160225|NCT01259492|472210892|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
131160226|NCT01259492|472210893|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
131160227|NCT01259492|472210894|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
131160228|NCT01259492|472210895|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
131160229|NCT01259492|472210892|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
131160230|NCT01259492|472210893|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
131160231|NCT01259492|472210894|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
131160232|NCT01259492|472210895|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
131160233|NCT01259492|472210892|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
131160234|NCT01259492|472210893|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
131160235|NCT01259492|472210894|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
131160236|NCT01259492|472210895|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
131160237|NCT01259492|472210892|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
131160238|NCT01259492|472210893|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
131160239|NCT01259492|472210894|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
131160240|NCT01259492|472210895|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
131160241|NCT01259492|472210892|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
131160242|NCT01259492|472210893|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
131160243|NCT01259492|472210894|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
131160244|NCT01259492|472210895|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
131160245|NCT01058369|472210903|FG000|Overall Study|Adverse Event|1|||
131160246|NCT01058369|472210903|FG000|Overall Study|Early termination study|1|||
131160247|NCT00663858|472210904|FG000|Overall Study|Adverse Event|9|||
131160248|NCT00663858|472210905|FG001|Overall Study|Adverse Event|1|||
131160249|NCT00663858|472210906|FG002|Overall Study|Adverse Event|6|||
131160250|NCT00663858|472210904|FG000|Overall Study|Lack of Efficacy|5|||
131160251|NCT00663858|472210905|FG001|Overall Study|Lack of Efficacy|1|||
131160252|NCT00663858|472210906|FG002|Overall Study|Lack of Efficacy|3|||
131160253|NCT00663858|472210904|FG000|Overall Study|Withdrawal by Subject|7|||
131160254|NCT00663858|472210905|FG001|Overall Study|Withdrawal by Subject|3|||
131160255|NCT00663858|472210906|FG002|Overall Study|Withdrawal by Subject|3|||
131160256|NCT00663858|472210904|FG000|Overall Study|Protocol Violation|5|||
131160257|NCT00663858|472210905|FG001|Overall Study|Protocol Violation|3|||
131160258|NCT00663858|472210906|FG002|Overall Study|Protocol Violation|4|||
131160259|NCT00663858|472210904|FG000|Overall Study|Other|8|||
131160260|NCT00663858|472210905|FG001|Overall Study|Other|2|||
131160261|NCT00663858|472210906|FG002|Overall Study|Other|4|||
131160262|NCT02940886|472210907|FG000|Overall Study|Adverse Event|7|||
131160263|NCT02940886|472210908|FG001|Overall Study|Adverse Event|3|||
131160264|NCT02940886|472210907|FG000|Overall Study|Protocol Violation|0|||
131160265|NCT02940886|472210908|FG001|Overall Study|Protocol Violation|2|||
131160266|NCT02940886|472210907|FG000|Overall Study|Withdrawal by Subject|28|||
131160267|NCT02940886|472210908|FG001|Overall Study|Withdrawal by Subject|20|||
131160268|NCT02940886|472210907|FG000|Overall Study|Death|1|||
131160269|NCT02940886|472210908|FG001|Overall Study|Death|0|||
131160270|NCT02940886|472210907|FG000|Overall Study|Lack of Efficacy|1|||
131160271|NCT02940886|472210908|FG001|Overall Study|Lack of Efficacy|0|||
131160272|NCT02940886|472210907|FG000|Overall Study|Lost to Follow-up|49|||
131160273|NCT02940886|472210908|FG001|Overall Study|Lost to Follow-up|21|||
131160274|NCT02940886|472210907|FG000|Overall Study|Physician Decision|9|||
131160275|NCT02940886|472210908|FG001|Overall Study|Physician Decision|4|||
131160276|NCT02940886|472210907|FG000|Overall Study|Sponsor decision|0|||
131160277|NCT02940886|472210908|FG001|Overall Study|Sponsor decision|1|||
131160278|NCT02940886|472210907|FG000|Overall Study|No treatment|7|||
131160279|NCT02940886|472210908|FG001|Overall Study|No treatment|2|||
131160280|NCT02940886|472210907|FG000|Overall Study|Enrolment error|0|||
131160281|NCT02940886|472210908|FG001|Overall Study|Enrolment error|1|||
131160282|NCT01306058|472210912|FG000|Overall Study|Death|1|||
131160283|NCT01306058|472210912|FG000|Overall Study|Enrolled but did not get treatment|1|||
131160284|NCT01666444|472210913|FG000|Overall Study|Did not initiate treatment|2|||
131160285|NCT01666444|472210914|FG001|Overall Study|Did not initiate treatment|1|||
131160286|NCT00084682|472210919|FG000|Overall Study|Withdrawal by Subject|1|||
131160287|NCT03238248|472210922|FG000|Overall Study|Death|5|||
131160288|NCT03238248|472210922|FG000|Overall Study|Withdrawal by Subject|7|||
131160289|NCT03238248|472210922|FG000|Overall Study|Participant proceeding to transplant|10|||
131160290|NCT03238248|472210922|FG000|Overall Study|Lack of Efficacy|4|||
131160291|NCT03238248|472210922|FG000|Overall Study|Physician Decision|3|||
131160292|NCT03238248|472210922|FG000|Overall Study|Transitioning to another study|1|||
131160293|NCT03238248|472210922|FG000|Overall Study|No longer benefiting|1|||
131160294|NCT03238248|472210922|FG000|Overall Study|Other complicating disease|1|||
130728819|NCT00086281|470628693|FG009|Phase 1|Protocol Violation|0|||
130728820|NCT00086281|470628694|FG010|Phase 1|Protocol Violation|1|||
130728821|NCT00086281|470628695|FG011|Phase 1|Protocol Violation|0|||
131160295|NCT03238248|472210922|FG000|Overall Study|Adverse Event|5|||
131160296|NCT03238248|472210922|FG000|Overall Study|Disease progression|26|||
131160297|NCT03238248|472210922|FG000|Overall Study|N/A participant is still on treatment|1|||
131160298|NCT03238248|472210922|FG000|Overall Study|Decline in condition|1|||
131160299|NCT03238248|472210922|FG000|Overall Study|Alternative therapy|2|||
131160300|NCT01013883|472210923|FG000|Overall Study|Lost to Follow-up|2|||
131160301|NCT01013883|472210924|FG001|Overall Study|Lost to Follow-up|2|||
131160302|NCT02241512|472210929|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
131160303|NCT02241512|472210930|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
131160304|NCT00641043|472210931|FG000|Overall Study|Adverse Event|6|||
131160305|NCT00641043|472210932|FG001|Overall Study|Adverse Event|4|||
131160306|NCT00641043|472210931|FG000|Overall Study|Protocol Violation|2|||
131160307|NCT00641043|472210932|FG001|Overall Study|Protocol Violation|3|||
131160308|NCT00641043|472210931|FG000|Overall Study|Lost to Follow-up|3|||
131160309|NCT00641043|472210932|FG001|Overall Study|Lost to Follow-up|2|||
131160310|NCT00641043|472210931|FG000|Overall Study|Withdrawal by Subject|4|||
131160311|NCT00641043|472210932|FG001|Overall Study|Withdrawal by Subject|4|||
131160312|NCT00641043|472210931|FG000|Overall Study|Other incl. lack of efficacy|4|||
131160313|NCT00641043|472210932|FG001|Overall Study|Other incl. lack of efficacy|2|||
131160314|NCT02584634|472210933|FG000|Overall Study|Adverse Event|3|||
131160315|NCT02584634|472210934|FG001|Overall Study|Adverse Event|5|||
131160316|NCT02584634|472210933|FG000|Overall Study|Death|0|||
131160317|NCT02584634|472210934|FG001|Overall Study|Death|1|||
131160318|NCT02584634|472210933|FG000|Overall Study|Lost to Follow-up|0|||
131160319|NCT02584634|472210934|FG001|Overall Study|Lost to Follow-up|1|||
131160320|NCT02584634|472210933|FG000|Overall Study|Physician Decision|1|||
131160321|NCT02584634|472210934|FG001|Overall Study|Physician Decision|2|||
131160322|NCT02584634|472210933|FG000|Overall Study|Progressive disease|7|||
131160323|NCT02584634|472210934|FG001|Overall Study|Progressive disease|15|||
131160324|NCT02584634|472210933|FG000|Overall Study|Withdrawal by Subject|1|||
131160325|NCT02584634|472210934|FG001|Overall Study|Withdrawal by Subject|1|||
131160326|NCT02584634|472210933|FG000|Overall Study|Other|0|||
131160327|NCT02584634|472210934|FG001|Overall Study|Other|6|||
131160328|NCT00474630|472210935|FG000|Overall Study|Adverse Event|98|||
131160329|NCT00474630|472210936|FG001|Overall Study|Adverse Event|26|||
131160330|NCT00474630|472210935|FG000|Overall Study|Lost to Follow-up|22|||
131160331|NCT00474630|472210936|FG001|Overall Study|Lost to Follow-up|15|||
131160332|NCT00474630|472210935|FG000|Overall Study|Withdrawal by Subject|21|||
131160333|NCT00474630|472210936|FG001|Overall Study|Withdrawal by Subject|15|||
131160334|NCT00474630|472210935|FG000|Overall Study|Protocol Violation|3|||
131160335|NCT00474630|472210936|FG001|Overall Study|Protocol Violation|4|||
131160336|NCT00474630|472210935|FG000|Overall Study|Lack of Efficacy|5|||
131160337|NCT00474630|472210936|FG001|Overall Study|Lack of Efficacy|6|||
131160338|NCT00474630|472210935|FG000|Overall Study|Drug noncompliance, other|11|||
131160339|NCT00474630|472210936|FG001|Overall Study|Drug noncompliance, other|4|||
131160340|NCT03088605|472210937|FG000|Overall Study|Withdrawal by Subject|1|||
131160341|NCT03088605|472210938|FG001|Overall Study|Withdrawal by Subject|0|||
131160342|NCT00283712|472210939|FG000|Overall Study|Death|0|||
131160343|NCT00283712|472210940|FG001|Overall Study|Death|1|||
131160344|NCT00098345|472210942|FG000|Overall Study|Adverse Event|7|||
131160345|NCT00098345|472210942|FG000|Overall Study|Withdrawal by Subject|2|||
131160346|NCT00098345|472210942|FG000|Overall Study|progression|4|||
131160347|NCT02564120|472210945|FG000|Overall Study|Did not return release forms|160|||
131160348|NCT02564120|472210945|FG000|Overall Study|Death|58|||
131160349|NCT02564120|472210945|FG000|Overall Study|Withdrawal by Subject|204|||
131160350|NCT02564120|472210945|FG000|Overall Study|Other medical condition|24|||
131160351|NCT01966731|472210948|FG000|Overall Study|Death|2|||
131160352|NCT01966731|472210948|FG000|Overall Study|Lost to Follow-up|1|||
131160353|NCT01966731|472210948|FG000|Overall Study|Physician Decision|2|||
131160354|NCT01966731|472210948|FG000|Overall Study|Follow up is not complete|600|||
130728822|NCT00086281|470628696|FG012|Phase 1|Protocol Violation|0|||
131160355|NCT01966731|472210948|FG000|Overall Study|Screening Failure|29|||
130728823|NCT00086281|470628697|FG013|Phase 1|Protocol Violation|0|||
131160356|NCT01966731|472210948|FG000|Overall Study|Found to be ineligible|1|||
131160357|NCT01380093|472210950|FG000|Naloxone Challenge Phase|Screen failures|21|||
131160358|NCT01380093|472210951|FG001|Naloxone Challenge Phase|Screen failures|0|||
131160359|NCT01380093|472210952|FG002|Naloxone Challenge Phase|Screen failures|0|||
131160360|NCT01380093|472210953|FG003|Naloxone Challenge Phase|Screen failures|0|||
131160361|NCT01380093|472210954|FG004|Naloxone Challenge Phase|Screen failures|0|||
131160362|NCT01380093|472210955|FG005|Naloxone Challenge Phase|Screen failures|0|||
131160363|NCT01380093|472210956|FG006|Naloxone Challenge Phase|Screen failures|0|||
130728824|NCT00086281|470628698|FG014|Phase 1|Protocol Violation|0|||
130728825|NCT00086281|470628684|FG000|Phase 1|Serious Adverse Event|0|||
131160364|NCT01380093|472210957|FG007|Naloxone Challenge Phase|Screen failures|0|||
131160365|NCT01380093|472210958|FG008|Naloxone Challenge Phase|Screen failures|0|||
131160366|NCT01380093|472210950|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131160367|NCT01380093|472210951|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
131160368|NCT01380093|472210952|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131160369|NCT01380093|472210953|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131160370|NCT01380093|472210954|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131160371|NCT01380093|472210955|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131160372|NCT01380093|472210956|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131160373|NCT01380093|472210957|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131160374|NCT01380093|472210958|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
131160375|NCT01380093|472210950|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131160376|NCT01380093|472210951|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
131160377|NCT01380093|472210952|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
131160378|NCT01380093|472210953|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131160379|NCT01380093|472210954|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131160380|NCT01380093|472210955|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131160381|NCT01380093|472210956|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131160382|NCT01380093|472210957|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131160383|NCT01380093|472210958|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
131160384|NCT01380093|472210950|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131160385|NCT01380093|472210951|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
131160386|NCT01380093|472210952|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131160387|NCT01380093|472210953|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131160388|NCT01380093|472210954|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131160389|NCT01380093|472210955|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131160390|NCT01380093|472210956|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131160391|NCT01380093|472210957|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131160392|NCT01380093|472210958|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
131160393|NCT01380093|472210950|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131160394|NCT01380093|472210951|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
131160395|NCT01380093|472210952|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
131160396|NCT01380093|472210953|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131160397|NCT01380093|472210954|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131160398|NCT01380093|472210955|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131160399|NCT01380093|472210956|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131160400|NCT01380093|472210957|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131160401|NCT01380093|472210958|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
131160402|NCT01380093|472210950|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131160403|NCT01380093|472210951|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
131160404|NCT01380093|472210952|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
131160405|NCT01380093|472210953|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131160406|NCT01380093|472210954|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131160407|NCT01380093|472210955|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131160408|NCT01380093|472210956|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131160409|NCT01380093|472210957|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131160410|NCT01380093|472210958|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
131160411|NCT01380093|472210950|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
131160412|NCT01380093|472210951|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
131160413|NCT01380093|472210952|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
131160414|NCT01380093|472210953|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
131160415|NCT01380093|472210954|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
131160416|NCT01380093|472210955|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
131160417|NCT01380093|472210956|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
131160418|NCT01380093|472210957|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
131160419|NCT01380093|472210958|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
131160420|NCT01380093|472210950|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131160421|NCT01380093|472210951|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131160422|NCT01380093|472210952|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
131160423|NCT01380093|472210953|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131160424|NCT01380093|472210954|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131160425|NCT01380093|472210955|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131160426|NCT01380093|472210956|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131160427|NCT01380093|472210957|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
131160428|NCT01380093|472210958|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130728826|NCT00086281|470628685|FG001|Phase 1|Serious Adverse Event|0|||
130728827|NCT00086281|470628686|FG002|Phase 1|Serious Adverse Event|0|||
130728828|NCT00086281|470628687|FG003|Phase 1|Serious Adverse Event|0|||
131160429|NCT01380093|472210950|FG000|Treatment Phase: Second Intervention|Other|0|||
131160430|NCT01380093|472210951|FG001|Treatment Phase: Second Intervention|Other|0|||
131160431|NCT01380093|472210952|FG002|Treatment Phase: Second Intervention|Other|0|||
131160432|NCT01380093|472210953|FG003|Treatment Phase: Second Intervention|Other|1|||
131160433|NCT01380093|472210954|FG004|Treatment Phase: Second Intervention|Other|0|||
131160434|NCT01380093|472210955|FG005|Treatment Phase: Second Intervention|Other|0|||
131160435|NCT01380093|472210956|FG006|Treatment Phase: Second Intervention|Other|0|||
131160436|NCT01380093|472210957|FG007|Treatment Phase: Second Intervention|Other|0|||
131160437|NCT01380093|472210958|FG008|Treatment Phase: Second Intervention|Other|0|||
131160438|NCT01380093|472210950|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
131160439|NCT01380093|472210951|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
131160440|NCT01380093|472210952|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
131160441|NCT01380093|472210953|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
131160442|NCT01380093|472210954|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
131160443|NCT01380093|472210955|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
131160444|NCT01380093|472210956|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
131160445|NCT01380093|472210957|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
131160446|NCT01380093|472210958|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
131160447|NCT01380093|472210950|FG000|Treatment Phase: Third Intervention|Other|0|||
131160448|NCT01380093|472210951|FG001|Treatment Phase: Third Intervention|Other|0|||
131160449|NCT01380093|472210952|FG002|Treatment Phase: Third Intervention|Other|0|||
131160450|NCT01380093|472210953|FG003|Treatment Phase: Third Intervention|Other|0|||
131160451|NCT01380093|472210954|FG004|Treatment Phase: Third Intervention|Other|0|||
131160452|NCT01380093|472210955|FG005|Treatment Phase: Third Intervention|Other|0|||
131160453|NCT01380093|472210956|FG006|Treatment Phase: Third Intervention|Other|0|||
131160454|NCT01380093|472210957|FG007|Treatment Phase: Third Intervention|Other|0|||
131160455|NCT01380093|472210958|FG008|Treatment Phase: Third Intervention|Other|1|||
131160456|NCT04734873|472210959|FG000|Overall Study|Lost to Follow-up|1|||
131160457|NCT04734873|472210960|FG001|Overall Study|Lost to Follow-up|3|||
131160458|NCT04734873|472210961|FG002|Overall Study|Lost to Follow-up|2|||
131160459|NCT04734873|472210959|FG000|Overall Study|Randomized but not dosed|1|||
131160460|NCT04734873|472210960|FG001|Overall Study|Randomized but not dosed|0|||
130728829|NCT00086281|470628688|FG004|Phase 1|Serious Adverse Event|0|||
130728830|NCT00086281|470628689|FG005|Phase 1|Serious Adverse Event|0|||
130728831|NCT00086281|470628690|FG006|Phase 1|Serious Adverse Event|0|||
131160461|NCT04734873|472210961|FG002|Overall Study|Randomized but not dosed|1|||
131160462|NCT00201201|472210962|FG000|Overall Study|Death|0|||
131160463|NCT00201201|472210963|FG001|Overall Study|Death|2|||
131160464|NCT00201201|472210962|FG000|Overall Study|Withdrawal by Subject|5|||
131160465|NCT00201201|472210963|FG001|Overall Study|Withdrawal by Subject|5|||
131160466|NCT01342640|472210965|FG000|Overall Study|Adverse Event|3|||
131160467|NCT01342640|472210965|FG000|Overall Study|Protocol Violation|16|||
131160468|NCT01342640|472210965|FG000|Overall Study|Lost to Follow-up|21|||
131160469|NCT01342640|472210965|FG000|Overall Study|Other|1|||
131160470|NCT04101422|472210967|FG000|Overall Study|Ineligible|1|||
131160471|NCT04101422|472210968|FG001|Overall Study|Ineligible|0|||
131160472|NCT04101422|472210969|FG002|Overall Study|Ineligible|9|||
131160473|NCT04101422|472210970|FG003|Overall Study|Ineligible|0|||
131160474|NCT04101422|472210967|FG000|Overall Study|Withdrawal by Subject|0|||
131160475|NCT04101422|472210968|FG001|Overall Study|Withdrawal by Subject|0|||
131160476|NCT04101422|472210969|FG002|Overall Study|Withdrawal by Subject|1|||
131160477|NCT04101422|472210970|FG003|Overall Study|Withdrawal by Subject|0|||
131160478|NCT04101422|472210967|FG000|Overall Study|Not attending to the stimuli|0|||
131160479|NCT04101422|472210968|FG001|Overall Study|Not attending to the stimuli|0|||
131160480|NCT04101422|472210969|FG002|Overall Study|Not attending to the stimuli|4|||
131160481|NCT04101422|472210970|FG003|Overall Study|Not attending to the stimuli|0|||
131160482|NCT04101422|472210967|FG000|Overall Study|Did not download app|0|||
131160483|NCT04101422|472210968|FG001|Overall Study|Did not download app|0|||
131160484|NCT04101422|472210969|FG002|Overall Study|Did not download app|0|||
131160485|NCT04101422|472210970|FG003|Overall Study|Did not download app|17|||
131160486|NCT04101422|472210967|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
131160487|NCT04101422|472210968|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
131160488|NCT04101422|472210969|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
131160489|NCT04101422|472210970|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
131160490|NCT00718861|472210973|FG000|Overall Study|Withdrawal by Subject|15|||
131160491|NCT00718861|472210974|FG001|Overall Study|Withdrawal by Subject|10|||
131160492|NCT00718861|472210973|FG000|Overall Study|Adverse Event|2|||
131160493|NCT00718861|472210974|FG001|Overall Study|Adverse Event|1|||
131160494|NCT00718861|472210973|FG000|Overall Study|Lost to Follow-up|2|||
131160495|NCT00718861|472210974|FG001|Overall Study|Lost to Follow-up|1|||
131160496|NCT00718861|472210973|FG000|Overall Study|Administrative Problems|1|||
131160497|NCT00718861|472210974|FG001|Overall Study|Administrative Problems|1|||
131160498|NCT00718861|472210973|FG000|Overall Study|Death|1|||
130728832|NCT00086281|470628691|FG007|Phase 1|Serious Adverse Event|0|||
131160499|NCT00718861|472210974|FG001|Overall Study|Death|5|||
131160500|NCT01749735|472210976|FG000|Overall Study|Withdrawal by Subject|1|||
131160501|NCT01749735|472210977|FG001|Overall Study|Withdrawal by Subject|0|||
131160502|NCT04382651|472210978|FG000|Overall Study|Death|26|||
131160503|NCT04382651|472210979|FG001|Overall Study|Death|23|||
131160504|NCT04382651|472210978|FG000|Overall Study|Lost to Follow-up|3|||
131160505|NCT04382651|472210979|FG001|Overall Study|Lost to Follow-up|4|||
131160506|NCT04382651|472210978|FG000|Overall Study|Withdrawal by Subject|2|||
131160507|NCT04382651|472210979|FG001|Overall Study|Withdrawal by Subject|0|||
131160508|NCT04382651|472210978|FG000|Overall Study|Physician Decision|0|||
131160509|NCT04382651|472210979|FG001|Overall Study|Physician Decision|1|||
131160510|NCT01873742|472210980|FG000|Overall Study|Lost to Follow-up|68|||
131160511|NCT01873742|472210981|FG001|Overall Study|Lost to Follow-up|76|||
131160512|NCT00790296|472210983|FG000|Overall Study|Did not meet study eligibility criteria|1|||
131160513|NCT00790296|472210984|FG001|Overall Study|Did not meet study eligibility criteria|1|||
131160514|NCT00790296|472210983|FG000|Overall Study|Adverse Event|0|||
131160515|NCT00790296|472210984|FG001|Overall Study|Adverse Event|1|||
131160516|NCT02612077|472210985|FG000|Overall Study|Adverse Event|3|||
131160517|NCT02612077|472210985|FG000|Overall Study|Withdrawal by Subject|9|||
131160518|NCT02612077|472210985|FG000|Overall Study|Protocol Violation|28|||
131160519|NCT02612077|472210985|FG000|Overall Study|Lost to Follow-up|20|||
131160520|NCT02612077|472210985|FG000|Overall Study|Death|377|||
131160521|NCT02612077|472210985|FG000|Overall Study|Moved or Changed Medical Team|23|||
131160522|NCT02612077|472210985|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
131160523|NCT02612077|472210985|FG000|Overall Study|Disease Progression|3|||
131160524|NCT02612077|472210985|FG000|Overall Study|Unknown reason|2|||
131160525|NCT02075255|472210986|FG000|Overall Study|Study specific withdrawal criteria|0|||
131160526|NCT02075255|472210987|FG001|Overall Study|Study specific withdrawal criteria|1|||
131160527|NCT02075255|472210988|FG002|Overall Study|Study specific withdrawal criteria|1|||
131160528|NCT02075255|472210986|FG000|Overall Study|Withdrawal by Subject|4|||
131160529|NCT02075255|472210987|FG001|Overall Study|Withdrawal by Subject|1|||
131160530|NCT02075255|472210988|FG002|Overall Study|Withdrawal by Subject|0|||
131160531|NCT02075255|472210986|FG000|Overall Study|Lost to Follow-up|0|||
131160532|NCT02075255|472210987|FG001|Overall Study|Lost to Follow-up|0|||
131160533|NCT02075255|472210988|FG002|Overall Study|Lost to Follow-up|1|||
131160534|NCT02075255|472210986|FG000|Overall Study|Adverse Event|0|||
131160535|NCT02075255|472210987|FG001|Overall Study|Adverse Event|0|||
131160536|NCT02075255|472210988|FG002|Overall Study|Adverse Event|1|||
131160537|NCT02075255|472210986|FG000|Overall Study|Death|0|||
131160538|NCT02075255|472210987|FG001|Overall Study|Death|2|||
131160539|NCT02075255|472210988|FG002|Overall Study|Death|0|||
131160540|NCT00301067|472210989|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
131160541|NCT00301067|472210990|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
131160542|NCT00301067|472210991|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
131160543|NCT00301067|472210992|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
131160544|NCT00301067|472210989|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
131160545|NCT00301067|472210990|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
131160546|NCT00301067|472210991|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
131160547|NCT00301067|472210992|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
131160548|NCT00301067|472210989|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
131160549|NCT00301067|472210990|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
131160550|NCT00301067|472210991|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
131160551|NCT00301067|472210992|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
131160552|NCT00301067|472210989|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
131160553|NCT00301067|472210990|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
131160554|NCT00301067|472210991|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
131160555|NCT00301067|472210992|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
131160556|NCT00301067|472210989|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
131160557|NCT00301067|472210990|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
131160558|NCT00301067|472210991|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
131160559|NCT00301067|472210992|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
131160560|NCT00301067|472210989|FG000|Follow up Until Death|Alive at last data cut point|1|||
131160561|NCT00301067|472210990|FG001|Follow up Until Death|Alive at last data cut point|0|||
131160562|NCT00301067|472210991|FG002|Follow up Until Death|Alive at last data cut point|0|||
131160563|NCT00301067|472210992|FG003|Follow up Until Death|Alive at last data cut point|1|||
131160564|NCT01751646|472210993|FG000|Overall Study|Lost to Follow-up|5|||
131160565|NCT01751646|472210994|FG001|Overall Study|Lost to Follow-up|1|||
131160566|NCT01751646|472210993|FG000|Overall Study|Withdrawal by Subject|0|||
131160567|NCT01751646|472210994|FG001|Overall Study|Withdrawal by Subject|4|||
131160568|NCT01751646|472210993|FG000|Overall Study|Starting hormone therapy|1|||
131160569|NCT01751646|472210994|FG001|Overall Study|Starting hormone therapy|0|||
131160570|NCT01751646|472210993|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
131160571|NCT01751646|472210994|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
131160572|NCT01751646|472210993|FG000|Overall Study|Inadvertent enrollment|1|||
131160573|NCT01751646|472210994|FG001|Overall Study|Inadvertent enrollment|1|||
131160574|NCT01751646|472210993|FG000|Overall Study|Moved out of the area|1|||
131160575|NCT01751646|472210994|FG001|Overall Study|Moved out of the area|5|||
131160576|NCT01751646|472210993|FG000|Overall Study|Inability to attend required visits|0|||
131160577|NCT01751646|472210994|FG001|Overall Study|Inability to attend required visits|1|||
131160578|NCT01751646|472210993|FG000|Overall Study|Off study due to multiple obligations|0|||
131160579|NCT01751646|472210994|FG001|Overall Study|Off study due to multiple obligations|1|||
131160580|NCT01751646|472210993|FG000|Overall Study|Fails to comply with study requirements|0|||
131160581|NCT01751646|472210994|FG001|Overall Study|Fails to comply with study requirements|1|||
131160582|NCT01751646|472210993|FG000|Overall Study|Childcare issues|1|||
131160583|NCT01751646|472210994|FG001|Overall Study|Childcare issues|1|||
131160584|NCT00853905|472210996|FG000|Overall Study|Lost to Follow-up|1|||
131160585|NCT00853905|472210997|FG001|Overall Study|Lost to Follow-up|3|||
131160586|NCT00853905|472210996|FG000|Overall Study|Withdrawal by Subject|0|||
131160587|NCT00853905|472210997|FG001|Overall Study|Withdrawal by Subject|1|||
131160588|NCT00853905|472210996|FG000|Overall Study|never had surgery|1|||
131160589|NCT00853905|472210997|FG001|Overall Study|never had surgery|0|||
131160590|NCT04538950|472210998|FG000|Overall Study|Pulmonary Issues|2|||
131160591|NCT04538950|472210998|FG000|Overall Study|illness|2|||
131160592|NCT00970294|472211001|FG000|Overall Study|Physician Decision|4|||
131160593|NCT00970294|472211001|FG000|Overall Study|Withdrawal by Subject|1|||
131160594|NCT00847561|472211002|FG000|Overall Study|Withdrawal by Subject|4|||
131160595|NCT00847561|472211003|FG001|Overall Study|Withdrawal by Subject|3|||
131160596|NCT00847561|472211002|FG000|Overall Study|Unable to schedule|9|||
131160597|NCT00847561|472211003|FG001|Overall Study|Unable to schedule|1|||
131160598|NCT01333189|472211004|FG000|Overall Study|Time constraints|1|||
131160599|NCT01333189|472211005|FG001|Overall Study|Time constraints|0|||
131160600|NCT01333189|472211004|FG000|Overall Study|Adverse Event|1|||
131160601|NCT01333189|472211005|FG001|Overall Study|Adverse Event|0|||
131160602|NCT01333189|472211004|FG000|Overall Study|Transportation difficulties|0|||
131160603|NCT01333189|472211005|FG001|Overall Study|Transportation difficulties|1|||
131160604|NCT01333189|472211004|FG000|Overall Study|Moved from region|0|||
131160605|NCT01333189|472211005|FG001|Overall Study|Moved from region|1|||
131160606|NCT01787591|472211007|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
131160607|NCT01787591|472211008|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
131160608|NCT01787591|472211009|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
131160609|NCT01787591|472211010|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
131160610|NCT02489630|472211012|FG000|Overall Study|Oversedation|1|||
131160611|NCT02489630|472211013|FG001|Overall Study|Oversedation|1|||
131160612|NCT02489630|472211012|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
131160613|NCT02489630|472211013|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
131160614|NCT01326962|472211014|FG000|Overall Study|Adverse Event|1|||
131160615|NCT01326962|472211014|FG000|Overall Study|Withdrawal by Subject|1|||
131160616|NCT01326962|472211014|FG000|Overall Study|Lost to Follow-up|3|||
131160617|NCT01326962|472211014|FG000|Overall Study|Other|2|||
131160618|NCT04799782|472211016|FG000|Washout|Physician Decision|2|||
131160619|NCT04799782|472211017|FG001|Washout|Physician Decision|0|||
131160620|NCT04799782|472211016|FG000|Washout|Withdrawal by Subject|0|||
131160621|NCT04799782|472211017|FG001|Washout|Withdrawal by Subject|2|||
131160622|NCT04799782|472211016|FG000|Washout|Lost to Follow-up|0|||
131160623|NCT04799782|472211017|FG001|Washout|Lost to Follow-up|1|||
131160624|NCT02606877|472211018|FG000|Overall Study|Adverse Event|3|||
131160625|NCT02606877|472211019|FG001|Overall Study|Adverse Event|0|||
131160626|NCT02606877|472211018|FG000|Overall Study|Non-compliance with protocol|0|||
131160627|NCT02606877|472211019|FG001|Overall Study|Non-compliance with protocol|1|||
131160628|NCT02606877|472211018|FG000|Overall Study|Other than listed above|1|||
131160629|NCT02606877|472211019|FG001|Overall Study|Other than listed above|0|||
131160630|NCT01318902|472211024|FG000|Overall Study|Symptomatic Deterioration|0|||
131160631|NCT01318902|472211025|FG001|Overall Study|Symptomatic Deterioration|1|||
131160632|NCT01318902|472211026|FG002|Overall Study|Symptomatic Deterioration|1|||
131160633|NCT01318902|472211027|FG003|Overall Study|Symptomatic Deterioration|2|||
131160634|NCT01318902|472211024|FG000|Overall Study|Withdrawal by Patient|0|||
131160635|NCT01318902|472211025|FG001|Overall Study|Withdrawal by Patient|1|||
130728833|NCT00086281|470628692|FG008|Phase 1|Serious Adverse Event|0|||
130728834|NCT00086281|470628693|FG009|Phase 1|Serious Adverse Event|0|||
130728835|NCT00086281|470628694|FG010|Phase 1|Serious Adverse Event|0|||
131160636|NCT01318902|472211026|FG002|Overall Study|Withdrawal by Patient|0|||
131160637|NCT01318902|472211027|FG003|Overall Study|Withdrawal by Patient|3|||
131160638|NCT01318902|472211024|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
131160639|NCT01318902|472211025|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
131160640|NCT01318902|472211026|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130728836|NCT00086281|470628695|FG011|Phase 1|Serious Adverse Event|0|||
131160641|NCT01318902|472211027|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
131160642|NCT01318902|472211024|FG000|Overall Study|Adverse Event|0|||
131160643|NCT01318902|472211025|FG001|Overall Study|Adverse Event|1|||
131160644|NCT01318902|472211026|FG002|Overall Study|Adverse Event|0|||
131160645|NCT01318902|472211027|FG003|Overall Study|Adverse Event|0|||
131160646|NCT01318902|472211024|FG000|Overall Study|Terminated by Sponsor|0|||
131160647|NCT01318902|472211025|FG001|Overall Study|Terminated by Sponsor|0|||
131160648|NCT01318902|472211026|FG002|Overall Study|Terminated by Sponsor|1|||
131160649|NCT01318902|472211027|FG003|Overall Study|Terminated by Sponsor|0|||
131160650|NCT00128206|472212905|FG000|Overall Study|Lost to Follow-up|137|||
131160651|NCT00128206|472212906|FG001|Overall Study|Lost to Follow-up|118|||
131160652|NCT00128206|472212905|FG000|Overall Study|Adverse Event|0|||
131160653|NCT00128206|472212906|FG001|Overall Study|Adverse Event|2|||
131160654|NCT01269125|472212907|FG000|Overall Study|Adverse Event|3|||
131160655|NCT01269125|472212908|FG001|Overall Study|Adverse Event|5|||
131160656|NCT01269125|472212909|FG002|Overall Study|Adverse Event|0|||
131160657|NCT01269125|472212907|FG000|Overall Study|Lost to Follow-up|4|||
131160658|NCT01269125|472212908|FG001|Overall Study|Lost to Follow-up|0|||
131160659|NCT01269125|472212909|FG002|Overall Study|Lost to Follow-up|0|||
131160660|NCT01040832|472212911|FG000|Overall Study|Adverse Event|4|||
131160661|NCT01040832|472212912|FG001|Overall Study|Adverse Event|5|||
131160662|NCT01040832|472212911|FG000|Overall Study|Death|4|||
131160663|NCT01040832|472212912|FG001|Overall Study|Death|6|||
131160664|NCT01040832|472212911|FG000|Overall Study|Withdrawal by Subject|2|||
131160665|NCT01040832|472212912|FG001|Overall Study|Withdrawal by Subject|3|||
131160666|NCT01040832|472212911|FG000|Overall Study|Progressive disease|32|||
131160667|NCT01040832|472212912|FG001|Overall Study|Progressive disease|17|||
131160668|NCT01040832|472212911|FG000|Overall Study|Symptomatic deterioration|2|||
131160669|NCT01040832|472212912|FG001|Overall Study|Symptomatic deterioration|5|||
131160670|NCT01040832|472212911|FG000|Overall Study|Other|2|||
131160671|NCT01040832|472212912|FG001|Overall Study|Other|1|||
131160672|NCT00592358|472212915|FG000|Overall Study|Withdrawal by Subject|2|||
131160673|NCT00592358|472212915|FG000|Overall Study|Adverse Event|1|||
131160674|NCT00592358|472212915|FG000|Overall Study|Lack of Efficacy|2|||
131160675|NCT00592358|472212915|FG000|Overall Study|Inability to swallow pills|1|||
131160676|NCT01166659|472212916|FG000|Overall Study|Subject Decision|8|||
131160677|NCT01166659|472212916|FG000|Overall Study|Investigator Decision|2|||
131160678|NCT01166659|472212916|FG000|Overall Study|Death|1|||
131160679|NCT01166659|472212916|FG000|Overall Study|Lost to Follow-up|1|||
131160680|NCT01166659|472212916|FG000|Overall Study|Study Closed at Site|1|||
131160681|NCT01371838|472212930|FG000|Overall Study|Withdrawal by Subject|27|||
131160682|NCT01371838|472212931|FG001|Overall Study|Withdrawal by Subject|33|||
131160683|NCT01371838|472212930|FG000|Overall Study|Lost to Follow-up|10|||
131160684|NCT01371838|472212931|FG001|Overall Study|Lost to Follow-up|20|||
131160685|NCT01371838|472212930|FG000|Overall Study|Death|3|||
131160686|NCT01371838|472212931|FG001|Overall Study|Death|4|||
131160687|NCT01371838|472212930|FG000|Overall Study|Protocol Violation|3|||
131160688|NCT01371838|472212931|FG001|Overall Study|Protocol Violation|0|||
131160689|NCT01371838|472212930|FG000|Overall Study|Investigator Decision|3|||
131160690|NCT01371838|472212931|FG001|Overall Study|Investigator Decision|8|||
131160691|NCT01371838|472212930|FG000|Overall Study|Last follow-up visit not conducted|2|||
131160692|NCT01371838|472212931|FG001|Overall Study|Last follow-up visit not conducted|0|||
131160693|NCT01371838|472212930|FG000|Overall Study|Lack of therapeutic response|0|||
131160694|NCT01371838|472212931|FG001|Overall Study|Lack of therapeutic response|1|||
131160695|NCT01371838|472212930|FG000|Overall Study|Surgery|1|||
131160696|NCT01371838|472212931|FG001|Overall Study|Surgery|0|||
131160697|NCT04275310|472212934|FG000|Overall Study|Non-randomized due to running out of funding|4|||
131160698|NCT04275310|472212935|FG001|Overall Study|Non-randomized due to running out of funding|0|||
131160699|NCT02225223|472212937|FG000|Overall Study|Death|10|||
131160700|NCT02225223|472212938|FG001|Overall Study|Death|1|||
131160701|NCT02225223|472212937|FG000|Overall Study|Lost to Follow-up|5|||
131160702|NCT02225223|472212938|FG001|Overall Study|Lost to Follow-up|0|||
131160703|NCT02225223|472212937|FG000|Overall Study|Other|1|||
131160704|NCT02225223|472212938|FG001|Overall Study|Other|2|||
131160705|NCT02225223|472212937|FG000|Overall Study|Physician Decision|1|||
131160706|NCT02225223|472212938|FG001|Overall Study|Physician Decision|0|||
131160707|NCT02225223|472212937|FG000|Overall Study|Withdrawal by Subject|2|||
131160708|NCT02225223|472212938|FG001|Overall Study|Withdrawal by Subject|2|||
131160709|NCT00958568|472212939|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
131160710|NCT00958568|472212940|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
131160711|NCT00958568|472212941|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
131160712|NCT00958568|472212942|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
131235409|NCT02270736|472490898|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
131235410|NCT02270736|472490894|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
131235411|NCT02270736|472490895|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130728837|NCT00086281|470628696|FG012|Phase 1|Serious Adverse Event|0|||
131160713|NCT00958568|472212939|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
131160714|NCT00958568|472212940|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
131160715|NCT00958568|472212941|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
131160716|NCT00958568|472212942|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
131235412|NCT02270736|472490896|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
131160717|NCT00958568|472212939|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
131160718|NCT00958568|472212940|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
131160719|NCT00958568|472212941|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
131160720|NCT00958568|472212942|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
131160721|NCT00958568|472212939|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
131160722|NCT00958568|472212940|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
131160723|NCT00958568|472212941|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
131160724|NCT00958568|472212942|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
131160725|NCT00958568|472212939|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
131160726|NCT00958568|472212940|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
131160727|NCT00958568|472212941|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
131160728|NCT00958568|472212942|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
131160729|NCT00958568|472212939|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
131160730|NCT00958568|472212940|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
131160731|NCT00958568|472212941|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
131160732|NCT00958568|472212942|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
131160733|NCT00958568|472212939|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
131160734|NCT00958568|472212940|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
131160735|NCT00958568|472212941|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
131160736|NCT00958568|472212942|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
131160737|NCT00958568|472212939|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
131160738|NCT00958568|472212940|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
131160739|NCT00958568|472212941|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
131160740|NCT00958568|472212942|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
131160741|NCT00958568|472212939|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
131160742|NCT00958568|472212940|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
131160743|NCT00958568|472212941|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
131160744|NCT00958568|472212942|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
131160745|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
130728838|NCT00086281|470628697|FG013|Phase 1|Serious Adverse Event|0|||
130728839|NCT00086281|470628698|FG014|Phase 1|Serious Adverse Event|1|||
130728840|NCT00086281|470628684|FG000|Phase 2|Adverse Event|0|||
130728841|NCT00086281|470628685|FG001|Phase 2|Adverse Event|0|||
130728842|NCT00086281|470628686|FG002|Phase 2|Adverse Event|0|||
130728843|NCT00086281|470628687|FG003|Phase 2|Adverse Event|0|||
130728844|NCT00086281|470628688|FG004|Phase 2|Adverse Event|0|||
130728845|NCT00086281|470628689|FG005|Phase 2|Adverse Event|0|||
130728846|NCT00086281|470628690|FG006|Phase 2|Adverse Event|0|||
130728847|NCT00086281|470628691|FG007|Phase 2|Adverse Event|0|||
130728848|NCT00086281|470628692|FG008|Phase 2|Adverse Event|0|||
130728849|NCT00086281|470628693|FG009|Phase 2|Adverse Event|0|||
130728850|NCT00086281|470628694|FG010|Phase 2|Adverse Event|0|||
130728851|NCT00086281|470628695|FG011|Phase 2|Adverse Event|0|||
130728852|NCT00086281|470628696|FG012|Phase 2|Adverse Event|1|||
130728853|NCT00086281|470628697|FG013|Phase 2|Adverse Event|1|||
130728854|NCT00086281|470628698|FG014|Phase 2|Adverse Event|0|||
130728855|NCT04759768|470628699|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
130728856|NCT04759768|470628700|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
130728857|NCT04759768|470628699|FG000|Washout (7 Days)|Physician Decision|0|||
130728858|NCT04759768|470628700|FG001|Washout (7 Days)|Physician Decision|1|||
130728859|NCT02996487|470628701|FG000|Overall Study|Lost to Follow-up|1|||
131160746|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
130728860|NCT02996487|470628702|FG001|Overall Study|Lost to Follow-up|1|||
131160747|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
131160748|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
131160749|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
131160750|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
131160751|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
131160752|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
130728861|NCT02996487|470628703|FG002|Overall Study|Lost to Follow-up|0|||
131160753|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
131160754|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
130728862|NCT02996487|470628701|FG000|Overall Study|Death|0|||
130728863|NCT02996487|470628702|FG001|Overall Study|Death|1|||
130728864|NCT02996487|470628703|FG002|Overall Study|Death|0|||
130728865|NCT02996487|470628701|FG000|Overall Study|Withdrawal by Subject|2|||
130728866|NCT02996487|470628702|FG001|Overall Study|Withdrawal by Subject|3|||
130728867|NCT02996487|470628703|FG002|Overall Study|Withdrawal by Subject|0|||
130728868|NCT02027428|470628704|FG000|Induction|Never treated|7|||
130728869|NCT02027428|470628705|FG001|Induction|Never treated|0|||
130728870|NCT02027428|470628706|FG002|Induction|Never treated|0|||
130728871|NCT02027428|470628704|FG000|Induction|Progressive disease|77|||
130728872|NCT02027428|470628705|FG001|Induction|Progressive disease|0|||
130728873|NCT02027428|470628706|FG002|Induction|Progressive disease|0|||
130728874|NCT02027428|470628704|FG000|Induction|Adverse Event|51|||
130728875|NCT02027428|470628705|FG001|Induction|Adverse Event|0|||
130728876|NCT02027428|470628706|FG002|Induction|Adverse Event|0|||
130728877|NCT02027428|470628704|FG000|Induction|Withdrawal by Subject|22|||
130728878|NCT02027428|470628705|FG001|Induction|Withdrawal by Subject|0|||
130728879|NCT02027428|470628706|FG002|Induction|Withdrawal by Subject|0|||
130728880|NCT02027428|470628704|FG000|Induction|Death|21|||
130728881|NCT02027428|470628705|FG001|Induction|Death|0|||
130728882|NCT02027428|470628706|FG002|Induction|Death|0|||
130728883|NCT02027428|470628704|FG000|Induction|Symptomatic deterioration|16|||
130728884|NCT02027428|470628705|FG001|Induction|Symptomatic deterioration|0|||
130728885|NCT02027428|470628706|FG002|Induction|Symptomatic deterioration|0|||
130728886|NCT02027428|470628704|FG000|Induction|Study terminated by sponsor|12|||
130728887|NCT02027428|470628705|FG001|Induction|Study terminated by sponsor|0|||
130728888|NCT02027428|470628706|FG002|Induction|Study terminated by sponsor|0|||
131160755|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
131160756|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
131160757|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
131160758|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
131160759|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
131160760|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
131160761|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
130728889|NCT02027428|470628704|FG000|Induction|Protocol Violation|1|||
130728890|NCT02027428|470628705|FG001|Induction|Protocol Violation|0|||
130728891|NCT02027428|470628706|FG002|Induction|Protocol Violation|0|||
130728892|NCT02027428|470628704|FG000|Induction|Miscellaneous|14|||
130728893|NCT02027428|470628705|FG001|Induction|Miscellaneous|0|||
130728894|NCT02027428|470628706|FG002|Induction|Miscellaneous|0|||
130728895|NCT02027428|470628704|FG000|Induction|Induction Treatment Ongoing|4|||
130728896|NCT02027428|470628705|FG001|Induction|Induction Treatment Ongoing|0|||
130728897|NCT02027428|470628706|FG002|Induction|Induction Treatment Ongoing|0|||
130728898|NCT02027428|470628704|FG000|Maintenance|Death|0|||
130728899|NCT02027428|470628705|FG001|Maintenance|Death|3|||
131160762|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
131160763|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
131160764|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
131160765|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
130728900|NCT02027428|470628706|FG002|Maintenance|Death|2|||
130728901|NCT02027428|470628704|FG000|Maintenance|Adverse Event|0|||
130728902|NCT02027428|470628705|FG001|Maintenance|Adverse Event|21|||
130728903|NCT02027428|470628706|FG002|Maintenance|Adverse Event|1|||
130728904|NCT02027428|470628704|FG000|Maintenance|Progressive disease|0|||
130728905|NCT02027428|470628705|FG001|Maintenance|Progressive disease|84|||
130728906|NCT02027428|470628706|FG002|Maintenance|Progressive disease|47|||
130728907|NCT02027428|470628704|FG000|Maintenance|Symptomatic deterioration|0|||
130728908|NCT02027428|470628705|FG001|Maintenance|Symptomatic deterioration|4|||
130728909|NCT02027428|470628706|FG002|Maintenance|Symptomatic deterioration|1|||
130728910|NCT02027428|470628704|FG000|Maintenance|Withdrawal by Subject|0|||
130728911|NCT02027428|470628705|FG001|Maintenance|Withdrawal by Subject|6|||
130728912|NCT02027428|470628706|FG002|Maintenance|Withdrawal by Subject|5|||
130780597|NCT00735709|470823124|FG002|Overall Study|Lack of Efficacy|2|||
130780598|NCT00735709|470823125|FG003|Overall Study|Lack of Efficacy|3|||
130780599|NCT00735709|470823122|FG000|Overall Study|Noncompliance|0|||
130780600|NCT00735709|470823123|FG001|Overall Study|Noncompliance|0|||
130780601|NCT00735709|470823124|FG002|Overall Study|Noncompliance|1|||
130780602|NCT00735709|470823125|FG003|Overall Study|Noncompliance|0|||
131160766|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
131160767|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
131160768|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
131235413|NCT02270736|472490897|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130728913|NCT02027428|470628704|FG000|Maintenance|Protocol Violation|0|||
130728914|NCT02027428|470628705|FG001|Maintenance|Protocol Violation|0|||
130728915|NCT02027428|470628706|FG002|Maintenance|Protocol Violation|1|||
130728916|NCT02027428|470628704|FG000|Maintenance|Other|0|||
130728917|NCT02027428|470628705|FG001|Maintenance|Other|6|||
130728918|NCT02027428|470628706|FG002|Maintenance|Other|3|||
130728919|NCT02027428|470628704|FG000|Survival Follow-up|Death|0|||
130728920|NCT02027428|470628705|FG001|Survival Follow-up|Death|78|||
130728921|NCT02027428|470628706|FG002|Survival Follow-up|Death|45|||
130728922|NCT02027428|470628704|FG000|Survival Follow-up|Lost to Follow-up|0|||
130728923|NCT02027428|470628705|FG001|Survival Follow-up|Lost to Follow-up|1|||
130728924|NCT02027428|470628706|FG002|Survival Follow-up|Lost to Follow-up|1|||
130728925|NCT01130597|470628707|FG000|Overall Study|Protocol-specified (High K+)|1|||
130728926|NCT01130597|470628707|FG000|Overall Study|Adverse Event|4|||
130728927|NCT01130597|470628707|FG000|Overall Study|Death|1|||
130780603|NCT00735709|470823122|FG000|Overall Study|Protocol deviations|1|||
130728928|NCT01130597|470628707|FG000|Overall Study|Protocol Violation|1|||
131160769|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
131160770|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
131160771|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
131160772|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
131160773|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
131160774|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
131160775|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
131160776|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
131160777|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
131160778|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
131160779|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
131160780|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
131160781|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
131160782|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
131160783|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
131160784|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
131160785|NCT00958568|472212939|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
131160786|NCT00958568|472212940|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
131160787|NCT00958568|472212941|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
131160788|NCT00958568|472212942|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
131160789|NCT00958568|472212939|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
131160790|NCT00958568|472212940|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
131160791|NCT00958568|472212941|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
131160792|NCT00958568|472212942|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
131160793|NCT00958568|472212939|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
131160794|NCT00958568|472212940|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
131160795|NCT00958568|472212941|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
131160796|NCT00958568|472212942|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
131160797|NCT00958568|472212939|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
131160798|NCT00958568|472212940|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
131160799|NCT00958568|472212941|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
131160800|NCT00958568|472212942|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
131160801|NCT00958568|472212939|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
131160802|NCT00958568|472212940|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
131160803|NCT00958568|472212941|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
131160804|NCT00958568|472212942|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
131160805|NCT00958568|472212939|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
131160806|NCT00958568|472212940|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
131160807|NCT00958568|472212941|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
131160808|NCT00958568|472212942|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
131160809|NCT00958568|472212939|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
131160810|NCT00958568|472212940|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
131160811|NCT00958568|472212941|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
131160812|NCT00958568|472212942|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
131160813|NCT00958568|472212939|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
131160814|NCT00958568|472212940|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
131160815|NCT00958568|472212941|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
131160816|NCT00958568|472212942|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
131160817|NCT00958568|472212939|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
131160818|NCT00958568|472212940|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
131160819|NCT00958568|472212941|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
131160820|NCT00958568|472212942|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
131160821|NCT00958568|472212939|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
131160822|NCT00958568|472212940|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
131160823|NCT00958568|472212941|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
131160824|NCT00958568|472212942|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
131160825|NCT01936649|472212953|FG000|Overall Study|Withdrawal by Subject|4|||
131160826|NCT01936649|472212953|FG000|Overall Study|Physician Decision|2|||
131160827|NCT01936649|472212953|FG000|Overall Study|Protocol Violation|2|||
131160828|NCT01936649|472212953|FG000|Overall Study|Other than specified above|5|||
130728945|NCT05794503|470628710|FG000|Overall Study|Operation Cancelled|2|||
130728946|NCT05794503|470628711|FG001|Overall Study|Operation Cancelled|0|||
130728947|NCT05794503|470628710|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
130728948|NCT05794503|470628711|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
131160829|NCT04498910|472212956|FG000|Overall Study|Lost to Follow-up|0|||
131160830|NCT04498910|472212957|FG001|Overall Study|Lost to Follow-up|1|||
131160831|NCT04498910|472212956|FG000|Overall Study|Withdrawal by Subject|2|||
131160832|NCT04498910|472212957|FG001|Overall Study|Withdrawal by Subject|1|||
131160833|NCT04498910|472212956|FG000|Overall Study|Adverse Event|1|||
131160834|NCT04498910|472212957|FG001|Overall Study|Adverse Event|0|||
131160835|NCT00909090|472212958|FG000|Overall Study|Lost to Follow-up|17|||
131160836|NCT00909090|472212959|FG001|Overall Study|Lost to Follow-up|17|||
131160837|NCT00611455|472212963|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
131160838|NCT00611455|472212964|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
131160839|NCT00611455|472212965|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
131160840|NCT00611455|472212963|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
131160841|NCT00611455|472212964|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131160842|NCT00611455|472212965|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
131160843|NCT00611455|472212963|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
131160844|NCT00611455|472212964|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
131160845|NCT00611455|472212965|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
131160846|NCT00611455|472212963|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
131160847|NCT00611455|472212964|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131160848|NCT00611455|472212965|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131160849|NCT00611455|472212963|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
131160850|NCT00611455|472212964|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
131160851|NCT00611455|472212965|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
131160852|NCT00611455|472212963|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
131160853|NCT00611455|472212964|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
131160854|NCT00611455|472212965|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
131160855|NCT00611455|472212963|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
131160856|NCT00611455|472212964|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
131160857|NCT00611455|472212965|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
131160858|NCT00611455|472212963|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
131160859|NCT00611455|472212964|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
131160860|NCT00611455|472212965|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
131160861|NCT00611455|472212963|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
131160862|NCT00611455|472212964|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
131160863|NCT00611455|472212965|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
131160864|NCT00611455|472212963|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
131160865|NCT00611455|472212964|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
131160866|NCT00611455|472212965|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
131160867|NCT00611455|472212963|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
131160868|NCT00611455|472212964|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
131160869|NCT00611455|472212965|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
131160870|NCT00611455|472212963|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
131160871|NCT00611455|472212964|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
131160872|NCT00611455|472212965|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
131160873|NCT00611455|472212963|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
131160874|NCT00611455|472212964|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
131160875|NCT00611455|472212965|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
131160876|NCT00611455|472212963|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
131160877|NCT00611455|472212964|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
131160878|NCT00611455|472212965|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
131160879|NCT00611455|472212963|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
131160880|NCT00611455|472212964|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
131160881|NCT00611455|472212965|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
131160882|NCT00611455|472212963|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
131160883|NCT00611455|472212964|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
131160884|NCT00611455|472212965|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
131160885|NCT00611455|472212963|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
131160886|NCT00611455|472212964|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
131160887|NCT00611455|472212965|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
131160888|NCT00611455|472212963|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
131160889|NCT00611455|472212964|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
131160890|NCT00611455|472212965|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
131160891|NCT00611455|472212963|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
130728949|NCT05794503|470628710|FG000|Overall Study|Protocol Violation|1|||
131160892|NCT00611455|472212964|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
131160893|NCT00611455|472212965|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
131160894|NCT00611455|472212963|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
131160895|NCT00611455|472212964|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
131160896|NCT00611455|472212965|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
131160897|NCT00611455|472212963|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
131160898|NCT00611455|472212964|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
131160899|NCT00611455|472212965|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
131160900|NCT01839188|472212966|FG000|Overall Study|Withdrawal by Subject|1|||
131160901|NCT04983901|472212967|FG000|Overall Study|Death|1|||
131160902|NCT04983901|472212968|FG001|Overall Study|Death|4|||
131160903|NCT04983901|472212967|FG000|Overall Study|Lost to Follow-up|3|||
131160904|NCT04983901|472212968|FG001|Overall Study|Lost to Follow-up|0|||
131160905|NCT04983901|472212967|FG000|Overall Study|Protocol Violation|1|||
131160906|NCT04983901|472212968|FG001|Overall Study|Protocol Violation|0|||
131160907|NCT04983901|472212967|FG000|Overall Study|Withdrawal by Subject|1|||
131160908|NCT04983901|472212968|FG001|Overall Study|Withdrawal by Subject|2|||
131160909|NCT03671369|472212973|FG000|Overall Study|Other|1|||
131160910|NCT03671369|472212973|FG000|Overall Study|Withdrawal by Subject|289|||
131160911|NCT03671369|472212973|FG000|Overall Study|Not willing to be vaccinated|1|||
131160912|NCT02732912|472212974|FG000|Overall Study|Discharged before night|2|||
131160913|NCT02732912|472212975|FG001|Overall Study|Discharged before night|6|||
131160914|NCT02732912|472212974|FG000|Overall Study|Incomplete completion of questionnaire|2|||
131160915|NCT02732912|472212975|FG001|Overall Study|Incomplete completion of questionnaire|3|||
131160916|NCT02732912|472212974|FG000|Overall Study|No outcome; discharged or refused|6|||
131160917|NCT02732912|472212975|FG001|Overall Study|No outcome; discharged or refused|9|||
131160918|NCT01507545|472212980|FG000|Overall Study|Withdrawal by Subject|6|||
131160919|NCT01507545|472212981|FG001|Overall Study|Withdrawal by Subject|2|||
131160920|NCT01507545|472212980|FG000|Overall Study|Lost to Follow-up|1|||
131160921|NCT01507545|472212981|FG001|Overall Study|Lost to Follow-up|0|||
131160922|NCT01507545|472212980|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
131160923|NCT01507545|472212981|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
131160924|NCT01507545|472212980|FG000|Overall Study|Progressive disease|60|||
131160925|NCT01507545|472212981|FG001|Overall Study|Progressive disease|27|||
131160926|NCT01507545|472212980|FG000|Overall Study|Other|6|||
131160927|NCT01507545|472212981|FG001|Overall Study|Other|4|||
131160928|NCT01671488|472212982|FG000|Overall Study|Withdrawal by Subject|1|||
131160929|NCT01022853|472212983|FG000|Overall Study|Progressive disease|2|||
131160930|NCT01022853|472212984|FG001|Overall Study|Progressive disease|3|||
131160931|NCT01022853|472212985|FG002|Overall Study|Progressive disease|11|||
131160932|NCT01022853|472212986|FG003|Overall Study|Progressive disease|7|||
131160933|NCT01022853|472212987|FG004|Overall Study|Progressive disease|1|||
131160934|NCT01022853|472212983|FG000|Overall Study|Dose-limiting toxicity|0|||
131160935|NCT01022853|472212984|FG001|Overall Study|Dose-limiting toxicity|0|||
131160936|NCT01022853|472212985|FG002|Overall Study|Dose-limiting toxicity|0|||
131160937|NCT01022853|472212986|FG003|Overall Study|Dose-limiting toxicity|0|||
131160938|NCT01022853|472212987|FG004|Overall Study|Dose-limiting toxicity|1|||
131160939|NCT01022853|472212983|FG000|Overall Study|Withdrawal by Subject|0|||
131160940|NCT01022853|472212984|FG001|Overall Study|Withdrawal by Subject|1|||
131160941|NCT01022853|472212985|FG002|Overall Study|Withdrawal by Subject|1|||
131160942|NCT01022853|472212986|FG003|Overall Study|Withdrawal by Subject|1|||
131160943|NCT01022853|472212987|FG004|Overall Study|Withdrawal by Subject|0|||
131160944|NCT01022853|472212983|FG000|Overall Study|Other not stated above|1|||
131160945|NCT01022853|472212984|FG001|Overall Study|Other not stated above|0|||
131160946|NCT01022853|472212985|FG002|Overall Study|Other not stated above|1|||
131160947|NCT01022853|472212986|FG003|Overall Study|Other not stated above|0|||
131160948|NCT01022853|472212987|FG004|Overall Study|Other not stated above|0|||
131160949|NCT01753518|472212988|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
131160950|NCT01753518|472212989|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
131160951|NCT01753518|472212988|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
131160952|NCT01753518|472212989|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
131160953|NCT01753518|472212988|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
131160954|NCT01753518|472212989|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
131160955|NCT01753518|472212988|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
131160956|NCT01753518|472212989|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
131160957|NCT01214434|472212990|FG000|Overall Study|Withdrawal by Subject|1|||
131160958|NCT01214434|472212991|FG001|Overall Study|Withdrawal by Subject|0|||
131160959|NCT01214434|472212990|FG000|Overall Study|Lost to Follow-up|2|||
131160960|NCT01214434|472212991|FG001|Overall Study|Lost to Follow-up|2|||
131160961|NCT01214434|472212990|FG000|Overall Study|Site error|1|||
131160962|NCT01214434|472212991|FG001|Overall Study|Site error|0|||
131160963|NCT00138151|472212992|FG000|Overall Study|Withdrawal by Subject|3|||
131235414|NCT02270736|472490898|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130728950|NCT05794503|470628711|FG001|Overall Study|Protocol Violation|0|||
131160964|NCT00138151|472212992|FG000|Overall Study|Physician Decision|1|||
131160965|NCT03503773|472212993|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
131160966|NCT03503773|472212994|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
131160967|NCT03503773|472212993|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
131160968|NCT03503773|472212994|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
131160969|NCT03503773|472212993|FG000|Overall Study|Not completing the primary ABPM|3|||
131160970|NCT03503773|472212994|FG001|Overall Study|Not completing the primary ABPM|1|||
131160971|NCT03503773|472212993|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
131160972|NCT03503773|472212994|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
131160973|NCT02675517|472213000|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
131160974|NCT02675517|472213000|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
131160975|NCT00425438|472213001|FG000|Overall Study|Termination by Sponsor|25|||
131160976|NCT00425438|472213002|FG001|Overall Study|Termination by Sponsor|27|||
131160977|NCT03494725|472213003|FG000|Overall Study|Withdrawal by Subject|0|||
130780604|NCT00735709|470823123|FG001|Overall Study|Protocol deviations|2|||
130780605|NCT00735709|470823124|FG002|Overall Study|Protocol deviations|1|||
130780606|NCT00735709|470823125|FG003|Overall Study|Protocol deviations|1|||
131160978|NCT03494725|472213004|FG001|Overall Study|Withdrawal by Subject|2|||
131160979|NCT03494725|472213003|FG000|Overall Study|Antibiotic use|1|||
131160980|NCT03494725|472213004|FG001|Overall Study|Antibiotic use|0|||
131160981|NCT02619253|472213005|FG000|Overall Study|Adverse Event|0|||
131160982|NCT02619253|472213006|FG001|Overall Study|Adverse Event|0|||
131160983|NCT02619253|472213007|FG002|Overall Study|Adverse Event|1|||
131160984|NCT02619253|472213008|FG003|Overall Study|Adverse Event|1|||
131160985|NCT02619253|472213009|FG004|Overall Study|Adverse Event|3|||
131160986|NCT02619253|472213005|FG000|Overall Study|Alternative Therapy|0|||
131160987|NCT02619253|472213006|FG001|Overall Study|Alternative Therapy|0|||
131160988|NCT02619253|472213007|FG002|Overall Study|Alternative Therapy|1|||
131160989|NCT02619253|472213008|FG003|Overall Study|Alternative Therapy|0|||
131160990|NCT02619253|472213009|FG004|Overall Study|Alternative Therapy|0|||
131160991|NCT02619253|472213005|FG000|Overall Study|Death|0|||
131160992|NCT02619253|472213006|FG001|Overall Study|Death|0|||
131160993|NCT02619253|472213007|FG002|Overall Study|Death|0|||
131160994|NCT02619253|472213008|FG003|Overall Study|Death|1|||
131160995|NCT02619253|472213009|FG004|Overall Study|Death|0|||
131160996|NCT02619253|472213005|FG000|Overall Study|Disease Progression|4|||
131160997|NCT02619253|472213006|FG001|Overall Study|Disease Progression|2|||
131235415|NCT02270736|472490894|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
130728951|NCT01589497|470628712|FG000|Overall Study|Withdrawal by Subject|0|||
130728952|NCT01589497|470628713|FG001|Overall Study|Withdrawal by Subject|1|||
130728953|NCT01589497|470628714|FG002|Overall Study|Withdrawal by Subject|0|||
130728954|NCT01589497|470628715|FG003|Overall Study|Withdrawal by Subject|1|||
130728955|NCT01589497|470628712|FG000|Overall Study|Death|1|||
130728956|NCT01589497|470628713|FG001|Overall Study|Death|0|||
130728957|NCT01589497|470628714|FG002|Overall Study|Death|0|||
130728958|NCT01589497|470628715|FG003|Overall Study|Death|0|||
130728959|NCT01589497|470628712|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
130728960|NCT01589497|470628713|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
130728961|NCT01589497|470628714|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
130728962|NCT01589497|470628715|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
130728963|NCT00143247|470628724|FG000|Overall Study|Death|8|||
130728964|NCT00143247|470628724|FG000|Overall Study|Adverse Event|19|||
130728965|NCT00143247|470628724|FG000|Overall Study|Lack of Efficacy|3|||
130728966|NCT00143247|470628724|FG000|Overall Study|Withdrawal by Subject|55|||
130728967|NCT00143247|470628724|FG000|Overall Study|Study terminated by sponsor|31|||
130728968|NCT00143247|470628724|FG000|Overall Study|Protocol Violation|15|||
130728969|NCT00143247|470628724|FG000|Overall Study|Lost to Follow-up|12|||
130728970|NCT00143247|470628724|FG000|Overall Study|following inaccurate lab adverse event|1|||
130728971|NCT00143247|470628724|FG000|Overall Study|Other|12|||
130728972|NCT02766283|470628725|FG000|Overall Study|Lost to Follow-up|27|||
130728973|NCT00721227|470628727|FG000|Overall Study|Lost to Follow-up|3|||
130728974|NCT00721227|470628728|FG001|Overall Study|Lost to Follow-up|0|||
130728975|NCT00721227|470628727|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
130728976|NCT00721227|470628728|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
130728977|NCT03654599|470628734|FG000|Overall Study|Lost to Follow-up|14|||
130728978|NCT03654599|470628735|FG001|Overall Study|Lost to Follow-up|12|||
130728979|NCT03654599|470628734|FG000|Overall Study|Death|8|||
130728980|NCT03654599|470628735|FG001|Overall Study|Death|6|||
130728981|NCT03654599|470628734|FG000|Overall Study|Withdrawal by Subject|6|||
130728982|NCT03654599|470628735|FG001|Overall Study|Withdrawal by Subject|4|||
130780607|NCT00735709|470823122|FG000|Overall Study|Voluntary Withdrawal|1|||
131160998|NCT02619253|472213007|FG002|Overall Study|Disease Progression|8|||
131160999|NCT02619253|472213008|FG003|Overall Study|Disease Progression|9|||
131161000|NCT02619253|472213009|FG004|Overall Study|Disease Progression|10|||
131161001|NCT02619253|472213005|FG000|Overall Study|Needed a disqualifying therapy|0|||
131161002|NCT02619253|472213006|FG001|Overall Study|Needed a disqualifying therapy|0|||
131161003|NCT02619253|472213007|FG002|Overall Study|Needed a disqualifying therapy|1|||
131161004|NCT02619253|472213008|FG003|Overall Study|Needed a disqualifying therapy|0|||
130728983|NCT01243775|470628736|FG000|Overall Study|Withdrawal by Subject|2|||
130728984|NCT06390826|470630495|FG000|Overall Study|Never Start Protocol Therapy|1|||
130728985|NCT06390826|470630495|FG000|Overall Study|Adverse Event|1|||
131161005|NCT02619253|472213009|FG004|Overall Study|Needed a disqualifying therapy|0|||
131161006|NCT02619253|472213005|FG000|Overall Study|Transferred to hospice|0|||
131161007|NCT02619253|472213006|FG001|Overall Study|Transferred to hospice|0|||
131161008|NCT02619253|472213007|FG002|Overall Study|Transferred to hospice|1|||
131161009|NCT02619253|472213008|FG003|Overall Study|Transferred to hospice|0|||
131161010|NCT02619253|472213009|FG004|Overall Study|Transferred to hospice|0|||
131161011|NCT02619253|472213005|FG000|Overall Study|Physician Decision|0|||
131161012|NCT02619253|472213006|FG001|Overall Study|Physician Decision|1|||
131161013|NCT02619253|472213007|FG002|Overall Study|Physician Decision|2|||
131161014|NCT02619253|472213008|FG003|Overall Study|Physician Decision|3|||
131161015|NCT02619253|472213009|FG004|Overall Study|Physician Decision|0|||
131161016|NCT02619253|472213005|FG000|Overall Study|Withdrawal by Subject|0|||
131161017|NCT02619253|472213006|FG001|Overall Study|Withdrawal by Subject|1|||
131161018|NCT02619253|472213007|FG002|Overall Study|Withdrawal by Subject|0|||
131161019|NCT02619253|472213008|FG003|Overall Study|Withdrawal by Subject|0|||
131161020|NCT02619253|472213009|FG004|Overall Study|Withdrawal by Subject|2|||
131161021|NCT00514449|472213010|FG000|Overall Study|Withdrawal by Subject|1|||
131161022|NCT00514449|472213011|FG001|Overall Study|Withdrawal by Subject|2|||
131161023|NCT00514449|472213010|FG000|Overall Study|Protocol Violation|1|||
131161024|NCT00514449|472213011|FG001|Overall Study|Protocol Violation|2|||
131161025|NCT00514449|472213010|FG000|Overall Study|Lost to Follow-up|1|||
131161026|NCT00514449|472213011|FG001|Overall Study|Lost to Follow-up|0|||
131161027|NCT00149825|472213015|FG000|Overall Study|Intolerance to medication side effects|1|||
131161028|NCT00149825|472213016|FG001|Overall Study|Intolerance to medication side effects|2|||
131161029|NCT00149825|472213015|FG000|Overall Study|Time commitments|2|||
131161030|NCT00149825|472213016|FG001|Overall Study|Time commitments|1|||
131161031|NCT00149825|472213015|FG000|Overall Study|Not liking insomnia therapy|1|||
131161032|NCT00149825|472213016|FG001|Overall Study|Not liking insomnia therapy|0|||
131161033|NCT00149825|472213015|FG000|Overall Study|Other|1|||
131161034|NCT00149825|472213016|FG001|Overall Study|Other|0|||
131161035|NCT01359982|472213017|FG000|Overall Study|Adverse Event|2|||
131161036|NCT01359982|472213018|FG001|Overall Study|Adverse Event|0|||
131161037|NCT01359982|472213019|FG002|Overall Study|Adverse Event|0|||
131161038|NCT01359982|472213020|FG003|Overall Study|Adverse Event|1|||
131161039|NCT01359982|472213021|FG004|Overall Study|Adverse Event|0|||
131161040|NCT01359982|472213022|FG005|Overall Study|Adverse Event|0|||
131161041|NCT01359982|472213017|FG000|Overall Study|Death|1|||
131161042|NCT01359982|472213018|FG001|Overall Study|Death|0|||
131161043|NCT01359982|472213019|FG002|Overall Study|Death|0|||
131161044|NCT01359982|472213020|FG003|Overall Study|Death|0|||
131161045|NCT01359982|472213021|FG004|Overall Study|Death|0|||
131161046|NCT01359982|472213022|FG005|Overall Study|Death|0|||
131161047|NCT00942708|472213023|FG000|Overall Study|Withdrawal by Subject|1|||
131161048|NCT01426386|472213028|FG000|Overall Study|Adverse Event|0|||
131161049|NCT01426386|472213029|FG001|Overall Study|Adverse Event|1|||
131161050|NCT01426386|472213030|FG002|Overall Study|Adverse Event|0|||
131161051|NCT01426386|472213031|FG003|Overall Study|Adverse Event|0|||
131161052|NCT01426386|472213032|FG004|Overall Study|Adverse Event|0|||
131161053|NCT01426386|472213033|FG005|Overall Study|Adverse Event|0|||
131161054|NCT01426386|472213028|FG000|Overall Study|Did not attend scheduled visit|1|||
131161055|NCT01426386|472213029|FG001|Overall Study|Did not attend scheduled visit|4|||
131161056|NCT01426386|472213030|FG002|Overall Study|Did not attend scheduled visit|0|||
131161057|NCT01426386|472213031|FG003|Overall Study|Did not attend scheduled visit|0|||
131161058|NCT01426386|472213032|FG004|Overall Study|Did not attend scheduled visit|2|||
131161059|NCT01426386|472213033|FG005|Overall Study|Did not attend scheduled visit|1|||
131161060|NCT01426386|472213028|FG000|Overall Study|Poor response|2|||
130728986|NCT06390826|470630495|FG000|Overall Study|Disease Progression|8|||
130728987|NCT01659125|470630496|FG000|Overall Study|Withdrawal by Subject|2|||
130728988|NCT01659125|470630496|FG000|Overall Study|Lost to Follow-up|7|||
131161061|NCT01426386|472213029|FG001|Overall Study|Poor response|1|||
131161062|NCT01426386|472213030|FG002|Overall Study|Poor response|2|||
131161063|NCT01426386|472213031|FG003|Overall Study|Poor response|0|||
131161064|NCT01426386|472213032|FG004|Overall Study|Poor response|1|||
131161065|NCT01426386|472213033|FG005|Overall Study|Poor response|0|||
131161066|NCT01426386|472213028|FG000|Overall Study|Personal reasons|0|||
130728989|NCT01659125|470630496|FG000|Overall Study|Technical Problem|1|||
130728990|NCT01659125|470630496|FG000|Overall Study|Time Constraints|2|||
131161067|NCT01426386|472213029|FG001|Overall Study|Personal reasons|0|||
131161068|NCT01426386|472213030|FG002|Overall Study|Personal reasons|0|||
131161069|NCT01426386|472213031|FG003|Overall Study|Personal reasons|0|||
131161070|NCT01426386|472213032|FG004|Overall Study|Personal reasons|1|||
131161071|NCT01426386|472213033|FG005|Overall Study|Personal reasons|0|||
131161072|NCT01096667|472213034|FG000|Overall Study|Lost to Follow-up|1|||
131161073|NCT01096667|472213035|FG001|Overall Study|Lost to Follow-up|1|||
131161074|NCT01096667|472213036|FG002|Overall Study|Lost to Follow-up|1|||
131161075|NCT01096667|472213037|FG003|Overall Study|Lost to Follow-up|0|||
131161076|NCT01096667|472213038|FG004|Overall Study|Lost to Follow-up|0|||
131161077|NCT01096667|472213034|FG000|Overall Study|Withdrawal by Subject|1|||
131161078|NCT01096667|472213035|FG001|Overall Study|Withdrawal by Subject|0|||
131161079|NCT01096667|472213036|FG002|Overall Study|Withdrawal by Subject|0|||
131161080|NCT01096667|472213037|FG003|Overall Study|Withdrawal by Subject|1|||
131161081|NCT01096667|472213038|FG004|Overall Study|Withdrawal by Subject|0|||
131161082|NCT01096667|472213034|FG000|Overall Study|Reason not available|0|||
131161083|NCT01096667|472213035|FG001|Overall Study|Reason not available|1|||
131161084|NCT01096667|472213036|FG002|Overall Study|Reason not available|1|||
131161085|NCT01096667|472213037|FG003|Overall Study|Reason not available|1|||
131161086|NCT01096667|472213038|FG004|Overall Study|Reason not available|0|||
131161087|NCT01096667|472213034|FG000|Overall Study|Protocol Violation|0|||
131161088|NCT01096667|472213035|FG001|Overall Study|Protocol Violation|0|||
131161089|NCT01096667|472213036|FG002|Overall Study|Protocol Violation|0|||
131161090|NCT01096667|472213037|FG003|Overall Study|Protocol Violation|1|||
131161091|NCT01096667|472213038|FG004|Overall Study|Protocol Violation|0|||
131161092|NCT01096667|472213034|FG000|Overall Study|Not treated|1|||
131161093|NCT01096667|472213035|FG001|Overall Study|Not treated|0|||
131161094|NCT01096667|472213036|FG002|Overall Study|Not treated|0|||
131161095|NCT01096667|472213037|FG003|Overall Study|Not treated|0|||
131161096|NCT01096667|472213038|FG004|Overall Study|Not treated|0|||
131161097|NCT00306891|472213039|FG000|Part A|Withdrawal by Subject|1|||
131161098|NCT00306891|472213040|FG001|Part A|Withdrawal by Subject|1|||
131161099|NCT00306891|472213041|FG002|Part A|Withdrawal by Subject|0|||
131161100|NCT00306891|472213042|FG003|Part A|Withdrawal by Subject|0|||
131161101|NCT00306891|472213039|FG000|Part A|Condition under investigation worsened|2|||
131161102|NCT00306891|472213040|FG001|Part A|Condition under investigation worsened|2|||
131161103|NCT00306891|472213041|FG002|Part A|Condition under investigation worsened|0|||
131161104|NCT00306891|472213042|FG003|Part A|Condition under investigation worsened|0|||
131161105|NCT00306891|472213039|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
131161106|NCT00306891|472213040|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
131161107|NCT00306891|472213041|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
131161108|NCT00306891|472213042|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
131161109|NCT00306891|472213039|FG000|Part A|Partial bowel obstruction|1|||
131161110|NCT00306891|472213040|FG001|Part A|Partial bowel obstruction|0|||
131161111|NCT00306891|472213041|FG002|Part A|Partial bowel obstruction|0|||
131161112|NCT00306891|472213042|FG003|Part A|Partial bowel obstruction|0|||
131161113|NCT00306891|472213039|FG000|Part A|Reaccumul. of ascites following drainage|0|||
131161114|NCT00306891|472213040|FG001|Part A|Reaccumul. of ascites following drainage|1|||
131161115|NCT00306891|472213041|FG002|Part A|Reaccumul. of ascites following drainage|0|||
131161116|NCT00306891|472213042|FG003|Part A|Reaccumul. of ascites following drainage|0|||
131161117|NCT00306891|472213039|FG000|Part A|Suspicion of second malignancy|0|||
131161118|NCT00306891|472213040|FG001|Part A|Suspicion of second malignancy|1|||
131161119|NCT00306891|472213041|FG002|Part A|Suspicion of second malignancy|0|||
131161120|NCT00306891|472213042|FG003|Part A|Suspicion of second malignancy|0|||
131161121|NCT00306891|472213039|FG000|Part A|QTC interval outwith elig. criteria|1|||
131161122|NCT00306891|472213040|FG001|Part A|QTC interval outwith elig. criteria|0|||
131161123|NCT00306891|472213041|FG002|Part A|QTC interval outwith elig. criteria|0|||
131161124|NCT00306891|472213042|FG003|Part A|QTC interval outwith elig. criteria|0|||
131161125|NCT00306891|472213039|FG000|Part B|Death|0|||
131161126|NCT00306891|472213040|FG001|Part B|Death|0|||
131161127|NCT00306891|472213041|FG002|Part B|Death|1|||
131161128|NCT00306891|472213042|FG003|Part B|Death|2|||
131161129|NCT00306891|472213039|FG000|Part B|Adverse Event|0|||
131161130|NCT00306891|472213040|FG001|Part B|Adverse Event|0|||
131161131|NCT00306891|472213041|FG002|Part B|Adverse Event|5|||
131161132|NCT00306891|472213042|FG003|Part B|Adverse Event|5|||
131161133|NCT00306891|472213039|FG000|Part B|Withdrawal by Subject|0|||
131161134|NCT00306891|472213040|FG001|Part B|Withdrawal by Subject|0|||
131161135|NCT00306891|472213041|FG002|Part B|Withdrawal by Subject|3|||
131161136|NCT00306891|472213042|FG003|Part B|Withdrawal by Subject|1|||
131161137|NCT00306891|472213039|FG000|Part B|Condition under investigation worsened|0|||
131161138|NCT00306891|472213040|FG001|Part B|Condition under investigation worsened|0|||
131161139|NCT00306891|472213041|FG002|Part B|Condition under investigation worsened|2|||
131161140|NCT00306891|472213042|FG003|Part B|Condition under investigation worsened|8|||
131161141|NCT00306891|472213039|FG000|Part B|Development of study specific disc crit.|0|||
131161142|NCT00306891|472213040|FG001|Part B|Development of study specific disc crit.|0|||
131161143|NCT00306891|472213041|FG002|Part B|Development of study specific disc crit.|0|||
131161144|NCT00306891|472213042|FG003|Part B|Development of study specific disc crit.|1|||
131161145|NCT00673673|472213043|FG000|Overall Study|Progressive disease|27|||
131161146|NCT00673673|472213043|FG000|Overall Study|Adverse Event|4|||
131161147|NCT00673673|472213043|FG000|Overall Study|Withdrawal by Subject|3|||
131161148|NCT00673673|472213043|FG000|Overall Study|Investigators' discretion|2|||
131161149|NCT00206518|472213044|FG000|Overall Study|Lack of Efficacy|6|||
131161150|NCT00206518|472213045|FG001|Overall Study|Lack of Efficacy|4|||
131161151|NCT00206518|472213044|FG000|Overall Study|Adverse Event|2|||
131161152|NCT00206518|472213045|FG001|Overall Study|Adverse Event|1|||
131161153|NCT00206518|472213044|FG000|Overall Study|Physician Decision|1|||
131161154|NCT00206518|472213045|FG001|Overall Study|Physician Decision|0|||
131161155|NCT00206518|472213044|FG000|Overall Study|Protocol Violation|1|||
131161156|NCT00206518|472213045|FG001|Overall Study|Protocol Violation|1|||
131161157|NCT00465738|472213047|FG000|Overall Study|Lost to Follow-up|2|||
131161158|NCT00465738|472213048|FG001|Overall Study|Lost to Follow-up|0|||
131161159|NCT00465738|472213047|FG000|Overall Study|Adverse Event|0|||
131161160|NCT00465738|472213048|FG001|Overall Study|Adverse Event|1|||
131161161|NCT00465738|472213047|FG000|Overall Study|Withdrawal by Subject|2|||
131161162|NCT00465738|472213048|FG001|Overall Study|Withdrawal by Subject|0|||
131161163|NCT00465738|472213047|FG000|Overall Study|Other|2|||
131161164|NCT00465738|472213048|FG001|Overall Study|Other|5|||
131161165|NCT02792777|472213049|FG000|Overall Study|Withdrawal by Subject|2|||
131161166|NCT02792777|472213050|FG001|Overall Study|Withdrawal by Subject|0|||
131161167|NCT02792777|472213049|FG000|Overall Study|Recording malfunction|2|||
131161168|NCT02792777|472213050|FG001|Overall Study|Recording malfunction|0|||
131161169|NCT02792777|472213049|FG000|Overall Study|Later determined to be ineligible|2|||
131161170|NCT02792777|472213050|FG001|Overall Study|Later determined to be ineligible|0|||
131161171|NCT02792777|472213049|FG000|Overall Study|Participant interviewed twice|1|||
131161172|NCT02792777|472213050|FG001|Overall Study|Participant interviewed twice|0|||
131161173|NCT01171521|472213053|FG000|Overall Study|Lost to Follow-up|5|||
131161174|NCT01171521|472213053|FG000|Overall Study|screen failure|1|||
131161175|NCT00515463|472213060|FG000|Overall Study|Physician Decision|4|||
131161176|NCT00515463|472213061|FG001|Overall Study|Physician Decision|2|||
131161177|NCT00515463|472213060|FG000|Overall Study|Adverse Event|1|||
131161178|NCT00515463|472213061|FG001|Overall Study|Adverse Event|2|||
131161179|NCT00515463|472213060|FG000|Overall Study|Withdrawal by Subject|3|||
131161180|NCT00515463|472213061|FG001|Overall Study|Withdrawal by Subject|4|||
131161181|NCT00515463|472213060|FG000|Overall Study|Lost to Follow-up|6|||
131161182|NCT00515463|472213061|FG001|Overall Study|Lost to Follow-up|5|||
131161183|NCT00515463|472213060|FG000|Overall Study|Other|0|||
131161184|NCT00515463|472213061|FG001|Overall Study|Other|1|||
131161185|NCT02269319|472213062|FG000|Overall Study|Lost to Follow-up|4|||
131161186|NCT02269319|472213063|FG001|Overall Study|Lost to Follow-up|3|||
131161187|NCT02269319|472213062|FG000|Overall Study|Adverse Event|0|||
131161188|NCT02269319|472213063|FG001|Overall Study|Adverse Event|1|||
131161189|NCT02269319|472213062|FG000|Overall Study|Instructions not followed|1|||
131161190|NCT02269319|472213063|FG001|Overall Study|Instructions not followed|0|||
131161191|NCT01589094|472213064|FG000|Overall Study|Did not receive treatment|2|||
131161192|NCT03575468|472213065|FG000|Overall Study|Withdrawal by Subject|3|||
131161193|NCT03575468|472213066|FG001|Overall Study|Withdrawal by Subject|0|||
131161194|NCT03575468|472213065|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
131161195|NCT03575468|472213066|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
131161196|NCT03575468|472213065|FG000|Overall Study|Lost to Follow-up|13|||
131161197|NCT03575468|472213066|FG001|Overall Study|Lost to Follow-up|17|||
131161198|NCT05243550|472214472|FG000|Overall Study|Ongoing in the Study|171|||
131161199|NCT05243550|472214472|FG000|Overall Study|Withdrawal by Subject|10|||
131161200|NCT05243550|472214472|FG000|Overall Study|Lost to Follow-up|7|||
131161201|NCT05243550|472214472|FG000|Overall Study|Adverse Event|3|||
131161202|NCT05243550|472214472|FG000|Overall Study|Noncompliance|1|||
131161203|NCT05243550|472214472|FG000|Overall Study|Physician Decision|1|||
131161204|NCT05243550|472214472|FG000|Overall Study|Other Reason|4|||
131161205|NCT00893113|472214477|FG000|Overall Study|Lost to Follow-up|4|||
131161206|NCT00893113|472214478|FG001|Overall Study|Lost to Follow-up|8|||
131161207|NCT00893113|472214477|FG000|Overall Study|Early Termination|1|||
131161208|NCT00893113|472214478|FG001|Overall Study|Early Termination|1|||
131161209|NCT00893113|472214477|FG000|Overall Study|Withdrew Consent|8|||
131161210|NCT00893113|472214478|FG001|Overall Study|Withdrew Consent|7|||
131161211|NCT03032068|472214479|FG000|Overall Study|Adverse Event|1|||
131161212|NCT00500149|472214480|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
131161213|NCT00500149|472214481|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
131161214|NCT00500149|472214480|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
130780608|NCT00735709|470823123|FG001|Overall Study|Voluntary Withdrawal|3|||
130780609|NCT00735709|470823124|FG002|Overall Study|Voluntary Withdrawal|5|||
130780610|NCT00735709|470823125|FG003|Overall Study|Voluntary Withdrawal|7|||
130780611|NCT00735709|470823122|FG000|Overall Study|Lost to Follow-up|0|||
130780612|NCT00735709|470823123|FG001|Overall Study|Lost to Follow-up|1|||
130780613|NCT00735709|470823124|FG002|Overall Study|Lost to Follow-up|1|||
131161215|NCT00500149|472214481|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
131161216|NCT00500149|472214480|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
131161217|NCT00500149|472214481|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
131161218|NCT00500149|472214480|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
131161219|NCT00500149|472214481|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
131161220|NCT00500149|472214480|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
131161221|NCT00500149|472214481|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
130728991|NCT01659125|470630496|FG000|Overall Study|Failed to Start Treatment|2|||
130728992|NCT02126826|470630497|FG000|Overall Study|Withdrawal by Subject|0|||
130728993|NCT02126826|470630498|FG001|Overall Study|Withdrawal by Subject|0|||
130728994|NCT02126826|470630499|FG002|Overall Study|Withdrawal by Subject|0|||
130728995|NCT02126826|470630500|FG003|Overall Study|Withdrawal by Subject|1|||
130728996|NCT02126826|470630501|FG004|Overall Study|Withdrawal by Subject|0|||
130728997|NCT02126826|470630502|FG005|Overall Study|Withdrawal by Subject|0|||
130728998|NCT02126826|470630503|FG006|Overall Study|Withdrawal by Subject|0|||
130728999|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #1|24|||
130729000|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #1|0|||
130729001|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
130729002|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
130729003|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130729004|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729005|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
130729006|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
130729007|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
130729008|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
130729009|NCT03888066|470630504|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
131161222|NCT00500149|472214480|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
131161223|NCT00500149|472214481|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
131161224|NCT00500149|472214480|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
131161225|NCT00500149|472214481|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
131161226|NCT00089843|472214482|FG000|Overall Study|Withdrawal by Subject|1|||
131161227|NCT00089843|472214483|FG001|Overall Study|Withdrawal by Subject|4|||
131161228|NCT00089843|472214484|FG002|Overall Study|Withdrawal by Subject|5|||
131161229|NCT00089843|472214485|FG003|Overall Study|Withdrawal by Subject|6|||
131161230|NCT00089843|472214482|FG000|Overall Study|Physician Decision|1|||
131161231|NCT00089843|472214483|FG001|Overall Study|Physician Decision|0|||
131161232|NCT00089843|472214484|FG002|Overall Study|Physician Decision|0|||
131161233|NCT00089843|472214485|FG003|Overall Study|Physician Decision|1|||
131161234|NCT03042611|472214486|FG000|Core Phase|Withdrawal by Subject|13|||
131161235|NCT03042611|472214487|FG001|Core Phase|Withdrawal by Subject|4|||
131161236|NCT03042611|472214488|FG002|Core Phase|Withdrawal by Subject|0|||
131161237|NCT03042611|472214489|FG003|Core Phase|Withdrawal by Subject|0|||
131161238|NCT03042611|472214486|FG000|Core Phase|Death|232|||
131161239|NCT03042611|472214487|FG001|Core Phase|Death|110|||
131161240|NCT03042611|472214488|FG002|Core Phase|Death|0|||
131161241|NCT03042611|472214489|FG003|Core Phase|Death|0|||
131161242|NCT03042611|472214486|FG000|Core Phase|Lost to Follow-up|4|||
131161243|NCT03042611|472214487|FG001|Core Phase|Lost to Follow-up|7|||
131161244|NCT03042611|472214488|FG002|Core Phase|Lost to Follow-up|0|||
131161245|NCT03042611|472214489|FG003|Core Phase|Lost to Follow-up|0|||
131161246|NCT03042611|472214486|FG000|Core Phase|Physician Decision|7|||
131161247|NCT03042611|472214487|FG001|Core Phase|Physician Decision|2|||
131161248|NCT03042611|472214488|FG002|Core Phase|Physician Decision|0|||
131161249|NCT03042611|472214489|FG003|Core Phase|Physician Decision|0|||
131161250|NCT03042611|472214486|FG000|Core Phase|Study Closed|0|||
131161251|NCT03042611|472214487|FG001|Core Phase|Study Closed|1|||
131161252|NCT03042611|472214488|FG002|Core Phase|Study Closed|0|||
131161253|NCT03042611|472214489|FG003|Core Phase|Study Closed|0|||
131161254|NCT03042611|472214486|FG000|Extension Phase|Death|0|||
131161255|NCT03042611|472214487|FG001|Extension Phase|Death|0|||
131161256|NCT03042611|472214488|FG002|Extension Phase|Death|34|||
131161257|NCT03042611|472214489|FG003|Extension Phase|Death|16|||
131161258|NCT03042611|472214486|FG000|Extension Phase|Lost to Follow-up|0|||
131161259|NCT03042611|472214487|FG001|Extension Phase|Lost to Follow-up|0|||
131161260|NCT03042611|472214488|FG002|Extension Phase|Lost to Follow-up|1|||
131161261|NCT03042611|472214489|FG003|Extension Phase|Lost to Follow-up|1|||
131161262|NCT03042611|472214486|FG000|Extension Phase|Study Closed|0|||
131161263|NCT03042611|472214487|FG001|Extension Phase|Study Closed|0|||
131161264|NCT03042611|472214488|FG002|Extension Phase|Study Closed|17|||
131161265|NCT03042611|472214489|FG003|Extension Phase|Study Closed|11|||
131161266|NCT04655586|472214499|FG000|Overall Study|Physician Decision|1|||
131235416|NCT02270736|472490895|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
131235417|NCT02270736|472490896|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
131161267|NCT04655586|472214500|FG001|Overall Study|Physician Decision|3|||
131161268|NCT04655586|472214501|FG002|Overall Study|Physician Decision|4|||
131161269|NCT04655586|472214499|FG000|Overall Study|Withdrawal by Subject|1|||
131235418|NCT02270736|472490897|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
130729010|NCT03888066|470630505|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
131161270|NCT04655586|472214500|FG001|Overall Study|Withdrawal by Subject|3|||
131161271|NCT04655586|472214501|FG002|Overall Study|Withdrawal by Subject|1|||
131161272|NCT00891657|472214506|FG000|Overall Study|Withdrawal by Subject|1|||
131161273|NCT00891657|472214507|FG001|Overall Study|Withdrawal by Subject|1|||
131161274|NCT02927171|472214510|FG000|Overall Study|Lost to Follow-up|0|||
131161275|NCT02927171|472214511|FG001|Overall Study|Lost to Follow-up|1|||
131161276|NCT04530825|472214516|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
131161277|NCT04530825|472214517|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
131161278|NCT04530825|472214518|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
131161279|NCT04530825|472214519|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
131161280|NCT04530825|472214516|FG000|Overall Study|Did not complete follow-up|3|||
131161281|NCT04530825|472214517|FG001|Overall Study|Did not complete follow-up|0|||
131161282|NCT04530825|472214518|FG002|Overall Study|Did not complete follow-up|0|||
131161283|NCT04530825|472214519|FG003|Overall Study|Did not complete follow-up|0|||
130729011|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
131161284|NCT00850499|472214521|FG000|Overall Study|Adverse Event|3|||
131161285|NCT00850499|472214522|FG001|Overall Study|Adverse Event|1|||
131161286|NCT00850499|472214521|FG000|Overall Study|Lack of Efficacy|0|||
131161287|NCT00850499|472214522|FG001|Overall Study|Lack of Efficacy|1|||
131161288|NCT00552305|472214523|FG000|Overall Study|Adverse Event|43|||
131161289|NCT00552305|472214523|FG000|Overall Study|Lack of Efficacy|120|||
131161290|NCT00552305|472214523|FG000|Overall Study|Lost to Follow-up|4|||
131161291|NCT00552305|472214523|FG000|Overall Study|Protocol Violation|3|||
131161292|NCT00552305|472214523|FG000|Overall Study|Withdrawal by Subject|44|||
131161293|NCT00552305|472214523|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
131161294|NCT00552305|472214523|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
131161295|NCT00552305|472214523|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
131161296|NCT00552305|472214523|FG000|Overall Study|Unsatisfactory compliance|11|||
131161297|NCT00552305|472214523|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
131161298|NCT00552305|472214523|FG000|Overall Study|AE/Other: prohibited drug required|1|||
131161299|NCT00552305|472214523|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
131161300|NCT00552305|472214523|FG000|Overall Study|Other: Site closed|4|||
131161301|NCT00552305|472214523|FG000|Overall Study|Other: Personal problems|1|||
131161302|NCT00552305|472214523|FG000|Overall Study|Other: Unable to attend visits|1|||
131161303|NCT00552305|472214523|FG000|Overall Study|Other: Subject underwent surgery|4|||
131161304|NCT00552305|472214523|FG000|Overall Study|Other: Subject became pregnant|1|||
131161305|NCT00552305|472214523|FG000|Overall Study|Other: Health problems, not drug related|1|||
131161306|NCT00552305|472214523|FG000|Overall Study|Other: Subject moved from area|2|||
131161307|NCT00552305|472214523|FG000|Overall Study|Other: Subject incarcerated|1|||
131161308|NCT00552305|472214523|FG000|Overall Study|Other: Subject went to rehab|1|||
131161309|NCT01849848|472214524|FG000|Overall Study|Physician Decision|1|||
131161310|NCT01849848|472214524|FG000|Overall Study|Progression of the primary disease|3|||
131161311|NCT03694522|472214528|FG000|Overall Study|Withdrawal by Subject|8|||
131161312|NCT03694522|472214529|FG001|Overall Study|Withdrawal by Subject|10|||
131161313|NCT03694522|472214528|FG000|Overall Study|Physician Decision|53|||
131161314|NCT03694522|472214529|FG001|Overall Study|Physician Decision|54|||
131161315|NCT03694522|472214528|FG000|Overall Study|Other|1|||
131161316|NCT03694522|472214529|FG001|Overall Study|Other|1|||
131161317|NCT03694522|472214528|FG000|Overall Study|Lost to Follow-up|0|||
131161318|NCT03694522|472214529|FG001|Overall Study|Lost to Follow-up|1|||
131161319|NCT02760407|472214530|FG000|Overall Study|Death|2|||
131161320|NCT02760407|472214531|FG001|Overall Study|Death|3|||
131161321|NCT02760407|472214532|FG002|Overall Study|Death|1|||
131161322|NCT02760407|472214533|FG003|Overall Study|Death|1|||
131161323|NCT02760407|472214530|FG000|Overall Study|Lost to Follow-up|1|||
131161324|NCT02760407|472214531|FG001|Overall Study|Lost to Follow-up|7|||
131161325|NCT02760407|472214532|FG002|Overall Study|Lost to Follow-up|4|||
130729012|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729013|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
131161326|NCT02760407|472214533|FG003|Overall Study|Lost to Follow-up|6|||
131161327|NCT02760407|472214530|FG000|Overall Study|Withdrawal by Subject|25|||
131161328|NCT02760407|472214531|FG001|Overall Study|Withdrawal by Subject|31|||
131161329|NCT02760407|472214532|FG002|Overall Study|Withdrawal by Subject|37|||
131161330|NCT02760407|472214533|FG003|Overall Study|Withdrawal by Subject|25|||
131161331|NCT02760407|472214530|FG000|Overall Study|Violation of Eligibility criteria|0|||
130729014|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
131161332|NCT02760407|472214531|FG001|Overall Study|Violation of Eligibility criteria|0|||
130780614|NCT00735709|470823125|FG003|Overall Study|Lost to Follow-up|1|||
131161333|NCT02760407|472214532|FG002|Overall Study|Violation of Eligibility criteria|1|||
131161334|NCT02760407|472214533|FG003|Overall Study|Violation of Eligibility criteria|1|||
131161335|NCT02760407|472214530|FG000|Overall Study|Personal reasons|0|||
131161336|NCT02760407|472214531|FG001|Overall Study|Personal reasons|0|||
131161337|NCT02760407|472214532|FG002|Overall Study|Personal reasons|0|||
131161338|NCT02760407|472214533|FG003|Overall Study|Personal reasons|1|||
131161339|NCT02760407|472214530|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
131161340|NCT02760407|472214531|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
131235419|NCT02270736|472490898|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
130729015|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130729016|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729017|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
130729018|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729019|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #2|5|||
130729020|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #2|0|||
130729021|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
130729022|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
130729023|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
130729024|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
130729025|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
130729026|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
130729027|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #3|11|||
130729028|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #3|0|||
130729029|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
130729030|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
130729031|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
130729032|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130729033|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130729034|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729035|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #4|3|||
130729036|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #4|0|||
130729037|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
130729038|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
130729039|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
130729040|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
131161341|NCT02760407|472214532|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
131161342|NCT02760407|472214533|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
131161343|NCT02760407|472214530|FG000|Overall Study|Use of prohibited Medication|0|||
131161344|NCT02760407|472214531|FG001|Overall Study|Use of prohibited Medication|0|||
131161345|NCT02760407|472214532|FG002|Overall Study|Use of prohibited Medication|1|||
131161346|NCT02760407|472214533|FG003|Overall Study|Use of prohibited Medication|0|||
131161347|NCT02760407|472214530|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
131161348|NCT02760407|472214531|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
131161349|NCT02760407|472214532|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
131161350|NCT02760407|472214533|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
131161351|NCT02760407|472214530|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
131161352|NCT02760407|472214531|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
131161353|NCT02760407|472214532|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
131161354|NCT02760407|472214533|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
131161355|NCT02760407|472214530|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
131161356|NCT02760407|472214531|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
131161357|NCT02760407|472214532|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
131161358|NCT02760407|472214533|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
131161359|NCT02760407|472214530|FG000|Overall Study|Inadequately Enrolled|0|||
131161360|NCT02760407|472214531|FG001|Overall Study|Inadequately Enrolled|0|||
131161361|NCT02760407|472214532|FG002|Overall Study|Inadequately Enrolled|0|||
131161362|NCT02760407|472214533|FG003|Overall Study|Inadequately Enrolled|1|||
131161363|NCT02760407|472214530|FG000|Overall Study|Withdrawal By PI's Decision|0|||
131161364|NCT02760407|472214531|FG001|Overall Study|Withdrawal By PI's Decision|1|||
131161365|NCT02760407|472214532|FG002|Overall Study|Withdrawal By PI's Decision|0|||
131161366|NCT02760407|472214533|FG003|Overall Study|Withdrawal By PI's Decision|0|||
131161367|NCT02760407|472214530|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
131161368|NCT02760407|472214531|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
131161369|NCT02760407|472214532|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
131161370|NCT02760407|472214533|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
131161371|NCT02760407|472214530|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
131235420|NCT02270736|472490894|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
131235421|NCT02270736|472490895|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130780615|NCT00735709|470823122|FG000|Overall Study|Excluded medication|1|||
130780616|NCT00735709|470823123|FG001|Overall Study|Excluded medication|0|||
131161372|NCT02760407|472214531|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
131161373|NCT02760407|472214532|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
131161374|NCT02760407|472214533|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
131161375|NCT02760407|472214530|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
131161376|NCT02760407|472214531|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
131161377|NCT02760407|472214532|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
131161378|NCT02760407|472214533|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
131161379|NCT02760407|472214530|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
131161380|NCT02760407|472214531|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
131161381|NCT02760407|472214532|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
131161382|NCT02760407|472214533|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
131161383|NCT02760407|472214530|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
131161384|NCT02760407|472214531|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
131161385|NCT02760407|472214532|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
131161386|NCT02760407|472214533|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
131161387|NCT02760407|472214530|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
131161388|NCT02760407|472214531|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
131161389|NCT02760407|472214532|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
131161390|NCT02760407|472214533|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
131161391|NCT02760407|472214530|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
131161392|NCT02760407|472214531|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
131161393|NCT02760407|472214532|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
131161394|NCT02760407|472214533|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
131161395|NCT02760407|472214530|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
131161396|NCT02760407|472214531|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
131161397|NCT02760407|472214532|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
131161398|NCT02760407|472214533|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
131161399|NCT02760407|472214530|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
131161400|NCT02760407|472214531|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
131161401|NCT02760407|472214532|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
131161402|NCT02760407|472214533|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
131161403|NCT01748760|472214534|FG000|Overall Study|Withdrawal by Subject|1|||
131161404|NCT01748760|472214535|FG001|Overall Study|Withdrawal by Subject|1|||
131161405|NCT01748760|472214534|FG000|Overall Study|Lost to Follow-up|5|||
131161406|NCT01748760|472214535|FG001|Overall Study|Lost to Follow-up|1|||
131161407|NCT03245814|472214536|FG000|Overall Study|Lost to Follow-up|5|||
131161408|NCT03245814|472214537|FG001|Overall Study|Lost to Follow-up|8|||
131161409|NCT03245814|472214536|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
131161410|NCT03245814|472214537|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
131161411|NCT01164501|472214538|FG000|Overall Study|Not treated|2|||
131161412|NCT01164501|472214539|FG001|Overall Study|Not treated|0|||
131161413|NCT01164501|472214540|FG002|Overall Study|Not treated|1|||
131161414|NCT01164501|472214538|FG000|Overall Study|Adverse Event|18|||
131161415|NCT01164501|472214539|FG001|Overall Study|Adverse Event|4|||
131161416|NCT01164501|472214540|FG002|Overall Study|Adverse Event|21|||
131161417|NCT01164501|472214538|FG000|Overall Study|Lack of Efficacy|0|||
131161418|NCT01164501|472214539|FG001|Overall Study|Lack of Efficacy|0|||
131161419|NCT01164501|472214540|FG002|Overall Study|Lack of Efficacy|1|||
131161420|NCT01164501|472214538|FG000|Overall Study|Non compliant with protocol|1|||
131161421|NCT01164501|472214539|FG001|Overall Study|Non compliant with protocol|1|||
131161422|NCT01164501|472214540|FG002|Overall Study|Non compliant with protocol|4|||
131161423|NCT01164501|472214538|FG000|Overall Study|Lost to Follow-up|3|||
131161424|NCT01164501|472214539|FG001|Overall Study|Lost to Follow-up|0|||
131161425|NCT01164501|472214540|FG002|Overall Study|Lost to Follow-up|3|||
131161426|NCT01164501|472214538|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
131161427|NCT01164501|472214539|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
131161428|NCT01164501|472214540|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
131161429|NCT01164501|472214538|FG000|Overall Study|Other reason not defined above|9|||
131161430|NCT01164501|472214539|FG001|Overall Study|Other reason not defined above|1|||
131161431|NCT01164501|472214540|FG002|Overall Study|Other reason not defined above|4|||
131161432|NCT00945191|472214541|FG000|Overall Study|Did not achieve a complete response|18|||
131161433|NCT00945191|472214541|FG000|Overall Study|Participant relocated to another state|1|||
131161434|NCT00945191|472214541|FG000|Overall Study|Disease progression|3|||
131235422|NCT02270736|472490896|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130780617|NCT00735709|470823124|FG002|Overall Study|Excluded medication|0|||
131161435|NCT00945191|472214541|FG000|Overall Study|Serious adverse event or adverse event|1|||
131161436|NCT00945191|472214541|FG000|Overall Study|Investigator's discretion|1|||
131161437|NCT00394914|472214544|FG000|Treatment Period|Adverse Event|0|||
131161438|NCT00394914|472214545|FG001|Treatment Period|Adverse Event|3|||
131161439|NCT00394914|472214546|FG002|Treatment Period|Adverse Event|1|||
131161440|NCT00394914|472214544|FG000|Treatment Period|Lost to Follow-up|0|||
131161441|NCT00394914|472214545|FG001|Treatment Period|Lost to Follow-up|1|||
131161442|NCT00394914|472214546|FG002|Treatment Period|Lost to Follow-up|0|||
131161443|NCT00394914|472214544|FG000|Treatment Period|Withdrawal by Subject|0|||
131161444|NCT00394914|472214545|FG001|Treatment Period|Withdrawal by Subject|2|||
131161445|NCT00394914|472214546|FG002|Treatment Period|Withdrawal by Subject|2|||
131161446|NCT00394914|472214544|FG000|Treatment Period|Noncompliance with protocol|0|||
131161447|NCT00394914|472214545|FG001|Treatment Period|Noncompliance with protocol|3|||
131161448|NCT00394914|472214546|FG002|Treatment Period|Noncompliance with protocol|2|||
131161449|NCT00394914|472214544|FG000|Treatment Period|Did not meet protocol eligibility|0|||
131161450|NCT00394914|472214545|FG001|Treatment Period|Did not meet protocol eligibility|1|||
131161451|NCT00394914|472214546|FG002|Treatment Period|Did not meet protocol eligibility|1|||
131161452|NCT00312377|472214551|FG000|Overall Study|Death|403|||
131161453|NCT00312377|472214552|FG001|Overall Study|Death|418|||
131161454|NCT00312377|472214551|FG000|Overall Study|Withdrawal by Subject|23|||
131161455|NCT00312377|472214552|FG001|Overall Study|Withdrawal by Subject|30|||
131161456|NCT00312377|472214551|FG000|Overall Study|Lost to Follow-up|9|||
131161457|NCT00312377|472214552|FG001|Overall Study|Lost to Follow-up|12|||
131161458|NCT00312377|472214551|FG000|Overall Study|Non-compliance|0|||
131161459|NCT00312377|472214552|FG001|Overall Study|Non-compliance|2|||
131161460|NCT00312377|472214551|FG000|Overall Study|Randomised but never received treatment|6|||
131161461|NCT00312377|472214552|FG001|Overall Study|Randomised but never received treatment|6|||
131161462|NCT00312377|472214551|FG000|Overall Study|Discontinue treatment survival follow up|202|||
131161463|NCT00312377|472214552|FG001|Overall Study|Discontinue treatment survival follow up|200|||
131161464|NCT00312377|472214551|FG000|Overall Study|Site ended participation in study|1|||
131161465|NCT00312377|472214552|FG001|Overall Study|Site ended participation in study|0|||
131161466|NCT00872898|472214553|FG000|Part Two - Double Blind|Adverse Event|4|||
131161467|NCT00872898|472214554|FG001|Part Two - Double Blind|Adverse Event|3|||
131161468|NCT00872898|472214553|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
131161469|NCT00872898|472214554|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
131161470|NCT00872898|472214553|FG000|Part Two - Double Blind|Protocol Violation|1|||
131161471|NCT00872898|472214554|FG001|Part Two - Double Blind|Protocol Violation|0|||
131161472|NCT00872898|472214553|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
131161473|NCT00872898|472214554|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
131161474|NCT00872898|472214553|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
131161475|NCT00872898|472214554|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
131161476|NCT00872898|472214553|FG000|Part Two - Double Blind|Other reasons|2|||
131161477|NCT00872898|472214554|FG001|Part Two - Double Blind|Other reasons|0|||
131161478|NCT01004146|472214560|FG000|Overall Study|Withdrawal by Subject|4|||
131161479|NCT01004146|472214561|FG001|Overall Study|Withdrawal by Subject|5|||
131161480|NCT01001494|472214568|FG000|Overall Study|Adverse Event|8|||
131161481|NCT01001494|472214569|FG001|Overall Study|Adverse Event|4|||
131161482|NCT01001494|472214570|FG002|Overall Study|Adverse Event|6|||
131161483|NCT01001494|472214568|FG000|Overall Study|Protocol Violation|0|||
131161484|NCT01001494|472214569|FG001|Overall Study|Protocol Violation|1|||
131161485|NCT01001494|472214570|FG002|Overall Study|Protocol Violation|1|||
131161486|NCT01001494|472214568|FG000|Overall Study|Lost to Follow-up|2|||
131161487|NCT01001494|472214569|FG001|Overall Study|Lost to Follow-up|0|||
131161488|NCT01001494|472214570|FG002|Overall Study|Lost to Follow-up|1|||
131161489|NCT01001494|472214568|FG000|Overall Study|Withdrawal by Subject|9|||
131161490|NCT01001494|472214569|FG001|Overall Study|Withdrawal by Subject|7|||
131161491|NCT01001494|472214570|FG002|Overall Study|Withdrawal by Subject|17|||
131161492|NCT01001494|472214568|FG000|Overall Study|COPD exacerbation|3|||
131161493|NCT01001494|472214569|FG001|Overall Study|COPD exacerbation|4|||
131161494|NCT01001494|472214570|FG002|Overall Study|COPD exacerbation|5|||
131161495|NCT01001494|472214568|FG000|Overall Study|Lack of Efficacy|2|||
131161496|NCT01001494|472214569|FG001|Overall Study|Lack of Efficacy|0|||
131161497|NCT01001494|472214570|FG002|Overall Study|Lack of Efficacy|8|||
131161498|NCT01001494|472214568|FG000|Overall Study|Other|0|||
131161499|NCT01001494|472214569|FG001|Overall Study|Other|1|||
131161500|NCT01001494|472214570|FG002|Overall Study|Other|3|||
131161501|NCT02179398|472214571|FG000|Overall Study|Lack of obligatory data|3|||
131161502|NCT02179398|472214572|FG001|Overall Study|Lack of obligatory data|3|||
131161503|NCT02179398|472214571|FG000|Overall Study|Lost to Follow-up|0|||
131161504|NCT02179398|472214572|FG001|Overall Study|Lost to Follow-up|1|||
131161505|NCT00408681|472214576|FG000|Overall Study|Lack of Efficacy|2|||
131161506|NCT00408681|472214576|FG000|Overall Study|Adverse Event|7|||
131161507|NCT02519231|472214582|FG000|Overall Study|Lost to Follow-up|2|||
131161508|NCT02519231|472214583|FG001|Overall Study|Lost to Follow-up|5|||
131161509|NCT02519231|472214582|FG000|Overall Study|Withdrawal by Subject|0|||
131161510|NCT02519231|472214583|FG001|Overall Study|Withdrawal by Subject|1|||
131161511|NCT00447421|472214584|FG000|Overall Study|Lack of Efficacy|1|||
131161512|NCT00447421|472214584|FG000|Overall Study|Adverse Event|3|||
131161513|NCT00447421|472214584|FG000|Overall Study|Sponsor Decision|2|||
131161514|NCT02124798|472214585|FG000|Overall Study|Adverse Event|3|||
131161515|NCT02124798|472214585|FG000|Overall Study|Lost to Follow-up|1|||
131161516|NCT01707147|472214589|FG000|Overall Study|Administered Trajenta prior to contract|5|||
131161517|NCT01707147|472214589|FG000|Overall Study|Patients who have not taken Trajenta|1|||
131161518|NCT01707147|472214589|FG000|Overall Study|Follow-up failure|17|||
131161519|NCT01707147|472214589|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
131161520|NCT02053246|472214590|FG000|Overall Study|Withdrawal by Subject|3|||
131161521|NCT02053246|472214590|FG000|Overall Study|Physician Decision|1|||
131161522|NCT02795156|472214591|FG000|Overall Study|Progressive Disease|22|||
131161523|NCT02795156|472214592|FG001|Overall Study|Progressive Disease|7|||
131161524|NCT02795156|472214593|FG002|Overall Study|Progressive Disease|34|||
131161525|NCT02795156|472214594|FG003|Overall Study|Progressive Disease|7|||
131161526|NCT02795156|472214591|FG000|Overall Study|Adverse Event|13|||
131161527|NCT02795156|472214592|FG001|Overall Study|Adverse Event|2|||
131161528|NCT02795156|472214593|FG002|Overall Study|Adverse Event|3|||
131161529|NCT02795156|472214594|FG003|Overall Study|Adverse Event|2|||
131161530|NCT02795156|472214591|FG000|Overall Study|Death|1|||
131161531|NCT02795156|472214592|FG001|Overall Study|Death|1|||
131161532|NCT02795156|472214593|FG002|Overall Study|Death|1|||
131161533|NCT02795156|472214594|FG003|Overall Study|Death|0|||
131161534|NCT02795156|472214591|FG000|Overall Study|Physician Decision|1|||
131161535|NCT02795156|472214592|FG001|Overall Study|Physician Decision|0|||
131161536|NCT02795156|472214593|FG002|Overall Study|Physician Decision|1|||
131161537|NCT02795156|472214594|FG003|Overall Study|Physician Decision|0|||
131161538|NCT02795156|472214591|FG000|Overall Study|Withdrawal by Subject|2|||
131161539|NCT02795156|472214592|FG001|Overall Study|Withdrawal by Subject|0|||
131161540|NCT02795156|472214593|FG002|Overall Study|Withdrawal by Subject|3|||
131161541|NCT02795156|472214594|FG003|Overall Study|Withdrawal by Subject|0|||
131161542|NCT02707757|472214595|FG000|Overall Study|Protocol Violation|3|||
131161543|NCT02707757|472214596|FG001|Overall Study|Protocol Violation|2|||
131161544|NCT02707757|472214595|FG000|Overall Study|Withdrawal by Subject|2|||
131161545|NCT02707757|472214596|FG001|Overall Study|Withdrawal by Subject|0|||
131161546|NCT02707757|472214595|FG000|Overall Study|Death|0|||
131161547|NCT02707757|472214596|FG001|Overall Study|Death|1|||
131161548|NCT02707757|472214595|FG000|Overall Study|Adverse Event|6|||
131161549|NCT02707757|472214596|FG001|Overall Study|Adverse Event|4|||
131161550|NCT02707757|472214595|FG000|Overall Study|Renal transplant/elective operation|1|||
131161551|NCT02707757|472214596|FG001|Overall Study|Renal transplant/elective operation|5|||
131161552|NCT00815308|472214597|FG000|Overall Study|Adverse Event|4|||
131161553|NCT00815308|472214597|FG000|Overall Study|Withdrawal by Subject|0|||
131161554|NCT00815308|472214597|FG000|Overall Study|Protocol Violation|6|||
131161555|NCT00638846|472214601|FG000|Overall Study|Adverse Event|0|||
131161556|NCT00638846|472214602|FG001|Overall Study|Adverse Event|1|||
131161557|NCT00638846|472214601|FG000|Overall Study|Lost to Follow-up|3|||
131161558|NCT00638846|472214602|FG001|Overall Study|Lost to Follow-up|2|||
131161559|NCT00638846|472214601|FG000|Overall Study|lens issue|1|||
131161560|NCT00638846|472214602|FG001|Overall Study|lens issue|3|||
131161561|NCT00652093|472214603|FG000|Overall Study|Withdrawal by Subject|0|||
131161562|NCT00652093|472214604|FG001|Overall Study|Withdrawal by Subject|0|||
131161563|NCT00652093|472214605|FG002|Overall Study|Withdrawal by Subject|1|||
131161564|NCT00652093|472214606|FG003|Overall Study|Withdrawal by Subject|0|||
131161565|NCT00652093|472214607|FG004|Overall Study|Withdrawal by Subject|1|||
131161566|NCT00652093|472214608|FG005|Overall Study|Withdrawal by Subject|0|||
131161567|NCT00652093|472214603|FG000|Overall Study|Physician Decision|0|||
131161568|NCT00652093|472214604|FG001|Overall Study|Physician Decision|0|||
131161569|NCT00652093|472214605|FG002|Overall Study|Physician Decision|0|||
130729041|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
130729042|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130729043|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
131161570|NCT00652093|472214606|FG003|Overall Study|Physician Decision|0|||
131161571|NCT00652093|472214607|FG004|Overall Study|Physician Decision|1|||
131161572|NCT00652093|472214608|FG005|Overall Study|Physician Decision|0|||
131161573|NCT01422304|472214611|FG000|Overall Study|Adverse Event|0|||
131161574|NCT01422304|472214612|FG001|Overall Study|Adverse Event|1|||
131161575|NCT01422304|472214611|FG000|Overall Study|Lost to Follow-up|14|||
131161576|NCT01422304|472214612|FG001|Overall Study|Lost to Follow-up|20|||
131161577|NCT01422304|472214611|FG000|Overall Study|Never Entered Follow-up|2|||
131161578|NCT01422304|472214612|FG001|Overall Study|Never Entered Follow-up|1|||
131161579|NCT01422304|472214611|FG000|Overall Study|Protocol Violation|1|||
131161580|NCT01422304|472214612|FG001|Overall Study|Protocol Violation|0|||
131161581|NCT01422304|472214611|FG000|Overall Study|Withdrawal by Subject|4|||
131161582|NCT01422304|472214612|FG001|Overall Study|Withdrawal by Subject|2|||
131161583|NCT01422304|472214611|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
131161584|NCT01422304|472214612|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
131161585|NCT01422304|472214611|FG000|Overall Study|Not Treated|3|||
131161586|NCT01422304|472214612|FG001|Overall Study|Not Treated|11|||
131161587|NCT02961764|472214613|FG000|Overall Study|Protocol Violation|0|||
131161588|NCT02961764|472214614|FG001|Overall Study|Protocol Violation|1|||
131161589|NCT02961764|472214613|FG000|Overall Study|Death|2|||
131161590|NCT02961764|472214614|FG001|Overall Study|Death|0|||
131161591|NCT02961764|472214613|FG000|Overall Study|Lost to Follow-up|35|||
131161592|NCT02961764|472214614|FG001|Overall Study|Lost to Follow-up|24|||
131161593|NCT02961764|472214613|FG000|Overall Study|Withdrawal by Subject|2|||
131161594|NCT02961764|472214614|FG001|Overall Study|Withdrawal by Subject|0|||
131161595|NCT00916721|472214615|FG000|Overall Study|Lost to Follow-up|0|||
131161596|NCT00916721|472214616|FG001|Overall Study|Lost to Follow-up|1|||
131161597|NCT00916721|472214615|FG000|Overall Study|Adverse Event|6|||
131161598|NCT00916721|472214616|FG001|Overall Study|Adverse Event|3|||
131161599|NCT00916721|472214615|FG000|Overall Study|Withdrawal by Subject|2|||
131161600|NCT00916721|472214616|FG001|Overall Study|Withdrawal by Subject|2|||
131161601|NCT00916721|472214615|FG000|Overall Study|Protocol Violation|2|||
131161602|NCT00916721|472214616|FG001|Overall Study|Protocol Violation|4|||
131161603|NCT01469052|472214619|FG000|Overall Study|Adverse Event|2|||
131161604|NCT01469052|472214620|FG001|Overall Study|Adverse Event|3|||
131161605|NCT01469052|472214621|FG002|Overall Study|Adverse Event|0|||
131161606|NCT01469052|472214622|FG003|Overall Study|Adverse Event|2|||
131161607|NCT01469052|472214623|FG004|Overall Study|Adverse Event|0|||
131161608|NCT01469052|472214624|FG005|Overall Study|Adverse Event|1|||
131161609|NCT01469052|472214619|FG000|Overall Study|Progressive disease|3|||
131161610|NCT01469052|472214620|FG001|Overall Study|Progressive disease|0|||
131161611|NCT01469052|472214621|FG002|Overall Study|Progressive disease|5|||
131161612|NCT01469052|472214622|FG003|Overall Study|Progressive disease|3|||
131161613|NCT01469052|472214623|FG004|Overall Study|Progressive disease|7|||
131161614|NCT01469052|472214624|FG005|Overall Study|Progressive disease|2|||
131161615|NCT01469052|472214619|FG000|Overall Study|Lack of Efficacy|0|||
131161616|NCT01469052|472214620|FG001|Overall Study|Lack of Efficacy|0|||
131161617|NCT01469052|472214621|FG002|Overall Study|Lack of Efficacy|0|||
131161618|NCT01469052|472214622|FG003|Overall Study|Lack of Efficacy|0|||
131161619|NCT01469052|472214623|FG004|Overall Study|Lack of Efficacy|0|||
131161620|NCT01469052|472214624|FG005|Overall Study|Lack of Efficacy|2|||
131161621|NCT01469052|472214619|FG000|Overall Study|Moved to rollover protocol|1|||
131161622|NCT01469052|472214620|FG001|Overall Study|Moved to rollover protocol|0|||
131161623|NCT01469052|472214621|FG002|Overall Study|Moved to rollover protocol|1|||
131161624|NCT01469052|472214622|FG003|Overall Study|Moved to rollover protocol|0|||
131161625|NCT01469052|472214623|FG004|Overall Study|Moved to rollover protocol|0|||
131161626|NCT01469052|472214624|FG005|Overall Study|Moved to rollover protocol|1|||
131161627|NCT01469052|472214619|FG000|Overall Study|Other|0|||
131161628|NCT01469052|472214620|FG001|Overall Study|Other|1|||
131161629|NCT01469052|472214621|FG002|Overall Study|Other|0|||
131161630|NCT01469052|472214622|FG003|Overall Study|Other|0|||
131161631|NCT01469052|472214623|FG004|Overall Study|Other|1|||
131161632|NCT01469052|472214624|FG005|Overall Study|Other|0|||
131161633|NCT01519427|472214626|FG000|Overall Study|disease progression|2|||
131161634|NCT03894904|472214627|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
131161635|NCT03894904|472214628|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
131161636|NCT03894904|472214627|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
131161637|NCT03894904|472214628|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
131161638|NCT02190435|472214629|FG000|Overall Study|First 12 patients were lead-ins|12|||
131161639|NCT02190435|472214630|FG001|Overall Study|First 12 patients were lead-ins|0|||
131161640|NCT02190435|472214629|FG000|Overall Study|3 consented screen fails|3|||
131161641|NCT02190435|472214630|FG001|Overall Study|3 consented screen fails|0|||
131161642|NCT05094154|472215880|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
131161643|NCT05094154|472215881|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
131161644|NCT05094154|472215880|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
131161645|NCT05094154|472215881|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
131161646|NCT02531035|472215890|FG000|Overall Study|Death|0|||
131161647|NCT02531035|472215891|FG001|Overall Study|Death|1|||
131161648|NCT02531035|472215890|FG000|Overall Study|Protocol Violation|1|||
131161649|NCT02531035|472215891|FG001|Overall Study|Protocol Violation|1|||
131161650|NCT02531035|472215890|FG000|Overall Study|Noncompliance with study drug|8|||
131161651|NCT02531035|472215891|FG001|Overall Study|Noncompliance with study drug|3|||
131161652|NCT02531035|472215890|FG000|Overall Study|Physician Decision|1|||
131161653|NCT02531035|472215891|FG001|Overall Study|Physician Decision|0|||
131161654|NCT02531035|472215890|FG000|Overall Study|Adverse Event|16|||
131161655|NCT02531035|472215891|FG001|Overall Study|Adverse Event|45|||
131161656|NCT02531035|472215890|FG000|Overall Study|Other|3|||
131161657|NCT02531035|472215891|FG001|Overall Study|Other|2|||
131161658|NCT02531035|472215890|FG000|Overall Study|Withdrawal by Subject|42|||
131161659|NCT02531035|472215891|FG001|Overall Study|Withdrawal by Subject|32|||
131161660|NCT02531035|472215890|FG000|Overall Study|Lost to Follow-up|8|||
131161661|NCT02531035|472215891|FG001|Overall Study|Lost to Follow-up|10|||
131161662|NCT02531035|472215890|FG000|Overall Study|Randomized, not treated|2|||
131161663|NCT02531035|472215891|FG001|Overall Study|Randomized, not treated|1|||
131161664|NCT01597622|472215901|FG000|Overall Study|Adverse Event|7|||
131161665|NCT01597622|472215901|FG000|Overall Study|Lack of Efficacy|3|||
131161666|NCT01597622|472215901|FG000|Overall Study|Protocol Violation|1|||
131161667|NCT01597622|472215901|FG000|Overall Study|Lost to Follow-up|1|||
131161668|NCT01597622|472215901|FG000|Overall Study|Investigator Discretion|5|||
131161669|NCT01597622|472215901|FG000|Overall Study|Withdrawal by Subject|20|||
131161670|NCT01597622|472215901|FG000|Overall Study|Death|1|||
131161671|NCT00521339|472215902|FG000|Treatment Phase|Adverse Event|2|||
131161672|NCT00521339|472215903|FG001|Treatment Phase|Adverse Event|0|||
131161673|NCT00521339|472215904|FG002|Treatment Phase|Adverse Event|0|||
131161674|NCT00521339|472215902|FG000|Treatment Phase|Intolerability to study drug|2|||
131161675|NCT00521339|472215903|FG001|Treatment Phase|Intolerability to study drug|0|||
131161676|NCT00521339|472215904|FG002|Treatment Phase|Intolerability to study drug|0|||
131161677|NCT00521339|472215902|FG000|Treatment Phase|Lack of Efficacy|3|||
131161678|NCT00521339|472215903|FG001|Treatment Phase|Lack of Efficacy|0|||
131161679|NCT00521339|472215904|FG002|Treatment Phase|Lack of Efficacy|0|||
131161680|NCT00521339|472215902|FG000|Treatment Phase|Withdrawal by Subject|3|||
131161681|NCT00521339|472215903|FG001|Treatment Phase|Withdrawal by Subject|0|||
131161682|NCT00521339|472215904|FG002|Treatment Phase|Withdrawal by Subject|0|||
131161683|NCT00521339|472215902|FG000|Treatment Phase|Lost to Follow-up|1|||
131161684|NCT00521339|472215903|FG001|Treatment Phase|Lost to Follow-up|0|||
131161685|NCT00521339|472215904|FG002|Treatment Phase|Lost to Follow-up|0|||
131161686|NCT00521339|472215902|FG000|Treatment Phase|Protocol Violation|1|||
131161687|NCT00521339|472215903|FG001|Treatment Phase|Protocol Violation|0|||
131161688|NCT00521339|472215904|FG002|Treatment Phase|Protocol Violation|0|||
131161689|NCT00521339|472215902|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
131161690|NCT00521339|472215903|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
131161691|NCT00521339|472215904|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
131161692|NCT00521339|472215902|FG000|Treatment Extension Phase|Death|0|||
131161693|NCT00521339|472215903|FG001|Treatment Extension Phase|Death|0|||
131161694|NCT00521339|472215904|FG002|Treatment Extension Phase|Death|1|||
131161695|NCT03314519|472215905|FG000|Overall Study|Protocol Violation|3|||
131161696|NCT03314519|472215906|FG001|Overall Study|Protocol Violation|2|||
131161697|NCT00950690|472215909|FG000|Overall Study|Death|4|||
131161698|NCT00950690|472215909|FG000|Overall Study|Adverse Event|15|||
131161699|NCT00950690|472215909|FG000|Overall Study|Lack of Efficacy|22|||
131161700|NCT00950690|472215909|FG000|Overall Study|Lost to Follow-up|40|||
131161701|NCT00950690|472215909|FG000|Overall Study|Other|163|||
131161702|NCT01713036|472215910|FG000|Overall Study|Death|1|||
131161703|NCT03567291|472215913|FG000|Period I|Adverse Event|14|||
131161704|NCT03567291|472215914|FG001|Period I|Adverse Event|0|||
131161705|NCT03567291|472215915|FG002|Period I|Adverse Event|0|||
131161706|NCT03567291|472215916|FG003|Period I|Adverse Event|0|||
131161707|NCT03567291|472215913|FG000|Period I|Protocol Violation|1|||
131161708|NCT03567291|472215914|FG001|Period I|Protocol Violation|0|||
131161709|NCT03567291|472215915|FG002|Period I|Protocol Violation|0|||
131161710|NCT03567291|472215916|FG003|Period I|Protocol Violation|0|||
131161711|NCT03567291|472215913|FG000|Period I|Withdrawal by Subject|23|||
131161712|NCT03567291|472215914|FG001|Period I|Withdrawal by Subject|0|||
131161713|NCT03567291|472215915|FG002|Period I|Withdrawal by Subject|0|||
131161714|NCT03567291|472215916|FG003|Period I|Withdrawal by Subject|0|||
131161715|NCT03567291|472215913|FG000|Period I|Lost to Follow-up|2|||
131161716|NCT03567291|472215914|FG001|Period I|Lost to Follow-up|0|||
131161717|NCT03567291|472215915|FG002|Period I|Lost to Follow-up|0|||
131161718|NCT03567291|472215916|FG003|Period I|Lost to Follow-up|0|||
131161719|NCT03567291|472215913|FG000|Period I|Terminated by sponsor|44|||
131161720|NCT03567291|472215914|FG001|Period I|Terminated by sponsor|0|||
131161721|NCT03567291|472215915|FG002|Period I|Terminated by sponsor|0|||
131161722|NCT03567291|472215916|FG003|Period I|Terminated by sponsor|0|||
131161723|NCT03567291|472215913|FG000|Period I|Missing or unknown|7|||
131161724|NCT03567291|472215914|FG001|Period I|Missing or unknown|0|||
131161725|NCT03567291|472215915|FG002|Period I|Missing or unknown|0|||
131161726|NCT03567291|472215916|FG003|Period I|Missing or unknown|0|||
131235423|NCT02270736|472490897|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
131161727|NCT03567291|472215913|FG000|Period II|Adverse Event|0|||
131161728|NCT03567291|472215914|FG001|Period II|Adverse Event|1|||
131161729|NCT03567291|472215915|FG002|Period II|Adverse Event|0|||
131161730|NCT03567291|472215916|FG003|Period II|Adverse Event|0|||
131161731|NCT03567291|472215913|FG000|Period II|Missing or unknown|0|||
131161732|NCT03567291|472215914|FG001|Period II|Missing or unknown|2|||
131161733|NCT03567291|472215915|FG002|Period II|Missing or unknown|1|||
131161734|NCT03567291|472215916|FG003|Period II|Missing or unknown|0|||
131161735|NCT03567291|472215913|FG000|Period III|Adverse Event|0|||
131161736|NCT03567291|472215914|FG001|Period III|Adverse Event|0|||
131161737|NCT03567291|472215915|FG002|Period III|Adverse Event|0|||
131161738|NCT03567291|472215916|FG003|Period III|Adverse Event|4|||
131161739|NCT03567291|472215913|FG000|Period III|Withdrawal by Subject|0|||
131161740|NCT03567291|472215914|FG001|Period III|Withdrawal by Subject|0|||
131161741|NCT03567291|472215915|FG002|Period III|Withdrawal by Subject|0|||
131161742|NCT03567291|472215916|FG003|Period III|Withdrawal by Subject|4|||
131161743|NCT03567291|472215913|FG000|Period III|Lost to Follow-up|0|||
131161744|NCT03567291|472215914|FG001|Period III|Lost to Follow-up|0|||
131161745|NCT03567291|472215915|FG002|Period III|Lost to Follow-up|0|||
131161746|NCT03567291|472215916|FG003|Period III|Lost to Follow-up|1|||
131161747|NCT03567291|472215913|FG000|Period III|Terminated by sponsor|0|||
131161748|NCT03567291|472215914|FG001|Period III|Terminated by sponsor|0|||
131161749|NCT03567291|472215915|FG002|Period III|Terminated by sponsor|0|||
131161750|NCT03567291|472215916|FG003|Period III|Terminated by sponsor|68|||
131161751|NCT03567291|472215913|FG000|Period III|Missing or unknown|0|||
131161752|NCT03567291|472215914|FG001|Period III|Missing or unknown|0|||
131161753|NCT03567291|472215915|FG002|Period III|Missing or unknown|0|||
131161754|NCT03567291|472215916|FG003|Period III|Missing or unknown|8|||
131161755|NCT01103349|472215917|FG000|Overall Study|Adverse Event|8|||
131161756|NCT01103349|472215918|FG001|Overall Study|Adverse Event|5|||
131161757|NCT01103349|472215919|FG002|Overall Study|Adverse Event|3|||
131161758|NCT01103349|472215917|FG000|Overall Study|Consent withdrawn|1|||
131161759|NCT01103349|472215918|FG001|Overall Study|Consent withdrawn|0|||
131161760|NCT01103349|472215919|FG002|Overall Study|Consent withdrawn|0|||
131161761|NCT01103349|472215917|FG000|Overall Study|Incorrectly included in the trial|1|||
131161762|NCT01103349|472215918|FG001|Overall Study|Incorrectly included in the trial|0|||
131161763|NCT01103349|472215919|FG002|Overall Study|Incorrectly included in the trial|0|||
131161764|NCT01103349|472215917|FG000|Overall Study|Withdrawal by Subject|1|||
131161765|NCT01103349|472215918|FG001|Overall Study|Withdrawal by Subject|1|||
131161766|NCT01103349|472215919|FG002|Overall Study|Withdrawal by Subject|0|||
131161767|NCT01103349|472215917|FG000|Overall Study|did not want to take trial medication|0|||
131161768|NCT01103349|472215918|FG001|Overall Study|did not want to take trial medication|1|||
131161769|NCT01103349|472215919|FG002|Overall Study|did not want to take trial medication|0|||
131161770|NCT01103349|472215917|FG000|Overall Study|forgot to take medication|0|||
131161771|NCT01103349|472215918|FG001|Overall Study|forgot to take medication|0|||
131161772|NCT01103349|472215919|FG002|Overall Study|forgot to take medication|1|||
131161773|NCT00090285|472215920|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
131161774|NCT00090285|472215921|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
131161775|NCT00090285|472215922|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131161776|NCT00090285|472215923|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131161777|NCT00090285|472215924|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131161778|NCT00090285|472215925|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
131161779|NCT00090285|472215920|FG000|Base Study Vaccination Period|Adverse Event|2|||
131161780|NCT00090285|472215921|FG001|Base Study Vaccination Period|Adverse Event|4|||
131161781|NCT00090285|472215922|FG002|Base Study Vaccination Period|Adverse Event|0|||
131161782|NCT00090285|472215923|FG003|Base Study Vaccination Period|Adverse Event|0|||
131161783|NCT00090285|472215924|FG004|Base Study Vaccination Period|Adverse Event|0|||
131161784|NCT00090285|472215925|FG005|Base Study Vaccination Period|Adverse Event|0|||
131161785|NCT00090285|472215920|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
131161786|NCT00090285|472215921|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
131161787|NCT00090285|472215922|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
131161788|NCT00090285|472215923|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
131161789|NCT00090285|472215924|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
131161790|NCT00090285|472215925|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
131161791|NCT00090285|472215920|FG000|Base Study Vaccination Period|Protocol Violation|2|||
131161792|NCT00090285|472215921|FG001|Base Study Vaccination Period|Protocol Violation|3|||
131161793|NCT00090285|472215922|FG002|Base Study Vaccination Period|Protocol Violation|0|||
131161794|NCT00090285|472215923|FG003|Base Study Vaccination Period|Protocol Violation|0|||
131161795|NCT00090285|472215924|FG004|Base Study Vaccination Period|Protocol Violation|0|||
131161796|NCT00090285|472215925|FG005|Base Study Vaccination Period|Protocol Violation|0|||
131161797|NCT00090285|472215920|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
131161798|NCT00090285|472215921|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
131161799|NCT00090285|472215922|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
131161800|NCT00090285|472215923|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
131161801|NCT00090285|472215924|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
131161802|NCT00090285|472215925|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
131161803|NCT00090285|472215920|FG000|Base Study Vaccination Period|Uncooperative|2|||
131161804|NCT00090285|472215921|FG001|Base Study Vaccination Period|Uncooperative|2|||
131235424|NCT02270736|472490898|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130780618|NCT00735709|470823125|FG003|Overall Study|Excluded medication|1|||
131161805|NCT00090285|472215922|FG002|Base Study Vaccination Period|Uncooperative|0|||
131161806|NCT00090285|472215923|FG003|Base Study Vaccination Period|Uncooperative|0|||
131161807|NCT00090285|472215924|FG004|Base Study Vaccination Period|Uncooperative|0|||
131161808|NCT00090285|472215925|FG005|Base Study Vaccination Period|Uncooperative|0|||
131161809|NCT00090285|472215920|FG000|Base Study Vaccination Period|Moved|20|||
130729044|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
130729045|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
130729046|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729047|NCT03888066|470630504|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
131161810|NCT00090285|472215921|FG001|Base Study Vaccination Period|Moved|21|||
131161811|NCT00090285|472215922|FG002|Base Study Vaccination Period|Moved|0|||
131161812|NCT00090285|472215923|FG003|Base Study Vaccination Period|Moved|0|||
131161813|NCT00090285|472215924|FG004|Base Study Vaccination Period|Moved|0|||
131161814|NCT00090285|472215925|FG005|Base Study Vaccination Period|Moved|0|||
131161815|NCT00090285|472215920|FG000|Base Study Vaccination Period|Site Terminated|1|||
131161816|NCT00090285|472215921|FG001|Base Study Vaccination Period|Site Terminated|0|||
131161817|NCT00090285|472215922|FG002|Base Study Vaccination Period|Site Terminated|0|||
131161818|NCT00090285|472215923|FG003|Base Study Vaccination Period|Site Terminated|0|||
131161819|NCT00090285|472215924|FG004|Base Study Vaccination Period|Site Terminated|0|||
131161820|NCT00090285|472215925|FG005|Base Study Vaccination Period|Site Terminated|0|||
131161821|NCT00090285|472215920|FG000|Base Study Vaccination Period|Other|2|||
131161822|NCT00090285|472215921|FG001|Base Study Vaccination Period|Other|2|||
131161823|NCT00090285|472215922|FG002|Base Study Vaccination Period|Other|0|||
131161824|NCT00090285|472215923|FG003|Base Study Vaccination Period|Other|0|||
131161825|NCT00090285|472215924|FG004|Base Study Vaccination Period|Other|0|||
131161826|NCT00090285|472215925|FG005|Base Study Vaccination Period|Other|0|||
131161827|NCT00090285|472215920|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
131161828|NCT00090285|472215921|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
131161829|NCT00090285|472215922|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
131161830|NCT00090285|472215923|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
130729048|NCT03888066|470630505|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130729049|NCT03888066|470630504|FG000|Run-in Phase|AE (Adverse Event)|17|||
130729050|NCT03888066|470630505|FG001|Run-in Phase|AE (Adverse Event)|0|||
130729051|NCT03888066|470630504|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
130729052|NCT03888066|470630505|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
130729053|NCT03888066|470630504|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130729054|NCT03888066|470630505|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729055|NCT03888066|470630504|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130729056|NCT03888066|470630505|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729057|NCT03888066|470630504|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
130729058|NCT03888066|470630505|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130729059|NCT03888066|470630504|FG000|Run-in Phase|Withdrawal by Subject|43|||
130729060|NCT03888066|470630505|FG001|Run-in Phase|Withdrawal by Subject|0|||
130729061|NCT03888066|470630504|FG000|Run-in Phase|AE; Physician Decision|1|||
130729062|NCT03888066|470630505|FG001|Run-in Phase|AE; Physician Decision|0|||
130729063|NCT03888066|470630504|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
130729064|NCT03888066|470630505|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130729065|NCT03888066|470630504|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
130729066|NCT03888066|470630505|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
130729067|NCT03888066|470630504|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
130729068|NCT03888066|470630505|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130729069|NCT03888066|470630504|FG000|Run-in Phase|Death|1|||
130729070|NCT03888066|470630505|FG001|Run-in Phase|Death|0|||
130729071|NCT03888066|470630504|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
130729072|NCT03888066|470630505|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
130729073|NCT03888066|470630504|FG000|Run-in Phase|Physician Decision|1|||
130729074|NCT03888066|470630505|FG001|Run-in Phase|Physician Decision|0|||
130729075|NCT03888066|470630504|FG000|Run-in Phase|Protocol Violation|13|||
130729076|NCT03888066|470630505|FG001|Run-in Phase|Protocol Violation|0|||
130729077|NCT03888066|470630504|FG000|Run-in Phase|Sponsor Request|34|||
130729078|NCT03888066|470630505|FG001|Run-in Phase|Sponsor Request|0|||
130729079|NCT03888066|470630504|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
130729080|NCT03888066|470630505|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
130729081|NCT03888066|470630504|FG000|Run-in Phase|Withdrawal Of Consent|1|||
130729082|NCT03888066|470630505|FG001|Run-in Phase|Withdrawal Of Consent|0|||
130729083|NCT03888066|470630504|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
130729084|NCT03888066|470630505|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
130729085|NCT03888066|470630504|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
130729086|NCT03888066|470630505|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
130729087|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
130780619|NCT01165307|470823126|FG000|Overall Study|Lost to Follow-up|11|||
131161831|NCT00090285|472215924|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
131161832|NCT00090285|472215925|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
130729088|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
130729089|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
130729090|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
131161833|NCT00090285|472215920|FG000|Base Study Vaccination Period|HIV positive|1|||
131161834|NCT00090285|472215921|FG001|Base Study Vaccination Period|HIV positive|1|||
131161835|NCT00090285|472215922|FG002|Base Study Vaccination Period|HIV positive|0|||
131161836|NCT00090285|472215923|FG003|Base Study Vaccination Period|HIV positive|0|||
131161837|NCT00090285|472215924|FG004|Base Study Vaccination Period|HIV positive|0|||
131161838|NCT00090285|472215925|FG005|Base Study Vaccination Period|HIV positive|0|||
131161839|NCT00090285|472215920|FG000|Base Study Follow-up Period|Adverse Event|3|||
131161840|NCT00090285|472215921|FG001|Base Study Follow-up Period|Adverse Event|10|||
131161841|NCT00090285|472215922|FG002|Base Study Follow-up Period|Adverse Event|0|||
131161842|NCT00090285|472215923|FG003|Base Study Follow-up Period|Adverse Event|0|||
131161843|NCT00090285|472215924|FG004|Base Study Follow-up Period|Adverse Event|0|||
131161844|NCT00090285|472215925|FG005|Base Study Follow-up Period|Adverse Event|0|||
131161845|NCT00090285|472215920|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
131161846|NCT00090285|472215921|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
131161847|NCT00090285|472215922|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
131161848|NCT00090285|472215923|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
131161849|NCT00090285|472215924|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
131161850|NCT00090285|472215925|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
131161851|NCT00090285|472215920|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
131161852|NCT00090285|472215921|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
131161853|NCT00090285|472215922|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
131161854|NCT00090285|472215923|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
131161855|NCT00090285|472215924|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
131161856|NCT00090285|472215925|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
131161857|NCT00090285|472215920|FG000|Base Study Follow-up Period|Moved|41|||
131161858|NCT00090285|472215921|FG001|Base Study Follow-up Period|Moved|36|||
131161859|NCT00090285|472215922|FG002|Base Study Follow-up Period|Moved|0|||
131161860|NCT00090285|472215923|FG003|Base Study Follow-up Period|Moved|0|||
131161861|NCT00090285|472215924|FG004|Base Study Follow-up Period|Moved|0|||
131161862|NCT00090285|472215925|FG005|Base Study Follow-up Period|Moved|0|||
131161863|NCT00090285|472215920|FG000|Base Study Follow-up Period|Other|2|||
131161864|NCT00090285|472215921|FG001|Base Study Follow-up Period|Other|0|||
131161865|NCT00090285|472215922|FG002|Base Study Follow-up Period|Other|0|||
131161866|NCT00090285|472215923|FG003|Base Study Follow-up Period|Other|0|||
131161867|NCT00090285|472215924|FG004|Base Study Follow-up Period|Other|0|||
131161868|NCT00090285|472215925|FG005|Base Study Follow-up Period|Other|0|||
131161869|NCT00090285|472215920|FG000|Base Study Follow-up Period|Protocol Violation|1|||
131161870|NCT00090285|472215921|FG001|Base Study Follow-up Period|Protocol Violation|0|||
131161871|NCT00090285|472215922|FG002|Base Study Follow-up Period|Protocol Violation|0|||
131161872|NCT00090285|472215923|FG003|Base Study Follow-up Period|Protocol Violation|0|||
131161873|NCT00090285|472215924|FG004|Base Study Follow-up Period|Protocol Violation|0|||
131161874|NCT00090285|472215925|FG005|Base Study Follow-up Period|Protocol Violation|0|||
131161875|NCT00090285|472215920|FG000|Base Study Follow-up Period|Uncooperative|3|||
131161876|NCT00090285|472215921|FG001|Base Study Follow-up Period|Uncooperative|4|||
131161877|NCT00090285|472215922|FG002|Base Study Follow-up Period|Uncooperative|0|||
131161878|NCT00090285|472215923|FG003|Base Study Follow-up Period|Uncooperative|0|||
131161879|NCT00090285|472215924|FG004|Base Study Follow-up Period|Uncooperative|0|||
131161880|NCT00090285|472215925|FG005|Base Study Follow-up Period|Uncooperative|0|||
131161881|NCT00090285|472215920|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
131161882|NCT00090285|472215921|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
130729091|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
130729092|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
131161883|NCT00090285|472215922|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
131161884|NCT00090285|472215923|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
131161885|NCT00090285|472215924|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
131161886|NCT00090285|472215925|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
131161887|NCT00090285|472215920|FG000|Extension 1|Adverse Event|0|||
131161888|NCT00090285|472215921|FG001|Extension 1|Adverse Event|0|||
131161889|NCT00090285|472215922|FG002|Extension 1|Adverse Event|2|||
131161890|NCT00090285|472215923|FG003|Extension 1|Adverse Event|0|||
131161891|NCT00090285|472215924|FG004|Extension 1|Adverse Event|0|||
131161892|NCT00090285|472215925|FG005|Extension 1|Adverse Event|0|||
130729093|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
131161893|NCT00090285|472215920|FG000|Extension 1|Lost to Follow-up|0|||
131161894|NCT00090285|472215921|FG001|Extension 1|Lost to Follow-up|0|||
131161895|NCT00090285|472215922|FG002|Extension 1|Lost to Follow-up|35|||
131161896|NCT00090285|472215923|FG003|Extension 1|Lost to Follow-up|0|||
131161897|NCT00090285|472215924|FG004|Extension 1|Lost to Follow-up|0|||
131161898|NCT00090285|472215925|FG005|Extension 1|Lost to Follow-up|0|||
131161899|NCT00090285|472215920|FG000|Extension 1|Withdrawal by Subject|0|||
131161900|NCT00090285|472215921|FG001|Extension 1|Withdrawal by Subject|0|||
131161901|NCT00090285|472215922|FG002|Extension 1|Withdrawal by Subject|13|||
131161902|NCT00090285|472215923|FG003|Extension 1|Withdrawal by Subject|1|||
131161903|NCT00090285|472215924|FG004|Extension 1|Withdrawal by Subject|0|||
131161904|NCT00090285|472215925|FG005|Extension 1|Withdrawal by Subject|0|||
131161905|NCT00090285|472215920|FG000|Extension 1|Other|0|||
131161906|NCT00090285|472215921|FG001|Extension 1|Other|0|||
131161907|NCT00090285|472215922|FG002|Extension 1|Other|4|||
131161908|NCT00090285|472215923|FG003|Extension 1|Other|0|||
131161909|NCT00090285|472215924|FG004|Extension 1|Other|0|||
131161910|NCT00090285|472215925|FG005|Extension 1|Other|0|||
131161911|NCT00090285|472215920|FG000|Extension 1|Moved|0|||
131161912|NCT00090285|472215921|FG001|Extension 1|Moved|0|||
131161913|NCT00090285|472215922|FG002|Extension 1|Moved|3|||
131161914|NCT00090285|472215923|FG003|Extension 1|Moved|0|||
131161915|NCT00090285|472215924|FG004|Extension 1|Moved|0|||
131161916|NCT00090285|472215925|FG005|Extension 1|Moved|0|||
131161917|NCT00090285|472215920|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
131161918|NCT00090285|472215921|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
131161919|NCT00090285|472215922|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
131161920|NCT00090285|472215923|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
131161921|NCT00090285|472215924|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
131161922|NCT00090285|472215925|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
131161923|NCT00090285|472215920|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131161924|NCT00090285|472215921|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131161925|NCT00090285|472215922|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131161926|NCT00090285|472215923|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
131161927|NCT00090285|472215924|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
131161928|NCT00090285|472215925|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
131161929|NCT00090285|472215920|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131235425|NCT02270736|472490894|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
131235426|NCT02270736|472490895|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
131235427|NCT02270736|472490896|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
131235428|NCT02270736|472490897|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
131235429|NCT02270736|472490898|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
131235430|NCT02270736|472490894|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
131235431|NCT02270736|472490895|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
131235432|NCT02270736|472490896|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
131235433|NCT02270736|472490897|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
131235434|NCT02270736|472490898|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
131235435|NCT02270736|472490894|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
131235436|NCT02270736|472490895|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
131235437|NCT02270736|472490896|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
131235438|NCT02270736|472490897|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
131235439|NCT02270736|472490898|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
131235440|NCT01631864|472490899|FG000|Overall Study|Withdrawal by Subject|0|||
131235441|NCT01631864|472490900|FG001|Overall Study|Withdrawal by Subject|1|||
131235442|NCT01631864|472490899|FG000|Overall Study|Adverse Event|2|||
131235443|NCT01631864|472490900|FG001|Overall Study|Adverse Event|3|||
131235444|NCT03702621|472490923|FG000|Overall Study|Physician Decision|6|||
131235445|NCT03702621|472490924|FG001|Overall Study|Physician Decision|6|||
131235446|NCT00527423|472490925|FG000|Overall Study|Protocol Violation|1|||
131235447|NCT00527423|472490925|FG000|Overall Study|Adverse Event|5|||
131235448|NCT00527423|472490925|FG000|Overall Study|Physician Decision|4|||
131235449|NCT00527423|472490925|FG000|Overall Study|Withdrawal by Subject|10|||
131235450|NCT00527423|472490925|FG000|Overall Study|Lost to Follow-up|4|||
131235451|NCT00527423|472490925|FG000|Overall Study|OTHER|4|||
131235452|NCT00527423|472490925|FG000|Overall Study|Death|9|||
131235453|NCT03194464|472490927|FG000|Overall Study|data not usable|2|||
131235454|NCT03103100|472490928|FG000|Overall Study|Adverse Event|1|||
130729094|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
130729095|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
130729096|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
131161930|NCT00090285|472215921|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131161931|NCT00090285|472215922|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131161932|NCT00090285|472215923|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
131161933|NCT00090285|472215924|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
131161934|NCT00090285|472215925|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
131161935|NCT00090285|472215920|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
131161936|NCT00090285|472215921|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
131161937|NCT00090285|472215922|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
131235455|NCT03103100|472490929|FG001|Overall Study|Adverse Event|0|||
131235456|NCT03103100|472490930|FG002|Overall Study|Adverse Event|0|||
131235457|NCT03103100|472490928|FG000|Overall Study|Physician Decision|1|||
131235458|NCT03103100|472490929|FG001|Overall Study|Physician Decision|0|||
131235459|NCT03103100|472490930|FG002|Overall Study|Physician Decision|2|||
131235460|NCT00436007|472490933|FG000|Overall Study|Withdrawal by Subject|5|||
131235461|NCT00436007|472490934|FG001|Overall Study|Withdrawal by Subject|3|||
130729097|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
130729098|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
130729099|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
130729100|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
130729101|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
130729102|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
130729103|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
131161938|NCT00090285|472215923|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
130729104|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
130729105|NCT03888066|470630504|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
130729106|NCT03888066|470630505|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
130729107|NCT03278626|470630506|FG000|Overall Study|Death|2|||
130729108|NCT03278626|470630506|FG000|Overall Study|Toxicity|1|||
130729109|NCT03278626|470630506|FG000|Overall Study|Disease Progression|2|||
130729110|NCT05013008|470630508|FG000|Overall Study|Exclusion from mBFAS|5|||
130729111|NCT05013008|470630509|FG001|Overall Study|Exclusion from mBFAS|25|||
131161939|NCT00090285|472215924|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
131161940|NCT00090285|472215925|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
131161941|NCT00907478|472215926|FG000|Overall Study|Ineligibility determined|0|||
131161942|NCT00907478|472215927|FG001|Overall Study|Ineligibility determined|0|||
131161943|NCT00907478|472215928|FG002|Overall Study|Ineligibility determined|1|||
131161944|NCT00907478|472215926|FG000|Overall Study|Noncompliance|0|||
131161945|NCT00907478|472215927|FG001|Overall Study|Noncompliance|0|||
131161946|NCT00907478|472215928|FG002|Overall Study|Noncompliance|1|||
131161947|NCT00907478|472215926|FG000|Overall Study|Adverse Event|3|||
131161948|NCT00907478|472215927|FG001|Overall Study|Adverse Event|1|||
131161949|NCT00907478|472215928|FG002|Overall Study|Adverse Event|2|||
131161950|NCT00907478|472215926|FG000|Overall Study|Withdrawal by Subject|8|||
131161951|NCT00907478|472215927|FG001|Overall Study|Withdrawal by Subject|9|||
131161952|NCT00907478|472215928|FG002|Overall Study|Withdrawal by Subject|6|||
131161953|NCT00907478|472215926|FG000|Overall Study|Requirement for alternative therapy|1|||
131161954|NCT00907478|472215927|FG001|Overall Study|Requirement for alternative therapy|2|||
131161955|NCT00907478|472215928|FG002|Overall Study|Requirement for alternative therapy|3|||
131161956|NCT00907478|472215926|FG000|Overall Study|Physician Decision|2|||
131161957|NCT00907478|472215927|FG001|Overall Study|Physician Decision|0|||
131161958|NCT00907478|472215928|FG002|Overall Study|Physician Decision|3|||
131161959|NCT00907478|472215926|FG000|Overall Study|Death|4|||
131161960|NCT00907478|472215927|FG001|Overall Study|Death|2|||
131161961|NCT00907478|472215928|FG002|Overall Study|Death|1|||
131161962|NCT00907478|472215926|FG000|Overall Study|Protocol-specified criteria|5|||
131161963|NCT00907478|472215927|FG001|Overall Study|Protocol-specified criteria|2|||
131161964|NCT00907478|472215928|FG002|Overall Study|Protocol-specified criteria|3|||
131161965|NCT00907478|472215926|FG000|Overall Study|Pregnancy|0|||
131161966|NCT00907478|472215927|FG001|Overall Study|Pregnancy|1|||
131161967|NCT00907478|472215928|FG002|Overall Study|Pregnancy|1|||
131161968|NCT00907478|472215926|FG000|Overall Study|Lost to Follow-up|1|||
131161969|NCT00907478|472215927|FG001|Overall Study|Lost to Follow-up|0|||
131161970|NCT00907478|472215928|FG002|Overall Study|Lost to Follow-up|0|||
131161971|NCT00907478|472215926|FG000|Overall Study|Other|3|||
131161972|NCT00907478|472215927|FG001|Overall Study|Other|0|||
131161973|NCT00907478|472215928|FG002|Overall Study|Other|1|||
131161974|NCT02639182|472215929|FG000|Overall Study|Disease Progression|50|||
131161975|NCT02639182|472215930|FG001|Overall Study|Disease Progression|49|||
131161976|NCT02639182|472215929|FG000|Overall Study|Adverse Event|7|||
131161977|NCT02639182|472215930|FG001|Overall Study|Adverse Event|5|||
131161978|NCT02639182|472215929|FG000|Overall Study|Physician Decision|3|||
131161979|NCT02639182|472215930|FG001|Overall Study|Physician Decision|3|||
131161980|NCT02639182|472215929|FG000|Overall Study|Withdrew Consent|5|||
131161981|NCT02639182|472215930|FG001|Overall Study|Withdrew Consent|4|||
131161982|NCT02639182|472215929|FG000|Overall Study|Lost to Follow-up|0|||
131161983|NCT02639182|472215930|FG001|Overall Study|Lost to Follow-up|1|||
131161984|NCT02639182|472215929|FG000|Overall Study|Study Closure|1|||
131161985|NCT02639182|472215930|FG001|Overall Study|Study Closure|2|||
131161986|NCT02639182|472215929|FG000|Overall Study|Sponsor Ended Study|0|||
131161987|NCT02639182|472215930|FG001|Overall Study|Sponsor Ended Study|1|||
131161988|NCT02639182|472215929|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
131161989|NCT02639182|472215930|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
130729112|NCT02077140|470630510|FG000|Overall Study|Lost to Follow-up|4|||
130729113|NCT02077140|470630511|FG001|Overall Study|Lost to Follow-up|1|||
130729114|NCT02077140|470630512|FG002|Overall Study|Lost to Follow-up|2|||
130729115|NCT02077140|470630513|FG003|Overall Study|Lost to Follow-up|2|||
131161990|NCT03069690|472215931|FG000|Pregnancy Intervention|Pregnancy loss|9|||
131161991|NCT03069690|472215932|FG001|Pregnancy Intervention|Pregnancy loss|4|||
131161992|NCT03069690|472215933|FG002|Pregnancy Intervention|Pregnancy loss|0|||
131161993|NCT03069690|472215934|FG003|Pregnancy Intervention|Pregnancy loss|0|||
131161994|NCT03069690|472215935|FG004|Pregnancy Intervention|Pregnancy loss|0|||
130729116|NCT02077140|470630514|FG004|Overall Study|Lost to Follow-up|3|||
130729117|NCT02077140|470630510|FG000|Overall Study|Withdrawal by Subject|0|||
130729118|NCT02077140|470630511|FG001|Overall Study|Withdrawal by Subject|1|||
130729119|NCT02077140|470630512|FG002|Overall Study|Withdrawal by Subject|0|||
130729120|NCT02077140|470630513|FG003|Overall Study|Withdrawal by Subject|2|||
130729121|NCT02077140|470630514|FG004|Overall Study|Withdrawal by Subject|2|||
130729122|NCT01762800|470630521|FG000|Overall Study|Adverse Event|8|||
131161995|NCT03069690|472215936|FG005|Pregnancy Intervention|Pregnancy loss|0|||
131161996|NCT03069690|472215931|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
131161997|NCT03069690|472215932|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
131161998|NCT03069690|472215933|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
130729123|NCT01762800|470630522|FG001|Overall Study|Adverse Event|13|||
131161999|NCT03069690|472215934|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
131162000|NCT03069690|472215935|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
131162001|NCT03069690|472215936|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
131162002|NCT03069690|472215931|FG000|Postpartum Intervention|Lost to Follow-up|0|||
131162003|NCT03069690|472215932|FG001|Postpartum Intervention|Lost to Follow-up|0|||
131162004|NCT03069690|472215933|FG002|Postpartum Intervention|Lost to Follow-up|5|||
131162005|NCT03069690|472215934|FG003|Postpartum Intervention|Lost to Follow-up|5|||
131162006|NCT03069690|472215935|FG004|Postpartum Intervention|Lost to Follow-up|2|||
131162007|NCT03069690|472215936|FG005|Postpartum Intervention|Lost to Follow-up|4|||
131162008|NCT03268746|472215941|FG000|Overall Study|Withdrawal by Subject|1|||
131162009|NCT01372878|472215942|FG000|Overall Study|Withdrawal by Subject|63|||
131162010|NCT01372878|472215942|FG000|Overall Study|Protocol Violation|17|||
131162011|NCT01372878|472215942|FG000|Overall Study|incomplete study procedure|104|||
131162012|NCT00117338|472215943|FG000|Overall Study|Adverse Event|0|||
131162013|NCT00117338|472215944|FG001|Overall Study|Adverse Event|1|||
131162014|NCT00117338|472215943|FG000|Overall Study|Protocol Violation|3|||
131162015|NCT00117338|472215944|FG001|Overall Study|Protocol Violation|2|||
131162016|NCT00117338|472215943|FG000|Overall Study|Withdrawal by Subject|1|||
131162017|NCT00117338|472215944|FG001|Overall Study|Withdrawal by Subject|0|||
131162018|NCT00117338|472215943|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
131162019|NCT00117338|472215944|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
131162020|NCT00117338|472215943|FG000|Overall Study|Lack of Efficacy|0|||
131162021|NCT00117338|472215944|FG001|Overall Study|Lack of Efficacy|1|||
131162022|NCT02240628|472215949|FG000|Overall Study|Physician Decision|6|||
131162023|NCT02240628|472215950|FG001|Overall Study|Physician Decision|5|||
131162024|NCT02385123|472215951|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
131162025|NCT01070303|472215955|FG000|Overall Study|Adverse Event|39|||
131162026|NCT01070303|472215955|FG000|Overall Study|Withdrawal by Subject|20|||
131162027|NCT01070303|472215955|FG000|Overall Study|Lost to Follow-up|9|||
131162028|NCT01070303|472215955|FG000|Overall Study|Protocol Violation|0|||
131162029|NCT01070303|472215955|FG000|Overall Study|Lack of Efficacy|2|||
131162030|NCT01070303|472215955|FG000|Overall Study|Administrative Reason|1|||
131162031|NCT01070303|472215955|FG000|Overall Study|Other|18|||
131162032|NCT02345434|472215956|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
131162033|NCT02345434|472215957|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
131162034|NCT02926573|472215958|FG000|Overall Study|Nausea|1|||
131162035|NCT02926573|472215959|FG001|Overall Study|Nausea|0|||
131162036|NCT02926573|472215958|FG000|Overall Study|Remain intubated|2|||
131162037|NCT02926573|472215959|FG001|Overall Study|Remain intubated|2|||
131162038|NCT02926573|472215958|FG000|Overall Study|Change in surgery plan|3|||
131162039|NCT02926573|472215959|FG001|Overall Study|Change in surgery plan|1|||
131162040|NCT02926573|472215958|FG000|Overall Study|Change to outpatient status|5|||
131162041|NCT02926573|472215959|FG001|Overall Study|Change to outpatient status|1|||
131162042|NCT02926573|472215958|FG000|Overall Study|Withdrawal by Subject|0|||
131162043|NCT02926573|472215959|FG001|Overall Study|Withdrawal by Subject|2|||
131162044|NCT02926573|472215958|FG000|Overall Study|Return to operating room|0|||
131162045|NCT02926573|472215959|FG001|Overall Study|Return to operating room|2|||
131162046|NCT02926573|472215958|FG000|Overall Study|Delirium|0|||
131162047|NCT02926573|472215959|FG001|Overall Study|Delirium|1|||
131162048|NCT00858702|472215962|FG000|Overall Study|Lack of Efficacy|1|||
131162049|NCT00858702|472215963|FG001|Overall Study|Lack of Efficacy|0|||
130729124|NCT01762800|470630521|FG000|Overall Study|Lack of Efficacy|3|||
131162050|NCT00858702|472215962|FG000|Overall Study|Protocol Violation|1|||
131162051|NCT00858702|472215963|FG001|Overall Study|Protocol Violation|1|||
131162052|NCT00858702|472215962|FG000|Overall Study|Other|2|||
131162053|NCT00858702|472215963|FG001|Overall Study|Other|1|||
131162054|NCT00858702|472215962|FG000|Overall Study|Withdrawal by Subject|1|||
131162055|NCT00858702|472215963|FG001|Overall Study|Withdrawal by Subject|0|||
130729125|NCT01762800|470630522|FG001|Overall Study|Lack of Efficacy|2|||
130729126|NCT01762800|470630521|FG000|Overall Study|Study Closed/Terminated|0|||
130729127|NCT01762800|470630522|FG001|Overall Study|Study Closed/Terminated|1|||
131162056|NCT00771030|472215964|FG000|Overall Study|Adverse Event|0|||
131162057|NCT00771030|472215965|FG001|Overall Study|Adverse Event|1|||
131162058|NCT00771030|472215966|FG002|Overall Study|Adverse Event|0|||
131162059|NCT00771030|472215967|FG003|Overall Study|Adverse Event|0|||
131162060|NCT00771030|472215968|FG004|Overall Study|Adverse Event|0|||
131162061|NCT00771030|472215969|FG005|Overall Study|Adverse Event|0|||
131162062|NCT00771030|472215970|FG006|Overall Study|Adverse Event|0|||
131162063|NCT02416908|472215976|FG000|Dose Escalation Phase|Adverse Event|0|||
131162064|NCT02416908|472215977|FG001|Dose Escalation Phase|Adverse Event|0|||
131162065|NCT02416908|472215978|FG002|Dose Escalation Phase|Adverse Event|3|||
131162066|NCT02416908|472215979|FG003|Dose Escalation Phase|Adverse Event|0|||
131162067|NCT02416908|472215976|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
131162068|NCT02416908|472215977|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
131162069|NCT02416908|472215978|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
131162070|NCT02416908|472215979|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131162071|NCT00940342|472215982|FG000|Overall Study|Adverse Event|0|||
131162072|NCT00940342|472215983|FG001|Overall Study|Adverse Event|2|||
131162073|NCT00940342|472215984|FG002|Overall Study|Adverse Event|1|||
131162074|NCT03792750|472215986|FG000|Overall Study|Death|3|||
131162075|NCT01172288|472215987|FG000|Overall Study|Adverse Event|1|||
131162076|NCT01172288|472215988|FG001|Overall Study|Adverse Event|0|||
131162077|NCT01172288|472215987|FG000|Overall Study|Protocol Violation|0|||
131162078|NCT01172288|472215988|FG001|Overall Study|Protocol Violation|1|||
131162079|NCT02902809|472215991|FG000|Overall Study|Discontinuation of asthma program|28|||
131162080|NCT00532259|472215992|FG000|Overall Study|Withdrawal by Subject|2|||
131162081|NCT00532259|472215992|FG000|Overall Study|Adverse Event|1|||
131162082|NCT00532259|472215992|FG000|Overall Study|Death|1|||
131162083|NCT00532259|472215992|FG000|Overall Study|Lack of Efficacy|21|||
131162084|NCT00532259|472215992|FG000|Overall Study|Lost to Follow-up|3|||
131162085|NCT00532259|472215992|FG000|Overall Study|Physician Decision|3|||
131162086|NCT00532259|472215992|FG000|Overall Study|Protocol Violation|1|||
131162087|NCT00793104|472215993|FG000|Overall Study|Lost to Follow-up|1|||
131162088|NCT00700752|472215996|FG000|First Intervention|Withdrawal by Subject|0|||
131162089|NCT00700752|472215997|FG001|First Intervention|Withdrawal by Subject|2|||
131162090|NCT01302769|472215998|FG000|Overall Study|Lost to Follow-up|1|||
131162091|NCT01302769|472215999|FG001|Overall Study|Lost to Follow-up|1|||
131162092|NCT04983940|472216000|FG000|Overall Study|Lost to Follow-up|14|||
131162093|NCT04983940|472216000|FG000|Overall Study|Lack of Efficacy|2|||
131162094|NCT01645930|472216001|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
131162095|NCT01645930|472216001|FG000|Overall Study|Progressive Disease|12|||
131162096|NCT01645930|472216001|FG000|Overall Study|Adverse Event|4|||
131162097|NCT01645930|472216001|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
131162098|NCT01645930|472216001|FG000|Overall Study|Withdrawal by Participant|2|||
131162099|NCT01645930|472216001|FG000|Overall Study|Reason not Defined|1|||
131162100|NCT02522377|472216002|FG000|Overall Study|Withdrawal by Subject|1|||
131162101|NCT02522377|472216003|FG001|Overall Study|Withdrawal by Subject|0|||
131162102|NCT02522377|472216002|FG000|Overall Study|Remission Achieved|3|||
131162103|NCT02522377|472216003|FG001|Overall Study|Remission Achieved|0|||
131162104|NCT02263365|472216007|FG000|Overall Study|Physician Decision|22|||
131162105|NCT02263365|472216008|FG001|Overall Study|Physician Decision|18|||
131162106|NCT01797432|472216012|FG000|Overall Study|Lost to Follow-up|1|||
131162107|NCT01797432|472216012|FG000|Overall Study|Adverse Event|1|||
131162108|NCT01797432|472216012|FG000|Overall Study|Withdrawal by Subject|1|||
131162109|NCT01797432|472216012|FG000|Overall Study|lived too far from study site|1|||
131162110|NCT00734929|472216014|FG000|Overall Study|Lost to Follow-up|1|||
131162111|NCT00734929|472216015|FG001|Overall Study|Lost to Follow-up|2|||
131162112|NCT00734929|472216014|FG000|Overall Study|No intervention/ screen fail|5|||
131162113|NCT00734929|472216015|FG001|Overall Study|No intervention/ screen fail|3|||
131162114|NCT03176966|472216019|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
131162115|NCT03176966|472216020|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
131162116|NCT03176966|472216019|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
131162117|NCT03176966|472216020|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
131162118|NCT03176966|472216019|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
131162119|NCT03176966|472216020|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
131162120|NCT03176966|472216019|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
131162121|NCT03176966|472216020|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
131162122|NCT03176966|472216019|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
131162123|NCT03176966|472216020|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
131162124|NCT03176966|472216019|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
131162125|NCT03176966|472216020|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
131162126|NCT03176966|472216019|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
131162127|NCT03176966|472216020|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
131162128|NCT01696877|472216021|FG000|Overall Study|Adverse Event|0|||
131162129|NCT01696877|472216022|FG001|Overall Study|Adverse Event|1|||
131162130|NCT00469014|472216023|FG000|Initial Phase Randomization|Disease Progression|0|||
131162131|NCT00469014|472216024|FG001|Initial Phase Randomization|Disease Progression|1|||
131235462|NCT00436007|472490935|FG002|Overall Study|Withdrawal by Subject|4|||
131235463|NCT00436007|472490933|FG000|Overall Study|Lost to Follow-up|14|||
131235464|NCT00436007|472490934|FG001|Overall Study|Lost to Follow-up|10|||
131162132|NCT00469014|472216025|FG002|Initial Phase Randomization|Disease Progression|1|||
131162133|NCT00469014|472216026|FG003|Initial Phase Randomization|Disease Progression|0|||
131162134|NCT00469014|472216023|FG000|Initial Phase Randomization|No Response|1|||
131162135|NCT00469014|472216024|FG001|Initial Phase Randomization|No Response|0|||
131162136|NCT00469014|472216025|FG002|Initial Phase Randomization|No Response|0|||
131162137|NCT00469014|472216026|FG003|Initial Phase Randomization|No Response|1|||
131162138|NCT00469014|472216023|FG000|Adaptive Randomization|Not Evaluable|1|||
131162139|NCT00469014|472216024|FG001|Adaptive Randomization|Not Evaluable|0|||
131162140|NCT00469014|472216025|FG002|Adaptive Randomization|Not Evaluable|0|||
131162141|NCT00469014|472216026|FG003|Adaptive Randomization|Not Evaluable|1|||
131162142|NCT00469014|472216023|FG000|Adaptive Randomization|No Response|0|||
131162143|NCT00469014|472216024|FG001|Adaptive Randomization|No Response|1|||
131162144|NCT00469014|472216025|FG002|Adaptive Randomization|No Response|0|||
131162145|NCT00469014|472216026|FG003|Adaptive Randomization|No Response|0|||
131162146|NCT00469014|472216023|FG000|Adaptive Randomization|Death|0|||
131162147|NCT00469014|472216024|FG001|Adaptive Randomization|Death|0|||
131162148|NCT00469014|472216025|FG002|Adaptive Randomization|Death|1|||
131162149|NCT00469014|472216026|FG003|Adaptive Randomization|Death|0|||
131162150|NCT00866294|472216027|FG000|Overall Study|Adverse Event|12|||
131162151|NCT00866294|472216028|FG001|Overall Study|Adverse Event|13|||
131162152|NCT00866294|472216029|FG002|Overall Study|Adverse Event|9|||
131162153|NCT00866294|472216027|FG000|Overall Study|Lack of Efficacy|7|||
131162154|NCT00866294|472216028|FG001|Overall Study|Lack of Efficacy|1|||
131162155|NCT00866294|472216029|FG002|Overall Study|Lack of Efficacy|0|||
131162156|NCT00866294|472216027|FG000|Overall Study|Protocol Violation|2|||
131162157|NCT00866294|472216028|FG001|Overall Study|Protocol Violation|0|||
131162158|NCT00866294|472216029|FG002|Overall Study|Protocol Violation|0|||
131162159|NCT00866294|472216027|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
131162160|NCT00866294|472216028|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131162161|NCT00866294|472216029|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
131162162|NCT00866294|472216027|FG000|Overall Study|Lost to Follow-up|1|||
131162163|NCT00866294|472216028|FG001|Overall Study|Lost to Follow-up|3|||
131162164|NCT00866294|472216029|FG002|Overall Study|Lost to Follow-up|0|||
131162165|NCT00866294|472216027|FG000|Overall Study|Physician Decision|6|||
131162166|NCT00866294|472216028|FG001|Overall Study|Physician Decision|2|||
131162167|NCT00866294|472216029|FG002|Overall Study|Physician Decision|1|||
131162168|NCT01903434|472216033|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
131162169|NCT01903434|472216034|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
131162170|NCT01903434|472216033|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
131162171|NCT01903434|472216034|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
131235465|NCT00436007|472490935|FG002|Overall Study|Lost to Follow-up|13|||
131235466|NCT00436007|472490933|FG000|Overall Study|Physician Decision|0|||
131235467|NCT00436007|472490934|FG001|Overall Study|Physician Decision|0|||
131235468|NCT00436007|472490935|FG002|Overall Study|Physician Decision|2|||
130729128|NCT01762800|470630521|FG000|Overall Study|Physician Decision|1|||
131162172|NCT01781026|472216038|FG000|Overall Study|Lack of Efficacy|2|||
131162173|NCT05270694|472217247|FG000|Overall Study|Death|1|||
131162174|NCT05270694|472217247|FG000|Overall Study|Medical issues impacted ability to participate|2|||
131162175|NCT05270694|472217247|FG000|Overall Study|Lost to Follow-up|3|||
131162176|NCT05270694|472217247|FG000|Overall Study|Withdrawal by Subject|3|||
131162179|NCT01240811|472217249|FG000|Overall Study|Physician Decision|0|||
131162180|NCT01240811|472217250|FG001|Overall Study|Physician Decision|1|||
131162181|NCT01240811|472217251|FG002|Overall Study|Physician Decision|0|||
131162182|NCT01240811|472217249|FG000|Overall Study|Withdrawal by Subject|0|||
131162183|NCT01240811|472217250|FG001|Overall Study|Withdrawal by Subject|0|||
131162184|NCT01240811|472217251|FG002|Overall Study|Withdrawal by Subject|1|||
131162185|NCT01543490|472217254|FG000|Overall Study|Adverse Event|4|||
131162186|NCT01543490|472217255|FG001|Overall Study|Adverse Event|0|||
131162187|NCT01543490|472217254|FG000|Overall Study|Physician Decision|1|||
130729129|NCT01762800|470630522|FG001|Overall Study|Physician Decision|1|||
130729130|NCT01762800|470630521|FG000|Overall Study|Withdrawal by Subject|7|||
131162188|NCT01543490|472217255|FG001|Overall Study|Physician Decision|0|||
131162189|NCT01543490|472217254|FG000|Overall Study|Lack of Efficacy|3|||
131162190|NCT01543490|472217255|FG001|Overall Study|Lack of Efficacy|3|||
131162191|NCT01543490|472217254|FG000|Overall Study|Lost to Follow-up|5|||
131162192|NCT01543490|472217255|FG001|Overall Study|Lost to Follow-up|0|||
131162193|NCT01543490|472217254|FG000|Overall Study|Withdrawal by Subject|2|||
131162194|NCT01543490|472217255|FG001|Overall Study|Withdrawal by Subject|0|||
131162195|NCT01543490|472217254|FG000|Overall Study|Other-Various Administrative Reasons|1|||
131162196|NCT01543490|472217255|FG001|Overall Study|Other-Various Administrative Reasons|2|||
131162197|NCT03918642|472217258|FG000|Overall Study|Lost to Follow-up|12|||
131162198|NCT03918642|472217259|FG001|Overall Study|Lost to Follow-up|10|||
130780620|NCT01165307|470823127|FG001|Overall Study|Lost to Follow-up|3|||
131162199|NCT03825042|472217260|FG000|Overall Study|Adverse Event|1|||
131235469|NCT00436007|472490933|FG000|Overall Study|Death|0|||
131162200|NCT03825042|472217261|FG001|Overall Study|Adverse Event|0|||
131162201|NCT03825042|472217260|FG000|Overall Study|Withdrawal by Subject|1|||
131162202|NCT03825042|472217261|FG001|Overall Study|Withdrawal by Subject|0|||
131162203|NCT01988012|472217269|FG000|Overall Study|Adverse Event|5|||
131162204|NCT01988012|472217269|FG000|Overall Study|Insufficient Therapeutic Response|3|||
131162205|NCT01988012|472217269|FG000|Overall Study|Patient Withdrawal of Consent|4|||
131162206|NCT01988012|472217269|FG000|Overall Study|Lost to Follow-up|1|||
131162207|NCT01988012|472217269|FG000|Overall Study|Physician Decision|1|||
131162208|NCT01988012|472217269|FG000|Overall Study|Protocol Violation|1|||
131162209|NCT01228071|472217270|FG000|Overall Study|Protocol Violation|1|||
131162210|NCT01228071|472217270|FG000|Overall Study|Withdrawal by Subject|1|||
131162211|NCT00553059|472217271|FG000|Overall Study|Deemed ineligible|1|||
131162212|NCT00553059|472217272|FG001|Overall Study|Deemed ineligible|1|||
131162213|NCT00553059|472217271|FG000|Overall Study|Drug supply not available|0|||
131162214|NCT00553059|472217272|FG001|Overall Study|Drug supply not available|1|||
131162215|NCT00859898|472217274|FG000|Overall Study|Lack of Efficacy|0|||
131162216|NCT00859898|472217275|FG001|Overall Study|Lack of Efficacy|1|||
131162217|NCT00859898|472217276|FG002|Overall Study|Lack of Efficacy|1|||
131162218|NCT00859898|472217274|FG000|Overall Study|Adverse Event|4|||
131162219|NCT00859898|472217275|FG001|Overall Study|Adverse Event|9|||
131162220|NCT00859898|472217276|FG002|Overall Study|Adverse Event|8|||
131162221|NCT00859898|472217274|FG000|Overall Study|Withdrawal by Subject|11|||
131162222|NCT00859898|472217275|FG001|Overall Study|Withdrawal by Subject|8|||
131162223|NCT00859898|472217276|FG002|Overall Study|Withdrawal by Subject|11|||
131162224|NCT00859898|472217274|FG000|Overall Study|Death|0|||
131162225|NCT00859898|472217275|FG001|Overall Study|Death|0|||
131162226|NCT00859898|472217276|FG002|Overall Study|Death|1|||
131162227|NCT00859898|472217274|FG000|Overall Study|Lost to Follow-up|10|||
131162228|NCT00859898|472217275|FG001|Overall Study|Lost to Follow-up|11|||
131162229|NCT00859898|472217276|FG002|Overall Study|Lost to Follow-up|5|||
131162230|NCT00859898|472217274|FG000|Overall Study|poor/non-compliance|2|||
131162231|NCT00859898|472217275|FG001|Overall Study|poor/non-compliance|0|||
131162232|NCT00859898|472217276|FG002|Overall Study|poor/non-compliance|0|||
131162233|NCT00859898|472217274|FG000|Overall Study|No longer meets criteria|0|||
131162234|NCT00859898|472217275|FG001|Overall Study|No longer meets criteria|1|||
131162235|NCT00859898|472217276|FG002|Overall Study|No longer meets criteria|0|||
131162236|NCT00859898|472217274|FG000|Overall Study|non-specified|1|||
131162237|NCT00859898|472217275|FG001|Overall Study|non-specified|1|||
131162238|NCT00859898|472217276|FG002|Overall Study|non-specified|1|||
131162239|NCT01302041|472217277|FG000|Overall Study|Death|5|||
131162240|NCT01302041|472217277|FG000|Overall Study|Withdrawal by Subject|4|||
131162241|NCT01302041|472217277|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
131162242|NCT01302041|472217277|FG000|Overall Study|Other-Miscellaneous Reason|2|||
131162243|NCT04504032|472217280|FG000|Overall Study|Adverse Event|1|||
131162244|NCT04504032|472217281|FG001|Overall Study|Adverse Event|2|||
131162245|NCT04504032|472217280|FG000|Overall Study|Lost to Follow-up|6|||
131162246|NCT04504032|472217281|FG001|Overall Study|Lost to Follow-up|9|||
131162247|NCT04504032|472217280|FG000|Overall Study|Protocol Violation|2|||
131162248|NCT04504032|472217281|FG001|Overall Study|Protocol Violation|0|||
131162249|NCT04504032|472217280|FG000|Overall Study|Study terminated by sponsor|1|||
131162250|NCT04504032|472217281|FG001|Overall Study|Study terminated by sponsor|2|||
131162251|NCT04504032|472217280|FG000|Overall Study|Withdrawal by Subject|9|||
131162252|NCT04504032|472217281|FG001|Overall Study|Withdrawal by Subject|11|||
131162253|NCT04504032|472217280|FG000|Overall Study|Disease progression prior to dosing|15|||
131162254|NCT04504032|472217281|FG001|Overall Study|Disease progression prior to dosing|3|||
131162255|NCT04504032|472217280|FG000|Overall Study|Drug supply issues|1|||
131162256|NCT04504032|472217281|FG001|Overall Study|Drug supply issues|1|||
131162257|NCT04504032|472217280|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
131162258|NCT04504032|472217281|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
131162259|NCT05232097|472217292|FG000|Overall Study|Physician Decision|1|||
131162260|NCT01327339|472217293|FG000|Overall Study|Protocol Violation|8|||
131162261|NCT03662334|472217296|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
131162262|NCT03662334|472217297|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
131162263|NCT01158950|472217299|FG000|1st Intervention (1 Day)|Physician Decision|1|||
131162264|NCT01158950|472217300|FG001|1st Intervention (1 Day)|Physician Decision|2|||
131162265|NCT00510692|472217302|FG000|Overall Study|Adverse Event|1|||
131162266|NCT00510692|472217303|FG001|Overall Study|Adverse Event|3|||
131162267|NCT00510692|472217302|FG000|Overall Study|Withdrawal by Subject|1|||
131162268|NCT00510692|472217303|FG001|Overall Study|Withdrawal by Subject|0|||
131162269|NCT01845077|472217304|FG000|Washout Period|Lost to Follow-up|0|||
131162270|NCT01845077|472217305|FG001|Washout Period|Lost to Follow-up|1|||
131162271|NCT01845077|472217306|FG002|Washout Period|Lost to Follow-up|0|||
131162272|NCT01845077|472217307|FG003|Washout Period|Lost to Follow-up|1|||
131162273|NCT01845077|472217308|FG004|Washout Period|Lost to Follow-up|0|||
131162274|NCT01845077|472217309|FG005|Washout Period|Lost to Follow-up|1|||
131162275|NCT01845077|472217304|FG000|Washout Period|Adverse Event|1|||
131162276|NCT01845077|472217305|FG001|Washout Period|Adverse Event|0|||
131162277|NCT01845077|472217306|FG002|Washout Period|Adverse Event|0|||
131162278|NCT01845077|472217307|FG003|Washout Period|Adverse Event|0|||
131162279|NCT01845077|472217308|FG004|Washout Period|Adverse Event|0|||
131162280|NCT01845077|472217309|FG005|Washout Period|Adverse Event|0|||
131162281|NCT01845077|472217304|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
131162282|NCT01845077|472217305|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
131162283|NCT01845077|472217306|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
131162284|NCT01845077|472217307|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
131162285|NCT01845077|472217308|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
131162286|NCT01845077|472217309|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
131162287|NCT01845077|472217304|FG000|Washout Period|Protocol Violation|0|||
131162288|NCT01845077|472217305|FG001|Washout Period|Protocol Violation|0|||
131162289|NCT01845077|472217306|FG002|Washout Period|Protocol Violation|0|||
131162290|NCT01845077|472217307|FG003|Washout Period|Protocol Violation|1|||
131162291|NCT01845077|472217308|FG004|Washout Period|Protocol Violation|1|||
131162292|NCT01845077|472217309|FG005|Washout Period|Protocol Violation|0|||
131162293|NCT01137435|472217313|FG000|Overall Study|Lost to Follow-up|24|||
131162294|NCT01137435|472217313|FG000|Overall Study|Off label usage|4|||
131162295|NCT00642616|472217316|FG000|Overall Study|Adverse Event|2|||
131162296|NCT00642616|472217317|FG001|Overall Study|Adverse Event|0|||
131162297|NCT00642616|472217318|FG002|Overall Study|Adverse Event|1|||
131162298|NCT00642616|472217319|FG003|Overall Study|Adverse Event|0|||
131162299|NCT00642616|472217316|FG000|Overall Study|Study Terminated by Sponsor|7|||
131162300|NCT00642616|472217317|FG001|Overall Study|Study Terminated by Sponsor|6|||
131162301|NCT00642616|472217318|FG002|Overall Study|Study Terminated by Sponsor|4|||
131162302|NCT00642616|472217319|FG003|Overall Study|Study Terminated by Sponsor|5|||
131162303|NCT00642616|472217316|FG000|Overall Study|Withdrawal by Subject|0|||
131162304|NCT00642616|472217317|FG001|Overall Study|Withdrawal by Subject|1|||
131162305|NCT00642616|472217318|FG002|Overall Study|Withdrawal by Subject|1|||
131162306|NCT00642616|472217319|FG003|Overall Study|Withdrawal by Subject|1|||
131162307|NCT00642616|472217316|FG000|Overall Study|Protocol Violation|0|||
131162308|NCT00642616|472217317|FG001|Overall Study|Protocol Violation|0|||
131162309|NCT00642616|472217318|FG002|Overall Study|Protocol Violation|2|||
131162310|NCT00642616|472217319|FG003|Overall Study|Protocol Violation|0|||
131162311|NCT00642616|472217316|FG000|Overall Study|Physician Decision|0|||
131162312|NCT00642616|472217317|FG001|Overall Study|Physician Decision|0|||
131162313|NCT00642616|472217318|FG002|Overall Study|Physician Decision|1|||
131162314|NCT00642616|472217319|FG003|Overall Study|Physician Decision|1|||
131162315|NCT00492921|472217320|FG000|Overall Study|Death|1|||
131162316|NCT00492921|472217321|FG001|Overall Study|Death|0|||
131162317|NCT00492921|472217322|FG002|Overall Study|Death|1|||
131162318|NCT00399802|472217323|FG000|Overall Study|Adverse Event|0|||
131162319|NCT00399802|472217324|FG001|Overall Study|Adverse Event|2|||
131162320|NCT00399802|472217323|FG000|Overall Study|Participant discontinued by mistake|0|||
131162321|NCT00399802|472217324|FG001|Overall Study|Participant discontinued by mistake|1|||
131162322|NCT00542815|472217325|FG000|Overall Study|Adverse Event|19|||
131162323|NCT00542815|472217326|FG001|Overall Study|Adverse Event|6|||
131162324|NCT00542815|472217327|FG002|Overall Study|Adverse Event|9|||
131162325|NCT00542815|472217325|FG000|Overall Study|Death|10|||
131162326|NCT00542815|472217326|FG001|Overall Study|Death|7|||
131162327|NCT00542815|472217327|FG002|Overall Study|Death|3|||
131162328|NCT00542815|472217325|FG000|Overall Study|Lack of Efficacy|9|||
131162329|NCT00542815|472217326|FG001|Overall Study|Lack of Efficacy|2|||
131162330|NCT00542815|472217327|FG002|Overall Study|Lack of Efficacy|0|||
131162331|NCT00542815|472217325|FG000|Overall Study|Physician Decision|2|||
131162332|NCT00542815|472217326|FG001|Overall Study|Physician Decision|1|||
131162333|NCT00542815|472217327|FG002|Overall Study|Physician Decision|0|||
131162334|NCT00542815|472217325|FG000|Overall Study|Protocol Violation|1|||
131162335|NCT00542815|472217326|FG001|Overall Study|Protocol Violation|1|||
131162336|NCT00542815|472217327|FG002|Overall Study|Protocol Violation|2|||
131162337|NCT00542815|472217325|FG000|Overall Study|Withdrawal by Subject|41|||
131162338|NCT00542815|472217326|FG001|Overall Study|Withdrawal by Subject|5|||
131162339|NCT00542815|472217327|FG002|Overall Study|Withdrawal by Subject|8|||
131162340|NCT00542815|472217325|FG000|Overall Study|Other reasons|24|||
131162341|NCT00542815|472217326|FG001|Overall Study|Other reasons|10|||
131162342|NCT00542815|472217327|FG002|Overall Study|Other reasons|10|||
131162343|NCT01520922|472217328|FG000|Treatment Phase|Physician Decision|2|||
131162344|NCT01520922|472217329|FG001|Treatment Phase|Physician Decision|1|||
131162345|NCT01520922|472217328|FG000|Treatment Phase|Progression|0|||
131162346|NCT01520922|472217329|FG001|Treatment Phase|Progression|2|||
131162347|NCT01520922|472217328|FG000|Treatment Phase|Adverse Event|3|||
131162348|NCT01520922|472217329|FG001|Treatment Phase|Adverse Event|5|||
131162349|NCT01520922|472217328|FG000|Follow up|Lost to Follow-up|0|||
131162350|NCT01520922|472217329|FG001|Follow up|Lost to Follow-up|1|||
131162351|NCT01520922|472217328|FG000|Survival Follow-up|Withdrawal by Subject|1|||
131162352|NCT01520922|472217329|FG001|Survival Follow-up|Withdrawal by Subject|0|||
131162353|NCT02955186|472217330|FG000|Overall Study|Withdrawal by Subject|6|||
131162354|NCT02955186|472217331|FG001|Overall Study|Withdrawal by Subject|2|||
131162355|NCT02955186|472217330|FG000|Overall Study|Protocol Violation|1|||
131162356|NCT02955186|472217331|FG001|Overall Study|Protocol Violation|0|||
131162357|NCT04770155|472217336|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131162358|NCT04770155|472217337|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131162359|NCT04770155|472217338|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131162360|NCT04770155|472217339|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131162361|NCT04770155|472217340|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131162362|NCT04770155|472217341|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131162363|NCT04770155|472217342|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131162364|NCT04770155|472217343|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
131162365|NCT03461289|472217345|FG000|Overall Study|Death|1|||
131162366|NCT01632878|472217346|FG000|Screening|Physician Decision|268|||
131162367|NCT01632878|472217346|FG000|Treatment|Lost to Follow-up|41|||
131162368|NCT01632878|472217346|FG000|Treatment|Withdrawal by Subject|36|||
131162369|NCT01632878|472217346|FG000|Treatment|Physician Decision|34|||
131162370|NCT01632878|472217346|FG000|Treatment|missing information|4|||
131162371|NCT01632878|472217346|FG000|Treatment|no information on study completion|43|||
131162372|NCT00081289|472217347|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
131162373|NCT00081289|472217348|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
131162374|NCT00081289|472217347|FG000|Overall Study|Ineligible / no protocol treatment|3|||
131162375|NCT00081289|472217348|FG001|Overall Study|Ineligible / no protocol treatment|4|||
131162376|NCT02749370|472217349|FG000|Overall Study|Withdrawal by Subject|11|||
131162377|NCT02749370|472217349|FG000|Overall Study|Lost to Follow-up|3|||
131162378|NCT03242759|472217350|FG000|Overall Study|Adverse Event|5|||
131162379|NCT03242759|472217351|FG001|Overall Study|Adverse Event|1|||
131162380|NCT03242759|472217350|FG000|Overall Study|Withdrawal by Subject|4|||
131162381|NCT03242759|472217351|FG001|Overall Study|Withdrawal by Subject|3|||
131162382|NCT03242759|472217350|FG000|Overall Study|Lost to Follow-up|3|||
131162383|NCT03242759|472217351|FG001|Overall Study|Lost to Follow-up|1|||
131162384|NCT03242759|472217350|FG000|Overall Study|Administrative problems|1|||
131162385|NCT03242759|472217351|FG001|Overall Study|Administrative problems|1|||
131162386|NCT03242759|472217350|FG000|Overall Study|Death|22|||
131162387|NCT03242759|472217351|FG001|Overall Study|Death|0|||
131162388|NCT03242759|472217350|FG000|Overall Study|Change visit schedule|0|||
131162389|NCT03242759|472217351|FG001|Overall Study|Change visit schedule|1|||
131162390|NCT02522481|472217356|FG000|Overall Study|discontinued|1|||
131162391|NCT02522481|472217356|FG000|Overall Study|Not dosed|2|||
131162392|NCT00404768|472217359|FG000|Part A and B|Withdrawn due to labor progression|1|||
131162393|NCT00404768|472217360|FG001|Part A and B|Withdrawn due to labor progression|0|||
131162394|NCT00404768|472217361|FG002|Part A and B|Withdrawn due to labor progression|0|||
131162395|NCT00404768|472217362|FG003|Part A and B|Withdrawn due to labor progression|0|||
131162396|NCT00404768|472217359|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
131162397|NCT00404768|472217360|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
131162398|NCT00404768|472217361|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
131162399|NCT00404768|472217362|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
131162400|NCT00404768|472217359|FG000|Part C|Adverse Event|0|||
131162401|NCT00404768|472217360|FG001|Part C|Adverse Event|0|||
131162402|NCT00404768|472217361|FG002|Part C|Adverse Event|0|||
131162403|NCT00404768|472217362|FG003|Part C|Adverse Event|3|||
131162404|NCT00404768|472217359|FG000|Part C|Lost to Follow-up|0|||
131162405|NCT00404768|472217360|FG001|Part C|Lost to Follow-up|0|||
131162406|NCT00404768|472217361|FG002|Part C|Lost to Follow-up|3|||
131162407|NCT00404768|472217362|FG003|Part C|Lost to Follow-up|1|||
131162408|NCT00404768|472217359|FG000|Part C|Withdrawal by Subject|0|||
131162409|NCT00404768|472217360|FG001|Part C|Withdrawal by Subject|0|||
131162410|NCT00404768|472217361|FG002|Part C|Withdrawal by Subject|2|||
131162411|NCT00404768|472217362|FG003|Part C|Withdrawal by Subject|1|||
131162412|NCT00404768|472217359|FG000|Part C|Early withdrawal from study medication|0|||
131162413|NCT00404768|472217360|FG001|Part C|Early withdrawal from study medication|0|||
131162414|NCT00404768|472217361|FG002|Part C|Early withdrawal from study medication|1|||
131162415|NCT00404768|472217362|FG003|Part C|Early withdrawal from study medication|0|||
131162416|NCT00404768|472217359|FG000|Part C|Participant did not respond to therapy|0|||
131162417|NCT00404768|472217360|FG001|Part C|Participant did not respond to therapy|0|||
131162418|NCT00404768|472217361|FG002|Part C|Participant did not respond to therapy|1|||
131162419|NCT00404768|472217362|FG003|Part C|Participant did not respond to therapy|1|||
131162420|NCT00404768|472217359|FG000|Part C|Physician withdrew the study medication|0|||
131162421|NCT00404768|472217360|FG001|Part C|Physician withdrew the study medication|0|||
131162422|NCT00404768|472217361|FG002|Part C|Physician withdrew the study medication|1|||
131162423|NCT00404768|472217362|FG003|Part C|Physician withdrew the study medication|0|||
131162424|NCT00404768|472217359|FG000|Part C|Participant delivered baby|0|||
131162425|NCT00404768|472217360|FG001|Part C|Participant delivered baby|0|||
131162426|NCT00404768|472217361|FG002|Part C|Participant delivered baby|0|||
131162427|NCT00404768|472217362|FG003|Part C|Participant delivered baby|1|||
131162428|NCT00404768|472217359|FG000|Part C|Unsatisfactory uterine response to IP|0|||
131162429|NCT00404768|472217360|FG001|Part C|Unsatisfactory uterine response to IP|0|||
131162430|NCT00404768|472217361|FG002|Part C|Unsatisfactory uterine response to IP|0|||
131162431|NCT00404768|472217362|FG003|Part C|Unsatisfactory uterine response to IP|1|||
131162432|NCT00404768|472217359|FG000|Part C|Active labor|0|||
131162433|NCT00404768|472217360|FG001|Part C|Active labor|0|||
131162434|NCT00404768|472217361|FG002|Part C|Active labor|0|||
131162435|NCT00404768|472217362|FG003|Part C|Active labor|1|||
131162436|NCT00404768|472217359|FG000|Part C|Lack of Efficacy|0|||
131162437|NCT00404768|472217360|FG001|Part C|Lack of Efficacy|0|||
131162438|NCT00404768|472217361|FG002|Part C|Lack of Efficacy|0|||
131162439|NCT00404768|472217362|FG003|Part C|Lack of Efficacy|2|||
131162440|NCT00404768|472217359|FG000|Part C|Treatment failure|0|||
131162441|NCT00404768|472217360|FG001|Part C|Treatment failure|0|||
131162442|NCT00404768|472217361|FG002|Part C|Treatment failure|0|||
131162443|NCT00404768|472217362|FG003|Part C|Treatment failure|1|||
131162444|NCT00404768|472217359|FG000|Part C|Investigator discretion|0|||
131162445|NCT00404768|472217360|FG001|Part C|Investigator discretion|0|||
131162446|NCT00404768|472217361|FG002|Part C|Investigator discretion|0|||
131162447|NCT00404768|472217362|FG003|Part C|Investigator discretion|1|||
131162448|NCT00404768|472217359|FG000|Part C|Researcher suspended study medication|0|||
131162449|NCT00404768|472217360|FG001|Part C|Researcher suspended study medication|0|||
131162450|NCT00404768|472217361|FG002|Part C|Researcher suspended study medication|0|||
131162451|NCT00404768|472217362|FG003|Part C|Researcher suspended study medication|1|||
131162452|NCT03123939|472217363|FG000|Overall Study|Lack of Efficacy|6|||
131162453|NCT03123939|472217363|FG000|Overall Study|Death|5|||
131162454|NCT03123939|472217363|FG000|Overall Study|Physician Decision|2|||
131162455|NCT03123939|472217363|FG000|Overall Study|Subject/guardian decision|2|||
131162456|NCT03123939|472217363|FG000|Overall Study|Lost to Follow-up|1|||
131162457|NCT03123939|472217363|FG000|Overall Study|New therapy for study indication|1|||
131162458|NCT03123939|472217363|FG000|Overall Study|Protocol deviation|1|||
131162459|NCT03123939|472217363|FG000|Overall Study|Progressive disease|18|||
131162460|NCT03123939|472217363|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
131162461|NCT03123939|472217363|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
131162462|NCT04773041|472217364|FG000|Overall Study|Unable to data match|1|||
131162463|NCT04773041|472217365|FG001|Overall Study|Unable to data match|0|||
131162464|NCT04773041|472217366|FG002|Overall Study|Unable to data match|0|||
131162465|NCT01118143|472217367|FG000|Overall Study|Withdrawal by Subject|2|||
131162466|NCT01118143|472217368|FG001|Overall Study|Withdrawal by Subject|5|||
131162467|NCT02112448|472217369|FG000|Overall Study|lab values precluding use of ketorolac|2|||
131162468|NCT02112448|472217370|FG001|Overall Study|lab values precluding use of ketorolac|2|||
131162469|NCT02112448|472217369|FG000|Overall Study|Protocol Violation|1|||
131162470|NCT02112448|472217370|FG001|Overall Study|Protocol Violation|2|||
131162471|NCT02112448|472217369|FG000|Overall Study|Physician Decision|4|||
131162472|NCT02112448|472217370|FG001|Overall Study|Physician Decision|6|||
131162473|NCT02112448|472217369|FG000|Overall Study|required heparin so could not use ketoro|1|||
131162474|NCT02112448|472217370|FG001|Overall Study|required heparin so could not use ketoro|0|||
131162475|NCT02100657|472219014|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
131162476|NCT02100657|472219015|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
131162477|NCT02100657|472219016|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
131162478|NCT02100657|472219014|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
131162479|NCT02100657|472219015|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
131162480|NCT02100657|472219016|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
131162481|NCT02100657|472219014|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
131162482|NCT02100657|472219015|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
131162483|NCT02100657|472219016|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
131162484|NCT02100657|472219014|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
131162485|NCT02100657|472219015|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
130729131|NCT01762800|470630522|FG001|Overall Study|Withdrawal by Subject|4|||
131162486|NCT02100657|472219016|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
131162487|NCT02100657|472219014|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
131162488|NCT02100657|472219015|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
131162489|NCT02100657|472219016|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
131162490|NCT02100657|472219014|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
131162491|NCT02100657|472219015|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
130729132|NCT02640482|470630524|FG000|Overall Study|Lost to Follow-up|3|||
131162492|NCT02100657|472219016|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
131162493|NCT02100657|472219014|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
131162494|NCT02100657|472219015|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
131162495|NCT02100657|472219016|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
131162496|NCT02100657|472219014|FG000|Cohort 3: Dose Level 3|Death|0|||
131162497|NCT02100657|472219015|FG001|Cohort 3: Dose Level 3|Death|0|||
131162498|NCT02100657|472219016|FG002|Cohort 3: Dose Level 3|Death|1|||
131162499|NCT02100657|472219014|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
131235470|NCT00436007|472490934|FG001|Overall Study|Death|1|||
131235471|NCT00436007|472490935|FG002|Overall Study|Death|3|||
131162500|NCT02100657|472219015|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
131162501|NCT02100657|472219016|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
131162502|NCT02100657|472219014|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
131162503|NCT02100657|472219015|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
131162504|NCT02100657|472219016|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
131162505|NCT02100657|472219014|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
131162506|NCT02100657|472219015|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
131162507|NCT02100657|472219016|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
131162508|NCT02100657|472219014|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
131162509|NCT02100657|472219015|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
131162510|NCT02100657|472219016|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
131162511|NCT02100657|472219014|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
131162512|NCT02100657|472219015|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
131162513|NCT02100657|472219016|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
131162514|NCT04168645|472219018|FG000|Overall Study|Lost to Follow-up|23|||
131162515|NCT04168645|472219019|FG001|Overall Study|Lost to Follow-up|28|||
131162516|NCT04168645|472219020|FG002|Overall Study|Lost to Follow-up|15|||
131162517|NCT04168645|472219021|FG003|Overall Study|Lost to Follow-up|12|||
131162518|NCT04168645|472219018|FG000|Overall Study|Death|1|||
131162519|NCT04168645|472219019|FG001|Overall Study|Death|1|||
131162520|NCT04168645|472219020|FG002|Overall Study|Death|0|||
131162521|NCT04168645|472219021|FG003|Overall Study|Death|0|||
131162522|NCT04168645|472219018|FG000|Overall Study|Withdrawal by Subject|5|||
131162523|NCT04168645|472219019|FG001|Overall Study|Withdrawal by Subject|2|||
131162524|NCT04168645|472219020|FG002|Overall Study|Withdrawal by Subject|2|||
131162525|NCT04168645|472219021|FG003|Overall Study|Withdrawal by Subject|2|||
131162526|NCT04168645|472219018|FG000|Overall Study|Administrative Withdrawal|3|||
131162527|NCT04168645|472219019|FG001|Overall Study|Administrative Withdrawal|1|||
131162528|NCT04168645|472219020|FG002|Overall Study|Administrative Withdrawal|1|||
131162529|NCT04168645|472219021|FG003|Overall Study|Administrative Withdrawal|3|||
131162530|NCT03132805|472219024|FG000|Overall Study|Lost to Follow-up|142|||
131162531|NCT03132805|472219025|FG001|Overall Study|Lost to Follow-up|141|||
131162532|NCT03132805|472219026|FG002|Overall Study|Lost to Follow-up|113|||
131162533|NCT01158534|472219029|FG000|Overall Study|Withdrawal by Subject|1|||
131162534|NCT01158534|472219029|FG000|Overall Study|Death|1|||
131162535|NCT01158534|472219029|FG000|Overall Study|Other|1|||
131162536|NCT02115815|472219030|FG000|Overall Study|Withdrawal by Subject|2|||
131162537|NCT02115815|472219031|FG001|Overall Study|Withdrawal by Subject|0|||
131162538|NCT02115815|472219032|FG002|Overall Study|Withdrawal by Subject|0|||
131162539|NCT02115815|472219033|FG003|Overall Study|Withdrawal by Subject|0|||
131162540|NCT02115815|472219034|FG004|Overall Study|Withdrawal by Subject|0|||
131162541|NCT02115815|472219035|FG005|Overall Study|Withdrawal by Subject|0|||
131162542|NCT02115815|472219036|FG006|Overall Study|Withdrawal by Subject|0|||
131162543|NCT02115815|472219030|FG000|Overall Study|Not enough drug to dose participant|0|||
131162544|NCT02115815|472219031|FG001|Overall Study|Not enough drug to dose participant|0|||
131162545|NCT02115815|472219032|FG002|Overall Study|Not enough drug to dose participant|0|||
131162546|NCT02115815|472219033|FG003|Overall Study|Not enough drug to dose participant|0|||
131162547|NCT02115815|472219034|FG004|Overall Study|Not enough drug to dose participant|0|||
131162548|NCT02115815|472219035|FG005|Overall Study|Not enough drug to dose participant|1|||
131162549|NCT02115815|472219036|FG006|Overall Study|Not enough drug to dose participant|0|||
131162550|NCT02115815|472219030|FG000|Overall Study|Missed appointment, randomized in error|0|||
131162551|NCT02115815|472219031|FG001|Overall Study|Missed appointment, randomized in error|0|||
131162552|NCT02115815|472219032|FG002|Overall Study|Missed appointment, randomized in error|0|||
131162553|NCT02115815|472219033|FG003|Overall Study|Missed appointment, randomized in error|0|||
131162554|NCT02115815|472219034|FG004|Overall Study|Missed appointment, randomized in error|0|||
131162555|NCT02115815|472219035|FG005|Overall Study|Missed appointment, randomized in error|1|||
131162556|NCT02115815|472219036|FG006|Overall Study|Missed appointment, randomized in error|0|||
131162557|NCT04003155|472219037|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
131162558|NCT04003155|472219038|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
131162559|NCT04003155|472219039|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
131162560|NCT04003155|472219040|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
131162561|NCT04003155|472219041|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
131162562|NCT04003155|472219037|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
131162563|NCT04003155|472219038|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
130729133|NCT02640482|470630525|FG001|Overall Study|Lost to Follow-up|0|||
131162564|NCT04003155|472219039|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
131162565|NCT04003155|472219040|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
131162566|NCT04003155|472219041|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
131162567|NCT04003155|472219037|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
131162568|NCT04003155|472219038|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
131162569|NCT04003155|472219039|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
131235472|NCT00436007|472490933|FG000|Overall Study|Other|0|||
131162570|NCT04003155|472219040|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
131162571|NCT04003155|472219041|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
131162572|NCT04003155|472219037|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
131162573|NCT04003155|472219038|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
131162574|NCT04003155|472219039|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
131162575|NCT04003155|472219040|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
131162576|NCT04003155|472219041|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
131162577|NCT04003155|472219037|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
131162578|NCT04003155|472219038|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
131162579|NCT04003155|472219039|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
131162580|NCT04003155|472219040|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
131162581|NCT04003155|472219041|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
131162582|NCT04003155|472219037|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
131162583|NCT04003155|472219038|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
131162584|NCT04003155|472219039|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
131162585|NCT04003155|472219040|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
131162586|NCT04003155|472219041|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
131235473|NCT00436007|472490934|FG001|Overall Study|Other|0|||
131235474|NCT00436007|472490935|FG002|Overall Study|Other|1|||
131235475|NCT01957488|472490937|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
131235476|NCT01957488|472490938|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
131235477|NCT01957488|472490939|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
131235478|NCT01957488|472490940|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
131235479|NCT01957488|472490941|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
131235480|NCT01957488|472490942|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
131235481|NCT01957488|472490937|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
131235482|NCT01957488|472490938|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
131235483|NCT01957488|472490939|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
131235484|NCT01957488|472490940|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
131235485|NCT01957488|472490941|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
131235486|NCT01957488|472490942|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
131235487|NCT01957488|472490937|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
131235488|NCT01957488|472490938|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
131235489|NCT01957488|472490939|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
131235490|NCT01957488|472490940|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
131235491|NCT01957488|472490941|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
131235492|NCT01957488|472490942|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
131235493|NCT01957488|472490937|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
131235494|NCT01957488|472490938|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
131235495|NCT01957488|472490939|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
131235496|NCT01957488|472490940|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
131235497|NCT01957488|472490941|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
131235498|NCT01957488|472490942|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
131235499|NCT01957488|472490937|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
131235500|NCT01957488|472490938|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
131235501|NCT01957488|472490939|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
131235502|NCT01957488|472490940|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
131235503|NCT01957488|472490941|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
131235504|NCT01957488|472490942|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
131235505|NCT01957488|472490937|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
131235506|NCT01957488|472490938|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
131235507|NCT01957488|472490939|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
131235508|NCT01957488|472490940|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
131235509|NCT01957488|472490941|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
131235510|NCT01957488|472490942|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
131235511|NCT01957488|472490937|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
131235512|NCT01957488|472490938|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
131235513|NCT01957488|472490939|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
131235514|NCT01957488|472490940|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
131235515|NCT01957488|472490941|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
131162587|NCT04003155|472219037|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
131162588|NCT04003155|472219038|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
131162589|NCT04003155|472219039|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
131162590|NCT04003155|472219040|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
131162591|NCT04003155|472219041|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
131235516|NCT01957488|472490942|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
131235517|NCT01957488|472490937|FG000|Test Period 2 (2 Weeks)|Other|1|||
131235518|NCT01957488|472490938|FG001|Test Period 2 (2 Weeks)|Other|0|||
131235519|NCT01957488|472490939|FG002|Test Period 2 (2 Weeks)|Other|0|||
131235520|NCT01957488|472490940|FG003|Test Period 2 (2 Weeks)|Other|0|||
131235521|NCT01957488|472490941|FG004|Test Period 2 (2 Weeks)|Other|0|||
131235522|NCT01957488|472490942|FG005|Test Period 2 (2 Weeks)|Other|0|||
131235523|NCT01957488|472490937|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
131235524|NCT01957488|472490938|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
131235525|NCT01957488|472490939|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
131235526|NCT01957488|472490940|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
131235527|NCT01957488|472490941|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
131235528|NCT01957488|472490942|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
131235529|NCT01957488|472490937|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
131235530|NCT01957488|472490938|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
131235531|NCT01957488|472490939|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
131235532|NCT01957488|472490940|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
131235533|NCT01957488|472490941|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
131235534|NCT01957488|472490942|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
131235535|NCT01957488|472490937|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
131235536|NCT01957488|472490938|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
131235537|NCT01957488|472490939|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
131235538|NCT01957488|472490940|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
131235539|NCT01957488|472490941|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
131235540|NCT01957488|472490942|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
131235541|NCT01957488|472490937|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
131235542|NCT01957488|472490938|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
131235543|NCT01957488|472490939|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
131235544|NCT01957488|472490940|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
131235545|NCT01957488|472490941|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
131235546|NCT01957488|472490942|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
131235547|NCT01957488|472490937|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
131235548|NCT01957488|472490938|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
131235549|NCT01957488|472490939|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
131235550|NCT01957488|472490940|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
131235551|NCT01957488|472490941|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
131235552|NCT01957488|472490942|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
131235553|NCT01439165|472490943|FG000|Overall Study|Protocol Violation|3|||
131235554|NCT01439165|472490944|FG001|Overall Study|Protocol Violation|0|||
131235555|NCT01439165|472490943|FG000|Overall Study|Lost to Follow-up|11|||
131235556|NCT01439165|472490944|FG001|Overall Study|Lost to Follow-up|1|||
131235557|NCT01439165|472490943|FG000|Overall Study|Withdrawal by Subject|7|||
131235558|NCT01439165|472490944|FG001|Overall Study|Withdrawal by Subject|1|||
131235559|NCT00810368|472490945|FG000|Overall Study|Lost to Follow-up|4|||
131235560|NCT00810368|472490946|FG001|Overall Study|Lost to Follow-up|2|||
131235561|NCT00810368|472490945|FG000|Overall Study|Lack of Efficacy|2|||
131235562|NCT00810368|472490946|FG001|Overall Study|Lack of Efficacy|0|||
131162592|NCT04003155|472219037|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
131162593|NCT04003155|472219038|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
131162594|NCT04003155|472219039|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
131162595|NCT04003155|472219040|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
131162596|NCT04003155|472219041|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
131162597|NCT04003155|472219037|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
131162598|NCT04003155|472219038|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
131162599|NCT04003155|472219039|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
131162600|NCT04003155|472219040|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
131162601|NCT04003155|472219041|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
131162602|NCT01912872|472219042|FG000|Overall Study|Lost to Follow-up|2|||
131162603|NCT01912872|472219043|FG001|Overall Study|Lost to Follow-up|3|||
131162604|NCT01912872|472219044|FG002|Overall Study|Lost to Follow-up|5|||
131162605|NCT01912872|472219045|FG003|Overall Study|Lost to Follow-up|5|||
131162606|NCT01912872|472219042|FG000|Overall Study|Other unspecified|3|||
131162607|NCT01912872|472219043|FG001|Overall Study|Other unspecified|1|||
131162608|NCT01912872|472219044|FG002|Overall Study|Other unspecified|3|||
131162609|NCT01912872|472219045|FG003|Overall Study|Other unspecified|0|||
131162610|NCT01912872|472219042|FG000|Overall Study|Informed consent withdrawn|0|||
131162611|NCT01912872|472219043|FG001|Overall Study|Informed consent withdrawn|0|||
131162612|NCT01912872|472219044|FG002|Overall Study|Informed consent withdrawn|1|||
131162613|NCT01912872|472219045|FG003|Overall Study|Informed consent withdrawn|1|||
131162614|NCT01912872|472219042|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
131162615|NCT01912872|472219043|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
131162616|NCT01912872|472219044|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
131162617|NCT01912872|472219045|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
131235563|NCT02433678|472490947|FG000|Overall Study|Lost to Follow-up|1|||
131235564|NCT02433678|472490948|FG001|Overall Study|Lost to Follow-up|2|||
131162618|NCT01912872|472219042|FG000|Overall Study|Protocol Violation|0|||
130729134|NCT00517881|470630526|FG000|Overall Study|Protocol Violation|2|||
131162619|NCT01912872|472219043|FG001|Overall Study|Protocol Violation|0|||
131235565|NCT03365375|472490954|FG000|Overall Study|Withdrawal by Subject|0|||
131162620|NCT01912872|472219044|FG002|Overall Study|Protocol Violation|1|||
131162621|NCT01912872|472219045|FG003|Overall Study|Protocol Violation|0|||
131162622|NCT01912872|472219042|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
131162623|NCT01912872|472219043|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131162624|NCT01912872|472219044|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131162625|NCT01912872|472219045|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
131162626|NCT01912872|472219042|FG000|Overall Study|Withdrawal of study medication|0|||
131162627|NCT01912872|472219043|FG001|Overall Study|Withdrawal of study medication|0|||
131162628|NCT01912872|472219044|FG002|Overall Study|Withdrawal of study medication|0|||
131162629|NCT01912872|472219045|FG003|Overall Study|Withdrawal of study medication|2|||
131162630|NCT01912872|472219042|FG000|Overall Study|Missing|0|||
131162631|NCT01912872|472219043|FG001|Overall Study|Missing|0|||
131162632|NCT01912872|472219044|FG002|Overall Study|Missing|0|||
131162633|NCT01912872|472219045|FG003|Overall Study|Missing|1|||
131162634|NCT02778867|472219046|FG000|Phase 1|Withdrawal by Subject|2|||
131162635|NCT02778867|472219047|FG001|Phase 1|Withdrawal by Subject|3|||
131162636|NCT02778867|472219048|FG002|Phase 1|Withdrawal by Subject|0|||
131162637|NCT02778867|472219049|FG003|Phase 1|Withdrawal by Subject|0|||
131162638|NCT02778867|472219046|FG000|Phase 2|Withdrawal by Subject|0|||
131162639|NCT02778867|472219047|FG001|Phase 2|Withdrawal by Subject|0|||
131162640|NCT02778867|472219048|FG002|Phase 2|Withdrawal by Subject|1|||
131162641|NCT02778867|472219049|FG003|Phase 2|Withdrawal by Subject|0|||
131162642|NCT02778867|472219046|FG000|Phase 2|Physician Decision|0|||
131162643|NCT02778867|472219047|FG001|Phase 2|Physician Decision|0|||
131162644|NCT02778867|472219048|FG002|Phase 2|Physician Decision|0|||
131162645|NCT02778867|472219049|FG003|Phase 2|Physician Decision|1|||
131162646|NCT02778867|472219046|FG000|Phase 2|Adverse Event|0|||
131162647|NCT02778867|472219047|FG001|Phase 2|Adverse Event|0|||
131162648|NCT02778867|472219048|FG002|Phase 2|Adverse Event|0|||
131162649|NCT02778867|472219049|FG003|Phase 2|Adverse Event|1|||
131162650|NCT00130208|472219056|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
131162651|NCT00130208|472219057|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
131162652|NCT00130208|472219056|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
131162653|NCT00130208|472219057|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
131162654|NCT00130208|472219056|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
131162655|NCT00130208|472219057|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
131162656|NCT00130208|472219056|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
131235566|NCT03365375|472490955|FG001|Overall Study|Withdrawal by Subject|1|||
131235567|NCT03365375|472490954|FG000|Overall Study|Lost to Follow-up|0|||
131235568|NCT03365375|472490955|FG001|Overall Study|Lost to Follow-up|4|||
131235569|NCT01966042|472490959|FG000|Overall Study|Death|2|||
131235570|NCT00266409|472490961|FG000|Overall Study|Lack of Efficacy|2|||
131235571|NCT00266409|472490962|FG001|Overall Study|Lack of Efficacy|6|||
131235572|NCT00266409|472490963|FG002|Overall Study|Lack of Efficacy|1|||
131235573|NCT00266409|472490964|FG003|Overall Study|Lack of Efficacy|2|||
131235574|NCT00266409|472490961|FG000|Overall Study|Adverse Event|7|||
131235575|NCT00266409|472490962|FG001|Overall Study|Adverse Event|2|||
131235576|NCT00266409|472490963|FG002|Overall Study|Adverse Event|1|||
131235577|NCT00266409|472490964|FG003|Overall Study|Adverse Event|1|||
131235578|NCT00266409|472490961|FG000|Overall Study|Lost to Follow-up|18|||
131235579|NCT00266409|472490962|FG001|Overall Study|Lost to Follow-up|21|||
131235580|NCT00266409|472490963|FG002|Overall Study|Lost to Follow-up|6|||
131235581|NCT00266409|472490964|FG003|Overall Study|Lost to Follow-up|8|||
131235582|NCT00266409|472490961|FG000|Overall Study|Withdrawal by Subject|6|||
131162657|NCT00130208|472219057|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
131162658|NCT00130208|472219056|FG000|Maintenance Period (26 Weeks)|Other|1|||
131162659|NCT00130208|472219057|FG001|Maintenance Period (26 Weeks)|Other|1|||
131162660|NCT00130208|472219056|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
131162661|NCT00130208|472219057|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
131162662|NCT00130208|472219056|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
131162663|NCT00130208|472219057|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
131162664|NCT00130208|472219056|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
131162665|NCT00130208|472219057|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
131162666|NCT00130208|472219056|FG000|Washout Period (8 Weeks)|Other|1|||
131162667|NCT00130208|472219057|FG001|Washout Period (8 Weeks)|Other|1|||
131162668|NCT00589472|472219058|FG000|Overall Study|Adverse Event|1|||
131162669|NCT02234583|472219059|FG000|Overall Study|Adverse Event|172|||
131162670|NCT02234583|472219060|FG001|Overall Study|Adverse Event|156|||
131162671|NCT02234583|472219059|FG000|Overall Study|Withdrawal by Subject|109|||
131162672|NCT02234583|472219060|FG001|Overall Study|Withdrawal by Subject|157|||
131162673|NCT02234583|472219059|FG000|Overall Study|Lost to Follow-up|0|||
131162674|NCT02234583|472219060|FG001|Overall Study|Lost to Follow-up|1|||
131162675|NCT02234583|472219059|FG000|Overall Study|Lack of Efficacy|58|||
131235583|NCT00266409|472490962|FG001|Overall Study|Withdrawal by Subject|10|||
131235584|NCT00266409|472490963|FG002|Overall Study|Withdrawal by Subject|3|||
131235585|NCT00266409|472490964|FG003|Overall Study|Withdrawal by Subject|9|||
131235586|NCT00266409|472490961|FG000|Overall Study|Protocol Violation|5|||
131235587|NCT00266409|472490962|FG001|Overall Study|Protocol Violation|3|||
131162676|NCT02234583|472219060|FG001|Overall Study|Lack of Efficacy|103|||
131162677|NCT02234583|472219059|FG000|Overall Study|Protocol Violation|35|||
131162678|NCT02234583|472219060|FG001|Overall Study|Protocol Violation|42|||
131162679|NCT02234583|472219059|FG000|Overall Study|Other|39|||
131162680|NCT02234583|472219060|FG001|Overall Study|Other|97|||
131162681|NCT01651052|472219063|FG000|Overall Study|Death|21|||
131162682|NCT01651052|472219063|FG000|Overall Study|Explant|1|||
131162683|NCT01651052|472219063|FG000|Overall Study|Withdrawal by Subject|1|||
131162684|NCT01651052|472219063|FG000|Overall Study|Lost to Follow-up|3|||
131162685|NCT00871858|472219066|FG000|Overall Study|Protocol Violation|3|||
131162686|NCT00871858|472219067|FG001|Overall Study|Protocol Violation|4|||
131162687|NCT00871858|472219066|FG000|Overall Study|Adverse Event|1|||
131162688|NCT00871858|472219067|FG001|Overall Study|Adverse Event|1|||
131162689|NCT00871858|472219066|FG000|Overall Study|Withdrawal by Subject|1|||
131162690|NCT00871858|472219067|FG001|Overall Study|Withdrawal by Subject|1|||
131162691|NCT00871858|472219066|FG000|Overall Study|Lost to Follow-up|0|||
131162692|NCT00871858|472219067|FG001|Overall Study|Lost to Follow-up|1|||
131162693|NCT01188798|472219068|FG000|Overall Study|Death|0|||
131162694|NCT01188798|472219069|FG001|Overall Study|Death|1|||
131162695|NCT01188798|472219068|FG000|Overall Study|Required additional transplant|1|||
131162696|NCT01188798|472219069|FG001|Overall Study|Required additional transplant|1|||
131162697|NCT01188798|472219068|FG000|Overall Study|Protocol closure|1|||
131162698|NCT01188798|472219069|FG001|Overall Study|Protocol closure|1|||
131162699|NCT02795767|472219070|FG000|Overall Study|Received Commercial Emicizumab|1|||
131162700|NCT02795767|472219071|FG001|Overall Study|Received Commercial Emicizumab|0|||
131162701|NCT02795767|472219072|FG002|Overall Study|Received Commercial Emicizumab|0|||
131162702|NCT01097330|472219088|FG000|Overall Study|Study terminated early|7|||
131162703|NCT01097330|472219089|FG001|Overall Study|Study terminated early|5|||
131162704|NCT01400971|472219090|FG000|Overall Study|Death|82|||
131162705|NCT01400971|472219090|FG000|Overall Study|Lost to Follow-up|196|||
131162706|NCT01400971|472219090|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
131162707|NCT01400971|472219090|FG000|Overall Study|Physician Decision|57|||
131162708|NCT01400971|472219090|FG000|Overall Study|Withdrawal by Subject|158|||
131162709|NCT01400971|472219090|FG000|Overall Study|Other|422|||
131162710|NCT03290300|472219093|FG000|Overall Study|Lost to Follow-up|3|||
131162711|NCT02746679|472219098|FG000|Overall Study|Lost to Follow-up|4|||
131162712|NCT02746679|472219099|FG001|Overall Study|Lost to Follow-up|6|||
131162713|NCT00487279|472219100|FG000|Overall Study|Death|1|||
131162714|NCT00487279|472219101|FG001|Overall Study|Death|0|||
131162715|NCT00487279|472219100|FG000|Overall Study|Withdrawal by Subject|0|||
131162716|NCT00487279|472219101|FG001|Overall Study|Withdrawal by Subject|2|||
131162717|NCT00501852|472219102|FG000|Overall Study|Adverse Event|3|||
131162718|NCT00501852|472219102|FG000|Overall Study|Withdrawal by Subject|2|||
131162719|NCT01416610|472219105|FG000|Overall Study|Adverse Event|4|||
131162720|NCT01416610|472219105|FG000|Overall Study|Adverse Event -Patient decision|3|||
131162721|NCT01416610|472219105|FG000|Overall Study|Lack of Efficacy|4|||
131162722|NCT01416610|472219105|FG000|Overall Study|No reason given|5|||
131162723|NCT01416610|472219105|FG000|Overall Study|Withdrawal by Subject|13|||
131162724|NCT01416610|472219105|FG000|Overall Study|Lost to Follow-up|7|||
131162725|NCT01416610|472219105|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
131162726|NCT01927562|472219106|FG000|Overall Study|Lost to Follow-up|30|||
131162727|NCT01927562|472219106|FG000|Overall Study|Withdrawal by Subject|3|||
131162728|NCT01927562|472219106|FG000|Overall Study|Physician Decision|5|||
131162729|NCT01618656|472219107|FG000|Overall Study|Withdrawal by Subject|7|||
131162730|NCT01618656|472219108|FG001|Overall Study|Withdrawal by Subject|3|||
131162731|NCT01618656|472219107|FG000|Overall Study|Physician Decision|1|||
131162732|NCT01618656|472219108|FG001|Overall Study|Physician Decision|1|||
131162733|NCT01899144|472219109|FG000|Treatment Period 2|Other|1|||
131162734|NCT01899144|472219109|FG000|Treatment Period 3|Other|2|||
131162735|NCT01899144|472219109|FG000|Treatment Period 5|Other|1|||
131162736|NCT00751881|472219110|FG000|Core Treatment Period|Not treated|1|||
131162737|NCT00751881|472219111|FG001|Core Treatment Period|Not treated|1|||
131162738|NCT00751881|472219112|FG002|Core Treatment Period|Not treated|2|||
131162739|NCT00751881|472219110|FG000|Core Treatment Period|Adverse Event|26|||
131162740|NCT00751881|472219111|FG001|Core Treatment Period|Adverse Event|54|||
131162741|NCT00751881|472219112|FG002|Core Treatment Period|Adverse Event|58|||
131162742|NCT00751881|472219110|FG000|Core Treatment Period|Lack of Efficacy|37|||
131162743|NCT00751881|472219111|FG001|Core Treatment Period|Lack of Efficacy|30|||
131162744|NCT00751881|472219112|FG002|Core Treatment Period|Lack of Efficacy|20|||
131162745|NCT00751881|472219110|FG000|Core Treatment Period|Poor compliance to protocol|15|||
131162746|NCT00751881|472219111|FG001|Core Treatment Period|Poor compliance to protocol|3|||
131162747|NCT00751881|472219112|FG002|Core Treatment Period|Poor compliance to protocol|4|||
131162748|NCT00751881|472219110|FG000|Core Treatment Period|Lost to Follow-up|6|||
131162749|NCT00751881|472219111|FG001|Core Treatment Period|Lost to Follow-up|4|||
131162750|NCT00751881|472219112|FG002|Core Treatment Period|Lost to Follow-up|3|||
131162751|NCT00751881|472219110|FG000|Core Treatment Period|Other: protocol deviation|3|||
131162752|NCT00751881|472219111|FG001|Core Treatment Period|Other: protocol deviation|3|||
131162753|NCT00751881|472219112|FG002|Core Treatment Period|Other: protocol deviation|7|||
130729135|NCT00517881|470630526|FG000|Overall Study|Adverse Event|1|||
130729136|NCT00517881|470630526|FG000|Overall Study|Renal transplantation|2|||
130729137|NCT02013817|470630531|FG000|Overall Study|Adverse Event|12|||
130729138|NCT02013817|470630531|FG000|Overall Study|Withdrawal by Subject|4|||
130729139|NCT02013817|470630531|FG000|Overall Study|Death|2|||
130729140|NCT02013817|470630531|FG000|Overall Study|Other|9|||
130729141|NCT03336528|470630532|FG000|Overall Study|Protocol Violation|1|||
130729142|NCT03336528|470630533|FG001|Overall Study|Protocol Violation|1|||
130729143|NCT03336528|470630532|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
130729144|NCT03336528|470630533|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
131162754|NCT00751881|472219110|FG000|Core Treatment Period|Other: wish to parent|5|||
130729145|NCT03336528|470630532|FG000|Overall Study|Did not receive study medication|1|||
130729146|NCT03336528|470630533|FG001|Overall Study|Did not receive study medication|2|||
130729147|NCT00230178|470630536|FG000|Overall Study|Adverse Event|1|||
130729148|NCT00230178|470630537|FG001|Overall Study|Adverse Event|5|||
130729149|NCT00230178|470630538|FG002|Overall Study|Adverse Event|2|||
130729150|NCT00230178|470630536|FG000|Overall Study|Withdrawal by Subject|0|||
130729151|NCT00230178|470630537|FG001|Overall Study|Withdrawal by Subject|0|||
130729152|NCT00230178|470630538|FG002|Overall Study|Withdrawal by Subject|1|||
130729153|NCT00230178|470630536|FG000|Overall Study|Various other reasons|3|||
130729154|NCT00230178|470630537|FG001|Overall Study|Various other reasons|2|||
130729155|NCT00230178|470630538|FG002|Overall Study|Various other reasons|4|||
130729156|NCT01753297|470630539|FG000|Overall Study|Lost to Follow-up|7|||
130729157|NCT01753297|470630540|FG001|Overall Study|Lost to Follow-up|2|||
130729158|NCT01753297|470630539|FG000|Overall Study|Withdrawal by Subject|26|||
130729159|NCT01753297|470630540|FG001|Overall Study|Withdrawal by Subject|23|||
130729160|NCT01753297|470630539|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
130729161|NCT01753297|470630540|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
130729162|NCT01753297|470630539|FG000|Overall Study|Death|0|||
130729163|NCT01753297|470630540|FG001|Overall Study|Death|2|||
130729164|NCT01753297|470630539|FG000|Overall Study|Did not attend end of study visit|7|||
130729165|NCT01753297|470630540|FG001|Overall Study|Did not attend end of study visit|8|||
130729166|NCT04974749|470630548|FG000|Overall Study|Withdrawal by Subject|2|||
130729167|NCT04974749|470630548|FG000|Overall Study|Gestation|1|||
130729168|NCT01645787|470630549|FG000|Washout (2 Weeks)|Adverse Event|1|||
130729169|NCT01645787|470630550|FG001|Washout (2 Weeks)|Adverse Event|0|||
130729170|NCT04315506|470630561|FG000|Overall Study|Lost to Follow-up|74|||
130729171|NCT04315506|470630562|FG001|Overall Study|Lost to Follow-up|82|||
130729172|NCT04315506|470630561|FG000|Overall Study|Withdrawal by Subject|8|||
130729173|NCT04315506|470630562|FG001|Overall Study|Withdrawal by Subject|8|||
130729174|NCT04315506|470630561|FG000|Overall Study|Physician Decision|0|||
130729175|NCT04315506|470630562|FG001|Overall Study|Physician Decision|1|||
130729176|NCT00958893|470630569|FG000|Overall Study|Study prematurely terminated|4|||
130729177|NCT00606632|470630578|FG000|Overall Study|Withdrawal by Subject|13|||
130729178|NCT00606632|470630578|FG000|Overall Study|Miscellaneous reasons|9|||
130729179|NCT00711880|470630579|FG000|Overall Study|Adverse Event|11|||
130729180|NCT00711880|470630580|FG001|Overall Study|Adverse Event|2|||
130729181|NCT00711880|470630579|FG000|Overall Study|Patient non-compliance|1|||
130729182|NCT00711880|470630580|FG001|Overall Study|Patient non-compliance|0|||
130729183|NCT00711880|470630579|FG000|Overall Study|Lack of Efficacy|1|||
130729184|NCT00711880|470630580|FG001|Overall Study|Lack of Efficacy|5|||
130729185|NCT02756208|470630583|FG000|Overall Study|Withdrawal by Subject|1|||
130729186|NCT02756208|470630584|FG001|Overall Study|Withdrawal by Subject|0|||
130729187|NCT02756208|470630585|FG002|Overall Study|Withdrawal by Subject|1|||
130729188|NCT02756208|470630586|FG003|Overall Study|Withdrawal by Subject|3|||
130729189|NCT02756208|470630583|FG000|Overall Study|Lost to Follow-up|3|||
130729190|NCT02756208|470630584|FG001|Overall Study|Lost to Follow-up|1|||
130729191|NCT02756208|470630585|FG002|Overall Study|Lost to Follow-up|1|||
130729192|NCT02756208|470630586|FG003|Overall Study|Lost to Follow-up|1|||
130729193|NCT02756208|470630583|FG000|Overall Study|Physician Decision|1|||
131162755|NCT00751881|472219111|FG001|Core Treatment Period|Other: wish to parent|7|||
131162756|NCT00751881|472219112|FG002|Core Treatment Period|Other: wish to parent|4|||
131162757|NCT00751881|472219110|FG000|Core Treatment Period|Other: personal/family constraints|6|||
131162758|NCT00751881|472219111|FG001|Core Treatment Period|Other: personal/family constraints|7|||
130729194|NCT02756208|470630584|FG001|Overall Study|Physician Decision|0|||
130729195|NCT02756208|470630585|FG002|Overall Study|Physician Decision|0|||
130729196|NCT02756208|470630586|FG003|Overall Study|Physician Decision|0|||
130729197|NCT02756208|470630583|FG000|Overall Study|Protocol Violation|0|||
130729198|NCT02756208|470630584|FG001|Overall Study|Protocol Violation|1|||
130729199|NCT02756208|470630585|FG002|Overall Study|Protocol Violation|0|||
130729200|NCT02756208|470630586|FG003|Overall Study|Protocol Violation|0|||
130729201|NCT01295320|470630589|FG000|Overall Study|Adverse Event|2|||
130729202|NCT01295320|470630589|FG000|Overall Study|Lost to Follow-up|4|||
130729203|NCT01295320|470630589|FG000|Overall Study|Withdrawal by Subject|2|||
130729204|NCT01295320|470630589|FG000|Overall Study|Subject was bedridden|1|||
130729205|NCT01295320|470630589|FG000|Overall Study|Unable to travel|1|||
130729206|NCT00652340|470630590|FG000|Overall Study|Had not progressed.|4|||
131162759|NCT00751881|472219112|FG002|Core Treatment Period|Other: personal/family constraints|10|||
131162760|NCT00751881|472219110|FG000|Core Treatment Period|Other: MS treatment change|6|||
131162761|NCT00751881|472219111|FG001|Core Treatment Period|Other: MS treatment change|4|||
131162762|NCT00751881|472219112|FG002|Core Treatment Period|Other: MS treatment change|4|||
131162763|NCT00751881|472219110|FG000|Core Treatment Period|Other: tolerability complaints|2|||
131162764|NCT00751881|472219111|FG001|Core Treatment Period|Other: tolerability complaints|0|||
131162765|NCT00751881|472219112|FG002|Core Treatment Period|Other: tolerability complaints|0|||
131162766|NCT00751881|472219110|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
131162767|NCT00751881|472219111|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
131162768|NCT00751881|472219112|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
131162769|NCT00751881|472219110|FG000|Extension Study Period|Adverse Event|18|||
131162770|NCT00751881|472219111|FG001|Extension Study Period|Adverse Event|20|||
131162771|NCT00751881|472219112|FG002|Extension Study Period|Adverse Event|21|||
131162772|NCT00751881|472219110|FG000|Extension Study Period|Lack of Efficacy|14|||
131162773|NCT00751881|472219111|FG001|Extension Study Period|Lack of Efficacy|10|||
131162774|NCT00751881|472219112|FG002|Extension Study Period|Lack of Efficacy|20|||
131162775|NCT00751881|472219110|FG000|Extension Study Period|Lost to Follow-up|4|||
131162776|NCT00751881|472219111|FG001|Extension Study Period|Lost to Follow-up|9|||
131162777|NCT00751881|472219112|FG002|Extension Study Period|Lost to Follow-up|6|||
131162778|NCT00751881|472219110|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
131162779|NCT00751881|472219111|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
131162780|NCT00751881|472219112|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
131162781|NCT00751881|472219110|FG000|Extension Study Period|Other than specified above|26|||
131162782|NCT00751881|472219111|FG001|Extension Study Period|Other than specified above|30|||
131162783|NCT00751881|472219112|FG002|Extension Study Period|Other than specified above|18|||
131162784|NCT00864227|472219115|FG000|Overall Study|Withdrawal by Subject|1|||
131162785|NCT00864227|472219115|FG000|Overall Study|Disease Relapse/Progression|3|||
131162786|NCT01765764|472219118|FG000|Treatment Period|Adverse Event|1|||
131162787|NCT01765764|472219119|FG001|Treatment Period|Adverse Event|2|||
131162788|NCT01765764|472219120|FG002|Treatment Period|Adverse Event|1|||
131162789|NCT01765764|472219118|FG000|Treatment Period|Lost to Follow-up|0|||
131162790|NCT01765764|472219119|FG001|Treatment Period|Lost to Follow-up|3|||
131162791|NCT01765764|472219120|FG002|Treatment Period|Lost to Follow-up|2|||
131162792|NCT01765764|472219118|FG000|Treatment Period|Personal Reasons|1|||
131162793|NCT01765764|472219119|FG001|Treatment Period|Personal Reasons|2|||
131162794|NCT01765764|472219120|FG002|Treatment Period|Personal Reasons|1|||
131162795|NCT01765764|472219118|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
131162796|NCT01765764|472219119|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
131162797|NCT01765764|472219120|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
131162798|NCT01558089|472219121|FG000|Overall Study|Adverse Event|1|||
131162799|NCT01558089|472219121|FG000|Overall Study|Lack of Efficacy|1|||
131162800|NCT01558089|472219121|FG000|Overall Study|Lost to Follow-up|5|||
131162801|NCT01558089|472219121|FG000|Overall Study|Withdrawal by Subject|6|||
131162802|NCT00651118|472219129|FG000|Overall Study|Adverse Event|4|||
131162803|NCT00651118|472219130|FG001|Overall Study|Adverse Event|0|||
131162804|NCT00651118|472219131|FG002|Overall Study|Adverse Event|1|||
131162805|NCT00651118|472219132|FG003|Overall Study|Adverse Event|1|||
131162806|NCT00651118|472219129|FG000|Overall Study|Protocol Violation|2|||
131162807|NCT00651118|472219130|FG001|Overall Study|Protocol Violation|2|||
131162808|NCT00651118|472219131|FG002|Overall Study|Protocol Violation|6|||
131162809|NCT00651118|472219132|FG003|Overall Study|Protocol Violation|2|||
131162810|NCT00651118|472219129|FG000|Overall Study|Lost to Follow-up|2|||
131162811|NCT00651118|472219130|FG001|Overall Study|Lost to Follow-up|0|||
131162812|NCT00651118|472219131|FG002|Overall Study|Lost to Follow-up|1|||
131162813|NCT00651118|472219132|FG003|Overall Study|Lost to Follow-up|2|||
131162814|NCT00651118|472219129|FG000|Overall Study|administrative|1|||
131162815|NCT00651118|472219130|FG001|Overall Study|administrative|4|||
131162816|NCT00651118|472219131|FG002|Overall Study|administrative|2|||
131162817|NCT00651118|472219132|FG003|Overall Study|administrative|1|||
131162818|NCT00651118|472219129|FG000|Overall Study|Withdrawal by Subject|0|||
131162819|NCT00651118|472219130|FG001|Overall Study|Withdrawal by Subject|1|||
131162820|NCT00651118|472219131|FG002|Overall Study|Withdrawal by Subject|1|||
131162821|NCT00651118|472219132|FG003|Overall Study|Withdrawal by Subject|1|||
130729207|NCT00652340|470630591|FG001|Overall Study|Had not progressed.|3|||
131162822|NCT00839098|472219133|FG000|Overall Study|Withdrawal by Subject|2|||
131162823|NCT00839098|472219134|FG001|Overall Study|Withdrawal by Subject|1|||
131162824|NCT00839098|472219135|FG002|Overall Study|Withdrawal by Subject|7|||
131162825|NCT00365976|472219136|FG000|Overall Study|Withdrawal by Subject|1|||
131162826|NCT00365976|472219137|FG001|Overall Study|Withdrawal by Subject|5|||
131162827|NCT00935220|472219142|FG000|Overall Study|Adverse Event|1|||
131162828|NCT00935220|472219142|FG000|Overall Study|Other reason (not specified)|1|||
131162829|NCT00798967|472219143|FG000|Overall Study|Adverse Event|2|||
131162830|NCT00798967|472219144|FG001|Overall Study|Adverse Event|3|||
131162831|NCT00798967|472219143|FG000|Overall Study|Withdrawal by Subject|0|||
130729208|NCT03682107|470630592|FG000|Overall Study|Withdrawal by Subject|0|||
131162832|NCT00798967|472219144|FG001|Overall Study|Withdrawal by Subject|1|||
131162833|NCT00798967|472219143|FG000|Overall Study|Physician Decision|1|||
131162834|NCT00798967|472219144|FG001|Overall Study|Physician Decision|0|||
131162835|NCT00798967|472219143|FG000|Overall Study|Randomized in error by site|1|||
131162836|NCT00798967|472219144|FG001|Overall Study|Randomized in error by site|0|||
131162837|NCT00336492|472219147|FG000|Overall Study|Adverse Event|4|||
131162838|NCT00336492|472219148|FG001|Overall Study|Adverse Event|3|||
131162839|NCT00336492|472219149|FG002|Overall Study|Adverse Event|6|||
131162840|NCT00336492|472219147|FG000|Overall Study|Lack of Efficacy|6|||
131162841|NCT00336492|472219148|FG001|Overall Study|Lack of Efficacy|1|||
131162842|NCT00336492|472219149|FG002|Overall Study|Lack of Efficacy|4|||
131162843|NCT00336492|472219147|FG000|Overall Study|Other|5|||
131162844|NCT00336492|472219148|FG001|Overall Study|Other|0|||
131162845|NCT00336492|472219149|FG002|Overall Study|Other|1|||
131162846|NCT01415440|472219150|FG000|Overall Study|Lost to Follow-up|0|||
131162847|NCT01415440|472219151|FG001|Overall Study|Lost to Follow-up|1|||
131162848|NCT01415440|472219152|FG002|Overall Study|Lost to Follow-up|2|||
131162849|NCT01415440|472219150|FG000|Overall Study|Physician Decision|3|||
131162850|NCT01415440|472219151|FG001|Overall Study|Physician Decision|0|||
131162851|NCT01415440|472219152|FG002|Overall Study|Physician Decision|0|||
131162852|NCT01415440|472219150|FG000|Overall Study|Withdrawal by Subject|1|||
131162853|NCT01415440|472219151|FG001|Overall Study|Withdrawal by Subject|0|||
131162854|NCT01415440|472219152|FG002|Overall Study|Withdrawal by Subject|0|||
131162855|NCT00227877|472219153|FG000|Pre-visit Assessment|Technical difficulties|7|||
131162856|NCT00227877|472219154|FG001|Pre-visit Assessment|Technical difficulties|3|||
131162857|NCT00227877|472219155|FG002|Pre-visit Assessment|Technical difficulties|0|||
131162858|NCT00227877|472219156|FG003|Pre-visit Assessment|Technical difficulties|0|||
131162859|NCT00227877|472219153|FG000|Post-visit Checklist|Lost to Follow-up|24|||
131162860|NCT00227877|472219154|FG001|Post-visit Checklist|Lost to Follow-up|13|||
131162861|NCT00227877|472219155|FG002|Post-visit Checklist|Lost to Follow-up|1|||
131162862|NCT00227877|472219156|FG003|Post-visit Checklist|Lost to Follow-up|0|||
131162863|NCT00227877|472219153|FG000|3-months Follow-up|Completed late|135|||
131162864|NCT00227877|472219154|FG001|3-months Follow-up|Completed late|128|||
131162865|NCT00227877|472219155|FG002|3-months Follow-up|Completed late|34|||
131162866|NCT00227877|472219156|FG003|3-months Follow-up|Completed late|8|||
131162867|NCT00227877|472219153|FG000|3-months Follow-up|Lost to Follow-up|178|||
131162868|NCT00227877|472219154|FG001|3-months Follow-up|Lost to Follow-up|139|||
131162869|NCT00227877|472219155|FG002|3-months Follow-up|Lost to Follow-up|18|||
131162870|NCT00227877|472219156|FG003|3-months Follow-up|Lost to Follow-up|13|||
131162871|NCT00227877|472219153|FG000|12-months Follow-up|Completed late|78|||
131162872|NCT00227877|472219154|FG001|12-months Follow-up|Completed late|74|||
131162873|NCT00227877|472219155|FG002|12-months Follow-up|Completed late|1|||
131162874|NCT00227877|472219156|FG003|12-months Follow-up|Completed late|0|||
131162875|NCT00227877|472219153|FG000|12-months Follow-up|Lost to Follow-up|232|||
131162876|NCT00227877|472219154|FG001|12-months Follow-up|Lost to Follow-up|189|||
131162877|NCT00227877|472219155|FG002|12-months Follow-up|Lost to Follow-up|30|||
131162878|NCT00227877|472219156|FG003|12-months Follow-up|Lost to Follow-up|26|||
131162879|NCT00633139|472219158|FG000|Overall Study|Non compliance|0|||
131162880|NCT00633139|472219159|FG001|Overall Study|Non compliance|0|||
131162881|NCT00633139|472219160|FG002|Overall Study|Non compliance|1|||
131162882|NCT00633139|472219158|FG000|Overall Study|Withdrawal by Subject|0|||
131162883|NCT00633139|472219159|FG001|Overall Study|Withdrawal by Subject|1|||
131162884|NCT00633139|472219160|FG002|Overall Study|Withdrawal by Subject|0|||
131162885|NCT02160977|472219162|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
131162886|NCT02160977|472219163|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
131162887|NCT02160977|472219162|FG000|Three Months After Surgery|Lost to Follow-up|0|||
131162888|NCT02160977|472219163|FG001|Three Months After Surgery|Lost to Follow-up|2|||
131162889|NCT02160977|472219162|FG000|Six Months After Surgery|Lost to Follow-up|2|||
131162890|NCT02160977|472219163|FG001|Six Months After Surgery|Lost to Follow-up|1|||
131162891|NCT01522651|472219167|FG000|Overall Study|Adverse Event|3|||
131162892|NCT01522651|472219168|FG001|Overall Study|Adverse Event|4|||
131162893|NCT01522651|472219169|FG002|Overall Study|Adverse Event|4|||
131162894|NCT01522651|472219170|FG003|Overall Study|Adverse Event|5|||
131162895|NCT01522651|472219171|FG004|Overall Study|Adverse Event|4|||
131162896|NCT01522651|472219167|FG000|Overall Study|Cardioversion|1|||
131162897|NCT01522651|472219168|FG001|Overall Study|Cardioversion|0|||
131162898|NCT01522651|472219169|FG002|Overall Study|Cardioversion|0|||
131162899|NCT01522651|472219170|FG003|Overall Study|Cardioversion|0|||
131162900|NCT01522651|472219171|FG004|Overall Study|Cardioversion|0|||
131162901|NCT01522651|472219167|FG000|Overall Study|Device Malfunction|0|||
131162902|NCT01522651|472219168|FG001|Overall Study|Device Malfunction|1|||
131162903|NCT01522651|472219169|FG002|Overall Study|Device Malfunction|0|||
131162904|NCT01522651|472219170|FG003|Overall Study|Device Malfunction|0|||
131162905|NCT01522651|472219171|FG004|Overall Study|Device Malfunction|0|||
131162906|NCT01522651|472219167|FG000|Overall Study|Investigator's Discretion|0|||
131162907|NCT01522651|472219168|FG001|Overall Study|Investigator's Discretion|1|||
131162908|NCT01522651|472219169|FG002|Overall Study|Investigator's Discretion|0|||
131162909|NCT01522651|472219170|FG003|Overall Study|Investigator's Discretion|0|||
130729209|NCT03682107|470630593|FG001|Overall Study|Withdrawal by Subject|1|||
131162910|NCT01522651|472219171|FG004|Overall Study|Investigator's Discretion|0|||
131162911|NCT01522651|472219167|FG000|Overall Study|Protocol Violation|3|||
131162912|NCT01522651|472219168|FG001|Overall Study|Protocol Violation|0|||
131162913|NCT01522651|472219169|FG002|Overall Study|Protocol Violation|0|||
131162914|NCT01522651|472219170|FG003|Overall Study|Protocol Violation|0|||
131162915|NCT01522651|472219171|FG004|Overall Study|Protocol Violation|0|||
131162916|NCT01522651|472219167|FG000|Overall Study|Reason Not Specified|0|||
131162917|NCT01522651|472219168|FG001|Overall Study|Reason Not Specified|0|||
131162918|NCT01522651|472219169|FG002|Overall Study|Reason Not Specified|0|||
131162919|NCT01522651|472219170|FG003|Overall Study|Reason Not Specified|1|||
131162920|NCT01522651|472219171|FG004|Overall Study|Reason Not Specified|0|||
131162921|NCT01522651|472219167|FG000|Overall Study|Participant Non-Compliance|1|||
131162922|NCT01522651|472219168|FG001|Overall Study|Participant Non-Compliance|0|||
131162923|NCT01522651|472219169|FG002|Overall Study|Participant Non-Compliance|0|||
131162924|NCT01522651|472219170|FG003|Overall Study|Participant Non-Compliance|0|||
131162925|NCT01522651|472219171|FG004|Overall Study|Participant Non-Compliance|0|||
131162926|NCT01522651|472219167|FG000|Overall Study|Withdrew Consent|1|||
131162927|NCT01522651|472219168|FG001|Overall Study|Withdrew Consent|1|||
131162928|NCT01522651|472219169|FG002|Overall Study|Withdrew Consent|0|||
131162929|NCT01522651|472219170|FG003|Overall Study|Withdrew Consent|1|||
131162930|NCT01522651|472219171|FG004|Overall Study|Withdrew Consent|1|||
131162931|NCT01522651|472219167|FG000|Overall Study|Randomized but Never Treated|0|||
131162932|NCT01522651|472219168|FG001|Overall Study|Randomized but Never Treated|1|||
131162933|NCT01522651|472219169|FG002|Overall Study|Randomized but Never Treated|0|||
131162934|NCT01522651|472219170|FG003|Overall Study|Randomized but Never Treated|1|||
131162935|NCT01522651|472219171|FG004|Overall Study|Randomized but Never Treated|1|||
131162936|NCT02658656|472219172|FG000|Screening|Failed eligibility criteria|0|||
131162937|NCT02658656|472219173|FG001|Screening|Failed eligibility criteria|0|||
131162938|NCT02658656|472219174|FG002|Screening|Failed eligibility criteria|263|||
131162939|NCT02658656|472219172|FG000|Randomization|Withdrawal by Subject|8|||
131162940|NCT02658656|472219173|FG001|Randomization|Withdrawal by Subject|7|||
131162941|NCT02658656|472219174|FG002|Randomization|Withdrawal by Subject|0|||
131162942|NCT02658656|472219172|FG000|Randomization|Lost to Follow-up|1|||
131162943|NCT02658656|472219173|FG001|Randomization|Lost to Follow-up|3|||
131162944|NCT02658656|472219174|FG002|Randomization|Lost to Follow-up|0|||
131162945|NCT02658656|472219172|FG000|Randomization|Adverse Event|4|||
131162946|NCT02658656|472219173|FG001|Randomization|Adverse Event|0|||
131162947|NCT02658656|472219174|FG002|Randomization|Adverse Event|0|||
131162948|NCT02658656|472219172|FG000|Randomization|Administrative Termination|3|||
131162949|NCT02658656|472219173|FG001|Randomization|Administrative Termination|1|||
131162950|NCT02658656|472219174|FG002|Randomization|Administrative Termination|0|||
131162951|NCT02658656|472219172|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
131162952|NCT02658656|472219173|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
131162953|NCT02658656|472219174|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
131162954|NCT02658656|472219172|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
131162955|NCT02658656|472219173|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
131162956|NCT02658656|472219174|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
131162957|NCT02658656|472219172|FG000|Randomization|Not eligible for Randomization|1|||
131162958|NCT02658656|472219173|FG001|Randomization|Not eligible for Randomization|0|||
131162959|NCT02658656|472219174|FG002|Randomization|Not eligible for Randomization|0|||
131162960|NCT02658656|472219172|FG000|Randomization|Protocol Violation|1|||
131162961|NCT02658656|472219173|FG001|Randomization|Protocol Violation|0|||
131162962|NCT02658656|472219174|FG002|Randomization|Protocol Violation|0|||
131162963|NCT01937130|472220752|FG000|Overall Study|Withdrawal by Subject|0|||
131162964|NCT01937130|472220753|FG001|Overall Study|Withdrawal by Subject|0|||
131162965|NCT01937130|472220754|FG002|Overall Study|Withdrawal by Subject|0|||
131162966|NCT01937130|472220755|FG003|Overall Study|Withdrawal by Subject|1|||
131162967|NCT01937130|472220752|FG000|Overall Study|Adverse Event|0|||
131162968|NCT01937130|472220753|FG001|Overall Study|Adverse Event|1|||
131162969|NCT01937130|472220754|FG002|Overall Study|Adverse Event|0|||
131162970|NCT01937130|472220755|FG003|Overall Study|Adverse Event|1|||
130729210|NCT03682107|470630594|FG002|Overall Study|Withdrawal by Subject|0|||
130729211|NCT03682107|470630595|FG003|Overall Study|Withdrawal by Subject|0|||
130729212|NCT03682107|470630596|FG004|Overall Study|Withdrawal by Subject|0|||
131162971|NCT01937130|472220752|FG000|Overall Study|Death|1|||
131162972|NCT01937130|472220753|FG001|Overall Study|Death|1|||
131162973|NCT01937130|472220754|FG002|Overall Study|Death|1|||
131162974|NCT01937130|472220755|FG003|Overall Study|Death|0|||
131162975|NCT01937130|472220752|FG000|Overall Study|Lost to Follow-up|2|||
131162976|NCT01937130|472220753|FG001|Overall Study|Lost to Follow-up|0|||
131162977|NCT01937130|472220754|FG002|Overall Study|Lost to Follow-up|2|||
131162978|NCT01937130|472220755|FG003|Overall Study|Lost to Follow-up|0|||
131162979|NCT01937130|472220752|FG000|Overall Study|Physician Decision|0|||
130729213|NCT04342819|470630597|FG000|Overall Study|Declined|4|||
131162980|NCT01937130|472220753|FG001|Overall Study|Physician Decision|1|||
131162981|NCT01937130|472220754|FG002|Overall Study|Physician Decision|0|||
131162982|NCT01937130|472220755|FG003|Overall Study|Physician Decision|0|||
131162983|NCT01937130|472220752|FG000|Overall Study|Patients unable to swallow|0|||
131162984|NCT01937130|472220753|FG001|Overall Study|Patients unable to swallow|1|||
131162985|NCT01937130|472220754|FG002|Overall Study|Patients unable to swallow|0|||
131162986|NCT01937130|472220755|FG003|Overall Study|Patients unable to swallow|0|||
131162987|NCT01937130|472220752|FG000|Overall Study|Patient lost to FU due to death|2|||
131162988|NCT01937130|472220753|FG001|Overall Study|Patient lost to FU due to death|0|||
131162989|NCT01937130|472220754|FG002|Overall Study|Patient lost to FU due to death|0|||
131162990|NCT01937130|472220755|FG003|Overall Study|Patient lost to FU due to death|0|||
131162991|NCT01614769|472220764|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
131162992|NCT01614769|472220765|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
131162993|NCT01614769|472220766|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
131162994|NCT01614769|472220767|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
131162995|NCT01614769|472220768|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
131162996|NCT01614769|472220769|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
131162997|NCT01614769|472220764|FG000|Period 1|Protocol Violation|0|||
131162998|NCT01614769|472220765|FG001|Period 1|Protocol Violation|0|||
131162999|NCT01614769|472220766|FG002|Period 1|Protocol Violation|0|||
131163000|NCT01614769|472220767|FG003|Period 1|Protocol Violation|1|||
131163001|NCT01614769|472220768|FG004|Period 1|Protocol Violation|0|||
131163002|NCT01614769|472220769|FG005|Period 1|Protocol Violation|0|||
131163003|NCT01614769|472220764|FG000|Period 1|Withdrawal by Subject|1|||
131163004|NCT01614769|472220765|FG001|Period 1|Withdrawal by Subject|0|||
131163005|NCT01614769|472220766|FG002|Period 1|Withdrawal by Subject|0|||
131163006|NCT01614769|472220767|FG003|Period 1|Withdrawal by Subject|0|||
131163007|NCT01614769|472220768|FG004|Period 1|Withdrawal by Subject|0|||
131163008|NCT01614769|472220769|FG005|Period 1|Withdrawal by Subject|0|||
131163009|NCT01614769|472220764|FG000|Period 3|Withdrawal by Subject|0|||
131163010|NCT01614769|472220765|FG001|Period 3|Withdrawal by Subject|0|||
131163011|NCT01614769|472220766|FG002|Period 3|Withdrawal by Subject|1|||
131163012|NCT01614769|472220767|FG003|Period 3|Withdrawal by Subject|0|||
131163013|NCT01614769|472220768|FG004|Period 3|Withdrawal by Subject|0|||
131163014|NCT01614769|472220769|FG005|Period 3|Withdrawal by Subject|0|||
131163015|NCT03123354|472220772|FG000|Overall Study|Physician Decision|6|||
131163016|NCT04760314|472220773|FG000|Induction Period|Withdrawal by Subject|0|||
131163017|NCT04760314|472220774|FG001|Induction Period|Withdrawal by Subject|1|||
131163018|NCT04760314|472220775|FG002|Induction Period|Withdrawal by Subject|1|||
131163019|NCT04760314|472220776|FG003|Induction Period|Withdrawal by Subject|0|||
131163020|NCT04760314|472220777|FG004|Induction Period|Withdrawal by Subject|0|||
131163021|NCT04760314|472220778|FG005|Induction Period|Withdrawal by Subject|0|||
131163022|NCT04760314|472220779|FG006|Induction Period|Withdrawal by Subject|0|||
131163023|NCT04760314|472220780|FG007|Induction Period|Withdrawal by Subject|0|||
131163024|NCT04760314|472220781|FG008|Induction Period|Withdrawal by Subject|0|||
131163025|NCT04760314|472220782|FG009|Induction Period|Withdrawal by Subject|0|||
131163026|NCT04760314|472220783|FG010|Induction Period|Withdrawal by Subject|0|||
131163027|NCT04760314|472220773|FG000|Induction Period|Adverse Event|0|||
131163028|NCT04760314|472220774|FG001|Induction Period|Adverse Event|0|||
131163029|NCT04760314|472220775|FG002|Induction Period|Adverse Event|2|||
131163030|NCT04760314|472220776|FG003|Induction Period|Adverse Event|0|||
131163031|NCT04760314|472220777|FG004|Induction Period|Adverse Event|0|||
131163032|NCT04760314|472220778|FG005|Induction Period|Adverse Event|0|||
131163033|NCT04760314|472220779|FG006|Induction Period|Adverse Event|0|||
131163034|NCT04760314|472220780|FG007|Induction Period|Adverse Event|0|||
131163035|NCT04760314|472220781|FG008|Induction Period|Adverse Event|0|||
131163036|NCT04760314|472220782|FG009|Induction Period|Adverse Event|0|||
131163037|NCT04760314|472220783|FG010|Induction Period|Adverse Event|0|||
131163038|NCT04760314|472220773|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
131163039|NCT04760314|472220774|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
131163040|NCT04760314|472220775|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
131163041|NCT04760314|472220776|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
131163042|NCT04760314|472220777|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
131163043|NCT04760314|472220778|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
131163044|NCT04760314|472220779|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
131163045|NCT04760314|472220780|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
131163046|NCT04760314|472220781|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
131163047|NCT04760314|472220782|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
131163048|NCT04760314|472220783|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
131163049|NCT04760314|472220773|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131163050|NCT04760314|472220774|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131163051|NCT04760314|472220775|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131163052|NCT04760314|472220776|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
131163053|NCT04760314|472220777|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131163054|NCT04760314|472220778|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
131163055|NCT04760314|472220779|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
131163056|NCT04760314|472220780|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131163057|NCT04760314|472220781|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131163058|NCT04760314|472220782|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131163059|NCT04760314|472220783|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
131163060|NCT04760314|472220773|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131163061|NCT04760314|472220774|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131163062|NCT04760314|472220775|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131163063|NCT04760314|472220776|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131163064|NCT04760314|472220777|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
131163065|NCT04760314|472220778|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131163066|NCT04760314|472220779|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131163067|NCT04760314|472220780|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131163068|NCT04760314|472220781|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131163069|NCT04760314|472220782|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131163070|NCT04760314|472220783|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
131163071|NCT04760314|472220773|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
131163072|NCT04760314|472220774|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
131163073|NCT04760314|472220775|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
131163074|NCT04760314|472220776|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
131163075|NCT04760314|472220777|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
131163076|NCT04760314|472220778|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
131163077|NCT04760314|472220779|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
131163078|NCT04760314|472220780|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
131163079|NCT04760314|472220781|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
131163080|NCT04760314|472220782|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
131163081|NCT04760314|472220783|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
131163082|NCT04760314|472220773|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131163083|NCT04760314|472220774|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131163084|NCT04760314|472220775|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131163085|NCT04760314|472220776|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131163086|NCT04760314|472220777|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131163087|NCT04760314|472220778|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131163088|NCT04760314|472220779|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131163089|NCT04760314|472220780|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
131163090|NCT04760314|472220781|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
131163091|NCT04760314|472220782|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
131163092|NCT04760314|472220783|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
131163093|NCT04760314|472220773|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131163094|NCT04760314|472220774|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131163095|NCT04760314|472220775|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131163096|NCT04760314|472220776|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131163097|NCT04760314|472220777|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131163098|NCT04760314|472220778|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131163099|NCT04760314|472220779|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131163100|NCT04760314|472220780|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
131163101|NCT04760314|472220781|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
131163102|NCT04760314|472220782|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
131163103|NCT04760314|472220783|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
131163104|NCT04760314|472220773|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131163105|NCT04760314|472220774|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131163106|NCT04760314|472220775|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131163107|NCT04760314|472220776|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131163108|NCT04760314|472220777|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131163109|NCT04760314|472220778|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131163110|NCT04760314|472220779|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131163111|NCT04760314|472220780|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
131163112|NCT04760314|472220781|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131163113|NCT04760314|472220782|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131163114|NCT04760314|472220783|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
131163115|NCT04760314|472220773|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
131163116|NCT04760314|472220774|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
131163117|NCT04760314|472220775|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
131163118|NCT04760314|472220776|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
131163119|NCT04760314|472220777|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
131163120|NCT04760314|472220778|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
131163121|NCT04760314|472220779|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
131163122|NCT04760314|472220780|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
131163123|NCT04760314|472220781|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
131163124|NCT04760314|472220782|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
131163125|NCT04760314|472220783|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
131163126|NCT00960440|472220784|FG000|Overall Study|Death|0|||
131163127|NCT00960440|472220785|FG001|Overall Study|Death|0|||
131163128|NCT00960440|472220786|FG002|Overall Study|Death|0|||
131163129|NCT00960440|472220787|FG003|Overall Study|Death|1|||
131163130|NCT00960440|472220784|FG000|Overall Study|Adverse Event|12|||
131163131|NCT00960440|472220785|FG001|Overall Study|Adverse Event|12|||
131163132|NCT00960440|472220786|FG002|Overall Study|Adverse Event|4|||
131163133|NCT00960440|472220787|FG003|Overall Study|Adverse Event|4|||
131163134|NCT00960440|472220784|FG000|Overall Study|Lack of Efficacy|2|||
131163135|NCT00960440|472220785|FG001|Overall Study|Lack of Efficacy|5|||
131163136|NCT00960440|472220786|FG002|Overall Study|Lack of Efficacy|3|||
131163137|NCT00960440|472220787|FG003|Overall Study|Lack of Efficacy|8|||
131163138|NCT00960440|472220784|FG000|Overall Study|Protocol Violation|2|||
131163139|NCT00960440|472220785|FG001|Overall Study|Protocol Violation|8|||
131163140|NCT00960440|472220786|FG002|Overall Study|Protocol Violation|3|||
131163141|NCT00960440|472220787|FG003|Overall Study|Protocol Violation|4|||
131163142|NCT00960440|472220784|FG000|Overall Study|Withdrawal by Subject|9|||
131163143|NCT00960440|472220785|FG001|Overall Study|Withdrawal by Subject|5|||
131163144|NCT00960440|472220786|FG002|Overall Study|Withdrawal by Subject|2|||
131163145|NCT00960440|472220787|FG003|Overall Study|Withdrawal by Subject|1|||
131163146|NCT00960440|472220784|FG000|Overall Study|Other|1|||
131163147|NCT00960440|472220785|FG001|Overall Study|Other|1|||
131163148|NCT00960440|472220786|FG002|Overall Study|Other|1|||
131163149|NCT00960440|472220787|FG003|Overall Study|Other|0|||
131163150|NCT03504774|472220788|FG000|Overall Study|Adverse Event|2|||
131163151|NCT03504774|472220789|FG001|Overall Study|Adverse Event|0|||
131163152|NCT03504774|472220788|FG000|Overall Study|Lost to Follow-up|0|||
131163153|NCT03504774|472220789|FG001|Overall Study|Lost to Follow-up|1|||
131163154|NCT03504774|472220788|FG000|Overall Study|Protocol Violation|11|||
131163155|NCT03504774|472220789|FG001|Overall Study|Protocol Violation|3|||
131163156|NCT03504774|472220788|FG000|Overall Study|failed wk 52 DBPCFC|1|||
131163157|NCT03504774|472220789|FG001|Overall Study|failed wk 52 DBPCFC|0|||
131163158|NCT00915005|472220795|FG000|Overall Study|Withdrawal by Subject|4|||
131163159|NCT00915005|472220796|FG001|Overall Study|Withdrawal by Subject|4|||
131163160|NCT00915005|472220795|FG000|Overall Study|Patient preferred protons therapy|6|||
131163161|NCT00915005|472220796|FG001|Overall Study|Patient preferred protons therapy|0|||
131163162|NCT00915005|472220795|FG000|Overall Study|Insurance denial|3|||
131163163|NCT00915005|472220796|FG001|Overall Study|Insurance denial|15|||
131163164|NCT03554005|472220799|FG000|Overall Study|Not in participant's best interest|0|||
131163165|NCT03554005|472220800|FG001|Overall Study|Not in participant's best interest|0|||
131163166|NCT03554005|472220801|FG002|Overall Study|Not in participant's best interest|0|||
131163167|NCT03554005|472220802|FG003|Overall Study|Not in participant's best interest|0|||
131163168|NCT03554005|472220803|FG004|Overall Study|Not in participant's best interest|0|||
131163169|NCT03554005|472220804|FG005|Overall Study|Not in participant's best interest|1|||
131163170|NCT03554005|472220799|FG000|Overall Study|Disease Progression|1|||
131163171|NCT03554005|472220800|FG001|Overall Study|Disease Progression|1|||
131163172|NCT03554005|472220801|FG002|Overall Study|Disease Progression|1|||
131163173|NCT03554005|472220802|FG003|Overall Study|Disease Progression|1|||
131163174|NCT03554005|472220803|FG004|Overall Study|Disease Progression|5|||
131163175|NCT03554005|472220804|FG005|Overall Study|Disease Progression|6|||
131163176|NCT03554005|472220799|FG000|Overall Study|Adverse Event|0|||
131163177|NCT03554005|472220800|FG001|Overall Study|Adverse Event|0|||
131163178|NCT03554005|472220801|FG002|Overall Study|Adverse Event|0|||
131163179|NCT03554005|472220802|FG003|Overall Study|Adverse Event|0|||
131163180|NCT03554005|472220803|FG004|Overall Study|Adverse Event|0|||
131163181|NCT03554005|472220804|FG005|Overall Study|Adverse Event|3|||
131163182|NCT03554005|472220799|FG000|Overall Study|Physician Decision|0|||
131163183|NCT03554005|472220800|FG001|Overall Study|Physician Decision|0|||
131163184|NCT03554005|472220801|FG002|Overall Study|Physician Decision|0|||
131163185|NCT03554005|472220802|FG003|Overall Study|Physician Decision|0|||
131163186|NCT03554005|472220803|FG004|Overall Study|Physician Decision|1|||
131163187|NCT03554005|472220804|FG005|Overall Study|Physician Decision|0|||
131163188|NCT03554005|472220799|FG000|Overall Study|Other|0|||
131163189|NCT03554005|472220800|FG001|Overall Study|Other|0|||
131163190|NCT03554005|472220801|FG002|Overall Study|Other|0|||
131163191|NCT03554005|472220802|FG003|Overall Study|Other|0|||
131163192|NCT03554005|472220803|FG004|Overall Study|Other|0|||
131163193|NCT03554005|472220804|FG005|Overall Study|Other|1|||
131163194|NCT00631488|472220805|FG000|Overall Study|Adverse Event|1|||
131163195|NCT00631488|472220806|FG001|Overall Study|Adverse Event|0|||
131163196|NCT00631488|472220807|FG002|Overall Study|Adverse Event|0|||
131163197|NCT00631488|472220805|FG000|Overall Study|Lost to Follow-up|2|||
131163198|NCT00631488|472220806|FG001|Overall Study|Lost to Follow-up|2|||
131163199|NCT00631488|472220807|FG002|Overall Study|Lost to Follow-up|0|||
131163200|NCT00631488|472220805|FG000|Overall Study|Physician Decision|1|||
131163201|NCT00631488|472220806|FG001|Overall Study|Physician Decision|0|||
131163202|NCT00631488|472220807|FG002|Overall Study|Physician Decision|1|||
131163203|NCT00631488|472220805|FG000|Overall Study|Protocol Violation|0|||
131163204|NCT00631488|472220806|FG001|Overall Study|Protocol Violation|0|||
131163205|NCT00631488|472220807|FG002|Overall Study|Protocol Violation|1|||
131163206|NCT03648476|472220808|FG000|Overall Study|Withdrawal by Subject|2|||
130729214|NCT04342819|470630597|FG000|Overall Study|Not meeeting selection criteria|1|||
130729215|NCT01569295|470630598|FG000|Overall Study|Progressive Disease|75|||
131163207|NCT03648476|472220809|FG001|Overall Study|Withdrawal by Subject|1|||
131163208|NCT02855411|472220811|FG000|Overall Study|Study terminated by sponsor|21|||
131163209|NCT02855411|472220811|FG000|Overall Study|Does not meet entrance criteria|14|||
131163210|NCT02546856|472220812|FG000|4 Months Evaluation|Death|2|||
131163211|NCT02546856|472220813|FG001|4 Months Evaluation|Death|3|||
131163212|NCT02546856|472220812|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
131163213|NCT02546856|472220813|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
131163214|NCT02546856|472220812|FG000|4 Months Evaluation|Lost to Follow-up|3|||
131163215|NCT02546856|472220813|FG001|4 Months Evaluation|Lost to Follow-up|3|||
131163216|NCT02546856|472220812|FG000|4 Months Evaluation|Physician Decision|3|||
131163217|NCT02546856|472220813|FG001|4 Months Evaluation|Physician Decision|0|||
131163218|NCT02546856|472220812|FG000|4 Months Evaluation|Working or living abroad|5|||
131163219|NCT02546856|472220813|FG001|4 Months Evaluation|Working or living abroad|1|||
131163220|NCT02546856|472220812|FG000|4 Months Evaluation|reasons not due to titration|4|||
131163221|NCT02546856|472220813|FG001|4 Months Evaluation|reasons not due to titration|1|||
131163222|NCT02546856|472220812|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
131163223|NCT02546856|472220813|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
131163224|NCT02546856|472220812|FG000|6 Months Evaluation|Death|1|||
131163225|NCT02546856|472220813|FG001|6 Months Evaluation|Death|1|||
131163226|NCT02546856|472220812|FG000|6 Months Evaluation|Lost to Follow-up|1|||
131163227|NCT02546856|472220813|FG001|6 Months Evaluation|Lost to Follow-up|1|||
131163228|NCT02546856|472220812|FG000|6 Months Evaluation|Working or living abroad|6|||
131163229|NCT02546856|472220813|FG001|6 Months Evaluation|Working or living abroad|4|||
131163230|NCT02546856|472220812|FG000|6 Months Evaluation|reasons not due to titration|0|||
131163231|NCT02546856|472220813|FG001|6 Months Evaluation|reasons not due to titration|1|||
131163232|NCT01097616|472220814|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
131163233|NCT01097616|472220815|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
131163234|NCT01097616|472220816|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
131163235|NCT01097616|472220817|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131163236|NCT01097616|472220818|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131163237|NCT01097616|472220819|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131163238|NCT01097616|472220820|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131163239|NCT01097616|472220821|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
131163240|NCT01097616|472220814|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
131163241|NCT01097616|472220815|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
131163242|NCT01097616|472220816|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
131163243|NCT01097616|472220817|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131163244|NCT01097616|472220818|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131163245|NCT01097616|472220819|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131163246|NCT01097616|472220820|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131163247|NCT01097616|472220821|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
131163248|NCT01097616|472220814|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
131163249|NCT01097616|472220815|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
131163250|NCT01097616|472220816|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
131163251|NCT01097616|472220817|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131163252|NCT01097616|472220818|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131163253|NCT01097616|472220819|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130729216|NCT01569295|470630599|FG001|Overall Study|Progressive Disease|139|||
130729217|NCT01569295|470630598|FG000|Overall Study|Adverse Event|39|||
130729218|NCT01569295|470630599|FG001|Overall Study|Adverse Event|14|||
130729219|NCT01569295|470630598|FG000|Overall Study|Withdrawal by Subject|25|||
130729220|NCT01569295|470630599|FG001|Overall Study|Withdrawal by Subject|12|||
130729221|NCT01569295|470630598|FG000|Overall Study|Death|19|||
130729222|NCT01569295|470630599|FG001|Overall Study|Death|15|||
130729223|NCT01569295|470630598|FG000|Overall Study|Physician Decision|13|||
130729224|NCT01569295|470630599|FG001|Overall Study|Physician Decision|18|||
130729225|NCT01569295|470630598|FG000|Overall Study|Study Terminated by Sponsor|24|||
130780621|NCT01165307|470823126|FG000|Overall Study|Withdrawal by Subject|2|||
130780622|NCT01165307|470823127|FG001|Overall Study|Withdrawal by Subject|0|||
131163254|NCT01097616|472220820|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131163255|NCT01097616|472220821|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
131163256|NCT01097616|472220814|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
131163257|NCT01097616|472220815|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
131235588|NCT00266409|472490963|FG002|Overall Study|Protocol Violation|4|||
130729226|NCT01569295|470630599|FG001|Overall Study|Study Terminated by Sponsor|2|||
131163258|NCT01097616|472220816|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131163259|NCT01097616|472220817|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131163260|NCT01097616|472220818|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131163261|NCT01097616|472220819|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131163262|NCT01097616|472220820|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131163263|NCT01097616|472220821|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
131163264|NCT01097616|472220814|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
131163265|NCT01097616|472220815|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
131163266|NCT01097616|472220816|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
131163267|NCT01097616|472220817|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131163268|NCT01097616|472220818|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131163269|NCT01097616|472220819|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131163270|NCT01097616|472220820|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131163271|NCT01097616|472220821|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
131163272|NCT01097616|472220814|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
131163273|NCT01097616|472220815|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
131163274|NCT01097616|472220816|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131163275|NCT01097616|472220817|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131163276|NCT01097616|472220818|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131163277|NCT01097616|472220819|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131163278|NCT01097616|472220820|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131163279|NCT01097616|472220821|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
131163280|NCT01097616|472220814|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
131163281|NCT01097616|472220815|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
131163282|NCT01097616|472220816|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131163283|NCT01097616|472220817|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131163284|NCT01097616|472220818|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131163285|NCT01097616|472220819|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131163286|NCT01097616|472220820|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131163287|NCT01097616|472220821|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
131163288|NCT01097616|472220814|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131163289|NCT01097616|472220815|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131163290|NCT01097616|472220816|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
131163291|NCT01097616|472220817|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131163292|NCT01097616|472220818|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131163293|NCT01097616|472220819|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131163294|NCT01097616|472220820|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131163295|NCT01097616|472220821|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
131163296|NCT01097616|472220814|FG000|Optional DB EXT Phase|Adverse Event|0|||
131163297|NCT01097616|472220815|FG001|Optional DB EXT Phase|Adverse Event|7|||
131163298|NCT01097616|472220816|FG002|Optional DB EXT Phase|Adverse Event|2|||
131163299|NCT01097616|472220817|FG003|Optional DB EXT Phase|Adverse Event|0|||
131163300|NCT01097616|472220818|FG004|Optional DB EXT Phase|Adverse Event|0|||
131163301|NCT01097616|472220819|FG005|Optional DB EXT Phase|Adverse Event|0|||
131163302|NCT01097616|472220820|FG006|Optional DB EXT Phase|Adverse Event|0|||
131163303|NCT01097616|472220821|FG007|Optional DB EXT Phase|Adverse Event|0|||
131163304|NCT01097616|472220814|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
131163305|NCT01097616|472220815|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
131163306|NCT01097616|472220816|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
131163307|NCT01097616|472220817|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
131163308|NCT01097616|472220818|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
131163309|NCT01097616|472220819|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
131163310|NCT01097616|472220820|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
131163311|NCT01097616|472220821|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
131163312|NCT01097616|472220814|FG000|Optional DB EXT Phase|Protocol Violation|0|||
131163313|NCT01097616|472220815|FG001|Optional DB EXT Phase|Protocol Violation|2|||
131163314|NCT01097616|472220816|FG002|Optional DB EXT Phase|Protocol Violation|3|||
131163315|NCT01097616|472220817|FG003|Optional DB EXT Phase|Protocol Violation|0|||
131163316|NCT01097616|472220818|FG004|Optional DB EXT Phase|Protocol Violation|0|||
131235589|NCT00266409|472490964|FG003|Overall Study|Protocol Violation|2|||
131235590|NCT00266409|472490961|FG000|Overall Study|Other|7|||
131235591|NCT00266409|472490962|FG001|Overall Study|Other|4|||
130780623|NCT01165307|470823126|FG000|Overall Study|Subject not available for contact|1|||
131235592|NCT00266409|472490963|FG002|Overall Study|Other|2|||
130780624|NCT01165307|470823127|FG001|Overall Study|Subject not available for contact|0|||
130780625|NCT02163395|470823133|FG000|Overall Study|Withdrawal by Subject|1|||
131163317|NCT01097616|472220819|FG005|Optional DB EXT Phase|Protocol Violation|0|||
131163318|NCT01097616|472220820|FG006|Optional DB EXT Phase|Protocol Violation|0|||
131235593|NCT00266409|472490964|FG003|Overall Study|Other|0|||
131235594|NCT01901055|472490968|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
131235595|NCT01901055|472490969|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
130729227|NCT01569295|470630598|FG000|Overall Study|Other Reason not Specified|3|||
131163319|NCT01097616|472220821|FG007|Optional DB EXT Phase|Protocol Violation|0|||
131163320|NCT01097616|472220814|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
131163321|NCT01097616|472220815|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
131163322|NCT01097616|472220816|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
131163323|NCT01097616|472220817|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
131163324|NCT01097616|472220818|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
131163325|NCT01097616|472220819|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
131163326|NCT01097616|472220820|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
131163327|NCT01097616|472220821|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
131163328|NCT01097616|472220814|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
131163329|NCT01097616|472220815|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
131163330|NCT01097616|472220816|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
131163331|NCT01097616|472220817|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
131163332|NCT01097616|472220818|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
131163333|NCT01097616|472220819|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
131163334|NCT01097616|472220820|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
131163335|NCT01097616|472220821|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
131163336|NCT01097616|472220814|FG000|Optional DB EXT Phase|Physician Decision|1|||
131163337|NCT01097616|472220815|FG001|Optional DB EXT Phase|Physician Decision|0|||
131163338|NCT01097616|472220816|FG002|Optional DB EXT Phase|Physician Decision|0|||
131163339|NCT01097616|472220817|FG003|Optional DB EXT Phase|Physician Decision|0|||
131163340|NCT01097616|472220818|FG004|Optional DB EXT Phase|Physician Decision|0|||
131163341|NCT01097616|472220819|FG005|Optional DB EXT Phase|Physician Decision|0|||
131163342|NCT01097616|472220820|FG006|Optional DB EXT Phase|Physician Decision|0|||
131163343|NCT01097616|472220821|FG007|Optional DB EXT Phase|Physician Decision|0|||
131163344|NCT01097616|472220814|FG000|DB RO Phase|Adverse Event|0|||
131163345|NCT01097616|472220815|FG001|DB RO Phase|Adverse Event|0|||
131163346|NCT01097616|472220816|FG002|DB RO Phase|Adverse Event|0|||
131163347|NCT01097616|472220817|FG003|DB RO Phase|Adverse Event|0|||
131163348|NCT01097616|472220818|FG004|DB RO Phase|Adverse Event|0|||
131163349|NCT01097616|472220819|FG005|DB RO Phase|Adverse Event|0|||
131163350|NCT01097616|472220820|FG006|DB RO Phase|Adverse Event|1|||
131163351|NCT01097616|472220821|FG007|DB RO Phase|Adverse Event|0|||
131163352|NCT01097616|472220814|FG000|DB RO Phase|Withdrawal by Subject|0|||
131163353|NCT01097616|472220815|FG001|DB RO Phase|Withdrawal by Subject|0|||
131163354|NCT01097616|472220816|FG002|DB RO Phase|Withdrawal by Subject|0|||
131163355|NCT01097616|472220817|FG003|DB RO Phase|Withdrawal by Subject|0|||
131163356|NCT01097616|472220818|FG004|DB RO Phase|Withdrawal by Subject|0|||
131163357|NCT01097616|472220819|FG005|DB RO Phase|Withdrawal by Subject|1|||
131163358|NCT01097616|472220820|FG006|DB RO Phase|Withdrawal by Subject|0|||
131163359|NCT01097616|472220821|FG007|DB RO Phase|Withdrawal by Subject|0|||
131163360|NCT01097616|472220814|FG000|DB RO Phase|Lost to Follow-up|0|||
131163361|NCT01097616|472220815|FG001|DB RO Phase|Lost to Follow-up|0|||
131163362|NCT01097616|472220816|FG002|DB RO Phase|Lost to Follow-up|0|||
131163363|NCT01097616|472220817|FG003|DB RO Phase|Lost to Follow-up|1|||
131163364|NCT01097616|472220818|FG004|DB RO Phase|Lost to Follow-up|1|||
131163365|NCT01097616|472220819|FG005|DB RO Phase|Lost to Follow-up|0|||
131163366|NCT01097616|472220820|FG006|DB RO Phase|Lost to Follow-up|0|||
131163367|NCT01097616|472220821|FG007|DB RO Phase|Lost to Follow-up|1|||
131163368|NCT01097616|472220814|FG000|DB RO Phase|Not Treated in RO|0|||
131163369|NCT01097616|472220815|FG001|DB RO Phase|Not Treated in RO|0|||
131163370|NCT01097616|472220816|FG002|DB RO Phase|Not Treated in RO|0|||
131163371|NCT01097616|472220817|FG003|DB RO Phase|Not Treated in RO|0|||
131163372|NCT01097616|472220818|FG004|DB RO Phase|Not Treated in RO|0|||
131163373|NCT01097616|472220819|FG005|DB RO Phase|Not Treated in RO|1|||
131163374|NCT01097616|472220820|FG006|DB RO Phase|Not Treated in RO|0|||
131163375|NCT01097616|472220821|FG007|DB RO Phase|Not Treated in RO|0|||
131163376|NCT01703819|472220825|FG000|Overall Study|Adverse Event|0|||
131163377|NCT01703819|472220826|FG001|Overall Study|Adverse Event|1|||
131163378|NCT01703819|472220825|FG000|Overall Study|Withdrawal by Subject|0|||
131163379|NCT01703819|472220826|FG001|Overall Study|Withdrawal by Subject|1|||
131163380|NCT04230486|472220827|FG000|Overall Study|Screen Failure|1|||
131163381|NCT03215264|472220828|FG000|Dose Level 2|Adverse Event|0|||
131163382|NCT03215264|472220829|FG001|Dose Level 2|Adverse Event|1|||
131163383|NCT03215264|472220830|FG002|Dose Level 2|Adverse Event|0|||
131163384|NCT03215264|472220828|FG000|Dose Level 3|Withdrawal by Subject|0|||
131163385|NCT03215264|472220829|FG001|Dose Level 3|Withdrawal by Subject|0|||
131163386|NCT03215264|472220830|FG002|Dose Level 3|Withdrawal by Subject|1|||
131163387|NCT02145156|472220831|FG000|Overall Study|No match to vaccination records|60|||
131163388|NCT02145156|472220832|FG001|Overall Study|No match to vaccination records|52|||
131163389|NCT02145156|472220833|FG002|Overall Study|No match to vaccination records|41|||
131163390|NCT02805907|472220836|FG000|Overall Study|Lost to Follow-up|3|||
131163391|NCT02805907|472220837|FG001|Overall Study|Lost to Follow-up|3|||
131163392|NCT03408873|472220838|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
131163393|NCT03408873|472220838|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
130729228|NCT01569295|470630599|FG001|Overall Study|Other Reason not Specified|5|||
130729229|NCT01569295|470630598|FG000|Overall Study|Non-Compliance with Study Drug|6|||
130729230|NCT01569295|470630599|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130729231|NCT01569295|470630598|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
130729232|NCT01569295|470630599|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
130729233|NCT01569295|470630598|FG000|Overall Study|Lost to Follow-up|1|||
130729234|NCT01569295|470630599|FG001|Overall Study|Lost to Follow-up|1|||
130729235|NCT03607487|470630600|FG000|Overall Study|Withdrawal by Subject|2|||
131163394|NCT03408873|472220838|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
131163395|NCT03408873|472220838|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
131163396|NCT03408873|472220838|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
131163397|NCT03408873|472220838|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
131163398|NCT01264965|472220839|FG000|Overall Study|Withdrawal by Subject|10|||
131163399|NCT01797783|472220840|FG000|Overall Study|Adverse Event|1|||
131163400|NCT01797783|472220841|FG001|Overall Study|Adverse Event|1|||
131163401|NCT01797783|472220840|FG000|Overall Study|Withdrawal by Subject|1|||
131163402|NCT01797783|472220841|FG001|Overall Study|Withdrawal by Subject|0|||
131163403|NCT00532883|472220842|FG000|Overall Study|Adverse Event|1|||
131163404|NCT00532883|472220843|FG001|Overall Study|Adverse Event|0|||
131163405|NCT00532883|472220844|FG002|Overall Study|Adverse Event|0|||
131163406|NCT00532883|472220845|FG003|Overall Study|Adverse Event|1|||
131163407|NCT00532883|472220842|FG000|Overall Study|Lost to Follow-up|1|||
131163408|NCT00532883|472220843|FG001|Overall Study|Lost to Follow-up|1|||
131163409|NCT00532883|472220844|FG002|Overall Study|Lost to Follow-up|1|||
131163410|NCT00532883|472220845|FG003|Overall Study|Lost to Follow-up|0|||
131163411|NCT00532883|472220842|FG000|Overall Study|Withdrawal by Subject|0|||
131163412|NCT00532883|472220843|FG001|Overall Study|Withdrawal by Subject|1|||
131163413|NCT00532883|472220844|FG002|Overall Study|Withdrawal by Subject|1|||
131163414|NCT00532883|472220845|FG003|Overall Study|Withdrawal by Subject|0|||
131163415|NCT00532883|472220842|FG000|Overall Study|Subject was Nonadherent|0|||
131163416|NCT00532883|472220843|FG001|Overall Study|Subject was Nonadherent|1|||
131163417|NCT00532883|472220844|FG002|Overall Study|Subject was Nonadherent|1|||
131163418|NCT00532883|472220845|FG003|Overall Study|Subject was Nonadherent|0|||
131163419|NCT00532883|472220842|FG000|Overall Study|Early Study Termination|4|||
131163420|NCT00532883|472220843|FG001|Overall Study|Early Study Termination|4|||
131163421|NCT00532883|472220844|FG002|Overall Study|Early Study Termination|1|||
131163422|NCT00532883|472220845|FG003|Overall Study|Early Study Termination|4|||
131163423|NCT03799718|472220846|FG000|Overall Study|Adverse Event|2|||
131163424|NCT02202031|472220847|FG000|Overall Study|Lost to Follow-up|1|||
131163425|NCT02202031|472220848|FG001|Overall Study|Lost to Follow-up|0|||
131163426|NCT02202031|472220847|FG000|Overall Study|Too Busy|1|||
131163427|NCT02202031|472220848|FG001|Overall Study|Too Busy|3|||
131163428|NCT02202031|472220847|FG000|Overall Study|Illness/Medical Reason|0|||
130729236|NCT03607487|470630601|FG001|Overall Study|Withdrawal by Subject|0|||
130729237|NCT03607487|470630602|FG002|Overall Study|Withdrawal by Subject|0|||
130729238|NCT03607487|470630603|FG003|Overall Study|Withdrawal by Subject|1|||
131163429|NCT02202031|472220848|FG001|Overall Study|Illness/Medical Reason|2|||
131163430|NCT02202031|472220847|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
131163431|NCT02202031|472220848|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
131163432|NCT01024465|472220856|FG000|Overall Study|Adverse Event|2|||
131163433|NCT01024465|472220856|FG000|Overall Study|Physician Decision|1|||
131163434|NCT03078608|472220857|FG000|Overall Study|Death|1|||
131163435|NCT03078608|472220858|FG001|Overall Study|Death|2|||
131163436|NCT03078608|472220859|FG002|Overall Study|Death|0|||
131163437|NCT03078608|472220860|FG003|Overall Study|Death|0|||
130729239|NCT01884337|470630604|FG000|Treatment|Adverse Event|2|||
130729240|NCT01884337|470630605|FG001|Treatment|Adverse Event|2|||
130729241|NCT01884337|470630604|FG000|Treatment|Subj. request to discont. treatment|2|||
130729242|NCT01884337|470630605|FG001|Treatment|Subj. request to discont. treatment|0|||
130780626|NCT02163395|470823133|FG000|Overall Study|Lost to Follow-up|3|||
130780627|NCT02163395|470823133|FG000|Overall Study|Adverse Event|1|||
131163438|NCT03078608|472220857|FG000|Overall Study|Withdrawal by Subject|8|||
131163439|NCT03078608|472220858|FG001|Overall Study|Withdrawal by Subject|1|||
131163440|NCT03078608|472220859|FG002|Overall Study|Withdrawal by Subject|0|||
131163441|NCT03078608|472220860|FG003|Overall Study|Withdrawal by Subject|0|||
131163442|NCT03078608|472220857|FG000|Overall Study|Lost to Follow-up|5|||
131163443|NCT03078608|472220858|FG001|Overall Study|Lost to Follow-up|8|||
131163444|NCT03078608|472220859|FG002|Overall Study|Lost to Follow-up|4|||
131163445|NCT03078608|472220860|FG003|Overall Study|Lost to Follow-up|1|||
131163446|NCT00723840|472220861|FG000|Overall Study|Lost to Follow-up|2|||
131163447|NCT00723840|472220861|FG000|Overall Study|Failure to return|18|||
131163448|NCT00723840|472220861|FG000|Overall Study|Withdrawal by Subject|55|||
130729243|NCT01884337|470630604|FG000|Follow-up Period|Lost to Follow-up|1|||
130729244|NCT01884337|470630605|FG001|Follow-up Period|Lost to Follow-up|1|||
130729245|NCT02455518|470630606|FG000|Overall Study|Protocol Violation|0|||
131163449|NCT00723840|472220861|FG000|Overall Study|Serious Adverse Events|3|||
131163450|NCT00723840|472220861|FG000|Overall Study|Other Medical Event|2|||
131163451|NCT00723840|472220861|FG000|Overall Study|Unspecified reason|2|||
130729246|NCT02455518|470630607|FG001|Overall Study|Protocol Violation|1|||
131163452|NCT02853331|472220867|FG000|Overall Study|Death|59|||
131163453|NCT02853331|472220868|FG001|Overall Study|Death|95|||
131163454|NCT02853331|472220867|FG000|Overall Study|Withdrawal by Subject|5|||
131163455|NCT02853331|472220868|FG001|Overall Study|Withdrawal by Subject|9|||
131163456|NCT02853331|472220867|FG000|Overall Study|Ongoing in study|368|||
131163457|NCT02853331|472220868|FG001|Overall Study|Ongoing in study|325|||
131163458|NCT02086565|472220874|FG000|Overall Study|Lost to Follow-up|9|||
131163459|NCT02086565|472220875|FG001|Overall Study|Lost to Follow-up|7|||
131163460|NCT02086565|472220874|FG000|Overall Study|Withdrawal by Subject|2|||
131163461|NCT02086565|472220875|FG001|Overall Study|Withdrawal by Subject|1|||
131163462|NCT02086565|472220874|FG000|Overall Study|Death|3|||
131163463|NCT02086565|472220875|FG001|Overall Study|Death|2|||
131163464|NCT02086565|472220874|FG000|Overall Study|withdrawn by research team|2|||
131163465|NCT02086565|472220875|FG001|Overall Study|withdrawn by research team|2|||
131163466|NCT02116972|472220878|FG000|Overall Study|Adverse Event|4|||
131163467|NCT02116972|472220879|FG001|Overall Study|Adverse Event|4|||
131163468|NCT02116972|472220880|FG002|Overall Study|Adverse Event|1|||
131163469|NCT02116972|472220878|FG000|Overall Study|Withdrawal by Subject|1|||
131163470|NCT02116972|472220879|FG001|Overall Study|Withdrawal by Subject|1|||
131163471|NCT02116972|472220880|FG002|Overall Study|Withdrawal by Subject|5|||
131163472|NCT02116972|472220878|FG000|Overall Study|Protocol Violation|1|||
131163473|NCT02116972|472220879|FG001|Overall Study|Protocol Violation|0|||
131163474|NCT02116972|472220880|FG002|Overall Study|Protocol Violation|1|||
131163475|NCT02116972|472220878|FG000|Overall Study|Lost to Follow-up|4|||
131163476|NCT02116972|472220879|FG001|Overall Study|Lost to Follow-up|3|||
131163477|NCT02116972|472220880|FG002|Overall Study|Lost to Follow-up|1|||
131163478|NCT02116972|472220878|FG000|Overall Study|Lack of Efficacy|6|||
130729247|NCT02455518|470630608|FG002|Overall Study|Protocol Violation|1|||
130729248|NCT02455518|470630609|FG003|Overall Study|Protocol Violation|3|||
130729249|NCT01038297|470630612|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
130729250|NCT01038297|470630613|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
130729251|NCT01038297|470630614|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
130729252|NCT02508935|470630615|FG000|Overall Study|Withdrawal by Subject|1|||
130729253|NCT02508935|470630615|FG000|Overall Study|Withdrawal by Caregiver|8|||
130729254|NCT02508935|470630615|FG000|Overall Study|Pain Score <4|1|||
130729255|NCT02508935|470630615|FG000|Overall Study|Emesis|3|||
130729256|NCT02508935|470630615|FG000|Overall Study|Adverse Event|3|||
130729257|NCT02508935|470630615|FG000|Overall Study|Protocol Violation|1|||
130729258|NCT02508935|470630615|FG000|Overall Study|Physician Decision|1|||
130729259|NCT02508935|470630615|FG000|Overall Study|Trial terminated by sponsor|5|||
130729260|NCT01973595|470630617|FG000|Washout|Withdrawal by Subject|1|||
130729261|NCT01973595|470630618|FG001|Washout|Withdrawal by Subject|0|||
130729262|NCT01973595|470630619|FG002|Washout|Withdrawal by Subject|1|||
130729263|NCT01973595|470630620|FG003|Washout|Withdrawal by Subject|0|||
130729264|NCT01275430|470630625|FG000|Overall Study|Adverse Event|1|||
130729265|NCT01275430|470630625|FG000|Overall Study|No Contrast Injection|6|||
130729266|NCT01275430|470630625|FG000|Overall Study|Device Malfunction|1|||
130729267|NCT01275430|470630625|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
130729268|NCT00710866|470630626|FG000|Overall Study|Protocol Violation|5|||
130729269|NCT00710866|470630627|FG001|Overall Study|Protocol Violation|4|||
130729270|NCT00710866|470630626|FG000|Overall Study|Withdrawal by Subject|2|||
130729271|NCT00710866|470630627|FG001|Overall Study|Withdrawal by Subject|1|||
130729272|NCT00710866|470630626|FG000|Overall Study|Lost to Follow-up|1|||
130729273|NCT00710866|470630627|FG001|Overall Study|Lost to Follow-up|0|||
131163479|NCT02116972|472220879|FG001|Overall Study|Lack of Efficacy|6|||
131163480|NCT02116972|472220880|FG002|Overall Study|Lack of Efficacy|5|||
131163481|NCT02116972|472220878|FG000|Overall Study|scheduling conflicts and relocation|3|||
131163482|NCT02116972|472220879|FG001|Overall Study|scheduling conflicts and relocation|3|||
131163483|NCT02116972|472220880|FG002|Overall Study|scheduling conflicts and relocation|6|||
131163484|NCT00784784|472220881|FG000|Overall Study|Withdrawal by Subject|2|||
131163485|NCT00784784|472220882|FG001|Overall Study|Withdrawal by Subject|2|||
131163486|NCT01041573|472220888|FG000|Overall Study|Withdrawal by Subject|2|||
131163487|NCT01041573|472220889|FG001|Overall Study|Withdrawal by Subject|5|||
131163488|NCT01041573|472220890|FG002|Overall Study|Withdrawal by Subject|2|||
131163489|NCT01041573|472220891|FG003|Overall Study|Withdrawal by Subject|0|||
131163490|NCT01041573|472220888|FG000|Overall Study|Death|1|||
130729274|NCT00710866|470630626|FG000|Overall Study|Failed to meet eligibility|1|||
130729275|NCT00710866|470630627|FG001|Overall Study|Failed to meet eligibility|1|||
130729276|NCT04036110|470630628|FG000|Overall Study|Lost to Follow-up|3|||
130729277|NCT04036110|470630629|FG001|Overall Study|Lost to Follow-up|2|||
130729278|NCT04036110|470630630|FG002|Overall Study|Lost to Follow-up|1|||
130729279|NCT04036110|470630628|FG000|Overall Study|Study Suspended|4|||
130729280|NCT04036110|470630629|FG001|Overall Study|Study Suspended|5|||
130729281|NCT04036110|470630630|FG002|Overall Study|Study Suspended|1|||
131163491|NCT01041573|472220889|FG001|Overall Study|Death|0|||
131163492|NCT01041573|472220890|FG002|Overall Study|Death|0|||
131163493|NCT01041573|472220891|FG003|Overall Study|Death|0|||
131163494|NCT01041573|472220888|FG000|Overall Study|Lost to Follow-up|0|||
131163495|NCT01041573|472220889|FG001|Overall Study|Lost to Follow-up|1|||
131163496|NCT01041573|472220890|FG002|Overall Study|Lost to Follow-up|2|||
131163497|NCT01041573|472220891|FG003|Overall Study|Lost to Follow-up|1|||
131163498|NCT01041573|472220888|FG000|Overall Study|Adverse Event|0|||
131163499|NCT01041573|472220889|FG001|Overall Study|Adverse Event|2|||
131163500|NCT01041573|472220890|FG002|Overall Study|Adverse Event|0|||
131163501|NCT01041573|472220891|FG003|Overall Study|Adverse Event|0|||
131163502|NCT01041573|472220888|FG000|Overall Study|relocation|1|||
130729282|NCT00396565|470630636|FG000|Overall Study|Physician Decision|3|||
130729283|NCT00396565|470630637|FG001|Overall Study|Physician Decision|1|||
130729284|NCT00396565|470630638|FG002|Overall Study|Physician Decision|2|||
130729285|NCT00396565|470630636|FG000|Overall Study|Adverse Event|5|||
130729286|NCT00396565|470630637|FG001|Overall Study|Adverse Event|13|||
130729287|NCT00396565|470630638|FG002|Overall Study|Adverse Event|3|||
130729288|NCT00396565|470630636|FG000|Overall Study|Withdrawal by Subject|8|||
130729289|NCT00396565|470630637|FG001|Overall Study|Withdrawal by Subject|13|||
130729290|NCT00396565|470630638|FG002|Overall Study|Withdrawal by Subject|1|||
130729291|NCT00396565|470630636|FG000|Overall Study|Lack of Efficacy|32|||
130729292|NCT00396565|470630637|FG001|Overall Study|Lack of Efficacy|64|||
130729293|NCT00396565|470630638|FG002|Overall Study|Lack of Efficacy|11|||
130729294|NCT04324021|470630640|FG000|Overall Study|Adverse Event|1|||
130729295|NCT04324021|470630641|FG001|Overall Study|Adverse Event|0|||
130729296|NCT04324021|470630642|FG002|Overall Study|Adverse Event|0|||
130729297|NCT04324021|470630640|FG000|Overall Study|Lack of Efficacy|0|||
131163503|NCT01041573|472220889|FG001|Overall Study|relocation|4|||
131163504|NCT01041573|472220890|FG002|Overall Study|relocation|3|||
131163505|NCT01041573|472220891|FG003|Overall Study|relocation|1|||
131163506|NCT01041573|472220888|FG000|Overall Study|further blood extraction|0|||
131163507|NCT01041573|472220889|FG001|Overall Study|further blood extraction|1|||
131163508|NCT01041573|472220890|FG002|Overall Study|further blood extraction|0|||
131163509|NCT01041573|472220891|FG003|Overall Study|further blood extraction|0|||
131163510|NCT01041573|472220888|FG000|Overall Study|positive to anti-HCV|1|||
131163511|NCT01041573|472220889|FG001|Overall Study|positive to anti-HCV|0|||
131163512|NCT01041573|472220890|FG002|Overall Study|positive to anti-HCV|0|||
131163513|NCT01041573|472220891|FG003|Overall Study|positive to anti-HCV|0|||
131163514|NCT04172831|472220892|FG000|Overall Study|Adverse Event|21|||
131163515|NCT04172831|472220893|FG001|Overall Study|Adverse Event|9|||
131163516|NCT04172831|472220892|FG000|Overall Study|Lack of Efficacy|2|||
131163517|NCT04172831|472220893|FG001|Overall Study|Lack of Efficacy|8|||
131163518|NCT04172831|472220892|FG000|Overall Study|Physician Decision|0|||
131163519|NCT04172831|472220893|FG001|Overall Study|Physician Decision|1|||
131163520|NCT04172831|472220892|FG000|Overall Study|Withdrawal by Subject|12|||
131163521|NCT04172831|472220893|FG001|Overall Study|Withdrawal by Subject|11|||
131163522|NCT04172831|472220892|FG000|Overall Study|Lost to Follow-up|4|||
131163523|NCT04172831|472220893|FG001|Overall Study|Lost to Follow-up|9|||
131163524|NCT04172831|472220892|FG000|Overall Study|COVID-19 related crisis|3|||
131163525|NCT04172831|472220893|FG001|Overall Study|COVID-19 related crisis|3|||
131163526|NCT04172831|472220892|FG000|Overall Study|Subject non-compliance|1|||
131163527|NCT04172831|472220893|FG001|Overall Study|Subject non-compliance|1|||
131163528|NCT04172831|472220892|FG000|Overall Study|Family emergency|1|||
131163529|NCT04172831|472220893|FG001|Overall Study|Family emergency|0|||
131163530|NCT00530712|472220896|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
131163531|NCT00530712|472220896|FG000|30 Day Follow-up Visit|Missed Visit|5|||
131163532|NCT00530712|472220896|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
131163533|NCT00530712|472220896|FG000|6 Month Follow-up Visit|Missed Visit|3|||
131163534|NCT00530712|472220896|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
131163535|NCT00530712|472220896|FG000|6 Month Follow-up Visit|Death|2|||
131163536|NCT00530712|472220896|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
131163537|NCT00530712|472220896|FG000|12 Month Follow-up Visit|Missed Visit|3|||
131163538|NCT00530712|472220896|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
131163539|NCT00530712|472220896|FG000|12 Month Follow-up Visit|Death|9|||
131163540|NCT03117049|472220902|FG000|Overall Study|Continued the follow-up period|109|||
131163541|NCT03117049|472220903|FG001|Overall Study|Continued the follow-up period|129|||
131163542|NCT03117049|472220902|FG000|Overall Study|Died|82|||
131163543|NCT03117049|472220903|FG001|Overall Study|Died|93|||
131163544|NCT03117049|472220902|FG000|Overall Study|Consent withdrawal|7|||
131235596|NCT01901055|472490968|FG000|Randomization But Not Titrated|Physician Decision|0|||
130729298|NCT04324021|470630641|FG001|Overall Study|Lack of Efficacy|0|||
131163545|NCT03117049|472220903|FG001|Overall Study|Consent withdrawal|6|||
131163546|NCT03117049|472220902|FG000|Overall Study|Missing contact|3|||
131163547|NCT03117049|472220903|FG001|Overall Study|Missing contact|3|||
130729299|NCT04324021|470630642|FG002|Overall Study|Lack of Efficacy|1|||
130729300|NCT04324021|470630640|FG000|Overall Study|Death|1|||
130729301|NCT04324021|470630641|FG001|Overall Study|Death|1|||
131163548|NCT02399475|472220908|FG000|Overall Study|Physician Decision|1|||
131163549|NCT02399475|472220909|FG001|Overall Study|Physician Decision|0|||
131163550|NCT02260193|472220910|FG000|Overall Study|Lack of Efficacy|0|||
131163551|NCT02260193|472220911|FG001|Overall Study|Lack of Efficacy|1|||
130729302|NCT04324021|470630642|FG002|Overall Study|Death|0|||
130729303|NCT03097991|470630643|FG000|Overall Study|Didn't meet study criteria|8|||
130729304|NCT03097991|470630644|FG001|Overall Study|Didn't meet study criteria|0|||
131163552|NCT02260193|472220912|FG002|Overall Study|Lack of Efficacy|6|||
131163553|NCT02260193|472220910|FG000|Overall Study|Adverse Event|3|||
131163554|NCT02260193|472220911|FG001|Overall Study|Adverse Event|4|||
131163555|NCT02260193|472220912|FG002|Overall Study|Adverse Event|1|||
131163556|NCT02260193|472220910|FG000|Overall Study|Protocol Violation|0|||
131163557|NCT02260193|472220911|FG001|Overall Study|Protocol Violation|4|||
131163558|NCT02260193|472220912|FG002|Overall Study|Protocol Violation|0|||
131163559|NCT02260193|472220910|FG000|Overall Study|Withdrawal by Subject|3|||
130729305|NCT03097991|470630643|FG000|Overall Study|Withdrawal by Subject|12|||
130729306|NCT03097991|470630644|FG001|Overall Study|Withdrawal by Subject|6|||
130729307|NCT03097991|470630643|FG000|Overall Study|Death of Baby|3|||
130729308|NCT03097991|470630644|FG001|Overall Study|Death of Baby|1|||
130729309|NCT03097991|470630643|FG000|Overall Study|Lost to Follow-up|24|||
130729310|NCT03097991|470630644|FG001|Overall Study|Lost to Follow-up|38|||
130729311|NCT03097991|470630643|FG000|Overall Study|Adverse Event|3|||
130729312|NCT03097991|470630644|FG001|Overall Study|Adverse Event|5|||
130729313|NCT00246324|470630645|FG000|Overall Study|Withdrawal by Subject|1|||
130729314|NCT02006732|470630646|FG000|Overall Study|Adverse Event|10|||
130729315|NCT02006732|470630647|FG001|Overall Study|Adverse Event|7|||
131163560|NCT02260193|472220911|FG001|Overall Study|Withdrawal by Subject|0|||
131163561|NCT02260193|472220912|FG002|Overall Study|Withdrawal by Subject|2|||
131163562|NCT02260193|472220910|FG000|Overall Study|Kidney Transplantation|0|||
131163563|NCT02260193|472220911|FG001|Overall Study|Kidney Transplantation|0|||
131163564|NCT02260193|472220912|FG002|Overall Study|Kidney Transplantation|1|||
131163565|NCT00408421|472222554|FG000|Treatment Initial Randomization|Adverse Event|5|||
131163566|NCT00408421|472222555|FG001|Treatment Initial Randomization|Adverse Event|9|||
131163567|NCT00408421|472222556|FG002|Treatment Initial Randomization|Adverse Event|0|||
130729316|NCT02006732|470630648|FG002|Overall Study|Adverse Event|4|||
130729317|NCT02006732|470630649|FG003|Overall Study|Adverse Event|2|||
130729318|NCT02006732|470630646|FG000|Overall Study|Lack of Efficacy|6|||
130729319|NCT02006732|470630647|FG001|Overall Study|Lack of Efficacy|3|||
130729320|NCT02006732|470630648|FG002|Overall Study|Lack of Efficacy|1|||
130729321|NCT02006732|470630649|FG003|Overall Study|Lack of Efficacy|1|||
130729322|NCT02006732|470630646|FG000|Overall Study|Protocol Violation|1|||
130729323|NCT02006732|470630647|FG001|Overall Study|Protocol Violation|1|||
130729324|NCT02006732|470630648|FG002|Overall Study|Protocol Violation|0|||
130729325|NCT02006732|470630649|FG003|Overall Study|Protocol Violation|0|||
130729326|NCT02006732|470630646|FG000|Overall Study|Lost to Follow-up|0|||
130729327|NCT02006732|470630647|FG001|Overall Study|Lost to Follow-up|1|||
130729328|NCT02006732|470630648|FG002|Overall Study|Lost to Follow-up|0|||
130729329|NCT02006732|470630649|FG003|Overall Study|Lost to Follow-up|0|||
130729330|NCT02006732|470630646|FG000|Overall Study|Withdrawal by Subject|3|||
130729331|NCT02006732|470630647|FG001|Overall Study|Withdrawal by Subject|0|||
130729332|NCT02006732|470630648|FG002|Overall Study|Withdrawal by Subject|4|||
130729333|NCT02006732|470630649|FG003|Overall Study|Withdrawal by Subject|1|||
130729334|NCT03052127|470630650|FG000|Overall Study|Withdrawal by Subject|0|||
130729335|NCT03052127|470630651|FG001|Overall Study|Withdrawal by Subject|0|||
130729336|NCT03052127|470630652|FG002|Overall Study|Withdrawal by Subject|0|||
130729337|NCT03052127|470630653|FG003|Overall Study|Withdrawal by Subject|0|||
130729338|NCT03052127|470630654|FG004|Overall Study|Withdrawal by Subject|0|||
130729339|NCT03052127|470630655|FG005|Overall Study|Withdrawal by Subject|0|||
130729340|NCT03052127|470630656|FG006|Overall Study|Withdrawal by Subject|0|||
130729341|NCT03052127|470630657|FG007|Overall Study|Withdrawal by Subject|1|||
131163568|NCT00408421|472222554|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
131163569|NCT00408421|472222555|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
131163570|NCT00408421|472222556|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
131163571|NCT00408421|472222554|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
131163572|NCT00408421|472222555|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
131163573|NCT00408421|472222556|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
131163574|NCT00408421|472222554|FG000|Treatment Initial Randomization|Physician Decision|1|||
130729342|NCT03052127|470630658|FG008|Overall Study|Withdrawal by Subject|1|||
130729343|NCT03052127|470630659|FG009|Overall Study|Withdrawal by Subject|1|||
130729344|NCT03052127|470630660|FG010|Overall Study|Withdrawal by Subject|0|||
130729345|NCT03052127|470630661|FG011|Overall Study|Withdrawal by Subject|0|||
130729346|NCT03052127|470630650|FG000|Overall Study|Discontinuation by Sponsor|0|||
130729347|NCT03052127|470630651|FG001|Overall Study|Discontinuation by Sponsor|0|||
130729348|NCT03052127|470630652|FG002|Overall Study|Discontinuation by Sponsor|0|||
130729349|NCT03052127|470630653|FG003|Overall Study|Discontinuation by Sponsor|0|||
130729350|NCT03052127|470630654|FG004|Overall Study|Discontinuation by Sponsor|0|||
130729351|NCT03052127|470630655|FG005|Overall Study|Discontinuation by Sponsor|0|||
131163575|NCT00408421|472222555|FG001|Treatment Initial Randomization|Physician Decision|0|||
130729352|NCT03052127|470630656|FG006|Overall Study|Discontinuation by Sponsor|0|||
130729353|NCT03052127|470630657|FG007|Overall Study|Discontinuation by Sponsor|0|||
131163576|NCT00408421|472222556|FG002|Treatment Initial Randomization|Physician Decision|0|||
131163577|NCT00408421|472222554|FG000|Treatment Initial Randomization|Protocol Violation|0|||
131163578|NCT00408421|472222555|FG001|Treatment Initial Randomization|Protocol Violation|1|||
131163579|NCT00408421|472222556|FG002|Treatment Initial Randomization|Protocol Violation|0|||
131163580|NCT00408421|472222554|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
131163581|NCT00408421|472222555|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
131163582|NCT00408421|472222556|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
131163583|NCT00408421|472222554|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
131163584|NCT00408421|472222555|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
131163585|NCT00408421|472222556|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
131163586|NCT00408421|472222554|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
131163587|NCT00408421|472222555|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
131163588|NCT00408421|472222556|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
131163589|NCT00408421|472222554|FG000|Treatment Re-Randomization|Adverse Event|2|||
131163590|NCT00408421|472222555|FG001|Treatment Re-Randomization|Adverse Event|2|||
131163591|NCT00408421|472222556|FG002|Treatment Re-Randomization|Adverse Event|4|||
131163592|NCT00408421|472222554|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
131163593|NCT00408421|472222555|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
131163594|NCT00408421|472222556|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
131163595|NCT00408421|472222554|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
131163596|NCT00408421|472222555|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
131163597|NCT00408421|472222556|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
131163598|NCT00408421|472222554|FG000|Treatment Re-Randomization|Physician Decision|1|||
131163599|NCT00408421|472222555|FG001|Treatment Re-Randomization|Physician Decision|3|||
131163600|NCT00408421|472222556|FG002|Treatment Re-Randomization|Physician Decision|0|||
131163601|NCT00408421|472222554|FG000|Treatment Re-Randomization|Protocol Violation|1|||
131163602|NCT00408421|472222555|FG001|Treatment Re-Randomization|Protocol Violation|1|||
131163603|NCT00408421|472222556|FG002|Treatment Re-Randomization|Protocol Violation|0|||
131163604|NCT00408421|472222554|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
131163605|NCT00408421|472222555|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
131163606|NCT00408421|472222556|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
131163607|NCT02322892|472222559|FG000|Overall Study|Surgery cancelled|1|||
131163608|NCT02322892|472222560|FG001|Overall Study|Surgery cancelled|2|||
131163609|NCT02322892|472222559|FG000|Overall Study|Met exclusion criteria|0|||
131163610|NCT02322892|472222560|FG001|Overall Study|Met exclusion criteria|1|||
131163611|NCT02322892|472222559|FG000|Overall Study|Protocol Violation|1|||
131163612|NCT02322892|472222560|FG001|Overall Study|Protocol Violation|0|||
131163613|NCT02125331|472222563|FG000|Overall Study|Protocol Violation|1|||
131163614|NCT02125331|472222564|FG001|Overall Study|Protocol Violation|0|||
131163615|NCT02125331|472222563|FG000|Overall Study|technical problem|2|||
131163616|NCT02125331|472222564|FG001|Overall Study|technical problem|0|||
131163617|NCT02125331|472222563|FG000|Overall Study|screen failure|2|||
131163618|NCT02125331|472222564|FG001|Overall Study|screen failure|0|||
131163619|NCT03009539|472222565|FG000|Overall Study|Lost to Follow-up|132|||
131163620|NCT03009539|472222566|FG001|Overall Study|Lost to Follow-up|113|||
131163621|NCT03009539|472222567|FG002|Overall Study|Lost to Follow-up|132|||
131163622|NCT03009539|472222568|FG003|Overall Study|Lost to Follow-up|113|||
131163623|NCT03151148|472222569|FG000|Overall Study|Lost to Follow-up|1|||
131163624|NCT03151148|472222570|FG001|Overall Study|Lost to Follow-up|0|||
131163625|NCT03151148|472222569|FG000|Overall Study|Withdrawal by Subject|1|||
131163626|NCT03151148|472222570|FG001|Overall Study|Withdrawal by Subject|0|||
131163627|NCT00710034|472222571|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
131163628|NCT00710034|472222572|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
131163629|NCT00710034|472222571|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
131163630|NCT00710034|472222572|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
131163631|NCT00710034|472222571|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
131163632|NCT00710034|472222572|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
131163633|NCT00710034|472222571|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
131163634|NCT00710034|472222572|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
131163635|NCT00710034|472222571|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
131163636|NCT00710034|472222572|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
131163637|NCT00710034|472222571|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
131163638|NCT00710034|472222572|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
131163639|NCT00710034|472222571|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
131163640|NCT00710034|472222572|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
131163641|NCT00710034|472222571|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
131163642|NCT00710034|472222572|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
131163643|NCT00710034|472222571|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
131163644|NCT00710034|472222572|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
131163645|NCT00710034|472222571|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
131163646|NCT00710034|472222572|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
131163647|NCT00710034|472222571|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
131163648|NCT00710034|472222572|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
131163649|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
131163650|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
131163651|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
131163652|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
131163653|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Death|8|||
131163654|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Death|3|||
131163655|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
131163656|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
131163657|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
131163658|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
131163659|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
131163660|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
131163661|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
131163662|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
131163663|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
131163664|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
131163665|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
131163666|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
131163667|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
131163668|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
131163669|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
131163670|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
131163671|NCT00494871|472222573|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
131163672|NCT00494871|472222574|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
131163673|NCT00494871|472222573|FG000|Follow-up (FU) Period|Adverse Event|1|||
131163674|NCT00494871|472222574|FG001|Follow-up (FU) Period|Adverse Event|1|||
131163675|NCT00494871|472222573|FG000|Follow-up (FU) Period|Death|13|||
131163676|NCT00494871|472222574|FG001|Follow-up (FU) Period|Death|12|||
131163677|NCT00494871|472222573|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
131163678|NCT00494871|472222574|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
131163679|NCT00494871|472222573|FG000|Follow-up (FU) Period|Physician Decision|0|||
131163680|NCT00494871|472222574|FG001|Follow-up (FU) Period|Physician Decision|1|||
131163681|NCT00494871|472222573|FG000|Follow-up (FU) Period|Protocol Violation|1|||
131163682|NCT00494871|472222574|FG001|Follow-up (FU) Period|Protocol Violation|0|||
131163683|NCT00494871|472222573|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
131163684|NCT00494871|472222574|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
131163685|NCT00494871|472222573|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
131163686|NCT00494871|472222574|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
131163687|NCT04543955|472222575|FG000|Overall Study|Company cancelled study|1|||
131163688|NCT04543955|472222576|FG001|Overall Study|Company cancelled study|0|||
131163689|NCT02601001|472222579|FG000|Dosing Period 2|Adverse Event|0|||
131163690|NCT02601001|472222580|FG001|Dosing Period 2|Adverse Event|0|||
131163691|NCT02601001|472222581|FG002|Dosing Period 2|Adverse Event|0|||
131163692|NCT02601001|472222582|FG003|Dosing Period 2|Adverse Event|0|||
131163693|NCT02601001|472222583|FG004|Dosing Period 2|Adverse Event|0|||
131163694|NCT02601001|472222584|FG005|Dosing Period 2|Adverse Event|0|||
131163695|NCT02601001|472222585|FG006|Dosing Period 2|Adverse Event|1|||
131163696|NCT02433210|472222587|FG000|Overall Study|Physician Decision|1|||
131163697|NCT02433210|472222588|FG001|Overall Study|Physician Decision|0|||
131163698|NCT02433210|472222589|FG002|Overall Study|Physician Decision|0|||
131163699|NCT01989546|472222590|FG000|Overall Study|Clinical Progression|1|||
131163700|NCT01989546|472222590|FG000|Overall Study|Disease progression on study|8|||
131163701|NCT01958671|472222591|FG000|Overall Study|Adverse Event|1|||
131163702|NCT01958671|472222592|FG001|Overall Study|Adverse Event|1|||
131163703|NCT01958671|472222593|FG002|Overall Study|Adverse Event|5|||
131163704|NCT01958671|472222591|FG000|Overall Study|Death|1|||
131163705|NCT01958671|472222592|FG001|Overall Study|Death|0|||
131163706|NCT01958671|472222593|FG002|Overall Study|Death|0|||
131163707|NCT01958671|472222591|FG000|Overall Study|Excluded medication|0|||
131163708|NCT01958671|472222592|FG001|Overall Study|Excluded medication|0|||
131163709|NCT01958671|472222593|FG002|Overall Study|Excluded medication|1|||
131163710|NCT01958671|472222591|FG000|Overall Study|Hyperglycemia|0|||
131163711|NCT01958671|472222592|FG001|Overall Study|Hyperglycemia|0|||
131163712|NCT01958671|472222593|FG002|Overall Study|Hyperglycemia|2|||
131163713|NCT01958671|472222591|FG000|Overall Study|Lost to Follow-up|7|||
131163714|NCT01958671|472222592|FG001|Overall Study|Lost to Follow-up|11|||
131163715|NCT01958671|472222593|FG002|Overall Study|Lost to Follow-up|7|||
131163716|NCT01958671|472222591|FG000|Overall Study|Non-compliance with study drug|1|||
131163717|NCT01958671|472222592|FG001|Overall Study|Non-compliance with study drug|1|||
131163718|NCT01958671|472222593|FG002|Overall Study|Non-compliance with study drug|1|||
131163719|NCT01958671|472222591|FG000|Overall Study|Pregnancy|0|||
131163720|NCT01958671|472222592|FG001|Overall Study|Pregnancy|0|||
131163721|NCT01958671|472222593|FG002|Overall Study|Pregnancy|1|||
131163722|NCT01958671|472222591|FG000|Overall Study|Protocol Violation|0|||
131163723|NCT01958671|472222592|FG001|Overall Study|Protocol Violation|1|||
131163724|NCT01958671|472222593|FG002|Overall Study|Protocol Violation|0|||
131163725|NCT01958671|472222591|FG000|Overall Study|Study site terminated by sponsor|1|||
131163726|NCT01958671|472222592|FG001|Overall Study|Study site terminated by sponsor|0|||
131163727|NCT01958671|472222593|FG002|Overall Study|Study site terminated by sponsor|1|||
131163728|NCT01958671|472222591|FG000|Overall Study|Participant moved|0|||
131163729|NCT01958671|472222592|FG001|Overall Study|Participant moved|0|||
131163730|NCT01958671|472222593|FG002|Overall Study|Participant moved|1|||
131163731|NCT01958671|472222591|FG000|Overall Study|Withdrawal by Subject|8|||
131163732|NCT01958671|472222592|FG001|Overall Study|Withdrawal by Subject|10|||
131163733|NCT01958671|472222593|FG002|Overall Study|Withdrawal by Subject|13|||
131163734|NCT02421120|472222595|FG000|Overall Study|Adverse Event|1|||
131163735|NCT02207530|472222596|FG000|Overall Study|Worsening condition under investigation|78|||
131163736|NCT02207530|472222596|FG000|Overall Study|Patient decision to stop study treatment|5|||
131163737|NCT02207530|472222596|FG000|Overall Study|Adverse Event|8|||
131163738|NCT02345161|472222597|FG000|Overall Study|Withdrawal by Subject|25|||
131163739|NCT02345161|472222598|FG001|Overall Study|Withdrawal by Subject|33|||
131163740|NCT02345161|472222597|FG000|Overall Study|Adverse Event|16|||
131163741|NCT02345161|472222598|FG001|Overall Study|Adverse Event|19|||
131163742|NCT02345161|472222597|FG000|Overall Study|Physician Decision|4|||
131163743|NCT02345161|472222598|FG001|Overall Study|Physician Decision|4|||
131163744|NCT02345161|472222597|FG000|Overall Study|Lost to Follow-up|0|||
131163745|NCT02345161|472222598|FG001|Overall Study|Lost to Follow-up|1|||
131163746|NCT00305006|472222605|FG000|Overall Study|Withdrawal by Subject|1|||
131163747|NCT00305006|472222606|FG001|Overall Study|Withdrawal by Subject|0|||
131163748|NCT00305006|472222605|FG000|Overall Study|Failure to complete pretest|0|||
131163749|NCT00305006|472222606|FG001|Overall Study|Failure to complete pretest|1|||
131163750|NCT02606045|472222610|FG000|Overall Study|Study closed before treament could begin|1|||
131163751|NCT02606045|472222611|FG001|Overall Study|Study closed before treament could begin|2|||
131163752|NCT00907881|472222612|FG000|Overall Study|Lost to Follow-up|59|||
131163753|NCT00907881|472222612|FG000|Overall Study|Noncompliance|5|||
131163754|NCT00907881|472222612|FG000|Overall Study|Withdrawal by Subject|5|||
131163755|NCT00907881|472222612|FG000|Overall Study|Protocol Violation|1|||
131163756|NCT00907881|472222612|FG000|Overall Study|Missing discontinuation information|15|||
131163757|NCT01996319|472222615|FG000|Overall Study|Protocol Violation|1|||
131163758|NCT01996319|472222616|FG001|Overall Study|Protocol Violation|0|||
131163759|NCT01996319|472222615|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
131163760|NCT01996319|472222616|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
131163761|NCT01996319|472222615|FG000|Overall Study|Adverse Event|2|||
131163762|NCT01996319|472222616|FG001|Overall Study|Adverse Event|2|||
131163763|NCT01671085|472222619|FG000|Overall Study|Withdrawal by Subject|1|||
131163764|NCT01671085|472222620|FG001|Overall Study|Withdrawal by Subject|0|||
131163765|NCT00637273|472222621|FG000|Overall Study|Adverse Event|11|||
131163766|NCT00637273|472222622|FG001|Overall Study|Adverse Event|5|||
131163767|NCT00637273|472222623|FG002|Overall Study|Adverse Event|7|||
131163768|NCT00637273|472222621|FG000|Overall Study|Lost to Follow-up|8|||
131163769|NCT00637273|472222622|FG001|Overall Study|Lost to Follow-up|9|||
131163770|NCT00637273|472222623|FG002|Overall Study|Lost to Follow-up|13|||
131163771|NCT00637273|472222621|FG000|Overall Study|Protocol Violation|2|||
131163772|NCT00637273|472222622|FG001|Overall Study|Protocol Violation|4|||
131163773|NCT00637273|472222623|FG002|Overall Study|Protocol Violation|1|||
131163774|NCT00637273|472222621|FG000|Overall Study|Withdrawal of Consent|18|||
131163775|NCT00637273|472222622|FG001|Overall Study|Withdrawal of Consent|6|||
131163776|NCT00637273|472222623|FG002|Overall Study|Withdrawal of Consent|18|||
131163777|NCT00637273|472222621|FG000|Overall Study|Investigator Decision|1|||
131163778|NCT00637273|472222622|FG001|Overall Study|Investigator Decision|3|||
131163779|NCT00637273|472222623|FG002|Overall Study|Investigator Decision|1|||
131163780|NCT00637273|472222621|FG000|Overall Study|Administrative|2|||
131235597|NCT01901055|472490969|FG001|Randomization But Not Titrated|Physician Decision|1|||
131235598|NCT01901055|472490968|FG000|Started Protocol to Week 6|Physician Decision|2|||
131163781|NCT00637273|472222622|FG001|Overall Study|Administrative|0|||
131163782|NCT00637273|472222623|FG002|Overall Study|Administrative|0|||
131163783|NCT00637273|472222621|FG000|Overall Study|Loss of Glucose Control|1|||
131163784|NCT00637273|472222622|FG001|Overall Study|Loss of Glucose Control|1|||
131163785|NCT00637273|472222623|FG002|Overall Study|Loss of Glucose Control|1|||
131163786|NCT00986258|472222624|FG000|Observation Period|Not eligible to be dosed|11|||
131163787|NCT00986258|472222624|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
131163788|NCT00986258|472222624|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
131163789|NCT00986258|472222624|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
131163790|NCT00986258|472222624|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
131163791|NCT00986258|472222624|FG000|Titration and Optimal Dose Period|Other|1|||
131163792|NCT00986258|472222624|FG000|Maintenance Period|Adverse Event|5|||
131163793|NCT00986258|472222624|FG000|Maintenance Period|Lack of Efficacy|2|||
131163794|NCT00986258|472222624|FG000|Maintenance Period|Withdrawal by Subject|2|||
131163795|NCT02616029|472222626|FG000|Overall Study|Adverse Event|1|||
131163796|NCT02616029|472222627|FG001|Overall Study|Adverse Event|0|||
131163797|NCT02616029|472222626|FG000|Overall Study|Death|0|||
131163798|NCT02616029|472222627|FG001|Overall Study|Death|1|||
131163799|NCT02616029|472222626|FG000|Overall Study|Protocol Violation|1|||
131163800|NCT02616029|472222627|FG001|Overall Study|Protocol Violation|0|||
131163801|NCT02616029|472222626|FG000|Overall Study|Withdrew Consent|1|||
131163802|NCT02616029|472222627|FG001|Overall Study|Withdrew Consent|0|||
131163803|NCT02616029|472222626|FG000|Overall Study|Enrolled and Never Treated|1|||
131163804|NCT02616029|472222627|FG001|Overall Study|Enrolled and Never Treated|1|||
131163805|NCT02214186|472222639|FG000|Overall Study|Lost to Follow-up|1|||
131163806|NCT02214186|472222640|FG001|Overall Study|Lost to Follow-up|1|||
131163807|NCT02214186|472222639|FG000|Overall Study|Protocol Violation|1|||
131163808|NCT02214186|472222640|FG001|Overall Study|Protocol Violation|1|||
131163809|NCT01525849|472222641|FG000|Overall Study|Lost to Follow-up|3|||
131163810|NCT01525849|472222642|FG001|Overall Study|Lost to Follow-up|2|||
131163811|NCT01525849|472222641|FG000|Overall Study|Withdrawal by Subject|1|||
131163812|NCT01525849|472222642|FG001|Overall Study|Withdrawal by Subject|9|||
131163813|NCT01525849|472222641|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
131163814|NCT01525849|472222642|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
131163815|NCT01525849|472222641|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
131163816|NCT01525849|472222642|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
131163817|NCT03964415|472222646|FG000|Overall Study|Sponsor's decision|1563|||
131163818|NCT03964415|472222647|FG001|Overall Study|Sponsor's decision|1528|||
131163819|NCT03964415|472222646|FG000|Overall Study|Lost to Follow-up|139|||
131163820|NCT03964415|472222647|FG001|Overall Study|Lost to Follow-up|146|||
131163821|NCT03964415|472222646|FG000|Overall Study|Withdrawal by Subject|68|||
131163822|NCT03964415|472222647|FG001|Overall Study|Withdrawal by Subject|72|||
131163823|NCT03964415|472222646|FG000|Overall Study|Physician Decision|34|||
131163824|NCT03964415|472222647|FG001|Overall Study|Physician Decision|48|||
131163825|NCT03964415|472222646|FG000|Overall Study|Adverse Event|3|||
131163826|NCT03964415|472222647|FG001|Overall Study|Adverse Event|0|||
131163827|NCT03964415|472222646|FG000|Overall Study|Death|4|||
131163828|NCT03964415|472222647|FG001|Overall Study|Death|6|||
131163829|NCT03964415|472222646|FG000|Overall Study|Protocol Violation|1|||
131163830|NCT03964415|472222647|FG001|Overall Study|Protocol Violation|4|||
131163831|NCT03964415|472222646|FG000|Overall Study|Other|35|||
131163832|NCT03964415|472222647|FG001|Overall Study|Other|38|||
131163833|NCT03964415|472222646|FG000|Overall Study|Randomized but not treated|6|||
131163834|NCT03964415|472222647|FG001|Overall Study|Randomized but not treated|7|||
131163835|NCT01734993|472222648|FG000|Overall Study|Adverse Event|1|||
131163836|NCT01734993|472222648|FG000|Overall Study|Lack of Efficacy|1|||
131163837|NCT04156646|472222652|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
131163838|NCT04156646|472222653|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
131163839|NCT00863928|472222660|FG000|Overall Study|Protocol Violation|26|||
131163840|NCT00863928|472222661|FG001|Overall Study|Protocol Violation|0|||
131163841|NCT00863928|472222660|FG000|Overall Study|Withdrawal by Subject|3|||
131163842|NCT00863928|472222661|FG001|Overall Study|Withdrawal by Subject|0|||
131163843|NCT00863928|472222660|FG000|Overall Study|surgery cancellation|4|||
131163844|NCT00863928|472222661|FG001|Overall Study|surgery cancellation|0|||
131163845|NCT00863928|472222660|FG000|Overall Study|medication allergy|3|||
131163846|NCT00863928|472222661|FG001|Overall Study|medication allergy|0|||
131163847|NCT01276847|472222665|FG000|Overall Study|Withdrawal by Subject|1|||
131163848|NCT01276847|472222666|FG001|Overall Study|Withdrawal by Subject|0|||
131163849|NCT01276847|472222667|FG002|Overall Study|Withdrawal by Subject|0|||
131163850|NCT03321929|472222668|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
131163851|NCT01259297|472222675|FG000|Double Blind Randomized Period|Death|1|||
131163852|NCT01259297|472222676|FG001|Double Blind Randomized Period|Death|1|||
131163853|NCT01259297|472222677|FG002|Double Blind Randomized Period|Death|1|||
131163854|NCT01259297|472222678|FG003|Double Blind Randomized Period|Death|2|||
131163855|NCT01259297|472222679|FG004|Double Blind Randomized Period|Death|1|||
131163856|NCT01259297|472222680|FG005|Double Blind Randomized Period|Death|5|||
131163857|NCT01259297|472222681|FG006|Double Blind Randomized Period|Death|2|||
131163858|NCT01259297|472222682|FG007|Double Blind Randomized Period|Death|1|||
131163859|NCT01259297|472222675|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
131163860|NCT01259297|472222676|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
131163861|NCT01259297|472222677|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
131163862|NCT01259297|472222678|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
131163863|NCT01259297|472222679|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
131163864|NCT01259297|472222680|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
131163865|NCT01259297|472222681|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
131163866|NCT01259297|472222682|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
131163867|NCT01259297|472222675|FG000|Double Blind Randomized Period|Other reasons|0|||
131163868|NCT01259297|472222676|FG001|Double Blind Randomized Period|Other reasons|1|||
131163869|NCT01259297|472222677|FG002|Double Blind Randomized Period|Other reasons|0|||
131163870|NCT01259297|472222678|FG003|Double Blind Randomized Period|Other reasons|0|||
131163871|NCT01259297|472222679|FG004|Double Blind Randomized Period|Other reasons|1|||
131163872|NCT01259297|472222680|FG005|Double Blind Randomized Period|Other reasons|2|||
131163873|NCT01259297|472222681|FG006|Double Blind Randomized Period|Other reasons|3|||
131163874|NCT01259297|472222682|FG007|Double Blind Randomized Period|Other reasons|1|||
131163875|NCT01345786|472222684|FG000|Overall Study|Adverse Event|0|||
131163876|NCT01345786|472222685|FG001|Overall Study|Adverse Event|1|||
131163877|NCT01345786|472222686|FG002|Overall Study|Adverse Event|3|||
131163878|NCT01345786|472222687|FG003|Overall Study|Adverse Event|1|||
131163879|NCT01345786|472222684|FG000|Overall Study|Subject withdrew consent|2|||
131163880|NCT01345786|472222685|FG001|Overall Study|Subject withdrew consent|2|||
131163881|NCT01345786|472222686|FG002|Overall Study|Subject withdrew consent|1|||
131163882|NCT01345786|472222687|FG003|Overall Study|Subject withdrew consent|0|||
131163883|NCT01345786|472222684|FG000|Overall Study|Noncompliance with protocol|1|||
131163884|NCT01345786|472222685|FG001|Overall Study|Noncompliance with protocol|0|||
131163885|NCT01345786|472222686|FG002|Overall Study|Noncompliance with protocol|1|||
131163886|NCT01345786|472222687|FG003|Overall Study|Noncompliance with protocol|0|||
131163887|NCT01345786|472222684|FG000|Overall Study|Administrative|3|||
131163888|NCT01345786|472222685|FG001|Overall Study|Administrative|5|||
131163889|NCT01345786|472222686|FG002|Overall Study|Administrative|0|||
131163890|NCT01345786|472222687|FG003|Overall Study|Administrative|0|||
131163891|NCT01345786|472222684|FG000|Overall Study|Lost to Follow-up|0|||
131163892|NCT01345786|472222685|FG001|Overall Study|Lost to Follow-up|0|||
131163893|NCT01345786|472222686|FG002|Overall Study|Lost to Follow-up|0|||
131163894|NCT01345786|472222687|FG003|Overall Study|Lost to Follow-up|2|||
131163895|NCT01963117|472222697|FG000|Overall Study|Death|1|||
131163896|NCT04430582|472222698|FG000|Overall Study|Found to meet exclusionary criteria|1|||
131163897|NCT04430582|472222699|FG001|Overall Study|Found to meet exclusionary criteria|0|||
131163898|NCT04430582|472222698|FG000|Overall Study|Withdrawal by Subject|0|||
131163899|NCT04430582|472222699|FG001|Overall Study|Withdrawal by Subject|1|||
131163900|NCT04267562|472224186|FG000|Assessed for Eligibility|Screen Failure|64|||
131163901|NCT04267562|472224186|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
131163902|NCT04267562|472224186|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
131163903|NCT04267562|472224186|FG000|Assessed for Eligibility|Site closure|6|||
131163904|NCT04267562|472224186|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
131163905|NCT04267562|472224186|FG000|Assessed for Eligibility|Physician Decision|1|||
131163906|NCT04267562|472224186|FG000|Month 24|Elective hysterectomy|1|||
131163907|NCT04267562|472224186|FG000|Month 24|Lost to Follow-up|1|||
131163908|NCT04267562|472224186|FG000|Month 36|Elective hysterectomy|2|||
131163909|NCT04267562|472224186|FG000|Month 36|Lost to Follow-up|3|||
131163910|NCT01850563|472224187|FG000|Overall Study|Not eligible|3|||
131163911|NCT01850563|472224188|FG001|Overall Study|Not eligible|0|||
131163912|NCT04359823|472224189|FG000|Overall Study|Lost to Follow-up|0|||
131163913|NCT04359823|472224190|FG001|Overall Study|Lost to Follow-up|1|||
131163914|NCT04359823|472224189|FG000|Overall Study|Withdrawal by Subject|0|||
131163915|NCT04359823|472224190|FG001|Overall Study|Withdrawal by Subject|1|||
131163916|NCT01505491|472224193|FG000|Overall Study|Other reason not listed|1|||
131163917|NCT01505491|472224194|FG001|Overall Study|Other reason not listed|0|||
131163918|NCT01505491|472224195|FG002|Overall Study|Other reason not listed|0|||
131163919|NCT01505491|472224193|FG000|Overall Study|Withdrawal by Subject|1|||
131163920|NCT01505491|472224194|FG001|Overall Study|Withdrawal by Subject|1|||
131163921|NCT01505491|472224195|FG002|Overall Study|Withdrawal by Subject|4|||
131163922|NCT01505491|472224193|FG000|Overall Study|Lost to Follow-up|0|||
131163923|NCT01505491|472224194|FG001|Overall Study|Lost to Follow-up|0|||
131163924|NCT01505491|472224195|FG002|Overall Study|Lost to Follow-up|1|||
131163925|NCT01740440|472224204|FG000|Overall Study|Lost to Follow-up|3|||
131163926|NCT00367640|472224205|FG000|Overall Study|Adverse Event|3|||
131163927|NCT00367640|472224206|FG001|Overall Study|Adverse Event|6|||
131163928|NCT00367640|472224207|FG002|Overall Study|Adverse Event|8|||
130729354|NCT03052127|470630658|FG008|Overall Study|Discontinuation by Sponsor|4|||
131163929|NCT00367640|472224208|FG003|Overall Study|Adverse Event|0|||
130729355|NCT03052127|470630659|FG009|Overall Study|Discontinuation by Sponsor|2|||
130729356|NCT03052127|470630660|FG010|Overall Study|Discontinuation by Sponsor|5|||
130729357|NCT03052127|470630661|FG011|Overall Study|Discontinuation by Sponsor|13|||
130729358|NCT03052127|470630650|FG000|Overall Study|Inability to comply with trial requirements|0|||
131163930|NCT00367640|472224205|FG000|Overall Study|Withdrawal by Subject|8|||
131163931|NCT00367640|472224206|FG001|Overall Study|Withdrawal by Subject|11|||
131163932|NCT00367640|472224207|FG002|Overall Study|Withdrawal by Subject|8|||
131163933|NCT00367640|472224208|FG003|Overall Study|Withdrawal by Subject|6|||
131163934|NCT00367640|472224205|FG000|Overall Study|Any other reason not above-mentioned|7|||
131163935|NCT00367640|472224206|FG001|Overall Study|Any other reason not above-mentioned|5|||
131163936|NCT00367640|472224207|FG002|Overall Study|Any other reason not above-mentioned|3|||
131163937|NCT00367640|472224208|FG003|Overall Study|Any other reason not above-mentioned|4|||
131163938|NCT01063751|472224210|FG000|Overall Study|Censored from analyses|42|||
131163939|NCT01063751|472224210|FG000|Overall Study|Withdrawal by Subject|34|||
131163940|NCT01063751|472224210|FG000|Overall Study|Lost to Follow-up|30|||
131163941|NCT01063751|472224210|FG000|Overall Study|Death|13|||
131163942|NCT01063751|472224210|FG000|Overall Study|Sponsored Terminated Study|60|||
131163943|NCT01063751|472224210|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
131163944|NCT01063751|472224210|FG000|Overall Study|Investigator site closed|10|||
131163945|NCT01063751|472224210|FG000|Overall Study|Revision|6|||
131163946|NCT01063751|472224210|FG000|Overall Study|Physician Decision|4|||
131163947|NCT00406315|472224218|FG000|Overall Study|Death|1|||
131163948|NCT00406315|472224218|FG000|Overall Study|Adverse Event|39|||
131163949|NCT00406315|472224218|FG000|Overall Study|Laboratory Abnormality|4|||
131163950|NCT00406315|472224218|FG000|Overall Study|Lack of Efficacy|13|||
131163951|NCT00406315|472224218|FG000|Overall Study|Other|33|||
131163952|NCT00406315|472224218|FG000|Overall Study|Lost to Follow-up|21|||
131163953|NCT00406315|472224218|FG000|Overall Study|Withdrawal by Subject|30|||
131163954|NCT01312428|472224219|FG000|Overall Study|Study Termination|3|||
131163955|NCT01312428|472224220|FG001|Overall Study|Study Termination|4|||
131163956|NCT00339183|472224222|FG000|Overall Study|Adverse Event|5|||
131163957|NCT00339183|472224223|FG001|Overall Study|Adverse Event|3|||
131163958|NCT00339183|472224222|FG000|Overall Study|Withdrawal by Subject|16|||
131163959|NCT00339183|472224223|FG001|Overall Study|Withdrawal by Subject|19|||
131163960|NCT00339183|472224222|FG000|Overall Study|Physician Decision|2|||
131163961|NCT00339183|472224223|FG001|Overall Study|Physician Decision|4|||
131163962|NCT00339183|472224222|FG000|Overall Study|Lost to Follow-up|17|||
131163963|NCT00339183|472224223|FG001|Overall Study|Lost to Follow-up|17|||
131163964|NCT00339183|472224222|FG000|Overall Study|Protocol-specified criteria|12|||
131163965|NCT00339183|472224223|FG001|Overall Study|Protocol-specified criteria|8|||
131163966|NCT00339183|472224222|FG000|Overall Study|Missing reason|3|||
131163967|NCT00339183|472224223|FG001|Overall Study|Missing reason|1|||
131163968|NCT00339183|472224222|FG000|Overall Study|Other|46|||
131163969|NCT00339183|472224223|FG001|Overall Study|Other|40|||
131163970|NCT00339183|472224222|FG000|Overall Study|Ongoing|20|||
131163971|NCT00339183|472224223|FG001|Overall Study|Ongoing|13|||
131163972|NCT00793819|472224224|FG000|Overall Study|Adverse Event|8|||
131163973|NCT00793819|472224225|FG001|Overall Study|Adverse Event|4|||
131163974|NCT00793819|472224224|FG000|Overall Study|Lack of Efficacy|1|||
131163975|NCT00793819|472224225|FG001|Overall Study|Lack of Efficacy|1|||
131163976|NCT00793819|472224224|FG000|Overall Study|Withdrawal by Subject|4|||
131163977|NCT00793819|472224225|FG001|Overall Study|Withdrawal by Subject|3|||
131163978|NCT00793819|472224224|FG000|Overall Study|Lost to Follow-up|1|||
131163979|NCT00793819|472224225|FG001|Overall Study|Lost to Follow-up|1|||
131163980|NCT00446446|472224226|FG000|Overall Study|Death|10|||
131163981|NCT00446446|472224226|FG000|Overall Study|Withdrawal by Subject|6|||
131163982|NCT00446446|472224226|FG000|Overall Study|Other|4|||
131163983|NCT00446446|472224226|FG000|Overall Study|Disease Progession|2|||
131163984|NCT00446446|472224226|FG000|Overall Study|Adverse Event|1|||
131163985|NCT00446446|472224226|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
131163986|NCT00611130|472224227|FG000|Overall Study|Lost to Follow-up|25|||
131163987|NCT00611130|472224228|FG001|Overall Study|Lost to Follow-up|29|||
131163988|NCT00611130|472224227|FG000|Overall Study|Protocol noncompliance|7|||
131163989|NCT00611130|472224228|FG001|Overall Study|Protocol noncompliance|6|||
131163990|NCT00611130|472224227|FG000|Overall Study|Withdrawal by Subject|6|||
131163991|NCT00611130|472224228|FG001|Overall Study|Withdrawal by Subject|5|||
131163992|NCT00611130|472224227|FG000|Overall Study|Other|5|||
131163993|NCT00611130|472224228|FG001|Overall Study|Other|4|||
131163994|NCT00611130|472224227|FG000|Overall Study|Incarceration|3|||
131163995|NCT00611130|472224228|FG001|Overall Study|Incarceration|2|||
131163996|NCT00611130|472224227|FG000|Overall Study|Administrative|1|||
131163997|NCT00611130|472224228|FG001|Overall Study|Administrative|1|||
131163998|NCT00611130|472224227|FG000|Overall Study|Adverse Event|1|||
131163999|NCT00611130|472224228|FG001|Overall Study|Adverse Event|0|||
131164000|NCT00611130|472224227|FG000|Overall Study|Death|1|||
131235599|NCT01901055|472490969|FG001|Started Protocol to Week 6|Physician Decision|1|||
131164001|NCT00611130|472224228|FG001|Overall Study|Death|0|||
131164002|NCT01455428|472224229|FG000|Overall Study|Protocol Violation|2|||
131164003|NCT01455428|472224230|FG001|Overall Study|Protocol Violation|1|||
131164004|NCT01455428|472224229|FG000|Overall Study|Adverse Event|6|||
131164005|NCT01455428|472224230|FG001|Overall Study|Adverse Event|2|||
131164006|NCT01455428|472224229|FG000|Overall Study|Lost to Follow-up|1|||
131164007|NCT01455428|472224230|FG001|Overall Study|Lost to Follow-up|1|||
131164008|NCT01455428|472224229|FG000|Overall Study|Withdrawal by Subject|2|||
131164009|NCT01455428|472224230|FG001|Overall Study|Withdrawal by Subject|5|||
131164010|NCT01455428|472224229|FG000|Overall Study|Did not meet entrance criteria|0|||
131164011|NCT01455428|472224230|FG001|Overall Study|Did not meet entrance criteria|2|||
131164012|NCT01455428|472224229|FG000|Overall Study|Insufficient clinical response|0|||
131164013|NCT01455428|472224230|FG001|Overall Study|Insufficient clinical response|2|||
131164014|NCT01455428|472224229|FG000|Overall Study|Did not receive treatment|1|||
131164015|NCT01455428|472224230|FG001|Overall Study|Did not receive treatment|1|||
131164016|NCT01455428|472224229|FG000|Overall Study|Other|2|||
131164017|NCT01455428|472224230|FG001|Overall Study|Other|4|||
131164018|NCT03303339|472224231|FG000|Overall Study|Death|2|||
131164019|NCT03303339|472224232|FG001|Overall Study|Death|2|||
131164020|NCT03303339|472224233|FG002|Overall Study|Death|2|||
131164021|NCT03303339|472224234|FG003|Overall Study|Death|1|||
131164022|NCT03303339|472224235|FG004|Overall Study|Death|4|||
131164023|NCT03303339|472224236|FG005|Overall Study|Death|2|||
131164024|NCT03303339|472224237|FG006|Overall Study|Death|2|||
131164025|NCT03303339|472224238|FG007|Overall Study|Death|2|||
131164026|NCT03303339|472224239|FG008|Overall Study|Death|3|||
131164027|NCT03303339|472224240|FG009|Overall Study|Death|3|||
131164028|NCT03303339|472224241|FG010|Overall Study|Death|4|||
131164029|NCT03303339|472224242|FG011|Overall Study|Death|24|||
131164030|NCT03303339|472224231|FG000|Overall Study|Study Terminated by Sponsor|0|||
131164031|NCT03303339|472224232|FG001|Overall Study|Study Terminated by Sponsor|0|||
131164032|NCT03303339|472224233|FG002|Overall Study|Study Terminated by Sponsor|0|||
131164033|NCT03303339|472224234|FG003|Overall Study|Study Terminated by Sponsor|0|||
131164034|NCT03303339|472224235|FG004|Overall Study|Study Terminated by Sponsor|0|||
131164035|NCT03303339|472224236|FG005|Overall Study|Study Terminated by Sponsor|0|||
131164036|NCT03303339|472224237|FG006|Overall Study|Study Terminated by Sponsor|0|||
131164037|NCT03303339|472224238|FG007|Overall Study|Study Terminated by Sponsor|0|||
131164038|NCT03303339|472224239|FG008|Overall Study|Study Terminated by Sponsor|1|||
131164039|NCT03303339|472224240|FG009|Overall Study|Study Terminated by Sponsor|0|||
131164040|NCT03303339|472224241|FG010|Overall Study|Study Terminated by Sponsor|1|||
131164041|NCT03303339|472224242|FG011|Overall Study|Study Terminated by Sponsor|1|||
131164042|NCT03303339|472224231|FG000|Overall Study|Withdrawal by Subject|1|||
131164043|NCT03303339|472224232|FG001|Overall Study|Withdrawal by Subject|0|||
131164044|NCT03303339|472224233|FG002|Overall Study|Withdrawal by Subject|0|||
131164045|NCT03303339|472224234|FG003|Overall Study|Withdrawal by Subject|0|||
131164046|NCT03303339|472224235|FG004|Overall Study|Withdrawal by Subject|0|||
131164047|NCT03303339|472224236|FG005|Overall Study|Withdrawal by Subject|1|||
131164048|NCT03303339|472224237|FG006|Overall Study|Withdrawal by Subject|1|||
131164049|NCT03303339|472224238|FG007|Overall Study|Withdrawal by Subject|0|||
131164050|NCT03303339|472224239|FG008|Overall Study|Withdrawal by Subject|0|||
131164051|NCT03303339|472224240|FG009|Overall Study|Withdrawal by Subject|0|||
131164052|NCT03303339|472224241|FG010|Overall Study|Withdrawal by Subject|0|||
131164053|NCT03303339|472224242|FG011|Overall Study|Withdrawal by Subject|2|||
131164054|NCT03303339|472224231|FG000|Overall Study|Physician Decision|0|||
131164055|NCT03303339|472224232|FG001|Overall Study|Physician Decision|0|||
131164056|NCT03303339|472224233|FG002|Overall Study|Physician Decision|0|||
131164057|NCT03303339|472224234|FG003|Overall Study|Physician Decision|0|||
131164058|NCT03303339|472224235|FG004|Overall Study|Physician Decision|1|||
131164059|NCT03303339|472224236|FG005|Overall Study|Physician Decision|0|||
131164060|NCT03303339|472224237|FG006|Overall Study|Physician Decision|0|||
131164061|NCT03303339|472224238|FG007|Overall Study|Physician Decision|0|||
131164062|NCT03303339|472224239|FG008|Overall Study|Physician Decision|0|||
131164063|NCT03303339|472224240|FG009|Overall Study|Physician Decision|0|||
131164064|NCT03303339|472224241|FG010|Overall Study|Physician Decision|0|||
131164065|NCT03303339|472224242|FG011|Overall Study|Physician Decision|0|||
131164066|NCT03303339|472224231|FG000|Overall Study|Safety/Non-compliance|0|||
131164067|NCT03303339|472224232|FG001|Overall Study|Safety/Non-compliance|0|||
131164068|NCT03303339|472224233|FG002|Overall Study|Safety/Non-compliance|0|||
131164069|NCT03303339|472224234|FG003|Overall Study|Safety/Non-compliance|0|||
131164070|NCT03303339|472224235|FG004|Overall Study|Safety/Non-compliance|0|||
131164071|NCT03303339|472224236|FG005|Overall Study|Safety/Non-compliance|0|||
131164072|NCT03303339|472224237|FG006|Overall Study|Safety/Non-compliance|0|||
131164073|NCT03303339|472224238|FG007|Overall Study|Safety/Non-compliance|0|||
131164074|NCT03303339|472224239|FG008|Overall Study|Safety/Non-compliance|0|||
131164075|NCT03303339|472224240|FG009|Overall Study|Safety/Non-compliance|0|||
131164076|NCT03303339|472224241|FG010|Overall Study|Safety/Non-compliance|0|||
131164077|NCT03303339|472224242|FG011|Overall Study|Safety/Non-compliance|1|||
131164078|NCT02062151|472224245|FG000|Overall Study|screen failure|1|||
131164079|NCT00751101|472224246|FG000|Overall Study|Withdrawal by Subject|1|||
131164080|NCT00751101|472224247|FG001|Overall Study|Withdrawal by Subject|0|||
131164081|NCT00751101|472224246|FG000|Overall Study|No HFS / Never Started Patch/|0|||
131164082|NCT00751101|472224247|FG001|Overall Study|No HFS / Never Started Patch/|4|||
131164083|NCT00751101|472224246|FG000|Overall Study|Never began capecitabine|1|||
131164084|NCT00751101|472224247|FG001|Overall Study|Never began capecitabine|0|||
131164085|NCT00751101|472224246|FG000|Overall Study|Physician Decision|0|||
131164086|NCT00751101|472224247|FG001|Overall Study|Physician Decision|1|||
131164087|NCT01905397|472224250|FG000|Overall Study|Death|0|||
131164088|NCT01905397|472224251|FG001|Overall Study|Death|1|||
131164089|NCT01905397|472224250|FG000|Overall Study|Withdrawal by Subject|2|||
131164090|NCT01905397|472224251|FG001|Overall Study|Withdrawal by Subject|0|||
131164091|NCT01905397|472224250|FG000|Overall Study|Surgery canceled/aborted|9|||
131164092|NCT01905397|472224251|FG001|Overall Study|Surgery canceled/aborted|5|||
131164093|NCT01905397|472224250|FG000|Overall Study|Incision < 7 cm|2|||
131164094|NCT01905397|472224251|FG001|Overall Study|Incision < 7 cm|0|||
131164095|NCT01905397|472224250|FG000|Overall Study|Wrong treatment|1|||
131164096|NCT01905397|472224251|FG001|Overall Study|Wrong treatment|1|||
131164097|NCT01905397|472224250|FG000|Overall Study|Device not applied|3|||
131164098|NCT01905397|472224251|FG001|Overall Study|Device not applied|0|||
131164099|NCT01905397|472224250|FG000|Overall Study|Dressing not applied in operating room|1|||
131164100|NCT01905397|472224251|FG001|Overall Study|Dressing not applied in operating room|0|||
131164101|NCT01905397|472224250|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
131164102|NCT01905397|472224251|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
131164103|NCT00455858|472224255|FG000|Overall Study|Lost to Follow-up|2|||
131164104|NCT00455858|472224255|FG000|Overall Study|Protocol Violation|1|||
131164105|NCT00455858|472224255|FG000|Overall Study|Lack of Efficacy|1|||
131164106|NCT00455858|472224255|FG000|Overall Study|Well controlled FPG without insulin|1|||
131164107|NCT00455858|472224255|FG000|Overall Study|Withdrawal|1|||
131164108|NCT02092389|472224257|FG000|Overall Study|Adverse Event|1|||
131164109|NCT02092389|472224257|FG000|Overall Study|Other|5|||
131164110|NCT01242020|472224258|FG000|Overall Study|Withdrawal by Subject|2|||
131164111|NCT01242020|472224259|FG001|Overall Study|Withdrawal by Subject|0|||
131164112|NCT01242020|472224258|FG000|Overall Study|Failed screening|1|||
131164113|NCT01242020|472224259|FG001|Overall Study|Failed screening|0|||
131164114|NCT00231062|472224264|FG000|Overall Study|Physician Decision|6|||
131164115|NCT01052012|472224265|FG000|Overall Study|Not treated|2|||
131164116|NCT01052012|472224266|FG001|Overall Study|Not treated|5|||
131164117|NCT01052012|472224267|FG002|Overall Study|Not treated|0|||
131164118|NCT01052012|472224268|FG003|Overall Study|Not treated|0|||
131164119|NCT01052012|472224269|FG004|Overall Study|Not treated|11|||
131164120|NCT01052012|472224270|FG005|Overall Study|Not treated|8|||
131164121|NCT01052012|472224265|FG000|Overall Study|Adverse Event|1|||
131164122|NCT01052012|472224266|FG001|Overall Study|Adverse Event|0|||
131164123|NCT01052012|472224267|FG002|Overall Study|Adverse Event|0|||
131164124|NCT01052012|472224268|FG003|Overall Study|Adverse Event|1|||
131164125|NCT01052012|472224269|FG004|Overall Study|Adverse Event|0|||
131164126|NCT01052012|472224270|FG005|Overall Study|Adverse Event|0|||
131164127|NCT01052012|472224265|FG000|Overall Study|Lost to Follow-up|0|||
131164128|NCT01052012|472224266|FG001|Overall Study|Lost to Follow-up|0|||
131164129|NCT01052012|472224267|FG002|Overall Study|Lost to Follow-up|0|||
131164130|NCT01052012|472224268|FG003|Overall Study|Lost to Follow-up|0|||
131164131|NCT01052012|472224269|FG004|Overall Study|Lost to Follow-up|1|||
131164132|NCT01052012|472224270|FG005|Overall Study|Lost to Follow-up|0|||
131164133|NCT01052012|472224265|FG000|Overall Study|Withdrawal by Subject|1|||
131164134|NCT01052012|472224266|FG001|Overall Study|Withdrawal by Subject|1|||
131164135|NCT01052012|472224267|FG002|Overall Study|Withdrawal by Subject|0|||
131164136|NCT01052012|472224268|FG003|Overall Study|Withdrawal by Subject|0|||
131164137|NCT01052012|472224269|FG004|Overall Study|Withdrawal by Subject|3|||
131164138|NCT01052012|472224270|FG005|Overall Study|Withdrawal by Subject|1|||
131164139|NCT01052012|472224265|FG000|Overall Study|Physician Decision|0|||
130729359|NCT03052127|470630651|FG001|Overall Study|Inability to comply with trial requirements|0|||
130729360|NCT03052127|470630652|FG002|Overall Study|Inability to comply with trial requirements|1|||
130729361|NCT03052127|470630653|FG003|Overall Study|Inability to comply with trial requirements|0|||
130729362|NCT03052127|470630654|FG004|Overall Study|Inability to comply with trial requirements|0|||
130729363|NCT03052127|470630655|FG005|Overall Study|Inability to comply with trial requirements|0|||
130729364|NCT03052127|470630656|FG006|Overall Study|Inability to comply with trial requirements|0|||
131164140|NCT01052012|472224266|FG001|Overall Study|Physician Decision|0|||
131164141|NCT01052012|472224267|FG002|Overall Study|Physician Decision|0|||
130729365|NCT03052127|470630657|FG007|Overall Study|Inability to comply with trial requirements|0|||
130729366|NCT03052127|470630658|FG008|Overall Study|Inability to comply with trial requirements|0|||
130729367|NCT03052127|470630659|FG009|Overall Study|Inability to comply with trial requirements|0|||
130729368|NCT03052127|470630660|FG010|Overall Study|Inability to comply with trial requirements|0|||
131164142|NCT01052012|472224268|FG003|Overall Study|Physician Decision|0|||
131164143|NCT01052012|472224269|FG004|Overall Study|Physician Decision|0|||
131164144|NCT01052012|472224270|FG005|Overall Study|Physician Decision|1|||
131164145|NCT01052012|472224265|FG000|Overall Study|Other|0|||
131164146|NCT01052012|472224266|FG001|Overall Study|Other|0|||
131164147|NCT01052012|472224267|FG002|Overall Study|Other|0|||
130729369|NCT03052127|470630661|FG011|Overall Study|Inability to comply with trial requirements|0|||
131164148|NCT01052012|472224268|FG003|Overall Study|Other|0|||
131164149|NCT01052012|472224269|FG004|Overall Study|Other|1|||
131164150|NCT01052012|472224270|FG005|Overall Study|Other|0|||
131164151|NCT02119104|472224274|FG000|Overall Study|Protocol Violation|16|||
131235600|NCT01901055|472490968|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
131164152|NCT02698423|472224276|FG000|Overall Study|Lost to Follow-up|19|||
131164153|NCT02698423|472224277|FG001|Overall Study|Lost to Follow-up|24|||
131164154|NCT03634072|472224278|FG000|Overall Study|Early termination of overall study|1|||
131164155|NCT03634072|472224279|FG001|Overall Study|Early termination of overall study|0|||
131164156|NCT01651260|472224282|FG000|Overall Study|unable to apply product|3|||
131164157|NCT02144220|472224283|FG000|Overall Study|technology incompatibility|9|||
131164158|NCT02144220|472224283|FG000|Overall Study|Lack of Efficacy|4|||
131164159|NCT02144220|472224283|FG000|Overall Study|Physician Decision|3|||
131164160|NCT02144220|472224283|FG000|Overall Study|Withdrawal by Subject|2|||
131164161|NCT02144220|472224283|FG000|Overall Study|Protocol Violation|1|||
131164162|NCT01952015|472224286|FG000|Induction|Protocol Violation|1|||
131164163|NCT01952015|472224286|FG000|Maintenance|Adverse Event|2|||
131164164|NCT01952015|472224286|FG000|Treatment Period 3|Physician Decision|9|||
131164165|NCT02239094|472224287|FG000|Overall Study|Withdrawal by Subject|1|||
131164166|NCT02239094|472224287|FG000|Overall Study|Remitted before started|1|||
131164167|NCT01597193|472224288|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
131164168|NCT01597193|472224289|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
131164169|NCT01597193|472224290|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
131164170|NCT01597193|472224291|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
131164171|NCT01597193|472224292|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
131164172|NCT01597193|472224293|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
131164173|NCT01597193|472224294|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
131164174|NCT01597193|472224288|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
131164175|NCT01597193|472224289|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
131164176|NCT01597193|472224290|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
131164177|NCT01597193|472224291|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
131164178|NCT01597193|472224292|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
131164179|NCT01597193|472224293|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
131164180|NCT01597193|472224294|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
131164181|NCT01597193|472224288|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
131164182|NCT01597193|472224289|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
131164183|NCT01597193|472224290|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
131164184|NCT01597193|472224291|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
131164185|NCT01597193|472224292|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
131164186|NCT01597193|472224293|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
131164187|NCT01597193|472224294|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
131164188|NCT01597193|472224288|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131164189|NCT01597193|472224289|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131164190|NCT01597193|472224290|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131164191|NCT01597193|472224291|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131164192|NCT01597193|472224292|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131164193|NCT01597193|472224293|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
131164194|NCT01597193|472224294|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
131164195|NCT01597193|472224288|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
131164196|NCT01597193|472224289|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
131164197|NCT01597193|472224290|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
131164198|NCT01597193|472224291|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
131164199|NCT01597193|472224292|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
131164200|NCT01597193|472224293|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
131164201|NCT01597193|472224294|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
131164202|NCT02508701|472224295|FG000|Overall Study|Lost to Follow-up|9|||
131164203|NCT02508701|472224296|FG001|Overall Study|Lost to Follow-up|5|||
131164204|NCT02508701|472224297|FG002|Overall Study|Lost to Follow-up|5|||
131164205|NCT02508701|472224298|FG003|Overall Study|Lost to Follow-up|3|||
131164206|NCT03184701|472224299|FG000|Overall Study|Death|3|||
131164207|NCT03184701|472224299|FG000|Overall Study|Physician Decision|3|||
131164208|NCT03184701|472224299|FG000|Overall Study|Withdrawal by Subject|6|||
131164209|NCT03184701|472224299|FG000|Overall Study|Lost to Follow-up|5|||
131164210|NCT00592501|472224301|FG000|Overall Study|Withdrawal by Subject|1|||
131164211|NCT00592501|472224301|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
131164212|NCT00053846|472224302|FG000|Overall Study|Changed mind|8|||
131164213|NCT00053846|472224303|FG001|Overall Study|Changed mind|13|||
131164214|NCT00053846|472224302|FG000|Overall Study|Became too ill|8|||
131164215|NCT00053846|472224303|FG001|Overall Study|Became too ill|7|||
131164216|NCT00053846|472224302|FG000|Overall Study|Expired|5|||
131164217|NCT00053846|472224303|FG001|Overall Study|Expired|0|||
131164218|NCT00053846|472224302|FG000|Overall Study|Became ineligible|3|||
131164219|NCT00053846|472224303|FG001|Overall Study|Became ineligible|1|||
131164220|NCT00053846|472224302|FG000|Overall Study|Did not return data|1|||
131164221|NCT00053846|472224303|FG001|Overall Study|Did not return data|2|||
131164222|NCT00053846|472224302|FG000|Overall Study|Quit due to side effects|1|||
131164223|NCT00053846|472224303|FG001|Overall Study|Quit due to side effects|3|||
131164224|NCT00053846|472224302|FG000|Overall Study|Pills too large|0|||
131164225|NCT00053846|472224303|FG001|Overall Study|Pills too large|1|||
131164226|NCT03880227|472224308|FG000|First Visit|Withdrawal by Subject|1|||
131164227|NCT03880227|472224309|FG001|First Visit|Withdrawal by Subject|0|||
131164228|NCT03880227|472224310|FG002|First Visit|Withdrawal by Subject|0|||
130780628|NCT00521365|470823137|FG000|Overall Study|Adverse Event|3|||
131164229|NCT03880227|472224311|FG003|First Visit|Withdrawal by Subject|0|||
131164230|NCT03880227|472224308|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
131164231|NCT03880227|472224309|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
131164232|NCT03880227|472224310|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
131164233|NCT03880227|472224311|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
131164234|NCT03880227|472224308|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
131164235|NCT03880227|472224309|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
131164236|NCT03880227|472224310|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
131164237|NCT03880227|472224311|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
131164238|NCT03880227|472224308|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
131164239|NCT03880227|472224309|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
131164240|NCT03880227|472224310|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
131164241|NCT03880227|472224311|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
131164242|NCT02229864|472224312|FG000|Overall Study|Death|2|||
131164243|NCT02229864|472224312|FG000|Overall Study|Lost to Follow-up|1|||
131164244|NCT01929044|472224316|FG000|Overall Study|Adverse Event|1|||
131164245|NCT01929044|472224317|FG001|Overall Study|Adverse Event|0|||
131164246|NCT01929044|472224316|FG000|Overall Study|Protocol Violation|9|||
131164247|NCT01929044|472224317|FG001|Overall Study|Protocol Violation|14|||
131164248|NCT01929044|472224316|FG000|Overall Study|Not Treated|1|||
131164249|NCT01929044|472224317|FG001|Overall Study|Not Treated|3|||
131164250|NCT01070784|472224318|FG000|Overall Study|Withdrawal by Subject|6|||
131164251|NCT01070784|472224319|FG001|Overall Study|Withdrawal by Subject|9|||
131164252|NCT01070784|472224318|FG000|Overall Study|Adverse Event|14|||
131164253|NCT01070784|472224319|FG001|Overall Study|Adverse Event|9|||
131164254|NCT01000064|472224321|FG000|Overall Study|Withdrawal by Subject|1|||
131164255|NCT01000064|472224322|FG001|Overall Study|Withdrawal by Subject|1|||
131164256|NCT02518620|472224323|FG000|Overall Study|Adverse Event|23|||
131164257|NCT02518620|472224324|FG001|Overall Study|Adverse Event|11|||
131164258|NCT02518620|472224323|FG000|Overall Study|Lack of Efficacy|2|||
131164259|NCT02518620|472224324|FG001|Overall Study|Lack of Efficacy|0|||
131164260|NCT02518620|472224323|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131164261|NCT02518620|472224324|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131164262|NCT02518620|472224323|FG000|Overall Study|Physician Decision|1|||
131164263|NCT02518620|472224324|FG001|Overall Study|Physician Decision|1|||
131164264|NCT02518620|472224323|FG000|Overall Study|Sponsor's Decision|0|||
131164265|NCT02518620|472224324|FG001|Overall Study|Sponsor's Decision|3|||
131164266|NCT02518620|472224323|FG000|Overall Study|Lost to Follow-up|1|||
131164267|NCT02518620|472224324|FG001|Overall Study|Lost to Follow-up|1|||
131164268|NCT02518620|472224323|FG000|Overall Study|Withdrawal by Subject|17|||
131164269|NCT02518620|472224324|FG001|Overall Study|Withdrawal by Subject|9|||
131164270|NCT02518620|472224323|FG000|Overall Study|Death|1|||
131164271|NCT02518620|472224324|FG001|Overall Study|Death|0|||
131164272|NCT02518620|472224323|FG000|Overall Study|Pregnancy Wish|3|||
131164273|NCT02518620|472224324|FG001|Overall Study|Pregnancy Wish|0|||
131164274|NCT02518620|472224323|FG000|Overall Study|Pregnancy|1|||
131164275|NCT02518620|472224324|FG001|Overall Study|Pregnancy|0|||
131164276|NCT02518620|472224323|FG000|Overall Study|Relocation|2|||
131164277|NCT02518620|472224324|FG001|Overall Study|Relocation|1|||
131164278|NCT01518192|472224325|FG000|Overall Study|Lost to Follow-up|29|||
131164279|NCT01518192|472224326|FG001|Overall Study|Lost to Follow-up|26|||
131164280|NCT01518192|472224327|FG002|Overall Study|Lost to Follow-up|35|||
131164281|NCT00085540|472224328|FG000|Overall Study|Withdrawal by Subject|0|||
131164282|NCT00085540|472224329|FG001|Overall Study|Withdrawal by Subject|1|||
131164283|NCT00085540|472224328|FG000|Overall Study|Protocol Violation|0|||
131164284|NCT00085540|472224329|FG001|Overall Study|Protocol Violation|1|||
131164285|NCT01605396|472224332|FG000|Overall Study|Adverse Event|5|||
131164286|NCT01605396|472224333|FG001|Overall Study|Adverse Event|3|||
131164287|NCT01605396|472224332|FG000|Overall Study|Lost to Follow-up|1|||
131164288|NCT01605396|472224333|FG001|Overall Study|Lost to Follow-up|0|||
131164289|NCT01605396|472224332|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131164290|NCT01605396|472224333|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131164291|NCT01605396|472224332|FG000|Overall Study|Physician Decision|2|||
131164292|NCT01605396|472224333|FG001|Overall Study|Physician Decision|2|||
131164293|NCT01605396|472224332|FG000|Overall Study|Progressive Disease|23|||
131164294|NCT01605396|472224333|FG001|Overall Study|Progressive Disease|27|||
131164295|NCT01605396|472224332|FG000|Overall Study|Withdrawal by Subject|4|||
131164296|NCT01605396|472224333|FG001|Overall Study|Withdrawal by Subject|2|||
131164297|NCT01605396|472224332|FG000|Overall Study|Transfer Off Study|4|||
131164298|NCT01605396|472224333|FG001|Overall Study|Transfer Off Study|5|||
131164299|NCT03090737|472224336|FG000|Overall Study|Other reasons|1|||
131164300|NCT03090737|472224336|FG000|Overall Study|Completed treatment as per protocol|17|||
131164301|NCT03090737|472224336|FG000|Overall Study|Maximum clinical benefit|2|||
131164302|NCT03090737|472224336|FG000|Overall Study|Adverse event unrelated to study drug|7|||
131164303|NCT03090737|472224336|FG000|Overall Study|Study drug toxicity|4|||
131164304|NCT03090737|472224336|FG000|Overall Study|Disease progression|98|||
131164305|NCT03141307|472224337|FG000|In-Hospital|Withdrawal by Subject|0|||
131164306|NCT03141307|472224338|FG001|In-Hospital|Withdrawal by Subject|2|||
131164307|NCT03141307|472224337|FG000|In-Hospital|Protocol Violation|4|||
131164308|NCT03141307|472224338|FG001|In-Hospital|Protocol Violation|0|||
131164309|NCT03141307|472224337|FG000|Follow-Up|Lost to Follow-up|97|||
131164310|NCT03141307|472224338|FG001|Follow-Up|Lost to Follow-up|54|||
131164311|NCT01770353|472224341|FG000|Overall Study|Progressive disease|2|||
131164312|NCT01770353|472224342|FG001|Overall Study|Progressive disease|1|||
131164313|NCT01770353|472224341|FG000|Overall Study|Adverse Event|0|||
131164314|NCT01770353|472224342|FG001|Overall Study|Adverse Event|1|||
131164315|NCT01770353|472224341|FG000|Overall Study|Protocol Violation|1|||
131164316|NCT01770353|472224342|FG001|Overall Study|Protocol Violation|0|||
131164317|NCT01770353|472224341|FG000|Overall Study|Physician Decision|0|||
131164318|NCT01770353|472224342|FG001|Overall Study|Physician Decision|3|||
131164319|NCT01770353|472224341|FG000|Overall Study|Clinical deterioration|3|||
131164320|NCT01770353|472224342|FG001|Overall Study|Clinical deterioration|6|||
131164321|NCT01770353|472224341|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
131164322|NCT01770353|472224342|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
131164323|NCT02574312|472224343|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
131164324|NCT02574312|472224344|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
131164325|NCT02078713|472226650|FG000|Overall Study|Lost to Follow-up|49|||
131164326|NCT02078713|472226651|FG001|Overall Study|Lost to Follow-up|55|||
131164327|NCT02078713|472226652|FG002|Overall Study|Lost to Follow-up|0|||
131164328|NCT02078713|472226653|FG003|Overall Study|Lost to Follow-up|0|||
131164329|NCT02078713|472226650|FG000|Overall Study|Pregnant at baseline|3|||
131164330|NCT02078713|472226651|FG001|Overall Study|Pregnant at baseline|5|||
131164331|NCT02078713|472226652|FG002|Overall Study|Pregnant at baseline|0|||
131164332|NCT02078713|472226653|FG003|Overall Study|Pregnant at baseline|0|||
131164333|NCT02078713|472226650|FG000|Overall Study|Enrolled twice|0|||
131164334|NCT02078713|472226651|FG001|Overall Study|Enrolled twice|1|||
131164335|NCT02078713|472226652|FG002|Overall Study|Enrolled twice|0|||
131164336|NCT02078713|472226653|FG003|Overall Study|Enrolled twice|0|||
131164337|NCT00696657|472226658|FG000|Overall Study|Protocol Violation|0|||
131164338|NCT00696657|472226659|FG001|Overall Study|Protocol Violation|0|||
131164339|NCT00696657|472226660|FG002|Overall Study|Protocol Violation|0|||
131164340|NCT00696657|472226661|FG003|Overall Study|Protocol Violation|0|||
131164341|NCT00696657|472226662|FG004|Overall Study|Protocol Violation|0|||
131164342|NCT00696657|472226663|FG005|Overall Study|Protocol Violation|1|||
131164343|NCT00696657|472226664|FG006|Overall Study|Protocol Violation|0|||
131164344|NCT00696657|472226665|FG007|Overall Study|Protocol Violation|0|||
131164345|NCT00696657|472226666|FG008|Overall Study|Protocol Violation|1|||
131164346|NCT00696657|472226658|FG000|Overall Study|Lack of Efficacy|0|||
131164347|NCT00696657|472226659|FG001|Overall Study|Lack of Efficacy|1|||
131164348|NCT00696657|472226660|FG002|Overall Study|Lack of Efficacy|0|||
131164349|NCT00696657|472226661|FG003|Overall Study|Lack of Efficacy|0|||
131164350|NCT00696657|472226662|FG004|Overall Study|Lack of Efficacy|0|||
131164351|NCT00696657|472226663|FG005|Overall Study|Lack of Efficacy|0|||
131164352|NCT00696657|472226664|FG006|Overall Study|Lack of Efficacy|0|||
131164353|NCT00696657|472226665|FG007|Overall Study|Lack of Efficacy|0|||
131164354|NCT00696657|472226666|FG008|Overall Study|Lack of Efficacy|0|||
131164355|NCT00696657|472226658|FG000|Overall Study|Withdrawal criteria|1|||
131164356|NCT00696657|472226659|FG001|Overall Study|Withdrawal criteria|3|||
131164357|NCT00696657|472226660|FG002|Overall Study|Withdrawal criteria|2|||
131164358|NCT00696657|472226661|FG003|Overall Study|Withdrawal criteria|2|||
131164359|NCT00696657|472226662|FG004|Overall Study|Withdrawal criteria|0|||
131164360|NCT00696657|472226663|FG005|Overall Study|Withdrawal criteria|0|||
131164361|NCT00696657|472226664|FG006|Overall Study|Withdrawal criteria|1|||
131164362|NCT00696657|472226665|FG007|Overall Study|Withdrawal criteria|1|||
131164363|NCT00696657|472226666|FG008|Overall Study|Withdrawal criteria|2|||
131164364|NCT00696657|472226658|FG000|Overall Study|Unclassified|0|||
131164365|NCT00696657|472226659|FG001|Overall Study|Unclassified|1|||
131164366|NCT00696657|472226660|FG002|Overall Study|Unclassified|3|||
131164367|NCT00696657|472226661|FG003|Overall Study|Unclassified|2|||
131164368|NCT00696657|472226662|FG004|Overall Study|Unclassified|4|||
131164369|NCT00696657|472226663|FG005|Overall Study|Unclassified|2|||
131164370|NCT00696657|472226664|FG006|Overall Study|Unclassified|0|||
131164371|NCT00696657|472226665|FG007|Overall Study|Unclassified|0|||
131164372|NCT00696657|472226666|FG008|Overall Study|Unclassified|1|||
131164373|NCT00696657|472226658|FG000|Overall Study|Adverse Event|0|||
131164374|NCT00696657|472226659|FG001|Overall Study|Adverse Event|0|||
131164375|NCT00696657|472226660|FG002|Overall Study|Adverse Event|3|||
131164376|NCT00696657|472226661|FG003|Overall Study|Adverse Event|7|||
131164377|NCT00696657|472226662|FG004|Overall Study|Adverse Event|6|||
131164378|NCT00696657|472226663|FG005|Overall Study|Adverse Event|9|||
131164379|NCT00696657|472226664|FG006|Overall Study|Adverse Event|14|||
131164380|NCT00696657|472226665|FG007|Overall Study|Adverse Event|2|||
131164381|NCT00696657|472226666|FG008|Overall Study|Adverse Event|5|||
131164382|NCT01790438|472226667|FG000|Overall Study|Adverse Event|3|||
131164383|NCT01790438|472226668|FG001|Overall Study|Adverse Event|2|||
131164384|NCT01790438|472226667|FG000|Overall Study|Death|4|||
131164385|NCT01790438|472226668|FG001|Overall Study|Death|0|||
131164386|NCT01790438|472226667|FG000|Overall Study|Lost to Follow-up|5|||
131164387|NCT01790438|472226668|FG001|Overall Study|Lost to Follow-up|2|||
131164388|NCT01790438|472226667|FG000|Overall Study|Withdrawal by Subject|13|||
131164389|NCT01790438|472226668|FG001|Overall Study|Withdrawal by Subject|2|||
130729370|NCT03052127|470630650|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130729371|NCT03052127|470630651|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
131164390|NCT01790438|472226667|FG000|Overall Study|Physician Decision|3|||
131164391|NCT01790438|472226668|FG001|Overall Study|Physician Decision|1|||
131164392|NCT01790438|472226667|FG000|Overall Study|Sponsor Decision|0|||
131164393|NCT01790438|472226668|FG001|Overall Study|Sponsor Decision|3|||
131164394|NCT01790438|472226667|FG000|Overall Study|Protocol Required Discontinuation|7|||
131164395|NCT01790438|472226668|FG001|Overall Study|Protocol Required Discontinuation|1|||
131164396|NCT02090114|472226672|FG000|Overall Study|Withdrawal by Subject|3|||
131164397|NCT02090114|472226673|FG001|Overall Study|Withdrawal by Subject|6|||
131164398|NCT02090114|472226674|FG002|Overall Study|Withdrawal by Subject|2|||
131164399|NCT02090114|472226675|FG003|Overall Study|Withdrawal by Subject|1|||
131164400|NCT02090114|472226672|FG000|Overall Study|Physician Decision|5|||
131164401|NCT02090114|472226673|FG001|Overall Study|Physician Decision|0|||
131164402|NCT02090114|472226674|FG002|Overall Study|Physician Decision|1|||
131164403|NCT02090114|472226675|FG003|Overall Study|Physician Decision|1|||
131164404|NCT02090114|472226672|FG000|Overall Study|Adverse Event|1|||
131164405|NCT02090114|472226673|FG001|Overall Study|Adverse Event|2|||
131164406|NCT02090114|472226674|FG002|Overall Study|Adverse Event|2|||
131164407|NCT02090114|472226675|FG003|Overall Study|Adverse Event|0|||
131164408|NCT02090114|472226672|FG000|Overall Study|Progressive Disease|20|||
131164409|NCT02090114|472226673|FG001|Overall Study|Progressive Disease|21|||
131164410|NCT02090114|472226674|FG002|Overall Study|Progressive Disease|23|||
131164411|NCT02090114|472226675|FG003|Overall Study|Progressive Disease|6|||
131164412|NCT02090114|472226672|FG000|Overall Study|Death|1|||
131164413|NCT02090114|472226673|FG001|Overall Study|Death|0|||
131164414|NCT02090114|472226674|FG002|Overall Study|Death|1|||
131164415|NCT02090114|472226675|FG003|Overall Study|Death|0|||
131164416|NCT00059215|472226678|FG000|Overall Study|Adverse Event|5|||
131164417|NCT00059215|472226679|FG001|Overall Study|Adverse Event|5|||
131164418|NCT00059215|472226680|FG002|Overall Study|Adverse Event|9|||
131164419|NCT00059215|472226681|FG003|Overall Study|Adverse Event|9|||
131164420|NCT00059215|472226678|FG000|Overall Study|Death|0|||
131164421|NCT00059215|472226679|FG001|Overall Study|Death|0|||
131164422|NCT00059215|472226680|FG002|Overall Study|Death|3|||
131164423|NCT00059215|472226681|FG003|Overall Study|Death|0|||
131164424|NCT00059215|472226678|FG000|Overall Study|Lost to Follow-up|1|||
131164425|NCT00059215|472226679|FG001|Overall Study|Lost to Follow-up|2|||
131164426|NCT00059215|472226680|FG002|Overall Study|Lost to Follow-up|0|||
131164427|NCT00059215|472226681|FG003|Overall Study|Lost to Follow-up|0|||
131164428|NCT00059215|472226678|FG000|Overall Study|Withdrawal by Subject|4|||
131164429|NCT00059215|472226679|FG001|Overall Study|Withdrawal by Subject|4|||
131164430|NCT00059215|472226680|FG002|Overall Study|Withdrawal by Subject|1|||
131164431|NCT00059215|472226681|FG003|Overall Study|Withdrawal by Subject|3|||
131164432|NCT00059215|472226678|FG000|Overall Study|Protocol Violation|1|||
131164433|NCT00059215|472226679|FG001|Overall Study|Protocol Violation|0|||
131164434|NCT00059215|472226680|FG002|Overall Study|Protocol Violation|1|||
131164435|NCT00059215|472226681|FG003|Overall Study|Protocol Violation|0|||
131164436|NCT00059215|472226678|FG000|Overall Study|Protocol entry criteria not met|1|||
131164437|NCT00059215|472226679|FG001|Overall Study|Protocol entry criteria not met|1|||
131164438|NCT00059215|472226680|FG002|Overall Study|Protocol entry criteria not met|0|||
131164439|NCT00059215|472226681|FG003|Overall Study|Protocol entry criteria not met|2|||
131164440|NCT00059215|472226678|FG000|Overall Study|Physician Decision|1|||
131164441|NCT00059215|472226679|FG001|Overall Study|Physician Decision|2|||
131164442|NCT00059215|472226680|FG002|Overall Study|Physician Decision|1|||
131164443|NCT00059215|472226681|FG003|Overall Study|Physician Decision|1|||
131164444|NCT04439838|472226682|FG000|Overall Study|Withdrawal by Subject|0|||
131164445|NCT04439838|472226683|FG001|Overall Study|Withdrawal by Subject|0|||
131164446|NCT04439838|472226684|FG002|Overall Study|Withdrawal by Subject|0|||
131164447|NCT04439838|472226685|FG003|Overall Study|Withdrawal by Subject|0|||
131164448|NCT04439838|472226686|FG004|Overall Study|Withdrawal by Subject|0|||
131164449|NCT04439838|472226687|FG005|Overall Study|Withdrawal by Subject|0|||
131164450|NCT04439838|472226688|FG006|Overall Study|Withdrawal by Subject|0|||
131164451|NCT04439838|472226689|FG007|Overall Study|Withdrawal by Subject|0|||
131164452|NCT04439838|472226690|FG008|Overall Study|Withdrawal by Subject|1|||
131164453|NCT04494633|472226691|FG000|Overall Study|Lost to Follow-up|5|||
131164454|NCT04494633|472226692|FG001|Overall Study|Lost to Follow-up|3|||
131164455|NCT04494633|472226691|FG000|Overall Study|Protocol Violation|1|||
131164456|NCT04494633|472226692|FG001|Overall Study|Protocol Violation|1|||
131164457|NCT00414310|472226693|FG000|Overall Study|Not treated|1|||
131164458|NCT00414310|472226694|FG001|Overall Study|Not treated|0|||
131164459|NCT01781429|472226695|FG000|Overall Study|Death|0|||
131164460|NCT01781429|472226696|FG001|Overall Study|Death|0|||
131164461|NCT01781429|472226697|FG002|Overall Study|Death|0|||
131164462|NCT01781429|472226698|FG003|Overall Study|Death|0|||
131164463|NCT01781429|472226699|FG004|Overall Study|Death|0|||
131164464|NCT01781429|472226700|FG005|Overall Study|Death|0|||
131164465|NCT01781429|472226701|FG006|Overall Study|Death|0|||
131164466|NCT01781429|472226702|FG007|Overall Study|Death|0|||
131164467|NCT01781429|472226703|FG008|Overall Study|Death|0|||
131164468|NCT01781429|472226704|FG009|Overall Study|Death|1|||
131235601|NCT01901055|472490969|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
131235602|NCT01901055|472490968|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
131164469|NCT01781429|472226705|FG010|Overall Study|Death|0|||
131164470|NCT01781429|472226706|FG011|Overall Study|Death|0|||
131164471|NCT01781429|472226707|FG012|Overall Study|Death|1|||
131164472|NCT01781429|472226708|FG013|Overall Study|Death|0|||
131164473|NCT01781429|472226709|FG014|Overall Study|Death|1|||
131164474|NCT01781429|472226710|FG015|Overall Study|Death|0|||
131164475|NCT01781429|472226695|FG000|Overall Study|Withdrawal by Subject|0|||
131164476|NCT01781429|472226696|FG001|Overall Study|Withdrawal by Subject|0|||
131164477|NCT01781429|472226697|FG002|Overall Study|Withdrawal by Subject|0|||
131164478|NCT01781429|472226698|FG003|Overall Study|Withdrawal by Subject|0|||
131164479|NCT01781429|472226699|FG004|Overall Study|Withdrawal by Subject|0|||
131164480|NCT01781429|472226700|FG005|Overall Study|Withdrawal by Subject|0|||
131164481|NCT01781429|472226701|FG006|Overall Study|Withdrawal by Subject|0|||
131164482|NCT01781429|472226702|FG007|Overall Study|Withdrawal by Subject|0|||
131164483|NCT01781429|472226703|FG008|Overall Study|Withdrawal by Subject|1|||
131164484|NCT01781429|472226704|FG009|Overall Study|Withdrawal by Subject|3|||
131164485|NCT01781429|472226705|FG010|Overall Study|Withdrawal by Subject|1|||
131164486|NCT01781429|472226706|FG011|Overall Study|Withdrawal by Subject|1|||
131164487|NCT01781429|472226707|FG012|Overall Study|Withdrawal by Subject|5|||
131164488|NCT01781429|472226708|FG013|Overall Study|Withdrawal by Subject|2|||
131164489|NCT01781429|472226709|FG014|Overall Study|Withdrawal by Subject|3|||
131164490|NCT01781429|472226710|FG015|Overall Study|Withdrawal by Subject|0|||
131164491|NCT01781429|472226695|FG000|Overall Study|Disease Progression|1|||
131164492|NCT01781429|472226696|FG001|Overall Study|Disease Progression|0|||
131164493|NCT01781429|472226697|FG002|Overall Study|Disease Progression|1|||
131164494|NCT01781429|472226698|FG003|Overall Study|Disease Progression|1|||
131164495|NCT01781429|472226699|FG004|Overall Study|Disease Progression|1|||
131164496|NCT01781429|472226700|FG005|Overall Study|Disease Progression|4|||
131164497|NCT01781429|472226701|FG006|Overall Study|Disease Progression|7|||
131164498|NCT01781429|472226702|FG007|Overall Study|Disease Progression|4|||
131164499|NCT01781429|472226703|FG008|Overall Study|Disease Progression|6|||
131164500|NCT01781429|472226704|FG009|Overall Study|Disease Progression|15|||
131164501|NCT01781429|472226705|FG010|Overall Study|Disease Progression|15|||
131164502|NCT01781429|472226706|FG011|Overall Study|Disease Progression|15|||
131164503|NCT01781429|472226707|FG012|Overall Study|Disease Progression|15|||
131164504|NCT01781429|472226708|FG013|Overall Study|Disease Progression|4|||
131164505|NCT01781429|472226709|FG014|Overall Study|Disease Progression|11|||
131164506|NCT01781429|472226710|FG015|Overall Study|Disease Progression|0|||
131164507|NCT01781429|472226695|FG000|Overall Study|Unacceptable Toxicity|0|||
131164508|NCT01781429|472226696|FG001|Overall Study|Unacceptable Toxicity|0|||
131164509|NCT01781429|472226697|FG002|Overall Study|Unacceptable Toxicity|0|||
131164510|NCT01781429|472226698|FG003|Overall Study|Unacceptable Toxicity|0|||
131164511|NCT01781429|472226699|FG004|Overall Study|Unacceptable Toxicity|0|||
131164512|NCT01781429|472226700|FG005|Overall Study|Unacceptable Toxicity|0|||
131164513|NCT01781429|472226701|FG006|Overall Study|Unacceptable Toxicity|0|||
131164514|NCT01781429|472226702|FG007|Overall Study|Unacceptable Toxicity|0|||
131164515|NCT01781429|472226703|FG008|Overall Study|Unacceptable Toxicity|0|||
131164516|NCT01781429|472226704|FG009|Overall Study|Unacceptable Toxicity|0|||
131164517|NCT01781429|472226705|FG010|Overall Study|Unacceptable Toxicity|0|||
131164518|NCT01781429|472226706|FG011|Overall Study|Unacceptable Toxicity|2|||
131164519|NCT01781429|472226707|FG012|Overall Study|Unacceptable Toxicity|0|||
131164520|NCT01781429|472226708|FG013|Overall Study|Unacceptable Toxicity|0|||
131164521|NCT01781429|472226709|FG014|Overall Study|Unacceptable Toxicity|0|||
131164522|NCT01781429|472226710|FG015|Overall Study|Unacceptable Toxicity|0|||
131164523|NCT01781429|472226695|FG000|Overall Study|Patient Condition Changed|0|||
131164524|NCT01781429|472226696|FG001|Overall Study|Patient Condition Changed|0|||
131164525|NCT01781429|472226697|FG002|Overall Study|Patient Condition Changed|0|||
131164526|NCT01781429|472226698|FG003|Overall Study|Patient Condition Changed|0|||
131164527|NCT01781429|472226699|FG004|Overall Study|Patient Condition Changed|0|||
131164528|NCT01781429|472226700|FG005|Overall Study|Patient Condition Changed|0|||
131164529|NCT01781429|472226701|FG006|Overall Study|Patient Condition Changed|0|||
131164530|NCT01781429|472226702|FG007|Overall Study|Patient Condition Changed|0|||
131164531|NCT01781429|472226703|FG008|Overall Study|Patient Condition Changed|0|||
131164532|NCT01781429|472226704|FG009|Overall Study|Patient Condition Changed|4|||
131164533|NCT01781429|472226705|FG010|Overall Study|Patient Condition Changed|0|||
131164534|NCT01781429|472226706|FG011|Overall Study|Patient Condition Changed|1|||
131164535|NCT01781429|472226707|FG012|Overall Study|Patient Condition Changed|0|||
131164536|NCT01781429|472226708|FG013|Overall Study|Patient Condition Changed|1|||
131164537|NCT01781429|472226709|FG014|Overall Study|Patient Condition Changed|0|||
131164538|NCT01781429|472226710|FG015|Overall Study|Patient Condition Changed|0|||
131164539|NCT01781429|472226695|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
131164540|NCT01781429|472226696|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
131164541|NCT01781429|472226697|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
130729372|NCT03052127|470630652|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729373|NCT03052127|470630653|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729374|NCT03052127|470630654|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130729375|NCT03052127|470630655|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130729376|NCT03052127|470630656|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130729377|NCT03052127|470630657|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729378|NCT03052127|470630658|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729379|NCT03052127|470630659|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729380|NCT03052127|470630660|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
131164542|NCT01781429|472226698|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
131164543|NCT01781429|472226699|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
131164544|NCT01781429|472226700|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
131164545|NCT01781429|472226701|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
131164546|NCT01781429|472226702|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
131164547|NCT01781429|472226703|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
131164548|NCT01781429|472226704|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
131164549|NCT01781429|472226705|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
131164550|NCT01781429|472226706|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
131164551|NCT01781429|472226707|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
131164552|NCT01781429|472226708|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
131164553|NCT01781429|472226709|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
131164554|NCT01781429|472226710|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
131164555|NCT01781429|472226695|FG000|Overall Study|Enrolled, but not treated|0|||
131164556|NCT01781429|472226696|FG001|Overall Study|Enrolled, but not treated|0|||
131164557|NCT01781429|472226697|FG002|Overall Study|Enrolled, but not treated|0|||
131164558|NCT01781429|472226698|FG003|Overall Study|Enrolled, but not treated|0|||
131164559|NCT01781429|472226699|FG004|Overall Study|Enrolled, but not treated|0|||
131164560|NCT01781429|472226700|FG005|Overall Study|Enrolled, but not treated|0|||
131164561|NCT01781429|472226701|FG006|Overall Study|Enrolled, but not treated|0|||
131164562|NCT01781429|472226702|FG007|Overall Study|Enrolled, but not treated|0|||
131164563|NCT01781429|472226703|FG008|Overall Study|Enrolled, but not treated|0|||
131164564|NCT01781429|472226704|FG009|Overall Study|Enrolled, but not treated|0|||
131164565|NCT01781429|472226705|FG010|Overall Study|Enrolled, but not treated|1|||
131164566|NCT01781429|472226706|FG011|Overall Study|Enrolled, but not treated|0|||
131164567|NCT01781429|472226707|FG012|Overall Study|Enrolled, but not treated|0|||
131164568|NCT01781429|472226708|FG013|Overall Study|Enrolled, but not treated|0|||
131164569|NCT01781429|472226709|FG014|Overall Study|Enrolled, but not treated|0|||
131164570|NCT01781429|472226710|FG015|Overall Study|Enrolled, but not treated|0|||
131164571|NCT00931892|472226711|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
131164572|NCT00931892|472226712|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
131164573|NCT00390780|472226713|FG000|Overall Study|Not completed|10|||
131164574|NCT00390780|472226714|FG001|Overall Study|Not completed|4|||
131164575|NCT00390780|472226713|FG000|Overall Study|Protocol Violation|6|||
131164576|NCT00390780|472226714|FG001|Overall Study|Protocol Violation|4|||
131164577|NCT00390780|472226713|FG000|Overall Study|Lost to Follow-up|3|||
131164578|NCT00390780|472226714|FG001|Overall Study|Lost to Follow-up|6|||
131164579|NCT00390780|472226713|FG000|Overall Study|Adverse Event|2|||
131164580|NCT00390780|472226714|FG001|Overall Study|Adverse Event|3|||
131164581|NCT00390780|472226713|FG000|Overall Study|Death|1|||
131164582|NCT00390780|472226714|FG001|Overall Study|Death|3|||
131164583|NCT00390780|472226713|FG000|Overall Study|Withdrawal by Subject|1|||
131164584|NCT00390780|472226714|FG001|Overall Study|Withdrawal by Subject|2|||
131164585|NCT00390780|472226713|FG000|Overall Study|Inclusion criteria not satisfied|0|||
131164586|NCT00390780|472226714|FG001|Overall Study|Inclusion criteria not satisfied|2|||
131164587|NCT00390780|472226713|FG000|Overall Study|Lost to follow up and other reasons|0|||
131164588|NCT00390780|472226714|FG001|Overall Study|Lost to follow up and other reasons|1|||
131164589|NCT00390780|472226713|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
131164590|NCT00390780|472226714|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
131164591|NCT00390780|472226713|FG000|Overall Study|SAE, death|0|||
131164592|NCT00390780|472226714|FG001|Overall Study|SAE, death|1|||
131164593|NCT01070550|472226715|FG000|Overall Study|Adverse Event|43|||
131164594|NCT01070550|472226716|FG001|Overall Study|Adverse Event|1|||
131164595|NCT01070550|472226717|FG002|Overall Study|Adverse Event|3|||
131164596|NCT01070550|472226718|FG003|Overall Study|Adverse Event|0|||
131164597|NCT01070550|472226719|FG004|Overall Study|Adverse Event|0|||
131164598|NCT01070550|472226720|FG005|Overall Study|Adverse Event|0|||
131164599|NCT01070550|472226715|FG000|Overall Study|Death|20|||
131164600|NCT01070550|472226716|FG001|Overall Study|Death|4|||
131235603|NCT01901055|472490969|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
131235604|NCT01901055|472490968|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
131164601|NCT01070550|472226717|FG002|Overall Study|Death|3|||
131164602|NCT01070550|472226718|FG003|Overall Study|Death|0|||
131164603|NCT01070550|472226719|FG004|Overall Study|Death|0|||
131164604|NCT01070550|472226720|FG005|Overall Study|Death|0|||
131164605|NCT01070550|472226715|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
131164606|NCT01070550|472226716|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
131164607|NCT01070550|472226717|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
131164608|NCT01070550|472226718|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
131164609|NCT01070550|472226719|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
131164610|NCT01070550|472226720|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
131164611|NCT01070550|472226715|FG000|Overall Study|Early termination|3|||
131164612|NCT01070550|472226716|FG001|Overall Study|Early termination|0|||
131164613|NCT01070550|472226717|FG002|Overall Study|Early termination|0|||
131164614|NCT01070550|472226718|FG003|Overall Study|Early termination|0|||
131164615|NCT01070550|472226719|FG004|Overall Study|Early termination|0|||
131164616|NCT01070550|472226720|FG005|Overall Study|Early termination|0|||
131164617|NCT01070550|472226715|FG000|Overall Study|Failed to return|450|||
131164618|NCT01070550|472226716|FG001|Overall Study|Failed to return|33|||
131164619|NCT01070550|472226717|FG002|Overall Study|Failed to return|144|||
131164620|NCT01070550|472226718|FG003|Overall Study|Failed to return|40|||
131164621|NCT01070550|472226719|FG004|Overall Study|Failed to return|1|||
131164622|NCT01070550|472226720|FG005|Overall Study|Failed to return|2|||
131164623|NCT01070550|472226715|FG000|Overall Study|Incomplete treatment|2|||
131164624|NCT01070550|472226716|FG001|Overall Study|Incomplete treatment|0|||
131164625|NCT01070550|472226717|FG002|Overall Study|Incomplete treatment|0|||
131164626|NCT01070550|472226718|FG003|Overall Study|Incomplete treatment|0|||
131164627|NCT01070550|472226719|FG004|Overall Study|Incomplete treatment|0|||
131164628|NCT01070550|472226720|FG005|Overall Study|Incomplete treatment|0|||
131164629|NCT01070550|472226715|FG000|Overall Study|Lab test not done|22|||
131164630|NCT01070550|472226716|FG001|Overall Study|Lab test not done|3|||
131164631|NCT01070550|472226717|FG002|Overall Study|Lab test not done|4|||
131164632|NCT01070550|472226718|FG003|Overall Study|Lab test not done|1|||
131164633|NCT01070550|472226719|FG004|Overall Study|Lab test not done|0|||
131164634|NCT01070550|472226720|FG005|Overall Study|Lab test not done|1|||
131164635|NCT01070550|472226715|FG000|Overall Study|Lack of Efficacy|65|||
131164636|NCT01070550|472226716|FG001|Overall Study|Lack of Efficacy|1|||
131164637|NCT01070550|472226717|FG002|Overall Study|Lack of Efficacy|5|||
131164638|NCT01070550|472226718|FG003|Overall Study|Lack of Efficacy|5|||
131164639|NCT01070550|472226719|FG004|Overall Study|Lack of Efficacy|0|||
131164640|NCT01070550|472226720|FG005|Overall Study|Lack of Efficacy|1|||
131164641|NCT01070550|472226715|FG000|Overall Study|Miscellaneous|12|||
131164642|NCT01070550|472226716|FG001|Overall Study|Miscellaneous|2|||
131164643|NCT01070550|472226717|FG002|Overall Study|Miscellaneous|3|||
131164644|NCT01070550|472226718|FG003|Overall Study|Miscellaneous|1|||
131164645|NCT01070550|472226719|FG004|Overall Study|Miscellaneous|0|||
131164646|NCT01070550|472226720|FG005|Overall Study|Miscellaneous|0|||
131164647|NCT01070550|472226715|FG000|Overall Study|New treatment started|3|||
131164648|NCT01070550|472226716|FG001|Overall Study|New treatment started|1|||
131164649|NCT01070550|472226717|FG002|Overall Study|New treatment started|0|||
131164650|NCT01070550|472226718|FG003|Overall Study|New treatment started|2|||
131164651|NCT01070550|472226719|FG004|Overall Study|New treatment started|0|||
131164652|NCT01070550|472226720|FG005|Overall Study|New treatment started|0|||
131164653|NCT01070550|472226715|FG000|Overall Study|Non-responders|493|||
131164654|NCT01070550|472226716|FG001|Overall Study|Non-responders|4|||
131164655|NCT01070550|472226717|FG002|Overall Study|Non-responders|21|||
131164656|NCT01070550|472226718|FG003|Overall Study|Non-responders|20|||
131164657|NCT01070550|472226719|FG004|Overall Study|Non-responders|0|||
131164658|NCT01070550|472226720|FG005|Overall Study|Non-responders|2|||
131164659|NCT01070550|472226715|FG000|Overall Study|Not categorized|33|||
131164660|NCT01070550|472226716|FG001|Overall Study|Not categorized|2|||
131164661|NCT01070550|472226717|FG002|Overall Study|Not categorized|6|||
131164662|NCT01070550|472226718|FG003|Overall Study|Not categorized|1|||
131164663|NCT01070550|472226719|FG004|Overall Study|Not categorized|0|||
131164664|NCT01070550|472226720|FG005|Overall Study|Not categorized|1|||
131164665|NCT01070550|472226715|FG000|Overall Study|Protocol Violation|15|||
131164666|NCT01070550|472226716|FG001|Overall Study|Protocol Violation|1|||
131164667|NCT01070550|472226717|FG002|Overall Study|Protocol Violation|1|||
131164668|NCT01070550|472226718|FG003|Overall Study|Protocol Violation|1|||
131164669|NCT01070550|472226719|FG004|Overall Study|Protocol Violation|0|||
131164670|NCT01070550|472226720|FG005|Overall Study|Protocol Violation|0|||
131164671|NCT01070550|472226715|FG000|Overall Study|Relapse|44|||
131164672|NCT01070550|472226716|FG001|Overall Study|Relapse|5|||
131164673|NCT01070550|472226717|FG002|Overall Study|Relapse|14|||
131164674|NCT01070550|472226718|FG003|Overall Study|Relapse|4|||
131164675|NCT01070550|472226719|FG004|Overall Study|Relapse|0|||
131164676|NCT01070550|472226720|FG005|Overall Study|Relapse|0|||
131164677|NCT01070550|472226715|FG000|Overall Study|Result not available|3|||
131164678|NCT01070550|472226716|FG001|Overall Study|Result not available|1|||
131164679|NCT01070550|472226717|FG002|Overall Study|Result not available|3|||
131164680|NCT01070550|472226718|FG003|Overall Study|Result not available|0|||
131164681|NCT01070550|472226719|FG004|Overall Study|Result not available|0|||
131164682|NCT01070550|472226720|FG005|Overall Study|Result not available|0|||
130729381|NCT03052127|470630661|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130729382|NCT03694327|470630662|FG000|Overall Study|Lost to Follow-up|13|||
130729383|NCT03694327|470630663|FG001|Overall Study|Lost to Follow-up|23|||
130729384|NCT01464931|470630664|FG000|Overall Study|Withdrawal by Subject|1|||
130729385|NCT01464931|470630665|FG001|Overall Study|Withdrawal by Subject|0|||
130729386|NCT01982812|470630668|FG000|Overall Study|Death|1|||
131164683|NCT01070550|472226715|FG000|Overall Study|Screen failure|1|||
131164684|NCT01070550|472226716|FG001|Overall Study|Screen failure|0|||
131164685|NCT01070550|472226717|FG002|Overall Study|Screen failure|0|||
131164686|NCT01070550|472226718|FG003|Overall Study|Screen failure|0|||
131164687|NCT01070550|472226719|FG004|Overall Study|Screen failure|0|||
131164688|NCT01070550|472226720|FG005|Overall Study|Screen failure|0|||
131164689|NCT01070550|472226715|FG000|Overall Study|Sponsor decision|1|||
131164690|NCT01070550|472226716|FG001|Overall Study|Sponsor decision|0|||
131164691|NCT01070550|472226717|FG002|Overall Study|Sponsor decision|0|||
131164692|NCT01070550|472226718|FG003|Overall Study|Sponsor decision|0|||
131164693|NCT01070550|472226719|FG004|Overall Study|Sponsor decision|0|||
131164694|NCT01070550|472226720|FG005|Overall Study|Sponsor decision|0|||
131164695|NCT01070550|472226715|FG000|Overall Study|Treatment duration shortened|1|||
131164696|NCT01070550|472226716|FG001|Overall Study|Treatment duration shortened|0|||
131164697|NCT01070550|472226717|FG002|Overall Study|Treatment duration shortened|0|||
131164698|NCT01070550|472226718|FG003|Overall Study|Treatment duration shortened|0|||
131164699|NCT01070550|472226719|FG004|Overall Study|Treatment duration shortened|0|||
131164700|NCT01070550|472226720|FG005|Overall Study|Treatment duration shortened|0|||
131164701|NCT01070550|472226715|FG000|Overall Study|Treatment interrupted|7|||
131164702|NCT01070550|472226716|FG001|Overall Study|Treatment interrupted|0|||
131164703|NCT01070550|472226717|FG002|Overall Study|Treatment interrupted|1|||
131164704|NCT01070550|472226718|FG003|Overall Study|Treatment interrupted|1|||
131164705|NCT01070550|472226719|FG004|Overall Study|Treatment interrupted|0|||
131164706|NCT01070550|472226720|FG005|Overall Study|Treatment interrupted|0|||
131164707|NCT01070550|472226715|FG000|Overall Study|Treatment not started|14|||
131164708|NCT01070550|472226716|FG001|Overall Study|Treatment not started|2|||
131164709|NCT01070550|472226717|FG002|Overall Study|Treatment not started|4|||
131164710|NCT01070550|472226718|FG003|Overall Study|Treatment not started|0|||
131164711|NCT01070550|472226719|FG004|Overall Study|Treatment not started|0|||
131164712|NCT01070550|472226720|FG005|Overall Study|Treatment not started|0|||
131164713|NCT01070550|472226715|FG000|Overall Study|Treatment restarted|0|||
131164714|NCT01070550|472226716|FG001|Overall Study|Treatment restarted|1|||
131164715|NCT01070550|472226717|FG002|Overall Study|Treatment restarted|0|||
131164716|NCT01070550|472226718|FG003|Overall Study|Treatment restarted|0|||
131164717|NCT01070550|472226719|FG004|Overall Study|Treatment restarted|0|||
131164718|NCT01070550|472226720|FG005|Overall Study|Treatment restarted|0|||
131164719|NCT01070550|472226715|FG000|Overall Study|Treatment stopped|3|||
131164720|NCT01070550|472226716|FG001|Overall Study|Treatment stopped|0|||
131164721|NCT01070550|472226717|FG002|Overall Study|Treatment stopped|0|||
131164722|NCT01070550|472226718|FG003|Overall Study|Treatment stopped|0|||
131164723|NCT01070550|472226719|FG004|Overall Study|Treatment stopped|0|||
131164724|NCT01070550|472226720|FG005|Overall Study|Treatment stopped|0|||
131164725|NCT01070550|472226715|FG000|Overall Study|Treatment unavailable|1|||
131164726|NCT01070550|472226716|FG001|Overall Study|Treatment unavailable|0|||
131164727|NCT01070550|472226717|FG002|Overall Study|Treatment unavailable|0|||
131164728|NCT01070550|472226718|FG003|Overall Study|Treatment unavailable|0|||
131164729|NCT01070550|472226719|FG004|Overall Study|Treatment unavailable|0|||
131164730|NCT01070550|472226720|FG005|Overall Study|Treatment unavailable|0|||
131164731|NCT01070550|472226715|FG000|Overall Study|Treatment was stopped early|7|||
131164732|NCT01070550|472226716|FG001|Overall Study|Treatment was stopped early|0|||
131164733|NCT01070550|472226717|FG002|Overall Study|Treatment was stopped early|0|||
131164734|NCT01070550|472226718|FG003|Overall Study|Treatment was stopped early|0|||
131164735|NCT01070550|472226719|FG004|Overall Study|Treatment was stopped early|0|||
131164736|NCT01070550|472226720|FG005|Overall Study|Treatment was stopped early|0|||
131164737|NCT01070550|472226715|FG000|Overall Study|Other|5|||
131164738|NCT01070550|472226716|FG001|Overall Study|Other|0|||
131164739|NCT01070550|472226717|FG002|Overall Study|Other|0|||
131164740|NCT01070550|472226718|FG003|Overall Study|Other|1|||
131164741|NCT01070550|472226719|FG004|Overall Study|Other|0|||
130729387|NCT01982812|470630669|FG001|Overall Study|Death|5|||
131164742|NCT01070550|472226720|FG005|Overall Study|Other|0|||
131164743|NCT01070550|472226715|FG000|Overall Study|Withdrawal by Subject|35|||
131164744|NCT01070550|472226716|FG001|Overall Study|Withdrawal by Subject|0|||
131164745|NCT01070550|472226717|FG002|Overall Study|Withdrawal by Subject|3|||
131164746|NCT01070550|472226718|FG003|Overall Study|Withdrawal by Subject|0|||
131164747|NCT01070550|472226719|FG004|Overall Study|Withdrawal by Subject|0|||
131164748|NCT01070550|472226720|FG005|Overall Study|Withdrawal by Subject|0|||
131164749|NCT01585961|472226721|FG000|Overall Study|Death|6|||
131164750|NCT01585961|472226721|FG000|Overall Study|Physician Decision|1|||
131164751|NCT01585961|472226721|FG000|Overall Study|Decision to use non-study catheter|1|||
131164752|NCT01585961|472226721|FG000|Overall Study|Withdrawal by Subject|1|||
131164753|NCT01585961|472226721|FG000|Overall Study|Lost to Follow-up|23|||
131164754|NCT01585961|472226721|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
131164755|NCT00109733|472226722|FG000|Overall Study|Protocol Violation|0|||
131164756|NCT00109733|472226723|FG001|Overall Study|Protocol Violation|1|||
131164757|NCT00109733|472226722|FG000|Overall Study|Stopped taking study drug|1|||
131164758|NCT00109733|472226723|FG001|Overall Study|Stopped taking study drug|1|||
131164759|NCT00109733|472226722|FG000|Overall Study|Non-compliant|0|||
131164760|NCT00109733|472226723|FG001|Overall Study|Non-compliant|1|||
131164761|NCT00109733|472226722|FG000|Overall Study|Could not commit time for study|1|||
131164762|NCT00109733|472226723|FG001|Overall Study|Could not commit time for study|1|||
131164763|NCT06094296|472226728|FG000|Overall Study|Progressive Disease|1|||
131164764|NCT06094296|472226729|FG001|Overall Study|Progressive Disease|0|||
131164765|NCT06094296|472226730|FG002|Overall Study|Progressive Disease|0|||
131164766|NCT06094296|472226731|FG003|Overall Study|Progressive Disease|0|||
131164767|NCT03332667|472226732|FG000|Overall Study|Adverse Event|0|||
131164768|NCT03332667|472226733|FG001|Overall Study|Adverse Event|0|||
131164769|NCT03332667|472226734|FG002|Overall Study|Adverse Event|2|||
131164770|NCT03332667|472226735|FG003|Overall Study|Adverse Event|1|||
131164771|NCT03332667|472226732|FG000|Overall Study|Withdrawal by Subject|2|||
131164772|NCT03332667|472226733|FG001|Overall Study|Withdrawal by Subject|1|||
131164773|NCT03332667|472226734|FG002|Overall Study|Withdrawal by Subject|5|||
131164774|NCT03332667|472226735|FG003|Overall Study|Withdrawal by Subject|1|||
131164775|NCT03332667|472226732|FG000|Overall Study|Disease Progression or Relapse|2|||
131164776|NCT03332667|472226733|FG001|Overall Study|Disease Progression or Relapse|1|||
131164777|NCT03332667|472226734|FG002|Overall Study|Disease Progression or Relapse|3|||
131164778|NCT03332667|472226735|FG003|Overall Study|Disease Progression or Relapse|0|||
131164779|NCT03332667|472226732|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
131164780|NCT03332667|472226733|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
131164781|NCT03332667|472226734|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
131164782|NCT03332667|472226735|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
131164783|NCT03332667|472226732|FG000|Overall Study|No Treatment Received|0|||
131164784|NCT03332667|472226733|FG001|Overall Study|No Treatment Received|0|||
131164785|NCT03332667|472226734|FG002|Overall Study|No Treatment Received|1|||
131164786|NCT03332667|472226735|FG003|Overall Study|No Treatment Received|0|||
131164787|NCT04964063|472226736|FG000|Overall Study|Adverse Event|4|||
131164788|NCT04964063|472226736|FG000|Overall Study|Lost to Follow-up|47|||
131164789|NCT04964063|472226736|FG000|Overall Study|Withdrawal by Subject|5|||
131164790|NCT04964063|472226736|FG000|Overall Study|Baseline Tasks Expired|41|||
131164791|NCT04964063|472226736|FG000|Overall Study|Participant withdrawn in error|1|||
131164792|NCT01035606|472226737|FG000|Overall Study|change in health, job demands,family|3|||
131164793|NCT01035606|472226738|FG001|Overall Study|change in health, job demands,family|3|||
131164794|NCT01035606|472226739|FG002|Overall Study|change in health, job demands,family|4|||
131164795|NCT01809262|472226740|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
130780629|NCT00521365|470823137|FG000|Overall Study|Lost to Follow-up|6|||
131164796|NCT01809262|472226741|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
131164797|NCT01809262|472226742|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
131164798|NCT01809262|472226743|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
131164799|NCT01809262|472226744|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
131164800|NCT01809262|472226745|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
131164801|NCT01809262|472226746|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
131164802|NCT01809262|472226747|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
131164803|NCT01809262|472226748|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
131164804|NCT01809262|472226749|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
131164805|NCT01809262|472226740|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131164806|NCT01809262|472226741|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
131164807|NCT01809262|472226742|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131164808|NCT01809262|472226743|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131164809|NCT01809262|472226744|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131164810|NCT01809262|472226745|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131164811|NCT01809262|472226746|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131164812|NCT01809262|472226747|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131164813|NCT01809262|472226748|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131164814|NCT01809262|472226749|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
131164815|NCT02064439|472226751|FG000|Overall Study|Adverse Event|51|||
131164816|NCT02064439|472226752|FG001|Overall Study|Adverse Event|47|||
131164817|NCT02064439|472226753|FG002|Overall Study|Adverse Event|46|||
131164818|NCT02064439|472226751|FG000|Overall Study|Death|0|||
130780630|NCT00521365|470823137|FG000|Overall Study|Protocol deviation|2|||
131164819|NCT02064439|472226752|FG001|Overall Study|Death|2|||
131164820|NCT02064439|472226753|FG002|Overall Study|Death|3|||
131164821|NCT02064439|472226751|FG000|Overall Study|Withdrawal by Subject|29|||
131164822|NCT02064439|472226752|FG001|Overall Study|Withdrawal by Subject|18|||
130780631|NCT00521365|470823137|FG000|Overall Study|Drug compliance|3|||
131164823|NCT02064439|472226753|FG002|Overall Study|Withdrawal by Subject|26|||
131164824|NCT02064439|472226751|FG000|Overall Study|Protocol Violation|3|||
131164825|NCT02064439|472226752|FG001|Overall Study|Protocol Violation|5|||
131164826|NCT02064439|472226753|FG002|Overall Study|Protocol Violation|3|||
131164827|NCT02064439|472226751|FG000|Overall Study|Lost to Follow-up|1|||
131164828|NCT02064439|472226752|FG001|Overall Study|Lost to Follow-up|3|||
131164829|NCT02064439|472226753|FG002|Overall Study|Lost to Follow-up|4|||
131164830|NCT02064439|472226751|FG000|Overall Study|Non-compliance with study medication|21|||
131164831|NCT02064439|472226752|FG001|Overall Study|Non-compliance with study medication|19|||
131164832|NCT02064439|472226753|FG002|Overall Study|Non-compliance with study medication|23|||
131164833|NCT02064439|472226751|FG000|Overall Study|Physician Decision|0|||
131164834|NCT02064439|472226752|FG001|Overall Study|Physician Decision|1|||
131164835|NCT02064439|472226753|FG002|Overall Study|Physician Decision|1|||
131164836|NCT02064439|472226751|FG000|Overall Study|Logistical difficulties|6|||
131164837|NCT02064439|472226752|FG001|Overall Study|Logistical difficulties|5|||
131164838|NCT02064439|472226753|FG002|Overall Study|Logistical difficulties|2|||
131164839|NCT02064439|472226751|FG000|Overall Study|Efficacy outcome reached|18|||
131164840|NCT02064439|472226752|FG001|Overall Study|Efficacy outcome reached|16|||
131164841|NCT02064439|472226753|FG002|Overall Study|Efficacy outcome reached|57|||
131164842|NCT02064439|472226751|FG000|Overall Study|Safety outcome reached|12|||
131164843|NCT02064439|472226752|FG001|Overall Study|Safety outcome reached|20|||
131164844|NCT02064439|472226753|FG002|Overall Study|Safety outcome reached|10|||
131164845|NCT02064439|472226751|FG000|Overall Study|Other|2|||
131164846|NCT02064439|472226752|FG001|Overall Study|Other|2|||
131164847|NCT02064439|472226753|FG002|Overall Study|Other|7|||
131164848|NCT02433288|472226754|FG000|Overall Study|Severe non-compliance to protocol|13|||
131164849|NCT02433288|472226755|FG001|Overall Study|Severe non-compliance to protocol|7|||
131164850|NCT02433288|472226754|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
131164851|NCT02433288|472226755|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
131164852|NCT02433288|472226754|FG000|Overall Study|Withdrawal by Subject|101|||
131164853|NCT02433288|472226755|FG001|Overall Study|Withdrawal by Subject|99|||
131164854|NCT02433288|472226754|FG000|Overall Study|Lost to Follow-up|2|||
131164855|NCT02433288|472226755|FG001|Overall Study|Lost to Follow-up|14|||
131164856|NCT02433288|472226754|FG000|Overall Study|Death|0|||
131164857|NCT02433288|472226755|FG001|Overall Study|Death|3|||
131164858|NCT03350750|472226756|FG000|Overall Study|Death|1|||
131164859|NCT03350750|472226757|FG001|Overall Study|Death|1|||
131164860|NCT01120093|472226762|FG000|Treatment Period 1|Adverse Event|0|||
131164861|NCT01120093|472226763|FG001|Treatment Period 1|Adverse Event|0|||
131164862|NCT01120093|472226764|FG002|Treatment Period 1|Adverse Event|1|||
131164863|NCT01120093|472226765|FG003|Treatment Period 1|Adverse Event|0|||
131164864|NCT01120093|472226766|FG004|Treatment Period 1|Adverse Event|1|||
131164865|NCT01120093|472226762|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131164866|NCT01120093|472226763|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131164867|NCT01120093|472226764|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131164868|NCT01120093|472226765|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131164869|NCT01120093|472226766|FG004|Treatment Period 1|Withdrawal by Subject|0|||
131164870|NCT01120093|472226762|FG000|Treatment Period 2|Adverse Event|0|||
131164871|NCT01120093|472226763|FG001|Treatment Period 2|Adverse Event|0|||
131164872|NCT01120093|472226764|FG002|Treatment Period 2|Adverse Event|0|||
131164873|NCT01120093|472226765|FG003|Treatment Period 2|Adverse Event|1|||
131164874|NCT01120093|472226766|FG004|Treatment Period 2|Adverse Event|0|||
131164875|NCT01120093|472226762|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131164876|NCT01120093|472226763|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131164877|NCT01120093|472226764|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131164878|NCT01120093|472226765|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131164879|NCT01120093|472226766|FG004|Treatment Period 2|Withdrawal by Subject|1|||
131164880|NCT01120093|472226762|FG000|Treatment Period 3|Lack of Efficacy|0|||
131164881|NCT01120093|472226763|FG001|Treatment Period 3|Lack of Efficacy|0|||
131164882|NCT01120093|472226764|FG002|Treatment Period 3|Lack of Efficacy|0|||
131164883|NCT01120093|472226765|FG003|Treatment Period 3|Lack of Efficacy|1|||
131164884|NCT01120093|472226766|FG004|Treatment Period 3|Lack of Efficacy|0|||
131164885|NCT01120093|472226762|FG000|Treatment Period 3|Adverse Event|0|||
131164886|NCT01120093|472226763|FG001|Treatment Period 3|Adverse Event|0|||
131164887|NCT01120093|472226764|FG002|Treatment Period 3|Adverse Event|0|||
131164888|NCT01120093|472226765|FG003|Treatment Period 3|Adverse Event|0|||
131235605|NCT01901055|472490969|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
131164889|NCT01120093|472226766|FG004|Treatment Period 3|Adverse Event|1|||
131164890|NCT01120093|472226762|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131164891|NCT01120093|472226763|FG001|Treatment Period 3|Withdrawal by Subject|0|||
131164892|NCT01120093|472226764|FG002|Treatment Period 3|Withdrawal by Subject|1|||
131164893|NCT01120093|472226765|FG003|Treatment Period 3|Withdrawal by Subject|0|||
131164894|NCT01120093|472226766|FG004|Treatment Period 3|Withdrawal by Subject|0|||
131164895|NCT01120093|472226762|FG000|Treatment Period 4|Adverse Event|1|||
131235606|NCT01901055|472490968|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
131164896|NCT01120093|472226763|FG001|Treatment Period 4|Adverse Event|0|||
131164897|NCT01120093|472226764|FG002|Treatment Period 4|Adverse Event|0|||
131164898|NCT01120093|472226765|FG003|Treatment Period 4|Adverse Event|0|||
131164899|NCT01120093|472226766|FG004|Treatment Period 4|Adverse Event|0|||
131164900|NCT01120093|472226762|FG000|Treatment Period 5|Adverse Event|0|||
131164901|NCT01120093|472226763|FG001|Treatment Period 5|Adverse Event|1|||
131164902|NCT01120093|472226764|FG002|Treatment Period 5|Adverse Event|0|||
131164903|NCT01120093|472226765|FG003|Treatment Period 5|Adverse Event|1|||
131164904|NCT01120093|472226766|FG004|Treatment Period 5|Adverse Event|0|||
131164905|NCT01849250|472226767|FG000|Overall Study|Withdrawal by Subject|1|||
131164906|NCT01849250|472226768|FG001|Overall Study|Withdrawal by Subject|0|||
131164907|NCT01849250|472226767|FG000|Overall Study|Not Evaluable|5|||
131164908|NCT01849250|472226768|FG001|Overall Study|Not Evaluable|3|||
131164909|NCT01849250|472226767|FG000|Overall Study|Screen Failure|1|||
131164910|NCT01849250|472226768|FG001|Overall Study|Screen Failure|0|||
131164911|NCT02184143|472226773|FG000|Overall Study|Withdrawal by Subject|4|||
131164912|NCT02184143|472226774|FG001|Overall Study|Withdrawal by Subject|4|||
131164913|NCT02184143|472226773|FG000|Overall Study|Lost to Follow-up|5|||
131164914|NCT02184143|472226774|FG001|Overall Study|Lost to Follow-up|3|||
131164915|NCT02184143|472226773|FG000|Overall Study|Death|1|||
131164916|NCT02184143|472226774|FG001|Overall Study|Death|0|||
131164917|NCT00257192|472226775|FG000|Overall Study|Adverse Event|21|||
131164918|NCT00257192|472226776|FG001|Overall Study|Adverse Event|10|||
131164919|NCT00257192|472226775|FG000|Overall Study|Laboratory abnormality|1|||
131164920|NCT00257192|472226776|FG001|Overall Study|Laboratory abnormality|1|||
131164921|NCT00257192|472226775|FG000|Overall Study|Lost to Follow-up|3|||
131164922|NCT00257192|472226776|FG001|Overall Study|Lost to Follow-up|3|||
131164923|NCT00257192|472226775|FG000|Overall Study|Insufficient clinical response|18|||
131164924|NCT00257192|472226776|FG001|Overall Study|Insufficient clinical response|18|||
131164925|NCT00257192|472226775|FG000|Overall Study|Withdrawal by Subject|14|||
131164926|NCT00257192|472226776|FG001|Overall Study|Withdrawal by Subject|2|||
131164927|NCT00257192|472226775|FG000|Overall Study|Randomized but not treated|0|||
131164928|NCT00257192|472226776|FG001|Overall Study|Randomized but not treated|1|||
131164929|NCT00257192|472226775|FG000|Overall Study|Study terminated by sponsor|1|||
131164930|NCT00257192|472226776|FG001|Overall Study|Study terminated by sponsor|0|||
131164931|NCT00257192|472226775|FG000|Overall Study|Miscellaneous|0|||
131164932|NCT00257192|472226776|FG001|Overall Study|Miscellaneous|4|||
131164933|NCT00570739|472226777|FG000|Overall Study|Adverse Event|8|||
131164934|NCT00570739|472226778|FG001|Overall Study|Adverse Event|6|||
131164935|NCT00570739|472226779|FG002|Overall Study|Adverse Event|2|||
131164936|NCT00570739|472226780|FG003|Overall Study|Adverse Event|2|||
131164937|NCT00570739|472226777|FG000|Overall Study|Lost to Follow-up|4|||
131164938|NCT00570739|472226778|FG001|Overall Study|Lost to Follow-up|5|||
131164939|NCT00570739|472226779|FG002|Overall Study|Lost to Follow-up|4|||
131164940|NCT00570739|472226780|FG003|Overall Study|Lost to Follow-up|1|||
131164941|NCT00570739|472226777|FG000|Overall Study|Physician Decision|1|||
131164942|NCT00570739|472226778|FG001|Overall Study|Physician Decision|1|||
131164943|NCT00570739|472226779|FG002|Overall Study|Physician Decision|0|||
131164944|NCT00570739|472226780|FG003|Overall Study|Physician Decision|0|||
131164945|NCT00570739|472226777|FG000|Overall Study|Withdrawal by Subject|7|||
131164946|NCT00570739|472226778|FG001|Overall Study|Withdrawal by Subject|7|||
131164947|NCT00570739|472226779|FG002|Overall Study|Withdrawal by Subject|3|||
131164948|NCT00570739|472226780|FG003|Overall Study|Withdrawal by Subject|5|||
131164949|NCT00570739|472226777|FG000|Overall Study|Required restricted medication|0|||
131164950|NCT00570739|472226778|FG001|Overall Study|Required restricted medication|0|||
131164951|NCT00570739|472226779|FG002|Overall Study|Required restricted medication|1|||
131164952|NCT00570739|472226780|FG003|Overall Study|Required restricted medication|0|||
131164953|NCT00570739|472226777|FG000|Overall Study|Met discontinuation criteria|1|||
131164954|NCT00570739|472226778|FG001|Overall Study|Met discontinuation criteria|0|||
131164955|NCT00570739|472226779|FG002|Overall Study|Met discontinuation criteria|1|||
131164956|NCT00570739|472226780|FG003|Overall Study|Met discontinuation criteria|1|||
131164957|NCT00570739|472226777|FG000|Overall Study|Other|0|||
131164958|NCT00570739|472226778|FG001|Overall Study|Other|2|||
131164959|NCT00570739|472226779|FG002|Overall Study|Other|5|||
131164960|NCT00570739|472226780|FG003|Overall Study|Other|3|||
131164961|NCT01921270|472226785|FG000|Overall Study|Withdrawal by Subject|1|||
131164962|NCT00844428|472226786|FG000|Screening Period|Screen Failure|3|||
131164963|NCT00844428|472226786|FG000|Extension Treatment Period|Death|1|||
131164964|NCT00844428|472226786|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
131164965|NCT00789477|472226787|FG000|Overall Study|Withdrawal by Subject|2|||
131164966|NCT00789477|472226788|FG001|Overall Study|Withdrawal by Subject|1|||
131164967|NCT00789477|472226789|FG002|Overall Study|Withdrawal by Subject|3|||
131164968|NCT00789477|472226790|FG003|Overall Study|Withdrawal by Subject|2|||
131164969|NCT00789477|472226791|FG004|Overall Study|Withdrawal by Subject|3|||
131164970|NCT00789477|472226787|FG000|Overall Study|Protocol Violation|1|||
131164971|NCT00789477|472226788|FG001|Overall Study|Protocol Violation|0|||
131164972|NCT00789477|472226789|FG002|Overall Study|Protocol Violation|0|||
131164973|NCT00789477|472226790|FG003|Overall Study|Protocol Violation|1|||
131164974|NCT00789477|472226791|FG004|Overall Study|Protocol Violation|0|||
131164975|NCT00789477|472226787|FG000|Overall Study|Adverse Event|3|||
131164976|NCT00789477|472226788|FG001|Overall Study|Adverse Event|3|||
131164977|NCT00789477|472226789|FG002|Overall Study|Adverse Event|1|||
131164978|NCT00789477|472226790|FG003|Overall Study|Adverse Event|0|||
131164979|NCT00789477|472226791|FG004|Overall Study|Adverse Event|0|||
131164980|NCT00789477|472226787|FG000|Overall Study|Death|1|||
131164981|NCT00789477|472226788|FG001|Overall Study|Death|1|||
131164982|NCT00789477|472226789|FG002|Overall Study|Death|2|||
131164983|NCT00789477|472226790|FG003|Overall Study|Death|2|||
131164984|NCT00789477|472226791|FG004|Overall Study|Death|0|||
131164985|NCT00789477|472226787|FG000|Overall Study|Lost to Follow-up|0|||
131164986|NCT00789477|472226788|FG001|Overall Study|Lost to Follow-up|1|||
131164987|NCT00789477|472226789|FG002|Overall Study|Lost to Follow-up|4|||
131164988|NCT00789477|472226790|FG003|Overall Study|Lost to Follow-up|2|||
131164989|NCT00789477|472226791|FG004|Overall Study|Lost to Follow-up|4|||
131164990|NCT00789477|472226787|FG000|Overall Study|Lack of Efficacy|2|||
131164991|NCT00789477|472226788|FG001|Overall Study|Lack of Efficacy|0|||
131164992|NCT00789477|472226789|FG002|Overall Study|Lack of Efficacy|0|||
131164993|NCT00789477|472226790|FG003|Overall Study|Lack of Efficacy|0|||
131164994|NCT00789477|472226791|FG004|Overall Study|Lack of Efficacy|0|||
131164995|NCT00789477|472226787|FG000|Overall Study|Other|2|||
131164996|NCT00789477|472226788|FG001|Overall Study|Other|0|||
131164997|NCT00789477|472226789|FG002|Overall Study|Other|1|||
131164998|NCT00789477|472226790|FG003|Overall Study|Other|3|||
131164999|NCT00789477|472226791|FG004|Overall Study|Other|0|||
131165000|NCT01844700|472226792|FG000|Overall Study|Lack of Efficacy|1|||
131165001|NCT01844700|472226793|FG001|Overall Study|Lack of Efficacy|0|||
131165002|NCT01844700|472226792|FG000|Overall Study|refused medication switch|1|||
131165003|NCT01844700|472226793|FG001|Overall Study|refused medication switch|0|||
131165004|NCT01844700|472226792|FG000|Overall Study|Withdrawal by Subject|1|||
131165005|NCT01844700|472226793|FG001|Overall Study|Withdrawal by Subject|0|||
131165006|NCT01844700|472226792|FG000|Overall Study|stopped taking meds|0|||
131165007|NCT01844700|472226793|FG001|Overall Study|stopped taking meds|1|||
131165008|NCT02680847|472226794|FG000|Overall Study|Other|2|||
131165009|NCT02680847|472226795|FG001|Overall Study|Other|0|||
131165010|NCT02680847|472226796|FG002|Overall Study|Other|0|||
131165011|NCT02680847|472226794|FG000|Overall Study|No longer met eligibility criteria|2|||
131165012|NCT02680847|472226795|FG001|Overall Study|No longer met eligibility criteria|2|||
131165013|NCT02680847|472226796|FG002|Overall Study|No longer met eligibility criteria|0|||
131165014|NCT02680847|472226794|FG000|Overall Study|Unwilling to participate in study|1|||
131165015|NCT02680847|472226795|FG001|Overall Study|Unwilling to participate in study|1|||
131165016|NCT02680847|472226796|FG002|Overall Study|Unwilling to participate in study|0|||
131165017|NCT02680847|472226794|FG000|Overall Study|Lack of Efficacy|0|||
131165018|NCT02680847|472226795|FG001|Overall Study|Lack of Efficacy|0|||
131165019|NCT02680847|472226796|FG002|Overall Study|Lack of Efficacy|2|||
131165020|NCT02680847|472226794|FG000|Overall Study|Adverse Event|0|||
131165021|NCT02680847|472226795|FG001|Overall Study|Adverse Event|0|||
131165022|NCT02680847|472226796|FG002|Overall Study|Adverse Event|1|||
131165023|NCT02375698|472226797|FG000|Overall Study|Withdrawal by Subject|0|||
131165024|NCT02375698|472226798|FG001|Overall Study|Withdrawal by Subject|2|||
131165025|NCT02375698|472226797|FG000|Overall Study|Physician Decision|2|||
131165026|NCT02375698|472226798|FG001|Overall Study|Physician Decision|0|||
131165027|NCT00772967|472226801|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
131165028|NCT00772967|472226802|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
131165029|NCT00772967|472226803|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
131165030|NCT00772967|472226804|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
131165031|NCT00772967|472226805|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
131165032|NCT00772967|472226806|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
131165033|NCT00772967|472226801|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
131165034|NCT00772967|472226802|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
131165035|NCT00772967|472226803|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
131165036|NCT00772967|472226804|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
131165037|NCT00772967|472226805|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
131165038|NCT00772967|472226806|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
131165039|NCT00772967|472226801|FG000|Crossover Treatment 3|Adverse Event|0|||
131165040|NCT00772967|472226802|FG001|Crossover Treatment 3|Adverse Event|0|||
131165041|NCT00772967|472226803|FG002|Crossover Treatment 3|Adverse Event|0|||
131165042|NCT00772967|472226804|FG003|Crossover Treatment 3|Adverse Event|0|||
131165043|NCT00772967|472226805|FG004|Crossover Treatment 3|Adverse Event|1|||
131165044|NCT00772967|472226806|FG005|Crossover Treatment 3|Adverse Event|0|||
131165045|NCT01595646|472226807|FG000|Overall Study|Withdrawal by Subject|1|||
131165046|NCT01595646|472226808|FG001|Overall Study|Withdrawal by Subject|0|||
131165047|NCT01595646|472226809|FG002|Overall Study|Withdrawal by Subject|0|||
131165048|NCT01161524|472226812|FG000|Core Study (23 Weeks)|Adverse Event|3|||
131165049|NCT01161524|472226813|FG001|Core Study (23 Weeks)|Adverse Event|0|||
131165050|NCT01161524|472226814|FG002|Core Study (23 Weeks)|Adverse Event|0|||
131165051|NCT01161524|472226812|FG000|Core Study (23 Weeks)|Other|1|||
131165052|NCT01161524|472226813|FG001|Core Study (23 Weeks)|Other|0|||
131165053|NCT01161524|472226814|FG002|Core Study (23 Weeks)|Other|0|||
131165054|NCT01161524|472226812|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
131165055|NCT01161524|472226813|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
130729388|NCT01982812|470630668|FG000|Overall Study|Adverse Event|0|||
130729389|NCT01982812|470630669|FG001|Overall Study|Adverse Event|5|||
130729390|NCT00307437|470630670|FG000|Controlled Period|Adverse Event|7|||
130729391|NCT00307437|470630671|FG001|Controlled Period|Adverse Event|2|||
130729392|NCT00307437|470630672|FG002|Controlled Period|Adverse Event|5|||
130729393|NCT00307437|470630673|FG003|Controlled Period|Adverse Event|0|||
130729394|NCT00307437|470630674|FG004|Controlled Period|Adverse Event|0|||
130729395|NCT00307437|470630675|FG005|Controlled Period|Adverse Event|0|||
130729396|NCT00307437|470630676|FG006|Controlled Period|Adverse Event|0|||
130729397|NCT00307437|470630670|FG000|Controlled Period|Death|0|||
130729398|NCT00307437|470630671|FG001|Controlled Period|Death|0|||
130729399|NCT00307437|470630672|FG002|Controlled Period|Death|1|||
130729400|NCT00307437|470630673|FG003|Controlled Period|Death|0|||
130729401|NCT00307437|470630674|FG004|Controlled Period|Death|0|||
130729402|NCT00307437|470630675|FG005|Controlled Period|Death|0|||
130729403|NCT00307437|470630676|FG006|Controlled Period|Death|0|||
130729404|NCT00307437|470630670|FG000|Controlled Period|Lack of Efficacy|2|||
130729405|NCT00307437|470630671|FG001|Controlled Period|Lack of Efficacy|0|||
130729406|NCT00307437|470630672|FG002|Controlled Period|Lack of Efficacy|0|||
130729407|NCT00307437|470630673|FG003|Controlled Period|Lack of Efficacy|0|||
130729408|NCT00307437|470630674|FG004|Controlled Period|Lack of Efficacy|0|||
130729409|NCT00307437|470630675|FG005|Controlled Period|Lack of Efficacy|0|||
130729410|NCT00307437|470630676|FG006|Controlled Period|Lack of Efficacy|0|||
130729411|NCT00307437|470630670|FG000|Controlled Period|Lost to Follow-up|2|||
130729412|NCT00307437|470630671|FG001|Controlled Period|Lost to Follow-up|3|||
130729413|NCT00307437|470630672|FG002|Controlled Period|Lost to Follow-up|0|||
130729414|NCT00307437|470630673|FG003|Controlled Period|Lost to Follow-up|0|||
130729415|NCT00307437|470630674|FG004|Controlled Period|Lost to Follow-up|0|||
130729416|NCT00307437|470630675|FG005|Controlled Period|Lost to Follow-up|0|||
130729417|NCT00307437|470630676|FG006|Controlled Period|Lost to Follow-up|0|||
130729418|NCT00307437|470630670|FG000|Controlled Period|Other|5|||
130729419|NCT00307437|470630671|FG001|Controlled Period|Other|1|||
130729420|NCT00307437|470630672|FG002|Controlled Period|Other|3|||
130729421|NCT00307437|470630673|FG003|Controlled Period|Other|0|||
130729422|NCT00307437|470630674|FG004|Controlled Period|Other|0|||
130729423|NCT00307437|470630675|FG005|Controlled Period|Other|0|||
130729424|NCT00307437|470630676|FG006|Controlled Period|Other|0|||
130729425|NCT00307437|470630670|FG000|After Controlled Period|Adverse Event|0|||
130729426|NCT00307437|470630671|FG001|After Controlled Period|Adverse Event|0|||
130729427|NCT00307437|470630672|FG002|After Controlled Period|Adverse Event|0|||
130729428|NCT00307437|470630673|FG003|After Controlled Period|Adverse Event|18|||
131165056|NCT01161524|472226814|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
131165057|NCT01161524|472226812|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
131165058|NCT01161524|472226813|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
131165059|NCT01161524|472226814|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
131165060|NCT01161524|472226812|FG000|Core Study (23 Weeks)|Subject Choice|3|||
131165061|NCT01161524|472226813|FG001|Core Study (23 Weeks)|Subject Choice|2|||
131165062|NCT01161524|472226814|FG002|Core Study (23 Weeks)|Subject Choice|0|||
131165063|NCT01161524|472226812|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
131165064|NCT01161524|472226813|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
131165065|NCT01161524|472226814|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
131165066|NCT01161524|472226812|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
131165067|NCT01161524|472226813|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
131165068|NCT01161524|472226814|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
131165069|NCT01161524|472226812|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
131165070|NCT01161524|472226813|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
131165071|NCT01161524|472226814|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
131165072|NCT01161524|472226812|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
131165073|NCT01161524|472226813|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
131165074|NCT01161524|472226814|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
131165075|NCT01161524|472226812|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
131165076|NCT01161524|472226813|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
131165077|NCT01161524|472226814|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
131165078|NCT02021812|472226819|FG000|Overall Study|Death|8|||
130729429|NCT00307437|470630674|FG004|After Controlled Period|Adverse Event|16|||
130729430|NCT00307437|470630675|FG005|After Controlled Period|Adverse Event|31|||
130729431|NCT00307437|470630676|FG006|After Controlled Period|Adverse Event|40|||
131165079|NCT02021812|472226819|FG000|Overall Study|Withdrawal by Subject|3|||
130729432|NCT00307437|470630670|FG000|After Controlled Period|Death|0|||
130729433|NCT00307437|470630671|FG001|After Controlled Period|Death|0|||
130729434|NCT00307437|470630672|FG002|After Controlled Period|Death|0|||
130729435|NCT00307437|470630673|FG003|After Controlled Period|Death|3|||
130729436|NCT00307437|470630674|FG004|After Controlled Period|Death|1|||
130729437|NCT00307437|470630675|FG005|After Controlled Period|Death|1|||
130729438|NCT00307437|470630676|FG006|After Controlled Period|Death|3|||
130729439|NCT00307437|470630670|FG000|After Controlled Period|Lack of Efficacy|0|||
130729440|NCT00307437|470630671|FG001|After Controlled Period|Lack of Efficacy|0|||
130729441|NCT00307437|470630672|FG002|After Controlled Period|Lack of Efficacy|0|||
130729442|NCT00307437|470630673|FG003|After Controlled Period|Lack of Efficacy|15|||
130729443|NCT00307437|470630674|FG004|After Controlled Period|Lack of Efficacy|17|||
130729444|NCT00307437|470630675|FG005|After Controlled Period|Lack of Efficacy|37|||
130729445|NCT00307437|470630676|FG006|After Controlled Period|Lack of Efficacy|24|||
130729446|NCT00307437|470630670|FG000|After Controlled Period|Lost to Follow-up|0|||
130729447|NCT00307437|470630671|FG001|After Controlled Period|Lost to Follow-up|0|||
130729448|NCT00307437|470630672|FG002|After Controlled Period|Lost to Follow-up|0|||
130729449|NCT00307437|470630673|FG003|After Controlled Period|Lost to Follow-up|7|||
130729450|NCT00307437|470630674|FG004|After Controlled Period|Lost to Follow-up|12|||
130729451|NCT00307437|470630675|FG005|After Controlled Period|Lost to Follow-up|13|||
130729452|NCT00307437|470630676|FG006|After Controlled Period|Lost to Follow-up|18|||
130729453|NCT00307437|470630670|FG000|After Controlled Period|Other|0|||
130729454|NCT00307437|470630671|FG001|After Controlled Period|Other|0|||
130729455|NCT00307437|470630672|FG002|After Controlled Period|Other|0|||
130729456|NCT00307437|470630673|FG003|After Controlled Period|Other|15|||
130729457|NCT00307437|470630674|FG004|After Controlled Period|Other|9|||
130729458|NCT00307437|470630675|FG005|After Controlled Period|Other|40|||
130729459|NCT00307437|470630676|FG006|After Controlled Period|Other|28|||
130729460|NCT00338728|470630677|FG000|Overall Study|Screen Failure|14|||
130729461|NCT02933255|470630683|FG000|Overall Study|Discontinued due to study closure.|1|||
130729462|NCT02933255|470630684|FG001|Overall Study|Discontinued due to study closure.|0|||
130729463|NCT04803305|470630685|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
130729464|NCT04803305|470630686|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
130729465|NCT04803305|470630685|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
130729466|NCT04803305|470630686|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
130729467|NCT04803305|470630685|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
130729468|NCT04803305|470630686|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
130729469|NCT04803305|470630685|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
130729470|NCT04803305|470630686|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
130729471|NCT04803305|470630685|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
130729472|NCT04803305|470630686|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
130729473|NCT04803305|470630685|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
130729474|NCT04803305|470630686|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
130729475|NCT04803305|470630685|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
131165080|NCT02021812|472226819|FG000|Overall Study|Lost to Follow-up|2|||
131165081|NCT02021812|472226819|FG000|Overall Study|Refuse to return, COVD 19|2|||
131165082|NCT01780389|472226821|FG000|Overall Study|Adverse Event|1|||
131165083|NCT02582749|472226822|FG000|Overall Study|Study terminated by funder|5|||
131165084|NCT02582749|472226823|FG001|Overall Study|Study terminated by funder|10|||
131165085|NCT02582749|472226822|FG000|Overall Study|Withdrawal by Subject|0|||
131165086|NCT02582749|472226823|FG001|Overall Study|Withdrawal by Subject|1|||
131165087|NCT02815397|472226826|FG000|Overall Study|Physician Decision|2|||
131165088|NCT01323673|472226827|FG000|Overall Study|Adverse Event|0|||
131165089|NCT01323673|472226828|FG001|Overall Study|Adverse Event|1|||
131165090|NCT01323673|472226827|FG000|Overall Study|Lost to Follow-up|0|||
131165091|NCT01323673|472226828|FG001|Overall Study|Lost to Follow-up|1|||
131165092|NCT01323673|472226827|FG000|Overall Study|Protocol Violation|1|||
131165093|NCT01323673|472226828|FG001|Overall Study|Protocol Violation|0|||
131165094|NCT01323673|472226827|FG000|Overall Study|Withdrawal by Subject|2|||
131165095|NCT01323673|472226828|FG001|Overall Study|Withdrawal by Subject|3|||
131165096|NCT04229446|472226832|FG000|Overall Study|Death|12|||
131165097|NCT04229446|472226833|FG001|Overall Study|Death|10|||
131165098|NCT04229446|472226832|FG000|Overall Study|Lost to Follow-up|5|||
131165099|NCT04229446|472226833|FG001|Overall Study|Lost to Follow-up|8|||
131165100|NCT03103750|472226834|FG000|Overall Study|Adverse Event|1|||
131165101|NCT03103750|472226835|FG001|Overall Study|Adverse Event|0|||
131165102|NCT03103750|472226834|FG000|Overall Study|Lost to Follow-up|1|||
131165103|NCT03103750|472226835|FG001|Overall Study|Lost to Follow-up|0|||
131165104|NCT03103750|472226834|FG000|Overall Study|PET Equipment Related|2|||
131165105|NCT03103750|472226835|FG001|Overall Study|PET Equipment Related|2|||
131165106|NCT03607682|472226836|FG000|Overall Study|Withdrawal by Subject|1|||
131165107|NCT03607682|472226836|FG000|Overall Study|Disease progression|1|||
131165108|NCT00376688|472226837|FG000|Overall Study|Adverse Event|3|||
131165109|NCT00376688|472226837|FG000|Overall Study|Death|1|||
131165110|NCT01254604|472228544|FG000|Overall Study|Lost to Follow-up|1|||
131165111|NCT01254604|472228545|FG001|Overall Study|Lost to Follow-up|1|||
131165112|NCT01254604|472228544|FG000|Overall Study|Protocol Violation|2|||
131165113|NCT01254604|472228545|FG001|Overall Study|Protocol Violation|2|||
130729476|NCT04803305|470630686|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
130729477|NCT04803305|470630685|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
130729478|NCT04803305|470630686|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
130729479|NCT05833139|470633565|FG000|Study Period 2|Adverse Event|1|||
130729480|NCT03922529|470633566|FG000|Overall Study|Withdrawal by Subject|13|||
131165114|NCT01254604|472228544|FG000|Overall Study|Withdrawal by Subject|2|||
131165115|NCT01254604|472228545|FG001|Overall Study|Withdrawal by Subject|4|||
131165116|NCT01254604|472228544|FG000|Overall Study|Adverse Event|3|||
131165117|NCT01254604|472228545|FG001|Overall Study|Adverse Event|2|||
131165118|NCT03074162|472228546|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
131165119|NCT03074162|472228547|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
131165120|NCT03074162|472228548|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
131165121|NCT03074162|472228549|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
131165122|NCT03074162|472228550|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
131165123|NCT03074162|472228551|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
131165124|NCT03074162|472228546|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
131165125|NCT03074162|472228547|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
131165126|NCT03074162|472228548|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
131165127|NCT03074162|472228549|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
131165128|NCT03074162|472228550|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
131165129|NCT03074162|472228551|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
131165130|NCT03074162|472228546|FG000|Period 3|Withdrawal by Subject|1|||
131165131|NCT03074162|472228547|FG001|Period 3|Withdrawal by Subject|0|||
131165132|NCT03074162|472228548|FG002|Period 3|Withdrawal by Subject|0|||
131165133|NCT03074162|472228549|FG003|Period 3|Withdrawal by Subject|0|||
131165134|NCT03074162|472228550|FG004|Period 3|Withdrawal by Subject|1|||
131165135|NCT03074162|472228551|FG005|Period 3|Withdrawal by Subject|0|||
131165136|NCT01993329|472228552|FG000|Period 2|Adverse Event|0|||
131165137|NCT01993329|472228553|FG001|Period 2|Adverse Event|0|||
131165138|NCT01993329|472228554|FG002|Period 2|Adverse Event|0|||
131165139|NCT01993329|472228555|FG003|Period 2|Adverse Event|0|||
131165140|NCT01993329|472228556|FG004|Period 2|Adverse Event|0|||
131165141|NCT01993329|472228557|FG005|Period 2|Adverse Event|1|||
131165142|NCT01993329|472228552|FG000|Wash-out|Personal reasons|0|||
131165143|NCT01993329|472228553|FG001|Wash-out|Personal reasons|1|||
131165144|NCT01993329|472228554|FG002|Wash-out|Personal reasons|0|||
131165145|NCT01993329|472228555|FG003|Wash-out|Personal reasons|0|||
131165146|NCT01993329|472228556|FG004|Wash-out|Personal reasons|0|||
131165147|NCT01993329|472228557|FG005|Wash-out|Personal reasons|0|||
131165148|NCT02948777|472228558|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
131165149|NCT05070429|472228559|FG000|Overall Study|Death|0|||
131165150|NCT05070429|472228560|FG001|Overall Study|Death|4|||
131165151|NCT05070429|472228559|FG000|Overall Study|Withdrawal by Subject|2|||
131165152|NCT05070429|472228560|FG001|Overall Study|Withdrawal by Subject|1|||
131165153|NCT05070429|472228559|FG000|Overall Study|Other|15|||
131165154|NCT05070429|472228560|FG001|Overall Study|Other|5|||
131165155|NCT02311478|472228561|FG000|Overall Study|Withdrawal by Subject|1|||
131165156|NCT02311478|472228561|FG000|Overall Study|Lost to Follow-up|5|||
131165157|NCT02311478|472228561|FG000|Overall Study|Failed IUD Insertion|1|||
131165158|NCT03242928|472228562|FG000|Overall Study|Adverse Event|2|||
131165159|NCT03242928|472228563|FG001|Overall Study|Adverse Event|1|||
131165160|NCT03242928|472228562|FG000|Overall Study|Lost to Follow-up|2|||
131165161|NCT03242928|472228563|FG001|Overall Study|Lost to Follow-up|0|||
131165162|NCT03242928|472228562|FG000|Overall Study|Physician Decision|0|||
131235607|NCT01901055|472490969|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
131165163|NCT03242928|472228563|FG001|Overall Study|Physician Decision|1|||
131165164|NCT03242928|472228562|FG000|Overall Study|Withdrawal by Subject|5|||
131165165|NCT03242928|472228563|FG001|Overall Study|Withdrawal by Subject|3|||
131165166|NCT03276936|472228564|FG000|Overall Study|Adverse Event|4|||
131165167|NCT03276936|472228565|FG001|Overall Study|Adverse Event|2|||
131165168|NCT03276936|472228564|FG000|Overall Study|Lost to Follow-up|16|||
131165169|NCT03276936|472228565|FG001|Overall Study|Lost to Follow-up|13|||
131165170|NCT03276936|472228564|FG000|Overall Study|Withdrawal by Subject|30|||
131165171|NCT03276936|472228565|FG001|Overall Study|Withdrawal by Subject|20|||
131165172|NCT03276936|472228564|FG000|Overall Study|Not mentioned|6|||
131165173|NCT03276936|472228565|FG001|Overall Study|Not mentioned|3|||
131165174|NCT03041116|472228566|FG000|Double-blind|Death|0|||
131165175|NCT03041116|472228567|FG001|Double-blind|Death|2|||
131165176|NCT03041116|472228566|FG000|Double-blind|Withdrawal by Subject|0|||
131165177|NCT03041116|472228567|FG001|Double-blind|Withdrawal by Subject|4|||
131165178|NCT03041116|472228566|FG000|Open-label|Death|1|||
131165179|NCT03041116|472228567|FG001|Open-label|Death|0|||
131165180|NCT03041116|472228566|FG000|Open-label|Termination of the study by Sponsor|39|||
131165181|NCT03041116|472228567|FG001|Open-label|Termination of the study by Sponsor|37|||
131165182|NCT03041116|472228566|FG000|Open-label|Withdrawal by Subject|1|||
131165183|NCT03041116|472228567|FG001|Open-label|Withdrawal by Subject|0|||
131165184|NCT00943319|472228568|FG000|Overall Study|Death|1|||
131165185|NCT02043301|472228569|FG000|Overall Study|Discontinued|0|||
131165186|NCT02043301|472228570|FG001|Overall Study|Discontinued|1|||
131165187|NCT02043301|472228571|FG002|Overall Study|Discontinued|0|||
131165188|NCT01798134|472228572|FG000|Overall Study|Lost to Follow-up|1|||
131165189|NCT01798134|472228572|FG000|Overall Study|Withdrawal by Subject|3|||
131165190|NCT01798134|472228572|FG000|Overall Study|Death|2|||
131165191|NCT01798134|472228572|FG000|Overall Study|Adverse Event|3|||
131165192|NCT01798134|472228572|FG000|Overall Study|Physician Decision|3|||
131165193|NCT01798134|472228572|FG000|Overall Study|Liver transplant/surgery|4|||
131165194|NCT02023164|472228573|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
131165195|NCT02023164|472228574|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
131165196|NCT02436577|472228575|FG000|Overall Study|Protocol Deviation|0|||
131165197|NCT02436577|472228576|FG001|Overall Study|Protocol Deviation|1|||
130729481|NCT03922529|470633567|FG001|Overall Study|Withdrawal by Subject|12|||
130729482|NCT03922529|470633566|FG000|Overall Study|Death|7|||
130729483|NCT03922529|470633567|FG001|Overall Study|Death|12|||
130729484|NCT03922529|470633566|FG000|Overall Study|Lost to Follow-up|12|||
130729485|NCT03922529|470633567|FG001|Overall Study|Lost to Follow-up|19|||
130729486|NCT03922529|470633566|FG000|Overall Study|Adverse Event|1|||
130729487|NCT03922529|470633567|FG001|Overall Study|Adverse Event|0|||
130729488|NCT03922529|470633566|FG000|Overall Study|Death after withdrawal|1|||
130729489|NCT03922529|470633567|FG001|Overall Study|Death after withdrawal|0|||
130729490|NCT03922529|470633566|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
130729491|NCT03922529|470633567|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
130729492|NCT03922529|470633566|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
130729493|NCT03922529|470633567|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
130729494|NCT02506153|470633568|FG000|Overall Study|Adverse Event|359|||
130729495|NCT02506153|470633569|FG001|Overall Study|Adverse Event|114|||
130729496|NCT02506153|470633568|FG000|Overall Study|Refused unrelated to adverse event|127|||
131165198|NCT02436577|472228577|FG002|Overall Study|Protocol Deviation|0|||
131165199|NCT02436577|472228578|FG003|Overall Study|Protocol Deviation|0|||
131165200|NCT02436577|472228579|FG004|Overall Study|Protocol Deviation|0|||
131165201|NCT02436577|472228580|FG005|Overall Study|Protocol Deviation|0|||
131165202|NCT03703375|472228584|FG000|Randomization Period|Withdrawal by Subject|0|||
131165203|NCT03703375|472228585|FG001|Randomization Period|Withdrawal by Subject|0|||
131165204|NCT03703375|472228586|FG002|Randomization Period|Withdrawal by Subject|0|||
131165205|NCT03703375|472228587|FG003|Randomization Period|Withdrawal by Subject|1|||
131165206|NCT03703375|472228584|FG000|Randomization Period|Completed safety run-in treatment|7|||
131165207|NCT03703375|472228585|FG001|Randomization Period|Completed safety run-in treatment|0|||
131165208|NCT03703375|472228586|FG002|Randomization Period|Completed safety run-in treatment|0|||
131165209|NCT03703375|472228587|FG003|Randomization Period|Completed safety run-in treatment|0|||
131165210|NCT03703375|472228584|FG000|Treatment Period|Other Reasons|0|||
131165211|NCT03703375|472228585|FG001|Treatment Period|Other Reasons|1|||
131165212|NCT03703375|472228586|FG002|Treatment Period|Other Reasons|0|||
131165213|NCT03703375|472228587|FG003|Treatment Period|Other Reasons|3|||
131165214|NCT03703375|472228584|FG000|Treatment Period|Consent Withdrawal|0|||
131165215|NCT03703375|472228585|FG001|Treatment Period|Consent Withdrawal|0|||
131165216|NCT03703375|472228586|FG002|Treatment Period|Consent Withdrawal|0|||
131165217|NCT03703375|472228587|FG003|Treatment Period|Consent Withdrawal|1|||
131165218|NCT03703375|472228584|FG000|Treatment Period|Death|1|||
131165219|NCT03703375|472228585|FG001|Treatment Period|Death|0|||
131165220|NCT03703375|472228586|FG002|Treatment Period|Death|1|||
131165221|NCT03703375|472228587|FG003|Treatment Period|Death|2|||
131165222|NCT03703375|472228584|FG000|Treatment Period|Toxicity of Study Treatment|2|||
131165223|NCT03703375|472228585|FG001|Treatment Period|Toxicity of Study Treatment|0|||
131165224|NCT03703375|472228586|FG002|Treatment Period|Toxicity of Study Treatment|4|||
131165225|NCT03703375|472228587|FG003|Treatment Period|Toxicity of Study Treatment|1|||
131165226|NCT03703375|472228584|FG000|Treatment Period|Progression|32|||
131165227|NCT03703375|472228585|FG001|Treatment Period|Progression|1|||
131165228|NCT03703375|472228586|FG002|Treatment Period|Progression|7|||
131165229|NCT03703375|472228587|FG003|Treatment Period|Progression|11|||
131165230|NCT03703375|472228584|FG000|Treatment Period|Completed treatment|7|||
131165231|NCT03703375|472228585|FG001|Treatment Period|Completed treatment|2|||
131165232|NCT03703375|472228586|FG002|Treatment Period|Completed treatment|0|||
131165233|NCT03703375|472228587|FG003|Treatment Period|Completed treatment|0|||
131165234|NCT02678741|472228590|FG000|Overall Study|Death|4|||
131165235|NCT02678741|472228590|FG000|Overall Study|Withdrawal by Subject|1|||
131165236|NCT02678741|472228590|FG000|Overall Study|ineligible|3|||
131165237|NCT02678741|472228590|FG000|Overall Study|Not RECIST Measurable|2|||
131165238|NCT02678741|472228590|FG000|Overall Study|Lack of Efficacy|10|||
131165239|NCT00903032|472228591|FG000|Overall Study|Withdrawal by Subject|5|||
131165240|NCT00903032|472228592|FG001|Overall Study|Withdrawal by Subject|3|||
131165241|NCT00903032|472228591|FG000|Overall Study|Lost to Follow-up|2|||
131165242|NCT00903032|472228592|FG001|Overall Study|Lost to Follow-up|2|||
131165243|NCT01876732|472228593|FG000|Overall Study|MMA was not over 800mg/dL|75|||
131165244|NCT00623467|472228594|FG000|Overall Study|Lost to Follow-up|1|||
131165245|NCT00623467|472228594|FG000|Overall Study|Protocol Violation|4|||
131165246|NCT00623467|472228594|FG000|Overall Study|Withdrawal by Subject|2|||
131165247|NCT02834403|472228599|FG000|Overall Study|Physician Decision|2|||
131165248|NCT02834403|472228600|FG001|Overall Study|Physician Decision|1|||
131165249|NCT02834403|472228601|FG002|Overall Study|Physician Decision|2|||
130729497|NCT02506153|470633569|FG001|Overall Study|Refused unrelated to adverse event|18|||
131165250|NCT02834403|472228602|FG003|Overall Study|Physician Decision|1|||
131165251|NCT02834403|472228603|FG004|Overall Study|Physician Decision|1|||
131165252|NCT02834403|472228604|FG005|Overall Study|Physician Decision|2|||
131165253|NCT02834403|472228605|FG006|Overall Study|Physician Decision|12|||
131165254|NCT02834403|472228599|FG000|Overall Study|Adverse Event|0|||
131165255|NCT02834403|472228600|FG001|Overall Study|Adverse Event|0|||
131165256|NCT02834403|472228601|FG002|Overall Study|Adverse Event|0|||
131165257|NCT02834403|472228602|FG003|Overall Study|Adverse Event|0|||
131165258|NCT02834403|472228603|FG004|Overall Study|Adverse Event|1|||
131165259|NCT02834403|472228604|FG005|Overall Study|Adverse Event|1|||
131165260|NCT02834403|472228605|FG006|Overall Study|Adverse Event|3|||
131165261|NCT02834403|472228599|FG000|Overall Study|Withdrawal by Subject|0|||
131165262|NCT02834403|472228600|FG001|Overall Study|Withdrawal by Subject|1|||
131165263|NCT02834403|472228601|FG002|Overall Study|Withdrawal by Subject|0|||
131165264|NCT02834403|472228602|FG003|Overall Study|Withdrawal by Subject|0|||
131165265|NCT02834403|472228603|FG004|Overall Study|Withdrawal by Subject|1|||
131165266|NCT02834403|472228604|FG005|Overall Study|Withdrawal by Subject|0|||
131165267|NCT02834403|472228605|FG006|Overall Study|Withdrawal by Subject|0|||
131165268|NCT02834403|472228599|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
131165269|NCT02834403|472228600|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
131165270|NCT02834403|472228601|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
131165271|NCT02834403|472228602|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
131165272|NCT02834403|472228603|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
131165273|NCT02834403|472228604|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
131165274|NCT02834403|472228605|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
131165275|NCT02341014|472228606|FG000|Overall Study|Adverse Event|0|||
131165276|NCT02341014|472228607|FG001|Overall Study|Adverse Event|1|||
131165277|NCT02341014|472228608|FG002|Overall Study|Adverse Event|0|||
131165278|NCT02341014|472228609|FG003|Overall Study|Adverse Event|0|||
131165279|NCT02341014|472228610|FG004|Overall Study|Adverse Event|2|||
131165280|NCT04705597|472228611|FG000|Overall Study|Death|16|||
131165281|NCT04705597|472228612|FG001|Overall Study|Death|9|||
131165282|NCT04705597|472228611|FG000|Overall Study|Lost to Follow-up|1|||
131165283|NCT04705597|472228612|FG001|Overall Study|Lost to Follow-up|0|||
131165284|NCT04705597|472228611|FG000|Overall Study|Withdrawal by Subject|1|||
131165285|NCT04705597|472228612|FG001|Overall Study|Withdrawal by Subject|2|||
131165286|NCT00273858|472228624|FG000|Overall Study|Not completed 24 month observation time|334|||
131165287|NCT00273858|472228624|FG000|Overall Study|Lost to Follow-up|101|||
131165288|NCT00273858|472228624|FG000|Overall Study|Withdrawal by Subject|21|||
131165289|NCT00273858|472228624|FG000|Overall Study|Adverse Event|81|||
131165290|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
131165291|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
131165292|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
131165293|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
131165294|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
131165295|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
131165296|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
131165297|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
131165298|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
130780632|NCT00521365|470823137|FG000|Overall Study|Usage of not allowed drugs|6|||
130780633|NCT03627832|470823138|FG000|Overall Study|Withdrawal by Subject|10|||
130780634|NCT03627832|470823139|FG001|Overall Study|Withdrawal by Subject|1|||
130780635|NCT03150082|470823140|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
130780636|NCT03150082|470823141|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
130780637|NCT01718483|470823142|FG000|Overall Study|Withdrawal by Subject|14|||
130780638|NCT01718483|470823143|FG001|Overall Study|Withdrawal by Subject|12|||
130780639|NCT01718483|470823142|FG000|Overall Study|Adverse Event|5|||
130780640|NCT01718483|470823143|FG001|Overall Study|Adverse Event|12|||
130780641|NCT01718483|470823142|FG000|Overall Study|Lost to Follow-up|8|||
130780642|NCT01718483|470823143|FG001|Overall Study|Lost to Follow-up|3|||
131165299|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
131165300|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
131165301|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
131165302|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
130780643|NCT01718483|470823142|FG000|Overall Study|Protocol Violation|4|||
131165303|NCT02232516|472228625|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
131165304|NCT02232516|472228625|FG000|Survival Follow-up|Death|15|||
131165305|NCT02232516|472228625|FG000|Survival Follow-up|Withdrawal by Subject|3|||
131165306|NCT02232516|472228625|FG000|Survival Follow-up|Lost to Follow-up|1|||
131165307|NCT02232516|472228625|FG000|Survival Follow-up|Still in follow-up|5|||
131165308|NCT00972244|472228626|FG000|Overall Study|Incorrect Enrolment|1|||
131165309|NCT00972244|472228627|FG001|Overall Study|Incorrect Enrolment|0|||
131165310|NCT00972244|472228628|FG002|Overall Study|Incorrect Enrolment|0|||
130780644|NCT01718483|470823143|FG001|Overall Study|Protocol Violation|2|||
131165311|NCT00972244|472228629|FG003|Overall Study|Incorrect Enrolment|0|||
131165312|NCT00972244|472228630|FG004|Overall Study|Incorrect Enrolment|0|||
131165313|NCT00972244|472228626|FG000|Overall Study|Adverse Event|0|||
131165314|NCT00972244|472228627|FG001|Overall Study|Adverse Event|1|||
131165315|NCT00972244|472228628|FG002|Overall Study|Adverse Event|1|||
131165316|NCT00972244|472228629|FG003|Overall Study|Adverse Event|0|||
131165317|NCT00972244|472228630|FG004|Overall Study|Adverse Event|0|||
131165318|NCT00972244|472228626|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
131165319|NCT00972244|472228627|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
131165320|NCT00972244|472228628|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
131165321|NCT00972244|472228629|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
131165322|NCT00972244|472228630|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
131165323|NCT00972244|472228626|FG000|Overall Study|Withdrawal by Subject|1|||
131165324|NCT00972244|472228627|FG001|Overall Study|Withdrawal by Subject|2|||
131165325|NCT00972244|472228628|FG002|Overall Study|Withdrawal by Subject|1|||
131165326|NCT00972244|472228629|FG003|Overall Study|Withdrawal by Subject|0|||
131165327|NCT00972244|472228630|FG004|Overall Study|Withdrawal by Subject|1|||
131165328|NCT00972244|472228626|FG000|Overall Study|Safety|0|||
131165329|NCT00972244|472228627|FG001|Overall Study|Safety|0|||
131165330|NCT00972244|472228628|FG002|Overall Study|Safety|0|||
131165331|NCT00972244|472228629|FG003|Overall Study|Safety|0|||
131165332|NCT00972244|472228630|FG004|Overall Study|Safety|1|||
131165333|NCT00972244|472228626|FG000|Overall Study|Death|1|||
131165334|NCT00972244|472228627|FG001|Overall Study|Death|0|||
131165335|NCT00972244|472228628|FG002|Overall Study|Death|0|||
131165336|NCT00972244|472228629|FG003|Overall Study|Death|0|||
131165337|NCT00972244|472228630|FG004|Overall Study|Death|0|||
131165338|NCT00972244|472228626|FG000|Overall Study|Various|0|||
131165339|NCT00972244|472228627|FG001|Overall Study|Various|0|||
131165340|NCT00972244|472228628|FG002|Overall Study|Various|0|||
131165341|NCT00972244|472228629|FG003|Overall Study|Various|0|||
131165342|NCT00972244|472228630|FG004|Overall Study|Various|2|||
131165343|NCT01258348|472228631|FG000|Overall Study|Adverse Event|1|||
131165344|NCT01258348|472228632|FG001|Overall Study|Adverse Event|1|||
131165345|NCT01258348|472228633|FG002|Overall Study|Adverse Event|3|||
131165346|NCT01258348|472228634|FG003|Overall Study|Adverse Event|2|||
131165347|NCT01258348|472228635|FG004|Overall Study|Adverse Event|4|||
131165348|NCT01258348|472228631|FG000|Overall Study|Progressive Disease|0|||
131165349|NCT01258348|472228632|FG001|Overall Study|Progressive Disease|3|||
131165350|NCT01258348|472228633|FG002|Overall Study|Progressive Disease|0|||
131165351|NCT01258348|472228634|FG003|Overall Study|Progressive Disease|2|||
131165352|NCT01258348|472228635|FG004|Overall Study|Progressive Disease|2|||
131165353|NCT01258348|472228631|FG000|Overall Study|Physician Decision|0|||
131165354|NCT01258348|472228632|FG001|Overall Study|Physician Decision|0|||
131165355|NCT01258348|472228633|FG002|Overall Study|Physician Decision|0|||
131165356|NCT01258348|472228634|FG003|Overall Study|Physician Decision|2|||
131165357|NCT01258348|472228635|FG004|Overall Study|Physician Decision|0|||
131165358|NCT01258348|472228631|FG000|Overall Study|Withdrawal by Subject|0|||
131165359|NCT01258348|472228632|FG001|Overall Study|Withdrawal by Subject|1|||
131165360|NCT01258348|472228633|FG002|Overall Study|Withdrawal by Subject|0|||
131165361|NCT01258348|472228634|FG003|Overall Study|Withdrawal by Subject|0|||
131165362|NCT01258348|472228635|FG004|Overall Study|Withdrawal by Subject|0|||
131165363|NCT01234402|472228641|FG000|Overall Study|Lost to Follow-up|0|||
131165364|NCT01234402|472228642|FG001|Overall Study|Lost to Follow-up|1|||
131165365|NCT01234402|472228643|FG002|Overall Study|Lost to Follow-up|3|||
131165366|NCT01234402|472228641|FG000|Overall Study|Withdrawal by Subject|1|||
131165367|NCT01234402|472228642|FG001|Overall Study|Withdrawal by Subject|3|||
131165368|NCT01234402|472228643|FG002|Overall Study|Withdrawal by Subject|4|||
131165369|NCT01234402|472228641|FG000|Overall Study|Never treated: Death|0|||
131165370|NCT01234402|472228642|FG001|Overall Study|Never treated: Death|0|||
131165371|NCT01234402|472228643|FG002|Overall Study|Never treated: Death|1|||
131165372|NCT01234402|472228641|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
131165373|NCT01234402|472228642|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
131165374|NCT01234402|472228643|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
131165375|NCT01234402|472228641|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
131165376|NCT01234402|472228642|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
131165377|NCT01234402|472228643|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
131165378|NCT02417233|472228645|FG000|Overall Study|Death|4|||
131165379|NCT02417233|472228646|FG001|Overall Study|Death|10|||
131165380|NCT02417233|472228647|FG002|Overall Study|Death|14|||
131165381|NCT02417233|472228645|FG000|Overall Study|Lost to Follow-up|27|||
131165382|NCT02417233|472228646|FG001|Overall Study|Lost to Follow-up|39|||
131235608|NCT01901055|472490968|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
131165383|NCT02417233|472228647|FG002|Overall Study|Lost to Follow-up|34|||
131165384|NCT02417233|472228645|FG000|Overall Study|Protocol Violation|2|||
131165385|NCT02417233|472228646|FG001|Overall Study|Protocol Violation|0|||
131165386|NCT02417233|472228647|FG002|Overall Study|Protocol Violation|2|||
131165387|NCT02417233|472228645|FG000|Overall Study|Withdrawal by Subject|2|||
131165388|NCT02417233|472228646|FG001|Overall Study|Withdrawal by Subject|1|||
131165389|NCT02417233|472228647|FG002|Overall Study|Withdrawal by Subject|8|||
131165390|NCT02417233|472228645|FG000|Overall Study|Relocation out of study area|1|||
131165391|NCT02417233|472228646|FG001|Overall Study|Relocation out of study area|0|||
131165392|NCT02417233|472228647|FG002|Overall Study|Relocation out of study area|1|||
131165393|NCT02417233|472228645|FG000|Overall Study|Mentally unstable|0|||
131165394|NCT02417233|472228646|FG001|Overall Study|Mentally unstable|1|||
131165395|NCT02417233|472228647|FG002|Overall Study|Mentally unstable|0|||
131165396|NCT03649321|472228648|FG000|Overall Study|Withdrawal by Subject|1|||
131165397|NCT03649321|472228649|FG001|Overall Study|Withdrawal by Subject|0|||
131165398|NCT03649321|472228648|FG000|Overall Study|Death|1|||
131165399|NCT03649321|472228649|FG001|Overall Study|Death|0|||
131165400|NCT00321984|472228650|FG000|Overall Study|Adverse Event|9|||
131165401|NCT00321984|472228651|FG001|Overall Study|Adverse Event|6|||
131165402|NCT00321984|472228652|FG002|Overall Study|Adverse Event|8|||
131165403|NCT00321984|472228650|FG000|Overall Study|Protocol Violation|0|||
131165404|NCT00321984|472228651|FG001|Overall Study|Protocol Violation|1|||
131165405|NCT00321984|472228652|FG002|Overall Study|Protocol Violation|1|||
131165406|NCT00321984|472228650|FG000|Overall Study|Lost to Follow-up|2|||
131165407|NCT00321984|472228651|FG001|Overall Study|Lost to Follow-up|4|||
131165408|NCT00321984|472228652|FG002|Overall Study|Lost to Follow-up|2|||
131165409|NCT00321984|472228650|FG000|Overall Study|Withdrawal by Subject|8|||
131165410|NCT00321984|472228651|FG001|Overall Study|Withdrawal by Subject|6|||
131165411|NCT00321984|472228652|FG002|Overall Study|Withdrawal by Subject|5|||
131165412|NCT00321984|472228650|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
131165413|NCT00321984|472228651|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
131165414|NCT00321984|472228652|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
131165415|NCT00321984|472228650|FG000|Overall Study|Lack of Efficacy|3|||
131165416|NCT00321984|472228651|FG001|Overall Study|Lack of Efficacy|1|||
131165417|NCT00321984|472228652|FG002|Overall Study|Lack of Efficacy|3|||
131165418|NCT00321984|472228650|FG000|Overall Study|Noncompliant|0|||
131165419|NCT00321984|472228651|FG001|Overall Study|Noncompliant|0|||
131165420|NCT00321984|472228652|FG002|Overall Study|Noncompliant|2|||
131165421|NCT00321984|472228650|FG000|Overall Study|Pregnancy|0|||
131165422|NCT00321984|472228651|FG001|Overall Study|Pregnancy|1|||
131165423|NCT00321984|472228652|FG002|Overall Study|Pregnancy|0|||
131165424|NCT00321984|472228650|FG000|Overall Study|Per Subject Request|1|||
131165425|NCT00321984|472228651|FG001|Overall Study|Per Subject Request|0|||
131165426|NCT00321984|472228652|FG002|Overall Study|Per Subject Request|0|||
131165427|NCT00321984|472228650|FG000|Overall Study|Per Investigator Request|1|||
131165428|NCT00321984|472228651|FG001|Overall Study|Per Investigator Request|0|||
131165429|NCT00321984|472228652|FG002|Overall Study|Per Investigator Request|0|||
131165430|NCT00321984|472228650|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
131165431|NCT00321984|472228651|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
131165432|NCT00321984|472228652|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
131165433|NCT02137772|472228654|FG000|Overall Study|Adverse Event|6|||
131165434|NCT02137772|472228655|FG001|Overall Study|Adverse Event|3|||
131165435|NCT02137772|472228654|FG000|Overall Study|Death|71|||
131165436|NCT02137772|472228655|FG001|Overall Study|Death|44|||
131165437|NCT02137772|472228654|FG000|Overall Study|Lost to Follow-up|8|||
131165438|NCT02137772|472228655|FG001|Overall Study|Lost to Follow-up|4|||
131165439|NCT02137772|472228654|FG000|Overall Study|Physician Decision|15|||
131165440|NCT02137772|472228655|FG001|Overall Study|Physician Decision|5|||
131165441|NCT02137772|472228654|FG000|Overall Study|Withdrawal by Subject|28|||
131165442|NCT02137772|472228655|FG001|Overall Study|Withdrawal by Subject|17|||
131165443|NCT02137772|472228654|FG000|Overall Study|Non-compliance with study drug|1|||
131165444|NCT02137772|472228655|FG001|Overall Study|Non-compliance with study drug|0|||
131165445|NCT02137772|472228654|FG000|Overall Study|Not treated|3|||
131165446|NCT02137772|472228655|FG001|Overall Study|Not treated|2|||
131165447|NCT00803244|472228656|FG000|Overall Study|Adverse Event|1|||
131165448|NCT00803244|472228657|FG001|Overall Study|Adverse Event|2|||
131165449|NCT00803244|472228656|FG000|Overall Study|Withdrawal by Subject|2|||
131165450|NCT00803244|472228657|FG001|Overall Study|Withdrawal by Subject|3|||
131165451|NCT00803244|472228656|FG000|Overall Study|Any other reason not above-mentioned|4|||
131165452|NCT00803244|472228657|FG001|Overall Study|Any other reason not above-mentioned|10|||
131165453|NCT00616239|472228659|FG000|Overall Study|Withdrawal by Subject|2|||
131165454|NCT02873715|472228660|FG000|Overall Study|Lost to Follow-up|84|||
131165455|NCT02873715|472228661|FG001|Overall Study|Lost to Follow-up|94|||
131165456|NCT02873715|472228660|FG000|Overall Study|Withdrawal by Subject|7|||
131165457|NCT02873715|472228661|FG001|Overall Study|Withdrawal by Subject|26|||
131165458|NCT03241173|472228665|FG000|Overall Study|Death|3|||
130729498|NCT02506153|470633568|FG000|Overall Study|Progression/relapse|91|||
131165459|NCT03241173|472228666|FG001|Overall Study|Death|2|||
131165460|NCT03241173|472228667|FG002|Overall Study|Death|4|||
131165461|NCT03241173|472228668|FG003|Overall Study|Death|4|||
131165462|NCT03241173|472228669|FG004|Overall Study|Death|2|||
131165463|NCT03241173|472228670|FG005|Overall Study|Death|2|||
131165464|NCT03241173|472228671|FG006|Overall Study|Death|3|||
131165465|NCT03241173|472228672|FG007|Overall Study|Death|1|||
131165466|NCT03241173|472228673|FG008|Overall Study|Death|0|||
131165467|NCT03241173|472228674|FG009|Overall Study|Death|5|||
131165468|NCT03241173|472228675|FG010|Overall Study|Death|4|||
131165469|NCT03241173|472228676|FG011|Overall Study|Death|3|||
131165470|NCT03241173|472228677|FG012|Overall Study|Death|0|||
131165471|NCT03241173|472228678|FG013|Overall Study|Death|0|||
131165472|NCT03241173|472228679|FG014|Overall Study|Death|0|||
131165473|NCT03241173|472228665|FG000|Overall Study|Withdrawal by Subject|0|||
131165474|NCT03241173|472228666|FG001|Overall Study|Withdrawal by Subject|0|||
131165475|NCT03241173|472228667|FG002|Overall Study|Withdrawal by Subject|1|||
131165476|NCT03241173|472228668|FG003|Overall Study|Withdrawal by Subject|0|||
131165477|NCT03241173|472228669|FG004|Overall Study|Withdrawal by Subject|0|||
131165478|NCT03241173|472228670|FG005|Overall Study|Withdrawal by Subject|1|||
131165479|NCT03241173|472228671|FG006|Overall Study|Withdrawal by Subject|0|||
131165480|NCT03241173|472228672|FG007|Overall Study|Withdrawal by Subject|0|||
131165481|NCT03241173|472228673|FG008|Overall Study|Withdrawal by Subject|0|||
131165482|NCT03241173|472228674|FG009|Overall Study|Withdrawal by Subject|0|||
131165483|NCT03241173|472228675|FG010|Overall Study|Withdrawal by Subject|0|||
131165484|NCT03241173|472228676|FG011|Overall Study|Withdrawal by Subject|0|||
131165485|NCT03241173|472228677|FG012|Overall Study|Withdrawal by Subject|0|||
131165486|NCT03241173|472228678|FG013|Overall Study|Withdrawal by Subject|0|||
131165487|NCT03241173|472228679|FG014|Overall Study|Withdrawal by Subject|0|||
131165488|NCT03241173|472228665|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
131165489|NCT03241173|472228666|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
131165490|NCT03241173|472228667|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131165491|NCT03241173|472228668|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
131165492|NCT03241173|472228669|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
131165493|NCT03241173|472228670|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
131165494|NCT03241173|472228671|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
131165495|NCT03241173|472228672|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
131165496|NCT03241173|472228673|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131165497|NCT03241173|472228674|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131165498|NCT03241173|472228675|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
131165499|NCT03241173|472228676|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
131165500|NCT03241173|472228677|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131165501|NCT03241173|472228678|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131165502|NCT03241173|472228679|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
131165503|NCT03241173|472228665|FG000|Overall Study|Lost to Follow-up|0|||
131165504|NCT03241173|472228666|FG001|Overall Study|Lost to Follow-up|0|||
131165505|NCT03241173|472228667|FG002|Overall Study|Lost to Follow-up|0|||
131165506|NCT03241173|472228668|FG003|Overall Study|Lost to Follow-up|0|||
131165507|NCT03241173|472228669|FG004|Overall Study|Lost to Follow-up|1|||
131165508|NCT03241173|472228670|FG005|Overall Study|Lost to Follow-up|0|||
131165509|NCT03241173|472228671|FG006|Overall Study|Lost to Follow-up|0|||
131165510|NCT03241173|472228672|FG007|Overall Study|Lost to Follow-up|0|||
131165511|NCT03241173|472228673|FG008|Overall Study|Lost to Follow-up|0|||
131165512|NCT03241173|472228674|FG009|Overall Study|Lost to Follow-up|1|||
131165513|NCT03241173|472228675|FG010|Overall Study|Lost to Follow-up|0|||
131165514|NCT03241173|472228676|FG011|Overall Study|Lost to Follow-up|0|||
131165515|NCT03241173|472228677|FG012|Overall Study|Lost to Follow-up|0|||
131165516|NCT03241173|472228678|FG013|Overall Study|Lost to Follow-up|0|||
131165517|NCT03241173|472228679|FG014|Overall Study|Lost to Follow-up|0|||
131165518|NCT00564629|472228680|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
131165519|NCT00564629|472228681|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
131165520|NCT03648996|472228682|FG000|Overall Study|Withdrawal by Subject|0|||
131165521|NCT03648996|472228683|FG001|Overall Study|Withdrawal by Subject|2|||
131165522|NCT03648996|472228684|FG002|Overall Study|Withdrawal by Subject|2|||
131165523|NCT03648996|472228682|FG000|Overall Study|Physician Decision|2|||
131165524|NCT03648996|472228683|FG001|Overall Study|Physician Decision|0|||
131165525|NCT03648996|472228684|FG002|Overall Study|Physician Decision|0|||
131165526|NCT00590681|472228688|FG000|Overall Study|Withdrawal by Subject|7|||
131165527|NCT00590681|472228688|FG000|Overall Study|Adverse Event|8|||
131165528|NCT00590681|472228688|FG000|Overall Study|Death|3|||
131165529|NCT00590681|472228688|FG000|Overall Study|Lost to Follow-up|1|||
131165530|NCT00590681|472228688|FG000|Overall Study|disease progression|1|||
131165531|NCT00443430|472228691|FG000|Overall Study|Lack of Efficacy|3|||
131165532|NCT00443430|472228692|FG001|Overall Study|Lack of Efficacy|3|||
131165533|NCT00443430|472228691|FG000|Overall Study|Adverse Event|1|||
131165534|NCT00443430|472228692|FG001|Overall Study|Adverse Event|1|||
130780645|NCT01718483|470823142|FG000|Overall Study|Other|1|||
130780646|NCT01718483|470823143|FG001|Overall Study|Other|4|||
130780647|NCT01718483|470823142|FG000|Overall Study|Pregnancy|1|||
130780648|NCT01718483|470823143|FG001|Overall Study|Pregnancy|1|||
130780649|NCT01718483|470823142|FG000|Overall Study|Lack of Efficacy|1|||
130780650|NCT01718483|470823143|FG001|Overall Study|Lack of Efficacy|0|||
131165535|NCT00064662|472228693|FG000|Overall Study|Death|1|||
131165536|NCT00064662|472228694|FG001|Overall Study|Death|1|||
131165537|NCT00064662|472228693|FG000|Overall Study|Lost to Follow-up|57|||
131165538|NCT00064662|472228694|FG001|Overall Study|Lost to Follow-up|44|||
131165539|NCT00064662|472228693|FG000|Overall Study|Withdrawal by Subject|14|||
131165540|NCT00064662|472228694|FG001|Overall Study|Withdrawal by Subject|14|||
131165541|NCT00064662|472228693|FG000|Overall Study|Administratively withdrawn|2|||
131165542|NCT00064662|472228694|FG001|Overall Study|Administratively withdrawn|2|||
131165543|NCT00504166|472228696|FG000|Overall Study|Adverse Event|1|||
131165544|NCT00504166|472228697|FG001|Overall Study|Adverse Event|4|||
131165545|NCT00504166|472228696|FG000|Overall Study|Withdrawal by Subject|3|||
131165546|NCT00504166|472228697|FG001|Overall Study|Withdrawal by Subject|6|||
131165547|NCT00504166|472228696|FG000|Overall Study|Physician Decision|1|||
131165548|NCT00504166|472228697|FG001|Overall Study|Physician Decision|1|||
131165549|NCT00504166|472228696|FG000|Overall Study|Lost to Follow-up|1|||
131165550|NCT00504166|472228697|FG001|Overall Study|Lost to Follow-up|3|||
131165551|NCT02650284|472228702|FG000|Overall Study|Lost to Follow-up|3|||
131165552|NCT02650284|472228703|FG001|Overall Study|Lost to Follow-up|3|||
131165553|NCT02650284|472228702|FG000|Overall Study|Consent incorrectly taken|0|||
131165554|NCT02650284|472228703|FG001|Overall Study|Consent incorrectly taken|1|||
131165555|NCT02807454|472228710|FG000|Overall Study|Adverse Event|1|||
131165556|NCT02807454|472228711|FG001|Overall Study|Adverse Event|0|||
131165557|NCT02807454|472228710|FG000|Overall Study|Withdrawal by Subject|0|||
131165558|NCT02807454|472228711|FG001|Overall Study|Withdrawal by Subject|1|||
131165559|NCT02807454|472228710|FG000|Overall Study|Progressive Disease|30|||
131165560|NCT02807454|472228711|FG001|Overall Study|Progressive Disease|3|||
131165561|NCT02807454|472228710|FG000|Overall Study|Other Reasons|1|||
131165562|NCT02807454|472228711|FG001|Overall Study|Other Reasons|1|||
131165563|NCT01165203|472228712|FG000|Active Phase|Serious Adverse Event|1|||
131165564|NCT01165203|472228713|FG001|Active Phase|Serious Adverse Event|0|||
131165565|NCT01165203|472228712|FG000|Active Phase|Withdrawal by Subject|2|||
131165566|NCT01165203|472228713|FG001|Active Phase|Withdrawal by Subject|1|||
131165567|NCT01165203|472228712|FG000|Active Phase|Migrated/moved from study area|0|||
131165568|NCT01165203|472228713|FG001|Active Phase|Migrated/moved from study area|1|||
131165569|NCT01165203|472228712|FG000|Active Phase|Lost to Follow-up|2|||
131165570|NCT01165203|472228713|FG001|Active Phase|Lost to Follow-up|0|||
131165571|NCT01165203|472228712|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
131165572|NCT01165203|472228713|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
131165573|NCT01165203|472228712|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
131165574|NCT01165203|472228713|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
131165575|NCT01165203|472228712|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
131165576|NCT01165203|472228713|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
131165577|NCT01165203|472228712|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
131165578|NCT01165203|472228713|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
131165579|NCT01165203|472228712|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
131165580|NCT01165203|472228713|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
131165581|NCT00374907|472228714|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
131165582|NCT00374907|472228715|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
131165583|NCT00374907|472228714|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
131165584|NCT00374907|472228715|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
131165585|NCT00374907|472228714|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
131165586|NCT00374907|472228715|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
131165587|NCT00374907|472228714|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
131165588|NCT00374907|472228715|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
131165589|NCT00374907|472228714|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
131165590|NCT00374907|472228715|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
131165591|NCT04598165|472228720|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
131165592|NCT04598165|472228721|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
131165593|NCT04598165|472228720|FG000|Completed 6-week Follow-up|Death|2|||
131165594|NCT04598165|472228721|FG001|Completed 6-week Follow-up|Death|1|||
131165595|NCT04598165|472228720|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
130780651|NCT03113968|470823154|FG000|Overall Study|Withdrawal by Subject|31|||
131165596|NCT04598165|472228721|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
131165597|NCT04598165|472228720|FG000|Completed 6-week Follow-up|Ineligible|4|||
131165598|NCT04598165|472228721|FG001|Completed 6-week Follow-up|Ineligible|3|||
131165599|NCT04598165|472228720|FG000|Completed 6-week Follow-up|Partner refusal|0|||
131165600|NCT04598165|472228721|FG001|Completed 6-week Follow-up|Partner refusal|1|||
130780652|NCT03113968|470823155|FG001|Overall Study|Withdrawal by Subject|4|||
131235609|NCT01901055|472490969|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
131235610|NCT01901055|472490968|FG000|Week 24|Withdrawal by Subject|13|||
131165601|NCT04598165|472228720|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
131165602|NCT04598165|472228721|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
131165603|NCT01200511|472228722|FG000|Overall Study|Lost to Follow-up|3|||
131165604|NCT01200511|472228722|FG000|Overall Study|Withdrawal by Subject|1|||
131165605|NCT01200511|472228722|FG000|Overall Study|Adverse Event|1|||
131165606|NCT02566525|472228723|FG000|Overall Study|Protocol Violation|3|||
131165607|NCT02566525|472228724|FG001|Overall Study|Protocol Violation|5|||
131165608|NCT00337467|472228725|FG000|Overall Study|Adverse Event|3|||
131165609|NCT00337467|472228725|FG000|Overall Study|Subject Withdrew Consent|2|||
131165610|NCT00337467|472228725|FG000|Overall Study|Pregnancy|1|||
131165611|NCT00337467|472228725|FG000|Overall Study|Lost to Follow-up|2|||
131165612|NCT00337467|472228725|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
131165613|NCT04083222|472228726|FG000|Overall Study|Voluntary Withdrawal|0|||
131165614|NCT04083222|472228727|FG001|Overall Study|Voluntary Withdrawal|1|||
131165615|NCT04083222|472228726|FG000|Overall Study|Reason not Specified|0|||
131165616|NCT04083222|472228727|FG001|Overall Study|Reason not Specified|1|||
131165617|NCT01663740|472228735|FG000|Overall Study|Lost to Follow-up|1|||
131165618|NCT01663740|472228736|FG001|Overall Study|Lost to Follow-up|4|||
131165619|NCT01663740|472228735|FG000|Overall Study|Other|9|||
131165620|NCT01663740|472228736|FG001|Overall Study|Other|2|||
131165621|NCT01663740|472228735|FG000|Overall Study|Inclusion/Exclusion not met|1|||
131165622|NCT01663740|472228736|FG001|Overall Study|Inclusion/Exclusion not met|0|||
131165623|NCT01663740|472228735|FG000|Overall Study|Death|0|||
131165624|NCT01663740|472228736|FG001|Overall Study|Death|1|||
131165625|NCT01663740|472228735|FG000|Overall Study|Withdrawal by Subject|2|||
131165626|NCT01663740|472228736|FG001|Overall Study|Withdrawal by Subject|1|||
131165627|NCT01663740|472228735|FG000|Overall Study|No end of study status|3|||
131165628|NCT01663740|472228736|FG001|Overall Study|No end of study status|0|||
131165629|NCT04400318|472230138|FG000|Overall Study|Adverse Event|1|||
131165630|NCT04400318|472230139|FG001|Overall Study|Adverse Event|0|||
131165631|NCT04400318|472230138|FG000|Overall Study|Withdrawal by Subject|1|||
131165632|NCT04400318|472230139|FG001|Overall Study|Withdrawal by Subject|1|||
131165633|NCT04400318|472230138|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
131165634|NCT04400318|472230139|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
131165635|NCT04191967|472230140|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
131165636|NCT04191967|472230140|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
131165637|NCT02410902|472230143|FG000|Overall Study|Adverse Event|2|||
131165638|NCT02410902|472230144|FG001|Overall Study|Adverse Event|3|||
131165639|NCT02410902|472230143|FG000|Overall Study|Lost to Follow-up|4|||
131165640|NCT02410902|472230144|FG001|Overall Study|Lost to Follow-up|1|||
131165641|NCT02410902|472230143|FG000|Overall Study|Protocol Violation|1|||
131165642|NCT02410902|472230144|FG001|Overall Study|Protocol Violation|4|||
131165643|NCT02410902|472230143|FG000|Overall Study|Withdrawal by Subject|6|||
131165644|NCT02410902|472230144|FG001|Overall Study|Withdrawal by Subject|8|||
131165645|NCT02410902|472230143|FG000|Overall Study|Non-Compliance|8|||
131165646|NCT02410902|472230144|FG001|Overall Study|Non-Compliance|2|||
131165647|NCT00747617|472230145|FG000|Overall Study|Lost to Follow-up|3|||
131165648|NCT00747617|472230146|FG001|Overall Study|Lost to Follow-up|1|||
131165649|NCT02279524|472230147|FG000|Overall Study|Withdrawal by Subject|3|||
131165650|NCT02279524|472230148|FG001|Overall Study|Withdrawal by Subject|6|||
131165651|NCT02279524|472230149|FG002|Overall Study|Withdrawal by Subject|3|||
131165652|NCT02279524|472230147|FG000|Overall Study|Adverse Event|4|||
131165653|NCT02279524|472230148|FG001|Overall Study|Adverse Event|3|||
131165654|NCT02279524|472230149|FG002|Overall Study|Adverse Event|2|||
131165655|NCT02279524|472230147|FG000|Overall Study|Lost to Follow-up|1|||
131165656|NCT02279524|472230148|FG001|Overall Study|Lost to Follow-up|1|||
131165657|NCT02279524|472230149|FG002|Overall Study|Lost to Follow-up|0|||
131165658|NCT02279524|472230147|FG000|Overall Study|Disallowed medication|1|||
131165659|NCT02279524|472230148|FG001|Overall Study|Disallowed medication|1|||
131165660|NCT02279524|472230149|FG002|Overall Study|Disallowed medication|2|||
131165661|NCT02279524|472230147|FG000|Overall Study|Bariatric surgery|1|||
131165662|NCT02279524|472230148|FG001|Overall Study|Bariatric surgery|0|||
131165663|NCT02279524|472230149|FG002|Overall Study|Bariatric surgery|0|||
131165664|NCT01746732|472230150|FG000|Lead-In Period|Withdrawal by Subject|1|||
131165665|NCT01746732|472230151|FG001|Lead-In Period|Withdrawal by Subject|0|||
131165666|NCT01746732|472230152|FG002|Lead-In Period|Withdrawal by Subject|0|||
131165667|NCT01746732|472230150|FG000|Period 1|Physician Decision|0|||
131165668|NCT01746732|472230151|FG001|Period 1|Physician Decision|1|||
131165669|NCT01746732|472230152|FG002|Period 1|Physician Decision|0|||
131165670|NCT01746732|472230150|FG000|Period 2|Withdrawal by Subject|0|||
131165671|NCT01746732|472230151|FG001|Period 2|Withdrawal by Subject|0|||
131235611|NCT01901055|472490969|FG001|Week 24|Withdrawal by Subject|19|||
131165672|NCT01746732|472230152|FG002|Period 2|Withdrawal by Subject|2|||
131165673|NCT01746732|472230150|FG000|Period 2|Adverse Event|0|||
131165674|NCT01746732|472230151|FG001|Period 2|Adverse Event|0|||
131165675|NCT01746732|472230152|FG002|Period 2|Adverse Event|1|||
131165676|NCT01746732|472230150|FG000|Period 2|Lost to Follow-up|0|||
131165677|NCT01746732|472230151|FG001|Period 2|Lost to Follow-up|0|||
131165678|NCT01746732|472230152|FG002|Period 2|Lost to Follow-up|1|||
131165679|NCT03509207|472230153|FG000|Overall Study|Death|2|||
131165680|NCT02817555|472230154|FG000|Overall Study|Death|1|||
131165681|NCT02817555|472230155|FG001|Overall Study|Death|3|||
131165682|NCT02817555|472230154|FG000|Overall Study|moved away|1|||
131165683|NCT02817555|472230155|FG001|Overall Study|moved away|0|||
131165684|NCT02817555|472230154|FG000|Overall Study|transplant|1|||
131165685|NCT02817555|472230155|FG001|Overall Study|transplant|1|||
131165686|NCT02817555|472230154|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
131165687|NCT02817555|472230155|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
131165688|NCT00137436|472230156|FG000|Overall Study|Adverse Event|13|||
131165689|NCT00137436|472230156|FG000|Overall Study|Death|2|||
131165690|NCT00137436|472230156|FG000|Overall Study|Lack of Efficacy|17|||
131165691|NCT00137436|472230156|FG000|Overall Study|Withdrawal by Subject|6|||
131165692|NCT00137436|472230156|FG000|Overall Study|Other|5|||
131165693|NCT04657016|472230157|FG000|Overall Study|Adverse Event|2|||
131165694|NCT04657016|472230158|FG001|Overall Study|Adverse Event|4|||
131165695|NCT04657016|472230157|FG000|Overall Study|Death|1|||
131165696|NCT04657016|472230158|FG001|Overall Study|Death|1|||
131165697|NCT04657016|472230157|FG000|Overall Study|Lost to Follow-up|24|||
131165698|NCT04657016|472230158|FG001|Overall Study|Lost to Follow-up|12|||
131165699|NCT04657016|472230157|FG000|Overall Study|Physician Decision|1|||
131165700|NCT04657016|472230158|FG001|Overall Study|Physician Decision|2|||
131165701|NCT04657016|472230157|FG000|Overall Study|Pregnancy|2|||
131165702|NCT04657016|472230158|FG001|Overall Study|Pregnancy|2|||
131165703|NCT04657016|472230157|FG000|Overall Study|Protocol Deviation|1|||
131165704|NCT04657016|472230158|FG001|Overall Study|Protocol Deviation|0|||
131165705|NCT04657016|472230157|FG000|Overall Study|Withdrawal by Subject|28|||
131165706|NCT04657016|472230158|FG001|Overall Study|Withdrawal by Subject|14|||
131165707|NCT04657016|472230157|FG000|Overall Study|Other - as reported by the investigator|6|||
131165708|NCT04657016|472230158|FG001|Overall Study|Other - as reported by the investigator|0|||
131165709|NCT00912015|472230162|FG000|Overall Study|Lack of Efficacy|1|||
131165710|NCT00912015|472230163|FG001|Overall Study|Lack of Efficacy|0|||
131165711|NCT00912015|472230164|FG002|Overall Study|Lack of Efficacy|0|||
131165712|NCT00912015|472230165|FG003|Overall Study|Lack of Efficacy|0|||
131165713|NCT00912015|472230162|FG000|Overall Study|Withdrawal by Subject|8|||
131165714|NCT00912015|472230163|FG001|Overall Study|Withdrawal by Subject|8|||
131165715|NCT00912015|472230164|FG002|Overall Study|Withdrawal by Subject|3|||
131165716|NCT00912015|472230165|FG003|Overall Study|Withdrawal by Subject|0|||
131165717|NCT00912015|472230162|FG000|Overall Study|Protocol Violation|1|||
131165718|NCT00912015|472230163|FG001|Overall Study|Protocol Violation|0|||
131165719|NCT00912015|472230164|FG002|Overall Study|Protocol Violation|0|||
131165720|NCT00912015|472230165|FG003|Overall Study|Protocol Violation|1|||
131165721|NCT00912015|472230162|FG000|Overall Study|Adverse Event|6|||
131165722|NCT00912015|472230163|FG001|Overall Study|Adverse Event|0|||
131165723|NCT00912015|472230164|FG002|Overall Study|Adverse Event|0|||
131165724|NCT00912015|472230165|FG003|Overall Study|Adverse Event|1|||
131165725|NCT01356602|472230166|FG000|Overall Study|Protocol Deviation|0|||
131165726|NCT01356602|472230167|FG001|Overall Study|Protocol Deviation|1|||
131165727|NCT01356602|472230168|FG002|Overall Study|Protocol Deviation|1|||
131165728|NCT01356602|472230166|FG000|Overall Study|Administrative Problems|1|||
131165729|NCT01356602|472230167|FG001|Overall Study|Administrative Problems|4|||
131165730|NCT01356602|472230168|FG002|Overall Study|Administrative Problems|5|||
131165731|NCT01356602|472230166|FG000|Overall Study|Lost to Follow-up|4|||
131165732|NCT01356602|472230167|FG001|Overall Study|Lost to Follow-up|5|||
131165733|NCT01356602|472230168|FG002|Overall Study|Lost to Follow-up|6|||
131165734|NCT01356602|472230166|FG000|Overall Study|Withdrawal by Subject|4|||
131165735|NCT01356602|472230167|FG001|Overall Study|Withdrawal by Subject|3|||
131165736|NCT01356602|472230168|FG002|Overall Study|Withdrawal by Subject|7|||
131165737|NCT01356602|472230166|FG000|Overall Study|Lack of Efficacy|0|||
131165738|NCT01356602|472230167|FG001|Overall Study|Lack of Efficacy|1|||
131165739|NCT01356602|472230168|FG002|Overall Study|Lack of Efficacy|4|||
131165740|NCT01356602|472230166|FG000|Overall Study|Adverse Event|0|||
131165741|NCT01356602|472230167|FG001|Overall Study|Adverse Event|1|||
131165742|NCT01356602|472230168|FG002|Overall Study|Adverse Event|1|||
131165743|NCT01115569|472230169|FG000|Conversion/Titration Phase|Adverse Event|59|||
131165744|NCT01115569|472230170|FG001|Conversion/Titration Phase|Adverse Event|0|||
131165745|NCT01115569|472230169|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
131165746|NCT01115569|472230170|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
131165747|NCT01115569|472230169|FG000|Conversion/Titration Phase|Physician Decision|5|||
131165748|NCT01115569|472230170|FG001|Conversion/Titration Phase|Physician Decision|0|||
130729499|NCT02506153|470633569|FG001|Overall Study|Progression/relapse|136|||
130729500|NCT02506153|470633568|FG000|Overall Study|Death|2|||
131165749|NCT01115569|472230169|FG000|Conversion/Titration Phase|Protocol Violation|68|||
130729501|NCT02506153|470633569|FG001|Overall Study|Death|1|||
130729502|NCT02506153|470633568|FG000|Overall Study|Other - not protocol specified|23|||
131165750|NCT01115569|472230170|FG001|Conversion/Titration Phase|Protocol Violation|0|||
131165751|NCT01115569|472230169|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
131165752|NCT01115569|472230170|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
130729503|NCT02506153|470633569|FG001|Overall Study|Other - not protocol specified|12|||
131165753|NCT01115569|472230169|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
131165754|NCT01115569|472230170|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
131165755|NCT01115569|472230169|FG000|Maintenance Phase|Adverse Event|0|||
131165756|NCT01115569|472230170|FG001|Maintenance Phase|Adverse Event|43|||
131165757|NCT01115569|472230169|FG000|Maintenance Phase|Lost to Follow-up|0|||
131165758|NCT01115569|472230170|FG001|Maintenance Phase|Lost to Follow-up|8|||
131165759|NCT01115569|472230169|FG000|Maintenance Phase|Physician Decision|0|||
131165760|NCT01115569|472230170|FG001|Maintenance Phase|Physician Decision|3|||
131165761|NCT01115569|472230169|FG000|Maintenance Phase|Protocol Violation|0|||
131165762|NCT01115569|472230170|FG001|Maintenance Phase|Protocol Violation|9|||
131165763|NCT01115569|472230169|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131165764|NCT01115569|472230170|FG001|Maintenance Phase|Withdrawal by Subject|27|||
131165765|NCT01115569|472230169|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
131165766|NCT01115569|472230170|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
131165767|NCT01115569|472230169|FG000|Maintenance Phase|Administrative|0|||
131165768|NCT01115569|472230170|FG001|Maintenance Phase|Administrative|1|||
131165769|NCT03097328|472230172|FG000|Overall Study|Still on Therapy|2|||
131165770|NCT03097328|472230172|FG000|Overall Study|Progressive Disease|29|||
131165771|NCT03097328|472230172|FG000|Overall Study|Adverse Event|4|||
131165772|NCT03097328|472230172|FG000|Overall Study|Withdrawal by Subject|1|||
131165773|NCT03097328|472230172|FG000|Overall Study|Physician Decision|1|||
131165774|NCT03097328|472230172|FG000|Overall Study|Patient Decision|1|||
131165775|NCT03097328|472230172|FG000|Overall Study|Ineligible for Study Drug|1|||
131165776|NCT02653976|472230173|FG000|Overall Study|Withdrawal by Subject|5|||
131165777|NCT02653976|472230173|FG000|Overall Study|Death|4|||
131165778|NCT00883558|472230174|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
131165779|NCT00883558|472230175|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
131165780|NCT00883558|472230176|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
131165781|NCT00883558|472230174|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
131165782|NCT00883558|472230175|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
131165783|NCT00883558|472230176|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
131165784|NCT00883558|472230174|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
131165785|NCT00883558|472230175|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
131165786|NCT00883558|472230176|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
131165787|NCT00883558|472230174|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
131165788|NCT00883558|472230175|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
131165789|NCT00883558|472230176|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
131165790|NCT00883558|472230174|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
131165791|NCT00883558|472230175|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
131165792|NCT00883558|472230176|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
131165793|NCT00625365|472230177|FG000|Overall Study|Withdrawal by Subject|1|||
131165794|NCT00625365|472230177|FG000|Overall Study|No IV access|5|||
131165795|NCT00625365|472230177|FG000|Overall Study|VSD|1|||
131165796|NCT00536731|472230194|FG000|Overall Study|Adverse Event|3|||
131165797|NCT00536731|472230195|FG001|Overall Study|Adverse Event|2|||
131165798|NCT00536731|472230196|FG002|Overall Study|Adverse Event|3|||
131165799|NCT00536731|472230194|FG000|Overall Study|Withdrawal by Subject|0|||
131165800|NCT00536731|472230195|FG001|Overall Study|Withdrawal by Subject|2|||
131165801|NCT00536731|472230196|FG002|Overall Study|Withdrawal by Subject|0|||
131165802|NCT00536731|472230194|FG000|Overall Study|Intake of prohibited conc. medication|0|||
131165803|NCT00536731|472230195|FG001|Overall Study|Intake of prohibited conc. medication|0|||
131165804|NCT00536731|472230196|FG002|Overall Study|Intake of prohibited conc. medication|1|||
131165805|NCT00536731|472230194|FG000|Overall Study|Safety reasons|0|||
131165806|NCT00536731|472230195|FG001|Overall Study|Safety reasons|0|||
131165807|NCT00536731|472230196|FG002|Overall Study|Safety reasons|1|||
131165808|NCT00536731|472230194|FG000|Overall Study|Other|1|||
131165809|NCT00536731|472230195|FG001|Overall Study|Other|1|||
131165810|NCT00536731|472230196|FG002|Overall Study|Other|0|||
131165811|NCT01675531|472230197|FG000|Overall Study|Adverse Event|9|||
131165812|NCT01675531|472230197|FG000|Overall Study|Withdrawal by Subject|7|||
131165813|NCT01675531|472230197|FG000|Overall Study|Lack of Efficacy|1|||
131165814|NCT01675531|472230197|FG000|Overall Study|Protocol Violation|8|||
131165815|NCT02795988|472230202|FG000|Phase 1b|Withdrawal by Subject|0|||
131165816|NCT02795988|472230203|FG001|Phase 1b|Withdrawal by Subject|1|||
131165817|NCT02795988|472230204|FG002|Phase 1b|Withdrawal by Subject|0|||
130729504|NCT02017015|470633570|FG000|Overall Study|Adverse Event|9|||
131165818|NCT02795988|472230205|FG003|Phase 1b|Withdrawal by Subject|0|||
131165819|NCT02795988|472230206|FG004|Phase 1b|Withdrawal by Subject|0|||
131165820|NCT02795988|472230207|FG005|Phase 1b|Withdrawal by Subject|0|||
131165821|NCT02795988|472230208|FG006|Phase 1b|Withdrawal by Subject|0|||
131165822|NCT02795988|472230202|FG000|Phase 1b|Death|1|||
131165823|NCT02795988|472230203|FG001|Phase 1b|Death|2|||
131235612|NCT01901055|472490968|FG000|Week 24|Physician Decision|1|||
131165824|NCT02795988|472230204|FG002|Phase 1b|Death|1|||
131165825|NCT02795988|472230205|FG003|Phase 1b|Death|0|||
131165826|NCT02795988|472230206|FG004|Phase 1b|Death|0|||
131165827|NCT02795988|472230207|FG005|Phase 1b|Death|0|||
131165828|NCT02795988|472230208|FG006|Phase 1b|Death|0|||
131165829|NCT02795988|472230202|FG000|Phase 1b|Physician Decision|0|||
131165830|NCT02795988|472230203|FG001|Phase 1b|Physician Decision|0|||
131165831|NCT02795988|472230204|FG002|Phase 1b|Physician Decision|1|||
131165832|NCT02795988|472230205|FG003|Phase 1b|Physician Decision|0|||
131165833|NCT02795988|472230206|FG004|Phase 1b|Physician Decision|0|||
131165834|NCT02795988|472230207|FG005|Phase 1b|Physician Decision|0|||
131165835|NCT02795988|472230208|FG006|Phase 1b|Physician Decision|0|||
131165836|NCT02795988|472230202|FG000|Phase 1b|Progressive Disease|2|||
131165837|NCT02795988|472230203|FG001|Phase 1b|Progressive Disease|2|||
131165838|NCT02795988|472230204|FG002|Phase 1b|Progressive Disease|0|||
131165839|NCT02795988|472230205|FG003|Phase 1b|Progressive Disease|0|||
131165840|NCT02795988|472230206|FG004|Phase 1b|Progressive Disease|0|||
131165841|NCT02795988|472230207|FG005|Phase 1b|Progressive Disease|0|||
131165842|NCT02795988|472230208|FG006|Phase 1b|Progressive Disease|0|||
131165843|NCT02795988|472230202|FG000|Phase 2|Withdrawal by Subject|0|||
131165844|NCT02795988|472230203|FG001|Phase 2|Withdrawal by Subject|0|||
131165845|NCT02795988|472230204|FG002|Phase 2|Withdrawal by Subject|0|||
131165846|NCT02795988|472230205|FG003|Phase 2|Withdrawal by Subject|1|||
131165847|NCT02795988|472230206|FG004|Phase 2|Withdrawal by Subject|0|||
131165848|NCT02795988|472230207|FG005|Phase 2|Withdrawal by Subject|0|||
131165849|NCT02795988|472230208|FG006|Phase 2|Withdrawal by Subject|0|||
131165850|NCT02795988|472230202|FG000|Phase 2|Death|0|||
131165851|NCT02795988|472230203|FG001|Phase 2|Death|0|||
131165852|NCT02795988|472230204|FG002|Phase 2|Death|0|||
131165853|NCT02795988|472230205|FG003|Phase 2|Death|17|||
131165854|NCT02795988|472230206|FG004|Phase 2|Death|17|||
131165855|NCT02795988|472230207|FG005|Phase 2|Death|0|||
131165856|NCT02795988|472230208|FG006|Phase 2|Death|0|||
131165857|NCT02795988|472230202|FG000|Phase 2|Other|0|||
131165858|NCT02795988|472230203|FG001|Phase 2|Other|0|||
131165859|NCT02795988|472230204|FG002|Phase 2|Other|0|||
131165860|NCT02795988|472230205|FG003|Phase 2|Other|1|||
131165861|NCT02795988|472230206|FG004|Phase 2|Other|0|||
131165862|NCT02795988|472230207|FG005|Phase 2|Other|0|||
131165863|NCT02795988|472230208|FG006|Phase 2|Other|0|||
131165864|NCT02795988|472230202|FG000|Phase 2 Extension|Death|0|||
131165865|NCT02795988|472230203|FG001|Phase 2 Extension|Death|0|||
131165866|NCT02795988|472230204|FG002|Phase 2 Extension|Death|0|||
131165867|NCT02795988|472230205|FG003|Phase 2 Extension|Death|0|||
131165868|NCT02795988|472230206|FG004|Phase 2 Extension|Death|0|||
131165869|NCT02795988|472230207|FG005|Phase 2 Extension|Death|5|||
131165870|NCT02795988|472230208|FG006|Phase 2 Extension|Death|6|||
131165871|NCT02795988|472230202|FG000|Phase 2 Extension|Other reasons|0|||
131165872|NCT02795988|472230203|FG001|Phase 2 Extension|Other reasons|0|||
131165873|NCT02795988|472230204|FG002|Phase 2 Extension|Other reasons|0|||
131165874|NCT02795988|472230205|FG003|Phase 2 Extension|Other reasons|0|||
131165875|NCT02795988|472230206|FG004|Phase 2 Extension|Other reasons|0|||
131165876|NCT02795988|472230207|FG005|Phase 2 Extension|Other reasons|2|||
131165877|NCT02795988|472230208|FG006|Phase 2 Extension|Other reasons|1|||
131165878|NCT01702363|472230211|FG000|Overall Study|Adverse Event|14|||
131165879|NCT01702363|472230211|FG000|Overall Study|Lack of Efficacy|4|||
131165880|NCT01702363|472230211|FG000|Overall Study|Withdrawal by Subject|2|||
131165881|NCT01293032|472230212|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
131165882|NCT01293032|472230213|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
131165883|NCT01293032|472230214|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
131165884|NCT01293032|472230215|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
131165885|NCT01293032|472230212|FG000|Treatment|Adverse Event|0|||
131235613|NCT01901055|472490969|FG001|Week 24|Physician Decision|0|||
130729505|NCT02017015|470633570|FG000|Overall Study|Withdrawal by Subject|21|||
130729506|NCT02017015|470633570|FG000|Overall Study|Death|4|||
130729507|NCT02017015|470633570|FG000|Overall Study|Progressive Disease|31|||
130729508|NCT02017015|470633570|FG000|Overall Study|Non-compliance with study drug|2|||
130729509|NCT02017015|470633570|FG000|Overall Study|Physician Decision|2|||
130729510|NCT04158245|470633571|FG000|Overall Study|Lost to Follow-up|1|||
130729511|NCT02567435|470633574|FG000|Overall Study|Death|1|||
130729512|NCT02567435|470633575|FG001|Overall Study|Death|1|||
130729513|NCT02567435|470633576|FG002|Overall Study|Death|0|||
130729514|NCT02567435|470633577|FG003|Overall Study|Death|0|||
130729515|NCT02567435|470633574|FG000|Overall Study|Ineligible|1|||
130729516|NCT02567435|470633575|FG001|Overall Study|Ineligible|3|||
131165886|NCT01293032|472230213|FG001|Treatment|Adverse Event|0|||
131165887|NCT01293032|472230214|FG002|Treatment|Adverse Event|1|||
131165888|NCT01293032|472230215|FG003|Treatment|Adverse Event|1|||
131165889|NCT01293032|472230212|FG000|Treatment|Withdrawal by Subject|2|||
130729517|NCT02567435|470633576|FG002|Overall Study|Ineligible|0|||
131165890|NCT01293032|472230213|FG001|Treatment|Withdrawal by Subject|4|||
131165891|NCT01293032|472230214|FG002|Treatment|Withdrawal by Subject|0|||
131165892|NCT01293032|472230215|FG003|Treatment|Withdrawal by Subject|0|||
131165893|NCT01293032|472230212|FG000|Treatment|Disease Progression, relapse|0|||
131165894|NCT01293032|472230213|FG001|Treatment|Disease Progression, relapse|1|||
131165895|NCT01293032|472230214|FG002|Treatment|Disease Progression, relapse|0|||
131165896|NCT01293032|472230215|FG003|Treatment|Disease Progression, relapse|0|||
131165897|NCT02985450|472230225|FG000|Overall Study|Lost to Follow-up|7|||
131165898|NCT00431847|472230226|FG000|Overall Study|completion of less than two study visits|6|||
131165899|NCT00431847|472230227|FG001|Overall Study|completion of less than two study visits|3|||
131165900|NCT00431847|472230228|FG002|Overall Study|completion of less than two study visits|4|||
131165901|NCT00431847|472230229|FG003|Overall Study|completion of less than two study visits|14|||
131165902|NCT00431847|472230230|FG004|Overall Study|completion of less than two study visits|0|||
131165903|NCT00431847|472230226|FG000|Overall Study|Protocol Violation|0|||
131165904|NCT00431847|472230227|FG001|Overall Study|Protocol Violation|0|||
131165905|NCT00431847|472230228|FG002|Overall Study|Protocol Violation|0|||
131165906|NCT00431847|472230229|FG003|Overall Study|Protocol Violation|0|||
131165907|NCT00431847|472230230|FG004|Overall Study|Protocol Violation|1|||
131165908|NCT01469013|472230233|FG000|Part A (Treatment Period)|Adverse Event|1|||
131165909|NCT01469013|472230234|FG001|Part A (Treatment Period)|Adverse Event|0|||
131165910|NCT01469013|472230235|FG002|Part A (Treatment Period)|Adverse Event|0|||
131165911|NCT01469013|472230236|FG003|Part A (Treatment Period)|Adverse Event|0|||
131165912|NCT01469013|472230237|FG004|Part A (Treatment Period)|Adverse Event|1|||
131165913|NCT01469013|472230238|FG005|Part A (Treatment Period)|Adverse Event|0|||
131165914|NCT01469013|472230239|FG006|Part A (Treatment Period)|Adverse Event|0|||
131165915|NCT01469013|472230240|FG007|Part A (Treatment Period)|Adverse Event|0|||
131165916|NCT01469013|472230241|FG008|Part A (Treatment Period)|Adverse Event|0|||
131165917|NCT01469013|472230242|FG009|Part A (Treatment Period)|Adverse Event|0|||
131165918|NCT01469013|472230243|FG010|Part A (Treatment Period)|Adverse Event|0|||
131165919|NCT01469013|472230244|FG011|Part A (Treatment Period)|Adverse Event|0|||
131165920|NCT01469013|472230245|FG012|Part A (Treatment Period)|Adverse Event|0|||
131165921|NCT01469013|472230233|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165922|NCT01469013|472230234|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165923|NCT01469013|472230235|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
131165924|NCT01469013|472230236|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165925|NCT01469013|472230237|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165926|NCT01469013|472230238|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165927|NCT01469013|472230239|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165928|NCT01469013|472230240|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165929|NCT01469013|472230241|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165930|NCT01469013|472230242|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165931|NCT01469013|472230243|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165932|NCT01469013|472230244|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165933|NCT01469013|472230245|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
131165934|NCT01469013|472230233|FG000|Part B (Extension Period)|Adverse Event|0|||
131165935|NCT01469013|472230234|FG001|Part B (Extension Period)|Adverse Event|0|||
131165936|NCT01469013|472230235|FG002|Part B (Extension Period)|Adverse Event|0|||
131165937|NCT01469013|472230236|FG003|Part B (Extension Period)|Adverse Event|0|||
131165938|NCT01469013|472230237|FG004|Part B (Extension Period)|Adverse Event|0|||
131165939|NCT01469013|472230238|FG005|Part B (Extension Period)|Adverse Event|2|||
131165940|NCT01469013|472230239|FG006|Part B (Extension Period)|Adverse Event|5|||
131165941|NCT01469013|472230240|FG007|Part B (Extension Period)|Adverse Event|5|||
131165942|NCT01469013|472230241|FG008|Part B (Extension Period)|Adverse Event|3|||
131165943|NCT01469013|472230242|FG009|Part B (Extension Period)|Adverse Event|3|||
131165944|NCT01469013|472230243|FG010|Part B (Extension Period)|Adverse Event|1|||
131165945|NCT01469013|472230244|FG011|Part B (Extension Period)|Adverse Event|6|||
131165946|NCT01469013|472230245|FG012|Part B (Extension Period)|Adverse Event|3|||
131165947|NCT01469013|472230233|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
131165948|NCT01469013|472230234|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
131165949|NCT01469013|472230235|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
131165950|NCT01469013|472230236|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
131165951|NCT01469013|472230237|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
131165952|NCT01469013|472230238|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
131165953|NCT01469013|472230239|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
131165954|NCT01469013|472230240|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
131165955|NCT01469013|472230241|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
131165956|NCT01469013|472230242|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
131165957|NCT01469013|472230243|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
131165958|NCT01469013|472230244|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
131165959|NCT01469013|472230245|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
131165960|NCT00002663|472230246|FG000|Overall Study|Death|4|||
131165961|NCT00002663|472230247|FG001|Overall Study|Death|1|||
131165962|NCT00002663|472230248|FG002|Overall Study|Death|1|||
131165963|NCT00002663|472230249|FG003|Overall Study|Death|0|||
131235614|NCT01901055|472490968|FG000|Week 36|Withdrawal by Subject|0|||
131235615|NCT01901055|472490969|FG001|Week 36|Withdrawal by Subject|5|||
131235616|NCT00635154|472490972|FG000|Overall Study|Alternative Treatment|8|||
131165964|NCT00002663|472230250|FG004|Overall Study|Death|0|||
131165965|NCT00002663|472230251|FG005|Overall Study|Death|13|||
131165966|NCT00002663|472230252|FG006|Overall Study|Death|0|||
131165967|NCT00002663|472230253|FG007|Overall Study|Death|1|||
131165968|NCT00002663|472230254|FG008|Overall Study|Death|1|||
131165969|NCT00002663|472230255|FG009|Overall Study|Death|1|||
131165970|NCT00002663|472230246|FG000|Overall Study|Lost to Follow-up|3|||
131165971|NCT00002663|472230247|FG001|Overall Study|Lost to Follow-up|0|||
131165972|NCT00002663|472230248|FG002|Overall Study|Lost to Follow-up|0|||
131165973|NCT00002663|472230249|FG003|Overall Study|Lost to Follow-up|1|||
131165974|NCT00002663|472230250|FG004|Overall Study|Lost to Follow-up|0|||
131165975|NCT00002663|472230251|FG005|Overall Study|Lost to Follow-up|1|||
131165976|NCT00002663|472230252|FG006|Overall Study|Lost to Follow-up|0|||
131165977|NCT00002663|472230253|FG007|Overall Study|Lost to Follow-up|0|||
131165978|NCT00002663|472230254|FG008|Overall Study|Lost to Follow-up|0|||
131165979|NCT00002663|472230255|FG009|Overall Study|Lost to Follow-up|0|||
131165980|NCT00002663|472230246|FG000|Overall Study|Other|0|||
131165981|NCT00002663|472230247|FG001|Overall Study|Other|1|||
131165982|NCT00002663|472230248|FG002|Overall Study|Other|0|||
131165983|NCT00002663|472230249|FG003|Overall Study|Other|0|||
131165984|NCT00002663|472230250|FG004|Overall Study|Other|0|||
131165985|NCT00002663|472230251|FG005|Overall Study|Other|1|||
131165986|NCT00002663|472230252|FG006|Overall Study|Other|1|||
131165987|NCT00002663|472230253|FG007|Overall Study|Other|0|||
131165988|NCT00002663|472230254|FG008|Overall Study|Other|0|||
131165989|NCT00002663|472230255|FG009|Overall Study|Other|0|||
131165990|NCT00002663|472230246|FG000|Overall Study|Physician Decision|0|||
131165991|NCT00002663|472230247|FG001|Overall Study|Physician Decision|0|||
131165992|NCT00002663|472230248|FG002|Overall Study|Physician Decision|0|||
131165993|NCT00002663|472230249|FG003|Overall Study|Physician Decision|0|||
131165994|NCT00002663|472230250|FG004|Overall Study|Physician Decision|1|||
131165995|NCT00002663|472230251|FG005|Overall Study|Physician Decision|0|||
131165996|NCT00002663|472230252|FG006|Overall Study|Physician Decision|0|||
131165997|NCT00002663|472230253|FG007|Overall Study|Physician Decision|0|||
131165998|NCT00002663|472230254|FG008|Overall Study|Physician Decision|1|||
131165999|NCT00002663|472230255|FG009|Overall Study|Physician Decision|1|||
131166000|NCT00002663|472230246|FG000|Overall Study|Adverse Event|0|||
131166001|NCT00002663|472230247|FG001|Overall Study|Adverse Event|0|||
131166002|NCT00002663|472230248|FG002|Overall Study|Adverse Event|0|||
131166003|NCT00002663|472230249|FG003|Overall Study|Adverse Event|1|||
130780653|NCT04805671|470823156|FG000|Overall Study|Death|2|||
130780654|NCT04805671|470823157|FG001|Overall Study|Death|7|||
130780655|NCT04805671|470823156|FG000|Overall Study|Lost to Follow-up|1|||
130780656|NCT04805671|470823157|FG001|Overall Study|Lost to Follow-up|0|||
130780657|NCT04805671|470823156|FG000|Overall Study|Withdrawal by Subject|9|||
130780658|NCT04805671|470823157|FG001|Overall Study|Withdrawal by Subject|7|||
130780659|NCT04805671|470823156|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
130780660|NCT04805671|470823157|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
130780661|NCT02111174|470823164|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
130780662|NCT02111174|470823165|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
131166004|NCT00002663|472230250|FG004|Overall Study|Adverse Event|0|||
131166005|NCT00002663|472230251|FG005|Overall Study|Adverse Event|0|||
131166006|NCT00002663|472230252|FG006|Overall Study|Adverse Event|0|||
131166007|NCT00002663|472230253|FG007|Overall Study|Adverse Event|1|||
131166008|NCT00002663|472230254|FG008|Overall Study|Adverse Event|0|||
131166009|NCT00002663|472230255|FG009|Overall Study|Adverse Event|0|||
131166010|NCT02142894|472230257|FG000|Overall Study|Protocol Violation|8|||
131166011|NCT00739297|472230258|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
131166012|NCT00739297|472230259|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
131166013|NCT00739297|472230260|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
131166014|NCT00739297|472230261|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
131166015|NCT00739297|472230262|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
131166016|NCT00739297|472230263|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
131166017|NCT00739297|472230264|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
131166018|NCT00739297|472230258|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
131166019|NCT00739297|472230259|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
131166020|NCT00739297|472230260|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
131166021|NCT00739297|472230261|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
131166022|NCT00739297|472230262|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
131166023|NCT00739297|472230263|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
131166024|NCT00739297|472230264|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
131166025|NCT02552355|472230268|FG000|Overall Study|Adverse Event|0|||
131166026|NCT02552355|472230269|FG001|Overall Study|Adverse Event|2|||
131166027|NCT02552355|472230270|FG002|Overall Study|Adverse Event|2|||
131166028|NCT02552355|472230271|FG003|Overall Study|Adverse Event|0|||
131166029|NCT02552355|472230268|FG000|Overall Study|Withdrawal by Subject|0|||
131166030|NCT02552355|472230269|FG001|Overall Study|Withdrawal by Subject|0|||
131166031|NCT02552355|472230270|FG002|Overall Study|Withdrawal by Subject|0|||
131166032|NCT02552355|472230271|FG003|Overall Study|Withdrawal by Subject|1|||
131166033|NCT01519245|472230272|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
131166034|NCT01519245|472230273|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
131166035|NCT00933335|472230274|FG000|Overall Study|Lost to Follow-up|1|||
131166036|NCT00933335|472230275|FG001|Overall Study|Lost to Follow-up|3|||
131166037|NCT00933335|472230274|FG000|Overall Study|Withdrawal by Subject|0|||
131166038|NCT00933335|472230275|FG001|Overall Study|Withdrawal by Subject|1|||
131166039|NCT00933335|472230274|FG000|Overall Study|Progressive Disease|0|||
130729518|NCT02567435|470633577|FG003|Overall Study|Ineligible|0|||
130729519|NCT02567435|470633574|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
130729520|NCT02567435|470633575|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
130729521|NCT02567435|470633576|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
130729522|NCT02567435|470633577|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
131166040|NCT00933335|472230275|FG001|Overall Study|Progressive Disease|11|||
131166041|NCT00933335|472230274|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
131166042|NCT00933335|472230275|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
131166043|NCT00933335|472230274|FG000|Overall Study|Co-morbid Illness|1|||
131166044|NCT00933335|472230275|FG001|Overall Study|Co-morbid Illness|0|||
131166045|NCT02084134|472230278|FG000|Overall Study|Protocol Violation|4|||
131166046|NCT02084134|472230279|FG001|Overall Study|Protocol Violation|2|||
131166047|NCT02084134|472230278|FG000|Overall Study|Death|0|||
131166048|NCT02084134|472230279|FG001|Overall Study|Death|1|||
131166049|NCT02379923|472230280|FG000|Overall Study|Death|5|||
131166050|NCT00426751|472230281|FG000|Overall Study|Adverse Event|8|||
131166051|NCT00426751|472230282|FG001|Overall Study|Adverse Event|1|||
131166052|NCT00426751|472230281|FG000|Overall Study|Lost to Follow-up|7|||
131166053|NCT00426751|472230282|FG001|Overall Study|Lost to Follow-up|6|||
131166054|NCT00426751|472230281|FG000|Overall Study|Consent Withdrawn|0|||
131166055|NCT00426751|472230282|FG001|Overall Study|Consent Withdrawn|1|||
131166056|NCT00426751|472230281|FG000|Overall Study|Other Reasons|7|||
131166057|NCT00426751|472230282|FG001|Overall Study|Other Reasons|12|||
131166058|NCT00968253|472230284|FG000|Overall Study|Death|0|||
131166059|NCT00968253|472230285|FG001|Overall Study|Death|0|||
131166060|NCT00968253|472230286|FG002|Overall Study|Death|2|||
131166061|NCT00968253|472230284|FG000|Overall Study|Withdrawal by Subject|0|||
131166062|NCT00968253|472230285|FG001|Overall Study|Withdrawal by Subject|0|||
131166063|NCT00968253|472230286|FG002|Overall Study|Withdrawal by Subject|1|||
131166064|NCT00968253|472230284|FG000|Overall Study|Disease Progression|0|||
131166065|NCT00968253|472230285|FG001|Overall Study|Disease Progression|3|||
131166066|NCT00968253|472230286|FG002|Overall Study|Disease Progression|3|||
131166067|NCT00968253|472230284|FG000|Overall Study|Adverse Event|0|||
131166068|NCT00968253|472230285|FG001|Overall Study|Adverse Event|0|||
131166069|NCT00968253|472230286|FG002|Overall Study|Adverse Event|1|||
131166070|NCT03141086|472230287|FG000|Overall Study|Study Terminated By Sponsor|1|||
131166071|NCT03141086|472230288|FG001|Overall Study|Study Terminated By Sponsor|1|||
131166072|NCT03141086|472230287|FG000|Overall Study|Withdrawal by Subject|0|||
131166073|NCT03141086|472230288|FG001|Overall Study|Withdrawal by Subject|1|||
131166074|NCT03141086|472230287|FG000|Overall Study|Protocol Violation|0|||
131166075|NCT03141086|472230288|FG001|Overall Study|Protocol Violation|1|||
131166076|NCT03141086|472230287|FG000|Overall Study|Adverse Event|0|||
131166077|NCT03141086|472230288|FG001|Overall Study|Adverse Event|2|||
131166078|NCT02488759|472230289|FG000|Overall Study|Disease progression|73|||
131166079|NCT02488759|472230290|FG001|Overall Study|Disease progression|111|||
131166080|NCT02488759|472230291|FG002|Overall Study|Disease progression|62|||
131166081|NCT02488759|472230292|FG003|Overall Study|Disease progression|7|||
131166082|NCT02488759|472230293|FG004|Overall Study|Disease progression|4|||
131166083|NCT02488759|472230294|FG005|Overall Study|Disease progression|2|||
131166084|NCT02488759|472230289|FG000|Overall Study|Study drug toxicity|11|||
131166085|NCT02488759|472230290|FG001|Overall Study|Study drug toxicity|33|||
131166086|NCT02488759|472230291|FG002|Overall Study|Study drug toxicity|31|||
131166087|NCT02488759|472230292|FG003|Overall Study|Study drug toxicity|0|||
131166088|NCT02488759|472230293|FG004|Overall Study|Study drug toxicity|0|||
131166089|NCT02488759|472230294|FG005|Overall Study|Study drug toxicity|2|||
131166090|NCT02488759|472230289|FG000|Overall Study|Adverse event unrelated to study drug|9|||
131166091|NCT02488759|472230290|FG001|Overall Study|Adverse event unrelated to study drug|11|||
131166092|NCT02488759|472230291|FG002|Overall Study|Adverse event unrelated to study drug|7|||
131166093|NCT02488759|472230292|FG003|Overall Study|Adverse event unrelated to study drug|0|||
131166094|NCT02488759|472230293|FG004|Overall Study|Adverse event unrelated to study drug|1|||
131166095|NCT02488759|472230294|FG005|Overall Study|Adverse event unrelated to study drug|0|||
131166096|NCT02488759|472230289|FG000|Overall Study|Participant request to discontinue study treatment|6|||
131166097|NCT02488759|472230290|FG001|Overall Study|Participant request to discontinue study treatment|8|||
131166098|NCT02488759|472230291|FG002|Overall Study|Participant request to discontinue study treatment|4|||
131166099|NCT02488759|472230292|FG003|Overall Study|Participant request to discontinue study treatment|0|||
131166100|NCT02488759|472230293|FG004|Overall Study|Participant request to discontinue study treatment|0|||
131166101|NCT02488759|472230294|FG005|Overall Study|Participant request to discontinue study treatment|0|||
131166102|NCT02488759|472230289|FG000|Overall Study|Withdrawal by Subject|4|||
131166103|NCT02488759|472230290|FG001|Overall Study|Withdrawal by Subject|0|||
131166104|NCT02488759|472230291|FG002|Overall Study|Withdrawal by Subject|3|||
131166105|NCT02488759|472230292|FG003|Overall Study|Withdrawal by Subject|0|||
131166106|NCT02488759|472230293|FG004|Overall Study|Withdrawal by Subject|0|||
131166107|NCT02488759|472230294|FG005|Overall Study|Withdrawal by Subject|2|||
131166108|NCT02488759|472230289|FG000|Overall Study|Lost to Follow-up|0|||
131166109|NCT02488759|472230290|FG001|Overall Study|Lost to Follow-up|0|||
131166110|NCT02488759|472230291|FG002|Overall Study|Lost to Follow-up|2|||
131166111|NCT02488759|472230292|FG003|Overall Study|Lost to Follow-up|0|||
131166112|NCT02488759|472230293|FG004|Overall Study|Lost to Follow-up|0|||
131166113|NCT02488759|472230294|FG005|Overall Study|Lost to Follow-up|0|||
131166114|NCT02488759|472230289|FG000|Overall Study|Maximum clinical benefit|3|||
131166115|NCT02488759|472230290|FG001|Overall Study|Maximum clinical benefit|0|||
131166116|NCT02488759|472230291|FG002|Overall Study|Maximum clinical benefit|1|||
131166117|NCT02488759|472230292|FG003|Overall Study|Maximum clinical benefit|0|||
131166118|NCT02488759|472230293|FG004|Overall Study|Maximum clinical benefit|0|||
131166119|NCT02488759|472230294|FG005|Overall Study|Maximum clinical benefit|0|||
131166120|NCT02488759|472230289|FG000|Overall Study|Other reasons|7|||
131166121|NCT02488759|472230290|FG001|Overall Study|Other reasons|32|||
131166122|NCT02488759|472230291|FG002|Overall Study|Other reasons|23|||
131166123|NCT02488759|472230292|FG003|Overall Study|Other reasons|1|||
131166124|NCT02488759|472230293|FG004|Overall Study|Other reasons|1|||
131166125|NCT02488759|472230294|FG005|Overall Study|Other reasons|1|||
131166126|NCT02429427|472230295|FG000|Overall Study|Adverse Event|220|||
131166127|NCT02429427|472230296|FG001|Overall Study|Adverse Event|92|||
131166128|NCT02429427|472230295|FG000|Overall Study|Protocol Violation|10|||
131166129|NCT02429427|472230296|FG001|Overall Study|Protocol Violation|6|||
131166130|NCT02429427|472230295|FG000|Overall Study|Lost to Follow-up|15|||
131166131|NCT02429427|472230296|FG001|Overall Study|Lost to Follow-up|6|||
131166132|NCT02429427|472230295|FG000|Overall Study|Withdrawal by Subject|64|||
131166133|NCT02429427|472230296|FG001|Overall Study|Withdrawal by Subject|34|||
131166134|NCT02429427|472230295|FG000|Overall Study|Other|62|||
131166135|NCT02429427|472230296|FG001|Overall Study|Other|41|||
131166136|NCT00719732|472230297|FG000|Overall Study|Lost to Follow-up|20|||
131166137|NCT00719732|472230297|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
131166138|NCT00719732|472230297|FG000|Overall Study|Illness not associated with device|1|||
131166139|NCT03625986|472231656|FG000|Randomization Period|Lost to Follow-up|7|||
131166140|NCT03625986|472231657|FG001|Randomization Period|Lost to Follow-up|12|||
131166141|NCT03625986|472231656|FG000|Randomization Period|Withdrawal by Subject|10|||
131166142|NCT03625986|472231657|FG001|Randomization Period|Withdrawal by Subject|6|||
131166143|NCT04920084|472231659|FG000|Overall Study|Adverse Event|1|||
131166144|NCT04920084|472231659|FG000|Overall Study|Lost to Follow-up|2|||
131166145|NCT04920084|472231659|FG000|Overall Study|Withdrawal by Subject|2|||
131166146|NCT01096446|472231660|FG000|Overall Study|Death|1|||
131166147|NCT01096446|472231661|FG001|Overall Study|Death|0|||
131166148|NCT01096446|472231660|FG000|Overall Study|Protocol Violation|2|||
131166149|NCT01096446|472231661|FG001|Overall Study|Protocol Violation|0|||
131166150|NCT00620321|472231662|FG000|Overall Study|Adverse Event|1|||
131166151|NCT00620321|472231663|FG001|Overall Study|Adverse Event|1|||
131166152|NCT00620321|472231662|FG000|Overall Study|Death|1|||
131166153|NCT00620321|472231663|FG001|Overall Study|Death|1|||
131166154|NCT00620321|472231662|FG000|Overall Study|Physician Decision|0|||
131166155|NCT00620321|472231663|FG001|Overall Study|Physician Decision|7|||
131166156|NCT00620321|472231662|FG000|Overall Study|Progressive Disease|5|||
131166157|NCT00620321|472231663|FG001|Overall Study|Progressive Disease|5|||
131166158|NCT00620321|472231662|FG000|Overall Study|Sponsor Decision|0|||
131166159|NCT00620321|472231663|FG001|Overall Study|Sponsor Decision|1|||
131166160|NCT00620321|472231662|FG000|Overall Study|Withdrawal by Subject|1|||
131166161|NCT00620321|472231663|FG001|Overall Study|Withdrawal by Subject|1|||
131166162|NCT01431144|472231664|FG000|Overall Study|Implant mobility and removal|2|||
131166163|NCT01431144|472231665|FG001|Overall Study|Implant mobility and removal|0|||
131166164|NCT00953043|472231672|FG000|Overall Study|Withdrawal by Subject|4|||
130780663|NCT02111174|470823164|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
130780664|NCT02111174|470823165|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
131166165|NCT00953043|472231673|FG001|Overall Study|Withdrawal by Subject|0|||
131166166|NCT00953043|472231672|FG000|Overall Study|Physician Decision|0|||
131166167|NCT00953043|472231673|FG001|Overall Study|Physician Decision|2|||
131166168|NCT01432262|472231674|FG000|Overall Study|Withdrawal by Subject|2|||
131166169|NCT01432262|472231675|FG001|Overall Study|Withdrawal by Subject|1|||
131166170|NCT01104558|472231676|FG000|Overall Study|Protocol Violation|6|||
131166171|NCT01104558|472231676|FG000|Overall Study|Missing of primary efficacy assessment|10|||
131166172|NCT01104558|472231676|FG000|Overall Study|Missing of genetic analysis results|1|||
131166173|NCT01755195|472231677|FG000|Overall Study|Participant noncompliance|2|||
131166174|NCT01755195|472231677|FG000|Overall Study|Switched to alternative treatment|4|||
131166175|NCT01755195|472231677|FG000|Overall Study|Withdrawal by Subject|1|||
131166176|NCT01755195|472231677|FG000|Overall Study|Participant refused to start treatment|1|||
131166177|NCT01755195|472231677|FG000|Overall Study|Participant has been consented for another trial|1|||
131166178|NCT01755195|472231677|FG000|Overall Study|Refused further treatment|3|||
131166179|NCT01755195|472231677|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
131166180|NCT02361762|472231678|FG000|Overall Study|Withdrawal by Subject|0|||
131166181|NCT02361762|472231679|FG001|Overall Study|Withdrawal by Subject|1|||
131166182|NCT02361762|472231678|FG000|Overall Study|Lost to Follow-up|0|||
131166183|NCT02361762|472231679|FG001|Overall Study|Lost to Follow-up|1|||
131166184|NCT01931462|472231680|FG000|Overall Study|Withdrawal by Subject|1|||
131166185|NCT02819310|472231681|FG000|Overall Study|Withdrawal by Subject|37|||
131166186|NCT02819310|472231681|FG000|Overall Study|Lost to Follow-up|16|||
131166187|NCT02819310|472231681|FG000|Overall Study|Adverse Event|13|||
131166188|NCT02819310|472231681|FG000|Overall Study|Lack of Efficacy|5|||
131166189|NCT02819310|472231681|FG000|Overall Study|Physician Decision|8|||
131166190|NCT02819310|472231681|FG000|Overall Study|Protocol Violation|30|||
131166191|NCT01881620|472231689|FG000|Overall Study|Protocol Violation|4|||
131166192|NCT04467164|472231693|FG000|Washout (1 Week)|Lost to Follow-up|2|||
131166193|NCT04467164|472231694|FG001|Washout (1 Week)|Lost to Follow-up|0|||
131166194|NCT01675011|472231702|FG000|Overall Study|Trial terminated by Sponsor|3|||
131166195|NCT01675011|472231703|FG001|Overall Study|Trial terminated by Sponsor|1|||
131166196|NCT00615290|472231704|FG000|Overall Study|Adverse Event|2|||
131166197|NCT00615290|472231704|FG000|Overall Study|Lost to Follow-up|3|||
131166198|NCT00615290|472231704|FG000|Overall Study|Withdrawal by Subject|1|||
131166199|NCT00615290|472231704|FG000|Overall Study|Other|2|||
131166200|NCT01252134|472231705|FG000|Period 1, 8 Hours|Personal Reasons|0|||
131166201|NCT01252134|472231706|FG001|Period 1, 8 Hours|Personal Reasons|1|||
131166202|NCT01252134|472231707|FG002|Period 1, 8 Hours|Personal Reasons|1|||
131166203|NCT01252134|472231708|FG003|Period 1, 8 Hours|Personal Reasons|0|||
131166204|NCT01252134|472231709|FG004|Period 1, 8 Hours|Personal Reasons|0|||
131166205|NCT01252134|472231710|FG005|Period 1, 8 Hours|Personal Reasons|0|||
131166206|NCT03650452|472231711|FG000|Overall Study|Physician Decision|1|||
131166207|NCT03650452|472231712|FG001|Overall Study|Physician Decision|0|||
131166208|NCT03650452|472231711|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
131166209|NCT03650452|472231712|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
131166210|NCT03650452|472231711|FG000|Overall Study|Adverse Event|3|||
131166211|NCT03650452|472231712|FG001|Overall Study|Adverse Event|4|||
131166212|NCT03650452|472231711|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
131166213|NCT03650452|472231712|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
131166214|NCT02273050|472231713|FG000|Overall Study|Adverse Event|4|||
131166215|NCT02273050|472231714|FG001|Overall Study|Adverse Event|3|||
131166216|NCT02273050|472231715|FG002|Overall Study|Adverse Event|3|||
131166217|NCT02273050|472231713|FG000|Overall Study|Death|0|||
131166218|NCT02273050|472231714|FG001|Overall Study|Death|0|||
131166219|NCT02273050|472231715|FG002|Overall Study|Death|1|||
131166220|NCT02273050|472231713|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
131166221|NCT02273050|472231714|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
131166222|NCT02273050|472231715|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
131166223|NCT02273050|472231713|FG000|Overall Study|Lack of Efficacy|0|||
131166224|NCT02273050|472231714|FG001|Overall Study|Lack of Efficacy|1|||
131166225|NCT02273050|472231715|FG002|Overall Study|Lack of Efficacy|1|||
131166226|NCT02273050|472231713|FG000|Overall Study|Withdrawal by Subject|17|||
131166227|NCT02273050|472231714|FG001|Overall Study|Withdrawal by Subject|14|||
131166228|NCT02273050|472231715|FG002|Overall Study|Withdrawal by Subject|16|||
131166229|NCT02273050|472231713|FG000|Overall Study|Lost to Follow-up|0|||
131166230|NCT02273050|472231714|FG001|Overall Study|Lost to Follow-up|2|||
131166231|NCT02273050|472231715|FG002|Overall Study|Lost to Follow-up|3|||
131166232|NCT02273050|472231713|FG000|Overall Study|Protocol Violation|3|||
131166233|NCT02273050|472231714|FG001|Overall Study|Protocol Violation|1|||
131166234|NCT02273050|472231715|FG002|Overall Study|Protocol Violation|4|||
131166235|NCT01795898|472231717|FG000|Overall Study|Adverse Event|27|||
131166236|NCT01795898|472231717|FG000|Overall Study|Lost to Follow-up|20|||
131166237|NCT01795898|472231717|FG000|Overall Study|Withdrawal of consent|6|||
131166238|NCT01795898|472231717|FG000|Overall Study|Diagnosed with metastasis|1|||
131166239|NCT01795898|472231717|FG000|Overall Study|No pain|1|||
131166240|NCT01795898|472231717|FG000|Overall Study|Death|1|||
131166241|NCT01795898|472231717|FG000|Overall Study|Withdrew consent & had adverse events|3|||
131166242|NCT01795898|472231717|FG000|Overall Study|Physician Decision|1|||
131166243|NCT03539458|472231718|FG000|Overall Study|Death|1|||
131166244|NCT01703286|472231719|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
131166245|NCT01703286|472231720|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
131166246|NCT01703286|472231721|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
131166247|NCT01703286|472231722|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
131166248|NCT01703286|472231723|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
131166249|NCT01703286|472231724|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
130729523|NCT03765788|470633578|FG000|Overall Study|Subject decision|2|||
131166250|NCT01703286|472231719|FG000|Period 2 Including Washout|Adverse Event|0|||
131166251|NCT01703286|472231720|FG001|Period 2 Including Washout|Adverse Event|0|||
131166252|NCT01703286|472231721|FG002|Period 2 Including Washout|Adverse Event|0|||
130729524|NCT03765788|470633579|FG001|Overall Study|Subject decision|3|||
130729525|NCT03765788|470633578|FG000|Overall Study|Physician Decision|2|||
131166253|NCT01703286|472231722|FG003|Period 2 Including Washout|Adverse Event|1|||
131166254|NCT01703286|472231723|FG004|Period 2 Including Washout|Adverse Event|0|||
131166255|NCT01703286|472231724|FG005|Period 2 Including Washout|Adverse Event|0|||
131166256|NCT01984346|472231725|FG000|Overall Study|Physician Decision|4|||
131166257|NCT01984346|472231726|FG001|Overall Study|Physician Decision|2|||
131166258|NCT01984346|472231725|FG000|Overall Study|Withdrawal by Subject|2|||
131166259|NCT01984346|472231726|FG001|Overall Study|Withdrawal by Subject|2|||
131166260|NCT01984346|472231725|FG000|Overall Study|Enrollment Closed|8|||
131166261|NCT01984346|472231726|FG001|Overall Study|Enrollment Closed|1|||
131166262|NCT01984346|472231725|FG000|Overall Study|Insurance Coverage|1|||
131166263|NCT01984346|472231726|FG001|Overall Study|Insurance Coverage|0|||
131166264|NCT01984346|472231725|FG000|Overall Study|Intra-operative Exclusion|2|||
131166265|NCT01984346|472231726|FG001|Overall Study|Intra-operative Exclusion|0|||
131166266|NCT02531373|472231731|FG000|Overall Study|Lack of Efficacy|0|||
131166267|NCT02531373|472231732|FG001|Overall Study|Lack of Efficacy|0|||
131166268|NCT02531373|472231733|FG002|Overall Study|Lack of Efficacy|0|||
131166269|NCT02531373|472231734|FG003|Overall Study|Lack of Efficacy|0|||
131166270|NCT02531373|472231735|FG004|Overall Study|Lack of Efficacy|3|||
131166271|NCT02531373|472231736|FG005|Overall Study|Lack of Efficacy|2|||
131166272|NCT02531373|472231737|FG006|Overall Study|Lack of Efficacy|4|||
131166273|NCT02531373|472231738|FG007|Overall Study|Lack of Efficacy|8|||
131166274|NCT02531373|472231739|FG008|Overall Study|Lack of Efficacy|5|||
131166275|NCT02531373|472231731|FG000|Overall Study|Lost to Follow-up|0|||
131166276|NCT02531373|472231732|FG001|Overall Study|Lost to Follow-up|0|||
131166277|NCT02531373|472231733|FG002|Overall Study|Lost to Follow-up|0|||
131166278|NCT02531373|472231734|FG003|Overall Study|Lost to Follow-up|0|||
131166279|NCT02531373|472231735|FG004|Overall Study|Lost to Follow-up|0|||
131166280|NCT02531373|472231736|FG005|Overall Study|Lost to Follow-up|2|||
131166281|NCT02531373|472231737|FG006|Overall Study|Lost to Follow-up|2|||
131166282|NCT02531373|472231738|FG007|Overall Study|Lost to Follow-up|0|||
131166283|NCT02531373|472231739|FG008|Overall Study|Lost to Follow-up|0|||
131166284|NCT02531373|472231731|FG000|Overall Study|Physician Decision|0|||
131166285|NCT02531373|472231732|FG001|Overall Study|Physician Decision|0|||
131166286|NCT02531373|472231733|FG002|Overall Study|Physician Decision|0|||
131166287|NCT02531373|472231734|FG003|Overall Study|Physician Decision|0|||
131166288|NCT02531373|472231735|FG004|Overall Study|Physician Decision|2|||
131166289|NCT02531373|472231736|FG005|Overall Study|Physician Decision|1|||
131166290|NCT02531373|472231737|FG006|Overall Study|Physician Decision|0|||
131166291|NCT02531373|472231738|FG007|Overall Study|Physician Decision|0|||
131166292|NCT02531373|472231739|FG008|Overall Study|Physician Decision|0|||
131166293|NCT02531373|472231731|FG000|Overall Study|Protocol Violation|0|||
131166294|NCT02531373|472231732|FG001|Overall Study|Protocol Violation|0|||
131166295|NCT02531373|472231733|FG002|Overall Study|Protocol Violation|0|||
131166296|NCT02531373|472231734|FG003|Overall Study|Protocol Violation|0|||
131166297|NCT02531373|472231735|FG004|Overall Study|Protocol Violation|0|||
131166298|NCT02531373|472231736|FG005|Overall Study|Protocol Violation|1|||
131166299|NCT02531373|472231737|FG006|Overall Study|Protocol Violation|1|||
131166300|NCT02531373|472231738|FG007|Overall Study|Protocol Violation|0|||
131166301|NCT02531373|472231739|FG008|Overall Study|Protocol Violation|1|||
131166302|NCT02531373|472231731|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131166303|NCT02531373|472231732|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131166304|NCT02531373|472231733|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131166305|NCT02531373|472231734|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131166306|NCT02531373|472231735|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131166307|NCT02531373|472231736|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
131166308|NCT02531373|472231737|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
131166309|NCT02531373|472231738|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
131166310|NCT02531373|472231739|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
131166311|NCT02531373|472231731|FG000|Overall Study|Withdrawal by Subject|0|||
131166312|NCT02531373|472231732|FG001|Overall Study|Withdrawal by Subject|0|||
131166313|NCT02531373|472231733|FG002|Overall Study|Withdrawal by Subject|0|||
131166314|NCT02531373|472231734|FG003|Overall Study|Withdrawal by Subject|0|||
131235617|NCT00635154|472490972|FG000|Overall Study|Other|4|||
131166315|NCT02531373|472231735|FG004|Overall Study|Withdrawal by Subject|3|||
131166316|NCT02531373|472231736|FG005|Overall Study|Withdrawal by Subject|0|||
131166317|NCT02531373|472231737|FG006|Overall Study|Withdrawal by Subject|0|||
130729526|NCT03765788|470633579|FG001|Overall Study|Physician Decision|4|||
130729527|NCT03765788|470633578|FG000|Overall Study|Death|0|||
131166318|NCT02531373|472231738|FG007|Overall Study|Withdrawal by Subject|0|||
131166319|NCT02531373|472231739|FG008|Overall Study|Withdrawal by Subject|0|||
131166320|NCT05058664|472231742|FG000|Overall Study|No follow-up data provided|4|||
131166321|NCT05058664|472231743|FG001|Overall Study|No follow-up data provided|0|||
131166322|NCT05058664|472231744|FG002|Overall Study|No follow-up data provided|2|||
131166323|NCT05058664|472231742|FG000|Overall Study|Withdrawal by Subject|0|||
131166324|NCT05058664|472231743|FG001|Overall Study|Withdrawal by Subject|0|||
131166325|NCT05058664|472231744|FG002|Overall Study|Withdrawal by Subject|1|||
131166326|NCT01597557|472231745|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
131166327|NCT01597557|472231746|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
131166328|NCT02389816|472231747|FG000|Overall Study|Randomized but Not Treated|1|||
131166329|NCT02389816|472231748|FG001|Overall Study|Randomized but Not Treated|0|||
131166330|NCT02389816|472231749|FG002|Overall Study|Randomized but Not Treated|0|||
131166331|NCT02389816|472231747|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
131166332|NCT02389816|472231748|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
131166333|NCT02389816|472231749|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
131166334|NCT02389816|472231747|FG000|Overall Study|Major Protocol Deviation|1|||
131166335|NCT02389816|472231748|FG001|Overall Study|Major Protocol Deviation|0|||
131166336|NCT02389816|472231749|FG002|Overall Study|Major Protocol Deviation|0|||
131166337|NCT02389816|472231747|FG000|Overall Study|Lost to Follow-up|1|||
131166338|NCT02389816|472231748|FG001|Overall Study|Lost to Follow-up|0|||
131166339|NCT02389816|472231749|FG002|Overall Study|Lost to Follow-up|0|||
131166340|NCT02389816|472231747|FG000|Overall Study|Withdrawal of Consent|6|||
131166341|NCT02389816|472231748|FG001|Overall Study|Withdrawal of Consent|4|||
131166342|NCT02389816|472231749|FG002|Overall Study|Withdrawal of Consent|4|||
131166343|NCT02389816|472231747|FG000|Overall Study|Lack of Efficacy|1|||
131166344|NCT02389816|472231748|FG001|Overall Study|Lack of Efficacy|0|||
131166345|NCT02389816|472231749|FG002|Overall Study|Lack of Efficacy|0|||
131166346|NCT02389816|472231747|FG000|Overall Study|Non Compliance with Study Drug|1|||
131166347|NCT02389816|472231748|FG001|Overall Study|Non Compliance with Study Drug|1|||
131166348|NCT02389816|472231749|FG002|Overall Study|Non Compliance with Study Drug|1|||
131166349|NCT02389816|472231747|FG000|Overall Study|Reason not Specified|0|||
131166350|NCT02389816|472231748|FG001|Overall Study|Reason not Specified|2|||
131166351|NCT02389816|472231749|FG002|Overall Study|Reason not Specified|0|||
131166352|NCT01594476|472231750|FG000|Overall Study|Protocol Violation|1|||
131166353|NCT01594476|472231751|FG001|Overall Study|Protocol Violation|3|||
131166354|NCT01106534|472231752|FG000|Overall Study|Withdrawal by Subject|18|||
131166355|NCT01106534|472231752|FG000|Overall Study|Lost to Follow-up|2|||
131166356|NCT01106534|472231752|FG000|Overall Study|Death|16|||
131166357|NCT01106534|472231752|FG000|Overall Study|Physician Decision|1|||
131166358|NCT01603641|472231758|FG000|Overall Study|Did not Receive Treatment|3|||
131166359|NCT01603641|472231758|FG000|Overall Study|Adverse Event|1|||
131166360|NCT01603641|472231758|FG000|Overall Study|Lack of Efficacy|1|||
131166361|NCT01603641|472231758|FG000|Overall Study|Lost to Follow-up|6|||
131166362|NCT01603641|472231758|FG000|Overall Study|Personal Reasons|18|||
131166363|NCT01603641|472231758|FG000|Overall Study|Other Miscellaneous Reasons|6|||
131166364|NCT03161678|472231759|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
131166365|NCT03161678|472231760|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
131166366|NCT03161678|472231761|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
131166367|NCT03161678|472231762|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
131166368|NCT03161678|472231763|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
131166369|NCT03161678|472231764|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
131166370|NCT03161678|472231759|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
131166371|NCT03161678|472231760|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
131166372|NCT03161678|472231761|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
131166373|NCT03161678|472231762|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
131166374|NCT03161678|472231763|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
131166375|NCT03161678|472231764|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
131166376|NCT03161678|472231759|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
131166377|NCT03161678|472231760|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
131166378|NCT03161678|472231761|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
131166379|NCT03161678|472231762|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
131166380|NCT03161678|472231763|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
131166381|NCT03161678|472231764|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
131166382|NCT03161678|472231759|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130780665|NCT02111174|470823164|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
130780666|NCT02111174|470823165|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
131166383|NCT03161678|472231760|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
131166384|NCT03161678|472231761|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
131166385|NCT03161678|472231762|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
131166386|NCT03161678|472231763|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
131166387|NCT03161678|472231764|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
131166388|NCT01757704|472231765|FG000|Overall Study|Protocol Violation|1|||
131166389|NCT01757704|472231766|FG001|Overall Study|Protocol Violation|3|||
131166390|NCT01879618|472231767|FG000|Overall Study|Does not meet entrance criteria|1|||
131166391|NCT01879618|472231767|FG000|Overall Study|Withdrawal by Subject|1|||
131166392|NCT01879618|472231767|FG000|Overall Study|Surgery;changed schedule; not available|8|||
131166393|NCT01879618|472231767|FG000|Overall Study|Protocol Violation|6|||
131166394|NCT01879618|472231767|FG000|Overall Study|Adverse Event|5|||
131166395|NCT02890329|472231770|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
131166396|NCT02890329|472231771|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
131166397|NCT02890329|472231772|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
131166398|NCT02890329|472231773|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
131166399|NCT02890329|472231774|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
131166400|NCT02890329|472231775|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
131166401|NCT02890329|472231770|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
131166402|NCT02890329|472231771|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
131166403|NCT02890329|472231772|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
131166404|NCT02890329|472231773|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
131166405|NCT02890329|472231774|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
131166406|NCT02890329|472231775|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
131166407|NCT02890329|472231770|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
131166408|NCT02890329|472231771|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
131166409|NCT02890329|472231772|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
131166410|NCT02890329|472231773|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
131166411|NCT02890329|472231774|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
131166412|NCT02890329|472231775|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
131166413|NCT02890329|472231770|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
131166414|NCT02890329|472231771|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
131166415|NCT02890329|472231772|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
131166416|NCT02890329|472231773|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
131166417|NCT02890329|472231774|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
131166418|NCT02890329|472231775|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
131166419|NCT00938327|472231776|FG000|Overall Study|Adverse Event|2|||
131166420|NCT00938327|472231776|FG000|Overall Study|Protocol Violation|1|||
131166421|NCT00938327|472231776|FG000|Overall Study|Withdrawal by Subject|4|||
131166422|NCT00938327|472231776|FG000|Overall Study|Lost to Follow-up|37|||
131166423|NCT00938327|472231776|FG000|Overall Study|2nd dose received outside of the study|7|||
131166424|NCT00938327|472231776|FG000|Overall Study|Vaccine not received as out of stock|9|||
131166425|NCT02749721|472231777|FG000|Screening|Withdrawal by Subject|1|||
131166426|NCT02749721|472231777|FG000|Screening|Lost to Follow-up|2|||
131166427|NCT02749721|472231777|FG000|Screening|Protocol Violation|3|||
131166428|NCT02749721|472231777|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
131166429|NCT02749721|472231777|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
131166430|NCT02691247|472231778|FG000|Overall Study|Withdrawal by Subject|1|||
131166431|NCT02691247|472231779|FG001|Overall Study|Withdrawal by Subject|2|||
131166432|NCT02691247|472231780|FG002|Overall Study|Withdrawal by Subject|2|||
131166433|NCT02691247|472231778|FG000|Overall Study|Lost to Follow-up|2|||
131166434|NCT02691247|472231779|FG001|Overall Study|Lost to Follow-up|0|||
131166435|NCT02691247|472231780|FG002|Overall Study|Lost to Follow-up|1|||
131166436|NCT01095250|472231785|FG000|Overall Study|administrative reasons|8|||
131166437|NCT01095250|472231786|FG001|Overall Study|administrative reasons|10|||
131166438|NCT01095250|472231787|FG002|Overall Study|administrative reasons|7|||
131166439|NCT01095250|472231788|FG003|Overall Study|administrative reasons|5|||
131166440|NCT01095250|472231785|FG000|Overall Study|Withdrawal by Subject|0|||
131166441|NCT01095250|472231786|FG001|Overall Study|Withdrawal by Subject|0|||
131166442|NCT01095250|472231787|FG002|Overall Study|Withdrawal by Subject|1|||
131166443|NCT01095250|472231788|FG003|Overall Study|Withdrawal by Subject|0|||
131166444|NCT00783705|472231790|FG000|Overall Study|Adverse Event|2|||
131166445|NCT00783705|472231791|FG001|Overall Study|Adverse Event|0|||
131166446|NCT00783705|472231790|FG000|Overall Study|Withdrawal by Subject|3|||
131166447|NCT00783705|472231791|FG001|Overall Study|Withdrawal by Subject|2|||
131166448|NCT00783705|472231790|FG000|Overall Study|Lost to Follow-up|1|||
131166449|NCT00783705|472231791|FG001|Overall Study|Lost to Follow-up|3|||
131166450|NCT03643432|472231792|FG000|Overall Study|Lost to Follow-up|1|||
131166451|NCT03643432|472231793|FG001|Overall Study|Lost to Follow-up|0|||
131166452|NCT00705224|472231796|FG000|Overall Study|Adverse Event|1|||
131166453|NCT00705224|472231796|FG000|Overall Study|Lack of Efficacy|2|||
131166454|NCT00705224|472231796|FG000|Overall Study|Withdrawal by Subject|3|||
131166455|NCT00705224|472231796|FG000|Overall Study|Lost to Follow-up|5|||
131166456|NCT01617434|472231797|FG000|Overall Study|Adverse Event|12|||
131166457|NCT01617434|472231798|FG001|Overall Study|Adverse Event|3|||
131166458|NCT01617434|472231797|FG000|Overall Study|Protocol Violation|8|||
131166459|NCT01617434|472231798|FG001|Overall Study|Protocol Violation|7|||
131166460|NCT01617434|472231797|FG000|Overall Study|Withdrawal Criteria|12|||
131166461|NCT01617434|472231798|FG001|Overall Study|Withdrawal Criteria|37|||
131166462|NCT01617434|472231797|FG000|Overall Study|Unclassified|3|||
131166463|NCT01617434|472231798|FG001|Overall Study|Unclassified|4|||
131235618|NCT00635154|472490972|FG000|Overall Study|Still on treatment|21|||
130729528|NCT03765788|470633579|FG001|Overall Study|Death|1|||
131166464|NCT03283163|472231799|FG000|Overall Study|Lost to Follow-up|1|||
131166465|NCT03283163|472231799|FG000|Overall Study|other life commitments|6|||
131166466|NCT03283163|472231799|FG000|Overall Study|COVID-19 institution wide halting|1|||
131235619|NCT01399736|472490973|FG000|Overall Study|Withdrawal by Subject|4|||
131235620|NCT01399736|472490974|FG001|Overall Study|Withdrawal by Subject|2|||
131235621|NCT01399736|472490973|FG000|Overall Study|Lost to Follow-up|0|||
131235622|NCT01399736|472490974|FG001|Overall Study|Lost to Follow-up|2|||
130780667|NCT02111174|470823164|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
131166467|NCT03283163|472231799|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
131166468|NCT03283163|472231799|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
131166469|NCT00237796|472231800|FG000|Overall Study|Baseline and one other ILSS required|10|||
131166470|NCT00237796|472231801|FG001|Overall Study|Baseline and one other ILSS required|5|||
131166471|NCT03596177|472231802|FG000|Single Blind Period|Withdrawal by Subject|1|||
131166472|NCT03596177|472231803|FG001|Single Blind Period|Withdrawal by Subject|1|||
131166473|NCT03596177|472231802|FG000|Single Blind Period|Other|1|||
131166474|NCT03596177|472231803|FG001|Single Blind Period|Other|0|||
131166475|NCT03596177|472231802|FG000|Double Blind Period|Withdrawal by Subject|0|||
131166476|NCT03596177|472231803|FG001|Double Blind Period|Withdrawal by Subject|1|||
131166477|NCT03596177|472231802|FG000|Double Blind Period|Other|0|||
131166478|NCT03596177|472231803|FG001|Double Blind Period|Other|4|||
131166479|NCT03596177|472231802|FG000|Double Blind Period|Death during safety follow-up|0|||
131166480|NCT03596177|472231803|FG001|Double Blind Period|Death during safety follow-up|1|||
131166481|NCT03860844|472231808|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
131166482|NCT03860844|472231809|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
131166483|NCT03860844|472231810|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
131166484|NCT03860844|472231808|FG000|Overall Study|Progressive disease|5|||
131166485|NCT03860844|472231809|FG001|Overall Study|Progressive disease|3|||
131166486|NCT03860844|472231810|FG002|Overall Study|Progressive disease|4|||
131166487|NCT03860844|472231808|FG000|Overall Study|Other, Not related to COVID-19|0|||
131166488|NCT03860844|472231809|FG001|Overall Study|Other, Not related to COVID-19|1|||
131166489|NCT03860844|472231810|FG002|Overall Study|Other, Not related to COVID-19|0|||
131166490|NCT01043185|472233185|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
131166491|NCT01043185|472233186|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
131166492|NCT01043185|472233187|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
131166493|NCT01043185|472233188|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
131166494|NCT01043185|472233189|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
131166495|NCT01043185|472233190|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
131166496|NCT01043185|472233191|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
131166497|NCT01043185|472233192|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
131166498|NCT01043185|472233193|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
131166499|NCT01043185|472233194|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
131166500|NCT00165646|472233195|FG000|Overall Study|Adverse Event|1|||
131166501|NCT00165646|472233196|FG001|Overall Study|Adverse Event|1|||
131166502|NCT00165646|472233197|FG002|Overall Study|Adverse Event|1|||
131166503|NCT00165646|472233195|FG000|Overall Study|Lack of Efficacy|1|||
131166504|NCT00165646|472233196|FG001|Overall Study|Lack of Efficacy|2|||
131166505|NCT00165646|472233197|FG002|Overall Study|Lack of Efficacy|0|||
131166506|NCT00165646|472233195|FG000|Overall Study|Withdrawal by Subject|0|||
131166507|NCT00165646|472233196|FG001|Overall Study|Withdrawal by Subject|2|||
131166508|NCT00165646|472233197|FG002|Overall Study|Withdrawal by Subject|1|||
131166509|NCT00165646|472233195|FG000|Overall Study|Physician Decision|2|||
131166510|NCT00165646|472233196|FG001|Overall Study|Physician Decision|0|||
131166511|NCT00165646|472233197|FG002|Overall Study|Physician Decision|2|||
131166512|NCT00165646|472233195|FG000|Overall Study|Protocol Violation|1|||
131166513|NCT00165646|472233196|FG001|Overall Study|Protocol Violation|0|||
131166514|NCT00165646|472233197|FG002|Overall Study|Protocol Violation|0|||
131166515|NCT00701727|472233198|FG000|First Treatment Period|Adverse Event|0|||
131166516|NCT00701727|472233199|FG001|First Treatment Period|Adverse Event|0|||
131166517|NCT00701727|472233198|FG000|First Treatment Period|Withdrawal by Subject|1|||
131166518|NCT00701727|472233199|FG001|First Treatment Period|Withdrawal by Subject|0|||
131166519|NCT00701727|472233198|FG000|First Treatment Period|sponsor decision|0|||
131166520|NCT00701727|472233199|FG001|First Treatment Period|sponsor decision|1|||
131166521|NCT00701727|472233198|FG000|First Treatment Period|Lost to Follow-up|0|||
131166522|NCT00701727|472233199|FG001|First Treatment Period|Lost to Follow-up|1|||
131166523|NCT00701727|472233198|FG000|Second Treatment Period|Withdrawal by Subject|2|||
131166524|NCT00701727|472233199|FG001|Second Treatment Period|Withdrawal by Subject|0|||
131166525|NCT00523341|472233202|FG000|Overall Study|Withdrawal by Subject|399|||
131166526|NCT00523341|472233203|FG001|Overall Study|Withdrawal by Subject|427|||
131166527|NCT00523341|472233202|FG000|Overall Study|Other|181|||
131166528|NCT00523341|472233203|FG001|Overall Study|Other|198|||
131166529|NCT00523341|472233202|FG000|Overall Study|Adverse Event|122|||
130780668|NCT02111174|470823165|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
130780669|NCT01657162|470823166|FG000|Overall Study|Adverse Event|26|||
131166530|NCT00523341|472233203|FG001|Overall Study|Adverse Event|155|||
131166531|NCT00523341|472233202|FG000|Overall Study|Death|101|||
131166532|NCT00523341|472233203|FG001|Overall Study|Death|110|||
130780670|NCT01657162|470823167|FG001|Overall Study|Adverse Event|36|||
130780671|NCT01657162|470823166|FG000|Overall Study|Withdrawal by Subject|13|||
130780672|NCT01657162|470823167|FG001|Overall Study|Withdrawal by Subject|13|||
130780673|NCT01657162|470823166|FG000|Overall Study|Continuing Significant Deterioration|9|||
130780674|NCT01657162|470823167|FG001|Overall Study|Continuing Significant Deterioration|3|||
130780675|NCT01657162|470823166|FG000|Overall Study|Refusal of Treatment|4|||
130780676|NCT01657162|470823167|FG001|Overall Study|Refusal of Treatment|6|||
130780677|NCT01657162|470823166|FG000|Overall Study|Lost to Follow-up|3|||
130780678|NCT01657162|470823167|FG001|Overall Study|Lost to Follow-up|4|||
131166533|NCT00523341|472233202|FG000|Overall Study|Lost to Follow-up|73|||
131166534|NCT00523341|472233203|FG001|Overall Study|Lost to Follow-up|61|||
131166535|NCT00523341|472233202|FG000|Overall Study|Non-compliance|20|||
131166536|NCT00523341|472233203|FG001|Overall Study|Non-compliance|13|||
131166537|NCT00523341|472233202|FG000|Overall Study|Physician Decision|14|||
131166538|NCT00523341|472233203|FG001|Overall Study|Physician Decision|13|||
131166539|NCT00523341|472233202|FG000|Overall Study|Requirement for Alternative Therapy|4|||
131166540|NCT00523341|472233203|FG001|Overall Study|Requirement for Alternative Therapy|14|||
131166541|NCT00523341|472233202|FG000|Overall Study|Protocol Deviation|6|||
131166542|NCT00523341|472233203|FG001|Overall Study|Protocol Deviation|5|||
131166543|NCT00523341|472233202|FG000|Overall Study|Ineligibility Determined|3|||
131166544|NCT00523341|472233203|FG001|Overall Study|Ineligibility Determined|4|||
131166545|NCT00523341|472233202|FG000|Overall Study|Disease Progression|1|||
131166546|NCT00523341|472233203|FG001|Overall Study|Disease Progression|0|||
131166547|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
131166548|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
131166549|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
131166550|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
131166551|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
131166552|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
131166553|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
131166554|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
131166555|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
131166556|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
131166557|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
131166558|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
131166559|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
131166560|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
131166561|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
131166562|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
131166563|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
131166564|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
131166565|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
131166566|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
131166567|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
131166568|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
131166569|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
131166570|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
131166571|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
131166572|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
131166573|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
131166574|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
131166575|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
131166576|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
131166577|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
131166578|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
131166579|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
131166580|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
131166581|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
131166582|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
131166583|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
131166584|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
131166585|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
131166586|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
131166587|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
131166588|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
131166589|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
131166590|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
131166591|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
131166592|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
131166593|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
131166594|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
131166595|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
131166596|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
131166597|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
131166598|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
131166599|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
131166600|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
131166601|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
131166602|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
131166603|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
131166604|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
131166605|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
131166606|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
131166607|NCT03395197|472233206|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
131166608|NCT03395197|472233207|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
131166609|NCT03395197|472233208|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
131166610|NCT03395197|472233209|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
131166611|NCT03395197|472233210|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
131166612|NCT03395197|472233211|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
131166613|NCT03395197|472233206|FG000|Analysis for DDR-Deficient Participants|Death|0|||
131166614|NCT03395197|472233207|FG001|Analysis for DDR-Deficient Participants|Death|0|||
131166615|NCT03395197|472233208|FG002|Analysis for DDR-Deficient Participants|Death|0|||
131166616|NCT03395197|472233209|FG003|Analysis for DDR-Deficient Participants|Death|0|||
131166617|NCT03395197|472233210|FG004|Analysis for DDR-Deficient Participants|Death|1|||
131166618|NCT03395197|472233211|FG005|Analysis for DDR-Deficient Participants|Death|4|||
131166619|NCT03395197|472233206|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
131166620|NCT03395197|472233207|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
131166621|NCT03395197|472233208|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
131166622|NCT03395197|472233209|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
131166623|NCT03395197|472233210|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
131166624|NCT03395197|472233211|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
131166625|NCT03395197|472233206|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
131166626|NCT03395197|472233207|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
131166627|NCT03395197|472233208|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
131166628|NCT03395197|472233209|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
131166629|NCT03395197|472233210|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
131166630|NCT03395197|472233211|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
131166631|NCT03395197|472233206|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
131166632|NCT03395197|472233207|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
131166633|NCT03395197|472233208|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
131166634|NCT03395197|472233209|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
131166635|NCT03395197|472233210|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
131166636|NCT03395197|472233211|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
131166637|NCT03395197|472233206|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
131166638|NCT03395197|472233207|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
131166639|NCT03395197|472233208|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
131166640|NCT03395197|472233209|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
131166641|NCT03395197|472233210|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
131166642|NCT03395197|472233211|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
131166643|NCT03395197|472233206|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
131166644|NCT03395197|472233207|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
131166645|NCT03395197|472233208|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
131166646|NCT03395197|472233209|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
131166647|NCT03395197|472233210|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
131166648|NCT03395197|472233211|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
131166649|NCT03395197|472233206|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
131166650|NCT03395197|472233207|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
131166651|NCT03395197|472233208|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
131166652|NCT03395197|472233209|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
131166653|NCT03395197|472233210|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
131166654|NCT03395197|472233211|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
131166655|NCT03395197|472233206|FG000|Analysis for DDR-Deficient Participants|Other|0|||
131166656|NCT03395197|472233207|FG001|Analysis for DDR-Deficient Participants|Other|0|||
131166657|NCT03395197|472233208|FG002|Analysis for DDR-Deficient Participants|Other|0|||
131166658|NCT03395197|472233209|FG003|Analysis for DDR-Deficient Participants|Other|0|||
131166659|NCT03395197|472233210|FG004|Analysis for DDR-Deficient Participants|Other|3|||
131166660|NCT03395197|472233211|FG005|Analysis for DDR-Deficient Participants|Other|3|||
131166661|NCT03395197|472233206|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
131166662|NCT03395197|472233207|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
131166663|NCT03395197|472233208|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
131166664|NCT03395197|472233209|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
131166665|NCT03395197|472233210|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
131166666|NCT03395197|472233211|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
131166667|NCT05137041|472233212|FG000|Overall Study|Lost to Follow-up|1|||
131166668|NCT05137041|472233213|FG001|Overall Study|Lost to Follow-up|1|||
131166669|NCT05137041|472233212|FG000|Overall Study|Withdrawal by Subject|0|||
131166670|NCT05137041|472233213|FG001|Overall Study|Withdrawal by Subject|2|||
131166671|NCT05137041|472233212|FG000|Overall Study|Reason not Specified|0|||
131166672|NCT05137041|472233213|FG001|Overall Study|Reason not Specified|1|||
131166673|NCT01605071|472233214|FG000|Overall Study|Withdrawal by Subject|3|||
131166674|NCT01605071|472233215|FG001|Overall Study|Withdrawal by Subject|2|||
131166675|NCT00392171|472233216|FG000|Overall Study|Did not meet inclusion criteria|4|||
131166676|NCT00392171|472233216|FG000|Overall Study|Disease progression|101|||
131166677|NCT03470922|472233218|FG000|Overall Study|Death|107|||
131166678|NCT03470922|472233219|FG001|Overall Study|Death|118|||
131166679|NCT03470922|472233218|FG000|Overall Study|Lost to Follow-up|5|||
131166680|NCT03470922|472233219|FG001|Overall Study|Lost to Follow-up|5|||
131166681|NCT03470922|472233218|FG000|Overall Study|Participant Withdrew Consent|4|||
131166682|NCT03470922|472233219|FG001|Overall Study|Participant Withdrew Consent|9|||
131166683|NCT03470922|472233218|FG000|Overall Study|Other reasons|1|||
131166684|NCT03470922|472233219|FG001|Overall Study|Other reasons|0|||
131166685|NCT03470922|472233218|FG000|Overall Study|Not reported|1|||
131166686|NCT03470922|472233219|FG001|Overall Study|Not reported|0|||
131166687|NCT02340819|472233220|FG000|Overall Study|Adverse Event|1|||
131166688|NCT02340819|472233220|FG000|Overall Study|Withdrawal by Subject|2|||
131166689|NCT02340819|472233220|FG000|Overall Study|Discontinued with other reason|1|||
131166690|NCT00028002|472233223|FG000|Overall Study|Withdrawal by Subject|3|||
131166691|NCT00028002|472233223|FG000|Overall Study|Ineligible|8|||
131166692|NCT01793051|472233224|FG000|Overall Study|Withdrawal by Subject|6|||
131166693|NCT01793051|472233225|FG001|Overall Study|Withdrawal by Subject|4|||
131166694|NCT01793051|472233224|FG000|Overall Study|Adverse Event|0|||
131166695|NCT01793051|472233225|FG001|Overall Study|Adverse Event|2|||
131166696|NCT01793051|472233224|FG000|Overall Study|Too ill to continue|1|||
131166697|NCT01793051|472233225|FG001|Overall Study|Too ill to continue|0|||
131166698|NCT01793051|472233224|FG000|Overall Study|Switched chemo|1|||
131166699|NCT01793051|472233225|FG001|Overall Study|Switched chemo|1|||
131166700|NCT01793051|472233224|FG000|Overall Study|Lack of compliance|1|||
131166701|NCT01793051|472233225|FG001|Overall Study|Lack of compliance|0|||
131166702|NCT01793051|472233224|FG000|Overall Study|Requested to be removed from the study|1|||
131166703|NCT01793051|472233225|FG001|Overall Study|Requested to be removed from the study|1|||
131166704|NCT04907539|472233228|FG000|Overall Study|Consent withdrawn|1|||
131166705|NCT04907539|472233229|FG001|Overall Study|Consent withdrawn|0|||
131166706|NCT04907539|472233228|FG000|Overall Study|Death|14|||
131166707|NCT04907539|472233229|FG001|Overall Study|Death|3|||
131166708|NCT00051558|472233230|FG000|Overall Study|Adverse Event|30|||
131166709|NCT00051558|472233231|FG001|Overall Study|Adverse Event|18|||
131166710|NCT00051558|472233230|FG000|Overall Study|Withdrawal by Subject|29|||
131166711|NCT00051558|472233231|FG001|Overall Study|Withdrawal by Subject|42|||
131166712|NCT00051558|472233230|FG000|Overall Study|Death|9|||
131166713|NCT00051558|472233231|FG001|Overall Study|Death|15|||
131166714|NCT00051558|472233230|FG000|Overall Study|Lost to Follow-up|4|||
131166715|NCT00051558|472233231|FG001|Overall Study|Lost to Follow-up|13|||
131166716|NCT00051558|472233230|FG000|Overall Study|Protocol Violation|3|||
131166717|NCT00051558|472233231|FG001|Overall Study|Protocol Violation|4|||
131166718|NCT00051558|472233230|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
131166719|NCT00051558|472233231|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
131166720|NCT00051558|472233230|FG000|Overall Study|Sponsor Decision|6|||
131166721|NCT00051558|472233231|FG001|Overall Study|Sponsor Decision|1|||
131166722|NCT00051558|472233230|FG000|Overall Study|Other|2|||
131166723|NCT00051558|472233231|FG001|Overall Study|Other|1|||
131166724|NCT00051558|472233230|FG000|Overall Study|Significant Lab Value|2|||
131166725|NCT00051558|472233231|FG001|Overall Study|Significant Lab Value|0|||
131166726|NCT00051558|472233230|FG000|Overall Study|Physician Decision|5|||
131166727|NCT00051558|472233231|FG001|Overall Study|Physician Decision|0|||
131166728|NCT01808118|472233235|FG000|Period 1|Adverse Event|15|||
131166729|NCT01808118|472233236|FG001|Period 1|Adverse Event|0|||
131166730|NCT01808118|472233237|FG002|Period 1|Adverse Event|0|||
131166731|NCT01808118|472233235|FG000|Period 1|Withdrew consent|24|||
131166732|NCT01808118|472233236|FG001|Period 1|Withdrew consent|0|||
131166733|NCT01808118|472233237|FG002|Period 1|Withdrew consent|0|||
131166734|NCT01808118|472233235|FG000|Period 1|Lost to Follow-up|9|||
131166735|NCT01808118|472233236|FG001|Period 1|Lost to Follow-up|0|||
131166736|NCT01808118|472233237|FG002|Period 1|Lost to Follow-up|0|||
131166737|NCT01808118|472233235|FG000|Period 1|Did not meet criteria for remission|303|||
131166738|NCT01808118|472233236|FG001|Period 1|Did not meet criteria for remission|0|||
131166739|NCT01808118|472233237|FG002|Period 1|Did not meet criteria for remission|0|||
131166740|NCT01808118|472233235|FG000|Period 1|Enrolled in error|7|||
131166741|NCT01808118|472233236|FG001|Period 1|Enrolled in error|0|||
131166742|NCT01808118|472233237|FG002|Period 1|Enrolled in error|0|||
131166743|NCT01808118|472233235|FG000|Period 1|Did not meet inclusion criteria|3|||
131166744|NCT01808118|472233236|FG001|Period 1|Did not meet inclusion criteria|0|||
131166745|NCT01808118|472233237|FG002|Period 1|Did not meet inclusion criteria|0|||
131166746|NCT01808118|472233235|FG000|Period 1|Non-conformance with inclusion criteria|3|||
131166747|NCT01808118|472233236|FG001|Period 1|Non-conformance with inclusion criteria|0|||
131166748|NCT01808118|472233237|FG002|Period 1|Non-conformance with inclusion criteria|0|||
131166749|NCT01808118|472233235|FG000|Period 1|Investigator decision: site closure|2|||
131166750|NCT01808118|472233236|FG001|Period 1|Investigator decision: site closure|0|||
131166751|NCT01808118|472233237|FG002|Period 1|Investigator decision: site closure|0|||
131166752|NCT01808118|472233235|FG000|Period 1|Non-compliance per sponsor|1|||
131166753|NCT01808118|472233236|FG001|Period 1|Non-compliance per sponsor|0|||
131166754|NCT01808118|472233237|FG002|Period 1|Non-compliance per sponsor|0|||
131166755|NCT01808118|472233235|FG000|Period 1|Lack of Efficacy|1|||
131166756|NCT01808118|472233236|FG001|Period 1|Lack of Efficacy|0|||
131166757|NCT01808118|472233237|FG002|Period 1|Lack of Efficacy|0|||
131166758|NCT01808118|472233235|FG000|Period 2|Adverse Event|0|||
131166759|NCT01808118|472233236|FG001|Period 2|Adverse Event|4|||
131166760|NCT01808118|472233237|FG002|Period 2|Adverse Event|0|||
131166761|NCT01808118|472233235|FG000|Period 2|Withdrew consent|0|||
131166762|NCT01808118|472233236|FG001|Period 2|Withdrew consent|7|||
131166763|NCT01808118|472233237|FG002|Period 2|Withdrew consent|6|||
131166764|NCT01808118|472233235|FG000|Period 2|Lost to Follow-up|0|||
131166765|NCT01808118|472233236|FG001|Period 2|Lost to Follow-up|0|||
131166766|NCT01808118|472233237|FG002|Period 2|Lost to Follow-up|2|||
131166767|NCT01808118|472233235|FG000|Period 2|Investigator no longer conducting trials|0|||
131166768|NCT01808118|472233236|FG001|Period 2|Investigator no longer conducting trials|1|||
131166769|NCT01808118|472233237|FG002|Period 2|Investigator no longer conducting trials|0|||
131166770|NCT01808118|472233235|FG000|Period 2|Switched to other therapy|0|||
131166771|NCT01808118|472233236|FG001|Period 2|Switched to other therapy|1|||
131166772|NCT01808118|472233237|FG002|Period 2|Switched to other therapy|0|||
131166773|NCT00718419|472233238|FG000|Overall Study|Adverse Event|2|||
131166774|NCT00718419|472233239|FG001|Overall Study|Adverse Event|1|||
131166775|NCT00718419|472233238|FG000|Overall Study|Physician Decision|1|||
131166776|NCT00718419|472233239|FG001|Overall Study|Physician Decision|6|||
131166777|NCT00718419|472233238|FG000|Overall Study|Sponsor decision|0|||
131166778|NCT00718419|472233239|FG001|Overall Study|Sponsor decision|1|||
131166779|NCT00718419|472233238|FG000|Overall Study|Withdrawal by Subject|0|||
131166780|NCT00718419|472233239|FG001|Overall Study|Withdrawal by Subject|5|||
131166781|NCT00718419|472233238|FG000|Overall Study|Progressive Disease|7|||
131166782|NCT00718419|472233239|FG001|Overall Study|Progressive Disease|25|||
131166783|NCT00718419|472233238|FG000|Overall Study|Death Due to Progressive Disease|2|||
131166784|NCT00718419|472233239|FG001|Overall Study|Death Due to Progressive Disease|0|||
131166785|NCT00718419|472233238|FG000|Overall Study|Death Due to Study Drug Related|0|||
131166786|NCT00718419|472233239|FG001|Overall Study|Death Due to Study Drug Related|1|||
131166787|NCT00718419|472233238|FG000|Overall Study|Death Due to Adverse Events|1|||
131166788|NCT00718419|472233239|FG001|Overall Study|Death Due to Adverse Events|0|||
131166789|NCT03952468|472233248|FG000|Overall Study|Death|0|||
131166790|NCT03952468|472233249|FG001|Overall Study|Death|1|||
131166791|NCT03952468|472233248|FG000|Overall Study|Adverse Event|0|||
131166792|NCT03952468|472233249|FG001|Overall Study|Adverse Event|1|||
131166793|NCT03952468|472233248|FG000|Overall Study|Physician Decision|1|||
131166794|NCT03952468|472233249|FG001|Overall Study|Physician Decision|0|||
131166795|NCT03952468|472233248|FG000|Overall Study|Lost to Follow-up|3|||
131166796|NCT03952468|472233249|FG001|Overall Study|Lost to Follow-up|4|||
131166797|NCT03952468|472233248|FG000|Overall Study|Withdrawal by Subject|2|||
131166798|NCT03952468|472233249|FG001|Overall Study|Withdrawal by Subject|1|||
131166799|NCT05132569|472233250|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
131166800|NCT05132569|472233251|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
131166801|NCT05132569|472233250|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
131166802|NCT05132569|472233251|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
131166803|NCT05132569|472233250|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
131166804|NCT05132569|472233251|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
131166805|NCT00365716|472233252|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
131235623|NCT03500484|472490975|FG000|Overall Study|Adverse Event|2|||
131166806|NCT00365716|472233253|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
131166807|NCT00365716|472233254|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131166808|NCT00365716|472233255|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131166809|NCT00365716|472233256|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131166810|NCT00365716|472233257|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131166811|NCT00365716|472233258|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
131166812|NCT00365716|472233252|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
131166813|NCT00365716|472233253|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
131166814|NCT00365716|472233254|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
131166815|NCT00365716|472233255|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
131166816|NCT00365716|472233256|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
131166817|NCT00365716|472233257|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
131166818|NCT00365716|472233258|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
131166819|NCT00365716|472233252|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
131166820|NCT00365716|472233253|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
131166821|NCT00365716|472233254|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
131166822|NCT00365716|472233255|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
131166823|NCT00365716|472233256|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
131166824|NCT00365716|472233257|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
131166825|NCT00365716|472233258|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
131166826|NCT00365716|472233252|FG000|Base Study (Day 1 to Month 7)|Other|0|||
131166827|NCT00365716|472233253|FG001|Base Study (Day 1 to Month 7)|Other|1|||
131166828|NCT00365716|472233254|FG002|Base Study (Day 1 to Month 7)|Other|0|||
131166829|NCT00365716|472233255|FG003|Base Study (Day 1 to Month 7)|Other|0|||
131166830|NCT00365716|472233256|FG004|Base Study (Day 1 to Month 7)|Other|0|||
131166831|NCT00365716|472233257|FG005|Base Study (Day 1 to Month 7)|Other|0|||
131166832|NCT00365716|472233258|FG006|Base Study (Day 1 to Month 7)|Other|0|||
131166833|NCT00365716|472233252|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
131166834|NCT00365716|472233253|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
131166835|NCT00365716|472233254|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
131166836|NCT00365716|472233255|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
131166837|NCT00365716|472233256|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
131166838|NCT00365716|472233257|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
131166839|NCT00365716|472233258|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
131166840|NCT00365716|472233252|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
131166841|NCT00365716|472233253|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
131166842|NCT00365716|472233254|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
131166843|NCT00365716|472233255|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
131166844|NCT00365716|472233256|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
131166845|NCT00365716|472233257|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
131166846|NCT00365716|472233258|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
131166847|NCT00365716|472233252|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
131166848|NCT00365716|472233253|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
131166849|NCT00365716|472233254|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
131166850|NCT00365716|472233255|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
131166851|NCT00365716|472233256|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
131166852|NCT00365716|472233257|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
131166853|NCT00365716|472233258|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
131166854|NCT00365716|472233252|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
131166855|NCT00365716|472233253|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
131166856|NCT00365716|472233254|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
131166857|NCT00365716|472233255|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
131166858|NCT00365716|472233256|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
131166859|NCT00365716|472233257|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
131166860|NCT00365716|472233258|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
131166861|NCT00365716|472233252|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
131166862|NCT00365716|472233253|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
131166863|NCT00365716|472233254|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
131166864|NCT00365716|472233255|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
131166865|NCT00365716|472233256|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
131166866|NCT00365716|472233257|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
131166867|NCT00365716|472233258|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
131166868|NCT00365716|472233252|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
131166869|NCT00365716|472233253|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
131166870|NCT00365716|472233254|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
131166871|NCT00365716|472233255|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
131166872|NCT00365716|472233256|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
131166873|NCT00365716|472233257|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
131166874|NCT00365716|472233258|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
131166875|NCT00365716|472233252|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
131166876|NCT00365716|472233253|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
131166877|NCT00365716|472233254|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
131166878|NCT00365716|472233255|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
131166879|NCT00365716|472233256|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
131166880|NCT00365716|472233257|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
131166881|NCT00365716|472233258|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
131166882|NCT00365716|472233252|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
131166883|NCT00365716|472233253|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
131166884|NCT00365716|472233254|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
131166885|NCT00365716|472233255|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
131166886|NCT00365716|472233256|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
131166887|NCT00365716|472233257|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
131166888|NCT00365716|472233258|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
131166889|NCT00365716|472233252|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
131166890|NCT00365716|472233253|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
131166891|NCT00365716|472233254|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
131166892|NCT00365716|472233255|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
131166893|NCT00365716|472233256|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
131166894|NCT00365716|472233257|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
131166895|NCT00365716|472233258|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
131166896|NCT00365716|472233252|FG000|Extension 1|Lost to Follow-up|0|||
131166897|NCT00365716|472233253|FG001|Extension 1|Lost to Follow-up|0|||
131166898|NCT00365716|472233254|FG002|Extension 1|Lost to Follow-up|0|||
131166899|NCT00365716|472233255|FG003|Extension 1|Lost to Follow-up|0|||
131166900|NCT00365716|472233256|FG004|Extension 1|Lost to Follow-up|0|||
131166901|NCT00365716|472233257|FG005|Extension 1|Lost to Follow-up|1|||
131166902|NCT00365716|472233258|FG006|Extension 1|Lost to Follow-up|0|||
131166903|NCT00365716|472233252|FG000|Extension 1|Other|0|||
131166904|NCT00365716|472233253|FG001|Extension 1|Other|0|||
131166905|NCT00365716|472233254|FG002|Extension 1|Other|0|||
131166906|NCT00365716|472233255|FG003|Extension 1|Other|0|||
131166907|NCT00365716|472233256|FG004|Extension 1|Other|0|||
131166908|NCT00365716|472233257|FG005|Extension 1|Other|9|||
131166909|NCT00365716|472233258|FG006|Extension 1|Other|0|||
131166910|NCT00365716|472233252|FG000|Extension 1|Moved|0|||
131166911|NCT00365716|472233253|FG001|Extension 1|Moved|0|||
131166912|NCT00365716|472233254|FG002|Extension 1|Moved|0|||
131166913|NCT00365716|472233255|FG003|Extension 1|Moved|0|||
131166914|NCT00365716|472233256|FG004|Extension 1|Moved|0|||
131166915|NCT00365716|472233257|FG005|Extension 1|Moved|4|||
131166916|NCT00365716|472233258|FG006|Extension 1|Moved|0|||
131166917|NCT00365716|472233252|FG000|Extension 1|Withdrawal by Subject|0|||
131166918|NCT00365716|472233253|FG001|Extension 1|Withdrawal by Subject|0|||
131166919|NCT00365716|472233254|FG002|Extension 1|Withdrawal by Subject|0|||
131166920|NCT00365716|472233255|FG003|Extension 1|Withdrawal by Subject|0|||
131166921|NCT00365716|472233256|FG004|Extension 1|Withdrawal by Subject|0|||
131166922|NCT00365716|472233257|FG005|Extension 1|Withdrawal by Subject|3|||
131166923|NCT00365716|472233258|FG006|Extension 1|Withdrawal by Subject|0|||
131166924|NCT00365716|472233252|FG000|Extension 1|Pregnancy|0|||
131166925|NCT00365716|472233253|FG001|Extension 1|Pregnancy|0|||
131166926|NCT00365716|472233254|FG002|Extension 1|Pregnancy|0|||
131166927|NCT00365716|472233255|FG003|Extension 1|Pregnancy|0|||
131166928|NCT00365716|472233256|FG004|Extension 1|Pregnancy|0|||
131166929|NCT00365716|472233257|FG005|Extension 1|Pregnancy|4|||
131166930|NCT00365716|472233258|FG006|Extension 1|Pregnancy|0|||
131166931|NCT00365716|472233252|FG000|Extension 1|Protocol Violation|0|||
131166932|NCT00365716|472233253|FG001|Extension 1|Protocol Violation|0|||
131166933|NCT00365716|472233254|FG002|Extension 1|Protocol Violation|0|||
131166934|NCT00365716|472233255|FG003|Extension 1|Protocol Violation|0|||
131166935|NCT00365716|472233256|FG004|Extension 1|Protocol Violation|0|||
131166936|NCT00365716|472233257|FG005|Extension 1|Protocol Violation|1|||
131166937|NCT00365716|472233258|FG006|Extension 1|Protocol Violation|0|||
131166938|NCT00365716|472233252|FG000|Extension 2|Lost to Follow-up|0|||
131166939|NCT00365716|472233253|FG001|Extension 2|Lost to Follow-up|0|||
131166940|NCT00365716|472233254|FG002|Extension 2|Lost to Follow-up|0|||
131166941|NCT00365716|472233255|FG003|Extension 2|Lost to Follow-up|0|||
131166942|NCT00365716|472233256|FG004|Extension 2|Lost to Follow-up|0|||
131166943|NCT00365716|472233257|FG005|Extension 2|Lost to Follow-up|0|||
131166944|NCT00365716|472233258|FG006|Extension 2|Lost to Follow-up|2|||
131166945|NCT00365716|472233252|FG000|Extension 2|Other|0|||
131166946|NCT00365716|472233253|FG001|Extension 2|Other|0|||
131166947|NCT00365716|472233254|FG002|Extension 2|Other|0|||
131166948|NCT00365716|472233255|FG003|Extension 2|Other|0|||
131166949|NCT00365716|472233256|FG004|Extension 2|Other|0|||
131166950|NCT00365716|472233257|FG005|Extension 2|Other|0|||
131166951|NCT00365716|472233258|FG006|Extension 2|Other|3|||
131166952|NCT00365716|472233252|FG000|Extension 2|Withdrawal by Subject|0|||
131166953|NCT00365716|472233253|FG001|Extension 2|Withdrawal by Subject|0|||
131166954|NCT00365716|472233254|FG002|Extension 2|Withdrawal by Subject|0|||
131166955|NCT00365716|472233255|FG003|Extension 2|Withdrawal by Subject|0|||
131166956|NCT00365716|472233256|FG004|Extension 2|Withdrawal by Subject|0|||
131166957|NCT00365716|472233257|FG005|Extension 2|Withdrawal by Subject|0|||
131166958|NCT00365716|472233258|FG006|Extension 2|Withdrawal by Subject|5|||
131166959|NCT05761444|472233259|FG000|Overall Study|Protocol Violation|2|||
131166960|NCT05761444|472233260|FG001|Overall Study|Protocol Violation|1|||
131166961|NCT05761444|472233259|FG000|Overall Study|Adverse Event|2|||
131166962|NCT05761444|472233260|FG001|Overall Study|Adverse Event|2|||
131166963|NCT05761444|472233259|FG000|Overall Study|Withdrawal by Subject|3|||
131166964|NCT05761444|472233260|FG001|Overall Study|Withdrawal by Subject|2|||
131166965|NCT05761444|472233259|FG000|Overall Study|Other|1|||
131166966|NCT05761444|472233260|FG001|Overall Study|Other|0|||
131166967|NCT00069576|472233263|FG000|Original Trial|Lost to Follow-up|25|||
131166968|NCT00069576|472233264|FG001|Original Trial|Lost to Follow-up|33|||
131166969|NCT00069576|472233263|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
131166970|NCT00069576|472233264|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
131166971|NCT04430738|472233265|FG000|Phase 1: Dose Escalation|Death|1|||
131166972|NCT04430738|472233266|FG001|Phase 1: Dose Escalation|Death|4|||
131166973|NCT04430738|472233267|FG002|Phase 1: Dose Escalation|Death|4|||
131166974|NCT04430738|472233268|FG003|Phase 1: Dose Escalation|Death|1|||
131166975|NCT04430738|472233269|FG004|Phase 1: Dose Escalation|Death|6|||
131166976|NCT04430738|472233270|FG005|Phase 1: Dose Escalation|Death|0|||
131166977|NCT04430738|472233265|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
131166978|NCT04430738|472233266|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
131166979|NCT04430738|472233267|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
131166980|NCT04430738|472233268|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
131166981|NCT04430738|472233269|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
131166982|NCT04430738|472233270|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
131166983|NCT04430738|472233265|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
131166984|NCT04430738|472233266|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
131166985|NCT04430738|472233267|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
131166986|NCT04430738|472233268|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
131166987|NCT04430738|472233269|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
131166988|NCT04430738|472233270|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
131166989|NCT04430738|472233265|FG000|Phase 1: Dose Escalation|Other|1|||
131166990|NCT04430738|472233266|FG001|Phase 1: Dose Escalation|Other|0|||
131166991|NCT04430738|472233267|FG002|Phase 1: Dose Escalation|Other|0|||
131166992|NCT04430738|472233268|FG003|Phase 1: Dose Escalation|Other|0|||
131166993|NCT04430738|472233269|FG004|Phase 1: Dose Escalation|Other|0|||
131166994|NCT04430738|472233270|FG005|Phase 1: Dose Escalation|Other|0|||
131166995|NCT04430738|472233265|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
131166996|NCT04430738|472233266|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
131166997|NCT04430738|472233267|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
131166998|NCT04430738|472233268|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
131166999|NCT04430738|472233269|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
131167000|NCT04430738|472233270|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
131167001|NCT04430738|472233265|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
131167002|NCT04430738|472233266|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
131167003|NCT04430738|472233267|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
131167004|NCT04430738|472233268|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
131167005|NCT04430738|472233269|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
131167006|NCT04430738|472233270|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
131167007|NCT05590793|472233271|FG000|Overall Study|Withdrawal by Subject|6|||
131167008|NCT05590793|472233271|FG000|Overall Study|Physician Decision|1|||
131167009|NCT02499146|472233279|FG000|Overall Study|Lost to Follow-up|1|||
131167010|NCT02499146|472233279|FG000|Overall Study|Withdrawal by Subject|1|||
131167011|NCT02499146|472233279|FG000|Overall Study|Other|2|||
131167012|NCT02499146|472233279|FG000|Overall Study|Ongoing at date of cut-off|9|||
131167013|NCT02499146|472233279|FG000|Overall Study|Began other treatment/therapy|13|||
131167014|NCT02275026|472233282|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
131167015|NCT02275026|472233282|FG000|Overall Study|Withdrawal by Subject|4|||
131167016|NCT02275026|472233282|FG000|Overall Study|Ineligible due to medical history|13|||
131167017|NCT02275026|472233282|FG000|Overall Study|MRI malfunction precluded testing|1|||
131167018|NCT02275026|472233282|FG000|Overall Study|Ineligible after MRI findings|1|||
131167019|NCT02275026|472233282|FG000|Overall Study|Lost to Follow-up|2|||
131167020|NCT02275026|472233282|FG000|Overall Study|Scanner failure|1|||
131167021|NCT05468086|472233283|FG000|Overall Study|Withdrawal by Subject|3|||
131167022|NCT05468086|472233283|FG000|Overall Study|Subject was found ineligible after consent|1|||
131167023|NCT01108809|472233284|FG000|Overall Study|Adverse Event|3|||
131167024|NCT01108809|472233284|FG000|Overall Study|Lost to Follow-up|1|||
131167025|NCT04238663|472233285|FG000|Overall Study|Lost to Follow-up|0|||
131167026|NCT04238663|472233286|FG001|Overall Study|Lost to Follow-up|1|||
131167027|NCT04238663|472233287|FG002|Overall Study|Lost to Follow-up|0|||
131167028|NCT01193348|472233288|FG000|Screening Period|Screen Failure|5|||
131167029|NCT01193348|472233288|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
131167030|NCT01193348|472233288|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
131167031|NCT01193348|472233288|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
131167032|NCT01193348|472233288|FG000|Extension Treatment Period|Physician Decision|1|||
131167033|NCT01193348|472233288|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
131167034|NCT04070378|472233289|FG000|Overall Study|Withdrawal by Subject|2|||
131167035|NCT04070378|472233289|FG000|Overall Study|Screen Failure|6|||
130729529|NCT03765788|470633578|FG000|Overall Study|Lost to Follow-up|1|||
131167036|NCT04070378|472233289|FG000|Overall Study|Physician Decision|1|||
131167037|NCT04070378|472233289|FG000|Overall Study|Adverse Event|1|||
131167038|NCT03259334|472233290|FG000|Overall Study|Adverse Event|3|||
131167039|NCT03259334|472233291|FG001|Overall Study|Adverse Event|8|||
131167040|NCT03259334|472233292|FG002|Overall Study|Adverse Event|5|||
131167041|NCT03259334|472233290|FG000|Overall Study|Withdrawal by Subject|4|||
131167042|NCT03259334|472233291|FG001|Overall Study|Withdrawal by Subject|2|||
131167043|NCT03259334|472233292|FG002|Overall Study|Withdrawal by Subject|4|||
131167044|NCT03259334|472233290|FG000|Overall Study|Physician Decision|1|||
131167045|NCT03259334|472233291|FG001|Overall Study|Physician Decision|0|||
131167046|NCT03259334|472233292|FG002|Overall Study|Physician Decision|0|||
131167047|NCT03259334|472233290|FG000|Overall Study|Lost to Follow-up|0|||
131167048|NCT03259334|472233291|FG001|Overall Study|Lost to Follow-up|2|||
131167049|NCT03259334|472233292|FG002|Overall Study|Lost to Follow-up|1|||
131167050|NCT03259334|472233290|FG000|Overall Study|Protocol Deviation|0|||
131167051|NCT03259334|472233291|FG001|Overall Study|Protocol Deviation|3|||
131167052|NCT03259334|472233292|FG002|Overall Study|Protocol Deviation|2|||
131167053|NCT03259334|472233290|FG000|Overall Study|Lack of Efficacy|2|||
131167054|NCT03259334|472233291|FG001|Overall Study|Lack of Efficacy|0|||
131167055|NCT03259334|472233292|FG002|Overall Study|Lack of Efficacy|1|||
131167056|NCT03259334|472233290|FG000|Overall Study|Randomized but never treated|0|||
131167057|NCT03259334|472233291|FG001|Overall Study|Randomized but never treated|2|||
131167058|NCT03259334|472233292|FG002|Overall Study|Randomized but never treated|0|||
131167059|NCT01721408|472233293|FG000|Overall Study|Adverse Event|6|||
131167060|NCT01721408|472233294|FG001|Overall Study|Adverse Event|1|||
131167061|NCT01721408|472233293|FG000|Overall Study|Death|1|||
131167062|NCT01721408|472233294|FG001|Overall Study|Death|0|||
131167063|NCT01721408|472233293|FG000|Overall Study|Insufficient clinical response|15|||
131167064|NCT01721408|472233294|FG001|Overall Study|Insufficient clinical response|6|||
131167065|NCT01721408|472233293|FG000|Overall Study|No longer willing to participate study|9|||
131167066|NCT01721408|472233294|FG001|Overall Study|No longer willing to participate study|10|||
131167067|NCT01721408|472233293|FG000|Overall Study|Protocol Violation|0|||
130729530|NCT03765788|470633579|FG001|Overall Study|Lost to Follow-up|0|||
130729531|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
130729532|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
130729533|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
130729534|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
130729535|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
130729536|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
130729537|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
130729538|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
130729539|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
130729540|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
130729541|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
130729542|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
130729543|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
130729544|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
130729545|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
130729546|NCT04856930|470633580|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130729547|NCT04856930|470633581|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
130729548|NCT04856930|470633582|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130780679|NCT01657162|470823166|FG000|Overall Study|Death|2|||
130780680|NCT01657162|470823167|FG001|Overall Study|Death|3|||
130780681|NCT01657162|470823166|FG000|Overall Study|Inability to Complete Study Procedures|1|||
131167068|NCT01721408|472233294|FG001|Overall Study|Protocol Violation|2|||
131167069|NCT01721408|472233293|FG000|Overall Study|Other|3|||
131167070|NCT01721408|472233294|FG001|Overall Study|Other|3|||
131167071|NCT01721408|472233293|FG000|Overall Study|Lost to Follow-up|1|||
131167072|NCT01721408|472233294|FG001|Overall Study|Lost to Follow-up|2|||
131167073|NCT01721408|472233293|FG000|Overall Study|Does not meet entrance criteria|1|||
131167074|NCT01721408|472233294|FG001|Overall Study|Does not meet entrance criteria|0|||
131167075|NCT01678807|472233295|FG000|Overall Study|Adverse Event|4|||
131167076|NCT01678807|472233296|FG001|Overall Study|Adverse Event|4|||
131167077|NCT01678807|472233297|FG002|Overall Study|Adverse Event|0|||
131167078|NCT01678807|472233295|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
131167079|NCT01678807|472233296|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
131167080|NCT01678807|472233297|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
131167081|NCT00370149|472233298|FG000|Overall Study|Physician Decision|16|||
131167082|NCT00370149|472233299|FG001|Overall Study|Physician Decision|16|||
131167083|NCT00370149|472233298|FG000|Overall Study|Protocol Violation|1|||
131167084|NCT00370149|472233299|FG001|Overall Study|Protocol Violation|0|||
131167085|NCT00370149|472233298|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
131167086|NCT00370149|472233299|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
131167087|NCT00370149|472233298|FG000|Overall Study|Pre-existing infection|0|||
131167088|NCT00370149|472233299|FG001|Overall Study|Pre-existing infection|1|||
131167089|NCT00370149|472233298|FG000|Overall Study|Antibiotic coated dressing placed|0|||
131167090|NCT00370149|472233299|FG001|Overall Study|Antibiotic coated dressing placed|1|||
131167091|NCT05113953|472234391|FG000|Overall Study|Adverse Event|5|||
131167092|NCT05113953|472234392|FG001|Overall Study|Adverse Event|0|||
131167093|NCT05113953|472234393|FG002|Overall Study|Adverse Event|3|||
131167094|NCT05113953|472234391|FG000|Overall Study|Lost to Follow-up|3|||
131167095|NCT05113953|472234392|FG001|Overall Study|Lost to Follow-up|4|||
131167096|NCT05113953|472234393|FG002|Overall Study|Lost to Follow-up|2|||
131167097|NCT05113953|472234391|FG000|Overall Study|Non-compliance with Study Drug|1|||
131167098|NCT05113953|472234392|FG001|Overall Study|Non-compliance with Study Drug|0|||
131167099|NCT05113953|472234393|FG002|Overall Study|Non-compliance with Study Drug|0|||
131167100|NCT05113953|472234391|FG000|Overall Study|Withdrawal by Subject|2|||
131167101|NCT05113953|472234392|FG001|Overall Study|Withdrawal by Subject|6|||
131167102|NCT05113953|472234393|FG002|Overall Study|Withdrawal by Subject|4|||
131167103|NCT05113953|472234391|FG000|Overall Study|Reason not Specified|2|||
131167104|NCT05113953|472234392|FG001|Overall Study|Reason not Specified|0|||
131167105|NCT05113953|472234393|FG002|Overall Study|Reason not Specified|0|||
131167106|NCT00502307|472234396|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
131167107|NCT00502307|472234397|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
131167108|NCT00502307|472234398|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
131167109|NCT00502307|472234396|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
131167110|NCT00502307|472234397|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
131167111|NCT00502307|472234398|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
131167112|NCT00502307|472234396|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
131167113|NCT00502307|472234397|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
131167114|NCT00502307|472234398|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
131167115|NCT00502307|472234396|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
131167116|NCT00502307|472234397|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
131167117|NCT00502307|472234398|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
131167118|NCT00502307|472234396|FG000|Maintenance Period|Progressive disease|80|||
131167119|NCT00502307|472234397|FG001|Maintenance Period|Progressive disease|0|||
131167120|NCT00502307|472234398|FG002|Maintenance Period|Progressive disease|0|||
131167121|NCT00502307|472234396|FG000|Maintenance Period|Discontinued due to other reasons|68|||
131167122|NCT00502307|472234397|FG001|Maintenance Period|Discontinued due to other reasons|0|||
131167123|NCT00502307|472234398|FG002|Maintenance Period|Discontinued due to other reasons|0|||
131167124|NCT00726323|472234401|FG000|Overall Study|Withdrawal by Subject|3|||
131167125|NCT00726323|472234402|FG001|Overall Study|Withdrawal by Subject|1|||
131167126|NCT00726323|472234401|FG000|Overall Study|Physician Decision|1|||
131167127|NCT00726323|472234402|FG001|Overall Study|Physician Decision|0|||
131167128|NCT00726323|472234401|FG000|Overall Study|Progressive disease|23|||
131167129|NCT00726323|472234402|FG001|Overall Study|Progressive disease|16|||
131167130|NCT00726323|472234401|FG000|Overall Study|Clinical progression|0|||
131167131|NCT00726323|472234402|FG001|Overall Study|Clinical progression|3|||
131167132|NCT00726323|472234401|FG000|Overall Study|Adverse Event|9|||
131167133|NCT00726323|472234402|FG001|Overall Study|Adverse Event|9|||
130729549|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
130729550|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
130729551|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
130729552|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
130729553|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
130729554|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
131167134|NCT00726323|472234401|FG000|Overall Study|Death|1|||
131167135|NCT00726323|472234402|FG001|Overall Study|Death|0|||
131167136|NCT00726323|472234401|FG000|Overall Study|Participant wished to discontinue|0|||
131167137|NCT00726323|472234402|FG001|Overall Study|Participant wished to discontinue|1|||
131167138|NCT00726323|472234401|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
131167139|NCT00726323|472234402|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
131167140|NCT04102098|472234409|FG000|Main Study Period|Ongoing in study|302|||
130729555|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
131167141|NCT04102098|472234410|FG001|Main Study Period|Ongoing in study|291|||
131167142|NCT04102098|472234409|FG000|Main Study Period|Death|20|||
131167143|NCT04102098|472234410|FG001|Main Study Period|Death|27|||
131167144|NCT04102098|472234409|FG000|Main Study Period|Lost to Follow-up|1|||
131167145|NCT04102098|472234410|FG001|Main Study Period|Lost to Follow-up|1|||
131167146|NCT04102098|472234409|FG000|Main Study Period|Physician Decision|0|||
131167147|NCT04102098|472234410|FG001|Main Study Period|Physician Decision|1|||
131167148|NCT04102098|472234409|FG000|Main Study Period|Withdrawal by Subject|11|||
131167149|NCT04102098|472234410|FG001|Main Study Period|Withdrawal by Subject|14|||
131167150|NCT04102098|472234409|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
131167151|NCT04102098|472234410|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
131167152|NCT04102098|472234409|FG000|Crossover: AS Who Crossed Over|Death|11|||
131167153|NCT04102098|472234410|FG001|Crossover: AS Who Crossed Over|Death|0|||
131167154|NCT04102098|472234409|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
131167155|NCT04102098|472234410|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
131167156|NCT04742907|472234411|FG000|Overall Study|Adverse Event|1|||
131167157|NCT04742907|472234412|FG001|Overall Study|Adverse Event|0|||
131167158|NCT04742907|472234413|FG002|Overall Study|Adverse Event|1|||
131167159|NCT04742907|472234411|FG000|Overall Study|Lost to Follow-up|3|||
131167160|NCT04742907|472234412|FG001|Overall Study|Lost to Follow-up|3|||
131167161|NCT04742907|472234413|FG002|Overall Study|Lost to Follow-up|2|||
131167162|NCT04742907|472234411|FG000|Overall Study|Physician Decision|0|||
131167163|NCT04742907|472234412|FG001|Overall Study|Physician Decision|1|||
131167164|NCT04742907|472234413|FG002|Overall Study|Physician Decision|0|||
131167165|NCT04742907|472234411|FG000|Overall Study|Protocol Violation|1|||
131167166|NCT04742907|472234412|FG001|Overall Study|Protocol Violation|1|||
131167167|NCT04742907|472234413|FG002|Overall Study|Protocol Violation|1|||
131167168|NCT04742907|472234411|FG000|Overall Study|Withdrawal by Subject|5|||
131167169|NCT04742907|472234412|FG001|Overall Study|Withdrawal by Subject|6|||
131167170|NCT04742907|472234413|FG002|Overall Study|Withdrawal by Subject|4|||
131167171|NCT04742907|472234411|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
131167172|NCT04742907|472234412|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
131167173|NCT04742907|472234413|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
131167174|NCT04742907|472234411|FG000|Overall Study|Did Not Receive the Study Drug|2|||
131167175|NCT04742907|472234412|FG001|Overall Study|Did Not Receive the Study Drug|4|||
131167176|NCT04742907|472234413|FG002|Overall Study|Did Not Receive the Study Drug|4|||
131167177|NCT02280291|472234414|FG000|Overall Study|Lost to Follow-up|2|||
131167178|NCT02280291|472234415|FG001|Overall Study|Lost to Follow-up|1|||
131167179|NCT02280291|472234416|FG002|Overall Study|Lost to Follow-up|3|||
131167180|NCT02280291|472234417|FG003|Overall Study|Lost to Follow-up|8|||
131167181|NCT02280291|472234414|FG000|Overall Study|Protocol Violation|1|||
131167182|NCT02280291|472234415|FG001|Overall Study|Protocol Violation|0|||
131167183|NCT02280291|472234416|FG002|Overall Study|Protocol Violation|0|||
131167184|NCT02280291|472234417|FG003|Overall Study|Protocol Violation|0|||
131167185|NCT02280291|472234414|FG000|Overall Study|Other|1|||
131167186|NCT02280291|472234415|FG001|Overall Study|Other|1|||
131167187|NCT02280291|472234416|FG002|Overall Study|Other|0|||
131167188|NCT02280291|472234417|FG003|Overall Study|Other|0|||
131167189|NCT00210158|472234419|FG000|Overall Study|Protocol Violation|0|||
131167190|NCT00210158|472234420|FG001|Overall Study|Protocol Violation|2|||
131167191|NCT04716933|472234421|FG000|Overall Study|Sponsor Decision|36|||
131167192|NCT04716933|472234422|FG001|Overall Study|Sponsor Decision|33|||
131167193|NCT04716933|472234421|FG000|Overall Study|Death|65|||
131167194|NCT04716933|472234422|FG001|Overall Study|Death|67|||
131167195|NCT03196505|472234423|FG000|Overall Study|Physician Decision|26|||
131167196|NCT03196505|472234424|FG001|Overall Study|Physician Decision|26|||
131167197|NCT01005719|472234425|FG000|Period 1|Adverse Event|0|||
131167198|NCT01005719|472234426|FG001|Period 1|Adverse Event|0|||
131167199|NCT01005719|472234427|FG002|Period 1|Adverse Event|0|||
131167200|NCT01005719|472234428|FG003|Period 1|Adverse Event|1|||
131167201|NCT01005719|472234429|FG004|Period 1|Adverse Event|0|||
131167202|NCT01005719|472234430|FG005|Period 1|Adverse Event|0|||
131167203|NCT01005719|472234425|FG000|Period 1|Delay in completing study procedures|0|||
130780682|NCT01657162|470823167|FG001|Overall Study|Inability to Complete Study Procedures|7|||
131167204|NCT01005719|472234426|FG001|Period 1|Delay in completing study procedures|0|||
131167205|NCT01005719|472234427|FG002|Period 1|Delay in completing study procedures|0|||
131167206|NCT01005719|472234428|FG003|Period 1|Delay in completing study procedures|0|||
131167207|NCT01005719|472234429|FG004|Period 1|Delay in completing study procedures|0|||
131167208|NCT01005719|472234430|FG005|Period 1|Delay in completing study procedures|1|||
131167209|NCT01005719|472234425|FG000|Period 2|Adverse Event|0|||
131167210|NCT01005719|472234426|FG001|Period 2|Adverse Event|0|||
131167211|NCT01005719|472234427|FG002|Period 2|Adverse Event|0|||
131167212|NCT01005719|472234428|FG003|Period 2|Adverse Event|0|||
131167213|NCT01005719|472234429|FG004|Period 2|Adverse Event|1|||
131167214|NCT01005719|472234430|FG005|Period 2|Adverse Event|1|||
131167215|NCT05187013|472234431|FG000|Overall Study|Withdrawal by Subject|1|||
131167216|NCT05187013|472234432|FG001|Overall Study|Withdrawal by Subject|1|||
131235624|NCT03500484|472490976|FG001|Overall Study|Adverse Event|0|||
131167217|NCT05187013|472234433|FG002|Overall Study|Withdrawal by Subject|0|||
131167218|NCT05187013|472234431|FG000|Overall Study|Death|0|||
131167219|NCT05187013|472234432|FG001|Overall Study|Death|1|||
131167220|NCT05187013|472234433|FG002|Overall Study|Death|0|||
130780683|NCT01657162|470823166|FG000|Overall Study|Protocol Violation|1|||
130780684|NCT01657162|470823167|FG001|Overall Study|Protocol Violation|0|||
130780685|NCT01657162|470823166|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
130780686|NCT01657162|470823167|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
130780687|NCT01657162|470823166|FG000|Overall Study|Other than Specified|0|||
131167221|NCT05187013|472234431|FG000|Overall Study|Lost to Follow-up|20|||
131167222|NCT05187013|472234432|FG001|Overall Study|Lost to Follow-up|17|||
131167223|NCT05187013|472234433|FG002|Overall Study|Lost to Follow-up|0|||
131167224|NCT05187013|472234431|FG000|Overall Study|Ongoing Participants|3|||
131167225|NCT05187013|472234432|FG001|Overall Study|Ongoing Participants|5|||
131167226|NCT05187013|472234433|FG002|Overall Study|Ongoing Participants|0|||
131167227|NCT04488822|472234434|FG000|Overall Study|Adverse Event|8|||
131167228|NCT04488822|472234434|FG000|Overall Study|Withdrawal by Subject|1|||
131167229|NCT03838367|472234435|FG000|Overall Study|Early termination of study|3|||
131167230|NCT03838367|472234436|FG001|Overall Study|Early termination of study|4|||
131167231|NCT03838367|472234437|FG002|Overall Study|Early termination of study|3|||
131167232|NCT03838367|472234438|FG003|Overall Study|Early termination of study|0|||
131167233|NCT03406104|472234439|FG000|Overall Study|Lost to Follow-up|2|||
131167234|NCT03406104|472234439|FG000|Overall Study|Withdrawal by Subject|2|||
131167235|NCT03406104|472234439|FG000|Overall Study|due to Covid patient did not want to travel|1|||
131167236|NCT03406104|472234439|FG000|Overall Study|Death|2|||
131167237|NCT03015610|472234445|FG000|Overall Study|Lost to Follow-up|1|||
131167238|NCT03015610|472234446|FG001|Overall Study|Lost to Follow-up|5|||
131167239|NCT05100199|472234448|FG000|Overall Study|Lost to Follow-up|5|||
131167240|NCT05100199|472234449|FG001|Overall Study|Lost to Follow-up|8|||
131167241|NCT05100199|472234450|FG002|Overall Study|Lost to Follow-up|3|||
131167242|NCT05100199|472234451|FG003|Overall Study|Lost to Follow-up|6|||
131167243|NCT05100199|472234448|FG000|Overall Study|Withdrawal by Subject|3|||
131167244|NCT05100199|472234449|FG001|Overall Study|Withdrawal by Subject|3|||
131167245|NCT05100199|472234450|FG002|Overall Study|Withdrawal by Subject|9|||
131167246|NCT05100199|472234451|FG003|Overall Study|Withdrawal by Subject|7|||
131167247|NCT05100199|472234448|FG000|Overall Study|Other|0|||
131167248|NCT05100199|472234449|FG001|Overall Study|Other|0|||
131167249|NCT05100199|472234450|FG002|Overall Study|Other|1|||
131167250|NCT05100199|472234451|FG003|Overall Study|Other|1|||
131167251|NCT00752609|472234452|FG000|Overall Study|Adverse Event|2|||
131167252|NCT00752609|472234453|FG001|Overall Study|Adverse Event|2|||
131167253|NCT00752609|472234452|FG000|Overall Study|Withdrawal by Subject|3|||
131167254|NCT00752609|472234453|FG001|Overall Study|Withdrawal by Subject|0|||
131167255|NCT00752609|472234452|FG000|Overall Study|Physician Decision|1|||
131167256|NCT00752609|472234453|FG001|Overall Study|Physician Decision|0|||
131167257|NCT00752609|472234452|FG000|Overall Study|Death|1|||
131167258|NCT00752609|472234453|FG001|Overall Study|Death|0|||
131167259|NCT00752609|472234452|FG000|Overall Study|Met exclusion criteria|1|||
131167260|NCT00752609|472234453|FG001|Overall Study|Met exclusion criteria|0|||
131167261|NCT00752609|472234452|FG000|Overall Study|Received Aranesp in error|1|||
131167262|NCT00752609|472234453|FG001|Overall Study|Received Aranesp in error|0|||
131167263|NCT00358917|472234456|FG000|Overall Study|Adverse Event|14|||
131167264|NCT00358917|472234457|FG001|Overall Study|Adverse Event|21|||
131167265|NCT00358917|472234456|FG000|Overall Study|Withdrawal by Subject|5|||
131167266|NCT00358917|472234457|FG001|Overall Study|Withdrawal by Subject|7|||
131167267|NCT00358917|472234456|FG000|Overall Study|Lost to Follow-up|20|||
131167268|NCT00358917|472234457|FG001|Overall Study|Lost to Follow-up|17|||
131167269|NCT00358917|472234456|FG000|Overall Study|Noncompliance|12|||
131167270|NCT00358917|472234457|FG001|Overall Study|Noncompliance|11|||
131167271|NCT00358917|472234456|FG000|Overall Study|Death|2|||
131167272|NCT00358917|472234457|FG001|Overall Study|Death|3|||
131167273|NCT00358917|472234456|FG000|Overall Study|Virologic failure|11|||
130780688|NCT01657162|470823167|FG001|Overall Study|Other than Specified|2|||
130780689|NCT00901342|470823168|FG000|Overall Study|Adverse Event|1|||
131167274|NCT00358917|472234457|FG001|Overall Study|Virologic failure|8|||
131167275|NCT00358917|472234456|FG000|Overall Study|Unable to Continue Participation|2|||
131167276|NCT00358917|472234457|FG001|Overall Study|Unable to Continue Participation|2|||
131167277|NCT05692154|472234458|FG000|Overall Study|Adverse Event|0|||
131167278|NCT05692154|472234459|FG001|Overall Study|Adverse Event|1|||
131167279|NCT01379534|472234470|FG000|Treatment Phase|Withdrawal by Subject|2|||
131167280|NCT01379534|472234471|FG001|Treatment Phase|Withdrawal by Subject|2|||
131167281|NCT01379534|472234470|FG000|Treatment Phase|Progressive disease|13|||
130780690|NCT00901342|470823168|FG000|Overall Study|Death|4|||
131167282|NCT01379534|472234471|FG001|Treatment Phase|Progressive disease|22|||
131167283|NCT01379534|472234470|FG000|Treatment Phase|Adverse Event|7|||
131167284|NCT01379534|472234471|FG001|Treatment Phase|Adverse Event|7|||
131167285|NCT01379534|472234470|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
131167286|NCT01379534|472234471|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
131235625|NCT03500484|472490975|FG000|Overall Study|Physician Decision|1|||
131167287|NCT01379534|472234470|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
131167288|NCT01379534|472234471|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
131167289|NCT01379534|472234470|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
131167290|NCT01379534|472234471|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
131167291|NCT01379534|472234470|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
131167292|NCT01379534|472234471|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
131167293|NCT05372575|472234478|FG000|Overall Study|Protocol Violation|7|||
131167294|NCT05372575|472234479|FG001|Overall Study|Protocol Violation|16|||
131167295|NCT01096550|472234480|FG000|Overall Study|discontinued site|10|||
131167296|NCT01096550|472234481|FG001|Overall Study|discontinued site|11|||
131167297|NCT01096550|472234480|FG000|Overall Study|non-regular treatment track at clinic|1|||
131167298|NCT01096550|472234481|FG001|Overall Study|non-regular treatment track at clinic|1|||
131167299|NCT01096550|472234480|FG000|Overall Study|clinic readmission|1|||
131167300|NCT01096550|472234481|FG001|Overall Study|clinic readmission|1|||
131167301|NCT01096550|472234480|FG000|Overall Study|Withdrawal by Subject|0|||
131167302|NCT01096550|472234481|FG001|Overall Study|Withdrawal by Subject|1|||
131167303|NCT01096550|472234480|FG000|Overall Study|non-African American participant|13|||
131167304|NCT01096550|472234481|FG001|Overall Study|non-African American participant|6|||
131167305|NCT01096550|472234480|FG000|Overall Study|Lost to Follow-up|12|||
131167306|NCT01096550|472234481|FG001|Overall Study|Lost to Follow-up|9|||
131167307|NCT02538666|472234484|FG000|Pre-Treatment|Disease progression|1|||
131167308|NCT02538666|472234485|FG001|Pre-Treatment|Disease progression|0|||
131167309|NCT02538666|472234486|FG002|Pre-Treatment|Disease progression|0|||
131167310|NCT02538666|472234484|FG000|Pre-Treatment|no longer meets study criteria|1|||
131167311|NCT02538666|472234485|FG001|Pre-Treatment|no longer meets study criteria|0|||
131167312|NCT02538666|472234486|FG002|Pre-Treatment|no longer meets study criteria|0|||
131167313|NCT02538666|472234484|FG000|Pre-Treatment|Withdrew Consent|0|||
131167314|NCT02538666|472234485|FG001|Pre-Treatment|Withdrew Consent|1|||
131167315|NCT02538666|472234486|FG002|Pre-Treatment|Withdrew Consent|1|||
131167316|NCT02538666|472234484|FG000|Treatment|Disease progression|270|||
131167317|NCT02538666|472234485|FG001|Treatment|Disease progression|227|||
131167318|NCT02538666|472234486|FG002|Treatment|Disease progression|165|||
131167319|NCT02538666|472234484|FG000|Treatment|Study drug toxicity|1|||
131167320|NCT02538666|472234485|FG001|Treatment|Study drug toxicity|29|||
131167321|NCT02538666|472234486|FG002|Treatment|Study drug toxicity|92|||
131167322|NCT02538666|472234484|FG000|Treatment|Death|0|||
131167323|NCT02538666|472234485|FG001|Treatment|Death|2|||
131167324|NCT02538666|472234486|FG002|Treatment|Death|3|||
131167325|NCT02538666|472234484|FG000|Treatment|Adverse event unrelated to study drug|8|||
131167326|NCT02538666|472234485|FG001|Treatment|Adverse event unrelated to study drug|10|||
131167327|NCT02538666|472234486|FG002|Treatment|Adverse event unrelated to study drug|15|||
131167328|NCT02538666|472234484|FG000|Treatment|Participant request to discontinue study treatment|3|||
131167329|NCT02538666|472234485|FG001|Treatment|Participant request to discontinue study treatment|6|||
131167330|NCT02538666|472234486|FG002|Treatment|Participant request to discontinue study treatment|11|||
131167331|NCT02538666|472234484|FG000|Treatment|Participant withdrew consent|2|||
131167332|NCT02538666|472234485|FG001|Treatment|Participant withdrew consent|5|||
131167333|NCT02538666|472234486|FG002|Treatment|Participant withdrew consent|3|||
131167334|NCT02538666|472234484|FG000|Treatment|Lost to Follow-up|0|||
131167335|NCT02538666|472234485|FG001|Treatment|Lost to Follow-up|1|||
131167336|NCT02538666|472234486|FG002|Treatment|Lost to Follow-up|1|||
131167337|NCT02538666|472234484|FG000|Treatment|Maximum clinical benefit|4|||
131167338|NCT02538666|472234485|FG001|Treatment|Maximum clinical benefit|3|||
131167339|NCT02538666|472234486|FG002|Treatment|Maximum clinical benefit|4|||
131167340|NCT02538666|472234484|FG000|Treatment|Poor/non-compliance|0|||
131167341|NCT02538666|472234485|FG001|Treatment|Poor/non-compliance|1|||
131167342|NCT02538666|472234486|FG002|Treatment|Poor/non-compliance|0|||
131167343|NCT02538666|472234484|FG000|Treatment|Participant no longer meets study criteria|0|||
131167344|NCT02538666|472234485|FG001|Treatment|Participant no longer meets study criteria|2|||
131167345|NCT02538666|472234486|FG002|Treatment|Participant no longer meets study criteria|0|||
131167346|NCT02538666|472234484|FG000|Treatment|Administrative reason by sponsor|0|||
131167347|NCT02538666|472234485|FG001|Treatment|Administrative reason by sponsor|0|||
131167348|NCT02538666|472234486|FG002|Treatment|Administrative reason by sponsor|1|||
131167349|NCT02538666|472234484|FG000|Treatment|Other reasons|8|||
131167350|NCT02538666|472234485|FG001|Treatment|Other reasons|15|||
131167351|NCT02538666|472234486|FG002|Treatment|Other reasons|5|||
131167352|NCT02538666|472234484|FG000|Treatment|Not reported|2|||
131167353|NCT02538666|472234485|FG001|Treatment|Not reported|2|||
131167354|NCT02538666|472234486|FG002|Treatment|Not reported|2|||
131167355|NCT00001262|472234487|FG000|Overall Study|Death|10|||
131235626|NCT03500484|472490976|FG001|Overall Study|Physician Decision|0|||
131235627|NCT03500484|472490975|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
131167356|NCT00001262|472234488|FG001|Overall Study|Death|11|||
131167357|NCT00001262|472234489|FG002|Overall Study|Death|0|||
131167358|NCT00001262|472234487|FG000|Overall Study|Withdrawal by Subject|0|||
131167359|NCT00001262|472234488|FG001|Overall Study|Withdrawal by Subject|3|||
131167360|NCT00001262|472234489|FG002|Overall Study|Withdrawal by Subject|0|||
131167361|NCT00878072|472234491|FG000|Overall Study|Withdrew consent|2|||
131167362|NCT01954121|472234495|FG000|Overall Study|Lack of Efficacy|94|||
131167363|NCT01954121|472234496|FG001|Overall Study|Lack of Efficacy|41|||
131167364|NCT01954121|472234495|FG000|Overall Study|Protocol Violation|0|||
131167365|NCT01954121|472234496|FG001|Overall Study|Protocol Violation|2|||
131167366|NCT01954121|472234495|FG000|Overall Study|Lost to Follow-up|5|||
131167367|NCT01954121|472234496|FG001|Overall Study|Lost to Follow-up|6|||
131167368|NCT01954121|472234495|FG000|Overall Study|Withdrawal by Subject|18|||
131167369|NCT01954121|472234496|FG001|Overall Study|Withdrawal by Subject|12|||
131167370|NCT01954121|472234495|FG000|Overall Study|Pregnancy|1|||
131167371|NCT01954121|472234496|FG001|Overall Study|Pregnancy|1|||
131167372|NCT01954121|472234495|FG000|Overall Study|AE, serious fatal|1|||
131167373|NCT01954121|472234496|FG001|Overall Study|AE, serious fatal|0|||
131167374|NCT01954121|472234495|FG000|Overall Study|AE, non-serious non-fatal|5|||
131167375|NCT01954121|472234496|FG001|Overall Study|AE, non-serious non-fatal|22|||
131167376|NCT01954121|472234495|FG000|Overall Study|SAE, non-fatal|1|||
131167377|NCT01954121|472234496|FG001|Overall Study|SAE, non-fatal|4|||
131167378|NCT01954121|472234495|FG000|Overall Study|Non-compliant with study procedures|1|||
131167379|NCT01954121|472234496|FG001|Overall Study|Non-compliant with study procedures|0|||
131167380|NCT01954121|472234495|FG000|Overall Study|Non-compliant patient|1|||
131167381|NCT01954121|472234496|FG001|Overall Study|Non-compliant patient|1|||
131167382|NCT01954121|472234495|FG000|Overall Study|Subject did not follow instructions|0|||
131167383|NCT01954121|472234496|FG001|Overall Study|Subject did not follow instructions|2|||
131167384|NCT02588248|472234504|FG000|Overall Study|Physician Decision|4|||
131167385|NCT02588248|472234505|FG001|Overall Study|Physician Decision|3|||
131167386|NCT01355068|472234508|FG000|First Intervention Period|Adverse Event|0|||
131167387|NCT01355068|472234509|FG001|First Intervention Period|Adverse Event|1|||
131167388|NCT01355068|472234508|FG000|First Intervention Period|Withdrawal by Subject|0|||
131167389|NCT01355068|472234509|FG001|First Intervention Period|Withdrawal by Subject|1|||
131167390|NCT02504892|472234510|FG000|Overall Study|Adverse event-pneumonitis|2|||
131167391|NCT00524745|472234511|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
131167392|NCT00524745|472234512|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
131167393|NCT00524745|472234513|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
131167394|NCT00524745|472234514|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
131167395|NCT01413178|472234515|FG000|Overall Study|Toxicity|1|||
131167396|NCT01413178|472234516|FG001|Overall Study|Toxicity|0|||
131167397|NCT01413178|472234515|FG000|Overall Study|Ineligible|0|||
131167398|NCT01413178|472234516|FG001|Overall Study|Ineligible|2|||
131167399|NCT00576693|472234517|FG000|Overall Study|Lost to Follow-up|7|||
131167400|NCT00576693|472234518|FG001|Overall Study|Lost to Follow-up|11|||
131167401|NCT00576693|472234517|FG000|Overall Study|Withdrawal by Subject|3|||
131167402|NCT00576693|472234518|FG001|Overall Study|Withdrawal by Subject|13|||
131167403|NCT00804193|472234519|FG000|Overall Study|Lack of baseline fungus|32|||
131167404|NCT00804193|472234520|FG001|Overall Study|Lack of baseline fungus|31|||
131167405|NCT00804193|472234521|FG002|Overall Study|Lack of baseline fungus|19|||
131167406|NCT00804193|472234519|FG000|Overall Study|Adverse Event|0|||
131167407|NCT00804193|472234520|FG001|Overall Study|Adverse Event|0|||
131167408|NCT00804193|472234521|FG002|Overall Study|Adverse Event|2|||
131167409|NCT00804193|472234519|FG000|Overall Study|Lack of Efficacy|1|||
131167410|NCT00804193|472234520|FG001|Overall Study|Lack of Efficacy|1|||
131167411|NCT00804193|472234521|FG002|Overall Study|Lack of Efficacy|3|||
131167412|NCT00804193|472234519|FG000|Overall Study|Protocol Violation|0|||
131167413|NCT00804193|472234520|FG001|Overall Study|Protocol Violation|8|||
131167414|NCT00804193|472234521|FG002|Overall Study|Protocol Violation|2|||
131167415|NCT00804193|472234519|FG000|Overall Study|Lost to Follow-up|3|||
131167416|NCT00804193|472234520|FG001|Overall Study|Lost to Follow-up|3|||
131167417|NCT00804193|472234521|FG002|Overall Study|Lost to Follow-up|4|||
131167418|NCT00804193|472234519|FG000|Overall Study|Withdrawal by Subject|3|||
131167419|NCT00804193|472234520|FG001|Overall Study|Withdrawal by Subject|1|||
131167420|NCT00804193|472234521|FG002|Overall Study|Withdrawal by Subject|2|||
131167421|NCT04072146|472234522|FG000|Overall Study|Adverse Event|0|||
131167422|NCT04072146|472234523|FG001|Overall Study|Adverse Event|1|||
131167423|NCT01987986|472234524|FG000|Overall Study|Lost to Follow-up|1|||
131167424|NCT01987986|472234525|FG001|Overall Study|Lost to Follow-up|0|||
131167425|NCT01987986|472234526|FG002|Overall Study|Lost to Follow-up|0|||
131167426|NCT01987986|472234527|FG003|Overall Study|Lost to Follow-up|0|||
131167427|NCT01987986|472234524|FG000|Overall Study|Adverse Event|1|||
131167428|NCT01987986|472234525|FG001|Overall Study|Adverse Event|0|||
131167429|NCT01987986|472234526|FG002|Overall Study|Adverse Event|2|||
131167430|NCT01987986|472234527|FG003|Overall Study|Adverse Event|0|||
131167431|NCT03987620|472234535|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
131167432|NCT03987620|472234536|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
131167433|NCT03987620|472234535|FG000|Overall Study|Adverse Event|3|||
131167434|NCT03987620|472234536|FG001|Overall Study|Adverse Event|0|||
131167435|NCT03987620|472234535|FG000|Overall Study|Lost to Follow-up|1|||
131167436|NCT03987620|472234536|FG001|Overall Study|Lost to Follow-up|2|||
131167437|NCT03987620|472234535|FG000|Overall Study|Physician Decision|0|||
131167438|NCT03987620|472234536|FG001|Overall Study|Physician Decision|1|||
131167439|NCT03987620|472234535|FG000|Overall Study|Pregnancy|1|||
131167440|NCT03987620|472234536|FG001|Overall Study|Pregnancy|0|||
131167441|NCT03987620|472234535|FG000|Overall Study|Withdrawal by Subject|7|||
131167442|NCT03987620|472234536|FG001|Overall Study|Withdrawal by Subject|1|||
131167443|NCT03987620|472234535|FG000|Overall Study|Other|2|||
131167444|NCT03987620|472234536|FG001|Overall Study|Other|5|||
131167445|NCT05128162|472234539|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
131167446|NCT05128162|472234539|FG000|Overall Study|Physician Decision|1|||
131167447|NCT05306873|472236280|FG000|Stage 2|Study stopped|1|||
131167448|NCT05306873|472236281|FG001|Stage 2|Study stopped|1|||
131167449|NCT05306873|472236282|FG002|Stage 2|Study stopped|0|||
131167450|NCT05306873|472236283|FG003|Stage 2|Study stopped|0|||
131167451|NCT05306873|472236280|FG000|Stage 2|Stage 2 Treatment Failure|2|||
131167452|NCT05306873|472236281|FG001|Stage 2|Stage 2 Treatment Failure|3|||
131167453|NCT05306873|472236282|FG002|Stage 2|Stage 2 Treatment Failure|0|||
131167454|NCT05306873|472236283|FG003|Stage 2|Stage 2 Treatment Failure|0|||
131167455|NCT05306873|472236280|FG000|Stage 2|Logistical issues due to participant moving|1|||
131167456|NCT05306873|472236281|FG001|Stage 2|Logistical issues due to participant moving|0|||
131167457|NCT05306873|472236282|FG002|Stage 2|Logistical issues due to participant moving|0|||
131167458|NCT05306873|472236283|FG003|Stage 2|Logistical issues due to participant moving|0|||
131167459|NCT05306873|472236280|FG000|Stage 3|Stage 3 Treatment Failure|0|||
131167460|NCT05306873|472236281|FG001|Stage 3|Stage 3 Treatment Failure|0|||
131167461|NCT05306873|472236282|FG002|Stage 3|Stage 3 Treatment Failure|0|||
131167462|NCT05306873|472236283|FG003|Stage 3|Stage 3 Treatment Failure|1|||
131167463|NCT05306873|472236280|FG000|Stage 3|Study Stopped|0|||
131167464|NCT05306873|472236281|FG001|Stage 3|Study Stopped|0|||
131167465|NCT05306873|472236282|FG002|Stage 3|Study Stopped|1|||
131167466|NCT05306873|472236283|FG003|Stage 3|Study Stopped|0|||
131167467|NCT00074412|472236285|FG000|Overall Study|Death|30|||
131167468|NCT00074412|472236286|FG001|Overall Study|Death|26|||
131167469|NCT00074412|472236285|FG000|Overall Study|Lost to Follow-up|52|||
131167470|NCT00074412|472236286|FG001|Overall Study|Lost to Follow-up|58|||
131167471|NCT01953328|472236287|FG000|Overall Study|Withdrawal by Subject|0|||
131167472|NCT01953328|472236288|FG001|Overall Study|Withdrawal by Subject|0|||
131167473|NCT01953328|472236289|FG002|Overall Study|Withdrawal by Subject|0|||
131167474|NCT01953328|472236290|FG003|Overall Study|Withdrawal by Subject|0|||
131167475|NCT01953328|472236291|FG004|Overall Study|Withdrawal by Subject|1|||
131167476|NCT01953328|472236292|FG005|Overall Study|Withdrawal by Subject|0|||
131167477|NCT01953328|472236293|FG006|Overall Study|Withdrawal by Subject|0|||
131167478|NCT01953328|472236294|FG007|Overall Study|Withdrawal by Subject|0|||
131167479|NCT01953328|472236287|FG000|Overall Study|Lost to Follow-up|0|||
131167480|NCT01953328|472236288|FG001|Overall Study|Lost to Follow-up|0|||
131167481|NCT01953328|472236289|FG002|Overall Study|Lost to Follow-up|0|||
131167482|NCT01953328|472236290|FG003|Overall Study|Lost to Follow-up|0|||
131167483|NCT01953328|472236291|FG004|Overall Study|Lost to Follow-up|1|||
131167484|NCT01953328|472236292|FG005|Overall Study|Lost to Follow-up|0|||
131167485|NCT01953328|472236293|FG006|Overall Study|Lost to Follow-up|0|||
131167486|NCT01953328|472236294|FG007|Overall Study|Lost to Follow-up|0|||
131167487|NCT02626819|472236297|FG000|Overall Study|Lost to Follow-up|3|||
131167488|NCT02626819|472236298|FG001|Overall Study|Lost to Follow-up|2|||
131167489|NCT02626819|472236297|FG000|Overall Study|Withdrawal by Subject|1|||
131167490|NCT02626819|472236298|FG001|Overall Study|Withdrawal by Subject|0|||
131167491|NCT02626819|472236297|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
131167492|NCT02626819|472236298|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
131167493|NCT01441440|472236304|FG000|Overall Study|Death|1|||
131167494|NCT01441440|472236305|FG001|Overall Study|Death|0|||
131167495|NCT01441440|472236306|FG002|Overall Study|Death|1|||
131167496|NCT01441440|472236304|FG000|Overall Study|Adverse Event|2|||
131167497|NCT01441440|472236305|FG001|Overall Study|Adverse Event|9|||
131167498|NCT01441440|472236306|FG002|Overall Study|Adverse Event|9|||
131167499|NCT01441440|472236304|FG000|Overall Study|Lost to Follow-up|0|||
131167500|NCT01441440|472236305|FG001|Overall Study|Lost to Follow-up|2|||
131167501|NCT01441440|472236306|FG002|Overall Study|Lost to Follow-up|1|||
131167502|NCT01441440|472236304|FG000|Overall Study|Withdrawal by Subject|11|||
131167503|NCT01441440|472236305|FG001|Overall Study|Withdrawal by Subject|9|||
131167504|NCT01441440|472236306|FG002|Overall Study|Withdrawal by Subject|9|||
131167505|NCT01441440|472236304|FG000|Overall Study|Pregnancy|1|||
131167506|NCT01441440|472236305|FG001|Overall Study|Pregnancy|0|||
131167507|NCT01441440|472236306|FG002|Overall Study|Pregnancy|0|||
131167508|NCT01441440|472236304|FG000|Overall Study|Lack of Efficacy|1|||
131167509|NCT01441440|472236305|FG001|Overall Study|Lack of Efficacy|0|||
131167510|NCT01441440|472236306|FG002|Overall Study|Lack of Efficacy|1|||
131167511|NCT01441440|472236304|FG000|Overall Study|Moving|0|||
131167512|NCT01441440|472236305|FG001|Overall Study|Moving|1|||
131167513|NCT01441440|472236306|FG002|Overall Study|Moving|1|||
131167514|NCT01441440|472236304|FG000|Overall Study|Work-related matter|0|||
131167515|NCT01441440|472236305|FG001|Overall Study|Work-related matter|1|||
131167516|NCT01441440|472236306|FG002|Overall Study|Work-related matter|0|||
131167517|NCT01441440|472236304|FG000|Overall Study|Difficllty in keeping the schedule|1|||
131167518|NCT01441440|472236305|FG001|Overall Study|Difficllty in keeping the schedule|1|||
131167519|NCT01441440|472236306|FG002|Overall Study|Difficllty in keeping the schedule|0|||
131167520|NCT01251276|472236307|FG000|Overall Study|Protocol Violation|1|||
131167521|NCT01251276|472236308|FG001|Overall Study|Protocol Violation|0|||
131167522|NCT01251276|472236307|FG000|Overall Study|Lost to Follow-up|0|||
131167523|NCT01251276|472236308|FG001|Overall Study|Lost to Follow-up|1|||
131167524|NCT00366548|472236309|FG000|Infant Series|Adverse Event|1|||
131167525|NCT00366548|472236310|FG001|Infant Series|Adverse Event|3|||
131167526|NCT00366548|472236309|FG000|Infant Series|Protocol Violation|0|||
131167527|NCT00366548|472236310|FG001|Infant Series|Protocol Violation|1|||
131167528|NCT00366548|472236309|FG000|Infant Series|Withdrawal by Subject|3|||
131167529|NCT00366548|472236310|FG001|Infant Series|Withdrawal by Subject|1|||
131167530|NCT00366548|472236309|FG000|After Infant Series|Withdrawal by Subject|3|||
131167531|NCT00366548|472236310|FG001|After Infant Series|Withdrawal by Subject|1|||
131167532|NCT00366548|472236309|FG000|After Infant Series|Adverse Event|2|||
131167533|NCT00366548|472236310|FG001|After Infant Series|Adverse Event|0|||
131167534|NCT00366548|472236309|FG000|After Infant Series|Lost to Follow-up|1|||
131167535|NCT00366548|472236310|FG001|After Infant Series|Lost to Follow-up|0|||
131167536|NCT02849990|472236311|FG000|Overall Study|Adverse Event|1|||
131167537|NCT02849990|472236311|FG000|Overall Study|Withdrawal by Subject|1|||
131167538|NCT01051986|472236313|FG000|Overall Study|Death|1|||
131167539|NCT01051986|472236314|FG001|Overall Study|Death|0|||
131167540|NCT01051986|472236313|FG000|Overall Study|Withdrawal by Subject|2|||
131167541|NCT01051986|472236314|FG001|Overall Study|Withdrawal by Subject|1|||
131167542|NCT01051986|472236313|FG000|Overall Study|Protocol Violation|2|||
131167543|NCT01051986|472236314|FG001|Overall Study|Protocol Violation|3|||
131167544|NCT02273752|472236316|FG000|Overall Study|Trial was terminated early|2|||
131167545|NCT01111539|472236317|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
131167546|NCT01111539|472236318|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131167547|NCT01111539|472236319|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131167548|NCT01111539|472236320|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131167549|NCT01111539|472236321|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
131167550|NCT01111539|472236317|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
131167551|NCT01111539|472236318|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131167552|NCT01111539|472236319|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131167553|NCT01111539|472236320|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131167554|NCT01111539|472236321|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
131167555|NCT01111539|472236317|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
131167556|NCT01111539|472236318|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131167557|NCT01111539|472236319|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131167558|NCT01111539|472236320|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131167559|NCT01111539|472236321|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
131167560|NCT01111539|472236317|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
131167561|NCT01111539|472236318|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
131167562|NCT01111539|472236319|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
131167563|NCT01111539|472236320|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
131167564|NCT01111539|472236321|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
131167565|NCT01111539|472236317|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
131167566|NCT01111539|472236318|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
131167567|NCT01111539|472236319|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
131167568|NCT01111539|472236320|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
131167569|NCT01111539|472236321|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
131167570|NCT01111539|472236317|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
131167571|NCT01111539|472236318|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131167572|NCT01111539|472236319|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131167573|NCT01111539|472236320|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131167574|NCT01111539|472236321|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
131167575|NCT01111539|472236317|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
131167576|NCT01111539|472236318|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
131167577|NCT01111539|472236319|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
131167578|NCT01111539|472236320|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
131167579|NCT01111539|472236321|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
131167580|NCT01111539|472236317|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
131167581|NCT01111539|472236318|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
131167582|NCT01111539|472236319|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
131167583|NCT01111539|472236320|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
131167584|NCT01111539|472236321|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
131167585|NCT01111539|472236317|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131167586|NCT01111539|472236318|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131167587|NCT01111539|472236319|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
131167588|NCT01111539|472236320|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
131167589|NCT01111539|472236321|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
131167590|NCT01111539|472236317|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
130729556|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
130729557|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
130729558|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
130729559|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
130729560|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
130729561|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
130729562|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130729563|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130729564|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
130729565|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
130729566|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
130729567|NCT04856930|470633580|FG000|Extension Period (16 Weeks)|Other than specified|0|||
130729568|NCT04856930|470633581|FG001|Extension Period (16 Weeks)|Other than specified|0|||
130729569|NCT04856930|470633582|FG002|Extension Period (16 Weeks)|Other than specified|1|||
130729570|NCT04856930|470633580|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
130729571|NCT04856930|470633581|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
130729572|NCT04856930|470633582|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
130729573|NCT04856930|470633580|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
130729574|NCT04856930|470633581|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
130729575|NCT04856930|470633582|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
130729576|NCT04856930|470633580|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
130729577|NCT04856930|470633581|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
130729578|NCT04856930|470633582|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
130729579|NCT04856930|470633580|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
130729580|NCT04856930|470633581|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
130729581|NCT04856930|470633582|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
130729582|NCT00678210|470633583|FG000|Overall Study|Adverse Event|1|||
130729583|NCT00678210|470633584|FG001|Overall Study|Adverse Event|2|||
130729584|NCT00678210|470633585|FG002|Overall Study|Adverse Event|3|||
130729585|NCT00678210|470633586|FG003|Overall Study|Adverse Event|3|||
130729586|NCT00678210|470633583|FG000|Overall Study|Lack of Efficacy|2|||
130729587|NCT00678210|470633584|FG001|Overall Study|Lack of Efficacy|3|||
131167591|NCT01111539|472236318|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
131167592|NCT01111539|472236319|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
131167593|NCT01111539|472236320|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
131167594|NCT01111539|472236321|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
131167595|NCT01111539|472236317|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
131167596|NCT01111539|472236318|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
131167597|NCT01111539|472236319|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
131167598|NCT01111539|472236320|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
131167599|NCT01111539|472236321|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
131167600|NCT01111539|472236317|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
131167601|NCT01111539|472236318|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
131167602|NCT01111539|472236319|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
131167603|NCT01111539|472236320|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
131167604|NCT01111539|472236321|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
131167605|NCT01111539|472236317|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
131167606|NCT01111539|472236318|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
131167607|NCT01111539|472236319|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
131167608|NCT01111539|472236320|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
131167609|NCT01111539|472236321|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
131167610|NCT01111539|472236317|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131167611|NCT01111539|472236318|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131167612|NCT01111539|472236319|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130729588|NCT00678210|470633585|FG002|Overall Study|Lack of Efficacy|1|||
130729589|NCT00678210|470633586|FG003|Overall Study|Lack of Efficacy|9|||
130729590|NCT00678210|470633583|FG000|Overall Study|Lost to Follow-up|4|||
131167613|NCT01111539|472236320|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
131167614|NCT01111539|472236321|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
131167615|NCT03628417|472236322|FG000|Overall Study|Death|1|||
131167616|NCT03628417|472236323|FG001|Overall Study|Death|1|||
130729591|NCT00678210|470633584|FG001|Overall Study|Lost to Follow-up|2|||
130729592|NCT00678210|470633585|FG002|Overall Study|Lost to Follow-up|0|||
130729593|NCT00678210|470633586|FG003|Overall Study|Lost to Follow-up|1|||
131167617|NCT02297438|472236324|FG000|Overall Study|Death|79|||
131167618|NCT02297438|472236325|FG001|Overall Study|Death|86|||
131167619|NCT02297438|472236324|FG000|Overall Study|Lost to Follow-up|9|||
131167620|NCT02297438|472236325|FG001|Overall Study|Lost to Follow-up|7|||
131167621|NCT02297438|472236324|FG000|Overall Study|Withdrawal by Subject|7|||
131167622|NCT02297438|472236325|FG001|Overall Study|Withdrawal by Subject|0|||
131167623|NCT02297438|472236324|FG000|Overall Study|Other|9|||
131167624|NCT02297438|472236325|FG001|Overall Study|Other|5|||
131167625|NCT02297438|472236324|FG000|Overall Study|Ongoing|65|||
131167626|NCT02297438|472236325|FG001|Overall Study|Ongoing|73|||
131167627|NCT02042404|472236331|FG000|Overall Study|Death|1|||
131167628|NCT02042404|472236332|FG001|Overall Study|Death|0|||
131167629|NCT02042404|472236331|FG000|Overall Study|Unrelated Adverse Event|3|||
131167630|NCT02042404|472236332|FG001|Overall Study|Unrelated Adverse Event|0|||
131167631|NCT02042404|472236331|FG000|Overall Study|Inability to meet time requirements|1|||
131167632|NCT02042404|472236332|FG001|Overall Study|Inability to meet time requirements|0|||
131167633|NCT00372190|472236333|FG000|Overall Study|Lost to Follow-up|3|||
131167634|NCT00372190|472236334|FG001|Overall Study|Lost to Follow-up|1|||
131167635|NCT01623531|472236335|FG000|Overall Study|Death|1|||
131167636|NCT01623531|472236336|FG001|Overall Study|Death|0|||
131167637|NCT01623531|472236335|FG000|Overall Study|Protocol Violation|2|||
131167638|NCT01623531|472236336|FG001|Overall Study|Protocol Violation|1|||
131167639|NCT01623531|472236335|FG000|Overall Study|Missing data at primary outcome time poi|1|||
131167640|NCT01623531|472236336|FG001|Overall Study|Missing data at primary outcome time poi|1|||
131167641|NCT01429792|472236337|FG000|Overall Study|Other Reasons|67|||
131167642|NCT01429792|472236337|FG000|Overall Study|Unknown Disposition|94|||
131167643|NCT01429792|472236337|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
131167644|NCT01429792|472236337|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
131167645|NCT01429792|472236337|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
131167646|NCT01429792|472236337|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
131167647|NCT01429792|472236337|FG000|Overall Study|Withdrawal by Subject|70|||
131167648|NCT01429792|472236337|FG000|Overall Study|Lost to Follow-up|88|||
131167649|NCT01617681|472236339|FG000|Period 1 Double Blind|Adverse Event|2|||
131167650|NCT01617681|472236340|FG001|Period 1 Double Blind|Adverse Event|0|||
131167651|NCT01617681|472236341|FG002|Period 1 Double Blind|Adverse Event|0|||
131167652|NCT01617681|472236342|FG003|Period 1 Double Blind|Adverse Event|2|||
131167653|NCT01617681|472236343|FG004|Period 1 Double Blind|Adverse Event|0|||
131167654|NCT01617681|472236339|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
131167655|NCT01617681|472236340|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
131167656|NCT01617681|472236341|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
131167657|NCT01617681|472236342|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
131167658|NCT01617681|472236343|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
131167659|NCT01617681|472236339|FG000|Period 2 Open Label|Adverse Event|0|||
131167660|NCT01617681|472236340|FG001|Period 2 Open Label|Adverse Event|0|||
131167661|NCT01617681|472236341|FG002|Period 2 Open Label|Adverse Event|0|||
131167662|NCT01617681|472236342|FG003|Period 2 Open Label|Adverse Event|0|||
131167663|NCT01617681|472236343|FG004|Period 2 Open Label|Adverse Event|3|||
131167664|NCT01617681|472236339|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
131167665|NCT01617681|472236340|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
131167666|NCT01617681|472236341|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
131167667|NCT01617681|472236342|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
131167668|NCT01617681|472236343|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
131167669|NCT01856595|472236346|FG000|Overall Study|Withdrawal by Subject|0|||
131167670|NCT01856595|472236347|FG001|Overall Study|Withdrawal by Subject|1|||
131167671|NCT01856595|472236348|FG002|Overall Study|Withdrawal by Subject|0|||
131167672|NCT01856595|472236349|FG003|Overall Study|Withdrawal by Subject|0|||
131167673|NCT01856595|472236350|FG004|Overall Study|Withdrawal by Subject|0|||
131167674|NCT01856595|472236351|FG005|Overall Study|Withdrawal by Subject|0|||
131167675|NCT01856595|472236352|FG006|Overall Study|Withdrawal by Subject|1|||
131167676|NCT01856595|472236353|FG007|Overall Study|Withdrawal by Subject|0|||
131167677|NCT01856595|472236354|FG008|Overall Study|Withdrawal by Subject|0|||
131167678|NCT01763905|472236358|FG000|Overall Study|Withdrawal by Subject|1|||
131167679|NCT01763905|472236359|FG001|Overall Study|Withdrawal by Subject|1|||
131167680|NCT01763905|472236360|FG002|Overall Study|Withdrawal by Subject|0|||
131167681|NCT01763905|472236361|FG003|Overall Study|Withdrawal by Subject|1|||
131167682|NCT01763905|472236358|FG000|Overall Study|Decision by sponsor|5|||
131167683|NCT01763905|472236359|FG001|Overall Study|Decision by sponsor|0|||
131167684|NCT01763905|472236360|FG002|Overall Study|Decision by sponsor|8|||
131167685|NCT01763905|472236361|FG003|Overall Study|Decision by sponsor|0|||
131167686|NCT01763905|472236358|FG000|Overall Study|Lost to Follow-up|0|||
131167687|NCT01763905|472236359|FG001|Overall Study|Lost to Follow-up|0|||
131167688|NCT01763905|472236360|FG002|Overall Study|Lost to Follow-up|1|||
131167689|NCT01763905|472236361|FG003|Overall Study|Lost to Follow-up|0|||
131167690|NCT03456713|472236362|FG000|Overall Study|Lost to Follow-up|1|||
131167691|NCT03456713|472236363|FG001|Overall Study|Lost to Follow-up|0|||
131167692|NCT03456713|472236364|FG002|Overall Study|Lost to Follow-up|0|||
131167693|NCT03456713|472236365|FG003|Overall Study|Lost to Follow-up|0|||
131167694|NCT00972478|472236372|FG000|Overall Study|Adverse Event|3|||
131167695|NCT00972478|472236373|FG001|Overall Study|Adverse Event|16|||
131167696|NCT00972478|472236372|FG000|Overall Study|Withdrawal by Subject|1|||
131167697|NCT00972478|472236373|FG001|Overall Study|Withdrawal by Subject|8|||
131167698|NCT00972478|472236372|FG000|Overall Study|Progression/Relapse|0|||
131167699|NCT00972478|472236373|FG001|Overall Study|Progression/Relapse|2|||
131167700|NCT00972478|472236372|FG000|Overall Study|Death|0|||
131167701|NCT00972478|472236373|FG001|Overall Study|Death|2|||
131167702|NCT00972478|472236372|FG000|Overall Study|Not protocol specified|1|||
131167703|NCT00972478|472236373|FG001|Overall Study|Not protocol specified|1|||
131167704|NCT00972478|472236372|FG000|Overall Study|Ineligible|1|||
131167705|NCT00972478|472236373|FG001|Overall Study|Ineligible|7|||
131167706|NCT00972478|472236372|FG000|Overall Study|Not start protocol treatment|1|||
131167707|NCT00972478|472236373|FG001|Overall Study|Not start protocol treatment|2|||
131167708|NCT02561000|472236374|FG000|Overall Study|Withdrawal by Subject|2|||
131167709|NCT02561000|472236375|FG001|Overall Study|Withdrawal by Subject|3|||
131167710|NCT02561000|472236376|FG002|Overall Study|Withdrawal by Subject|0|||
131167711|NCT02561000|472236374|FG000|Overall Study|Adverse Event|0|||
131167712|NCT02561000|472236375|FG001|Overall Study|Adverse Event|1|||
131167713|NCT02561000|472236376|FG002|Overall Study|Adverse Event|0|||
131167714|NCT01522976|472236377|FG000|Overall Study|Ineligible|4|||
131167715|NCT01522976|472236378|FG001|Overall Study|Ineligible|0|||
131167716|NCT01522976|472236379|FG002|Overall Study|Ineligible|1|||
131167717|NCT01522976|472236377|FG000|Overall Study|Death|7|||
131167718|NCT01522976|472236378|FG001|Overall Study|Death|6|||
131167719|NCT01522976|472236379|FG002|Overall Study|Death|2|||
131167720|NCT01522976|472236377|FG000|Overall Study|Still on treatment|9|||
131167721|NCT01522976|472236378|FG001|Overall Study|Still on treatment|9|||
131167722|NCT01522976|472236379|FG002|Overall Study|Still on treatment|6|||
131167723|NCT01522976|472236377|FG000|Overall Study|Disease progression|28|||
131167724|NCT01522976|472236378|FG001|Overall Study|Disease progression|30|||
131167725|NCT01522976|472236379|FG002|Overall Study|Disease progression|25|||
131167726|NCT01522976|472236377|FG000|Overall Study|Adverse Event|17|||
131167727|NCT01522976|472236378|FG001|Overall Study|Adverse Event|7|||
131167728|NCT01522976|472236379|FG002|Overall Study|Adverse Event|18|||
131167729|NCT01522976|472236377|FG000|Overall Study|Refusal unrelated to adverse event|10|||
131167730|NCT01522976|472236378|FG001|Overall Study|Refusal unrelated to adverse event|13|||
131167731|NCT01522976|472236379|FG002|Overall Study|Refusal unrelated to adverse event|14|||
131167732|NCT01522976|472236377|FG000|Overall Study|Not protocol specified|22|||
131167733|NCT01522976|472236378|FG001|Overall Study|Not protocol specified|27|||
131167734|NCT01522976|472236379|FG002|Overall Study|Not protocol specified|27|||
131167735|NCT04075266|472236382|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
131167736|NCT04075266|472236383|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
131167737|NCT04075266|472236382|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
131167738|NCT04075266|472236383|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
131167739|NCT06150573|472236384|FG000|Overall Study|Did not meet study criteria|1|||
131167740|NCT06150573|472236385|FG001|Overall Study|Did not meet study criteria|0|||
131167741|NCT06150573|472236384|FG000|Overall Study|Adverse Event|1|||
131167742|NCT06150573|472236385|FG001|Overall Study|Adverse Event|0|||
131167743|NCT06150573|472236384|FG000|Overall Study|Lost to Follow-up|0|||
131167744|NCT06150573|472236385|FG001|Overall Study|Lost to Follow-up|1|||
131167745|NCT06150573|472236384|FG000|Overall Study|Protocol Violation|0|||
131167746|NCT06150573|472236385|FG001|Overall Study|Protocol Violation|1|||
131167747|NCT06150573|472236384|FG000|Overall Study|Withdrawal by Subject|2|||
131167748|NCT06150573|472236385|FG001|Overall Study|Withdrawal by Subject|0|||
131167749|NCT00069095|472236386|FG000|Primary Treatment Phase|Ongoing|0|||
131167750|NCT00069095|472236387|FG001|Primary Treatment Phase|Ongoing|0|||
131167751|NCT00069095|472236388|FG002|Primary Treatment Phase|Ongoing|5|||
131167752|NCT00069095|472236389|FG003|Primary Treatment Phase|Ongoing|7|||
131167753|NCT00069095|472236390|FG004|Primary Treatment Phase|Ongoing|7|||
131167754|NCT00069095|472236391|FG005|Primary Treatment Phase|Ongoing|4|||
131167755|NCT00069095|472236386|FG000|Primary Treatment Phase|Admin/Other|29|||
131167756|NCT00069095|472236387|FG001|Primary Treatment Phase|Admin/Other|38|||
131167757|NCT00069095|472236388|FG002|Primary Treatment Phase|Admin/Other|31|||
131167758|NCT00069095|472236389|FG003|Primary Treatment Phase|Admin/Other|45|||
131167759|NCT00069095|472236390|FG004|Primary Treatment Phase|Admin/Other|48|||
131167760|NCT00069095|472236391|FG005|Primary Treatment Phase|Admin/Other|42|||
131167761|NCT00069095|472236386|FG000|Primary Treatment Phase|Adverse Event|99|||
131167762|NCT00069095|472236387|FG001|Primary Treatment Phase|Adverse Event|92|||
131235628|NCT03500484|472490976|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
131235629|NCT02795104|472490977|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
131167763|NCT00069095|472236388|FG002|Primary Treatment Phase|Adverse Event|71|||
131167764|NCT00069095|472236389|FG003|Primary Treatment Phase|Adverse Event|72|||
131167765|NCT00069095|472236390|FG004|Primary Treatment Phase|Adverse Event|109|||
131167766|NCT00069095|472236391|FG005|Primary Treatment Phase|Adverse Event|101|||
131167767|NCT00069095|472236386|FG000|Primary Treatment Phase|Death|14|||
131167768|NCT00069095|472236387|FG001|Primary Treatment Phase|Death|8|||
131167769|NCT00069095|472236388|FG002|Primary Treatment Phase|Death|2|||
131167770|NCT00069095|472236389|FG003|Primary Treatment Phase|Death|5|||
131167771|NCT00069095|472236390|FG004|Primary Treatment Phase|Death|8|||
131167772|NCT00069095|472236391|FG005|Primary Treatment Phase|Death|8|||
131167773|NCT00069095|472236386|FG000|Primary Treatment Phase|Failure to return|5|||
131167774|NCT00069095|472236387|FG001|Primary Treatment Phase|Failure to return|5|||
131167775|NCT00069095|472236388|FG002|Primary Treatment Phase|Failure to return|0|||
131167776|NCT00069095|472236389|FG003|Primary Treatment Phase|Failure to return|0|||
131167777|NCT00069095|472236390|FG004|Primary Treatment Phase|Failure to return|0|||
131167778|NCT00069095|472236391|FG005|Primary Treatment Phase|Failure to return|2|||
131167779|NCT00069095|472236386|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
131167780|NCT00069095|472236387|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
131167781|NCT00069095|472236388|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
131167782|NCT00069095|472236389|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
131167783|NCT00069095|472236390|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
130729594|NCT00678210|470633583|FG000|Overall Study|Withdrawal by Subject|3|||
130729595|NCT00678210|470633584|FG001|Overall Study|Withdrawal by Subject|4|||
130729596|NCT00678210|470633585|FG002|Overall Study|Withdrawal by Subject|1|||
130729597|NCT00678210|470633586|FG003|Overall Study|Withdrawal by Subject|7|||
130729598|NCT00678210|470633583|FG000|Overall Study|Other|1|||
130729599|NCT00678210|470633584|FG001|Overall Study|Other|0|||
130729600|NCT00678210|470633585|FG002|Overall Study|Other|1|||
130729601|NCT00678210|470633586|FG003|Overall Study|Other|0|||
130729602|NCT04825912|470633587|FG000|Overall Study|Death|3|||
130729603|NCT04825912|470633587|FG000|Overall Study|Withdrawal by Subject|1|||
130729604|NCT00974922|470633588|FG000|Overall Study|study terminated|24|||
130729605|NCT03965689|470633591|FG000|Overall Study|Too sick to get study intervention|2|||
130729606|NCT03022084|470633592|FG000|Overall Study|Lost to Follow-up|2|||
130729607|NCT03022084|470633593|FG001|Overall Study|Lost to Follow-up|3|||
130729608|NCT01173120|470633594|FG000|Overall Study|Lack of Efficacy|2|||
130729609|NCT01173120|470633594|FG000|Overall Study|Lost to Follow-up|1|||
130729610|NCT01173120|470633594|FG000|Overall Study|Participant Decision|2|||
130729611|NCT01173120|470633594|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
130729612|NCT01173120|470633594|FG000|Overall Study|Switch-Participant Decision|12|||
130729613|NCT01173120|470633594|FG000|Overall Study|Switch-Difficulty With Device|12|||
130729614|NCT00113763|470633595|FG000|Overall Study|Adverse Event|5|||
130729615|NCT00113763|470633596|FG001|Overall Study|Adverse Event|2|||
130729616|NCT00113763|470633595|FG000|Overall Study|Disease Progression|28|||
130729617|NCT00113763|470633596|FG001|Overall Study|Disease Progression|14|||
130729618|NCT00113763|470633595|FG000|Overall Study|Lost to Follow-up|10|||
130729619|NCT00113763|470633596|FG001|Overall Study|Lost to Follow-up|0|||
130729620|NCT00113763|470633595|FG000|Overall Study|Withdrawal by Subject|1|||
130729621|NCT00113763|470633596|FG001|Overall Study|Withdrawal by Subject|4|||
130729622|NCT00113763|470633595|FG000|Overall Study|Other|27|||
130729623|NCT00113763|470633596|FG001|Overall Study|Other|6|||
130729624|NCT00113763|470633595|FG000|Overall Study|Non-compliance|1|||
130729625|NCT00113763|470633596|FG001|Overall Study|Non-compliance|0|||
130729626|NCT00113763|470633595|FG000|Overall Study|Ongoing|1|||
130729627|NCT00113763|470633596|FG001|Overall Study|Ongoing|0|||
130729628|NCT01207583|470633597|FG000|Overall Study|Withdrawal by Subject|0|||
130729629|NCT01207583|470633598|FG001|Overall Study|Withdrawal by Subject|3|||
131167784|NCT00069095|472236391|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
131167785|NCT00069095|472236386|FG000|Primary Treatment Phase|Refused treatment|15|||
131167786|NCT00069095|472236387|FG001|Primary Treatment Phase|Refused treatment|26|||
131167787|NCT00069095|472236388|FG002|Primary Treatment Phase|Refused treatment|17|||
131167788|NCT00069095|472236389|FG003|Primary Treatment Phase|Refused treatment|31|||
131167789|NCT00069095|472236390|FG004|Primary Treatment Phase|Refused treatment|24|||
131167790|NCT00069095|472236391|FG005|Primary Treatment Phase|Refused treatment|27|||
131167791|NCT00069095|472236386|FG000|Primary Treatment Phase|Withdrew|2|||
131167792|NCT00069095|472236387|FG001|Primary Treatment Phase|Withdrew|3|||
131167793|NCT00069095|472236388|FG002|Primary Treatment Phase|Withdrew|8|||
131167794|NCT00069095|472236389|FG003|Primary Treatment Phase|Withdrew|2|||
130729630|NCT01207583|470633599|FG002|Overall Study|Withdrawal by Subject|1|||
130729631|NCT01207583|470633597|FG000|Overall Study|Participant failed to return|1|||
130729632|NCT01207583|470633598|FG001|Overall Study|Participant failed to return|0|||
131167795|NCT00069095|472236390|FG004|Primary Treatment Phase|Withdrew|4|||
130729633|NCT01207583|470633599|FG002|Overall Study|Participant failed to return|0|||
130729634|NCT01207583|470633597|FG000|Overall Study|Lost to Follow-up|0|||
130729635|NCT01207583|470633598|FG001|Overall Study|Lost to Follow-up|2|||
130729636|NCT01207583|470633599|FG002|Overall Study|Lost to Follow-up|0|||
131167796|NCT00069095|472236391|FG005|Primary Treatment Phase|Withdrew|9|||
131235630|NCT02795104|472490978|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
130729637|NCT01383707|470633600|FG000|Overall Study|Consent withdrawal|6|||
130729638|NCT01383707|470633600|FG000|Overall Study|Death|19|||
130729639|NCT01383707|470633600|FG000|Overall Study|Other|8|||
130729640|NCT01383707|470633600|FG000|Overall Study|Sponsor's decision|2|||
130729641|NCT01383707|470633600|FG000|Overall Study|Adverse Event|14|||
130729642|NCT01383707|470633600|FG000|Overall Study|Progressive disease|23|||
130729643|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
131167797|NCT00069095|472236386|FG000|Primary Treatment Phase|Other Violation|0|||
131167798|NCT00069095|472236387|FG001|Primary Treatment Phase|Other Violation|1|||
131167799|NCT00069095|472236388|FG002|Primary Treatment Phase|Other Violation|1|||
131167800|NCT00069095|472236389|FG003|Primary Treatment Phase|Other Violation|1|||
131167801|NCT00069095|472236390|FG004|Primary Treatment Phase|Other Violation|0|||
131167802|NCT00069095|472236391|FG005|Primary Treatment Phase|Other Violation|1|||
131167803|NCT00069095|472236386|FG000|Primary Treatment Phase|Violation criteria|0|||
131167804|NCT00069095|472236387|FG001|Primary Treatment Phase|Violation criteria|2|||
131167805|NCT00069095|472236388|FG002|Primary Treatment Phase|Violation criteria|4|||
131167806|NCT00069095|472236389|FG003|Primary Treatment Phase|Violation criteria|3|||
131167807|NCT00069095|472236390|FG004|Primary Treatment Phase|Violation criteria|1|||
131167808|NCT00069095|472236391|FG005|Primary Treatment Phase|Violation criteria|5|||
131167809|NCT00069095|472236386|FG000|Post-study Treatment Phase|Missing reason|1|||
131167810|NCT00069095|472236387|FG001|Post-study Treatment Phase|Missing reason|3|||
131167811|NCT00069095|472236388|FG002|Post-study Treatment Phase|Missing reason|12|||
131167812|NCT00069095|472236389|FG003|Post-study Treatment Phase|Missing reason|8|||
131167813|NCT00069095|472236390|FG004|Post-study Treatment Phase|Missing reason|18|||
131167814|NCT00069095|472236391|FG005|Post-study Treatment Phase|Missing reason|17|||
131167815|NCT00069095|472236386|FG000|Post-study Treatment Phase|Adverse Event|2|||
131167816|NCT00069095|472236387|FG001|Post-study Treatment Phase|Adverse Event|3|||
131167817|NCT00069095|472236388|FG002|Post-study Treatment Phase|Adverse Event|1|||
131167818|NCT00069095|472236389|FG003|Post-study Treatment Phase|Adverse Event|0|||
131167819|NCT00069095|472236390|FG004|Post-study Treatment Phase|Adverse Event|5|||
131167820|NCT00069095|472236391|FG005|Post-study Treatment Phase|Adverse Event|1|||
131167821|NCT00069095|472236386|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
131167822|NCT00069095|472236387|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
131167823|NCT00069095|472236388|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
131167824|NCT00069095|472236389|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
131167825|NCT00069095|472236390|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
131167826|NCT00069095|472236391|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
131167827|NCT00069095|472236386|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
131167828|NCT00069095|472236387|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
131167829|NCT00069095|472236388|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
131167830|NCT00069095|472236389|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
131167831|NCT00069095|472236390|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
131167832|NCT00069095|472236391|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
131167833|NCT00069095|472236386|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
131167834|NCT00069095|472236387|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
131167835|NCT00069095|472236388|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
131167836|NCT00069095|472236389|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
131167837|NCT00069095|472236390|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
131167838|NCT00069095|472236391|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
131167839|NCT00069095|472236386|FG000|Post-study Treatment Phase|Participant had complete response|1|||
131167840|NCT00069095|472236387|FG001|Post-study Treatment Phase|Participant had complete response|1|||
131167841|NCT00069095|472236388|FG002|Post-study Treatment Phase|Participant had complete response|0|||
131167842|NCT00069095|472236389|FG003|Post-study Treatment Phase|Participant had complete response|0|||
131167843|NCT00069095|472236390|FG004|Post-study Treatment Phase|Participant had complete response|0|||
131167844|NCT00069095|472236391|FG005|Post-study Treatment Phase|Participant had complete response|0|||
131167845|NCT00069095|472236386|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
131167846|NCT00069095|472236387|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
131167847|NCT00069095|472236388|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
131167848|NCT00069095|472236389|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
131167849|NCT00069095|472236390|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
131167850|NCT00069095|472236391|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
131167851|NCT00069095|472236386|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
131167852|NCT00069095|472236387|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
131167853|NCT00069095|472236388|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
131167854|NCT00069095|472236389|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
131167855|NCT00069095|472236390|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
131167856|NCT00069095|472236391|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
131167857|NCT00069095|472236386|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
131167858|NCT00069095|472236387|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
131167859|NCT00069095|472236388|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
131167860|NCT00069095|472236389|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
131167861|NCT00069095|472236390|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
131167862|NCT00069095|472236391|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
131167863|NCT00069095|472236386|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
131167864|NCT00069095|472236387|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
131167865|NCT00069095|472236388|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
131167866|NCT00069095|472236389|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
131167867|NCT00069095|472236390|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
131167868|NCT00069095|472236391|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
131167869|NCT00069095|472236386|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
131167870|NCT00069095|472236387|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
131167871|NCT00069095|472236388|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
131167872|NCT00069095|472236389|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
131167873|NCT00069095|472236390|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
131167874|NCT00069095|472236391|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
131167875|NCT00069095|472236386|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
131167876|NCT00069095|472236387|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
131167877|NCT00069095|472236388|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
131167878|NCT00069095|472236389|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
131167879|NCT00069095|472236390|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
131167880|NCT00069095|472236391|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
131167881|NCT00069095|472236386|FG000|Post-study Treatment Phase|Surgery|0|||
131167882|NCT00069095|472236387|FG001|Post-study Treatment Phase|Surgery|0|||
131167883|NCT00069095|472236388|FG002|Post-study Treatment Phase|Surgery|0|||
131167884|NCT00069095|472236389|FG003|Post-study Treatment Phase|Surgery|1|||
131167885|NCT00069095|472236390|FG004|Post-study Treatment Phase|Surgery|1|||
131167886|NCT00069095|472236391|FG005|Post-study Treatment Phase|Surgery|0|||
131167887|NCT00069095|472236386|FG000|Post-study Treatment Phase|Death|0|||
131167888|NCT00069095|472236387|FG001|Post-study Treatment Phase|Death|0|||
131167889|NCT00069095|472236388|FG002|Post-study Treatment Phase|Death|0|||
131167890|NCT00069095|472236389|FG003|Post-study Treatment Phase|Death|0|||
131167891|NCT00069095|472236390|FG004|Post-study Treatment Phase|Death|1|||
131167892|NCT00069095|472236391|FG005|Post-study Treatment Phase|Death|0|||
131167893|NCT00069095|472236386|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
131167894|NCT00069095|472236387|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
131167895|NCT00069095|472236388|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
131167896|NCT00069095|472236389|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
131167897|NCT00069095|472236390|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
131167898|NCT00069095|472236391|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
131167899|NCT00069095|472236386|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
131167900|NCT00069095|472236387|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
131167901|NCT00069095|472236388|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
131167902|NCT00069095|472236389|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
131167903|NCT00069095|472236390|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
131167904|NCT00069095|472236391|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
131167905|NCT00069095|472236386|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
131167906|NCT00069095|472236387|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
131167907|NCT00069095|472236388|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
131167908|NCT00069095|472236389|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
131167909|NCT00069095|472236390|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
131167910|NCT00069095|472236391|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
131167911|NCT00069095|472236386|FG000|Post-study Treatment Phase|Investigator decision|0|||
131167912|NCT00069095|472236387|FG001|Post-study Treatment Phase|Investigator decision|0|||
131167913|NCT00069095|472236388|FG002|Post-study Treatment Phase|Investigator decision|0|||
131167914|NCT00069095|472236389|FG003|Post-study Treatment Phase|Investigator decision|0|||
131167915|NCT00069095|472236390|FG004|Post-study Treatment Phase|Investigator decision|0|||
131167916|NCT00069095|472236391|FG005|Post-study Treatment Phase|Investigator decision|1|||
131167917|NCT00069095|472236386|FG000|Follow-up Phase|Death|174|||
131167918|NCT00069095|472236387|FG001|Follow-up Phase|Death|206|||
131167919|NCT00069095|472236388|FG002|Follow-up Phase|Death|120|||
131167920|NCT00069095|472236389|FG003|Follow-up Phase|Death|112|||
131167921|NCT00069095|472236390|FG004|Follow-up Phase|Death|92|||
131167922|NCT00069095|472236391|FG005|Follow-up Phase|Death|101|||
131167923|NCT03508622|472236392|FG000|Overall Study|Protocol Violation|1|||
131167924|NCT03508622|472236393|FG001|Overall Study|Protocol Violation|0|||
131167925|NCT03508622|472236392|FG000|Overall Study|Withdrawal by Subject|1|||
131167926|NCT03508622|472236393|FG001|Overall Study|Withdrawal by Subject|0|||
131167927|NCT03508622|472236392|FG000|Overall Study|Lost to Follow-up|16|||
131167928|NCT03508622|472236393|FG001|Overall Study|Lost to Follow-up|0|||
131167929|NCT03508622|472236392|FG000|Overall Study|Incomplete data|0|||
131235631|NCT02795104|472490979|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
131167930|NCT03508622|472236393|FG001|Overall Study|Incomplete data|24|||
131167931|NCT05114590|472236394|FG000|Overall Study|Adverse Event|1|||
131167932|NCT05114590|472236394|FG000|Overall Study|Investigator decision|1|||
131167933|NCT05114590|472236394|FG000|Overall Study|Lost to Follow-up|5|||
131167934|NCT05114590|472236394|FG000|Overall Study|Withdrawal by Subject|5|||
131167935|NCT05114590|472236394|FG000|Overall Study|Other|2|||
131167936|NCT04590937|472236395|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
131167937|NCT01544595|472236398|FG000|Status at Week 68|Adverse Event|3|||
131167938|NCT01544595|472236399|FG001|Status at Week 68|Adverse Event|2|||
131167939|NCT01544595|472236400|FG002|Status at Week 68|Adverse Event|1|||
131167940|NCT01544595|472236401|FG003|Status at Week 68|Adverse Event|0|||
131167941|NCT01544595|472236402|FG004|Status at Week 68|Adverse Event|0|||
131167942|NCT01544595|472236403|FG005|Status at Week 68|Adverse Event|0|||
131167943|NCT01544595|472236398|FG000|Status at Week 68|Lack of Efficacy|1|||
131167944|NCT01544595|472236399|FG001|Status at Week 68|Lack of Efficacy|0|||
131167945|NCT01544595|472236400|FG002|Status at Week 68|Lack of Efficacy|0|||
131167946|NCT01544595|472236401|FG003|Status at Week 68|Lack of Efficacy|0|||
131167947|NCT01544595|472236402|FG004|Status at Week 68|Lack of Efficacy|0|||
131167948|NCT01544595|472236403|FG005|Status at Week 68|Lack of Efficacy|0|||
131167949|NCT01544595|472236398|FG000|Status at Week 68|Lost to Follow-up|1|||
131167950|NCT01544595|472236399|FG001|Status at Week 68|Lost to Follow-up|1|||
131167951|NCT01544595|472236400|FG002|Status at Week 68|Lost to Follow-up|0|||
131167952|NCT01544595|472236401|FG003|Status at Week 68|Lost to Follow-up|0|||
131167953|NCT01544595|472236402|FG004|Status at Week 68|Lost to Follow-up|0|||
131167954|NCT01544595|472236403|FG005|Status at Week 68|Lost to Follow-up|0|||
131167955|NCT01544595|472236398|FG000|Status at Week 68|Non-compliance with study treatment|1|||
131167956|NCT01544595|472236399|FG001|Status at Week 68|Non-compliance with study treatment|0|||
131167957|NCT01544595|472236400|FG002|Status at Week 68|Non-compliance with study treatment|0|||
131167958|NCT01544595|472236401|FG003|Status at Week 68|Non-compliance with study treatment|1|||
131167959|NCT01544595|472236402|FG004|Status at Week 68|Non-compliance with study treatment|0|||
131235632|NCT02795104|472490977|FG000|Overall Study|Withdrawal by Subject|0|||
131235633|NCT02795104|472490978|FG001|Overall Study|Withdrawal by Subject|2|||
131167960|NCT01544595|472236403|FG005|Status at Week 68|Non-compliance with study treatment|0|||
131167961|NCT01544595|472236398|FG000|Status at Week 68|Protocol Violation|2|||
131167962|NCT01544595|472236399|FG001|Status at Week 68|Protocol Violation|0|||
131167963|NCT01544595|472236400|FG002|Status at Week 68|Protocol Violation|1|||
131167964|NCT01544595|472236401|FG003|Status at Week 68|Protocol Violation|1|||
131167965|NCT01544595|472236402|FG004|Status at Week 68|Protocol Violation|0|||
131167966|NCT01544595|472236403|FG005|Status at Week 68|Protocol Violation|0|||
131167967|NCT01544595|472236398|FG000|Status at Week 68|Technical problems|1|||
131167968|NCT01544595|472236399|FG001|Status at Week 68|Technical problems|0|||
131167969|NCT01544595|472236400|FG002|Status at Week 68|Technical problems|0|||
131167970|NCT01544595|472236401|FG003|Status at Week 68|Technical problems|1|||
131167971|NCT01544595|472236402|FG004|Status at Week 68|Technical problems|0|||
131167972|NCT01544595|472236403|FG005|Status at Week 68|Technical problems|0|||
131167973|NCT01544595|472236398|FG000|Status at Week 68|Withdrawal by Subject|0|||
131167974|NCT01544595|472236399|FG001|Status at Week 68|Withdrawal by Subject|1|||
131167975|NCT01544595|472236400|FG002|Status at Week 68|Withdrawal by Subject|1|||
130729644|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
130729645|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
130729646|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
130729647|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
130729648|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
130729649|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
131167976|NCT01544595|472236401|FG003|Status at Week 68|Withdrawal by Subject|2|||
131167977|NCT01544595|472236402|FG004|Status at Week 68|Withdrawal by Subject|0|||
131167978|NCT01544595|472236403|FG005|Status at Week 68|Withdrawal by Subject|0|||
131167979|NCT01544595|472236398|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
131167980|NCT01544595|472236399|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
131167981|NCT01544595|472236400|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
131235634|NCT02795104|472490979|FG002|Overall Study|Withdrawal by Subject|0|||
131235635|NCT02795104|472490977|FG000|Overall Study|Lost to Follow-up|0|||
130729650|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
130729651|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
130729652|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
131167982|NCT01544595|472236401|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
131167983|NCT01544595|472236402|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
131167984|NCT01544595|472236403|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
131167985|NCT01544595|472236398|FG000|Status at Week 156|Withdrawal by Subject|9|||
131167986|NCT01544595|472236399|FG001|Status at Week 156|Withdrawal by Subject|10|||
131167987|NCT01544595|472236400|FG002|Status at Week 156|Withdrawal by Subject|4|||
131167988|NCT01544595|472236401|FG003|Status at Week 156|Withdrawal by Subject|9|||
130780691|NCT00901342|470823168|FG000|Overall Study|Disease progression|1|||
131167989|NCT01544595|472236402|FG004|Status at Week 156|Withdrawal by Subject|20|||
131167990|NCT01544595|472236403|FG005|Status at Week 156|Withdrawal by Subject|6|||
131167991|NCT01544595|472236398|FG000|Status at Week 156|Adverse Event|9|||
131167992|NCT01544595|472236399|FG001|Status at Week 156|Adverse Event|11|||
131167993|NCT01544595|472236400|FG002|Status at Week 156|Adverse Event|1|||
131167994|NCT01544595|472236401|FG003|Status at Week 156|Adverse Event|3|||
131167995|NCT01544595|472236402|FG004|Status at Week 156|Adverse Event|4|||
131167996|NCT01544595|472236403|FG005|Status at Week 156|Adverse Event|2|||
131167997|NCT01544595|472236398|FG000|Status at Week 156|Lost to Follow-up|4|||
131167998|NCT01544595|472236399|FG001|Status at Week 156|Lost to Follow-up|4|||
131167999|NCT01544595|472236400|FG002|Status at Week 156|Lost to Follow-up|0|||
130729653|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
130729654|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
131168000|NCT01544595|472236401|FG003|Status at Week 156|Lost to Follow-up|1|||
131168001|NCT01544595|472236402|FG004|Status at Week 156|Lost to Follow-up|4|||
131168002|NCT01544595|472236403|FG005|Status at Week 156|Lost to Follow-up|1|||
131168003|NCT01544595|472236398|FG000|Status at Week 156|Non-compliance with study treatement|0|||
131168004|NCT01544595|472236399|FG001|Status at Week 156|Non-compliance with study treatement|1|||
131168005|NCT01544595|472236400|FG002|Status at Week 156|Non-compliance with study treatement|0|||
131168006|NCT01544595|472236401|FG003|Status at Week 156|Non-compliance with study treatement|1|||
131168007|NCT01544595|472236402|FG004|Status at Week 156|Non-compliance with study treatement|0|||
131168008|NCT01544595|472236403|FG005|Status at Week 156|Non-compliance with study treatement|1|||
131168009|NCT01544595|472236398|FG000|Status at Week 156|Physician Decision|0|||
131168010|NCT01544595|472236399|FG001|Status at Week 156|Physician Decision|3|||
131168011|NCT01544595|472236400|FG002|Status at Week 156|Physician Decision|1|||
131168012|NCT01544595|472236401|FG003|Status at Week 156|Physician Decision|0|||
131168013|NCT01544595|472236402|FG004|Status at Week 156|Physician Decision|0|||
131168014|NCT01544595|472236403|FG005|Status at Week 156|Physician Decision|0|||
131168015|NCT01544595|472236398|FG000|Status at Week 156|Pregnancy|2|||
131168016|NCT01544595|472236399|FG001|Status at Week 156|Pregnancy|3|||
131168017|NCT01544595|472236400|FG002|Status at Week 156|Pregnancy|0|||
131168018|NCT01544595|472236401|FG003|Status at Week 156|Pregnancy|0|||
131168019|NCT01544595|472236402|FG004|Status at Week 156|Pregnancy|0|||
131168020|NCT01544595|472236403|FG005|Status at Week 156|Pregnancy|0|||
131168021|NCT01544595|472236398|FG000|Status at Week 156|Protocol Violation|3|||
131168022|NCT01544595|472236399|FG001|Status at Week 156|Protocol Violation|1|||
131168023|NCT01544595|472236400|FG002|Status at Week 156|Protocol Violation|2|||
131168024|NCT01544595|472236401|FG003|Status at Week 156|Protocol Violation|2|||
131168025|NCT01544595|472236402|FG004|Status at Week 156|Protocol Violation|0|||
131168026|NCT01544595|472236403|FG005|Status at Week 156|Protocol Violation|0|||
131168027|NCT01544595|472236398|FG000|Status at Week 156|Technical problems|3|||
131168028|NCT01544595|472236399|FG001|Status at Week 156|Technical problems|1|||
131168029|NCT01544595|472236400|FG002|Status at Week 156|Technical problems|0|||
131168030|NCT01544595|472236401|FG003|Status at Week 156|Technical problems|1|||
131168031|NCT01544595|472236402|FG004|Status at Week 156|Technical problems|0|||
131168032|NCT01544595|472236403|FG005|Status at Week 156|Technical problems|0|||
131168033|NCT01544595|472236398|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
131168034|NCT01544595|472236399|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
131168035|NCT01544595|472236400|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
131168036|NCT01544595|472236401|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
131168037|NCT01544595|472236402|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
131168038|NCT01544595|472236403|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
131168039|NCT01544595|472236398|FG000|Status at Week 156|Lack of Efficacy|1|||
131168040|NCT01544595|472236399|FG001|Status at Week 156|Lack of Efficacy|0|||
131168041|NCT01544595|472236400|FG002|Status at Week 156|Lack of Efficacy|1|||
131168042|NCT01544595|472236401|FG003|Status at Week 156|Lack of Efficacy|4|||
131168043|NCT01544595|472236402|FG004|Status at Week 156|Lack of Efficacy|10|||
131168044|NCT01544595|472236403|FG005|Status at Week 156|Lack of Efficacy|5|||
131168045|NCT04333433|472236410|FG000|Overall Study|Withdrawal by Subject|6|||
131168046|NCT04333433|472236411|FG001|Overall Study|Withdrawal by Subject|3|||
131168047|NCT04333433|472236410|FG000|Overall Study|Death|3|||
131168048|NCT04333433|472236411|FG001|Overall Study|Death|0|||
131168049|NCT04333433|472236410|FG000|Overall Study|Lost to Follow-up|6|||
131168050|NCT04333433|472236411|FG001|Overall Study|Lost to Follow-up|1|||
131168051|NCT04333433|472236410|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
131168052|NCT04333433|472236411|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
131168053|NCT00320385|472236412|FG000|Overall Study|Lost to Follow-up|7|||
131168054|NCT00320385|472236413|FG001|Overall Study|Lost to Follow-up|10|||
131168055|NCT00320385|472236412|FG000|Overall Study|Withdrawal by Subject|6|||
131168056|NCT00320385|472236413|FG001|Overall Study|Withdrawal by Subject|7|||
130729655|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
131168057|NCT00320385|472236412|FG000|Overall Study|Sponsor Terminated Study|2|||
131168058|NCT00320385|472236413|FG001|Overall Study|Sponsor Terminated Study|1|||
131168059|NCT00320385|472236412|FG000|Overall Study|Investigator Decision|0|||
131168060|NCT00320385|472236413|FG001|Overall Study|Investigator Decision|1|||
131168061|NCT00320385|472236412|FG000|Overall Study|Death|1|||
131168062|NCT00320385|472236413|FG001|Overall Study|Death|2|||
131168063|NCT00320385|472236412|FG000|Overall Study|Serious Adverse Event|1|||
131168064|NCT00320385|472236413|FG001|Overall Study|Serious Adverse Event|0|||
131168065|NCT00320385|472236412|FG000|Overall Study|Withdrew Consent|1|||
131168066|NCT00320385|472236413|FG001|Overall Study|Withdrew Consent|0|||
131168067|NCT00320385|472236412|FG000|Overall Study|Adverse Event|0|||
131168068|NCT00320385|472236413|FG001|Overall Study|Adverse Event|1|||
131168069|NCT03844633|472236422|FG000|1 Week FU|Lost to Follow-up|0|||
131168070|NCT03844633|472236423|FG001|1 Week FU|Lost to Follow-up|1|||
131168071|NCT03844633|472236424|FG002|1 Week FU|Lost to Follow-up|4|||
131168072|NCT03844633|472236422|FG000|12-month Follow-up|Lost to Follow-up|7|||
131168073|NCT03844633|472236423|FG001|12-month Follow-up|Lost to Follow-up|5|||
131168074|NCT03844633|472236424|FG002|12-month Follow-up|Lost to Follow-up|8|||
131168075|NCT03288779|472236425|FG000|Overall Study|Withdrawal by Subject|3|||
131168076|NCT00872170|472236426|FG000|Overall Study|Adverse Event|1|||
131168077|NCT00872170|472236427|FG001|Overall Study|Adverse Event|0|||
131168078|NCT00601523|472236428|FG000|Overall Study|Adverse Event|42|||
131168079|NCT00601523|472236429|FG001|Overall Study|Adverse Event|14|||
131168080|NCT00601523|472236428|FG000|Overall Study|Lack of Efficacy|3|||
131168081|NCT00601523|472236429|FG001|Overall Study|Lack of Efficacy|0|||
131168082|NCT00601523|472236428|FG000|Overall Study|Protocol Violation|5|||
131168083|NCT00601523|472236429|FG001|Overall Study|Protocol Violation|1|||
131168084|NCT00601523|472236428|FG000|Overall Study|Lost to Follow-up|0|||
131168085|NCT00601523|472236429|FG001|Overall Study|Lost to Follow-up|1|||
131168086|NCT00601523|472236428|FG000|Overall Study|Withdrawal by Subject|18|||
131168087|NCT00601523|472236429|FG001|Overall Study|Withdrawal by Subject|9|||
131168088|NCT00601523|472236428|FG000|Overall Study|Other|9|||
131168089|NCT00601523|472236429|FG001|Overall Study|Other|1|||
131168090|NCT01064648|472236430|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
131168091|NCT01064648|472236431|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
131168092|NCT01064648|472236432|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
131168093|NCT01064648|472236433|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
131168094|NCT01064648|472236430|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
131168095|NCT01064648|472236431|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
131168096|NCT01064648|472236432|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
131168097|NCT01064648|472236433|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
131168098|NCT01064648|472236430|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
131168099|NCT01064648|472236431|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
131168100|NCT01064648|472236432|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
131168101|NCT01064648|472236433|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
131168102|NCT01064648|472236430|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
131168103|NCT01064648|472236431|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
131168104|NCT01064648|472236432|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
131168105|NCT01064648|472236433|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
131168106|NCT01064648|472236430|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
131168107|NCT01064648|472236431|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
131168108|NCT01064648|472236432|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
131168109|NCT01064648|472236433|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
131168110|NCT01064648|472236430|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
131168111|NCT01064648|472236431|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
131168112|NCT01064648|472236432|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
131168113|NCT01064648|472236433|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
131235636|NCT02795104|472490978|FG001|Overall Study|Lost to Follow-up|0|||
131235637|NCT02795104|472490979|FG002|Overall Study|Lost to Follow-up|1|||
131235638|NCT00948675|472490980|FG000|Overall Study|Lost to Follow-up|1|||
131235639|NCT00948675|472490981|FG001|Overall Study|Lost to Follow-up|0|||
131235640|NCT02660242|472490986|FG000|Glucose Tabs|Lost to Follow-up|1|||
131168114|NCT01064648|472236430|FG000|Phase II|Adverse Event|0|||
131168115|NCT01064648|472236431|FG001|Phase II|Adverse Event|0|||
131168116|NCT01064648|472236432|FG002|Phase II|Adverse Event|15|||
131168117|NCT01064648|472236433|FG003|Phase II|Adverse Event|8|||
131235641|NCT02660242|472490986|FG000|Glucagon Injection|Lost to Follow-up|1|||
131235642|NCT00770510|472490987|FG000|Overall Study|Lost to Follow-up|2|||
131235643|NCT00770510|472490987|FG000|Overall Study|Pregnancy|1|||
131235644|NCT00770510|472490987|FG000|Overall Study|Withdrawal by Subject|2|||
131235645|NCT02192099|472490990|FG000|Overall Study|Adverse Event|1|||
131235646|NCT02192099|472490990|FG000|Overall Study|Lost to Follow-up|2|||
131235647|NCT02192099|472490990|FG000|Overall Study|Physician Decision|1|||
131235648|NCT02192099|472490990|FG000|Overall Study|Pregnancy|1|||
131168118|NCT01064648|472236430|FG000|Phase II|Death|0|||
131168119|NCT01064648|472236431|FG001|Phase II|Death|0|||
131168120|NCT01064648|472236432|FG002|Phase II|Death|4|||
131168121|NCT01064648|472236433|FG003|Phase II|Death|5|||
131168122|NCT01064648|472236430|FG000|Phase II|Withdrawal by Subject|0|||
131168123|NCT01064648|472236431|FG001|Phase II|Withdrawal by Subject|0|||
131168124|NCT01064648|472236432|FG002|Phase II|Withdrawal by Subject|2|||
130729656|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
130729657|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
130729658|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130729659|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130729660|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130729661|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130729662|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130729663|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
130729664|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
130729665|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
130729666|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
130729667|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
130729668|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130729669|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130729670|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130729671|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130729672|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130729673|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
130729674|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
130729675|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
130729676|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
130729677|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
130729678|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130729679|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130729680|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130729681|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130729682|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130729683|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729684|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729685|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729686|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
130729687|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729688|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729689|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729690|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729691|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729692|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130729693|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
130729694|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
131168125|NCT01064648|472236433|FG003|Phase II|Withdrawal by Subject|5|||
131168126|NCT01064648|472236430|FG000|Phase II|Progression|0|||
131168127|NCT01064648|472236431|FG001|Phase II|Progression|0|||
131168128|NCT01064648|472236432|FG002|Phase II|Progression|21|||
131168129|NCT01064648|472236433|FG003|Phase II|Progression|27|||
131168130|NCT01064648|472236430|FG000|Phase II|Non-protocol specified|0|||
131168131|NCT01064648|472236431|FG001|Phase II|Non-protocol specified|0|||
131168132|NCT01064648|472236432|FG002|Phase II|Non-protocol specified|5|||
131168133|NCT01064648|472236433|FG003|Phase II|Non-protocol specified|3|||
131168134|NCT01064648|472236430|FG000|Phase II|Under Review|0|||
131168135|NCT01064648|472236431|FG001|Phase II|Under Review|0|||
131168136|NCT01064648|472236432|FG002|Phase II|Under Review|2|||
131168137|NCT01064648|472236433|FG003|Phase II|Under Review|0|||
131168138|NCT00977574|472236434|FG000|Overall Study|Never Treated|4|||
131168139|NCT00977574|472236435|FG001|Overall Study|Never Treated|2|||
131168140|NCT00977574|472236436|FG002|Overall Study|Never Treated|4|||
131168141|NCT05281523|472236437|FG000|Overall Study|Adverse Event|1|||
131168142|NCT05281523|472236438|FG001|Overall Study|Adverse Event|1|||
131168143|NCT05281523|472236437|FG000|Overall Study|Physician Decision|1|||
131168144|NCT05281523|472236438|FG001|Overall Study|Physician Decision|1|||
131168145|NCT05281523|472236437|FG000|Overall Study|Withdrawal by Subject|5|||
131168146|NCT05281523|472236438|FG001|Overall Study|Withdrawal by Subject|15|||
131168147|NCT05281523|472236437|FG000|Overall Study|GCP violations|3|||
131168148|NCT05281523|472236438|FG001|Overall Study|GCP violations|4|||
131168149|NCT04491877|472238618|FG000|Overall Study|Protocol Deviation|1|||
131168150|NCT04491877|472238619|FG001|Overall Study|Protocol Deviation|0|||
130729695|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
130729696|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
130729697|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
131168151|NCT04491877|472238620|FG002|Overall Study|Protocol Deviation|2|||
131168152|NCT04491877|472238621|FG003|Overall Study|Protocol Deviation|0|||
131168153|NCT04491877|472238622|FG004|Overall Study|Protocol Deviation|0|||
130729698|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
131168154|NCT04491877|472238623|FG005|Overall Study|Protocol Deviation|0|||
131168155|NCT04491877|472238624|FG006|Overall Study|Protocol Deviation|1|||
131168156|NCT04491877|472238625|FG007|Overall Study|Protocol Deviation|1|||
131168157|NCT04491877|472238626|FG008|Overall Study|Protocol Deviation|0|||
130729699|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
130729700|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
130729701|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
130729702|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
130729703|NCT03104400|470633601|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729704|NCT03104400|470633602|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729705|NCT03104400|470633603|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729706|NCT03104400|470633604|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
130729707|NCT03104400|470633605|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729708|NCT03104400|470633606|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729709|NCT03104400|470633607|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729710|NCT03104400|470633608|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729711|NCT03104400|470633609|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729712|NCT03104400|470633610|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130729713|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
130729714|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
130729715|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
130729716|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
130729717|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
130729718|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
130729719|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
130729720|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
131168158|NCT04491877|472238618|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
131168159|NCT04491877|472238619|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131168160|NCT04491877|472238620|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131168161|NCT04491877|472238621|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
131168162|NCT04491877|472238622|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131168163|NCT04491877|472238623|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
131168164|NCT04491877|472238624|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
131168165|NCT04491877|472238625|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
131168166|NCT04491877|472238626|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
131168167|NCT04491877|472238618|FG000|Overall Study|Lost to Follow-up|0|||
131168168|NCT04491877|472238619|FG001|Overall Study|Lost to Follow-up|2|||
131168169|NCT04491877|472238620|FG002|Overall Study|Lost to Follow-up|0|||
131168170|NCT04491877|472238621|FG003|Overall Study|Lost to Follow-up|0|||
131168171|NCT04491877|472238622|FG004|Overall Study|Lost to Follow-up|0|||
131168172|NCT04491877|472238623|FG005|Overall Study|Lost to Follow-up|0|||
131168173|NCT04491877|472238624|FG006|Overall Study|Lost to Follow-up|2|||
131168174|NCT04491877|472238625|FG007|Overall Study|Lost to Follow-up|1|||
131168175|NCT04491877|472238626|FG008|Overall Study|Lost to Follow-up|1|||
131168176|NCT00418834|472238634|FG000|Overall Study|Adverse Event|16|||
131168177|NCT00418834|472238635|FG001|Overall Study|Adverse Event|9|||
131168178|NCT00418834|472238634|FG000|Overall Study|Lost to Follow-up|0|||
131168179|NCT00418834|472238635|FG001|Overall Study|Lost to Follow-up|1|||
131168180|NCT00418834|472238634|FG000|Overall Study|Protocol Violation|4|||
131168181|NCT00418834|472238635|FG001|Overall Study|Protocol Violation|3|||
131168182|NCT00418834|472238634|FG000|Overall Study|Withdrawal by Subject|3|||
131168183|NCT00418834|472238635|FG001|Overall Study|Withdrawal by Subject|7|||
131168184|NCT02364947|472238639|FG000|Overall Study|Withdrawal by Subject|10|||
131168185|NCT02364947|472238640|FG001|Overall Study|Withdrawal by Subject|8|||
131168186|NCT02364947|472238641|FG002|Overall Study|Withdrawal by Subject|9|||
131168187|NCT02364947|472238639|FG000|Overall Study|Adverse Event|45|||
131168188|NCT02364947|472238640|FG001|Overall Study|Adverse Event|33|||
131168189|NCT02364947|472238641|FG002|Overall Study|Adverse Event|11|||
131168190|NCT02364947|472238639|FG000|Overall Study|Protocol Violation|1|||
131168191|NCT02364947|472238640|FG001|Overall Study|Protocol Violation|1|||
131168192|NCT02364947|472238641|FG002|Overall Study|Protocol Violation|1|||
131168193|NCT02364947|472238639|FG000|Overall Study|Physician Decision|3|||
130729721|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
130729722|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
130729723|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130729724|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130729725|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130729726|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130729727|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
131168194|NCT02364947|472238640|FG001|Overall Study|Physician Decision|2|||
131168195|NCT02364947|472238641|FG002|Overall Study|Physician Decision|5|||
131168196|NCT02364947|472238639|FG000|Overall Study|Death|0|||
131168197|NCT02364947|472238640|FG001|Overall Study|Death|1|||
131168198|NCT02364947|472238641|FG002|Overall Study|Death|0|||
131168199|NCT02163993|472238642|FG000|Treatment Period|Adverse Event|0|||
131168200|NCT02163993|472238643|FG001|Treatment Period|Adverse Event|1|||
131168201|NCT02163993|472238644|FG002|Treatment Period|Adverse Event|0|||
131168202|NCT02163993|472238645|FG003|Treatment Period|Adverse Event|0|||
131168203|NCT02163993|472238646|FG004|Treatment Period|Adverse Event|1|||
131168204|NCT02163993|472238642|FG000|Treatment Period|Lost to Follow-up|2|||
130780692|NCT00901342|470823168|FG000|Overall Study|Withdrawal by Subject|9|||
130780693|NCT00751140|470823177|FG000|Overall Study|benign angioma excluded from analysis|1|||
130780694|NCT04001803|470823178|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
130780695|NCT04001803|470823178|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
130780696|NCT04001803|470823178|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
130780697|NCT04001803|470823178|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
130780698|NCT04001803|470823178|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
130780699|NCT04001803|470823178|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
130780700|NCT04001803|470823178|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
130780701|NCT04001803|470823178|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
130780702|NCT04001803|470823178|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
130780703|NCT04001803|470823178|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
131168205|NCT02163993|472238643|FG001|Treatment Period|Lost to Follow-up|3|||
131168206|NCT02163993|472238644|FG002|Treatment Period|Lost to Follow-up|1|||
131168207|NCT02163993|472238645|FG003|Treatment Period|Lost to Follow-up|3|||
131168208|NCT02163993|472238646|FG004|Treatment Period|Lost to Follow-up|1|||
131168209|NCT02163993|472238642|FG000|Treatment Period|Physician Decision|1|||
131168210|NCT02163993|472238643|FG001|Treatment Period|Physician Decision|0|||
131168211|NCT02163993|472238644|FG002|Treatment Period|Physician Decision|0|||
131168212|NCT02163993|472238645|FG003|Treatment Period|Physician Decision|0|||
131168213|NCT02163993|472238646|FG004|Treatment Period|Physician Decision|0|||
131168214|NCT02163993|472238642|FG000|Treatment Period|Protocol Violation|2|||
131168215|NCT02163993|472238643|FG001|Treatment Period|Protocol Violation|1|||
131168216|NCT02163993|472238644|FG002|Treatment Period|Protocol Violation|0|||
131168217|NCT02163993|472238645|FG003|Treatment Period|Protocol Violation|1|||
131168218|NCT02163993|472238646|FG004|Treatment Period|Protocol Violation|2|||
131168219|NCT02163993|472238642|FG000|Treatment Period|Withdrawal by Subject|6|||
131168220|NCT02163993|472238643|FG001|Treatment Period|Withdrawal by Subject|4|||
131168221|NCT02163993|472238644|FG002|Treatment Period|Withdrawal by Subject|1|||
131168222|NCT02163993|472238645|FG003|Treatment Period|Withdrawal by Subject|4|||
131168223|NCT02163993|472238646|FG004|Treatment Period|Withdrawal by Subject|1|||
131168224|NCT02163993|472238642|FG000|Treatment Period|Not treated|1|||
131168225|NCT02163993|472238643|FG001|Treatment Period|Not treated|0|||
131168226|NCT02163993|472238644|FG002|Treatment Period|Not treated|0|||
131168227|NCT02163993|472238645|FG003|Treatment Period|Not treated|1|||
131168228|NCT02163993|472238646|FG004|Treatment Period|Not treated|2|||
131168229|NCT02163993|472238642|FG000|Post-treatment Period|Adverse Event|0|||
131168230|NCT02163993|472238643|FG001|Post-treatment Period|Adverse Event|0|||
131168231|NCT02163993|472238644|FG002|Post-treatment Period|Adverse Event|1|||
131168232|NCT02163993|472238645|FG003|Post-treatment Period|Adverse Event|0|||
131168233|NCT02163993|472238646|FG004|Post-treatment Period|Adverse Event|0|||
131168234|NCT02163993|472238642|FG000|Post-treatment Period|Lost to Follow-up|2|||
131168235|NCT02163993|472238643|FG001|Post-treatment Period|Lost to Follow-up|2|||
131168236|NCT02163993|472238644|FG002|Post-treatment Period|Lost to Follow-up|3|||
131168237|NCT02163993|472238645|FG003|Post-treatment Period|Lost to Follow-up|1|||
131168238|NCT02163993|472238646|FG004|Post-treatment Period|Lost to Follow-up|0|||
131168239|NCT02163993|472238642|FG000|Post-treatment Period|Protocol Violation|0|||
131168240|NCT02163993|472238643|FG001|Post-treatment Period|Protocol Violation|0|||
131168241|NCT02163993|472238644|FG002|Post-treatment Period|Protocol Violation|0|||
131168242|NCT02163993|472238645|FG003|Post-treatment Period|Protocol Violation|0|||
131168243|NCT02163993|472238646|FG004|Post-treatment Period|Protocol Violation|1|||
131168244|NCT02163993|472238642|FG000|Post-treatment Period|Withdrawal by Subject|2|||
131168245|NCT02163993|472238643|FG001|Post-treatment Period|Withdrawal by Subject|4|||
131168246|NCT02163993|472238644|FG002|Post-treatment Period|Withdrawal by Subject|0|||
131168247|NCT02163993|472238645|FG003|Post-treatment Period|Withdrawal by Subject|1|||
131168248|NCT02163993|472238646|FG004|Post-treatment Period|Withdrawal by Subject|2|||
131168249|NCT00853489|472238647|FG000|Overall Study|Lost to Follow-up|5|||
131168250|NCT00853489|472238648|FG001|Overall Study|Lost to Follow-up|2|||
131168251|NCT05525975|472238649|FG000|Overall Study|Surgery cancellation|4|||
130780704|NCT02493517|470823179|FG000|Overall Study|Protocol Violation|1|||
130780705|NCT02493517|470823180|FG001|Overall Study|Protocol Violation|2|||
131168252|NCT05525975|472238650|FG001|Overall Study|Surgery cancellation|5|||
131168253|NCT05525975|472238649|FG000|Overall Study|didn't fill prescription|1|||
131168254|NCT05525975|472238650|FG001|Overall Study|didn't fill prescription|0|||
131168255|NCT05525975|472238649|FG000|Overall Study|Withdrawal by Subject|0|||
131168256|NCT05525975|472238650|FG001|Overall Study|Withdrawal by Subject|3|||
131168257|NCT01701583|472238651|FG000|Overall Study|Withdrawal by Subject|2|||
131168258|NCT01701583|472238652|FG001|Overall Study|Withdrawal by Subject|0|||
131168259|NCT02750813|472238653|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
131168260|NCT02750813|472238654|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
131168261|NCT02750813|472238653|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
131168262|NCT02750813|472238654|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
131168263|NCT01998581|472238655|FG000|Overall Study|Refused repeat treatment|20|||
131168264|NCT01998581|472238656|FG001|Overall Study|Refused repeat treatment|4|||
131168265|NCT01998581|472238655|FG000|Overall Study|Protocol Violation|1|||
131168266|NCT01998581|472238656|FG001|Overall Study|Protocol Violation|0|||
131168267|NCT01998581|472238655|FG000|Overall Study|Withdrawal by Subject|8|||
131168268|NCT01998581|472238656|FG001|Overall Study|Withdrawal by Subject|1|||
131168269|NCT01998581|472238655|FG000|Overall Study|Lost to Follow-up|12|||
131168270|NCT01998581|472238656|FG001|Overall Study|Lost to Follow-up|4|||
131168271|NCT01998581|472238655|FG000|Overall Study|Adverse Event|1|||
131168272|NCT01998581|472238656|FG001|Overall Study|Adverse Event|1|||
131168273|NCT01998581|472238655|FG000|Overall Study|Other reasons|3|||
131168274|NCT01998581|472238656|FG001|Overall Study|Other reasons|2|||
131168275|NCT01998581|472238655|FG000|Overall Study|Randomized but withdrew before treatment|1|||
131168276|NCT01998581|472238656|FG001|Overall Study|Randomized but withdrew before treatment|0|||
131168277|NCT01345123|472238657|FG000|Overall Study|participants no longer with health plan|79|||
131168278|NCT01345123|472238658|FG001|Overall Study|participants no longer with health plan|85|||
131168279|NCT01345123|472238659|FG002|Overall Study|participants no longer with health plan|88|||
131168280|NCT02245568|472238660|FG000|Overall Study|Study terminated by Sponsor|346|||
131168281|NCT02245568|472238660|FG000|Overall Study|Adverse Event|144|||
131168282|NCT02245568|472238660|FG000|Overall Study|Lack of Efficacy|98|||
131168283|NCT02245568|472238660|FG000|Overall Study|Withdrawal by Caregiver|85|||
131168284|NCT02245568|472238660|FG000|Overall Study|Withdrawal by Subject|77|||
131168285|NCT02245568|472238660|FG000|Overall Study|Withdrawal by Legal Representative|31|||
131168286|NCT02245568|472238660|FG000|Overall Study|Missing (Site closure)|16|||
131168287|NCT02245568|472238660|FG000|Overall Study|Physician Decision|14|||
131235649|NCT02192099|472490990|FG000|Overall Study|Protocol Violation|8|||
131235650|NCT02192099|472490990|FG000|Overall Study|Study Terminated by Sponsor|32|||
131235651|NCT02192099|472490990|FG000|Overall Study|Withdrawal by Subject|11|||
130729728|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
131168288|NCT02245568|472238660|FG000|Overall Study|Non-compliance with study drug|11|||
131168289|NCT02245568|472238660|FG000|Overall Study|Death|9|||
131168290|NCT02245568|472238660|FG000|Overall Study|Blue staining|6|||
131168291|NCT02245568|472238660|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
131168292|NCT02245568|472238660|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
131168293|NCT02245568|472238660|FG000|Overall Study|Lost to Follow-up|5|||
131168294|NCT01725152|472238661|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
131168295|NCT01725152|472238662|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
131168296|NCT01725152|472238661|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
131168297|NCT01725152|472238662|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
131168298|NCT01725152|472238661|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
131168299|NCT01725152|472238662|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
131168300|NCT01725152|472238661|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
131168301|NCT01725152|472238662|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
131168302|NCT02044159|472238663|FG000|Overall Study|Consent declined (deferred consent)|2|||
131168303|NCT02044159|472238664|FG001|Overall Study|Consent declined (deferred consent)|4|||
131168304|NCT02044159|472238663|FG000|Overall Study|No longer eligible, drug not given|1|||
131168305|NCT02044159|472238664|FG001|Overall Study|No longer eligible, drug not given|0|||
131168306|NCT02044159|472238663|FG000|Overall Study|Nurse declined to give study drug|1|||
131168307|NCT02044159|472238664|FG001|Overall Study|Nurse declined to give study drug|0|||
131168308|NCT02808312|472238665|FG000|Overall Study|Enrolled but Never Treated|0|||
131168309|NCT02808312|472238666|FG001|Overall Study|Enrolled but Never Treated|0|||
131168310|NCT02808312|472238667|FG002|Overall Study|Enrolled but Never Treated|1|||
131168311|NCT02808312|472238668|FG003|Overall Study|Enrolled but Never Treated|0|||
131168312|NCT02808312|472238669|FG004|Overall Study|Enrolled but Never Treated|0|||
131168313|NCT03100942|472238670|FG000|Randomized Treatment Period|Withdrew Consent|4|||
131168314|NCT03100942|472238671|FG001|Randomized Treatment Period|Withdrew Consent|5|||
131168315|NCT03100942|472238672|FG002|Randomized Treatment Period|Withdrew Consent|3|||
131168316|NCT03100942|472238673|FG003|Randomized Treatment Period|Withdrew Consent|3|||
131168317|NCT03100942|472238674|FG004|Randomized Treatment Period|Withdrew Consent|0|||
131168318|NCT03100942|472238675|FG005|Randomized Treatment Period|Withdrew Consent|0|||
131168319|NCT03100942|472238676|FG006|Randomized Treatment Period|Withdrew Consent|0|||
131168320|NCT03100942|472238670|FG000|Randomized Treatment Period|Adverse Event|5|||
131168321|NCT03100942|472238671|FG001|Randomized Treatment Period|Adverse Event|2|||
131168322|NCT03100942|472238672|FG002|Randomized Treatment Period|Adverse Event|1|||
131168323|NCT03100942|472238673|FG003|Randomized Treatment Period|Adverse Event|0|||
131235652|NCT02192099|472490990|FG000|Overall Study|Miscellaneous Reasons|5|||
130729729|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
130729730|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
130729731|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
130729732|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
130729733|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130729734|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130729735|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130729736|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
131168324|NCT03100942|472238674|FG004|Randomized Treatment Period|Adverse Event|0|||
131168325|NCT03100942|472238675|FG005|Randomized Treatment Period|Adverse Event|0|||
131168326|NCT03100942|472238676|FG006|Randomized Treatment Period|Adverse Event|0|||
131168327|NCT03100942|472238670|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
131168328|NCT03100942|472238671|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
131168329|NCT03100942|472238672|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
131168330|NCT03100942|472238673|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
131168331|NCT03100942|472238674|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
131168332|NCT03100942|472238675|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
131168333|NCT03100942|472238676|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
131168334|NCT03100942|472238670|FG000|Randomized Treatment Period|Protocol Violation|0|||
131168335|NCT03100942|472238671|FG001|Randomized Treatment Period|Protocol Violation|1|||
131168336|NCT03100942|472238672|FG002|Randomized Treatment Period|Protocol Violation|1|||
131168337|NCT03100942|472238673|FG003|Randomized Treatment Period|Protocol Violation|1|||
131168338|NCT03100942|472238674|FG004|Randomized Treatment Period|Protocol Violation|0|||
131168339|NCT03100942|472238675|FG005|Randomized Treatment Period|Protocol Violation|0|||
131168340|NCT03100942|472238676|FG006|Randomized Treatment Period|Protocol Violation|0|||
131168341|NCT03100942|472238670|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
131168342|NCT03100942|472238671|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
131168343|NCT03100942|472238672|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
131168344|NCT03100942|472238673|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
131168345|NCT03100942|472238674|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
131168346|NCT03100942|472238675|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
131168347|NCT03100942|472238676|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
131168348|NCT03100942|472238670|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
131168349|NCT03100942|472238671|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
131168350|NCT03100942|472238672|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
131168351|NCT03100942|472238673|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
131168352|NCT03100942|472238674|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
131168353|NCT03100942|472238675|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
131168354|NCT03100942|472238676|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
131168355|NCT03100942|472238670|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131168356|NCT03100942|472238671|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131168357|NCT03100942|472238672|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131168358|NCT03100942|472238673|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131168359|NCT03100942|472238674|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131168360|NCT03100942|472238675|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
131168361|NCT03100942|472238676|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
131168362|NCT04184622|472238677|FG000|Primary Treatment Period|Adverse Event|6|||
131168363|NCT04184622|472238678|FG001|Primary Treatment Period|Adverse Event|4|||
131168364|NCT04184622|472238679|FG002|Primary Treatment Period|Adverse Event|8|||
131168365|NCT04184622|472238680|FG003|Primary Treatment Period|Adverse Event|6|||
131168366|NCT04184622|472238677|FG000|Primary Treatment Period|Death|4|||
131168367|NCT04184622|472238678|FG001|Primary Treatment Period|Death|4|||
131168368|NCT04184622|472238679|FG002|Primary Treatment Period|Death|2|||
131168369|NCT04184622|472238680|FG003|Primary Treatment Period|Death|1|||
131168370|NCT04184622|472238677|FG000|Primary Treatment Period|Lost to Follow-up|41|||
131168371|NCT04184622|472238678|FG001|Primary Treatment Period|Lost to Follow-up|17|||
131168372|NCT04184622|472238679|FG002|Primary Treatment Period|Lost to Follow-up|15|||
131168373|NCT04184622|472238680|FG003|Primary Treatment Period|Lost to Follow-up|13|||
131168374|NCT04184622|472238677|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
131168375|NCT04184622|472238678|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
131168376|NCT04184622|472238679|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
131168377|NCT04184622|472238680|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
131168378|NCT04184622|472238677|FG000|Primary Treatment Period|Physician Decision|0|||
130729737|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130729738|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
131168379|NCT04184622|472238678|FG001|Primary Treatment Period|Physician Decision|0|||
131168380|NCT04184622|472238679|FG002|Primary Treatment Period|Physician Decision|3|||
131168381|NCT04184622|472238680|FG003|Primary Treatment Period|Physician Decision|1|||
131168382|NCT04184622|472238677|FG000|Primary Treatment Period|Pregnancy|4|||
131168383|NCT04184622|472238678|FG001|Primary Treatment Period|Pregnancy|3|||
131168384|NCT04184622|472238679|FG002|Primary Treatment Period|Pregnancy|4|||
131168385|NCT04184622|472238680|FG003|Primary Treatment Period|Pregnancy|1|||
130729739|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
131168386|NCT04184622|472238677|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
130729740|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
131168387|NCT04184622|472238678|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
130729741|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
131168388|NCT04184622|472238679|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
131168389|NCT04184622|472238680|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
131168390|NCT04184622|472238677|FG000|Additional Treatment Period|Adverse Event|1|||
131168391|NCT04184622|472238678|FG001|Additional Treatment Period|Adverse Event|2|||
131168392|NCT04184622|472238679|FG002|Additional Treatment Period|Adverse Event|1|||
131168393|NCT04184622|472238680|FG003|Additional Treatment Period|Adverse Event|0|||
131168394|NCT04184622|472238677|FG000|Additional Treatment Period|Death|0|||
131168395|NCT04184622|472238678|FG001|Additional Treatment Period|Death|0|||
131168396|NCT04184622|472238679|FG002|Additional Treatment Period|Death|1|||
131168397|NCT04184622|472238680|FG003|Additional Treatment Period|Death|1|||
131168398|NCT04184622|472238677|FG000|Additional Treatment Period|Lost to Follow-up|6|||
131168399|NCT04184622|472238678|FG001|Additional Treatment Period|Lost to Follow-up|4|||
131168400|NCT04184622|472238679|FG002|Additional Treatment Period|Lost to Follow-up|8|||
131168401|NCT04184622|472238680|FG003|Additional Treatment Period|Lost to Follow-up|6|||
131168402|NCT04184622|472238677|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
131168403|NCT04184622|472238678|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
131168404|NCT04184622|472238679|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
131168405|NCT04184622|472238680|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
131168406|NCT04184622|472238677|FG000|Additional Treatment Period|Physician Decision|0|||
131168407|NCT04184622|472238678|FG001|Additional Treatment Period|Physician Decision|0|||
131168408|NCT04184622|472238679|FG002|Additional Treatment Period|Physician Decision|1|||
131168409|NCT04184622|472238680|FG003|Additional Treatment Period|Physician Decision|0|||
131168410|NCT04184622|472238677|FG000|Additional Treatment Period|Pregnancy|0|||
131168411|NCT04184622|472238678|FG001|Additional Treatment Period|Pregnancy|0|||
131168412|NCT04184622|472238679|FG002|Additional Treatment Period|Pregnancy|0|||
131168413|NCT04184622|472238680|FG003|Additional Treatment Period|Pregnancy|1|||
131168414|NCT04184622|472238677|FG000|Additional Treatment Period|Protocol deviation|0|||
131168415|NCT04184622|472238678|FG001|Additional Treatment Period|Protocol deviation|0|||
131168416|NCT04184622|472238679|FG002|Additional Treatment Period|Protocol deviation|1|||
131168417|NCT04184622|472238680|FG003|Additional Treatment Period|Protocol deviation|0|||
131168418|NCT04184622|472238677|FG000|Additional Treatment Period|Site closed|1|||
131168419|NCT04184622|472238678|FG001|Additional Treatment Period|Site closed|0|||
131168420|NCT04184622|472238679|FG002|Additional Treatment Period|Site closed|1|||
131168421|NCT04184622|472238680|FG003|Additional Treatment Period|Site closed|0|||
131168422|NCT04184622|472238677|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
131168423|NCT04184622|472238678|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
131168424|NCT04184622|472238679|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
131168425|NCT04184622|472238680|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
131168426|NCT04184622|472238677|FG000|Safety Follow-up Period|Adverse Event|6|||
131168427|NCT04184622|472238678|FG001|Safety Follow-up Period|Adverse Event|8|||
131168428|NCT04184622|472238679|FG002|Safety Follow-up Period|Adverse Event|9|||
131168429|NCT04184622|472238680|FG003|Safety Follow-up Period|Adverse Event|16|||
131168430|NCT04184622|472238677|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
131168431|NCT04184622|472238678|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
131168432|NCT04184622|472238679|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
131168433|NCT04184622|472238680|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
131168434|NCT04184622|472238677|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
131168435|NCT04184622|472238678|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
131168436|NCT04184622|472238679|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
131168437|NCT04184622|472238680|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
131168438|NCT04184622|472238677|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
131168439|NCT04184622|472238678|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
131168440|NCT04184622|472238679|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
131168441|NCT04184622|472238680|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
131168442|NCT04184622|472238677|FG000|Safety Follow-up Period|Physician Decision|1|||
131168443|NCT04184622|472238678|FG001|Safety Follow-up Period|Physician Decision|0|||
131168444|NCT04184622|472238679|FG002|Safety Follow-up Period|Physician Decision|0|||
131168445|NCT04184622|472238680|FG003|Safety Follow-up Period|Physician Decision|1|||
131168446|NCT04184622|472238677|FG000|Safety Follow-up Period|Pregnancy|1|||
131168447|NCT04184622|472238678|FG001|Safety Follow-up Period|Pregnancy|3|||
131168448|NCT04184622|472238679|FG002|Safety Follow-up Period|Pregnancy|0|||
131168449|NCT04184622|472238680|FG003|Safety Follow-up Period|Pregnancy|6|||
130729742|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
131168450|NCT04184622|472238677|FG000|Safety Follow-up Period|Protocol deviation|1|||
131168451|NCT04184622|472238678|FG001|Safety Follow-up Period|Protocol deviation|0|||
131168452|NCT04184622|472238679|FG002|Safety Follow-up Period|Protocol deviation|0|||
131168453|NCT04184622|472238680|FG003|Safety Follow-up Period|Protocol deviation|0|||
131168454|NCT04184622|472238677|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
131168455|NCT04184622|472238678|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
131168456|NCT04184622|472238679|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
131168457|NCT04184622|472238680|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
131168458|NCT04426825|472238681|FG000|Overall Study|Death|17|||
131168459|NCT04426825|472238681|FG000|Overall Study|Lost to Follow-up|1|||
131168460|NCT04426825|472238681|FG000|Overall Study|Study terminated by sponsor|5|||
131168461|NCT01263691|472238685|FG000|Overall Study|Lost to Follow-up|1|||
131168462|NCT01263691|472238686|FG001|Overall Study|Lost to Follow-up|0|||
131168463|NCT01263691|472238687|FG002|Overall Study|Lost to Follow-up|1|||
131168464|NCT01263691|472238688|FG003|Overall Study|Lost to Follow-up|1|||
131168465|NCT01263691|472238689|FG004|Overall Study|Lost to Follow-up|0|||
131168466|NCT01263691|472238690|FG005|Overall Study|Lost to Follow-up|0|||
131168467|NCT01263691|472238685|FG000|Overall Study|Withdrawal by Subject|1|||
131168468|NCT01263691|472238686|FG001|Overall Study|Withdrawal by Subject|0|||
131168469|NCT01263691|472238687|FG002|Overall Study|Withdrawal by Subject|0|||
131168470|NCT01263691|472238688|FG003|Overall Study|Withdrawal by Subject|0|||
131168471|NCT01263691|472238689|FG004|Overall Study|Withdrawal by Subject|0|||
131168472|NCT01263691|472238690|FG005|Overall Study|Withdrawal by Subject|0|||
131168473|NCT01263691|472238685|FG000|Overall Study|Adverse Event|1|||
131168474|NCT01263691|472238686|FG001|Overall Study|Adverse Event|0|||
131168475|NCT01263691|472238687|FG002|Overall Study|Adverse Event|0|||
131168476|NCT01263691|472238688|FG003|Overall Study|Adverse Event|0|||
131168477|NCT01263691|472238689|FG004|Overall Study|Adverse Event|0|||
131168478|NCT01263691|472238690|FG005|Overall Study|Adverse Event|0|||
130729743|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
131168479|NCT01028651|472238691|FG000|Overall Study|Death|2|||
130729744|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130729745|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130729746|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130729747|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130729748|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
130729749|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
130729750|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
130729751|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
130729752|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
130729753|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130729754|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130729755|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130729756|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
131168480|NCT01028651|472238691|FG000|Overall Study|Adverse Event|1|||
131168481|NCT01554956|472238692|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
131168482|NCT01554956|472238693|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
131168483|NCT01554956|472238694|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
130729757|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130729758|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130729759|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
131168484|NCT01554956|472238692|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
131168485|NCT01554956|472238693|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
131168486|NCT01554956|472238694|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
131168487|NCT01554956|472238692|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
131168488|NCT01554956|472238693|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
131168489|NCT01554956|472238694|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
131168490|NCT00913978|472238696|FG000|Overall Study|Surgeon choice|1|||
131168491|NCT00913978|472238697|FG001|Overall Study|Surgeon choice|3|||
131168492|NCT01327651|472238701|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
131168493|NCT01327651|472238702|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
131168494|NCT01327651|472238703|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
131168495|NCT01327651|472238704|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
131168496|NCT01327651|472238705|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
131168497|NCT01327651|472238706|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
130729760|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
131168498|NCT01327651|472238707|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
131168499|NCT01327651|472238708|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
131168500|NCT01327651|472238709|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
131168501|NCT01327651|472238701|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
130729761|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
130729762|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
130729763|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130729764|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131168502|NCT01327651|472238702|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131168503|NCT01327651|472238703|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131168504|NCT01327651|472238704|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131168505|NCT01327651|472238705|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130729765|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131168506|NCT01327651|472238706|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131168507|NCT01327651|472238707|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131168508|NCT01327651|472238708|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131168509|NCT01327651|472238709|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
131168510|NCT01327651|472238701|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
131168511|NCT01327651|472238702|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
130729766|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130729767|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130729768|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130729769|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130729770|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
130729771|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
131168512|NCT01327651|472238703|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
131168513|NCT01327651|472238704|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
131168514|NCT01327651|472238705|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
131168515|NCT01327651|472238706|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
131168516|NCT01327651|472238707|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
131168517|NCT01327651|472238708|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
131168518|NCT01327651|472238709|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
131168519|NCT01327651|472238701|FG000|Post Study Follow-up|Lost to Follow-up|0|||
131168520|NCT01327651|472238702|FG001|Post Study Follow-up|Lost to Follow-up|1|||
131168521|NCT01327651|472238703|FG002|Post Study Follow-up|Lost to Follow-up|1|||
131168522|NCT01327651|472238704|FG003|Post Study Follow-up|Lost to Follow-up|0|||
131168523|NCT01327651|472238705|FG004|Post Study Follow-up|Lost to Follow-up|0|||
131168524|NCT01327651|472238706|FG005|Post Study Follow-up|Lost to Follow-up|0|||
131168525|NCT01327651|472238707|FG006|Post Study Follow-up|Lost to Follow-up|4|||
131168526|NCT01327651|472238708|FG007|Post Study Follow-up|Lost to Follow-up|1|||
131168527|NCT01327651|472238709|FG008|Post Study Follow-up|Lost to Follow-up|2|||
131168528|NCT03249792|472238714|FG000|Arms 1, 2, and 4|Death|1|||
131168529|NCT03249792|472238715|FG001|Arms 1, 2, and 4|Death|1|||
131168530|NCT03249792|472238716|FG002|Arms 1, 2, and 4|Death|0|||
131168531|NCT03249792|472238717|FG003|Arms 1, 2, and 4|Death|2|||
131168532|NCT03249792|472238718|FG004|Arms 1, 2, and 4|Death|3|||
131168533|NCT03249792|472238719|FG005|Arms 1, 2, and 4|Death|2|||
131168534|NCT03249792|472238720|FG006|Arms 1, 2, and 4|Death|2|||
131168535|NCT03249792|472238721|FG007|Arms 1, 2, and 4|Death|4|||
131168536|NCT03249792|472238722|FG008|Arms 1, 2, and 4|Death|2|||
131168537|NCT03249792|472238723|FG009|Arms 1, 2, and 4|Death|1|||
131168538|NCT03249792|472238724|FG010|Arms 1, 2, and 4|Death|7|||
131168539|NCT03249792|472238725|FG011|Arms 1, 2, and 4|Death|7|||
131168540|NCT03249792|472238726|FG012|Arms 1, 2, and 4|Death|12|||
131168541|NCT03249792|472238727|FG013|Arms 1, 2, and 4|Death|7|||
131168542|NCT03249792|472238728|FG014|Arms 1, 2, and 4|Death|0|||
131168543|NCT03249792|472238729|FG015|Arms 1, 2, and 4|Death|4|||
131168544|NCT03249792|472238730|FG016|Arms 1, 2, and 4|Death|4|||
131168545|NCT03249792|472238731|FG017|Arms 1, 2, and 4|Death|12|||
131168546|NCT03249792|472238732|FG018|Arms 1, 2, and 4|Death|6|||
131168547|NCT03249792|472238733|FG019|Arms 1, 2, and 4|Death|4|||
131168548|NCT03249792|472238734|FG020|Arms 1, 2, and 4|Death|2|||
131168549|NCT03249792|472238735|FG021|Arms 1, 2, and 4|Death|3|||
131168550|NCT03249792|472238736|FG022|Arms 1, 2, and 4|Death|1|||
131168551|NCT03249792|472238737|FG023|Arms 1, 2, and 4|Death|1|||
131168552|NCT03249792|472238738|FG024|Arms 1, 2, and 4|Death|4|||
131168553|NCT03249792|472238739|FG025|Arms 1, 2, and 4|Death|0|||
131168554|NCT03249792|472238740|FG026|Arms 1, 2, and 4|Death|0|||
131168555|NCT03249792|472238741|FG027|Arms 1, 2, and 4|Death|0|||
131168556|NCT03249792|472238742|FG028|Arms 1, 2, and 4|Death|0|||
131168557|NCT03249792|472238743|FG029|Arms 1, 2, and 4|Death|0|||
131168558|NCT03249792|472238744|FG030|Arms 1, 2, and 4|Death|0|||
131168559|NCT03249792|472238745|FG031|Arms 1, 2, and 4|Death|0|||
131168560|NCT03249792|472238746|FG032|Arms 1, 2, and 4|Death|0|||
131168561|NCT03249792|472238714|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168562|NCT03249792|472238715|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168563|NCT03249792|472238716|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131168564|NCT03249792|472238717|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168565|NCT03249792|472238718|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168566|NCT03249792|472238719|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131168567|NCT03249792|472238720|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
131168568|NCT03249792|472238721|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168569|NCT03249792|472238722|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
131168570|NCT03249792|472238723|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131168571|NCT03249792|472238724|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
131168572|NCT03249792|472238725|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
131168573|NCT03249792|472238726|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
130729772|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
131168574|NCT03249792|472238727|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
131168575|NCT03249792|472238728|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168576|NCT03249792|472238729|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168577|NCT03249792|472238730|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
131168578|NCT03249792|472238731|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168579|NCT03249792|472238732|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131168580|NCT03249792|472238733|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168581|NCT03249792|472238734|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168582|NCT03249792|472238735|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168583|NCT03249792|472238736|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131168584|NCT03249792|472238737|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
131168585|NCT03249792|472238738|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168586|NCT03249792|472238739|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168587|NCT03249792|472238740|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168588|NCT03249792|472238741|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168589|NCT03249792|472238742|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168590|NCT03249792|472238743|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168591|NCT03249792|472238744|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168592|NCT03249792|472238745|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168593|NCT03249792|472238746|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
131168594|NCT03249792|472238714|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
131168595|NCT03249792|472238715|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
131168596|NCT03249792|472238716|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
131168597|NCT03249792|472238717|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
131168598|NCT03249792|472238718|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
131168599|NCT03249792|472238719|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
131168600|NCT03249792|472238720|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
131168601|NCT03249792|472238721|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
131168602|NCT03249792|472238722|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
131168603|NCT03249792|472238723|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
131168604|NCT03249792|472238724|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
131168605|NCT03249792|472238725|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
131168606|NCT03249792|472238726|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
131168607|NCT03249792|472238727|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
131168608|NCT03249792|472238728|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
131168609|NCT03249792|472238729|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
131168610|NCT03249792|472238730|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
131168611|NCT03249792|472238731|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
131168612|NCT03249792|472238732|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
131168613|NCT03249792|472238733|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
131168614|NCT03249792|472238734|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
131168615|NCT03249792|472238735|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
131168616|NCT03249792|472238736|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
131168617|NCT03249792|472238737|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
131168618|NCT03249792|472238738|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
131168619|NCT03249792|472238739|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
131168620|NCT03249792|472238740|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
131168621|NCT03249792|472238741|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
131168622|NCT03249792|472238742|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
131168623|NCT03249792|472238743|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
131168624|NCT03249792|472238744|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
131168625|NCT03249792|472238745|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
131168626|NCT03249792|472238746|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
131168627|NCT03249792|472238714|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168628|NCT03249792|472238715|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168629|NCT03249792|472238716|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168630|NCT03249792|472238717|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168631|NCT03249792|472238718|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168632|NCT03249792|472238719|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168633|NCT03249792|472238720|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168634|NCT03249792|472238721|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168635|NCT03249792|472238722|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
131168636|NCT03249792|472238723|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168637|NCT03249792|472238724|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168638|NCT03249792|472238725|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168639|NCT03249792|472238726|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168640|NCT03249792|472238727|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168641|NCT03249792|472238728|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168642|NCT03249792|472238729|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168643|NCT03249792|472238730|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
131168644|NCT03249792|472238731|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
131168645|NCT03249792|472238732|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168646|NCT03249792|472238733|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
131168647|NCT03249792|472238734|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168648|NCT03249792|472238735|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168649|NCT03249792|472238736|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168650|NCT03249792|472238737|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168651|NCT03249792|472238738|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168652|NCT03249792|472238739|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168653|NCT03249792|472238740|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
130729773|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
130729774|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
130729775|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
131168654|NCT03249792|472238741|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168655|NCT03249792|472238742|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168656|NCT03249792|472238743|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168657|NCT03249792|472238744|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168658|NCT03249792|472238745|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168659|NCT03249792|472238746|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
131168660|NCT03249792|472238714|FG000|Switch Over Period|Withdrawal by Subject|0|||
131168661|NCT03249792|472238715|FG001|Switch Over Period|Withdrawal by Subject|0|||
131168662|NCT03249792|472238716|FG002|Switch Over Period|Withdrawal by Subject|0|||
131168663|NCT03249792|472238717|FG003|Switch Over Period|Withdrawal by Subject|0|||
131168664|NCT03249792|472238718|FG004|Switch Over Period|Withdrawal by Subject|0|||
131168665|NCT03249792|472238719|FG005|Switch Over Period|Withdrawal by Subject|0|||
131168666|NCT03249792|472238720|FG006|Switch Over Period|Withdrawal by Subject|0|||
131168667|NCT03249792|472238721|FG007|Switch Over Period|Withdrawal by Subject|0|||
131168668|NCT03249792|472238722|FG008|Switch Over Period|Withdrawal by Subject|0|||
131168669|NCT03249792|472238723|FG009|Switch Over Period|Withdrawal by Subject|0|||
131168670|NCT03249792|472238724|FG010|Switch Over Period|Withdrawal by Subject|0|||
131168671|NCT03249792|472238725|FG011|Switch Over Period|Withdrawal by Subject|0|||
131168672|NCT03249792|472238726|FG012|Switch Over Period|Withdrawal by Subject|0|||
131168673|NCT03249792|472238727|FG013|Switch Over Period|Withdrawal by Subject|0|||
131168674|NCT03249792|472238728|FG014|Switch Over Period|Withdrawal by Subject|0|||
131168675|NCT03249792|472238729|FG015|Switch Over Period|Withdrawal by Subject|0|||
131168676|NCT03249792|472238730|FG016|Switch Over Period|Withdrawal by Subject|0|||
131168677|NCT03249792|472238731|FG017|Switch Over Period|Withdrawal by Subject|0|||
131168678|NCT03249792|472238732|FG018|Switch Over Period|Withdrawal by Subject|0|||
131168679|NCT03249792|472238733|FG019|Switch Over Period|Withdrawal by Subject|0|||
131168680|NCT03249792|472238734|FG020|Switch Over Period|Withdrawal by Subject|0|||
131168681|NCT03249792|472238735|FG021|Switch Over Period|Withdrawal by Subject|0|||
131168682|NCT03249792|472238736|FG022|Switch Over Period|Withdrawal by Subject|0|||
131168683|NCT03249792|472238737|FG023|Switch Over Period|Withdrawal by Subject|0|||
131168684|NCT03249792|472238738|FG024|Switch Over Period|Withdrawal by Subject|0|||
131168685|NCT03249792|472238739|FG025|Switch Over Period|Withdrawal by Subject|0|||
131168686|NCT03249792|472238740|FG026|Switch Over Period|Withdrawal by Subject|0|||
131168687|NCT03249792|472238741|FG027|Switch Over Period|Withdrawal by Subject|0|||
131168688|NCT03249792|472238742|FG028|Switch Over Period|Withdrawal by Subject|0|||
131168689|NCT03249792|472238743|FG029|Switch Over Period|Withdrawal by Subject|0|||
131168690|NCT03249792|472238744|FG030|Switch Over Period|Withdrawal by Subject|0|||
131168691|NCT03249792|472238745|FG031|Switch Over Period|Withdrawal by Subject|1|||
131168692|NCT03249792|472238746|FG032|Switch Over Period|Withdrawal by Subject|0|||
131168693|NCT03249792|472238714|FG000|Switch Over Period|Progressive Disease|0|||
131168694|NCT03249792|472238715|FG001|Switch Over Period|Progressive Disease|0|||
131168695|NCT03249792|472238716|FG002|Switch Over Period|Progressive Disease|0|||
131168696|NCT03249792|472238717|FG003|Switch Over Period|Progressive Disease|0|||
131168697|NCT03249792|472238718|FG004|Switch Over Period|Progressive Disease|0|||
131168698|NCT03249792|472238719|FG005|Switch Over Period|Progressive Disease|0|||
131168699|NCT03249792|472238720|FG006|Switch Over Period|Progressive Disease|0|||
131168700|NCT03249792|472238721|FG007|Switch Over Period|Progressive Disease|0|||
131168701|NCT03249792|472238722|FG008|Switch Over Period|Progressive Disease|0|||
131168702|NCT03249792|472238723|FG009|Switch Over Period|Progressive Disease|0|||
131168703|NCT03249792|472238724|FG010|Switch Over Period|Progressive Disease|0|||
131168704|NCT03249792|472238725|FG011|Switch Over Period|Progressive Disease|0|||
131168705|NCT03249792|472238726|FG012|Switch Over Period|Progressive Disease|0|||
131168706|NCT03249792|472238727|FG013|Switch Over Period|Progressive Disease|0|||
131168707|NCT03249792|472238728|FG014|Switch Over Period|Progressive Disease|0|||
131168708|NCT03249792|472238729|FG015|Switch Over Period|Progressive Disease|0|||
131168709|NCT03249792|472238730|FG016|Switch Over Period|Progressive Disease|0|||
131168710|NCT03249792|472238731|FG017|Switch Over Period|Progressive Disease|0|||
131168711|NCT03249792|472238732|FG018|Switch Over Period|Progressive Disease|0|||
131168712|NCT03249792|472238733|FG019|Switch Over Period|Progressive Disease|0|||
131168713|NCT03249792|472238734|FG020|Switch Over Period|Progressive Disease|0|||
131168714|NCT03249792|472238735|FG021|Switch Over Period|Progressive Disease|0|||
131168715|NCT03249792|472238736|FG022|Switch Over Period|Progressive Disease|0|||
131168716|NCT03249792|472238737|FG023|Switch Over Period|Progressive Disease|0|||
131168717|NCT03249792|472238738|FG024|Switch Over Period|Progressive Disease|0|||
131168718|NCT03249792|472238739|FG025|Switch Over Period|Progressive Disease|0|||
131168719|NCT03249792|472238740|FG026|Switch Over Period|Progressive Disease|1|||
131168720|NCT03249792|472238741|FG027|Switch Over Period|Progressive Disease|0|||
131168721|NCT03249792|472238742|FG028|Switch Over Period|Progressive Disease|1|||
131168722|NCT03249792|472238743|FG029|Switch Over Period|Progressive Disease|2|||
131168723|NCT03249792|472238744|FG030|Switch Over Period|Progressive Disease|1|||
131168724|NCT03249792|472238745|FG031|Switch Over Period|Progressive Disease|0|||
130729776|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
131168725|NCT03249792|472238746|FG032|Switch Over Period|Progressive Disease|1|||
131168726|NCT03249792|472238714|FG000|Switch Over Period|Adverse Event|0|||
131168727|NCT03249792|472238715|FG001|Switch Over Period|Adverse Event|0|||
131168728|NCT03249792|472238716|FG002|Switch Over Period|Adverse Event|0|||
131168729|NCT03249792|472238717|FG003|Switch Over Period|Adverse Event|0|||
131168730|NCT03249792|472238718|FG004|Switch Over Period|Adverse Event|0|||
131168731|NCT03249792|472238719|FG005|Switch Over Period|Adverse Event|0|||
131168732|NCT03249792|472238720|FG006|Switch Over Period|Adverse Event|0|||
131168733|NCT03249792|472238721|FG007|Switch Over Period|Adverse Event|0|||
131168734|NCT03249792|472238722|FG008|Switch Over Period|Adverse Event|0|||
131168735|NCT03249792|472238723|FG009|Switch Over Period|Adverse Event|0|||
131168736|NCT03249792|472238724|FG010|Switch Over Period|Adverse Event|0|||
131168737|NCT03249792|472238725|FG011|Switch Over Period|Adverse Event|0|||
131168738|NCT03249792|472238726|FG012|Switch Over Period|Adverse Event|0|||
131168739|NCT03249792|472238727|FG013|Switch Over Period|Adverse Event|0|||
131168740|NCT03249792|472238728|FG014|Switch Over Period|Adverse Event|0|||
131168741|NCT03249792|472238729|FG015|Switch Over Period|Adverse Event|0|||
131168742|NCT03249792|472238730|FG016|Switch Over Period|Adverse Event|0|||
131168743|NCT03249792|472238731|FG017|Switch Over Period|Adverse Event|0|||
131168744|NCT03249792|472238732|FG018|Switch Over Period|Adverse Event|0|||
131168745|NCT03249792|472238733|FG019|Switch Over Period|Adverse Event|0|||
131168746|NCT03249792|472238734|FG020|Switch Over Period|Adverse Event|0|||
131168747|NCT03249792|472238735|FG021|Switch Over Period|Adverse Event|0|||
131168748|NCT03249792|472238736|FG022|Switch Over Period|Adverse Event|0|||
131168749|NCT03249792|472238737|FG023|Switch Over Period|Adverse Event|0|||
131168750|NCT03249792|472238738|FG024|Switch Over Period|Adverse Event|0|||
131168751|NCT03249792|472238739|FG025|Switch Over Period|Adverse Event|1|||
131168752|NCT03249792|472238740|FG026|Switch Over Period|Adverse Event|0|||
131168753|NCT03249792|472238741|FG027|Switch Over Period|Adverse Event|1|||
131168754|NCT03249792|472238742|FG028|Switch Over Period|Adverse Event|0|||
131168755|NCT03249792|472238743|FG029|Switch Over Period|Adverse Event|0|||
131168756|NCT03249792|472238744|FG030|Switch Over Period|Adverse Event|0|||
131168757|NCT03249792|472238745|FG031|Switch Over Period|Adverse Event|0|||
131168758|NCT03249792|472238746|FG032|Switch Over Period|Adverse Event|0|||
131168759|NCT00850759|472238750|FG000|Overall Study|Lost to Follow-up|7|||
131168760|NCT00850759|472238751|FG001|Overall Study|Lost to Follow-up|5|||
131168761|NCT00850759|472238752|FG002|Overall Study|Lost to Follow-up|5|||
131168762|NCT00850759|472238753|FG003|Overall Study|Lost to Follow-up|3|||
131168763|NCT02918266|472238754|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
131168764|NCT02918266|472238755|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131168765|NCT02918266|472238756|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131168766|NCT02918266|472238757|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131168767|NCT02918266|472238758|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131168768|NCT02918266|472238759|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131168769|NCT02918266|472238760|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
131168770|NCT02918266|472238761|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131168771|NCT02918266|472238762|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
131168772|NCT02918266|472238763|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131168773|NCT02918266|472238764|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
131168774|NCT01259856|472238765|FG000|Overall Study|Adverse Event|12|||
131168775|NCT01259856|472238766|FG001|Overall Study|Adverse Event|9|||
131168776|NCT01259856|472238765|FG000|Overall Study|Death|0|||
131168777|NCT01259856|472238766|FG001|Overall Study|Death|1|||
131168778|NCT01259856|472238765|FG000|Overall Study|Lack of Efficacy|3|||
131168779|NCT01259856|472238766|FG001|Overall Study|Lack of Efficacy|1|||
131168780|NCT01259856|472238765|FG000|Overall Study|Lost to Follow-up|1|||
131168781|NCT01259856|472238766|FG001|Overall Study|Lost to Follow-up|1|||
131168782|NCT01259856|472238765|FG000|Overall Study|Physician Decision|2|||
131168783|NCT01259856|472238766|FG001|Overall Study|Physician Decision|1|||
131168784|NCT01259856|472238765|FG000|Overall Study|Withdrawal by Subject|9|||
131168785|NCT01259856|472238766|FG001|Overall Study|Withdrawal by Subject|10|||
131168786|NCT01259856|472238765|FG000|Overall Study|Treatment never started|0|||
131168787|NCT01259856|472238766|FG001|Overall Study|Treatment never started|6|||
131168788|NCT01259856|472238765|FG000|Overall Study|Study closure by sponsor|40|||
131168789|NCT01259856|472238766|FG001|Overall Study|Study closure by sponsor|41|||
131168790|NCT01259856|472238765|FG000|Overall Study|Patient developed other disease|0|||
131168791|NCT01259856|472238766|FG001|Overall Study|Patient developed other disease|1|||
131168792|NCT01259856|472238765|FG000|Overall Study|Transfer to another study|0|||
131168793|NCT01259856|472238766|FG001|Overall Study|Transfer to another study|1|||
131168794|NCT01259856|472238765|FG000|Overall Study|Unknown/missing|2|||
131168795|NCT01259856|472238766|FG001|Overall Study|Unknown/missing|2|||
131168796|NCT01253044|472238767|FG000|Overall Study|Lost to Follow-up|38|||
131168797|NCT01253044|472238768|FG001|Overall Study|Lost to Follow-up|29|||
131168798|NCT01201798|472238777|FG000|Overall Study|Adverse Event|2|||
131168799|NCT01201798|472238778|FG001|Overall Study|Adverse Event|0|||
131168800|NCT01201798|472238777|FG000|Overall Study|Lost to Follow-up|3|||
131168801|NCT01201798|472238778|FG001|Overall Study|Lost to Follow-up|5|||
131168802|NCT01201798|472238777|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
131168803|NCT01201798|472238778|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
131168804|NCT01201798|472238777|FG000|Overall Study|Noncompliance|1|||
131168805|NCT01201798|472238778|FG001|Overall Study|Noncompliance|0|||
131168806|NCT01201798|472238777|FG000|Overall Study|Protocol Violation|1|||
131168807|NCT01201798|472238778|FG001|Overall Study|Protocol Violation|1|||
131168808|NCT01201798|472238777|FG000|Overall Study|Treatment Failure|1|||
131168809|NCT01201798|472238778|FG001|Overall Study|Treatment Failure|8|||
131168810|NCT00525148|472238779|FG000|Overall Study|Other Adverse Event|3|||
131168811|NCT00525148|472238780|FG001|Overall Study|Other Adverse Event|5|||
131168812|NCT00525148|472238781|FG002|Overall Study|Other Adverse Event|1|||
131168813|NCT00525148|472238782|FG003|Overall Study|Other Adverse Event|8|||
131168814|NCT00525148|472238779|FG000|Overall Study|Progressive disease|18|||
131168815|NCT00525148|472238780|FG001|Overall Study|Progressive disease|30|||
131168816|NCT00525148|472238781|FG002|Overall Study|Progressive disease|6|||
131168817|NCT00525148|472238782|FG003|Overall Study|Progressive disease|49|||
131168818|NCT00525148|472238779|FG000|Overall Study|Refused continuation of study medication|0|||
131168819|NCT00525148|472238780|FG001|Overall Study|Refused continuation of study medication|2|||
131168820|NCT00525148|472238781|FG002|Overall Study|Refused continuation of study medication|0|||
131168821|NCT00525148|472238782|FG003|Overall Study|Refused continuation of study medication|1|||
131168822|NCT00525148|472238779|FG000|Overall Study|Other than stated|2|||
131168823|NCT00525148|472238780|FG001|Overall Study|Other than stated|1|||
131168824|NCT00525148|472238781|FG002|Overall Study|Other than stated|0|||
131168825|NCT00525148|472238782|FG003|Overall Study|Other than stated|3|||
131168826|NCT00830037|472238785|FG000|Overall Study|Withdrawal by Subject|2|||
131168827|NCT00830037|472238786|FG001|Overall Study|Withdrawal by Subject|3|||
131168828|NCT00830037|472238785|FG000|Overall Study|Lost to Follow-up|1|||
131168829|NCT00830037|472238786|FG001|Overall Study|Lost to Follow-up|2|||
131168830|NCT00830037|472238785|FG000|Overall Study|Active when terminated by DSMB|15|||
131168831|NCT00830037|472238786|FG001|Overall Study|Active when terminated by DSMB|14|||
131168832|NCT00114972|472238787|FG000|Overall Study|Withdrawal by Subject|40|||
131168833|NCT00114972|472238788|FG001|Overall Study|Withdrawal by Subject|7|||
131168834|NCT00114972|472238787|FG000|Overall Study|Lost to Follow-up|8|||
131168835|NCT00114972|472238788|FG001|Overall Study|Lost to Follow-up|5|||
131168836|NCT01425190|472238789|FG000|Overall Study|Full dose not consumed.|1|||
131168837|NCT01425190|472238790|FG001|Overall Study|Full dose not consumed.|0|||
131168838|NCT01425190|472238791|FG002|Overall Study|Full dose not consumed.|0|||
131168839|NCT00829166|472238793|FG000|Overall Study|Death|305|||
131168840|NCT00829166|472238794|FG001|Overall Study|Death|333|||
131168841|NCT00829166|472238793|FG000|Overall Study|Lost to Follow-up|5|||
131168842|NCT00829166|472238794|FG001|Overall Study|Lost to Follow-up|4|||
131168843|NCT00829166|472238793|FG000|Overall Study|Physician's Decision|4|||
131168844|NCT00829166|472238794|FG001|Overall Study|Physician's Decision|3|||
131168845|NCT00829166|472238793|FG000|Overall Study|Subject's Decision|41|||
131168846|NCT00829166|472238794|FG001|Overall Study|Subject's Decision|55|||
131168847|NCT00829166|472238793|FG000|Overall Study|Sponsor's Decision|137|||
131168848|NCT00829166|472238794|FG001|Overall Study|Sponsor's Decision|98|||
131168849|NCT00829166|472238793|FG000|Overall Study|Reason Not Specified|3|||
131168850|NCT00829166|472238794|FG001|Overall Study|Reason Not Specified|3|||
131168851|NCT01635933|472238795|FG000|Overall Study|Adverse Event|1|||
131168852|NCT01635933|472238796|FG001|Overall Study|Adverse Event|0|||
131168853|NCT01635933|472238795|FG000|Overall Study|Lost to Follow-up|0|||
131168854|NCT01635933|472238796|FG001|Overall Study|Lost to Follow-up|5|||
131168855|NCT01635933|472238795|FG000|Overall Study|Subject decision|1|||
131168856|NCT01635933|472238796|FG001|Overall Study|Subject decision|1|||
131168857|NCT01635933|472238795|FG000|Overall Study|Noncompliance|0|||
131168858|NCT01635933|472238796|FG001|Overall Study|Noncompliance|1|||
131168859|NCT01635933|472238795|FG000|Overall Study|No longer had transportation|0|||
131168860|NCT01635933|472238796|FG001|Overall Study|No longer had transportation|1|||
131168861|NCT03510663|472238797|FG000|Overall Study|Withdrawal by Subject|0|||
131168862|NCT03510663|472238798|FG001|Overall Study|Withdrawal by Subject|1|||
131168863|NCT03510663|472238799|FG002|Overall Study|Withdrawal by Subject|0|||
131168864|NCT03510663|472238800|FG003|Overall Study|Withdrawal by Subject|0|||
131168865|NCT03510663|472238801|FG004|Overall Study|Withdrawal by Subject|0|||
131168866|NCT03510663|472238802|FG005|Overall Study|Withdrawal by Subject|0|||
131168867|NCT03510663|472238803|FG006|Overall Study|Withdrawal by Subject|0|||
131168868|NCT03510663|472238804|FG007|Overall Study|Withdrawal by Subject|0|||
131168869|NCT01555463|472238805|FG000|Treatment|Adverse Event|6|||
131168870|NCT01555463|472238806|FG001|Treatment|Adverse Event|12|||
131168871|NCT01555463|472238805|FG000|Treatment|Withdrawal by Subject|24|||
131168872|NCT01555463|472238806|FG001|Treatment|Withdrawal by Subject|36|||
131168873|NCT01555463|472238805|FG000|Treatment|Lost to Follow-up|28|||
131168874|NCT01555463|472238806|FG001|Treatment|Lost to Follow-up|23|||
131168875|NCT01555463|472238805|FG000|Treatment|Protocol Violation|4|||
131168876|NCT01555463|472238806|FG001|Treatment|Protocol Violation|5|||
131168877|NCT01555463|472238805|FG000|Treatment|Other reason|2|||
131168878|NCT01555463|472238806|FG001|Treatment|Other reason|3|||
131168879|NCT01555463|472238805|FG000|Follow up|Adverse Event|2|||
131168880|NCT01555463|472238806|FG001|Follow up|Adverse Event|5|||
131168881|NCT01555463|472238805|FG000|Follow up|Death|0|||
131168882|NCT01555463|472238806|FG001|Follow up|Death|1|||
131168883|NCT01555463|472238805|FG000|Follow up|Withdrawal by Subject|22|||
131168884|NCT01555463|472238806|FG001|Follow up|Withdrawal by Subject|22|||
131168885|NCT01555463|472238805|FG000|Follow up|Lost to Follow-up|9|||
131168886|NCT01555463|472238806|FG001|Follow up|Lost to Follow-up|10|||
131168887|NCT01555463|472238805|FG000|Follow up|Protocol Violation|2|||
131168888|NCT01555463|472238806|FG001|Follow up|Protocol Violation|4|||
131168889|NCT01555463|472238805|FG000|Follow up|Other reason|3|||
131168890|NCT01555463|472238806|FG001|Follow up|Other reason|3|||
131168891|NCT02026271|472238807|FG000|Overall Study|Adverse Event|2|||
131168892|NCT02026271|472238808|FG001|Overall Study|Adverse Event|3|||
131168893|NCT02026271|472238809|FG002|Overall Study|Adverse Event|2|||
131168894|NCT02026271|472238810|FG003|Overall Study|Adverse Event|3|||
131168895|NCT02026271|472238811|FG004|Overall Study|Adverse Event|0|||
131168896|NCT02026271|472238807|FG000|Overall Study|Withdrawal by Subject|0|||
131168897|NCT02026271|472238808|FG001|Overall Study|Withdrawal by Subject|0|||
131168898|NCT02026271|472238809|FG002|Overall Study|Withdrawal by Subject|0|||
131168899|NCT02026271|472238810|FG003|Overall Study|Withdrawal by Subject|0|||
131168900|NCT02026271|472238811|FG004|Overall Study|Withdrawal by Subject|1|||
131168901|NCT04370028|472238812|FG000|Overall Study|Withdrawal by Subject|695|||
131168902|NCT04370028|472238812|FG000|Overall Study|Protocol Violation|9|||
131168903|NCT04370028|472238812|FG000|Overall Study|Adverse Event|3|||
131168904|NCT00540449|472238813|FG000|Overall Study|Adverse Event|12|||
131168905|NCT00540449|472238814|FG001|Overall Study|Adverse Event|32|||
131168906|NCT00540449|472238813|FG000|Overall Study|Sponsor's Decision|1|||
131168907|NCT00540449|472238814|FG001|Overall Study|Sponsor's Decision|1|||
131168908|NCT00540449|472238813|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
131168909|NCT00540449|472238814|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
131168910|NCT00540449|472238813|FG000|Overall Study|Lost to Follow-up|19|||
131168911|NCT00540449|472238814|FG001|Overall Study|Lost to Follow-up|17|||
131168912|NCT00540449|472238813|FG000|Overall Study|Subject Non-Compliant|7|||
131168913|NCT00540449|472238814|FG001|Overall Study|Subject Non-Compliant|5|||
131168914|NCT00540449|472238813|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
131168915|NCT00540449|472238814|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
131168916|NCT00540449|472238813|FG000|Overall Study|Withdrawal by Subject|10|||
131168917|NCT00540449|472238814|FG001|Overall Study|Withdrawal by Subject|10|||
131168918|NCT00540449|472238813|FG000|Overall Study|Other|1|||
131168919|NCT00540449|472238814|FG001|Overall Study|Other|4|||
131168920|NCT02928406|472238817|FG000|Overall Study|Death|780|||
131168921|NCT02928406|472238817|FG000|Overall Study|Progressive disease|3|||
131168922|NCT02928406|472238817|FG000|Overall Study|Lost to Follow-up|49|||
131168923|NCT02928406|472238817|FG000|Overall Study|Non-compliance|2|||
131168924|NCT02928406|472238817|FG000|Overall Study|Withdrawal by Subject|40|||
131168925|NCT02928406|472238817|FG000|Overall Study|Study terminated by sponsor|57|||
131168926|NCT02928406|472238817|FG000|Overall Study|Physician Decision|1|||
131168927|NCT02928406|472238817|FG000|Overall Study|Various reasons|72|||
131168928|NCT02149836|472238819|FG000|Overall Study|Withdrawal by Subject|1|||
131168929|NCT01204658|472238820|FG000|Primary Phase|Adverse Event|0|||
131168930|NCT01204658|472238821|FG001|Primary Phase|Adverse Event|0|||
131168931|NCT01204658|472238822|FG002|Primary Phase|Adverse Event|1|||
131168932|NCT01204658|472238823|FG003|Primary Phase|Adverse Event|0|||
130780706|NCT02493517|470823179|FG000|Overall Study|Withdrawal by Subject|1|||
130780707|NCT02493517|470823180|FG001|Overall Study|Withdrawal by Subject|2|||
130780708|NCT02493517|470823179|FG000|Overall Study|Adverse Event|0|||
130780709|NCT02493517|470823180|FG001|Overall Study|Adverse Event|2|||
130780710|NCT02493517|470823179|FG000|Overall Study|Missed study visit|0|||
130780711|NCT02493517|470823180|FG001|Overall Study|Missed study visit|1|||
130780712|NCT03718429|470823182|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
130780713|NCT03718429|470823183|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
130780714|NCT03718429|470823184|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
130780715|NCT03718429|470823185|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
130780716|NCT05404711|470823187|FG000|Completed Study Visit|Withdrawal by Subject|1|||
130780717|NCT05404711|470823187|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
130780718|NCT05404711|470823187|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
130780719|NCT05404711|470823187|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
130780720|NCT05404711|470823187|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
130780721|NCT05404711|470823187|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
130780722|NCT00325819|470823188|FG000|Overall Study|Study product lost in mail|2|||
130780723|NCT00325819|470823189|FG001|Overall Study|Study product lost in mail|1|||
131168933|NCT00786838|472238824|FG000|Overall Study|Physician Decision|4|||
131168934|NCT00786838|472238824|FG000|Overall Study|Death|4|||
131168935|NCT00786838|472238824|FG000|Overall Study|Adverse Event|6|||
131168936|NCT00786838|472238824|FG000|Overall Study|Progressive disease|31|||
131168937|NCT00786838|472238824|FG000|Overall Study|Withdrawal by Subject|4|||
131168938|NCT04937816|472238825|FG000|Overall Study|Study drug stopped, reason missing|5|||
130729777|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
130729778|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
130729779|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
131168939|NCT04937816|472238826|FG001|Overall Study|Study drug stopped, reason missing|3|||
131168940|NCT04937816|472238827|FG002|Overall Study|Study drug stopped, reason missing|4|||
131168941|NCT04937816|472238828|FG003|Overall Study|Study drug stopped, reason missing|6|||
131168942|NCT04937816|472238829|FG004|Overall Study|Study drug stopped, reason missing|1|||
131168943|NCT04937816|472238830|FG005|Overall Study|Study drug stopped, reason missing|0|||
131168944|NCT04937816|472238831|FG006|Overall Study|Study drug stopped, reason missing|0|||
131168945|NCT04937816|472238825|FG000|Overall Study|Other than stated below|173|||
131168946|NCT04937816|472238826|FG001|Overall Study|Other than stated below|143|||
131168947|NCT04937816|472238827|FG002|Overall Study|Other than stated below|125|||
131168948|NCT04937816|472238828|FG003|Overall Study|Other than stated below|44|||
131168949|NCT04937816|472238829|FG004|Overall Study|Other than stated below|45|||
131168950|NCT04937816|472238830|FG005|Overall Study|Other than stated below|28|||
131168951|NCT04937816|472238831|FG006|Overall Study|Other than stated below|31|||
131168952|NCT04937816|472238825|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
131168953|NCT04937816|472238826|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
131168954|NCT04937816|472238827|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
131168955|NCT04937816|472238828|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
131168956|NCT04937816|472238829|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
131168957|NCT04937816|472238830|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
131168958|NCT04937816|472238831|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
131168959|NCT04937816|472238825|FG000|Overall Study|Lost to Follow-up|15|||
131168960|NCT04937816|472238826|FG001|Overall Study|Lost to Follow-up|9|||
131168961|NCT04937816|472238827|FG002|Overall Study|Lost to Follow-up|6|||
131168962|NCT04937816|472238828|FG003|Overall Study|Lost to Follow-up|6|||
131168963|NCT04937816|472238829|FG004|Overall Study|Lost to Follow-up|16|||
131168964|NCT04937816|472238830|FG005|Overall Study|Lost to Follow-up|11|||
131168965|NCT04937816|472238831|FG006|Overall Study|Lost to Follow-up|17|||
131168966|NCT04937816|472238825|FG000|Overall Study|Protocol Violation|15|||
131168967|NCT04937816|472238826|FG001|Overall Study|Protocol Violation|15|||
131168968|NCT04937816|472238827|FG002|Overall Study|Protocol Violation|12|||
131168969|NCT04937816|472238828|FG003|Overall Study|Protocol Violation|30|||
131168970|NCT04937816|472238829|FG004|Overall Study|Protocol Violation|24|||
131168971|NCT04937816|472238830|FG005|Overall Study|Protocol Violation|5|||
131168972|NCT04937816|472238831|FG006|Overall Study|Protocol Violation|5|||
131168973|NCT04937816|472238825|FG000|Overall Study|Adverse Event|303|||
131168974|NCT04937816|472238826|FG001|Overall Study|Adverse Event|267|||
131168975|NCT04937816|472238827|FG002|Overall Study|Adverse Event|273|||
131168976|NCT04937816|472238828|FG003|Overall Study|Adverse Event|553|||
131168977|NCT04937816|472238829|FG004|Overall Study|Adverse Event|575|||
131168978|NCT04937816|472238830|FG005|Overall Study|Adverse Event|343|||
131168979|NCT04937816|472238831|FG006|Overall Study|Adverse Event|337|||
131168980|NCT04937816|472238825|FG000|Overall Study|Not treated|4|||
131168981|NCT04937816|472238826|FG001|Overall Study|Not treated|2|||
131168982|NCT04937816|472238827|FG002|Overall Study|Not treated|2|||
131168983|NCT04937816|472238828|FG003|Overall Study|Not treated|2|||
131168984|NCT04937816|472238829|FG004|Overall Study|Not treated|1|||
131168985|NCT04937816|472238830|FG005|Overall Study|Not treated|4|||
131168986|NCT04937816|472238831|FG006|Overall Study|Not treated|0|||
131168987|NCT04038255|472240421|FG000|Overall Study|Lost to Follow-up|0|||
131168988|NCT04038255|472240422|FG001|Overall Study|Lost to Follow-up|9|||
131168989|NCT04038255|472240423|FG002|Overall Study|Lost to Follow-up|5|||
131168990|NCT04038255|472240421|FG000|Overall Study|Withdrawal by Subject|0|||
131168991|NCT04038255|472240422|FG001|Overall Study|Withdrawal by Subject|0|||
131168992|NCT04038255|472240423|FG002|Overall Study|Withdrawal by Subject|1|||
131168993|NCT05183867|472240426|FG000|Overall Study|Withdrawal by Subject|3|||
131168994|NCT05183867|472240427|FG001|Overall Study|Withdrawal by Subject|2|||
131168995|NCT05183867|472240428|FG002|Overall Study|Withdrawal by Subject|0|||
131168996|NCT01286272|472240429|FG000|Overall Study|Ineligible after beginning treatment|1|||
131168997|NCT01286272|472240430|FG001|Overall Study|Ineligible after beginning treatment|3|||
131168998|NCT00423085|472240435|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
131168999|NCT00423085|472240436|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
131169000|NCT00423085|472240437|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
131169001|NCT00423085|472240438|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
131169002|NCT00423085|472240435|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
131169003|NCT00423085|472240436|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
131169004|NCT00423085|472240437|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
131169005|NCT00423085|472240438|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131169006|NCT00423085|472240435|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
131169007|NCT00423085|472240436|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
131169008|NCT00423085|472240437|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
131169009|NCT00423085|472240438|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
131169010|NCT00423085|472240435|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
130729780|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
130729781|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
130729782|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
131169011|NCT00423085|472240436|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
131169012|NCT00423085|472240437|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
131169013|NCT00423085|472240438|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
131169014|NCT00423085|472240435|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
131169015|NCT00423085|472240436|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
131169016|NCT00423085|472240437|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
131169017|NCT00423085|472240438|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
131169018|NCT00423085|472240435|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
131169019|NCT00423085|472240436|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
131169020|NCT00423085|472240437|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
131169021|NCT00423085|472240438|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
131169022|NCT00423085|472240435|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
131169023|NCT00423085|472240436|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
131169024|NCT00423085|472240437|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
131169025|NCT00423085|472240438|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
131169026|NCT00423085|472240435|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
131169027|NCT00423085|472240436|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
131169028|NCT00423085|472240437|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
131169029|NCT00423085|472240438|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
131169030|NCT00423085|472240435|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
131169031|NCT00423085|472240436|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
131169032|NCT00423085|472240437|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
131169033|NCT00423085|472240438|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
131169034|NCT00423085|472240435|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
131169035|NCT00423085|472240436|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
131169036|NCT00423085|472240437|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
131169037|NCT00423085|472240438|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
131169038|NCT00423085|472240435|FG000|52-Week Open-Label Extension Phase|Death|0|||
131169039|NCT00423085|472240436|FG001|52-Week Open-Label Extension Phase|Death|0|||
131169040|NCT00423085|472240437|FG002|52-Week Open-Label Extension Phase|Death|0|||
131169041|NCT00423085|472240438|FG003|52-Week Open-Label Extension Phase|Death|2|||
131169042|NCT00769704|472240439|FG000|Overall Study|Lost to Follow-up|3|||
131169043|NCT00769704|472240440|FG001|Overall Study|Lost to Follow-up|2|||
131169044|NCT00769704|472240439|FG000|Overall Study|Death|95|||
131169045|NCT00769704|472240440|FG001|Overall Study|Death|190|||
131169046|NCT00769704|472240439|FG000|Overall Study|Withdrawal by Subject|12|||
131169047|NCT00769704|472240440|FG001|Overall Study|Withdrawal by Subject|5|||
131169048|NCT00769704|472240439|FG000|Overall Study|Other|1|||
131169049|NCT00769704|472240440|FG001|Overall Study|Other|2|||
131169050|NCT04346628|472240445|FG000|Overall Study|Lost to Follow-up|4|||
131169051|NCT04346628|472240446|FG001|Overall Study|Lost to Follow-up|4|||
131169052|NCT04346628|472240445|FG000|Overall Study|Withdrew (had personal reasons)|2|||
131169053|NCT04346628|472240446|FG001|Overall Study|Withdrew (had personal reasons)|5|||
131169054|NCT04346628|472240445|FG000|Overall Study|Withdrew (medication intolerant)|0|||
131169055|NCT04346628|472240446|FG001|Overall Study|Withdrew (medication intolerant)|3|||
131169056|NCT04346628|472240445|FG000|Overall Study|Withdrew (declined intervention)|0|||
131169057|NCT04346628|472240446|FG001|Overall Study|Withdrew (declined intervention)|1|||
131169058|NCT01202227|472240451|FG000|Overall Study|Adverse Event|16|||
131169059|NCT01202227|472240451|FG000|Overall Study|Withdrawal by Subject|2|||
131169060|NCT01202227|472240451|FG000|Overall Study|Lack of Efficacy|1|||
131169061|NCT00643487|472240452|FG000|Overall Study|Technical difficulty|3|||
131169062|NCT04402008|472240453|FG000|Overall Study|Adverse Event|0|||
131169063|NCT04402008|472240454|FG001|Overall Study|Adverse Event|0|||
131169064|NCT04402008|472240455|FG002|Overall Study|Adverse Event|0|||
131169065|NCT04402008|472240456|FG003|Overall Study|Adverse Event|1|||
131169066|NCT04402008|472240457|FG004|Overall Study|Adverse Event|0|||
131169067|NCT04402008|472240458|FG005|Overall Study|Adverse Event|0|||
131169068|NCT04402008|472240459|FG006|Overall Study|Adverse Event|0|||
131169069|NCT04402008|472240453|FG000|Overall Study|Disease Progression|3|||
131169070|NCT04402008|472240454|FG001|Overall Study|Disease Progression|2|||
130729783|NCT03104400|470633601|FG000|Period 2 Week 56 - 260)|Other|0|||
131169071|NCT04402008|472240455|FG002|Overall Study|Disease Progression|3|||
131169072|NCT04402008|472240456|FG003|Overall Study|Disease Progression|3|||
131169073|NCT04402008|472240457|FG004|Overall Study|Disease Progression|4|||
131169074|NCT04402008|472240458|FG005|Overall Study|Disease Progression|3|||
131169075|NCT04402008|472240459|FG006|Overall Study|Disease Progression|10|||
131169076|NCT04402008|472240453|FG000|Overall Study|Withdrawal by Subject|0|||
130729784|NCT03104400|470633602|FG001|Period 2 Week 56 - 260)|Other|0|||
130729785|NCT03104400|470633603|FG002|Period 2 Week 56 - 260)|Other|0|||
130729786|NCT03104400|470633604|FG003|Period 2 Week 56 - 260)|Other|0|||
130729787|NCT03104400|470633605|FG004|Period 2 Week 56 - 260)|Other|0|||
130729788|NCT03104400|470633606|FG005|Period 2 Week 56 - 260)|Other|0|||
130729789|NCT03104400|470633607|FG006|Period 2 Week 56 - 260)|Other|0|||
130729790|NCT03104400|470633608|FG007|Period 2 Week 56 - 260)|Other|0|||
130729791|NCT03104400|470633609|FG008|Period 2 Week 56 - 260)|Other|1|||
130729792|NCT03104400|470633610|FG009|Period 2 Week 56 - 260)|Other|1|||
131169077|NCT04402008|472240454|FG001|Overall Study|Withdrawal by Subject|1|||
131169078|NCT04402008|472240455|FG002|Overall Study|Withdrawal by Subject|0|||
131169079|NCT04402008|472240456|FG003|Overall Study|Withdrawal by Subject|0|||
131169080|NCT04402008|472240457|FG004|Overall Study|Withdrawal by Subject|1|||
131169081|NCT04402008|472240458|FG005|Overall Study|Withdrawal by Subject|0|||
131169082|NCT04402008|472240459|FG006|Overall Study|Withdrawal by Subject|0|||
131169083|NCT04402008|472240453|FG000|Overall Study|Sponsor Decision|0|||
131169084|NCT04402008|472240454|FG001|Overall Study|Sponsor Decision|0|||
131169085|NCT04402008|472240455|FG002|Overall Study|Sponsor Decision|0|||
131169086|NCT04402008|472240456|FG003|Overall Study|Sponsor Decision|0|||
131169087|NCT04402008|472240457|FG004|Overall Study|Sponsor Decision|0|||
131169088|NCT04402008|472240458|FG005|Overall Study|Sponsor Decision|0|||
131169089|NCT04402008|472240459|FG006|Overall Study|Sponsor Decision|3|||
131169090|NCT04402008|472240453|FG000|Overall Study|Death|0|||
131169091|NCT04402008|472240454|FG001|Overall Study|Death|0|||
131169092|NCT04402008|472240455|FG002|Overall Study|Death|0|||
131169093|NCT04402008|472240456|FG003|Overall Study|Death|0|||
131169094|NCT04402008|472240457|FG004|Overall Study|Death|1|||
131169095|NCT04402008|472240458|FG005|Overall Study|Death|0|||
131169096|NCT04402008|472240459|FG006|Overall Study|Death|2|||
131169097|NCT04402008|472240453|FG000|Overall Study|Other|0|||
131169098|NCT04402008|472240454|FG001|Overall Study|Other|0|||
131169099|NCT04402008|472240455|FG002|Overall Study|Other|0|||
131169100|NCT04402008|472240456|FG003|Overall Study|Other|0|||
131169101|NCT04402008|472240457|FG004|Overall Study|Other|0|||
131169102|NCT04402008|472240458|FG005|Overall Study|Other|0|||
131169103|NCT04402008|472240459|FG006|Overall Study|Other|5|||
131169104|NCT01533935|472240460|FG000|Overall Study|Adverse Event|5|||
131169105|NCT01533935|472240461|FG001|Overall Study|Adverse Event|7|||
131169106|NCT01533935|472240462|FG002|Overall Study|Adverse Event|1|||
131169107|NCT01533935|472240463|FG003|Overall Study|Adverse Event|5|||
131169108|NCT01533935|472240464|FG004|Overall Study|Adverse Event|3|||
130729825|NCT02129608|470633615|FG000|Overall Study|Lost to Follow-up|0|||
130729826|NCT02129608|470633616|FG001|Overall Study|Lost to Follow-up|1|||
130729827|NCT02129608|470633617|FG002|Overall Study|Lost to Follow-up|1|||
130729828|NCT02129608|470633615|FG000|Overall Study|Withdrawal by Subject|0|||
130729829|NCT02129608|470633616|FG001|Overall Study|Withdrawal by Subject|0|||
130729830|NCT02129608|470633617|FG002|Overall Study|Withdrawal by Subject|2|||
130729831|NCT02437903|470633620|FG000|Overall Study|Adverse Event|1|||
130729832|NCT02437903|470633620|FG000|Overall Study|Withdrawal by Subject|1|||
130729833|NCT02437903|470633620|FG000|Overall Study|Lost to Follow-up|3|||
130729834|NCT00616421|470633621|FG000|Overall Study|Withdrawal by Subject|9|||
130729835|NCT00616421|470633622|FG001|Overall Study|Withdrawal by Subject|11|||
130729836|NCT00616421|470633623|FG002|Overall Study|Withdrawal by Subject|8|||
130729837|NCT00616421|470633621|FG000|Overall Study|Lost to Follow-up|12|||
130729838|NCT00616421|470633622|FG001|Overall Study|Lost to Follow-up|26|||
131169109|NCT01533935|472240460|FG000|Overall Study|Protocol Violation|0|||
130729839|NCT00616421|470633623|FG002|Overall Study|Lost to Follow-up|30|||
130780724|NCT00325819|470823188|FG000|Overall Study|Did not take a dose of study product|4|||
130780725|NCT00325819|470823189|FG001|Overall Study|Did not take a dose of study product|9|||
131169110|NCT01533935|472240461|FG001|Overall Study|Protocol Violation|2|||
131169111|NCT01533935|472240462|FG002|Overall Study|Protocol Violation|0|||
130729840|NCT00616421|470633621|FG000|Overall Study|Inappropriate enrollment|3|||
130729841|NCT00616421|470633622|FG001|Overall Study|Inappropriate enrollment|0|||
130729842|NCT00616421|470633623|FG002|Overall Study|Inappropriate enrollment|1|||
130729843|NCT00616421|470633621|FG000|Overall Study|Administrative reason|1|||
130729844|NCT00616421|470633622|FG001|Overall Study|Administrative reason|0|||
130729845|NCT00616421|470633623|FG002|Overall Study|Administrative reason|0|||
130780726|NCT00325819|470823188|FG000|Overall Study|Lost to Follow-up|3|||
130780727|NCT00325819|470823189|FG001|Overall Study|Lost to Follow-up|3|||
130780728|NCT02346877|470823190|FG000|Overall Study|Adverse Event|1|||
130729846|NCT00616421|470633621|FG000|Overall Study|Protocol Violation|0|||
130729847|NCT00616421|470633622|FG001|Overall Study|Protocol Violation|1|||
130780729|NCT02346877|470823191|FG001|Overall Study|Adverse Event|0|||
130729848|NCT00616421|470633623|FG002|Overall Study|Protocol Violation|2|||
130729849|NCT00616421|470633621|FG000|Overall Study|Unable to classify|1|||
130780730|NCT02346877|470823190|FG000|Overall Study|Administrative Decision|1|||
131169112|NCT01533935|472240463|FG003|Overall Study|Protocol Violation|0|||
131169113|NCT01533935|472240464|FG004|Overall Study|Protocol Violation|0|||
131169114|NCT01533935|472240460|FG000|Overall Study|Lost to Follow-up|0|||
131169115|NCT01533935|472240461|FG001|Overall Study|Lost to Follow-up|0|||
131169116|NCT01533935|472240462|FG002|Overall Study|Lost to Follow-up|1|||
131169117|NCT01533935|472240463|FG003|Overall Study|Lost to Follow-up|0|||
131169118|NCT01533935|472240464|FG004|Overall Study|Lost to Follow-up|0|||
131169119|NCT01533935|472240460|FG000|Overall Study|Withdrawal by Subject|0|||
131169120|NCT01533935|472240461|FG001|Overall Study|Withdrawal by Subject|4|||
131169121|NCT01533935|472240462|FG002|Overall Study|Withdrawal by Subject|5|||
131169122|NCT01533935|472240463|FG003|Overall Study|Withdrawal by Subject|2|||
131169123|NCT01533935|472240464|FG004|Overall Study|Withdrawal by Subject|4|||
131169124|NCT01533935|472240460|FG000|Overall Study|Other reason not defined above|1|||
131169125|NCT01533935|472240461|FG001|Overall Study|Other reason not defined above|0|||
131169126|NCT01533935|472240462|FG002|Overall Study|Other reason not defined above|1|||
131169127|NCT01533935|472240463|FG003|Overall Study|Other reason not defined above|0|||
131169128|NCT01533935|472240464|FG004|Overall Study|Other reason not defined above|1|||
131169129|NCT03430245|472240465|FG000|Overall Study|Withdrawal by Subject|6|||
131169130|NCT03430245|472240465|FG000|Overall Study|Lost to Follow-up|1|||
131169131|NCT05628181|472240466|FG000|Overall Study|Death|2|||
131169132|NCT05628181|472240467|FG001|Overall Study|Death|4|||
131169133|NCT05628181|472240468|FG002|Overall Study|Death|0|||
131169134|NCT01428063|472240469|FG000|Overall Study|Lack of Efficacy|8|||
131169135|NCT01428063|472240470|FG001|Overall Study|Lack of Efficacy|4|||
131169136|NCT01428063|472240471|FG002|Overall Study|Lack of Efficacy|1|||
131169137|NCT01428063|472240469|FG000|Overall Study|Adverse Event|2|||
131169138|NCT01428063|472240470|FG001|Overall Study|Adverse Event|3|||
131169139|NCT01428063|472240471|FG002|Overall Study|Adverse Event|0|||
131169140|NCT01428063|472240469|FG000|Overall Study|Lost to Follow-up|0|||
131169141|NCT01428063|472240470|FG001|Overall Study|Lost to Follow-up|2|||
131169142|NCT01428063|472240471|FG002|Overall Study|Lost to Follow-up|0|||
131169143|NCT01428063|472240469|FG000|Overall Study|No longer meets study criteria|0|||
131169144|NCT01428063|472240470|FG001|Overall Study|No longer meets study criteria|1|||
131169145|NCT01428063|472240471|FG002|Overall Study|No longer meets study criteria|0|||
131169146|NCT02284906|472240472|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131169147|NCT02284906|472240473|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
131169148|NCT02284906|472240474|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131169149|NCT02284906|472240472|FG000|Overall Study|Major Protocol Deviation|0|||
131169150|NCT02284906|472240473|FG001|Overall Study|Major Protocol Deviation|1|||
131169151|NCT02284906|472240474|FG002|Overall Study|Major Protocol Deviation|0|||
131169152|NCT02284906|472240472|FG000|Overall Study|Voluntary Withdrawal|2|||
131169153|NCT02284906|472240473|FG001|Overall Study|Voluntary Withdrawal|4|||
131169154|NCT02284906|472240474|FG002|Overall Study|Voluntary Withdrawal|5|||
131169155|NCT02284906|472240472|FG000|Overall Study|Study Termination|0|||
131169156|NCT02284906|472240473|FG001|Overall Study|Study Termination|11|||
131169157|NCT02284906|472240474|FG002|Overall Study|Study Termination|14|||
131169158|NCT02284906|472240472|FG000|Overall Study|Reason not Specified|1|||
131169159|NCT02284906|472240473|FG001|Overall Study|Reason not Specified|1|||
131169160|NCT02284906|472240474|FG002|Overall Study|Reason not Specified|0|||
131169161|NCT00316303|472240476|FG000|Overall Study|Lost to Follow-up|11|||
131169162|NCT00316303|472240477|FG001|Overall Study|Lost to Follow-up|16|||
131169163|NCT00532948|472240478|FG000|Overall Study|Protocol Violation|1|||
131169164|NCT00532948|472240479|FG001|Overall Study|Protocol Violation|0|||
131169165|NCT00532948|472240480|FG002|Overall Study|Protocol Violation|0|||
131169166|NCT00532948|472240478|FG000|Overall Study|Death|3|||
131169167|NCT00532948|472240479|FG001|Overall Study|Death|3|||
131169168|NCT00532948|472240480|FG002|Overall Study|Death|4|||
131169169|NCT00532948|472240478|FG000|Overall Study|Violation of selection criteria at entry|0|||
131169170|NCT00532948|472240479|FG001|Overall Study|Violation of selection criteria at entry|1|||
131169171|NCT00532948|472240480|FG002|Overall Study|Violation of selection criteria at entry|0|||
131169172|NCT00532948|472240478|FG000|Overall Study|Failure to return|0|||
131169173|NCT00532948|472240479|FG001|Overall Study|Failure to return|1|||
131169174|NCT00532948|472240480|FG002|Overall Study|Failure to return|0|||
131169175|NCT02575079|472240481|FG000|Overall Study|Death|3|||
131169176|NCT02575079|472240482|FG001|Overall Study|Death|0|||
131169177|NCT02575079|472240481|FG000|Overall Study|Withdrawal by Subject|3|||
131169178|NCT02575079|472240482|FG001|Overall Study|Withdrawal by Subject|0|||
131169179|NCT00788775|472240489|FG000|Overall Study|Progressive Disease|8|||
131169180|NCT00788775|472240490|FG001|Overall Study|Progressive Disease|6|||
131169181|NCT00788775|472240489|FG000|Overall Study|Withdrawal by Subject|0|||
131169182|NCT00788775|472240490|FG001|Overall Study|Withdrawal by Subject|2|||
131169183|NCT00788775|472240489|FG000|Overall Study|Patient Non-Compliance|1|||
131169184|NCT00788775|472240490|FG001|Overall Study|Patient Non-Compliance|0|||
131169185|NCT00788775|472240489|FG000|Overall Study|Patient's measurable disease resected.|1|||
131169186|NCT00788775|472240490|FG001|Overall Study|Patient's measurable disease resected.|0|||
131169187|NCT00578864|472240491|FG000|Overall Study|Death|1|||
131169188|NCT00578864|472240492|FG001|Overall Study|Death|0|||
131169189|NCT01087528|472240496|FG000|Overall Study|Withdrawal by Subject|1|||
131169190|NCT01087528|472240496|FG000|Overall Study|Incomplete CE procedure|6|||
131169191|NCT00905307|472240501|FG000|Overall Study|Switched to Open Label Rescue|7|||
131169192|NCT00905307|472240502|FG001|Overall Study|Switched to Open Label Rescue|17|||
131169193|NCT00905307|472240503|FG002|Overall Study|Switched to Open Label Rescue|11|||
131169194|NCT00905307|472240504|FG003|Overall Study|Switched to Open Label Rescue|11|||
131169195|NCT00905307|472240505|FG004|Overall Study|Switched to Open Label Rescue|4|||
131169196|NCT00905307|472240506|FG005|Overall Study|Switched to Open Label Rescue|15|||
131169197|NCT00905307|472240501|FG000|Overall Study|Lost to Follow-up|0|||
131169198|NCT00905307|472240502|FG001|Overall Study|Lost to Follow-up|0|||
131169199|NCT00905307|472240503|FG002|Overall Study|Lost to Follow-up|0|||
131169200|NCT00905307|472240504|FG003|Overall Study|Lost to Follow-up|0|||
131169201|NCT00905307|472240505|FG004|Overall Study|Lost to Follow-up|1|||
131169202|NCT00905307|472240506|FG005|Overall Study|Lost to Follow-up|1|||
131169203|NCT00905307|472240501|FG000|Overall Study|Adverse Event|3|||
131169204|NCT00905307|472240502|FG001|Overall Study|Adverse Event|4|||
131169205|NCT00905307|472240503|FG002|Overall Study|Adverse Event|5|||
131169206|NCT00905307|472240504|FG003|Overall Study|Adverse Event|11|||
131169207|NCT00905307|472240505|FG004|Overall Study|Adverse Event|3|||
131169208|NCT00905307|472240506|FG005|Overall Study|Adverse Event|5|||
131169209|NCT00905307|472240501|FG000|Overall Study|Withdrawal by Subject|5|||
131169210|NCT00905307|472240502|FG001|Overall Study|Withdrawal by Subject|13|||
131169211|NCT00905307|472240503|FG002|Overall Study|Withdrawal by Subject|15|||
131169212|NCT00905307|472240504|FG003|Overall Study|Withdrawal by Subject|11|||
131169213|NCT00905307|472240505|FG004|Overall Study|Withdrawal by Subject|4|||
131169214|NCT00905307|472240506|FG005|Overall Study|Withdrawal by Subject|13|||
131169215|NCT00905307|472240501|FG000|Overall Study|Protocol Violation|1|||
131169216|NCT00905307|472240502|FG001|Overall Study|Protocol Violation|0|||
131169217|NCT00905307|472240503|FG002|Overall Study|Protocol Violation|1|||
131169218|NCT00905307|472240504|FG003|Overall Study|Protocol Violation|0|||
131169219|NCT00905307|472240505|FG004|Overall Study|Protocol Violation|0|||
131169220|NCT00905307|472240506|FG005|Overall Study|Protocol Violation|0|||
131169221|NCT00905307|472240501|FG000|Overall Study|Lack of Efficacy|6|||
131169222|NCT00905307|472240502|FG001|Overall Study|Lack of Efficacy|3|||
131169223|NCT00905307|472240503|FG002|Overall Study|Lack of Efficacy|5|||
131169224|NCT00905307|472240504|FG003|Overall Study|Lack of Efficacy|4|||
131169225|NCT00905307|472240505|FG004|Overall Study|Lack of Efficacy|4|||
131169226|NCT00905307|472240506|FG005|Overall Study|Lack of Efficacy|8|||
131169227|NCT04060667|472240507|FG000|Overall Study|Lost to Follow-up|75|||
131169228|NCT04060667|472240508|FG001|Overall Study|Lost to Follow-up|10|||
131169229|NCT01035255|472240510|FG000|Overall Study|Death|724|||
131169230|NCT01035255|472240511|FG001|Overall Study|Death|844|||
131169231|NCT01035255|472240510|FG000|Overall Study|Lost to Follow-up|2|||
131169232|NCT01035255|472240511|FG001|Overall Study|Lost to Follow-up|5|||
131169233|NCT01035255|472240510|FG000|Overall Study|patient's request|15|||
131169234|NCT01035255|472240511|FG001|Overall Study|patient's request|13|||
131169235|NCT01912729|472240512|FG000|Overall Study|Withdrawal by Subject|0|||
131169236|NCT01912729|472240513|FG001|Overall Study|Withdrawal by Subject|1|||
131169237|NCT00195260|472240515|FG000|Part 1: Dose Escalation|Adverse Event|0|||
131169238|NCT00195260|472240516|FG001|Part 1: Dose Escalation|Adverse Event|1|||
131169239|NCT00195260|472240517|FG002|Part 1: Dose Escalation|Adverse Event|0|||
131169240|NCT00195260|472240518|FG003|Part 1: Dose Escalation|Adverse Event|1|||
131169241|NCT00195260|472240519|FG004|Part 1: Dose Escalation|Adverse Event|1|||
131169242|NCT00195260|472240520|FG005|Part 1: Dose Escalation|Adverse Event|0|||
131169243|NCT00195260|472240521|FG006|Part 1: Dose Escalation|Adverse Event|3|||
131169244|NCT00195260|472240522|FG007|Part 1: Dose Escalation|Adverse Event|0|||
131169245|NCT00195260|472240523|FG008|Part 1: Dose Escalation|Adverse Event|0|||
131169246|NCT00195260|472240524|FG009|Part 1: Dose Escalation|Adverse Event|0|||
131169247|NCT00195260|472240525|FG010|Part 1: Dose Escalation|Adverse Event|0|||
131169248|NCT00195260|472240515|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131169249|NCT00195260|472240516|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131169250|NCT00195260|472240517|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131169251|NCT00195260|472240518|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131169252|NCT00195260|472240519|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
131169253|NCT00195260|472240520|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131169254|NCT00195260|472240521|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131169255|NCT00195260|472240522|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
131169256|NCT00195260|472240523|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131169257|NCT00195260|472240524|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131169258|NCT00195260|472240525|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131169259|NCT00195260|472240515|FG000|Part 1: Dose Escalation|Death|0|||
131169260|NCT00195260|472240516|FG001|Part 1: Dose Escalation|Death|0|||
131169261|NCT00195260|472240517|FG002|Part 1: Dose Escalation|Death|0|||
130729850|NCT00616421|470633622|FG001|Overall Study|Unable to classify|0|||
130729851|NCT00616421|470633623|FG002|Overall Study|Unable to classify|0|||
131169262|NCT00195260|472240518|FG003|Part 1: Dose Escalation|Death|0|||
131169263|NCT00195260|472240519|FG004|Part 1: Dose Escalation|Death|0|||
131169264|NCT00195260|472240520|FG005|Part 1: Dose Escalation|Death|0|||
131169265|NCT00195260|472240521|FG006|Part 1: Dose Escalation|Death|0|||
131169266|NCT00195260|472240522|FG007|Part 1: Dose Escalation|Death|1|||
130729852|NCT02661217|470633624|FG000|Overall Study|Physician Decision|12|||
130780731|NCT02346877|470823191|FG001|Overall Study|Administrative Decision|0|||
130780732|NCT02346877|470823190|FG000|Overall Study|Sponsor Decision|12|||
131169267|NCT00195260|472240523|FG008|Part 1: Dose Escalation|Death|0|||
131169268|NCT00195260|472240524|FG009|Part 1: Dose Escalation|Death|0|||
131169269|NCT00195260|472240525|FG010|Part 1: Dose Escalation|Death|0|||
131169270|NCT00195260|472240515|FG000|Part 1: Dose Escalation|Disease Progression|3|||
131169271|NCT00195260|472240516|FG001|Part 1: Dose Escalation|Disease Progression|2|||
131169272|NCT00195260|472240517|FG002|Part 1: Dose Escalation|Disease Progression|5|||
131169273|NCT00195260|472240518|FG003|Part 1: Dose Escalation|Disease Progression|6|||
131169274|NCT00195260|472240519|FG004|Part 1: Dose Escalation|Disease Progression|4|||
131169275|NCT00195260|472240520|FG005|Part 1: Dose Escalation|Disease Progression|6|||
131169276|NCT00195260|472240521|FG006|Part 1: Dose Escalation|Disease Progression|7|||
131169277|NCT00195260|472240522|FG007|Part 1: Dose Escalation|Disease Progression|4|||
131169278|NCT00195260|472240523|FG008|Part 1: Dose Escalation|Disease Progression|0|||
131169279|NCT00195260|472240524|FG009|Part 1: Dose Escalation|Disease Progression|0|||
131169280|NCT00195260|472240525|FG010|Part 1: Dose Escalation|Disease Progression|0|||
131169281|NCT00195260|472240515|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
131169282|NCT00195260|472240516|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
131169283|NCT00195260|472240517|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
131169284|NCT00195260|472240518|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131169285|NCT00195260|472240519|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131169286|NCT00195260|472240520|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
131169287|NCT00195260|472240521|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131169288|NCT00195260|472240522|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131169289|NCT00195260|472240523|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131169290|NCT00195260|472240524|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131169291|NCT00195260|472240525|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
131169292|NCT00195260|472240515|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131169293|NCT00195260|472240516|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131169294|NCT00195260|472240517|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131169295|NCT00195260|472240518|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131169296|NCT00195260|472240519|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131169297|NCT00195260|472240520|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131169298|NCT00195260|472240521|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131169299|NCT00195260|472240522|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
131169300|NCT00195260|472240523|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
131169301|NCT00195260|472240524|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
131169302|NCT00195260|472240525|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
131169303|NCT00195260|472240515|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131169304|NCT00195260|472240516|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131169305|NCT00195260|472240517|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131169306|NCT00195260|472240518|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131169307|NCT00195260|472240519|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131169308|NCT00195260|472240520|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131169309|NCT00195260|472240521|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131169310|NCT00195260|472240522|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
131169311|NCT00195260|472240523|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
131169312|NCT00195260|472240524|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
131169313|NCT00195260|472240525|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
131169314|NCT00195260|472240515|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131169315|NCT00195260|472240516|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131169316|NCT00195260|472240517|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131169317|NCT00195260|472240518|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131169318|NCT00195260|472240519|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131169319|NCT00195260|472240520|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131169320|NCT00195260|472240521|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131169321|NCT00195260|472240522|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
131169322|NCT00195260|472240523|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
131169323|NCT00195260|472240524|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
131169324|NCT00195260|472240525|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
131169325|NCT00195260|472240515|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131169326|NCT00195260|472240516|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131169327|NCT00195260|472240517|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131169328|NCT00195260|472240518|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131169329|NCT00195260|472240519|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131169330|NCT00195260|472240520|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131235653|NCT00927810|472490993|FG000|Overall Study|Withdrawal by Subject|0|||
130780733|NCT02346877|470823191|FG001|Overall Study|Sponsor Decision|0|||
130729853|NCT02661217|470633625|FG001|Overall Study|Physician Decision|15|||
130729854|NCT02661217|470633624|FG000|Overall Study|Lost to Follow-up|1|||
130729855|NCT02661217|470633625|FG001|Overall Study|Lost to Follow-up|4|||
130729856|NCT02661217|470633624|FG000|Overall Study|Protocol Deviation|0|||
130729857|NCT02661217|470633625|FG001|Overall Study|Protocol Deviation|4|||
131169331|NCT00195260|472240521|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131169332|NCT00195260|472240522|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
131169333|NCT00195260|472240523|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
131169334|NCT00195260|472240524|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
131169335|NCT00195260|472240525|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
131169336|NCT01952834|472240528|FG000|Overall Study|Adverse Event|1|||
131169337|NCT03007953|472240529|FG000|Overall Study|Withdrawal by Subject|5|||
131169338|NCT03007953|472240530|FG001|Overall Study|Withdrawal by Subject|2|||
131169339|NCT03007953|472240529|FG000|Overall Study|Death|5|||
131169340|NCT03007953|472240530|FG001|Overall Study|Death|7|||
131169341|NCT03007953|472240529|FG000|Overall Study|Lost to Follow-up|3|||
131169342|NCT03007953|472240530|FG001|Overall Study|Lost to Follow-up|2|||
131169343|NCT03007953|472240529|FG000|Overall Study|Enrolled in Hospice|3|||
131169344|NCT03007953|472240530|FG001|Overall Study|Enrolled in Hospice|2|||
131169345|NCT03196297|472240531|FG000|Main Period|Withdrawal by Subject|4|||
131169346|NCT03196297|472240531|FG000|Extension Period|Withdrawal by Subject|1|||
131169347|NCT03196297|472240531|FG000|Extension Period|Lack of Efficacy|2|||
131169348|NCT02213198|472240536|FG000|Baseline|No show for intake|7|||
131169349|NCT02213198|472240537|FG001|Baseline|No show for intake|9|||
131169350|NCT02213198|472240536|FG000|Baseline|Withdrawal by Subject|34|||
131169351|NCT02213198|472240537|FG001|Baseline|Withdrawal by Subject|11|||
131169352|NCT02213198|472240536|FG000|Baseline|transferred out of clinic|7|||
131169353|NCT02213198|472240537|FG001|Baseline|transferred out of clinic|9|||
131169354|NCT02213198|472240536|FG000|Baseline|Lost to Follow-up|40|||
131169355|NCT02213198|472240537|FG001|Baseline|Lost to Follow-up|21|||
131169356|NCT02213198|472240536|FG000|Baseline|incarcerated,violent|0|||
131169357|NCT02213198|472240537|FG001|Baseline|incarcerated,violent|1|||
131169358|NCT02213198|472240536|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
131169359|NCT02213198|472240537|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
131169360|NCT02213198|472240536|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
131169361|NCT02213198|472240537|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
131169362|NCT02213198|472240536|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
131169363|NCT02213198|472240537|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
131169364|NCT02213198|472240536|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
131169365|NCT02213198|472240537|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
131169366|NCT02213198|472240536|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
131169367|NCT02213198|472240537|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
131169368|NCT02213198|472240536|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
131169369|NCT02213198|472240537|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
131169370|NCT04743635|472240538|FG000|Overall Study|Lost to Follow-up|2|||
131169371|NCT04743635|472240539|FG001|Overall Study|Lost to Follow-up|0|||
131169372|NCT03382899|472240540|FG000|Overall Study|Ineligibility Determined|0|||
131169373|NCT03382899|472240541|FG001|Overall Study|Ineligibility Determined|1|||
131169374|NCT03382899|472240540|FG000|Overall Study|Lost to Follow-up|0|||
131169375|NCT03382899|472240541|FG001|Overall Study|Lost to Follow-up|1|||
131169376|NCT03382899|472240540|FG000|Overall Study|Sponsor's decision|31|||
131169377|NCT03382899|472240541|FG001|Overall Study|Sponsor's decision|28|||
131169378|NCT03382899|472240540|FG000|Overall Study|Withdrawal by Subject|0|||
131169379|NCT03382899|472240541|FG001|Overall Study|Withdrawal by Subject|5|||
131169380|NCT02689219|472240544|FG000|Overall Study|Death|1|||
131169381|NCT02689219|472240545|FG001|Overall Study|Death|1|||
131169382|NCT02689219|472240544|FG000|Overall Study|Disease Progression|10|||
131169383|NCT02689219|472240545|FG001|Overall Study|Disease Progression|6|||
131169384|NCT02426658|472240546|FG000|Overall Study|Withdrawal by Subject|1|||
131169385|NCT02426658|472240546|FG000|Overall Study|Patient expired before treatment|2|||
131169386|NCT00524316|472240547|FG000|Overall Study|Withdrawal by Subject|2|||
130729858|NCT02661217|470633624|FG000|Overall Study|Non-compliance with study treatment|5|||
131169387|NCT00524316|472240547|FG000|Overall Study|Adverse Event|7|||
131169388|NCT00524316|472240547|FG000|Overall Study|Disease Progression|7|||
131169389|NCT01199263|472240548|FG000|Overall Study|Ineligible|0|||
131169390|NCT01199263|472240549|FG001|Overall Study|Ineligible|2|||
131169391|NCT01199263|472240548|FG000|Overall Study|Never Treated|6|||
131169392|NCT01199263|472240549|FG001|Overall Study|Never Treated|0|||
131169393|NCT01402284|472240550|FG000|Overall Study|Withdrawal consent|2|||
131169394|NCT01402284|472240550|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
131169395|NCT01402284|472240550|FG000|Overall Study|Physician Decision|1|||
131169396|NCT01402284|472240550|FG000|Overall Study|Disease progression on study|10|||
130729859|NCT02661217|470633625|FG001|Overall Study|Non-compliance with study treatment|5|||
130729860|NCT02661217|470633624|FG000|Overall Study|Death|21|||
130729861|NCT02661217|470633625|FG001|Overall Study|Death|15|||
131169397|NCT00905021|472240554|FG000|Overall Study|Adverse Event|2|||
130780734|NCT02346877|470823190|FG000|Overall Study|Missing|5|||
130780735|NCT02346877|470823191|FG001|Overall Study|Missing|0|||
130780736|NCT04376515|470823194|FG000|Overall Study|Found to have been vaccinated before study start|6|||
130780737|NCT04376515|470823195|FG001|Overall Study|Found to have been vaccinated before study start|6|||
131169398|NCT05513391|472240555|FG000|Overall Study|Adverse Event|1|||
131169399|NCT05513391|472240556|FG001|Overall Study|Adverse Event|0|||
130780738|NCT03811821|470823196|FG000|Overall Study|Adverse Event|1|||
131169400|NCT05513391|472240555|FG000|Overall Study|Protocol Deviation|0|||
131169401|NCT05513391|472240556|FG001|Overall Study|Protocol Deviation|1|||
131169402|NCT05513391|472240555|FG000|Overall Study|Withdrawal by Subject|3|||
131169403|NCT05513391|472240556|FG001|Overall Study|Withdrawal by Subject|1|||
131169404|NCT05513391|472240555|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
131169405|NCT05513391|472240556|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
131169406|NCT05513391|472240555|FG000|Overall Study|Lost to Follow-up|0|||
131169407|NCT05513391|472240556|FG001|Overall Study|Lost to Follow-up|2|||
131169408|NCT00436215|472240557|FG000|Overall Study|Refused further treatment|3|||
131169409|NCT00436215|472240557|FG000|Overall Study|Small bowel obstruction|1|||
131169410|NCT00309777|472240558|FG000|Overall Study|Adverse Event|13|||
131169411|NCT00309777|472240559|FG001|Overall Study|Adverse Event|2|||
131169412|NCT00309777|472240560|FG002|Overall Study|Adverse Event|8|||
131169413|NCT00309777|472240561|FG003|Overall Study|Adverse Event|1|||
131169414|NCT00309777|472240558|FG000|Overall Study|Protocol Violation|4|||
131169415|NCT00309777|472240559|FG001|Overall Study|Protocol Violation|1|||
131169416|NCT00309777|472240560|FG002|Overall Study|Protocol Violation|3|||
131169417|NCT00309777|472240561|FG003|Overall Study|Protocol Violation|1|||
131169418|NCT00309777|472240558|FG000|Overall Study|Withdrawal by Subject|6|||
131169419|NCT00309777|472240559|FG001|Overall Study|Withdrawal by Subject|5|||
131169420|NCT00309777|472240560|FG002|Overall Study|Withdrawal by Subject|7|||
131169421|NCT00309777|472240561|FG003|Overall Study|Withdrawal by Subject|2|||
131169422|NCT00309777|472240558|FG000|Overall Study|Lost to Follow-up|0|||
131169423|NCT00309777|472240559|FG001|Overall Study|Lost to Follow-up|0|||
131169424|NCT00309777|472240560|FG002|Overall Study|Lost to Follow-up|1|||
131169425|NCT00309777|472240561|FG003|Overall Study|Lost to Follow-up|0|||
131169426|NCT00309777|472240558|FG000|Overall Study|Death|0|||
131169427|NCT00309777|472240559|FG001|Overall Study|Death|1|||
131169428|NCT00309777|472240560|FG002|Overall Study|Death|0|||
131169429|NCT00309777|472240561|FG003|Overall Study|Death|0|||
131169430|NCT05513053|472240562|FG000|Overall Study|Lost to Follow-up|9|||
131169431|NCT05513053|472240563|FG001|Overall Study|Lost to Follow-up|11|||
131169432|NCT05513053|472240562|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131169433|NCT05513053|472240563|FG001|Overall Study|Withdrawal by parent/guardian|0|||
131169434|NCT05513053|472240562|FG000|Overall Study|Withdrawal by Subject|2|||
131169435|NCT05513053|472240563|FG001|Overall Study|Withdrawal by Subject|9|||
131169436|NCT05513053|472240562|FG000|Overall Study|Protocol Violation|6|||
131169437|NCT05513053|472240563|FG001|Overall Study|Protocol Violation|3|||
131169438|NCT05513053|472240562|FG000|Overall Study|Adverse Event|0|||
131169439|NCT05513053|472240563|FG001|Overall Study|Adverse Event|2|||
131169440|NCT03050359|472242082|FG000|Overall Study|Randomized But Not Treated|2|||
131169441|NCT03050359|472242083|FG001|Overall Study|Randomized But Not Treated|0|||
131169442|NCT03050359|472242082|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
131169443|NCT03050359|472242083|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
131169444|NCT03050359|472242082|FG000|Overall Study|Significant Protocol Deviation|2|||
131169445|NCT03050359|472242083|FG001|Overall Study|Significant Protocol Deviation|3|||
131169446|NCT03050359|472242082|FG000|Overall Study|Lost to Follow-up|2|||
131169447|NCT03050359|472242083|FG001|Overall Study|Lost to Follow-up|1|||
131169448|NCT03050359|472242082|FG000|Overall Study|Voluntary Withdrawal|4|||
131169449|NCT03050359|472242083|FG001|Overall Study|Voluntary Withdrawal|6|||
131169450|NCT03050359|472242082|FG000|Overall Study|Pregnancy|1|||
130780739|NCT03811821|470823197|FG001|Overall Study|Adverse Event|1|||
130780740|NCT03811821|470823196|FG000|Overall Study|Withdrawal by Subject|5|||
131169451|NCT03050359|472242083|FG001|Overall Study|Pregnancy|0|||
131169452|NCT03050359|472242082|FG000|Overall Study|Reason Not Specified|1|||
131169453|NCT03050359|472242083|FG001|Overall Study|Reason Not Specified|0|||
131169454|NCT02614287|472242084|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
131169455|NCT02614287|472242085|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
131169456|NCT02614287|472242084|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
131169457|NCT02614287|472242085|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
131169458|NCT02614287|472242084|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
131169459|NCT02614287|472242085|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
131235654|NCT00927810|472490994|FG001|Overall Study|Withdrawal by Subject|3|||
131169460|NCT02614287|472242084|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
130780741|NCT03811821|470823197|FG001|Overall Study|Withdrawal by Subject|4|||
131169461|NCT02614287|472242085|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
131169462|NCT02614287|472242084|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
131169463|NCT02614287|472242085|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
131169464|NCT02614287|472242084|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
131169465|NCT02614287|472242085|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
131169466|NCT02614287|472242084|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
131169467|NCT02614287|472242085|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
131169468|NCT02614287|472242084|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
131169469|NCT02614287|472242085|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
131169470|NCT00492856|472242086|FG000|Induction|Adverse Event|2|||
131169471|NCT00492856|472242087|FG001|Induction|Adverse Event|0|||
130729862|NCT02661217|470633624|FG000|Overall Study|Adverse Event|10|||
130729863|NCT02661217|470633625|FG001|Overall Study|Adverse Event|8|||
130729864|NCT02661217|470633624|FG000|Overall Study|Withdrawal by Subject|15|||
131169472|NCT00492856|472242088|FG002|Induction|Adverse Event|0|||
131169473|NCT00492856|472242089|FG003|Induction|Adverse Event|0|||
131169474|NCT00492856|472242086|FG000|Induction|Withdrawal by Subject|1|||
131169475|NCT00492856|472242087|FG001|Induction|Withdrawal by Subject|0|||
131169476|NCT00492856|472242088|FG002|Induction|Withdrawal by Subject|0|||
131169477|NCT00492856|472242089|FG003|Induction|Withdrawal by Subject|0|||
131169478|NCT00492856|472242086|FG000|Induction|Death|3|||
131169479|NCT00492856|472242087|FG001|Induction|Death|0|||
131169480|NCT00492856|472242088|FG002|Induction|Death|0|||
131169481|NCT00492856|472242089|FG003|Induction|Death|0|||
131169482|NCT00492856|472242086|FG000|Consolidation|Adverse Event|6|||
131169483|NCT00492856|472242087|FG001|Consolidation|Adverse Event|0|||
131169484|NCT00492856|472242088|FG002|Consolidation|Adverse Event|0|||
131169485|NCT00492856|472242089|FG003|Consolidation|Adverse Event|0|||
131169486|NCT00492856|472242086|FG000|Consolidation|Not protocol specified|2|||
131169487|NCT00492856|472242087|FG001|Consolidation|Not protocol specified|0|||
131169488|NCT00492856|472242088|FG002|Consolidation|Not protocol specified|0|||
131169489|NCT00492856|472242089|FG003|Consolidation|Not protocol specified|0|||
131169490|NCT00492856|472242086|FG000|Consolidation|Lost to Follow-up|1|||
131169491|NCT00492856|472242087|FG001|Consolidation|Lost to Follow-up|0|||
131169492|NCT00492856|472242088|FG002|Consolidation|Lost to Follow-up|0|||
131169493|NCT00492856|472242089|FG003|Consolidation|Lost to Follow-up|0|||
131169494|NCT00492856|472242086|FG000|Post-consolidation|Adverse Event|0|||
131169495|NCT00492856|472242087|FG001|Post-consolidation|Adverse Event|4|||
131169496|NCT00492856|472242088|FG002|Post-consolidation|Adverse Event|0|||
131169497|NCT00492856|472242089|FG003|Post-consolidation|Adverse Event|1|||
131169498|NCT00492856|472242086|FG000|Post-consolidation|Withdrawal by Subject|0|||
131169499|NCT00492856|472242087|FG001|Post-consolidation|Withdrawal by Subject|4|||
131169500|NCT00492856|472242088|FG002|Post-consolidation|Withdrawal by Subject|0|||
131169501|NCT00492856|472242089|FG003|Post-consolidation|Withdrawal by Subject|0|||
131169502|NCT00492856|472242086|FG000|Post-consolidation|Death|0|||
131169503|NCT00492856|472242087|FG001|Post-consolidation|Death|1|||
131169504|NCT00492856|472242088|FG002|Post-consolidation|Death|0|||
131169505|NCT00492856|472242089|FG003|Post-consolidation|Death|0|||
131169506|NCT00492856|472242086|FG000|Post-consolidation|Not protocol specified|0|||
131169507|NCT00492856|472242087|FG001|Post-consolidation|Not protocol specified|1|||
131169508|NCT00492856|472242088|FG002|Post-consolidation|Not protocol specified|0|||
131169509|NCT00492856|472242089|FG003|Post-consolidation|Not protocol specified|0|||
131169510|NCT00492856|472242086|FG000|Post-consolidation|Lost to Follow-up|0|||
131169511|NCT00492856|472242087|FG001|Post-consolidation|Lost to Follow-up|2|||
131169512|NCT00492856|472242088|FG002|Post-consolidation|Lost to Follow-up|0|||
131169513|NCT00492856|472242089|FG003|Post-consolidation|Lost to Follow-up|0|||
131169514|NCT00492856|472242086|FG000|Post-consolidation|Observation Arm|0|||
131169515|NCT00492856|472242087|FG001|Post-consolidation|Observation Arm|0|||
131169516|NCT00492856|472242088|FG002|Post-consolidation|Observation Arm|27|||
131169517|NCT00492856|472242089|FG003|Post-consolidation|Observation Arm|0|||
131169518|NCT01520324|472242090|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
131169519|NCT03488472|472242091|FG000|Overall Study|disease progression additional mets|1|||
131169520|NCT00441441|472242095|FG000|Overall Study|Adverse Event|2|||
131169521|NCT00441441|472242096|FG001|Overall Study|Adverse Event|1|||
131169522|NCT00441441|472242095|FG000|Overall Study|Protocol Violation|4|||
130729865|NCT02661217|470633625|FG001|Overall Study|Withdrawal by Subject|19|||
130729866|NCT02661217|470633624|FG000|Overall Study|Did not enter follow-up epoch|7|||
131169523|NCT00441441|472242096|FG001|Overall Study|Protocol Violation|6|||
131169524|NCT00441441|472242095|FG000|Overall Study|Exacerbation of asthma|1|||
131169525|NCT00441441|472242096|FG001|Overall Study|Exacerbation of asthma|2|||
131169526|NCT00441441|472242095|FG000|Overall Study|Withdrawal by Subject|1|||
131169527|NCT00441441|472242096|FG001|Overall Study|Withdrawal by Subject|2|||
131169528|NCT00441441|472242095|FG000|Overall Study|Other|3|||
131169529|NCT00441441|472242096|FG001|Overall Study|Other|3|||
131169530|NCT00262080|472242097|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
131169531|NCT00262080|472242098|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
131169532|NCT00262080|472242099|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
131169533|NCT00262080|472242097|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
131169534|NCT00262080|472242098|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
131169535|NCT00262080|472242099|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
131169536|NCT00262080|472242097|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
131169537|NCT00262080|472242098|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
130729867|NCT02661217|470633625|FG001|Overall Study|Did not enter follow-up epoch|10|||
130729868|NCT02661217|470633624|FG000|Overall Study|Death - no study drug received|1|||
130729869|NCT02661217|470633625|FG001|Overall Study|Death - no study drug received|2|||
130729870|NCT02661217|470633624|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
130729871|NCT02661217|470633625|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
130729872|NCT03593395|470633626|FG000|Overall Study|Lost to Follow-up|48|||
130729873|NCT03593395|470633627|FG001|Overall Study|Lost to Follow-up|3|||
130729874|NCT03593395|470633626|FG000|Overall Study|Withdrawal by Subject|5|||
130729875|NCT03593395|470633627|FG001|Overall Study|Withdrawal by Subject|24|||
130729876|NCT03593395|470633626|FG000|Overall Study|Death|2|||
130729877|NCT03593395|470633627|FG001|Overall Study|Death|3|||
130780742|NCT03811821|470823196|FG000|Overall Study|Lost to Follow-up|2|||
130780743|NCT03811821|470823197|FG001|Overall Study|Lost to Follow-up|2|||
130780744|NCT03811821|470823196|FG000|Overall Study|Contraindication for treatment|0|||
130780745|NCT03811821|470823197|FG001|Overall Study|Contraindication for treatment|1|||
130780746|NCT03811821|470823196|FG000|Overall Study|Tolerability|0|||
130780747|NCT03811821|470823197|FG001|Overall Study|Tolerability|3|||
130780748|NCT03811821|470823196|FG000|Overall Study|Comorbidities|0|||
130780749|NCT03811821|470823197|FG001|Overall Study|Comorbidities|2|||
130780750|NCT01683604|470823199|FG000|Overall Study|Adverse Event|2|||
130780751|NCT01683604|470823199|FG000|Overall Study|Lack of Efficacy|1|||
130780752|NCT01683604|470823199|FG000|Overall Study|Other|2|||
130780753|NCT01949142|470823200|FG000|Overall Study|Withdrawal of consent|1|||
130780754|NCT01949142|470823201|FG001|Overall Study|Withdrawal of consent|0|||
130780755|NCT01949142|470823200|FG000|Overall Study|Lost to Follow-up|1|||
130780756|NCT01949142|470823201|FG001|Overall Study|Lost to Follow-up|1|||
130780757|NCT01949142|470823200|FG000|Overall Study|Parent changed their mind|1|||
130780758|NCT01949142|470823201|FG001|Overall Study|Parent changed their mind|0|||
130780759|NCT03677869|470823204|FG000|Overall Study|Withdrawal by Subject|1|||
130780760|NCT04265261|470823205|FG000|Overall Study|Adverse Event|2|||
130780761|NCT04265261|470823206|FG001|Overall Study|Adverse Event|0|||
130780762|NCT04265261|470823207|FG002|Overall Study|Adverse Event|0|||
130780763|NCT04265261|470823205|FG000|Overall Study|Death|1|||
130780764|NCT04265261|470823206|FG001|Overall Study|Death|0|||
130780765|NCT04265261|470823207|FG002|Overall Study|Death|0|||
131169538|NCT00262080|472242099|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
131169539|NCT00262080|472242097|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
131169540|NCT00262080|472242098|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
131169541|NCT00262080|472242099|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
131169542|NCT00262080|472242097|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
131169543|NCT00262080|472242098|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
131169544|NCT00262080|472242099|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
130729878|NCT03593395|470633626|FG000|Overall Study|Physician Decision|0|||
131169545|NCT00262080|472242097|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
131169546|NCT00262080|472242098|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
131169547|NCT00262080|472242099|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
131169548|NCT03580382|472242100|FG000|Overall Study|Early Termination of Study|0|||
131169549|NCT03580382|472242101|FG001|Overall Study|Early Termination of Study|3|||
131169550|NCT05619172|472242102|FG000|Safety Cohort 1|Death|7|||
131169551|NCT05619172|472242103|FG001|Safety Cohort 1|Death|0|||
131169552|NCT05619172|472242102|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
131169553|NCT05619172|472242103|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
131169554|NCT05619172|472242102|FG000|Safety Cohort 2|Death|0|||
131169555|NCT05619172|472242103|FG001|Safety Cohort 2|Death|1|||
131169556|NCT05619172|472242102|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
131169557|NCT05619172|472242103|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
131169558|NCT04009096|472242104|FG000|Overall Study|Withdrawal by Subject|0|||
131169559|NCT04009096|472242105|FG001|Overall Study|Withdrawal by Subject|7|||
130780766|NCT04265261|470823205|FG000|Overall Study|Lost to Follow-up|4|||
130780767|NCT04265261|470823206|FG001|Overall Study|Lost to Follow-up|1|||
130780768|NCT04265261|470823207|FG002|Overall Study|Lost to Follow-up|3|||
130780769|NCT04265261|470823205|FG000|Overall Study|Non-Compliance with Study Drug|1|||
131169560|NCT04009096|472242106|FG002|Overall Study|Withdrawal by Subject|0|||
131169561|NCT04009096|472242104|FG000|Overall Study|Physician Decision|0|||
131169562|NCT04009096|472242105|FG001|Overall Study|Physician Decision|1|||
130729879|NCT03593395|470633627|FG001|Overall Study|Physician Decision|6|||
130729880|NCT03593395|470633626|FG000|Overall Study|Participant Relocated|19|||
130780770|NCT04265261|470823206|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130780771|NCT04265261|470823207|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130780772|NCT04265261|470823205|FG000|Overall Study|Physician Decision|0|||
130780773|NCT04265261|470823206|FG001|Overall Study|Physician Decision|0|||
131169563|NCT04009096|472242106|FG002|Overall Study|Physician Decision|0|||
131169564|NCT05151471|472242107|FG000|Overall Study|Adverse Event|21|||
131169565|NCT05151471|472242108|FG001|Overall Study|Adverse Event|16|||
130780774|NCT04265261|470823207|FG002|Overall Study|Physician Decision|1|||
130780775|NCT04265261|470823205|FG000|Overall Study|Protocol Deviation|0|||
131169566|NCT05151471|472242107|FG000|Overall Study|Death|1|||
131169567|NCT05151471|472242108|FG001|Overall Study|Death|0|||
131169568|NCT05151471|472242107|FG000|Overall Study|Lost to Follow-up|0|||
131169569|NCT05151471|472242108|FG001|Overall Study|Lost to Follow-up|1|||
131169570|NCT05151471|472242107|FG000|Overall Study|Withdrawal by Subject|7|||
131169571|NCT05151471|472242108|FG001|Overall Study|Withdrawal by Subject|9|||
131169572|NCT05151471|472242107|FG000|Overall Study|Study terminated by sponsor|49|||
131169573|NCT05151471|472242108|FG001|Overall Study|Study terminated by sponsor|47|||
131169574|NCT05151471|472242107|FG000|Overall Study|Other|2|||
131169575|NCT05151471|472242108|FG001|Overall Study|Other|1|||
131169576|NCT04263142|472242109|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
131169577|NCT04263142|472242110|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
131169578|NCT04263142|472242111|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
131169579|NCT04263142|472242112|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
131169580|NCT04263142|472242113|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
131169581|NCT04263142|472242109|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
131169582|NCT04263142|472242110|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
131169583|NCT04263142|472242111|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
131169584|NCT04263142|472242112|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
131169585|NCT04263142|472242113|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
131169586|NCT00450372|472242115|FG000|Overall Study|Physician Decision|1|||
130729881|NCT03593395|470633627|FG001|Overall Study|Participant Relocated|3|||
130729882|NCT03593395|470633626|FG000|Overall Study|No Information|1|||
130729883|NCT03593395|470633627|FG001|Overall Study|No Information|7|||
130729884|NCT01524978|470633628|FG000|Overall Study|Other|16|||
130729885|NCT01524978|470633629|FG001|Overall Study|Other|2|||
130729886|NCT01524978|470633630|FG002|Overall Study|Other|1|||
130729887|NCT01524978|470633631|FG003|Overall Study|Other|2|||
130729888|NCT01524978|470633632|FG004|Overall Study|Other|1|||
130729889|NCT01524978|470633633|FG005|Overall Study|Other|3|||
130729890|NCT01524978|470633634|FG006|Overall Study|Other|17|||
130729891|NCT01524978|470633635|FG007|Overall Study|Other|1|||
130729892|NCT01524978|470633636|FG008|Overall Study|Other|2|||
130729893|NCT01524978|470633637|FG009|Overall Study|Other|2|||
130729894|NCT01524978|470633638|FG010|Overall Study|Other|5|||
130729895|NCT01524978|470633628|FG000|Overall Study|Withdrawal by Subject|12|||
130729896|NCT01524978|470633629|FG001|Overall Study|Withdrawal by Subject|0|||
130729897|NCT01524978|470633630|FG002|Overall Study|Withdrawal by Subject|1|||
130729898|NCT01524978|470633631|FG003|Overall Study|Withdrawal by Subject|1|||
130729899|NCT01524978|470633632|FG004|Overall Study|Withdrawal by Subject|3|||
130729900|NCT01524978|470633633|FG005|Overall Study|Withdrawal by Subject|1|||
130729901|NCT01524978|470633634|FG006|Overall Study|Withdrawal by Subject|6|||
130729902|NCT01524978|470633635|FG007|Overall Study|Withdrawal by Subject|2|||
130729903|NCT01524978|470633636|FG008|Overall Study|Withdrawal by Subject|4|||
130729904|NCT01524978|470633637|FG009|Overall Study|Withdrawal by Subject|0|||
130729905|NCT01524978|470633638|FG010|Overall Study|Withdrawal by Subject|5|||
130729906|NCT01524978|470633628|FG000|Overall Study|Lost to Follow-up|0|||
130729907|NCT01524978|470633629|FG001|Overall Study|Lost to Follow-up|0|||
130729908|NCT01524978|470633630|FG002|Overall Study|Lost to Follow-up|3|||
130729909|NCT01524978|470633631|FG003|Overall Study|Lost to Follow-up|0|||
130729910|NCT01524978|470633632|FG004|Overall Study|Lost to Follow-up|1|||
130729911|NCT01524978|470633633|FG005|Overall Study|Lost to Follow-up|1|||
130729912|NCT01524978|470633634|FG006|Overall Study|Lost to Follow-up|2|||
130729913|NCT01524978|470633635|FG007|Overall Study|Lost to Follow-up|0|||
130729914|NCT01524978|470633636|FG008|Overall Study|Lost to Follow-up|1|||
130729915|NCT01524978|470633637|FG009|Overall Study|Lost to Follow-up|1|||
130729916|NCT01524978|470633638|FG010|Overall Study|Lost to Follow-up|1|||
130729917|NCT01524978|470633628|FG000|Overall Study|Death|34|||
130729918|NCT01524978|470633629|FG001|Overall Study|Death|2|||
130729919|NCT01524978|470633630|FG002|Overall Study|Death|5|||
130729920|NCT01524978|470633631|FG003|Overall Study|Death|24|||
131169587|NCT03010423|472242116|FG000|Overall Study|Study termination|8|||
131169588|NCT00879814|472242122|FG000|Overall Study|Adverse Event|0|||
131169589|NCT00879814|472242123|FG001|Overall Study|Adverse Event|1|||
130729921|NCT01524978|470633632|FG004|Overall Study|Death|4|||
130729922|NCT01524978|470633633|FG005|Overall Study|Death|4|||
130729923|NCT01524978|470633634|FG006|Overall Study|Death|1|||
130729924|NCT01524978|470633635|FG007|Overall Study|Death|9|||
130729925|NCT01524978|470633636|FG008|Overall Study|Death|5|||
130729926|NCT01524978|470633637|FG009|Overall Study|Death|6|||
130729927|NCT01524978|470633638|FG010|Overall Study|Death|17|||
130729928|NCT00185588|470633641|FG000|Overall Study|Adverse Event|3|||
130729929|NCT00185588|470633642|FG001|Overall Study|Adverse Event|1|||
130729930|NCT00185588|470633643|FG002|Overall Study|Adverse Event|4|||
131169590|NCT00879814|472242124|FG002|Overall Study|Adverse Event|0|||
131169591|NCT00879814|472242125|FG003|Overall Study|Adverse Event|0|||
131169592|NCT00879814|472242122|FG000|Overall Study|Lost to Follow-up|1|||
131169593|NCT00879814|472242123|FG001|Overall Study|Lost to Follow-up|0|||
130729931|NCT00185588|470633644|FG003|Overall Study|Adverse Event|2|||
130729932|NCT00185588|470633641|FG000|Overall Study|Lost to Follow-up|0|||
130729933|NCT00185588|470633642|FG001|Overall Study|Lost to Follow-up|0|||
131169594|NCT00879814|472242124|FG002|Overall Study|Lost to Follow-up|0|||
131169595|NCT00879814|472242125|FG003|Overall Study|Lost to Follow-up|2|||
131169596|NCT00879814|472242122|FG000|Overall Study|Participant Failed to Return|0|||
131169597|NCT00879814|472242123|FG001|Overall Study|Participant Failed to Return|0|||
131169598|NCT00879814|472242124|FG002|Overall Study|Participant Failed to Return|0|||
131169599|NCT00879814|472242125|FG003|Overall Study|Participant Failed to Return|1|||
131169600|NCT00879814|472242122|FG000|Overall Study|Withdrawal by Subject|3|||
131169601|NCT00879814|472242123|FG001|Overall Study|Withdrawal by Subject|1|||
131169602|NCT00879814|472242124|FG002|Overall Study|Withdrawal by Subject|1|||
131169603|NCT00879814|472242125|FG003|Overall Study|Withdrawal by Subject|2|||
131169604|NCT00879814|472242122|FG000|Overall Study|Physician Decision|0|||
131169605|NCT00879814|472242123|FG001|Overall Study|Physician Decision|0|||
131169606|NCT00879814|472242124|FG002|Overall Study|Physician Decision|1|||
131169607|NCT00879814|472242125|FG003|Overall Study|Physician Decision|0|||
131169608|NCT00879814|472242122|FG000|Overall Study|Other|0|||
131169609|NCT00879814|472242123|FG001|Overall Study|Other|0|||
131169610|NCT00879814|472242124|FG002|Overall Study|Other|1|||
131169611|NCT00879814|472242125|FG003|Overall Study|Other|0|||
131169612|NCT00630812|472242138|FG000|Randomisation to First Dose|Adverse Event|1|||
131169613|NCT00630812|472242139|FG001|Randomisation to First Dose|Adverse Event|1|||
131169614|NCT00630812|472242138|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
131169615|NCT00630812|472242139|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
131169616|NCT00630812|472242138|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
131169617|NCT00630812|472242139|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
131169618|NCT00630812|472242138|FG000|Randomisation to First Dose|Protocol Violation|4|||
131169619|NCT00630812|472242139|FG001|Randomisation to First Dose|Protocol Violation|1|||
131169620|NCT00630812|472242138|FG000|Double Blind Treatment Period|Adverse Event|13|||
131169621|NCT00630812|472242139|FG001|Double Blind Treatment Period|Adverse Event|5|||
131169622|NCT00630812|472242138|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
131169623|NCT00630812|472242139|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
131169624|NCT00630812|472242138|FG000|Double Blind Treatment Period|Physician Decision|2|||
131169625|NCT00630812|472242139|FG001|Double Blind Treatment Period|Physician Decision|1|||
131169626|NCT00630812|472242138|FG000|Double Blind Treatment Period|Protocol Violation|1|||
131169627|NCT00630812|472242139|FG001|Double Blind Treatment Period|Protocol Violation|0|||
131169628|NCT00630812|472242138|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
131169629|NCT00630812|472242139|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
131169630|NCT00630812|472242138|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
131169631|NCT00630812|472242139|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
131169632|NCT00630812|472242138|FG000|Double Blind Treatment Period|Non-compliance|0|||
131169633|NCT00630812|472242139|FG001|Double Blind Treatment Period|Non-compliance|1|||
131169634|NCT03656926|472242146|FG000|Overall Study|Adverse Event|5|||
131169635|NCT03656926|472242147|FG001|Overall Study|Adverse Event|4|||
131169636|NCT03656926|472242146|FG000|Overall Study|Withdrawal by Subject|7|||
131169637|NCT03656926|472242147|FG001|Overall Study|Withdrawal by Subject|2|||
131169638|NCT03656926|472242146|FG000|Overall Study|Screen fail after randomization|1|||
131169639|NCT03656926|472242147|FG001|Overall Study|Screen fail after randomization|0|||
131169640|NCT03656926|472242146|FG000|Overall Study|PI decision due to patient condition|1|||
131169641|NCT03656926|472242147|FG001|Overall Study|PI decision due to patient condition|0|||
131169642|NCT03656926|472242146|FG000|Overall Study|Patient unresponsiveness|1|||
131169643|NCT03656926|472242147|FG001|Overall Study|Patient unresponsiveness|0|||
131169644|NCT05610176|472242148|FG000|Overall Study|Death|6|||
131169645|NCT00506077|472242149|FG000|Treatment Period 1|Adverse Event|2|||
131169646|NCT00506077|472242150|FG001|Treatment Period 1|Adverse Event|1|||
131169647|NCT00506077|472242149|FG000|Treatment Period 1|Lost to Follow-up|0|||
131169648|NCT00506077|472242150|FG001|Treatment Period 1|Lost to Follow-up|2|||
131169649|NCT00506077|472242149|FG000|Treatment Period 1|Withdrawal by Subject|2|||
131169650|NCT00506077|472242150|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131169651|NCT00506077|472242149|FG000|Treatment Period 2|Adverse Event|0|||
131169652|NCT00506077|472242150|FG001|Treatment Period 2|Adverse Event|1|||
131169653|NCT00506077|472242149|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131169654|NCT00506077|472242150|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131169655|NCT01753076|472242151|FG000|Overall Study|Adverse Event|17|||
131169656|NCT01753076|472242152|FG001|Overall Study|Adverse Event|18|||
131169657|NCT01753076|472242151|FG000|Overall Study|Lack of Efficacy|3|||
131169658|NCT01753076|472242152|FG001|Overall Study|Lack of Efficacy|1|||
131169659|NCT01753076|472242151|FG000|Overall Study|Lost to Follow-up|2|||
131169660|NCT01753076|472242152|FG001|Overall Study|Lost to Follow-up|1|||
130780776|NCT04265261|470823206|FG001|Overall Study|Protocol Deviation|2|||
131169661|NCT01753076|472242151|FG000|Overall Study|Physician Decision|4|||
131169662|NCT01753076|472242152|FG001|Overall Study|Physician Decision|2|||
131169663|NCT01753076|472242151|FG000|Overall Study|Withdrawal by Subject|14|||
131169664|NCT01753076|472242152|FG001|Overall Study|Withdrawal by Subject|24|||
131169665|NCT01753076|472242151|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
131169666|NCT01753076|472242152|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
131169667|NCT03885726|472242156|FG000|Overall Study|Staffing issues/lost interest|1|||
131169668|NCT03885726|472242156|FG000|Overall Study|Early discharge from hospital|3|||
131169669|NCT01217190|472242157|FG000|Second Dosing|Withdrawal by Subject|0|||
131169670|NCT01217190|472242158|FG001|Second Dosing|Withdrawal by Subject|2|||
131169671|NCT03116399|472242159|FG000|Overall Study|Death|8|||
131169672|NCT03116399|472242160|FG001|Overall Study|Death|3|||
131169673|NCT03116399|472242159|FG000|Overall Study|Lost to Follow-up|7|||
131169674|NCT03116399|472242160|FG001|Overall Study|Lost to Follow-up|11|||
131169675|NCT03116399|472242159|FG000|Overall Study|Investigator Decision|1|||
131169676|NCT03116399|472242160|FG001|Overall Study|Investigator Decision|1|||
131169677|NCT03116399|472242159|FG000|Overall Study|Withdrawal by Subject|24|||
131169678|NCT03116399|472242160|FG001|Overall Study|Withdrawal by Subject|9|||
131169679|NCT02868216|472242163|FG000|Overall Study|Death|0|||
131169680|NCT02868216|472242164|FG001|Overall Study|Death|1|||
131169681|NCT02868216|472242163|FG000|Overall Study|coronary artery bypass|1|||
131169682|NCT02868216|472242164|FG001|Overall Study|coronary artery bypass|0|||
131169683|NCT02868216|472242163|FG000|Overall Study|Withdrawal by Subject|7|||
131169684|NCT02868216|472242164|FG001|Overall Study|Withdrawal by Subject|5|||
131169685|NCT02702193|472242165|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
131169686|NCT02702193|472242166|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
131169687|NCT02702193|472242165|FG000|4 Month Follow up|Withdrawal by Subject|1|||
131169688|NCT02702193|472242166|FG001|4 Month Follow up|Withdrawal by Subject|0|||
131169689|NCT02702193|472242165|FG000|4 Month Follow up|Lost to Follow-up|17|||
131169690|NCT02702193|472242166|FG001|4 Month Follow up|Lost to Follow-up|18|||
131169691|NCT02702193|472242165|FG000|8 Month Follow up|Withdrawal by Subject|1|||
131169692|NCT02702193|472242166|FG001|8 Month Follow up|Withdrawal by Subject|0|||
131169693|NCT02702193|472242165|FG000|8 Month Follow up|Lost to Follow-up|14|||
131169694|NCT02702193|472242166|FG001|8 Month Follow up|Lost to Follow-up|18|||
131169695|NCT02702193|472242165|FG000|12 Month Follow up|Withdrawal by Subject|1|||
131169696|NCT02702193|472242166|FG001|12 Month Follow up|Withdrawal by Subject|0|||
131169697|NCT02702193|472242165|FG000|12 Month Follow up|Lost to Follow-up|16|||
131169698|NCT02702193|472242166|FG001|12 Month Follow up|Lost to Follow-up|18|||
131169699|NCT00610935|472242171|FG000|Overall Study|Lost to Follow-up|0|||
131169700|NCT00610935|472242172|FG001|Overall Study|Lost to Follow-up|1|||
131169701|NCT00610935|472242171|FG000|Overall Study|Withdrawal by Subject|0|||
131169702|NCT00610935|472242172|FG001|Overall Study|Withdrawal by Subject|2|||
131169703|NCT00610935|472242171|FG000|Overall Study|Sponsor Discontinuation|1|||
131169704|NCT00610935|472242172|FG001|Overall Study|Sponsor Discontinuation|0|||
131169705|NCT00740779|472242173|FG000|Overall Study|Adverse Event|4|||
131169706|NCT00740779|472242174|FG001|Overall Study|Adverse Event|6|||
131169707|NCT00740779|472242175|FG002|Overall Study|Adverse Event|3|||
131169708|NCT00740779|472242173|FG000|Overall Study|Protocol Violation|1|||
131169709|NCT00740779|472242174|FG001|Overall Study|Protocol Violation|1|||
131169710|NCT00740779|472242175|FG002|Overall Study|Protocol Violation|1|||
131169711|NCT00740779|472242173|FG000|Overall Study|Lack of Efficacy|0|||
131169712|NCT00740779|472242174|FG001|Overall Study|Lack of Efficacy|0|||
131169713|NCT00740779|472242175|FG002|Overall Study|Lack of Efficacy|2|||
131169714|NCT00740779|472242173|FG000|Overall Study|Withdrawal by Subject|2|||
131169715|NCT00740779|472242174|FG001|Overall Study|Withdrawal by Subject|4|||
131169716|NCT00740779|472242175|FG002|Overall Study|Withdrawal by Subject|2|||
131169717|NCT00740779|472242173|FG000|Overall Study|Lost to Follow-up|2|||
131169718|NCT00740779|472242174|FG001|Overall Study|Lost to Follow-up|3|||
131169719|NCT00740779|472242175|FG002|Overall Study|Lost to Follow-up|5|||
131169720|NCT00850460|472242178|FG000|Overall Study|Lost to Follow-up|4|||
131169721|NCT00850460|472242179|FG001|Overall Study|Lost to Follow-up|4|||
131169722|NCT02399813|472242185|FG000|Overall Study|Progressive Disease-Radiographic|2|||
131169723|NCT02399813|472242185|FG000|Overall Study|Death|20|||
131169724|NCT02399813|472242185|FG000|Overall Study|Withdrawal by Subject|3|||
131169725|NCT02399813|472242185|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
131169726|NCT02399813|472242185|FG000|Overall Study|Lost to Follow-up|2|||
131169727|NCT02399813|472242185|FG000|Overall Study|Other than specified|5|||
131169728|NCT00988559|472242186|FG000|Overall Study|Withdrawal by Subject|1|||
130729934|NCT00185588|470633643|FG002|Overall Study|Lost to Follow-up|1|||
130729935|NCT00185588|470633644|FG003|Overall Study|Lost to Follow-up|2|||
131169729|NCT00988559|472242187|FG001|Overall Study|Withdrawal by Subject|1|||
131169730|NCT00988559|472242188|FG002|Overall Study|Withdrawal by Subject|0|||
131169731|NCT00988559|472242189|FG003|Overall Study|Withdrawal by Subject|1|||
131169732|NCT00988559|472242186|FG000|Overall Study|Pregnancy|0|||
131169733|NCT00988559|472242187|FG001|Overall Study|Pregnancy|1|||
131169734|NCT00988559|472242188|FG002|Overall Study|Pregnancy|1|||
131169735|NCT00988559|472242189|FG003|Overall Study|Pregnancy|0|||
131169736|NCT00988559|472242186|FG000|Overall Study|Lost to Follow-up|0|||
131169737|NCT00988559|472242187|FG001|Overall Study|Lost to Follow-up|0|||
131169738|NCT00988559|472242188|FG002|Overall Study|Lost to Follow-up|1|||
131169739|NCT00988559|472242189|FG003|Overall Study|Lost to Follow-up|0|||
131169740|NCT02224846|472242190|FG000|Period 1 (Month 3)|Adverse Event|2|||
131169741|NCT02224846|472242191|FG001|Period 1 (Month 3)|Adverse Event|1|||
130780777|NCT04265261|470823207|FG002|Overall Study|Protocol Deviation|0|||
131169742|NCT02224846|472242190|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
131169743|NCT02224846|472242191|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
131169744|NCT02224846|472242190|FG000|Period 1 (Month 3)|Protocol Violation|4|||
131169745|NCT02224846|472242191|FG001|Period 1 (Month 3)|Protocol Violation|8|||
131169746|NCT02224846|472242190|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
131169747|NCT02224846|472242191|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
131169748|NCT02224846|472242190|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
131169749|NCT02224846|472242191|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
131169750|NCT02224846|472242190|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
131169751|NCT02224846|472242191|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
131169752|NCT02224846|472242190|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
131169753|NCT02224846|472242191|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
131169754|NCT02224846|472242190|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
131169755|NCT02224846|472242191|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
131169756|NCT02224846|472242190|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
131169757|NCT02224846|472242191|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
131169758|NCT02224846|472242190|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
131169759|NCT02224846|472242191|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
131169760|NCT02224846|472242190|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
131169761|NCT02224846|472242191|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
131169762|NCT02224846|472242190|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
131169763|NCT02224846|472242191|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
131169764|NCT02224846|472242190|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
131169765|NCT02224846|472242191|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
131169766|NCT02224846|472242190|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
131169767|NCT02224846|472242191|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
131169768|NCT02224846|472242190|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
131169769|NCT02224846|472242191|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
131169770|NCT02224846|472242190|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
131169771|NCT02224846|472242191|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
131169772|NCT02224846|472242190|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
131169773|NCT02224846|472242191|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
131169774|NCT03280550|472242192|FG000|Overall Study|Withdrawal by Subject|2|||
131169775|NCT03280550|472242193|FG001|Overall Study|Withdrawal by Subject|2|||
131169776|NCT03280550|472242192|FG000|Overall Study|Physician Decision|0|||
131169777|NCT03280550|472242193|FG001|Overall Study|Physician Decision|1|||
131169778|NCT02203838|472242196|FG000|Overall Study|Lack of Efficacy|7|||
131169779|NCT02203838|472242197|FG001|Overall Study|Lack of Efficacy|0|||
131169780|NCT02203838|472242198|FG002|Overall Study|Lack of Efficacy|1|||
131169781|NCT02203838|472242199|FG003|Overall Study|Lack of Efficacy|1|||
131169782|NCT02203838|472242196|FG000|Overall Study|Adverse Event|46|||
131169783|NCT02203838|472242197|FG001|Overall Study|Adverse Event|6|||
131169784|NCT02203838|472242198|FG002|Overall Study|Adverse Event|3|||
131169785|NCT02203838|472242199|FG003|Overall Study|Adverse Event|2|||
131169786|NCT02203838|472242196|FG000|Overall Study|Lost to Follow-up|39|||
131169787|NCT02203838|472242197|FG001|Overall Study|Lost to Follow-up|3|||
131169788|NCT02203838|472242198|FG002|Overall Study|Lost to Follow-up|2|||
131169789|NCT02203838|472242199|FG003|Overall Study|Lost to Follow-up|1|||
131169790|NCT02203838|472242196|FG000|Overall Study|Protocol Violation|7|||
131169791|NCT02203838|472242197|FG001|Overall Study|Protocol Violation|3|||
131169792|NCT02203838|472242198|FG002|Overall Study|Protocol Violation|0|||
131169793|NCT02203838|472242199|FG003|Overall Study|Protocol Violation|0|||
131169794|NCT02203838|472242196|FG000|Overall Study|Withdrawal by Subject|83|||
131169795|NCT02203838|472242197|FG001|Overall Study|Withdrawal by Subject|10|||
131169796|NCT02203838|472242198|FG002|Overall Study|Withdrawal by Subject|8|||
131169797|NCT02203838|472242199|FG003|Overall Study|Withdrawal by Subject|11|||
131169798|NCT02203838|472242196|FG000|Overall Study|Physician Decision|27|||
130729936|NCT00185588|470633641|FG000|Overall Study|Withdrawal by Subject|0|||
130729937|NCT00185588|470633642|FG001|Overall Study|Withdrawal by Subject|1|||
130729938|NCT00185588|470633643|FG002|Overall Study|Withdrawal by Subject|0|||
130729939|NCT00185588|470633644|FG003|Overall Study|Withdrawal by Subject|0|||
130729940|NCT00185588|470633641|FG000|Overall Study|Physician Decision|0|||
131169799|NCT02203838|472242197|FG001|Overall Study|Physician Decision|0|||
131169800|NCT02203838|472242198|FG002|Overall Study|Physician Decision|2|||
131169801|NCT02203838|472242199|FG003|Overall Study|Physician Decision|3|||
131169802|NCT02203838|472242196|FG000|Overall Study|Other|1|||
131169803|NCT02203838|472242197|FG001|Overall Study|Other|0|||
131169804|NCT02203838|472242198|FG002|Overall Study|Other|0|||
131169805|NCT02203838|472242199|FG003|Overall Study|Other|0|||
131169806|NCT03345836|472242200|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
131169807|NCT03345836|472242201|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
131169808|NCT03345836|472242202|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
131169809|NCT03345836|472242203|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
131235655|NCT00927810|472490995|FG002|Overall Study|Withdrawal by Subject|0|||
131235656|NCT00927810|472490996|FG003|Overall Study|Withdrawal by Subject|1|||
131169810|NCT03345836|472242204|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
131169811|NCT03345836|472242205|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
131169812|NCT03345836|472242200|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
131169813|NCT03345836|472242201|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
131169814|NCT03345836|472242202|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
131169815|NCT03345836|472242203|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
131169816|NCT03345836|472242204|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
131169817|NCT03345836|472242205|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
131169818|NCT03345836|472242200|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
131169819|NCT03345836|472242201|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
130780778|NCT04265261|470823205|FG000|Overall Study|Withdrawal by Subject|2|||
130780779|NCT04265261|470823206|FG001|Overall Study|Withdrawal by Subject|1|||
130780780|NCT04265261|470823207|FG002|Overall Study|Withdrawal by Subject|4|||
130780781|NCT00447902|470823208|FG000|Overall Study|Adverse Event|0|||
130780782|NCT00447902|470823209|FG001|Overall Study|Adverse Event|3|||
130780783|NCT00447902|470823208|FG000|Overall Study|Protocol Violation|1|||
130780784|NCT00447902|470823209|FG001|Overall Study|Protocol Violation|0|||
130780785|NCT00447902|470823208|FG000|Overall Study|Withdrawal by Subject|0|||
130780786|NCT00447902|470823209|FG001|Overall Study|Withdrawal by Subject|1|||
130780787|NCT00447902|470823208|FG000|Overall Study|included patients who discontinued|1|||
130780788|NCT00447902|470823209|FG001|Overall Study|included patients who discontinued|1|||
130780789|NCT00447902|470823208|FG000|Overall Study|Lack of Efficacy|2|||
130780790|NCT00447902|470823209|FG001|Overall Study|Lack of Efficacy|1|||
130780791|NCT02358031|470824781|FG000|Overall Study|Death|253|||
130780792|NCT02358031|470824782|FG001|Overall Study|Death|237|||
130780793|NCT02358031|470824783|FG002|Overall Study|Death|266|||
130780794|NCT02358031|470824781|FG000|Overall Study|Lost to Follow-up|1|||
130780795|NCT02358031|470824782|FG001|Overall Study|Lost to Follow-up|1|||
130780796|NCT02358031|470824783|FG002|Overall Study|Lost to Follow-up|0|||
130780797|NCT02358031|470824781|FG000|Overall Study|Withdrawal by Subject|19|||
130780798|NCT02358031|470824782|FG001|Overall Study|Withdrawal by Subject|14|||
130780799|NCT02358031|470824783|FG002|Overall Study|Withdrawal by Subject|18|||
130780800|NCT02358031|470824781|FG000|Overall Study|Sponsor Decision|26|||
130780801|NCT02358031|470824782|FG001|Overall Study|Sponsor Decision|28|||
130780802|NCT02358031|470824783|FG002|Overall Study|Sponsor Decision|16|||
130780803|NCT05664581|470824784|FG000|Overall Study|Withdrawal by Subject|2|||
130780804|NCT02787304|470824785|FG000|Overall Study|Adverse Event|9|||
130780805|NCT02787304|470824786|FG001|Overall Study|Adverse Event|3|||
130780806|NCT02787304|470824787|FG002|Overall Study|Adverse Event|8|||
130780807|NCT02787304|470824788|FG003|Overall Study|Adverse Event|1|||
130780808|NCT02787304|470824785|FG000|Overall Study|Withdrawal by Subject|1|||
130780809|NCT02787304|470824786|FG001|Overall Study|Withdrawal by Subject|4|||
130780810|NCT02787304|470824787|FG002|Overall Study|Withdrawal by Subject|0|||
130780811|NCT02787304|470824788|FG003|Overall Study|Withdrawal by Subject|0|||
130780812|NCT02787304|470824785|FG000|Overall Study|Lost to Follow-up|1|||
130780813|NCT02787304|470824786|FG001|Overall Study|Lost to Follow-up|0|||
130780814|NCT02787304|470824787|FG002|Overall Study|Lost to Follow-up|0|||
131169820|NCT03345836|472242202|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
131169821|NCT03345836|472242203|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
131169822|NCT03345836|472242204|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
131169823|NCT03345836|472242205|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
131169824|NCT03345836|472242200|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
131169825|NCT03345836|472242201|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
131169826|NCT03345836|472242202|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
131169827|NCT03345836|472242203|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
131169828|NCT03345836|472242204|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
131169829|NCT03345836|472242205|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
131169830|NCT03345836|472242200|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
131169831|NCT03345836|472242201|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
131169832|NCT03345836|472242202|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
131169833|NCT03345836|472242203|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
131169834|NCT03345836|472242204|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
131169835|NCT03345836|472242205|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
130780815|NCT02787304|470824788|FG003|Overall Study|Lost to Follow-up|1|||
130780816|NCT02787304|470824785|FG000|Overall Study|Noncompliance with study drug|0|||
130780817|NCT02787304|470824786|FG001|Overall Study|Noncompliance with study drug|0|||
130780818|NCT02787304|470824787|FG002|Overall Study|Noncompliance with study drug|1|||
130780819|NCT02787304|470824788|FG003|Overall Study|Noncompliance with study drug|0|||
130780820|NCT02787304|470824785|FG000|Overall Study|Physician Decision|0|||
130780821|NCT02787304|470824786|FG001|Overall Study|Physician Decision|0|||
130780822|NCT02787304|470824787|FG002|Overall Study|Physician Decision|1|||
130780823|NCT02787304|470824788|FG003|Overall Study|Physician Decision|0|||
131169836|NCT03345836|472242200|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
131169837|NCT03345836|472242201|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
131169838|NCT03345836|472242202|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
131169839|NCT03345836|472242203|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
131169840|NCT03345836|472242204|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
131169841|NCT03345836|472242205|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
131169842|NCT03345836|472242200|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
131169843|NCT03345836|472242201|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
131169844|NCT03345836|472242202|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
131169845|NCT03345836|472242203|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
131169846|NCT03345836|472242204|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
131169847|NCT03345836|472242205|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
131169848|NCT03345836|472242200|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
131169849|NCT03345836|472242201|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
131169850|NCT03345836|472242202|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
131169851|NCT03345836|472242203|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
131169852|NCT03345836|472242204|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
131169853|NCT03345836|472242205|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
131169854|NCT03345836|472242200|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
131169855|NCT03345836|472242201|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
131169856|NCT03345836|472242202|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
131169857|NCT03345836|472242203|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
131169858|NCT03345836|472242204|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
131169859|NCT03345836|472242205|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
131169860|NCT03345836|472242200|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
131169861|NCT03345836|472242201|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
131169862|NCT03345836|472242202|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
131169863|NCT03345836|472242203|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
131169864|NCT03345836|472242204|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
131169865|NCT03345836|472242205|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
131169866|NCT03345836|472242200|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
131169867|NCT03345836|472242201|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
131169868|NCT03345836|472242202|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
131169869|NCT03345836|472242203|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
131169870|NCT03345836|472242204|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
131169871|NCT03345836|472242205|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
131169872|NCT05091060|472242208|FG000|Overall Study|Lost to Follow-up|1|||
131169873|NCT02775864|472242209|FG000|Overall Study|Data ended end of 2010|1764|||
131169874|NCT02775864|472242210|FG001|Overall Study|Data ended end of 2010|2880|||
131169875|NCT02775864|472242211|FG002|Overall Study|Data ended end of 2010|1140|||
131169876|NCT02775864|472242212|FG003|Overall Study|Data ended end of 2010|1194|||
131169877|NCT02775864|472242209|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
131169878|NCT02775864|472242210|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
131169879|NCT02775864|472242211|FG002|Overall Study|Medicaid eligibility discontinued|720|||
131169880|NCT02775864|472242212|FG003|Overall Study|Medicaid eligibility discontinued|890|||
131169881|NCT03827473|472242220|FG000|Overall Study|Withdrawal by Subject|1|||
131169882|NCT03827473|472242221|FG001|Overall Study|Withdrawal by Subject|0|||
131169883|NCT01575197|472243795|FG000|Overall Study|Migration out of study area|1|||
131169884|NCT01575197|472243796|FG001|Overall Study|Migration out of study area|5|||
131169885|NCT01575197|472243797|FG002|Overall Study|Migration out of study area|4|||
131169886|NCT01575197|472243795|FG000|Overall Study|SAE|0|||
131169887|NCT01575197|472243796|FG001|Overall Study|SAE|1|||
131169888|NCT01575197|472243797|FG002|Overall Study|SAE|0|||
131169889|NCT01575197|472243795|FG000|Overall Study|Lost to Follow-up|0|||
131169890|NCT01575197|472243796|FG001|Overall Study|Lost to Follow-up|1|||
131169891|NCT01575197|472243797|FG002|Overall Study|Lost to Follow-up|0|||
131169892|NCT01575197|472243795|FG000|Overall Study|Withdrawal by Subject|0|||
131169893|NCT01575197|472243796|FG001|Overall Study|Withdrawal by Subject|1|||
130729941|NCT00185588|470633642|FG001|Overall Study|Physician Decision|0|||
130729942|NCT00185588|470633643|FG002|Overall Study|Physician Decision|1|||
130729943|NCT00185588|470633644|FG003|Overall Study|Physician Decision|0|||
131169894|NCT01575197|472243797|FG002|Overall Study|Withdrawal by Subject|1|||
131169895|NCT01575197|472243795|FG000|Overall Study|Protocol Violation|2|||
131169896|NCT01575197|472243796|FG001|Overall Study|Protocol Violation|1|||
131169897|NCT01575197|472243797|FG002|Overall Study|Protocol Violation|1|||
131169898|NCT00520676|472243808|FG000|Overall Study|Death|84|||
131169899|NCT00520676|472243809|FG001|Overall Study|Death|81|||
131169900|NCT00520676|472243808|FG000|Overall Study|Lost to Follow-up|6|||
130729944|NCT02604407|470633645|FG000|Overall Study|Adverse Event|0|||
131169901|NCT00520676|472243809|FG001|Overall Study|Lost to Follow-up|10|||
131169902|NCT00520676|472243808|FG000|Overall Study|Physician Decision|4|||
131169903|NCT00520676|472243809|FG001|Overall Study|Physician Decision|1|||
131169904|NCT00520676|472243808|FG000|Overall Study|Withdrawal by Subject|7|||
131169905|NCT00520676|472243809|FG001|Overall Study|Withdrawal by Subject|11|||
131169906|NCT02179515|472243810|FG000|Overall Study|switched to alternative treatment|0|||
131169907|NCT02179515|472243811|FG001|Overall Study|switched to alternative treatment|1|||
131169908|NCT02179515|472243812|FG002|Overall Study|switched to alternative treatment|1|||
131169909|NCT02179515|472243810|FG000|Overall Study|Death|0|||
131169910|NCT02179515|472243811|FG001|Overall Study|Death|1|||
131169911|NCT02179515|472243812|FG002|Overall Study|Death|1|||
131169912|NCT02179515|472243810|FG000|Overall Study|refused further treatment|0|||
131169913|NCT02179515|472243811|FG001|Overall Study|refused further treatment|3|||
131169914|NCT02179515|472243812|FG002|Overall Study|refused further treatment|4|||
131169915|NCT02179515|472243810|FG000|Overall Study|Disease progression on study|2|||
131169916|NCT02179515|472243811|FG001|Overall Study|Disease progression on study|11|||
131169917|NCT02179515|472243812|FG002|Overall Study|Disease progression on study|8|||
131169918|NCT03484923|472243813|FG000|Overall Study|Adverse Event|3|||
131169919|NCT03484923|472243814|FG001|Overall Study|Adverse Event|3|||
131169920|NCT03484923|472243815|FG002|Overall Study|Adverse Event|5|||
131169921|NCT03484923|472243816|FG003|Overall Study|Adverse Event|11|||
131169922|NCT03484923|472243817|FG004|Overall Study|Adverse Event|1|||
131169923|NCT03484923|472243813|FG000|Overall Study|Death|2|||
131169924|NCT03484923|472243814|FG001|Overall Study|Death|2|||
131169925|NCT03484923|472243815|FG002|Overall Study|Death|3|||
131169926|NCT03484923|472243816|FG003|Overall Study|Death|0|||
131169927|NCT03484923|472243817|FG004|Overall Study|Death|1|||
131169928|NCT03484923|472243813|FG000|Overall Study|Physician Decision|6|||
131169929|NCT03484923|472243814|FG001|Overall Study|Physician Decision|7|||
131169930|NCT03484923|472243815|FG002|Overall Study|Physician Decision|6|||
131169931|NCT03484923|472243816|FG003|Overall Study|Physician Decision|3|||
131169932|NCT03484923|472243817|FG004|Overall Study|Physician Decision|2|||
131169933|NCT03484923|472243813|FG000|Overall Study|Progressive disease|33|||
131169934|NCT03484923|472243814|FG001|Overall Study|Progressive disease|28|||
131169935|NCT03484923|472243815|FG002|Overall Study|Progressive disease|26|||
131169936|NCT03484923|472243816|FG003|Overall Study|Progressive disease|30|||
131169937|NCT03484923|472243817|FG004|Overall Study|Progressive disease|16|||
131169938|NCT03484923|472243813|FG000|Overall Study|Subject Decision|1|||
131169939|NCT03484923|472243814|FG001|Overall Study|Subject Decision|3|||
131169940|NCT03484923|472243815|FG002|Overall Study|Subject Decision|3|||
131169941|NCT03484923|472243816|FG003|Overall Study|Subject Decision|0|||
131169942|NCT03484923|472243817|FG004|Overall Study|Subject Decision|1|||
131169943|NCT03165721|472243822|FG000|Overall Study|Refused further treatment|3|||
131169944|NCT03165721|472243823|FG001|Overall Study|Refused further treatment|0|||
131169945|NCT03165721|472243824|FG002|Overall Study|Refused further treatment|0|||
131169946|NCT03165721|472243822|FG000|Overall Study|Physician Decision|1|||
131169947|NCT03165721|472243823|FG001|Overall Study|Physician Decision|0|||
131169948|NCT03165721|472243824|FG002|Overall Study|Physician Decision|0|||
131169949|NCT01863849|472243825|FG000|Overall Study|Lost to Follow-up|1|||
130729945|NCT02604407|470633646|FG001|Overall Study|Adverse Event|7|||
130729946|NCT02604407|470633647|FG002|Overall Study|Adverse Event|5|||
130729947|NCT02604407|470633645|FG000|Overall Study|Protocol Violation|2|||
130729948|NCT02604407|470633646|FG001|Overall Study|Protocol Violation|0|||
130729949|NCT02604407|470633647|FG002|Overall Study|Protocol Violation|0|||
131169950|NCT01863849|472243826|FG001|Overall Study|Lost to Follow-up|0|||
131235657|NCT00927810|472490993|FG000|Overall Study|Lost to Follow-up|0|||
131235658|NCT00927810|472490994|FG001|Overall Study|Lost to Follow-up|2|||
131235659|NCT00927810|472490995|FG002|Overall Study|Lost to Follow-up|1|||
131235660|NCT00927810|472490996|FG003|Overall Study|Lost to Follow-up|1|||
131235661|NCT00927810|472490993|FG000|Overall Study|Death|0|||
131235662|NCT00927810|472490994|FG001|Overall Study|Death|2|||
131235663|NCT00927810|472490995|FG002|Overall Study|Death|0|||
131235664|NCT00927810|472490996|FG003|Overall Study|Death|0|||
131235665|NCT00927810|472490993|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131235666|NCT00927810|472490994|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131235667|NCT00927810|472490995|FG002|Overall Study|Abnormal laboratory value(s)|0|||
131235668|NCT00927810|472490996|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130729950|NCT02604407|470633645|FG000|Overall Study|Withdrawal by Subject|3|||
131169951|NCT01457118|472243827|FG000|Overall Study|Adverse Event|1|||
131169952|NCT01457118|472243828|FG001|Overall Study|Adverse Event|0|||
131169953|NCT01457118|472243829|FG002|Overall Study|Adverse Event|0|||
131169954|NCT01457118|472243830|FG003|Overall Study|Adverse Event|1|||
131169955|NCT01457118|472243827|FG000|Overall Study|Clinical Progression|0|||
131169956|NCT01457118|472243828|FG001|Overall Study|Clinical Progression|1|||
130729951|NCT02604407|470633646|FG001|Overall Study|Withdrawal by Subject|3|||
131169957|NCT01457118|472243829|FG002|Overall Study|Clinical Progression|0|||
131169958|NCT01457118|472243830|FG003|Overall Study|Clinical Progression|1|||
131169959|NCT01457118|472243827|FG000|Overall Study|Physician Decision|2|||
131169960|NCT01457118|472243828|FG001|Overall Study|Physician Decision|0|||
130729952|NCT02604407|470633647|FG002|Overall Study|Withdrawal by Subject|5|||
130729953|NCT02604407|470633645|FG000|Overall Study|Lost to Follow-up|2|||
130729954|NCT02604407|470633646|FG001|Overall Study|Lost to Follow-up|1|||
130729955|NCT02604407|470633647|FG002|Overall Study|Lost to Follow-up|2|||
130729956|NCT02604407|470633645|FG000|Overall Study|Lack of Efficacy|1|||
130729957|NCT02604407|470633646|FG001|Overall Study|Lack of Efficacy|0|||
130729958|NCT02604407|470633647|FG002|Overall Study|Lack of Efficacy|0|||
130729959|NCT02604407|470633645|FG000|Overall Study|Other|3|||
130729960|NCT02604407|470633646|FG001|Overall Study|Other|1|||
130729961|NCT02604407|470633647|FG002|Overall Study|Other|4|||
130729962|NCT02481869|470633648|FG000|Overall Study|Lost to Follow-up|3|||
130729963|NCT02481869|470633649|FG001|Overall Study|Lost to Follow-up|4|||
130729964|NCT02481869|470633648|FG000|Overall Study|Withdrawal by Subject|2|||
131169961|NCT01457118|472243829|FG002|Overall Study|Physician Decision|0|||
131169962|NCT01457118|472243830|FG003|Overall Study|Physician Decision|0|||
131169963|NCT01457118|472243827|FG000|Overall Study|Progressive Disease by RECIST|12|||
131235669|NCT00198029|472491000|FG000|Overall Study|Withdrawal by Subject|4|||
131235670|NCT02001558|472491001|FG000|Overall Study|Lost to Follow-up|8|||
131235671|NCT02001558|472491002|FG001|Overall Study|Lost to Follow-up|14|||
131235672|NCT04128007|472491003|FG000|Overall Study|Withdrawal by Subject|9|||
131235673|NCT04128007|472491004|FG001|Overall Study|Withdrawal by Subject|6|||
131235674|NCT04128007|472491003|FG000|Overall Study|Protocol Violation|1|||
131235675|NCT04128007|472491004|FG001|Overall Study|Protocol Violation|0|||
131235676|NCT04128007|472491003|FG000|Overall Study|Lost to Follow-up|8|||
131235677|NCT04128007|472491004|FG001|Overall Study|Lost to Follow-up|7|||
131235678|NCT04128007|472491003|FG000|Overall Study|Adverse Event|5|||
131235679|NCT04128007|472491004|FG001|Overall Study|Adverse Event|2|||
131235680|NCT04128007|472491003|FG000|Overall Study|Not reported|0|||
131235681|NCT04128007|472491004|FG001|Overall Study|Not reported|2|||
131235682|NCT00788957|472491010|FG000|Part 1|Death|8|||
131235683|NCT00788957|472491011|FG001|Part 1|Death|0|||
131235684|NCT00788957|472491012|FG002|Part 1|Death|0|||
131235685|NCT00788957|472491013|FG003|Part 1|Death|0|||
131235686|NCT00788957|472491014|FG004|Part 1|Death|0|||
131235687|NCT00788957|472491015|FG005|Part 1|Death|0|||
131235688|NCT00788957|472491010|FG000|Part 1|Lost to Follow-up|1|||
131235689|NCT00788957|472491011|FG001|Part 1|Lost to Follow-up|0|||
131235690|NCT00788957|472491012|FG002|Part 1|Lost to Follow-up|0|||
131235691|NCT00788957|472491013|FG003|Part 1|Lost to Follow-up|0|||
131235692|NCT00788957|472491014|FG004|Part 1|Lost to Follow-up|0|||
131235693|NCT00788957|472491015|FG005|Part 1|Lost to Follow-up|0|||
131235694|NCT00788957|472491010|FG000|Part 2|Withdrawal by Subject|0|||
131235695|NCT00788957|472491011|FG001|Part 2|Withdrawal by Subject|9|||
131235696|NCT00788957|472491012|FG002|Part 2|Withdrawal by Subject|5|||
130729965|NCT02481869|470633649|FG001|Overall Study|Withdrawal by Subject|0|||
130780824|NCT02787304|470824785|FG000|Overall Study|Study terminated by sponsor|25|||
131169964|NCT01457118|472243828|FG001|Overall Study|Progressive Disease by RECIST|3|||
130780825|NCT02787304|470824786|FG001|Overall Study|Study terminated by sponsor|31|||
131169965|NCT01457118|472243829|FG002|Overall Study|Progressive Disease by RECIST|1|||
131169966|NCT01457118|472243830|FG003|Overall Study|Progressive Disease by RECIST|0|||
131169967|NCT01457118|472243827|FG000|Overall Study|Withdrawal by Subject|5|||
131169968|NCT01457118|472243828|FG001|Overall Study|Withdrawal by Subject|0|||
131169969|NCT01457118|472243829|FG002|Overall Study|Withdrawal by Subject|0|||
131169970|NCT01457118|472243830|FG003|Overall Study|Withdrawal by Subject|0|||
131169971|NCT00115349|472243831|FG000|Overall Study|Study closed due to low enrollment.|11|||
131169972|NCT00115349|472243832|FG001|Overall Study|Study closed due to low enrollment.|9|||
131169973|NCT01718509|472243835|FG000|Overall Study|Lost to Follow-up|18|||
131169974|NCT01718509|472243836|FG001|Overall Study|Lost to Follow-up|15|||
131169975|NCT01718509|472243835|FG000|Overall Study|Withdrawal by Subject|7|||
131169976|NCT01718509|472243836|FG001|Overall Study|Withdrawal by Subject|13|||
131169977|NCT01718509|472243835|FG000|Overall Study|Adverse Event|5|||
131169978|NCT01718509|472243836|FG001|Overall Study|Adverse Event|7|||
131169979|NCT01718509|472243835|FG000|Overall Study|Other|13|||
131235697|NCT00788957|472491013|FG003|Part 2|Withdrawal by Subject|3|||
131235698|NCT00788957|472491014|FG004|Part 2|Withdrawal by Subject|0|||
131235699|NCT00788957|472491015|FG005|Part 2|Withdrawal by Subject|0|||
131235700|NCT00788957|472491010|FG000|Part 2|Death|0|||
131235701|NCT00788957|472491011|FG001|Part 2|Death|32|||
130780826|NCT02787304|470824787|FG002|Overall Study|Study terminated by sponsor|31|||
130729966|NCT03908437|470633650|FG000|Overall Study|Death|0|||
130729967|NCT03908437|470633651|FG001|Overall Study|Death|1|||
130729968|NCT03908437|470633650|FG000|Overall Study|Lost to Follow-up|31|||
130729969|NCT03908437|470633651|FG001|Overall Study|Lost to Follow-up|24|||
131169980|NCT01718509|472243836|FG001|Overall Study|Other|11|||
130729970|NCT00191191|470633652|FG000|Overall Study|Entry Criteria Exclusion|2|||
131169981|NCT01718509|472243835|FG000|Overall Study|Protocol Violation|4|||
131169982|NCT01718509|472243836|FG001|Overall Study|Protocol Violation|2|||
131235702|NCT00788957|472491012|FG002|Part 2|Death|35|||
131235703|NCT00788957|472491013|FG003|Part 2|Death|37|||
131235704|NCT00788957|472491014|FG004|Part 2|Death|0|||
131235705|NCT00788957|472491015|FG005|Part 2|Death|0|||
131235706|NCT00788957|472491010|FG000|Part 2|Lost to Follow-up|0|||
131169983|NCT01718509|472243835|FG000|Overall Study|Lack of Efficacy|1|||
131169984|NCT01718509|472243836|FG001|Overall Study|Lack of Efficacy|0|||
131169985|NCT00390416|472243839|FG000|Overall Study|Withdrawal by Subject|1|||
131169986|NCT00390416|472243839|FG000|Overall Study|Not treated|3|||
131169987|NCT01219959|472243840|FG000|Overall Study|Adverse Event|6|||
131169988|NCT01219959|472243841|FG001|Overall Study|Adverse Event|14|||
131169989|NCT01219959|472243840|FG000|Overall Study|Physician Decision|0|||
131169990|NCT01219959|472243841|FG001|Overall Study|Physician Decision|4|||
131169991|NCT01219959|472243840|FG000|Overall Study|Withdrawal by Subject|0|||
131169992|NCT01219959|472243841|FG001|Overall Study|Withdrawal by Subject|2|||
131169993|NCT01219959|472243840|FG000|Overall Study|Renal Transplantation|0|||
131169994|NCT01219959|472243841|FG001|Overall Study|Renal Transplantation|3|||
131169995|NCT01219959|472243840|FG000|Overall Study|Other|1|||
131169996|NCT01219959|472243841|FG001|Overall Study|Other|0|||
131169997|NCT01728584|472243842|FG000|Overall Study|Adverse Event|1|||
131169998|NCT01728584|472243843|FG001|Overall Study|Adverse Event|0|||
131169999|NCT01728584|472243844|FG002|Overall Study|Adverse Event|0|||
131170000|NCT01728584|472243845|FG003|Overall Study|Adverse Event|0|||
131170001|NCT01728584|472243842|FG000|Overall Study|Physician Decision|4|||
131170002|NCT01728584|472243843|FG001|Overall Study|Physician Decision|0|||
131170003|NCT01728584|472243844|FG002|Overall Study|Physician Decision|1|||
131170004|NCT01728584|472243845|FG003|Overall Study|Physician Decision|0|||
131170005|NCT01728584|472243842|FG000|Overall Study|Withdrawal by Subject|1|||
131170006|NCT01728584|472243843|FG001|Overall Study|Withdrawal by Subject|0|||
131170007|NCT01728584|472243844|FG002|Overall Study|Withdrawal by Subject|0|||
131170008|NCT01728584|472243845|FG003|Overall Study|Withdrawal by Subject|0|||
131170009|NCT01728584|472243842|FG000|Overall Study|Screen failure|1|||
131170010|NCT01728584|472243843|FG001|Overall Study|Screen failure|0|||
131170011|NCT01728584|472243844|FG002|Overall Study|Screen failure|0|||
131170012|NCT01728584|472243845|FG003|Overall Study|Screen failure|0|||
131170013|NCT01728584|472243842|FG000|Overall Study|Other reason (not specified)|1|||
131170014|NCT01728584|472243843|FG001|Overall Study|Other reason (not specified)|0|||
131170015|NCT01728584|472243844|FG002|Overall Study|Other reason (not specified)|0|||
131170016|NCT01728584|472243845|FG003|Overall Study|Other reason (not specified)|1|||
131170017|NCT02935634|472243846|FG000|Randomization|Participant withdrew consent|0|||
131170018|NCT02935634|472243847|FG001|Randomization|Participant withdrew consent|1|||
131170019|NCT02935634|472243848|FG002|Randomization|Participant withdrew consent|0|||
131170020|NCT02935634|472243849|FG003|Randomization|Participant withdrew consent|0|||
131170021|NCT02935634|472243850|FG004|Randomization|Participant withdrew consent|0|||
131170022|NCT02935634|472243851|FG005|Randomization|Participant withdrew consent|0|||
131170023|NCT02935634|472243846|FG000|Randomization|Death|2|||
131170024|NCT02935634|472243847|FG001|Randomization|Death|1|||
131170025|NCT02935634|472243848|FG002|Randomization|Death|1|||
131170026|NCT02935634|472243849|FG003|Randomization|Death|0|||
131170027|NCT02935634|472243850|FG004|Randomization|Death|0|||
131170028|NCT02935634|472243851|FG005|Randomization|Death|0|||
131170029|NCT02935634|472243846|FG000|Randomization|Other reasons|0|||
131170030|NCT02935634|472243847|FG001|Randomization|Other reasons|2|||
131170031|NCT02935634|472243848|FG002|Randomization|Other reasons|2|||
131170032|NCT02935634|472243849|FG003|Randomization|Other reasons|0|||
131170033|NCT02935634|472243850|FG004|Randomization|Other reasons|0|||
131170034|NCT02935634|472243851|FG005|Randomization|Other reasons|0|||
131170035|NCT02935634|472243846|FG000|Treatment: Track 1|Disease progression|15|||
131170036|NCT02935634|472243847|FG001|Treatment: Track 1|Disease progression|17|||
131170037|NCT02935634|472243848|FG002|Treatment: Track 1|Disease progression|28|||
131170038|NCT02935634|472243849|FG003|Treatment: Track 1|Disease progression|4|||
131170039|NCT02935634|472243850|FG004|Treatment: Track 1|Disease progression|6|||
131170040|NCT02935634|472243851|FG005|Treatment: Track 1|Disease progression|2|||
131170041|NCT02935634|472243846|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
131170042|NCT02935634|472243847|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
131170043|NCT02935634|472243848|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
131170044|NCT02935634|472243849|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
131170045|NCT02935634|472243850|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
131170046|NCT02935634|472243851|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
130729971|NCT00191191|470633653|FG001|Overall Study|Entry Criteria Exclusion|0|||
130729972|NCT00191191|470633652|FG000|Overall Study|Treated with Another Systemic Agent|1|||
130729973|NCT00191191|470633653|FG001|Overall Study|Treated with Another Systemic Agent|1|||
130729974|NCT00191191|470633652|FG000|Overall Study|Adverse Event|11|||
131170047|NCT02935634|472243846|FG000|Treatment: Track 1|Lost to Follow-up|1|||
130729975|NCT00191191|470633653|FG001|Overall Study|Adverse Event|21|||
131170048|NCT02935634|472243847|FG001|Treatment: Track 1|Lost to Follow-up|0|||
131170049|NCT02935634|472243848|FG002|Treatment: Track 1|Lost to Follow-up|0|||
131170050|NCT02935634|472243849|FG003|Treatment: Track 1|Lost to Follow-up|0|||
131170051|NCT02935634|472243850|FG004|Treatment: Track 1|Lost to Follow-up|0|||
131170052|NCT02935634|472243851|FG005|Treatment: Track 1|Lost to Follow-up|0|||
131170053|NCT02935634|472243846|FG000|Treatment: Track 1|Study drug toxicity|2|||
131170054|NCT02935634|472243847|FG001|Treatment: Track 1|Study drug toxicity|1|||
131170055|NCT02935634|472243848|FG002|Treatment: Track 1|Study drug toxicity|3|||
131170056|NCT02935634|472243849|FG003|Treatment: Track 1|Study drug toxicity|0|||
131170057|NCT02935634|472243850|FG004|Treatment: Track 1|Study drug toxicity|0|||
131170058|NCT02935634|472243851|FG005|Treatment: Track 1|Study drug toxicity|1|||
131170059|NCT02935634|472243846|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
131170060|NCT02935634|472243847|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
131170061|NCT02935634|472243848|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
131170062|NCT02935634|472243849|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
131170063|NCT02935634|472243850|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
131170064|NCT02935634|472243851|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
131170065|NCT02935634|472243846|FG000|Treatment: Track 1|Participant withdrew consent|2|||
131170066|NCT02935634|472243847|FG001|Treatment: Track 1|Participant withdrew consent|0|||
131170067|NCT02935634|472243848|FG002|Treatment: Track 1|Participant withdrew consent|1|||
131170068|NCT02935634|472243849|FG003|Treatment: Track 1|Participant withdrew consent|0|||
131170069|NCT02935634|472243850|FG004|Treatment: Track 1|Participant withdrew consent|1|||
131170070|NCT02935634|472243851|FG005|Treatment: Track 1|Participant withdrew consent|0|||
131170071|NCT02935634|472243846|FG000|Treatment: Track 1|Other reasons|0|||
131170072|NCT02935634|472243847|FG001|Treatment: Track 1|Other reasons|0|||
131170073|NCT02935634|472243848|FG002|Treatment: Track 1|Other reasons|2|||
131170074|NCT02935634|472243849|FG003|Treatment: Track 1|Other reasons|0|||
131170075|NCT02935634|472243850|FG004|Treatment: Track 1|Other reasons|0|||
131170076|NCT02935634|472243851|FG005|Treatment: Track 1|Other reasons|0|||
131170077|NCT02935634|472243846|FG000|Treatment: Track 2|Disease progression|13|||
131170078|NCT02935634|472243847|FG001|Treatment: Track 2|Disease progression|26|||
131170079|NCT02935634|472243848|FG002|Treatment: Track 2|Disease progression|20|||
131170080|NCT02935634|472243849|FG003|Treatment: Track 2|Disease progression|5|||
131170081|NCT02935634|472243850|FG004|Treatment: Track 2|Disease progression|1|||
131170082|NCT02935634|472243851|FG005|Treatment: Track 2|Disease progression|4|||
131170083|NCT02935634|472243846|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
131170084|NCT02935634|472243847|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
131170085|NCT02935634|472243848|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
131170086|NCT02935634|472243849|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
131170087|NCT02935634|472243850|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
131170088|NCT02935634|472243851|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
131170089|NCT02935634|472243846|FG000|Treatment: Track 2|Study drug toxicity|7|||
131170090|NCT02935634|472243847|FG001|Treatment: Track 2|Study drug toxicity|3|||
131170091|NCT02935634|472243848|FG002|Treatment: Track 2|Study drug toxicity|0|||
131170092|NCT02935634|472243849|FG003|Treatment: Track 2|Study drug toxicity|0|||
131170093|NCT02935634|472243850|FG004|Treatment: Track 2|Study drug toxicity|0|||
131170094|NCT02935634|472243851|FG005|Treatment: Track 2|Study drug toxicity|0|||
131170095|NCT02935634|472243846|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
131170096|NCT02935634|472243847|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
131170097|NCT02935634|472243848|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
131170098|NCT02935634|472243849|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
131170099|NCT02935634|472243850|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
131170100|NCT02935634|472243851|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
131170101|NCT02935634|472243846|FG000|Treatment: Track 2|Participant withdrew consent|0|||
131170102|NCT02935634|472243847|FG001|Treatment: Track 2|Participant withdrew consent|1|||
131170103|NCT02935634|472243848|FG002|Treatment: Track 2|Participant withdrew consent|1|||
131170104|NCT02935634|472243849|FG003|Treatment: Track 2|Participant withdrew consent|0|||
131170105|NCT02935634|472243850|FG004|Treatment: Track 2|Participant withdrew consent|1|||
131170106|NCT02935634|472243851|FG005|Treatment: Track 2|Participant withdrew consent|0|||
131170107|NCT05906732|472243852|FG000|Overall Study|Withdrawal by Subject|1|||
131170108|NCT05906732|472243853|FG001|Overall Study|Withdrawal by Subject|0|||
131170109|NCT05906732|472243854|FG002|Overall Study|Withdrawal by Subject|0|||
131170110|NCT05906732|472243855|FG003|Overall Study|Withdrawal by Subject|0|||
131170111|NCT05906732|472243852|FG000|Overall Study|Physician Decision|2|||
131170112|NCT05906732|472243853|FG001|Overall Study|Physician Decision|4|||
131170113|NCT05906732|472243854|FG002|Overall Study|Physician Decision|0|||
131170114|NCT05906732|472243855|FG003|Overall Study|Physician Decision|0|||
131170115|NCT00471536|472243862|FG000|Overall Study|Withdrawal by Subject|1|||
131170116|NCT02651194|472243863|FG000|Overall Study|Lost to Follow-up|3|||
131170117|NCT02651194|472243863|FG000|Overall Study|Other|2|||
131170118|NCT02496585|472243864|FG000|Overall Study|Death|3|||
131170119|NCT02496585|472243865|FG001|Overall Study|Death|0|||
131170120|NCT02496585|472243864|FG000|Overall Study|Lost to Follow-up|2|||
131170121|NCT02496585|472243865|FG001|Overall Study|Lost to Follow-up|0|||
130729976|NCT00191191|470633652|FG000|Overall Study|Progressive Disease|84|||
130729977|NCT00191191|470633653|FG001|Overall Study|Progressive Disease|72|||
131170122|NCT02496585|472243864|FG000|Overall Study|Withdrawal by Subject|1|||
131170123|NCT02496585|472243865|FG001|Overall Study|Withdrawal by Subject|2|||
131170124|NCT02496585|472243864|FG000|Overall Study|Progression of Malignancy|4|||
131170125|NCT02496585|472243865|FG001|Overall Study|Progression of Malignancy|1|||
131170126|NCT01864018|472243868|FG000|Overall Study|Ineligible|3|||
131170127|NCT01864018|472243869|FG001|Overall Study|Ineligible|1|||
131170128|NCT03609359|472243872|FG000|Overall Study|Progression of primary disease (PD)|25|||
131170129|NCT03609359|472243872|FG000|Overall Study|Patient's refusal|1|||
131170130|NCT03609359|472243872|FG000|Overall Study|Physician Decision|1|||
131170131|NCT03609359|472243872|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
131170132|NCT04285346|472243873|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
131170133|NCT04285346|472243874|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
131170134|NCT04285346|472243873|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
131170135|NCT04285346|472243874|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
131170136|NCT04285346|472243873|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
131170137|NCT04285346|472243874|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
131170138|NCT01975272|472243875|FG000|Overall Study|Excluded after protocol amendment|1|||
131170139|NCT01975272|472243876|FG001|Overall Study|Excluded after protocol amendment|1|||
131170140|NCT01975272|472243877|FG002|Overall Study|Excluded after protocol amendment|2|||
131170141|NCT01915849|472243880|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
131170142|NCT01915849|472243881|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
131170143|NCT01915849|472243882|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
131170144|NCT01915849|472243883|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
131170145|NCT01915849|472243880|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
131170146|NCT01915849|472243881|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131170147|NCT01915849|472243882|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131170148|NCT01915849|472243883|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
131170149|NCT01318083|472243884|FG000|Overall Study|Adverse Event|4|||
131170150|NCT01318083|472243885|FG001|Overall Study|Adverse Event|1|||
131170151|NCT01318083|472243886|FG002|Overall Study|Adverse Event|2|||
131170152|NCT01318083|472243884|FG000|Overall Study|Withdrawal by Subject|1|||
131170153|NCT01318083|472243885|FG001|Overall Study|Withdrawal by Subject|0|||
131170154|NCT01318083|472243886|FG002|Overall Study|Withdrawal by Subject|2|||
131170155|NCT01318083|472243884|FG000|Overall Study|Lack of Efficacy|0|||
131170156|NCT01318083|472243885|FG001|Overall Study|Lack of Efficacy|0|||
131170157|NCT01318083|472243886|FG002|Overall Study|Lack of Efficacy|1|||
131170158|NCT01318083|472243884|FG000|Overall Study|Treatment Complications|1|||
131170159|NCT01318083|472243885|FG001|Overall Study|Treatment Complications|0|||
131170160|NCT01318083|472243886|FG002|Overall Study|Treatment Complications|0|||
131170161|NCT01318083|472243884|FG000|Overall Study|Lack of Study Medication Compliance|0|||
131170162|NCT01318083|472243885|FG001|Overall Study|Lack of Study Medication Compliance|1|||
131170163|NCT01318083|472243886|FG002|Overall Study|Lack of Study Medication Compliance|0|||
131170164|NCT03552549|472243887|FG000|Overall Study|Disease progression|25|||
131170165|NCT03552549|472243888|FG001|Overall Study|Disease progression|17|||
131170166|NCT03552549|472243887|FG000|Overall Study|Adverse event in first 12 months|12|||
131170167|NCT03552549|472243888|FG001|Overall Study|Adverse event in first 12 months|8|||
131170168|NCT03552549|472243887|FG000|Overall Study|Withdrawal by Subject|7|||
131170169|NCT03552549|472243888|FG001|Overall Study|Withdrawal by Subject|7|||
131170170|NCT03552549|472243887|FG000|Overall Study|Unknown (no reason provided)|4|||
131170171|NCT03552549|472243888|FG001|Overall Study|Unknown (no reason provided)|2|||
131170172|NCT03552549|472243887|FG000|Overall Study|Not in participant's best interest|2|||
131170173|NCT03552549|472243888|FG001|Overall Study|Not in participant's best interest|1|||
131170174|NCT03552549|472243887|FG000|Overall Study|Did not complete study treatment|2|||
131170175|NCT03552549|472243888|FG001|Overall Study|Did not complete study treatment|3|||
131170176|NCT03552549|472243887|FG000|Overall Study|Did not meet eligibility criteria|1|||
131170177|NCT03552549|472243888|FG001|Overall Study|Did not meet eligibility criteria|0|||
131170178|NCT03552549|472243887|FG000|Overall Study|Administrative|0|||
131170179|NCT03552549|472243888|FG001|Overall Study|Administrative|14|||
131170180|NCT02761993|472243891|FG000|Overall Study|Adverse Event|0|||
131170181|NCT02761993|472243892|FG001|Overall Study|Adverse Event|2|||
131235707|NCT00788957|472491011|FG001|Part 2|Lost to Follow-up|0|||
131235708|NCT00788957|472491012|FG002|Part 2|Lost to Follow-up|3|||
131170182|NCT02761993|472243893|FG002|Overall Study|Adverse Event|0|||
131170183|NCT02761993|472243891|FG000|Overall Study|Lost to Follow-up|1|||
131170184|NCT02761993|472243892|FG001|Overall Study|Lost to Follow-up|3|||
131170185|NCT02761993|472243893|FG002|Overall Study|Lost to Follow-up|2|||
131170186|NCT02761993|472243891|FG000|Overall Study|Withdrawal by Subject|1|||
131170187|NCT02761993|472243892|FG001|Overall Study|Withdrawal by Subject|1|||
131170188|NCT02761993|472243893|FG002|Overall Study|Withdrawal by Subject|2|||
131170189|NCT01465178|472243894|FG000|Overall Study|Withdrawal by Subject|1|||
131170190|NCT01465178|472243895|FG001|Overall Study|Withdrawal by Subject|0|||
131170191|NCT00875017|472243898|FG000|First Intervention|Withdrawal by Subject|1|||
131170192|NCT00875017|472243899|FG001|First Intervention|Withdrawal by Subject|0|||
131170193|NCT00875017|472243900|FG002|First Intervention|Withdrawal by Subject|1|||
130780827|NCT02787304|470824788|FG003|Overall Study|Study terminated by sponsor|32|||
131170194|NCT00875017|472243901|FG003|First Intervention|Withdrawal by Subject|0|||
131235709|NCT00788957|472491013|FG003|Part 2|Lost to Follow-up|0|||
131235710|NCT00788957|472491014|FG004|Part 2|Lost to Follow-up|0|||
131235711|NCT00788957|472491015|FG005|Part 2|Lost to Follow-up|0|||
131235712|NCT00788957|472491010|FG000|Part 2|On-study at time of data cut-off|0|||
131235713|NCT00788957|472491011|FG001|Part 2|On-study at time of data cut-off|1|||
131235714|NCT00788957|472491012|FG002|Part 2|On-study at time of data cut-off|1|||
131235715|NCT00788957|472491013|FG003|Part 2|On-study at time of data cut-off|1|||
131235716|NCT00788957|472491014|FG004|Part 2|On-study at time of data cut-off|0|||
131235717|NCT00788957|472491015|FG005|Part 2|On-study at time of data cut-off|0|||
131235718|NCT00788957|472491010|FG000|Part 3|Withdrawal by Subject|0|||
130780828|NCT01051921|470824789|FG000|Overall Study|Physician Decision|9|||
130780829|NCT01051921|470824789|FG000|Overall Study|Adverse Event|8|||
130780830|NCT01051921|470824789|FG000|Overall Study|Withdrawal by Subject|7|||
131170195|NCT00875017|472243902|FG004|First Intervention|Withdrawal by Subject|0|||
131170196|NCT00875017|472243903|FG005|First Intervention|Withdrawal by Subject|0|||
131170197|NCT00875017|472243898|FG000|First Intervention|Adverse Event|0|||
131170198|NCT00875017|472243899|FG001|First Intervention|Adverse Event|0|||
131170199|NCT00875017|472243900|FG002|First Intervention|Adverse Event|0|||
131170200|NCT00875017|472243901|FG003|First Intervention|Adverse Event|1|||
131170201|NCT00875017|472243902|FG004|First Intervention|Adverse Event|0|||
131170202|NCT00875017|472243903|FG005|First Intervention|Adverse Event|0|||
131170203|NCT00875017|472243898|FG000|First Intervention|Problems collecting rectal effluent|1|||
131170204|NCT00875017|472243899|FG001|First Intervention|Problems collecting rectal effluent|0|||
131170205|NCT00875017|472243900|FG002|First Intervention|Problems collecting rectal effluent|0|||
131170206|NCT00875017|472243901|FG003|First Intervention|Problems collecting rectal effluent|0|||
131170207|NCT00875017|472243902|FG004|First Intervention|Problems collecting rectal effluent|0|||
131170208|NCT00875017|472243903|FG005|First Intervention|Problems collecting rectal effluent|0|||
131170209|NCT00875017|472243898|FG000|First Intervention|Intolerance to nasogastric tube|0|||
131170210|NCT00875017|472243899|FG001|First Intervention|Intolerance to nasogastric tube|0|||
131170211|NCT00875017|472243900|FG002|First Intervention|Intolerance to nasogastric tube|0|||
131170212|NCT00875017|472243901|FG003|First Intervention|Intolerance to nasogastric tube|0|||
131170213|NCT00875017|472243902|FG004|First Intervention|Intolerance to nasogastric tube|1|||
131170214|NCT00875017|472243903|FG005|First Intervention|Intolerance to nasogastric tube|0|||
131170215|NCT00875017|472243898|FG000|Washout|Problem collecting rectal effluent|0|||
131170216|NCT00875017|472243899|FG001|Washout|Problem collecting rectal effluent|0|||
131170217|NCT00875017|472243900|FG002|Washout|Problem collecting rectal effluent|1|||
131170218|NCT00875017|472243901|FG003|Washout|Problem collecting rectal effluent|0|||
131170219|NCT00875017|472243902|FG004|Washout|Problem collecting rectal effluent|0|||
131170220|NCT00875017|472243903|FG005|Washout|Problem collecting rectal effluent|0|||
131170221|NCT00875017|472243898|FG000|Second Intervention|Adverse Event|0|||
131170222|NCT00875017|472243899|FG001|Second Intervention|Adverse Event|0|||
131170223|NCT00875017|472243900|FG002|Second Intervention|Adverse Event|0|||
131170224|NCT00875017|472243901|FG003|Second Intervention|Adverse Event|1|||
131170225|NCT00875017|472243902|FG004|Second Intervention|Adverse Event|0|||
131170226|NCT00875017|472243903|FG005|Second Intervention|Adverse Event|0|||
131170227|NCT00875017|472243898|FG000|Washout|Problems collecting rectal effluent|0|||
131170228|NCT00875017|472243899|FG001|Washout|Problems collecting rectal effluent|1|||
131170229|NCT00875017|472243900|FG002|Washout|Problems collecting rectal effluent|0|||
131170230|NCT00875017|472243901|FG003|Washout|Problems collecting rectal effluent|0|||
131170231|NCT00875017|472243902|FG004|Washout|Problems collecting rectal effluent|0|||
131170232|NCT00875017|472243903|FG005|Washout|Problems collecting rectal effluent|0|||
131170233|NCT00875017|472243898|FG000|Third Intervention|Adverse Event|0|||
131170234|NCT00875017|472243899|FG001|Third Intervention|Adverse Event|1|||
131170235|NCT00875017|472243900|FG002|Third Intervention|Adverse Event|1|||
131170236|NCT00875017|472243901|FG003|Third Intervention|Adverse Event|0|||
131170237|NCT00875017|472243902|FG004|Third Intervention|Adverse Event|0|||
131170238|NCT00875017|472243903|FG005|Third Intervention|Adverse Event|0|||
131170239|NCT00875017|472243898|FG000|Washout|Withdrawal by Subject|0|||
131170240|NCT00875017|472243899|FG001|Washout|Withdrawal by Subject|0|||
131170241|NCT00875017|472243900|FG002|Washout|Withdrawal by Subject|0|||
131170242|NCT00875017|472243901|FG003|Washout|Withdrawal by Subject|0|||
131170243|NCT00875017|472243902|FG004|Washout|Withdrawal by Subject|1|||
131170244|NCT00875017|472243903|FG005|Washout|Withdrawal by Subject|0|||
131170245|NCT00875017|472243898|FG000|Fourth Intervention|Inability to comply with fasting|0|||
131170246|NCT00875017|472243899|FG001|Fourth Intervention|Inability to comply with fasting|0|||
131170247|NCT00875017|472243900|FG002|Fourth Intervention|Inability to comply with fasting|0|||
131170248|NCT00875017|472243901|FG003|Fourth Intervention|Inability to comply with fasting|0|||
131170249|NCT00875017|472243902|FG004|Fourth Intervention|Inability to comply with fasting|0|||
131170250|NCT00875017|472243903|FG005|Fourth Intervention|Inability to comply with fasting|1|||
131170251|NCT03342469|472243904|FG000|Overall Study|Withdrawal by Subject|0|||
131170252|NCT03342469|472243905|FG001|Overall Study|Withdrawal by Subject|1|||
131235719|NCT00788957|472491011|FG001|Part 3|Withdrawal by Subject|0|||
131235720|NCT00788957|472491012|FG002|Part 3|Withdrawal by Subject|0|||
131235721|NCT00788957|472491013|FG003|Part 3|Withdrawal by Subject|0|||
131235722|NCT00788957|472491014|FG004|Part 3|Withdrawal by Subject|0|||
131170253|NCT03342469|472243906|FG002|Overall Study|Withdrawal by Subject|0|||
131170254|NCT03342469|472243907|FG003|Overall Study|Withdrawal by Subject|0|||
131170255|NCT01477892|472243908|FG000|Overall Study|Withdrawal by Subject|0|||
131170256|NCT01477892|472243909|FG001|Overall Study|Withdrawal by Subject|2|||
131170257|NCT05515601|472243915|FG000|Overall Study|Withdrawal by Subject|1|||
131170258|NCT05515601|472243916|FG001|Overall Study|Withdrawal by Subject|3|||
131170259|NCT05515601|472243917|FG002|Overall Study|Withdrawal by Subject|2|||
131170260|NCT05515601|472243918|FG003|Overall Study|Withdrawal by Subject|1|||
131170261|NCT05515601|472243919|FG004|Overall Study|Withdrawal by Subject|1|||
131170262|NCT05515601|472243920|FG005|Overall Study|Withdrawal by Subject|1|||
131170263|NCT05515601|472243915|FG000|Overall Study|Lost to Follow-up|0|||
131170264|NCT05515601|472243916|FG001|Overall Study|Lost to Follow-up|0|||
131170265|NCT05515601|472243917|FG002|Overall Study|Lost to Follow-up|0|||
131170266|NCT05515601|472243918|FG003|Overall Study|Lost to Follow-up|0|||
131170267|NCT05515601|472243919|FG004|Overall Study|Lost to Follow-up|1|||
131170268|NCT05515601|472243920|FG005|Overall Study|Lost to Follow-up|0|||
131170269|NCT00777491|472243921|FG000|Overall Study|Protocol Violation|0|||
131170270|NCT00777491|472243922|FG001|Overall Study|Protocol Violation|2|||
131170271|NCT00777491|472243921|FG000|Overall Study|Did not receive any protocol treatment|2|||
131170272|NCT00777491|472243922|FG001|Overall Study|Did not receive any protocol treatment|0|||
131170273|NCT04160468|472243923|FG000|Overall Study|Lost to Follow-up|19|||
131170274|NCT04160468|472243924|FG001|Overall Study|Lost to Follow-up|4|||
131170275|NCT04160468|472243923|FG000|Overall Study|Randomized but not dosed|6|||
131170276|NCT04160468|472243924|FG001|Overall Study|Randomized but not dosed|0|||
131170277|NCT04160468|472243923|FG000|Overall Study|Withdrawal by Subject|4|||
131170278|NCT04160468|472243924|FG001|Overall Study|Withdrawal by Subject|1|||
131170279|NCT04160468|472243923|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
131170280|NCT04160468|472243924|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
131170281|NCT04160468|472243923|FG000|Overall Study|Participant incarcerated|1|||
131170282|NCT04160468|472243924|FG001|Overall Study|Participant incarcerated|0|||
131170283|NCT01912768|472243925|FG000|Overall Study|Adverse Event|2|||
131170284|NCT01912768|472243926|FG001|Overall Study|Adverse Event|0|||
131170285|NCT01912768|472243925|FG000|Overall Study|Lost to Follow-up|2|||
131170286|NCT01912768|472243926|FG001|Overall Study|Lost to Follow-up|1|||
131170287|NCT01912768|472243925|FG000|Overall Study|Withdrawal by Subject|5|||
131170288|NCT01912768|472243926|FG001|Overall Study|Withdrawal by Subject|3|||
131170289|NCT01912768|472243925|FG000|Overall Study|Randomized in error|1|||
131170290|NCT01912768|472243926|FG001|Overall Study|Randomized in error|0|||
131170291|NCT01187901|472243927|FG000|Overall Study|Protocol Violation|1|||
131170292|NCT01187901|472243928|FG001|Overall Study|Protocol Violation|0|||
131170293|NCT01187901|472243927|FG000|Overall Study|Lost to Follow-up|1|||
131170294|NCT01187901|472243928|FG001|Overall Study|Lost to Follow-up|2|||
131170295|NCT01187901|472243927|FG000|Overall Study|Unrelated Health Reasons|1|||
131170296|NCT01187901|472243928|FG001|Overall Study|Unrelated Health Reasons|2|||
131170297|NCT01187901|472243927|FG000|Overall Study|Suspected Allergic Reaction|1|||
131170298|NCT01187901|472243928|FG001|Overall Study|Suspected Allergic Reaction|1|||
131170299|NCT01187901|472243927|FG000|Overall Study|Adverse Event|3|||
131170300|NCT01187901|472243928|FG001|Overall Study|Adverse Event|0|||
131170301|NCT01187901|472243927|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
131170302|NCT01187901|472243928|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
131170303|NCT01187901|472243927|FG000|Overall Study|Pregnancy|0|||
131170304|NCT01187901|472243928|FG001|Overall Study|Pregnancy|2|||
131170305|NCT00540436|472243931|FG000|First 12-Week Treatment Period|Adverse Event|1|||
131170306|NCT00540436|472243931|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
131170307|NCT00540436|472243931|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
131170308|NCT00540436|472243931|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
131170309|NCT03255291|472243932|FG000|Overall Study|Determined to be ineligible|10|||
131170310|NCT03255291|472243933|FG001|Overall Study|Determined to be ineligible|12|||
131170311|NCT03255291|472243934|FG002|Overall Study|Determined to be ineligible|6|||
131170312|NCT03255291|472243935|FG003|Overall Study|Determined to be ineligible|6|||
131170313|NCT03255291|472243936|FG004|Overall Study|Determined to be ineligible|5|||
131170314|NCT03255291|472243937|FG005|Overall Study|Determined to be ineligible|10|||
131170315|NCT03255291|472243932|FG000|Overall Study|Baseline data collection issues|3|||
131170316|NCT03255291|472243933|FG001|Overall Study|Baseline data collection issues|0|||
131170317|NCT03255291|472243934|FG002|Overall Study|Baseline data collection issues|0|||
131235723|NCT00788957|472491015|FG005|Part 3|Withdrawal by Subject|2|||
130729978|NCT00191191|470633652|FG000|Overall Study|Toxicity After Dose Reduction|7|||
131170318|NCT03255291|472243935|FG003|Overall Study|Baseline data collection issues|0|||
131170319|NCT03255291|472243936|FG004|Overall Study|Baseline data collection issues|2|||
131170320|NCT03255291|472243937|FG005|Overall Study|Baseline data collection issues|0|||
131170321|NCT01745393|472243938|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
131235724|NCT00788957|472491010|FG000|Part 3|Death|0|||
130729979|NCT00191191|470633653|FG001|Overall Study|Toxicity After Dose Reduction|8|||
131170322|NCT01745393|472243939|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
131235725|NCT00788957|472491011|FG001|Part 3|Death|0|||
130780831|NCT01051921|470824789|FG000|Overall Study|Lost to Follow-up|4|||
130780832|NCT01051921|470824789|FG000|Overall Study|virological failure|1|||
130780833|NCT01051921|470824789|FG000|Overall Study|patient moved|1|||
130780834|NCT01325350|470824792|FG000|Overall Study|Adverse Event|3|||
130780835|NCT01325350|470824793|FG001|Overall Study|Adverse Event|3|||
130780836|NCT01325350|470824794|FG002|Overall Study|Adverse Event|3|||
130780837|NCT01325350|470824795|FG003|Overall Study|Adverse Event|1|||
130780838|NCT01325350|470824796|FG004|Overall Study|Adverse Event|2|||
130780839|NCT01325350|470824792|FG000|Overall Study|Pregnancy|0|||
130780840|NCT01325350|470824793|FG001|Overall Study|Pregnancy|0|||
130780841|NCT01325350|470824794|FG002|Overall Study|Pregnancy|1|||
130780842|NCT01325350|470824795|FG003|Overall Study|Pregnancy|0|||
130780843|NCT01325350|470824796|FG004|Overall Study|Pregnancy|1|||
130780844|NCT01325350|470824792|FG000|Overall Study|Lost to Follow-up|1|||
130780845|NCT01325350|470824793|FG001|Overall Study|Lost to Follow-up|0|||
130780846|NCT01325350|470824794|FG002|Overall Study|Lost to Follow-up|5|||
130780847|NCT01325350|470824795|FG003|Overall Study|Lost to Follow-up|1|||
130780848|NCT01325350|470824796|FG004|Overall Study|Lost to Follow-up|5|||
130780849|NCT01325350|470824792|FG000|Overall Study|Personal Reasons|2|||
130780850|NCT01325350|470824793|FG001|Overall Study|Personal Reasons|1|||
130780851|NCT01325350|470824794|FG002|Overall Study|Personal Reasons|6|||
130780852|NCT01325350|470824795|FG003|Overall Study|Personal Reasons|5|||
130780853|NCT01325350|470824796|FG004|Overall Study|Personal Reasons|3|||
130780854|NCT01325350|470824792|FG000|Overall Study|Protocol Violation|0|||
130780855|NCT01325350|470824793|FG001|Overall Study|Protocol Violation|0|||
130780856|NCT01325350|470824794|FG002|Overall Study|Protocol Violation|0|||
130780857|NCT01325350|470824795|FG003|Overall Study|Protocol Violation|1|||
130780858|NCT01325350|470824796|FG004|Overall Study|Protocol Violation|0|||
130780859|NCT01325350|470824792|FG000|Overall Study|Withdrawal by Subject|0|||
130780860|NCT01325350|470824793|FG001|Overall Study|Withdrawal by Subject|0|||
130780861|NCT01325350|470824794|FG002|Overall Study|Withdrawal by Subject|1|||
130780862|NCT01325350|470824795|FG003|Overall Study|Withdrawal by Subject|1|||
130780863|NCT01325350|470824796|FG004|Overall Study|Withdrawal by Subject|0|||
130780864|NCT01325350|470824792|FG000|Overall Study|Did Not Receive Treatment|0|||
130780865|NCT01325350|470824793|FG001|Overall Study|Did Not Receive Treatment|1|||
130780866|NCT01325350|470824794|FG002|Overall Study|Did Not Receive Treatment|1|||
130780867|NCT01325350|470824795|FG003|Overall Study|Did Not Receive Treatment|0|||
130780868|NCT01325350|470824796|FG004|Overall Study|Did Not Receive Treatment|1|||
130780869|NCT01053741|470824799|FG000|2nd Study Intervention|Physician Decision|0|||
130780870|NCT01053741|470824800|FG001|2nd Study Intervention|Physician Decision|1|||
130780871|NCT01831427|470824802|FG000|Overall Study|Adverse Event|0|||
130780872|NCT01831427|470824803|FG001|Overall Study|Adverse Event|1|||
130780873|NCT01831427|470824804|FG002|Overall Study|Adverse Event|0|||
130780874|NCT01831427|470824805|FG003|Overall Study|Adverse Event|0|||
131170323|NCT01745393|472243938|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
131170324|NCT01745393|472243939|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
131170325|NCT01745393|472243938|FG000|12-month Follow-up|Lost to Follow-up|6|||
131170326|NCT01745393|472243939|FG001|12-month Follow-up|Lost to Follow-up|5|||
131170327|NCT00471445|472243941|FG000|Overall Study|Withdrawal by Subject|1|||
131170328|NCT00471445|472243942|FG001|Overall Study|Withdrawal by Subject|1|||
131170329|NCT00471445|472243941|FG000|Overall Study|Ineligible|1|||
131170330|NCT00471445|472243942|FG001|Overall Study|Ineligible|0|||
131170331|NCT00471445|472243941|FG000|Overall Study|Protocol Violation|0|||
131170332|NCT00471445|472243942|FG001|Overall Study|Protocol Violation|1|||
131170333|NCT01067508|472243949|FG000|Overall Study|Physician Decision|0|||
131170334|NCT01067508|472243950|FG001|Overall Study|Physician Decision|1|||
131170335|NCT01067508|472243949|FG000|Overall Study|Withdrawal by Subject|0|||
131170336|NCT01067508|472243950|FG001|Overall Study|Withdrawal by Subject|1|||
131170337|NCT00444626|472243953|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
131170338|NCT00444626|472243953|FG000|Initial Treatment Period|Adverse Event|1|||
131170339|NCT00444626|472243953|FG000|Initial Treatment Period|Lost to Follow-up|9|||
131170340|NCT04715230|472243954|FG000|Overall Study|Withdrawal by Subject|1|||
131170341|NCT04715230|472243955|FG001|Overall Study|Withdrawal by Subject|0|||
131235726|NCT00788957|472491012|FG002|Part 3|Death|0|||
130780875|NCT01831427|470824806|FG004|Overall Study|Adverse Event|0|||
130780876|NCT01831427|470824807|FG005|Overall Study|Adverse Event|1|||
130780877|NCT01831427|470824808|FG006|Overall Study|Adverse Event|0|||
130780878|NCT01831427|470824809|FG007|Overall Study|Adverse Event|1|||
130780879|NCT01831427|470824810|FG008|Overall Study|Adverse Event|0|||
130780880|NCT01831427|470824811|FG009|Overall Study|Adverse Event|0|||
130780881|NCT01831427|470824812|FG010|Overall Study|Adverse Event|2|||
130780882|NCT01831427|470824802|FG000|Overall Study|Investigator's Discretion|0|||
130780883|NCT01831427|470824803|FG001|Overall Study|Investigator's Discretion|0|||
130780884|NCT01831427|470824804|FG002|Overall Study|Investigator's Discretion|0|||
130780885|NCT01831427|470824805|FG003|Overall Study|Investigator's Discretion|1|||
130780886|NCT01831427|470824806|FG004|Overall Study|Investigator's Discretion|0|||
130780887|NCT01831427|470824807|FG005|Overall Study|Investigator's Discretion|0|||
130780888|NCT01831427|470824808|FG006|Overall Study|Investigator's Discretion|0|||
131235727|NCT00788957|472491013|FG003|Part 3|Death|0|||
131170342|NCT04715230|472243956|FG002|Overall Study|Withdrawal by Subject|0|||
131170343|NCT04715230|472243954|FG000|Overall Study|Lost to Follow-up|0|||
131170344|NCT04715230|472243955|FG001|Overall Study|Lost to Follow-up|5|||
131170345|NCT04715230|472243956|FG002|Overall Study|Lost to Follow-up|1|||
131170346|NCT04594239|472243957|FG000|Overall Study|Withdrawal by Subject|3|||
131170347|NCT04594239|472243958|FG001|Overall Study|Withdrawal by Subject|4|||
131170348|NCT04594239|472243959|FG002|Overall Study|Withdrawal by Subject|2|||
131170349|NCT04594239|472243960|FG003|Overall Study|Withdrawal by Subject|4|||
131170350|NCT04594239|472243957|FG000|Overall Study|Lost to Follow-up|8|||
131170351|NCT04594239|472243958|FG001|Overall Study|Lost to Follow-up|5|||
131170352|NCT04594239|472243959|FG002|Overall Study|Lost to Follow-up|4|||
131170353|NCT04594239|472243960|FG003|Overall Study|Lost to Follow-up|6|||
131170354|NCT04594239|472243957|FG000|Overall Study|Subject relocated|0|||
131170355|NCT04594239|472243958|FG001|Overall Study|Subject relocated|0|||
131170356|NCT04594239|472243959|FG002|Overall Study|Subject relocated|0|||
131170357|NCT04594239|472243960|FG003|Overall Study|Subject relocated|1|||
131170358|NCT00091390|472243961|FG000|Overall Study|Protocol Violation|1|||
131170359|NCT00091390|472243961|FG000|Overall Study|No protocol treatment|3|||
131170360|NCT03229759|472243964|FG000|Overall Study|Screen Failure|30|||
131170361|NCT02326467|472245369|FG000|Overall Study|Withdrawal by Subject|1|||
131170362|NCT00434512|472245370|FG000|Overall Study|Migrated/moved from study area|0|||
131170363|NCT00434512|472245371|FG001|Overall Study|Migrated/moved from study area|0|||
131170364|NCT00434512|472245372|FG002|Overall Study|Migrated/moved from study area|0|||
131170365|NCT00434512|472245373|FG003|Overall Study|Migrated/moved from study area|1|||
131170366|NCT00434512|472245374|FG004|Overall Study|Migrated/moved from study area|1|||
131170367|NCT00434512|472245375|FG005|Overall Study|Migrated/moved from study area|1|||
131170368|NCT00434512|472245370|FG000|Overall Study|Other|0|||
131170369|NCT00434512|472245371|FG001|Overall Study|Other|1|||
131170370|NCT00434512|472245372|FG002|Overall Study|Other|0|||
131170371|NCT00434512|472245373|FG003|Overall Study|Other|0|||
131170372|NCT00434512|472245374|FG004|Overall Study|Other|0|||
131170373|NCT00434512|472245375|FG005|Overall Study|Other|0|||
131170374|NCT04281030|472245382|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
131170375|NCT04281030|472245383|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
131170376|NCT04281030|472245382|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
131170377|NCT04281030|472245383|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
131170378|NCT01361009|472245384|FG000|Overall Study|Protocol Violation|116|||
131170379|NCT02116660|472245386|FG000|Overall Study|Deteriorating renal function|0|||
131170380|NCT02116660|472245387|FG001|Overall Study|Deteriorating renal function|1|||
131170381|NCT02116660|472245386|FG000|Overall Study|Adverse Event|1|||
131170382|NCT02116660|472245387|FG001|Overall Study|Adverse Event|1|||
131170383|NCT02116660|472245386|FG000|Overall Study|Withdrawal by Subject|0|||
131170384|NCT02116660|472245387|FG001|Overall Study|Withdrawal by Subject|2|||
131170385|NCT02116660|472245386|FG000|Overall Study|Organization reason|1|||
131170386|NCT02116660|472245387|FG001|Overall Study|Organization reason|0|||
131170387|NCT00411788|472245388|FG000|Overall Study|Protocol Violation|1|||
131170388|NCT00411788|472245388|FG000|Overall Study|Adverse Event|1|||
131235728|NCT00788957|472491014|FG004|Part 3|Death|8|||
131235729|NCT00788957|472491015|FG005|Part 3|Death|8|||
131235730|NCT00788957|472491010|FG000|Part 3|On-study at time of data cut-off|0|||
131235731|NCT00788957|472491011|FG001|Part 3|On-study at time of data cut-off|0|||
131235732|NCT00788957|472491012|FG002|Part 3|On-study at time of data cut-off|0|||
131235733|NCT00788957|472491013|FG003|Part 3|On-study at time of data cut-off|0|||
131235734|NCT00788957|472491014|FG004|Part 3|On-study at time of data cut-off|1|||
131170389|NCT01727713|472245392|FG000|Overall Study|Lost to Follow-up|5|||
131170390|NCT01727713|472245392|FG000|Overall Study|Adverse Event|10|||
131170391|NCT01727713|472245392|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
131170392|NCT01727713|472245392|FG000|Overall Study|Withdrawal by Subject|13|||
131170393|NCT01727713|472245392|FG000|Overall Study|Protocol Deviation|2|||
131170394|NCT01100307|472245398|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
131170395|NCT01100307|472245399|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
131170396|NCT01100307|472245398|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
131170397|NCT01100307|472245399|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
131235735|NCT00788957|472491015|FG005|Part 3|On-study at time of data cut-off|0|||
131170398|NCT01100307|472245398|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
130729980|NCT00191191|470633652|FG000|Overall Study|Family/Caregiver Decision|5|||
131170399|NCT01100307|472245399|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
131170400|NCT01100307|472245398|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
131170401|NCT01100307|472245399|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
131170402|NCT01100307|472245398|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
131170403|NCT01100307|472245399|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
131235736|NCT03276975|472491016|FG000|Overall Study|Withdrawal by Subject|1|||
130729981|NCT00191191|470633653|FG001|Overall Study|Family/Caregiver Decision|7|||
131235737|NCT03276975|472491017|FG001|Overall Study|Withdrawal by Subject|0|||
130780889|NCT01831427|470824809|FG007|Overall Study|Investigator's Discretion|0|||
130780890|NCT01831427|470824810|FG008|Overall Study|Investigator's Discretion|0|||
130780891|NCT01831427|470824811|FG009|Overall Study|Investigator's Discretion|0|||
130780892|NCT01831427|470824812|FG010|Overall Study|Investigator's Discretion|0|||
130780893|NCT01831427|470824802|FG000|Overall Study|Withdrew Consent|0|||
130780894|NCT01831427|470824803|FG001|Overall Study|Withdrew Consent|0|||
130780895|NCT01831427|470824804|FG002|Overall Study|Withdrew Consent|0|||
130780896|NCT01831427|470824805|FG003|Overall Study|Withdrew Consent|0|||
130780897|NCT01831427|470824806|FG004|Overall Study|Withdrew Consent|0|||
130780898|NCT01831427|470824807|FG005|Overall Study|Withdrew Consent|0|||
130780899|NCT01831427|470824808|FG006|Overall Study|Withdrew Consent|2|||
130780900|NCT01831427|470824809|FG007|Overall Study|Withdrew Consent|0|||
130780901|NCT01831427|470824810|FG008|Overall Study|Withdrew Consent|0|||
130780902|NCT01831427|470824811|FG009|Overall Study|Withdrew Consent|1|||
130780903|NCT01831427|470824812|FG010|Overall Study|Withdrew Consent|1|||
130780904|NCT00536510|470824813|FG000|Overall Study|Adverse Event|27|||
130780905|NCT00536510|470824814|FG001|Overall Study|Adverse Event|4|||
130780906|NCT00536510|470824813|FG000|Overall Study|Lost to Follow-up|11|||
130780907|NCT00536510|470824814|FG001|Overall Study|Lost to Follow-up|8|||
130780908|NCT00536510|470824813|FG000|Overall Study|Protocol Violation|4|||
130780909|NCT00536510|470824814|FG001|Overall Study|Protocol Violation|5|||
130780910|NCT00536510|470824813|FG000|Overall Study|Withdrawal by Subject|16|||
130780911|NCT00536510|470824814|FG001|Overall Study|Withdrawal by Subject|9|||
130780912|NCT00536510|470824813|FG000|Overall Study|Flushing with Product|20|||
130780913|NCT00536510|470824814|FG001|Overall Study|Flushing with Product|0|||
130780914|NCT00536510|470824813|FG000|Overall Study|Laboratory Adverse Event|2|||
130780915|NCT00536510|470824814|FG001|Overall Study|Laboratory Adverse Event|1|||
130780916|NCT00536510|470824813|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
130780917|NCT00536510|470824814|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
130780918|NCT02169505|470824815|FG000|Overall Study|Withdrawal by Subject|1|||
130780919|NCT00048035|470824816|FG000|Core Period|Early Withdrawals|4|||
130780920|NCT00048035|470824817|FG001|Core Period|Early Withdrawals|2|||
130780921|NCT00048035|470824818|FG002|Core Period|Early Withdrawals|1|||
130780922|NCT00048035|470824819|FG003|Core Period|Early Withdrawals|1|||
131170404|NCT01100307|472245398|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
131170405|NCT01100307|472245399|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
131170406|NCT04891770|472245400|FG000|Overall Study|Withdrew consent|1|||
131170407|NCT04891770|472245401|FG001|Overall Study|Withdrew consent|3|||
131170408|NCT04891770|472245402|FG002|Overall Study|Withdrew consent|0|||
131170409|NCT04891770|472245400|FG000|Overall Study|Enrolled but never treated|0|||
131170410|NCT04891770|472245401|FG001|Overall Study|Enrolled but never treated|0|||
131170411|NCT04891770|472245402|FG002|Overall Study|Enrolled but never treated|1|||
131170412|NCT04891770|472245400|FG000|Overall Study|Investigator's discretion|0|||
131170413|NCT04891770|472245401|FG001|Overall Study|Investigator's discretion|1|||
131170414|NCT04891770|472245402|FG002|Overall Study|Investigator's discretion|0|||
131170415|NCT05122650|472245403|FG000|Overall Study|Adverse Event|4|||
131170416|NCT05122650|472245404|FG001|Overall Study|Adverse Event|16|||
131170417|NCT05122650|472245405|FG002|Overall Study|Adverse Event|11|||
131170418|NCT05122650|472245406|FG003|Overall Study|Adverse Event|12|||
131170419|NCT05122650|472245403|FG000|Overall Study|Lack of Efficacy|0|||
131170420|NCT05122650|472245404|FG001|Overall Study|Lack of Efficacy|1|||
131170421|NCT05122650|472245405|FG002|Overall Study|Lack of Efficacy|1|||
131170422|NCT05122650|472245406|FG003|Overall Study|Lack of Efficacy|2|||
131170423|NCT05122650|472245403|FG000|Overall Study|Lost to Follow-up|1|||
131170424|NCT05122650|472245404|FG001|Overall Study|Lost to Follow-up|1|||
131170425|NCT05122650|472245405|FG002|Overall Study|Lost to Follow-up|3|||
131170426|NCT05122650|472245406|FG003|Overall Study|Lost to Follow-up|0|||
131170427|NCT05122650|472245403|FG000|Overall Study|Non-compliance with study intervention|0|||
131170428|NCT05122650|472245404|FG001|Overall Study|Non-compliance with study intervention|0|||
131170429|NCT05122650|472245405|FG002|Overall Study|Non-compliance with study intervention|0|||
131170430|NCT05122650|472245406|FG003|Overall Study|Non-compliance with study intervention|2|||
131170431|NCT05122650|472245403|FG000|Overall Study|Protocol Violation|0|||
131170432|NCT05122650|472245404|FG001|Overall Study|Protocol Violation|1|||
131170433|NCT05122650|472245405|FG002|Overall Study|Protocol Violation|0|||
131170434|NCT05122650|472245406|FG003|Overall Study|Protocol Violation|1|||
131170435|NCT05122650|472245403|FG000|Overall Study|Randomized by mistake|0|||
131170436|NCT05122650|472245404|FG001|Overall Study|Randomized by mistake|0|||
131170437|NCT05122650|472245405|FG002|Overall Study|Randomized by mistake|3|||
131170438|NCT05122650|472245406|FG003|Overall Study|Randomized by mistake|2|||
130780923|NCT00048035|470824820|FG004|Core Period|Early Withdrawals|1|||
130780924|NCT00048035|470824821|FG005|Core Period|Early Withdrawals|1|||
130780925|NCT00048035|470824822|FG006|Core Period|Early Withdrawals|0|||
130780926|NCT00048035|470824823|FG007|Core Period|Early Withdrawals|0|||
130780927|NCT00048035|470824816|FG000|Extension Year 1|Early Withdrawals|0|||
130780928|NCT00048035|470824817|FG001|Extension Year 1|Early Withdrawals|0|||
130780929|NCT00048035|470824818|FG002|Extension Year 1|Early Withdrawals|0|||
130780930|NCT00048035|470824819|FG003|Extension Year 1|Early Withdrawals|0|||
131170439|NCT05122650|472245403|FG000|Overall Study|Sponsor request|0|||
131170440|NCT05122650|472245404|FG001|Overall Study|Sponsor request|1|||
131170441|NCT05122650|472245405|FG002|Overall Study|Sponsor request|1|||
131170442|NCT05122650|472245406|FG003|Overall Study|Sponsor request|2|||
131170443|NCT05122650|472245403|FG000|Overall Study|Withdrawal by Subject|3|||
131170444|NCT05122650|472245404|FG001|Overall Study|Withdrawal by Subject|7|||
131170445|NCT05122650|472245405|FG002|Overall Study|Withdrawal by Subject|4|||
131170446|NCT05122650|472245406|FG003|Overall Study|Withdrawal by Subject|8|||
131170447|NCT05122650|472245403|FG000|Overall Study|Other|5|||
131170448|NCT05122650|472245404|FG001|Overall Study|Other|0|||
131170449|NCT05122650|472245405|FG002|Overall Study|Other|0|||
131170450|NCT05122650|472245406|FG003|Overall Study|Other|0|||
131170451|NCT04360187|472245417|FG000|Double-Blind Treatment|Adverse Event|9|||
131170452|NCT04360187|472245418|FG001|Double-Blind Treatment|Adverse Event|11|||
131170453|NCT04360187|472245417|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
131170454|NCT04360187|472245418|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
131170455|NCT04360187|472245417|FG000|Double-Blind Treatment|Physician Decision|1|||
131170456|NCT04360187|472245418|FG001|Double-Blind Treatment|Physician Decision|0|||
131170457|NCT04360187|472245417|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
131170458|NCT04360187|472245418|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
131170459|NCT04360187|472245417|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
131170460|NCT04360187|472245418|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
131170461|NCT04360187|472245417|FG000|Follow-Up|Lost to Follow-up|1|||
131170462|NCT04360187|472245418|FG001|Follow-Up|Lost to Follow-up|0|||
131170463|NCT00222729|472245424|FG000|Overall Study|Adverse Event|3|||
131170464|NCT00515008|472245425|FG000|Overall Study|Lost to Follow-up|1|||
131170465|NCT00515008|472245426|FG001|Overall Study|Lost to Follow-up|0|||
131170466|NCT00515008|472245425|FG000|Overall Study|Declined|0|||
131170467|NCT00515008|472245426|FG001|Overall Study|Declined|3|||
131170468|NCT00515008|472245425|FG000|Overall Study|Left the Boston Area|1|||
131170469|NCT00515008|472245426|FG001|Overall Study|Left the Boston Area|1|||
131170470|NCT00515008|472245425|FG000|Overall Study|Scheduling conflict|1|||
131170471|NCT00515008|472245426|FG001|Overall Study|Scheduling conflict|0|||
131170472|NCT01798706|472245427|FG000|Overall Study|Adverse Event|15|||
131170473|NCT01798706|472245428|FG001|Overall Study|Adverse Event|10|||
131170474|NCT01798706|472245427|FG000|Overall Study|Lack of Efficacy|0|||
131170475|NCT01798706|472245428|FG001|Overall Study|Lack of Efficacy|2|||
131170476|NCT01798706|472245427|FG000|Overall Study|Poor compliance to protocol|1|||
131170477|NCT01798706|472245428|FG001|Overall Study|Poor compliance to protocol|0|||
131170478|NCT01798706|472245427|FG000|Overall Study|Other than specified above|5|||
131170479|NCT01798706|472245428|FG001|Overall Study|Other than specified above|9|||
131170480|NCT00496873|472245429|FG000|Overall Study|Ineligible|2|||
131170481|NCT00496873|472245429|FG000|Overall Study|Death|2|||
131170482|NCT00496873|472245429|FG000|Overall Study|Withdrawal by Subject|3|||
131170483|NCT03238235|472245430|FG000|Overall Study|Adverse Event|2|||
131170484|NCT03238235|472245431|FG001|Overall Study|Adverse Event|0|||
131170485|NCT03238235|472245430|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
131170486|NCT03238235|472245431|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
131170487|NCT05896761|472245434|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
131170488|NCT05896761|472245435|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
131170489|NCT05896761|472245434|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
131170490|NCT05896761|472245435|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
131170491|NCT02028338|472245436|FG000|Overall Study|Withdrawal by Subject|3|||
131170492|NCT02028338|472245437|FG001|Overall Study|Withdrawal by Subject|1|||
131170493|NCT02028338|472245436|FG000|Overall Study|Unable to contact participant|1|||
131170494|NCT02028338|472245437|FG001|Overall Study|Unable to contact participant|0|||
131170495|NCT01842620|472245442|FG000|Period 1|Withdrawal by Subject|1|||
131170496|NCT01842620|472245443|FG001|Period 1|Withdrawal by Subject|0|||
131170497|NCT00256867|472245444|FG000|Overall Study|Adverse Event|0|||
131170498|NCT00256867|472245445|FG001|Overall Study|Adverse Event|1|||
131170499|NCT00256867|472245446|FG002|Overall Study|Adverse Event|1|||
131170500|NCT00256867|472245447|FG003|Overall Study|Adverse Event|1|||
131170501|NCT00256867|472245448|FG004|Overall Study|Adverse Event|2|||
131170502|NCT00256867|472245449|FG005|Overall Study|Adverse Event|2|||
131170503|NCT00256867|472245450|FG006|Overall Study|Adverse Event|1|||
131170504|NCT00256867|472245451|FG007|Overall Study|Adverse Event|4|||
131170505|NCT00256867|472245444|FG000|Overall Study|Lost to Follow-up|2|||
131170506|NCT00256867|472245445|FG001|Overall Study|Lost to Follow-up|2|||
131170507|NCT00256867|472245446|FG002|Overall Study|Lost to Follow-up|2|||
131170508|NCT00256867|472245447|FG003|Overall Study|Lost to Follow-up|3|||
131170509|NCT00256867|472245448|FG004|Overall Study|Lost to Follow-up|2|||
131170510|NCT00256867|472245449|FG005|Overall Study|Lost to Follow-up|0|||
131170511|NCT00256867|472245450|FG006|Overall Study|Lost to Follow-up|1|||
130729982|NCT00191191|470633652|FG000|Overall Study|Lost to Follow-up|1|||
131170512|NCT00256867|472245451|FG007|Overall Study|Lost to Follow-up|2|||
131170513|NCT00256867|472245444|FG000|Overall Study|Protocol Violation|0|||
131170514|NCT00256867|472245445|FG001|Overall Study|Protocol Violation|0|||
131170515|NCT00256867|472245446|FG002|Overall Study|Protocol Violation|0|||
131170516|NCT00256867|472245447|FG003|Overall Study|Protocol Violation|1|||
131170517|NCT00256867|472245448|FG004|Overall Study|Protocol Violation|0|||
131170518|NCT00256867|472245449|FG005|Overall Study|Protocol Violation|1|||
131170519|NCT00256867|472245450|FG006|Overall Study|Protocol Violation|0|||
131170520|NCT00256867|472245451|FG007|Overall Study|Protocol Violation|1|||
131170521|NCT00256867|472245444|FG000|Overall Study|Withdrawal by Subject|0|||
131170522|NCT00256867|472245445|FG001|Overall Study|Withdrawal by Subject|0|||
131170523|NCT00256867|472245446|FG002|Overall Study|Withdrawal by Subject|1|||
131170524|NCT00256867|472245447|FG003|Overall Study|Withdrawal by Subject|1|||
131170525|NCT00256867|472245448|FG004|Overall Study|Withdrawal by Subject|2|||
131170526|NCT00256867|472245449|FG005|Overall Study|Withdrawal by Subject|2|||
131170527|NCT00256867|472245450|FG006|Overall Study|Withdrawal by Subject|3|||
131170528|NCT00256867|472245451|FG007|Overall Study|Withdrawal by Subject|2|||
131170529|NCT00256867|472245444|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131170530|NCT00256867|472245445|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
131170531|NCT00256867|472245446|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131170532|NCT00256867|472245447|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131170533|NCT00256867|472245448|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131170534|NCT00256867|472245449|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131170535|NCT00256867|472245450|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131170536|NCT00256867|472245451|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
131170537|NCT00256867|472245444|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131170538|NCT00256867|472245445|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131170539|NCT00256867|472245446|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130780931|NCT00048035|470824820|FG004|Extension Year 1|Early Withdrawals|0|||
130780932|NCT00048035|470824821|FG005|Extension Year 1|Early Withdrawals|0|||
130780933|NCT00048035|470824822|FG006|Extension Year 1|Early Withdrawals|11|||
130780934|NCT00048035|470824823|FG007|Extension Year 1|Early Withdrawals|11|||
130780935|NCT00048035|470824816|FG000|Extension Year 2|Early Withdrawals|0|||
131170540|NCT00256867|472245447|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131170541|NCT00256867|472245448|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131170542|NCT00256867|472245449|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131170543|NCT00256867|472245450|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
131170544|NCT00256867|472245451|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
131170545|NCT00256867|472245444|FG000|Overall Study|Investigator's Decision|0|||
131170546|NCT00256867|472245445|FG001|Overall Study|Investigator's Decision|0|||
131170547|NCT00256867|472245446|FG002|Overall Study|Investigator's Decision|0|||
131170548|NCT00256867|472245447|FG003|Overall Study|Investigator's Decision|0|||
131170549|NCT00256867|472245448|FG004|Overall Study|Investigator's Decision|1|||
131170550|NCT00256867|472245449|FG005|Overall Study|Investigator's Decision|0|||
131170551|NCT00256867|472245450|FG006|Overall Study|Investigator's Decision|0|||
131170552|NCT00256867|472245451|FG007|Overall Study|Investigator's Decision|0|||
131170553|NCT00256867|472245444|FG000|Overall Study|Non-compliance with study medication|0|||
131170554|NCT00256867|472245445|FG001|Overall Study|Non-compliance with study medication|0|||
131170555|NCT00256867|472245446|FG002|Overall Study|Non-compliance with study medication|0|||
131170556|NCT00256867|472245447|FG003|Overall Study|Non-compliance with study medication|0|||
131235738|NCT03283709|472491027|FG000|Overall Study|trial terminated|0|||
131235739|NCT03283709|472491028|FG001|Overall Study|trial terminated|1|||
131235740|NCT01734772|472491029|FG000|Overall Study|Adverse Event|1|||
131235741|NCT01734772|472491030|FG001|Overall Study|Adverse Event|2|||
131235742|NCT01734772|472491029|FG000|Overall Study|Withdrawal by Subject|0|||
131235743|NCT01734772|472491030|FG001|Overall Study|Withdrawal by Subject|1|||
131235744|NCT02994056|472491031|FG000|Overall Study|Death|8|||
131235745|NCT02994056|472491031|FG000|Overall Study|Withdrew Consent|1|||
131235746|NCT02199509|472491034|FG000|Overall Study|Suicidal Ideation|0|||
131235747|NCT02199509|472491035|FG001|Overall Study|Suicidal Ideation|1|||
131235748|NCT02199509|472491034|FG000|Overall Study|Misunderstood titration schedule|1|||
131235749|NCT02199509|472491035|FG001|Overall Study|Misunderstood titration schedule|0|||
131235750|NCT04947579|472491039|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
131235751|NCT04947579|472491040|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
131170557|NCT00256867|472245448|FG004|Overall Study|Non-compliance with study medication|0|||
131170558|NCT00256867|472245449|FG005|Overall Study|Non-compliance with study medication|0|||
131170559|NCT00256867|472245450|FG006|Overall Study|Non-compliance with study medication|0|||
131170560|NCT00256867|472245451|FG007|Overall Study|Non-compliance with study medication|1|||
131170561|NCT00256867|472245444|FG000|Overall Study|Participant travelled Overseas|0|||
131170562|NCT00256867|472245445|FG001|Overall Study|Participant travelled Overseas|1|||
131170563|NCT00256867|472245446|FG002|Overall Study|Participant travelled Overseas|0|||
131170564|NCT00256867|472245447|FG003|Overall Study|Participant travelled Overseas|0|||
131235752|NCT04947579|472491041|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
131235753|NCT04947579|472491042|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
131235754|NCT04947579|472491043|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
131170565|NCT00256867|472245448|FG004|Overall Study|Participant travelled Overseas|0|||
131170566|NCT00256867|472245449|FG005|Overall Study|Participant travelled Overseas|0|||
131170567|NCT00256867|472245450|FG006|Overall Study|Participant travelled Overseas|0|||
131170568|NCT00256867|472245451|FG007|Overall Study|Participant travelled Overseas|0|||
131170569|NCT00256867|472245444|FG000|Overall Study|Participant out of assessment window|0|||
131170570|NCT00256867|472245445|FG001|Overall Study|Participant out of assessment window|0|||
131170571|NCT00256867|472245446|FG002|Overall Study|Participant out of assessment window|1|||
131170572|NCT00256867|472245447|FG003|Overall Study|Participant out of assessment window|0|||
131170573|NCT00256867|472245448|FG004|Overall Study|Participant out of assessment window|0|||
131170574|NCT00256867|472245449|FG005|Overall Study|Participant out of assessment window|0|||
131170575|NCT00256867|472245450|FG006|Overall Study|Participant out of assessment window|0|||
131170576|NCT00256867|472245451|FG007|Overall Study|Participant out of assessment window|0|||
131170577|NCT00256867|472245444|FG000|Overall Study|Withdrawal by participant|0|||
131170578|NCT00256867|472245445|FG001|Overall Study|Withdrawal by participant|0|||
131170579|NCT00256867|472245446|FG002|Overall Study|Withdrawal by participant|0|||
131170580|NCT00256867|472245447|FG003|Overall Study|Withdrawal by participant|0|||
131170581|NCT00256867|472245448|FG004|Overall Study|Withdrawal by participant|0|||
131170582|NCT00256867|472245449|FG005|Overall Study|Withdrawal by participant|1|||
131170583|NCT00256867|472245450|FG006|Overall Study|Withdrawal by participant|0|||
131170584|NCT00256867|472245451|FG007|Overall Study|Withdrawal by participant|0|||
131170585|NCT02739594|472245452|FG000|Overall Study|Undesired Event|3|||
131170586|NCT02739594|472245453|FG001|Overall Study|Undesired Event|4|||
131170587|NCT02739594|472245452|FG000|Overall Study|Violation of Eligibility Criteria|1|||
131170588|NCT02739594|472245453|FG001|Overall Study|Violation of Eligibility Criteria|2|||
131170589|NCT02739594|472245452|FG000|Overall Study|Protocol Violation|5|||
131170590|NCT02739594|472245453|FG001|Overall Study|Protocol Violation|6|||
131170591|NCT02739594|472245452|FG000|Overall Study|Death|4|||
131170592|NCT02739594|472245453|FG001|Overall Study|Death|2|||
131170593|NCT02739594|472245452|FG000|Overall Study|Renal Insufficiency|4|||
131170594|NCT02739594|472245453|FG001|Overall Study|Renal Insufficiency|6|||
131170595|NCT02739594|472245452|FG000|Overall Study|Administrative Reasons|1|||
131170596|NCT02739594|472245453|FG001|Overall Study|Administrative Reasons|3|||
131170597|NCT02739594|472245452|FG000|Overall Study|Withdrawal by Subject|1|||
131170598|NCT02739594|472245453|FG001|Overall Study|Withdrawal by Subject|1|||
131170599|NCT02739594|472245452|FG000|Overall Study|Lost to Follow-up|0|||
131170600|NCT02739594|472245453|FG001|Overall Study|Lost to Follow-up|1|||
131170601|NCT02739594|472245452|FG000|Overall Study|Elevated Serum Creatinine|0|||
131170602|NCT02739594|472245453|FG001|Overall Study|Elevated Serum Creatinine|1|||
131170603|NCT02739594|472245452|FG000|Overall Study|Other|6|||
131170604|NCT02739594|472245453|FG001|Overall Study|Other|2|||
131170605|NCT00527111|472245456|FG000|Overall Study|Adverse Event|14|||
131170606|NCT00527111|472245457|FG001|Overall Study|Adverse Event|13|||
131170607|NCT00527111|472245456|FG000|Overall Study|Death|0|||
131170608|NCT00527111|472245457|FG001|Overall Study|Death|1|||
131170609|NCT00527111|472245456|FG000|Overall Study|Investigator Request|2|||
131170610|NCT00527111|472245457|FG001|Overall Study|Investigator Request|1|||
131170611|NCT00527111|472245456|FG000|Overall Study|Patient Request|2|||
131170612|NCT00527111|472245457|FG001|Overall Study|Patient Request|5|||
131170613|NCT00527111|472245456|FG000|Overall Study|Other|2|||
131170614|NCT00527111|472245457|FG001|Overall Study|Other|2|||
131170615|NCT01930799|472245460|FG000|Overall Study|Withdrawal by Subject|3|||
131170616|NCT01930799|472245460|FG000|Overall Study|Lost to Follow-up|5|||
131170617|NCT00952289|472245462|FG000|All Participants|Death|9|||
131170618|NCT00952289|472245463|FG001|All Participants|Death|9|||
131170619|NCT00952289|472245462|FG000|All Participants|Adverse Event|8|||
131170620|NCT00952289|472245463|FG001|All Participants|Adverse Event|8|||
131170621|NCT00952289|472245462|FG000|All Participants|Disease progression|3|||
131170622|NCT00952289|472245463|FG001|All Participants|Disease progression|12|||
131170623|NCT00952289|472245462|FG000|All Participants|Withdrawal by Subject|1|||
131170624|NCT00952289|472245463|FG001|All Participants|Withdrawal by Subject|10|||
131170625|NCT00952289|472245462|FG000|All Participants|Data lost during site relocation|0|||
131170626|NCT00952289|472245463|FG001|All Participants|Data lost during site relocation|1|||
131170627|NCT00952289|472245462|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
131170628|NCT00952289|472245463|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
131170629|NCT00952289|472245462|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
131170630|NCT00952289|472245463|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
131170631|NCT00952289|472245462|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
131170632|NCT00952289|472245463|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
131235755|NCT04947579|472491044|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
131170633|NCT00952289|472245462|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
131170634|NCT00952289|472245463|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
131170635|NCT00952289|472245462|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
131170636|NCT00952289|472245463|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
131170637|NCT01921257|472245466|FG000|Overall Study|Adverse Event|1|||
131170638|NCT01921257|472245466|FG000|Overall Study|Protocol Violation|1|||
131170639|NCT01921257|472245466|FG000|Overall Study|Withdrawal by Subject|1|||
131170640|NCT00364845|472245467|FG000|Overall Study|Adverse Event|1|||
131170641|NCT00364845|472245468|FG001|Overall Study|Adverse Event|0|||
131170642|NCT00364845|472245467|FG000|Overall Study|Withdrawal by Subject|2|||
131170643|NCT00364845|472245468|FG001|Overall Study|Withdrawal by Subject|1|||
131170644|NCT00364845|472245467|FG000|Overall Study|Physician Decision|8|||
131170645|NCT00364845|472245468|FG001|Overall Study|Physician Decision|8|||
131170646|NCT00364845|472245467|FG000|Overall Study|Lost to Follow-up|0|||
131170647|NCT00364845|472245468|FG001|Overall Study|Lost to Follow-up|1|||
131170648|NCT00364845|472245467|FG000|Overall Study|Death|0|||
131170649|NCT00364845|472245468|FG001|Overall Study|Death|1|||
131170650|NCT03591146|472245469|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
131170651|NCT03591146|472245470|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
131170652|NCT03591146|472245471|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
131170653|NCT03591146|472245472|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
131170654|NCT03591146|472245473|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
131170655|NCT03591146|472245469|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
131170656|NCT03591146|472245470|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
131170657|NCT03591146|472245471|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
131170658|NCT03591146|472245472|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
131170659|NCT03591146|472245473|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
131170660|NCT03591146|472245469|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
131170661|NCT03591146|472245470|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
131170662|NCT03591146|472245471|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
131170663|NCT03591146|472245472|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
131170664|NCT03591146|472245473|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
131170665|NCT03591146|472245469|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
131170666|NCT03591146|472245470|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
131170667|NCT03591146|472245471|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
131170668|NCT03591146|472245472|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
131170669|NCT03591146|472245473|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
131170670|NCT04737031|472245474|FG000|Overall Study|Patients who did not have a treatment visit|0|||
131170671|NCT04737031|472245475|FG001|Overall Study|Patients who did not have a treatment visit|31|||
131170672|NCT04737031|472245476|FG002|Overall Study|Patients who did not have a treatment visit|93|||
131170673|NCT04737031|472245477|FG003|Overall Study|Patients who did not have a treatment visit|227|||
131170674|NCT03453151|472245478|FG000|Overall Study|Withdrawal by Subject|1|||
131170675|NCT03453151|472245478|FG000|Overall Study|Physician Decision|3|||
131170676|NCT01468909|472245482|FG000|Overall Study|Never Treated|2|||
131170677|NCT01468909|472245483|FG001|Overall Study|Never Treated|2|||
131170678|NCT01511419|472245486|FG000|Dose 2|Physician Decision|1|||
131170679|NCT01511419|472245487|FG001|Dose 2|Physician Decision|0|||
131170680|NCT02678780|472245488|FG000|Overall Study|Adverse Event|11|||
131170681|NCT02678780|472245489|FG001|Overall Study|Adverse Event|14|||
131170682|NCT02678780|472245488|FG000|Overall Study|Withdrawal by Subject|2|||
131170683|NCT02678780|472245489|FG001|Overall Study|Withdrawal by Subject|1|||
131170684|NCT02678780|472245488|FG000|Overall Study|Sponsor discontinuation|7|||
131170685|NCT02678780|472245489|FG001|Overall Study|Sponsor discontinuation|4|||
131170686|NCT02678780|472245488|FG000|Overall Study|Death|1|||
131170687|NCT02678780|472245489|FG001|Overall Study|Death|1|||
131170688|NCT02678780|472245488|FG000|Overall Study|Other|6|||
131170689|NCT02678780|472245489|FG001|Overall Study|Other|8|||
131170690|NCT00488618|472245495|FG000|Overall Study|Adverse Event|13|||
131170691|NCT00488618|472245496|FG001|Overall Study|Adverse Event|17|||
131170692|NCT00488618|472245495|FG000|Overall Study|Insufficient Therapeutic Response|18|||
131170693|NCT00488618|472245496|FG001|Overall Study|Insufficient Therapeutic Response|11|||
131170694|NCT00488618|472245495|FG000|Overall Study|Protocol Violation|0|||
131170695|NCT00488618|472245496|FG001|Overall Study|Protocol Violation|2|||
131170696|NCT00488618|472245495|FG000|Overall Study|Withdrawal of Consent|15|||
131170697|NCT00488618|472245496|FG001|Overall Study|Withdrawal of Consent|13|||
131170698|NCT00488618|472245495|FG000|Overall Study|Lost to Follow-up|1|||
131170699|NCT00488618|472245496|FG001|Overall Study|Lost to Follow-up|0|||
131170700|NCT00948818|472246724|FG000|Overall Study|Adverse Event|10|||
131170701|NCT00948818|472246725|FG001|Overall Study|Adverse Event|32|||
131170702|NCT00948818|472246724|FG000|Overall Study|Protocol Violation|9|||
131170703|NCT00948818|472246725|FG001|Overall Study|Protocol Violation|10|||
131170704|NCT00948818|472246724|FG000|Overall Study|Withdrawal by Subject|25|||
131170705|NCT00948818|472246725|FG001|Overall Study|Withdrawal by Subject|25|||
131170706|NCT00948818|472246724|FG000|Overall Study|Lost to Follow-up|10|||
131170707|NCT00948818|472246725|FG001|Overall Study|Lost to Follow-up|17|||
131170708|NCT00948818|472246724|FG000|Overall Study|Lack of Efficacy|4|||
131170709|NCT00948818|472246725|FG001|Overall Study|Lack of Efficacy|5|||
131170710|NCT00948818|472246724|FG000|Overall Study|Other Reason|4|||
131170711|NCT00948818|472246725|FG001|Overall Study|Other Reason|5|||
131170712|NCT00745368|472246726|FG000|Overall Study|Unable to provide sample|3|||
131170713|NCT00111475|472246727|FG000|Overall Study|Lost to Follow-up|0|||
131170714|NCT00111475|472246728|FG001|Overall Study|Lost to Follow-up|0|||
131170715|NCT00111475|472246729|FG002|Overall Study|Lost to Follow-up|0|||
131170716|NCT00111475|472246730|FG003|Overall Study|Lost to Follow-up|0|||
131170717|NCT00111475|472246731|FG004|Overall Study|Lost to Follow-up|0|||
131170718|NCT00111475|472246732|FG005|Overall Study|Lost to Follow-up|1|||
131170719|NCT00111475|472246733|FG006|Overall Study|Lost to Follow-up|0|||
131170720|NCT00111475|472246734|FG007|Overall Study|Lost to Follow-up|0|||
131170721|NCT00111475|472246735|FG008|Overall Study|Lost to Follow-up|0|||
131170722|NCT00111475|472246736|FG009|Overall Study|Lost to Follow-up|0|||
131170723|NCT03303092|472246737|FG000|Overall Study|Adverse Event|1|||
131170724|NCT03303092|472246738|FG001|Overall Study|Adverse Event|0|||
131170725|NCT03303092|472246739|FG002|Overall Study|Adverse Event|1|||
131170726|NCT03303092|472246737|FG000|Overall Study|Protocol Violation|1|||
131170727|NCT03303092|472246738|FG001|Overall Study|Protocol Violation|5|||
131170728|NCT03303092|472246739|FG002|Overall Study|Protocol Violation|1|||
131170729|NCT03303092|472246737|FG000|Overall Study|Withdrawal by Subject|1|||
131170730|NCT03303092|472246738|FG001|Overall Study|Withdrawal by Subject|1|||
131170731|NCT03303092|472246739|FG002|Overall Study|Withdrawal by Subject|3|||
131170732|NCT00833248|472246745|FG000|Overall Study|Adverse Event|3|||
131170733|NCT00833248|472246746|FG001|Overall Study|Adverse Event|0|||
131170734|NCT00833248|472246745|FG000|Overall Study|Protocol Violation|1|||
131170735|NCT00833248|472246746|FG001|Overall Study|Protocol Violation|2|||
131170736|NCT00833248|472246745|FG000|Overall Study|Withdrawal by Subject|0|||
131170737|NCT00833248|472246746|FG001|Overall Study|Withdrawal by Subject|1|||
131170738|NCT02006667|472246747|FG000|Overall Study|Adverse Event|3|||
131170739|NCT02006667|472246747|FG000|Overall Study|Death|2|||
131170740|NCT02006667|472246747|FG000|Overall Study|Withdrawal by Subject|1|||
131170741|NCT02939937|472246748|FG000|Overall Study|Adverse Event|5|||
131170742|NCT02939937|472246749|FG001|Overall Study|Adverse Event|0|||
131170743|NCT02939937|472246748|FG000|Overall Study|Lost to Follow-up|1|||
131170744|NCT02939937|472246749|FG001|Overall Study|Lost to Follow-up|3|||
131170745|NCT01826422|472246750|FG000|Overall Study|Withdrawal by Subject|1|||
131170746|NCT01826422|472246751|FG001|Overall Study|Withdrawal by Subject|3|||
131170747|NCT03439748|472246757|FG000|Overall Study|Withdrawal by Subject|11|||
131170748|NCT03439748|472246758|FG001|Overall Study|Withdrawal by Subject|17|||
131170749|NCT05131451|472246759|FG000|Overall Study|Protocol Violation|1|||
131170750|NCT05131451|472246760|FG001|Overall Study|Protocol Violation|0|||
131170751|NCT00782418|472246767|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
131170752|NCT00782418|472246768|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131170753|NCT00782418|472246769|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131170754|NCT00782418|472246770|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131170755|NCT00782418|472246771|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131170756|NCT00782418|472246772|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131170757|NCT00782418|472246773|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
131170758|NCT00782418|472246767|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
131170759|NCT00782418|472246768|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
131170760|NCT00782418|472246769|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
131170761|NCT00782418|472246770|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
131170762|NCT00782418|472246771|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
131170763|NCT00782418|472246772|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
131170764|NCT00782418|472246773|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
130780936|NCT00048035|470824817|FG001|Extension Year 2|Early Withdrawals|0|||
130780937|NCT00048035|470824818|FG002|Extension Year 2|Early Withdrawals|0|||
130780938|NCT00048035|470824819|FG003|Extension Year 2|Early Withdrawals|0|||
130780939|NCT00048035|470824820|FG004|Extension Year 2|Early Withdrawals|0|||
130780940|NCT00048035|470824821|FG005|Extension Year 2|Early Withdrawals|0|||
131170765|NCT02324842|472246774|FG000|Overall Study|Lost to Follow-up|1|||
131170766|NCT02324842|472246775|FG001|Overall Study|Lost to Follow-up|1|||
131170767|NCT02324842|472246776|FG002|Overall Study|Lost to Follow-up|2|||
131170768|NCT02750800|472246777|FG000|Overall Study|Adverse Event|18|||
131170769|NCT02750800|472246777|FG000|Overall Study|Lost to Follow-up|12|||
131170770|NCT02750800|472246777|FG000|Overall Study|Investigator decision|53|||
131170771|NCT02750800|472246777|FG000|Overall Study|Patient request|12|||
131170772|NCT02750800|472246777|FG000|Overall Study|Other, not specified|3|||
131170773|NCT03298412|472246778|FG000|Run-in Period|Other, Not Specified|1|||
131170774|NCT03298412|472246778|FG000|Run-in Period|Disease Progression|1|||
131170775|NCT03298412|472246778|FG000|Run-in Period|Ineligibility Determined|1|||
131170776|NCT03298412|472246778|FG000|Run-in Period|Decision by Sponsor|6|||
131170777|NCT01894477|472246779|FG000|Overall Study|Protocol Violation|0|||
131170778|NCT01894477|472246780|FG001|Overall Study|Protocol Violation|1|||
131170779|NCT01894477|472246779|FG000|Overall Study|protocol changed due SC changed to cord|0|||
130780941|NCT00048035|470824822|FG006|Extension Year 2|Early Withdrawals|3|||
130780942|NCT00048035|470824823|FG007|Extension Year 2|Early Withdrawals|3|||
130780943|NCT05137717|470824824|FG000|Overall Study|Death|2|||
131235756|NCT04947579|472491039|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
130729983|NCT00191191|470633653|FG001|Overall Study|Lost to Follow-up|0|||
131170780|NCT01894477|472246780|FG001|Overall Study|protocol changed due SC changed to cord|1|||
131170781|NCT05631548|472246782|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
131170782|NCT05631548|472246783|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
131170783|NCT01592409|472246784|FG000|Overall Study|Withdrawal by Subject|0|||
131170784|NCT01592409|472246785|FG001|Overall Study|Withdrawal by Subject|1|||
131170785|NCT01409031|472246790|FG000|Overall Study|transferred to other hosp|1|||
131170786|NCT01409031|472246791|FG001|Overall Study|transferred to other hosp|0|||
131170787|NCT00995345|472246793|FG000|Overall Study|Withdrawal by Subject|4|||
131170788|NCT00995345|472246794|FG001|Overall Study|Withdrawal by Subject|2|||
131170789|NCT00995345|472246795|FG002|Overall Study|Withdrawal by Subject|1|||
131170790|NCT00995345|472246796|FG003|Overall Study|Withdrawal by Subject|3|||
131170791|NCT00995345|472246797|FG004|Overall Study|Withdrawal by Subject|1|||
131170792|NCT00995345|472246793|FG000|Overall Study|Adverse Event|3|||
131170793|NCT00995345|472246794|FG001|Overall Study|Adverse Event|1|||
131170794|NCT00995345|472246795|FG002|Overall Study|Adverse Event|2|||
131170795|NCT00995345|472246796|FG003|Overall Study|Adverse Event|0|||
131170796|NCT00995345|472246797|FG004|Overall Study|Adverse Event|1|||
131170797|NCT00995345|472246793|FG000|Overall Study|Lost to Follow-up|2|||
131170798|NCT00995345|472246794|FG001|Overall Study|Lost to Follow-up|2|||
131170799|NCT00995345|472246795|FG002|Overall Study|Lost to Follow-up|2|||
131170800|NCT00995345|472246796|FG003|Overall Study|Lost to Follow-up|1|||
131170801|NCT00995345|472246797|FG004|Overall Study|Lost to Follow-up|0|||
131170802|NCT00995345|472246793|FG000|Overall Study|all other reasons combined|2|||
131170803|NCT00995345|472246794|FG001|Overall Study|all other reasons combined|2|||
131170804|NCT00995345|472246795|FG002|Overall Study|all other reasons combined|2|||
131170805|NCT00995345|472246796|FG003|Overall Study|all other reasons combined|1|||
131170806|NCT00995345|472246797|FG004|Overall Study|all other reasons combined|3|||
131170807|NCT01860534|472246798|FG000|ROP #1|Needed treatment for ROP|0|||
131170808|NCT01860534|472246799|FG001|ROP #1|Needed treatment for ROP|1|||
131170809|NCT01860534|472246798|FG000|ROP #2|discharged prior to ROP #2|1|||
131170810|NCT01860534|472246799|FG001|ROP #2|discharged prior to ROP #2|0|||
131170811|NCT04171037|472246802|FG000|Overall Study|Lost to Follow-up|1|||
131170812|NCT04171037|472246803|FG001|Overall Study|Lost to Follow-up|0|||
131170813|NCT04171037|472246802|FG000|Overall Study|Physician Decision|3|||
131170814|NCT04171037|472246803|FG001|Overall Study|Physician Decision|3|||
131170815|NCT01934894|472246804|FG000|Overall Study|Adverse Event|1|||
131170816|NCT01934894|472246805|FG001|Overall Study|Adverse Event|2|||
131170817|NCT01934894|472246804|FG000|Overall Study|Death|2|||
131170818|NCT01934894|472246805|FG001|Overall Study|Death|0|||
131170819|NCT01934894|472246804|FG000|Overall Study|Withdrawal by Subject|0|||
131170820|NCT01934894|472246805|FG001|Overall Study|Withdrawal by Subject|1|||
131170821|NCT01934894|472246804|FG000|Overall Study|Progressive Disease|3|||
131170822|NCT01934894|472246805|FG001|Overall Study|Progressive Disease|2|||
131170823|NCT00748540|472246807|FG000|Overall Study|Physician Decision|1|||
131170824|NCT02993224|472246808|FG000|Core Phase - Period 1|Adverse Event|4|||
131170825|NCT02993224|472246808|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
131170826|NCT02993224|472246808|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
131170827|NCT02993224|472246808|FG000|Core Phase- Period 2|Adverse Event|1|||
131170828|NCT02993224|472246808|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
131170829|NCT02993224|472246808|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
131170830|NCT02993224|472246808|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
131170831|NCT02993224|472246808|FG000|Extension Phase|Adverse Event|3|||
131170832|NCT02993224|472246808|FG000|Extension Phase|Withdrawal by Subject|3|||
131170833|NCT02993224|472246808|FG000|Extension Phase|Lost to Follow-up|2|||
131170834|NCT02993224|472246808|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
131170835|NCT03136185|472246815|FG000|Overall Study|Adverse Event|0|||
131170836|NCT03136185|472246816|FG001|Overall Study|Adverse Event|1|||
131170837|NCT03136185|472246817|FG002|Overall Study|Adverse Event|3|||
131170838|NCT03136185|472246818|FG003|Overall Study|Adverse Event|1|||
131170839|NCT03136185|472246819|FG004|Overall Study|Adverse Event|2|||
130729984|NCT00191191|470633652|FG000|Overall Study|Physician Decision|3|||
130729985|NCT00191191|470633653|FG001|Overall Study|Physician Decision|2|||
130729986|NCT00191191|470633652|FG000|Overall Study|Good Clinical Practice Violation|0|||
130729987|NCT00191191|470633653|FG001|Overall Study|Good Clinical Practice Violation|1|||
130729988|NCT05445492|470633654|FG000|Overall Study|Physician Decision|1|||
130729989|NCT04238650|470633655|FG000|Overall Study|Withdrawal by Subject|0|||
130729990|NCT04238650|470633656|FG001|Overall Study|Withdrawal by Subject|1|||
131170840|NCT03136185|472246820|FG005|Overall Study|Adverse Event|2|||
131235757|NCT04947579|472491040|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
131235758|NCT04947579|472491041|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
131235759|NCT04947579|472491042|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
130729991|NCT04289363|470633657|FG000|Overall Study|Lost to Follow-up|14|||
131170841|NCT03136185|472246821|FG006|Overall Study|Adverse Event|5|||
131170842|NCT03136185|472246822|FG007|Overall Study|Adverse Event|1|||
131170843|NCT03136185|472246823|FG008|Overall Study|Adverse Event|1|||
131170844|NCT03136185|472246815|FG000|Overall Study|Death|0|||
131170845|NCT03136185|472246816|FG001|Overall Study|Death|0|||
131170846|NCT03136185|472246817|FG002|Overall Study|Death|0|||
131170847|NCT03136185|472246818|FG003|Overall Study|Death|1|||
131170848|NCT03136185|472246819|FG004|Overall Study|Death|1|||
131170849|NCT03136185|472246820|FG005|Overall Study|Death|0|||
131170850|NCT03136185|472246821|FG006|Overall Study|Death|1|||
131170851|NCT03136185|472246822|FG007|Overall Study|Death|0|||
131170852|NCT03136185|472246823|FG008|Overall Study|Death|0|||
131170853|NCT03136185|472246815|FG000|Overall Study|Physician Decision|3|||
131170854|NCT03136185|472246816|FG001|Overall Study|Physician Decision|1|||
131170855|NCT03136185|472246817|FG002|Overall Study|Physician Decision|1|||
131170856|NCT03136185|472246818|FG003|Overall Study|Physician Decision|2|||
131170857|NCT03136185|472246819|FG004|Overall Study|Physician Decision|1|||
131170858|NCT03136185|472246820|FG005|Overall Study|Physician Decision|2|||
131170859|NCT03136185|472246821|FG006|Overall Study|Physician Decision|1|||
131170860|NCT03136185|472246822|FG007|Overall Study|Physician Decision|0|||
131170861|NCT03136185|472246823|FG008|Overall Study|Physician Decision|1|||
131170862|NCT03136185|472246815|FG000|Overall Study|Protocol Defined Disease Progression|0|||
131170863|NCT03136185|472246816|FG001|Overall Study|Protocol Defined Disease Progression|0|||
131170864|NCT03136185|472246817|FG002|Overall Study|Protocol Defined Disease Progression|1|||
131170865|NCT03136185|472246818|FG003|Overall Study|Protocol Defined Disease Progression|0|||
131170866|NCT03136185|472246819|FG004|Overall Study|Protocol Defined Disease Progression|0|||
131170867|NCT03136185|472246820|FG005|Overall Study|Protocol Defined Disease Progression|1|||
131170868|NCT03136185|472246821|FG006|Overall Study|Protocol Defined Disease Progression|0|||
131170869|NCT03136185|472246822|FG007|Overall Study|Protocol Defined Disease Progression|1|||
131170870|NCT03136185|472246823|FG008|Overall Study|Protocol Defined Disease Progression|1|||
131170871|NCT03136185|472246815|FG000|Overall Study|Withdrawal by Subject|1|||
131170872|NCT03136185|472246816|FG001|Overall Study|Withdrawal by Subject|0|||
131170873|NCT03136185|472246817|FG002|Overall Study|Withdrawal by Subject|1|||
131170874|NCT03136185|472246818|FG003|Overall Study|Withdrawal by Subject|1|||
131170875|NCT03136185|472246819|FG004|Overall Study|Withdrawal by Subject|1|||
131170876|NCT03136185|472246820|FG005|Overall Study|Withdrawal by Subject|1|||
131170877|NCT03136185|472246821|FG006|Overall Study|Withdrawal by Subject|2|||
131170878|NCT03136185|472246822|FG007|Overall Study|Withdrawal by Subject|3|||
131170879|NCT03136185|472246823|FG008|Overall Study|Withdrawal by Subject|3|||
131170880|NCT03136185|472246815|FG000|Overall Study|Not Reported|4|||
131170881|NCT03136185|472246816|FG001|Overall Study|Not Reported|1|||
131170882|NCT03136185|472246817|FG002|Overall Study|Not Reported|0|||
131170883|NCT03136185|472246818|FG003|Overall Study|Not Reported|1|||
131170884|NCT03136185|472246819|FG004|Overall Study|Not Reported|0|||
131170885|NCT03136185|472246820|FG005|Overall Study|Not Reported|2|||
131170886|NCT03136185|472246821|FG006|Overall Study|Not Reported|1|||
131235760|NCT04947579|472491043|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
131235761|NCT04947579|472491044|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
131235762|NCT04947579|472491039|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
131235763|NCT04947579|472491040|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
131235764|NCT04947579|472491041|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
131235765|NCT04947579|472491042|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
131235766|NCT04947579|472491043|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
131235767|NCT04947579|472491044|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
131235768|NCT04947579|472491039|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
131235769|NCT04947579|472491040|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
131235770|NCT04947579|472491041|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
131235771|NCT04947579|472491042|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
131235772|NCT04947579|472491043|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
131170887|NCT03136185|472246822|FG007|Overall Study|Not Reported|1|||
131170888|NCT03136185|472246823|FG008|Overall Study|Not Reported|0|||
131170889|NCT00488033|472246831|FG000|Overall Study|Withdrawal by Subject|1|||
131170890|NCT00488033|472246832|FG001|Overall Study|Withdrawal by Subject|0|||
131170891|NCT01423617|472246833|FG000|Overall Study|Lost to Follow-up|0|||
130729992|NCT04289363|470633658|FG001|Overall Study|Lost to Follow-up|0|||
131170892|NCT01423617|472246834|FG001|Overall Study|Lost to Follow-up|1|||
130729993|NCT03348163|470633662|FG000|Overall Study|Withdrawal by Subject|2|||
131170893|NCT01515306|472246835|FG000|Overall Study|Adverse Event|3|||
131170894|NCT01515306|472246836|FG001|Overall Study|Adverse Event|2|||
131170895|NCT01515306|472246835|FG000|Overall Study|Progressive Disease|19|||
131170896|NCT01515306|472246836|FG001|Overall Study|Progressive Disease|9|||
131170897|NCT01515306|472246835|FG000|Overall Study|Withdrawal by Subject|1|||
131170898|NCT01515306|472246836|FG001|Overall Study|Withdrawal by Subject|2|||
131170899|NCT01515306|472246835|FG000|Overall Study|Physician Decision|1|||
131170900|NCT01515306|472246836|FG001|Overall Study|Physician Decision|1|||
131170901|NCT00634244|472246840|FG000|Overall Study|Never started treatment|0|||
131170902|NCT00634244|472246841|FG001|Overall Study|Never started treatment|1|||
131170903|NCT00634244|472246842|FG002|Overall Study|Never started treatment|0|||
131170904|NCT00634244|472246840|FG000|Overall Study|Death|1|||
131170905|NCT00634244|472246841|FG001|Overall Study|Death|6|||
131170906|NCT00634244|472246842|FG002|Overall Study|Death|0|||
131170907|NCT00634244|472246840|FG000|Overall Study|Adverse Event|0|||
131170908|NCT00634244|472246841|FG001|Overall Study|Adverse Event|2|||
131170909|NCT00634244|472246842|FG002|Overall Study|Adverse Event|0|||
131170910|NCT00634244|472246840|FG000|Overall Study|Withdrawal by Subject|0|||
131170911|NCT00634244|472246841|FG001|Overall Study|Withdrawal by Subject|1|||
131170912|NCT00634244|472246842|FG002|Overall Study|Withdrawal by Subject|0|||
131170913|NCT00634244|472246840|FG000|Overall Study|Physician Decision|0|||
131170914|NCT00634244|472246841|FG001|Overall Study|Physician Decision|1|||
131170915|NCT00634244|472246842|FG002|Overall Study|Physician Decision|0|||
131170916|NCT00634244|472246840|FG000|Overall Study|Disease progression/relapse|0|||
131170917|NCT00634244|472246841|FG001|Overall Study|Disease progression/relapse|1|||
131170918|NCT00634244|472246842|FG002|Overall Study|Disease progression/relapse|0|||
131170919|NCT00634244|472246840|FG000|Overall Study|Other complicating disease|0|||
131170920|NCT00634244|472246841|FG001|Overall Study|Other complicating disease|1|||
131170921|NCT00634244|472246842|FG002|Overall Study|Other complicating disease|0|||
131170922|NCT04369430|472246849|FG000|Overall Study|Adverse Event|2|||
131170923|NCT04369430|472246850|FG001|Overall Study|Adverse Event|3|||
131170924|NCT04369430|472246849|FG000|Overall Study|Death|1|||
131170925|NCT04369430|472246850|FG001|Overall Study|Death|0|||
131170926|NCT04369430|472246849|FG000|Overall Study|Withdrawal by Subject|4|||
131170927|NCT04369430|472246850|FG001|Overall Study|Withdrawal by Subject|3|||
130729994|NCT03348163|470633663|FG001|Overall Study|Withdrawal by Subject|0|||
130729995|NCT02585778|470633664|FG000|Overall Study|Adverse Event|17|||
130729996|NCT02585778|470633665|FG001|Overall Study|Adverse Event|4|||
130729997|NCT02585778|470633664|FG000|Overall Study|Participant did not wish to continue|9|||
130729998|NCT02585778|470633665|FG001|Overall Study|Participant did not wish to continue|4|||
130729999|NCT02585778|470633664|FG000|Overall Study|Poor compliance to study protocol|0|||
130730000|NCT02585778|470633665|FG001|Overall Study|Poor compliance to study protocol|2|||
130730001|NCT02585778|470633664|FG000|Overall Study|Death|0|||
130730002|NCT02585778|470633665|FG001|Overall Study|Death|1|||
130730003|NCT02585778|470633664|FG000|Overall Study|Randomized but not treated|1|||
130730004|NCT02585778|470633665|FG001|Overall Study|Randomized but not treated|2|||
130730005|NCT02585778|470633664|FG000|Overall Study|Other than specified above|6|||
130730006|NCT02585778|470633665|FG001|Overall Study|Other than specified above|2|||
130730007|NCT02370238|470633667|FG000|Overall Study|Death|42|||
130730008|NCT02370238|470633668|FG001|Overall Study|Death|35|||
130730009|NCT02370238|470633667|FG000|Overall Study|Lost to Follow-up|1|||
130730010|NCT02370238|470633668|FG001|Overall Study|Lost to Follow-up|3|||
130730011|NCT02370238|470633667|FG000|Overall Study|Withdrawal by Subject|2|||
130730012|NCT02370238|470633668|FG001|Overall Study|Withdrawal by Subject|6|||
130730013|NCT02370238|470633667|FG000|Overall Study|Other|2|||
130730014|NCT02370238|470633668|FG001|Overall Study|Other|1|||
130730015|NCT02789137|470633671|FG000|Overall Study|Dropped out/Died|58|||
130730016|NCT01482312|470633674|FG000|Period 1, 90 Minutes of Wear|Other|1|||
130730017|NCT01482312|470633675|FG001|Period 1, 90 Minutes of Wear|Other|0|||
130730018|NCT01482312|470633676|FG002|Period 1, 90 Minutes of Wear|Other|0|||
130730019|NCT01482312|470633674|FG000|Period 2, 90 Minutes of Wear|Other|1|||
130730020|NCT01482312|470633675|FG001|Period 2, 90 Minutes of Wear|Other|0|||
130730021|NCT01482312|470633676|FG002|Period 2, 90 Minutes of Wear|Other|0|||
130730022|NCT03597295|470633678|FG000|Overall Study|Death|70|||
130730023|NCT03597295|470633678|FG000|Overall Study|Lost to Follow-up|7|||
130730024|NCT00428116|470633679|FG000|Overall Study|Death|1|||
130730025|NCT00428116|470633680|FG001|Overall Study|Death|0|||
130730026|NCT00428116|470633679|FG000|Overall Study|Withdrawal by Subject|1|||
130730027|NCT00428116|470633680|FG001|Overall Study|Withdrawal by Subject|0|||
130730028|NCT00428116|470633679|FG000|Overall Study|Lost to Follow-up|1|||
130730029|NCT00428116|470633680|FG001|Overall Study|Lost to Follow-up|0|||
130730030|NCT02125877|470633681|FG000|Overall Study|Physician Decision|1|||
131170928|NCT04369430|472246849|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
131170929|NCT04369430|472246850|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
131170930|NCT04369430|472246849|FG000|Overall Study|Lost to Follow-up|0|||
131170931|NCT04369430|472246850|FG001|Overall Study|Lost to Follow-up|1|||
131170932|NCT02435277|472246851|FG000|Overall Study|Adverse Event|1|||
130730031|NCT02125877|470633682|FG001|Overall Study|Physician Decision|0|||
130730032|NCT02125877|470633681|FG000|Overall Study|Death|0|||
130730033|NCT02125877|470633682|FG001|Overall Study|Death|1|||
130730034|NCT02125877|470633681|FG000|Overall Study|Administrative problems|0|||
130730035|NCT02125877|470633682|FG001|Overall Study|Administrative problems|1|||
130730036|NCT02125877|470633681|FG000|Overall Study|Participant/guardian decision|0|||
131170933|NCT02435277|472246852|FG001|Overall Study|Adverse Event|1|||
131170934|NCT02435277|472246853|FG002|Overall Study|Adverse Event|0|||
130730037|NCT02125877|470633682|FG001|Overall Study|Participant/guardian decision|2|||
131170935|NCT02435277|472246854|FG003|Overall Study|Adverse Event|0|||
131235773|NCT04947579|472491044|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
131235774|NCT04947579|472491039|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
131235775|NCT04947579|472491040|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
131235776|NCT04947579|472491041|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
131235777|NCT04947579|472491042|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
131235778|NCT04947579|472491043|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
131235779|NCT04947579|472491044|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
131170936|NCT02435277|472246851|FG000|Overall Study|Withdrawal by Subject|1|||
131170937|NCT02435277|472246852|FG001|Overall Study|Withdrawal by Subject|0|||
131170938|NCT02435277|472246853|FG002|Overall Study|Withdrawal by Subject|0|||
131170939|NCT02435277|472246854|FG003|Overall Study|Withdrawal by Subject|0|||
131170940|NCT00008138|472246855|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
131170941|NCT00008138|472246855|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
131170942|NCT00008138|472246855|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
131170943|NCT00008138|472246855|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
131170944|NCT00008138|472246855|FG000|Interval Debulking|Withdrawal by Subject|2|||
131170945|NCT00008138|472246855|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
131170946|NCT00008138|472246855|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
131170947|NCT00008138|472246855|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
131170948|NCT00937768|472246860|FG000|Overall Study|Refused Further Treatment|3|||
131170949|NCT00937768|472246861|FG001|Overall Study|Refused Further Treatment|2|||
131170950|NCT00937768|472246860|FG000|Overall Study|Disease Progression|1|||
131170951|NCT00937768|472246861|FG001|Overall Study|Disease Progression|1|||
131170952|NCT00937768|472246860|FG000|Overall Study|Alternate Treatment|0|||
131170953|NCT00937768|472246861|FG001|Overall Study|Alternate Treatment|1|||
131170954|NCT00937768|472246860|FG000|Overall Study|No Further Funding|4|||
131170955|NCT00937768|472246861|FG001|Overall Study|No Further Funding|4|||
131170956|NCT00992446|472246864|FG000|Overall Study|Disease Progression|1|||
131170957|NCT00992446|472246864|FG000|Overall Study|Withdrawal by Subject|2|||
131170958|NCT00992446|472246864|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
131170959|NCT03675737|472246866|FG000|Overall Study|Death|593|||
131170960|NCT03675737|472246867|FG001|Overall Study|Death|660|||
131170961|NCT03675737|472246866|FG000|Overall Study|Lost to Follow-up|1|||
131170962|NCT03675737|472246867|FG001|Overall Study|Lost to Follow-up|5|||
131170963|NCT03675737|472246866|FG000|Overall Study|Physician Decision|1|||
131170964|NCT03675737|472246867|FG001|Overall Study|Physician Decision|0|||
131170965|NCT03675737|472246866|FG000|Overall Study|Withdrawal by Subject|14|||
131170966|NCT03675737|472246867|FG001|Overall Study|Withdrawal by Subject|12|||
131170967|NCT03675737|472246866|FG000|Overall Study|Ongoing in Study|181|||
131170968|NCT03675737|472246867|FG001|Overall Study|Ongoing in Study|112|||
131170969|NCT02349789|472248307|FG000|Overall Study|Withdrawal by Subject|2|||
131170970|NCT00683475|472248308|FG000|Overall Study|Withdrawal by Subject|1|||
131170971|NCT00683475|472248309|FG001|Overall Study|Withdrawal by Subject|0|||
131170972|NCT00683475|472248308|FG000|Overall Study|Never Treated: Adverse Event|2|||
131170973|NCT00683475|472248309|FG001|Overall Study|Never Treated: Adverse Event|3|||
131170974|NCT00683475|472248308|FG000|Overall Study|Never Treated: Progressive Disease|1|||
131170975|NCT00683475|472248309|FG001|Overall Study|Never Treated: Progressive Disease|0|||
131170976|NCT02922634|472248310|FG000|Overall Study|Withdrawal by Subject|5|||
131170977|NCT02922634|472248310|FG000|Overall Study|Did not have their surgery|5|||
131170978|NCT02723604|472248311|FG000|Overall Study|ineligible|1|||
131170979|NCT02723604|472248311|FG000|Overall Study|never received treatment|1|||
131170980|NCT00762372|472248312|FG000|Overall Study|Adverse Event|1|||
131170981|NCT00762372|472248313|FG001|Overall Study|Adverse Event|0|||
131170982|NCT00762372|472248314|FG002|Overall Study|Adverse Event|0|||
131170983|NCT03364335|472248315|FG000|Overall Study|Adverse Event|3|||
131170984|NCT03364335|472248316|FG001|Overall Study|Adverse Event|4|||
131170985|NCT03364335|472248317|FG002|Overall Study|Adverse Event|1|||
131170986|NCT03364335|472248318|FG003|Overall Study|Adverse Event|2|||
131170987|NCT03364335|472248319|FG004|Overall Study|Adverse Event|0|||
131170988|NCT03364335|472248315|FG000|Overall Study|Lost to Follow-up|7|||
131170989|NCT03364335|472248316|FG001|Overall Study|Lost to Follow-up|7|||
131170990|NCT03364335|472248317|FG002|Overall Study|Lost to Follow-up|10|||
131170991|NCT03364335|472248318|FG003|Overall Study|Lost to Follow-up|11|||
131170992|NCT03364335|472248319|FG004|Overall Study|Lost to Follow-up|11|||
131170993|NCT03987919|472248320|FG000|Overall Study|Adverse Event|1|||
131170994|NCT03987919|472248321|FG001|Overall Study|Adverse Event|4|||
131170995|NCT03987919|472248322|FG002|Overall Study|Adverse Event|1|||
131170996|NCT03987919|472248323|FG003|Overall Study|Adverse Event|3|||
131170997|NCT03987919|472248320|FG000|Overall Study|Death|4|||
131170998|NCT03987919|472248321|FG001|Overall Study|Death|4|||
131170999|NCT03987919|472248322|FG002|Overall Study|Death|4|||
131171000|NCT03987919|472248323|FG003|Overall Study|Death|1|||
131171001|NCT03987919|472248320|FG000|Overall Study|Lost to Follow-up|5|||
131171002|NCT03987919|472248321|FG001|Overall Study|Lost to Follow-up|6|||
131235780|NCT04947579|472491039|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
131235781|NCT04947579|472491040|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
131171003|NCT03987919|472248322|FG002|Overall Study|Lost to Follow-up|8|||
130780944|NCT05137717|470824824|FG000|Overall Study|Withdrawal by Subject|6|||
130780945|NCT02035553|470824825|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
130780946|NCT02035553|470824826|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
130780947|NCT02035553|470824825|FG000|Overall Study|Adverse Event|10|||
130780948|NCT02035553|470824826|FG001|Overall Study|Adverse Event|6|||
130780949|NCT02035553|470824825|FG000|Overall Study|Physician Decision|3|||
130780950|NCT02035553|470824826|FG001|Overall Study|Physician Decision|2|||
130780951|NCT02035553|470824825|FG000|Overall Study|Lack of Efficacy|1|||
130780952|NCT02035553|470824826|FG001|Overall Study|Lack of Efficacy|1|||
130780953|NCT02035553|470824825|FG000|Overall Study|Withdrawal by Subject|4|||
130780954|NCT02035553|470824826|FG001|Overall Study|Withdrawal by Subject|7|||
130780955|NCT02035553|470824825|FG000|Overall Study|Non-compliance with Study Drug|0|||
130780956|NCT02035553|470824826|FG001|Overall Study|Non-compliance with Study Drug|1|||
130780957|NCT02035553|470824825|FG000|Overall Study|Lost to Follow-up|0|||
130780958|NCT02035553|470824826|FG001|Overall Study|Lost to Follow-up|1|||
130780959|NCT02035553|470824825|FG000|Overall Study|Other Reason|0|||
130780960|NCT02035553|470824826|FG001|Overall Study|Other Reason|4|||
130780961|NCT00509899|470824828|FG000|Overall Study|Progressive disease|1|||
130780962|NCT00509899|470824829|FG001|Overall Study|Progressive disease|3|||
130780963|NCT00509899|470824830|FG002|Overall Study|Progressive disease|5|||
130780964|NCT00509899|470824831|FG003|Overall Study|Progressive disease|1|||
130780965|NCT00509899|470824832|FG004|Overall Study|Progressive disease|0|||
130780966|NCT00509899|470824833|FG005|Overall Study|Progressive disease|1|||
130780967|NCT00509899|470824834|FG006|Overall Study|Progressive disease|0|||
130780968|NCT00509899|470824835|FG007|Overall Study|Progressive disease|0|||
130780969|NCT00509899|470824828|FG000|Overall Study|Unacceptable Toxicity|1|||
130780970|NCT00509899|470824829|FG001|Overall Study|Unacceptable Toxicity|0|||
130780971|NCT00509899|470824830|FG002|Overall Study|Unacceptable Toxicity|0|||
130780972|NCT00509899|470824831|FG003|Overall Study|Unacceptable Toxicity|2|||
130780973|NCT00509899|470824832|FG004|Overall Study|Unacceptable Toxicity|0|||
130780974|NCT00509899|470824833|FG005|Overall Study|Unacceptable Toxicity|0|||
130780975|NCT00509899|470824834|FG006|Overall Study|Unacceptable Toxicity|0|||
130780976|NCT00509899|470824835|FG007|Overall Study|Unacceptable Toxicity|0|||
130780977|NCT00509899|470824828|FG000|Overall Study|Withdrawal by Subject|6|||
130780978|NCT00509899|470824829|FG001|Overall Study|Withdrawal by Subject|2|||
130780979|NCT00509899|470824830|FG002|Overall Study|Withdrawal by Subject|3|||
130780980|NCT00509899|470824831|FG003|Overall Study|Withdrawal by Subject|0|||
130780981|NCT00509899|470824832|FG004|Overall Study|Withdrawal by Subject|3|||
130780982|NCT00509899|470824833|FG005|Overall Study|Withdrawal by Subject|2|||
130780983|NCT00509899|470824834|FG006|Overall Study|Withdrawal by Subject|0|||
130780984|NCT00509899|470824835|FG007|Overall Study|Withdrawal by Subject|0|||
130780985|NCT00509899|470824828|FG000|Overall Study|Physician Decision|4|||
130780986|NCT00509899|470824829|FG001|Overall Study|Physician Decision|2|||
131171004|NCT03987919|472248323|FG003|Overall Study|Lost to Follow-up|12|||
131171005|NCT03987919|472248320|FG000|Overall Study|Physician Decision|0|||
131171006|NCT03987919|472248321|FG001|Overall Study|Physician Decision|2|||
131171007|NCT03987919|472248322|FG002|Overall Study|Physician Decision|0|||
131171008|NCT03987919|472248323|FG003|Overall Study|Physician Decision|4|||
131171009|NCT03987919|472248320|FG000|Overall Study|Pregnancy|1|||
131171010|NCT03987919|472248321|FG001|Overall Study|Pregnancy|0|||
131171011|NCT03987919|472248322|FG002|Overall Study|Pregnancy|1|||
131171012|NCT03987919|472248323|FG003|Overall Study|Pregnancy|1|||
131171013|NCT03987919|472248320|FG000|Overall Study|Protocol Violation|0|||
131171014|NCT03987919|472248321|FG001|Overall Study|Protocol Violation|1|||
131171015|NCT03987919|472248322|FG002|Overall Study|Protocol Violation|0|||
131171016|NCT03987919|472248323|FG003|Overall Study|Protocol Violation|0|||
131171017|NCT03987919|472248320|FG000|Overall Study|Site terminated by Sponsor|0|||
131171018|NCT03987919|472248321|FG001|Overall Study|Site terminated by Sponsor|0|||
131171019|NCT03987919|472248322|FG002|Overall Study|Site terminated by Sponsor|0|||
131171020|NCT03987919|472248323|FG003|Overall Study|Site terminated by Sponsor|1|||
131171021|NCT03987919|472248320|FG000|Overall Study|Withdrawal by Subject|7|||
131171022|NCT03987919|472248321|FG001|Overall Study|Withdrawal by Subject|7|||
131171023|NCT03987919|472248322|FG002|Overall Study|Withdrawal by Subject|8|||
131171024|NCT03987919|472248323|FG003|Overall Study|Withdrawal by Subject|4|||
130780987|NCT00509899|470824830|FG002|Overall Study|Physician Decision|7|||
130780988|NCT00509899|470824831|FG003|Overall Study|Physician Decision|0|||
130780989|NCT00509899|470824832|FG004|Overall Study|Physician Decision|1|||
130780990|NCT00509899|470824833|FG005|Overall Study|Physician Decision|4|||
130780991|NCT00509899|470824834|FG006|Overall Study|Physician Decision|0|||
130780992|NCT00509899|470824835|FG007|Overall Study|Physician Decision|0|||
130780993|NCT00509899|470824828|FG000|Overall Study|Intercurrent Illness|1|||
130780994|NCT00509899|470824829|FG001|Overall Study|Intercurrent Illness|0|||
130780995|NCT00509899|470824830|FG002|Overall Study|Intercurrent Illness|0|||
131171025|NCT03987919|472248320|FG000|Overall Study|Other - as reported by the investigator|1|||
131171026|NCT03987919|472248321|FG001|Overall Study|Other - as reported by the investigator|3|||
131171027|NCT03987919|472248322|FG002|Overall Study|Other - as reported by the investigator|2|||
131171028|NCT03987919|472248323|FG003|Overall Study|Other - as reported by the investigator|0|||
131171029|NCT01194804|472248324|FG000|Overall Study|Withdrawal by Subject|1|||
131171030|NCT01303380|472248325|FG000|Overall Study|Lack of compliance to study procedures|1|||
131171031|NCT03621943|472248326|FG000|First Randomized Intervention|Lost to Follow-up|51|||
131171032|NCT03621943|472248327|FG001|First Randomized Intervention|Lost to Follow-up|54|||
131171033|NCT03621943|472248326|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
131171034|NCT03621943|472248327|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
131171035|NCT03621943|472248326|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
131171036|NCT03621943|472248327|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
131171037|NCT03621943|472248326|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
131171038|NCT03621943|472248327|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
131171039|NCT00315705|472248328|FG000|Phase 1|Refused further treatment|1|||
131171040|NCT00315705|472248328|FG000|Phase 1|Failure to achieve response|8|||
131171041|NCT00315705|472248328|FG000|Phase 1|Disease relapse|4|||
131171042|NCT00315705|472248328|FG000|Phase 1|Scheduled for transplant|9|||
131171043|NCT00315705|472248328|FG000|Phase 1|Death|3|||
131171044|NCT00315705|472248328|FG000|Phase 2|Physician Decision|4|||
131171045|NCT00315705|472248328|FG000|Phase 2|Adverse Event|1|||
131171046|NCT00315705|472248328|FG000|Phase 2|Failure to achieve response|3|||
131171047|NCT00315705|472248328|FG000|Phase 2|Disease relapse|1|||
131171048|NCT00315705|472248328|FG000|Phase 2|Scheduled for transplant|8|||
131171049|NCT00315705|472248328|FG000|Phase 2|Other|1|||
131171050|NCT00315705|472248328|FG000|Phase 2|Death|7|||
131171051|NCT00748553|472248329|FG000|Overall Study|Adverse Event|0|||
131171052|NCT00748553|472248330|FG001|Overall Study|Adverse Event|1|||
131171053|NCT00748553|472248329|FG000|Overall Study|disease progression|2|||
131171054|NCT00748553|472248330|FG001|Overall Study|disease progression|0|||
131171055|NCT00748553|472248329|FG000|Overall Study|noncompliance|1|||
131171056|NCT00748553|472248330|FG001|Overall Study|noncompliance|0|||
131171057|NCT01716533|472248332|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
131171058|NCT01716533|472248333|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
131171059|NCT01716533|472248334|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
131171060|NCT01716533|472248335|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
131171061|NCT01716533|472248332|FG000|Overall Study|Withdrawal by Subject|0|||
131171062|NCT01716533|472248333|FG001|Overall Study|Withdrawal by Subject|0|||
131171063|NCT01716533|472248334|FG002|Overall Study|Withdrawal by Subject|0|||
131171064|NCT01716533|472248335|FG003|Overall Study|Withdrawal by Subject|5|||
131171065|NCT01716533|472248332|FG000|Overall Study|Death|0|||
131171066|NCT01716533|472248333|FG001|Overall Study|Death|0|||
131171067|NCT01716533|472248334|FG002|Overall Study|Death|0|||
131171068|NCT01716533|472248335|FG003|Overall Study|Death|2|||
131171069|NCT01716533|472248332|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
131171070|NCT01716533|472248333|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
131171071|NCT01716533|472248334|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
131171072|NCT01716533|472248335|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
131171073|NCT03446651|472248339|FG000|Overall Study|Lost to Follow-up|4|||
131171074|NCT03446651|472248340|FG001|Overall Study|Lost to Follow-up|0|||
131171075|NCT03446651|472248339|FG000|Overall Study|Open Label Participants|5|||
131171076|NCT03446651|472248340|FG001|Overall Study|Open Label Participants|0|||
131171077|NCT05142332|472248341|FG000|Overall Study|Withdrawal by Subject|0|||
131171078|NCT05142332|472248342|FG001|Overall Study|Withdrawal by Subject|1|||
131171079|NCT05142332|472248343|FG002|Overall Study|Withdrawal by Subject|2|||
131171080|NCT05142332|472248344|FG003|Overall Study|Withdrawal by Subject|0|||
131171081|NCT05142332|472248345|FG004|Overall Study|Withdrawal by Subject|0|||
131171082|NCT05142332|472248346|FG005|Overall Study|Withdrawal by Subject|2|||
131171083|NCT05142332|472248347|FG006|Overall Study|Withdrawal by Subject|6|||
131171084|NCT05142332|472248341|FG000|Overall Study|Left ED|3|||
131171085|NCT05142332|472248342|FG001|Overall Study|Left ED|0|||
131171086|NCT05142332|472248343|FG002|Overall Study|Left ED|4|||
131171087|NCT05142332|472248344|FG003|Overall Study|Left ED|6|||
131171088|NCT05142332|472248345|FG004|Overall Study|Left ED|1|||
131171089|NCT05142332|472248346|FG005|Overall Study|Left ED|2|||
131171090|NCT05142332|472248347|FG006|Overall Study|Left ED|6|||
131171091|NCT05142332|472248341|FG000|Overall Study|Physician Decision|0|||
131171092|NCT05142332|472248342|FG001|Overall Study|Physician Decision|0|||
131171093|NCT05142332|472248343|FG002|Overall Study|Physician Decision|2|||
131171094|NCT05142332|472248344|FG003|Overall Study|Physician Decision|1|||
131171095|NCT05142332|472248345|FG004|Overall Study|Physician Decision|0|||
131171096|NCT05142332|472248346|FG005|Overall Study|Physician Decision|0|||
131171097|NCT05142332|472248347|FG006|Overall Study|Physician Decision|3|||
131171098|NCT05142332|472248341|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
131171099|NCT05142332|472248342|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
131171100|NCT05142332|472248343|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
131171101|NCT05142332|472248344|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
131171102|NCT05142332|472248345|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
131171103|NCT05142332|472248346|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
130780996|NCT00509899|470824831|FG003|Overall Study|Intercurrent Illness|1|||
130780997|NCT00509899|470824832|FG004|Overall Study|Intercurrent Illness|0|||
130780998|NCT00509899|470824833|FG005|Overall Study|Intercurrent Illness|1|||
130780999|NCT00509899|470824834|FG006|Overall Study|Intercurrent Illness|0|||
130781000|NCT00509899|470824835|FG007|Overall Study|Intercurrent Illness|0|||
130781001|NCT00509899|470824828|FG000|Overall Study|Death|2|||
130781002|NCT00509899|470824829|FG001|Overall Study|Death|2|||
130781003|NCT00509899|470824830|FG002|Overall Study|Death|3|||
130781004|NCT00509899|470824831|FG003|Overall Study|Death|0|||
130781005|NCT00509899|470824832|FG004|Overall Study|Death|1|||
130781006|NCT00509899|470824833|FG005|Overall Study|Death|1|||
130781007|NCT00509899|470824834|FG006|Overall Study|Death|1|||
130781008|NCT00509899|470824835|FG007|Overall Study|Death|1|||
130781009|NCT00509899|470824828|FG000|Overall Study|Lack of Efficacy|1|||
130781010|NCT00509899|470824829|FG001|Overall Study|Lack of Efficacy|0|||
130781011|NCT00509899|470824830|FG002|Overall Study|Lack of Efficacy|2|||
130781012|NCT00509899|470824831|FG003|Overall Study|Lack of Efficacy|0|||
130781013|NCT00509899|470824832|FG004|Overall Study|Lack of Efficacy|0|||
130781014|NCT00509899|470824833|FG005|Overall Study|Lack of Efficacy|1|||
130781015|NCT00509899|470824834|FG006|Overall Study|Lack of Efficacy|0|||
130781016|NCT00509899|470824835|FG007|Overall Study|Lack of Efficacy|0|||
130781017|NCT02735980|470824836|FG000|Overall Study|Adverse Event|0|||
130781018|NCT02735980|470824837|FG001|Overall Study|Adverse Event|4|||
130781019|NCT02735980|470824838|FG002|Overall Study|Adverse Event|1|||
130781020|NCT02735980|470824836|FG000|Overall Study|Death|5|||
130781021|NCT02735980|470824837|FG001|Overall Study|Death|4|||
130781022|NCT02735980|470824838|FG002|Overall Study|Death|0|||
130781023|NCT02735980|470824836|FG000|Overall Study|Physician Decision|3|||
130781024|NCT02735980|470824837|FG001|Overall Study|Physician Decision|1|||
130781025|NCT02735980|470824838|FG002|Overall Study|Physician Decision|0|||
130781026|NCT02735980|470824836|FG000|Overall Study|Screen failure|1|||
130781027|NCT02735980|470824837|FG001|Overall Study|Screen failure|0|||
130781028|NCT02735980|470824838|FG002|Overall Study|Screen failure|0|||
130781029|NCT02735980|470824836|FG000|Overall Study|Withdrawal by Subject|1|||
130781030|NCT02735980|470824837|FG001|Overall Study|Withdrawal by Subject|2|||
130781031|NCT02735980|470824838|FG002|Overall Study|Withdrawal by Subject|0|||
130781032|NCT03713684|470824839|FG000|Overall Study|Adverse Event|1|||
130781033|NCT03713684|470824840|FG001|Overall Study|Adverse Event|3|||
130781034|NCT03713684|470824841|FG002|Overall Study|Adverse Event|1|||
130781035|NCT03713684|470824842|FG003|Overall Study|Adverse Event|0|||
130781036|NCT03713684|470824839|FG000|Overall Study|Poor compliance to protocol|2|||
130781037|NCT03713684|470824840|FG001|Overall Study|Poor compliance to protocol|1|||
130781038|NCT03713684|470824841|FG002|Overall Study|Poor compliance to protocol|0|||
130781039|NCT03713684|470824842|FG003|Overall Study|Poor compliance to protocol|1|||
130781040|NCT03713684|470824839|FG000|Overall Study|Withdrawal by Subject|14|||
130781041|NCT03713684|470824840|FG001|Overall Study|Withdrawal by Subject|6|||
130781042|NCT03713684|470824841|FG002|Overall Study|Withdrawal by Subject|14|||
131171104|NCT05142332|472248347|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
131171105|NCT02052778|472248350|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
131171106|NCT02052778|472248351|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
131171107|NCT02052778|472248352|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
131171108|NCT02052778|472248353|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
131171109|NCT02052778|472248354|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
131171110|NCT02052778|472248355|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
131171111|NCT02052778|472248356|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131171112|NCT02052778|472248357|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
131171113|NCT02052778|472248358|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
131171114|NCT02052778|472248359|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
131171115|NCT02052778|472248360|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
131171116|NCT02052778|472248361|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
131171117|NCT02052778|472248362|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
131171118|NCT02052778|472248363|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
131235782|NCT04947579|472491041|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
130781043|NCT03713684|470824842|FG003|Overall Study|Withdrawal by Subject|16|||
130781044|NCT03713684|470824839|FG000|Overall Study|Other than specified|69|||
130781045|NCT03713684|470824840|FG001|Overall Study|Other than specified|77|||
130781046|NCT03713684|470824841|FG002|Overall Study|Other than specified|73|||
130781047|NCT03713684|470824842|FG003|Overall Study|Other than specified|70|||
130781048|NCT02185417|470824843|FG000|Overall Study|Death|448|||
130781049|NCT02185417|470824844|FG001|Overall Study|Death|446|||
130781050|NCT02185417|470824845|FG002|Overall Study|Death|0|||
130781051|NCT02185417|470824843|FG000|Overall Study|Withdrawal by Subject|7|||
130781052|NCT02185417|470824844|FG001|Overall Study|Withdrawal by Subject|12|||
130781053|NCT02185417|470824845|FG002|Overall Study|Withdrawal by Subject|0|||
130781054|NCT02595502|470824846|FG000|Period 1|Adverse Event|0|||
131171119|NCT02052778|472248364|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131171120|NCT02052778|472248365|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131171121|NCT02052778|472248366|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131171122|NCT02052778|472248367|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131171123|NCT02052778|472248368|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131171124|NCT02052778|472248369|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131171125|NCT02052778|472248370|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131171126|NCT02052778|472248371|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131171127|NCT02052778|472248372|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
131171128|NCT02052778|472248350|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
131171129|NCT02052778|472248351|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
131171130|NCT02052778|472248352|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
131171131|NCT02052778|472248353|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
131171132|NCT02052778|472248354|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
131171133|NCT02052778|472248355|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
131171134|NCT02052778|472248356|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
131171135|NCT02052778|472248357|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
131171136|NCT02052778|472248358|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
131171137|NCT02052778|472248359|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171138|NCT02052778|472248360|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171139|NCT02052778|472248361|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
131171140|NCT02052778|472248362|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
131171141|NCT02052778|472248363|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
131171142|NCT02052778|472248364|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171143|NCT02052778|472248365|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171144|NCT02052778|472248366|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171145|NCT02052778|472248367|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171146|NCT02052778|472248368|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171147|NCT02052778|472248369|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171148|NCT02052778|472248370|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171149|NCT02052778|472248371|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171150|NCT02052778|472248372|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
131171151|NCT02052778|472248350|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171152|NCT02052778|472248351|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171153|NCT02052778|472248352|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171154|NCT02052778|472248353|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171155|NCT02052778|472248354|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171156|NCT02052778|472248355|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171157|NCT02052778|472248356|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171158|NCT02052778|472248357|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171159|NCT02052778|472248358|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171160|NCT02052778|472248359|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171161|NCT02052778|472248360|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171162|NCT02052778|472248361|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171163|NCT02052778|472248362|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171164|NCT02052778|472248363|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
131171165|NCT02052778|472248364|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171166|NCT02052778|472248365|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171167|NCT02052778|472248366|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171168|NCT02052778|472248367|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171169|NCT02052778|472248368|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171170|NCT02052778|472248369|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171171|NCT02052778|472248370|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171172|NCT02052778|472248371|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171173|NCT02052778|472248372|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
131171174|NCT02052778|472248350|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
131171175|NCT02052778|472248351|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
131171176|NCT02052778|472248352|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
131171177|NCT02052778|472248353|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
131171178|NCT02052778|472248354|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
131171179|NCT02052778|472248355|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
131171180|NCT02052778|472248356|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
131235783|NCT04947579|472491042|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
131235784|NCT04947579|472491043|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
131235785|NCT04947579|472491044|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
131235786|NCT04947579|472491039|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
131235787|NCT04947579|472491040|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
131235788|NCT04947579|472491041|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
131235789|NCT04947579|472491042|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
131235790|NCT04947579|472491043|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
131235791|NCT04947579|472491044|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
131235792|NCT04947579|472491039|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
131235793|NCT04947579|472491040|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
131235794|NCT04947579|472491041|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
131235795|NCT04947579|472491042|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
131235796|NCT04947579|472491043|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
131235797|NCT04947579|472491044|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
131235798|NCT04947579|472491039|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
131235799|NCT04947579|472491040|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
131235800|NCT04947579|472491041|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
131235801|NCT04947579|472491042|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
131235802|NCT04947579|472491043|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
131235803|NCT04947579|472491044|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
131235804|NCT04947579|472491039|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
131235805|NCT04947579|472491040|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
131235806|NCT04947579|472491041|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
131235807|NCT04947579|472491042|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
131235808|NCT04947579|472491043|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
131235809|NCT04947579|472491044|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
131235810|NCT04947579|472491039|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
131235811|NCT04947579|472491040|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
131235812|NCT04947579|472491041|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
131235813|NCT04947579|472491042|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
131235814|NCT04947579|472491043|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
131235815|NCT04947579|472491044|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
131235816|NCT02448771|472491045|FG000|Overall Study|Disease Progression|30|||
131235817|NCT02448771|472491045|FG000|Overall Study|Unacceptable Toxicity|1|||
130730038|NCT02125877|470633681|FG000|Overall Study|Withdrawal by Subject|2|||
131171181|NCT02052778|472248357|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
131171182|NCT02052778|472248358|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
131171183|NCT02052778|472248359|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
131171184|NCT02052778|472248360|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
131171185|NCT02052778|472248361|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
131171186|NCT02052778|472248362|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
131171187|NCT02052778|472248363|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
131171188|NCT02052778|472248364|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
131171189|NCT02052778|472248365|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
131171190|NCT02052778|472248366|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
131171191|NCT02052778|472248367|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
131171192|NCT02052778|472248368|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
131171193|NCT02052778|472248369|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
131171194|NCT02052778|472248370|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
131171195|NCT02052778|472248371|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
130730039|NCT02125877|470633682|FG001|Overall Study|Withdrawal by Subject|1|||
130730040|NCT02125877|470633681|FG000|Overall Study|Protocol deviation|4|||
130730041|NCT02125877|470633682|FG001|Overall Study|Protocol deviation|1|||
130730042|NCT02125877|470633681|FG000|Overall Study|Adverse Event|6|||
131171196|NCT02052778|472248372|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
130730043|NCT02125877|470633682|FG001|Overall Study|Adverse Event|4|||
130730044|NCT01685840|470633683|FG000|Overall Study|Death|77|||
130730045|NCT01685840|470633684|FG001|Overall Study|Death|66|||
130730046|NCT01685840|470633683|FG000|Overall Study|Lost to Follow-up|27|||
130730047|NCT01685840|470633684|FG001|Overall Study|Lost to Follow-up|25|||
130730048|NCT01685840|470633683|FG000|Overall Study|Physician Decision|3|||
130730049|NCT01685840|470633684|FG001|Overall Study|Physician Decision|7|||
131171197|NCT02052778|472248350|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171198|NCT02052778|472248351|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130730050|NCT01685840|470633683|FG000|Overall Study|Withdrawal by Subject|14|||
130730051|NCT01685840|470633684|FG001|Overall Study|Withdrawal by Subject|17|||
130730052|NCT01685840|470633683|FG000|Overall Study|Futility|197|||
130730053|NCT01685840|470633684|FG001|Overall Study|Futility|200|||
130730054|NCT01685840|470633683|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
130730055|NCT01685840|470633684|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
130730056|NCT01128543|470633685|FG000|Overall Study|Withdrawal by Subject|3|||
130730057|NCT01128543|470633685|FG000|Overall Study|Protocol Violation|1|||
130730058|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
130730059|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
130730060|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
130730061|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Death|1|||
130730062|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Death|3|||
130730063|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Death|1|||
130730064|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
130730065|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
130730066|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
130730067|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
130730068|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
130730069|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
130730070|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
130730071|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
130730072|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
130730073|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
130730074|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
130730075|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
130730076|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
130730077|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
130730078|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
130730079|NCT00299130|470633689|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
130730080|NCT00299130|470633690|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
130730081|NCT00299130|470633691|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
130730082|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
130730083|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
130730084|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
130730085|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
130730086|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
130730087|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
130730088|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
130730089|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
130730090|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
130730091|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
130730092|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
130730093|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
130730094|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
130730095|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
130730096|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
130730097|NCT00299130|470633689|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
130730098|NCT00299130|470633690|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
130730099|NCT00299130|470633691|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
130730100|NCT00299130|470633689|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
130730101|NCT00299130|470633690|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
130730102|NCT00299130|470633691|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
130730103|NCT00299130|470633689|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
130730104|NCT00299130|470633690|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
130730105|NCT00299130|470633691|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
130730106|NCT00299130|470633689|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
130730107|NCT00299130|470633690|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
130730108|NCT00299130|470633691|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
130730109|NCT01198132|470633692|FG000|Overall Study|Withdrawal by Subject|4|||
130730110|NCT01198132|470633693|FG001|Overall Study|Withdrawal by Subject|5|||
130730111|NCT01198132|470633692|FG000|Overall Study|Physician Decision|5|||
130730112|NCT01198132|470633693|FG001|Overall Study|Physician Decision|4|||
130730113|NCT01198132|470633692|FG000|Overall Study|Other Unspecified|3|||
130730114|NCT01198132|470633693|FG001|Overall Study|Other Unspecified|6|||
130730115|NCT01198132|470633692|FG000|Overall Study|Lack of Efficacy|2|||
130730116|NCT01198132|470633693|FG001|Overall Study|Lack of Efficacy|3|||
130730117|NCT01198132|470633692|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
130730118|NCT01198132|470633693|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
130730119|NCT01198132|470633692|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
131171199|NCT02052778|472248352|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171200|NCT02052778|472248353|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171201|NCT02052778|472248354|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171202|NCT02052778|472248355|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130781055|NCT02595502|470824847|FG001|Period 1|Adverse Event|1|||
130781056|NCT02595502|470824846|FG000|Period 1|Withdrawal by Subject|1|||
130781057|NCT02595502|470824847|FG001|Period 1|Withdrawal by Subject|0|||
130781058|NCT02595502|470824846|FG000|Period 1|Lost to Follow-up|0|||
130781059|NCT02595502|470824847|FG001|Period 1|Lost to Follow-up|1|||
130781060|NCT02595502|470824846|FG000|Period 2|Adverse Event|1|||
130781061|NCT02595502|470824847|FG001|Period 2|Adverse Event|1|||
130781062|NCT02595502|470824846|FG000|Period 2|Received incorrect lens at Period 1|0|||
130781063|NCT02595502|470824847|FG001|Period 2|Received incorrect lens at Period 1|1|||
130781064|NCT02595502|470824846|FG000|Period 3|Protocol Violation|0|||
130781065|NCT02595502|470824847|FG001|Period 3|Protocol Violation|1|||
130781066|NCT02595502|470824846|FG000|Period 3|Lost to Follow-up|1|||
130781067|NCT02595502|470824847|FG001|Period 3|Lost to Follow-up|0|||
130781068|NCT02595502|470824846|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
130781069|NCT02595502|470824847|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
130781070|NCT00974311|470824848|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
130781071|NCT00974311|470824849|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
130781072|NCT00974311|470824848|FG000|DB Phase (up to 24 Months)|Death|561|||
130781073|NCT00974311|470824849|FG001|DB Phase (up to 24 Months)|Death|298|||
130781074|NCT00974311|470824848|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
130781075|NCT00974311|470824849|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
130781076|NCT00974311|470824848|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
130781077|NCT00974311|470824849|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
130781078|NCT00974311|470824848|FG000|DB Phase (up to 24 Months)|Other|1|||
131171203|NCT02052778|472248356|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171204|NCT02052778|472248357|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171205|NCT02052778|472248358|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
131171206|NCT02052778|472248359|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171207|NCT02052778|472248360|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171208|NCT02052778|472248361|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131235818|NCT02448771|472491045|FG000|Overall Study|Physician Decision|3|||
130730120|NCT01198132|470633693|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
130730121|NCT01198132|470633692|FG000|Overall Study|Adverse Event|0|||
130730122|NCT01198132|470633693|FG001|Overall Study|Adverse Event|1|||
130730123|NCT01198132|470633692|FG000|Overall Study|Protocol Violation|1|||
130730124|NCT01198132|470633693|FG001|Overall Study|Protocol Violation|0|||
130730125|NCT03516513|470633696|FG000|Overall Study|Withdrawal by Subject|2|||
130730126|NCT03516513|470633697|FG001|Overall Study|Withdrawal by Subject|2|||
130730127|NCT03516513|470633698|FG002|Overall Study|Withdrawal by Subject|0|||
130730128|NCT03516513|470633699|FG003|Overall Study|Withdrawal by Subject|0|||
130730129|NCT03071276|470633701|FG000|Overall Study|Adverse Event|1|||
130730130|NCT03071276|470633701|FG000|Overall Study|Lack of Efficacy|14|||
130730131|NCT03390426|470633702|FG000|Overall Study|Protocol Violation|0|||
130730132|NCT03390426|470633703|FG001|Overall Study|Protocol Violation|1|||
130730133|NCT00548093|470633708|FG000|Overall Study|Death|33|||
130730134|NCT00548093|470633709|FG001|Overall Study|Death|13|||
130730135|NCT00548093|470633708|FG000|Overall Study|Lost to Follow-up|3|||
130730136|NCT00548093|470633709|FG001|Overall Study|Lost to Follow-up|1|||
130730137|NCT00548093|470633708|FG000|Overall Study|Objective progression or relapse|1|||
130730138|NCT00548093|470633709|FG001|Overall Study|Objective progression or relapse|1|||
130730139|NCT00548093|470633708|FG000|Overall Study|Other|11|||
130730140|NCT00548093|470633709|FG001|Overall Study|Other|1|||
130730141|NCT00548093|470633708|FG000|Overall Study|Withdrawal by Subject|1|||
130730142|NCT00548093|470633709|FG001|Overall Study|Withdrawal by Subject|0|||
130730143|NCT00548093|470633708|FG000|Overall Study|Completed post-treatment follow-up|1|||
130730144|NCT00548093|470633709|FG001|Overall Study|Completed post-treatment follow-up|0|||
130730145|NCT02516553|470633710|FG000|Overall Study|Progressive disease|2|||
130730146|NCT02516553|470633711|FG001|Overall Study|Progressive disease|2|||
130730147|NCT02516553|470633712|FG002|Overall Study|Progressive disease|3|||
130730148|NCT02516553|470633713|FG003|Overall Study|Progressive disease|5|||
130730149|NCT02516553|470633714|FG004|Overall Study|Progressive disease|3|||
130781079|NCT00974311|470824849|FG001|DB Phase (up to 24 Months)|Other|0|||
130781080|NCT00974311|470824848|FG000|OLE Phase (up to 77 Months)|Death|14|||
130730150|NCT02516553|470633715|FG005|Overall Study|Progressive disease|0|||
130781081|NCT00974311|470824849|FG001|OLE Phase (up to 77 Months)|Death|21|||
130730151|NCT02516553|470633716|FG006|Overall Study|Progressive disease|5|||
130730152|NCT02516553|470633717|FG007|Overall Study|Progressive disease|5|||
130730153|NCT02516553|470633718|FG008|Overall Study|Progressive disease|11|||
130730154|NCT02516553|470633719|FG009|Overall Study|Progressive disease|3|||
130730155|NCT02516553|470633720|FG010|Overall Study|Progressive disease|10|||
130730156|NCT02516553|470633721|FG011|Overall Study|Progressive disease|8|||
130730157|NCT02516553|470633722|FG012|Overall Study|Progressive disease|8|||
130781082|NCT00974311|470824848|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
130781083|NCT00974311|470824849|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
130781084|NCT00974311|470824848|FG000|OLE Phase (up to 77 Months)|Other|15|||
130781085|NCT00974311|470824849|FG001|OLE Phase (up to 77 Months)|Other|2|||
130781086|NCT00974311|470824848|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
130781087|NCT00974311|470824849|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
130781088|NCT05556148|470824850|FG000|Overall Study|Early Termination|29|||
130781089|NCT05556148|470824850|FG000|Overall Study|Baseline Tasks Expired|4|||
130781090|NCT05556148|470824850|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
130781091|NCT05556148|470824850|FG000|Overall Study|No Longer Wished to Participate|1|||
130781092|NCT05556148|470824850|FG000|Overall Study|Bacterial Conjunctivitis|1|||
130781093|NCT00458003|470824851|FG000|Overall Study|Non protocol spinal anesthesia|1|||
130781094|NCT00458003|470824852|FG001|Overall Study|Non protocol spinal anesthesia|1|||
131171209|NCT02052778|472248362|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130781095|NCT00809445|470824853|FG000|1 Month Follow-up|Lost contact|1|||
130781096|NCT00809445|470824854|FG001|1 Month Follow-up|Lost contact|2|||
130781097|NCT00809445|470824855|FG002|1 Month Follow-up|Lost contact|1|||
130781098|NCT00809445|470824853|FG000|1 Month Follow-up|Withdrew consent|1|||
130781099|NCT00809445|470824854|FG001|1 Month Follow-up|Withdrew consent|1|||
130781100|NCT00809445|470824855|FG002|1 Month Follow-up|Withdrew consent|1|||
130781101|NCT00809445|470824853|FG000|1 Month Follow-up|Death|0|||
130781102|NCT00809445|470824854|FG001|1 Month Follow-up|Death|1|||
130781103|NCT00809445|470824855|FG002|1 Month Follow-up|Death|1|||
130781104|NCT00809445|470824853|FG000|1 Month Follow-up|Incarcerated|0|||
130781105|NCT00809445|470824854|FG001|1 Month Follow-up|Incarcerated|0|||
130781106|NCT00809445|470824855|FG002|1 Month Follow-up|Incarcerated|1|||
130781107|NCT00809445|470824853|FG000|6 Month Follow-up|Lost contact|16|||
130781108|NCT00809445|470824854|FG001|6 Month Follow-up|Lost contact|14|||
130781109|NCT00809445|470824855|FG002|6 Month Follow-up|Lost contact|14|||
130781110|NCT00809445|470824853|FG000|6 Month Follow-up|Death|2|||
130781111|NCT00809445|470824854|FG001|6 Month Follow-up|Death|1|||
130781112|NCT00809445|470824855|FG002|6 Month Follow-up|Death|1|||
130781113|NCT00809445|470824853|FG000|6 Month Follow-up|Incarcerated|6|||
130781114|NCT00809445|470824854|FG001|6 Month Follow-up|Incarcerated|8|||
130781115|NCT00809445|470824855|FG002|6 Month Follow-up|Incarcerated|8|||
130781116|NCT00809445|470824853|FG000|6 Month Follow-up|Withdrew consent|0|||
130781117|NCT00809445|470824854|FG001|6 Month Follow-up|Withdrew consent|0|||
130781118|NCT00809445|470824855|FG002|6 Month Follow-up|Withdrew consent|1|||
130781119|NCT02048722|470824856|FG000|2 Cycles of Treatment|Adverse Event|2|||
130781120|NCT02048722|470824856|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
130781121|NCT02048722|470824856|FG000|2 Cycles of Treatment|Progressive Disease|2|||
130781122|NCT02048722|470824856|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
130781123|NCT02048722|470824856|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
130781124|NCT02048722|470824856|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
130781125|NCT04144322|470824857|FG000|Overall Study|Lack of Efficacy|2|||
130781126|NCT04144322|470824858|FG001|Overall Study|Lack of Efficacy|2|||
130781127|NCT01272908|470824862|FG000|Initial Treatment Period|Adverse Event|1|||
130781128|NCT01272908|470824862|FG000|Initial Treatment Period|Lack of Efficacy|5|||
130781129|NCT01272908|470824862|FG000|Initial Treatment Period|Protocol Violation|1|||
130781130|NCT01272908|470824862|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
130781131|NCT01272908|470824862|FG000|Re-Treatment Period|Adverse Event|2|||
130781132|NCT01272908|470824862|FG000|Re-Treatment Period|Lack of Efficacy|3|||
130781133|NCT01272908|470824862|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
130781134|NCT02131064|470824863|FG000|Overall Study|Death|5|||
130781135|NCT02131064|470824864|FG001|Overall Study|Death|6|||
130781136|NCT02131064|470824863|FG000|Overall Study|Lost to Follow-up|4|||
130781137|NCT02131064|470824864|FG001|Overall Study|Lost to Follow-up|8|||
130781138|NCT02131064|470824863|FG000|Overall Study|Withdrawal by Subject|14|||
130781139|NCT02131064|470824864|FG001|Overall Study|Withdrawal by Subject|18|||
130781140|NCT02131064|470824863|FG000|Overall Study|Other|2|||
130781141|NCT02131064|470824864|FG001|Overall Study|Other|2|||
131171210|NCT02052778|472248363|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
130781142|NCT03489343|470824867|FG000|Overall Study|Documented progressive disease|1|||
130781143|NCT03489343|470824868|FG001|Overall Study|Documented progressive disease|0|||
131171211|NCT02052778|472248364|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130781144|NCT03489343|470824869|FG002|Overall Study|Documented progressive disease|3|||
130781145|NCT03489343|470824870|FG003|Overall Study|Documented progressive disease|1|||
130781146|NCT03489343|470824871|FG004|Overall Study|Documented progressive disease|3|||
130781147|NCT03489343|470824872|FG005|Overall Study|Documented progressive disease|5|||
130781148|NCT03489343|470824873|FG006|Overall Study|Documented progressive disease|4|||
130781149|NCT03489343|470824867|FG000|Overall Study|Adverse Event|0|||
130781150|NCT03489343|470824868|FG001|Overall Study|Adverse Event|1|||
130781151|NCT03489343|470824869|FG002|Overall Study|Adverse Event|0|||
130781152|NCT03489343|470824870|FG003|Overall Study|Adverse Event|0|||
130781153|NCT03489343|470824871|FG004|Overall Study|Adverse Event|0|||
130781154|NCT03489343|470824872|FG005|Overall Study|Adverse Event|1|||
131235819|NCT02448771|472491045|FG000|Overall Study|Started new therapy|2|||
131235820|NCT00770315|472491046|FG000|Overall Study|Adverse Event|11|||
131235821|NCT00770315|472491047|FG001|Overall Study|Adverse Event|17|||
131235822|NCT00770315|472491048|FG002|Overall Study|Adverse Event|16|||
131235823|NCT00770315|472491049|FG003|Overall Study|Adverse Event|6|||
131235824|NCT00770315|472491046|FG000|Overall Study|Lost to Follow-up|9|||
131235825|NCT00770315|472491047|FG001|Overall Study|Lost to Follow-up|5|||
131235826|NCT00770315|472491048|FG002|Overall Study|Lost to Follow-up|10|||
131235827|NCT00770315|472491049|FG003|Overall Study|Lost to Follow-up|3|||
131235828|NCT00770315|472491046|FG000|Overall Study|Withdrawal by Subject|13|||
131235829|NCT00770315|472491047|FG001|Overall Study|Withdrawal by Subject|17|||
131235830|NCT00770315|472491048|FG002|Overall Study|Withdrawal by Subject|24|||
131235831|NCT00770315|472491049|FG003|Overall Study|Withdrawal by Subject|20|||
131235832|NCT00770315|472491046|FG000|Overall Study|Noncompliance with Protocol|7|||
131235833|NCT00770315|472491047|FG001|Overall Study|Noncompliance with Protocol|4|||
131235834|NCT00770315|472491048|FG002|Overall Study|Noncompliance with Protocol|7|||
131235835|NCT00770315|472491049|FG003|Overall Study|Noncompliance with Protocol|9|||
131235836|NCT02683187|472491050|FG000|Overall Study|Failed IV access|3|||
131235837|NCT02683187|472491050|FG000|Overall Study|Withdrawal by Subject|5|||
131235838|NCT02585258|472491051|FG000|Overall Study|Adverse Event|28|||
131235839|NCT02585258|472491052|FG001|Overall Study|Adverse Event|29|||
131235840|NCT02585258|472491051|FG000|Overall Study|Death|3|||
131235841|NCT02585258|472491052|FG001|Overall Study|Death|2|||
131235842|NCT02585258|472491051|FG000|Overall Study|Lack of Efficacy|7|||
131235843|NCT02585258|472491052|FG001|Overall Study|Lack of Efficacy|9|||
131235844|NCT02585258|472491051|FG000|Overall Study|includes covid-related access problems|42|||
131235845|NCT02585258|472491052|FG001|Overall Study|includes covid-related access problems|46|||
131235846|NCT02585258|472491051|FG000|Overall Study|Lost to Follow-up|5|||
131235847|NCT02585258|472491052|FG001|Overall Study|Lost to Follow-up|2|||
131235848|NCT01919190|472493158|FG000|Overall Study|Intra-op findings, etc.|3|||
131235849|NCT01919190|472493159|FG001|Overall Study|Intra-op findings, etc.|0|||
131235850|NCT02322047|472493165|FG000|Overall Study|Physician Decision|1|||
131235851|NCT02322047|472493166|FG001|Overall Study|Physician Decision|0|||
131235852|NCT02322047|472493167|FG002|Overall Study|Physician Decision|0|||
131235853|NCT02322047|472493168|FG003|Overall Study|Physician Decision|0|||
131235854|NCT02322047|472493165|FG000|Overall Study|Withdrawal by Subject|1|||
131235855|NCT02322047|472493166|FG001|Overall Study|Withdrawal by Subject|0|||
131235856|NCT02322047|472493167|FG002|Overall Study|Withdrawal by Subject|0|||
131235857|NCT02322047|472493168|FG003|Overall Study|Withdrawal by Subject|1|||
131235858|NCT02322047|472493165|FG000|Overall Study|Adverse Event|0|||
131235859|NCT02322047|472493166|FG001|Overall Study|Adverse Event|1|||
131235860|NCT02322047|472493167|FG002|Overall Study|Adverse Event|0|||
131235861|NCT02322047|472493168|FG003|Overall Study|Adverse Event|0|||
131235862|NCT02322047|472493165|FG000|Overall Study|Lost to Follow-up|0|||
131235863|NCT02322047|472493166|FG001|Overall Study|Lost to Follow-up|0|||
131235864|NCT02322047|472493167|FG002|Overall Study|Lost to Follow-up|1|||
131235865|NCT02322047|472493168|FG003|Overall Study|Lost to Follow-up|1|||
131235866|NCT02207231|472493169|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
131171212|NCT02052778|472248365|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171213|NCT02052778|472248366|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171214|NCT02052778|472248367|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171215|NCT02052778|472248368|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171216|NCT02052778|472248369|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171217|NCT02052778|472248370|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171218|NCT02052778|472248371|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171219|NCT02052778|472248372|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
131171220|NCT02052778|472248350|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171221|NCT02052778|472248351|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171222|NCT02052778|472248352|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171223|NCT02052778|472248353|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171224|NCT02052778|472248354|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171225|NCT02052778|472248355|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
131171226|NCT02052778|472248356|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171227|NCT02052778|472248357|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171228|NCT02052778|472248358|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171229|NCT02052778|472248359|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171230|NCT02052778|472248360|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131235867|NCT02207231|472493170|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
131235868|NCT02207231|472493171|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
131235869|NCT02207231|472493172|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
131235870|NCT02207231|472493169|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
131235871|NCT02207231|472493170|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
130730158|NCT02516553|470633723|FG013|Overall Study|Progressive disease|2|||
130730159|NCT02516553|470633724|FG014|Overall Study|Progressive disease|2|||
130730160|NCT02516553|470633725|FG015|Overall Study|Progressive disease|2|||
130730161|NCT02516553|470633726|FG016|Overall Study|Progressive disease|1|||
130730162|NCT02516553|470633727|FG017|Overall Study|Progressive disease|9|||
130730163|NCT02516553|470633728|FG018|Overall Study|Progressive disease|12|||
130730164|NCT02516553|470633729|FG019|Overall Study|Progressive disease|7|||
130730165|NCT02516553|470633730|FG020|Overall Study|Progressive disease|16|||
130730166|NCT02516553|470633731|FG021|Overall Study|Progressive disease|18|||
130730167|NCT02516553|470633710|FG000|Overall Study|Dose limiting toxicity|0|||
131171231|NCT02052778|472248361|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171232|NCT02052778|472248362|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
131171233|NCT02052778|472248363|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171234|NCT02052778|472248364|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171235|NCT02052778|472248365|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171236|NCT02052778|472248366|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171237|NCT02052778|472248367|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171238|NCT02052778|472248368|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171239|NCT02052778|472248369|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171240|NCT02052778|472248370|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171241|NCT02052778|472248371|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171242|NCT02052778|472248372|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
131171243|NCT02052778|472248350|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171244|NCT02052778|472248351|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171245|NCT02052778|472248352|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171246|NCT02052778|472248353|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171247|NCT02052778|472248354|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171248|NCT02052778|472248355|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171249|NCT02052778|472248356|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171250|NCT02052778|472248357|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131235872|NCT02207231|472493171|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
131235873|NCT02207231|472493172|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
131235874|NCT02207231|472493169|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
131235875|NCT02207231|472493170|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
131235876|NCT02207231|472493171|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
131235877|NCT02207231|472493172|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
131235878|NCT02207231|472493169|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
131235879|NCT02207231|472493170|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
131235880|NCT02207231|472493171|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
131235881|NCT02207231|472493172|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
131235882|NCT02207231|472493169|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
131235883|NCT02207231|472493170|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
131235884|NCT02207231|472493171|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
131235885|NCT02207231|472493172|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
131235886|NCT02207231|472493169|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
131235887|NCT02207231|472493170|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
131235888|NCT02207231|472493171|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
131235889|NCT02207231|472493172|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
131235890|NCT02207231|472493169|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
131235891|NCT02207231|472493170|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
131235892|NCT02207231|472493171|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
131235893|NCT02207231|472493172|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
131235894|NCT02207231|472493169|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
131235895|NCT02207231|472493170|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
131235896|NCT02207231|472493171|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
131235897|NCT02207231|472493172|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
131235898|NCT02207231|472493169|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
131235899|NCT02207231|472493170|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
131235900|NCT02207231|472493171|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
131235901|NCT02207231|472493172|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
131235902|NCT02207231|472493169|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
130730168|NCT02516553|470633711|FG001|Overall Study|Dose limiting toxicity|0|||
130730169|NCT02516553|470633712|FG002|Overall Study|Dose limiting toxicity|0|||
131235903|NCT02207231|472493170|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
130730170|NCT02516553|470633713|FG003|Overall Study|Dose limiting toxicity|0|||
130730171|NCT02516553|470633714|FG004|Overall Study|Dose limiting toxicity|3|||
130781155|NCT03489343|470824873|FG006|Overall Study|Adverse Event|0|||
130781156|NCT03489343|470824867|FG000|Overall Study|Withdrawal by Subject|0|||
130781157|NCT03489343|470824868|FG001|Overall Study|Withdrawal by Subject|0|||
130781158|NCT03489343|470824869|FG002|Overall Study|Withdrawal by Subject|0|||
130781159|NCT03489343|470824870|FG003|Overall Study|Withdrawal by Subject|1|||
130781160|NCT03489343|470824871|FG004|Overall Study|Withdrawal by Subject|0|||
130781161|NCT03489343|470824872|FG005|Overall Study|Withdrawal by Subject|1|||
130781162|NCT03489343|470824873|FG006|Overall Study|Withdrawal by Subject|1|||
130781163|NCT03489343|470824867|FG000|Overall Study|Clinical progression|0|||
130781164|NCT03489343|470824868|FG001|Overall Study|Clinical progression|0|||
130781165|NCT03489343|470824869|FG002|Overall Study|Clinical progression|0|||
130781166|NCT03489343|470824870|FG003|Overall Study|Clinical progression|1|||
130781167|NCT03489343|470824871|FG004|Overall Study|Clinical progression|0|||
130781168|NCT03489343|470824872|FG005|Overall Study|Clinical progression|0|||
130781169|NCT03489343|470824873|FG006|Overall Study|Clinical progression|1|||
130781170|NCT01158261|470824874|FG000|Overall Study|Lost to Follow-up|9|||
130781171|NCT01158261|470824874|FG000|Overall Study|Death|7|||
130781172|NCT01158261|470824874|FG000|Overall Study|Withdrawal by Subject|1|||
130781173|NCT03143101|470824875|FG000|Overall Study|Withdrawal by Subject|0|||
130781174|NCT03143101|470824876|FG001|Overall Study|Withdrawal by Subject|1|||
130781175|NCT03143101|470824877|FG002|Overall Study|Withdrawal by Subject|0|||
130781176|NCT03143101|470824875|FG000|Overall Study|Lost to Follow-up|2|||
130781177|NCT03143101|470824876|FG001|Overall Study|Lost to Follow-up|2|||
130781178|NCT03143101|470824877|FG002|Overall Study|Lost to Follow-up|0|||
130781179|NCT01630135|470824881|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
130781180|NCT01630135|470824882|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
130781181|NCT02899065|470824884|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
130781182|NCT02899065|470824885|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
130781183|NCT02899065|470824884|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
130781184|NCT02899065|470824885|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
130781185|NCT02899065|470824884|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
130781186|NCT02899065|470824885|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
130781187|NCT00971867|470824886|FG000|Overall Study|Adverse Event|4|||
130781188|NCT00971867|470824886|FG000|Overall Study|Participant Withdrew Consent|1|||
130781189|NCT00971867|470824886|FG000|Overall Study|Disease Progression|6|||
130781190|NCT05227118|470824890|FG000|Overall Study|Adverse Event|0|||
130781191|NCT05227118|470824891|FG001|Overall Study|Adverse Event|0|||
130781192|NCT05227118|470824892|FG002|Overall Study|Adverse Event|1|||
130781193|NCT05227118|470824893|FG003|Overall Study|Adverse Event|0|||
130781194|NCT05227118|470824890|FG000|Overall Study|Withdrawal by Subject|0|||
130781195|NCT05227118|470824891|FG001|Overall Study|Withdrawal by Subject|0|||
130781196|NCT05227118|470824892|FG002|Overall Study|Withdrawal by Subject|2|||
130781197|NCT05227118|470824893|FG003|Overall Study|Withdrawal by Subject|0|||
130781198|NCT03727841|470824899|FG000|Overall Study|Physician Decision|3|||
130781199|NCT03727841|470824900|FG001|Overall Study|Physician Decision|1|||
130781200|NCT01601496|470824901|FG000|Overall Study|Physician Decision|1|||
130781201|NCT01601496|470824901|FG000|Overall Study|Withdrawal by Subject|1|||
130781202|NCT01601496|470824901|FG000|Overall Study|Lost to Follow-up|6|||
130781203|NCT01601496|470824901|FG000|Overall Study|Death|4|||
130781204|NCT01601496|470824901|FG000|Overall Study|Other: patient refusal to continue|3|||
130781205|NCT03243305|470824902|FG000|Overall Study|Lost to Follow-up|250|||
130781206|NCT03243305|470824902|FG000|Overall Study|Withdrawal by Subject|170|||
130781207|NCT03243305|470824902|FG000|Overall Study|Pregnancy|104|||
131171251|NCT02052778|472248358|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171252|NCT02052778|472248359|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171253|NCT02052778|472248360|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171254|NCT02052778|472248361|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171255|NCT02052778|472248362|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171256|NCT02052778|472248363|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171257|NCT02052778|472248364|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
131171258|NCT02052778|472248365|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
131171259|NCT02052778|472248366|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
130781208|NCT03243305|470824902|FG000|Overall Study|Non-Compliance with Study Drug|38|||
130781209|NCT03243305|470824902|FG000|Overall Study|Adverse Event|23|||
130781210|NCT03243305|470824902|FG000|Overall Study|No sexually active|26|||
130781211|NCT03243305|470824902|FG000|Overall Study|Physician Decision|22|||
130781212|NCT03243305|470824902|FG000|Overall Study|Protocol Violation|22|||
130781213|NCT03243305|470824902|FG000|Overall Study|Study method no longer primary method|12|||
130781214|NCT03243305|470824902|FG000|Overall Study|Study Terminated by Sponsor|1|||
130781215|NCT03243305|470824902|FG000|Overall Study|Early terminations|267|||
130781216|NCT02689804|470824903|FG000|Overall Study|Withdrawal by Subject|2|||
130781217|NCT02689804|470824904|FG001|Overall Study|Withdrawal by Subject|0|||
130781218|NCT01166750|470824912|FG000|Overall Study|Lost to Follow-up|1|||
130730172|NCT02516553|470633715|FG005|Overall Study|Dose limiting toxicity|1|||
130730173|NCT02516553|470633716|FG006|Overall Study|Dose limiting toxicity|1|||
130730174|NCT02516553|470633717|FG007|Overall Study|Dose limiting toxicity|0|||
131171260|NCT02052778|472248367|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
131171261|NCT02052778|472248368|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
131171262|NCT02052778|472248369|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
131171263|NCT02052778|472248370|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
131171264|NCT02052778|472248371|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
131171265|NCT02052778|472248372|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
131171266|NCT02052778|472248350|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171267|NCT02052778|472248351|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171268|NCT02052778|472248352|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171269|NCT02052778|472248353|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171270|NCT02052778|472248354|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171271|NCT02052778|472248355|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171272|NCT02052778|472248356|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171273|NCT02052778|472248357|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171274|NCT02052778|472248358|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171275|NCT02052778|472248359|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171276|NCT02052778|472248360|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171277|NCT02052778|472248361|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171278|NCT02052778|472248362|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171279|NCT02052778|472248363|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171280|NCT02052778|472248364|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
131171281|NCT02052778|472248365|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
131171282|NCT02052778|472248366|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171283|NCT02052778|472248367|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
131171284|NCT02052778|472248368|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
131171285|NCT02052778|472248369|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
131171286|NCT02052778|472248370|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
131171287|NCT02052778|472248371|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
131171288|NCT02052778|472248372|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
131171289|NCT02052778|472248350|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171290|NCT02052778|472248351|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171291|NCT02052778|472248352|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171292|NCT02052778|472248353|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171293|NCT02052778|472248354|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171294|NCT02052778|472248355|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171295|NCT02052778|472248356|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171296|NCT02052778|472248357|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171297|NCT02052778|472248358|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171298|NCT02052778|472248359|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171299|NCT02052778|472248360|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171300|NCT02052778|472248361|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171301|NCT02052778|472248362|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171302|NCT02052778|472248363|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171303|NCT02052778|472248364|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
131171304|NCT02052778|472248365|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
131171305|NCT02052778|472248366|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
131171306|NCT02052778|472248367|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171307|NCT02052778|472248368|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
131171308|NCT02052778|472248369|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
131171309|NCT02052778|472248370|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171310|NCT02052778|472248371|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171311|NCT02052778|472248372|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
131171312|NCT02052778|472248350|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171313|NCT02052778|472248351|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171314|NCT02052778|472248352|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171315|NCT02052778|472248353|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171316|NCT02052778|472248354|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130730175|NCT02516553|470633718|FG008|Overall Study|Dose limiting toxicity|1|||
130730176|NCT02516553|470633719|FG009|Overall Study|Dose limiting toxicity|0|||
131171317|NCT02052778|472248355|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171318|NCT02052778|472248356|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171319|NCT02052778|472248357|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171320|NCT02052778|472248358|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171321|NCT02052778|472248359|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171322|NCT02052778|472248360|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171323|NCT02052778|472248361|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171324|NCT02052778|472248362|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171325|NCT02052778|472248363|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171326|NCT02052778|472248364|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
131171327|NCT02052778|472248365|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
131171328|NCT02052778|472248366|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171329|NCT02052778|472248367|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171330|NCT02052778|472248368|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171331|NCT02052778|472248369|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171332|NCT02052778|472248370|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171333|NCT02052778|472248371|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171334|NCT02052778|472248372|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
131171335|NCT02052778|472248350|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171336|NCT02052778|472248351|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171337|NCT02052778|472248352|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171338|NCT02052778|472248353|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171339|NCT02052778|472248354|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171340|NCT02052778|472248355|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171341|NCT02052778|472248356|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171342|NCT02052778|472248357|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171343|NCT02052778|472248358|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171344|NCT02052778|472248359|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171345|NCT02052778|472248360|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171346|NCT02052778|472248361|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171347|NCT02052778|472248362|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171348|NCT02052778|472248363|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171349|NCT02052778|472248364|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
131171350|NCT02052778|472248365|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
131171351|NCT02052778|472248366|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171352|NCT02052778|472248367|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171353|NCT02052778|472248368|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171354|NCT02052778|472248369|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
131171355|NCT02052778|472248370|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171356|NCT02052778|472248371|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171357|NCT02052778|472248372|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
131171358|NCT02052778|472248350|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
131171359|NCT02052778|472248351|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
131171360|NCT02052778|472248352|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
131171361|NCT02052778|472248353|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
131171362|NCT02052778|472248354|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
131171363|NCT02052778|472248355|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
131171364|NCT02052778|472248356|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
131171365|NCT02052778|472248357|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
131171366|NCT02052778|472248358|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
131171367|NCT02052778|472248359|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
131171368|NCT02052778|472248360|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
131171369|NCT02052778|472248361|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
131171370|NCT02052778|472248362|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
131171371|NCT02052778|472248363|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
131171372|NCT02052778|472248364|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
131171373|NCT02052778|472248365|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
131171374|NCT02052778|472248366|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
131171375|NCT02052778|472248367|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
131171376|NCT02052778|472248368|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
131171377|NCT02052778|472248369|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
131171378|NCT02052778|472248370|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
131171379|NCT02052778|472248371|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
130730177|NCT02516553|470633720|FG010|Overall Study|Dose limiting toxicity|0|||
130730178|NCT02516553|470633721|FG011|Overall Study|Dose limiting toxicity|1|||
131171380|NCT02052778|472248372|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
131171381|NCT02052778|472248350|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171382|NCT02052778|472248351|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171383|NCT02052778|472248352|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171384|NCT02052778|472248353|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171385|NCT02052778|472248354|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171386|NCT02052778|472248355|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171387|NCT02052778|472248356|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171388|NCT02052778|472248357|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171389|NCT02052778|472248358|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171390|NCT02052778|472248359|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171391|NCT02052778|472248360|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171392|NCT02052778|472248361|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171393|NCT02052778|472248362|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171394|NCT02052778|472248363|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171395|NCT02052778|472248364|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
131171396|NCT02052778|472248365|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
131171397|NCT02052778|472248366|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
131171398|NCT02052778|472248367|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171399|NCT02052778|472248368|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
131171400|NCT02052778|472248369|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171401|NCT02052778|472248370|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171402|NCT02052778|472248371|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171403|NCT02052778|472248372|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
131171404|NCT02052778|472248350|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171405|NCT02052778|472248351|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171406|NCT02052778|472248352|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171407|NCT02052778|472248353|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171408|NCT02052778|472248354|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171409|NCT02052778|472248355|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171410|NCT02052778|472248356|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171411|NCT02052778|472248357|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171412|NCT02052778|472248358|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171413|NCT02052778|472248359|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171414|NCT02052778|472248360|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171415|NCT02052778|472248361|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171416|NCT02052778|472248362|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171417|NCT02052778|472248363|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171418|NCT02052778|472248364|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171419|NCT02052778|472248365|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171420|NCT02052778|472248366|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171421|NCT02052778|472248367|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171422|NCT02052778|472248368|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171423|NCT02052778|472248369|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171424|NCT02052778|472248370|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171425|NCT02052778|472248371|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
131171426|NCT02052778|472248372|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
131171427|NCT02052778|472248350|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171428|NCT02052778|472248351|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171429|NCT02052778|472248352|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171430|NCT02052778|472248353|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171431|NCT02052778|472248354|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171432|NCT02052778|472248355|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171433|NCT02052778|472248356|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171434|NCT02052778|472248357|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171435|NCT02052778|472248358|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171436|NCT02052778|472248359|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171437|NCT02052778|472248360|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171438|NCT02052778|472248361|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171439|NCT02052778|472248362|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171440|NCT02052778|472248363|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171441|NCT02052778|472248364|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171442|NCT02052778|472248365|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131235904|NCT02207231|472493171|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
131235905|NCT02207231|472493172|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
130730179|NCT02516553|470633722|FG012|Overall Study|Dose limiting toxicity|0|||
131171443|NCT02052778|472248366|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171444|NCT02052778|472248367|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171445|NCT02052778|472248368|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171446|NCT02052778|472248369|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171447|NCT02052778|472248370|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
131171448|NCT02052778|472248371|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130730180|NCT02516553|470633723|FG013|Overall Study|Dose limiting toxicity|1|||
130730181|NCT02516553|470633724|FG014|Overall Study|Dose limiting toxicity|0|||
130730182|NCT02516553|470633725|FG015|Overall Study|Dose limiting toxicity|0|||
130730183|NCT02516553|470633726|FG016|Overall Study|Dose limiting toxicity|1|||
131171449|NCT02052778|472248372|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
131171450|NCT02052778|472248350|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171451|NCT02052778|472248351|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171452|NCT02052778|472248352|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130730184|NCT02516553|470633727|FG017|Overall Study|Dose limiting toxicity|1|||
130730185|NCT02516553|470633728|FG018|Overall Study|Dose limiting toxicity|0|||
130730186|NCT02516553|470633729|FG019|Overall Study|Dose limiting toxicity|2|||
130730187|NCT02516553|470633730|FG020|Overall Study|Dose limiting toxicity|0|||
130730188|NCT02516553|470633731|FG021|Overall Study|Dose limiting toxicity|0|||
130730189|NCT02516553|470633710|FG000|Overall Study|Other Adverse Events|0|||
130730190|NCT02516553|470633711|FG001|Overall Study|Other Adverse Events|0|||
130730191|NCT02516553|470633712|FG002|Overall Study|Other Adverse Events|0|||
130730192|NCT02516553|470633713|FG003|Overall Study|Other Adverse Events|1|||
130730193|NCT02516553|470633714|FG004|Overall Study|Other Adverse Events|0|||
130730194|NCT02516553|470633715|FG005|Overall Study|Other Adverse Events|1|||
130730195|NCT02516553|470633716|FG006|Overall Study|Other Adverse Events|0|||
130730196|NCT02516553|470633717|FG007|Overall Study|Other Adverse Events|0|||
130730197|NCT02516553|470633718|FG008|Overall Study|Other Adverse Events|0|||
130730198|NCT02516553|470633719|FG009|Overall Study|Other Adverse Events|1|||
130730199|NCT02516553|470633720|FG010|Overall Study|Other Adverse Events|3|||
130730200|NCT02516553|470633721|FG011|Overall Study|Other Adverse Events|2|||
130730201|NCT02516553|470633722|FG012|Overall Study|Other Adverse Events|0|||
130730202|NCT02516553|470633723|FG013|Overall Study|Other Adverse Events|1|||
130730203|NCT02516553|470633724|FG014|Overall Study|Other Adverse Events|0|||
130730204|NCT02516553|470633725|FG015|Overall Study|Other Adverse Events|0|||
130730205|NCT02516553|470633726|FG016|Overall Study|Other Adverse Events|0|||
130730206|NCT02516553|470633727|FG017|Overall Study|Other Adverse Events|2|||
130730207|NCT02516553|470633728|FG018|Overall Study|Other Adverse Events|1|||
130730208|NCT02516553|470633729|FG019|Overall Study|Other Adverse Events|2|||
130730209|NCT02516553|470633730|FG020|Overall Study|Other Adverse Events|2|||
130730210|NCT02516553|470633731|FG021|Overall Study|Other Adverse Events|1|||
131171453|NCT02052778|472248353|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171454|NCT02052778|472248354|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171455|NCT02052778|472248355|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171456|NCT02052778|472248356|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171457|NCT02052778|472248357|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171458|NCT02052778|472248358|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171459|NCT02052778|472248359|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171460|NCT02052778|472248360|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171461|NCT02052778|472248361|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171462|NCT02052778|472248362|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171463|NCT02052778|472248363|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171464|NCT02052778|472248364|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171465|NCT02052778|472248365|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171466|NCT02052778|472248366|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171467|NCT02052778|472248367|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171468|NCT02052778|472248368|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171469|NCT02052778|472248369|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171470|NCT02052778|472248370|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171471|NCT02052778|472248371|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
131171472|NCT02052778|472248372|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
130730211|NCT02516553|470633710|FG000|Overall Study|Refused to continue trial medication|0|||
130781219|NCT01166750|470824913|FG001|Overall Study|Lost to Follow-up|0|||
130730212|NCT02516553|470633711|FG001|Overall Study|Refused to continue trial medication|0|||
130730213|NCT02516553|470633712|FG002|Overall Study|Refused to continue trial medication|0|||
130730214|NCT02516553|470633713|FG003|Overall Study|Refused to continue trial medication|0|||
130730215|NCT02516553|470633714|FG004|Overall Study|Refused to continue trial medication|0|||
130730216|NCT02516553|470633715|FG005|Overall Study|Refused to continue trial medication|0|||
131171473|NCT02052778|472248350|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171474|NCT02052778|472248351|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171475|NCT02052778|472248352|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171476|NCT02052778|472248353|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171477|NCT02052778|472248354|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171478|NCT02052778|472248355|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171479|NCT02052778|472248356|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171480|NCT02052778|472248357|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171481|NCT02052778|472248358|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171482|NCT02052778|472248359|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171483|NCT02052778|472248360|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171484|NCT02052778|472248361|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171485|NCT02052778|472248362|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171486|NCT02052778|472248363|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171487|NCT02052778|472248364|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171488|NCT02052778|472248365|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171489|NCT02052778|472248366|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171490|NCT02052778|472248367|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171491|NCT02052778|472248368|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171492|NCT02052778|472248369|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171493|NCT02052778|472248370|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171494|NCT02052778|472248371|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
131171495|NCT02052778|472248372|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
131171496|NCT02052778|472248350|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171497|NCT02052778|472248351|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171498|NCT02052778|472248352|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171499|NCT02052778|472248353|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171500|NCT02052778|472248354|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171501|NCT02052778|472248355|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171502|NCT02052778|472248356|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171503|NCT02052778|472248357|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171504|NCT02052778|472248358|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171505|NCT02052778|472248359|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171506|NCT02052778|472248360|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171507|NCT02052778|472248361|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171508|NCT02052778|472248362|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171509|NCT02052778|472248363|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171510|NCT02052778|472248364|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171511|NCT02052778|472248365|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171512|NCT02052778|472248366|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171513|NCT02052778|472248367|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171514|NCT02052778|472248368|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171515|NCT02052778|472248369|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171516|NCT02052778|472248370|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171517|NCT02052778|472248371|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
131171518|NCT02052778|472248372|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
131171519|NCT02052778|472248350|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
131171520|NCT02052778|472248351|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
131171521|NCT02052778|472248352|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
131171522|NCT02052778|472248353|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
131171523|NCT02052778|472248354|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
131171524|NCT02052778|472248355|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
131171525|NCT02052778|472248356|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
131171526|NCT02052778|472248357|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
131171527|NCT02052778|472248358|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
131171528|NCT02052778|472248359|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
131171529|NCT02052778|472248360|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
131171530|NCT02052778|472248361|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
131171531|NCT02052778|472248362|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
131171532|NCT02052778|472248363|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
131171533|NCT02052778|472248364|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
131171534|NCT02052778|472248365|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
131171535|NCT02052778|472248366|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
131171536|NCT02052778|472248367|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
131171537|NCT02052778|472248368|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
131235906|NCT02207231|472493169|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
130781220|NCT01585246|470824914|FG000|Overall Study|Lost to Follow-up|0|||
130781221|NCT01585246|470824915|FG001|Overall Study|Lost to Follow-up|0|||
130781222|NCT01585246|470824916|FG002|Overall Study|Lost to Follow-up|2|||
130781223|NCT01585246|470824917|FG003|Overall Study|Lost to Follow-up|1|||
130781224|NCT01585246|470824918|FG004|Overall Study|Lost to Follow-up|0|||
130781225|NCT01585246|470824914|FG000|Overall Study|Protocol Violation|0|||
130781226|NCT01585246|470824915|FG001|Overall Study|Protocol Violation|0|||
130781227|NCT01585246|470824916|FG002|Overall Study|Protocol Violation|0|||
130781228|NCT01585246|470824917|FG003|Overall Study|Protocol Violation|0|||
130781229|NCT01585246|470824918|FG004|Overall Study|Protocol Violation|1|||
130781230|NCT01585246|470824914|FG000|Overall Study|Withdrawal by Subject|0|||
130781231|NCT01585246|470824915|FG001|Overall Study|Withdrawal by Subject|0|||
130781232|NCT01585246|470824916|FG002|Overall Study|Withdrawal by Subject|1|||
130781233|NCT01585246|470824917|FG003|Overall Study|Withdrawal by Subject|2|||
130781234|NCT01585246|470824918|FG004|Overall Study|Withdrawal by Subject|1|||
130781235|NCT01585246|470824914|FG000|Overall Study|Other|0|||
130781236|NCT01585246|470824915|FG001|Overall Study|Other|1|||
130781237|NCT01585246|470824916|FG002|Overall Study|Other|1|||
130781238|NCT01585246|470824917|FG003|Overall Study|Other|1|||
130781239|NCT01585246|470824918|FG004|Overall Study|Other|0|||
130781240|NCT04396626|470824919|FG000|Overall Study|Premature termination of study|975|||
130781241|NCT02417753|470824920|FG000|Overall Study|Death|1|||
130781242|NCT03771963|470824923|FG000|Overall Study|Lost to Follow-up|22|||
130781243|NCT03771963|470824923|FG000|Overall Study|Withdrawal of Consent|10|||
130781244|NCT03014206|470824924|FG000|Overall Study|Registration Violation|12|||
130781245|NCT02998151|470824927|FG000|Overall Study|Withdrawal by Subject|3|||
130781246|NCT02998151|470824927|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
130781247|NCT02998151|470824927|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
130781248|NCT02155985|470824930|FG000|Overall Study|Withdrawal by Subject|0|||
130781249|NCT02155985|470824931|FG001|Overall Study|Withdrawal by Subject|0|||
130781250|NCT02155985|470824932|FG002|Overall Study|Withdrawal by Subject|1|||
130781251|NCT02155985|470824930|FG000|Overall Study|Lost to Follow-up|1|||
130781252|NCT02155985|470824931|FG001|Overall Study|Lost to Follow-up|0|||
130781253|NCT02155985|470824932|FG002|Overall Study|Lost to Follow-up|0|||
130781254|NCT02573259|470824933|FG000|Overall Study|Death|1|||
130781255|NCT02573259|470824934|FG001|Overall Study|Death|6|||
130781256|NCT02573259|470824935|FG002|Overall Study|Death|5|||
130781257|NCT02573259|470824936|FG003|Overall Study|Death|6|||
130781258|NCT02573259|470824937|FG004|Overall Study|Death|9|||
130781259|NCT02573259|470824938|FG005|Overall Study|Death|32|||
130781260|NCT02573259|470824939|FG006|Overall Study|Death|21|||
130781261|NCT02573259|470824933|FG000|Overall Study|Lost to Follow-up|0|||
130781262|NCT02573259|470824934|FG001|Overall Study|Lost to Follow-up|0|||
130781263|NCT02573259|470824935|FG002|Overall Study|Lost to Follow-up|0|||
130781264|NCT02573259|470824936|FG003|Overall Study|Lost to Follow-up|0|||
130781265|NCT02573259|470824937|FG004|Overall Study|Lost to Follow-up|0|||
130781266|NCT02573259|470824938|FG005|Overall Study|Lost to Follow-up|2|||
130781267|NCT02573259|470824939|FG006|Overall Study|Lost to Follow-up|1|||
130781268|NCT02573259|470824933|FG000|Overall Study|Participant refused further follow-up|0|||
130781269|NCT02573259|470824934|FG001|Overall Study|Participant refused further follow-up|2|||
130781270|NCT02573259|470824935|FG002|Overall Study|Participant refused further follow-up|1|||
130781271|NCT02573259|470824936|FG003|Overall Study|Participant refused further follow-up|0|||
130781272|NCT02573259|470824937|FG004|Overall Study|Participant refused further follow-up|3|||
130781273|NCT02573259|470824938|FG005|Overall Study|Participant refused further follow-up|20|||
130781274|NCT02573259|470824939|FG006|Overall Study|Participant refused further follow-up|7|||
130781275|NCT02573259|470824933|FG000|Overall Study|Other|0|||
130781276|NCT02573259|470824934|FG001|Overall Study|Other|0|||
130781277|NCT02573259|470824935|FG002|Overall Study|Other|0|||
130781278|NCT02573259|470824936|FG003|Overall Study|Other|0|||
130781279|NCT02573259|470824937|FG004|Overall Study|Other|1|||
131171538|NCT02052778|472248369|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
131171539|NCT02052778|472248370|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
131171540|NCT02052778|472248371|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
131171541|NCT02052778|472248372|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
131171542|NCT02052778|472248350|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
130781280|NCT02573259|470824938|FG005|Overall Study|Other|4|||
130781281|NCT02573259|470824939|FG006|Overall Study|Other|5|||
130781282|NCT01367249|470824945|FG000|Overall Study|Withdrawal by Subject|6|||
130781283|NCT01367249|470824946|FG001|Overall Study|Withdrawal by Subject|6|||
130781284|NCT01367249|470824945|FG000|Overall Study|Other|3|||
130781285|NCT01367249|470824946|FG001|Overall Study|Other|10|||
130781286|NCT01817075|470824947|FG000|Overall Study|Adverse Event|7|||
130781287|NCT01817075|470824948|FG001|Overall Study|Adverse Event|5|||
130781288|NCT01817075|470824947|FG000|Overall Study|Physician Decision|9|||
130781289|NCT01817075|470824948|FG001|Overall Study|Physician Decision|12|||
130781290|NCT01817075|470824947|FG000|Overall Study|Withdrawal by Subject|31|||
130781291|NCT01817075|470824948|FG001|Overall Study|Withdrawal by Subject|15|||
130781292|NCT01817075|470824947|FG000|Overall Study|Received Sorafenib after enrollment|0|||
130781293|NCT01817075|470824948|FG001|Overall Study|Received Sorafenib after enrollment|1|||
130781294|NCT01817075|470824947|FG000|Overall Study|Ineligible|0|||
130781295|NCT01817075|470824948|FG001|Overall Study|Ineligible|2|||
130781296|NCT03101150|470827353|FG000|Overall Study|Lost to Follow-up|2|||
130781297|NCT03101150|470827354|FG001|Overall Study|Lost to Follow-up|4|||
130781298|NCT03101150|470827353|FG000|Overall Study|Miscarriage|3|||
130781299|NCT03101150|470827354|FG001|Overall Study|Miscarriage|6|||
130781300|NCT02063672|470827357|FG000|Overall Study|Ongoing Follow-up|27|||
130781301|NCT02063672|470827358|FG001|Overall Study|Ongoing Follow-up|14|||
130781302|NCT02063672|470827357|FG000|Overall Study|Death|5|||
130781303|NCT02063672|470827358|FG001|Overall Study|Death|3|||
130781304|NCT02063672|470827357|FG000|Overall Study|Lost to Follow-up|1|||
130781305|NCT02063672|470827358|FG001|Overall Study|Lost to Follow-up|3|||
130781306|NCT02063672|470827357|FG000|Overall Study|Withdrawal by Subject|2|||
130781307|NCT02063672|470827358|FG001|Overall Study|Withdrawal by Subject|2|||
130781308|NCT00619827|470827360|FG000|Overall Study|Adverse Event|1|||
130781309|NCT00619827|470827361|FG001|Overall Study|Adverse Event|2|||
130781310|NCT00619827|470827360|FG000|Overall Study|Withdrawal by Subject|2|||
130781311|NCT00619827|470827361|FG001|Overall Study|Withdrawal by Subject|2|||
130781312|NCT01063855|470827362|FG000|Overall Study|Adverse Event|4|||
130781313|NCT01063855|470827363|FG001|Overall Study|Adverse Event|4|||
130781314|NCT01063855|470827362|FG000|Overall Study|Death|0|||
130781315|NCT01063855|470827363|FG001|Overall Study|Death|1|||
130781316|NCT01063855|470827362|FG000|Overall Study|Lost to Follow-up|8|||
130781317|NCT01063855|470827363|FG001|Overall Study|Lost to Follow-up|4|||
130781318|NCT01063855|470827362|FG000|Overall Study|Pregnancy|1|||
130781319|NCT01063855|470827363|FG001|Overall Study|Pregnancy|0|||
130781320|NCT01063855|470827362|FG000|Overall Study|Lack of Efficacy|0|||
130781321|NCT01063855|470827363|FG001|Overall Study|Lack of Efficacy|1|||
130781322|NCT01063855|470827362|FG000|Overall Study|Withdrawal by Subject|11|||
130781323|NCT01063855|470827363|FG001|Overall Study|Withdrawal by Subject|8|||
130781324|NCT01063855|470827362|FG000|Overall Study|Reason not specified|13|||
130781325|NCT01063855|470827363|FG001|Overall Study|Reason not specified|11|||
130781326|NCT02498678|470827378|FG000|Overall Study|interference from the surgical team|0|||
130781327|NCT02498678|470827379|FG001|Overall Study|interference from the surgical team|2|||
130781328|NCT02619617|470827387|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
130781329|NCT02619617|470827388|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
130781330|NCT02619617|470827387|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
130781331|NCT02619617|470827388|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
130781332|NCT01854697|470827389|FG000|Overall Study|Adverse Event|1|||
130781333|NCT01854697|470827390|FG001|Overall Study|Adverse Event|0|||
130781334|NCT01854697|470827391|FG002|Overall Study|Adverse Event|0|||
130781335|NCT01854697|470827392|FG003|Overall Study|Adverse Event|0|||
130781336|NCT01854697|470827393|FG004|Overall Study|Adverse Event|1|||
130781337|NCT01854697|470827389|FG000|Overall Study|Lost to Follow-up|4|||
130781338|NCT01854697|470827390|FG001|Overall Study|Lost to Follow-up|1|||
130781339|NCT01854697|470827391|FG002|Overall Study|Lost to Follow-up|1|||
130781340|NCT01854697|470827392|FG003|Overall Study|Lost to Follow-up|2|||
130781341|NCT01854697|470827393|FG004|Overall Study|Lost to Follow-up|0|||
130781342|NCT01854697|470827389|FG000|Overall Study|To enter another AbbVie study|1|||
130781343|NCT01854697|470827390|FG001|Overall Study|To enter another AbbVie study|0|||
130781344|NCT01854697|470827391|FG002|Overall Study|To enter another AbbVie study|0|||
130781345|NCT01854697|470827392|FG003|Overall Study|To enter another AbbVie study|0|||
130781346|NCT01854697|470827393|FG004|Overall Study|To enter another AbbVie study|1|||
130781347|NCT01854697|470827389|FG000|Overall Study|Withdrew Consent|0|||
130781348|NCT01854697|470827390|FG001|Overall Study|Withdrew Consent|1|||
131171543|NCT02052778|472248351|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171544|NCT02052778|472248352|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171545|NCT02052778|472248353|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
130781349|NCT01854697|470827391|FG002|Overall Study|Withdrew Consent|0|||
130781350|NCT01854697|470827392|FG003|Overall Study|Withdrew Consent|1|||
130781351|NCT01854697|470827393|FG004|Overall Study|Withdrew Consent|0|||
130781352|NCT01854697|470827389|FG000|Overall Study|Other|0|||
130781353|NCT01854697|470827390|FG001|Overall Study|Other|1|||
130781354|NCT01854697|470827391|FG002|Overall Study|Other|1|||
130781355|NCT01854697|470827392|FG003|Overall Study|Other|0|||
130781356|NCT01854697|470827393|FG004|Overall Study|Other|0|||
130781357|NCT00115778|470827397|FG000|Overall Study|Withdrawal by Subject|0|||
130781358|NCT00115778|470827398|FG001|Overall Study|Withdrawal by Subject|1|||
130781359|NCT00528424|470827401|FG000|Overall Study|Lost to Follow-up|13|||
130781360|NCT00528424|470827401|FG000|Overall Study|Withdrew consent|2|||
130781361|NCT00528424|470827401|FG000|Overall Study|Administrative reason|2|||
130781362|NCT00528424|470827401|FG000|Overall Study|Other|12|||
130781363|NCT02515630|470827402|FG000|Overall Study|Withdrawal by Subject|5|||
130781364|NCT02515630|470827402|FG000|Overall Study|Adverse Event|4|||
130781365|NCT02515630|470827402|FG000|Overall Study|Physician Decision|4|||
130781366|NCT02515630|470827402|FG000|Overall Study|Death|2|||
130781367|NCT02515630|470827402|FG000|Overall Study|Disease Progression|1|||
130781368|NCT00483652|470827403|FG000|Double-blind Treatment Period|Protocol Violation|2|||
130781369|NCT00483652|470827404|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130781370|NCT00483652|470827403|FG000|Double-blind Treatment Period|Adverse Event|3|||
130781371|NCT00483652|470827404|FG001|Double-blind Treatment Period|Adverse Event|4|||
130781372|NCT00483652|470827403|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
130781373|NCT00483652|470827404|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
130781374|NCT00483652|470827403|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
130781375|NCT00483652|470827404|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
130781376|NCT00468585|470827405|FG000|Overall Study|Patient not treated|1|||
130781377|NCT00468585|470827406|FG001|Overall Study|Patient not treated|0|||
130781378|NCT00468585|470827407|FG002|Overall Study|Patient not treated|1|||
130781379|NCT00468585|470827408|FG003|Overall Study|Patient not treated|0|||
130781380|NCT00468585|470827405|FG000|Overall Study|Patient found to be ineligible|0|||
131171546|NCT02052778|472248354|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171547|NCT02052778|472248355|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171548|NCT02052778|472248356|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171549|NCT02052778|472248357|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171550|NCT02052778|472248358|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171551|NCT02052778|472248359|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171552|NCT02052778|472248360|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171553|NCT02052778|472248361|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171554|NCT02052778|472248362|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171555|NCT02052778|472248363|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171556|NCT02052778|472248364|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171557|NCT02052778|472248365|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171558|NCT02052778|472248366|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171559|NCT02052778|472248367|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171560|NCT02052778|472248368|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171561|NCT02052778|472248369|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171562|NCT02052778|472248370|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171563|NCT02052778|472248371|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
131171564|NCT02052778|472248372|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
131171565|NCT01094730|472248379|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
131171566|NCT01094730|472248380|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
131171567|NCT01094730|472248379|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
131171568|NCT01094730|472248380|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
131171569|NCT01094730|472248379|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
131171570|NCT01094730|472248380|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
131171571|NCT01094730|472248379|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
131171572|NCT01094730|472248380|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
131171573|NCT01094730|472248379|FG000|Period 2 (14 Days)|Protocol Violation|2|||
131171574|NCT01094730|472248380|FG001|Period 2 (14 Days)|Protocol Violation|0|||
131171575|NCT01094730|472248379|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
131171576|NCT01094730|472248380|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
131171577|NCT01094730|472248379|FG000|Period 2 (14 Days)|Adverse Event|0|||
131171578|NCT01094730|472248380|FG001|Period 2 (14 Days)|Adverse Event|1|||
131171579|NCT01094730|472248379|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
131171580|NCT01094730|472248380|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
131171581|NCT01842308|472248381|FG000|Overall Study|Withdrawal by Subject|0|||
131171582|NCT01842308|472248382|FG001|Overall Study|Withdrawal by Subject|0|||
131235907|NCT02207231|472493170|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
131235908|NCT02207231|472493171|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
131235909|NCT02207231|472493172|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
131235910|NCT02207231|472493169|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
131235911|NCT02207231|472493170|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
131235912|NCT02207231|472493171|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
131235913|NCT02207231|472493172|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
131235914|NCT02207231|472493169|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
131235915|NCT02207231|472493170|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
131235916|NCT02207231|472493171|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
131235917|NCT02207231|472493172|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
131235918|NCT02207231|472493169|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
131235919|NCT02207231|472493170|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
131235920|NCT02207231|472493171|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
131171583|NCT01842308|472248383|FG002|Overall Study|Withdrawal by Subject|0|||
131235921|NCT02207231|472493172|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
131235922|NCT02207231|472493169|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
131171584|NCT01842308|472248384|FG003|Overall Study|Withdrawal by Subject|0|||
131171585|NCT01842308|472248385|FG004|Overall Study|Withdrawal by Subject|1|||
131171586|NCT00987623|472248386|FG000|Overall Study|Lost to Follow-up|2|||
131171587|NCT00987623|472248387|FG001|Overall Study|Lost to Follow-up|1|||
131171588|NCT00987623|472248386|FG000|Overall Study|Time/job conflict|2|||
131171589|NCT00987623|472248387|FG001|Overall Study|Time/job conflict|0|||
131171590|NCT00987623|472248386|FG000|Overall Study|Discomfort|1|||
131171591|NCT00987623|472248387|FG001|Overall Study|Discomfort|0|||
131171592|NCT00987623|472248386|FG000|Overall Study|Biomicroscopy|0|||
130730217|NCT02516553|470633716|FG006|Overall Study|Refused to continue trial medication|0|||
130730218|NCT02516553|470633717|FG007|Overall Study|Refused to continue trial medication|0|||
130730219|NCT02516553|470633718|FG008|Overall Study|Refused to continue trial medication|0|||
130730220|NCT02516553|470633719|FG009|Overall Study|Refused to continue trial medication|0|||
130730221|NCT02516553|470633720|FG010|Overall Study|Refused to continue trial medication|1|||
130730222|NCT02516553|470633721|FG011|Overall Study|Refused to continue trial medication|0|||
130730223|NCT02516553|470633722|FG012|Overall Study|Refused to continue trial medication|0|||
130730224|NCT02516553|470633723|FG013|Overall Study|Refused to continue trial medication|0|||
130730225|NCT02516553|470633724|FG014|Overall Study|Refused to continue trial medication|0|||
130730226|NCT02516553|470633725|FG015|Overall Study|Refused to continue trial medication|0|||
130730227|NCT02516553|470633726|FG016|Overall Study|Refused to continue trial medication|0|||
130730228|NCT02516553|470633727|FG017|Overall Study|Refused to continue trial medication|0|||
130730229|NCT02516553|470633728|FG018|Overall Study|Refused to continue trial medication|1|||
130730230|NCT02516553|470633729|FG019|Overall Study|Refused to continue trial medication|0|||
130730231|NCT02516553|470633730|FG020|Overall Study|Refused to continue trial medication|0|||
130730232|NCT02516553|470633731|FG021|Overall Study|Refused to continue trial medication|1|||
130730233|NCT02516553|470633710|FG000|Overall Study|other reasons than listed|0|||
130730234|NCT02516553|470633711|FG001|Overall Study|other reasons than listed|0|||
130730235|NCT02516553|470633712|FG002|Overall Study|other reasons than listed|0|||
130730236|NCT02516553|470633713|FG003|Overall Study|other reasons than listed|0|||
130730237|NCT02516553|470633714|FG004|Overall Study|other reasons than listed|0|||
130730238|NCT02516553|470633715|FG005|Overall Study|other reasons than listed|0|||
130730239|NCT02516553|470633716|FG006|Overall Study|other reasons than listed|0|||
130730240|NCT02516553|470633717|FG007|Overall Study|other reasons than listed|1|||
130730241|NCT02516553|470633718|FG008|Overall Study|other reasons than listed|1|||
130730242|NCT02516553|470633719|FG009|Overall Study|other reasons than listed|0|||
130730243|NCT02516553|470633720|FG010|Overall Study|other reasons than listed|1|||
130730244|NCT02516553|470633721|FG011|Overall Study|other reasons than listed|1|||
130730245|NCT02516553|470633722|FG012|Overall Study|other reasons than listed|0|||
130730246|NCT02516553|470633723|FG013|Overall Study|other reasons than listed|0|||
130730247|NCT02516553|470633724|FG014|Overall Study|other reasons than listed|0|||
130730248|NCT02516553|470633725|FG015|Overall Study|other reasons than listed|0|||
130730249|NCT02516553|470633726|FG016|Overall Study|other reasons than listed|0|||
130730250|NCT02516553|470633727|FG017|Overall Study|other reasons than listed|0|||
130730251|NCT02516553|470633728|FG018|Overall Study|other reasons than listed|0|||
130730252|NCT02516553|470633729|FG019|Overall Study|other reasons than listed|0|||
130730253|NCT02516553|470633730|FG020|Overall Study|other reasons than listed|2|||
130730254|NCT02516553|470633731|FG021|Overall Study|other reasons than listed|2|||
130730255|NCT02924727|470633736|FG000|Overall Study|Withdrawal by Subject|2|||
130730256|NCT02924727|470633737|FG001|Overall Study|Withdrawal by Subject|4|||
130730257|NCT02924727|470633736|FG000|Overall Study|Lost to Follow-up|2|||
130730258|NCT02924727|470633737|FG001|Overall Study|Lost to Follow-up|5|||
130730259|NCT02924727|470633736|FG000|Overall Study|Death|221|||
130730260|NCT02924727|470633737|FG001|Overall Study|Death|247|||
130730261|NCT02924727|470633736|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
130730262|NCT02924727|470633737|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
130730263|NCT00509795|470633740|FG000|Overall Study|Adverse Event|4|||
130730264|NCT00509795|470633741|FG001|Overall Study|Adverse Event|3|||
130730265|NCT00509795|470633742|FG002|Overall Study|Adverse Event|5|||
130730266|NCT00509795|470633743|FG003|Overall Study|Adverse Event|4|||
130730267|NCT00509795|470633740|FG000|Overall Study|Death|3|||
130730268|NCT00509795|470633741|FG001|Overall Study|Death|1|||
130730269|NCT00509795|470633742|FG002|Overall Study|Death|2|||
130730270|NCT00509795|470633743|FG003|Overall Study|Death|7|||
130730271|NCT00509795|470633740|FG000|Overall Study|Lack of Efficacy|0|||
130730272|NCT00509795|470633741|FG001|Overall Study|Lack of Efficacy|0|||
130730273|NCT00509795|470633742|FG002|Overall Study|Lack of Efficacy|2|||
130781381|NCT00468585|470827406|FG001|Overall Study|Patient found to be ineligible|0|||
130781382|NCT00468585|470827407|FG002|Overall Study|Patient found to be ineligible|1|||
131171593|NCT00987623|472248387|FG001|Overall Study|Biomicroscopy|1|||
131171594|NCT00987623|472248386|FG000|Overall Study|Influenza|0|||
131171595|NCT00987623|472248387|FG001|Overall Study|Influenza|1|||
131171596|NCT01401010|472248388|FG000|Overall Study|Could not interpret assay results|1|||
130730274|NCT00509795|470633743|FG003|Overall Study|Lack of Efficacy|2|||
130730275|NCT00509795|470633740|FG000|Overall Study|Lost to Follow-up|1|||
130730276|NCT00509795|470633741|FG001|Overall Study|Lost to Follow-up|2|||
130730277|NCT00509795|470633742|FG002|Overall Study|Lost to Follow-up|4|||
130730278|NCT00509795|470633743|FG003|Overall Study|Lost to Follow-up|4|||
130730279|NCT00509795|470633740|FG000|Overall Study|OTHER|1|||
131171597|NCT01401010|472248389|FG001|Overall Study|Could not interpret assay results|0|||
131171598|NCT03135028|472248390|FG000|Overall Study|Death|6|||
131171599|NCT03135028|472248390|FG000|Overall Study|Study Terminated by Sponsor|2|||
131171600|NCT03135028|472248390|FG000|Overall Study|Withdrew Consent|1|||
131171601|NCT01814800|472248392|FG000|Overall Study|Adverse Event|2|||
131171602|NCT01814800|472248392|FG000|Overall Study|Pregnancy|1|||
131171603|NCT01814800|472248392|FG000|Overall Study|Sponsor decision|1|||
131171604|NCT01814800|472248392|FG000|Overall Study|Subject relocation|1|||
131171605|NCT04436822|472248393|FG000|Overall Study|Physician Decision|2|||
131171606|NCT04436822|472248394|FG001|Overall Study|Physician Decision|0|||
131171607|NCT04436822|472248393|FG000|Overall Study|Sponsor request|1|||
131171608|NCT04436822|472248394|FG001|Overall Study|Sponsor request|0|||
131171609|NCT04436822|472248393|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131171610|NCT04436822|472248394|FG001|Overall Study|Withdrawal by parent/guardian|3|||
131171611|NCT04436822|472248393|FG000|Overall Study|Unsuccessful procedure|0|||
131171612|NCT04436822|472248394|FG001|Overall Study|Unsuccessful procedure|1|||
131171613|NCT04436822|472248393|FG000|Overall Study|Withdrawal due to Covid-19|8|||
131171614|NCT04436822|472248394|FG001|Overall Study|Withdrawal due to Covid-19|1|||
131171615|NCT04436822|472248393|FG000|Overall Study|Withdrawal by Subject|1|||
131171616|NCT04436822|472248394|FG001|Overall Study|Withdrawal by Subject|0|||
131171617|NCT04436822|472248393|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
131171618|NCT04436822|472248394|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
131171619|NCT01689207|472248395|FG000|Overall Study|Adverse Event|0|||
131171620|NCT01689207|472248396|FG001|Overall Study|Adverse Event|1|||
131171621|NCT01689207|472248397|FG002|Overall Study|Adverse Event|0|||
131171622|NCT01689207|472248398|FG003|Overall Study|Adverse Event|0|||
131171623|NCT01689207|472248399|FG004|Overall Study|Adverse Event|2|||
131171624|NCT01689207|472248400|FG005|Overall Study|Adverse Event|1|||
131171625|NCT01689207|472248401|FG006|Overall Study|Adverse Event|0|||
131171626|NCT01689207|472248402|FG007|Overall Study|Adverse Event|0|||
131171627|NCT01689207|472248403|FG008|Overall Study|Adverse Event|1|||
131171628|NCT01689207|472248404|FG009|Overall Study|Adverse Event|0|||
131171629|NCT01689207|472248405|FG010|Overall Study|Adverse Event|0|||
131171630|NCT00303108|472248409|FG000|Overall Study|Adverse Event|5|||
131171631|NCT00303108|472248410|FG001|Overall Study|Adverse Event|6|||
131171632|NCT00303108|472248411|FG002|Overall Study|Adverse Event|7|||
131171633|NCT00303108|472248409|FG000|Overall Study|Patient Request|4|||
131171634|NCT00303108|472248410|FG001|Overall Study|Patient Request|2|||
131171635|NCT00303108|472248411|FG002|Overall Study|Patient Request|8|||
131171636|NCT00303108|472248409|FG000|Overall Study|Failed Entry|1|||
131171637|NCT00303108|472248410|FG001|Overall Study|Failed Entry|0|||
131171638|NCT00303108|472248411|FG002|Overall Study|Failed Entry|1|||
131171639|NCT00303108|472248409|FG000|Overall Study|ineligible|2|||
131171640|NCT00303108|472248410|FG001|Overall Study|ineligible|1|||
131171641|NCT00303108|472248411|FG002|Overall Study|ineligible|0|||
131171642|NCT03201198|472248412|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
131171643|NCT03201198|472248413|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
131171644|NCT03201198|472248412|FG000|Overall Study|Withdrawal by Subject|2|||
131171645|NCT03201198|472248413|FG001|Overall Study|Withdrawal by Subject|3|||
131171646|NCT03855137|472248414|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
131171647|NCT03855137|472248415|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
131171648|NCT03855137|472248416|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
131171649|NCT03855137|472248414|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
131171650|NCT03855137|472248415|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
131171651|NCT03855137|472248416|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
131171652|NCT03855137|472248414|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
131171653|NCT03855137|472248415|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
131171654|NCT03855137|472248416|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
131171655|NCT03855137|472248414|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
131171656|NCT03855137|472248415|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
131171657|NCT03855137|472248416|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
131171658|NCT03855137|472248414|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
131171659|NCT03855137|472248415|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
131171660|NCT03855137|472248416|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
131171661|NCT03855137|472248414|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
131171662|NCT03855137|472248415|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
131171663|NCT03855137|472248416|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
131171664|NCT03855137|472248414|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
131171665|NCT03855137|472248415|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
131171666|NCT03855137|472248416|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
131171667|NCT03855137|472248414|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
131171668|NCT03855137|472248415|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
131171669|NCT03855137|472248416|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
131171670|NCT03855137|472248414|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
131171671|NCT03855137|472248415|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
131171672|NCT03855137|472248416|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
131171673|NCT03855137|472248414|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
131171674|NCT03855137|472248415|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
131171675|NCT03855137|472248416|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
131171676|NCT02427477|472248422|FG000|Period 1|Adverse Event|1|||
131171677|NCT02427477|472248423|FG001|Period 1|Adverse Event|0|||
130730280|NCT00509795|470633741|FG001|Overall Study|OTHER|0|||
130730281|NCT00509795|470633742|FG002|Overall Study|OTHER|4|||
130730282|NCT00509795|470633743|FG003|Overall Study|OTHER|1|||
130730283|NCT00509795|470633740|FG000|Overall Study|Protocol Violation|3|||
130730284|NCT00509795|470633741|FG001|Overall Study|Protocol Violation|0|||
130730285|NCT00509795|470633742|FG002|Overall Study|Protocol Violation|3|||
130730286|NCT00509795|470633743|FG003|Overall Study|Protocol Violation|1|||
130730287|NCT00509795|470633740|FG000|Overall Study|Withdrawal by Subject|10|||
130730288|NCT00509795|470633741|FG001|Overall Study|Withdrawal by Subject|5|||
130730289|NCT00509795|470633742|FG002|Overall Study|Withdrawal by Subject|7|||
130730290|NCT00509795|470633743|FG003|Overall Study|Withdrawal by Subject|8|||
130730291|NCT02759692|470633747|FG000|Period 1|Test article no longer available|1|||
130730292|NCT02759692|470633748|FG001|Period 1|Test article no longer available|1|||
130730293|NCT02759692|470633747|FG000|Period 1|No longer meets eligibility criteria.|1|||
130730294|NCT02759692|470633748|FG001|Period 1|No longer meets eligibility criteria.|0|||
130730295|NCT02759692|470633747|FG000|Period 1|Miss-Randomized|1|||
130730296|NCT02759692|470633748|FG001|Period 1|Miss-Randomized|1|||
130730297|NCT02759692|470633747|FG000|Period 2|Lost to Follow-up|1|||
130730298|NCT02759692|470633748|FG001|Period 2|Lost to Follow-up|0|||
130730299|NCT02759692|470633747|FG000|Period 2|Test article no longer available|0|||
130730300|NCT02759692|470633748|FG001|Period 2|Test article no longer available|1|||
130730301|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
130730302|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
130730303|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
130730304|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
130730305|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
130730306|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
130730307|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
130730308|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
130730309|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
130730310|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
130730311|NCT00451178|470633749|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
130730312|NCT00451178|470633750|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
130730313|NCT00451178|470633749|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
130730314|NCT00451178|470633750|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
130730315|NCT00451178|470633749|FG000|Prior to Maintenance Therapy|PD|2|||
130730316|NCT00451178|470633750|FG001|Prior to Maintenance Therapy|PD|0|||
130781383|NCT00468585|470827408|FG003|Overall Study|Patient found to be ineligible|0|||
130781384|NCT00468585|470827405|FG000|Overall Study|Adverse Event|0|||
130781385|NCT00468585|470827406|FG001|Overall Study|Adverse Event|0|||
130781386|NCT00468585|470827407|FG002|Overall Study|Adverse Event|1|||
130781387|NCT00468585|470827408|FG003|Overall Study|Adverse Event|0|||
130781388|NCT00468585|470827405|FG000|Overall Study|Withdrawal by Subject|0|||
130781389|NCT00468585|470827406|FG001|Overall Study|Withdrawal by Subject|0|||
130781390|NCT00468585|470827407|FG002|Overall Study|Withdrawal by Subject|2|||
130781391|NCT00468585|470827408|FG003|Overall Study|Withdrawal by Subject|1|||
130781392|NCT02154139|470827413|FG000|Overall Study|Injection not administered|2|||
130781393|NCT02154139|470827413|FG000|Overall Study|Other|2|||
130781394|NCT02154139|470827413|FG000|Overall Study|Investigator transferred|3|||
130781395|NCT02087774|470827416|FG000|Overall Study|Were absent day of data collection|8|||
130781396|NCT02087774|470827417|FG001|Overall Study|Were absent day of data collection|20|||
130781397|NCT02157519|470827427|FG000|Overall Study|Death|3|||
130781398|NCT02157519|470827428|FG001|Overall Study|Death|1|||
130781399|NCT02157519|470827427|FG000|Overall Study|Withdrawal by Subject|7|||
131171678|NCT02635737|472248427|FG000|Overall Study|Protocol Violation|1|||
131171679|NCT02065622|472248428|FG000|Induction Study|Adverse Event|13|||
130730317|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
130781400|NCT02157519|470827428|FG001|Overall Study|Withdrawal by Subject|0|||
130781401|NCT02157519|470827427|FG000|Overall Study|Lost to Follow-up|1|||
130781402|NCT02157519|470827428|FG001|Overall Study|Lost to Follow-up|0|||
130781403|NCT01656395|470827429|FG000|Overall Study|Adverse Event|1|||
131171680|NCT02065622|472248429|FG001|Induction Study|Adverse Event|19|||
130730318|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
130730319|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
130730320|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
130781404|NCT01656395|470827430|FG001|Overall Study|Adverse Event|14|||
131171681|NCT02065622|472248430|FG002|Induction Study|Adverse Event|0|||
131171682|NCT02065622|472248431|FG003|Induction Study|Adverse Event|0|||
131171683|NCT02065622|472248432|FG004|Induction Study|Adverse Event|0|||
131171684|NCT02065622|472248428|FG000|Induction Study|Withdrawal by Subject|3|||
131171685|NCT02065622|472248429|FG001|Induction Study|Withdrawal by Subject|5|||
131171686|NCT02065622|472248430|FG002|Induction Study|Withdrawal by Subject|0|||
131171687|NCT02065622|472248431|FG003|Induction Study|Withdrawal by Subject|0|||
131171688|NCT02065622|472248432|FG004|Induction Study|Withdrawal by Subject|0|||
131171689|NCT02065622|472248428|FG000|Induction Study|Lost to Follow-up|1|||
131171690|NCT02065622|472248429|FG001|Induction Study|Lost to Follow-up|0|||
131171691|NCT02065622|472248430|FG002|Induction Study|Lost to Follow-up|0|||
130730321|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
130730322|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
130730323|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
130730324|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
130730325|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
130730326|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
130730327|NCT00451178|470633749|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
130730328|NCT00451178|470633750|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
130730329|NCT00451178|470633749|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
130730330|NCT00451178|470633750|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
130730331|NCT03207867|470633753|FG000|Overall Study|Adverse Event|1|||
130730332|NCT03207867|470633754|FG001|Overall Study|Adverse Event|0|||
130730333|NCT03207867|470633755|FG002|Overall Study|Adverse Event|1|||
130730334|NCT03207867|470633756|FG003|Overall Study|Adverse Event|0|||
130730335|NCT03207867|470633757|FG004|Overall Study|Adverse Event|0|||
130730336|NCT03207867|470633758|FG005|Overall Study|Adverse Event|2|||
130730337|NCT03207867|470633759|FG006|Overall Study|Adverse Event|1|||
130730338|NCT03207867|470633760|FG007|Overall Study|Adverse Event|1|||
130730339|NCT03207867|470633761|FG008|Overall Study|Adverse Event|2|||
130730340|NCT03207867|470633762|FG009|Overall Study|Adverse Event|2|||
130730341|NCT03207867|470633763|FG010|Overall Study|Adverse Event|0|||
130730342|NCT03207867|470633764|FG011|Overall Study|Adverse Event|0|||
130730343|NCT03207867|470633765|FG012|Overall Study|Adverse Event|0|||
130730344|NCT03207867|470633766|FG013|Overall Study|Adverse Event|0|||
130730345|NCT03207867|470633767|FG014|Overall Study|Adverse Event|0|||
130730346|NCT03207867|470633768|FG015|Overall Study|Adverse Event|0|||
130730347|NCT03207867|470633769|FG016|Overall Study|Adverse Event|3|||
130730348|NCT03207867|470633770|FG017|Overall Study|Adverse Event|1|||
130730349|NCT03207867|470633771|FG018|Overall Study|Adverse Event|2|||
130730350|NCT03207867|470633772|FG019|Overall Study|Adverse Event|1|||
130730351|NCT03207867|470633773|FG020|Overall Study|Adverse Event|0|||
130730352|NCT03207867|470633774|FG021|Overall Study|Adverse Event|0|||
130730353|NCT03207867|470633775|FG022|Overall Study|Adverse Event|0|||
130730354|NCT03207867|470633776|FG023|Overall Study|Adverse Event|0|||
130730355|NCT03207867|470633753|FG000|Overall Study|Death|0|||
130730356|NCT03207867|470633754|FG001|Overall Study|Death|0|||
130730357|NCT03207867|470633755|FG002|Overall Study|Death|0|||
130730358|NCT03207867|470633756|FG003|Overall Study|Death|0|||
130730359|NCT03207867|470633757|FG004|Overall Study|Death|0|||
130730360|NCT03207867|470633758|FG005|Overall Study|Death|1|||
130730361|NCT03207867|470633759|FG006|Overall Study|Death|0|||
130730362|NCT03207867|470633760|FG007|Overall Study|Death|3|||
130730363|NCT03207867|470633761|FG008|Overall Study|Death|1|||
130730364|NCT03207867|470633762|FG009|Overall Study|Death|2|||
130730365|NCT03207867|470633763|FG010|Overall Study|Death|0|||
130730366|NCT03207867|470633764|FG011|Overall Study|Death|1|||
130730367|NCT03207867|470633765|FG012|Overall Study|Death|0|||
131171692|NCT02065622|472248431|FG003|Induction Study|Lost to Follow-up|0|||
131171693|NCT02065622|472248432|FG004|Induction Study|Lost to Follow-up|0|||
131171694|NCT02065622|472248428|FG000|Induction Study|Lack of Efficacy|22|||
131171695|NCT02065622|472248429|FG001|Induction Study|Lack of Efficacy|27|||
131171696|NCT02065622|472248430|FG002|Induction Study|Lack of Efficacy|0|||
131171697|NCT02065622|472248431|FG003|Induction Study|Lack of Efficacy|0|||
131171698|NCT02065622|472248432|FG004|Induction Study|Lack of Efficacy|0|||
131171699|NCT02065622|472248428|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
131171700|NCT02065622|472248429|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
131171701|NCT02065622|472248430|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
130730368|NCT03207867|470633766|FG013|Overall Study|Death|1|||
131171702|NCT02065622|472248431|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
130730369|NCT03207867|470633767|FG014|Overall Study|Death|0|||
130730370|NCT03207867|470633768|FG015|Overall Study|Death|0|||
130730371|NCT03207867|470633769|FG016|Overall Study|Death|0|||
130730372|NCT03207867|470633770|FG017|Overall Study|Death|2|||
130730373|NCT03207867|470633771|FG018|Overall Study|Death|0|||
131171703|NCT02065622|472248432|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
130730374|NCT03207867|470633772|FG019|Overall Study|Death|1|||
130730375|NCT03207867|470633773|FG020|Overall Study|Death|0|||
130730376|NCT03207867|470633774|FG021|Overall Study|Death|0|||
130781405|NCT01656395|470827431|FG002|Overall Study|Adverse Event|5|||
130781406|NCT01656395|470827432|FG003|Overall Study|Adverse Event|4|||
130781407|NCT01656395|470827433|FG004|Overall Study|Adverse Event|5|||
130781408|NCT01656395|470827434|FG005|Overall Study|Adverse Event|7|||
130781409|NCT01656395|470827435|FG006|Overall Study|Adverse Event|0|||
130781410|NCT01656395|470827436|FG007|Overall Study|Adverse Event|0|||
130781411|NCT01656395|470827429|FG000|Overall Study|Lack of Efficacy|1|||
131171704|NCT02065622|472248428|FG000|Induction Study|Subject Noncompliance|1|||
131171705|NCT02065622|472248429|FG001|Induction Study|Subject Noncompliance|1|||
131171706|NCT02065622|472248430|FG002|Induction Study|Subject Noncompliance|0|||
131171707|NCT02065622|472248431|FG003|Induction Study|Subject Noncompliance|0|||
131171708|NCT02065622|472248432|FG004|Induction Study|Subject Noncompliance|0|||
131171709|NCT02065622|472248428|FG000|Induction Study|Other, Not Specified|3|||
131171710|NCT02065622|472248429|FG001|Induction Study|Other, Not Specified|2|||
131171711|NCT02065622|472248430|FG002|Induction Study|Other, Not Specified|0|||
131171712|NCT02065622|472248431|FG003|Induction Study|Other, Not Specified|0|||
131171713|NCT02065622|472248432|FG004|Induction Study|Other, Not Specified|0|||
131171714|NCT02065622|472248428|FG000|Maintenance Study|Adverse Event|0|||
130730377|NCT03207867|470633775|FG022|Overall Study|Death|0|||
130730378|NCT03207867|470633776|FG023|Overall Study|Death|0|||
130730379|NCT03207867|470633753|FG000|Overall Study|Physician Decision|3|||
130730380|NCT03207867|470633754|FG001|Overall Study|Physician Decision|5|||
130730381|NCT03207867|470633755|FG002|Overall Study|Physician Decision|0|||
130730382|NCT03207867|470633756|FG003|Overall Study|Physician Decision|3|||
130730383|NCT03207867|470633757|FG004|Overall Study|Physician Decision|2|||
130730384|NCT03207867|470633758|FG005|Overall Study|Physician Decision|0|||
130730385|NCT03207867|470633759|FG006|Overall Study|Physician Decision|0|||
130730386|NCT03207867|470633760|FG007|Overall Study|Physician Decision|0|||
130730387|NCT03207867|470633761|FG008|Overall Study|Physician Decision|4|||
130730388|NCT03207867|470633762|FG009|Overall Study|Physician Decision|2|||
130730389|NCT03207867|470633763|FG010|Overall Study|Physician Decision|0|||
130730390|NCT03207867|470633764|FG011|Overall Study|Physician Decision|4|||
130730391|NCT03207867|470633765|FG012|Overall Study|Physician Decision|0|||
130730392|NCT03207867|470633766|FG013|Overall Study|Physician Decision|0|||
131171715|NCT02065622|472248429|FG001|Maintenance Study|Adverse Event|0|||
131171716|NCT02065622|472248430|FG002|Maintenance Study|Adverse Event|25|||
131171717|NCT02065622|472248431|FG003|Maintenance Study|Adverse Event|22|||
131171718|NCT02065622|472248432|FG004|Maintenance Study|Adverse Event|11|||
131171719|NCT02065622|472248428|FG000|Maintenance Study|Withdrawal by Subject|0|||
131171720|NCT02065622|472248429|FG001|Maintenance Study|Withdrawal by Subject|0|||
131171721|NCT02065622|472248430|FG002|Maintenance Study|Withdrawal by Subject|11|||
131171722|NCT02065622|472248431|FG003|Maintenance Study|Withdrawal by Subject|5|||
131171723|NCT02065622|472248432|FG004|Maintenance Study|Withdrawal by Subject|7|||
131171724|NCT02065622|472248428|FG000|Maintenance Study|Lost to Follow-up|0|||
131171725|NCT02065622|472248429|FG001|Maintenance Study|Lost to Follow-up|0|||
131171726|NCT02065622|472248430|FG002|Maintenance Study|Lost to Follow-up|4|||
131171727|NCT02065622|472248431|FG003|Maintenance Study|Lost to Follow-up|1|||
131171728|NCT02065622|472248432|FG004|Maintenance Study|Lost to Follow-up|1|||
131171729|NCT02065622|472248428|FG000|Maintenance Study|Lack of Efficacy|0|||
131171730|NCT02065622|472248429|FG001|Maintenance Study|Lack of Efficacy|0|||
131171731|NCT02065622|472248430|FG002|Maintenance Study|Lack of Efficacy|70|||
131171732|NCT02065622|472248431|FG003|Maintenance Study|Lack of Efficacy|55|||
131171733|NCT02065622|472248432|FG004|Maintenance Study|Lack of Efficacy|19|||
131171734|NCT02065622|472248428|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
131171735|NCT02065622|472248429|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
131171736|NCT02065622|472248430|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
131171737|NCT02065622|472248431|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
131171738|NCT02065622|472248432|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
131171739|NCT02065622|472248428|FG000|Maintenance Study|Subject Non-Compliance|0|||
131171740|NCT02065622|472248429|FG001|Maintenance Study|Subject Non-Compliance|0|||
131171741|NCT02065622|472248430|FG002|Maintenance Study|Subject Non-Compliance|1|||
131171742|NCT02065622|472248431|FG003|Maintenance Study|Subject Non-Compliance|3|||
131171743|NCT02065622|472248432|FG004|Maintenance Study|Subject Non-Compliance|2|||
131171744|NCT02065622|472248428|FG000|Maintenance Study|Other, Not Specified|0|||
131171745|NCT02065622|472248429|FG001|Maintenance Study|Other, Not Specified|0|||
130730393|NCT03207867|470633767|FG014|Overall Study|Physician Decision|2|||
130730394|NCT03207867|470633768|FG015|Overall Study|Physician Decision|1|||
130730395|NCT03207867|470633769|FG016|Overall Study|Physician Decision|1|||
130730396|NCT03207867|470633770|FG017|Overall Study|Physician Decision|2|||
130781412|NCT01656395|470827430|FG001|Overall Study|Lack of Efficacy|8|||
130781413|NCT01656395|470827431|FG002|Overall Study|Lack of Efficacy|6|||
130781414|NCT01656395|470827432|FG003|Overall Study|Lack of Efficacy|1|||
131171746|NCT02065622|472248430|FG002|Maintenance Study|Other, Not Specified|6|||
131171747|NCT02065622|472248431|FG003|Maintenance Study|Other, Not Specified|14|||
131171748|NCT02065622|472248432|FG004|Maintenance Study|Other, Not Specified|2|||
131171749|NCT02065622|472248428|FG000|Maintenance Study|Unknown Reason|0|||
131171750|NCT02065622|472248429|FG001|Maintenance Study|Unknown Reason|0|||
130781415|NCT01656395|470827433|FG004|Overall Study|Lack of Efficacy|1|||
130781416|NCT01656395|470827434|FG005|Overall Study|Lack of Efficacy|6|||
130781417|NCT01656395|470827435|FG006|Overall Study|Lack of Efficacy|0|||
130781418|NCT01656395|470827436|FG007|Overall Study|Lack of Efficacy|0|||
130781419|NCT01656395|470827429|FG000|Overall Study|Lost to Follow-up|1|||
130781420|NCT01656395|470827430|FG001|Overall Study|Lost to Follow-up|0|||
130781421|NCT01656395|470827431|FG002|Overall Study|Lost to Follow-up|0|||
130781422|NCT01656395|470827432|FG003|Overall Study|Lost to Follow-up|0|||
130781423|NCT01656395|470827433|FG004|Overall Study|Lost to Follow-up|0|||
130781424|NCT01656395|470827434|FG005|Overall Study|Lost to Follow-up|0|||
130781425|NCT01656395|470827435|FG006|Overall Study|Lost to Follow-up|0|||
130781426|NCT01656395|470827436|FG007|Overall Study|Lost to Follow-up|0|||
130781427|NCT01656395|470827429|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130781428|NCT01656395|470827430|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130781429|NCT01656395|470827431|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130781430|NCT01656395|470827432|FG003|Overall Study|Non-Compliance with Study Drug|0|||
130781431|NCT01656395|470827433|FG004|Overall Study|Non-Compliance with Study Drug|1|||
130781432|NCT01656395|470827434|FG005|Overall Study|Non-Compliance with Study Drug|1|||
130781433|NCT01656395|470827435|FG006|Overall Study|Non-Compliance with Study Drug|0|||
130781434|NCT01656395|470827436|FG007|Overall Study|Non-Compliance with Study Drug|0|||
130781435|NCT01656395|470827429|FG000|Overall Study|Other|0|||
130781436|NCT01656395|470827430|FG001|Overall Study|Other|0|||
130781437|NCT01656395|470827431|FG002|Overall Study|Other|1|||
130781438|NCT01656395|470827432|FG003|Overall Study|Other|0|||
130781439|NCT01656395|470827433|FG004|Overall Study|Other|0|||
130781440|NCT01656395|470827434|FG005|Overall Study|Other|1|||
130781441|NCT01656395|470827435|FG006|Overall Study|Other|0|||
130781442|NCT01656395|470827436|FG007|Overall Study|Other|0|||
130781443|NCT01656395|470827429|FG000|Overall Study|Physician Decision|2|||
130781444|NCT01656395|470827430|FG001|Overall Study|Physician Decision|3|||
130781445|NCT01656395|470827431|FG002|Overall Study|Physician Decision|3|||
130781446|NCT01656395|470827432|FG003|Overall Study|Physician Decision|2|||
130781447|NCT01656395|470827433|FG004|Overall Study|Physician Decision|3|||
130781448|NCT01656395|470827434|FG005|Overall Study|Physician Decision|3|||
130781449|NCT01656395|470827435|FG006|Overall Study|Physician Decision|0|||
130781450|NCT01656395|470827436|FG007|Overall Study|Physician Decision|0|||
130781451|NCT01656395|470827429|FG000|Overall Study|Pregnancy|0|||
130781452|NCT01656395|470827430|FG001|Overall Study|Pregnancy|0|||
130781453|NCT01656395|470827431|FG002|Overall Study|Pregnancy|1|||
130781454|NCT01656395|470827432|FG003|Overall Study|Pregnancy|0|||
130781455|NCT01656395|470827433|FG004|Overall Study|Pregnancy|0|||
130781456|NCT01656395|470827434|FG005|Overall Study|Pregnancy|0|||
131171751|NCT02065622|472248430|FG002|Maintenance Study|Unknown Reason|0|||
131171752|NCT02065622|472248431|FG003|Maintenance Study|Unknown Reason|1|||
131171753|NCT02065622|472248432|FG004|Maintenance Study|Unknown Reason|0|||
131171754|NCT01687413|472248433|FG000|Overall Study|Withdrawal by Subject|0|||
131171755|NCT01687413|472248434|FG001|Overall Study|Withdrawal by Subject|2|||
131171756|NCT01687413|472248433|FG000|Overall Study|Not eligible|0|||
131171757|NCT01687413|472248434|FG001|Overall Study|Not eligible|2|||
131171758|NCT01687413|472248433|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
131171759|NCT01687413|472248434|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
131171760|NCT01767194|472248437|FG000|Overall Study|Adverse Event|1|||
131171761|NCT01767194|472248438|FG001|Overall Study|Adverse Event|1|||
131171762|NCT01767194|472248437|FG000|Overall Study|Death|0|||
131171763|NCT01767194|472248438|FG001|Overall Study|Death|1|||
131171764|NCT01767194|472248437|FG000|Overall Study|Lack of Efficacy|12|||
131171765|NCT01767194|472248438|FG001|Overall Study|Lack of Efficacy|11|||
131171766|NCT01767194|472248437|FG000|Overall Study|Physician Decision|2|||
131171767|NCT01767194|472248438|FG001|Overall Study|Physician Decision|23|||
131171768|NCT01767194|472248437|FG000|Overall Study|Withdrawal by Subject|0|||
131171769|NCT01767194|472248438|FG001|Overall Study|Withdrawal by Subject|1|||
131171770|NCT01767194|472248437|FG000|Overall Study|Ineligible|1|||
131171771|NCT01767194|472248438|FG001|Overall Study|Ineligible|1|||
131171772|NCT01767194|472248437|FG000|Overall Study|Refusal by patient/parent|2|||
131171773|NCT01767194|472248438|FG001|Overall Study|Refusal by patient/parent|4|||
131171774|NCT01767194|472248437|FG000|Overall Study|Criteria not met on time for next cycle|0|||
131171775|NCT01767194|472248438|FG001|Overall Study|Criteria not met on time for next cycle|1|||
130781457|NCT01656395|470827435|FG006|Overall Study|Pregnancy|0|||
130781458|NCT01656395|470827436|FG007|Overall Study|Pregnancy|0|||
130781459|NCT01656395|470827429|FG000|Overall Study|Progressive Disease|0|||
130781460|NCT01656395|470827430|FG001|Overall Study|Progressive Disease|0|||
130781461|NCT01656395|470827431|FG002|Overall Study|Progressive Disease|0|||
130781462|NCT01656395|470827432|FG003|Overall Study|Progressive Disease|0|||
130781463|NCT01656395|470827433|FG004|Overall Study|Progressive Disease|0|||
130781464|NCT01656395|470827434|FG005|Overall Study|Progressive Disease|1|||
130781465|NCT01656395|470827435|FG006|Overall Study|Progressive Disease|0|||
131171776|NCT04973228|472248439|FG000|Overall Study|Adverse Event|2|||
131171777|NCT04973228|472248440|FG001|Overall Study|Adverse Event|3|||
131171778|NCT04973228|472248439|FG000|Overall Study|Lack of Efficacy|1|||
131171779|NCT04973228|472248440|FG001|Overall Study|Lack of Efficacy|3|||
131235923|NCT02207231|472493170|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
130730397|NCT03207867|470633771|FG018|Overall Study|Physician Decision|1|||
130730398|NCT03207867|470633772|FG019|Overall Study|Physician Decision|3|||
130730399|NCT03207867|470633773|FG020|Overall Study|Physician Decision|0|||
130730400|NCT03207867|470633774|FG021|Overall Study|Physician Decision|0|||
130730401|NCT03207867|470633775|FG022|Overall Study|Physician Decision|0|||
130730402|NCT03207867|470633776|FG023|Overall Study|Physician Decision|0|||
130730403|NCT03207867|470633753|FG000|Overall Study|Progressive Disease|7|||
130730404|NCT03207867|470633754|FG001|Overall Study|Progressive Disease|7|||
130730405|NCT03207867|470633755|FG002|Overall Study|Progressive Disease|9|||
130730406|NCT03207867|470633756|FG003|Overall Study|Progressive Disease|10|||
130730407|NCT03207867|470633757|FG004|Overall Study|Progressive Disease|11|||
130730408|NCT03207867|470633758|FG005|Overall Study|Progressive Disease|10|||
130730409|NCT03207867|470633759|FG006|Overall Study|Progressive Disease|9|||
130730410|NCT03207867|470633760|FG007|Overall Study|Progressive Disease|8|||
130730411|NCT03207867|470633761|FG008|Overall Study|Progressive Disease|19|||
130730412|NCT03207867|470633762|FG009|Overall Study|Progressive Disease|23|||
130730413|NCT03207867|470633763|FG010|Overall Study|Progressive Disease|2|||
130730414|NCT03207867|470633764|FG011|Overall Study|Progressive Disease|24|||
130730415|NCT03207867|470633765|FG012|Overall Study|Progressive Disease|3|||
130730416|NCT03207867|470633766|FG013|Overall Study|Progressive Disease|11|||
130730417|NCT03207867|470633767|FG014|Overall Study|Progressive Disease|9|||
130730418|NCT03207867|470633768|FG015|Overall Study|Progressive Disease|5|||
130730419|NCT03207867|470633769|FG016|Overall Study|Progressive Disease|10|||
130730420|NCT03207867|470633770|FG017|Overall Study|Progressive Disease|14|||
130730421|NCT03207867|470633771|FG018|Overall Study|Progressive Disease|13|||
130730422|NCT03207867|470633772|FG019|Overall Study|Progressive Disease|14|||
130730423|NCT03207867|470633773|FG020|Overall Study|Progressive Disease|6|||
130730424|NCT03207867|470633774|FG021|Overall Study|Progressive Disease|3|||
130730425|NCT03207867|470633775|FG022|Overall Study|Progressive Disease|3|||
130730426|NCT03207867|470633776|FG023|Overall Study|Progressive Disease|3|||
130730427|NCT03207867|470633753|FG000|Overall Study|Patient/guardian Decision|0|||
130730428|NCT03207867|470633754|FG001|Overall Study|Patient/guardian Decision|0|||
130730429|NCT03207867|470633755|FG002|Overall Study|Patient/guardian Decision|1|||
130730430|NCT03207867|470633756|FG003|Overall Study|Patient/guardian Decision|1|||
130730431|NCT03207867|470633757|FG004|Overall Study|Patient/guardian Decision|1|||
130730432|NCT03207867|470633758|FG005|Overall Study|Patient/guardian Decision|2|||
130730433|NCT03207867|470633759|FG006|Overall Study|Patient/guardian Decision|1|||
130730434|NCT03207867|470633760|FG007|Overall Study|Patient/guardian Decision|0|||
130730435|NCT03207867|470633761|FG008|Overall Study|Patient/guardian Decision|1|||
130730436|NCT03207867|470633762|FG009|Overall Study|Patient/guardian Decision|0|||
130730437|NCT03207867|470633763|FG010|Overall Study|Patient/guardian Decision|0|||
130730438|NCT03207867|470633764|FG011|Overall Study|Patient/guardian Decision|1|||
130730439|NCT03207867|470633765|FG012|Overall Study|Patient/guardian Decision|0|||
130730440|NCT03207867|470633766|FG013|Overall Study|Patient/guardian Decision|1|||
130730441|NCT03207867|470633767|FG014|Overall Study|Patient/guardian Decision|2|||
130730442|NCT03207867|470633768|FG015|Overall Study|Patient/guardian Decision|0|||
130730443|NCT03207867|470633769|FG016|Overall Study|Patient/guardian Decision|1|||
130730444|NCT03207867|470633770|FG017|Overall Study|Patient/guardian Decision|3|||
130730445|NCT03207867|470633771|FG018|Overall Study|Patient/guardian Decision|4|||
130730446|NCT03207867|470633772|FG019|Overall Study|Patient/guardian Decision|1|||
130730447|NCT03207867|470633773|FG020|Overall Study|Patient/guardian Decision|0|||
130730448|NCT03207867|470633774|FG021|Overall Study|Patient/guardian Decision|0|||
130730449|NCT03207867|470633775|FG022|Overall Study|Patient/guardian Decision|0|||
130730450|NCT03207867|470633776|FG023|Overall Study|Patient/guardian Decision|0|||
130730451|NCT02447744|470633777|FG000|Overall Study|Withdrawal by Subject|3|||
130730452|NCT02447744|470633778|FG001|Overall Study|Withdrawal by Subject|1|||
130730453|NCT02447744|470633777|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
130730454|NCT02447744|470633778|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
130730455|NCT00912912|470633779|FG000|Overall Study|Withdrawal by Subject|1|||
130730456|NCT00912912|470633779|FG000|Overall Study|Disease Progression|3|||
130730457|NCT00306995|470633780|FG000|Study Part I|Withdrawal by Subject|0|||
130730458|NCT00306995|470633781|FG001|Study Part I|Withdrawal by Subject|0|||
130730459|NCT00306995|470633782|FG002|Study Part I|Withdrawal by Subject|0|||
130730460|NCT00306995|470633783|FG003|Study Part I|Withdrawal by Subject|0|||
130730461|NCT00306995|470633784|FG004|Study Part I|Withdrawal by Subject|0|||
130730462|NCT00306995|470633785|FG005|Study Part I|Withdrawal by Subject|0|||
130730463|NCT00306995|470633786|FG006|Study Part I|Withdrawal by Subject|1|||
130730464|NCT00306995|470633780|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
130730465|NCT00306995|470633781|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
130730466|NCT00306995|470633782|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
130730467|NCT00306995|470633783|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
130730468|NCT00306995|470633784|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
130730469|NCT00306995|470633785|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
130730470|NCT00306995|470633786|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
130781466|NCT01656395|470827436|FG007|Overall Study|Progressive Disease|0|||
131171780|NCT04973228|472248439|FG000|Overall Study|Lost to Follow-up|12|||
131171781|NCT04973228|472248440|FG001|Overall Study|Lost to Follow-up|4|||
131171782|NCT04973228|472248439|FG000|Overall Study|Withdrawal by Subject|11|||
131171783|NCT04973228|472248440|FG001|Overall Study|Withdrawal by Subject|4|||
131171784|NCT04973228|472248439|FG000|Overall Study|Did not tolerate application|1|||
131171785|NCT04973228|472248440|FG001|Overall Study|Did not tolerate application|0|||
131171786|NCT04973228|472248439|FG000|Overall Study|Wanted to early terminate and use own product|0|||
131171787|NCT04973228|472248440|FG001|Overall Study|Wanted to early terminate and use own product|1|||
131171788|NCT04973228|472248439|FG000|Overall Study|Missed visits due to new work schedule|1|||
131171789|NCT04973228|472248440|FG001|Overall Study|Missed visits due to new work schedule|0|||
131171790|NCT00406640|472248456|FG000|Acute Phase|Adverse Event|18|||
131171791|NCT00406640|472248457|FG001|Acute Phase|Adverse Event|13|||
131171792|NCT00406640|472248456|FG000|Acute Phase|Failed to Return|5|||
131171793|NCT00406640|472248457|FG001|Acute Phase|Failed to Return|1|||
131171794|NCT00406640|472248456|FG000|Acute Phase|Physician Decision|0|||
131171795|NCT00406640|472248457|FG001|Acute Phase|Physician Decision|1|||
131171796|NCT00406640|472248456|FG000|Acute Phase|Lost to Follow-up|7|||
131171797|NCT00406640|472248457|FG001|Acute Phase|Lost to Follow-up|4|||
131171798|NCT00406640|472248456|FG000|Acute Phase|Protocol deviation|4|||
131171799|NCT00406640|472248457|FG001|Acute Phase|Protocol deviation|10|||
131171800|NCT00406640|472248456|FG000|Acute Phase|Protocol Violation|3|||
131171801|NCT00406640|472248457|FG001|Acute Phase|Protocol Violation|2|||
131171802|NCT00406640|472248456|FG000|Acute Phase|Withdrawal by Subject|11|||
131171803|NCT00406640|472248457|FG001|Acute Phase|Withdrawal by Subject|9|||
131171804|NCT00406640|472248456|FG000|Acute Phase|Lack of Efficacy|3|||
131171805|NCT00406640|472248457|FG001|Acute Phase|Lack of Efficacy|3|||
131171806|NCT00406640|472248456|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
131171807|NCT00406640|472248457|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
131171808|NCT00406640|472248456|FG000|DB Continuation Phase for Responders|Death|1|||
131171809|NCT00406640|472248457|FG001|DB Continuation Phase for Responders|Death|0|||
131171810|NCT00406640|472248456|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
131171811|NCT00406640|472248457|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
131171812|NCT00406640|472248456|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
131171813|NCT00406640|472248457|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
131171814|NCT00406640|472248456|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
131171815|NCT00406640|472248457|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
131171816|NCT00406640|472248456|FG000|DB Continuation Phase for Responders|non-compliance|7|||
131171817|NCT00406640|472248457|FG001|DB Continuation Phase for Responders|non-compliance|5|||
131171818|NCT00406640|472248456|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
131171819|NCT00406640|472248457|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
131171820|NCT00406640|472248456|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
131171821|NCT00406640|472248457|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
131171822|NCT00406640|472248456|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
131171823|NCT00406640|472248457|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
131171824|NCT00406640|472248456|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
131171825|NCT00406640|472248457|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
131171826|NCT00406640|472248456|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
131171827|NCT00406640|472248457|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
131171828|NCT00406640|472248456|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
131171829|NCT00406640|472248457|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
131171830|NCT00406640|472248456|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
131171831|NCT00406640|472248457|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
131171832|NCT00406640|472248456|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
131171833|NCT00406640|472248457|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
131171834|NCT00406640|472248456|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
131171835|NCT00406640|472248457|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
131171836|NCT00406640|472248456|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
131171837|NCT00406640|472248457|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
131171838|NCT01454401|472248458|FG000|Overall Study|Death|1|||
131171839|NCT01454401|472248458|FG000|Overall Study|hospitalised|1|||
131171840|NCT01454401|472248458|FG000|Overall Study|osteomyelitis|2|||
131171841|NCT01454401|472248458|FG000|Overall Study|non-adherence|1|||
131171842|NCT00755846|472250419|FG000|Overall Study|Adverse Event|0|||
131171843|NCT00755846|472250420|FG001|Overall Study|Adverse Event|0|||
131171844|NCT00755846|472250421|FG002|Overall Study|Adverse Event|0|||
131171845|NCT00755846|472250422|FG003|Overall Study|Adverse Event|1|||
131171846|NCT00755846|472250423|FG004|Overall Study|Adverse Event|3|||
131171847|NCT00755846|472250424|FG005|Overall Study|Adverse Event|2|||
131171848|NCT00755846|472250419|FG000|Overall Study|Protocol Violation|1|||
131171849|NCT00755846|472250420|FG001|Overall Study|Protocol Violation|1|||
131171850|NCT00755846|472250421|FG002|Overall Study|Protocol Violation|1|||
131171851|NCT00755846|472250422|FG003|Overall Study|Protocol Violation|1|||
130781467|NCT01656395|470827429|FG000|Overall Study|Protocol Violation|6|||
130781468|NCT01656395|470827430|FG001|Overall Study|Protocol Violation|6|||
130781469|NCT01656395|470827431|FG002|Overall Study|Protocol Violation|9|||
130781470|NCT01656395|470827432|FG003|Overall Study|Protocol Violation|2|||
130781471|NCT01656395|470827433|FG004|Overall Study|Protocol Violation|4|||
130781472|NCT01656395|470827434|FG005|Overall Study|Protocol Violation|10|||
130781473|NCT01656395|470827435|FG006|Overall Study|Protocol Violation|0|||
130781474|NCT01656395|470827436|FG007|Overall Study|Protocol Violation|0|||
130781475|NCT01656395|470827429|FG000|Overall Study|Screen Failure|2|||
130781476|NCT01656395|470827430|FG001|Overall Study|Screen Failure|1|||
130781477|NCT01656395|470827431|FG002|Overall Study|Screen Failure|7|||
130781478|NCT01656395|470827432|FG003|Overall Study|Screen Failure|1|||
130781479|NCT01656395|470827433|FG004|Overall Study|Screen Failure|0|||
130781480|NCT01656395|470827434|FG005|Overall Study|Screen Failure|8|||
130781481|NCT01656395|470827435|FG006|Overall Study|Screen Failure|0|||
130781482|NCT01656395|470827436|FG007|Overall Study|Screen Failure|0|||
130781483|NCT01656395|470827429|FG000|Overall Study|Withdrawal by Subject|3|||
130781484|NCT01656395|470827430|FG001|Overall Study|Withdrawal by Subject|1|||
130781485|NCT01656395|470827431|FG002|Overall Study|Withdrawal by Subject|4|||
130781486|NCT01656395|470827432|FG003|Overall Study|Withdrawal by Subject|2|||
130781487|NCT01656395|470827433|FG004|Overall Study|Withdrawal by Subject|0|||
130781488|NCT01656395|470827434|FG005|Overall Study|Withdrawal by Subject|3|||
130781489|NCT01656395|470827435|FG006|Overall Study|Withdrawal by Subject|0|||
130781490|NCT01656395|470827436|FG007|Overall Study|Withdrawal by Subject|0|||
130781491|NCT03075267|470827437|FG000|Overall Study|Protocol Violation|1|||
130781492|NCT03075267|470827438|FG001|Overall Study|Protocol Violation|0|||
130781493|NCT03075267|470827439|FG002|Overall Study|Protocol Violation|0|||
130781494|NCT00676403|470827440|FG000|Overall Study|Adverse Event|1|||
131171852|NCT00755846|472250423|FG004|Overall Study|Protocol Violation|1|||
131171853|NCT00755846|472250424|FG005|Overall Study|Protocol Violation|1|||
131171854|NCT00755846|472250419|FG000|Overall Study|Lost to Follow-up|0|||
131171855|NCT00755846|472250420|FG001|Overall Study|Lost to Follow-up|2|||
131171856|NCT00755846|472250421|FG002|Overall Study|Lost to Follow-up|1|||
131171857|NCT00755846|472250422|FG003|Overall Study|Lost to Follow-up|0|||
131171858|NCT00755846|472250423|FG004|Overall Study|Lost to Follow-up|4|||
131171859|NCT00755846|472250424|FG005|Overall Study|Lost to Follow-up|2|||
131171860|NCT00755846|472250419|FG000|Overall Study|Withdrawal by Subject|2|||
131171861|NCT00755846|472250420|FG001|Overall Study|Withdrawal by Subject|3|||
131171862|NCT00755846|472250421|FG002|Overall Study|Withdrawal by Subject|5|||
131171863|NCT00755846|472250422|FG003|Overall Study|Withdrawal by Subject|2|||
131171864|NCT00755846|472250423|FG004|Overall Study|Withdrawal by Subject|0|||
131171865|NCT00755846|472250424|FG005|Overall Study|Withdrawal by Subject|1|||
131171866|NCT00755846|472250419|FG000|Overall Study|Hyperglycemic Rescue|21|||
131171867|NCT00755846|472250420|FG001|Overall Study|Hyperglycemic Rescue|7|||
131171868|NCT00755846|472250421|FG002|Overall Study|Hyperglycemic Rescue|5|||
131171869|NCT00755846|472250422|FG003|Overall Study|Hyperglycemic Rescue|8|||
131171870|NCT00755846|472250423|FG004|Overall Study|Hyperglycemic Rescue|8|||
131171871|NCT00755846|472250424|FG005|Overall Study|Hyperglycemic Rescue|7|||
131171872|NCT00755846|472250419|FG000|Overall Study|Physician Decision|1|||
131171873|NCT00755846|472250420|FG001|Overall Study|Physician Decision|3|||
131171874|NCT00755846|472250421|FG002|Overall Study|Physician Decision|0|||
131171875|NCT00755846|472250422|FG003|Overall Study|Physician Decision|1|||
131171876|NCT00755846|472250423|FG004|Overall Study|Physician Decision|0|||
131171877|NCT00755846|472250424|FG005|Overall Study|Physician Decision|1|||
130781495|NCT00676403|470827441|FG001|Overall Study|Adverse Event|2|||
130781496|NCT00676403|470827442|FG002|Overall Study|Adverse Event|0|||
130781497|NCT00676403|470827443|FG003|Overall Study|Adverse Event|5|||
131171878|NCT00755846|472250419|FG000|Overall Study|Administrative Error|0|||
131171879|NCT00755846|472250420|FG001|Overall Study|Administrative Error|1|||
131171880|NCT00755846|472250421|FG002|Overall Study|Administrative Error|0|||
131171881|NCT00755846|472250422|FG003|Overall Study|Administrative Error|0|||
131171882|NCT00755846|472250423|FG004|Overall Study|Administrative Error|0|||
131171883|NCT00755846|472250424|FG005|Overall Study|Administrative Error|0|||
131171884|NCT00755846|472250419|FG000|Overall Study|Participant Non-compliance|0|||
131171885|NCT00755846|472250420|FG001|Overall Study|Participant Non-compliance|0|||
131171886|NCT00755846|472250421|FG002|Overall Study|Participant Non-compliance|0|||
131171887|NCT00755846|472250422|FG003|Overall Study|Participant Non-compliance|0|||
131171888|NCT00755846|472250423|FG004|Overall Study|Participant Non-compliance|1|||
131171889|NCT00755846|472250424|FG005|Overall Study|Participant Non-compliance|0|||
130781498|NCT00676403|470827444|FG004|Overall Study|Adverse Event|1|||
131171890|NCT00352755|472250425|FG000|Overall Study|Physician Decision|1|||
131171891|NCT00352755|472250425|FG000|Overall Study|Adverse Event|1|||
131171892|NCT02429258|472250428|FG000|Overall Study|Withdrawal by Subject|2|||
130781499|NCT00676403|470827445|FG005|Overall Study|Adverse Event|2|||
131171893|NCT02429258|472250429|FG001|Overall Study|Withdrawal by Subject|0|||
131171894|NCT02429258|472250428|FG000|Overall Study|Protocol Violation|0|||
130781500|NCT00676403|470827440|FG000|Overall Study|Lost to Follow-up|0|||
130781501|NCT00676403|470827441|FG001|Overall Study|Lost to Follow-up|0|||
131171895|NCT02429258|472250429|FG001|Overall Study|Protocol Violation|1|||
130730471|NCT05422625|470633787|FG000|Overall Study|Withdrawal by Subject|1|||
130730472|NCT05422625|470633788|FG001|Overall Study|Withdrawal by Subject|0|||
130730473|NCT04324073|470635538|FG000|Overall Study|withdrew consent|0|||
130730474|NCT04324073|470635539|FG001|Overall Study|withdrew consent|4|||
130730475|NCT04324073|470635540|FG002|Overall Study|withdrew consent|2|||
130730476|NCT04324073|470635541|FG003|Overall Study|withdrew consent|8|||
130730477|NCT06400238|470635546|FG000|Overall Study|Started Protocol Therapy|2|||
130730478|NCT06400238|470635546|FG000|Overall Study|Adverse Event|1|||
130730479|NCT06400238|470635546|FG000|Overall Study|Death|1|||
130730480|NCT06400238|470635546|FG000|Overall Study|Disease Progression|27|||
130730481|NCT06400238|470635546|FG000|Overall Study|Withdrawal by Subject|2|||
130730482|NCT06400238|470635546|FG000|Overall Study|Physician Decision|2|||
130730483|NCT01277601|470635549|FG000|Overall Study|Adverse Event|5|||
131171896|NCT02397694|472250430|FG000|Double-Blinded Phase|Adverse Event|1|||
131171897|NCT02397694|472250431|FG001|Double-Blinded Phase|Adverse Event|0|||
131171898|NCT02397694|472250430|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
131171899|NCT02397694|472250431|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
131171900|NCT02397694|472250430|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
131171901|NCT02397694|472250431|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
131171902|NCT02397694|472250430|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
131171903|NCT02397694|472250431|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
131171904|NCT02397694|472250430|FG000|Open Label Extension Phase|Protocol Violation|1|||
131171905|NCT02397694|472250431|FG001|Open Label Extension Phase|Protocol Violation|0|||
131171906|NCT02397694|472250430|FG000|Open Label Extension Phase|Withdrew Consent|3|||
131171907|NCT02397694|472250431|FG001|Open Label Extension Phase|Withdrew Consent|1|||
131171908|NCT02397694|472250430|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
131171909|NCT02397694|472250431|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
131171910|NCT01694420|472250433|FG000|Overall Study|Lost to Follow-up|3|||
131171911|NCT02670915|472250436|FG000|Overall Study|Withdrawal by Subject|0|||
131171912|NCT02670915|472250437|FG001|Overall Study|Withdrawal by Subject|1|||
131171913|NCT02670915|472250438|FG002|Overall Study|Withdrawal by Subject|4|||
131171914|NCT02670915|472250436|FG000|Overall Study|Withdrawal by parent/guardian|4|||
131171915|NCT02670915|472250437|FG001|Overall Study|Withdrawal by parent/guardian|4|||
131171916|NCT02670915|472250438|FG002|Overall Study|Withdrawal by parent/guardian|1|||
131171917|NCT02670915|472250436|FG000|Overall Study|Unclassified|0|||
131171918|NCT02670915|472250437|FG001|Overall Study|Unclassified|3|||
131171919|NCT02670915|472250438|FG002|Overall Study|Unclassified|0|||
131171920|NCT00818207|472250439|FG000|Overall Study|Adverse Event|6|||
131171921|NCT00818207|472250440|FG001|Overall Study|Adverse Event|0|||
131171922|NCT00818207|472250439|FG000|Overall Study|Lost to Follow-up|160|||
131171923|NCT00818207|472250440|FG001|Overall Study|Lost to Follow-up|146|||
131171924|NCT00818207|472250439|FG000|Overall Study|Multiple reasons|11|||
131171925|NCT00818207|472250440|FG001|Overall Study|Multiple reasons|12|||
131171926|NCT00818207|472250439|FG000|Overall Study|Withdrawal by Subject|42|||
131171927|NCT00818207|472250440|FG001|Overall Study|Withdrawal by Subject|104|||
131171928|NCT00818207|472250439|FG000|Overall Study|Death|3|||
131171929|NCT00818207|472250440|FG001|Overall Study|Death|5|||
131171930|NCT02616185|472250441|FG000|Overall Study|Death|0|||
131171931|NCT02616185|472250442|FG001|Overall Study|Death|0|||
131171932|NCT02616185|472250443|FG002|Overall Study|Death|0|||
131171933|NCT02616185|472250444|FG003|Overall Study|Death|1|||
131171934|NCT02616185|472250445|FG004|Overall Study|Death|2|||
131171935|NCT02616185|472250446|FG005|Overall Study|Death|0|||
131171936|NCT02616185|472250447|FG006|Overall Study|Death|0|||
131171937|NCT02616185|472250448|FG007|Overall Study|Death|2|||
131171938|NCT02616185|472250449|FG008|Overall Study|Death|1|||
131171939|NCT02616185|472250441|FG000|Overall Study|Study terminated by sponsor|0|||
131171940|NCT02616185|472250442|FG001|Overall Study|Study terminated by sponsor|0|||
131171941|NCT02616185|472250443|FG002|Overall Study|Study terminated by sponsor|1|||
131171942|NCT02616185|472250444|FG003|Overall Study|Study terminated by sponsor|0|||
131171943|NCT02616185|472250445|FG004|Overall Study|Study terminated by sponsor|0|||
131235924|NCT02207231|472493171|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
131235925|NCT02207231|472493172|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
131235926|NCT02207231|472493169|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
130730484|NCT01277601|470635550|FG001|Overall Study|Adverse Event|3|||
130730485|NCT01277601|470635551|FG002|Overall Study|Adverse Event|0|||
130730486|NCT01277601|470635552|FG003|Overall Study|Adverse Event|7|||
130730487|NCT01277601|470635549|FG000|Overall Study|Withdrawal by Subject|18|||
130730488|NCT01277601|470635550|FG001|Overall Study|Withdrawal by Subject|21|||
131235927|NCT02207231|472493170|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
130730489|NCT01277601|470635551|FG002|Overall Study|Withdrawal by Subject|8|||
131171944|NCT02616185|472250446|FG005|Overall Study|Study terminated by sponsor|0|||
131171945|NCT02616185|472250447|FG006|Overall Study|Study terminated by sponsor|5|||
131171946|NCT02616185|472250448|FG007|Overall Study|Study terminated by sponsor|2|||
131171947|NCT02616185|472250449|FG008|Overall Study|Study terminated by sponsor|0|||
131171948|NCT02616185|472250441|FG000|Overall Study|Participant refused further follow-up|1|||
130781502|NCT00676403|470827442|FG002|Overall Study|Lost to Follow-up|0|||
130781503|NCT00676403|470827443|FG003|Overall Study|Lost to Follow-up|0|||
130781504|NCT00676403|470827444|FG004|Overall Study|Lost to Follow-up|0|||
130781505|NCT00676403|470827445|FG005|Overall Study|Lost to Follow-up|1|||
130781506|NCT00676403|470827440|FG000|Overall Study|Reason Unspecified|1|||
130781507|NCT00676403|470827441|FG001|Overall Study|Reason Unspecified|0|||
130781508|NCT00676403|470827442|FG002|Overall Study|Reason Unspecified|1|||
130781509|NCT00676403|470827443|FG003|Overall Study|Reason Unspecified|0|||
130781510|NCT00676403|470827444|FG004|Overall Study|Reason Unspecified|0|||
130781511|NCT00676403|470827445|FG005|Overall Study|Reason Unspecified|1|||
130781512|NCT00676403|470827440|FG000|Overall Study|Withdrawal by Subject|0|||
130781513|NCT00676403|470827441|FG001|Overall Study|Withdrawal by Subject|0|||
130781514|NCT00676403|470827442|FG002|Overall Study|Withdrawal by Subject|0|||
130781515|NCT00676403|470827443|FG003|Overall Study|Withdrawal by Subject|0|||
130781516|NCT00676403|470827444|FG004|Overall Study|Withdrawal by Subject|0|||
130781517|NCT00676403|470827445|FG005|Overall Study|Withdrawal by Subject|1|||
130781518|NCT01746862|470827449|FG000|Overall Study|Withdrawal by Subject|1|||
130781519|NCT01746862|470827450|FG001|Overall Study|Withdrawal by Subject|1|||
130781520|NCT01746862|470827449|FG000|Overall Study|Protocol Violation|1|||
130781521|NCT01746862|470827450|FG001|Overall Study|Protocol Violation|0|||
130781522|NCT01746862|470827449|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
130781523|NCT01746862|470827450|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
130781524|NCT01746862|470827449|FG000|Overall Study|Entered puberty during the study|1|||
130781525|NCT01746862|470827450|FG001|Overall Study|Entered puberty during the study|0|||
130781526|NCT04742673|470827451|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
130781527|NCT04742673|470827452|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
130781528|NCT06058390|470827454|FG000|Overall Study|Lost to Follow-up|0|||
130781529|NCT06058390|470827455|FG001|Overall Study|Lost to Follow-up|0|||
130781530|NCT06058390|470827456|FG002|Overall Study|Lost to Follow-up|2|||
130781531|NCT06058390|470827457|FG003|Overall Study|Lost to Follow-up|1|||
130781532|NCT06058390|470827454|FG000|Overall Study|Physician Decision|0|||
130781533|NCT06058390|470827455|FG001|Overall Study|Physician Decision|0|||
130781534|NCT06058390|470827456|FG002|Overall Study|Physician Decision|0|||
130781535|NCT06058390|470827457|FG003|Overall Study|Physician Decision|1|||
130781536|NCT06058390|470827454|FG000|Overall Study|Participants did not receive any study intervention|0|||
130781537|NCT06058390|470827455|FG001|Overall Study|Participants did not receive any study intervention|0|||
130781538|NCT06058390|470827456|FG002|Overall Study|Participants did not receive any study intervention|0|||
130781539|NCT06058390|470827457|FG003|Overall Study|Participants did not receive any study intervention|1|||
130781540|NCT03361306|470827458|FG000|Overall Study|Death|6|||
130781541|NCT04073303|470827459|FG000|Overall Study|Adverse Event|0|||
130781542|NCT04073303|470827460|FG001|Overall Study|Adverse Event|2|||
130781543|NCT04073303|470827459|FG000|Overall Study|Withdrawal by Subject|16|||
130781544|NCT04073303|470827460|FG001|Overall Study|Withdrawal by Subject|36|||
130781545|NCT04073303|470827459|FG000|Overall Study|Lost to Follow-up|6|||
130781546|NCT04073303|470827460|FG001|Overall Study|Lost to Follow-up|1|||
130781547|NCT04073303|470827459|FG000|Overall Study|Protocol Deviation|0|||
130781548|NCT04073303|470827460|FG001|Overall Study|Protocol Deviation|4|||
130781549|NCT04073303|470827459|FG000|Overall Study|Other|1|||
130781550|NCT04073303|470827460|FG001|Overall Study|Other|1|||
130781551|NCT03589807|470827468|FG000|Overall Study|Lost to Follow-up|0|||
130781552|NCT03589807|470827469|FG001|Overall Study|Lost to Follow-up|2|||
130781553|NCT03589807|470827470|FG002|Overall Study|Lost to Follow-up|2|||
130781554|NCT03589807|470827471|FG003|Overall Study|Lost to Follow-up|3|||
130781555|NCT03589807|470827472|FG004|Overall Study|Lost to Follow-up|1|||
130781556|NCT03589807|470827473|FG005|Overall Study|Lost to Follow-up|1|||
130781557|NCT03589807|470827468|FG000|Overall Study|Withdrawal by Subject|0|||
130781558|NCT03589807|470827469|FG001|Overall Study|Withdrawal by Subject|5|||
130781559|NCT03589807|470827470|FG002|Overall Study|Withdrawal by Subject|0|||
130781560|NCT03589807|470827471|FG003|Overall Study|Withdrawal by Subject|0|||
130781561|NCT03589807|470827472|FG004|Overall Study|Withdrawal by Subject|0|||
130781562|NCT03589807|470827473|FG005|Overall Study|Withdrawal by Subject|0|||
130781563|NCT03589807|470827468|FG000|Overall Study|Protocol Violation|0|||
131171949|NCT02616185|472250442|FG001|Overall Study|Participant refused further follow-up|1|||
131171950|NCT02616185|472250443|FG002|Overall Study|Participant refused further follow-up|2|||
131171951|NCT02616185|472250444|FG003|Overall Study|Participant refused further follow-up|3|||
131171952|NCT02616185|472250445|FG004|Overall Study|Participant refused further follow-up|4|||
131171953|NCT02616185|472250446|FG005|Overall Study|Participant refused further follow-up|0|||
131171954|NCT02616185|472250447|FG006|Overall Study|Participant refused further follow-up|3|||
131171955|NCT02616185|472250448|FG007|Overall Study|Participant refused further follow-up|4|||
131171956|NCT02616185|472250449|FG008|Overall Study|Participant refused further follow-up|3|||
130781564|NCT03589807|470827469|FG001|Overall Study|Protocol Violation|0|||
130781565|NCT03589807|470827470|FG002|Overall Study|Protocol Violation|0|||
131171957|NCT02616185|472250441|FG000|Overall Study|Not reported|0|||
131235928|NCT02207231|472493171|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
130781566|NCT03589807|470827471|FG003|Overall Study|Protocol Violation|1|||
130781567|NCT03589807|470827472|FG004|Overall Study|Protocol Violation|0|||
130781568|NCT03589807|470827473|FG005|Overall Study|Protocol Violation|0|||
130781569|NCT03589807|470827468|FG000|Overall Study|Enrolled but treatment not administered|0|||
131171958|NCT02616185|472250442|FG001|Overall Study|Not reported|0|||
131171959|NCT02616185|472250443|FG002|Overall Study|Not reported|0|||
130781570|NCT03589807|470827469|FG001|Overall Study|Enrolled but treatment not administered|0|||
130781571|NCT03589807|470827470|FG002|Overall Study|Enrolled but treatment not administered|0|||
130781572|NCT03589807|470827471|FG003|Overall Study|Enrolled but treatment not administered|0|||
130781573|NCT03589807|470827472|FG004|Overall Study|Enrolled but treatment not administered|1|||
130781574|NCT03589807|470827473|FG005|Overall Study|Enrolled but treatment not administered|0|||
130781575|NCT00810069|470827474|FG000|Lead-in Period I|Adverse Event|43|||
130781576|NCT00810069|470827475|FG001|Lead-in Period I|Adverse Event|0|||
130781577|NCT00810069|470827476|FG002|Lead-in Period I|Adverse Event|0|||
130781578|NCT00810069|470827474|FG000|Lead-in Period I|Lack of Efficacy|1|||
130781579|NCT00810069|470827475|FG001|Lead-in Period I|Lack of Efficacy|0|||
130781580|NCT00810069|470827476|FG002|Lead-in Period I|Lack of Efficacy|0|||
130781581|NCT00810069|470827474|FG000|Lead-in Period I|Lost to Follow-up|19|||
130781582|NCT00810069|470827475|FG001|Lead-in Period I|Lost to Follow-up|0|||
130781583|NCT00810069|470827476|FG002|Lead-in Period I|Lost to Follow-up|0|||
130781584|NCT00810069|470827474|FG000|Lead-in Period I|Physician Decision|1|||
130781585|NCT00810069|470827475|FG001|Lead-in Period I|Physician Decision|0|||
130781586|NCT00810069|470827476|FG002|Lead-in Period I|Physician Decision|0|||
130781587|NCT00810069|470827474|FG000|Lead-in Period I|Protocol Violation|1|||
130781588|NCT00810069|470827475|FG001|Lead-in Period I|Protocol Violation|0|||
130781589|NCT00810069|470827476|FG002|Lead-in Period I|Protocol Violation|0|||
130781590|NCT00810069|470827474|FG000|Lead-in Period I|Withdrawal by Subject|46|||
130781591|NCT00810069|470827475|FG001|Lead-in Period I|Withdrawal by Subject|0|||
130781592|NCT00810069|470827476|FG002|Lead-in Period I|Withdrawal by Subject|0|||
130781593|NCT00810069|470827474|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
130781594|NCT00810069|470827475|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
130781595|NCT00810069|470827476|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
130781596|NCT00810069|470827474|FG000|Lead-in Period I|Randomization criteria not met|158|||
130781597|NCT00810069|470827475|FG001|Lead-in Period I|Randomization criteria not met|0|||
130781598|NCT00810069|470827476|FG002|Lead-in Period I|Randomization criteria not met|0|||
130781599|NCT00810069|470827474|FG000|Double-Blind Period II|Adverse Event|0|||
130781600|NCT00810069|470827475|FG001|Double-Blind Period II|Adverse Event|9|||
130781601|NCT00810069|470827476|FG002|Double-Blind Period II|Adverse Event|8|||
130781602|NCT00810069|470827474|FG000|Double-Blind Period II|Lack of Efficacy|0|||
130781603|NCT00810069|470827475|FG001|Double-Blind Period II|Lack of Efficacy|7|||
130781604|NCT00810069|470827476|FG002|Double-Blind Period II|Lack of Efficacy|12|||
130781605|NCT00810069|470827474|FG000|Double-Blind Period II|Lost to Follow-up|0|||
130781606|NCT00810069|470827475|FG001|Double-Blind Period II|Lost to Follow-up|9|||
130781607|NCT00810069|470827476|FG002|Double-Blind Period II|Lost to Follow-up|9|||
130781608|NCT00810069|470827474|FG000|Double-Blind Period II|Physician Decision|0|||
130781609|NCT00810069|470827475|FG001|Double-Blind Period II|Physician Decision|0|||
130781610|NCT00810069|470827476|FG002|Double-Blind Period II|Physician Decision|1|||
130781611|NCT00810069|470827474|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
130781612|NCT00810069|470827475|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
130781613|NCT00810069|470827476|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
130781614|NCT00810069|470827474|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
130781615|NCT00810069|470827475|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
130781616|NCT00810069|470827476|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
131171960|NCT02616185|472250444|FG003|Overall Study|Not reported|1|||
131171961|NCT02616185|472250445|FG004|Overall Study|Not reported|3|||
131171962|NCT02616185|472250446|FG005|Overall Study|Not reported|1|||
131171963|NCT02616185|472250447|FG006|Overall Study|Not reported|0|||
131171964|NCT02616185|472250448|FG007|Overall Study|Not reported|5|||
131171965|NCT02616185|472250449|FG008|Overall Study|Not reported|2|||
131171966|NCT02494778|472250450|FG000|Overall Study|Death|3|||
131171967|NCT02494778|472250450|FG000|Overall Study|Other|173|||
130781617|NCT00810069|470827474|FG000|Double-Blind Period II|Clinical relapse|0|||
131171968|NCT02494778|472250450|FG000|Overall Study|Lack of Efficacy|4|||
131171969|NCT02494778|472250450|FG000|Overall Study|Adverse Event|18|||
131171970|NCT02494778|472250450|FG000|Overall Study|Withdrawal by Subject|20|||
130781618|NCT00810069|470827475|FG001|Double-Blind Period II|Clinical relapse|3|||
130781619|NCT00810069|470827476|FG002|Double-Blind Period II|Clinical relapse|0|||
130781620|NCT00810069|470827474|FG000|Double-Blind Period II|Protocol Violation|0|||
130781621|NCT00810069|470827475|FG001|Double-Blind Period II|Protocol Violation|7|||
130781622|NCT00810069|470827476|FG002|Double-Blind Period II|Protocol Violation|6|||
130781623|NCT04767373|470827479|FG000|Overall Study|Death|6|||
130781624|NCT04767373|470827480|FG001|Overall Study|Death|3|||
130781625|NCT04767373|470827479|FG000|Overall Study|Lost to Follow-up|67|||
130781626|NCT04767373|470827480|FG001|Overall Study|Lost to Follow-up|35|||
130781627|NCT04767373|470827479|FG000|Overall Study|Physician Decision|15|||
131171971|NCT02494778|472250450|FG000|Overall Study|Lost to Follow-up|2|||
131171972|NCT02494778|472250450|FG000|Overall Study|Noncompliant with study drug admin.|1|||
131171973|NCT03725202|472250455|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
131171974|NCT03725202|472250456|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
131171975|NCT03725202|472250457|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
131171976|NCT03725202|472250458|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
131171977|NCT03725202|472250459|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
131171978|NCT03725202|472250460|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
131171979|NCT03725202|472250461|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
131171980|NCT03725202|472250462|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
131171981|NCT03725202|472250455|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
131171982|NCT03725202|472250456|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
131171983|NCT03725202|472250457|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
131171984|NCT03725202|472250458|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
131171985|NCT03725202|472250459|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
131171986|NCT03725202|472250460|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
131171987|NCT03725202|472250461|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
131171988|NCT03725202|472250462|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
131171989|NCT03725202|472250455|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
131171990|NCT03725202|472250456|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131171991|NCT03725202|472250457|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131171992|NCT03725202|472250458|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131171993|NCT03725202|472250459|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131171994|NCT03725202|472250460|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131171995|NCT03725202|472250461|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131171996|NCT03725202|472250462|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
131171997|NCT03725202|472250455|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
131171998|NCT03725202|472250456|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131171999|NCT03725202|472250457|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131172000|NCT03725202|472250458|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131172001|NCT03725202|472250459|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131172002|NCT03725202|472250460|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131172003|NCT03725202|472250461|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131172004|NCT03725202|472250462|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
131172005|NCT03725202|472250455|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
131172006|NCT03725202|472250456|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
131172007|NCT03725202|472250457|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
131172008|NCT03725202|472250458|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
131172009|NCT03725202|472250459|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
131172010|NCT03725202|472250460|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130730490|NCT01277601|470635552|FG003|Overall Study|Withdrawal by Subject|17|||
130730491|NCT01277601|470635549|FG000|Overall Study|Lost to Follow-up|7|||
130730492|NCT01277601|470635550|FG001|Overall Study|Lost to Follow-up|9|||
130730493|NCT01277601|470635551|FG002|Overall Study|Lost to Follow-up|4|||
130730494|NCT01277601|470635552|FG003|Overall Study|Lost to Follow-up|2|||
130730495|NCT01277601|470635549|FG000|Overall Study|Physician Decision|3|||
130730496|NCT01277601|470635550|FG001|Overall Study|Physician Decision|5|||
130730497|NCT01277601|470635551|FG002|Overall Study|Physician Decision|1|||
130730498|NCT01277601|470635552|FG003|Overall Study|Physician Decision|6|||
130730499|NCT01277601|470635549|FG000|Overall Study|Pregnancy|2|||
130730500|NCT01277601|470635550|FG001|Overall Study|Pregnancy|2|||
130730501|NCT01277601|470635551|FG002|Overall Study|Pregnancy|4|||
130730502|NCT01277601|470635552|FG003|Overall Study|Pregnancy|1|||
130730503|NCT01277601|470635549|FG000|Overall Study|Noncompliance with Study Drug|1|||
130730504|NCT01277601|470635550|FG001|Overall Study|Noncompliance with Study Drug|3|||
130730505|NCT01277601|470635551|FG002|Overall Study|Noncompliance with Study Drug|2|||
130730506|NCT01277601|470635552|FG003|Overall Study|Noncompliance with Study Drug|0|||
130730507|NCT01277601|470635549|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
130730508|NCT01277601|470635550|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
130730509|NCT01277601|470635551|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
130730510|NCT01277601|470635552|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
130730511|NCT01277601|470635549|FG000|Overall Study|Protocol Violation|0|||
130730512|NCT01277601|470635550|FG001|Overall Study|Protocol Violation|2|||
130730513|NCT01277601|470635551|FG002|Overall Study|Protocol Violation|5|||
130730514|NCT01277601|470635552|FG003|Overall Study|Protocol Violation|0|||
130730515|NCT01277601|470635549|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
131172011|NCT03725202|472250461|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
131172012|NCT03725202|472250462|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
131172013|NCT03725202|472250455|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131172014|NCT03725202|472250456|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131235929|NCT02207231|472493172|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
131235930|NCT02207231|472493169|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
131235931|NCT02207231|472493170|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
130730516|NCT01277601|470635550|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
130730517|NCT01277601|470635551|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
130730518|NCT01277601|470635552|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
130730519|NCT04034927|470635553|FG000|Overall Study|Adverse Event|4|||
130730520|NCT04034927|470635554|FG001|Overall Study|Adverse Event|9|||
130730521|NCT04034927|470635553|FG000|Overall Study|Death|0|||
130730522|NCT04034927|470635554|FG001|Overall Study|Death|1|||
130730523|NCT04034927|470635553|FG000|Overall Study|Withdrawal by Subject|0|||
130730524|NCT04034927|470635554|FG001|Overall Study|Withdrawal by Subject|3|||
130730525|NCT04034927|470635553|FG000|Overall Study|Still on Treatment|2|||
130730526|NCT04034927|470635554|FG001|Overall Study|Still on Treatment|1|||
130730527|NCT04034927|470635553|FG000|Overall Study|Other|1|||
130730528|NCT04034927|470635554|FG001|Overall Study|Other|1|||
130730529|NCT03996447|470635555|FG000|First MRI Examination|Adverse Event|2|||
130730530|NCT03996447|470635556|FG001|First MRI Examination|Adverse Event|0|||
130730531|NCT03996447|470635555|FG000|First MRI Examination|Withdrawal by Subject|1|||
130730532|NCT03996447|470635556|FG001|First MRI Examination|Withdrawal by Subject|2|||
130730533|NCT03996447|470635555|FG000|First MRI Examination|Protocol Violation|0|||
130730534|NCT03996447|470635556|FG001|First MRI Examination|Protocol Violation|1|||
130730535|NCT03996447|470635555|FG000|Washout|Adverse Event|2|||
130730536|NCT03996447|470635556|FG001|Washout|Adverse Event|0|||
130730537|NCT03996447|470635555|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
130730538|NCT03996447|470635556|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
130730539|NCT03996447|470635555|FG000|Washout|Withdrawal by Subject|0|||
130730540|NCT03996447|470635556|FG001|Washout|Withdrawal by Subject|1|||
130730541|NCT03996447|470635555|FG000|Washout|Other reason|1|||
130730542|NCT03996447|470635556|FG001|Washout|Other reason|1|||
130730543|NCT02291510|470635557|FG000|Overall Study|Adverse Event|0|||
130730544|NCT02291510|470635558|FG001|Overall Study|Adverse Event|0|||
130730545|NCT02291510|470635559|FG002|Overall Study|Adverse Event|0|||
130730546|NCT02291510|470635560|FG003|Overall Study|Adverse Event|1|||
130730547|NCT06390839|470635561|FG000|Overall Study|Ineligible|2|||
130730548|NCT06390839|470635561|FG000|Overall Study|Never start protocol therapy|3|||
130730549|NCT06390839|470635561|FG000|Overall Study|Adverse Event|1|||
130730550|NCT06390839|470635561|FG000|Overall Study|Alternative therapy|2|||
130730551|NCT06390839|470635561|FG000|Overall Study|Death|3|||
130730552|NCT06390839|470635561|FG000|Overall Study|Disease progression|28|||
130730553|NCT06390839|470635561|FG000|Overall Study|Withdrawal by Subject|2|||
130730554|NCT06390839|470635561|FG000|Overall Study|Complicating disease|1|||
130730555|NCT06390839|470635561|FG000|Overall Study|Noncompliance|1|||
130730556|NCT04458922|470635562|FG000|Overall Study|Withdrawal by Subject|1|||
130730557|NCT04458922|470635563|FG001|Overall Study|Withdrawal by Subject|0|||
130730558|NCT04458922|470635564|FG002|Overall Study|Withdrawal by Subject|2|||
130730559|NCT04458922|470635562|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
130730560|NCT04458922|470635563|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
130730561|NCT04458922|470635564|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
130730562|NCT04458922|470635562|FG000|Overall Study|Adverse Event|1|||
130730563|NCT04458922|470635563|FG001|Overall Study|Adverse Event|0|||
130730564|NCT04458922|470635564|FG002|Overall Study|Adverse Event|0|||
130730565|NCT04458922|470635562|FG000|Overall Study|Started new study|0|||
130730566|NCT04458922|470635563|FG001|Overall Study|Started new study|0|||
130781628|NCT04767373|470827480|FG001|Overall Study|Physician Decision|4|||
130781629|NCT04767373|470827479|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130781630|NCT04767373|470827480|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130781631|NCT04767373|470827479|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
130781632|NCT04767373|470827480|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
130781633|NCT04767373|470827479|FG000|Overall Study|Other|1|||
130781634|NCT04767373|470827480|FG001|Overall Study|Other|2|||
130781635|NCT00593918|470827481|FG000|Overall Study|Withdrawal by Subject|5|||
130781636|NCT00593918|470827482|FG001|Overall Study|Withdrawal by Subject|24|||
130781637|NCT02983045|470827483|FG000|Overall Study|Withdrawal by Subject|0|||
130781638|NCT02983045|470827484|FG001|Overall Study|Withdrawal by Subject|1|||
130781639|NCT02983045|470827485|FG002|Overall Study|Withdrawal by Subject|0|||
130781640|NCT02983045|470827486|FG003|Overall Study|Withdrawal by Subject|5|||
130781641|NCT02983045|470827487|FG004|Overall Study|Withdrawal by Subject|0|||
130781642|NCT02983045|470827488|FG005|Overall Study|Withdrawal by Subject|72|||
130781643|NCT02983045|470827489|FG006|Overall Study|Withdrawal by Subject|0|||
130781644|NCT02983045|470827490|FG007|Overall Study|Withdrawal by Subject|0|||
130781645|NCT02983045|470827491|FG008|Overall Study|Withdrawal by Subject|0|||
130730567|NCT04458922|470635564|FG002|Overall Study|Started new study|1|||
130730568|NCT04458922|470635562|FG000|Overall Study|Progressive disease|6|||
130730569|NCT04458922|470635563|FG001|Overall Study|Progressive disease|8|||
130730570|NCT04458922|470635564|FG002|Overall Study|Progressive disease|2|||
130781646|NCT02983045|470827492|FG009|Overall Study|Withdrawal by Subject|2|||
130781647|NCT02983045|470827483|FG000|Overall Study|Lost to Follow-up|0|||
130781648|NCT02983045|470827484|FG001|Overall Study|Lost to Follow-up|0|||
130781649|NCT02983045|470827485|FG002|Overall Study|Lost to Follow-up|0|||
130781650|NCT02983045|470827486|FG003|Overall Study|Lost to Follow-up|0|||
130781651|NCT02983045|470827487|FG004|Overall Study|Lost to Follow-up|0|||
130781652|NCT02983045|470827488|FG005|Overall Study|Lost to Follow-up|10|||
130781653|NCT02983045|470827489|FG006|Overall Study|Lost to Follow-up|0|||
130781654|NCT02983045|470827490|FG007|Overall Study|Lost to Follow-up|0|||
130781655|NCT02983045|470827491|FG008|Overall Study|Lost to Follow-up|0|||
130781656|NCT02983045|470827492|FG009|Overall Study|Lost to Follow-up|0|||
130781657|NCT02658669|470827493|FG000|Overall Study|Lost to Follow-up|7|||
130781658|NCT02658669|470827494|FG001|Overall Study|Lost to Follow-up|5|||
130781659|NCT03421379|470827496|FG000|Period 1|Withdrawal by Subject|0|||
130781660|NCT03421379|470827497|FG001|Period 1|Withdrawal by Subject|1|||
130781661|NCT03421379|470827496|FG000|Period 1|Physician Decision|1|||
130781662|NCT03421379|470827497|FG001|Period 1|Physician Decision|1|||
130781663|NCT03421379|470827496|FG000|Period 1|Did not receive treatment|1|||
130781664|NCT03421379|470827497|FG001|Period 1|Did not receive treatment|2|||
130781665|NCT02782741|470827498|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
130781666|NCT02782741|470827499|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
130781667|NCT02782741|470827500|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
130781668|NCT02782741|470827498|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
130781669|NCT02782741|470827499|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
130781670|NCT02782741|470827500|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
130781671|NCT02782741|470827498|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
130781672|NCT02782741|470827499|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
130781673|NCT02782741|470827500|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
130781674|NCT02782741|470827498|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
130781675|NCT02782741|470827499|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
130781676|NCT02782741|470827500|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
130781677|NCT02782741|470827498|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
130781678|NCT02782741|470827499|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
130781679|NCT02782741|470827500|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
130781680|NCT04157088|470827501|FG000|Overall Study|Study terminated by sponsor|23|||
130781681|NCT04157088|470827501|FG000|Overall Study|Withdrawal by Subject|4|||
130781682|NCT04157088|470827501|FG000|Overall Study|Lost to Follow-up|2|||
130781683|NCT04157088|470827501|FG000|Overall Study|Death|1|||
130781684|NCT00196105|470827504|FG000|Overall Study|Lost to Follow-up|4|||
130781685|NCT00196105|470827505|FG001|Overall Study|Lost to Follow-up|5|||
130781686|NCT00196105|470827506|FG002|Overall Study|Lost to Follow-up|7|||
130781687|NCT04863872|470827507|FG000|Overall Study|Withdrawal by Subject|4|||
130781688|NCT04863872|470827508|FG001|Overall Study|Withdrawal by Subject|15|||
130781689|NCT04863872|470827507|FG000|Overall Study|Death|5|||
130781690|NCT04863872|470827508|FG001|Overall Study|Death|2|||
130781691|NCT04863872|470827507|FG000|Overall Study|Lost to Follow-up|2|||
130781692|NCT04863872|470827508|FG001|Overall Study|Lost to Follow-up|1|||
130781693|NCT04058028|470827509|FG000|Overall Study|Withdrawal of Consent from Study|12|||
130781694|NCT04058028|470827510|FG001|Overall Study|Withdrawal of Consent from Study|8|||
130781695|NCT04058028|470827511|FG002|Overall Study|Withdrawal of Consent from Study|6|||
130781696|NCT04058028|470827512|FG003|Overall Study|Withdrawal of Consent from Study|7|||
130781697|NCT04058028|470827509|FG000|Overall Study|Decision by Sponsor|13|||
130781698|NCT04058028|470827510|FG001|Overall Study|Decision by Sponsor|4|||
130781699|NCT04058028|470827511|FG002|Overall Study|Decision by Sponsor|1|||
130781700|NCT04058028|470827512|FG003|Overall Study|Decision by Sponsor|35|||
130781701|NCT04058028|470827509|FG000|Overall Study|Lost to Follow-up|1|||
130781702|NCT04058028|470827510|FG001|Overall Study|Lost to Follow-up|1|||
130781703|NCT04058028|470827511|FG002|Overall Study|Lost to Follow-up|1|||
130781704|NCT04058028|470827512|FG003|Overall Study|Lost to Follow-up|0|||
130781705|NCT04058028|470827509|FG000|Overall Study|Death|0|||
130781706|NCT04058028|470827510|FG001|Overall Study|Death|1|||
130781707|NCT04058028|470827511|FG002|Overall Study|Death|0|||
130781708|NCT04058028|470827512|FG003|Overall Study|Death|0|||
130781709|NCT00485069|470827513|FG000|Overall Study|Adverse Event|10|||
130781710|NCT00485069|470827514|FG001|Overall Study|Adverse Event|4|||
130781711|NCT00485069|470827513|FG000|Overall Study|Lack of Efficacy|2|||
130781712|NCT00485069|470827514|FG001|Overall Study|Lack of Efficacy|1|||
130781713|NCT00485069|470827513|FG000|Overall Study|Protocol Violation|0|||
130781714|NCT00485069|470827514|FG001|Overall Study|Protocol Violation|1|||
130781715|NCT00485069|470827513|FG000|Overall Study|Withdrawal by Subject|6|||
130781716|NCT00485069|470827514|FG001|Overall Study|Withdrawal by Subject|6|||
130781717|NCT00992017|470827516|FG000|Overall Study|Lost to Follow-up|2|||
130781718|NCT00992017|470827516|FG000|Overall Study|Withdrawal by Subject|2|||
130781719|NCT00992017|470827516|FG000|Overall Study|Unable to get to clinic|5|||
130781720|NCT00992017|470827516|FG000|Overall Study|Not adhere to study requirements|1|||
130781721|NCT02864407|470827517|FG000|Overall Study|Protocol Violation|3|||
130781722|NCT02864407|470827517|FG000|Overall Study|Lost to Follow-up|115|||
131235932|NCT02207231|472493171|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
131235933|NCT02207231|472493172|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
131235934|NCT02207231|472493169|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
131235935|NCT02207231|472493170|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
131235936|NCT02207231|472493171|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
131235937|NCT02207231|472493172|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
131235938|NCT02207231|472493169|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
131235939|NCT02207231|472493170|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
131235940|NCT02207231|472493171|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
131235941|NCT02207231|472493172|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
131235942|NCT02207231|472493169|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
131235943|NCT02207231|472493170|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
131235944|NCT02207231|472493171|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
131235945|NCT02207231|472493172|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
131235946|NCT02207231|472493169|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
131235947|NCT02207231|472493170|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
131235948|NCT02207231|472493171|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
131235949|NCT02207231|472493172|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
131235950|NCT00502775|472493176|FG000|Overall Study|Adverse Event|1|||
131235951|NCT00502775|472493177|FG001|Overall Study|Adverse Event|2|||
131235952|NCT00502775|472493178|FG002|Overall Study|Adverse Event|1|||
131235953|NCT00502775|472493176|FG000|Overall Study|Protocol Violation|1|||
131235954|NCT00502775|472493177|FG001|Overall Study|Protocol Violation|5|||
131235955|NCT00502775|472493178|FG002|Overall Study|Protocol Violation|2|||
131235956|NCT00502775|472493176|FG000|Overall Study|Withdrawal by Subject|1|||
131235957|NCT00502775|472493177|FG001|Overall Study|Withdrawal by Subject|1|||
131235958|NCT00502775|472493178|FG002|Overall Study|Withdrawal by Subject|2|||
131235959|NCT00502775|472493176|FG000|Overall Study|Sponsor Terminated Study|1|||
131235960|NCT00502775|472493177|FG001|Overall Study|Sponsor Terminated Study|0|||
131235961|NCT00502775|472493178|FG002|Overall Study|Sponsor Terminated Study|1|||
131235962|NCT00502775|472493176|FG000|Overall Study|Non-compliance with eDiary|4|||
131235963|NCT00502775|472493177|FG001|Overall Study|Non-compliance with eDiary|1|||
131235964|NCT00502775|472493178|FG002|Overall Study|Non-compliance with eDiary|1|||
131235965|NCT00502775|472493176|FG000|Overall Study|Subject unable to swallow capsule|1|||
131235966|NCT00502775|472493177|FG001|Overall Study|Subject unable to swallow capsule|0|||
131235967|NCT00502775|472493178|FG002|Overall Study|Subject unable to swallow capsule|1|||
131235968|NCT00502775|472493176|FG000|Overall Study|Logpad compliance <80%|1|||
131235969|NCT00502775|472493177|FG001|Overall Study|Logpad compliance <80%|0|||
131235970|NCT00502775|472493178|FG002|Overall Study|Logpad compliance <80%|0|||
131235971|NCT00502775|472493176|FG000|Overall Study|Randomized in error|0|||
131235972|NCT00502775|472493177|FG001|Overall Study|Randomized in error|1|||
131235973|NCT00502775|472493178|FG002|Overall Study|Randomized in error|1|||
131235974|NCT00502775|472493176|FG000|Overall Study|Non-compliance|0|||
131235975|NCT00502775|472493177|FG001|Overall Study|Non-compliance|2|||
131235976|NCT00502775|472493178|FG002|Overall Study|Non-compliance|2|||
131235977|NCT00502775|472493176|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
131235978|NCT00502775|472493177|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
131235979|NCT00502775|472493178|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
131235980|NCT00502775|472493176|FG000|Overall Study|Declining pollen counts|0|||
131235981|NCT00502775|472493177|FG001|Overall Study|Declining pollen counts|1|||
131235982|NCT00502775|472493178|FG002|Overall Study|Declining pollen counts|1|||
131235983|NCT00502775|472493176|FG000|Overall Study|Subject in jail|0|||
131235984|NCT00502775|472493177|FG001|Overall Study|Subject in jail|1|||
130730571|NCT04458922|470635562|FG000|Overall Study|Death|1|||
130730572|NCT04458922|470635563|FG001|Overall Study|Death|0|||
130730573|NCT04458922|470635564|FG002|Overall Study|Death|2|||
130730574|NCT04458922|470635562|FG000|Overall Study|Participant started chemotherapy|0|||
130730575|NCT04458922|470635563|FG001|Overall Study|Participant started chemotherapy|1|||
130730576|NCT04458922|470635564|FG002|Overall Study|Participant started chemotherapy|0|||
130730577|NCT06351371|470635566|FG000|Overall Study|Mutation Status Not Confirmed|9|||
130730578|NCT06351371|470635566|FG000|Overall Study|Ineligible|1|||
130730579|NCT06351371|470635566|FG000|Overall Study|Adverse Event|4|||
130730580|NCT06351371|470635566|FG000|Overall Study|Death|1|||
130730581|NCT06351371|470635566|FG000|Overall Study|Disease progression|14|||
130730582|NCT06351371|470635566|FG000|Overall Study|Withdrawal by Subject|3|||
131235985|NCT00502775|472493178|FG002|Overall Study|Subject in jail|0|||
131235986|NCT00502775|472493176|FG000|Overall Study|Subject took disallowed drug|0|||
131235987|NCT00502775|472493177|FG001|Overall Study|Subject took disallowed drug|0|||
131235988|NCT00502775|472493178|FG002|Overall Study|Subject took disallowed drug|1|||
131235989|NCT00287118|472493187|FG000|Overall Study|Adverse Event|30|||
131235990|NCT00287118|472493187|FG000|Overall Study|Death|1|||
130730583|NCT06351371|470635566|FG000|Overall Study|Physician Decision|3|||
130730584|NCT03203850|470635567|FG000|Overall Study|Subject/guardian decision|4|||
130730585|NCT03203850|470635568|FG001|Overall Study|Subject/guardian decision|3|||
131172015|NCT03725202|472250457|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
131172016|NCT03725202|472250458|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131172017|NCT03725202|472250459|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131172018|NCT03725202|472250460|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131172019|NCT03725202|472250461|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131172020|NCT03725202|472250462|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
131172021|NCT03725202|472250455|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
131172022|NCT03725202|472250456|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
131172023|NCT03725202|472250457|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
131172024|NCT03725202|472250458|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
131172025|NCT03725202|472250459|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
131172026|NCT03725202|472250460|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
131172027|NCT03725202|472250461|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
131172028|NCT03725202|472250462|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
131172029|NCT03725202|472250455|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
131172030|NCT03725202|472250456|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
131172031|NCT03725202|472250457|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
131172032|NCT03725202|472250458|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
131172033|NCT03725202|472250459|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
131172034|NCT03725202|472250460|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
131172035|NCT03725202|472250461|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
131172036|NCT03725202|472250462|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
131172037|NCT03725202|472250455|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
131172038|NCT03725202|472250456|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
131172039|NCT03725202|472250457|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
131172040|NCT03725202|472250458|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
131172041|NCT03725202|472250459|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
131172042|NCT03725202|472250460|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
131172043|NCT03725202|472250461|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
131172044|NCT03725202|472250462|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
131172045|NCT03725202|472250455|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131172046|NCT03725202|472250456|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131172047|NCT03725202|472250457|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131172048|NCT03725202|472250458|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131172049|NCT03725202|472250459|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131172050|NCT03725202|472250460|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131172051|NCT03725202|472250461|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
131172052|NCT03725202|472250462|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
131172053|NCT03725202|472250455|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131172054|NCT03725202|472250456|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131172055|NCT03725202|472250457|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131172056|NCT03725202|472250458|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131172057|NCT03725202|472250459|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131172058|NCT03725202|472250460|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
131172059|NCT03725202|472250461|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131172060|NCT03725202|472250462|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
131172061|NCT03725202|472250455|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
131172062|NCT03725202|472250456|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
131172063|NCT03725202|472250457|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
131172064|NCT03725202|472250458|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
131172065|NCT03725202|472250459|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
131172066|NCT03725202|472250460|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
131172067|NCT03725202|472250461|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
130730586|NCT03203850|470635567|FG000|Overall Study|Adverse Event|3|||
130730587|NCT03203850|470635568|FG001|Overall Study|Adverse Event|0|||
130730588|NCT03203850|470635567|FG000|Overall Study|Death|1|||
130730589|NCT03203850|470635568|FG001|Overall Study|Death|0|||
130730590|NCT01009814|470635570|FG000|Overall Study|No longer met study criteria|1|||
130730591|NCT01009814|470635571|FG001|Overall Study|No longer met study criteria|1|||
130730592|NCT01009814|470635572|FG002|Overall Study|No longer met study criteria|0|||
130730593|NCT01009814|470635573|FG003|Overall Study|No longer met study criteria|0|||
130730594|NCT01009814|470635574|FG004|Overall Study|No longer met study criteria|0|||
131235991|NCT00287118|472493187|FG000|Overall Study|Lack of Efficacy|11|||
130730595|NCT00618371|470635575|FG000|Overall Study|Withdrawal by Subject|2|||
131172068|NCT03725202|472250462|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
131172069|NCT01328249|472250465|FG000|Overall Study|Adverse Event|3|||
131172070|NCT01328249|472250466|FG001|Overall Study|Adverse Event|0|||
131172071|NCT01328249|472250465|FG000|Overall Study|Disease progression|1|||
131172072|NCT01328249|472250466|FG001|Overall Study|Disease progression|0|||
131172073|NCT01328249|472250465|FG000|Overall Study|Withdrawal by Subject|1|||
130730596|NCT03348631|470635578|FG000|Overall Study|Not Eligible, No treatment|0|||
130730597|NCT03348631|470635579|FG001|Overall Study|Not Eligible, No treatment|1|||
130730598|NCT03348631|470635578|FG000|Overall Study|Not Eligible, Treated|2|||
130730599|NCT03348631|470635579|FG001|Overall Study|Not Eligible, Treated|0|||
130730600|NCT03348631|470635578|FG000|Overall Study|Eligible, No Treatment|1|||
130730601|NCT03348631|470635579|FG001|Overall Study|Eligible, No Treatment|0|||
130730602|NCT00451204|470635580|FG000|Overall Study|Adverse Event|4|||
130730603|NCT00451204|470635581|FG001|Overall Study|Adverse Event|6|||
130730604|NCT00451204|470635580|FG000|Overall Study|Lack of Efficacy|4|||
130730605|NCT00451204|470635581|FG001|Overall Study|Lack of Efficacy|4|||
130730606|NCT00451204|470635580|FG000|Overall Study|Lost to Follow-up|4|||
130730607|NCT00451204|470635581|FG001|Overall Study|Lost to Follow-up|4|||
130730608|NCT00451204|470635580|FG000|Overall Study|Protocol Violation|1|||
130730609|NCT00451204|470635581|FG001|Overall Study|Protocol Violation|0|||
130730610|NCT00451204|470635580|FG000|Overall Study|Patient refusal|8|||
130730611|NCT00451204|470635581|FG001|Overall Study|Patient refusal|4|||
130730612|NCT00451204|470635580|FG000|Overall Study|Other|1|||
130730613|NCT00451204|470635581|FG001|Overall Study|Other|2|||
130730614|NCT03055624|470635582|FG000|Overall Study|Study closed|9|||
130730615|NCT01582152|470635583|FG000|Overall Study|Disease Progression|4|||
130730616|NCT01582152|470635584|FG001|Overall Study|Disease Progression|5|||
130730617|NCT01582152|470635583|FG000|Overall Study|Adverse Event|2|||
130730618|NCT01582152|470635584|FG001|Overall Study|Adverse Event|1|||
130730619|NCT02794870|470635590|FG000|Overall Study|Withdrawal by Subject|2|||
130730620|NCT02794870|470635591|FG001|Overall Study|Withdrawal by Subject|0|||
130730621|NCT04172597|470635595|FG000|Overall Study|Disease Progression|0|||
130730622|NCT04172597|470635596|FG001|Overall Study|Disease Progression|0|||
130730623|NCT04172597|470635597|FG002|Overall Study|Disease Progression|0|||
130730624|NCT04172597|470635598|FG003|Overall Study|Disease Progression|0|||
130730625|NCT04172597|470635599|FG004|Overall Study|Disease Progression|1|||
130730626|NCT00794339|470635600|FG000|Overall Study|Withdrawal by Subject|3|||
130730627|NCT00794339|470635600|FG000|Overall Study|Ineligible|4|||
130730628|NCT00794339|470635600|FG000|Overall Study|Tx prior to ATSM|3|||
130730629|NCT00794339|470635600|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
130730630|NCT00794339|470635600|FG000|Overall Study|Tx not per protocol|1|||
130730631|NCT01611857|470635601|FG000|Overall Study|Withdrawal by Subject|0|||
130730632|NCT01611857|470635602|FG001|Overall Study|Withdrawal by Subject|2|||
130730633|NCT00362336|470635619|FG000|Overall Study|Serious Adverse Event|1|||
130730634|NCT00362336|470635620|FG001|Overall Study|Serious Adverse Event|0|||
130730635|NCT00362336|470635621|FG002|Overall Study|Serious Adverse Event|1|||
130730636|NCT00362336|470635619|FG000|Overall Study|Protocol Violation|0|||
130730637|NCT00362336|470635620|FG001|Overall Study|Protocol Violation|0|||
130730638|NCT00362336|470635621|FG002|Overall Study|Protocol Violation|1|||
130730639|NCT00362336|470635619|FG000|Overall Study|Lost to Follow-up|6|||
130730640|NCT00362336|470635620|FG001|Overall Study|Lost to Follow-up|4|||
130730641|NCT00362336|470635621|FG002|Overall Study|Lost to Follow-up|0|||
130730642|NCT00362336|470635619|FG000|Overall Study|Withdrawal by Subject|3|||
130730643|NCT00362336|470635620|FG001|Overall Study|Withdrawal by Subject|3|||
130730644|NCT00362336|470635621|FG002|Overall Study|Withdrawal by Subject|1|||
130730645|NCT04414618|470635622|FG000|Overall Study|Death|3|||
130730646|NCT04414618|470635623|FG001|Overall Study|Death|3|||
130730647|NCT04414618|470635622|FG000|Overall Study|Withdrawal by Subject|2|||
130730648|NCT04414618|470635623|FG001|Overall Study|Withdrawal by Subject|1|||
130730649|NCT04414618|470635622|FG000|Overall Study|Lost to Follow-up|2|||
130730650|NCT04414618|470635623|FG001|Overall Study|Lost to Follow-up|3|||
130730651|NCT04414618|470635622|FG000|Overall Study|Physician Decision|1|||
130730652|NCT04414618|470635623|FG001|Overall Study|Physician Decision|0|||
130730653|NCT00658879|470635624|FG000|Overall Study|Protocol Violation|1|||
130730654|NCT01121562|470635625|FG000|Overall Study|Objective progression or relapse|8|||
130730655|NCT01121562|470635625|FG000|Overall Study|Withdrawal by Subject|1|||
130730656|NCT01121562|470635625|FG000|Overall Study|Adverse Event|1|||
130730657|NCT01121562|470635625|FG000|Overall Study|Sponsor Decision|1|||
130730658|NCT01121562|470635625|FG000|Overall Study|Met study discontinuation criteria|1|||
130730659|NCT02075515|470635626|FG000|Overall Study|Serious Adverse Event|1|||
130730660|NCT02075515|470635627|FG001|Overall Study|Serious Adverse Event|1|||
130730661|NCT02075515|470635628|FG002|Overall Study|Serious Adverse Event|1|||
130730662|NCT02075515|470635626|FG000|Overall Study|Non-Serious Adverse Event|0|||
130730663|NCT02075515|470635627|FG001|Overall Study|Non-Serious Adverse Event|1|||
130730664|NCT02075515|470635628|FG002|Overall Study|Non-Serious Adverse Event|0|||
130730665|NCT02075515|470635626|FG000|Overall Study|Withdrawal by Subject|2|||
131172074|NCT01328249|472250466|FG001|Overall Study|Withdrawal by Subject|1|||
130730666|NCT02075515|470635627|FG001|Overall Study|Withdrawal by Subject|0|||
130730667|NCT02075515|470635628|FG002|Overall Study|Withdrawal by Subject|1|||
130730668|NCT02075515|470635626|FG000|Overall Study|Lost to Follow-up|1|||
130730669|NCT02075515|470635627|FG001|Overall Study|Lost to Follow-up|3|||
130730670|NCT02075515|470635628|FG002|Overall Study|Lost to Follow-up|6|||
130730671|NCT00378573|470635631|FG000|Treatment Period|Adverse Event|9|||
131172075|NCT01328249|472250465|FG000|Overall Study|Moved before end of treatment visit|1|||
131172076|NCT01328249|472250466|FG001|Overall Study|Moved before end of treatment visit|0|||
131172077|NCT01328249|472250465|FG000|Overall Study|Subject choice|1|||
131172078|NCT01328249|472250466|FG001|Overall Study|Subject choice|1|||
131172079|NCT01328249|472250465|FG000|Overall Study|Protocol Violation|0|||
131172080|NCT01328249|472250466|FG001|Overall Study|Protocol Violation|1|||
131172081|NCT01215734|472250467|FG000|Overall Study|Death|0|||
131172082|NCT01215734|472250468|FG001|Overall Study|Death|1|||
131172083|NCT01346371|472250469|FG000|Overall Study|Lost to Follow-up|2|||
131172084|NCT01346371|472250470|FG001|Overall Study|Lost to Follow-up|0|||
131172085|NCT02330549|472250472|FG000|Overall Study|Adverse Event|1|||
131172086|NCT02330549|472250473|FG001|Overall Study|Adverse Event|0|||
131172087|NCT02330549|472250472|FG000|Overall Study|Subject withdrew consent|2|||
131172088|NCT02330549|472250473|FG001|Overall Study|Subject withdrew consent|1|||
131172089|NCT02330549|472250472|FG000|Overall Study|Failure to meet randomization criteria|1|||
131172090|NCT02330549|472250473|FG001|Overall Study|Failure to meet randomization criteria|0|||
131172091|NCT00495495|472250479|FG000|Overall Study|Protocol Violation|99|||
131172092|NCT02702518|472250483|FG000|Overall Study|Lost to Follow-up|3|||
131172093|NCT02702518|472250484|FG001|Overall Study|Lost to Follow-up|4|||
131172094|NCT01670656|472250485|FG000|Overall Study|Non-compliance with study drug|0|||
131172095|NCT01670656|472250486|FG001|Overall Study|Non-compliance with study drug|0|||
131172096|NCT01670656|472250487|FG002|Overall Study|Non-compliance with study drug|3|||
131172097|NCT01670656|472250488|FG003|Overall Study|Non-compliance with study drug|0|||
131172098|NCT01670656|472250489|FG004|Overall Study|Non-compliance with study drug|1|||
131172099|NCT01670656|472250485|FG000|Overall Study|Pregnancy|0|||
131172100|NCT01670656|472250486|FG001|Overall Study|Pregnancy|0|||
131172101|NCT01670656|472250487|FG002|Overall Study|Pregnancy|0|||
130730672|NCT00378573|470635631|FG000|Treatment Period|Physician Decision|1|||
130730673|NCT00378573|470635631|FG000|Treatment Period|Withdrawal by Subject|2|||
130730674|NCT00378573|470635631|FG000|Treatment Period|Disease Progression|4|||
130730675|NCT00378573|470635631|FG000|Treatment Period|Sponsor decision to close study|1|||
130730676|NCT00378573|470635631|FG000|Follow-up|Death|12|||
130730677|NCT00378573|470635631|FG000|Follow-up|Lost to Follow-up|1|||
130730678|NCT00378573|470635631|FG000|Follow-up|Withdrawal by Subject|1|||
130730679|NCT01372748|470635632|FG000|Overall Study|Lost to Follow-up|16|||
130730680|NCT01372748|470635633|FG001|Overall Study|Lost to Follow-up|34|||
130730681|NCT01372748|470635632|FG000|Overall Study|Withdrawal by Subject|7|||
130730682|NCT01372748|470635633|FG001|Overall Study|Withdrawal by Subject|5|||
130730683|NCT00134901|470635634|FG000|Overall Study|Lost to Follow-up|5|||
130730684|NCT00134901|470635635|FG001|Overall Study|Lost to Follow-up|5|||
130730685|NCT00134901|470635634|FG000|Overall Study|discontinued intervention|12|||
130730686|NCT00134901|470635635|FG001|Overall Study|discontinued intervention|10|||
130730687|NCT00445432|470635638|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
130730688|NCT00445432|470635639|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
130730689|NCT00445432|470635640|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
130730690|NCT00445432|470635641|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
130730691|NCT00445432|470635638|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
130730692|NCT00445432|470635639|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
130730693|NCT00445432|470635640|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
130730694|NCT00445432|470635641|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
130730695|NCT00445432|470635638|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
130730696|NCT00445432|470635639|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
130730697|NCT00445432|470635640|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
130730698|NCT00445432|470635641|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
130730699|NCT00445432|470635638|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
130730700|NCT00445432|470635639|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
130730701|NCT00445432|470635640|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
130730702|NCT00445432|470635641|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
130730703|NCT00445432|470635638|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
130730704|NCT00445432|470635639|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
130730705|NCT00445432|470635640|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
130730706|NCT00445432|470635641|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
130730707|NCT00445432|470635638|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
130730708|NCT00445432|470635639|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
130730709|NCT00445432|470635640|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
130730710|NCT00445432|470635641|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
131172102|NCT01670656|472250488|FG003|Overall Study|Pregnancy|0|||
130730711|NCT00445432|470635638|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
130781723|NCT02864407|470827517|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
131172103|NCT01670656|472250489|FG004|Overall Study|Pregnancy|1|||
131172104|NCT01670656|472250485|FG000|Overall Study|Withdrawal by Subject|1|||
131172105|NCT01670656|472250486|FG001|Overall Study|Withdrawal by Subject|1|||
131172106|NCT01670656|472250487|FG002|Overall Study|Withdrawal by Subject|0|||
130781724|NCT02864407|470827517|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
130781725|NCT02864407|470827517|FG000|Overall Study|Consent prior to the contract date|1|||
130781726|NCT04577794|470827525|FG000|Overall Study|Adverse Event|1|||
130781727|NCT04577794|470827526|FG001|Overall Study|Adverse Event|1|||
130781728|NCT02849080|470827527|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
130781729|NCT02849080|470827528|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
130781730|NCT02849080|470827529|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
130781731|NCT02849080|470827530|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
130781732|NCT02849080|470827527|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
130781733|NCT02849080|470827528|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
130781734|NCT02849080|470827529|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
130781735|NCT02849080|470827530|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
130781736|NCT02849080|470827527|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
130781737|NCT02849080|470827528|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
130781738|NCT02849080|470827529|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
130781739|NCT02849080|470827530|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
130781740|NCT02849080|470827527|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
130781741|NCT02849080|470827528|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
130781742|NCT02849080|470827529|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
130781743|NCT02849080|470827530|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
130781744|NCT02849080|470827527|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
130781745|NCT02849080|470827528|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
130781746|NCT02849080|470827529|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
130781747|NCT02849080|470827530|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
130781748|NCT02849080|470827527|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
130781749|NCT02849080|470827528|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
131235992|NCT00287118|472493187|FG000|Overall Study|Lost to Follow-up|1|||
131235993|NCT00287118|472493187|FG000|Overall Study|Protocol Violation|2|||
131235994|NCT00287118|472493187|FG000|Overall Study|Other|7|||
131235995|NCT00262600|472493188|FG000|Overall Study|Lost to Follow-up|17|||
131235996|NCT00262600|472493189|FG001|Overall Study|Lost to Follow-up|31|||
131235997|NCT00262600|472493190|FG002|Overall Study|Lost to Follow-up|41|||
131235998|NCT00262600|472493188|FG000|Overall Study|Withdrawal by Subject|128|||
131235999|NCT00262600|472493189|FG001|Overall Study|Withdrawal by Subject|145|||
131236000|NCT00262600|472493190|FG002|Overall Study|Withdrawal by Subject|139|||
131236001|NCT00262600|472493188|FG000|Overall Study|Not Treated|32|||
131236002|NCT00262600|472493189|FG001|Overall Study|Not Treated|17|||
131236003|NCT00262600|472493190|FG002|Overall Study|Not Treated|24|||
131236004|NCT00262600|472493188|FG000|Overall Study|Other|58|||
131236005|NCT00262600|472493189|FG001|Overall Study|Other|59|||
131236006|NCT00262600|472493190|FG002|Overall Study|Other|62|||
131236007|NCT02906709|472493199|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
131236008|NCT02906709|472493200|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
131236009|NCT02906709|472493199|FG000|Phase A (Week 0 to Week 16)|Death|0|||
131236010|NCT02906709|472493200|FG001|Phase A (Week 0 to Week 16)|Death|1|||
131236011|NCT02906709|472493199|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
131236012|NCT02906709|472493200|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
131236013|NCT02906709|472493199|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
131236014|NCT02906709|472493200|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
130730712|NCT00445432|470635639|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
130730713|NCT00445432|470635640|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
130730714|NCT00445432|470635641|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
130730715|NCT01699815|470635642|FG000|Overall Study|Protocol Violation|4|||
130730716|NCT01699815|470635643|FG001|Overall Study|Protocol Violation|7|||
130730717|NCT01699815|470635642|FG000|Overall Study|record could not be located|1|||
130730718|NCT01699815|470635643|FG001|Overall Study|record could not be located|0|||
130730719|NCT01699815|470635642|FG000|Overall Study|Adverse Event|0|||
130730720|NCT01699815|470635643|FG001|Overall Study|Adverse Event|1|||
130730721|NCT00356525|470635644|FG000|Overall Study|Progressive Disease|8|||
130730722|NCT00356525|470635645|FG001|Overall Study|Progressive Disease|5|||
130730723|NCT00356525|470635646|FG002|Overall Study|Progressive Disease|4|||
130730724|NCT00356525|470635647|FG003|Overall Study|Progressive Disease|2|||
130730725|NCT00356525|470635644|FG000|Overall Study|Adverse Event|1|||
130730726|NCT00356525|470635645|FG001|Overall Study|Adverse Event|3|||
130730727|NCT00356525|470635646|FG002|Overall Study|Adverse Event|1|||
130730728|NCT00356525|470635647|FG003|Overall Study|Adverse Event|1|||
130730729|NCT00356525|470635644|FG000|Overall Study|Lost to Follow-up|1|||
130730730|NCT00356525|470635645|FG001|Overall Study|Lost to Follow-up|0|||
130730731|NCT00356525|470635646|FG002|Overall Study|Lost to Follow-up|0|||
130730732|NCT00356525|470635647|FG003|Overall Study|Lost to Follow-up|0|||
130730733|NCT00356525|470635644|FG000|Overall Study|Physician Decision|2|||
130730734|NCT00356525|470635645|FG001|Overall Study|Physician Decision|2|||
131236015|NCT02153398|472493201|FG000|Overall Study|Withdrawal by Subject|1|||
131236016|NCT02153398|472493202|FG001|Overall Study|Withdrawal by Subject|0|||
130730735|NCT00356525|470635646|FG002|Overall Study|Physician Decision|2|||
130730736|NCT00356525|470635647|FG003|Overall Study|Physician Decision|1|||
130730737|NCT00356525|470635644|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
130730738|NCT00356525|470635645|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
130730739|NCT00356525|470635646|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
130730740|NCT00356525|470635647|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
130730741|NCT00356525|470635644|FG000|Overall Study|Withdrawal by Subject|1|||
130730742|NCT00356525|470635645|FG001|Overall Study|Withdrawal by Subject|1|||
130730743|NCT00356525|470635646|FG002|Overall Study|Withdrawal by Subject|0|||
130730744|NCT00356525|470635647|FG003|Overall Study|Withdrawal by Subject|3|||
130730745|NCT00356525|470635644|FG000|Overall Study|Death|0|||
130730746|NCT00356525|470635645|FG001|Overall Study|Death|0|||
130730747|NCT00356525|470635646|FG002|Overall Study|Death|0|||
130730748|NCT00356525|470635647|FG003|Overall Study|Death|1|||
130730749|NCT00356525|470635644|FG000|Overall Study|Sponsor Decision|0|||
130730750|NCT00356525|470635645|FG001|Overall Study|Sponsor Decision|0|||
130730751|NCT00356525|470635646|FG002|Overall Study|Sponsor Decision|0|||
130730752|NCT00356525|470635647|FG003|Overall Study|Sponsor Decision|1|||
130730753|NCT04487067|470635670|FG000|Overall Study|Adverse Event|3|||
130730754|NCT04487067|470635670|FG000|Overall Study|Death Other Than Progressive Disease|60|||
130730755|NCT04487067|470635670|FG000|Overall Study|Death Due To Progressive Disease|40|||
130730756|NCT04487067|470635670|FG000|Overall Study|Lost to Follow-up|3|||
130730757|NCT04487067|470635670|FG000|Overall Study|Progressive Disease|1|||
130730758|NCT04487067|470635670|FG000|Overall Study|Protocol Violation|3|||
130730759|NCT04487067|470635670|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
130730760|NCT04487067|470635670|FG000|Overall Study|Withdrawal by Subject|15|||
130730761|NCT02211417|470635671|FG000|Overall Study|Withdrawal by Subject|11|||
130730762|NCT02211417|470635672|FG001|Overall Study|Withdrawal by Subject|8|||
130730763|NCT02211417|470635671|FG000|Overall Study|Protocol Violation|1|||
130730764|NCT02211417|470635672|FG001|Overall Study|Protocol Violation|0|||
130730765|NCT02211417|470635671|FG000|Overall Study|Pregnancy|0|||
130730766|NCT02211417|470635672|FG001|Overall Study|Pregnancy|1|||
130730767|NCT02211417|470635671|FG000|Overall Study|Lost to Follow-up|2|||
130730768|NCT02211417|470635672|FG001|Overall Study|Lost to Follow-up|3|||
130730769|NCT02211417|470635671|FG000|Overall Study|Adverse Event|1|||
130730770|NCT02211417|470635672|FG001|Overall Study|Adverse Event|4|||
130730771|NCT01755091|470635673|FG000|Overall Study|Withdrawal by Subject|6|||
130730772|NCT01755091|470635674|FG001|Overall Study|Withdrawal by Subject|1|||
130730773|NCT01755091|470635675|FG002|Overall Study|Withdrawal by Subject|3|||
130730774|NCT01755091|470635673|FG000|Overall Study|Adverse Event|1|||
130730775|NCT01755091|470635674|FG001|Overall Study|Adverse Event|1|||
130730776|NCT01755091|470635675|FG002|Overall Study|Adverse Event|1|||
130730777|NCT01755091|470635673|FG000|Overall Study|Lost to Follow-up|1|||
130730778|NCT01755091|470635674|FG001|Overall Study|Lost to Follow-up|0|||
130730779|NCT01755091|470635675|FG002|Overall Study|Lost to Follow-up|1|||
130730780|NCT01755091|470635673|FG000|Overall Study|Physician Decision|1|||
130730781|NCT01755091|470635674|FG001|Overall Study|Physician Decision|1|||
130730782|NCT01755091|470635675|FG002|Overall Study|Physician Decision|2|||
130730783|NCT00490841|470635676|FG000|Overall Study|Death|5|||
130730784|NCT00490841|470635676|FG000|Overall Study|Withdrawal by Subject|4|||
130730785|NCT00490841|470635676|FG000|Overall Study|Lost to Follow-up|1|||
130730786|NCT00490841|470635676|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
130730787|NCT06385483|470635677|FG000|Overall Study|Withdrawal by Subject|2|||
130730788|NCT06385483|470635677|FG000|Overall Study|Never start protocol therapy|2|||
130730789|NCT06385483|470635677|FG000|Overall Study|Disease progression|15|||
130730790|NCT01098487|470635678|FG000|Overall Study|Adverse Event|22|||
130730791|NCT01098487|470635678|FG000|Overall Study|Lack of Efficacy|11|||
130730792|NCT01098487|470635678|FG000|Overall Study|Withdrawal by Subject|7|||
130730793|NCT01098487|470635678|FG000|Overall Study|Lost to Follow-up|3|||
130730794|NCT01098487|470635678|FG000|Overall Study|Physician Decision|1|||
130730795|NCT00345631|470635679|FG000|Overall Study|Withdrawal by Subject|1|||
130730796|NCT00345631|470635680|FG001|Overall Study|Withdrawal by Subject|0|||
130730797|NCT00345631|470635681|FG002|Overall Study|Withdrawal by Subject|1|||
130781750|NCT02849080|470827529|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
130781751|NCT02849080|470827530|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
130730798|NCT00345631|470635679|FG000|Overall Study|Adverse Event|0|||
130730799|NCT00345631|470635680|FG001|Overall Study|Adverse Event|1|||
130730800|NCT00345631|470635681|FG002|Overall Study|Adverse Event|0|||
130730801|NCT00345631|470635679|FG000|Overall Study|Lost to Follow-up|3|||
130730802|NCT00345631|470635680|FG001|Overall Study|Lost to Follow-up|7|||
130730803|NCT00345631|470635681|FG002|Overall Study|Lost to Follow-up|4|||
130730804|NCT00345631|470635679|FG000|Overall Study|Other reasons|0|||
130730805|NCT00345631|470635680|FG001|Overall Study|Other reasons|0|||
130730806|NCT00345631|470635681|FG002|Overall Study|Other reasons|1|||
130730807|NCT01301729|470635682|FG000|Overall Study|Withdrawal by Subject|2|||
130730808|NCT01301729|470635682|FG000|Overall Study|Participant did not Return for Treatment|1|||
130730809|NCT01301729|470635682|FG000|Overall Study|Violated Selection Criteria|1|||
130730810|NCT01885195|470635683|FG000|Overall Study|Adverse Event|29|||
130730811|NCT01885195|470635683|FG000|Overall Study|Death|1|||
130730812|NCT01885195|470635683|FG000|Overall Study|Disease Progression|67|||
131236017|NCT02153398|472493203|FG002|Overall Study|Withdrawal by Subject|0|||
131236018|NCT02153398|472493204|FG003|Overall Study|Withdrawal by Subject|0|||
131236019|NCT02153398|472493205|FG004|Overall Study|Withdrawal by Subject|0|||
131236020|NCT02153398|472493201|FG000|Overall Study|Adverse Event|0|||
131236021|NCT02153398|472493202|FG001|Overall Study|Adverse Event|0|||
131236022|NCT02153398|472493203|FG002|Overall Study|Adverse Event|1|||
131236023|NCT02153398|472493204|FG003|Overall Study|Adverse Event|1|||
131236024|NCT02153398|472493205|FG004|Overall Study|Adverse Event|0|||
131236025|NCT00721409|472493206|FG000|Overall Study|Global deterioration of health status|2|||
131236026|NCT00721409|472493207|FG001|Overall Study|Global deterioration of health status|6|||
131236027|NCT00721409|472493208|FG002|Overall Study|Global deterioration of health status|3|||
131236028|NCT00721409|472493206|FG000|Overall Study|Death|0|||
131236029|NCT00721409|472493207|FG001|Overall Study|Death|1|||
131236030|NCT00721409|472493208|FG002|Overall Study|Death|0|||
131236031|NCT00721409|472493206|FG000|Overall Study|Randomized not Treated|0|||
131236032|NCT00721409|472493207|FG001|Overall Study|Randomized not Treated|1|||
131236033|NCT00721409|472493208|FG002|Overall Study|Randomized not Treated|4|||
131236034|NCT00721409|472493206|FG000|Overall Study|Reason not specified|1|||
131236035|NCT00721409|472493207|FG001|Overall Study|Reason not specified|0|||
131236036|NCT00721409|472493208|FG002|Overall Study|Reason not specified|2|||
131236037|NCT00721409|472493206|FG000|Overall Study|Adverse Event|0|||
131236038|NCT00721409|472493207|FG001|Overall Study|Adverse Event|13|||
131236039|NCT00721409|472493208|FG002|Overall Study|Adverse Event|2|||
131236040|NCT00721409|472493206|FG000|Overall Study|Lost to Follow-up|0|||
131236041|NCT00721409|472493207|FG001|Overall Study|Lost to Follow-up|0|||
131236042|NCT00721409|472493208|FG002|Overall Study|Lost to Follow-up|1|||
131236043|NCT00721409|472493206|FG000|Overall Study|Withdrawal by Subject|1|||
131236044|NCT00721409|472493207|FG001|Overall Study|Withdrawal by Subject|6|||
131236045|NCT00721409|472493208|FG002|Overall Study|Withdrawal by Subject|5|||
130730813|NCT01885195|470635683|FG000|Overall Study|Protocol Deviation|2|||
130730814|NCT01885195|470635683|FG000|Overall Study|Physician Decision|3|||
130730815|NCT01885195|470635683|FG000|Overall Study|Patient/guardian decision|8|||
130730816|NCT04700137|470635684|FG000|Overall Study|Lost to Follow-up|1|||
130730817|NCT04700137|470635685|FG001|Overall Study|Lost to Follow-up|6|||
130730818|NCT04700137|470635686|FG002|Overall Study|Lost to Follow-up|1|||
130730819|NCT04700137|470635687|FG003|Overall Study|Lost to Follow-up|1|||
130730820|NCT04700137|470635684|FG000|Overall Study|Withdrawal by Subject|0|||
130730821|NCT04700137|470635685|FG001|Overall Study|Withdrawal by Subject|0|||
130730822|NCT04700137|470635686|FG002|Overall Study|Withdrawal by Subject|1|||
130730823|NCT04700137|470635687|FG003|Overall Study|Withdrawal by Subject|0|||
130730824|NCT04700137|470635684|FG000|Overall Study|Death|0|||
130730825|NCT04700137|470635685|FG001|Overall Study|Death|0|||
130730826|NCT04700137|470635686|FG002|Overall Study|Death|1|||
130730827|NCT04700137|470635687|FG003|Overall Study|Death|0|||
130730828|NCT01320150|470635689|FG000|Overall Study|Protocol Violation|15|||
130730829|NCT01320150|470635689|FG000|Overall Study|Withdrawal by Subject|5|||
130730830|NCT01320150|470635689|FG000|Overall Study|Death|2|||
130730831|NCT01320150|470635689|FG000|Overall Study|Lost to Follow-up|44|||
130730832|NCT00919854|470635692|FG000|Overall Study|Adverse Event|1|||
130730833|NCT00985491|470635693|FG000|Overall Study|Adverse Event|8|||
130730834|NCT00985491|470635693|FG000|Overall Study|device migration|7|||
130730835|NCT00985491|470635693|FG000|Overall Study|Withdrawal by Subject|1|||
130730836|NCT00985491|470635693|FG000|Overall Study|implant failure|3|||
130730837|NCT04386616|470635700|FG000|Overall Study|Death|22|||
130730838|NCT04386616|470635701|FG001|Overall Study|Death|22|||
130730839|NCT04386616|470635702|FG002|Overall Study|Death|21|||
130730840|NCT04386616|470635700|FG000|Overall Study|Lost to Follow-up|5|||
130730841|NCT04386616|470635701|FG001|Overall Study|Lost to Follow-up|8|||
130730842|NCT04386616|470635702|FG002|Overall Study|Lost to Follow-up|6|||
130730843|NCT04386616|470635700|FG000|Overall Study|Withdrawal by Subject|2|||
130730844|NCT04386616|470635701|FG001|Overall Study|Withdrawal by Subject|4|||
130730845|NCT04386616|470635702|FG002|Overall Study|Withdrawal by Subject|1|||
130730846|NCT04386616|470635700|FG000|Overall Study|Adverse Event|1|||
130730847|NCT04386616|470635701|FG001|Overall Study|Adverse Event|1|||
130781752|NCT01819727|470827531|FG000|Overall Study|Adverse Event|8|||
130730848|NCT04386616|470635702|FG002|Overall Study|Adverse Event|0|||
130730849|NCT01862484|470635703|FG000|Overall Study|Lack of Efficacy|1|||
130730850|NCT01862484|470635704|FG001|Overall Study|Lack of Efficacy|1|||
130730851|NCT01862484|470635703|FG000|Overall Study|Lost to Follow-up|1|||
130781753|NCT01819727|470827532|FG001|Overall Study|Adverse Event|9|||
130781754|NCT01819727|470827531|FG000|Overall Study|Death|1|||
131236046|NCT00721409|472493206|FG000|Overall Study|Objective progression or relapse|8|||
131236047|NCT00721409|472493207|FG001|Overall Study|Objective progression or relapse|55|||
131236048|NCT00721409|472493208|FG002|Overall Study|Objective progression or relapse|62|||
131236049|NCT02402166|472493209|FG000|Overall Study|Adverse Event|2|||
130730852|NCT01862484|470635704|FG001|Overall Study|Lost to Follow-up|2|||
130730853|NCT01862484|470635703|FG000|Overall Study|Protocol Violation|0|||
130730854|NCT01862484|470635704|FG001|Overall Study|Protocol Violation|2|||
130781755|NCT01819727|470827532|FG001|Overall Study|Death|0|||
130781756|NCT01819727|470827531|FG000|Overall Study|Lost to Follow-up|1|||
130781757|NCT01819727|470827532|FG001|Overall Study|Lost to Follow-up|1|||
130781758|NCT01819727|470827531|FG000|Overall Study|Physician Decision|3|||
130781759|NCT01819727|470827532|FG001|Overall Study|Physician Decision|2|||
131172107|NCT01670656|472250488|FG003|Overall Study|Withdrawal by Subject|0|||
131172108|NCT01670656|472250489|FG004|Overall Study|Withdrawal by Subject|0|||
130730855|NCT01862484|470635703|FG000|Overall Study|Withdrawal by Subject|0|||
130730856|NCT01862484|470635704|FG001|Overall Study|Withdrawal by Subject|3|||
130730857|NCT01632280|470635705|FG000|Overall Study|Withdrawal by Subject|1|||
130730858|NCT01632280|470635706|FG001|Overall Study|Withdrawal by Subject|0|||
130730859|NCT00993421|470635707|FG000|Overall Study|Adverse Event|2|||
130730860|NCT00993421|470635708|FG001|Overall Study|Adverse Event|7|||
130730861|NCT00993421|470635709|FG002|Overall Study|Adverse Event|6|||
131172109|NCT01670656|472250485|FG000|Overall Study|Non-compliance with protocol|0|||
130730862|NCT00993421|470635710|FG003|Overall Study|Adverse Event|9|||
130730863|NCT00993421|470635711|FG004|Overall Study|Adverse Event|5|||
130730864|NCT00993421|470635712|FG005|Overall Study|Adverse Event|7|||
130730865|NCT00993421|470635713|FG006|Overall Study|Adverse Event|1|||
130730866|NCT00993421|470635707|FG000|Overall Study|Sponsor Decision|36|||
130730867|NCT00993421|470635708|FG001|Overall Study|Sponsor Decision|31|||
130730868|NCT00993421|470635709|FG002|Overall Study|Sponsor Decision|28|||
130730869|NCT00993421|470635710|FG003|Overall Study|Sponsor Decision|30|||
130730870|NCT00993421|470635711|FG004|Overall Study|Sponsor Decision|38|||
130730871|NCT00993421|470635712|FG005|Overall Study|Sponsor Decision|30|||
130730872|NCT00993421|470635713|FG006|Overall Study|Sponsor Decision|29|||
130730873|NCT00993421|470635707|FG000|Overall Study|Lost to Follow-up|3|||
130730874|NCT00993421|470635708|FG001|Overall Study|Lost to Follow-up|5|||
130730875|NCT00993421|470635709|FG002|Overall Study|Lost to Follow-up|5|||
130730876|NCT00993421|470635710|FG003|Overall Study|Lost to Follow-up|0|||
130730877|NCT00993421|470635711|FG004|Overall Study|Lost to Follow-up|0|||
130730878|NCT00993421|470635712|FG005|Overall Study|Lost to Follow-up|0|||
130730879|NCT00993421|470635713|FG006|Overall Study|Lost to Follow-up|6|||
130730880|NCT00993421|470635707|FG000|Overall Study|Withdrawal by Subject|3|||
130730881|NCT00993421|470635708|FG001|Overall Study|Withdrawal by Subject|2|||
130730882|NCT00993421|470635709|FG002|Overall Study|Withdrawal by Subject|3|||
130730883|NCT00993421|470635710|FG003|Overall Study|Withdrawal by Subject|3|||
130730884|NCT00993421|470635711|FG004|Overall Study|Withdrawal by Subject|3|||
130730885|NCT00993421|470635712|FG005|Overall Study|Withdrawal by Subject|5|||
130730886|NCT00993421|470635713|FG006|Overall Study|Withdrawal by Subject|3|||
130730887|NCT00993421|470635707|FG000|Overall Study|Death|0|||
130730888|NCT00993421|470635708|FG001|Overall Study|Death|0|||
130730889|NCT00993421|470635709|FG002|Overall Study|Death|0|||
130730890|NCT00993421|470635710|FG003|Overall Study|Death|0|||
130730891|NCT00993421|470635711|FG004|Overall Study|Death|0|||
130730892|NCT00993421|470635712|FG005|Overall Study|Death|0|||
130730893|NCT00993421|470635713|FG006|Overall Study|Death|1|||
130730894|NCT00993421|470635707|FG000|Overall Study|Entry Criteria Exclusion|0|||
130730895|NCT00993421|470635708|FG001|Overall Study|Entry Criteria Exclusion|0|||
130730896|NCT00993421|470635709|FG002|Overall Study|Entry Criteria Exclusion|1|||
130730897|NCT00993421|470635710|FG003|Overall Study|Entry Criteria Exclusion|3|||
130730898|NCT00993421|470635711|FG004|Overall Study|Entry Criteria Exclusion|0|||
130730899|NCT00993421|470635712|FG005|Overall Study|Entry Criteria Exclusion|1|||
130730900|NCT00993421|470635713|FG006|Overall Study|Entry Criteria Exclusion|0|||
130730901|NCT00993421|470635707|FG000|Overall Study|Physician Decision|0|||
130730902|NCT00993421|470635708|FG001|Overall Study|Physician Decision|0|||
130730903|NCT00993421|470635709|FG002|Overall Study|Physician Decision|0|||
130730904|NCT00993421|470635710|FG003|Overall Study|Physician Decision|0|||
130730905|NCT00993421|470635711|FG004|Overall Study|Physician Decision|0|||
130730906|NCT00993421|470635712|FG005|Overall Study|Physician Decision|1|||
130730907|NCT00993421|470635713|FG006|Overall Study|Physician Decision|1|||
131172110|NCT01670656|472250486|FG001|Overall Study|Non-compliance with protocol|3|||
131172111|NCT01670656|472250487|FG002|Overall Study|Non-compliance with protocol|1|||
131172112|NCT01670656|472250488|FG003|Overall Study|Non-compliance with protocol|1|||
131172113|NCT01670656|472250489|FG004|Overall Study|Non-compliance with protocol|2|||
130730908|NCT00993421|470635707|FG000|Overall Study|Protocol Violation|0|||
130730909|NCT00993421|470635708|FG001|Overall Study|Protocol Violation|0|||
130730910|NCT00993421|470635709|FG002|Overall Study|Protocol Violation|0|||
130781760|NCT01819727|470827531|FG000|Overall Study|Pregnancy|1|||
130730911|NCT00993421|470635710|FG003|Overall Study|Protocol Violation|0|||
130730912|NCT00993421|470635711|FG004|Overall Study|Protocol Violation|0|||
130730913|NCT00993421|470635712|FG005|Overall Study|Protocol Violation|2|||
130730914|NCT00993421|470635713|FG006|Overall Study|Protocol Violation|1|||
131172114|NCT01670656|472250485|FG000|Overall Study|Adverse Event|2|||
130730915|NCT02215967|470635714|FG000|Overall Study|Patient became ineligible for treatment|0|||
130730916|NCT02215967|470635715|FG001|Overall Study|Patient became ineligible for treatment|0|||
130730917|NCT02215967|470635716|FG002|Overall Study|Patient became ineligible for treatment|0|||
130730918|NCT02215967|470635717|FG003|Overall Study|Patient became ineligible for treatment|3|||
130781761|NCT01819727|470827532|FG001|Overall Study|Pregnancy|0|||
131172115|NCT01670656|472250486|FG001|Overall Study|Adverse Event|2|||
130730919|NCT02215967|470635714|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
130730920|NCT02215967|470635715|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
130730921|NCT02215967|470635716|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
130730922|NCT02215967|470635717|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
130730923|NCT00352417|470635721|FG000|Overall Study|Adverse Event|1|||
130730924|NCT00352417|470635722|FG001|Overall Study|Adverse Event|0|||
130730925|NCT00352417|470635721|FG000|Overall Study|Protocol Violation|0|||
130730926|NCT00352417|470635722|FG001|Overall Study|Protocol Violation|2|||
130730927|NCT00352417|470635721|FG000|Overall Study|Withdrawal by Subject|1|||
130730928|NCT00352417|470635722|FG001|Overall Study|Withdrawal by Subject|2|||
130730929|NCT00352417|470635721|FG000|Overall Study|Lost to Follow-up|1|||
130730930|NCT00352417|470635722|FG001|Overall Study|Lost to Follow-up|0|||
130730931|NCT00352417|470635721|FG000|Overall Study|Schedule Change|2|||
130730932|NCT00352417|470635722|FG001|Overall Study|Schedule Change|1|||
130730933|NCT05292183|470637285|FG000|Overall Study|Adverse Event|1|||
130730934|NCT00371033|470637288|FG000|Overall Study|Lost to Follow-up|3|||
130730935|NCT00371033|470637289|FG001|Overall Study|Lost to Follow-up|2|||
130730936|NCT00371033|470637288|FG000|Overall Study|No longer interested|2|||
130730937|NCT00371033|470637289|FG001|Overall Study|No longer interested|0|||
130730938|NCT00371033|470637288|FG000|Overall Study|Uknown|3|||
130730939|NCT00371033|470637289|FG001|Overall Study|Uknown|1|||
130730940|NCT03631199|470637290|FG000|Overall Study|Progressive disease|9|||
130730941|NCT03631199|470637291|FG001|Overall Study|Progressive disease|5|||
130730942|NCT03631199|470637292|FG002|Overall Study|Progressive disease|5|||
130730943|NCT03631199|470637293|FG003|Overall Study|Progressive disease|149|||
130730944|NCT03631199|470637294|FG004|Overall Study|Progressive disease|148|||
130730945|NCT03631199|470637290|FG000|Overall Study|Physician Decision|0|||
130730946|NCT03631199|470637291|FG001|Overall Study|Physician Decision|2|||
130730947|NCT03631199|470637292|FG002|Overall Study|Physician Decision|3|||
130730948|NCT03631199|470637293|FG003|Overall Study|Physician Decision|19|||
130730949|NCT03631199|470637294|FG004|Overall Study|Physician Decision|13|||
130730950|NCT03631199|470637290|FG000|Overall Study|Adverse Event|1|||
130730951|NCT03631199|470637291|FG001|Overall Study|Adverse Event|1|||
130730952|NCT03631199|470637292|FG002|Overall Study|Adverse Event|0|||
130730953|NCT03631199|470637293|FG003|Overall Study|Adverse Event|28|||
130730954|NCT03631199|470637294|FG004|Overall Study|Adverse Event|29|||
130730955|NCT03631199|470637290|FG000|Overall Study|Death|0|||
130730956|NCT03631199|470637291|FG001|Overall Study|Death|1|||
130730957|NCT03631199|470637292|FG002|Overall Study|Death|0|||
130730958|NCT03631199|470637293|FG003|Overall Study|Death|35|||
130730959|NCT03631199|470637294|FG004|Overall Study|Death|48|||
130730960|NCT03631199|470637290|FG000|Overall Study|Subject decision|0|||
130730961|NCT03631199|470637291|FG001|Overall Study|Subject decision|1|||
130730962|NCT03631199|470637292|FG002|Overall Study|Subject decision|0|||
130730963|NCT03631199|470637293|FG003|Overall Study|Subject decision|12|||
130730964|NCT03631199|470637294|FG004|Overall Study|Subject decision|12|||
130730965|NCT03631199|470637290|FG000|Overall Study|No treated|0|||
130730966|NCT03631199|470637291|FG001|Overall Study|No treated|0|||
130730967|NCT03631199|470637292|FG002|Overall Study|No treated|0|||
130730968|NCT03631199|470637293|FG003|Overall Study|No treated|0|||
130730969|NCT03631199|470637294|FG004|Overall Study|No treated|1|||
130730970|NCT03631199|470637290|FG000|Overall Study|Treatment ongoing|0|||
130730971|NCT03631199|470637291|FG001|Overall Study|Treatment ongoing|1|||
130730972|NCT03631199|470637292|FG002|Overall Study|Treatment ongoing|1|||
130730973|NCT03631199|470637293|FG003|Overall Study|Treatment ongoing|76|||
130730974|NCT03631199|470637294|FG004|Overall Study|Treatment ongoing|71|||
130730975|NCT03631199|470637290|FG000|Overall Study|Guardian decision|0|||
130730976|NCT03631199|470637291|FG001|Overall Study|Guardian decision|0|||
130730977|NCT03631199|470637292|FG002|Overall Study|Guardian decision|0|||
130730978|NCT03631199|470637293|FG003|Overall Study|Guardian decision|1|||
130730979|NCT03631199|470637294|FG004|Overall Study|Guardian decision|1|||
130730980|NCT01272037|470637297|FG000|Overall Study|Death|25|||
130730981|NCT01272037|470637298|FG001|Overall Study|Death|28|||
131172116|NCT01670656|472250487|FG002|Overall Study|Adverse Event|2|||
131172117|NCT01670656|472250488|FG003|Overall Study|Adverse Event|3|||
131172118|NCT01670656|472250489|FG004|Overall Study|Adverse Event|3|||
131172119|NCT01670656|472250485|FG000|Overall Study|Subject withdrew consent|0|||
131172120|NCT01670656|472250486|FG001|Overall Study|Subject withdrew consent|1|||
130730982|NCT01272037|470637297|FG000|Overall Study|Adverse Event|12|||
130730983|NCT01272037|470637298|FG001|Overall Study|Adverse Event|7|||
130781762|NCT01819727|470827531|FG000|Overall Study|Protocol Violation|0|||
131172121|NCT01670656|472250487|FG002|Overall Study|Subject withdrew consent|2|||
131172122|NCT01670656|472250488|FG003|Overall Study|Subject withdrew consent|1|||
130730984|NCT01272037|470637297|FG000|Overall Study|Withdrawal by Subject|175|||
130730985|NCT01272037|470637298|FG001|Overall Study|Withdrawal by Subject|93|||
130730986|NCT01272037|470637297|FG000|Overall Study|Disease progression|70|||
130730987|NCT01272037|470637298|FG001|Overall Study|Disease progression|111|||
130730988|NCT01272037|470637297|FG000|Overall Study|Other reason|42|||
131172123|NCT01670656|472250489|FG004|Overall Study|Subject withdrew consent|1|||
130730989|NCT01272037|470637298|FG001|Overall Study|Other reason|41|||
130730990|NCT01272037|470637297|FG000|Overall Study|Delinquent data|24|||
131172124|NCT01670656|472250485|FG000|Overall Study|Lost to Follow-up|0|||
131172125|NCT01670656|472250486|FG001|Overall Study|Lost to Follow-up|0|||
131172126|NCT01670656|472250487|FG002|Overall Study|Lost to Follow-up|0|||
131172127|NCT01670656|472250488|FG003|Overall Study|Lost to Follow-up|0|||
131172128|NCT01670656|472250489|FG004|Overall Study|Lost to Follow-up|3|||
130730991|NCT01272037|470637298|FG001|Overall Study|Delinquent data|19|||
130730992|NCT01272037|470637297|FG000|Overall Study|Reason under review|33|||
130730993|NCT01272037|470637298|FG001|Overall Study|Reason under review|29|||
130730994|NCT01272037|470637297|FG000|Overall Study|On treatment|626|||
130730995|NCT01272037|470637298|FG001|Overall Study|On treatment|632|||
130730996|NCT02847260|470637299|FG000|Overall Study|Adverse Event|3|||
130730997|NCT02847260|470637299|FG000|Overall Study|Withdrawal by Subject|2|||
130730998|NCT02847260|470637299|FG000|Overall Study|Clinical Deterioration|1|||
130730999|NCT02847260|470637299|FG000|Overall Study|Physician Decision|1|||
130731000|NCT03698019|470637300|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
130731001|NCT03698019|470637301|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
130731002|NCT03698019|470637300|FG000|Step 1: Registration|Withdrawal by Subject|7|||
130731003|NCT03698019|470637301|FG001|Step 1: Registration|Withdrawal by Subject|2|||
130731004|NCT03698019|470637300|FG000|Step 1: Registration|Toxicity|0|||
130731005|NCT03698019|470637301|FG001|Step 1: Registration|Toxicity|1|||
130731006|NCT03698019|470637300|FG000|Step 1: Registration|Disease Progression|0|||
130731007|NCT03698019|470637301|FG001|Step 1: Registration|Disease Progression|12|||
130731008|NCT03698019|470637300|FG000|Step 1: Registration|Co-morbidities|0|||
130731009|NCT03698019|470637301|FG001|Step 1: Registration|Co-morbidities|1|||
130731010|NCT03698019|470637300|FG000|Step 1: Registration|Scheduling Issues|1|||
130731011|NCT03698019|470637301|FG001|Step 1: Registration|Scheduling Issues|0|||
130731012|NCT03698019|470637300|FG000|Step 1: Registration|Participant Refusal|0|||
130731013|NCT03698019|470637301|FG001|Step 1: Registration|Participant Refusal|1|||
130731014|NCT03698019|470637300|FG000|Step 2: Surgery|Participant Refusal|2|||
130731015|NCT03698019|470637301|FG001|Step 2: Surgery|Participant Refusal|1|||
130731016|NCT03698019|470637300|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
130731017|NCT03698019|470637301|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
130731018|NCT03698019|470637300|FG000|Step 2: Surgery|Metastatic Disease|16|||
130731019|NCT03698019|470637301|FG001|Step 2: Surgery|Metastatic Disease|9|||
130731020|NCT03698019|470637300|FG000|Step 2: Surgery|Residual Disease|2|||
130731021|NCT03698019|470637301|FG001|Step 2: Surgery|Residual Disease|1|||
130731022|NCT03698019|470637300|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
130731023|NCT03698019|470637301|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
130731024|NCT03698019|470637300|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
130731025|NCT03698019|470637301|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
130731026|NCT03698019|470637300|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
130731027|NCT03698019|470637301|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
130731028|NCT03698019|470637300|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
130731029|NCT03698019|470637301|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
130731030|NCT03698019|470637300|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
131172129|NCT01670656|472250485|FG000|Overall Study|Subject moved|0|||
131172130|NCT01670656|472250486|FG001|Overall Study|Subject moved|0|||
131172131|NCT01670656|472250487|FG002|Overall Study|Subject moved|0|||
131172132|NCT01670656|472250488|FG003|Overall Study|Subject moved|1|||
131172133|NCT01670656|472250489|FG004|Overall Study|Subject moved|0|||
131172134|NCT00789958|472250490|FG000|Overall Study|Adverse Event|3|||
131172135|NCT00789958|472250490|FG000|Overall Study|Withdrawal by Subject|4|||
131172136|NCT00789958|472250490|FG000|Overall Study|Progression|3|||
131172137|NCT00789958|472250490|FG000|Overall Study|not protocol specified|1|||
131172138|NCT00789958|472250490|FG000|Overall Study|Not eligible/not analyzable|26|||
131172139|NCT03331666|472250491|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
131172140|NCT03331666|472250492|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
131172141|NCT03583372|472250494|FG000|Overall Study|Withdrawal by Subject|6|||
131172142|NCT03583372|472250495|FG001|Overall Study|Withdrawal by Subject|11|||
131172143|NCT03583372|472250496|FG002|Overall Study|Withdrawal by Subject|7|||
131172144|NCT03583372|472250497|FG003|Overall Study|Withdrawal by Subject|8|||
131172145|NCT03583372|472250494|FG000|Overall Study|Lost to Follow-up|4|||
131172146|NCT03583372|472250495|FG001|Overall Study|Lost to Follow-up|6|||
131172147|NCT03583372|472250496|FG002|Overall Study|Lost to Follow-up|3|||
131172148|NCT03583372|472250497|FG003|Overall Study|Lost to Follow-up|2|||
131172149|NCT03583372|472250494|FG000|Overall Study|Adverse Event|1|||
130731031|NCT03698019|470637301|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
130781763|NCT01819727|470827532|FG001|Overall Study|Protocol Violation|2|||
131172150|NCT03583372|472250495|FG001|Overall Study|Adverse Event|3|||
131172151|NCT03583372|472250496|FG002|Overall Study|Adverse Event|4|||
130731032|NCT03698019|470637300|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
131172152|NCT03583372|472250497|FG003|Overall Study|Adverse Event|4|||
131172153|NCT03583372|472250494|FG000|Overall Study|Physician Decision|0|||
131172154|NCT03583372|472250495|FG001|Overall Study|Physician Decision|1|||
131236050|NCT02402166|472493209|FG000|Overall Study|Withdrawal by Subject|2|||
130731033|NCT03698019|470637301|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
130731034|NCT03698019|470637300|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
130731035|NCT03698019|470637301|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
130731036|NCT03698019|470637300|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
130731037|NCT03698019|470637301|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
130731038|NCT00588770|470637302|FG000|Overall Study|Disease progression|85|||
130731039|NCT00588770|470637303|FG001|Overall Study|Disease progression|68|||
130731040|NCT00588770|470637302|FG000|Overall Study|Adverse Event|29|||
130731041|NCT00588770|470637303|FG001|Overall Study|Adverse Event|58|||
130731042|NCT00588770|470637302|FG000|Overall Study|Death|13|||
130731043|NCT00588770|470637303|FG001|Overall Study|Death|22|||
130731044|NCT00588770|470637302|FG000|Overall Study|Withdrawal by Subject|15|||
130731045|NCT00588770|470637303|FG001|Overall Study|Withdrawal by Subject|25|||
130731046|NCT00588770|470637302|FG000|Overall Study|Alternative therapy|2|||
130731047|NCT00588770|470637303|FG001|Overall Study|Alternative therapy|4|||
130731048|NCT00588770|470637302|FG000|Overall Study|Other complicating disease|3|||
130731049|NCT00588770|470637303|FG001|Overall Study|Other complicating disease|2|||
130731050|NCT00588770|470637302|FG000|Overall Study|Not start protocol therapy|0|||
130731051|NCT00588770|470637303|FG001|Overall Study|Not start protocol therapy|9|||
130731052|NCT00588770|470637302|FG000|Overall Study|Lack of Efficacy|8|||
130731053|NCT00588770|470637303|FG001|Overall Study|Lack of Efficacy|10|||
130731054|NCT00588770|470637302|FG000|Overall Study|Physician discretion|2|||
130731055|NCT00588770|470637303|FG001|Overall Study|Physician discretion|0|||
130731056|NCT00588770|470637302|FG000|Overall Study|Patient non-compliance|2|||
130731057|NCT00588770|470637303|FG001|Overall Study|Patient non-compliance|2|||
130731058|NCT01856192|470637304|FG000|Overall Study|Adverse Event|12|||
130731059|NCT01856192|470637305|FG001|Overall Study|Adverse Event|4|||
130731060|NCT01856192|470637304|FG000|Overall Study|Alternative therapy|0|||
130731061|NCT01856192|470637305|FG001|Overall Study|Alternative therapy|3|||
130731062|NCT01856192|470637304|FG000|Overall Study|Death|3|||
130731063|NCT01856192|470637305|FG001|Overall Study|Death|5|||
130781764|NCT01819727|470827531|FG000|Overall Study|Study Terminated by Sponsor|0|||
131172155|NCT03583372|472250496|FG002|Overall Study|Physician Decision|1|||
131172156|NCT03583372|472250497|FG003|Overall Study|Physician Decision|1|||
131172157|NCT03583372|472250494|FG000|Overall Study|Lack of Efficacy|0|||
131172158|NCT03583372|472250495|FG001|Overall Study|Lack of Efficacy|1|||
131172159|NCT03583372|472250496|FG002|Overall Study|Lack of Efficacy|0|||
131172160|NCT03583372|472250497|FG003|Overall Study|Lack of Efficacy|1|||
131172161|NCT03583372|472250494|FG000|Overall Study|Death|1|||
131172162|NCT03583372|472250495|FG001|Overall Study|Death|0|||
131172163|NCT03583372|472250496|FG002|Overall Study|Death|0|||
131172164|NCT03583372|472250497|FG003|Overall Study|Death|0|||
131172165|NCT03583372|472250494|FG000|Overall Study|Protocol Violation|0|||
131172166|NCT03583372|472250495|FG001|Overall Study|Protocol Violation|1|||
131172167|NCT03583372|472250496|FG002|Overall Study|Protocol Violation|0|||
131172168|NCT03583372|472250497|FG003|Overall Study|Protocol Violation|0|||
131172169|NCT03583372|472250494|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
131172170|NCT03583372|472250495|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
131172171|NCT03583372|472250496|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
131172172|NCT03583372|472250497|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
131172173|NCT03583372|472250494|FG000|Overall Study|Did Not Receive Study Drug|0|||
131172174|NCT03583372|472250495|FG001|Overall Study|Did Not Receive Study Drug|1|||
131172175|NCT03583372|472250496|FG002|Overall Study|Did Not Receive Study Drug|0|||
131172176|NCT03583372|472250497|FG003|Overall Study|Did Not Receive Study Drug|0|||
131172177|NCT03583372|472250494|FG000|Overall Study|Captured as Other in the Database|1|||
131172178|NCT03583372|472250495|FG001|Overall Study|Captured as Other in the Database|2|||
131172179|NCT03583372|472250496|FG002|Overall Study|Captured as Other in the Database|4|||
131172180|NCT03583372|472250497|FG003|Overall Study|Captured as Other in the Database|1|||
131172181|NCT04831515|472250505|FG000|First Intervention|Adverse Event|0|||
131172182|NCT04831515|472250506|FG001|First Intervention|Adverse Event|1|||
131172183|NCT01640925|472250507|FG000|Overall Study|Withdrawal by Subject|1|||
131172184|NCT01640925|472250508|FG001|Overall Study|Withdrawal by Subject|0|||
131172185|NCT01640925|472250507|FG000|Overall Study|Previously enrolled in this trial|13|||
131172186|NCT01640925|472250508|FG001|Overall Study|Previously enrolled in this trial|11|||
131172187|NCT01030458|472250514|FG000|Overall Study|Lost to Follow-up|9|||
131172188|NCT01030458|472250515|FG001|Overall Study|Lost to Follow-up|10|||
131172189|NCT01030458|472250514|FG000|Overall Study|Withdrawal by Subject|2|||
131172190|NCT01030458|472250515|FG001|Overall Study|Withdrawal by Subject|3|||
130731064|NCT01856192|470637304|FG000|Overall Study|Lack of Efficacy|0|||
130731065|NCT01856192|470637305|FG001|Overall Study|Lack of Efficacy|5|||
130731066|NCT01856192|470637304|FG000|Overall Study|Withdrawal by Subject|1|||
130731067|NCT01856192|470637305|FG001|Overall Study|Withdrawal by Subject|1|||
130731068|NCT01856192|470637304|FG000|Overall Study|Other diseases|1|||
130731069|NCT01856192|470637305|FG001|Overall Study|Other diseases|0|||
130781765|NCT01819727|470827532|FG001|Overall Study|Study Terminated by Sponsor|1|||
130781766|NCT01819727|470827531|FG000|Overall Study|Withdrawal by Subject|6|||
130731070|NCT01856192|470637304|FG000|Overall Study|Never started treatment|7|||
131236051|NCT02402166|472493209|FG000|Overall Study|Lost to Follow-up|1|||
131236052|NCT02428699|472493214|FG000|Washout Period 1|Screen Failure|1|||
131236053|NCT02428699|472493215|FG001|Washout Period 1|Screen Failure|2|||
131236054|NCT00995410|472493218|FG000|Overall Study|Adverse Event|51|||
131236055|NCT00995410|472493218|FG000|Overall Study|Withdrawal by Subject|7|||
131236056|NCT00995410|472493218|FG000|Overall Study|Lost to Follow-up|2|||
131236057|NCT00995410|472493218|FG000|Overall Study|Misc|28|||
131236058|NCT02483975|472493219|FG000|Overall Study|Adverse Event|0|||
131236059|NCT02483975|472493220|FG001|Overall Study|Adverse Event|1|||
131236060|NCT02483975|472493219|FG000|Overall Study|Lost to Follow-up|0|||
131236061|NCT02483975|472493220|FG001|Overall Study|Lost to Follow-up|1|||
131236062|NCT02483975|472493219|FG000|Overall Study|Physician Decision|2|||
131236063|NCT02483975|472493220|FG001|Overall Study|Physician Decision|0|||
131236064|NCT01505530|472493221|FG000|Overall Study|Progressive Disease|19|||
131236065|NCT01505530|472493222|FG001|Overall Study|Progressive Disease|17|||
131236066|NCT01505530|472493223|FG002|Overall Study|Progressive Disease|18|||
131236067|NCT01505530|472493221|FG000|Overall Study|Adverse Event|1|||
131236068|NCT01505530|472493222|FG001|Overall Study|Adverse Event|1|||
131236069|NCT01505530|472493223|FG002|Overall Study|Adverse Event|0|||
131236070|NCT01505530|472493221|FG000|Overall Study|Withdrawal by Subject|7|||
131236071|NCT01505530|472493222|FG001|Overall Study|Withdrawal by Subject|8|||
131236072|NCT01505530|472493223|FG002|Overall Study|Withdrawal by Subject|6|||
131236073|NCT01505530|472493221|FG000|Overall Study|Physician Decision|6|||
131236074|NCT01505530|472493222|FG001|Overall Study|Physician Decision|2|||
131236075|NCT01505530|472493223|FG002|Overall Study|Physician Decision|5|||
131236076|NCT01505530|472493221|FG000|Overall Study|Sponsor Decision|1|||
131236077|NCT01505530|472493222|FG001|Overall Study|Sponsor Decision|8|||
131236078|NCT01505530|472493223|FG002|Overall Study|Sponsor Decision|7|||
131236079|NCT01505530|472493221|FG000|Overall Study|Death|7|||
131236080|NCT01505530|472493222|FG001|Overall Study|Death|6|||
131236081|NCT01505530|472493223|FG002|Overall Study|Death|5|||
131236082|NCT01505530|472493221|FG000|Overall Study|entry criteria not met|0|||
131236083|NCT01505530|472493222|FG001|Overall Study|entry criteria not met|1|||
131236084|NCT01505530|472493223|FG002|Overall Study|entry criteria not met|0|||
131236085|NCT02752776|472493224|FG000|Overall Study|Adverse Event|15|||
131236086|NCT02752776|472493225|FG001|Overall Study|Adverse Event|23|||
131236087|NCT02752776|472493226|FG002|Overall Study|Adverse Event|11|||
131236088|NCT02752776|472493224|FG000|Overall Study|Lack of Efficacy|2|||
131236089|NCT02752776|472493225|FG001|Overall Study|Lack of Efficacy|6|||
131236090|NCT02752776|472493226|FG002|Overall Study|Lack of Efficacy|14|||
131236091|NCT02752776|472493224|FG000|Overall Study|Lost to Follow-up|11|||
131236092|NCT02752776|472493225|FG001|Overall Study|Lost to Follow-up|12|||
131236093|NCT02752776|472493226|FG002|Overall Study|Lost to Follow-up|4|||
131236094|NCT02752776|472493224|FG000|Overall Study|Non-compliance with study treatment|0|||
131236095|NCT02752776|472493225|FG001|Overall Study|Non-compliance with study treatment|0|||
131236096|NCT02752776|472493226|FG002|Overall Study|Non-compliance with study treatment|1|||
131236097|NCT02752776|472493224|FG000|Overall Study|Physician Decision|2|||
131236098|NCT02752776|472493225|FG001|Overall Study|Physician Decision|6|||
131236099|NCT02752776|472493226|FG002|Overall Study|Physician Decision|2|||
131236100|NCT02752776|472493224|FG000|Overall Study|Pregnancy|1|||
131236101|NCT02752776|472493225|FG001|Overall Study|Pregnancy|6|||
130731071|NCT01856192|470637305|FG001|Overall Study|Never started treatment|5|||
130731072|NCT01856192|470637304|FG000|Overall Study|Path ineligible|20|||
130731073|NCT01856192|470637305|FG001|Overall Study|Path ineligible|34|||
130731074|NCT01856192|470637304|FG000|Overall Study|Non-path ineligible|2|||
130731075|NCT01856192|470637305|FG001|Overall Study|Non-path ineligible|2|||
130731076|NCT01856192|470637304|FG000|Overall Study|Physician Decision|1|||
130731077|NCT01856192|470637305|FG001|Overall Study|Physician Decision|1|||
130731078|NCT01856192|470637304|FG000|Overall Study|Suspicion of progressive disease|1|||
130731079|NCT01856192|470637305|FG001|Overall Study|Suspicion of progressive disease|0|||
130731080|NCT01856192|470637304|FG000|Overall Study|Non-compliance|1|||
130731081|NCT01856192|470637305|FG001|Overall Study|Non-compliance|0|||
130731082|NCT02642042|470637306|FG000|Overall Study|Adverse Event|22|||
130731083|NCT02642042|470637306|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
131236102|NCT02752776|472493226|FG002|Overall Study|Pregnancy|3|||
131236103|NCT02752776|472493224|FG000|Overall Study|Protocol Violation|10|||
131236104|NCT02752776|472493225|FG001|Overall Study|Protocol Violation|13|||
131236105|NCT02752776|472493226|FG002|Overall Study|Protocol Violation|6|||
131236106|NCT02752776|472493224|FG000|Overall Study|Subject/guardian decision|8|||
131236107|NCT02752776|472493225|FG001|Overall Study|Subject/guardian decision|6|||
131236108|NCT02752776|472493226|FG002|Overall Study|Subject/guardian decision|4|||
131236109|NCT02752776|472493224|FG000|Overall Study|Death|0|||
130731084|NCT02642042|470637306|FG000|Overall Study|Progression/Relapse|28|||
131236110|NCT02752776|472493225|FG001|Overall Study|Death|0|||
131236111|NCT02752776|472493226|FG002|Overall Study|Death|1|||
131236112|NCT02752776|472493224|FG000|Overall Study|Withdrawal by Subject|3|||
131236113|NCT02752776|472493225|FG001|Overall Study|Withdrawal by Subject|4|||
131236114|NCT02752776|472493226|FG002|Overall Study|Withdrawal by Subject|2|||
131236115|NCT02492958|472493227|FG000|Overall Study|Withdrawal by Subject|0|||
131236116|NCT02492958|472493228|FG001|Overall Study|Withdrawal by Subject|0|||
130781767|NCT01819727|470827532|FG001|Overall Study|Withdrawal by Subject|11|||
130781768|NCT01819727|470827531|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
130781769|NCT01819727|470827532|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
130781770|NCT01819727|470827531|FG000|Overall Study|Quit due to lack of health benifits|0|||
130781771|NCT01819727|470827532|FG001|Overall Study|Quit due to lack of health benifits|1|||
130781772|NCT03839394|470827536|FG000|Overall Study|Lost to Follow-up|6|||
130781773|NCT03839394|470827537|FG001|Overall Study|Lost to Follow-up|8|||
130781774|NCT03839394|470827536|FG000|Overall Study|Withdrawal by Subject|0|||
131172191|NCT01030458|472250514|FG000|Overall Study|Logistical reasons|9|||
131172192|NCT01030458|472250515|FG001|Overall Study|Logistical reasons|5|||
131172193|NCT01030458|472250514|FG000|Overall Study|Moved or changed job|6|||
131172194|NCT01030458|472250515|FG001|Overall Study|Moved or changed job|13|||
131172195|NCT01030458|472250514|FG000|Overall Study|Side effect of medication|1|||
131172196|NCT01030458|472250515|FG001|Overall Study|Side effect of medication|1|||
131172197|NCT02420223|472250516|FG000|Overall Study|Adverse Event|1|||
131172198|NCT02420223|472250517|FG001|Overall Study|Adverse Event|0|||
131172199|NCT02420223|472250516|FG000|Overall Study|Physician Decision|0|||
131172200|NCT02420223|472250517|FG001|Overall Study|Physician Decision|2|||
131172201|NCT02345252|472250524|FG000|Double-Blind Phase|Adverse Event|2|||
131172202|NCT02345252|472250525|FG001|Double-Blind Phase|Adverse Event|3|||
131172203|NCT02345252|472250524|FG000|Double-Blind Phase|Death|1|||
131172204|NCT02345252|472250525|FG001|Double-Blind Phase|Death|2|||
131172205|NCT02345252|472250524|FG000|Double-Blind Phase|Lack of Efficacy|1|||
131172206|NCT02345252|472250525|FG001|Double-Blind Phase|Lack of Efficacy|0|||
131172207|NCT02345252|472250524|FG000|Double-Blind Phase|Investigator's Discretion|4|||
131172208|NCT02345252|472250525|FG001|Double-Blind Phase|Investigator's Discretion|6|||
131172209|NCT02345252|472250524|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
131172210|NCT02345252|472250525|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
131172211|NCT02345252|472250524|FG000|Double-Blind Phase|Protocol Violation|2|||
131172212|NCT02345252|472250525|FG001|Double-Blind Phase|Protocol Violation|1|||
131172213|NCT02345252|472250524|FG000|Double-Blind Phase|Withdrew Consent|21|||
131172214|NCT02345252|472250525|FG001|Double-Blind Phase|Withdrew Consent|23|||
131172215|NCT02345252|472250524|FG000|Double-Blind Phase|Lost to Follow-up|8|||
131172216|NCT02345252|472250525|FG001|Double-Blind Phase|Lost to Follow-up|10|||
131172217|NCT02345252|472250524|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
131172218|NCT02345252|472250525|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
131172219|NCT01980706|472250526|FG000|Overall Study|Withdrawal by Subject|9|||
131172220|NCT01980706|472250527|FG001|Overall Study|Withdrawal by Subject|6|||
131172221|NCT01980706|472250528|FG002|Overall Study|Withdrawal by Subject|2|||
131172222|NCT01980706|472250526|FG000|Overall Study|Adverse Event|1|||
131172223|NCT01980706|472250527|FG001|Overall Study|Adverse Event|2|||
131172224|NCT01980706|472250528|FG002|Overall Study|Adverse Event|5|||
131172225|NCT01980706|472250526|FG000|Overall Study|Lost to Follow-up|3|||
131172226|NCT01980706|472250527|FG001|Overall Study|Lost to Follow-up|4|||
131172227|NCT01980706|472250528|FG002|Overall Study|Lost to Follow-up|3|||
131172228|NCT01980706|472250526|FG000|Overall Study|miscellaneous|4|||
131172229|NCT01980706|472250527|FG001|Overall Study|miscellaneous|5|||
131172230|NCT01980706|472250528|FG002|Overall Study|miscellaneous|3|||
131172231|NCT04056455|472250529|FG000|Overall Study|Adverse Event|1|||
131172232|NCT04056455|472250530|FG001|Overall Study|Adverse Event|0|||
131172233|NCT03521687|472250531|FG000|Overall Study|Adverse Event|4|||
131172234|NCT03521687|472250531|FG000|Overall Study|Physician Decision|1|||
131172235|NCT01151579|472250534|FG000|Overall Study|Physician Decision|3|||
131172236|NCT01151579|472250535|FG001|Overall Study|Physician Decision|1|||
131172237|NCT01151579|472250534|FG000|Overall Study|Withdrawal by Subject|3|||
131172238|NCT01151579|472250535|FG001|Overall Study|Withdrawal by Subject|2|||
131172239|NCT01151579|472250534|FG000|Overall Study|Not meet inclusion criteria|6|||
131172240|NCT01151579|472250535|FG001|Overall Study|Not meet inclusion criteria|4|||
131172241|NCT01276457|472250536|FG000|Core Study|Adverse Event|6|||
131172242|NCT01276457|472250537|FG001|Core Study|Adverse Event|3|||
131172243|NCT01276457|472250536|FG000|Core Study|Lost to Follow-up|1|||
131172244|NCT01276457|472250537|FG001|Core Study|Lost to Follow-up|2|||
131172245|NCT01276457|472250536|FG000|Core Study|Administrative problems|1|||
131172246|NCT01276457|472250537|FG001|Core Study|Administrative problems|1|||
131172247|NCT01276457|472250536|FG000|Core Study|Death|2|||
131172248|NCT01276457|472250537|FG001|Core Study|Death|2|||
131172249|NCT01276457|472250536|FG000|Core Study|Lack of Efficacy|3|||
131172250|NCT01276457|472250537|FG001|Core Study|Lack of Efficacy|12|||
131172251|NCT01276457|472250536|FG000|Extension Study|Lost to Follow-up|3|||
131172252|NCT01276457|472250537|FG001|Extension Study|Lost to Follow-up|0|||
131172253|NCT01276457|472250536|FG000|Extension Study|Death|0|||
131172254|NCT01276457|472250537|FG001|Extension Study|Death|1|||
131172255|NCT01276457|472250536|FG000|Extension Study|Lack of Efficacy|3|||
131172256|NCT01276457|472250537|FG001|Extension Study|Lack of Efficacy|1|||
131172257|NCT02065869|472250543|FG000|Overall Study|Death|7|||
131172258|NCT02065869|472250543|FG000|Overall Study|Disease relapse|16|||
131172259|NCT02065869|472250543|FG000|Overall Study|Lost to Follow-up|4|||
131172260|NCT02065869|472250543|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
130781775|NCT03839394|470827537|FG001|Overall Study|Withdrawal by Subject|2|||
131172261|NCT02065869|472250543|FG000|Overall Study|Withdrawal by Subject|1|||
131172262|NCT03807739|472250544|FG000|Overall Study|Adverse Event|1|||
131172263|NCT03807739|472250545|FG001|Overall Study|Adverse Event|0|||
131172264|NCT03807739|472250546|FG002|Overall Study|Adverse Event|0|||
130731085|NCT02642042|470637306|FG000|Overall Study|Death|1|||
130731086|NCT02642042|470637306|FG000|Overall Study|Not Protocol Specified|2|||
130731087|NCT04976621|470637307|FG000|Overall Study|Lost to Follow-up|2|||
130731088|NCT04976621|470637308|FG001|Overall Study|Lost to Follow-up|1|||
130731089|NCT04976621|470637307|FG000|Overall Study|Withdrawal by Subject|1|||
130731090|NCT04976621|470637308|FG001|Overall Study|Withdrawal by Subject|0|||
130731091|NCT01495702|470637314|FG000|Randomized Phase|Randomized But Not Treated|1|||
130731092|NCT01495702|470637315|FG001|Randomized Phase|Randomized But Not Treated|4|||
130731093|NCT01495702|470637314|FG000|Randomized Phase|Adverse Event|2|||
130731094|NCT01495702|470637315|FG001|Randomized Phase|Adverse Event|2|||
130731095|NCT01495702|470637314|FG000|Randomized Phase|Death|1|||
130731096|NCT01495702|470637315|FG001|Randomized Phase|Death|0|||
130731097|NCT01495702|470637314|FG000|Randomized Phase|Lack of Efficacy|2|||
130731098|NCT01495702|470637315|FG001|Randomized Phase|Lack of Efficacy|0|||
130731099|NCT01495702|470637314|FG000|Randomized Phase|Investigators Discretion|2|||
130731100|NCT01495702|470637315|FG001|Randomized Phase|Investigators Discretion|0|||
130731101|NCT01495702|470637314|FG000|Randomized Phase|Withdrew Consent|10|||
130731102|NCT01495702|470637315|FG001|Randomized Phase|Withdrew Consent|18|||
130731103|NCT01495702|470637314|FG000|Randomized Phase|Lost to Follow-up|4|||
130731104|NCT01495702|470637315|FG001|Randomized Phase|Lost to Follow-up|3|||
130731105|NCT01495702|470637314|FG000|Randomized Phase|Participant Noncompliance|1|||
130731106|NCT01495702|470637315|FG001|Randomized Phase|Participant Noncompliance|0|||
130731107|NCT01495702|470637314|FG000|Randomized Phase|Protocol Violation|3|||
130731108|NCT01495702|470637315|FG001|Randomized Phase|Protocol Violation|1|||
130731109|NCT04152863|470637316|FG000|Overall Study|Death|13|||
130731110|NCT04152863|470637317|FG001|Overall Study|Death|12|||
130731111|NCT04152863|470637318|FG002|Overall Study|Death|7|||
130731112|NCT04152863|470637316|FG000|Overall Study|Physician Decision|1|||
130731113|NCT04152863|470637317|FG001|Overall Study|Physician Decision|1|||
130731114|NCT04152863|470637318|FG002|Overall Study|Physician Decision|1|||
130731115|NCT04152863|470637316|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
130731116|NCT04152863|470637317|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
130731117|NCT04152863|470637318|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
130731118|NCT04152863|470637316|FG000|Overall Study|Withdrawal by Subject|2|||
130731119|NCT04152863|470637317|FG001|Overall Study|Withdrawal by Subject|1|||
130731120|NCT04152863|470637318|FG002|Overall Study|Withdrawal by Subject|3|||
130731121|NCT00196326|470637319|FG000|Overall Study|Did not meet protocol requirements|64|||
130731122|NCT00196326|470637319|FG000|Overall Study|Non-compliance with the protocol|81|||
130731123|NCT00196326|470637319|FG000|Overall Study|Physician Decision|3|||
130731124|NCT00196326|470637319|FG000|Overall Study|Withdrawal by Subject|225|||
130731125|NCT00196326|470637319|FG000|Overall Study|Adverse Event|253|||
130731126|NCT00196326|470637319|FG000|Overall Study|Pregnancy|34|||
130731127|NCT00196326|470637319|FG000|Overall Study|Lost to Follow-up|304|||
130731128|NCT00196326|470637319|FG000|Overall Study|Other|22|||
130731129|NCT02797171|470637320|FG000|Overall Study|Lost to Follow-up|2|||
130731130|NCT02797171|470637321|FG001|Overall Study|Lost to Follow-up|0|||
130731131|NCT02797171|470637322|FG002|Overall Study|Lost to Follow-up|2|||
130731132|NCT02797171|470637323|FG003|Overall Study|Lost to Follow-up|1|||
130731133|NCT02797171|470637324|FG004|Overall Study|Lost to Follow-up|2|||
130731134|NCT02797171|470637325|FG005|Overall Study|Lost to Follow-up|0|||
130731135|NCT02797171|470637320|FG000|Overall Study|Withdrawal by Subject|1|||
130731136|NCT02797171|470637321|FG001|Overall Study|Withdrawal by Subject|1|||
130731137|NCT02797171|470637322|FG002|Overall Study|Withdrawal by Subject|0|||
130731138|NCT02797171|470637323|FG003|Overall Study|Withdrawal by Subject|0|||
130731139|NCT02797171|470637324|FG004|Overall Study|Withdrawal by Subject|0|||
130731140|NCT02797171|470637325|FG005|Overall Study|Withdrawal by Subject|0|||
130731141|NCT02797171|470637320|FG000|Overall Study|Protocol Violation|1|||
130731142|NCT02797171|470637321|FG001|Overall Study|Protocol Violation|0|||
130731143|NCT02797171|470637322|FG002|Overall Study|Protocol Violation|0|||
130731144|NCT02797171|470637323|FG003|Overall Study|Protocol Violation|0|||
130731145|NCT02797171|470637324|FG004|Overall Study|Protocol Violation|0|||
130731146|NCT02797171|470637325|FG005|Overall Study|Protocol Violation|0|||
130731147|NCT02797171|470637320|FG000|Overall Study|Participant unable to adhere|0|||
130731148|NCT02797171|470637321|FG001|Overall Study|Participant unable to adhere|1|||
130731149|NCT02797171|470637322|FG002|Overall Study|Participant unable to adhere|0|||
130731150|NCT02797171|470637323|FG003|Overall Study|Participant unable to adhere|0|||
130731151|NCT02797171|470637324|FG004|Overall Study|Participant unable to adhere|0|||
130731152|NCT02797171|470637325|FG005|Overall Study|Participant unable to adhere|0|||
130731153|NCT02797171|470637320|FG000|Overall Study|Not Randomized|0|||
130731154|NCT02797171|470637321|FG001|Overall Study|Not Randomized|0|||
130731155|NCT02797171|470637322|FG002|Overall Study|Not Randomized|0|||
130731156|NCT02797171|470637323|FG003|Overall Study|Not Randomized|0|||
130731157|NCT02797171|470637324|FG004|Overall Study|Not Randomized|0|||
130731158|NCT02797171|470637325|FG005|Overall Study|Not Randomized|1|||
130731159|NCT02540083|470637326|FG000|Overall Study|Withdrawal by Subject|16|||
131172265|NCT03807739|472250547|FG003|Overall Study|Adverse Event|0|||
131172266|NCT03807739|472250544|FG000|Overall Study|Withdrawal by Subject|1|||
131172267|NCT03807739|472250545|FG001|Overall Study|Withdrawal by Subject|0|||
131172268|NCT03807739|472250546|FG002|Overall Study|Withdrawal by Subject|0|||
131172269|NCT03807739|472250547|FG003|Overall Study|Withdrawal by Subject|0|||
131172270|NCT02371759|472250550|FG000|Overall Study|Protocol Violation|3|||
131172271|NCT02371759|472250551|FG001|Overall Study|Protocol Violation|1|||
131172272|NCT02371759|472250552|FG002|Overall Study|Protocol Violation|1|||
131172273|NCT02371759|472250553|FG003|Overall Study|Protocol Violation|0|||
131172274|NCT02371759|472250554|FG004|Overall Study|Protocol Violation|3|||
131172275|NCT02371759|472250555|FG005|Overall Study|Protocol Violation|1|||
131172276|NCT02371759|472250556|FG006|Overall Study|Protocol Violation|0|||
131172277|NCT02371759|472250557|FG007|Overall Study|Protocol Violation|3|||
131172278|NCT02371759|472250550|FG000|Overall Study|Withdrawal by Subject|0|||
131172279|NCT02371759|472250551|FG001|Overall Study|Withdrawal by Subject|0|||
131172280|NCT02371759|472250552|FG002|Overall Study|Withdrawal by Subject|0|||
131172281|NCT02371759|472250553|FG003|Overall Study|Withdrawal by Subject|0|||
131172282|NCT02371759|472250554|FG004|Overall Study|Withdrawal by Subject|0|||
131172283|NCT02371759|472250555|FG005|Overall Study|Withdrawal by Subject|0|||
131172284|NCT02371759|472250556|FG006|Overall Study|Withdrawal by Subject|0|||
131172285|NCT02371759|472250557|FG007|Overall Study|Withdrawal by Subject|1|||
131172286|NCT03375112|472250560|FG000|Overall Study|Withdrawal by Subject|3|||
131172287|NCT03375112|472250561|FG001|Overall Study|Withdrawal by Subject|0|||
131172288|NCT00243230|472250562|FG000|Double-Blind Period|Adverse Event|0|||
131172289|NCT00243230|472250563|FG001|Double-Blind Period|Adverse Event|2|||
131172290|NCT00243230|472250564|FG002|Double-Blind Period|Adverse Event|2|||
131172291|NCT00243230|472250565|FG003|Double-Blind Period|Adverse Event|0|||
131172292|NCT00243230|472250562|FG000|Double-Blind Period|Withdrawal by Subject|1|||
131172293|NCT00243230|472250563|FG001|Double-Blind Period|Withdrawal by Subject|0|||
131172294|NCT00243230|472250564|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131172295|NCT00243230|472250565|FG003|Double-Blind Period|Withdrawal by Subject|0|||
131172296|NCT00243230|472250562|FG000|Double-Blind Period|Protocol Violation|0|||
131172297|NCT00243230|472250563|FG001|Double-Blind Period|Protocol Violation|0|||
131172298|NCT00243230|472250564|FG002|Double-Blind Period|Protocol Violation|1|||
131172299|NCT00243230|472250565|FG003|Double-Blind Period|Protocol Violation|0|||
131172300|NCT00243230|472250562|FG000|Double-Blind Period|Randomized but Not Treated|0|||
131172301|NCT00243230|472250563|FG001|Double-Blind Period|Randomized but Not Treated|0|||
131172302|NCT00243230|472250564|FG002|Double-Blind Period|Randomized but Not Treated|2|||
131172303|NCT00243230|472250565|FG003|Double-Blind Period|Randomized but Not Treated|0|||
131172304|NCT00243230|472250562|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
131172305|NCT00243230|472250563|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
131172306|NCT00243230|472250564|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
131172307|NCT00243230|472250565|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
131172308|NCT00243230|472250562|FG000|Open Label Period|Adverse Event|0|||
131172309|NCT00243230|472250563|FG001|Open Label Period|Adverse Event|0|||
131172310|NCT00243230|472250564|FG002|Open Label Period|Adverse Event|0|||
131172311|NCT00243230|472250565|FG003|Open Label Period|Adverse Event|2|||
130731160|NCT01427608|470637327|FG000|Overall Study|Death|1|||
130731161|NCT01427608|470637328|FG001|Overall Study|Death|0|||
130731162|NCT01427608|470637327|FG000|Overall Study|Withdrawal by Subject|7|||
130731163|NCT01427608|470637328|FG001|Overall Study|Withdrawal by Subject|3|||
130731164|NCT01427608|470637327|FG000|Overall Study|Relapsed-all cause|13|||
130731165|NCT01427608|470637328|FG001|Overall Study|Relapsed-all cause|34|||
130731166|NCT01427608|470637327|FG000|Overall Study|Events not attributed to study meds|0|||
130731167|NCT01427608|470637328|FG001|Overall Study|Events not attributed to study meds|1|||
130731168|NCT03993379|470637329|FG000|Overall Study|The study was terminated early due to business decision.|0|||
130731169|NCT03993379|470637330|FG001|Overall Study|The study was terminated early due to business decision.|2|||
131172312|NCT00243230|472250562|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
131172313|NCT00243230|472250563|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
131172314|NCT00243230|472250564|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
131172315|NCT00243230|472250565|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
131172316|NCT00243230|472250562|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
131172317|NCT00243230|472250563|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
131172318|NCT00243230|472250564|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
131172319|NCT00243230|472250565|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
131172320|NCT00243230|472250562|FG000|Open Label Period|Lost to Follow-up|0|||
131172321|NCT00243230|472250563|FG001|Open Label Period|Lost to Follow-up|0|||
130731170|NCT03993379|470637331|FG002|Overall Study|The study was terminated early due to business decision.|0|||
130731171|NCT03993379|470637332|FG003|Overall Study|The study was terminated early due to business decision.|0|||
130781776|NCT02895295|470827540|FG000|Overall Study|Survey Non-response|71|||
130731172|NCT03993379|470637329|FG000|Overall Study|Withdrawal by Subject|0|||
130731173|NCT03993379|470637330|FG001|Overall Study|Withdrawal by Subject|1|||
130731174|NCT03993379|470637331|FG002|Overall Study|Withdrawal by Subject|0|||
130731175|NCT03993379|470637332|FG003|Overall Study|Withdrawal by Subject|0|||
130731176|NCT03790657|470637333|FG000|Overall Study|Adverse Event|1|||
130731177|NCT03790657|470637334|FG001|Overall Study|Adverse Event|1|||
130731178|NCT03790657|470637333|FG000|Overall Study|Withdrawal by Subject|1|||
130731179|NCT03790657|470637334|FG001|Overall Study|Withdrawal by Subject|1|||
130731180|NCT01807065|470637335|FG000|Overall Study|Receive no sip-T due to IV access|1|||
130731181|NCT01807065|470637336|FG001|Overall Study|Receive no sip-T due to IV access|1|||
130731182|NCT05246670|470637341|FG000|Overall Study|Withdrawal by Subject|2|||
130731183|NCT05246670|470637342|FG001|Overall Study|Withdrawal by Subject|3|||
130731184|NCT05246670|470637343|FG002|Overall Study|Withdrawal by Subject|0|||
130731185|NCT05246670|470637344|FG003|Overall Study|Withdrawal by Subject|1|||
130731186|NCT05246670|470637341|FG000|Overall Study|Adverse Event|0|||
130731187|NCT05246670|470637342|FG001|Overall Study|Adverse Event|0|||
130731188|NCT05246670|470637343|FG002|Overall Study|Adverse Event|1|||
130731189|NCT05246670|470637344|FG003|Overall Study|Adverse Event|0|||
130731190|NCT05246670|470637341|FG000|Overall Study|Physician Decision|1|||
130731191|NCT05246670|470637342|FG001|Overall Study|Physician Decision|0|||
130731192|NCT05246670|470637343|FG002|Overall Study|Physician Decision|0|||
130731193|NCT05246670|470637344|FG003|Overall Study|Physician Decision|0|||
130731194|NCT05246670|470637341|FG000|Overall Study|Protocol Violation|1|||
130731195|NCT05246670|470637342|FG001|Overall Study|Protocol Violation|0|||
130731196|NCT05246670|470637343|FG002|Overall Study|Protocol Violation|0|||
130731197|NCT05246670|470637344|FG003|Overall Study|Protocol Violation|0|||
130731198|NCT00799058|470637345|FG000|Overall Study|Withdrawal by Subject|2|||
130731199|NCT00799058|470637346|FG001|Overall Study|Withdrawal by Subject|2|||
130731200|NCT00799058|470637347|FG002|Overall Study|Withdrawal by Subject|2|||
130731201|NCT00799058|470637345|FG000|Overall Study|Lost to Follow-up|1|||
130731202|NCT00799058|470637346|FG001|Overall Study|Lost to Follow-up|2|||
130731203|NCT00799058|470637347|FG002|Overall Study|Lost to Follow-up|1|||
130731204|NCT00799058|470637345|FG000|Overall Study|Adverse Event|0|||
130731205|NCT00799058|470637346|FG001|Overall Study|Adverse Event|2|||
130731206|NCT00799058|470637347|FG002|Overall Study|Adverse Event|0|||
130731207|NCT00799058|470637345|FG000|Overall Study|Pregnancy|1|||
130731208|NCT00799058|470637346|FG001|Overall Study|Pregnancy|0|||
130731209|NCT00799058|470637347|FG002|Overall Study|Pregnancy|0|||
130731210|NCT00799058|470637345|FG000|Overall Study|Not adherent|3|||
130731211|NCT00799058|470637346|FG001|Overall Study|Not adherent|2|||
130731212|NCT00799058|470637347|FG002|Overall Study|Not adherent|1|||
130731213|NCT00799058|470637345|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
130731214|NCT00799058|470637346|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
130731215|NCT00799058|470637347|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
130731216|NCT00799058|470637345|FG000|Overall Study|IP dispensing error|1|||
130731217|NCT00799058|470637346|FG001|Overall Study|IP dispensing error|0|||
130731218|NCT00799058|470637347|FG002|Overall Study|IP dispensing error|0|||
130731219|NCT00799058|470637345|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
130731220|NCT00799058|470637346|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
130731221|NCT00799058|470637347|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
130731222|NCT00799058|470637345|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
130731223|NCT00799058|470637346|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
130731224|NCT00799058|470637347|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
130731225|NCT00799058|470637345|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
130731226|NCT00799058|470637346|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
130731227|NCT00799058|470637347|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
130731228|NCT00799058|470637345|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
130731229|NCT00799058|470637346|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
130731230|NCT00799058|470637347|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
130731231|NCT03639779|470637348|FG000|Overall Study|Lost to Follow-up|1|||
130731232|NCT02088697|470637349|FG000|Period I|Physician Decision|1|||
131172322|NCT00243230|472250564|FG002|Open Label Period|Lost to Follow-up|0|||
130731233|NCT02088697|470637350|FG001|Period I|Physician Decision|4|||
130731234|NCT02088697|470637349|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
130731235|NCT02088697|470637350|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
130731236|NCT00462904|470637351|FG000|Overall Study|Lost to Follow-up|1|||
130731237|NCT05219448|470637352|FG000|Overall Study|Lost to Follow-up|9|||
130731238|NCT05219448|470637353|FG001|Overall Study|Lost to Follow-up|0|||
130731239|NCT00911300|470637357|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
130731240|NCT00911300|470637358|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
130731241|NCT00911300|470637357|FG000|Overall Study|Death|1|||
130731242|NCT00911300|470637358|FG001|Overall Study|Death|0|||
130781777|NCT02895295|470827541|FG001|Overall Study|Survey Non-response|94|||
130731243|NCT00911300|470637357|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
130731244|NCT00911300|470637358|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
130731245|NCT00911300|470637357|FG000|Overall Study|Adverse Event|14|||
130731246|NCT00911300|470637358|FG001|Overall Study|Adverse Event|6|||
130731247|NCT00911300|470637357|FG000|Overall Study|Protocol Violation|3|||
130731248|NCT00911300|470637358|FG001|Overall Study|Protocol Violation|2|||
130731249|NCT00911300|470637357|FG000|Overall Study|Consent Withdrawn|4|||
130731250|NCT00911300|470637358|FG001|Overall Study|Consent Withdrawn|12|||
130731251|NCT00911300|470637357|FG000|Overall Study|Coronary Angiography Performed|1|||
130731252|NCT00911300|470637358|FG001|Overall Study|Coronary Angiography Performed|0|||
130731253|NCT00911300|470637357|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
130731254|NCT00911300|470637358|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
130731255|NCT00911300|470637357|FG000|Overall Study|Received Commercial Treatment|1|||
130731256|NCT00911300|470637358|FG001|Overall Study|Received Commercial Treatment|0|||
130731257|NCT00911300|470637357|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
130731258|NCT00911300|470637358|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
130731259|NCT00911300|470637357|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
130731260|NCT00911300|470637358|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
130731261|NCT00911300|470637357|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
130731262|NCT00911300|470637358|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
130731263|NCT00911300|470637357|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
130731264|NCT00911300|470637358|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
130731265|NCT00911300|470637357|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
130731266|NCT00911300|470637358|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
130731267|NCT00911300|470637357|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
130731268|NCT00911300|470637358|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
130731269|NCT00911300|470637357|FG000|Overall Study|International Normalized Ratio Too High|0|||
130731270|NCT00911300|470637358|FG001|Overall Study|International Normalized Ratio Too High|1|||
130731271|NCT00911300|470637357|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
130731272|NCT00911300|470637358|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
130731273|NCT00911300|470637357|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
130731274|NCT00911300|470637358|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
130731275|NCT00911300|470637357|FG000|Overall Study|Physician Decision|0|||
130731276|NCT00911300|470637358|FG001|Overall Study|Physician Decision|1|||
130731277|NCT00911300|470637357|FG000|Overall Study|Treatment Stopped by Mistake|0|||
130731278|NCT00911300|470637358|FG001|Overall Study|Treatment Stopped by Mistake|1|||
130731279|NCT00911300|470637357|FG000|Overall Study|Randomized; No Study Medication Received|0|||
130731280|NCT00911300|470637358|FG001|Overall Study|Randomized; No Study Medication Received|2|||
130731281|NCT02287922|470637359|FG000|Overall Study|Adverse Event|1|||
130731282|NCT02287922|470637360|FG001|Overall Study|Adverse Event|1|||
130731283|NCT02287922|470637361|FG002|Overall Study|Adverse Event|3|||
130731284|NCT02287922|470637362|FG003|Overall Study|Adverse Event|4|||
130731285|NCT02287922|470637359|FG000|Overall Study|Withdrawal by Subject|1|||
130731286|NCT02287922|470637360|FG001|Overall Study|Withdrawal by Subject|1|||
130731287|NCT02287922|470637361|FG002|Overall Study|Withdrawal by Subject|1|||
130731288|NCT02287922|470637362|FG003|Overall Study|Withdrawal by Subject|2|||
130731289|NCT02287922|470637359|FG000|Overall Study|Lost to Follow-up|0|||
130731290|NCT02287922|470637360|FG001|Overall Study|Lost to Follow-up|0|||
130731291|NCT02287922|470637361|FG002|Overall Study|Lost to Follow-up|1|||
130731292|NCT02287922|470637362|FG003|Overall Study|Lost to Follow-up|0|||
130731293|NCT02287922|470637359|FG000|Overall Study|Sponsor's decision|0|||
130731294|NCT02287922|470637360|FG001|Overall Study|Sponsor's decision|0|||
130731295|NCT02287922|470637361|FG002|Overall Study|Sponsor's decision|0|||
130731296|NCT02287922|470637362|FG003|Overall Study|Sponsor's decision|1|||
130731297|NCT02287922|470637359|FG000|Overall Study|Other|1|||
130731298|NCT02287922|470637360|FG001|Overall Study|Other|0|||
130731299|NCT02287922|470637361|FG002|Overall Study|Other|2|||
130731300|NCT02287922|470637362|FG003|Overall Study|Other|0|||
130731301|NCT04152291|470637363|FG000|Overall Study|Covid-19 restrictions|27|||
130731302|NCT04152291|470637363|FG000|Overall Study|Withdrawal by Subject|3|||
130731303|NCT05124691|470637364|FG000|Phase II|Eligibility criteria|0|||
130731304|NCT05124691|470637365|FG001|Phase II|Eligibility criteria|1|||
130731305|NCT05124691|470637366|FG002|Phase II|Eligibility criteria|0|||
130731306|NCT05124691|470637364|FG000|Phase II|Withdrawal by Subject|6|||
130731307|NCT05124691|470637365|FG001|Phase II|Withdrawal by Subject|2|||
130731308|NCT05124691|470637366|FG002|Phase II|Withdrawal by Subject|3|||
130731309|NCT05124691|470637364|FG000|Phase III|Withdrawal by Subject|6|||
130731310|NCT05124691|470637365|FG001|Phase III|Withdrawal by Subject|4|||
130731311|NCT05124691|470637366|FG002|Phase III|Withdrawal by Subject|4|||
130781778|NCT02895295|470827542|FG002|Overall Study|Survey Non-response|92|||
130781779|NCT04821830|470827545|FG000|Overall Study|Withdrawal by Subject|1|||
130781780|NCT04821830|470827546|FG001|Overall Study|Withdrawal by Subject|0|||
130781781|NCT03163446|470829051|FG000|Overall Study|Unable to return for Day 180 visit|2|||
130781782|NCT03163446|470829052|FG001|Overall Study|Unable to return for Day 180 visit|0|||
130731312|NCT05124691|470637364|FG000|Phase III|Lost to Follow-up|1|||
130731313|NCT05124691|470637365|FG001|Phase III|Lost to Follow-up|0|||
130731314|NCT05124691|470637366|FG002|Phase III|Lost to Follow-up|0|||
130731315|NCT04223752|470637369|FG000|Overall Study|Participant enrolled in error|0|||
130731316|NCT04223752|470637370|FG001|Overall Study|Participant enrolled in error|0|||
130731317|NCT04223752|470637371|FG002|Overall Study|Participant enrolled in error|0|||
130731318|NCT04223752|470637372|FG003|Overall Study|Participant enrolled in error|0|||
130731319|NCT04223752|470637373|FG004|Overall Study|Participant enrolled in error|1|||
130731320|NCT04223752|470637369|FG000|Overall Study|Death|0|||
130731321|NCT04223752|470637370|FG001|Overall Study|Death|0|||
130731322|NCT04223752|470637371|FG002|Overall Study|Death|0|||
130731323|NCT04223752|470637372|FG003|Overall Study|Death|2|||
130731324|NCT04223752|470637373|FG004|Overall Study|Death|1|||
130731325|NCT04739800|470637374|FG000|Overall Study|Adverse Event|2|||
130731326|NCT04739800|470637375|FG001|Overall Study|Adverse Event|1|||
130731327|NCT04739800|470637376|FG002|Overall Study|Adverse Event|4|||
130731328|NCT04739800|470637377|FG003|Overall Study|Adverse Event|5|||
130731329|NCT04739800|470637374|FG000|Overall Study|Never Treated|2|||
130731330|NCT04739800|470637375|FG001|Overall Study|Never Treated|0|||
130731331|NCT04739800|470637376|FG002|Overall Study|Never Treated|1|||
130731332|NCT04739800|470637377|FG003|Overall Study|Never Treated|1|||
130731333|NCT04739800|470637374|FG000|Overall Study|On Treatment|5|||
130731334|NCT04739800|470637375|FG001|Overall Study|On Treatment|9|||
130731335|NCT04739800|470637376|FG002|Overall Study|On Treatment|9|||
130731336|NCT04739800|470637377|FG003|Overall Study|On Treatment|9|||
130731337|NCT04739800|470637374|FG000|Overall Study|Symptomatic Deterioration|1|||
130731338|NCT04739800|470637375|FG001|Overall Study|Symptomatic Deterioration|1|||
130731339|NCT04739800|470637376|FG002|Overall Study|Symptomatic Deterioration|3|||
130731340|NCT04739800|470637377|FG003|Overall Study|Symptomatic Deterioration|0|||
130731341|NCT04739800|470637374|FG000|Overall Study|Withdrawal by Subject|1|||
130731342|NCT04739800|470637375|FG001|Overall Study|Withdrawal by Subject|2|||
130731343|NCT04739800|470637376|FG002|Overall Study|Withdrawal by Subject|1|||
130731344|NCT04739800|470637377|FG003|Overall Study|Withdrawal by Subject|3|||
130731345|NCT04739800|470637374|FG000|Overall Study|Other Reason|1|||
130731346|NCT04739800|470637375|FG001|Overall Study|Other Reason|3|||
130731347|NCT04739800|470637376|FG002|Overall Study|Other Reason|5|||
130731348|NCT04739800|470637377|FG003|Overall Study|Other Reason|4|||
130731349|NCT02779855|470637378|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
130731350|NCT02779855|470637379|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
130731351|NCT02779855|470637380|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
130731352|NCT00447993|470637381|FG000|Overall Study|Lost to Follow-up|0|||
130731353|NCT00447993|470637382|FG001|Overall Study|Lost to Follow-up|0|||
130731354|NCT00447993|470637383|FG002|Overall Study|Lost to Follow-up|2|||
130731355|NCT00447993|470637384|FG003|Overall Study|Lost to Follow-up|2|||
130731356|NCT00447993|470637381|FG000|Overall Study|Withdrawal by Subject|0|||
130731357|NCT00447993|470637382|FG001|Overall Study|Withdrawal by Subject|0|||
130731358|NCT00447993|470637383|FG002|Overall Study|Withdrawal by Subject|2|||
130731359|NCT00447993|470637384|FG003|Overall Study|Withdrawal by Subject|2|||
130731360|NCT02503787|470637389|FG000|Enrollment|Withdrawal by Subject|6|||
130731361|NCT02503787|470637389|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
130731362|NCT02503787|470637389|FG000|Enrollment|Physician Decision|2|||
130731363|NCT02503787|470637389|FG000|Enrollment|Insurance issue|2|||
130731364|NCT02503787|470637389|FG000|Enrollment|Lost to Follow-up|1|||
130731365|NCT02503787|470637389|FG000|Enrollment|Study closure|1|||
130731366|NCT02503787|470637389|FG000|Enrollment|Adverse Event|1|||
130731367|NCT02503787|470637389|FG000|Enrollment|Protocol Violation|1|||
130731368|NCT02503787|470637389|FG000|Enrollment|Inability to implant system|1|||
130731369|NCT02503787|470637389|FG000|Enrollment|Unable to be programmed|1|||
130731370|NCT02503787|470637389|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
130731371|NCT02503787|470637389|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
130731372|NCT02503787|470637389|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
130731373|NCT02503787|470637389|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
130731374|NCT02503787|470637389|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
130731375|NCT02503787|470637389|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
130731376|NCT04787627|470637390|FG000|Overall Study|Withdrawal by Subject|3|||
130731377|NCT04787627|470637391|FG001|Overall Study|Withdrawal by Subject|0|||
130731378|NCT04787627|470637390|FG000|Overall Study|Physician Decision|2|||
130731379|NCT04787627|470637391|FG001|Overall Study|Physician Decision|0|||
130731380|NCT04787627|470637390|FG000|Overall Study|Excluded|0|||
130731381|NCT04787627|470637391|FG001|Overall Study|Excluded|1|||
130731382|NCT00174954|470637393|FG000|Overall Study|Adverse Event|2|||
130731383|NCT00174954|470637393|FG000|Overall Study|No tophi found in MRI|1|||
130731384|NCT00174954|470637393|FG000|Overall Study|Physician Decision|1|||
130731385|NCT00839254|470637394|FG000|Overall Study|Protocol Violation|0|||
130731386|NCT00839254|470637395|FG001|Overall Study|Protocol Violation|1|||
130731387|NCT00839254|470637396|FG002|Overall Study|Protocol Violation|1|||
130731388|NCT00839254|470637397|FG003|Overall Study|Protocol Violation|1|||
130731389|NCT00839254|470637398|FG004|Overall Study|Protocol Violation|0|||
130781783|NCT03163446|470829051|FG000|Overall Study|Withdrawal by Subject|2|||
130781784|NCT03163446|470829052|FG001|Overall Study|Withdrawal by Subject|6|||
130781785|NCT03163446|470829051|FG000|Overall Study|Death|16|||
130781786|NCT03163446|470829052|FG001|Overall Study|Death|5|||
130781787|NCT03163446|470829051|FG000|Overall Study|Lost to Follow-up|6|||
130781788|NCT03163446|470829052|FG001|Overall Study|Lost to Follow-up|5|||
130781789|NCT03163446|470829051|FG000|Overall Study|Physician Decision|1|||
130781790|NCT03163446|470829052|FG001|Overall Study|Physician Decision|1|||
130781791|NCT03163446|470829051|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
130781792|NCT03163446|470829052|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
130781793|NCT01317641|470829053|FG000|Overall Study|Not treated|0|||
130781794|NCT01317641|470829054|FG001|Overall Study|Not treated|0|||
130781795|NCT01317641|470829055|FG002|Overall Study|Not treated|0|||
130781796|NCT01317641|470829056|FG003|Overall Study|Not treated|0|||
130781797|NCT01317641|470829057|FG004|Overall Study|Not treated|0|||
130781798|NCT01317641|470829058|FG005|Overall Study|Not treated|0|||
130781799|NCT01317641|470829059|FG006|Overall Study|Not treated|0|||
130781800|NCT01317641|470829060|FG007|Overall Study|Not treated|1|||
130781801|NCT01317641|470829061|FG008|Overall Study|Not treated|1|||
130781802|NCT01317641|470829053|FG000|Overall Study|Adverse Event|0|||
130781803|NCT01317641|470829054|FG001|Overall Study|Adverse Event|1|||
130781804|NCT01317641|470829055|FG002|Overall Study|Adverse Event|0|||
130781805|NCT01317641|470829056|FG003|Overall Study|Adverse Event|1|||
130781806|NCT01317641|470829057|FG004|Overall Study|Adverse Event|0|||
130781807|NCT01317641|470829058|FG005|Overall Study|Adverse Event|0|||
130781808|NCT01317641|470829059|FG006|Overall Study|Adverse Event|2|||
130781809|NCT01317641|470829060|FG007|Overall Study|Adverse Event|1|||
130781810|NCT01317641|470829061|FG008|Overall Study|Adverse Event|0|||
131172323|NCT00243230|472250565|FG003|Open Label Period|Lost to Follow-up|2|||
131172324|NCT00243230|472250562|FG000|Open Label Period|Withdrawal by Subject|0|||
131172325|NCT00243230|472250563|FG001|Open Label Period|Withdrawal by Subject|0|||
131172326|NCT00243230|472250564|FG002|Open Label Period|Withdrawal by Subject|0|||
131172327|NCT00243230|472250565|FG003|Open Label Period|Withdrawal by Subject|2|||
131172328|NCT00243230|472250562|FG000|Open Label Period|Protocol Violation|0|||
131172329|NCT00243230|472250563|FG001|Open Label Period|Protocol Violation|0|||
131172330|NCT00243230|472250564|FG002|Open Label Period|Protocol Violation|0|||
131172331|NCT00243230|472250565|FG003|Open Label Period|Protocol Violation|2|||
131172332|NCT00243230|472250562|FG000|Open Label Period|Administrative Reason|0|||
131172333|NCT00243230|472250563|FG001|Open Label Period|Administrative Reason|0|||
131172334|NCT00243230|472250564|FG002|Open Label Period|Administrative Reason|0|||
131172335|NCT00243230|472250565|FG003|Open Label Period|Administrative Reason|63|||
131172336|NCT05118386|472250568|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
131172337|NCT05118386|472250569|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
131172338|NCT05118386|472250570|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
131172339|NCT05118386|472250571|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
131172340|NCT05118386|472250572|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
131172341|NCT05118386|472250573|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
131172342|NCT05118386|472250568|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
131172343|NCT05118386|472250569|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
131172344|NCT05118386|472250570|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
131172345|NCT05118386|472250571|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
131172346|NCT05118386|472250572|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
131172347|NCT05118386|472250573|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
131172348|NCT00894413|472250574|FG000|Overall Study|Physician Decision|0|||
131172349|NCT00894413|472250575|FG001|Overall Study|Physician Decision|2|||
130781811|NCT01317641|470829053|FG000|Overall Study|Protocol Violation|1|||
131172350|NCT00894413|472250574|FG000|Overall Study|Adverse Event|0|||
131172351|NCT00894413|472250575|FG001|Overall Study|Adverse Event|2|||
131172352|NCT00894413|472250574|FG000|Overall Study|Withdrawal by Subject|0|||
131172353|NCT00894413|472250575|FG001|Overall Study|Withdrawal by Subject|4|||
131172354|NCT02669862|472251929|FG000|Overall Study|Lost to Follow-up|0|||
131172355|NCT02669862|472251930|FG001|Overall Study|Lost to Follow-up|2|||
131172356|NCT02669862|472251931|FG002|Overall Study|Lost to Follow-up|1|||
130781812|NCT01317641|470829054|FG001|Overall Study|Protocol Violation|0|||
130781813|NCT01317641|470829055|FG002|Overall Study|Protocol Violation|0|||
130781814|NCT01317641|470829056|FG003|Overall Study|Protocol Violation|0|||
131172357|NCT02669862|472251929|FG000|Overall Study|Withdrawal by Subject|2|||
131172358|NCT02669862|472251930|FG001|Overall Study|Withdrawal by Subject|2|||
131172359|NCT02669862|472251931|FG002|Overall Study|Withdrawal by Subject|3|||
130781815|NCT01317641|470829057|FG004|Overall Study|Protocol Violation|0|||
130781816|NCT01317641|470829058|FG005|Overall Study|Protocol Violation|0|||
130781817|NCT01317641|470829059|FG006|Overall Study|Protocol Violation|0|||
130781818|NCT01317641|470829060|FG007|Overall Study|Protocol Violation|0|||
130781819|NCT01317641|470829061|FG008|Overall Study|Protocol Violation|0|||
130781820|NCT01317641|470829053|FG000|Overall Study|Disease progression|0|||
130781821|NCT01317641|470829054|FG001|Overall Study|Disease progression|0|||
130781822|NCT01317641|470829055|FG002|Overall Study|Disease progression|0|||
130781823|NCT01317641|470829056|FG003|Overall Study|Disease progression|0|||
130781824|NCT01317641|470829057|FG004|Overall Study|Disease progression|0|||
130781825|NCT01317641|470829058|FG005|Overall Study|Disease progression|0|||
131236117|NCT02492958|472493229|FG002|Overall Study|Withdrawal by Subject|1|||
131236118|NCT02492958|472493230|FG003|Overall Study|Withdrawal by Subject|0|||
131236119|NCT02492958|472493227|FG000|Overall Study|Adverse Event|1|||
131236120|NCT02492958|472493228|FG001|Overall Study|Adverse Event|0|||
131236121|NCT02492958|472493229|FG002|Overall Study|Adverse Event|1|||
131236122|NCT02492958|472493230|FG003|Overall Study|Adverse Event|0|||
131236123|NCT01193608|472493231|FG000|Overall Study|Other|0|||
131236124|NCT01193608|472493232|FG001|Overall Study|Other|1|||
131236125|NCT01193608|472493233|FG002|Overall Study|Other|0|||
131236126|NCT01193608|472493234|FG003|Overall Study|Other|0|||
131236127|NCT01193608|472493235|FG004|Overall Study|Other|0|||
131236128|NCT01193608|472493236|FG005|Overall Study|Other|0|||
131236129|NCT01193608|472493231|FG000|Overall Study|Withdrawal by Subject|0|||
131236130|NCT01193608|472493232|FG001|Overall Study|Withdrawal by Subject|1|||
131236131|NCT01193608|472493233|FG002|Overall Study|Withdrawal by Subject|2|||
131236132|NCT01193608|472493234|FG003|Overall Study|Withdrawal by Subject|3|||
131236133|NCT01193608|472493235|FG004|Overall Study|Withdrawal by Subject|3|||
131236134|NCT01193608|472493236|FG005|Overall Study|Withdrawal by Subject|0|||
131236135|NCT01193608|472493231|FG000|Overall Study|Lost to Follow-up|0|||
131236136|NCT01193608|472493232|FG001|Overall Study|Lost to Follow-up|0|||
131236137|NCT01193608|472493233|FG002|Overall Study|Lost to Follow-up|0|||
131236138|NCT01193608|472493234|FG003|Overall Study|Lost to Follow-up|0|||
131236139|NCT01193608|472493235|FG004|Overall Study|Lost to Follow-up|1|||
131236140|NCT01193608|472493236|FG005|Overall Study|Lost to Follow-up|2|||
131236141|NCT01193608|472493231|FG000|Overall Study|Adverse Event|0|||
131236142|NCT01193608|472493232|FG001|Overall Study|Adverse Event|0|||
131236143|NCT01193608|472493233|FG002|Overall Study|Adverse Event|0|||
131236144|NCT01193608|472493234|FG003|Overall Study|Adverse Event|0|||
131236145|NCT01193608|472493235|FG004|Overall Study|Adverse Event|1|||
131236146|NCT01193608|472493236|FG005|Overall Study|Adverse Event|0|||
131236147|NCT00712010|472493237|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
131236148|NCT01946165|472493238|FG000|Overall Study|Physician Decision|2|||
131236149|NCT01946165|472493239|FG001|Overall Study|Physician Decision|0|||
131236150|NCT01946165|472493238|FG000|Overall Study|Withdrawal by Subject|0|||
131236151|NCT01946165|472493239|FG001|Overall Study|Withdrawal by Subject|2|||
131236152|NCT01400113|472493240|FG000|Overall Study|Withdrawal by Subject|1|||
131236153|NCT01400113|472493241|FG001|Overall Study|Withdrawal by Subject|1|||
131236154|NCT01179919|472493242|FG000|Overall Study|Protocol Violation|1|||
131236155|NCT01179919|472493242|FG000|Overall Study|Adverse Event|1|||
131236156|NCT00806156|472493246|FG000|Overall Study|Death|35|||
131236157|NCT00806156|472493247|FG001|Overall Study|Death|95|||
131236158|NCT00806156|472493246|FG000|Overall Study|Did not meet eligibility criteria|1|||
131236159|NCT00806156|472493247|FG001|Overall Study|Did not meet eligibility criteria|0|||
131236160|NCT00806156|472493246|FG000|Overall Study|Study terminated by Sponsor|2|||
131236161|NCT00806156|472493247|FG001|Overall Study|Study terminated by Sponsor|40|||
131236162|NCT00806156|472493246|FG000|Overall Study|Consent withdrawn by subject|1|||
131236163|NCT00806156|472493247|FG001|Overall Study|Consent withdrawn by subject|3|||
131236164|NCT00806156|472493246|FG000|Overall Study|Lost to Follow-up|0|||
131236165|NCT00806156|472493247|FG001|Overall Study|Lost to Follow-up|1|||
131236166|NCT02796664|472493250|FG000|Overall Study|Withdrawal by Subject|0|||
131236167|NCT02796664|472493251|FG001|Overall Study|Withdrawal by Subject|3|||
131236168|NCT02796664|472493250|FG000|Overall Study|Noncompliance|1|||
130781826|NCT01317641|470829059|FG006|Overall Study|Disease progression|0|||
130781827|NCT01317641|470829060|FG007|Overall Study|Disease progression|3|||
130781828|NCT01317641|470829061|FG008|Overall Study|Disease progression|4|||
130781829|NCT01317641|470829053|FG000|Overall Study|Withdrawal by Subject|0|||
130781830|NCT01317641|470829054|FG001|Overall Study|Withdrawal by Subject|0|||
131236169|NCT02796664|472493251|FG001|Overall Study|Noncompliance|1|||
131236170|NCT02796664|472493250|FG000|Overall Study|Death|0|||
131236171|NCT02796664|472493251|FG001|Overall Study|Death|1|||
131236172|NCT02246478|472493252|FG000|Multiple-dose Phase|Protocol Violation|1|||
131236173|NCT02246478|472493253|FG001|Multiple-dose Phase|Protocol Violation|0|||
131236174|NCT02246478|472493254|FG002|Multiple-dose Phase|Protocol Violation|0|||
131236175|NCT02246478|472493255|FG003|Multiple-dose Phase|Protocol Violation|1|||
130781831|NCT01317641|470829055|FG002|Overall Study|Withdrawal by Subject|0|||
131236176|NCT01089647|472493258|FG000|Overall Study|Lost to Follow-up|2|||
131236177|NCT01089647|472493259|FG001|Overall Study|Lost to Follow-up|2|||
130781832|NCT01317641|470829056|FG003|Overall Study|Withdrawal by Subject|0|||
131236178|NCT01089647|472493258|FG000|Overall Study|Withdrawal by Subject|2|||
130781833|NCT01317641|470829057|FG004|Overall Study|Withdrawal by Subject|0|||
131236179|NCT01089647|472493259|FG001|Overall Study|Withdrawal by Subject|1|||
131236180|NCT01089647|472493258|FG000|Overall Study|Adverse Event|0|||
131236181|NCT01089647|472493259|FG001|Overall Study|Adverse Event|1|||
131236182|NCT01531205|472493260|FG000|Overall Study|Did not proceed to surgery|1|||
130731390|NCT00839254|470637399|FG005|Overall Study|Protocol Violation|0|||
130731391|NCT00839254|470637400|FG006|Overall Study|Protocol Violation|1|||
130731392|NCT00839254|470637401|FG007|Overall Study|Protocol Violation|2|||
130731393|NCT00839254|470637394|FG000|Overall Study|Physician Decision|0|||
130731394|NCT00839254|470637395|FG001|Overall Study|Physician Decision|1|||
130731395|NCT00839254|470637396|FG002|Overall Study|Physician Decision|0|||
130731396|NCT00839254|470637397|FG003|Overall Study|Physician Decision|0|||
130731397|NCT00839254|470637398|FG004|Overall Study|Physician Decision|0|||
130731398|NCT00839254|470637399|FG005|Overall Study|Physician Decision|0|||
130731399|NCT00839254|470637400|FG006|Overall Study|Physician Decision|0|||
130731400|NCT00839254|470637401|FG007|Overall Study|Physician Decision|1|||
130731401|NCT00839254|470637394|FG000|Overall Study|Wrong treatment number allocation|0|||
130731402|NCT00839254|470637395|FG001|Overall Study|Wrong treatment number allocation|1|||
131236183|NCT02780687|472493271|FG000|Overall Study|Adverse Event|1|||
131236184|NCT02780687|472493272|FG001|Overall Study|Adverse Event|1|||
131236185|NCT02780687|472493271|FG000|Overall Study|Withdrawal by Subject|2|||
131236186|NCT02780687|472493272|FG001|Overall Study|Withdrawal by Subject|1|||
131236187|NCT02780687|472493271|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
131236188|NCT02780687|472493272|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
131236189|NCT02780687|472493271|FG000|Overall Study|progressive disease|29|||
131236190|NCT02780687|472493272|FG001|Overall Study|progressive disease|6|||
130731403|NCT00839254|470637396|FG002|Overall Study|Wrong treatment number allocation|0|||
131172360|NCT02669862|472251929|FG000|Overall Study|moved|0|||
131172361|NCT02669862|472251930|FG001|Overall Study|moved|1|||
131172362|NCT02669862|472251931|FG002|Overall Study|moved|0|||
131172363|NCT02669862|472251929|FG000|Overall Study|Protocol Violation|0|||
131172364|NCT02669862|472251930|FG001|Overall Study|Protocol Violation|0|||
131172365|NCT02669862|472251931|FG002|Overall Study|Protocol Violation|1|||
131172366|NCT00311181|472251932|FG000|Overall Study|Final DFTs were not obtained|96|||
131172367|NCT01000727|472251937|FG000|Overall Study|Lost to Follow-up|41|||
131172368|NCT01000727|472251938|FG001|Overall Study|Lost to Follow-up|43|||
131172369|NCT01000727|472251937|FG000|Overall Study|Withdrawal by Subject|111|||
131172370|NCT01000727|472251938|FG001|Overall Study|Withdrawal by Subject|109|||
131172371|NCT01000727|472251937|FG000|Overall Study|Study closed/terminated|23|||
131172372|NCT01000727|472251938|FG001|Overall Study|Study closed/terminated|24|||
131172373|NCT03137121|472251939|FG000|Overall Study|Withdrawal by Subject|0|||
131172374|NCT03137121|472251940|FG001|Overall Study|Withdrawal by Subject|1|||
131172375|NCT01026389|472251945|FG000|Overall Study|Withdrawal by Subject|1|||
131172376|NCT01026389|472251946|FG001|Overall Study|Withdrawal by Subject|3|||
131172377|NCT01026389|472251945|FG000|Overall Study|change of treatment, patient moved|4|||
131172378|NCT01026389|472251946|FG001|Overall Study|change of treatment, patient moved|2|||
131172379|NCT00836277|472251947|FG000|Overall Study|Not evaluable for response|6|||
131172380|NCT01995136|472251948|FG000|Overall Study|Change in residence|1|||
131172381|NCT03544268|472251949|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
131172382|NCT03544268|472251950|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
131236191|NCT00368277|472493273|FG000|Overall Study|Adverse Event|33|||
131236192|NCT00368277|472493274|FG001|Overall Study|Adverse Event|49|||
131236193|NCT00368277|472493273|FG000|Overall Study|Death|2|||
131236194|NCT00368277|472493274|FG001|Overall Study|Death|1|||
130731404|NCT00839254|470637397|FG003|Overall Study|Wrong treatment number allocation|0|||
130731405|NCT00839254|470637398|FG004|Overall Study|Wrong treatment number allocation|0|||
130731406|NCT00839254|470637399|FG005|Overall Study|Wrong treatment number allocation|1|||
130731407|NCT00839254|470637400|FG006|Overall Study|Wrong treatment number allocation|0|||
130731408|NCT00839254|470637401|FG007|Overall Study|Wrong treatment number allocation|0|||
130731409|NCT00839254|470637394|FG000|Overall Study|Adverse Event|12|||
130731410|NCT00839254|470637395|FG001|Overall Study|Adverse Event|6|||
130731411|NCT00839254|470637396|FG002|Overall Study|Adverse Event|3|||
130731412|NCT00839254|470637397|FG003|Overall Study|Adverse Event|5|||
130731413|NCT00839254|470637398|FG004|Overall Study|Adverse Event|2|||
130731414|NCT00839254|470637399|FG005|Overall Study|Adverse Event|1|||
130731415|NCT00839254|470637400|FG006|Overall Study|Adverse Event|0|||
130731416|NCT00839254|470637401|FG007|Overall Study|Adverse Event|1|||
130731417|NCT00839254|470637394|FG000|Overall Study|Withdrawal by Subject|87|||
130731418|NCT00839254|470637395|FG001|Overall Study|Withdrawal by Subject|53|||
131172383|NCT04410198|472251951|FG000|Overall Study|Death|10|||
131172384|NCT04410198|472251951|FG000|Overall Study|Withdrawal by Subject|7|||
131172385|NCT04410198|472251951|FG000|Overall Study|Transferred/Relocation|4|||
131172386|NCT04410198|472251951|FG000|Overall Study|Kidney Transplant|9|||
131172387|NCT04410198|472251951|FG000|Overall Study|Adverse Event|4|||
131172388|NCT04410198|472251951|FG000|Overall Study|Physician Decision|2|||
130731419|NCT00839254|470637396|FG002|Overall Study|Withdrawal by Subject|54|||
130731420|NCT00839254|470637397|FG003|Overall Study|Withdrawal by Subject|32|||
130731421|NCT00839254|470637398|FG004|Overall Study|Withdrawal by Subject|27|||
130731422|NCT00839254|470637399|FG005|Overall Study|Withdrawal by Subject|15|||
130731423|NCT00839254|470637400|FG006|Overall Study|Withdrawal by Subject|22|||
130731424|NCT00839254|470637401|FG007|Overall Study|Withdrawal by Subject|9|||
131172389|NCT04410198|472251951|FG000|Overall Study|Other than specified|1|||
130731425|NCT00839254|470637394|FG000|Overall Study|Wrong group allocation|0|||
130731426|NCT00839254|470637395|FG001|Overall Study|Wrong group allocation|0|||
130731427|NCT00839254|470637396|FG002|Overall Study|Wrong group allocation|0|||
130731428|NCT00839254|470637397|FG003|Overall Study|Wrong group allocation|0|||
130731429|NCT00839254|470637398|FG004|Overall Study|Wrong group allocation|0|||
130731430|NCT00839254|470637399|FG005|Overall Study|Wrong group allocation|0|||
130731431|NCT00839254|470637400|FG006|Overall Study|Wrong group allocation|1|||
130731432|NCT00839254|470637401|FG007|Overall Study|Wrong group allocation|0|||
130731433|NCT00839254|470637394|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
130731434|NCT00839254|470637395|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731435|NCT00839254|470637396|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731436|NCT00839254|470637397|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731437|NCT00839254|470637398|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731438|NCT00839254|470637399|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
130781834|NCT01317641|470829058|FG005|Overall Study|Withdrawal by Subject|0|||
131172390|NCT01830543|472251954|FG000|Overall Study|Subject Decision|19|||
131172391|NCT01830543|472251955|FG001|Overall Study|Subject Decision|21|||
131172392|NCT01830543|472251956|FG002|Overall Study|Subject Decision|57|||
131172393|NCT01830543|472251954|FG000|Overall Study|Adverse Event|91|||
131172394|NCT01830543|472251955|FG001|Overall Study|Adverse Event|77|||
131172395|NCT01830543|472251956|FG002|Overall Study|Adverse Event|76|||
131172396|NCT01830543|472251954|FG000|Overall Study|Death|20|||
131172397|NCT01830543|472251955|FG001|Overall Study|Death|22|||
131172398|NCT01830543|472251956|FG002|Overall Study|Death|22|||
131172399|NCT01830543|472251954|FG000|Overall Study|Protocol Violation|3|||
131172400|NCT01830543|472251955|FG001|Overall Study|Protocol Violation|7|||
131172401|NCT01830543|472251956|FG002|Overall Study|Protocol Violation|7|||
131172402|NCT01830543|472251954|FG000|Overall Study|Physician Decision|11|||
131172403|NCT01830543|472251955|FG001|Overall Study|Physician Decision|5|||
131172404|NCT01830543|472251956|FG002|Overall Study|Physician Decision|12|||
131172405|NCT01830543|472251954|FG000|Overall Study|Withdrawal by consent|3|||
131172406|NCT01830543|472251955|FG001|Overall Study|Withdrawal by consent|3|||
131172407|NCT01830543|472251956|FG002|Overall Study|Withdrawal by consent|3|||
131172408|NCT01830543|472251954|FG000|Overall Study|Other|12|||
131172409|NCT01830543|472251955|FG001|Overall Study|Other|17|||
131172410|NCT01830543|472251956|FG002|Overall Study|Other|37|||
131172411|NCT02695524|472251959|FG000|Overall Study|Lost to Follow-up|3|||
131172412|NCT02695524|472251960|FG001|Overall Study|Lost to Follow-up|2|||
131172413|NCT02695524|472251959|FG000|Overall Study|Death|0|||
131172414|NCT02695524|472251960|FG001|Overall Study|Death|1|||
131172415|NCT00377611|472251963|FG000|Overall Study|Adverse Event|2|||
131172416|NCT00377611|472251964|FG001|Overall Study|Adverse Event|9|||
131172417|NCT00377611|472251963|FG000|Overall Study|Protocol Violation|2|||
131172418|NCT00377611|472251964|FG001|Overall Study|Protocol Violation|0|||
131172419|NCT00377611|472251963|FG000|Overall Study|Withdrawal by Subject|0|||
131172420|NCT00377611|472251964|FG001|Overall Study|Withdrawal by Subject|5|||
131172421|NCT00377611|472251963|FG000|Overall Study|Lost to Follow-up|18|||
131172422|NCT00377611|472251964|FG001|Overall Study|Lost to Follow-up|16|||
131172423|NCT00377611|472251963|FG000|Overall Study|Other|0|||
131172424|NCT00377611|472251964|FG001|Overall Study|Other|3|||
131172425|NCT01332019|472251977|FG000|Overall Study|Was Not Dosed|1|||
131172426|NCT01332019|472251978|FG001|Overall Study|Was Not Dosed|0|||
131172427|NCT01332019|472251977|FG000|Overall Study|Other|16|||
131172428|NCT01332019|472251978|FG001|Overall Study|Other|18|||
131172429|NCT01332019|472251977|FG000|Overall Study|Death|2|||
131172430|NCT01332019|472251978|FG001|Overall Study|Death|1|||
131172431|NCT01332019|472251977|FG000|Overall Study|Physician Decision|4|||
131172432|NCT01332019|472251978|FG001|Overall Study|Physician Decision|3|||
131172433|NCT01332019|472251977|FG000|Overall Study|Withdrawal by Subject|73|||
131172434|NCT01332019|472251978|FG001|Overall Study|Withdrawal by Subject|71|||
131172435|NCT01332019|472251977|FG000|Overall Study|Lost to Follow-up|4|||
131172436|NCT01332019|472251978|FG001|Overall Study|Lost to Follow-up|7|||
131172437|NCT01332019|472251977|FG000|Overall Study|Adverse Event|13|||
131172438|NCT01332019|472251978|FG001|Overall Study|Adverse Event|22|||
131172439|NCT00871377|472251979|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131172440|NCT00871377|472251980|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131172441|NCT00871377|472251981|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
131172442|NCT00871377|472251982|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131172443|NCT00871377|472251983|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131172444|NCT00871377|472251984|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
131172445|NCT00871377|472251979|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
131172446|NCT00871377|472251980|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
131172447|NCT00871377|472251981|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
131172448|NCT00871377|472251982|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
131172449|NCT00871377|472251983|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
131172450|NCT00871377|472251984|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
131172451|NCT00871377|472251979|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
131172452|NCT00871377|472251980|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
131236195|NCT00368277|472493273|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
131236196|NCT00368277|472493274|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
131236197|NCT00368277|472493273|FG000|Overall Study|Protocol deviation|7|||
131236198|NCT00368277|472493274|FG001|Overall Study|Protocol deviation|0|||
131236199|NCT00368277|472493273|FG000|Overall Study|Patient withdrew consent|32|||
131236200|NCT00368277|472493274|FG001|Overall Study|Patient withdrew consent|28|||
131236201|NCT00368277|472493273|FG000|Overall Study|Lost to Follow-up|8|||
131236202|NCT00368277|472493274|FG001|Overall Study|Lost to Follow-up|6|||
131236203|NCT04646109|472493281|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
131236204|NCT04646109|472493282|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
131236205|NCT01867242|472493285|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
131236206|NCT01867242|472493286|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
131236207|NCT01867242|472493287|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
131236208|NCT01790568|472493293|FG000|Overall Study|Progression prior to transplant|0|||
131236209|NCT01790568|472493294|FG001|Overall Study|Progression prior to transplant|1|||
131236210|NCT00264810|472493295|FG000|Baseline|Withdrawal by Subject|10|||
131236211|NCT00264810|472493296|FG001|Baseline|Withdrawal by Subject|10|||
131236212|NCT00264810|472493295|FG000|Baseline|Physician Decision|7|||
131236213|NCT00264810|472493296|FG001|Baseline|Physician Decision|8|||
131236214|NCT00264810|472493295|FG000|Baseline|Subject Compliance Failure|3|||
131236215|NCT00264810|472493296|FG001|Baseline|Subject Compliance Failure|3|||
131236216|NCT00264810|472493295|FG000|Baseline|Insufficient Seizure Frequency|2|||
131236217|NCT00264810|472493296|FG001|Baseline|Insufficient Seizure Frequency|2|||
131236218|NCT00264810|472493295|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
131236219|NCT00264810|472493296|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
131236220|NCT00264810|472493295|FG000|Baseline|Other|0|||
131236221|NCT00264810|472493296|FG001|Baseline|Other|1|||
131236222|NCT00264810|472493295|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
131236223|NCT00264810|472493296|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
131236224|NCT00264810|472493295|FG000|Stimulation Optimization Period|Death|0|||
131236225|NCT00264810|472493296|FG001|Stimulation Optimization Period|Death|1|||
131236226|NCT00264810|472493295|FG000|Blinded Evaluation Period|Explant due to infection|1|||
131236227|NCT00264810|472493296|FG001|Blinded Evaluation Period|Explant due to infection|1|||
131236228|NCT00264810|472493295|FG000|Open Label Evaluation Period|Explant due to infection|1|||
131236229|NCT00264810|472493296|FG001|Open Label Evaluation Period|Explant due to infection|1|||
131236230|NCT00264810|472493295|FG000|Open Label Evaluation Period|Death|3|||
131236231|NCT00264810|472493296|FG001|Open Label Evaluation Period|Death|2|||
131236232|NCT00264810|472493295|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
131236233|NCT00264810|472493296|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
131236234|NCT02093689|472493297|FG000|Overall Study|Physician Decision|4|||
131236235|NCT02093689|472493298|FG001|Overall Study|Physician Decision|0|||
131236236|NCT02093689|472493299|FG002|Overall Study|Physician Decision|0|||
131236237|NCT01575054|472493300|FG000|Overall Study|Other Reasons|5|||
131236238|NCT01575054|472493301|FG001|Overall Study|Other Reasons|3|||
131236239|NCT01575054|472493300|FG000|Overall Study|Protocol Violation|2|||
131236240|NCT01575054|472493301|FG001|Overall Study|Protocol Violation|1|||
131236241|NCT01575054|472493300|FG000|Overall Study|Personal Reasons|10|||
130731439|NCT00839254|470637400|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731440|NCT00839254|470637401|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
130731441|NCT00839254|470637394|FG000|Overall Study|Withdrawn due to non-compliance|2|||
130731442|NCT00839254|470637395|FG001|Overall Study|Withdrawn due to non-compliance|0|||
130731443|NCT00839254|470637396|FG002|Overall Study|Withdrawn due to non-compliance|0|||
130731444|NCT00839254|470637397|FG003|Overall Study|Withdrawn due to non-compliance|0|||
130731445|NCT00839254|470637398|FG004|Overall Study|Withdrawn due to non-compliance|0|||
130731446|NCT00839254|470637399|FG005|Overall Study|Withdrawn due to non-compliance|0|||
130731447|NCT00839254|470637400|FG006|Overall Study|Withdrawn due to non-compliance|0|||
130731448|NCT00839254|470637401|FG007|Overall Study|Withdrawn due to non-compliance|0|||
130731449|NCT00839254|470637394|FG000|Overall Study|Lost to Follow-up|51|||
130731450|NCT00839254|470637395|FG001|Overall Study|Lost to Follow-up|30|||
130731451|NCT00839254|470637396|FG002|Overall Study|Lost to Follow-up|32|||
130731452|NCT00839254|470637397|FG003|Overall Study|Lost to Follow-up|24|||
130731453|NCT00839254|470637398|FG004|Overall Study|Lost to Follow-up|8|||
130731454|NCT00839254|470637399|FG005|Overall Study|Lost to Follow-up|8|||
130731455|NCT00839254|470637400|FG006|Overall Study|Lost to Follow-up|4|||
130731456|NCT00839254|470637401|FG007|Overall Study|Lost to Follow-up|2|||
130731457|NCT00489827|470637404|FG000|Overall Study|Intraoperative exclusion criteria|1|||
130731458|NCT00489827|470637405|FG001|Overall Study|Intraoperative exclusion criteria|1|||
130731459|NCT00489827|470637404|FG000|Overall Study|Intraoperative exclusion criteria|1|||
130731460|NCT00489827|470637405|FG001|Overall Study|Intraoperative exclusion criteria|1|||
130731461|NCT02296931|470637406|FG000|Overall Study|Protocol Violation|0|||
130731462|NCT02296931|470637407|FG001|Overall Study|Protocol Violation|2|||
131236242|NCT01575054|472493301|FG001|Overall Study|Personal Reasons|11|||
131236243|NCT01575054|472493300|FG000|Overall Study|Lost to Follow-up|3|||
131236244|NCT01575054|472493301|FG001|Overall Study|Lost to Follow-up|3|||
130781835|NCT01317641|470829059|FG006|Overall Study|Withdrawal by Subject|1|||
130781836|NCT01317641|470829060|FG007|Overall Study|Withdrawal by Subject|0|||
130781837|NCT01317641|470829061|FG008|Overall Study|Withdrawal by Subject|0|||
130781838|NCT00611806|470829062|FG000|Overall Study|Withdrawal by Subject|8|||
130781839|NCT00611806|470829063|FG001|Overall Study|Withdrawal by Subject|2|||
130781840|NCT00611806|470829062|FG000|Overall Study|Adverse Event|2|||
130781841|NCT00611806|470829063|FG001|Overall Study|Adverse Event|1|||
130781842|NCT00611806|470829062|FG000|Overall Study|Lost to Follow-up|6|||
130781843|NCT00611806|470829063|FG001|Overall Study|Lost to Follow-up|0|||
130781844|NCT00715559|470829064|FG000|Overall Study|medication not tolerated - nausea|1|||
130781845|NCT00230048|470829065|FG000|Overall Study|Lost to Follow-up|13|||
130781846|NCT00230048|470829066|FG001|Overall Study|Lost to Follow-up|18|||
130781847|NCT01566604|470829067|FG000|Overall Study|Patient's inability to use the device|1|||
130781848|NCT01566604|470829068|FG001|Overall Study|Patient's inability to use the device|0|||
130781849|NCT01566604|470829067|FG000|Overall Study|Administrative problems|1|||
130781850|NCT01566604|470829068|FG001|Overall Study|Administrative problems|0|||
130781851|NCT01566604|470829067|FG000|Overall Study|Lack of Efficacy|1|||
130781852|NCT01566604|470829068|FG001|Overall Study|Lack of Efficacy|2|||
130781853|NCT01566604|470829067|FG000|Overall Study|Protocol deviation|2|||
130781854|NCT01566604|470829068|FG001|Overall Study|Protocol deviation|0|||
130781855|NCT01566604|470829067|FG000|Overall Study|Abnormal laboratory value|2|||
130781856|NCT01566604|470829068|FG001|Overall Study|Abnormal laboratory value|0|||
130781857|NCT01566604|470829067|FG000|Overall Study|Death|4|||
130781858|NCT01566604|470829068|FG001|Overall Study|Death|1|||
130781859|NCT01566604|470829067|FG000|Overall Study|Adverse Event|4|||
130781860|NCT01566604|470829068|FG001|Overall Study|Adverse Event|2|||
130781861|NCT01566604|470829067|FG000|Overall Study|Withdrawal by Subject|9|||
130781862|NCT01566604|470829068|FG001|Overall Study|Withdrawal by Subject|6|||
130781863|NCT03225170|470829069|FG000|Overall Study|Lost to Follow-up|4|||
130781864|NCT03225170|470829070|FG001|Overall Study|Lost to Follow-up|4|||
130781865|NCT03225170|470829071|FG002|Overall Study|Lost to Follow-up|0|||
130781866|NCT03225170|470829069|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
130781867|NCT03225170|470829070|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
130781868|NCT03225170|470829071|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
130781869|NCT00661089|470829078|FG000|Overall Study|1 subject withdrawal|0|||
130781870|NCT00661089|470829079|FG001|Overall Study|1 subject withdrawal|1|||
130781871|NCT00661089|470829078|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
130781872|NCT00661089|470829079|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
130781873|NCT00274742|470829080|FG000|Overall Study|Adverse Event|0|||
130781874|NCT00274742|470829081|FG001|Overall Study|Adverse Event|4|||
130781875|NCT00274742|470829082|FG002|Overall Study|Adverse Event|1|||
130781876|NCT00274742|470829083|FG003|Overall Study|Adverse Event|4|||
130781877|NCT00274742|470829084|FG004|Overall Study|Adverse Event|12|||
130781878|NCT00274742|470829085|FG005|Overall Study|Adverse Event|3|||
130781879|NCT00274742|470829080|FG000|Overall Study|Lost to Follow-up|0|||
130781880|NCT00274742|470829081|FG001|Overall Study|Lost to Follow-up|0|||
130781881|NCT00274742|470829082|FG002|Overall Study|Lost to Follow-up|0|||
130781882|NCT00274742|470829083|FG003|Overall Study|Lost to Follow-up|0|||
130781883|NCT00274742|470829084|FG004|Overall Study|Lost to Follow-up|1|||
130781884|NCT00274742|470829085|FG005|Overall Study|Lost to Follow-up|0|||
130781885|NCT00274742|470829080|FG000|Overall Study|End of Study|0|||
130781886|NCT00274742|470829081|FG001|Overall Study|End of Study|0|||
130781887|NCT00274742|470829082|FG002|Overall Study|End of Study|0|||
130781888|NCT00274742|470829083|FG003|Overall Study|End of Study|1|||
130781889|NCT00274742|470829084|FG004|Overall Study|End of Study|0|||
130781890|NCT00274742|470829085|FG005|Overall Study|End of Study|0|||
130781891|NCT00274742|470829080|FG000|Overall Study|Disease Progression|0|||
130781892|NCT00274742|470829081|FG001|Overall Study|Disease Progression|1|||
130781893|NCT00274742|470829082|FG002|Overall Study|Disease Progression|1|||
130781894|NCT00274742|470829083|FG003|Overall Study|Disease Progression|0|||
130781895|NCT00274742|470829084|FG004|Overall Study|Disease Progression|1|||
130781896|NCT00274742|470829085|FG005|Overall Study|Disease Progression|0|||
131172453|NCT00871377|472251981|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
131172454|NCT00871377|472251982|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
131172455|NCT00871377|472251983|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
130781897|NCT00274742|470829080|FG000|Overall Study|Other|0|||
130781898|NCT00274742|470829081|FG001|Overall Study|Other|3|||
130781899|NCT00274742|470829082|FG002|Overall Study|Other|0|||
130781900|NCT00274742|470829083|FG003|Overall Study|Other|0|||
130781901|NCT00274742|470829084|FG004|Overall Study|Other|2|||
130781902|NCT00274742|470829085|FG005|Overall Study|Other|0|||
130781903|NCT01529606|470829089|FG000|Overall Study|Lost to Follow-up|21|||
130781904|NCT01529606|470829090|FG001|Overall Study|Lost to Follow-up|18|||
130781905|NCT01900444|470829094|FG000|Overall Study|Protocol Violation|2|||
130781906|NCT01900444|470829094|FG000|Overall Study|Lost to Follow-up|1|||
130781907|NCT00072384|470829097|FG000|Overall Study|Physician Decision|1|||
130781908|NCT00072384|470829097|FG000|Overall Study|Ineligible|8|||
131172456|NCT00871377|472251984|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
131236245|NCT01575054|472493300|FG000|Overall Study|Adverse Event|9|||
131236246|NCT01575054|472493301|FG001|Overall Study|Adverse Event|8|||
131236247|NCT03481309|472493302|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
131236248|NCT03481309|472493303|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
131236249|NCT03481309|472493304|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
131236250|NCT03481309|472493305|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
131236251|NCT03481309|472493306|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
131236252|NCT03481309|472493307|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
131236253|NCT03309956|472493310|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
131236254|NCT03495869|472493311|FG000|Overall Study|Lost to Follow-up|4|||
131236255|NCT03495869|472493312|FG001|Overall Study|Lost to Follow-up|17|||
131236256|NCT03495869|472493313|FG002|Overall Study|Lost to Follow-up|8|||
131236257|NCT03495869|472493314|FG003|Overall Study|Lost to Follow-up|14|||
131236258|NCT03495869|472493311|FG000|Overall Study|Withdrawal by Subject|0|||
131236259|NCT03495869|472493312|FG001|Overall Study|Withdrawal by Subject|3|||
131236260|NCT03495869|472493313|FG002|Overall Study|Withdrawal by Subject|0|||
131236261|NCT03495869|472493314|FG003|Overall Study|Withdrawal by Subject|3|||
131236262|NCT03495869|472493311|FG000|Overall Study|Dropped from study|0|||
131236263|NCT03495869|472493312|FG001|Overall Study|Dropped from study|7|||
131236264|NCT03495869|472493313|FG002|Overall Study|Dropped from study|2|||
131236265|NCT03495869|472493314|FG003|Overall Study|Dropped from study|4|||
131236266|NCT02768298|472493315|FG000|Overall Study|Adverse Event|1|||
131236267|NCT02768298|472493316|FG001|Overall Study|Adverse Event|4|||
131236268|NCT02768298|472493315|FG000|Overall Study|Death|2|||
131236269|NCT02768298|472493316|FG001|Overall Study|Death|1|||
131236270|NCT02768298|472493315|FG000|Overall Study|Non-compliance with study treatment|0|||
131236271|NCT02768298|472493316|FG001|Overall Study|Non-compliance with study treatment|1|||
131236272|NCT02768298|472493315|FG000|Overall Study|Subject/guardian decision|1|||
131236273|NCT02768298|472493316|FG001|Overall Study|Subject/guardian decision|0|||
131236274|NCT02768298|472493315|FG000|Overall Study|Withdrawal of informed consent|0|||
131236275|NCT02768298|472493316|FG001|Overall Study|Withdrawal of informed consent|1|||
131236276|NCT04634409|472493317|FG000|Overall Study|Death|0|||
131236277|NCT04634409|472493318|FG001|Overall Study|Death|0|||
131236278|NCT04634409|472493319|FG002|Overall Study|Death|0|||
131236279|NCT04634409|472493320|FG003|Overall Study|Death|0|||
131236280|NCT04634409|472493321|FG004|Overall Study|Death|0|||
131236281|NCT04634409|472493322|FG005|Overall Study|Death|0|||
131236282|NCT04634409|472493323|FG006|Overall Study|Death|0|||
131236283|NCT04634409|472493324|FG007|Overall Study|Death|0|||
131236284|NCT04634409|472493325|FG008|Overall Study|Death|0|||
131236285|NCT04634409|472493326|FG009|Overall Study|Death|0|||
131236286|NCT04634409|472493327|FG010|Overall Study|Death|1|||
131236287|NCT04634409|472493328|FG011|Overall Study|Death|0|||
131236288|NCT04634409|472493329|FG012|Overall Study|Death|1|||
131236289|NCT04634409|472493330|FG013|Overall Study|Death|0|||
131236290|NCT04634409|472493331|FG014|Overall Study|Death|0|||
131236291|NCT04634409|472493332|FG015|Overall Study|Death|0|||
131236292|NCT04634409|472493333|FG016|Overall Study|Death|0|||
131236293|NCT04634409|472493334|FG017|Overall Study|Death|0|||
131236294|NCT04634409|472493335|FG018|Overall Study|Death|0|||
131236295|NCT04634409|472493336|FG019|Overall Study|Death|0|||
131236296|NCT04634409|472493337|FG020|Overall Study|Death|0|||
131236297|NCT04634409|472493338|FG021|Overall Study|Death|0|||
131236298|NCT04634409|472493339|FG022|Overall Study|Death|0|||
131236299|NCT04634409|472493340|FG023|Overall Study|Death|0|||
131236300|NCT04634409|472493341|FG024|Overall Study|Death|0|||
131236301|NCT04634409|472493342|FG025|Overall Study|Death|0|||
131236302|NCT04634409|472493343|FG026|Overall Study|Death|0|||
131236303|NCT04634409|472493317|FG000|Overall Study|Adverse Event|0|||
131236304|NCT04634409|472493318|FG001|Overall Study|Adverse Event|0|||
131236305|NCT04634409|472493319|FG002|Overall Study|Adverse Event|1|||
131236306|NCT04634409|472493320|FG003|Overall Study|Adverse Event|0|||
131236307|NCT04634409|472493321|FG004|Overall Study|Adverse Event|0|||
131236308|NCT04634409|472493322|FG005|Overall Study|Adverse Event|1|||
131236309|NCT04634409|472493323|FG006|Overall Study|Adverse Event|0|||
131236310|NCT04634409|472493324|FG007|Overall Study|Adverse Event|0|||
131236311|NCT04634409|472493325|FG008|Overall Study|Adverse Event|0|||
131236312|NCT04634409|472493326|FG009|Overall Study|Adverse Event|0|||
131236313|NCT04634409|472493327|FG010|Overall Study|Adverse Event|0|||
131236314|NCT04634409|472493328|FG011|Overall Study|Adverse Event|0|||
131236315|NCT04634409|472493329|FG012|Overall Study|Adverse Event|0|||
131236316|NCT04634409|472493330|FG013|Overall Study|Adverse Event|0|||
131236317|NCT04634409|472493331|FG014|Overall Study|Adverse Event|0|||
131236318|NCT04634409|472493332|FG015|Overall Study|Adverse Event|0|||
131236319|NCT04634409|472493333|FG016|Overall Study|Adverse Event|0|||
131236320|NCT04634409|472493334|FG017|Overall Study|Adverse Event|0|||
131236321|NCT04634409|472493335|FG018|Overall Study|Adverse Event|0|||
131236322|NCT04634409|472493336|FG019|Overall Study|Adverse Event|0|||
131236323|NCT04634409|472493337|FG020|Overall Study|Adverse Event|0|||
131236324|NCT04634409|472493338|FG021|Overall Study|Adverse Event|0|||
131236325|NCT04634409|472493339|FG022|Overall Study|Adverse Event|0|||
131172457|NCT00871377|472251979|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
131172458|NCT00871377|472251980|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
131172459|NCT00871377|472251981|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
131172460|NCT00871377|472251982|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
131172461|NCT00871377|472251983|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
131172462|NCT00871377|472251984|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
131172463|NCT00871377|472251979|FG000|Third Intervention (10 Weeks)|Death|0|||
131172464|NCT00871377|472251980|FG001|Third Intervention (10 Weeks)|Death|0|||
131172465|NCT00871377|472251981|FG002|Third Intervention (10 Weeks)|Death|0|||
131172466|NCT00871377|472251982|FG003|Third Intervention (10 Weeks)|Death|1|||
131172467|NCT00871377|472251983|FG004|Third Intervention (10 Weeks)|Death|0|||
131172468|NCT00871377|472251984|FG005|Third Intervention (10 Weeks)|Death|0|||
131172469|NCT01395368|472251986|FG000|Overall Study|Physician Decision|14|||
131172470|NCT01395368|472251986|FG000|Overall Study|Withdrawal by Subject|2|||
131172471|NCT00288860|472251993|FG000|Overall Study|Did not complete intake|4|||
131172472|NCT00288860|472251994|FG001|Overall Study|Did not complete intake|8|||
131172473|NCT00288860|472251993|FG000|Overall Study|Death|4|||
131172474|NCT00288860|472251994|FG001|Overall Study|Death|3|||
131172475|NCT00288860|472251993|FG000|Overall Study|Withdrawal by Subject|20|||
131172476|NCT00288860|472251994|FG001|Overall Study|Withdrawal by Subject|15|||
131172477|NCT00288860|472251993|FG000|Overall Study|Lost to Follow-up|74|||
131172478|NCT00288860|472251994|FG001|Overall Study|Lost to Follow-up|71|||
131172479|NCT04017442|472251995|FG000|Overall Study|Withdrawal by Subject|0|||
131172480|NCT04017442|472251996|FG001|Overall Study|Withdrawal by Subject|3|||
131172481|NCT04017442|472251995|FG000|Overall Study|Lost to Follow-up|21|||
131172482|NCT04017442|472251996|FG001|Overall Study|Lost to Follow-up|19|||
131172483|NCT02586233|472251997|FG000|Overall Study|Randomized but did not receive treatment|0|||
131172484|NCT02586233|472251998|FG001|Overall Study|Randomized but did not receive treatment|1|||
131172485|NCT02586233|472251999|FG002|Overall Study|Randomized but did not receive treatment|0|||
131172486|NCT02586233|472252000|FG003|Overall Study|Randomized but did not receive treatment|0|||
131172487|NCT02586233|472252001|FG004|Overall Study|Randomized but did not receive treatment|0|||
131172488|NCT02586233|472252002|FG005|Overall Study|Randomized but did not receive treatment|2|||
131172489|NCT02586233|472252003|FG006|Overall Study|Randomized but did not receive treatment|2|||
131172490|NCT02586233|472251997|FG000|Overall Study|Death|0|||
131172491|NCT02586233|472251998|FG001|Overall Study|Death|1|||
131172492|NCT02586233|472251999|FG002|Overall Study|Death|0|||
131172493|NCT02586233|472252000|FG003|Overall Study|Death|0|||
131172494|NCT02586233|472252001|FG004|Overall Study|Death|2|||
131172495|NCT02586233|472252002|FG005|Overall Study|Death|0|||
131172496|NCT02586233|472252003|FG006|Overall Study|Death|0|||
131172497|NCT01757405|472252004|FG000|Overall Study|Lost to Follow-up|1|||
131172498|NCT01757405|472252005|FG001|Overall Study|Lost to Follow-up|1|||
131172499|NCT01757405|472252004|FG000|Overall Study|Withdrawal by Subject|0|||
131172500|NCT01757405|472252005|FG001|Overall Study|Withdrawal by Subject|1|||
131172501|NCT00082758|472252007|FG000|Overall Study|Adverse Event|0|||
131172502|NCT00082758|472252008|FG001|Overall Study|Adverse Event|2|||
131172503|NCT00082758|472252009|FG002|Overall Study|Adverse Event|0|||
131172504|NCT00082758|472252007|FG000|Overall Study|Lack of Efficacy|12|||
131172505|NCT00082758|472252008|FG001|Overall Study|Lack of Efficacy|13|||
131172506|NCT00082758|472252009|FG002|Overall Study|Lack of Efficacy|0|||
131172507|NCT00082758|472252007|FG000|Overall Study|Physician Decision|0|||
131172508|NCT00082758|472252008|FG001|Overall Study|Physician Decision|1|||
131172509|NCT00082758|472252009|FG002|Overall Study|Physician Decision|0|||
131172510|NCT00082758|472252007|FG000|Overall Study|Withdrawal by Subject|3|||
131172511|NCT00082758|472252008|FG001|Overall Study|Withdrawal by Subject|0|||
131172512|NCT00082758|472252009|FG002|Overall Study|Withdrawal by Subject|0|||
131172513|NCT00082758|472252007|FG000|Overall Study|Protocol Violation|0|||
131172514|NCT00082758|472252008|FG001|Overall Study|Protocol Violation|1|||
131172515|NCT00082758|472252009|FG002|Overall Study|Protocol Violation|0|||
131172516|NCT00238303|472252010|FG000|Overall Study|Withdrawal by Subject|11|||
131172517|NCT00238303|472252011|FG001|Overall Study|Withdrawal by Subject|1|||
131172518|NCT00238303|472252012|FG002|Overall Study|Withdrawal by Subject|2|||
131172519|NCT00238303|472252010|FG000|Overall Study|Death|1|||
131172520|NCT00238303|472252011|FG001|Overall Study|Death|0|||
131172521|NCT00238303|472252012|FG002|Overall Study|Death|1|||
131172522|NCT00238303|472252010|FG000|Overall Study|Other Medical Problems|2|||
131172523|NCT00238303|472252011|FG001|Overall Study|Other Medical Problems|0|||
131172524|NCT00238303|472252012|FG002|Overall Study|Other Medical Problems|2|||
131172525|NCT00238303|472252010|FG000|Overall Study|Poor tolerance of study treatment|1|||
131172526|NCT00238303|472252011|FG001|Overall Study|Poor tolerance of study treatment|0|||
131172527|NCT00238303|472252012|FG002|Overall Study|Poor tolerance of study treatment|1|||
131172528|NCT00238303|472252010|FG000|Overall Study|Adverse Event|0|||
131172529|NCT00238303|472252011|FG001|Overall Study|Adverse Event|1|||
131172530|NCT00238303|472252012|FG002|Overall Study|Adverse Event|3|||
131172531|NCT01248130|472252016|FG000|Overall Study|Protocol Violation|1|||
131172532|NCT01248130|472252017|FG001|Overall Study|Protocol Violation|0|||
131172533|NCT01248130|472252016|FG000|Overall Study|Ineligible|1|||
131172534|NCT01248130|472252017|FG001|Overall Study|Ineligible|0|||
130781909|NCT01825200|470829098|FG000|Overall Study|Lost to Follow-up|5|||
130781910|NCT01825200|470829099|FG001|Overall Study|Lost to Follow-up|6|||
130781911|NCT01825200|470829098|FG000|Overall Study|Withdrawal by Subject|0|||
130781912|NCT01825200|470829099|FG001|Overall Study|Withdrawal by Subject|1|||
130781913|NCT00490035|470829100|FG000|Overall Study|AE, non-serious non-fatal|3|||
130781914|NCT00490035|470829101|FG001|Overall Study|AE, non-serious non-fatal|4|||
130781915|NCT00490035|470829102|FG002|Overall Study|AE, non-serious non-fatal|4|||
130781916|NCT00490035|470829103|FG003|Overall Study|AE, non-serious non-fatal|5|||
130781917|NCT00490035|470829100|FG000|Overall Study|Lost to Follow-up|2|||
130781918|NCT00490035|470829101|FG001|Overall Study|Lost to Follow-up|0|||
130781919|NCT00490035|470829102|FG002|Overall Study|Lost to Follow-up|1|||
130781920|NCT00490035|470829103|FG003|Overall Study|Lost to Follow-up|0|||
130781921|NCT00490035|470829100|FG000|Overall Study|Withdrawal by Subject|2|||
130781922|NCT00490035|470829101|FG001|Overall Study|Withdrawal by Subject|1|||
130781923|NCT00490035|470829102|FG002|Overall Study|Withdrawal by Subject|1|||
130781924|NCT00490035|470829103|FG003|Overall Study|Withdrawal by Subject|0|||
130781925|NCT00490035|470829100|FG000|Overall Study|Other reason|0|||
130781926|NCT00490035|470829101|FG001|Overall Study|Other reason|1|||
130781927|NCT00490035|470829102|FG002|Overall Study|Other reason|3|||
130781928|NCT00490035|470829103|FG003|Overall Study|Other reason|1|||
130781929|NCT00490035|470829100|FG000|Overall Study|AE, serious fatal|1|||
130781930|NCT00490035|470829101|FG001|Overall Study|AE, serious fatal|0|||
130781931|NCT00490035|470829102|FG002|Overall Study|AE, serious fatal|0|||
130781932|NCT00490035|470829103|FG003|Overall Study|AE, serious fatal|0|||
130781933|NCT00490035|470829100|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
130781934|NCT00490035|470829101|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
130781935|NCT00490035|470829102|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
130781936|NCT00490035|470829103|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
130781937|NCT00490035|470829100|FG000|Overall Study|AE of unknown type|0|||
130781938|NCT00490035|470829101|FG001|Overall Study|AE of unknown type|0|||
130781939|NCT00490035|470829102|FG002|Overall Study|AE of unknown type|2|||
130781940|NCT00490035|470829103|FG003|Overall Study|AE of unknown type|0|||
130781941|NCT00731822|470829104|FG000|Overall Study|Adverse Event|2|||
130781942|NCT00731822|470829105|FG001|Overall Study|Adverse Event|1|||
130781943|NCT00731822|470829104|FG000|Overall Study|Protocol Violation|1|||
130781944|NCT00731822|470829105|FG001|Overall Study|Protocol Violation|0|||
130781945|NCT00731822|470829104|FG000|Overall Study|Lost to Follow-up|1|||
130781946|NCT00731822|470829105|FG001|Overall Study|Lost to Follow-up|0|||
130781947|NCT05209880|470829115|FG000|1-Month Follow-up|Spoke with Doctor|5|||
130781948|NCT05209880|470829116|FG001|1-Month Follow-up|Spoke with Doctor|5|||
130781949|NCT05209880|470829115|FG000|1-Month Follow-up|Lost to Follow-up|7|||
130781950|NCT05209880|470829116|FG001|1-Month Follow-up|Lost to Follow-up|9|||
130781951|NCT05209880|470829115|FG000|1-Month Follow-up|Discontinued|0|||
130781952|NCT05209880|470829116|FG001|1-Month Follow-up|Discontinued|1|||
130781953|NCT05209880|470829115|FG000|3-Month Follow-up|Spoke with Doctor|17|||
130781954|NCT05209880|470829116|FG001|3-Month Follow-up|Spoke with Doctor|7|||
130781955|NCT05209880|470829115|FG000|3-Month Follow-up|Lost to Follow-up|8|||
130781956|NCT05209880|470829116|FG001|3-Month Follow-up|Lost to Follow-up|10|||
130781957|NCT05209880|470829115|FG000|3-Month Follow-up|Discontinued|1|||
130781958|NCT05209880|470829116|FG001|3-Month Follow-up|Discontinued|3|||
130781959|NCT05209880|470829115|FG000|6-Month Follow-up|Spoke with Doctor|25|||
130781960|NCT05209880|470829116|FG001|6-Month Follow-up|Spoke with Doctor|14|||
130781961|NCT05209880|470829115|FG000|6-Month Follow-up|Lost to Follow-up|9|||
130781962|NCT05209880|470829116|FG001|6-Month Follow-up|Lost to Follow-up|14|||
130781963|NCT05209880|470829115|FG000|6-Month Follow-up|Discontinued|1|||
130781964|NCT05209880|470829116|FG001|6-Month Follow-up|Discontinued|3|||
130781965|NCT04817332|470829117|FG000|Overall Study|Lost to Follow-up|3|||
130781966|NCT04817332|470829118|FG001|Overall Study|Lost to Follow-up|3|||
130781967|NCT04817332|470829117|FG000|Overall Study|Protocol Violation|2|||
130781968|NCT04817332|470829118|FG001|Overall Study|Protocol Violation|0|||
131172535|NCT01358877|472252018|FG000|Overall Study|Death|80|||
131172536|NCT01358877|472252019|FG001|Overall Study|Death|89|||
131172537|NCT01358877|472252018|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
131172538|NCT01358877|472252019|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
131172539|NCT01358877|472252018|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
131172540|NCT01358877|472252019|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
130781975|NCT05635045|470829126|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
130781976|NCT05635045|470829127|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
130781977|NCT05635045|470829128|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
130781978|NCT05635045|470829129|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
130781979|NCT01435759|470829133|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
130781980|NCT01435759|470829134|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
130781981|NCT01435759|470829135|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
130781982|NCT01435759|470829136|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
130781983|NCT01435759|470829137|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
131172541|NCT01358877|472252018|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
131172542|NCT01358877|472252019|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
131172543|NCT01358877|472252018|FG000|Overall Study|Other|142|||
131172544|NCT01358877|472252019|FG001|Overall Study|Other|129|||
131172545|NCT01911845|472252024|FG000|Overall Study|Adverse Event|2|||
131172546|NCT01911845|472252024|FG000|Overall Study|Lost to Follow-up|1|||
131172547|NCT01911845|472252024|FG000|Overall Study|Other (not specified)|3|||
131172548|NCT01994226|472252025|FG000|Overall Study|Protocol Violation|13|||
131172549|NCT01994226|472252026|FG001|Overall Study|Protocol Violation|10|||
131172550|NCT01994226|472252025|FG000|Overall Study|Early Cessation of treatment|6|||
131172551|NCT01994226|472252026|FG001|Overall Study|Early Cessation of treatment|11|||
131172552|NCT04507867|472252032|FG000|Overall Study|Death|7|||
131172553|NCT04507867|472252033|FG001|Overall Study|Death|1|||
131172554|NCT01954251|472252037|FG000|Overall Study|Adverse Event|5|||
131172555|NCT01954251|472252038|FG001|Overall Study|Adverse Event|7|||
131172556|NCT01954251|472252037|FG000|Overall Study|Lost to Follow-up|6|||
130781984|NCT01435759|470829138|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
131172557|NCT01954251|472252038|FG001|Overall Study|Lost to Follow-up|6|||
131172558|NCT01954251|472252037|FG000|Overall Study|Withdrawal by Subject|2|||
131172559|NCT01954251|472252038|FG001|Overall Study|Withdrawal by Subject|6|||
131172560|NCT00779324|472252039|FG000|Overall Study|Lost to Follow-up|2|||
131172561|NCT00779324|472252040|FG001|Overall Study|Lost to Follow-up|1|||
131172562|NCT00779324|472252039|FG000|Overall Study|Withdrawal by Subject|4|||
131172563|NCT00779324|472252040|FG001|Overall Study|Withdrawal by Subject|2|||
131172564|NCT00779324|472252039|FG000|Overall Study|Missed visit|1|||
131172565|NCT00779324|472252040|FG001|Overall Study|Missed visit|1|||
131172566|NCT02207556|472252041|FG000|Overall Study|Physician Decision|1|||
131172567|NCT02207556|472252042|FG001|Overall Study|Physician Decision|0|||
131172568|NCT02207556|472252041|FG000|Overall Study|Withdrawal by Subject|1|||
131172569|NCT02207556|472252042|FG001|Overall Study|Withdrawal by Subject|0|||
131172570|NCT02207556|472252041|FG000|Overall Study|Death|0|||
131172571|NCT02207556|472252042|FG001|Overall Study|Death|5|||
131172572|NCT03558555|472252043|FG000|Overall Study|Lost to Follow-up|2|||
131172573|NCT03558555|472252044|FG001|Overall Study|Lost to Follow-up|1|||
131172574|NCT01958125|472252045|FG000|Overall Study|Missing diary data|2|||
131172575|NCT01958125|472252046|FG001|Overall Study|Missing diary data|6|||
131172576|NCT01958125|472252045|FG000|Overall Study|No headache attacks|0|||
131172577|NCT01958125|472252046|FG001|Overall Study|No headache attacks|2|||
131172578|NCT00781599|472252049|FG000|Overall Study|Lost to Follow-up|7|||
131172579|NCT00781599|472252050|FG001|Overall Study|Lost to Follow-up|4|||
131172580|NCT01106625|472252051|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
131172581|NCT01106625|472252052|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
131172582|NCT01106625|472252053|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
131172583|NCT01106625|472252051|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
131172584|NCT01106625|472252052|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
131172585|NCT01106625|472252053|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
131172586|NCT01106625|472252051|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
131172587|NCT01106625|472252052|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
131172588|NCT01106625|472252053|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
131172589|NCT01106625|472252051|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
131172590|NCT01106625|472252052|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
131172591|NCT01106625|472252053|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
131172592|NCT01106625|472252051|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
131172593|NCT01106625|472252052|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
131172594|NCT01106625|472252053|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
131172595|NCT01106625|472252051|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
131172596|NCT01106625|472252052|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
131172597|NCT01106625|472252053|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
131172598|NCT01106625|472252051|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
131172599|NCT01106625|472252052|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
131172600|NCT01106625|472252053|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
131172601|NCT01106625|472252051|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
131172602|NCT01106625|472252052|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
131172603|NCT01106625|472252053|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
131172604|NCT01106625|472252051|FG000|Core Period: Baseline to Week 26|Other|8|||
131172605|NCT01106625|472252052|FG001|Core Period: Baseline to Week 26|Other|7|||
131172606|NCT01106625|472252053|FG002|Core Period: Baseline to Week 26|Other|4|||
131172607|NCT01106625|472252051|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
131172608|NCT01106625|472252052|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
131172609|NCT01106625|472252053|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
131172610|NCT01106625|472252051|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
131172611|NCT01106625|472252052|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
130781985|NCT01435759|470829133|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
130781986|NCT01435759|470829134|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
130781987|NCT01435759|470829135|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
130781988|NCT01435759|470829136|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
130781989|NCT01435759|470829137|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
130781990|NCT01435759|470829138|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
130781991|NCT01435759|470829133|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
130781992|NCT01435759|470829134|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130781993|NCT01435759|470829135|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130781994|NCT01435759|470829136|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130781995|NCT01435759|470829137|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130781996|NCT01435759|470829138|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
131172612|NCT01106625|472252053|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
131172613|NCT01106625|472252051|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
131172614|NCT01106625|472252052|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
131172615|NCT01106625|472252053|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
131172616|NCT01106625|472252051|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131172617|NCT01106625|472252052|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
131172618|NCT01106625|472252053|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
131172619|NCT01106625|472252051|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
131172620|NCT01106625|472252052|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
131172621|NCT01106625|472252053|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
131172622|NCT01106625|472252051|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
131172623|NCT01106625|472252052|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
131172624|NCT01106625|472252053|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
131172625|NCT01106625|472252051|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
131172626|NCT01106625|472252052|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
131172627|NCT01106625|472252053|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
131172628|NCT01106625|472252051|FG000|Extension Period: Week 26 to Week 52|Other|5|||
131172629|NCT01106625|472252052|FG001|Extension Period: Week 26 to Week 52|Other|5|||
131172630|NCT01106625|472252053|FG002|Extension Period: Week 26 to Week 52|Other|4|||
131172631|NCT02509598|472252054|FG000|Overall Study|Withdrawal by Subject|1|||
131172632|NCT02196038|472252055|FG000|Overall Study|Death|16|||
131172633|NCT02196038|472252056|FG001|Overall Study|Death|21|||
131172634|NCT02196038|472252055|FG000|Overall Study|Withdrawal by Subject|0|||
131172635|NCT02196038|472252056|FG001|Overall Study|Withdrawal by Subject|1|||
131172636|NCT02196038|472252055|FG000|Overall Study|Lost to Follow-up|1|||
131172637|NCT02196038|472252056|FG001|Overall Study|Lost to Follow-up|0|||
131172638|NCT01474746|472252061|FG000|Overall Study|Lost to Follow-up|1|||
131172639|NCT01474746|472252062|FG001|Overall Study|Lost to Follow-up|1|||
131172640|NCT01474746|472252061|FG000|Overall Study|Withdrawal by Subject|2|||
131172641|NCT01474746|472252062|FG001|Overall Study|Withdrawal by Subject|1|||
131172642|NCT02605447|472252064|FG000|Overall Study|Death|66|||
131172643|NCT02605447|472252064|FG000|Overall Study|Physician Decision|1|||
131172644|NCT02605447|472252064|FG000|Overall Study|Lost to Follow-up|24|||
131172645|NCT02605447|472252064|FG000|Overall Study|Withdrawal by Subject|10|||
131172646|NCT02605447|472252064|FG000|Overall Study|Not disclosed|1|||
131172647|NCT02045212|472252068|FG000|Overall Study|Adverse Event|0|||
131172648|NCT02045212|472252069|FG001|Overall Study|Adverse Event|1|||
131172649|NCT02045212|472252068|FG000|Overall Study|Withdrawal by Subject|1|||
131172650|NCT02045212|472252069|FG001|Overall Study|Withdrawal by Subject|0|||
131172651|NCT02045212|472252068|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
131172652|NCT02045212|472252069|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
131172653|NCT03213626|472252073|FG000|Overall Study|Adverse Event|1|||
131172654|NCT03213626|472252073|FG000|Overall Study|Progressive Disease|6|||
130781997|NCT01435759|470829133|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
130781998|NCT01435759|470829134|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
131172655|NCT00786032|472253796|FG000|Overall Study|Death|4|||
131172656|NCT00786032|472253796|FG000|Overall Study|Withdrawal by Subject|14|||
131172657|NCT00786032|472253796|FG000|Overall Study|Did not complete in the timeframe|6|||
131172658|NCT02625324|472253797|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
131172659|NCT02625324|472253797|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
131172660|NCT02625324|472253797|FG000|6-Month Follow-up Subject Accountability|Death|5|||
131172661|NCT02625324|472253797|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
131172662|NCT02625324|472253797|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
131172663|NCT02625324|472253797|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
131172664|NCT02625324|472253797|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
130781999|NCT01435759|470829135|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
131172665|NCT02625324|472253797|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
131172666|NCT02625324|472253797|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
131172667|NCT02625324|472253797|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
131172668|NCT02625324|472253797|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
131172669|NCT02625324|472253797|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
131172670|NCT02625324|472253797|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
131172671|NCT02625324|472253797|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
131172672|NCT02625324|472253797|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
131172673|NCT02625324|472253797|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
131172674|NCT02625324|472253797|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
131172675|NCT02457182|472253798|FG000|Overall Study|Lost to Follow-up|1|||
131172676|NCT02457182|472253799|FG001|Overall Study|Lost to Follow-up|0|||
131172677|NCT02294318|472253802|FG000|Overall Study|Worsening of drinking|3|||
131172678|NCT02294318|472253803|FG001|Overall Study|Worsening of drinking|0|||
131172679|NCT02294318|472253802|FG000|Overall Study|Not exposed to intervention|0|||
131172680|NCT02294318|472253803|FG001|Overall Study|Not exposed to intervention|2|||
131172681|NCT01116687|472253804|FG000|Overall Study|Withdrawal by Subject|4|||
131172682|NCT00789191|472253807|FG000|Overall Study|Adverse Event|2|||
131172683|NCT00789191|472253808|FG001|Overall Study|Adverse Event|4|||
131172684|NCT00789191|472253807|FG000|Overall Study|Lack of Efficacy|0|||
131172685|NCT00789191|472253808|FG001|Overall Study|Lack of Efficacy|5|||
131172686|NCT00789191|472253807|FG000|Overall Study|Protocol Violation|5|||
131172687|NCT00789191|472253808|FG001|Overall Study|Protocol Violation|3|||
131172688|NCT00789191|472253807|FG000|Overall Study|Withdrawal Criteria|2|||
131172689|NCT00789191|472253808|FG001|Overall Study|Withdrawal Criteria|4|||
131172690|NCT00789191|472253807|FG000|Overall Study|Unclassified|5|||
131172691|NCT00789191|472253808|FG001|Overall Study|Unclassified|3|||
131172692|NCT03497429|472253809|FG000|Overall Study|Progressive disease|3|||
131172693|NCT03497429|472253810|FG001|Overall Study|Progressive disease|4|||
131172694|NCT03497429|472253809|FG000|Overall Study|Adverse Event|0|||
131172695|NCT03497429|472253810|FG001|Overall Study|Adverse Event|2|||
131172696|NCT01009983|472253811|FG000|Overall Study|necessary scans not completed|1|||
131172697|NCT00506948|472253812|FG000|Overall Study|Death|4|||
131172698|NCT00506948|472253812|FG000|Overall Study|Adverse Event|5|||
131172699|NCT00506948|472253812|FG000|Overall Study|Physician Decision|1|||
131172700|NCT02174861|472253813|FG000|Overall Study|Decision by sponsor|8|||
131172701|NCT02174861|472253813|FG000|Overall Study|Withdrawal by Subject|124|||
131172702|NCT02174861|472253813|FG000|Overall Study|Lost to Follow-up|26|||
131172703|NCT00165841|472253817|FG000|Overall Study|Adverse Event|2|||
131172704|NCT00165841|472253818|FG001|Overall Study|Adverse Event|3|||
131172705|NCT00165841|472253817|FG000|Overall Study|Lack of Efficacy|6|||
131172706|NCT00165841|472253818|FG001|Overall Study|Lack of Efficacy|33|||
131172707|NCT00165841|472253817|FG000|Overall Study|Lost to Follow-up|4|||
131172708|NCT00165841|472253818|FG001|Overall Study|Lost to Follow-up|4|||
131172709|NCT00165841|472253817|FG000|Overall Study|Withdrawal by Subject|7|||
131172710|NCT00165841|472253818|FG001|Overall Study|Withdrawal by Subject|8|||
131172711|NCT00165841|472253817|FG000|Overall Study|Physician Decision|1|||
131172712|NCT00165841|472253818|FG001|Overall Study|Physician Decision|0|||
131172713|NCT00165841|472253817|FG000|Overall Study|Protocol Violation|6|||
131172714|NCT00165841|472253818|FG001|Overall Study|Protocol Violation|8|||
131172715|NCT00165841|472253817|FG000|Overall Study|Other|3|||
131172716|NCT00165841|472253818|FG001|Overall Study|Other|5|||
131172717|NCT00165841|472253817|FG000|Overall Study|Medication Noncompliance|1|||
131172718|NCT00165841|472253818|FG001|Overall Study|Medication Noncompliance|1|||
131172719|NCT00254293|472253819|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
131172720|NCT00254293|472253820|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
131172721|NCT00254293|472253821|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
131172722|NCT00254293|472253822|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
131172723|NCT00254293|472253823|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
131172724|NCT00254293|472253824|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
131172725|NCT00254293|472253825|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
131172726|NCT00254293|472253819|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131172727|NCT00254293|472253820|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131172728|NCT00254293|472253821|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
131172729|NCT00254293|472253822|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131172730|NCT00254293|472253823|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131172731|NCT00254293|472253824|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131172732|NCT00254293|472253825|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
131172733|NCT00254293|472253819|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131172734|NCT00254293|472253820|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131172735|NCT00254293|472253821|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
131172736|NCT00254293|472253822|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131236326|NCT04634409|472493340|FG023|Overall Study|Adverse Event|0|||
131172737|NCT00254293|472253823|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131236327|NCT04634409|472493341|FG024|Overall Study|Adverse Event|0|||
131172738|NCT00254293|472253824|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131172739|NCT00254293|472253825|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
131172740|NCT00254293|472253819|FG000|LTE Open Label Variable SC Dosing|Death|0|||
131172741|NCT00254293|472253820|FG001|LTE Open Label Variable SC Dosing|Death|0|||
131172742|NCT00254293|472253821|FG002|LTE Open Label Variable SC Dosing|Death|1|||
131172743|NCT00254293|472253822|FG003|LTE Open Label Variable SC Dosing|Death|0|||
131172744|NCT00254293|472253823|FG004|LTE Open Label Variable SC Dosing|Death|0|||
131172745|NCT00254293|472253824|FG005|LTE Open Label Variable SC Dosing|Death|0|||
131172746|NCT00254293|472253825|FG006|LTE Open Label Variable SC Dosing|Death|0|||
131172747|NCT00254293|472253819|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
131172748|NCT00254293|472253820|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
131172749|NCT00254293|472253821|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
131172750|NCT00254293|472253822|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
131172751|NCT00254293|472253823|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
131172752|NCT00254293|472253824|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
131172753|NCT00254293|472253825|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
131172754|NCT00254293|472253819|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
131172755|NCT00254293|472253820|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
131172756|NCT00254293|472253821|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
131172757|NCT00254293|472253822|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
131172758|NCT00254293|472253823|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
131172759|NCT00254293|472253824|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
131172760|NCT00254293|472253825|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
131172761|NCT00254293|472253819|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131172762|NCT00254293|472253820|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131172763|NCT00254293|472253821|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
131172764|NCT00254293|472253822|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131172765|NCT00254293|472253823|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131172766|NCT00254293|472253824|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131172767|NCT00254293|472253825|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
131172768|NCT00254293|472253819|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131172769|NCT00254293|472253820|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131172770|NCT00254293|472253821|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
131172771|NCT00254293|472253822|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131172772|NCT00254293|472253823|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131172773|NCT00254293|472253824|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131172774|NCT00254293|472253825|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
131172775|NCT00254293|472253819|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131172776|NCT00254293|472253820|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131172777|NCT00254293|472253821|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
131172778|NCT00254293|472253822|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131172779|NCT00254293|472253823|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131172780|NCT00254293|472253824|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131172781|NCT00254293|472253825|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
131172782|NCT00254293|472253819|FG000|LTE Open Label Variable SC Dosing|Other|0|||
131172783|NCT00254293|472253820|FG001|LTE Open Label Variable SC Dosing|Other|0|||
131172784|NCT00254293|472253821|FG002|LTE Open Label Variable SC Dosing|Other|2|||
131172785|NCT00254293|472253822|FG003|LTE Open Label Variable SC Dosing|Other|0|||
131172786|NCT00254293|472253823|FG004|LTE Open Label Variable SC Dosing|Other|0|||
131172787|NCT00254293|472253824|FG005|LTE Open Label Variable SC Dosing|Other|0|||
130731463|NCT01590277|470637408|FG000|Overall Study|Withdrawal by Subject|3|||
130731464|NCT01590277|470637408|FG000|Overall Study|Withdrawal by Subject|2|||
130731465|NCT01590277|470637408|FG000|Overall Study|Withdrawal by Subject|1|||
130731466|NCT01590277|470637408|FG000|Overall Study|Withdrawal by Subject|1|||
130731467|NCT01377012|470637409|FG000|Core Study|Study terminated by Sponsor|47|||
130731468|NCT01377012|470637410|FG001|Core Study|Study terminated by Sponsor|54|||
130731469|NCT01377012|470637411|FG002|Core Study|Study terminated by Sponsor|46|||
130731470|NCT01377012|470637409|FG000|Core Study|Technical problems|1|||
130731471|NCT01377012|470637410|FG001|Core Study|Technical problems|0|||
130731472|NCT01377012|470637411|FG002|Core Study|Technical problems|0|||
130731473|NCT01377012|470637409|FG000|Core Study|Withdrawal by Subject|15|||
130782000|NCT01435759|470829136|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
131172788|NCT00254293|472253825|FG006|LTE Open Label Variable SC Dosing|Other|0|||
131172789|NCT00254293|472253819|FG000|LTE Open Label Fixed Dosing|Death|0|||
131172790|NCT00254293|472253820|FG001|LTE Open Label Fixed Dosing|Death|0|||
131172791|NCT00254293|472253821|FG002|LTE Open Label Fixed Dosing|Death|0|||
131172792|NCT00254293|472253822|FG003|LTE Open Label Fixed Dosing|Death|0|||
131172793|NCT00254293|472253823|FG004|LTE Open Label Fixed Dosing|Death|0|||
131172794|NCT00254293|472253824|FG005|LTE Open Label Fixed Dosing|Death|0|||
130731474|NCT01377012|470637410|FG001|Core Study|Withdrawal by Subject|23|||
130731475|NCT01377012|470637411|FG002|Core Study|Withdrawal by Subject|18|||
131172795|NCT00254293|472253825|FG006|LTE Open Label Fixed Dosing|Death|3|||
131172796|NCT00254293|472253819|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
131172797|NCT00254293|472253820|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
131172798|NCT00254293|472253821|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
131172799|NCT00254293|472253822|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
131172800|NCT00254293|472253823|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
131172801|NCT00254293|472253824|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
131172802|NCT00254293|472253825|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
131172803|NCT00254293|472253819|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131172804|NCT00254293|472253820|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131236328|NCT04634409|472493342|FG025|Overall Study|Adverse Event|0|||
131172805|NCT00254293|472253821|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131172806|NCT00254293|472253822|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131172807|NCT00254293|472253823|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131236329|NCT04634409|472493343|FG026|Overall Study|Adverse Event|0|||
131236330|NCT04634409|472493317|FG000|Overall Study|Lost to Follow-up|3|||
131236331|NCT04634409|472493318|FG001|Overall Study|Lost to Follow-up|1|||
131236332|NCT04634409|472493319|FG002|Overall Study|Lost to Follow-up|1|||
131236333|NCT04634409|472493320|FG003|Overall Study|Lost to Follow-up|3|||
131236334|NCT04634409|472493321|FG004|Overall Study|Lost to Follow-up|1|||
131236335|NCT04634409|472493322|FG005|Overall Study|Lost to Follow-up|1|||
131236336|NCT04634409|472493323|FG006|Overall Study|Lost to Follow-up|1|||
131236337|NCT04634409|472493324|FG007|Overall Study|Lost to Follow-up|3|||
131236338|NCT04634409|472493325|FG008|Overall Study|Lost to Follow-up|3|||
131236339|NCT04634409|472493326|FG009|Overall Study|Lost to Follow-up|11|||
131236340|NCT04634409|472493327|FG010|Overall Study|Lost to Follow-up|8|||
131236341|NCT04634409|472493328|FG011|Overall Study|Lost to Follow-up|15|||
131236342|NCT04634409|472493329|FG012|Overall Study|Lost to Follow-up|3|||
131236343|NCT04634409|472493330|FG013|Overall Study|Lost to Follow-up|2|||
131236344|NCT04634409|472493331|FG014|Overall Study|Lost to Follow-up|7|||
131236345|NCT04634409|472493332|FG015|Overall Study|Lost to Follow-up|0|||
131236346|NCT04634409|472493333|FG016|Overall Study|Lost to Follow-up|0|||
131236347|NCT04634409|472493334|FG017|Overall Study|Lost to Follow-up|0|||
131236348|NCT04634409|472493335|FG018|Overall Study|Lost to Follow-up|0|||
131236349|NCT04634409|472493336|FG019|Overall Study|Lost to Follow-up|0|||
131236350|NCT04634409|472493337|FG020|Overall Study|Lost to Follow-up|0|||
131236351|NCT04634409|472493338|FG021|Overall Study|Lost to Follow-up|0|||
131236352|NCT04634409|472493339|FG022|Overall Study|Lost to Follow-up|0|||
131236353|NCT04634409|472493340|FG023|Overall Study|Lost to Follow-up|0|||
131236354|NCT04634409|472493341|FG024|Overall Study|Lost to Follow-up|0|||
131236355|NCT04634409|472493342|FG025|Overall Study|Lost to Follow-up|0|||
131236356|NCT04634409|472493343|FG026|Overall Study|Lost to Follow-up|0|||
131236357|NCT04634409|472493317|FG000|Overall Study|Withdrawal by Subject|3|||
131236358|NCT04634409|472493318|FG001|Overall Study|Withdrawal by Subject|1|||
131236359|NCT04634409|472493319|FG002|Overall Study|Withdrawal by Subject|6|||
131236360|NCT04634409|472493320|FG003|Overall Study|Withdrawal by Subject|4|||
131236361|NCT04634409|472493321|FG004|Overall Study|Withdrawal by Subject|2|||
131236362|NCT04634409|472493322|FG005|Overall Study|Withdrawal by Subject|0|||
131236363|NCT04634409|472493323|FG006|Overall Study|Withdrawal by Subject|0|||
131236364|NCT04634409|472493324|FG007|Overall Study|Withdrawal by Subject|2|||
131236365|NCT04634409|472493325|FG008|Overall Study|Withdrawal by Subject|3|||
131236366|NCT04634409|472493326|FG009|Overall Study|Withdrawal by Subject|2|||
131236367|NCT04634409|472493327|FG010|Overall Study|Withdrawal by Subject|3|||
131236368|NCT04634409|472493328|FG011|Overall Study|Withdrawal by Subject|2|||
131236369|NCT04634409|472493329|FG012|Overall Study|Withdrawal by Subject|2|||
131236370|NCT04634409|472493330|FG013|Overall Study|Withdrawal by Subject|1|||
131236371|NCT04634409|472493331|FG014|Overall Study|Withdrawal by Subject|5|||
131236372|NCT04634409|472493332|FG015|Overall Study|Withdrawal by Subject|0|||
131236373|NCT04634409|472493333|FG016|Overall Study|Withdrawal by Subject|0|||
131236374|NCT04634409|472493334|FG017|Overall Study|Withdrawal by Subject|1|||
131236375|NCT04634409|472493335|FG018|Overall Study|Withdrawal by Subject|0|||
131236376|NCT04634409|472493336|FG019|Overall Study|Withdrawal by Subject|0|||
131236377|NCT04634409|472493337|FG020|Overall Study|Withdrawal by Subject|0|||
131236378|NCT04634409|472493338|FG021|Overall Study|Withdrawal by Subject|0|||
131236379|NCT04634409|472493339|FG022|Overall Study|Withdrawal by Subject|0|||
131236380|NCT04634409|472493340|FG023|Overall Study|Withdrawal by Subject|1|||
131236381|NCT04634409|472493341|FG024|Overall Study|Withdrawal by Subject|0|||
131236382|NCT04634409|472493342|FG025|Overall Study|Withdrawal by Subject|0|||
131236383|NCT04634409|472493343|FG026|Overall Study|Withdrawal by Subject|0|||
131236384|NCT04634409|472493317|FG000|Overall Study|Other - As reported by Investigator|1|||
131236385|NCT04634409|472493318|FG001|Overall Study|Other - As reported by Investigator|0|||
131236386|NCT04634409|472493319|FG002|Overall Study|Other - As reported by Investigator|0|||
131172808|NCT00254293|472253824|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
131236387|NCT04634409|472493320|FG003|Overall Study|Other - As reported by Investigator|0|||
131236388|NCT04634409|472493321|FG004|Overall Study|Other - As reported by Investigator|0|||
131236389|NCT04634409|472493322|FG005|Overall Study|Other - As reported by Investigator|0|||
131172809|NCT00254293|472253825|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
131172810|NCT00254293|472253819|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131172811|NCT00254293|472253820|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131172812|NCT00254293|472253821|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131172813|NCT00254293|472253822|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131172814|NCT00254293|472253823|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131172815|NCT00254293|472253824|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
131172816|NCT00254293|472253825|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
131172817|NCT00254293|472253819|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131172818|NCT00254293|472253820|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131172819|NCT00254293|472253821|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131172820|NCT00254293|472253822|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131172821|NCT00254293|472253823|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131172822|NCT00254293|472253824|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
131172823|NCT00254293|472253825|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
131172824|NCT00254293|472253819|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131172825|NCT00254293|472253820|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131172826|NCT00254293|472253821|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131172827|NCT00254293|472253822|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131172828|NCT00254293|472253823|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131172829|NCT00254293|472253824|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
131172830|NCT00254293|472253825|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
131172831|NCT00254293|472253819|FG000|LTE Open Label Fixed Dosing|Other|0|||
131172832|NCT00254293|472253820|FG001|LTE Open Label Fixed Dosing|Other|0|||
131172833|NCT00254293|472253821|FG002|LTE Open Label Fixed Dosing|Other|0|||
131172834|NCT00254293|472253822|FG003|LTE Open Label Fixed Dosing|Other|0|||
131172835|NCT00254293|472253823|FG004|LTE Open Label Fixed Dosing|Other|0|||
131172836|NCT00254293|472253824|FG005|LTE Open Label Fixed Dosing|Other|0|||
131172837|NCT00254293|472253825|FG006|LTE Open Label Fixed Dosing|Other|1|||
131172838|NCT03196193|472253832|FG000|Overall Study|Adverse Event|1|||
131172839|NCT03196193|472253833|FG001|Overall Study|Adverse Event|0|||
131172840|NCT03196193|472253832|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
131172841|NCT03196193|472253833|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
131172842|NCT02709083|472253834|FG000|Overall Study|Original PI left institution|7|||
131172843|NCT01697267|472253835|FG000|Overall Study|Death|3|||
131172844|NCT01697267|472253836|FG001|Overall Study|Death|1|||
131172845|NCT01697267|472253835|FG000|Overall Study|Withdrawal by Subject|5|||
131172846|NCT01697267|472253836|FG001|Overall Study|Withdrawal by Subject|5|||
131172847|NCT01697267|472253835|FG000|Overall Study|Adverse Event|2|||
131172848|NCT01697267|472253836|FG001|Overall Study|Adverse Event|1|||
131172849|NCT01697267|472253835|FG000|Overall Study|Lost to Follow-up|2|||
131172850|NCT01697267|472253836|FG001|Overall Study|Lost to Follow-up|4|||
131172851|NCT01697267|472253835|FG000|Overall Study|Physician Decision|2|||
131172852|NCT01697267|472253836|FG001|Overall Study|Physician Decision|4|||
130731476|NCT01377012|470637409|FG000|Core Study|Protocol Violation|7|||
130731477|NCT01377012|470637410|FG001|Core Study|Protocol Violation|3|||
130731478|NCT01377012|470637411|FG002|Core Study|Protocol Violation|2|||
130731479|NCT01377012|470637409|FG000|Core Study|Pregnancy|0|||
130731480|NCT01377012|470637410|FG001|Core Study|Pregnancy|0|||
130731481|NCT01377012|470637411|FG002|Core Study|Pregnancy|1|||
130731482|NCT01377012|470637409|FG000|Core Study|Physician Decision|5|||
130731483|NCT01377012|470637410|FG001|Core Study|Physician Decision|4|||
130731484|NCT01377012|470637411|FG002|Core Study|Physician Decision|10|||
130731485|NCT01377012|470637409|FG000|Core Study|Non-Compliant with study treatment|0|||
130731486|NCT01377012|470637410|FG001|Core Study|Non-Compliant with study treatment|0|||
130731487|NCT01377012|470637411|FG002|Core Study|Non-Compliant with study treatment|1|||
130731488|NCT01377012|470637409|FG000|Core Study|No Longer require treatment|0|||
130731489|NCT01377012|470637410|FG001|Core Study|No Longer require treatment|0|||
130731490|NCT01377012|470637411|FG002|Core Study|No Longer require treatment|1|||
130731491|NCT01377012|470637409|FG000|Core Study|Lost to Follow-up|7|||
130731492|NCT01377012|470637410|FG001|Core Study|Lost to Follow-up|5|||
130731493|NCT01377012|470637411|FG002|Core Study|Lost to Follow-up|4|||
130731494|NCT01377012|470637409|FG000|Core Study|Lack of Efficacy|41|||
130731495|NCT01377012|470637410|FG001|Core Study|Lack of Efficacy|28|||
131172853|NCT00568958|472253845|FG000|Allocation|Withdrawal by Subject|7|||
131172854|NCT00568958|472253846|FG001|Allocation|Withdrawal by Subject|3|||
131172855|NCT00568958|472253845|FG000|Allocation|Physician Decision|2|||
131172856|NCT00568958|472253846|FG001|Allocation|Physician Decision|0|||
131172857|NCT00568958|472253845|FG000|Follow-Up|Withdrawal by Subject|6|||
131172858|NCT00568958|472253846|FG001|Follow-Up|Withdrawal by Subject|6|||
131172859|NCT00568958|472253845|FG000|Follow-Up|Physician Decision|1|||
131172860|NCT00568958|472253846|FG001|Follow-Up|Physician Decision|1|||
130731496|NCT01377012|470637411|FG002|Core Study|Lack of Efficacy|37|||
130731497|NCT01377012|470637409|FG000|Core Study|Death|1|||
130731498|NCT01377012|470637410|FG001|Core Study|Death|1|||
130731499|NCT01377012|470637411|FG002|Core Study|Death|1|||
131172861|NCT00568958|472253845|FG000|Follow-Up|Family Emergency|1|||
131172862|NCT00568958|472253846|FG001|Follow-Up|Family Emergency|0|||
131172863|NCT00568958|472253845|FG000|Follow-Up|Adverse Event|1|||
131172864|NCT00568958|472253846|FG001|Follow-Up|Adverse Event|0|||
131172865|NCT01354353|472253851|FG000|Overall Study|Adverse Event|1|||
131172866|NCT01354353|472253852|FG001|Overall Study|Adverse Event|0|||
131172867|NCT01354353|472253853|FG002|Overall Study|Adverse Event|0|||
131172868|NCT01354353|472253854|FG003|Overall Study|Adverse Event|4|||
131172869|NCT01354353|472253855|FG004|Overall Study|Adverse Event|0|||
131172870|NCT01354353|472253856|FG005|Overall Study|Adverse Event|5|||
131172871|NCT01354353|472253851|FG000|Overall Study|Entry Criteria Not Met|0|||
131172872|NCT01354353|472253852|FG001|Overall Study|Entry Criteria Not Met|0|||
131172873|NCT01354353|472253853|FG002|Overall Study|Entry Criteria Not Met|0|||
131172874|NCT01354353|472253854|FG003|Overall Study|Entry Criteria Not Met|1|||
131172875|NCT01354353|472253855|FG004|Overall Study|Entry Criteria Not Met|1|||
131172876|NCT01354353|472253856|FG005|Overall Study|Entry Criteria Not Met|0|||
131172877|NCT01354353|472253851|FG000|Overall Study|Physician Decision|0|||
131172878|NCT01354353|472253852|FG001|Overall Study|Physician Decision|1|||
131172879|NCT01354353|472253853|FG002|Overall Study|Physician Decision|1|||
131172880|NCT01354353|472253854|FG003|Overall Study|Physician Decision|0|||
131172881|NCT01354353|472253855|FG004|Overall Study|Physician Decision|0|||
131172882|NCT01354353|472253856|FG005|Overall Study|Physician Decision|0|||
131172883|NCT01354353|472253851|FG000|Overall Study|Withdrawal by Subject|2|||
131172884|NCT01354353|472253852|FG001|Overall Study|Withdrawal by Subject|0|||
131172885|NCT01354353|472253853|FG002|Overall Study|Withdrawal by Subject|1|||
131172886|NCT01354353|472253854|FG003|Overall Study|Withdrawal by Subject|0|||
131172887|NCT01354353|472253855|FG004|Overall Study|Withdrawal by Subject|0|||
131172888|NCT01354353|472253856|FG005|Overall Study|Withdrawal by Subject|1|||
131172889|NCT02681055|472253857|FG000|Weeks 5-12|Adverse Event|1|||
131172890|NCT02156492|472253860|FG000|Period 1|No Reason Given|0|||
131172891|NCT02156492|472253861|FG001|Period 1|No Reason Given|1|||
131172892|NCT02156492|472253862|FG002|Period 1|No Reason Given|0|||
131172893|NCT02156492|472253860|FG000|Period 3|Adverse Event|0|||
131172894|NCT02156492|472253861|FG001|Period 3|Adverse Event|1|||
131172895|NCT02156492|472253862|FG002|Period 3|Adverse Event|0|||
131172896|NCT01104584|472253868|FG000|Overall Study|Study drug never administered|21|||
131172897|NCT01104584|472253868|FG000|Overall Study|Study prematurely discontinued|2|||
131172898|NCT02561299|472253871|FG000|Overall Study|Death|2|||
131172899|NCT02561299|472253872|FG001|Overall Study|Death|4|||
131172900|NCT02561299|472253871|FG000|Overall Study|Lost to Follow-up|1|||
131172901|NCT02561299|472253872|FG001|Overall Study|Lost to Follow-up|0|||
131172902|NCT02561299|472253871|FG000|Overall Study|Withdrawal by Subject|2|||
131172903|NCT02561299|472253872|FG001|Overall Study|Withdrawal by Subject|2|||
131172904|NCT00501046|472253877|FG000|Overall Study|Adverse Event|21|||
131172905|NCT00501046|472253878|FG001|Overall Study|Adverse Event|25|||
131172906|NCT00501046|472253877|FG000|Overall Study|Death|23|||
131172907|NCT00501046|472253878|FG001|Overall Study|Death|30|||
131172908|NCT00501046|472253877|FG000|Overall Study|Lost to Follow-up|14|||
131172909|NCT00501046|472253878|FG001|Overall Study|Lost to Follow-up|13|||
131172910|NCT00501046|472253877|FG000|Overall Study|Physician Decision|7|||
131172911|NCT00501046|472253878|FG001|Overall Study|Physician Decision|2|||
131172912|NCT00501046|472253877|FG000|Overall Study|Pregnancy|0|||
131172913|NCT00501046|472253878|FG001|Overall Study|Pregnancy|3|||
131172914|NCT00501046|472253877|FG000|Overall Study|Protocol Violation|2|||
131172915|NCT00501046|472253878|FG001|Overall Study|Protocol Violation|1|||
131172916|NCT00501046|472253877|FG000|Overall Study|Withdrawal by Subject|84|||
131172917|NCT00501046|472253878|FG001|Overall Study|Withdrawal by Subject|83|||
131172918|NCT00501046|472253877|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
131172919|NCT00501046|472253878|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
131172920|NCT00436566|472253882|FG000|Overall Study|Withdrawal by Subject|2|||
131172921|NCT00436566|472253882|FG000|Overall Study|Protocol Violation|1|||
131172922|NCT01188564|472253883|FG000|Double-blind Phase|randomized not treated|1|||
131172923|NCT01188564|472253884|FG001|Double-blind Phase|randomized not treated|0|||
131172924|NCT00617409|472253885|FG000|Overall Study|Withdrawal by Subject|4|||
131172925|NCT00617409|472253886|FG001|Overall Study|Withdrawal by Subject|1|||
131172926|NCT00617409|472253887|FG002|Overall Study|Withdrawal by Subject|2|||
131172927|NCT00617409|472253885|FG000|Overall Study|Adverse Event|0|||
131172928|NCT00617409|472253886|FG001|Overall Study|Adverse Event|2|||
131172929|NCT00617409|472253887|FG002|Overall Study|Adverse Event|3|||
131172930|NCT00617409|472253885|FG000|Overall Study|Disease Progression|8|||
131172931|NCT00617409|472253886|FG001|Overall Study|Disease Progression|8|||
131172932|NCT00617409|472253887|FG002|Overall Study|Disease Progression|18|||
131172933|NCT00617409|472253885|FG000|Overall Study|Death|3|||
131172934|NCT00617409|472253886|FG001|Overall Study|Death|5|||
131172935|NCT00617409|472253887|FG002|Overall Study|Death|4|||
131172936|NCT00617409|472253885|FG000|Overall Study|Alternative Therapy|1|||
131172937|NCT00617409|472253886|FG001|Overall Study|Alternative Therapy|2|||
131172938|NCT00617409|472253887|FG002|Overall Study|Alternative Therapy|0|||
131172939|NCT00668200|472253906|FG000|Overall Study|Withdrawal by Subject|2|||
131172940|NCT00668200|472253906|FG000|Overall Study|Lost to Follow-up|1|||
131172941|NCT01496430|472253907|FG000|Overall Study|Adverse Event|0|||
131172942|NCT01496430|472253908|FG001|Overall Study|Adverse Event|0|||
131172943|NCT01496430|472253909|FG002|Overall Study|Adverse Event|1|||
131172944|NCT01496430|472253907|FG000|Overall Study|Major Protocol Deviation|0|||
131172945|NCT01496430|472253908|FG001|Overall Study|Major Protocol Deviation|0|||
131172946|NCT01496430|472253909|FG002|Overall Study|Major Protocol Deviation|1|||
131172947|NCT01496430|472253907|FG000|Overall Study|Lost to Follow-up|2|||
131172948|NCT01496430|472253908|FG001|Overall Study|Lost to Follow-up|3|||
131172949|NCT01496430|472253909|FG002|Overall Study|Lost to Follow-up|1|||
131172950|NCT01496430|472253907|FG000|Overall Study|Voluntary Withdrawal|2|||
131172951|NCT01496430|472253908|FG001|Overall Study|Voluntary Withdrawal|1|||
131172952|NCT01496430|472253909|FG002|Overall Study|Voluntary Withdrawal|6|||
131172953|NCT01496430|472253907|FG000|Overall Study|Principal Investigator Discretion|0|||
131172954|NCT01496430|472253908|FG001|Overall Study|Principal Investigator Discretion|1|||
131172955|NCT01496430|472253909|FG002|Overall Study|Principal Investigator Discretion|1|||
131172956|NCT01496430|472253907|FG000|Overall Study|Other|2|||
131172957|NCT01496430|472253908|FG001|Overall Study|Other|0|||
131172958|NCT01496430|472253909|FG002|Overall Study|Other|0|||
131172959|NCT00997321|472253910|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
131172960|NCT00997321|472253911|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
131172961|NCT02512068|472253916|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
131172962|NCT02512068|472253917|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
131172963|NCT02512068|472253916|FG000|Overall Study|Major Protocol Deviation|1|||
131172964|NCT02512068|472253917|FG001|Overall Study|Major Protocol Deviation|0|||
131172965|NCT02512068|472253916|FG000|Overall Study|Voluntary Withdrawal|0|||
131172966|NCT02512068|472253917|FG001|Overall Study|Voluntary Withdrawal|1|||
131172967|NCT02512068|472253916|FG000|Overall Study|Lack of Efficacy|0|||
131172968|NCT02512068|472253917|FG001|Overall Study|Lack of Efficacy|1|||
131172969|NCT02512068|472253916|FG000|Overall Study|Reason Not Specified|3|||
131172970|NCT02512068|472253917|FG001|Overall Study|Reason Not Specified|5|||
131172971|NCT01098461|472253927|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
131172972|NCT01098461|472253928|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
131172973|NCT01098461|472253929|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
131172974|NCT01098461|472253930|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
131172975|NCT01098461|472253927|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
131172976|NCT01098461|472253928|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
131172977|NCT01098461|472253929|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
131172978|NCT01098461|472253930|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
131172979|NCT01098461|472253927|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
131172980|NCT01098461|472253928|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
131172981|NCT01098461|472253929|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
131172982|NCT01098461|472253930|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
131172983|NCT01098461|472253927|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
131172984|NCT01098461|472253928|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
131172985|NCT01098461|472253929|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
131172986|NCT01098461|472253930|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
131172987|NCT01098461|472253927|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
131172988|NCT01098461|472253928|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
131172989|NCT01098461|472253929|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
131172990|NCT01098461|472253930|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
131172991|NCT01098461|472253927|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
131172992|NCT01098461|472253928|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
131172993|NCT01098461|472253929|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
131172994|NCT01098461|472253930|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
131172995|NCT01098461|472253927|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
131236390|NCT04634409|472493323|FG006|Overall Study|Other - As reported by Investigator|0|||
131236391|NCT04634409|472493324|FG007|Overall Study|Other - As reported by Investigator|6|||
130731500|NCT01377012|470637409|FG000|Core Study|Adverse Event|10|||
130731501|NCT01377012|470637410|FG001|Core Study|Adverse Event|14|||
130731502|NCT01377012|470637411|FG002|Core Study|Adverse Event|13|||
130731503|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
130731504|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
130731505|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
130731506|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
130731507|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
130731508|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
130731509|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
130731510|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
130731511|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
130731512|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
131236392|NCT04634409|472493325|FG008|Overall Study|Other - As reported by Investigator|4|||
131236393|NCT04634409|472493326|FG009|Overall Study|Other - As reported by Investigator|0|||
131236394|NCT04634409|472493327|FG010|Overall Study|Other - As reported by Investigator|1|||
131236395|NCT04634409|472493328|FG011|Overall Study|Other - As reported by Investigator|2|||
131236396|NCT04634409|472493329|FG012|Overall Study|Other - As reported by Investigator|2|||
131236397|NCT04634409|472493330|FG013|Overall Study|Other - As reported by Investigator|1|||
131236398|NCT04634409|472493331|FG014|Overall Study|Other - As reported by Investigator|0|||
131236399|NCT04634409|472493332|FG015|Overall Study|Other - As reported by Investigator|0|||
131236400|NCT04634409|472493333|FG016|Overall Study|Other - As reported by Investigator|0|||
131236401|NCT04634409|472493334|FG017|Overall Study|Other - As reported by Investigator|0|||
131236402|NCT04634409|472493335|FG018|Overall Study|Other - As reported by Investigator|0|||
131236403|NCT04634409|472493336|FG019|Overall Study|Other - As reported by Investigator|0|||
131236404|NCT04634409|472493337|FG020|Overall Study|Other - As reported by Investigator|0|||
131236405|NCT04634409|472493338|FG021|Overall Study|Other - As reported by Investigator|0|||
131236406|NCT04634409|472493339|FG022|Overall Study|Other - As reported by Investigator|0|||
131236407|NCT04634409|472493340|FG023|Overall Study|Other - As reported by Investigator|0|||
131236408|NCT04634409|472493341|FG024|Overall Study|Other - As reported by Investigator|0|||
131236409|NCT04634409|472493342|FG025|Overall Study|Other - As reported by Investigator|0|||
131236410|NCT04634409|472493343|FG026|Overall Study|Other - As reported by Investigator|0|||
131236411|NCT02346201|472493345|FG000|Overall Study|Adverse Event|3|||
131236412|NCT02346201|472493346|FG001|Overall Study|Adverse Event|2|||
131236413|NCT02346201|472493345|FG000|Overall Study|Lost to Follow-up|1|||
131236414|NCT02346201|472493346|FG001|Overall Study|Lost to Follow-up|0|||
131236415|NCT02346201|472493345|FG000|Overall Study|Withdrawal by Subject|6|||
130731513|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
130731514|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
131172996|NCT01098461|472253928|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
131172997|NCT01098461|472253929|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
131172998|NCT01098461|472253930|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
131172999|NCT01153763|472253931|FG000|Overall Study|Study Closed|16|||
131173000|NCT01153763|472253931|FG000|Overall Study|Lost to Follow-up|1|||
131173001|NCT01153763|472253931|FG000|Overall Study|Physician Decision|2|||
131173002|NCT01153763|472253931|FG000|Overall Study|Withdrawal by Subject|2|||
131173003|NCT01766336|472253932|FG000|Overall Study|Adverse Event|11|||
131173004|NCT01766336|472253933|FG001|Overall Study|Adverse Event|8|||
131173005|NCT01766336|472253932|FG000|Overall Study|Death|4|||
131173006|NCT01766336|472253933|FG001|Overall Study|Death|3|||
131173007|NCT01766336|472253932|FG000|Overall Study|Lost to Follow-up|1|||
131173008|NCT01766336|472253933|FG001|Overall Study|Lost to Follow-up|3|||
131173009|NCT01766336|472253932|FG000|Overall Study|Physician Decision|4|||
131173010|NCT01766336|472253933|FG001|Overall Study|Physician Decision|2|||
131173011|NCT01766336|472253932|FG000|Overall Study|Protocol Violation|0|||
131173012|NCT01766336|472253933|FG001|Overall Study|Protocol Violation|1|||
131173013|NCT01766336|472253932|FG000|Overall Study|Sponsor Decision|52|||
131173014|NCT01766336|472253933|FG001|Overall Study|Sponsor Decision|43|||
131173015|NCT01766336|472253932|FG000|Overall Study|Withdrawal by Subject|18|||
131173016|NCT01766336|472253933|FG001|Overall Study|Withdrawal by Subject|15|||
131173017|NCT04544709|472253934|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
131173018|NCT03011840|472253935|FG000|Overall Study|Not received PIL in post PIL phase|0|||
131173019|NCT03011840|472253936|FG001|Overall Study|Not received PIL in post PIL phase|21|||
131173020|NCT00369668|472253937|FG000|Overall Study|Lack of Efficacy|4|||
131173021|NCT00369668|472253938|FG001|Overall Study|Lack of Efficacy|5|||
131173022|NCT00369668|472253939|FG002|Overall Study|Lack of Efficacy|7|||
131173023|NCT00142519|472253943|FG000|Overall Study|Not Treated|7|||
131173024|NCT00142519|472253944|FG001|Overall Study|Not Treated|9|||
131173025|NCT00142519|472253943|FG000|Overall Study|Protocol Violation|1|||
131173026|NCT00142519|472253944|FG001|Overall Study|Protocol Violation|0|||
131173027|NCT00142519|472253943|FG000|Overall Study|Withdrawal by Subject|10|||
131173028|NCT00142519|472253944|FG001|Overall Study|Withdrawal by Subject|7|||
131173029|NCT01005732|472253945|FG000|Overall Study|Lost to Follow-up|10|||
131173030|NCT01005732|472253945|FG000|Overall Study|Death|1|||
131173031|NCT02596711|472253946|FG000|Overall Study|Lost to Follow-up|1|||
131173032|NCT02596711|472253947|FG001|Overall Study|Lost to Follow-up|2|||
131173033|NCT02596711|472253948|FG002|Overall Study|Lost to Follow-up|3|||
131173034|NCT01552928|472253949|FG000|Period 3|Adverse Event|0|||
131173035|NCT01552928|472253950|FG001|Period 3|Adverse Event|0|||
131173036|NCT01552928|472253951|FG002|Period 3|Adverse Event|1|||
131173037|NCT01552928|472253952|FG003|Period 3|Adverse Event|0|||
131236416|NCT02346201|472493346|FG001|Overall Study|Withdrawal by Subject|3|||
131236417|NCT02346201|472493345|FG000|Overall Study|Unavailable for future follow-up|0|||
131236418|NCT02346201|472493346|FG001|Overall Study|Unavailable for future follow-up|1|||
131236419|NCT02346201|472493345|FG000|Overall Study|Physician Decision|0|||
131173038|NCT04570657|472253954|FG000|Overall Study|Adverse Event|0|||
131173039|NCT04570657|472253955|FG001|Overall Study|Adverse Event|0|||
131173040|NCT04570657|472253956|FG002|Overall Study|Adverse Event|1|||
131236420|NCT02346201|472493346|FG001|Overall Study|Physician Decision|1|||
131173041|NCT04570657|472253954|FG000|Overall Study|Lost to Follow-up|0|||
131173042|NCT04570657|472253955|FG001|Overall Study|Lost to Follow-up|0|||
131173043|NCT04570657|472253956|FG002|Overall Study|Lost to Follow-up|1|||
131173044|NCT04570657|472253954|FG000|Overall Study|Physician Decision|0|||
131173045|NCT04570657|472253955|FG001|Overall Study|Physician Decision|1|||
131173046|NCT04570657|472253956|FG002|Overall Study|Physician Decision|0|||
131173047|NCT04570657|472253954|FG000|Overall Study|Withdrawal by Subject|1|||
131173048|NCT04570657|472253955|FG001|Overall Study|Withdrawal by Subject|2|||
131173049|NCT04570657|472253956|FG002|Overall Study|Withdrawal by Subject|2|||
131173050|NCT00424528|472256569|FG000|Overall Study|Adverse Event|2|||
131173051|NCT00424528|472256570|FG001|Overall Study|Adverse Event|1|||
131173052|NCT00424528|472256571|FG002|Overall Study|Adverse Event|2|||
131173053|NCT00424528|472256569|FG000|Overall Study|Protocol Violation|1|||
131173054|NCT00424528|472256570|FG001|Overall Study|Protocol Violation|1|||
131173055|NCT00424528|472256571|FG002|Overall Study|Protocol Violation|0|||
131173056|NCT00424528|472256569|FG000|Overall Study|Lost to Follow-up|0|||
131173057|NCT00424528|472256570|FG001|Overall Study|Lost to Follow-up|1|||
131173058|NCT00424528|472256571|FG002|Overall Study|Lost to Follow-up|0|||
131173059|NCT00424528|472256569|FG000|Overall Study|noncompliance with study requirements|2|||
131173060|NCT00424528|472256570|FG001|Overall Study|noncompliance with study requirements|1|||
131173061|NCT00424528|472256571|FG002|Overall Study|noncompliance with study requirements|2|||
131173062|NCT00967226|472256573|FG000|Overall Study|Adverse Event|0|||
131173063|NCT00967226|472256574|FG001|Overall Study|Adverse Event|5|||
131173064|NCT00967226|472256573|FG000|Overall Study|Protocol Violation|2|||
131173065|NCT00967226|472256574|FG001|Overall Study|Protocol Violation|0|||
131173066|NCT00967226|472256573|FG000|Overall Study|Physician Decision|0|||
131173067|NCT00967226|472256574|FG001|Overall Study|Physician Decision|1|||
131173068|NCT00605722|472256575|FG000|Overall Study|Adverse Event|6|||
131173069|NCT00605722|472256575|FG000|Overall Study|Insufficient therapeutic response|44|||
131173070|NCT00605722|472256575|FG000|Overall Study|Failure to return|1|||
130731515|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
131173071|NCT04031404|472256579|FG000|Baseline|Lost to Follow-up|0|||
131173072|NCT04031404|472256580|FG001|Baseline|Lost to Follow-up|1|||
131173073|NCT04031404|472256579|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
131173074|NCT04031404|472256580|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
131173075|NCT04031404|472256579|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
131173076|NCT04031404|472256580|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
131173077|NCT04031404|472256579|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
131173078|NCT04031404|472256580|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
131173079|NCT04031404|472256579|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
131173080|NCT04031404|472256580|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
131173081|NCT01626352|472256581|FG000|Overall Study|Disease Progression|3|||
131173082|NCT01626352|472256581|FG000|Overall Study|Intercurrent Illness|2|||
131173083|NCT01626352|472256581|FG000|Overall Study|Death|2|||
131173084|NCT01626352|472256581|FG000|Overall Study|Withdrawal by Subject|1|||
131173085|NCT01626352|472256581|FG000|Overall Study|Non-Compliance|1|||
131173086|NCT01626352|472256581|FG000|Overall Study|Never Treated|1|||
131173087|NCT02796391|472256582|FG000|Overall Study|Lost to Follow-up|2|||
131173088|NCT02796391|472256583|FG001|Overall Study|Lost to Follow-up|2|||
131173089|NCT02796391|472256584|FG002|Overall Study|Lost to Follow-up|13|||
131173090|NCT02796391|472256585|FG003|Overall Study|Lost to Follow-up|8|||
131173091|NCT02796391|472256586|FG004|Overall Study|Lost to Follow-up|14|||
131173092|NCT02796391|472256587|FG005|Overall Study|Lost to Follow-up|13|||
131173093|NCT02796391|472256582|FG000|Overall Study|COVID|0|||
131173094|NCT02796391|472256583|FG001|Overall Study|COVID|0|||
131173095|NCT02796391|472256584|FG002|Overall Study|COVID|5|||
131173096|NCT02796391|472256585|FG003|Overall Study|COVID|5|||
131173097|NCT02796391|472256586|FG004|Overall Study|COVID|2|||
131173098|NCT02796391|472256587|FG005|Overall Study|COVID|4|||
131173099|NCT02796391|472256582|FG000|Overall Study|Participant did not like study cigarettes|0|||
130731516|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
130731517|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
130731518|NCT01377012|470637409|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
131173100|NCT02796391|472256583|FG001|Overall Study|Participant did not like study cigarettes|0|||
131173101|NCT02796391|472256584|FG002|Overall Study|Participant did not like study cigarettes|3|||
131173102|NCT02796391|472256585|FG003|Overall Study|Participant did not like study cigarettes|0|||
131173103|NCT02796391|472256586|FG004|Overall Study|Participant did not like study cigarettes|0|||
131173104|NCT02796391|472256587|FG005|Overall Study|Participant did not like study cigarettes|0|||
131173105|NCT02796391|472256582|FG000|Overall Study|Withdrawal by Subject|1|||
131173106|NCT02796391|472256583|FG001|Overall Study|Withdrawal by Subject|1|||
131173107|NCT02796391|472256584|FG002|Overall Study|Withdrawal by Subject|4|||
131173108|NCT02796391|472256585|FG003|Overall Study|Withdrawal by Subject|3|||
131173109|NCT02796391|472256586|FG004|Overall Study|Withdrawal by Subject|4|||
131173110|NCT02796391|472256587|FG005|Overall Study|Withdrawal by Subject|3|||
131173111|NCT02796391|472256582|FG000|Overall Study|Adverse Event|0|||
131173112|NCT02796391|472256583|FG001|Overall Study|Adverse Event|0|||
130731519|NCT01377012|470637410|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
130731520|NCT01377012|470637411|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
131173113|NCT02796391|472256584|FG002|Overall Study|Adverse Event|0|||
131173114|NCT02796391|472256585|FG003|Overall Study|Adverse Event|1|||
131173115|NCT02796391|472256586|FG004|Overall Study|Adverse Event|0|||
131173116|NCT02796391|472256587|FG005|Overall Study|Adverse Event|0|||
131173117|NCT02796391|472256582|FG000|Overall Study|Protocol Violation|0|||
131173118|NCT02796391|472256583|FG001|Overall Study|Protocol Violation|0|||
131173119|NCT02796391|472256584|FG002|Overall Study|Protocol Violation|0|||
131173120|NCT02796391|472256585|FG003|Overall Study|Protocol Violation|1|||
131173121|NCT02796391|472256586|FG004|Overall Study|Protocol Violation|0|||
131173122|NCT02796391|472256587|FG005|Overall Study|Protocol Violation|0|||
131173123|NCT00831441|472256588|FG000|Randomized|Death|82|||
131173124|NCT00831441|472256589|FG001|Randomized|Death|81|||
131173125|NCT00831441|472256588|FG000|Randomized|Adverse Event|248|||
131173126|NCT00831441|472256589|FG001|Randomized|Adverse Event|321|||
131173127|NCT00831441|472256588|FG000|Randomized|Emergency procedure|2|||
131173128|NCT00831441|472256589|FG001|Randomized|Emergency procedure|2|||
131173129|NCT00831441|472256588|FG000|Randomized|Elective procedure|26|||
131173130|NCT00831441|472256589|FG001|Randomized|Elective procedure|25|||
131173131|NCT00831441|472256588|FG000|Randomized|Physician Decision|26|||
131173132|NCT00831441|472256589|FG001|Randomized|Physician Decision|35|||
131173133|NCT00831441|472256588|FG000|Randomized|No longer met criteria|13|||
131173134|NCT00831441|472256589|FG001|Randomized|No longer met criteria|19|||
131173135|NCT00831441|472256588|FG000|Randomized|Withdrawal by Subject|178|||
131173136|NCT00831441|472256589|FG001|Randomized|Withdrawal by Subject|212|||
131173137|NCT00831441|472256588|FG000|Randomized|Lost to Follow-up|26|||
131173138|NCT00831441|472256589|FG001|Randomized|Lost to Follow-up|35|||
131173139|NCT00831441|472256588|FG000|Randomized|Administrative reason by sponsor|2780|||
131173140|NCT00831441|472256589|FG001|Randomized|Administrative reason by sponsor|2671|||
131173141|NCT00831441|472256588|FG000|Randomized|poor/non-compliance|30|||
131173142|NCT00831441|472256589|FG001|Randomized|poor/non-compliance|38|||
131173143|NCT00831441|472256588|FG000|Randomized|non-specified|276|||
131173144|NCT00831441|472256589|FG001|Randomized|non-specified|266|||
131173145|NCT00831441|472256588|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
131173146|NCT00831441|472256589|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
131173147|NCT00831441|472256588|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
131173148|NCT00831441|472256589|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
131173149|NCT00831441|472256588|FG000|Follow Up (30 Days)|Death|63|||
131173150|NCT00831441|472256589|FG001|Follow Up (30 Days)|Death|86|||
131173151|NCT00831441|472256588|FG000|Follow Up (30 Days)|non-specified|16|||
131173152|NCT00831441|472256589|FG001|Follow Up (30 Days)|non-specified|26|||
131173153|NCT00831441|472256588|FG000|Follow Up (30 Days)|missing end of study status|0|||
131173154|NCT00831441|472256589|FG001|Follow Up (30 Days)|missing end of study status|1|||
131173155|NCT05674344|472256590|FG000|Overall Study|Screen Fail|21|||
131173156|NCT05674344|472256590|FG000|Overall Study|Incomplete study procedures|3|||
131173157|NCT00111917|472256591|FG000|Overall Study|Withdrawal by Subject|1|||
131173158|NCT00111917|472256592|FG001|Overall Study|Withdrawal by Subject|1|||
131173159|NCT00798655|472256593|FG000|Overall Study|Did not receive at least one dose of pan|2|||
131173160|NCT00343291|472256594|FG000|Overall Study|Adverse Event|13|||
131173161|NCT00343291|472256595|FG001|Overall Study|Adverse Event|13|||
131173162|NCT00343291|472256594|FG000|Overall Study|Death|3|||
131173163|NCT00343291|472256595|FG001|Overall Study|Death|2|||
131173164|NCT00343291|472256594|FG000|Overall Study|Progressive disease|33|||
131173165|NCT00343291|472256595|FG001|Overall Study|Progressive disease|34|||
131173166|NCT00343291|472256594|FG000|Overall Study|Withdrawal by Subject|0|||
131173167|NCT00343291|472256595|FG001|Overall Study|Withdrawal by Subject|2|||
131173168|NCT00343291|472256594|FG000|Overall Study|Other|8|||
131173169|NCT00343291|472256595|FG001|Overall Study|Other|5|||
131173170|NCT00960934|472256596|FG000|Overall Study|Adverse Event|2|||
131173171|NCT00960934|472256597|FG001|Overall Study|Adverse Event|3|||
131173172|NCT00960934|472256598|FG002|Overall Study|Adverse Event|3|||
131173173|NCT00960934|472256599|FG003|Overall Study|Adverse Event|2|||
131173174|NCT00960934|472256600|FG004|Overall Study|Adverse Event|4|||
131173175|NCT00960934|472256601|FG005|Overall Study|Adverse Event|3|||
131173176|NCT00960934|472256596|FG000|Overall Study|Lack of Efficacy|1|||
131173177|NCT00960934|472256597|FG001|Overall Study|Lack of Efficacy|0|||
131173178|NCT00960934|472256598|FG002|Overall Study|Lack of Efficacy|0|||
131173179|NCT00960934|472256599|FG003|Overall Study|Lack of Efficacy|0|||
131173180|NCT00960934|472256600|FG004|Overall Study|Lack of Efficacy|0|||
131173181|NCT00960934|472256601|FG005|Overall Study|Lack of Efficacy|0|||
131173182|NCT00960934|472256596|FG000|Overall Study|Lost to Follow-up|0|||
131173183|NCT00960934|472256597|FG001|Overall Study|Lost to Follow-up|1|||
131173184|NCT00960934|472256598|FG002|Overall Study|Lost to Follow-up|0|||
130731521|NCT00805961|470637414|FG000|Modality Therapy|Withdrawal by Subject|1|||
131173185|NCT00960934|472256599|FG003|Overall Study|Lost to Follow-up|0|||
131173186|NCT00960934|472256600|FG004|Overall Study|Lost to Follow-up|0|||
131173187|NCT00960934|472256601|FG005|Overall Study|Lost to Follow-up|0|||
131173188|NCT00960934|472256596|FG000|Overall Study|Other|2|||
131173189|NCT00960934|472256597|FG001|Overall Study|Other|1|||
131173190|NCT00960934|472256598|FG002|Overall Study|Other|5|||
131173191|NCT00960934|472256599|FG003|Overall Study|Other|4|||
131173192|NCT00960934|472256600|FG004|Overall Study|Other|2|||
131173193|NCT00960934|472256601|FG005|Overall Study|Other|2|||
131173194|NCT00960934|472256596|FG000|Overall Study|Physician Decision|0|||
131173195|NCT00960934|472256597|FG001|Overall Study|Physician Decision|1|||
131173196|NCT00960934|472256598|FG002|Overall Study|Physician Decision|0|||
131173197|NCT00960934|472256599|FG003|Overall Study|Physician Decision|0|||
131173198|NCT00960934|472256600|FG004|Overall Study|Physician Decision|0|||
131173199|NCT00960934|472256601|FG005|Overall Study|Physician Decision|0|||
131173200|NCT00960934|472256596|FG000|Overall Study|Progressive Disease|1|||
131173201|NCT00960934|472256597|FG001|Overall Study|Progressive Disease|1|||
131173202|NCT00960934|472256598|FG002|Overall Study|Progressive Disease|0|||
131173203|NCT00960934|472256599|FG003|Overall Study|Progressive Disease|0|||
131173204|NCT00960934|472256600|FG004|Overall Study|Progressive Disease|1|||
131173205|NCT00960934|472256601|FG005|Overall Study|Progressive Disease|1|||
131173206|NCT00960934|472256596|FG000|Overall Study|Protocol Violation|3|||
131173207|NCT00960934|472256597|FG001|Overall Study|Protocol Violation|4|||
131173208|NCT00960934|472256598|FG002|Overall Study|Protocol Violation|0|||
131173209|NCT00960934|472256599|FG003|Overall Study|Protocol Violation|3|||
131173210|NCT00960934|472256600|FG004|Overall Study|Protocol Violation|3|||
131173211|NCT00960934|472256601|FG005|Overall Study|Protocol Violation|2|||
131173212|NCT00960934|472256596|FG000|Overall Study|Withdrawal by Subject|5|||
131173213|NCT00960934|472256597|FG001|Overall Study|Withdrawal by Subject|6|||
131173214|NCT00960934|472256598|FG002|Overall Study|Withdrawal by Subject|4|||
131173215|NCT00960934|472256599|FG003|Overall Study|Withdrawal by Subject|5|||
131173216|NCT00960934|472256600|FG004|Overall Study|Withdrawal by Subject|5|||
131173217|NCT00960934|472256601|FG005|Overall Study|Withdrawal by Subject|7|||
131173218|NCT00960934|472256596|FG000|Overall Study|Study Terminated by Sponsor|50|||
131173219|NCT00960934|472256597|FG001|Overall Study|Study Terminated by Sponsor|46|||
131173220|NCT00960934|472256598|FG002|Overall Study|Study Terminated by Sponsor|52|||
131173221|NCT00960934|472256599|FG003|Overall Study|Study Terminated by Sponsor|50|||
131173222|NCT00960934|472256600|FG004|Overall Study|Study Terminated by Sponsor|49|||
131173223|NCT00960934|472256601|FG005|Overall Study|Study Terminated by Sponsor|49|||
131173224|NCT05254613|472256611|FG000|Overall Study|Lost to Follow-up|0|||
131173225|NCT05254613|472256612|FG001|Overall Study|Lost to Follow-up|0|||
131173226|NCT05254613|472256613|FG002|Overall Study|Lost to Follow-up|1|||
131173227|NCT00839423|472256616|FG000|Overall Study|Adverse Event|4|||
131173228|NCT00839423|472256617|FG001|Overall Study|Adverse Event|3|||
131173229|NCT00839423|472256618|FG002|Overall Study|Adverse Event|7|||
131173230|NCT00839423|472256619|FG003|Overall Study|Adverse Event|16|||
131173231|NCT00839423|472256616|FG000|Overall Study|Lack of Efficacy|6|||
131173232|NCT00839423|472256617|FG001|Overall Study|Lack of Efficacy|6|||
131173233|NCT00839423|472256618|FG002|Overall Study|Lack of Efficacy|3|||
131173234|NCT00839423|472256619|FG003|Overall Study|Lack of Efficacy|2|||
131173235|NCT00839423|472256616|FG000|Overall Study|Non-compliance|0|||
131173236|NCT00839423|472256617|FG001|Overall Study|Non-compliance|0|||
131173237|NCT00839423|472256618|FG002|Overall Study|Non-compliance|0|||
131173238|NCT00839423|472256619|FG003|Overall Study|Non-compliance|1|||
131173239|NCT00839423|472256616|FG000|Overall Study|Protocol Violation|0|||
131173240|NCT00839423|472256617|FG001|Overall Study|Protocol Violation|1|||
131173241|NCT00839423|472256618|FG002|Overall Study|Protocol Violation|2|||
131173242|NCT00839423|472256619|FG003|Overall Study|Protocol Violation|0|||
131173243|NCT00839423|472256616|FG000|Overall Study|Withdrawal of consent|4|||
131173244|NCT00839423|472256617|FG001|Overall Study|Withdrawal of consent|0|||
131173245|NCT00839423|472256618|FG002|Overall Study|Withdrawal of consent|4|||
131173246|NCT00839423|472256619|FG003|Overall Study|Withdrawal of consent|1|||
131173247|NCT00839423|472256616|FG000|Overall Study|Lost to Follow-up|1|||
131173248|NCT00839423|472256617|FG001|Overall Study|Lost to Follow-up|0|||
131173249|NCT00839423|472256618|FG002|Overall Study|Lost to Follow-up|1|||
130731522|NCT00805961|470637414|FG000|Modality Therapy|Adverse Event|1|||
130731523|NCT00805961|470637414|FG000|Modality Therapy|Disease Progression|2|||
131173250|NCT00839423|472256619|FG003|Overall Study|Lost to Follow-up|0|||
131173251|NCT00839423|472256616|FG000|Overall Study|Administrative or other reasons|3|||
131173252|NCT00839423|472256617|FG001|Overall Study|Administrative or other reasons|0|||
131173253|NCT00839423|472256618|FG002|Overall Study|Administrative or other reasons|1|||
131173254|NCT00839423|472256619|FG003|Overall Study|Administrative or other reasons|0|||
131173255|NCT01071096|472256620|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
131173256|NCT01071096|472256621|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
131173257|NCT04348656|472256622|FG000|Overall Study|Withdrawal by Subject|2|||
131173258|NCT04348656|472256623|FG001|Overall Study|Withdrawal by Subject|0|||
131173259|NCT04348656|472256622|FG000|Overall Study|Lost to Follow-up|11|||
131173260|NCT04348656|472256623|FG001|Overall Study|Lost to Follow-up|6|||
131173261|NCT03072719|472256624|FG000|Overall Study|Adverse Event|1|||
131173262|NCT03072719|472256625|FG001|Overall Study|Adverse Event|1|||
131173263|NCT00882999|472256626|FG000|Overall Study|Adverse Event|0|||
131236421|NCT02346201|472493345|FG000|Overall Study|Missed final visit|0|||
131173264|NCT00882999|472256627|FG001|Overall Study|Adverse Event|0|||
131173265|NCT00882999|472256628|FG002|Overall Study|Adverse Event|0|||
131173266|NCT00882999|472256629|FG003|Overall Study|Adverse Event|0|||
131236422|NCT02346201|472493346|FG001|Overall Study|Missed final visit|2|||
131236423|NCT03708211|472493348|FG000|Overall Study|Progressive Disease|10|||
131236424|NCT03708211|472493349|FG001|Overall Study|Progressive Disease|7|||
131236425|NCT03708211|472493348|FG000|Overall Study|Withdrawal by Subject|0|||
131236426|NCT03708211|472493349|FG001|Overall Study|Withdrawal by Subject|1|||
131236427|NCT03708211|472493348|FG000|Overall Study|Other|2|||
131236428|NCT03708211|472493349|FG001|Overall Study|Other|0|||
131236429|NCT01508936|472493351|FG000|Overall Study|Adverse Event|11|||
131236430|NCT01508936|472493352|FG001|Overall Study|Adverse Event|32|||
131236431|NCT01508936|472493351|FG000|Overall Study|Lack of Efficacy|0|||
131236432|NCT01508936|472493352|FG001|Overall Study|Lack of Efficacy|1|||
131236433|NCT01508936|472493351|FG000|Overall Study|Withdrawal by Subject|4|||
131236434|NCT01508936|472493352|FG001|Overall Study|Withdrawal by Subject|18|||
130731524|NCT00805961|470637414|FG000|Treatment-Free Interval|Adverse Event|3|||
130731525|NCT00805961|470637414|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
130731526|NCT00805961|470637414|FG000|Treatment-Free Interval|Physician Decision|1|||
130731527|NCT00805961|470637414|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
130731528|NCT00805961|470637414|FG000|Maintenance Treatment|Lack of Efficacy|13|||
130731529|NCT00805961|470637414|FG000|Maintenance Treatment|Intercurrent Illness|7|||
130731530|NCT00805961|470637414|FG000|Maintenance Treatment|Adverse Event|6|||
130731531|NCT00805961|470637414|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
130731532|NCT00805961|470637414|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
130731533|NCT00805961|470637414|FG000|Maintenance Treatment|Withdrawn Consent|1|||
130731534|NCT04380961|470637415|FG000|Overall Study|Lost to Follow-up|17|||
130731535|NCT04380961|470637416|FG001|Overall Study|Lost to Follow-up|11|||
130731536|NCT04380961|470637415|FG000|Overall Study|Withdrawal by Subject|3|||
130731537|NCT04380961|470637416|FG001|Overall Study|Withdrawal by Subject|0|||
130731538|NCT04380961|470637415|FG000|Overall Study|Death|22|||
130731539|NCT04380961|470637416|FG001|Overall Study|Death|16|||
130731540|NCT04380961|470637415|FG000|Overall Study|Other|1|||
130731541|NCT04380961|470637416|FG001|Overall Study|Other|0|||
130731542|NCT04380961|470637415|FG000|Overall Study|Randomized but Not Treated|1|||
130731543|NCT04380961|470637416|FG001|Overall Study|Randomized but Not Treated|2|||
130731544|NCT03736031|470637417|FG000|Overall Study|Death|2|||
130731545|NCT03736031|470637418|FG001|Overall Study|Death|4|||
130731546|NCT03736031|470637417|FG000|Overall Study|Lost to Follow-up|21|||
130731547|NCT03736031|470637418|FG001|Overall Study|Lost to Follow-up|2|||
130731548|NCT03736031|470637417|FG000|Overall Study|Withdrawal by Subject|9|||
130731549|NCT03736031|470637418|FG001|Overall Study|Withdrawal by Subject|0|||
130731550|NCT03514017|470637419|FG000|Overall Study|Death|1|||
130731551|NCT03514017|470637419|FG000|Overall Study|Adverse Event|1|||
131173267|NCT00882999|472256630|FG004|Overall Study|Adverse Event|1|||
131173268|NCT00882999|472256631|FG005|Overall Study|Adverse Event|0|||
131173269|NCT00882999|472256632|FG006|Overall Study|Adverse Event|0|||
131236435|NCT01508936|472493351|FG000|Overall Study|Protocol Violation|2|||
131236436|NCT01508936|472493352|FG001|Overall Study|Protocol Violation|3|||
131236437|NCT01508936|472493351|FG000|Overall Study|Lost to Follow-up|2|||
131236438|NCT01508936|472493352|FG001|Overall Study|Lost to Follow-up|9|||
131236439|NCT01508936|472493351|FG000|Overall Study|Other|0|||
131236440|NCT01508936|472493352|FG001|Overall Study|Other|5|||
131236441|NCT01508936|472493351|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
131236442|NCT01508936|472493352|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
131236443|NCT00462982|472493353|FG000|Overall Study|Adverse Event|1|||
131236444|NCT00462982|472493353|FG000|Overall Study|Patient Not Treated|2|||
131236445|NCT00679367|472493354|FG000|Overall Study|Adverse Event|7|||
131236446|NCT00679367|472493354|FG000|Overall Study|inability to swallow oral drugs|1|||
131236447|NCT00679367|472493354|FG000|Overall Study|Lack of Efficacy|3|||
131236448|NCT00679367|472493354|FG000|Overall Study|Withdrawal by Subject|1|||
131236449|NCT04603937|472493357|FG000|Overall Study|Adverse Event|9|||
131236450|NCT04603937|472493358|FG001|Overall Study|Adverse Event|10|||
131236451|NCT04603937|472493357|FG000|Overall Study|Withdrawal by Subject|7|||
131236452|NCT04603937|472493358|FG001|Overall Study|Withdrawal by Subject|6|||
131236453|NCT04603937|472493357|FG000|Overall Study|Lost to Follow-up|5|||
131236454|NCT04603937|472493358|FG001|Overall Study|Lost to Follow-up|6|||
131236455|NCT04603937|472493357|FG000|Overall Study|Physician Decision|0|||
131236456|NCT04603937|472493358|FG001|Overall Study|Physician Decision|1|||
131236457|NCT04603937|472493357|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
131236458|NCT04603937|472493358|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
131236459|NCT02518685|472493359|FG000|Overall Study|Adverse Event|29|||
131236460|NCT02518685|472493360|FG001|Overall Study|Adverse Event|1|||
131236461|NCT02518685|472493359|FG000|Overall Study|Withdrawal by Subject|10|||
131236462|NCT02518685|472493360|FG001|Overall Study|Withdrawal by Subject|3|||
131173270|NCT00882999|472256626|FG000|Overall Study|Death|0|||
131173271|NCT00882999|472256627|FG001|Overall Study|Death|1|||
131173272|NCT00882999|472256628|FG002|Overall Study|Death|0|||
131173273|NCT00882999|472256629|FG003|Overall Study|Death|0|||
131173274|NCT00882999|472256630|FG004|Overall Study|Death|0|||
131173275|NCT00882999|472256631|FG005|Overall Study|Death|0|||
131173276|NCT00882999|472256632|FG006|Overall Study|Death|0|||
131173277|NCT00882999|472256626|FG000|Overall Study|Withdrawal by Subject|7|||
131173278|NCT00882999|472256627|FG001|Overall Study|Withdrawal by Subject|6|||
131173279|NCT00882999|472256628|FG002|Overall Study|Withdrawal by Subject|3|||
131173280|NCT00882999|472256629|FG003|Overall Study|Withdrawal by Subject|3|||
131173281|NCT00882999|472256630|FG004|Overall Study|Withdrawal by Subject|6|||
131173282|NCT00882999|472256631|FG005|Overall Study|Withdrawal by Subject|5|||
131173283|NCT00882999|472256632|FG006|Overall Study|Withdrawal by Subject|5|||
131173284|NCT00882999|472256626|FG000|Overall Study|Lost to Follow-up|0|||
131173285|NCT00882999|472256627|FG001|Overall Study|Lost to Follow-up|1|||
131173286|NCT00882999|472256628|FG002|Overall Study|Lost to Follow-up|1|||
131173287|NCT00882999|472256629|FG003|Overall Study|Lost to Follow-up|2|||
131173288|NCT00882999|472256630|FG004|Overall Study|Lost to Follow-up|1|||
131173289|NCT00882999|472256631|FG005|Overall Study|Lost to Follow-up|1|||
131173290|NCT00882999|472256632|FG006|Overall Study|Lost to Follow-up|2|||
131173291|NCT00882999|472256626|FG000|Overall Study|Physician Decision|1|||
131173292|NCT00882999|472256627|FG001|Overall Study|Physician Decision|0|||
131173293|NCT00882999|472256628|FG002|Overall Study|Physician Decision|0|||
131173294|NCT00882999|472256629|FG003|Overall Study|Physician Decision|0|||
131173295|NCT00882999|472256630|FG004|Overall Study|Physician Decision|0|||
131173296|NCT00882999|472256631|FG005|Overall Study|Physician Decision|1|||
131173297|NCT00882999|472256632|FG006|Overall Study|Physician Decision|1|||
131173298|NCT02387372|472256633|FG000|Overall Study|Not Treated|1|||
131173299|NCT02387372|472256634|FG001|Overall Study|Not Treated|0|||
131173300|NCT00937560|472256635|FG000|Initial Treatment|Death|6|||
131173301|NCT00937560|472256635|FG000|Initial Treatment|Withdraw consent|3|||
131173302|NCT00937560|472256635|FG000|Initial Treatment|Adverse Event|1|||
131173303|NCT00937560|472256635|FG000|Initial Treatment|Lost to Follow-up|1|||
131173304|NCT00937560|472256635|FG000|Initial Treatment|No end of study page|10|||
131173305|NCT00937560|472256635|FG000|Maintenance Treatment|Death|12|||
131173306|NCT00937560|472256635|FG000|Maintenance Treatment|Withdraw consent|5|||
131173307|NCT00937560|472256635|FG000|Maintenance Treatment|According to protocol|1|||
131173308|NCT00848549|472256636|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
131173309|NCT00848549|472256637|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
131173310|NCT00848549|472256636|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
131173311|NCT00848549|472256637|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
131173312|NCT00848549|472256636|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
131173313|NCT00848549|472256637|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
131173314|NCT00848549|472256636|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
131173315|NCT00848549|472256637|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
131173316|NCT00848549|472256636|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
131173317|NCT00848549|472256637|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
131173318|NCT00848549|472256636|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
131173319|NCT00848549|472256637|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
131173320|NCT00848549|472256636|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
131173321|NCT00848549|472256637|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
131173322|NCT00848549|472256636|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
131173323|NCT00848549|472256637|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
131173324|NCT00848549|472256636|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
131173325|NCT00848549|472256637|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
131236463|NCT02518685|472493359|FG000|Overall Study|relocation, study fatigue|7|||
131173326|NCT00848549|472256636|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
131173327|NCT00848549|472256637|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
131173328|NCT00848549|472256636|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
131173329|NCT00848549|472256637|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
131173330|NCT00848549|472256636|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
131236464|NCT02518685|472493360|FG001|Overall Study|relocation, study fatigue|2|||
131173331|NCT00848549|472256637|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
131173332|NCT00848549|472256636|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
131173333|NCT00848549|472256637|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
131173334|NCT00848549|472256636|FG000|E2090-E044-314 (Extension Study)|Other|5|||
131173335|NCT00848549|472256637|FG001|E2090-E044-314 (Extension Study)|Other|6|||
131173336|NCT02106455|472256644|FG000|Overall Study|Case Report Form Uncollected|6|||
131173337|NCT02106455|472256644|FG000|Overall Study|Protocol Deviation|2|||
131173338|NCT01576016|472256645|FG000|Lead Safety|Death|132|||
131173339|NCT01576016|472256646|FG001|Lead Safety|Death|0|||
131173340|NCT01576016|472256645|FG000|Lead Safety|Withdrawal by Subject|81|||
131173341|NCT01576016|472256646|FG001|Lead Safety|Withdrawal by Subject|0|||
131236465|NCT02518685|472493359|FG000|Overall Study|Pregnancy|1|||
131236466|NCT02518685|472493360|FG001|Overall Study|Pregnancy|0|||
131236467|NCT02518685|472493359|FG000|Overall Study|Physician Decision|1|||
131236468|NCT02518685|472493360|FG001|Overall Study|Physician Decision|0|||
131236469|NCT02518685|472493359|FG000|Overall Study|Lost to Follow-up|1|||
131236470|NCT02518685|472493360|FG001|Overall Study|Lost to Follow-up|4|||
131236471|NCT01922349|472493361|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
131236472|NCT01922349|472493362|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
131236473|NCT01922349|472493363|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
131236474|NCT01922349|472493364|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
131236475|NCT01611090|472493365|FG000|Randomized Period|Lost to Follow-up|8|||
131236476|NCT01611090|472493366|FG001|Randomized Period|Lost to Follow-up|3|||
131236477|NCT01611090|472493367|FG002|Randomized Period|Lost to Follow-up|0|||
131236478|NCT01611090|472493365|FG000|Randomized Period|Withdrawal by Subject|22|||
131236479|NCT01611090|472493366|FG001|Randomized Period|Withdrawal by Subject|26|||
131236480|NCT01611090|472493367|FG002|Randomized Period|Withdrawal by Subject|0|||
131236481|NCT01611090|472493365|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
131236482|NCT01611090|472493366|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
131236483|NCT01611090|472493367|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
131173342|NCT01576016|472256645|FG000|Lead Safety|System Explanted without Replacement|24|||
131173343|NCT01576016|472256646|FG001|Lead Safety|System Explanted without Replacement|0|||
131173344|NCT01576016|472256645|FG000|Lead Safety|Physician Decision|14|||
131173345|NCT01576016|472256646|FG001|Lead Safety|Physician Decision|0|||
131173346|NCT01576016|472256645|FG000|Lead Safety|Lost to Follow-up|13|||
131173347|NCT01576016|472256646|FG001|Lead Safety|Lost to Follow-up|0|||
131173348|NCT01576016|472256645|FG000|Lead Safety|Unsuccessful implant|2|||
131173349|NCT01576016|472256646|FG001|Lead Safety|Unsuccessful implant|0|||
131173350|NCT01576016|472256645|FG000|Lead Safety|Sponsor request|1|||
131173351|NCT01576016|472256646|FG001|Lead Safety|Sponsor request|0|||
131173352|NCT01576016|472256645|FG000|Lead Safety|Device replaced with CRT-D|1|||
131173353|NCT01576016|472256646|FG001|Lead Safety|Device replaced with CRT-D|0|||
131173354|NCT01576016|472256645|FG000|Lead Safety|Patient on Palliative Care|1|||
131173355|NCT01576016|472256646|FG001|Lead Safety|Patient on Palliative Care|0|||
131173356|NCT01576016|472256645|FG000|Lead Safety|Patient noncompliance|1|||
131173357|NCT01576016|472256646|FG001|Lead Safety|Patient noncompliance|0|||
131173358|NCT01576016|472256645|FG000|Lead Safety|Too far from study site|1|||
131236484|NCT01611090|472493365|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
131236485|NCT01611090|472493366|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
131173359|NCT01576016|472256646|FG001|Lead Safety|Too far from study site|0|||
131173360|NCT01576016|472256645|FG000|Lead Safety|System deactivated|1|||
131173361|NCT01576016|472256646|FG001|Lead Safety|System deactivated|0|||
131173362|NCT01576016|472256645|FG000|Lead Safety|Patient no longer followed by study PI|1|||
131173363|NCT01576016|472256646|FG001|Lead Safety|Patient no longer followed by study PI|0|||
131173364|NCT01576016|472256645|FG000|MRI Safety|Withdrawal by Subject|0|||
131173365|NCT01576016|472256646|FG001|MRI Safety|Withdrawal by Subject|10|||
131173366|NCT01576016|472256645|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
131173367|NCT01576016|472256646|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
131173368|NCT01576016|472256645|FG000|MRI Safety|Has not yet completed MRI scan|0|||
131173369|NCT01576016|472256646|FG001|MRI Safety|Has not yet completed MRI scan|56|||
131173370|NCT01576016|472256645|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
131173371|NCT01576016|472256646|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
131173372|NCT02488551|472256649|FG000|Overall Study|Lost to Follow-up|4|||
131173373|NCT02488551|472256650|FG001|Overall Study|Lost to Follow-up|7|||
131173374|NCT02488551|472256651|FG002|Overall Study|Lost to Follow-up|0|||
131173375|NCT02488551|472256652|FG003|Overall Study|Lost to Follow-up|0|||
131173376|NCT02488551|472256649|FG000|Overall Study|Military Deployment|1|||
131173377|NCT02488551|472256650|FG001|Overall Study|Military Deployment|1|||
131173378|NCT02488551|472256651|FG002|Overall Study|Military Deployment|0|||
131173379|NCT02488551|472256652|FG003|Overall Study|Military Deployment|0|||
131173380|NCT02546674|472256663|FG000|Overall Study|Adverse Event|19|||
131173381|NCT02546674|472256663|FG000|Overall Study|Death|1|||
131173382|NCT02546674|472256663|FG000|Overall Study|Lost to Follow-up|1|||
131173383|NCT02546674|472256663|FG000|Overall Study|Physician Decision|13|||
131173384|NCT02546674|472256663|FG000|Overall Study|Pregnancy|1|||
131173385|NCT02546674|472256663|FG000|Overall Study|Progressive Disease|2|||
131173386|NCT02546674|472256663|FG000|Overall Study|Protocol Deviation|2|||
131173387|NCT02546674|472256663|FG000|Overall Study|Subject/Guardian Decision|6|||
131173388|NCT02546674|472256663|FG000|Overall Study|Withdrawal of Informed Consent|3|||
131173389|NCT02864940|472256668|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
131173390|NCT02864940|472256669|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
131173391|NCT02175771|472256670|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
131173392|NCT02175771|472256671|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131173393|NCT02175771|472256672|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131173394|NCT02175771|472256673|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131173395|NCT02175771|472256674|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131173396|NCT02175771|472256675|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131236486|NCT01611090|472493367|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
131236487|NCT00922779|472493368|FG000|Overall Study|Adverse Event|67|||
131236488|NCT00922779|472493368|FG000|Overall Study|Pregnancy|7|||
131173397|NCT02175771|472256676|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131173398|NCT02175771|472256677|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131173399|NCT02175771|472256678|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131173400|NCT02175771|472256670|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
131173401|NCT02175771|472256671|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131173402|NCT02175771|472256672|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131173403|NCT02175771|472256673|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131173404|NCT02175771|472256674|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131173405|NCT02175771|472256675|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131173406|NCT02175771|472256676|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131173407|NCT02175771|472256677|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131173408|NCT02175771|472256678|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131173409|NCT02175771|472256670|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
131173410|NCT02175771|472256671|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131173411|NCT02175771|472256672|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131173412|NCT02175771|472256673|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131173413|NCT02175771|472256674|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131173414|NCT02175771|472256675|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131173415|NCT02175771|472256676|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131173416|NCT02175771|472256677|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131173417|NCT02175771|472256678|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131173418|NCT02175771|472256670|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
131173419|NCT02175771|472256671|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
131173420|NCT02175771|472256672|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
131173421|NCT02175771|472256673|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
131173422|NCT02175771|472256674|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
131173423|NCT02175771|472256675|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
131173424|NCT02175771|472256676|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
131173425|NCT02175771|472256677|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
131173426|NCT02175771|472256678|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
131173427|NCT02175771|472256670|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
131173428|NCT02175771|472256671|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131173429|NCT02175771|472256672|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131173430|NCT02175771|472256673|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131173431|NCT02175771|472256674|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131173432|NCT02175771|472256675|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131173433|NCT02175771|472256676|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131173434|NCT02175771|472256677|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131173435|NCT02175771|472256678|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131173436|NCT02175771|472256670|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
131173437|NCT02175771|472256671|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131173438|NCT02175771|472256672|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131173439|NCT02175771|472256673|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131173440|NCT02175771|472256674|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131173441|NCT02175771|472256675|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131173442|NCT02175771|472256676|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131173443|NCT02175771|472256677|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131173444|NCT02175771|472256678|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131173445|NCT02175771|472256670|FG000|Run-In Period (Pre-assignment)|Other|8|||
131173446|NCT02175771|472256671|FG001|Run-In Period (Pre-assignment)|Other|0|||
131173447|NCT02175771|472256672|FG002|Run-In Period (Pre-assignment)|Other|0|||
131173448|NCT02175771|472256673|FG003|Run-In Period (Pre-assignment)|Other|0|||
131173449|NCT02175771|472256674|FG004|Run-In Period (Pre-assignment)|Other|0|||
131173450|NCT02175771|472256675|FG005|Run-In Period (Pre-assignment)|Other|0|||
131173451|NCT02175771|472256676|FG006|Run-In Period (Pre-assignment)|Other|0|||
131173452|NCT02175771|472256677|FG007|Run-In Period (Pre-assignment)|Other|0|||
131173453|NCT02175771|472256678|FG008|Run-In Period (Pre-assignment)|Other|0|||
131173454|NCT02175771|472256670|FG000|Treatment Period|Adverse Event|0|||
131173455|NCT02175771|472256671|FG001|Treatment Period|Adverse Event|2|||
131173456|NCT02175771|472256672|FG002|Treatment Period|Adverse Event|1|||
131173457|NCT02175771|472256673|FG003|Treatment Period|Adverse Event|1|||
131173458|NCT02175771|472256674|FG004|Treatment Period|Adverse Event|1|||
131173459|NCT02175771|472256675|FG005|Treatment Period|Adverse Event|3|||
131173460|NCT02175771|472256676|FG006|Treatment Period|Adverse Event|2|||
131173461|NCT02175771|472256677|FG007|Treatment Period|Adverse Event|0|||
131173462|NCT02175771|472256678|FG008|Treatment Period|Adverse Event|1|||
131173463|NCT02175771|472256670|FG000|Treatment Period|Withdrawal by Subject|0|||
131173464|NCT02175771|472256671|FG001|Treatment Period|Withdrawal by Subject|9|||
131173465|NCT02175771|472256672|FG002|Treatment Period|Withdrawal by Subject|3|||
131173466|NCT02175771|472256673|FG003|Treatment Period|Withdrawal by Subject|6|||
131173467|NCT02175771|472256674|FG004|Treatment Period|Withdrawal by Subject|2|||
131173468|NCT02175771|472256675|FG005|Treatment Period|Withdrawal by Subject|4|||
131173469|NCT02175771|472256676|FG006|Treatment Period|Withdrawal by Subject|2|||
131173470|NCT02175771|472256677|FG007|Treatment Period|Withdrawal by Subject|9|||
131173471|NCT02175771|472256678|FG008|Treatment Period|Withdrawal by Subject|2|||
131173472|NCT02175771|472256670|FG000|Treatment Period|Noncompliance|0|||
131173473|NCT02175771|472256671|FG001|Treatment Period|Noncompliance|1|||
131173474|NCT02175771|472256672|FG002|Treatment Period|Noncompliance|2|||
131173475|NCT02175771|472256673|FG003|Treatment Period|Noncompliance|0|||
131173476|NCT02175771|472256674|FG004|Treatment Period|Noncompliance|0|||
131173477|NCT02175771|472256675|FG005|Treatment Period|Noncompliance|0|||
131173478|NCT02175771|472256676|FG006|Treatment Period|Noncompliance|0|||
131173479|NCT02175771|472256677|FG007|Treatment Period|Noncompliance|0|||
131173480|NCT02175771|472256678|FG008|Treatment Period|Noncompliance|1|||
131173481|NCT02175771|472256670|FG000|Treatment Period|Protocol Violation|0|||
131173482|NCT02175771|472256671|FG001|Treatment Period|Protocol Violation|0|||
131173483|NCT02175771|472256672|FG002|Treatment Period|Protocol Violation|0|||
131173484|NCT02175771|472256673|FG003|Treatment Period|Protocol Violation|0|||
131173485|NCT02175771|472256674|FG004|Treatment Period|Protocol Violation|0|||
131173486|NCT02175771|472256675|FG005|Treatment Period|Protocol Violation|0|||
131173487|NCT02175771|472256676|FG006|Treatment Period|Protocol Violation|0|||
131173488|NCT02175771|472256677|FG007|Treatment Period|Protocol Violation|1|||
131173489|NCT02175771|472256678|FG008|Treatment Period|Protocol Violation|0|||
131173490|NCT02175771|472256670|FG000|Treatment Period|Disease progression|0|||
131173491|NCT02175771|472256671|FG001|Treatment Period|Disease progression|0|||
131173492|NCT02175771|472256672|FG002|Treatment Period|Disease progression|0|||
131173493|NCT02175771|472256673|FG003|Treatment Period|Disease progression|0|||
131173494|NCT02175771|472256674|FG004|Treatment Period|Disease progression|0|||
131173495|NCT02175771|472256675|FG005|Treatment Period|Disease progression|0|||
131173496|NCT02175771|472256676|FG006|Treatment Period|Disease progression|0|||
131173497|NCT02175771|472256677|FG007|Treatment Period|Disease progression|2|||
131173498|NCT02175771|472256678|FG008|Treatment Period|Disease progression|0|||
131173499|NCT02175771|472256670|FG000|Treatment Period|Lost to Follow-up|0|||
131173500|NCT02175771|472256671|FG001|Treatment Period|Lost to Follow-up|3|||
131173501|NCT02175771|472256672|FG002|Treatment Period|Lost to Follow-up|1|||
131173502|NCT02175771|472256673|FG003|Treatment Period|Lost to Follow-up|3|||
131173503|NCT02175771|472256674|FG004|Treatment Period|Lost to Follow-up|1|||
131173504|NCT02175771|472256675|FG005|Treatment Period|Lost to Follow-up|2|||
131173505|NCT02175771|472256676|FG006|Treatment Period|Lost to Follow-up|1|||
131173506|NCT02175771|472256677|FG007|Treatment Period|Lost to Follow-up|2|||
131173507|NCT02175771|472256678|FG008|Treatment Period|Lost to Follow-up|2|||
131173508|NCT02175771|472256670|FG000|Treatment Period|Lack of Efficacy|0|||
131173509|NCT02175771|472256671|FG001|Treatment Period|Lack of Efficacy|0|||
131173510|NCT02175771|472256672|FG002|Treatment Period|Lack of Efficacy|0|||
131173511|NCT02175771|472256673|FG003|Treatment Period|Lack of Efficacy|0|||
131173512|NCT02175771|472256674|FG004|Treatment Period|Lack of Efficacy|0|||
131173513|NCT02175771|472256675|FG005|Treatment Period|Lack of Efficacy|1|||
131173514|NCT02175771|472256676|FG006|Treatment Period|Lack of Efficacy|0|||
131173515|NCT02175771|472256677|FG007|Treatment Period|Lack of Efficacy|1|||
131173516|NCT02175771|472256678|FG008|Treatment Period|Lack of Efficacy|0|||
131173517|NCT02175771|472256670|FG000|Treatment Period|Other|0|||
131173518|NCT02175771|472256671|FG001|Treatment Period|Other|1|||
131173519|NCT02175771|472256672|FG002|Treatment Period|Other|0|||
131173520|NCT02175771|472256673|FG003|Treatment Period|Other|3|||
131173521|NCT02175771|472256674|FG004|Treatment Period|Other|1|||
131173522|NCT02175771|472256675|FG005|Treatment Period|Other|0|||
131173523|NCT02175771|472256676|FG006|Treatment Period|Other|0|||
131173524|NCT02175771|472256677|FG007|Treatment Period|Other|2|||
131173525|NCT02175771|472256678|FG008|Treatment Period|Other|0|||
131173526|NCT03364673|472256679|FG000|Overall Study|Withdrawal by Subject|2|||
131173527|NCT03364673|472256679|FG000|Overall Study|Injury unrelated to study|3|||
131173528|NCT02232087|472256680|FG000|Overall Study|Withdrawal by Subject|2|||
131173529|NCT02232087|472256681|FG001|Overall Study|Withdrawal by Subject|0|||
131173530|NCT02232087|472256682|FG002|Overall Study|Withdrawal by Subject|0|||
131173531|NCT02232087|472256683|FG003|Overall Study|Withdrawal by Subject|0|||
131173532|NCT02232087|472256684|FG004|Overall Study|Withdrawal by Subject|0|||
131173533|NCT02232087|472256685|FG005|Overall Study|Withdrawal by Subject|1|||
131173534|NCT02232087|472256680|FG000|Overall Study|poor inhalation technique|0|||
131173535|NCT02232087|472256681|FG001|Overall Study|poor inhalation technique|1|||
131173536|NCT02232087|472256682|FG002|Overall Study|poor inhalation technique|0|||
131173537|NCT02232087|472256683|FG003|Overall Study|poor inhalation technique|0|||
131173538|NCT02232087|472256684|FG004|Overall Study|poor inhalation technique|0|||
131173539|NCT02232087|472256685|FG005|Overall Study|poor inhalation technique|2|||
131173540|NCT02232087|472256680|FG000|Overall Study|protocol stop criteria|0|||
131173541|NCT02232087|472256681|FG001|Overall Study|protocol stop criteria|1|||
131173542|NCT02232087|472256682|FG002|Overall Study|protocol stop criteria|0|||
131173543|NCT02232087|472256683|FG003|Overall Study|protocol stop criteria|1|||
131173544|NCT02232087|472256684|FG004|Overall Study|protocol stop criteria|0|||
130782001|NCT01435759|470829137|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130782002|NCT01435759|470829138|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130782003|NCT01435759|470829133|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
130782004|NCT01435759|470829134|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130782005|NCT01435759|470829135|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130782006|NCT01435759|470829136|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130782007|NCT01435759|470829137|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130782008|NCT01435759|470829138|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130782009|NCT01435759|470829133|FG000|Antidepressant Lead-in Phase|Other|119|||
130782010|NCT01435759|470829134|FG001|Antidepressant Lead-in Phase|Other|0|||
130782011|NCT01435759|470829135|FG002|Antidepressant Lead-in Phase|Other|0|||
130782012|NCT01435759|470829136|FG003|Antidepressant Lead-in Phase|Other|0|||
130782013|NCT01435759|470829137|FG004|Antidepressant Lead-in Phase|Other|0|||
130782014|NCT01435759|470829138|FG005|Antidepressant Lead-in Phase|Other|0|||
130782015|NCT01435759|470829133|FG000|Double-blind Phase|Adverse Event|7|||
130782016|NCT01435759|470829134|FG001|Double-blind Phase|Adverse Event|0|||
130782017|NCT01435759|470829135|FG002|Double-blind Phase|Adverse Event|1|||
131173545|NCT02232087|472256685|FG005|Overall Study|protocol stop criteria|0|||
131173546|NCT02232087|472256680|FG000|Overall Study|Adverse Event|0|||
131173547|NCT02232087|472256681|FG001|Overall Study|Adverse Event|0|||
131173548|NCT02232087|472256682|FG002|Overall Study|Adverse Event|0|||
131173549|NCT02232087|472256683|FG003|Overall Study|Adverse Event|0|||
131173550|NCT02232087|472256684|FG004|Overall Study|Adverse Event|1|||
131173551|NCT02232087|472256685|FG005|Overall Study|Adverse Event|0|||
131173552|NCT02208024|472256686|FG000|Overall Study|Withdrawal by Subject|1|||
131173553|NCT04096326|472256687|FG000|Overall Study|Withdrawal by Subject|0|||
131173554|NCT04096326|472256688|FG001|Overall Study|Withdrawal by Subject|0|||
131173555|NCT04096326|472256689|FG002|Overall Study|Withdrawal by Subject|0|||
131173556|NCT04096326|472256690|FG003|Overall Study|Withdrawal by Subject|0|||
131173557|NCT04096326|472256691|FG004|Overall Study|Withdrawal by Subject|0|||
131173558|NCT04096326|472256692|FG005|Overall Study|Withdrawal by Subject|0|||
131173559|NCT04096326|472256693|FG006|Overall Study|Withdrawal by Subject|1|||
131173560|NCT04096326|472256694|FG007|Overall Study|Withdrawal by Subject|0|||
131173561|NCT04096326|472256695|FG008|Overall Study|Withdrawal by Subject|0|||
131173562|NCT04096326|472256696|FG009|Overall Study|Withdrawal by Subject|0|||
131173563|NCT04096326|472256687|FG000|Overall Study|Lost to Follow-up|0|||
131173564|NCT04096326|472256688|FG001|Overall Study|Lost to Follow-up|1|||
131173565|NCT04096326|472256689|FG002|Overall Study|Lost to Follow-up|0|||
131173566|NCT04096326|472256690|FG003|Overall Study|Lost to Follow-up|0|||
131173567|NCT04096326|472256691|FG004|Overall Study|Lost to Follow-up|0|||
131173568|NCT04096326|472256692|FG005|Overall Study|Lost to Follow-up|0|||
131173569|NCT04096326|472256693|FG006|Overall Study|Lost to Follow-up|0|||
131173570|NCT04096326|472256694|FG007|Overall Study|Lost to Follow-up|0|||
131173571|NCT04096326|472256695|FG008|Overall Study|Lost to Follow-up|0|||
131173572|NCT04096326|472256696|FG009|Overall Study|Lost to Follow-up|0|||
131173573|NCT04096326|472256687|FG000|Overall Study|COVID-19-related reasons|0|||
131173574|NCT04096326|472256688|FG001|Overall Study|COVID-19-related reasons|0|||
131173575|NCT04096326|472256689|FG002|Overall Study|COVID-19-related reasons|0|||
131173576|NCT04096326|472256690|FG003|Overall Study|COVID-19-related reasons|0|||
131173577|NCT04096326|472256691|FG004|Overall Study|COVID-19-related reasons|1|||
131173578|NCT04096326|472256692|FG005|Overall Study|COVID-19-related reasons|5|||
131173579|NCT04096326|472256693|FG006|Overall Study|COVID-19-related reasons|0|||
131173580|NCT04096326|472256694|FG007|Overall Study|COVID-19-related reasons|0|||
131173581|NCT04096326|472256695|FG008|Overall Study|COVID-19-related reasons|0|||
131173582|NCT04096326|472256696|FG009|Overall Study|COVID-19-related reasons|0|||
131173583|NCT00194025|472256697|FG000|Overall Study|Adverse Event|1|||
131173584|NCT00194025|472256697|FG000|Overall Study|non-adherence with study medication|4|||
131173585|NCT04804033|472256699|FG000|Period 1: DBT Phase|Adverse Event|1|||
131173586|NCT04804033|472256700|FG001|Period 1: DBT Phase|Adverse Event|5|||
131173587|NCT04804033|472256701|FG002|Period 1: DBT Phase|Adverse Event|3|||
131173588|NCT04804033|472256702|FG003|Period 1: DBT Phase|Adverse Event|4|||
131173589|NCT04804033|472256699|FG000|Period 1: DBT Phase|Death|1|||
131173590|NCT04804033|472256700|FG001|Period 1: DBT Phase|Death|0|||
130782018|NCT01435759|470829136|FG003|Double-blind Phase|Adverse Event|1|||
131173591|NCT04804033|472256701|FG002|Period 1: DBT Phase|Death|0|||
131173592|NCT04804033|472256702|FG003|Period 1: DBT Phase|Death|0|||
131173593|NCT04804033|472256699|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
131173594|NCT04804033|472256700|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
131173595|NCT04804033|472256701|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
131173596|NCT04804033|472256702|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
130782019|NCT01435759|470829137|FG004|Double-blind Phase|Adverse Event|1|||
130782020|NCT01435759|470829138|FG005|Double-blind Phase|Adverse Event|3|||
130782021|NCT01435759|470829133|FG000|Double-blind Phase|Protocol Violation|2|||
131173597|NCT04804033|472256699|FG000|Period 1: DBT Phase|Non-compliance|1|||
131173598|NCT04804033|472256700|FG001|Period 1: DBT Phase|Non-compliance|0|||
131173599|NCT04804033|472256701|FG002|Period 1: DBT Phase|Non-compliance|1|||
131173600|NCT04804033|472256702|FG003|Period 1: DBT Phase|Non-compliance|2|||
131173601|NCT04804033|472256699|FG000|Period 1: DBT Phase|Other|0|||
131173602|NCT04804033|472256700|FG001|Period 1: DBT Phase|Other|1|||
131173603|NCT04804033|472256701|FG002|Period 1: DBT Phase|Other|0|||
131173604|NCT04804033|472256702|FG003|Period 1: DBT Phase|Other|0|||
131173605|NCT04804033|472256699|FG000|Period 1: DBT Phase|Pregnancy|2|||
131173606|NCT04804033|472256700|FG001|Period 1: DBT Phase|Pregnancy|0|||
131173607|NCT04804033|472256701|FG002|Period 1: DBT Phase|Pregnancy|0|||
131173608|NCT04804033|472256702|FG003|Period 1: DBT Phase|Pregnancy|0|||
131173609|NCT04804033|472256699|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
131173610|NCT04804033|472256700|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
131173611|NCT04804033|472256701|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
131173612|NCT04804033|472256702|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
131173613|NCT04804033|472256699|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
131173614|NCT04804033|472256700|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
131173615|NCT04804033|472256701|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
131173616|NCT04804033|472256702|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
131173617|NCT04804033|472256699|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
131173618|NCT04804033|472256700|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
131173619|NCT04804033|472256701|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
131173620|NCT04804033|472256702|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
131173621|NCT04804033|472256699|FG000|Period 2: OLE Phase|Adverse Event|3|||
131173622|NCT04804033|472256700|FG001|Period 2: OLE Phase|Adverse Event|4|||
131173623|NCT04804033|472256701|FG002|Period 2: OLE Phase|Adverse Event|2|||
131173624|NCT04804033|472256702|FG003|Period 2: OLE Phase|Adverse Event|0|||
131173625|NCT04804033|472256699|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
131173626|NCT04804033|472256700|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
131173627|NCT04804033|472256701|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
131173628|NCT04804033|472256702|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
131173629|NCT04804033|472256699|FG000|Period 2: OLE Phase|Non-compliance|2|||
131173630|NCT04804033|472256700|FG001|Period 2: OLE Phase|Non-compliance|2|||
131173631|NCT04804033|472256701|FG002|Period 2: OLE Phase|Non-compliance|0|||
131173632|NCT04804033|472256702|FG003|Period 2: OLE Phase|Non-compliance|1|||
131173633|NCT04804033|472256699|FG000|Period 2: OLE Phase|Other|0|||
131173634|NCT04804033|472256700|FG001|Period 2: OLE Phase|Other|2|||
131173635|NCT04804033|472256701|FG002|Period 2: OLE Phase|Other|0|||
131173636|NCT04804033|472256702|FG003|Period 2: OLE Phase|Other|0|||
131173637|NCT04804033|472256699|FG000|Period 2: OLE Phase|Physician Decision|1|||
131173638|NCT04804033|472256700|FG001|Period 2: OLE Phase|Physician Decision|1|||
131173639|NCT04804033|472256701|FG002|Period 2: OLE Phase|Physician Decision|0|||
131173640|NCT04804033|472256702|FG003|Period 2: OLE Phase|Physician Decision|0|||
131173641|NCT04804033|472256699|FG000|Period 2: OLE Phase|Pregnancy|0|||
131173642|NCT04804033|472256700|FG001|Period 2: OLE Phase|Pregnancy|0|||
131173643|NCT04804033|472256701|FG002|Period 2: OLE Phase|Pregnancy|2|||
131173644|NCT04804033|472256702|FG003|Period 2: OLE Phase|Pregnancy|0|||
131173645|NCT04804033|472256699|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
131173646|NCT04804033|472256700|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
131173647|NCT04804033|472256701|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
131173648|NCT04804033|472256702|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
131173649|NCT04804033|472256699|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
131173650|NCT04804033|472256700|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
131173651|NCT04804033|472256701|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
131173652|NCT04804033|472256702|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
131173653|NCT04804033|472256699|FG000|Period 2: OLE Phase|Not reported|0|||
131173654|NCT04804033|472256700|FG001|Period 2: OLE Phase|Not reported|2|||
131173655|NCT04804033|472256701|FG002|Period 2: OLE Phase|Not reported|0|||
131173656|NCT04804033|472256702|FG003|Period 2: OLE Phase|Not reported|0|||
130782022|NCT01435759|470829134|FG001|Double-blind Phase|Protocol Violation|0|||
131173657|NCT04804033|472256699|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
131173658|NCT04804033|472256700|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
131173659|NCT04804033|472256701|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
131173660|NCT04804033|472256702|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
131173661|NCT04804033|472256699|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
131173662|NCT04804033|472256700|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
131173663|NCT04804033|472256701|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
131173664|NCT04804033|472256702|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
131173665|NCT04804033|472256699|FG000|Period 3: Follow-up Phase|Other|0|||
131173666|NCT04804033|472256700|FG001|Period 3: Follow-up Phase|Other|1|||
131173667|NCT04804033|472256701|FG002|Period 3: Follow-up Phase|Other|2|||
131173668|NCT04804033|472256702|FG003|Period 3: Follow-up Phase|Other|1|||
131173669|NCT04804033|472256699|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
131173670|NCT04804033|472256700|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
131173671|NCT04804033|472256701|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
131173672|NCT04804033|472256702|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
131173673|NCT04804033|472256699|FG000|Period 3: Follow-up Phase|Not reported|18|||
130782023|NCT01435759|470829135|FG002|Double-blind Phase|Protocol Violation|1|||
131173674|NCT04804033|472256700|FG001|Period 3: Follow-up Phase|Not reported|15|||
131173675|NCT04804033|472256701|FG002|Period 3: Follow-up Phase|Not reported|1|||
131173676|NCT04804033|472256702|FG003|Period 3: Follow-up Phase|Not reported|4|||
131173677|NCT00543569|472256703|FG000|Overall Study|Death|2|||
131173678|NCT00543569|472256704|FG001|Overall Study|Death|2|||
131173679|NCT00543569|472256705|FG002|Overall Study|Death|3|||
131173680|NCT00543569|472256706|FG003|Overall Study|Death|1|||
131173681|NCT00543569|472256703|FG000|Overall Study|Lost to Follow-up|0|||
131173682|NCT00543569|472256704|FG001|Overall Study|Lost to Follow-up|0|||
131173683|NCT00543569|472256705|FG002|Overall Study|Lost to Follow-up|1|||
131173684|NCT00543569|472256706|FG003|Overall Study|Lost to Follow-up|1|||
131173685|NCT00543569|472256703|FG000|Overall Study|Miscellaneous Reasons|7|||
131173686|NCT00543569|472256704|FG001|Overall Study|Miscellaneous Reasons|3|||
131173687|NCT00543569|472256705|FG002|Overall Study|Miscellaneous Reasons|11|||
131173688|NCT00543569|472256706|FG003|Overall Study|Miscellaneous Reasons|4|||
131173689|NCT00543569|472256703|FG000|Overall Study|Randomized but never received study drug|3|||
131173690|NCT00543569|472256704|FG001|Overall Study|Randomized but never received study drug|3|||
131173691|NCT00543569|472256705|FG002|Overall Study|Randomized but never received study drug|5|||
131173692|NCT00543569|472256706|FG003|Overall Study|Randomized but never received study drug|3|||
131173693|NCT05373706|472256709|FG000|Overall Study|Lost to Follow-up|2|||
131173694|NCT05373706|472256710|FG001|Overall Study|Lost to Follow-up|2|||
131173695|NCT03628508|472256714|FG000|Overall Study|Lost to Follow-up|1|||
131173696|NCT02402218|472256717|FG000|Overall Study|Did not pickup study medication|12|||
131173697|NCT02402218|472256718|FG001|Overall Study|Did not pickup study medication|9|||
131173698|NCT02402218|472256719|FG002|Overall Study|Did not pickup study medication|13|||
131173699|NCT02402218|472256717|FG000|Overall Study|Lack of Efficacy|0|||
131173700|NCT02402218|472256718|FG001|Overall Study|Lack of Efficacy|1|||
131173701|NCT02402218|472256719|FG002|Overall Study|Lack of Efficacy|1|||
131173702|NCT02402218|472256717|FG000|Overall Study|Death|1|||
131173703|NCT02402218|472256718|FG001|Overall Study|Death|0|||
131173704|NCT02402218|472256719|FG002|Overall Study|Death|0|||
131173705|NCT02402218|472256717|FG000|Overall Study|Reinfection|0|||
131173706|NCT02402218|472256718|FG001|Overall Study|Reinfection|0|||
131173707|NCT02402218|472256719|FG002|Overall Study|Reinfection|1|||
131173708|NCT02402218|472256717|FG000|Overall Study|Adverse Event|0|||
131173709|NCT02402218|472256718|FG001|Overall Study|Adverse Event|2|||
131173710|NCT02402218|472256719|FG002|Overall Study|Adverse Event|1|||
131173711|NCT02402218|472256717|FG000|Overall Study|Withdrawal by Subject|1|||
131173712|NCT02402218|472256718|FG001|Overall Study|Withdrawal by Subject|1|||
131173713|NCT02402218|472256719|FG002|Overall Study|Withdrawal by Subject|1|||
131173714|NCT00807846|472256721|FG000|Overall Study|Adverse Event|5|||
131173715|NCT00807846|472256722|FG001|Overall Study|Adverse Event|0|||
131173716|NCT00807846|472256721|FG000|Overall Study|Lack of Efficacy|2|||
131173717|NCT00807846|472256722|FG001|Overall Study|Lack of Efficacy|0|||
131173718|NCT00807846|472256721|FG000|Overall Study|Protocol Violation|2|||
131173719|NCT00807846|472256722|FG001|Overall Study|Protocol Violation|1|||
131173720|NCT00807846|472256721|FG000|Overall Study|Withdrawal by Subject|2|||
131173721|NCT00807846|472256722|FG001|Overall Study|Withdrawal by Subject|1|||
131173722|NCT00807846|472256721|FG000|Overall Study|Other|1|||
131173723|NCT00807846|472256722|FG001|Overall Study|Other|2|||
131173724|NCT01081873|472256723|FG000|Overall Study|Death|86|||
131173725|NCT01081873|472256723|FG000|Overall Study|Withdrawal by Subject|10|||
131173726|NCT01081873|472256723|FG000|Overall Study|Lost to Follow-up|142|||
131173727|NCT01081873|472256723|FG000|Overall Study|Progression of prostate cancer|13|||
131173728|NCT01081873|472256723|FG000|Overall Study|Other|47|||
131173729|NCT02491073|472256725|FG000|Overall Study|screen failure|1|||
131173730|NCT02491073|472256726|FG001|Overall Study|screen failure|0|||
131173731|NCT03738566|472256727|FG000|Initial Study Phase|Withdrawal by Subject|1|||
131173732|NCT03738566|472256728|FG001|Initial Study Phase|Withdrawal by Subject|1|||
131173733|NCT03738566|472256729|FG002|Initial Study Phase|Withdrawal by Subject|2|||
131173734|NCT03738566|472256730|FG003|Initial Study Phase|Withdrawal by Subject|0|||
131173735|NCT03738566|472256727|FG000|Initial Study Phase|Death|0|||
131173736|NCT03738566|472256728|FG001|Initial Study Phase|Death|1|||
131173737|NCT03738566|472256729|FG002|Initial Study Phase|Death|0|||
131173738|NCT03738566|472256730|FG003|Initial Study Phase|Death|0|||
131173739|NCT03738566|472256727|FG000|Initial Study Phase|Treatment failure|5|||
131173740|NCT03738566|472256728|FG001|Initial Study Phase|Treatment failure|0|||
131173741|NCT03738566|472256729|FG002|Initial Study Phase|Treatment failure|0|||
131173742|NCT03738566|472256730|FG003|Initial Study Phase|Treatment failure|0|||
131173743|NCT03738566|472256727|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
131173744|NCT03738566|472256728|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
131173745|NCT03738566|472256729|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
131173746|NCT03738566|472256730|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
131236489|NCT00922779|472493368|FG000|Overall Study|Withdrawal by Subject|308|||
131173747|NCT03126539|472256736|FG000|Overall Study|Lost to Follow-up|1|||
131173748|NCT03126539|472256737|FG001|Overall Study|Lost to Follow-up|1|||
131173749|NCT03126539|472256738|FG002|Overall Study|Lost to Follow-up|1|||
131173750|NCT03126539|472256739|FG003|Overall Study|Lost to Follow-up|0|||
130782024|NCT01435759|470829136|FG003|Double-blind Phase|Protocol Violation|2|||
130782025|NCT01435759|470829137|FG004|Double-blind Phase|Protocol Violation|0|||
130782026|NCT01435759|470829138|FG005|Double-blind Phase|Protocol Violation|1|||
130782027|NCT01435759|470829133|FG000|Double-blind Phase|Withdrawal by Subject|17|||
130782028|NCT01435759|470829134|FG001|Double-blind Phase|Withdrawal by Subject|4|||
130782029|NCT01435759|470829135|FG002|Double-blind Phase|Withdrawal by Subject|3|||
131173751|NCT03126539|472256740|FG004|Overall Study|Lost to Follow-up|0|||
131173752|NCT02632110|472256741|FG000|Overall Study|Withdrawal by Subject|1|||
131173753|NCT02632110|472256742|FG001|Overall Study|Withdrawal by Subject|1|||
131173754|NCT02632110|472256743|FG002|Overall Study|Withdrawal by Subject|0|||
131173755|NCT02632110|472256744|FG003|Overall Study|Withdrawal by Subject|0|||
131173756|NCT02632110|472256745|FG004|Overall Study|Withdrawal by Subject|1|||
131173757|NCT02632110|472256746|FG005|Overall Study|Withdrawal by Subject|1|||
131173758|NCT02632110|472256747|FG006|Overall Study|Withdrawal by Subject|3|||
131173759|NCT02632110|472256748|FG007|Overall Study|Withdrawal by Subject|3|||
131173760|NCT02632110|472256749|FG008|Overall Study|Withdrawal by Subject|1|||
131173761|NCT02632110|472256750|FG009|Overall Study|Withdrawal by Subject|1|||
131173762|NCT03352414|472256751|FG000|Overall Study|Ineligible by operative criteria|12|||
131173763|NCT03352414|472256752|FG001|Overall Study|Ineligible by operative criteria|10|||
131173764|NCT00516269|472256755|FG000|Overall Study|Adverse Event|2|||
131173765|NCT00516269|472256756|FG001|Overall Study|Adverse Event|1|||
131173766|NCT00516269|472256755|FG000|Overall Study|Lost to Follow-up|0|||
131173767|NCT00516269|472256756|FG001|Overall Study|Lost to Follow-up|1|||
131173768|NCT00516269|472256755|FG000|Overall Study|Protocol Violation|0|||
131173769|NCT00516269|472256756|FG001|Overall Study|Protocol Violation|1|||
131173770|NCT01079962|472256757|FG000|Overall Study|Adverse Event|2|||
131173771|NCT01079962|472256758|FG001|Overall Study|Adverse Event|2|||
131173772|NCT01079962|472256757|FG000|Overall Study|Withdrawal by Subject|5|||
131173773|NCT01079962|472256758|FG001|Overall Study|Withdrawal by Subject|7|||
131173774|NCT01079962|472256757|FG000|Overall Study|Protocol Violation|2|||
131173775|NCT01079962|472256758|FG001|Overall Study|Protocol Violation|2|||
131173776|NCT01079962|472256757|FG000|Overall Study|No blood pressure (BP) control|3|||
131173777|NCT01079962|472256758|FG001|Overall Study|No blood pressure (BP) control|0|||
131173778|NCT01079962|472256757|FG000|Overall Study|Inclusion/exclusion criteria|1|||
131173779|NCT01079962|472256758|FG001|Overall Study|Inclusion/exclusion criteria|3|||
131173780|NCT01079962|472256757|FG000|Overall Study|Participant not returning for next visit|1|||
131173781|NCT01079962|472256758|FG001|Overall Study|Participant not returning for next visit|0|||
131173782|NCT01079962|472256757|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
131173783|NCT01079962|472256758|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
131173784|NCT01072539|472256759|FG000|Overall Study|Treated prior to the Site Initiation|1|||
131173785|NCT01072539|472256759|FG000|Overall Study|Protocol Violation|2|||
131173786|NCT01331239|472256760|FG000|Part II: Core Study|Adverse Event|0|||
131173787|NCT01331239|472256761|FG001|Part II: Core Study|Adverse Event|3|||
131173788|NCT01331239|472256762|FG002|Part II: Core Study|Adverse Event|0|||
131173789|NCT01331239|472256760|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
131173790|NCT01331239|472256761|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
131173791|NCT01331239|472256762|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
131173792|NCT01331239|472256760|FG000|Part II: Core Study|Withdrawal by Subject|0|||
131173793|NCT01331239|472256761|FG001|Part II: Core Study|Withdrawal by Subject|2|||
131173794|NCT01331239|472256762|FG002|Part II: Core Study|Withdrawal by Subject|0|||
131173795|NCT01331239|472256760|FG000|Part II: Core Study|Administrative problems|0|||
131173796|NCT01331239|472256761|FG001|Part II: Core Study|Administrative problems|1|||
131173797|NCT01331239|472256762|FG002|Part II: Core Study|Administrative problems|0|||
131173798|NCT00946530|472256763|FG000|Overall Study|Withdrawal by Subject|0|||
131173799|NCT00946530|472256764|FG001|Overall Study|Withdrawal by Subject|3|||
131173800|NCT00946530|472256765|FG002|Overall Study|Withdrawal by Subject|0|||
131173801|NCT00946530|472256766|FG003|Overall Study|Withdrawal by Subject|3|||
131173802|NCT00946530|472256763|FG000|Overall Study|Physician Decision|1|||
130782030|NCT01435759|470829136|FG003|Double-blind Phase|Withdrawal by Subject|4|||
130782031|NCT01435759|470829137|FG004|Double-blind Phase|Withdrawal by Subject|2|||
130782032|NCT01435759|470829138|FG005|Double-blind Phase|Withdrawal by Subject|2|||
130782033|NCT01435759|470829133|FG000|Double-blind Phase|Lost to Follow-up|31|||
130782034|NCT01435759|470829134|FG001|Double-blind Phase|Lost to Follow-up|1|||
130782035|NCT01435759|470829135|FG002|Double-blind Phase|Lost to Follow-up|2|||
131173803|NCT00946530|472256764|FG001|Overall Study|Physician Decision|1|||
131173804|NCT00946530|472256765|FG002|Overall Study|Physician Decision|1|||
131173805|NCT00946530|472256766|FG003|Overall Study|Physician Decision|1|||
131173806|NCT01008995|472256767|FG000|Controlled Period|Adverse Event|1|||
131173807|NCT01008995|472256768|FG001|Controlled Period|Adverse Event|2|||
131173808|NCT01008995|472256769|FG002|Controlled Period|Adverse Event|0|||
131173809|NCT01008995|472256770|FG003|Controlled Period|Adverse Event|0|||
131173810|NCT01008995|472256767|FG000|Controlled Period|Other|2|||
131173811|NCT01008995|472256768|FG001|Controlled Period|Other|1|||
131173812|NCT01008995|472256769|FG002|Controlled Period|Other|0|||
131173813|NCT01008995|472256770|FG003|Controlled Period|Other|0|||
131173814|NCT01008995|472256767|FG000|After Controlled Period|Adverse Event|0|||
131236490|NCT00922779|472493368|FG000|Overall Study|Lost to Follow-up|44|||
131173815|NCT01008995|472256768|FG001|After Controlled Period|Adverse Event|0|||
131173816|NCT01008995|472256769|FG002|After Controlled Period|Adverse Event|1|||
131173817|NCT01008995|472256770|FG003|After Controlled Period|Adverse Event|1|||
131173818|NCT01008995|472256767|FG000|After Controlled Period|Other|0|||
131173819|NCT01008995|472256768|FG001|After Controlled Period|Other|0|||
131173820|NCT01008995|472256769|FG002|After Controlled Period|Other|1|||
131173821|NCT01008995|472256770|FG003|After Controlled Period|Other|0|||
131173822|NCT00115804|472256773|FG000|Overall Study|Adverse Event|2|||
131173823|NCT01877382|472256776|FG000|Dose Escalation|Progressive disease|2|||
131173824|NCT01877382|472256777|FG001|Dose Escalation|Progressive disease|0|||
131173825|NCT01877382|472256778|FG002|Dose Escalation|Progressive disease|1|||
131173826|NCT01877382|472256779|FG003|Dose Escalation|Progressive disease|6|||
131173827|NCT01877382|472256780|FG004|Dose Escalation|Progressive disease|1|||
131173828|NCT01877382|472256781|FG005|Dose Escalation|Progressive disease|0|||
131173829|NCT01877382|472256782|FG006|Dose Escalation|Progressive disease|3|||
131173830|NCT01877382|472256783|FG007|Dose Escalation|Progressive disease|10|||
131173831|NCT01877382|472256784|FG008|Dose Escalation|Progressive disease|4|||
131173832|NCT01877382|472256785|FG009|Dose Escalation|Progressive disease|2|||
131173833|NCT01877382|472256786|FG010|Dose Escalation|Progressive disease|3|||
131173834|NCT01877382|472256787|FG011|Dose Escalation|Progressive disease|3|||
131236491|NCT00922779|472493368|FG000|Overall Study|Other|27|||
131236492|NCT00922779|472493368|FG000|Overall Study|Missing|1874|||
131236493|NCT01298570|472494928|FG000|Overall Study|Disease progression, relapse during acti|64|||
131236494|NCT01298570|472494929|FG001|Overall Study|Disease progression, relapse during acti|40|||
131236495|NCT01298570|472494928|FG000|Overall Study|Adverse Event|20|||
131236496|NCT01298570|472494929|FG001|Overall Study|Adverse Event|2|||
131236497|NCT01298570|472494928|FG000|Overall Study|Withdrawal by Subject|21|||
131236498|NCT01298570|472494929|FG001|Overall Study|Withdrawal by Subject|6|||
131236499|NCT01298570|472494928|FG000|Overall Study|Treatment delay > 4 weeks|4|||
131236500|NCT01298570|472494929|FG001|Overall Study|Treatment delay > 4 weeks|5|||
131236501|NCT01298570|472494928|FG000|Overall Study|Physician Decision|4|||
131236502|NCT01298570|472494929|FG001|Overall Study|Physician Decision|2|||
131236503|NCT01298570|472494928|FG000|Overall Study|Other complicating disease|2|||
131236504|NCT01298570|472494929|FG001|Overall Study|Other complicating disease|1|||
131236505|NCT01298570|472494928|FG000|Overall Study|Surgery|2|||
131236506|NCT01298570|472494929|FG001|Overall Study|Surgery|1|||
131236507|NCT01298570|472494928|FG000|Overall Study|Symptomatic progression/deterioration|3|||
131236508|NCT01298570|472494929|FG001|Overall Study|Symptomatic progression/deterioration|2|||
131236509|NCT01298570|472494928|FG000|Overall Study|Death|0|||
131236510|NCT01298570|472494929|FG001|Overall Study|Death|1|||
131236511|NCT01298570|472494928|FG000|Overall Study|Ineligibility|0|||
131236512|NCT01298570|472494929|FG001|Overall Study|Ineligibility|1|||
131236513|NCT01210001|472494930|FG000|Overall Study|Not treated|1|||
131236514|NCT01210001|472494931|FG001|Overall Study|Not treated|0|||
131236515|NCT01210001|472494932|FG002|Overall Study|Not treated|0|||
131236516|NCT01210001|472494930|FG000|Overall Study|Adverse Event|4|||
131236517|NCT01210001|472494931|FG001|Overall Study|Adverse Event|2|||
131236518|NCT01210001|472494932|FG002|Overall Study|Adverse Event|5|||
131236519|NCT01210001|472494930|FG000|Overall Study|Non compliant with protocol|2|||
131236520|NCT01210001|472494931|FG001|Overall Study|Non compliant with protocol|2|||
131236521|NCT01210001|472494932|FG002|Overall Study|Non compliant with protocol|3|||
131236522|NCT01210001|472494930|FG000|Overall Study|Lost to Follow-up|4|||
131236523|NCT01210001|472494931|FG001|Overall Study|Lost to Follow-up|3|||
131236524|NCT01210001|472494932|FG002|Overall Study|Lost to Follow-up|2|||
131236525|NCT01210001|472494930|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
131236526|NCT01210001|472494931|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
131236527|NCT01210001|472494932|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
131236528|NCT01210001|472494930|FG000|Overall Study|Other reason not defined above|2|||
131236529|NCT01210001|472494931|FG001|Overall Study|Other reason not defined above|2|||
131236530|NCT01210001|472494932|FG002|Overall Study|Other reason not defined above|1|||
131236531|NCT01739790|472494933|FG000|Overall Study|Early Trial Termination|2|||
131236532|NCT01739790|472494934|FG001|Overall Study|Early Trial Termination|4|||
131236533|NCT01451762|472494938|FG000|Overall Study|Lost to Follow-up|3|||
131236534|NCT01451762|472494939|FG001|Overall Study|Lost to Follow-up|6|||
131236535|NCT01451762|472494940|FG002|Overall Study|Lost to Follow-up|6|||
131173835|NCT01877382|472256788|FG012|Dose Escalation|Progressive disease|13|||
131173836|NCT01877382|472256789|FG013|Dose Escalation|Progressive disease|1|||
131173837|NCT01877382|472256790|FG014|Dose Escalation|Progressive disease|0|||
131173838|NCT01877382|472256776|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
131173839|NCT01877382|472256777|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131236536|NCT04471207|472494941|FG000|Overall Study|Lost to Follow-up|4|||
131236537|NCT04471207|472494942|FG001|Overall Study|Lost to Follow-up|1|||
131236538|NCT04471207|472494941|FG000|Overall Study|Medication Contraindication|0|||
131236539|NCT04471207|472494942|FG001|Overall Study|Medication Contraindication|1|||
131236540|NCT04471207|472494941|FG000|Overall Study|Loss of Interest|2|||
131236541|NCT04471207|472494942|FG001|Overall Study|Loss of Interest|1|||
130782036|NCT01435759|470829136|FG003|Double-blind Phase|Lost to Follow-up|0|||
130782037|NCT01435759|470829137|FG004|Double-blind Phase|Lost to Follow-up|3|||
130782038|NCT01435759|470829138|FG005|Double-blind Phase|Lost to Follow-up|3|||
130782039|NCT01435759|470829133|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
130782040|NCT01435759|470829134|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130782041|NCT01435759|470829135|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130782042|NCT01435759|470829136|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130782043|NCT01435759|470829137|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
130782044|NCT01435759|470829138|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130782045|NCT01435759|470829133|FG000|Double-blind Phase|Other|8|||
130782046|NCT01435759|470829134|FG001|Double-blind Phase|Other|2|||
130782047|NCT01435759|470829135|FG002|Double-blind Phase|Other|0|||
130782048|NCT01435759|470829136|FG003|Double-blind Phase|Other|2|||
130782049|NCT01435759|470829137|FG004|Double-blind Phase|Other|0|||
130782050|NCT01435759|470829138|FG005|Double-blind Phase|Other|0|||
130782051|NCT02849587|470829141|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
130782052|NCT02849587|470829142|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
130782053|NCT02849587|470829143|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
130782054|NCT02849587|470829141|FG000|Overall Study|Withdrawal by Subject|0|||
130782055|NCT02849587|470829142|FG001|Overall Study|Withdrawal by Subject|1|||
130782056|NCT02849587|470829143|FG002|Overall Study|Withdrawal by Subject|0|||
130782057|NCT02421419|470829147|FG000|Overall Study|Physician Decision|0|||
130782058|NCT02421419|470829148|FG001|Overall Study|Physician Decision|0|||
130782059|NCT02421419|470829149|FG002|Overall Study|Physician Decision|1|||
131173840|NCT01877382|472256778|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173841|NCT01877382|472256779|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
131173842|NCT01877382|472256780|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173843|NCT01877382|472256781|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173844|NCT01877382|472256782|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
131173845|NCT01877382|472256783|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173846|NCT01877382|472256784|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173847|NCT01877382|472256785|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173848|NCT01877382|472256786|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173849|NCT01877382|472256787|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173850|NCT01877382|472256788|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173851|NCT01877382|472256789|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173852|NCT01877382|472256790|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131173853|NCT01877382|472256776|FG000|Dose Escalation|Clinical progression|0|||
131173854|NCT01877382|472256777|FG001|Dose Escalation|Clinical progression|1|||
131173855|NCT01877382|472256778|FG002|Dose Escalation|Clinical progression|0|||
131173856|NCT01877382|472256779|FG003|Dose Escalation|Clinical progression|2|||
131173857|NCT01877382|472256780|FG004|Dose Escalation|Clinical progression|0|||
131173858|NCT01877382|472256781|FG005|Dose Escalation|Clinical progression|0|||
131173859|NCT01877382|472256782|FG006|Dose Escalation|Clinical progression|1|||
131173860|NCT01877382|472256783|FG007|Dose Escalation|Clinical progression|0|||
131173861|NCT01877382|472256784|FG008|Dose Escalation|Clinical progression|0|||
131173862|NCT01877382|472256785|FG009|Dose Escalation|Clinical progression|1|||
131173863|NCT01877382|472256786|FG010|Dose Escalation|Clinical progression|0|||
131173864|NCT01877382|472256787|FG011|Dose Escalation|Clinical progression|0|||
131173865|NCT01877382|472256788|FG012|Dose Escalation|Clinical progression|2|||
131173866|NCT01877382|472256789|FG013|Dose Escalation|Clinical progression|1|||
131173867|NCT01877382|472256790|FG014|Dose Escalation|Clinical progression|0|||
131173868|NCT01877382|472256776|FG000|Dose Escalation|Adverse Event|0|||
131173869|NCT01877382|472256777|FG001|Dose Escalation|Adverse Event|0|||
131173870|NCT01877382|472256778|FG002|Dose Escalation|Adverse Event|0|||
131173871|NCT01877382|472256779|FG003|Dose Escalation|Adverse Event|4|||
131173872|NCT01877382|472256780|FG004|Dose Escalation|Adverse Event|1|||
131173873|NCT01877382|472256781|FG005|Dose Escalation|Adverse Event|2|||
131173874|NCT01877382|472256782|FG006|Dose Escalation|Adverse Event|1|||
131173875|NCT01877382|472256783|FG007|Dose Escalation|Adverse Event|2|||
131173876|NCT01877382|472256784|FG008|Dose Escalation|Adverse Event|0|||
131173877|NCT01877382|472256785|FG009|Dose Escalation|Adverse Event|0|||
131173878|NCT01877382|472256786|FG010|Dose Escalation|Adverse Event|0|||
131173879|NCT01877382|472256787|FG011|Dose Escalation|Adverse Event|0|||
131173880|NCT01877382|472256788|FG012|Dose Escalation|Adverse Event|1|||
131173881|NCT01877382|472256789|FG013|Dose Escalation|Adverse Event|0|||
131173882|NCT01877382|472256790|FG014|Dose Escalation|Adverse Event|0|||
130782060|NCT01275144|470829157|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
131173883|NCT01877382|472256776|FG000|Dose Escalation|Withdrawal by Subject|0|||
130782061|NCT01275144|470829158|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
130782062|NCT01365130|470829159|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
130782063|NCT05607576|470829161|FG000|Overall Study|immediate sensor error|2|||
130782064|NCT05607576|470829161|FG000|Overall Study|Physician Decision|2|||
130782065|NCT00810199|470829162|FG000|Overall Study|Adverse Event|24|||
130782066|NCT00810199|470829163|FG001|Overall Study|Adverse Event|26|||
130782067|NCT00810199|470829162|FG000|Overall Study|Death|4|||
130782068|NCT00810199|470829163|FG001|Overall Study|Death|6|||
130782069|NCT00810199|470829162|FG000|Overall Study|Withdrew consent|9|||
130782070|NCT00810199|470829163|FG001|Overall Study|Withdrew consent|12|||
130782071|NCT00810199|470829162|FG000|Overall Study|Insufficient therapeutic response|5|||
130782072|NCT00810199|470829163|FG001|Overall Study|Insufficient therapeutic response|14|||
130782073|NCT00810199|470829162|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
130782074|NCT00810199|470829163|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
130782075|NCT00810199|470829162|FG000|Overall Study|Administrative/Other|5|||
130782076|NCT00810199|470829163|FG001|Overall Study|Administrative/Other|6|||
130782077|NCT00810199|470829162|FG000|Overall Study|Protocol Violation|2|||
130782078|NCT00810199|470829163|FG001|Overall Study|Protocol Violation|6|||
130782079|NCT00810199|470829162|FG000|Overall Study|Failure to return|1|||
130782080|NCT00810199|470829163|FG001|Overall Study|Failure to return|4|||
130782081|NCT00810199|470829162|FG000|Overall Study|Did not receive study drug|2|||
130782082|NCT00810199|470829163|FG001|Overall Study|Did not receive study drug|1|||
131236542|NCT04471207|472494941|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
131173884|NCT01877382|472256777|FG001|Dose Escalation|Withdrawal by Subject|0|||
131173885|NCT01877382|472256778|FG002|Dose Escalation|Withdrawal by Subject|0|||
131173886|NCT01877382|472256779|FG003|Dose Escalation|Withdrawal by Subject|0|||
131173887|NCT01877382|472256780|FG004|Dose Escalation|Withdrawal by Subject|0|||
131173888|NCT01877382|472256781|FG005|Dose Escalation|Withdrawal by Subject|3|||
131173889|NCT01877382|472256782|FG006|Dose Escalation|Withdrawal by Subject|2|||
131173890|NCT01877382|472256783|FG007|Dose Escalation|Withdrawal by Subject|1|||
131173891|NCT01877382|472256784|FG008|Dose Escalation|Withdrawal by Subject|1|||
131173892|NCT01877382|472256785|FG009|Dose Escalation|Withdrawal by Subject|0|||
131173893|NCT01877382|472256786|FG010|Dose Escalation|Withdrawal by Subject|0|||
131173894|NCT01877382|472256787|FG011|Dose Escalation|Withdrawal by Subject|0|||
131173895|NCT01877382|472256788|FG012|Dose Escalation|Withdrawal by Subject|0|||
131173896|NCT01877382|472256789|FG013|Dose Escalation|Withdrawal by Subject|0|||
131173897|NCT01877382|472256790|FG014|Dose Escalation|Withdrawal by Subject|0|||
131173898|NCT01877382|472256776|FG000|Dose Escalation|Protocol Violation|0|||
131173899|NCT01877382|472256777|FG001|Dose Escalation|Protocol Violation|0|||
131173900|NCT01877382|472256778|FG002|Dose Escalation|Protocol Violation|0|||
131173901|NCT01877382|472256779|FG003|Dose Escalation|Protocol Violation|0|||
131173902|NCT01877382|472256780|FG004|Dose Escalation|Protocol Violation|0|||
131173903|NCT01877382|472256781|FG005|Dose Escalation|Protocol Violation|0|||
131173904|NCT01877382|472256782|FG006|Dose Escalation|Protocol Violation|1|||
131173905|NCT01877382|472256783|FG007|Dose Escalation|Protocol Violation|0|||
131173906|NCT01877382|472256784|FG008|Dose Escalation|Protocol Violation|0|||
131173907|NCT01877382|472256785|FG009|Dose Escalation|Protocol Violation|0|||
131173908|NCT01877382|472256786|FG010|Dose Escalation|Protocol Violation|0|||
131173909|NCT01877382|472256787|FG011|Dose Escalation|Protocol Violation|0|||
131173910|NCT01877382|472256788|FG012|Dose Escalation|Protocol Violation|0|||
131173911|NCT01877382|472256789|FG013|Dose Escalation|Protocol Violation|0|||
131173912|NCT01877382|472256790|FG014|Dose Escalation|Protocol Violation|0|||
131173913|NCT01877382|472256776|FG000|Dose Escalation|Study terminated by sponsor|0|||
130782083|NCT01091246|470829164|FG000|Overall Study|Lost to Follow-up|23|||
130782084|NCT01091246|470829165|FG001|Overall Study|Lost to Follow-up|11|||
130782085|NCT01091246|470829166|FG002|Overall Study|Lost to Follow-up|7|||
130782086|NCT01091246|470829164|FG000|Overall Study|Adverse Event|1|||
130782087|NCT01091246|470829165|FG001|Overall Study|Adverse Event|0|||
130782088|NCT01091246|470829166|FG002|Overall Study|Adverse Event|1|||
131236543|NCT04471207|472494942|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
131173914|NCT01877382|472256777|FG001|Dose Escalation|Study terminated by sponsor|0|||
131173915|NCT01877382|472256778|FG002|Dose Escalation|Study terminated by sponsor|0|||
131173916|NCT01877382|472256779|FG003|Dose Escalation|Study terminated by sponsor|0|||
131173917|NCT01877382|472256780|FG004|Dose Escalation|Study terminated by sponsor|0|||
131173918|NCT01877382|472256781|FG005|Dose Escalation|Study terminated by sponsor|0|||
131173919|NCT01877382|472256782|FG006|Dose Escalation|Study terminated by sponsor|0|||
131173920|NCT01877382|472256783|FG007|Dose Escalation|Study terminated by sponsor|1|||
131173921|NCT01877382|472256784|FG008|Dose Escalation|Study terminated by sponsor|1|||
131173922|NCT01877382|472256785|FG009|Dose Escalation|Study terminated by sponsor|0|||
131173923|NCT01877382|472256786|FG010|Dose Escalation|Study terminated by sponsor|0|||
131173924|NCT01877382|472256787|FG011|Dose Escalation|Study terminated by sponsor|0|||
130782089|NCT01091246|470829164|FG000|Overall Study|Withdrawal by Subject|9|||
131173925|NCT01877382|472256788|FG012|Dose Escalation|Study terminated by sponsor|3|||
130782090|NCT01091246|470829165|FG001|Overall Study|Withdrawal by Subject|5|||
130782091|NCT01091246|470829166|FG002|Overall Study|Withdrawal by Subject|4|||
131236544|NCT04471207|472494941|FG000|Overall Study|Scheduling Conflicts|3|||
131236545|NCT04471207|472494942|FG001|Overall Study|Scheduling Conflicts|1|||
131236546|NCT04471207|472494941|FG000|Overall Study|Physician Decision|1|||
131236547|NCT04471207|472494942|FG001|Overall Study|Physician Decision|0|||
131236548|NCT04471207|472494941|FG000|Overall Study|Unwilling to Use System|0|||
131236549|NCT04471207|472494942|FG001|Overall Study|Unwilling to Use System|1|||
131236550|NCT00561730|472494943|FG000|Overall Study|Adverse Event|2|||
131236551|NCT00561730|472494943|FG000|Overall Study|Handling of the drug|1|||
131236552|NCT00561730|472494943|FG000|Overall Study|Lost to Follow-up|5|||
131236553|NCT00561730|472494943|FG000|Overall Study|Not specified reasons|1|||
131236554|NCT01644500|472494944|FG000|Overall Study|Adverse Event|6|||
131236555|NCT01644500|472494945|FG001|Overall Study|Adverse Event|1|||
131236556|NCT01644500|472494946|FG002|Overall Study|Adverse Event|2|||
131236557|NCT01644500|472494944|FG000|Overall Study|Death|0|||
131236558|NCT01644500|472494945|FG001|Overall Study|Death|1|||
131236559|NCT01644500|472494946|FG002|Overall Study|Death|0|||
131236560|NCT01644500|472494944|FG000|Overall Study|Lost to Follow-up|3|||
131236561|NCT01644500|472494945|FG001|Overall Study|Lost to Follow-up|8|||
131236562|NCT01644500|472494946|FG002|Overall Study|Lost to Follow-up|0|||
131236563|NCT01644500|472494944|FG000|Overall Study|Protocol Violation|1|||
131236564|NCT01644500|472494945|FG001|Overall Study|Protocol Violation|1|||
131236565|NCT01644500|472494946|FG002|Overall Study|Protocol Violation|0|||
131236566|NCT01644500|472494944|FG000|Overall Study|Withdrawal by Subject|11|||
131236567|NCT01644500|472494945|FG001|Overall Study|Withdrawal by Subject|12|||
131236568|NCT01644500|472494946|FG002|Overall Study|Withdrawal by Subject|12|||
131236569|NCT01644500|472494944|FG000|Overall Study|Physician Decision|1|||
131236570|NCT01644500|472494945|FG001|Overall Study|Physician Decision|1|||
131236571|NCT01644500|472494946|FG002|Overall Study|Physician Decision|1|||
131236572|NCT03331042|472494953|FG000|Overall Study|Protocol Violation|1|||
131236573|NCT03331042|472494954|FG001|Overall Study|Protocol Violation|0|||
131236574|NCT03331042|472494955|FG002|Overall Study|Protocol Violation|0|||
131236575|NCT03331042|472494956|FG003|Overall Study|Protocol Violation|0|||
131236576|NCT03331042|472494953|FG000|Overall Study|Physician Decision|0|||
131236577|NCT03331042|472494954|FG001|Overall Study|Physician Decision|0|||
131236578|NCT03331042|472494955|FG002|Overall Study|Physician Decision|1|||
131236579|NCT03331042|472494956|FG003|Overall Study|Physician Decision|0|||
131236580|NCT03331042|472494953|FG000|Overall Study|Lost to Follow-up|0|||
131236581|NCT03331042|472494954|FG001|Overall Study|Lost to Follow-up|0|||
131236582|NCT03331042|472494955|FG002|Overall Study|Lost to Follow-up|0|||
131236583|NCT03331042|472494956|FG003|Overall Study|Lost to Follow-up|1|||
131173926|NCT01877382|472256789|FG013|Dose Escalation|Study terminated by sponsor|0|||
131173927|NCT01877382|472256790|FG014|Dose Escalation|Study terminated by sponsor|0|||
131173928|NCT01877382|472256776|FG000|Dose Escalation|Death|0|||
131173929|NCT01877382|472256777|FG001|Dose Escalation|Death|0|||
131173930|NCT01877382|472256778|FG002|Dose Escalation|Death|0|||
131173931|NCT01877382|472256779|FG003|Dose Escalation|Death|0|||
131173932|NCT01877382|472256780|FG004|Dose Escalation|Death|0|||
131173933|NCT01877382|472256781|FG005|Dose Escalation|Death|0|||
131173934|NCT01877382|472256782|FG006|Dose Escalation|Death|0|||
131173935|NCT01877382|472256783|FG007|Dose Escalation|Death|1|||
131173936|NCT01877382|472256784|FG008|Dose Escalation|Death|0|||
131173937|NCT01877382|472256785|FG009|Dose Escalation|Death|0|||
131173938|NCT01877382|472256786|FG010|Dose Escalation|Death|0|||
131173939|NCT01877382|472256787|FG011|Dose Escalation|Death|0|||
131173940|NCT01877382|472256788|FG012|Dose Escalation|Death|1|||
131173941|NCT01877382|472256789|FG013|Dose Escalation|Death|1|||
131173942|NCT01877382|472256790|FG014|Dose Escalation|Death|0|||
131173943|NCT01877382|472256776|FG000|Dose Expansion|Progressive disease|0|||
131236584|NCT00322491|472494960|FG000|Overall Study|Adverse Event|1|||
131236585|NCT00322491|472494961|FG001|Overall Study|Adverse Event|0|||
131236586|NCT00322491|472494960|FG000|Overall Study|Death|1|||
131236587|NCT00322491|472494961|FG001|Overall Study|Death|2|||
131236588|NCT01400425|472494963|FG000|Overall Study|Withdrawal by Subject|10|||
131236589|NCT00688064|472494965|FG000|Overall Study|Protocol Violation|0|||
131236590|NCT00688064|472494966|FG001|Overall Study|Protocol Violation|1|||
131236591|NCT00688064|472494965|FG000|Overall Study|Adverse Event|2|||
131173944|NCT01877382|472256777|FG001|Dose Expansion|Progressive disease|0|||
131236592|NCT00688064|472494966|FG001|Overall Study|Adverse Event|4|||
131236593|NCT00688064|472494965|FG000|Overall Study|Withdrawal by Subject|7|||
131236594|NCT00688064|472494966|FG001|Overall Study|Withdrawal by Subject|7|||
131236595|NCT00688064|472494965|FG000|Overall Study|Lost to Follow-up|10|||
131173945|NCT01877382|472256778|FG002|Dose Expansion|Progressive disease|0|||
131173946|NCT01877382|472256779|FG003|Dose Expansion|Progressive disease|0|||
131173947|NCT01877382|472256780|FG004|Dose Expansion|Progressive disease|0|||
131173948|NCT01877382|472256781|FG005|Dose Expansion|Progressive disease|0|||
131236596|NCT00688064|472494966|FG001|Overall Study|Lost to Follow-up|10|||
131236597|NCT00688064|472494965|FG000|Overall Study|Lack of Efficacy|0|||
131236598|NCT00688064|472494966|FG001|Overall Study|Lack of Efficacy|1|||
130782092|NCT01091246|470829164|FG000|Overall Study|Subject not dosed|2|||
131173949|NCT01877382|472256782|FG006|Dose Expansion|Progressive disease|0|||
131236599|NCT00688064|472494965|FG000|Overall Study|Pregnancy|1|||
131173950|NCT01877382|472256783|FG007|Dose Expansion|Progressive disease|0|||
131173951|NCT01877382|472256784|FG008|Dose Expansion|Progressive disease|0|||
131173952|NCT01877382|472256785|FG009|Dose Expansion|Progressive disease|0|||
131173953|NCT01877382|472256786|FG010|Dose Expansion|Progressive disease|0|||
131173954|NCT01877382|472256787|FG011|Dose Expansion|Progressive disease|0|||
131173955|NCT01877382|472256788|FG012|Dose Expansion|Progressive disease|0|||
131173956|NCT01877382|472256789|FG013|Dose Expansion|Progressive disease|0|||
131173957|NCT01877382|472256790|FG014|Dose Expansion|Progressive disease|11|||
131173958|NCT01877382|472256776|FG000|Dose Expansion|Clinical progression|0|||
131173959|NCT01877382|472256777|FG001|Dose Expansion|Clinical progression|0|||
131173960|NCT01877382|472256778|FG002|Dose Expansion|Clinical progression|0|||
131173961|NCT01877382|472256779|FG003|Dose Expansion|Clinical progression|0|||
131173962|NCT01877382|472256780|FG004|Dose Expansion|Clinical progression|0|||
131173963|NCT01877382|472256781|FG005|Dose Expansion|Clinical progression|0|||
131173964|NCT01877382|472256782|FG006|Dose Expansion|Clinical progression|0|||
131173965|NCT01877382|472256783|FG007|Dose Expansion|Clinical progression|0|||
131173966|NCT01877382|472256784|FG008|Dose Expansion|Clinical progression|0|||
131173967|NCT01877382|472256785|FG009|Dose Expansion|Clinical progression|0|||
131173968|NCT01877382|472256786|FG010|Dose Expansion|Clinical progression|0|||
131173969|NCT01877382|472256787|FG011|Dose Expansion|Clinical progression|0|||
131173970|NCT01877382|472256788|FG012|Dose Expansion|Clinical progression|0|||
131173971|NCT01877382|472256789|FG013|Dose Expansion|Clinical progression|0|||
131173972|NCT01877382|472256790|FG014|Dose Expansion|Clinical progression|6|||
131173973|NCT01877382|472256776|FG000|Dose Expansion|Adverse Event|0|||
131173974|NCT01877382|472256777|FG001|Dose Expansion|Adverse Event|0|||
131173975|NCT01877382|472256778|FG002|Dose Expansion|Adverse Event|0|||
131173976|NCT01877382|472256779|FG003|Dose Expansion|Adverse Event|0|||
131173977|NCT01877382|472256780|FG004|Dose Expansion|Adverse Event|0|||
131173978|NCT01877382|472256781|FG005|Dose Expansion|Adverse Event|0|||
131173979|NCT01877382|472256782|FG006|Dose Expansion|Adverse Event|0|||
131173980|NCT01877382|472256783|FG007|Dose Expansion|Adverse Event|0|||
131173981|NCT01877382|472256784|FG008|Dose Expansion|Adverse Event|0|||
131173982|NCT01877382|472256785|FG009|Dose Expansion|Adverse Event|0|||
131173983|NCT01877382|472256786|FG010|Dose Expansion|Adverse Event|0|||
131173984|NCT01877382|472256787|FG011|Dose Expansion|Adverse Event|0|||
131173985|NCT01877382|472256788|FG012|Dose Expansion|Adverse Event|0|||
131173986|NCT01877382|472256789|FG013|Dose Expansion|Adverse Event|0|||
131173987|NCT01877382|472256790|FG014|Dose Expansion|Adverse Event|1|||
131173988|NCT01877382|472256776|FG000|Dose Expansion|Death|0|||
131173989|NCT01877382|472256777|FG001|Dose Expansion|Death|0|||
131173990|NCT01877382|472256778|FG002|Dose Expansion|Death|0|||
131173991|NCT01877382|472256779|FG003|Dose Expansion|Death|0|||
131173992|NCT01877382|472256780|FG004|Dose Expansion|Death|0|||
131173993|NCT01877382|472256781|FG005|Dose Expansion|Death|0|||
131173994|NCT01877382|472256782|FG006|Dose Expansion|Death|0|||
131173995|NCT01877382|472256783|FG007|Dose Expansion|Death|0|||
131173996|NCT01877382|472256784|FG008|Dose Expansion|Death|0|||
131173997|NCT01877382|472256785|FG009|Dose Expansion|Death|0|||
131173998|NCT01877382|472256786|FG010|Dose Expansion|Death|0|||
131173999|NCT01877382|472256787|FG011|Dose Expansion|Death|0|||
131174000|NCT01877382|472256788|FG012|Dose Expansion|Death|0|||
131174001|NCT01877382|472256789|FG013|Dose Expansion|Death|0|||
131174002|NCT01877382|472256790|FG014|Dose Expansion|Death|1|||
131174003|NCT01877382|472256776|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174004|NCT01877382|472256777|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174005|NCT01877382|472256778|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174006|NCT01877382|472256779|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174007|NCT01877382|472256780|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174008|NCT01877382|472256781|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174009|NCT01877382|472256782|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174010|NCT01877382|472256783|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174011|NCT01877382|472256784|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174012|NCT01877382|472256785|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174013|NCT01877382|472256786|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174014|NCT01877382|472256787|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174015|NCT01877382|472256788|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174016|NCT01877382|472256789|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
131174017|NCT01877382|472256790|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
131174018|NCT02020031|472258422|FG000|Overall Study|Physician Decision|1|||
131174019|NCT02020031|472258423|FG001|Overall Study|Physician Decision|1|||
131174020|NCT02338492|472258428|FG000|Overall Study|Death|32|||
131174021|NCT02338492|472258428|FG000|Overall Study|Adverse Event|3|||
131174022|NCT02338492|472258428|FG000|Overall Study|Lost to Follow-up|4|||
131174023|NCT02338492|472258428|FG000|Overall Study|Reason not captured above|6|||
131174024|NCT01944969|472258429|FG000|Overall Study|Adverse Event|1|||
131174025|NCT01944969|472258429|FG000|Overall Study|Lack of Efficacy|1|||
131174026|NCT01944969|472258429|FG000|Overall Study|Non-compliance with IMP|1|||
131174027|NCT01944969|472258429|FG000|Overall Study|Administrative or other reasons|23|||
131174028|NCT03421964|472258441|FG000|Overall Study|Lost to Follow-up|11|||
131174029|NCT03421964|472258442|FG001|Overall Study|Lost to Follow-up|21|||
131174030|NCT03421964|472258441|FG000|Overall Study|Withdrawal by Subject|9|||
131174031|NCT03421964|472258442|FG001|Overall Study|Withdrawal by Subject|3|||
131174032|NCT03421964|472258441|FG000|Overall Study|Incarcerated|1|||
131174033|NCT03421964|472258442|FG001|Overall Study|Incarcerated|0|||
131174034|NCT03421964|472258441|FG000|Overall Study|Inpt Treatment Facility|1|||
131174035|NCT03421964|472258442|FG001|Overall Study|Inpt Treatment Facility|1|||
131174036|NCT03421964|472258441|FG000|Overall Study|Virtual Platform Issues|1|||
131174037|NCT03421964|472258442|FG001|Overall Study|Virtual Platform Issues|1|||
131174038|NCT02938585|472258443|FG000|Overall Study|Withdrawal by parent or guardian|0|||
131174039|NCT02938585|472258444|FG001|Overall Study|Withdrawal by parent or guardian|1|||
131174040|NCT02938585|472258445|FG002|Overall Study|Withdrawal by parent or guardian|0|||
131174041|NCT02938585|472258446|FG003|Overall Study|Withdrawal by parent or guardian|0|||
131174042|NCT02938585|472258443|FG000|Overall Study|Withdrawal by Subject|0|||
131174043|NCT02938585|472258444|FG001|Overall Study|Withdrawal by Subject|0|||
131174044|NCT02938585|472258445|FG002|Overall Study|Withdrawal by Subject|0|||
131174045|NCT02938585|472258446|FG003|Overall Study|Withdrawal by Subject|5|||
131174046|NCT00229203|472258447|FG000|Overall Study|Progressive disease|18|||
131174047|NCT00229203|472258448|FG001|Overall Study|Progressive disease|9|||
131174048|NCT00229203|472258447|FG000|Overall Study|Toxicity|6|||
131174049|NCT00229203|472258448|FG001|Overall Study|Toxicity|1|||
131174050|NCT00229203|472258447|FG000|Overall Study|Death|4|||
131174051|NCT00229203|472258448|FG001|Overall Study|Death|2|||
131174052|NCT00229203|472258447|FG000|Overall Study|Other|3|||
131174053|NCT00229203|472258448|FG001|Overall Study|Other|3|||
131174054|NCT00229203|472258447|FG000|Overall Study|Withdrawal by Subject|1|||
131174055|NCT00229203|472258448|FG001|Overall Study|Withdrawal by Subject|4|||
131174056|NCT00213980|472258449|FG000|Overall Study|Withdrawal by Subject|3|||
131174057|NCT00213980|472258450|FG001|Overall Study|Withdrawal by Subject|1|||
131174058|NCT00213980|472258449|FG000|Overall Study|Adverse Event|1|||
131174059|NCT00213980|472258450|FG001|Overall Study|Adverse Event|1|||
131174060|NCT00213980|472258449|FG000|Overall Study|Disease progression|0|||
131174061|NCT00213980|472258450|FG001|Overall Study|Disease progression|2|||
131174062|NCT00213980|472258449|FG000|Overall Study|Developed ovarian cancer|1|||
131174063|NCT00213980|472258450|FG001|Overall Study|Developed ovarian cancer|0|||
131174064|NCT00213980|472258449|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
131174065|NCT00213980|472258450|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
131174066|NCT03607838|472258451|FG000|Overall Study|Lack of Efficacy|14|||
131174067|NCT03607838|472258452|FG001|Overall Study|Lack of Efficacy|20|||
131174068|NCT03607838|472258451|FG000|Overall Study|Withdrawal by Subject|13|||
131174069|NCT03607838|472258452|FG001|Overall Study|Withdrawal by Subject|8|||
131174070|NCT03607838|472258451|FG000|Overall Study|Lost to Follow-up|6|||
131174071|NCT03607838|472258452|FG001|Overall Study|Lost to Follow-up|11|||
131174072|NCT03607838|472258451|FG000|Overall Study|Adverse Event|2|||
131174073|NCT03607838|472258452|FG001|Overall Study|Adverse Event|2|||
131174074|NCT03607838|472258451|FG000|Overall Study|Physician Decision|2|||
131174075|NCT03607838|472258452|FG001|Overall Study|Physician Decision|0|||
131174076|NCT03607838|472258451|FG000|Overall Study|Failure to meet randomization criteria|1|||
131174077|NCT03607838|472258452|FG001|Overall Study|Failure to meet randomization criteria|2|||
131174078|NCT03607838|472258451|FG000|Overall Study|Pregnancy|1|||
131174079|NCT03607838|472258452|FG001|Overall Study|Pregnancy|0|||
131174080|NCT03607838|472258451|FG000|Overall Study|Protocol Violation|1|||
131174081|NCT03607838|472258452|FG001|Overall Study|Protocol Violation|0|||
131174082|NCT03607838|472258451|FG000|Overall Study|Due to work|1|||
131174083|NCT03607838|472258452|FG001|Overall Study|Due to work|0|||
131174084|NCT03607838|472258451|FG000|Overall Study|Litigation|0|||
131174085|NCT03607838|472258452|FG001|Overall Study|Litigation|1|||
131174086|NCT03607838|472258451|FG000|Overall Study|Temperature excursion for study drug|0|||
131174087|NCT03607838|472258452|FG001|Overall Study|Temperature excursion for study drug|1|||
131174088|NCT03607838|472258451|FG000|Overall Study|Change of mind|0|||
131174089|NCT03607838|472258452|FG001|Overall Study|Change of mind|1|||
131174090|NCT02411201|472258453|FG000|Overall Study|Adverse Event|2|||
131174091|NCT02411201|472258453|FG000|Overall Study|Withdrawal by Subject|2|||
131174092|NCT02411201|472258453|FG000|Overall Study|Age group completed|2|||
131174093|NCT01260467|472258454|FG000|Overall Study|Withdrawal by Subject|2|||
131174094|NCT03364608|472258463|FG000|Overall Study|Withdrawal by Subject|4|||
131174095|NCT03364608|472258463|FG000|Overall Study|Protocol Violation|2|||
131174096|NCT03364608|472258463|FG000|Overall Study|Lost to Follow-up|2|||
131174097|NCT03888391|472258466|FG000|Overall Study|Lost to Follow-up|15|||
131174098|NCT00423735|472258467|FG000|Overall Study|Ineligible / No protocol treatment|8|||
131174099|NCT00423735|472258468|FG001|Overall Study|Ineligible / No protocol treatment|6|||
131174100|NCT00423735|472258469|FG002|Overall Study|Ineligible / No protocol treatment|0|||
131174101|NCT00579501|472258476|FG000|Overall Study|Death|1|||
131174102|NCT00579501|472258476|FG000|Overall Study|End of neoadjuvant therapy|25|||
131174103|NCT00579501|472258476|FG000|Overall Study|toxicity|1|||
131174104|NCT00579501|472258476|FG000|Overall Study|Secondary lesion|1|||
131174105|NCT00579501|472258476|FG000|Overall Study|Radiation therapy before surgery|1|||
131174106|NCT02504268|472258478|FG000|Overall Study|Adverse Event|18|||
131174107|NCT02504268|472258479|FG001|Overall Study|Adverse Event|8|||
131174108|NCT02504268|472258480|FG002|Overall Study|Adverse Event|14|||
131174109|NCT02504268|472258481|FG003|Overall Study|Adverse Event|0|||
131174110|NCT02504268|472258482|FG004|Overall Study|Adverse Event|0|||
131174111|NCT02504268|472258483|FG005|Overall Study|Adverse Event|0|||
131174112|NCT02504268|472258484|FG006|Overall Study|Adverse Event|0|||
131174113|NCT02504268|472258485|FG007|Overall Study|Adverse Event|0|||
131174114|NCT02504268|472258486|FG008|Overall Study|Adverse Event|0|||
131174115|NCT02504268|472258478|FG000|Overall Study|Withdrawal of Consent|11|||
131174116|NCT02504268|472258479|FG001|Overall Study|Withdrawal of Consent|10|||
131174117|NCT02504268|472258480|FG002|Overall Study|Withdrawal of Consent|3|||
131174118|NCT02504268|472258481|FG003|Overall Study|Withdrawal of Consent|0|||
131174119|NCT02504268|472258482|FG004|Overall Study|Withdrawal of Consent|0|||
131174120|NCT02504268|472258483|FG005|Overall Study|Withdrawal of Consent|0|||
131174121|NCT02504268|472258484|FG006|Overall Study|Withdrawal of Consent|0|||
131174122|NCT02504268|472258485|FG007|Overall Study|Withdrawal of Consent|0|||
131174123|NCT02504268|472258486|FG008|Overall Study|Withdrawal of Consent|0|||
131174124|NCT02504268|472258478|FG000|Overall Study|Pregnancy|2|||
131174125|NCT02504268|472258479|FG001|Overall Study|Pregnancy|0|||
131174126|NCT02504268|472258480|FG002|Overall Study|Pregnancy|0|||
131174127|NCT02504268|472258481|FG003|Overall Study|Pregnancy|0|||
131174128|NCT02504268|472258482|FG004|Overall Study|Pregnancy|0|||
131174129|NCT02504268|472258483|FG005|Overall Study|Pregnancy|0|||
131174130|NCT02504268|472258484|FG006|Overall Study|Pregnancy|0|||
131174131|NCT02504268|472258485|FG007|Overall Study|Pregnancy|0|||
131174132|NCT02504268|472258486|FG008|Overall Study|Pregnancy|0|||
131174133|NCT02504268|472258478|FG000|Overall Study|Lost to Follow-up|3|||
131174134|NCT02504268|472258479|FG001|Overall Study|Lost to Follow-up|6|||
131174135|NCT02504268|472258480|FG002|Overall Study|Lost to Follow-up|4|||
131174136|NCT02504268|472258481|FG003|Overall Study|Lost to Follow-up|0|||
131174137|NCT02504268|472258482|FG004|Overall Study|Lost to Follow-up|0|||
131174138|NCT02504268|472258483|FG005|Overall Study|Lost to Follow-up|0|||
131174139|NCT02504268|472258484|FG006|Overall Study|Lost to Follow-up|0|||
131174140|NCT02504268|472258485|FG007|Overall Study|Lost to Follow-up|0|||
131174141|NCT02504268|472258486|FG008|Overall Study|Lost to Follow-up|0|||
131174142|NCT02504268|472258478|FG000|Overall Study|Death|1|||
131174143|NCT02504268|472258479|FG001|Overall Study|Death|1|||
131174144|NCT02504268|472258480|FG002|Overall Study|Death|0|||
131174145|NCT02504268|472258481|FG003|Overall Study|Death|0|||
131174146|NCT02504268|472258482|FG004|Overall Study|Death|0|||
131174147|NCT02504268|472258483|FG005|Overall Study|Death|0|||
131174148|NCT02504268|472258484|FG006|Overall Study|Death|0|||
131174149|NCT02504268|472258485|FG007|Overall Study|Death|0|||
131174150|NCT02504268|472258486|FG008|Overall Study|Death|0|||
131174151|NCT02504268|472258478|FG000|Overall Study|Subject Request to Discontinue|11|||
131174152|NCT02504268|472258479|FG001|Overall Study|Subject Request to Discontinue|3|||
131174153|NCT02504268|472258480|FG002|Overall Study|Subject Request to Discontinue|6|||
131174154|NCT02504268|472258481|FG003|Overall Study|Subject Request to Discontinue|0|||
131174155|NCT02504268|472258482|FG004|Overall Study|Subject Request to Discontinue|0|||
131174156|NCT02504268|472258483|FG005|Overall Study|Subject Request to Discontinue|0|||
131174157|NCT02504268|472258484|FG006|Overall Study|Subject Request to Discontinue|0|||
131174158|NCT02504268|472258485|FG007|Overall Study|Subject Request to Discontinue|0|||
131174159|NCT02504268|472258486|FG008|Overall Study|Subject Request to Discontinue|0|||
131174160|NCT02504268|472258478|FG000|Overall Study|No Longer Meets Study Criteria|2|||
131174161|NCT02504268|472258479|FG001|Overall Study|No Longer Meets Study Criteria|3|||
131174162|NCT02504268|472258480|FG002|Overall Study|No Longer Meets Study Criteria|0|||
131174163|NCT02504268|472258481|FG003|Overall Study|No Longer Meets Study Criteria|0|||
131174164|NCT02504268|472258482|FG004|Overall Study|No Longer Meets Study Criteria|0|||
131174165|NCT02504268|472258483|FG005|Overall Study|No Longer Meets Study Criteria|0|||
131174166|NCT02504268|472258484|FG006|Overall Study|No Longer Meets Study Criteria|0|||
131174167|NCT02504268|472258485|FG007|Overall Study|No Longer Meets Study Criteria|0|||
131174168|NCT02504268|472258486|FG008|Overall Study|No Longer Meets Study Criteria|0|||
131174169|NCT02504268|472258478|FG000|Overall Study|Lack of Efficacy|11|||
131174170|NCT02504268|472258479|FG001|Overall Study|Lack of Efficacy|35|||
131174171|NCT02504268|472258480|FG002|Overall Study|Lack of Efficacy|9|||
131174172|NCT02504268|472258481|FG003|Overall Study|Lack of Efficacy|0|||
131174173|NCT02504268|472258482|FG004|Overall Study|Lack of Efficacy|0|||
131174174|NCT02504268|472258483|FG005|Overall Study|Lack of Efficacy|0|||
131174175|NCT02504268|472258484|FG006|Overall Study|Lack of Efficacy|0|||
131174176|NCT02504268|472258485|FG007|Overall Study|Lack of Efficacy|0|||
131174177|NCT02504268|472258486|FG008|Overall Study|Lack of Efficacy|0|||
131174178|NCT02504268|472258478|FG000|Overall Study|Poor/Non-Compliance|3|||
131174179|NCT02504268|472258479|FG001|Overall Study|Poor/Non-Compliance|2|||
130782093|NCT01091246|470829165|FG001|Overall Study|Subject not dosed|0|||
130782094|NCT01091246|470829166|FG002|Overall Study|Subject not dosed|1|||
131174180|NCT02504268|472258480|FG002|Overall Study|Poor/Non-Compliance|3|||
131174181|NCT02504268|472258481|FG003|Overall Study|Poor/Non-Compliance|0|||
131174182|NCT02504268|472258482|FG004|Overall Study|Poor/Non-Compliance|0|||
131174183|NCT02504268|472258483|FG005|Overall Study|Poor/Non-Compliance|0|||
131174184|NCT02504268|472258484|FG006|Overall Study|Poor/Non-Compliance|0|||
131174185|NCT02504268|472258485|FG007|Overall Study|Poor/Non-Compliance|0|||
131174186|NCT02504268|472258486|FG008|Overall Study|Poor/Non-Compliance|0|||
131174187|NCT02504268|472258478|FG000|Overall Study|Not Disclosed|1|||
131174188|NCT02504268|472258479|FG001|Overall Study|Not Disclosed|0|||
131174189|NCT02504268|472258480|FG002|Overall Study|Not Disclosed|2|||
131174190|NCT02504268|472258481|FG003|Overall Study|Not Disclosed|0|||
131174191|NCT02504268|472258482|FG004|Overall Study|Not Disclosed|0|||
131174192|NCT02504268|472258483|FG005|Overall Study|Not Disclosed|0|||
131174193|NCT02504268|472258484|FG006|Overall Study|Not Disclosed|0|||
131174194|NCT02504268|472258485|FG007|Overall Study|Not Disclosed|0|||
131174195|NCT02504268|472258486|FG008|Overall Study|Not Disclosed|0|||
131174196|NCT03025217|472258487|FG000|Overall Study|Pregnancy|1|||
131174197|NCT03025217|472258487|FG000|Overall Study|Lost to Follow-up|1|||
131174198|NCT03025217|472258487|FG000|Overall Study|Not eligible, poor English|2|||
131174199|NCT04069156|472258488|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
131174200|NCT04069156|472258489|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
131174201|NCT04069156|472258488|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
131174202|NCT04069156|472258489|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
131174203|NCT04069156|472258488|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
131174204|NCT04069156|472258489|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
131174205|NCT04069156|472258488|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
131174206|NCT04069156|472258489|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
131174207|NCT00209170|472258492|FG000|Overall Study|Adverse Event|0|||
131174208|NCT00209170|472258493|FG001|Overall Study|Adverse Event|1|||
131174209|NCT00209170|472258492|FG000|Overall Study|Withdrawal by Subject|2|||
131174210|NCT00209170|472258493|FG001|Overall Study|Withdrawal by Subject|1|||
131174211|NCT00209170|472258492|FG000|Overall Study|Lack of Efficacy|0|||
131174212|NCT00209170|472258493|FG001|Overall Study|Lack of Efficacy|1|||
131174213|NCT03150095|472258494|FG000|Overall Study|Death|0|||
131174214|NCT03150095|472258495|FG001|Overall Study|Death|1|||
131174215|NCT03150095|472258494|FG000|Overall Study|Lost to Follow-up|1|||
131174216|NCT03150095|472258495|FG001|Overall Study|Lost to Follow-up|1|||
131174217|NCT03150095|472258494|FG000|Overall Study|Withdrawal by Subject|4|||
131174218|NCT03150095|472258495|FG001|Overall Study|Withdrawal by Subject|0|||
131174219|NCT03150095|472258494|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
131174220|NCT03150095|472258495|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
131174221|NCT02124707|472258496|FG000|Overall Study|Adverse Event|5|||
131174222|NCT02124707|472258496|FG000|Overall Study|Physician Decision|1|||
131174223|NCT02124707|472258496|FG000|Overall Study|Death|1|||
131174224|NCT01088438|472258509|FG000|Overall Study|Withdrawal by Subject|11|||
131174225|NCT01088438|472258510|FG001|Overall Study|Withdrawal by Subject|6|||
131174226|NCT01088438|472258509|FG000|Overall Study|Lost to Follow-up|18|||
131174227|NCT01088438|472258510|FG001|Overall Study|Lost to Follow-up|30|||
131174228|NCT00089479|472258511|FG000|Overall Study|Death|108|||
131174229|NCT00089479|472258512|FG001|Overall Study|Death|75|||
131174230|NCT00089479|472258511|FG000|Overall Study|Withdrawal by Subject|86|||
131174231|NCT00089479|472258512|FG001|Overall Study|Withdrawal by Subject|107|||
131174232|NCT00089479|472258511|FG000|Overall Study|Lost to Follow-up|137|||
130782095|NCT05502302|470829169|FG000|Overall Study|Lost to Follow-up|6|||
130782096|NCT05502302|470829169|FG000|Overall Study|Death|2|||
130782097|NCT01628848|470829173|FG000|Overall Study|Adverse Event|9|||
130782098|NCT01628848|470829174|FG001|Overall Study|Adverse Event|7|||
130782099|NCT01628848|470829173|FG000|Overall Study|Lack of Efficacy|0|||
130782100|NCT01628848|470829174|FG001|Overall Study|Lack of Efficacy|4|||
130782101|NCT01628848|470829173|FG000|Overall Study|Withdrawal by Subject|0|||
130782102|NCT01628848|470829174|FG001|Overall Study|Withdrawal by Subject|2|||
130782103|NCT01628848|470829173|FG000|Overall Study|Physician Decision|3|||
131174233|NCT00089479|472258512|FG001|Overall Study|Lost to Follow-up|107|||
131174234|NCT00511342|472258515|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
131174235|NCT00511342|472258516|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
131174236|NCT00511342|472258515|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
131174237|NCT00511342|472258516|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
130782104|NCT01628848|470829174|FG001|Overall Study|Physician Decision|1|||
130782105|NCT00003471|470829175|FG000|Overall Study|Not evaluable|4|||
130782106|NCT02104895|470829176|FG000|Overall Study|Withdrawal by Subject|0|||
131174238|NCT00511342|472258515|FG000|Overall Study|Pregnancy|0|||
131174239|NCT00511342|472258516|FG001|Overall Study|Pregnancy|1|||
131174240|NCT00511342|472258515|FG000|Overall Study|Pregnancy wish|0|||
131174241|NCT00511342|472258516|FG001|Overall Study|Pregnancy wish|1|||
131174242|NCT00511342|472258515|FG000|Overall Study|Lost to Follow-up|1|||
131174243|NCT00511342|472258516|FG001|Overall Study|Lost to Follow-up|5|||
131174244|NCT00511342|472258515|FG000|Overall Study|Other Reason|2|||
131174245|NCT00511342|472258516|FG001|Overall Study|Other Reason|2|||
131174246|NCT01124448|472258517|FG000|Overall Study|Lost to Follow-up|0|||
131174247|NCT01124448|472258518|FG001|Overall Study|Lost to Follow-up|3|||
131174248|NCT01124448|472258517|FG000|Overall Study|Protocol Violation|2|||
131174249|NCT01124448|472258518|FG001|Overall Study|Protocol Violation|0|||
131174250|NCT03198754|472258520|FG000|Overall Study|Withdrawal by Subject|5|||
131174251|NCT03198754|472258521|FG001|Overall Study|Withdrawal by Subject|4|||
131174252|NCT03198754|472258520|FG000|Overall Study|Lost to Follow-up|4|||
131174253|NCT03198754|472258521|FG001|Overall Study|Lost to Follow-up|3|||
131174254|NCT03198754|472258520|FG000|Overall Study|Ineligible|2|||
131174255|NCT03198754|472258521|FG001|Overall Study|Ineligible|1|||
131174256|NCT00718666|472258524|FG000|Booster Phase Year 5|No active participation request|0|||
131174257|NCT00718666|472258525|FG001|Booster Phase Year 5|No active participation request|0|||
131174258|NCT00718666|472258526|FG002|Booster Phase Year 5|No active participation request|1|||
131174259|NCT00718666|472258524|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
131174260|NCT00718666|472258525|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
131174261|NCT00718666|472258526|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
131174262|NCT00718666|472258524|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
131174263|NCT00718666|472258525|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
131174264|NCT00718666|472258526|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
131174265|NCT00718666|472258524|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
131174266|NCT00718666|472258525|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
131174267|NCT00718666|472258526|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
131174268|NCT00421343|472258532|FG000|Overall Study|Death|1|||
131174269|NCT00421343|472258532|FG000|Overall Study|Withdrawal by Subject|2|||
131174270|NCT00421343|472258532|FG000|Overall Study|Lost to Follow-up|3|||
131174271|NCT03471767|472258535|FG000|Overall Study|Withdrawal by Subject|3|||
131174272|NCT03471767|472258536|FG001|Overall Study|Withdrawal by Subject|1|||
131174273|NCT03471767|472258535|FG000|Overall Study|Adverse Event|1|||
131174274|NCT03471767|472258536|FG001|Overall Study|Adverse Event|0|||
131174275|NCT03471767|472258535|FG000|Overall Study|Lost to Follow-up|1|||
131174276|NCT03471767|472258536|FG001|Overall Study|Lost to Follow-up|0|||
131174277|NCT03471767|472258535|FG000|Overall Study|PI Withdrawal|1|||
131174278|NCT03471767|472258536|FG001|Overall Study|PI Withdrawal|3|||
131174279|NCT00678587|472258537|FG000|Overall Study|Adverse Event|3|||
131174280|NCT00678587|472258538|FG001|Overall Study|Adverse Event|3|||
131174281|NCT00678587|472258537|FG000|Overall Study|Lack of Efficacy|1|||
131174282|NCT00678587|472258538|FG001|Overall Study|Lack of Efficacy|0|||
131174283|NCT00678587|472258537|FG000|Overall Study|Protocol Violation|2|||
131174284|NCT00678587|472258538|FG001|Overall Study|Protocol Violation|1|||
131174285|NCT00678587|472258537|FG000|Overall Study|Study Closed/Terminated|1|||
131174286|NCT00678587|472258538|FG001|Overall Study|Study Closed/Terminated|0|||
131174287|NCT00678587|472258537|FG000|Overall Study|Lost to Follow-up|3|||
131174288|NCT00678587|472258538|FG001|Overall Study|Lost to Follow-up|5|||
131174289|NCT00678587|472258537|FG000|Overall Study|Investigator Discretion|2|||
131174290|NCT00678587|472258538|FG001|Overall Study|Investigator Discretion|6|||
131174291|NCT00678587|472258537|FG000|Overall Study|Withdrew Consent|8|||
131174292|NCT00678587|472258538|FG001|Overall Study|Withdrew Consent|3|||
131174293|NCT01952730|472258539|FG000|Overall Study|FDA shut down core lab used by study|1|||
131174294|NCT01479374|472258544|FG000|Overall Study|Adverse Event|2|||
131174295|NCT01479374|472258545|FG001|Overall Study|Adverse Event|1|||
131174296|NCT01479374|472258546|FG002|Overall Study|Adverse Event|0|||
131174297|NCT01479374|472258544|FG000|Overall Study|Lost to Follow-up|1|||
131174298|NCT01479374|472258545|FG001|Overall Study|Lost to Follow-up|2|||
131174299|NCT01479374|472258546|FG002|Overall Study|Lost to Follow-up|0|||
131174300|NCT01479374|472258544|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
131174301|NCT01479374|472258545|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
131174302|NCT01479374|472258546|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
131174303|NCT01479374|472258544|FG000|Overall Study|Other|0|||
131174304|NCT01479374|472258545|FG001|Overall Study|Other|4|||
131174305|NCT01479374|472258546|FG002|Overall Study|Other|5|||
131174306|NCT01606761|472258547|FG000|Prior to Week 24|Lost to Follow-up|0|||
131174307|NCT01606761|472258548|FG001|Prior to Week 24|Lost to Follow-up|3|||
131174308|NCT01606761|472258549|FG002|Prior to Week 24|Lost to Follow-up|2|||
131174309|NCT01606761|472258550|FG003|Prior to Week 24|Lost to Follow-up|0|||
131174310|NCT01606761|472258551|FG004|Prior to Week 24|Lost to Follow-up|0|||
131174311|NCT01606761|472258547|FG000|Prior to Week 24|Withdrawal by Subject|12|||
131174312|NCT01606761|472258548|FG001|Prior to Week 24|Withdrawal by Subject|10|||
131174313|NCT01606761|472258549|FG002|Prior to Week 24|Withdrawal by Subject|9|||
131174314|NCT01606761|472258550|FG003|Prior to Week 24|Withdrawal by Subject|0|||
131174315|NCT01606761|472258551|FG004|Prior to Week 24|Withdrawal by Subject|0|||
131174316|NCT01606761|472258547|FG000|Prior to Week 24|Adverse Event|11|||
131174317|NCT01606761|472258548|FG001|Prior to Week 24|Adverse Event|18|||
131174318|NCT01606761|472258549|FG002|Prior to Week 24|Adverse Event|22|||
131174319|NCT01606761|472258550|FG003|Prior to Week 24|Adverse Event|0|||
131174320|NCT01606761|472258551|FG004|Prior to Week 24|Adverse Event|0|||
131174321|NCT01606761|472258547|FG000|Prior to Week 24|Lack of Efficacy|15|||
130782107|NCT02104895|470829177|FG001|Overall Study|Withdrawal by Subject|14|||
130782108|NCT02668640|470829178|FG000|Overall Study|Lost to Follow-up|13|||
130782109|NCT02668640|470829178|FG000|Overall Study|Other, not specified|1|||
130782110|NCT01107925|470829180|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
130782111|NCT01107925|470829181|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130782112|NCT01107925|470829182|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130782113|NCT01107925|470829183|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130782114|NCT01107925|470829184|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
130782115|NCT01107925|470829185|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130782116|NCT01107925|470829180|FG000|Period 2|Withdrawal by Subject|0|||
130782117|NCT01107925|470829181|FG001|Period 2|Withdrawal by Subject|1|||
130782118|NCT01107925|470829182|FG002|Period 2|Withdrawal by Subject|0|||
130782119|NCT01107925|470829183|FG003|Period 2|Withdrawal by Subject|0|||
130782120|NCT01107925|470829184|FG004|Period 2|Withdrawal by Subject|0|||
130782121|NCT01107925|470829185|FG005|Period 2|Withdrawal by Subject|1|||
130782122|NCT03311945|470829186|FG000|Overall Study|Adverse Event|2|||
130782123|NCT03311945|470829186|FG000|Overall Study|Lack of Efficacy|1|||
130782124|NCT04877990|470829187|FG000|Treatment|Other reasons|3|||
130782125|NCT04877990|470829188|FG001|Treatment|Other reasons|1|||
130782126|NCT04877990|470829187|FG000|Treatment|Administrative reasons by sponsor|17|||
130782127|NCT04877990|470829188|FG001|Treatment|Administrative reasons by sponsor|33|||
130782128|NCT04877990|470829187|FG000|Treatment|Withdrawal by Subject|2|||
130782129|NCT04877990|470829188|FG001|Treatment|Withdrawal by Subject|6|||
130782130|NCT04877990|470829187|FG000|Treatment|Adverse Event|2|||
130782131|NCT04877990|470829188|FG001|Treatment|Adverse Event|1|||
130782132|NCT01619878|470829189|FG000|6 Week Follow-up Phase|Adverse Event|1|||
130782133|NCT01619878|470829189|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
130782134|NCT01619878|470829189|FG000|Follow-up at 12 Months of Age|Death|2|||
130782135|NCT00960804|470829190|FG000|Overall Study|Adverse Event|1|||
130782136|NCT00960804|470829191|FG001|Overall Study|Adverse Event|0|||
130782137|NCT00960804|470829192|FG002|Overall Study|Adverse Event|0|||
130782138|NCT00960804|470829190|FG000|Overall Study|Withdrawal by Subject|1|||
130782139|NCT00960804|470829191|FG001|Overall Study|Withdrawal by Subject|0|||
130782140|NCT00960804|470829192|FG002|Overall Study|Withdrawal by Subject|0|||
130782141|NCT00960804|470829190|FG000|Overall Study|Study terminated by the sponsor|5|||
130782142|NCT00960804|470829191|FG001|Overall Study|Study terminated by the sponsor|4|||
130782143|NCT00960804|470829192|FG002|Overall Study|Study terminated by the sponsor|10|||
130782144|NCT03810456|470829193|FG000|Treatment|Urgent Family Matters|3|||
130782145|NCT03810456|470829194|FG001|Treatment|Urgent Family Matters|0|||
130782146|NCT03810456|470829195|FG002|Treatment|Urgent Family Matters|0|||
130782147|NCT03810456|470829193|FG000|Treatment|Scheduling Conflicts|0|||
130782148|NCT03810456|470829194|FG001|Treatment|Scheduling Conflicts|11|||
130782149|NCT03810456|470829195|FG002|Treatment|Scheduling Conflicts|0|||
130782150|NCT03810456|470829193|FG000|Treatment|No Longer Interested|0|||
130782151|NCT03810456|470829194|FG001|Treatment|No Longer Interested|12|||
130782152|NCT03810456|470829195|FG002|Treatment|No Longer Interested|0|||
130782153|NCT03810456|470829193|FG000|Treatment|Transportation Issues|0|||
130782154|NCT03810456|470829194|FG001|Treatment|Transportation Issues|1|||
130782155|NCT03810456|470829195|FG002|Treatment|Transportation Issues|0|||
130782156|NCT03810456|470829193|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
130782157|NCT03810456|470829194|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
130782158|NCT03810456|470829195|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
130782159|NCT03810456|470829193|FG000|1 Month Follow-Up|Relocated to Different State|1|||
130782160|NCT03810456|470829194|FG001|1 Month Follow-Up|Relocated to Different State|0|||
130782161|NCT03810456|470829195|FG002|1 Month Follow-Up|Relocated to Different State|1|||
130782162|NCT03810456|470829193|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
130782163|NCT03810456|470829194|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
130782164|NCT03810456|470829195|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
130782165|NCT03810456|470829193|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
130782166|NCT03810456|470829194|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
130782167|NCT03810456|470829195|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
130782168|NCT03810456|470829193|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
130782169|NCT03810456|470829194|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
130782170|NCT03810456|470829195|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
131174322|NCT01606761|472258548|FG001|Prior to Week 24|Lack of Efficacy|14|||
131174323|NCT01606761|472258549|FG002|Prior to Week 24|Lack of Efficacy|8|||
131174324|NCT01606761|472258550|FG003|Prior to Week 24|Lack of Efficacy|0|||
130782171|NCT03810456|470829193|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
130782172|NCT03810456|470829194|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
130782173|NCT03810456|470829195|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
130782174|NCT03810456|470829193|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
130782175|NCT03810456|470829194|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
130782176|NCT03810456|470829195|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
130782177|NCT00490919|470829196|FG000|Open-label Run-in Period|Adverse Event|239|||
130782178|NCT00490919|470829197|FG001|Open-label Run-in Period|Adverse Event|0|||
131174325|NCT01606761|472258551|FG004|Prior to Week 24|Lack of Efficacy|0|||
131236600|NCT00688064|472494966|FG001|Overall Study|Pregnancy|0|||
131174326|NCT01606761|472258547|FG000|Prior to Week 24|Physician Decision|0|||
131174327|NCT01606761|472258548|FG001|Prior to Week 24|Physician Decision|3|||
131174328|NCT01606761|472258549|FG002|Prior to Week 24|Physician Decision|1|||
131174329|NCT01606761|472258550|FG003|Prior to Week 24|Physician Decision|0|||
131174330|NCT01606761|472258551|FG004|Prior to Week 24|Physician Decision|0|||
131174331|NCT01606761|472258547|FG000|Prior to Week 24|Other|4|||
131174332|NCT01606761|472258548|FG001|Prior to Week 24|Other|7|||
131174333|NCT01606761|472258549|FG002|Prior to Week 24|Other|5|||
131174334|NCT01606761|472258550|FG003|Prior to Week 24|Other|0|||
131174335|NCT01606761|472258551|FG004|Prior to Week 24|Other|0|||
131174336|NCT01606761|472258547|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
131174337|NCT01606761|472258548|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
131174338|NCT01606761|472258549|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
131174339|NCT01606761|472258550|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
131174340|NCT01606761|472258551|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
131174341|NCT01606761|472258547|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
131174342|NCT01606761|472258548|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
131174343|NCT01606761|472258549|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
131174344|NCT01606761|472258550|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
131174345|NCT01606761|472258551|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
131174346|NCT01606761|472258547|FG000|Week 24 to Week 52|Adverse Event|0|||
131174347|NCT01606761|472258548|FG001|Week 24 to Week 52|Adverse Event|11|||
131174348|NCT01606761|472258549|FG002|Week 24 to Week 52|Adverse Event|14|||
131174349|NCT01606761|472258550|FG003|Week 24 to Week 52|Adverse Event|3|||
131174350|NCT01606761|472258551|FG004|Week 24 to Week 52|Adverse Event|15|||
131174351|NCT01606761|472258547|FG000|Week 24 to Week 52|Death|0|||
131174352|NCT01606761|472258548|FG001|Week 24 to Week 52|Death|0|||
131174353|NCT01606761|472258549|FG002|Week 24 to Week 52|Death|2|||
131174354|NCT01606761|472258550|FG003|Week 24 to Week 52|Death|1|||
131174355|NCT01606761|472258551|FG004|Week 24 to Week 52|Death|0|||
131174356|NCT01606761|472258547|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
131174357|NCT01606761|472258548|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
131174358|NCT01606761|472258549|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
131174359|NCT01606761|472258550|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
131174360|NCT01606761|472258551|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
131174361|NCT01606761|472258547|FG000|Week 24 to Week 52|Physician Decision|0|||
131174362|NCT01606761|472258548|FG001|Week 24 to Week 52|Physician Decision|1|||
131174363|NCT01606761|472258549|FG002|Week 24 to Week 52|Physician Decision|1|||
131174364|NCT01606761|472258550|FG003|Week 24 to Week 52|Physician Decision|0|||
131174365|NCT01606761|472258551|FG004|Week 24 to Week 52|Physician Decision|0|||
131174366|NCT01606761|472258547|FG000|Week 24 to Week 52|Other|0|||
131174367|NCT01606761|472258548|FG001|Week 24 to Week 52|Other|1|||
131174368|NCT01606761|472258549|FG002|Week 24 to Week 52|Other|5|||
131174369|NCT01606761|472258550|FG003|Week 24 to Week 52|Other|2|||
131174370|NCT01606761|472258551|FG004|Week 24 to Week 52|Other|2|||
131174371|NCT01606761|472258547|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
131174372|NCT01606761|472258548|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
131174373|NCT01606761|472258549|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
131174374|NCT01606761|472258550|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
131174375|NCT01606761|472258551|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
131174376|NCT01606761|472258547|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
131174377|NCT01606761|472258548|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
131174378|NCT01606761|472258549|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
131174379|NCT01606761|472258550|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
131174380|NCT01606761|472258551|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
131174381|NCT01606761|472258547|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
131174382|NCT01606761|472258548|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
131174383|NCT01606761|472258549|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
131174384|NCT01606761|472258550|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
131174385|NCT01606761|472258551|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
131174386|NCT01606761|472258547|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
131174387|NCT01606761|472258548|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
131174388|NCT01606761|472258549|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
131174389|NCT01606761|472258550|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
131174390|NCT01606761|472258551|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
131174391|NCT05086289|472258552|FG000|Overall Study|Adverse Event|4|||
131174392|NCT05086289|472258553|FG001|Overall Study|Adverse Event|2|||
131174393|NCT05086289|472258552|FG000|Overall Study|Lost to Follow-up|2|||
131174394|NCT05086289|472258553|FG001|Overall Study|Lost to Follow-up|0|||
131174395|NCT05086289|472258552|FG000|Overall Study|Non-compliance with study drug|2|||
131174396|NCT05086289|472258553|FG001|Overall Study|Non-compliance with study drug|1|||
131174397|NCT05086289|472258552|FG000|Overall Study|Physician Decision|2|||
131174398|NCT05086289|472258553|FG001|Overall Study|Physician Decision|0|||
131174399|NCT05086289|472258552|FG000|Overall Study|Withdrawal by Subject|5|||
131236601|NCT00688064|472494965|FG000|Overall Study|Any other reasons|1|||
131174400|NCT05086289|472258553|FG001|Overall Study|Withdrawal by Subject|2|||
131174401|NCT01996748|472258554|FG000|Overall Study|Personal reason|1|||
131174402|NCT01996748|472258555|FG001|Overall Study|Personal reason|0|||
131174403|NCT01996748|472258554|FG000|Overall Study|Physician Decision|2|||
131174404|NCT01996748|472258555|FG001|Overall Study|Physician Decision|0|||
131174405|NCT01996748|472258554|FG000|Overall Study|Adverse Event|1|||
131174406|NCT01996748|472258555|FG001|Overall Study|Adverse Event|4|||
131174407|NCT01996748|472258554|FG000|Overall Study|Withdrawal by Subject|0|||
131174408|NCT01996748|472258555|FG001|Overall Study|Withdrawal by Subject|1|||
131174409|NCT01996748|472258554|FG000|Overall Study|Lost to Follow-up|4|||
131174410|NCT01996748|472258555|FG001|Overall Study|Lost to Follow-up|1|||
131174411|NCT03599141|472258559|FG000|Overall Study|Lost to Follow-up|3|||
131174412|NCT03599141|472258560|FG001|Overall Study|Lost to Follow-up|1|||
131174413|NCT01165021|472258561|FG000|Overall Study|Death|1|||
131174414|NCT01419665|472258562|FG000|Combination Treatment|Adverse Event|7|||
131174415|NCT01419665|472258563|FG001|Combination Treatment|Adverse Event|10|||
131174416|NCT01419665|472258562|FG000|Combination Treatment|Physician Decision|5|||
131174417|NCT01419665|472258563|FG001|Combination Treatment|Physician Decision|8|||
131174418|NCT01419665|472258562|FG000|Combination Treatment|Protocol Violation|6|||
131174419|NCT01419665|472258563|FG001|Combination Treatment|Protocol Violation|2|||
131174420|NCT01419665|472258562|FG000|Combination Treatment|disease progression|10|||
131174421|NCT01419665|472258563|FG001|Combination Treatment|disease progression|9|||
131174422|NCT01419665|472258562|FG000|Combination Treatment|Death|5|||
131174423|NCT01419665|472258563|FG001|Combination Treatment|Death|7|||
131174424|NCT01419665|472258562|FG000|Combination Treatment|administrative problems|0|||
131174425|NCT01419665|472258563|FG001|Combination Treatment|administrative problems|1|||
131174426|NCT01419665|472258562|FG000|Combination Treatment|Withdrawal by Subject|5|||
131174427|NCT01419665|472258563|FG001|Combination Treatment|Withdrawal by Subject|4|||
131174428|NCT01419665|472258562|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
131174429|NCT01419665|472258563|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
131174430|NCT01419665|472258562|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
131174431|NCT01419665|472258563|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
131174432|NCT01419665|472258562|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
131174433|NCT01419665|472258563|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
131174434|NCT01419665|472258562|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
131174435|NCT01419665|472258563|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
131174436|NCT01419665|472258562|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
131174437|NCT01419665|472258563|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
131174438|NCT01419665|472258562|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
131174439|NCT01419665|472258563|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
131174440|NCT01419665|472258562|FG000|Maintenance Treatment and/or Follow up|Death|1|||
131174441|NCT01419665|472258563|FG001|Maintenance Treatment and/or Follow up|Death|2|||
131174442|NCT01419665|472258562|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
131174443|NCT01419665|472258563|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
131174444|NCT01419665|472258562|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
131174445|NCT01419665|472258563|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
131174446|NCT01419665|472258562|FG000|Open Label Phase|Death|1|||
131174447|NCT01419665|472258563|FG001|Open Label Phase|Death|0|||
131174448|NCT01419665|472258562|FG000|Open Label Phase|disease progression|0|||
131174449|NCT01419665|472258563|FG001|Open Label Phase|disease progression|1|||
131174450|NCT02998554|472258569|FG000|Overall Study|Adverse Event|8|||
131174451|NCT02998554|472258570|FG001|Overall Study|Adverse Event|3|||
131174452|NCT02998554|472258569|FG000|Overall Study|Protocol deviation|1|||
131174453|NCT02998554|472258570|FG001|Overall Study|Protocol deviation|0|||
131174454|NCT02998554|472258569|FG000|Overall Study|Withdrawal by Subject|2|||
131174455|NCT02998554|472258570|FG001|Overall Study|Withdrawal by Subject|6|||
131174456|NCT02998554|472258569|FG000|Overall Study|Lost to Follow-up|0|||
131174457|NCT02998554|472258570|FG001|Overall Study|Lost to Follow-up|1|||
131174458|NCT02998554|472258569|FG000|Overall Study|Lack of Efficacy|0|||
131174459|NCT02998554|472258570|FG001|Overall Study|Lack of Efficacy|1|||
131174460|NCT01752842|472258571|FG000|Overall Study|Adverse Event|3|||
131174461|NCT01752842|472258572|FG001|Overall Study|Adverse Event|0|||
131174462|NCT01752842|472258571|FG000|Overall Study|Withdrawal by Subject|0|||
131174463|NCT01752842|472258572|FG001|Overall Study|Withdrawal by Subject|2|||
131174464|NCT01683071|472258573|FG000|Part 1|Lack of Efficacy|1|||
131174465|NCT01683071|472258574|FG001|Part 1|Lack of Efficacy|0|||
131174466|NCT01683071|472258575|FG002|Part 1|Lack of Efficacy|0|||
131174467|NCT01683071|472258576|FG003|Part 1|Lack of Efficacy|3|||
131174468|NCT01683071|472258577|FG004|Part 1|Lack of Efficacy|0|||
131174469|NCT01683071|472258578|FG005|Part 1|Lack of Efficacy|0|||
131174470|NCT01683071|472258573|FG000|Part 1|Withdrawal by Subject|1|||
131174471|NCT01683071|472258574|FG001|Part 1|Withdrawal by Subject|2|||
131174472|NCT01683071|472258575|FG002|Part 1|Withdrawal by Subject|2|||
131174473|NCT01683071|472258576|FG003|Part 1|Withdrawal by Subject|1|||
131174474|NCT01683071|472258577|FG004|Part 1|Withdrawal by Subject|0|||
131174475|NCT01683071|472258578|FG005|Part 1|Withdrawal by Subject|0|||
131174476|NCT01683071|472258573|FG000|Part 1|Surgery Cancelled|1|||
131174477|NCT01683071|472258574|FG001|Part 1|Surgery Cancelled|0|||
131174478|NCT01683071|472258575|FG002|Part 1|Surgery Cancelled|0|||
131174479|NCT01683071|472258576|FG003|Part 1|Surgery Cancelled|0|||
131174480|NCT01683071|472258577|FG004|Part 1|Surgery Cancelled|0|||
130782179|NCT00490919|470829198|FG002|Open-label Run-in Period|Adverse Event|0|||
130782180|NCT00490919|470829196|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
130782181|NCT00490919|470829197|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
130782182|NCT00490919|470829198|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
130782183|NCT00490919|470829196|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
130782184|NCT00490919|470829197|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
130782185|NCT00490919|470829198|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
130782186|NCT00490919|470829196|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
131174481|NCT01683071|472258578|FG005|Part 1|Surgery Cancelled|0|||
131174482|NCT01683071|472258573|FG000|Part 1|Did not receive study drug|1|||
131174483|NCT01683071|472258574|FG001|Part 1|Did not receive study drug|0|||
131174484|NCT01683071|472258575|FG002|Part 1|Did not receive study drug|0|||
131174485|NCT01683071|472258576|FG003|Part 1|Did not receive study drug|1|||
131174486|NCT01683071|472258577|FG004|Part 1|Did not receive study drug|0|||
131174487|NCT01683071|472258578|FG005|Part 1|Did not receive study drug|0|||
131174488|NCT01683071|472258573|FG000|Part 1|Early termination; met exclusion criteria|0|||
131174489|NCT01683071|472258574|FG001|Part 1|Early termination; met exclusion criteria|2|||
131174490|NCT01683071|472258575|FG002|Part 1|Early termination; met exclusion criteria|1|||
131174491|NCT01683071|472258576|FG003|Part 1|Early termination; met exclusion criteria|0|||
131174492|NCT01683071|472258577|FG004|Part 1|Early termination; met exclusion criteria|0|||
131174493|NCT01683071|472258578|FG005|Part 1|Early termination; met exclusion criteria|0|||
131174494|NCT01683071|472258573|FG000|Part 2|Lack of Efficacy|0|||
131174495|NCT01683071|472258574|FG001|Part 2|Lack of Efficacy|0|||
131174496|NCT01683071|472258575|FG002|Part 2|Lack of Efficacy|0|||
131174497|NCT01683071|472258576|FG003|Part 2|Lack of Efficacy|0|||
131174498|NCT01683071|472258577|FG004|Part 2|Lack of Efficacy|3|||
131174499|NCT01683071|472258578|FG005|Part 2|Lack of Efficacy|4|||
131174500|NCT01683071|472258573|FG000|Part 2|Lost to Follow-up|0|||
131174501|NCT01683071|472258574|FG001|Part 2|Lost to Follow-up|0|||
131174502|NCT01683071|472258575|FG002|Part 2|Lost to Follow-up|0|||
131174503|NCT01683071|472258576|FG003|Part 2|Lost to Follow-up|0|||
131174504|NCT01683071|472258577|FG004|Part 2|Lost to Follow-up|2|||
131174505|NCT01683071|472258578|FG005|Part 2|Lost to Follow-up|0|||
131174506|NCT01683071|472258573|FG000|Part 2|Withdrawal by Subject|0|||
131174507|NCT01683071|472258574|FG001|Part 2|Withdrawal by Subject|0|||
131174508|NCT01683071|472258575|FG002|Part 2|Withdrawal by Subject|0|||
131174509|NCT01683071|472258576|FG003|Part 2|Withdrawal by Subject|0|||
131174510|NCT01683071|472258577|FG004|Part 2|Withdrawal by Subject|3|||
131174511|NCT01683071|472258578|FG005|Part 2|Withdrawal by Subject|3|||
131174512|NCT01683071|472258573|FG000|Part 2|Surgery cancelled|0|||
131174513|NCT01683071|472258574|FG001|Part 2|Surgery cancelled|0|||
131174514|NCT01683071|472258575|FG002|Part 2|Surgery cancelled|0|||
131174515|NCT01683071|472258576|FG003|Part 2|Surgery cancelled|0|||
131174516|NCT01683071|472258577|FG004|Part 2|Surgery cancelled|4|||
131174517|NCT01683071|472258578|FG005|Part 2|Surgery cancelled|2|||
131174518|NCT01683071|472258573|FG000|Part 2|Did not receive study drug|0|||
131174519|NCT01683071|472258574|FG001|Part 2|Did not receive study drug|0|||
131174520|NCT01683071|472258575|FG002|Part 2|Did not receive study drug|0|||
131174521|NCT01683071|472258576|FG003|Part 2|Did not receive study drug|0|||
131174522|NCT01683071|472258577|FG004|Part 2|Did not receive study drug|2|||
131174523|NCT01683071|472258578|FG005|Part 2|Did not receive study drug|1|||
131174524|NCT01683071|472258573|FG000|Part 2|Met exclusion criterion|0|||
131174525|NCT01683071|472258574|FG001|Part 2|Met exclusion criterion|0|||
131174526|NCT01683071|472258575|FG002|Part 2|Met exclusion criterion|0|||
131174527|NCT01683071|472258576|FG003|Part 2|Met exclusion criterion|0|||
131174528|NCT01683071|472258577|FG004|Part 2|Met exclusion criterion|1|||
131174529|NCT01683071|472258578|FG005|Part 2|Met exclusion criterion|1|||
131174530|NCT01683071|472258573|FG000|Part 2|Protocol deviation|0|||
131174531|NCT01683071|472258574|FG001|Part 2|Protocol deviation|0|||
131174532|NCT01683071|472258575|FG002|Part 2|Protocol deviation|0|||
131174533|NCT01683071|472258576|FG003|Part 2|Protocol deviation|0|||
131174534|NCT01683071|472258577|FG004|Part 2|Protocol deviation|1|||
131174535|NCT01683071|472258578|FG005|Part 2|Protocol deviation|2|||
131174536|NCT01683071|472258573|FG000|Part 2|Withdrawal by investigator decision|0|||
131174537|NCT01683071|472258574|FG001|Part 2|Withdrawal by investigator decision|0|||
131174538|NCT01683071|472258575|FG002|Part 2|Withdrawal by investigator decision|0|||
131174539|NCT01683071|472258576|FG003|Part 2|Withdrawal by investigator decision|0|||
131174540|NCT01683071|472258577|FG004|Part 2|Withdrawal by investigator decision|1|||
131174541|NCT01683071|472258578|FG005|Part 2|Withdrawal by investigator decision|2|||
131174542|NCT01968187|472258582|FG000|Overall Study|Adverse Event|0|||
131174543|NCT01968187|472258583|FG001|Overall Study|Adverse Event|1|||
131174544|NCT01968187|472258582|FG000|Overall Study|Randomized but not treated|1|||
131174545|NCT01968187|472258583|FG001|Overall Study|Randomized but not treated|0|||
131174546|NCT04095286|472258586|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131174547|NCT04095286|472258587|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
131174548|NCT04095286|472258588|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131174549|NCT04095286|472258589|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131174550|NCT04095286|472258590|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131174551|NCT04095286|472258591|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131174552|NCT04095286|472258586|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
131174553|NCT04095286|472258587|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
131174554|NCT04095286|472258588|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
131174555|NCT04095286|472258589|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
131174556|NCT04095286|472258590|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
131174557|NCT04095286|472258591|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
131174558|NCT04095286|472258586|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
131174559|NCT04095286|472258587|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
131174560|NCT04095286|472258588|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
131174561|NCT04095286|472258589|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
131174562|NCT04095286|472258590|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
131174563|NCT04095286|472258591|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
131174564|NCT04095286|472258586|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131174565|NCT04095286|472258587|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131174566|NCT04095286|472258588|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
131174567|NCT04095286|472258589|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131174568|NCT04095286|472258590|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131174569|NCT04095286|472258591|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
131174570|NCT04095286|472258586|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
131174571|NCT04095286|472258587|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
131174572|NCT04095286|472258588|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
131174573|NCT04095286|472258589|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
131174574|NCT04095286|472258590|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
131174575|NCT04095286|472258591|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
131174576|NCT04092816|472260565|FG000|Overall Study|Lost to Follow-up|1|||
131174577|NCT04092816|472260566|FG001|Overall Study|Lost to Follow-up|2|||
131174578|NCT02115113|472260567|FG000|Participants in Run-in Period|Death|0|||
131174579|NCT02115113|472260568|FG001|Participants in Run-in Period|Death|0|||
131174580|NCT02115113|472260569|FG002|Participants in Run-in Period|Death|1|||
131174581|NCT02115113|472260567|FG000|Participants in Run-in Period|Administrative problems|0|||
131174582|NCT02115113|472260568|FG001|Participants in Run-in Period|Administrative problems|0|||
131174583|NCT02115113|472260569|FG002|Participants in Run-in Period|Administrative problems|1|||
131174584|NCT02115113|472260567|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
131174585|NCT02115113|472260568|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
131174586|NCT02115113|472260569|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
131174587|NCT02115113|472260567|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
131174588|NCT02115113|472260568|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
131174589|NCT02115113|472260569|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
131174590|NCT02115113|472260567|FG000|Participants Randomized|Lost to Follow-up|1|||
131174591|NCT02115113|472260568|FG001|Participants Randomized|Lost to Follow-up|0|||
131174592|NCT02115113|472260569|FG002|Participants Randomized|Lost to Follow-up|0|||
131174593|NCT02115113|472260567|FG000|Participants Randomized|Death|1|||
131174594|NCT02115113|472260568|FG001|Participants Randomized|Death|0|||
131174595|NCT02115113|472260569|FG002|Participants Randomized|Death|0|||
131174596|NCT02395653|472260570|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
131174597|NCT02395653|472260570|FG000|Overall Study|Consent Withdrawn at Screening|1|||
131174598|NCT02395653|472260570|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
131174599|NCT02395653|472260570|FG000|Overall Study|Investigator Decision at Screening|1|||
131174600|NCT02395653|472260570|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
131174601|NCT02395653|472260570|FG000|Overall Study|Withdrawal by Subject|1|||
131174602|NCT02395653|472260570|FG000|Overall Study|Lost to Follow-up|1|||
131174603|NCT00296725|472260574|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
131174604|NCT00296725|472260574|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
131174605|NCT00296725|472260574|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
131174606|NCT02622724|472260575|FG000|Overall Study|Death|51|||
131174607|NCT02622724|472260576|FG001|Overall Study|Death|53|||
131174608|NCT02622724|472260575|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
131174609|NCT02622724|472260576|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
131174610|NCT02622724|472260575|FG000|Overall Study|Early termination of study|38|||
131174611|NCT02622724|472260576|FG001|Overall Study|Early termination of study|43|||
131174612|NCT00487084|472260577|FG000|Overall Study|Did not receive intervention|4|||
131174613|NCT00487084|472260578|FG001|Overall Study|Did not receive intervention|3|||
131174614|NCT00487084|472260579|FG002|Overall Study|Did not receive intervention|5|||
131174615|NCT00356863|472260580|FG000|Overall Study|Death|16|||
131174616|NCT00356863|472260581|FG001|Overall Study|Death|32|||
131174617|NCT00356863|472260580|FG000|Overall Study|Lost to Follow-up|76|||
131174618|NCT00356863|472260581|FG001|Overall Study|Lost to Follow-up|43|||
131174619|NCT00333619|472260582|FG000|Overall Study|Death|12|||
131174620|NCT00333619|472260583|FG001|Overall Study|Death|6|||
131174621|NCT00333619|472260582|FG000|Overall Study|Withdrawal by Subject|6|||
131174622|NCT00333619|472260583|FG001|Overall Study|Withdrawal by Subject|1|||
131174623|NCT00333619|472260582|FG000|Overall Study|Lost to Follow-up|3|||
131174624|NCT00333619|472260583|FG001|Overall Study|Lost to Follow-up|3|||
131174625|NCT00280150|472260584|FG000|Overall Study|Adverse Event|0|||
131174626|NCT00280150|472260585|FG001|Overall Study|Adverse Event|1|||
131174627|NCT00280150|472260586|FG002|Overall Study|Adverse Event|2|||
131174628|NCT00280150|472260587|FG003|Overall Study|Adverse Event|3|||
131174629|NCT00280150|472260584|FG000|Overall Study|Lack of Efficacy|0|||
131174630|NCT00280150|472260585|FG001|Overall Study|Lack of Efficacy|0|||
131174631|NCT00280150|472260586|FG002|Overall Study|Lack of Efficacy|0|||
131174632|NCT00280150|472260587|FG003|Overall Study|Lack of Efficacy|3|||
131174633|NCT00280150|472260584|FG000|Overall Study|Physician Decision|0|||
131174634|NCT00280150|472260585|FG001|Overall Study|Physician Decision|0|||
131174635|NCT00280150|472260586|FG002|Overall Study|Physician Decision|0|||
131174636|NCT00280150|472260587|FG003|Overall Study|Physician Decision|1|||
131174637|NCT00280150|472260584|FG000|Overall Study|Protocol Violation|0|||
131174638|NCT00280150|472260585|FG001|Overall Study|Protocol Violation|0|||
131174639|NCT00280150|472260586|FG002|Overall Study|Protocol Violation|0|||
131174640|NCT00280150|472260587|FG003|Overall Study|Protocol Violation|1|||
131174641|NCT00280150|472260584|FG000|Overall Study|Withdrawal by Subject|0|||
131174642|NCT00280150|472260585|FG001|Overall Study|Withdrawal by Subject|0|||
131174643|NCT00280150|472260586|FG002|Overall Study|Withdrawal by Subject|0|||
131174644|NCT00280150|472260587|FG003|Overall Study|Withdrawal by Subject|1|||
131174645|NCT00280150|472260584|FG000|Overall Study|Did not get consolidation therapy|3|||
131174646|NCT00280150|472260585|FG001|Overall Study|Did not get consolidation therapy|0|||
131174647|NCT00280150|472260586|FG002|Overall Study|Did not get consolidation therapy|3|||
131174648|NCT00280150|472260587|FG003|Overall Study|Did not get consolidation therapy|0|||
131174649|NCT00280150|472260584|FG000|Overall Study|Declining Performance Status|0|||
131174650|NCT00280150|472260585|FG001|Overall Study|Declining Performance Status|0|||
131174651|NCT00280150|472260586|FG002|Overall Study|Declining Performance Status|0|||
131174652|NCT00280150|472260587|FG003|Overall Study|Declining Performance Status|1|||
131174653|NCT02690207|472260594|FG000|Overall Study|Lost to Follow-up|48|||
131174654|NCT02690207|472260594|FG000|Overall Study|Withdrawal by Subject|46|||
131174655|NCT02690207|472260594|FG000|Overall Study|Protocol Violation|2|||
131174656|NCT02690207|472260594|FG000|Overall Study|Serious adverse event|110|||
131174657|NCT02690207|472260594|FG000|Overall Study|Non-serious Adverse Event|18|||
131174658|NCT02690207|472260594|FG000|Overall Study|Migrated/moved from study area|5|||
131174659|NCT02690207|472260594|FG000|Overall Study|Suspected HZ Episode|1|||
131174660|NCT02690207|472260594|FG000|Overall Study|Other reasons for withdrawal|23|||
131174661|NCT03712345|472260597|FG000|Overall Study|Failure to meet randomization criteria|0|||
131174662|NCT03712345|472260598|FG001|Overall Study|Failure to meet randomization criteria|0|||
131174663|NCT03712345|472260599|FG002|Overall Study|Failure to meet randomization criteria|1|||
131174664|NCT00485589|472260600|FG000|Overall Study|Death|2|||
131174665|NCT00485589|472260601|FG001|Overall Study|Death|2|||
131174666|NCT00485589|472260602|FG002|Overall Study|Death|0|||
131174667|NCT00485589|472260600|FG000|Overall Study|Failure to return|6|||
131174668|NCT00485589|472260601|FG001|Overall Study|Failure to return|5|||
131174669|NCT00485589|472260602|FG002|Overall Study|Failure to return|1|||
131174670|NCT00485589|472260600|FG000|Overall Study|Protocol Violation|1|||
131174671|NCT00485589|472260601|FG001|Overall Study|Protocol Violation|0|||
131174672|NCT00485589|472260602|FG002|Overall Study|Protocol Violation|0|||
131174673|NCT00485589|472260600|FG000|Overall Study|Violation of selection criteria at entry|0|||
131174674|NCT00485589|472260601|FG001|Overall Study|Violation of selection criteria at entry|3|||
131174675|NCT00485589|472260602|FG002|Overall Study|Violation of selection criteria at entry|1|||
131174676|NCT00485589|472260600|FG000|Overall Study|Administrative/Other|1|||
131174677|NCT00485589|472260601|FG001|Overall Study|Administrative/Other|2|||
131174678|NCT00485589|472260602|FG002|Overall Study|Administrative/Other|1|||
131174679|NCT00485589|472260600|FG000|Overall Study|Insufficient therapeutic response|10|||
131174680|NCT00485589|472260601|FG001|Overall Study|Insufficient therapeutic response|3|||
131174681|NCT00485589|472260602|FG002|Overall Study|Insufficient therapeutic response|1|||
131174682|NCT00485589|472260600|FG000|Overall Study|Refused treatment/did not cooperate|1|||
131174683|NCT00485589|472260601|FG001|Overall Study|Refused treatment/did not cooperate|0|||
131174684|NCT00485589|472260602|FG002|Overall Study|Refused treatment/did not cooperate|2|||
131174685|NCT00485589|472260600|FG000|Overall Study|Withdrawal by Subject|3|||
131174686|NCT00485589|472260601|FG001|Overall Study|Withdrawal by Subject|2|||
131174687|NCT00485589|472260602|FG002|Overall Study|Withdrawal by Subject|2|||
131174688|NCT00485589|472260600|FG000|Overall Study|Adverse Event|3|||
131174689|NCT00485589|472260601|FG001|Overall Study|Adverse Event|3|||
131174690|NCT00485589|472260602|FG002|Overall Study|Adverse Event|10|||
131174691|NCT02585999|472260603|FG000|Overall Study|Lost to Follow-up|1|||
131174692|NCT02585999|472260603|FG000|Overall Study|Protocol Violation|1|||
131174693|NCT01369849|472260604|FG000|Overall Study|Ineligible prior to treatment|0|||
131174694|NCT01369849|472260605|FG001|Overall Study|Ineligible prior to treatment|0|||
131174695|NCT01369849|472260606|FG002|Overall Study|Ineligible prior to treatment|1|||
131174696|NCT01369849|472260604|FG000|Overall Study|Ineligible after receiving treatment|0|||
131174697|NCT01369849|472260605|FG001|Overall Study|Ineligible after receiving treatment|1|||
131174698|NCT01369849|472260606|FG002|Overall Study|Ineligible after receiving treatment|0|||
131174699|NCT00756886|472260610|FG000|Overall Study|Lost to Follow-up|1|||
131174700|NCT00756886|472260611|FG001|Overall Study|Lost to Follow-up|0|||
131174701|NCT00756886|472260610|FG000|Overall Study|Adverse Event|0|||
131174702|NCT00756886|472260611|FG001|Overall Study|Adverse Event|3|||
131174703|NCT00756886|472260610|FG000|Overall Study|Lack of Efficacy|1|||
131174704|NCT00756886|472260611|FG001|Overall Study|Lack of Efficacy|0|||
131174705|NCT00756886|472260610|FG000|Overall Study|Ineligible|9|||
131174706|NCT00756886|472260611|FG001|Overall Study|Ineligible|4|||
131174707|NCT00174785|472260612|FG000|Overall Study|Adverse Event|293|||
131174708|NCT00174785|472260613|FG001|Overall Study|Adverse Event|191|||
131174709|NCT00174785|472260612|FG000|Overall Study|Protocol Violation|14|||
131174710|NCT00174785|472260613|FG001|Overall Study|Protocol Violation|14|||
131174711|NCT00174785|472260612|FG000|Overall Study|Withdrawal by Subject|173|||
131174712|NCT00174785|472260613|FG001|Overall Study|Withdrawal by Subject|175|||
131174713|NCT00174785|472260612|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
131174714|NCT00174785|472260613|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
131174715|NCT00174785|472260612|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
131174716|NCT00174785|472260613|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
131174717|NCT00174785|472260612|FG000|Overall Study|Other prohibited medication|5|||
131174718|NCT00174785|472260613|FG001|Overall Study|Other prohibited medication|3|||
131174719|NCT00174785|472260612|FG000|Overall Study|Family request|6|||
131174720|NCT00174785|472260613|FG001|Overall Study|Family request|8|||
131174721|NCT00174785|472260612|FG000|Overall Study|Not pre-specified/Not coded|56|||
131174722|NCT00174785|472260613|FG001|Overall Study|Not pre-specified/Not coded|70|||
131174723|NCT00120289|472260615|FG000|Overall Study|Death|96|||
131174724|NCT00120289|472260616|FG001|Overall Study|Death|82|||
131174725|NCT00120289|472260615|FG000|Overall Study|Lost to Follow-up|11|||
131174726|NCT00120289|472260616|FG001|Overall Study|Lost to Follow-up|14|||
131174727|NCT00120289|472260615|FG000|Overall Study|Withdrawal by Subject|14|||
131174728|NCT00120289|472260616|FG001|Overall Study|Withdrawal by Subject|13|||
131174729|NCT00310388|472260617|FG000|Primary Reporting Phase|Adverse Event|101|||
131174730|NCT00310388|472260618|FG001|Primary Reporting Phase|Adverse Event|0|||
131174731|NCT00310388|472260617|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
131174732|NCT00310388|472260618|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
131174733|NCT00310388|472260617|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
131174734|NCT00310388|472260618|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
131174735|NCT00310388|472260617|FG000|Primary Reporting Phase|Protocol Violation|10|||
131174736|NCT00310388|472260618|FG001|Primary Reporting Phase|Protocol Violation|0|||
131174737|NCT00310388|472260617|FG000|Primary Reporting Phase|Pregnancy|3|||
131174738|NCT00310388|472260618|FG001|Primary Reporting Phase|Pregnancy|0|||
131174739|NCT00310388|472260617|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
131174740|NCT00310388|472260618|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
131174741|NCT00310388|472260617|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
131174742|NCT00310388|472260618|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
131174743|NCT00310388|472260617|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
131174744|NCT00310388|472260618|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
131174745|NCT00310388|472260617|FG000|Primary Reporting Phase|Physician Decision|2|||
131174746|NCT00310388|472260618|FG001|Primary Reporting Phase|Physician Decision|0|||
131174747|NCT00310388|472260617|FG000|Primary Reporting Phase|Request of the sponsor|19|||
131174748|NCT00310388|472260618|FG001|Primary Reporting Phase|Request of the sponsor|0|||
131174749|NCT00310388|472260617|FG000|Primary Reporting Phase|Failed to return|8|||
131174750|NCT00310388|472260618|FG001|Primary Reporting Phase|Failed to return|0|||
131174751|NCT00310388|472260617|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
131174752|NCT00310388|472260618|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
131174753|NCT00310388|472260617|FG000|Primary Reporting Phase|Participant request|2|||
131174754|NCT00310388|472260618|FG001|Primary Reporting Phase|Participant request|0|||
131174755|NCT00310388|472260617|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
131174756|NCT00310388|472260618|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
131174757|NCT00310388|472260617|FG000|Primary Reporting Phase|Discontinuation of study|1|||
131174758|NCT00310388|472260618|FG001|Primary Reporting Phase|Discontinuation of study|0|||
131174759|NCT00310388|472260617|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
131174760|NCT00310388|472260618|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
131174761|NCT00310388|472260617|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
131174762|NCT00310388|472260618|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
130782187|NCT00490919|470829197|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
130782188|NCT00490919|470829198|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
130782189|NCT00490919|470829196|FG000|Open-label Run-in Period|Administrative|40|||
130782190|NCT00490919|470829197|FG001|Open-label Run-in Period|Administrative|0|||
130782191|NCT00490919|470829198|FG002|Open-label Run-in Period|Administrative|0|||
130782192|NCT00490919|470829196|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
130782193|NCT00490919|470829197|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
130782194|NCT00490919|470829198|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
130782195|NCT00490919|470829196|FG000|Double-blind Phase|Adverse Event|0|||
130782196|NCT00490919|470829197|FG001|Double-blind Phase|Adverse Event|40|||
130782197|NCT00490919|470829198|FG002|Double-blind Phase|Adverse Event|20|||
130782198|NCT00490919|470829196|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130782199|NCT00490919|470829197|FG001|Double-blind Phase|Withdrawal by Subject|10|||
130782200|NCT00490919|470829198|FG002|Double-blind Phase|Withdrawal by Subject|11|||
130782201|NCT00490919|470829196|FG000|Double-blind Phase|Lost to Follow-up|0|||
130782202|NCT00490919|470829197|FG001|Double-blind Phase|Lost to Follow-up|8|||
130782203|NCT00490919|470829198|FG002|Double-blind Phase|Lost to Follow-up|11|||
130782204|NCT00490919|470829196|FG000|Double-blind Phase|Lack of Efficacy|0|||
130782205|NCT00490919|470829197|FG001|Double-blind Phase|Lack of Efficacy|22|||
130782206|NCT00490919|470829198|FG002|Double-blind Phase|Lack of Efficacy|36|||
130782207|NCT00490919|470829196|FG000|Double-blind Phase|Administrative|0|||
130782208|NCT00490919|470829197|FG001|Double-blind Phase|Administrative|6|||
130782209|NCT00490919|470829198|FG002|Double-blind Phase|Administrative|6|||
130782210|NCT01228591|470831060|FG000|Baseline|Lack of Efficacy|1|||
130782211|NCT01228591|470831061|FG001|Baseline|Lack of Efficacy|2|||
130782212|NCT01921517|470831062|FG000|Overall Study|Lost to Follow-up|5|||
130782213|NCT01921517|470831063|FG001|Overall Study|Lost to Follow-up|0|||
130782214|NCT01921517|470831062|FG000|Overall Study|Newly diagnosed health concern|2|||
130782215|NCT01921517|470831063|FG001|Overall Study|Newly diagnosed health concern|0|||
130782216|NCT01921517|470831062|FG000|Overall Study|Physician Decision|0|||
130782217|NCT01921517|470831063|FG001|Overall Study|Physician Decision|2|||
130782218|NCT01921517|470831062|FG000|Overall Study|Withdrawal by Subject|7|||
130782219|NCT01921517|470831063|FG001|Overall Study|Withdrawal by Subject|3|||
130782220|NCT01921517|470831062|FG000|Overall Study|Subject missed final imaging|1|||
130782221|NCT01921517|470831063|FG001|Overall Study|Subject missed final imaging|4|||
130782222|NCT03110354|470831069|FG000|Overall Study|Death|1|||
130782223|NCT03110354|470831070|FG001|Overall Study|Death|0|||
130782224|NCT03110354|470831071|FG002|Overall Study|Death|0|||
130782225|NCT03110354|470831072|FG003|Overall Study|Death|1|||
130782226|NCT03110354|470831073|FG004|Overall Study|Death|0|||
130782227|NCT03110354|470831069|FG000|Overall Study|Start of new therapy|0|||
130782228|NCT03110354|470831070|FG001|Overall Study|Start of new therapy|0|||
131174763|NCT00310388|472260617|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
131174764|NCT00310388|472260618|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
131174765|NCT00310388|472260617|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
131174766|NCT00310388|472260618|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
131174767|NCT00310388|472260617|FG000|Primary Reporting Phase|Participant passed away|1|||
131174768|NCT00310388|472260618|FG001|Primary Reporting Phase|Participant passed away|0|||
131174769|NCT00310388|472260617|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
131174770|NCT00310388|472260618|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
131174771|NCT00310388|472260617|FG000|Primary Reporting Phase|Missing|1|||
131174772|NCT00310388|472260618|FG001|Primary Reporting Phase|Missing|0|||
131174773|NCT00310388|472260617|FG000|Primary Reporting Phase|Other|1|||
131174774|NCT00310388|472260618|FG001|Primary Reporting Phase|Other|0|||
131174775|NCT00310388|472260617|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
131174776|NCT00310388|472260618|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
131174777|NCT00310388|472260617|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
131174778|NCT00310388|472260618|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
131174779|NCT00310388|472260617|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
131174780|NCT00310388|472260618|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
131174781|NCT00310388|472260617|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
131174782|NCT00310388|472260618|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
131174783|NCT01163253|472260626|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
131174784|NCT01163253|472260627|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
131174785|NCT01163253|472260626|FG000|Overall Study|Study Terminated by Sponsor|978|||
131174786|NCT01163253|472260627|FG001|Overall Study|Study Terminated by Sponsor|349|||
130782229|NCT03110354|470831071|FG002|Overall Study|Start of new therapy|0|||
130782230|NCT03110354|470831072|FG003|Overall Study|Start of new therapy|0|||
130782231|NCT03110354|470831073|FG004|Overall Study|Start of new therapy|1|||
130782232|NCT03110354|470831069|FG000|Overall Study|Failure to achieve response|2|||
130782233|NCT03110354|470831070|FG001|Overall Study|Failure to achieve response|3|||
130782234|NCT03110354|470831071|FG002|Overall Study|Failure to achieve response|0|||
130782235|NCT03110354|470831072|FG003|Overall Study|Failure to achieve response|2|||
130782236|NCT03110354|470831073|FG004|Overall Study|Failure to achieve response|1|||
131174787|NCT01163253|472260626|FG000|Overall Study|Protocol Violation|43|||
131174788|NCT01163253|472260627|FG001|Overall Study|Protocol Violation|12|||
131174789|NCT01163253|472260626|FG000|Overall Study|Withdrawal by Subject|199|||
131174790|NCT01163253|472260627|FG001|Overall Study|Withdrawal by Subject|50|||
131174791|NCT01163253|472260626|FG000|Overall Study|Medication Error|1|||
131174792|NCT01163253|472260627|FG001|Overall Study|Medication Error|0|||
131174793|NCT01163253|472260626|FG000|Overall Study|Lost to Follow-up|125|||
131174794|NCT01163253|472260627|FG001|Overall Study|Lost to Follow-up|23|||
131174795|NCT01163253|472260626|FG000|Overall Study|Insufficient Clinical Response|423|||
131174796|NCT01163253|472260627|FG001|Overall Study|Insufficient Clinical Response|29|||
131174797|NCT01163253|472260626|FG000|Overall Study|Adverse Event|300|||
131174798|NCT01163253|472260627|FG001|Overall Study|Adverse Event|78|||
131174799|NCT01163253|472260626|FG000|Overall Study|Death|17|||
131174800|NCT01163253|472260627|FG001|Overall Study|Death|5|||
131174801|NCT01163253|472260626|FG000|Overall Study|Ongoing|13|||
131174802|NCT01163253|472260627|FG001|Overall Study|Ongoing|4|||
131174803|NCT01163253|472260626|FG000|Overall Study|Other Unspecified|170|||
131236602|NCT00688064|472494966|FG001|Overall Study|Any other reasons|3|||
131236603|NCT00001849|472494967|FG000|Overall Study|Death|4|||
131236604|NCT00001849|472494967|FG000|Overall Study|Lost to Follow-up|2|||
131236605|NCT00001849|472494967|FG000|Overall Study|Withdrawal by Subject|2|||
131236606|NCT00001849|472494967|FG000|Overall Study|tumor remained occult|6|||
131236607|NCT00442936|472494968|FG000|Overall Study|Protocol Violation|1|||
131236608|NCT00442936|472494969|FG001|Overall Study|Protocol Violation|0|||
131236609|NCT00442936|472494970|FG002|Overall Study|Protocol Violation|1|||
131236610|NCT00442936|472494971|FG003|Overall Study|Protocol Violation|1|||
131236611|NCT00524459|472494972|FG000|Overall Study|Withdrawal by Subject|1|||
131174804|NCT01163253|472260627|FG001|Overall Study|Other Unspecified|34|||
131174805|NCT02492997|472260628|FG000|Overall Study|Withdrawal by Subject|1|||
131174806|NCT02492997|472260629|FG001|Overall Study|Withdrawal by Subject|0|||
131174807|NCT02492997|472260628|FG000|Overall Study|Gained Weight|1|||
131236612|NCT00524459|472494972|FG000|Overall Study|Other|1|||
131236613|NCT01574248|472494973|FG000|Overall Study|Withdrawal by Subject|2|||
131174808|NCT02492997|472260629|FG001|Overall Study|Gained Weight|0|||
131174809|NCT02492997|472260628|FG000|Overall Study|Lost to Follow-up|0|||
131174810|NCT02492997|472260629|FG001|Overall Study|Lost to Follow-up|1|||
131174811|NCT01397552|472260630|FG000|Overall Study|Adverse Event|1|||
131174812|NCT01397552|472260631|FG001|Overall Study|Adverse Event|0|||
131174813|NCT01397552|472260630|FG000|Overall Study|Withdrawal by Subject|2|||
131174814|NCT01397552|472260631|FG001|Overall Study|Withdrawal by Subject|1|||
131174815|NCT02130427|472260632|FG000|Overall Study|Imaging results not interpretable|30|||
131174816|NCT00862849|472260637|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
131174817|NCT00862849|472260638|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
131174818|NCT00862849|472260639|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
131174819|NCT00862849|472260640|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
131174820|NCT00862849|472260641|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
131174821|NCT00862849|472260642|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
131174822|NCT00862849|472260637|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
131174823|NCT00862849|472260638|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
131174824|NCT00862849|472260639|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
131174825|NCT00862849|472260640|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
131174826|NCT00862849|472260641|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
131174827|NCT00862849|472260642|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
131174828|NCT04032171|472260648|FG000|Overall Study|Study Termination|1|||
131174829|NCT04032171|472260649|FG001|Overall Study|Study Termination|0|||
131236614|NCT01574248|472494974|FG001|Overall Study|Withdrawal by Subject|0|||
131236615|NCT01574248|472494973|FG000|Overall Study|Missing primary endpoint data|1|||
131236616|NCT01574248|472494974|FG001|Overall Study|Missing primary endpoint data|0|||
131236617|NCT01424722|472494975|FG000|Overall Study|Sponsor terminated investigation|2258|||
131236618|NCT01781286|472494976|FG000|Overall Study|Lost to Follow-up|0|||
131236619|NCT01781286|472494977|FG001|Overall Study|Lost to Follow-up|0|||
131236620|NCT01781286|472494978|FG002|Overall Study|Lost to Follow-up|0|||
131174830|NCT00992784|472260650|FG000|Overall Study|Adverse Event|2|||
131236621|NCT01781286|472494979|FG003|Overall Study|Lost to Follow-up|0|||
131174831|NCT00992784|472260651|FG001|Overall Study|Adverse Event|1|||
131236622|NCT01781286|472494980|FG004|Overall Study|Lost to Follow-up|0|||
131236623|NCT01781286|472494981|FG005|Overall Study|Lost to Follow-up|1|||
131174832|NCT00992784|472260652|FG002|Overall Study|Adverse Event|0|||
131174833|NCT00992784|472260650|FG000|Overall Study|Withdrawal by Subject|1|||
131236624|NCT01781286|472494976|FG000|Overall Study|Time Constraints|2|||
131236625|NCT01781286|472494977|FG001|Overall Study|Time Constraints|0|||
131174834|NCT00992784|472260651|FG001|Overall Study|Withdrawal by Subject|1|||
131174835|NCT00992784|472260652|FG002|Overall Study|Withdrawal by Subject|1|||
131174836|NCT01363713|472260657|FG000|Overall Study|Adverse Event|1|||
131174837|NCT01363713|472260657|FG000|Overall Study|Protocol Violation|3|||
131236626|NCT01781286|472494978|FG002|Overall Study|Time Constraints|2|||
131236627|NCT01781286|472494979|FG003|Overall Study|Time Constraints|0|||
131236628|NCT01781286|472494980|FG004|Overall Study|Time Constraints|0|||
131236629|NCT01781286|472494981|FG005|Overall Study|Time Constraints|0|||
130782237|NCT03110354|470831069|FG000|Overall Study|Progressive disease|1|||
130782238|NCT03110354|470831070|FG001|Overall Study|Progressive disease|1|||
130782239|NCT03110354|470831071|FG002|Overall Study|Progressive disease|3|||
130782240|NCT03110354|470831072|FG003|Overall Study|Progressive disease|4|||
130782241|NCT03110354|470831073|FG004|Overall Study|Progressive disease|2|||
130782242|NCT03110354|470831069|FG000|Overall Study|Adverse Event|0|||
130782243|NCT03110354|470831070|FG001|Overall Study|Adverse Event|0|||
130782244|NCT03110354|470831071|FG002|Overall Study|Adverse Event|0|||
130782245|NCT03110354|470831072|FG003|Overall Study|Adverse Event|2|||
130782246|NCT03110354|470831073|FG004|Overall Study|Adverse Event|2|||
130782247|NCT03110354|470831069|FG000|Overall Study|Other|0|||
130782248|NCT03110354|470831070|FG001|Overall Study|Other|0|||
130782249|NCT03110354|470831071|FG002|Overall Study|Other|0|||
130782250|NCT03110354|470831072|FG003|Overall Study|Other|1|||
130782251|NCT03110354|470831073|FG004|Overall Study|Other|1|||
130782252|NCT00116688|470831079|FG000|Overall Study|Protocol deviation|1|||
130782253|NCT00116688|470831080|FG001|Overall Study|Protocol deviation|0|||
130782254|NCT00116688|470831079|FG000|Overall Study|Noncompliance|3|||
130782255|NCT00116688|470831080|FG001|Overall Study|Noncompliance|1|||
130782256|NCT00116688|470831079|FG000|Overall Study|Adverse Event|11|||
130782257|NCT00116688|470831080|FG001|Overall Study|Adverse Event|0|||
130782258|NCT00116688|470831079|FG000|Overall Study|Withdrawal by Subject|26|||
130782259|NCT00116688|470831080|FG001|Overall Study|Withdrawal by Subject|2|||
130782260|NCT00116688|470831079|FG000|Overall Study|Requirement for alternative therapy|11|||
130782261|NCT00116688|470831080|FG001|Overall Study|Requirement for alternative therapy|1|||
130782262|NCT00116688|470831079|FG000|Overall Study|Physician Decision|7|||
130782263|NCT00116688|470831080|FG001|Overall Study|Physician Decision|0|||
130782264|NCT00116688|470831079|FG000|Overall Study|Lost to Follow-up|3|||
130782265|NCT00116688|470831080|FG001|Overall Study|Lost to Follow-up|0|||
130782266|NCT00116688|470831079|FG000|Overall Study|Death|15|||
130782267|NCT00116688|470831080|FG001|Overall Study|Death|0|||
130782268|NCT00116688|470831079|FG000|Overall Study|Protocol-specified criteria|3|||
130782269|NCT00116688|470831080|FG001|Overall Study|Protocol-specified criteria|0|||
130782270|NCT00116688|470831079|FG000|Overall Study|Pregnancy|1|||
130782271|NCT00116688|470831080|FG001|Overall Study|Pregnancy|0|||
130782272|NCT00116688|470831079|FG000|Overall Study|Other|11|||
130782273|NCT00116688|470831080|FG001|Overall Study|Other|0|||
130782274|NCT01775670|470831085|FG000|Overall Study|Lost to Follow-up|1|||
130782275|NCT01775670|470831086|FG001|Overall Study|Lost to Follow-up|1|||
130782276|NCT01298700|470831087|FG000|Overall Study|Adverse Event|50|||
130782277|NCT01298700|470831088|FG001|Overall Study|Adverse Event|51|||
130782278|NCT01298700|470831087|FG000|Overall Study|Lack of Efficacy|9|||
130782279|NCT01298700|470831088|FG001|Overall Study|Lack of Efficacy|14|||
130782280|NCT01298700|470831087|FG000|Overall Study|Lost to Follow-up|5|||
130782281|NCT01298700|470831088|FG001|Overall Study|Lost to Follow-up|2|||
130782282|NCT01298700|470831087|FG000|Overall Study|Withdrawal by Subject|12|||
130782283|NCT01298700|470831088|FG001|Overall Study|Withdrawal by Subject|9|||
130782284|NCT01298700|470831087|FG000|Overall Study|Protocol Violation|6|||
130782285|NCT01298700|470831088|FG001|Overall Study|Protocol Violation|4|||
131174838|NCT01363713|472260657|FG000|Overall Study|Withdrawal by Subject|2|||
131174839|NCT02108951|472260665|FG000|Overall Study|Lost to Follow-up|1|||
131174840|NCT02108951|472260665|FG000|Overall Study|Patient's/guardian's decision|1|||
131174841|NCT02108951|472260665|FG000|Overall Study|Study Terminated by Sponsor|14|||
131174842|NCT03806179|472260666|FG000|Overall Study|Progressive disease|0|||
131174843|NCT03806179|472260667|FG001|Overall Study|Progressive disease|2|||
131174844|NCT00608530|472260670|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
131174845|NCT00608530|472260671|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
131236630|NCT01781286|472494976|FG000|Overall Study|Noncompliance|0|||
131236631|NCT01781286|472494977|FG001|Overall Study|Noncompliance|0|||
130782286|NCT01298700|470831087|FG000|Overall Study|Other Miscellaneous Reasons|16|||
130782287|NCT01298700|470831088|FG001|Overall Study|Other Miscellaneous Reasons|15|||
130782288|NCT01298700|470831087|FG000|Overall Study|Did not Receive Study Drug|3|||
130782289|NCT01298700|470831088|FG001|Overall Study|Did not Receive Study Drug|5|||
130782290|NCT04006145|470831091|FG000|Overall Study|Lost to Follow-up|0|||
130782291|NCT04006145|470831092|FG001|Overall Study|Lost to Follow-up|1|||
130782292|NCT04006145|470831091|FG000|Overall Study|Other|1|||
130782293|NCT04006145|470831092|FG001|Overall Study|Other|2|||
130782294|NCT00010257|470831095|FG000|Overall Study|Withdrawal by Subject|1|||
130782295|NCT00010257|470831096|FG001|Overall Study|Withdrawal by Subject|0|||
130782296|NCT00643760|470831097|FG000|Overall Study|Adverse Event|11|||
130782297|NCT00643760|470831098|FG001|Overall Study|Adverse Event|5|||
130782298|NCT00643760|470831099|FG002|Overall Study|Adverse Event|12|||
130782299|NCT00643760|470831100|FG003|Overall Study|Adverse Event|21|||
130782300|NCT00643760|470831101|FG004|Overall Study|Adverse Event|6|||
131174846|NCT00608530|472260672|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
131236632|NCT01781286|472494978|FG002|Overall Study|Noncompliance|0|||
130782301|NCT00643760|470831097|FG000|Overall Study|Lack of Efficacy|3|||
130782302|NCT00643760|470831098|FG001|Overall Study|Lack of Efficacy|1|||
130782303|NCT00643760|470831099|FG002|Overall Study|Lack of Efficacy|0|||
131174847|NCT00608530|472260673|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
130782304|NCT00643760|470831100|FG003|Overall Study|Lack of Efficacy|4|||
130782305|NCT00643760|470831101|FG004|Overall Study|Lack of Efficacy|3|||
130782306|NCT00643760|470831097|FG000|Overall Study|Protocol Violation|7|||
130782307|NCT00643760|470831098|FG001|Overall Study|Protocol Violation|6|||
130782308|NCT00643760|470831099|FG002|Overall Study|Protocol Violation|4|||
130782309|NCT00643760|470831100|FG003|Overall Study|Protocol Violation|4|||
130782310|NCT00643760|470831101|FG004|Overall Study|Protocol Violation|6|||
130782311|NCT00643760|470831097|FG000|Overall Study|Lost to Follow-up|6|||
130782312|NCT00643760|470831098|FG001|Overall Study|Lost to Follow-up|2|||
130782313|NCT00643760|470831099|FG002|Overall Study|Lost to Follow-up|1|||
130782314|NCT00643760|470831100|FG003|Overall Study|Lost to Follow-up|3|||
130782315|NCT00643760|470831101|FG004|Overall Study|Lost to Follow-up|3|||
130782316|NCT00643760|470831097|FG000|Overall Study|Investigator Discretion|0|||
130782317|NCT00643760|470831098|FG001|Overall Study|Investigator Discretion|0|||
130782318|NCT00643760|470831099|FG002|Overall Study|Investigator Discretion|0|||
130782319|NCT00643760|470831100|FG003|Overall Study|Investigator Discretion|2|||
130782320|NCT00643760|470831101|FG004|Overall Study|Investigator Discretion|0|||
130782321|NCT00643760|470831097|FG000|Overall Study|Withdrawal by Subject|3|||
130782322|NCT00643760|470831098|FG001|Overall Study|Withdrawal by Subject|1|||
130782323|NCT00643760|470831099|FG002|Overall Study|Withdrawal by Subject|2|||
130782324|NCT00643760|470831100|FG003|Overall Study|Withdrawal by Subject|4|||
130782325|NCT00643760|470831101|FG004|Overall Study|Withdrawal by Subject|1|||
131174848|NCT00608530|472260670|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
131174849|NCT00608530|472260671|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
131174850|NCT00608530|472260672|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
131174851|NCT00608530|472260673|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
131174852|NCT00608530|472260670|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
131174853|NCT00608530|472260671|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
131174854|NCT00608530|472260672|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
131174855|NCT00608530|472260673|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
131174856|NCT00608530|472260670|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
131174857|NCT00608530|472260671|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
131174858|NCT00608530|472260672|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
131174859|NCT00608530|472260673|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
131174860|NCT00608530|472260670|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
131174861|NCT00608530|472260671|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
131174862|NCT00608530|472260672|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
131174863|NCT00608530|472260673|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
131174864|NCT00608530|472260670|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
131174865|NCT00608530|472260671|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
131174866|NCT00608530|472260672|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
131174867|NCT00608530|472260673|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
131174868|NCT00305253|472260676|FG000|Overall Study|Withdrawal by Subject|0|||
131174869|NCT00305253|472260677|FG001|Overall Study|Withdrawal by Subject|1|||
131174870|NCT01357915|472260678|FG000|Overall Study|Lost to Follow-up|3|||
131174871|NCT01357915|472260679|FG001|Overall Study|Lost to Follow-up|0|||
131174872|NCT01019486|472260682|FG000|Overall Study|Withdrawal by Subject|1|||
131174873|NCT01019486|472260683|FG001|Overall Study|Withdrawal by Subject|1|||
131174874|NCT01019486|472260684|FG002|Overall Study|Withdrawal by Subject|1|||
131174875|NCT02841787|472260685|FG000|Overall Study|Lost to Follow-up|1|||
131174876|NCT02841787|472260686|FG001|Overall Study|Lost to Follow-up|0|||
131174877|NCT02841787|472260687|FG002|Overall Study|Lost to Follow-up|0|||
131174878|NCT02841787|472260685|FG000|Overall Study|Symptoms dropped below threshold|1|||
131174879|NCT02841787|472260686|FG001|Overall Study|Symptoms dropped below threshold|0|||
131174880|NCT02841787|472260687|FG002|Overall Study|Symptoms dropped below threshold|0|||
131174881|NCT02841787|472260685|FG000|Overall Study|Withdrawal by Subject|1|||
131174882|NCT02841787|472260686|FG001|Overall Study|Withdrawal by Subject|4|||
131174883|NCT02841787|472260687|FG002|Overall Study|Withdrawal by Subject|0|||
131174884|NCT03633227|472260688|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
131174885|NCT03633227|472260689|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
130782326|NCT00104052|470831105|FG000|Overall Study|Adverse Event|1|||
130782327|NCT00104052|470831105|FG000|Overall Study|Lack of Efficacy|26|||
130782328|NCT00104052|470831105|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
130782329|NCT01241279|470831110|FG000|Overall Study|Lost to Follow-up|0|||
130782330|NCT01241279|470831111|FG001|Overall Study|Lost to Follow-up|1|||
130782331|NCT00239720|470831112|FG000|Overall Study|Adverse Event|1|||
130782332|NCT00239720|470831113|FG001|Overall Study|Adverse Event|0|||
131174886|NCT03633227|472260688|FG000|Double Blind (DB), up to Week 48|Death|2|||
131174887|NCT03633227|472260689|FG001|Double Blind (DB), up to Week 48|Death|1|||
131174888|NCT03633227|472260688|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
131174889|NCT03633227|472260689|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
131174890|NCT03633227|472260688|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
131174891|NCT03633227|472260689|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
131174892|NCT03633227|472260688|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
131174893|NCT03633227|472260689|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
131174894|NCT03633227|472260688|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
131174895|NCT03633227|472260689|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
131174896|NCT03633227|472260688|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
131174897|NCT03633227|472260689|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
131174898|NCT03633227|472260688|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
131174899|NCT03633227|472260689|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
131174900|NCT03633227|472260688|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
131174901|NCT03633227|472260689|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
131174902|NCT03633227|472260688|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
131174903|NCT03633227|472260689|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
131174904|NCT03633227|472260688|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
131174905|NCT03633227|472260689|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
131174906|NCT03633227|472260688|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
131174907|NCT03633227|472260689|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
131174908|NCT02951988|472260694|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
131174909|NCT02951988|472260695|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
131174910|NCT02951988|472260696|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
131174911|NCT02951988|472260697|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
131174912|NCT02951988|472260694|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
131174913|NCT02951988|472260695|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
131174914|NCT02951988|472260696|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
131174915|NCT02951988|472260697|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
131174916|NCT02951988|472260694|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
131174917|NCT02951988|472260695|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
131174918|NCT02951988|472260696|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
131174919|NCT02951988|472260697|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
131174920|NCT02951988|472260694|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
131174921|NCT02951988|472260695|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
131174922|NCT02951988|472260696|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
131174923|NCT02951988|472260697|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
131174924|NCT02951988|472260694|FG000|Open-Label Treatment Period|Protocol Violation|22|||
131174925|NCT02951988|472260695|FG001|Open-Label Treatment Period|Protocol Violation|0|||
131174926|NCT02951988|472260696|FG002|Open-Label Treatment Period|Protocol Violation|0|||
131174927|NCT02951988|472260697|FG003|Open-Label Treatment Period|Protocol Violation|0|||
131174928|NCT02951988|472260694|FG000|Open-Label Treatment Period|Pregnancy|2|||
131174929|NCT02951988|472260695|FG001|Open-Label Treatment Period|Pregnancy|0|||
131174930|NCT02951988|472260696|FG002|Open-Label Treatment Period|Pregnancy|0|||
131174931|NCT02951988|472260697|FG003|Open-Label Treatment Period|Pregnancy|0|||
131174932|NCT02951988|472260694|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
131174933|NCT02951988|472260695|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
131174934|NCT02951988|472260696|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
131174935|NCT02951988|472260697|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
131174936|NCT02951988|472260694|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
131174937|NCT02951988|472260695|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
131174938|NCT02951988|472260696|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
131174939|NCT02951988|472260697|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
131174940|NCT02951988|472260694|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
131174941|NCT02951988|472260695|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
131174942|NCT02951988|472260696|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
131174943|NCT02951988|472260697|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
131174944|NCT02951988|472260694|FG000|Open-Label Treatment Period|Adverse Event|45|||
131174945|NCT02951988|472260695|FG001|Open-Label Treatment Period|Adverse Event|0|||
131174946|NCT02951988|472260696|FG002|Open-Label Treatment Period|Adverse Event|0|||
131174947|NCT02951988|472260697|FG003|Open-Label Treatment Period|Adverse Event|0|||
131174948|NCT02951988|472260694|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
131174949|NCT02951988|472260695|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
131174950|NCT02951988|472260696|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
131174951|NCT02951988|472260697|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
131174952|NCT02951988|472260694|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
131174953|NCT02951988|472260695|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
131174954|NCT02951988|472260696|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
131174955|NCT02951988|472260697|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
131174956|NCT02951988|472260694|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
130782333|NCT00239720|470831112|FG000|Overall Study|Lost to Follow-up|0|||
130782334|NCT00239720|470831113|FG001|Overall Study|Lost to Follow-up|1|||
130782335|NCT01145482|470831114|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
130782336|NCT01145482|470831115|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
130782337|NCT01405560|470831116|FG000|Overall Study|Physician Decision|1|||
130782338|NCT01699750|470831120|FG000|Overall Study|Withdrew Consent|0|||
130782339|NCT01699750|470831121|FG001|Overall Study|Withdrew Consent|1|||
130782340|NCT01699750|470831120|FG000|Overall Study|Other|0|||
130782341|NCT01699750|470831121|FG001|Overall Study|Other|2|||
130782342|NCT01484951|470831122|FG000|Overall Study|Adverse Event|3|||
130782343|NCT01484951|470831122|FG000|Overall Study|Personal Reasons|1|||
130782344|NCT01484951|470831122|FG000|Overall Study|Non-Compliance|1|||
130782345|NCT02119299|470831123|FG000|Overall Study|Withdrawal by Subject|7|||
130782346|NCT02119299|470831123|FG000|Overall Study|Lack of Efficacy|1|||
130782347|NCT02119299|470831123|FG000|Overall Study|Pregnancy|1|||
130782348|NCT02452047|470831124|FG000|Overall Study|Adverse Event|0|||
130782349|NCT02452047|470831125|FG001|Overall Study|Adverse Event|1|||
130782350|NCT02452047|470831126|FG002|Overall Study|Adverse Event|1|||
130782351|NCT02452047|470831124|FG000|Overall Study|Death|1|||
130782352|NCT02452047|470831125|FG001|Overall Study|Death|3|||
130782353|NCT02452047|470831126|FG002|Overall Study|Death|1|||
130782354|NCT02452047|470831124|FG000|Overall Study|Physician Decision|1|||
130782355|NCT02452047|470831125|FG001|Overall Study|Physician Decision|0|||
130782356|NCT02452047|470831126|FG002|Overall Study|Physician Decision|0|||
130782357|NCT02452047|470831124|FG000|Overall Study|Lost to Follow-up|1|||
130782358|NCT02452047|470831125|FG001|Overall Study|Lost to Follow-up|1|||
130782359|NCT02452047|470831126|FG002|Overall Study|Lost to Follow-up|0|||
130782360|NCT02452047|470831124|FG000|Overall Study|Withdrawal by Subject|1|||
130782361|NCT02452047|470831125|FG001|Overall Study|Withdrawal by Subject|0|||
130782362|NCT02452047|470831126|FG002|Overall Study|Withdrawal by Subject|0|||
130782363|NCT01249417|470831127|FG000|Randomised Population|Study treatment not received|0|||
130782364|NCT01249417|470831128|FG001|Randomised Population|Study treatment not received|0|||
130782365|NCT01249417|470831129|FG002|Randomised Population|Study treatment not received|2|||
130782366|NCT01249417|470831127|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
130782367|NCT01249417|470831128|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
130782368|NCT01249417|470831129|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
130782369|NCT01249417|470831127|FG000|Treatment Phase - ITT Population|Other|0|||
130782370|NCT01249417|470831128|FG001|Treatment Phase - ITT Population|Other|0|||
131174957|NCT02951988|472260695|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
131174958|NCT02951988|472260696|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
131174959|NCT02951988|472260697|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
131174960|NCT02951988|472260694|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
131174961|NCT02951988|472260695|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
131174962|NCT02951988|472260696|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
131174963|NCT02951988|472260697|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
131174964|NCT02951988|472260694|FG000|Double-Blind Treatment Period|Pregnancy|0|||
131174965|NCT02951988|472260695|FG001|Double-Blind Treatment Period|Pregnancy|1|||
131174966|NCT02951988|472260696|FG002|Double-Blind Treatment Period|Pregnancy|1|||
131174967|NCT02951988|472260697|FG003|Double-Blind Treatment Period|Pregnancy|0|||
131174968|NCT02951988|472260694|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131174969|NCT02951988|472260695|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
131174970|NCT02951988|472260696|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
131174971|NCT02951988|472260697|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
131174972|NCT02951988|472260694|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131174973|NCT02951988|472260695|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
131174974|NCT02951988|472260696|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
131174975|NCT02951988|472260697|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
131174976|NCT02951988|472260694|FG000|Double-Blind Treatment Period|Adverse Event|0|||
131174977|NCT02951988|472260695|FG001|Double-Blind Treatment Period|Adverse Event|8|||
131174978|NCT02951988|472260696|FG002|Double-Blind Treatment Period|Adverse Event|3|||
131174979|NCT02951988|472260697|FG003|Double-Blind Treatment Period|Adverse Event|6|||
131174980|NCT02951988|472260694|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
131174981|NCT02951988|472260695|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
131174982|NCT02951988|472260696|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
131174983|NCT02951988|472260697|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
131174984|NCT01655823|472260698|FG000|Overall Study|Lost to Follow-up|0|||
131174985|NCT01655823|472260699|FG001|Overall Study|Lost to Follow-up|1|||
131174986|NCT01655823|472260700|FG002|Overall Study|Lost to Follow-up|0|||
130782371|NCT01249417|470831129|FG002|Treatment Phase - ITT Population|Other|1|||
130782372|NCT01249417|470831127|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
130782373|NCT01249417|470831128|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
130782374|NCT01249417|470831129|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
130782375|NCT01249417|470831127|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
131174987|NCT01655823|472260701|FG003|Overall Study|Lost to Follow-up|0|||
131174988|NCT01655823|472260702|FG004|Overall Study|Lost to Follow-up|1|||
131174989|NCT01655823|472260698|FG000|Overall Study|Withdrawal by Subject|0|||
131174990|NCT01655823|472260699|FG001|Overall Study|Withdrawal by Subject|1|||
131174991|NCT01655823|472260700|FG002|Overall Study|Withdrawal by Subject|0|||
131174992|NCT01655823|472260701|FG003|Overall Study|Withdrawal by Subject|1|||
131174993|NCT01655823|472260702|FG004|Overall Study|Withdrawal by Subject|0|||
131174994|NCT04799405|472260705|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
131174995|NCT01934192|472260708|FG000|Overall Study|Protocol Violation|0|||
131174996|NCT01934192|472260709|FG001|Overall Study|Protocol Violation|0|||
131174997|NCT01934192|472260710|FG002|Overall Study|Protocol Violation|0|||
131174998|NCT01934192|472260711|FG003|Overall Study|Protocol Violation|1|||
131174999|NCT01934192|472260708|FG000|Overall Study|Other: reached stopping criteria|6|||
131175000|NCT01934192|472260709|FG001|Overall Study|Other: reached stopping criteria|5|||
131175001|NCT01934192|472260710|FG002|Overall Study|Other: reached stopping criteria|1|||
131175002|NCT01934192|472260711|FG003|Overall Study|Other: reached stopping criteria|0|||
131175003|NCT01934192|472260708|FG000|Overall Study|Physician Decision|3|||
131175004|NCT01934192|472260709|FG001|Overall Study|Physician Decision|2|||
131175005|NCT01934192|472260710|FG002|Overall Study|Physician Decision|0|||
131175006|NCT01934192|472260711|FG003|Overall Study|Physician Decision|0|||
131175007|NCT01189435|472260712|FG000|Overall Study|Withdrawal by Subject|1|||
131175008|NCT01189435|472260712|FG000|Overall Study|Physician Decision|1|||
131175009|NCT03095521|472260718|FG000|Overall Study|Withdrawal by Subject|0|||
131175010|NCT03095521|472260719|FG001|Overall Study|Withdrawal by Subject|1|||
130782376|NCT01249417|470831128|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
131175011|NCT03095521|472260718|FG000|Overall Study|Lost to Follow-up|0|||
131175012|NCT03095521|472260719|FG001|Overall Study|Lost to Follow-up|1|||
131175013|NCT01536119|472260720|FG000|Overall Study|Lost to Follow-up|17|||
131175014|NCT01536119|472260721|FG001|Overall Study|Lost to Follow-up|14|||
131175015|NCT01810042|472260722|FG000|Overall Study|Lost to Follow-up|10|||
131175016|NCT02773238|472260724|FG000|Overall Study|Lack of Efficacy|4|||
131175017|NCT03162055|472262699|FG000|Overall Study|Adverse Event|6|||
131175018|NCT03162055|472262700|FG001|Overall Study|Adverse Event|5|||
131175019|NCT03162055|472262699|FG000|Overall Study|Death|3|||
131175020|NCT03162055|472262700|FG001|Overall Study|Death|3|||
131175021|NCT03162055|472262699|FG000|Overall Study|Lost to Follow-up|0|||
131175022|NCT03162055|472262700|FG001|Overall Study|Lost to Follow-up|1|||
131175023|NCT03162055|472262699|FG000|Overall Study|Study-specific withdrawal criteria|22|||
131175024|NCT03162055|472262700|FG001|Overall Study|Study-specific withdrawal criteria|14|||
131175025|NCT03162055|472262699|FG000|Overall Study|Withdrawal by Subject|17|||
131175026|NCT03162055|472262700|FG001|Overall Study|Withdrawal by Subject|2|||
131175027|NCT03162055|472262699|FG000|Overall Study|Did not receive treatment|2|||
131175028|NCT03162055|472262700|FG001|Overall Study|Did not receive treatment|0|||
131175029|NCT03162055|472262699|FG000|Overall Study|Incorrect randomization|4|||
131175030|NCT03162055|472262700|FG001|Overall Study|Incorrect randomization|3|||
131175031|NCT03162055|472262699|FG000|Overall Study|Other|8|||
131175032|NCT03162055|472262700|FG001|Overall Study|Other|15|||
131175033|NCT01993615|472262704|FG000|Overall Study|Death|1|||
131175034|NCT01993615|472262705|FG001|Overall Study|Death|0|||
131175035|NCT00798694|472262707|FG000|Overall Study|Lost to Follow-up|1|||
131175036|NCT00798694|472262708|FG001|Overall Study|Lost to Follow-up|1|||
131175037|NCT00798694|472262707|FG000|Overall Study|Physician Decision|1|||
131175038|NCT00798694|472262708|FG001|Overall Study|Physician Decision|0|||
131175039|NCT01774344|472262710|FG000|Overall Study|Withdrawal by Subject|3|||
131175040|NCT01774344|472262711|FG001|Overall Study|Withdrawal by Subject|10|||
131175041|NCT01774344|472262710|FG000|Overall Study|Protocol Violation|0|||
131175042|NCT01774344|472262711|FG001|Overall Study|Protocol Violation|1|||
131175043|NCT01774344|472262710|FG000|Overall Study|Lost to Follow-up|4|||
131175044|NCT01774344|472262711|FG001|Overall Study|Lost to Follow-up|10|||
131175045|NCT01774344|472262710|FG000|Overall Study|End of survival follow-up not available|2|||
131175046|NCT01774344|472262711|FG001|Overall Study|End of survival follow-up not available|2|||
131175047|NCT01774344|472262710|FG000|Overall Study|Data collection finished|4|||
131175048|NCT01774344|472262711|FG001|Overall Study|Data collection finished|14|||
131175049|NCT01774344|472262710|FG000|Overall Study|Other|0|||
131175050|NCT01774344|472262711|FG001|Overall Study|Other|1|||
131175051|NCT01774344|472262710|FG000|Overall Study|Did not enter Survival Follow up|49|||
131175052|NCT01774344|472262711|FG001|Overall Study|Did not enter Survival Follow up|83|||
131175053|NCT01658579|472262716|FG000|Treatment Period A|Other|0|||
131175054|NCT01658579|472262717|FG001|Treatment Period A|Other|0|||
131175055|NCT01658579|472262718|FG002|Treatment Period A|Other|1|||
131175056|NCT01658579|472262719|FG003|Treatment Period A|Other|1|||
131175057|NCT01658579|472262716|FG000|Treatment Period A|Adverse Event|1|||
131175058|NCT01658579|472262717|FG001|Treatment Period A|Adverse Event|0|||
131175059|NCT01658579|472262718|FG002|Treatment Period A|Adverse Event|0|||
131175060|NCT01658579|472262719|FG003|Treatment Period A|Adverse Event|0|||
131175061|NCT01658579|472262716|FG000|Treatment Period B|Other|0|||
131175062|NCT01658579|472262717|FG001|Treatment Period B|Other|0|||
131175063|NCT01658579|472262718|FG002|Treatment Period B|Other|0|||
131175064|NCT01658579|472262719|FG003|Treatment Period B|Other|1|||
131175065|NCT03029650|472262722|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
131175066|NCT03029650|472262723|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
131175067|NCT03029650|472262722|FG000|Washout (1 Week)|Physician Decision|0|||
131175068|NCT03029650|472262723|FG001|Washout (1 Week)|Physician Decision|1|||
131175069|NCT01875367|472262724|FG000|Overall Study|Not complete at least 2 questionaries|4|||
131175070|NCT01875367|472262725|FG001|Overall Study|Not complete at least 2 questionaries|2|||
131175071|NCT01875367|472262724|FG000|Overall Study|Not receive study treatment|1|||
131175072|NCT01875367|472262725|FG001|Overall Study|Not receive study treatment|0|||
131175073|NCT02237157|472262728|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
131175074|NCT02237157|472262729|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
131175075|NCT02237157|472262730|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
131175076|NCT02237157|472262731|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
131175077|NCT02237157|472262728|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
131175078|NCT02237157|472262729|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
131175079|NCT02237157|472262730|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
131175080|NCT02237157|472262731|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
131175081|NCT04533815|472262732|FG000|Overall Study|Adverse Event|2|||
131175082|NCT04533815|472262732|FG000|Overall Study|Site withdrew|5|||
131175083|NCT05836818|472262733|FG000|Overall Study|Physician Decision|1|||
131175084|NCT05836818|472262734|FG001|Overall Study|Physician Decision|1|||
131175085|NCT05836818|472262735|FG002|Overall Study|Physician Decision|0|||
131175086|NCT05836818|472262733|FG000|Overall Study|Withdrawal by Subject|0|||
131175087|NCT05836818|472262734|FG001|Overall Study|Withdrawal by Subject|0|||
131175088|NCT05836818|472262735|FG002|Overall Study|Withdrawal by Subject|1|||
131175089|NCT05836818|472262733|FG000|Overall Study|Later found to be previously vaccinated|0|||
131175090|NCT05836818|472262734|FG001|Overall Study|Later found to be previously vaccinated|1|||
131175091|NCT05836818|472262735|FG002|Overall Study|Later found to be previously vaccinated|3|||
131175092|NCT05836818|472262733|FG000|Overall Study|Pregnancy|0|||
131175093|NCT05836818|472262734|FG001|Overall Study|Pregnancy|1|||
131175094|NCT05836818|472262735|FG002|Overall Study|Pregnancy|0|||
131175095|NCT05836818|472262733|FG000|Overall Study|Allergic to vaccines|0|||
131175096|NCT05836818|472262734|FG001|Overall Study|Allergic to vaccines|1|||
131175097|NCT05836818|472262735|FG002|Overall Study|Allergic to vaccines|0|||
131175098|NCT03977727|472262736|FG000|Second Treatment|Lost to Follow-up|0|||
131175099|NCT03977727|472262737|FG001|Second Treatment|Lost to Follow-up|3|||
131175100|NCT00603980|472262739|FG000|Study Qualification|Protocol Violation|3|||
131236633|NCT01781286|472494979|FG003|Overall Study|Noncompliance|1|||
131236634|NCT01781286|472494980|FG004|Overall Study|Noncompliance|0|||
131236635|NCT01781286|472494981|FG005|Overall Study|Noncompliance|0|||
131236636|NCT03594123|472494982|FG000|Overall Study|Lost to Follow-up|0|||
131236637|NCT03594123|472494983|FG001|Overall Study|Lost to Follow-up|1|||
131236638|NCT03594123|472494982|FG000|Overall Study|Adverse Event|8|||
131236639|NCT03594123|472494983|FG001|Overall Study|Adverse Event|5|||
131236640|NCT03594123|472494982|FG000|Overall Study|Site Terminated by Sponsor|4|||
131236641|NCT03594123|472494983|FG001|Overall Study|Site Terminated by Sponsor|1|||
131236642|NCT03594123|472494982|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
131236643|NCT03594123|472494983|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
131236644|NCT03594123|472494982|FG000|Overall Study|Lack of Efficacy|1|||
131236645|NCT03594123|472494983|FG001|Overall Study|Lack of Efficacy|0|||
131175101|NCT00603980|472262739|FG000|Study Qualification|Inconsistent data reporting|13|||
131175102|NCT00603980|472262739|FG000|Main Study|14th subject completed trial|1|||
131175103|NCT02683525|472262740|FG000|Overall Study|Lost to Follow-up|1|||
131175104|NCT02683525|472262740|FG000|Overall Study|Physician Decision|1|||
131175105|NCT02683525|472262740|FG000|Overall Study|Disease Progression|6|||
131175106|NCT01627067|472262741|FG000|Overall Study|Screen Failure|1|||
131236646|NCT03594123|472494982|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
131236647|NCT03594123|472494983|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
131236648|NCT00818883|472494984|FG000|Overall Study|Adverse Event|28|||
131175107|NCT00926796|472262745|FG000|Overall Study|Did not receive randomized treatment|4|||
131175108|NCT00926796|472262746|FG001|Overall Study|Did not receive randomized treatment|7|||
131175109|NCT00926796|472262745|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
131175110|NCT00926796|472262746|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
131175111|NCT00926796|472262745|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
131175112|NCT00926796|472262746|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
131175113|NCT00926796|472262745|FG000|Overall Study|Adverse Event|7|||
131175114|NCT00926796|472262746|FG001|Overall Study|Adverse Event|14|||
131175115|NCT00926796|472262745|FG000|Overall Study|Lost to Follow-up|22|||
131175116|NCT00926796|472262746|FG001|Overall Study|Lost to Follow-up|13|||
131175117|NCT00926796|472262745|FG000|Overall Study|Protocol Violation|15|||
131175118|NCT00926796|472262746|FG001|Overall Study|Protocol Violation|11|||
131175119|NCT00926796|472262745|FG000|Overall Study|Withdrawal by Subject|1|||
131175120|NCT00926796|472262746|FG001|Overall Study|Withdrawal by Subject|0|||
131175121|NCT01341652|472262747|FG000|Overall Study|Incorrect Random Assignment|0|||
131175122|NCT01341652|472262748|FG001|Overall Study|Incorrect Random Assignment|1|||
131175123|NCT01341652|472262747|FG000|Overall Study|ineligible; presence metastatic disease|0|||
131175124|NCT01341652|472262748|FG001|Overall Study|ineligible; presence metastatic disease|1|||
131175125|NCT00632463|472262752|FG000|Overall Study|Adverse Event|0|||
131175126|NCT00632463|472262753|FG001|Overall Study|Adverse Event|1|||
131175127|NCT00632463|472262754|FG002|Overall Study|Adverse Event|0|||
131175128|NCT00586924|472262755|FG000|Overall Study|Adverse event/serious adverse event|0|||
131175129|NCT00586924|472262756|FG001|Overall Study|Adverse event/serious adverse event|0|||
131175130|NCT00586924|472262757|FG002|Overall Study|Adverse event/serious adverse event|0|||
131175131|NCT00586924|472262758|FG003|Overall Study|Adverse event/serious adverse event|1|||
131175132|NCT00586924|472262759|FG004|Overall Study|Adverse event/serious adverse event|0|||
131175133|NCT00586924|472262760|FG005|Overall Study|Adverse event/serious adverse event|2|||
131175134|NCT00586924|472262755|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
131175135|NCT00586924|472262756|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
131175136|NCT00586924|472262757|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
131175137|NCT00586924|472262758|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
131175138|NCT00586924|472262759|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
131175139|NCT00586924|472262760|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
131175140|NCT00586924|472262755|FG000|Overall Study|Disease progression|0|||
131175141|NCT00586924|472262756|FG001|Overall Study|Disease progression|0|||
131175142|NCT00586924|472262757|FG002|Overall Study|Disease progression|0|||
131175143|NCT00586924|472262758|FG003|Overall Study|Disease progression|1|||
131175144|NCT00586924|472262759|FG004|Overall Study|Disease progression|1|||
131175145|NCT00586924|472262760|FG005|Overall Study|Disease progression|0|||
131175146|NCT00586924|472262755|FG000|Overall Study|Development of neutralizing antibodies|2|||
131175147|NCT00586924|472262756|FG001|Overall Study|Development of neutralizing antibodies|2|||
131175148|NCT00586924|472262757|FG002|Overall Study|Development of neutralizing antibodies|2|||
131175149|NCT00586924|472262758|FG003|Overall Study|Development of neutralizing antibodies|0|||
131175150|NCT00586924|472262759|FG004|Overall Study|Development of neutralizing antibodies|0|||
131175151|NCT00586924|472262760|FG005|Overall Study|Development of neutralizing antibodies|22|||
131175152|NCT00586924|472262755|FG000|Overall Study|Complete response|0|||
131175153|NCT00586924|472262756|FG001|Overall Study|Complete response|1|||
131175154|NCT00586924|472262757|FG002|Overall Study|Complete response|0|||
131175155|NCT00586924|472262758|FG003|Overall Study|Complete response|0|||
131175156|NCT00586924|472262759|FG004|Overall Study|Complete response|2|||
131175157|NCT00586924|472262760|FG005|Overall Study|Complete response|2|||
131175158|NCT00586924|472262755|FG000|Overall Study|Other|1|||
131175159|NCT00586924|472262756|FG001|Overall Study|Other|0|||
131175160|NCT00586924|472262757|FG002|Overall Study|Other|1|||
131175161|NCT00586924|472262758|FG003|Overall Study|Other|1|||
131175162|NCT00586924|472262759|FG004|Overall Study|Other|1|||
131175163|NCT00586924|472262760|FG005|Overall Study|Other|6|||
131175164|NCT04167306|472262761|FG000|Overall Study|Lost to Follow-up|2|||
131175165|NCT04167306|472262762|FG001|Overall Study|Lost to Follow-up|2|||
131175166|NCT04167306|472262763|FG002|Overall Study|Lost to Follow-up|5|||
131175167|NCT04167306|472262764|FG003|Overall Study|Lost to Follow-up|5|||
131175168|NCT04167306|472262761|FG000|Overall Study|Adverse Event|13|||
131175169|NCT04167306|472262762|FG001|Overall Study|Adverse Event|14|||
131175170|NCT04167306|472262763|FG002|Overall Study|Adverse Event|5|||
131175171|NCT04167306|472262764|FG003|Overall Study|Adverse Event|4|||
131175172|NCT04167306|472262761|FG000|Overall Study|Withdrawal by Subject|4|||
131175173|NCT04167306|472262762|FG001|Overall Study|Withdrawal by Subject|6|||
131175174|NCT04167306|472262763|FG002|Overall Study|Withdrawal by Subject|8|||
131175175|NCT04167306|472262764|FG003|Overall Study|Withdrawal by Subject|3|||
131175176|NCT04167306|472262761|FG000|Overall Study|covid|1|||
131175177|NCT04167306|472262762|FG001|Overall Study|covid|1|||
131175178|NCT04167306|472262763|FG002|Overall Study|covid|2|||
131175179|NCT04167306|472262764|FG003|Overall Study|covid|1|||
131175180|NCT04167306|472262761|FG000|Overall Study|concomitant medication|0|||
131175181|NCT04167306|472262762|FG001|Overall Study|concomitant medication|0|||
131175182|NCT04167306|472262763|FG002|Overall Study|concomitant medication|0|||
131175183|NCT04167306|472262764|FG003|Overall Study|concomitant medication|1|||
131175184|NCT04167306|472262761|FG000|Overall Study|Alcohol treatment|0|||
131175185|NCT04167306|472262762|FG001|Overall Study|Alcohol treatment|4|||
131175186|NCT04167306|472262763|FG002|Overall Study|Alcohol treatment|3|||
131175187|NCT04167306|472262764|FG003|Overall Study|Alcohol treatment|2|||
131175188|NCT04167306|472262761|FG000|Overall Study|non-compliance|0|||
131175189|NCT04167306|472262762|FG001|Overall Study|non-compliance|0|||
131175190|NCT04167306|472262763|FG002|Overall Study|non-compliance|1|||
131175191|NCT04167306|472262764|FG003|Overall Study|non-compliance|0|||
131175192|NCT04167306|472262761|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
131175193|NCT04167306|472262762|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
131175194|NCT04167306|472262763|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
131175195|NCT04167306|472262764|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
131175196|NCT04146467|472262768|FG000|Overall Study|Adverse Event|0|||
131175197|NCT04146467|472262769|FG001|Overall Study|Adverse Event|1|||
131175198|NCT04146467|472262768|FG000|Overall Study|Lost to Follow-up|0|||
131175199|NCT04146467|472262769|FG001|Overall Study|Lost to Follow-up|2|||
131175200|NCT03731364|472262772|FG000|Overall Study|Adverse Event|0|||
131175201|NCT03731364|472262773|FG001|Overall Study|Adverse Event|0|||
131175202|NCT03731364|472262774|FG002|Overall Study|Adverse Event|1|||
131175203|NCT03731364|472262775|FG003|Overall Study|Adverse Event|2|||
131175204|NCT03731364|472262776|FG004|Overall Study|Adverse Event|1|||
131175205|NCT02357849|472262777|FG000|Overall Study|Withdrawal by Subject|2|||
131175206|NCT02357849|472262778|FG001|Overall Study|Withdrawal by Subject|3|||
131175207|NCT04633473|472262779|FG000|Overall Study|Withdrawal by Subject|6|||
131175208|NCT01982773|472262781|FG000|Overall Study|Withdrawal by Subject|1|||
131175209|NCT01982773|472262782|FG001|Overall Study|Withdrawal by Subject|3|||
131175210|NCT01982773|472262781|FG000|Overall Study|Lost to Follow-up|7|||
131175211|NCT01982773|472262782|FG001|Overall Study|Lost to Follow-up|1|||
131175212|NCT01029886|472262785|FG000|Overall Study|Adverse Event|12|||
131175213|NCT01029886|472262786|FG001|Overall Study|Adverse Event|25|||
131175214|NCT01029886|472262785|FG000|Overall Study|Lost to Follow-up|1|||
131175215|NCT01029886|472262786|FG001|Overall Study|Lost to Follow-up|0|||
131175216|NCT01029886|472262785|FG000|Overall Study|Physician Decision|2|||
131175217|NCT01029886|472262786|FG001|Overall Study|Physician Decision|6|||
131175218|NCT01029886|472262785|FG000|Overall Study|Protocol Violation|17|||
131175219|NCT01029886|472262786|FG001|Overall Study|Protocol Violation|5|||
131175220|NCT01029886|472262785|FG000|Overall Study|Withdrawal by Subject|8|||
131175221|NCT01029886|472262786|FG001|Overall Study|Withdrawal by Subject|18|||
131175222|NCT01029886|472262785|FG000|Overall Study|Entry Criteria Not Met|13|||
131175223|NCT01029886|472262786|FG001|Overall Study|Entry Criteria Not Met|5|||
131175224|NCT01029886|472262785|FG000|Overall Study|Sponsor Decision|1|||
131175225|NCT01029886|472262786|FG001|Overall Study|Sponsor Decision|0|||
131175226|NCT01029886|472262785|FG000|Overall Study|Loss Glucose Control|7|||
131175227|NCT01029886|472262786|FG001|Overall Study|Loss Glucose Control|1|||
131175228|NCT03294681|472262787|FG000|Overall Study|Withdrawal by Subject|1|||
131175229|NCT03089216|472262788|FG000|Overall Study|Adverse Event|0|||
131175230|NCT03089216|472262789|FG001|Overall Study|Adverse Event|0|||
131175231|NCT03089216|472262790|FG002|Overall Study|Adverse Event|0|||
131175232|NCT03089216|472262791|FG003|Overall Study|Adverse Event|1|||
131175233|NCT00417976|472262796|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
131175234|NCT00417976|472262796|FG000|Overall Study|Treatment -related toxicity|2|||
131175235|NCT01778127|472262799|FG000|Overall Study|Lost to Follow-up|5|||
131175236|NCT01778127|472262800|FG001|Overall Study|Lost to Follow-up|1|||
131175237|NCT01778127|472262801|FG002|Overall Study|Lost to Follow-up|2|||
131175238|NCT01778127|472262799|FG000|Overall Study|Withdrawal by Subject|3|||
131175239|NCT01778127|472262800|FG001|Overall Study|Withdrawal by Subject|1|||
131175240|NCT01778127|472262801|FG002|Overall Study|Withdrawal by Subject|4|||
131175241|NCT01348425|472262805|FG000|Overall Study|Imaging was not taken.|1|||
131175242|NCT01348425|472262806|FG001|Overall Study|Imaging was not taken.|1|||
131175243|NCT02720016|472262807|FG000|Overall Study|Separation of couple|6|||
131175244|NCT02720016|472262808|FG001|Overall Study|Separation of couple|8|||
131175245|NCT02720016|472262809|FG002|Overall Study|Separation of couple|2|||
131175246|NCT02720016|472262807|FG000|Overall Study|Withdrawal by Subject|6|||
131175247|NCT02720016|472262808|FG001|Overall Study|Withdrawal by Subject|6|||
131175248|NCT02720016|472262809|FG002|Overall Study|Withdrawal by Subject|4|||
131175249|NCT02720016|472262807|FG000|Overall Study|Scheduling issues|2|||
131175250|NCT02720016|472262808|FG001|Overall Study|Scheduling issues|4|||
131175251|NCT02720016|472262809|FG002|Overall Study|Scheduling issues|7|||
131175252|NCT02720016|472262807|FG000|Overall Study|Childcare|2|||
131175253|NCT02720016|472262808|FG001|Overall Study|Childcare|0|||
131175254|NCT02720016|472262809|FG002|Overall Study|Childcare|2|||
131175255|NCT02720016|472262807|FG000|Overall Study|Withdrawal by PI|2|||
131175256|NCT02720016|472262808|FG001|Overall Study|Withdrawal by PI|2|||
131175257|NCT02720016|472262809|FG002|Overall Study|Withdrawal by PI|0|||
131175258|NCT02720016|472262807|FG000|Overall Study|Moved away|2|||
131175259|NCT02720016|472262808|FG001|Overall Study|Moved away|0|||
131175260|NCT02720016|472262809|FG002|Overall Study|Moved away|0|||
131175261|NCT02720016|472262807|FG000|Overall Study|Not Primary Health Concern|0|||
131175262|NCT02720016|472262808|FG001|Overall Study|Not Primary Health Concern|0|||
131175263|NCT02720016|472262809|FG002|Overall Study|Not Primary Health Concern|2|||
131175264|NCT02720016|472262807|FG000|Overall Study|Transportation issues|0|||
131175265|NCT02720016|472262808|FG001|Overall Study|Transportation issues|0|||
131175266|NCT02720016|472262809|FG002|Overall Study|Transportation issues|1|||
131175267|NCT02720016|472262807|FG000|Overall Study|Other|0|||
131175268|NCT02720016|472262808|FG001|Overall Study|Other|0|||
131175269|NCT02720016|472262809|FG002|Overall Study|Other|2|||
131175270|NCT03722784|472262814|FG000|Overall Study|Withdrawal by Subject|1|||
131175271|NCT03722784|472262815|FG001|Overall Study|Withdrawal by Subject|0|||
131175272|NCT03722784|472262814|FG000|Overall Study|Physician Decision|1|||
131175273|NCT03722784|472262815|FG001|Overall Study|Physician Decision|1|||
131175274|NCT03722784|472262814|FG000|Overall Study|Protocol Violation|0|||
130782377|NCT01249417|470831129|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
130782378|NCT01249417|470831127|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
130782379|NCT01249417|470831128|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
130782380|NCT01249417|470831129|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
130782381|NCT00917124|470831130|FG000|Overall Study|Protocol Violation|4|||
130782382|NCT00917124|470831131|FG001|Overall Study|Protocol Violation|6|||
130782383|NCT00126594|470831133|FG000|Overall Study|Ineligible|2|||
130782384|NCT00126594|470831134|FG001|Overall Study|Ineligible|0|||
130782385|NCT00126594|470831133|FG000|Overall Study|Withdrawal by Subject|0|||
130782386|NCT00126594|470831134|FG001|Overall Study|Withdrawal by Subject|4|||
130782387|NCT00126594|470831133|FG000|Overall Study|Physician Decision|1|||
130782388|NCT00126594|470831134|FG001|Overall Study|Physician Decision|3|||
130782389|NCT00126594|470831133|FG000|Overall Study|Adverse Event|7|||
130782390|NCT00126594|470831134|FG001|Overall Study|Adverse Event|5|||
130782391|NCT00126594|470831133|FG000|Overall Study|Non-compliance|0|||
130782392|NCT00126594|470831134|FG001|Overall Study|Non-compliance|1|||
130782393|NCT00126594|470831133|FG000|Overall Study|Disease Progression|29|||
130782394|NCT00126594|470831134|FG001|Overall Study|Disease Progression|24|||
130782395|NCT03769649|470831135|FG000|Overall Study|Lost to Follow-up|4|||
130782396|NCT01290718|470831138|FG000|Overall Study|Early termination of the study|4|||
130782397|NCT00473655|470831139|FG000|Overall Study|Lost to Follow-up|9|||
131175275|NCT03722784|472262815|FG001|Overall Study|Protocol Violation|1|||
131175276|NCT01963208|472262816|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
131175277|NCT01963208|472262817|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
131175278|NCT01963208|472262818|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
131175279|NCT01963208|472262819|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
131175280|NCT01963208|472262820|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
131175281|NCT01963208|472262821|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
131175282|NCT01963208|472262816|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
131175283|NCT01963208|472262817|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
131175284|NCT01963208|472262818|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
131175285|NCT01963208|472262819|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
131175286|NCT01963208|472262820|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
130782398|NCT00473655|470831140|FG001|Overall Study|Lost to Follow-up|5|||
130782399|NCT00473655|470831141|FG002|Overall Study|Lost to Follow-up|8|||
131175287|NCT01963208|472262821|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
131175288|NCT01963208|472262816|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
131175289|NCT01963208|472262817|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
131175290|NCT01963208|472262818|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
131175291|NCT01963208|472262819|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
131175292|NCT01963208|472262820|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
131175293|NCT01963208|472262821|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
131175294|NCT01963208|472262816|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
131175295|NCT01963208|472262817|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
131175296|NCT01963208|472262818|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
131175297|NCT01963208|472262819|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
131175298|NCT01963208|472262820|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
131175299|NCT01963208|472262821|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
131175300|NCT01963208|472262816|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
131175301|NCT01963208|472262817|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
131175302|NCT01963208|472262818|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
131175303|NCT01963208|472262819|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
131175304|NCT01963208|472262820|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
131175305|NCT01963208|472262821|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
131175306|NCT01963208|472262816|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
131175307|NCT01963208|472262817|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
131175308|NCT01963208|472262818|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
131175309|NCT01963208|472262819|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
131175310|NCT01963208|472262820|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
131175311|NCT01963208|472262821|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
131175312|NCT01963208|472262816|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
131175313|NCT01963208|472262817|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
131175314|NCT01963208|472262818|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
131175315|NCT01963208|472262819|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
131175316|NCT01963208|472262820|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
131175317|NCT01963208|472262821|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
130782400|NCT00243919|470831142|FG000|Overall Study|Death|3|||
130782401|NCT00243919|470831143|FG001|Overall Study|Death|4|||
130782402|NCT00243919|470831144|FG002|Overall Study|Death|6|||
130782403|NCT00243919|470831142|FG000|Overall Study|Withdrawal by Subject|6|||
131175318|NCT01963208|472262816|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
131175319|NCT01963208|472262817|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
131175320|NCT01963208|472262818|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
131175321|NCT01963208|472262819|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
131175322|NCT01963208|472262820|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
131175323|NCT01963208|472262821|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
131175324|NCT01963208|472262816|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
131175325|NCT01963208|472262817|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
131175326|NCT01963208|472262818|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
131175327|NCT01963208|472262819|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
131175328|NCT01963208|472262820|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
131175329|NCT01963208|472262821|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
131175330|NCT01963208|472262816|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
131175331|NCT01963208|472262817|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
131175332|NCT01963208|472262818|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
131175333|NCT01963208|472262819|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
131175334|NCT01963208|472262820|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
131175335|NCT01963208|472262821|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
131175336|NCT01963208|472262816|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
131175337|NCT01963208|472262817|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
131175338|NCT01963208|472262818|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
131175339|NCT01963208|472262819|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
131175340|NCT01963208|472262820|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
131175341|NCT01963208|472262821|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
131175342|NCT01963208|472262816|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
131175343|NCT01963208|472262817|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
131175344|NCT01963208|472262818|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
131175345|NCT01963208|472262819|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
131175346|NCT01963208|472262820|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
131175347|NCT01963208|472262821|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
131175348|NCT01963208|472262816|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
131175349|NCT01963208|472262817|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
131175350|NCT01963208|472262818|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
131175351|NCT01963208|472262819|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
131175352|NCT01963208|472262820|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
131175353|NCT01963208|472262821|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
131175354|NCT01963208|472262816|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
131175355|NCT01963208|472262817|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
131175356|NCT01963208|472262818|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
131175357|NCT01963208|472262819|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
131175358|NCT01963208|472262820|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
131175359|NCT01963208|472262821|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
131175360|NCT00448916|472262822|FG000|Overall Study|Adverse Event|2|||
131175361|NCT00448916|472262823|FG001|Overall Study|Adverse Event|2|||
131175362|NCT00448916|472262824|FG002|Overall Study|Adverse Event|3|||
131175363|NCT00448916|472262825|FG003|Overall Study|Adverse Event|2|||
131175364|NCT00448916|472262822|FG000|Overall Study|Lack of Efficacy|1|||
131175365|NCT00448916|472262823|FG001|Overall Study|Lack of Efficacy|0|||
131175366|NCT00448916|472262824|FG002|Overall Study|Lack of Efficacy|2|||
131175367|NCT00448916|472262825|FG003|Overall Study|Lack of Efficacy|1|||
131175368|NCT00448916|472262822|FG000|Overall Study|Withdrawal by Subject|3|||
131175369|NCT00448916|472262823|FG001|Overall Study|Withdrawal by Subject|3|||
131175370|NCT00448916|472262824|FG002|Overall Study|Withdrawal by Subject|1|||
131175371|NCT00448916|472262825|FG003|Overall Study|Withdrawal by Subject|1|||
131175372|NCT00448916|472262822|FG000|Overall Study|Other|1|||
131175373|NCT00448916|472262823|FG001|Overall Study|Other|0|||
131175374|NCT00448916|472262824|FG002|Overall Study|Other|0|||
131175375|NCT00448916|472262825|FG003|Overall Study|Other|0|||
131175376|NCT00448916|472262822|FG000|Overall Study|Lost to Follow-up|0|||
131175377|NCT00448916|472262823|FG001|Overall Study|Lost to Follow-up|1|||
131175378|NCT00448916|472262824|FG002|Overall Study|Lost to Follow-up|0|||
131175379|NCT00448916|472262825|FG003|Overall Study|Lost to Follow-up|1|||
131175380|NCT00448916|472262822|FG000|Overall Study|Protocol Violation|0|||
131175381|NCT00448916|472262823|FG001|Overall Study|Protocol Violation|0|||
131175382|NCT00448916|472262824|FG002|Overall Study|Protocol Violation|0|||
131175383|NCT00448916|472262825|FG003|Overall Study|Protocol Violation|1|||
131175384|NCT03707158|472262828|FG000|Midtreatment|Lost to Follow-up|16|||
131175385|NCT03707158|472262829|FG001|Midtreatment|Lost to Follow-up|7|||
131175386|NCT03707158|472262828|FG000|Midtreatment|Withdrawal by Subject|28|||
131175387|NCT03707158|472262829|FG001|Midtreatment|Withdrawal by Subject|19|||
131175388|NCT03707158|472262828|FG000|Posttreatment|Lost to Follow-up|0|||
131175389|NCT03707158|472262829|FG001|Posttreatment|Lost to Follow-up|5|||
131175390|NCT03707158|472262828|FG000|Follow-up|Lost to Follow-up|19|||
131175391|NCT03707158|472262829|FG001|Follow-up|Lost to Follow-up|18|||
131175392|NCT03707158|472262828|FG000|Follow-up|Withdrawal by Subject|13|||
131175393|NCT03707158|472262829|FG001|Follow-up|Withdrawal by Subject|6|||
131175394|NCT01208038|472262830|FG000|Overall Study|Withdrawal by Subject|1|||
131175395|NCT03260205|472262831|FG000|Overall Study|Adverse Event|2|||
131175396|NCT03260205|472262832|FG001|Overall Study|Adverse Event|0|||
131175397|NCT03260205|472262833|FG002|Overall Study|Adverse Event|2|||
131175398|NCT03260205|472262834|FG003|Overall Study|Adverse Event|2|||
131175399|NCT03260205|472262835|FG004|Overall Study|Adverse Event|4|||
131175400|NCT03260205|472262831|FG000|Overall Study|Lost to Follow-up|2|||
131175401|NCT03260205|472262832|FG001|Overall Study|Lost to Follow-up|2|||
131175402|NCT03260205|472262833|FG002|Overall Study|Lost to Follow-up|1|||
131175403|NCT03260205|472262834|FG003|Overall Study|Lost to Follow-up|1|||
131175404|NCT03260205|472262835|FG004|Overall Study|Lost to Follow-up|5|||
131175405|NCT03260205|472262831|FG000|Overall Study|Protocol Violation|0|||
131175406|NCT03260205|472262832|FG001|Overall Study|Protocol Violation|0|||
131175407|NCT03260205|472262833|FG002|Overall Study|Protocol Violation|2|||
131175408|NCT03260205|472262834|FG003|Overall Study|Protocol Violation|0|||
131175409|NCT03260205|472262835|FG004|Overall Study|Protocol Violation|1|||
131175410|NCT03260205|472262831|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
131175411|NCT03260205|472262832|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
131175412|NCT03260205|472262833|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
131175413|NCT03260205|472262834|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
131175414|NCT03260205|472262835|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
131175415|NCT03260205|472262831|FG000|Overall Study|Other: Unspecified|0|||
131175416|NCT03260205|472262832|FG001|Overall Study|Other: Unspecified|0|||
131175417|NCT03260205|472262833|FG002|Overall Study|Other: Unspecified|3|||
131175418|NCT03260205|472262834|FG003|Overall Study|Other: Unspecified|1|||
131175419|NCT03260205|472262835|FG004|Overall Study|Other: Unspecified|1|||
131175420|NCT03260205|472262831|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
131175421|NCT03260205|472262832|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
131175422|NCT03260205|472262833|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
131175423|NCT03260205|472262834|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
131175424|NCT03260205|472262835|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
131175425|NCT05301322|472262836|FG000|Overall Study|Adverse Event|7|||
131175426|NCT05301322|472262837|FG001|Overall Study|Adverse Event|3|||
131175427|NCT05301322|472262836|FG000|Overall Study|Death|0|||
131175428|NCT05301322|472262837|FG001|Overall Study|Death|1|||
131175429|NCT05301322|472262836|FG000|Overall Study|Lost to Follow-up|2|||
131175430|NCT05301322|472262837|FG001|Overall Study|Lost to Follow-up|1|||
131175431|NCT05301322|472262836|FG000|Overall Study|Protocol Violation|3|||
131175432|NCT05301322|472262837|FG001|Overall Study|Protocol Violation|1|||
131175433|NCT05301322|472262836|FG000|Overall Study|Withdrawal by Subject|3|||
131175434|NCT05301322|472262837|FG001|Overall Study|Withdrawal by Subject|0|||
131175435|NCT05301322|472262836|FG000|Overall Study|Other|4|||
131175436|NCT05301322|472262837|FG001|Overall Study|Other|0|||
131175437|NCT00808249|472262840|FG000|Overall Study|Adverse Event|4|||
131175438|NCT00808249|472262841|FG001|Overall Study|Adverse Event|7|||
131175439|NCT00808249|472262842|FG002|Overall Study|Adverse Event|10|||
131175440|NCT00808249|472262843|FG003|Overall Study|Adverse Event|6|||
131175441|NCT00808249|472262840|FG000|Overall Study|Lost to Follow-up|2|||
131175442|NCT00808249|472262841|FG001|Overall Study|Lost to Follow-up|3|||
131175443|NCT00808249|472262842|FG002|Overall Study|Lost to Follow-up|3|||
131175444|NCT00808249|472262843|FG003|Overall Study|Lost to Follow-up|5|||
131175445|NCT00808249|472262840|FG000|Overall Study|Withdrawal by Subject|4|||
131175446|NCT00808249|472262841|FG001|Overall Study|Withdrawal by Subject|0|||
131175447|NCT00808249|472262842|FG002|Overall Study|Withdrawal by Subject|2|||
131175448|NCT00808249|472262843|FG003|Overall Study|Withdrawal by Subject|4|||
131175449|NCT00808249|472262840|FG000|Overall Study|Protocol Violation|3|||
130782404|NCT00243919|470831143|FG001|Overall Study|Withdrawal by Subject|6|||
130782405|NCT00243919|470831144|FG002|Overall Study|Withdrawal by Subject|2|||
130782406|NCT00243919|470831142|FG000|Overall Study|Lost to Follow-up|6|||
130782407|NCT00243919|470831143|FG001|Overall Study|Lost to Follow-up|7|||
131175450|NCT00808249|472262841|FG001|Overall Study|Protocol Violation|3|||
131175451|NCT00808249|472262842|FG002|Overall Study|Protocol Violation|3|||
131175452|NCT00808249|472262843|FG003|Overall Study|Protocol Violation|0|||
131175453|NCT00808249|472262840|FG000|Overall Study|Lack of Efficacy|1|||
131175454|NCT00808249|472262841|FG001|Overall Study|Lack of Efficacy|1|||
131175455|NCT00808249|472262842|FG002|Overall Study|Lack of Efficacy|0|||
131175456|NCT00808249|472262843|FG003|Overall Study|Lack of Efficacy|0|||
131175457|NCT00808249|472262840|FG000|Overall Study|study specific discontinuation criteria|1|||
131175458|NCT00808249|472262841|FG001|Overall Study|study specific discontinuation criteria|0|||
131175459|NCT00808249|472262842|FG002|Overall Study|study specific discontinuation criteria|1|||
131175460|NCT00808249|472262843|FG003|Overall Study|study specific discontinuation criteria|0|||
131175461|NCT00808249|472262840|FG000|Overall Study|All other reasons|2|||
131175462|NCT00808249|472262841|FG001|Overall Study|All other reasons|1|||
131175463|NCT00808249|472262842|FG002|Overall Study|All other reasons|3|||
131175464|NCT00808249|472262843|FG003|Overall Study|All other reasons|1|||
131175465|NCT03829332|472262844|FG000|Overall Study|Death|225|||
131175466|NCT03829332|472262845|FG001|Overall Study|Death|230|||
131175467|NCT03829332|472262844|FG000|Overall Study|Lost to Follow-up|1|||
131175468|NCT03829332|472262845|FG001|Overall Study|Lost to Follow-up|3|||
131175469|NCT03829332|472262844|FG000|Overall Study|Physician Decision|1|||
131175470|NCT03829332|472262845|FG001|Overall Study|Physician Decision|0|||
131175471|NCT03829332|472262844|FG000|Overall Study|Sponsor Decision|71|||
131175472|NCT03829332|472262845|FG001|Overall Study|Sponsor Decision|72|||
131175473|NCT03829332|472262844|FG000|Overall Study|Withdrawal by Subject|11|||
131175474|NCT03829332|472262845|FG001|Overall Study|Withdrawal by Subject|9|||
131175475|NCT00430521|472262846|FG000|Overall Study|Adverse Event|0|||
131175476|NCT00430521|472262847|FG001|Overall Study|Adverse Event|0|||
131175477|NCT00430521|472262848|FG002|Overall Study|Adverse Event|0|||
131175478|NCT00430521|472262849|FG003|Overall Study|Adverse Event|0|||
131175479|NCT00430521|472262850|FG004|Overall Study|Adverse Event|0|||
131175480|NCT00430521|472262851|FG005|Overall Study|Adverse Event|2|||
131175481|NCT00430521|472262852|FG006|Overall Study|Adverse Event|1|||
131175482|NCT00430521|472262853|FG007|Overall Study|Adverse Event|0|||
131175483|NCT00430521|472262846|FG000|Overall Study|Lost to Follow-up|7|||
131175484|NCT00430521|472262847|FG001|Overall Study|Lost to Follow-up|8|||
131175485|NCT00430521|472262848|FG002|Overall Study|Lost to Follow-up|3|||
131175486|NCT00430521|472262849|FG003|Overall Study|Lost to Follow-up|5|||
131175487|NCT00430521|472262850|FG004|Overall Study|Lost to Follow-up|5|||
131175488|NCT00430521|472262851|FG005|Overall Study|Lost to Follow-up|2|||
131175489|NCT00430521|472262852|FG006|Overall Study|Lost to Follow-up|8|||
131175490|NCT00430521|472262853|FG007|Overall Study|Lost to Follow-up|10|||
131175491|NCT00430521|472262846|FG000|Overall Study|Pregnancy|0|||
131175492|NCT00430521|472262847|FG001|Overall Study|Pregnancy|0|||
131175493|NCT00430521|472262848|FG002|Overall Study|Pregnancy|0|||
131175494|NCT00430521|472262849|FG003|Overall Study|Pregnancy|0|||
131175495|NCT00430521|472262850|FG004|Overall Study|Pregnancy|0|||
131175496|NCT00430521|472262851|FG005|Overall Study|Pregnancy|0|||
131175497|NCT00430521|472262852|FG006|Overall Study|Pregnancy|1|||
131175498|NCT00430521|472262853|FG007|Overall Study|Pregnancy|0|||
131175499|NCT00430521|472262846|FG000|Overall Study|Vaccine Expired|0|||
131175500|NCT00430521|472262847|FG001|Overall Study|Vaccine Expired|0|||
131175501|NCT00430521|472262848|FG002|Overall Study|Vaccine Expired|0|||
131175502|NCT00430521|472262849|FG003|Overall Study|Vaccine Expired|0|||
131175503|NCT00430521|472262850|FG004|Overall Study|Vaccine Expired|0|||
131175504|NCT00430521|472262851|FG005|Overall Study|Vaccine Expired|1|||
131175505|NCT00430521|472262852|FG006|Overall Study|Vaccine Expired|0|||
131175506|NCT00430521|472262853|FG007|Overall Study|Vaccine Expired|0|||
131175507|NCT00430521|472262846|FG000|Overall Study|Protocol Violation|1|||
131175508|NCT00430521|472262847|FG001|Overall Study|Protocol Violation|0|||
131175509|NCT00430521|472262848|FG002|Overall Study|Protocol Violation|0|||
131175510|NCT00430521|472262849|FG003|Overall Study|Protocol Violation|0|||
131175511|NCT00430521|472262850|FG004|Overall Study|Protocol Violation|0|||
131175512|NCT00430521|472262851|FG005|Overall Study|Protocol Violation|0|||
131175513|NCT00430521|472262852|FG006|Overall Study|Protocol Violation|0|||
131175514|NCT00430521|472262853|FG007|Overall Study|Protocol Violation|0|||
131175515|NCT00430521|472262846|FG000|Overall Study|Withdrawal by Subject|3|||
131175516|NCT00430521|472262847|FG001|Overall Study|Withdrawal by Subject|1|||
131175517|NCT00430521|472262848|FG002|Overall Study|Withdrawal by Subject|0|||
131175518|NCT00430521|472262849|FG003|Overall Study|Withdrawal by Subject|3|||
131175519|NCT00430521|472262850|FG004|Overall Study|Withdrawal by Subject|0|||
131175520|NCT00430521|472262851|FG005|Overall Study|Withdrawal by Subject|0|||
131175521|NCT00430521|472262852|FG006|Overall Study|Withdrawal by Subject|0|||
131175522|NCT00430521|472262853|FG007|Overall Study|Withdrawal by Subject|2|||
131175523|NCT05108805|472262854|FG000|Overall Study|T-cell expansion was not successful.|5|||
131175524|NCT04752189|472262855|FG000|Overall Study|Withdrawal by Subject|0|||
131175525|NCT04752189|472262856|FG001|Overall Study|Withdrawal by Subject|150|||
131175526|NCT04752189|472262855|FG000|Overall Study|Lost to Follow-up|261|||
131175527|NCT04752189|472262856|FG001|Overall Study|Lost to Follow-up|126|||
131175528|NCT03422133|472262857|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
131175529|NCT03422133|472262858|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
131175530|NCT03003403|472262859|FG000|Overall Study|Ineligible|8|||
131175531|NCT03003403|472262860|FG001|Overall Study|Ineligible|7|||
131175532|NCT03003403|472262859|FG000|Overall Study|Withdrawal by Subject|3|||
131175533|NCT03003403|472262860|FG001|Overall Study|Withdrawal by Subject|1|||
131175534|NCT02198651|472264458|FG000|Lead-in Period|Withdrew consent|13|||
131175535|NCT02198651|472264459|FG001|Lead-in Period|Withdrew consent|0|||
131175536|NCT02198651|472264460|FG002|Lead-in Period|Withdrew consent|0|||
131175537|NCT02198651|472264461|FG003|Lead-in Period|Withdrew consent|0|||
131175538|NCT02198651|472264462|FG004|Lead-in Period|Withdrew consent|0|||
131175539|NCT02198651|472264458|FG000|Lead-in Period|Adverse Event|2|||
131175540|NCT02198651|472264459|FG001|Lead-in Period|Adverse Event|0|||
131175541|NCT02198651|472264460|FG002|Lead-in Period|Adverse Event|0|||
131175542|NCT02198651|472264461|FG003|Lead-in Period|Adverse Event|0|||
131175543|NCT02198651|472264462|FG004|Lead-in Period|Adverse Event|0|||
131175544|NCT02198651|472264458|FG000|Lead-in Period|Other, not specified|22|||
131236649|NCT00818883|472494985|FG001|Overall Study|Adverse Event|19|||
131175545|NCT02198651|472264459|FG001|Lead-in Period|Other, not specified|0|||
131175546|NCT02198651|472264460|FG002|Lead-in Period|Other, not specified|0|||
131175547|NCT02198651|472264461|FG003|Lead-in Period|Other, not specified|0|||
131175548|NCT02198651|472264462|FG004|Lead-in Period|Other, not specified|0|||
131175549|NCT02198651|472264458|FG000|Double-blind Period|Withdrew consent|0|||
131175550|NCT02198651|472264459|FG001|Double-blind Period|Withdrew consent|4|||
131175551|NCT02198651|472264460|FG002|Double-blind Period|Withdrew consent|0|||
131175552|NCT02198651|472264461|FG003|Double-blind Period|Withdrew consent|0|||
131175553|NCT02198651|472264462|FG004|Double-blind Period|Withdrew consent|0|||
131175554|NCT02198651|472264458|FG000|Double-blind Period|Adverse Event|0|||
131175555|NCT02198651|472264459|FG001|Double-blind Period|Adverse Event|1|||
131175556|NCT02198651|472264460|FG002|Double-blind Period|Adverse Event|0|||
131175557|NCT02198651|472264461|FG003|Double-blind Period|Adverse Event|0|||
131175558|NCT02198651|472264462|FG004|Double-blind Period|Adverse Event|0|||
131175559|NCT02198651|472264458|FG000|Double-blind Period|Other, not specified|0|||
131175560|NCT02198651|472264459|FG001|Double-blind Period|Other, not specified|4|||
131175561|NCT02198651|472264460|FG002|Double-blind Period|Other, not specified|1|||
131175562|NCT02198651|472264461|FG003|Double-blind Period|Other, not specified|0|||
131175563|NCT02198651|472264462|FG004|Double-blind Period|Other, not specified|0|||
131175564|NCT02198651|472264458|FG000|Open-label Rescue Period|Withdrew consent|0|||
131175565|NCT02198651|472264459|FG001|Open-label Rescue Period|Withdrew consent|0|||
131175566|NCT02198651|472264460|FG002|Open-label Rescue Period|Withdrew consent|0|||
131175567|NCT02198651|472264461|FG003|Open-label Rescue Period|Withdrew consent|2|||
131175568|NCT02198651|472264462|FG004|Open-label Rescue Period|Withdrew consent|0|||
131175569|NCT02198651|472264458|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
131175570|NCT02198651|472264459|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
131175571|NCT02198651|472264460|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
131175572|NCT02198651|472264461|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
131175573|NCT02198651|472264462|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
131175574|NCT02871401|472264469|FG000|Overall Study|Adverse Event|1|||
131175575|NCT02871401|472264470|FG001|Overall Study|Adverse Event|0|||
131175576|NCT01120379|472264471|FG000|One Year Timepoint|Withdrawal by Subject|41|||
131175577|NCT01120379|472264471|FG000|One Year Timepoint|Lost to Follow-up|115|||
131175578|NCT01120379|472264471|FG000|One Year Timepoint|Death|108|||
131175579|NCT01120379|472264471|FG000|One Year Timepoint|Physician Decision|9|||
131175580|NCT01120379|472264471|FG000|One Year Timepoint|Any other reason for early termination|5|||
131175581|NCT01120379|472264471|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
131175582|NCT01120379|472264471|FG000|Two Year Timepoint|Lost to Follow-up|87|||
131175583|NCT01120379|472264471|FG000|Two Year Timepoint|Death|123|||
131175584|NCT01120379|472264471|FG000|Two Year Timepoint|Physician Decision|12|||
131175585|NCT01120379|472264471|FG000|Two Year Timepoint|Any other reason for early termination|4|||
131175586|NCT01120379|472264471|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
131175587|NCT01120379|472264471|FG000|Three Year Timepoint|Lost to Follow-up|43|||
131175588|NCT01120379|472264471|FG000|Three Year Timepoint|Death|120|||
131175589|NCT01120379|472264471|FG000|Three Year Timepoint|Physician Decision|9|||
131175590|NCT01120379|472264471|FG000|Three Year Timepoint|Any other reason for early termination|17|||
131175591|NCT01120379|472264471|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
131175592|NCT01120379|472264471|FG000|Four Year Timepoint|Lost to Follow-up|10|||
131175593|NCT01120379|472264471|FG000|Four Year Timepoint|Death|131|||
131175594|NCT01120379|472264471|FG000|Four Year Timepoint|Physician Decision|5|||
131175595|NCT01120379|472264471|FG000|Four Year Timepoint|Any other reason for early termination|217|||
131175596|NCT02370498|472264477|FG000|Overall Study|Adverse Event|10|||
131175597|NCT02370498|472264478|FG001|Overall Study|Adverse Event|8|||
131175598|NCT02370498|472264477|FG000|Overall Study|Death|263|||
131175599|NCT02370498|472264478|FG001|Overall Study|Death|265|||
131175600|NCT02370498|472264477|FG000|Overall Study|Protocol Violation|1|||
131175601|NCT02370498|472264478|FG001|Overall Study|Protocol Violation|2|||
131175602|NCT02370498|472264477|FG000|Overall Study|Withdrawal by Subject|7|||
131175603|NCT02370498|472264478|FG001|Overall Study|Withdrawal by Subject|12|||
131175604|NCT02370498|472264477|FG000|Overall Study|Sponsor's decision|15|||
131175605|NCT02370498|472264478|FG001|Overall Study|Sponsor's decision|9|||
131175606|NCT01089582|472264480|FG000|Overall Study|Death|2|||
131175607|NCT01089582|472264480|FG000|Overall Study|Adverse Event|15|||
131175608|NCT01089582|472264480|FG000|Overall Study|Lost to Follow-up|8|||
131175609|NCT01089582|472264480|FG000|Overall Study|Other|4|||
131175610|NCT01089582|472264480|FG000|Overall Study|Withdrawal by Subject|1|||
131175611|NCT02108600|472264482|FG000|Overall Study|Withdrawal by Subject|2|||
131175612|NCT02108600|472264483|FG001|Overall Study|Withdrawal by Subject|0|||
131175613|NCT02108600|472264482|FG000|Overall Study|Lost to Follow-up|1|||
131175614|NCT02108600|472264483|FG001|Overall Study|Lost to Follow-up|1|||
131175615|NCT03943953|472264484|FG000|Trial of ITG 1|Lost to Follow-up|19|||
131175616|NCT03943953|472264485|FG001|Trial of ITG 1|Lost to Follow-up|1|||
131175617|NCT03943953|472264484|FG000|Trial of ITG 2|Lost to Follow-up|8|||
131236650|NCT00818883|472494984|FG000|Overall Study|Protocol Violation|2|||
131236651|NCT00818883|472494985|FG001|Overall Study|Protocol Violation|2|||
131175618|NCT03943953|472264485|FG001|Trial of ITG 2|Lost to Follow-up|0|||
131175619|NCT03943953|472264484|FG000|Trial of ITG 3|Lost to Follow-up|2|||
131175620|NCT03943953|472264485|FG001|Trial of ITG 3|Lost to Follow-up|0|||
131175621|NCT03943953|472264484|FG000|Trial of ITG 4|Lost to Follow-up|2|||
131175622|NCT03943953|472264485|FG001|Trial of ITG 4|Lost to Follow-up|0|||
131175623|NCT00289185|472264486|FG000|Overall Study|Withdrawal by Subject|4|||
131175624|NCT00289185|472264487|FG001|Overall Study|Withdrawal by Subject|8|||
131175625|NCT00289185|472264486|FG000|Overall Study|Lost to Follow-up|23|||
131175626|NCT00289185|472264487|FG001|Overall Study|Lost to Follow-up|17|||
131175627|NCT00289185|472264486|FG000|Overall Study|Death|1|||
131175628|NCT00289185|472264487|FG001|Overall Study|Death|1|||
131175629|NCT02432040|472264488|FG000|Overall Study|Lack of Efficacy|3|||
131175630|NCT02432040|472264489|FG001|Overall Study|Lack of Efficacy|0|||
131175631|NCT02432040|472264488|FG000|Overall Study|Lost to Follow-up|4|||
131175632|NCT02432040|472264489|FG001|Overall Study|Lost to Follow-up|5|||
131175633|NCT02432040|472264488|FG000|Overall Study|Physician Decision|1|||
131175634|NCT02432040|472264489|FG001|Overall Study|Physician Decision|1|||
131175635|NCT01514188|472264490|FG000|Overall Study|Adverse Event|3|||
131175636|NCT01514188|472264491|FG001|Overall Study|Adverse Event|5|||
131175637|NCT01514188|472264490|FG000|Overall Study|Withdrawal by Subject|2|||
131175638|NCT01514188|472264491|FG001|Overall Study|Withdrawal by Subject|4|||
131175639|NCT01514188|472264490|FG000|Overall Study|Protocol Violation|2|||
131175640|NCT01514188|472264491|FG001|Overall Study|Protocol Violation|4|||
131175641|NCT01514188|472264490|FG000|Overall Study|Physician Decision|0|||
131175642|NCT01514188|472264491|FG001|Overall Study|Physician Decision|2|||
131175643|NCT01514188|472264490|FG000|Overall Study|Disease Progression|13|||
131175644|NCT01514188|472264491|FG001|Overall Study|Disease Progression|14|||
131175645|NCT01514188|472264490|FG000|Overall Study|Death|1|||
131175646|NCT01514188|472264491|FG001|Overall Study|Death|3|||
131175647|NCT01514188|472264490|FG000|Overall Study|Other|2|||
131175648|NCT01514188|472264491|FG001|Overall Study|Other|1|||
131175649|NCT02932332|472264496|FG000|Overall Study|Withdrawal by Subject|1|||
131175650|NCT02932332|472264497|FG001|Overall Study|Withdrawal by Subject|1|||
131175651|NCT02932332|472264498|FG002|Overall Study|Withdrawal by Subject|0|||
131175652|NCT02932332|472264499|FG003|Overall Study|Withdrawal by Subject|1|||
131175653|NCT02932332|472264496|FG000|Overall Study|Chest pain|0|||
131175654|NCT02932332|472264497|FG001|Overall Study|Chest pain|0|||
131175655|NCT02932332|472264498|FG002|Overall Study|Chest pain|0|||
131175656|NCT02932332|472264499|FG003|Overall Study|Chest pain|1|||
131175657|NCT02932332|472264496|FG000|Overall Study|Not Dyspneic cough|1|||
131175658|NCT02932332|472264497|FG001|Overall Study|Not Dyspneic cough|2|||
131175659|NCT02932332|472264498|FG002|Overall Study|Not Dyspneic cough|1|||
131175660|NCT02932332|472264499|FG003|Overall Study|Not Dyspneic cough|0|||
131175661|NCT00488592|472264504|FG000|Overall Study|Withdrawal by Subject|1|||
131175662|NCT00488592|472264504|FG000|Overall Study|Disease progression|1|||
131175663|NCT00488592|472264504|FG000|Overall Study|Enrolled but not treated|1|||
131175664|NCT00621855|472264505|FG000|Overall Study|Adverse Event|32|||
131175665|NCT00621855|472264506|FG001|Overall Study|Adverse Event|31|||
131175666|NCT00621855|472264507|FG002|Overall Study|Adverse Event|48|||
131175667|NCT00621855|472264508|FG003|Overall Study|Adverse Event|34|||
131175668|NCT00621855|472264509|FG004|Overall Study|Adverse Event|31|||
131236652|NCT00818883|472494984|FG000|Overall Study|Lost to Follow-up|3|||
131236653|NCT00818883|472494985|FG001|Overall Study|Lost to Follow-up|2|||
131236654|NCT00818883|472494984|FG000|Overall Study|Withdrawal by Subject|16|||
131236655|NCT00818883|472494985|FG001|Overall Study|Withdrawal by Subject|14|||
131236656|NCT00818883|472494984|FG000|Overall Study|Lack of Efficacy|0|||
131236657|NCT00818883|472494985|FG001|Overall Study|Lack of Efficacy|2|||
131236658|NCT00818883|472494984|FG000|Overall Study|Other|2|||
131236659|NCT00818883|472494985|FG001|Overall Study|Other|7|||
131175669|NCT00621855|472264505|FG000|Overall Study|Lost to Follow-up|0|||
131175670|NCT00621855|472264506|FG001|Overall Study|Lost to Follow-up|1|||
131175671|NCT00621855|472264507|FG002|Overall Study|Lost to Follow-up|3|||
131175672|NCT00621855|472264508|FG003|Overall Study|Lost to Follow-up|4|||
131175673|NCT00621855|472264509|FG004|Overall Study|Lost to Follow-up|1|||
131175674|NCT00621855|472264505|FG000|Overall Study|Protocol Violation|16|||
131175675|NCT00621855|472264506|FG001|Overall Study|Protocol Violation|8|||
131175676|NCT00621855|472264507|FG002|Overall Study|Protocol Violation|6|||
131175677|NCT00621855|472264508|FG003|Overall Study|Protocol Violation|7|||
131175678|NCT00621855|472264509|FG004|Overall Study|Protocol Violation|8|||
131175679|NCT00621855|472264505|FG000|Overall Study|Withdrawal by Subject|16|||
131175680|NCT00621855|472264506|FG001|Overall Study|Withdrawal by Subject|11|||
131175681|NCT00621855|472264507|FG002|Overall Study|Withdrawal by Subject|13|||
131175682|NCT00621855|472264508|FG003|Overall Study|Withdrawal by Subject|13|||
131175683|NCT00621855|472264509|FG004|Overall Study|Withdrawal by Subject|9|||
131175684|NCT00621855|472264505|FG000|Overall Study|Other|9|||
131175685|NCT00621855|472264506|FG001|Overall Study|Other|7|||
131175686|NCT00621855|472264507|FG002|Overall Study|Other|6|||
131175687|NCT00621855|472264508|FG003|Overall Study|Other|5|||
131175688|NCT00621855|472264509|FG004|Overall Study|Other|4|||
131175689|NCT00621855|472264505|FG000|Overall Study|Patients did not receive study drug|3|||
131236660|NCT00973700|472494988|FG000|Overall Study|Withdrawal by Subject|2|||
131175690|NCT00621855|472264506|FG001|Overall Study|Patients did not receive study drug|3|||
131175691|NCT00621855|472264507|FG002|Overall Study|Patients did not receive study drug|5|||
131175692|NCT00621855|472264508|FG003|Overall Study|Patients did not receive study drug|4|||
131175693|NCT00621855|472264509|FG004|Overall Study|Patients did not receive study drug|2|||
131175694|NCT02953782|472264510|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
131175695|NCT02953782|472264511|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
131175696|NCT02953782|472264512|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
131175697|NCT02953782|472264513|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
131175698|NCT02953782|472264514|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
131175699|NCT02953782|472264515|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
131175700|NCT02953782|472264516|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
131175701|NCT02953782|472264517|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
131175702|NCT02953782|472264510|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
131175703|NCT02953782|472264511|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
131175704|NCT02953782|472264512|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
131175705|NCT02953782|472264513|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
131175706|NCT02953782|472264514|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
131175707|NCT02953782|472264515|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
131175708|NCT02953782|472264516|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
131175709|NCT02953782|472264517|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
131175710|NCT02953782|472264510|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
131175711|NCT02953782|472264511|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
131175712|NCT02953782|472264512|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
131175713|NCT02953782|472264513|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
131175714|NCT02953782|472264514|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
131175715|NCT02953782|472264515|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
131175716|NCT02953782|472264516|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
131175717|NCT02953782|472264517|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
131175718|NCT02953782|472264510|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131175719|NCT02953782|472264511|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131175720|NCT02953782|472264512|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
131175721|NCT02953782|472264513|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
131175722|NCT02953782|472264514|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131175723|NCT02953782|472264515|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131175724|NCT02953782|472264516|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131175725|NCT02953782|472264517|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
131175726|NCT02953782|472264510|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
131175727|NCT02953782|472264511|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
131175728|NCT02953782|472264512|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
131175729|NCT02953782|472264513|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
131175730|NCT02953782|472264514|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
131175731|NCT02953782|472264515|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
131175732|NCT02953782|472264516|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
131175733|NCT02953782|472264517|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
131175734|NCT02953782|472264510|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
131175735|NCT02953782|472264511|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
131175736|NCT02953782|472264512|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
131175737|NCT02953782|472264513|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
131175738|NCT02953782|472264514|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
131175739|NCT02953782|472264515|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
131175740|NCT02953782|472264516|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
131175741|NCT02953782|472264517|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
131175742|NCT02953782|472264510|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
131175743|NCT02953782|472264511|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
131175744|NCT02953782|472264512|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
131175745|NCT02953782|472264513|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
131175746|NCT02953782|472264514|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
131175747|NCT02953782|472264515|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
131175748|NCT02953782|472264516|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
131175749|NCT02953782|472264517|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
131175750|NCT02953782|472264510|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131175751|NCT02953782|472264511|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131175752|NCT02953782|472264512|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131236661|NCT00973700|472494989|FG001|Overall Study|Withdrawal by Subject|2|||
131236662|NCT00973700|472494990|FG002|Overall Study|Withdrawal by Subject|8|||
131236663|NCT00973700|472494991|FG003|Overall Study|Withdrawal by Subject|4|||
131236664|NCT00973700|472494992|FG004|Overall Study|Withdrawal by Subject|4|||
131236665|NCT00973700|472494988|FG000|Overall Study|Lost to Follow-up|5|||
131236666|NCT00973700|472494989|FG001|Overall Study|Lost to Follow-up|0|||
131236667|NCT00973700|472494990|FG002|Overall Study|Lost to Follow-up|1|||
131236668|NCT00973700|472494991|FG003|Overall Study|Lost to Follow-up|8|||
131236669|NCT00973700|472494992|FG004|Overall Study|Lost to Follow-up|5|||
131236670|NCT00973700|472494988|FG000|Overall Study|Inappropriate enrolment|0|||
131236671|NCT00973700|472494989|FG001|Overall Study|Inappropriate enrolment|0|||
131236672|NCT00973700|472494990|FG002|Overall Study|Inappropriate enrolment|0|||
131236673|NCT00973700|472494991|FG003|Overall Study|Inappropriate enrolment|4|||
131236674|NCT00973700|472494992|FG004|Overall Study|Inappropriate enrolment|0|||
131236675|NCT00973700|472494988|FG000|Overall Study|Unable to Classify|0|||
131236676|NCT00973700|472494989|FG001|Overall Study|Unable to Classify|0|||
131236677|NCT00973700|472494990|FG002|Overall Study|Unable to Classify|1|||
131236678|NCT00973700|472494991|FG003|Overall Study|Unable to Classify|2|||
131236679|NCT00973700|472494992|FG004|Overall Study|Unable to Classify|1|||
131236680|NCT05518487|472494993|FG000|Overall Study|Withdrawal by Subject|3|||
131236681|NCT00454636|472494995|FG000|Overall Study|Adverse Event|10|||
131236682|NCT00454636|472494996|FG001|Overall Study|Adverse Event|6|||
131236683|NCT00454636|472494997|FG002|Overall Study|Adverse Event|9|||
131236684|NCT00454636|472494998|FG003|Overall Study|Adverse Event|15|||
131236685|NCT00454636|472494995|FG000|Overall Study|Disease Progression|11|||
131236686|NCT00454636|472494996|FG001|Overall Study|Disease Progression|12|||
131236687|NCT00454636|472494997|FG002|Overall Study|Disease Progression|4|||
131236688|NCT00454636|472494998|FG003|Overall Study|Disease Progression|11|||
131236689|NCT00454636|472494995|FG000|Overall Study|Protocol Violation|3|||
131236690|NCT00454636|472494996|FG001|Overall Study|Protocol Violation|2|||
131236691|NCT00454636|472494997|FG002|Overall Study|Protocol Violation|3|||
131236692|NCT00454636|472494998|FG003|Overall Study|Protocol Violation|3|||
131236693|NCT00454636|472494995|FG000|Overall Study|Death|6|||
131236694|NCT00454636|472494996|FG001|Overall Study|Death|1|||
131236695|NCT00454636|472494997|FG002|Overall Study|Death|1|||
131236696|NCT00454636|472494998|FG003|Overall Study|Death|1|||
131236697|NCT00454636|472494995|FG000|Overall Study|Patient refusal|1|||
131236698|NCT00454636|472494996|FG001|Overall Study|Patient refusal|1|||
131236699|NCT00454636|472494997|FG002|Overall Study|Patient refusal|3|||
131236700|NCT00454636|472494998|FG003|Overall Study|Patient refusal|2|||
131236701|NCT00454636|472494995|FG000|Overall Study|Lost to Follow-up|0|||
131236702|NCT00454636|472494996|FG001|Overall Study|Lost to Follow-up|1|||
130782408|NCT00243919|470831144|FG002|Overall Study|Lost to Follow-up|3|||
130782409|NCT00243919|470831142|FG000|Overall Study|Administrative Error|1|||
131175753|NCT02953782|472264513|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131175754|NCT02953782|472264514|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131175755|NCT02953782|472264515|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131175756|NCT02953782|472264516|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
131175757|NCT02953782|472264517|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
131175758|NCT01737840|472264518|FG000|Overall Study|Diagnosed with an other pathology|2|||
131175759|NCT01737840|472264519|FG001|Overall Study|Diagnosed with an other pathology|2|||
131175760|NCT03105700|472264520|FG000|Overall Study|screen fail|3|||
131175761|NCT03105700|472264520|FG000|Overall Study|Lost to Follow-up|4|||
131175762|NCT00403559|472264521|FG000|Overall Study|Adverse Event|0|||
131175763|NCT00403559|472264522|FG001|Overall Study|Adverse Event|1|||
131175764|NCT00403559|472264521|FG000|Overall Study|Lost to Follow-up|3|||
131175765|NCT00403559|472264522|FG001|Overall Study|Lost to Follow-up|3|||
131175766|NCT00403559|472264521|FG000|Overall Study|Withdrawal by Subject|1|||
131175767|NCT00403559|472264522|FG001|Overall Study|Withdrawal by Subject|0|||
131175768|NCT01253421|472264525|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
131175769|NCT01253421|472264526|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
131175770|NCT01253421|472264527|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
131175771|NCT01253421|472264528|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
131175772|NCT01253421|472264529|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
131175773|NCT01253421|472264525|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
131236703|NCT00454636|472494997|FG002|Overall Study|Lost to Follow-up|0|||
130782410|NCT00243919|470831143|FG001|Overall Study|Administrative Error|0|||
131175774|NCT01253421|472264526|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
131236704|NCT00454636|472494998|FG003|Overall Study|Lost to Follow-up|0|||
131236705|NCT00525590|472495006|FG000|Overall Study|Adverse Event|3|||
131236706|NCT00525590|472495006|FG000|Overall Study|Physician Decision|3|||
131236707|NCT00525590|472495006|FG000|Overall Study|Withdrawal by Subject|16|||
131236708|NCT00525590|472495006|FG000|Overall Study|Lost to Follow-up|1|||
131236709|NCT00525590|472495006|FG000|Overall Study|Death|9|||
131236710|NCT00525590|472495006|FG000|Overall Study|Other|13|||
131236711|NCT01025037|472495007|FG000|Overall Study|Adverse Event|3|||
131236712|NCT01025037|472495007|FG000|Overall Study|Lost to Follow-up|7|||
131236713|NCT01025037|472495007|FG000|Overall Study|Withdrawal by Subject|1|||
130782411|NCT00243919|470831144|FG002|Overall Study|Administrative Error|0|||
130782412|NCT00243919|470831142|FG000|Overall Study|Physician Decision|1|||
130782413|NCT00243919|470831143|FG001|Overall Study|Physician Decision|1|||
130782414|NCT00243919|470831144|FG002|Overall Study|Physician Decision|0|||
130782415|NCT02059239|470831145|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
130782416|NCT02059239|470831146|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
130782417|NCT02059239|470831145|FG000|Overall Study|Physician Decision|1|||
130782418|NCT02059239|470831146|FG001|Overall Study|Physician Decision|0|||
130782419|NCT01268267|470831147|FG000|Overall Study|Protocol Violation|1|||
130782420|NCT04176939|470831148|FG000|Overall Study|Withdrawal by Subject|5|||
130782421|NCT04176939|470831148|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
130782422|NCT04176939|470831148|FG000|Overall Study|Lost to Follow-up|2|||
130782423|NCT04176939|470831148|FG000|Overall Study|Unspecified reason|4|||
130782424|NCT04176939|470831148|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
130782425|NCT04919317|470831155|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
130782426|NCT04919317|470831156|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
130782427|NCT04919317|470831155|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
130782428|NCT04919317|470831156|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
130782429|NCT02869789|470831157|FG000|Overall Study|Disease progression|184|||
130782430|NCT02869789|470831158|FG001|Overall Study|Disease progression|109|||
130782431|NCT02869789|470831159|FG002|Overall Study|Disease progression|260|||
130782432|NCT02869789|470831160|FG003|Overall Study|Disease progression|19|||
130782433|NCT02869789|470831157|FG000|Overall Study|Study drug toxicity|90|||
130782434|NCT02869789|470831158|FG001|Overall Study|Study drug toxicity|32|||
130782435|NCT02869789|470831159|FG002|Overall Study|Study drug toxicity|55|||
130782436|NCT02869789|470831160|FG003|Overall Study|Study drug toxicity|14|||
130782437|NCT02869789|470831157|FG000|Overall Study|Death|7|||
130782438|NCT02869789|470831158|FG001|Overall Study|Death|3|||
130782439|NCT02869789|470831159|FG002|Overall Study|Death|5|||
130782440|NCT02869789|470831160|FG003|Overall Study|Death|1|||
130782441|NCT02869789|470831157|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
130782442|NCT02869789|470831158|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
130782443|NCT02869789|470831159|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
130782444|NCT02869789|470831160|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
130782445|NCT02869789|470831157|FG000|Overall Study|Participant request to discontinue study treatment|10|||
130782446|NCT02869789|470831158|FG001|Overall Study|Participant request to discontinue study treatment|5|||
130782447|NCT02869789|470831159|FG002|Overall Study|Participant request to discontinue study treatment|5|||
130782448|NCT02869789|470831160|FG003|Overall Study|Participant request to discontinue study treatment|3|||
130782449|NCT02869789|470831157|FG000|Overall Study|Withdrawal by Subject|5|||
130782450|NCT02869789|470831158|FG001|Overall Study|Withdrawal by Subject|2|||
130782451|NCT02869789|470831159|FG002|Overall Study|Withdrawal by Subject|7|||
130782452|NCT02869789|470831160|FG003|Overall Study|Withdrawal by Subject|2|||
130782453|NCT02869789|470831157|FG000|Overall Study|Lost to Follow-up|0|||
130782454|NCT02869789|470831158|FG001|Overall Study|Lost to Follow-up|0|||
130782455|NCT02869789|470831159|FG002|Overall Study|Lost to Follow-up|2|||
130782456|NCT02869789|470831160|FG003|Overall Study|Lost to Follow-up|0|||
130782457|NCT02869789|470831157|FG000|Overall Study|Maximum clinical benefit|5|||
130782458|NCT02869789|470831158|FG001|Overall Study|Maximum clinical benefit|2|||
131175775|NCT01253421|472264527|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
131175776|NCT01253421|472264528|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
131175777|NCT01253421|472264529|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
131175778|NCT01253421|472264525|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
131175779|NCT01253421|472264526|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
131175780|NCT01253421|472264527|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
131175781|NCT01253421|472264528|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
131175782|NCT01253421|472264529|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
131175783|NCT01253421|472264525|FG000|Assessment and Scheduling|Physician Decision|1|||
131175784|NCT01253421|472264526|FG001|Assessment and Scheduling|Physician Decision|0|||
131175785|NCT01253421|472264527|FG002|Assessment and Scheduling|Physician Decision|0|||
131175786|NCT01253421|472264528|FG003|Assessment and Scheduling|Physician Decision|0|||
131175787|NCT01253421|472264529|FG004|Assessment and Scheduling|Physician Decision|0|||
131175788|NCT01253421|472264525|FG000|Drug+Scanning Visit|Physician Decision|0|||
131175789|NCT01253421|472264526|FG001|Drug+Scanning Visit|Physician Decision|0|||
131175790|NCT01253421|472264527|FG002|Drug+Scanning Visit|Physician Decision|0|||
131175791|NCT01253421|472264528|FG003|Drug+Scanning Visit|Physician Decision|0|||
131175792|NCT01253421|472264529|FG004|Drug+Scanning Visit|Physician Decision|1|||
130782459|NCT02869789|470831159|FG002|Overall Study|Maximum clinical benefit|1|||
130782460|NCT02869789|470831160|FG003|Overall Study|Maximum clinical benefit|0|||
131175793|NCT00929734|472264530|FG000|Overall Study|Lost to Follow-up|2|||
131175794|NCT00929734|472264531|FG001|Overall Study|Lost to Follow-up|1|||
130782461|NCT02869789|470831157|FG000|Overall Study|Poor/Non-compliance|0|||
130782462|NCT02869789|470831158|FG001|Overall Study|Poor/Non-compliance|2|||
130782463|NCT02869789|470831159|FG002|Overall Study|Poor/Non-compliance|1|||
130782464|NCT02869789|470831160|FG003|Overall Study|Poor/Non-compliance|0|||
131175795|NCT00929734|472264530|FG000|Overall Study|Withdrawal by Subject|0|||
131175796|NCT00929734|472264531|FG001|Overall Study|Withdrawal by Subject|2|||
131175797|NCT02921919|472264532|FG000|Overall Study|Other|5|||
131175798|NCT02921919|472264533|FG001|Overall Study|Other|6|||
131175799|NCT02921919|472264532|FG000|Overall Study|Lost to Follow-up|0|||
131175800|NCT02921919|472264533|FG001|Overall Study|Lost to Follow-up|1|||
131175801|NCT02921919|472264532|FG000|Overall Study|Withdrawal by Subject|5|||
131175802|NCT02921919|472264533|FG001|Overall Study|Withdrawal by Subject|1|||
131236714|NCT00337571|472495008|FG000|Overall Study|Lack of Efficacy|3|||
131236715|NCT00337571|472495009|FG001|Overall Study|Lack of Efficacy|0|||
131236716|NCT00337571|472495010|FG002|Overall Study|Lack of Efficacy|0|||
131236717|NCT00337571|472495011|FG003|Overall Study|Lack of Efficacy|0|||
131236718|NCT00337571|472495008|FG000|Overall Study|Adverse Event|4|||
131236719|NCT00337571|472495009|FG001|Overall Study|Adverse Event|5|||
131236720|NCT00337571|472495010|FG002|Overall Study|Adverse Event|8|||
131236721|NCT00337571|472495011|FG003|Overall Study|Adverse Event|4|||
131236722|NCT00337571|472495008|FG000|Overall Study|Withdrawal by Subject|2|||
131236723|NCT00337571|472495009|FG001|Overall Study|Withdrawal by Subject|2|||
131236724|NCT00337571|472495010|FG002|Overall Study|Withdrawal by Subject|1|||
131236725|NCT00337571|472495011|FG003|Overall Study|Withdrawal by Subject|0|||
131236726|NCT00337571|472495008|FG000|Overall Study|Lost to Follow-up|3|||
131236727|NCT00337571|472495009|FG001|Overall Study|Lost to Follow-up|1|||
131236728|NCT00337571|472495010|FG002|Overall Study|Lost to Follow-up|0|||
131236729|NCT00337571|472495011|FG003|Overall Study|Lost to Follow-up|1|||
131236730|NCT00337571|472495008|FG000|Overall Study|Poor/noncompliance|1|||
131236731|NCT00337571|472495009|FG001|Overall Study|Poor/noncompliance|1|||
131236732|NCT00337571|472495010|FG002|Overall Study|Poor/noncompliance|1|||
131236733|NCT00337571|472495011|FG003|Overall Study|Poor/noncompliance|1|||
131236734|NCT00337571|472495008|FG000|Overall Study|No longer met study criteria|1|||
131236735|NCT00337571|472495009|FG001|Overall Study|No longer met study criteria|0|||
131236736|NCT00337571|472495010|FG002|Overall Study|No longer met study criteria|0|||
131236737|NCT00337571|472495011|FG003|Overall Study|No longer met study criteria|0|||
131236738|NCT00337571|472495008|FG000|Overall Study|High Potassium level|0|||
131236739|NCT00337571|472495009|FG001|Overall Study|High Potassium level|0|||
131236740|NCT00337571|472495010|FG002|Overall Study|High Potassium level|0|||
131236741|NCT00337571|472495011|FG003|Overall Study|High Potassium level|1|||
131236742|NCT01890915|472495013|FG000|Overall Study|Adverse Event|1|||
131236743|NCT01890915|472495014|FG001|Overall Study|Adverse Event|0|||
131236744|NCT01890915|472495013|FG000|Overall Study|Protocol Violation|2|||
131236745|NCT01890915|472495014|FG001|Overall Study|Protocol Violation|0|||
131236746|NCT01890915|472495013|FG000|Overall Study|Equipment Malfunction|0|||
131236747|NCT01890915|472495014|FG001|Overall Study|Equipment Malfunction|1|||
131236748|NCT02114697|472495015|FG000|Overall Study|Study terminated|5|||
131236749|NCT02114697|472495016|FG001|Overall Study|Study terminated|4|||
131236750|NCT00424489|472495017|FG000|Overall Study|Death|3|||
131236751|NCT00449150|472495024|FG000|Overall Study|Adverse Event|11|||
131236752|NCT00449150|472495025|FG001|Overall Study|Adverse Event|18|||
131236753|NCT00449150|472495026|FG002|Overall Study|Adverse Event|9|||
131236754|NCT00449150|472495024|FG000|Overall Study|Lack of Efficacy|1|||
131236755|NCT00449150|472495025|FG001|Overall Study|Lack of Efficacy|2|||
131236756|NCT00449150|472495026|FG002|Overall Study|Lack of Efficacy|2|||
131236757|NCT00449150|472495024|FG000|Overall Study|Other|16|||
131236758|NCT00449150|472495025|FG001|Overall Study|Other|13|||
131236759|NCT00449150|472495026|FG002|Overall Study|Other|14|||
131236760|NCT00449150|472495024|FG000|Overall Study|Withdrawal by Subject|17|||
131236761|NCT00449150|472495025|FG001|Overall Study|Withdrawal by Subject|18|||
131236762|NCT00449150|472495026|FG002|Overall Study|Withdrawal by Subject|21|||
131236763|NCT00449150|472495024|FG000|Overall Study|Protocol Violation|1|||
131236764|NCT00449150|472495025|FG001|Overall Study|Protocol Violation|2|||
131236765|NCT00449150|472495026|FG002|Overall Study|Protocol Violation|1|||
131236766|NCT03552757|472495027|FG000|Overall Study|Withdrawal by Subject|10|||
131236767|NCT03552757|472495028|FG001|Overall Study|Withdrawal by Subject|5|||
131236768|NCT03552757|472495029|FG002|Overall Study|Withdrawal by Subject|12|||
131175803|NCT02921919|472264532|FG000|Overall Study|Disease Progression|47|||
131175804|NCT02921919|472264533|FG001|Overall Study|Disease Progression|38|||
131236769|NCT03552757|472495027|FG000|Overall Study|Lost to Follow-up|2|||
131236770|NCT03552757|472495028|FG001|Overall Study|Lost to Follow-up|7|||
131175805|NCT02921919|472264532|FG000|Overall Study|Physician Decision|3|||
131175806|NCT02921919|472264533|FG001|Overall Study|Physician Decision|2|||
131175807|NCT02921919|472264532|FG000|Overall Study|Adverse Event|6|||
131175808|NCT02921919|472264533|FG001|Overall Study|Adverse Event|4|||
131236771|NCT03552757|472495029|FG002|Overall Study|Lost to Follow-up|7|||
131236772|NCT03552757|472495027|FG000|Overall Study|Death|1|||
131236773|NCT03552757|472495028|FG001|Overall Study|Death|1|||
131236774|NCT03552757|472495029|FG002|Overall Study|Death|1|||
131236775|NCT02674334|472495030|FG000|Overall Study|Lost to Follow-up|5|||
131236776|NCT02674334|472495031|FG001|Overall Study|Lost to Follow-up|3|||
131175809|NCT03666858|472264534|FG000|Cohort 1|Adverse Event|1|||
131236777|NCT02674334|472495030|FG000|Overall Study|participant difficulty breathing|1|||
131175810|NCT03666858|472264535|FG001|Cohort 1|Adverse Event|0|||
131236778|NCT02674334|472495031|FG001|Overall Study|participant difficulty breathing|0|||
131236779|NCT02674334|472495030|FG000|Overall Study|NIRS not recording|1|||
131236780|NCT02674334|472495031|FG001|Overall Study|NIRS not recording|0|||
131236781|NCT01345019|472495042|FG000|Blinded Treatment Phase|Death|147|||
131236782|NCT01345019|472495043|FG001|Blinded Treatment Phase|Death|137|||
131236783|NCT01345019|472495042|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
131236784|NCT01345019|472495043|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
131236785|NCT01345019|472495042|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
131175811|NCT03666858|472264534|FG000|Cohort 2|Adverse Event|0|||
131175812|NCT03666858|472264535|FG001|Cohort 2|Adverse Event|1|||
130782465|NCT02869789|470831157|FG000|Overall Study|Participant no longer meets study criteria|0|||
130782466|NCT02869789|470831158|FG001|Overall Study|Participant no longer meets study criteria|1|||
131175813|NCT00980980|472264536|FG000|Overall Study|Withdrawal by Hospital|0|||
131175814|NCT00980980|472264537|FG001|Overall Study|Withdrawal by Hospital|1|||
131175815|NCT00980980|472264538|FG002|Overall Study|Withdrawal by Hospital|0|||
131175816|NCT00121992|472264540|FG000|Overall Study|Treatment not received|2|||
131175817|NCT00121992|472264541|FG001|Overall Study|Treatment not received|11|||
131175818|NCT03282357|472264542|FG000|Overall Study|Lost to Follow-up|3|||
131175819|NCT03282357|472264542|FG000|Overall Study|Withdrawal by Subject|4|||
131175820|NCT03282357|472264542|FG000|Overall Study|Adverse Event|1|||
131175821|NCT03282357|472264542|FG000|Overall Study|Other|9|||
131175822|NCT00547378|472264543|FG000|Randomized Cohort|Withdrawal by Subject|7|||
131175823|NCT00547378|472264544|FG001|Randomized Cohort|Withdrawal by Subject|5|||
131236786|NCT01345019|472495043|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
131236787|NCT01345019|472495042|FG000|Blinded Treatment Phase|Disease Progression|12|||
130782467|NCT02869789|470831159|FG002|Overall Study|Participant no longer meets study criteria|1|||
131175824|NCT00547378|472264545|FG002|Randomized Cohort|Withdrawal by Subject|0|||
130782468|NCT02869789|470831160|FG003|Overall Study|Participant no longer meets study criteria|0|||
130782469|NCT02869789|470831157|FG000|Overall Study|Administrative reason by sponsor|0|||
130782470|NCT02869789|470831158|FG001|Overall Study|Administrative reason by sponsor|0|||
130782471|NCT02869789|470831159|FG002|Overall Study|Administrative reason by sponsor|1|||
130782472|NCT02869789|470831160|FG003|Overall Study|Administrative reason by sponsor|0|||
130782473|NCT02869789|470831157|FG000|Overall Study|Other reasons|4|||
130782474|NCT02869789|470831158|FG001|Overall Study|Other reasons|8|||
130782475|NCT02869789|470831159|FG002|Overall Study|Other reasons|6|||
130782476|NCT02869789|470831160|FG003|Overall Study|Other reasons|0|||
130782477|NCT02127658|470831175|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
130782478|NCT02127658|470831176|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
130782479|NCT02127658|470831175|FG000|Overall Study|Withdrawal by Subject|0|||
130782480|NCT02127658|470831176|FG001|Overall Study|Withdrawal by Subject|2|||
130782481|NCT02127658|470831175|FG000|Overall Study|Physician Decision|0|||
130782482|NCT02127658|470831176|FG001|Overall Study|Physician Decision|1|||
130782483|NCT01443858|470831177|FG000|Overall Study|Withdrawal by Subject|9|||
130782484|NCT01443858|470831178|FG001|Overall Study|Withdrawal by Subject|8|||
130782485|NCT01443858|470831179|FG002|Overall Study|Withdrawal by Subject|5|||
130782486|NCT01443858|470831177|FG000|Overall Study|Lack of Efficacy|1|||
130782487|NCT01443858|470831178|FG001|Overall Study|Lack of Efficacy|0|||
130782488|NCT01443858|470831179|FG002|Overall Study|Lack of Efficacy|0|||
130782489|NCT01443858|470831177|FG000|Overall Study|Lost to Follow-up|5|||
130782490|NCT01443858|470831178|FG001|Overall Study|Lost to Follow-up|5|||
130782491|NCT01443858|470831179|FG002|Overall Study|Lost to Follow-up|2|||
130782492|NCT01867008|470831180|FG000|Overall Study|Withdrawal by Subject|1|||
130782493|NCT01534273|470831181|FG000|Period 1|Physician Decision|0|||
130782494|NCT01534273|470831182|FG001|Period 1|Physician Decision|0|||
130782495|NCT01534273|470831183|FG002|Period 1|Physician Decision|0|||
130782496|NCT01534273|470831184|FG003|Period 1|Physician Decision|1|||
130782497|NCT01534273|470831185|FG004|Period 1|Physician Decision|0|||
130782498|NCT01534273|470831186|FG005|Period 1|Physician Decision|0|||
130782499|NCT01534273|470831187|FG006|Period 1|Physician Decision|0|||
131175825|NCT00547378|472264543|FG000|Randomized Cohort|Death|0|||
131236788|NCT01345019|472495043|FG001|Blinded Treatment Phase|Disease Progression|10|||
131236789|NCT01345019|472495042|FG000|Blinded Treatment Phase|Adverse Event|6|||
131236790|NCT01345019|472495043|FG001|Blinded Treatment Phase|Adverse Event|13|||
130782500|NCT03586050|470831188|FG000|Overall Study|Death|3|||
130782501|NCT03586050|470831188|FG000|Overall Study|Withdrawal by Subject|2|||
131175826|NCT00547378|472264544|FG001|Randomized Cohort|Death|1|||
131175827|NCT00547378|472264545|FG002|Randomized Cohort|Death|0|||
131175828|NCT00547378|472264543|FG000|Randomized Cohort|Lost to Follow-up|1|||
131175829|NCT00547378|472264544|FG001|Randomized Cohort|Lost to Follow-up|0|||
130782502|NCT01211145|470831189|FG000|Overall Study|Reason not specified|3|||
130782503|NCT01211145|470831190|FG001|Overall Study|Reason not specified|2|||
130782504|NCT01211145|470831191|FG002|Overall Study|Reason not specified|2|||
131175830|NCT00547378|472264545|FG002|Randomized Cohort|Lost to Follow-up|0|||
131236791|NCT01345019|472495042|FG000|Blinded Treatment Phase|Administrative Decision|10|||
131236792|NCT01345019|472495043|FG001|Blinded Treatment Phase|Administrative Decision|8|||
130782505|NCT01211145|470831192|FG003|Overall Study|Reason not specified|1|||
130782506|NCT01211145|470831189|FG000|Overall Study|Lost to Follow-up|3|||
130782507|NCT01211145|470831190|FG001|Overall Study|Lost to Follow-up|2|||
130782508|NCT01211145|470831191|FG002|Overall Study|Lost to Follow-up|1|||
130782509|NCT01211145|470831192|FG003|Overall Study|Lost to Follow-up|2|||
130782510|NCT01211145|470831189|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130782511|NCT01211145|470831190|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130782512|NCT01211145|470831191|FG002|Overall Study|Study-specific withdrawal criteria|0|||
130782513|NCT01211145|470831192|FG003|Overall Study|Study-specific withdrawal criteria|0|||
130782514|NCT01211145|470831189|FG000|Overall Study|Severe noncompliance to protocol|1|||
130782515|NCT01211145|470831190|FG001|Overall Study|Severe noncompliance to protocol|0|||
130782516|NCT01211145|470831191|FG002|Overall Study|Severe noncompliance to protocol|0|||
130782517|NCT01211145|470831192|FG003|Overall Study|Severe noncompliance to protocol|0|||
130782518|NCT01211145|470831189|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
130782519|NCT01211145|470831190|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
130782520|NCT01211145|470831191|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
130782521|NCT01211145|470831192|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
130782522|NCT01211145|470831189|FG000|Overall Study|Patient decision|2|||
130782523|NCT01211145|470831190|FG001|Overall Study|Patient decision|1|||
130782524|NCT01211145|470831191|FG002|Overall Study|Patient decision|0|||
130782525|NCT01211145|470831192|FG003|Overall Study|Patient decision|2|||
130782526|NCT00570401|470831193|FG000|Overall Study|Adverse Event|2|||
130782527|NCT00385918|470831196|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
130782528|NCT00385918|470831197|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
130782529|NCT00385918|470831198|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
130782530|NCT00385918|470831196|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
130782531|NCT00385918|470831197|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
130782532|NCT00385918|470831198|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
130782533|NCT00385918|470831196|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
130782534|NCT00385918|470831197|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
130782535|NCT00385918|470831198|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
130782536|NCT00385918|470831196|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
130782537|NCT00385918|470831197|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
130782538|NCT00385918|470831198|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
130782539|NCT00385918|470831196|FG000|Intervention Phase After Randomization|Physician Decision|1|||
130782540|NCT00385918|470831197|FG001|Intervention Phase After Randomization|Physician Decision|0|||
130782541|NCT00385918|470831198|FG002|Intervention Phase After Randomization|Physician Decision|0|||
130782542|NCT00385918|470831196|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
130782543|NCT00385918|470831197|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
130782544|NCT00385918|470831198|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
130782545|NCT01676701|470831199|FG000|Overall Study|Protocol Violation|1|||
130782546|NCT01676701|470831200|FG001|Overall Study|Protocol Violation|0|||
130782547|NCT01676701|470831199|FG000|Overall Study|Sponsor Decision|3|||
130782548|NCT01676701|470831200|FG001|Overall Study|Sponsor Decision|4|||
130782549|NCT02115607|470831211|FG000|Overall Study|Withdrawal by Subject|1|||
130782550|NCT00549549|470831213|FG000|Overall Study|Adverse Event|5|||
130782551|NCT00549549|470831214|FG001|Overall Study|Adverse Event|3|||
130782552|NCT00549549|470831215|FG002|Overall Study|Adverse Event|1|||
130782553|NCT00549549|470831216|FG003|Overall Study|Adverse Event|9|||
130782554|NCT00549549|470831213|FG000|Overall Study|Lack of Efficacy|9|||
130782555|NCT00549549|470831214|FG001|Overall Study|Lack of Efficacy|6|||
130782556|NCT00549549|470831215|FG002|Overall Study|Lack of Efficacy|4|||
130782557|NCT00549549|470831216|FG003|Overall Study|Lack of Efficacy|2|||
130782558|NCT00549549|470831213|FG000|Overall Study|Lost to Follow-up|1|||
131175831|NCT00547378|472264543|FG000|Randomized Cohort|Adverse Event|1|||
131175832|NCT00547378|472264544|FG001|Randomized Cohort|Adverse Event|0|||
131175833|NCT00547378|472264545|FG002|Randomized Cohort|Adverse Event|0|||
131175834|NCT00547378|472264543|FG000|Randomized Cohort|Other reasons|2|||
131175835|NCT00547378|472264544|FG001|Randomized Cohort|Other reasons|0|||
131175836|NCT00547378|472264545|FG002|Randomized Cohort|Other reasons|0|||
131175837|NCT00547378|472264543|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
131175838|NCT00547378|472264544|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
131175839|NCT00547378|472264545|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
130782559|NCT00549549|470831214|FG001|Overall Study|Lost to Follow-up|0|||
130782560|NCT00549549|470831215|FG002|Overall Study|Lost to Follow-up|1|||
130782561|NCT00549549|470831216|FG003|Overall Study|Lost to Follow-up|2|||
130782562|NCT00549549|470831213|FG000|Overall Study|Withdrawal by Subject|0|||
130782563|NCT00549549|470831214|FG001|Overall Study|Withdrawal by Subject|4|||
130782564|NCT00549549|470831215|FG002|Overall Study|Withdrawal by Subject|1|||
131175840|NCT00547378|472264543|FG000|All Implanted Cohort|Adverse Event|4|||
131175841|NCT00547378|472264544|FG001|All Implanted Cohort|Adverse Event|10|||
130782565|NCT00549549|470831216|FG003|Overall Study|Withdrawal by Subject|0|||
130782566|NCT00549549|470831213|FG000|Overall Study|Other|9|||
130782567|NCT00549549|470831214|FG001|Overall Study|Other|9|||
130782568|NCT00549549|470831215|FG002|Overall Study|Other|9|||
130782569|NCT00549549|470831216|FG003|Overall Study|Other|11|||
130782570|NCT00549549|470831213|FG000|Overall Study|Randomized but not treated|0|||
130782571|NCT00549549|470831214|FG001|Overall Study|Randomized but not treated|0|||
130782572|NCT00549549|470831215|FG002|Overall Study|Randomized but not treated|1|||
130782573|NCT00549549|470831216|FG003|Overall Study|Randomized but not treated|1|||
130782574|NCT02227784|470831220|FG000|Double-Blind Phase|Adverse Event|3|||
130782575|NCT02227784|470831221|FG001|Double-Blind Phase|Adverse Event|2|||
130782576|NCT02227784|470831222|FG002|Double-Blind Phase|Adverse Event|1|||
130782577|NCT02227784|470831223|FG003|Double-Blind Phase|Adverse Event|3|||
130782578|NCT02227784|470831224|FG004|Double-Blind Phase|Adverse Event|0|||
130782579|NCT02227784|470831220|FG000|Double-Blind Phase|Physician Decision|1|||
130782580|NCT02227784|470831221|FG001|Double-Blind Phase|Physician Decision|0|||
130782581|NCT02227784|470831222|FG002|Double-Blind Phase|Physician Decision|0|||
130782582|NCT02227784|470831223|FG003|Double-Blind Phase|Physician Decision|1|||
130782583|NCT02227784|470831224|FG004|Double-Blind Phase|Physician Decision|0|||
130782584|NCT02227784|470831220|FG000|Double-Blind Phase|Protocol Violation|0|||
130782585|NCT02227784|470831221|FG001|Double-Blind Phase|Protocol Violation|0|||
130782586|NCT02227784|470831222|FG002|Double-Blind Phase|Protocol Violation|1|||
130782587|NCT02227784|470831223|FG003|Double-Blind Phase|Protocol Violation|1|||
130782588|NCT02227784|470831224|FG004|Double-Blind Phase|Protocol Violation|0|||
130782589|NCT02227784|470831220|FG000|Double-Blind Phase|Sponsor Decision|34|||
130782590|NCT02227784|470831221|FG001|Double-Blind Phase|Sponsor Decision|15|||
130782591|NCT02227784|470831222|FG002|Double-Blind Phase|Sponsor Decision|14|||
130782592|NCT02227784|470831223|FG003|Double-Blind Phase|Sponsor Decision|32|||
130782593|NCT02227784|470831224|FG004|Double-Blind Phase|Sponsor Decision|0|||
130782594|NCT02227784|470831220|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130782595|NCT02227784|470831221|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
130782596|NCT02227784|470831222|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
130782597|NCT02227784|470831223|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
130782598|NCT02227784|470831224|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130782599|NCT02227784|470831220|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130782600|NCT02227784|470831221|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130782601|NCT02227784|470831222|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130782602|NCT02227784|470831223|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130782603|NCT02227784|470831224|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
130782604|NCT02227784|470831220|FG000|Open-Label Extension Phase (OLE)|Death|0|||
130782605|NCT02227784|470831221|FG001|Open-Label Extension Phase (OLE)|Death|0|||
130782606|NCT02227784|470831222|FG002|Open-Label Extension Phase (OLE)|Death|0|||
130782607|NCT02227784|470831223|FG003|Open-Label Extension Phase (OLE)|Death|0|||
130782608|NCT02227784|470831224|FG004|Open-Label Extension Phase (OLE)|Death|1|||
130782609|NCT02227784|470831220|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130782610|NCT02227784|470831221|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130782611|NCT02227784|470831222|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130782612|NCT02227784|470831223|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130782613|NCT02227784|470831224|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
130782614|NCT02227784|470831220|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130782615|NCT02227784|470831221|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130782616|NCT02227784|470831222|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130782617|NCT02227784|470831223|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130782618|NCT02227784|470831224|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
130782619|NCT02155699|470831225|FG000|Overall Study|Withdrawal by Subject|0|||
130782620|NCT02155699|470831226|FG001|Overall Study|Withdrawal by Subject|3|||
130782621|NCT02155699|470831227|FG002|Overall Study|Withdrawal by Subject|6|||
130782622|NCT02155699|470831228|FG003|Overall Study|Withdrawal by Subject|1|||
130782623|NCT02155699|470831225|FG000|Overall Study|Lost to Follow-up|0|||
130782624|NCT02155699|470831226|FG001|Overall Study|Lost to Follow-up|0|||
131175842|NCT00547378|472264545|FG002|All Implanted Cohort|Adverse Event|17|||
131175843|NCT00547378|472264543|FG000|All Implanted Cohort|Lost to Follow-up|0|||
131175844|NCT00547378|472264544|FG001|All Implanted Cohort|Lost to Follow-up|1|||
131175845|NCT00547378|472264545|FG002|All Implanted Cohort|Lost to Follow-up|14|||
131175846|NCT00547378|472264543|FG000|All Implanted Cohort|Death|3|||
131175847|NCT00547378|472264544|FG001|All Implanted Cohort|Death|1|||
131175848|NCT00547378|472264545|FG002|All Implanted Cohort|Death|4|||
131175849|NCT00547378|472264543|FG000|All Implanted Cohort|Physician Decision|0|||
130782625|NCT02155699|470831227|FG002|Overall Study|Lost to Follow-up|0|||
131236793|NCT01345019|472495042|FG000|Blinded Treatment Phase|Noncompliance|5|||
130782626|NCT02155699|470831228|FG003|Overall Study|Lost to Follow-up|3|||
130782627|NCT02155699|470831225|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
130782628|NCT02155699|470831226|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
130782629|NCT02155699|470831227|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
131175850|NCT00547378|472264544|FG001|All Implanted Cohort|Physician Decision|2|||
131175851|NCT00547378|472264545|FG002|All Implanted Cohort|Physician Decision|6|||
130782630|NCT02155699|470831228|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
130782631|NCT00102596|470831229|FG000|Part A|Screen failures|6|||
130782632|NCT00102596|470831230|FG001|Part A|Screen failures|0|||
130782633|NCT00102596|470831229|FG000|Part A|Adverse Event|1|||
130782634|NCT00102596|470831230|FG001|Part A|Adverse Event|0|||
130782635|NCT02688933|470831235|FG000|Overall Study|Adverse Event|3|||
130782636|NCT02688933|470831236|FG001|Overall Study|Adverse Event|1|||
130782637|NCT02688933|470831235|FG000|Overall Study|Lack of Efficacy|2|||
130782638|NCT02688933|470831236|FG001|Overall Study|Lack of Efficacy|2|||
130782639|NCT02688933|470831235|FG000|Overall Study|Poor compliance to protocol|7|||
130782640|NCT02688933|470831236|FG001|Overall Study|Poor compliance to protocol|4|||
130782641|NCT02688933|470831235|FG000|Overall Study|Hypoglycemia|2|||
130782642|NCT02688933|470831236|FG001|Overall Study|Hypoglycemia|0|||
130782643|NCT02688933|470831235|FG000|Overall Study|Other than Specified|14|||
130782644|NCT02688933|470831236|FG001|Overall Study|Other than Specified|25|||
130782645|NCT02688933|470831235|FG000|Overall Study|Lost to Follow-up|1|||
130782646|NCT02688933|470831236|FG001|Overall Study|Lost to Follow-up|5|||
130782647|NCT00248651|470831237|FG000|Overall Study|Withdrawal by Subject|28|||
130782648|NCT00248651|470831238|FG001|Overall Study|Withdrawal by Subject|40|||
130782649|NCT00248651|470831239|FG002|Overall Study|Withdrawal by Subject|32|||
130782650|NCT00828113|470831240|FG000|Overall Study|Withdrawal by Subject|27|||
130782651|NCT00828113|470831241|FG001|Overall Study|Withdrawal by Subject|26|||
130782652|NCT00828113|470831240|FG000|Overall Study|Lost to Follow-up|3|||
130782653|NCT00828113|470831241|FG001|Overall Study|Lost to Follow-up|5|||
130782654|NCT02287038|470831242|FG000|Overall Study|Stopped attending appointments|3|||
130782655|NCT02287038|470831243|FG001|Overall Study|Stopped attending appointments|2|||
130782656|NCT02287038|470831242|FG000|Overall Study|Anxiety after starting medication|0|||
131175852|NCT00547378|472264543|FG000|All Implanted Cohort|Site closure|2|||
131175853|NCT00547378|472264544|FG001|All Implanted Cohort|Site closure|0|||
131175854|NCT00547378|472264545|FG002|All Implanted Cohort|Site closure|1|||
131175855|NCT00547378|472264543|FG000|All Implanted Cohort|Other reasons|1|||
131175856|NCT00547378|472264544|FG001|All Implanted Cohort|Other reasons|0|||
131175857|NCT00547378|472264545|FG002|All Implanted Cohort|Other reasons|1|||
131175858|NCT01586156|472264546|FG000|Overall Study|Pregnancy|0|||
131175859|NCT01586156|472264547|FG001|Overall Study|Pregnancy|1|||
131175860|NCT01586156|472264548|FG002|Overall Study|Pregnancy|0|||
131175861|NCT04105244|472264549|FG000|Overall Study|Withdrawal by Subject|10|||
131175862|NCT04105244|472264550|FG001|Overall Study|Withdrawal by Subject|12|||
131175863|NCT04105244|472264549|FG000|Overall Study|Lost to Follow-up|20|||
131175864|NCT04105244|472264550|FG001|Overall Study|Lost to Follow-up|15|||
131175865|NCT04105244|472264549|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
131175866|NCT04105244|472264550|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
131175867|NCT04105244|472264549|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
131175868|NCT04105244|472264550|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
131175869|NCT01449682|472264551|FG000|Overall Study|Death|0|||
131175870|NCT01449682|472264552|FG001|Overall Study|Death|1|||
131175871|NCT01449682|472264551|FG000|Overall Study|Adverse Event|1|||
131175872|NCT01449682|472264552|FG001|Overall Study|Adverse Event|0|||
131175873|NCT02112994|472264553|FG000|Overall Study|Progressive Disease|0|||
131175874|NCT02112994|472264554|FG001|Overall Study|Progressive Disease|0|||
131175875|NCT02112994|472264555|FG002|Overall Study|Progressive Disease|1|||
131175876|NCT02112994|472264553|FG000|Overall Study|Pregnancy|0|||
131175877|NCT02112994|472264554|FG001|Overall Study|Pregnancy|1|||
131175878|NCT02112994|472264555|FG002|Overall Study|Pregnancy|1|||
131175879|NCT02112994|472264553|FG000|Overall Study|Liver Transplant|0|||
131175880|NCT02112994|472264554|FG001|Overall Study|Liver Transplant|1|||
131175881|NCT02112994|472264555|FG002|Overall Study|Liver Transplant|0|||
131175882|NCT02112994|472264553|FG000|Overall Study|Withdrawal by Subject|0|||
131175883|NCT02112994|472264554|FG001|Overall Study|Withdrawal by Subject|0|||
131175884|NCT02112994|472264555|FG002|Overall Study|Withdrawal by Subject|1|||
131175885|NCT02768194|472264556|FG000|Period 1|Adverse Event|0|||
131175886|NCT02768194|472264557|FG001|Period 1|Adverse Event|0|||
131175887|NCT02768194|472264558|FG002|Period 1|Adverse Event|0|||
131175888|NCT02768194|472264559|FG003|Period 1|Adverse Event|1|||
131175889|NCT02768194|472264560|FG004|Period 1|Adverse Event|0|||
130782657|NCT02287038|470831243|FG001|Overall Study|Anxiety after starting medication|1|||
130782658|NCT02287038|470831242|FG000|Overall Study|Nausea after starting medication|1|||
130782659|NCT02287038|470831243|FG001|Overall Study|Nausea after starting medication|0|||
131175890|NCT02768194|472264561|FG005|Period 1|Adverse Event|0|||
131175891|NCT02768194|472264556|FG000|Period 2|Other (Reason not specified)|1|||
131175892|NCT02768194|472264557|FG001|Period 2|Other (Reason not specified)|0|||
131175893|NCT02768194|472264558|FG002|Period 2|Other (Reason not specified)|0|||
131175894|NCT02768194|472264559|FG003|Period 2|Other (Reason not specified)|0|||
131175895|NCT02768194|472264560|FG004|Period 2|Other (Reason not specified)|0|||
131175896|NCT02768194|472264561|FG005|Period 2|Other (Reason not specified)|0|||
130782660|NCT02287038|470831242|FG000|Overall Study|Abnormal ECG after starting medication|1|||
131175897|NCT02768194|472264556|FG000|Period 3|Other (Reason not specified)|0|||
131175898|NCT02768194|472264557|FG001|Period 3|Other (Reason not specified)|1|||
131175899|NCT02768194|472264558|FG002|Period 3|Other (Reason not specified)|0|||
131175900|NCT02768194|472264559|FG003|Period 3|Other (Reason not specified)|0|||
131175901|NCT02768194|472264560|FG004|Period 3|Other (Reason not specified)|0|||
131175902|NCT02768194|472264561|FG005|Period 3|Other (Reason not specified)|0|||
131175903|NCT04863014|472264562|FG000|Overall Study|Lost to Follow-up|3|||
131175904|NCT04863014|472264563|FG001|Overall Study|Lost to Follow-up|2|||
131175905|NCT04863014|472264562|FG000|Overall Study|Subject Decision|0|||
131175906|NCT04863014|472264563|FG001|Overall Study|Subject Decision|4|||
131175907|NCT01553916|472264564|FG000|Overall Study|Withdrawal by Subject|2|||
131175908|NCT01553916|472264564|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
131175909|NCT04348591|472264570|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
131175910|NCT04348591|472264571|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
131175911|NCT04348591|472264570|FG000|Imaging Session (120 Min)|Physician Decision|0|||
131175912|NCT04348591|472264571|FG001|Imaging Session (120 Min)|Physician Decision|1|||
131175913|NCT04348591|472264570|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
131175914|NCT04348591|472264571|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
131175915|NCT02104804|472264572|FG000|Overall Study|Did not take study medication|0|||
131175916|NCT02104804|472264573|FG001|Overall Study|Did not take study medication|1|||
131175917|NCT02104804|472264572|FG000|Overall Study|Study specific discontinuation criteria|6|||
131175918|NCT02104804|472264573|FG001|Overall Study|Study specific discontinuation criteria|1|||
131175919|NCT02104804|472264572|FG000|Overall Study|Other listed|2|||
131175920|NCT02104804|472264573|FG001|Overall Study|Other listed|1|||
131175921|NCT02104804|472264572|FG000|Overall Study|Protocol Violation|0|||
131175922|NCT02104804|472264573|FG001|Overall Study|Protocol Violation|1|||
131175923|NCT02104804|472264572|FG000|Overall Study|Adverse Event|4|||
131175924|NCT02104804|472264573|FG001|Overall Study|Adverse Event|3|||
131175925|NCT02104804|472264572|FG000|Overall Study|Withdrawal by Subject|4|||
131175926|NCT02104804|472264573|FG001|Overall Study|Withdrawal by Subject|12|||
131175927|NCT04501679|472264574|FG000|Overall Study|Pregnancy|0|||
131175928|NCT04501679|472264575|FG001|Overall Study|Pregnancy|1|||
131175929|NCT04501679|472264574|FG000|Overall Study|Adverse Event|4|||
131175930|NCT04501679|472264575|FG001|Overall Study|Adverse Event|2|||
131175931|NCT04501679|472264574|FG000|Overall Study|Withdrawal by Subject|2|||
131175932|NCT04501679|472264575|FG001|Overall Study|Withdrawal by Subject|0|||
131175933|NCT04501679|472264574|FG000|Overall Study|Physician Decision|1|||
131175934|NCT04501679|472264575|FG001|Overall Study|Physician Decision|0|||
131175935|NCT04501679|472264574|FG000|Overall Study|Lost to Follow-up|2|||
131175936|NCT04501679|472264575|FG001|Overall Study|Lost to Follow-up|0|||
131175937|NCT01968954|472264582|FG000|Overall Study|Adverse Event|6|||
131175938|NCT01968954|472264583|FG001|Overall Study|Adverse Event|3|||
131175939|NCT01968954|472264582|FG000|Overall Study|Death|1|||
131175940|NCT01968954|472264583|FG001|Overall Study|Death|2|||
131175941|NCT01968954|472264582|FG000|Overall Study|Lost to Follow-up|6|||
131175942|NCT01968954|472264583|FG001|Overall Study|Lost to Follow-up|4|||
131175943|NCT01968954|472264582|FG000|Overall Study|Withdrawal by Subject|20|||
131175944|NCT01968954|472264583|FG001|Overall Study|Withdrawal by Subject|23|||
131175945|NCT01968954|472264582|FG000|Overall Study|Other|7|||
131175946|NCT01968954|472264583|FG001|Overall Study|Other|8|||
131175947|NCT01968954|472264582|FG000|Overall Study|Protocol Violation|0|||
131175948|NCT01968954|472264583|FG001|Overall Study|Protocol Violation|1|||
131175949|NCT01968954|472264582|FG000|Overall Study|Did not met inclusion criteria|0|||
131175950|NCT01968954|472264583|FG001|Overall Study|Did not met inclusion criteria|2|||
131175951|NCT00751114|472264584|FG000|Overall Study|Adverse Event|2|||
131175952|NCT00751114|472264585|FG001|Overall Study|Adverse Event|4|||
131175953|NCT00751114|472264584|FG000|Overall Study|Protocol Violation|8|||
131175954|NCT00751114|472264585|FG001|Overall Study|Protocol Violation|9|||
131175955|NCT00751114|472264584|FG000|Overall Study|Withdrawal by Subject|9|||
131175956|NCT00751114|472264585|FG001|Overall Study|Withdrawal by Subject|4|||
131175957|NCT00751114|472264584|FG000|Overall Study|Lost to Follow-up|4|||
131175958|NCT00751114|472264585|FG001|Overall Study|Lost to Follow-up|7|||
131175959|NCT00751114|472264584|FG000|Overall Study|Lack of Efficacy|0|||
131175960|NCT00751114|472264585|FG001|Overall Study|Lack of Efficacy|7|||
131175961|NCT00751114|472264584|FG000|Overall Study|Not Treated|13|||
131175962|NCT00751114|472264585|FG001|Overall Study|Not Treated|1|||
131175963|NCT00751114|472264584|FG000|Overall Study|Out of country for 2 months|1|||
131175964|NCT00751114|472264585|FG001|Overall Study|Out of country for 2 months|0|||
130782661|NCT02287038|470831243|FG001|Overall Study|Abnormal ECG after starting medication|0|||
131175965|NCT00751114|472264584|FG000|Overall Study|Move to another city|1|||
131175966|NCT00751114|472264585|FG001|Overall Study|Move to another city|0|||
131175967|NCT05319080|472264586|FG000|Overall Study|Withdrawal by Subject|2|||
131175968|NCT05319080|472264586|FG000|Overall Study|Physician Decision|4|||
131175969|NCT02358369|472264587|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
131175970|NCT02358369|472264588|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
131175971|NCT02358369|472264589|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
131175972|NCT02358369|472264590|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
131175973|NCT02358369|472264591|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
131175974|NCT02358369|472264587|FG000|Treatment Period A/B|Adverse Event|0|||
131175975|NCT02358369|472264588|FG001|Treatment Period A/B|Adverse Event|0|||
131175976|NCT02358369|472264589|FG002|Treatment Period A/B|Adverse Event|1|||
131175977|NCT02358369|472264590|FG003|Treatment Period A/B|Adverse Event|2|||
131175978|NCT02358369|472264591|FG004|Treatment Period A/B|Adverse Event|0|||
131175979|NCT02358369|472264587|FG000|Treatment Period A/B|Death|0|||
131175980|NCT02358369|472264588|FG001|Treatment Period A/B|Death|0|||
131175981|NCT02358369|472264589|FG002|Treatment Period A/B|Death|1|||
131175982|NCT02358369|472264590|FG003|Treatment Period A/B|Death|0|||
131175983|NCT02358369|472264591|FG004|Treatment Period A/B|Death|0|||
131175984|NCT02358369|472264587|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
131175985|NCT02358369|472264588|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
131175986|NCT02358369|472264589|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
131175987|NCT02358369|472264590|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
131175988|NCT02358369|472264591|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
131175989|NCT02358369|472264587|FG000|Treatment Period C|Adverse Event|0|||
131175990|NCT02358369|472264588|FG001|Treatment Period C|Adverse Event|0|||
131175991|NCT02358369|472264589|FG002|Treatment Period C|Adverse Event|0|||
131175992|NCT02358369|472264590|FG003|Treatment Period C|Adverse Event|0|||
131175993|NCT02358369|472264591|FG004|Treatment Period C|Adverse Event|7|||
131175994|NCT03259490|472264596|FG000|Period 1|Withdrawal by Subject|0|||
131175995|NCT03259490|472264597|FG001|Period 1|Withdrawal by Subject|1|||
131175996|NCT03259490|472264596|FG000|Period 2|Protocol Violation|1|||
131175997|NCT03259490|472264597|FG001|Period 2|Protocol Violation|0|||
131175998|NCT00434122|472264598|FG000|Overall Study|Non-compliance with protocol|0|||
131175999|NCT00434122|472264599|FG001|Overall Study|Non-compliance with protocol|1|||
131176000|NCT00434122|472264598|FG000|Overall Study|loss of subject contact|1|||
131176001|NCT00434122|472264599|FG001|Overall Study|loss of subject contact|1|||
131176002|NCT00434122|472264598|FG000|Overall Study|Personal reasons|1|||
131176003|NCT00434122|472264599|FG001|Overall Study|Personal reasons|1|||
131176004|NCT00434122|472264598|FG000|Overall Study|Large follicle size|2|||
131176005|NCT00434122|472264599|FG001|Overall Study|Large follicle size|2|||
131176006|NCT00434122|472264598|FG000|Overall Study|Low follicular response.|1|||
131176007|NCT00434122|472264599|FG001|Overall Study|Low follicular response.|2|||
131176008|NCT00434122|472264598|FG000|Overall Study|Travelling of subject.|1|||
131176009|NCT00434122|472264599|FG001|Overall Study|Travelling of subject.|0|||
131176010|NCT04191577|472264603|FG000|Overall Study|Withdrawal by Subject|2|||
131176011|NCT04191577|472264604|FG001|Overall Study|Withdrawal by Subject|2|||
131176012|NCT04191577|472264605|FG002|Overall Study|Withdrawal by Subject|1|||
131176013|NCT04191577|472264603|FG000|Overall Study|Physician Decision|1|||
131176014|NCT04191577|472264604|FG001|Overall Study|Physician Decision|1|||
131176015|NCT04191577|472264605|FG002|Overall Study|Physician Decision|0|||
131176016|NCT04191577|472264603|FG000|Overall Study|Adverse Event|0|||
131176017|NCT04191577|472264604|FG001|Overall Study|Adverse Event|0|||
131176018|NCT04191577|472264605|FG002|Overall Study|Adverse Event|1|||
131176019|NCT04191577|472264603|FG000|Overall Study|Death|0|||
131176020|NCT04191577|472264604|FG001|Overall Study|Death|0|||
131176021|NCT04191577|472264605|FG002|Overall Study|Death|1|||
131176022|NCT03655717|472264606|FG000|Overall Study|Withdrawal by Subject|4|||
131176023|NCT03655717|472264607|FG001|Overall Study|Withdrawal by Subject|8|||
131176024|NCT03655717|472264608|FG002|Overall Study|Withdrawal by Subject|1|||
131176025|NCT03655717|472264609|FG003|Overall Study|Withdrawal by Subject|0|||
131176026|NCT03655717|472264610|FG004|Overall Study|Withdrawal by Subject|0|||
131176027|NCT03655717|472264611|FG005|Overall Study|Withdrawal by Subject|1|||
131176028|NCT03655717|472264612|FG006|Overall Study|Withdrawal by Subject|3|||
131176029|NCT03655717|472264613|FG007|Overall Study|Withdrawal by Subject|1|||
131176030|NCT03655717|472264614|FG008|Overall Study|Withdrawal by Subject|2|||
131176031|NCT03655717|472264615|FG009|Overall Study|Withdrawal by Subject|0|||
131176032|NCT03655717|472264616|FG010|Overall Study|Withdrawal by Subject|0|||
131176033|NCT03655717|472264617|FG011|Overall Study|Withdrawal by Subject|1|||
131176034|NCT03655717|472264618|FG012|Overall Study|Withdrawal by Subject|0|||
131176035|NCT03655717|472264619|FG013|Overall Study|Withdrawal by Subject|3|||
131176036|NCT03655717|472264620|FG014|Overall Study|Withdrawal by Subject|0|||
131176037|NCT03655717|472264621|FG015|Overall Study|Withdrawal by Subject|1|||
131176038|NCT03655717|472264622|FG016|Overall Study|Withdrawal by Subject|0|||
131176039|NCT03655717|472264623|FG017|Overall Study|Withdrawal by Subject|0|||
131176040|NCT03655717|472264624|FG018|Overall Study|Withdrawal by Subject|1|||
131176041|NCT03655717|472264625|FG019|Overall Study|Withdrawal by Subject|0|||
131176042|NCT03655717|472264626|FG020|Overall Study|Withdrawal by Subject|0|||
131176043|NCT03655717|472264627|FG021|Overall Study|Withdrawal by Subject|1|||
131176044|NCT03655717|472264628|FG022|Overall Study|Withdrawal by Subject|2|||
131176045|NCT03655717|472264629|FG023|Overall Study|Withdrawal by Subject|1|||
131176046|NCT03655717|472264630|FG024|Overall Study|Withdrawal by Subject|1|||
131176047|NCT03655717|472264631|FG025|Overall Study|Withdrawal by Subject|0|||
131176048|NCT03655717|472264606|FG000|Overall Study|Physician Decision|3|||
131176049|NCT03655717|472264607|FG001|Overall Study|Physician Decision|3|||
131176050|NCT03655717|472264608|FG002|Overall Study|Physician Decision|0|||
130782662|NCT02700048|470831265|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
130782663|NCT02700048|470831266|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
130782664|NCT02175225|470831267|FG000|Overall Study|Withdrawal by Subject|1|||
130782665|NCT02175225|470831268|FG001|Overall Study|Withdrawal by Subject|2|||
130782666|NCT02175225|470831267|FG000|Overall Study|Lost to Follow-up|6|||
130782667|NCT02175225|470831268|FG001|Overall Study|Lost to Follow-up|7|||
130782668|NCT02175225|470831267|FG000|Overall Study|Study drug not administered|1|||
130782669|NCT02175225|470831268|FG001|Overall Study|Study drug not administered|2|||
130782670|NCT01121263|470831269|FG000|Overall Study|Death|3|||
130782671|NCT01121263|470831270|FG001|Overall Study|Death|2|||
130782672|NCT01121263|470831269|FG000|Overall Study|Lost to Follow-up|22|||
130782673|NCT01121263|470831270|FG001|Overall Study|Lost to Follow-up|12|||
130782674|NCT01121263|470831269|FG000|Overall Study|Withdrawal by Subject|0|||
130782675|NCT01121263|470831270|FG001|Overall Study|Withdrawal by Subject|1|||
130782676|NCT02007720|470831271|FG000|Overall Study|Withdrawal by Subject|9|||
130782677|NCT02007720|470831272|FG001|Overall Study|Withdrawal by Subject|11|||
130782678|NCT02007720|470831271|FG000|Overall Study|study terminated by sponsor|58|||
130782679|NCT02007720|470831272|FG001|Overall Study|study terminated by sponsor|54|||
130782680|NCT02007720|470831271|FG000|Overall Study|technical problem|4|||
130782681|NCT02007720|470831272|FG001|Overall Study|technical problem|2|||
130782682|NCT02007720|470831271|FG000|Overall Study|patient followd less than 165 days|11|||
130782683|NCT02007720|470831272|FG001|Overall Study|patient followd less than 165 days|5|||
130782684|NCT01386606|470833126|FG000|Overall Study|Adverse Event|0|||
130782685|NCT01386606|470833127|FG001|Overall Study|Adverse Event|1|||
130782686|NCT01386606|470833128|FG002|Overall Study|Adverse Event|0|||
130782687|NCT01386606|470833129|FG003|Overall Study|Adverse Event|0|||
130782688|NCT01386606|470833126|FG000|Overall Study|Withdrawal by Subject|0|||
130782689|NCT01386606|470833127|FG001|Overall Study|Withdrawal by Subject|1|||
130782690|NCT01386606|470833128|FG002|Overall Study|Withdrawal by Subject|1|||
130782691|NCT01386606|470833129|FG003|Overall Study|Withdrawal by Subject|0|||
130782692|NCT01386606|470833126|FG000|Overall Study|Protocol Violation|1|||
130782693|NCT01386606|470833127|FG001|Overall Study|Protocol Violation|0|||
130782694|NCT01386606|470833128|FG002|Overall Study|Protocol Violation|1|||
130782695|NCT01386606|470833129|FG003|Overall Study|Protocol Violation|1|||
130782696|NCT01386606|470833126|FG000|Overall Study|Lost to Follow-up|2|||
130782697|NCT01386606|470833127|FG001|Overall Study|Lost to Follow-up|0|||
131236794|NCT01345019|472495043|FG001|Blinded Treatment Phase|Noncompliance|3|||
131236795|NCT01345019|472495042|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
131236796|NCT01345019|472495043|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
131236797|NCT01345019|472495042|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
131236798|NCT01345019|472495043|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
131236799|NCT01345019|472495042|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
131236800|NCT01345019|472495043|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
131236801|NCT01345019|472495042|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
131236802|NCT01345019|472495043|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
131236803|NCT01345019|472495042|FG000|Open Label Treatment Phase|Death|49|||
131236804|NCT01345019|472495043|FG001|Open Label Treatment Phase|Death|48|||
131236805|NCT01345019|472495042|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
130782698|NCT01386606|470833128|FG002|Overall Study|Lost to Follow-up|0|||
130782699|NCT01386606|470833129|FG003|Overall Study|Lost to Follow-up|0|||
130782700|NCT01386606|470833126|FG000|Overall Study|Subject incarcerated|0|||
130782701|NCT01386606|470833127|FG001|Overall Study|Subject incarcerated|1|||
131176051|NCT03655717|472264609|FG003|Overall Study|Physician Decision|0|||
131176052|NCT03655717|472264610|FG004|Overall Study|Physician Decision|0|||
131176053|NCT03655717|472264611|FG005|Overall Study|Physician Decision|0|||
131176054|NCT03655717|472264612|FG006|Overall Study|Physician Decision|0|||
131176055|NCT03655717|472264613|FG007|Overall Study|Physician Decision|0|||
131176056|NCT03655717|472264614|FG008|Overall Study|Physician Decision|0|||
131176057|NCT03655717|472264615|FG009|Overall Study|Physician Decision|1|||
131176058|NCT03655717|472264616|FG010|Overall Study|Physician Decision|0|||
131176059|NCT03655717|472264617|FG011|Overall Study|Physician Decision|0|||
131176060|NCT03655717|472264618|FG012|Overall Study|Physician Decision|0|||
131176061|NCT03655717|472264619|FG013|Overall Study|Physician Decision|0|||
131176062|NCT03655717|472264620|FG014|Overall Study|Physician Decision|0|||
131176063|NCT03655717|472264621|FG015|Overall Study|Physician Decision|0|||
131236806|NCT01345019|472495043|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
130782702|NCT01386606|470833128|FG002|Overall Study|Subject incarcerated|0|||
130782703|NCT01386606|470833129|FG003|Overall Study|Subject incarcerated|0|||
130782704|NCT01386606|470833126|FG000|Overall Study|Unable to draw PK|1|||
130782705|NCT01386606|470833127|FG001|Overall Study|Unable to draw PK|0|||
130782706|NCT01386606|470833128|FG002|Overall Study|Unable to draw PK|0|||
130782707|NCT01386606|470833129|FG003|Overall Study|Unable to draw PK|0|||
130782708|NCT01386606|470833126|FG000|Overall Study|T levels too high|0|||
130782709|NCT01386606|470833127|FG001|Overall Study|T levels too high|1|||
131176064|NCT03655717|472264622|FG016|Overall Study|Physician Decision|0|||
131176065|NCT03655717|472264623|FG017|Overall Study|Physician Decision|0|||
131176066|NCT03655717|472264624|FG018|Overall Study|Physician Decision|0|||
131176067|NCT03655717|472264625|FG019|Overall Study|Physician Decision|1|||
131176068|NCT03655717|472264626|FG020|Overall Study|Physician Decision|0|||
131176069|NCT03655717|472264627|FG021|Overall Study|Physician Decision|0|||
131176070|NCT03655717|472264628|FG022|Overall Study|Physician Decision|0|||
131176071|NCT03655717|472264629|FG023|Overall Study|Physician Decision|1|||
131176072|NCT03655717|472264630|FG024|Overall Study|Physician Decision|0|||
131176073|NCT03655717|472264631|FG025|Overall Study|Physician Decision|0|||
131176074|NCT03655717|472264606|FG000|Overall Study|Lost to Follow-up|3|||
131176075|NCT03655717|472264607|FG001|Overall Study|Lost to Follow-up|1|||
131176076|NCT03655717|472264608|FG002|Overall Study|Lost to Follow-up|0|||
131176077|NCT03655717|472264609|FG003|Overall Study|Lost to Follow-up|1|||
131176078|NCT03655717|472264610|FG004|Overall Study|Lost to Follow-up|0|||
131176079|NCT03655717|472264611|FG005|Overall Study|Lost to Follow-up|1|||
131176080|NCT03655717|472264612|FG006|Overall Study|Lost to Follow-up|0|||
131176081|NCT03655717|472264613|FG007|Overall Study|Lost to Follow-up|0|||
131176082|NCT03655717|472264614|FG008|Overall Study|Lost to Follow-up|0|||
131176083|NCT03655717|472264615|FG009|Overall Study|Lost to Follow-up|0|||
131176084|NCT03655717|472264616|FG010|Overall Study|Lost to Follow-up|0|||
131176085|NCT03655717|472264617|FG011|Overall Study|Lost to Follow-up|1|||
131176086|NCT03655717|472264618|FG012|Overall Study|Lost to Follow-up|0|||
131176087|NCT03655717|472264619|FG013|Overall Study|Lost to Follow-up|0|||
131176088|NCT03655717|472264620|FG014|Overall Study|Lost to Follow-up|0|||
131176089|NCT03655717|472264621|FG015|Overall Study|Lost to Follow-up|0|||
131176090|NCT03655717|472264622|FG016|Overall Study|Lost to Follow-up|0|||
131176091|NCT03655717|472264623|FG017|Overall Study|Lost to Follow-up|0|||
131176092|NCT03655717|472264624|FG018|Overall Study|Lost to Follow-up|0|||
131176093|NCT03655717|472264625|FG019|Overall Study|Lost to Follow-up|0|||
131176094|NCT03655717|472264626|FG020|Overall Study|Lost to Follow-up|0|||
131176095|NCT03655717|472264627|FG021|Overall Study|Lost to Follow-up|0|||
131176096|NCT03655717|472264628|FG022|Overall Study|Lost to Follow-up|0|||
131176097|NCT03655717|472264629|FG023|Overall Study|Lost to Follow-up|0|||
131176098|NCT03655717|472264630|FG024|Overall Study|Lost to Follow-up|0|||
131176099|NCT03655717|472264631|FG025|Overall Study|Lost to Follow-up|0|||
131176100|NCT01185249|472264632|FG000|Overall Study|Patients discharged or change in status|42|||
131176101|NCT03521193|472264633|FG000|Overall Study|Withdrawal by Subject|8|||
131176102|NCT03521193|472264634|FG001|Overall Study|Withdrawal by Subject|0|||
131176103|NCT03521193|472264633|FG000|Overall Study|non compliant to ASA treatment|8|||
131176104|NCT03521193|472264634|FG001|Overall Study|non compliant to ASA treatment|0|||
131176105|NCT00406783|472264637|FG000|Overall Study|Adverse Event|4|||
131176106|NCT00406783|472264638|FG001|Overall Study|Adverse Event|4|||
131176107|NCT00406783|472264637|FG000|Overall Study|Treatment Failure|2|||
131176108|NCT00406783|472264638|FG001|Overall Study|Treatment Failure|3|||
131176109|NCT00406783|472264637|FG000|Overall Study|Lost to Follow-up|3|||
131176110|NCT00406783|472264638|FG001|Overall Study|Lost to Follow-up|0|||
131176111|NCT00406783|472264637|FG000|Overall Study|Withdrawal by Subject|1|||
131176112|NCT00406783|472264638|FG001|Overall Study|Withdrawal by Subject|4|||
131176113|NCT00406783|472264637|FG000|Overall Study|Protocol Violation|4|||
131176114|NCT00406783|472264638|FG001|Overall Study|Protocol Violation|4|||
131176115|NCT00012012|472264639|FG000|Overall Study|Protocol Violation|1|||
131176116|NCT00012012|472264640|FG001|Overall Study|Protocol Violation|1|||
131176117|NCT00012012|472264639|FG000|Overall Study|Withdrawal by Subject|0|||
131176118|NCT00012012|472264640|FG001|Overall Study|Withdrawal by Subject|2|||
131176119|NCT01391819|472264641|FG000|Overall Study|Withdrawal by Subject|56|||
131176120|NCT01391819|472264641|FG000|Overall Study|Migrated/moved from study area|82|||
131176121|NCT01391819|472264641|FG000|Overall Study|Lost to Follow-up|252|||
131176122|NCT01391819|472264641|FG000|Overall Study|Death|3|||
131176123|NCT01391819|472264641|FG000|Overall Study|Other|9|||
131176124|NCT00479557|472264647|FG000|Overall Study|Death|0|||
131176125|NCT00479557|472264648|FG001|Overall Study|Death|0|||
131176126|NCT00479557|472264649|FG002|Overall Study|Death|0|||
131176127|NCT00479557|472264650|FG003|Overall Study|Death|0|||
131176128|NCT00479557|472264651|FG004|Overall Study|Death|0|||
131176129|NCT00479557|472264652|FG005|Overall Study|Death|1|||
131176130|NCT00479557|472264653|FG006|Overall Study|Death|0|||
130782710|NCT01386606|470833128|FG002|Overall Study|T levels too high|1|||
131176131|NCT00479557|472264647|FG000|Overall Study|Lack of Efficacy|1|||
131176132|NCT00479557|472264648|FG001|Overall Study|Lack of Efficacy|0|||
131176133|NCT00479557|472264649|FG002|Overall Study|Lack of Efficacy|0|||
131176134|NCT00479557|472264650|FG003|Overall Study|Lack of Efficacy|0|||
131176135|NCT00479557|472264651|FG004|Overall Study|Lack of Efficacy|0|||
131176136|NCT00479557|472264652|FG005|Overall Study|Lack of Efficacy|0|||
131176137|NCT00479557|472264653|FG006|Overall Study|Lack of Efficacy|0|||
131176138|NCT00479557|472264647|FG000|Overall Study|Lost to Follow-up|0|||
131176139|NCT00479557|472264648|FG001|Overall Study|Lost to Follow-up|2|||
131176140|NCT00479557|472264649|FG002|Overall Study|Lost to Follow-up|0|||
131176141|NCT00479557|472264650|FG003|Overall Study|Lost to Follow-up|2|||
131176142|NCT00479557|472264651|FG004|Overall Study|Lost to Follow-up|0|||
131176143|NCT00479557|472264652|FG005|Overall Study|Lost to Follow-up|0|||
131176144|NCT00479557|472264653|FG006|Overall Study|Lost to Follow-up|0|||
131176145|NCT00479557|472264647|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
131176146|NCT00479557|472264648|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
131176147|NCT00479557|472264649|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
131176148|NCT00479557|472264650|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
131176149|NCT00479557|472264651|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
131176150|NCT00479557|472264652|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
131176151|NCT00479557|472264653|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
131176152|NCT00479557|472264647|FG000|Overall Study|AE not related to Study Drug|1|||
131176153|NCT00479557|472264648|FG001|Overall Study|AE not related to Study Drug|3|||
131176154|NCT00479557|472264649|FG002|Overall Study|AE not related to Study Drug|0|||
131176155|NCT00479557|472264650|FG003|Overall Study|AE not related to Study Drug|0|||
131176156|NCT00479557|472264651|FG004|Overall Study|AE not related to Study Drug|2|||
131176157|NCT00479557|472264652|FG005|Overall Study|AE not related to Study Drug|2|||
131176158|NCT00479557|472264653|FG006|Overall Study|AE not related to Study Drug|1|||
131176159|NCT00479557|472264647|FG000|Overall Study|Caregiver Request|2|||
131176160|NCT00479557|472264648|FG001|Overall Study|Caregiver Request|2|||
131176161|NCT00479557|472264649|FG002|Overall Study|Caregiver Request|2|||
131176162|NCT00479557|472264650|FG003|Overall Study|Caregiver Request|0|||
131176163|NCT00479557|472264651|FG004|Overall Study|Caregiver Request|1|||
131176164|NCT00479557|472264652|FG005|Overall Study|Caregiver Request|2|||
131176165|NCT00479557|472264653|FG006|Overall Study|Caregiver Request|0|||
131176166|NCT00479557|472264647|FG000|Overall Study|Investigator Request|0|||
131176167|NCT00479557|472264648|FG001|Overall Study|Investigator Request|0|||
131176168|NCT00479557|472264649|FG002|Overall Study|Investigator Request|1|||
131176169|NCT00479557|472264650|FG003|Overall Study|Investigator Request|0|||
131176170|NCT00479557|472264651|FG004|Overall Study|Investigator Request|0|||
131176171|NCT00479557|472264652|FG005|Overall Study|Investigator Request|0|||
131176172|NCT00479557|472264653|FG006|Overall Study|Investigator Request|0|||
131176173|NCT00479557|472264647|FG000|Overall Study|Subject Request|3|||
131176174|NCT00479557|472264648|FG001|Overall Study|Subject Request|0|||
131176175|NCT00479557|472264649|FG002|Overall Study|Subject Request|1|||
131176176|NCT00479557|472264650|FG003|Overall Study|Subject Request|1|||
131176177|NCT00479557|472264651|FG004|Overall Study|Subject Request|1|||
131176178|NCT00479557|472264652|FG005|Overall Study|Subject Request|4|||
131176179|NCT00479557|472264653|FG006|Overall Study|Subject Request|1|||
131176180|NCT00479557|472264647|FG000|Overall Study|Other|2|||
131176181|NCT00479557|472264648|FG001|Overall Study|Other|3|||
131176182|NCT00479557|472264649|FG002|Overall Study|Other|1|||
131176183|NCT00479557|472264650|FG003|Overall Study|Other|0|||
131176184|NCT00479557|472264651|FG004|Overall Study|Other|0|||
131176185|NCT00479557|472264652|FG005|Overall Study|Other|3|||
131176186|NCT00479557|472264653|FG006|Overall Study|Other|0|||
131176187|NCT03073213|472266283|FG000|Multiple Dose Period|Protocol Violation|0|||
131176188|NCT03073213|472266284|FG001|Multiple Dose Period|Protocol Violation|0|||
131176189|NCT03073213|472266285|FG002|Multiple Dose Period|Protocol Violation|1|||
131176190|NCT01617655|472266289|FG000|Overall Study|Adverse Event|2|||
131176191|NCT01617655|472266290|FG001|Overall Study|Adverse Event|3|||
131176192|NCT01617655|472266289|FG000|Overall Study|Poor compliance to protocol|1|||
131176193|NCT01617655|472266290|FG001|Overall Study|Poor compliance to protocol|4|||
131176194|NCT01617655|472266289|FG000|Overall Study|Participants moved|0|||
131176195|NCT01617655|472266290|FG001|Overall Study|Participants moved|4|||
131176196|NCT01617655|472266289|FG000|Overall Study|Consent withdrawn by participant|1|||
131176197|NCT01617655|472266290|FG001|Overall Study|Consent withdrawn by participant|1|||
131176198|NCT01617655|472266289|FG000|Overall Study|Last visit outside protocol visit window|1|||
131176199|NCT01617655|472266290|FG001|Overall Study|Last visit outside protocol visit window|10|||
131176200|NCT01617655|472266289|FG000|Overall Study|Site closure|3|||
131176201|NCT01617655|472266290|FG001|Overall Study|Site closure|5|||
131176202|NCT01617655|472266289|FG000|Overall Study|Other than specified above|1|||
131176203|NCT01617655|472266290|FG001|Overall Study|Other than specified above|2|||
131176204|NCT01175213|472266293|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
131176205|NCT01175213|472266294|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
131176206|NCT01175213|472266293|FG000|IGSC, 10%/rHuPH20|Death|1|||
131176207|NCT01175213|472266294|FG001|IGSC, 10%/rHuPH20|Death|0|||
131176208|NCT01175213|472266293|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
131176209|NCT01175213|472266294|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
131176210|NCT01175213|472266293|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
131176211|NCT01175213|472266294|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
131176212|NCT01175213|472266293|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
131176213|NCT01175213|472266294|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
131176214|NCT01175213|472266293|FG000|Safety Follow-up|Adverse Event|1|||
131176215|NCT01175213|472266294|FG001|Safety Follow-up|Adverse Event|0|||
131176216|NCT00003476|472266296|FG000|Overall Study|Not evaluable|1|||
131176217|NCT03057951|472266297|FG000|Overall Study|Adverse Event|553|||
131176218|NCT03057951|472266298|FG001|Overall Study|Adverse Event|575|||
131176219|NCT03057951|472266297|FG000|Overall Study|Protocol Violation|30|||
131176220|NCT03057951|472266298|FG001|Overall Study|Protocol Violation|24|||
131176221|NCT03057951|472266297|FG000|Overall Study|Lost to Follow-up|6|||
131236807|NCT01345019|472495042|FG000|Open Label Treatment Phase|Adverse Event|30|||
131236808|NCT01345019|472495043|FG001|Open Label Treatment Phase|Adverse Event|51|||
131236809|NCT01345019|472495042|FG000|Open Label Treatment Phase|Administrative Decision|30|||
131236810|NCT01345019|472495043|FG001|Open Label Treatment Phase|Administrative Decision|15|||
131236811|NCT01345019|472495042|FG000|Open Label Treatment Phase|Disease Progression|17|||
131236812|NCT01345019|472495043|FG001|Open Label Treatment Phase|Disease Progression|18|||
131236813|NCT01345019|472495042|FG000|Open Label Treatment Phase|Noncompliance|5|||
131236814|NCT01345019|472495043|FG001|Open Label Treatment Phase|Noncompliance|4|||
131236815|NCT01345019|472495042|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
131236816|NCT01345019|472495043|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
131236817|NCT01345019|472495042|FG000|Open Label Treatment Phase|Pregnancy|1|||
131236818|NCT01345019|472495043|FG001|Open Label Treatment Phase|Pregnancy|0|||
131236819|NCT01345019|472495042|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
131236820|NCT01345019|472495043|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
131236821|NCT01345019|472495042|FG000|Open Label Treatment Phase|Protocol Violation|0|||
131236822|NCT01345019|472495043|FG001|Open Label Treatment Phase|Protocol Violation|1|||
131236823|NCT03830164|472495047|FG000|Overall Study|Adverse Event|0|||
131236824|NCT03830164|472495048|FG001|Overall Study|Adverse Event|2|||
131236825|NCT03830164|472495049|FG002|Overall Study|Adverse Event|0|||
131236826|NCT03830164|472495047|FG000|Overall Study|Lack of Efficacy|1|||
131236827|NCT03830164|472495048|FG001|Overall Study|Lack of Efficacy|5|||
131236828|NCT03830164|472495049|FG002|Overall Study|Lack of Efficacy|0|||
131236829|NCT03830164|472495047|FG000|Overall Study|Lost to Follow-up|0|||
131236830|NCT03830164|472495048|FG001|Overall Study|Lost to Follow-up|1|||
131236831|NCT03830164|472495049|FG002|Overall Study|Lost to Follow-up|0|||
131236832|NCT03830164|472495047|FG000|Overall Study|Withdrawal by Subject|1|||
131236833|NCT03830164|472495048|FG001|Overall Study|Withdrawal by Subject|0|||
131236834|NCT03830164|472495049|FG002|Overall Study|Withdrawal by Subject|0|||
131236835|NCT00386009|472495050|FG000|Overall Study|Adverse Event|0|||
131236836|NCT00386009|472495051|FG001|Overall Study|Adverse Event|2|||
131236837|NCT00386009|472495050|FG000|Overall Study|Death|1|||
131236838|NCT00386009|472495051|FG001|Overall Study|Death|0|||
131236839|NCT00386009|472495050|FG000|Overall Study|Entry Criteria Not Met|0|||
131236840|NCT00386009|472495051|FG001|Overall Study|Entry Criteria Not Met|2|||
131236841|NCT00386009|472495050|FG000|Overall Study|Lost to Follow-up|1|||
131236842|NCT00386009|472495051|FG001|Overall Study|Lost to Follow-up|1|||
131236843|NCT00386009|472495050|FG000|Overall Study|Protocol Violation|1|||
131236844|NCT00386009|472495051|FG001|Overall Study|Protocol Violation|0|||
131236845|NCT00386009|472495050|FG000|Overall Study|Sponsor Decision|1|||
131236846|NCT00386009|472495051|FG001|Overall Study|Sponsor Decision|1|||
131176222|NCT03057951|472266298|FG001|Overall Study|Lost to Follow-up|16|||
131176223|NCT03057951|472266297|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
131176224|NCT03057951|472266298|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
131176225|NCT03057951|472266297|FG000|Overall Study|Study drug stopped, reason missing|6|||
131176226|NCT03057951|472266298|FG001|Overall Study|Study drug stopped, reason missing|1|||
131176227|NCT03057951|472266297|FG000|Overall Study|Medical advice|6|||
131176228|NCT03057951|472266298|FG001|Overall Study|Medical advice|2|||
131176229|NCT03057951|472266297|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
131176230|NCT03057951|472266298|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
131176231|NCT03057951|472266297|FG000|Overall Study|Investigator decision|2|||
131176232|NCT03057951|472266298|FG001|Overall Study|Investigator decision|0|||
131176233|NCT03057951|472266297|FG000|Overall Study|Patient decision|5|||
131176234|NCT03057951|472266298|FG001|Overall Study|Patient decision|2|||
131176235|NCT03057951|472266297|FG000|Overall Study|Not attending study visits|3|||
131176236|NCT03057951|472266298|FG001|Overall Study|Not attending study visits|0|||
131176237|NCT03057951|472266297|FG000|Overall Study|Patient moved away|3|||
131176238|NCT03057951|472266298|FG001|Overall Study|Patient moved away|4|||
131176239|NCT03057951|472266297|FG000|Overall Study|Other reason than stated above|23|||
131176240|NCT03057951|472266298|FG001|Overall Study|Other reason than stated above|29|||
131176241|NCT03057951|472266297|FG000|Overall Study|Not treated|2|||
131176242|NCT03057951|472266298|FG001|Overall Study|Not treated|1|||
131176243|NCT00696436|472266299|FG000|Overall Study|Adverse Event|7|||
131176244|NCT00696436|472266300|FG001|Overall Study|Adverse Event|9|||
131176245|NCT00696436|472266301|FG002|Overall Study|Adverse Event|8|||
131236847|NCT00386009|472495050|FG000|Overall Study|Withdrawal by Subject|5|||
131236848|NCT00386009|472495051|FG001|Overall Study|Withdrawal by Subject|4|||
131236849|NCT00995553|472495052|FG000|Overall Study|Withdrawal by Subject|2|||
131236850|NCT00995553|472495053|FG001|Overall Study|Withdrawal by Subject|6|||
131236851|NCT02465567|472495054|FG000|Overall Study|Adverse Event|118|||
131236852|NCT02465567|472495055|FG001|Overall Study|Adverse Event|113|||
131236853|NCT02465567|472495056|FG002|Overall Study|Adverse Event|147|||
131236854|NCT02465567|472495057|FG003|Overall Study|Adverse Event|138|||
131176246|NCT00696436|472266302|FG003|Overall Study|Adverse Event|6|||
131176247|NCT00696436|472266303|FG004|Overall Study|Adverse Event|4|||
131176248|NCT00696436|472266299|FG000|Overall Study|Protocol Violation|3|||
131176249|NCT00696436|472266300|FG001|Overall Study|Protocol Violation|2|||
131176250|NCT00696436|472266301|FG002|Overall Study|Protocol Violation|2|||
131176251|NCT00696436|472266302|FG003|Overall Study|Protocol Violation|0|||
131176252|NCT00696436|472266303|FG004|Overall Study|Protocol Violation|1|||
131176253|NCT00696436|472266299|FG000|Overall Study|Lost to Follow-up|1|||
131176254|NCT00696436|472266300|FG001|Overall Study|Lost to Follow-up|6|||
131176255|NCT00696436|472266301|FG002|Overall Study|Lost to Follow-up|2|||
131176256|NCT00696436|472266302|FG003|Overall Study|Lost to Follow-up|4|||
131176257|NCT00696436|472266303|FG004|Overall Study|Lost to Follow-up|3|||
131176258|NCT00696436|472266299|FG000|Overall Study|Withdrawal by Subject|4|||
131176259|NCT00696436|472266300|FG001|Overall Study|Withdrawal by Subject|11|||
131176260|NCT00696436|472266301|FG002|Overall Study|Withdrawal by Subject|5|||
131176261|NCT00696436|472266302|FG003|Overall Study|Withdrawal by Subject|7|||
131176262|NCT00696436|472266303|FG004|Overall Study|Withdrawal by Subject|1|||
131176263|NCT00696436|472266299|FG000|Overall Study|Lack of Efficacy|3|||
131176264|NCT00696436|472266300|FG001|Overall Study|Lack of Efficacy|1|||
131176265|NCT00696436|472266301|FG002|Overall Study|Lack of Efficacy|5|||
131176266|NCT00696436|472266302|FG003|Overall Study|Lack of Efficacy|2|||
131176267|NCT00696436|472266303|FG004|Overall Study|Lack of Efficacy|4|||
131176268|NCT00696436|472266299|FG000|Overall Study|Participant Unavailability|2|||
131176269|NCT00696436|472266300|FG001|Overall Study|Participant Unavailability|0|||
131176270|NCT00696436|472266301|FG002|Overall Study|Participant Unavailability|2|||
131176271|NCT00696436|472266302|FG003|Overall Study|Participant Unavailability|1|||
131176272|NCT00696436|472266303|FG004|Overall Study|Participant Unavailability|0|||
131176273|NCT00696436|472266299|FG000|Overall Study|Administrative Error|2|||
131176274|NCT00696436|472266300|FG001|Overall Study|Administrative Error|0|||
131176275|NCT00696436|472266301|FG002|Overall Study|Administrative Error|2|||
131176276|NCT00696436|472266302|FG003|Overall Study|Administrative Error|0|||
131176277|NCT00696436|472266303|FG004|Overall Study|Administrative Error|0|||
131176278|NCT00696436|472266299|FG000|Overall Study|Participant Non-compliance|0|||
131176279|NCT00696436|472266300|FG001|Overall Study|Participant Non-compliance|0|||
131176280|NCT00696436|472266301|FG002|Overall Study|Participant Non-compliance|1|||
131176281|NCT00696436|472266302|FG003|Overall Study|Participant Non-compliance|2|||
131176282|NCT00696436|472266303|FG004|Overall Study|Participant Non-compliance|0|||
131176283|NCT00696436|472266299|FG000|Overall Study|Administrative Decision|1|||
131176284|NCT00696436|472266300|FG001|Overall Study|Administrative Decision|0|||
131176285|NCT00696436|472266301|FG002|Overall Study|Administrative Decision|0|||
131176286|NCT00696436|472266302|FG003|Overall Study|Administrative Decision|0|||
131176287|NCT00696436|472266303|FG004|Overall Study|Administrative Decision|0|||
131176288|NCT00696436|472266299|FG000|Overall Study|Missing|0|||
131176289|NCT00696436|472266300|FG001|Overall Study|Missing|1|||
131176290|NCT00696436|472266301|FG002|Overall Study|Missing|1|||
131176291|NCT00696436|472266302|FG003|Overall Study|Missing|0|||
131176292|NCT00696436|472266303|FG004|Overall Study|Missing|0|||
131176293|NCT02282982|472266304|FG000|Overall Study|Lost to Follow-up|15|||
131176294|NCT02282982|472266304|FG000|Overall Study|Withdrew consent|2|||
131176295|NCT02282982|472266304|FG000|Overall Study|Death|4|||
131176296|NCT02282982|472266304|FG000|Overall Study|Lack of product|156|||
131176297|NCT02282982|472266304|FG000|Overall Study|Palivizumab is ended|11|||
131176298|NCT02282982|472266304|FG000|Overall Study|Other, not specified|18|||
131176299|NCT02924688|472266305|FG000|Overall Study|Adverse Event|9|||
131176300|NCT02924688|472266306|FG001|Overall Study|Adverse Event|3|||
131176301|NCT02924688|472266307|FG002|Overall Study|Adverse Event|2|||
131176302|NCT02924688|472266308|FG003|Overall Study|Adverse Event|2|||
131176303|NCT02924688|472266309|FG004|Overall Study|Adverse Event|3|||
131176304|NCT02924688|472266310|FG005|Overall Study|Adverse Event|2|||
131176305|NCT02924688|472266305|FG000|Overall Study|Lack of Efficacy|2|||
131176306|NCT02924688|472266306|FG001|Overall Study|Lack of Efficacy|3|||
131176307|NCT02924688|472266307|FG002|Overall Study|Lack of Efficacy|4|||
131176308|NCT02924688|472266308|FG003|Overall Study|Lack of Efficacy|2|||
131176309|NCT02924688|472266309|FG004|Overall Study|Lack of Efficacy|1|||
131176310|NCT02924688|472266310|FG005|Overall Study|Lack of Efficacy|1|||
131176311|NCT02924688|472266305|FG000|Overall Study|Protocol Violation|3|||
131176312|NCT02924688|472266306|FG001|Overall Study|Protocol Violation|7|||
131176313|NCT02924688|472266307|FG002|Overall Study|Protocol Violation|5|||
131176314|NCT02924688|472266308|FG003|Overall Study|Protocol Violation|6|||
131236855|NCT02465567|472495054|FG000|Overall Study|Lack of Efficacy|103|||
131176315|NCT02924688|472266309|FG004|Overall Study|Protocol Violation|2|||
131176316|NCT02924688|472266310|FG005|Overall Study|Protocol Violation|2|||
131176317|NCT02924688|472266305|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
131176318|NCT02924688|472266306|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
131176319|NCT02924688|472266307|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
131176320|NCT02924688|472266308|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
131176321|NCT02924688|472266309|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
131176322|NCT02924688|472266310|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
131176323|NCT02924688|472266305|FG000|Overall Study|Lost to Follow-up|2|||
131176324|NCT02924688|472266306|FG001|Overall Study|Lost to Follow-up|4|||
131176325|NCT02924688|472266307|FG002|Overall Study|Lost to Follow-up|2|||
131176326|NCT02924688|472266308|FG003|Overall Study|Lost to Follow-up|4|||
131176327|NCT02924688|472266309|FG004|Overall Study|Lost to Follow-up|2|||
131236856|NCT02465567|472495055|FG001|Overall Study|Lack of Efficacy|102|||
131236857|NCT02465567|472495056|FG002|Overall Study|Lack of Efficacy|171|||
131236858|NCT02465567|472495057|FG003|Overall Study|Lack of Efficacy|135|||
131236859|NCT02465567|472495054|FG000|Overall Study|Withdrawal by Subject|104|||
131236860|NCT02465567|472495055|FG001|Overall Study|Withdrawal by Subject|94|||
131236861|NCT02465567|472495056|FG002|Overall Study|Withdrawal by Subject|123|||
131236862|NCT02465567|472495057|FG003|Overall Study|Withdrawal by Subject|130|||
131236863|NCT02465567|472495054|FG000|Overall Study|Physician Decision|23|||
131236864|NCT02465567|472495055|FG001|Overall Study|Physician Decision|33|||
131236865|NCT02465567|472495056|FG002|Overall Study|Physician Decision|38|||
131236866|NCT02465567|472495057|FG003|Overall Study|Physician Decision|28|||
131236867|NCT02465567|472495054|FG000|Overall Study|Major Protocol Deviation|24|||
131236868|NCT02465567|472495055|FG001|Overall Study|Major Protocol Deviation|26|||
131236869|NCT02465567|472495056|FG002|Overall Study|Major Protocol Deviation|22|||
131236870|NCT02465567|472495057|FG003|Overall Study|Major Protocol Deviation|25|||
131236871|NCT02465567|472495054|FG000|Overall Study|Lost to Follow-up|25|||
131236872|NCT02465567|472495055|FG001|Overall Study|Lost to Follow-up|21|||
131236873|NCT02465567|472495056|FG002|Overall Study|Lost to Follow-up|19|||
131236874|NCT02465567|472495057|FG003|Overall Study|Lost to Follow-up|15|||
131236875|NCT02465567|472495054|FG000|Overall Study|Protocol Specified Criteria|20|||
131176328|NCT02924688|472266310|FG005|Overall Study|Lost to Follow-up|4|||
131176329|NCT02924688|472266305|FG000|Overall Study|Physician Decision|2|||
131176330|NCT02924688|472266306|FG001|Overall Study|Physician Decision|1|||
131176331|NCT02924688|472266307|FG002|Overall Study|Physician Decision|0|||
131176332|NCT02924688|472266308|FG003|Overall Study|Physician Decision|1|||
131176333|NCT02924688|472266309|FG004|Overall Study|Physician Decision|1|||
131176334|NCT02924688|472266310|FG005|Overall Study|Physician Decision|1|||
131176335|NCT02924688|472266305|FG000|Overall Study|Withdrawal by Subject|14|||
131176336|NCT02924688|472266306|FG001|Overall Study|Withdrawal by Subject|13|||
131176337|NCT02924688|472266307|FG002|Overall Study|Withdrawal by Subject|9|||
131176338|NCT02924688|472266308|FG003|Overall Study|Withdrawal by Subject|12|||
131176339|NCT02924688|472266309|FG004|Overall Study|Withdrawal by Subject|13|||
131176340|NCT02924688|472266310|FG005|Overall Study|Withdrawal by Subject|14|||
131176341|NCT00848250|472266313|FG000|Overall Study|surgery was completed without cardiopulm|0|||
131176342|NCT00848250|472266314|FG001|Overall Study|surgery was completed without cardiopulm|1|||
131176343|NCT00571688|472266318|FG000|Overall Study|Lost to Follow-up|3|||
131176344|NCT00571688|472266319|FG001|Overall Study|Lost to Follow-up|6|||
131176345|NCT00571688|472266318|FG000|Overall Study|subject did not tolerate Consta|1|||
131176346|NCT00571688|472266319|FG001|Overall Study|subject did not tolerate Consta|0|||
131176347|NCT00571688|472266318|FG000|Overall Study|subject moved out of the area|1|||
131176348|NCT00571688|472266319|FG001|Overall Study|subject moved out of the area|0|||
131176349|NCT03457103|472266320|FG000|Overall Study|illness/hospitalization|4|||
131176350|NCT03457103|472266321|FG001|Overall Study|illness/hospitalization|2|||
131176351|NCT03457103|472266320|FG000|Overall Study|Lost to Follow-up|2|||
131176352|NCT03457103|472266321|FG001|Overall Study|Lost to Follow-up|1|||
131176353|NCT03457103|472266320|FG000|Overall Study|Withdrawal by Subject|1|||
131176354|NCT03457103|472266321|FG001|Overall Study|Withdrawal by Subject|2|||
131176355|NCT03457103|472266320|FG000|Overall Study|financial/ insurance issues|1|||
131176356|NCT03457103|472266321|FG001|Overall Study|financial/ insurance issues|1|||
131176357|NCT00502320|472266322|FG000|Overall Study|Lost to Follow-up|1|||
131176358|NCT00502320|472266323|FG001|Overall Study|Lost to Follow-up|1|||
131176359|NCT00502320|472266322|FG000|Overall Study|Withdrew Consent|1|||
131176360|NCT00502320|472266323|FG001|Overall Study|Withdrew Consent|0|||
131176361|NCT00502320|472266322|FG000|Overall Study|No longer met criteria|1|||
131176362|NCT00502320|472266323|FG001|Overall Study|No longer met criteria|0|||
131176363|NCT00502320|472266322|FG000|Overall Study|Screen Failure|0|||
131176364|NCT00502320|472266323|FG001|Overall Study|Screen Failure|1|||
131176365|NCT00502320|472266322|FG000|Overall Study|Adverse Event|3|||
131176366|NCT00502320|472266323|FG001|Overall Study|Adverse Event|5|||
131176367|NCT03654755|472266329|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
131176368|NCT03654755|472266330|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
131176369|NCT03654755|472266331|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
131176370|NCT03654755|472266329|FG000|Overall Study|Withdrawal by Subject|2|||
131176371|NCT03654755|472266330|FG001|Overall Study|Withdrawal by Subject|4|||
131176372|NCT03654755|472266331|FG002|Overall Study|Withdrawal by Subject|8|||
131176373|NCT03654755|472266329|FG000|Overall Study|Lost to Follow-up|1|||
131176374|NCT03654755|472266330|FG001|Overall Study|Lost to Follow-up|3|||
131236876|NCT02465567|472495055|FG001|Overall Study|Protocol Specified Criteria|10|||
131176375|NCT03654755|472266331|FG002|Overall Study|Lost to Follow-up|7|||
131176376|NCT03654755|472266329|FG000|Overall Study|Physician Decision|0|||
131176377|NCT03654755|472266330|FG001|Overall Study|Physician Decision|1|||
131176378|NCT03654755|472266331|FG002|Overall Study|Physician Decision|0|||
131176379|NCT03654755|472266329|FG000|Overall Study|Adverse Event|0|||
131176380|NCT03654755|472266330|FG001|Overall Study|Adverse Event|0|||
131176381|NCT03654755|472266331|FG002|Overall Study|Adverse Event|4|||
131176382|NCT03654755|472266329|FG000|Overall Study|Lack of Efficacy|0|||
131236877|NCT02465567|472495056|FG002|Overall Study|Protocol Specified Criteria|9|||
131236878|NCT02465567|472495057|FG003|Overall Study|Protocol Specified Criteria|12|||
130782711|NCT01386606|470833129|FG003|Overall Study|T levels too high|0|||
130782712|NCT02188160|470833130|FG000|Overall Study|Adverse Event|1|||
130782713|NCT02188160|470833131|FG001|Overall Study|Adverse Event|0|||
130782714|NCT02188160|470833130|FG000|Overall Study|Use of an excluded medication|0|||
130782715|NCT02188160|470833131|FG001|Overall Study|Use of an excluded medication|1|||
130782716|NCT04113694|470833132|FG000|Overall Study|Adverse Event|2|||
130782717|NCT04113694|470833132|FG000|Overall Study|Lost to Follow-up|2|||
130782718|NCT04113694|470833132|FG000|Overall Study|Withdrawal by Subject|6|||
130782719|NCT04113694|470833132|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
130782720|NCT04980014|470833139|FG000|Overall Study|Participants who are Duplicated|1|||
130782721|NCT04980014|470833139|FG000|Overall Study|Follow-up Failure|13|||
130782722|NCT04980014|470833139|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
130782723|NCT04980014|470833139|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
130782724|NCT04980014|470833139|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
130782725|NCT01095835|470833140|FG000|Overall Study|Adverse Event|8|||
130782726|NCT01095835|470833141|FG001|Overall Study|Adverse Event|6|||
130782727|NCT01095835|470833142|FG002|Overall Study|Adverse Event|6|||
130782728|NCT01095835|470833140|FG000|Overall Study|Lack of Efficacy|0|||
130782729|NCT01095835|470833141|FG001|Overall Study|Lack of Efficacy|1|||
131176383|NCT03654755|472266330|FG001|Overall Study|Lack of Efficacy|0|||
131176384|NCT03654755|472266331|FG002|Overall Study|Lack of Efficacy|1|||
131176385|NCT02394808|472266332|FG000|Period 1|Unsatisfactory lens fitting|0|||
131176386|NCT02394808|472266333|FG001|Period 1|Unsatisfactory lens fitting|1|||
131176387|NCT02394808|472266332|FG000|Period 2|Lost to Follow-up|1|||
131176388|NCT02394808|472266333|FG001|Period 2|Lost to Follow-up|0|||
131176389|NCT04580394|472266335|FG000|First Intervention|Incorrectly Randomized|1|||
131176390|NCT04580394|472266335|FG000|First Intervention|Physician Decision|1|||
131176391|NCT04580394|472266335|FG000|First Intervention|Lost to Follow-up|1|||
131176392|NCT04580394|472266335|FG000|Washout (One Week)|Withdrawal by Subject|1|||
131176393|NCT04580394|472266335|FG000|Washout (One Week)|Adverse Event|1|||
131176394|NCT04580394|472266335|FG000|Washout (One Week)|Withdrawal by Subject|2|||
131176395|NCT04580394|472266335|FG000|Third Intervention|Adverse Event|1|||
131176396|NCT04580394|472266335|FG000|Third Intervention|Withdrawal by Subject|1|||
131176397|NCT04580394|472266335|FG000|Washout (One Week)|Withdrawal by Subject|2|||
131176398|NCT00642746|472266337|FG000|Overall Study|Patient unevaluable|1|||
131176399|NCT00642746|472266338|FG001|Overall Study|Patient unevaluable|0|||
131176400|NCT03337152|472266341|FG000|Overall Study|Physician Decision|1|||
131176401|NCT03337152|472266342|FG001|Overall Study|Physician Decision|0|||
131176402|NCT03337152|472266341|FG000|Overall Study|Lost to Follow-up|1|||
131176403|NCT03337152|472266342|FG001|Overall Study|Lost to Follow-up|3|||
131176404|NCT03337152|472266341|FG000|Overall Study|Adverse Event|3|||
131176405|NCT03337152|472266342|FG001|Overall Study|Adverse Event|1|||
131176406|NCT03337152|472266341|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
131176407|NCT03337152|472266342|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
131176408|NCT00077610|472266343|FG000|Overall Study|Adverse Event|9|||
131176409|NCT00077610|472266344|FG001|Overall Study|Adverse Event|7|||
131176410|NCT00077610|472266345|FG002|Overall Study|Adverse Event|1|||
131176411|NCT00077610|472266343|FG000|Overall Study|Lost to Follow-up|0|||
131176412|NCT00077610|472266344|FG001|Overall Study|Lost to Follow-up|1|||
131236879|NCT02465567|472495054|FG000|Overall Study|Administrative Reasons|12|||
131236880|NCT02465567|472495055|FG001|Overall Study|Administrative Reasons|9|||
131176413|NCT00077610|472266345|FG002|Overall Study|Lost to Follow-up|2|||
131176414|NCT00077610|472266343|FG000|Overall Study|Withdrawal by Subject|4|||
131176415|NCT00077610|472266344|FG001|Overall Study|Withdrawal by Subject|10|||
131176416|NCT00077610|472266345|FG002|Overall Study|Withdrawal by Subject|6|||
131176417|NCT00077610|472266343|FG000|Overall Study|Death|17|||
131176418|NCT00077610|472266344|FG001|Overall Study|Death|13|||
131176419|NCT00077610|472266345|FG002|Overall Study|Death|13|||
131176420|NCT00077610|472266343|FG000|Overall Study|Renal transplant|12|||
131176421|NCT00077610|472266344|FG001|Overall Study|Renal transplant|15|||
131176422|NCT00077610|472266345|FG002|Overall Study|Renal transplant|11|||
131176423|NCT00077610|472266343|FG000|Overall Study|Withdrew from dialysis care|5|||
131176424|NCT00077610|472266344|FG001|Overall Study|Withdrew from dialysis care|0|||
131176425|NCT00077610|472266345|FG002|Overall Study|Withdrew from dialysis care|3|||
131176426|NCT00077610|472266343|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131176427|NCT00077610|472266344|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130782730|NCT01095835|470833142|FG002|Overall Study|Lack of Efficacy|0|||
131176428|NCT00077610|472266345|FG002|Overall Study|Insufficient Therapeutic Response|0|||
131176429|NCT00077610|472266343|FG000|Overall Study|Multiple blood transfusions|0|||
131176430|NCT00077610|472266344|FG001|Overall Study|Multiple blood transfusions|0|||
131176431|NCT00077610|472266345|FG002|Overall Study|Multiple blood transfusions|1|||
131176432|NCT00077610|472266343|FG000|Overall Study|Principal Investigator's decision|1|||
131176433|NCT00077610|472266344|FG001|Overall Study|Principal Investigator's decision|0|||
131176434|NCT00077610|472266345|FG002|Overall Study|Principal Investigator's decision|1|||
131176435|NCT00077610|472266343|FG000|Overall Study|Worsening of health condition|1|||
130782731|NCT01095835|470833140|FG000|Overall Study|Physician Decision|0|||
130782732|NCT01095835|470833141|FG001|Overall Study|Physician Decision|0|||
130782733|NCT01095835|470833142|FG002|Overall Study|Physician Decision|1|||
130782734|NCT01095835|470833140|FG000|Overall Study|Withdrawal by Subject|1|||
130782735|NCT01095835|470833141|FG001|Overall Study|Withdrawal by Subject|3|||
130782736|NCT01095835|470833142|FG002|Overall Study|Withdrawal by Subject|0|||
130782737|NCT01095835|470833140|FG000|Overall Study|Non study compliance|0|||
130782738|NCT01095835|470833141|FG001|Overall Study|Non study compliance|0|||
130782739|NCT01095835|470833142|FG002|Overall Study|Non study compliance|1|||
130782740|NCT01095835|470833140|FG000|Overall Study|Protocol Violation|1|||
130782741|NCT01095835|470833141|FG001|Overall Study|Protocol Violation|2|||
130782742|NCT01095835|470833142|FG002|Overall Study|Protocol Violation|0|||
130782743|NCT01965327|470833147|FG000|Overall Study|Physician Decision|2|||
130782744|NCT03964207|470833149|FG000|First Treatment|Withdrawal by Subject|1|||
130782745|NCT03964207|470833150|FG001|First Treatment|Withdrawal by Subject|2|||
130782746|NCT03964207|470833149|FG000|First Treatment|Protocol Violation|1|||
130782747|NCT03964207|470833150|FG001|First Treatment|Protocol Violation|0|||
130782748|NCT03964207|470833149|FG000|First Treatment|Lost to Follow-up|1|||
130782749|NCT03964207|470833150|FG001|First Treatment|Lost to Follow-up|0|||
130782750|NCT03964207|470833149|FG000|Second Treatment|Lost to Follow-up|0|||
130782751|NCT03964207|470833150|FG001|Second Treatment|Lost to Follow-up|1|||
130782752|NCT03964207|470833149|FG000|Second Treatment|Adverse Event|1|||
130782753|NCT03964207|470833150|FG001|Second Treatment|Adverse Event|2|||
130782754|NCT01294423|470833151|FG000|Overall Study|Adverse Event|1|||
130782755|NCT01294423|470833152|FG001|Overall Study|Adverse Event|2|||
130782756|NCT01294423|470833153|FG002|Overall Study|Adverse Event|3|||
130782757|NCT01294423|470833151|FG000|Overall Study|Withdrawal by Subject|1|||
130782758|NCT01294423|470833152|FG001|Overall Study|Withdrawal by Subject|2|||
130782759|NCT01294423|470833153|FG002|Overall Study|Withdrawal by Subject|2|||
130782760|NCT01294423|470833151|FG000|Overall Study|subject no longer meets study criteria|2|||
130782761|NCT01294423|470833152|FG001|Overall Study|subject no longer meets study criteria|5|||
130782762|NCT01294423|470833153|FG002|Overall Study|subject no longer meets study criteria|2|||
131176436|NCT00077610|472266344|FG001|Overall Study|Worsening of health condition|1|||
131176437|NCT00077610|472266345|FG002|Overall Study|Worsening of health condition|0|||
131176438|NCT00077610|472266343|FG000|Overall Study|Given Epogen in hospital|1|||
131176439|NCT00077610|472266344|FG001|Overall Study|Given Epogen in hospital|0|||
131176440|NCT00077610|472266345|FG002|Overall Study|Given Epogen in hospital|0|||
131176441|NCT00077610|472266343|FG000|Overall Study|Transferred to other unit|0|||
131176442|NCT00077610|472266344|FG001|Overall Study|Transferred to other unit|0|||
131176443|NCT00077610|472266345|FG002|Overall Study|Transferred to other unit|1|||
131176444|NCT00077610|472266343|FG000|Overall Study|Transferred to nursing home|0|||
131176445|NCT00077610|472266344|FG001|Overall Study|Transferred to nursing home|0|||
131176446|NCT00077610|472266345|FG002|Overall Study|Transferred to nursing home|1|||
131176447|NCT00077610|472266343|FG000|Overall Study|Transfer to satellite unit|1|||
131176448|NCT00077610|472266344|FG001|Overall Study|Transfer to satellite unit|0|||
131176449|NCT00077610|472266345|FG002|Overall Study|Transfer to satellite unit|0|||
131176450|NCT00077610|472266343|FG000|Overall Study|Transfer to other center for surgery|1|||
131176451|NCT00077610|472266344|FG001|Overall Study|Transfer to other center for surgery|0|||
131176452|NCT00077610|472266345|FG002|Overall Study|Transfer to other center for surgery|0|||
131176453|NCT00077610|472266343|FG000|Overall Study|Change in dialysis modality|1|||
131176454|NCT00077610|472266344|FG001|Overall Study|Change in dialysis modality|0|||
131176455|NCT00077610|472266345|FG002|Overall Study|Change in dialysis modality|0|||
131176456|NCT00077610|472266343|FG000|Overall Study|Relocation|0|||
131176457|NCT00077610|472266344|FG001|Overall Study|Relocation|8|||
131176458|NCT00077610|472266345|FG002|Overall Study|Relocation|5|||
131176459|NCT00077610|472266343|FG000|Overall Study|Financial issues|0|||
131176460|NCT00077610|472266344|FG001|Overall Study|Financial issues|1|||
131176461|NCT00077610|472266345|FG002|Overall Study|Financial issues|0|||
131176462|NCT00077610|472266343|FG000|Overall Study|Sponsors decision to withdraw|0|||
131176463|NCT00077610|472266344|FG001|Overall Study|Sponsors decision to withdraw|0|||
131176464|NCT00077610|472266345|FG002|Overall Study|Sponsors decision to withdraw|1|||
130782763|NCT01294423|470833151|FG000|Overall Study|poor/non-compliance|1|||
131176465|NCT00976950|472266346|FG000|Overall Study|Adverse Event|3|||
131176466|NCT00976950|472266346|FG000|Overall Study|Events with no relationship to Aptivus|3|||
131176467|NCT00304915|472266347|FG000|Overall Study|Lost to Follow-up|11|||
131176468|NCT00304915|472266348|FG001|Overall Study|Lost to Follow-up|11|||
131176469|NCT00304915|472266347|FG000|Overall Study|Death|4|||
131176470|NCT00304915|472266348|FG001|Overall Study|Death|5|||
131176471|NCT00304915|472266347|FG000|Overall Study|Withdrawal by Subject|3|||
130782764|NCT01294423|470833152|FG001|Overall Study|poor/non-compliance|0|||
130782765|NCT01294423|470833153|FG002|Overall Study|poor/non-compliance|1|||
131176472|NCT00304915|472266348|FG001|Overall Study|Withdrawal by Subject|0|||
130782766|NCT00301834|470833156|FG000|Overall Study|Death|1|||
130782767|NCT02026141|470833158|FG000|Overall Study|Protocol Violation|0|||
130782768|NCT02026141|470833159|FG001|Overall Study|Protocol Violation|1|||
130782769|NCT01607593|470833160|FG000|Overall Study|Adverse Event|15|||
131176473|NCT01069523|472266357|FG000|Overall Study|Withdrawal by Subject|4|||
130782770|NCT01607593|470833160|FG000|Overall Study|Lack of Efficacy|16|||
130782771|NCT01607593|470833160|FG000|Overall Study|Lost to Follow-up|25|||
130782772|NCT01607593|470833160|FG000|Overall Study|Continuation|33|||
130782773|NCT01607593|470833160|FG000|Overall Study|Other|4|||
130782774|NCT02771275|470833161|FG000|Overall Study|Reoperation|3|||
130782775|NCT02771275|470833161|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
130782776|NCT05081388|470833162|FG000|Overall Study|Adverse Event|1|||
130782777|NCT05081388|470833163|FG001|Overall Study|Adverse Event|0|||
130782778|NCT05081388|470833164|FG002|Overall Study|Adverse Event|0|||
130782779|NCT05081388|470833165|FG003|Overall Study|Adverse Event|0|||
130782780|NCT05081388|470833166|FG004|Overall Study|Adverse Event|0|||
130782781|NCT05081388|470833162|FG000|Overall Study|Lost to Follow-up|0|||
130782782|NCT05081388|470833163|FG001|Overall Study|Lost to Follow-up|1|||
130782783|NCT05081388|470833164|FG002|Overall Study|Lost to Follow-up|0|||
130782784|NCT05081388|470833165|FG003|Overall Study|Lost to Follow-up|0|||
130782785|NCT05081388|470833166|FG004|Overall Study|Lost to Follow-up|0|||
130782786|NCT05081388|470833162|FG000|Overall Study|Subject decision|0|||
130782787|NCT05081388|470833163|FG001|Overall Study|Subject decision|0|||
130782788|NCT05081388|470833164|FG002|Overall Study|Subject decision|0|||
130782789|NCT05081388|470833165|FG003|Overall Study|Subject decision|1|||
130782790|NCT05081388|470833166|FG004|Overall Study|Subject decision|0|||
130782791|NCT02219685|470833167|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
130782792|NCT02219685|470833168|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
130782793|NCT02219685|470833167|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
131176474|NCT01069523|472266358|FG001|Overall Study|Withdrawal by Subject|7|||
131176475|NCT01551758|472266377|FG000|Overall Study|Adverse Event|29|||
131176476|NCT01551758|472266378|FG001|Overall Study|Adverse Event|43|||
131176477|NCT01551758|472266377|FG000|Overall Study|Lack of Efficacy|0|||
131176478|NCT01551758|472266378|FG001|Overall Study|Lack of Efficacy|1|||
131176479|NCT01551758|472266377|FG000|Overall Study|Protocol Violation|5|||
131176480|NCT01551758|472266378|FG001|Overall Study|Protocol Violation|6|||
131176481|NCT01551758|472266377|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
131176482|NCT01551758|472266378|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
131176483|NCT01551758|472266377|FG000|Overall Study|Lost to Follow-up|29|||
131176484|NCT01551758|472266378|FG001|Overall Study|Lost to Follow-up|25|||
131176485|NCT01551758|472266377|FG000|Overall Study|Physician Decision|9|||
131176486|NCT01551758|472266378|FG001|Overall Study|Physician Decision|3|||
131176487|NCT01551758|472266377|FG000|Overall Study|Withdrawal by Subject|14|||
131176488|NCT01551758|472266378|FG001|Overall Study|Withdrawal by Subject|17|||
131176489|NCT03670641|472266383|FG000|Overall Study|Lost to Follow-up|3|||
131176490|NCT01096849|472266384|FG000|Overall Study|Consent Withdrawn|1|||
131176491|NCT01096849|472266385|FG001|Overall Study|Consent Withdrawn|4|||
131176492|NCT01096849|472266386|FG002|Overall Study|Consent Withdrawn|2|||
131176493|NCT01096849|472266384|FG000|Overall Study|Lack of Efficacy|0|||
131176494|NCT01096849|472266385|FG001|Overall Study|Lack of Efficacy|2|||
131176495|NCT01096849|472266386|FG002|Overall Study|Lack of Efficacy|0|||
131176496|NCT01096849|472266384|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
131176497|NCT01096849|472266385|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
131176498|NCT01096849|472266386|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
131176499|NCT01096849|472266384|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
131176500|NCT01096849|472266385|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
131176501|NCT01096849|472266386|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
131176502|NCT01096849|472266384|FG000|Overall Study|Administrative Reasons|0|||
131176503|NCT01096849|472266385|FG001|Overall Study|Administrative Reasons|1|||
131176504|NCT01096849|472266386|FG002|Overall Study|Administrative Reasons|2|||
131176505|NCT01096849|472266384|FG000|Overall Study|Lost to Follow-up|1|||
131176506|NCT01096849|472266385|FG001|Overall Study|Lost to Follow-up|3|||
131236881|NCT02465567|472495056|FG002|Overall Study|Administrative Reasons|11|||
131236882|NCT02465567|472495057|FG003|Overall Study|Administrative Reasons|5|||
131236883|NCT02465567|472495054|FG000|Overall Study|Randomized but not treated|1|||
131236884|NCT02465567|472495055|FG001|Overall Study|Randomized but not treated|5|||
131236885|NCT02465567|472495056|FG002|Overall Study|Randomized but not treated|4|||
131236886|NCT02465567|472495057|FG003|Overall Study|Randomized but not treated|5|||
131236887|NCT02465567|472495054|FG000|Overall Study|enrolled in >1 studies|18|||
131176507|NCT01096849|472266386|FG002|Overall Study|Lost to Follow-up|1|||
130782794|NCT02219685|470833168|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
130782795|NCT00427908|470833169|FG000|Primary Phase|Lost to Follow-up|4|||
130782796|NCT00427908|470833170|FG001|Primary Phase|Lost to Follow-up|0|||
131176508|NCT00118482|472266388|FG000|Overall Study|Lost to Follow-up|7|||
131176509|NCT00118482|472266389|FG001|Overall Study|Lost to Follow-up|7|||
131176510|NCT00118482|472266388|FG000|Overall Study|Withdrawal by Subject|23|||
131176511|NCT00118482|472266389|FG001|Overall Study|Withdrawal by Subject|22|||
131176512|NCT00242580|472266390|FG000|Overall Study|Adverse Event|3|||
130782797|NCT00427908|470833171|FG002|Primary Phase|Lost to Follow-up|2|||
130782798|NCT00427908|470833172|FG003|Primary Phase|Lost to Follow-up|0|||
130782799|NCT00427908|470833169|FG000|Primary Phase|Withdrawal by Subject|1|||
130782800|NCT00427908|470833170|FG001|Primary Phase|Withdrawal by Subject|2|||
131176513|NCT00242580|472266391|FG001|Overall Study|Adverse Event|0|||
131176514|NCT00242580|472266392|FG002|Overall Study|Adverse Event|2|||
131176515|NCT00242580|472266390|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131176516|NCT00242580|472266391|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
131176517|NCT00242580|472266392|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
131176518|NCT00242580|472266390|FG000|Overall Study|Protocol Violation|0|||
131176519|NCT00242580|472266391|FG001|Overall Study|Protocol Violation|0|||
131176520|NCT00242580|472266392|FG002|Overall Study|Protocol Violation|1|||
131176521|NCT00242580|472266390|FG000|Overall Study|Subject withdrew consent|2|||
131176522|NCT00242580|472266391|FG001|Overall Study|Subject withdrew consent|2|||
131176523|NCT00242580|472266392|FG002|Overall Study|Subject withdrew consent|5|||
131236888|NCT02465567|472495055|FG001|Overall Study|enrolled in >1 studies|11|||
131236889|NCT02465567|472495056|FG002|Overall Study|enrolled in >1 studies|19|||
131236890|NCT02465567|472495057|FG003|Overall Study|enrolled in >1 studies|15|||
131176524|NCT00242580|472266390|FG000|Overall Study|Lost to Follow-up|0|||
131176525|NCT00242580|472266391|FG001|Overall Study|Lost to Follow-up|3|||
131176526|NCT00242580|472266392|FG002|Overall Study|Lost to Follow-up|0|||
131176527|NCT00242580|472266390|FG000|Overall Study|Death|1|||
131176528|NCT00242580|472266391|FG001|Overall Study|Death|2|||
131176529|NCT00242580|472266392|FG002|Overall Study|Death|1|||
131176530|NCT01232894|472266393|FG000|Overall Study|Lost to Follow-up|0|||
131176531|NCT01232894|472266394|FG001|Overall Study|Lost to Follow-up|1|||
131176532|NCT01232894|472266393|FG000|Overall Study|Death|1|||
131176533|NCT01232894|472266394|FG001|Overall Study|Death|0|||
131176534|NCT01232894|472266393|FG000|Overall Study|Protocol Violation|1|||
131176535|NCT01232894|472266394|FG001|Overall Study|Protocol Violation|1|||
131176536|NCT01232894|472266393|FG000|Overall Study|Withdrawal by Subject|8|||
131176537|NCT01232894|472266394|FG001|Overall Study|Withdrawal by Subject|5|||
131176538|NCT01232894|472266393|FG000|Overall Study|Physician Decision|2|||
131176539|NCT01232894|472266394|FG001|Overall Study|Physician Decision|1|||
131176540|NCT03970395|472266397|FG000|Overall Study|Withdrawal by Subject|3|||
131176541|NCT03970395|472266398|FG001|Overall Study|Withdrawal by Subject|4|||
131176542|NCT03970395|472266397|FG000|Overall Study|Lost to Follow-up|4|||
131176543|NCT03970395|472266398|FG001|Overall Study|Lost to Follow-up|8|||
131176544|NCT00125190|472266399|FG000|Overall Study|Subject/Parent Decision|7|||
131176545|NCT00125190|472266399|FG000|Overall Study|Non-compliance|2|||
131176546|NCT00125190|472266399|FG000|Overall Study|Adverse Event|1|||
131176547|NCT00125190|472266399|FG000|Overall Study|Other|1|||
131176548|NCT00125190|472266399|FG000|Overall Study|Lost to Follow-up|4|||
131176549|NCT00414960|472266402|FG000|Overall Study|Adverse Event|4|||
131176550|NCT00414960|472266403|FG001|Overall Study|Adverse Event|0|||
131176551|NCT00414960|472266402|FG000|Overall Study|Withdrawal by Subject|3|||
131176552|NCT00414960|472266403|FG001|Overall Study|Withdrawal by Subject|0|||
131176553|NCT00414960|472266402|FG000|Overall Study|Physician Decision|0|||
131176554|NCT00414960|472266403|FG001|Overall Study|Physician Decision|1|||
131176555|NCT00264849|472266405|FG000|Overall Study|Adverse Event|7|||
131176556|NCT00264849|472266406|FG001|Overall Study|Adverse Event|2|||
131176557|NCT00264849|472266405|FG000|Overall Study|Withdrawal by Subject|7|||
131176558|NCT00264849|472266406|FG001|Overall Study|Withdrawal by Subject|11|||
131176559|NCT00264849|472266405|FG000|Overall Study|Protocol Violation|5|||
131176560|NCT00264849|472266406|FG001|Overall Study|Protocol Violation|3|||
131176561|NCT00264849|472266405|FG000|Overall Study|Lack of Efficacy|1|||
131176562|NCT00264849|472266406|FG001|Overall Study|Lack of Efficacy|6|||
131176563|NCT00264849|472266405|FG000|Overall Study|Lost to Follow-up|0|||
131176564|NCT00264849|472266406|FG001|Overall Study|Lost to Follow-up|2|||
131176565|NCT00264849|472266405|FG000|Overall Study|Death|0|||
131176566|NCT00264849|472266406|FG001|Overall Study|Death|1|||
131176567|NCT00264849|472266405|FG000|Overall Study|Administrative Problems|2|||
131176568|NCT00264849|472266406|FG001|Overall Study|Administrative Problems|0|||
131176569|NCT00099359|472266407|FG000|Overall Study|Death|11|||
131176570|NCT00099359|472266408|FG001|Overall Study|Death|15|||
131176571|NCT00099359|472266409|FG002|Overall Study|Death|17|||
131176572|NCT00099359|472266407|FG000|Overall Study|Withdrawal by Subject|19|||
131176573|NCT00099359|472266408|FG001|Overall Study|Withdrawal by Subject|19|||
131176574|NCT00099359|472266409|FG002|Overall Study|Withdrawal by Subject|23|||
131176575|NCT00099359|472266407|FG000|Overall Study|Lost to Follow-up|15|||
131176576|NCT00099359|472266408|FG001|Overall Study|Lost to Follow-up|24|||
131176577|NCT00099359|472266409|FG002|Overall Study|Lost to Follow-up|24|||
131176578|NCT00099359|472266407|FG000|Overall Study|moved out of area|9|||
131176579|NCT00099359|472266408|FG001|Overall Study|moved out of area|7|||
131176580|NCT00099359|472266409|FG002|Overall Study|moved out of area|4|||
131176581|NCT01822691|472266412|FG000|Overall Study|Withdrawal by Subject|2|||
131176582|NCT02756650|472266413|FG000|Overall Study|Physician Decision|1|||
131176583|NCT02756650|472266413|FG000|Overall Study|Adverse Event|1|||
131176584|NCT04465396|472266416|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
131176585|NCT04465396|472266417|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
131176586|NCT04465396|472266418|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
131176587|NCT04465396|472266419|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
131176588|NCT02648724|472266420|FG000|Overall Study|Withdrawal by Subject|0|||
131176589|NCT02648724|472266421|FG001|Overall Study|Withdrawal by Subject|1|||
131176590|NCT02648724|472266422|FG002|Overall Study|Withdrawal by Subject|1|||
131176591|NCT02648724|472266423|FG003|Overall Study|Withdrawal by Subject|0|||
131176592|NCT02648724|472266424|FG004|Overall Study|Withdrawal by Subject|1|||
131176593|NCT02648724|472266425|FG005|Overall Study|Withdrawal by Subject|0|||
131176594|NCT02648724|472266426|FG006|Overall Study|Withdrawal by Subject|0|||
131176595|NCT02648724|472266420|FG000|Overall Study|Progressive disease|2|||
131176596|NCT02648724|472266421|FG001|Overall Study|Progressive disease|2|||
131176597|NCT02648724|472266422|FG002|Overall Study|Progressive disease|2|||
131176598|NCT02648724|472266423|FG003|Overall Study|Progressive disease|3|||
131176599|NCT02648724|472266424|FG004|Overall Study|Progressive disease|22|||
131176600|NCT02648724|472266425|FG005|Overall Study|Progressive disease|7|||
131176601|NCT02648724|472266426|FG006|Overall Study|Progressive disease|8|||
131176602|NCT02648724|472266420|FG000|Overall Study|Other reason (unknown)|1|||
131176603|NCT02648724|472266421|FG001|Overall Study|Other reason (unknown)|0|||
131176604|NCT02648724|472266422|FG002|Overall Study|Other reason (unknown)|0|||
131176605|NCT02648724|472266423|FG003|Overall Study|Other reason (unknown)|0|||
131176606|NCT02648724|472266424|FG004|Overall Study|Other reason (unknown)|0|||
131176607|NCT02648724|472266425|FG005|Overall Study|Other reason (unknown)|0|||
131176608|NCT02648724|472266426|FG006|Overall Study|Other reason (unknown)|0|||
131176609|NCT02648724|472266420|FG000|Overall Study|Protocol Violation|0|||
131176610|NCT02648724|472266421|FG001|Overall Study|Protocol Violation|0|||
131176611|NCT02648724|472266422|FG002|Overall Study|Protocol Violation|0|||
131176612|NCT02648724|472266423|FG003|Overall Study|Protocol Violation|0|||
131176613|NCT02648724|472266424|FG004|Overall Study|Protocol Violation|1|||
131176614|NCT02648724|472266425|FG005|Overall Study|Protocol Violation|0|||
131176615|NCT02648724|472266426|FG006|Overall Study|Protocol Violation|0|||
131176616|NCT02648724|472266420|FG000|Overall Study|Death|0|||
131176617|NCT02648724|472266421|FG001|Overall Study|Death|0|||
131176618|NCT02648724|472266422|FG002|Overall Study|Death|0|||
131176619|NCT02648724|472266423|FG003|Overall Study|Death|0|||
131176620|NCT02648724|472266424|FG004|Overall Study|Death|0|||
131176621|NCT02648724|472266425|FG005|Overall Study|Death|0|||
131176622|NCT02648724|472266426|FG006|Overall Study|Death|3|||
131176623|NCT02648724|472266420|FG000|Overall Study|Physician Decision|0|||
131176624|NCT02648724|472266421|FG001|Overall Study|Physician Decision|0|||
131176625|NCT02648724|472266422|FG002|Overall Study|Physician Decision|0|||
131176626|NCT02648724|472266423|FG003|Overall Study|Physician Decision|0|||
131176627|NCT02648724|472266424|FG004|Overall Study|Physician Decision|1|||
131176628|NCT02648724|472266425|FG005|Overall Study|Physician Decision|0|||
131176629|NCT02648724|472266426|FG006|Overall Study|Physician Decision|1|||
131176630|NCT02648724|472266420|FG000|Overall Study|Transferred to named patient program|0|||
131176631|NCT02648724|472266421|FG001|Overall Study|Transferred to named patient program|0|||
131176632|NCT02648724|472266422|FG002|Overall Study|Transferred to named patient program|0|||
131176633|NCT02648724|472266423|FG003|Overall Study|Transferred to named patient program|0|||
131176634|NCT02648724|472266424|FG004|Overall Study|Transferred to named patient program|0|||
131176635|NCT02648724|472266425|FG005|Overall Study|Transferred to named patient program|1|||
131176636|NCT02648724|472266426|FG006|Overall Study|Transferred to named patient program|0|||
131176637|NCT03076190|472266428|FG000|Overall Study|Lost to Follow-up|9|||
131176638|NCT03076190|472266429|FG001|Overall Study|Lost to Follow-up|34|||
131176639|NCT03076190|472266428|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
131176640|NCT03076190|472266429|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
131176641|NCT02034474|472266430|FG000|Overall Study|Adverse Event|3|||
131176642|NCT02034474|472266431|FG001|Overall Study|Adverse Event|2|||
131176643|NCT02034474|472266430|FG000|Overall Study|Withdrawal by Subject|1|||
131176644|NCT02034474|472266431|FG001|Overall Study|Withdrawal by Subject|2|||
131176645|NCT00675103|472266432|FG000|Overall Study|Lack of Efficacy|2|||
131176646|NCT00675103|472266432|FG000|Overall Study|Adverse Event|1|||
131176647|NCT00975195|472266435|FG000|Overall Study|Adverse Event|108|||
131176648|NCT00975195|472266436|FG001|Overall Study|Adverse Event|101|||
131176649|NCT00975195|472266435|FG000|Overall Study|Lack of Efficacy|6|||
131176650|NCT00975195|472266436|FG001|Overall Study|Lack of Efficacy|6|||
131176651|NCT00975195|472266435|FG000|Overall Study|Protocol Violation|27|||
131176652|NCT00975195|472266436|FG001|Overall Study|Protocol Violation|23|||
131176653|NCT00975195|472266435|FG000|Overall Study|Lost to Follow-up|9|||
131176654|NCT00975195|472266436|FG001|Overall Study|Lost to Follow-up|7|||
131176655|NCT00975195|472266435|FG000|Overall Study|Withdrawal by Subject|48|||
131176656|NCT00975195|472266436|FG001|Overall Study|Withdrawal by Subject|61|||
131176657|NCT00975195|472266435|FG000|Overall Study|Other reason not defined above|29|||
131176658|NCT00975195|472266436|FG001|Overall Study|Other reason not defined above|33|||
131176659|NCT00975195|472266435|FG000|Overall Study|Not treated|1|||
131176660|NCT00975195|472266436|FG001|Overall Study|Not treated|2|||
131176661|NCT01179347|472268099|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
131176662|NCT01179347|472268100|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
131176663|NCT01179347|472268099|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
131176664|NCT01179347|472268100|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
131176665|NCT01179347|472268099|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
130782801|NCT00427908|470833171|FG002|Primary Phase|Withdrawal by Subject|1|||
130782802|NCT00427908|470833172|FG003|Primary Phase|Withdrawal by Subject|0|||
130782803|NCT00427908|470833169|FG000|Primary Phase|Adverse Event|0|||
130782804|NCT00427908|470833170|FG001|Primary Phase|Adverse Event|1|||
130782805|NCT00427908|470833171|FG002|Primary Phase|Adverse Event|0|||
130782806|NCT00427908|470833172|FG003|Primary Phase|Adverse Event|0|||
130782807|NCT04202497|470833173|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
130782808|NCT04202497|470833174|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
131176666|NCT01179347|472268100|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
131176667|NCT01179347|472268099|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
131176668|NCT01179347|472268100|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
131176669|NCT01179347|472268099|FG000|Double-blind Period (12 Weeks)|Other|2|||
131176670|NCT01179347|472268100|FG001|Double-blind Period (12 Weeks)|Other|4|||
131176671|NCT01179347|472268099|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
131176672|NCT01179347|472268100|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
131176673|NCT01179347|472268099|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
131176674|NCT01179347|472268100|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
131176675|NCT01179347|472268099|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
131176676|NCT01179347|472268100|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
131176677|NCT01179347|472268099|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
131176678|NCT01179347|472268100|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
131176679|NCT01179347|472268099|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
131176680|NCT01179347|472268100|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
131176681|NCT01179347|472268099|FG000|Open-label Period (12 Weeks)|Other|7|||
131176682|NCT01179347|472268100|FG001|Open-label Period (12 Weeks)|Other|4|||
131176683|NCT02586077|472268101|FG000|Overall Study|Withdrawal by Subject|1|||
131176684|NCT02586077|472268101|FG000|Overall Study|Physician Decision|4|||
131176685|NCT02586077|472268101|FG000|Overall Study|Lost to Follow-up|3|||
131176686|NCT01245764|472268102|FG000|Study Phase A|Other|3|||
131176687|NCT01245764|472268103|FG001|Study Phase A|Other|2|||
131176688|NCT01245764|472268104|FG002|Study Phase A|Other|3|||
131176689|NCT01245764|472268105|FG003|Study Phase A|Other|1|||
131176690|NCT01245764|472268102|FG000|Study Phase A|Protocol Violation|6|||
131176691|NCT01245764|472268103|FG001|Study Phase A|Protocol Violation|3|||
131176692|NCT01245764|472268104|FG002|Study Phase A|Protocol Violation|2|||
131176693|NCT01245764|472268105|FG003|Study Phase A|Protocol Violation|2|||
131176694|NCT01245764|472268102|FG000|Study Phase A|Lost to Follow-up|0|||
131176695|NCT01245764|472268103|FG001|Study Phase A|Lost to Follow-up|0|||
131176696|NCT01245764|472268104|FG002|Study Phase A|Lost to Follow-up|5|||
131176697|NCT01245764|472268105|FG003|Study Phase A|Lost to Follow-up|0|||
131176698|NCT00781963|472268108|FG000|Overall Study|Death|3|||
131176699|NCT00781963|472268109|FG001|Overall Study|Death|0|||
131176700|NCT00781963|472268108|FG000|Overall Study|Lost to Follow-up|2|||
131176701|NCT00781963|472268109|FG001|Overall Study|Lost to Follow-up|1|||
131176702|NCT00781963|472268108|FG000|Overall Study|Withdrawal by Subject|3|||
131176703|NCT00781963|472268109|FG001|Overall Study|Withdrawal by Subject|1|||
131176704|NCT00781963|472268108|FG000|Overall Study|Refused follow-up|9|||
131176705|NCT00781963|472268109|FG001|Overall Study|Refused follow-up|0|||
131176706|NCT02064205|472268110|FG000|Overall Study|Withdrawal by Subject|1|||
131176707|NCT02062463|472268115|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
131176708|NCT02062463|472268116|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
131176709|NCT02062463|472268117|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
131176710|NCT02062463|472268118|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
131176711|NCT02062463|472268115|FG000|Stage 2|Adverse Event|0|||
131176712|NCT02062463|472268116|FG001|Stage 2|Adverse Event|0|||
131176713|NCT02062463|472268117|FG002|Stage 2|Adverse Event|12|||
131176714|NCT02062463|472268118|FG003|Stage 2|Adverse Event|20|||
131176715|NCT02062463|472268115|FG000|Stage 2|Lack of Efficacy|0|||
131176716|NCT02062463|472268116|FG001|Stage 2|Lack of Efficacy|0|||
131176717|NCT02062463|472268117|FG002|Stage 2|Lack of Efficacy|3|||
131176718|NCT02062463|472268118|FG003|Stage 2|Lack of Efficacy|4|||
131176719|NCT02062463|472268115|FG000|Stage 2|Lost to Follow-up|0|||
131176720|NCT02062463|472268116|FG001|Stage 2|Lost to Follow-up|0|||
131176721|NCT02062463|472268117|FG002|Stage 2|Lost to Follow-up|20|||
131176722|NCT02062463|472268118|FG003|Stage 2|Lost to Follow-up|20|||
131176723|NCT02062463|472268115|FG000|Stage 2|Non-Compliance|0|||
131176724|NCT02062463|472268116|FG001|Stage 2|Non-Compliance|0|||
130782809|NCT04202497|470833175|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
130782810|NCT04202497|470833176|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
131176725|NCT02062463|472268117|FG002|Stage 2|Non-Compliance|0|||
131176726|NCT02062463|472268118|FG003|Stage 2|Non-Compliance|1|||
131176727|NCT02062463|472268115|FG000|Stage 2|Other than specified|0|||
131176728|NCT02062463|472268116|FG001|Stage 2|Other than specified|0|||
131176729|NCT02062463|472268117|FG002|Stage 2|Other than specified|3|||
131176730|NCT02062463|472268118|FG003|Stage 2|Other than specified|1|||
131176731|NCT02062463|472268115|FG000|Stage 2|Withdrawal by Subject|0|||
131176732|NCT02062463|472268116|FG001|Stage 2|Withdrawal by Subject|0|||
131236891|NCT02465567|472495054|FG000|Overall Study|missing PI Signature|1|||
131236892|NCT02465567|472495055|FG001|Overall Study|missing PI Signature|0|||
130782811|NCT00069264|470833178|FG000|Overall Study|Adverse Event|3|||
130782812|NCT00069264|470833178|FG000|Overall Study|Progressive Disease|23|||
130782813|NCT00069264|470833178|FG000|Overall Study|Withdrawal by Subject|3|||
130782814|NCT00069264|470833178|FG000|Overall Study|Discon Therapy|3|||
130782815|NCT05547386|470833179|FG000|Overall Study|Withdrawal by Subject|7|||
130782816|NCT04622969|470833180|FG000|Overall Study|Withdrawal by Subject|2|||
130782817|NCT04622969|470833181|FG001|Overall Study|Withdrawal by Subject|3|||
130782818|NCT04467515|470833182|FG000|Overall Study|Lost to Follow-up|1|||
130782819|NCT04467515|470833183|FG001|Overall Study|Lost to Follow-up|0|||
130782820|NCT04467515|470833184|FG002|Overall Study|Lost to Follow-up|0|||
130782821|NCT04467515|470833182|FG000|Overall Study|Withdrawal by Subject|1|||
130782822|NCT04467515|470833183|FG001|Overall Study|Withdrawal by Subject|0|||
130782823|NCT04467515|470833184|FG002|Overall Study|Withdrawal by Subject|1|||
130782824|NCT04467515|470833182|FG000|Overall Study|Progressive Disease|0|||
130782825|NCT04467515|470833183|FG001|Overall Study|Progressive Disease|1|||
130782826|NCT04467515|470833184|FG002|Overall Study|Progressive Disease|3|||
130782827|NCT04467515|470833182|FG000|Overall Study|Death|0|||
130782828|NCT04467515|470833183|FG001|Overall Study|Death|1|||
130782829|NCT04467515|470833184|FG002|Overall Study|Death|0|||
130782830|NCT05616013|470833187|FG000|Overall Study|Adverse Event|6|||
130782831|NCT05616013|470833188|FG001|Overall Study|Adverse Event|12|||
130782832|NCT05616013|470833189|FG002|Overall Study|Adverse Event|8|||
130782833|NCT05616013|470833190|FG003|Overall Study|Adverse Event|4|||
130782834|NCT05616013|470833191|FG004|Overall Study|Adverse Event|6|||
130782835|NCT05616013|470833192|FG005|Overall Study|Adverse Event|8|||
130782836|NCT05616013|470833193|FG006|Overall Study|Adverse Event|3|||
130782837|NCT05616013|470833194|FG007|Overall Study|Adverse Event|6|||
130782838|NCT05616013|470833195|FG008|Overall Study|Adverse Event|1|||
130782839|NCT05616013|470833187|FG000|Overall Study|Lost to Follow-up|5|||
130782840|NCT05616013|470833188|FG001|Overall Study|Lost to Follow-up|4|||
130782841|NCT05616013|470833189|FG002|Overall Study|Lost to Follow-up|3|||
130782842|NCT05616013|470833190|FG003|Overall Study|Lost to Follow-up|2|||
131176733|NCT02062463|472268117|FG002|Stage 2|Withdrawal by Subject|15|||
131176734|NCT02062463|472268118|FG003|Stage 2|Withdrawal by Subject|10|||
131176735|NCT01830816|472268125|FG000|Overall Study|Progressive Disease|12|||
131176736|NCT01830816|472268126|FG001|Overall Study|Progressive Disease|7|||
131236893|NCT02465567|472495056|FG002|Overall Study|missing PI Signature|0|||
131176737|NCT01830816|472268127|FG002|Overall Study|Progressive Disease|7|||
131176738|NCT01830816|472268125|FG000|Overall Study|Adverse Event|3|||
131176739|NCT01830816|472268126|FG001|Overall Study|Adverse Event|4|||
131176740|NCT01830816|472268127|FG002|Overall Study|Adverse Event|0|||
131176741|NCT01830816|472268125|FG000|Overall Study|Study Terminated by Sponsor|1|||
131176742|NCT01830816|472268126|FG001|Overall Study|Study Terminated by Sponsor|1|||
131176743|NCT01830816|472268127|FG002|Overall Study|Study Terminated by Sponsor|0|||
131176744|NCT01830816|472268125|FG000|Overall Study|Withdrawal by Subject|1|||
131176745|NCT01830816|472268126|FG001|Overall Study|Withdrawal by Subject|1|||
131176746|NCT01830816|472268127|FG002|Overall Study|Withdrawal by Subject|0|||
131176747|NCT01830816|472268125|FG000|Overall Study|Lost to Follow-up|0|||
131176748|NCT01830816|472268126|FG001|Overall Study|Lost to Follow-up|1|||
131176749|NCT01830816|472268127|FG002|Overall Study|Lost to Follow-up|0|||
131176750|NCT01830816|472268125|FG000|Overall Study|Symptomatic Deterioration|1|||
131176751|NCT01830816|472268126|FG001|Overall Study|Symptomatic Deterioration|0|||
131176752|NCT01830816|472268127|FG002|Overall Study|Symptomatic Deterioration|0|||
131176753|NCT01830816|472268125|FG000|Overall Study|Reason not Specified|2|||
131176754|NCT01830816|472268126|FG001|Overall Study|Reason not Specified|0|||
131176755|NCT01830816|472268127|FG002|Overall Study|Reason not Specified|0|||
131176756|NCT04124692|472268128|FG000|Overall Study|Medical reason|0|||
131176757|NCT04124692|472268129|FG001|Overall Study|Medical reason|1|||
131176758|NCT04124692|472268128|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
131176759|NCT04124692|472268129|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
131176760|NCT04124692|472268128|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
131176761|NCT04124692|472268129|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
131176762|NCT04124692|472268128|FG000|Overall Study|Lost to Follow-up|2|||
130782843|NCT05616013|470833191|FG004|Overall Study|Lost to Follow-up|0|||
130782844|NCT05616013|470833192|FG005|Overall Study|Lost to Follow-up|5|||
130782845|NCT05616013|470833193|FG006|Overall Study|Lost to Follow-up|2|||
130782846|NCT05616013|470833194|FG007|Overall Study|Lost to Follow-up|1|||
130782847|NCT05616013|470833195|FG008|Overall Study|Lost to Follow-up|2|||
130782848|NCT05616013|470833187|FG000|Overall Study|Non-compliance with study requirements|2|||
130782849|NCT05616013|470833188|FG001|Overall Study|Non-compliance with study requirements|2|||
130782850|NCT05616013|470833189|FG002|Overall Study|Non-compliance with study requirements|2|||
131176763|NCT04124692|472268129|FG001|Overall Study|Lost to Follow-up|4|||
131176764|NCT04124692|472268128|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
131176765|NCT04124692|472268129|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
131236894|NCT02465567|472495057|FG003|Overall Study|missing PI Signature|0|||
131236895|NCT00950807|472495062|FG000|Treatment Period 1|Lack of Efficacy|1|||
131236896|NCT00950807|472495063|FG001|Treatment Period 1|Lack of Efficacy|0|||
131236897|NCT00950807|472495064|FG002|Treatment Period 1|Lack of Efficacy|0|||
131236898|NCT00950807|472495065|FG003|Treatment Period 1|Lack of Efficacy|0|||
131236899|NCT00950807|472495066|FG004|Treatment Period 1|Lack of Efficacy|0|||
131236900|NCT00950807|472495067|FG005|Treatment Period 1|Lack of Efficacy|1|||
131236901|NCT00950807|472495068|FG006|Treatment Period 1|Lack of Efficacy|0|||
131236902|NCT00950807|472495069|FG007|Treatment Period 1|Lack of Efficacy|0|||
131236903|NCT00950807|472495070|FG008|Treatment Period 1|Lack of Efficacy|0|||
131236904|NCT00950807|472495071|FG009|Treatment Period 1|Lack of Efficacy|0|||
131236905|NCT00950807|472495062|FG000|Treatment Period 1|Protocol Violation|1|||
131236906|NCT00950807|472495063|FG001|Treatment Period 1|Protocol Violation|0|||
131236907|NCT00950807|472495064|FG002|Treatment Period 1|Protocol Violation|0|||
131236908|NCT00950807|472495065|FG003|Treatment Period 1|Protocol Violation|0|||
131236909|NCT00950807|472495066|FG004|Treatment Period 1|Protocol Violation|0|||
131236910|NCT00950807|472495067|FG005|Treatment Period 1|Protocol Violation|0|||
131236911|NCT00950807|472495068|FG006|Treatment Period 1|Protocol Violation|0|||
131236912|NCT00950807|472495069|FG007|Treatment Period 1|Protocol Violation|0|||
131236913|NCT00950807|472495070|FG008|Treatment Period 1|Protocol Violation|0|||
131236914|NCT00950807|472495071|FG009|Treatment Period 1|Protocol Violation|0|||
131236915|NCT00950807|472495062|FG000|Treatment Period 1|Lost to Follow-up|0|||
131236916|NCT00950807|472495063|FG001|Treatment Period 1|Lost to Follow-up|0|||
131236917|NCT00950807|472495064|FG002|Treatment Period 1|Lost to Follow-up|1|||
131236918|NCT00950807|472495065|FG003|Treatment Period 1|Lost to Follow-up|0|||
131236919|NCT00950807|472495066|FG004|Treatment Period 1|Lost to Follow-up|0|||
131236920|NCT00950807|472495067|FG005|Treatment Period 1|Lost to Follow-up|0|||
131236921|NCT00950807|472495068|FG006|Treatment Period 1|Lost to Follow-up|0|||
131236922|NCT00950807|472495069|FG007|Treatment Period 1|Lost to Follow-up|0|||
131236923|NCT00950807|472495070|FG008|Treatment Period 1|Lost to Follow-up|0|||
131236924|NCT00950807|472495071|FG009|Treatment Period 1|Lost to Follow-up|0|||
131236925|NCT00950807|472495062|FG000|Treatment Period 1|Withdrawal by Subject|1|||
131236926|NCT00950807|472495063|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131236927|NCT00950807|472495064|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131176766|NCT00205699|472268132|FG000|Overall Study|Lost to Follow-up|1|||
131176767|NCT00205699|472268133|FG001|Overall Study|Lost to Follow-up|3|||
131176768|NCT00205699|472268134|FG002|Overall Study|Lost to Follow-up|5|||
131176769|NCT00205699|472268132|FG000|Overall Study|Adverse Event|1|||
131176770|NCT00205699|472268133|FG001|Overall Study|Adverse Event|0|||
131176771|NCT00205699|472268134|FG002|Overall Study|Adverse Event|0|||
131176772|NCT00205699|472268132|FG000|Overall Study|Withdrawal by Subject|1|||
131176773|NCT00205699|472268133|FG001|Overall Study|Withdrawal by Subject|2|||
131236928|NCT00950807|472495065|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131236929|NCT00950807|472495066|FG004|Treatment Period 1|Withdrawal by Subject|1|||
131236930|NCT00950807|472495067|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131176774|NCT00205699|472268134|FG002|Overall Study|Withdrawal by Subject|1|||
131176775|NCT00205699|472268132|FG000|Overall Study|Lack of Efficacy|0|||
131176776|NCT00205699|472268133|FG001|Overall Study|Lack of Efficacy|1|||
131176777|NCT00205699|472268134|FG002|Overall Study|Lack of Efficacy|0|||
131176778|NCT01754922|472268137|FG000|Overall Study|Adverse Event|0|||
131176779|NCT01754922|472268138|FG001|Overall Study|Adverse Event|1|||
131176780|NCT01199055|472268146|FG000|Overall Study|Death|0|||
131176781|NCT01199055|472268147|FG001|Overall Study|Death|1|||
131176782|NCT01199055|472268148|FG002|Overall Study|Death|0|||
131176783|NCT01199055|472268146|FG000|Overall Study|Physician Decision|0|||
130782851|NCT05616013|470833190|FG003|Overall Study|Non-compliance with study requirements|3|||
131176784|NCT01199055|472268147|FG001|Overall Study|Physician Decision|1|||
131236931|NCT00950807|472495068|FG006|Treatment Period 1|Withdrawal by Subject|0|||
131236932|NCT00950807|472495069|FG007|Treatment Period 1|Withdrawal by Subject|0|||
131236933|NCT00950807|472495070|FG008|Treatment Period 1|Withdrawal by Subject|1|||
130782852|NCT05616013|470833191|FG004|Overall Study|Non-compliance with study requirements|0|||
131176785|NCT01199055|472268148|FG002|Overall Study|Physician Decision|1|||
131176786|NCT01199055|472268146|FG000|Overall Study|Progressive disease|2|||
131236934|NCT00950807|472495071|FG009|Treatment Period 1|Withdrawal by Subject|0|||
131236935|NCT00950807|472495062|FG000|Treatment Period 1|Adverse Event|0|||
131176787|NCT01199055|472268147|FG001|Overall Study|Progressive disease|1|||
131176788|NCT01199055|472268148|FG002|Overall Study|Progressive disease|2|||
131176789|NCT01199055|472268146|FG000|Overall Study|Withdrawal by Subject|0|||
131236936|NCT00950807|472495063|FG001|Treatment Period 1|Adverse Event|0|||
131236937|NCT00950807|472495064|FG002|Treatment Period 1|Adverse Event|0|||
131236938|NCT00950807|472495065|FG003|Treatment Period 1|Adverse Event|0|||
131236939|NCT00950807|472495066|FG004|Treatment Period 1|Adverse Event|0|||
131236940|NCT00950807|472495067|FG005|Treatment Period 1|Adverse Event|1|||
131236941|NCT00950807|472495068|FG006|Treatment Period 1|Adverse Event|0|||
131176790|NCT01199055|472268147|FG001|Overall Study|Withdrawal by Subject|0|||
131176791|NCT01199055|472268148|FG002|Overall Study|Withdrawal by Subject|1|||
131176792|NCT02662985|472268149|FG000|Treatment Period 1|Adverse Event|0|||
131176793|NCT02662985|472268150|FG001|Treatment Period 1|Adverse Event|2|||
131176794|NCT02662985|472268149|FG000|Treatment Period 1|Protocol Violation|0|||
131176795|NCT02662985|472268150|FG001|Treatment Period 1|Protocol Violation|1|||
131176796|NCT02662985|472268149|FG000|Treatment Period 1|Physician Decision|1|||
131176797|NCT02662985|472268150|FG001|Treatment Period 1|Physician Decision|0|||
131176798|NCT02662985|472268149|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131176799|NCT02662985|472268150|FG001|Treatment Period 1|Withdrawal by Subject|1|||
131176800|NCT02662985|472268149|FG000|Treatment Period 2|Lack of Efficacy|0|||
131176801|NCT02662985|472268150|FG001|Treatment Period 2|Lack of Efficacy|1|||
131176802|NCT02662985|472268149|FG000|Treatment Period 2|Lost to Follow-up|1|||
131176803|NCT02662985|472268150|FG001|Treatment Period 2|Lost to Follow-up|0|||
131176804|NCT02662985|472268149|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
131176805|NCT02662985|472268150|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
131176806|NCT02662985|472268149|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
131176807|NCT02662985|472268150|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
131176808|NCT02662985|472268149|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
131176809|NCT02662985|472268150|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
131176810|NCT02662985|472268149|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
131176811|NCT02662985|472268150|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
131176812|NCT02662985|472268149|FG000|Treatment Period 3 (Extension Period)|Death|0|||
131176813|NCT02662985|472268150|FG001|Treatment Period 3 (Extension Period)|Death|1|||
131176814|NCT03442829|472268151|FG000|Overall Study|Scheduling clash|3|||
131176815|NCT03442829|472268152|FG001|Overall Study|Scheduling clash|1|||
131176816|NCT03442829|472268151|FG000|Overall Study|Illness unrelated to study|1|||
131176817|NCT03442829|472268152|FG001|Overall Study|Illness unrelated to study|1|||
131176818|NCT01486784|472268153|FG000|Overall Study|Withdrawal by Subject|0|||
131176819|NCT01486784|472268154|FG001|Overall Study|Withdrawal by Subject|0|||
131176820|NCT01486784|472268155|FG002|Overall Study|Withdrawal by Subject|1|||
131176821|NCT01486784|472268156|FG003|Overall Study|Withdrawal by Subject|0|||
131176822|NCT01486784|472268157|FG004|Overall Study|Withdrawal by Subject|1|||
131176823|NCT01486784|472268158|FG005|Overall Study|Withdrawal by Subject|2|||
131176824|NCT01486784|472268153|FG000|Overall Study|Subject did not meet entry criteria|0|||
131176825|NCT01486784|472268154|FG001|Overall Study|Subject did not meet entry criteria|0|||
131176826|NCT01486784|472268155|FG002|Overall Study|Subject did not meet entry criteria|0|||
131176827|NCT01486784|472268156|FG003|Overall Study|Subject did not meet entry criteria|0|||
131176828|NCT01486784|472268157|FG004|Overall Study|Subject did not meet entry criteria|1|||
131176829|NCT01486784|472268158|FG005|Overall Study|Subject did not meet entry criteria|0|||
131176830|NCT01486784|472268153|FG000|Overall Study|Death|0|||
131176831|NCT01486784|472268154|FG001|Overall Study|Death|0|||
131176832|NCT01486784|472268155|FG002|Overall Study|Death|0|||
131176833|NCT01486784|472268156|FG003|Overall Study|Death|0|||
131176834|NCT01486784|472268157|FG004|Overall Study|Death|0|||
131176835|NCT01486784|472268158|FG005|Overall Study|Death|1|||
131176836|NCT01021852|472268161|FG000|Treatment Period 1|Adverse Event|3|||
131176837|NCT01021852|472268162|FG001|Treatment Period 1|Adverse Event|1|||
131176838|NCT01021852|472268163|FG002|Treatment Period 1|Adverse Event|1|||
131176839|NCT01021852|472268164|FG003|Treatment Period 1|Adverse Event|0|||
131176840|NCT01021852|472268165|FG004|Treatment Period 1|Adverse Event|2|||
131176841|NCT01021852|472268166|FG005|Treatment Period 1|Adverse Event|2|||
131176842|NCT01021852|472268167|FG006|Treatment Period 1|Adverse Event|0|||
131176843|NCT01021852|472268168|FG007|Treatment Period 1|Adverse Event|0|||
131176844|NCT01021852|472268161|FG000|Treatment Period 1|Pregnancy|0|||
131176845|NCT01021852|472268162|FG001|Treatment Period 1|Pregnancy|0|||
131176846|NCT01021852|472268163|FG002|Treatment Period 1|Pregnancy|1|||
131176847|NCT01021852|472268164|FG003|Treatment Period 1|Pregnancy|0|||
131176848|NCT01021852|472268165|FG004|Treatment Period 1|Pregnancy|0|||
131176849|NCT01021852|472268166|FG005|Treatment Period 1|Pregnancy|0|||
131176850|NCT01021852|472268167|FG006|Treatment Period 1|Pregnancy|0|||
131176851|NCT01021852|472268168|FG007|Treatment Period 1|Pregnancy|0|||
131176852|NCT01021852|472268161|FG000|Treatment Period 1|Withdrawal by Subject|0|||
131176853|NCT01021852|472268162|FG001|Treatment Period 1|Withdrawal by Subject|0|||
131176854|NCT01021852|472268163|FG002|Treatment Period 1|Withdrawal by Subject|0|||
131176855|NCT01021852|472268164|FG003|Treatment Period 1|Withdrawal by Subject|0|||
131176856|NCT01021852|472268165|FG004|Treatment Period 1|Withdrawal by Subject|1|||
131176857|NCT01021852|472268166|FG005|Treatment Period 1|Withdrawal by Subject|0|||
131176858|NCT01021852|472268167|FG006|Treatment Period 1|Withdrawal by Subject|0|||
131176859|NCT01021852|472268168|FG007|Treatment Period 1|Withdrawal by Subject|1|||
131176860|NCT01021852|472268161|FG000|Treatment Period 1|Not Treated|0|||
131176861|NCT01021852|472268162|FG001|Treatment Period 1|Not Treated|0|||
131176862|NCT01021852|472268163|FG002|Treatment Period 1|Not Treated|0|||
131176863|NCT01021852|472268164|FG003|Treatment Period 1|Not Treated|2|||
131176864|NCT01021852|472268165|FG004|Treatment Period 1|Not Treated|0|||
131176865|NCT01021852|472268166|FG005|Treatment Period 1|Not Treated|0|||
131176866|NCT01021852|472268167|FG006|Treatment Period 1|Not Treated|0|||
131176867|NCT01021852|472268168|FG007|Treatment Period 1|Not Treated|0|||
131176868|NCT01021852|472268161|FG000|Washout Period-Placebo|Adverse Event|0|||
131176869|NCT01021852|472268162|FG001|Washout Period-Placebo|Adverse Event|0|||
131176870|NCT01021852|472268163|FG002|Washout Period-Placebo|Adverse Event|0|||
131176871|NCT01021852|472268164|FG003|Washout Period-Placebo|Adverse Event|1|||
131176872|NCT01021852|472268165|FG004|Washout Period-Placebo|Adverse Event|0|||
131176873|NCT01021852|472268166|FG005|Washout Period-Placebo|Adverse Event|1|||
131176874|NCT01021852|472268167|FG006|Washout Period-Placebo|Adverse Event|0|||
131176875|NCT01021852|472268168|FG007|Washout Period-Placebo|Adverse Event|0|||
131176876|NCT01021852|472268161|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
131236942|NCT00950807|472495069|FG007|Treatment Period 1|Adverse Event|0|||
131236943|NCT00950807|472495070|FG008|Treatment Period 1|Adverse Event|0|||
131236944|NCT00950807|472495071|FG009|Treatment Period 1|Adverse Event|0|||
131236945|NCT00950807|472495062|FG000|Washout Period 1|Lack of Efficacy|0|||
131236946|NCT00950807|472495063|FG001|Washout Period 1|Lack of Efficacy|0|||
131236947|NCT00950807|472495064|FG002|Washout Period 1|Lack of Efficacy|0|||
131236948|NCT00950807|472495065|FG003|Washout Period 1|Lack of Efficacy|0|||
131236949|NCT00950807|472495066|FG004|Washout Period 1|Lack of Efficacy|0|||
131236950|NCT00950807|472495067|FG005|Washout Period 1|Lack of Efficacy|0|||
131236951|NCT00950807|472495068|FG006|Washout Period 1|Lack of Efficacy|1|||
131236952|NCT00950807|472495069|FG007|Washout Period 1|Lack of Efficacy|0|||
131236953|NCT00950807|472495070|FG008|Washout Period 1|Lack of Efficacy|0|||
130782853|NCT05616013|470833192|FG005|Overall Study|Non-compliance with study requirements|2|||
131176877|NCT01021852|472268162|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
131176878|NCT01021852|472268163|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
131176879|NCT01021852|472268164|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
131176880|NCT01021852|472268165|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
131176881|NCT01021852|472268166|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
131176882|NCT01021852|472268167|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
131176883|NCT01021852|472268168|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
131176884|NCT01021852|472268161|FG000|Washout Period-Placebo|Protocol Violation|0|||
131176885|NCT01021852|472268162|FG001|Washout Period-Placebo|Protocol Violation|0|||
131176886|NCT01021852|472268163|FG002|Washout Period-Placebo|Protocol Violation|0|||
131176887|NCT01021852|472268164|FG003|Washout Period-Placebo|Protocol Violation|0|||
131176888|NCT01021852|472268165|FG004|Washout Period-Placebo|Protocol Violation|0|||
131176889|NCT01021852|472268166|FG005|Washout Period-Placebo|Protocol Violation|0|||
131176890|NCT01021852|472268167|FG006|Washout Period-Placebo|Protocol Violation|1|||
131176891|NCT01021852|472268168|FG007|Washout Period-Placebo|Protocol Violation|0|||
131176892|NCT01021852|472268161|FG000|Washout Period-No Drug|Adverse Event|1|||
131176893|NCT01021852|472268162|FG001|Washout Period-No Drug|Adverse Event|0|||
131176894|NCT01021852|472268163|FG002|Washout Period-No Drug|Adverse Event|0|||
131176895|NCT01021852|472268164|FG003|Washout Period-No Drug|Adverse Event|0|||
131176896|NCT01021852|472268165|FG004|Washout Period-No Drug|Adverse Event|0|||
131176897|NCT01021852|472268166|FG005|Washout Period-No Drug|Adverse Event|1|||
131176898|NCT01021852|472268167|FG006|Washout Period-No Drug|Adverse Event|0|||
131176899|NCT01021852|472268168|FG007|Washout Period-No Drug|Adverse Event|0|||
131176900|NCT01021852|472268161|FG000|Treatment Period 2|Adverse Event|0|||
131176901|NCT01021852|472268162|FG001|Treatment Period 2|Adverse Event|1|||
131176902|NCT01021852|472268163|FG002|Treatment Period 2|Adverse Event|0|||
131176903|NCT01021852|472268164|FG003|Treatment Period 2|Adverse Event|0|||
131176904|NCT01021852|472268165|FG004|Treatment Period 2|Adverse Event|1|||
131176905|NCT01021852|472268166|FG005|Treatment Period 2|Adverse Event|0|||
131176906|NCT01021852|472268167|FG006|Treatment Period 2|Adverse Event|1|||
131176907|NCT01021852|472268168|FG007|Treatment Period 2|Adverse Event|0|||
131176908|NCT01021852|472268161|FG000|Treatment Period 2|Lack of Efficacy|0|||
131176909|NCT01021852|472268162|FG001|Treatment Period 2|Lack of Efficacy|0|||
131176910|NCT01021852|472268163|FG002|Treatment Period 2|Lack of Efficacy|0|||
131176911|NCT01021852|472268164|FG003|Treatment Period 2|Lack of Efficacy|0|||
131176912|NCT01021852|472268165|FG004|Treatment Period 2|Lack of Efficacy|0|||
131176913|NCT01021852|472268166|FG005|Treatment Period 2|Lack of Efficacy|1|||
131176914|NCT01021852|472268167|FG006|Treatment Period 2|Lack of Efficacy|0|||
131176915|NCT01021852|472268168|FG007|Treatment Period 2|Lack of Efficacy|0|||
131176916|NCT01021852|472268161|FG000|Treatment Period 2|Physician Decision|0|||
131176917|NCT01021852|472268162|FG001|Treatment Period 2|Physician Decision|0|||
131176918|NCT01021852|472268163|FG002|Treatment Period 2|Physician Decision|1|||
131236954|NCT00950807|472495071|FG009|Washout Period 1|Lack of Efficacy|0|||
131236955|NCT00950807|472495062|FG000|Washout Period 1|Withdrawal by Subject|0|||
131236956|NCT00950807|472495063|FG001|Washout Period 1|Withdrawal by Subject|0|||
131176919|NCT01021852|472268164|FG003|Treatment Period 2|Physician Decision|0|||
131176920|NCT01021852|472268165|FG004|Treatment Period 2|Physician Decision|0|||
131176921|NCT01021852|472268166|FG005|Treatment Period 2|Physician Decision|0|||
131176922|NCT01021852|472268167|FG006|Treatment Period 2|Physician Decision|0|||
131176923|NCT01021852|472268168|FG007|Treatment Period 2|Physician Decision|0|||
131176924|NCT01021852|472268161|FG000|Treatment Period 2|Protocol Violation|0|||
131176925|NCT01021852|472268162|FG001|Treatment Period 2|Protocol Violation|0|||
131176926|NCT01021852|472268163|FG002|Treatment Period 2|Protocol Violation|0|||
131176927|NCT01021852|472268164|FG003|Treatment Period 2|Protocol Violation|0|||
131176928|NCT01021852|472268165|FG004|Treatment Period 2|Protocol Violation|1|||
131236957|NCT00950807|472495064|FG002|Washout Period 1|Withdrawal by Subject|0|||
130782854|NCT05616013|470833193|FG006|Overall Study|Non-compliance with study requirements|1|||
130782855|NCT05616013|470833194|FG007|Overall Study|Non-compliance with study requirements|1|||
130782856|NCT05616013|470833195|FG008|Overall Study|Non-compliance with study requirements|4|||
130782857|NCT05616013|470833187|FG000|Overall Study|Withdrawal by Subject|11|||
130782858|NCT05616013|470833188|FG001|Overall Study|Withdrawal by Subject|9|||
130782859|NCT05616013|470833189|FG002|Overall Study|Withdrawal by Subject|8|||
130782860|NCT05616013|470833190|FG003|Overall Study|Withdrawal by Subject|6|||
130782861|NCT05616013|470833191|FG004|Overall Study|Withdrawal by Subject|3|||
130782862|NCT05616013|470833192|FG005|Overall Study|Withdrawal by Subject|4|||
130782863|NCT05616013|470833193|FG006|Overall Study|Withdrawal by Subject|6|||
130782864|NCT05616013|470833194|FG007|Overall Study|Withdrawal by Subject|5|||
130782865|NCT05616013|470833195|FG008|Overall Study|Withdrawal by Subject|4|||
130782866|NCT05616013|470833187|FG000|Overall Study|Physician Decision|0|||
130782867|NCT05616013|470833188|FG001|Overall Study|Physician Decision|0|||
130782868|NCT05616013|470833189|FG002|Overall Study|Physician Decision|1|||
130782869|NCT05616013|470833190|FG003|Overall Study|Physician Decision|0|||
130782870|NCT05616013|470833191|FG004|Overall Study|Physician Decision|0|||
131176929|NCT01021852|472268166|FG005|Treatment Period 2|Protocol Violation|0|||
131176930|NCT01021852|472268167|FG006|Treatment Period 2|Protocol Violation|1|||
131176931|NCT01021852|472268168|FG007|Treatment Period 2|Protocol Violation|0|||
131176932|NCT01021852|472268161|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131176933|NCT01021852|472268162|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131176934|NCT01021852|472268163|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131176935|NCT01021852|472268164|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131176936|NCT01021852|472268165|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131176937|NCT01021852|472268166|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131176938|NCT01021852|472268167|FG006|Treatment Period 2|Withdrawal by Subject|1|||
131176939|NCT01021852|472268168|FG007|Treatment Period 2|Withdrawal by Subject|2|||
131176940|NCT02493426|472268169|FG000|Overall Study|Withdrawal by Subject|0|||
131176941|NCT02493426|472268170|FG001|Overall Study|Withdrawal by Subject|1|||
131176942|NCT03491553|472268171|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
131176943|NCT03491553|472268172|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
131176944|NCT03491553|472268173|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
131176945|NCT03491553|472268174|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
131176946|NCT03491553|472268175|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
131176947|NCT03491553|472268176|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
131176948|NCT03491553|472268171|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
131176949|NCT03491553|472268172|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
131176950|NCT03491553|472268173|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
131176951|NCT03491553|472268174|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
131176952|NCT03491553|472268175|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
131176953|NCT03491553|472268176|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
131176954|NCT02128763|472268181|FG000|Overall Study|Death|1|||
131176955|NCT02128763|472268182|FG001|Overall Study|Death|0|||
131176956|NCT02128763|472268181|FG000|Overall Study|Lost to Follow-up|19|||
131176957|NCT02128763|472268182|FG001|Overall Study|Lost to Follow-up|16|||
131176958|NCT00363246|472268183|FG000|Overall Study|Death|40|||
131176959|NCT00363246|472268183|FG000|Overall Study|Withdrawal by Subject|19|||
131176960|NCT00363246|472268183|FG000|Overall Study|Lost to Follow-up|14|||
131176961|NCT00363246|472268183|FG000|Overall Study|Bad health|6|||
131176962|NCT00363246|472268183|FG000|Overall Study|Stopped using wheelchair|11|||
131176963|NCT00363246|472268183|FG000|Overall Study|Subject expressed security concerns|2|||
131176964|NCT00363246|472268183|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
131176965|NCT01608724|472268188|FG000|Overall Study|Withdrawal by Subject|131|||
131176966|NCT01608724|472268188|FG000|Overall Study|Lost to Follow-up|41|||
131176967|NCT01608724|472268188|FG000|Overall Study|Study-specific discontinuation criteria|32|||
131176968|NCT01608724|472268188|FG000|Overall Study|Adverse Event|29|||
131176969|NCT01608724|472268188|FG000|Overall Study|Protocol Violation|6|||
131176970|NCT01608724|472268188|FG000|Overall Study|bood sugar too high, etc.|3|||
131176971|NCT01608724|472268188|FG000|Overall Study|Safety reasons|1|||
130782871|NCT05616013|470833192|FG005|Overall Study|Physician Decision|1|||
130782872|NCT05616013|470833193|FG006|Overall Study|Physician Decision|3|||
130782873|NCT05616013|470833194|FG007|Overall Study|Physician Decision|0|||
130782874|NCT05616013|470833195|FG008|Overall Study|Physician Decision|0|||
131236958|NCT00950807|472495065|FG003|Washout Period 1|Withdrawal by Subject|0|||
131236959|NCT00950807|472495066|FG004|Washout Period 1|Withdrawal by Subject|0|||
130782875|NCT05616013|470833187|FG000|Overall Study|Protocol Violation|0|||
130782876|NCT05616013|470833188|FG001|Overall Study|Protocol Violation|0|||
130782877|NCT05616013|470833189|FG002|Overall Study|Protocol Violation|0|||
131176972|NCT04387136|472268189|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
131176973|NCT04387136|472268190|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
131176974|NCT00717366|472268191|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
131176975|NCT00717366|472268192|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
131176976|NCT00717366|472268191|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
131176977|NCT00717366|472268192|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
131176978|NCT00717366|472268191|FG000|Core Study Period (20 Weeks)|Death|0|||
131176979|NCT00717366|472268192|FG001|Core Study Period (20 Weeks)|Death|1|||
131176980|NCT00717366|472268191|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
131236960|NCT00950807|472495067|FG005|Washout Period 1|Withdrawal by Subject|0|||
131236961|NCT00950807|472495068|FG006|Washout Period 1|Withdrawal by Subject|0|||
131236962|NCT00950807|472495069|FG007|Washout Period 1|Withdrawal by Subject|0|||
131176981|NCT00717366|472268192|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
131176982|NCT00717366|472268191|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
131176983|NCT00717366|472268192|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
131176984|NCT00717366|472268191|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
131176985|NCT00717366|472268192|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
131176986|NCT00717366|472268191|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
131176987|NCT00717366|472268192|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
131176988|NCT00910429|472268193|FG000|Overall Study|Death|18|||
131176989|NCT00910429|472268194|FG001|Overall Study|Death|12|||
131176990|NCT00910429|472268193|FG000|Overall Study|Withdrawal by Subject|3|||
131176991|NCT00910429|472268194|FG001|Overall Study|Withdrawal by Subject|2|||
131176992|NCT00910429|472268193|FG000|Overall Study|Protocol Violation|1|||
131236963|NCT00950807|472495070|FG008|Washout Period 1|Withdrawal by Subject|1|||
131236964|NCT00950807|472495071|FG009|Washout Period 1|Withdrawal by Subject|0|||
131236965|NCT00950807|472495062|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
131236966|NCT00950807|472495063|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131236967|NCT00950807|472495064|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131236968|NCT00950807|472495065|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131236969|NCT00950807|472495066|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131236970|NCT00950807|472495067|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131236971|NCT00950807|472495068|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
131236972|NCT00950807|472495069|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
131236973|NCT00950807|472495070|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131236974|NCT00950807|472495071|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
131176993|NCT00910429|472268194|FG001|Overall Study|Protocol Violation|0|||
131176994|NCT00910429|472268193|FG000|Overall Study|Lost to Follow-up|2|||
131176995|NCT00910429|472268194|FG001|Overall Study|Lost to Follow-up|1|||
131176996|NCT00910429|472268193|FG000|Overall Study|Adverse Event|10|||
131176997|NCT00910429|472268194|FG001|Overall Study|Adverse Event|5|||
131176998|NCT00910429|472268193|FG000|Overall Study|Drug non-compliance|1|||
131176999|NCT00910429|472268194|FG001|Overall Study|Drug non-compliance|0|||
131177000|NCT00910429|472268193|FG000|Overall Study|Lack of Efficacy|4|||
131177001|NCT00910429|472268194|FG001|Overall Study|Lack of Efficacy|1|||
131177002|NCT02121756|472268196|FG000|Overall Study|Adverse Event|3|||
131177003|NCT02121756|472268197|FG001|Overall Study|Adverse Event|0|||
131177004|NCT02121756|472268196|FG000|Overall Study|Protocol Violation|1|||
131177005|NCT02121756|472268197|FG001|Overall Study|Protocol Violation|1|||
131177006|NCT02121756|472268196|FG000|Overall Study|Physician Decision|2|||
131177007|NCT02121756|472268197|FG001|Overall Study|Physician Decision|1|||
131177008|NCT00255086|472268200|FG000|Overall Study|Adverse Event|1|||
131177009|NCT00255086|472268201|FG001|Overall Study|Adverse Event|1|||
131177010|NCT00255086|472268200|FG000|Overall Study|Protocol Violation|1|||
131177011|NCT00255086|472268201|FG001|Overall Study|Protocol Violation|1|||
131177012|NCT02365584|472268203|FG000|Overall Study|Adverse Event|2|||
131177013|NCT02365584|472268204|FG001|Overall Study|Adverse Event|2|||
131177014|NCT02365584|472268203|FG000|Overall Study|Withdrawal by Subject|1|||
131177015|NCT02365584|472268204|FG001|Overall Study|Withdrawal by Subject|0|||
131177016|NCT02365584|472268203|FG000|Overall Study|Disease Progression|9|||
131177017|NCT02365584|472268204|FG001|Overall Study|Disease Progression|12|||
131177018|NCT00349752|472268205|FG000|Overall Study|Adverse Event|8|||
131177019|NCT00349752|472268206|FG001|Overall Study|Adverse Event|12|||
131177020|NCT00349752|472268205|FG000|Overall Study|Lack of Efficacy|37|||
131177021|NCT00349752|472268206|FG001|Overall Study|Lack of Efficacy|42|||
131177022|NCT00349752|472268205|FG000|Overall Study|Lost to Follow-up|4|||
131177023|NCT00349752|472268206|FG001|Overall Study|Lost to Follow-up|2|||
131177024|NCT00349752|472268205|FG000|Overall Study|Personal reasons|6|||
131177025|NCT00349752|472268206|FG001|Overall Study|Personal reasons|5|||
131177026|NCT00349752|472268205|FG000|Overall Study|Other: Required exclusionary medication|0|||
131177027|NCT00349752|472268206|FG001|Overall Study|Other: Required exclusionary medication|1|||
131177028|NCT00349752|472268205|FG000|Overall Study|Other: Non compliance|0|||
131177029|NCT00349752|472268206|FG001|Overall Study|Other: Non compliance|1|||
131177030|NCT00349752|472268205|FG000|Overall Study|Other: Patient stopped steroids|0|||
131236975|NCT00950807|472495062|FG000|Washout Period 1|Adverse Event|2|||
131177031|NCT00349752|472268206|FG001|Overall Study|Other: Patient stopped steroids|1|||
131177032|NCT00349752|472268205|FG000|Overall Study|Other: Patient's steroid use|1|||
131177033|NCT00349752|472268206|FG001|Overall Study|Other: Patient's steroid use|0|||
131177034|NCT00349752|472268205|FG000|Overall Study|Other: Ineligible|1|||
131177035|NCT00349752|472268206|FG001|Overall Study|Other: Ineligible|0|||
131177036|NCT00349752|472268205|FG000|Overall Study|Other: Inadvertently unblinded|1|||
130782878|NCT05616013|470833190|FG003|Overall Study|Protocol Violation|0|||
130782879|NCT05616013|470833191|FG004|Overall Study|Protocol Violation|0|||
130782880|NCT05616013|470833192|FG005|Overall Study|Protocol Violation|0|||
130782881|NCT05616013|470833193|FG006|Overall Study|Protocol Violation|1|||
130782882|NCT05616013|470833194|FG007|Overall Study|Protocol Violation|0|||
130782883|NCT05616013|470833195|FG008|Overall Study|Protocol Violation|2|||
130782884|NCT05616013|470833187|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
131177037|NCT00349752|472268206|FG001|Overall Study|Other: Inadvertently unblinded|0|||
131236976|NCT00950807|472495063|FG001|Washout Period 1|Adverse Event|0|||
130782885|NCT05616013|470833188|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
130782886|NCT05616013|470833189|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
130782887|NCT05616013|470833190|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
130782888|NCT05616013|470833191|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
130782889|NCT05616013|470833192|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
130782890|NCT05616013|470833193|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
130782891|NCT05616013|470833194|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
130782892|NCT05616013|470833195|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
130782893|NCT05616013|470833187|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
130782894|NCT05616013|470833188|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130782895|NCT05616013|470833189|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130782896|NCT05616013|470833190|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130782897|NCT05616013|470833191|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130782898|NCT05616013|470833192|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130782899|NCT05616013|470833193|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130782900|NCT05616013|470833194|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130782901|NCT05616013|470833195|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130782902|NCT05616013|470833187|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
130782903|NCT05616013|470833188|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130782904|NCT05616013|470833189|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130782905|NCT05616013|470833190|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130782906|NCT05616013|470833191|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130782907|NCT05616013|470833192|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130782908|NCT05616013|470833193|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130782909|NCT05616013|470833194|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130782910|NCT05616013|470833195|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130782911|NCT05616013|470833187|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130782912|NCT05616013|470833188|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
130782913|NCT05616013|470833189|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130782914|NCT05616013|470833190|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130782915|NCT05616013|470833191|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130782916|NCT05616013|470833192|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
131177038|NCT00349752|472268205|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
131177039|NCT00349752|472268206|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
131177040|NCT01973452|472268207|FG000|Overall Study|Lack of Efficacy|0|||
131177041|NCT01973452|472268208|FG001|Overall Study|Lack of Efficacy|1|||
131177042|NCT01973452|472268207|FG000|Overall Study|Lost to Follow-up|1|||
131177043|NCT01973452|472268208|FG001|Overall Study|Lost to Follow-up|0|||
131177044|NCT01973452|472268207|FG000|Overall Study|Withdrawal by Subject|10|||
131177045|NCT01973452|472268208|FG001|Overall Study|Withdrawal by Subject|9|||
131177046|NCT01973452|472268207|FG000|Overall Study|Ineligible|1|||
131177047|NCT01973452|472268208|FG001|Overall Study|Ineligible|1|||
131177048|NCT01973452|472268207|FG000|Overall Study|Surgery canceled by participant|5|||
131177049|NCT01973452|472268208|FG001|Overall Study|Surgery canceled by participant|3|||
131177050|NCT05294211|472268214|FG000|Overall Study|Withdrawal by Subject|3|||
131177051|NCT05294211|472268214|FG000|Overall Study|Physician Decision|2|||
131177052|NCT05294211|472268214|FG000|Overall Study|Progressed to active labor|1|||
131177053|NCT05294211|472268214|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
131177054|NCT05294211|472268214|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
131177055|NCT00064350|472268215|FG000|Induction Treatment|Disease Progression|5|||
131177056|NCT00064350|472268216|FG001|Induction Treatment|Disease Progression|1|||
131177057|NCT00064350|472268217|FG002|Induction Treatment|Disease Progression|110|||
131236977|NCT00950807|472495064|FG002|Washout Period 1|Adverse Event|0|||
131177058|NCT00064350|472268215|FG000|Induction Treatment|Adverse Event|0|||
131177059|NCT00064350|472268216|FG001|Induction Treatment|Adverse Event|2|||
131177060|NCT00064350|472268217|FG002|Induction Treatment|Adverse Event|49|||
131177061|NCT00064350|472268215|FG000|Induction Treatment|Death|0|||
131177062|NCT00064350|472268216|FG001|Induction Treatment|Death|0|||
131177063|NCT00064350|472268217|FG002|Induction Treatment|Death|9|||
131177064|NCT00064350|472268215|FG000|Induction Treatment|Withdrawal by Subject|0|||
131177065|NCT00064350|472268216|FG001|Induction Treatment|Withdrawal by Subject|0|||
131177066|NCT00064350|472268217|FG002|Induction Treatment|Withdrawal by Subject|21|||
131177067|NCT00064350|472268215|FG000|Induction Treatment|Ineligible or never started treatment|3|||
131177068|NCT00064350|472268216|FG001|Induction Treatment|Ineligible or never started treatment|6|||
131177069|NCT00064350|472268217|FG002|Induction Treatment|Ineligible or never started treatment|34|||
131177070|NCT00064350|472268215|FG000|Induction Treatment|Other|0|||
131177071|NCT00064350|472268216|FG001|Induction Treatment|Other|0|||
131177072|NCT00064350|472268217|FG002|Induction Treatment|Other|13|||
131177073|NCT00064350|472268215|FG000|Randomization|Adverse Event|8|||
131177074|NCT00064350|472268216|FG001|Randomization|Adverse Event|3|||
131177075|NCT00064350|472268217|FG002|Randomization|Adverse Event|0|||
131177076|NCT00064350|472268215|FG000|Randomization|Death|3|||
131177077|NCT00064350|472268216|FG001|Randomization|Death|0|||
131177078|NCT00064350|472268217|FG002|Randomization|Death|0|||
131177079|NCT00064350|472268215|FG000|Randomization|Withdrawal by Subject|1|||
131177080|NCT00064350|472268216|FG001|Randomization|Withdrawal by Subject|0|||
131177081|NCT00064350|472268217|FG002|Randomization|Withdrawal by Subject|0|||
131177082|NCT00064350|472268215|FG000|Randomization|Ineligible or never started treatment|9|||
131177083|NCT00064350|472268216|FG001|Randomization|Ineligible or never started treatment|15|||
131177084|NCT00064350|472268217|FG002|Randomization|Ineligible or never started treatment|0|||
131177085|NCT00064350|472268215|FG000|Randomization|Other|5|||
131177086|NCT00064350|472268216|FG001|Randomization|Other|0|||
131177087|NCT00064350|472268217|FG002|Randomization|Other|0|||
131177088|NCT00064350|472268215|FG000|Cross-Over|Adverse Event|0|||
131177089|NCT00064350|472268216|FG001|Cross-Over|Adverse Event|1|||
131177090|NCT00064350|472268217|FG002|Cross-Over|Adverse Event|0|||
131177091|NCT00064350|472268215|FG000|Cross-Over|Death|1|||
131177092|NCT00064350|472268216|FG001|Cross-Over|Death|3|||
131177093|NCT00064350|472268217|FG002|Cross-Over|Death|0|||
131177094|NCT00064350|472268215|FG000|Cross-Over|Withdrawal by Subject|2|||
131177095|NCT00064350|472268216|FG001|Cross-Over|Withdrawal by Subject|2|||
131177096|NCT00064350|472268217|FG002|Cross-Over|Withdrawal by Subject|0|||
131177097|NCT00064350|472268215|FG000|Cross-Over|Ineligible or never started treatment|3|||
131177098|NCT00064350|472268216|FG001|Cross-Over|Ineligible or never started treatment|6|||
131177099|NCT00064350|472268217|FG002|Cross-Over|Ineligible or never started treatment|0|||
131177100|NCT00064350|472268215|FG000|Cross-Over|Other|0|||
131177101|NCT00064350|472268216|FG001|Cross-Over|Other|2|||
131177102|NCT00064350|472268217|FG002|Cross-Over|Other|0|||
131177103|NCT00838916|472268218|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
131177104|NCT00838916|472268219|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
131177105|NCT00838916|472268218|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
131177106|NCT00838916|472268219|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
131177107|NCT00838916|472268218|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
131177108|NCT00838916|472268219|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
131177109|NCT00838916|472268218|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
131177110|NCT00838916|472268219|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
131177111|NCT00838916|472268218|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
131177112|NCT00838916|472268219|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
131177113|NCT00838916|472268218|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
131177114|NCT00838916|472268219|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
131177115|NCT00838916|472268218|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
131177116|NCT00838916|472268219|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
131177117|NCT00838916|472268218|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
131177118|NCT00838916|472268219|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
131177119|NCT00838916|472268218|FG000|Treatment Period (156 Weeks)|Missing|3|||
131177120|NCT00838916|472268219|FG001|Treatment Period (156 Weeks)|Missing|1|||
131177121|NCT00838916|472268218|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
131177122|NCT00838916|472268219|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
131177123|NCT00838916|472268218|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
131177124|NCT00838916|472268219|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
131177125|NCT00838916|472268218|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
131177126|NCT00838916|472268219|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
131177127|NCT00838916|472268218|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
131177128|NCT00838916|472268219|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
131177129|NCT00838916|472268218|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
131177130|NCT00838916|472268219|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
131177131|NCT00838916|472268218|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
131177132|NCT00838916|472268219|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
131177133|NCT00838916|472268218|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
131177134|NCT00838916|472268219|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
131177135|NCT00838916|472268218|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
131177136|NCT00838916|472268219|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
131177137|NCT00838916|472268218|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
130782917|NCT05616013|470833193|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130782918|NCT05616013|470833194|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130782919|NCT05616013|470833195|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130782920|NCT05616013|470833187|FG000|Overall Study|Participant Decision, Time Constraints|0|||
130782921|NCT05616013|470833188|FG001|Overall Study|Participant Decision, Time Constraints|1|||
130782922|NCT05616013|470833189|FG002|Overall Study|Participant Decision, Time Constraints|0|||
130782923|NCT05616013|470833190|FG003|Overall Study|Participant Decision, Time Constraints|0|||
130782924|NCT05616013|470833191|FG004|Overall Study|Participant Decision, Time Constraints|0|||
130782925|NCT05616013|470833192|FG005|Overall Study|Participant Decision, Time Constraints|0|||
130782926|NCT05616013|470833193|FG006|Overall Study|Participant Decision, Time Constraints|0|||
130782927|NCT05616013|470833194|FG007|Overall Study|Participant Decision, Time Constraints|0|||
130782928|NCT05616013|470833195|FG008|Overall Study|Participant Decision, Time Constraints|0|||
130782929|NCT05616013|470833187|FG000|Overall Study|Prohibited Concomitant Medication|0|||
130782930|NCT05616013|470833188|FG001|Overall Study|Prohibited Concomitant Medication|0|||
130782931|NCT05616013|470833189|FG002|Overall Study|Prohibited Concomitant Medication|1|||
130782932|NCT05616013|470833190|FG003|Overall Study|Prohibited Concomitant Medication|0|||
130782933|NCT05616013|470833191|FG004|Overall Study|Prohibited Concomitant Medication|0|||
130782934|NCT05616013|470833192|FG005|Overall Study|Prohibited Concomitant Medication|0|||
130782935|NCT05616013|470833193|FG006|Overall Study|Prohibited Concomitant Medication|0|||
130782936|NCT05616013|470833194|FG007|Overall Study|Prohibited Concomitant Medication|0|||
130782937|NCT05616013|470833195|FG008|Overall Study|Prohibited Concomitant Medication|0|||
130782938|NCT05616013|470833187|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
130782939|NCT05616013|470833188|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
130782940|NCT05616013|470833189|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
130782941|NCT05616013|470833190|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
130782942|NCT05616013|470833191|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
130782943|NCT05616013|470833192|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
130782944|NCT05616013|470833193|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
130782945|NCT05616013|470833194|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
130782946|NCT05616013|470833195|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
130782947|NCT05616013|470833187|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130782948|NCT05616013|470833188|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130782949|NCT05616013|470833189|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130782950|NCT05616013|470833190|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
130782951|NCT05616013|470833191|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130782952|NCT05616013|470833192|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130782953|NCT05616013|470833193|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130782954|NCT05616013|470833194|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130782955|NCT05616013|470833195|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130782956|NCT05616013|470833187|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130782957|NCT05616013|470833188|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130782958|NCT05616013|470833189|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130782959|NCT05616013|470833190|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130782960|NCT05616013|470833191|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130782961|NCT05616013|470833192|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130782962|NCT05616013|470833193|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
130782963|NCT05616013|470833194|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130782964|NCT05616013|470833195|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130782965|NCT05616013|470833187|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130782966|NCT05616013|470833188|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130782967|NCT05616013|470833189|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130782968|NCT05616013|470833190|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130782969|NCT05616013|470833191|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130782970|NCT05616013|470833192|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130782971|NCT05616013|470833193|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130782972|NCT05616013|470833194|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
131236978|NCT00950807|472495065|FG003|Washout Period 1|Adverse Event|1|||
131236979|NCT00950807|472495066|FG004|Washout Period 1|Adverse Event|1|||
131236980|NCT00950807|472495067|FG005|Washout Period 1|Adverse Event|0|||
131236981|NCT00950807|472495068|FG006|Washout Period 1|Adverse Event|0|||
131236982|NCT00950807|472495069|FG007|Washout Period 1|Adverse Event|0|||
131236983|NCT00950807|472495070|FG008|Washout Period 1|Adverse Event|0|||
131236984|NCT00950807|472495071|FG009|Washout Period 1|Adverse Event|0|||
131236985|NCT00950807|472495062|FG000|Treatment Period 2|Lack of Efficacy|1|||
131236986|NCT00950807|472495063|FG001|Treatment Period 2|Lack of Efficacy|0|||
131236987|NCT00950807|472495064|FG002|Treatment Period 2|Lack of Efficacy|0|||
131236988|NCT00950807|472495065|FG003|Treatment Period 2|Lack of Efficacy|0|||
131236989|NCT00950807|472495066|FG004|Treatment Period 2|Lack of Efficacy|0|||
131236990|NCT00950807|472495067|FG005|Treatment Period 2|Lack of Efficacy|0|||
131236991|NCT00950807|472495068|FG006|Treatment Period 2|Lack of Efficacy|0|||
131236992|NCT00950807|472495069|FG007|Treatment Period 2|Lack of Efficacy|0|||
131236993|NCT00950807|472495070|FG008|Treatment Period 2|Lack of Efficacy|0|||
131236994|NCT00950807|472495071|FG009|Treatment Period 2|Lack of Efficacy|0|||
131236995|NCT00950807|472495062|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131236996|NCT00950807|472495063|FG001|Treatment Period 2|Withdrawal by Subject|0|||
131236997|NCT00950807|472495064|FG002|Treatment Period 2|Withdrawal by Subject|0|||
131236998|NCT00950807|472495065|FG003|Treatment Period 2|Withdrawal by Subject|0|||
131236999|NCT00950807|472495066|FG004|Treatment Period 2|Withdrawal by Subject|0|||
131237000|NCT00950807|472495067|FG005|Treatment Period 2|Withdrawal by Subject|0|||
131237001|NCT00950807|472495068|FG006|Treatment Period 2|Withdrawal by Subject|1|||
131237002|NCT00950807|472495069|FG007|Treatment Period 2|Withdrawal by Subject|2|||
131237003|NCT00950807|472495070|FG008|Treatment Period 2|Withdrawal by Subject|0|||
131237004|NCT00950807|472495071|FG009|Treatment Period 2|Withdrawal by Subject|0|||
131237005|NCT00950807|472495062|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
131237006|NCT00950807|472495063|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131237007|NCT00950807|472495064|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131237008|NCT00950807|472495065|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131237009|NCT00950807|472495066|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131237010|NCT00950807|472495067|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131237011|NCT00950807|472495068|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131237012|NCT00950807|472495069|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131237013|NCT00950807|472495070|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131237014|NCT00950807|472495071|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
131237015|NCT00950807|472495062|FG000|Treatment Period 2|Adverse Event|0|||
131237016|NCT00950807|472495063|FG001|Treatment Period 2|Adverse Event|1|||
131237017|NCT00950807|472495064|FG002|Treatment Period 2|Adverse Event|0|||
131237018|NCT00950807|472495065|FG003|Treatment Period 2|Adverse Event|1|||
131237019|NCT00950807|472495066|FG004|Treatment Period 2|Adverse Event|0|||
131237020|NCT00950807|472495067|FG005|Treatment Period 2|Adverse Event|1|||
131237021|NCT00950807|472495068|FG006|Treatment Period 2|Adverse Event|0|||
131237022|NCT00950807|472495069|FG007|Treatment Period 2|Adverse Event|1|||
131237023|NCT00950807|472495070|FG008|Treatment Period 2|Adverse Event|0|||
131237024|NCT00950807|472495071|FG009|Treatment Period 2|Adverse Event|0|||
131237025|NCT00950807|472495062|FG000|Washout Period 2|Lack of Efficacy|1|||
131237026|NCT00950807|472495063|FG001|Washout Period 2|Lack of Efficacy|0|||
131237027|NCT00950807|472495064|FG002|Washout Period 2|Lack of Efficacy|0|||
131237028|NCT00950807|472495065|FG003|Washout Period 2|Lack of Efficacy|0|||
131237029|NCT00950807|472495066|FG004|Washout Period 2|Lack of Efficacy|0|||
131237030|NCT00950807|472495067|FG005|Washout Period 2|Lack of Efficacy|0|||
131237031|NCT00950807|472495068|FG006|Washout Period 2|Lack of Efficacy|0|||
131237032|NCT00950807|472495069|FG007|Washout Period 2|Lack of Efficacy|0|||
131237033|NCT00950807|472495070|FG008|Washout Period 2|Lack of Efficacy|0|||
131237034|NCT00950807|472495071|FG009|Washout Period 2|Lack of Efficacy|0|||
131237035|NCT00950807|472495062|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131237036|NCT00950807|472495063|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
131237037|NCT00950807|472495064|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131237038|NCT00950807|472495065|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131237039|NCT00950807|472495066|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
131237040|NCT00950807|472495067|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131237041|NCT00950807|472495068|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
131237042|NCT00950807|472495069|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
131237043|NCT00950807|472495070|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131237044|NCT00950807|472495071|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
131237045|NCT00950807|472495062|FG000|Washout Period 2|Adverse Event|3|||
131237046|NCT00950807|472495063|FG001|Washout Period 2|Adverse Event|0|||
131237047|NCT00950807|472495064|FG002|Washout Period 2|Adverse Event|0|||
131237048|NCT00950807|472495065|FG003|Washout Period 2|Adverse Event|1|||
131237049|NCT00950807|472495066|FG004|Washout Period 2|Adverse Event|0|||
131237050|NCT00950807|472495067|FG005|Washout Period 2|Adverse Event|0|||
131237051|NCT00950807|472495068|FG006|Washout Period 2|Adverse Event|0|||
131237052|NCT00950807|472495069|FG007|Washout Period 2|Adverse Event|0|||
131237053|NCT00950807|472495070|FG008|Washout Period 2|Adverse Event|0|||
131237054|NCT00950807|472495071|FG009|Washout Period 2|Adverse Event|0|||
131237055|NCT00950807|472495062|FG000|Treatment Period 3|Withdrawal by Subject|0|||
131237056|NCT00950807|472495063|FG001|Treatment Period 3|Withdrawal by Subject|0|||
131237057|NCT00950807|472495064|FG002|Treatment Period 3|Withdrawal by Subject|0|||
131237058|NCT00950807|472495065|FG003|Treatment Period 3|Withdrawal by Subject|0|||
131237059|NCT00950807|472495066|FG004|Treatment Period 3|Withdrawal by Subject|0|||
131237060|NCT00950807|472495067|FG005|Treatment Period 3|Withdrawal by Subject|0|||
131237061|NCT00950807|472495068|FG006|Treatment Period 3|Withdrawal by Subject|0|||
131237062|NCT00950807|472495069|FG007|Treatment Period 3|Withdrawal by Subject|0|||
131237063|NCT00950807|472495070|FG008|Treatment Period 3|Withdrawal by Subject|0|||
131237064|NCT00950807|472495071|FG009|Treatment Period 3|Withdrawal by Subject|1|||
131237065|NCT00950807|472495062|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
131237066|NCT00950807|472495063|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131237067|NCT00950807|472495064|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131237068|NCT00950807|472495065|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131237069|NCT00950807|472495066|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131237070|NCT00950807|472495067|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131237071|NCT00950807|472495068|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131237072|NCT00950807|472495069|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
131237073|NCT00950807|472495070|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131237074|NCT00950807|472495071|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
131237075|NCT00950807|472495062|FG000|Treatment Period 3|Adverse Event|0|||
131237076|NCT00950807|472495063|FG001|Treatment Period 3|Adverse Event|0|||
131237077|NCT00950807|472495064|FG002|Treatment Period 3|Adverse Event|0|||
131237078|NCT00950807|472495065|FG003|Treatment Period 3|Adverse Event|0|||
131237079|NCT00950807|472495066|FG004|Treatment Period 3|Adverse Event|0|||
131237080|NCT00950807|472495067|FG005|Treatment Period 3|Adverse Event|0|||
131237081|NCT00950807|472495068|FG006|Treatment Period 3|Adverse Event|1|||
131237082|NCT00950807|472495069|FG007|Treatment Period 3|Adverse Event|0|||
131237083|NCT00950807|472495070|FG008|Treatment Period 3|Adverse Event|0|||
131237084|NCT00950807|472495071|FG009|Treatment Period 3|Adverse Event|0|||
131237085|NCT00337077|472495072|FG000|Overall Study|Progressive disease|25|||
131237086|NCT00337077|472495073|FG001|Overall Study|Progressive disease|37|||
131237087|NCT00337077|472495074|FG002|Overall Study|Progressive disease|19|||
131237088|NCT00337077|472495072|FG000|Overall Study|Adverse Event|7|||
131237089|NCT00337077|472495073|FG001|Overall Study|Adverse Event|7|||
131237090|NCT00337077|472495074|FG002|Overall Study|Adverse Event|1|||
131237091|NCT00337077|472495072|FG000|Overall Study|Death|0|||
131237092|NCT00337077|472495073|FG001|Overall Study|Death|1|||
131237093|NCT00337077|472495074|FG002|Overall Study|Death|0|||
131237094|NCT00337077|472495072|FG000|Overall Study|Withdrawal by Subject|7|||
131237095|NCT00337077|472495073|FG001|Overall Study|Withdrawal by Subject|2|||
131237096|NCT00337077|472495074|FG002|Overall Study|Withdrawal by Subject|2|||
131237097|NCT00337077|472495072|FG000|Overall Study|Alternative therapy|1|||
131237098|NCT00337077|472495073|FG001|Overall Study|Alternative therapy|0|||
131237099|NCT00337077|472495074|FG002|Overall Study|Alternative therapy|0|||
131237100|NCT00337077|472495072|FG000|Overall Study|Physician Decision|1|||
131237101|NCT00337077|472495073|FG001|Overall Study|Physician Decision|4|||
131237102|NCT00337077|472495074|FG002|Overall Study|Physician Decision|2|||
131237103|NCT00337077|472495072|FG000|Overall Study|Never started treatment|1|||
131237104|NCT00337077|472495073|FG001|Overall Study|Never started treatment|1|||
131177138|NCT00838916|472268219|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
131177139|NCT00838916|472268218|FG000|Follow-up Period (8 Weeks)|Missing|3|||
131177140|NCT00838916|472268219|FG001|Follow-up Period (8 Weeks)|Missing|0|||
131177141|NCT01842607|472268220|FG000|Overall Study|Adverse Event|11|||
131177142|NCT01842607|472268220|FG000|Overall Study|Lack of Efficacy|19|||
131177143|NCT01842607|472268220|FG000|Overall Study|Protocol Violation|8|||
131177144|NCT01842607|472268220|FG000|Overall Study|Protocol defined stopping criteria|2|||
131177145|NCT01842607|472268220|FG000|Overall Study|Lost to Follow-up|3|||
131177146|NCT01842607|472268220|FG000|Overall Study|Physician Decision|9|||
131177147|NCT01842607|472268220|FG000|Overall Study|Withdrawal by Subject|14|||
131177148|NCT01927419|472268221|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
131177149|NCT01927419|472268222|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
131177150|NCT01927419|472268221|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
131177151|NCT01927419|472268222|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
131237105|NCT00337077|472495074|FG002|Overall Study|Never started treatment|0|||
131237106|NCT00337077|472495072|FG000|Overall Study|Ineligible|1|||
131237107|NCT00337077|472495073|FG001|Overall Study|Ineligible|1|||
131237108|NCT00337077|472495074|FG002|Overall Study|Ineligible|1|||
131237109|NCT04803357|472495081|FG000|Overall Study|Withdrawal by Subject|31|||
131237110|NCT04803357|472495082|FG001|Overall Study|Withdrawal by Subject|5|||
131237111|NCT00182091|472495083|FG000|Overall Study|Withdrawal by Subject|1|||
131237112|NCT00182091|472495084|FG001|Overall Study|Withdrawal by Subject|0|||
131237113|NCT00182091|472495085|FG002|Overall Study|Withdrawal by Subject|0|||
131177152|NCT01927419|472268221|FG000|Treatment Period|Disease progression|17|||
131177153|NCT01927419|472268222|FG001|Treatment Period|Disease progression|20|||
131237114|NCT00182091|472495086|FG003|Overall Study|Withdrawal by Subject|0|||
130782973|NCT05616013|470833195|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
130782974|NCT05616013|470833187|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
130782975|NCT05616013|470833188|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
130782976|NCT05616013|470833189|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
130782977|NCT05616013|470833190|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
130782978|NCT05616013|470833191|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
130782979|NCT05616013|470833192|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
130782980|NCT05616013|470833193|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
130782981|NCT05616013|470833194|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
130782982|NCT05616013|470833195|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
130782983|NCT05116202|470833196|FG000|Overall Study|Study Terminated by Sponsor|21|||
130782984|NCT05116202|470833197|FG001|Overall Study|Study Terminated by Sponsor|38|||
130782985|NCT05116202|470833198|FG002|Overall Study|Study Terminated by Sponsor|17|||
130782986|NCT05116202|470833199|FG003|Overall Study|Study Terminated by Sponsor|18|||
130782987|NCT05116202|470833200|FG004|Overall Study|Study Terminated by Sponsor|0|||
130782988|NCT05116202|470833196|FG000|Overall Study|Withdrawal by Subject|0|||
130782989|NCT05116202|470833197|FG001|Overall Study|Withdrawal by Subject|1|||
130782990|NCT05116202|470833198|FG002|Overall Study|Withdrawal by Subject|1|||
130782991|NCT05116202|470833199|FG003|Overall Study|Withdrawal by Subject|1|||
130782992|NCT05116202|470833200|FG004|Overall Study|Withdrawal by Subject|1|||
130782993|NCT05116202|470833196|FG000|Overall Study|Lost to Follow-up|0|||
130782994|NCT05116202|470833197|FG001|Overall Study|Lost to Follow-up|0|||
130782995|NCT05116202|470833198|FG002|Overall Study|Lost to Follow-up|0|||
130782996|NCT05116202|470833199|FG003|Overall Study|Lost to Follow-up|0|||
130782997|NCT05116202|470833200|FG004|Overall Study|Lost to Follow-up|2|||
130782998|NCT05116202|470833196|FG000|Overall Study|Death|1|||
130782999|NCT05116202|470833197|FG001|Overall Study|Death|1|||
130783000|NCT05116202|470833198|FG002|Overall Study|Death|2|||
130783001|NCT05116202|470833199|FG003|Overall Study|Death|1|||
130783002|NCT05116202|470833200|FG004|Overall Study|Death|5|||
131177154|NCT01927419|472268221|FG000|Treatment Period|Study drug toxicity|48|||
131177155|NCT01927419|472268222|FG001|Treatment Period|Study drug toxicity|10|||
131177156|NCT01927419|472268221|FG000|Treatment Period|Death|0|||
131177157|NCT01927419|472268222|FG001|Treatment Period|Death|1|||
131177158|NCT01927419|472268221|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
131177159|NCT01927419|472268222|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
131177160|NCT01927419|472268221|FG000|Treatment Period|Participant request to discontinue|12|||
131177161|NCT01927419|472268222|FG001|Treatment Period|Participant request to discontinue|4|||
131177162|NCT01927419|472268221|FG000|Treatment Period|Withdrawal by Subject|1|||
131177163|NCT01927419|472268222|FG001|Treatment Period|Withdrawal by Subject|1|||
131177164|NCT01927419|472268221|FG000|Treatment Period|Maximum Clinical Benefit|6|||
131177165|NCT01927419|472268222|FG001|Treatment Period|Maximum Clinical Benefit|2|||
131177166|NCT01927419|472268221|FG000|Treatment Period|Other reasons|3|||
131177167|NCT01927419|472268222|FG001|Treatment Period|Other reasons|4|||
131177168|NCT01927419|472268221|FG000|Treatment Period|Not Reported|1|||
131177169|NCT01927419|472268222|FG001|Treatment Period|Not Reported|1|||
131177170|NCT03488251|472268223|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
131177171|NCT03488251|472268224|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
131177172|NCT03488251|472268225|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
131177173|NCT03488251|472268226|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
131177174|NCT03488251|472268223|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
131177175|NCT03488251|472268224|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
131177176|NCT03488251|472268225|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
131177177|NCT03488251|472268226|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
131177178|NCT03488251|472268223|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
131177179|NCT03488251|472268224|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
131177180|NCT03488251|472268225|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
131177181|NCT03488251|472268226|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
131177182|NCT03488251|472268223|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
131177183|NCT03488251|472268224|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
131177184|NCT03488251|472268225|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
131177185|NCT03488251|472268226|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
131177186|NCT03488251|472268223|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
130783003|NCT03834506|470833201|FG000|Overall Study|Death|336|||
130783004|NCT03834506|470833202|FG001|Overall Study|Death|326|||
130783005|NCT03834506|470833201|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130783006|NCT03834506|470833202|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130783007|NCT03834506|470833201|FG000|Overall Study|Withdrawal by Subject|10|||
131177187|NCT03488251|472268224|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
131177188|NCT03488251|472268225|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
131177189|NCT03488251|472268226|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
131177190|NCT03600714|472268227|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
131177191|NCT02379390|472268228|FG000|Overall Study|Adverse Event|1|||
131177192|NCT02379390|472268229|FG001|Overall Study|Adverse Event|1|||
131177193|NCT02379390|472268228|FG000|Overall Study|Investigator's decision|1|||
131177194|NCT02379390|472268229|FG001|Overall Study|Investigator's decision|0|||
131177195|NCT02379390|472268228|FG000|Overall Study|Study Termination|0|||
131177196|NCT02379390|472268229|FG001|Overall Study|Study Termination|1|||
131177197|NCT01244191|472268230|FG000|Overall Study|Progressive disease|295|||
131177198|NCT01244191|472268231|FG001|Overall Study|Progressive disease|350|||
131177199|NCT01244191|472268230|FG000|Overall Study|Clinical disease progression|54|||
131177200|NCT01244191|472268231|FG001|Overall Study|Clinical disease progression|36|||
131177201|NCT01244191|472268230|FG000|Overall Study|Adverse Event|65|||
131177202|NCT01244191|472268231|FG001|Overall Study|Adverse Event|48|||
131177203|NCT01244191|472268230|FG000|Overall Study|Death|22|||
131177204|NCT01244191|472268231|FG001|Overall Study|Death|29|||
131177205|NCT01244191|472268230|FG000|Overall Study|Lost to Follow-up|0|||
131177206|NCT01244191|472268231|FG001|Overall Study|Lost to Follow-up|2|||
131177207|NCT01244191|472268230|FG000|Overall Study|Protocol Violation|1|||
131177208|NCT01244191|472268231|FG001|Overall Study|Protocol Violation|2|||
131177209|NCT01244191|472268230|FG000|Overall Study|Withdrawal by Subject|31|||
131177210|NCT01244191|472268231|FG001|Overall Study|Withdrawal by Subject|23|||
131177211|NCT01244191|472268230|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
131177212|NCT01244191|472268231|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
131177213|NCT02164513|472268232|FG000|Overall Study|Adverse Event|162|||
131177214|NCT02164513|472268233|FG001|Overall Study|Adverse Event|180|||
131177215|NCT02164513|472268234|FG002|Overall Study|Adverse Event|111|||
131177216|NCT02164513|472268232|FG000|Overall Study|Other: Study Closed or terminated|5|||
131177217|NCT02164513|472268233|FG001|Overall Study|Other: Study Closed or terminated|2|||
131177218|NCT02164513|472268234|FG002|Overall Study|Other: Study Closed or terminated|4|||
131177219|NCT02164513|472268232|FG000|Overall Study|Lost to Follow-up|30|||
131177220|NCT02164513|472268233|FG001|Overall Study|Lost to Follow-up|36|||
131177221|NCT02164513|472268234|FG002|Overall Study|Lost to Follow-up|22|||
131177222|NCT02164513|472268232|FG000|Overall Study|Physician Decision|47|||
131177223|NCT02164513|472268233|FG001|Overall Study|Physician Decision|57|||
131177224|NCT02164513|472268234|FG002|Overall Study|Physician Decision|28|||
131177225|NCT02164513|472268232|FG000|Overall Study|Withdrawal by Subject|192|||
131177226|NCT02164513|472268233|FG001|Overall Study|Withdrawal by Subject|261|||
131177227|NCT02164513|472268234|FG002|Overall Study|Withdrawal by Subject|130|||
131177228|NCT02164513|472268232|FG000|Overall Study|Other: Reason not provided by site|1|||
131177229|NCT02164513|472268233|FG001|Overall Study|Other: Reason not provided by site|0|||
131177230|NCT02164513|472268234|FG002|Overall Study|Other: Reason not provided by site|0|||
131177231|NCT02509494|472268242|FG000|Overall Study|Lost to Follow-up|8|||
131177232|NCT02509494|472268243|FG001|Overall Study|Lost to Follow-up|47|||
131177233|NCT02509494|472268244|FG002|Overall Study|Lost to Follow-up|19|||
131177234|NCT02509494|472268245|FG003|Overall Study|Lost to Follow-up|6|||
131177235|NCT02509494|472268246|FG004|Overall Study|Lost to Follow-up|3|||
131177236|NCT02509494|472268247|FG005|Overall Study|Lost to Follow-up|3|||
131177237|NCT02509494|472268248|FG006|Overall Study|Lost to Follow-up|1|||
131177238|NCT02509494|472268249|FG007|Overall Study|Lost to Follow-up|3|||
131177239|NCT02509494|472268250|FG008|Overall Study|Lost to Follow-up|1|||
131177240|NCT02509494|472268242|FG000|Overall Study|Physician Decision|2|||
131177241|NCT02509494|472268243|FG001|Overall Study|Physician Decision|1|||
131177242|NCT02509494|472268244|FG002|Overall Study|Physician Decision|0|||
131177243|NCT02509494|472268245|FG003|Overall Study|Physician Decision|0|||
131177244|NCT02509494|472268246|FG004|Overall Study|Physician Decision|0|||
131177245|NCT02509494|472268247|FG005|Overall Study|Physician Decision|0|||
131177246|NCT02509494|472268248|FG006|Overall Study|Physician Decision|0|||
131177247|NCT02509494|472268249|FG007|Overall Study|Physician Decision|0|||
131177248|NCT02509494|472268250|FG008|Overall Study|Physician Decision|0|||
131177249|NCT02509494|472268242|FG000|Overall Study|Withdrawal by Subject|4|||
131177250|NCT02509494|472268243|FG001|Overall Study|Withdrawal by Subject|17|||
131177251|NCT02509494|472268244|FG002|Overall Study|Withdrawal by Subject|7|||
131177252|NCT02509494|472268245|FG003|Overall Study|Withdrawal by Subject|5|||
131177253|NCT02509494|472268246|FG004|Overall Study|Withdrawal by Subject|0|||
131177254|NCT02509494|472268247|FG005|Overall Study|Withdrawal by Subject|6|||
131177255|NCT02509494|472268248|FG006|Overall Study|Withdrawal by Subject|1|||
131177256|NCT02509494|472268249|FG007|Overall Study|Withdrawal by Subject|2|||
131177257|NCT02509494|472268250|FG008|Overall Study|Withdrawal by Subject|1|||
131177258|NCT02509494|472268242|FG000|Overall Study|Death|0|||
131177259|NCT02509494|472268243|FG001|Overall Study|Death|1|||
131177260|NCT02509494|472268244|FG002|Overall Study|Death|0|||
131177261|NCT02509494|472268245|FG003|Overall Study|Death|0|||
131177262|NCT02509494|472268246|FG004|Overall Study|Death|1|||
131177263|NCT02509494|472268247|FG005|Overall Study|Death|0|||
131177264|NCT02509494|472268248|FG006|Overall Study|Death|0|||
131177265|NCT02509494|472268249|FG007|Overall Study|Death|1|||
131177266|NCT02509494|472268250|FG008|Overall Study|Death|0|||
131177267|NCT02509494|472268242|FG000|Overall Study|Other|0|||
131177268|NCT02509494|472268243|FG001|Overall Study|Other|4|||
131177269|NCT02509494|472268244|FG002|Overall Study|Other|5|||
131177270|NCT02509494|472268245|FG003|Overall Study|Other|0|||
131177271|NCT02509494|472268246|FG004|Overall Study|Other|0|||
131177272|NCT02509494|472268247|FG005|Overall Study|Other|0|||
131177273|NCT02509494|472268248|FG006|Overall Study|Other|0|||
131177274|NCT02509494|472268249|FG007|Overall Study|Other|0|||
131177275|NCT02509494|472268250|FG008|Overall Study|Other|0|||
131177276|NCT02509494|472268242|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131177277|NCT02509494|472268243|FG001|Overall Study|Non-Compliance With Study Drug|11|||
131177278|NCT02509494|472268244|FG002|Overall Study|Non-Compliance With Study Drug|7|||
131177279|NCT02509494|472268245|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131177280|NCT02509494|472268246|FG004|Overall Study|Non-Compliance With Study Drug|1|||
131177281|NCT02509494|472268247|FG005|Overall Study|Non-Compliance With Study Drug|2|||
131177282|NCT02509494|472268248|FG006|Overall Study|Non-Compliance With Study Drug|1|||
131177283|NCT02509494|472268249|FG007|Overall Study|Non-Compliance With Study Drug|1|||
131177284|NCT02509494|472268250|FG008|Overall Study|Non-Compliance With Study Drug|0|||
131177285|NCT01511107|472268251|FG000|Overall Study|Ineligible|3|||
131177286|NCT01511107|472268252|FG001|Overall Study|Ineligible|2|||
131177287|NCT01511107|472268251|FG000|Overall Study|Lost to Follow-up|10|||
131177288|NCT01511107|472268252|FG001|Overall Study|Lost to Follow-up|19|||
131177289|NCT01511107|472268251|FG000|Overall Study|Withdrawal by Subject|9|||
131177290|NCT01511107|472268252|FG001|Overall Study|Withdrawal by Subject|20|||
131177291|NCT00369967|472270084|FG000|Overall Study|Lost to Follow-up|23|||
131177292|NCT00369967|472270085|FG001|Overall Study|Lost to Follow-up|12|||
131177293|NCT03225716|472270091|FG000|Overall Study|Withdrawal by Subject|2|||
131177294|NCT03225716|472270092|FG001|Overall Study|Withdrawal by Subject|2|||
131177295|NCT03225716|472270093|FG002|Overall Study|Withdrawal by Subject|0|||
131177296|NCT03225716|472270091|FG000|Overall Study|Lack of Efficacy|1|||
131177297|NCT03225716|472270092|FG001|Overall Study|Lack of Efficacy|0|||
131177298|NCT03225716|472270093|FG002|Overall Study|Lack of Efficacy|0|||
131177299|NCT03225716|472270091|FG000|Overall Study|Adverse Event|2|||
131177300|NCT03225716|472270092|FG001|Overall Study|Adverse Event|0|||
131177301|NCT03225716|472270093|FG002|Overall Study|Adverse Event|1|||
131177302|NCT03225716|472270091|FG000|Overall Study|Study early termination by Sponsor|0|||
131177303|NCT03225716|472270092|FG001|Overall Study|Study early termination by Sponsor|0|||
131177304|NCT03225716|472270093|FG002|Overall Study|Study early termination by Sponsor|2|||
131177305|NCT01107405|472270094|FG000|Overall Study|Adverse Event|1|||
131177306|NCT01107405|472270095|FG001|Overall Study|Adverse Event|1|||
131177307|NCT01107405|472270096|FG002|Overall Study|Adverse Event|0|||
131177308|NCT01107405|472270097|FG003|Overall Study|Adverse Event|0|||
131177309|NCT01107405|472270098|FG004|Overall Study|Adverse Event|2|||
131177310|NCT01107405|472270094|FG000|Overall Study|Withdrawal by Subject|1|||
131177311|NCT01107405|472270095|FG001|Overall Study|Withdrawal by Subject|0|||
131177312|NCT01107405|472270096|FG002|Overall Study|Withdrawal by Subject|1|||
131177313|NCT01107405|472270097|FG003|Overall Study|Withdrawal by Subject|2|||
131177314|NCT01107405|472270098|FG004|Overall Study|Withdrawal by Subject|1|||
131177315|NCT01107405|472270094|FG000|Overall Study|Protocol Violation|0|||
131177316|NCT01107405|472270095|FG001|Overall Study|Protocol Violation|0|||
131177317|NCT01107405|472270096|FG002|Overall Study|Protocol Violation|1|||
131177318|NCT01107405|472270097|FG003|Overall Study|Protocol Violation|1|||
131177319|NCT01107405|472270098|FG004|Overall Study|Protocol Violation|0|||
131177320|NCT01895452|472270102|FG000|Overall Study|Adverse Event|1|||
131177321|NCT01895452|472270103|FG001|Overall Study|Adverse Event|4|||
131177322|NCT01895452|472270102|FG000|Overall Study|Lost to Follow-up|1|||
131177323|NCT01895452|472270103|FG001|Overall Study|Lost to Follow-up|5|||
131177324|NCT01895452|472270102|FG000|Overall Study|Pregnancy|0|||
131177325|NCT01895452|472270103|FG001|Overall Study|Pregnancy|1|||
131177326|NCT01895452|472270102|FG000|Overall Study|Withdrawal by Subject|2|||
131177327|NCT01895452|472270103|FG001|Overall Study|Withdrawal by Subject|14|||
131177328|NCT01895452|472270102|FG000|Overall Study|Underlying disease|0|||
131177329|NCT01895452|472270103|FG001|Overall Study|Underlying disease|3|||
131177330|NCT01895452|472270102|FG000|Overall Study|Noncompliance with study drug|0|||
131177331|NCT01895452|472270103|FG001|Overall Study|Noncompliance with study drug|1|||
131177332|NCT01653158|472270104|FG000|Overall Study|Death|0|||
131177333|NCT01653158|472270105|FG001|Overall Study|Death|0|||
131177334|NCT01653158|472270106|FG002|Overall Study|Death|0|||
131177335|NCT01653158|472270107|FG003|Overall Study|Death|1|||
131177336|NCT01653158|472270108|FG004|Overall Study|Death|0|||
131177337|NCT01653158|472270109|FG005|Overall Study|Death|0|||
131177338|NCT01653158|472270110|FG006|Overall Study|Death|0|||
131177339|NCT01653158|472270111|FG007|Overall Study|Death|2|||
131177340|NCT01653158|472270104|FG000|Overall Study|Adverse Event|0|||
131177341|NCT01653158|472270105|FG001|Overall Study|Adverse Event|0|||
131177342|NCT01653158|472270106|FG002|Overall Study|Adverse Event|0|||
131177343|NCT01653158|472270107|FG003|Overall Study|Adverse Event|1|||
131177344|NCT01653158|472270108|FG004|Overall Study|Adverse Event|0|||
131177345|NCT01653158|472270109|FG005|Overall Study|Adverse Event|0|||
131177346|NCT01653158|472270110|FG006|Overall Study|Adverse Event|0|||
130783008|NCT03834506|470833202|FG001|Overall Study|Withdrawal by Subject|8|||
130783009|NCT03834506|470833201|FG000|Overall Study|Sponsor decision|165|||
130783010|NCT03834506|470833202|FG001|Overall Study|Sponsor decision|178|||
130783011|NCT03834506|470833201|FG000|Overall Study|Physician Decision|3|||
130783012|NCT03834506|470833202|FG001|Overall Study|Physician Decision|1|||
130783013|NCT03834506|470833201|FG000|Overall Study|Lost to Follow-up|0|||
130783014|NCT03834506|470833202|FG001|Overall Study|Lost to Follow-up|1|||
130783015|NCT05067972|470833203|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
130783016|NCT05067972|470833204|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
130783017|NCT05067972|470833205|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
130783018|NCT05067972|470833206|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
130783019|NCT05067972|470833207|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
130783020|NCT05067972|470833208|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
130783021|NCT05067972|470833209|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
130783022|NCT05067972|470833203|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
130783023|NCT05067972|470833204|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
130783024|NCT05067972|470833205|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
131177347|NCT01653158|472270111|FG007|Overall Study|Adverse Event|3|||
131177348|NCT01653158|472270104|FG000|Overall Study|Other|0|||
131177349|NCT01653158|472270105|FG001|Overall Study|Other|0|||
131177350|NCT01653158|472270106|FG002|Overall Study|Other|0|||
131177351|NCT01653158|472270107|FG003|Overall Study|Other|0|||
131177352|NCT01653158|472270108|FG004|Overall Study|Other|0|||
131177353|NCT01653158|472270109|FG005|Overall Study|Other|0|||
131177354|NCT01653158|472270110|FG006|Overall Study|Other|0|||
131177355|NCT01653158|472270111|FG007|Overall Study|Other|1|||
131177356|NCT01653158|472270104|FG000|Overall Study|Progressive disease|0|||
131177357|NCT01653158|472270105|FG001|Overall Study|Progressive disease|0|||
131177358|NCT01653158|472270106|FG002|Overall Study|Progressive disease|0|||
131177359|NCT01653158|472270107|FG003|Overall Study|Progressive disease|0|||
131177360|NCT01653158|472270108|FG004|Overall Study|Progressive disease|1|||
131177361|NCT01653158|472270109|FG005|Overall Study|Progressive disease|1|||
131177362|NCT01653158|472270110|FG006|Overall Study|Progressive disease|2|||
131177363|NCT01653158|472270111|FG007|Overall Study|Progressive disease|9|||
131177364|NCT01653158|472270104|FG000|Overall Study|Withdrawal by Subject|1|||
131177365|NCT01653158|472270105|FG001|Overall Study|Withdrawal by Subject|0|||
131177366|NCT01653158|472270106|FG002|Overall Study|Withdrawal by Subject|0|||
131177367|NCT01653158|472270107|FG003|Overall Study|Withdrawal by Subject|0|||
131177368|NCT01653158|472270108|FG004|Overall Study|Withdrawal by Subject|0|||
131177369|NCT01653158|472270109|FG005|Overall Study|Withdrawal by Subject|0|||
131177370|NCT01653158|472270110|FG006|Overall Study|Withdrawal by Subject|0|||
131177371|NCT01653158|472270111|FG007|Overall Study|Withdrawal by Subject|0|||
131177372|NCT00980343|472270114|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
131177373|NCT00980343|472270115|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
131177374|NCT01194869|472270120|FG000|Overall Study|Disease Progression|2|||
131177375|NCT01194869|472270120|FG000|Overall Study|Toxicity|2|||
131177376|NCT04321252|472270121|FG000|Overall Study|Withdrawal by Subject|0|||
131177377|NCT04321252|472270122|FG001|Overall Study|Withdrawal by Subject|0|||
131177378|NCT04321252|472270123|FG002|Overall Study|Withdrawal by Subject|0|||
131177379|NCT04321252|472270124|FG003|Overall Study|Withdrawal by Subject|0|||
131177380|NCT04321252|472270125|FG004|Overall Study|Withdrawal by Subject|0|||
131177381|NCT04321252|472270126|FG005|Overall Study|Withdrawal by Subject|1|||
131177382|NCT04321252|472270127|FG006|Overall Study|Withdrawal by Subject|0|||
131177383|NCT04321252|472270128|FG007|Overall Study|Withdrawal by Subject|0|||
131177384|NCT04321252|472270129|FG008|Overall Study|Withdrawal by Subject|0|||
131177385|NCT03004469|472270130|FG000|Overall Study|Adverse Event|6|||
131177386|NCT03004469|472270131|FG001|Overall Study|Adverse Event|4|||
131177387|NCT03004469|472270132|FG002|Overall Study|Adverse Event|6|||
131177388|NCT03004469|472270130|FG000|Overall Study|Lack of Efficacy|1|||
131177389|NCT03004469|472270131|FG001|Overall Study|Lack of Efficacy|0|||
131177390|NCT03004469|472270132|FG002|Overall Study|Lack of Efficacy|1|||
131177391|NCT03004469|472270130|FG000|Overall Study|Lost to Follow-up|23|||
131177392|NCT03004469|472270131|FG001|Overall Study|Lost to Follow-up|14|||
131177393|NCT03004469|472270132|FG002|Overall Study|Lost to Follow-up|6|||
131177394|NCT03004469|472270130|FG000|Overall Study|Non-Compliance with Study Drug|2|||
131177395|NCT03004469|472270131|FG001|Overall Study|Non-Compliance with Study Drug|0|||
131177396|NCT03004469|472270132|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131177397|NCT03004469|472270130|FG000|Overall Study|Protocol Violation|0|||
130783025|NCT05067972|470833206|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
130783026|NCT05067972|470833207|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
130783027|NCT05067972|470833208|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
131177398|NCT03004469|472270131|FG001|Overall Study|Protocol Violation|0|||
131177399|NCT03004469|472270132|FG002|Overall Study|Protocol Violation|1|||
131177400|NCT03004469|472270130|FG000|Overall Study|Withdrawal by Subject|29|||
131177401|NCT03004469|472270131|FG001|Overall Study|Withdrawal by Subject|27|||
131177402|NCT03004469|472270132|FG002|Overall Study|Withdrawal by Subject|10|||
131177403|NCT03004469|472270130|FG000|Overall Study|Other unspecified reason|0|||
131237115|NCT04955691|472499919|FG000|Period 2|Discontinued intervention|1|||
131237116|NCT04955691|472499920|FG001|Period 2|Discontinued intervention|2|||
131237117|NCT04924608|472499921|FG000|Overall Study|Adverse Event|10|||
131237118|NCT04924608|472499922|FG001|Overall Study|Adverse Event|6|||
131237119|NCT04924608|472499921|FG000|Overall Study|Lost to Follow-up|1|||
131237120|NCT04924608|472499922|FG001|Overall Study|Lost to Follow-up|1|||
131237121|NCT04924608|472499921|FG000|Overall Study|Ongoing at the data cut-off date|54|||
131237122|NCT04924608|472499922|FG001|Overall Study|Ongoing at the data cut-off date|60|||
131237123|NCT04924608|472499921|FG000|Overall Study|Progressive Disease|2|||
131237124|NCT04924608|472499922|FG001|Overall Study|Progressive Disease|0|||
131237125|NCT04924608|472499921|FG000|Overall Study|Withdrawal by Subject|3|||
131237126|NCT04924608|472499922|FG001|Overall Study|Withdrawal by Subject|6|||
131237127|NCT04924608|472499921|FG000|Overall Study|Other reason|1|||
131237128|NCT04924608|472499922|FG001|Overall Study|Other reason|1|||
131237129|NCT04459416|472499923|FG000|Overall Study|Lost to Follow-up|2|||
131237130|NCT04459416|472499924|FG001|Overall Study|Lost to Follow-up|0|||
131237131|NCT04459416|472499923|FG000|Overall Study|Withdrawal by Subject|8|||
131237132|NCT04459416|472499924|FG001|Overall Study|Withdrawal by Subject|10|||
131237133|NCT04459416|472499923|FG000|Overall Study|Disease progression|0|||
131237134|NCT04459416|472499924|FG001|Overall Study|Disease progression|3|||
131237135|NCT05665595|472499925|FG000|Overall Study|Ongoing|692|||
131237136|NCT05665595|472499926|FG001|Overall Study|Ongoing|698|||
131237137|NCT05665595|472499925|FG000|Overall Study|Withdrawal by Subject|2|||
131237138|NCT05665595|472499926|FG001|Overall Study|Withdrawal by Subject|2|||
131237139|NCT05665595|472499925|FG000|Overall Study|Lost to Follow-up|1|||
131237140|NCT05665595|472499926|FG001|Overall Study|Lost to Follow-up|0|||
131237141|NCT05665595|472499925|FG000|Overall Study|Death|6|||
131177404|NCT03004469|472270131|FG001|Overall Study|Other unspecified reason|4|||
131177405|NCT03004469|472270132|FG002|Overall Study|Other unspecified reason|1|||
131177406|NCT00259740|472270133|FG000|Overall Study|Physician Decision|1|||
131177407|NCT00259740|472270134|FG001|Overall Study|Physician Decision|1|||
131177408|NCT00259740|472270133|FG000|Overall Study|Adverse Event|0|||
131177409|NCT00259740|472270134|FG001|Overall Study|Adverse Event|2|||
131177410|NCT00259740|472270133|FG000|Overall Study|Withdrawal by Subject|2|||
131177411|NCT00259740|472270134|FG001|Overall Study|Withdrawal by Subject|6|||
131177412|NCT00259740|472270133|FG000|Overall Study|Death|1|||
131177413|NCT00259740|472270134|FG001|Overall Study|Death|1|||
131177414|NCT00259740|472270133|FG000|Overall Study|Disease progression|19|||
131177415|NCT00259740|472270134|FG001|Overall Study|Disease progression|36|||
131177416|NCT00259740|472270133|FG000|Overall Study|Ongoing|17|||
131177417|NCT00259740|472270134|FG001|Overall Study|Ongoing|3|||
131177418|NCT00259740|472270133|FG000|Overall Study|Other|3|||
131177419|NCT00259740|472270134|FG001|Overall Study|Other|0|||
131177420|NCT00259740|472270133|FG000|Overall Study|Requirement for alternative therapy|0|||
131177421|NCT00259740|472270134|FG001|Overall Study|Requirement for alternative therapy|4|||
131177422|NCT00190983|472270135|FG000|Overall Study|Inevaluable (never treated)|2|||
131177423|NCT02287402|472270136|FG000|Treatment Period|Adverse Event|17|||
131177424|NCT02287402|472270136|FG000|Treatment Period|Voluntary Withdrawal|10|||
131177425|NCT02287402|472270136|FG000|Follow-up|Lost to Follow-up|1|||
131177426|NCT02287402|472270136|FG000|Follow-up|Voluntary Withdrawal|2|||
131177427|NCT01844830|472270137|FG000|Overall Study|Withdrawal by Subject|1|||
131177428|NCT01844830|472270138|FG001|Overall Study|Withdrawal by Subject|0|||
131177429|NCT04247815|472270139|FG000|Overall Study|Adverse Event|1|||
131177430|NCT04247815|472270140|FG001|Overall Study|Adverse Event|0|||
131177431|NCT04247815|472270139|FG000|Overall Study|Withdrawal by Subject|1|||
131177432|NCT04247815|472270140|FG001|Overall Study|Withdrawal by Subject|0|||
131177433|NCT04247815|472270139|FG000|Overall Study|Protocol Violation|0|||
131177434|NCT04247815|472270140|FG001|Overall Study|Protocol Violation|1|||
131177435|NCT01453998|472270142|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
131177436|NCT01453998|472270143|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
131177437|NCT01453998|472270144|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
131177438|NCT03495453|472270151|FG000|Overall Study|Withdrawal by Subject|0|||
131177439|NCT03495453|472270152|FG001|Overall Study|Withdrawal by Subject|1|||
131177440|NCT03341923|472270155|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
131177441|NCT03341923|472270156|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
131237142|NCT05665595|472499926|FG001|Overall Study|Death|1|||
131237143|NCT05771428|472499927|FG000|Overall Study|Adverse Event|0|||
131237144|NCT05771428|472499928|FG001|Overall Study|Adverse Event|1|||
131237145|NCT05771428|472499929|FG002|Overall Study|Adverse Event|1|||
130783028|NCT05067972|470833209|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
131177442|NCT04929613|472270157|FG000|Overall Study|Withdrawal by Subject|12|||
131177443|NCT01742078|472270158|FG000|Overall Study|Withdrawal by Subject|0|||
131177444|NCT01742078|472270159|FG001|Overall Study|Withdrawal by Subject|0|||
131177445|NCT01742078|472270160|FG002|Overall Study|Withdrawal by Subject|0|||
131177446|NCT01742078|472270161|FG003|Overall Study|Withdrawal by Subject|1|||
131177447|NCT01742078|472270162|FG004|Overall Study|Withdrawal by Subject|0|||
131237146|NCT05771428|472499930|FG003|Overall Study|Adverse Event|1|||
131237147|NCT05771428|472499927|FG000|Overall Study|Withdrawal by Subject|3|||
130783029|NCT05067972|470833203|FG000|Part 1: Treatment|Progressive Disease|3|||
130783030|NCT05067972|470833204|FG001|Part 1: Treatment|Progressive Disease|3|||
130783031|NCT05067972|470833205|FG002|Part 1: Treatment|Progressive Disease|4|||
130783032|NCT05067972|470833206|FG003|Part 1: Treatment|Progressive Disease|2|||
130783033|NCT05067972|470833207|FG004|Part 1: Treatment|Progressive Disease|3|||
130783034|NCT05067972|470833208|FG005|Part 1: Treatment|Progressive Disease|0|||
130783035|NCT05067972|470833209|FG006|Part 1: Treatment|Progressive Disease|2|||
130783036|NCT05067972|470833203|FG000|Part 1: Treatment|Physician Decision|0|||
130783037|NCT05067972|470833204|FG001|Part 1: Treatment|Physician Decision|0|||
130783038|NCT05067972|470833205|FG002|Part 1: Treatment|Physician Decision|0|||
130783039|NCT05067972|470833206|FG003|Part 1: Treatment|Physician Decision|1|||
130783040|NCT05067972|470833207|FG004|Part 1: Treatment|Physician Decision|0|||
130783041|NCT05067972|470833208|FG005|Part 1: Treatment|Physician Decision|0|||
130783042|NCT05067972|470833209|FG006|Part 1: Treatment|Physician Decision|0|||
130783043|NCT05067972|470833203|FG000|Part 1: Treatment|Death|0|||
130783044|NCT05067972|470833204|FG001|Part 1: Treatment|Death|0|||
130783045|NCT05067972|470833205|FG002|Part 1: Treatment|Death|0|||
130783046|NCT05067972|470833206|FG003|Part 1: Treatment|Death|2|||
130783047|NCT05067972|470833207|FG004|Part 1: Treatment|Death|0|||
130783048|NCT05067972|470833208|FG005|Part 1: Treatment|Death|0|||
130783049|NCT05067972|470833209|FG006|Part 1: Treatment|Death|0|||
130783050|NCT05067972|470833203|FG000|Part 1: Treatment|Adverse Event|0|||
130783051|NCT05067972|470833204|FG001|Part 1: Treatment|Adverse Event|0|||
130783052|NCT05067972|470833205|FG002|Part 1: Treatment|Adverse Event|0|||
130783053|NCT05067972|470833206|FG003|Part 1: Treatment|Adverse Event|0|||
130783054|NCT05067972|470833207|FG004|Part 1: Treatment|Adverse Event|0|||
130783055|NCT05067972|470833208|FG005|Part 1: Treatment|Adverse Event|2|||
130783056|NCT05067972|470833209|FG006|Part 1: Treatment|Adverse Event|1|||
130783057|NCT05067972|470833203|FG000|Part 1: Follow-up|Adverse Event|0|||
130783058|NCT05067972|470833204|FG001|Part 1: Follow-up|Adverse Event|0|||
130783059|NCT05067972|470833205|FG002|Part 1: Follow-up|Adverse Event|0|||
130783060|NCT05067972|470833206|FG003|Part 1: Follow-up|Adverse Event|0|||
130783061|NCT05067972|470833207|FG004|Part 1: Follow-up|Adverse Event|0|||
130783062|NCT05067972|470833208|FG005|Part 1: Follow-up|Adverse Event|1|||
130783063|NCT05067972|470833209|FG006|Part 1: Follow-up|Adverse Event|0|||
130783064|NCT05067972|470833203|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
130783065|NCT05067972|470833204|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
130783066|NCT05067972|470833205|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
130783067|NCT05067972|470833206|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
130783068|NCT05067972|470833207|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
130783069|NCT05067972|470833208|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
130783070|NCT05067972|470833209|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
130783071|NCT05067972|470833203|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130783072|NCT05067972|470833204|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130783073|NCT05067972|470833205|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130783074|NCT05067972|470833206|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130783075|NCT05067972|470833207|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130783076|NCT05067972|470833208|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
130783077|NCT05067972|470833209|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130783078|NCT05067972|470833203|FG000|Part 1: Follow-up|Physician Decision|0|||
130783079|NCT05067972|470833204|FG001|Part 1: Follow-up|Physician Decision|0|||
130783080|NCT05067972|470833205|FG002|Part 1: Follow-up|Physician Decision|0|||
130783081|NCT05067972|470833206|FG003|Part 1: Follow-up|Physician Decision|1|||
130783082|NCT05067972|470833207|FG004|Part 1: Follow-up|Physician Decision|0|||
130783083|NCT05067972|470833208|FG005|Part 1: Follow-up|Physician Decision|0|||
130783084|NCT05067972|470833209|FG006|Part 1: Follow-up|Physician Decision|0|||
130783085|NCT05067972|470833203|FG000|Part 1: Follow-up|Death|1|||
130783086|NCT05067972|470833204|FG001|Part 1: Follow-up|Death|2|||
130783087|NCT05067972|470833205|FG002|Part 1: Follow-up|Death|1|||
130783088|NCT05067972|470833206|FG003|Part 1: Follow-up|Death|0|||
130783089|NCT05067972|470833207|FG004|Part 1: Follow-up|Death|1|||
130783090|NCT05067972|470833208|FG005|Part 1: Follow-up|Death|0|||
130783091|NCT05067972|470833209|FG006|Part 1: Follow-up|Death|1|||
130783092|NCT04391842|470833210|FG000|Overall Study|Withdrawal by Subject|2|||
130783093|NCT01676012|470833211|FG000|Overall Study|Adverse Event|2|||
130783094|NCT01676012|470833211|FG000|Overall Study|incomplete set of videos|1|||
130783095|NCT02667301|470833216|FG000|Overall Study|Adverse Event|1|||
130783096|NCT02667301|470833216|FG000|Overall Study|Lack of Efficacy|1|||
130783097|NCT02283658|470833217|FG000|Overall Study|Withdrawal by Subject|1|||
130783098|NCT03528551|470833219|FG000|Overall Study|Lost to Follow-up|0|||
130783099|NCT03528551|470833220|FG001|Overall Study|Lost to Follow-up|1|||
130783100|NCT03528551|470833221|FG002|Overall Study|Lost to Follow-up|0|||
130783101|NCT03528551|470833219|FG000|Overall Study|Transferred to other arm/group|2|||
130783102|NCT03528551|470833220|FG001|Overall Study|Transferred to other arm/group|3|||
130783103|NCT03528551|470833221|FG002|Overall Study|Transferred to other arm/group|0|||
130783104|NCT03528551|470833219|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130783105|NCT03528551|470833220|FG001|Overall Study|Withdrawal by parent/guardian|5|||
130783106|NCT03528551|470833221|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131177448|NCT01742078|472270163|FG005|Overall Study|Withdrawal by Subject|0|||
131177449|NCT01742078|472270164|FG006|Overall Study|Withdrawal by Subject|0|||
131177450|NCT01742078|472270165|FG007|Overall Study|Withdrawal by Subject|0|||
131177451|NCT01742078|472270166|FG008|Overall Study|Withdrawal by Subject|0|||
131177452|NCT03247413|472270170|FG000|Overall Study|Lost to Follow-up|28|||
131177453|NCT02767856|472270171|FG000|Overall Study|Lost to Follow-up|9|||
131177454|NCT02767856|472270172|FG001|Overall Study|Lost to Follow-up|1|||
131177455|NCT02767856|472270171|FG000|Overall Study|Withdrawal by Subject|2|||
131177456|NCT02767856|472270172|FG001|Overall Study|Withdrawal by Subject|1|||
131177457|NCT00091026|472270175|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
131177458|NCT00091026|472270176|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
131177459|NCT00091026|472270175|FG000|Overall Study|Patient withdrew and never received trea|0|||
131177460|NCT00091026|472270176|FG001|Overall Study|Patient withdrew and never received trea|2|||
131177461|NCT00091026|472270175|FG000|Overall Study|Unknown-never received treatment|0|||
131177462|NCT00091026|472270176|FG001|Overall Study|Unknown-never received treatment|1|||
131177463|NCT04397718|472270177|FG000|Overall Study|Death|7|||
131177464|NCT04397718|472270178|FG001|Overall Study|Death|11|||
131177465|NCT04397718|472270177|FG000|Overall Study|Lost to Follow-up|0|||
131177466|NCT04397718|472270178|FG001|Overall Study|Lost to Follow-up|4|||
131177467|NCT01797965|472270179|FG000|Overall Study|Adverse Event|104|||
131177468|NCT01797965|472270180|FG001|Overall Study|Adverse Event|129|||
131177469|NCT01797965|472270181|FG002|Overall Study|Adverse Event|4|||
131177470|NCT01797965|472270182|FG003|Overall Study|Adverse Event|21|||
131177471|NCT01797965|472270179|FG000|Overall Study|Lost to Follow-up|9|||
131177472|NCT01797965|472270180|FG001|Overall Study|Lost to Follow-up|8|||
131177473|NCT01797965|472270181|FG002|Overall Study|Lost to Follow-up|1|||
131177474|NCT01797965|472270182|FG003|Overall Study|Lost to Follow-up|2|||
131177475|NCT01797965|472270179|FG000|Overall Study|Consent withdrawn|130|||
131177476|NCT01797965|472270180|FG001|Overall Study|Consent withdrawn|117|||
131177477|NCT01797965|472270181|FG002|Overall Study|Consent withdrawn|3|||
131177478|NCT01797965|472270182|FG003|Overall Study|Consent withdrawn|35|||
131177479|NCT01797965|472270179|FG000|Overall Study|Investigator decision|21|||
131177480|NCT01797965|472270180|FG001|Overall Study|Investigator decision|15|||
131177481|NCT01797965|472270181|FG002|Overall Study|Investigator decision|0|||
131177482|NCT01797965|472270182|FG003|Overall Study|Investigator decision|0|||
131177483|NCT01797965|472270179|FG000|Overall Study|Death|2|||
131177484|NCT01797965|472270180|FG001|Overall Study|Death|4|||
131177485|NCT01797965|472270181|FG002|Overall Study|Death|0|||
131177486|NCT01797965|472270182|FG003|Overall Study|Death|0|||
131177487|NCT01797965|472270179|FG000|Overall Study|Disease progression, defined by protocol|3|||
131177488|NCT01797965|472270180|FG001|Overall Study|Disease progression, defined by protocol|1|||
131177489|NCT01797965|472270181|FG002|Overall Study|Disease progression, defined by protocol|0|||
131177490|NCT01797965|472270182|FG003|Overall Study|Disease progression, defined by protocol|0|||
131177491|NCT01797965|472270179|FG000|Overall Study|Reason Not Specified|280|||
131177492|NCT01797965|472270180|FG001|Overall Study|Reason Not Specified|295|||
131177493|NCT01797965|472270181|FG002|Overall Study|Reason Not Specified|0|||
131177494|NCT01797965|472270182|FG003|Overall Study|Reason Not Specified|15|||
131177495|NCT01025817|472270184|FG000|Completed Study Medication|Adverse Event|66|||
131177496|NCT01025817|472270185|FG001|Completed Study Medication|Adverse Event|39|||
131177497|NCT01025817|472270184|FG000|Completed Study Medication|Protocol Deviation|9|||
131177498|NCT01025817|472270185|FG001|Completed Study Medication|Protocol Deviation|8|||
131177499|NCT01025817|472270184|FG000|Completed Study Medication|Withdrawal by Subject|8|||
131177500|NCT01025817|472270185|FG001|Completed Study Medication|Withdrawal by Subject|9|||
131177501|NCT01025817|472270184|FG000|Completed Study Medication|Administrative problems|7|||
131177502|NCT01025817|472270185|FG001|Completed Study Medication|Administrative problems|5|||
131177503|NCT01025817|472270184|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
131177504|NCT01025817|472270185|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
131177505|NCT01025817|472270184|FG000|Completed Study Medication|Abnormal test procedure|4|||
131177506|NCT01025817|472270185|FG001|Completed Study Medication|Abnormal test procedure|0|||
131177507|NCT01025817|472270184|FG000|Completed Study Medication|Graft loss|2|||
131177508|NCT01025817|472270185|FG001|Completed Study Medication|Graft loss|5|||
131177509|NCT01025817|472270184|FG000|Completed Study Medication|Death|2|||
131177510|NCT01025817|472270185|FG001|Completed Study Medication|Death|2|||
131177511|NCT01025817|472270184|FG000|Completed Study Medication|Abnormal lab values|0|||
131177512|NCT01025817|472270185|FG001|Completed Study Medication|Abnormal lab values|2|||
131177513|NCT01025817|472270184|FG000|Completed Study Medication|Subject no longer required study drug|0|||
131177514|NCT01025817|472270185|FG001|Completed Study Medication|Subject no longer required study drug|1|||
130783107|NCT03528551|470833219|FG000|Overall Study|Protocol Violation|0|||
131177515|NCT01025817|472270184|FG000|Completed Study Medication|Lost to Follow-up|0|||
131177516|NCT01025817|472270185|FG001|Completed Study Medication|Lost to Follow-up|1|||
131177517|NCT01025817|472270184|FG000|Completed Study|Withdrawal by Subject|8|||
131177518|NCT01025817|472270185|FG001|Completed Study|Withdrawal by Subject|16|||
131177519|NCT01025817|472270184|FG000|Completed Study|Death|6|||
131237148|NCT05771428|472499928|FG001|Overall Study|Withdrawal by Subject|2|||
131177520|NCT01025817|472270185|FG001|Completed Study|Death|5|||
131177521|NCT01025817|472270184|FG000|Completed Study|Missing|2|||
131177522|NCT01025817|472270185|FG001|Completed Study|Missing|0|||
131177523|NCT01025817|472270184|FG000|Completed Study|Lost to Follow-up|0|||
131177524|NCT01025817|472270185|FG001|Completed Study|Lost to Follow-up|1|||
131177525|NCT00973921|472270186|FG000|Overall Study|IVUS results were not available|9|||
131177526|NCT04404010|472270190|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
131177527|NCT04404010|472270191|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
131177528|NCT02120157|472270192|FG000|Overall Study|Death|8|||
131177529|NCT00441103|472270196|FG000|Overall Study|Adverse Event|2|||
131177530|NCT00441103|472270197|FG001|Overall Study|Adverse Event|1|||
131177531|NCT00441103|472270196|FG000|Overall Study|Death|1|||
131177532|NCT00441103|472270197|FG001|Overall Study|Death|0|||
131177533|NCT00441103|472270196|FG000|Overall Study|Disease Progression|2|||
131177534|NCT00441103|472270197|FG001|Overall Study|Disease Progression|0|||
131177535|NCT00441103|472270196|FG000|Overall Study|Lost to Follow-up|1|||
131177536|NCT00441103|472270197|FG001|Overall Study|Lost to Follow-up|0|||
131177537|NCT00441103|472270196|FG000|Overall Study|Protocol Violation|1|||
131177538|NCT00441103|472270197|FG001|Overall Study|Protocol Violation|0|||
131177539|NCT00441103|472270196|FG000|Overall Study|Participant unable to use Rebiject II|1|||
131177540|NCT00441103|472270197|FG001|Overall Study|Participant unable to use Rebiject II|0|||
131177541|NCT00441103|472270196|FG000|Overall Study|Participant refused MRI|1|||
131177542|NCT00441103|472270197|FG001|Overall Study|Participant refused MRI|0|||
131177543|NCT00441103|472270196|FG000|Overall Study|Inclusion criteria absent|1|||
131177544|NCT00441103|472270197|FG001|Overall Study|Inclusion criteria absent|0|||
131177545|NCT00441103|472270196|FG000|Overall Study|Non-compliant|0|||
131177546|NCT00441103|472270197|FG001|Overall Study|Non-compliant|1|||
131177547|NCT00441103|472270196|FG000|Overall Study|Participant decided to withdraw|1|||
131177548|NCT00441103|472270197|FG001|Overall Study|Participant decided to withdraw|0|||
131177549|NCT00441103|472270196|FG000|Overall Study|Participant's reason|0|||
131177550|NCT00441103|472270197|FG001|Overall Study|Participant's reason|1|||
131177551|NCT00441103|472270196|FG000|Overall Study|Participant decided to stop|0|||
131177552|NCT00441103|472270197|FG001|Overall Study|Participant decided to stop|1|||
131177553|NCT01354431|472270200|FG000|Pre-Treatment Period|Not reported|1|||
131177554|NCT01354431|472270201|FG001|Pre-Treatment Period|Not reported|0|||
131177555|NCT01354431|472270202|FG002|Pre-Treatment Period|Not reported|0|||
131177556|NCT01354431|472270200|FG000|Treatment Period|Disease Progression|50|||
131177557|NCT01354431|472270201|FG001|Treatment Period|Disease Progression|40|||
131177558|NCT01354431|472270202|FG002|Treatment Period|Disease Progression|44|||
131177559|NCT01354431|472270200|FG000|Treatment Period|Study Drug Toxicity|5|||
131177560|NCT01354431|472270201|FG001|Treatment Period|Study Drug Toxicity|8|||
131177561|NCT01354431|472270202|FG002|Treatment Period|Study Drug Toxicity|4|||
131177562|NCT01354431|472270200|FG000|Treatment Period|Death|0|||
131177563|NCT01354431|472270201|FG001|Treatment Period|Death|1|||
131177564|NCT01354431|472270202|FG002|Treatment Period|Death|0|||
131177565|NCT01354431|472270200|FG000|Treatment Period|AE unrelated to study drug|1|||
131177566|NCT01354431|472270201|FG001|Treatment Period|AE unrelated to study drug|2|||
131177567|NCT01354431|472270202|FG002|Treatment Period|AE unrelated to study drug|5|||
131177568|NCT01354431|472270200|FG000|Treatment Period|Participant request to discontinue|2|||
131177569|NCT01354431|472270201|FG001|Treatment Period|Participant request to discontinue|2|||
131177570|NCT01354431|472270202|FG002|Treatment Period|Participant request to discontinue|1|||
131177571|NCT01354431|472270200|FG000|Treatment Period|Participant withdrew consent|0|||
131177572|NCT01354431|472270201|FG001|Treatment Period|Participant withdrew consent|1|||
131177573|NCT01354431|472270202|FG002|Treatment Period|Participant withdrew consent|0|||
131177574|NCT01354431|472270200|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
131177575|NCT01354431|472270201|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
131177576|NCT01354431|472270202|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
131177577|NCT02802878|472270203|FG000|Overall Study|Withdrawal by Subject|3|||
131177578|NCT02802878|472270204|FG001|Overall Study|Withdrawal by Subject|3|||
131177579|NCT02802878|472270203|FG000|Overall Study|Protocol Violation|1|||
131177580|NCT02802878|472270204|FG001|Overall Study|Protocol Violation|0|||
131177581|NCT01599754|472270205|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
131177582|NCT01599754|472270206|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
131177583|NCT01599754|472270205|FG000|Overall Study|Participant noncompliance|4|||
131177584|NCT01599754|472270206|FG001|Overall Study|Participant noncompliance|4|||
131177585|NCT01599754|472270205|FG000|Overall Study|Lost to Follow-up|13|||
131177586|NCT01599754|472270206|FG001|Overall Study|Lost to Follow-up|6|||
131177587|NCT01599754|472270205|FG000|Overall Study|Death|31|||
131177588|NCT01599754|472270206|FG001|Overall Study|Death|33|||
131177589|NCT01599754|472270205|FG000|Overall Study|Adverse Event|3|||
131177590|NCT01599754|472270206|FG001|Overall Study|Adverse Event|2|||
131177591|NCT01599754|472270205|FG000|Overall Study|Investigator decision|1|||
131177592|NCT01599754|472270206|FG001|Overall Study|Investigator decision|3|||
131177593|NCT01599754|472270205|FG000|Overall Study|Withdrawal by Subject|24|||
131177594|NCT01599754|472270206|FG001|Overall Study|Withdrawal by Subject|25|||
131177595|NCT01599754|472270205|FG000|Overall Study|Study terminated by sponsor|282|||
131177596|NCT01599754|472270206|FG001|Overall Study|Study terminated by sponsor|285|||
131177597|NCT01029002|472270207|FG000|Overall Study|Lost to Follow-up|2|||
131177598|NCT01029002|472270208|FG001|Overall Study|Lost to Follow-up|4|||
131177599|NCT00702052|472270209|FG000|Overall Study|Adverse Event|23|||
131177600|NCT00702052|472270209|FG000|Overall Study|Disease Progression|30|||
131177601|NCT00702052|472270209|FG000|Overall Study|Withdrawal by Subject|5|||
131177602|NCT01577160|472270210|FG000|Overall Study|Adverse Event|9|||
131177603|NCT01577160|472270210|FG000|Overall Study|Lack of Efficacy|15|||
131177604|NCT01577160|472270210|FG000|Overall Study|Lost to Follow-up|40|||
131177605|NCT01577160|472270210|FG000|Overall Study|Withdrawal by Subject|18|||
131177606|NCT01577160|472270210|FG000|Overall Study|Subject Uncooperative|7|||
131177607|NCT01577160|472270210|FG000|Overall Study|Other|9|||
131177608|NCT00101192|472270211|FG000|Overall Study|Ineligible|6|||
131177609|NCT00101192|472270211|FG000|Overall Study|Inevaluable|1|||
130783108|NCT03528551|470833220|FG001|Overall Study|Protocol Violation|3|||
130783109|NCT03528551|470833221|FG002|Overall Study|Protocol Violation|0|||
130783110|NCT03528551|470833219|FG000|Overall Study|Withdrawal by Subject|0|||
130783111|NCT03528551|470833220|FG001|Overall Study|Withdrawal by Subject|7|||
130783112|NCT03528551|470833221|FG002|Overall Study|Withdrawal by Subject|0|||
130783113|NCT00689338|470833222|FG000|Overall Study|Death|65|||
130783114|NCT00689338|470833222|FG000|Overall Study|Adverse Event|13|||
130783115|NCT00689338|470833222|FG000|Overall Study|Insufficient Clinical Response|1|||
130783116|NCT00689338|470833222|FG000|Overall Study|Lack of Efficacy|6|||
131177610|NCT02618928|472270212|FG000|Overall Study|Failure to Return|28|||
131177611|NCT02618928|472270212|FG000|Overall Study|Insufficient Virological Response|1|||
131177612|NCT02618928|472270212|FG000|Overall Study|Withdrawal by Subject|2|||
131177613|NCT02618928|472270212|FG000|Overall Study|Death|3|||
131177614|NCT02618928|472270212|FG000|Overall Study|Other|11|||
131177615|NCT02618928|472270212|FG000|Overall Study|Missing|6|||
131177616|NCT02618928|472270212|FG000|Overall Study|Treatment Never Started|7|||
131177617|NCT00916370|472270215|FG000|Overall Study|Death|3|||
131177618|NCT00916370|472270216|FG001|Overall Study|Death|1|||
131177619|NCT00916370|472270215|FG000|Overall Study|Withdrawal by Subject|2|||
131177620|NCT00916370|472270216|FG001|Overall Study|Withdrawal by Subject|0|||
131177621|NCT00916370|472270215|FG000|Overall Study|Physician Decision|0|||
131177622|NCT00916370|472270216|FG001|Overall Study|Physician Decision|1|||
131177623|NCT01317615|472270217|FG000|Overall Study|Disease progression|25|||
131177624|NCT01317615|472270217|FG000|Overall Study|New cancer therapy|5|||
131177625|NCT01317615|472270217|FG000|Overall Study|Death|6|||
131177626|NCT01317615|472270217|FG000|Overall Study|Withdrawal by Subject|5|||
131177627|NCT01317615|472270217|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131177628|NCT01317615|472270217|FG000|Overall Study|Adverse Event|7|||
131177629|NCT00438399|472270218|FG000|Overall Study|Lost to Follow-up|2|||
131177630|NCT00438399|472270219|FG001|Overall Study|Lost to Follow-up|2|||
131177631|NCT00438399|472270220|FG002|Overall Study|Lost to Follow-up|1|||
131177632|NCT00438399|472270221|FG003|Overall Study|Lost to Follow-up|1|||
131177633|NCT00438399|472270222|FG004|Overall Study|Lost to Follow-up|1|||
131177634|NCT00438399|472270223|FG005|Overall Study|Lost to Follow-up|1|||
131177635|NCT00438399|472270218|FG000|Overall Study|Adverse Event|0|||
131177636|NCT00438399|472270219|FG001|Overall Study|Adverse Event|0|||
131177637|NCT00438399|472270220|FG002|Overall Study|Adverse Event|1|||
131177638|NCT00438399|472270221|FG003|Overall Study|Adverse Event|1|||
131177639|NCT00438399|472270222|FG004|Overall Study|Adverse Event|0|||
131177640|NCT00438399|472270223|FG005|Overall Study|Adverse Event|1|||
131177641|NCT00438399|472270218|FG000|Overall Study|Withdrawal by Subject|5|||
131177642|NCT00438399|472270219|FG001|Overall Study|Withdrawal by Subject|6|||
131177643|NCT00438399|472270220|FG002|Overall Study|Withdrawal by Subject|3|||
131177644|NCT00438399|472270221|FG003|Overall Study|Withdrawal by Subject|2|||
131177645|NCT00438399|472270222|FG004|Overall Study|Withdrawal by Subject|2|||
131177646|NCT00438399|472270223|FG005|Overall Study|Withdrawal by Subject|2|||
131177647|NCT00438399|472270218|FG000|Overall Study|Protocol Violation|0|||
131177648|NCT00438399|472270219|FG001|Overall Study|Protocol Violation|0|||
131177649|NCT00438399|472270220|FG002|Overall Study|Protocol Violation|1|||
131177650|NCT00438399|472270221|FG003|Overall Study|Protocol Violation|0|||
131177651|NCT00438399|472270222|FG004|Overall Study|Protocol Violation|0|||
131177652|NCT00438399|472270223|FG005|Overall Study|Protocol Violation|1|||
131177653|NCT00438399|472270218|FG000|Overall Study|Subje stopped study|0|||
131177654|NCT00438399|472270219|FG001|Overall Study|Subje stopped study|0|||
131177655|NCT00438399|472270220|FG002|Overall Study|Subje stopped study|1|||
131177656|NCT00438399|472270221|FG003|Overall Study|Subje stopped study|0|||
131177657|NCT00438399|472270222|FG004|Overall Study|Subje stopped study|0|||
131177658|NCT00438399|472270223|FG005|Overall Study|Subje stopped study|0|||
131177659|NCT00438399|472270218|FG000|Overall Study|Pregnancy|0|||
131177660|NCT00438399|472270219|FG001|Overall Study|Pregnancy|0|||
131177661|NCT00438399|472270220|FG002|Overall Study|Pregnancy|0|||
131177662|NCT00438399|472270221|FG003|Overall Study|Pregnancy|0|||
131177663|NCT00438399|472270222|FG004|Overall Study|Pregnancy|0|||
131177664|NCT00438399|472270223|FG005|Overall Study|Pregnancy|1|||
131177665|NCT00438399|472270218|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
131177666|NCT00438399|472270219|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
131177667|NCT00438399|472270220|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
131177668|NCT00438399|472270221|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
131177669|NCT00438399|472270222|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
131177670|NCT00438399|472270223|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
131177671|NCT01935336|472270225|FG000|Overall Study|Adverse Event|1|||
131177672|NCT01935336|472270226|FG001|Overall Study|Adverse Event|0|||
131177673|NCT01935336|472270227|FG002|Overall Study|Adverse Event|0|||
131177674|NCT01935336|472270228|FG003|Overall Study|Adverse Event|0|||
131177675|NCT01935336|472270225|FG000|Overall Study|Progressive disease|5|||
131177676|NCT01935336|472270226|FG001|Overall Study|Progressive disease|3|||
131177677|NCT01935336|472270227|FG002|Overall Study|Progressive disease|47|||
131177678|NCT01935336|472270228|FG003|Overall Study|Progressive disease|66|||
131177679|NCT00592553|472270229|FG000|Overall Study|Protocol Noncompliance|1|||
131177680|NCT00592553|472270230|FG001|Overall Study|Protocol Noncompliance|0|||
131177681|NCT00592553|472270231|FG002|Overall Study|Protocol Noncompliance|0|||
131177682|NCT01146951|472272320|FG000|Overall Study|Adverse Event|4|||
131177683|NCT01146951|472272321|FG001|Overall Study|Adverse Event|1|||
131177684|NCT01747811|472272323|FG000|Overall Study|Lack of Efficacy|2|||
131177685|NCT01747811|472272324|FG001|Overall Study|Lack of Efficacy|4|||
131177686|NCT01337167|472272328|FG000|Infant Series|Adverse Event|1|||
131177687|NCT01337167|472272329|FG001|Infant Series|Adverse Event|1|||
131177688|NCT01337167|472272328|FG000|Infant Series|Death|1|||
131177689|NCT01337167|472272329|FG001|Infant Series|Death|1|||
131177690|NCT01337167|472272328|FG000|Infant Series|Lost to Follow-up|13|||
131177691|NCT01337167|472272329|FG001|Infant Series|Lost to Follow-up|7|||
131177692|NCT01337167|472272328|FG000|Infant Series|Non-compliance with study drug|2|||
131177693|NCT01337167|472272329|FG001|Infant Series|Non-compliance with study drug|1|||
131177694|NCT01337167|472272328|FG000|Infant Series|Physician Decision|3|||
131177695|NCT01337167|472272329|FG001|Infant Series|Physician Decision|1|||
131177696|NCT01337167|472272328|FG000|Infant Series|Protocol Violation|22|||
131177697|NCT01337167|472272329|FG001|Infant Series|Protocol Violation|9|||
131177698|NCT01337167|472272328|FG000|Infant Series|Withdrawal by Subject|15|||
131177699|NCT01337167|472272329|FG001|Infant Series|Withdrawal by Subject|4|||
131177700|NCT01337167|472272328|FG000|Infant Series|Randomized but not vaccinated|5|||
131177701|NCT01337167|472272329|FG001|Infant Series|Randomized but not vaccinated|3|||
131177702|NCT01337167|472272328|FG000|Interim Period|Lost to Follow-up|51|||
131177703|NCT01337167|472272329|FG001|Interim Period|Lost to Follow-up|23|||
131177704|NCT01337167|472272328|FG000|Interim Period|Non-compliance with study drug|1|||
131177705|NCT01337167|472272329|FG001|Interim Period|Non-compliance with study drug|0|||
131177706|NCT01337167|472272328|FG000|Interim Period|Physician Decision|6|||
131177707|NCT01337167|472272329|FG001|Interim Period|Physician Decision|3|||
131177708|NCT01337167|472272328|FG000|Interim Period|Protocol Violation|5|||
131177709|NCT01337167|472272329|FG001|Interim Period|Protocol Violation|3|||
131177710|NCT01337167|472272328|FG000|Interim Period|Withdrawal by Subject|18|||
131177711|NCT01337167|472272329|FG001|Interim Period|Withdrawal by Subject|10|||
131177712|NCT01337167|472272328|FG000|Interim Period|Other protocol criterion not met|0|||
131177713|NCT01337167|472272329|FG001|Interim Period|Other protocol criterion not met|1|||
131177714|NCT01337167|472272328|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
131177715|NCT01337167|472272329|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
131177716|NCT01337167|472272328|FG000|Toddler Vaccinations|Protocol Violation|0|||
131177717|NCT01337167|472272329|FG001|Toddler Vaccinations|Protocol Violation|1|||
131177718|NCT01337167|472272328|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
131177719|NCT01337167|472272329|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
131177720|NCT03833817|472272330|FG000|Overall Study|Withdrawal by Subject|3|||
131177721|NCT03833817|472272331|FG001|Overall Study|Withdrawal by Subject|3|||
131177722|NCT03833817|472272330|FG000|Overall Study|Lost to Follow-up|3|||
131177723|NCT03833817|472272331|FG001|Overall Study|Lost to Follow-up|3|||
131177724|NCT02126670|472272336|FG000|Overall Study|Withdrawal by Subject|1|||
131177725|NCT02126670|472272337|FG001|Overall Study|Withdrawal by Subject|0|||
131177726|NCT02126670|472272338|FG002|Overall Study|Withdrawal by Subject|0|||
131177727|NCT02126670|472272339|FG003|Overall Study|Withdrawal by Subject|1|||
131177728|NCT03363919|472272342|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
131177729|NCT03363919|472272343|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
131177730|NCT03363919|472272342|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
131177731|NCT03363919|472272343|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
131177732|NCT01646398|472272344|FG000|Overall Study|Withdrawal by Subject|1|||
131177733|NCT01646398|472272345|FG001|Overall Study|Withdrawal by Subject|0|||
131177734|NCT00255034|472272346|FG000|Overall Study|Withdrawal by Subject|15|||
131177735|NCT00255034|472272347|FG001|Overall Study|Withdrawal by Subject|38|||
131177736|NCT01827319|472272348|FG000|Overall Study|Lost to Follow-up|3|||
131177737|NCT03947255|472272352|FG000|Overall Study|Study Closure by Sponsor|2|||
131177738|NCT03947255|472272353|FG001|Overall Study|Study Closure by Sponsor|2|||
131177739|NCT03947255|472272352|FG000|Overall Study|Withdrawal by Subject|2|||
131177740|NCT03947255|472272353|FG001|Overall Study|Withdrawal by Subject|2|||
131237149|NCT05771428|472499929|FG002|Overall Study|Withdrawal by Subject|1|||
131237150|NCT05771428|472499930|FG003|Overall Study|Withdrawal by Subject|4|||
131237151|NCT05771428|472499927|FG000|Overall Study|Other|0|||
131237152|NCT05771428|472499928|FG001|Overall Study|Other|1|||
131237153|NCT05771428|472499929|FG002|Overall Study|Other|2|||
131237154|NCT05771428|472499930|FG003|Overall Study|Other|1|||
131237155|NCT05771428|472499927|FG000|Overall Study|Randomized but Not Treated|0|||
131237156|NCT05771428|472499928|FG001|Overall Study|Randomized but Not Treated|0|||
131237157|NCT05771428|472499929|FG002|Overall Study|Randomized but Not Treated|1|||
131237158|NCT05771428|472499930|FG003|Overall Study|Randomized but Not Treated|0|||
131237159|NCT05795153|472499931|FG000|Overall Study|Adverse Event|2|||
131237160|NCT05795153|472499931|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131237161|NCT05795153|472499931|FG000|Overall Study|Lost to Follow-up|1|||
131237162|NCT05795153|472499931|FG000|Overall Study|Subject decision|2|||
131237163|NCT04025229|472499932|FG000|Overall Study|Adverse Event|1|||
131237164|NCT04025229|472499933|FG001|Overall Study|Adverse Event|0|||
131237165|NCT04025229|472499932|FG000|Overall Study|Withdrawal by Subject|0|||
131237166|NCT04025229|472499933|FG001|Overall Study|Withdrawal by Subject|2|||
131237167|NCT04025229|472499932|FG000|Overall Study|Death|0|||
131237168|NCT04025229|472499933|FG001|Overall Study|Death|1|||
131237169|NCT04025229|472499932|FG000|Overall Study|Physician Decision|0|||
131237170|NCT04025229|472499933|FG001|Overall Study|Physician Decision|1|||
131237171|NCT03760744|472499934|FG000|Overall Study|Lost to Follow-up|3|||
131237172|NCT03760744|472499935|FG001|Overall Study|Lost to Follow-up|0|||
131237173|NCT04579380|472499936|FG000|Overall Study|Death|9|||
131237174|NCT04579380|472499937|FG001|Overall Study|Death|22|||
131237175|NCT04579380|472499938|FG002|Overall Study|Death|22|||
131237176|NCT04579380|472499939|FG003|Overall Study|Death|17|||
131237177|NCT04579380|472499940|FG004|Overall Study|Death|6|||
131237178|NCT04579380|472499941|FG005|Overall Study|Death|21|||
131237179|NCT04579380|472499942|FG006|Overall Study|Death|10|||
131237180|NCT04579380|472499943|FG007|Overall Study|Death|11|||
131237181|NCT04579380|472499944|FG008|Overall Study|Death|25|||
131237182|NCT04579380|472499936|FG000|Overall Study|Withdrawal by Subject|0|||
131237183|NCT04579380|472499937|FG001|Overall Study|Withdrawal by Subject|3|||
131237184|NCT04579380|472499938|FG002|Overall Study|Withdrawal by Subject|4|||
131237185|NCT04579380|472499939|FG003|Overall Study|Withdrawal by Subject|0|||
131237186|NCT04579380|472499940|FG004|Overall Study|Withdrawal by Subject|1|||
131237187|NCT04579380|472499941|FG005|Overall Study|Withdrawal by Subject|2|||
131237188|NCT04579380|472499942|FG006|Overall Study|Withdrawal by Subject|0|||
131237189|NCT04579380|472499943|FG007|Overall Study|Withdrawal by Subject|1|||
131237190|NCT04579380|472499944|FG008|Overall Study|Withdrawal by Subject|2|||
131237191|NCT04579380|472499936|FG000|Overall Study|Ongoing|2|||
131237192|NCT04579380|472499937|FG001|Overall Study|Ongoing|6|||
131237193|NCT04579380|472499938|FG002|Overall Study|Ongoing|4|||
131237194|NCT04579380|472499939|FG003|Overall Study|Ongoing|8|||
131237195|NCT04579380|472499940|FG004|Overall Study|Ongoing|5|||
131237196|NCT04579380|472499941|FG005|Overall Study|Ongoing|8|||
131237197|NCT04579380|472499942|FG006|Overall Study|Ongoing|3|||
131237198|NCT04579380|472499943|FG007|Overall Study|Ongoing|19|||
131237199|NCT04579380|472499944|FG008|Overall Study|Ongoing|6|||
131237200|NCT03769168|472499945|FG000|Overall Study|Adverse Event|0|||
131237201|NCT03769168|472499946|FG001|Overall Study|Adverse Event|1|||
131237202|NCT03769168|472499945|FG000|Overall Study|Lack of Efficacy|2|||
131237203|NCT03769168|472499946|FG001|Overall Study|Lack of Efficacy|4|||
131237204|NCT03769168|472499945|FG000|Overall Study|Post study access to treatment|3|||
131237205|NCT03769168|472499946|FG001|Overall Study|Post study access to treatment|11|||
131237206|NCT03769168|472499945|FG000|Overall Study|Physician Decision|1|||
130783117|NCT00689338|470833222|FG000|Overall Study|Other|8|||
130783118|NCT00689338|470833222|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
130783119|NCT00689338|470833222|FG000|Overall Study|Lost to Follow-up|5|||
131237207|NCT03769168|472499946|FG001|Overall Study|Physician Decision|4|||
131237208|NCT03769168|472499945|FG000|Overall Study|Subject Decision|2|||
131237209|NCT03769168|472499946|FG001|Overall Study|Subject Decision|4|||
131237210|NCT03769168|472499945|FG000|Overall Study|Guardian decision|1|||
131237211|NCT03769168|472499946|FG001|Overall Study|Guardian decision|0|||
131237212|NCT01991977|472499947|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
131237213|NCT01991977|472499947|FG000|Overall Study|Withdrew after start of treatment|5|||
131237214|NCT02180724|472499948|FG000|Overall Study|Death|26|||
131237215|NCT02180724|472499949|FG001|Overall Study|Death|1|||
131237216|NCT02180724|472499948|FG000|Overall Study|Lost to Follow-up|3|||
131237217|NCT02180724|472499949|FG001|Overall Study|Lost to Follow-up|1|||
131237218|NCT02180724|472499948|FG000|Overall Study|Withdrawal by Subject|4|||
130783120|NCT00689338|470833222|FG000|Overall Study|Withdrawal by Subject|3|||
130783121|NCT00689338|470833222|FG000|Overall Study|Protocol Violation|15|||
131237219|NCT02180724|472499949|FG001|Overall Study|Withdrawal by Subject|2|||
131237220|NCT02180724|472499948|FG000|Overall Study|PI Decision|5|||
131237221|NCT02180724|472499949|FG001|Overall Study|PI Decision|2|||
131237222|NCT02180724|472499948|FG000|Overall Study|Study terminated by sponsor|54|||
131237223|NCT02180724|472499949|FG001|Overall Study|Study terminated by sponsor|8|||
131237224|NCT03913195|472499950|FG000|Overall Study|Adverse Event|0|||
131177741|NCT03947255|472272352|FG000|Overall Study|Lost to Follow-up|2|||
131177742|NCT03947255|472272353|FG001|Overall Study|Lost to Follow-up|0|||
131177743|NCT03947255|472272352|FG000|Overall Study|Death|0|||
131177744|NCT03947255|472272353|FG001|Overall Study|Death|2|||
131177745|NCT00363051|472272354|FG000|Overall Study|Adminstrative problems|1|||
131177746|NCT00363051|472272355|FG001|Overall Study|Adminstrative problems|1|||
131177747|NCT00363051|472272354|FG000|Overall Study|Adverse Event|21|||
131177748|NCT00363051|472272355|FG001|Overall Study|Adverse Event|12|||
131177749|NCT00363051|472272354|FG000|Overall Study|New Cancer Therapy|2|||
131177750|NCT00363051|472272355|FG001|Overall Study|New Cancer Therapy|1|||
131177751|NCT00363051|472272354|FG000|Overall Study|Withdrawal by Subject|11|||
131177752|NCT00363051|472272355|FG001|Overall Study|Withdrawal by Subject|3|||
131177753|NCT00363051|472272354|FG000|Overall Study|Lost to Follow-up|0|||
131177754|NCT00363051|472272355|FG001|Overall Study|Lost to Follow-up|1|||
131177755|NCT00363051|472272354|FG000|Overall Study|Protocol Violation|0|||
131177756|NCT00363051|472272355|FG001|Overall Study|Protocol Violation|2|||
131177757|NCT00363051|472272354|FG000|Overall Study|Death|3|||
131177758|NCT00363051|472272355|FG001|Overall Study|Death|2|||
131177759|NCT00830115|472272358|FG000|Overall Study|Adverse Event|2|||
131177760|NCT00830115|472272358|FG000|Overall Study|Improvement/recovery|1|||
131177761|NCT01207388|472272366|FG000|Overall Study|Death|67|||
131177762|NCT01207388|472272366|FG000|Overall Study|Withdrawal by Subject|1|||
131177763|NCT01885078|472272367|FG000|Treatment Period|Adverse Event|52|||
131177764|NCT01885078|472272368|FG001|Treatment Period|Adverse Event|136|||
131177765|NCT01885078|472272369|FG002|Treatment Period|Adverse Event|30|||
131177766|NCT01885078|472272370|FG003|Treatment Period|Adverse Event|73|||
131177767|NCT01885078|472272371|FG004|Treatment Period|Adverse Event|17|||
131177768|NCT01885078|472272372|FG005|Treatment Period|Adverse Event|72|||
131177769|NCT01885078|472272373|FG006|Treatment Period|Adverse Event|24|||
131177770|NCT01885078|472272374|FG007|Treatment Period|Adverse Event|5|||
131177771|NCT01885078|472272375|FG008|Treatment Period|Adverse Event|0|||
131177772|NCT01885078|472272376|FG009|Treatment Period|Adverse Event|0|||
131177773|NCT01885078|472272367|FG000|Treatment Period|Death|13|||
131177774|NCT01885078|472272368|FG001|Treatment Period|Death|33|||
131177775|NCT01885078|472272369|FG002|Treatment Period|Death|5|||
131177776|NCT01885078|472272370|FG003|Treatment Period|Death|9|||
131177777|NCT01885078|472272371|FG004|Treatment Period|Death|2|||
131177778|NCT01885078|472272372|FG005|Treatment Period|Death|10|||
131177779|NCT01885078|472272373|FG006|Treatment Period|Death|3|||
131177780|NCT01885078|472272374|FG007|Treatment Period|Death|2|||
131177781|NCT01885078|472272375|FG008|Treatment Period|Death|0|||
131177782|NCT01885078|472272376|FG009|Treatment Period|Death|0|||
131177783|NCT01885078|472272367|FG000|Treatment Period|Lack of Efficacy|12|||
131177784|NCT01885078|472272368|FG001|Treatment Period|Lack of Efficacy|33|||
131177785|NCT01885078|472272369|FG002|Treatment Period|Lack of Efficacy|10|||
131177786|NCT01885078|472272370|FG003|Treatment Period|Lack of Efficacy|23|||
131177787|NCT01885078|472272371|FG004|Treatment Period|Lack of Efficacy|24|||
131177788|NCT01885078|472272372|FG005|Treatment Period|Lack of Efficacy|58|||
131177789|NCT01885078|472272373|FG006|Treatment Period|Lack of Efficacy|9|||
131177790|NCT01885078|472272374|FG007|Treatment Period|Lack of Efficacy|5|||
131177791|NCT01885078|472272375|FG008|Treatment Period|Lack of Efficacy|0|||
131177792|NCT01885078|472272376|FG009|Treatment Period|Lack of Efficacy|0|||
131177793|NCT01885078|472272367|FG000|Treatment Period|Lost to Follow-up|16|||
131177794|NCT01885078|472272368|FG001|Treatment Period|Lost to Follow-up|19|||
131177795|NCT01885078|472272369|FG002|Treatment Period|Lost to Follow-up|7|||
131177796|NCT01885078|472272370|FG003|Treatment Period|Lost to Follow-up|9|||
131177797|NCT01885078|472272371|FG004|Treatment Period|Lost to Follow-up|2|||
131177798|NCT01885078|472272372|FG005|Treatment Period|Lost to Follow-up|8|||
131177799|NCT01885078|472272373|FG006|Treatment Period|Lost to Follow-up|2|||
131177800|NCT01885078|472272374|FG007|Treatment Period|Lost to Follow-up|0|||
131177801|NCT01885078|472272375|FG008|Treatment Period|Lost to Follow-up|0|||
131177802|NCT01885078|472272376|FG009|Treatment Period|Lost to Follow-up|0|||
131177803|NCT01885078|472272367|FG000|Treatment Period|Physician Decision|19|||
131177804|NCT01885078|472272368|FG001|Treatment Period|Physician Decision|21|||
131177805|NCT01885078|472272369|FG002|Treatment Period|Physician Decision|5|||
131177806|NCT01885078|472272370|FG003|Treatment Period|Physician Decision|12|||
131177807|NCT01885078|472272371|FG004|Treatment Period|Physician Decision|9|||
131177808|NCT01885078|472272372|FG005|Treatment Period|Physician Decision|24|||
131177809|NCT01885078|472272373|FG006|Treatment Period|Physician Decision|4|||
131177810|NCT01885078|472272374|FG007|Treatment Period|Physician Decision|3|||
131177811|NCT01885078|472272375|FG008|Treatment Period|Physician Decision|0|||
131177812|NCT01885078|472272376|FG009|Treatment Period|Physician Decision|0|||
131177813|NCT01885078|472272367|FG000|Treatment Period|Protocol Violation|3|||
131177814|NCT01885078|472272368|FG001|Treatment Period|Protocol Violation|5|||
131177815|NCT01885078|472272369|FG002|Treatment Period|Protocol Violation|0|||
131177816|NCT01885078|472272370|FG003|Treatment Period|Protocol Violation|3|||
131177817|NCT01885078|472272371|FG004|Treatment Period|Protocol Violation|1|||
131177818|NCT01885078|472272372|FG005|Treatment Period|Protocol Violation|6|||
131177819|NCT01885078|472272373|FG006|Treatment Period|Protocol Violation|0|||
131177820|NCT01885078|472272374|FG007|Treatment Period|Protocol Violation|0|||
131177821|NCT01885078|472272375|FG008|Treatment Period|Protocol Violation|0|||
131177822|NCT01885078|472272376|FG009|Treatment Period|Protocol Violation|0|||
131177823|NCT01885078|472272367|FG000|Treatment Period|Sponsor Decision|245|||
131177824|NCT01885078|472272368|FG001|Treatment Period|Sponsor Decision|648|||
131177825|NCT01885078|472272369|FG002|Treatment Period|Sponsor Decision|49|||
131177826|NCT01885078|472272370|FG003|Treatment Period|Sponsor Decision|90|||
131177827|NCT01885078|472272371|FG004|Treatment Period|Sponsor Decision|20|||
131177828|NCT01885078|472272372|FG005|Treatment Period|Sponsor Decision|38|||
131177829|NCT01885078|472272373|FG006|Treatment Period|Sponsor Decision|162|||
131177830|NCT01885078|472272374|FG007|Treatment Period|Sponsor Decision|3|||
131177831|NCT01885078|472272375|FG008|Treatment Period|Sponsor Decision|0|||
131177832|NCT01885078|472272376|FG009|Treatment Period|Sponsor Decision|0|||
131177833|NCT01885078|472272367|FG000|Treatment Period|Withdrawal by Subject|72|||
131177834|NCT01885078|472272368|FG001|Treatment Period|Withdrawal by Subject|132|||
131177835|NCT01885078|472272369|FG002|Treatment Period|Withdrawal by Subject|25|||
131177836|NCT01885078|472272370|FG003|Treatment Period|Withdrawal by Subject|63|||
131177837|NCT01885078|472272371|FG004|Treatment Period|Withdrawal by Subject|15|||
131177838|NCT01885078|472272372|FG005|Treatment Period|Withdrawal by Subject|34|||
131177839|NCT01885078|472272373|FG006|Treatment Period|Withdrawal by Subject|17|||
131177840|NCT01885078|472272374|FG007|Treatment Period|Withdrawal by Subject|10|||
131177841|NCT01885078|472272375|FG008|Treatment Period|Withdrawal by Subject|0|||
131177842|NCT01885078|472272376|FG009|Treatment Period|Withdrawal by Subject|0|||
131177843|NCT01885078|472272367|FG000|Treatment Period|Other|0|||
131177844|NCT01885078|472272368|FG001|Treatment Period|Other|0|||
131177845|NCT01885078|472272369|FG002|Treatment Period|Other|0|||
131177846|NCT01885078|472272370|FG003|Treatment Period|Other|1|||
131177847|NCT01885078|472272371|FG004|Treatment Period|Other|0|||
131177848|NCT01885078|472272372|FG005|Treatment Period|Other|0|||
131177849|NCT01885078|472272373|FG006|Treatment Period|Other|0|||
131177850|NCT01885078|472272374|FG007|Treatment Period|Other|0|||
131177851|NCT01885078|472272375|FG008|Treatment Period|Other|0|||
131177852|NCT01885078|472272376|FG009|Treatment Period|Other|0|||
131177853|NCT01885078|472272367|FG000|Step-down Period|Sponsor Decision|0|||
131177854|NCT01885078|472272368|FG001|Step-down Period|Sponsor Decision|0|||
131177855|NCT01885078|472272369|FG002|Step-down Period|Sponsor Decision|0|||
131177856|NCT01885078|472272370|FG003|Step-down Period|Sponsor Decision|0|||
131177857|NCT01885078|472272371|FG004|Step-down Period|Sponsor Decision|0|||
131177858|NCT01885078|472272372|FG005|Step-down Period|Sponsor Decision|0|||
131177859|NCT01885078|472272373|FG006|Step-down Period|Sponsor Decision|0|||
131177860|NCT01885078|472272374|FG007|Step-down Period|Sponsor Decision|0|||
131177861|NCT01885078|472272375|FG008|Step-down Period|Sponsor Decision|1|||
131177862|NCT01885078|472272376|FG009|Step-down Period|Sponsor Decision|1|||
131177863|NCT01885078|472272367|FG000|Step-down Period|Adverse Event|0|||
131177864|NCT01885078|472272368|FG001|Step-down Period|Adverse Event|0|||
131177865|NCT01885078|472272369|FG002|Step-down Period|Adverse Event|0|||
131177866|NCT01885078|472272370|FG003|Step-down Period|Adverse Event|0|||
131177867|NCT01885078|472272371|FG004|Step-down Period|Adverse Event|0|||
131177868|NCT01885078|472272372|FG005|Step-down Period|Adverse Event|0|||
131177869|NCT01885078|472272373|FG006|Step-down Period|Adverse Event|0|||
131177870|NCT01885078|472272374|FG007|Step-down Period|Adverse Event|0|||
131177871|NCT01885078|472272375|FG008|Step-down Period|Adverse Event|29|||
131177872|NCT01885078|472272376|FG009|Step-down Period|Adverse Event|38|||
131177873|NCT01885078|472272367|FG000|Step-down Period|Withdrawal by Subject|0|||
131177874|NCT01885078|472272368|FG001|Step-down Period|Withdrawal by Subject|0|||
131177875|NCT01885078|472272369|FG002|Step-down Period|Withdrawal by Subject|0|||
131177876|NCT01885078|472272370|FG003|Step-down Period|Withdrawal by Subject|0|||
131177877|NCT01885078|472272371|FG004|Step-down Period|Withdrawal by Subject|0|||
131177878|NCT01885078|472272372|FG005|Step-down Period|Withdrawal by Subject|0|||
131177879|NCT01885078|472272373|FG006|Step-down Period|Withdrawal by Subject|0|||
131177880|NCT01885078|472272374|FG007|Step-down Period|Withdrawal by Subject|0|||
131177881|NCT01885078|472272375|FG008|Step-down Period|Withdrawal by Subject|25|||
131177882|NCT01885078|472272376|FG009|Step-down Period|Withdrawal by Subject|15|||
131177883|NCT01885078|472272367|FG000|Step-down Period|Physician Decision|0|||
131177884|NCT01885078|472272368|FG001|Step-down Period|Physician Decision|0|||
131177885|NCT01885078|472272369|FG002|Step-down Period|Physician Decision|0|||
131177886|NCT01885078|472272370|FG003|Step-down Period|Physician Decision|0|||
131177887|NCT01885078|472272371|FG004|Step-down Period|Physician Decision|0|||
131177888|NCT01885078|472272372|FG005|Step-down Period|Physician Decision|0|||
130783122|NCT00846586|470833223|FG000|Overall Study|Adverse Event|20|||
131177889|NCT01885078|472272373|FG006|Step-down Period|Physician Decision|0|||
131177890|NCT01885078|472272374|FG007|Step-down Period|Physician Decision|0|||
131177891|NCT01885078|472272375|FG008|Step-down Period|Physician Decision|7|||
131177892|NCT01885078|472272376|FG009|Step-down Period|Physician Decision|2|||
131177893|NCT01885078|472272367|FG000|Step-down Period|Death|0|||
131177894|NCT01885078|472272368|FG001|Step-down Period|Death|0|||
131177895|NCT01885078|472272369|FG002|Step-down Period|Death|0|||
131177896|NCT01885078|472272370|FG003|Step-down Period|Death|0|||
131177897|NCT01885078|472272371|FG004|Step-down Period|Death|0|||
131177898|NCT01885078|472272372|FG005|Step-down Period|Death|0|||
131177899|NCT01885078|472272373|FG006|Step-down Period|Death|0|||
131237225|NCT03913195|472499951|FG001|Overall Study|Adverse Event|0|||
131237226|NCT03913195|472499952|FG002|Overall Study|Adverse Event|1|||
131237227|NCT03913195|472499953|FG003|Overall Study|Adverse Event|1|||
131177900|NCT01885078|472272374|FG007|Step-down Period|Death|0|||
131177901|NCT01885078|472272375|FG008|Step-down Period|Death|4|||
131177902|NCT01885078|472272376|FG009|Step-down Period|Death|3|||
131177903|NCT01885078|472272367|FG000|Step-down Period|Lost to Follow-up|0|||
131177904|NCT01885078|472272368|FG001|Step-down Period|Lost to Follow-up|0|||
131177905|NCT01885078|472272369|FG002|Step-down Period|Lost to Follow-up|0|||
131177906|NCT01885078|472272370|FG003|Step-down Period|Lost to Follow-up|0|||
131177907|NCT01885078|472272371|FG004|Step-down Period|Lost to Follow-up|0|||
131177908|NCT01885078|472272372|FG005|Step-down Period|Lost to Follow-up|0|||
131177909|NCT01885078|472272373|FG006|Step-down Period|Lost to Follow-up|0|||
131177910|NCT01885078|472272374|FG007|Step-down Period|Lost to Follow-up|0|||
131177911|NCT01885078|472272375|FG008|Step-down Period|Lost to Follow-up|1|||
131177912|NCT01885078|472272376|FG009|Step-down Period|Lost to Follow-up|1|||
131177913|NCT01885078|472272367|FG000|Step-down Period|Lack of Efficacy|0|||
131177914|NCT01885078|472272368|FG001|Step-down Period|Lack of Efficacy|0|||
131177915|NCT01885078|472272369|FG002|Step-down Period|Lack of Efficacy|0|||
131177916|NCT01885078|472272370|FG003|Step-down Period|Lack of Efficacy|0|||
131177917|NCT01885078|472272371|FG004|Step-down Period|Lack of Efficacy|0|||
131177918|NCT01885078|472272372|FG005|Step-down Period|Lack of Efficacy|0|||
131177919|NCT01885078|472272373|FG006|Step-down Period|Lack of Efficacy|0|||
131177920|NCT01885078|472272374|FG007|Step-down Period|Lack of Efficacy|0|||
131177921|NCT01885078|472272375|FG008|Step-down Period|Lack of Efficacy|1|||
131177922|NCT01885078|472272376|FG009|Step-down Period|Lack of Efficacy|0|||
131177923|NCT01885078|472272367|FG000|Step-down Period|Protocol Violation|0|||
131177924|NCT01885078|472272368|FG001|Step-down Period|Protocol Violation|0|||
131177925|NCT01885078|472272369|FG002|Step-down Period|Protocol Violation|0|||
131177926|NCT01885078|472272370|FG003|Step-down Period|Protocol Violation|0|||
131177927|NCT01885078|472272371|FG004|Step-down Period|Protocol Violation|0|||
131177928|NCT01885078|472272372|FG005|Step-down Period|Protocol Violation|0|||
131177929|NCT01885078|472272373|FG006|Step-down Period|Protocol Violation|0|||
131177930|NCT01885078|472272374|FG007|Step-down Period|Protocol Violation|0|||
131177931|NCT01885078|472272375|FG008|Step-down Period|Protocol Violation|1|||
131177932|NCT01885078|472272376|FG009|Step-down Period|Protocol Violation|1|||
131177933|NCT03115112|472272377|FG000|Overall Study|Adverse Event|5|||
131177934|NCT03115112|472272378|FG001|Overall Study|Adverse Event|1|||
131177935|NCT03115112|472272377|FG000|Overall Study|Withdrawal by Subject|4|||
131177936|NCT03115112|472272378|FG001|Overall Study|Withdrawal by Subject|2|||
131177937|NCT03115112|472272377|FG000|Overall Study|Lost to Follow-up|0|||
131177938|NCT03115112|472272378|FG001|Overall Study|Lost to Follow-up|1|||
131177939|NCT03115112|472272377|FG000|Overall Study|Death|1|||
131177940|NCT03115112|472272378|FG001|Overall Study|Death|0|||
131177941|NCT03115112|472272377|FG000|Overall Study|Pregnancy|1|||
131177942|NCT03115112|472272378|FG001|Overall Study|Pregnancy|0|||
131177943|NCT03115112|472272377|FG000|Overall Study|Site closure|1|||
131177944|NCT03115112|472272378|FG001|Overall Study|Site closure|1|||
131177945|NCT04019795|472272380|FG000|Overall Study|Withdrawal by Subject|1|||
131177946|NCT04019795|472272381|FG001|Overall Study|Withdrawal by Subject|2|||
131177947|NCT04019795|472272382|FG002|Overall Study|Withdrawal by Subject|2|||
131177948|NCT04019795|472272383|FG003|Overall Study|Withdrawal by Subject|1|||
131177949|NCT04019795|472272380|FG000|Overall Study|Lost to Follow-up|0|||
131177950|NCT04019795|472272381|FG001|Overall Study|Lost to Follow-up|1|||
131177951|NCT04019795|472272382|FG002|Overall Study|Lost to Follow-up|1|||
131177952|NCT04019795|472272383|FG003|Overall Study|Lost to Follow-up|2|||
131177953|NCT04019795|472272380|FG000|Overall Study|Treatment non-compliance|3|||
131177954|NCT04019795|472272381|FG001|Overall Study|Treatment non-compliance|1|||
131177955|NCT04019795|472272382|FG002|Overall Study|Treatment non-compliance|2|||
131177956|NCT04019795|472272383|FG003|Overall Study|Treatment non-compliance|0|||
131177957|NCT04019795|472272380|FG000|Overall Study|Physician Decision|0|||
131177958|NCT04019795|472272381|FG001|Overall Study|Physician Decision|0|||
131177959|NCT04019795|472272382|FG002|Overall Study|Physician Decision|1|||
131177960|NCT04019795|472272383|FG003|Overall Study|Physician Decision|0|||
131177961|NCT04019795|472272380|FG000|Overall Study|Adverse Event|1|||
131177962|NCT04019795|472272381|FG001|Overall Study|Adverse Event|0|||
131177963|NCT04019795|472272382|FG002|Overall Study|Adverse Event|0|||
131177964|NCT04019795|472272383|FG003|Overall Study|Adverse Event|0|||
131177965|NCT01204697|472272384|FG000|Overall Study|Death|26|||
131177966|NCT01204697|472272385|FG001|Overall Study|Death|27|||
131177967|NCT01204697|472272384|FG000|Overall Study|Lost to Follow-up|3|||
131177968|NCT01204697|472272385|FG001|Overall Study|Lost to Follow-up|4|||
131237228|NCT03913195|472499954|FG004|Overall Study|Adverse Event|0|||
131177969|NCT01204697|472272384|FG000|Overall Study|Withdrawal by Subject|2|||
131177970|NCT01204697|472272385|FG001|Overall Study|Withdrawal by Subject|4|||
131177971|NCT01204697|472272384|FG000|Overall Study|Randomized, but not treated|0|||
131177972|NCT01204697|472272385|FG001|Overall Study|Randomized, but not treated|1|||
131177973|NCT01205451|472272386|FG000|Overall Study|Lost to Follow-up|1|||
131237229|NCT03913195|472499950|FG000|Overall Study|Withdrawal by Subject|0|||
131177974|NCT01205451|472272387|FG001|Overall Study|Lost to Follow-up|1|||
131177975|NCT01205451|472272386|FG000|Overall Study|Withdrawal by Subject|5|||
131177976|NCT01205451|472272387|FG001|Overall Study|Withdrawal by Subject|9|||
131177977|NCT01170702|472272388|FG000|Overall Study|Exclusion criteria met after consent|1|||
131177978|NCT01170702|472272389|FG001|Overall Study|Exclusion criteria met after consent|2|||
131177979|NCT01170702|472272390|FG002|Overall Study|Exclusion criteria met after consent|0|||
131177980|NCT01170702|472272391|FG003|Overall Study|Exclusion criteria met after consent|2|||
131177981|NCT01677507|472272392|FG000|Initial Assignment|Adverse Event|0|||
131177982|NCT01677507|472272393|FG001|Initial Assignment|Adverse Event|1|||
131177983|NCT01677507|472272392|FG000|Initial Assignment|Protocol Violation|0|||
131177984|NCT01677507|472272393|FG001|Initial Assignment|Protocol Violation|1|||
131177985|NCT01677507|472272392|FG000|Second Assigment|Withdrawal by Subject|2|||
131177986|NCT01677507|472272393|FG001|Second Assigment|Withdrawal by Subject|2|||
131177987|NCT01677507|472272392|FG000|Second Assigment|Adverse Event|1|||
131177988|NCT01677507|472272393|FG001|Second Assigment|Adverse Event|3|||
131177989|NCT00712933|472272400|FG000|Overall Study|Adverse Event|69|||
131177990|NCT00712933|472272400|FG000|Overall Study|Lack of Efficacy|6|||
131177991|NCT00712933|472272400|FG000|Overall Study|Lost to Follow-up|22|||
131177992|NCT00712933|472272400|FG000|Overall Study|Non-compliance with study drug|13|||
131177993|NCT00712933|472272400|FG000|Overall Study|Other Pregnancy|37|||
131177994|NCT00712933|472272400|FG000|Overall Study|Sponsor decision|14|||
131177995|NCT00712933|472272400|FG000|Overall Study|Withdrew consent|4|||
131177996|NCT00712933|472272400|FG000|Overall Study|Hip replacement surgery|1|||
131177997|NCT00712933|472272400|FG000|Overall Study|Involved in Clinical research|3|||
131177998|NCT00712933|472272400|FG000|Overall Study|Participant hospitalized|1|||
131177999|NCT00712933|472272400|FG000|Overall Study|Participant travelled overseas|2|||
131178000|NCT00712933|472272400|FG000|Overall Study|Death of patient|1|||
131178001|NCT00712933|472272400|FG000|Overall Study|Other Physician decision|1|||
131178002|NCT00712933|472272400|FG000|Overall Study|Not committed to contraception|1|||
131178003|NCT00712933|472272400|FG000|Overall Study|Participant received medication|1|||
131178004|NCT00712933|472272400|FG000|Overall Study|Physician Decision|36|||
131178005|NCT00712933|472272400|FG000|Overall Study|Protocol Violation|4|||
131178006|NCT00712933|472272400|FG000|Overall Study|Withdrawal by Subject|151|||
131178007|NCT03084718|472272404|FG000|Overall Study|Withdrawal by Subject|4|||
131178008|NCT03084718|472272405|FG001|Overall Study|Withdrawal by Subject|3|||
131178009|NCT03084718|472272406|FG002|Overall Study|Withdrawal by Subject|4|||
131178010|NCT03084718|472272407|FG003|Overall Study|Withdrawal by Subject|0|||
131178011|NCT03084718|472272408|FG004|Overall Study|Withdrawal by Subject|0|||
131178012|NCT03084718|472272404|FG000|Overall Study|Physician Decision|1|||
131178013|NCT03084718|472272405|FG001|Overall Study|Physician Decision|0|||
131178014|NCT03084718|472272406|FG002|Overall Study|Physician Decision|0|||
131178015|NCT03084718|472272407|FG003|Overall Study|Physician Decision|0|||
131178016|NCT03084718|472272408|FG004|Overall Study|Physician Decision|0|||
131178017|NCT03084718|472272404|FG000|Overall Study|Adverse Event|3|||
131178018|NCT03084718|472272405|FG001|Overall Study|Adverse Event|5|||
131178019|NCT03084718|472272406|FG002|Overall Study|Adverse Event|5|||
131178020|NCT03084718|472272407|FG003|Overall Study|Adverse Event|8|||
131178021|NCT03084718|472272408|FG004|Overall Study|Adverse Event|2|||
131178022|NCT03084718|472272404|FG000|Overall Study|Lack of Efficacy|2|||
131178023|NCT03084718|472272405|FG001|Overall Study|Lack of Efficacy|0|||
131178024|NCT03084718|472272406|FG002|Overall Study|Lack of Efficacy|1|||
131178025|NCT03084718|472272407|FG003|Overall Study|Lack of Efficacy|4|||
131178026|NCT03084718|472272408|FG004|Overall Study|Lack of Efficacy|0|||
131178027|NCT03084718|472272404|FG000|Overall Study|Lost to Follow-up|0|||
131178028|NCT03084718|472272405|FG001|Overall Study|Lost to Follow-up|1|||
131178029|NCT03084718|472272406|FG002|Overall Study|Lost to Follow-up|0|||
131178030|NCT03084718|472272407|FG003|Overall Study|Lost to Follow-up|0|||
131178031|NCT03084718|472272408|FG004|Overall Study|Lost to Follow-up|2|||
131178032|NCT03084718|472272404|FG000|Overall Study|Protocol Violation|0|||
131178033|NCT03084718|472272405|FG001|Overall Study|Protocol Violation|0|||
131178034|NCT03084718|472272406|FG002|Overall Study|Protocol Violation|1|||
131178035|NCT03084718|472272407|FG003|Overall Study|Protocol Violation|0|||
131178036|NCT03084718|472272408|FG004|Overall Study|Protocol Violation|0|||
131178037|NCT03084718|472272404|FG000|Overall Study|Death|0|||
131178038|NCT03084718|472272405|FG001|Overall Study|Death|1|||
131178039|NCT03084718|472272406|FG002|Overall Study|Death|0|||
131178040|NCT03084718|472272407|FG003|Overall Study|Death|0|||
131178041|NCT03084718|472272408|FG004|Overall Study|Death|0|||
131178042|NCT03084718|472272404|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
131178043|NCT03084718|472272405|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
131178044|NCT03084718|472272406|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
131178045|NCT03084718|472272407|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
131178046|NCT03084718|472272408|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
131178047|NCT00424294|472272409|FG000|Overall Study|Adverse Event|4|||
131178048|NCT00424294|472272410|FG001|Overall Study|Adverse Event|10|||
131178049|NCT00424294|472272409|FG000|Overall Study|Lack of Efficacy|2|||
131178050|NCT00424294|472272410|FG001|Overall Study|Lack of Efficacy|1|||
131178051|NCT00424294|472272409|FG000|Overall Study|Withdrawal by Subject|1|||
131178052|NCT00424294|472272410|FG001|Overall Study|Withdrawal by Subject|2|||
131178053|NCT00424294|472272409|FG000|Overall Study|Other|0|||
131178054|NCT00424294|472272410|FG001|Overall Study|Other|2|||
131178055|NCT00424294|472272409|FG000|Overall Study|Randomized but not Treated|1|||
131178056|NCT00424294|472272410|FG001|Overall Study|Randomized but not Treated|0|||
131178057|NCT01464788|472272411|FG000|Overall Study|Lost to Follow-up|0|||
131178058|NCT01464788|472272412|FG001|Overall Study|Lost to Follow-up|1|||
131178059|NCT01464788|472272413|FG002|Overall Study|Lost to Follow-up|0|||
131178060|NCT01464788|472272411|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
131178061|NCT01464788|472272412|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
131178062|NCT01464788|472272413|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
131178063|NCT00239837|472272415|FG000|Overall Study|Lost to Follow-up|3|||
131178064|NCT00239837|472272416|FG001|Overall Study|Lost to Follow-up|7|||
131178065|NCT01153893|472272417|FG000|Overall Study|Adverse Event|1|||
131178066|NCT01153893|472272418|FG001|Overall Study|Adverse Event|0|||
131178067|NCT01838590|472272419|FG000|Overall Study|Lack of Efficacy|12|||
131178068|NCT01838590|472272420|FG001|Overall Study|Lack of Efficacy|4|||
131178069|NCT01838590|472272419|FG000|Overall Study|Lost to Follow-up|0|||
131178070|NCT01838590|472272420|FG001|Overall Study|Lost to Follow-up|1|||
131178071|NCT00536978|472272421|FG000|Overall Study|Not eligible for Adback Infusion|22|||
131178072|NCT03550131|472272423|FG000|Overall Study|Lost to Follow-up|16|||
131178073|NCT03550131|472272424|FG001|Overall Study|Lost to Follow-up|24|||
131178074|NCT03550131|472272423|FG000|Overall Study|Withdrawal by Subject|36|||
131178075|NCT03550131|472272424|FG001|Overall Study|Withdrawal by Subject|28|||
131178076|NCT03550131|472272423|FG000|Overall Study|Illness of dyad member|10|||
131178077|NCT03550131|472272424|FG001|Overall Study|Illness of dyad member|2|||
131178078|NCT03550131|472272423|FG000|Overall Study|Death of person with dementia|4|||
131178079|NCT03550131|472272424|FG001|Overall Study|Death of person with dementia|8|||
131178080|NCT01318512|472272425|FG000|Maintenance Period (6 Months)|Death|2|||
131178081|NCT01318512|472272425|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
131178082|NCT01364233|472272429|FG000|Overall Study|Lost to Follow-up|1|||
131178083|NCT00302718|472272433|FG000|Overall Study|Participant left the hospital|1|||
131178084|NCT00302718|472272434|FG001|Overall Study|Participant left the hospital|0|||
131178085|NCT00302718|472272435|FG002|Overall Study|Participant left the hospital|0|||
131178086|NCT00302718|472272436|FG003|Overall Study|Participant left the hospital|1|||
131178087|NCT00302718|472272433|FG000|Overall Study|Withdrawal by Subject|0|||
131178088|NCT00302718|472272434|FG001|Overall Study|Withdrawal by Subject|1|||
131178089|NCT00302718|472272435|FG002|Overall Study|Withdrawal by Subject|0|||
131178090|NCT00302718|472272436|FG003|Overall Study|Withdrawal by Subject|0|||
131178091|NCT00302718|472272433|FG000|Overall Study|Participant left primary care setting|0|||
131178092|NCT00302718|472272434|FG001|Overall Study|Participant left primary care setting|0|||
131178093|NCT00302718|472272435|FG002|Overall Study|Participant left primary care setting|2|||
131178094|NCT00302718|472272436|FG003|Overall Study|Participant left primary care setting|1|||
131178095|NCT00819585|472272437|FG000|Core Study|Adverse Event|2|||
131178096|NCT00819585|472272438|FG001|Core Study|Adverse Event|1|||
131178097|NCT00819585|472272439|FG002|Core Study|Adverse Event|1|||
131178098|NCT00819585|472272440|FG003|Core Study|Adverse Event|4|||
131178099|NCT00819585|472272441|FG004|Core Study|Adverse Event|1|||
131178100|NCT00819585|472272442|FG005|Core Study|Adverse Event|0|||
131178101|NCT00819585|472272443|FG006|Core Study|Adverse Event|2|||
131178102|NCT00819585|472272444|FG007|Core Study|Adverse Event|0|||
131178103|NCT00819585|472272445|FG008|Core Study|Adverse Event|0|||
131178104|NCT00819585|472272446|FG009|Core Study|Adverse Event|0|||
131178105|NCT00819585|472272447|FG010|Core Study|Adverse Event|0|||
131178106|NCT00819585|472272437|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
131178107|NCT00819585|472272438|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
131178108|NCT00819585|472272439|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
131178109|NCT00819585|472272440|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
131178110|NCT00819585|472272441|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
131178111|NCT00819585|472272442|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
131178112|NCT00819585|472272443|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
131178113|NCT00819585|472272444|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
131178114|NCT00819585|472272445|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
131178115|NCT00819585|472272446|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
131178116|NCT00819585|472272447|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
131178117|NCT00819585|472272437|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
131178118|NCT00819585|472272438|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
131178119|NCT00819585|472272439|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
131178120|NCT00819585|472272440|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
131178121|NCT00819585|472272441|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
131178122|NCT00819585|472272442|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
131178123|NCT00819585|472272443|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
131178124|NCT00819585|472272444|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
131178125|NCT00819585|472272445|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
130783123|NCT00846586|470833224|FG001|Overall Study|Adverse Event|10|||
130783124|NCT00846586|470833223|FG000|Overall Study|Subject withdrew consent|8|||
130783125|NCT00846586|470833224|FG001|Overall Study|Subject withdrew consent|10|||
130783126|NCT00846586|470833223|FG000|Overall Study|Administrative problems|5|||
130783127|NCT00846586|470833224|FG001|Overall Study|Administrative problems|4|||
130783128|NCT00846586|470833223|FG000|Overall Study|Death|2|||
130783129|NCT00846586|470833224|FG001|Overall Study|Death|0|||
130783130|NCT00846586|470833223|FG000|Overall Study|Protocol deviation|2|||
130783131|NCT00846586|470833224|FG001|Overall Study|Protocol deviation|6|||
130783132|NCT00846586|470833223|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130783133|NCT00846586|470833224|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130783134|NCT00846586|470833223|FG000|Overall Study|Lost to Follow-up|1|||
130783135|NCT00846586|470833224|FG001|Overall Study|Lost to Follow-up|4|||
130783136|NCT00846586|470833223|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130783137|NCT00846586|470833224|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130783138|NCT00735007|470833225|FG000|Overall Study|Adverse Event|4|||
130783139|NCT00735007|470833225|FG000|Overall Study|Protocol Violation|1|||
130783140|NCT01061606|470833226|FG000|Overall Study|Adverse Event|1|||
130783141|NCT01061606|470833226|FG000|Overall Study|Death|1|||
130783142|NCT01061606|470833226|FG000|Overall Study|Disease Progression|4|||
130783143|NCT01061606|470833226|FG000|Overall Study|alternative therapy|2|||
130783144|NCT00715403|470833227|FG000|Overall Study|Progressive disease|0|||
130783145|NCT00715403|470833228|FG001|Overall Study|Progressive disease|1|||
130783146|NCT00715403|470833229|FG002|Overall Study|Progressive disease|3|||
130783147|NCT00715403|470833230|FG003|Overall Study|Progressive disease|9|||
130783148|NCT00715403|470833231|FG004|Overall Study|Progressive disease|5|||
130783149|NCT00715403|470833232|FG005|Overall Study|Progressive disease|14|||
130783150|NCT00715403|470833233|FG006|Overall Study|Progressive disease|1|||
130783151|NCT00715403|470833227|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
130783152|NCT00715403|470833228|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
130783153|NCT00715403|470833229|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
131178126|NCT00819585|472272446|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
131178127|NCT00819585|472272447|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
131178128|NCT00819585|472272437|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
131178129|NCT00819585|472272438|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
131178130|NCT00819585|472272439|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
131178131|NCT00819585|472272440|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
131178132|NCT00819585|472272441|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
131178133|NCT00819585|472272442|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
131178134|NCT00819585|472272443|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
131178135|NCT00819585|472272444|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
131178136|NCT00819585|472272445|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
131178137|NCT00819585|472272446|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
131178138|NCT00819585|472272447|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
131178139|NCT00819585|472272437|FG000|Core Study|Subject Withdrew Consent|0|||
131178140|NCT00819585|472272438|FG001|Core Study|Subject Withdrew Consent|3|||
131178141|NCT00819585|472272439|FG002|Core Study|Subject Withdrew Consent|2|||
131178142|NCT00819585|472272440|FG003|Core Study|Subject Withdrew Consent|1|||
131178143|NCT00819585|472272441|FG004|Core Study|Subject Withdrew Consent|0|||
131178144|NCT00819585|472272442|FG005|Core Study|Subject Withdrew Consent|0|||
131178145|NCT00819585|472272443|FG006|Core Study|Subject Withdrew Consent|3|||
131178146|NCT00819585|472272444|FG007|Core Study|Subject Withdrew Consent|0|||
131178147|NCT00819585|472272445|FG008|Core Study|Subject Withdrew Consent|0|||
131178148|NCT00819585|472272446|FG009|Core Study|Subject Withdrew Consent|0|||
131178149|NCT00819585|472272447|FG010|Core Study|Subject Withdrew Consent|0|||
131178150|NCT00819585|472272437|FG000|Core Study|Lost to Follow-up|2|||
131178151|NCT00819585|472272438|FG001|Core Study|Lost to Follow-up|1|||
131178152|NCT00819585|472272439|FG002|Core Study|Lost to Follow-up|2|||
131178153|NCT00819585|472272440|FG003|Core Study|Lost to Follow-up|0|||
131178154|NCT00819585|472272441|FG004|Core Study|Lost to Follow-up|1|||
131178155|NCT00819585|472272442|FG005|Core Study|Lost to Follow-up|1|||
131178156|NCT00819585|472272443|FG006|Core Study|Lost to Follow-up|1|||
131178157|NCT00819585|472272444|FG007|Core Study|Lost to Follow-up|0|||
131178158|NCT00819585|472272445|FG008|Core Study|Lost to Follow-up|0|||
131178159|NCT00819585|472272446|FG009|Core Study|Lost to Follow-up|0|||
131178160|NCT00819585|472272447|FG010|Core Study|Lost to Follow-up|0|||
131178161|NCT00819585|472272437|FG000|Core Study|Administrative Problems|0|||
131178162|NCT00819585|472272438|FG001|Core Study|Administrative Problems|0|||
131178163|NCT00819585|472272439|FG002|Core Study|Administrative Problems|0|||
131178164|NCT00819585|472272440|FG003|Core Study|Administrative Problems|0|||
130783154|NCT00715403|470833230|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
130783155|NCT00715403|470833231|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
130783156|NCT00715403|470833232|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
130783157|NCT00715403|470833233|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
131178165|NCT00819585|472272441|FG004|Core Study|Administrative Problems|0|||
131178166|NCT00819585|472272442|FG005|Core Study|Administrative Problems|0|||
131237230|NCT03913195|472499951|FG001|Overall Study|Withdrawal by Subject|0|||
131237231|NCT03913195|472499952|FG002|Overall Study|Withdrawal by Subject|1|||
131237232|NCT03913195|472499953|FG003|Overall Study|Withdrawal by Subject|0|||
131237233|NCT03913195|472499954|FG004|Overall Study|Withdrawal by Subject|1|||
131237234|NCT03913195|472499950|FG000|Overall Study|non adherence to study|0|||
131237235|NCT03913195|472499951|FG001|Overall Study|non adherence to study|0|||
131237236|NCT03913195|472499952|FG002|Overall Study|non adherence to study|1|||
131237237|NCT03913195|472499953|FG003|Overall Study|non adherence to study|0|||
131237238|NCT03913195|472499954|FG004|Overall Study|non adherence to study|0|||
131237239|NCT02141438|472499963|FG000|Overall Study|Death|1308|||
131237240|NCT02141438|472499963|FG000|Overall Study|Lost to Follow-up|84|||
131237241|NCT02141438|472499963|FG000|Overall Study|Withdrawal by Subject|52|||
131237242|NCT02141438|472499963|FG000|Overall Study|Physician Decision|1|||
131237243|NCT02141438|472499963|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
131237244|NCT02180711|472499964|FG000|Overall Study|Death|0|||
131237245|NCT02180711|472499965|FG001|Overall Study|Death|1|||
131237246|NCT02180711|472499966|FG002|Overall Study|Death|0|||
131237247|NCT02180711|472499967|FG003|Overall Study|Death|0|||
131237248|NCT02180711|472499968|FG004|Overall Study|Death|7|||
131237249|NCT02180711|472499969|FG005|Overall Study|Death|0|||
131237250|NCT02180711|472499970|FG006|Overall Study|Death|1|||
131237251|NCT02180711|472499971|FG007|Overall Study|Death|3|||
131237252|NCT02180711|472499964|FG000|Overall Study|Lost to Follow-up|0|||
131237253|NCT02180711|472499965|FG001|Overall Study|Lost to Follow-up|1|||
131237254|NCT02180711|472499966|FG002|Overall Study|Lost to Follow-up|0|||
131237255|NCT02180711|472499967|FG003|Overall Study|Lost to Follow-up|0|||
131237256|NCT02180711|472499968|FG004|Overall Study|Lost to Follow-up|1|||
131237257|NCT02180711|472499969|FG005|Overall Study|Lost to Follow-up|1|||
131237258|NCT02180711|472499970|FG006|Overall Study|Lost to Follow-up|0|||
131237259|NCT02180711|472499971|FG007|Overall Study|Lost to Follow-up|3|||
131237260|NCT02180711|472499964|FG000|Overall Study|Withdrawal by Subject|2|||
131237261|NCT02180711|472499965|FG001|Overall Study|Withdrawal by Subject|1|||
131237262|NCT02180711|472499966|FG002|Overall Study|Withdrawal by Subject|0|||
131237263|NCT02180711|472499967|FG003|Overall Study|Withdrawal by Subject|4|||
131237264|NCT02180711|472499968|FG004|Overall Study|Withdrawal by Subject|3|||
131237265|NCT02180711|472499969|FG005|Overall Study|Withdrawal by Subject|0|||
131237266|NCT02180711|472499970|FG006|Overall Study|Withdrawal by Subject|3|||
131237267|NCT02180711|472499971|FG007|Overall Study|Withdrawal by Subject|2|||
131237268|NCT02180711|472499964|FG000|Overall Study|- Disease Progression|0|||
131237269|NCT02180711|472499965|FG001|Overall Study|- Disease Progression|1|||
131237270|NCT02180711|472499966|FG002|Overall Study|- Disease Progression|0|||
131237271|NCT02180711|472499967|FG003|Overall Study|- Disease Progression|0|||
131237272|NCT02180711|472499968|FG004|Overall Study|- Disease Progression|0|||
131237273|NCT02180711|472499969|FG005|Overall Study|- Disease Progression|0|||
131237274|NCT02180711|472499970|FG006|Overall Study|- Disease Progression|0|||
131237275|NCT02180711|472499971|FG007|Overall Study|- Disease Progression|0|||
131237276|NCT02180711|472499964|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
131237277|NCT02180711|472499965|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
131237278|NCT02180711|472499966|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
131237279|NCT02180711|472499967|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
131237280|NCT02180711|472499968|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
131237281|NCT02180711|472499969|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
131237282|NCT02180711|472499970|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
131237283|NCT02180711|472499971|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
131237284|NCT02180711|472499964|FG000|Overall Study|- Study Terminated by Sponsor|2|||
131237285|NCT02180711|472499965|FG001|Overall Study|- Study Terminated by Sponsor|3|||
131237286|NCT02180711|472499966|FG002|Overall Study|- Study Terminated by Sponsor|0|||
131237287|NCT02180711|472499967|FG003|Overall Study|- Study Terminated by Sponsor|5|||
131237288|NCT02180711|472499968|FG004|Overall Study|- Study Terminated by Sponsor|32|||
131237289|NCT02180711|472499969|FG005|Overall Study|- Study Terminated by Sponsor|0|||
131237290|NCT02180711|472499970|FG006|Overall Study|- Study Terminated by Sponsor|4|||
131237291|NCT02180711|472499971|FG007|Overall Study|- Study Terminated by Sponsor|13|||
131237292|NCT02180711|472499964|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
131237293|NCT02180711|472499965|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
131237294|NCT02180711|472499966|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
131237295|NCT02180711|472499967|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
131237296|NCT02180711|472499968|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
131237297|NCT02180711|472499969|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
131237298|NCT02180711|472499970|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
131237299|NCT02180711|472499971|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
131237300|NCT02180711|472499964|FG000|Overall Study|- Other|1|||
131237301|NCT02180711|472499965|FG001|Overall Study|- Other|0|||
131237302|NCT02180711|472499966|FG002|Overall Study|- Other|0|||
131237303|NCT02180711|472499967|FG003|Overall Study|- Other|1|||
131178167|NCT00819585|472272443|FG006|Core Study|Administrative Problems|2|||
131178168|NCT00819585|472272444|FG007|Core Study|Administrative Problems|0|||
131178169|NCT00819585|472272445|FG008|Core Study|Administrative Problems|0|||
131178170|NCT00819585|472272446|FG009|Core Study|Administrative Problems|0|||
131178171|NCT00819585|472272447|FG010|Core Study|Administrative Problems|0|||
131178172|NCT00819585|472272437|FG000|Core Study|Death|0|||
131178173|NCT00819585|472272438|FG001|Core Study|Death|0|||
131178174|NCT00819585|472272439|FG002|Core Study|Death|0|||
131178175|NCT00819585|472272440|FG003|Core Study|Death|0|||
131178176|NCT00819585|472272441|FG004|Core Study|Death|0|||
131178177|NCT00819585|472272442|FG005|Core Study|Death|0|||
131178178|NCT00819585|472272443|FG006|Core Study|Death|1|||
131178179|NCT00819585|472272444|FG007|Core Study|Death|0|||
131178180|NCT00819585|472272445|FG008|Core Study|Death|0|||
131178181|NCT00819585|472272446|FG009|Core Study|Death|0|||
131178182|NCT00819585|472272447|FG010|Core Study|Death|0|||
131178183|NCT00819585|472272437|FG000|Core Study|Protocol Violation|0|||
131178184|NCT00819585|472272438|FG001|Core Study|Protocol Violation|0|||
131178185|NCT00819585|472272439|FG002|Core Study|Protocol Violation|1|||
131178186|NCT00819585|472272440|FG003|Core Study|Protocol Violation|0|||
131178187|NCT00819585|472272441|FG004|Core Study|Protocol Violation|0|||
131178188|NCT00819585|472272442|FG005|Core Study|Protocol Violation|1|||
131178189|NCT00819585|472272443|FG006|Core Study|Protocol Violation|3|||
131178190|NCT00819585|472272444|FG007|Core Study|Protocol Violation|0|||
131178191|NCT00819585|472272445|FG008|Core Study|Protocol Violation|0|||
131178192|NCT00819585|472272446|FG009|Core Study|Protocol Violation|0|||
131178193|NCT00819585|472272447|FG010|Core Study|Protocol Violation|0|||
131178194|NCT00819585|472272437|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
131178195|NCT00819585|472272438|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
131178196|NCT00819585|472272439|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
131178197|NCT00819585|472272440|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
131178198|NCT00819585|472272441|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
131178199|NCT00819585|472272442|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
131178200|NCT00819585|472272443|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
131178201|NCT00819585|472272444|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
131178202|NCT00819585|472272445|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
131178203|NCT00819585|472272446|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
131178204|NCT00819585|472272447|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
131178205|NCT00819585|472272437|FG000|Extension Study|Subject Withdrew Consent|0|||
131178206|NCT00819585|472272438|FG001|Extension Study|Subject Withdrew Consent|0|||
131178207|NCT00819585|472272439|FG002|Extension Study|Subject Withdrew Consent|0|||
131178208|NCT00819585|472272440|FG003|Extension Study|Subject Withdrew Consent|0|||
131178209|NCT00819585|472272441|FG004|Extension Study|Subject Withdrew Consent|0|||
131178210|NCT00819585|472272442|FG005|Extension Study|Subject Withdrew Consent|0|||
131178211|NCT00819585|472272443|FG006|Extension Study|Subject Withdrew Consent|0|||
131178212|NCT00819585|472272444|FG007|Extension Study|Subject Withdrew Consent|0|||
131178213|NCT00819585|472272445|FG008|Extension Study|Subject Withdrew Consent|3|||
131178214|NCT00819585|472272446|FG009|Extension Study|Subject Withdrew Consent|0|||
131178215|NCT00819585|472272447|FG010|Extension Study|Subject Withdrew Consent|1|||
131178216|NCT00819585|472272437|FG000|Extension Study|Lost to Follow-up|0|||
131178217|NCT00819585|472272438|FG001|Extension Study|Lost to Follow-up|0|||
131178218|NCT00819585|472272439|FG002|Extension Study|Lost to Follow-up|0|||
131178219|NCT00819585|472272440|FG003|Extension Study|Lost to Follow-up|0|||
131178220|NCT00819585|472272441|FG004|Extension Study|Lost to Follow-up|0|||
131178221|NCT00819585|472272442|FG005|Extension Study|Lost to Follow-up|0|||
131178222|NCT00819585|472272443|FG006|Extension Study|Lost to Follow-up|0|||
131178223|NCT00819585|472272444|FG007|Extension Study|Lost to Follow-up|0|||
131178224|NCT00819585|472272445|FG008|Extension Study|Lost to Follow-up|2|||
131178225|NCT00819585|472272446|FG009|Extension Study|Lost to Follow-up|1|||
131178226|NCT00819585|472272447|FG010|Extension Study|Lost to Follow-up|1|||
131178227|NCT00819585|472272437|FG000|Extension Study|Death|0|||
131178228|NCT00819585|472272438|FG001|Extension Study|Death|0|||
131178229|NCT00819585|472272439|FG002|Extension Study|Death|0|||
131178230|NCT00819585|472272440|FG003|Extension Study|Death|0|||
131178231|NCT00819585|472272441|FG004|Extension Study|Death|0|||
131178232|NCT00819585|472272442|FG005|Extension Study|Death|0|||
131178233|NCT00819585|472272443|FG006|Extension Study|Death|0|||
131178234|NCT00819585|472272444|FG007|Extension Study|Death|0|||
131178235|NCT00819585|472272445|FG008|Extension Study|Death|2|||
131178236|NCT00819585|472272446|FG009|Extension Study|Death|0|||
131178237|NCT00819585|472272447|FG010|Extension Study|Death|0|||
131178238|NCT00632541|472272448|FG000|Overall Study|Adverse Event|7|||
131178239|NCT02159469|472272452|FG000|Overall Study|Missing Completion status|1|||
131178240|NCT02159469|472272452|FG000|Overall Study|Adverse Event|5|||
131178241|NCT02159469|472272452|FG000|Overall Study|Non-compliance|2|||
131178242|NCT02159469|472272452|FG000|Overall Study|Withdrawal by Subject|9|||
131178243|NCT02159469|472272452|FG000|Overall Study|Lost to Follow-up|1|||
131178244|NCT02159469|472272452|FG000|Overall Study|Sponsor's request|2|||
131178245|NCT02159469|472272452|FG000|Overall Study|Met Stopping Criteria|3|||
131178246|NCT02159469|472272452|FG000|Overall Study|Other|1|||
131178247|NCT02159469|472272452|FG000|Overall Study|Multiple|29|||
131178248|NCT02927873|472272453|FG000|Overall Study|Lost to Follow-up|0|||
131178249|NCT02927873|472272454|FG001|Overall Study|Lost to Follow-up|1|||
131178250|NCT02927873|472272455|FG002|Overall Study|Lost to Follow-up|0|||
131178251|NCT02927873|472272456|FG003|Overall Study|Lost to Follow-up|0|||
131178252|NCT02927873|472272457|FG004|Overall Study|Lost to Follow-up|0|||
131178253|NCT02927873|472272458|FG005|Overall Study|Lost to Follow-up|0|||
131178254|NCT02927873|472272453|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131178255|NCT02927873|472272454|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
131178256|NCT02927873|472272455|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131178257|NCT02927873|472272456|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131178258|NCT02927873|472272457|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131178259|NCT02927873|472272458|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
131178260|NCT02927873|472272453|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131178261|NCT02927873|472272454|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131178262|NCT02927873|472272455|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131178263|NCT02927873|472272456|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131178264|NCT02927873|472272457|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131178265|NCT02927873|472272458|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131178266|NCT02927873|472272453|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
131178267|NCT02927873|472272454|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
131178268|NCT02927873|472272455|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
131178269|NCT02927873|472272456|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
131178270|NCT02927873|472272457|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
131178271|NCT02927873|472272458|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
131178272|NCT02927873|472272453|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
131178273|NCT02927873|472272454|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
131178274|NCT02927873|472272455|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
131178275|NCT02927873|472272456|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
131178276|NCT02927873|472272457|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
131178277|NCT02927873|472272458|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
131178278|NCT02927873|472272453|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
131178279|NCT02927873|472272454|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
131178280|NCT02927873|472272455|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
131178281|NCT02927873|472272456|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
131178282|NCT02927873|472272457|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
131178283|NCT02927873|472272458|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
131178284|NCT03629041|472272459|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
131178285|NCT03629041|472272460|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
131178286|NCT03629041|472272461|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
131178287|NCT03629041|472272462|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
131178288|NCT00393913|472272469|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
131178289|NCT00393913|472272469|FG000|Initial Assessment|Withdrawal by Subject|16|||
131178290|NCT00393913|472272469|FG000|CPAP|Withdrawal by Subject|3|||
131178291|NCT00393913|472272469|FG000|CPAP|Physician Decision|1|||
131178292|NCT00393913|472272469|FG000|CPAP|TEchnical problem with CPAP|3|||
131178293|NCT00995670|472272472|FG000|Overall Study|Failed arterial cannulation|1|||
131178294|NCT00995670|472272473|FG001|Overall Study|Failed arterial cannulation|0|||
131178295|NCT00995670|472272474|FG002|Overall Study|Failed arterial cannulation|3|||
131178296|NCT00383721|472272478|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
131178297|NCT00383721|472272479|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
131178298|NCT00383721|472272480|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
131178299|NCT00383721|472272481|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
131178300|NCT00383721|472272482|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
131178301|NCT00383721|472272478|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
131178302|NCT00383721|472272479|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
131178303|NCT00383721|472272480|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
131178304|NCT00383721|472272481|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
131178305|NCT00383721|472272482|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
131178306|NCT00383721|472272478|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
131178307|NCT00383721|472272479|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
131178308|NCT00383721|472272480|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
131178309|NCT00383721|472272481|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
131178310|NCT00383721|472272482|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
131178311|NCT00383721|472272478|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
131178312|NCT00383721|472272479|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
131178313|NCT00383721|472272480|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
130783158|NCT00715403|470833227|FG000|Overall Study|Other Adverse Event than DLT|1|||
130783159|NCT00715403|470833228|FG001|Overall Study|Other Adverse Event than DLT|0|||
130783160|NCT00715403|470833229|FG002|Overall Study|Other Adverse Event than DLT|0|||
130783161|NCT00715403|470833230|FG003|Overall Study|Other Adverse Event than DLT|0|||
130783162|NCT00715403|470833231|FG004|Overall Study|Other Adverse Event than DLT|0|||
130783163|NCT00715403|470833232|FG005|Overall Study|Other Adverse Event than DLT|2|||
130783164|NCT00715403|470833233|FG006|Overall Study|Other Adverse Event than DLT|0|||
130783165|NCT00715403|470833227|FG000|Overall Study|Protocol Violation|0|||
130783166|NCT00715403|470833228|FG001|Overall Study|Protocol Violation|0|||
130783167|NCT00715403|470833229|FG002|Overall Study|Protocol Violation|0|||
130783168|NCT00715403|470833230|FG003|Overall Study|Protocol Violation|0|||
130783169|NCT00715403|470833231|FG004|Overall Study|Protocol Violation|0|||
130783170|NCT00715403|470833232|FG005|Overall Study|Protocol Violation|1|||
130783171|NCT00715403|470833233|FG006|Overall Study|Protocol Violation|0|||
130783172|NCT00715403|470833227|FG000|Overall Study|Other reason not defined above|0|||
130783173|NCT00715403|470833228|FG001|Overall Study|Other reason not defined above|0|||
130783174|NCT00715403|470833229|FG002|Overall Study|Other reason not defined above|1|||
130783175|NCT00715403|470833230|FG003|Overall Study|Other reason not defined above|0|||
130783176|NCT00715403|470833231|FG004|Overall Study|Other reason not defined above|1|||
130783177|NCT00715403|470833232|FG005|Overall Study|Other reason not defined above|1|||
130783178|NCT00715403|470833233|FG006|Overall Study|Other reason not defined above|0|||
130783179|NCT01789047|470833234|FG000|Overall Study|Adverse Event|3|||
130783180|NCT01789047|470833235|FG001|Overall Study|Adverse Event|2|||
130783181|NCT01789047|470833234|FG000|Overall Study|Withdrawal by Subject|1|||
130783182|NCT01789047|470833235|FG001|Overall Study|Withdrawal by Subject|2|||
130783183|NCT03644017|470833236|FG000|Overall Study|Access Abandonment|5|||
130783184|NCT03644017|470833236|FG000|Overall Study|Kidney Transplant|2|||
130783185|NCT02340000|470833239|FG000|Time Period 1|Withdrawal by Subject|6|||
130783186|NCT02340000|470833240|FG001|Time Period 1|Withdrawal by Subject|8|||
130783187|NCT02340000|470833239|FG000|Time Period 1|Lost to Follow-up|6|||
130783188|NCT02340000|470833240|FG001|Time Period 1|Lost to Follow-up|7|||
130783189|NCT02340000|470833239|FG000|Time Period 2|Withdrawal by Subject|9|||
130783190|NCT02340000|470833240|FG001|Time Period 2|Withdrawal by Subject|7|||
130783191|NCT02340000|470833239|FG000|Time Period 2|Lost to Follow-up|10|||
130783192|NCT02340000|470833240|FG001|Time Period 2|Lost to Follow-up|8|||
130783193|NCT01883895|470833245|FG000|Overall Study|Lost to Follow-up|2|||
130783194|NCT00073918|470833246|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
130783195|NCT00073918|470833246|FG000|Overall Study|Rapid disease progression|2|||
130783196|NCT00073918|470833246|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
130783197|NCT00919633|470833249|FG000|Overall Study|Adverse Event|1|||
130783198|NCT00919633|470833250|FG001|Overall Study|Adverse Event|9|||
130783199|NCT00919633|470833251|FG002|Overall Study|Adverse Event|12|||
130783200|NCT00919633|470833252|FG003|Overall Study|Adverse Event|10|||
130783201|NCT00919633|470833249|FG000|Overall Study|Death|0|||
130783202|NCT00919633|470833250|FG001|Overall Study|Death|0|||
130783203|NCT00919633|470833251|FG002|Overall Study|Death|2|||
130783204|NCT00919633|470833252|FG003|Overall Study|Death|0|||
130783205|NCT00919633|470833249|FG000|Overall Study|Lack of Efficacy|17|||
130783206|NCT00919633|470833250|FG001|Overall Study|Lack of Efficacy|3|||
130783207|NCT00919633|470833251|FG002|Overall Study|Lack of Efficacy|2|||
130783208|NCT00919633|470833252|FG003|Overall Study|Lack of Efficacy|3|||
130783209|NCT00919633|470833249|FG000|Overall Study|Withdrawal by Subject|1|||
130783210|NCT00919633|470833250|FG001|Overall Study|Withdrawal by Subject|2|||
130783211|NCT00919633|470833251|FG002|Overall Study|Withdrawal by Subject|4|||
130783212|NCT00919633|470833252|FG003|Overall Study|Withdrawal by Subject|3|||
130783213|NCT00919633|470833249|FG000|Overall Study|Lost to Follow-up|3|||
130783214|NCT00919633|470833250|FG001|Overall Study|Lost to Follow-up|1|||
130783215|NCT00919633|470833251|FG002|Overall Study|Lost to Follow-up|0|||
130783216|NCT00919633|470833252|FG003|Overall Study|Lost to Follow-up|2|||
130783217|NCT00919633|470833249|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
130783218|NCT00919633|470833250|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
130783219|NCT00919633|470833251|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
130783220|NCT00919633|470833252|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
130783221|NCT00919633|470833249|FG000|Overall Study|Protocol Violation|0|||
130783222|NCT00919633|470833250|FG001|Overall Study|Protocol Violation|0|||
130783223|NCT00919633|470833251|FG002|Overall Study|Protocol Violation|0|||
130783224|NCT00919633|470833252|FG003|Overall Study|Protocol Violation|1|||
130783225|NCT00919633|470833249|FG000|Overall Study|Physician Decision|0|||
130783226|NCT00919633|470833250|FG001|Overall Study|Physician Decision|0|||
130783227|NCT00919633|470833251|FG002|Overall Study|Physician Decision|0|||
130783228|NCT00919633|470833252|FG003|Overall Study|Physician Decision|1|||
130783229|NCT00919633|470833249|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
130783230|NCT00919633|470833250|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
130783231|NCT00919633|470833251|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
130783232|NCT00919633|470833252|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
130783233|NCT00919633|470833249|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
130783234|NCT00919633|470833250|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
130783235|NCT00919633|470833251|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
130783236|NCT00919633|470833252|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
130783237|NCT02481050|470834916|FG000|Overall Study|Adverse Event|1|||
130783238|NCT02481050|470834916|FG000|Overall Study|Disease Progression|47|||
130783239|NCT02481050|470834916|FG000|Overall Study|Withdrawal by Subject|7|||
130783240|NCT02481050|470834916|FG000|Overall Study|Other|3|||
130783241|NCT03246347|470834919|FG000|Overall Study|On Study|23|||
130783242|NCT01022203|470834920|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
130783243|NCT01022203|470834921|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
130783244|NCT01022203|470834920|FG000|Post Treatment Assessment|Physician Decision|2|||
130783245|NCT01022203|470834921|FG001|Post Treatment Assessment|Physician Decision|0|||
130783246|NCT01022203|470834920|FG000|Post Treatment Assessment|Adverse Event|0|||
130783247|NCT01022203|470834921|FG001|Post Treatment Assessment|Adverse Event|2|||
130783248|NCT01022203|470834920|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
130783249|NCT01022203|470834921|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
130783250|NCT03638128|470834924|FG000|Overall Study|Withdrawal by Subject|1|||
130783251|NCT03638128|470834925|FG001|Overall Study|Withdrawal by Subject|7|||
130783252|NCT03638128|470834926|FG002|Overall Study|Withdrawal by Subject|6|||
130783253|NCT03638128|470834924|FG000|Overall Study|Sponsor Decision|15|||
130783254|NCT03638128|470834925|FG001|Overall Study|Sponsor Decision|12|||
130783255|NCT03638128|470834926|FG002|Overall Study|Sponsor Decision|19|||
130783256|NCT03638128|470834924|FG000|Overall Study|Lost to Follow-up|0|||
130783257|NCT03638128|470834925|FG001|Overall Study|Lost to Follow-up|0|||
130783258|NCT03638128|470834926|FG002|Overall Study|Lost to Follow-up|1|||
130783259|NCT00903201|470834928|FG000|Overall Study|Adverse Event|1|||
130783260|NCT00903201|470834929|FG001|Overall Study|Adverse Event|4|||
130783261|NCT00903201|470834930|FG002|Overall Study|Adverse Event|0|||
130783262|NCT00903201|470834928|FG000|Overall Study|Protocol Violation|2|||
130783263|NCT00903201|470834929|FG001|Overall Study|Protocol Violation|1|||
130783264|NCT00903201|470834930|FG002|Overall Study|Protocol Violation|0|||
130783265|NCT00903201|470834928|FG000|Overall Study|Lost to Follow-up|0|||
130783266|NCT00903201|470834929|FG001|Overall Study|Lost to Follow-up|1|||
130783267|NCT00903201|470834930|FG002|Overall Study|Lost to Follow-up|0|||
130783268|NCT00903201|470834928|FG000|Overall Study|Physician Decision|1|||
131178314|NCT00383721|472272481|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
131178315|NCT00383721|472272482|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
131178316|NCT00383721|472272478|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
131178317|NCT00383721|472272479|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
131178318|NCT00383721|472272480|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
131178319|NCT00383721|472272481|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
131178320|NCT00383721|472272482|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
131178321|NCT00383721|472272478|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
131178322|NCT00383721|472272479|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
131178323|NCT00383721|472272480|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
131178324|NCT00383721|472272481|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
131178325|NCT00383721|472272482|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
131178326|NCT00383721|472272478|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
131178327|NCT00383721|472272479|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
131178328|NCT00383721|472272480|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
131178329|NCT00383721|472272481|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
131178330|NCT00383721|472272482|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
131178331|NCT00383721|472272478|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
131178332|NCT00383721|472272479|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
131178333|NCT00383721|472272480|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
131178334|NCT00383721|472272481|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
131178335|NCT00383721|472272482|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
131178336|NCT00383721|472272478|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
131178337|NCT00383721|472272479|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
131178338|NCT00383721|472272480|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
131178339|NCT00383721|472272481|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
131178340|NCT00383721|472272482|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
131178341|NCT00383721|472272478|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
131178342|NCT00383721|472272479|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
130783269|NCT00903201|470834929|FG001|Overall Study|Physician Decision|0|||
130783270|NCT00903201|470834930|FG002|Overall Study|Physician Decision|1|||
130783271|NCT00903201|470834928|FG000|Overall Study|Withdrawal by Subject|1|||
130783272|NCT00903201|470834929|FG001|Overall Study|Withdrawal by Subject|0|||
130783273|NCT00903201|470834930|FG002|Overall Study|Withdrawal by Subject|1|||
130783274|NCT00329108|470834931|FG000|Overall Study|Adverse Event|2|||
130783275|NCT00329108|470834932|FG001|Overall Study|Adverse Event|2|||
130783276|NCT00329108|470834931|FG000|Overall Study|Lack of Efficacy|3|||
130783277|NCT00329108|470834932|FG001|Overall Study|Lack of Efficacy|3|||
130783278|NCT00329108|470834931|FG000|Overall Study|Withdrawal by Subject|0|||
130783279|NCT00329108|470834932|FG001|Overall Study|Withdrawal by Subject|2|||
130783280|NCT00329108|470834931|FG000|Overall Study|symptomatic deterioration|1|||
130783281|NCT00329108|470834932|FG001|Overall Study|symptomatic deterioration|1|||
130783282|NCT00329108|470834931|FG000|Overall Study|Subject no longer willing to participate|2|||
130783283|NCT00329108|470834932|FG001|Overall Study|Subject no longer willing to participate|2|||
130783284|NCT00329108|470834931|FG000|Overall Study|study terminated by sponsor|1|||
130783285|NCT00329108|470834932|FG001|Overall Study|study terminated by sponsor|0|||
130783286|NCT00329108|470834931|FG000|Overall Study|withdrew patient after SAE resolved|1|||
130783287|NCT00329108|470834932|FG001|Overall Study|withdrew patient after SAE resolved|0|||
130783288|NCT00329108|470834931|FG000|Overall Study|Protocol Violation|0|||
130783289|NCT00329108|470834932|FG001|Overall Study|Protocol Violation|2|||
130783290|NCT01094288|470834935|FG000|Overall Study|Adverse Event|0|||
130783291|NCT01094288|470834936|FG001|Overall Study|Adverse Event|3|||
130783292|NCT01094288|470834937|FG002|Overall Study|Adverse Event|1|||
130783293|NCT01094288|470834938|FG003|Overall Study|Adverse Event|1|||
130783294|NCT01094288|470834939|FG004|Overall Study|Adverse Event|0|||
131178343|NCT00383721|472272480|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
130783295|NCT01094288|470834940|FG005|Overall Study|Adverse Event|0|||
130783296|NCT01094288|470834941|FG006|Overall Study|Adverse Event|0|||
130783297|NCT01094288|470834942|FG007|Overall Study|Adverse Event|0|||
130783298|NCT01094288|470834935|FG000|Overall Study|Withdrawal by Subject|0|||
130783299|NCT01094288|470834936|FG001|Overall Study|Withdrawal by Subject|1|||
130783300|NCT01094288|470834937|FG002|Overall Study|Withdrawal by Subject|2|||
130783301|NCT01094288|470834938|FG003|Overall Study|Withdrawal by Subject|0|||
130783302|NCT01094288|470834939|FG004|Overall Study|Withdrawal by Subject|0|||
130783303|NCT01094288|470834940|FG005|Overall Study|Withdrawal by Subject|0|||
130783304|NCT01094288|470834941|FG006|Overall Study|Withdrawal by Subject|0|||
130783305|NCT01094288|470834942|FG007|Overall Study|Withdrawal by Subject|2|||
130783306|NCT01094288|470834935|FG000|Overall Study|Initiation of Alternative Therapy|0|||
130783307|NCT01094288|470834936|FG001|Overall Study|Initiation of Alternative Therapy|0|||
130783308|NCT01094288|470834937|FG002|Overall Study|Initiation of Alternative Therapy|1|||
130783309|NCT01094288|470834938|FG003|Overall Study|Initiation of Alternative Therapy|0|||
130783310|NCT01094288|470834939|FG004|Overall Study|Initiation of Alternative Therapy|0|||
130783311|NCT01094288|470834940|FG005|Overall Study|Initiation of Alternative Therapy|0|||
130783312|NCT01094288|470834941|FG006|Overall Study|Initiation of Alternative Therapy|0|||
130783313|NCT01094288|470834942|FG007|Overall Study|Initiation of Alternative Therapy|0|||
130783314|NCT01094288|470834935|FG000|Overall Study|Reason not Specified|2|||
130783315|NCT01094288|470834936|FG001|Overall Study|Reason not Specified|3|||
130783316|NCT01094288|470834937|FG002|Overall Study|Reason not Specified|0|||
130783317|NCT01094288|470834938|FG003|Overall Study|Reason not Specified|1|||
130783318|NCT01094288|470834939|FG004|Overall Study|Reason not Specified|0|||
130783319|NCT01094288|470834940|FG005|Overall Study|Reason not Specified|0|||
130783320|NCT01094288|470834941|FG006|Overall Study|Reason not Specified|0|||
130783321|NCT01094288|470834942|FG007|Overall Study|Reason not Specified|0|||
130783322|NCT01094288|470834935|FG000|Overall Study|Ongoing Participants|0|||
130783323|NCT01094288|470834936|FG001|Overall Study|Ongoing Participants|3|||
130783324|NCT01094288|470834937|FG002|Overall Study|Ongoing Participants|0|||
130783325|NCT01094288|470834938|FG003|Overall Study|Ongoing Participants|0|||
130783326|NCT01094288|470834939|FG004|Overall Study|Ongoing Participants|0|||
130783327|NCT01094288|470834940|FG005|Overall Study|Ongoing Participants|0|||
130783328|NCT01094288|470834941|FG006|Overall Study|Ongoing Participants|0|||
130783329|NCT01094288|470834942|FG007|Overall Study|Ongoing Participants|0|||
130783330|NCT02611882|470834943|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
130783331|NCT02611882|470834944|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
130783332|NCT02611882|470834945|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
130783333|NCT01389232|470834946|FG000|Overall Study|Had scaffold removed|15|||
130783334|NCT01389232|470834946|FG000|Overall Study|Personal reasons|2|||
130783335|NCT01389232|470834946|FG000|Overall Study|Adverse Event|1|||
130783336|NCT01389232|470834946|FG000|Overall Study|Death|1|||
130783337|NCT01317940|470834947|FG000|Overall Study|Death|1|||
130783338|NCT01317940|470834948|FG001|Overall Study|Death|0|||
130783339|NCT01317940|470834949|FG002|Overall Study|Death|1|||
130783340|NCT01317940|470834950|FG003|Overall Study|Death|0|||
130783341|NCT01317940|470834951|FG004|Overall Study|Death|0|||
130783342|NCT01317940|470834952|FG005|Overall Study|Death|0|||
130783343|NCT01317940|470834947|FG000|Overall Study|Lost to Follow-up|0|||
131178344|NCT00383721|472272481|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
131237304|NCT02180711|472499968|FG004|Overall Study|- Other|0|||
130783344|NCT01317940|470834948|FG001|Overall Study|Lost to Follow-up|0|||
130783345|NCT01317940|470834949|FG002|Overall Study|Lost to Follow-up|1|||
130783346|NCT01317940|470834950|FG003|Overall Study|Lost to Follow-up|1|||
130783347|NCT01317940|470834951|FG004|Overall Study|Lost to Follow-up|1|||
130783348|NCT01317940|470834952|FG005|Overall Study|Lost to Follow-up|0|||
130783349|NCT01317940|470834947|FG000|Overall Study|Change in therapy plan|0|||
130783350|NCT01317940|470834948|FG001|Overall Study|Change in therapy plan|0|||
130783351|NCT01317940|470834949|FG002|Overall Study|Change in therapy plan|3|||
130783352|NCT01317940|470834950|FG003|Overall Study|Change in therapy plan|0|||
130783353|NCT01317940|470834951|FG004|Overall Study|Change in therapy plan|0|||
130783354|NCT01317940|470834952|FG005|Overall Study|Change in therapy plan|0|||
130783355|NCT02371616|470834954|FG000|Overall Study|Protocol Violation|2|||
130783356|NCT02371616|470834955|FG001|Overall Study|Protocol Violation|1|||
130783357|NCT02371616|470834954|FG000|Overall Study|Adverse Event|0|||
130783358|NCT02371616|470834955|FG001|Overall Study|Adverse Event|1|||
130783359|NCT02371616|470834954|FG000|Overall Study|Withdrawal of Consent|1|||
130783360|NCT02371616|470834955|FG001|Overall Study|Withdrawal of Consent|0|||
130783361|NCT02371616|470834954|FG000|Overall Study|Other (Not specified)|1|||
130783362|NCT02371616|470834955|FG001|Overall Study|Other (Not specified)|5|||
130783363|NCT00754741|470834956|FG000|Overall Study|Died or disenrolled|57|||
130783364|NCT00754741|470834957|FG001|Overall Study|Died or disenrolled|69|||
130783365|NCT00754741|470834958|FG002|Overall Study|Died or disenrolled|54|||
130783366|NCT04152200|470834960|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
130783367|NCT04152200|470834961|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
130783368|NCT00593814|470834962|FG000|Overall Study|Death|7|||
130783369|NCT00593814|470834963|FG001|Overall Study|Death|0|||
130783370|NCT00593814|470834962|FG000|Overall Study|Withdrawal by Subject|7|||
130783371|NCT00593814|470834963|FG001|Overall Study|Withdrawal by Subject|0|||
130783372|NCT00593814|470834962|FG000|Overall Study|Lost to Follow-up|7|||
130783373|NCT00593814|470834963|FG001|Overall Study|Lost to Follow-up|0|||
130783374|NCT00593814|470834962|FG000|Overall Study|Physician Decision|3|||
130783375|NCT00593814|470834963|FG001|Overall Study|Physician Decision|0|||
130783376|NCT02699996|470834964|FG000|Overall Study|Withdrawal by Subject|5|||
130783377|NCT02699996|470834965|FG001|Overall Study|Withdrawal by Subject|2|||
130783378|NCT04069715|470834966|FG000|Overall Study|Lost to Follow-up|1|||
130783379|NCT04069715|470834967|FG001|Overall Study|Lost to Follow-up|1|||
130783380|NCT04069715|470834966|FG000|Overall Study|Physician Decision|1|||
130783381|NCT04069715|470834967|FG001|Overall Study|Physician Decision|1|||
130783382|NCT04069715|470834966|FG000|Overall Study|Withdrawal by Subject|3|||
130783383|NCT04069715|470834967|FG001|Overall Study|Withdrawal by Subject|3|||
130783384|NCT03205150|470834968|FG000|Overall Study|Protocol deviation|1|||
130783385|NCT03205150|470834969|FG001|Overall Study|Protocol deviation|3|||
130783386|NCT03205150|470834970|FG002|Overall Study|Protocol deviation|0|||
130783387|NCT03205150|470834968|FG000|Overall Study|Patient/guardian decision|0|||
130783388|NCT03205150|470834969|FG001|Overall Study|Patient/guardian decision|3|||
130783389|NCT03205150|470834970|FG002|Overall Study|Patient/guardian decision|0|||
130783390|NCT03205150|470834968|FG000|Overall Study|Adverse Event|1|||
130783391|NCT03205150|470834969|FG001|Overall Study|Adverse Event|1|||
130783392|NCT03205150|470834970|FG002|Overall Study|Adverse Event|1|||
130783393|NCT03205150|470834968|FG000|Overall Study|Lost to Follow-up|0|||
130783394|NCT03205150|470834969|FG001|Overall Study|Lost to Follow-up|0|||
130783395|NCT03205150|470834970|FG002|Overall Study|Lost to Follow-up|1|||
130783396|NCT02723188|470834971|FG000|Overall Study|Withdrawal by Subject|1|||
130783397|NCT02723188|470834972|FG001|Overall Study|Withdrawal by Subject|0|||
130783398|NCT02723188|470834973|FG002|Overall Study|Withdrawal by Subject|0|||
130783399|NCT01198002|470834976|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
130783400|NCT01198002|470834977|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
130783401|NCT01198002|470834978|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
130783402|NCT01198002|470834976|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
130783403|NCT01198002|470834977|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
130783404|NCT01198002|470834978|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
130783405|NCT01198002|470834976|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
130783406|NCT01198002|470834977|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
130783407|NCT01198002|470834978|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
130783408|NCT01198002|470834976|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
130783409|NCT01198002|470834977|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
130783410|NCT01198002|470834978|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
130783411|NCT01198002|470834976|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
130783412|NCT01198002|470834977|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
130783413|NCT01198002|470834978|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
130783414|NCT01198002|470834976|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
130783415|NCT01198002|470834977|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
130783416|NCT01198002|470834978|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
131178345|NCT00383721|472272482|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
131178346|NCT00383721|472272478|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
130783417|NCT01198002|470834976|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
130783418|NCT01198002|470834977|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
131178347|NCT00383721|472272479|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
131178348|NCT00383721|472272480|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
131178349|NCT00383721|472272481|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
131178350|NCT00383721|472272482|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
131178351|NCT00383721|472272478|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
131178352|NCT00383721|472272479|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
131178353|NCT00383721|472272480|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
131178354|NCT00383721|472272481|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
131178355|NCT00383721|472272482|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
131178356|NCT00383721|472272478|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
131178357|NCT00383721|472272479|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
131178358|NCT00383721|472272480|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
131178359|NCT00383721|472272481|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
131178360|NCT00383721|472272482|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
131178361|NCT00383721|472272478|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
131178362|NCT00383721|472272479|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
131178363|NCT00383721|472272480|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
131178364|NCT00383721|472272481|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
131178365|NCT00383721|472272482|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
131178366|NCT00383721|472272478|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
131178367|NCT00383721|472272479|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
131178368|NCT00383721|472272480|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
131178369|NCT00383721|472272481|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
131178370|NCT00383721|472272482|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
131178371|NCT00383721|472272478|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
131178372|NCT00383721|472272479|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
131178373|NCT00383721|472272480|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
131178374|NCT00383721|472272481|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
131178375|NCT00383721|472272482|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
131178376|NCT00383721|472272478|FG000|26-Week Treatment Safety Extension|Administrative|1|||
131178377|NCT00383721|472272479|FG001|26-Week Treatment Safety Extension|Administrative|2|||
131178378|NCT00383721|472272480|FG002|26-Week Treatment Safety Extension|Administrative|3|||
131178379|NCT00383721|472272481|FG003|26-Week Treatment Safety Extension|Administrative|1|||
131178380|NCT00383721|472272482|FG004|26-Week Treatment Safety Extension|Administrative|0|||
131178381|NCT03519516|472272483|FG000|Overall Study|Adverse Event|0|||
131178382|NCT03519516|472272484|FG001|Overall Study|Adverse Event|1|||
131178383|NCT02475850|472273939|FG000|Overall Study|Death|155|||
131178384|NCT02475850|472273940|FG001|Overall Study|Death|141|||
131178385|NCT02475850|472273939|FG000|Overall Study|Lost to Follow-up|217|||
131178386|NCT02475850|472273940|FG001|Overall Study|Lost to Follow-up|188|||
131178387|NCT02475850|472273939|FG000|Overall Study|Withdrawal by Subject|221|||
131178388|NCT02475850|472273940|FG001|Overall Study|Withdrawal by Subject|155|||
131178389|NCT02667457|472273941|FG000|Overall Study|Withdrawal by Subject|1|||
131178390|NCT02667457|472273942|FG001|Overall Study|Withdrawal by Subject|0|||
131178391|NCT02667457|472273941|FG000|Overall Study|Other Reason|0|||
131178392|NCT02667457|472273942|FG001|Overall Study|Other Reason|2|||
131178393|NCT03297216|472273947|FG000|Overall Study|Death|0|||
131178394|NCT03297216|472273948|FG001|Overall Study|Death|1|||
131178395|NCT03297216|472273947|FG000|Overall Study|Miscarriage|0|||
131178396|NCT03297216|472273948|FG001|Overall Study|Miscarriage|2|||
131178397|NCT03297216|472273947|FG000|Overall Study|Lost to Follow-up|3|||
131178398|NCT03297216|472273948|FG001|Overall Study|Lost to Follow-up|2|||
131178399|NCT02700919|472273949|FG000|Overall Study|Physician Decision|1|||
131178400|NCT02700919|472273950|FG001|Overall Study|Physician Decision|0|||
131178401|NCT02700919|472273951|FG002|Overall Study|Physician Decision|0|||
131178402|NCT02700919|472273949|FG000|Overall Study|Protocol Violation|1|||
131178403|NCT02700919|472273950|FG001|Overall Study|Protocol Violation|0|||
131178404|NCT02700919|472273951|FG002|Overall Study|Protocol Violation|0|||
131178405|NCT02700919|472273949|FG000|Overall Study|Adverse Event|1|||
131178406|NCT02700919|472273950|FG001|Overall Study|Adverse Event|3|||
131178407|NCT02700919|472273951|FG002|Overall Study|Adverse Event|1|||
131178408|NCT02700919|472273949|FG000|Overall Study|Withdrawal by Subject|5|||
131178409|NCT02700919|472273950|FG001|Overall Study|Withdrawal by Subject|8|||
131178410|NCT02700919|472273951|FG002|Overall Study|Withdrawal by Subject|2|||
131178411|NCT02700919|472273949|FG000|Overall Study|Lost to Follow-up|2|||
131178412|NCT02700919|472273950|FG001|Overall Study|Lost to Follow-up|0|||
131178413|NCT02700919|472273951|FG002|Overall Study|Lost to Follow-up|0|||
131178414|NCT02700919|472273949|FG000|Overall Study|Other|2|||
131178415|NCT02700919|472273950|FG001|Overall Study|Other|1|||
131178416|NCT02700919|472273951|FG002|Overall Study|Other|1|||
131178417|NCT03434418|472273952|FG000|Overall Study|Disease Progression|11|||
131178418|NCT03434418|472273952|FG000|Overall Study|Adverse Event|2|||
130783419|NCT01198002|470834978|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
130783420|NCT01198002|470834976|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
130783421|NCT01198002|470834977|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
130783422|NCT01198002|470834978|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
130783423|NCT01198002|470834976|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
130783424|NCT01198002|470834977|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
130783425|NCT01198002|470834978|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
130783426|NCT01198002|470834976|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
130783427|NCT01198002|470834977|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
130783428|NCT01198002|470834978|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
130783429|NCT01198002|470834976|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
130783430|NCT01198002|470834977|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
130783431|NCT01198002|470834978|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
130783432|NCT01198002|470834976|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
130783433|NCT01198002|470834977|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
130783434|NCT01198002|470834978|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
130783435|NCT01198002|470834976|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
130783436|NCT01198002|470834977|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
131178419|NCT03434418|472273952|FG000|Overall Study|Physician Decision|1|||
131178420|NCT03434418|472273952|FG000|Overall Study|Decline in Performance Status (PS)|1|||
131178421|NCT01061736|472273962|FG000|Overall Study|Dose regimen not selected|0|||
131178422|NCT01061736|472273963|FG001|Overall Study|Dose regimen not selected|0|||
131178423|NCT01061736|472273964|FG002|Overall Study|Dose regimen not selected|0|||
131178424|NCT01061736|472273965|FG003|Overall Study|Dose regimen not selected|0|||
131178425|NCT01061736|472273966|FG004|Overall Study|Dose regimen not selected|0|||
131178426|NCT01061736|472273967|FG005|Overall Study|Dose regimen not selected|0|||
131178427|NCT01061736|472273968|FG006|Overall Study|Dose regimen not selected|79|||
131178428|NCT01061736|472273969|FG007|Overall Study|Dose regimen not selected|0|||
131178429|NCT01061736|472273970|FG008|Overall Study|Dose regimen not selected|0|||
131178430|NCT01061736|472273971|FG009|Overall Study|Dose regimen not selected|0|||
131178431|NCT01061736|472273962|FG000|Overall Study|Adverse Event|13|||
131178432|NCT01061736|472273963|FG001|Overall Study|Adverse Event|1|||
131178433|NCT01061736|472273964|FG002|Overall Study|Adverse Event|3|||
131178434|NCT01061736|472273965|FG003|Overall Study|Adverse Event|2|||
131178435|NCT01061736|472273966|FG004|Overall Study|Adverse Event|4|||
131178436|NCT01061736|472273967|FG005|Overall Study|Adverse Event|1|||
131178437|NCT01061736|472273968|FG006|Overall Study|Adverse Event|4|||
131178438|NCT01061736|472273969|FG007|Overall Study|Adverse Event|63|||
131178439|NCT01061736|472273970|FG008|Overall Study|Adverse Event|67|||
131178440|NCT01061736|472273971|FG009|Overall Study|Adverse Event|34|||
131178441|NCT01061736|472273962|FG000|Overall Study|Lack of Efficacy|0|||
131178442|NCT01061736|472273963|FG001|Overall Study|Lack of Efficacy|2|||
131178443|NCT01061736|472273964|FG002|Overall Study|Lack of Efficacy|1|||
131178444|NCT01061736|472273965|FG003|Overall Study|Lack of Efficacy|1|||
131178445|NCT01061736|472273966|FG004|Overall Study|Lack of Efficacy|1|||
131178446|NCT01061736|472273967|FG005|Overall Study|Lack of Efficacy|2|||
131178447|NCT01061736|472273968|FG006|Overall Study|Lack of Efficacy|1|||
131178448|NCT01061736|472273969|FG007|Overall Study|Lack of Efficacy|9|||
131178449|NCT01061736|472273970|FG008|Overall Study|Lack of Efficacy|9|||
131178450|NCT01061736|472273971|FG009|Overall Study|Lack of Efficacy|10|||
131178451|NCT01061736|472273962|FG000|Overall Study|Poor compliance to protocol|0|||
131178452|NCT01061736|472273963|FG001|Overall Study|Poor compliance to protocol|0|||
131178453|NCT01061736|472273964|FG002|Overall Study|Poor compliance to protocol|0|||
131178454|NCT01061736|472273965|FG003|Overall Study|Poor compliance to protocol|0|||
131178455|NCT01061736|472273966|FG004|Overall Study|Poor compliance to protocol|0|||
131178456|NCT01061736|472273967|FG005|Overall Study|Poor compliance to protocol|0|||
131178457|NCT01061736|472273968|FG006|Overall Study|Poor compliance to protocol|0|||
131178458|NCT01061736|472273969|FG007|Overall Study|Poor compliance to protocol|2|||
131178459|NCT01061736|472273970|FG008|Overall Study|Poor compliance to protocol|5|||
131178460|NCT01061736|472273971|FG009|Overall Study|Poor compliance to protocol|9|||
131178461|NCT01061736|472273962|FG000|Overall Study|Not treated|0|||
131178462|NCT01061736|472273963|FG001|Overall Study|Not treated|0|||
131178463|NCT01061736|472273964|FG002|Overall Study|Not treated|0|||
131178464|NCT01061736|472273965|FG003|Overall Study|Not treated|0|||
130783437|NCT01198002|470834978|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
130783438|NCT01198002|470834976|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
131178465|NCT01061736|472273966|FG004|Overall Study|Not treated|1|||
131178466|NCT01061736|472273967|FG005|Overall Study|Not treated|0|||
131178467|NCT01061736|472273968|FG006|Overall Study|Not treated|0|||
131178468|NCT01061736|472273969|FG007|Overall Study|Not treated|2|||
131178469|NCT01061736|472273970|FG008|Overall Study|Not treated|1|||
131178470|NCT01061736|472273971|FG009|Overall Study|Not treated|0|||
131178471|NCT01061736|472273962|FG000|Overall Study|Other than specified above|0|||
131178472|NCT01061736|472273963|FG001|Overall Study|Other than specified above|1|||
131178473|NCT01061736|472273964|FG002|Overall Study|Other than specified above|2|||
131178474|NCT01061736|472273965|FG003|Overall Study|Other than specified above|0|||
130783439|NCT01198002|470834977|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
130783440|NCT01198002|470834978|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
130783441|NCT01198002|470834976|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
130783442|NCT01198002|470834977|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
130783443|NCT01198002|470834978|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
130783444|NCT00789321|470834982|FG000|Overall Study|Adverse Event|0|||
130783445|NCT00789321|470834983|FG001|Overall Study|Adverse Event|1|||
130783446|NCT03652818|470834987|FG000|Overall Study|Adverse Event|1|||
130783447|NCT03652818|470834988|FG001|Overall Study|Adverse Event|0|||
130783448|NCT03652818|470834989|FG002|Overall Study|Adverse Event|0|||
131237305|NCT02180711|472499969|FG005|Overall Study|- Other|0|||
131237306|NCT02180711|472499970|FG006|Overall Study|- Other|0|||
131237307|NCT02180711|472499971|FG007|Overall Study|- Other|0|||
131237308|NCT03215030|472499974|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
130783449|NCT03652818|470834990|FG003|Overall Study|Adverse Event|0|||
130783450|NCT03652818|470834991|FG004|Overall Study|Adverse Event|0|||
131178475|NCT01061736|472273966|FG004|Overall Study|Other than specified above|1|||
131178476|NCT01061736|472273967|FG005|Overall Study|Other than specified above|0|||
131178477|NCT01061736|472273968|FG006|Overall Study|Other than specified above|0|||
131178478|NCT01061736|472273969|FG007|Overall Study|Other than specified above|18|||
131178479|NCT01061736|472273970|FG008|Overall Study|Other than specified above|15|||
131178480|NCT01061736|472273971|FG009|Overall Study|Other than specified above|21|||
131178481|NCT02168803|472273972|FG000|Overall Study|Lost to Follow-up|1|||
131178482|NCT02168803|472273973|FG001|Overall Study|Lost to Follow-up|0|||
131178483|NCT02168803|472273974|FG002|Overall Study|Lost to Follow-up|1|||
131178484|NCT02168803|472273972|FG000|Overall Study|Withdrawal by Subject|1|||
131178485|NCT02168803|472273973|FG001|Overall Study|Withdrawal by Subject|1|||
131178486|NCT02168803|472273974|FG002|Overall Study|Withdrawal by Subject|2|||
131178487|NCT02168803|472273972|FG000|Overall Study|Physician Decision|0|||
131178488|NCT02168803|472273973|FG001|Overall Study|Physician Decision|1|||
131178489|NCT02168803|472273974|FG002|Overall Study|Physician Decision|0|||
131178490|NCT02168803|472273972|FG000|Overall Study|Adverse Event|0|||
131178491|NCT02168803|472273973|FG001|Overall Study|Adverse Event|1|||
131178492|NCT02168803|472273974|FG002|Overall Study|Adverse Event|1|||
131178493|NCT02168803|472273972|FG000|Overall Study|Death|0|||
131178494|NCT02168803|472273973|FG001|Overall Study|Death|0|||
131178495|NCT02168803|472273974|FG002|Overall Study|Death|1|||
131178496|NCT02168803|472273972|FG000|Overall Study|Sponsor Decision|0|||
131178497|NCT02168803|472273973|FG001|Overall Study|Sponsor Decision|0|||
131178498|NCT02168803|472273974|FG002|Overall Study|Sponsor Decision|1|||
131178499|NCT01114373|472273979|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
131178500|NCT01114373|472273980|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
131178501|NCT01114373|472273979|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
131178502|NCT01114373|472273980|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
131178503|NCT01114373|472273979|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
131178504|NCT01114373|472273980|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
131178505|NCT01114373|472273979|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
131178506|NCT01114373|472273980|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
131178507|NCT03444870|472273983|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
131178508|NCT03444870|472273984|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
131178509|NCT03444870|472273985|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
131178510|NCT03444870|472273986|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
131178511|NCT03444870|472273987|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
131178512|NCT03444870|472273988|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
131178513|NCT03444870|472273983|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
131178514|NCT03444870|472273984|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
131178515|NCT03444870|472273985|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
131178516|NCT03444870|472273986|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
131178517|NCT03444870|472273987|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
131178518|NCT03444870|472273988|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
131178519|NCT03444870|472273983|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
131178520|NCT03444870|472273984|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
131178521|NCT03444870|472273985|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
131178522|NCT03444870|472273986|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
131178523|NCT03444870|472273987|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
131178524|NCT03444870|472273988|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
131178525|NCT03444870|472273983|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
131178526|NCT03444870|472273984|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
131178527|NCT03444870|472273985|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
131178528|NCT03444870|472273986|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
131237309|NCT03215030|472499975|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
130783451|NCT03652818|470834987|FG000|Overall Study|Physician Decision|1|||
130783452|NCT03652818|470834988|FG001|Overall Study|Physician Decision|0|||
130783453|NCT03652818|470834989|FG002|Overall Study|Physician Decision|0|||
130783454|NCT03652818|470834990|FG003|Overall Study|Physician Decision|0|||
130783455|NCT03652818|470834991|FG004|Overall Study|Physician Decision|0|||
130783456|NCT03652818|470834987|FG000|Overall Study|Lost to Follow-up|0|||
130783457|NCT03652818|470834988|FG001|Overall Study|Lost to Follow-up|1|||
130783458|NCT03652818|470834989|FG002|Overall Study|Lost to Follow-up|2|||
130783459|NCT03652818|470834990|FG003|Overall Study|Lost to Follow-up|1|||
130783460|NCT03652818|470834991|FG004|Overall Study|Lost to Follow-up|1|||
130783461|NCT01930539|470834996|FG000|Overall Study|Withdrawal by Subject|2|||
130783462|NCT01930539|470834997|FG001|Overall Study|Withdrawal by Subject|2|||
130783463|NCT00830219|470834998|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130783464|NCT00830219|470834999|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130783465|NCT01811732|470835000|FG000|Overall Study|Lost to Follow-up|24|||
130783466|NCT01811732|470835001|FG001|Overall Study|Lost to Follow-up|30|||
130783467|NCT01811732|470835000|FG000|Overall Study|Withdrawal by Subject|16|||
130783468|NCT01811732|470835001|FG001|Overall Study|Withdrawal by Subject|10|||
130783469|NCT01811732|470835000|FG000|Overall Study|Adverse Event|3|||
130783470|NCT01811732|470835001|FG001|Overall Study|Adverse Event|9|||
130783471|NCT01811732|470835000|FG000|Overall Study|Lack of Efficacy|3|||
130783472|NCT01811732|470835001|FG001|Overall Study|Lack of Efficacy|1|||
130783473|NCT01811732|470835000|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
130783474|NCT01811732|470835001|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
130783475|NCT01811732|470835000|FG000|Overall Study|Physician Decision|2|||
130783476|NCT01811732|470835001|FG001|Overall Study|Physician Decision|0|||
130783477|NCT01811732|470835000|FG000|Overall Study|Death|1|||
130783478|NCT01811732|470835001|FG001|Overall Study|Death|1|||
130783479|NCT01811732|470835000|FG000|Overall Study|Insufficient venous access|0|||
130783480|NCT01811732|470835001|FG001|Overall Study|Insufficient venous access|1|||
130783481|NCT01811732|470835000|FG000|Overall Study|Protocol Violation|0|||
130783482|NCT01811732|470835001|FG001|Overall Study|Protocol Violation|1|||
130783483|NCT01811732|470835000|FG000|Overall Study|Subject incarcerated|1|||
130783484|NCT01811732|470835001|FG001|Overall Study|Subject incarcerated|2|||
130783485|NCT01811732|470835000|FG000|Overall Study|Admitted to another facility|1|||
130783486|NCT01811732|470835001|FG001|Overall Study|Admitted to another facility|0|||
130783487|NCT01811732|470835000|FG000|Overall Study|Correct study drug not available on site|1|||
130783488|NCT01811732|470835001|FG001|Overall Study|Correct study drug not available on site|0|||
130783489|NCT00288912|470835004|FG000|Overall Study|Developed exclusion criterion|4|||
130783490|NCT00288912|470835005|FG001|Overall Study|Developed exclusion criterion|6|||
130783491|NCT00288912|470835006|FG002|Overall Study|Developed exclusion criterion|7|||
130783492|NCT00288912|470835004|FG000|Overall Study|Lost to Follow-up|9|||
130783493|NCT00288912|470835005|FG001|Overall Study|Lost to Follow-up|6|||
130783494|NCT00288912|470835006|FG002|Overall Study|Lost to Follow-up|9|||
130783495|NCT00288912|470835004|FG000|Overall Study|Withdrawal by Subject|4|||
130783496|NCT00288912|470835005|FG001|Overall Study|Withdrawal by Subject|5|||
130783497|NCT00288912|470835006|FG002|Overall Study|Withdrawal by Subject|12|||
130783498|NCT01868646|470835007|FG000|Overall Study|Do not meet inclusion criteria|3|||
130783499|NCT01868646|470835008|FG001|Overall Study|Do not meet inclusion criteria|5|||
130783500|NCT01783743|470835013|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
130783501|NCT01783743|470835014|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
130783502|NCT01783743|470835013|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
130783503|NCT01783743|470835014|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
130783504|NCT01783743|470835013|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
130783505|NCT01783743|470835014|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
130783506|NCT00728494|470835027|FG000|Overall Study|Adverse Event|7|||
130783507|NCT00728494|470835028|FG001|Overall Study|Adverse Event|0|||
130783508|NCT00728494|470835027|FG000|Overall Study|Withdrawal by Subject|0|||
130783509|NCT00728494|470835028|FG001|Overall Study|Withdrawal by Subject|2|||
130783510|NCT00728494|470835027|FG000|Overall Study|Lack of Efficacy|2|||
130783511|NCT00728494|470835028|FG001|Overall Study|Lack of Efficacy|4|||
130783512|NCT00728494|470835027|FG000|Overall Study|No data available|0|||
130783513|NCT00728494|470835028|FG001|Overall Study|No data available|1|||
130783514|NCT03439137|470835029|FG000|Overall Study|Adverse Event|16|||
130783515|NCT03439137|470835030|FG001|Overall Study|Adverse Event|12|||
130783516|NCT03439137|470835029|FG000|Overall Study|Physician Decision|0|||
130783517|NCT03439137|470835030|FG001|Overall Study|Physician Decision|5|||
130783518|NCT03439137|470835029|FG000|Overall Study|Withdrawal by Subject|14|||
131178529|NCT03444870|472273987|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
131178530|NCT03444870|472273988|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
131178531|NCT03444870|472273983|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
130783519|NCT03439137|470835030|FG001|Overall Study|Withdrawal by Subject|4|||
130783520|NCT03439137|470835029|FG000|Overall Study|Conducting rescue therapy|2|||
130783521|NCT03439137|470835030|FG001|Overall Study|Conducting rescue therapy|1|||
130783522|NCT03439137|470835029|FG000|Overall Study|Difficult to control Hb|10|||
131178532|NCT03444870|472273984|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
131178533|NCT03444870|472273985|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
131178534|NCT03444870|472273986|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
131178535|NCT03444870|472273987|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
131178536|NCT03444870|472273988|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
131178537|NCT03444870|472273983|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
131178538|NCT03444870|472273984|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
131178539|NCT03444870|472273985|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
131178540|NCT03444870|472273986|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
131178541|NCT03444870|472273987|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
131178542|NCT03444870|472273988|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
131178543|NCT03444870|472273983|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
131178544|NCT03444870|472273984|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
131178545|NCT03444870|472273985|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
131178546|NCT03444870|472273986|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
131178547|NCT03444870|472273987|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
131178548|NCT03444870|472273988|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
131178549|NCT03444870|472273983|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
131178550|NCT03444870|472273984|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
131178551|NCT03444870|472273985|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
131178552|NCT03444870|472273986|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
131178553|NCT03444870|472273987|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
131178554|NCT03444870|472273988|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
131178555|NCT03444870|472273983|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
131178556|NCT03444870|472273984|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
131178557|NCT03444870|472273985|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
131178558|NCT03444870|472273986|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
131178559|NCT03444870|472273987|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
131178560|NCT03444870|472273988|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
131178561|NCT03444870|472273983|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131178562|NCT03444870|472273984|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131178563|NCT03444870|472273985|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131178564|NCT03444870|472273986|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
131178565|NCT03444870|472273987|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
131178566|NCT03444870|472273988|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
131178567|NCT03444870|472273983|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
131178568|NCT03444870|472273984|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
131178569|NCT03444870|472273985|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
131178570|NCT03444870|472273986|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
131178571|NCT03444870|472273987|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
131178572|NCT03444870|472273988|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
131178573|NCT03444870|472273983|FG000|Open-Label Extension (OLE) Period|Death|0|||
131178574|NCT03444870|472273984|FG001|Open-Label Extension (OLE) Period|Death|0|||
131178575|NCT03444870|472273985|FG002|Open-Label Extension (OLE) Period|Death|0|||
131178576|NCT03444870|472273986|FG003|Open-Label Extension (OLE) Period|Death|0|||
131178577|NCT03444870|472273987|FG004|Open-Label Extension (OLE) Period|Death|1|||
131178578|NCT03444870|472273988|FG005|Open-Label Extension (OLE) Period|Death|0|||
131178579|NCT02310906|472273991|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
131178580|NCT02310906|472273992|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
131178581|NCT02310906|472273993|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
131178582|NCT02310906|472273994|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
131178583|NCT02310906|472273991|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
131178584|NCT02310906|472273992|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
131178585|NCT02310906|472273993|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
131178586|NCT02310906|472273994|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
131178587|NCT02310906|472273991|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
131178588|NCT02310906|472273992|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
131178589|NCT02310906|472273993|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
131178590|NCT02310906|472273994|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
131178591|NCT02310906|472273991|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
131178592|NCT02310906|472273992|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
131178593|NCT02310906|472273993|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
131178594|NCT02310906|472273994|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
131178595|NCT02680587|472273995|FG000|Overall Study|Withdrawal by Subject|1|||
131178596|NCT02680587|472273996|FG001|Overall Study|Withdrawal by Subject|0|||
131178597|NCT00098020|472274000|FG000|Overall Study|Adverse Event|2|||
131178598|NCT00098020|472274000|FG000|Overall Study|Lost to Follow-up|1|||
131178599|NCT00098020|472274000|FG000|Overall Study|elevated liver enzymes|1|||
131237310|NCT03215030|472499976|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
131237311|NCT03215030|472499977|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
131237312|NCT03215030|472499978|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
131237313|NCT03215030|472499979|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
131237314|NCT03215030|472499980|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
131237315|NCT03215030|472499981|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
131237316|NCT03215030|472499982|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
131237317|NCT03215030|472499983|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
131237318|NCT03215030|472499984|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
131237319|NCT03215030|472499985|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
131237320|NCT03215030|472499974|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
131237321|NCT03215030|472499975|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131237322|NCT03215030|472499976|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131237323|NCT03215030|472499977|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
131237324|NCT03215030|472499978|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131237325|NCT03215030|472499979|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131237326|NCT03215030|472499980|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131237327|NCT03215030|472499981|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131237328|NCT03215030|472499982|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131237329|NCT03215030|472499983|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131237330|NCT03215030|472499984|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131178600|NCT00098020|472274000|FG000|Overall Study|Low urine PCR|1|||
131178601|NCT00098020|472274000|FG000|Overall Study|Low epidermal growth factor receptor|1|||
131178602|NCT01840228|472274002|FG000|Overall Study|Lost to Follow-up|1|||
131178603|NCT01840228|472274003|FG001|Overall Study|Lost to Follow-up|1|||
131178604|NCT01295580|472274006|FG000|Overall Study|Protocol Violation|4|||
131178605|NCT01295580|472274007|FG001|Overall Study|Protocol Violation|2|||
131178606|NCT01295580|472274006|FG000|Overall Study|Withdrawal by Subject|1|||
131178607|NCT01295580|472274007|FG001|Overall Study|Withdrawal by Subject|4|||
131178608|NCT01295580|472274006|FG000|Overall Study|Adverse Event|2|||
131178609|NCT01295580|472274007|FG001|Overall Study|Adverse Event|1|||
131178610|NCT01295580|472274006|FG000|Overall Study|Lost to Follow-up|1|||
131178611|NCT01295580|472274007|FG001|Overall Study|Lost to Follow-up|0|||
131178612|NCT01295580|472274006|FG000|Overall Study|Lack of Efficacy|1|||
131178613|NCT01295580|472274007|FG001|Overall Study|Lack of Efficacy|0|||
131178614|NCT01295580|472274006|FG000|Overall Study|Other: inconvenience|1|||
131178615|NCT01295580|472274007|FG001|Overall Study|Other: inconvenience|0|||
131178616|NCT01295580|472274006|FG000|Overall Study|Other: family objection|0|||
131178617|NCT01295580|472274007|FG001|Overall Study|Other: family objection|1|||
131178618|NCT02022033|472274013|FG000|Overall Study|Physician Decision|1|||
131178619|NCT01879319|472274016|FG000|Overall Study|Withdrawal by Subject|1|||
131178620|NCT01879319|472274017|FG001|Overall Study|Withdrawal by Subject|0|||
131178621|NCT01879319|472274016|FG000|Overall Study|Lost to Follow-up|1|||
131178622|NCT01879319|472274017|FG001|Overall Study|Lost to Follow-up|5|||
131178623|NCT01360762|472274018|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
131178624|NCT01360762|472274018|FG000|Main Study Period (12-month Treatment)|Death|5|||
131178625|NCT01360762|472274018|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
131178626|NCT01360762|472274018|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
131178627|NCT01360762|472274018|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
131178628|NCT01360762|472274018|FG000|Whole Study Period|Lost to Follow-up|10|||
131178629|NCT01360762|472274018|FG000|Whole Study Period|Death|7|||
131178630|NCT01360762|472274018|FG000|Whole Study Period|Patient relapsed|18|||
131178631|NCT01360762|472274018|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
131178632|NCT01103778|472274019|FG000|Overall Study|Lost to Follow-up|1|||
131178633|NCT01103778|472274019|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
131178634|NCT01103778|472274019|FG000|Overall Study|Screen failure|1|||
131178635|NCT04724733|472274020|FG000|Overall Study|Lost to Follow-up|1|||
131178636|NCT04724733|472274021|FG001|Overall Study|Lost to Follow-up|1|||
131178637|NCT04724733|472274022|FG002|Overall Study|Lost to Follow-up|1|||
131178638|NCT03986190|472274023|FG000|Overall Study|Withdrawal by Subject|12|||
131178639|NCT03986190|472274024|FG001|Overall Study|Withdrawal by Subject|0|||
131237331|NCT03215030|472499985|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
131178640|NCT04511819|472274025|FG000|Overall Study|Non-compliance with study drug|5|||
131178641|NCT04511819|472274026|FG001|Overall Study|Non-compliance with study drug|1|||
131178642|NCT04511819|472274025|FG000|Overall Study|Withdrawal by Subject|0|||
131178643|NCT04511819|472274026|FG001|Overall Study|Withdrawal by Subject|3|||
131178644|NCT04511819|472274025|FG000|Overall Study|Adverse Event|0|||
131178645|NCT04511819|472274026|FG001|Overall Study|Adverse Event|1|||
131178646|NCT04511819|472274025|FG000|Overall Study|Protocol deviation|1|||
131178647|NCT04511819|472274026|FG001|Overall Study|Protocol deviation|0|||
131237332|NCT03215030|472499974|FG000|Part 1: Dose Escalation|Death|15|||
130783523|NCT03439137|470835030|FG001|Overall Study|Difficult to control Hb|2|||
131178648|NCT00084929|472274027|FG000|Overall Study|ineligible - medical contraindication|1|||
131237333|NCT03215030|472499975|FG001|Part 1: Dose Escalation|Death|6|||
131237334|NCT03215030|472499976|FG002|Part 1: Dose Escalation|Death|6|||
131237335|NCT03215030|472499977|FG003|Part 1: Dose Escalation|Death|8|||
131237336|NCT03215030|472499978|FG004|Part 1: Dose Escalation|Death|0|||
131178649|NCT00084929|472274027|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
131178650|NCT00084929|472274027|FG000|Overall Study|Ineligible - Medical history|6|||
131178651|NCT00084929|472274027|FG000|Overall Study|Withdrawal by Subject|10|||
131178652|NCT00084929|472274027|FG000|Overall Study|Missing/incomplete CTC exam|9|||
131178653|NCT00084929|472274027|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
131178654|NCT00844649|472274028|FG000|Overall Study|Progressive Disease|196|||
131178655|NCT00844649|472274029|FG001|Overall Study|Progressive Disease|245|||
131178656|NCT00844649|472274028|FG000|Overall Study|Adverse Event|128|||
131178657|NCT00844649|472274029|FG001|Overall Study|Adverse Event|73|||
131178658|NCT00844649|472274028|FG000|Overall Study|Physician Decision|25|||
131178659|NCT00844649|472274029|FG001|Overall Study|Physician Decision|18|||
131178660|NCT00844649|472274028|FG000|Overall Study|Protocol Violation|10|||
131178661|NCT00844649|472274029|FG001|Overall Study|Protocol Violation|6|||
131178662|NCT00844649|472274028|FG000|Overall Study|Withdrawal by Subject|28|||
131178663|NCT00844649|472274029|FG001|Overall Study|Withdrawal by Subject|39|||
131178664|NCT00844649|472274028|FG000|Overall Study|Other|7|||
131178665|NCT00844649|472274029|FG001|Overall Study|Other|10|||
131178666|NCT00844649|472274028|FG000|Overall Study|Withdrew prior to starting treatment|11|||
131178667|NCT00844649|472274029|FG001|Overall Study|Withdrew prior to starting treatment|27|||
131178668|NCT00664209|472274030|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
131178669|NCT00664209|472274030|FG000|Study Treatment Period|Physician Decision|4|||
131178670|NCT00664209|472274030|FG000|Study Treatment Period|Withdrawal by Subject|2|||
131178671|NCT00065442|472274041|FG000|Overall Study|Lost to Follow-up|1|||
131178672|NCT00065442|472274042|FG001|Overall Study|Lost to Follow-up|1|||
131178673|NCT00065442|472274041|FG000|Overall Study|Death|121|||
131178674|NCT00065442|472274042|FG001|Overall Study|Death|210|||
131178675|NCT00065442|472274041|FG000|Overall Study|Withdrawal by Subject|3|||
131178676|NCT00065442|472274042|FG001|Overall Study|Withdrawal by Subject|9|||
131178677|NCT01594333|472274043|FG000|Overall Study|Death|96|||
131178678|NCT01594333|472274044|FG001|Overall Study|Death|83|||
131178679|NCT01594333|472274043|FG000|Overall Study|Lost to Follow-up|5|||
131178680|NCT01594333|472274044|FG001|Overall Study|Lost to Follow-up|5|||
131178681|NCT01594333|472274043|FG000|Overall Study|Withdrawal by Subject|60|||
131178682|NCT01594333|472274044|FG001|Overall Study|Withdrawal by Subject|63|||
131178683|NCT00589979|472274045|FG000|Run-In Period|Adverse Event|5|||
131178684|NCT00589979|472274046|FG001|Run-In Period|Adverse Event|0|||
131178685|NCT00589979|472274047|FG002|Run-In Period|Adverse Event|0|||
131178686|NCT00589979|472274045|FG000|Run-In Period|Protocol Violation|3|||
131178687|NCT00589979|472274046|FG001|Run-In Period|Protocol Violation|0|||
131178688|NCT00589979|472274047|FG002|Run-In Period|Protocol Violation|0|||
131178689|NCT00589979|472274045|FG000|Run-In Period|Did not qualify for randomization|54|||
131178690|NCT00589979|472274046|FG001|Run-In Period|Did not qualify for randomization|0|||
131178691|NCT00589979|472274047|FG002|Run-In Period|Did not qualify for randomization|0|||
131178692|NCT00589979|472274045|FG000|Run-In Period|Withdrawal by Subject|10|||
131178693|NCT00589979|472274046|FG001|Run-In Period|Withdrawal by Subject|0|||
131178694|NCT00589979|472274047|FG002|Run-In Period|Withdrawal by Subject|0|||
131178695|NCT00589979|472274045|FG000|Run-In Period|Informed Consent Withdrawn|4|||
131178696|NCT00589979|472274046|FG001|Run-In Period|Informed Consent Withdrawn|0|||
131178697|NCT00589979|472274047|FG002|Run-In Period|Informed Consent Withdrawn|0|||
131178698|NCT00589979|472274045|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
131178699|NCT00589979|472274046|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
131178700|NCT00589979|472274047|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
131178701|NCT00589979|472274045|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
131178702|NCT00589979|472274046|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
131178703|NCT00589979|472274047|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
131178704|NCT00589979|472274045|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
131178705|NCT00589979|472274046|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
131178706|NCT00589979|472274047|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
131178707|NCT00589979|472274045|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
131178708|NCT00589979|472274046|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
131237337|NCT03215030|472499979|FG005|Part 1: Dose Escalation|Death|0|||
130783524|NCT03439137|470835029|FG000|Overall Study|Initiation of a renal transplant|0|||
131178709|NCT00589979|472274047|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
131178710|NCT00589979|472274045|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
131178711|NCT00589979|472274046|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
131178712|NCT00589979|472274047|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
131178713|NCT00589979|472274045|FG000|Double-Blind Treatment Period 2|Other|0|||
131178714|NCT00589979|472274046|FG001|Double-Blind Treatment Period 2|Other|0|||
131178715|NCT00589979|472274047|FG002|Double-Blind Treatment Period 2|Other|1|||
131178716|NCT00589979|472274045|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
131178717|NCT00589979|472274046|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
130783525|NCT03439137|470835030|FG001|Overall Study|Initiation of a renal transplant|2|||
131178718|NCT00589979|472274047|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
131178719|NCT00589979|472274045|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
131178720|NCT00589979|472274046|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
131178721|NCT00589979|472274047|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
131178722|NCT00712322|472274048|FG000|Overall Study|Protocol deviation|0|||
131178723|NCT00712322|472274049|FG001|Overall Study|Protocol deviation|1|||
131178724|NCT00712322|472274050|FG002|Overall Study|Protocol deviation|0|||
131178725|NCT02670330|472274052|FG000|Overall Study|Protocol Deviation|1|||
131178726|NCT02670330|472274053|FG001|Overall Study|Protocol Deviation|0|||
131178727|NCT02670330|472274052|FG000|Overall Study|Study Terminated By Sponsor|36|||
131178728|NCT02670330|472274053|FG001|Overall Study|Study Terminated By Sponsor|43|||
131178729|NCT02670330|472274052|FG000|Overall Study|Adverse Event|1|||
131178730|NCT02670330|472274053|FG001|Overall Study|Adverse Event|3|||
131178731|NCT02670330|472274052|FG000|Overall Study|Withdrawal by Subject|34|||
131178732|NCT02670330|472274053|FG001|Overall Study|Withdrawal by Subject|29|||
131178733|NCT02670330|472274052|FG000|Overall Study|Lost to Follow-up|3|||
131178734|NCT02670330|472274053|FG001|Overall Study|Lost to Follow-up|2|||
131178735|NCT02180217|472274056|FG000|Overall Study|Adverse Event|3|||
131178736|NCT02180217|472274057|FG001|Overall Study|Adverse Event|2|||
131178737|NCT02180217|472274058|FG002|Overall Study|Adverse Event|22|||
131178738|NCT02180217|472274056|FG000|Overall Study|Death|1|||
131178739|NCT02180217|472274057|FG001|Overall Study|Death|1|||
131178740|NCT02180217|472274058|FG002|Overall Study|Death|0|||
131178741|NCT02180217|472274056|FG000|Overall Study|Withdrawal by Subject|1|||
131178742|NCT02180217|472274057|FG001|Overall Study|Withdrawal by Subject|1|||
131178743|NCT02180217|472274058|FG002|Overall Study|Withdrawal by Subject|4|||
131178744|NCT02180217|472274056|FG000|Overall Study|Subject/Guardian decision|5|||
131178745|NCT02180217|472274057|FG001|Overall Study|Subject/Guardian decision|3|||
131178746|NCT02180217|472274058|FG002|Overall Study|Subject/Guardian decision|6|||
131178747|NCT02180217|472274056|FG000|Overall Study|Physician Decision|1|||
131178748|NCT02180217|472274057|FG001|Overall Study|Physician Decision|1|||
131178749|NCT02180217|472274058|FG002|Overall Study|Physician Decision|6|||
131178750|NCT02180217|472274056|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131178751|NCT02180217|472274057|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131178752|NCT02180217|472274058|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
131178753|NCT00878215|472274059|FG000|Overall Study|Determined to be ineligible|0|||
131178754|NCT00878215|472274060|FG001|Overall Study|Determined to be ineligible|10|||
131178755|NCT00878215|472274061|FG002|Overall Study|Determined to be ineligible|0|||
131178756|NCT00878215|472274062|FG003|Overall Study|Determined to be ineligible|0|||
131178757|NCT00738374|472274063|FG000|Induction Treatment Phase|Adverse Event|14|||
131178758|NCT00738374|472274064|FG001|Induction Treatment Phase|Adverse Event|0|||
131178759|NCT00738374|472274065|FG002|Induction Treatment Phase|Adverse Event|0|||
131178760|NCT00738374|472274066|FG003|Induction Treatment Phase|Adverse Event|0|||
131178761|NCT00738374|472274063|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
131178762|NCT00738374|472274064|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
131178763|NCT00738374|472274065|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
131178764|NCT00738374|472274066|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
131178765|NCT00738374|472274063|FG000|Induction Treatment Phase|Physician Decision|2|||
131178766|NCT00738374|472274064|FG001|Induction Treatment Phase|Physician Decision|0|||
131178767|NCT00738374|472274065|FG002|Induction Treatment Phase|Physician Decision|0|||
131178768|NCT00738374|472274066|FG003|Induction Treatment Phase|Physician Decision|0|||
131178769|NCT00738374|472274063|FG000|Induction Treatment Phase|Protocol Violation|2|||
131178770|NCT00738374|472274064|FG001|Induction Treatment Phase|Protocol Violation|0|||
131178771|NCT00738374|472274065|FG002|Induction Treatment Phase|Protocol Violation|0|||
131178772|NCT00738374|472274066|FG003|Induction Treatment Phase|Protocol Violation|0|||
131178773|NCT00738374|472274063|FG000|Induction Treatment Phase|Non-compliance|1|||
131178774|NCT00738374|472274064|FG001|Induction Treatment Phase|Non-compliance|0|||
131178775|NCT00738374|472274065|FG002|Induction Treatment Phase|Non-compliance|0|||
131178776|NCT00738374|472274066|FG003|Induction Treatment Phase|Non-compliance|0|||
131178777|NCT00738374|472274063|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
131178778|NCT00738374|472274064|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
130783526|NCT01240382|470835032|FG000|Overall Study|Adverse Event|2|||
131178779|NCT00738374|472274065|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
131178780|NCT00738374|472274066|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
131178781|NCT00738374|472274063|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
131178782|NCT00738374|472274064|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
130783527|NCT01240382|470835033|FG001|Overall Study|Adverse Event|1|||
131178783|NCT00738374|472274065|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
131178784|NCT00738374|472274066|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
131178785|NCT00738374|472274063|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
131178786|NCT00738374|472274064|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
131178787|NCT00738374|472274065|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
131237338|NCT03215030|472499980|FG006|Part 1: Dose Escalation|Death|0|||
131178788|NCT00738374|472274066|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
131178789|NCT00738374|472274063|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
131178790|NCT00738374|472274064|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
131178791|NCT00738374|472274065|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
131178792|NCT00738374|472274066|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
131178793|NCT00738374|472274063|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
131178794|NCT00738374|472274064|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
131178795|NCT00738374|472274065|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
131178796|NCT00738374|472274066|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
131178797|NCT00738374|472274063|FG000|Maintenance Treatment/Observation Phase|Other|0|||
131178798|NCT00738374|472274064|FG001|Maintenance Treatment/Observation Phase|Other|1|||
131178799|NCT00738374|472274065|FG002|Maintenance Treatment/Observation Phase|Other|0|||
131178800|NCT00738374|472274066|FG003|Maintenance Treatment/Observation Phase|Other|0|||
131178801|NCT03334396|472274067|FG000|Overall Study|Adverse Event|1|||
131178802|NCT03334396|472274068|FG001|Overall Study|Adverse Event|0|||
131178803|NCT03334396|472274069|FG002|Overall Study|Adverse Event|1|||
131178804|NCT03334396|472274070|FG003|Overall Study|Adverse Event|0|||
131178805|NCT03334396|472274071|FG004|Overall Study|Adverse Event|0|||
131178806|NCT03334396|472274072|FG005|Overall Study|Adverse Event|0|||
131178807|NCT03334396|472274073|FG006|Overall Study|Adverse Event|0|||
131178808|NCT03334396|472274074|FG007|Overall Study|Adverse Event|0|||
131178809|NCT03334396|472274067|FG000|Overall Study|Lack of Efficacy|10|||
131178810|NCT03334396|472274068|FG001|Overall Study|Lack of Efficacy|4|||
131178811|NCT03334396|472274069|FG002|Overall Study|Lack of Efficacy|1|||
131178812|NCT03334396|472274070|FG003|Overall Study|Lack of Efficacy|3|||
131178813|NCT03334396|472274071|FG004|Overall Study|Lack of Efficacy|1|||
131178814|NCT03334396|472274072|FG005|Overall Study|Lack of Efficacy|0|||
131178815|NCT03334396|472274073|FG006|Overall Study|Lack of Efficacy|0|||
131178816|NCT03334396|472274074|FG007|Overall Study|Lack of Efficacy|1|||
131178817|NCT03334396|472274067|FG000|Overall Study|Lost to Follow-up|0|||
131178818|NCT03334396|472274068|FG001|Overall Study|Lost to Follow-up|0|||
131178819|NCT03334396|472274069|FG002|Overall Study|Lost to Follow-up|1|||
131178820|NCT03334396|472274070|FG003|Overall Study|Lost to Follow-up|0|||
131178821|NCT03334396|472274071|FG004|Overall Study|Lost to Follow-up|0|||
131178822|NCT03334396|472274072|FG005|Overall Study|Lost to Follow-up|0|||
131178823|NCT03334396|472274073|FG006|Overall Study|Lost to Follow-up|1|||
131178824|NCT03334396|472274074|FG007|Overall Study|Lost to Follow-up|0|||
131178825|NCT03334396|472274067|FG000|Overall Study|Physician Decision|1|||
131178826|NCT03334396|472274068|FG001|Overall Study|Physician Decision|0|||
131178827|NCT03334396|472274069|FG002|Overall Study|Physician Decision|0|||
131178828|NCT03334396|472274070|FG003|Overall Study|Physician Decision|0|||
131178829|NCT03334396|472274071|FG004|Overall Study|Physician Decision|0|||
131178830|NCT03334396|472274072|FG005|Overall Study|Physician Decision|0|||
131178831|NCT03334396|472274073|FG006|Overall Study|Physician Decision|0|||
131178832|NCT03334396|472274074|FG007|Overall Study|Physician Decision|0|||
131178833|NCT03334396|472274067|FG000|Overall Study|Withdrawal by Subject|10|||
131178834|NCT03334396|472274068|FG001|Overall Study|Withdrawal by Subject|5|||
131178835|NCT03334396|472274069|FG002|Overall Study|Withdrawal by Subject|7|||
131178836|NCT03334396|472274070|FG003|Overall Study|Withdrawal by Subject|2|||
131178837|NCT03334396|472274071|FG004|Overall Study|Withdrawal by Subject|2|||
131178838|NCT03334396|472274072|FG005|Overall Study|Withdrawal by Subject|1|||
131178839|NCT03334396|472274073|FG006|Overall Study|Withdrawal by Subject|2|||
131178840|NCT03334396|472274074|FG007|Overall Study|Withdrawal by Subject|0|||
131178841|NCT03334396|472274067|FG000|Overall Study|Pregnancy|0|||
131178842|NCT03334396|472274068|FG001|Overall Study|Pregnancy|1|||
131178843|NCT03334396|472274069|FG002|Overall Study|Pregnancy|0|||
131178844|NCT03334396|472274070|FG003|Overall Study|Pregnancy|0|||
131178845|NCT03334396|472274071|FG004|Overall Study|Pregnancy|0|||
131178846|NCT03334396|472274072|FG005|Overall Study|Pregnancy|0|||
131178847|NCT03334396|472274073|FG006|Overall Study|Pregnancy|0|||
131178848|NCT03334396|472274074|FG007|Overall Study|Pregnancy|0|||
131178849|NCT03334396|472274067|FG000|Overall Study|Ineligible|0|||
131178850|NCT03334396|472274068|FG001|Overall Study|Ineligible|1|||
131178851|NCT03334396|472274069|FG002|Overall Study|Ineligible|0|||
130783528|NCT01240382|470835032|FG000|Overall Study|Lack of Efficacy|0|||
131178852|NCT03334396|472274070|FG003|Overall Study|Ineligible|0|||
131178853|NCT03334396|472274071|FG004|Overall Study|Ineligible|0|||
131178854|NCT03334396|472274072|FG005|Overall Study|Ineligible|0|||
131178855|NCT03334396|472274073|FG006|Overall Study|Ineligible|0|||
131178856|NCT03334396|472274074|FG007|Overall Study|Ineligible|0|||
131178857|NCT03334396|472274067|FG000|Overall Study|Started New Job|1|||
131178858|NCT03334396|472274068|FG001|Overall Study|Started New Job|0|||
131178859|NCT03334396|472274069|FG002|Overall Study|Started New Job|0|||
131178860|NCT03334396|472274070|FG003|Overall Study|Started New Job|0|||
131178861|NCT03334396|472274071|FG004|Overall Study|Started New Job|0|||
131178862|NCT03334396|472274072|FG005|Overall Study|Started New Job|0|||
131178863|NCT03334396|472274073|FG006|Overall Study|Started New Job|0|||
131178864|NCT03334396|472274074|FG007|Overall Study|Started New Job|0|||
131178865|NCT01969799|472274075|FG000|Overall Study|Adverse Event|0|||
131178866|NCT01969799|472274076|FG001|Overall Study|Adverse Event|1|||
131178867|NCT01969799|472274075|FG000|Overall Study|Death|16|||
131178868|NCT01969799|472274076|FG001|Overall Study|Death|11|||
131178869|NCT01969799|472274075|FG000|Overall Study|Lost to Follow-up|0|||
131178870|NCT01969799|472274076|FG001|Overall Study|Lost to Follow-up|2|||
131178871|NCT01969799|472274075|FG000|Overall Study|Physician Decision|1|||
131178872|NCT01969799|472274076|FG001|Overall Study|Physician Decision|0|||
131178873|NCT03337139|472274079|FG000|Phase I|Withdrawal by Subject|10|||
131178874|NCT03337139|472274080|FG001|Phase I|Withdrawal by Subject|0|||
131178875|NCT00077376|472274081|FG000|Overall Study|Adverse Event|8|||
131178876|NCT00077376|472274081|FG000|Overall Study|Withdrawal by Subject|2|||
131178877|NCT00077376|472274081|FG000|Overall Study|Death|1|||
131178878|NCT00077376|472274081|FG000|Overall Study|Physician Decision|1|||
131178879|NCT00077376|472274081|FG000|Overall Study|Alternative therapy|5|||
131178880|NCT00077376|472274081|FG000|Overall Study|Complicating disease|1|||
131178881|NCT00077376|472274081|FG000|Overall Study|Still on treatment|1|||
131178882|NCT00077376|472274081|FG000|Overall Study|Symptomatic deterioration|1|||
131178883|NCT00077376|472274081|FG000|Overall Study|Surgery|1|||
131178884|NCT00077376|472274081|FG000|Overall Study|Insurance ran out|1|||
131178885|NCT03288493|472274082|FG000|Overall Study|Withdrawal by Subject|4|||
131178886|NCT03288493|472274083|FG001|Overall Study|Withdrawal by Subject|0|||
131178887|NCT03288493|472274084|FG002|Overall Study|Withdrawal by Subject|0|||
131178888|NCT03288493|472274085|FG003|Overall Study|Withdrawal by Subject|0|||
131178889|NCT03288493|472274086|FG004|Overall Study|Withdrawal by Subject|0|||
131178890|NCT03288493|472274087|FG005|Overall Study|Withdrawal by Subject|2|||
131178891|NCT03288493|472274088|FG006|Overall Study|Withdrawal by Subject|0|||
131178892|NCT03288493|472274082|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
131178893|NCT03288493|472274083|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
131178894|NCT03288493|472274084|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
131178895|NCT03288493|472274085|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
131178896|NCT03288493|472274086|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
131178897|NCT03288493|472274087|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
131178898|NCT03288493|472274088|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
131178899|NCT03288493|472274082|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
131178900|NCT03288493|472274083|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
131178901|NCT03288493|472274084|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
131178902|NCT03288493|472274085|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
131178903|NCT03288493|472274086|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
131178904|NCT03288493|472274087|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
131178905|NCT03288493|472274088|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
131178906|NCT03288493|472274082|FG000|Overall Study|Death|2|||
131178907|NCT03288493|472274083|FG001|Overall Study|Death|0|||
131178908|NCT03288493|472274084|FG002|Overall Study|Death|0|||
131178909|NCT03288493|472274085|FG003|Overall Study|Death|0|||
131178910|NCT03288493|472274086|FG004|Overall Study|Death|0|||
131178911|NCT03288493|472274087|FG005|Overall Study|Death|0|||
131178912|NCT03288493|472274088|FG006|Overall Study|Death|0|||
131178913|NCT03288493|472274082|FG000|Overall Study|other reason not listed above|2|||
131178914|NCT03288493|472274083|FG001|Overall Study|other reason not listed above|0|||
131178915|NCT03288493|472274084|FG002|Overall Study|other reason not listed above|0|||
131178916|NCT03288493|472274085|FG003|Overall Study|other reason not listed above|0|||
131178917|NCT03288493|472274086|FG004|Overall Study|other reason not listed above|0|||
131178918|NCT03288493|472274087|FG005|Overall Study|other reason not listed above|0|||
131178919|NCT03288493|472274088|FG006|Overall Study|other reason not listed above|0|||
131178920|NCT03784027|472274089|FG000|Period 1|Withdrawal by Subject|0|||
131178921|NCT03784027|472274090|FG001|Period 1|Withdrawal by Subject|1|||
131178922|NCT01255306|472276094|FG000|Overall Study|Physician Decision|1|||
131178923|NCT01255306|472276095|FG001|Overall Study|Physician Decision|1|||
131178924|NCT01283997|472276096|FG000|Overall Study|Physician Decision|8|||
131178925|NCT01283997|472276097|FG001|Overall Study|Physician Decision|10|||
131178926|NCT01283997|472276096|FG000|Overall Study|Withdrawal by Subject|3|||
131178927|NCT01283997|472276097|FG001|Overall Study|Withdrawal by Subject|2|||
131178928|NCT01283997|472276096|FG000|Overall Study|Physically unable to continue|0|||
131178929|NCT01283997|472276097|FG001|Overall Study|Physically unable to continue|1|||
131178930|NCT01283997|472276096|FG000|Overall Study|Progressive disease|1|||
131178931|NCT01283997|472276097|FG001|Overall Study|Progressive disease|0|||
131178932|NCT01283997|472276096|FG000|Overall Study|Other|4|||
131178933|NCT01283997|472276097|FG001|Overall Study|Other|4|||
130783529|NCT01240382|470835033|FG001|Overall Study|Lack of Efficacy|2|||
130783530|NCT01240382|470835032|FG000|Overall Study|Fear of adverse events|0|||
130783531|NCT01240382|470835033|FG001|Overall Study|Fear of adverse events|1|||
130783532|NCT02456727|470835034|FG000|Overall Study|Lost to Follow-up|63|||
130783533|NCT02456727|470835035|FG001|Overall Study|Lost to Follow-up|65|||
130783534|NCT02456727|470835034|FG000|Overall Study|Death|2|||
130783535|NCT02456727|470835035|FG001|Overall Study|Death|1|||
130783536|NCT02456727|470835034|FG000|Overall Study|Withdrawal by Subject|1|||
130783537|NCT02456727|470835035|FG001|Overall Study|Withdrawal by Subject|10|||
130783538|NCT02456727|470835034|FG000|Overall Study|Never Initiated Treatment|43|||
130783539|NCT02456727|470835035|FG001|Overall Study|Never Initiated Treatment|30|||
130783540|NCT02643693|470835036|FG000|Overall Study|Physician Decision|0|||
130783541|NCT02643693|470835037|FG001|Overall Study|Physician Decision|1|||
130783542|NCT02643693|470835038|FG002|Overall Study|Physician Decision|0|||
130783543|NCT02643693|470835039|FG003|Overall Study|Physician Decision|0|||
130783544|NCT02643693|470835040|FG004|Overall Study|Physician Decision|0|||
130783545|NCT02643693|470835041|FG005|Overall Study|Physician Decision|0|||
130783546|NCT02643693|470835036|FG000|Overall Study|Withdrawal by Subject|0|||
130783547|NCT02643693|470835037|FG001|Overall Study|Withdrawal by Subject|1|||
130783548|NCT02643693|470835038|FG002|Overall Study|Withdrawal by Subject|0|||
130783549|NCT02643693|470835039|FG003|Overall Study|Withdrawal by Subject|0|||
130783550|NCT02643693|470835040|FG004|Overall Study|Withdrawal by Subject|0|||
130783551|NCT02643693|470835041|FG005|Overall Study|Withdrawal by Subject|0|||
130783552|NCT02643693|470835036|FG000|Overall Study|Protocol Adherence Issues|2|||
130783553|NCT02643693|470835037|FG001|Overall Study|Protocol Adherence Issues|0|||
130783554|NCT02643693|470835038|FG002|Overall Study|Protocol Adherence Issues|1|||
130783555|NCT02643693|470835039|FG003|Overall Study|Protocol Adherence Issues|0|||
130783556|NCT02643693|470835040|FG004|Overall Study|Protocol Adherence Issues|0|||
130783557|NCT02643693|470835041|FG005|Overall Study|Protocol Adherence Issues|1|||
130783558|NCT00888654|470835042|FG000|Overall Study|Problems swallowing oral meds.|1|||
130783559|NCT00888654|470835042|FG000|Overall Study|Not enough oral meds before surgery|3|||
130783560|NCT00888654|470835042|FG000|Overall Study|Surgery aborted|2|||
130783561|NCT00888654|470835042|FG000|Overall Study|Withdrawal by Subject|1|||
130783562|NCT00888654|470835042|FG000|Overall Study|Inelig. due to contraindication of med|1|||
130783563|NCT00888654|470835042|FG000|Overall Study|Change in surg date|1|||
130783564|NCT00888654|470835042|FG000|Overall Study|Stopped meds due to headaches|1|||
130783565|NCT03829462|470835046|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
130783566|NCT03829462|470835047|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
130783567|NCT03829462|470835046|FG000|Overall Study|No treatment due to progression disease|0|||
130783568|NCT03829462|470835047|FG001|Overall Study|No treatment due to progression disease|1|||
130783569|NCT02277028|470835049|FG000|Overall Study|Lost to Follow-up|1|||
130783570|NCT02277028|470835050|FG001|Overall Study|Lost to Follow-up|0|||
130783571|NCT02277028|470835049|FG000|Overall Study|Withdrawal by Subject|0|||
130783572|NCT02277028|470835050|FG001|Overall Study|Withdrawal by Subject|1|||
130783573|NCT02718911|470835051|FG000|Overall Study|Adverse Event|0|||
130783574|NCT02718911|470835052|FG001|Overall Study|Adverse Event|0|||
130783575|NCT02718911|470835053|FG002|Overall Study|Adverse Event|0|||
130783576|NCT02718911|470835054|FG003|Overall Study|Adverse Event|0|||
130783577|NCT02718911|470835055|FG004|Overall Study|Adverse Event|0|||
130783578|NCT02718911|470835056|FG005|Overall Study|Adverse Event|0|||
130783579|NCT02718911|470835057|FG006|Overall Study|Adverse Event|0|||
130783580|NCT02718911|470835058|FG007|Overall Study|Adverse Event|0|||
130783581|NCT02718911|470835059|FG008|Overall Study|Adverse Event|0|||
130783582|NCT02718911|470835060|FG009|Overall Study|Adverse Event|2|||
130783583|NCT02718911|470835051|FG000|Overall Study|Death|2|||
131237339|NCT03215030|472499981|FG007|Part 1: Dose Escalation|Death|0|||
131237340|NCT03215030|472499982|FG008|Part 1: Dose Escalation|Death|0|||
131237341|NCT03215030|472499983|FG009|Part 1: Dose Escalation|Death|0|||
131237342|NCT03215030|472499984|FG010|Part 1: Dose Escalation|Death|0|||
131237343|NCT03215030|472499985|FG011|Part 1: Dose Escalation|Death|0|||
131237344|NCT03215030|472499974|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
131237345|NCT03215030|472499975|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
131237346|NCT03215030|472499976|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
131237347|NCT03215030|472499977|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
130783584|NCT02718911|470835052|FG001|Overall Study|Death|3|||
130783585|NCT02718911|470835053|FG002|Overall Study|Death|1|||
130783586|NCT02718911|470835054|FG003|Overall Study|Death|0|||
130783587|NCT02718911|470835055|FG004|Overall Study|Death|1|||
130783588|NCT02718911|470835056|FG005|Overall Study|Death|3|||
130783589|NCT02718911|470835057|FG006|Overall Study|Death|1|||
130783590|NCT02718911|470835058|FG007|Overall Study|Death|1|||
130783591|NCT02718911|470835059|FG008|Overall Study|Death|4|||
131237348|NCT03215030|472499978|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
131237349|NCT03215030|472499979|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
130783592|NCT02718911|470835060|FG009|Overall Study|Death|3|||
130783593|NCT02718911|470835051|FG000|Overall Study|Lost to Follow-up|0|||
130783594|NCT02718911|470835052|FG001|Overall Study|Lost to Follow-up|0|||
131237350|NCT03215030|472499980|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
131178934|NCT02017899|472276098|FG000|Overall Study|Withdrawal by Subject|0|||
131178935|NCT02017899|472276099|FG001|Overall Study|Withdrawal by Subject|0|||
131178936|NCT02017899|472276100|FG002|Overall Study|Withdrawal by Subject|0|||
131178937|NCT02017899|472276101|FG003|Overall Study|Withdrawal by Subject|1|||
131178938|NCT02017899|472276102|FG004|Overall Study|Withdrawal by Subject|1|||
131178939|NCT02017899|472276103|FG005|Overall Study|Withdrawal by Subject|0|||
131178940|NCT01677624|472276107|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
131178941|NCT00804843|472276108|FG000|Overall Study|Protocol Violation|1|||
131178942|NCT00804843|472276109|FG001|Overall Study|Protocol Violation|0|||
131178943|NCT00804843|472276108|FG000|Overall Study|Adverse Event|8|||
131178944|NCT00804843|472276109|FG001|Overall Study|Adverse Event|5|||
131178945|NCT00804843|472276108|FG000|Overall Study|Withdrawal by Subject|1|||
131178946|NCT00804843|472276109|FG001|Overall Study|Withdrawal by Subject|2|||
131178947|NCT00884221|472276114|FG000|Overall Study|Withdrawal by Subject|0|||
131178948|NCT00884221|472276115|FG001|Overall Study|Withdrawal by Subject|3|||
131178949|NCT00884221|472276114|FG000|Overall Study|Adverse Event|6|||
131178950|NCT00884221|472276115|FG001|Overall Study|Adverse Event|3|||
131178951|NCT00884221|472276114|FG000|Overall Study|Protocol Violation|16|||
131178952|NCT00884221|472276115|FG001|Overall Study|Protocol Violation|13|||
131178953|NCT00884221|472276114|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
131178954|NCT00884221|472276115|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
131178955|NCT01975246|472276118|FG000|Overall Study|Adverse Event|2|||
131178956|NCT01975246|472276119|FG001|Overall Study|Adverse Event|1|||
131178957|NCT01975246|472276118|FG000|Overall Study|Lack of Efficacy|1|||
131178958|NCT01975246|472276119|FG001|Overall Study|Lack of Efficacy|0|||
131178959|NCT01975246|472276118|FG000|Overall Study|Protocol Violation|1|||
131178960|NCT01975246|472276119|FG001|Overall Study|Protocol Violation|0|||
131178961|NCT01975246|472276118|FG000|Overall Study|Other than stated|0|||
131178962|NCT01975246|472276119|FG001|Overall Study|Other than stated|1|||
131178963|NCT01263093|472276120|FG000|Washout|Physician Decision|1|||
131178964|NCT01263093|472276121|FG001|Washout|Physician Decision|0|||
131178965|NCT01263093|472276120|FG000|Period 2|Adverse Event|1|||
131178966|NCT01263093|472276121|FG001|Period 2|Adverse Event|0|||
131178967|NCT00424346|472276122|FG000|Core Study|Adverse Event|5|||
131178968|NCT00424346|472276123|FG001|Core Study|Adverse Event|3|||
131178969|NCT00424346|472276124|FG002|Core Study|Adverse Event|1|||
131178970|NCT00424346|472276125|FG003|Core Study|Adverse Event|1|||
131178971|NCT00424346|472276122|FG000|Core Study|Abnormal Laboratory Values|0|||
131178972|NCT00424346|472276123|FG001|Core Study|Abnormal Laboratory Values|1|||
131178973|NCT00424346|472276124|FG002|Core Study|Abnormal Laboratory Values|0|||
131178974|NCT00424346|472276125|FG003|Core Study|Abnormal Laboratory Values|0|||
131178975|NCT00424346|472276122|FG000|Core Study|Lack of Efficacy|1|||
131178976|NCT00424346|472276123|FG001|Core Study|Lack of Efficacy|3|||
131178977|NCT00424346|472276124|FG002|Core Study|Lack of Efficacy|0|||
131178978|NCT00424346|472276125|FG003|Core Study|Lack of Efficacy|4|||
131178979|NCT00424346|472276122|FG000|Core Study|Withdrawal by Subject|1|||
131178980|NCT00424346|472276123|FG001|Core Study|Withdrawal by Subject|0|||
131178981|NCT00424346|472276124|FG002|Core Study|Withdrawal by Subject|0|||
131178982|NCT00424346|472276125|FG003|Core Study|Withdrawal by Subject|2|||
131178983|NCT00424346|472276122|FG000|Core Study|Lost to Follow-up|1|||
131178984|NCT00424346|472276123|FG001|Core Study|Lost to Follow-up|1|||
131178985|NCT00424346|472276124|FG002|Core Study|Lost to Follow-up|0|||
131178986|NCT00424346|472276125|FG003|Core Study|Lost to Follow-up|0|||
131178987|NCT00424346|472276122|FG000|Core Study|Administrative Problems|1|||
131178988|NCT00424346|472276123|FG001|Core Study|Administrative Problems|0|||
131178989|NCT00424346|472276124|FG002|Core Study|Administrative Problems|1|||
131178990|NCT00424346|472276125|FG003|Core Study|Administrative Problems|0|||
131178991|NCT00424346|472276122|FG000|Core Study|Protocol Violation|0|||
131178992|NCT00424346|472276123|FG001|Core Study|Protocol Violation|0|||
131178993|NCT00424346|472276124|FG002|Core Study|Protocol Violation|2|||
131178994|NCT00424346|472276125|FG003|Core Study|Protocol Violation|0|||
131178995|NCT00424346|472276122|FG000|Extension Phase|Adverse Event|0|||
131178996|NCT00424346|472276123|FG001|Extension Phase|Adverse Event|9|||
131178997|NCT00424346|472276124|FG002|Extension Phase|Adverse Event|5|||
131178998|NCT00424346|472276125|FG003|Extension Phase|Adverse Event|4|||
131178999|NCT00424346|472276122|FG000|Extension Phase|Lack of Efficacy|0|||
131179000|NCT00424346|472276123|FG001|Extension Phase|Lack of Efficacy|16|||
131179001|NCT00424346|472276124|FG002|Extension Phase|Lack of Efficacy|14|||
131179002|NCT00424346|472276125|FG003|Extension Phase|Lack of Efficacy|11|||
131179003|NCT00424346|472276122|FG000|Extension Phase|Withdrawal by Subject|0|||
131179004|NCT00424346|472276123|FG001|Extension Phase|Withdrawal by Subject|5|||
131179005|NCT00424346|472276124|FG002|Extension Phase|Withdrawal by Subject|3|||
131179006|NCT00424346|472276125|FG003|Extension Phase|Withdrawal by Subject|4|||
131179007|NCT00424346|472276122|FG000|Extension Phase|Lost to Follow-up|0|||
131179008|NCT00424346|472276123|FG001|Extension Phase|Lost to Follow-up|2|||
131179009|NCT00424346|472276124|FG002|Extension Phase|Lost to Follow-up|0|||
131237351|NCT03215030|472499981|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
131237352|NCT03215030|472499982|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
131237353|NCT03215030|472499983|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
131237354|NCT03215030|472499984|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
131237355|NCT03215030|472499985|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
131237356|NCT03215030|472499974|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237357|NCT03215030|472499975|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237358|NCT03215030|472499976|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237359|NCT03215030|472499977|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237360|NCT03215030|472499978|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237361|NCT03215030|472499979|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237362|NCT03215030|472499980|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237363|NCT03215030|472499981|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
131237364|NCT03215030|472499982|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237365|NCT03215030|472499983|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237366|NCT03215030|472499984|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237367|NCT03215030|472499985|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
131237368|NCT03215030|472499974|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131237369|NCT03215030|472499975|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131237370|NCT03215030|472499976|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131237371|NCT03215030|472499977|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131237372|NCT03215030|472499978|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
131237373|NCT03215030|472499979|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
131237374|NCT03215030|472499980|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
131237375|NCT03215030|472499981|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
131237376|NCT03215030|472499982|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131237377|NCT03215030|472499983|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131237378|NCT03215030|472499984|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131237379|NCT03215030|472499985|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
131237380|NCT03215030|472499974|FG000|Part 2: Dose Expansion|Death|0|||
131237381|NCT03215030|472499975|FG001|Part 2: Dose Expansion|Death|0|||
131237382|NCT03215030|472499976|FG002|Part 2: Dose Expansion|Death|0|||
131237383|NCT03215030|472499977|FG003|Part 2: Dose Expansion|Death|0|||
131237384|NCT03215030|472499978|FG004|Part 2: Dose Expansion|Death|3|||
131237385|NCT03215030|472499979|FG005|Part 2: Dose Expansion|Death|1|||
131237386|NCT03215030|472499980|FG006|Part 2: Dose Expansion|Death|5|||
131237387|NCT03215030|472499981|FG007|Part 2: Dose Expansion|Death|4|||
131237388|NCT03215030|472499982|FG008|Part 2: Dose Expansion|Death|0|||
131237389|NCT03215030|472499983|FG009|Part 2: Dose Expansion|Death|0|||
131237390|NCT03215030|472499984|FG010|Part 2: Dose Expansion|Death|0|||
131237391|NCT03215030|472499985|FG011|Part 2: Dose Expansion|Death|0|||
131237392|NCT03215030|472499974|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
131237393|NCT03215030|472499975|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
131237394|NCT03215030|472499976|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
131237395|NCT03215030|472499977|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
131237396|NCT03215030|472499978|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
131237397|NCT03215030|472499979|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
131237398|NCT03215030|472499980|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
131237399|NCT03215030|472499981|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
131237400|NCT03215030|472499982|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
131237401|NCT03215030|472499983|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
131237402|NCT03215030|472499984|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
131237403|NCT03215030|472499985|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
131237404|NCT03215030|472499974|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
131237405|NCT03215030|472499975|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
131237406|NCT03215030|472499976|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
131237407|NCT03215030|472499977|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
131237408|NCT03215030|472499978|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
131237409|NCT03215030|472499979|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
131237410|NCT03215030|472499980|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
131237411|NCT03215030|472499981|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
131237412|NCT03215030|472499982|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
131237413|NCT03215030|472499983|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
131237414|NCT03215030|472499984|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
131237415|NCT03215030|472499985|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
131237416|NCT03215030|472499974|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131237417|NCT03215030|472499975|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131237418|NCT03215030|472499976|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131237419|NCT03215030|472499977|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131237420|NCT03215030|472499978|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131237421|NCT03215030|472499979|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131237422|NCT03215030|472499980|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131237423|NCT03215030|472499981|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131237424|NCT03215030|472499982|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
131237425|NCT03215030|472499983|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
131237426|NCT03215030|472499984|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131237427|NCT03215030|472499985|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
131237428|NCT03215030|472499974|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
131237429|NCT03215030|472499975|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
131237430|NCT03215030|472499976|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
131237431|NCT03215030|472499977|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
131237432|NCT03215030|472499978|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
131237433|NCT03215030|472499979|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
131237434|NCT03215030|472499980|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
131237435|NCT03215030|472499981|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
131237436|NCT03215030|472499982|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
131237437|NCT03215030|472499983|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
131237438|NCT03215030|472499984|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
131237439|NCT03215030|472499985|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
131237440|NCT03215030|472499974|FG000|Part 3: Dose Extension|Death|0|||
131237441|NCT03215030|472499975|FG001|Part 3: Dose Extension|Death|0|||
131237442|NCT03215030|472499976|FG002|Part 3: Dose Extension|Death|0|||
131237443|NCT03215030|472499977|FG003|Part 3: Dose Extension|Death|0|||
131237444|NCT03215030|472499978|FG004|Part 3: Dose Extension|Death|0|||
131237445|NCT03215030|472499979|FG005|Part 3: Dose Extension|Death|0|||
131237446|NCT03215030|472499980|FG006|Part 3: Dose Extension|Death|0|||
131237447|NCT03215030|472499981|FG007|Part 3: Dose Extension|Death|0|||
131237448|NCT03215030|472499982|FG008|Part 3: Dose Extension|Death|19|||
131237449|NCT03215030|472499983|FG009|Part 3: Dose Extension|Death|20|||
131237450|NCT03215030|472499984|FG010|Part 3: Dose Extension|Death|0|||
131237451|NCT03215030|472499985|FG011|Part 3: Dose Extension|Death|0|||
131237452|NCT03215030|472499974|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
131237453|NCT03215030|472499975|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
131237454|NCT03215030|472499976|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
131237455|NCT03215030|472499977|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
131237456|NCT03215030|472499978|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
131237457|NCT03215030|472499979|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
131237458|NCT03215030|472499980|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
131237459|NCT03215030|472499981|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
131237460|NCT03215030|472499982|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
131237461|NCT03215030|472499983|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
131237462|NCT03215030|472499984|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
131237463|NCT03215030|472499985|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
131237464|NCT03215030|472499974|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131237465|NCT03215030|472499975|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131237466|NCT03215030|472499976|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131237467|NCT03215030|472499977|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131237468|NCT03215030|472499978|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131237469|NCT03215030|472499979|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131237470|NCT03215030|472499980|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131237471|NCT03215030|472499981|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131237472|NCT03215030|472499982|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131237473|NCT03215030|472499983|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
131237474|NCT03215030|472499984|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
131237475|NCT03215030|472499985|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
131237476|NCT01374919|472499986|FG000|Overall Study|Withdrawal by Subject|2|||
131237477|NCT05086744|472499987|FG000|Part A|Adverse Event|0|||
131237478|NCT05086744|472499988|FG001|Part A|Adverse Event|1|||
131179010|NCT00424346|472276125|FG003|Extension Phase|Lost to Follow-up|0|||
131179011|NCT00424346|472276122|FG000|Extension Phase|Administrative Problems|0|||
131179012|NCT00424346|472276123|FG001|Extension Phase|Administrative Problems|69|||
131179013|NCT00424346|472276124|FG002|Extension Phase|Administrative Problems|32|||
131179014|NCT00424346|472276125|FG003|Extension Phase|Administrative Problems|35|||
131179015|NCT00424346|472276122|FG000|Extension Phase|Death|0|||
131179016|NCT00424346|472276123|FG001|Extension Phase|Death|0|||
131179017|NCT00424346|472276124|FG002|Extension Phase|Death|0|||
131179018|NCT00424346|472276125|FG003|Extension Phase|Death|1|||
131179019|NCT00424346|472276122|FG000|Extension Phase|Protocol Violation|0|||
131179020|NCT00424346|472276123|FG001|Extension Phase|Protocol Violation|1|||
131179021|NCT00424346|472276124|FG002|Extension Phase|Protocol Violation|1|||
131179022|NCT00424346|472276125|FG003|Extension Phase|Protocol Violation|0|||
131179023|NCT00571519|472276126|FG000|Overall Study|Subject withdrew consent|0|||
131179024|NCT00571519|472276127|FG001|Overall Study|Subject withdrew consent|1|||
131179025|NCT00571519|472276128|FG002|Overall Study|Subject withdrew consent|0|||
131237479|NCT05086744|472499987|FG000|Part A|Lack of Efficacy|3|||
131237480|NCT05086744|472499988|FG001|Part A|Lack of Efficacy|0|||
131237481|NCT05086744|472499987|FG000|Part A|Protocol deviation|1|||
131237482|NCT05086744|472499988|FG001|Part A|Protocol deviation|0|||
131237483|NCT05086744|472499987|FG000|Part A|Subject decision|1|||
131237484|NCT05086744|472499988|FG001|Part A|Subject decision|0|||
131237485|NCT05086744|472499987|FG000|Part B|Adverse Event|0|||
131237486|NCT05086744|472499988|FG001|Part B|Adverse Event|1|||
131237487|NCT05086744|472499987|FG000|Part B|Lack of Efficacy|0|||
131237488|NCT05086744|472499988|FG001|Part B|Lack of Efficacy|1|||
131237489|NCT05086744|472499987|FG000|Part B|Study terminated by sponsor|1|||
131237490|NCT05086744|472499988|FG001|Part B|Study terminated by sponsor|6|||
131237491|NCT06629454|472499991|FG000|Overall Study|Withdraw by Clinician Decision|1|||
131237492|NCT03584516|472499992|FG000|Part 1|Death|2|||
131237493|NCT03584516|472499993|FG001|Part 1|Death|3|||
131237494|NCT03584516|472499994|FG002|Part 1|Death|0|||
131237495|NCT03584516|472499995|FG003|Part 1|Death|0|||
131237496|NCT03584516|472499996|FG004|Part 1|Death|0|||
131237497|NCT03584516|472499997|FG005|Part 1|Death|0|||
131237498|NCT03584516|472499992|FG000|Part 1|Withdrawal by Subject|2|||
131237499|NCT03584516|472499993|FG001|Part 1|Withdrawal by Subject|0|||
131237500|NCT03584516|472499994|FG002|Part 1|Withdrawal by Subject|0|||
131237501|NCT03584516|472499995|FG003|Part 1|Withdrawal by Subject|0|||
131237502|NCT03584516|472499996|FG004|Part 1|Withdrawal by Subject|0|||
131237503|NCT03584516|472499997|FG005|Part 1|Withdrawal by Subject|0|||
131237504|NCT03584516|472499992|FG000|Part 1|Lost to Follow-up|1|||
131237505|NCT03584516|472499993|FG001|Part 1|Lost to Follow-up|0|||
131237506|NCT03584516|472499994|FG002|Part 1|Lost to Follow-up|0|||
131237507|NCT03584516|472499995|FG003|Part 1|Lost to Follow-up|0|||
131237508|NCT03584516|472499996|FG004|Part 1|Lost to Follow-up|0|||
131237509|NCT03584516|472499997|FG005|Part 1|Lost to Follow-up|0|||
131237510|NCT03584516|472499992|FG000|Part 1|Study Terminated by Sponsor|0|||
131237511|NCT03584516|472499993|FG001|Part 1|Study Terminated by Sponsor|2|||
131237512|NCT03584516|472499994|FG002|Part 1|Study Terminated by Sponsor|0|||
131237513|NCT03584516|472499995|FG003|Part 1|Study Terminated by Sponsor|0|||
131237514|NCT03584516|472499996|FG004|Part 1|Study Terminated by Sponsor|0|||
131237515|NCT03584516|472499997|FG005|Part 1|Study Terminated by Sponsor|0|||
131237516|NCT03584516|472499992|FG000|Part 1 Expansion|Death|0|||
131237517|NCT03584516|472499993|FG001|Part 1 Expansion|Death|0|||
131237518|NCT03584516|472499994|FG002|Part 1 Expansion|Death|9|||
131237519|NCT03584516|472499995|FG003|Part 1 Expansion|Death|8|||
131237520|NCT03584516|472499996|FG004|Part 1 Expansion|Death|4|||
131237521|NCT03584516|472499997|FG005|Part 1 Expansion|Death|5|||
131237522|NCT03584516|472499992|FG000|Part 1 Expansion|Lost to Follow-up|0|||
131237523|NCT03584516|472499993|FG001|Part 1 Expansion|Lost to Follow-up|0|||
131237524|NCT03584516|472499994|FG002|Part 1 Expansion|Lost to Follow-up|0|||
131237525|NCT03584516|472499995|FG003|Part 1 Expansion|Lost to Follow-up|1|||
131237526|NCT03584516|472499996|FG004|Part 1 Expansion|Lost to Follow-up|0|||
131237527|NCT03584516|472499997|FG005|Part 1 Expansion|Lost to Follow-up|0|||
131237528|NCT03584516|472499992|FG000|Part 1 Expansion|Physician Decision|0|||
131237529|NCT03584516|472499993|FG001|Part 1 Expansion|Physician Decision|0|||
131237530|NCT03584516|472499994|FG002|Part 1 Expansion|Physician Decision|4|||
131237531|NCT03584516|472499995|FG003|Part 1 Expansion|Physician Decision|3|||
131237532|NCT03584516|472499996|FG004|Part 1 Expansion|Physician Decision|2|||
131237533|NCT03584516|472499997|FG005|Part 1 Expansion|Physician Decision|3|||
131237534|NCT03584516|472499992|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
131237535|NCT03584516|472499993|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
131237536|NCT03584516|472499994|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
131237537|NCT03584516|472499995|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
131237538|NCT03584516|472499996|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
131237539|NCT03584516|472499997|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
131179026|NCT00571519|472276129|FG003|Overall Study|Subject withdrew consent|2|||
131179027|NCT00571519|472276130|FG004|Overall Study|Subject withdrew consent|1|||
131179028|NCT00571519|472276131|FG005|Overall Study|Subject withdrew consent|1|||
131179029|NCT00571519|472276132|FG006|Overall Study|Subject withdrew consent|2|||
131179030|NCT00571519|472276126|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
131179031|NCT00571519|472276127|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
131179032|NCT00571519|472276128|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
131237540|NCT03584516|472499992|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
131237541|NCT03584516|472499993|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
131237542|NCT03584516|472499994|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
131237543|NCT03584516|472499995|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
131237544|NCT03584516|472499996|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
131237545|NCT03584516|472499997|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
131237546|NCT03584516|472499992|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
131237547|NCT03584516|472499993|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
131237548|NCT03584516|472499994|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
131237549|NCT03584516|472499995|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
131179033|NCT00571519|472276129|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
131179034|NCT00571519|472276130|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
131179035|NCT00571519|472276131|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
131179036|NCT00571519|472276132|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
131179037|NCT00571519|472276126|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
131179038|NCT00571519|472276127|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
131179039|NCT00571519|472276128|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
131179040|NCT00571519|472276129|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
131179041|NCT00571519|472276130|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
131179042|NCT00571519|472276131|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
131179043|NCT00571519|472276132|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
131179044|NCT00571519|472276126|FG000|Overall Study|Termination of study by Sponsor|2|||
131179045|NCT00571519|472276127|FG001|Overall Study|Termination of study by Sponsor|7|||
131179046|NCT00571519|472276128|FG002|Overall Study|Termination of study by Sponsor|10|||
131179047|NCT00571519|472276129|FG003|Overall Study|Termination of study by Sponsor|24|||
131179048|NCT00571519|472276130|FG004|Overall Study|Termination of study by Sponsor|8|||
131179049|NCT00571519|472276131|FG005|Overall Study|Termination of study by Sponsor|9|||
131179050|NCT00571519|472276132|FG006|Overall Study|Termination of study by Sponsor|22|||
131179051|NCT00571519|472276126|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131179052|NCT00571519|472276127|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131179053|NCT00571519|472276128|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
131179054|NCT00571519|472276129|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131179055|NCT00571519|472276130|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131179056|NCT00571519|472276131|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131179057|NCT00571519|472276132|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
131179058|NCT02499575|472276133|FG000|Overall Study|Protocol Violation|0|||
131179059|NCT02499575|472276134|FG001|Overall Study|Protocol Violation|1|||
131179060|NCT02658968|472276135|FG000|Received Rituximab|Adverse Event|0|||
131179061|NCT02658968|472276136|FG001|Received Rituximab|Adverse Event|0|||
131179062|NCT02658968|472276137|FG002|Received Rituximab|Adverse Event|0|||
131179063|NCT02658968|472276138|FG003|Received Rituximab|Adverse Event|0|||
131179064|NCT02658968|472276139|FG004|Received Rituximab|Adverse Event|1|||
131179065|NCT02658968|472276135|FG000|Received Rituximab|Progressive disease|0|||
131179066|NCT02658968|472276136|FG001|Received Rituximab|Progressive disease|0|||
131179067|NCT02658968|472276137|FG002|Received Rituximab|Progressive disease|0|||
131179068|NCT02658968|472276138|FG003|Received Rituximab|Progressive disease|0|||
131179069|NCT02658968|472276139|FG004|Received Rituximab|Progressive disease|1|||
131179070|NCT02658968|472276135|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
131179071|NCT02658968|472276136|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
131179072|NCT02658968|472276137|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
131179073|NCT02658968|472276138|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
131179074|NCT02658968|472276139|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
131179075|NCT02658968|472276135|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
131179076|NCT02658968|472276136|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
131179077|NCT02658968|472276137|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
131179078|NCT02658968|472276138|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
131179079|NCT02658968|472276139|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
131179080|NCT02658968|472276135|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
131179081|NCT02658968|472276136|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
131179082|NCT02658968|472276137|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
131179083|NCT02658968|472276138|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
131179084|NCT02658968|472276139|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
131179085|NCT02658968|472276135|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
131179086|NCT02658968|472276136|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
131179087|NCT02658968|472276137|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
131179088|NCT02658968|472276138|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
131179089|NCT02658968|472276139|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
131179090|NCT02658968|472276135|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
131179091|NCT02658968|472276136|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
131179092|NCT02658968|472276137|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
131179093|NCT02658968|472276138|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
131179094|NCT02658968|472276139|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
130783595|NCT02718911|470835053|FG002|Overall Study|Lost to Follow-up|0|||
130783596|NCT02718911|470835054|FG003|Overall Study|Lost to Follow-up|0|||
130783597|NCT02718911|470835055|FG004|Overall Study|Lost to Follow-up|0|||
130783598|NCT02718911|470835056|FG005|Overall Study|Lost to Follow-up|0|||
130783599|NCT02718911|470835057|FG006|Overall Study|Lost to Follow-up|0|||
130783600|NCT02718911|470835058|FG007|Overall Study|Lost to Follow-up|0|||
130783601|NCT02718911|470835059|FG008|Overall Study|Lost to Follow-up|1|||
130783602|NCT02718911|470835060|FG009|Overall Study|Lost to Follow-up|0|||
130783603|NCT02718911|470835051|FG000|Overall Study|Physician Decision|2|||
130783604|NCT02718911|470835052|FG001|Overall Study|Physician Decision|0|||
130783605|NCT02718911|470835053|FG002|Overall Study|Physician Decision|1|||
130783606|NCT02718911|470835054|FG003|Overall Study|Physician Decision|1|||
130783607|NCT02718911|470835055|FG004|Overall Study|Physician Decision|0|||
130783608|NCT02718911|470835056|FG005|Overall Study|Physician Decision|0|||
130783609|NCT02718911|470835057|FG006|Overall Study|Physician Decision|0|||
130783610|NCT02718911|470835058|FG007|Overall Study|Physician Decision|1|||
130783611|NCT02718911|470835059|FG008|Overall Study|Physician Decision|2|||
130783612|NCT02718911|470835060|FG009|Overall Study|Physician Decision|1|||
130783613|NCT02718911|470835051|FG000|Overall Study|Withdrawal by Subject|0|||
130783614|NCT02718911|470835052|FG001|Overall Study|Withdrawal by Subject|0|||
130783615|NCT02718911|470835053|FG002|Overall Study|Withdrawal by Subject|0|||
130783616|NCT02718911|470835054|FG003|Overall Study|Withdrawal by Subject|0|||
130783617|NCT02718911|470835055|FG004|Overall Study|Withdrawal by Subject|1|||
130783618|NCT02718911|470835056|FG005|Overall Study|Withdrawal by Subject|0|||
130783619|NCT02718911|470835057|FG006|Overall Study|Withdrawal by Subject|0|||
130783620|NCT02718911|470835058|FG007|Overall Study|Withdrawal by Subject|0|||
130783621|NCT02718911|470835059|FG008|Overall Study|Withdrawal by Subject|1|||
130783622|NCT02718911|470835060|FG009|Overall Study|Withdrawal by Subject|4|||
130783623|NCT02718911|470835051|FG000|Overall Study|Reason Not Collected|0|||
130783624|NCT02718911|470835052|FG001|Overall Study|Reason Not Collected|0|||
130783625|NCT02718911|470835053|FG002|Overall Study|Reason Not Collected|1|||
130783626|NCT02718911|470835054|FG003|Overall Study|Reason Not Collected|0|||
130783627|NCT02718911|470835055|FG004|Overall Study|Reason Not Collected|0|||
130783628|NCT02718911|470835056|FG005|Overall Study|Reason Not Collected|0|||
130783629|NCT02718911|470835057|FG006|Overall Study|Reason Not Collected|2|||
130783630|NCT02718911|470835058|FG007|Overall Study|Reason Not Collected|1|||
130783631|NCT02718911|470835059|FG008|Overall Study|Reason Not Collected|4|||
130783632|NCT02718911|470835060|FG009|Overall Study|Reason Not Collected|9|||
130783633|NCT01172873|470835064|FG000|Overall Study|Withdrawal by Subject|3|||
130783634|NCT01172873|470835065|FG001|Overall Study|Withdrawal by Subject|2|||
130783635|NCT05518539|470835068|FG000|Overall Study|Lost to Follow-up|6|||
130783636|NCT02053493|470835071|FG000|Overall Study|Withdrawal by Subject|1|||
130783637|NCT02053493|470835072|FG001|Overall Study|Withdrawal by Subject|1|||
130783638|NCT00791999|470835073|FG000|Overall Study|Protocol planed withdrawal|14|||
130783639|NCT00791999|470835074|FG001|Overall Study|Protocol planed withdrawal|11|||
130783640|NCT00791999|470835075|FG002|Overall Study|Protocol planed withdrawal|11|||
130783641|NCT00791999|470835076|FG003|Overall Study|Protocol planed withdrawal|45|||
130783642|NCT00791999|470835073|FG000|Overall Study|Withdrawal by Subject|0|||
130783643|NCT00791999|470835074|FG001|Overall Study|Withdrawal by Subject|1|||
130783644|NCT00791999|470835075|FG002|Overall Study|Withdrawal by Subject|0|||
130783645|NCT00791999|470835076|FG003|Overall Study|Withdrawal by Subject|2|||
130783646|NCT00791999|470835073|FG000|Overall Study|Protocol Violation|3|||
130783647|NCT00791999|470835074|FG001|Overall Study|Protocol Violation|0|||
130783648|NCT00791999|470835075|FG002|Overall Study|Protocol Violation|1|||
130783649|NCT00791999|470835076|FG003|Overall Study|Protocol Violation|0|||
130783650|NCT00791999|470835073|FG000|Overall Study|Adverse Event|3|||
130783651|NCT00791999|470835074|FG001|Overall Study|Adverse Event|3|||
130783652|NCT00791999|470835075|FG002|Overall Study|Adverse Event|7|||
130783653|NCT00791999|470835076|FG003|Overall Study|Adverse Event|3|||
130783654|NCT00791999|470835073|FG000|Overall Study|Lack of Efficacy|0|||
131179095|NCT00574119|472276140|FG000|Overall Study|Adverse Event|1|||
131179096|NCT00574119|472276140|FG000|Overall Study|Protocol Violation|1|||
131179097|NCT00574119|472276140|FG000|Overall Study|Withdrawal by Subject|1|||
130783655|NCT00791999|470835074|FG001|Overall Study|Lack of Efficacy|1|||
130783656|NCT00791999|470835075|FG002|Overall Study|Lack of Efficacy|0|||
130783657|NCT00791999|470835076|FG003|Overall Study|Lack of Efficacy|2|||
130783658|NCT00791999|470835073|FG000|Overall Study|Reason other than those above|1|||
130783659|NCT00791999|470835074|FG001|Overall Study|Reason other than those above|0|||
130783660|NCT00791999|470835075|FG002|Overall Study|Reason other than those above|1|||
130783661|NCT00791999|470835076|FG003|Overall Study|Reason other than those above|0|||
130783662|NCT01710020|470835077|FG000|Period 1|Protocol Violation|1|||
130783663|NCT00086190|470835078|FG000|Overall Study|Adverse Event|6|||
130783664|NCT00086190|470835079|FG001|Overall Study|Adverse Event|2|||
130783665|NCT00086190|470835080|FG002|Overall Study|Adverse Event|2|||
130783666|NCT00086190|470835078|FG000|Overall Study|Withdrawal by Subject|0|||
130783667|NCT00086190|470835079|FG001|Overall Study|Withdrawal by Subject|2|||
130783668|NCT00086190|470835080|FG002|Overall Study|Withdrawal by Subject|2|||
130783669|NCT00086190|470835078|FG000|Overall Study|Protocol Violation|1|||
131237550|NCT03584516|472499996|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
131237551|NCT03584516|472499997|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
131237552|NCT03584516|472499992|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
131237553|NCT03584516|472499993|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
131237554|NCT03584516|472499994|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
131237555|NCT03584516|472499995|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
131237556|NCT03584516|472499996|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
131237557|NCT03584516|472499997|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
131237558|NCT04050462|472499998|FG000|Overall Study|Withdrawal by Subject|1|||
131237559|NCT04050462|472499999|FG001|Overall Study|Withdrawal by Subject|0|||
131237560|NCT04050462|472500000|FG002|Overall Study|Withdrawal by Subject|0|||
131237561|NCT04511702|472500003|FG000|Overall Study|Lost to Follow-up|3|||
131237562|NCT04511702|472500004|FG001|Overall Study|Lost to Follow-up|0|||
131237563|NCT04511702|472500005|FG002|Overall Study|Lost to Follow-up|4|||
131237564|NCT04511702|472500003|FG000|Overall Study|Withdrawal by Subject|17|||
131237565|NCT04511702|472500004|FG001|Overall Study|Withdrawal by Subject|1|||
131237566|NCT04511702|472500005|FG002|Overall Study|Withdrawal by Subject|8|||
131237567|NCT03100903|472500006|FG000|Overall Study|Withdrawal by Subject|0|||
131237568|NCT03100903|472500007|FG001|Overall Study|Withdrawal by Subject|0|||
131237569|NCT03100903|472500008|FG002|Overall Study|Withdrawal by Subject|1|||
131237570|NCT04659993|472500009|FG000|Overall Study|Withdrawal by Subject|2|||
131237571|NCT04659993|472500009|FG000|Overall Study|Lost to Follow-up|2|||
131237572|NCT05846646|472500010|FG000|Overall Study|Physician Decision|1|||
131237573|NCT05846646|472500011|FG001|Overall Study|Physician Decision|0|||
131237574|NCT05846646|472500012|FG002|Overall Study|Physician Decision|0|||
131237575|NCT05846646|472500010|FG000|Overall Study|Lack of Efficacy|1|||
131237576|NCT05846646|472500011|FG001|Overall Study|Lack of Efficacy|1|||
131179098|NCT00574119|472276140|FG000|Overall Study|Physician Decision|1|||
131179099|NCT03039738|472276145|FG000|Overall Study|Incomplete data sets|54|||
131179100|NCT03039738|472276146|FG001|Overall Study|Incomplete data sets|0|||
131179101|NCT00912340|472276148|FG000|Overall Study|Adverse Event|2|||
131179102|NCT00912340|472276149|FG001|Overall Study|Adverse Event|4|||
131179103|NCT00912340|472276150|FG002|Overall Study|Adverse Event|0|||
131179104|NCT00912340|472276148|FG000|Overall Study|Protocol revised to remove arm|0|||
131179105|NCT00912340|472276149|FG001|Overall Study|Protocol revised to remove arm|0|||
131179106|NCT00912340|472276150|FG002|Overall Study|Protocol revised to remove arm|4|||
131179107|NCT01517412|472276153|FG000|Overall Study|Adverse Event|10|||
131179108|NCT01517412|472276154|FG001|Overall Study|Adverse Event|11|||
131179109|NCT01517412|472276153|FG000|Overall Study|Lack of Efficacy|10|||
131179110|NCT01517412|472276154|FG001|Overall Study|Lack of Efficacy|5|||
131179111|NCT01517412|472276153|FG000|Overall Study|Poor compliance to protocol|8|||
131179112|NCT01517412|472276154|FG001|Overall Study|Poor compliance to protocol|3|||
131179113|NCT01517412|472276153|FG000|Overall Study|Other than specified above|8|||
131179114|NCT01517412|472276154|FG001|Overall Study|Other than specified above|5|||
131179115|NCT01253187|472276155|FG000|Period 2|Withdrawal by Subject|0|||
131179116|NCT01253187|472276156|FG001|Period 2|Withdrawal by Subject|0|||
131179117|NCT01253187|472276157|FG002|Period 2|Withdrawal by Subject|0|||
131179118|NCT01253187|472276158|FG003|Period 2|Withdrawal by Subject|0|||
131179119|NCT01253187|472276159|FG004|Period 2|Withdrawal by Subject|1|||
131179120|NCT01253187|472276160|FG005|Period 2|Withdrawal by Subject|0|||
131179121|NCT01253187|472276155|FG000|Period 3|Pregnancy|1|||
131179122|NCT01253187|472276156|FG001|Period 3|Pregnancy|0|||
131179123|NCT01253187|472276157|FG002|Period 3|Pregnancy|0|||
131179124|NCT01253187|472276158|FG003|Period 3|Pregnancy|0|||
131179125|NCT01253187|472276159|FG004|Period 3|Pregnancy|0|||
131179126|NCT01253187|472276160|FG005|Period 3|Pregnancy|0|||
131179127|NCT01253187|472276155|FG000|Period 3|difficulty with blood sampling|0|||
131179128|NCT01253187|472276156|FG001|Period 3|difficulty with blood sampling|1|||
131179129|NCT01253187|472276157|FG002|Period 3|difficulty with blood sampling|0|||
131179130|NCT01253187|472276158|FG003|Period 3|difficulty with blood sampling|0|||
131179131|NCT01253187|472276159|FG004|Period 3|difficulty with blood sampling|0|||
131179132|NCT01253187|472276160|FG005|Period 3|difficulty with blood sampling|0|||
131179133|NCT01253187|472276155|FG000|Period 3|non-compliance|0|||
131179134|NCT01253187|472276156|FG001|Period 3|non-compliance|0|||
131179135|NCT01253187|472276157|FG002|Period 3|non-compliance|0|||
131179136|NCT01253187|472276158|FG003|Period 3|non-compliance|0|||
131179137|NCT01253187|472276159|FG004|Period 3|non-compliance|1|||
131179138|NCT01253187|472276160|FG005|Period 3|non-compliance|0|||
131179139|NCT01956240|472276166|FG000|Overall Study|Lost to Follow-up|6|||
131179140|NCT01956240|472276167|FG001|Overall Study|Lost to Follow-up|20|||
131179141|NCT01956240|472276166|FG000|Overall Study|Adverse Event|17|||
131179142|NCT01956240|472276167|FG001|Overall Study|Adverse Event|4|||
131179143|NCT00600028|472276170|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
131179144|NCT00600028|472276171|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
131179145|NCT00600028|472276170|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
131179146|NCT00600028|472276171|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
131179147|NCT00600028|472276170|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
131179148|NCT00600028|472276171|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
131179149|NCT03172481|472276172|FG000|Double-blind|Withdrawal by Subject|1|||
131179150|NCT03172481|472276173|FG001|Double-blind|Withdrawal by Subject|0|||
131179151|NCT02716194|472276174|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
131179152|NCT02716194|472276175|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
131179153|NCT02716194|472276176|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
131179154|NCT01957709|472276180|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
131179155|NCT01610076|472276181|FG000|Overall Study|Technical issue with video|0|||
131179156|NCT01610076|472276182|FG001|Overall Study|Technical issue with video|1|||
131179157|NCT01610076|472276181|FG000|Overall Study|Lost to Follow-up|3|||
131179158|NCT01610076|472276182|FG001|Overall Study|Lost to Follow-up|4|||
131179159|NCT02899377|472276185|FG000|Overall Study|Adverse Event|1|||
131179160|NCT02899377|472276186|FG001|Overall Study|Adverse Event|0|||
131179161|NCT00469209|472276188|FG000|Overall Study|Adverse Event|1|||
131179162|NCT00469209|472276189|FG001|Overall Study|Adverse Event|0|||
131179163|NCT00469209|472276190|FG002|Overall Study|Adverse Event|1|||
131179164|NCT00865189|472276194|FG000|Overall Study|Other|1|||
131179165|NCT00865189|472276195|FG001|Overall Study|Other|2|||
131179166|NCT00865189|472276194|FG000|Overall Study|Death|4|||
131179167|NCT00865189|472276195|FG001|Overall Study|Death|11|||
131179168|NCT00865189|472276194|FG000|Overall Study|Lost to Follow-up|6|||
131179169|NCT00865189|472276195|FG001|Overall Study|Lost to Follow-up|6|||
131179170|NCT00865189|472276194|FG000|Overall Study|Withdrawal by Subject|1|||
131179171|NCT00865189|472276195|FG001|Overall Study|Withdrawal by Subject|0|||
131179172|NCT00843843|472276201|FG000|Overall Study|Physician Decision|1|||
131179173|NCT00843843|472276202|FG001|Overall Study|Physician Decision|1|||
131179174|NCT00843843|472276201|FG000|Overall Study|Protocol Violation|1|||
131179175|NCT00843843|472276202|FG001|Overall Study|Protocol Violation|1|||
131179176|NCT00418379|472276203|FG000|Year 1|Adverse Event|9|||
131179177|NCT00418379|472276204|FG001|Year 1|Adverse Event|15|||
131179178|NCT00418379|472276205|FG002|Year 1|Adverse Event|3|||
131179179|NCT00418379|472276203|FG000|Year 1|Withdrawal by Subject|7|||
131179180|NCT00418379|472276204|FG001|Year 1|Withdrawal by Subject|8|||
131179181|NCT00418379|472276205|FG002|Year 1|Withdrawal by Subject|5|||
131179182|NCT00418379|472276203|FG000|Year 1|Any other reason not above-mentioned|2|||
131179183|NCT00418379|472276204|FG001|Year 1|Any other reason not above-mentioned|5|||
131179184|NCT00418379|472276205|FG002|Year 1|Any other reason not above-mentioned|7|||
131179185|NCT00418379|472276203|FG000|Year 2|Adverse Event|5|||
131179186|NCT00418379|472276204|FG001|Year 2|Adverse Event|2|||
131179187|NCT00418379|472276205|FG002|Year 2|Adverse Event|1|||
131179188|NCT00418379|472276203|FG000|Year 2|Withdrawal by Subject|1|||
131179189|NCT00418379|472276204|FG001|Year 2|Withdrawal by Subject|1|||
131179190|NCT00418379|472276205|FG002|Year 2|Withdrawal by Subject|3|||
131179191|NCT00418379|472276203|FG000|Year 2|Any other reason not above-mentioned|2|||
131179192|NCT00418379|472276204|FG001|Year 2|Any other reason not above-mentioned|1|||
131179193|NCT00418379|472276205|FG002|Year 2|Any other reason not above-mentioned|6|||
131179194|NCT00418379|472276203|FG000|Year 3|Withdrawal by Subject|1|||
131179195|NCT00418379|472276204|FG001|Year 3|Withdrawal by Subject|1|||
131179196|NCT00418379|472276205|FG002|Year 3|Withdrawal by Subject|2|||
131179197|NCT00418379|472276203|FG000|Year 3|Any other reason not above-mentioned|2|||
131179198|NCT00418379|472276204|FG001|Year 3|Any other reason not above-mentioned|1|||
131179199|NCT00418379|472276205|FG002|Year 3|Any other reason not above-mentioned|1|||
131179200|NCT00418379|472276203|FG000|Year 4|Adverse Event|0|||
131179201|NCT00418379|472276204|FG001|Year 4|Adverse Event|1|||
131179202|NCT00418379|472276205|FG002|Year 4|Adverse Event|0|||
131179203|NCT00418379|472276203|FG000|Year 4|Withdrawal by Subject|2|||
131179204|NCT00418379|472276204|FG001|Year 4|Withdrawal by Subject|3|||
131179205|NCT00418379|472276205|FG002|Year 4|Withdrawal by Subject|2|||
131179206|NCT00418379|472276203|FG000|Year 4|Any other reason not above-mentioned|1|||
131179207|NCT00418379|472276204|FG001|Year 4|Any other reason not above-mentioned|1|||
131179208|NCT00418379|472276205|FG002|Year 4|Any other reason not above-mentioned|0|||
131179209|NCT00418379|472276203|FG000|Year 5|Adverse Event|0|||
131179210|NCT00418379|472276204|FG001|Year 5|Adverse Event|1|||
131179211|NCT00418379|472276205|FG002|Year 5|Adverse Event|0|||
131237577|NCT05846646|472500012|FG002|Overall Study|Lack of Efficacy|0|||
131179212|NCT00418379|472276203|FG000|Year 5|Any other reason not above-mentioned|2|||
131179213|NCT00418379|472276204|FG001|Year 5|Any other reason not above-mentioned|4|||
131179214|NCT00418379|472276205|FG002|Year 5|Any other reason not above-mentioned|3|||
131179215|NCT00565058|472276206|FG000|Overall Study|Adverse Event|1|||
131179216|NCT00565058|472276207|FG001|Overall Study|Adverse Event|0|||
131179217|NCT00830804|472276210|FG000|Overall Study|Lost to Follow-up|4|||
131237578|NCT05846646|472500010|FG000|Overall Study|Early Study Termination|1|||
130783670|NCT00086190|470835079|FG001|Overall Study|Protocol Violation|0|||
131179218|NCT00830804|472276210|FG000|Overall Study|Death|1|||
131179219|NCT00830804|472276210|FG000|Overall Study|Unable to get to clinic|7|||
131179220|NCT00830804|472276210|FG000|Overall Study|Consent withdrawn|2|||
131179221|NCT00830804|472276210|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
131179222|NCT03428997|472276218|FG000|Overall Study|Sponsor decision.|1|||
131179223|NCT03428997|472276218|FG000|Overall Study|Withdrawal by Subject|3|||
131179224|NCT03428997|472276218|FG000|Overall Study|Lost to Follow-up|4|||
131179225|NCT00510068|472276223|FG000|Double-blind Period|Disease progression|98|||
131179226|NCT00510068|472276224|FG001|Double-blind Period|Disease progression|169|||
131179227|NCT00510068|472276223|FG000|Double-blind Period|Final primary analysis|52|||
131179228|NCT00510068|472276224|FG001|Double-blind Period|Final primary analysis|18|||
131179229|NCT00510068|472276223|FG000|Double-blind Period|Adverse Event|37|||
131179230|NCT00510068|472276224|FG001|Double-blind Period|Adverse Event|7|||
131179231|NCT00510068|472276223|FG000|Double-blind Period|Withdrawal by Subject|8|||
131179232|NCT00510068|472276224|FG001|Double-blind Period|Withdrawal by Subject|6|||
131179233|NCT00510068|472276223|FG000|Double-blind Period|Death|4|||
131179234|NCT00510068|472276224|FG001|Double-blind Period|Death|3|||
131179235|NCT00510068|472276223|FG000|Double-blind Period|Abnormal test result (s)|1|||
131179236|NCT00510068|472276224|FG001|Double-blind Period|Abnormal test result (s)|0|||
131179237|NCT00510068|472276223|FG000|Double-blind Period|Lost to Follow-up|1|||
131179238|NCT00510068|472276224|FG001|Double-blind Period|Lost to Follow-up|0|||
131179239|NCT00510068|472276223|FG000|Double-blind Period|Protocol Violation|6|||
131179240|NCT00510068|472276224|FG001|Double-blind Period|Protocol Violation|0|||
131179241|NCT00510068|472276223|FG000|Open-label Period|Disease Progression|124|||
131179242|NCT00510068|472276224|FG001|Open-label Period|Disease Progression|0|||
131179243|NCT00510068|472276223|FG000|Open-label Period|Adverse Event|46|||
131179244|NCT00510068|472276224|FG001|Open-label Period|Adverse Event|0|||
131179245|NCT00510068|472276223|FG000|Open-label Period|Withdrawal by Subject|21|||
131179246|NCT00510068|472276224|FG001|Open-label Period|Withdrawal by Subject|0|||
131179247|NCT00510068|472276223|FG000|Open-label Period|Administrative problems|17|||
131179248|NCT00510068|472276224|FG001|Open-label Period|Administrative problems|0|||
131179249|NCT00510068|472276223|FG000|Open-label Period|Death|7|||
131179250|NCT00510068|472276224|FG001|Open-label Period|Death|0|||
131179251|NCT00510068|472276223|FG000|Open-label Period|New cancer therapy|7|||
131179252|NCT00510068|472276224|FG001|Open-label Period|New cancer therapy|0|||
131179253|NCT00510068|472276223|FG000|Open-label Period|Protocol Violation|2|||
131179254|NCT00510068|472276224|FG001|Open-label Period|Protocol Violation|0|||
131179255|NCT00510068|472276223|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
131179256|NCT00510068|472276224|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
131179257|NCT01397448|472276226|FG000|Overall Study|Adverse Event|4|||
131179258|NCT01397448|472276227|FG001|Overall Study|Adverse Event|4|||
131179259|NCT01397448|472276228|FG002|Overall Study|Adverse Event|6|||
131179260|NCT01397448|472276226|FG000|Overall Study|Withdrawal by Subject|4|||
131179261|NCT01397448|472276227|FG001|Overall Study|Withdrawal by Subject|4|||
131179262|NCT01397448|472276228|FG002|Overall Study|Withdrawal by Subject|3|||
131179263|NCT01397448|472276226|FG000|Overall Study|Lack of Efficacy|2|||
131179264|NCT01397448|472276227|FG001|Overall Study|Lack of Efficacy|0|||
131179265|NCT01397448|472276228|FG002|Overall Study|Lack of Efficacy|5|||
131179266|NCT01397448|472276226|FG000|Overall Study|Other|8|||
131179267|NCT01397448|472276227|FG001|Overall Study|Other|7|||
131179268|NCT01397448|472276228|FG002|Overall Study|Other|4|||
131179269|NCT03691610|472276230|FG000|Overall Study|Adverse Event|0|||
131179270|NCT03691610|472276231|FG001|Overall Study|Adverse Event|1|||
131179271|NCT03691610|472276232|FG002|Overall Study|Adverse Event|0|||
131179272|NCT03691610|472276233|FG003|Overall Study|Adverse Event|0|||
131179273|NCT03691610|472276230|FG000|Overall Study|Protocol Deviation|15|||
131179274|NCT03691610|472276231|FG001|Overall Study|Protocol Deviation|8|||
131179275|NCT03691610|472276232|FG002|Overall Study|Protocol Deviation|1|||
131179276|NCT03691610|472276233|FG003|Overall Study|Protocol Deviation|2|||
131179277|NCT03691610|472276230|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
131179278|NCT03691610|472276231|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
131179279|NCT03691610|472276232|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
131179280|NCT03691610|472276233|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
131179281|NCT03691610|472276230|FG000|Overall Study|Lost to Follow-up|20|||
131179282|NCT03691610|472276231|FG001|Overall Study|Lost to Follow-up|11|||
131179283|NCT03691610|472276232|FG002|Overall Study|Lost to Follow-up|5|||
131179284|NCT03691610|472276233|FG003|Overall Study|Lost to Follow-up|2|||
131179285|NCT00622869|472276241|FG000|Overall Study|Subject Withdrew Consent|13|||
131179286|NCT00622869|472276242|FG001|Overall Study|Subject Withdrew Consent|17|||
131179287|NCT00622869|472276243|FG002|Overall Study|Subject Withdrew Consent|11|||
131179288|NCT00622869|472276241|FG000|Overall Study|Administrative Problems|11|||
131179289|NCT00622869|472276242|FG001|Overall Study|Administrative Problems|17|||
131179290|NCT00622869|472276243|FG002|Overall Study|Administrative Problems|13|||
131179291|NCT00622869|472276241|FG000|Overall Study|Death|12|||
131179292|NCT00622869|472276242|FG001|Overall Study|Death|15|||
131179293|NCT00622869|472276243|FG002|Overall Study|Death|10|||
131179294|NCT00622869|472276241|FG000|Overall Study|Lost to Follow-up|2|||
131179295|NCT00622869|472276242|FG001|Overall Study|Lost to Follow-up|4|||
131179296|NCT00622869|472276243|FG002|Overall Study|Lost to Follow-up|2|||
131237579|NCT05846646|472500011|FG001|Overall Study|Early Study Termination|2|||
131237580|NCT05846646|472500012|FG002|Overall Study|Early Study Termination|0|||
131237581|NCT02489318|472500013|FG000|Randomized|Withdrawal by Subject|0|||
131237582|NCT02489318|472500014|FG001|Randomized|Withdrawal by Subject|1|||
131237583|NCT02489318|472500013|FG000|Treated|Adverse Event|19|||
131237584|NCT02489318|472500014|FG001|Treated|Adverse Event|62|||
131237585|NCT02489318|472500013|FG000|Treated|Death|13|||
131237586|NCT02489318|472500014|FG001|Treated|Death|11|||
131237587|NCT02489318|472500013|FG000|Treated|Physician Decision|4|||
131237588|NCT02489318|472500014|FG001|Treated|Physician Decision|6|||
131237589|NCT02489318|472500013|FG000|Treated|Protocol Violation|1|||
131237590|NCT02489318|472500014|FG001|Treated|Protocol Violation|2|||
131237591|NCT02489318|472500013|FG000|Treated|Withdrawal by Subject|37|||
131237592|NCT02489318|472500014|FG001|Treated|Withdrawal by Subject|36|||
131237593|NCT02489318|472500013|FG000|Treated|Other: Progressive Disease|245|||
131237594|NCT02489318|472500014|FG001|Treated|Other: Progressive Disease|138|||
131237595|NCT02489318|472500013|FG000|Treated|Other|0|||
131237596|NCT02489318|472500014|FG001|Treated|Other|2|||
131237597|NCT02489318|472500013|FG000|Treated|Ongoing|0|||
131237598|NCT02489318|472500014|FG001|Treated|Ongoing|267|||
131237599|NCT05151744|472500015|FG000|Overall Study|Adverse Event|6|||
131237600|NCT05151744|472500016|FG001|Overall Study|Adverse Event|2|||
131237601|NCT05151744|472500015|FG000|Overall Study|Death|1|||
131237602|NCT05151744|472500016|FG001|Overall Study|Death|2|||
131237603|NCT05151744|472500015|FG000|Overall Study|Lack of Efficacy|1|||
131237604|NCT05151744|472500016|FG001|Overall Study|Lack of Efficacy|1|||
131237605|NCT05151744|472500015|FG000|Overall Study|Lost to Follow-up|2|||
131237606|NCT05151744|472500016|FG001|Overall Study|Lost to Follow-up|2|||
131237607|NCT05151744|472500015|FG000|Overall Study|Need for Rescue Treatment|0|||
131237608|NCT05151744|472500016|FG001|Overall Study|Need for Rescue Treatment|1|||
131237609|NCT05151744|472500015|FG000|Overall Study|Non-compliance with Study Drug|0|||
131237610|NCT05151744|472500016|FG001|Overall Study|Non-compliance with Study Drug|1|||
131237611|NCT05151744|472500015|FG000|Overall Study|Reason not Specified|10|||
131237612|NCT05151744|472500016|FG001|Overall Study|Reason not Specified|0|||
131237613|NCT05151744|472500015|FG000|Overall Study|Physician Decision|2|||
131237614|NCT05151744|472500016|FG001|Overall Study|Physician Decision|1|||
131237615|NCT05151744|472500015|FG000|Overall Study|Protocol Violation|1|||
131237616|NCT05151744|472500016|FG001|Overall Study|Protocol Violation|0|||
131237617|NCT05151744|472500015|FG000|Overall Study|Withdrawal by Subject|6|||
131237618|NCT05151744|472500016|FG001|Overall Study|Withdrawal by Subject|3|||
131237619|NCT04493424|472500017|FG000|Overall Study|Termination of the trial by the sponsor|89|||
131237620|NCT04493424|472500017|FG000|Overall Study|Withdrawal by Subject|9|||
131237621|NCT04493424|472500017|FG000|Overall Study|Lost to Follow-up|2|||
131237622|NCT04493424|472500017|FG000|Overall Study|Lack of Efficacy|3|||
131237623|NCT04493424|472500017|FG000|Overall Study|Adverse Event|5|||
131237624|NCT03569293|472500021|FG000|Overall Study|Adverse Event|4|||
131237625|NCT03569293|472500022|FG001|Overall Study|Adverse Event|1|||
131237626|NCT03569293|472500023|FG002|Overall Study|Adverse Event|5|||
131237627|NCT03569293|472500024|FG003|Overall Study|Adverse Event|1|||
131237628|NCT03569293|472500025|FG004|Overall Study|Adverse Event|0|||
131237629|NCT03569293|472500026|FG005|Overall Study|Adverse Event|0|||
131237630|NCT03569293|472500021|FG000|Overall Study|Withdrawal by Subject|16|||
131237631|NCT03569293|472500022|FG001|Overall Study|Withdrawal by Subject|2|||
131237632|NCT03569293|472500023|FG002|Overall Study|Withdrawal by Subject|4|||
131237633|NCT03569293|472500024|FG003|Overall Study|Withdrawal by Subject|1|||
131237634|NCT03569293|472500025|FG004|Overall Study|Withdrawal by Subject|0|||
131237635|NCT03569293|472500026|FG005|Overall Study|Withdrawal by Subject|0|||
131237636|NCT03569293|472500021|FG000|Overall Study|Lost to Follow-up|1|||
131237637|NCT03569293|472500022|FG001|Overall Study|Lost to Follow-up|3|||
131237638|NCT03569293|472500023|FG002|Overall Study|Lost to Follow-up|1|||
131237639|NCT03569293|472500024|FG003|Overall Study|Lost to Follow-up|1|||
131237640|NCT03569293|472500025|FG004|Overall Study|Lost to Follow-up|0|||
131237641|NCT03569293|472500026|FG005|Overall Study|Lost to Follow-up|0|||
131237642|NCT03569293|472500021|FG000|Overall Study|Other|8|||
131237643|NCT03569293|472500022|FG001|Overall Study|Other|2|||
131237644|NCT03569293|472500023|FG002|Overall Study|Other|1|||
131237645|NCT03569293|472500024|FG003|Overall Study|Other|1|||
131237646|NCT03569293|472500025|FG004|Overall Study|Other|0|||
131237647|NCT03569293|472500026|FG005|Overall Study|Other|0|||
131237648|NCT03569293|472500021|FG000|Overall Study|Ongoing at Time of Analysis|8|||
131237649|NCT03569293|472500022|FG001|Overall Study|Ongoing at Time of Analysis|1|||
131237650|NCT03569293|472500023|FG002|Overall Study|Ongoing at Time of Analysis|3|||
131237651|NCT03569293|472500024|FG003|Overall Study|Ongoing at Time of Analysis|0|||
131237652|NCT03569293|472500025|FG004|Overall Study|Ongoing at Time of Analysis|0|||
131237653|NCT03569293|472500026|FG005|Overall Study|Ongoing at Time of Analysis|0|||
131237654|NCT05228470|472500027|FG000|Overall Study|Death|6|||
131237655|NCT05228470|472500028|FG001|Overall Study|Death|11|||
131237656|NCT05228470|472500027|FG000|Overall Study|Withdrawal by Subject|1|||
131237657|NCT05228470|472500028|FG001|Overall Study|Withdrawal by Subject|8|||
131237658|NCT05228470|472500027|FG000|Overall Study|Ongoing|1|||
131237659|NCT05228470|472500028|FG001|Overall Study|Ongoing|11|||
131237660|NCT01171898|472500029|FG000|Overall Study|Death|0|||
131179297|NCT00622869|472276241|FG000|Overall Study|Graft Loss|5|||
131179298|NCT00622869|472276242|FG001|Overall Study|Graft Loss|3|||
131179299|NCT00622869|472276243|FG002|Overall Study|Graft Loss|2|||
131179300|NCT00622869|472276241|FG000|Overall Study|Missing|0|||
131179301|NCT00622869|472276242|FG001|Overall Study|Missing|1|||
131179302|NCT00622869|472276243|FG002|Overall Study|Missing|1|||
131179303|NCT00645567|472276244|FG000|Overall Study|Adverse Event|1|||
131179304|NCT02475395|472276248|FG000|Overall Study|Protocol Violation|30|||
131179305|NCT02475395|472276249|FG001|Overall Study|Protocol Violation|3|||
131179306|NCT03730194|472276250|FG000|First Stage Treatment|Withdrawal by Subject|1|||
131179307|NCT03730194|472276251|FG001|First Stage Treatment|Withdrawal by Subject|1|||
131179308|NCT03730194|472276252|FG002|First Stage Treatment|Withdrawal by Subject|0|||
131179309|NCT03730194|472276253|FG003|First Stage Treatment|Withdrawal by Subject|0|||
131179310|NCT03730194|472276254|FG004|First Stage Treatment|Withdrawal by Subject|0|||
131179311|NCT03730194|472276255|FG005|First Stage Treatment|Withdrawal by Subject|0|||
131179312|NCT03730194|472276250|FG000|First Stage Treatment|Protocol Violation|3|||
131179313|NCT03730194|472276251|FG001|First Stage Treatment|Protocol Violation|3|||
131179314|NCT03730194|472276252|FG002|First Stage Treatment|Protocol Violation|0|||
131179315|NCT03730194|472276253|FG003|First Stage Treatment|Protocol Violation|0|||
131179316|NCT03730194|472276254|FG004|First Stage Treatment|Protocol Violation|0|||
131179317|NCT03730194|472276255|FG005|First Stage Treatment|Protocol Violation|0|||
131179318|NCT00115765|472276256|FG000|Overall Study|Withdrawal by Subject|22|||
131179319|NCT00115765|472276257|FG001|Overall Study|Withdrawal by Subject|53|||
131179320|NCT00115765|472276258|FG002|Overall Study|Withdrawal by Subject|76|||
131179321|NCT00115765|472276259|FG003|Overall Study|Withdrawal by Subject|15|||
131179322|NCT00115765|472276256|FG000|Overall Study|Physician Decision|4|||
131179323|NCT00115765|472276257|FG001|Overall Study|Physician Decision|15|||
131179324|NCT00115765|472276258|FG002|Overall Study|Physician Decision|18|||
131179325|NCT00115765|472276259|FG003|Overall Study|Physician Decision|13|||
131179326|NCT00115765|472276256|FG000|Overall Study|Lost to Follow-up|3|||
131179327|NCT00115765|472276257|FG001|Overall Study|Lost to Follow-up|20|||
131179328|NCT00115765|472276258|FG002|Overall Study|Lost to Follow-up|18|||
131179329|NCT00115765|472276259|FG003|Overall Study|Lost to Follow-up|1|||
131179330|NCT00115765|472276256|FG000|Overall Study|Other|6|||
131179331|NCT00115765|472276257|FG001|Overall Study|Other|12|||
131179332|NCT00115765|472276258|FG002|Overall Study|Other|9|||
131179333|NCT00115765|472276259|FG003|Overall Study|Other|2|||
131179334|NCT03814590|472276264|FG000|Overall Study|Adverse Event|0|||
131179335|NCT03814590|472276265|FG001|Overall Study|Adverse Event|0|||
131179336|NCT03814590|472276266|FG002|Overall Study|Adverse Event|0|||
131179337|NCT03814590|472276267|FG003|Overall Study|Adverse Event|0|||
131179338|NCT03814590|472276268|FG004|Overall Study|Adverse Event|0|||
131179339|NCT03814590|472276269|FG005|Overall Study|Adverse Event|1|||
131179340|NCT03814590|472276270|FG006|Overall Study|Adverse Event|1|||
131179341|NCT03814590|472276271|FG007|Overall Study|Adverse Event|1|||
131179342|NCT03814590|472276272|FG008|Overall Study|Adverse Event|0|||
131179343|NCT03814590|472276273|FG009|Overall Study|Adverse Event|0|||
131179344|NCT03814590|472276274|FG010|Overall Study|Adverse Event|1|||
131179345|NCT03814590|472276275|FG011|Overall Study|Adverse Event|0|||
131179346|NCT03814590|472276276|FG012|Overall Study|Adverse Event|3|||
131179347|NCT03814590|472276277|FG013|Overall Study|Adverse Event|0|||
131179348|NCT03814590|472276264|FG000|Overall Study|Lost to Follow-up|0|||
131179349|NCT03814590|472276265|FG001|Overall Study|Lost to Follow-up|2|||
131179350|NCT03814590|472276266|FG002|Overall Study|Lost to Follow-up|1|||
131179351|NCT03814590|472276267|FG003|Overall Study|Lost to Follow-up|0|||
131179352|NCT03814590|472276268|FG004|Overall Study|Lost to Follow-up|1|||
131179353|NCT03814590|472276269|FG005|Overall Study|Lost to Follow-up|1|||
131179354|NCT03814590|472276270|FG006|Overall Study|Lost to Follow-up|1|||
131179355|NCT03814590|472276271|FG007|Overall Study|Lost to Follow-up|1|||
131179356|NCT03814590|472276272|FG008|Overall Study|Lost to Follow-up|0|||
131179357|NCT03814590|472276273|FG009|Overall Study|Lost to Follow-up|0|||
131179358|NCT03814590|472276274|FG010|Overall Study|Lost to Follow-up|1|||
131179359|NCT03814590|472276275|FG011|Overall Study|Lost to Follow-up|0|||
131179360|NCT03814590|472276276|FG012|Overall Study|Lost to Follow-up|0|||
131179361|NCT03814590|472276277|FG013|Overall Study|Lost to Follow-up|1|||
131179362|NCT03814590|472276264|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179363|NCT03814590|472276265|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179364|NCT03814590|472276266|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179365|NCT03814590|472276267|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179366|NCT03814590|472276268|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179367|NCT03814590|472276269|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179368|NCT03814590|472276270|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179369|NCT03814590|472276271|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130783671|NCT00086190|470835080|FG002|Overall Study|Protocol Violation|0|||
130783672|NCT00086190|470835078|FG000|Overall Study|Moved|1|||
130783673|NCT00086190|470835079|FG001|Overall Study|Moved|0|||
130783674|NCT00086190|470835080|FG002|Overall Study|Moved|0|||
130783675|NCT00086190|470835078|FG000|Overall Study|Worsening depression|0|||
130783676|NCT00086190|470835079|FG001|Overall Study|Worsening depression|0|||
130783677|NCT00086190|470835080|FG002|Overall Study|Worsening depression|2|||
130783678|NCT03902613|470835084|FG000|Overall Study|Physician Decision|1|||
130783679|NCT02027025|470835085|FG000|Overall Study|Adverse Event|0|||
130783680|NCT02027025|470835086|FG001|Overall Study|Adverse Event|1|||
130783681|NCT02027025|470835087|FG002|Overall Study|Adverse Event|1|||
130783682|NCT02027025|470835085|FG000|Overall Study|Protocol Violation|1|||
130783683|NCT02027025|470835086|FG001|Overall Study|Protocol Violation|0|||
130783684|NCT02027025|470835087|FG002|Overall Study|Protocol Violation|0|||
130783685|NCT02027025|470835085|FG000|Overall Study|Lost to Follow-up|0|||
130783686|NCT02027025|470835086|FG001|Overall Study|Lost to Follow-up|2|||
130783687|NCT02027025|470835087|FG002|Overall Study|Lost to Follow-up|0|||
130783688|NCT02027025|470835085|FG000|Overall Study|Withdrawal by Subject|0|||
130783689|NCT02027025|470835086|FG001|Overall Study|Withdrawal by Subject|1|||
130783690|NCT02027025|470835087|FG002|Overall Study|Withdrawal by Subject|0|||
130783691|NCT02027025|470835085|FG000|Overall Study|Sponsor's decision|0|||
130783692|NCT02027025|470835086|FG001|Overall Study|Sponsor's decision|1|||
130783693|NCT02027025|470835087|FG002|Overall Study|Sponsor's decision|0|||
130783694|NCT00732069|470835088|FG000|Washout After First Study Drug|Adverse Event|1|||
130783695|NCT00732069|470835089|FG001|Washout After First Study Drug|Adverse Event|0|||
130783696|NCT00732069|470835090|FG002|Washout After First Study Drug|Adverse Event|0|||
130783697|NCT00732069|470835091|FG003|Washout After First Study Drug|Adverse Event|0|||
130783698|NCT00732069|470835092|FG004|Washout After First Study Drug|Adverse Event|0|||
130783699|NCT00732069|470835093|FG005|Washout After First Study Drug|Adverse Event|0|||
130783700|NCT01190813|470835094|FG000|Overall Study|Lost to Follow-up|1|||
130783701|NCT01190813|470835095|FG001|Overall Study|Lost to Follow-up|2|||
130783702|NCT01190813|470835094|FG000|Overall Study|Withdrawal by Subject|2|||
130783703|NCT01190813|470835095|FG001|Overall Study|Withdrawal by Subject|1|||
130783704|NCT01190813|470835094|FG000|Overall Study|Refused study treatment after randomized|1|||
130783705|NCT01190813|470835095|FG001|Overall Study|Refused study treatment after randomized|0|||
130783706|NCT01190813|470835094|FG000|Overall Study|Adverse Event|0|||
130783707|NCT01190813|470835095|FG001|Overall Study|Adverse Event|1|||
130783708|NCT04194814|470835096|FG000|Overall Study|Physician Decision|3|||
130783709|NCT04194814|470835097|FG001|Overall Study|Physician Decision|0|||
130783710|NCT04194814|470835096|FG000|Overall Study|Withdrawal by Subject|0|||
130783711|NCT04194814|470835097|FG001|Overall Study|Withdrawal by Subject|2|||
130783712|NCT00916578|470836719|FG000|Overall Study|Physician Decision|2|||
130783713|NCT00916578|470836719|FG000|Overall Study|Withdrawal by Subject|3|||
130783714|NCT00916578|470836719|FG000|Overall Study|Insurance Denial|2|||
130783715|NCT02737358|470836722|FG000|Overall Study|Withdrawal by Subject|7|||
130783716|NCT02737358|470836723|FG001|Overall Study|Withdrawal by Subject|12|||
130783717|NCT02737358|470836722|FG000|Overall Study|Lost to Follow-up|2|||
130783718|NCT02737358|470836723|FG001|Overall Study|Lost to Follow-up|3|||
130783719|NCT03191799|470836729|FG000|Overall Study|Withdrawal by Subject|4|||
130783720|NCT03191799|470836729|FG000|Overall Study|Physician Decision|2|||
130783721|NCT03191799|470836729|FG000|Overall Study|Lost to Follow-up|1|||
130783722|NCT03191799|470836729|FG000|Overall Study|Death|2|||
130783723|NCT00748241|470836735|FG000|Overall Study|Implant failure|1|||
130783724|NCT00748241|470836735|FG000|Overall Study|Lost to Follow-up|5|||
130783725|NCT00748241|470836735|FG000|Overall Study|Death|2|||
130783726|NCT02974868|470836745|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
130783727|NCT02974868|470836746|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
130783728|NCT02974868|470836747|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
130783729|NCT02974868|470836748|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
130783730|NCT02974868|470836745|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
130783731|NCT02974868|470836746|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
130783732|NCT02974868|470836747|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
130783733|NCT02974868|470836748|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
130783734|NCT02974868|470836745|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
130783735|NCT02974868|470836746|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
130783736|NCT02974868|470836747|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
130783737|NCT02974868|470836748|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
130783738|NCT02974868|470836745|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
130783739|NCT02974868|470836746|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
130783740|NCT02974868|470836747|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
130783741|NCT02974868|470836748|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
130783742|NCT00706004|470836749|FG000|Overall Study|Did not meet eligibility criteria|2|||
130783743|NCT00297648|470836752|FG000|Overall Study|Adverse Event|13|||
130783744|NCT00297648|470836752|FG000|Overall Study|Lack of Efficacy|18|||
130783745|NCT00297648|470836752|FG000|Overall Study|Lost to Follow-up|1|||
131179370|NCT03814590|472276272|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179371|NCT03814590|472276273|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
131179372|NCT03814590|472276274|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179373|NCT03814590|472276275|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179374|NCT03814590|472276276|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179375|NCT03814590|472276277|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
131179376|NCT03814590|472276264|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131179377|NCT03814590|472276265|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131179378|NCT03814590|472276266|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131179379|NCT03814590|472276267|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131179380|NCT03814590|472276268|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131179381|NCT03814590|472276269|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
131179382|NCT03814590|472276270|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
131179383|NCT03814590|472276271|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
131179384|NCT03814590|472276272|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131179385|NCT03814590|472276273|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
131179386|NCT03814590|472276274|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
131179387|NCT03814590|472276275|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
131179388|NCT03814590|472276276|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
131179389|NCT03814590|472276277|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
131179390|NCT03814590|472276264|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179391|NCT03814590|472276265|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179392|NCT03814590|472276266|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179393|NCT03814590|472276267|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179394|NCT03814590|472276268|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179395|NCT03814590|472276269|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179396|NCT03814590|472276270|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179397|NCT03814590|472276271|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131179398|NCT03814590|472276272|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179399|NCT03814590|472276273|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
131179400|NCT03814590|472276274|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179401|NCT03814590|472276275|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179402|NCT03814590|472276276|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179403|NCT03814590|472276277|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
131179404|NCT03814590|472276264|FG000|Overall Study|UNKNOWN REASON|0|||
131179405|NCT03814590|472276265|FG001|Overall Study|UNKNOWN REASON|0|||
131179406|NCT03814590|472276266|FG002|Overall Study|UNKNOWN REASON|0|||
131179407|NCT03814590|472276267|FG003|Overall Study|UNKNOWN REASON|0|||
131179408|NCT03814590|472276268|FG004|Overall Study|UNKNOWN REASON|0|||
131179409|NCT03814590|472276269|FG005|Overall Study|UNKNOWN REASON|0|||
131179410|NCT03814590|472276270|FG006|Overall Study|UNKNOWN REASON|0|||
131179411|NCT03814590|472276271|FG007|Overall Study|UNKNOWN REASON|1|||
131179412|NCT03814590|472276272|FG008|Overall Study|UNKNOWN REASON|0|||
131179413|NCT03814590|472276273|FG009|Overall Study|UNKNOWN REASON|0|||
131179414|NCT03814590|472276274|FG010|Overall Study|UNKNOWN REASON|0|||
131179415|NCT03814590|472276275|FG011|Overall Study|UNKNOWN REASON|0|||
131179416|NCT03814590|472276276|FG012|Overall Study|UNKNOWN REASON|0|||
131179417|NCT03814590|472276277|FG013|Overall Study|UNKNOWN REASON|0|||
131179418|NCT02260648|472276278|FG000|Overall Study|Adverse Event|3|||
131179419|NCT02260648|472276279|FG001|Overall Study|Adverse Event|0|||
131179420|NCT02260648|472276280|FG002|Overall Study|Adverse Event|1|||
131179421|NCT02260648|472276278|FG000|Overall Study|Withdrawal by Subject|1|||
131179422|NCT02260648|472276279|FG001|Overall Study|Withdrawal by Subject|1|||
131179423|NCT02260648|472276280|FG002|Overall Study|Withdrawal by Subject|0|||
131179424|NCT02260648|472276278|FG000|Overall Study|Protocol Violation|1|||
131179425|NCT02260648|472276279|FG001|Overall Study|Protocol Violation|0|||
131179426|NCT02260648|472276280|FG002|Overall Study|Protocol Violation|0|||
131179427|NCT02260648|472276278|FG000|Overall Study|Discontinue Due to Study Termination|13|||
131179428|NCT02260648|472276279|FG001|Overall Study|Discontinue Due to Study Termination|12|||
131179429|NCT02260648|472276280|FG002|Overall Study|Discontinue Due to Study Termination|7|||
131179430|NCT03956225|472276281|FG000|Overall Study|Lack of Efficacy|1|||
131179431|NCT03956225|472276282|FG001|Overall Study|Lack of Efficacy|1|||
131179432|NCT03956225|472276281|FG000|Overall Study|Lost to Follow-up|0|||
131179433|NCT03956225|472276282|FG001|Overall Study|Lost to Follow-up|1|||
131179434|NCT03956225|472276281|FG000|Overall Study|Withdrawal by Subject|2|||
131179435|NCT03956225|472276282|FG001|Overall Study|Withdrawal by Subject|1|||
131179436|NCT03956225|472276281|FG000|Overall Study|Other Reasons|2|||
131179437|NCT03956225|472276282|FG001|Overall Study|Other Reasons|1|||
131179438|NCT04093258|472276283|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
131179439|NCT04093258|472276284|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
131179440|NCT00594204|472276285|FG000|Overall Study|Adverse Event|15|||
131179441|NCT00594204|472276286|FG001|Overall Study|Adverse Event|3|||
131179442|NCT00594204|472276285|FG000|Overall Study|Lost to Follow-up|9|||
131179443|NCT00594204|472276286|FG001|Overall Study|Lost to Follow-up|5|||
131179444|NCT00594204|472276285|FG000|Overall Study|Withdrawal by Subject|23|||
131179445|NCT00594204|472276286|FG001|Overall Study|Withdrawal by Subject|29|||
131179446|NCT00594204|472276285|FG000|Overall Study|Other|4|||
131179447|NCT00594204|472276286|FG001|Overall Study|Other|3|||
131179448|NCT00594204|472276285|FG000|Overall Study|Lack of Efficacy|3|||
131179449|NCT00594204|472276286|FG001|Overall Study|Lack of Efficacy|4|||
131179450|NCT00594204|472276285|FG000|Overall Study|Randomized but not treated|4|||
131179451|NCT00594204|472276286|FG001|Overall Study|Randomized but not treated|1|||
131179452|NCT00562640|472278308|FG000|Overall Study|Death|0|||
131179453|NCT00562640|472278309|FG001|Overall Study|Death|1|||
131179454|NCT00562640|472278310|FG002|Overall Study|Death|1|||
131179455|NCT00562640|472278311|FG003|Overall Study|Death|0|||
131179456|NCT05263921|472278312|FG000|Overall Study|Other: family emergency.|0|||
131179457|NCT05263921|472278313|FG001|Overall Study|Other: family emergency.|0|||
131179458|NCT05263921|472278314|FG002|Overall Study|Other: family emergency.|1|||
131179459|NCT05263921|472278315|FG003|Overall Study|Other: family emergency.|0|||
131179460|NCT04656418|472278316|FG000|Overall Study|Withdrawal by Subject|1|||
131179461|NCT04656418|472278317|FG001|Overall Study|Withdrawal by Subject|3|||
131179462|NCT03097614|472278318|FG000|Overall Study|Adverse Event|3|||
131179463|NCT02254551|472278328|FG000|Dose Escalation|Physician Decision|1|||
131179464|NCT02254551|472278328|FG000|Dose Escalation|Dose-limiting toxicity|2|||
131179465|NCT03587584|472278332|FG000|Overall Study|SOC deviations|4|||
131179466|NCT03587584|472278333|FG001|Overall Study|SOC deviations|6|||
131179467|NCT03587584|472278332|FG000|Overall Study|Incomplete data|0|||
131179468|NCT03587584|472278333|FG001|Overall Study|Incomplete data|3|||
131179469|NCT00387348|472278334|FG000|Overall Study|Death|1|||
131179470|NCT00387348|472278335|FG001|Overall Study|Death|1|||
131179471|NCT00387348|472278336|FG002|Overall Study|Death|0|||
131179472|NCT00387348|472278334|FG000|Overall Study|Physician Decision|1|||
131179473|NCT00387348|472278335|FG001|Overall Study|Physician Decision|0|||
131179474|NCT00387348|472278336|FG002|Overall Study|Physician Decision|1|||
131179475|NCT00387348|472278334|FG000|Overall Study|Withdrawal by Subject|0|||
131179476|NCT00387348|472278335|FG001|Overall Study|Withdrawal by Subject|2|||
131179477|NCT00387348|472278336|FG002|Overall Study|Withdrawal by Subject|2|||
131179478|NCT00387348|472278334|FG000|Overall Study|Adverse Event|1|||
131179479|NCT00387348|472278335|FG001|Overall Study|Adverse Event|0|||
131179480|NCT00387348|472278336|FG002|Overall Study|Adverse Event|1|||
131179481|NCT00505752|472278337|FG000|Overall Study|Adverse Event|1|||
131179482|NCT00505752|472278338|FG001|Overall Study|Adverse Event|0|||
131179483|NCT00505752|472278339|FG002|Overall Study|Adverse Event|1|||
131179484|NCT00505752|472278340|FG003|Overall Study|Adverse Event|0|||
131179485|NCT00505752|472278337|FG000|Overall Study|Lost to Follow-up|1|||
131179486|NCT00505752|472278338|FG001|Overall Study|Lost to Follow-up|0|||
131179487|NCT00505752|472278339|FG002|Overall Study|Lost to Follow-up|0|||
131179488|NCT00505752|472278340|FG003|Overall Study|Lost to Follow-up|0|||
131179489|NCT00505752|472278337|FG000|Overall Study|Lack of ovarian response|1|||
131179490|NCT00505752|472278338|FG001|Overall Study|Lack of ovarian response|3|||
131179491|NCT00505752|472278339|FG002|Overall Study|Lack of ovarian response|0|||
131179492|NCT00505752|472278340|FG003|Overall Study|Lack of ovarian response|0|||
131179493|NCT00505752|472278337|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
131179494|NCT00505752|472278338|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
131179495|NCT00505752|472278339|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
131179496|NCT00505752|472278340|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
131179497|NCT00505752|472278337|FG000|Overall Study|No oocytes retrieved|0|||
131179498|NCT00505752|472278338|FG001|Overall Study|No oocytes retrieved|2|||
131179499|NCT00505752|472278339|FG002|Overall Study|No oocytes retrieved|0|||
131179500|NCT00505752|472278340|FG003|Overall Study|No oocytes retrieved|1|||
131179501|NCT00505752|472278337|FG000|Overall Study|No Fertilization|1|||
131179502|NCT00505752|472278338|FG001|Overall Study|No Fertilization|1|||
131179503|NCT00505752|472278339|FG002|Overall Study|No Fertilization|2|||
131179504|NCT00505752|472278340|FG003|Overall Study|No Fertilization|1|||
131179505|NCT00505752|472278337|FG000|Overall Study|All embryos/blastocysts discarded|0|||
131179506|NCT00505752|472278338|FG001|Overall Study|All embryos/blastocysts discarded|0|||
131179507|NCT00505752|472278339|FG002|Overall Study|All embryos/blastocysts discarded|1|||
131179508|NCT00505752|472278340|FG003|Overall Study|All embryos/blastocysts discarded|1|||
131179509|NCT00505752|472278337|FG000|Overall Study|Other|1|||
131179510|NCT00505752|472278338|FG001|Overall Study|Other|2|||
131179511|NCT00505752|472278339|FG002|Overall Study|Other|1|||
131179512|NCT00505752|472278340|FG003|Overall Study|Other|2|||
131237661|NCT01171898|472500030|FG001|Overall Study|Death|0|||
131237662|NCT01171898|472500031|FG002|Overall Study|Death|2|||
131237663|NCT01171898|472500032|FG003|Overall Study|Death|0|||
131237664|NCT01171898|472500029|FG000|Overall Study|Lost to Follow-up|0|||
131237665|NCT01171898|472500030|FG001|Overall Study|Lost to Follow-up|1|||
131237666|NCT01171898|472500031|FG002|Overall Study|Lost to Follow-up|1|||
131237667|NCT01171898|472500032|FG003|Overall Study|Lost to Follow-up|1|||
131237668|NCT01171898|472500029|FG000|Overall Study|Withdrawal by Subject|1|||
131237669|NCT01171898|472500030|FG001|Overall Study|Withdrawal by Subject|4|||
131237670|NCT01171898|472500031|FG002|Overall Study|Withdrawal by Subject|6|||
131237671|NCT01171898|472500032|FG003|Overall Study|Withdrawal by Subject|3|||
131237672|NCT01171898|472500029|FG000|Overall Study|Terminated by Sponsor|1|||
131237673|NCT01171898|472500030|FG001|Overall Study|Terminated by Sponsor|0|||
131237674|NCT01171898|472500031|FG002|Overall Study|Terminated by Sponsor|0|||
131237675|NCT01171898|472500032|FG003|Overall Study|Terminated by Sponsor|0|||
131237676|NCT01171898|472500029|FG000|Overall Study|Ongoing|1|||
131237677|NCT01171898|472500030|FG001|Overall Study|Ongoing|9|||
131237678|NCT01171898|472500031|FG002|Overall Study|Ongoing|3|||
131237679|NCT01171898|472500032|FG003|Overall Study|Ongoing|0|||
131237680|NCT01171898|472500029|FG000|Overall Study|Other|1|||
131237681|NCT01171898|472500030|FG001|Overall Study|Other|5|||
131237682|NCT01171898|472500031|FG002|Overall Study|Other|0|||
131237683|NCT01171898|472500032|FG003|Overall Study|Other|2|||
131237684|NCT04053868|472500033|FG000|Overall Study|Withdrawal by Subject|1|||
131237685|NCT04053868|472500034|FG001|Overall Study|Withdrawal by Subject|0|||
131237686|NCT02932410|472500035|FG000|Overall Study|Death|7|||
131237687|NCT02932410|472500036|FG001|Overall Study|Death|6|||
131237688|NCT02932410|472500037|FG002|Overall Study|Death|0|||
131237689|NCT02932410|472500038|FG003|Overall Study|Death|0|||
131237690|NCT02932410|472500035|FG000|Overall Study|Lost to Follow-up|1|||
131237691|NCT02932410|472500036|FG001|Overall Study|Lost to Follow-up|2|||
131237692|NCT02932410|472500037|FG002|Overall Study|Lost to Follow-up|0|||
131237693|NCT02932410|472500038|FG003|Overall Study|Lost to Follow-up|0|||
131237694|NCT02932410|472500035|FG000|Overall Study|Parent/Subjects decision|6|||
131237695|NCT02932410|472500036|FG001|Overall Study|Parent/Subjects decision|6|||
131237696|NCT02932410|472500037|FG002|Overall Study|Parent/Subjects decision|1|||
131237697|NCT02932410|472500038|FG003|Overall Study|Parent/Subjects decision|0|||
131237698|NCT02932410|472500035|FG000|Overall Study|Physician Decision|0|||
131237699|NCT02932410|472500036|FG001|Overall Study|Physician Decision|1|||
131237700|NCT02932410|472500037|FG002|Overall Study|Physician Decision|0|||
131237701|NCT02932410|472500038|FG003|Overall Study|Physician Decision|0|||
131237702|NCT05037097|472500039|FG000|Overall Study|Withdrawal by Subject|0|||
131237703|NCT05037097|472500040|FG001|Overall Study|Withdrawal by Subject|1|||
131237704|NCT05037097|472500041|FG002|Overall Study|Withdrawal by Subject|0|||
131237705|NCT05037097|472500042|FG003|Overall Study|Withdrawal by Subject|1|||
131237706|NCT05037097|472500043|FG004|Overall Study|Withdrawal by Subject|0|||
131237707|NCT05037097|472500044|FG005|Overall Study|Withdrawal by Subject|2|||
131237708|NCT05037097|472500045|FG006|Overall Study|Withdrawal by Subject|0|||
131237709|NCT05037097|472500046|FG007|Overall Study|Withdrawal by Subject|0|||
131237710|NCT05037097|472500039|FG000|Overall Study|Lost to Follow-up|0|||
131237711|NCT05037097|472500040|FG001|Overall Study|Lost to Follow-up|1|||
131237712|NCT05037097|472500041|FG002|Overall Study|Lost to Follow-up|0|||
131237713|NCT05037097|472500042|FG003|Overall Study|Lost to Follow-up|0|||
131237714|NCT05037097|472500043|FG004|Overall Study|Lost to Follow-up|1|||
131237715|NCT05037097|472500044|FG005|Overall Study|Lost to Follow-up|1|||
131237716|NCT05037097|472500045|FG006|Overall Study|Lost to Follow-up|0|||
131237717|NCT05037097|472500046|FG007|Overall Study|Lost to Follow-up|0|||
131237718|NCT04510857|472500053|FG000|Overall Study|Withdrawal by Subject|1|||
131237719|NCT04510857|472500054|FG001|Overall Study|Withdrawal by Subject|2|||
131237720|NCT04992273|472500055|FG000|Overall Study|Lost to Follow-up|0|||
131237721|NCT04992273|472500056|FG001|Overall Study|Lost to Follow-up|1|||
131237722|NCT05415410|472500057|FG000|Overall Study|Death|3|||
131237723|NCT05415410|472500058|FG001|Overall Study|Death|6|||
131237724|NCT05415410|472500059|FG002|Overall Study|Death|1|||
131237725|NCT05415410|472500057|FG000|Overall Study|Trial Terminated by Sponsor|1|||
131237726|NCT05415410|472500058|FG001|Overall Study|Trial Terminated by Sponsor|5|||
131237727|NCT05415410|472500059|FG002|Overall Study|Trial Terminated by Sponsor|0|||
131237728|NCT05415410|472500057|FG000|Overall Study|Adverse Event|2|||
131237729|NCT05415410|472500058|FG001|Overall Study|Adverse Event|1|||
131237730|NCT05415410|472500059|FG002|Overall Study|Adverse Event|0|||
131237731|NCT05415410|472500057|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
131237732|NCT05415410|472500058|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
131237733|NCT05415410|472500059|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
131237734|NCT05415410|472500057|FG000|Overall Study|Withdrawal by Subject|1|||
131237735|NCT05415410|472500058|FG001|Overall Study|Withdrawal by Subject|0|||
131237736|NCT05415410|472500059|FG002|Overall Study|Withdrawal by Subject|0|||
131237737|NCT05415410|472500057|FG000|Overall Study|Pregnancy|5|||
131237738|NCT05415410|472500058|FG001|Overall Study|Pregnancy|2|||
131237739|NCT05415410|472500059|FG002|Overall Study|Pregnancy|0|||
131237740|NCT04010240|472500060|FG000|Overall Study|IHC not performed|2299|||
131237741|NCT02819362|472500064|FG000|Overall Study|On-site MRI could not be performed|70|||
131179513|NCT01149343|472278343|FG000|Overall Study|Withdrawal by Subject|1|||
131179514|NCT01149343|472278344|FG001|Overall Study|Withdrawal by Subject|1|||
131179515|NCT01149343|472278345|FG002|Overall Study|Withdrawal by Subject|1|||
131179516|NCT01149343|472278346|FG003|Overall Study|Withdrawal by Subject|5|||
131179517|NCT01149343|472278343|FG000|Overall Study|Death|10|||
131179518|NCT01149343|472278344|FG001|Overall Study|Death|13|||
131179519|NCT01149343|472278345|FG002|Overall Study|Death|18|||
131179520|NCT01149343|472278346|FG003|Overall Study|Death|18|||
131179521|NCT01149343|472278343|FG000|Overall Study|Lost to Follow-up|1|||
131179522|NCT01149343|472278344|FG001|Overall Study|Lost to Follow-up|0|||
131179523|NCT01149343|472278345|FG002|Overall Study|Lost to Follow-up|0|||
131179524|NCT01149343|472278346|FG003|Overall Study|Lost to Follow-up|1|||
131179525|NCT01149343|472278343|FG000|Overall Study|Other|8|||
131179526|NCT01149343|472278344|FG001|Overall Study|Other|10|||
131179527|NCT01149343|472278345|FG002|Overall Study|Other|2|||
131179528|NCT01149343|472278346|FG003|Overall Study|Other|14|||
131179529|NCT01149343|472278343|FG000|Overall Study|Sponsor study termination|0|||
131179530|NCT01149343|472278344|FG001|Overall Study|Sponsor study termination|0|||
131179531|NCT01149343|472278345|FG002|Overall Study|Sponsor study termination|0|||
131179532|NCT01149343|472278346|FG003|Overall Study|Sponsor study termination|2|||
131179533|NCT01149343|472278343|FG000|Overall Study|Recurrence / Progressive disease|0|||
131179534|NCT01149343|472278344|FG001|Overall Study|Recurrence / Progressive disease|0|||
131179535|NCT01149343|472278345|FG002|Overall Study|Recurrence / Progressive disease|1|||
131179536|NCT01149343|472278346|FG003|Overall Study|Recurrence / Progressive disease|0|||
131179537|NCT01925612|472278347|FG000|Overall Study|Progressive Disease|1|||
131179538|NCT01925612|472278348|FG001|Overall Study|Progressive Disease|1|||
131179539|NCT01925612|472278349|FG002|Overall Study|Progressive Disease|1|||
131179540|NCT01925612|472278350|FG003|Overall Study|Progressive Disease|0|||
131179541|NCT01925612|472278351|FG004|Overall Study|Progressive Disease|0|||
131179542|NCT01925612|472278347|FG000|Overall Study|Adverse Event|3|||
131179543|NCT01925612|472278348|FG001|Overall Study|Adverse Event|3|||
131179544|NCT01925612|472278349|FG002|Overall Study|Adverse Event|0|||
131179545|NCT01925612|472278350|FG003|Overall Study|Adverse Event|1|||
131179546|NCT01925612|472278351|FG004|Overall Study|Adverse Event|2|||
131179547|NCT01093755|472278355|FG000|Overall Study|Withdrawal by Subject|3|||
131179548|NCT01093755|472278356|FG001|Overall Study|Withdrawal by Subject|4|||
131179549|NCT00225147|472278357|FG000|Open-label Phase|Lost to Follow-up|0|||
131179550|NCT00225147|472278358|FG001|Open-label Phase|Lost to Follow-up|0|||
131179551|NCT00225147|472278359|FG002|Open-label Phase|Lost to Follow-up|0|||
131179552|NCT00225147|472278360|FG003|Open-label Phase|Lost to Follow-up|4|||
131179553|NCT00225147|472278357|FG000|Open-label Phase|Withdrawal by Subject|0|||
131179554|NCT00225147|472278358|FG001|Open-label Phase|Withdrawal by Subject|0|||
131179555|NCT00225147|472278359|FG002|Open-label Phase|Withdrawal by Subject|0|||
131179556|NCT00225147|472278360|FG003|Open-label Phase|Withdrawal by Subject|6|||
131179557|NCT00868166|472278364|FG000|Overall Study|Death|58|||
131179558|NCT00868166|472278365|FG001|Overall Study|Death|65|||
131179559|NCT00868166|472278364|FG000|Overall Study|Withdrawal by Subject|33|||
131179560|NCT00868166|472278365|FG001|Overall Study|Withdrawal by Subject|25|||
131179561|NCT00868166|472278364|FG000|Overall Study|Protocol Violation|1|||
131179562|NCT00868166|472278365|FG001|Overall Study|Protocol Violation|0|||
131179563|NCT00868166|472278364|FG000|Overall Study|Lost to Follow-up|1|||
131179564|NCT00868166|472278365|FG001|Overall Study|Lost to Follow-up|3|||
131179565|NCT00868166|472278364|FG000|Overall Study|Adverse Event|9|||
131179566|NCT00868166|472278365|FG001|Overall Study|Adverse Event|10|||
131179567|NCT00868166|472278364|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
131179568|NCT00868166|472278365|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
131179569|NCT00868166|472278364|FG000|Overall Study|Non-compliance with IMP|1|||
131179570|NCT00868166|472278365|FG001|Overall Study|Non-compliance with IMP|1|||
131179571|NCT01231607|472278375|FG000|Overall Study|Adverse Event|0|||
131179572|NCT01231607|472278376|FG001|Overall Study|Adverse Event|8|||
131179573|NCT01231607|472278377|FG002|Overall Study|Adverse Event|4|||
131179574|NCT01231607|472278378|FG003|Overall Study|Adverse Event|4|||
131179575|NCT01231607|472278379|FG004|Overall Study|Adverse Event|5|||
131179576|NCT01231607|472278375|FG000|Overall Study|Lost to Follow-up|13|||
131179577|NCT01231607|472278376|FG001|Overall Study|Lost to Follow-up|11|||
131179578|NCT01231607|472278377|FG002|Overall Study|Lost to Follow-up|10|||
131179579|NCT01231607|472278378|FG003|Overall Study|Lost to Follow-up|10|||
131179580|NCT01231607|472278379|FG004|Overall Study|Lost to Follow-up|4|||
131179581|NCT01231607|472278375|FG000|Overall Study|Physician Decision|4|||
131179582|NCT01231607|472278376|FG001|Overall Study|Physician Decision|4|||
131179583|NCT01231607|472278377|FG002|Overall Study|Physician Decision|3|||
131179584|NCT01231607|472278378|FG003|Overall Study|Physician Decision|5|||
131179585|NCT01231607|472278379|FG004|Overall Study|Physician Decision|4|||
131179586|NCT01231607|472278375|FG000|Overall Study|Protocol Violation|3|||
131179587|NCT01231607|472278376|FG001|Overall Study|Protocol Violation|2|||
131179588|NCT01231607|472278377|FG002|Overall Study|Protocol Violation|0|||
131179589|NCT01231607|472278378|FG003|Overall Study|Protocol Violation|2|||
131179590|NCT01231607|472278379|FG004|Overall Study|Protocol Violation|2|||
131179591|NCT01231607|472278375|FG000|Overall Study|Withdrawal by Subject|9|||
130783746|NCT00297648|470836752|FG000|Overall Study|Withdrawal by Subject|3|||
131179592|NCT01231607|472278376|FG001|Overall Study|Withdrawal by Subject|9|||
131179593|NCT01231607|472278377|FG002|Overall Study|Withdrawal by Subject|14|||
131179594|NCT01231607|472278378|FG003|Overall Study|Withdrawal by Subject|17|||
131179595|NCT01231607|472278379|FG004|Overall Study|Withdrawal by Subject|9|||
131179596|NCT02267278|472278380|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
131179597|NCT02267278|472278380|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
131179598|NCT02267278|472278380|FG000|Overall Study|Developed new cancer diagnoses|2|||
131179599|NCT02267278|472278380|FG000|Overall Study|prescribed prohibited medication|1|||
131179600|NCT00085917|472278388|FG000|Overall Study|Adverse Event|4|||
131179601|NCT00085917|472278389|FG001|Overall Study|Adverse Event|3|||
131179602|NCT03372603|472278391|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
131179603|NCT03372603|472278392|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
131179604|NCT03372603|472278391|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
131179605|NCT03372603|472278392|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
131179606|NCT01153841|472278393|FG000|Overall Study|Adverse Event|1|||
131179607|NCT01153841|472278394|FG001|Overall Study|Adverse Event|0|||
131179608|NCT01153841|472278393|FG000|Overall Study|Withdrawal by Subject|1|||
131179609|NCT01153841|472278394|FG001|Overall Study|Withdrawal by Subject|0|||
131179610|NCT01153841|472278393|FG000|Overall Study|Protocol Violation|2|||
131179611|NCT01153841|472278394|FG001|Overall Study|Protocol Violation|0|||
131179612|NCT01153841|472278393|FG000|Overall Study|Lost to Follow-up|2|||
131179613|NCT01153841|472278394|FG001|Overall Study|Lost to Follow-up|0|||
131179614|NCT02553317|472278396|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
131179615|NCT02553317|472278397|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
131179616|NCT02553317|472278396|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
131179617|NCT02553317|472278397|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
131179618|NCT02553317|472278396|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
131179619|NCT02553317|472278397|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
131179620|NCT02553317|472278396|FG000|Overall Treatment Period + Follow-up|Death|1|||
131179621|NCT02553317|472278397|FG001|Overall Treatment Period + Follow-up|Death|3|||
131179622|NCT02553317|472278396|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
131179623|NCT02553317|472278397|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
131179624|NCT02553317|472278396|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
131179625|NCT02553317|472278397|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
131179626|NCT02553317|472278396|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
131179627|NCT02553317|472278397|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
131179628|NCT02553317|472278396|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
131179629|NCT02553317|472278397|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
130783747|NCT00297648|470836752|FG000|Overall Study|Other: Incompliance|1|||
130783748|NCT03575702|470836753|FG000|Overall Study|Withdrawal by Subject|1|||
130783749|NCT03575702|470836754|FG001|Overall Study|Withdrawal by Subject|1|||
130783750|NCT03575702|470836753|FG000|Overall Study|Lost to Follow-up|1|||
130783751|NCT03575702|470836754|FG001|Overall Study|Lost to Follow-up|2|||
130783752|NCT03575702|470836753|FG000|Overall Study|Protocol Violation|0|||
130783753|NCT03575702|470836754|FG001|Overall Study|Protocol Violation|1|||
130783754|NCT03575702|470836753|FG000|Overall Study|Patient non compliance|4|||
130783755|NCT03575702|470836754|FG001|Overall Study|Patient non compliance|0|||
130783756|NCT03903172|470836755|FG000|Overall Study|screen fail|4|||
130783757|NCT03903172|470836756|FG001|Overall Study|screen fail|1|||
130783758|NCT01545388|470836757|FG000|Overall Study|Adverse Event|2|||
130783759|NCT01545388|470836758|FG001|Overall Study|Adverse Event|4|||
130783760|NCT01545388|470836759|FG002|Overall Study|Adverse Event|1|||
130783761|NCT01545388|470836757|FG000|Overall Study|Lack of Efficacy|3|||
130783762|NCT01545388|470836758|FG001|Overall Study|Lack of Efficacy|2|||
130783763|NCT01545388|470836759|FG002|Overall Study|Lack of Efficacy|5|||
130783764|NCT01545388|470836757|FG000|Overall Study|Participant moved or relocated|1|||
130783765|NCT01545388|470836758|FG001|Overall Study|Participant moved or relocated|0|||
130783766|NCT01545388|470836759|FG002|Overall Study|Participant moved or relocated|0|||
130783767|NCT01545388|470836757|FG000|Overall Study|Withdrawal by Subject|1|||
131179630|NCT02553317|472278396|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
131179631|NCT02553317|472278397|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
131179632|NCT02553317|472278396|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
131179633|NCT02553317|472278397|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
131179634|NCT03483116|472278398|FG000|Overall Study|Adverse Event|0|||
131179635|NCT03483116|472278399|FG001|Overall Study|Adverse Event|1|||
131179636|NCT03483116|472278400|FG002|Overall Study|Adverse Event|0|||
131179637|NCT03483116|472278401|FG003|Overall Study|Adverse Event|1|||
131179638|NCT03483116|472278398|FG000|Overall Study|Protocol Violation|1|||
131179639|NCT03483116|472278399|FG001|Overall Study|Protocol Violation|0|||
130783768|NCT01545388|470836758|FG001|Overall Study|Withdrawal by Subject|4|||
131237742|NCT05400655|472500065|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
131237743|NCT05400655|472500066|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
131237744|NCT05400655|472500067|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
131237745|NCT05400655|472500068|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
131237746|NCT05400655|472500069|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
131237747|NCT05400655|472500070|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
131237748|NCT05400655|472500071|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
131237749|NCT05400655|472500072|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
131237750|NCT05400655|472500073|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
131237751|NCT05400655|472500074|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
131237752|NCT05400655|472500075|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
131237753|NCT05400655|472500076|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
131237754|NCT05400655|472500077|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
131237755|NCT05400655|472500078|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
131237756|NCT05400655|472500079|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
131237757|NCT05400655|472500080|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
131237758|NCT05400655|472500081|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
131237759|NCT05400655|472500082|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
131237760|NCT05400655|472500083|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
131237761|NCT05400655|472500084|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
131237762|NCT05400655|472500085|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
131237763|NCT05400655|472500086|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
131237764|NCT05400655|472500065|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237765|NCT05400655|472500066|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237766|NCT05400655|472500067|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237767|NCT05400655|472500068|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237768|NCT05400655|472500069|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237769|NCT05400655|472500070|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237770|NCT05400655|472500071|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237771|NCT05400655|472500072|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237772|NCT05400655|472500073|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237773|NCT05400655|472500074|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237774|NCT05400655|472500075|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237775|NCT05400655|472500076|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237776|NCT05400655|472500077|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
131237777|NCT05400655|472500078|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237778|NCT05400655|472500079|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237779|NCT05400655|472500080|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237780|NCT05400655|472500081|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
131237781|NCT05400655|472500082|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237782|NCT05400655|472500083|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
131237783|NCT05400655|472500084|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
131237784|NCT05400655|472500085|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237785|NCT05400655|472500086|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
131237786|NCT05400655|472500065|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237787|NCT05400655|472500066|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237788|NCT05400655|472500067|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237789|NCT05400655|472500068|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237790|NCT05400655|472500069|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237791|NCT05400655|472500070|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237792|NCT05400655|472500071|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131179640|NCT03483116|472278400|FG002|Overall Study|Protocol Violation|0|||
131179641|NCT03483116|472278401|FG003|Overall Study|Protocol Violation|7|||
131179642|NCT03483116|472278398|FG000|Overall Study|Lost to Follow-up|9|||
131179643|NCT03483116|472278399|FG001|Overall Study|Lost to Follow-up|4|||
131179644|NCT03483116|472278400|FG002|Overall Study|Lost to Follow-up|9|||
131179645|NCT03483116|472278401|FG003|Overall Study|Lost to Follow-up|5|||
131179646|NCT03483116|472278398|FG000|Overall Study|Death|1|||
131179647|NCT03483116|472278399|FG001|Overall Study|Death|0|||
131179648|NCT03483116|472278400|FG002|Overall Study|Death|2|||
131179649|NCT03483116|472278401|FG003|Overall Study|Death|1|||
131179650|NCT03483116|472278398|FG000|Overall Study|Withdrawal by Subject|14|||
131179651|NCT03483116|472278399|FG001|Overall Study|Withdrawal by Subject|16|||
131179652|NCT03483116|472278400|FG002|Overall Study|Withdrawal by Subject|14|||
131179653|NCT03483116|472278401|FG003|Overall Study|Withdrawal by Subject|16|||
131179654|NCT03483116|472278398|FG000|Overall Study|Unknown other reason|3|||
131179655|NCT03483116|472278399|FG001|Overall Study|Unknown other reason|2|||
131179656|NCT03483116|472278400|FG002|Overall Study|Unknown other reason|1|||
131179657|NCT03483116|472278401|FG003|Overall Study|Unknown other reason|1|||
131179658|NCT01181102|472278402|FG000|Overall Study|Adverse Event|28|||
131179659|NCT01181102|472278403|FG001|Overall Study|Adverse Event|26|||
131237793|NCT05400655|472500072|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237794|NCT05400655|472500073|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131179660|NCT01181102|472278402|FG000|Overall Study|Lack of Efficacy|3|||
131179661|NCT01181102|472278403|FG001|Overall Study|Lack of Efficacy|1|||
131179662|NCT01181102|472278402|FG000|Overall Study|Lost to Follow-up|2|||
131179663|NCT01181102|472278403|FG001|Overall Study|Lost to Follow-up|0|||
131179664|NCT01181102|472278402|FG000|Overall Study|Physician Decision|3|||
131179665|NCT01181102|472278403|FG001|Overall Study|Physician Decision|1|||
131179666|NCT01181102|472278402|FG000|Overall Study|Protocol Violation|5|||
131179667|NCT01181102|472278403|FG001|Overall Study|Protocol Violation|6|||
131179668|NCT01181102|472278402|FG000|Overall Study|Withdrawal by Subject|10|||
131179669|NCT01181102|472278403|FG001|Overall Study|Withdrawal by Subject|12|||
131179670|NCT03176277|472278409|FG000|Part A Dose Escalation Study|Adverse Event|1|||
131179671|NCT03176277|472278410|FG001|Part A Dose Escalation Study|Adverse Event|0|||
131179672|NCT03176277|472278411|FG002|Part A Dose Escalation Study|Adverse Event|1|||
131179673|NCT03176277|472278412|FG003|Part A Dose Escalation Study|Adverse Event|0|||
131179674|NCT03176277|472278409|FG000|Part A Dose Escalation Study|Physician Decision|1|||
131179675|NCT03176277|472278410|FG001|Part A Dose Escalation Study|Physician Decision|1|||
131179676|NCT03176277|472278411|FG002|Part A Dose Escalation Study|Physician Decision|2|||
131179677|NCT03176277|472278412|FG003|Part A Dose Escalation Study|Physician Decision|0|||
131179678|NCT03176277|472278409|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
131179679|NCT03176277|472278410|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
131179680|NCT03176277|472278411|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
131179681|NCT03176277|472278412|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
131179682|NCT03176277|472278409|FG000|Part A Dose Escalation Study|Progressive disease|3|||
131179683|NCT03176277|472278410|FG001|Part A Dose Escalation Study|Progressive disease|1|||
131179684|NCT03176277|472278411|FG002|Part A Dose Escalation Study|Progressive disease|3|||
131179685|NCT03176277|472278412|FG003|Part A Dose Escalation Study|Progressive disease|0|||
131179686|NCT00634114|472278413|FG000|Overall Study|Adverse Event|6|||
131179687|NCT00634114|472278414|FG001|Overall Study|Adverse Event|8|||
131179688|NCT00634114|472278415|FG002|Overall Study|Adverse Event|3|||
131179689|NCT00634114|472278413|FG000|Overall Study|Withdrawal by Subject|9|||
131179690|NCT00634114|472278414|FG001|Overall Study|Withdrawal by Subject|6|||
131179691|NCT00634114|472278415|FG002|Overall Study|Withdrawal by Subject|11|||
131179692|NCT00634114|472278413|FG000|Overall Study|Lost to Follow-up|0|||
131179693|NCT00634114|472278414|FG001|Overall Study|Lost to Follow-up|0|||
131179694|NCT00634114|472278415|FG002|Overall Study|Lost to Follow-up|1|||
131179695|NCT00634114|472278413|FG000|Overall Study|Protocol Violation|3|||
131179696|NCT00634114|472278414|FG001|Overall Study|Protocol Violation|3|||
131179697|NCT00634114|472278415|FG002|Overall Study|Protocol Violation|1|||
131179698|NCT00634114|472278413|FG000|Overall Study|Pregnancy|1|||
131179699|NCT00634114|472278414|FG001|Overall Study|Pregnancy|0|||
131179700|NCT00634114|472278415|FG002|Overall Study|Pregnancy|0|||
131179701|NCT00634114|472278413|FG000|Overall Study|Incorrect enrolment|0|||
131179702|NCT00634114|472278414|FG001|Overall Study|Incorrect enrolment|1|||
131179703|NCT00634114|472278415|FG002|Overall Study|Incorrect enrolment|0|||
131179704|NCT00634114|472278413|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
131179705|NCT00634114|472278414|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
131179706|NCT00634114|472278415|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
131179707|NCT00634114|472278413|FG000|Overall Study|Difficult to continue|3|||
131179708|NCT00634114|472278414|FG001|Overall Study|Difficult to continue|1|||
131179709|NCT00634114|472278415|FG002|Overall Study|Difficult to continue|1|||
131179710|NCT00634114|472278413|FG000|Overall Study|Other reason|1|||
131179711|NCT00634114|472278414|FG001|Overall Study|Other reason|1|||
131179712|NCT00634114|472278415|FG002|Overall Study|Other reason|1|||
131179713|NCT00567541|472278418|FG000|Overall Study|Adverse Event|0|||
131179714|NCT00567541|472278419|FG001|Overall Study|Adverse Event|1|||
131179715|NCT01890512|472278420|FG000|Overall Study|Physician Decision|1|||
131179716|NCT01890512|472278420|FG000|Overall Study|Withdrawal by Subject|1|||
131179717|NCT01890512|472278420|FG000|Overall Study|Protocol Violation|1|||
131179718|NCT01529385|472278421|FG000|Overall Study|Lost to Follow-up|2|||
131179719|NCT01529385|472278422|FG001|Overall Study|Lost to Follow-up|1|||
131179720|NCT00964158|472278425|FG000|Overall Study|Lost to Follow-up|0|||
131179721|NCT00964158|472278426|FG001|Overall Study|Lost to Follow-up|1|||
131179722|NCT00964158|472278427|FG002|Overall Study|Lost to Follow-up|2|||
131179723|NCT00964158|472278425|FG000|Overall Study|Withdrawal by Subject|0|||
131179724|NCT00964158|472278426|FG001|Overall Study|Withdrawal by Subject|0|||
131179725|NCT00964158|472278427|FG002|Overall Study|Withdrawal by Subject|6|||
131179726|NCT00986427|472278428|FG000|Overall Study|Lost to Follow-up|2|||
131179727|NCT00986427|472278429|FG001|Overall Study|Lost to Follow-up|0|||
131179728|NCT00986427|472278428|FG000|Overall Study|Lack of Efficacy|1|||
131179729|NCT00986427|472278429|FG001|Overall Study|Lack of Efficacy|0|||
131179730|NCT00986427|472278428|FG000|Overall Study|Withdrawal by Subject|1|||
131179731|NCT00986427|472278429|FG001|Overall Study|Withdrawal by Subject|0|||
131179732|NCT01401465|472278430|FG000|Treatment Period 1|Adverse Event|4|||
131179733|NCT01401465|472278431|FG001|Treatment Period 1|Adverse Event|1|||
131179734|NCT01401465|472278430|FG000|Treatment Period 1|Pregnancy|0|||
131179735|NCT01401465|472278431|FG001|Treatment Period 1|Pregnancy|1|||
131179736|NCT01401465|472278430|FG000|Treatment Period 1|Protocol Violation|5|||
131179737|NCT01401465|472278431|FG001|Treatment Period 1|Protocol Violation|0|||
131179738|NCT01401465|472278430|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130783769|NCT01545388|470836759|FG002|Overall Study|Withdrawal by Subject|2|||
130783770|NCT01545388|470836757|FG000|Overall Study|Other|1|||
130783771|NCT01545388|470836758|FG001|Overall Study|Other|1|||
130783772|NCT01545388|470836759|FG002|Overall Study|Other|0|||
130783773|NCT01255163|470836760|FG000|Overall Study|Withdrawal by Subject|1|||
130783774|NCT01255163|470836761|FG001|Overall Study|Withdrawal by Subject|0|||
131237795|NCT05400655|472500074|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237796|NCT05400655|472500075|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237797|NCT05400655|472500076|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237798|NCT05400655|472500077|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237799|NCT05400655|472500078|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
131237800|NCT05400655|472500079|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237801|NCT05400655|472500080|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237802|NCT05400655|472500081|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
131237803|NCT05400655|472500082|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237804|NCT05400655|472500083|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
131237805|NCT05400655|472500084|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237806|NCT05400655|472500085|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237807|NCT05400655|472500086|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
131237808|NCT05400655|472500065|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237809|NCT05400655|472500066|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237810|NCT05400655|472500067|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237811|NCT05400655|472500068|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237812|NCT05400655|472500069|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237813|NCT05400655|472500070|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237814|NCT05400655|472500071|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237815|NCT05400655|472500072|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237816|NCT05400655|472500073|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237817|NCT05400655|472500074|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237818|NCT05400655|472500075|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237819|NCT05400655|472500076|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237820|NCT05400655|472500077|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237821|NCT05400655|472500078|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237822|NCT05400655|472500079|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237823|NCT05400655|472500080|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237824|NCT05400655|472500081|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
131237825|NCT05400655|472500082|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
131237826|NCT05400655|472500083|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
131237827|NCT05400655|472500084|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
131237828|NCT05400655|472500085|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
131237829|NCT05400655|472500086|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
131237830|NCT05400655|472500065|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237831|NCT05400655|472500066|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237832|NCT05400655|472500067|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237833|NCT05400655|472500068|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237834|NCT05400655|472500069|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237835|NCT05400655|472500070|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237836|NCT05400655|472500071|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237837|NCT05400655|472500072|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237838|NCT05400655|472500073|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237839|NCT05400655|472500074|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237840|NCT05400655|472500075|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237841|NCT05400655|472500076|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237842|NCT05400655|472500077|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237843|NCT05400655|472500078|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237844|NCT05400655|472500079|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237845|NCT05400655|472500080|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237846|NCT05400655|472500081|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237847|NCT05400655|472500082|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
131237848|NCT05400655|472500083|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
130783775|NCT01255163|470836760|FG000|Overall Study|Lost to Follow-up|2|||
130783776|NCT01255163|470836761|FG001|Overall Study|Lost to Follow-up|0|||
131237849|NCT05400655|472500084|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237850|NCT05400655|472500085|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237851|NCT05400655|472500086|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
131237852|NCT05400655|472500065|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237853|NCT05400655|472500066|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237854|NCT05400655|472500067|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237855|NCT05400655|472500068|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237856|NCT05400655|472500069|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
130783777|NCT01255163|470836760|FG000|Overall Study|Adverse Event|0|||
131179739|NCT01401465|472278431|FG001|Treatment Period 1|Withdrawal by Subject|4|||
131179740|NCT01401465|472278430|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
131179741|NCT01401465|472278431|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
131179742|NCT01401465|472278430|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
131179743|NCT01401465|472278431|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
131179744|NCT01401465|472278430|FG000|Treatment Period 1|Scheduling Difficulties|1|||
131179745|NCT01401465|472278431|FG001|Treatment Period 1|Scheduling Difficulties|1|||
131179746|NCT01401465|472278430|FG000|Treatment Period 2|Lost to Follow-up|0|||
131179747|NCT01401465|472278431|FG001|Treatment Period 2|Lost to Follow-up|1|||
131179748|NCT01401465|472278430|FG000|Treatment Period 2|Withdrawal by Subject|0|||
131179749|NCT01401465|472278431|FG001|Treatment Period 2|Withdrawal by Subject|1|||
131179750|NCT01115738|472278432|FG000|Overall Study|Death|1|||
131179751|NCT01115738|472278433|FG001|Overall Study|Death|0|||
131179752|NCT01115738|472278434|FG002|Overall Study|Death|0|||
131179753|NCT01115738|472278432|FG000|Overall Study|Lost to Follow-up|0|||
131179754|NCT01115738|472278433|FG001|Overall Study|Lost to Follow-up|0|||
131179755|NCT01115738|472278434|FG002|Overall Study|Lost to Follow-up|1|||
131179756|NCT01115738|472278432|FG000|Overall Study|Physician Decision|18|||
131179757|NCT01115738|472278433|FG001|Overall Study|Physician Decision|15|||
131179758|NCT01115738|472278434|FG002|Overall Study|Physician Decision|17|||
131179759|NCT01115738|472278432|FG000|Overall Study|Withdrawal by Subject|6|||
131179760|NCT01115738|472278433|FG001|Overall Study|Withdrawal by Subject|6|||
131179761|NCT01115738|472278434|FG002|Overall Study|Withdrawal by Subject|9|||
131179762|NCT01054976|472278446|FG000|Overall Study|Adverse Event|16|||
131179763|NCT01054976|472278446|FG000|Overall Study|Uncooperative participations to study|7|||
131179764|NCT01054976|472278446|FG000|Overall Study|Withdrawal by Subject|4|||
131179765|NCT01054976|472278446|FG000|Overall Study|Other|8|||
131179766|NCT01763866|472278447|FG000|Overall Study|Withdrawal by Subject|2|||
131179767|NCT01763866|472278448|FG001|Overall Study|Withdrawal by Subject|1|||
131179768|NCT01763866|472278449|FG002|Overall Study|Withdrawal by Subject|4|||
131179769|NCT01763866|472278450|FG003|Overall Study|Withdrawal by Subject|0|||
131179770|NCT01763866|472278451|FG004|Overall Study|Withdrawal by Subject|0|||
131179771|NCT01763866|472278452|FG005|Overall Study|Withdrawal by Subject|3|||
131179772|NCT01763866|472278453|FG006|Overall Study|Withdrawal by Subject|4|||
131179773|NCT01763866|472278454|FG007|Overall Study|Withdrawal by Subject|0|||
131179774|NCT01763866|472278455|FG008|Overall Study|Withdrawal by Subject|1|||
131179775|NCT01763866|472278456|FG009|Overall Study|Withdrawal by Subject|1|||
131179776|NCT01763866|472278457|FG010|Overall Study|Withdrawal by Subject|2|||
131179777|NCT01763866|472278458|FG011|Overall Study|Withdrawal by Subject|2|||
131179778|NCT01763866|472278459|FG012|Overall Study|Withdrawal by Subject|2|||
131179779|NCT01763866|472278460|FG013|Overall Study|Withdrawal by Subject|0|||
131179780|NCT01763866|472278461|FG014|Overall Study|Withdrawal by Subject|6|||
131179781|NCT01763866|472278462|FG015|Overall Study|Withdrawal by Subject|3|||
131179782|NCT01763866|472278463|FG016|Overall Study|Withdrawal by Subject|0|||
131179783|NCT01763866|472278464|FG017|Overall Study|Withdrawal by Subject|1|||
131179784|NCT01763866|472278465|FG018|Overall Study|Withdrawal by Subject|1|||
131179785|NCT01763866|472278466|FG019|Overall Study|Withdrawal by Subject|1|||
131179786|NCT01763866|472278467|FG020|Overall Study|Withdrawal by Subject|2|||
131179787|NCT01763866|472278468|FG021|Overall Study|Withdrawal by Subject|1|||
131179788|NCT01763866|472278469|FG022|Overall Study|Withdrawal by Subject|2|||
131179789|NCT01763866|472278470|FG023|Overall Study|Withdrawal by Subject|1|||
131179790|NCT01763866|472278447|FG000|Overall Study|Decision by sponsor|0|||
131179791|NCT01763866|472278448|FG001|Overall Study|Decision by sponsor|0|||
131179792|NCT01763866|472278449|FG002|Overall Study|Decision by sponsor|1|||
131179793|NCT01763866|472278450|FG003|Overall Study|Decision by sponsor|0|||
131179794|NCT01763866|472278451|FG004|Overall Study|Decision by sponsor|2|||
131179795|NCT01763866|472278452|FG005|Overall Study|Decision by sponsor|0|||
131179796|NCT01763866|472278453|FG006|Overall Study|Decision by sponsor|2|||
131179797|NCT01763866|472278454|FG007|Overall Study|Decision by sponsor|0|||
131179798|NCT01763866|472278455|FG008|Overall Study|Decision by sponsor|2|||
131179799|NCT01763866|472278456|FG009|Overall Study|Decision by sponsor|0|||
131179800|NCT01763866|472278457|FG010|Overall Study|Decision by sponsor|6|||
131179801|NCT01763866|472278458|FG011|Overall Study|Decision by sponsor|0|||
131179802|NCT01763866|472278459|FG012|Overall Study|Decision by sponsor|1|||
131179803|NCT01763866|472278460|FG013|Overall Study|Decision by sponsor|0|||
131179804|NCT01763866|472278461|FG014|Overall Study|Decision by sponsor|5|||
131179805|NCT01763866|472278462|FG015|Overall Study|Decision by sponsor|0|||
131179806|NCT01763866|472278463|FG016|Overall Study|Decision by sponsor|0|||
131179807|NCT01763866|472278464|FG017|Overall Study|Decision by sponsor|0|||
131179808|NCT01763866|472278465|FG018|Overall Study|Decision by sponsor|4|||
131179809|NCT01763866|472278466|FG019|Overall Study|Decision by sponsor|0|||
131179810|NCT01763866|472278467|FG020|Overall Study|Decision by sponsor|2|||
131237857|NCT05400655|472500070|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131179811|NCT01763866|472278468|FG021|Overall Study|Decision by sponsor|0|||
131179812|NCT01763866|472278469|FG022|Overall Study|Decision by sponsor|1|||
131179813|NCT01763866|472278470|FG023|Overall Study|Decision by sponsor|0|||
131179814|NCT01763866|472278447|FG000|Overall Study|Lost to Follow-up|0|||
131237858|NCT05400655|472500071|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237859|NCT05400655|472500072|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237860|NCT05400655|472500073|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237861|NCT05400655|472500074|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237862|NCT05400655|472500075|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237863|NCT05400655|472500076|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237864|NCT05400655|472500077|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237865|NCT05400655|472500078|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237866|NCT05400655|472500079|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237867|NCT05400655|472500080|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237868|NCT05400655|472500081|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
131237869|NCT05400655|472500082|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
131237870|NCT05400655|472500083|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
131237871|NCT05400655|472500084|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
131237872|NCT05400655|472500085|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
131237873|NCT05400655|472500086|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
131237874|NCT05301751|472500087|FG000|Overall Study|Withdrawal by Subject|0|||
131237875|NCT05301751|472500088|FG001|Overall Study|Withdrawal by Subject|0|||
131179815|NCT01763866|472278448|FG001|Overall Study|Lost to Follow-up|0|||
131179816|NCT01763866|472278449|FG002|Overall Study|Lost to Follow-up|0|||
131179817|NCT01763866|472278450|FG003|Overall Study|Lost to Follow-up|0|||
131179818|NCT01763866|472278451|FG004|Overall Study|Lost to Follow-up|0|||
131179819|NCT01763866|472278452|FG005|Overall Study|Lost to Follow-up|0|||
131179820|NCT01763866|472278453|FG006|Overall Study|Lost to Follow-up|1|||
131179821|NCT01763866|472278454|FG007|Overall Study|Lost to Follow-up|0|||
131179822|NCT01763866|472278455|FG008|Overall Study|Lost to Follow-up|0|||
131179823|NCT01763866|472278456|FG009|Overall Study|Lost to Follow-up|0|||
131179824|NCT01763866|472278457|FG010|Overall Study|Lost to Follow-up|0|||
131179825|NCT01763866|472278458|FG011|Overall Study|Lost to Follow-up|0|||
131179826|NCT01763866|472278459|FG012|Overall Study|Lost to Follow-up|1|||
131179827|NCT01763866|472278460|FG013|Overall Study|Lost to Follow-up|0|||
131179828|NCT01763866|472278461|FG014|Overall Study|Lost to Follow-up|1|||
131179829|NCT01763866|472278462|FG015|Overall Study|Lost to Follow-up|0|||
131179830|NCT01763866|472278463|FG016|Overall Study|Lost to Follow-up|0|||
131179831|NCT01763866|472278464|FG017|Overall Study|Lost to Follow-up|0|||
131179832|NCT01763866|472278465|FG018|Overall Study|Lost to Follow-up|1|||
131179833|NCT01763866|472278466|FG019|Overall Study|Lost to Follow-up|1|||
131179834|NCT01763866|472278467|FG020|Overall Study|Lost to Follow-up|0|||
131179835|NCT01763866|472278468|FG021|Overall Study|Lost to Follow-up|0|||
131179836|NCT01763866|472278469|FG022|Overall Study|Lost to Follow-up|0|||
131179837|NCT01763866|472278470|FG023|Overall Study|Lost to Follow-up|1|||
131179838|NCT01763866|472278447|FG000|Overall Study|Death|0|||
131179839|NCT01763866|472278448|FG001|Overall Study|Death|0|||
131179840|NCT01763866|472278449|FG002|Overall Study|Death|0|||
131179841|NCT01763866|472278450|FG003|Overall Study|Death|0|||
131179842|NCT01763866|472278451|FG004|Overall Study|Death|0|||
131179843|NCT01763866|472278452|FG005|Overall Study|Death|0|||
131179844|NCT01763866|472278453|FG006|Overall Study|Death|0|||
131179845|NCT01763866|472278454|FG007|Overall Study|Death|0|||
131179846|NCT01763866|472278455|FG008|Overall Study|Death|0|||
131179847|NCT01763866|472278456|FG009|Overall Study|Death|0|||
131179848|NCT01763866|472278457|FG010|Overall Study|Death|0|||
131179849|NCT01763866|472278458|FG011|Overall Study|Death|0|||
131179850|NCT01763866|472278459|FG012|Overall Study|Death|0|||
131179851|NCT01763866|472278460|FG013|Overall Study|Death|0|||
131179852|NCT01763866|472278461|FG014|Overall Study|Death|0|||
131179853|NCT01763866|472278462|FG015|Overall Study|Death|0|||
131179854|NCT01763866|472278463|FG016|Overall Study|Death|1|||
131179855|NCT01763866|472278464|FG017|Overall Study|Death|0|||
130783778|NCT01255163|470836761|FG001|Overall Study|Adverse Event|2|||
130783779|NCT01255163|470836760|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
130783780|NCT01255163|470836761|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
130783781|NCT02495389|470836762|FG000|Overall Study|Withdrawal by Subject|40|||
130783782|NCT01802385|470836766|FG000|Overall Study|Death|106|||
130783783|NCT01802385|470836767|FG001|Overall Study|Death|120|||
130783784|NCT03834493|470836768|FG000|Overall Study|Participants Ongoing|311|||
130783785|NCT03834493|470836769|FG001|Overall Study|Participants Ongoing|324|||
130783786|NCT03834493|470836768|FG000|Overall Study|Withdrawal by Subject|20|||
130783787|NCT03834493|470836769|FG001|Overall Study|Withdrawal by Subject|17|||
130783788|NCT03834493|470836768|FG000|Overall Study|Physician Decision|1|||
130783789|NCT03834493|470836769|FG001|Overall Study|Physician Decision|0|||
130783790|NCT03834493|470836768|FG000|Overall Study|Death|289|||
130783791|NCT03834493|470836769|FG001|Overall Study|Death|282|||
130783792|NCT05559905|470836770|FG000|Overall Study|Withdrawal by Subject|1|||
131179856|NCT01763866|472278465|FG018|Overall Study|Death|0|||
131179857|NCT01763866|472278466|FG019|Overall Study|Death|0|||
131179858|NCT01763866|472278467|FG020|Overall Study|Death|0|||
131179859|NCT01763866|472278468|FG021|Overall Study|Death|0|||
130783793|NCT05559905|470836771|FG001|Overall Study|Withdrawal by Subject|0|||
130783794|NCT05559905|470836772|FG002|Overall Study|Withdrawal by Subject|0|||
130783795|NCT05559905|470836770|FG000|Overall Study|Not Reported|1|||
130783796|NCT05559905|470836771|FG001|Overall Study|Not Reported|0|||
130783797|NCT05559905|470836772|FG002|Overall Study|Not Reported|0|||
130783798|NCT04003103|470836773|FG000|Overall Study|Death|1|||
130783799|NCT04003103|470836774|FG001|Overall Study|Death|0|||
130783800|NCT04003103|470836775|FG002|Overall Study|Death|0|||
130783801|NCT04003103|470836773|FG000|Overall Study|Lost to Follow-up|4|||
130783802|NCT04003103|470836774|FG001|Overall Study|Lost to Follow-up|3|||
130783803|NCT04003103|470836775|FG002|Overall Study|Lost to Follow-up|2|||
130783804|NCT04003103|470836773|FG000|Overall Study|Withdrawal by Subject|10|||
130783805|NCT04003103|470836774|FG001|Overall Study|Withdrawal by Subject|1|||
130783806|NCT04003103|470836775|FG002|Overall Study|Withdrawal by Subject|1|||
130783807|NCT04003103|470836773|FG000|Overall Study|Status not recorded|0|||
130783808|NCT04003103|470836774|FG001|Overall Study|Status not recorded|2|||
130783809|NCT04003103|470836775|FG002|Overall Study|Status not recorded|0|||
130783810|NCT05002972|470836777|FG000|Overall Study|Withdrawal by Subject|2|||
130783811|NCT00983372|470836778|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
130783812|NCT00983372|470836778|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
130783813|NCT00983372|470836778|FG000|Diltiazem ER Alone|Adverse Event|1|||
130783814|NCT04613518|470836783|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
130783815|NCT04613518|470836784|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
130783816|NCT04613518|470836785|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
130783817|NCT04613518|470836783|FG000|Double-Blind Treatment Period|Adverse Event|2|||
130783818|NCT04613518|470836784|FG001|Double-Blind Treatment Period|Adverse Event|0|||
130783819|NCT04613518|470836785|FG002|Double-Blind Treatment Period|Adverse Event|1|||
130783820|NCT04613518|470836783|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
130783821|NCT04613518|470836784|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
130783822|NCT04613518|470836785|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
130783823|NCT04613518|470836783|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
130783824|NCT04613518|470836784|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
130783825|NCT04613518|470836785|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
130783826|NCT04613518|470836783|FG000|Double-Blind Treatment Period|Other Reasons|2|||
130783827|NCT04613518|470836784|FG001|Double-Blind Treatment Period|Other Reasons|0|||
130783828|NCT04613518|470836785|FG002|Double-Blind Treatment Period|Other Reasons|0|||
130783829|NCT04613518|470836783|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
130783830|NCT04613518|470836784|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
130783831|NCT04613518|470836785|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
131179860|NCT01763866|472278469|FG022|Overall Study|Death|0|||
131179861|NCT01763866|472278470|FG023|Overall Study|Death|0|||
131179862|NCT01669811|472278477|FG000|Overall Study|Investigator decision|0|||
131179863|NCT01669811|472278478|FG001|Overall Study|Investigator decision|1|||
131179864|NCT01669811|472278477|FG000|Overall Study|Withdrawal by Subject|1|||
131179865|NCT01669811|472278478|FG001|Overall Study|Withdrawal by Subject|2|||
131179866|NCT01669811|472278477|FG000|Overall Study|Adverse Event|2|||
131179867|NCT01669811|472278478|FG001|Overall Study|Adverse Event|6|||
131179868|NCT01669811|472278477|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131179869|NCT01669811|472278478|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
131179870|NCT03245723|472278484|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
131179871|NCT03245723|472278485|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
131179872|NCT03245723|472278484|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
131179873|NCT03245723|472278485|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
131179874|NCT03245723|472278484|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
131179875|NCT03245723|472278485|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
130783832|NCT04613518|470836783|FG000|Open-Label Treatment Period|Adverse Event|1|||
131179876|NCT03245723|472278484|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
131179877|NCT03245723|472278485|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
130783833|NCT04613518|470836784|FG001|Open-Label Treatment Period|Adverse Event|0|||
130783834|NCT04613518|470836785|FG002|Open-Label Treatment Period|Adverse Event|3|||
130783835|NCT04613518|470836783|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
130783836|NCT04613518|470836784|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
130783837|NCT04613518|470836785|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
130783838|NCT04613518|470836783|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
130783839|NCT04613518|470836784|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
131179878|NCT06025396|472280530|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
131179879|NCT06025396|472280531|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
131179880|NCT06025396|472280532|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
131179881|NCT06025396|472280533|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
131179882|NCT06025396|472280534|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
131179883|NCT06025396|472280530|FG000|Overall Study|Withdrawal by Subject|0|||
131179884|NCT06025396|472280531|FG001|Overall Study|Withdrawal by Subject|1|||
131179885|NCT06025396|472280532|FG002|Overall Study|Withdrawal by Subject|1|||
131179886|NCT06025396|472280533|FG003|Overall Study|Withdrawal by Subject|0|||
131179887|NCT06025396|472280534|FG004|Overall Study|Withdrawal by Subject|0|||
131179888|NCT00646113|472280535|FG000|Overall Study|Lost to Follow-up|5|||
130783840|NCT04613518|470836785|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
130783841|NCT04613518|470836783|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
130783842|NCT04613518|470836784|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
130783843|NCT04613518|470836785|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
130783844|NCT04613518|470836783|FG000|Open-Label Treatment Period|Other reasons|1|||
130783845|NCT04613518|470836784|FG001|Open-Label Treatment Period|Other reasons|0|||
131237876|NCT05301751|472500089|FG002|Overall Study|Withdrawal by Subject|1|||
131237877|NCT05301751|472500090|FG003|Overall Study|Withdrawal by Subject|0|||
131237878|NCT01364597|472500093|FG000|Overall Study|Adverse Event|4|||
131237879|NCT01364597|472500094|FG001|Overall Study|Adverse Event|5|||
131237880|NCT01364597|472500095|FG002|Overall Study|Adverse Event|16|||
131237881|NCT01364597|472500096|FG003|Overall Study|Adverse Event|7|||
131237882|NCT01364597|472500093|FG000|Overall Study|Lack of Efficacy|4|||
131237883|NCT01364597|472500094|FG001|Overall Study|Lack of Efficacy|4|||
131237884|NCT01364597|472500095|FG002|Overall Study|Lack of Efficacy|23|||
131237885|NCT01364597|472500096|FG003|Overall Study|Lack of Efficacy|8|||
131237886|NCT01364597|472500093|FG000|Overall Study|Protocol Violation|0|||
131237887|NCT01364597|472500094|FG001|Overall Study|Protocol Violation|0|||
131237888|NCT01364597|472500095|FG002|Overall Study|Protocol Violation|2|||
131237889|NCT01364597|472500096|FG003|Overall Study|Protocol Violation|0|||
131237890|NCT01364597|472500093|FG000|Overall Study|Lost to Follow-up|0|||
131237891|NCT01364597|472500094|FG001|Overall Study|Lost to Follow-up|0|||
131237892|NCT01364597|472500095|FG002|Overall Study|Lost to Follow-up|5|||
131237893|NCT01364597|472500096|FG003|Overall Study|Lost to Follow-up|3|||
131237894|NCT01364597|472500093|FG000|Overall Study|Withdrawal by Subject|4|||
131237895|NCT01364597|472500094|FG001|Overall Study|Withdrawal by Subject|1|||
131237896|NCT01364597|472500095|FG002|Overall Study|Withdrawal by Subject|18|||
131237897|NCT01364597|472500096|FG003|Overall Study|Withdrawal by Subject|6|||
131237898|NCT01364597|472500093|FG000|Overall Study|Non compliance|1|||
131237899|NCT01364597|472500094|FG001|Overall Study|Non compliance|0|||
131237900|NCT01364597|472500095|FG002|Overall Study|Non compliance|1|||
131237901|NCT01364597|472500096|FG003|Overall Study|Non compliance|0|||
131237902|NCT01364597|472500093|FG000|Overall Study|Lack of compliance|1|||
131237903|NCT01364597|472500094|FG001|Overall Study|Lack of compliance|0|||
131237904|NCT01364597|472500095|FG002|Overall Study|Lack of compliance|0|||
131237905|NCT01364597|472500096|FG003|Overall Study|Lack of compliance|0|||
131237906|NCT01364597|472500093|FG000|Overall Study|End of treatment epilepsy|1|||
131237907|NCT01364597|472500094|FG001|Overall Study|End of treatment epilepsy|0|||
131237908|NCT01364597|472500095|FG002|Overall Study|End of treatment epilepsy|0|||
131237909|NCT01364597|472500096|FG003|Overall Study|End of treatment epilepsy|0|||
131237910|NCT01364597|472500093|FG000|Overall Study|No Seizures|1|||
131237911|NCT01364597|472500094|FG001|Overall Study|No Seizures|0|||
131237912|NCT01364597|472500095|FG002|Overall Study|No Seizures|0|||
130783846|NCT04613518|470836785|FG002|Open-Label Treatment Period|Other reasons|0|||
130783847|NCT01619865|470836786|FG000|Overall Study|Adverse Event|1|||
130783848|NCT01619865|470836786|FG000|Overall Study|Death|2|||
131179889|NCT00646113|472280535|FG000|Overall Study|Adverse Event|3|||
131179890|NCT02109744|472280536|FG000|Overall Study|Death|1|||
131179891|NCT02109744|472280537|FG001|Overall Study|Death|1|||
131179892|NCT02109744|472280536|FG000|Overall Study|no marrow exam|1|||
131179893|NCT02109744|472280537|FG001|Overall Study|no marrow exam|0|||
131179894|NCT04095442|472280538|FG000|Overall Study|Lost to Follow-up|0|||
131179895|NCT04095442|472280539|FG001|Overall Study|Lost to Follow-up|1|||
131179896|NCT04095442|472280538|FG000|Overall Study|Screen failure|1|||
131179897|NCT04095442|472280539|FG001|Overall Study|Screen failure|0|||
131179898|NCT00603733|472280546|FG000|Active Phase ITT|Adverse Event|8|||
131179899|NCT00603733|472280547|FG001|Active Phase ITT|Adverse Event|7|||
131179900|NCT00603733|472280546|FG000|Active Phase ITT|Withdrawal by Subject|0|||
131179901|NCT00603733|472280547|FG001|Active Phase ITT|Withdrawal by Subject|3|||
131179902|NCT00603733|472280546|FG000|Active Phase ITT|Lost to Follow-up|0|||
131179903|NCT00603733|472280547|FG001|Active Phase ITT|Lost to Follow-up|1|||
131179904|NCT00603733|472280546|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
131179905|NCT00603733|472280547|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
131179906|NCT00603733|472280546|FG000|Active Phase ITT|Lack of Efficacy|1|||
131179907|NCT00603733|472280547|FG001|Active Phase ITT|Lack of Efficacy|2|||
131237913|NCT01364597|472500096|FG003|Overall Study|No Seizures|0|||
131237914|NCT01364597|472500093|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
131237915|NCT01364597|472500094|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
131237916|NCT01364597|472500095|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
131237917|NCT01364597|472500096|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
131237918|NCT01364597|472500093|FG000|Overall Study|Cure|1|||
131237919|NCT01364597|472500094|FG001|Overall Study|Cure|0|||
131237920|NCT01364597|472500095|FG002|Overall Study|Cure|0|||
131179908|NCT00603733|472280546|FG000|Active Phase ITT|Subject moved, site closed|1|||
131179909|NCT00603733|472280547|FG001|Active Phase ITT|Subject moved, site closed|1|||
131179910|NCT00603733|472280546|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
131179911|NCT00603733|472280547|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
131179912|NCT00603733|472280546|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
131179913|NCT00603733|472280547|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
131179914|NCT00603733|472280546|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
131179915|NCT00603733|472280547|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
131179916|NCT00603733|472280546|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
131179917|NCT00603733|472280547|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
131179918|NCT00603733|472280546|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
131179919|NCT00603733|472280547|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
131179920|NCT00603733|472280546|FG000|Maintenance Phase ITT|Adverse Event|3|||
131179921|NCT00603733|472280547|FG001|Maintenance Phase ITT|Adverse Event|6|||
131179922|NCT00603733|472280546|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
131179923|NCT00603733|472280547|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
131179924|NCT00603733|472280546|FG000|Maintenance Phase ITT|Protocol Violation|1|||
131179925|NCT00603733|472280547|FG001|Maintenance Phase ITT|Protocol Violation|1|||
131179926|NCT00603733|472280546|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
131179927|NCT00603733|472280547|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
131179928|NCT00603733|472280546|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
131179929|NCT00603733|472280547|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
131179930|NCT00603733|472280546|FG000|Maintenance Phase ITT|Physician Decision|0|||
131179931|NCT00603733|472280547|FG001|Maintenance Phase ITT|Physician Decision|1|||
131179932|NCT00603733|472280546|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
131179933|NCT00603733|472280547|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
131179934|NCT01297309|472280550|FG000|Overall Study|Eligibility failure|2|||
131179935|NCT01297309|472280550|FG000|Overall Study|Screen failure|2|||
131179936|NCT01297309|472280550|FG000|Overall Study|Withdrawal by Subject|5|||
131179937|NCT01297309|472280550|FG000|Overall Study|Adverse Event|1|||
131179938|NCT01297309|472280550|FG000|Overall Study|Investigator Decision|2|||
131179939|NCT01297309|472280550|FG000|Overall Study|Death|1|||
131179940|NCT01297309|472280550|FG000|Overall Study|Participant not entering extensionperiod|1|||
131179941|NCT02759562|472280551|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
131179942|NCT02759562|472280552|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
131179943|NCT02759562|472280551|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
131179944|NCT02759562|472280552|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
131179945|NCT04624672|472280555|FG000|Overall Study|Early Study Closure|2|||
131179946|NCT04624672|472280556|FG001|Overall Study|Early Study Closure|1|||
131179947|NCT03472040|472280557|FG000|Overall Study|Physician Decision|0|||
131179948|NCT03472040|472280558|FG001|Overall Study|Physician Decision|3|||
131179949|NCT03472040|472280557|FG000|Overall Study|Withdrawal by Subject|10|||
131179950|NCT03472040|472280558|FG001|Overall Study|Withdrawal by Subject|23|||
131179951|NCT03472040|472280557|FG000|Overall Study|Perceived Lack of Efficacy|29|||
131179952|NCT03472040|472280558|FG001|Overall Study|Perceived Lack of Efficacy|30|||
131179953|NCT03472040|472280557|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
131179954|NCT03472040|472280558|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
131179955|NCT03472040|472280557|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
131179956|NCT03472040|472280558|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
131179957|NCT03472040|472280557|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
131179958|NCT03472040|472280558|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
131179959|NCT03472040|472280557|FG000|Overall Study|Subject Non-compliance|2|||
131179960|NCT03472040|472280558|FG001|Overall Study|Subject Non-compliance|5|||
131179961|NCT03472040|472280557|FG000|Overall Study|Discontinuation due to Rash|0|||
131179962|NCT03472040|472280558|FG001|Overall Study|Discontinuation due to Rash|1|||
131179963|NCT03472040|472280557|FG000|Overall Study|Subsequent Ineligibility|0|||
131179964|NCT03472040|472280558|FG001|Overall Study|Subsequent Ineligibility|2|||
131179965|NCT03472040|472280557|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
131179966|NCT03472040|472280558|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
131179967|NCT02769832|472280559|FG000|Overall Study|Death|30|||
131179968|NCT02685995|472280568|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
131179969|NCT02685995|472280569|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
131179970|NCT03625141|472280570|FG000|Overall Study|Adverse Event|0|||
131179971|NCT03625141|472280571|FG001|Overall Study|Adverse Event|2|||
131179972|NCT03625141|472280570|FG000|Overall Study|Study Terminated By Sponsor|1|||
131179973|NCT03625141|472280571|FG001|Overall Study|Study Terminated By Sponsor|13|||
131179974|NCT03625141|472280570|FG000|Overall Study|Withdrawal by Subject|3|||
131179975|NCT03625141|472280571|FG001|Overall Study|Withdrawal by Subject|0|||
131179976|NCT03625141|472280570|FG000|Overall Study|Withdrawal Of Consent|0|||
131179977|NCT03625141|472280571|FG001|Overall Study|Withdrawal Of Consent|1|||
131179978|NCT03625141|472280570|FG000|Overall Study|Death|11|||
131179979|NCT03625141|472280571|FG001|Overall Study|Death|47|||
131179980|NCT03625141|472280570|FG000|Overall Study|Progressive Disease|0|||
131179981|NCT03625141|472280571|FG001|Overall Study|Progressive Disease|2|||
131179982|NCT03819218|472280572|FG000|Overall Study|Protocol Violation|1|||
131179983|NCT00433446|472280573|FG000|Overall Study|Adverse Event|4|||
131179984|NCT00433446|472280573|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
131179985|NCT00433446|472280573|FG000|Overall Study|Progression|44|||
131179986|NCT00433446|472280573|FG000|Overall Study|Other - Not Protocol specified|3|||
131179987|NCT00433446|472280573|FG000|Overall Study|Ineligible|9|||
131179988|NCT02501902|472280574|FG000|Overall Study|Subject Refused Further Follow-up|0|||
131237921|NCT01364597|472500096|FG003|Overall Study|Cure|0|||
131237922|NCT01364597|472500093|FG000|Overall Study|Patient was moving|0|||
131237923|NCT01364597|472500094|FG001|Overall Study|Patient was moving|1|||
131237924|NCT01364597|472500095|FG002|Overall Study|Patient was moving|0|||
131237925|NCT01364597|472500096|FG003|Overall Study|Patient was moving|0|||
131237926|NCT01364597|472500093|FG000|Overall Study|Seizures resolved|0|||
131237927|NCT01364597|472500094|FG001|Overall Study|Seizures resolved|0|||
131237928|NCT01364597|472500095|FG002|Overall Study|Seizures resolved|1|||
131237929|NCT01364597|472500096|FG003|Overall Study|Seizures resolved|0|||
131237930|NCT01364597|472500093|FG000|Overall Study|Patient became seizure-free after surgery|0|||
131237931|NCT01364597|472500094|FG001|Overall Study|Patient became seizure-free after surgery|0|||
131237932|NCT01364597|472500095|FG002|Overall Study|Patient became seizure-free after surgery|1|||
131237933|NCT01364597|472500096|FG003|Overall Study|Patient became seizure-free after surgery|0|||
131237934|NCT01364597|472500093|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
131237935|NCT01364597|472500094|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
131237936|NCT01364597|472500095|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
131237937|NCT01364597|472500096|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
131237938|NCT01364597|472500093|FG000|Overall Study|Patient cured from Epilepsy|0|||
131237939|NCT01364597|472500094|FG001|Overall Study|Patient cured from Epilepsy|0|||
131237940|NCT01364597|472500095|FG002|Overall Study|Patient cured from Epilepsy|1|||
131237941|NCT01364597|472500096|FG003|Overall Study|Patient cured from Epilepsy|0|||
131237942|NCT01364597|472500093|FG000|Overall Study|Investigator decision|0|||
131237943|NCT01364597|472500094|FG001|Overall Study|Investigator decision|0|||
131237944|NCT01364597|472500095|FG002|Overall Study|Investigator decision|1|||
131237945|NCT01364597|472500096|FG003|Overall Study|Investigator decision|0|||
131237946|NCT01364597|472500093|FG000|Overall Study|Sponsor recommended discontinuation|0|||
131237947|NCT01364597|472500094|FG001|Overall Study|Sponsor recommended discontinuation|0|||
131237948|NCT01364597|472500095|FG002|Overall Study|Sponsor recommended discontinuation|0|||
131237949|NCT01364597|472500096|FG003|Overall Study|Sponsor recommended discontinuation|1|||
131237950|NCT01364597|472500093|FG000|Overall Study|Parents went abroad with the patient|0|||
131237951|NCT01364597|472500094|FG001|Overall Study|Parents went abroad with the patient|0|||
131237952|NCT01364597|472500095|FG002|Overall Study|Parents went abroad with the patient|1|||
131237953|NCT01364597|472500096|FG003|Overall Study|Parents went abroad with the patient|0|||
131237954|NCT01364597|472500093|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
131237955|NCT01364597|472500094|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
131237956|NCT01364597|472500095|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
131237957|NCT01364597|472500096|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
131237958|NCT01364597|472500093|FG000|Overall Study|BRV administration dropout|0|||
131237959|NCT01364597|472500094|FG001|Overall Study|BRV administration dropout|0|||
131237960|NCT01364597|472500095|FG002|Overall Study|BRV administration dropout|1|||
131237961|NCT01364597|472500096|FG003|Overall Study|BRV administration dropout|0|||
131237962|NCT01364597|472500093|FG000|Overall Study|Dropout|0|||
131237963|NCT01364597|472500094|FG001|Overall Study|Dropout|0|||
131237964|NCT01364597|472500095|FG002|Overall Study|Dropout|3|||
131237965|NCT01364597|472500096|FG003|Overall Study|Dropout|1|||
131237966|NCT01364597|472500093|FG000|Overall Study|Unreliable subject|0|||
131237967|NCT01364597|472500094|FG001|Overall Study|Unreliable subject|0|||
131237968|NCT01364597|472500095|FG002|Overall Study|Unreliable subject|0|||
131237969|NCT01364597|472500096|FG003|Overall Study|Unreliable subject|1|||
131237970|NCT01364597|472500093|FG000|Overall Study|Other|0|||
131237971|NCT01364597|472500094|FG001|Overall Study|Other|0|||
131237972|NCT01364597|472500095|FG002|Overall Study|Other|0|||
131237973|NCT01364597|472500096|FG003|Overall Study|Other|1|||
131237974|NCT04424927|472500097|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
131237975|NCT04424927|472500098|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
131237976|NCT04424927|472500099|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
130783849|NCT01619865|470836786|FG000|Overall Study|subject not able to comply|1|||
131237977|NCT04424927|472500100|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
131237978|NCT04424927|472500101|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
131237979|NCT04424927|472500097|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
131237980|NCT04424927|472500098|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
131237981|NCT04424927|472500099|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
131179989|NCT02501902|472280575|FG001|Overall Study|Subject Refused Further Follow-up|0|||
131179990|NCT02501902|472280576|FG002|Overall Study|Subject Refused Further Follow-up|0|||
131179991|NCT02501902|472280577|FG003|Overall Study|Subject Refused Further Follow-up|0|||
131237982|NCT04424927|472500100|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
131237983|NCT04424927|472500101|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
131237984|NCT04424927|472500097|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
131237985|NCT04424927|472500098|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
131237986|NCT04424927|472500099|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
131237987|NCT04424927|472500100|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
131237988|NCT04424927|472500101|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
131237989|NCT04424927|472500097|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
131237990|NCT04424927|472500098|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
131237991|NCT04424927|472500099|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
131237992|NCT04424927|472500100|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
131237993|NCT04424927|472500101|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
131237994|NCT04424927|472500097|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
131237995|NCT04424927|472500098|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
131237996|NCT04424927|472500099|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
131237997|NCT04424927|472500100|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
131237998|NCT04424927|472500101|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
131237999|NCT04424927|472500097|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
131238000|NCT04424927|472500098|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
131238001|NCT04424927|472500099|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
131238002|NCT04424927|472500100|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
131238003|NCT04424927|472500101|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
131238004|NCT04424927|472500097|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
131238005|NCT04424927|472500098|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
131238006|NCT04424927|472500099|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
131238007|NCT04424927|472500100|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
131238008|NCT04424927|472500101|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
131238009|NCT04424927|472500097|FG000|Double-blind Period (24 Weeks)|Other|0|||
131238010|NCT04424927|472500098|FG001|Double-blind Period (24 Weeks)|Other|1|||
131238011|NCT04424927|472500099|FG002|Double-blind Period (24 Weeks)|Other|3|||
131238012|NCT04424927|472500100|FG003|Double-blind Period (24 Weeks)|Other|1|||
131238013|NCT04424927|472500101|FG004|Double-blind Period (24 Weeks)|Other|0|||
131238014|NCT03771898|472500102|FG000|Overall Study|Adverse Event|1|||
131238015|NCT03771898|472500103|FG001|Overall Study|Adverse Event|0|||
131238016|NCT03771898|472500104|FG002|Overall Study|Adverse Event|0|||
131238017|NCT03771898|472500105|FG003|Overall Study|Adverse Event|0|||
131238018|NCT03771898|472500106|FG004|Overall Study|Adverse Event|0|||
131238019|NCT03771898|472500102|FG000|Overall Study|Lost to Follow-up|1|||
131238020|NCT03771898|472500103|FG001|Overall Study|Lost to Follow-up|1|||
131238021|NCT03771898|472500104|FG002|Overall Study|Lost to Follow-up|1|||
131238022|NCT03771898|472500105|FG003|Overall Study|Lost to Follow-up|0|||
131238023|NCT03771898|472500106|FG004|Overall Study|Lost to Follow-up|0|||
131238024|NCT03771898|472500102|FG000|Overall Study|Withdrawal by parent/guardian|1|||
131238025|NCT03771898|472500103|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131238026|NCT03771898|472500104|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131238027|NCT03771898|472500105|FG003|Overall Study|Withdrawal by parent/guardian|0|||
131238028|NCT03771898|472500106|FG004|Overall Study|Withdrawal by parent/guardian|0|||
131238029|NCT03771898|472500102|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
131238030|NCT03771898|472500103|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
131238031|NCT03771898|472500104|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
131238032|NCT03771898|472500105|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
131238033|NCT03771898|472500106|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
131238034|NCT01546987|472500107|FG000|Overall Study|Protocol Violation|3|||
131238035|NCT01546987|472500108|FG001|Overall Study|Protocol Violation|4|||
131238036|NCT03263936|472500109|FG000|Overall Study|Adverse Event|0|||
131238037|NCT03263936|472500110|FG001|Overall Study|Adverse Event|1|||
131238038|NCT03263936|472500111|FG002|Overall Study|Adverse Event|0|||
130733271|NCT01496976|470642885|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
130733272|NCT05938621|470642886|FG000|Overall Study|Lost to Follow-up|1|||
130733273|NCT05938621|470642887|FG001|Overall Study|Lost to Follow-up|5|||
130733274|NCT05938621|470642888|FG002|Overall Study|Lost to Follow-up|2|||
130733275|NCT05938621|470642889|FG003|Overall Study|Lost to Follow-up|2|||
130733276|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
130733277|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
131238039|NCT03263936|472500109|FG000|Overall Study|Death|0|||
131238040|NCT03263936|472500110|FG001|Overall Study|Death|1|||
131238041|NCT03263936|472500111|FG002|Overall Study|Death|0|||
131238042|NCT04083976|472500112|FG000|Overall Study|Lost to Follow-up|3|||
130733278|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
130733279|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
131179992|NCT02501902|472280578|FG004|Overall Study|Subject Refused Further Follow-up|0|||
131179993|NCT02501902|472280579|FG005|Overall Study|Subject Refused Further Follow-up|0|||
131179994|NCT02501902|472280580|FG006|Overall Study|Subject Refused Further Follow-up|0|||
131179995|NCT02501902|472280581|FG007|Overall Study|Subject Refused Further Follow-up|1|||
131179996|NCT02501902|472280574|FG000|Overall Study|Study Terminated by Sponsor|0|||
131179997|NCT02501902|472280575|FG001|Overall Study|Study Terminated by Sponsor|3|||
131179998|NCT02501902|472280576|FG002|Overall Study|Study Terminated by Sponsor|0|||
131179999|NCT02501902|472280577|FG003|Overall Study|Study Terminated by Sponsor|1|||
131180000|NCT02501902|472280578|FG004|Overall Study|Study Terminated by Sponsor|1|||
131180001|NCT02501902|472280579|FG005|Overall Study|Study Terminated by Sponsor|0|||
131180002|NCT02501902|472280580|FG006|Overall Study|Study Terminated by Sponsor|2|||
131180003|NCT02501902|472280581|FG007|Overall Study|Study Terminated by Sponsor|4|||
131180004|NCT02501902|472280574|FG000|Overall Study|Death|3|||
131180005|NCT02501902|472280575|FG001|Overall Study|Death|4|||
131180006|NCT02501902|472280576|FG002|Overall Study|Death|4|||
131180007|NCT02501902|472280577|FG003|Overall Study|Death|10|||
131180008|NCT02501902|472280578|FG004|Overall Study|Death|10|||
131180009|NCT02501902|472280579|FG005|Overall Study|Death|11|||
131180010|NCT02501902|472280580|FG006|Overall Study|Death|7|||
131180011|NCT02501902|472280581|FG007|Overall Study|Death|15|||
131180012|NCT02513771|472280582|FG000|Overall Study|Lost to Follow-up|1|||
131180013|NCT02513771|472280583|FG001|Overall Study|Lost to Follow-up|1|||
131180014|NCT02513771|472280582|FG000|Overall Study|Not being able to get to clinic|1|||
131180015|NCT02513771|472280583|FG001|Overall Study|Not being able to get to clinic|0|||
131180016|NCT01797445|472280584|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
131180017|NCT01797445|472280585|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
131180018|NCT01797445|472280584|FG000|Double-Blind Phase|Adverse Event|3|||
131180019|NCT01797445|472280585|FG001|Double-Blind Phase|Adverse Event|0|||
131180020|NCT01797445|472280584|FG000|Double-Blind Phase|Death|5|||
131180021|NCT01797445|472280585|FG001|Double-Blind Phase|Death|4|||
131180022|NCT01797445|472280584|FG000|Double-Blind Phase|Pregnancy|0|||
131180023|NCT01797445|472280585|FG001|Double-Blind Phase|Pregnancy|1|||
131180024|NCT01797445|472280584|FG000|Double-Blind Phase|Lack of Efficacy|1|||
131180025|NCT01797445|472280585|FG001|Double-Blind Phase|Lack of Efficacy|2|||
131180026|NCT01797445|472280584|FG000|Double-Blind Phase|Investigator's Discretion|15|||
131180027|NCT01797445|472280585|FG001|Double-Blind Phase|Investigator's Discretion|17|||
131180028|NCT01797445|472280584|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
131180029|NCT01797445|472280585|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
131180030|NCT01797445|472280584|FG000|Double-Blind Phase|Protocol Violation|0|||
131180031|NCT01797445|472280585|FG001|Double-Blind Phase|Protocol Violation|1|||
131180032|NCT01797445|472280584|FG000|Double-Blind Phase|Withdrew Consent|20|||
131180033|NCT01797445|472280585|FG001|Double-Blind Phase|Withdrew Consent|35|||
131180034|NCT01797445|472280584|FG000|Double-Blind Phase|Lost to Follow-up|34|||
131180035|NCT01797445|472280585|FG001|Double-Blind Phase|Lost to Follow-up|26|||
131180036|NCT01797445|472280584|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
131180037|NCT01797445|472280585|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
131180038|NCT01595438|472280586|FG000|Overall Study|Lost to Follow-up|20|||
131180039|NCT01595438|472280587|FG001|Overall Study|Lost to Follow-up|20|||
131180040|NCT01595438|472280586|FG000|Overall Study|Withdrawal by Subject|12|||
131180041|NCT01595438|472280587|FG001|Overall Study|Withdrawal by Subject|12|||
131180042|NCT01595438|472280586|FG000|Overall Study|Other Eligibility criteria|11|||
131180043|NCT01595438|472280587|FG001|Overall Study|Other Eligibility criteria|9|||
131180044|NCT00650091|472280588|FG000|Amended Study Design|Withdrawal by Subject|12|||
131180045|NCT00650091|472280589|FG001|Amended Study Design|Withdrawal by Subject|11|||
131180046|NCT00650091|472280590|FG002|Amended Study Design|Withdrawal by Subject|0|||
131180047|NCT00650091|472280588|FG000|Amended Study Design|Physician Decision|5|||
131180048|NCT00650091|472280589|FG001|Amended Study Design|Physician Decision|0|||
131180049|NCT00650091|472280590|FG002|Amended Study Design|Physician Decision|0|||
131180050|NCT00650091|472280588|FG000|Amended Study Design|Adverse Event|1|||
131180051|NCT00650091|472280589|FG001|Amended Study Design|Adverse Event|4|||
131180052|NCT00650091|472280590|FG002|Amended Study Design|Adverse Event|0|||
131180053|NCT00650091|472280588|FG000|Amended Study Design|Lung transplantation|4|||
131180054|NCT00650091|472280589|FG001|Amended Study Design|Lung transplantation|2|||
131180055|NCT00650091|472280590|FG002|Amended Study Design|Lung transplantation|0|||
131180056|NCT00650091|472280588|FG000|Amended Study Design|Other|1|||
131180057|NCT00650091|472280589|FG001|Amended Study Design|Other|3|||
130733280|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
130733281|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
130733282|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
131180058|NCT00650091|472280590|FG002|Amended Study Design|Other|0|||
131180059|NCT04116073|472280599|FG000|Overall Study|Withdrawal by Subject|2|||
131180060|NCT04116073|472280599|FG000|Overall Study|failed to maintained eligibility|1|||
131180061|NCT01429077|472280604|FG000|Overall Study|Lost to Follow-up|0|||
131180062|NCT01429077|472280605|FG001|Overall Study|Lost to Follow-up|3|||
131180063|NCT03067129|472280606|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
131238043|NCT04083976|472500113|FG001|Overall Study|Lost to Follow-up|0|||
131238044|NCT04083976|472500114|FG002|Overall Study|Lost to Follow-up|0|||
131238045|NCT04083976|472500115|FG003|Overall Study|Lost to Follow-up|1|||
131238046|NCT04083976|472500112|FG000|Overall Study|Withdrawal by Subject|16|||
131238047|NCT04083976|472500113|FG001|Overall Study|Withdrawal by Subject|1|||
131238048|NCT04083976|472500114|FG002|Overall Study|Withdrawal by Subject|9|||
131238049|NCT04083976|472500115|FG003|Overall Study|Withdrawal by Subject|0|||
131238050|NCT04083976|472500112|FG000|Overall Study|Sponsor Decision|14|||
131238051|NCT04083976|472500113|FG001|Overall Study|Sponsor Decision|0|||
131238052|NCT04083976|472500114|FG002|Overall Study|Sponsor Decision|0|||
131238053|NCT04083976|472500115|FG003|Overall Study|Sponsor Decision|7|||
131238054|NCT04083976|472500112|FG000|Overall Study|Other|1|||
131238055|NCT04083976|472500113|FG001|Overall Study|Other|0|||
131238056|NCT04083976|472500114|FG002|Overall Study|Other|1|||
131238057|NCT04083976|472500115|FG003|Overall Study|Other|0|||
131238058|NCT02710123|472500116|FG000|Overall Study|Lost to Follow-up|3|||
131238059|NCT02710123|472500117|FG001|Overall Study|Lost to Follow-up|4|||
131238060|NCT02710123|472500116|FG000|Overall Study|Withdrawal by Subject|1|||
131238061|NCT02710123|472500117|FG001|Overall Study|Withdrawal by Subject|1|||
131238062|NCT02710123|472500116|FG000|Overall Study|Illness unrelated to study intervention|1|||
131238063|NCT02710123|472500117|FG001|Overall Study|Illness unrelated to study intervention|0|||
131238064|NCT05381948|472500118|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
131238065|NCT05381948|472500119|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
131238066|NCT05381948|472500120|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
131238067|NCT05381948|472500118|FG000|Overall Study|Adverse Event: Non-ocular|0|||
131238068|NCT05381948|472500119|FG001|Overall Study|Adverse Event: Non-ocular|1|||
131238069|NCT05381948|472500120|FG002|Overall Study|Adverse Event: Non-ocular|0|||
131238070|NCT05381948|472500118|FG000|Overall Study|Lost to Follow-up|1|||
131238071|NCT05381948|472500119|FG001|Overall Study|Lost to Follow-up|0|||
131238072|NCT05381948|472500120|FG002|Overall Study|Lost to Follow-up|0|||
131238073|NCT05381948|472500118|FG000|Overall Study|Protocol Deviation|0|||
131238074|NCT05381948|472500119|FG001|Overall Study|Protocol Deviation|2|||
131238075|NCT05381948|472500120|FG002|Overall Study|Protocol Deviation|0|||
131238076|NCT05381948|472500118|FG000|Overall Study|Withdrawal by Subject|1|||
131238077|NCT05381948|472500119|FG001|Overall Study|Withdrawal by Subject|0|||
131238078|NCT05381948|472500120|FG002|Overall Study|Withdrawal by Subject|1|||
131238079|NCT05381948|472500118|FG000|Overall Study|Death|0|||
131238080|NCT05381948|472500119|FG001|Overall Study|Death|2|||
131238081|NCT05381948|472500120|FG002|Overall Study|Death|0|||
131238082|NCT05381948|472500118|FG000|Overall Study|Discontinued study without receiving study drug|0|||
131238083|NCT05381948|472500119|FG001|Overall Study|Discontinued study without receiving study drug|0|||
131180064|NCT03067129|472280607|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
131180065|NCT03067129|472280608|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
131180066|NCT03067129|472280609|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
131180067|NCT03067129|472280606|FG000|Overall Study|Withdrawal by Subject|0|||
131180068|NCT03067129|472280607|FG001|Overall Study|Withdrawal by Subject|0|||
131180069|NCT03067129|472280608|FG002|Overall Study|Withdrawal by Subject|1|||
131180070|NCT03067129|472280609|FG003|Overall Study|Withdrawal by Subject|2|||
131180071|NCT03067129|472280606|FG000|Overall Study|Lost to Follow-up|5|||
131180072|NCT03067129|472280607|FG001|Overall Study|Lost to Follow-up|5|||
131180073|NCT03067129|472280608|FG002|Overall Study|Lost to Follow-up|4|||
131180074|NCT03067129|472280609|FG003|Overall Study|Lost to Follow-up|3|||
131180075|NCT02806947|472280610|FG000|Overall Study|Withdrawal by Subject|5|||
131180076|NCT02806947|472280611|FG001|Overall Study|Withdrawal by Subject|1|||
131180077|NCT02029638|472280613|FG000|Overall Study|Death|0|||
131180078|NCT02029638|472280614|FG001|Overall Study|Death|0|||
131180079|NCT02029638|472280615|FG002|Overall Study|Death|1|||
131180080|NCT02029638|472280613|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
131180081|NCT02029638|472280614|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
131180082|NCT02029638|472280615|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
131180083|NCT02563925|472280616|FG000|Overall Study|Withdrawal by Subject|2|||
131180084|NCT00400712|472280617|FG000|Overall Study|Death|1|||
131180085|NCT00400712|472280618|FG001|Overall Study|Death|0|||
131180086|NCT00400712|472280617|FG000|Overall Study|Withdrawal by Subject|11|||
131180087|NCT00400712|472280618|FG001|Overall Study|Withdrawal by Subject|12|||
131180088|NCT00400712|472280617|FG000|Overall Study|Physician Decision|5|||
131238084|NCT05381948|472500120|FG002|Overall Study|Discontinued study without receiving study drug|1|||
131238085|NCT03690219|472500123|FG000|Overall Study|no injuries|9|||
131238086|NCT03690219|472500124|FG001|Overall Study|no injuries|20|||
131238087|NCT03690219|472500123|FG000|Overall Study|missing information|7|||
131238088|NCT03690219|472500124|FG001|Overall Study|missing information|7|||
131238089|NCT05343000|472500125|FG000|Overall Study|Physician Decision|2|||
131238090|NCT04791709|472500126|FG000|Overall Study|Withdrawal by Subject|3|||
131238091|NCT01696773|472500131|FG000|Days 15-27, Washout|Adverse Event|1|||
131180089|NCT00400712|472280618|FG001|Overall Study|Physician Decision|4|||
131180090|NCT04685499|472280621|FG000|Overall Study|Study Terminated Early|1|||
131180091|NCT01996904|472280622|FG000|Overall Study|Lost to Follow-up|38|||
131238092|NCT01696773|472500132|FG001|Days 15-27, Washout|Adverse Event|0|||
131180092|NCT01996904|472280623|FG001|Overall Study|Lost to Follow-up|27|||
131180093|NCT04664855|472280624|FG000|Overall Study|Withdrawal by Subject|0|||
131180094|NCT04664855|472280625|FG001|Overall Study|Withdrawal by Subject|2|||
131180095|NCT05127421|472280626|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
131180096|NCT05127421|472280627|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
131180097|NCT05127421|472280628|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
131180098|NCT05127421|472280629|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
131180099|NCT05127421|472280626|FG000|4-Week Double-Blind Period|Physician Decision|1|||
131180100|NCT05127421|472280627|FG001|4-Week Double-Blind Period|Physician Decision|0|||
131180101|NCT05127421|472280628|FG002|4-Week Double-Blind Period|Physician Decision|0|||
131180102|NCT05127421|472280629|FG003|4-Week Double-Blind Period|Physician Decision|0|||
131180103|NCT05127421|472280626|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
131180104|NCT05127421|472280627|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
131180105|NCT05127421|472280628|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
131180106|NCT05127421|472280629|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
131180107|NCT05127421|472280626|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
131180108|NCT05127421|472280627|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
131180109|NCT05127421|472280628|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
131180110|NCT05127421|472280629|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
131238093|NCT02386553|472500133|FG000|Overall Study|Reason Not Specified|1|||
131180111|NCT05127421|472280626|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
131180112|NCT05127421|472280627|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
131180113|NCT05127421|472280628|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
131180114|NCT05127421|472280629|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
131180115|NCT05127421|472280626|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
131238094|NCT02386553|472500134|FG001|Overall Study|Reason Not Specified|1|||
131238095|NCT02386553|472500133|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
131238096|NCT02386553|472500134|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
130733283|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
130733284|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
131180116|NCT05127421|472280627|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
131180117|NCT05127421|472280628|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
131180118|NCT05127421|472280629|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
131180119|NCT05127421|472280626|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
131180120|NCT05127421|472280627|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
131238097|NCT04649359|472500135|FG000|Overall Study|Withdrawal by Subject|7|||
130733285|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
130733286|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
130733287|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
130733288|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130733289|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130733290|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130733291|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
130733292|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130733293|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130733294|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
130733295|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
130733296|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
130733297|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130733298|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130733299|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130733300|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130733301|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130733302|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130733303|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
130733304|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
130733305|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
130733306|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130733307|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130733308|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130733309|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130733310|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130733311|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130783850|NCT01494818|470836787|FG000|Overall Study|Relocation|1|||
131180121|NCT05127421|472280628|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
131180122|NCT05127421|472280629|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
131180123|NCT05127421|472280626|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
131180124|NCT05127421|472280627|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
130783851|NCT01494818|470836788|FG001|Overall Study|Relocation|2|||
131180125|NCT05127421|472280628|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
131180126|NCT05127421|472280629|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
131180127|NCT02219087|472280630|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
131180128|NCT02219087|472280631|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
131180129|NCT00574496|472280632|FG000|Overall Study|Withdrawal by Subject|1|||
131180130|NCT03543358|472280633|FG000|Overall Study|Death|1|||
131180131|NCT03543358|472280634|FG001|Overall Study|Death|0|||
131180132|NCT03543358|472280633|FG000|Overall Study|Disease Progression|1|||
131180133|NCT03543358|472280634|FG001|Overall Study|Disease Progression|0|||
131180134|NCT03543358|472280633|FG000|Overall Study|Parent Study Closure|1|||
131180135|NCT03543358|472280634|FG001|Overall Study|Parent Study Closure|0|||
131180136|NCT01518244|472280635|FG000|Overall Study|Adverse Event|3|||
131180137|NCT01766817|472280636|FG000|Overall Study|Drug-related adverse event|1|||
131180138|NCT01766817|472280637|FG001|Overall Study|Drug-related adverse event|2|||
131180139|NCT01766817|472280638|FG002|Overall Study|Drug-related adverse event|1|||
131180140|NCT01766817|472280636|FG000|Overall Study|Drug-unrelated adverse event|3|||
131180141|NCT01766817|472280637|FG001|Overall Study|Drug-unrelated adverse event|3|||
131180142|NCT01766817|472280638|FG002|Overall Study|Drug-unrelated adverse event|3|||
131180143|NCT01766817|472280636|FG000|Overall Study|Death|1|||
131180144|NCT01766817|472280637|FG001|Overall Study|Death|1|||
131180145|NCT01766817|472280638|FG002|Overall Study|Death|0|||
131180146|NCT01766817|472280636|FG000|Overall Study|Unable to take study drug|0|||
131180147|NCT01766817|472280637|FG001|Overall Study|Unable to take study drug|1|||
131180148|NCT01766817|472280638|FG002|Overall Study|Unable to take study drug|0|||
131180149|NCT01766817|472280636|FG000|Overall Study|Withdrawal by Subject|2|||
131180150|NCT01766817|472280637|FG001|Overall Study|Withdrawal by Subject|0|||
131180151|NCT01766817|472280638|FG002|Overall Study|Withdrawal by Subject|3|||
131180152|NCT01766817|472280636|FG000|Overall Study|Subject non-compliance|0|||
131180153|NCT01766817|472280637|FG001|Overall Study|Subject non-compliance|1|||
131180154|NCT01766817|472280638|FG002|Overall Study|Subject non-compliance|2|||
131180155|NCT01766817|472280636|FG000|Overall Study|Physician Decision|3|||
131180156|NCT01766817|472280637|FG001|Overall Study|Physician Decision|3|||
131180157|NCT01766817|472280638|FG002|Overall Study|Physician Decision|4|||
131180158|NCT01766817|472280636|FG000|Overall Study|Other|1|||
131180159|NCT01766817|472280637|FG001|Overall Study|Other|0|||
131180160|NCT01766817|472280638|FG002|Overall Study|Other|0|||
131180161|NCT00870818|472280639|FG000|Overall Study|Lost to Follow-up|3|||
131180162|NCT00870818|472280640|FG001|Overall Study|Lost to Follow-up|2|||
131180163|NCT00870818|472280641|FG002|Overall Study|Lost to Follow-up|1|||
131180164|NCT00870818|472280642|FG003|Overall Study|Lost to Follow-up|0|||
131180165|NCT00870818|472280643|FG004|Overall Study|Lost to Follow-up|0|||
131180166|NCT00870818|472280639|FG000|Overall Study|Withdrawal by Subject|0|||
131180167|NCT00870818|472280640|FG001|Overall Study|Withdrawal by Subject|0|||
131180168|NCT00870818|472280641|FG002|Overall Study|Withdrawal by Subject|1|||
131180169|NCT00870818|472280642|FG003|Overall Study|Withdrawal by Subject|2|||
131180170|NCT00870818|472280643|FG004|Overall Study|Withdrawal by Subject|0|||
131180171|NCT00870818|472280639|FG000|Overall Study|Terminated by sponsor|29|||
131180172|NCT00870818|472280640|FG001|Overall Study|Terminated by sponsor|70|||
131180173|NCT00870818|472280641|FG002|Overall Study|Terminated by sponsor|36|||
131180174|NCT00870818|472280642|FG003|Overall Study|Terminated by sponsor|36|||
131180175|NCT00870818|472280643|FG004|Overall Study|Terminated by sponsor|38|||
131180176|NCT00870818|472280639|FG000|Overall Study|Other|0|||
131180177|NCT00870818|472280640|FG001|Overall Study|Other|1|||
131180178|NCT00870818|472280641|FG002|Overall Study|Other|0|||
131180179|NCT00870818|472280642|FG003|Overall Study|Other|0|||
131180180|NCT00870818|472280643|FG004|Overall Study|Other|0|||
131180181|NCT00178464|472280644|FG000|Overall Study|Withdrawal by Subject|1|||
131180182|NCT00178464|472280644|FG000|Overall Study|Physician Decision|1|||
131180183|NCT04900038|472280646|FG000|Overall Study|Adverse Event|1|||
131180184|NCT04900038|472280647|FG001|Overall Study|Adverse Event|0|||
131180185|NCT04900038|472280648|FG002|Overall Study|Adverse Event|1|||
131180186|NCT04900038|472280649|FG003|Overall Study|Adverse Event|1|||
131180187|NCT04900038|472280646|FG000|Overall Study|Withdrawal by Subject|0|||
131180188|NCT04900038|472280647|FG001|Overall Study|Withdrawal by Subject|1|||
131180189|NCT04900038|472280648|FG002|Overall Study|Withdrawal by Subject|0|||
131180190|NCT04900038|472280649|FG003|Overall Study|Withdrawal by Subject|0|||
131180191|NCT04900038|472280646|FG000|Overall Study|Study terminated by sponsor|18|||
131180192|NCT04900038|472280647|FG001|Overall Study|Study terminated by sponsor|15|||
131180193|NCT04900038|472280648|FG002|Overall Study|Study terminated by sponsor|17|||
131180194|NCT04900038|472280649|FG003|Overall Study|Study terminated by sponsor|14|||
131180195|NCT04900038|472280646|FG000|Overall Study|Protocol Deviation|1|||
131180196|NCT04900038|472280647|FG001|Overall Study|Protocol Deviation|1|||
131180197|NCT04900038|472280648|FG002|Overall Study|Protocol Deviation|0|||
131180198|NCT04900038|472280649|FG003|Overall Study|Protocol Deviation|0|||
131180199|NCT04900038|472280646|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
131180200|NCT04900038|472280647|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
131180201|NCT04900038|472280648|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
130783852|NCT01494818|470836787|FG000|Overall Study|Lost to Follow-up|1|||
130783853|NCT01494818|470836788|FG001|Overall Study|Lost to Follow-up|0|||
130783854|NCT01077323|470836789|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
130783855|NCT01077323|470836790|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
130783856|NCT01077323|470836791|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
130783857|NCT01077323|470836789|FG000|Overall Study|Dispensing of drug in baseline period|0|||
130783858|NCT01077323|470836790|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
130783859|NCT01077323|470836791|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
130783860|NCT01077323|470836789|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
130783861|NCT01077323|470836790|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
130783862|NCT01077323|470836791|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
130783863|NCT00617357|470836792|FG000|Overall Study|Lost to Follow-up|7|||
130783864|NCT00617357|470836792|FG000|Overall Study|Death|5|||
130783865|NCT00617357|470836792|FG000|Overall Study|insurance concerns|2|||
130783866|NCT00617357|470836792|FG000|Overall Study|Withdrawal by Subject|1|||
130783867|NCT00617357|470836792|FG000|Overall Study|Physician Decision|1|||
130783868|NCT02153918|470836793|FG000|Overall Study|Refused further treatment|1|||
130783869|NCT01764841|470836794|FG000|Overall Study|Logistical Difficulties|0|||
130783870|NCT01764841|470836795|FG001|Overall Study|Logistical Difficulties|1|||
130783871|NCT01764841|470836796|FG002|Overall Study|Logistical Difficulties|0|||
130783872|NCT01764841|470836797|FG003|Overall Study|Logistical Difficulties|0|||
130783873|NCT01764841|470836794|FG000|Overall Study|Death|3|||
130783874|NCT01764841|470836795|FG001|Overall Study|Death|0|||
130783875|NCT01764841|470836796|FG002|Overall Study|Death|1|||
130783876|NCT01764841|470836797|FG003|Overall Study|Death|4|||
130783877|NCT01764841|470836794|FG000|Overall Study|No Follow Up|1|||
130783878|NCT01764841|470836795|FG001|Overall Study|No Follow Up|0|||
130783879|NCT01764841|470836796|FG002|Overall Study|No Follow Up|1|||
130783880|NCT01764841|470836797|FG003|Overall Study|No Follow Up|0|||
130783881|NCT01764841|470836794|FG000|Overall Study|Protocol Violation|0|||
130783882|NCT01764841|470836795|FG001|Overall Study|Protocol Violation|1|||
130783883|NCT01764841|470836796|FG002|Overall Study|Protocol Violation|0|||
130783884|NCT01764841|470836797|FG003|Overall Study|Protocol Violation|0|||
130783885|NCT01764841|470836794|FG000|Overall Study|Withdrawal by Subject|16|||
130783886|NCT01764841|470836795|FG001|Overall Study|Withdrawal by Subject|24|||
130783887|NCT01764841|470836796|FG002|Overall Study|Withdrawal by Subject|11|||
130783888|NCT01764841|470836797|FG003|Overall Study|Withdrawal by Subject|15|||
130783889|NCT01764841|470836794|FG000|Overall Study|Lost to Follow-up|3|||
130783890|NCT01764841|470836795|FG001|Overall Study|Lost to Follow-up|0|||
130783891|NCT01764841|470836796|FG002|Overall Study|Lost to Follow-up|1|||
130783892|NCT01764841|470836797|FG003|Overall Study|Lost to Follow-up|0|||
130783893|NCT02616783|470836799|FG000|Overall Study|Randomized but Not Treated|1|||
130783894|NCT02616783|470836800|FG001|Overall Study|Randomized but Not Treated|0|||
130783895|NCT02616783|470836799|FG000|Overall Study|Adverse Event|1|||
130783896|NCT02616783|470836800|FG001|Overall Study|Adverse Event|0|||
130783897|NCT02616783|470836799|FG000|Overall Study|Death|1|||
130783898|NCT02616783|470836800|FG001|Overall Study|Death|0|||
130783899|NCT02616783|470836799|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130783900|NCT02616783|470836800|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130783901|NCT02616783|470836799|FG000|Overall Study|Protocol Violation|1|||
130783902|NCT02616783|470836800|FG001|Overall Study|Protocol Violation|1|||
130783903|NCT02616783|470836799|FG000|Overall Study|Withdrew Consent|1|||
131238098|NCT04649359|472500136|FG001|Overall Study|Withdrawal by Subject|7|||
131238099|NCT04649359|472500135|FG000|Overall Study|Death|41|||
131238100|NCT04649359|472500136|FG001|Overall Study|Death|26|||
131238101|NCT04649359|472500135|FG000|Overall Study|Ongoing in the study|75|||
131238102|NCT04649359|472500136|FG001|Overall Study|Ongoing in the study|31|||
131238103|NCT02446132|472500137|FG000|Overall Study|Adverse Event|10|||
131238104|NCT02446132|472500138|FG001|Overall Study|Adverse Event|27|||
131238105|NCT02446132|472500139|FG002|Overall Study|Adverse Event|27|||
131238106|NCT02446132|472500137|FG000|Overall Study|Death|2|||
130783904|NCT02616783|470836800|FG001|Overall Study|Withdrew Consent|1|||
130783905|NCT04344301|470836801|FG000|Overall Study|Withdrawal by Subject|1|||
130783906|NCT04344301|470836802|FG001|Overall Study|Withdrawal by Subject|0|||
130783907|NCT04344301|470836801|FG000|Overall Study|Death|0|||
130783908|NCT04344301|470836802|FG001|Overall Study|Death|1|||
130783909|NCT01747499|470836803|FG000|Overall Study|Steroid refractory aGvHD|1|||
130783910|NCT01747499|470836804|FG001|Overall Study|Steroid refractory aGvHD|0|||
130783911|NCT01747499|470836805|FG002|Overall Study|Steroid refractory aGvHD|0|||
130783912|NCT01747499|470836806|FG003|Overall Study|Steroid refractory aGvHD|1|||
131238107|NCT02446132|472500138|FG001|Overall Study|Death|13|||
131238108|NCT02446132|472500139|FG002|Overall Study|Death|10|||
130783913|NCT01747499|470836807|FG004|Overall Study|Steroid refractory aGvHD|4|||
130783914|NCT01747499|470836803|FG000|Overall Study|Physician Decision|0|||
130783915|NCT01747499|470836804|FG001|Overall Study|Physician Decision|1|||
130783916|NCT01747499|470836805|FG002|Overall Study|Physician Decision|0|||
130783917|NCT01747499|470836806|FG003|Overall Study|Physician Decision|0|||
131238109|NCT02446132|472500137|FG000|Overall Study|Lack of Efficacy|1|||
130783918|NCT01747499|470836807|FG004|Overall Study|Physician Decision|2|||
130783919|NCT01747499|470836803|FG000|Overall Study|Death|0|||
130783920|NCT01747499|470836804|FG001|Overall Study|Death|0|||
130783921|NCT01747499|470836805|FG002|Overall Study|Death|0|||
130783922|NCT01747499|470836806|FG003|Overall Study|Death|1|||
130783923|NCT01747499|470836807|FG004|Overall Study|Death|1|||
130783924|NCT01747499|470836803|FG000|Overall Study|Withdrawal by Subject|0|||
130783925|NCT01747499|470836804|FG001|Overall Study|Withdrawal by Subject|0|||
130783926|NCT01747499|470836805|FG002|Overall Study|Withdrawal by Subject|0|||
130783927|NCT01747499|470836806|FG003|Overall Study|Withdrawal by Subject|0|||
130783928|NCT01747499|470836807|FG004|Overall Study|Withdrawal by Subject|6|||
130783929|NCT01747499|470836803|FG000|Overall Study|Developed AML and death|0|||
130783930|NCT01747499|470836804|FG001|Overall Study|Developed AML and death|0|||
130783931|NCT01747499|470836805|FG002|Overall Study|Developed AML and death|0|||
130783932|NCT01747499|470836806|FG003|Overall Study|Developed AML and death|0|||
130783933|NCT01747499|470836807|FG004|Overall Study|Developed AML and death|1|||
130783934|NCT01747499|470836803|FG000|Overall Study|Determined not to be eligible|0|||
130783935|NCT01747499|470836804|FG001|Overall Study|Determined not to be eligible|0|||
130783936|NCT01747499|470836805|FG002|Overall Study|Determined not to be eligible|0|||
130783937|NCT01747499|470836806|FG003|Overall Study|Determined not to be eligible|0|||
130783938|NCT01747499|470836807|FG004|Overall Study|Determined not to be eligible|1|||
130783939|NCT00072410|470836808|FG000|Overall Study|Progressive disease|0|||
130783940|NCT00072410|470836809|FG001|Overall Study|Progressive disease|3|||
130783941|NCT00372424|470836810|FG000|Overall Study|Adverse Event|2|||
130783942|NCT00372424|470836810|FG000|Overall Study|Withdrawal by Subject|1|||
130783943|NCT00372424|470836810|FG000|Overall Study|Death|1|||
130783944|NCT00372424|470836810|FG000|Overall Study|Objective Progression or Relapse|14|||
130783945|NCT00372424|470836810|FG000|Overall Study|Other|7|||
130783946|NCT00372424|470836810|FG000|Overall Study|Enrolled, Not Treated|1|||
130783947|NCT05214118|470836813|FG000|Overall Study|Lost to Follow-up|0|||
130783948|NCT05214118|470836814|FG001|Overall Study|Lost to Follow-up|2|||
130783949|NCT05214118|470836813|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
130783950|NCT05214118|470836814|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
130783951|NCT05214118|470836813|FG000|Overall Study|moved|1|||
130783952|NCT05214118|470836814|FG001|Overall Study|moved|0|||
130783953|NCT04010461|470836815|FG000|Overall Study|COVID based withdrawal|5|||
130783954|NCT04010461|470836815|FG000|Overall Study|Withdrawal by Subject|5|||
130783955|NCT04010461|470836815|FG000|Overall Study|Adverse Event|1|||
130783956|NCT04010461|470836815|FG000|Overall Study|No Motor Threshold obtainable|1|||
130783957|NCT04010461|470836815|FG000|Overall Study|Physician Decision|1|||
130783958|NCT03797898|470836816|FG000|Overall Study|Lost to Follow-up|60|||
130783959|NCT03797898|470836817|FG001|Overall Study|Lost to Follow-up|69|||
130783960|NCT03797898|470836816|FG000|Overall Study|Withdrawal by Subject|9|||
130783961|NCT03797898|470836817|FG001|Overall Study|Withdrawal by Subject|7|||
130783962|NCT03797898|470836816|FG000|Overall Study|Became ineligible|5|||
130783963|NCT03797898|470836817|FG001|Overall Study|Became ineligible|2|||
130783964|NCT00577317|470836818|FG000|Overall Study|Study Terminated|0|||
130783965|NCT00577317|470836819|FG001|Overall Study|Study Terminated|2|||
130783966|NCT04460326|470836820|FG000|Completed at Least 4 Meals|Early discharge|5|||
131238110|NCT02446132|472500138|FG001|Overall Study|Lack of Efficacy|10|||
131238111|NCT02446132|472500139|FG002|Overall Study|Lack of Efficacy|6|||
131238112|NCT02446132|472500137|FG000|Overall Study|Lost to Follow-up|2|||
131238113|NCT02446132|472500138|FG001|Overall Study|Lost to Follow-up|4|||
131238114|NCT02446132|472500139|FG002|Overall Study|Lost to Follow-up|5|||
131238115|NCT02446132|472500137|FG000|Overall Study|Non-compliance With Study Drug|2|||
131238116|NCT02446132|472500138|FG001|Overall Study|Non-compliance With Study Drug|2|||
131238117|NCT02446132|472500139|FG002|Overall Study|Non-compliance With Study Drug|3|||
131238118|NCT02446132|472500137|FG000|Overall Study|Physician Decision|1|||
131238119|NCT02446132|472500138|FG001|Overall Study|Physician Decision|8|||
131238120|NCT02446132|472500139|FG002|Overall Study|Physician Decision|13|||
131238121|NCT02446132|472500137|FG000|Overall Study|Protocol Deviation|0|||
130783967|NCT04460326|470836821|FG001|Completed at Least 4 Meals|Early discharge|5|||
130783968|NCT04460326|470836820|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
131238122|NCT02446132|472500138|FG001|Overall Study|Protocol Deviation|0|||
131238123|NCT02446132|472500139|FG002|Overall Study|Protocol Deviation|1|||
131238124|NCT02446132|472500137|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
131238125|NCT02446132|472500138|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
130783969|NCT04460326|470836821|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
130783970|NCT04460326|470836820|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
130783971|NCT04460326|470836821|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
130783972|NCT04460326|470836820|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
130783973|NCT04460326|470836821|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
130783974|NCT04460326|470836820|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
130783975|NCT04460326|470836821|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
131238126|NCT02446132|472500139|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
131238127|NCT02446132|472500137|FG000|Overall Study|Study Terminated by Sponsor|4|||
130783976|NCT04460326|470836820|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
130783977|NCT04460326|470836821|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
130783978|NCT04794751|470836824|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
130783979|NCT04794751|470836825|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
130783980|NCT04794751|470836824|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
130783981|NCT04794751|470836825|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
130783982|NCT04794751|470836824|FG000|Period 1|Protocol Violation|0|||
130783983|NCT04794751|470836825|FG001|Period 1|Protocol Violation|2|||
130783984|NCT04794751|470836824|FG000|Period 1|Withdrawal by Subject|0|||
130783985|NCT04794751|470836825|FG001|Period 1|Withdrawal by Subject|1|||
130783986|NCT04794751|470836824|FG000|Period 2|Withdrawal by Subject|0|||
130783987|NCT04794751|470836825|FG001|Period 2|Withdrawal by Subject|1|||
130783988|NCT04794751|470836824|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
130783989|NCT04794751|470836825|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
130783990|NCT04794751|470836824|FG000|Period 2|Protocol Violation|1|||
130783991|NCT04794751|470836825|FG001|Period 2|Protocol Violation|0|||
130783992|NCT00780975|470836830|FG000|Overall Study|Progressive disease|3|||
130783993|NCT00780975|470836830|FG000|Overall Study|Toxicity|5|||
130783994|NCT01939314|470836833|FG000|Overall Study|Withdrawal by Subject|3|||
130783995|NCT01939314|470836834|FG001|Overall Study|Withdrawal by Subject|1|||
130783996|NCT01939314|470836833|FG000|Overall Study|Protocol Violation|1|||
130783997|NCT01939314|470836834|FG001|Overall Study|Protocol Violation|0|||
130783998|NCT01939314|470836833|FG000|Overall Study|Pregnancy|0|||
130783999|NCT01939314|470836834|FG001|Overall Study|Pregnancy|1|||
130784000|NCT01939314|470836833|FG000|Overall Study|Lost to Follow-up|5|||
130784001|NCT01939314|470836834|FG001|Overall Study|Lost to Follow-up|6|||
130784002|NCT00969228|470836835|FG000|Overall Study|Adverse Event|1|||
130784003|NCT00969228|470836836|FG001|Overall Study|Adverse Event|0|||
130784004|NCT00969228|470836835|FG000|Overall Study|Withdrawal by Subject|4|||
130784005|NCT00969228|470836836|FG001|Overall Study|Withdrawal by Subject|0|||
130784006|NCT00969228|470836835|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
130784007|NCT00969228|470836836|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
130784008|NCT02563899|470836837|FG000|Overall Study|Protocol Violation|1|||
130784009|NCT02563899|470836838|FG001|Overall Study|Protocol Violation|0|||
130784010|NCT02563899|470836839|FG002|Overall Study|Protocol Violation|0|||
130784011|NCT02563899|470836840|FG003|Overall Study|Protocol Violation|0|||
130784012|NCT02563899|470836837|FG000|Overall Study|Withdrawal by Subject|0|||
130784013|NCT02563899|470836838|FG001|Overall Study|Withdrawal by Subject|0|||
130784014|NCT02563899|470836839|FG002|Overall Study|Withdrawal by Subject|1|||
131180202|NCT04900038|472280649|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
131180203|NCT04900038|472280646|FG000|Overall Study|Lost to Follow-up|0|||
131180204|NCT04900038|472280647|FG001|Overall Study|Lost to Follow-up|0|||
131180205|NCT04900038|472280648|FG002|Overall Study|Lost to Follow-up|0|||
131180206|NCT04900038|472280649|FG003|Overall Study|Lost to Follow-up|1|||
131180207|NCT02227108|472280652|FG000|Overall Study|Did not receive treatment|2|||
131180208|NCT02227108|472280652|FG000|Overall Study|Other|3|||
131180209|NCT02227108|472280652|FG000|Overall Study|Progressive disease|17|||
131180210|NCT02227108|472280652|FG000|Overall Study|Initiation of alternative therapy|2|||
131180211|NCT02227108|472280652|FG000|Overall Study|Investigator discretion|1|||
131180212|NCT02227108|472280652|FG000|Overall Study|Adverse Event|6|||
131180213|NCT02486952|472280653|FG000|Overall Study|Not Started Induction Therapy|3|||
131180214|NCT02486952|472280653|FG000|Overall Study|Adverse Event|1|||
131180215|NCT02486952|472280653|FG000|Overall Study|Death|15|||
131180216|NCT02486952|472280653|FG000|Overall Study|Lack of Efficacy|3|||
131180217|NCT02486952|472280653|FG000|Overall Study|Lost to Follow-up|26|||
131180218|NCT02486952|472280653|FG000|Overall Study|Other|2|||
131180219|NCT01928485|472280655|FG000|Overall Study|Physician Decision|0|||
131180220|NCT01928485|472280656|FG001|Overall Study|Physician Decision|1|||
131180221|NCT04111107|472280657|FG000|Overall Study|Withdrawal by Subject|6|||
131180222|NCT04111107|472280657|FG000|Overall Study|Declining Health|5|||
131180223|NCT02721251|472280660|FG000|Overall Study|Withdrawal by Subject|8|||
130784015|NCT02563899|470836840|FG003|Overall Study|Withdrawal by Subject|0|||
130784016|NCT03669588|470836841|FG000|Overall Study|Adverse Event|1|||
130784017|NCT03669588|470836842|FG001|Overall Study|Adverse Event|0|||
130784018|NCT03669588|470836841|FG000|Overall Study|Physician Decision|0|||
130784019|NCT03669588|470836842|FG001|Overall Study|Physician Decision|1|||
131180224|NCT02721251|472280661|FG001|Overall Study|Withdrawal by Subject|7|||
131180225|NCT02721251|472280662|FG002|Overall Study|Withdrawal by Subject|9|||
131180226|NCT02721251|472280660|FG000|Overall Study|poor adherence|2|||
130784020|NCT03669588|470836841|FG000|Overall Study|Protocol Violation|1|||
130784021|NCT03669588|470836842|FG001|Overall Study|Protocol Violation|0|||
131180227|NCT02721251|472280661|FG001|Overall Study|poor adherence|2|||
130784022|NCT03669588|470836841|FG000|Overall Study|Sponsor Decision|1|||
130784023|NCT03669588|470836842|FG001|Overall Study|Sponsor Decision|1|||
130784024|NCT03669588|470836841|FG000|Overall Study|Withdrawal by Subject|1|||
130784025|NCT03669588|470836842|FG001|Overall Study|Withdrawal by Subject|4|||
131180228|NCT02721251|472280662|FG002|Overall Study|poor adherence|2|||
131180229|NCT01714817|472280663|FG000|Year 1 Period|Lack of Efficacy|11|||
131180230|NCT01714817|472280664|FG001|Year 1 Period|Lack of Efficacy|9|||
131180231|NCT01714817|472280663|FG000|Year 1 Period|Adverse Event|20|||
131180232|NCT01714817|472280664|FG001|Year 1 Period|Adverse Event|17|||
131180233|NCT01714817|472280663|FG000|Year 1 Period|Withdrawal by Subject|6|||
131180234|NCT01714817|472280664|FG001|Year 1 Period|Withdrawal by Subject|7|||
131180235|NCT01714817|472280663|FG000|Year 1 Period|Death|1|||
131180236|NCT01714817|472280664|FG001|Year 1 Period|Death|1|||
131180237|NCT01714817|472280663|FG000|Year 1 Period|Lost to Follow-up|0|||
131180238|NCT01714817|472280664|FG001|Year 1 Period|Lost to Follow-up|2|||
131180239|NCT01714817|472280663|FG000|Year 1 Period|Poor / non-compliance|0|||
131180240|NCT01714817|472280664|FG001|Year 1 Period|Poor / non-compliance|1|||
131180241|NCT01714817|472280663|FG000|Year 1 Period|Pregnancy|2|||
131180242|NCT01714817|472280664|FG001|Year 1 Period|Pregnancy|0|||
131180243|NCT01714817|472280663|FG000|Year 1 Period|Participant no longer meets criteria|6|||
131180244|NCT01714817|472280664|FG001|Year 1 Period|Participant no longer meets criteria|2|||
131180245|NCT01714817|472280663|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
131180246|NCT01714817|472280664|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
131180247|NCT01714817|472280663|FG000|Year 1 Period|Change in Concomitant Medication|0|||
131180248|NCT01714817|472280664|FG001|Year 1 Period|Change in Concomitant Medication|1|||
131180249|NCT01714817|472280663|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
131180250|NCT01714817|472280664|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
131180251|NCT01714817|472280663|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
131180252|NCT01714817|472280664|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
131180253|NCT01714817|472280663|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
131180254|NCT01714817|472280664|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
131180255|NCT01714817|472280663|FG000|Year 2 Period|Lack of Efficacy|4|||
131180256|NCT01714817|472280664|FG001|Year 2 Period|Lack of Efficacy|12|||
131180257|NCT01714817|472280663|FG000|Year 2 Period|Adverse Event|7|||
131180258|NCT01714817|472280664|FG001|Year 2 Period|Adverse Event|6|||
131180259|NCT01714817|472280663|FG000|Year 2 Period|Participant request to stop treatment|4|||
131180260|NCT01714817|472280664|FG001|Year 2 Period|Participant request to stop treatment|4|||
131180261|NCT01714817|472280663|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
131180262|NCT01714817|472280664|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
131180263|NCT01714817|472280663|FG000|Year 2 Period|Participant withdrew consent|1|||
131180264|NCT01714817|472280664|FG001|Year 2 Period|Participant withdrew consent|5|||
130733312|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
131180265|NCT01714817|472280663|FG000|Year 2 Period|Participant no longer meets criteria|1|||
131180266|NCT01714817|472280664|FG001|Year 2 Period|Participant no longer meets criteria|4|||
130733313|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
130733314|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
130733315|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130733316|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130733317|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130733318|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
130733319|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130733320|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130733321|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
130733322|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130733323|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130733324|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130733325|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130733326|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130733327|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130733328|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130733329|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130733330|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131180267|NCT01714817|472280663|FG000|Year 2 Period|Lost to Follow-up|2|||
131180268|NCT01714817|472280664|FG001|Year 2 Period|Lost to Follow-up|0|||
131180269|NCT01714817|472280663|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
131180270|NCT01714817|472280664|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
131180271|NCT01714817|472280663|FG000|Year 2 Period|Pregnancy|1|||
131180272|NCT01714817|472280664|FG001|Year 2 Period|Pregnancy|1|||
131180273|NCT01714817|472280663|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
131180274|NCT01714817|472280664|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
131180275|NCT01714817|472280663|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
131180276|NCT01714817|472280664|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
131180277|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
131180278|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
131180279|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
131180280|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
131180281|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
131180282|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
131180283|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
131180284|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
131180285|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
131180286|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
131180287|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
131180288|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
131180289|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
131180290|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
131180291|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
131180292|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
131180293|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
131180294|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
131180295|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
131180296|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
131180297|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
131180298|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
131180299|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
131180300|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
131180301|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
131180302|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
131180303|NCT01714817|472280663|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
131180304|NCT01714817|472280664|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
131180305|NCT02921763|472280665|FG000|Overall Study|Adverse Event|4|||
131180306|NCT02921763|472280665|FG000|Overall Study|Lost to Follow-up|4|||
131180307|NCT02921763|472280665|FG000|Overall Study|Lack of Efficacy|3|||
131180308|NCT02921763|472280665|FG000|Overall Study|Protocol Violation|2|||
131180309|NCT02921763|472280665|FG000|Overall Study|Withdrawal by Subject|2|||
131180310|NCT02921763|472280665|FG000|Overall Study|Physician Decision|1|||
131180311|NCT02921763|472280665|FG000|Overall Study|No data obtained|2|||
131180312|NCT04142216|472280666|FG000|Overall Study|Hospitalization|0|||
131180313|NCT04142216|472280667|FG001|Overall Study|Hospitalization|2|||
131180314|NCT04142216|472280666|FG000|Overall Study|Death|3|||
131180315|NCT04142216|472280667|FG001|Overall Study|Death|1|||
131180316|NCT04142216|472280666|FG000|Overall Study|Referral to another hemodialysis unit|3|||
131180317|NCT04142216|472280667|FG001|Overall Study|Referral to another hemodialysis unit|2|||
131180318|NCT04142216|472280666|FG000|Overall Study|Use of clove|0|||
131180319|NCT04142216|472280667|FG001|Overall Study|Use of clove|1|||
131180320|NCT01582971|472280668|FG000|Overall Study|Death|2|||
131180321|NCT01582971|472280669|FG001|Overall Study|Death|1|||
131180322|NCT01582971|472280668|FG000|Overall Study|Lost to Follow-up|18|||
131180323|NCT01582971|472280669|FG001|Overall Study|Lost to Follow-up|21|||
131180324|NCT01582971|472280668|FG000|Overall Study|Withdrawal by Subject|4|||
131180325|NCT01582971|472280669|FG001|Overall Study|Withdrawal by Subject|2|||
131180326|NCT01582971|472280668|FG000|Overall Study|Other|15|||
131180327|NCT01582971|472280669|FG001|Overall Study|Other|13|||
131180328|NCT02554253|472280677|FG000|Overall Study|ineligible after enrollment|1|||
131180329|NCT02554253|472280678|FG001|Overall Study|ineligible after enrollment|0|||
131180330|NCT02554253|472280677|FG000|Overall Study|converted to transcatheter procedure|0|||
131180331|NCT02554253|472280678|FG001|Overall Study|converted to transcatheter procedure|1|||
131180332|NCT02554253|472280677|FG000|Overall Study|received both drugs|0|||
131180333|NCT02554253|472280678|FG001|Overall Study|received both drugs|1|||
131180334|NCT01736254|472280681|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
131180335|NCT01736254|472280681|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
131180336|NCT02559206|472280682|FG000|Overall Study|Adverse Event|0|||
131180337|NCT02559206|472280683|FG001|Overall Study|Adverse Event|4|||
131180338|NCT02559206|472280684|FG002|Overall Study|Adverse Event|1|||
131180339|NCT02559206|472280685|FG003|Overall Study|Adverse Event|5|||
131180340|NCT02559206|472280686|FG004|Overall Study|Adverse Event|3|||
131180341|NCT02559206|472280687|FG005|Overall Study|Adverse Event|0|||
131180342|NCT02559206|472280688|FG006|Overall Study|Adverse Event|1|||
131180343|NCT02559206|472280689|FG007|Overall Study|Adverse Event|0|||
131180344|NCT02559206|472280682|FG000|Overall Study|Protocol Violation|1|||
131180345|NCT02559206|472280683|FG001|Overall Study|Protocol Violation|0|||
131180346|NCT02559206|472280684|FG002|Overall Study|Protocol Violation|1|||
131180347|NCT02559206|472280685|FG003|Overall Study|Protocol Violation|0|||
131180348|NCT02559206|472280686|FG004|Overall Study|Protocol Violation|0|||
131180349|NCT02559206|472280687|FG005|Overall Study|Protocol Violation|2|||
131180350|NCT02559206|472280688|FG006|Overall Study|Protocol Violation|0|||
131180351|NCT02559206|472280689|FG007|Overall Study|Protocol Violation|0|||
131180352|NCT02559206|472280682|FG000|Overall Study|Withdrawal by Subject|3|||
131180353|NCT02559206|472280683|FG001|Overall Study|Withdrawal by Subject|3|||
131180354|NCT02559206|472280684|FG002|Overall Study|Withdrawal by Subject|1|||
131180355|NCT02559206|472280685|FG003|Overall Study|Withdrawal by Subject|3|||
131180356|NCT02559206|472280686|FG004|Overall Study|Withdrawal by Subject|5|||
131180357|NCT02559206|472280687|FG005|Overall Study|Withdrawal by Subject|4|||
131180358|NCT02559206|472280688|FG006|Overall Study|Withdrawal by Subject|1|||
131180359|NCT02559206|472280689|FG007|Overall Study|Withdrawal by Subject|2|||
131180360|NCT02559206|472280682|FG000|Overall Study|Lost to Follow-up|3|||
131180361|NCT02559206|472280683|FG001|Overall Study|Lost to Follow-up|5|||
131180362|NCT02559206|472280684|FG002|Overall Study|Lost to Follow-up|3|||
131180363|NCT02559206|472280685|FG003|Overall Study|Lost to Follow-up|3|||
131180364|NCT02559206|472280686|FG004|Overall Study|Lost to Follow-up|2|||
131180365|NCT02559206|472280687|FG005|Overall Study|Lost to Follow-up|5|||
131180366|NCT02559206|472280688|FG006|Overall Study|Lost to Follow-up|1|||
131180367|NCT02559206|472280689|FG007|Overall Study|Lost to Follow-up|4|||
131180368|NCT02559206|472280682|FG000|Overall Study|Lack of Efficacy|1|||
131180369|NCT02559206|472280683|FG001|Overall Study|Lack of Efficacy|0|||
131180370|NCT02559206|472280684|FG002|Overall Study|Lack of Efficacy|3|||
131180371|NCT02559206|472280685|FG003|Overall Study|Lack of Efficacy|2|||
131180372|NCT02559206|472280686|FG004|Overall Study|Lack of Efficacy|2|||
131180373|NCT02559206|472280687|FG005|Overall Study|Lack of Efficacy|3|||
131180374|NCT02559206|472280688|FG006|Overall Study|Lack of Efficacy|3|||
131180375|NCT02559206|472280689|FG007|Overall Study|Lack of Efficacy|3|||
131180376|NCT02559206|472280682|FG000|Overall Study|Other Not Specified|0|||
131180377|NCT02559206|472280683|FG001|Overall Study|Other Not Specified|0|||
131180378|NCT02559206|472280684|FG002|Overall Study|Other Not Specified|0|||
131180379|NCT02559206|472280685|FG003|Overall Study|Other Not Specified|1|||
131180380|NCT02559206|472280686|FG004|Overall Study|Other Not Specified|0|||
131180381|NCT02559206|472280687|FG005|Overall Study|Other Not Specified|0|||
131180382|NCT02559206|472280688|FG006|Overall Study|Other Not Specified|0|||
131180383|NCT02559206|472280689|FG007|Overall Study|Other Not Specified|0|||
131180384|NCT01561560|472280690|FG000|First Two Weeks of Wear|Time/job conflict|0|||
131180385|NCT01561560|472280691|FG001|First Two Weeks of Wear|Time/job conflict|1|||
131180386|NCT01561560|472280690|FG000|First Two Weeks of Wear|Adverse Event|0|||
131180387|NCT01561560|472280691|FG001|First Two Weeks of Wear|Adverse Event|1|||
131180388|NCT01561560|472280690|FG000|Second Two Weeks of Wear|Adverse Event|0|||
131180389|NCT01561560|472280691|FG001|Second Two Weeks of Wear|Adverse Event|1|||
131180390|NCT01871896|472280694|FG000|Overall Study|Lost to Follow-up|1|||
131180391|NCT01512108|472281894|FG000|Overall Study|Adverse Event|9|||
131180392|NCT01512108|472281895|FG001|Overall Study|Adverse Event|4|||
131180393|NCT01512108|472281894|FG000|Overall Study|Protocol Violation|1|||
131180394|NCT01512108|472281895|FG001|Overall Study|Protocol Violation|2|||
131180395|NCT01512108|472281894|FG000|Overall Study|Withdrawal Criteria|1|||
131180396|NCT01512108|472281895|FG001|Overall Study|Withdrawal Criteria|0|||
131180397|NCT01512108|472281894|FG000|Overall Study|Unclassified|11|||
131180398|NCT01512108|472281895|FG001|Overall Study|Unclassified|3|||
131180399|NCT06422377|472281900|FG000|Overall Study|Study Terminated by Sponsor|1|||
131180400|NCT02843178|472281903|FG000|Overall Study|Lost to Follow-up|8|||
131180401|NCT02843178|472281904|FG001|Overall Study|Lost to Follow-up|8|||
131180402|NCT02843178|472281905|FG002|Overall Study|Lost to Follow-up|6|||
131180403|NCT02843178|472281906|FG003|Overall Study|Lost to Follow-up|3|||
131180404|NCT02843178|472281903|FG000|Overall Study|Withdrawal by Subject|0|||
131180405|NCT02843178|472281904|FG001|Overall Study|Withdrawal by Subject|0|||
131180406|NCT02843178|472281905|FG002|Overall Study|Withdrawal by Subject|1|||
131180407|NCT02843178|472281906|FG003|Overall Study|Withdrawal by Subject|1|||
131180408|NCT03287245|472281910|FG000|Overall Study|Study terminated by sponsor|3|||
131180409|NCT03287245|472281911|FG001|Overall Study|Study terminated by sponsor|0|||
131180410|NCT03287245|472281912|FG002|Overall Study|Study terminated by sponsor|3|||
131180411|NCT03287245|472281913|FG003|Overall Study|Study terminated by sponsor|1|||
131180412|NCT03287245|472281910|FG000|Overall Study|Adverse Event|1|||
131180413|NCT03287245|472281911|FG001|Overall Study|Adverse Event|0|||
131180414|NCT03287245|472281912|FG002|Overall Study|Adverse Event|0|||
131180415|NCT03287245|472281913|FG003|Overall Study|Adverse Event|0|||
131180416|NCT03287245|472281910|FG000|Overall Study|Withdrawal by Subject|8|||
131180417|NCT03287245|472281911|FG001|Overall Study|Withdrawal by Subject|3|||
131180418|NCT03287245|472281912|FG002|Overall Study|Withdrawal by Subject|3|||
131180419|NCT03287245|472281913|FG003|Overall Study|Withdrawal by Subject|0|||
130733331|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
131180420|NCT03287245|472281910|FG000|Overall Study|Physician Decision|3|||
131180421|NCT03287245|472281911|FG001|Overall Study|Physician Decision|2|||
131180422|NCT03287245|472281912|FG002|Overall Study|Physician Decision|0|||
131180423|NCT03287245|472281913|FG003|Overall Study|Physician Decision|0|||
131180424|NCT02701192|472281914|FG000|Overall Study|Protocol Violation|2|||
131180425|NCT02701192|472281914|FG000|Overall Study|Lost to Follow-up|4|||
131180426|NCT00949910|472281915|FG000|Overall Study|Progressive Disease|3750|||
130733332|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733333|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131238128|NCT02446132|472500138|FG001|Overall Study|Study Terminated by Sponsor|35|||
131238129|NCT02446132|472500139|FG002|Overall Study|Study Terminated by Sponsor|58|||
131238130|NCT02446132|472500137|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
131238131|NCT02446132|472500138|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
131238132|NCT02446132|472500139|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
131238133|NCT02446132|472500137|FG000|Overall Study|Withdrawal by Subject|11|||
131238134|NCT02446132|472500138|FG001|Overall Study|Withdrawal by Subject|29|||
131238135|NCT02446132|472500139|FG002|Overall Study|Withdrawal by Subject|25|||
131238136|NCT02446132|472500137|FG000|Overall Study|Reason not Specified|4|||
131238137|NCT02446132|472500138|FG001|Overall Study|Reason not Specified|16|||
131238138|NCT02446132|472500139|FG002|Overall Study|Reason not Specified|10|||
131238139|NCT02446132|472500137|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
131238140|NCT02446132|472500138|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
131238141|NCT02446132|472500139|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
131238142|NCT05526248|472500140|FG000|Overall Study|Lost to Follow-up|1|||
131238143|NCT05526248|472500140|FG000|Overall Study|Adverse Event|2|||
131238144|NCT05526248|472500140|FG000|Overall Study|Withdrawal by Subject|1|||
131238145|NCT03123120|472500141|FG000|Overall Study|Lost to Follow-up|0|||
131238146|NCT03123120|472500142|FG001|Overall Study|Lost to Follow-up|1|||
131238147|NCT03123120|472500141|FG000|Overall Study|Withdrawal by Subject|0|||
131238148|NCT03123120|472500142|FG001|Overall Study|Withdrawal by Subject|1|||
131238149|NCT02152982|472500146|FG000|Overall Study|Withdrawal by Subject|17|||
131238150|NCT02152982|472500147|FG001|Overall Study|Withdrawal by Subject|16|||
131238151|NCT02152982|472500146|FG000|Overall Study|Did not start treatment|11|||
131238152|NCT02152982|472500147|FG001|Overall Study|Did not start treatment|5|||
131238153|NCT02152982|472500146|FG000|Overall Study|Disease progression|41|||
131238154|NCT02152982|472500147|FG001|Overall Study|Disease progression|52|||
131238155|NCT02152982|472500146|FG000|Overall Study|Adverse Event|7|||
131238156|NCT02152982|472500147|FG001|Overall Study|Adverse Event|12|||
131238157|NCT02152982|472500146|FG000|Overall Study|Complicating disease|1|||
131238158|NCT02152982|472500147|FG001|Overall Study|Complicating disease|1|||
131238159|NCT02152982|472500146|FG000|Overall Study|Death|0|||
131238160|NCT02152982|472500147|FG001|Overall Study|Death|3|||
131238161|NCT02152982|472500146|FG000|Overall Study|Physician Decision|3|||
131238162|NCT02152982|472500147|FG001|Overall Study|Physician Decision|0|||
131238163|NCT03648541|472500148|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
131238164|NCT03648541|472500149|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
131238165|NCT03648541|472500148|FG000|Re-induction Period Only|Lack of Efficacy|7|||
131238166|NCT03648541|472500149|FG001|Re-induction Period Only|Lack of Efficacy|0|||
131238167|NCT03648541|472500148|FG000|Maintenance Period Only|Missing|0|||
131238168|NCT03648541|472500149|FG001|Maintenance Period Only|Missing|1|||
131238169|NCT03648541|472500148|FG000|Maintenance Period Only|Other not listed below|0|||
131238170|NCT03648541|472500149|FG001|Maintenance Period Only|Other not listed below|4|||
131238171|NCT03648541|472500148|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
131238172|NCT03648541|472500149|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
131238173|NCT03648541|472500148|FG000|Maintenance Period Only|Protocol Violation|0|||
131238174|NCT03648541|472500149|FG001|Maintenance Period Only|Protocol Violation|1|||
131238175|NCT03648541|472500148|FG000|Maintenance Period Only|Lack of Efficacy|0|||
131238176|NCT03648541|472500149|FG001|Maintenance Period Only|Lack of Efficacy|18|||
131238177|NCT03648541|472500148|FG000|Maintenance Period Only|Adverse Event|0|||
131238178|NCT03648541|472500149|FG001|Maintenance Period Only|Adverse Event|4|||
131238179|NCT03648541|472500148|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
131238180|NCT03648541|472500149|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
131238181|NCT03135548|472500150|FG000|Overall Study|Lost to Follow-up|3|||
131238182|NCT03135548|472500151|FG001|Overall Study|Lost to Follow-up|0|||
131238183|NCT03135548|472500152|FG002|Overall Study|Lost to Follow-up|0|||
131238184|NCT03135548|472500150|FG000|Overall Study|Withdrawal by Subject|2|||
131238185|NCT03135548|472500151|FG001|Overall Study|Withdrawal by Subject|2|||
131238186|NCT03135548|472500152|FG002|Overall Study|Withdrawal by Subject|1|||
131238187|NCT03135548|472500150|FG000|Overall Study|Other than listed|0|||
131238188|NCT03135548|472500151|FG001|Overall Study|Other than listed|2|||
131238189|NCT03135548|472500152|FG002|Overall Study|Other than listed|2|||
131238190|NCT02632175|472500153|FG000|Overall Study|Withdrawal by Subject|6|||
131238191|NCT02632175|472500153|FG000|Overall Study|Lost to Follow-up|1|||
130733334|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
131238192|NCT02632175|472500153|FG000|Overall Study|Lack of Efficacy|18|||
131238193|NCT02632175|472500153|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
131238194|NCT02632175|472500153|FG000|Overall Study|Subject noncompliance|3|||
131238195|NCT02632175|472500153|FG000|Overall Study|other|2|||
131238196|NCT03901963|472500155|FG000|Overall Study|Lost to Follow-up|1|||
131238197|NCT03901963|472500156|FG001|Overall Study|Lost to Follow-up|1|||
131238198|NCT03901963|472500155|FG000|Overall Study|Physician Decision|1|||
131238199|NCT03901963|472500156|FG001|Overall Study|Physician Decision|2|||
131238200|NCT03901963|472500155|FG000|Overall Study|Protocol Violation|1|||
131238201|NCT03901963|472500156|FG001|Overall Study|Protocol Violation|1|||
130784026|NCT03669588|470836841|FG000|Overall Study|Rescue Therapy Needed|0|||
131180427|NCT00949910|472281915|FG000|Overall Study|Symptomatic Deterioration|1088|||
131180428|NCT00949910|472281915|FG000|Overall Study|Lost to Follow-up|100|||
131180429|NCT00949910|472281915|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
131180430|NCT00949910|472281915|FG000|Overall Study|Participant Refusal|390|||
131180431|NCT00949910|472281915|FG000|Overall Study|Death Due to Malignant Disease|456|||
131180432|NCT00949910|472281915|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
131180433|NCT00949910|472281915|FG000|Overall Study|Death Due to Adverse Event|115|||
131180434|NCT00949910|472281915|FG000|Overall Study|Death Due to Toxicity|3|||
131180435|NCT00949910|472281915|FG000|Overall Study|Death from Unknown Cause|5|||
131180436|NCT00949910|472281915|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
131180437|NCT00949910|472281915|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
131180438|NCT00949910|472281915|FG000|Overall Study|Switched to Commercial Treatment|4|||
131180439|NCT00949910|472281915|FG000|Overall Study|Violation of Eligibility|23|||
131180440|NCT00949910|472281915|FG000|Overall Study|Logistical Reasons|13|||
130784027|NCT03669588|470836842|FG001|Overall Study|Rescue Therapy Needed|1|||
130784028|NCT00369343|470836845|FG000|Double-blind Phase|Adverse Event|19|||
130784029|NCT00369343|470836846|FG001|Double-blind Phase|Adverse Event|4|||
130784030|NCT00369343|470836845|FG000|Double-blind Phase|Failed to return|2|||
130784031|NCT00369343|470836846|FG001|Double-blind Phase|Failed to return|0|||
130784032|NCT00369343|470836845|FG000|Double-blind Phase|Lost to Follow-up|9|||
130784033|NCT00369343|470836846|FG001|Double-blind Phase|Lost to Follow-up|2|||
130784034|NCT00369343|470836845|FG000|Double-blind Phase|Protocol Violation|2|||
130784035|NCT00369343|470836846|FG001|Double-blind Phase|Protocol Violation|0|||
130784036|NCT00369343|470836845|FG000|Double-blind Phase|Withdrawal by Subject|8|||
130784037|NCT00369343|470836846|FG001|Double-blind Phase|Withdrawal by Subject|6|||
130784038|NCT00369343|470836845|FG000|Double-blind Phase|Lack of Efficacy|0|||
130784039|NCT00369343|470836846|FG001|Double-blind Phase|Lack of Efficacy|4|||
130784040|NCT00369343|470836845|FG000|Double-blind Phase|Protocol deviation|4|||
130784041|NCT00369343|470836846|FG001|Double-blind Phase|Protocol deviation|0|||
130784042|NCT00369343|470836845|FG000|Open-label Phase|Adverse Event|19|||
130784043|NCT00369343|470836846|FG001|Open-label Phase|Adverse Event|7|||
130784044|NCT00369343|470836845|FG000|Open-label Phase|Failed to return|4|||
130784045|NCT00369343|470836846|FG001|Open-label Phase|Failed to return|0|||
131180441|NCT00949910|472281915|FG000|Overall Study|Non-Compliance|10|||
131180442|NCT00949910|472281915|FG000|Overall Study|Prolonged Dosing Interruption|4|||
131180443|NCT00949910|472281915|FG000|Overall Study|Adverse Event|83|||
131180444|NCT00949910|472281915|FG000|Overall Study|Serious Adverse Event|6|||
131180445|NCT00949910|472281915|FG000|Overall Study|Physician/Participant Decision|7|||
131180446|NCT00949910|472281915|FG000|Overall Study|Other|4|||
131180447|NCT00949910|472281915|FG000|Overall Study|No Data|9|||
131180448|NCT02150213|472281916|FG000|Overall Study|Lost to Follow-up|1|||
131180449|NCT02150213|472281916|FG000|Overall Study|Withdrawal by Subject|1|||
131180450|NCT02678312|472281917|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
131180451|NCT02678312|472281918|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
131180452|NCT02678312|472281919|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
131180453|NCT02678312|472281920|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
131180454|NCT02678312|472281921|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
131180455|NCT02678312|472281917|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
131180456|NCT02678312|472281918|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
131180457|NCT02678312|472281919|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
131180458|NCT02678312|472281920|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
131180459|NCT02678312|472281921|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
131180460|NCT02678312|472281917|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
131180461|NCT02678312|472281918|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
131180462|NCT02678312|472281919|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
131180463|NCT02678312|472281920|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
131180464|NCT02678312|472281921|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
131180465|NCT02678312|472281917|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
131180466|NCT02678312|472281918|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
131180467|NCT02678312|472281919|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
131180468|NCT02678312|472281920|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
131180469|NCT02678312|472281921|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
131180470|NCT02678312|472281917|FG000|Part 2 Double Blind Epoch|Death|0|||
131180471|NCT02678312|472281918|FG001|Part 2 Double Blind Epoch|Death|0|||
131180472|NCT02678312|472281919|FG002|Part 2 Double Blind Epoch|Death|0|||
131180473|NCT02678312|472281920|FG003|Part 2 Double Blind Epoch|Death|8|||
131180474|NCT02678312|472281921|FG004|Part 2 Double Blind Epoch|Death|12|||
131180475|NCT02678312|472281917|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
131180476|NCT02678312|472281918|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
130784046|NCT00369343|470836845|FG000|Open-label Phase|Physician Decision|2|||
130784047|NCT00369343|470836846|FG001|Open-label Phase|Physician Decision|0|||
130784048|NCT00369343|470836845|FG000|Open-label Phase|Lost to Follow-up|5|||
130784049|NCT00369343|470836846|FG001|Open-label Phase|Lost to Follow-up|3|||
131180477|NCT02678312|472281919|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
131180478|NCT02678312|472281920|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
131180479|NCT02678312|472281921|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
131180480|NCT02678312|472281917|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
131180481|NCT02678312|472281918|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
131180482|NCT02678312|472281919|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
131180483|NCT02678312|472281920|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
131180484|NCT02678312|472281921|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
131180485|NCT02678312|472281917|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
131180486|NCT02678312|472281918|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
131180487|NCT02678312|472281919|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
131180488|NCT02678312|472281920|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
131180489|NCT02678312|472281921|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
131180490|NCT00971425|472281922|FG000|Overall Study|Adverse Event|1|||
131180491|NCT00971425|472281923|FG001|Overall Study|Adverse Event|1|||
131180492|NCT00971425|472281922|FG000|Overall Study|Withdrawal by Subject|0|||
131180493|NCT00971425|472281923|FG001|Overall Study|Withdrawal by Subject|1|||
131180494|NCT02293993|472281926|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
131180495|NCT02293993|472281927|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
131180496|NCT02293993|472281928|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
131180497|NCT02293993|472281929|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
131180498|NCT02293993|472281926|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
131180499|NCT02293993|472281927|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
131180500|NCT02293993|472281928|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
131180501|NCT02293993|472281929|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
131180502|NCT02293993|472281926|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
131180503|NCT02293993|472281927|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
131180504|NCT02293993|472281928|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
131180505|NCT02293993|472281929|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
131180506|NCT02293993|472281926|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
131180507|NCT02293993|472281927|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
131180508|NCT02293993|472281928|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
131180509|NCT02293993|472281929|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
131180510|NCT02293993|472281926|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
131180511|NCT02293993|472281927|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
131180512|NCT02293993|472281928|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
131180513|NCT02293993|472281929|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
131180514|NCT01188538|472281933|FG000|Overall Study|Lost to Follow-up|0|||
131180515|NCT01188538|472281934|FG001|Overall Study|Lost to Follow-up|1|||
131180516|NCT01280266|472281939|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
131180517|NCT01280266|472281940|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
131180518|NCT01280266|472281939|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
131180519|NCT01280266|472281940|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
131180520|NCT04295356|472281941|FG000|Overall Study|Physician Decision|1|||
131180521|NCT04295356|472281942|FG001|Overall Study|Physician Decision|0|||
131180522|NCT04295356|472281941|FG000|Overall Study|Lost to Follow-up|0|||
131180523|NCT04295356|472281942|FG001|Overall Study|Lost to Follow-up|3|||
131180524|NCT04295356|472281941|FG000|Overall Study|Protocol Violation|0|||
131180525|NCT04295356|472281942|FG001|Overall Study|Protocol Violation|1|||
131180526|NCT01106391|472281945|FG000|Overall Study|Death|12|||
131180527|NCT01106391|472281945|FG000|Overall Study|Withdrawal by Subject|7|||
131180528|NCT04268004|472281952|FG000|Overall Study|Excluded from analyses|0|||
131180529|NCT04268004|472281953|FG001|Overall Study|Excluded from analyses|1|||
131180530|NCT01381718|472281954|FG000|Overall Study|Withdrawal by Subject|2|||
131180531|NCT01381718|472281955|FG001|Overall Study|Withdrawal by Subject|5|||
131180532|NCT01381718|472281954|FG000|Overall Study|Lost to Follow-up|3|||
131180533|NCT01381718|472281955|FG001|Overall Study|Lost to Follow-up|5|||
131180534|NCT01381718|472281954|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
131180535|NCT01381718|472281955|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
131238202|NCT03901963|472500155|FG000|Overall Study|Withdrawal by Subject|4|||
131238203|NCT03901963|472500156|FG001|Overall Study|Withdrawal by Subject|11|||
131238204|NCT03901963|472500155|FG000|Overall Study|Ongoing|84|||
131238205|NCT03901963|472500156|FG001|Overall Study|Ongoing|73|||
131238206|NCT03901963|472500155|FG000|Overall Study|Randomized but not treated|3|||
131238207|NCT03901963|472500156|FG001|Overall Study|Randomized but not treated|3|||
131238208|NCT02854436|472500159|FG000|Overall Study|Adverse Event|1|||
130784050|NCT00369343|470836845|FG000|Open-label Phase|inadvertently reported study completers|3|||
130784051|NCT00369343|470836846|FG001|Open-label Phase|inadvertently reported study completers|2|||
130784052|NCT00369343|470836845|FG000|Open-label Phase|Protocol Violation|1|||
130784053|NCT00369343|470836846|FG001|Open-label Phase|Protocol Violation|3|||
130784054|NCT00369343|470836845|FG000|Open-label Phase|Withdrawal by Subject|15|||
130784055|NCT00369343|470836846|FG001|Open-label Phase|Withdrawal by Subject|6|||
130784056|NCT00369343|470836845|FG000|Open-label Phase|Lack of Efficacy|4|||
130784057|NCT00369343|470836846|FG001|Open-label Phase|Lack of Efficacy|3|||
130784058|NCT00369343|470836845|FG000|Open-label Phase|Lack of continuance tolerability|3|||
130784059|NCT00369343|470836846|FG001|Open-label Phase|Lack of continuance tolerability|4|||
130784060|NCT00369343|470836845|FG000|Open-label Phase|did not take study drug|1|||
130784061|NCT00369343|470836846|FG001|Open-label Phase|did not take study drug|2|||
130784062|NCT01100502|470836849|FG000|Overall Study|Withdrawal by Subject|18|||
130784063|NCT01100502|470836850|FG001|Overall Study|Withdrawal by Subject|25|||
130784064|NCT01100502|470836849|FG000|Overall Study|Lost to Follow-up|13|||
130784065|NCT01100502|470836850|FG001|Overall Study|Lost to Follow-up|28|||
130784066|NCT01100502|470836849|FG000|Overall Study|Site request to end participation in study|0|||
130784067|NCT01100502|470836850|FG001|Overall Study|Site request to end participation in study|1|||
130784068|NCT01100502|470836849|FG000|Overall Study|Death|45|||
130784069|NCT01100502|470836850|FG001|Overall Study|Death|40|||
130784070|NCT02322749|470836851|FG000|Period 2|Adverse Event|0|||
130784071|NCT02322749|470836852|FG001|Period 2|Adverse Event|0|||
130784072|NCT02322749|470836853|FG002|Period 2|Adverse Event|0|||
130784073|NCT02322749|470836854|FG003|Period 2|Adverse Event|1|||
130784074|NCT02322749|470836855|FG004|Period 2|Adverse Event|0|||
130784075|NCT02322749|470836856|FG005|Period 2|Adverse Event|0|||
130784076|NCT02322749|470836851|FG000|Period 2|Withdrawal by Subject|0|||
130784077|NCT02322749|470836852|FG001|Period 2|Withdrawal by Subject|0|||
130784078|NCT02322749|470836853|FG002|Period 2|Withdrawal by Subject|0|||
130784079|NCT02322749|470836854|FG003|Period 2|Withdrawal by Subject|1|||
130784080|NCT02322749|470836855|FG004|Period 2|Withdrawal by Subject|0|||
130784081|NCT02322749|470836856|FG005|Period 2|Withdrawal by Subject|0|||
130784082|NCT02322749|470836851|FG000|Period 3|Withdrawal by Subject|0|||
131180536|NCT01522443|472281958|FG000|Overall Study|No longer receiving clinical benefit|36|||
131180537|NCT01522443|472281959|FG001|Overall Study|No longer receiving clinical benefit|28|||
131180538|NCT01522443|472281958|FG000|Overall Study|Adverse Event|10|||
131180539|NCT01522443|472281959|FG001|Overall Study|Adverse Event|15|||
131180540|NCT01522443|472281958|FG000|Overall Study|Withdrawal by Subject|5|||
131180541|NCT01522443|472281959|FG001|Overall Study|Withdrawal by Subject|8|||
131238209|NCT02854436|472500159|FG000|Overall Study|Death|208|||
130733335|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733336|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733337|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733338|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733339|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130733340|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130733341|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
130733342|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130733343|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130733344|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130733345|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130733346|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130733347|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130733348|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
130733349|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130733350|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130733351|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130733352|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130733353|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130733354|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130733355|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130733356|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130733357|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
130733358|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130733359|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130733360|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130733361|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130733362|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130733363|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130733364|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
131180542|NCT01522443|472281958|FG000|Overall Study|No study treatment given|1|||
131180543|NCT01522443|472281959|FG001|Overall Study|No study treatment given|1|||
131180544|NCT01522443|472281958|FG000|Overall Study|Other|1|||
131180545|NCT01522443|472281959|FG001|Overall Study|Other|3|||
131180546|NCT05590767|472281962|FG000|Overall Study|Protocol Violation|1|||
131180547|NCT05590767|472281962|FG000|Overall Study|surgery canceled|1|||
131180548|NCT05590767|472281962|FG000|Overall Study|interscalene brachial block not performed|1|||
131180549|NCT01764256|472281963|FG000|Received All Vaccinations|Adverse Event|1|||
131180550|NCT01764256|472281964|FG001|Received All Vaccinations|Adverse Event|1|||
131180551|NCT01764256|472281965|FG002|Received All Vaccinations|Adverse Event|0|||
131180552|NCT01764256|472281966|FG003|Received All Vaccinations|Adverse Event|0|||
131180553|NCT01764256|472281963|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
131180554|NCT01764256|472281964|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
131180555|NCT01764256|472281965|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
131180556|NCT01764256|472281966|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
131180557|NCT01764256|472281963|FG000|Received All Vaccinations|Lost to Follow-up|1|||
131180558|NCT01764256|472281964|FG001|Received All Vaccinations|Lost to Follow-up|0|||
131180559|NCT01764256|472281965|FG002|Received All Vaccinations|Lost to Follow-up|0|||
131180560|NCT01764256|472281966|FG003|Received All Vaccinations|Lost to Follow-up|0|||
131180561|NCT01764256|472281963|FG000|Completed Study|Lost to Follow-up|0|||
131180562|NCT01764256|472281964|FG001|Completed Study|Lost to Follow-up|0|||
131180563|NCT01764256|472281965|FG002|Completed Study|Lost to Follow-up|0|||
131180564|NCT01764256|472281966|FG003|Completed Study|Lost to Follow-up|1|||
131180565|NCT00776555|472281978|FG000|Overall Study|Study terminated|3|||
131180566|NCT00776555|472281979|FG001|Overall Study|Study terminated|0|||
131180567|NCT02940626|472281980|FG000|Overall Study|Death|40|||
131180568|NCT02940626|472281981|FG001|Overall Study|Death|32|||
131180569|NCT02940626|472281980|FG000|Overall Study|Lost to Follow-up|5|||
131180570|NCT02940626|472281981|FG001|Overall Study|Lost to Follow-up|2|||
131180571|NCT02940626|472281980|FG000|Overall Study|Withdrawal by Subject|1|||
131180572|NCT02940626|472281981|FG001|Overall Study|Withdrawal by Subject|0|||
131180573|NCT02940626|472281980|FG000|Overall Study|Transfer to Hospice Care|1|||
131180574|NCT02940626|472281981|FG001|Overall Study|Transfer to Hospice Care|0|||
131180575|NCT02940626|472281980|FG000|Overall Study|Prohibited Concomitant Medication|0|||
131180576|NCT02940626|472281981|FG001|Overall Study|Prohibited Concomitant Medication|1|||
131180577|NCT00585923|472281983|FG000|Overall Study|Physician decided not to continue|31|||
131180578|NCT00585923|472281984|FG001|Overall Study|Physician decided not to continue|33|||
131180579|NCT00618449|472281985|FG000|Overall Study|Lost to Follow-up|98|||
131180580|NCT00618449|472281986|FG001|Overall Study|Lost to Follow-up|110|||
131180581|NCT01441115|472281987|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
131180582|NCT04311177|472281992|FG000|Overall Study|Adverse Event|3|||
131180583|NCT04311177|472281993|FG001|Overall Study|Adverse Event|1|||
131180584|NCT04311177|472281992|FG000|Overall Study|Physician Decision|4|||
131180585|NCT04311177|472281993|FG001|Overall Study|Physician Decision|3|||
131180586|NCT04311177|472281992|FG000|Overall Study|Withdrawal by Subject|1|||
131180587|NCT04311177|472281993|FG001|Overall Study|Withdrawal by Subject|0|||
131180588|NCT03454412|472281998|FG000|Baseline Assesment|Physician Decision|12|||
131180589|NCT01681576|472281999|FG000|Period 1|Adverse Event|1|||
131180590|NCT01681576|472282000|FG001|Period 1|Adverse Event|0|||
131180591|NCT01681576|472281999|FG000|Period 1|Protocol Deviation|1|||
131180592|NCT01681576|472282000|FG001|Period 1|Protocol Deviation|0|||
131180593|NCT01681576|472281999|FG000|Period 2|subject/guardian decision|3|||
131180594|NCT01681576|472282000|FG001|Period 2|subject/guardian decision|1|||
131180595|NCT01681576|472281999|FG000|Period 2|Non-compliance with study treatment|1|||
131180596|NCT01681576|472282000|FG001|Period 2|Non-compliance with study treatment|0|||
131180597|NCT00377429|472282004|FG000|Overall Study|Withdrawal by Subject|5|||
131180598|NCT00377429|472282004|FG000|Overall Study|Adverse Event|8|||
131180599|NCT00377429|472282004|FG000|Overall Study|Physician Decision|1|||
131180600|NCT00377429|472282004|FG000|Overall Study|Patient non-compliance|1|||
131180601|NCT00453180|472283664|FG000|Overall Study|Lost to Follow-up|2|||
131180602|NCT00453180|472283665|FG001|Overall Study|Lost to Follow-up|1|||
131180603|NCT00453180|472283664|FG000|Overall Study|Adverse Event|1|||
131180604|NCT00453180|472283665|FG001|Overall Study|Adverse Event|2|||
131180605|NCT02420795|472283672|FG000|Overall Study|Withdrawal by Subject|1|||
131180606|NCT02420795|472283673|FG001|Overall Study|Withdrawal by Subject|0|||
131180607|NCT02420795|472283674|FG002|Overall Study|Withdrawal by Subject|0|||
131180608|NCT02420795|472283672|FG000|Overall Study|Adverse Event|1|||
131180609|NCT02420795|472283673|FG001|Overall Study|Adverse Event|0|||
131180610|NCT02420795|472283674|FG002|Overall Study|Adverse Event|0|||
131180611|NCT02420795|472283672|FG000|Overall Study|Progressive disease|2|||
131180612|NCT02420795|472283673|FG001|Overall Study|Progressive disease|2|||
131180613|NCT02420795|472283674|FG002|Overall Study|Progressive disease|4|||
131180614|NCT02420795|472283672|FG000|Overall Study|Death|0|||
131180615|NCT02420795|472283673|FG001|Overall Study|Death|0|||
131180616|NCT02420795|472283674|FG002|Overall Study|Death|1|||
131180617|NCT01002742|472283677|FG000|Overall Study|Determined to be ineligible|0|||
131180618|NCT01002742|472283678|FG001|Overall Study|Determined to be ineligible|1|||
131180619|NCT02862548|472283690|FG000|Randomized Phase (Up to Week 48)|Death|0|||
131180620|NCT02862548|472283691|FG001|Randomized Phase (Up to Week 48)|Death|1|||
131180621|NCT02862548|472283690|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
131180622|NCT02862548|472283691|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
131180623|NCT02862548|472283690|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
131180624|NCT02862548|472283691|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
131180625|NCT02862548|472283690|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
131180626|NCT02862548|472283691|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
131180627|NCT00880763|472283692|FG000|Extension Period (Part 2)|Adverse Event|0|||
131180628|NCT00880763|472283693|FG001|Extension Period (Part 2)|Adverse Event|0|||
131180629|NCT00880763|472283694|FG002|Extension Period (Part 2)|Adverse Event|1|||
131180630|NCT00880763|472283695|FG003|Extension Period (Part 2)|Adverse Event|1|||
131180631|NCT00880763|472283692|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
131180632|NCT00880763|472283693|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
131180633|NCT00880763|472283694|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
131180634|NCT00880763|472283695|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
131180635|NCT00880763|472283692|FG000|Extension Period (Part 2)|Physician Decision|0|||
131180636|NCT00880763|472283693|FG001|Extension Period (Part 2)|Physician Decision|1|||
131180637|NCT00880763|472283694|FG002|Extension Period (Part 2)|Physician Decision|1|||
131180638|NCT00880763|472283695|FG003|Extension Period (Part 2)|Physician Decision|0|||
131180639|NCT00880763|472283692|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
131180640|NCT00880763|472283693|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
131180641|NCT00880763|472283694|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
131180642|NCT00880763|472283695|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
131180643|NCT00656084|472283696|FG000|Overall Study|Adverse Event|4|||
131180644|NCT00656084|472283696|FG000|Overall Study|Withdrawal by Subject|1|||
131180645|NCT00656084|472283696|FG000|Overall Study|Patient Request|1|||
131180646|NCT00656084|472283696|FG000|Overall Study|Investigator Request|1|||
131180647|NCT01293006|472283697|FG000|Period 2|Lost to Follow-up|1|||
131180648|NCT01293006|472283698|FG001|Period 2|Lost to Follow-up|0|||
131180649|NCT01293006|472283699|FG002|Period 2|Lost to Follow-up|0|||
131180650|NCT01293006|472283700|FG003|Period 2|Lost to Follow-up|0|||
131180651|NCT01494987|472283701|FG000|Overall Study|Adverse Event|6|||
131180652|NCT01494987|472283702|FG001|Overall Study|Adverse Event|5|||
131180653|NCT01494987|472283701|FG000|Overall Study|Hyperglycemia|6|||
131180654|NCT01494987|472283702|FG001|Overall Study|Hyperglycemia|4|||
131180655|NCT01494987|472283701|FG000|Overall Study|Investigator's Discretion|1|||
131180656|NCT01494987|472283702|FG001|Overall Study|Investigator's Discretion|2|||
131180657|NCT01494987|472283701|FG000|Overall Study|Lost to Follow-up|1|||
131180658|NCT01494987|472283702|FG001|Overall Study|Lost to Follow-up|1|||
131180659|NCT01494987|472283701|FG000|Overall Study|Protocol Violation|3|||
131180660|NCT01494987|472283702|FG001|Overall Study|Protocol Violation|3|||
131180661|NCT01494987|472283701|FG000|Overall Study|Subject Non-Compliance|9|||
131180662|NCT01494987|472283702|FG001|Overall Study|Subject Non-Compliance|10|||
131180663|NCT01494987|472283701|FG000|Overall Study|Subject Withdrew Consent|2|||
131180664|NCT01494987|472283702|FG001|Overall Study|Subject Withdrew Consent|3|||
131180665|NCT00436982|472283703|FG000|Overall Study|Withdrawal by Subject|3|||
131180666|NCT00436982|472283704|FG001|Overall Study|Withdrawal by Subject|1|||
131180667|NCT00436982|472283703|FG000|Overall Study|Did not receive allocated intervention|0|||
131180668|NCT00436982|472283704|FG001|Overall Study|Did not receive allocated intervention|1|||
131180669|NCT00436982|472283703|FG000|Overall Study|no RSA data|1|||
131180670|NCT00436982|472283704|FG001|Overall Study|no RSA data|2|||
131180671|NCT00953225|472283705|FG000|Overall Study|Withdrawal by Subject|2|||
131180672|NCT00953225|472283706|FG001|Overall Study|Withdrawal by Subject|0|||
131180673|NCT02384395|472283710|FG000|Overall Study|Physician Decision|4|||
131180674|NCT02384395|472283710|FG000|Overall Study|Withdrawal by Subject|3|||
131180675|NCT02384395|472283710|FG000|Overall Study|Lost to Follow-up|3|||
131180676|NCT00291499|472283714|FG000|Overall Study|Adverse Event|3|||
131180677|NCT00291499|472283715|FG001|Overall Study|Adverse Event|8|||
131180678|NCT00291499|472283714|FG000|Overall Study|Change to other therapy|2|||
131180679|NCT00291499|472283715|FG001|Overall Study|Change to other therapy|1|||
131180680|NCT00291499|472283714|FG000|Overall Study|Intercurrent illness|1|||
131180681|NCT00291499|472283715|FG001|Overall Study|Intercurrent illness|0|||
131180682|NCT00291499|472283714|FG000|Overall Study|Protocol Violation|2|||
131180683|NCT00291499|472283715|FG001|Overall Study|Protocol Violation|2|||
131180684|NCT00291499|472283714|FG000|Overall Study|Other reasons|1|||
131180685|NCT00291499|472283715|FG001|Overall Study|Other reasons|4|||
131180686|NCT03939637|472283716|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
131180687|NCT03939637|472283717|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
131180688|NCT03939637|472283716|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
131180689|NCT03939637|472283717|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
131180690|NCT03783442|472283718|FG000|Overall Study|Death|252|||
131180691|NCT03783442|472283719|FG001|Overall Study|Death|268|||
131180692|NCT03783442|472283718|FG000|Overall Study|Withdrawal by Subject|19|||
131238210|NCT02854436|472500159|FG000|Overall Study|Lost to Follow-up|5|||
131238211|NCT02854436|472500159|FG000|Overall Study|Withdrawal by Subject|24|||
131238212|NCT02854436|472500159|FG000|Overall Study|Other|45|||
131238213|NCT02854436|472500159|FG000|Overall Study|Physician Decision|6|||
131238214|NCT04557124|472500160|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
131238215|NCT04557124|472500161|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
131238216|NCT04557124|472500160|FG000|Mid-point (1 Month)|Missed testing|5|||
131238217|NCT04557124|472500161|FG001|Mid-point (1 Month)|Missed testing|4|||
131238218|NCT04557124|472500160|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
131238219|NCT04557124|472500161|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
131238220|NCT04557124|472500160|FG000|Post-testing (2 Months)|Missed testing|1|||
131238221|NCT04557124|472500161|FG001|Post-testing (2 Months)|Missed testing|5|||
131238222|NCT04557124|472500160|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
131238223|NCT04557124|472500161|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
131238224|NCT04557124|472500160|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
131238225|NCT04557124|472500161|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
131238226|NCT02088554|472500162|FG000|Overall Study|Exited before procedure|130|||
131180693|NCT03783442|472283719|FG001|Overall Study|Withdrawal by Subject|21|||
131180694|NCT03783442|472283718|FG000|Overall Study|Lost to Follow-up|7|||
131180695|NCT03783442|472283719|FG001|Overall Study|Lost to Follow-up|6|||
131180696|NCT03783442|472283718|FG000|Overall Study|Sponsor Ended Study|48|||
131180697|NCT03783442|472283719|FG001|Overall Study|Sponsor Ended Study|28|||
131180698|NCT04325906|472283720|FG000|Overall Study|Withdrawal by Subject|2|||
131180699|NCT04325906|472283721|FG001|Overall Study|Withdrawal by Subject|0|||
131180700|NCT01082367|472283722|FG000|Double-blind Period|Administrative problems|0|||
131180701|NCT01082367|472283723|FG001|Double-blind Period|Administrative problems|1|||
131180702|NCT01082367|472283722|FG000|Double-blind Period|Lack of Efficacy|5|||
131180703|NCT01082367|472283723|FG001|Double-blind Period|Lack of Efficacy|11|||
131180704|NCT01082367|472283722|FG000|Double-blind Period|Adverse Event|0|||
131180705|NCT01082367|472283723|FG001|Double-blind Period|Adverse Event|1|||
131180706|NCT01082367|472283722|FG000|Follow-up (F-U) Period|Administrative problems|1|||
131180707|NCT01082367|472283723|FG001|Follow-up (F-U) Period|Administrative problems|0|||
131180708|NCT01082367|472283722|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
131180709|NCT01082367|472283723|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
131180710|NCT01082367|472283722|FG000|Follow-up (F-U) Period|Adverse Event|0|||
131180711|NCT01082367|472283723|FG001|Follow-up (F-U) Period|Adverse Event|1|||
131180712|NCT00881361|472283724|FG000|Overall Study|Terminated prior to surgery|27|||
131180713|NCT00881361|472283725|FG001|Overall Study|Terminated prior to surgery|7|||
131180714|NCT00881361|472283726|FG002|Overall Study|Terminated prior to surgery|0|||
131180715|NCT00881361|472283724|FG000|Overall Study|Ineligible|17|||
131180716|NCT00881361|472283725|FG001|Overall Study|Ineligible|2|||
131180717|NCT00881361|472283726|FG002|Overall Study|Ineligible|2|||
131180718|NCT01413542|472283731|FG000|Overall Study|Physician Decision|1|||
131180719|NCT01413542|472283732|FG001|Overall Study|Physician Decision|0|||
131180720|NCT01413542|472283733|FG002|Overall Study|Physician Decision|3|||
131180721|NCT01413542|472283734|FG003|Overall Study|Physician Decision|0|||
131180722|NCT01413542|472283731|FG000|Overall Study|Adverse Event|0|||
131180723|NCT01413542|472283732|FG001|Overall Study|Adverse Event|0|||
131180724|NCT01413542|472283733|FG002|Overall Study|Adverse Event|0|||
131180725|NCT01413542|472283734|FG003|Overall Study|Adverse Event|1|||
131180726|NCT02505542|472283735|FG000|Part A: Open-Label Period|Adverse Event|31|||
131180727|NCT02505542|472283736|FG001|Part A: Open-Label Period|Adverse Event|0|||
131180728|NCT02505542|472283737|FG002|Part A: Open-Label Period|Adverse Event|0|||
131180729|NCT02505542|472283738|FG003|Part A: Open-Label Period|Adverse Event|0|||
131180730|NCT02505542|472283735|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
131180731|NCT02505542|472283736|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
131180732|NCT02505542|472283737|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
131180733|NCT02505542|472283738|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
131180734|NCT02505542|472283735|FG000|Part A: Open-Label Period|Protocol Violation|1|||
131180735|NCT02505542|472283736|FG001|Part A: Open-Label Period|Protocol Violation|0|||
131180736|NCT02505542|472283737|FG002|Part A: Open-Label Period|Protocol Violation|0|||
131180737|NCT02505542|472283738|FG003|Part A: Open-Label Period|Protocol Violation|0|||
131180738|NCT02505542|472283735|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
131180739|NCT02505542|472283736|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
131180740|NCT02505542|472283737|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
131180741|NCT02505542|472283738|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
131238227|NCT02088554|472500162|FG000|Overall Study|Attempted but not implanted|31|||
131238228|NCT02088554|472500162|FG000|Overall Study|Implant not attempted|19|||
131238229|NCT02088554|472500162|FG000|Overall Study|Pending next visit|532|||
131238230|NCT02088554|472500162|FG000|Overall Study|Death|170|||
131180742|NCT02505542|472283735|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
131180743|NCT02505542|472283736|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
131180744|NCT02505542|472283737|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
131238231|NCT02088554|472500162|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
131238232|NCT02088554|472500162|FG000|Overall Study|Lost to Follow-up|23|||
131180745|NCT02505542|472283738|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
131180746|NCT02505542|472283735|FG000|Part A: Open-Label Period|New medical history available|1|||
131180747|NCT02505542|472283736|FG001|Part A: Open-Label Period|New medical history available|0|||
131180748|NCT02505542|472283737|FG002|Part A: Open-Label Period|New medical history available|0|||
131180749|NCT02505542|472283738|FG003|Part A: Open-Label Period|New medical history available|0|||
131180750|NCT02505542|472283735|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
131180751|NCT02505542|472283736|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
131180752|NCT02505542|472283737|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
131180753|NCT02505542|472283738|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
131180754|NCT02505542|472283735|FG000|Part A: Open-Label Period|Pregnancy|2|||
131180755|NCT02505542|472283736|FG001|Part A: Open-Label Period|Pregnancy|0|||
131180756|NCT02505542|472283737|FG002|Part A: Open-Label Period|Pregnancy|0|||
131180757|NCT02505542|472283738|FG003|Part A: Open-Label Period|Pregnancy|0|||
131180758|NCT02505542|472283735|FG000|Part A: Open-Label Period|Sponsor directive|1|||
131180759|NCT02505542|472283736|FG001|Part A: Open-Label Period|Sponsor directive|0|||
131180760|NCT02505542|472283737|FG002|Part A: Open-Label Period|Sponsor directive|0|||
131180761|NCT02505542|472283738|FG003|Part A: Open-Label Period|Sponsor directive|0|||
131180762|NCT02505542|472283735|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
131180763|NCT02505542|472283736|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
131180764|NCT02505542|472283737|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
131180765|NCT02505542|472283738|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
131180766|NCT02505542|472283735|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
131180767|NCT02505542|472283736|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
131180768|NCT02505542|472283737|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
131180769|NCT02505542|472283738|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
131180770|NCT02505542|472283735|FG000|Part A: Open-Label Period|Non-compliance|1|||
131180771|NCT02505542|472283736|FG001|Part A: Open-Label Period|Non-compliance|0|||
131180772|NCT02505542|472283737|FG002|Part A: Open-Label Period|Non-compliance|0|||
131180773|NCT02505542|472283738|FG003|Part A: Open-Label Period|Non-compliance|0|||
131180774|NCT02505542|472283735|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
131180775|NCT02505542|472283736|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
131180776|NCT02505542|472283737|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
131180777|NCT02505542|472283738|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
131180778|NCT02505542|472283735|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
131180779|NCT02505542|472283736|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
131180780|NCT02505542|472283737|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
131180781|NCT02505542|472283738|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
131180782|NCT02505542|472283735|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
131180783|NCT02505542|472283736|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
131180784|NCT02505542|472283737|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
131180785|NCT02505542|472283738|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
131180786|NCT02505542|472283735|FG000|Part B: Double-Blind Period|Adverse Event|0|||
131180787|NCT02505542|472283736|FG001|Part B: Double-Blind Period|Adverse Event|0|||
131180788|NCT02505542|472283737|FG002|Part B: Double-Blind Period|Adverse Event|1|||
131180789|NCT02505542|472283738|FG003|Part B: Double-Blind Period|Adverse Event|3|||
131180790|NCT02505542|472283735|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
131180791|NCT02505542|472283736|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
131180792|NCT02505542|472283737|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
131180793|NCT02505542|472283738|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
131180794|NCT02505542|472283735|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
131180795|NCT02505542|472283736|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
131180796|NCT02505542|472283737|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
131180797|NCT02505542|472283738|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
131180798|NCT02505542|472283735|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
131180799|NCT02505542|472283736|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
131180800|NCT02505542|472283737|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
131180801|NCT02505542|472283738|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
131180802|NCT02505542|472283735|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
131180803|NCT02505542|472283736|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
131180804|NCT02505542|472283737|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
131180805|NCT02505542|472283738|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
131180806|NCT02505542|472283735|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
131180807|NCT02505542|472283736|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
131180808|NCT02505542|472283737|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
131180809|NCT02505542|472283738|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
131238233|NCT02088554|472500162|FG000|Overall Study|Explanted|32|||
130784083|NCT02322749|470836852|FG001|Period 3|Withdrawal by Subject|0|||
131238234|NCT02088554|472500162|FG000|Overall Study|Any other reason not covered by previous categories|11|||
130733365|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130733366|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
130733367|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130733368|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130733369|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130733370|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130733371|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130733372|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130733373|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130733374|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130733375|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733376|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
130733377|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
130733378|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733379|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733380|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733381|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733382|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733383|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130733384|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
130733385|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
130733386|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130733387|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130733388|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130733389|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130733390|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130733391|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130733392|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130733393|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130733394|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
130733395|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130733396|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130733397|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130733398|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130733399|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130733400|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130733401|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130733402|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130733403|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
130733404|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130733405|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130733406|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130733407|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130733408|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130733409|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130733410|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130733411|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130733412|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130733413|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
130733414|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130733415|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130733416|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130733417|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130733418|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130733419|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130733420|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130733421|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130733422|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
130733423|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130784084|NCT02322749|470836853|FG002|Period 3|Withdrawal by Subject|1|||
130784085|NCT02322749|470836854|FG003|Period 3|Withdrawal by Subject|0|||
130784086|NCT02322749|470836855|FG004|Period 3|Withdrawal by Subject|0|||
130784087|NCT02322749|470836856|FG005|Period 3|Withdrawal by Subject|0|||
130784088|NCT05158140|470836867|FG000|Overall Study|Death|0|||
130784089|NCT05158140|470836868|FG001|Overall Study|Death|0|||
130784090|NCT05158140|470836869|FG002|Overall Study|Death|0|||
130784091|NCT05158140|470836870|FG003|Overall Study|Death|1|||
130784092|NCT05158140|470836867|FG000|Overall Study|Lost to Follow-up|3|||
130784093|NCT05158140|470836868|FG001|Overall Study|Lost to Follow-up|6|||
130784094|NCT05158140|470836869|FG002|Overall Study|Lost to Follow-up|4|||
130784095|NCT05158140|470836870|FG003|Overall Study|Lost to Follow-up|3|||
130784096|NCT05158140|470836867|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130784097|NCT05158140|470836868|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
131238235|NCT04623216|472500163|FG000|Overall Study|Death|5|||
131238236|NCT04623216|472500164|FG001|Overall Study|Death|2|||
131238237|NCT04623216|472500165|FG002|Overall Study|Death|0|||
131238238|NCT04623216|472500166|FG003|Overall Study|Death|0|||
131238239|NCT04623216|472500163|FG000|Overall Study|Terminated by Sponsor|3|||
131238240|NCT04623216|472500164|FG001|Overall Study|Terminated by Sponsor|2|||
131238241|NCT04623216|472500165|FG002|Overall Study|Terminated by Sponsor|2|||
131238242|NCT04623216|472500166|FG003|Overall Study|Terminated by Sponsor|0|||
131238243|NCT04623216|472500163|FG000|Overall Study|Physician Decision|1|||
131238244|NCT04623216|472500164|FG001|Overall Study|Physician Decision|0|||
131238245|NCT04623216|472500165|FG002|Overall Study|Physician Decision|0|||
131238246|NCT04623216|472500166|FG003|Overall Study|Physician Decision|0|||
131238247|NCT04424407|472500167|FG000|Overall Study|Withdrawal by Subject|2|||
131238248|NCT04424407|472500167|FG000|Overall Study|Lost to Follow-up|1|||
131238249|NCT03803943|472500170|FG000|Overall Study|Withdrawal by Subject|2|||
131238250|NCT03803943|472500171|FG001|Overall Study|Withdrawal by Subject|2|||
131238251|NCT03803943|472500172|FG002|Overall Study|Withdrawal by Subject|2|||
131238252|NCT03803943|472500173|FG003|Overall Study|Withdrawal by Subject|2|||
131238253|NCT03521154|472500181|FG000|Overall Study|Ongoing study at data cut-off|111|||
131238254|NCT03521154|472500182|FG001|Overall Study|Ongoing study at data cut-off|52|||
131238255|NCT03499964|472500183|FG000|Overall Study|Lack of Efficacy|6|||
131238256|NCT03499964|472500184|FG001|Overall Study|Lack of Efficacy|26|||
131238257|NCT03499964|472500183|FG000|Overall Study|Adverse Event|1|||
131238258|NCT03499964|472500184|FG001|Overall Study|Adverse Event|0|||
131238259|NCT03499964|472500183|FG000|Overall Study|Death|1|||
131238260|NCT03499964|472500184|FG001|Overall Study|Death|0|||
131238261|NCT03499964|472500183|FG000|Overall Study|Withdrawal by Subject|2|||
131238262|NCT03499964|472500184|FG001|Overall Study|Withdrawal by Subject|1|||
131238263|NCT03499964|472500183|FG000|Overall Study|Lost to Follow-up|1|||
131238264|NCT03499964|472500184|FG001|Overall Study|Lost to Follow-up|0|||
131180810|NCT02505542|472283735|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
131180811|NCT02505542|472283736|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
131180812|NCT02505542|472283737|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
131180813|NCT02505542|472283738|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
131180814|NCT02505542|472283735|FG000|Part B: Double-Blind Period|Miscalculation|0|||
131180815|NCT02505542|472283736|FG001|Part B: Double-Blind Period|Miscalculation|1|||
131180816|NCT02505542|472283737|FG002|Part B: Double-Blind Period|Miscalculation|0|||
131180817|NCT02505542|472283738|FG003|Part B: Double-Blind Period|Miscalculation|0|||
131180818|NCT02505542|472283735|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
131180819|NCT02505542|472283736|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
131180820|NCT02505542|472283737|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
131180821|NCT02505542|472283738|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
131180822|NCT02759861|472283739|FG000|Overall Study|Death|1|||
131180823|NCT00225212|472283746|FG000|Overall Study|Disease progression|2|||
131180824|NCT00225212|472283746|FG000|Overall Study|Death|1|||
131180825|NCT00225212|472283746|FG000|Overall Study|Adverse Event|2|||
131180826|NCT00225212|472283746|FG000|Overall Study|Intercurrent illness|1|||
131238265|NCT05218499|472500185|FG000|Overall Study|Not treated|1|||
131238266|NCT05218499|472500186|FG001|Overall Study|Not treated|1|||
130784098|NCT05158140|470836869|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
131180827|NCT05159362|472283749|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
131238267|NCT05218499|472500187|FG002|Overall Study|Not treated|8|||
130784099|NCT05158140|470836870|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
131180828|NCT05159362|472283750|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
131180829|NCT05159362|472283751|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
131180830|NCT01309841|472283752|FG000|Overall Study|Other|0|||
131180831|NCT01309841|472283753|FG001|Overall Study|Other|1|||
131238268|NCT05218499|472500185|FG000|Overall Study|Death|2|||
131238269|NCT05218499|472500186|FG001|Overall Study|Death|0|||
131238270|NCT05218499|472500187|FG002|Overall Study|Death|0|||
131238271|NCT05218499|472500185|FG000|Overall Study|Other than listed|3|||
131238272|NCT05218499|472500186|FG001|Overall Study|Other than listed|7|||
131238273|NCT05218499|472500187|FG002|Overall Study|Other than listed|10|||
131238274|NCT05218499|472500185|FG000|Overall Study|Protocol deviation|5|||
131238275|NCT05218499|472500186|FG001|Overall Study|Protocol deviation|6|||
131238276|NCT05218499|472500187|FG002|Overall Study|Protocol deviation|4|||
131238277|NCT05218499|472500185|FG000|Overall Study|Technical problems|0|||
131238278|NCT05218499|472500186|FG001|Overall Study|Technical problems|1|||
131238279|NCT05218499|472500187|FG002|Overall Study|Technical problems|0|||
131238280|NCT05218499|472500185|FG000|Overall Study|Burden of trial procedures|0|||
131238281|NCT05218499|472500186|FG001|Overall Study|Burden of trial procedures|1|||
131238282|NCT05218499|472500187|FG002|Overall Study|Burden of trial procedures|2|||
131238283|NCT05218499|472500185|FG000|Overall Study|Clinical disease progression|6|||
131238284|NCT05218499|472500186|FG001|Overall Study|Clinical disease progression|6|||
131238285|NCT05218499|472500187|FG002|Overall Study|Clinical disease progression|11|||
131238286|NCT05218499|472500185|FG000|Overall Study|Objective disease progression|44|||
131238287|NCT05218499|472500186|FG001|Overall Study|Objective disease progression|61|||
131238288|NCT05218499|472500187|FG002|Overall Study|Objective disease progression|42|||
131238289|NCT05218499|472500185|FG000|Overall Study|Adverse Event|11|||
131238290|NCT05218499|472500186|FG001|Overall Study|Adverse Event|36|||
131238291|NCT05218499|472500187|FG002|Overall Study|Adverse Event|9|||
131238292|NCT05218499|472500185|FG000|Overall Study|On treatment at time of snapshot|18|||
131238293|NCT05218499|472500186|FG001|Overall Study|On treatment at time of snapshot|29|||
131238294|NCT05218499|472500187|FG002|Overall Study|On treatment at time of snapshot|0|||
131238295|NCT05386680|472500188|FG000|Overall Study|Guardian decision|2|||
131238296|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
131238297|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
131238298|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131238299|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131238300|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131238301|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
131238302|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
131238303|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131238304|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131238305|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131238306|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131238307|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131238308|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131238309|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
131238310|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238311|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238312|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238313|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238314|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238315|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
131238316|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
131238317|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238318|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238319|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238320|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238321|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238322|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238323|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
131238324|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
131238325|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238326|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238327|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238328|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238329|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238330|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
131238331|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238332|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238333|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238334|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238335|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238336|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238337|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
131238338|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131238339|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131238340|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131238341|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131238342|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130784100|NCT05158140|470836867|FG000|Overall Study|Withdrawal by Subject|3|||
130784101|NCT05158140|470836868|FG001|Overall Study|Withdrawal by Subject|7|||
130784102|NCT05158140|470836869|FG002|Overall Study|Withdrawal by Subject|3|||
130784103|NCT05158140|470836870|FG003|Overall Study|Withdrawal by Subject|7|||
130784104|NCT04414787|470836875|FG000|Overall Study|Patient Death|18|||
130784105|NCT04414787|470836876|FG001|Overall Study|Patient Death|18|||
130784106|NCT04414787|470836877|FG002|Overall Study|Patient Death|15|||
130784107|NCT04414787|470836878|FG003|Overall Study|Patient Death|15|||
130784108|NCT04414787|470836875|FG000|Overall Study|Patient Hospitalization|1|||
130784109|NCT04414787|470836876|FG001|Overall Study|Patient Hospitalization|1|||
130784110|NCT04414787|470836877|FG002|Overall Study|Patient Hospitalization|2|||
130784111|NCT04414787|470836878|FG003|Overall Study|Patient Hospitalization|2|||
130784112|NCT04414787|470836875|FG000|Overall Study|Lost to Follow-up|7|||
130784113|NCT04414787|470836876|FG001|Overall Study|Lost to Follow-up|7|||
130784114|NCT04414787|470836877|FG002|Overall Study|Lost to Follow-up|5|||
130784115|NCT04414787|470836878|FG003|Overall Study|Lost to Follow-up|5|||
130784116|NCT04414787|470836875|FG000|Overall Study|Residence in post-acute care facility|3|||
130784117|NCT04414787|470836876|FG001|Overall Study|Residence in post-acute care facility|3|||
130784118|NCT04414787|470836877|FG002|Overall Study|Residence in post-acute care facility|5|||
130784119|NCT04414787|470836878|FG003|Overall Study|Residence in post-acute care facility|5|||
130784120|NCT00807365|470836882|FG000|Overall Study|Study Terminated|5|||
130784121|NCT01526785|470836883|FG000|Overall Study|Study Terminated by Sponsor|8|||
130784122|NCT01526785|470836883|FG000|Overall Study|Death|2|||
130784123|NCT01526785|470836883|FG000|Overall Study|Physician Decision|1|||
130784124|NCT01526785|470836883|FG000|Overall Study|Withdrawal by Subject|2|||
130784125|NCT01814007|470836891|FG000|Overall Study|Withdrawal by Subject|1|||
130784126|NCT04350827|470836892|FG000|Overall Study|Lost to Follow-up|1|||
130784127|NCT04350827|470836893|FG001|Overall Study|Lost to Follow-up|2|||
130784128|NCT00945243|470838686|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
130784129|NCT03256578|470838687|FG000|Overall Study|Excluded Post Randomization|66|||
130784130|NCT03256578|470838688|FG001|Overall Study|Excluded Post Randomization|56|||
130784131|NCT04969289|470838691|FG000|Overall Study|Lost to Follow-up|13|||
130784132|NCT04969289|470838692|FG001|Overall Study|Lost to Follow-up|9|||
130784133|NCT03028142|470838693|FG000|Overall Study|Adverse Event|1|||
130784134|NCT03028142|470838694|FG001|Overall Study|Adverse Event|1|||
130784135|NCT03028142|470838695|FG002|Overall Study|Adverse Event|0|||
130784136|NCT03028142|470838696|FG003|Overall Study|Adverse Event|0|||
130784137|NCT03028142|470838697|FG004|Overall Study|Adverse Event|0|||
130784138|NCT03028142|470838698|FG005|Overall Study|Adverse Event|1|||
130784139|NCT03028142|470838693|FG000|Overall Study|Withdrawal by Subject|0|||
130784140|NCT03028142|470838694|FG001|Overall Study|Withdrawal by Subject|0|||
130784141|NCT03028142|470838695|FG002|Overall Study|Withdrawal by Subject|0|||
130784142|NCT03028142|470838696|FG003|Overall Study|Withdrawal by Subject|0|||
130784143|NCT03028142|470838697|FG004|Overall Study|Withdrawal by Subject|1|||
130784144|NCT03028142|470838698|FG005|Overall Study|Withdrawal by Subject|0|||
130784145|NCT02810418|470838699|FG000|Arm A Dose Escalation|Adverse Event|2|||
130784146|NCT02810418|470838700|FG001|Arm A Dose Escalation|Adverse Event|1|||
130784147|NCT02810418|470838701|FG002|Arm A Dose Escalation|Adverse Event|0|||
131238343|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
131238344|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
131238345|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131238346|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131238347|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131238348|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131238349|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131238350|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
131238351|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130784148|NCT02810418|470838702|FG003|Arm A Dose Escalation|Adverse Event|0|||
130784149|NCT02810418|470838703|FG004|Arm A Dose Escalation|Adverse Event|0|||
130784150|NCT02810418|470838704|FG005|Arm A Dose Escalation|Adverse Event|0|||
131238352|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238353|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130784151|NCT02810418|470838705|FG006|Arm A Dose Escalation|Adverse Event|0|||
130784152|NCT02810418|470838699|FG000|Dose Expansion|Adverse Event|0|||
130784153|NCT02810418|470838700|FG001|Dose Expansion|Adverse Event|1|||
130784154|NCT02810418|470838701|FG002|Dose Expansion|Adverse Event|1|||
130784155|NCT02810418|470838702|FG003|Dose Expansion|Adverse Event|0|||
130784156|NCT02810418|470838703|FG004|Dose Expansion|Adverse Event|0|||
130784157|NCT02810418|470838704|FG005|Dose Expansion|Adverse Event|0|||
130784158|NCT02810418|470838705|FG006|Dose Expansion|Adverse Event|0|||
130784159|NCT02810418|470838699|FG000|Dose Expansion|Physician Decision|0|||
130784160|NCT02810418|470838700|FG001|Dose Expansion|Physician Decision|0|||
130784161|NCT02810418|470838701|FG002|Dose Expansion|Physician Decision|2|||
130784162|NCT02810418|470838702|FG003|Dose Expansion|Physician Decision|0|||
130784163|NCT02810418|470838703|FG004|Dose Expansion|Physician Decision|0|||
131180832|NCT01309841|472283754|FG002|Overall Study|Other|1|||
131180833|NCT01309841|472283752|FG000|Overall Study|Lost to Follow-up|7|||
131180834|NCT01309841|472283753|FG001|Overall Study|Lost to Follow-up|6|||
131180835|NCT01309841|472283754|FG002|Overall Study|Lost to Follow-up|4|||
131180836|NCT01309841|472283752|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
131180837|NCT01309841|472283753|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
131180838|NCT01309841|472283754|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
131180839|NCT01309841|472283752|FG000|Overall Study|Lack of Efficacy|0|||
131180840|NCT01309841|472283753|FG001|Overall Study|Lack of Efficacy|0|||
131180841|NCT01309841|472283754|FG002|Overall Study|Lack of Efficacy|2|||
131180842|NCT01309841|472283752|FG000|Overall Study|Adverse Event|9|||
131180843|NCT01309841|472283753|FG001|Overall Study|Adverse Event|22|||
131180844|NCT01309841|472283754|FG002|Overall Study|Adverse Event|11|||
131180845|NCT01309841|472283752|FG000|Overall Study|Death|1|||
131180846|NCT01309841|472283753|FG001|Overall Study|Death|0|||
131180847|NCT01309841|472283754|FG002|Overall Study|Death|0|||
131180848|NCT01309841|472283752|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131180849|NCT01309841|472283753|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
131180850|NCT01309841|472283754|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
131180851|NCT01309841|472283752|FG000|Overall Study|Withdrawal by Subject|17|||
131180852|NCT01309841|472283753|FG001|Overall Study|Withdrawal by Subject|6|||
131180853|NCT01309841|472283754|FG002|Overall Study|Withdrawal by Subject|13|||
131180854|NCT01309841|472283752|FG000|Overall Study|Did Not Receive Treatment|2|||
131180855|NCT01309841|472283753|FG001|Overall Study|Did Not Receive Treatment|0|||
131180856|NCT01309841|472283754|FG002|Overall Study|Did Not Receive Treatment|1|||
131180857|NCT01309841|472283752|FG000|Overall Study|Severe non-compliance with protocol|0|||
131180858|NCT01309841|472283753|FG001|Overall Study|Severe non-compliance with protocol|5|||
131180859|NCT01309841|472283754|FG002|Overall Study|Severe non-compliance with protocol|2|||
131180860|NCT00105560|472283755|FG000|Overall Study|Lost to Follow-up|1|||
131180861|NCT03699631|472283757|FG000|Overall Study|Adverse Event|3|||
131180862|NCT01324622|472283758|FG000|Overall Study|Lost to Follow-up|7|||
131180863|NCT01324622|472283759|FG001|Overall Study|Lost to Follow-up|7|||
131180864|NCT01324622|472283758|FG000|Overall Study|Death|1|||
131180865|NCT01324622|472283759|FG001|Overall Study|Death|0|||
131180866|NCT01324622|472283758|FG000|Overall Study|Lack of Efficacy|1|||
131180867|NCT01324622|472283759|FG001|Overall Study|Lack of Efficacy|0|||
131180868|NCT00138424|472283760|FG000|Overall Study|Physician Decision|0|||
131180869|NCT00138424|472283761|FG001|Overall Study|Physician Decision|1|||
131180870|NCT00138424|472283762|FG002|Overall Study|Physician Decision|0|||
131180871|NCT00138424|472283763|FG003|Overall Study|Physician Decision|0|||
131180872|NCT00413062|472283764|FG000|Overall Study|Adverse event/serious adverse event|289|||
131180873|NCT00413062|472283765|FG001|Overall Study|Adverse event/serious adverse event|56|||
131180874|NCT00413062|472283764|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
131180875|NCT00413062|472283765|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
131180876|NCT00413062|472283764|FG000|Overall Study|Withdrawal of informed consent|111|||
131180877|NCT00413062|472283765|FG001|Overall Study|Withdrawal of informed consent|36|||
131180878|NCT00413062|472283764|FG000|Overall Study|Pregnancy|15|||
131180879|NCT00413062|472283765|FG001|Overall Study|Pregnancy|5|||
131180880|NCT00413062|472283764|FG000|Overall Study|Pregnancy wish|17|||
131180881|NCT00413062|472283765|FG001|Overall Study|Pregnancy wish|6|||
131180882|NCT00413062|472283764|FG000|Overall Study|Lost to Follow-up|175|||
131180883|NCT00413062|472283765|FG001|Overall Study|Lost to Follow-up|73|||
131180884|NCT00413062|472283764|FG000|Overall Study|Other reason|70|||
131180885|NCT00413062|472283765|FG001|Overall Study|Other reason|34|||
131180886|NCT02176291|472283766|FG000|Overall Study|Death|1|||
131180887|NCT02176291|472283767|FG001|Overall Study|Death|0|||
131180888|NCT02176291|472283766|FG000|Overall Study|non compliance with protocol|2|||
131180889|NCT02176291|472283767|FG001|Overall Study|non compliance with protocol|0|||
131180890|NCT02176291|472283766|FG000|Overall Study|Withdrawal by Subject|2|||
131180891|NCT02176291|472283767|FG001|Overall Study|Withdrawal by Subject|0|||
131180892|NCT02815293|472283770|FG000|Overall Study|Study termination by sponsor|10|||
131180893|NCT02815293|472283771|FG001|Overall Study|Study termination by sponsor|7|||
131180894|NCT02815293|472283772|FG002|Overall Study|Study termination by sponsor|0|||
131180895|NCT02815293|472283770|FG000|Overall Study|Participants not randomized|0|||
131180896|NCT02815293|472283771|FG001|Overall Study|Participants not randomized|0|||
131180897|NCT02815293|472283772|FG002|Overall Study|Participants not randomized|18|||
131180898|NCT02815293|472283770|FG000|Overall Study|Adverse Event|0|||
131180899|NCT02815293|472283771|FG001|Overall Study|Adverse Event|1|||
131180900|NCT02815293|472283772|FG002|Overall Study|Adverse Event|0|||
131180901|NCT00006604|472283775|FG000|Overall Study|Met study objective - no further FU|1|||
131180902|NCT00006604|472283776|FG001|Overall Study|Met study objective - no further FU|0|||
131180903|NCT00006604|472283777|FG002|Overall Study|Met study objective - no further FU|0|||
131180904|NCT00006604|472283778|FG003|Overall Study|Met study objective - no further FU|0|||
131180905|NCT00006604|472283779|FG004|Overall Study|Met study objective - no further FU|0|||
131180906|NCT00006604|472283780|FG005|Overall Study|Met study objective - no further FU|0|||
131180907|NCT00006604|472283781|FG006|Overall Study|Met study objective - no further FU|0|||
131180908|NCT00006604|472283782|FG007|Overall Study|Met study objective - no further FU|0|||
131180909|NCT00006604|472283783|FG008|Overall Study|Met study objective - no further FU|0|||
131180910|NCT00006604|472283784|FG009|Overall Study|Met study objective - no further FU|0|||
131180911|NCT00006604|472283785|FG010|Overall Study|Met study objective - no further FU|0|||
131180912|NCT00006604|472283786|FG011|Overall Study|Met study objective - no further FU|0|||
131180913|NCT00006604|472283787|FG012|Overall Study|Met study objective - no further FU|0|||
131180914|NCT00006604|472283788|FG013|Overall Study|Met study objective - no further FU|0|||
131180915|NCT00006604|472283789|FG014|Overall Study|Met study objective - no further FU|1|||
131180916|NCT00006604|472283790|FG015|Overall Study|Met study objective - no further FU|1|||
131180917|NCT00006604|472283791|FG016|Overall Study|Met study objective - no further FU|0|||
131180918|NCT00006604|472283775|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
131180919|NCT00006604|472283776|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
131180920|NCT00006604|472283777|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
131180921|NCT00006604|472283778|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
131180922|NCT00006604|472283779|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
131180923|NCT00006604|472283780|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
131180924|NCT00006604|472283781|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
131180925|NCT00006604|472283782|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
131180926|NCT00006604|472283783|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
131180927|NCT00006604|472283784|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
131180928|NCT00006604|472283785|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
131180929|NCT00006604|472283786|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
131180930|NCT00006604|472283787|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
131180931|NCT00006604|472283788|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
131180932|NCT00006604|472283789|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
131180933|NCT00006604|472283790|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
131180934|NCT00006604|472283791|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
131180935|NCT00006604|472283775|FG000|Overall Study|Death|0|||
131180936|NCT00006604|472283776|FG001|Overall Study|Death|0|||
131180937|NCT00006604|472283777|FG002|Overall Study|Death|0|||
131180938|NCT00006604|472283778|FG003|Overall Study|Death|0|||
131180939|NCT00006604|472283779|FG004|Overall Study|Death|0|||
131180940|NCT00006604|472283780|FG005|Overall Study|Death|0|||
131180941|NCT00006604|472283781|FG006|Overall Study|Death|0|||
131180942|NCT00006604|472283782|FG007|Overall Study|Death|0|||
131180943|NCT00006604|472283783|FG008|Overall Study|Death|0|||
131180944|NCT00006604|472283784|FG009|Overall Study|Death|1|||
131180945|NCT00006604|472283785|FG010|Overall Study|Death|1|||
131180946|NCT00006604|472283786|FG011|Overall Study|Death|1|||
131180947|NCT00006604|472283787|FG012|Overall Study|Death|0|||
131180948|NCT00006604|472283788|FG013|Overall Study|Death|0|||
131180949|NCT00006604|472283789|FG014|Overall Study|Death|0|||
131180950|NCT00006604|472283790|FG015|Overall Study|Death|0|||
131180951|NCT00006604|472283791|FG016|Overall Study|Death|0|||
131180952|NCT00006604|472283775|FG000|Overall Study|Severe debilitation, unable to continue|0|||
131180953|NCT00006604|472283776|FG001|Overall Study|Severe debilitation, unable to continue|0|||
131180954|NCT00006604|472283777|FG002|Overall Study|Severe debilitation, unable to continue|0|||
131180955|NCT00006604|472283778|FG003|Overall Study|Severe debilitation, unable to continue|0|||
131180956|NCT00006604|472283779|FG004|Overall Study|Severe debilitation, unable to continue|0|||
131180957|NCT00006604|472283780|FG005|Overall Study|Severe debilitation, unable to continue|0|||
131180958|NCT00006604|472283781|FG006|Overall Study|Severe debilitation, unable to continue|3|||
131180959|NCT00006604|472283782|FG007|Overall Study|Severe debilitation, unable to continue|0|||
131180960|NCT00006604|472283783|FG008|Overall Study|Severe debilitation, unable to continue|0|||
131180961|NCT00006604|472283784|FG009|Overall Study|Severe debilitation, unable to continue|5|||
131180962|NCT00006604|472283785|FG010|Overall Study|Severe debilitation, unable to continue|0|||
131180963|NCT00006604|472283786|FG011|Overall Study|Severe debilitation, unable to continue|2|||
130733424|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130733425|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130733426|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130733427|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
131180964|NCT00006604|472283787|FG012|Overall Study|Severe debilitation, unable to continue|1|||
131180965|NCT00006604|472283788|FG013|Overall Study|Severe debilitation, unable to continue|0|||
131180966|NCT00006604|472283789|FG014|Overall Study|Severe debilitation, unable to continue|2|||
131180967|NCT00006604|472283790|FG015|Overall Study|Severe debilitation, unable to continue|0|||
131180968|NCT00006604|472283791|FG016|Overall Study|Severe debilitation, unable to continue|0|||
131180969|NCT00006604|472283775|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
131180970|NCT00006604|472283776|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
131180971|NCT00006604|472283777|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
130733428|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
131238354|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238355|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238356|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238357|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238358|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
131238359|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238360|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238361|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238362|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238363|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238364|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238365|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
131238366|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
131238367|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
131238368|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
131238369|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131238370|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131238371|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
131238372|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
131238373|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131238374|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131238375|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131238376|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131238377|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131238378|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131238379|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
131238380|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238381|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
131238382|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238383|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238384|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238385|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
131238386|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238387|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238388|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238389|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238390|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238391|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238392|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238393|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
131238394|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
131238395|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238396|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238397|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238398|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238399|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
131238400|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238401|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238402|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238403|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238404|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238405|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131180972|NCT00006604|472283778|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
131180973|NCT00006604|472283779|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
131180974|NCT00006604|472283780|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
131180975|NCT00006604|472283781|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
131180976|NCT00006604|472283782|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
131180977|NCT00006604|472283783|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
131180978|NCT00006604|472283784|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
131180979|NCT00006604|472283785|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
131180980|NCT00006604|472283786|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
131180981|NCT00006604|472283787|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
131180982|NCT00006604|472283788|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
131180983|NCT00006604|472283789|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
130784164|NCT02810418|470838704|FG005|Dose Expansion|Physician Decision|0|||
130784165|NCT02810418|470838705|FG006|Dose Expansion|Physician Decision|0|||
130784166|NCT02810418|470838699|FG000|Arm B Dose Escalation|Adverse Event|0|||
130784167|NCT02810418|470838700|FG001|Arm B Dose Escalation|Adverse Event|0|||
130784168|NCT02810418|470838701|FG002|Arm B Dose Escalation|Adverse Event|0|||
130784169|NCT02810418|470838702|FG003|Arm B Dose Escalation|Adverse Event|0|||
130784170|NCT02810418|470838703|FG004|Arm B Dose Escalation|Adverse Event|1|||
130784171|NCT02810418|470838704|FG005|Arm B Dose Escalation|Adverse Event|2|||
130784172|NCT02810418|470838705|FG006|Arm B Dose Escalation|Adverse Event|0|||
131180984|NCT00006604|472283790|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
131238406|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238407|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
131238408|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131238409|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131238410|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131238411|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
131238412|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
131238413|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131238414|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131238415|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
131238416|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
131238417|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131238418|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131238419|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131238420|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131238421|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
131238422|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238423|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238424|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238425|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238426|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238427|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238428|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238429|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
131238430|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
131238431|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238432|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131180985|NCT00006604|472283791|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
131180986|NCT00006604|472283775|FG000|Overall Study|Site closing|0|||
131180987|NCT00006604|472283776|FG001|Overall Study|Site closing|0|||
131180988|NCT00006604|472283777|FG002|Overall Study|Site closing|1|||
131180989|NCT00006604|472283778|FG003|Overall Study|Site closing|1|||
131180990|NCT00006604|472283779|FG004|Overall Study|Site closing|0|||
131180991|NCT00006604|472283780|FG005|Overall Study|Site closing|0|||
131180992|NCT00006604|472283781|FG006|Overall Study|Site closing|0|||
131180993|NCT00006604|472283782|FG007|Overall Study|Site closing|1|||
131180994|NCT00006604|472283783|FG008|Overall Study|Site closing|0|||
131180995|NCT00006604|472283784|FG009|Overall Study|Site closing|0|||
131180996|NCT00006604|472283785|FG010|Overall Study|Site closing|0|||
131180997|NCT00006604|472283786|FG011|Overall Study|Site closing|1|||
131180998|NCT00006604|472283787|FG012|Overall Study|Site closing|1|||
131180999|NCT00006604|472283788|FG013|Overall Study|Site closing|1|||
131181000|NCT00006604|472283789|FG014|Overall Study|Site closing|0|||
131181001|NCT00006604|472283790|FG015|Overall Study|Site closing|0|||
131181002|NCT00006604|472283791|FG016|Overall Study|Site closing|1|||
131181003|NCT00006604|472283775|FG000|Overall Study|Withdrawal by Subject|1|||
131181004|NCT00006604|472283776|FG001|Overall Study|Withdrawal by Subject|0|||
131181005|NCT00006604|472283777|FG002|Overall Study|Withdrawal by Subject|2|||
131181006|NCT00006604|472283778|FG003|Overall Study|Withdrawal by Subject|0|||
131181007|NCT00006604|472283779|FG004|Overall Study|Withdrawal by Subject|1|||
131181008|NCT00006604|472283780|FG005|Overall Study|Withdrawal by Subject|2|||
131238433|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238434|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238435|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
131238436|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238437|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130784173|NCT02224625|470838706|FG000|Irritation|Adverse Event|6|||
130784174|NCT02224625|470838706|FG000|Sensitization|Adverse Event|55|||
130784175|NCT01100853|470838715|FG000|Overall Study|Lost to Follow-up|11|||
131181009|NCT00006604|472283781|FG006|Overall Study|Withdrawal by Subject|2|||
131181010|NCT00006604|472283782|FG007|Overall Study|Withdrawal by Subject|0|||
131181011|NCT00006604|472283783|FG008|Overall Study|Withdrawal by Subject|1|||
130784176|NCT01100853|470838716|FG001|Overall Study|Lost to Follow-up|6|||
130784177|NCT01100853|470838715|FG000|Overall Study|Received <4 study injections|10|||
130784178|NCT01100853|470838716|FG001|Overall Study|Received <4 study injections|13|||
130784179|NCT01100853|470838715|FG000|Overall Study|Withdrawal by Subject|6|||
130784180|NCT01100853|470838716|FG001|Overall Study|Withdrawal by Subject|4|||
130784181|NCT01162343|470838717|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
130784182|NCT01162343|470838717|FG000|Overall Study|Refused psychiatrist assessment|12|||
130784183|NCT02579629|470838731|FG000|Overall Study|Withdrawal by Subject|0|||
130784184|NCT02579629|470838732|FG001|Overall Study|Withdrawal by Subject|1|||
130784185|NCT02579629|470838733|FG002|Overall Study|Withdrawal by Subject|0|||
130784186|NCT02579629|470838731|FG000|Overall Study|Screen Failure|2|||
130784187|NCT02579629|470838732|FG001|Overall Study|Screen Failure|0|||
130784188|NCT02579629|470838733|FG002|Overall Study|Screen Failure|2|||
130784189|NCT00266708|470838734|FG000|Overall Study|No renal function|1|||
130784190|NCT00266708|470838735|FG001|Overall Study|No renal function|1|||
130784191|NCT00266708|470838734|FG000|Overall Study|Refused biopsy|3|||
130784192|NCT00266708|470838735|FG001|Overall Study|Refused biopsy|6|||
130784193|NCT00266708|470838734|FG000|Overall Study|Asthma|0|||
130784194|NCT00266708|470838735|FG001|Overall Study|Asthma|2|||
130784195|NCT01926028|470838736|FG000|Overall Study|Lost to Follow-up|7|||
130784196|NCT01926028|470838737|FG001|Overall Study|Lost to Follow-up|6|||
130784197|NCT01926028|470838738|FG002|Overall Study|Lost to Follow-up|0|||
130784198|NCT01926028|470838736|FG000|Overall Study|Physician Decision|1|||
130784199|NCT01926028|470838737|FG001|Overall Study|Physician Decision|5|||
130784200|NCT01926028|470838738|FG002|Overall Study|Physician Decision|0|||
130784201|NCT01926028|470838736|FG000|Overall Study|Withdrawal by Subject|9|||
130784202|NCT01926028|470838737|FG001|Overall Study|Withdrawal by Subject|9|||
130784203|NCT01926028|470838738|FG002|Overall Study|Withdrawal by Subject|2|||
130784204|NCT01926028|470838736|FG000|Overall Study|Non compliance or other reasons|4|||
130784205|NCT01926028|470838737|FG001|Overall Study|Non compliance or other reasons|2|||
130784206|NCT01926028|470838738|FG002|Overall Study|Non compliance or other reasons|0|||
130784207|NCT04635839|470838739|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
130784208|NCT04635839|470838740|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
130784209|NCT02870868|470838741|FG000|Overall Study|Withdrawal by Subject|2|||
130784210|NCT02870868|470838742|FG001|Overall Study|Withdrawal by Subject|1|||
130784211|NCT00744939|470838743|FG000|Overall Study|Withdrawal by Subject|9|||
130784212|NCT00744939|470838743|FG000|Overall Study|Protocol Violation|13|||
130784213|NCT00744939|470838743|FG000|Overall Study|Death|24|||
130784214|NCT00744939|470838743|FG000|Overall Study|distance|4|||
131181012|NCT00006604|472283784|FG009|Overall Study|Withdrawal by Subject|3|||
131181013|NCT00006604|472283785|FG010|Overall Study|Withdrawal by Subject|2|||
131181014|NCT00006604|472283786|FG011|Overall Study|Withdrawal by Subject|0|||
131181015|NCT00006604|472283787|FG012|Overall Study|Withdrawal by Subject|1|||
131181016|NCT00006604|472283788|FG013|Overall Study|Withdrawal by Subject|2|||
131181017|NCT00006604|472283789|FG014|Overall Study|Withdrawal by Subject|1|||
131181018|NCT00006604|472283790|FG015|Overall Study|Withdrawal by Subject|0|||
131181019|NCT00006604|472283791|FG016|Overall Study|Withdrawal by Subject|1|||
131181020|NCT00006604|472283775|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
131181021|NCT00006604|472283776|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
131181022|NCT00006604|472283777|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
131181023|NCT00006604|472283778|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
131181024|NCT00006604|472283779|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
131181025|NCT00006604|472283780|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
131181026|NCT00006604|472283781|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
131181027|NCT00006604|472283782|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
131181028|NCT00006604|472283783|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
131181029|NCT00006604|472283784|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
131181030|NCT00006604|472283785|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
131181031|NCT00006604|472283786|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
131181032|NCT00006604|472283787|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
131181033|NCT00006604|472283788|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
131181034|NCT00006604|472283789|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
131181035|NCT00006604|472283790|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
131181036|NCT00006604|472283791|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
131181037|NCT00006604|472283775|FG000|Overall Study|Lost to Follow-up|0|||
131181038|NCT00006604|472283776|FG001|Overall Study|Lost to Follow-up|0|||
130784215|NCT00744939|470838743|FG000|Overall Study|Lost to Follow-up|12|||
130784216|NCT00744939|470838743|FG000|Overall Study|Medical history exclusionary|1|||
130784217|NCT00744939|470838743|FG000|Overall Study|Did not receive Magnevist|7|||
130784218|NCT00744939|470838743|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
130784219|NCT00744939|470838743|FG000|Overall Study|coma|1|||
131181039|NCT00006604|472283777|FG002|Overall Study|Lost to Follow-up|0|||
131181040|NCT00006604|472283778|FG003|Overall Study|Lost to Follow-up|0|||
130784220|NCT00744939|470838743|FG000|Overall Study|incorrect race|1|||
131181041|NCT00006604|472283779|FG004|Overall Study|Lost to Follow-up|0|||
131181042|NCT00006604|472283780|FG005|Overall Study|Lost to Follow-up|0|||
131181043|NCT00006604|472283781|FG006|Overall Study|Lost to Follow-up|0|||
131181044|NCT00006604|472283782|FG007|Overall Study|Lost to Follow-up|1|||
131181045|NCT00006604|472283783|FG008|Overall Study|Lost to Follow-up|0|||
131181046|NCT00006604|472283784|FG009|Overall Study|Lost to Follow-up|2|||
131181047|NCT00006604|472283785|FG010|Overall Study|Lost to Follow-up|0|||
131181048|NCT00006604|472283786|FG011|Overall Study|Lost to Follow-up|0|||
131181049|NCT00006604|472283787|FG012|Overall Study|Lost to Follow-up|0|||
131238438|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238439|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238440|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238441|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238442|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238443|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238444|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
131238445|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238446|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238447|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238448|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238449|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
131238450|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131238451|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131238452|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131238453|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
131238454|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131238455|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131238456|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131238457|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131238458|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131238459|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131181050|NCT00006604|472283788|FG013|Overall Study|Lost to Follow-up|0|||
131181051|NCT00006604|472283789|FG014|Overall Study|Lost to Follow-up|0|||
131181052|NCT00006604|472283790|FG015|Overall Study|Lost to Follow-up|1|||
131181053|NCT00006604|472283791|FG016|Overall Study|Lost to Follow-up|3|||
131181054|NCT00006604|472283775|FG000|Overall Study|Other Reason|0|||
131181055|NCT00006604|472283776|FG001|Overall Study|Other Reason|0|||
131181056|NCT00006604|472283777|FG002|Overall Study|Other Reason|0|||
131181057|NCT00006604|472283778|FG003|Overall Study|Other Reason|0|||
131181058|NCT00006604|472283779|FG004|Overall Study|Other Reason|0|||
131181059|NCT00006604|472283780|FG005|Overall Study|Other Reason|1|||
131181060|NCT00006604|472283781|FG006|Overall Study|Other Reason|0|||
131181061|NCT00006604|472283782|FG007|Overall Study|Other Reason|0|||
131181062|NCT00006604|472283783|FG008|Overall Study|Other Reason|0|||
131181063|NCT00006604|472283784|FG009|Overall Study|Other Reason|1|||
131181064|NCT00006604|472283785|FG010|Overall Study|Other Reason|0|||
131181065|NCT00006604|472283786|FG011|Overall Study|Other Reason|0|||
131181066|NCT00006604|472283787|FG012|Overall Study|Other Reason|0|||
131181067|NCT00006604|472283788|FG013|Overall Study|Other Reason|0|||
131181068|NCT00006604|472283789|FG014|Overall Study|Other Reason|0|||
131181069|NCT00006604|472283790|FG015|Overall Study|Other Reason|0|||
131181070|NCT00006604|472283791|FG016|Overall Study|Other Reason|0|||
131181071|NCT01056341|472283792|FG000|Overall Study|Treatment Intolerance|0|||
131181072|NCT01056341|472283793|FG001|Overall Study|Treatment Intolerance|2|||
131181073|NCT01056341|472283794|FG002|Overall Study|Treatment Intolerance|0|||
131238460|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131181074|NCT01056341|472283795|FG003|Overall Study|Treatment Intolerance|2|||
131181075|NCT01056341|472283796|FG004|Overall Study|Treatment Intolerance|0|||
131181076|NCT01056341|472283792|FG000|Overall Study|Lack of Efficacy|32|||
131181077|NCT01056341|472283793|FG001|Overall Study|Lack of Efficacy|30|||
131181078|NCT01056341|472283794|FG002|Overall Study|Lack of Efficacy|7|||
131181079|NCT01056341|472283795|FG003|Overall Study|Lack of Efficacy|25|||
131181080|NCT01056341|472283796|FG004|Overall Study|Lack of Efficacy|9|||
131181081|NCT01056341|472283792|FG000|Overall Study|Other reasons|4|||
131181082|NCT01056341|472283793|FG001|Overall Study|Other reasons|4|||
131181083|NCT01056341|472283794|FG002|Overall Study|Other reasons|8|||
131181084|NCT01056341|472283795|FG003|Overall Study|Other reasons|9|||
131238461|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131181085|NCT01056341|472283796|FG004|Overall Study|Other reasons|5|||
131181086|NCT01167582|472283797|FG000|Overall Study|Lost to Follow-up|0|||
131181087|NCT01167582|472283798|FG001|Overall Study|Lost to Follow-up|1|||
131181088|NCT00805545|472283799|FG000|Overall Study|Protocol Violation|3|||
131181089|NCT00805545|472283800|FG001|Overall Study|Protocol Violation|2|||
131181090|NCT00805545|472283799|FG000|Overall Study|Protocol Violation|3|||
131181091|NCT00805545|472283800|FG001|Overall Study|Protocol Violation|1|||
131181092|NCT01182337|472283801|FG000|Overall Study|Withdrawal by Subject|3|||
131181093|NCT01182337|472283802|FG001|Overall Study|Withdrawal by Subject|1|||
131181094|NCT01182337|472283801|FG000|Overall Study|Lost to Follow-up|0|||
131238462|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131238463|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
131238464|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131181095|NCT01182337|472283802|FG001|Overall Study|Lost to Follow-up|1|||
131181096|NCT03448224|472283803|FG000|Overall Study|Provided same answer to every question|1|||
131181097|NCT03448224|472283804|FG001|Overall Study|Provided same answer to every question|0|||
131181098|NCT01021813|472283805|FG000|DB Treatment Phase|Adverse Event|60|||
131181099|NCT01021813|472283806|FG001|DB Treatment Phase|Adverse Event|22|||
131238465|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131238466|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131238467|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131238468|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131181100|NCT01021813|472283807|FG002|DB Treatment Phase|Adverse Event|0|||
131181101|NCT01021813|472283808|FG003|DB Treatment Phase|Adverse Event|0|||
131181102|NCT01021813|472283809|FG004|DB Treatment Phase|Adverse Event|0|||
131181103|NCT01021813|472283805|FG000|DB Treatment Phase|Lack of Efficacy|44|||
131181104|NCT01021813|472283806|FG001|DB Treatment Phase|Lack of Efficacy|28|||
131181105|NCT01021813|472283807|FG002|DB Treatment Phase|Lack of Efficacy|0|||
131181106|NCT01021813|472283808|FG003|DB Treatment Phase|Lack of Efficacy|0|||
131238469|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131238470|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131238471|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
131238472|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
131238473|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131238474|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131238475|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131238476|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131238477|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
131238478|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131238479|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131238480|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131238481|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131238482|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131238483|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131238484|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131238485|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
131238486|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130733429|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130733430|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130733431|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
130733432|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130733433|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130733434|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130733435|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130733436|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130733437|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
131181107|NCT01021813|472283809|FG004|DB Treatment Phase|Lack of Efficacy|0|||
131181108|NCT01021813|472283805|FG000|DB Treatment Phase|Lost to Follow-up|14|||
131181109|NCT01021813|472283806|FG001|DB Treatment Phase|Lost to Follow-up|12|||
131181110|NCT01021813|472283807|FG002|DB Treatment Phase|Lost to Follow-up|0|||
131181111|NCT01021813|472283808|FG003|DB Treatment Phase|Lost to Follow-up|0|||
131181112|NCT01021813|472283809|FG004|DB Treatment Phase|Lost to Follow-up|0|||
131181113|NCT01021813|472283805|FG000|DB Treatment Phase|Physician Decision|17|||
131181114|NCT01021813|472283806|FG001|DB Treatment Phase|Physician Decision|8|||
131181115|NCT01021813|472283807|FG002|DB Treatment Phase|Physician Decision|0|||
131181116|NCT01021813|472283808|FG003|DB Treatment Phase|Physician Decision|0|||
131181117|NCT01021813|472283809|FG004|DB Treatment Phase|Physician Decision|0|||
131238487|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131181118|NCT01021813|472283805|FG000|DB Treatment Phase|Pregnancy|1|||
131181119|NCT01021813|472283806|FG001|DB Treatment Phase|Pregnancy|0|||
131238488|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131238489|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131238490|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131238491|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
131181120|NCT01021813|472283807|FG002|DB Treatment Phase|Pregnancy|0|||
131181121|NCT01021813|472283808|FG003|DB Treatment Phase|Pregnancy|0|||
131181122|NCT01021813|472283809|FG004|DB Treatment Phase|Pregnancy|0|||
131181123|NCT01021813|472283805|FG000|DB Treatment Phase|Protocol Violation|4|||
131181124|NCT01021813|472283806|FG001|DB Treatment Phase|Protocol Violation|3|||
131181125|NCT01021813|472283807|FG002|DB Treatment Phase|Protocol Violation|0|||
131181126|NCT01021813|472283808|FG003|DB Treatment Phase|Protocol Violation|0|||
131181127|NCT01021813|472283809|FG004|DB Treatment Phase|Protocol Violation|0|||
131181128|NCT01021813|472283805|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
131181129|NCT01021813|472283806|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
131181130|NCT01021813|472283807|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
131181131|NCT01021813|472283808|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
131181132|NCT01021813|472283809|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
131181133|NCT01021813|472283805|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
131181134|NCT01021813|472283806|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
131181135|NCT01021813|472283807|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
131181136|NCT01021813|472283808|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
131181137|NCT01021813|472283809|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
131181138|NCT01021813|472283805|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
131181139|NCT01021813|472283806|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
131181140|NCT01021813|472283807|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
131181141|NCT01021813|472283808|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
131181142|NCT01021813|472283809|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
131181143|NCT01021813|472283805|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
131181144|NCT01021813|472283806|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
131181145|NCT01021813|472283807|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
131181146|NCT01021813|472283808|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
131181147|NCT01021813|472283809|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
131181148|NCT01021813|472283805|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
131181149|NCT01021813|472283806|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
131181150|NCT01021813|472283807|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
131181151|NCT01021813|472283808|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
131181152|NCT01021813|472283809|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
131181153|NCT01021813|472283805|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
131181154|NCT01021813|472283806|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
131181155|NCT01021813|472283807|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
131181156|NCT01021813|472283808|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
131181157|NCT01021813|472283809|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
131181158|NCT03103906|472283810|FG000|Overall Study|Adverse Event|2|||
131181159|NCT03103906|472283811|FG001|Overall Study|Adverse Event|3|||
131181160|NCT03103906|472283810|FG000|Overall Study|Other|2|||
131181161|NCT03103906|472283811|FG001|Overall Study|Other|0|||
131181162|NCT03571256|472283812|FG000|Overall Study|Adverse Event|3|||
131181163|NCT03571256|472283813|FG001|Overall Study|Adverse Event|0|||
131181164|NCT03571256|472283814|FG002|Overall Study|Adverse Event|1|||
131181165|NCT03571256|472283812|FG000|Overall Study|Withdrawal by Subject|3|||
131181166|NCT03571256|472283813|FG001|Overall Study|Withdrawal by Subject|1|||
131181167|NCT03571256|472283814|FG002|Overall Study|Withdrawal by Subject|1|||
131181168|NCT03571256|472283812|FG000|Overall Study|Other than specified|0|||
131181169|NCT03571256|472283813|FG001|Overall Study|Other than specified|1|||
131181170|NCT03571256|472283814|FG002|Overall Study|Other than specified|1|||
131181171|NCT03571256|472283812|FG000|Overall Study|Protocol Violation|0|||
131181172|NCT03571256|472283813|FG001|Overall Study|Protocol Violation|1|||
131181173|NCT03571256|472283814|FG002|Overall Study|Protocol Violation|1|||
131181174|NCT00575094|472283815|FG000|Overall Study|Adverse Event|2|||
131181175|NCT00575094|472283815|FG000|Overall Study|Withdrawal by Subject|1|||
131181176|NCT00772382|472283820|FG000|Overall Study|Adverse Event|19|||
131181177|NCT00772382|472283820|FG000|Overall Study|Death|6|||
131181178|NCT00772382|472283820|FG000|Overall Study|Lack of Efficacy|4|||
131181179|NCT00772382|472283820|FG000|Overall Study|Physician Decision|5|||
131181180|NCT00772382|472283820|FG000|Overall Study|Protocol Violation|1|||
131181181|NCT00772382|472283820|FG000|Overall Study|Withdrawal by Subject|10|||
131181182|NCT00772382|472283820|FG000|Overall Study|Other Reasons|10|||
131181183|NCT00643604|472283822|FG000|Overall Study|Death|1|||
131181184|NCT02702011|472283825|FG000|Overall Study|Withdrawal by Subject|0|||
131181185|NCT02702011|472283826|FG001|Overall Study|Withdrawal by Subject|1|||
131181186|NCT02702011|472283827|FG002|Overall Study|Withdrawal by Subject|0|||
131181187|NCT02702011|472283828|FG003|Overall Study|Withdrawal by Subject|0|||
131181188|NCT02007954|472283830|FG000|Overall Study|Received liver transplant|3|||
131181189|NCT02007954|472283830|FG000|Overall Study|Switch in treatment modality|2|||
131181190|NCT02007954|472283830|FG000|Overall Study|Disease progression and unrelated AE|1|||
131181191|NCT02007954|472283830|FG000|Overall Study|Death|1|||
131181192|NCT01195363|472283833|FG000|Overall Study|Lost to Follow-up|7|||
131181193|NCT01195363|472283834|FG001|Overall Study|Lost to Follow-up|4|||
131181194|NCT01195363|472283833|FG000|Overall Study|Adverse Event|3|||
131181195|NCT01195363|472283834|FG001|Overall Study|Adverse Event|1|||
131181196|NCT01195363|472283833|FG000|Overall Study|Lack of Efficacy|0|||
131181197|NCT01195363|472283834|FG001|Overall Study|Lack of Efficacy|4|||
131181198|NCT01195363|472283833|FG000|Overall Study|incarceration|1|||
131181199|NCT01195363|472283834|FG001|Overall Study|incarceration|0|||
131181200|NCT00475540|472283835|FG000|36 Months|Lost to Follow-up|4|||
131181201|NCT00475540|472283836|FG001|36 Months|Lost to Follow-up|4|||
131181202|NCT00475540|472283835|FG000|36 Months|Death|1|||
131181203|NCT00475540|472283836|FG001|36 Months|Death|2|||
131181204|NCT00475540|472283835|FG000|36 Months|Censored due to reoperation|3|||
131181205|NCT00475540|472283836|FG001|36 Months|Censored due to reoperation|0|||
131181206|NCT02726113|472283841|FG000|Total Enrollment|Physician Decision|0|||
131181207|NCT02726113|472283842|FG001|Total Enrollment|Physician Decision|1|||
131181208|NCT02726113|472283841|FG000|Total Enrollment|Protocol Violation|1|||
131181209|NCT02726113|472283842|FG001|Total Enrollment|Protocol Violation|0|||
131181210|NCT02726113|472283841|FG000|Total Enrollment|Withdrawal by Subject|2|||
131181211|NCT02726113|472283842|FG001|Total Enrollment|Withdrawal by Subject|1|||
131181212|NCT02726113|472283841|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
131181213|NCT02726113|472283842|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
131181214|NCT02726113|472283841|FG000|Genomic Analysis|Protocol Violation|1|||
131181215|NCT02726113|472283842|FG001|Genomic Analysis|Protocol Violation|0|||
131181216|NCT02726113|472283841|FG000|Genomic Analysis|Withdrawal by Subject|2|||
131181217|NCT02726113|472283842|FG001|Genomic Analysis|Withdrawal by Subject|1|||
131181218|NCT02726113|472283841|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
131181219|NCT02726113|472283842|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
131181220|NCT05691829|472285610|FG000|Overall Study|Physician Decision|2|||
131181221|NCT05691829|472285610|FG000|Overall Study|Eligibility criteria not met|3|||
131181222|NCT00640146|472285614|FG000|Overall Study|Adverse Event|2|||
131181223|NCT00640146|472285615|FG001|Overall Study|Adverse Event|0|||
131181224|NCT00640146|472285614|FG000|Overall Study|Lost to Follow-up|0|||
131181225|NCT00640146|472285615|FG001|Overall Study|Lost to Follow-up|1|||
131181226|NCT00640146|472285614|FG000|Overall Study|Lack of Efficacy|0|||
131181227|NCT00640146|472285615|FG001|Overall Study|Lack of Efficacy|1|||
131181228|NCT00640146|472285614|FG000|Overall Study|Withdrawal by Subject|1|||
131181229|NCT00640146|472285615|FG001|Overall Study|Withdrawal by Subject|1|||
131181230|NCT00640146|472285614|FG000|Overall Study|Randomized but not treated|1|||
131181231|NCT00640146|472285615|FG001|Overall Study|Randomized but not treated|3|||
131181232|NCT04847141|472285618|FG000|Overall Study|Adverse Event|1|||
131181233|NCT04847141|472285619|FG001|Overall Study|Adverse Event|0|||
131181234|NCT04847141|472285620|FG002|Overall Study|Adverse Event|1|||
131181235|NCT04847141|472285618|FG000|Overall Study|Withdrawal by Subject|2|||
131181236|NCT04847141|472285619|FG001|Overall Study|Withdrawal by Subject|4|||
131181237|NCT04847141|472285620|FG002|Overall Study|Withdrawal by Subject|3|||
131181238|NCT04847141|472285618|FG000|Overall Study|Lost to Follow-up|7|||
131181239|NCT04847141|472285619|FG001|Overall Study|Lost to Follow-up|5|||
131181240|NCT04847141|472285620|FG002|Overall Study|Lost to Follow-up|7|||
131181241|NCT04847141|472285618|FG000|Overall Study|Reason not Specified|0|||
131181242|NCT04847141|472285619|FG001|Overall Study|Reason not Specified|1|||
131181243|NCT04847141|472285620|FG002|Overall Study|Reason not Specified|0|||
131181244|NCT02215616|472285621|FG000|Overall Study|Sponsor requested to stop study drug|0|||
131181245|NCT02215616|472285622|FG001|Overall Study|Sponsor requested to stop study drug|0|||
131181246|NCT02215616|472285623|FG002|Overall Study|Sponsor requested to stop study drug|1|||
131181247|NCT02215616|472285624|FG003|Overall Study|Sponsor requested to stop study drug|4|||
131181248|NCT02215616|472285621|FG000|Overall Study|Death|1|||
131181249|NCT02215616|472285622|FG001|Overall Study|Death|0|||
131181250|NCT02215616|472285623|FG002|Overall Study|Death|0|||
131181251|NCT02215616|472285624|FG003|Overall Study|Death|0|||
131181252|NCT02215616|472285621|FG000|Overall Study|Adverse Event|7|||
131181253|NCT02215616|472285622|FG001|Overall Study|Adverse Event|4|||
131181254|NCT02215616|472285623|FG002|Overall Study|Adverse Event|9|||
131181255|NCT02215616|472285624|FG003|Overall Study|Adverse Event|2|||
131181256|NCT02215616|472285621|FG000|Overall Study|Withdrawal by Subject|1|||
131181257|NCT02215616|472285622|FG001|Overall Study|Withdrawal by Subject|8|||
131181258|NCT02215616|472285623|FG002|Overall Study|Withdrawal by Subject|2|||
131181259|NCT02215616|472285624|FG003|Overall Study|Withdrawal by Subject|5|||
131181260|NCT02215616|472285621|FG000|Overall Study|Non-compliance|0|||
131181261|NCT02215616|472285622|FG001|Overall Study|Non-compliance|2|||
131181262|NCT02215616|472285623|FG002|Overall Study|Non-compliance|1|||
131181263|NCT02215616|472285624|FG003|Overall Study|Non-compliance|0|||
131181264|NCT02215616|472285621|FG000|Overall Study|Protocol Violation|0|||
131181265|NCT02215616|472285622|FG001|Overall Study|Protocol Violation|2|||
131181266|NCT02215616|472285623|FG002|Overall Study|Protocol Violation|0|||
131181267|NCT02215616|472285624|FG003|Overall Study|Protocol Violation|0|||
131181268|NCT02215616|472285621|FG000|Overall Study|Lost to Follow-up|1|||
131181269|NCT02215616|472285622|FG001|Overall Study|Lost to Follow-up|1|||
131181270|NCT02215616|472285623|FG002|Overall Study|Lost to Follow-up|0|||
131181271|NCT02215616|472285624|FG003|Overall Study|Lost to Follow-up|1|||
131181272|NCT02215616|472285621|FG000|Overall Study|Other than specified|1|||
131181273|NCT02215616|472285622|FG001|Overall Study|Other than specified|0|||
131181274|NCT02215616|472285623|FG002|Overall Study|Other than specified|1|||
131181275|NCT02215616|472285624|FG003|Overall Study|Other than specified|1|||
131181276|NCT04058158|472285625|FG000|Period 1|Death|1|||
131181277|NCT04058158|472285626|FG001|Period 1|Death|0|||
131181278|NCT04058158|472285625|FG000|Period 1|Adverse Event|1|||
131181279|NCT04058158|472285626|FG001|Period 1|Adverse Event|1|||
131181280|NCT04058158|472285625|FG000|Period 1|Pregnancy|0|||
131181281|NCT04058158|472285626|FG001|Period 1|Pregnancy|1|||
131181282|NCT02528253|472285629|FG000|Overall Study|Adverse Event|3|||
131181283|NCT02528253|472285630|FG001|Overall Study|Adverse Event|4|||
131181284|NCT02528253|472285631|FG002|Overall Study|Adverse Event|4|||
131181285|NCT02528253|472285632|FG003|Overall Study|Adverse Event|8|||
131181286|NCT02528253|472285633|FG004|Overall Study|Adverse Event|18|||
131181287|NCT02528253|472285629|FG000|Overall Study|Death|2|||
131181288|NCT02528253|472285630|FG001|Overall Study|Death|2|||
131181289|NCT02528253|472285631|FG002|Overall Study|Death|1|||
131181290|NCT02528253|472285632|FG003|Overall Study|Death|0|||
131181291|NCT02528253|472285633|FG004|Overall Study|Death|1|||
131181292|NCT02528253|472285629|FG000|Overall Study|Insufficient clinical response|7|||
131181293|NCT02528253|472285630|FG001|Overall Study|Insufficient clinical response|10|||
131181294|NCT02528253|472285631|FG002|Overall Study|Insufficient clinical response|13|||
131181295|NCT02528253|472285632|FG003|Overall Study|Insufficient clinical response|12|||
131181296|NCT02528253|472285633|FG004|Overall Study|Insufficient clinical response|16|||
131181297|NCT02528253|472285629|FG000|Overall Study|Lost to Follow-up|16|||
131181298|NCT02528253|472285630|FG001|Overall Study|Lost to Follow-up|9|||
131181299|NCT02528253|472285631|FG002|Overall Study|Lost to Follow-up|31|||
131181300|NCT02528253|472285632|FG003|Overall Study|Lost to Follow-up|16|||
131181301|NCT02528253|472285633|FG004|Overall Study|Lost to Follow-up|34|||
131181302|NCT02528253|472285629|FG000|Overall Study|Other|21|||
131181303|NCT02528253|472285630|FG001|Overall Study|Other|22|||
131181304|NCT02528253|472285631|FG002|Overall Study|Other|58|||
131181305|NCT02528253|472285632|FG003|Overall Study|Other|52|||
131181306|NCT02528253|472285633|FG004|Overall Study|Other|76|||
131181307|NCT02528253|472285629|FG000|Overall Study|Withdrawal by Subject|25|||
131181308|NCT02528253|472285630|FG001|Overall Study|Withdrawal by Subject|20|||
131181309|NCT02528253|472285631|FG002|Overall Study|Withdrawal by Subject|29|||
131181310|NCT02528253|472285632|FG003|Overall Study|Withdrawal by Subject|48|||
131181311|NCT02528253|472285633|FG004|Overall Study|Withdrawal by Subject|73|||
131181312|NCT02528253|472285629|FG000|Overall Study|Protocol Violation|1|||
131181313|NCT02528253|472285630|FG001|Overall Study|Protocol Violation|2|||
131181314|NCT02528253|472285631|FG002|Overall Study|Protocol Violation|4|||
131181315|NCT02528253|472285632|FG003|Overall Study|Protocol Violation|0|||
131181316|NCT02528253|472285633|FG004|Overall Study|Protocol Violation|4|||
131181317|NCT02528253|472285629|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
131181318|NCT02528253|472285630|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
131181319|NCT02528253|472285631|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
131181320|NCT02528253|472285632|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
131181321|NCT02528253|472285633|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
131181322|NCT00094835|472285634|FG000|Overall Study|Physician Decision|1|||
131181323|NCT00094835|472285635|FG001|Overall Study|Physician Decision|0|||
131181324|NCT00094835|472285636|FG002|Overall Study|Physician Decision|0|||
131181325|NCT00094835|472285637|FG003|Overall Study|Physician Decision|0|||
131181326|NCT00094835|472285638|FG004|Overall Study|Physician Decision|0|||
131181327|NCT00094835|472285639|FG005|Overall Study|Physician Decision|1|||
131181328|NCT00094835|472285640|FG006|Overall Study|Physician Decision|0|||
131181329|NCT00094835|472285634|FG000|Overall Study|Withdrawal by Subject|0|||
131181330|NCT00094835|472285635|FG001|Overall Study|Withdrawal by Subject|0|||
131181331|NCT00094835|472285636|FG002|Overall Study|Withdrawal by Subject|0|||
131181332|NCT00094835|472285637|FG003|Overall Study|Withdrawal by Subject|0|||
131181333|NCT00094835|472285638|FG004|Overall Study|Withdrawal by Subject|0|||
131181334|NCT00094835|472285639|FG005|Overall Study|Withdrawal by Subject|0|||
131181335|NCT00094835|472285640|FG006|Overall Study|Withdrawal by Subject|1|||
131181336|NCT00094835|472285634|FG000|Overall Study|Lost to Follow-up|0|||
131181337|NCT00094835|472285635|FG001|Overall Study|Lost to Follow-up|0|||
131181338|NCT00094835|472285636|FG002|Overall Study|Lost to Follow-up|0|||
131181339|NCT00094835|472285637|FG003|Overall Study|Lost to Follow-up|0|||
131181340|NCT00094835|472285638|FG004|Overall Study|Lost to Follow-up|1|||
131181341|NCT00094835|472285639|FG005|Overall Study|Lost to Follow-up|0|||
131181342|NCT00094835|472285640|FG006|Overall Study|Lost to Follow-up|0|||
131181343|NCT00094835|472285634|FG000|Overall Study|Death|1|||
131181344|NCT00094835|472285635|FG001|Overall Study|Death|0|||
131181345|NCT00094835|472285636|FG002|Overall Study|Death|0|||
131181346|NCT00094835|472285637|FG003|Overall Study|Death|0|||
131181347|NCT00094835|472285638|FG004|Overall Study|Death|1|||
131181348|NCT00094835|472285639|FG005|Overall Study|Death|0|||
131181349|NCT00094835|472285640|FG006|Overall Study|Death|0|||
131181350|NCT00094835|472285634|FG000|Overall Study|Non-compliance|1|||
131181351|NCT00094835|472285635|FG001|Overall Study|Non-compliance|2|||
131181352|NCT00094835|472285636|FG002|Overall Study|Non-compliance|2|||
131181353|NCT00094835|472285637|FG003|Overall Study|Non-compliance|0|||
131181354|NCT00094835|472285638|FG004|Overall Study|Non-compliance|2|||
131181355|NCT00094835|472285639|FG005|Overall Study|Non-compliance|2|||
131181356|NCT00094835|472285640|FG006|Overall Study|Non-compliance|1|||
131181357|NCT00094835|472285634|FG000|Overall Study|Other|1|||
131181358|NCT00094835|472285635|FG001|Overall Study|Other|1|||
131181359|NCT00094835|472285636|FG002|Overall Study|Other|1|||
131181360|NCT00094835|472285637|FG003|Overall Study|Other|1|||
131181361|NCT00094835|472285638|FG004|Overall Study|Other|0|||
131181362|NCT00094835|472285639|FG005|Overall Study|Other|0|||
131181363|NCT00094835|472285640|FG006|Overall Study|Other|0|||
131181364|NCT02966353|472285643|FG000|Overall Study|Withdrawal by Subject|7|||
131181365|NCT02966353|472285643|FG000|Overall Study|Adverse Event|4|||
131181366|NCT02966353|472285643|FG000|Overall Study|Death|4|||
131181367|NCT02966353|472285643|FG000|Overall Study|Physician Decision|3|||
131181368|NCT02966353|472285643|FG000|Overall Study|Progressive disease|2|||
131181369|NCT02966353|472285643|FG000|Overall Study|Protocol deviation|2|||
131181370|NCT05905601|472285646|FG000|Overall Study|Lost to Follow-up|1|||
131181371|NCT05905601|472285647|FG001|Overall Study|Lost to Follow-up|3|||
131181372|NCT03024255|472285648|FG000|Overall Study|Adverse Event|1|||
131181373|NCT03024255|472285649|FG001|Overall Study|Adverse Event|4|||
131181374|NCT03024255|472285650|FG002|Overall Study|Adverse Event|8|||
131181375|NCT03024255|472285651|FG003|Overall Study|Adverse Event|0|||
131181376|NCT03024255|472285648|FG000|Overall Study|Withdrawal by Subject|3|||
131181377|NCT03024255|472285649|FG001|Overall Study|Withdrawal by Subject|1|||
131181378|NCT03024255|472285650|FG002|Overall Study|Withdrawal by Subject|0|||
131181379|NCT03024255|472285651|FG003|Overall Study|Withdrawal by Subject|3|||
131181380|NCT03024255|472285648|FG000|Overall Study|Protocol Violation|0|||
131181381|NCT03024255|472285649|FG001|Overall Study|Protocol Violation|0|||
131181382|NCT03024255|472285650|FG002|Overall Study|Protocol Violation|2|||
131181383|NCT03024255|472285651|FG003|Overall Study|Protocol Violation|0|||
131181384|NCT03024255|472285648|FG000|Overall Study|Lost to Follow-up|1|||
131181385|NCT03024255|472285649|FG001|Overall Study|Lost to Follow-up|2|||
131181386|NCT03024255|472285650|FG002|Overall Study|Lost to Follow-up|1|||
131181387|NCT03024255|472285651|FG003|Overall Study|Lost to Follow-up|1|||
131181388|NCT03024255|472285648|FG000|Overall Study|Lack of Efficacy|1|||
131181389|NCT03024255|472285649|FG001|Overall Study|Lack of Efficacy|0|||
131181390|NCT03024255|472285650|FG002|Overall Study|Lack of Efficacy|0|||
131181391|NCT03024255|472285651|FG003|Overall Study|Lack of Efficacy|0|||
131181392|NCT03024255|472285648|FG000|Overall Study|Protocol Noncompliance|1|||
131181393|NCT03024255|472285649|FG001|Overall Study|Protocol Noncompliance|1|||
131181394|NCT03024255|472285650|FG002|Overall Study|Protocol Noncompliance|0|||
131181395|NCT03024255|472285651|FG003|Overall Study|Protocol Noncompliance|1|||
131181396|NCT03583606|472285652|FG000|Overall Study|Lost to Follow-up|0|||
131181397|NCT03583606|472285653|FG001|Overall Study|Lost to Follow-up|1|||
131181398|NCT03583606|472285654|FG002|Overall Study|Lost to Follow-up|0|||
131181399|NCT03583606|472285652|FG000|Overall Study|Ineligible at baseline|1|||
131181400|NCT03583606|472285653|FG001|Overall Study|Ineligible at baseline|0|||
131181401|NCT03583606|472285654|FG002|Overall Study|Ineligible at baseline|0|||
131181402|NCT03250377|472285659|FG000|Overall Study|Adverse Event|2|||
131181403|NCT03250377|472285660|FG001|Overall Study|Adverse Event|4|||
131181404|NCT03250377|472285661|FG002|Overall Study|Adverse Event|0|||
131181405|NCT03250377|472285662|FG003|Overall Study|Adverse Event|4|||
131181406|NCT03250377|472285659|FG000|Overall Study|Lack of Efficacy|5|||
131181407|NCT03250377|472285660|FG001|Overall Study|Lack of Efficacy|14|||
131181408|NCT03250377|472285661|FG002|Overall Study|Lack of Efficacy|1|||
131181409|NCT03250377|472285662|FG003|Overall Study|Lack of Efficacy|3|||
131181410|NCT03250377|472285659|FG000|Overall Study|Protocol Violation|0|||
131181411|NCT03250377|472285660|FG001|Overall Study|Protocol Violation|2|||
131181412|NCT03250377|472285661|FG002|Overall Study|Protocol Violation|0|||
131181413|NCT03250377|472285662|FG003|Overall Study|Protocol Violation|1|||
131181414|NCT03250377|472285659|FG000|Overall Study|Lost to Follow-up|0|||
131181415|NCT03250377|472285660|FG001|Overall Study|Lost to Follow-up|1|||
131181416|NCT03250377|472285661|FG002|Overall Study|Lost to Follow-up|0|||
131181417|NCT03250377|472285662|FG003|Overall Study|Lost to Follow-up|0|||
131181418|NCT03250377|472285659|FG000|Overall Study|Withdrawal by Subject|7|||
131181419|NCT03250377|472285660|FG001|Overall Study|Withdrawal by Subject|7|||
130733438|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130733439|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
131181420|NCT03250377|472285661|FG002|Overall Study|Withdrawal by Subject|0|||
131181421|NCT03250377|472285662|FG003|Overall Study|Withdrawal by Subject|4|||
131181422|NCT03250377|472285659|FG000|Overall Study|Investigator's Judgment|1|||
131181423|NCT03250377|472285660|FG001|Overall Study|Investigator's Judgment|0|||
131181424|NCT03250377|472285661|FG002|Overall Study|Investigator's Judgment|0|||
131181425|NCT03250377|472285662|FG003|Overall Study|Investigator's Judgment|0|||
131181426|NCT03250377|472285659|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
131181427|NCT03250377|472285660|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
131181428|NCT03250377|472285661|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
130784221|NCT04040439|470838744|FG000|Overall Study|Invalid registration|11|||
130784222|NCT04040439|470838744|FG000|Overall Study|No IC* on publication of study results|2|||
130784223|NCT01309386|470838745|FG000|Overall Study|Other|2|||
130784224|NCT01309386|470838746|FG001|Overall Study|Other|0|||
130784225|NCT01309386|470838745|FG000|Overall Study|Withdrawal by Subject|2|||
130784226|NCT01309386|470838746|FG001|Overall Study|Withdrawal by Subject|0|||
130784227|NCT01309386|470838745|FG000|Overall Study|Progressive disease|9|||
131238492|NCT04033445|472500189|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238493|NCT04033445|472500190|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238494|NCT04033445|472500191|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238495|NCT04033445|472500192|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238496|NCT04033445|472500193|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130784228|NCT01309386|470838746|FG001|Overall Study|Progressive disease|11|||
130784229|NCT01309386|470838745|FG000|Overall Study|Physician Decision|1|||
130784230|NCT01309386|470838746|FG001|Overall Study|Physician Decision|1|||
130784231|NCT01309386|470838745|FG000|Overall Study|Lack of Efficacy|3|||
130784232|NCT01309386|470838746|FG001|Overall Study|Lack of Efficacy|1|||
130784233|NCT01309386|470838745|FG000|Overall Study|Adverse Event|5|||
130784234|NCT01309386|470838746|FG001|Overall Study|Adverse Event|8|||
130784235|NCT01674725|470838747|FG000|Overall Study|Adverse Event|1|||
130784236|NCT01674725|470838748|FG001|Overall Study|Adverse Event|0|||
130784237|NCT01674725|470838747|FG000|Overall Study|Did not receive study drug|1|||
130784238|NCT01674725|470838748|FG001|Overall Study|Did not receive study drug|0|||
130784239|NCT01674725|470838747|FG000|Overall Study|Withdrawal by Subject|1|||
130784240|NCT01674725|470838748|FG001|Overall Study|Withdrawal by Subject|0|||
130784241|NCT01674725|470838747|FG000|Overall Study|Lost to Follow-up|0|||
130784242|NCT01674725|470838748|FG001|Overall Study|Lost to Follow-up|1|||
130784243|NCT02900352|470838749|FG000|Overall Study|Lost to Follow-up|28|||
130784244|NCT02900352|470838750|FG001|Overall Study|Lost to Follow-up|17|||
130784245|NCT03074695|470838751|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
130784246|NCT03074695|470838752|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
130784247|NCT03074695|470838751|FG000|Overall Study|Research staff not available|1|||
130784248|NCT03074695|470838752|FG001|Overall Study|Research staff not available|2|||
130784249|NCT03074695|470838751|FG000|Overall Study|Did not receive neuraxial block|2|||
130784250|NCT03074695|470838752|FG001|Overall Study|Did not receive neuraxial block|2|||
130784251|NCT01774981|470838753|FG000|Overall Study|Adverse Event|0|||
130784252|NCT01774981|470838754|FG001|Overall Study|Adverse Event|0|||
130784253|NCT01774981|470838755|FG002|Overall Study|Adverse Event|0|||
130784254|NCT01774981|470838756|FG003|Overall Study|Adverse Event|0|||
130784255|NCT01774981|470838757|FG004|Overall Study|Adverse Event|0|||
130784256|NCT01774981|470838758|FG005|Overall Study|Adverse Event|1|||
130784257|NCT01774981|470838759|FG006|Overall Study|Adverse Event|0|||
130784258|NCT01774981|470838760|FG007|Overall Study|Adverse Event|0|||
130784259|NCT01774981|470838753|FG000|Overall Study|Withdrawal by Subject|0|||
130784260|NCT01774981|470838754|FG001|Overall Study|Withdrawal by Subject|0|||
130784261|NCT01774981|470838755|FG002|Overall Study|Withdrawal by Subject|0|||
130784262|NCT01774981|470838756|FG003|Overall Study|Withdrawal by Subject|0|||
130784263|NCT01774981|470838757|FG004|Overall Study|Withdrawal by Subject|0|||
130784264|NCT01774981|470838758|FG005|Overall Study|Withdrawal by Subject|0|||
130784265|NCT01774981|470838759|FG006|Overall Study|Withdrawal by Subject|0|||
130784266|NCT01774981|470838760|FG007|Overall Study|Withdrawal by Subject|1|||
130784267|NCT01774981|470838753|FG000|Overall Study|Death|0|||
130784268|NCT01774981|470838754|FG001|Overall Study|Death|0|||
130784269|NCT01774981|470838755|FG002|Overall Study|Death|0|||
130784270|NCT01774981|470838756|FG003|Overall Study|Death|0|||
131238497|NCT04033445|472500194|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238498|NCT04033445|472500195|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238499|NCT04033445|472500196|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
130784271|NCT01774981|470838757|FG004|Overall Study|Death|1|||
130784272|NCT01774981|470838758|FG005|Overall Study|Death|0|||
130784273|NCT01774981|470838759|FG006|Overall Study|Death|0|||
130784274|NCT01774981|470838760|FG007|Overall Study|Death|0|||
130784275|NCT00960193|470838761|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
130784276|NCT00083915|470838762|FG000|Overall Study|Death|6|||
130784277|NCT00083915|470838763|FG001|Overall Study|Death|3|||
130784278|NCT00083915|470838762|FG000|Overall Study|Physician Decision|11|||
130784279|NCT00083915|470838763|FG001|Overall Study|Physician Decision|6|||
130784280|NCT00083915|470838762|FG000|Overall Study|Withdrawal by Subject|8|||
130784281|NCT00083915|470838763|FG001|Overall Study|Withdrawal by Subject|3|||
130784282|NCT00083915|470838762|FG000|Overall Study|disease progression|18|||
130784283|NCT00083915|470838763|FG001|Overall Study|disease progression|23|||
130784284|NCT00083915|470838762|FG000|Overall Study|Failure to collect|3|||
130784285|NCT00083915|470838763|FG001|Overall Study|Failure to collect|0|||
130784286|NCT00083915|470838762|FG000|Overall Study|No response|3|||
130784287|NCT00083915|470838763|FG001|Overall Study|No response|1|||
131181429|NCT03250377|472285662|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
131181430|NCT03250377|472285659|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
131181431|NCT03250377|472285660|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
131181432|NCT03250377|472285661|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
131181433|NCT03250377|472285662|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
131181434|NCT03250377|472285659|FG000|Overall Study|Epilepsy Surgery|0|||
131181435|NCT03250377|472285660|FG001|Overall Study|Epilepsy Surgery|1|||
131181436|NCT03250377|472285661|FG002|Overall Study|Epilepsy Surgery|2|||
131181437|NCT03250377|472285662|FG003|Overall Study|Epilepsy Surgery|0|||
131181438|NCT03250377|472285659|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
131181439|NCT03250377|472285660|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
131181440|NCT03250377|472285661|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
131181441|NCT03250377|472285662|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
131181442|NCT03250377|472285659|FG000|Overall Study|Request From The Sponsor|0|||
131181443|NCT03250377|472285660|FG001|Overall Study|Request From The Sponsor|1|||
131181444|NCT03250377|472285661|FG002|Overall Study|Request From The Sponsor|0|||
131181445|NCT03250377|472285662|FG003|Overall Study|Request From The Sponsor|0|||
131181446|NCT03250377|472285659|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
131181447|NCT03250377|472285660|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
131181448|NCT03250377|472285661|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
131181449|NCT03250377|472285662|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
131181450|NCT03250377|472285659|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
131181451|NCT03250377|472285660|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
131181452|NCT03250377|472285661|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
131181453|NCT03250377|472285662|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
131181454|NCT03250377|472285659|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
131181455|NCT03250377|472285660|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
131181456|NCT03250377|472285661|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
131181457|NCT03250377|472285662|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
131181458|NCT03250377|472285659|FG000|Overall Study|Pregnancy Event|0|||
131181459|NCT03250377|472285660|FG001|Overall Study|Pregnancy Event|1|||
131181460|NCT03250377|472285661|FG002|Overall Study|Pregnancy Event|0|||
131181461|NCT03250377|472285662|FG003|Overall Study|Pregnancy Event|0|||
131181462|NCT03250377|472285659|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
131181463|NCT03250377|472285660|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
131181464|NCT03250377|472285661|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
131181465|NCT03250377|472285662|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
131181466|NCT03250377|472285659|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
131181467|NCT03250377|472285660|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
131181468|NCT03250377|472285661|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
131181469|NCT03250377|472285662|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
131181470|NCT03250377|472285659|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
131181471|NCT03250377|472285660|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
131181472|NCT03250377|472285661|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
131181473|NCT03250377|472285662|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
131181474|NCT03250377|472285659|FG000|Overall Study|Patient requested to change hospital|0|||
131181475|NCT03250377|472285660|FG001|Overall Study|Patient requested to change hospital|0|||
131181476|NCT03250377|472285661|FG002|Overall Study|Patient requested to change hospital|0|||
131181477|NCT03250377|472285662|FG003|Overall Study|Patient requested to change hospital|1|||
131181478|NCT03250377|472285659|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
131181479|NCT03250377|472285660|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
131181480|NCT03250377|472285661|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
131181481|NCT03250377|472285662|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
131181482|NCT00817206|472285663|FG000|Overall Study|Adverse Event|10|||
131181483|NCT00817206|472285664|FG001|Overall Study|Adverse Event|3|||
131181484|NCT00817206|472285663|FG000|Overall Study|Protocol Violation|0|||
131181485|NCT00817206|472285664|FG001|Overall Study|Protocol Violation|2|||
131181486|NCT00817206|472285663|FG000|Overall Study|Lost to Follow-up|0|||
131181487|NCT00817206|472285664|FG001|Overall Study|Lost to Follow-up|1|||
131181488|NCT00817206|472285663|FG000|Overall Study|Death|2|||
131181489|NCT00817206|472285664|FG001|Overall Study|Death|0|||
131181490|NCT00817206|472285663|FG000|Overall Study|Withdrawal by Subject|7|||
131181491|NCT00817206|472285664|FG001|Overall Study|Withdrawal by Subject|3|||
131181492|NCT00817206|472285663|FG000|Overall Study|Physician Decision|2|||
131181493|NCT00817206|472285664|FG001|Overall Study|Physician Decision|0|||
131181494|NCT00126581|472285665|FG000|Overall Study|Adverse Event|3|||
131181495|NCT00126581|472285666|FG001|Overall Study|Adverse Event|7|||
131181496|NCT00126581|472285665|FG000|Overall Study|Death|3|||
131181497|NCT00126581|472285666|FG001|Overall Study|Death|2|||
131238500|NCT04033445|472500197|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238501|NCT04033445|472500198|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238502|NCT04033445|472500199|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238503|NCT04033445|472500200|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238504|NCT04033445|472500201|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238505|NCT04033445|472500202|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
131238506|NCT04033445|472500189|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131238507|NCT04033445|472500190|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131238508|NCT04033445|472500191|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131238509|NCT04033445|472500192|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131238510|NCT04033445|472500193|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131238511|NCT04033445|472500194|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131238512|NCT04033445|472500195|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131238513|NCT04033445|472500196|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131238514|NCT04033445|472500197|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
131238515|NCT04033445|472500198|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
131238516|NCT04033445|472500199|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
131238517|NCT04033445|472500200|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
131238518|NCT04033445|472500201|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
131238519|NCT04033445|472500202|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
131238520|NCT04033445|472500189|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131238521|NCT04033445|472500190|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131238522|NCT04033445|472500191|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131238523|NCT04033445|472500192|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131238524|NCT04033445|472500193|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131238525|NCT04033445|472500194|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131238526|NCT04033445|472500195|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131238527|NCT04033445|472500196|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131238528|NCT04033445|472500197|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
131238529|NCT04033445|472500198|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
131238530|NCT04033445|472500199|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
131238531|NCT04033445|472500200|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
131238532|NCT04033445|472500201|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
131238533|NCT04033445|472500202|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
131238534|NCT04033445|472500189|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238535|NCT04033445|472500190|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238536|NCT04033445|472500191|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238537|NCT04033445|472500192|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238538|NCT04033445|472500193|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238539|NCT04033445|472500194|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238540|NCT04033445|472500195|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238541|NCT04033445|472500196|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238542|NCT04033445|472500197|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238543|NCT04033445|472500198|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238544|NCT04033445|472500199|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
131238545|NCT04033445|472500200|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
131238546|NCT04033445|472500201|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
131238547|NCT04033445|472500202|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
131238548|NCT04033445|472500189|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131238549|NCT04033445|472500190|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131238550|NCT04033445|472500191|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131238551|NCT04033445|472500192|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131238552|NCT04033445|472500193|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131238553|NCT04033445|472500194|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131238554|NCT04033445|472500195|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131238555|NCT04033445|472500196|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131238556|NCT04033445|472500197|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130784288|NCT00083915|470838762|FG000|Overall Study|Insurance issues|1|||
130784289|NCT00083915|470838763|FG001|Overall Study|Insurance issues|1|||
130784290|NCT01239797|470838764|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
130784291|NCT01239797|470838765|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
130784292|NCT01239797|470838764|FG000|Randomized Participants|Participant withdrew consent|1|||
130784293|NCT01239797|470838765|FG001|Randomized Participants|Participant withdrew consent|7|||
130784294|NCT01239797|470838764|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
131238557|NCT04033445|472500198|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
131238558|NCT04033445|472500199|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
131238559|NCT04033445|472500200|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
131238560|NCT04033445|472500201|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
131238561|NCT04033445|472500202|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
131238562|NCT04033445|472500189|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131238563|NCT04033445|472500190|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131238564|NCT04033445|472500191|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131238565|NCT04033445|472500192|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131238566|NCT04033445|472500193|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131238567|NCT04033445|472500194|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131238568|NCT04033445|472500195|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131238569|NCT04033445|472500196|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131238570|NCT04033445|472500197|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
131238571|NCT04033445|472500198|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
131238572|NCT04033445|472500199|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
131238573|NCT04033445|472500200|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
131238574|NCT04033445|472500201|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
131238575|NCT04033445|472500202|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
131238576|NCT04033445|472500189|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238577|NCT04033445|472500190|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238578|NCT04033445|472500191|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238579|NCT04033445|472500192|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238580|NCT04033445|472500193|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238581|NCT04033445|472500194|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238582|NCT04033445|472500195|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238583|NCT04033445|472500196|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238584|NCT04033445|472500197|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238585|NCT04033445|472500198|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238586|NCT04033445|472500199|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238587|NCT04033445|472500200|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238588|NCT04033445|472500201|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
131238589|NCT04033445|472500202|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
131238590|NCT04033445|472500189|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
131238591|NCT04033445|472500190|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
131238592|NCT04033445|472500191|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
131238593|NCT04033445|472500192|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
131238594|NCT04033445|472500193|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
131238595|NCT04033445|472500194|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
131238596|NCT04033445|472500195|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
131238597|NCT04033445|472500196|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
131238598|NCT04033445|472500197|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
131238599|NCT04033445|472500198|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
131238600|NCT04033445|472500199|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
131238601|NCT04033445|472500200|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
131238602|NCT04033445|472500201|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
131238603|NCT04033445|472500202|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
131238604|NCT04033445|472500189|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238605|NCT04033445|472500190|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238606|NCT04033445|472500191|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238607|NCT04033445|472500192|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238608|NCT04033445|472500193|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238609|NCT04033445|472500194|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238610|NCT04033445|472500195|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238611|NCT04033445|472500196|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238612|NCT04033445|472500197|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238613|NCT04033445|472500198|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
131238614|NCT04033445|472500199|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238615|NCT04033445|472500200|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
131238616|NCT04033445|472500201|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
131238617|NCT04033445|472500202|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
131238618|NCT04632927|472500204|FG000|Overall Study|Adverse Event|0|||
131238619|NCT04632927|472500205|FG001|Overall Study|Adverse Event|1|||
131238620|NCT04632927|472500204|FG000|Overall Study|Lack of Efficacy|0|||
131181498|NCT00126581|472285665|FG000|Overall Study|Withdrawal by Subject|1|||
131181499|NCT00126581|472285666|FG001|Overall Study|Withdrawal by Subject|4|||
131181500|NCT00126581|472285665|FG000|Overall Study|Alternative therapy|3|||
131181501|NCT00126581|472285666|FG001|Overall Study|Alternative therapy|3|||
131181502|NCT00126581|472285665|FG000|Overall Study|Other illness/MD discretion|3|||
131181503|NCT00126581|472285666|FG001|Overall Study|Other illness/MD discretion|4|||
131181504|NCT03728140|472285668|FG000|Overall Study|Abnormal embryo transfer operation|10|||
131181505|NCT03728140|472285669|FG001|Overall Study|Abnormal embryo transfer operation|7|||
131181506|NCT02034552|472285670|FG000|Overall Study|Never treated|3|||
131181507|NCT02034552|472285671|FG001|Overall Study|Never treated|2|||
131181508|NCT02034552|472285672|FG002|Overall Study|Never treated|0|||
131181509|NCT02034552|472285670|FG000|Overall Study|Radiological progression|3|||
131181510|NCT02034552|472285671|FG001|Overall Study|Radiological progression|5|||
131181511|NCT02034552|472285672|FG002|Overall Study|Radiological progression|4|||
131181512|NCT02034552|472285670|FG000|Overall Study|AE not assoc. with disease progression|1|||
131181513|NCT02034552|472285671|FG001|Overall Study|AE not assoc. with disease progression|4|||
131181514|NCT02034552|472285672|FG002|Overall Study|AE not assoc. with disease progression|2|||
131181515|NCT02034552|472285670|FG000|Overall Study|AE associated with disease progression|0|||
131181516|NCT02034552|472285671|FG001|Overall Study|AE associated with disease progression|1|||
131181517|NCT02034552|472285672|FG002|Overall Study|AE associated with disease progression|0|||
131181518|NCT02034552|472285670|FG000|Overall Study|Withdrawal by Subject|2|||
131181519|NCT02034552|472285671|FG001|Overall Study|Withdrawal by Subject|1|||
131181520|NCT02034552|472285672|FG002|Overall Study|Withdrawal by Subject|1|||
131181521|NCT02034552|472285670|FG000|Overall Study|Non-compliance with study drug|0|||
131181522|NCT02034552|472285671|FG001|Overall Study|Non-compliance with study drug|0|||
131181523|NCT02034552|472285672|FG002|Overall Study|Non-compliance with study drug|1|||
131181524|NCT02034552|472285670|FG000|Overall Study|Clinical progression|5|||
131181525|NCT02034552|472285671|FG001|Overall Study|Clinical progression|7|||
131181526|NCT02034552|472285672|FG002|Overall Study|Clinical progression|9|||
131181527|NCT05224076|472285673|FG000|Overall Study|Lost to Follow-up|24|||
131181528|NCT04190186|472285674|FG000|Overall Study|ILR is no longer functioning|0|||
131181529|NCT04190186|472285675|FG001|Overall Study|ILR is no longer functioning|1|||
131181530|NCT04190186|472285674|FG000|Overall Study|Lost to Follow-up|0|||
131181531|NCT04190186|472285675|FG001|Overall Study|Lost to Follow-up|1|||
131181532|NCT04190186|472285674|FG000|Overall Study|Withdrawal by Subject|2|||
131181533|NCT04190186|472285675|FG001|Overall Study|Withdrawal by Subject|0|||
131181534|NCT04190186|472285674|FG000|Overall Study|Subject choice to explant|1|||
131181535|NCT04190186|472285675|FG001|Overall Study|Subject choice to explant|0|||
131181536|NCT04190186|472285674|FG000|Overall Study|Physician Decision|0|||
131181537|NCT04190186|472285675|FG001|Overall Study|Physician Decision|1|||
131181538|NCT04190186|472285674|FG000|Overall Study|Study was stopped|4|||
131181539|NCT04190186|472285675|FG001|Overall Study|Study was stopped|5|||
131181540|NCT02016898|472285676|FG000|Overall Study|Death|1|||
131181541|NCT02016898|472285677|FG001|Overall Study|Death|1|||
131181542|NCT02016898|472285676|FG000|Overall Study|Lost to Follow-up|4|||
131181543|NCT02016898|472285677|FG001|Overall Study|Lost to Follow-up|4|||
131181544|NCT01665768|472285678|FG000|Overall Study|Adverse Event|3|||
131181545|NCT01665768|472285678|FG000|Overall Study|Lack of Efficacy|19|||
131181546|NCT01665768|472285678|FG000|Overall Study|Withdrawal by Subject|1|||
131181547|NCT00618995|472285679|FG000|Period 1|Adverse Event|0|||
131181548|NCT00618995|472285680|FG001|Period 1|Adverse Event|0|||
131181549|NCT00618995|472285681|FG002|Period 1|Adverse Event|1|||
131181550|NCT00618995|472285682|FG003|Period 1|Adverse Event|0|||
131181551|NCT00618995|472285679|FG000|Period 1|Protocol Violation|0|||
131181552|NCT00618995|472285680|FG001|Period 1|Protocol Violation|1|||
131181553|NCT00618995|472285681|FG002|Period 1|Protocol Violation|1|||
131181554|NCT00618995|472285682|FG003|Period 1|Protocol Violation|0|||
131181555|NCT00618995|472285679|FG000|Period 2|Protocol Violation|0|||
131181556|NCT00618995|472285680|FG001|Period 2|Protocol Violation|0|||
131181557|NCT00618995|472285681|FG002|Period 2|Protocol Violation|1|||
131181558|NCT00618995|472285682|FG003|Period 2|Protocol Violation|0|||
131181559|NCT00618995|472285679|FG000|Period 4|Adverse Event|1|||
131181560|NCT00618995|472285680|FG001|Period 4|Adverse Event|0|||
131181561|NCT00618995|472285681|FG002|Period 4|Adverse Event|0|||
131181562|NCT00618995|472285682|FG003|Period 4|Adverse Event|0|||
131181563|NCT02988219|472285685|FG000|Overall Study|Lack of Efficacy|1|||
131181564|NCT02988219|472285686|FG001|Overall Study|Lack of Efficacy|1|||
131181565|NCT02988219|472285685|FG000|Overall Study|Withdrawal by Subject|0|||
131181566|NCT02988219|472285686|FG001|Overall Study|Withdrawal by Subject|2|||
131238621|NCT04632927|472500205|FG001|Overall Study|Lack of Efficacy|4|||
131181567|NCT00992186|472285687|FG000|Overall Study|Withdrawal by Subject|2|||
131238622|NCT04632927|472500204|FG000|Overall Study|Loss of efficacy|0|||
131181568|NCT00992186|472285687|FG000|Overall Study|Protocol Violation|1|||
131181569|NCT00992186|472285687|FG000|Overall Study|Physician Decision|1|||
131181570|NCT00992186|472285687|FG000|Overall Study|Adverse Event|9|||
131181571|NCT00992186|472285687|FG000|Overall Study|Progressive Disease|30|||
131238623|NCT04632927|472500205|FG001|Overall Study|Loss of efficacy|1|||
131238624|NCT04632927|472500204|FG000|Overall Study|Non-compliance with study drug|0|||
131238625|NCT04632927|472500205|FG001|Overall Study|Non-compliance with study drug|1|||
131238626|NCT04632927|472500204|FG000|Overall Study|Physician Decision|0|||
131238627|NCT04632927|472500205|FG001|Overall Study|Physician Decision|1|||
131238628|NCT04632927|472500204|FG000|Overall Study|Subject decision|0|||
131238629|NCT04632927|472500205|FG001|Overall Study|Subject decision|1|||
131238630|NCT04632927|472500204|FG000|Overall Study|Withdrawal by Subject|0|||
131238631|NCT04632927|472500205|FG001|Overall Study|Withdrawal by Subject|1|||
131238632|NCT03827291|472500209|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
131238633|NCT03827291|472500210|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
131238634|NCT04795466|472500211|FG000|Overall Study|Adverse Event|3|||
131238635|NCT04795466|472500212|FG001|Overall Study|Adverse Event|1|||
131238636|NCT04795466|472500211|FG000|Overall Study|Physician Decision|1|||
131238637|NCT04795466|472500212|FG001|Overall Study|Physician Decision|0|||
131238638|NCT04795466|472500211|FG000|Overall Study|Withdrawal by Subject|2|||
131238639|NCT04795466|472500212|FG001|Overall Study|Withdrawal by Subject|1|||
131238640|NCT03782792|472500213|FG000|Overall Study|Patient left the country|0|||
131238641|NCT03782792|472500214|FG001|Overall Study|Patient left the country|1|||
131238642|NCT03782792|472500213|FG000|Overall Study|Withdrawal by Subject|1|||
131238643|NCT03782792|472500214|FG001|Overall Study|Withdrawal by Subject|2|||
131238644|NCT04652726|472500217|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
131238645|NCT04652726|472500218|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
131238646|NCT04652726|472500219|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
131238647|NCT04652726|472500217|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
131238648|NCT04652726|472500218|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
131238649|NCT04652726|472500219|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
131238650|NCT04431726|472500222|FG000|Overall Study|Ongoing in the Study|55|||
131238651|NCT03748641|472500223|FG000|Overall Study|Ongoing|155|||
131238652|NCT03748641|472500224|FG001|Overall Study|Ongoing|148|||
131238653|NCT03748641|472500225|FG002|Overall Study|Ongoing|66|||
131238654|NCT03748641|472500226|FG003|Overall Study|Ongoing|79|||
131238655|NCT03748641|472500227|FG004|Overall Study|Ongoing|84|||
131238656|NCT03748641|472500223|FG000|Overall Study|Death|54|||
131238657|NCT03748641|472500224|FG001|Overall Study|Death|59|||
131238658|NCT03748641|472500225|FG002|Overall Study|Death|51|||
131238659|NCT03748641|472500226|FG003|Overall Study|Death|42|||
131238660|NCT03748641|472500227|FG004|Overall Study|Death|9|||
131238661|NCT03748641|472500223|FG000|Overall Study|Lost to Follow-up|0|||
131238662|NCT03748641|472500224|FG001|Overall Study|Lost to Follow-up|2|||
131238663|NCT03748641|472500225|FG002|Overall Study|Lost to Follow-up|1|||
131238664|NCT03748641|472500226|FG003|Overall Study|Lost to Follow-up|0|||
131238665|NCT03748641|472500227|FG004|Overall Study|Lost to Follow-up|0|||
131238666|NCT03748641|472500223|FG000|Overall Study|Withdrawal by Subject|3|||
131238667|NCT03748641|472500224|FG001|Overall Study|Withdrawal by Subject|2|||
131238668|NCT03748641|472500225|FG002|Overall Study|Withdrawal by Subject|5|||
131238669|NCT03748641|472500226|FG003|Overall Study|Withdrawal by Subject|3|||
131238670|NCT03748641|472500227|FG004|Overall Study|Withdrawal by Subject|2|||
131238671|NCT03732820|472500229|FG000|Overall Study|Death|168|||
131238672|NCT03732820|472500230|FG001|Overall Study|Death|203|||
131238673|NCT03732820|472500229|FG000|Overall Study|Other|2|||
131238674|NCT03732820|472500230|FG001|Overall Study|Other|2|||
131238675|NCT03732820|472500229|FG000|Overall Study|Failure to meet randomisation criteria|1|||
131238676|NCT03732820|472500230|FG001|Overall Study|Failure to meet randomisation criteria|1|||
131238677|NCT03732820|472500229|FG000|Overall Study|Patient decision|14|||
131238678|NCT03732820|472500230|FG001|Overall Study|Patient decision|10|||
131238679|NCT03732820|472500229|FG000|Overall Study|Screen failure|0|||
131238680|NCT03732820|472500230|FG001|Overall Study|Screen failure|1|||
131238681|NCT03732820|472500229|FG000|Overall Study|Patients ongoing study at data cut off|210|||
131238682|NCT03732820|472500230|FG001|Overall Study|Patients ongoing study at data cut off|178|||
131181572|NCT00992186|472285687|FG000|Overall Study|Refusal To Receive Study Agent|3|||
131181573|NCT01896856|472285688|FG000|Overall Study|Transportation issues / Non-compliance|0|||
131181574|NCT01896856|472285689|FG001|Overall Study|Transportation issues / Non-compliance|0|||
131181575|NCT01896856|472285690|FG002|Overall Study|Transportation issues / Non-compliance|1|||
131181576|NCT01896856|472285691|FG003|Overall Study|Transportation issues / Non-compliance|0|||
131181577|NCT01896856|472285692|FG004|Overall Study|Transportation issues / Non-compliance|0|||
131181578|NCT01896856|472285693|FG005|Overall Study|Transportation issues / Non-compliance|0|||
131181579|NCT00282867|472285694|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
131238683|NCT03732820|472500229|FG000|Overall Study|Lost to Follow-up|4|||
131238684|NCT03732820|472500230|FG001|Overall Study|Lost to Follow-up|2|||
131238685|NCT05014412|472500231|FG000|Overall Study|Death|11|||
131238686|NCT05014412|472500232|FG001|Overall Study|Death|7|||
131238687|NCT05014412|472500233|FG002|Overall Study|Death|4|||
131238688|NCT05014412|472500234|FG003|Overall Study|Death|7|||
130784295|NCT01239797|470838765|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
131238689|NCT05014412|472500231|FG000|Overall Study|Withdrawal by Subject|1|||
131238690|NCT05014412|472500232|FG001|Overall Study|Withdrawal by Subject|1|||
131238691|NCT05014412|472500233|FG002|Overall Study|Withdrawal by Subject|1|||
131181580|NCT00282867|472285695|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
131181581|NCT00282867|472285696|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
131181582|NCT02677220|472285697|FG000|Overall Study|Adverse Event|1|||
131181583|NCT00965146|472285698|FG000|Overall Study|Death|7|||
131181584|NCT00965146|472285698|FG000|Overall Study|Lost to Follow-up|22|||
131181585|NCT00965146|472285698|FG000|Overall Study|Withdrawal by Subject|17|||
131181586|NCT00965146|472285698|FG000|Overall Study|Unable to return|1|||
131181587|NCT00965146|472285698|FG000|Overall Study|Unwilling to return|11|||
131181588|NCT00965146|472285698|FG000|Overall Study|Intercurrent illness|1|||
131181589|NCT00965146|472285698|FG000|Overall Study|Revision / Removal of Study Implant|6|||
131181590|NCT00965146|472285698|FG000|Overall Study|Overall Study Termination|145|||
131181591|NCT00830960|472285699|FG000|Overall Study|Death|5|||
131181592|NCT00830960|472285700|FG001|Overall Study|Death|4|||
131181593|NCT00830960|472285701|FG002|Overall Study|Death|3|||
131181594|NCT00830960|472285702|FG003|Overall Study|Death|2|||
131181595|NCT00830960|472285703|FG004|Overall Study|Death|6|||
131181596|NCT00830960|472285704|FG005|Overall Study|Death|1|||
131181597|NCT00830960|472285699|FG000|Overall Study|Lost to Follow-up|1|||
131181598|NCT00830960|472285700|FG001|Overall Study|Lost to Follow-up|1|||
131181599|NCT00830960|472285701|FG002|Overall Study|Lost to Follow-up|1|||
131181600|NCT00830960|472285702|FG003|Overall Study|Lost to Follow-up|0|||
131181601|NCT00830960|472285703|FG004|Overall Study|Lost to Follow-up|0|||
131181602|NCT00830960|472285704|FG005|Overall Study|Lost to Follow-up|1|||
131181603|NCT00830960|472285699|FG000|Overall Study|Withdrawal by Subject|19|||
131181604|NCT00830960|472285700|FG001|Overall Study|Withdrawal by Subject|19|||
131181605|NCT00830960|472285701|FG002|Overall Study|Withdrawal by Subject|18|||
131181606|NCT00830960|472285702|FG003|Overall Study|Withdrawal by Subject|23|||
131181607|NCT00830960|472285703|FG004|Overall Study|Withdrawal by Subject|16|||
131181608|NCT00830960|472285704|FG005|Overall Study|Withdrawal by Subject|21|||
131181609|NCT00830960|472285699|FG000|Overall Study|Sponsor Decision|1|||
131181610|NCT00830960|472285700|FG001|Overall Study|Sponsor Decision|2|||
131181611|NCT00830960|472285701|FG002|Overall Study|Sponsor Decision|3|||
131181612|NCT00830960|472285702|FG003|Overall Study|Sponsor Decision|4|||
131181613|NCT00830960|472285703|FG004|Overall Study|Sponsor Decision|5|||
131181614|NCT00830960|472285704|FG005|Overall Study|Sponsor Decision|7|||
131181615|NCT00830960|472285699|FG000|Overall Study|No study drug received|7|||
131181616|NCT00830960|472285700|FG001|Overall Study|No study drug received|2|||
131181617|NCT00830960|472285701|FG002|Overall Study|No study drug received|4|||
131181618|NCT00830960|472285702|FG003|Overall Study|No study drug received|3|||
131181619|NCT00830960|472285703|FG004|Overall Study|No study drug received|5|||
131181620|NCT00830960|472285704|FG005|Overall Study|No study drug received|7|||
131181621|NCT02855450|472285705|FG000|Overall Study|Adverse Event|1|||
131181622|NCT02855450|472285706|FG001|Overall Study|Adverse Event|0|||
131181623|NCT02855450|472285705|FG000|Overall Study|Lost to Follow-up|4|||
131181624|NCT02855450|472285706|FG001|Overall Study|Lost to Follow-up|0|||
131181625|NCT01504971|472285707|FG000|Overall Study|Physician Decision|13|||
131181626|NCT00936117|472285708|FG000|Overall Study|Adverse Event|7|||
131181627|NCT00936117|472285708|FG000|Overall Study|Unable to continue oral medication|3|||
131181628|NCT01376245|472285709|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
131181629|NCT01376245|472285710|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
131181630|NCT01376245|472285711|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
131181631|NCT01376245|472285712|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
131181632|NCT01376245|472285713|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
131181633|NCT01376245|472285709|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
131181634|NCT01376245|472285710|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
131181635|NCT01376245|472285711|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
131181636|NCT01376245|472285712|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
131181637|NCT01376245|472285713|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
131181638|NCT01376245|472285709|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
131181639|NCT01376245|472285710|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
131181640|NCT01376245|472285711|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
131181641|NCT01376245|472285712|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
131181642|NCT01376245|472285713|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
131181643|NCT01376245|472285709|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
131181644|NCT01376245|472285710|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
131181645|NCT01376245|472285711|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
131181646|NCT01376245|472285712|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
131181647|NCT01376245|472285713|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
131181648|NCT01376245|472285709|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
131181649|NCT01376245|472285710|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
131181650|NCT01376245|472285711|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
131181651|NCT01376245|472285712|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
130784296|NCT01239797|470838764|FG000|Treated Participants|Disease progression|185|||
130784297|NCT01239797|470838765|FG001|Treated Participants|Disease progression|185|||
130784298|NCT01239797|470838764|FG000|Treated Participants|Study drug toxicity|39|||
130784299|NCT01239797|470838765|FG001|Treated Participants|Study drug toxicity|45|||
130784300|NCT01239797|470838764|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
130784301|NCT01239797|470838765|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
130784302|NCT01239797|470838764|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
130784303|NCT01239797|470838765|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
130784304|NCT01239797|470838764|FG000|Treated Participants|Administrative reason by sponsor|13|||
130784305|NCT01239797|470838765|FG001|Treated Participants|Administrative reason by sponsor|4|||
130784306|NCT01239797|470838764|FG000|Treated Participants|Other reasons|14|||
130784307|NCT01239797|470838765|FG001|Treated Participants|Other reasons|14|||
130784308|NCT01239797|470838764|FG000|Treated Participants|Participant withdrew consent|6|||
130784309|NCT01239797|470838765|FG001|Treated Participants|Participant withdrew consent|11|||
130784310|NCT01239797|470838764|FG000|Treated Participants|Death|1|||
130784311|NCT01239797|470838765|FG001|Treated Participants|Death|1|||
130784312|NCT01239797|470838764|FG000|Treated Participants|Participant no longer meets study criteria|1|||
130784313|NCT01239797|470838765|FG001|Treated Participants|Participant no longer meets study criteria|1|||
130784314|NCT01239797|470838764|FG000|Treated Participants|Poor/non-compliance|0|||
130784315|NCT01239797|470838765|FG001|Treated Participants|Poor/non-compliance|1|||
130784316|NCT00853762|470838769|FG000|Overall Study|Premature Termination|16|||
130784317|NCT00853762|470838770|FG001|Overall Study|Premature Termination|15|||
130784318|NCT00853762|470838771|FG002|Overall Study|Premature Termination|14|||
130784319|NCT00853762|470838772|FG003|Overall Study|Premature Termination|21|||
130784320|NCT00853762|470838769|FG000|Overall Study|Protocol Violation|0|||
130784321|NCT00853762|470838770|FG001|Overall Study|Protocol Violation|0|||
130784322|NCT00853762|470838771|FG002|Overall Study|Protocol Violation|0|||
130784323|NCT00853762|470838772|FG003|Overall Study|Protocol Violation|1|||
130784324|NCT00853762|470838769|FG000|Overall Study|Withdrawal by Subject|0|||
130784325|NCT00853762|470838770|FG001|Overall Study|Withdrawal by Subject|0|||
130784326|NCT00853762|470838771|FG002|Overall Study|Withdrawal by Subject|1|||
130784327|NCT00853762|470838772|FG003|Overall Study|Withdrawal by Subject|0|||
130784328|NCT00853762|470838769|FG000|Overall Study|Other|0|||
130784329|NCT00853762|470838770|FG001|Overall Study|Other|2|||
130784330|NCT00853762|470838771|FG002|Overall Study|Other|0|||
130784331|NCT00853762|470838772|FG003|Overall Study|Other|0|||
130784332|NCT00853762|470838769|FG000|Overall Study|Randomised but not Treated|0|||
130784333|NCT00853762|470838770|FG001|Overall Study|Randomised but not Treated|2|||
130784334|NCT00853762|470838771|FG002|Overall Study|Randomised but not Treated|2|||
130784335|NCT00853762|470838772|FG003|Overall Study|Randomised but not Treated|0|||
130784336|NCT02000921|470838773|FG000|Overall Study|Withdrawal by Subject|3|||
130784337|NCT02000921|470838774|FG001|Overall Study|Withdrawal by Subject|10|||
130784338|NCT02000921|470838775|FG002|Overall Study|Withdrawal by Subject|5|||
130784339|NCT02000921|470838773|FG000|Overall Study|Lost to Follow-up|2|||
130784340|NCT02000921|470838774|FG001|Overall Study|Lost to Follow-up|4|||
130784341|NCT02000921|470838775|FG002|Overall Study|Lost to Follow-up|5|||
130784342|NCT02000921|470838773|FG000|Overall Study|Physician Decision|0|||
130784343|NCT02000921|470838774|FG001|Overall Study|Physician Decision|2|||
130784344|NCT02000921|470838775|FG002|Overall Study|Physician Decision|0|||
130784345|NCT02051296|470838780|FG000|Overall Study|Lost to Follow-up|1|||
130784346|NCT02051296|470838781|FG001|Overall Study|Lost to Follow-up|2|||
130784347|NCT02051296|470838780|FG000|Overall Study|withdraw prior to treatment|7|||
130784348|NCT02051296|470838781|FG001|Overall Study|withdraw prior to treatment|7|||
130784349|NCT02631941|470838782|FG000|Overall Study|Physician Decision|0|||
130784350|NCT02631941|470838783|FG001|Overall Study|Physician Decision|1|||
130784351|NCT02631941|470838784|FG002|Overall Study|Physician Decision|0|||
130784352|NCT02631941|470838785|FG003|Overall Study|Physician Decision|0|||
130784353|NCT02631941|470838786|FG004|Overall Study|Physician Decision|0|||
130784354|NCT02631941|470838787|FG005|Overall Study|Physician Decision|0|||
130784355|NCT02631941|470838788|FG006|Overall Study|Physician Decision|0|||
130784356|NCT02631941|470838789|FG007|Overall Study|Physician Decision|0|||
130784357|NCT02631941|470838790|FG008|Overall Study|Physician Decision|0|||
130784358|NCT02631941|470838791|FG009|Overall Study|Physician Decision|0|||
130784359|NCT02631941|470838782|FG000|Overall Study|Adverse Event|0|||
130784360|NCT02631941|470838783|FG001|Overall Study|Adverse Event|1|||
130784361|NCT02631941|470838784|FG002|Overall Study|Adverse Event|0|||
130784362|NCT02631941|470838785|FG003|Overall Study|Adverse Event|0|||
130784363|NCT02631941|470838786|FG004|Overall Study|Adverse Event|0|||
130784364|NCT02631941|470838787|FG005|Overall Study|Adverse Event|0|||
130784365|NCT02631941|470838788|FG006|Overall Study|Adverse Event|0|||
130784366|NCT02631941|470838789|FG007|Overall Study|Adverse Event|0|||
130784367|NCT02631941|470838790|FG008|Overall Study|Adverse Event|0|||
130784368|NCT02631941|470838791|FG009|Overall Study|Adverse Event|0|||
130784369|NCT02631941|470838782|FG000|Overall Study|Withdrawal by Subject|0|||
130784370|NCT02631941|470838783|FG001|Overall Study|Withdrawal by Subject|0|||
130784371|NCT02631941|470838784|FG002|Overall Study|Withdrawal by Subject|0|||
131238692|NCT05014412|472500234|FG003|Overall Study|Withdrawal by Subject|2|||
130784372|NCT02631941|470838785|FG003|Overall Study|Withdrawal by Subject|0|||
130784373|NCT02631941|470838786|FG004|Overall Study|Withdrawal by Subject|1|||
130784374|NCT02631941|470838787|FG005|Overall Study|Withdrawal by Subject|0|||
130784375|NCT02631941|470838788|FG006|Overall Study|Withdrawal by Subject|0|||
130784376|NCT02631941|470838789|FG007|Overall Study|Withdrawal by Subject|1|||
130784377|NCT02631941|470838790|FG008|Overall Study|Withdrawal by Subject|0|||
130784378|NCT02631941|470838791|FG009|Overall Study|Withdrawal by Subject|0|||
130784379|NCT02631941|470838782|FG000|Overall Study|Lost to Follow-up|0|||
130784380|NCT02631941|470838783|FG001|Overall Study|Lost to Follow-up|0|||
130784381|NCT02631941|470838784|FG002|Overall Study|Lost to Follow-up|0|||
130784382|NCT02631941|470838785|FG003|Overall Study|Lost to Follow-up|0|||
130784383|NCT02631941|470838786|FG004|Overall Study|Lost to Follow-up|0|||
130784384|NCT02631941|470838787|FG005|Overall Study|Lost to Follow-up|0|||
130784385|NCT02631941|470838788|FG006|Overall Study|Lost to Follow-up|0|||
130784386|NCT02631941|470838789|FG007|Overall Study|Lost to Follow-up|0|||
130784387|NCT02631941|470838790|FG008|Overall Study|Lost to Follow-up|1|||
130784388|NCT02631941|470838791|FG009|Overall Study|Lost to Follow-up|0|||
130784389|NCT02915835|470838792|FG000|Overall Study|Physician Decision|1|||
130784390|NCT02915835|470838793|FG001|Overall Study|Physician Decision|0|||
130784391|NCT02915835|470838792|FG000|Overall Study|Withdrawal by Subject|0|||
130784392|NCT02915835|470838793|FG001|Overall Study|Withdrawal by Subject|1|||
130784393|NCT03722576|470838794|FG000|Overall Study|Withdrawal by Subject|3|||
130784394|NCT03722576|470838794|FG000|Overall Study|Adverse Event|2|||
130784395|NCT03722576|470838794|FG000|Overall Study|Physician Decision|1|||
130784396|NCT03722576|470838794|FG000|Overall Study|Lost to Follow-up|1|||
130784397|NCT02513550|470838797|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
130784398|NCT02513550|470838798|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
130784399|NCT02513550|470838799|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
130784400|NCT02513550|470838800|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
130784401|NCT02513550|470838801|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
131181652|NCT01376245|472285713|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
131181653|NCT01376245|472285709|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
131181654|NCT01376245|472285710|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
131181655|NCT01376245|472285711|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
131181656|NCT01376245|472285712|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
131181657|NCT01376245|472285713|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
131181658|NCT01376245|472285709|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
131181659|NCT01376245|472285710|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
131181660|NCT01376245|472285711|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
131181661|NCT01376245|472285712|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
131181662|NCT01376245|472285713|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
131181663|NCT01376245|472285709|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
131181664|NCT01376245|472285710|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
131181665|NCT01376245|472285711|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
131181666|NCT01376245|472285712|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
131181667|NCT01376245|472285713|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
131181668|NCT01376245|472285709|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
131181669|NCT01376245|472285710|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
131181670|NCT01376245|472285711|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
131181671|NCT01376245|472285712|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
131181672|NCT01376245|472285713|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
131181673|NCT01376245|472285709|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131181674|NCT01376245|472285710|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
131181675|NCT01376245|472285711|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
131181676|NCT01376245|472285712|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
131181677|NCT01376245|472285713|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
131181678|NCT01376245|472285709|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
131181679|NCT01376245|472285710|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
131181680|NCT01376245|472285711|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
131181681|NCT01376245|472285712|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
131238693|NCT05014412|472500231|FG000|Overall Study|Ongoing|21|||
131238694|NCT05014412|472500232|FG001|Overall Study|Ongoing|4|||
130784402|NCT02513550|470838802|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
130784403|NCT02513550|470838797|FG000|Double Blind Treatment Period|Adverse Event|5|||
130784404|NCT02513550|470838798|FG001|Double Blind Treatment Period|Adverse Event|13|||
130784405|NCT02513550|470838799|FG002|Double Blind Treatment Period|Adverse Event|17|||
131238695|NCT05014412|472500233|FG002|Overall Study|Ongoing|6|||
130784406|NCT02513550|470838800|FG003|Double Blind Treatment Period|Adverse Event|0|||
130784407|NCT02513550|470838801|FG004|Double Blind Treatment Period|Adverse Event|1|||
131181682|NCT01376245|472285713|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
131181683|NCT01376245|472285709|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
131181684|NCT01376245|472285710|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
131181685|NCT01376245|472285711|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
131181686|NCT01376245|472285712|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
131181687|NCT01376245|472285713|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
131181688|NCT01335698|472285714|FG000|Treatment Stage 1|Lack of Efficacy|3|||
131181689|NCT01335698|472285715|FG001|Treatment Stage 1|Lack of Efficacy|1|||
131181690|NCT01335698|472285716|FG002|Treatment Stage 1|Lack of Efficacy|3|||
131181691|NCT01335698|472285717|FG003|Treatment Stage 1|Lack of Efficacy|3|||
131181692|NCT01335698|472285718|FG004|Treatment Stage 1|Lack of Efficacy|1|||
131181693|NCT01335698|472285714|FG000|Treatment Stage 1|Adverse Event|1|||
131181694|NCT01335698|472285715|FG001|Treatment Stage 1|Adverse Event|2|||
131181695|NCT01335698|472285716|FG002|Treatment Stage 1|Adverse Event|2|||
131181696|NCT01335698|472285717|FG003|Treatment Stage 1|Adverse Event|1|||
131181697|NCT01335698|472285718|FG004|Treatment Stage 1|Adverse Event|1|||
131181698|NCT01335698|472285714|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
131181699|NCT01335698|472285715|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
131181700|NCT01335698|472285716|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
131181701|NCT01335698|472285717|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
131181702|NCT01335698|472285718|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
131181703|NCT01335698|472285714|FG000|Treatment Stage 1|Lost to Follow-up|1|||
131181704|NCT01335698|472285715|FG001|Treatment Stage 1|Lost to Follow-up|1|||
131181705|NCT01335698|472285716|FG002|Treatment Stage 1|Lost to Follow-up|0|||
131181706|NCT01335698|472285717|FG003|Treatment Stage 1|Lost to Follow-up|0|||
131181707|NCT01335698|472285718|FG004|Treatment Stage 1|Lost to Follow-up|0|||
131181708|NCT01335698|472285714|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
131181709|NCT01335698|472285715|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
131181710|NCT01335698|472285716|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
131181711|NCT01335698|472285717|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
131181712|NCT01335698|472285718|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
131181713|NCT01335698|472285714|FG000|Treatment Stage 1|No longer meets study criteria|1|||
131181714|NCT01335698|472285715|FG001|Treatment Stage 1|No longer meets study criteria|1|||
131181715|NCT01335698|472285716|FG002|Treatment Stage 1|No longer meets study criteria|0|||
131181716|NCT01335698|472285717|FG003|Treatment Stage 1|No longer meets study criteria|1|||
131181717|NCT01335698|472285718|FG004|Treatment Stage 1|No longer meets study criteria|0|||
131181718|NCT01335698|472285714|FG000|Treatment Stage 1|Other|1|||
131181719|NCT01335698|472285715|FG001|Treatment Stage 1|Other|0|||
131181720|NCT01335698|472285716|FG002|Treatment Stage 1|Other|0|||
131181721|NCT01335698|472285717|FG003|Treatment Stage 1|Other|1|||
131181722|NCT01335698|472285718|FG004|Treatment Stage 1|Other|0|||
131181723|NCT01335698|472285714|FG000|Treatment Stage 2|Lack of Efficacy|2|||
131181724|NCT01335698|472285715|FG001|Treatment Stage 2|Lack of Efficacy|1|||
131181725|NCT01335698|472285716|FG002|Treatment Stage 2|Lack of Efficacy|3|||
131181726|NCT01335698|472285717|FG003|Treatment Stage 2|Lack of Efficacy|1|||
131181727|NCT01335698|472285718|FG004|Treatment Stage 2|Lack of Efficacy|0|||
131181728|NCT01335698|472285714|FG000|Treatment Stage 2|Adverse Event|2|||
131181729|NCT01335698|472285715|FG001|Treatment Stage 2|Adverse Event|0|||
131181730|NCT01335698|472285716|FG002|Treatment Stage 2|Adverse Event|0|||
131181731|NCT01335698|472285717|FG003|Treatment Stage 2|Adverse Event|3|||
131181732|NCT01335698|472285718|FG004|Treatment Stage 2|Adverse Event|0|||
130733440|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130733441|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130733442|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130733443|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130733444|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
130733445|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130733446|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130733447|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
130733448|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
130733449|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130733450|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130733451|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130733452|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130784408|NCT02513550|470838802|FG005|Double Blind Treatment Period|Adverse Event|0|||
131181733|NCT01335698|472285714|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
131181734|NCT01335698|472285715|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
131181735|NCT01335698|472285716|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
131181736|NCT01335698|472285717|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
131181737|NCT01335698|472285718|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
131181738|NCT01335698|472285714|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
131181739|NCT01335698|472285715|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
131181740|NCT01335698|472285716|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
131181741|NCT01335698|472285717|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
131181742|NCT01335698|472285718|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
131181743|NCT01335698|472285714|FG000|Treatment Stage 2|Lost to Follow-up|1|||
131181744|NCT01335698|472285715|FG001|Treatment Stage 2|Lost to Follow-up|0|||
131181745|NCT01335698|472285716|FG002|Treatment Stage 2|Lost to Follow-up|0|||
131181746|NCT01335698|472285717|FG003|Treatment Stage 2|Lost to Follow-up|0|||
131181747|NCT01335698|472285718|FG004|Treatment Stage 2|Lost to Follow-up|0|||
131181748|NCT01335698|472285714|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
131181749|NCT01335698|472285715|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
131181750|NCT01335698|472285716|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
131181751|NCT01335698|472285717|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
131181752|NCT01335698|472285718|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
131181753|NCT01335698|472285714|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
131181754|NCT01335698|472285715|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
131181755|NCT01335698|472285716|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
131181756|NCT01335698|472285717|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
131181757|NCT01335698|472285718|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
131181758|NCT01335698|472285714|FG000|Treatment Stage 2|Switched to another formulation|1|||
131181759|NCT01335698|472285715|FG001|Treatment Stage 2|Switched to another formulation|1|||
131181760|NCT01335698|472285716|FG002|Treatment Stage 2|Switched to another formulation|0|||
131181761|NCT01335698|472285717|FG003|Treatment Stage 2|Switched to another formulation|0|||
131181762|NCT01335698|472285718|FG004|Treatment Stage 2|Switched to another formulation|0|||
131181763|NCT01357889|472285719|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
131181764|NCT01357889|472285720|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
131181765|NCT01357889|472285719|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
131181766|NCT01357889|472285720|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
131181767|NCT01357889|472285719|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
131181768|NCT01357889|472285720|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
131181769|NCT01357889|472285719|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
131181770|NCT01357889|472285720|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
131181771|NCT01357889|472285719|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
131181772|NCT01357889|472285720|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
131181773|NCT01357889|472285719|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
131181774|NCT01357889|472285720|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
131181775|NCT01357889|472285719|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
131181776|NCT01357889|472285720|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
131181777|NCT01357889|472285719|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
131181778|NCT01357889|472285720|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
131181779|NCT01357889|472285719|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
131181780|NCT01357889|472285720|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
131181781|NCT01357889|472285719|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
131181782|NCT01357889|472285720|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
131181783|NCT01357889|472285719|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
131181784|NCT01357889|472285720|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
131181785|NCT01357889|472285719|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
131181786|NCT01357889|472285720|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
131181787|NCT01357889|472285719|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
131181788|NCT01357889|472285720|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
131181789|NCT01086150|472285727|FG000|Overall Study|Withdrawal by Subject|0|||
131181790|NCT01086150|472285728|FG001|Overall Study|Withdrawal by Subject|4|||
131181791|NCT01086150|472285729|FG002|Overall Study|Withdrawal by Subject|1|||
131181792|NCT01086150|472285727|FG000|Overall Study|Lost to Follow-up|0|||
131181793|NCT01086150|472285728|FG001|Overall Study|Lost to Follow-up|1|||
131181794|NCT01086150|472285729|FG002|Overall Study|Lost to Follow-up|0|||
131181795|NCT01086150|472285727|FG000|Overall Study|Screen Failure|0|||
131181796|NCT01086150|472285728|FG001|Overall Study|Screen Failure|1|||
131181797|NCT01086150|472285729|FG002|Overall Study|Screen Failure|0|||
131181798|NCT00764478|472285730|FG000|Overall Study|Adverse Event|1|||
131181799|NCT00764478|472285731|FG001|Overall Study|Adverse Event|1|||
131181800|NCT00764478|472285732|FG002|Overall Study|Adverse Event|1|||
131181801|NCT00764478|472285730|FG000|Overall Study|Withdrawal by Subject|7|||
131181802|NCT00764478|472285731|FG001|Overall Study|Withdrawal by Subject|12|||
131181803|NCT00764478|472285732|FG002|Overall Study|Withdrawal by Subject|1|||
131181804|NCT00764478|472285730|FG000|Overall Study|Lost to Follow-up|7|||
131181805|NCT00764478|472285731|FG001|Overall Study|Lost to Follow-up|8|||
131181806|NCT00764478|472285732|FG002|Overall Study|Lost to Follow-up|5|||
131181807|NCT00764478|472285730|FG000|Overall Study|Protocol Violation|0|||
130784409|NCT02513550|470838797|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
130784410|NCT02513550|470838798|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
130784411|NCT02513550|470838799|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
130784412|NCT02513550|470838800|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
130784413|NCT02513550|470838801|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
130784414|NCT02513550|470838802|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
130784415|NCT02513550|470838797|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
130784416|NCT02513550|470838798|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
130784417|NCT02513550|470838799|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
130784418|NCT02513550|470838800|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
130784419|NCT02513550|470838801|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
130784420|NCT02513550|470838802|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
130784421|NCT02513550|470838797|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130784422|NCT02513550|470838798|FG001|Double Blind Treatment Period|Protocol Violation|1|||
130784423|NCT02513550|470838799|FG002|Double Blind Treatment Period|Protocol Violation|4|||
130784424|NCT02513550|470838800|FG003|Double Blind Treatment Period|Protocol Violation|0|||
130784425|NCT02513550|470838801|FG004|Double Blind Treatment Period|Protocol Violation|0|||
130784426|NCT02513550|470838802|FG005|Double Blind Treatment Period|Protocol Violation|0|||
130784427|NCT02513550|470838797|FG000|Double Blind Treatment Period|Physician Decision|2|||
130784428|NCT02513550|470838798|FG001|Double Blind Treatment Period|Physician Decision|0|||
130784429|NCT02513550|470838799|FG002|Double Blind Treatment Period|Physician Decision|4|||
130784430|NCT02513550|470838800|FG003|Double Blind Treatment Period|Physician Decision|0|||
130784431|NCT02513550|470838801|FG004|Double Blind Treatment Period|Physician Decision|0|||
130784432|NCT02513550|470838802|FG005|Double Blind Treatment Period|Physician Decision|0|||
130784433|NCT02513550|470838797|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
130784434|NCT02513550|470838798|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
130784435|NCT02513550|470838799|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
130784436|NCT02513550|470838800|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
130784437|NCT02513550|470838801|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
130784438|NCT02513550|470838802|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
130784439|NCT02513550|470838797|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130784440|NCT02513550|470838798|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130784441|NCT02513550|470838799|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
131238696|NCT05014412|472500234|FG003|Overall Study|Ongoing|20|||
130784442|NCT02513550|470838800|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130784443|NCT02513550|470838801|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
131181808|NCT00764478|472285731|FG001|Overall Study|Protocol Violation|1|||
131181809|NCT00764478|472285732|FG002|Overall Study|Protocol Violation|1|||
131181810|NCT02270684|472285733|FG000|Overall Study|Lost to Follow-up|0|||
131181811|NCT02270684|472285734|FG001|Overall Study|Lost to Follow-up|3|||
131181812|NCT02270684|472285733|FG000|Overall Study|Study terminated|1|||
131181813|NCT02270684|472285734|FG001|Overall Study|Study terminated|0|||
131181814|NCT01740388|472285735|FG000|Overall Study|Withdrawal by Subject|1|||
131181815|NCT01740388|472285736|FG001|Overall Study|Withdrawal by Subject|2|||
131181816|NCT01740388|472285735|FG000|Overall Study|Lost to Follow-up|2|||
131181817|NCT01740388|472285736|FG001|Overall Study|Lost to Follow-up|0|||
131181818|NCT01740388|472285735|FG000|Overall Study|Physician Decision|2|||
131181819|NCT01740388|472285736|FG001|Overall Study|Physician Decision|6|||
131181820|NCT01740388|472285735|FG000|Overall Study|Subjects missing data, completed|41|||
131181821|NCT01740388|472285736|FG001|Overall Study|Subjects missing data, completed|36|||
131181822|NCT00862121|472285739|FG000|Overall Study|Adverse Event|1|||
131181823|NCT00862121|472285740|FG001|Overall Study|Adverse Event|2|||
131181824|NCT00862121|472285739|FG000|Overall Study|Lack of Efficacy|0|||
131181825|NCT00862121|472285740|FG001|Overall Study|Lack of Efficacy|3|||
131181826|NCT00862121|472285739|FG000|Overall Study|Protocol Violation|0|||
131181827|NCT00862121|472285740|FG001|Overall Study|Protocol Violation|1|||
131181828|NCT00862121|472285739|FG000|Overall Study|Exclusion criterion violation|0|||
131181829|NCT00862121|472285740|FG001|Overall Study|Exclusion criterion violation|1|||
131181830|NCT00862121|472285739|FG000|Overall Study|Incorrect randomisation|0|||
131181831|NCT00862121|472285740|FG001|Overall Study|Incorrect randomisation|1|||
131181832|NCT00171314|472285745|FG000|Overall Study|Adverse Event|44|||
131181833|NCT00171314|472285746|FG001|Overall Study|Adverse Event|41|||
131181834|NCT00171314|472285745|FG000|Overall Study|Lack of Efficacy|19|||
131181835|NCT00171314|472285746|FG001|Overall Study|Lack of Efficacy|14|||
131238697|NCT05074433|472500237|FG000|Overall Study|Adverse Event|0|||
131181836|NCT00171314|472285745|FG000|Overall Study|Withdrawal by Subject|9|||
131181837|NCT00171314|472285746|FG001|Overall Study|Withdrawal by Subject|6|||
131238698|NCT05074433|472500238|FG001|Overall Study|Adverse Event|2|||
131238699|NCT05074433|472500239|FG002|Overall Study|Adverse Event|0|||
130784444|NCT02513550|470838802|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
131181838|NCT00171314|472285745|FG000|Overall Study|Abnormal Test Procedure Results|9|||
131181839|NCT00171314|472285746|FG001|Overall Study|Abnormal Test Procedure Results|3|||
131238700|NCT05074433|472500240|FG003|Overall Study|Adverse Event|1|||
131238701|NCT05074433|472500237|FG000|Overall Study|Sponsor Request|0|||
131238702|NCT05074433|472500238|FG001|Overall Study|Sponsor Request|1|||
131238703|NCT05074433|472500239|FG002|Overall Study|Sponsor Request|1|||
131238704|NCT05074433|472500240|FG003|Overall Study|Sponsor Request|0|||
131238705|NCT05074433|472500237|FG000|Overall Study|Death|1|||
131238706|NCT05074433|472500238|FG001|Overall Study|Death|0|||
131238707|NCT05074433|472500239|FG002|Overall Study|Death|0|||
131238708|NCT05074433|472500240|FG003|Overall Study|Death|0|||
131238709|NCT05074433|472500237|FG000|Overall Study|Lost to Follow-up|0|||
131238710|NCT05074433|472500238|FG001|Overall Study|Lost to Follow-up|0|||
131238711|NCT05074433|472500239|FG002|Overall Study|Lost to Follow-up|2|||
131238712|NCT05074433|472500240|FG003|Overall Study|Lost to Follow-up|0|||
131238713|NCT05074433|472500237|FG000|Overall Study|Subject Decision|8|||
131238714|NCT05074433|472500238|FG001|Overall Study|Subject Decision|6|||
131238715|NCT05074433|472500239|FG002|Overall Study|Subject Decision|4|||
131238716|NCT05074433|472500240|FG003|Overall Study|Subject Decision|5|||
131238717|NCT04397263|472500241|FG000|Overall Study|Withdrawal by Subject|2|||
131238718|NCT04281485|472500244|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
131238719|NCT04281485|472500245|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
131238720|NCT04281485|472500244|FG000|Overall Study|Ongoing (Safety data collection)|10|||
131238721|NCT04281485|472500245|FG001|Overall Study|Ongoing (Safety data collection)|5|||
131238722|NCT02365597|472500250|FG000|Overall Study|Lost to Follow-up|0|||
131238723|NCT02365597|472500251|FG001|Overall Study|Lost to Follow-up|1|||
131238724|NCT02365597|472500252|FG002|Overall Study|Lost to Follow-up|0|||
131238725|NCT02365597|472500253|FG003|Overall Study|Lost to Follow-up|1|||
131238726|NCT02365597|472500250|FG000|Overall Study|Withdrawal by Subject|1|||
131238727|NCT02365597|472500251|FG001|Overall Study|Withdrawal by Subject|8|||
131238728|NCT02365597|472500252|FG002|Overall Study|Withdrawal by Subject|5|||
131238729|NCT02365597|472500253|FG003|Overall Study|Withdrawal by Subject|1|||
131238730|NCT02365597|472500250|FG000|Overall Study|Sponsor's decision|1|||
131238731|NCT02365597|472500251|FG001|Overall Study|Sponsor's decision|3|||
131238732|NCT02365597|472500252|FG002|Overall Study|Sponsor's decision|13|||
131238733|NCT02365597|472500253|FG003|Overall Study|Sponsor's decision|0|||
131238734|NCT02365597|472500250|FG000|Overall Study|Other|0|||
131238735|NCT02365597|472500251|FG001|Overall Study|Other|4|||
131238736|NCT02365597|472500252|FG002|Overall Study|Other|0|||
131238737|NCT02365597|472500253|FG003|Overall Study|Other|0|||
131238738|NCT02365597|472500250|FG000|Overall Study|Enrolled but not treated|0|||
131238739|NCT02365597|472500251|FG001|Overall Study|Enrolled but not treated|1|||
131238740|NCT02365597|472500252|FG002|Overall Study|Enrolled but not treated|1|||
131238741|NCT02365597|472500253|FG003|Overall Study|Enrolled but not treated|0|||
131238742|NCT02365597|472500250|FG000|Overall Study|Ongoing|0|||
131238743|NCT02365597|472500251|FG001|Overall Study|Ongoing|0|||
131238744|NCT02365597|472500252|FG002|Overall Study|Ongoing|0|||
131238745|NCT02365597|472500253|FG003|Overall Study|Ongoing|17|||
131238746|NCT04066244|472500255|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
131238747|NCT04066244|472500256|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
131238748|NCT04066244|472500257|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
131238749|NCT04066244|472500258|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
131238750|NCT04066244|472500259|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
131238751|NCT04066244|472500260|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
131238752|NCT04066244|472500255|FG000|Part 2 (Cohort 5)|Death|0|||
131238753|NCT04066244|472500256|FG001|Part 2 (Cohort 5)|Death|0|||
131238754|NCT04066244|472500257|FG002|Part 2 (Cohort 5)|Death|0|||
131238755|NCT04066244|472500258|FG003|Part 2 (Cohort 5)|Death|0|||
131238756|NCT04066244|472500259|FG004|Part 2 (Cohort 5)|Death|0|||
131238757|NCT04066244|472500260|FG005|Part 2 (Cohort 5)|Death|2|||
131238758|NCT04066244|472500255|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
131238759|NCT04066244|472500256|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
131238760|NCT04066244|472500257|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
131238761|NCT04066244|472500258|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
131238762|NCT04066244|472500259|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
131238763|NCT04066244|472500260|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
131238764|NCT04066244|472500255|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
131238765|NCT04066244|472500256|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
131238766|NCT04066244|472500257|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
131238767|NCT04066244|472500258|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
131238768|NCT04066244|472500259|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
131238769|NCT04066244|472500260|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
131238770|NCT03752970|472500264|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
131238771|NCT03752970|472500265|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
131238772|NCT03752970|472500266|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
131238773|NCT03752970|472500264|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
131238774|NCT03752970|472500265|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
131238775|NCT03752970|472500266|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
131238776|NCT03752970|472500264|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
131238777|NCT03752970|472500265|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
130784445|NCT02513550|470838797|FG000|Double Blind Treatment Period|Due to personal business|2|||
130784446|NCT02513550|470838798|FG001|Double Blind Treatment Period|Due to personal business|0|||
130784447|NCT02513550|470838799|FG002|Double Blind Treatment Period|Due to personal business|1|||
130784448|NCT02513550|470838800|FG003|Double Blind Treatment Period|Due to personal business|0|||
130784449|NCT02513550|470838801|FG004|Double Blind Treatment Period|Due to personal business|0|||
130784450|NCT02513550|470838802|FG005|Double Blind Treatment Period|Due to personal business|0|||
130784451|NCT02513550|470838797|FG000|Double Blind Treatment Period|Death|1|||
130784452|NCT02513550|470838798|FG001|Double Blind Treatment Period|Death|0|||
130784453|NCT02513550|470838799|FG002|Double Blind Treatment Period|Death|2|||
130784454|NCT02513550|470838800|FG003|Double Blind Treatment Period|Death|0|||
130784455|NCT02513550|470838801|FG004|Double Blind Treatment Period|Death|0|||
131238778|NCT03752970|472500266|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
131238779|NCT03752970|472500264|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
131238780|NCT03752970|472500265|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
131238781|NCT03752970|472500266|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
131238782|NCT03752970|472500264|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
131238783|NCT03752970|472500265|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
131238784|NCT03752970|472500266|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
131238785|NCT04876391|472500267|FG000|Overall Study|Withdrawal by Subject|1|||
131238786|NCT04876391|472500268|FG001|Overall Study|Withdrawal by Subject|10|||
131238787|NCT04876391|472500267|FG000|Overall Study|Lost to Follow-up|2|||
131238788|NCT04876391|472500268|FG001|Overall Study|Lost to Follow-up|4|||
131238789|NCT04876391|472500267|FG000|Overall Study|Lack of Efficacy|0|||
131238790|NCT04876391|472500268|FG001|Overall Study|Lack of Efficacy|2|||
131238791|NCT04876391|472500267|FG000|Overall Study|Adverse Event|3|||
131238792|NCT04876391|472500268|FG001|Overall Study|Adverse Event|1|||
131238793|NCT04876391|472500267|FG000|Overall Study|Patient non-compliance|0|||
131238794|NCT04876391|472500268|FG001|Overall Study|Patient non-compliance|1|||
131238795|NCT04876391|472500267|FG000|Overall Study|Personal reasons|0|||
131238796|NCT04876391|472500268|FG001|Overall Study|Personal reasons|1|||
131238797|NCT04876391|472500267|FG000|Overall Study|Withdrawn as per protocol|2|||
131238798|NCT04876391|472500268|FG001|Overall Study|Withdrawn as per protocol|2|||
131238799|NCT03976362|472500272|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
131238800|NCT03976362|472500273|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
131238801|NCT03976362|472500274|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
131238802|NCT03976362|472500272|FG000|Induction Phase|Death|62|||
131238803|NCT03976362|472500273|FG001|Induction Phase|Death|0|||
131238804|NCT03976362|472500274|FG002|Induction Phase|Death|0|||
130784456|NCT02513550|470838802|FG005|Double Blind Treatment Period|Death|0|||
130784457|NCT02513550|470838797|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
130784458|NCT02513550|470838798|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
131181840|NCT00171314|472285745|FG000|Overall Study|Protocol Violation|3|||
131181841|NCT00171314|472285746|FG001|Overall Study|Protocol Violation|7|||
131181842|NCT00171314|472285745|FG000|Overall Study|Administrative Problems|4|||
131181843|NCT00171314|472285746|FG001|Overall Study|Administrative Problems|3|||
131181844|NCT00171314|472285745|FG000|Overall Study|Lost to Follow-up|1|||
131181845|NCT00171314|472285746|FG001|Overall Study|Lost to Follow-up|3|||
131181846|NCT00171314|472285745|FG000|Overall Study|Death|2|||
131181847|NCT00171314|472285746|FG001|Overall Study|Death|1|||
131181848|NCT01033487|472285750|FG000|Fourth Intervention Period|Adverse Event|0|||
131181849|NCT01033487|472285751|FG001|Fourth Intervention Period|Adverse Event|0|||
131181850|NCT01033487|472285752|FG002|Fourth Intervention Period|Adverse Event|0|||
131181851|NCT01033487|472285753|FG003|Fourth Intervention Period|Adverse Event|0|||
131181852|NCT01033487|472285754|FG004|Fourth Intervention Period|Adverse Event|0|||
131181853|NCT01033487|472285755|FG005|Fourth Intervention Period|Adverse Event|0|||
131181854|NCT01033487|472285756|FG006|Fourth Intervention Period|Adverse Event|0|||
131181855|NCT01033487|472285757|FG007|Fourth Intervention Period|Adverse Event|0|||
131181856|NCT01033487|472285758|FG008|Fourth Intervention Period|Adverse Event|1|||
131181857|NCT01033487|472285759|FG009|Fourth Intervention Period|Adverse Event|0|||
131181858|NCT02939599|472285760|FG000|Overall Study|Adverse Event|1|||
131181859|NCT02939599|472285761|FG001|Overall Study|Adverse Event|0|||
131181860|NCT02939599|472285760|FG000|Overall Study|Study Terminated By Sponsor|2|||
131181861|NCT02939599|472285761|FG001|Overall Study|Study Terminated By Sponsor|2|||
131181862|NCT03479216|472285765|FG000|Overall Study|Withdrawal by Subject|3|||
131181863|NCT03479216|472285766|FG001|Overall Study|Withdrawal by Subject|2|||
131181864|NCT03479216|472285765|FG000|Overall Study|Physician Decision|2|||
131238805|NCT03976362|472500272|FG000|Maintenance Phase|Participants Ongoing|0|||
131238806|NCT03976362|472500273|FG001|Maintenance Phase|Participants Ongoing|106|||
131238807|NCT03976362|472500274|FG002|Maintenance Phase|Participants Ongoing|103|||
131238808|NCT03976362|472500272|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130784459|NCT02513550|470838799|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
130784460|NCT02513550|470838800|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
131181865|NCT03479216|472285766|FG001|Overall Study|Physician Decision|3|||
131181866|NCT02148211|472285769|FG000|Overall Study|Lost to Follow-up|352|||
131181867|NCT03326869|472287477|FG000|Overall Study|Study data has been lost to natural disa|1|||
131181868|NCT03326869|472287478|FG001|Overall Study|Study data has been lost to natural disa|1|||
131181869|NCT03287869|472287482|FG000|Overall Study|Adverse Event|14|||
131181870|NCT03287869|472287483|FG001|Overall Study|Adverse Event|12|||
131181871|NCT03287869|472287482|FG000|Overall Study|Lack of Efficacy|1|||
131181872|NCT03287869|472287483|FG001|Overall Study|Lack of Efficacy|0|||
131181873|NCT03287869|472287482|FG000|Overall Study|Lost to Follow-up|13|||
131181874|NCT03287869|472287483|FG001|Overall Study|Lost to Follow-up|19|||
131181875|NCT03287869|472287482|FG000|Overall Study|Non-Compliance With Study Drug|5|||
131181876|NCT03287869|472287483|FG001|Overall Study|Non-Compliance With Study Drug|9|||
131181877|NCT03287869|472287482|FG000|Overall Study|Progressive Disease|1|||
131181878|NCT03287869|472287483|FG001|Overall Study|Progressive Disease|0|||
131181879|NCT03287869|472287482|FG000|Overall Study|Protocol Deviation|2|||
131181880|NCT03287869|472287483|FG001|Overall Study|Protocol Deviation|1|||
131181881|NCT03287869|472287482|FG000|Overall Study|Withdrawal by Subject|36|||
131181882|NCT03287869|472287483|FG001|Overall Study|Withdrawal by Subject|43|||
131181883|NCT03287869|472287482|FG000|Overall Study|Early Closure of the Site|0|||
131181884|NCT03287869|472287483|FG001|Overall Study|Early Closure of the Site|1|||
131181885|NCT03287869|472287482|FG000|Overall Study|Physician Decision|5|||
131181886|NCT03287869|472287483|FG001|Overall Study|Physician Decision|5|||
131181887|NCT03287869|472287482|FG000|Overall Study|Reason not Specified|6|||
131181888|NCT03287869|472287483|FG001|Overall Study|Reason not Specified|3|||
131181889|NCT03488238|472287484|FG000|Overall Study|Equipment malfunction|1|||
131181890|NCT03488238|472287484|FG000|Overall Study|Adverse Event|1|||
131181891|NCT02670928|472287485|FG000|Overall Study|Adverse Event|3|||
131181892|NCT02670928|472287486|FG001|Overall Study|Adverse Event|1|||
131181893|NCT02670928|472287485|FG000|Overall Study|Withdrawal by Subject|4|||
131181894|NCT02670928|472287486|FG001|Overall Study|Withdrawal by Subject|0|||
131181895|NCT02670928|472287485|FG000|Overall Study|Lost to Follow-up|1|||
131181896|NCT02670928|472287486|FG001|Overall Study|Lost to Follow-up|0|||
131181897|NCT02670928|472287485|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
131181898|NCT02670928|472287486|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
131181899|NCT02591238|472287487|FG000|Overall Study|Pregnancy|1|||
131181900|NCT02591238|472287488|FG001|Overall Study|Pregnancy|0|||
131181901|NCT02591238|472287489|FG002|Overall Study|Pregnancy|0|||
131181902|NCT02591238|472287490|FG003|Overall Study|Pregnancy|0|||
131181903|NCT02591238|472287487|FG000|Overall Study|Withdrawal by Subject|0|||
131181904|NCT02591238|472287488|FG001|Overall Study|Withdrawal by Subject|0|||
131181905|NCT02591238|472287489|FG002|Overall Study|Withdrawal by Subject|0|||
131181906|NCT02591238|472287490|FG003|Overall Study|Withdrawal by Subject|1|||
131181907|NCT02591238|472287487|FG000|Overall Study|influenza|0|||
131181908|NCT02591238|472287488|FG001|Overall Study|influenza|0|||
131181909|NCT02591238|472287489|FG002|Overall Study|influenza|0|||
131181910|NCT02591238|472287490|FG003|Overall Study|influenza|1|||
131181911|NCT02591238|472287487|FG000|Overall Study|personal circumstances|0|||
131181912|NCT02591238|472287488|FG001|Overall Study|personal circumstances|0|||
131238809|NCT03976362|472500273|FG001|Maintenance Phase|Withdrawal by Subject|4|||
131181913|NCT02591238|472287489|FG002|Overall Study|personal circumstances|0|||
131181914|NCT02591238|472287490|FG003|Overall Study|personal circumstances|1|||
131181915|NCT02591238|472287487|FG000|Overall Study|personal circumstances|0|||
131181916|NCT02591238|472287488|FG001|Overall Study|personal circumstances|1|||
131181917|NCT02591238|472287489|FG002|Overall Study|personal circumstances|0|||
131181918|NCT02591238|472287490|FG003|Overall Study|personal circumstances|0|||
131181919|NCT00525785|472287492|FG000|Overall Study|Withdrawal by Subject|1|||
131181920|NCT00525785|472287492|FG000|Overall Study|Lack of Efficacy|1|||
131181921|NCT00525785|472287492|FG000|Overall Study|Physician Decision|1|||
131181922|NCT01316939|472287493|FG000|Overall Study|Study closed/terminated|26|||
131181923|NCT01316939|472287494|FG001|Overall Study|Study closed/terminated|25|||
131181924|NCT01316939|472287495|FG002|Overall Study|Study closed/terminated|23|||
131181925|NCT01316939|472287493|FG000|Overall Study|Lack of Efficacy|24|||
131181926|NCT01316939|472287494|FG001|Overall Study|Lack of Efficacy|25|||
131181927|NCT01316939|472287495|FG002|Overall Study|Lack of Efficacy|25|||
131181928|NCT01316939|472287493|FG000|Overall Study|Adverse Event|9|||
131181929|NCT01316939|472287494|FG001|Overall Study|Adverse Event|12|||
131181930|NCT01316939|472287495|FG002|Overall Study|Adverse Event|11|||
131181931|NCT01316939|472287493|FG000|Overall Study|Withdrawal by Subject|1|||
131181932|NCT01316939|472287494|FG001|Overall Study|Withdrawal by Subject|3|||
131181933|NCT01316939|472287495|FG002|Overall Study|Withdrawal by Subject|6|||
131181934|NCT01316939|472287493|FG000|Overall Study|Physician Decision|2|||
131181935|NCT01316939|472287494|FG001|Overall Study|Physician Decision|2|||
131181936|NCT01316939|472287495|FG002|Overall Study|Physician Decision|1|||
131238810|NCT03976362|472500274|FG002|Maintenance Phase|Withdrawal by Subject|4|||
131181937|NCT01316939|472287493|FG000|Overall Study|Lost to Follow-up|0|||
131181938|NCT01316939|472287494|FG001|Overall Study|Lost to Follow-up|0|||
131181939|NCT01316939|472287495|FG002|Overall Study|Lost to Follow-up|2|||
131181940|NCT01316939|472287493|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
131181941|NCT01316939|472287494|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
131181942|NCT01316939|472287495|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
131181943|NCT01316939|472287493|FG000|Overall Study|Protocol Violation|0|||
131181944|NCT01316939|472287494|FG001|Overall Study|Protocol Violation|1|||
131181945|NCT01316939|472287495|FG002|Overall Study|Protocol Violation|0|||
131181946|NCT01634113|472287496|FG000|Overall Study|Not treated|0|||
131181947|NCT01634113|472287497|FG001|Overall Study|Not treated|0|||
131181948|NCT01634113|472287498|FG002|Overall Study|Not treated|1|||
131181949|NCT00324740|472287499|FG000|Overall Study|Withdrawal by Subject|1|||
131181950|NCT00324740|472287500|FG001|Overall Study|Withdrawal by Subject|0|||
131181951|NCT00324740|472287501|FG002|Overall Study|Withdrawal by Subject|1|||
131181952|NCT00520299|472287504|FG000|Overall Study|Withdrawal by Subject|0|||
131181953|NCT00520299|472287505|FG001|Overall Study|Withdrawal by Subject|0|||
131181954|NCT00520299|472287506|FG002|Overall Study|Withdrawal by Subject|2|||
131181955|NCT00520299|472287504|FG000|Overall Study|Progressive disease|0|||
131181956|NCT00520299|472287505|FG001|Overall Study|Progressive disease|3|||
131181957|NCT00520299|472287506|FG002|Overall Study|Progressive disease|4|||
131181958|NCT01352845|472287507|FG000|Overall Study|Lost to Follow-up|313|||
131181959|NCT01352845|472287508|FG001|Overall Study|Lost to Follow-up|92|||
131181960|NCT01352845|472287507|FG000|Overall Study|No Longer Willing to Participate|205|||
131181961|NCT01352845|472287508|FG001|Overall Study|No Longer Willing to Participate|58|||
131181962|NCT01352845|472287507|FG000|Overall Study|Withdrawal by Subject|48|||
131181963|NCT01352845|472287508|FG001|Overall Study|Withdrawal by Subject|16|||
131181964|NCT01352845|472287507|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
131181965|NCT01352845|472287508|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
131181966|NCT01352845|472287507|FG000|Overall Study|Pregnancy|27|||
131181967|NCT01352845|472287508|FG001|Overall Study|Pregnancy|7|||
131181968|NCT01352845|472287507|FG000|Overall Study|Adverse Event|22|||
131181969|NCT01352845|472287508|FG001|Overall Study|Adverse Event|6|||
131181970|NCT01352845|472287507|FG000|Overall Study|Other|17|||
131181971|NCT01352845|472287508|FG001|Overall Study|Other|7|||
131181972|NCT01352845|472287507|FG000|Overall Study|Protocol Violation|12|||
131181973|NCT01352845|472287508|FG001|Overall Study|Protocol Violation|6|||
131181974|NCT01352845|472287507|FG000|Overall Study|Death|3|||
131181975|NCT01352845|472287508|FG001|Overall Study|Death|0|||
131181976|NCT01357980|472287512|FG000|Overall Study|Lack of Efficacy|0|||
131181977|NCT01357980|472287513|FG001|Overall Study|Lack of Efficacy|1|||
131181978|NCT01357980|472287514|FG002|Overall Study|Lack of Efficacy|0|||
131181979|NCT01357980|472287515|FG003|Overall Study|Lack of Efficacy|0|||
131181980|NCT01357980|472287512|FG000|Overall Study|Consent withdrawn|0|||
131181981|NCT01357980|472287513|FG001|Overall Study|Consent withdrawn|0|||
131181982|NCT01357980|472287514|FG002|Overall Study|Consent withdrawn|1|||
131181983|NCT01357980|472287515|FG003|Overall Study|Consent withdrawn|0|||
131181984|NCT04507776|472287516|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
131181985|NCT01624506|472287517|FG000|Overall Study|Lost to Follow-up|29|||
131181986|NCT01624506|472287518|FG001|Overall Study|Lost to Follow-up|15|||
131181987|NCT01624506|472287517|FG000|Overall Study|Withdrawal by Subject|9|||
131181988|NCT01624506|472287518|FG001|Overall Study|Withdrawal by Subject|2|||
131181989|NCT01624506|472287517|FG000|Overall Study|Death|1|||
131181990|NCT01624506|472287518|FG001|Overall Study|Death|0|||
131181991|NCT01624506|472287517|FG000|Overall Study|LINX explants|23|||
131181992|NCT01624506|472287518|FG001|Overall Study|LINX explants|0|||
131181993|NCT01624506|472287517|FG000|Overall Study|Adverse Event|3|||
131181994|NCT01624506|472287518|FG001|Overall Study|Adverse Event|0|||
131181995|NCT00132314|472287522|FG000|Overall Study|Lost to Follow-up|70|||
131181996|NCT00132314|472287523|FG001|Overall Study|Lost to Follow-up|62|||
131181997|NCT00132314|472287522|FG000|Overall Study|Lacked SSN|1|||
131181998|NCT00132314|472287523|FG001|Overall Study|Lacked SSN|3|||
131181999|NCT00132314|472287522|FG000|Overall Study|Refused intervention at baseline|2|||
131182000|NCT00132314|472287523|FG001|Overall Study|Refused intervention at baseline|7|||
131182001|NCT02514772|472287524|FG000|Overall Study|Adverse Event|1|||
131182002|NCT02514772|472287525|FG001|Overall Study|Adverse Event|0|||
131182003|NCT02514772|472287524|FG000|Overall Study|Death|0|||
131182004|NCT02514772|472287525|FG001|Overall Study|Death|1|||
131182005|NCT02514772|472287524|FG000|Overall Study|Withdrawal by Subject|2|||
131182006|NCT02514772|472287525|FG001|Overall Study|Withdrawal by Subject|1|||
131182007|NCT01415908|472287526|FG000|Overall Study|Withdrawal by Subject|1|||
131182008|NCT01415908|472287527|FG001|Overall Study|Withdrawal by Subject|0|||
131182009|NCT00793182|472287528|FG000|Overall Study|Adverse Event|0|||
131182010|NCT00793182|472287529|FG001|Overall Study|Adverse Event|1|||
131182011|NCT00851253|472287536|FG000|Overall Study|Disease Progression|1|||
131182012|NCT00851253|472287537|FG001|Overall Study|Disease Progression|0|||
131182013|NCT02197897|472287538|FG000|Overall Study|not eligible|1|||
131182014|NCT01705587|472287544|FG000|Overall Study|Withdrawal by Subject|0|||
131182015|NCT01705587|472287545|FG001|Overall Study|Withdrawal by Subject|1|||
131182016|NCT01532570|472287547|FG000|Overall Study|Lack of Efficacy|1|||
131182017|NCT01532570|472287548|FG001|Overall Study|Lack of Efficacy|0|||
131182018|NCT01532570|472287549|FG002|Overall Study|Lack of Efficacy|0|||
131182019|NCT01532570|472287550|FG003|Overall Study|Lack of Efficacy|0|||
131182020|NCT01532570|472287547|FG000|Overall Study|Withdrawal by Subject|0|||
130784461|NCT02513550|470838801|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130784462|NCT02513550|470838802|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130784463|NCT02513550|470838797|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
130784464|NCT02513550|470838798|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
130784465|NCT02513550|470838799|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
130784466|NCT02513550|470838800|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
130784467|NCT02513550|470838801|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
130784468|NCT02513550|470838802|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
130784469|NCT02513550|470838797|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
130784470|NCT02513550|470838798|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
130784471|NCT02513550|470838799|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
130784472|NCT02513550|470838800|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130784473|NCT02513550|470838801|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130784474|NCT02513550|470838802|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130784475|NCT02513550|470838797|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
130784476|NCT02513550|470838798|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
130784477|NCT02513550|470838799|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
130784478|NCT02513550|470838800|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
130784479|NCT02513550|470838801|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
130784480|NCT02513550|470838802|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
130784481|NCT02513550|470838797|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
130784482|NCT02513550|470838798|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
130784483|NCT02513550|470838799|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
130784484|NCT02513550|470838800|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
130784485|NCT02513550|470838801|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
130784486|NCT02513550|470838802|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
130784487|NCT02513550|470838797|FG000|Post-Treatment Follow-up Period|Death|0|||
130784488|NCT02513550|470838798|FG001|Post-Treatment Follow-up Period|Death|0|||
130784489|NCT02513550|470838799|FG002|Post-Treatment Follow-up Period|Death|1|||
130784490|NCT02513550|470838800|FG003|Post-Treatment Follow-up Period|Death|0|||
130784491|NCT02513550|470838801|FG004|Post-Treatment Follow-up Period|Death|0|||
130784492|NCT02513550|470838802|FG005|Post-Treatment Follow-up Period|Death|0|||
130784493|NCT02513550|470838797|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
130784494|NCT02513550|470838798|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
130784495|NCT02513550|470838799|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
130784496|NCT02513550|470838800|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
130784497|NCT02513550|470838801|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
130784498|NCT02513550|470838802|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
130784499|NCT02513550|470838797|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130784500|NCT02513550|470838798|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130784501|NCT02513550|470838799|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
130784502|NCT02513550|470838800|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130784503|NCT02513550|470838801|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
131182021|NCT01532570|472287548|FG001|Overall Study|Withdrawal by Subject|1|||
131182022|NCT01532570|472287549|FG002|Overall Study|Withdrawal by Subject|0|||
131182023|NCT01532570|472287550|FG003|Overall Study|Withdrawal by Subject|0|||
131182024|NCT01329341|472287556|FG000|Overall Study|Withdrawal by Subject|44|||
131182025|NCT03017846|472287557|FG000|Overall Study|Lost to Follow-up|3|||
131182026|NCT03017846|472287557|FG000|Overall Study|Adverse Event|2|||
131182027|NCT04603391|472287558|FG000|First Intervention (4 Days)|Adverse Event|1|||
131182028|NCT04603391|472287559|FG001|First Intervention (4 Days)|Adverse Event|0|||
131182029|NCT04603391|472287558|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
131238811|NCT03976362|472500272|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
131238812|NCT03976362|472500273|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
131238813|NCT03976362|472500274|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
131238814|NCT03976362|472500272|FG000|Maintenance Phase|Death|0|||
130784504|NCT02513550|470838802|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130784505|NCT02513550|470838797|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
130784506|NCT02513550|470838798|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
131238815|NCT03976362|472500273|FG001|Maintenance Phase|Death|186|||
131238816|NCT03976362|472500274|FG002|Maintenance Phase|Death|187|||
130784507|NCT02513550|470838799|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
131182030|NCT04603391|472287559|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
131182031|NCT02151682|472287560|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
131182032|NCT02151682|472287561|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
131238817|NCT04767282|472500275|FG000|Overall Study|Refused or did not begin surveys|6|||
130784508|NCT02513550|470838800|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
130784509|NCT02513550|470838801|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
131182033|NCT02151682|472287562|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
131182034|NCT02151682|472287563|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
131182035|NCT02151682|472287564|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
131182036|NCT02151682|472287565|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
131182037|NCT02151682|472287560|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
131182038|NCT02151682|472287561|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
131182039|NCT02151682|472287562|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
131182040|NCT02151682|472287563|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
131182041|NCT02151682|472287564|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
131182042|NCT02151682|472287565|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
131182043|NCT02151682|472287560|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
131182044|NCT02151682|472287561|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
131182045|NCT02151682|472287562|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
131182046|NCT02151682|472287563|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
131182047|NCT02151682|472287564|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
131182048|NCT02151682|472287565|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
131182049|NCT02151682|472287560|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
131182050|NCT02151682|472287561|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
131182051|NCT02151682|472287562|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
131182052|NCT02151682|472287563|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
131182053|NCT02151682|472287564|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
131182054|NCT02151682|472287565|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
131182055|NCT02151682|472287560|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
131182056|NCT02151682|472287561|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
131182057|NCT02151682|472287562|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
131182058|NCT02151682|472287563|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
131182059|NCT02151682|472287564|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
131182060|NCT02151682|472287565|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
131182061|NCT02151682|472287560|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
131182062|NCT02151682|472287561|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
131182063|NCT02151682|472287562|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
131182064|NCT02151682|472287563|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
131182065|NCT02151682|472287564|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
131182066|NCT02151682|472287565|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
131182067|NCT02151682|472287560|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
131182068|NCT02151682|472287561|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
131182069|NCT02151682|472287562|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
131182070|NCT02151682|472287563|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
131182071|NCT02151682|472287564|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
131182072|NCT02151682|472287565|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
131182073|NCT02151682|472287560|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
131182074|NCT02151682|472287561|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
131182075|NCT02151682|472287562|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
131182076|NCT02151682|472287563|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
131182077|NCT02151682|472287564|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
131182078|NCT02151682|472287565|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
131182079|NCT02151682|472287560|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
131182080|NCT02151682|472287561|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
131182081|NCT02151682|472287562|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
130733453|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130733454|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130733455|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130733456|NCT03598790|470642890|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130733457|NCT03598790|470642891|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
131182082|NCT02151682|472287563|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
131182083|NCT02151682|472287564|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
131182084|NCT02151682|472287565|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
131182085|NCT02151682|472287560|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
131182086|NCT02151682|472287561|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
131182087|NCT02151682|472287562|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
131182088|NCT02151682|472287563|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
131182089|NCT02151682|472287564|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
131182090|NCT02151682|472287565|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
131182091|NCT02151682|472287560|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
131182092|NCT02151682|472287561|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
131182093|NCT02151682|472287562|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
131182094|NCT02151682|472287563|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
131182095|NCT02151682|472287564|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
131182096|NCT02151682|472287565|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
131182097|NCT02151682|472287560|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
131182098|NCT02151682|472287561|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
130733458|NCT03598790|470642892|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
130733459|NCT03598790|470642893|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130733460|NCT03598790|470642894|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130733461|NCT03598790|470642895|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130733462|NCT03598790|470642896|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130733463|NCT03598790|470642897|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130733464|NCT03598790|470642898|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130733465|NCT03598790|470642890|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130733466|NCT03598790|470642891|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130733467|NCT03598790|470642892|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130733468|NCT03598790|470642893|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
130733469|NCT03598790|470642894|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
130733470|NCT03598790|470642895|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
130733471|NCT03598790|470642896|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130733472|NCT03598790|470642897|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130733473|NCT03598790|470642898|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130733474|NCT03598790|470642890|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130733475|NCT03598790|470642891|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130733476|NCT03598790|470642892|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130733477|NCT03598790|470642893|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
130733478|NCT03598790|470642894|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130733479|NCT03598790|470642895|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130733480|NCT03598790|470642896|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130733481|NCT03598790|470642897|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130733482|NCT03598790|470642898|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130733483|NCT03598790|470642890|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130733484|NCT03598790|470642891|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130733485|NCT03598790|470642892|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130733486|NCT03598790|470642893|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
130733487|NCT03598790|470642894|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130733488|NCT03598790|470642895|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130733489|NCT03598790|470642896|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130733490|NCT03598790|470642897|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130733491|NCT03598790|470642898|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130733492|NCT03598790|470642890|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130733493|NCT03598790|470642891|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130733494|NCT03598790|470642892|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130733495|NCT03598790|470642893|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
130733496|NCT03598790|470642894|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
130733497|NCT03598790|470642895|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130733498|NCT03598790|470642896|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130733499|NCT03598790|470642897|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130733500|NCT03598790|470642898|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130733501|NCT03598790|470642890|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130733502|NCT03598790|470642891|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130733503|NCT03598790|470642892|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130733504|NCT03598790|470642893|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
130733505|NCT03598790|470642894|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130733506|NCT03598790|470642895|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130733507|NCT03598790|470642896|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130733508|NCT03598790|470642897|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130733509|NCT03598790|470642898|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
131182099|NCT02151682|472287562|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
131182100|NCT02151682|472287563|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
131182101|NCT02151682|472287564|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
131238818|NCT04767282|472500276|FG001|Overall Study|Refused or did not begin surveys|2|||
131238819|NCT04767282|472500277|FG002|Overall Study|Refused or did not begin surveys|2|||
131182102|NCT02151682|472287565|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
131182103|NCT02151682|472287560|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
131182104|NCT02151682|472287561|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
131182105|NCT02151682|472287562|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
131182106|NCT02151682|472287563|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
131182107|NCT02151682|472287564|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
131182108|NCT02151682|472287565|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
131182109|NCT02151682|472287560|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
131182110|NCT02151682|472287561|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
131182111|NCT02151682|472287562|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
131182112|NCT02151682|472287563|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
131182113|NCT02151682|472287564|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
131182114|NCT02151682|472287565|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
131182115|NCT02151682|472287560|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
131182116|NCT02151682|472287561|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
131182117|NCT02151682|472287562|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
131182118|NCT02151682|472287563|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
131182119|NCT02151682|472287564|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
131182120|NCT02151682|472287565|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
131182121|NCT02151682|472287560|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
131182122|NCT02151682|472287561|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
131182123|NCT02151682|472287562|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
131182124|NCT02151682|472287563|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
131182125|NCT02151682|472287564|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
131182126|NCT02151682|472287565|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
131182127|NCT02151682|472287560|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
131182128|NCT02151682|472287561|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
131182129|NCT02151682|472287562|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
131182130|NCT02151682|472287563|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
131182131|NCT02151682|472287564|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
131182132|NCT02151682|472287565|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
131182133|NCT02151682|472287560|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
131182134|NCT02151682|472287561|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
131182135|NCT02151682|472287562|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
131182136|NCT02151682|472287563|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
131182137|NCT02151682|472287564|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
131182138|NCT02151682|472287565|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
131182139|NCT00168064|472287566|FG000|Overall Study|Adverse Event|26|||
131182140|NCT00168064|472287567|FG001|Overall Study|Adverse Event|22|||
131182141|NCT00168064|472287566|FG000|Overall Study|Withdrawal by Subject|3|||
131182142|NCT00168064|472287567|FG001|Overall Study|Withdrawal by Subject|4|||
131182143|NCT00168064|472287566|FG000|Overall Study|Lack of Efficacy|4|||
131182144|NCT00168064|472287567|FG001|Overall Study|Lack of Efficacy|4|||
131182145|NCT00168064|472287566|FG000|Overall Study|Lost to Follow-up|4|||
131182146|NCT00168064|472287567|FG001|Overall Study|Lost to Follow-up|3|||
131182147|NCT00168064|472287566|FG000|Overall Study|Non-compliance|2|||
131182148|NCT00168064|472287567|FG001|Overall Study|Non-compliance|3|||
131182149|NCT00168064|472287566|FG000|Overall Study|Concurrent Illness|4|||
131182150|NCT00168064|472287567|FG001|Overall Study|Concurrent Illness|3|||
131182151|NCT00168064|472287566|FG000|Overall Study|Subject's Best interest|2|||
131182152|NCT00168064|472287567|FG001|Overall Study|Subject's Best interest|2|||
131182153|NCT00168064|472287566|FG000|Overall Study|Various|4|||
131182154|NCT00168064|472287567|FG001|Overall Study|Various|3|||
131182155|NCT00318565|472287568|FG000|Overall Study|Excluded per protocol|24|||
131182156|NCT02431468|472287569|FG000|Overall Study|Adverse Event|2|||
131182157|NCT02431468|472287570|FG001|Overall Study|Adverse Event|4|||
131182158|NCT02431468|472287571|FG002|Overall Study|Adverse Event|5|||
131238820|NCT04767282|472500275|FG000|Overall Study|Duplicate household previously enrolled|2|||
131238821|NCT04767282|472500276|FG001|Overall Study|Duplicate household previously enrolled|0|||
131182159|NCT02431468|472287569|FG000|Overall Study|Withdrawal by Subject|4|||
131238822|NCT04767282|472500277|FG002|Overall Study|Duplicate household previously enrolled|8|||
131238823|NCT04767282|472500275|FG000|Overall Study|Unable to confirm legal guardian|0|||
131182160|NCT02431468|472287570|FG001|Overall Study|Withdrawal by Subject|12|||
131182161|NCT02431468|472287571|FG002|Overall Study|Withdrawal by Subject|2|||
131182162|NCT02431468|472287569|FG000|Overall Study|noncompliance, investigator termination,|2|||
131182163|NCT02431468|472287570|FG001|Overall Study|noncompliance, investigator termination,|2|||
131182164|NCT02431468|472287571|FG002|Overall Study|noncompliance, investigator termination,|2|||
130784510|NCT02513550|470838802|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
130784511|NCT00192114|470838806|FG000|Overall Study|Objective Tumor Progression|19|||
130784512|NCT00192114|470838806|FG000|Overall Study|Adverse Event|2|||
130784513|NCT00192114|470838806|FG000|Overall Study|Clinical Progression|2|||
130784514|NCT00192114|470838806|FG000|Overall Study|Death|1|||
130784515|NCT00492297|470838807|FG000|Treatment|Death|2|||
131182165|NCT01361919|472287572|FG000|Overall Study|technical issues|10|||
131182166|NCT01361919|472287573|FG001|Overall Study|technical issues|12|||
131182167|NCT01361919|472287574|FG002|Overall Study|technical issues|10|||
131182168|NCT03589885|472287578|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
131182169|NCT03589885|472287579|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
131182170|NCT03589885|472287580|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
131182171|NCT03589885|472287581|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
131182172|NCT03589885|472287582|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
131182173|NCT03589885|472287578|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
131182174|NCT03589885|472287579|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
131182175|NCT03589885|472287580|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
131182176|NCT03589885|472287581|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
131182177|NCT03589885|472287582|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
131182178|NCT03589885|472287578|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
131182179|NCT03589885|472287579|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
131182180|NCT03589885|472287580|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
131182181|NCT03589885|472287581|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
131182182|NCT03589885|472287582|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
131182183|NCT03589885|472287578|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
131182184|NCT03589885|472287579|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
131182185|NCT03589885|472287580|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
131182186|NCT03589885|472287581|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
131182187|NCT03589885|472287582|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
131182188|NCT03589885|472287578|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
131182189|NCT03589885|472287579|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
131182190|NCT03589885|472287580|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
131182191|NCT03589885|472287581|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
131182192|NCT03589885|472287582|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
131182193|NCT03589885|472287578|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
131182194|NCT03589885|472287579|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
131182195|NCT03589885|472287580|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
131182196|NCT03589885|472287581|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
131182197|NCT03589885|472287582|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
131182198|NCT03589885|472287578|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
131182199|NCT03589885|472287579|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
131182200|NCT03589885|472287580|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
131182201|NCT03589885|472287581|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
131182202|NCT03589885|472287582|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
131182203|NCT03589885|472287578|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
131182204|NCT03589885|472287579|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
131182205|NCT03589885|472287580|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
131182206|NCT03589885|472287581|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
131182207|NCT03589885|472287582|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
131182208|NCT00039741|472287583|FG000|Overall Study|Death|0|||
131182209|NCT00039741|472287584|FG001|Overall Study|Death|1|||
131182210|NCT00039741|472287585|FG002|Overall Study|Death|0|||
131182211|NCT00039741|472287586|FG003|Overall Study|Death|0|||
131182212|NCT00039741|472287583|FG000|Overall Study|Lost to Follow-up|3|||
131182213|NCT00039741|472287584|FG001|Overall Study|Lost to Follow-up|1|||
131182214|NCT00039741|472287585|FG002|Overall Study|Lost to Follow-up|5|||
131182215|NCT00039741|472287586|FG003|Overall Study|Lost to Follow-up|2|||
131238824|NCT04767282|472500276|FG001|Overall Study|Unable to confirm legal guardian|2|||
130784516|NCT00492297|470838807|FG000|Treatment|Study terminated by sponsor|3|||
131182216|NCT00039741|472287583|FG000|Overall Study|Confounding medical condition|1|||
131182217|NCT00039741|472287584|FG001|Overall Study|Confounding medical condition|0|||
131182218|NCT00039741|472287585|FG002|Overall Study|Confounding medical condition|0|||
131182219|NCT00039741|472287586|FG003|Overall Study|Confounding medical condition|0|||
131182220|NCT00039741|472287583|FG000|Overall Study|Not able to get to clinic|5|||
131182221|NCT00039741|472287584|FG001|Overall Study|Not able to get to clinic|2|||
131182222|NCT00039741|472287585|FG002|Overall Study|Not able to get to clinic|0|||
131238825|NCT04767282|472500277|FG002|Overall Study|Unable to confirm legal guardian|8|||
131182223|NCT00039741|472287586|FG003|Overall Study|Not able to get to clinic|3|||
131182224|NCT00039741|472287583|FG000|Overall Study|Moved|3|||
131182225|NCT00039741|472287584|FG001|Overall Study|Moved|2|||
131182226|NCT00039741|472287585|FG002|Overall Study|Moved|3|||
131182227|NCT00039741|472287586|FG003|Overall Study|Moved|6|||
131182228|NCT00039741|472287583|FG000|Overall Study|Non-compliance with protocol|1|||
131182229|NCT00039741|472287584|FG001|Overall Study|Non-compliance with protocol|0|||
131182230|NCT00039741|472287585|FG002|Overall Study|Non-compliance with protocol|1|||
131182231|NCT00039741|472287586|FG003|Overall Study|Non-compliance with protocol|0|||
131182232|NCT00039741|472287583|FG000|Overall Study|Withdrew consent|0|||
131182233|NCT00039741|472287584|FG001|Overall Study|Withdrew consent|5|||
131182234|NCT00039741|472287585|FG002|Overall Study|Withdrew consent|0|||
131182235|NCT00039741|472287586|FG003|Overall Study|Withdrew consent|1|||
131182236|NCT00039741|472287583|FG000|Overall Study|Missed final visit|2|||
131182237|NCT00039741|472287584|FG001|Overall Study|Missed final visit|1|||
131182238|NCT00039741|472287585|FG002|Overall Study|Missed final visit|2|||
131182239|NCT00039741|472287586|FG003|Overall Study|Missed final visit|2|||
131182240|NCT01767519|472287587|FG000|Overall Study|Other Reasons|4|||
131182241|NCT01767519|472287588|FG001|Overall Study|Other Reasons|4|||
131182242|NCT01767519|472287589|FG002|Overall Study|Other Reasons|2|||
131182243|NCT01767519|472287587|FG000|Overall Study|Protocol Violation|0|||
131182244|NCT01767519|472287588|FG001|Overall Study|Protocol Violation|3|||
131182245|NCT01767519|472287589|FG002|Overall Study|Protocol Violation|0|||
131182246|NCT01767519|472287587|FG000|Overall Study|Personal Reasons|1|||
131182247|NCT01767519|472287588|FG001|Overall Study|Personal Reasons|0|||
131182248|NCT01767519|472287589|FG002|Overall Study|Personal Reasons|0|||
131182249|NCT01767519|472287587|FG000|Overall Study|Lost to Follow-up|3|||
131182250|NCT01767519|472287588|FG001|Overall Study|Lost to Follow-up|1|||
131182251|NCT01767519|472287589|FG002|Overall Study|Lost to Follow-up|2|||
131182252|NCT01767519|472287587|FG000|Overall Study|Lack of Efficacy|1|||
131182253|NCT01767519|472287588|FG001|Overall Study|Lack of Efficacy|0|||
131182254|NCT01767519|472287589|FG002|Overall Study|Lack of Efficacy|0|||
131182255|NCT01767519|472287587|FG000|Overall Study|Adverse Event|5|||
131182256|NCT01767519|472287588|FG001|Overall Study|Adverse Event|5|||
131182257|NCT01767519|472287589|FG002|Overall Study|Adverse Event|1|||
131182258|NCT00946881|472287590|FG000|First Treatment|Withdrawal by Subject|1|||
131182259|NCT00946881|472287590|FG000|First Treatment|Patient relocated to another state|1|||
131182260|NCT00946881|472287590|FG000|Retreatment|Withdrawal by Subject|1|||
131182261|NCT00293423|472287591|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
131182262|NCT00293423|472287592|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
131182263|NCT00293423|472287591|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
131182264|NCT00293423|472287592|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
131182265|NCT00293423|472287591|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
131182266|NCT00293423|472287592|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
131182267|NCT00293423|472287591|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
131182268|NCT00293423|472287592|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
131182269|NCT00293423|472287591|FG000|Surgical Resection|processing error during surgical resection|1|||
131182270|NCT00293423|472287592|FG001|Surgical Resection|processing error during surgical resection|0|||
131182271|NCT00293423|472287591|FG000|Surgical Resection|Withdrawal by Subject|4|||
131182272|NCT00293423|472287592|FG001|Surgical Resection|Withdrawal by Subject|0|||
131182273|NCT00293423|472287591|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
131182274|NCT00293423|472287592|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
131182275|NCT00507416|472287593|FG000|Overall Study|Adverse Event|58|||
131182276|NCT00507416|472287594|FG001|Overall Study|Adverse Event|67|||
131182277|NCT00507416|472287595|FG002|Overall Study|Adverse Event|65|||
131182278|NCT00507416|472287593|FG000|Overall Study|Protocol Violation|1|||
131182279|NCT00507416|472287594|FG001|Overall Study|Protocol Violation|2|||
131182280|NCT00507416|472287595|FG002|Overall Study|Protocol Violation|0|||
131238826|NCT04767282|472500275|FG000|Overall Study|Withdrawal by Subject|0|||
131182281|NCT00507416|472287593|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
131182282|NCT00507416|472287594|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
131182283|NCT00507416|472287595|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
131182284|NCT00507416|472287593|FG000|Overall Study|Progressive Disease|20|||
131182285|NCT00507416|472287594|FG001|Overall Study|Progressive Disease|10|||
131182286|NCT00507416|472287595|FG002|Overall Study|Progressive Disease|13|||
131182287|NCT00507416|472287593|FG000|Overall Study|Patient declined further treatment|18|||
131182288|NCT00507416|472287594|FG001|Overall Study|Patient declined further treatment|14|||
131182289|NCT00507416|472287595|FG002|Overall Study|Patient declined further treatment|11|||
131182290|NCT00507416|472287593|FG000|Overall Study|Other|11|||
131182291|NCT00507416|472287594|FG001|Overall Study|Other|16|||
131182292|NCT00507416|472287595|FG002|Overall Study|Other|13|||
131182293|NCT00507416|472287593|FG000|Overall Study|Did not Receive Study Treatment|3|||
131182294|NCT00507416|472287594|FG001|Overall Study|Did not Receive Study Treatment|9|||
131182295|NCT00507416|472287595|FG002|Overall Study|Did not Receive Study Treatment|4|||
131182296|NCT02157506|472287598|FG000|Overall Study|Adverse Event|0|||
131182297|NCT02157506|472287599|FG001|Overall Study|Adverse Event|1|||
131182298|NCT02157506|472287600|FG002|Overall Study|Adverse Event|0|||
131182299|NCT02157506|472287601|FG003|Overall Study|Adverse Event|0|||
131182300|NCT02157506|472287602|FG004|Overall Study|Adverse Event|0|||
131238827|NCT04767282|472500276|FG001|Overall Study|Withdrawal by Subject|0|||
131238828|NCT04767282|472500277|FG002|Overall Study|Withdrawal by Subject|6|||
131238829|NCT04767282|472500275|FG000|Overall Study|Survey comprehension challenges|4|||
131238830|NCT04767282|472500276|FG001|Overall Study|Survey comprehension challenges|0|||
131238831|NCT04767282|472500277|FG002|Overall Study|Survey comprehension challenges|0|||
131238832|NCT03473743|472500278|FG000|Overall Study|Withdrawal by Subject|0|||
131238833|NCT03473743|472500279|FG001|Overall Study|Withdrawal by Subject|0|||
131238834|NCT03473743|472500280|FG002|Overall Study|Withdrawal by Subject|0|||
131238835|NCT03473743|472500281|FG003|Overall Study|Withdrawal by Subject|0|||
131238836|NCT03473743|472500282|FG004|Overall Study|Withdrawal by Subject|0|||
131238837|NCT03473743|472500283|FG005|Overall Study|Withdrawal by Subject|0|||
131238838|NCT03473743|472500284|FG006|Overall Study|Withdrawal by Subject|0|||
131238839|NCT03473743|472500285|FG007|Overall Study|Withdrawal by Subject|3|||
131182301|NCT02157506|472287598|FG000|Overall Study|Lost to Follow-up|0|||
131182302|NCT02157506|472287599|FG001|Overall Study|Lost to Follow-up|0|||
131182303|NCT02157506|472287600|FG002|Overall Study|Lost to Follow-up|1|||
131182304|NCT02157506|472287601|FG003|Overall Study|Lost to Follow-up|0|||
131182305|NCT02157506|472287602|FG004|Overall Study|Lost to Follow-up|0|||
131182306|NCT03101514|472287603|FG000|Overall Study|Withdrawal by Subject|4|||
131182307|NCT03101514|472287603|FG000|Overall Study|Protocol Violation|2|||
131182308|NCT03101514|472287603|FG000|Overall Study|patient's information was incomplete|1|||
131182309|NCT03498287|472287607|FG000|Overall Study|Withdrawal by Subject|3|||
131182310|NCT03498287|472287608|FG001|Overall Study|Withdrawal by Subject|0|||
131182311|NCT03498287|472287607|FG000|Overall Study|Protocol Violation|0|||
131182312|NCT03498287|472287608|FG001|Overall Study|Protocol Violation|4|||
131182313|NCT03498287|472287607|FG000|Overall Study|Adverse Event|0|||
131182314|NCT03498287|472287608|FG001|Overall Study|Adverse Event|1|||
131182315|NCT01374217|472287611|FG000|Overall Study|Lack of Efficacy|13|||
131182316|NCT01117012|472287612|FG000|Overall Study|Adverse Event|0|||
131182317|NCT01117012|472287613|FG001|Overall Study|Adverse Event|1|||
131182318|NCT01117012|472287612|FG000|Overall Study|Death|1|||
131182319|NCT01117012|472287613|FG001|Overall Study|Death|1|||
131182320|NCT01117012|472287612|FG000|Overall Study|Withdrawal by Subject|3|||
131182321|NCT01117012|472287613|FG001|Overall Study|Withdrawal by Subject|0|||
131182322|NCT01117012|472287612|FG000|Overall Study|Undefined|4|||
131182323|NCT01117012|472287613|FG001|Overall Study|Undefined|3|||
131182324|NCT03695393|472287616|FG000|Overall Study|Death|3|||
131182325|NCT03695393|472287617|FG001|Overall Study|Death|1|||
131182326|NCT03695393|472287616|FG000|Overall Study|Lost to Follow-up|0|||
131182327|NCT03695393|472287617|FG001|Overall Study|Lost to Follow-up|1|||
131182328|NCT01641991|472287618|FG000|Overall Study|Physician Decision|0|||
131182329|NCT01641991|472287619|FG001|Overall Study|Physician Decision|1|||
131182330|NCT01641991|472287620|FG002|Overall Study|Physician Decision|7|||
131182331|NCT01641991|472287621|FG003|Overall Study|Physician Decision|5|||
131182332|NCT01641991|472287618|FG000|Overall Study|Withdrawal by Subject|4|||
131182333|NCT01641991|472287619|FG001|Overall Study|Withdrawal by Subject|2|||
131182334|NCT01641991|472287620|FG002|Overall Study|Withdrawal by Subject|1|||
131182335|NCT01641991|472287621|FG003|Overall Study|Withdrawal by Subject|5|||
131182336|NCT01641991|472287618|FG000|Overall Study|Adverse Event|2|||
131182337|NCT01641991|472287619|FG001|Overall Study|Adverse Event|1|||
131182338|NCT01641991|472287620|FG002|Overall Study|Adverse Event|2|||
131182339|NCT01641991|472287621|FG003|Overall Study|Adverse Event|1|||
131182340|NCT01641991|472287618|FG000|Overall Study|Lost to Follow-up|0|||
131182341|NCT01641991|472287619|FG001|Overall Study|Lost to Follow-up|2|||
131182342|NCT01641991|472287620|FG002|Overall Study|Lost to Follow-up|3|||
131182343|NCT01641991|472287621|FG003|Overall Study|Lost to Follow-up|1|||
131182344|NCT01641991|472287618|FG000|Overall Study|Protocol Violation|1|||
131182345|NCT01641991|472287619|FG001|Overall Study|Protocol Violation|1|||
131238840|NCT03473743|472500278|FG000|Overall Study|Other|0|||
131238841|NCT03473743|472500279|FG001|Overall Study|Other|0|||
131238842|NCT03473743|472500280|FG002|Overall Study|Other|0|||
131238843|NCT03473743|472500281|FG003|Overall Study|Other|1|||
131238844|NCT03473743|472500282|FG004|Overall Study|Other|0|||
131238845|NCT03473743|472500283|FG005|Overall Study|Other|0|||
131182346|NCT01641991|472287620|FG002|Overall Study|Protocol Violation|3|||
131182347|NCT01641991|472287621|FG003|Overall Study|Protocol Violation|0|||
131182348|NCT01641991|472287618|FG000|Overall Study|Pregnancy|0|||
131182349|NCT01641991|472287619|FG001|Overall Study|Pregnancy|0|||
131182350|NCT01641991|472287620|FG002|Overall Study|Pregnancy|1|||
131182351|NCT01641991|472287621|FG003|Overall Study|Pregnancy|0|||
131182352|NCT01641991|472287618|FG000|Overall Study|no longer eligible|2|||
131182353|NCT01641991|472287619|FG001|Overall Study|no longer eligible|1|||
131182354|NCT01641991|472287620|FG002|Overall Study|no longer eligible|0|||
131182355|NCT01641991|472287621|FG003|Overall Study|no longer eligible|4|||
131182356|NCT00673894|472287622|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
131182357|NCT00673894|472287623|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
131238846|NCT03473743|472500284|FG006|Overall Study|Other|0|||
131182358|NCT00673894|472287622|FG000|First Intervention 4 Weeks|Adverse Event|1|||
131182359|NCT00673894|472287623|FG001|First Intervention 4 Weeks|Adverse Event|0|||
131182360|NCT00493974|472287624|FG000|Overall Study|Death|1|||
131238847|NCT03473743|472500285|FG007|Overall Study|Other|0|||
131238848|NCT03473743|472500278|FG000|Overall Study|Ongoing|0|||
131238849|NCT03473743|472500279|FG001|Overall Study|Ongoing|0|||
131238850|NCT03473743|472500280|FG002|Overall Study|Ongoing|6|||
131182361|NCT00493974|472287625|FG001|Overall Study|Death|2|||
131182362|NCT00493974|472287624|FG000|Overall Study|Withdrawal by Subject|8|||
131182363|NCT00493974|472287625|FG001|Overall Study|Withdrawal by Subject|6|||
131182364|NCT00493974|472287624|FG000|Overall Study|Lost to Follow-up|4|||
131238851|NCT03473743|472500281|FG003|Overall Study|Ongoing|8|||
131238852|NCT03473743|472500282|FG004|Overall Study|Ongoing|1|||
131238853|NCT03473743|472500283|FG005|Overall Study|Ongoing|1|||
131238854|NCT03473743|472500284|FG006|Overall Study|Ongoing|22|||
131238855|NCT03473743|472500285|FG007|Overall Study|Ongoing|24|||
131238856|NCT03473743|472500278|FG000|Overall Study|Randomized but not treated|0|||
131238857|NCT03473743|472500279|FG001|Overall Study|Randomized but not treated|0|||
131238858|NCT03473743|472500280|FG002|Overall Study|Randomized but not treated|0|||
131238859|NCT03473743|472500281|FG003|Overall Study|Randomized but not treated|0|||
131238860|NCT03473743|472500282|FG004|Overall Study|Randomized but not treated|0|||
131238861|NCT03473743|472500283|FG005|Overall Study|Randomized but not treated|0|||
131238862|NCT03473743|472500284|FG006|Overall Study|Randomized but not treated|1|||
131238863|NCT03473743|472500285|FG007|Overall Study|Randomized but not treated|1|||
131238864|NCT03822832|472500290|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
131238865|NCT03822832|472500291|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
131238866|NCT03822832|472500290|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
131238867|NCT03822832|472500291|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
131238868|NCT03822832|472500290|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
131238869|NCT03822832|472500291|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
131238870|NCT03822832|472500290|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
131238871|NCT03822832|472500291|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
131238872|NCT03822832|472500290|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
131238873|NCT03822832|472500291|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
131238874|NCT03822832|472500290|FG000|Re-allocation|Not re-allocated to open label period|2|||
131238875|NCT03822832|472500291|FG001|Re-allocation|Not re-allocated to open label period|6|||
131238876|NCT03822832|472500290|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
131238877|NCT03822832|472500291|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
131238878|NCT03822832|472500290|FG000|Period 2 - Open Label Period|Adverse Event|0|||
131238879|NCT03822832|472500291|FG001|Period 2 - Open Label Period|Adverse Event|3|||
131238880|NCT05613088|472500292|FG000|Treatment|Ongoing Study Treatment|9|||
131238881|NCT05613088|472500293|FG001|Treatment|Ongoing Study Treatment|2|||
131238882|NCT05613088|472500292|FG000|Treatment|Adverse Event|3|||
131182365|NCT00493974|472287625|FG001|Overall Study|Lost to Follow-up|6|||
131182366|NCT02555657|472287626|FG000|Overall Study|Death|274|||
131182367|NCT02555657|472287627|FG001|Overall Study|Death|262|||
131182368|NCT02555657|472287626|FG000|Overall Study|Physician Decision|0|||
131182369|NCT02555657|472287627|FG001|Overall Study|Physician Decision|1|||
131182370|NCT02555657|472287626|FG000|Overall Study|Sponsor Decision|27|||
131182371|NCT02555657|472287627|FG001|Overall Study|Sponsor Decision|15|||
131182372|NCT02555657|472287626|FG000|Overall Study|Withdrawal by Subject|11|||
131182373|NCT02555657|472287627|FG001|Overall Study|Withdrawal by Subject|32|||
131182374|NCT02807363|472287628|FG000|Dosing Period|Adverse Event|0|||
131182375|NCT02807363|472287629|FG001|Dosing Period|Adverse Event|1|||
131182376|NCT02807363|472287630|FG002|Dosing Period|Adverse Event|0|||
131182377|NCT02807363|472287631|FG003|Dosing Period|Adverse Event|0|||
131238883|NCT05613088|472500293|FG001|Treatment|Adverse Event|1|||
131238884|NCT05613088|472500292|FG000|Treatment|Other Reasons|0|||
131238885|NCT05613088|472500293|FG001|Treatment|Other Reasons|1|||
131238886|NCT05613088|472500292|FG000|Treatment|Progressive Disease|58|||
131238887|NCT05613088|472500293|FG001|Treatment|Progressive Disease|26|||
131238888|NCT05613088|472500292|FG000|Treatment|Withdrawal by Subject|0|||
131238889|NCT05613088|472500293|FG001|Treatment|Withdrawal by Subject|4|||
131238890|NCT04981912|472500295|FG000|Overall Study|Physician Decision|2|||
131238891|NCT00980954|472500296|FG000|Overall Study|Protocol Violation|9|||
131238892|NCT00980954|472500297|FG001|Overall Study|Protocol Violation|15|||
131238893|NCT01711632|472500298|FG000|Overall Study|Adverse Event|4|||
131182378|NCT01578785|472287632|FG000|Overall Study|Withdrawal by Subject|0|||
131182379|NCT01578785|472287633|FG001|Overall Study|Withdrawal by Subject|1|||
131182380|NCT01578785|472287632|FG000|Overall Study|Study terminated by sponsor|59|||
131182381|NCT01578785|472287633|FG001|Overall Study|Study terminated by sponsor|118|||
131182382|NCT00966693|472287634|FG000|Overall Study|Adverse Event|0|||
131182383|NCT00966693|472287635|FG001|Overall Study|Adverse Event|0|||
131238894|NCT01711632|472500298|FG000|Overall Study|Death|3|||
131238895|NCT01711632|472500298|FG000|Overall Study|Lost to Follow-up|3|||
131238896|NCT01711632|472500298|FG000|Overall Study|Withdrawal by Subject|4|||
131238897|NCT01711632|472500298|FG000|Overall Study|Progressive disease|2|||
131238898|NCT01711632|472500298|FG000|Overall Study|No follow up required in re-treatment|3|||
131238899|NCT01711632|472500298|FG000|Overall Study|No follow up required in re-treatment|3|||
131182384|NCT00966693|472287636|FG002|Overall Study|Adverse Event|1|||
131182385|NCT00966693|472287637|FG003|Overall Study|Adverse Event|2|||
131238900|NCT04315181|472500299|FG000|Overall Study|Non-responsive to drug conditions.|1|||
131238901|NCT05630547|472500303|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
131238902|NCT05630547|472500304|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
131238903|NCT05630547|472500305|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
131238904|NCT05630547|472500306|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
131238905|NCT05630547|472500303|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
131238906|NCT05630547|472500304|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
131238907|NCT05630547|472500305|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
131238908|NCT05630547|472500306|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
131238909|NCT05630547|472500303|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
131238910|NCT05630547|472500304|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
131238911|NCT05630547|472500305|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
131238912|NCT05630547|472500306|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
131238913|NCT05630547|472500303|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
131238914|NCT05630547|472500304|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
131182386|NCT00966693|472287634|FG000|Overall Study|Death|0|||
131182387|NCT00966693|472287635|FG001|Overall Study|Death|0|||
131182388|NCT00966693|472287636|FG002|Overall Study|Death|1|||
131182389|NCT00966693|472287637|FG003|Overall Study|Death|0|||
131182390|NCT00966693|472287634|FG000|Overall Study|Withdrawal by Subject|1|||
131182391|NCT00966693|472287635|FG001|Overall Study|Withdrawal by Subject|0|||
131182392|NCT00966693|472287636|FG002|Overall Study|Withdrawal by Subject|0|||
131182393|NCT00966693|472287637|FG003|Overall Study|Withdrawal by Subject|5|||
131182394|NCT00966693|472287634|FG000|Overall Study|Disease Progression|0|||
131182395|NCT00966693|472287635|FG001|Overall Study|Disease Progression|0|||
131182396|NCT00966693|472287636|FG002|Overall Study|Disease Progression|1|||
131182397|NCT00966693|472287637|FG003|Overall Study|Disease Progression|16|||
131182398|NCT03371732|472287638|FG000|Overall Study|Withdrawal by Subject|9|||
131182399|NCT03371732|472287639|FG001|Overall Study|Withdrawal by Subject|3|||
131182400|NCT03371732|472287638|FG000|Overall Study|Refusal to continue|3|||
131182401|NCT03371732|472287639|FG001|Overall Study|Refusal to continue|4|||
131182402|NCT00599027|472287642|FG000|Overall Study|Withdrawal by Subject|1|||
131182403|NCT00599027|472287643|FG001|Overall Study|Withdrawal by Subject|1|||
131182404|NCT00599027|472287642|FG000|Overall Study|Adverse Event|0|||
131182405|NCT00599027|472287643|FG001|Overall Study|Adverse Event|1|||
131182406|NCT00599027|472287642|FG000|Overall Study|Treatment Failure|0|||
131182407|NCT00599027|472287643|FG001|Overall Study|Treatment Failure|1|||
131182408|NCT02581982|472287644|FG000|Overall Study|Lack of Efficacy|12|||
131182409|NCT02581982|472287644|FG000|Overall Study|Adverse Event|3|||
131182410|NCT02581982|472287644|FG000|Overall Study|Physician Decision|1|||
131182411|NCT00405821|472287645|FG000|Overall Study|Death|5|||
131182412|NCT00405821|472287646|FG001|Overall Study|Death|7|||
131182413|NCT00405821|472287645|FG000|Overall Study|Lost to Follow-up|7|||
131182414|NCT00405821|472287646|FG001|Overall Study|Lost to Follow-up|7|||
131182415|NCT00405821|472287645|FG000|Overall Study|Protocol Violation|1|||
131182416|NCT00405821|472287646|FG001|Overall Study|Protocol Violation|0|||
131182417|NCT00405821|472287645|FG000|Overall Study|initiated ART|9|||
131182418|NCT00405821|472287646|FG001|Overall Study|initiated ART|8|||
131182419|NCT02031432|472287662|FG000|Overall Study|Protocol Violation|1|||
131182420|NCT02031432|472287662|FG000|Overall Study|Lack of Efficacy|5|||
131182421|NCT02031432|472287662|FG000|Overall Study|Cancer Progression|2|||
131182422|NCT02031432|472287662|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
131182423|NCT02031432|472287662|FG000|Overall Study|Adverse Event|8|||
131182424|NCT02031432|472287662|FG000|Overall Study|Withdrawal by Subject|5|||
131182425|NCT02031432|472287662|FG000|Overall Study|Lost to Follow-up|1|||
131182426|NCT02031432|472287662|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
131182427|NCT02031432|472287662|FG000|Overall Study|Death|10|||
131238915|NCT05630547|472500305|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
131238916|NCT05630547|472500306|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
131238917|NCT05630547|472500303|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
131182428|NCT01181778|472287663|FG000|Overall Study|Physician Decision|48|||
131182429|NCT01617187|472287664|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
131182430|NCT01617187|472287665|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
131182431|NCT01617187|472287666|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
131182432|NCT01617187|472287667|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
131182433|NCT01617187|472287664|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
131182434|NCT01617187|472287665|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
131182435|NCT01617187|472287666|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
131182436|NCT01617187|472287667|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
131182437|NCT01617187|472287664|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
131182438|NCT01617187|472287665|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
131182439|NCT01617187|472287666|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
131182440|NCT01617187|472287667|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
131182441|NCT01617187|472287664|FG000|Treatment Through Study Completion|Adverse Event|1|||
131182442|NCT01617187|472287665|FG001|Treatment Through Study Completion|Adverse Event|1|||
131182443|NCT01617187|472287666|FG002|Treatment Through Study Completion|Adverse Event|0|||
131182444|NCT01617187|472287667|FG003|Treatment Through Study Completion|Adverse Event|1|||
131182445|NCT01617187|472287664|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
131182446|NCT01617187|472287665|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
131182447|NCT01617187|472287666|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
131182448|NCT01617187|472287667|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
131182449|NCT01617187|472287664|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
131182450|NCT01617187|472287665|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
131182451|NCT01617187|472287666|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
131182452|NCT01617187|472287667|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
131182453|NCT01617187|472287664|FG000|Treatment Through Study Completion|Protocol Violation|1|||
131182454|NCT01617187|472287665|FG001|Treatment Through Study Completion|Protocol Violation|0|||
131182455|NCT01617187|472287666|FG002|Treatment Through Study Completion|Protocol Violation|0|||
131182456|NCT01617187|472287667|FG003|Treatment Through Study Completion|Protocol Violation|1|||
131182457|NCT01265420|472287668|FG000|Overall Study|Lost to Follow-up|1|||
131182458|NCT03862131|472287669|FG000|Overall Study|Lost to Follow-up|1|||
131182459|NCT03862131|472287670|FG001|Overall Study|Lost to Follow-up|0|||
131182460|NCT03862131|472287671|FG002|Overall Study|Lost to Follow-up|1|||
131182461|NCT03862131|472287669|FG000|Overall Study|Determined to be ineligible|0|||
131182462|NCT03862131|472287670|FG001|Overall Study|Determined to be ineligible|0|||
131182463|NCT03862131|472287671|FG002|Overall Study|Determined to be ineligible|5|||
131182464|NCT03862131|472287669|FG000|Overall Study|Death|4|||
131182465|NCT03862131|472287670|FG001|Overall Study|Death|4|||
131182466|NCT03862131|472287671|FG002|Overall Study|Death|0|||
131182467|NCT03862131|472287669|FG000|Overall Study|Withdrawal by Subject|5|||
131182468|NCT03862131|472287670|FG001|Overall Study|Withdrawal by Subject|3|||
131182469|NCT03862131|472287671|FG002|Overall Study|Withdrawal by Subject|0|||
131182470|NCT03862131|472287669|FG000|Overall Study|Physician Decision|0|||
131182471|NCT03862131|472287670|FG001|Overall Study|Physician Decision|1|||
131182472|NCT03862131|472287671|FG002|Overall Study|Physician Decision|0|||
131182473|NCT01770145|472289315|FG000|Baseline|Adverse Event|20|||
131182474|NCT01770145|472289315|FG000|Baseline|Withdrawal by Subject|1|||
131182475|NCT01770145|472289315|FG000|Baseline|Lost to Follow-up|1|||
131182476|NCT01770145|472289315|FG000|Baseline|Unable to define optimal dose|4|||
131182477|NCT01770145|472289315|FG000|Treatment|Adverse Event|3|||
131182478|NCT01770145|472289315|FG000|Treatment|Withdrawal by Subject|1|||
131182479|NCT00595868|472289316|FG000|Overall Study|Lost to Follow-up|45|||
131182480|NCT00595868|472289317|FG001|Overall Study|Lost to Follow-up|50|||
131182481|NCT03788967|472289319|FG000|Overall Study|Lost to Follow-up|14|||
131182482|NCT03788967|472289320|FG001|Overall Study|Lost to Follow-up|10|||
131182483|NCT03788967|472289319|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
131182484|NCT03788967|472289320|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
131182485|NCT03788967|472289319|FG000|Overall Study|Participant Withdrawal of Consent|13|||
131182486|NCT03788967|472289320|FG001|Overall Study|Participant Withdrawal of Consent|5|||
131182487|NCT03788967|472289319|FG000|Overall Study|Adverse Event|1|||
131182488|NCT03788967|472289320|FG001|Overall Study|Adverse Event|1|||
131182489|NCT03788967|472289319|FG000|Overall Study|COVID-19|1|||
131182490|NCT03788967|472289320|FG001|Overall Study|COVID-19|2|||
131182491|NCT04432376|472289321|FG000|Double-blind Treatment Period|Adverse Event|2|||
131182492|NCT04432376|472289322|FG001|Double-blind Treatment Period|Adverse Event|6|||
131182493|NCT04432376|472289323|FG002|Double-blind Treatment Period|Adverse Event|0|||
131182494|NCT04432376|472289321|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
131182495|NCT04432376|472289322|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
131182496|NCT04432376|472289323|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
131182497|NCT04432376|472289321|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
131182498|NCT04432376|472289322|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
131182499|NCT04432376|472289323|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
131182500|NCT04432376|472289321|FG000|Double-blind Treatment Period|Protocol Violation|0|||
131182501|NCT04432376|472289322|FG001|Double-blind Treatment Period|Protocol Violation|1|||
131182502|NCT04432376|472289323|FG002|Double-blind Treatment Period|Protocol Violation|0|||
131182503|NCT04432376|472289321|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
131182504|NCT04432376|472289322|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
131182505|NCT04432376|472289323|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
131182506|NCT02455388|472289324|FG000|Overall Study|Protocol Violation|1|||
131182507|NCT02455388|472289325|FG001|Overall Study|Protocol Violation|0|||
131182508|NCT02455388|472289326|FG002|Overall Study|Protocol Violation|4|||
131182509|NCT02455388|472289324|FG000|Overall Study|Withdrawal by Subject|0|||
131182510|NCT02455388|472289325|FG001|Overall Study|Withdrawal by Subject|0|||
131182511|NCT02455388|472289326|FG002|Overall Study|Withdrawal by Subject|7|||
131182512|NCT03628599|472289328|FG000|Overall Study|Adverse Event|0|||
131182513|NCT03628599|472289329|FG001|Overall Study|Adverse Event|1|||
131182514|NCT00801892|472289330|FG000|Main Study Period|Withdrawal by Subject|0|||
131182515|NCT00801892|472289331|FG001|Main Study Period|Withdrawal by Subject|1|||
131182516|NCT00801892|472289330|FG000|Sham Crossover Period|Lost to Follow-up|0|||
131182517|NCT00801892|472289331|FG001|Sham Crossover Period|Lost to Follow-up|2|||
131182518|NCT00093470|472289339|FG000|Overall Study|Disease progression|39|||
131182519|NCT00093470|472289340|FG001|Overall Study|Disease progression|0|||
131182520|NCT00093470|472289339|FG000|Overall Study|Adverse Event|15|||
131182521|NCT00093470|472289340|FG001|Overall Study|Adverse Event|0|||
131182522|NCT00093470|472289339|FG000|Overall Study|Death|2|||
131182523|NCT00093470|472289340|FG001|Overall Study|Death|0|||
131182524|NCT00093470|472289339|FG000|Overall Study|Withdrawal by Subject|8|||
131182525|NCT00093470|472289340|FG001|Overall Study|Withdrawal by Subject|0|||
131182526|NCT00093470|472289339|FG000|Overall Study|Alternative therapy|2|||
131182527|NCT00093470|472289340|FG001|Overall Study|Alternative therapy|0|||
131182528|NCT00093470|472289339|FG000|Overall Study|Other complicating disease|3|||
131182529|NCT00093470|472289340|FG001|Overall Study|Other complicating disease|0|||
131182530|NCT00093470|472289339|FG000|Overall Study|Physician Decision|2|||
131182531|NCT00093470|472289340|FG001|Overall Study|Physician Decision|0|||
131182532|NCT00093470|472289339|FG000|Overall Study|Never started treatment|1|||
131182533|NCT00093470|472289340|FG001|Overall Study|Never started treatment|0|||
131182534|NCT00093470|472289339|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
131182535|NCT00093470|472289340|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
131182536|NCT00448760|472289346|FG000|Overall Study|Death|3|||
131182537|NCT01306032|472289349|FG000|First Intervention|Adverse Event|1|||
131182538|NCT01306032|472289350|FG001|First Intervention|Adverse Event|0|||
131182539|NCT01306032|472289351|FG002|First Intervention|Adverse Event|1|||
131182540|NCT01306032|472289352|FG003|First Intervention|Adverse Event|0|||
131182541|NCT01306032|472289353|FG004|First Intervention|Adverse Event|0|||
131182542|NCT01306032|472289354|FG005|First Intervention|Adverse Event|1|||
131182543|NCT01306032|472289349|FG000|First Intervention|Withdrawal by Subject|0|||
131182544|NCT01306032|472289350|FG001|First Intervention|Withdrawal by Subject|2|||
131182545|NCT01306032|472289351|FG002|First Intervention|Withdrawal by Subject|0|||
131182546|NCT01306032|472289352|FG003|First Intervention|Withdrawal by Subject|1|||
131182547|NCT01306032|472289353|FG004|First Intervention|Withdrawal by Subject|0|||
131182548|NCT01306032|472289354|FG005|First Intervention|Withdrawal by Subject|0|||
131182549|NCT01306032|472289349|FG000|First Intervention|Death|0|||
131182550|NCT01306032|472289350|FG001|First Intervention|Death|0|||
131182551|NCT01306032|472289351|FG002|First Intervention|Death|1|||
131182552|NCT01306032|472289352|FG003|First Intervention|Death|0|||
131182553|NCT01306032|472289353|FG004|First Intervention|Death|0|||
131182554|NCT01306032|472289354|FG005|First Intervention|Death|0|||
131182555|NCT01306032|472289349|FG000|First Intervention|Ineligible|0|||
131182556|NCT01306032|472289350|FG001|First Intervention|Ineligible|0|||
131182557|NCT01306032|472289351|FG002|First Intervention|Ineligible|0|||
131182558|NCT01306032|472289352|FG003|First Intervention|Ineligible|0|||
131182559|NCT01306032|472289353|FG004|First Intervention|Ineligible|0|||
131182560|NCT01306032|472289354|FG005|First Intervention|Ineligible|1|||
131182561|NCT01306032|472289349|FG000|First Intervention|Progressive disease|0|||
131182562|NCT01306032|472289350|FG001|First Intervention|Progressive disease|0|||
131182563|NCT01306032|472289351|FG002|First Intervention|Progressive disease|0|||
131182564|NCT01306032|472289352|FG003|First Intervention|Progressive disease|0|||
131182565|NCT01306032|472289353|FG004|First Intervention|Progressive disease|2|||
131182566|NCT01306032|472289354|FG005|First Intervention|Progressive disease|0|||
131182567|NCT01306032|472289349|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
131182568|NCT01306032|472289350|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
131182569|NCT01306032|472289351|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
131182570|NCT01306032|472289352|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
131182571|NCT01306032|472289353|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
131182572|NCT01306032|472289354|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
131182573|NCT01306032|472289349|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
131182574|NCT01306032|472289350|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
131182575|NCT01306032|472289351|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
131182576|NCT01306032|472289352|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
131182577|NCT01306032|472289353|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
131182578|NCT01306032|472289354|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
131182579|NCT01213264|472289355|FG000|Overall Study|Adverse Event|1|||
131182580|NCT01213264|472289356|FG001|Overall Study|Adverse Event|0|||
131182581|NCT01213264|472289357|FG002|Overall Study|Adverse Event|0|||
131182582|NCT01213264|472289355|FG000|Overall Study|Lost to Follow-up|1|||
131182583|NCT01213264|472289356|FG001|Overall Study|Lost to Follow-up|2|||
131182584|NCT01213264|472289357|FG002|Overall Study|Lost to Follow-up|6|||
131182585|NCT03260894|472289359|FG000|Overall Study|Death|6|||
131182586|NCT03260894|472289360|FG001|Overall Study|Death|8|||
131182587|NCT03260894|472289359|FG000|Overall Study|Withdrawal by Subject|4|||
131182588|NCT03260894|472289360|FG001|Overall Study|Withdrawal by Subject|11|||
131182589|NCT03260894|472289359|FG000|Overall Study|On-going at clinical cut off date|36|||
131182590|NCT03260894|472289360|FG001|Overall Study|On-going at clinical cut off date|31|||
131182591|NCT05014542|472289362|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
131182592|NCT05014542|472289363|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
131182593|NCT05014542|472289362|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
131182594|NCT05014542|472289363|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
131182595|NCT05014542|472289362|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
131182596|NCT05014542|472289363|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
131182597|NCT05014542|472289362|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
131182598|NCT05014542|472289363|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
131182599|NCT05507580|472289364|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
131182600|NCT05507580|472289365|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
131182601|NCT05507580|472289366|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
131182602|NCT05507580|472289367|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
131182603|NCT05507580|472289368|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
131182604|NCT05507580|472289369|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
131182605|NCT05507580|472289364|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
131182606|NCT05507580|472289365|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
131182607|NCT05507580|472289366|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131182608|NCT05507580|472289367|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131182609|NCT05507580|472289368|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131182610|NCT05507580|472289369|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
131182611|NCT05507580|472289364|FG000|Double-Blind Treatment Period|Other, not specified|5|||
131182612|NCT05507580|472289365|FG001|Double-Blind Treatment Period|Other, not specified|4|||
131182613|NCT05507580|472289366|FG002|Double-Blind Treatment Period|Other, not specified|0|||
131182614|NCT05507580|472289367|FG003|Double-Blind Treatment Period|Other, not specified|0|||
131182615|NCT05507580|472289368|FG004|Double-Blind Treatment Period|Other, not specified|0|||
131182616|NCT05507580|472289369|FG005|Double-Blind Treatment Period|Other, not specified|0|||
131182617|NCT05507580|472289364|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
131182618|NCT05507580|472289365|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
131182619|NCT05507580|472289366|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
131182620|NCT05507580|472289367|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
131182621|NCT05507580|472289368|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
131182622|NCT05507580|472289369|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
131182623|NCT05507580|472289364|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
131182624|NCT05507580|472289365|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
131182625|NCT05507580|472289366|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
131182626|NCT05507580|472289367|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
131182627|NCT05507580|472289368|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
131182628|NCT05507580|472289369|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
131182629|NCT05507580|472289364|FG000|Single-Blind Treatment Period|Other, not specified|0|||
131182630|NCT05507580|472289365|FG001|Single-Blind Treatment Period|Other, not specified|0|||
131182631|NCT05507580|472289366|FG002|Single-Blind Treatment Period|Other, not specified|2|||
131182632|NCT05507580|472289367|FG003|Single-Blind Treatment Period|Other, not specified|7|||
131182633|NCT05507580|472289368|FG004|Single-Blind Treatment Period|Other, not specified|3|||
131182634|NCT05507580|472289369|FG005|Single-Blind Treatment Period|Other, not specified|5|||
131182635|NCT00555568|472289370|FG000|Overall Study|Lost to Follow-up|26|||
131182636|NCT00555568|472289371|FG001|Overall Study|Lost to Follow-up|16|||
131182637|NCT00555568|472289372|FG002|Overall Study|Lost to Follow-up|16|||
131182638|NCT04702984|472289375|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
131182639|NCT03496662|472289376|FG000|Overall Study|Adverse Event|0|||
131182640|NCT03496662|472289377|FG001|Overall Study|Adverse Event|0|||
131182641|NCT03496662|472289378|FG002|Overall Study|Adverse Event|4|||
131182642|NCT03496662|472289376|FG000|Overall Study|Withdrawal by Subject|1|||
131182643|NCT03496662|472289377|FG001|Overall Study|Withdrawal by Subject|0|||
131182644|NCT03496662|472289378|FG002|Overall Study|Withdrawal by Subject|2|||
131182645|NCT03496662|472289376|FG000|Overall Study|Death|0|||
131182646|NCT03496662|472289377|FG001|Overall Study|Death|0|||
131182647|NCT03496662|472289378|FG002|Overall Study|Death|2|||
131182648|NCT03496662|472289376|FG000|Overall Study|Noncompliance|0|||
131182649|NCT03496662|472289377|FG001|Overall Study|Noncompliance|0|||
131182650|NCT03496662|472289378|FG002|Overall Study|Noncompliance|1|||
131182651|NCT02378883|472289379|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
131182652|NCT02378883|472289379|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
131182653|NCT02378883|472289379|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
131182654|NCT02378883|472289379|FG000|30 Day Follow-Up|Physician Decision|2|||
131182655|NCT02378883|472289379|FG000|30 Day Follow-Up|Missed Visit|2|||
131182656|NCT02378883|472289379|FG000|30 Day Follow-Up|Death|1|||
131182657|NCT02378883|472289379|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
131182658|NCT02378883|472289379|FG000|12 Months Follow-Up|Death|2|||
131182659|NCT03037307|472289380|FG000|Period 1|Did Not Meet Study Criteria|0|||
131182660|NCT03037307|472289381|FG001|Period 1|Did Not Meet Study Criteria|0|||
131182661|NCT03037307|472289382|FG002|Period 1|Did Not Meet Study Criteria|0|||
131182662|NCT03037307|472289383|FG003|Period 1|Did Not Meet Study Criteria|1|||
131182663|NCT03037307|472289384|FG004|Period 1|Did Not Meet Study Criteria|0|||
131182664|NCT03037307|472289385|FG005|Period 1|Did Not Meet Study Criteria|0|||
131182665|NCT00691093|472289387|FG000|Overall Study|Adverse Event|1|||
131182666|NCT00691093|472289387|FG000|Overall Study|Lost to Follow-up|1|||
131182667|NCT00691093|472289387|FG000|Overall Study|Lack of Efficacy|1|||
131182668|NCT00691093|472289387|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
131182669|NCT00493467|472289388|FG000|Overall Study|Death|1|||
131182670|NCT05489081|472289389|FG000|Overall Study|student left classroom|0|||
131182671|NCT05489081|472289390|FG001|Overall Study|student left classroom|1|||
131182672|NCT05489081|472289389|FG000|Overall Study|teacher left school|0|||
131182673|NCT05489081|472289390|FG001|Overall Study|teacher left school|2|||
131182674|NCT00810810|472289391|FG000|Overall Study|Withdrawal by Subject|0|||
131182675|NCT00810810|472289392|FG001|Overall Study|Withdrawal by Subject|8|||
131182676|NCT00810810|472289393|FG002|Overall Study|Withdrawal by Subject|10|||
131182677|NCT00810810|472289394|FG003|Overall Study|Withdrawal by Subject|8|||
131182678|NCT00810810|472289391|FG000|Overall Study|Physician Decision|0|||
131182679|NCT00810810|472289392|FG001|Overall Study|Physician Decision|3|||
131182680|NCT00810810|472289393|FG002|Overall Study|Physician Decision|1|||
131182681|NCT00810810|472289394|FG003|Overall Study|Physician Decision|5|||
131182682|NCT01409993|472289395|FG000|Overall Study|Adverse Event|4|||
131182683|NCT01409993|472289396|FG001|Overall Study|Adverse Event|4|||
131182684|NCT01409993|472289397|FG002|Overall Study|Adverse Event|3|||
131182685|NCT01409993|472289398|FG003|Overall Study|Adverse Event|1|||
131182686|NCT01409993|472289395|FG000|Overall Study|Withdrawal by Subject|0|||
131182687|NCT01409993|472289396|FG001|Overall Study|Withdrawal by Subject|0|||
131182688|NCT01409993|472289397|FG002|Overall Study|Withdrawal by Subject|0|||
131182689|NCT01409993|472289398|FG003|Overall Study|Withdrawal by Subject|4|||
131182690|NCT01409993|472289395|FG000|Overall Study|Lost to Follow-up|0|||
131182691|NCT01409993|472289396|FG001|Overall Study|Lost to Follow-up|1|||
131182692|NCT01409993|472289397|FG002|Overall Study|Lost to Follow-up|0|||
131182693|NCT01409993|472289398|FG003|Overall Study|Lost to Follow-up|0|||
131182694|NCT01700985|472289399|FG000|Overall Study|Incarcerated|0|||
131182695|NCT01700985|472289400|FG001|Overall Study|Incarcerated|1|||
131182696|NCT03074149|472289403|FG000|Overall Study|Reason unknown|22|||
131182697|NCT03074149|472289404|FG001|Overall Study|Reason unknown|35|||
131182698|NCT03074149|472289403|FG000|Overall Study|Death|10|||
131182699|NCT03074149|472289404|FG001|Overall Study|Death|45|||
131182700|NCT00067470|472289405|FG000|Overall Study|Withdrawal by Subject|0|||
131182701|NCT00067470|472289406|FG001|Overall Study|Withdrawal by Subject|1|||
131182702|NCT00050622|472289407|FG000|Overall Study|Adverse Event|1|||
131182703|NCT00426556|472289410|FG000|Phase I - Core Phase|Disease Progression|0|||
131182704|NCT00426556|472289411|FG001|Phase I - Core Phase|Disease Progression|6|||
131182705|NCT00426556|472289412|FG002|Phase I - Core Phase|Disease Progression|2|||
131182706|NCT00426556|472289413|FG003|Phase I - Core Phase|Disease Progression|0|||
131182707|NCT00426556|472289410|FG000|Phase I - Core Phase|Adverse Event|1|||
131182708|NCT00426556|472289411|FG001|Phase I - Core Phase|Adverse Event|3|||
131182709|NCT00426556|472289412|FG002|Phase I - Core Phase|Adverse Event|1|||
131182710|NCT00426556|472289413|FG003|Phase I - Core Phase|Adverse Event|0|||
131182711|NCT00426556|472289410|FG000|Phase I - Core Phase|Death|0|||
131182712|NCT00426556|472289411|FG001|Phase I - Core Phase|Death|1|||
131182713|NCT00426556|472289412|FG002|Phase I - Core Phase|Death|0|||
131182714|NCT00426556|472289413|FG003|Phase I - Core Phase|Death|0|||
131182715|NCT00426556|472289410|FG000|Phase I - Extension Phase|Adverse Event|0|||
131182716|NCT00426556|472289411|FG001|Phase I - Extension Phase|Adverse Event|1|||
131182717|NCT00426556|472289412|FG002|Phase I - Extension Phase|Adverse Event|1|||
131182718|NCT00426556|472289413|FG003|Phase I - Extension Phase|Adverse Event|0|||
131182719|NCT00426556|472289410|FG000|Phase I - Extension Phase|Disease Progression|5|||
131182720|NCT00426556|472289411|FG001|Phase I - Extension Phase|Disease Progression|5|||
131182721|NCT00426556|472289412|FG002|Phase I - Extension Phase|Disease Progression|6|||
131182722|NCT00426556|472289413|FG003|Phase I - Extension Phase|Disease Progression|0|||
131182723|NCT00426556|472289410|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
131182724|NCT00426556|472289411|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
131182725|NCT00426556|472289412|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
131182726|NCT00426556|472289413|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
131182727|NCT00426556|472289410|FG000|Phase II - Core Phase|Disease Progression|0|||
131182728|NCT00426556|472289411|FG001|Phase II - Core Phase|Disease Progression|0|||
131182729|NCT00426556|472289412|FG002|Phase II - Core Phase|Disease Progression|0|||
131182730|NCT00426556|472289413|FG003|Phase II - Core Phase|Disease Progression|16|||
131182731|NCT00426556|472289410|FG000|Phase II - Core Phase|Adverse Event|0|||
131182732|NCT00426556|472289411|FG001|Phase II - Core Phase|Adverse Event|0|||
131182733|NCT00426556|472289412|FG002|Phase II - Core Phase|Adverse Event|0|||
131182734|NCT00426556|472289413|FG003|Phase II - Core Phase|Adverse Event|8|||
131182735|NCT00426556|472289410|FG000|Phase II - Extension Phase|Disease Progression|0|||
131182736|NCT00426556|472289411|FG001|Phase II - Extension Phase|Disease Progression|0|||
131182737|NCT00426556|472289412|FG002|Phase II - Extension Phase|Disease Progression|0|||
131182738|NCT00426556|472289413|FG003|Phase II - Extension Phase|Disease Progression|21|||
131182739|NCT00426556|472289410|FG000|Phase II - Extension Phase|Adverse Event|0|||
131182740|NCT00426556|472289411|FG001|Phase II - Extension Phase|Adverse Event|0|||
131182741|NCT00426556|472289412|FG002|Phase II - Extension Phase|Adverse Event|0|||
131182742|NCT00426556|472289413|FG003|Phase II - Extension Phase|Adverse Event|2|||
131182743|NCT03970824|472289415|FG000|Overall Study|Withdrawal by Subject|1|||
131182744|NCT03970824|472289416|FG001|Overall Study|Withdrawal by Subject|1|||
131182745|NCT03970824|472289417|FG002|Overall Study|Withdrawal by Subject|3|||
131182746|NCT03970824|472289415|FG000|Overall Study|Lost to Follow-up|0|||
131182747|NCT03970824|472289416|FG001|Overall Study|Lost to Follow-up|2|||
131182748|NCT03970824|472289417|FG002|Overall Study|Lost to Follow-up|1|||
131182749|NCT03970824|472289415|FG000|Overall Study|Adverse Event|1|||
131182750|NCT03970824|472289416|FG001|Overall Study|Adverse Event|0|||
131182751|NCT03970824|472289417|FG002|Overall Study|Adverse Event|0|||
131182752|NCT00416312|472289418|FG000|Overall Study|tumors not visible on imaging|2|||
131182753|NCT00050960|472289421|FG000|Overall Study|Progressive Disease|137|||
131182754|NCT00050960|472289422|FG001|Overall Study|Progressive Disease|93|||
131182755|NCT00050960|472289421|FG000|Overall Study|Stable Disease|19|||
131182756|NCT00050960|472289422|FG001|Overall Study|Stable Disease|48|||
131182757|NCT00050960|472289421|FG000|Overall Study|Partial Response|14|||
131182758|NCT00050960|472289422|FG001|Overall Study|Partial Response|19|||
131182759|NCT00050960|472289421|FG000|Overall Study|Complete Response|0|||
131182760|NCT00050960|472289422|FG001|Overall Study|Complete Response|2|||
131182761|NCT00050960|472289421|FG000|Overall Study|Adverse Event|62|||
131182762|NCT00050960|472289422|FG001|Overall Study|Adverse Event|61|||
131182763|NCT00050960|472289421|FG000|Overall Study|Lost to Follow-up|0|||
131182764|NCT00050960|472289422|FG001|Overall Study|Lost to Follow-up|1|||
131182765|NCT00050960|472289421|FG000|Overall Study|Withdrawal by Subject|23|||
131182766|NCT00050960|472289422|FG001|Overall Study|Withdrawal by Subject|18|||
131182767|NCT00050960|472289421|FG000|Overall Study|Administrative|31|||
131182768|NCT00050960|472289422|FG001|Overall Study|Administrative|46|||
131182769|NCT00050960|472289421|FG000|Overall Study|Non-compliance|3|||
131182770|NCT00050960|472289422|FG001|Overall Study|Non-compliance|1|||
131182771|NCT00050960|472289421|FG000|Overall Study|Death|13|||
131182772|NCT00050960|472289422|FG001|Overall Study|Death|15|||
131182773|NCT02727660|472289423|FG000|Overall Study|Lack of Efficacy|40|||
131182774|NCT02727660|472289424|FG001|Overall Study|Lack of Efficacy|40|||
131182775|NCT02727660|472289425|FG002|Overall Study|Lack of Efficacy|70|||
131182776|NCT02727660|472289423|FG000|Overall Study|Adverse Event|28|||
131182777|NCT02727660|472289424|FG001|Overall Study|Adverse Event|21|||
131182778|NCT02727660|472289425|FG002|Overall Study|Adverse Event|32|||
131182779|NCT02727660|472289423|FG000|Overall Study|Withdrawal by Subject|26|||
131182780|NCT02727660|472289424|FG001|Overall Study|Withdrawal by Subject|25|||
131182781|NCT02727660|472289425|FG002|Overall Study|Withdrawal by Subject|30|||
131182782|NCT02727660|472289423|FG000|Overall Study|Physician Decision|3|||
131182783|NCT02727660|472289424|FG001|Overall Study|Physician Decision|8|||
131182784|NCT02727660|472289425|FG002|Overall Study|Physician Decision|14|||
131182785|NCT02727660|472289423|FG000|Overall Study|Lost to Follow-up|5|||
131182786|NCT02727660|472289424|FG001|Overall Study|Lost to Follow-up|9|||
131182787|NCT02727660|472289425|FG002|Overall Study|Lost to Follow-up|8|||
131182788|NCT02727660|472289423|FG000|Overall Study|Protocol Violation|7|||
131182789|NCT02727660|472289424|FG001|Overall Study|Protocol Violation|5|||
131182790|NCT02727660|472289425|FG002|Overall Study|Protocol Violation|5|||
131182791|NCT02727660|472289423|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
131182792|NCT02727660|472289424|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
131238918|NCT05630547|472500304|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
131238919|NCT05630547|472500305|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
131182793|NCT02727660|472289425|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
131182794|NCT02727660|472289423|FG000|Overall Study|Administrative Reasons|2|||
131182795|NCT02727660|472289424|FG001|Overall Study|Administrative Reasons|3|||
131182796|NCT02727660|472289425|FG002|Overall Study|Administrative Reasons|4|||
131182797|NCT00305604|472289426|FG000|Overall Study|Adverse Event|6|||
131182798|NCT00305604|472289427|FG001|Overall Study|Adverse Event|3|||
131182799|NCT00305604|472289426|FG000|Overall Study|Lack of Efficacy|11|||
131182800|NCT00305604|472289427|FG001|Overall Study|Lack of Efficacy|18|||
131182801|NCT00305604|472289426|FG000|Overall Study|Lost to Follow-up|0|||
131182802|NCT00305604|472289427|FG001|Overall Study|Lost to Follow-up|4|||
131182803|NCT00305604|472289426|FG000|Overall Study|Protocol Violation|2|||
131182804|NCT00305604|472289427|FG001|Overall Study|Protocol Violation|1|||
131182805|NCT00305604|472289426|FG000|Overall Study|Withdrawal by Subject|12|||
131182806|NCT00305604|472289427|FG001|Overall Study|Withdrawal by Subject|21|||
131182807|NCT00305604|472289426|FG000|Overall Study|Patient moved|1|||
131182808|NCT00305604|472289427|FG001|Overall Study|Patient moved|0|||
131182809|NCT01248364|472289428|FG000|Overall Study|Adverse Event|0|||
131182810|NCT01248364|472289429|FG001|Overall Study|Adverse Event|1|||
131182811|NCT01248364|472289430|FG002|Overall Study|Adverse Event|0|||
131182812|NCT01248364|472289431|FG003|Overall Study|Adverse Event|0|||
131182813|NCT00764946|472289432|FG000|Overall Study|Lack of Efficacy|1|||
131182814|NCT00764946|472289433|FG001|Overall Study|Lack of Efficacy|0|||
131182815|NCT00764946|472289434|FG002|Overall Study|Lack of Efficacy|0|||
131182816|NCT00764946|472289432|FG000|Overall Study|Lost to Follow-up|3|||
131182817|NCT00764946|472289433|FG001|Overall Study|Lost to Follow-up|4|||
131182818|NCT00764946|472289434|FG002|Overall Study|Lost to Follow-up|0|||
131182819|NCT00764946|472289432|FG000|Overall Study|Physician Decision|2|||
131182820|NCT00764946|472289433|FG001|Overall Study|Physician Decision|4|||
131182821|NCT00764946|472289434|FG002|Overall Study|Physician Decision|0|||
131182822|NCT00764946|472289432|FG000|Overall Study|Adverse Event|3|||
131182823|NCT00764946|472289433|FG001|Overall Study|Adverse Event|2|||
131182824|NCT00764946|472289434|FG002|Overall Study|Adverse Event|1|||
131182825|NCT00764946|472289432|FG000|Overall Study|Withdrawal by Subject|3|||
131182826|NCT00764946|472289433|FG001|Overall Study|Withdrawal by Subject|6|||
131182827|NCT00764946|472289434|FG002|Overall Study|Withdrawal by Subject|2|||
131182828|NCT00764946|472289432|FG000|Overall Study|Never Treated|1|||
131182829|NCT00764946|472289433|FG001|Overall Study|Never Treated|1|||
131182830|NCT00764946|472289434|FG002|Overall Study|Never Treated|1|||
131182831|NCT01192204|472289436|FG000|Overall Study|could not keep recall appointments|1|||
131182832|NCT01192204|472289437|FG001|Overall Study|could not keep recall appointments|0|||
131182833|NCT02146248|472289438|FG000|Overall Study|Withdrawal by Subject|2|||
131182834|NCT02247401|472289444|FG000|Overall Study|Adverse Event|1|||
131182835|NCT02247401|472289445|FG001|Overall Study|Adverse Event|0|||
131182836|NCT02247401|472289446|FG002|Overall Study|Adverse Event|0|||
131182837|NCT02247401|472289444|FG000|Overall Study|Withdrawal by Subject|4|||
131182838|NCT02247401|472289445|FG001|Overall Study|Withdrawal by Subject|1|||
131182839|NCT02247401|472289446|FG002|Overall Study|Withdrawal by Subject|1|||
131182840|NCT02247401|472289444|FG000|Overall Study|Lost to Follow-up|1|||
131182841|NCT02247401|472289445|FG001|Overall Study|Lost to Follow-up|1|||
131182842|NCT02247401|472289446|FG002|Overall Study|Lost to Follow-up|1|||
131182843|NCT02188719|472289451|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
131182844|NCT02188719|472289452|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
131182845|NCT02188719|472289453|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
131182846|NCT02188719|472289454|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
131182847|NCT01164865|472289455|FG000|Overall Study|Lost to Follow-up|2|||
131182848|NCT01164865|472289456|FG001|Overall Study|Lost to Follow-up|1|||
131182849|NCT00192036|472289457|FG000|Overall Study|Protocol Violation|3|||
131182850|NCT00192036|472289457|FG000|Overall Study|Adverse Event|6|||
131182851|NCT00192036|472289457|FG000|Overall Study|Patient/Physician Perception|1|||
131182852|NCT00192036|472289457|FG000|Overall Study|Objective Tumor Progression|4|||
131182853|NCT00192036|472289457|FG000|Overall Study|Clinical Disease Progression|1|||
131182854|NCT00192036|472289457|FG000|Overall Study|Death|1|||
131182855|NCT00192036|472289457|FG000|Overall Study|Unknown or Not Specified|5|||
131182856|NCT00476996|472289459|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
131238920|NCT05630547|472500306|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
131238921|NCT05630547|472500303|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
131238922|NCT05630547|472500304|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
131238923|NCT05630547|472500305|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
131238924|NCT05630547|472500306|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
131238925|NCT05630547|472500303|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
131238926|NCT05630547|472500304|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
131182857|NCT00476996|472289460|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
131182858|NCT00476996|472289461|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
131182859|NCT00476996|472289462|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
131182860|NCT00476996|472289459|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
131182861|NCT00476996|472289460|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
131182862|NCT00476996|472289461|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
131182863|NCT00476996|472289462|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
131182864|NCT00476996|472289459|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
131182865|NCT00476996|472289460|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
131182866|NCT00476996|472289461|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
131182867|NCT00476996|472289462|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
131182868|NCT00476996|472289459|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
131182869|NCT00476996|472289460|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
131182870|NCT00476996|472289461|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
131182871|NCT00476996|472289462|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
131182872|NCT00476996|472289459|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
131182873|NCT00476996|472289460|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
131238927|NCT05630547|472500305|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
131238928|NCT05630547|472500306|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
131238929|NCT05630547|472500303|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
131238930|NCT05630547|472500304|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
131238931|NCT05630547|472500305|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
131238932|NCT05630547|472500306|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
131238933|NCT05630547|472500303|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
131238934|NCT05630547|472500304|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
131238935|NCT05630547|472500305|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
131238936|NCT05630547|472500306|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
131238937|NCT05630547|472500303|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
131238938|NCT05630547|472500304|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
131238939|NCT05630547|472500305|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
131238940|NCT05630547|472500306|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
131238941|NCT05956665|472500307|FG000|Overall Study|Death|1|||
131238942|NCT05956665|472500307|FG000|Overall Study|Withdrawal by Subject|1|||
131238943|NCT04948333|472500308|FG000|Overall Study|Adverse Event|6|||
131238944|NCT04948333|472500309|FG001|Overall Study|Adverse Event|4|||
131238945|NCT04948333|472500310|FG002|Overall Study|Adverse Event|0|||
131238946|NCT04948333|472500311|FG003|Overall Study|Adverse Event|2|||
131238947|NCT04948333|472500308|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
131238948|NCT04948333|472500309|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
131238949|NCT04948333|472500310|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131238950|NCT04948333|472500311|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
131238951|NCT04948333|472500308|FG000|Overall Study|Progressive Disease|1|||
131238952|NCT04948333|472500309|FG001|Overall Study|Progressive Disease|5|||
131238953|NCT04948333|472500310|FG002|Overall Study|Progressive Disease|0|||
131238954|NCT04948333|472500311|FG003|Overall Study|Progressive Disease|0|||
131238955|NCT04948333|472500308|FG000|Overall Study|Physician Decision|2|||
131238956|NCT04948333|472500309|FG001|Overall Study|Physician Decision|2|||
131238957|NCT04948333|472500310|FG002|Overall Study|Physician Decision|0|||
131238958|NCT04948333|472500311|FG003|Overall Study|Physician Decision|0|||
131238959|NCT04948333|472500308|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
131238960|NCT04948333|472500309|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
131238961|NCT04948333|472500310|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
131238962|NCT04948333|472500311|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
131182874|NCT00476996|472289461|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
131182875|NCT00476996|472289462|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
131182876|NCT00476996|472289459|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
131182877|NCT00476996|472289460|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
131182878|NCT00476996|472289461|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
131182879|NCT00476996|472289462|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
131182880|NCT00476996|472289459|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
131182881|NCT00476996|472289460|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
131182882|NCT00476996|472289461|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
131182883|NCT00476996|472289462|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
131182884|NCT00476996|472289459|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
131182885|NCT00476996|472289460|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
131182886|NCT00476996|472289461|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
131182887|NCT00476996|472289462|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
131182888|NCT00476996|472289459|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
131182889|NCT00476996|472289460|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
131182890|NCT00476996|472289461|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
131182891|NCT00476996|472289462|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
131182892|NCT00476996|472289459|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
131182893|NCT00476996|472289460|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
131182894|NCT00476996|472289461|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
131182895|NCT00476996|472289462|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
131182896|NCT00476996|472289459|FG000|OLE Phase (From Week 48)|Death|0|||
131182897|NCT00476996|472289460|FG001|OLE Phase (From Week 48)|Death|0|||
131182898|NCT00476996|472289461|FG002|OLE Phase (From Week 48)|Death|0|||
131238963|NCT04948333|472500308|FG000|Overall Study|Withdrawal by Subject|2|||
131238964|NCT04948333|472500309|FG001|Overall Study|Withdrawal by Subject|0|||
131238965|NCT04948333|472500310|FG002|Overall Study|Withdrawal by Subject|0|||
130733510|NCT05929651|470642908|FG000|Overall Study|Protocol Deviation|1|||
130733511|NCT05929651|470642908|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
130733512|NCT02260570|470642909|FG000|Overall Study|Withdrawal by Subject|2|||
130733513|NCT02260570|470642910|FG001|Overall Study|Withdrawal by Subject|1|||
130733514|NCT02260570|470642909|FG000|Overall Study|Physician Decision|1|||
130733515|NCT02260570|470642910|FG001|Overall Study|Physician Decision|1|||
131182899|NCT00476996|472289462|FG003|OLE Phase (From Week 48)|Death|7|||
131182900|NCT00476996|472289459|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
131182901|NCT00476996|472289460|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
131182902|NCT00476996|472289461|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
131182903|NCT00476996|472289462|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
131182904|NCT00476996|472289459|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
131182905|NCT00476996|472289460|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
131182906|NCT00476996|472289461|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
131182907|NCT00476996|472289462|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
131182908|NCT00476996|472289459|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
131182909|NCT00476996|472289460|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
131182910|NCT00476996|472289461|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
131182911|NCT00476996|472289462|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
131182912|NCT00476996|472289459|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
131182913|NCT00476996|472289460|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
131182914|NCT00476996|472289461|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
131182915|NCT00476996|472289462|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
131182916|NCT01769469|472289465|FG000|Overall Study|Consent Withdrawn|5|||
131182917|NCT01769469|472289465|FG000|Overall Study|Moved Out Of Area|3|||
131182918|NCT01769469|472289465|FG000|Overall Study|Lost to Follow-up|17|||
131182919|NCT01769469|472289465|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
131182920|NCT01769469|472289465|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
131182921|NCT02394795|472289473|FG000|Overall Study|Adverse Event|92|||
131182922|NCT02394795|472289474|FG001|Overall Study|Adverse Event|70|||
131182923|NCT02394795|472289473|FG000|Overall Study|Lost to Follow-up|0|||
131182924|NCT02394795|472289474|FG001|Overall Study|Lost to Follow-up|1|||
131182925|NCT02394795|472289473|FG000|Overall Study|Withdrawal by Subject|17|||
131182926|NCT02394795|472289474|FG001|Overall Study|Withdrawal by Subject|26|||
131182927|NCT02394795|472289473|FG000|Overall Study|Lack of Efficacy|181|||
131182928|NCT02394795|472289474|FG001|Overall Study|Lack of Efficacy|211|||
131182929|NCT02394795|472289473|FG000|Overall Study|Death|4|||
131182930|NCT02394795|472289474|FG001|Overall Study|Death|5|||
131182931|NCT02394795|472289473|FG000|Overall Study|Physician Decision|109|||
131182932|NCT02394795|472289474|FG001|Overall Study|Physician Decision|93|||
131182933|NCT02293902|472289478|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
131182934|NCT02293902|472289479|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
131182935|NCT02293902|472289480|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
131182936|NCT02293902|472289481|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
131182937|NCT02293902|472289482|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
131182938|NCT02293902|472289478|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
131182939|NCT02293902|472289479|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
131182940|NCT02293902|472289480|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
131182941|NCT02293902|472289481|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
131182942|NCT02293902|472289482|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
131182943|NCT02293902|472289478|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
131182944|NCT02293902|472289479|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
131182945|NCT02293902|472289480|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
131182946|NCT02293902|472289481|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
131182947|NCT02293902|472289482|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
131182948|NCT02293902|472289478|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
131182949|NCT02293902|472289479|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
131182950|NCT02293902|472289480|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
131182951|NCT02293902|472289481|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
131182952|NCT02293902|472289482|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
131182953|NCT02293902|472289478|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
131182954|NCT02293902|472289479|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
131182955|NCT02293902|472289480|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
131182956|NCT02293902|472289481|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
131182957|NCT02293902|472289482|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
131238966|NCT04948333|472500311|FG003|Overall Study|Withdrawal by Subject|1|||
131238967|NCT04948333|472500308|FG000|Overall Study|Protocol Violation|0|||
131238968|NCT04948333|472500309|FG001|Overall Study|Protocol Violation|1|||
131238969|NCT04948333|472500310|FG002|Overall Study|Protocol Violation|0|||
131238970|NCT04948333|472500311|FG003|Overall Study|Protocol Violation|0|||
131238971|NCT04948333|472500308|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
131238972|NCT04948333|472500309|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
131238973|NCT04948333|472500310|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
131238974|NCT04948333|472500311|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
131238975|NCT03517969|472500312|FG000|Overall Study|Never started protocol treatment|3|||
131238976|NCT03517969|472500313|FG001|Overall Study|Never started protocol treatment|5|||
131238977|NCT03517969|472500312|FG000|Overall Study|Disease progression|11|||
131238978|NCT03517969|472500313|FG001|Overall Study|Disease progression|16|||
131238979|NCT03517969|472500312|FG000|Overall Study|PSA progression|8|||
131238980|NCT03517969|472500313|FG001|Overall Study|PSA progression|1|||
131238981|NCT03517969|472500312|FG000|Overall Study|Clinical progression|4|||
131238982|NCT03517969|472500313|FG001|Overall Study|Clinical progression|2|||
131238983|NCT03517969|472500312|FG000|Overall Study|Adverse Event|5|||
131238984|NCT03517969|472500313|FG001|Overall Study|Adverse Event|4|||
131238985|NCT03517969|472500312|FG000|Overall Study|Intercurrent illness|1|||
131238986|NCT03517969|472500313|FG001|Overall Study|Intercurrent illness|2|||
131238987|NCT03517969|472500312|FG000|Overall Study|Death|1|||
131238988|NCT03517969|472500313|FG001|Overall Study|Death|1|||
131238989|NCT03517969|472500312|FG000|Overall Study|Withdrawal by Subject|1|||
131238990|NCT03517969|472500313|FG001|Overall Study|Withdrawal by Subject|2|||
131238991|NCT03517969|472500312|FG000|Overall Study|Physician Decision|1|||
131238992|NCT03517969|472500313|FG001|Overall Study|Physician Decision|1|||
131238993|NCT03517969|472500312|FG000|Overall Study|No clinical benefit|1|||
131238994|NCT03517969|472500313|FG001|Overall Study|No clinical benefit|0|||
131238995|NCT03517969|472500312|FG000|Overall Study|Delayed treatment for dental treatment|1|||
131238996|NCT03517969|472500313|FG001|Overall Study|Delayed treatment for dental treatment|0|||
131238997|NCT03517969|472500312|FG000|Overall Study|Difficult to maintain appointment|0|||
131238998|NCT03517969|472500313|FG001|Overall Study|Difficult to maintain appointment|1|||
131238999|NCT03517969|472500312|FG000|Overall Study|Protocol Violation|0|||
131239000|NCT03517969|472500313|FG001|Overall Study|Protocol Violation|1|||
131239001|NCT00977470|472500317|FG000|Overall Study|Lack of Efficacy|32|||
131239002|NCT00977470|472500318|FG001|Overall Study|Lack of Efficacy|30|||
131239003|NCT00977470|472500317|FG000|Overall Study|Physician Decision|2|||
131239004|NCT00977470|472500318|FG001|Overall Study|Physician Decision|0|||
131239005|NCT00977470|472500317|FG000|Overall Study|Adverse Event|1|||
131239006|NCT00977470|472500318|FG001|Overall Study|Adverse Event|2|||
131239007|NCT00977470|472500317|FG000|Overall Study|Protocol Violation|1|||
131239008|NCT00977470|472500318|FG001|Overall Study|Protocol Violation|0|||
131239009|NCT00977470|472500317|FG000|Overall Study|Withdrawal by Subject|0|||
131239010|NCT00977470|472500318|FG001|Overall Study|Withdrawal by Subject|2|||
131239011|NCT00977470|472500317|FG000|Overall Study|Death|0|||
131239012|NCT00977470|472500318|FG001|Overall Study|Death|2|||
131239013|NCT00977470|472500317|FG000|Overall Study|clinical decline|0|||
131239014|NCT00977470|472500318|FG001|Overall Study|clinical decline|1|||
131239015|NCT00977470|472500317|FG000|Overall Study|prolonged recovery post-surgery|0|||
131239016|NCT00977470|472500318|FG001|Overall Study|prolonged recovery post-surgery|1|||
131239017|NCT00977470|472500317|FG000|Overall Study|Still on-study|2|||
131239018|NCT00977470|472500318|FG001|Overall Study|Still on-study|0|||
131239019|NCT01467427|472500335|FG000|Overall Study|Withdrawal by Subject|1|||
131239020|NCT01467427|472500336|FG001|Overall Study|Withdrawal by Subject|0|||
131239021|NCT01467427|472500335|FG000|Overall Study|Not continuing in extension phase|0|||
131239022|NCT01467427|472500336|FG001|Overall Study|Not continuing in extension phase|2|||
131239023|NCT01467427|472500335|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
131239024|NCT01467427|472500336|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
131239025|NCT01467427|472500335|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
131239026|NCT01467427|472500336|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
131239027|NCT01467427|472500335|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
131239028|NCT01467427|472500336|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
131239029|NCT01467427|472500335|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
131239030|NCT01467427|472500336|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
131239031|NCT01946204|472500337|FG000|Overall Study|Death|38|||
131239032|NCT01946204|472500338|FG001|Overall Study|Death|59|||
131239033|NCT01946204|472500337|FG000|Overall Study|Withdrawal by Subject|37|||
131239034|NCT01946204|472500338|FG001|Overall Study|Withdrawal by Subject|50|||
131239035|NCT01946204|472500337|FG000|Overall Study|Lost to Follow-up|3|||
131239036|NCT01946204|472500338|FG001|Overall Study|Lost to Follow-up|7|||
131239037|NCT01946204|472500337|FG000|Overall Study|Ongoing|316|||
131239038|NCT01946204|472500338|FG001|Overall Study|Ongoing|687|||
131239039|NCT01946204|472500337|FG000|Overall Study|Other|7|||
131239040|NCT01946204|472500338|FG001|Overall Study|Other|3|||
131239041|NCT03462719|472500339|FG000|Overall Study|Withdrawal by Subject|4|||
131239042|NCT03462719|472500340|FG001|Overall Study|Withdrawal by Subject|3|||
131239043|NCT03462719|472500339|FG000|Overall Study|Ongoing|87|||
131239044|NCT03462719|472500340|FG001|Overall Study|Ongoing|72|||
131239045|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
131239046|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
130784517|NCT00492297|470838807|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
131239047|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
131239048|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
131239049|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
131239050|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
131182958|NCT02332798|472291580|FG000|Overall Study|Unwilling to Participate in Study|0|||
131182959|NCT02332798|472291581|FG001|Overall Study|Unwilling to Participate in Study|1|||
131182960|NCT02332798|472291582|FG002|Overall Study|Unwilling to Participate in Study|1|||
131182961|NCT02332798|472291580|FG000|Overall Study|Positive Urine Drug Test|0|||
131182962|NCT02332798|472291581|FG001|Overall Study|Positive Urine Drug Test|1|||
131182963|NCT02332798|472291582|FG002|Overall Study|Positive Urine Drug Test|0|||
131182964|NCT02332798|472291580|FG000|Overall Study|Abnormal Laboratory Findings|1|||
131182965|NCT02332798|472291581|FG001|Overall Study|Abnormal Laboratory Findings|0|||
131182966|NCT02332798|472291582|FG002|Overall Study|Abnormal Laboratory Findings|0|||
131182967|NCT05406440|472291583|FG000|Overall Study|Lost to Follow-up|0|||
131182968|NCT05406440|472291584|FG001|Overall Study|Lost to Follow-up|0|||
131182969|NCT05406440|472291585|FG002|Overall Study|Lost to Follow-up|0|||
131182970|NCT05406440|472291586|FG003|Overall Study|Lost to Follow-up|0|||
131182971|NCT05406440|472291587|FG004|Overall Study|Lost to Follow-up|2|||
131182972|NCT05406440|472291588|FG005|Overall Study|Lost to Follow-up|0|||
131182973|NCT05406440|472291589|FG006|Overall Study|Lost to Follow-up|0|||
131182974|NCT05406440|472291583|FG000|Overall Study|Physician Decision|0|||
131182975|NCT05406440|472291584|FG001|Overall Study|Physician Decision|0|||
131239051|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
131239052|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
131239053|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
131239054|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
131239055|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
131239056|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
131239057|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
131239058|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
131239059|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
131239060|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
131239061|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
131239062|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
131239063|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
131239064|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
131239065|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
131239066|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
131239067|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
131239068|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
131239069|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
131239070|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
131239071|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
131239072|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
131239073|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
131239074|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
131239075|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
131239076|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
131239077|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
131239078|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
131239079|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
131239080|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
131239081|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
131239082|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
131239083|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
131239084|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
131239085|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
131239086|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
131239087|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
131239088|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
131239089|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
131239090|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
131239091|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
131239092|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
131239093|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
131239094|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
131182976|NCT05406440|472291585|FG002|Overall Study|Physician Decision|0|||
131239095|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
131239096|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
131239097|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
131239098|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
131239099|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
131182977|NCT05406440|472291586|FG003|Overall Study|Physician Decision|0|||
131239100|NCT04951622|472500341|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
131182978|NCT05406440|472291587|FG004|Overall Study|Physician Decision|1|||
131182979|NCT05406440|472291588|FG005|Overall Study|Physician Decision|0|||
131182980|NCT05406440|472291589|FG006|Overall Study|Physician Decision|0|||
131182981|NCT05406440|472291583|FG000|Overall Study|Withdrawal by Subject|0|||
131182982|NCT05406440|472291584|FG001|Overall Study|Withdrawal by Subject|0|||
131182983|NCT05406440|472291585|FG002|Overall Study|Withdrawal by Subject|0|||
131182984|NCT05406440|472291586|FG003|Overall Study|Withdrawal by Subject|0|||
131182985|NCT05406440|472291587|FG004|Overall Study|Withdrawal by Subject|0|||
131182986|NCT05406440|472291588|FG005|Overall Study|Withdrawal by Subject|2|||
131182987|NCT05406440|472291589|FG006|Overall Study|Withdrawal by Subject|0|||
131182988|NCT04268303|472291590|FG000|Overall Study|Lost to Follow-up|1|||
131182989|NCT04268303|472291591|FG001|Overall Study|Lost to Follow-up|1|||
131182990|NCT04268303|472291592|FG002|Overall Study|Lost to Follow-up|2|||
131182991|NCT04268303|472291590|FG000|Overall Study|Withdrawal by Subject|0|||
131182992|NCT04268303|472291591|FG001|Overall Study|Withdrawal by Subject|1|||
131182993|NCT04268303|472291592|FG002|Overall Study|Withdrawal by Subject|1|||
131182994|NCT04268303|472291590|FG000|Overall Study|Adverse Event|2|||
131182995|NCT04268303|472291591|FG001|Overall Study|Adverse Event|0|||
131182996|NCT04268303|472291592|FG002|Overall Study|Adverse Event|0|||
131182997|NCT03927911|472291593|FG000|Overall Study|problems with eDiary|0|||
131182998|NCT03927911|472291594|FG001|Overall Study|problems with eDiary|1|||
131182999|NCT03927911|472291595|FG002|Overall Study|problems with eDiary|0|||
131183000|NCT03927911|472291596|FG003|Overall Study|problems with eDiary|1|||
131183001|NCT03927911|472291597|FG004|Overall Study|problems with eDiary|0|||
131183002|NCT03927911|472291598|FG005|Overall Study|problems with eDiary|4|||
131183003|NCT03927911|472291593|FG000|Overall Study|Adverse Event|0|||
131183004|NCT03927911|472291594|FG001|Overall Study|Adverse Event|0|||
131183005|NCT03927911|472291595|FG002|Overall Study|Adverse Event|0|||
131183006|NCT03927911|472291596|FG003|Overall Study|Adverse Event|0|||
131183007|NCT03927911|472291597|FG004|Overall Study|Adverse Event|0|||
131183008|NCT03927911|472291598|FG005|Overall Study|Adverse Event|1|||
131183009|NCT03927911|472291593|FG000|Overall Study|not treated -study terminated by sponsor|0|||
131183010|NCT03927911|472291594|FG001|Overall Study|not treated -study terminated by sponsor|1|||
131183011|NCT03927911|472291595|FG002|Overall Study|not treated -study terminated by sponsor|0|||
131183012|NCT03927911|472291596|FG003|Overall Study|not treated -study terminated by sponsor|0|||
131183013|NCT03927911|472291597|FG004|Overall Study|not treated -study terminated by sponsor|0|||
131183014|NCT03927911|472291598|FG005|Overall Study|not treated -study terminated by sponsor|0|||
131183015|NCT03927911|472291593|FG000|Overall Study|Surgery cancelled|0|||
131183016|NCT03927911|472291594|FG001|Overall Study|Surgery cancelled|0|||
131183017|NCT03927911|472291595|FG002|Overall Study|Surgery cancelled|0|||
131183018|NCT03927911|472291596|FG003|Overall Study|Surgery cancelled|1|||
131183019|NCT03927911|472291597|FG004|Overall Study|Surgery cancelled|0|||
131183020|NCT03927911|472291598|FG005|Overall Study|Surgery cancelled|1|||
131183021|NCT03927911|472291593|FG000|Overall Study|Protocol Violation|0|||
131183022|NCT03927911|472291594|FG001|Overall Study|Protocol Violation|0|||
131183023|NCT03927911|472291595|FG002|Overall Study|Protocol Violation|0|||
131183024|NCT03927911|472291596|FG003|Overall Study|Protocol Violation|0|||
131183025|NCT03927911|472291597|FG004|Overall Study|Protocol Violation|0|||
131183026|NCT03927911|472291598|FG005|Overall Study|Protocol Violation|1|||
131183027|NCT01824693|472291599|FG000|Overall Study|Death|0|||
131183028|NCT01824693|472291600|FG001|Overall Study|Death|1|||
131183029|NCT01824693|472291601|FG002|Overall Study|Death|0|||
131183030|NCT01824693|472291599|FG000|Overall Study|Physician Decision|1|||
131183031|NCT01824693|472291600|FG001|Overall Study|Physician Decision|1|||
131183032|NCT01824693|472291601|FG002|Overall Study|Physician Decision|1|||
131183033|NCT01824693|472291599|FG000|Overall Study|Withdrawal by Subject|0|||
131183034|NCT01824693|472291600|FG001|Overall Study|Withdrawal by Subject|0|||
131183035|NCT01824693|472291601|FG002|Overall Study|Withdrawal by Subject|1|||
131239101|NCT04951622|472500342|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
131239102|NCT04951622|472500343|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
131239103|NCT04951622|472500344|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
131183036|NCT01824693|472291599|FG000|Overall Study|Progressive Disease|0|||
131183037|NCT01824693|472291600|FG001|Overall Study|Progressive Disease|5|||
131183038|NCT01824693|472291601|FG002|Overall Study|Progressive Disease|0|||
131183039|NCT01824693|472291599|FG000|Overall Study|Ineligible|0|||
131183040|NCT01824693|472291600|FG001|Overall Study|Ineligible|0|||
131183041|NCT01824693|472291601|FG002|Overall Study|Ineligible|3|||
131183042|NCT01824693|472291599|FG000|Overall Study|No Transplant Planned|0|||
131183043|NCT01824693|472291600|FG001|Overall Study|No Transplant Planned|0|||
131183044|NCT01824693|472291601|FG002|Overall Study|No Transplant Planned|10|||
131183045|NCT01175590|472291602|FG000|Overall Study|Lost to Follow-up|1|||
131183046|NCT01175590|472291603|FG001|Overall Study|Lost to Follow-up|0|||
131183047|NCT01175590|472291602|FG000|Overall Study|Withdrawal by Subject|0|||
131183048|NCT01175590|472291603|FG001|Overall Study|Withdrawal by Subject|2|||
131183049|NCT01175590|472291602|FG000|Overall Study|Adverse Event|4|||
131183050|NCT01175590|472291603|FG001|Overall Study|Adverse Event|0|||
131183051|NCT01175590|472291602|FG000|Overall Study|Physician Decision|1|||
131183052|NCT01175590|472291603|FG001|Overall Study|Physician Decision|4|||
131183053|NCT01175590|472291602|FG000|Overall Study|Lack of Efficacy|1|||
131183054|NCT01175590|472291603|FG001|Overall Study|Lack of Efficacy|1|||
131183055|NCT01175590|472291602|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
131183056|NCT01175590|472291603|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
131183057|NCT01175590|472291602|FG000|Overall Study|Treated not as randomized|3|||
131183058|NCT01175590|472291603|FG001|Overall Study|Treated not as randomized|2|||
131183059|NCT01175590|472291602|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
131183060|NCT01175590|472291603|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
131183061|NCT01175590|472291602|FG000|Overall Study|Protocol Violation|0|||
131183062|NCT01175590|472291603|FG001|Overall Study|Protocol Violation|1|||
131183063|NCT00092677|472291614|FG000|Overall Study|Lost to Follow-up|0|||
131183064|NCT00092677|472291615|FG001|Overall Study|Lost to Follow-up|2|||
131183065|NCT00092677|472291614|FG000|Overall Study|Adminstrative|5|||
131183066|NCT00092677|472291615|FG001|Overall Study|Adminstrative|9|||
131183067|NCT01601704|472291616|FG000|Overall Study|Randomized but not dispensed study med|1|||
131183068|NCT01601704|472291617|FG001|Overall Study|Randomized but not dispensed study med|4|||
131183069|NCT00877006|472291623|FG000|Treatment Period|Death|2|||
131183070|NCT00877006|472291624|FG001|Treatment Period|Death|1|||
131183071|NCT00877006|472291623|FG000|Treatment Period|Adverse Event|10|||
131183072|NCT00877006|472291624|FG001|Treatment Period|Adverse Event|3|||
131183073|NCT00877006|472291623|FG000|Treatment Period|Withdrawal by Subject|2|||
131183074|NCT00877006|472291624|FG001|Treatment Period|Withdrawal by Subject|3|||
131183075|NCT00877006|472291623|FG000|Treatment Period|Protocol Violation|1|||
131183076|NCT00877006|472291624|FG001|Treatment Period|Protocol Violation|0|||
131183077|NCT00877006|472291623|FG000|Treatment Period|Lost to Follow-up|0|||
131183078|NCT00877006|472291624|FG001|Treatment Period|Lost to Follow-up|1|||
131183079|NCT00877006|472291623|FG000|Treatment Period|Disease Progression|1|||
131183080|NCT00877006|472291624|FG001|Treatment Period|Disease Progression|2|||
131183081|NCT00877006|472291623|FG000|Treatment Period|Started New Treatment Regimen|2|||
131183082|NCT00877006|472291624|FG001|Treatment Period|Started New Treatment Regimen|5|||
131183083|NCT00877006|472291623|FG000|Treatment Period|Other|4|||
131183084|NCT00877006|472291624|FG001|Treatment Period|Other|4|||
131183085|NCT00877006|472291623|FG000|Treatment Period|Randomized but Not Treated|3|||
131183086|NCT00877006|472291624|FG001|Treatment Period|Randomized but Not Treated|8|||
131183087|NCT00877006|472291623|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
131183088|NCT00877006|472291624|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
131183089|NCT00877006|472291623|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
131183090|NCT00877006|472291624|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
131183091|NCT00877006|472291623|FG000|Long-Term Follow-up Period|Death|26|||
131183092|NCT00877006|472291624|FG001|Long-Term Follow-up Period|Death|18|||
131183093|NCT00877006|472291623|FG000|Long-Term Follow-up Period|Other|7|||
131183094|NCT00877006|472291624|FG001|Long-Term Follow-up Period|Other|9|||
131183095|NCT04671342|472291625|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
131183096|NCT04671342|472291625|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
131183097|NCT04671342|472291625|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
131183098|NCT04671342|472291625|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
131183099|NCT04671342|472291625|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
131183100|NCT04671342|472291625|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
131183101|NCT01188096|472291626|FG000|Overall Study|progression of disease|4|||
131183102|NCT01188096|472291626|FG000|Overall Study|Withdrawal by Subject|2|||
131183103|NCT02062398|472291627|FG000|Overall Study|Implant removal|1|||
131183104|NCT01779648|472291628|FG000|Overall Study|Protocol Violation|1|||
131183105|NCT01779648|472291629|FG001|Overall Study|Protocol Violation|0|||
131183106|NCT00415519|472291630|FG000|Overall Study|Adverse Event|1|||
131183107|NCT00415519|472291631|FG001|Overall Study|Adverse Event|0|||
131183108|NCT00415519|472291630|FG000|Overall Study|Withdrawal by Subject|2|||
131183109|NCT00415519|472291631|FG001|Overall Study|Withdrawal by Subject|0|||
131183110|NCT00415519|472291630|FG000|Overall Study|Patient's convenience|1|||
131183111|NCT00415519|472291631|FG001|Overall Study|Patient's convenience|0|||
131183112|NCT03485222|472291632|FG000|Overall Study|Death|0|||
131183113|NCT03485222|472291633|FG001|Overall Study|Death|1|||
131183114|NCT03485222|472291632|FG000|Overall Study|Lost to Follow-up|2|||
131183115|NCT03485222|472291633|FG001|Overall Study|Lost to Follow-up|1|||
131183116|NCT03657810|472291636|FG000|Overall Study|Adverse Event|0|||
131183117|NCT03657810|472291637|FG001|Overall Study|Adverse Event|1|||
131183118|NCT03657810|472291638|FG002|Overall Study|Adverse Event|0|||
131183119|NCT03657810|472291636|FG000|Overall Study|Lack of Efficacy|4|||
131183120|NCT03657810|472291637|FG001|Overall Study|Lack of Efficacy|1|||
131183121|NCT03657810|472291638|FG002|Overall Study|Lack of Efficacy|3|||
131183122|NCT03657810|472291636|FG000|Overall Study|Protocol Violation|1|||
131183123|NCT03657810|472291637|FG001|Overall Study|Protocol Violation|0|||
131183124|NCT03657810|472291638|FG002|Overall Study|Protocol Violation|0|||
131183125|NCT03657810|472291636|FG000|Overall Study|Lost to Follow-up|0|||
131239104|NCT04951622|472500345|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
131239105|NCT04951622|472500341|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
131239106|NCT04951622|472500342|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
131239107|NCT04951622|472500343|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
131239108|NCT04951622|472500344|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
131239109|NCT04951622|472500345|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
131239110|NCT04951622|472500341|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
131239111|NCT04951622|472500342|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
131239112|NCT04951622|472500343|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
131239113|NCT04951622|472500344|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
131239114|NCT04951622|472500345|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
131239115|NCT04951622|472500341|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
131239116|NCT04951622|472500342|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
131239117|NCT04951622|472500343|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
131239118|NCT04951622|472500344|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
131239119|NCT04951622|472500345|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
131239120|NCT04951622|472500341|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
131239121|NCT04951622|472500342|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
131239122|NCT04951622|472500343|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
131239123|NCT04951622|472500344|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
131239124|NCT04951622|472500345|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
131239125|NCT04951622|472500341|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
131239126|NCT04951622|472500342|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
131239127|NCT04951622|472500343|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
131239128|NCT04951622|472500344|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
131239129|NCT04951622|472500345|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
131239130|NCT04951622|472500341|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
131239131|NCT04951622|472500342|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
131239132|NCT04951622|472500343|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
131239133|NCT04951622|472500344|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
131239134|NCT04951622|472500345|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
131239135|NCT04951622|472500341|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
131239136|NCT04951622|472500342|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
131239137|NCT04951622|472500343|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
131239138|NCT04951622|472500344|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
131239139|NCT04951622|472500345|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
131239140|NCT04951622|472500341|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
131239141|NCT04951622|472500342|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
131239142|NCT04951622|472500343|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
131183126|NCT03657810|472291637|FG001|Overall Study|Lost to Follow-up|1|||
131183127|NCT03657810|472291638|FG002|Overall Study|Lost to Follow-up|0|||
131183128|NCT03657810|472291636|FG000|Overall Study|Not provided|0|||
131183129|NCT03657810|472291637|FG001|Overall Study|Not provided|1|||
131183130|NCT03657810|472291638|FG002|Overall Study|Not provided|0|||
131183131|NCT00688545|472291639|FG000|Overall Study|Lost to Follow-up|1|||
131183132|NCT00688545|472291640|FG001|Overall Study|Lost to Follow-up|4|||
131183133|NCT00688545|472291639|FG000|Overall Study|Insurance/cost of drug|0|||
131183134|NCT00688545|472291640|FG001|Overall Study|Insurance/cost of drug|1|||
131183135|NCT00688545|472291639|FG000|Overall Study|Withdrawal by Subject|2|||
131183136|NCT00688545|472291640|FG001|Overall Study|Withdrawal by Subject|3|||
131183137|NCT00688545|472291639|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
131183138|NCT00688545|472291640|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
131183139|NCT03911869|472291641|FG000|Safety Lead-in Phase|Death|7|||
131183140|NCT03911869|472291642|FG001|Safety Lead-in Phase|Death|0|||
131183141|NCT03911869|472291643|FG002|Safety Lead-in Phase|Death|0|||
131183142|NCT03911869|472291641|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
131183143|NCT03911869|472291642|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
131183144|NCT03911869|472291643|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
131183145|NCT03911869|472291641|FG000|Safety Lead-in Phase|Other|1|||
131183146|NCT03911869|472291642|FG001|Safety Lead-in Phase|Other|0|||
131183147|NCT03911869|472291643|FG002|Safety Lead-in Phase|Other|0|||
131183148|NCT03911869|472291641|FG000|Phase 2|Death|0|||
131183149|NCT03911869|472291642|FG001|Phase 2|Death|3|||
131183150|NCT03911869|472291643|FG002|Phase 2|Death|0|||
131183151|NCT01878097|472291644|FG000|Baseline|Surveys not fully completed|2497|||
131183152|NCT01878097|472291645|FG001|Baseline|Surveys not fully completed|1800|||
131183153|NCT01878097|472291644|FG000|Implementation Year 1|Surveys not fully completed|3202|||
131183154|NCT01878097|472291645|FG001|Implementation Year 1|Surveys not fully completed|2549|||
131183155|NCT01878097|472291644|FG000|Implementation Year 2|Surveys not fully completed|3281|||
131183156|NCT01878097|472291645|FG001|Implementation Year 2|Surveys not fully completed|2841|||
131183157|NCT01878097|472291644|FG000|Implementation Year 3|Surveys not fully completed|3494|||
131183158|NCT01878097|472291645|FG001|Implementation Year 3|Surveys not fully completed|2980|||
131183159|NCT01878097|472291644|FG000|Implementation Year 4|Surveys not fully completed|3604|||
131183160|NCT01878097|472291645|FG001|Implementation Year 4|Surveys not fully completed|3007|||
131183161|NCT00367341|472291647|FG000|Overall Study|Physician Decision|1|||
131183162|NCT00367341|472291648|FG001|Overall Study|Physician Decision|0|||
131183163|NCT00367341|472291647|FG000|Overall Study|Protocol Violation|1|||
131183164|NCT00367341|472291648|FG001|Overall Study|Protocol Violation|0|||
131183165|NCT02119026|472291651|FG000|1st-line Treatment|Adverse Event|9|||
131183166|NCT02119026|472291652|FG001|1st-line Treatment|Adverse Event|14|||
131183167|NCT02119026|472291651|FG000|1st-line Treatment|Physician Decision|3|||
131183168|NCT02119026|472291652|FG001|1st-line Treatment|Physician Decision|8|||
131183169|NCT02119026|472291651|FG000|1st-line Treatment|Withdrawal by Subject|4|||
131183170|NCT02119026|472291652|FG001|1st-line Treatment|Withdrawal by Subject|10|||
131183171|NCT02119026|472291651|FG000|1st-line Treatment|Patient condition or compliance|6|||
131183172|NCT02119026|472291652|FG001|1st-line Treatment|Patient condition or compliance|4|||
131239143|NCT04951622|472500344|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
131183173|NCT02119026|472291651|FG000|1st-line Treatment|Surgery of metastases|2|||
131183174|NCT02119026|472291652|FG001|1st-line Treatment|Surgery of metastases|1|||
131183175|NCT02119026|472291651|FG000|1st-line Treatment|Death|2|||
131183176|NCT02119026|472291652|FG001|1st-line Treatment|Death|1|||
131183177|NCT02119026|472291651|FG000|2nd-line Treatment|Lost to Follow-up|2|||
131183178|NCT02119026|472291652|FG001|2nd-line Treatment|Lost to Follow-up|0|||
131183179|NCT02119026|472291651|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
131183180|NCT02119026|472291652|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
131183181|NCT02119026|472291651|FG000|2nd-line Treatment|Adverse Event|4|||
131183182|NCT02119026|472291652|FG001|2nd-line Treatment|Adverse Event|1|||
131183183|NCT01373918|472291653|FG000|Overall Study|Physician Decision|0|||
131183184|NCT01373918|472291654|FG001|Overall Study|Physician Decision|1|||
131183185|NCT03004976|472291655|FG000|Overall Study|Lost to Follow-up|7|||
131183186|NCT03004976|472291656|FG001|Overall Study|Lost to Follow-up|5|||
131183187|NCT03004976|472291655|FG000|Overall Study|Physician Decision|1|||
131239144|NCT04951622|472500345|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
131239145|NCT02364557|472500348|FG000|Overall Study|Protocol Violation|3|||
131239146|NCT02364557|472500349|FG001|Overall Study|Protocol Violation|1|||
131239147|NCT06061081|472500350|FG000|Overall Study|Withdrawal by Subject|1|||
131239148|NCT06061081|472500351|FG001|Overall Study|Withdrawal by Subject|0|||
131239149|NCT06061081|472500352|FG002|Overall Study|Withdrawal by Subject|0|||
131239150|NCT06061081|472500353|FG003|Overall Study|Withdrawal by Subject|0|||
131239151|NCT06061081|472500354|FG004|Overall Study|Withdrawal by Subject|0|||
131239152|NCT04878432|472500355|FG000|Overall Study|Adverse Event|1|||
131183188|NCT03004976|472291656|FG001|Overall Study|Physician Decision|0|||
131183189|NCT03004976|472291655|FG000|Overall Study|Withdrawal by Subject|1|||
131183190|NCT03004976|472291656|FG001|Overall Study|Withdrawal by Subject|0|||
131183191|NCT03004976|472291655|FG000|Overall Study|Death|4|||
131183192|NCT03004976|472291656|FG001|Overall Study|Death|1|||
131183193|NCT02786836|472291659|FG000|Overall Study|Death|1|||
131183194|NCT02786836|472291659|FG000|Overall Study|Lack of Efficacy|2|||
131183195|NCT02786836|472291659|FG000|Overall Study|Protocol Violation|3|||
131183196|NCT02786836|472291659|FG000|Overall Study|Withdrawal by Subject|3|||
131239153|NCT04878432|472500355|FG000|Overall Study|Death|2|||
131239154|NCT04878432|472500355|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130733516|NCT05026177|470642911|FG000|Overall Study|Adverse Event|33|||
130733517|NCT05026177|470642912|FG001|Overall Study|Adverse Event|33|||
130733518|NCT05026177|470642913|FG002|Overall Study|Adverse Event|17|||
131183197|NCT02786836|472291659|FG000|Overall Study|Liver Transplantation|2|||
131183198|NCT02786836|472291659|FG000|Overall Study|Device or Pharmacy Issues|3|||
131183199|NCT01143714|472291661|FG000|Overall Study|Adverse Event|4|||
131183200|NCT01143714|472291662|FG001|Overall Study|Adverse Event|2|||
131183201|NCT01143714|472291661|FG000|Overall Study|Withdrawal by Subject|1|||
131183202|NCT01143714|472291662|FG001|Overall Study|Withdrawal by Subject|0|||
131183203|NCT01143714|472291661|FG000|Overall Study|Subject non-compliance|0|||
131183204|NCT01143714|472291662|FG001|Overall Study|Subject non-compliance|1|||
131183205|NCT01143714|472291661|FG000|Overall Study|wound closed = deemed healed|1|||
131183206|NCT01143714|472291662|FG001|Overall Study|wound closed = deemed healed|0|||
131183207|NCT01143714|472291661|FG000|Overall Study|wound size increased|1|||
131183208|NCT01143714|472291662|FG001|Overall Study|wound size increased|0|||
131183209|NCT01387074|472291665|FG000|Overall Study|Lost to Follow-up|7|||
131183210|NCT01387074|472291665|FG000|Overall Study|Lack of Efficacy|1|||
131183211|NCT00150345|472291666|FG000|Overall Study|Death|5|||
131183212|NCT00150345|472291667|FG001|Overall Study|Death|2|||
131183213|NCT00150345|472291666|FG000|Overall Study|Adverse Event|8|||
130733519|NCT05026177|470642911|FG000|Overall Study|Lost to Follow-up|7|||
131183214|NCT00150345|472291667|FG001|Overall Study|Adverse Event|6|||
131183215|NCT00150345|472291666|FG000|Overall Study|Lack of Efficacy|5|||
131183216|NCT00150345|472291667|FG001|Overall Study|Lack of Efficacy|4|||
131183217|NCT00150345|472291666|FG000|Overall Study|Withdrawal by Subject|3|||
131183218|NCT00150345|472291667|FG001|Overall Study|Withdrawal by Subject|4|||
131183219|NCT00150345|472291666|FG000|Overall Study|Laboratory abnormality|1|||
131183220|NCT00150345|472291667|FG001|Overall Study|Laboratory abnormality|2|||
131183221|NCT00150345|472291666|FG000|Overall Study|Other|12|||
131183222|NCT00150345|472291667|FG001|Overall Study|Other|14|||
131183223|NCT03892707|472291674|FG000|Overall Study|Screen failure|6|||
131183224|NCT03892707|472291675|FG001|Overall Study|Screen failure|0|||
131183225|NCT03892707|472291674|FG000|Overall Study|Pain resolution|0|||
131183226|NCT03892707|472291675|FG001|Overall Study|Pain resolution|4|||
131183227|NCT03892707|472291674|FG000|Overall Study|Withdrawal by Subject|0|||
131183228|NCT03892707|472291675|FG001|Overall Study|Withdrawal by Subject|1|||
131183229|NCT03892707|472291674|FG000|Overall Study|Other (long business trip)|0|||
131183230|NCT03892707|472291675|FG001|Overall Study|Other (long business trip)|1|||
131183231|NCT01807949|472291676|FG000|Overall Study|Adverse Event|1|||
131183232|NCT01807949|472291677|FG001|Overall Study|Adverse Event|2|||
131183233|NCT01807949|472291678|FG002|Overall Study|Adverse Event|2|||
131183234|NCT01807949|472291676|FG000|Overall Study|Withdrawal by Subject|1|||
131183235|NCT01807949|472291677|FG001|Overall Study|Withdrawal by Subject|2|||
131183236|NCT01807949|472291678|FG002|Overall Study|Withdrawal by Subject|2|||
131183237|NCT01807949|472291676|FG000|Overall Study|Non-Compliance|0|||
131183238|NCT01807949|472291677|FG001|Overall Study|Non-Compliance|0|||
131183239|NCT01807949|472291678|FG002|Overall Study|Non-Compliance|1|||
131183240|NCT01807949|472291676|FG000|Overall Study|Undefined|0|||
131183241|NCT01807949|472291677|FG001|Overall Study|Undefined|1|||
131183242|NCT01807949|472291678|FG002|Overall Study|Undefined|2|||
131183243|NCT01807949|472291676|FG000|Overall Study|Randomized But Not Treated|0|||
131183244|NCT01807949|472291677|FG001|Overall Study|Randomized But Not Treated|2|||
131183245|NCT01807949|472291678|FG002|Overall Study|Randomized But Not Treated|2|||
131183246|NCT02137837|472291681|FG000|Overall Study|Adverse Event|0|||
131183247|NCT02137837|472291682|FG001|Overall Study|Adverse Event|2|||
131183248|NCT02137837|472291683|FG002|Overall Study|Adverse Event|1|||
131183249|NCT02137837|472291681|FG000|Overall Study|Refusal unrelated to adverse event|2|||
131183250|NCT02137837|472291682|FG001|Overall Study|Refusal unrelated to adverse event|2|||
131183251|NCT02137837|472291683|FG002|Overall Study|Refusal unrelated to adverse event|1|||
131183252|NCT02137837|472291681|FG000|Overall Study|Progression/relapse|9|||
131183253|NCT02137837|472291682|FG001|Overall Study|Progression/relapse|7|||
131183254|NCT02137837|472291683|FG002|Overall Study|Progression/relapse|7|||
131183255|NCT02137837|472291681|FG000|Overall Study|Not protocol specified|2|||
131183256|NCT02137837|472291682|FG001|Overall Study|Not protocol specified|1|||
131183257|NCT02137837|472291683|FG002|Overall Study|Not protocol specified|3|||
131183258|NCT02141217|472291684|FG000|Overall Study|Adverse Event|1|||
131183259|NCT02141217|472291685|FG001|Overall Study|Adverse Event|2|||
131183260|NCT02141217|472291684|FG000|Overall Study|Protocol Violation|1|||
131183261|NCT02141217|472291685|FG001|Overall Study|Protocol Violation|4|||
131183262|NCT02141217|472291684|FG000|Overall Study|Withdrawal by Subject|6|||
131183263|NCT02141217|472291685|FG001|Overall Study|Withdrawal by Subject|0|||
131183264|NCT02141217|472291684|FG000|Overall Study|Lost to Follow-up|1|||
131183265|NCT02141217|472291685|FG001|Overall Study|Lost to Follow-up|1|||
131183266|NCT02141217|472291684|FG000|Overall Study|Physician Decision|1|||
131183267|NCT02141217|472291685|FG001|Overall Study|Physician Decision|0|||
131183268|NCT02141217|472291684|FG000|Overall Study|Surgical Intervention|1|||
131183269|NCT02141217|472291685|FG001|Overall Study|Surgical Intervention|1|||
131183270|NCT06000501|472291689|FG000|Overall Study|Screen failure|3|||
131183271|NCT06000501|472291689|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
131183272|NCT06000501|472291689|FG000|Overall Study|Physician Decision|4|||
131183273|NCT06000501|472291689|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
131183274|NCT06000501|472291689|FG000|Overall Study|Scheduling issues|2|||
131183275|NCT01588353|472291690|FG000|Step2|Withdrawal by Subject|0|||
131183276|NCT01588353|472291691|FG001|Step2|Withdrawal by Subject|1|||
131183277|NCT01588353|472291692|FG002|Step2|Withdrawal by Subject|0|||
131183278|NCT01588353|472291690|FG000|Step3|Adverse Event|0|||
131183279|NCT01588353|472291691|FG001|Step3|Adverse Event|0|||
131183280|NCT01588353|472291692|FG002|Step3|Adverse Event|2|||
131183281|NCT05067452|472291694|FG000|Overall Study|Lost to Follow-up|0|||
131183282|NCT05067452|472291695|FG001|Overall Study|Lost to Follow-up|4|||
131183283|NCT02156804|472291696|FG000|Overall Study|Withdrawal by Subject|1|||
131183284|NCT03228394|472291697|FG000|Overall Study|Lost to Follow-up|0|||
131183285|NCT03228394|472291698|FG001|Overall Study|Lost to Follow-up|0|||
131183286|NCT03228394|472291699|FG002|Overall Study|Lost to Follow-up|1|||
131183287|NCT03228394|472291700|FG003|Overall Study|Lost to Follow-up|1|||
131183288|NCT03228394|472291701|FG004|Overall Study|Lost to Follow-up|0|||
131183289|NCT03228394|472291702|FG005|Overall Study|Lost to Follow-up|0|||
131183290|NCT03228394|472291703|FG006|Overall Study|Lost to Follow-up|2|||
131183291|NCT03228394|472291704|FG007|Overall Study|Lost to Follow-up|0|||
131183292|NCT03228394|472291697|FG000|Overall Study|Withdrawal by Subject|0|||
131183293|NCT03228394|472291698|FG001|Overall Study|Withdrawal by Subject|0|||
131183294|NCT03228394|472291699|FG002|Overall Study|Withdrawal by Subject|1|||
131183295|NCT03228394|472291700|FG003|Overall Study|Withdrawal by Subject|0|||
131183296|NCT03228394|472291701|FG004|Overall Study|Withdrawal by Subject|0|||
131183297|NCT03228394|472291702|FG005|Overall Study|Withdrawal by Subject|0|||
131183298|NCT03228394|472291703|FG006|Overall Study|Withdrawal by Subject|1|||
131183299|NCT03228394|472291704|FG007|Overall Study|Withdrawal by Subject|3|||
131183300|NCT03228394|472291697|FG000|Overall Study|Protocol Violation|0|||
131183301|NCT03228394|472291698|FG001|Overall Study|Protocol Violation|0|||
131183302|NCT03228394|472291699|FG002|Overall Study|Protocol Violation|0|||
131183303|NCT03228394|472291700|FG003|Overall Study|Protocol Violation|1|||
131183304|NCT03228394|472291701|FG004|Overall Study|Protocol Violation|0|||
131183305|NCT03228394|472291702|FG005|Overall Study|Protocol Violation|0|||
131183306|NCT03228394|472291703|FG006|Overall Study|Protocol Violation|0|||
131183307|NCT03228394|472291704|FG007|Overall Study|Protocol Violation|0|||
131183308|NCT03228394|472291697|FG000|Overall Study|Physician Decision|0|||
131183309|NCT03228394|472291698|FG001|Overall Study|Physician Decision|0|||
131183310|NCT03228394|472291699|FG002|Overall Study|Physician Decision|0|||
131183311|NCT03228394|472291700|FG003|Overall Study|Physician Decision|0|||
131183312|NCT03228394|472291701|FG004|Overall Study|Physician Decision|0|||
131183313|NCT03228394|472291702|FG005|Overall Study|Physician Decision|0|||
131183314|NCT03228394|472291703|FG006|Overall Study|Physician Decision|1|||
131183315|NCT03228394|472291704|FG007|Overall Study|Physician Decision|0|||
131183316|NCT03228394|472291697|FG000|Overall Study|Noncompliance|0|||
131183317|NCT03228394|472291698|FG001|Overall Study|Noncompliance|0|||
131183318|NCT03228394|472291699|FG002|Overall Study|Noncompliance|0|||
131183319|NCT03228394|472291700|FG003|Overall Study|Noncompliance|0|||
131183320|NCT03228394|472291701|FG004|Overall Study|Noncompliance|0|||
131183321|NCT03228394|472291702|FG005|Overall Study|Noncompliance|0|||
131183322|NCT03228394|472291703|FG006|Overall Study|Noncompliance|1|||
131183323|NCT03228394|472291704|FG007|Overall Study|Noncompliance|0|||
131183324|NCT04581863|472291705|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
131183325|NCT04581863|472291706|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
131183326|NCT01803711|472291709|FG000|Overall Study|Adverse Event|1|||
131183327|NCT01803711|472291710|FG001|Overall Study|Adverse Event|1|||
131183328|NCT01170221|472291714|FG000|Overall Study|Lost to Follow-up|22|||
131183329|NCT01170221|472291715|FG001|Overall Study|Lost to Follow-up|21|||
131183330|NCT01170221|472291714|FG000|Overall Study|Withdrawal by Subject|9|||
131183331|NCT01170221|472291715|FG001|Overall Study|Withdrawal by Subject|7|||
131183332|NCT01170221|472291714|FG000|Overall Study|Subject completed only screening and LFU|1|||
131183333|NCT01170221|472291715|FG001|Overall Study|Subject completed only screening and LFU|0|||
131183334|NCT01170221|472291714|FG000|Overall Study|Randomized but not treated|1|||
131183335|NCT01170221|472291715|FG001|Overall Study|Randomized but not treated|0|||
131183336|NCT00432562|472291716|FG000|Overall Study|Death|3|||
131183337|NCT00432562|472291717|FG001|Overall Study|Death|0|||
131183338|NCT02693691|472291718|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
131183339|NCT02693691|472291718|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
131183340|NCT02693691|472291718|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
131183341|NCT02693691|472291718|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
131183342|NCT02693691|472291718|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
131183343|NCT02693691|472291718|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
131183344|NCT02693691|472291718|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
131183345|NCT01315847|472291721|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
131183346|NCT01315847|472291722|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
131183347|NCT01315847|472291721|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
131183348|NCT01315847|472291722|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
131183349|NCT05425719|472291725|FG000|Overall Study|Lost to Follow-up|4|||
131183350|NCT05425719|472291726|FG001|Overall Study|Lost to Follow-up|0|||
131183351|NCT05425719|472291725|FG000|Overall Study|Withdrew consent|1|||
131183352|NCT05425719|472291726|FG001|Overall Study|Withdrew consent|1|||
131183353|NCT04682353|472291729|FG000|Overall Study|Lost to Follow-up|0|||
131183354|NCT04682353|472291730|FG001|Overall Study|Lost to Follow-up|1|||
131183355|NCT04682353|472291731|FG002|Overall Study|Lost to Follow-up|0|||
131183356|NCT04682353|472291732|FG003|Overall Study|Lost to Follow-up|1|||
131183357|NCT04682353|472291729|FG000|Overall Study|Personal reasons|0|||
131183358|NCT04682353|472291730|FG001|Overall Study|Personal reasons|1|||
131183359|NCT04682353|472291731|FG002|Overall Study|Personal reasons|0|||
131183360|NCT04682353|472291732|FG003|Overall Study|Personal reasons|0|||
131183361|NCT01586806|472291733|FG000|Overall Study|Protocol Violation|0|||
131183362|NCT01586806|472291734|FG001|Overall Study|Protocol Violation|1|||
131183363|NCT01586806|472291735|FG002|Overall Study|Protocol Violation|0|||
131183364|NCT01586806|472291733|FG000|Overall Study|Withdrawal by Subject|1|||
131183365|NCT01586806|472291734|FG001|Overall Study|Withdrawal by Subject|0|||
131183366|NCT01586806|472291735|FG002|Overall Study|Withdrawal by Subject|0|||
131183367|NCT01586806|472291733|FG000|Overall Study|Lost to Follow-up|2|||
131183368|NCT01586806|472291734|FG001|Overall Study|Lost to Follow-up|3|||
131183369|NCT01586806|472291735|FG002|Overall Study|Lost to Follow-up|2|||
131183370|NCT00862654|472291736|FG000|Overall Study|Lack of Efficacy|1|||
131183371|NCT00862654|472291737|FG001|Overall Study|Lack of Efficacy|0|||
131183372|NCT00862654|472291738|FG002|Overall Study|Lack of Efficacy|1|||
131183373|NCT00862654|472291739|FG003|Overall Study|Lack of Efficacy|0|||
131183374|NCT00862654|472291736|FG000|Overall Study|Lost to Follow-up|1|||
131183375|NCT00862654|472291737|FG001|Overall Study|Lost to Follow-up|2|||
131239155|NCT04878432|472500355|FG000|Overall Study|Withdrawal by Subject|6|||
131239156|NCT04878432|472500355|FG000|Overall Study|Progressive Disease|7|||
131239157|NCT04878432|472500355|FG000|Overall Study|New Therapy for Study Indication|7|||
131239158|NCT04878432|472500355|FG000|Overall Study|Physician Decision|11|||
131183376|NCT00862654|472291738|FG002|Overall Study|Lost to Follow-up|1|||
131183377|NCT00862654|472291739|FG003|Overall Study|Lost to Follow-up|3|||
131183378|NCT00862654|472291736|FG000|Overall Study|Adverse Event|0|||
131183379|NCT00862654|472291737|FG001|Overall Study|Adverse Event|1|||
131183380|NCT00862654|472291738|FG002|Overall Study|Adverse Event|1|||
131183381|NCT00862654|472291739|FG003|Overall Study|Adverse Event|0|||
131183382|NCT00862654|472291736|FG000|Overall Study|Pregnancy|1|||
131183383|NCT00862654|472291737|FG001|Overall Study|Pregnancy|1|||
131183384|NCT00862654|472291738|FG002|Overall Study|Pregnancy|0|||
131183385|NCT00862654|472291739|FG003|Overall Study|Pregnancy|0|||
131183386|NCT00862654|472291736|FG000|Overall Study|Withdrawal by Subject|2|||
131183387|NCT00862654|472291737|FG001|Overall Study|Withdrawal by Subject|2|||
131183388|NCT00862654|472291738|FG002|Overall Study|Withdrawal by Subject|2|||
131183389|NCT00862654|472291739|FG003|Overall Study|Withdrawal by Subject|3|||
131183390|NCT00862654|472291736|FG000|Overall Study|Subject mistake|0|||
131183391|NCT00862654|472291737|FG001|Overall Study|Subject mistake|1|||
131183392|NCT00862654|472291738|FG002|Overall Study|Subject mistake|0|||
131183393|NCT00862654|472291739|FG003|Overall Study|Subject mistake|0|||
131183394|NCT00862654|472291736|FG000|Overall Study|Familly constraint|0|||
131183395|NCT00862654|472291737|FG001|Overall Study|Familly constraint|1|||
131183396|NCT00862654|472291738|FG002|Overall Study|Familly constraint|0|||
131183397|NCT00862654|472291739|FG003|Overall Study|Familly constraint|0|||
131183398|NCT00862654|472291736|FG000|Overall Study|Never used study drugs|1|||
131183399|NCT00862654|472291737|FG001|Overall Study|Never used study drugs|0|||
131183400|NCT00862654|472291738|FG002|Overall Study|Never used study drugs|0|||
131183401|NCT00862654|472291739|FG003|Overall Study|Never used study drugs|0|||
131183402|NCT00862654|472291736|FG000|Overall Study|Included after end of inclusions|0|||
131183403|NCT00862654|472291737|FG001|Overall Study|Included after end of inclusions|0|||
131183404|NCT00862654|472291738|FG002|Overall Study|Included after end of inclusions|1|||
131183405|NCT00862654|472291739|FG003|Overall Study|Included after end of inclusions|0|||
131183406|NCT04377672|472291740|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
131183407|NCT03954444|472291741|FG000|Overall Study|Withdrawal by Subject|5|||
131183408|NCT03954444|472291742|FG001|Overall Study|Withdrawal by Subject|5|||
131183409|NCT03954444|472291743|FG002|Overall Study|Withdrawal by Subject|5|||
131183410|NCT03954444|472291741|FG000|Overall Study|Adverse Event|1|||
131183411|NCT03954444|472291742|FG001|Overall Study|Adverse Event|3|||
131183412|NCT03954444|472291743|FG002|Overall Study|Adverse Event|2|||
131183413|NCT03954444|472291741|FG000|Overall Study|Protocol Violation|0|||
131239159|NCT04541589|472500358|FG000|Treatment Period|Adverse Event|8|||
131239160|NCT04541589|472500359|FG001|Treatment Period|Adverse Event|2|||
131239161|NCT04541589|472500358|FG000|Treatment Period|Physician Decision|3|||
131239162|NCT04541589|472500359|FG001|Treatment Period|Physician Decision|1|||
131239163|NCT04541589|472500358|FG000|Treatment Period|Subject decision|7|||
131239164|NCT04541589|472500359|FG001|Treatment Period|Subject decision|4|||
131239165|NCT04541589|472500358|FG000|Treatment Period|Withdrawal by Subject|1|||
131239166|NCT04541589|472500359|FG001|Treatment Period|Withdrawal by Subject|0|||
131239167|NCT04541589|472500358|FG000|Safety Follow-up Period|Adverse Event|2|||
131239168|NCT04541589|472500359|FG001|Safety Follow-up Period|Adverse Event|1|||
131183414|NCT03954444|472291742|FG001|Overall Study|Protocol Violation|3|||
131183415|NCT03954444|472291743|FG002|Overall Study|Protocol Violation|5|||
131183416|NCT03954444|472291741|FG000|Overall Study|Use of prohibited therapy|1|||
131183417|NCT03954444|472291742|FG001|Overall Study|Use of prohibited therapy|1|||
130733520|NCT05026177|470642912|FG001|Overall Study|Lost to Follow-up|6|||
131183418|NCT03954444|472291743|FG002|Overall Study|Use of prohibited therapy|2|||
131183419|NCT03954444|472291741|FG000|Overall Study|Lost to Follow-up|1|||
131183420|NCT03954444|472291742|FG001|Overall Study|Lost to Follow-up|0|||
131183421|NCT03954444|472291743|FG002|Overall Study|Lost to Follow-up|1|||
131183422|NCT03954444|472291741|FG000|Overall Study|Non-compliant with study drug application|2|||
131183423|NCT03954444|472291742|FG001|Overall Study|Non-compliant with study drug application|2|||
131183424|NCT03954444|472291743|FG002|Overall Study|Non-compliant with study drug application|0|||
131183425|NCT03954444|472291741|FG000|Overall Study|Administrative reasons|0|||
130733521|NCT05026177|470642913|FG002|Overall Study|Lost to Follow-up|8|||
131183426|NCT03954444|472291742|FG001|Overall Study|Administrative reasons|0|||
131183427|NCT03954444|472291743|FG002|Overall Study|Administrative reasons|1|||
131239169|NCT04541589|472500358|FG000|Safety Follow-up Period|Physician Decision|1|||
131183428|NCT03954444|472291741|FG000|Overall Study|Miscellaneous|3|||
131183429|NCT03954444|472291742|FG001|Overall Study|Miscellaneous|2|||
131183430|NCT03954444|472291743|FG002|Overall Study|Miscellaneous|1|||
131183431|NCT02447458|472291744|FG000|Overall Study|Other|0|||
131183432|NCT02447458|472291745|FG001|Overall Study|Other|0|||
131183433|NCT02447458|472291746|FG002|Overall Study|Other|1|||
131183434|NCT02447458|472291747|FG003|Overall Study|Other|0|||
131183435|NCT02447458|472291748|FG004|Overall Study|Other|0|||
131183436|NCT02447458|472291749|FG005|Overall Study|Other|0|||
131183437|NCT02133742|472291750|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
131183438|NCT02133742|472291750|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
131183439|NCT02133742|472291750|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
131183440|NCT02133742|472291750|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
131183441|NCT02133742|472291750|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
131183442|NCT01688635|472291752|FG000|Washout 1|Withdrawal by Subject|1|||
131183443|NCT01688635|472291753|FG001|Washout 1|Withdrawal by Subject|0|||
131183444|NCT01688635|472291752|FG000|Washout 1|Adverse Event|0|||
131183445|NCT01688635|472291753|FG001|Washout 1|Adverse Event|1|||
131183446|NCT01688635|472291752|FG000|Washout 1|Physician Decision|0|||
131183447|NCT01688635|472291753|FG001|Washout 1|Physician Decision|1|||
131183448|NCT01688635|472291752|FG000|Washout 2|Physician Decision|1|||
131183449|NCT01688635|472291753|FG001|Washout 2|Physician Decision|0|||
131183450|NCT01688635|472291752|FG000|Washout 2|Withdrawal by Subject|1|||
131183451|NCT01688635|472291753|FG001|Washout 2|Withdrawal by Subject|0|||
131183452|NCT01688635|472291752|FG000|Washout 2|Sponsor Decision|1|||
131183453|NCT01688635|472291753|FG001|Washout 2|Sponsor Decision|2|||
131183454|NCT01688635|472291752|FG000|Washout 3|Withdrawal by Subject|1|||
131183455|NCT01688635|472291753|FG001|Washout 3|Withdrawal by Subject|0|||
131183456|NCT02947022|472291755|FG000|Overall Study|Study Stopped|1|||
131183457|NCT01230749|472291756|FG000|Overall Study|Adverse Event|0|||
131183458|NCT01230749|472291757|FG001|Overall Study|Adverse Event|0|||
131183459|NCT01230749|472291758|FG002|Overall Study|Adverse Event|0|||
131183460|NCT01230749|472291759|FG003|Overall Study|Adverse Event|1|||
131183461|NCT01230749|472291756|FG000|Overall Study|Physician Decision|0|||
131183462|NCT01230749|472291757|FG001|Overall Study|Physician Decision|0|||
131183463|NCT01230749|472291758|FG002|Overall Study|Physician Decision|1|||
131183464|NCT01230749|472291759|FG003|Overall Study|Physician Decision|0|||
131183465|NCT01230749|472291756|FG000|Overall Study|Withdrawal by Subject|0|||
131183466|NCT01230749|472291757|FG001|Overall Study|Withdrawal by Subject|1|||
131183467|NCT01230749|472291758|FG002|Overall Study|Withdrawal by Subject|0|||
131183468|NCT01230749|472291759|FG003|Overall Study|Withdrawal by Subject|0|||
131183469|NCT01230749|472291756|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
131183470|NCT01230749|472291757|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
131183471|NCT01230749|472291758|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
131183472|NCT01230749|472291759|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
131183473|NCT05742841|472293759|FG000|Overall Study|Withdrawal by Subject|1|||
131183474|NCT05742841|472293759|FG000|Overall Study|Lost to Follow-up|1|||
131183475|NCT04134728|472293760|FG000|Overall Study|Adverse Event|3|||
131183476|NCT04134728|472293761|FG001|Overall Study|Adverse Event|2|||
131183477|NCT04134728|472293762|FG002|Overall Study|Adverse Event|9|||
131183478|NCT04134728|472293763|FG003|Overall Study|Adverse Event|0|||
131183479|NCT04134728|472293764|FG004|Overall Study|Adverse Event|0|||
131183480|NCT04134728|472293765|FG005|Overall Study|Adverse Event|0|||
131183481|NCT04134728|472293760|FG000|Overall Study|Lack of Efficacy|3|||
131183482|NCT04134728|472293761|FG001|Overall Study|Lack of Efficacy|3|||
131183483|NCT04134728|472293762|FG002|Overall Study|Lack of Efficacy|1|||
131183484|NCT04134728|472293763|FG003|Overall Study|Lack of Efficacy|2|||
131183485|NCT04134728|472293764|FG004|Overall Study|Lack of Efficacy|0|||
131183486|NCT04134728|472293765|FG005|Overall Study|Lack of Efficacy|0|||
131183487|NCT04134728|472293760|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
131183488|NCT04134728|472293761|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131183489|NCT04134728|472293762|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
131183490|NCT04134728|472293763|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131183491|NCT04134728|472293764|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131183492|NCT04134728|472293765|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
131183493|NCT04134728|472293760|FG000|Overall Study|Protocol Deviation|0|||
131183494|NCT04134728|472293761|FG001|Overall Study|Protocol Deviation|0|||
131183495|NCT04134728|472293762|FG002|Overall Study|Protocol Deviation|1|||
131183496|NCT04134728|472293763|FG003|Overall Study|Protocol Deviation|0|||
131183497|NCT04134728|472293764|FG004|Overall Study|Protocol Deviation|0|||
131183498|NCT04134728|472293765|FG005|Overall Study|Protocol Deviation|0|||
131183499|NCT04134728|472293760|FG000|Overall Study|Informed Consent Withdrawn|3|||
131183500|NCT04134728|472293761|FG001|Overall Study|Informed Consent Withdrawn|6|||
131183501|NCT04134728|472293762|FG002|Overall Study|Informed Consent Withdrawn|8|||
131183502|NCT04134728|472293763|FG003|Overall Study|Informed Consent Withdrawn|1|||
131183503|NCT04134728|472293764|FG004|Overall Study|Informed Consent Withdrawn|1|||
131183504|NCT04134728|472293765|FG005|Overall Study|Informed Consent Withdrawn|0|||
131183505|NCT04134728|472293760|FG000|Overall Study|Physician Decision|2|||
131183506|NCT04134728|472293761|FG001|Overall Study|Physician Decision|0|||
131183507|NCT04134728|472293762|FG002|Overall Study|Physician Decision|0|||
131183508|NCT04134728|472293763|FG003|Overall Study|Physician Decision|0|||
131183509|NCT04134728|472293764|FG004|Overall Study|Physician Decision|0|||
131183510|NCT04134728|472293765|FG005|Overall Study|Physician Decision|0|||
131183511|NCT04134728|472293760|FG000|Overall Study|Lost to Follow-up|1|||
131183512|NCT04134728|472293761|FG001|Overall Study|Lost to Follow-up|2|||
131183513|NCT04134728|472293762|FG002|Overall Study|Lost to Follow-up|1|||
131183514|NCT04134728|472293763|FG003|Overall Study|Lost to Follow-up|0|||
131183515|NCT04134728|472293764|FG004|Overall Study|Lost to Follow-up|0|||
131183516|NCT04134728|472293765|FG005|Overall Study|Lost to Follow-up|1|||
131183517|NCT04134728|472293760|FG000|Overall Study|Investigator Site Closed|0|||
131183518|NCT04134728|472293761|FG001|Overall Study|Investigator Site Closed|1|||
131183519|NCT04134728|472293762|FG002|Overall Study|Investigator Site Closed|1|||
131183520|NCT04134728|472293763|FG003|Overall Study|Investigator Site Closed|0|||
131183521|NCT04134728|472293764|FG004|Overall Study|Investigator Site Closed|0|||
131183522|NCT04134728|472293765|FG005|Overall Study|Investigator Site Closed|0|||
131183523|NCT01711541|472293770|FG000|Overall Study|Cancel prior to treatment|0|||
131183524|NCT01711541|472293771|FG001|Overall Study|Cancel prior to treatment|0|||
131183525|NCT01711541|472293772|FG002|Overall Study|Cancel prior to treatment|0|||
131183526|NCT01711541|472293773|FG003|Overall Study|Cancel prior to treatment|1|||
131183527|NCT01711541|472293774|FG004|Overall Study|Cancel prior to treatment|0|||
131183528|NCT01711541|472293770|FG000|Overall Study|Ineligible|0|||
131183529|NCT01711541|472293771|FG001|Overall Study|Ineligible|1|||
131183530|NCT01711541|472293772|FG002|Overall Study|Ineligible|0|||
131183531|NCT01711541|472293773|FG003|Overall Study|Ineligible|0|||
131183532|NCT01711541|472293774|FG004|Overall Study|Ineligible|0|||
131183533|NCT00728936|472293775|FG000|Overall Study|Withdrawal by Subject|0|||
131183534|NCT00728936|472293776|FG001|Overall Study|Withdrawal by Subject|0|||
131183535|NCT00728936|472293777|FG002|Overall Study|Withdrawal by Subject|0|||
131183536|NCT00728936|472293778|FG003|Overall Study|Withdrawal by Subject|0|||
131183537|NCT00728936|472293779|FG004|Overall Study|Withdrawal by Subject|0|||
131183538|NCT00728936|472293780|FG005|Overall Study|Withdrawal by Subject|1|||
131183539|NCT00728936|472293781|FG006|Overall Study|Withdrawal by Subject|0|||
131183540|NCT05355818|472293787|FG000|Overall Study|Adverse Event|1|||
131183541|NCT05355818|472293788|FG001|Overall Study|Adverse Event|1|||
131183542|NCT05355818|472293787|FG000|Overall Study|Lack of Efficacy|2|||
131183543|NCT05355818|472293788|FG001|Overall Study|Lack of Efficacy|1|||
131183544|NCT05355818|472293787|FG000|Overall Study|Lost to Follow-up|0|||
131183545|NCT05355818|472293788|FG001|Overall Study|Lost to Follow-up|1|||
131183546|NCT03325556|472293797|FG000|Open-label Period|Lack of Response in OL period|70|||
131183547|NCT03325556|472293798|FG001|Open-label Period|Lack of Response in OL period|0|||
131183548|NCT03325556|472293799|FG002|Open-label Period|Lack of Response in OL period|0|||
131183549|NCT03325556|472293797|FG000|Open-label Period|Adverse Event|27|||
131183550|NCT03325556|472293798|FG001|Open-label Period|Adverse Event|0|||
131183551|NCT03325556|472293799|FG002|Open-label Period|Adverse Event|0|||
131183552|NCT03325556|472293797|FG000|Open-label Period|Death|1|||
131183553|NCT03325556|472293798|FG001|Open-label Period|Death|0|||
131183554|NCT03325556|472293799|FG002|Open-label Period|Death|0|||
131183555|NCT03325556|472293797|FG000|Open-label Period|Lost to Follow-up|1|||
131183556|NCT03325556|472293798|FG001|Open-label Period|Lost to Follow-up|0|||
131183557|NCT03325556|472293799|FG002|Open-label Period|Lost to Follow-up|0|||
131183558|NCT03325556|472293797|FG000|Open-label Period|Non-compliance with study drug|5|||
131183559|NCT03325556|472293798|FG001|Open-label Period|Non-compliance with study drug|0|||
131183560|NCT03325556|472293799|FG002|Open-label Period|Non-compliance with study drug|0|||
131183561|NCT03325556|472293797|FG000|Open-label Period|Use of prohibited medication|1|||
131183562|NCT03325556|472293798|FG001|Open-label Period|Use of prohibited medication|0|||
131183563|NCT03325556|472293799|FG002|Open-label Period|Use of prohibited medication|0|||
131183564|NCT03325556|472293797|FG000|Open-label Period|Protocol Violation|4|||
131183565|NCT03325556|472293798|FG001|Open-label Period|Protocol Violation|0|||
131183566|NCT03325556|472293799|FG002|Open-label Period|Protocol Violation|0|||
131183567|NCT03325556|472293797|FG000|Open-label Period|Withdrawal by Subject|17|||
131183568|NCT03325556|472293798|FG001|Open-label Period|Withdrawal by Subject|0|||
131183569|NCT03325556|472293799|FG002|Open-label Period|Withdrawal by Subject|0|||
131183570|NCT03325556|472293797|FG000|Open-label Period|Not otherwise specified|8|||
131183571|NCT03325556|472293798|FG001|Open-label Period|Not otherwise specified|0|||
131183572|NCT03325556|472293799|FG002|Open-label Period|Not otherwise specified|0|||
131183573|NCT03325556|472293797|FG000|Open-label Period|Administrative discont. at study termination|41|||
131183574|NCT03325556|472293798|FG001|Open-label Period|Administrative discont. at study termination|0|||
131183575|NCT03325556|472293799|FG002|Open-label Period|Administrative discont. at study termination|0|||
131183576|NCT03325556|472293797|FG000|Double-blind Period|Relapse|0|||
131183577|NCT03325556|472293798|FG001|Double-blind Period|Relapse|15|||
131183578|NCT03325556|472293799|FG002|Double-blind Period|Relapse|34|||
131183579|NCT03325556|472293797|FG000|Double-blind Period|Adverse Event|0|||
131239170|NCT04541589|472500359|FG001|Safety Follow-up Period|Physician Decision|0|||
131239171|NCT04541589|472500358|FG000|Safety Follow-up Period|Subject decision|5|||
131239172|NCT04541589|472500359|FG001|Safety Follow-up Period|Subject decision|3|||
131239173|NCT04541589|472500358|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
131239174|NCT04541589|472500359|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
131239175|NCT04108208|472500360|FG000|Overall Study|Withdrawal by Subject|2|||
131239176|NCT04108208|472500361|FG001|Overall Study|Withdrawal by Subject|6|||
131239177|NCT04108208|472500360|FG000|Overall Study|other-ongoing|20|||
131239178|NCT04108208|472500361|FG001|Overall Study|other-ongoing|40|||
131239179|NCT04108208|472500360|FG000|Overall Study|Death|1|||
131239180|NCT04108208|472500361|FG001|Overall Study|Death|4|||
131239181|NCT04108208|472500360|FG000|Overall Study|Lost to Follow-up|2|||
131239182|NCT04108208|472500361|FG001|Overall Study|Lost to Follow-up|0|||
131239183|NCT04689828|472500365|FG000|Overall Study|Subject decision|5|||
131239184|NCT04689828|472500366|FG001|Overall Study|Subject decision|5|||
131239185|NCT04689828|472500365|FG000|Overall Study|Adverse Event|12|||
131239186|NCT04689828|472500366|FG001|Overall Study|Adverse Event|12|||
131239187|NCT04689828|472500365|FG000|Overall Study|Physician Decision|24|||
131239188|NCT04689828|472500366|FG001|Overall Study|Physician Decision|32|||
131239189|NCT04689828|472500365|FG000|Overall Study|Progressive disease|54|||
131239190|NCT04689828|472500366|FG001|Overall Study|Progressive disease|173|||
131239191|NCT04689828|472500365|FG000|Overall Study|Death|0|||
131239192|NCT04689828|472500366|FG001|Overall Study|Death|1|||
131239193|NCT04689828|472500365|FG000|Overall Study|Lost to Follow-up|1|||
131239194|NCT04689828|472500366|FG001|Overall Study|Lost to Follow-up|0|||
131239195|NCT04689828|472500365|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
131239196|NCT04689828|472500366|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
131239197|NCT04689828|472500365|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
131239198|NCT04689828|472500366|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
131239199|NCT04689828|472500365|FG000|Overall Study|Participants not treated|7|||
131239200|NCT04689828|472500366|FG001|Overall Study|Participants not treated|2|||
131239201|NCT03978624|472500367|FG000|Overall Study|Protocol Violation|1|||
131239202|NCT03978624|472500368|FG001|Overall Study|Protocol Violation|0|||
131239203|NCT04347239|472500369|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
131239204|NCT04347239|472500370|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
131239205|NCT04347239|472500371|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
131239206|NCT04347239|472500369|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
131239207|NCT04347239|472500370|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
131239208|NCT04347239|472500371|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
131239209|NCT04181827|472500372|FG000|Overall Study|Ongoing|124|||
131239210|NCT04181827|472500373|FG001|Overall Study|Ongoing|157|||
131239211|NCT04181827|472500372|FG000|Overall Study|Death|82|||
131239212|NCT04181827|472500373|FG001|Overall Study|Death|50|||
131239213|NCT04181827|472500372|FG000|Overall Study|Lost to Follow-up|0|||
131239214|NCT04181827|472500373|FG001|Overall Study|Lost to Follow-up|1|||
131239215|NCT04181827|472500372|FG000|Overall Study|Withdrawal by Subject|5|||
131239216|NCT04181827|472500373|FG001|Overall Study|Withdrawal by Subject|0|||
131239217|NCT02770170|472500374|FG000|Overall Study|Withdrawal by Subject|0|||
131239218|NCT02770170|472500375|FG001|Overall Study|Withdrawal by Subject|0|||
131239219|NCT02770170|472500376|FG002|Overall Study|Withdrawal by Subject|0|||
131239220|NCT02770170|472500377|FG003|Overall Study|Withdrawal by Subject|2|||
131239221|NCT02770170|472500374|FG000|Overall Study|due to pregnancy|1|||
131239222|NCT02770170|472500375|FG001|Overall Study|due to pregnancy|0|||
131239223|NCT02770170|472500376|FG002|Overall Study|due to pregnancy|0|||
131239224|NCT02770170|472500377|FG003|Overall Study|due to pregnancy|0|||
131239225|NCT02770170|472500374|FG000|Overall Study|Lack of Efficacy|2|||
131239226|NCT02770170|472500375|FG001|Overall Study|Lack of Efficacy|0|||
131239227|NCT02770170|472500376|FG002|Overall Study|Lack of Efficacy|0|||
131239228|NCT02770170|472500377|FG003|Overall Study|Lack of Efficacy|1|||
131239229|NCT02770170|472500374|FG000|Overall Study|Adverse Event|4|||
131239230|NCT02770170|472500375|FG001|Overall Study|Adverse Event|3|||
131239231|NCT02770170|472500376|FG002|Overall Study|Adverse Event|5|||
131239232|NCT02770170|472500377|FG003|Overall Study|Adverse Event|3|||
130733522|NCT05026177|470642911|FG000|Overall Study|Noncompliance with study drug|6|||
131239233|NCT02770170|472500374|FG000|Overall Study|due to disease worsening|0|||
131239234|NCT02770170|472500375|FG001|Overall Study|due to disease worsening|0|||
131239235|NCT02770170|472500376|FG002|Overall Study|due to disease worsening|0|||
131239236|NCT02770170|472500377|FG003|Overall Study|due to disease worsening|1|||
131239237|NCT06028438|472500378|FG000|Overall Study|Adverse Event|3|||
131239238|NCT06028438|472500379|FG001|Overall Study|Adverse Event|9|||
131239239|NCT06028438|472500378|FG000|Overall Study|Lack of Efficacy|1|||
131239240|NCT06028438|472500379|FG001|Overall Study|Lack of Efficacy|1|||
131239241|NCT06028438|472500378|FG000|Overall Study|Lost to Follow-up|1|||
131239242|NCT06028438|472500379|FG001|Overall Study|Lost to Follow-up|0|||
131239243|NCT06028438|472500378|FG000|Overall Study|Withdrawal by Subject|1|||
131239244|NCT06028438|472500379|FG001|Overall Study|Withdrawal by Subject|0|||
131239245|NCT06028438|472500378|FG000|Overall Study|Other|3|||
131239246|NCT06028438|472500379|FG001|Overall Study|Other|3|||
131239247|NCT04248803|472500380|FG000|Overall Study|Lost to Follow-up|7|||
131239248|NCT04248803|472500381|FG001|Overall Study|Lost to Follow-up|7|||
131239249|NCT04248803|472500382|FG002|Overall Study|Lost to Follow-up|7|||
131239250|NCT04248803|472500383|FG003|Overall Study|Lost to Follow-up|7|||
131239251|NCT04248803|472500384|FG004|Overall Study|Lost to Follow-up|7|||
131239252|NCT04248803|472500385|FG005|Overall Study|Lost to Follow-up|7|||
131239253|NCT00843882|472500391|FG000|Step 1|Lack of Efficacy|14|||
131239254|NCT00843882|472500392|FG001|Step 1|Lack of Efficacy|10|||
131239255|NCT00843882|472500393|FG002|Step 1|Lack of Efficacy|21|||
131239256|NCT00843882|472500391|FG000|Step 1|Adverse Event|8|||
131239257|NCT00843882|472500392|FG001|Step 1|Adverse Event|17|||
131239258|NCT00843882|472500393|FG002|Step 1|Adverse Event|20|||
131239259|NCT00843882|472500391|FG000|Step 1|Death|1|||
131239260|NCT00843882|472500392|FG001|Step 1|Death|2|||
131239261|NCT00843882|472500393|FG002|Step 1|Death|4|||
131239262|NCT00843882|472500391|FG000|Step 1|Withdrawal by Subject|6|||
131239263|NCT00843882|472500392|FG001|Step 1|Withdrawal by Subject|12|||
131239264|NCT00843882|472500393|FG002|Step 1|Withdrawal by Subject|9|||
131239265|NCT00843882|472500391|FG000|Step 1|Physician Decision|0|||
131239266|NCT00843882|472500392|FG001|Step 1|Physician Decision|5|||
131239267|NCT00843882|472500393|FG002|Step 1|Physician Decision|1|||
131239268|NCT00843882|472500391|FG000|Step 1|Patient and physician's decision|0|||
131239269|NCT00843882|472500392|FG001|Step 1|Patient and physician's decision|0|||
131239270|NCT00843882|472500393|FG002|Step 1|Patient and physician's decision|1|||
131239271|NCT00843882|472500391|FG000|Step 1|Other complicating disease|1|||
131239272|NCT00843882|472500392|FG001|Step 1|Other complicating disease|3|||
131239273|NCT00843882|472500393|FG002|Step 1|Other complicating disease|4|||
131239274|NCT00843882|472500391|FG000|Step 1|Alternative therapy|0|||
131239275|NCT00843882|472500392|FG001|Step 1|Alternative therapy|1|||
131239276|NCT00843882|472500393|FG002|Step 1|Alternative therapy|1|||
131239277|NCT00843882|472500391|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
131239278|NCT00843882|472500392|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
131239279|NCT00843882|472500393|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
131239280|NCT00843882|472500391|FG000|Step 1|Off treatment reason unknown|0|||
131239281|NCT00843882|472500392|FG001|Step 1|Off treatment reason unknown|1|||
131239282|NCT00843882|472500393|FG002|Step 1|Off treatment reason unknown|4|||
131239283|NCT00843882|472500391|FG000|Step 1|Never started treatment|2|||
131239284|NCT00843882|472500392|FG001|Step 1|Never started treatment|0|||
131239285|NCT00843882|472500393|FG002|Step 1|Never started treatment|0|||
131239286|NCT00843882|472500391|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
131239287|NCT00843882|472500392|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
131239288|NCT00843882|472500393|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
131239289|NCT00843882|472500391|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
131239290|NCT00843882|472500392|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
131239291|NCT00843882|472500393|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
131239292|NCT00843882|472500391|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
131239293|NCT00843882|472500392|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
131239294|NCT00843882|472500393|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
131239295|NCT00843882|472500391|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
131239296|NCT00843882|472500392|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
131239297|NCT00843882|472500393|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
131239298|NCT00843882|472500391|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
131239299|NCT00843882|472500392|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
131239300|NCT00843882|472500393|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
131239301|NCT00843882|472500391|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
131239302|NCT00843882|472500392|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
131239303|NCT00843882|472500393|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
131239304|NCT00843882|472500391|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
131239305|NCT00843882|472500392|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
131239306|NCT00843882|472500393|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
131239307|NCT03581123|472500394|FG000|2-month Follow-up|Withdrawal by Subject|5|||
131239308|NCT03581123|472500395|FG001|2-month Follow-up|Withdrawal by Subject|4|||
130733523|NCT05026177|470642912|FG001|Overall Study|Noncompliance with study drug|2|||
131239309|NCT03581123|472500396|FG002|2-month Follow-up|Withdrawal by Subject|6|||
131239310|NCT03581123|472500397|FG003|2-month Follow-up|Withdrawal by Subject|4|||
131239311|NCT03581123|472500394|FG000|2-month Follow-up|Lost to Follow-up|8|||
131239312|NCT03581123|472500395|FG001|2-month Follow-up|Lost to Follow-up|1|||
131239313|NCT03581123|472500396|FG002|2-month Follow-up|Lost to Follow-up|2|||
131239314|NCT03581123|472500397|FG003|2-month Follow-up|Lost to Follow-up|2|||
131239315|NCT03581123|472500394|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
131239316|NCT03581123|472500395|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
131239317|NCT03581123|472500396|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
131239318|NCT03581123|472500397|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
131183580|NCT03325556|472293798|FG001|Double-blind Period|Adverse Event|3|||
131183581|NCT03325556|472293799|FG002|Double-blind Period|Adverse Event|1|||
131183582|NCT03325556|472293797|FG000|Double-blind Period|Noncompliance with study drug|0|||
131183583|NCT03325556|472293798|FG001|Double-blind Period|Noncompliance with study drug|0|||
131183584|NCT03325556|472293799|FG002|Double-blind Period|Noncompliance with study drug|1|||
131183585|NCT03325556|472293797|FG000|Double-blind Period|Use of prohibited medication|0|||
131183586|NCT03325556|472293798|FG001|Double-blind Period|Use of prohibited medication|1|||
131183587|NCT03325556|472293799|FG002|Double-blind Period|Use of prohibited medication|0|||
131183588|NCT03325556|472293797|FG000|Double-blind Period|Physician Decision|0|||
131183589|NCT03325556|472293798|FG001|Double-blind Period|Physician Decision|0|||
131183590|NCT03325556|472293799|FG002|Double-blind Period|Physician Decision|1|||
131183591|NCT03325556|472293797|FG000|Double-blind Period|Withdrawal by Subject|0|||
131183592|NCT03325556|472293798|FG001|Double-blind Period|Withdrawal by Subject|6|||
131183593|NCT03325556|472293799|FG002|Double-blind Period|Withdrawal by Subject|4|||
131183594|NCT03325556|472293797|FG000|Double-blind Period|Not otherwise specified|0|||
131183595|NCT03325556|472293798|FG001|Double-blind Period|Not otherwise specified|1|||
131183596|NCT03325556|472293799|FG002|Double-blind Period|Not otherwise specified|5|||
131183597|NCT03325556|472293797|FG000|Double-blind Period|Administrative discont. at study termination|0|||
131183598|NCT03325556|472293798|FG001|Double-blind Period|Administrative discont. at study termination|35|||
131183599|NCT03325556|472293799|FG002|Double-blind Period|Administrative discont. at study termination|31|||
131183600|NCT00510484|472293800|FG000|Wash-out Period|Adverse Event|0|||
131183601|NCT00510484|472293801|FG001|Wash-out Period|Adverse Event|1|||
131239319|NCT03581123|472500394|FG000|6-Month Follow-up|Lost to Follow-up|3|||
131239320|NCT03581123|472500395|FG001|6-Month Follow-up|Lost to Follow-up|3|||
131239321|NCT03581123|472500396|FG002|6-Month Follow-up|Lost to Follow-up|1|||
131239322|NCT03581123|472500397|FG003|6-Month Follow-up|Lost to Follow-up|1|||
131239323|NCT03581123|472500394|FG000|12-Month Follow-up|Lost to Follow-up|4|||
131239324|NCT03581123|472500395|FG001|12-Month Follow-up|Lost to Follow-up|3|||
131239325|NCT03581123|472500396|FG002|12-Month Follow-up|Lost to Follow-up|4|||
131239326|NCT03581123|472500397|FG003|12-Month Follow-up|Lost to Follow-up|5|||
131239327|NCT02252172|472500399|FG000|Overall Study|Lost to Follow-up|9|||
131239328|NCT02252172|472500400|FG001|Overall Study|Lost to Follow-up|6|||
131239329|NCT02252172|472500399|FG000|Overall Study|Death|218|||
131239330|NCT02252172|472500400|FG001|Overall Study|Death|175|||
131239331|NCT02252172|472500399|FG000|Overall Study|Withdrawal by Subject|20|||
131239332|NCT02252172|472500400|FG001|Overall Study|Withdrawal by Subject|15|||
131239333|NCT02252172|472500399|FG000|Overall Study|Physician Decision|0|||
131239334|NCT02252172|472500400|FG001|Overall Study|Physician Decision|1|||
131239335|NCT02252172|472500399|FG000|Overall Study|End of data collection|122|||
131239336|NCT02252172|472500400|FG001|Overall Study|End of data collection|170|||
131239337|NCT02252172|472500399|FG000|Overall Study|Site closure|0|||
131239338|NCT02252172|472500400|FG001|Overall Study|Site closure|1|||
131239339|NCT04399837|472500401|FG000|Overall Study|Other than listed|0|||
131239340|NCT04399837|472500402|FG001|Overall Study|Other than listed|2|||
131239341|NCT04399837|472500403|FG002|Overall Study|Other than listed|2|||
131239342|NCT04399837|472500404|FG003|Overall Study|Other than listed|3|||
131239343|NCT04399837|472500401|FG000|Overall Study|Withdrawal by Subject|1|||
131239344|NCT04399837|472500402|FG001|Overall Study|Withdrawal by Subject|2|||
131239345|NCT04399837|472500403|FG002|Overall Study|Withdrawal by Subject|1|||
131239346|NCT04399837|472500404|FG003|Overall Study|Withdrawal by Subject|1|||
131239347|NCT04610346|472500405|FG000|Overall Study|Withdrawal by Subject|1|||
131239348|NCT04610346|472500406|FG001|Overall Study|Withdrawal by Subject|1|||
131239349|NCT04610346|472500405|FG000|Overall Study|did not complete shelter onboarding|2|||
131239350|NCT04610346|472500406|FG001|Overall Study|did not complete shelter onboarding|1|||
131239351|NCT05097989|472500407|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131239352|NCT05097989|472500408|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131239353|NCT05097989|472500409|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131239354|NCT05097989|472500410|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131239355|NCT05097989|472500411|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131239356|NCT05097989|472500412|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
131239357|NCT05097989|472500413|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131239358|NCT05097989|472500414|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131239359|NCT05097989|472500415|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
131239360|NCT05097989|472500407|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
131239361|NCT05097989|472500408|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
131239362|NCT05097989|472500409|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
131239363|NCT05097989|472500410|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
131239364|NCT05097989|472500411|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
131239365|NCT05097989|472500412|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
131239366|NCT05097989|472500413|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
131239367|NCT05097989|472500414|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
131239368|NCT05097989|472500415|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
131239369|NCT05097989|472500407|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131183602|NCT00340834|472293804|FG000|Core Phase of Study|Adverse Event|26|||
131183603|NCT00340834|472293805|FG001|Core Phase of Study|Adverse Event|9|||
131183604|NCT00340834|472293806|FG002|Core Phase of Study|Adverse Event|9|||
131183605|NCT00340834|472293807|FG003|Core Phase of Study|Adverse Event|0|||
131183606|NCT00340834|472293808|FG004|Core Phase of Study|Adverse Event|0|||
131183607|NCT00340834|472293804|FG000|Core Phase of Study|Withdrawal by Subject|11|||
131183608|NCT00340834|472293805|FG001|Core Phase of Study|Withdrawal by Subject|9|||
131183609|NCT00340834|472293806|FG002|Core Phase of Study|Withdrawal by Subject|16|||
131183610|NCT00340834|472293807|FG003|Core Phase of Study|Withdrawal by Subject|0|||
131183611|NCT00340834|472293808|FG004|Core Phase of Study|Withdrawal by Subject|0|||
131183612|NCT00340834|472293804|FG000|Core Phase of Study|Administrative Problems|6|||
131183613|NCT00340834|472293805|FG001|Core Phase of Study|Administrative Problems|2|||
131183614|NCT00340834|472293806|FG002|Core Phase of Study|Administrative Problems|7|||
131183615|NCT00340834|472293807|FG003|Core Phase of Study|Administrative Problems|0|||
131183616|NCT00340834|472293808|FG004|Core Phase of Study|Administrative Problems|0|||
131183617|NCT00340834|472293804|FG000|Core Phase of Study|Lack of Efficacy|3|||
131183618|NCT00340834|472293805|FG001|Core Phase of Study|Lack of Efficacy|3|||
131183619|NCT00340834|472293806|FG002|Core Phase of Study|Lack of Efficacy|7|||
131183620|NCT00340834|472293807|FG003|Core Phase of Study|Lack of Efficacy|0|||
131183621|NCT00340834|472293808|FG004|Core Phase of Study|Lack of Efficacy|0|||
131183622|NCT00340834|472293804|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
131183623|NCT00340834|472293805|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
131183624|NCT00340834|472293806|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
131183625|NCT00340834|472293807|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
131183626|NCT00340834|472293808|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
131183627|NCT00340834|472293804|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
131183628|NCT00340834|472293805|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
131183629|NCT00340834|472293806|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
131183630|NCT00340834|472293807|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
131183631|NCT00340834|472293808|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
131183632|NCT00340834|472293804|FG000|Core Phase of Study|Lost to Follow-up|1|||
131183633|NCT00340834|472293805|FG001|Core Phase of Study|Lost to Follow-up|1|||
131183634|NCT00340834|472293806|FG002|Core Phase of Study|Lost to Follow-up|4|||
131183635|NCT00340834|472293807|FG003|Core Phase of Study|Lost to Follow-up|0|||
131183636|NCT00340834|472293808|FG004|Core Phase of Study|Lost to Follow-up|0|||
131183637|NCT00340834|472293804|FG000|Core Phase of Study|Death|2|||
131183638|NCT00340834|472293805|FG001|Core Phase of Study|Death|0|||
131183639|NCT00340834|472293806|FG002|Core Phase of Study|Death|0|||
131183640|NCT00340834|472293807|FG003|Core Phase of Study|Death|0|||
131183641|NCT00340834|472293808|FG004|Core Phase of Study|Death|0|||
131183642|NCT00340834|472293804|FG000|Core Phase of Study|Protocol Violation|0|||
131183643|NCT00340834|472293805|FG001|Core Phase of Study|Protocol Violation|0|||
131183644|NCT00340834|472293806|FG002|Core Phase of Study|Protocol Violation|2|||
131183645|NCT00340834|472293807|FG003|Core Phase of Study|Protocol Violation|0|||
131183646|NCT00340834|472293808|FG004|Core Phase of Study|Protocol Violation|0|||
131183647|NCT00340834|472293804|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
131183648|NCT00340834|472293805|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
131183649|NCT00340834|472293806|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
131183650|NCT00340834|472293807|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
131183651|NCT00340834|472293808|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
131183652|NCT00340834|472293804|FG000|Extension Phase of Study|Subject withdrew consent|26|||
131183653|NCT00340834|472293805|FG001|Extension Phase of Study|Subject withdrew consent|31|||
131183654|NCT00340834|472293806|FG002|Extension Phase of Study|Subject withdrew consent|0|||
131183655|NCT00340834|472293807|FG003|Extension Phase of Study|Subject withdrew consent|12|||
131183656|NCT00340834|472293808|FG004|Extension Phase of Study|Subject withdrew consent|15|||
131183657|NCT00340834|472293804|FG000|Extension Phase of Study|Adverse Event|21|||
131183658|NCT00340834|472293805|FG001|Extension Phase of Study|Adverse Event|22|||
131183659|NCT00340834|472293806|FG002|Extension Phase of Study|Adverse Event|0|||
131183660|NCT00340834|472293807|FG003|Extension Phase of Study|Adverse Event|19|||
131183661|NCT00340834|472293808|FG004|Extension Phase of Study|Adverse Event|7|||
131183662|NCT00340834|472293804|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
131183663|NCT00340834|472293805|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
131183664|NCT00340834|472293806|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
131183665|NCT00340834|472293807|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
131183666|NCT00340834|472293808|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
131183667|NCT00340834|472293804|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
131183668|NCT00340834|472293805|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
131183669|NCT00340834|472293806|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
131183670|NCT00340834|472293807|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
131239370|NCT05097989|472500408|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131239371|NCT05097989|472500409|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131239372|NCT05097989|472500410|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131239373|NCT05097989|472500411|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131239374|NCT05097989|472500412|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
131239375|NCT05097989|472500413|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
131239376|NCT05097989|472500414|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
131239377|NCT05097989|472500415|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
131239378|NCT05097989|472500407|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131239379|NCT05097989|472500408|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131239380|NCT05097989|472500409|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
131239381|NCT05097989|472500410|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131239382|NCT05097989|472500411|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131239383|NCT05097989|472500412|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
131239384|NCT05097989|472500413|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131239385|NCT05097989|472500414|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
131239386|NCT05097989|472500415|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
131239387|NCT05097989|472500407|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131239388|NCT05097989|472500408|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131239389|NCT05097989|472500409|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
131239390|NCT05097989|472500410|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131239391|NCT05097989|472500411|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131239392|NCT05097989|472500412|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131183671|NCT00340834|472293808|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
131183672|NCT00340834|472293804|FG000|Extension Phase of Study|Lost to Follow-up|1|||
131183673|NCT00340834|472293805|FG001|Extension Phase of Study|Lost to Follow-up|1|||
131183674|NCT00340834|472293806|FG002|Extension Phase of Study|Lost to Follow-up|0|||
131183675|NCT00340834|472293807|FG003|Extension Phase of Study|Lost to Follow-up|2|||
131183676|NCT00340834|472293808|FG004|Extension Phase of Study|Lost to Follow-up|3|||
131183677|NCT00340834|472293804|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
131183678|NCT00340834|472293805|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
131183679|NCT00340834|472293806|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
131183680|NCT00340834|472293807|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
131183681|NCT00340834|472293808|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
131183682|NCT00340834|472293804|FG000|Extension Phase of Study|Administrative problems|3|||
131183683|NCT00340834|472293805|FG001|Extension Phase of Study|Administrative problems|0|||
131183684|NCT00340834|472293806|FG002|Extension Phase of Study|Administrative problems|0|||
131183685|NCT00340834|472293807|FG003|Extension Phase of Study|Administrative problems|1|||
131183686|NCT00340834|472293808|FG004|Extension Phase of Study|Administrative problems|1|||
131183687|NCT00340834|472293804|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
131183688|NCT00340834|472293805|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
131183689|NCT00340834|472293806|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
131183690|NCT00340834|472293807|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
131183691|NCT00340834|472293808|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
131183692|NCT00340834|472293804|FG000|Extension Phase of Study|Protocol Violation|3|||
131183693|NCT00340834|472293805|FG001|Extension Phase of Study|Protocol Violation|0|||
131183694|NCT00340834|472293806|FG002|Extension Phase of Study|Protocol Violation|0|||
131183695|NCT00340834|472293807|FG003|Extension Phase of Study|Protocol Violation|0|||
131183696|NCT00340834|472293808|FG004|Extension Phase of Study|Protocol Violation|0|||
131183697|NCT00340834|472293804|FG000|Extension Phase of Study|Death|0|||
131183698|NCT00340834|472293805|FG001|Extension Phase of Study|Death|0|||
131183699|NCT00340834|472293806|FG002|Extension Phase of Study|Death|0|||
131183700|NCT00340834|472293807|FG003|Extension Phase of Study|Death|0|||
131183701|NCT00340834|472293808|FG004|Extension Phase of Study|Death|1|||
131183702|NCT00762268|472293809|FG000|Overall Study|Withdrawal by Subject|3|||
131183703|NCT00762268|472293810|FG001|Overall Study|Withdrawal by Subject|3|||
131183704|NCT01457924|472293811|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
131183705|NCT01457924|472293812|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
131183706|NCT01457924|472293813|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
131183707|NCT01457924|472293814|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
131183708|NCT01457924|472293815|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
131183709|NCT01457924|472293811|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
131183710|NCT01457924|472293812|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
131183711|NCT01457924|472293813|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
131183712|NCT01457924|472293814|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
131183713|NCT01457924|472293815|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
131239393|NCT05097989|472500413|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131239394|NCT05097989|472500414|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131239395|NCT05097989|472500415|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
131239396|NCT05097989|472500407|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131239397|NCT05097989|472500408|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
131239398|NCT05097989|472500409|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131239399|NCT05097989|472500410|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131239400|NCT05097989|472500411|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131239401|NCT05097989|472500412|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131239402|NCT05097989|472500413|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131239403|NCT05097989|472500414|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131239404|NCT05097989|472500415|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
131239405|NCT05097989|472500407|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131183714|NCT01457924|472293811|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
131183715|NCT01457924|472293812|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
131183716|NCT01457924|472293813|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
131183717|NCT01457924|472293814|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
131183718|NCT01457924|472293815|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
131183719|NCT01457924|472293811|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
131183720|NCT01457924|472293812|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
131183721|NCT01457924|472293813|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
131183722|NCT01457924|472293814|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
131183723|NCT01457924|472293815|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
131183724|NCT01457924|472293811|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
131183725|NCT01457924|472293812|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
131183726|NCT01457924|472293813|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
131183727|NCT01457924|472293814|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
131183728|NCT01457924|472293815|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
131183729|NCT01457924|472293811|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
131183730|NCT01457924|472293812|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
131183731|NCT01457924|472293813|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
131183732|NCT01457924|472293814|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
131183733|NCT01457924|472293815|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
131183734|NCT01457924|472293811|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
131239406|NCT05097989|472500408|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131239407|NCT05097989|472500409|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131239408|NCT05097989|472500410|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131239409|NCT05097989|472500411|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131239410|NCT05097989|472500412|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131239411|NCT05097989|472500413|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131239412|NCT05097989|472500414|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131239413|NCT05097989|472500415|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131239414|NCT05097989|472500407|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131239415|NCT05097989|472500408|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131239416|NCT05097989|472500409|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131239417|NCT05097989|472500410|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131239418|NCT05097989|472500411|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
131239419|NCT05097989|472500412|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131239420|NCT05097989|472500413|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131239421|NCT05097989|472500414|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131239422|NCT05097989|472500415|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
131239423|NCT05097989|472500407|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131239424|NCT05097989|472500408|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131239425|NCT05097989|472500409|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131239426|NCT05097989|472500410|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
131239427|NCT05097989|472500411|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131239428|NCT05097989|472500412|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131239429|NCT05097989|472500413|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131239430|NCT05097989|472500414|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131239431|NCT05097989|472500415|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131239432|NCT05097989|472500407|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
131239433|NCT05097989|472500408|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
131239434|NCT05097989|472500409|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
131239435|NCT05097989|472500410|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
131239436|NCT05097989|472500411|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
131239437|NCT05097989|472500412|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
131239438|NCT05097989|472500413|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
131239439|NCT05097989|472500414|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
131239440|NCT05097989|472500415|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
131239441|NCT05097989|472500407|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
131239442|NCT05097989|472500408|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
131239443|NCT05097989|472500409|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
131239444|NCT05097989|472500410|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
131239445|NCT05097989|472500411|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
131239446|NCT05097989|472500412|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
131239447|NCT05097989|472500413|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
131239448|NCT05097989|472500414|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
131239449|NCT05097989|472500415|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
131239450|NCT05097989|472500407|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
131239451|NCT05097989|472500408|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
131239452|NCT05097989|472500409|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
131239453|NCT05097989|472500410|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
131239454|NCT05097989|472500411|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
131239455|NCT05097989|472500412|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
131239456|NCT05097989|472500413|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
131239457|NCT05097989|472500414|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
131239458|NCT05097989|472500415|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
131239459|NCT05097989|472500407|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
131239460|NCT05097989|472500408|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
131239461|NCT05097989|472500409|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131239462|NCT05097989|472500410|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131239463|NCT05097989|472500411|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131239464|NCT05097989|472500412|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131239465|NCT05097989|472500413|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131239466|NCT05097989|472500414|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131239467|NCT05097989|472500415|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
131239468|NCT05097989|472500407|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
131239469|NCT05097989|472500408|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
131239470|NCT05097989|472500409|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
131239471|NCT05097989|472500410|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
131239472|NCT05097989|472500411|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
131239473|NCT05097989|472500412|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
131239474|NCT05097989|472500413|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
131239475|NCT05097989|472500414|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
131239476|NCT05097989|472500415|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
131239477|NCT04677738|472500417|FG000|Overall Study|Withdrawal by Subject|4|||
131239478|NCT04677738|472500418|FG001|Overall Study|Withdrawal by Subject|2|||
131239479|NCT03822468|472500419|FG000|Treatment Period|Progressive disease|98|||
131239480|NCT03822468|472500420|FG001|Treatment Period|Progressive disease|94|||
131239481|NCT03822468|472500419|FG000|Treatment Period|Adverse Event|21|||
131239482|NCT03822468|472500420|FG001|Treatment Period|Adverse Event|24|||
131239483|NCT03822468|472500419|FG000|Treatment Period|Withdrawal by Subject|9|||
131239484|NCT03822468|472500420|FG001|Treatment Period|Withdrawal by Subject|5|||
131239485|NCT03822468|472500419|FG000|Treatment Period|Physician Decision|9|||
131239486|NCT03822468|472500420|FG001|Treatment Period|Physician Decision|7|||
131239487|NCT03822468|472500419|FG000|Treatment Period|Protocol Violation|2|||
131239488|NCT03822468|472500420|FG001|Treatment Period|Protocol Violation|1|||
131239489|NCT03822468|472500419|FG000|Treatment Period|Death|2|||
131239490|NCT03822468|472500420|FG001|Treatment Period|Death|3|||
131239491|NCT03822468|472500419|FG000|Treatment Period|Lost to Follow-up|1|||
131239492|NCT03822468|472500420|FG001|Treatment Period|Lost to Follow-up|1|||
131239493|NCT03822468|472500419|FG000|Treatment Period|Sponsor decision|46|||
131239494|NCT03822468|472500420|FG001|Treatment Period|Sponsor decision|53|||
131239495|NCT03822468|472500419|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
131239496|NCT03822468|472500420|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
131239497|NCT03822468|472500419|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
131239498|NCT03822468|472500420|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
131239499|NCT03822468|472500419|FG000|Post-treatment Efficacy Follow-up|Death|1|||
131239500|NCT03822468|472500420|FG001|Post-treatment Efficacy Follow-up|Death|0|||
131239501|NCT03822468|472500419|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
131239502|NCT03822468|472500420|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
131239503|NCT03822468|472500419|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
131239504|NCT03822468|472500420|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
131239505|NCT03822468|472500419|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
131239506|NCT03822468|472500420|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
131239507|NCT03822468|472500419|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
131239508|NCT03822468|472500420|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
131183735|NCT01457924|472293812|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
131183736|NCT01457924|472293813|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
131183737|NCT01457924|472293814|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
131183738|NCT01457924|472293815|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
131183739|NCT01457924|472293811|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
131183740|NCT01457924|472293812|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
131183741|NCT01457924|472293813|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
131183742|NCT01457924|472293814|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
131183743|NCT01457924|472293815|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
131183744|NCT01457924|472293811|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
131183745|NCT01457924|472293812|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
131183746|NCT01457924|472293813|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
131183747|NCT01457924|472293814|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
131183748|NCT01457924|472293815|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
131183749|NCT01457924|472293811|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
131183750|NCT01457924|472293812|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
131183751|NCT01457924|472293813|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
131183752|NCT01457924|472293814|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
131183753|NCT01457924|472293815|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
131183754|NCT01457924|472293811|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
131183755|NCT01457924|472293812|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
131183756|NCT01457924|472293813|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
131183757|NCT01457924|472293814|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
131183758|NCT01457924|472293815|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
131183759|NCT01457924|472293811|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
131183760|NCT01457924|472293812|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
131183761|NCT01457924|472293813|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
131183762|NCT01457924|472293814|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
131183763|NCT01457924|472293815|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
131183764|NCT01457924|472293811|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
131183765|NCT01457924|472293812|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
131183766|NCT01457924|472293813|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
131183767|NCT01457924|472293814|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
131183768|NCT01457924|472293815|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
131183769|NCT01181141|472293816|FG000|Overall Study|Adverse Event|2|||
131183770|NCT01181141|472293817|FG001|Overall Study|Adverse Event|1|||
131183771|NCT01181141|472293816|FG000|Overall Study|Lack of Efficacy|1|||
131183772|NCT01181141|472293817|FG001|Overall Study|Lack of Efficacy|0|||
131183773|NCT01181141|472293816|FG000|Overall Study|Lost to Follow-up|1|||
131183774|NCT01181141|472293817|FG001|Overall Study|Lost to Follow-up|1|||
131183775|NCT01181141|472293816|FG000|Overall Study|Physician Decision|2|||
131183776|NCT01181141|472293817|FG001|Overall Study|Physician Decision|0|||
131183777|NCT01181141|472293816|FG000|Overall Study|Protocol Violation|3|||
131183778|NCT01181141|472293817|FG001|Overall Study|Protocol Violation|1|||
131183779|NCT01181141|472293816|FG000|Overall Study|Withdrawal by Subject|3|||
131183780|NCT01181141|472293817|FG001|Overall Study|Withdrawal by Subject|1|||
131183781|NCT00290589|472293818|FG000|Overall Study|Lost to Follow-up|2|||
131183782|NCT00290589|472293819|FG001|Overall Study|Lost to Follow-up|2|||
131183783|NCT00118911|472293820|FG000|Overall Study|Withdrawal by Subject|2|||
131183784|NCT00118911|472293821|FG001|Overall Study|Withdrawal by Subject|5|||
131183785|NCT01438307|472293822|FG000|Overall Study|Death|1|||
131183786|NCT01438307|472293823|FG001|Overall Study|Death|1|||
131183787|NCT00973622|472293825|FG000|Overall Study|did not attend MRI|14|||
131183788|NCT00973622|472293826|FG001|Overall Study|did not attend MRI|3|||
131183789|NCT00973622|472293825|FG000|Overall Study|did not pass MRI screen|6|||
131183790|NCT00973622|472293826|FG001|Overall Study|did not pass MRI screen|0|||
131183791|NCT00973622|472293825|FG000|Overall Study|did not complete rTMS sessions|11|||
131183792|NCT00973622|472293826|FG001|Overall Study|did not complete rTMS sessions|2|||
131183793|NCT03814005|472293830|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
131183794|NCT03814005|472293831|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
131183795|NCT03814005|472293832|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
131183796|NCT03814005|472293830|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
131183797|NCT03814005|472293831|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
131183798|NCT03814005|472293832|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
131183799|NCT03814005|472293830|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
131183800|NCT03814005|472293831|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
131183801|NCT03814005|472293832|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
131183802|NCT03814005|472293830|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
131183803|NCT03814005|472293831|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
131183804|NCT03814005|472293832|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
131183805|NCT03814005|472293830|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
131239509|NCT04838613|472504210|FG000|Overall Study|Withdrawal by Subject|3|||
131239510|NCT04838613|472504211|FG001|Overall Study|Withdrawal by Subject|6|||
131239511|NCT04838613|472504210|FG000|Overall Study|Protocol Deviation|3|||
131239512|NCT04838613|472504211|FG001|Overall Study|Protocol Deviation|2|||
131239513|NCT04838613|472504210|FG000|Overall Study|Technical Problems|0|||
131239514|NCT04838613|472504211|FG001|Overall Study|Technical Problems|5|||
131239515|NCT04838613|472504210|FG000|Overall Study|Physician Decision|2|||
131239516|NCT04838613|472504211|FG001|Overall Study|Physician Decision|0|||
131239517|NCT04157348|472504213|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
131239518|NCT04157348|472504214|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
131239519|NCT04157348|472504213|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
131239520|NCT04157348|472504214|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
131239521|NCT04157348|472504213|FG000|Double-blind Treatment Period|Adverse Event|0|||
131239522|NCT04157348|472504214|FG001|Double-blind Treatment Period|Adverse Event|1|||
131239523|NCT04157348|472504213|FG000|Open-label Extension Period|Adverse Event|1|||
131239524|NCT04157348|472504214|FG001|Open-label Extension Period|Adverse Event|1|||
131239525|NCT04157348|472504213|FG000|Open-label Extension Period|Death|0|||
131239526|NCT04157348|472504214|FG001|Open-label Extension Period|Death|1|||
131239527|NCT04157348|472504213|FG000|Open-label Extension Period|Lack of Efficacy|2|||
131239528|NCT04157348|472504214|FG001|Open-label Extension Period|Lack of Efficacy|2|||
131239529|NCT04157348|472504213|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
131239530|NCT04157348|472504214|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
131239531|NCT04157348|472504213|FG000|Open-label Extension Period|Ongoing|60|||
131239532|NCT04157348|472504214|FG001|Open-label Extension Period|Ongoing|57|||
131239533|NCT04157348|472504213|FG000|Open-label Extension Period|other reasons|1|||
131239534|NCT04157348|472504214|FG001|Open-label Extension Period|other reasons|1|||
131239535|NCT04970654|472504215|FG000|Overall Study|Withdrawal by parents/guardian|1|||
131239536|NCT04970654|472504216|FG001|Overall Study|Withdrawal by parents/guardian|2|||
131239537|NCT04970654|472504215|FG000|Overall Study|Unclassified|2|||
131239538|NCT04970654|472504216|FG001|Overall Study|Unclassified|1|||
131239539|NCT04970654|472504215|FG000|Overall Study|Lost to Follow-up|1|||
131239540|NCT04970654|472504216|FG001|Overall Study|Lost to Follow-up|0|||
131239541|NCT05163353|472504218|FG000|Overall Study|Adverse Event|1|||
131239542|NCT05163353|472504219|FG001|Overall Study|Adverse Event|0|||
131239543|NCT05163353|472504218|FG000|Overall Study|Withdrawal by Subject|21|||
131239544|NCT05163353|472504219|FG001|Overall Study|Withdrawal by Subject|6|||
131239545|NCT05163353|472504218|FG000|Overall Study|Protocol Violation|0|||
131239546|NCT05163353|472504219|FG001|Overall Study|Protocol Violation|1|||
131239547|NCT05163353|472504218|FG000|Overall Study|Lost to Follow-up|13|||
131239548|NCT05163353|472504219|FG001|Overall Study|Lost to Follow-up|2|||
131239549|NCT06176768|472504220|FG000|Overall Study|Adverse Event|1|||
131239550|NCT06176768|472504221|FG001|Overall Study|Adverse Event|0|||
131239551|NCT06176768|472504220|FG000|Overall Study|Assigned treatment by mistake|1|||
131239552|NCT06176768|472504221|FG001|Overall Study|Assigned treatment by mistake|0|||
131239553|NCT06176768|472504220|FG000|Overall Study|Lost to Follow-up|0|||
131239554|NCT06176768|472504221|FG001|Overall Study|Lost to Follow-up|3|||
131239555|NCT06176768|472504220|FG000|Overall Study|Physician Decision|1|||
131239556|NCT06176768|472504221|FG001|Overall Study|Physician Decision|0|||
131239557|NCT06176768|472504220|FG000|Overall Study|Protocol deviation|3|||
131239558|NCT06176768|472504221|FG001|Overall Study|Protocol deviation|1|||
131239559|NCT06176768|472504220|FG000|Overall Study|Other|1|||
131239560|NCT06176768|472504221|FG001|Overall Study|Other|0|||
131239561|NCT06176768|472504220|FG000|Overall Study|Withdrawal by Subject|6|||
131239562|NCT06176768|472504221|FG001|Overall Study|Withdrawal by Subject|9|||
131239563|NCT04666259|472504222|FG000|Treatment Phase|Physician Decision|9|||
131239564|NCT04666259|472504223|FG001|Treatment Phase|Physician Decision|3|||
131239565|NCT04666259|472504224|FG002|Treatment Phase|Physician Decision|3|||
131239566|NCT04666259|472504222|FG000|Treatment Phase|Adverse Event|3|||
131239567|NCT04666259|472504223|FG001|Treatment Phase|Adverse Event|1|||
131239568|NCT04666259|472504224|FG002|Treatment Phase|Adverse Event|0|||
131239569|NCT04666259|472504222|FG000|Treatment Phase|Subject decision|1|||
131239570|NCT04666259|472504223|FG001|Treatment Phase|Subject decision|2|||
131239571|NCT04666259|472504224|FG002|Treatment Phase|Subject decision|0|||
131239572|NCT04666259|472504222|FG000|Treatment Phase|Progressive disease|0|||
131183806|NCT03814005|472293831|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
131183807|NCT03814005|472293832|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
131183808|NCT03814005|472293830|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
131183809|NCT03814005|472293831|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
131183810|NCT03814005|472293832|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
131183811|NCT03395223|472293833|FG000|Overall Study|Lost to Follow-up|3|||
131183812|NCT03395223|472293833|FG000|Overall Study|Other|1|||
131183813|NCT01855945|472293839|FG000|Overall Study|Adverse Event|0|||
131183814|NCT01855945|472293840|FG001|Overall Study|Adverse Event|0|||
131183815|NCT01855945|472293841|FG002|Overall Study|Adverse Event|0|||
131183816|NCT01855945|472293842|FG003|Overall Study|Adverse Event|0|||
131183817|NCT01855945|472293843|FG004|Overall Study|Adverse Event|0|||
131183818|NCT01855945|472293844|FG005|Overall Study|Adverse Event|0|||
131183819|NCT01855945|472293845|FG006|Overall Study|Adverse Event|1|||
131183820|NCT01855945|472293846|FG007|Overall Study|Adverse Event|0|||
131183821|NCT01855945|472293847|FG008|Overall Study|Adverse Event|0|||
131183822|NCT01855945|472293848|FG009|Overall Study|Adverse Event|0|||
131183823|NCT01855945|472293849|FG010|Overall Study|Adverse Event|0|||
131183824|NCT01855945|472293850|FG011|Overall Study|Adverse Event|0|||
131183825|NCT01855945|472293839|FG000|Overall Study|Death|0|||
131183826|NCT01855945|472293840|FG001|Overall Study|Death|0|||
131183827|NCT01855945|472293841|FG002|Overall Study|Death|0|||
131183828|NCT01855945|472293842|FG003|Overall Study|Death|0|||
131183829|NCT01855945|472293843|FG004|Overall Study|Death|0|||
131183830|NCT01855945|472293844|FG005|Overall Study|Death|0|||
131183831|NCT01855945|472293845|FG006|Overall Study|Death|2|||
131183832|NCT01855945|472293846|FG007|Overall Study|Death|0|||
131183833|NCT01855945|472293847|FG008|Overall Study|Death|0|||
131183834|NCT01855945|472293848|FG009|Overall Study|Death|0|||
131183835|NCT01855945|472293849|FG010|Overall Study|Death|0|||
131183836|NCT01855945|472293850|FG011|Overall Study|Death|0|||
131183837|NCT01855945|472293839|FG000|Overall Study|Lost to Follow-up|11|||
131183838|NCT01855945|472293840|FG001|Overall Study|Lost to Follow-up|10|||
131183839|NCT01855945|472293841|FG002|Overall Study|Lost to Follow-up|7|||
131183840|NCT01855945|472293842|FG003|Overall Study|Lost to Follow-up|3|||
131183841|NCT01855945|472293843|FG004|Overall Study|Lost to Follow-up|0|||
131183842|NCT01855945|472293844|FG005|Overall Study|Lost to Follow-up|3|||
131183843|NCT01855945|472293845|FG006|Overall Study|Lost to Follow-up|4|||
131183844|NCT01855945|472293846|FG007|Overall Study|Lost to Follow-up|7|||
131183845|NCT01855945|472293847|FG008|Overall Study|Lost to Follow-up|2|||
131183846|NCT01855945|472293848|FG009|Overall Study|Lost to Follow-up|0|||
131183847|NCT01855945|472293849|FG010|Overall Study|Lost to Follow-up|0|||
131183848|NCT01855945|472293850|FG011|Overall Study|Lost to Follow-up|2|||
131183849|NCT01855945|472293839|FG000|Overall Study|Other - Unclassified|1|||
131183850|NCT01855945|472293840|FG001|Overall Study|Other - Unclassified|1|||
131183851|NCT01855945|472293841|FG002|Overall Study|Other - Unclassified|1|||
131183852|NCT01855945|472293842|FG003|Overall Study|Other - Unclassified|0|||
131183853|NCT01855945|472293843|FG004|Overall Study|Other - Unclassified|0|||
131183854|NCT01855945|472293844|FG005|Overall Study|Other - Unclassified|0|||
131183855|NCT01855945|472293845|FG006|Overall Study|Other - Unclassified|2|||
131183856|NCT01855945|472293846|FG007|Overall Study|Other - Unclassified|1|||
131183857|NCT01855945|472293847|FG008|Overall Study|Other - Unclassified|0|||
131183858|NCT01855945|472293848|FG009|Overall Study|Other - Unclassified|0|||
131183859|NCT01855945|472293849|FG010|Overall Study|Other - Unclassified|1|||
131183860|NCT01855945|472293850|FG011|Overall Study|Other - Unclassified|0|||
131183861|NCT01855945|472293839|FG000|Overall Study|Withdrawal by Subject|4|||
131183862|NCT01855945|472293840|FG001|Overall Study|Withdrawal by Subject|0|||
131183863|NCT01855945|472293841|FG002|Overall Study|Withdrawal by Subject|4|||
131183864|NCT01855945|472293842|FG003|Overall Study|Withdrawal by Subject|1|||
131183865|NCT01855945|472293843|FG004|Overall Study|Withdrawal by Subject|1|||
131183866|NCT01855945|472293844|FG005|Overall Study|Withdrawal by Subject|0|||
131183867|NCT01855945|472293845|FG006|Overall Study|Withdrawal by Subject|1|||
131183868|NCT01855945|472293846|FG007|Overall Study|Withdrawal by Subject|0|||
131183869|NCT01855945|472293847|FG008|Overall Study|Withdrawal by Subject|0|||
131183870|NCT01855945|472293848|FG009|Overall Study|Withdrawal by Subject|2|||
131183871|NCT01855945|472293849|FG010|Overall Study|Withdrawal by Subject|4|||
131183872|NCT01855945|472293850|FG011|Overall Study|Withdrawal by Subject|1|||
131183873|NCT01135017|472293851|FG000|Overall Study|Adverse Event|3|||
131183874|NCT01135017|472293852|FG001|Overall Study|Adverse Event|8|||
131183875|NCT01135017|472293851|FG000|Overall Study|Other than above|3|||
131183876|NCT01135017|472293852|FG001|Overall Study|Other than above|4|||
131183877|NCT01148693|472293853|FG000|Overall Study|Attempts for cannulation were failed|13|||
131183878|NCT01148693|472293854|FG001|Overall Study|Attempts for cannulation were failed|10|||
131183879|NCT01074658|472293857|FG000|Overall Study|No implant attempted|19|||
131183880|NCT01342952|472293858|FG000|Overall Study|Adverse Event|0|||
131183881|NCT01342952|472293859|FG001|Overall Study|Adverse Event|5|||
131183882|NCT01342952|472293860|FG002|Overall Study|Adverse Event|1|||
131183883|NCT01342952|472293861|FG003|Overall Study|Adverse Event|0|||
131183884|NCT01342952|472293858|FG000|Overall Study|Lost to Follow-up|0|||
131239573|NCT04666259|472504223|FG001|Treatment Phase|Progressive disease|1|||
131239574|NCT04666259|472504224|FG002|Treatment Phase|Progressive disease|0|||
131239575|NCT04666259|472504222|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
131239576|NCT04666259|472504223|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
131239577|NCT04666259|472504224|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
131239578|NCT04666259|472504222|FG000|Safety Follow-up Phase|Physician Decision|2|||
131239579|NCT04666259|472504223|FG001|Safety Follow-up Phase|Physician Decision|0|||
131239580|NCT04666259|472504224|FG002|Safety Follow-up Phase|Physician Decision|0|||
131239581|NCT04666259|472504222|FG000|Safety Follow-up Phase|Subject decision|1|||
131239582|NCT04666259|472504223|FG001|Safety Follow-up Phase|Subject decision|0|||
131239583|NCT04666259|472504224|FG002|Safety Follow-up Phase|Subject decision|0|||
131239584|NCT04666259|472504222|FG000|Safety Follow-up Phase|Death|0|||
131239585|NCT04666259|472504223|FG001|Safety Follow-up Phase|Death|1|||
131239586|NCT04666259|472504224|FG002|Safety Follow-up Phase|Death|0|||
131239587|NCT02632409|472504237|FG000|Randomized|AE unrelated to study Drug|0|||
131239588|NCT02632409|472504238|FG001|Randomized|AE unrelated to study Drug|1|||
131239589|NCT02632409|472504237|FG000|Randomized|Participant withdrew consent|2|||
131239590|NCT02632409|472504238|FG001|Randomized|Participant withdrew consent|1|||
131239591|NCT02632409|472504237|FG000|Randomized|No Longer meets study criteria|5|||
131239592|NCT02632409|472504238|FG001|Randomized|No Longer meets study criteria|0|||
131239593|NCT02632409|472504237|FG000|Randomized|other reasons|1|||
131239594|NCT02632409|472504238|FG001|Randomized|other reasons|0|||
131239595|NCT02632409|472504237|FG000|Treatment Period|Ongoing Treatment|20|||
131239596|NCT02632409|472504238|FG001|Treatment Period|Ongoing Treatment|21|||
131239597|NCT02632409|472504237|FG000|Treatment Period|Disease Recurrence|147|||
131239598|NCT02632409|472504238|FG001|Treatment Period|Disease Recurrence|90|||
131183885|NCT01342952|472293859|FG001|Overall Study|Lost to Follow-up|2|||
131183886|NCT01342952|472293860|FG002|Overall Study|Lost to Follow-up|0|||
131183887|NCT01342952|472293861|FG003|Overall Study|Lost to Follow-up|0|||
131183888|NCT01342952|472293858|FG000|Overall Study|Withdrawal by Subject|1|||
131183889|NCT01342952|472293859|FG001|Overall Study|Withdrawal by Subject|1|||
131183890|NCT01342952|472293860|FG002|Overall Study|Withdrawal by Subject|0|||
131183891|NCT01342952|472293861|FG003|Overall Study|Withdrawal by Subject|0|||
131183892|NCT01342952|472293858|FG000|Overall Study|Physician Decision|3|||
131183893|NCT01342952|472293859|FG001|Overall Study|Physician Decision|3|||
131183894|NCT01342952|472293860|FG002|Overall Study|Physician Decision|1|||
131183895|NCT01342952|472293861|FG003|Overall Study|Physician Decision|0|||
131183896|NCT01162304|472293866|FG000|Overall Study|Beck scale to high|11|||
131183897|NCT00425100|472293867|FG000|Overall Study|Adverse Event|36|||
131183898|NCT00425100|472293867|FG000|Overall Study|Lack of Efficacy|4|||
131183899|NCT00425100|472293867|FG000|Overall Study|Lost to Follow-up|2|||
131183900|NCT00425100|472293867|FG000|Overall Study|Protocol Violation|4|||
131183901|NCT00425100|472293867|FG000|Overall Study|Withdrawal by Subject|7|||
131183902|NCT03495817|472293868|FG000|26 Week Open Label|Adverse Event|3|||
131183903|NCT03495817|472293868|FG000|26 Week Open Label|Withdrawal by Subject|4|||
131183904|NCT03495817|472293868|FG000|26 Week Open Label|Lost to Follow-up|1|||
131183905|NCT03495817|472293868|FG000|26 Week Extension|Lost to Follow-up|2|||
131183906|NCT04169061|472293869|FG000|Overall Study|Adverse Event|2|||
131183907|NCT04169061|472293869|FG000|Overall Study|Death|1|||
131183908|NCT04169061|472293869|FG000|Overall Study|Withdrawal by Subject|1|||
131183909|NCT04169061|472293869|FG000|Overall Study|Protocol Violation|1|||
131183910|NCT04585451|472293870|FG000|Overall Study|Withdrawal by Subject|26|||
131183911|NCT04585451|472293871|FG001|Overall Study|Withdrawal by Subject|0|||
131183912|NCT00326417|472293872|FG000|Overall Study|Withdrawal by Subject|0|||
131183913|NCT00326417|472293873|FG001|Overall Study|Withdrawal by Subject|0|||
131183914|NCT00326417|472293874|FG002|Overall Study|Withdrawal by Subject|1|||
131183915|NCT00326417|472293875|FG003|Overall Study|Withdrawal by Subject|0|||
131183916|NCT00326417|472293872|FG000|Overall Study|Arm Closed|7|||
131183917|NCT00326417|472293873|FG001|Overall Study|Arm Closed|0|||
131183918|NCT00326417|472293874|FG002|Overall Study|Arm Closed|0|||
131183919|NCT00326417|472293875|FG003|Overall Study|Arm Closed|3|||
131183920|NCT00326417|472293872|FG000|Overall Study|Death|7|||
131239599|NCT02632409|472504237|FG000|Treatment Period|Study Drug Toxicity|8|||
131239600|NCT02632409|472504238|FG001|Treatment Period|Study Drug Toxicity|49|||
131239601|NCT02632409|472504237|FG000|Treatment Period|Death|1|||
131239602|NCT02632409|472504238|FG001|Treatment Period|Death|0|||
131239603|NCT02632409|472504237|FG000|Treatment Period|AE unrelated to study drug|15|||
131183921|NCT00326417|472293873|FG001|Overall Study|Death|0|||
131183922|NCT00326417|472293874|FG002|Overall Study|Death|0|||
131183923|NCT00326417|472293875|FG003|Overall Study|Death|0|||
131183924|NCT00844285|472293876|FG000|Overall Study|Other|0|||
131239604|NCT02632409|472504238|FG001|Treatment Period|AE unrelated to study drug|16|||
131183925|NCT00844285|472293877|FG001|Overall Study|Other|1|||
131183926|NCT00844285|472293878|FG002|Overall Study|Other|0|||
131183927|NCT00844285|472293876|FG000|Overall Study|Other than specified|95|||
131183928|NCT00844285|472293877|FG001|Overall Study|Other than specified|129|||
131183929|NCT00844285|472293878|FG002|Overall Study|Other than specified|12|||
131183930|NCT00844285|472293876|FG000|Overall Study|Site closure|256|||
131183931|NCT00844285|472293877|FG001|Overall Study|Site closure|450|||
131183932|NCT00844285|472293878|FG002|Overall Study|Site closure|50|||
131183933|NCT00844285|472293876|FG000|Overall Study|Follow-up < 8 years|16|||
131183934|NCT00844285|472293877|FG001|Overall Study|Follow-up < 8 years|23|||
131183935|NCT00844285|472293878|FG002|Overall Study|Follow-up < 8 years|4|||
131183936|NCT00844285|472293876|FG000|Overall Study|Protocol Violation|26|||
131183937|NCT00844285|472293877|FG001|Overall Study|Protocol Violation|28|||
131183938|NCT00844285|472293878|FG002|Overall Study|Protocol Violation|54|||
131183939|NCT00844285|472293876|FG000|Overall Study|Death|22|||
131183940|NCT00844285|472293877|FG001|Overall Study|Death|21|||
131183941|NCT00844285|472293878|FG002|Overall Study|Death|8|||
131183942|NCT00844285|472293876|FG000|Overall Study|Withdrew Consent|344|||
131183943|NCT00844285|472293877|FG001|Overall Study|Withdrew Consent|466|||
131183944|NCT00844285|472293878|FG002|Overall Study|Withdrew Consent|70|||
131183945|NCT00844285|472293876|FG000|Overall Study|Lost to Follow-up|330|||
131183946|NCT00844285|472293877|FG001|Overall Study|Lost to Follow-up|486|||
131183947|NCT00844285|472293878|FG002|Overall Study|Lost to Follow-up|74|||
131183948|NCT00555906|472293883|FG000|Phase 1|Objective Progression or Relapse|3|||
131183949|NCT00555906|472293884|FG001|Phase 1|Objective Progression or Relapse|5|||
131183950|NCT00555906|472293885|FG002|Phase 1|Objective Progression or Relapse|3|||
131183951|NCT00555906|472293886|FG003|Phase 1|Objective Progression or Relapse|1|||
131183952|NCT00555906|472293887|FG004|Phase 1|Objective Progression or Relapse|0|||
131183953|NCT00555906|472293883|FG000|Phase 1|Global Deterioration of Health Status|0|||
131183954|NCT00555906|472293884|FG001|Phase 1|Global Deterioration of Health Status|1|||
131183955|NCT00555906|472293885|FG002|Phase 1|Global Deterioration of Health Status|1|||
131183956|NCT00555906|472293886|FG003|Phase 1|Global Deterioration of Health Status|1|||
131183957|NCT00555906|472293887|FG004|Phase 1|Global Deterioration of Health Status|0|||
131183958|NCT00555906|472293883|FG000|Phase 1|Adverse Event|0|||
131183959|NCT00555906|472293884|FG001|Phase 1|Adverse Event|0|||
131183960|NCT00555906|472293885|FG002|Phase 1|Adverse Event|3|||
131183961|NCT00555906|472293886|FG003|Phase 1|Adverse Event|2|||
131183962|NCT00555906|472293887|FG004|Phase 1|Adverse Event|0|||
131183963|NCT00555906|472293883|FG000|Phase 1|Withdrawal by Subject|0|||
131183964|NCT00555906|472293884|FG001|Phase 1|Withdrawal by Subject|0|||
131183965|NCT00555906|472293885|FG002|Phase 1|Withdrawal by Subject|0|||
131183966|NCT00555906|472293886|FG003|Phase 1|Withdrawal by Subject|1|||
131183967|NCT00555906|472293887|FG004|Phase 1|Withdrawal by Subject|0|||
131183968|NCT00555906|472293883|FG000|Phase 2|Adverse Event|0|||
131183969|NCT00555906|472293884|FG001|Phase 2|Adverse Event|0|||
131183970|NCT00555906|472293885|FG002|Phase 2|Adverse Event|0|||
131183971|NCT00555906|472293886|FG003|Phase 2|Adverse Event|0|||
131183972|NCT00555906|472293887|FG004|Phase 2|Adverse Event|4|||
131183973|NCT00555906|472293883|FG000|Phase 2|Global Deterioration of Health Status|0|||
131183974|NCT00555906|472293884|FG001|Phase 2|Global Deterioration of Health Status|0|||
131183975|NCT00555906|472293885|FG002|Phase 2|Global Deterioration of Health Status|0|||
131183976|NCT00555906|472293886|FG003|Phase 2|Global Deterioration of Health Status|0|||
131183977|NCT00555906|472293887|FG004|Phase 2|Global Deterioration of Health Status|2|||
131183978|NCT00555906|472293883|FG000|Phase 2|Objective Progression or Relapse|0|||
131183979|NCT00555906|472293884|FG001|Phase 2|Objective Progression or Relapse|0|||
131183980|NCT00555906|472293885|FG002|Phase 2|Objective Progression or Relapse|0|||
131183981|NCT00555906|472293886|FG003|Phase 2|Objective Progression or Relapse|0|||
131183982|NCT00555906|472293887|FG004|Phase 2|Objective Progression or Relapse|16|||
131183983|NCT00555906|472293883|FG000|Phase 2|Withdrawal by Subject|0|||
131183984|NCT00555906|472293884|FG001|Phase 2|Withdrawal by Subject|0|||
131183985|NCT00555906|472293885|FG002|Phase 2|Withdrawal by Subject|0|||
131183986|NCT00555906|472293886|FG003|Phase 2|Withdrawal by Subject|0|||
131183987|NCT00555906|472293887|FG004|Phase 2|Withdrawal by Subject|2|||
131183988|NCT00555906|472293883|FG000|Phase 2|Other|0|||
131183989|NCT00555906|472293884|FG001|Phase 2|Other|0|||
131183990|NCT00555906|472293885|FG002|Phase 2|Other|0|||
131183991|NCT00555906|472293886|FG003|Phase 2|Other|0|||
131183992|NCT00555906|472293887|FG004|Phase 2|Other|6|||
131183993|NCT00555906|472293883|FG000|Phase 2|Randomized but not Treated|0|||
131183994|NCT00555906|472293884|FG001|Phase 2|Randomized but not Treated|0|||
131183995|NCT00555906|472293885|FG002|Phase 2|Randomized but not Treated|0|||
131183996|NCT00555906|472293886|FG003|Phase 2|Randomized but not Treated|0|||
131183997|NCT00555906|472293887|FG004|Phase 2|Randomized but not Treated|2|||
131183998|NCT04046341|472293888|FG000|Overall Study|Lost to Follow-up|2|||
131239605|NCT02632409|472504237|FG000|Treatment Period|Request to discontinue treatment|4|||
131183999|NCT04046341|472293888|FG000|Overall Study|Withdrawal by Subject|1|||
131184000|NCT00405652|472293891|FG000|Overall Study|Adverse Event|4|||
131184001|NCT03505749|472293892|FG000|Overall Study|Lost to Follow-up|7|||
131184002|NCT03505749|472293893|FG001|Overall Study|Lost to Follow-up|11|||
131184003|NCT03505749|472293892|FG000|Overall Study|Withdrawal by Subject|6|||
131184004|NCT03505749|472293893|FG001|Overall Study|Withdrawal by Subject|0|||
131184005|NCT03505749|472293892|FG000|Overall Study|Discharged from treatment|3|||
131184006|NCT03505749|472293893|FG001|Overall Study|Discharged from treatment|6|||
131184007|NCT00435994|472293894|FG000|Overall Study|Lost to Follow-up|7|||
131184008|NCT00435994|472293895|FG001|Overall Study|Lost to Follow-up|0|||
131184009|NCT00435994|472293896|FG002|Overall Study|Lost to Follow-up|0|||
131184010|NCT03549117|472293900|FG000|Overall Study|Withdrawal by Subject|1|||
131184011|NCT03549117|472293901|FG001|Overall Study|Withdrawal by Subject|0|||
131184012|NCT00888615|472293902|FG000|Overall Study|No treatment|2|||
131184013|NCT02091921|472293905|FG000|Overall Study|Adverse Event|3|||
131184014|NCT03307629|472293906|FG000|Overall Study|Withdrawal by Subject|0|||
131184015|NCT03307629|472293907|FG001|Overall Study|Withdrawal by Subject|0|||
131184016|NCT03307629|472293908|FG002|Overall Study|Withdrawal by Subject|0|||
131184017|NCT03307629|472293909|FG003|Overall Study|Withdrawal by Subject|2|||
131184018|NCT03307629|472293906|FG000|Overall Study|Disease Progression|0|||
131184019|NCT03307629|472293907|FG001|Overall Study|Disease Progression|0|||
131184020|NCT03307629|472293908|FG002|Overall Study|Disease Progression|0|||
131184021|NCT03307629|472293909|FG003|Overall Study|Disease Progression|3|||
131184022|NCT03307629|472293906|FG000|Overall Study|Death|0|||
131184023|NCT03307629|472293907|FG001|Overall Study|Death|3|||
131184024|NCT03307629|472293908|FG002|Overall Study|Death|0|||
131184025|NCT03307629|472293909|FG003|Overall Study|Death|1|||
131184026|NCT00719953|472293914|FG000|Overall Study|Adverse Event|4|||
131184027|NCT01626989|472293915|FG000|Screening Period|Screen Failure|15|||
131184028|NCT01626989|472293916|FG001|Screening Period|Screen Failure|0|||
131184029|NCT01626989|472293917|FG002|Screening Period|Screen Failure|0|||
131184030|NCT01626989|472293915|FG000|Screening Period|Withdrawal by Subject|2|||
131184031|NCT01626989|472293916|FG001|Screening Period|Withdrawal by Subject|0|||
131184032|NCT01626989|472293917|FG002|Screening Period|Withdrawal by Subject|0|||
131184033|NCT04021706|472295521|FG000|Overall Study|Adverse Event|2|||
131184034|NCT04021706|472295522|FG001|Overall Study|Adverse Event|0|||
131184035|NCT04021706|472295521|FG000|Overall Study|Withdrawal by Subject|1|||
131184036|NCT04021706|472295522|FG001|Overall Study|Withdrawal by Subject|2|||
131184037|NCT04021706|472295521|FG000|Overall Study|Physician Decision|1|||
131184038|NCT04021706|472295522|FG001|Overall Study|Physician Decision|0|||
131184039|NCT01412151|472295523|FG000|Week 0 - 306 - Treatment Period|Death|1|||
131184040|NCT01412151|472295523|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
131184041|NCT01412151|472295523|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
131184042|NCT01412151|472295523|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
131184043|NCT03127852|472295525|FG000|Overall Study|Withdrawal by Subject|4|||
131184044|NCT03127852|472295526|FG001|Overall Study|Withdrawal by Subject|1|||
131184045|NCT03127852|472295525|FG000|Overall Study|Death|1|||
131184046|NCT03127852|472295526|FG001|Overall Study|Death|1|||
131184047|NCT00859573|472295528|FG000|Overall Study|Withdrawal by Subject|4|||
131184048|NCT00859573|472295529|FG001|Overall Study|Withdrawal by Subject|1|||
131184049|NCT00859573|472295528|FG000|Overall Study|Physician Decision|1|||
131184050|NCT00859573|472295529|FG001|Overall Study|Physician Decision|1|||
131184051|NCT01432457|472295530|FG000|Overall Study|Adverse Event|7|||
131184052|NCT01432457|472295531|FG001|Overall Study|Adverse Event|10|||
131184053|NCT01432457|472295532|FG002|Overall Study|Adverse Event|16|||
131184054|NCT01432457|472295530|FG000|Overall Study|Lack of Efficacy|2|||
131184055|NCT01432457|472295531|FG001|Overall Study|Lack of Efficacy|1|||
131184056|NCT01432457|472295532|FG002|Overall Study|Lack of Efficacy|1|||
131184057|NCT01432457|472295530|FG000|Overall Study|Lost to Follow-up|11|||
131184058|NCT01432457|472295531|FG001|Overall Study|Lost to Follow-up|15|||
131184059|NCT01432457|472295532|FG002|Overall Study|Lost to Follow-up|20|||
131184060|NCT01432457|472295530|FG000|Overall Study|Protocol Violation|3|||
131184061|NCT01432457|472295531|FG001|Overall Study|Protocol Violation|2|||
131184062|NCT01432457|472295532|FG002|Overall Study|Protocol Violation|6|||
131184063|NCT01432457|472295530|FG000|Overall Study|Withdrawal by Subject|6|||
131184064|NCT01432457|472295531|FG001|Overall Study|Withdrawal by Subject|11|||
131184065|NCT01432457|472295532|FG002|Overall Study|Withdrawal by Subject|9|||
131239606|NCT02632409|472504238|FG001|Treatment Period|Request to discontinue treatment|19|||
131239607|NCT02632409|472504237|FG000|Treatment Period|Participant withdrew consent|7|||
131239608|NCT02632409|472504238|FG001|Treatment Period|Participant withdrew consent|5|||
131239609|NCT02632409|472504237|FG000|Treatment Period|Lost to Follow-up|0|||
131184066|NCT01432457|472295530|FG000|Overall Study|Reasons not defined|2|||
131184067|NCT01432457|472295531|FG001|Overall Study|Reasons not defined|3|||
131184068|NCT01432457|472295532|FG002|Overall Study|Reasons not defined|4|||
131184069|NCT01432457|472295530|FG000|Overall Study|Did not take study drug|6|||
131184070|NCT01432457|472295531|FG001|Overall Study|Did not take study drug|6|||
131184071|NCT01432457|472295532|FG002|Overall Study|Did not take study drug|3|||
131184072|NCT02574481|472295533|FG000|Overall Study|Withdrawal by Subject|29|||
131184073|NCT02574481|472295534|FG001|Overall Study|Withdrawal by Subject|15|||
131184074|NCT02574481|472295535|FG002|Overall Study|Withdrawal by Subject|4|||
131184075|NCT02574481|472295536|FG003|Overall Study|Withdrawal by Subject|1|||
131184076|NCT02574481|472295533|FG000|Overall Study|Adverse Event|5|||
131239610|NCT02632409|472504238|FG001|Treatment Period|Lost to Follow-up|1|||
131239611|NCT02632409|472504237|FG000|Treatment Period|Maximum clinical benefit|1|||
131184077|NCT02574481|472295534|FG001|Overall Study|Adverse Event|1|||
131184078|NCT02574481|472295535|FG002|Overall Study|Adverse Event|1|||
131184079|NCT02574481|472295536|FG003|Overall Study|Adverse Event|0|||
131184080|NCT02574481|472295533|FG000|Overall Study|Visit Missed|15|||
131184081|NCT02574481|472295534|FG001|Overall Study|Visit Missed|7|||
131184082|NCT02574481|472295535|FG002|Overall Study|Visit Missed|5|||
131184083|NCT02574481|472295536|FG003|Overall Study|Visit Missed|0|||
131184084|NCT02574481|472295533|FG000|Overall Study|Other|7|||
131184085|NCT02574481|472295534|FG001|Overall Study|Other|2|||
131184086|NCT02574481|472295535|FG002|Overall Study|Other|0|||
131184087|NCT02574481|472295536|FG003|Overall Study|Other|0|||
131184088|NCT02574481|472295533|FG000|Overall Study|Death|48|||
131184089|NCT02574481|472295534|FG001|Overall Study|Death|26|||
131184090|NCT02574481|472295535|FG002|Overall Study|Death|12|||
131184091|NCT02574481|472295536|FG003|Overall Study|Death|4|||
131184092|NCT02574481|472295533|FG000|Overall Study|Physician Decision|5|||
131184093|NCT02574481|472295534|FG001|Overall Study|Physician Decision|2|||
131184094|NCT02574481|472295535|FG002|Overall Study|Physician Decision|0|||
131184095|NCT02574481|472295536|FG003|Overall Study|Physician Decision|0|||
131184096|NCT02574481|472295533|FG000|Overall Study|Lost to Follow-up|5|||
131184097|NCT02574481|472295534|FG001|Overall Study|Lost to Follow-up|1|||
131184098|NCT02574481|472295535|FG002|Overall Study|Lost to Follow-up|3|||
131184099|NCT02574481|472295536|FG003|Overall Study|Lost to Follow-up|0|||
131184100|NCT02905825|472295541|FG000|Overall Study|Protocol Violation|11|||
131184101|NCT02905825|472295541|FG000|Overall Study|Device Malfunction|1|||
131184102|NCT01281189|472295542|FG000|Overall Study|Adverse Event|7|||
131184103|NCT01281189|472295543|FG001|Overall Study|Adverse Event|9|||
131184104|NCT01281189|472295542|FG000|Overall Study|Lost to Follow-up|6|||
131184105|NCT01281189|472295543|FG001|Overall Study|Lost to Follow-up|4|||
131184106|NCT01281189|472295542|FG000|Overall Study|Withdrawal by Subject|21|||
131184107|NCT01281189|472295543|FG001|Overall Study|Withdrawal by Subject|24|||
131184108|NCT01281189|472295542|FG000|Overall Study|Physician Decision|2|||
131184109|NCT01281189|472295543|FG001|Overall Study|Physician Decision|3|||
131184110|NCT01281189|472295542|FG000|Overall Study|Death|103|||
131184111|NCT01281189|472295543|FG001|Overall Study|Death|91|||
131184112|NCT01281189|472295542|FG000|Overall Study|Other|8|||
131184113|NCT01281189|472295543|FG001|Overall Study|Other|12|||
131184114|NCT01136746|472295544|FG000|Overall Study|Lost to Follow-up|0|||
131184115|NCT01136746|472295545|FG001|Overall Study|Lost to Follow-up|2|||
131184116|NCT01136746|472295544|FG000|Overall Study|Protocol Violation|2|||
131239612|NCT02632409|472504238|FG001|Treatment Period|Maximum clinical benefit|0|||
131239613|NCT02632409|472504237|FG000|Treatment Period|No longer meets study criteria|3|||
131184117|NCT01136746|472295545|FG001|Overall Study|Protocol Violation|1|||
131184118|NCT01136746|472295544|FG000|Overall Study|Death|1|||
131184119|NCT01136746|472295545|FG001|Overall Study|Death|0|||
131239614|NCT02632409|472504238|FG001|Treatment Period|No longer meets study criteria|0|||
131239615|NCT02632409|472504237|FG000|Treatment Period|Administrative Reason by sponsor|0|||
131239616|NCT02632409|472504238|FG001|Treatment Period|Administrative Reason by sponsor|1|||
131239617|NCT02632409|472504237|FG000|Treatment Period|Other Reasons|10|||
131239618|NCT02632409|472504238|FG001|Treatment Period|Other Reasons|6|||
131239619|NCT02137850|472504239|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
131239620|NCT02137850|472504240|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
131239621|NCT02137850|472504241|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
131239622|NCT02137850|472504239|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
131239623|NCT02137850|472504240|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
131184120|NCT01090102|472295551|FG000|First 12 Weeks|Withdrawal by Subject|1|||
131184121|NCT01090102|472295552|FG001|First 12 Weeks|Withdrawal by Subject|1|||
131184122|NCT01090102|472295551|FG000|First 12 Weeks|Adverse Event|2|||
131184123|NCT01090102|472295552|FG001|First 12 Weeks|Adverse Event|0|||
131184124|NCT01090102|472295551|FG000|First 12 Weeks|Death|1|||
131184125|NCT01090102|472295552|FG001|First 12 Weeks|Death|1|||
131184126|NCT01090102|472295551|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
131184127|NCT01090102|472295552|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
131184128|NCT03518034|472295553|FG000|Overall Study|Not Treated|5|||
131184129|NCT03518034|472295554|FG001|Overall Study|Not Treated|1|||
131184130|NCT03518034|472295553|FG000|Overall Study|Withdrawal by Subject|309|||
131184131|NCT03518034|472295554|FG001|Overall Study|Withdrawal by Subject|351|||
131184132|NCT03518034|472295553|FG000|Overall Study|Lost to Follow-up|446|||
131239624|NCT02137850|472504241|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
131184133|NCT03518034|472295554|FG001|Overall Study|Lost to Follow-up|458|||
131184134|NCT03518034|472295553|FG000|Overall Study|Adverse Event|138|||
131184135|NCT03518034|472295554|FG001|Overall Study|Adverse Event|130|||
131184136|NCT03518034|472295553|FG000|Overall Study|Lack of Efficacy|11|||
131184137|NCT03518034|472295554|FG001|Overall Study|Lack of Efficacy|23|||
131184138|NCT03518034|472295553|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
131239625|NCT02137850|472504239|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
131184139|NCT03518034|472295554|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
131184140|NCT03518034|472295553|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
131239626|NCT02137850|472504240|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
131239627|NCT02137850|472504241|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
131239628|NCT02137850|472504239|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
131184141|NCT03518034|472295554|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
131184142|NCT03518034|472295553|FG000|Overall Study|Other, Not Specified|84|||
131184143|NCT03518034|472295554|FG001|Overall Study|Other, Not Specified|53|||
131184144|NCT03518034|472295553|FG000|Overall Study|Reason Missing|2|||
131184145|NCT03518034|472295554|FG001|Overall Study|Reason Missing|3|||
131184146|NCT00010803|472295560|FG000|Overall Study|Withdrawal by Subject|97|||
131184147|NCT00010803|472295561|FG001|Overall Study|Withdrawal by Subject|98|||
131184148|NCT01019252|472295562|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
131184149|NCT01019252|472295563|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
131184150|NCT01019252|472295562|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
131184151|NCT01019252|472295563|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
131184152|NCT01019252|472295562|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
131184153|NCT01019252|472295563|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
131184154|NCT01019252|472295562|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
131184155|NCT01019252|472295563|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
131184156|NCT02273037|472295564|FG000|Overall Study|Lost to Follow-up|1|||
131184157|NCT02273037|472295565|FG001|Overall Study|Lost to Follow-up|0|||
131184158|NCT02273037|472295564|FG000|Overall Study|Delivered before monitoring initiated|1|||
131184159|NCT02273037|472295565|FG001|Overall Study|Delivered before monitoring initiated|3|||
131184160|NCT02273037|472295564|FG000|Overall Study|Breech delivery|2|||
131184161|NCT02273037|472295565|FG001|Overall Study|Breech delivery|3|||
131184162|NCT02273037|472295564|FG000|Overall Study|Multiple delivery|2|||
131184163|NCT02273037|472295565|FG001|Overall Study|Multiple delivery|2|||
131184164|NCT02273037|472295564|FG000|Overall Study|Other complication|2|||
131184165|NCT02273037|472295565|FG001|Overall Study|Other complication|0|||
131184166|NCT03351478|472295568|FG000|Overall Study|At the subject's own request|11|||
131184167|NCT03351478|472295569|FG001|Overall Study|At the subject's own request|12|||
131184168|NCT03351478|472295570|FG002|Overall Study|At the subject's own request|5|||
131184169|NCT03351478|472295568|FG000|Overall Study|Adverse Event|1|||
131184170|NCT03351478|472295569|FG001|Overall Study|Adverse Event|2|||
131184171|NCT03351478|472295570|FG002|Overall Study|Adverse Event|1|||
131184172|NCT03351478|472295568|FG000|Overall Study|Poor compliance to protocol|1|||
131184173|NCT03351478|472295569|FG001|Overall Study|Poor compliance to protocol|0|||
131184174|NCT03351478|472295570|FG002|Overall Study|Poor compliance to protocol|0|||
131184175|NCT03351478|472295568|FG000|Overall Study|Reason not Specified|1|||
131184176|NCT03351478|472295569|FG001|Overall Study|Reason not Specified|3|||
131184177|NCT03351478|472295570|FG002|Overall Study|Reason not Specified|0|||
131184178|NCT03351478|472295568|FG000|Overall Study|Lost to Follow-up|0|||
131184179|NCT03351478|472295569|FG001|Overall Study|Lost to Follow-up|0|||
131184180|NCT03351478|472295570|FG002|Overall Study|Lost to Follow-up|1|||
131184181|NCT00985738|472295574|FG000|Overall Study|Study closed prematurely|8|||
131184182|NCT00985738|472295575|FG001|Overall Study|Study closed prematurely|8|||
131184183|NCT02227849|472295577|FG000|Overall Study|Adverse Event|4|||
131184184|NCT02227849|472295577|FG000|Overall Study|Physician Decision|1|||
131184185|NCT02227849|472295577|FG000|Overall Study|Withdrawal by Subject|3|||
131184186|NCT01590212|472295580|FG000|Overall Study|Withdrawal by Subject|2|||
131184187|NCT01590212|472295581|FG001|Overall Study|Withdrawal by Subject|2|||
131184188|NCT01590212|472295582|FG002|Overall Study|Withdrawal by Subject|2|||
131184189|NCT01590212|472295580|FG000|Overall Study|Lost to Follow-up|1|||
131184190|NCT01590212|472295581|FG001|Overall Study|Lost to Follow-up|2|||
131184191|NCT01590212|472295582|FG002|Overall Study|Lost to Follow-up|3|||
131184192|NCT02533401|472295583|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
131184193|NCT02533401|472295583|FG000|Overall Study|Death|5|||
131184194|NCT02533401|472295583|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
131184195|NCT02533401|472295583|FG000|Overall Study|Lost to Follow-up|1|||
131184196|NCT02533401|472295583|FG000|Overall Study|Violation of Selection Criteria|1|||
131184197|NCT04897594|472295586|FG000|Overall Study|Lost to Follow-up|0|||
131184198|NCT04897594|472295587|FG001|Overall Study|Lost to Follow-up|1|||
131184199|NCT04897594|472295588|FG002|Overall Study|Lost to Follow-up|1|||
131184200|NCT04897594|472295586|FG000|Overall Study|Sponsor Decision|0|||
131184201|NCT04897594|472295587|FG001|Overall Study|Sponsor Decision|0|||
131184202|NCT04897594|472295588|FG002|Overall Study|Sponsor Decision|1|||
131184203|NCT04897594|472295586|FG000|Overall Study|Withdrawal by Subject|1|||
131184204|NCT04897594|472295587|FG001|Overall Study|Withdrawal by Subject|0|||
131184205|NCT04897594|472295588|FG002|Overall Study|Withdrawal by Subject|1|||
131184206|NCT01467661|472295598|FG000|Overall Study|Adverse Event|16|||
131184207|NCT01467661|472295598|FG000|Overall Study|Withdrawal by Subject|1|||
131184208|NCT01467661|472295598|FG000|Overall Study|Lack of Efficacy|3|||
131184209|NCT01467661|472295598|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
131184210|NCT00270998|472295601|FG000|3 Month Follow-up|Adverse Event|1|||
131184211|NCT00270998|472295602|FG001|3 Month Follow-up|Adverse Event|0|||
131184212|NCT00270998|472295603|FG002|3 Month Follow-up|Adverse Event|0|||
131184213|NCT00270998|472295601|FG000|3 Month Follow-up|Lack of Efficacy|1|||
131184214|NCT00270998|472295602|FG001|3 Month Follow-up|Lack of Efficacy|2|||
131184215|NCT00270998|472295603|FG002|3 Month Follow-up|Lack of Efficacy|1|||
131184216|NCT00270998|472295601|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
131184217|NCT00270998|472295602|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
131184218|NCT00270998|472295603|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
131239629|NCT02137850|472504240|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
131239630|NCT02137850|472504241|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
131239631|NCT02137850|472504239|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
131239632|NCT02137850|472504240|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
131239633|NCT02137850|472504241|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
131239634|NCT02137850|472504239|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
131239635|NCT02137850|472504240|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
131239636|NCT02137850|472504241|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
131239637|NCT02137850|472504239|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
131239638|NCT02137850|472504240|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
131239639|NCT02137850|472504241|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
131239640|NCT02137850|472504239|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
131239641|NCT02137850|472504240|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
131239642|NCT02137850|472504241|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
131239643|NCT02137850|472504239|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
131239644|NCT02137850|472504240|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
131239645|NCT02137850|472504241|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
131239646|NCT02137850|472504239|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
131239647|NCT02137850|472504240|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
131239648|NCT02137850|472504241|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
130784518|NCT00492297|470838807|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
130784519|NCT00492297|470838807|FG000|Survival Only Follow-up|Death|46|||
130784520|NCT00492297|470838807|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
130784521|NCT00492297|470838807|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
130784522|NCT01408706|470838809|FG000|Overall Study|Physician Decision|1|||
131184219|NCT00270998|472295601|FG000|3 Month Follow-up|Pessary did not fit|12|||
131184220|NCT00270998|472295602|FG001|3 Month Follow-up|Pessary did not fit|0|||
131184221|NCT00270998|472295603|FG002|3 Month Follow-up|Pessary did not fit|0|||
131239649|NCT02137850|472504239|FG000|Main Phase: Prophylaxis|Other|0|||
131239650|NCT02137850|472504240|FG001|Main Phase: Prophylaxis|Other|1|||
131239651|NCT02137850|472504241|FG002|Main Phase: Prophylaxis|Other|0|||
131239652|NCT02137850|472504239|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
131239653|NCT02137850|472504240|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
131239654|NCT02137850|472504241|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
131239655|NCT02137850|472504239|FG000|Main Phase: Prophylaxis|Early site closure|0|||
131239656|NCT02137850|472504240|FG001|Main Phase: Prophylaxis|Early site closure|2|||
131239657|NCT02137850|472504241|FG002|Main Phase: Prophylaxis|Early site closure|0|||
131239658|NCT02137850|472504239|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
131184222|NCT00270998|472295601|FG000|3 Month Follow-up|Personal/family health|1|||
131184223|NCT00270998|472295602|FG001|3 Month Follow-up|Personal/family health|1|||
131184224|NCT00270998|472295603|FG002|3 Month Follow-up|Personal/family health|0|||
131184225|NCT00270998|472295601|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
131184226|NCT00270998|472295602|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
131184227|NCT00270998|472295603|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
131184228|NCT00270998|472295601|FG000|12 Month Follow-up|Lack of Efficacy|5|||
131184229|NCT00270998|472295602|FG001|12 Month Follow-up|Lack of Efficacy|4|||
131184230|NCT00270998|472295603|FG002|12 Month Follow-up|Lack of Efficacy|3|||
131184231|NCT00270998|472295601|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
131184232|NCT00270998|472295602|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
131184233|NCT00270998|472295603|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
131184234|NCT00270998|472295601|FG000|12 Month Follow-up|Pessary did not fit|1|||
131184235|NCT00270998|472295602|FG001|12 Month Follow-up|Pessary did not fit|0|||
131184236|NCT00270998|472295603|FG002|12 Month Follow-up|Pessary did not fit|0|||
131184237|NCT00270998|472295601|FG000|12 Month Follow-up|Personal/family health|0|||
131184238|NCT00270998|472295602|FG001|12 Month Follow-up|Personal/family health|5|||
131184239|NCT00270998|472295603|FG002|12 Month Follow-up|Personal/family health|1|||
131184240|NCT00270998|472295601|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
131184241|NCT00270998|472295602|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
131184242|NCT00270998|472295603|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
131184243|NCT00636441|472295604|FG000|Overall Study|Adverse Event|0|||
131184244|NCT00636441|472295605|FG001|Overall Study|Adverse Event|1|||
131184245|NCT00636441|472295606|FG002|Overall Study|Adverse Event|1|||
131239659|NCT02137850|472504240|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
131239660|NCT02137850|472504241|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
131239661|NCT02137850|472504239|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
131239662|NCT02137850|472504240|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
131239663|NCT02137850|472504241|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
131239664|NCT02137850|472504239|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
131239665|NCT02137850|472504240|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
131239666|NCT02137850|472504241|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
131184246|NCT00636441|472295607|FG003|Overall Study|Adverse Event|0|||
131184247|NCT00636441|472295608|FG004|Overall Study|Adverse Event|0|||
131184248|NCT00636441|472295609|FG005|Overall Study|Adverse Event|1|||
131184249|NCT00636441|472295610|FG006|Overall Study|Adverse Event|0|||
131184250|NCT00636441|472295604|FG000|Overall Study|Late, ineligible|0|||
131184251|NCT00636441|472295605|FG001|Overall Study|Late, ineligible|0|||
131184252|NCT00636441|472295606|FG002|Overall Study|Late, ineligible|0|||
131184253|NCT00636441|472295607|FG003|Overall Study|Late, ineligible|0|||
131184254|NCT00636441|472295608|FG004|Overall Study|Late, ineligible|0|||
131184255|NCT00636441|472295609|FG005|Overall Study|Late, ineligible|0|||
131184256|NCT00636441|472295610|FG006|Overall Study|Late, ineligible|1|||
131184257|NCT00636441|472295604|FG000|Overall Study|Screen Failure|0|||
131184258|NCT00636441|472295605|FG001|Overall Study|Screen Failure|0|||
131184259|NCT00636441|472295606|FG002|Overall Study|Screen Failure|0|||
131184260|NCT00636441|472295607|FG003|Overall Study|Screen Failure|0|||
131184261|NCT00636441|472295608|FG004|Overall Study|Screen Failure|0|||
131184262|NCT00636441|472295609|FG005|Overall Study|Screen Failure|0|||
131184263|NCT00636441|472295610|FG006|Overall Study|Screen Failure|17|||
131184264|NCT03219567|472295615|FG000|Overall Study|Withdrawal by Subject|0|||
131184265|NCT03219567|472295616|FG001|Overall Study|Withdrawal by Subject|1|||
131184266|NCT02849626|472295617|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
131184267|NCT02849626|472295618|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
131184268|NCT02849626|472295619|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
131184269|NCT02849626|472295620|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
131184270|NCT02849626|472295617|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
131184271|NCT02849626|472295618|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
131184272|NCT02849626|472295619|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
131184273|NCT02849626|472295620|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
131184274|NCT02849626|472295617|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
131184275|NCT02849626|472295618|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
131184276|NCT02849626|472295619|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
131184277|NCT02849626|472295620|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
131184278|NCT02849626|472295617|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
131184279|NCT02849626|472295618|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
131184280|NCT02849626|472295619|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
131184281|NCT02849626|472295620|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
131184282|NCT02849626|472295617|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
131184283|NCT02849626|472295618|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
131184284|NCT02849626|472295619|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
131184285|NCT02849626|472295620|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
131184286|NCT02849626|472295617|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
131184287|NCT02849626|472295618|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
131184288|NCT02849626|472295619|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
131184289|NCT02849626|472295620|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
131184290|NCT02849626|472295617|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
131184291|NCT02849626|472295618|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
131184292|NCT02849626|472295619|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
131184293|NCT02849626|472295620|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
131184294|NCT02849626|472295617|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
131184295|NCT02849626|472295618|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
131184296|NCT02849626|472295619|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
131184297|NCT02849626|472295620|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
131184298|NCT02849626|472295617|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
131184299|NCT02849626|472295618|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
131184300|NCT02849626|472295619|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
131184301|NCT02849626|472295620|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
131184302|NCT02849626|472295617|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
131184303|NCT02849626|472295618|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
131184304|NCT02849626|472295619|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
131184305|NCT02849626|472295620|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
131184306|NCT02849626|472295617|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
131184307|NCT02849626|472295618|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
131184308|NCT02849626|472295619|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
131184309|NCT02849626|472295620|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
131184310|NCT01654523|472295621|FG000|Overall Study|Withdrawal by Subject|1|||
131184311|NCT01313208|472295622|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
131184312|NCT01313208|472295623|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
131184313|NCT01313208|472295622|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
131184314|NCT01313208|472295623|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
131184315|NCT01313208|472295622|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
131184316|NCT01313208|472295623|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
131184317|NCT01313208|472295622|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
131184318|NCT01313208|472295623|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
131184319|NCT01313208|472295622|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
131184320|NCT01313208|472295623|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
131184321|NCT01313208|472295622|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
131184322|NCT01313208|472295623|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
131184323|NCT01313208|472295622|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
131184324|NCT01313208|472295623|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
131184325|NCT01313208|472295622|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
131184326|NCT01313208|472295623|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
131184327|NCT01313208|472295622|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
131184328|NCT01313208|472295623|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
131184329|NCT01957787|472295624|FG000|Overall Study|Death|18|||
131184330|NCT01957787|472295624|FG000|Overall Study|Lost to Follow-up|3|||
131184331|NCT01957787|472295624|FG000|Overall Study|Withdrawal by Subject|3|||
131184332|NCT01957787|472295624|FG000|Overall Study|Entered Hospice or Similar Program|2|||
131184333|NCT01957787|472295624|FG000|Overall Study|Index Tumor(s) Resected|2|||
131184334|NCT01957787|472295624|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
131184335|NCT01957787|472295624|FG000|Overall Study|Local therapy, not cryoablation|6|||
131184336|NCT04176445|472295625|FG000|Overall Study|Adverse Event|0|||
131184337|NCT04176445|472295626|FG001|Overall Study|Adverse Event|1|||
131184338|NCT04176445|472295625|FG000|Overall Study|change plans weaning after first intervention|0|||
131184339|NCT04176445|472295626|FG001|Overall Study|change plans weaning after first intervention|1|||
131239667|NCT02137850|472504239|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
131184340|NCT03846219|472295630|FG000|Overall Study|Withdrawal by Subject|3|||
131184341|NCT03846219|472295631|FG001|Overall Study|Withdrawal by Subject|2|||
131184342|NCT03846219|472295632|FG002|Overall Study|Withdrawal by Subject|2|||
131184343|NCT03846219|472295630|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
131184344|NCT03846219|472295631|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
131184345|NCT03846219|472295632|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
131184346|NCT03846219|472295630|FG000|Overall Study|Physician Decision|0|||
131184347|NCT03846219|472295631|FG001|Overall Study|Physician Decision|0|||
131184348|NCT03846219|472295632|FG002|Overall Study|Physician Decision|2|||
131184349|NCT05109702|472295633|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
131184350|NCT05109702|472295634|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
131184351|NCT05109702|472295635|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
131184352|NCT05109702|472295633|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
131184353|NCT05109702|472295634|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
131184354|NCT05109702|472295635|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
131184355|NCT05109702|472295633|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
131184356|NCT05109702|472295634|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
131184357|NCT05109702|472295635|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
131184358|NCT05109702|472295633|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
131184359|NCT05109702|472295634|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
131184360|NCT05109702|472295635|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
131239668|NCT02137850|472504240|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
131239669|NCT02137850|472504241|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
131239670|NCT02137850|472504239|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
131239671|NCT02137850|472504240|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
131239672|NCT02137850|472504241|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
131239673|NCT02137850|472504239|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
131239674|NCT02137850|472504240|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
131239675|NCT02137850|472504241|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
131239676|NCT02137850|472504239|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
131239677|NCT02137850|472504240|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
131239678|NCT02137850|472504241|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
131239679|NCT02137850|472504239|FG000|Extension Phase: Prophylaxis|Other|0|||
131184361|NCT05109702|472295633|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
131184362|NCT05109702|472295634|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
131184363|NCT05109702|472295635|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
131184364|NCT02322411|472295642|FG000|Overall Study|Lost to Follow-up|4|||
131184365|NCT02322411|472295643|FG001|Overall Study|Lost to Follow-up|7|||
131184366|NCT02322411|472295642|FG000|Overall Study|Withdrawal by Subject|1|||
131239680|NCT02137850|472504240|FG001|Extension Phase: Prophylaxis|Other|1|||
131239681|NCT02137850|472504241|FG002|Extension Phase: Prophylaxis|Other|0|||
131239682|NCT02137850|472504239|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
131239683|NCT02137850|472504240|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
131239684|NCT02137850|472504241|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
131239685|NCT05494788|472504242|FG000|Initial Treatment Period|Adverse Event|2|||
131239686|NCT05494788|472504242|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
131184367|NCT02322411|472295643|FG001|Overall Study|Withdrawal by Subject|0|||
131184368|NCT01392378|472295646|FG000|Infant Series|Adverse Event|0|||
131239687|NCT05494788|472504242|FG000|Extension Period|Adverse Event|1|||
131239688|NCT05494788|472504242|FG000|Extension Period|Withdrawal by Subject|1|||
131239689|NCT04178122|472504243|FG000|Overall Study|Withdrawal by Subject|1|||
131239690|NCT04178122|472504244|FG001|Overall Study|Withdrawal by Subject|1|||
131239691|NCT04178122|472504243|FG000|Overall Study|Death|2|||
131239692|NCT04178122|472504244|FG001|Overall Study|Death|0|||
131184369|NCT01392378|472295647|FG001|Infant Series|Adverse Event|0|||
131184370|NCT01392378|472295648|FG002|Infant Series|Adverse Event|0|||
131184371|NCT01392378|472295649|FG003|Infant Series|Adverse Event|1|||
131184372|NCT01392378|472295650|FG004|Infant Series|Adverse Event|0|||
131184373|NCT01392378|472295646|FG000|Infant Series|Lost to Follow-up|0|||
131184374|NCT01392378|472295647|FG001|Infant Series|Lost to Follow-up|0|||
131184375|NCT01392378|472295648|FG002|Infant Series|Lost to Follow-up|0|||
131184376|NCT01392378|472295649|FG003|Infant Series|Lost to Follow-up|1|||
131184377|NCT01392378|472295650|FG004|Infant Series|Lost to Follow-up|0|||
131184378|NCT01392378|472295646|FG000|Infant Series|Protocol Violation|0|||
131184379|NCT01392378|472295647|FG001|Infant Series|Protocol Violation|1|||
131184380|NCT01392378|472295648|FG002|Infant Series|Protocol Violation|0|||
131184381|NCT01392378|472295649|FG003|Infant Series|Protocol Violation|0|||
131184382|NCT01392378|472295650|FG004|Infant Series|Protocol Violation|0|||
131184383|NCT01392378|472295646|FG000|Infant Series|Withdrawal by Parent|4|||
131184384|NCT01392378|472295647|FG001|Infant Series|Withdrawal by Parent|1|||
131184385|NCT01392378|472295648|FG002|Infant Series|Withdrawal by Parent|0|||
131184386|NCT01392378|472295649|FG003|Infant Series|Withdrawal by Parent|0|||
131184387|NCT01392378|472295650|FG004|Infant Series|Withdrawal by Parent|0|||
131184388|NCT01392378|472295646|FG000|After Infant Series|Lost to Follow-up|0|||
131184389|NCT01392378|472295647|FG001|After Infant Series|Lost to Follow-up|0|||
131184390|NCT01392378|472295648|FG002|After Infant Series|Lost to Follow-up|1|||
131184391|NCT01392378|472295649|FG003|After Infant Series|Lost to Follow-up|0|||
131184392|NCT01392378|472295650|FG004|After Infant Series|Lost to Follow-up|0|||
131184393|NCT01392378|472295646|FG000|After Infant Series|Withdrawal by Parent|0|||
131184394|NCT01392378|472295647|FG001|After Infant Series|Withdrawal by Parent|1|||
131184395|NCT01392378|472295648|FG002|After Infant Series|Withdrawal by Parent|1|||
131184396|NCT01392378|472295649|FG003|After Infant Series|Withdrawal by Parent|0|||
131184397|NCT01392378|472295650|FG004|After Infant Series|Withdrawal by Parent|1|||
131239693|NCT04178122|472504243|FG000|Overall Study|Did not complete testing|3|||
131239694|NCT04178122|472504244|FG001|Overall Study|Did not complete testing|13|||
131239695|NCT06086028|472504245|FG000|Overall Study|Withdrawal by Subject|1|||
131239696|NCT06086028|472504246|FG001|Overall Study|Withdrawal by Subject|1|||
131239697|NCT06086028|472504245|FG000|Overall Study|Lost to Follow-up|2|||
131239698|NCT06086028|472504246|FG001|Overall Study|Lost to Follow-up|3|||
131239699|NCT04028843|472504247|FG000|Overall Study|Lost to Follow-up|32|||
131239700|NCT04028843|472504248|FG001|Overall Study|Lost to Follow-up|39|||
131239701|NCT04028843|472504247|FG000|Overall Study|Adverse Event|1|||
131239702|NCT04028843|472504248|FG001|Overall Study|Adverse Event|0|||
131239703|NCT04028843|472504247|FG000|Overall Study|Non-viable Pregnancy|0|||
131239704|NCT04028843|472504248|FG001|Overall Study|Non-viable Pregnancy|1|||
131239705|NCT04028843|472504247|FG000|Overall Study|Withdrawal by Subject|4|||
131239706|NCT04028843|472504248|FG001|Overall Study|Withdrawal by Subject|2|||
131239707|NCT04278417|472504249|FG000|Overall Study|Withdrawal by Subject|20|||
131239708|NCT04278417|472504250|FG001|Overall Study|Withdrawal by Subject|20|||
131239709|NCT04278417|472504249|FG000|Overall Study|Progressive disease|0|||
131239710|NCT04278417|472504250|FG001|Overall Study|Progressive disease|2|||
131239711|NCT04278417|472504249|FG000|Overall Study|Physician Decision|4|||
131239712|NCT04278417|472504250|FG001|Overall Study|Physician Decision|6|||
131239713|NCT04278417|472504249|FG000|Overall Study|Lost to Follow-up|11|||
131239714|NCT04278417|472504250|FG001|Overall Study|Lost to Follow-up|13|||
131239715|NCT04278417|472504249|FG000|Overall Study|Death|8|||
131239716|NCT04278417|472504250|FG001|Overall Study|Death|9|||
131239717|NCT04278417|472504249|FG000|Overall Study|Adverse Event|3|||
131239718|NCT04278417|472504250|FG001|Overall Study|Adverse Event|5|||
130733524|NCT05026177|470642913|FG002|Overall Study|Noncompliance with study drug|1|||
131184398|NCT01392378|472295646|FG000|Toddler Dose|Lost to Follow-up|0|||
131184399|NCT01392378|472295647|FG001|Toddler Dose|Lost to Follow-up|0|||
131184400|NCT01392378|472295648|FG002|Toddler Dose|Lost to Follow-up|0|||
131184401|NCT01392378|472295649|FG003|Toddler Dose|Lost to Follow-up|1|||
131184402|NCT01392378|472295650|FG004|Toddler Dose|Lost to Follow-up|0|||
131239719|NCT03298451|472504251|FG000|Overall Study|Death|275|||
131184403|NCT01392378|472295646|FG000|Toddler Dose|Withdrawal by Parent|0|||
131239720|NCT03298451|472504252|FG001|Overall Study|Death|260|||
131184404|NCT01392378|472295647|FG001|Toddler Dose|Withdrawal by Parent|1|||
131184405|NCT01392378|472295648|FG002|Toddler Dose|Withdrawal by Parent|0|||
131239721|NCT03298451|472504253|FG002|Overall Study|Death|122|||
131239722|NCT03298451|472504254|FG003|Overall Study|Death|280|||
131239723|NCT03298451|472504251|FG000|Overall Study|Lost to Follow-up|1|||
131239724|NCT03298451|472504252|FG001|Overall Study|Lost to Follow-up|1|||
131239725|NCT03298451|472504253|FG002|Overall Study|Lost to Follow-up|0|||
131239726|NCT03298451|472504254|FG003|Overall Study|Lost to Follow-up|7|||
131239727|NCT03298451|472504251|FG000|Overall Study|Withdrawal by Subject|9|||
131239728|NCT03298451|472504252|FG001|Overall Study|Withdrawal by Subject|7|||
131239729|NCT03298451|472504253|FG002|Overall Study|Withdrawal by Subject|1|||
131239730|NCT03298451|472504254|FG003|Overall Study|Withdrawal by Subject|20|||
131239731|NCT05182606|472504255|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
131239732|NCT05480943|472504256|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
131184406|NCT01392378|472295649|FG003|Toddler Dose|Withdrawal by Parent|1|||
131184407|NCT01392378|472295650|FG004|Toddler Dose|Withdrawal by Parent|1|||
131184408|NCT02713789|472295651|FG000|Overall Study|Lost to Follow-up|0|||
131184409|NCT02713789|472295652|FG001|Overall Study|Lost to Follow-up|1|||
131184410|NCT02713789|472295653|FG002|Overall Study|Lost to Follow-up|1|||
131184411|NCT00367432|472295654|FG000|First Period (16 Weeks)|Adverse Event|6|||
131184412|NCT00367432|472295655|FG001|First Period (16 Weeks)|Adverse Event|0|||
131184413|NCT00367432|472295654|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
131184414|NCT00367432|472295655|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
131184415|NCT00367432|472295654|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
131184416|NCT00367432|472295655|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
131184417|NCT00367432|472295654|FG000|First Period (16 Weeks)|Other Reason|2|||
131184418|NCT00367432|472295655|FG001|First Period (16 Weeks)|Other Reason|0|||
131184419|NCT00367432|472295654|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
131184420|NCT00367432|472295655|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
131184421|NCT00367432|472295654|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
131184422|NCT00367432|472295655|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
131184423|NCT00367432|472295654|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
131184424|NCT00367432|472295655|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
131184425|NCT00367432|472295654|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
131184426|NCT00367432|472295655|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
131184427|NCT00367432|472295654|FG000|Second Period (up to 54 Months)|Other Reason|6|||
131184428|NCT00367432|472295655|FG001|Second Period (up to 54 Months)|Other Reason|2|||
131184429|NCT00903370|472295656|FG000|Overall Study|Death|13|||
131184430|NCT00903370|472295657|FG001|Overall Study|Death|10|||
131184431|NCT00903370|472295656|FG000|Overall Study|Withdrawal by Subject|9|||
131184432|NCT00903370|472295657|FG001|Overall Study|Withdrawal by Subject|6|||
131184433|NCT00903370|472295656|FG000|Overall Study|Lost to Follow-up|6|||
131239733|NCT05480943|472504256|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
131239734|NCT05480943|472504256|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
131239735|NCT05480943|472504256|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
131239736|NCT02257736|472504257|FG000|Overall Study|Progressive disease|365|||
131239737|NCT02257736|472504258|FG001|Overall Study|Progressive disease|327|||
131239738|NCT02257736|472504257|FG000|Overall Study|Adverse Event|45|||
131239739|NCT02257736|472504258|FG001|Overall Study|Adverse Event|56|||
131239740|NCT02257736|472504257|FG000|Overall Study|Withdrawal by Subject|21|||
131239741|NCT02257736|472504258|FG001|Overall Study|Withdrawal by Subject|38|||
131239742|NCT02257736|472504257|FG000|Overall Study|Death|11|||
131239743|NCT02257736|472504258|FG001|Overall Study|Death|6|||
131239744|NCT02257736|472504257|FG000|Overall Study|Physician Decision|5|||
131239745|NCT02257736|472504258|FG001|Overall Study|Physician Decision|9|||
131239746|NCT02257736|472504257|FG000|Overall Study|Non-Compliance with study drug|1|||
131239747|NCT02257736|472504258|FG001|Overall Study|Non-Compliance with study drug|2|||
131239748|NCT02257736|472504257|FG000|Overall Study|Protocol Violation|1|||
131239749|NCT02257736|472504258|FG001|Overall Study|Protocol Violation|0|||
131239750|NCT02257736|472504257|FG000|Overall Study|Other|1|||
131239751|NCT02257736|472504258|FG001|Overall Study|Other|7|||
131239752|NCT02257736|472504257|FG000|Overall Study|Randomized, not treated|1|||
131239753|NCT02257736|472504258|FG001|Overall Study|Randomized, not treated|2|||
131239754|NCT00136435|472504259|FG000|Overall Study|Ineligible|8|||
131239755|NCT00136435|472504259|FG000|Overall Study|Induction Death|1|||
131239756|NCT00136435|472504259|FG000|Overall Study|Induction Failure|10|||
131239757|NCT00136435|472504259|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
131239758|NCT00136435|472504259|FG000|Overall Study|Withdrawal by Subject|3|||
131239759|NCT00136435|472504259|FG000|Overall Study|Adverse Event|19|||
131239760|NCT00136435|472504259|FG000|Overall Study|Relapse|4|||
131239761|NCT00136435|472504259|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
131239762|NCT04083781|472504260|FG000|Main Part|Physician Decision|0|||
131239763|NCT04083781|472504261|FG001|Main Part|Physician Decision|1|||
131239764|NCT04083781|472504262|FG002|Main Part|Physician Decision|2|||
131239765|NCT04083781|472504263|FG003|Main Part|Physician Decision|0|||
131239766|NCT04083781|472504260|FG000|Main Part|Death|1|||
131239767|NCT04083781|472504261|FG001|Main Part|Death|3|||
131239768|NCT04083781|472504262|FG002|Main Part|Death|1|||
131239769|NCT04083781|472504263|FG003|Main Part|Death|0|||
131184434|NCT00903370|472295657|FG001|Overall Study|Lost to Follow-up|8|||
131184435|NCT00014911|472295658|FG000|Overall Study|Adverse Event|1|||
131184436|NCT00014911|472295658|FG000|Overall Study|Lost to Follow-up|1|||
131239770|NCT04083781|472504260|FG000|Main Part|Withdrawal by Subject|5|||
131239771|NCT04083781|472504261|FG001|Main Part|Withdrawal by Subject|2|||
131239772|NCT04083781|472504262|FG002|Main Part|Withdrawal by Subject|3|||
131239773|NCT04083781|472504263|FG003|Main Part|Withdrawal by Subject|7|||
131239774|NCT04083781|472504260|FG000|Extension Part|Physician Decision|0|||
131239775|NCT04083781|472504261|FG001|Extension Part|Physician Decision|0|||
131239776|NCT04083781|472504262|FG002|Extension Part|Physician Decision|0|||
131239777|NCT04083781|472504263|FG003|Extension Part|Physician Decision|1|||
131239778|NCT04083781|472504260|FG000|Extension Part|Death|0|||
131239779|NCT04083781|472504261|FG001|Extension Part|Death|1|||
131239780|NCT04083781|472504262|FG002|Extension Part|Death|0|||
131239781|NCT04083781|472504263|FG003|Extension Part|Death|1|||
131239782|NCT04083781|472504260|FG000|Extension Part|Withdrawal by Subject|0|||
131239783|NCT04083781|472504261|FG001|Extension Part|Withdrawal by Subject|1|||
131239784|NCT04083781|472504262|FG002|Extension Part|Withdrawal by Subject|0|||
131239785|NCT04083781|472504263|FG003|Extension Part|Withdrawal by Subject|0|||
131239786|NCT04083781|472504260|FG000|Extension Part|Ongoing|13|||
131239787|NCT04083781|472504261|FG001|Extension Part|Ongoing|25|||
131239788|NCT04083781|472504262|FG002|Extension Part|Ongoing|15|||
131239789|NCT04083781|472504263|FG003|Extension Part|Ongoing|51|||
131239790|NCT03633721|472504264|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
131239791|NCT03633721|472504265|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
131239792|NCT03633721|472504266|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
131239793|NCT03633721|472504267|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
131239794|NCT02457832|472504268|FG000|Training|Lost to Follow-up|10|||
131239795|NCT02457832|472504269|FG001|Training|Lost to Follow-up|6|||
131239796|NCT02457832|472504270|FG002|Training|Lost to Follow-up|3|||
131239797|NCT02457832|472504268|FG000|One Month Washout|Lost to Follow-up|0|||
131239798|NCT02457832|472504269|FG001|One Month Washout|Lost to Follow-up|1|||
131239799|NCT02457832|472504270|FG002|One Month Washout|Lost to Follow-up|1|||
131239800|NCT03431350|472504271|FG000|Overall Study|ONGOING|0|||
131239801|NCT03431350|472504272|FG001|Overall Study|ONGOING|0|||
131239802|NCT03431350|472504273|FG002|Overall Study|ONGOING|2|||
131239803|NCT03431350|472504274|FG003|Overall Study|ONGOING|0|||
131239804|NCT03431350|472504275|FG004|Overall Study|ONGOING|1|||
131239805|NCT03431350|472504276|FG005|Overall Study|ONGOING|3|||
131239806|NCT03431350|472504277|FG006|Overall Study|ONGOING|0|||
131239807|NCT03431350|472504278|FG007|Overall Study|ONGOING|1|||
131239808|NCT03431350|472504279|FG008|Overall Study|ONGOING|3|||
131239809|NCT03431350|472504280|FG009|Overall Study|ONGOING|4|||
131239810|NCT03431350|472504281|FG010|Overall Study|ONGOING|2|||
131239811|NCT03431350|472504282|FG011|Overall Study|ONGOING|1|||
131239812|NCT03431350|472504271|FG000|Overall Study|Death|6|||
131239813|NCT03431350|472504272|FG001|Overall Study|Death|5|||
131239814|NCT03431350|472504273|FG002|Overall Study|Death|18|||
131239815|NCT03431350|472504274|FG003|Overall Study|Death|7|||
131239816|NCT03431350|472504275|FG004|Overall Study|Death|4|||
131239817|NCT03431350|472504276|FG005|Overall Study|Death|3|||
131239818|NCT03431350|472504277|FG006|Overall Study|Death|2|||
131239819|NCT03431350|472504278|FG007|Overall Study|Death|0|||
131239820|NCT03431350|472504279|FG008|Overall Study|Death|0|||
131239821|NCT03431350|472504280|FG009|Overall Study|Death|0|||
131239822|NCT03431350|472504281|FG010|Overall Study|Death|4|||
131239823|NCT03431350|472504282|FG011|Overall Study|Death|0|||
131239824|NCT03431350|472504271|FG000|Overall Study|Lost to Follow-up|0|||
131239825|NCT03431350|472504272|FG001|Overall Study|Lost to Follow-up|1|||
131239826|NCT03431350|472504273|FG002|Overall Study|Lost to Follow-up|0|||
131239827|NCT03431350|472504274|FG003|Overall Study|Lost to Follow-up|0|||
131239828|NCT03431350|472504275|FG004|Overall Study|Lost to Follow-up|0|||
131239829|NCT03431350|472504276|FG005|Overall Study|Lost to Follow-up|0|||
131239830|NCT03431350|472504277|FG006|Overall Study|Lost to Follow-up|0|||
131239831|NCT03431350|472504278|FG007|Overall Study|Lost to Follow-up|0|||
131239832|NCT03431350|472504279|FG008|Overall Study|Lost to Follow-up|0|||
131239833|NCT03431350|472504280|FG009|Overall Study|Lost to Follow-up|0|||
131239834|NCT03431350|472504281|FG010|Overall Study|Lost to Follow-up|0|||
131239835|NCT03431350|472504282|FG011|Overall Study|Lost to Follow-up|0|||
131239836|NCT03431350|472504271|FG000|Overall Study|Withdrawal by Subject|0|||
131239837|NCT03431350|472504272|FG001|Overall Study|Withdrawal by Subject|0|||
131239838|NCT03431350|472504273|FG002|Overall Study|Withdrawal by Subject|0|||
130784523|NCT01408706|470838810|FG001|Overall Study|Physician Decision|0|||
130784524|NCT00113607|470838811|FG000|Overall Study|Adverse Event|40|||
131239839|NCT03431350|472504274|FG003|Overall Study|Withdrawal by Subject|1|||
131239840|NCT03431350|472504275|FG004|Overall Study|Withdrawal by Subject|1|||
131239841|NCT03431350|472504276|FG005|Overall Study|Withdrawal by Subject|1|||
131239842|NCT03431350|472504277|FG006|Overall Study|Withdrawal by Subject|0|||
131239843|NCT03431350|472504278|FG007|Overall Study|Withdrawal by Subject|0|||
131239844|NCT03431350|472504279|FG008|Overall Study|Withdrawal by Subject|0|||
131239845|NCT03431350|472504280|FG009|Overall Study|Withdrawal by Subject|2|||
131239846|NCT03431350|472504281|FG010|Overall Study|Withdrawal by Subject|0|||
131239847|NCT03431350|472504282|FG011|Overall Study|Withdrawal by Subject|1|||
131239848|NCT03431350|472504271|FG000|Overall Study|Other|0|||
131239849|NCT03431350|472504272|FG001|Overall Study|Other|0|||
131239850|NCT03431350|472504273|FG002|Overall Study|Other|1|||
131239851|NCT03431350|472504274|FG003|Overall Study|Other|3|||
131239852|NCT03431350|472504275|FG004|Overall Study|Other|2|||
131239853|NCT03431350|472504276|FG005|Overall Study|Other|2|||
131184437|NCT00014911|472295658|FG000|Overall Study|Withdrawal by Subject|6|||
131184438|NCT00014911|472295658|FG000|Overall Study|Unknown Reasons|2|||
131184439|NCT00014911|472295658|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
131184440|NCT01924299|472295659|FG000|Period 2|Withdrawal by Subject|1|||
131184441|NCT01924299|472295660|FG001|Period 2|Withdrawal by Subject|0|||
131184442|NCT01924299|472295659|FG000|Period 2|Adverse Event|0|||
131184443|NCT01924299|472295660|FG001|Period 2|Adverse Event|1|||
131184444|NCT00141037|472295661|FG000|Overall Study|Physician Decision|1|||
131184445|NCT00141037|472295662|FG001|Overall Study|Physician Decision|2|||
131184446|NCT00141037|472295661|FG000|Overall Study|Lost to Follow-up|3|||
131184447|NCT00141037|472295662|FG001|Overall Study|Lost to Follow-up|1|||
131184448|NCT00141037|472295661|FG000|Overall Study|Protocol Violation|0|||
131184449|NCT00141037|472295662|FG001|Overall Study|Protocol Violation|2|||
131184450|NCT00141037|472295661|FG000|Overall Study|Withdrawal by Subject|2|||
131184451|NCT00141037|472295662|FG001|Overall Study|Withdrawal by Subject|1|||
131184452|NCT00141037|472295661|FG000|Overall Study|Other|0|||
131184453|NCT00141037|472295662|FG001|Overall Study|Other|1|||
131184454|NCT00141037|472295661|FG000|Overall Study|Moved from area|1|||
131184455|NCT00141037|472295662|FG001|Overall Study|Moved from area|7|||
131184456|NCT00141037|472295661|FG000|Overall Study|Graft Failure|3|||
131184457|NCT00141037|472295662|FG001|Overall Study|Graft Failure|4|||
131184458|NCT04179786|472295663|FG000|Overall Study|Withdrawal by Subject|8|||
131184459|NCT01938001|472295664|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
131184460|NCT01938001|472295665|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
131184461|NCT01938001|472295664|FG000|Pre-Treatment|Death|1|||
131184462|NCT01938001|472295665|FG001|Pre-Treatment|Death|0|||
131184463|NCT01938001|472295664|FG000|Treatment|Death|2|||
131184464|NCT01938001|472295665|FG001|Treatment|Death|0|||
131184465|NCT01938001|472295664|FG000|Treatment|Adverse Event|14|||
131184466|NCT01938001|472295665|FG001|Treatment|Adverse Event|8|||
131184467|NCT01938001|472295664|FG000|Treatment|Progressive Disease|21|||
131184468|NCT01938001|472295665|FG001|Treatment|Progressive Disease|54|||
131184469|NCT01938001|472295664|FG000|Treatment|Withdrawal by Subject|13|||
131184470|NCT01938001|472295665|FG001|Treatment|Withdrawal by Subject|7|||
131184471|NCT01938001|472295664|FG000|Treatment|Other reasons|2|||
131184472|NCT01938001|472295665|FG001|Treatment|Other reasons|1|||
131184473|NCT03310580|472295666|FG000|Overall Study|Adverse Event|0|||
131184474|NCT03310580|472295667|FG001|Overall Study|Adverse Event|1|||
131184475|NCT03310580|472295668|FG002|Overall Study|Adverse Event|0|||
131184476|NCT04186663|472295671|FG000|Overall Study|Lost to Follow-up|1|||
131184477|NCT04186663|472295671|FG000|Overall Study|Unable to complete blood draw|3|||
131184478|NCT01184846|472295672|FG000|Overall Study|Adverse Event|2|||
131184479|NCT01184846|472295672|FG000|Overall Study|Insufficient response|1|||
131184480|NCT00355134|472297311|FG000|Core Phase|Withdrawal by Subject|35|||
131184481|NCT00355134|472297312|FG001|Core Phase|Withdrawal by Subject|24|||
131184482|NCT00355134|472297313|FG002|Core Phase|Withdrawal by Subject|35|||
131184483|NCT00355134|472297314|FG003|Core Phase|Withdrawal by Subject|0|||
131184484|NCT00355134|472297315|FG004|Core Phase|Withdrawal by Subject|0|||
131184485|NCT00355134|472297311|FG000|Core Phase|Adverse Event|28|||
131184486|NCT00355134|472297312|FG001|Core Phase|Adverse Event|22|||
131184487|NCT00355134|472297313|FG002|Core Phase|Adverse Event|16|||
131184488|NCT00355134|472297314|FG003|Core Phase|Adverse Event|0|||
131184489|NCT00355134|472297315|FG004|Core Phase|Adverse Event|0|||
131184490|NCT00355134|472297311|FG000|Core Phase|Lost to Follow-up|17|||
131184491|NCT00355134|472297312|FG001|Core Phase|Lost to Follow-up|13|||
131184492|NCT00355134|472297313|FG002|Core Phase|Lost to Follow-up|21|||
131184493|NCT00355134|472297314|FG003|Core Phase|Lost to Follow-up|0|||
131184494|NCT00355134|472297315|FG004|Core Phase|Lost to Follow-up|0|||
131184495|NCT00355134|472297311|FG000|Core Phase|Abnormal laboratory value(s)|19|||
131184496|NCT00355134|472297312|FG001|Core Phase|Abnormal laboratory value(s)|14|||
131184497|NCT00355134|472297313|FG002|Core Phase|Abnormal laboratory value(s)|2|||
131184498|NCT00355134|472297314|FG003|Core Phase|Abnormal laboratory value(s)|0|||
131184499|NCT00355134|472297315|FG004|Core Phase|Abnormal laboratory value(s)|0|||
131184500|NCT00355134|472297311|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
131184501|NCT00355134|472297312|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
131184502|NCT00355134|472297313|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
131184503|NCT00355134|472297314|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
131184504|NCT00355134|472297315|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
131184505|NCT00355134|472297311|FG000|Core Phase|Administrative problems|5|||
131184506|NCT00355134|472297312|FG001|Core Phase|Administrative problems|3|||
131184507|NCT00355134|472297313|FG002|Core Phase|Administrative problems|5|||
131184508|NCT00355134|472297314|FG003|Core Phase|Administrative problems|0|||
131184509|NCT00355134|472297315|FG004|Core Phase|Administrative problems|0|||
131184510|NCT00355134|472297311|FG000|Core Phase|Protocol Violation|3|||
131184511|NCT00355134|472297312|FG001|Core Phase|Protocol Violation|2|||
131184512|NCT00355134|472297313|FG002|Core Phase|Protocol Violation|2|||
131184513|NCT00355134|472297314|FG003|Core Phase|Protocol Violation|0|||
131184514|NCT00355134|472297315|FG004|Core Phase|Protocol Violation|0|||
131184515|NCT00355134|472297311|FG000|Core Phase|Abnormal test procedure result(s)|1|||
131239854|NCT03431350|472504277|FG006|Overall Study|Other|4|||
131239855|NCT03431350|472504278|FG007|Overall Study|Other|0|||
131239856|NCT03431350|472504279|FG008|Overall Study|Other|14|||
131239857|NCT03431350|472504280|FG009|Overall Study|Other|11|||
131239858|NCT03431350|472504281|FG010|Overall Study|Other|11|||
131239859|NCT03431350|472504282|FG011|Overall Study|Other|15|||
131239860|NCT02141074|472504283|FG000|Pre-prophylaxis|Adverse Event|3|||
131239861|NCT02141074|472504284|FG001|Pre-prophylaxis|Adverse Event|0|||
131239862|NCT02141074|472504283|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
131239863|NCT02141074|472504284|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
131239864|NCT02141074|472504283|FG000|Prophylaxis|Adverse Event|0|||
131239865|NCT02141074|472504284|FG001|Prophylaxis|Adverse Event|4|||
131239866|NCT02141074|472504283|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
131239867|NCT02141074|472504284|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
131239868|NCT02141074|472504283|FG000|Prophylaxis|Withdrawal by Subject|0|||
131239869|NCT02141074|472504284|FG001|Prophylaxis|Withdrawal by Subject|1|||
131239870|NCT04325828|472504285|FG000|Overall Study|Ongoing|26|||
131239871|NCT04439188|472504286|FG000|Overall Study|Ineligible|3|||
131239872|NCT04439188|472504286|FG000|Overall Study|Adverse Event|4|||
131239873|NCT04439188|472504286|FG000|Overall Study|Death|1|||
131239874|NCT04439188|472504286|FG000|Overall Study|Disease Progression|25|||
131239875|NCT04439188|472504286|FG000|Overall Study|Withdrawal by Subject|2|||
131239876|NCT03210714|472504287|FG000|Overall Study|Adverse Event|6|||
131239877|NCT03210714|472504287|FG000|Overall Study|Physician Decision|1|||
131239878|NCT03210714|472504287|FG000|Overall Study|Progressive disease|11|||
131239879|NCT03210714|472504287|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
131239880|NCT02883062|472504294|FG000|Overall Study|Withdrawal by Subject|6|||
131239881|NCT02883062|472504295|FG001|Overall Study|Withdrawal by Subject|0|||
131239882|NCT03683030|472504296|FG000|Overall Study|Enrolled but screen failures|12|||
131239883|NCT03683030|472504297|FG001|Overall Study|Enrolled but screen failures|7|||
131239884|NCT03683030|472504296|FG000|Overall Study|Enrolled but no catheter inserted|11|||
131239885|NCT03683030|472504297|FG001|Overall Study|Enrolled but no catheter inserted|13|||
131239886|NCT03683030|472504296|FG000|Overall Study|Withdrawal by Subject|0|||
131239887|NCT03683030|472504297|FG001|Overall Study|Withdrawal by Subject|2|||
131239888|NCT03683030|472504296|FG000|Overall Study|Early termination by subject|1|||
131239889|NCT03683030|472504297|FG001|Overall Study|Early termination by subject|0|||
131239890|NCT03683030|472504296|FG000|Overall Study|Lost to Follow-up|0|||
131239891|NCT03683030|472504297|FG001|Overall Study|Lost to Follow-up|6|||
131239892|NCT03683030|472504296|FG000|Overall Study|Death|0|||
131239893|NCT03683030|472504297|FG001|Overall Study|Death|2|||
131239894|NCT03683030|472504296|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
131239895|NCT03683030|472504297|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
131239896|NCT05321069|472504298|FG000|Overall Study|Adverse Event|52|||
131239897|NCT05321069|472504299|FG001|Overall Study|Adverse Event|52|||
131239898|NCT05321069|472504300|FG002|Overall Study|Adverse Event|64|||
131239899|NCT05321069|472504298|FG000|Overall Study|Protocol Violation|1|||
131239900|NCT05321069|472504299|FG001|Overall Study|Protocol Violation|1|||
131239901|NCT05321069|472504300|FG002|Overall Study|Protocol Violation|0|||
131239902|NCT05321069|472504298|FG000|Overall Study|Withdrawal by Subject|23|||
131239903|NCT05321069|472504299|FG001|Overall Study|Withdrawal by Subject|18|||
131239904|NCT05321069|472504300|FG002|Overall Study|Withdrawal by Subject|12|||
131239905|NCT05321069|472504298|FG000|Overall Study|Lost to Follow-up|1|||
131239906|NCT05321069|472504299|FG001|Overall Study|Lost to Follow-up|0|||
131239907|NCT05321069|472504300|FG002|Overall Study|Lost to Follow-up|1|||
131239908|NCT05321069|472504298|FG000|Overall Study|No reason stated by the participants|23|||
131239909|NCT05321069|472504299|FG001|Overall Study|No reason stated by the participants|22|||
131239910|NCT05321069|472504300|FG002|Overall Study|No reason stated by the participants|16|||
131239911|NCT05321069|472504298|FG000|Overall Study|Lack of Efficacy|1|||
131239912|NCT05321069|472504299|FG001|Overall Study|Lack of Efficacy|1|||
131239913|NCT05321069|472504300|FG002|Overall Study|Lack of Efficacy|0|||
131239914|NCT03390504|472504301|FG000|Overall Study|Lost to Follow-up|2|||
131239915|NCT03390504|472504302|FG001|Overall Study|Lost to Follow-up|4|||
131239916|NCT03390504|472504303|FG002|Overall Study|Lost to Follow-up|0|||
131239917|NCT03390504|472504304|FG003|Overall Study|Lost to Follow-up|1|||
131239918|NCT03390504|472504301|FG000|Overall Study|Withdrawal by Subject|3|||
131239919|NCT03390504|472504302|FG001|Overall Study|Withdrawal by Subject|15|||
131239920|NCT03390504|472504303|FG002|Overall Study|Withdrawal by Subject|5|||
131239921|NCT03390504|472504304|FG003|Overall Study|Withdrawal by Subject|2|||
131239922|NCT03390504|472504301|FG000|Overall Study|Other|1|||
131239923|NCT03390504|472504302|FG001|Overall Study|Other|2|||
131239924|NCT03390504|472504303|FG002|Overall Study|Other|2|||
131239925|NCT03390504|472504304|FG003|Overall Study|Other|6|||
131239926|NCT03492177|472504305|FG000|Overall Study|Adverse Event|1|||
131239927|NCT03492177|472504306|FG001|Overall Study|Adverse Event|0|||
131239928|NCT03492177|472504307|FG002|Overall Study|Adverse Event|0|||
131239929|NCT03492177|472504305|FG000|Overall Study|Death|3|||
131239930|NCT03492177|472504306|FG001|Overall Study|Death|0|||
131239931|NCT03492177|472504307|FG002|Overall Study|Death|3|||
131239932|NCT03492177|472504305|FG000|Overall Study|Lack of Efficacy|1|||
131184516|NCT00355134|472297312|FG001|Core Phase|Abnormal test procedure result(s)|2|||
131184517|NCT00355134|472297313|FG002|Core Phase|Abnormal test procedure result(s)|1|||
131184518|NCT00355134|472297314|FG003|Core Phase|Abnormal test procedure result(s)|0|||
131184519|NCT00355134|472297315|FG004|Core Phase|Abnormal test procedure result(s)|0|||
131184520|NCT00355134|472297311|FG000|Core Phase|Condition no longer requires study drug|1|||
131184521|NCT00355134|472297312|FG001|Core Phase|Condition no longer requires study drug|0|||
131184522|NCT00355134|472297313|FG002|Core Phase|Condition no longer requires study drug|1|||
131184523|NCT00355134|472297314|FG003|Core Phase|Condition no longer requires study drug|0|||
131184524|NCT00355134|472297315|FG004|Core Phase|Condition no longer requires study drug|0|||
131184525|NCT00355134|472297311|FG000|Extension Phase|Withdrawal by Subject|7|||
131184526|NCT00355134|472297312|FG001|Extension Phase|Withdrawal by Subject|11|||
131184527|NCT00355134|472297313|FG002|Extension Phase|Withdrawal by Subject|0|||
131184528|NCT00355134|472297314|FG003|Extension Phase|Withdrawal by Subject|7|||
131184529|NCT00355134|472297315|FG004|Extension Phase|Withdrawal by Subject|5|||
131184530|NCT00355134|472297311|FG000|Extension Phase|Adverse Event|13|||
131184531|NCT00355134|472297312|FG001|Extension Phase|Adverse Event|9|||
131184532|NCT00355134|472297313|FG002|Extension Phase|Adverse Event|0|||
131184533|NCT00355134|472297314|FG003|Extension Phase|Adverse Event|3|||
131184534|NCT00355134|472297315|FG004|Extension Phase|Adverse Event|5|||
131184535|NCT00355134|472297311|FG000|Extension Phase|Lost to Follow-up|2|||
131184536|NCT00355134|472297312|FG001|Extension Phase|Lost to Follow-up|6|||
131184537|NCT00355134|472297313|FG002|Extension Phase|Lost to Follow-up|0|||
131184538|NCT00355134|472297314|FG003|Extension Phase|Lost to Follow-up|2|||
131184539|NCT00355134|472297315|FG004|Extension Phase|Lost to Follow-up|4|||
131184540|NCT00355134|472297311|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
131184541|NCT00355134|472297312|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
131184542|NCT00355134|472297313|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
131184543|NCT00355134|472297314|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
131184544|NCT00355134|472297315|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
131184545|NCT00355134|472297311|FG000|Extension Phase|Administrative problems|2|||
131184546|NCT00355134|472297312|FG001|Extension Phase|Administrative problems|4|||
131184547|NCT00355134|472297313|FG002|Extension Phase|Administrative problems|0|||
131184548|NCT00355134|472297314|FG003|Extension Phase|Administrative problems|1|||
131184549|NCT00355134|472297315|FG004|Extension Phase|Administrative problems|1|||
131184550|NCT00355134|472297311|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
131184551|NCT00355134|472297312|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
131184552|NCT00355134|472297313|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
131184553|NCT00355134|472297314|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
131184554|NCT00355134|472297315|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
131184555|NCT00355134|472297311|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
131184556|NCT00355134|472297312|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
131184557|NCT00355134|472297313|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
131184558|NCT00355134|472297314|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
131184559|NCT00355134|472297315|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
131184560|NCT00355134|472297311|FG000|Extension Phase|Protocol Violation|0|||
131184561|NCT00355134|472297312|FG001|Extension Phase|Protocol Violation|0|||
131184562|NCT00355134|472297313|FG002|Extension Phase|Protocol Violation|0|||
131184563|NCT00355134|472297314|FG003|Extension Phase|Protocol Violation|1|||
131184564|NCT00355134|472297315|FG004|Extension Phase|Protocol Violation|0|||
131184565|NCT02848313|472297316|FG000|Overall Study|Adverse Event|1|||
131184566|NCT02848313|472297317|FG001|Overall Study|Adverse Event|2|||
131184567|NCT02848313|472297316|FG000|Overall Study|Lack of Efficacy|0|||
131184568|NCT02848313|472297317|FG001|Overall Study|Lack of Efficacy|1|||
131184569|NCT02848313|472297316|FG000|Overall Study|Withdrawal by Subject|1|||
131184570|NCT02848313|472297317|FG001|Overall Study|Withdrawal by Subject|1|||
131184571|NCT02848313|472297316|FG000|Overall Study|Lost to follow up|1|||
131184572|NCT02848313|472297317|FG001|Overall Study|Lost to follow up|0|||
131184573|NCT01544478|472297318|FG000|Overall Study|Adverse Event|1|||
131184574|NCT01544478|472297318|FG000|Overall Study|Death|1|||
131184575|NCT01544478|472297318|FG000|Overall Study|Lost to Follow-up|48|||
131184576|NCT01544478|472297318|FG000|Overall Study|Physician Decision|15|||
131184577|NCT01544478|472297318|FG000|Overall Study|Pregnancy|1|||
131184578|NCT01544478|472297318|FG000|Overall Study|Withdrawal by Subject|52|||
131184579|NCT03382262|472297322|FG000|Overall Study|Physician Decision|0|||
130733525|NCT05026177|470642911|FG000|Overall Study|Physician Decision|4|||
131184580|NCT03382262|472297323|FG001|Overall Study|Physician Decision|0|||
131184581|NCT03382262|472297324|FG002|Overall Study|Physician Decision|1|||
131184582|NCT03382262|472297325|FG003|Overall Study|Physician Decision|0|||
131184583|NCT03382262|472297322|FG000|Overall Study|Withdrawal by Subject|0|||
131184584|NCT03382262|472297323|FG001|Overall Study|Withdrawal by Subject|0|||
131184585|NCT03382262|472297324|FG002|Overall Study|Withdrawal by Subject|0|||
131184586|NCT03382262|472297325|FG003|Overall Study|Withdrawal by Subject|1|||
131184587|NCT02038790|472297327|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
131184588|NCT02038790|472297328|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
131184589|NCT00438464|472297332|FG000|Overall Study|Terminated Early|14|||
131184590|NCT00438464|472297333|FG001|Overall Study|Terminated Early|5|||
131184591|NCT00438464|472297332|FG000|Overall Study|Incomplete data submission|0|||
131184592|NCT00438464|472297333|FG001|Overall Study|Incomplete data submission|2|||
131184593|NCT03943446|472297335|FG000|Overall Study|Lost to Follow-up|0|||
131184594|NCT03943446|472297336|FG001|Overall Study|Lost to Follow-up|0|||
131184595|NCT03943446|472297337|FG002|Overall Study|Lost to Follow-up|1|||
131184596|NCT03943446|472297335|FG000|Overall Study|Withdrawal by Subject|1|||
131184597|NCT03943446|472297336|FG001|Overall Study|Withdrawal by Subject|1|||
131184598|NCT03943446|472297337|FG002|Overall Study|Withdrawal by Subject|2|||
131184599|NCT03943446|472297335|FG000|Overall Study|Study Terminated by Sponsor|1|||
131184600|NCT03943446|472297336|FG001|Overall Study|Study Terminated by Sponsor|2|||
131184601|NCT03943446|472297337|FG002|Overall Study|Study Terminated by Sponsor|1|||
131184602|NCT03943446|472297335|FG000|Overall Study|Reason not Specified|5|||
131184603|NCT03943446|472297336|FG001|Overall Study|Reason not Specified|1|||
131184604|NCT03943446|472297337|FG002|Overall Study|Reason not Specified|3|||
131184605|NCT04209530|472297340|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
131184606|NCT04209530|472297341|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
131184607|NCT04209530|472297340|FG000|Overall Study|Withdrawal by Subject|0|||
131184608|NCT04209530|472297341|FG001|Overall Study|Withdrawal by Subject|1|||
131184609|NCT03673956|472297344|FG000|Overall Study|Lost to Follow-up|1|||
131184610|NCT03673956|472297345|FG001|Overall Study|Lost to Follow-up|0|||
131184611|NCT03673956|472297346|FG002|Overall Study|Lost to Follow-up|0|||
131184612|NCT03673956|472297347|FG003|Overall Study|Lost to Follow-up|0|||
131184613|NCT03673956|472297344|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
131184614|NCT03673956|472297345|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
131184615|NCT03673956|472297346|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
131184616|NCT03673956|472297347|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
131184617|NCT03094832|472297350|FG000|Overall Study|Lost to Follow-up|0|||
131184618|NCT03094832|472297351|FG001|Overall Study|Lost to Follow-up|0|||
131184619|NCT03094832|472297352|FG002|Overall Study|Lost to Follow-up|0|||
131184620|NCT03094832|472297353|FG003|Overall Study|Lost to Follow-up|1|||
131184621|NCT03094832|472297354|FG004|Overall Study|Lost to Follow-up|1|||
131184622|NCT03094832|472297350|FG000|Overall Study|Death|1|||
131184623|NCT03094832|472297351|FG001|Overall Study|Death|0|||
131184624|NCT03094832|472297352|FG002|Overall Study|Death|0|||
131184625|NCT03094832|472297353|FG003|Overall Study|Death|0|||
131184626|NCT03094832|472297354|FG004|Overall Study|Death|0|||
131184627|NCT03094832|472297350|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
131184628|NCT03094832|472297351|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
131184629|NCT03094832|472297352|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
131184630|NCT03094832|472297353|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
131184631|NCT03094832|472297354|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
131184632|NCT03094832|472297350|FG000|Overall Study|Other|13|||
131184633|NCT03094832|472297351|FG001|Overall Study|Other|20|||
131184634|NCT03094832|472297352|FG002|Overall Study|Other|1|||
131184635|NCT03094832|472297353|FG003|Overall Study|Other|7|||
131184636|NCT03094832|472297354|FG004|Overall Study|Other|1|||
131184637|NCT00788697|472297359|FG000|Overall Study|No study drug administered|12|||
131184638|NCT00788697|472297359|FG000|Overall Study|Training Patients|74|||
131184639|NCT00788697|472297359|FG000|Overall Study|no truth standard procedure available|5|||
131184640|NCT00788697|472297359|FG000|Overall Study|Technically inadequate truth standard|1|||
131184641|NCT00788697|472297359|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
131184642|NCT01998880|472297360|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
131184643|NCT01998880|472297361|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
131184644|NCT01998880|472297360|FG000|Overall Study|Disease Progression|1|||
131184645|NCT01998880|472297361|FG001|Overall Study|Disease Progression|8|||
131184646|NCT01998880|472297360|FG000|Overall Study|Withdrew Consent|2|||
131184647|NCT01998880|472297361|FG001|Overall Study|Withdrew Consent|1|||
131184648|NCT01998880|472297360|FG000|Overall Study|Death|3|||
131184649|NCT01998880|472297361|FG001|Overall Study|Death|6|||
131184650|NCT01998880|472297360|FG000|Overall Study|Insufficient Therapeutic Response|1|||
131184651|NCT01998880|472297361|FG001|Overall Study|Insufficient Therapeutic Response|5|||
131184652|NCT01998880|472297360|FG000|Overall Study|Administrative/Other|1|||
131184653|NCT01998880|472297361|FG001|Overall Study|Administrative/Other|1|||
131184654|NCT01998880|472297360|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
131184655|NCT01998880|472297361|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
131184656|NCT01998880|472297360|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
131184657|NCT01998880|472297361|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
131184658|NCT01998880|472297360|FG000|Overall Study|Did Not Receive Treatment|3|||
131184659|NCT01998880|472297361|FG001|Overall Study|Did Not Receive Treatment|2|||
131184660|NCT02671461|472297362|FG000|Treatment|Adverse Event|0|||
131184661|NCT02671461|472297363|FG001|Treatment|Adverse Event|0|||
131184662|NCT02671461|472297364|FG002|Treatment|Adverse Event|1|||
131239933|NCT03492177|472504306|FG001|Overall Study|Lack of Efficacy|2|||
130784525|NCT00113607|470838812|FG001|Overall Study|Adverse Event|71|||
131239934|NCT03492177|472504307|FG002|Overall Study|Lack of Efficacy|0|||
131239935|NCT03492177|472504305|FG000|Overall Study|Other|1|||
131239936|NCT03492177|472504306|FG001|Overall Study|Other|0|||
131239937|NCT03492177|472504307|FG002|Overall Study|Other|0|||
131239938|NCT03492177|472504305|FG000|Overall Study|Ongoing|16|||
131239939|NCT03492177|472504306|FG001|Overall Study|Ongoing|19|||
131239940|NCT03492177|472504307|FG002|Overall Study|Ongoing|17|||
131239941|NCT00980538|472504308|FG000|Overall Study|Lost to Follow-up|20|||
131239942|NCT00980538|472504308|FG000|Overall Study|Sponsor's Decision|4|||
131239943|NCT00980538|472504308|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
131239944|NCT00980538|472504308|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
131239945|NCT00980538|472504308|FG000|Overall Study|Switch to Commercially Available Medication|25|||
131239946|NCT00980538|472504308|FG000|Overall Study|Participant Non-Compliant|9|||
131239947|NCT00980538|472504308|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
131239948|NCT00980538|472504308|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
131239949|NCT00980538|472504308|FG000|Overall Study|Other|60|||
131239950|NCT00980538|472504308|FG000|Overall Study|Other|1|||
131239951|NCT03069937|472504309|FG000|Overall Study|Second primary malignancy noted|1|||
131239952|NCT04197713|472504310|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
131239953|NCT04197713|472504311|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
131239954|NCT03589326|472504313|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
131239955|NCT03589326|472504314|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
131239956|NCT03589326|472504313|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
131239957|NCT03589326|472504314|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
131239958|NCT03589326|472504313|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
131239959|NCT03589326|472504314|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
131239960|NCT03589326|472504313|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
131239961|NCT03589326|472504314|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
131239962|NCT03589326|472504313|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
131239963|NCT03589326|472504314|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
131239964|NCT04484142|472504315|FG000|Overall Study|Adverse Event|13|||
131239965|NCT04484142|472504315|FG000|Overall Study|Progressive Disease|87|||
131239966|NCT04484142|472504315|FG000|Overall Study|Clinical Progression|10|||
131239967|NCT04484142|472504315|FG000|Overall Study|Withdrawal by Subject|6|||
131239968|NCT04484142|472504315|FG000|Overall Study|Physician Decision|1|||
131239969|NCT04762277|472504316|FG000|Overall Study|Withdrawal by Subject|0|||
131239970|NCT04762277|472504317|FG001|Overall Study|Withdrawal by Subject|2|||
131239971|NCT04762277|472504316|FG000|Overall Study|Protocol Violation|0|||
131239972|NCT04762277|472504317|FG001|Overall Study|Protocol Violation|1|||
131239973|NCT04762277|472504316|FG000|Overall Study|Adverse Event|1|||
131239974|NCT04762277|472504317|FG001|Overall Study|Adverse Event|0|||
131239975|NCT05663866|472504318|FG000|Overall Study|Adverse Event|0|||
131239976|NCT05663866|472504319|FG001|Overall Study|Adverse Event|0|||
131239977|NCT05663866|472504320|FG002|Overall Study|Adverse Event|1|||
131239978|NCT05663866|472504321|FG003|Overall Study|Adverse Event|0|||
131239979|NCT05663866|472504318|FG000|Overall Study|Physician Decision|0|||
131239980|NCT05663866|472504319|FG001|Overall Study|Physician Decision|0|||
131239981|NCT05663866|472504320|FG002|Overall Study|Physician Decision|0|||
131239982|NCT05663866|472504321|FG003|Overall Study|Physician Decision|1|||
131239983|NCT05663866|472504318|FG000|Overall Study|Withdrawal by Subject|0|||
131239984|NCT05663866|472504319|FG001|Overall Study|Withdrawal by Subject|2|||
131239985|NCT05663866|472504320|FG002|Overall Study|Withdrawal by Subject|1|||
131239986|NCT05663866|472504321|FG003|Overall Study|Withdrawal by Subject|2|||
131239987|NCT05663866|472504318|FG000|Overall Study|Progressive disease|4|||
131239988|NCT05663866|472504319|FG001|Overall Study|Progressive disease|8|||
131239989|NCT05663866|472504320|FG002|Overall Study|Progressive disease|5|||
131239990|NCT05663866|472504321|FG003|Overall Study|Progressive disease|2|||
131239991|NCT05663866|472504318|FG000|Overall Study|Other|1|||
131239992|NCT05663866|472504319|FG001|Overall Study|Other|0|||
131239993|NCT05663866|472504320|FG002|Overall Study|Other|0|||
131239994|NCT05663866|472504321|FG003|Overall Study|Other|0|||
131239995|NCT05663866|472504318|FG000|Overall Study|Ongoing|1|||
131239996|NCT05663866|472504319|FG001|Overall Study|Ongoing|27|||
131239997|NCT05663866|472504320|FG002|Overall Study|Ongoing|6|||
131239998|NCT05663866|472504321|FG003|Overall Study|Ongoing|1|||
131239999|NCT04390763|472504323|FG000|Safety run-in Part|Adverse Event|4|||
130733526|NCT05026177|470642912|FG001|Overall Study|Physician Decision|1|||
131240000|NCT04390763|472504324|FG001|Safety run-in Part|Adverse Event|0|||
131240001|NCT04390763|472504325|FG002|Safety run-in Part|Adverse Event|0|||
131240002|NCT04390763|472504326|FG003|Safety run-in Part|Adverse Event|0|||
131240003|NCT04390763|472504323|FG000|Safety run-in Part|Physician Decision|1|||
131240004|NCT04390763|472504324|FG001|Safety run-in Part|Physician Decision|0|||
131240005|NCT04390763|472504325|FG002|Safety run-in Part|Physician Decision|0|||
131240006|NCT04390763|472504326|FG003|Safety run-in Part|Physician Decision|0|||
131240007|NCT04390763|472504323|FG000|Safety run-in Part|Progressive Disease|6|||
131240008|NCT04390763|472504324|FG001|Safety run-in Part|Progressive Disease|0|||
131240009|NCT04390763|472504325|FG002|Safety run-in Part|Progressive Disease|0|||
131240010|NCT04390763|472504326|FG003|Safety run-in Part|Progressive Disease|0|||
131240011|NCT04390763|472504323|FG000|Randomized Part|Adverse Event|0|||
131240012|NCT04390763|472504324|FG001|Randomized Part|Adverse Event|11|||
131240013|NCT04390763|472504325|FG002|Randomized Part|Adverse Event|5|||
131240014|NCT04390763|472504326|FG003|Randomized Part|Adverse Event|5|||
131240015|NCT04390763|472504323|FG000|Randomized Part|Death|0|||
131240016|NCT04390763|472504324|FG001|Randomized Part|Death|3|||
131240017|NCT04390763|472504325|FG002|Randomized Part|Death|4|||
131240018|NCT04390763|472504326|FG003|Randomized Part|Death|2|||
131240019|NCT04390763|472504323|FG000|Randomized Part|Physician Decision|0|||
131240020|NCT04390763|472504324|FG001|Randomized Part|Physician Decision|2|||
131240021|NCT04390763|472504325|FG002|Randomized Part|Physician Decision|2|||
131240022|NCT04390763|472504326|FG003|Randomized Part|Physician Decision|9|||
131240023|NCT04390763|472504323|FG000|Randomized Part|Progressive Disease|0|||
131240024|NCT04390763|472504324|FG001|Randomized Part|Progressive Disease|24|||
131240025|NCT04390763|472504325|FG002|Randomized Part|Progressive Disease|31|||
131240026|NCT04390763|472504326|FG003|Randomized Part|Progressive Disease|23|||
131240027|NCT04390763|472504323|FG000|Randomized Part|Study terminated by sponsor|0|||
131240028|NCT04390763|472504324|FG001|Randomized Part|Study terminated by sponsor|1|||
131240029|NCT04390763|472504325|FG002|Randomized Part|Study terminated by sponsor|0|||
131240030|NCT04390763|472504326|FG003|Randomized Part|Study terminated by sponsor|0|||
131240031|NCT04390763|472504323|FG000|Randomized Part|Participant Decision|0|||
131240032|NCT04390763|472504324|FG001|Randomized Part|Participant Decision|5|||
131240033|NCT04390763|472504325|FG002|Randomized Part|Participant Decision|7|||
131240034|NCT04390763|472504326|FG003|Randomized Part|Participant Decision|6|||
131240035|NCT04390763|472504323|FG000|Randomized Part|Not treated|0|||
131240036|NCT04390763|472504324|FG001|Randomized Part|Not treated|4|||
131240037|NCT04390763|472504325|FG002|Randomized Part|Not treated|2|||
131240038|NCT04390763|472504326|FG003|Randomized Part|Not treated|7|||
131240039|NCT03820986|472504327|FG000|Overall Study|Death|201|||
131240040|NCT03820986|472504328|FG001|Overall Study|Death|175|||
131240041|NCT03820986|472504327|FG000|Overall Study|Lost to Follow-up|1|||
131240042|NCT03820986|472504328|FG001|Overall Study|Lost to Follow-up|1|||
131240043|NCT03820986|472504327|FG000|Overall Study|Physician Decision|1|||
131240044|NCT03820986|472504328|FG001|Overall Study|Physician Decision|0|||
131240045|NCT03820986|472504327|FG000|Overall Study|Sponsor Decision|122|||
131240046|NCT03820986|472504328|FG001|Overall Study|Sponsor Decision|160|||
131240047|NCT03820986|472504327|FG000|Overall Study|Withdrawal by Subject|9|||
131240048|NCT03820986|472504328|FG001|Overall Study|Withdrawal by Subject|4|||
131240049|NCT05368558|472504333|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
131240050|NCT05368558|472504334|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
131240051|NCT05368558|472504335|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
131240052|NCT05368558|472504336|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131240053|NCT05368558|472504337|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131240054|NCT05368558|472504338|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131240055|NCT05368558|472504339|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131240056|NCT05368558|472504340|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131240057|NCT05368558|472504341|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131240058|NCT05368558|472504342|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131240059|NCT05368558|472504343|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131184663|NCT02671461|472297362|FG000|Treatment|Administrative Reason by Sponsor|1|||
131184664|NCT02671461|472297363|FG001|Treatment|Administrative Reason by Sponsor|3|||
131184665|NCT02671461|472297364|FG002|Treatment|Administrative Reason by Sponsor|4|||
131184666|NCT02671461|472297362|FG000|Treatment|Randomized, not treated|1|||
131184667|NCT02671461|472297363|FG001|Treatment|Randomized, not treated|0|||
131184668|NCT02671461|472297364|FG002|Treatment|Randomized, not treated|0|||
131184669|NCT02671461|472297362|FG000|Follow-up|Withdrawal by Subject|1|||
131184670|NCT02671461|472297363|FG001|Follow-up|Withdrawal by Subject|0|||
131184671|NCT02671461|472297364|FG002|Follow-up|Withdrawal by Subject|0|||
131184672|NCT02671461|472297362|FG000|Follow-up|Lost to Follow-up|0|||
131184673|NCT02671461|472297363|FG001|Follow-up|Lost to Follow-up|0|||
131184674|NCT02671461|472297364|FG002|Follow-up|Lost to Follow-up|1|||
131184675|NCT02671461|472297362|FG000|Follow-up|Administrative Reason by Sponsor|0|||
131184676|NCT02671461|472297363|FG001|Follow-up|Administrative Reason by Sponsor|1|||
131184677|NCT02671461|472297364|FG002|Follow-up|Administrative Reason by Sponsor|0|||
131184678|NCT01412060|472297365|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
131184679|NCT01412060|472297366|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
131240060|NCT05368558|472504344|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
131240061|NCT05368558|472504333|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131240062|NCT05368558|472504334|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131240063|NCT05368558|472504335|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131240064|NCT05368558|472504336|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
131240065|NCT05368558|472504337|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131240066|NCT05368558|472504338|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
131240067|NCT05368558|472504339|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131240068|NCT05368558|472504340|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131240069|NCT05368558|472504341|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131240070|NCT05368558|472504342|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131240071|NCT05368558|472504343|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131240072|NCT05368558|472504344|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
131240073|NCT05368558|472504333|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240074|NCT05368558|472504334|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240075|NCT05368558|472504335|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240076|NCT05368558|472504336|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
131240077|NCT05368558|472504337|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240078|NCT05368558|472504338|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240079|NCT05368558|472504339|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240080|NCT05368558|472504340|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240081|NCT05368558|472504341|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240082|NCT05368558|472504342|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240083|NCT05368558|472504343|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240084|NCT05368558|472504344|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
131240085|NCT05368558|472504333|FG000|Blinded Extension Period (BEP)|other|0|||
131240086|NCT05368558|472504334|FG001|Blinded Extension Period (BEP)|other|0|||
131240087|NCT05368558|472504335|FG002|Blinded Extension Period (BEP)|other|0|||
131240088|NCT05368558|472504336|FG003|Blinded Extension Period (BEP)|other|0|||
131240089|NCT05368558|472504337|FG004|Blinded Extension Period (BEP)|other|0|||
131240090|NCT05368558|472504338|FG005|Blinded Extension Period (BEP)|other|1|||
131240091|NCT05368558|472504339|FG006|Blinded Extension Period (BEP)|other|0|||
131240092|NCT05368558|472504340|FG007|Blinded Extension Period (BEP)|other|0|||
131240093|NCT05368558|472504341|FG008|Blinded Extension Period (BEP)|other|0|||
131240094|NCT05368558|472504342|FG009|Blinded Extension Period (BEP)|other|0|||
131240095|NCT05368558|472504343|FG010|Blinded Extension Period (BEP)|other|0|||
131240096|NCT05368558|472504344|FG011|Blinded Extension Period (BEP)|other|0|||
131240097|NCT04340843|472504345|FG000|Overall Study|Adverse Event|0|||
131240098|NCT04340843|472504346|FG001|Overall Study|Adverse Event|2|||
131240099|NCT04340843|472504345|FG000|Overall Study|Withdrawal by Subject|0|||
131240100|NCT04340843|472504346|FG001|Overall Study|Withdrawal by Subject|2|||
131240101|NCT04623775|472504347|FG000|Randomization|No Longer Meets Study Criteria|2|||
131240102|NCT04623775|472504348|FG001|Randomization|No Longer Meets Study Criteria|1|||
131240103|NCT04623775|472504349|FG002|Randomization|No Longer Meets Study Criteria|0|||
131240104|NCT04623775|472504350|FG003|Randomization|No Longer Meets Study Criteria|0|||
131240105|NCT04623775|472504347|FG000|Randomization|Withdrew Consent|0|||
131240106|NCT04623775|472504348|FG001|Randomization|Withdrew Consent|0|||
131240107|NCT04623775|472504349|FG002|Randomization|Withdrew Consent|0|||
131240108|NCT04623775|472504350|FG003|Randomization|Withdrew Consent|1|||
131184680|NCT01412060|472297367|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
131184681|NCT01412060|472297365|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
131184682|NCT01412060|472297366|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
131184683|NCT01412060|472297367|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
131184684|NCT01412060|472297365|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
131184685|NCT01412060|472297366|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
131184686|NCT01412060|472297367|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
131184687|NCT01412060|472297365|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
131184688|NCT01412060|472297366|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
131184689|NCT01412060|472297367|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
131184690|NCT01412060|472297365|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
131184691|NCT01412060|472297366|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
131184692|NCT01412060|472297367|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
131184693|NCT01412060|472297365|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
131184694|NCT01412060|472297366|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
131184695|NCT01412060|472297367|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
131184696|NCT01412060|472297365|FG000|Period Between RIP and SP|Adverse Event|4|||
131184697|NCT01412060|472297366|FG001|Period Between RIP and SP|Adverse Event|0|||
131184698|NCT01412060|472297367|FG002|Period Between RIP and SP|Adverse Event|0|||
131184699|NCT01412060|472297365|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
131184700|NCT01412060|472297366|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
131184701|NCT01412060|472297367|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
131184702|NCT01412060|472297365|FG000|Period Between RIP and SP|Protocol Violation|2|||
131184703|NCT01412060|472297366|FG001|Period Between RIP and SP|Protocol Violation|0|||
131184704|NCT01412060|472297367|FG002|Period Between RIP and SP|Protocol Violation|0|||
131240109|NCT04623775|472504347|FG000|Randomization|Other Reasons|0|||
131240110|NCT04623775|472504348|FG001|Randomization|Other Reasons|0|||
131240111|NCT04623775|472504349|FG002|Randomization|Other Reasons|0|||
131240112|NCT04623775|472504350|FG003|Randomization|Other Reasons|1|||
131240113|NCT04623775|472504347|FG000|Treatment Period|participant withdrew consent|4|||
131240114|NCT04623775|472504348|FG001|Treatment Period|participant withdrew consent|0|||
131240115|NCT04623775|472504349|FG002|Treatment Period|participant withdrew consent|1|||
130784526|NCT00113607|470838811|FG000|Overall Study|Death|8|||
130784527|NCT00113607|470838812|FG001|Overall Study|Death|8|||
130784528|NCT00113607|470838811|FG000|Overall Study|Withdrawal by Subject|50|||
130784529|NCT00113607|470838812|FG001|Overall Study|Withdrawal by Subject|58|||
131184705|NCT01412060|472297365|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
131184706|NCT01412060|472297366|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
131240116|NCT04623775|472504350|FG003|Treatment Period|participant withdrew consent|2|||
131240117|NCT04623775|472504347|FG000|Treatment Period|Death|3|||
131240118|NCT04623775|472504348|FG001|Treatment Period|Death|1|||
131240119|NCT04623775|472504349|FG002|Treatment Period|Death|4|||
131240120|NCT04623775|472504350|FG003|Treatment Period|Death|2|||
131240121|NCT04623775|472504347|FG000|Treatment Period|Lost to Follow-up|0|||
131240122|NCT04623775|472504348|FG001|Treatment Period|Lost to Follow-up|2|||
131240123|NCT04623775|472504349|FG002|Treatment Period|Lost to Follow-up|0|||
131240124|NCT04623775|472504350|FG003|Treatment Period|Lost to Follow-up|0|||
131240125|NCT04623775|472504347|FG000|Treatment Period|poor/non compliance|0|||
131240126|NCT04623775|472504348|FG001|Treatment Period|poor/non compliance|0|||
131240127|NCT04623775|472504349|FG002|Treatment Period|poor/non compliance|1|||
131240128|NCT04623775|472504350|FG003|Treatment Period|poor/non compliance|0|||
131240129|NCT04623775|472504347|FG000|Treatment Period|participant no longer meets study criteria|0|||
131240130|NCT04623775|472504348|FG001|Treatment Period|participant no longer meets study criteria|1|||
131240131|NCT04623775|472504349|FG002|Treatment Period|participant no longer meets study criteria|0|||
131240132|NCT04623775|472504350|FG003|Treatment Period|participant no longer meets study criteria|0|||
131240133|NCT04623775|472504347|FG000|Treatment Period|administrative reasons by sponsor|3|||
131240134|NCT04623775|472504348|FG001|Treatment Period|administrative reasons by sponsor|2|||
131240135|NCT04623775|472504349|FG002|Treatment Period|administrative reasons by sponsor|0|||
131240136|NCT04623775|472504350|FG003|Treatment Period|administrative reasons by sponsor|0|||
131240137|NCT04623775|472504347|FG000|Treatment Period|other reasons|2|||
131240138|NCT04623775|472504348|FG001|Treatment Period|other reasons|0|||
131240139|NCT04623775|472504349|FG002|Treatment Period|other reasons|1|||
131240140|NCT04623775|472504350|FG003|Treatment Period|other reasons|1|||
131240141|NCT04623775|472504347|FG000|Treatment Period|disease progression|40|||
131240142|NCT04623775|472504348|FG001|Treatment Period|disease progression|35|||
131240143|NCT04623775|472504349|FG002|Treatment Period|disease progression|63|||
131240144|NCT04623775|472504350|FG003|Treatment Period|disease progression|63|||
131240145|NCT04623775|472504347|FG000|Treatment Period|study drug toxicity|12|||
131240146|NCT04623775|472504348|FG001|Treatment Period|study drug toxicity|15|||
131240147|NCT04623775|472504349|FG002|Treatment Period|study drug toxicity|13|||
131240148|NCT04623775|472504350|FG003|Treatment Period|study drug toxicity|12|||
131240149|NCT04623775|472504347|FG000|Treatment Period|AE unrelated to study drug|4|||
131240150|NCT04623775|472504348|FG001|Treatment Period|AE unrelated to study drug|9|||
131240151|NCT04623775|472504349|FG002|Treatment Period|AE unrelated to study drug|12|||
131240152|NCT04623775|472504350|FG003|Treatment Period|AE unrelated to study drug|9|||
131240153|NCT04623775|472504347|FG000|Treatment Period|participant request to discontinue treatment|0|||
131240154|NCT04623775|472504348|FG001|Treatment Period|participant request to discontinue treatment|2|||
131240155|NCT04623775|472504349|FG002|Treatment Period|participant request to discontinue treatment|2|||
131240156|NCT04623775|472504350|FG003|Treatment Period|participant request to discontinue treatment|0|||
131240157|NCT02101853|472504351|FG000|Block 1 Induction|Adverse Event|11|||
131184707|NCT01412060|472297367|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
131184708|NCT01412060|472297365|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
131184709|NCT01412060|472297366|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
131184710|NCT01412060|472297367|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
131184711|NCT01412060|472297365|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
131184712|NCT01412060|472297366|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
131240158|NCT02101853|472504352|FG001|Block 1 Induction|Adverse Event|0|||
131240159|NCT02101853|472504353|FG002|Block 1 Induction|Adverse Event|0|||
131240160|NCT02101853|472504354|FG003|Block 1 Induction|Adverse Event|0|||
131240161|NCT02101853|472504355|FG004|Block 1 Induction|Adverse Event|0|||
131240162|NCT02101853|472504356|FG005|Block 1 Induction|Adverse Event|0|||
131240163|NCT02101853|472504351|FG000|Block 1 Induction|Death|20|||
131240164|NCT02101853|472504352|FG001|Block 1 Induction|Death|0|||
131184713|NCT01412060|472297367|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
131240165|NCT02101853|472504353|FG002|Block 1 Induction|Death|0|||
131240166|NCT02101853|472504354|FG003|Block 1 Induction|Death|0|||
131240167|NCT02101853|472504355|FG004|Block 1 Induction|Death|0|||
131240168|NCT02101853|472504356|FG005|Block 1 Induction|Death|0|||
131240169|NCT02101853|472504351|FG000|Block 1 Induction|Lack of Efficacy|6|||
131184714|NCT01412060|472297365|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
131184715|NCT01412060|472297366|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
131184716|NCT01412060|472297367|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
131184717|NCT01412060|472297365|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
131184718|NCT01412060|472297366|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
131184719|NCT01412060|472297367|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
131184720|NCT01412060|472297365|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
131184721|NCT01412060|472297366|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
131184722|NCT01412060|472297367|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
131240170|NCT02101853|472504352|FG001|Block 1 Induction|Lack of Efficacy|0|||
131240171|NCT02101853|472504353|FG002|Block 1 Induction|Lack of Efficacy|0|||
131240172|NCT02101853|472504354|FG003|Block 1 Induction|Lack of Efficacy|0|||
131240173|NCT02101853|472504355|FG004|Block 1 Induction|Lack of Efficacy|0|||
131240174|NCT02101853|472504356|FG005|Block 1 Induction|Lack of Efficacy|0|||
131240175|NCT02101853|472504351|FG000|Block 1 Induction|Physician Decision|61|||
131240176|NCT02101853|472504352|FG001|Block 1 Induction|Physician Decision|0|||
131240177|NCT02101853|472504353|FG002|Block 1 Induction|Physician Decision|0|||
131240178|NCT02101853|472504354|FG003|Block 1 Induction|Physician Decision|0|||
131240179|NCT02101853|472504355|FG004|Block 1 Induction|Physician Decision|0|||
131240180|NCT02101853|472504356|FG005|Block 1 Induction|Physician Decision|0|||
131240181|NCT02101853|472504351|FG000|Block 1 Induction|Protocol Violation|2|||
131240182|NCT02101853|472504352|FG001|Block 1 Induction|Protocol Violation|0|||
131240183|NCT02101853|472504353|FG002|Block 1 Induction|Protocol Violation|0|||
131240184|NCT02101853|472504354|FG003|Block 1 Induction|Protocol Violation|0|||
131240185|NCT02101853|472504355|FG004|Block 1 Induction|Protocol Violation|0|||
131240186|NCT02101853|472504356|FG005|Block 1 Induction|Protocol Violation|0|||
131240187|NCT02101853|472504351|FG000|Block 1 Induction|Withdrawal by Subject|65|||
131240188|NCT02101853|472504352|FG001|Block 1 Induction|Withdrawal by Subject|0|||
131240189|NCT02101853|472504353|FG002|Block 1 Induction|Withdrawal by Subject|0|||
131184723|NCT01412060|472297365|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
131184724|NCT01412060|472297366|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
131184725|NCT01412060|472297367|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
131184726|NCT01412060|472297365|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
131184727|NCT01412060|472297366|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
131184728|NCT01412060|472297367|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
131184729|NCT01412060|472297365|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
131184730|NCT01412060|472297366|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
131184731|NCT01412060|472297367|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
131184732|NCT01412060|472297365|FG000|Period Between SP and DBP|Protocol Violation|2|||
131184733|NCT01412060|472297366|FG001|Period Between SP and DBP|Protocol Violation|0|||
131184734|NCT01412060|472297367|FG002|Period Between SP and DBP|Protocol Violation|0|||
131184735|NCT01412060|472297365|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
131184736|NCT01412060|472297366|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
131184737|NCT01412060|472297367|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
131184738|NCT01412060|472297365|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
131184739|NCT01412060|472297366|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
131184740|NCT01412060|472297367|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
131184741|NCT01412060|472297365|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
131184742|NCT01412060|472297366|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
131184743|NCT01412060|472297367|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
131184744|NCT01412060|472297365|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
131184745|NCT01412060|472297366|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
131184746|NCT01412060|472297367|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
131184747|NCT01412060|472297365|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
131184748|NCT01412060|472297366|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
131184749|NCT01412060|472297367|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
131184750|NCT01412060|472297365|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
131184751|NCT01412060|472297366|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
131184752|NCT01412060|472297367|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
131184753|NCT01412060|472297365|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
131184754|NCT01412060|472297366|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
131184755|NCT01412060|472297367|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
131184756|NCT01412060|472297365|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
131184757|NCT01412060|472297366|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
131184758|NCT01412060|472297367|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
131184759|NCT01412060|472297365|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
130733527|NCT05026177|470642913|FG002|Overall Study|Physician Decision|0|||
131184760|NCT01412060|472297366|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
131184761|NCT01412060|472297367|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
131184762|NCT01412060|472297365|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
131184763|NCT01412060|472297366|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
131184764|NCT01412060|472297367|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
131184765|NCT00004732|472297369|FG000|Overall Study|Withdrawal by Subject|36|||
131184766|NCT00004732|472297370|FG001|Overall Study|Withdrawal by Subject|64|||
131184767|NCT00004732|472297369|FG000|Overall Study|Lost to Follow-up|33|||
131184768|NCT00004732|472297370|FG001|Overall Study|Lost to Follow-up|47|||
131184769|NCT02674685|472297374|FG000|Overall Study|Withdrawal by Subject|4|||
131184770|NCT02661464|472297376|FG000|Overall Study|Lost to Follow-up|28|||
131184771|NCT02661464|472297377|FG001|Overall Study|Lost to Follow-up|0|||
131184772|NCT02661464|472297378|FG002|Overall Study|Lost to Follow-up|0|||
131184773|NCT02661464|472297379|FG003|Overall Study|Lost to Follow-up|0|||
131184774|NCT02661464|472297376|FG000|Overall Study|Withdrawal by Subject|3|||
131184775|NCT02661464|472297377|FG001|Overall Study|Withdrawal by Subject|1|||
131184776|NCT02661464|472297378|FG002|Overall Study|Withdrawal by Subject|0|||
131184777|NCT02661464|472297379|FG003|Overall Study|Withdrawal by Subject|0|||
131184778|NCT02661464|472297376|FG000|Overall Study|Participants terminated prematurely|288|||
131184779|NCT02661464|472297377|FG001|Overall Study|Participants terminated prematurely|52|||
131184780|NCT02661464|472297378|FG002|Overall Study|Participants terminated prematurely|1|||
131184781|NCT02661464|472297379|FG003|Overall Study|Participants terminated prematurely|1|||
131184782|NCT02661464|472297376|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
131184783|NCT02661464|472297377|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
131184784|NCT02661464|472297378|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
131184785|NCT02661464|472297379|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
131184786|NCT05567393|472297383|FG000|Overall Study|Voluntary Withdrawal|0|||
131184787|NCT05567393|472297384|FG001|Overall Study|Voluntary Withdrawal|0|||
131184788|NCT05567393|472297385|FG002|Overall Study|Voluntary Withdrawal|0|||
131184789|NCT05567393|472297386|FG003|Overall Study|Voluntary Withdrawal|0|||
131184790|NCT05567393|472297387|FG004|Overall Study|Voluntary Withdrawal|0|||
131184791|NCT05567393|472297388|FG005|Overall Study|Voluntary Withdrawal|0|||
131184792|NCT05567393|472297389|FG006|Overall Study|Voluntary Withdrawal|0|||
131184793|NCT05567393|472297390|FG007|Overall Study|Voluntary Withdrawal|0|||
131184794|NCT05567393|472297391|FG008|Overall Study|Voluntary Withdrawal|0|||
131184795|NCT05567393|472297392|FG009|Overall Study|Voluntary Withdrawal|0|||
131184796|NCT05567393|472297393|FG010|Overall Study|Voluntary Withdrawal|0|||
131184797|NCT05567393|472297394|FG011|Overall Study|Voluntary Withdrawal|0|||
131184798|NCT05567393|472297395|FG012|Overall Study|Voluntary Withdrawal|0|||
131184799|NCT05567393|472297396|FG013|Overall Study|Voluntary Withdrawal|1|||
131184800|NCT05567393|472297397|FG014|Overall Study|Voluntary Withdrawal|0|||
131184801|NCT05567393|472297398|FG015|Overall Study|Voluntary Withdrawal|0|||
131184802|NCT05567393|472297399|FG016|Overall Study|Voluntary Withdrawal|0|||
131184803|NCT05567393|472297400|FG017|Overall Study|Voluntary Withdrawal|0|||
131184804|NCT03148756|472297401|FG000|Overall Study|Study Terminated|0|||
131184805|NCT03148756|472297402|FG001|Overall Study|Study Terminated|1|||
131184806|NCT04199793|472297405|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
131184807|NCT04199793|472297406|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
131184808|NCT04199793|472297405|FG000|Overall Study|Withdrawal by Subject|1|||
131184809|NCT04199793|472297406|FG001|Overall Study|Withdrawal by Subject|1|||
131184810|NCT03820726|472297411|FG000|Overall Study|Other than listed|23|||
131184811|NCT03820726|472297411|FG000|Overall Study|Withdrawal by Subject|37|||
131184812|NCT03820726|472297411|FG000|Overall Study|Lost to Follow-up|3|||
131184813|NCT03820726|472297411|FG000|Overall Study|Protocol deviation|1|||
131184814|NCT03820726|472297411|FG000|Overall Study|Adverse Event|146|||
131184815|NCT03820726|472297411|FG000|Overall Study|Not treated|1|||
131184816|NCT00345540|472297415|FG000|Overall Study|Withdrawal by Subject|1|||
131184817|NCT01406652|472297416|FG000|Overall Study|Lost-to-follow-up|3|||
131184818|NCT01406652|472297417|FG001|Overall Study|Lost-to-follow-up|4|||
131184819|NCT01406652|472297416|FG000|Overall Study|Withdrawal by Subject|2|||
131184820|NCT01406652|472297417|FG001|Overall Study|Withdrawal by Subject|2|||
131184821|NCT01406652|472297416|FG000|Overall Study|Insufficient follow-up|5|||
131184822|NCT01406652|472297417|FG001|Overall Study|Insufficient follow-up|4|||
131184823|NCT01406652|472297416|FG000|Overall Study|Infection not sure|10|||
131184824|NCT01406652|472297417|FG001|Overall Study|Infection not sure|10|||
131184825|NCT02762708|472297421|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
131184826|NCT02762708|472297422|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
131184827|NCT02762708|472297423|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
131184828|NCT02762708|472297424|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
131184829|NCT01468701|472297429|FG000|Overall Study|Not eligible|91|||
131184830|NCT01468701|472297430|FG001|Overall Study|Not eligible|140|||
131184831|NCT01468701|472297431|FG002|Overall Study|Not eligible|29|||
131184832|NCT01468701|472297432|FG003|Overall Study|Not eligible|12|||
131184833|NCT01468701|472297433|FG004|Overall Study|Not eligible|22|||
131184834|NCT01468701|472297434|FG005|Overall Study|Not eligible|2|||
131184835|NCT01468701|472297435|FG006|Overall Study|Not eligible|39|||
131184836|NCT01468701|472297436|FG007|Overall Study|Not eligible|1|||
131184837|NCT01468701|472297437|FG008|Overall Study|Not eligible|40|||
131184838|NCT01468701|472297438|FG009|Overall Study|Not eligible|126|||
131184839|NCT01468701|472297439|FG010|Overall Study|Not eligible|39|||
131184840|NCT01468701|472297440|FG011|Overall Study|Not eligible|33|||
131184841|NCT01468701|472297441|FG012|Overall Study|Not eligible|1|||
131184842|NCT01468701|472297442|FG013|Overall Study|Not eligible|19|||
131184843|NCT01468701|472297443|FG014|Overall Study|Not eligible|1|||
131184844|NCT01468701|472297444|FG015|Overall Study|Not eligible|32|||
131184845|NCT01468701|472297445|FG016|Overall Study|Not eligible|0|||
131184846|NCT01468701|472297429|FG000|Overall Study|Lost to Follow-up|306|||
131184847|NCT01468701|472297430|FG001|Overall Study|Lost to Follow-up|0|||
131184848|NCT01468701|472297431|FG002|Overall Study|Lost to Follow-up|0|||
131184849|NCT01468701|472297432|FG003|Overall Study|Lost to Follow-up|0|||
131184850|NCT01468701|472297433|FG004|Overall Study|Lost to Follow-up|0|||
131184851|NCT01468701|472297434|FG005|Overall Study|Lost to Follow-up|0|||
131184852|NCT01468701|472297435|FG006|Overall Study|Lost to Follow-up|0|||
131184853|NCT01468701|472297436|FG007|Overall Study|Lost to Follow-up|0|||
131184854|NCT01468701|472297437|FG008|Overall Study|Lost to Follow-up|215|||
131184855|NCT01468701|472297438|FG009|Overall Study|Lost to Follow-up|309|||
131184856|NCT01468701|472297439|FG010|Overall Study|Lost to Follow-up|224|||
131184857|NCT01468701|472297440|FG011|Overall Study|Lost to Follow-up|212|||
131184858|NCT01468701|472297441|FG012|Overall Study|Lost to Follow-up|11|||
131184859|NCT01468701|472297442|FG013|Overall Study|Lost to Follow-up|164|||
131184860|NCT01468701|472297443|FG014|Overall Study|Lost to Follow-up|17|||
131184861|NCT01468701|472297444|FG015|Overall Study|Lost to Follow-up|127|||
131184862|NCT01468701|472297445|FG016|Overall Study|Lost to Follow-up|1|||
131184863|NCT01468701|472297429|FG000|Overall Study|Withdrawal by Subject|165|||
131184864|NCT01468701|472297430|FG001|Overall Study|Withdrawal by Subject|0|||
131184865|NCT01468701|472297431|FG002|Overall Study|Withdrawal by Subject|0|||
131184866|NCT01468701|472297432|FG003|Overall Study|Withdrawal by Subject|0|||
131184867|NCT01468701|472297433|FG004|Overall Study|Withdrawal by Subject|0|||
131184868|NCT01468701|472297434|FG005|Overall Study|Withdrawal by Subject|0|||
131184869|NCT01468701|472297435|FG006|Overall Study|Withdrawal by Subject|0|||
131184870|NCT01468701|472297436|FG007|Overall Study|Withdrawal by Subject|0|||
131184871|NCT01468701|472297437|FG008|Overall Study|Withdrawal by Subject|83|||
131184872|NCT01468701|472297438|FG009|Overall Study|Withdrawal by Subject|88|||
131184873|NCT01468701|472297439|FG010|Overall Study|Withdrawal by Subject|100|||
131184874|NCT01468701|472297440|FG011|Overall Study|Withdrawal by Subject|114|||
131184875|NCT01468701|472297441|FG012|Overall Study|Withdrawal by Subject|9|||
131184876|NCT01468701|472297442|FG013|Overall Study|Withdrawal by Subject|47|||
131184877|NCT01468701|472297443|FG014|Overall Study|Withdrawal by Subject|6|||
131184878|NCT01468701|472297444|FG015|Overall Study|Withdrawal by Subject|31|||
131184879|NCT01468701|472297445|FG016|Overall Study|Withdrawal by Subject|0|||
131184880|NCT01468701|472297429|FG000|Overall Study|Other reasons than listed|437|||
131184881|NCT01468701|472297430|FG001|Overall Study|Other reasons than listed|0|||
131184882|NCT01468701|472297431|FG002|Overall Study|Other reasons than listed|0|||
131184883|NCT01468701|472297432|FG003|Overall Study|Other reasons than listed|0|||
131184884|NCT01468701|472297433|FG004|Overall Study|Other reasons than listed|0|||
131184885|NCT01468701|472297434|FG005|Overall Study|Other reasons than listed|0|||
131184886|NCT01468701|472297435|FG006|Overall Study|Other reasons than listed|0|||
131184887|NCT01468701|472297436|FG007|Overall Study|Other reasons than listed|0|||
131184888|NCT01468701|472297437|FG008|Overall Study|Other reasons than listed|318|||
131184889|NCT01468701|472297438|FG009|Overall Study|Other reasons than listed|658|||
131184890|NCT01468701|472297439|FG010|Overall Study|Other reasons than listed|433|||
131184891|NCT01468701|472297440|FG011|Overall Study|Other reasons than listed|504|||
131184892|NCT01468701|472297441|FG012|Overall Study|Other reasons than listed|28|||
131184893|NCT01468701|472297442|FG013|Overall Study|Other reasons than listed|239|||
131184894|NCT01468701|472297443|FG014|Overall Study|Other reasons than listed|39|||
131184895|NCT01468701|472297444|FG015|Overall Study|Other reasons than listed|172|||
131184896|NCT01468701|472297445|FG016|Overall Study|Other reasons than listed|0|||
131184897|NCT01468701|472297429|FG000|Overall Study|No end of study case report form|0|||
131184898|NCT01468701|472297430|FG001|Overall Study|No end of study case report form|0|||
131184899|NCT01468701|472297431|FG002|Overall Study|No end of study case report form|0|||
131184900|NCT01468701|472297432|FG003|Overall Study|No end of study case report form|0|||
131184901|NCT01468701|472297433|FG004|Overall Study|No end of study case report form|0|||
131184902|NCT01468701|472297434|FG005|Overall Study|No end of study case report form|0|||
131184903|NCT01468701|472297435|FG006|Overall Study|No end of study case report form|0|||
131184904|NCT01468701|472297436|FG007|Overall Study|No end of study case report form|0|||
131184905|NCT01468701|472297437|FG008|Overall Study|No end of study case report form|4|||
131184906|NCT01468701|472297438|FG009|Overall Study|No end of study case report form|1|||
131184907|NCT01468701|472297439|FG010|Overall Study|No end of study case report form|2|||
131184908|NCT01468701|472297440|FG011|Overall Study|No end of study case report form|3|||
131184909|NCT01468701|472297441|FG012|Overall Study|No end of study case report form|0|||
131240190|NCT02101853|472504354|FG003|Block 1 Induction|Withdrawal by Subject|0|||
131240191|NCT02101853|472504355|FG004|Block 1 Induction|Withdrawal by Subject|0|||
131240192|NCT02101853|472504356|FG005|Block 1 Induction|Withdrawal by Subject|0|||
131240193|NCT02101853|472504351|FG000|Block 1 Induction|Ineligible|8|||
131240194|NCT02101853|472504352|FG001|Block 1 Induction|Ineligible|0|||
131184910|NCT01468701|472297442|FG013|Overall Study|No end of study case report form|1|||
131184911|NCT01468701|472297443|FG014|Overall Study|No end of study case report form|0|||
131184912|NCT01468701|472297444|FG015|Overall Study|No end of study case report form|0|||
131184913|NCT01468701|472297445|FG016|Overall Study|No end of study case report form|0|||
131184914|NCT01468701|472297429|FG000|Overall Study|Not being followed up|0|||
131184915|NCT01468701|472297430|FG001|Overall Study|Not being followed up|4963|||
131184916|NCT01468701|472297431|FG002|Overall Study|Not being followed up|1755|||
131184917|NCT01468701|472297432|FG003|Overall Study|Not being followed up|703|||
131184918|NCT01468701|472297433|FG004|Overall Study|Not being followed up|1714|||
131184919|NCT01468701|472297434|FG005|Overall Study|Not being followed up|126|||
131184920|NCT01468701|472297435|FG006|Overall Study|Not being followed up|1170|||
131184921|NCT01468701|472297436|FG007|Overall Study|Not being followed up|4|||
131184922|NCT01468701|472297437|FG008|Overall Study|Not being followed up|0|||
131184923|NCT01468701|472297438|FG009|Overall Study|Not being followed up|0|||
131184924|NCT01468701|472297439|FG010|Overall Study|Not being followed up|0|||
131184925|NCT01468701|472297440|FG011|Overall Study|Not being followed up|0|||
131184926|NCT01468701|472297441|FG012|Overall Study|Not being followed up|0|||
131184927|NCT01468701|472297442|FG013|Overall Study|Not being followed up|0|||
131184928|NCT01468701|472297443|FG014|Overall Study|Not being followed up|0|||
131184929|NCT01468701|472297444|FG015|Overall Study|Not being followed up|0|||
131184930|NCT01468701|472297445|FG016|Overall Study|Not being followed up|0|||
131184931|NCT01068717|472297446|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
131184932|NCT01068717|472297447|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
131184933|NCT01068717|472297448|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
131184934|NCT01068717|472297449|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
131184935|NCT01822223|472297450|FG000|Overall Study|Death|0|||
131184936|NCT01822223|472297451|FG001|Overall Study|Death|1|||
131184937|NCT00719862|472297462|FG000|Overall Study|Adverse Event|1|||
131184938|NCT00719862|472297463|FG001|Overall Study|Adverse Event|2|||
131184939|NCT00719862|472297462|FG000|Overall Study|Lack of Efficacy|3|||
131184940|NCT00719862|472297463|FG001|Overall Study|Lack of Efficacy|0|||
131184941|NCT00719862|472297462|FG000|Overall Study|Non-Compliance|1|||
131184942|NCT00719862|472297463|FG001|Overall Study|Non-Compliance|0|||
131184943|NCT00719862|472297462|FG000|Overall Study|Withdrawal by Subject|1|||
131184944|NCT00719862|472297463|FG001|Overall Study|Withdrawal by Subject|0|||
131184945|NCT00719862|472297462|FG000|Overall Study|Lost to Follow-up|0|||
131184946|NCT00719862|472297463|FG001|Overall Study|Lost to Follow-up|1|||
131184947|NCT00719862|472297462|FG000|Overall Study|Other|2|||
131184948|NCT00719862|472297463|FG001|Overall Study|Other|3|||
131184949|NCT00892957|472297464|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
131184950|NCT00892957|472297465|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
131184951|NCT00892957|472297464|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
131184952|NCT00892957|472297465|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
131240195|NCT02101853|472504353|FG002|Block 1 Induction|Ineligible|0|||
131184953|NCT01999946|472297466|FG000|Overall Study|Participant not released from jail|2|||
131240196|NCT02101853|472504354|FG003|Block 1 Induction|Ineligible|0|||
131240197|NCT02101853|472504355|FG004|Block 1 Induction|Ineligible|0|||
131240198|NCT02101853|472504356|FG005|Block 1 Induction|Ineligible|0|||
131240199|NCT02101853|472504351|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
131240200|NCT02101853|472504352|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
131240201|NCT02101853|472504353|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
131240202|NCT02101853|472504354|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
131240203|NCT02101853|472504355|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
131240204|NCT02101853|472504356|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
131240205|NCT02101853|472504351|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
131240206|NCT02101853|472504352|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131184954|NCT01999946|472297467|FG001|Overall Study|Participant not released from jail|2|||
131184955|NCT01999946|472297468|FG002|Overall Study|Participant not released from jail|0|||
131184956|NCT01999946|472297466|FG000|Overall Study|Not included in primary outcome analysis|0|||
131184957|NCT01999946|472297467|FG001|Overall Study|Not included in primary outcome analysis|0|||
131184958|NCT01999946|472297468|FG002|Overall Study|Not included in primary outcome analysis|79|||
131184959|NCT04876599|472297471|FG000|Overall Study|Missed|2|||
131184960|NCT04876599|472297472|FG001|Overall Study|Missed|0|||
131184961|NCT04876599|472297471|FG000|Overall Study|Declined|2|||
131184962|NCT04876599|472297472|FG001|Overall Study|Declined|3|||
131240207|NCT02101853|472504353|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131240208|NCT02101853|472504354|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131240209|NCT02101853|472504355|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131240210|NCT02101853|472504356|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131240211|NCT02101853|472504351|FG000|Post Induction Randomization|Adverse Event|0|||
131240212|NCT02101853|472504352|FG001|Post Induction Randomization|Adverse Event|3|||
131240213|NCT02101853|472504353|FG002|Post Induction Randomization|Adverse Event|8|||
131240214|NCT02101853|472504354|FG003|Post Induction Randomization|Adverse Event|4|||
131240215|NCT02101853|472504355|FG004|Post Induction Randomization|Adverse Event|4|||
131240216|NCT02101853|472504356|FG005|Post Induction Randomization|Adverse Event|0|||
131240217|NCT02101853|472504351|FG000|Post Induction Randomization|Death|0|||
131240218|NCT02101853|472504352|FG001|Post Induction Randomization|Death|9|||
131240219|NCT02101853|472504353|FG002|Post Induction Randomization|Death|2|||
131240220|NCT02101853|472504354|FG003|Post Induction Randomization|Death|2|||
131240221|NCT02101853|472504355|FG004|Post Induction Randomization|Death|0|||
131240222|NCT02101853|472504356|FG005|Post Induction Randomization|Death|0|||
131240223|NCT02101853|472504351|FG000|Post Induction Randomization|Lack of Efficacy|0|||
131240224|NCT02101853|472504352|FG001|Post Induction Randomization|Lack of Efficacy|14|||
131240225|NCT02101853|472504353|FG002|Post Induction Randomization|Lack of Efficacy|23|||
131240226|NCT02101853|472504354|FG003|Post Induction Randomization|Lack of Efficacy|18|||
131240227|NCT02101853|472504355|FG004|Post Induction Randomization|Lack of Efficacy|21|||
131240228|NCT02101853|472504356|FG005|Post Induction Randomization|Lack of Efficacy|0|||
131240229|NCT02101853|472504351|FG000|Post Induction Randomization|Physician Decision|0|||
131240230|NCT02101853|472504352|FG001|Post Induction Randomization|Physician Decision|43|||
131240231|NCT02101853|472504353|FG002|Post Induction Randomization|Physician Decision|23|||
131240232|NCT02101853|472504354|FG003|Post Induction Randomization|Physician Decision|14|||
131240233|NCT02101853|472504355|FG004|Post Induction Randomization|Physician Decision|14|||
131240234|NCT02101853|472504356|FG005|Post Induction Randomization|Physician Decision|0|||
131240235|NCT02101853|472504351|FG000|Post Induction Randomization|Protocol Violation|0|||
131240236|NCT02101853|472504352|FG001|Post Induction Randomization|Protocol Violation|3|||
131240237|NCT02101853|472504353|FG002|Post Induction Randomization|Protocol Violation|0|||
131240238|NCT02101853|472504354|FG003|Post Induction Randomization|Protocol Violation|0|||
131240239|NCT02101853|472504355|FG004|Post Induction Randomization|Protocol Violation|0|||
131240240|NCT02101853|472504356|FG005|Post Induction Randomization|Protocol Violation|0|||
131240241|NCT02101853|472504351|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
131240242|NCT02101853|472504352|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
131240243|NCT02101853|472504353|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
131184963|NCT03175562|472297473|FG000|Overall Study|Adverse Event|1|||
131184964|NCT03175562|472297473|FG000|Overall Study|Lost to Follow-up|3|||
131184965|NCT03175562|472297473|FG000|Overall Study|Withdrawal by Subject|7|||
131184966|NCT03175562|472297473|FG000|Overall Study|Other (Not Specified)|5|||
131184967|NCT02146833|472297474|FG000|Overall Study|Death|10|||
131184968|NCT02146833|472297474|FG000|Overall Study|No longer consented to study treatment|1|||
131184969|NCT03700736|472297479|FG000|Overall Study|Pregnancy|1|||
131184970|NCT03700736|472297480|FG001|Overall Study|Pregnancy|1|||
131184971|NCT03700736|472297479|FG000|Overall Study|Withdrawal by Subject|2|||
131240244|NCT02101853|472504354|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
131240245|NCT02101853|472504355|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
131240246|NCT02101853|472504356|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
131240247|NCT02101853|472504351|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131240248|NCT02101853|472504352|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131240249|NCT02101853|472504353|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131240250|NCT02101853|472504354|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
131240251|NCT02101853|472504355|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131240252|NCT02101853|472504356|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
131240253|NCT02101853|472504351|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
131240254|NCT02101853|472504352|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
131240255|NCT02101853|472504353|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
131240256|NCT02101853|472504354|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
131240257|NCT02101853|472504355|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
131240258|NCT02101853|472504356|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
131240259|NCT02101853|472504351|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130733528|NCT05026177|470642911|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
131184972|NCT03700736|472297480|FG001|Overall Study|Withdrawal by Subject|6|||
131184973|NCT00642018|472297481|FG000|Overall Study|Adverse Event|11|||
131184974|NCT00642018|472297482|FG001|Overall Study|Adverse Event|36|||
131184975|NCT00642018|472297481|FG000|Overall Study|Withdrawal by Subject|4|||
131184976|NCT00642018|472297482|FG001|Overall Study|Withdrawal by Subject|10|||
131184977|NCT00642018|472297481|FG000|Overall Study|Progressive Disease|13|||
131184978|NCT00642018|472297482|FG001|Overall Study|Progressive Disease|18|||
131184979|NCT00642018|472297481|FG000|Overall Study|Physician Decision|0|||
131184980|NCT00642018|472297482|FG001|Overall Study|Physician Decision|10|||
131240260|NCT02101853|472504352|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
131240261|NCT02101853|472504353|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
131240262|NCT02101853|472504354|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
131240263|NCT02101853|472504355|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
131240264|NCT02101853|472504356|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
131240265|NCT02101853|472504351|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
131240266|NCT02101853|472504352|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
131240267|NCT02101853|472504353|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
131240268|NCT02101853|472504354|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
131240269|NCT02101853|472504355|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
131240270|NCT02101853|472504356|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
131240271|NCT02101853|472504351|FG000|Blinatumomab Salvage Therapy|Death|0|||
131240272|NCT02101853|472504352|FG001|Blinatumomab Salvage Therapy|Death|0|||
131240273|NCT02101853|472504353|FG002|Blinatumomab Salvage Therapy|Death|0|||
131240274|NCT02101853|472504354|FG003|Blinatumomab Salvage Therapy|Death|0|||
131240275|NCT02101853|472504355|FG004|Blinatumomab Salvage Therapy|Death|0|||
131240276|NCT02101853|472504356|FG005|Blinatumomab Salvage Therapy|Death|2|||
131240277|NCT02101853|472504351|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
131240278|NCT02101853|472504352|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
131240279|NCT02101853|472504353|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
131240280|NCT02101853|472504354|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
131240281|NCT02101853|472504355|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
131240282|NCT02101853|472504356|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
131240283|NCT02101853|472504351|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
131240284|NCT02101853|472504352|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
131240285|NCT02101853|472504353|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
131240286|NCT02101853|472504354|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
131240287|NCT02101853|472504355|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
131240288|NCT02101853|472504356|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
131240289|NCT02101853|472504351|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
131240290|NCT02101853|472504352|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
131240291|NCT02101853|472504353|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
131240292|NCT02101853|472504354|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
131240293|NCT02101853|472504355|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
131240294|NCT02101853|472504356|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
131240295|NCT02112916|472504357|FG000|Overall Study|Adverse Event|6|||
131240296|NCT02112916|472504358|FG001|Overall Study|Adverse Event|9|||
131240297|NCT02112916|472504359|FG002|Overall Study|Adverse Event|3|||
131240298|NCT02112916|472504360|FG003|Overall Study|Adverse Event|2|||
131240299|NCT02112916|472504357|FG000|Overall Study|Death|9|||
131240300|NCT02112916|472504358|FG001|Overall Study|Death|9|||
131240301|NCT02112916|472504359|FG002|Overall Study|Death|3|||
131240302|NCT02112916|472504360|FG003|Overall Study|Death|4|||
131240303|NCT02112916|472504357|FG000|Overall Study|Lost to Follow-up|1|||
131240304|NCT02112916|472504358|FG001|Overall Study|Lost to Follow-up|0|||
131240305|NCT02112916|472504359|FG002|Overall Study|Lost to Follow-up|0|||
131240306|NCT02112916|472504360|FG003|Overall Study|Lost to Follow-up|0|||
131240307|NCT02112916|472504357|FG000|Overall Study|Physician Decision|94|||
131240308|NCT02112916|472504358|FG001|Overall Study|Physician Decision|72|||
131240309|NCT02112916|472504359|FG002|Overall Study|Physician Decision|24|||
131184981|NCT00642018|472297481|FG000|Overall Study|Protocol Violation|0|||
131184982|NCT00642018|472297482|FG001|Overall Study|Protocol Violation|1|||
131184983|NCT00642018|472297481|FG000|Overall Study|Death|0|||
131184984|NCT00642018|472297482|FG001|Overall Study|Death|3|||
131184985|NCT00642018|472297481|FG000|Overall Study|Entry Criteria Not Met|0|||
131184986|NCT00642018|472297482|FG001|Overall Study|Entry Criteria Not Met|1|||
131184987|NCT04126031|472297485|FG000|Part A|Withdrawal by Subject|0|||
131184988|NCT04126031|472297486|FG001|Part A|Withdrawal by Subject|0|||
131240310|NCT02112916|472504360|FG003|Overall Study|Physician Decision|15|||
131240311|NCT02112916|472504357|FG000|Overall Study|Withdrawal by Subject|5|||
131240312|NCT02112916|472504358|FG001|Overall Study|Withdrawal by Subject|3|||
131240313|NCT02112916|472504359|FG002|Overall Study|Withdrawal by Subject|1|||
131240314|NCT02112916|472504360|FG003|Overall Study|Withdrawal by Subject|1|||
131240315|NCT02112916|472504357|FG000|Overall Study|Ineligible|4|||
131240316|NCT02112916|472504358|FG001|Overall Study|Ineligible|8|||
131240317|NCT02112916|472504359|FG002|Overall Study|Ineligible|3|||
131240318|NCT02112916|472504360|FG003|Overall Study|Ineligible|8|||
131240319|NCT02112916|472504357|FG000|Overall Study|Inevaluable|6|||
131240320|NCT02112916|472504358|FG001|Overall Study|Inevaluable|4|||
131240321|NCT02112916|472504359|FG002|Overall Study|Inevaluable|5|||
131240322|NCT02112916|472504360|FG003|Overall Study|Inevaluable|5|||
131240323|NCT02112916|472504357|FG000|Overall Study|Refusal of further protocol therapy|19|||
131240324|NCT02112916|472504358|FG001|Overall Study|Refusal of further protocol therapy|16|||
131240325|NCT02112916|472504359|FG002|Overall Study|Refusal of further protocol therapy|1|||
131240326|NCT02112916|472504360|FG003|Overall Study|Refusal of further protocol therapy|7|||
131240327|NCT02112916|472504357|FG000|Overall Study|Development of SMN|1|||
131184989|NCT04126031|472297487|FG002|Part A|Withdrawal by Subject|1|||
131184990|NCT04126031|472297488|FG003|Part A|Withdrawal by Subject|0|||
131184991|NCT04126031|472297489|FG004|Part A|Withdrawal by Subject|0|||
131184992|NCT04126031|472297490|FG005|Part A|Withdrawal by Subject|0|||
131184993|NCT04126031|472297485|FG000|Part A|Other|1|||
131184994|NCT04126031|472297486|FG001|Part A|Other|0|||
131184995|NCT04126031|472297487|FG002|Part A|Other|0|||
131184996|NCT04126031|472297488|FG003|Part A|Other|0|||
131184997|NCT04126031|472297489|FG004|Part A|Other|0|||
131184998|NCT04126031|472297490|FG005|Part A|Other|0|||
131184999|NCT04126031|472297485|FG000|Part B|Adverse Event|0|||
131185000|NCT04126031|472297486|FG001|Part B|Adverse Event|0|||
131185001|NCT04126031|472297487|FG002|Part B|Adverse Event|0|||
131185002|NCT04126031|472297488|FG003|Part B|Adverse Event|0|||
131185003|NCT04126031|472297489|FG004|Part B|Adverse Event|0|||
131185004|NCT04126031|472297490|FG005|Part B|Adverse Event|2|||
131185005|NCT04126031|472297485|FG000|Part B|Pre-existing hypertransaminasemia|0|||
131185006|NCT04126031|472297486|FG001|Part B|Pre-existing hypertransaminasemia|0|||
131185007|NCT04126031|472297487|FG002|Part B|Pre-existing hypertransaminasemia|0|||
131185008|NCT04126031|472297488|FG003|Part B|Pre-existing hypertransaminasemia|0|||
131185009|NCT04126031|472297489|FG004|Part B|Pre-existing hypertransaminasemia|1|||
131185010|NCT04126031|472297490|FG005|Part B|Pre-existing hypertransaminasemia|0|||
131185011|NCT00131664|472297491|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
131185012|NCT00131664|472297492|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
131185013|NCT00131664|472297493|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
131185014|NCT00131664|472297494|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
131185015|NCT00131664|472297495|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
131185016|NCT00131664|472297496|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
131185017|NCT00131664|472297491|FG000|First Period (First 6 Months)|Death|0|||
131185018|NCT00131664|472297492|FG001|First Period (First 6 Months)|Death|1|||
131185019|NCT00131664|472297493|FG002|First Period (First 6 Months)|Death|0|||
131185020|NCT00131664|472297494|FG003|First Period (First 6 Months)|Death|0|||
131185021|NCT00131664|472297495|FG004|First Period (First 6 Months)|Death|0|||
131185022|NCT00131664|472297496|FG005|First Period (First 6 Months)|Death|0|||
131185023|NCT00131664|472297491|FG000|First Period (First 6 Months)|Protocol Violation|2|||
131185024|NCT00131664|472297492|FG001|First Period (First 6 Months)|Protocol Violation|2|||
131185025|NCT00131664|472297493|FG002|First Period (First 6 Months)|Protocol Violation|1|||
131185026|NCT00131664|472297494|FG003|First Period (First 6 Months)|Protocol Violation|0|||
131185027|NCT00131664|472297495|FG004|First Period (First 6 Months)|Protocol Violation|0|||
131185028|NCT00131664|472297496|FG005|First Period (First 6 Months)|Protocol Violation|0|||
131185029|NCT00131664|472297491|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
131185030|NCT00131664|472297492|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
131185031|NCT00131664|472297493|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
131185032|NCT00131664|472297494|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
131185033|NCT00131664|472297495|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
131185034|NCT00131664|472297496|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
131185035|NCT00131664|472297491|FG000|First Period (First 6 Months)|Adverse Event|9|||
131185036|NCT00131664|472297492|FG001|First Period (First 6 Months)|Adverse Event|4|||
131185037|NCT00131664|472297493|FG002|First Period (First 6 Months)|Adverse Event|5|||
131185038|NCT00131664|472297494|FG003|First Period (First 6 Months)|Adverse Event|0|||
131185039|NCT00131664|472297495|FG004|First Period (First 6 Months)|Adverse Event|0|||
131185040|NCT00131664|472297496|FG005|First Period (First 6 Months)|Adverse Event|0|||
131185041|NCT00131664|472297491|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
131185042|NCT00131664|472297492|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
131185043|NCT00131664|472297493|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
131185044|NCT00131664|472297494|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
131185045|NCT00131664|472297495|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
131240328|NCT02112916|472504358|FG001|Overall Study|Development of SMN|0|||
131185046|NCT00131664|472297496|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
131185047|NCT00131664|472297491|FG000|First Period (First 6 Months)|Administrative reasons|2|||
131185048|NCT00131664|472297492|FG001|First Period (First 6 Months)|Administrative reasons|0|||
131240329|NCT02112916|472504359|FG002|Overall Study|Development of SMN|0|||
131240330|NCT02112916|472504360|FG003|Overall Study|Development of SMN|1|||
131240331|NCT02112916|472504357|FG000|Overall Study|Relapse/Progression|10|||
131240332|NCT02112916|472504358|FG001|Overall Study|Relapse/Progression|18|||
131240333|NCT02112916|472504359|FG002|Overall Study|Relapse/Progression|15|||
131240334|NCT02112916|472504360|FG003|Overall Study|Relapse/Progression|2|||
131240335|NCT02112916|472504357|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
131240336|NCT02112916|472504358|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
131240337|NCT02112916|472504359|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
131240338|NCT02112916|472504360|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
131240339|NCT02112916|472504357|FG000|Overall Study|Still on Therapy|44|||
131240340|NCT02112916|472504358|FG001|Overall Study|Still on Therapy|47|||
131240341|NCT02112916|472504359|FG002|Overall Study|Still on Therapy|3|||
131240342|NCT02112916|472504360|FG003|Overall Study|Still on Therapy|2|||
131240343|NCT02112916|472504357|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
131240344|NCT02112916|472504358|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
131240345|NCT02112916|472504359|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
131240346|NCT02112916|472504360|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
131240347|NCT02112916|472504357|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
131240348|NCT02112916|472504358|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
131240349|NCT02112916|472504359|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
131240350|NCT02112916|472504360|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
131240351|NCT05615363|472504363|FG000|Overall Study|Adverse Event|0|||
131240352|NCT05615363|472504364|FG001|Overall Study|Adverse Event|4|||
131240353|NCT05615363|472504365|FG002|Overall Study|Adverse Event|4|||
131240354|NCT05615363|472504366|FG003|Overall Study|Adverse Event|3|||
131240355|NCT05615363|472504367|FG004|Overall Study|Adverse Event|1|||
131240356|NCT05615363|472504363|FG000|Overall Study|Physician Decision|2|||
131240357|NCT05615363|472504364|FG001|Overall Study|Physician Decision|0|||
131240358|NCT05615363|472504365|FG002|Overall Study|Physician Decision|4|||
131240359|NCT05615363|472504366|FG003|Overall Study|Physician Decision|1|||
131240360|NCT05615363|472504367|FG004|Overall Study|Physician Decision|3|||
131240361|NCT05615363|472504363|FG000|Overall Study|Protocol Violation|2|||
131240362|NCT05615363|472504364|FG001|Overall Study|Protocol Violation|0|||
131240363|NCT05615363|472504365|FG002|Overall Study|Protocol Violation|0|||
131240364|NCT05615363|472504366|FG003|Overall Study|Protocol Violation|0|||
131240365|NCT05615363|472504367|FG004|Overall Study|Protocol Violation|1|||
131240366|NCT05615363|472504363|FG000|Overall Study|Withdrawal by Subject|0|||
131240367|NCT05615363|472504364|FG001|Overall Study|Withdrawal by Subject|0|||
131240368|NCT05615363|472504365|FG002|Overall Study|Withdrawal by Subject|1|||
131240369|NCT05615363|472504366|FG003|Overall Study|Withdrawal by Subject|0|||
131240370|NCT05615363|472504367|FG004|Overall Study|Withdrawal by Subject|0|||
131240371|NCT01638546|472504368|FG000|Overall Study|Adverse Event|1|||
131240372|NCT01638546|472504369|FG001|Overall Study|Adverse Event|3|||
131240373|NCT04495751|472504370|FG000|Overall Study|Withdrawal by Subject|1|||
131240374|NCT04495751|472504371|FG001|Overall Study|Withdrawal by Subject|0|||
131240375|NCT04495751|472504370|FG000|Overall Study|Lost to Follow-up|1|||
131240376|NCT04495751|472504371|FG001|Overall Study|Lost to Follow-up|0|||
131240377|NCT03289754|472504372|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
131240378|NCT04873934|472504373|FG000|Overall Study|Adverse Event|0|||
131185049|NCT00131664|472297493|FG002|First Period (First 6 Months)|Administrative reasons|5|||
131185050|NCT00131664|472297494|FG003|First Period (First 6 Months)|Administrative reasons|0|||
131185051|NCT00131664|472297495|FG004|First Period (First 6 Months)|Administrative reasons|0|||
131185052|NCT00131664|472297496|FG005|First Period (First 6 Months)|Administrative reasons|0|||
131185053|NCT00131664|472297491|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
131185054|NCT00131664|472297492|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
131185055|NCT00131664|472297493|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
131185056|NCT00131664|472297494|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
131185057|NCT00131664|472297495|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
131185058|NCT00131664|472297496|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
131185059|NCT00131664|472297491|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
131185060|NCT00131664|472297492|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
131185061|NCT00131664|472297493|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
131185062|NCT00131664|472297494|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
131185063|NCT00131664|472297495|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
131185064|NCT00131664|472297496|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
131240379|NCT04873934|472504374|FG001|Overall Study|Adverse Event|1|||
131240380|NCT04873934|472504373|FG000|Overall Study|Death|0|||
131240381|NCT04873934|472504374|FG001|Overall Study|Death|2|||
131240382|NCT04873934|472504373|FG000|Overall Study|Lost to Follow-up|13|||
131240383|NCT04873934|472504374|FG001|Overall Study|Lost to Follow-up|9|||
131240384|NCT04873934|472504373|FG000|Overall Study|Physician Decision|1|||
131240385|NCT04873934|472504374|FG001|Overall Study|Physician Decision|1|||
131240386|NCT04873934|472504373|FG000|Overall Study|Protocol deviation|2|||
131240387|NCT04873934|472504374|FG001|Overall Study|Protocol deviation|1|||
131185065|NCT00131664|472297491|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
131185066|NCT00131664|472297492|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
131185067|NCT00131664|472297493|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
131185068|NCT00131664|472297494|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
131185069|NCT00131664|472297495|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
131185070|NCT00131664|472297496|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
131185071|NCT00131664|472297491|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
131185072|NCT00131664|472297492|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
131185073|NCT00131664|472297493|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
131185074|NCT00131664|472297494|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
131185075|NCT00131664|472297495|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
131185076|NCT00131664|472297496|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
131185077|NCT00131664|472297491|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
131185078|NCT00131664|472297492|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
131185079|NCT00131664|472297493|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
131185080|NCT00131664|472297494|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
131185081|NCT00131664|472297495|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
131185082|NCT00131664|472297496|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
131185083|NCT00131664|472297491|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
131185084|NCT00131664|472297492|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
131185085|NCT00131664|472297493|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
131185086|NCT00131664|472297494|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
131185087|NCT00131664|472297495|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
131185088|NCT00131664|472297496|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
131185089|NCT00617656|472297497|FG000|Overall Study|Inclusion error|4|||
131185090|NCT00617656|472297498|FG001|Overall Study|Inclusion error|4|||
131185091|NCT00617656|472297499|FG002|Overall Study|Inclusion error|0|||
131185092|NCT00617656|472297500|FG003|Overall Study|Inclusion error|0|||
131185093|NCT00617656|472297497|FG000|Overall Study|Missing data|44|||
131185094|NCT00617656|472297498|FG001|Overall Study|Missing data|30|||
131185095|NCT00617656|472297499|FG002|Overall Study|Missing data|13|||
131185096|NCT00617656|472297500|FG003|Overall Study|Missing data|6|||
131185097|NCT00617656|472297497|FG000|Overall Study|Withdrawal by Subject|0|||
131185098|NCT00617656|472297498|FG001|Overall Study|Withdrawal by Subject|2|||
131185099|NCT00617656|472297499|FG002|Overall Study|Withdrawal by Subject|0|||
131185100|NCT00617656|472297500|FG003|Overall Study|Withdrawal by Subject|0|||
131185101|NCT03706040|472299144|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
131185102|NCT03706040|472299145|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
131185103|NCT03706040|472299146|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
131185104|NCT03706040|472299147|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
131185105|NCT03706040|472299148|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
131185106|NCT03706040|472299149|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
131185107|NCT03706040|472299150|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
131185108|NCT03706040|472299144|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
131185109|NCT03706040|472299145|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
131185110|NCT03706040|472299146|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
131185111|NCT03706040|472299147|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
131185112|NCT03706040|472299148|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
131185113|NCT03706040|472299149|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
131185114|NCT03706040|472299150|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
131185115|NCT03706040|472299144|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
131185116|NCT03706040|472299145|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
131185117|NCT03706040|472299146|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
131185118|NCT03706040|472299147|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
131185119|NCT03706040|472299148|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
131185120|NCT03706040|472299149|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
131185121|NCT03706040|472299150|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
131185122|NCT03706040|472299144|FG000|Period A (Week 0 to Week 16)|Other|2|||
131185123|NCT03706040|472299145|FG001|Period A (Week 0 to Week 16)|Other|0|||
131185124|NCT03706040|472299146|FG002|Period A (Week 0 to Week 16)|Other|2|||
131185125|NCT03706040|472299147|FG003|Period A (Week 0 to Week 16)|Other|0|||
131185126|NCT03706040|472299148|FG004|Period A (Week 0 to Week 16)|Other|0|||
131185127|NCT03706040|472299149|FG005|Period A (Week 0 to Week 16)|Other|0|||
131185128|NCT03706040|472299150|FG006|Period A (Week 0 to Week 16)|Other|0|||
131185129|NCT03706040|472299144|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
131185130|NCT03706040|472299145|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
131185131|NCT03706040|472299146|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
131185132|NCT03706040|472299147|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
131185133|NCT03706040|472299148|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
131185134|NCT03706040|472299149|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
131185135|NCT03706040|472299150|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
131185136|NCT03706040|472299144|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
131185137|NCT03706040|472299145|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
131185138|NCT03706040|472299146|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
131185139|NCT03706040|472299147|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
131185140|NCT03706040|472299148|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
131185141|NCT03706040|472299149|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
131185142|NCT03706040|472299150|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
131185143|NCT03706040|472299144|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131185144|NCT03706040|472299145|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131185145|NCT03706040|472299146|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131185146|NCT03706040|472299147|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131185147|NCT03706040|472299148|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
131185148|NCT03706040|472299149|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
131185149|NCT03706040|472299150|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
131185150|NCT03706040|472299144|FG000|Period B (Week 16 to Week 52)|Other|0|||
131185151|NCT03706040|472299145|FG001|Period B (Week 16 to Week 52)|Other|0|||
131185152|NCT03706040|472299146|FG002|Period B (Week 16 to Week 52)|Other|0|||
131185153|NCT03706040|472299147|FG003|Period B (Week 16 to Week 52)|Other|4|||
131185154|NCT03706040|472299148|FG004|Period B (Week 16 to Week 52)|Other|5|||
131185155|NCT03706040|472299149|FG005|Period B (Week 16 to Week 52)|Other|23|||
131185156|NCT03706040|472299150|FG006|Period B (Week 16 to Week 52)|Other|17|||
131185157|NCT03077243|472299151|FG000|Overall Study|Death|1|||
131185158|NCT03077243|472299152|FG001|Overall Study|Death|2|||
131185159|NCT03077243|472299153|FG002|Overall Study|Death|0|||
131185160|NCT03077243|472299154|FG003|Overall Study|Death|0|||
131185161|NCT03077243|472299151|FG000|Overall Study|Withdrawal by Subject|1|||
131185162|NCT03077243|472299152|FG001|Overall Study|Withdrawal by Subject|3|||
131185163|NCT03077243|472299153|FG002|Overall Study|Withdrawal by Subject|0|||
131185164|NCT03077243|472299154|FG003|Overall Study|Withdrawal by Subject|0|||
131185165|NCT03077243|472299151|FG000|Overall Study|Physician Decision|1|||
131185166|NCT03077243|472299152|FG001|Overall Study|Physician Decision|0|||
131185167|NCT03077243|472299153|FG002|Overall Study|Physician Decision|0|||
131185168|NCT03077243|472299154|FG003|Overall Study|Physician Decision|0|||
131185169|NCT03077243|472299151|FG000|Overall Study|Research at two study sites terminated early|0|||
131185170|NCT03077243|472299152|FG001|Overall Study|Research at two study sites terminated early|0|||
131185171|NCT03077243|472299153|FG002|Overall Study|Research at two study sites terminated early|0|||
131185172|NCT03077243|472299154|FG003|Overall Study|Research at two study sites terminated early|69|||
131185173|NCT00212758|472299157|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
131185174|NCT00212758|472299158|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
131185175|NCT00212758|472299157|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
131185176|NCT00212758|472299158|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
131185177|NCT01673490|472299159|FG000|Overall Study|Lost to Follow-up|1|||
131185178|NCT01673490|472299159|FG000|Overall Study|Adverse Event|3|||
131185179|NCT01673490|472299159|FG000|Overall Study|Withdrawal by Subject|3|||
131185180|NCT02940860|472299167|FG000|Overall Study|Non-serious AE|1|||
131185181|NCT02940860|472299168|FG001|Overall Study|Non-serious AE|2|||
131185182|NCT02940860|472299167|FG000|Overall Study|Serious AE|7|||
131185183|NCT02940860|472299168|FG001|Overall Study|Serious AE|3|||
131185184|NCT02940860|472299167|FG000|Overall Study|Withdrawal by Subject|19|||
131185185|NCT02940860|472299168|FG001|Overall Study|Withdrawal by Subject|9|||
131185186|NCT02940860|472299167|FG000|Overall Study|Lost to Follow-up|13|||
131185187|NCT02940860|472299168|FG001|Overall Study|Lost to Follow-up|7|||
131185188|NCT02940860|472299167|FG000|Overall Study|Physician Decision|5|||
131185189|NCT02940860|472299168|FG001|Overall Study|Physician Decision|3|||
131185190|NCT02940860|472299167|FG000|Overall Study|Sponsor Decision|0|||
131185191|NCT02940860|472299168|FG001|Overall Study|Sponsor Decision|1|||
131185192|NCT02940860|472299167|FG000|Overall Study|Protocol Violation|0|||
131185193|NCT02940860|472299168|FG001|Overall Study|Protocol Violation|2|||
131185194|NCT02940860|472299167|FG000|Overall Study|Death|3|||
131185195|NCT02940860|472299168|FG001|Overall Study|Death|2|||
131185196|NCT02940860|472299167|FG000|Overall Study|Moved, poor venous access, transport|6|||
131185197|NCT02940860|472299168|FG001|Overall Study|Moved, poor venous access, transport|4|||
131185198|NCT02940860|472299167|FG000|Overall Study|Not treated|2|||
131185199|NCT02940860|472299168|FG001|Overall Study|Not treated|2|||
131185200|NCT02715804|472299169|FG000|Overall Study|Death|222|||
131185201|NCT02715804|472299170|FG001|Overall Study|Death|106|||
131240388|NCT04873934|472504373|FG000|Overall Study|Subject decision|1|||
131240389|NCT04873934|472504374|FG001|Overall Study|Subject decision|8|||
131185202|NCT02715804|472299169|FG000|Overall Study|Withdrawal by Subject|5|||
131240390|NCT04873934|472504373|FG000|Overall Study|Withdrew consent|0|||
131185203|NCT02715804|472299170|FG001|Overall Study|Withdrawal by Subject|4|||
131185204|NCT02715804|472299169|FG000|Overall Study|Other than specified|2|||
131240391|NCT04873934|472504374|FG001|Overall Study|Withdrew consent|4|||
131185205|NCT02715804|472299170|FG001|Overall Study|Other than specified|3|||
131185206|NCT02431793|472299171|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
131185207|NCT02431793|472299172|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
131185208|NCT02431793|472299173|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
131185209|NCT02431793|472299171|FG000|Overall Study|Withdrawal by Subject|7|||
131185210|NCT02431793|472299172|FG001|Overall Study|Withdrawal by Subject|5|||
131185211|NCT02431793|472299173|FG002|Overall Study|Withdrawal by Subject|5|||
131185212|NCT02431793|472299171|FG000|Overall Study|Lost to Follow-up|101|||
131185213|NCT02431793|472299172|FG001|Overall Study|Lost to Follow-up|122|||
131185214|NCT02431793|472299173|FG002|Overall Study|Lost to Follow-up|104|||
131185215|NCT03276572|472299177|FG000|Overall Study|In follow-up|0|||
131185216|NCT03276572|472299178|FG001|Overall Study|In follow-up|0|||
131185217|NCT03276572|472299179|FG002|Overall Study|In follow-up|0|||
131185218|NCT03276572|472299180|FG003|Overall Study|In follow-up|0|||
131240392|NCT04873934|472504373|FG000|Overall Study|Missing|1|||
131240393|NCT04873934|472504374|FG001|Overall Study|Missing|0|||
131240394|NCT05239039|472504375|FG000|Overall Study|Withdrawal by Subject|0|||
131240395|NCT05239039|472504376|FG001|Overall Study|Withdrawal by Subject|1|||
131240396|NCT04116853|472504377|FG000|Overall Study|Adverse Event|1|||
131240397|NCT04116853|472504378|FG001|Overall Study|Adverse Event|3|||
131240398|NCT04116853|472504377|FG000|Overall Study|Lost to Follow-up|2|||
131240399|NCT04116853|472504378|FG001|Overall Study|Lost to Follow-up|0|||
131240400|NCT04116853|472504377|FG000|Overall Study|Incarceration|0|||
131240401|NCT04116853|472504378|FG001|Overall Study|Incarceration|1|||
131240402|NCT04116853|472504377|FG000|Overall Study|Pregnancy|1|||
131240403|NCT04116853|472504378|FG001|Overall Study|Pregnancy|1|||
131240404|NCT04116853|472504377|FG000|Overall Study|Began Other Weight Loss program|4|||
131240405|NCT04116853|472504378|FG001|Overall Study|Began Other Weight Loss program|8|||
131240406|NCT04116853|472504377|FG000|Overall Study|Began Anti-Obesity Medication|3|||
131240407|NCT04116853|472504378|FG001|Overall Study|Began Anti-Obesity Medication|3|||
131240408|NCT04116853|472504377|FG000|Overall Study|Protocol Violation|0|||
131240409|NCT04116853|472504378|FG001|Overall Study|Protocol Violation|1|||
131240410|NCT04926831|472504379|FG000|Overall Study|Withdrawal by Subject|2|||
131240411|NCT04926831|472504379|FG000|Overall Study|Adverse Event|2|||
131240412|NCT00936390|472504382|FG000|Overall Study|Protocol Violation|21|||
131240413|NCT00936390|472504383|FG001|Overall Study|Protocol Violation|25|||
131240414|NCT05905783|472504384|FG000|Overall Study|Lost to Follow-up|12|||
131240415|NCT05905783|472504385|FG001|Overall Study|Lost to Follow-up|18|||
131240416|NCT05905783|472504384|FG000|Overall Study|Withdrawal by Subject|29|||
131240417|NCT05905783|472504385|FG001|Overall Study|Withdrawal by Subject|37|||
131240418|NCT05905783|472504384|FG000|Overall Study|Decision by sponsor|69|||
131240419|NCT05905783|472504385|FG001|Overall Study|Decision by sponsor|65|||
131240420|NCT03584854|472504386|FG000|Overall Study|Primary outcome not measured|1|||
131240421|NCT03584854|472504387|FG001|Overall Study|Primary outcome not measured|2|||
131240422|NCT04025879|472504388|FG000|Randomization|Participant withdrew consent|0|||
131240423|NCT04025879|472504389|FG001|Randomization|Participant withdrew consent|1|||
131240424|NCT04025879|472504388|FG000|Randomization|Participant no longer met study criteria|1|||
131240425|NCT04025879|472504389|FG001|Randomization|Participant no longer met study criteria|1|||
131240426|NCT04025879|472504388|FG000|Treatment|Ongoing treatment|10|||
131240427|NCT04025879|472504389|FG001|Treatment|Ongoing treatment|8|||
131240428|NCT04025879|472504388|FG000|Treatment|Disease progression/recurrence|36|||
131240429|NCT04025879|472504389|FG001|Treatment|Disease progression/recurrence|72|||
131240430|NCT04025879|472504388|FG000|Treatment|Study drug toxicity|36|||
131240431|NCT04025879|472504389|FG001|Treatment|Study drug toxicity|13|||
131240432|NCT04025879|472504388|FG000|Treatment|Death|2|||
131240433|NCT04025879|472504389|FG001|Treatment|Death|0|||
131240434|NCT04025879|472504388|FG000|Treatment|Adverse event unrelated to study drug|21|||
131240435|NCT04025879|472504389|FG001|Treatment|Adverse event unrelated to study drug|14|||
131240436|NCT04025879|472504388|FG000|Treatment|Participant request to discontinue study treatment|16|||
131240437|NCT04025879|472504389|FG001|Treatment|Participant request to discontinue study treatment|8|||
131240438|NCT04025879|472504388|FG000|Treatment|Participant withdrew consent|1|||
130733529|NCT05026177|470642912|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
131185219|NCT03276572|472299181|FG004|Overall Study|In follow-up|0|||
131185220|NCT03276572|472299182|FG005|Overall Study|In follow-up|1|||
131185221|NCT03276572|472299183|FG006|Overall Study|In follow-up|1|||
131240439|NCT04025879|472504389|FG001|Treatment|Participant withdrew consent|3|||
131240440|NCT04025879|472504388|FG000|Treatment|Participant no longer meets study criteria|3|||
131240441|NCT04025879|472504389|FG001|Treatment|Participant no longer meets study criteria|2|||
131240442|NCT04025879|472504388|FG000|Treatment|Lost to Follow-up|1|||
131240443|NCT04025879|472504389|FG001|Treatment|Lost to Follow-up|0|||
131240444|NCT04025879|472504388|FG000|Treatment|Other reasons|15|||
131240445|NCT04025879|472504389|FG001|Treatment|Other reasons|17|||
131240446|NCT04025879|472504388|FG000|Treatment|Administrative reason by sponsor|0|||
131240447|NCT04025879|472504389|FG001|Treatment|Administrative reason by sponsor|1|||
131240448|NCT04025879|472504388|FG000|Treatment|Not reported|2|||
131240449|NCT04025879|472504389|FG001|Treatment|Not reported|0|||
131240450|NCT03482635|472504391|FG000|Overall Study|Lack of Efficacy|0|||
131185222|NCT03276572|472299177|FG000|Overall Study|Lost to Follow-up|0|||
131185223|NCT03276572|472299178|FG001|Overall Study|Lost to Follow-up|0|||
131185224|NCT03276572|472299179|FG002|Overall Study|Lost to Follow-up|0|||
131185225|NCT03276572|472299180|FG003|Overall Study|Lost to Follow-up|0|||
131185226|NCT03276572|472299181|FG004|Overall Study|Lost to Follow-up|0|||
131185227|NCT03276572|472299182|FG005|Overall Study|Lost to Follow-up|0|||
131185228|NCT03276572|472299183|FG006|Overall Study|Lost to Follow-up|1|||
131185229|NCT00607919|472299184|FG000|Acute Phase|Adverse Event|9|||
131185230|NCT00607919|472299185|FG001|Acute Phase|Adverse Event|2|||
131185231|NCT00607919|472299184|FG000|Acute Phase|Entry Criteria Not Met|1|||
131185232|NCT00607919|472299185|FG001|Acute Phase|Entry Criteria Not Met|1|||
131185233|NCT00607919|472299184|FG000|Acute Phase|Lack of Efficacy|1|||
131185234|NCT00607919|472299185|FG001|Acute Phase|Lack of Efficacy|2|||
131185235|NCT00607919|472299184|FG000|Acute Phase|Lost to Follow-up|9|||
131185236|NCT00607919|472299185|FG001|Acute Phase|Lost to Follow-up|3|||
131185237|NCT00607919|472299184|FG000|Acute Phase|Parent/Caregiver Decision|6|||
131185238|NCT00607919|472299185|FG001|Acute Phase|Parent/Caregiver Decision|4|||
131185239|NCT00607919|472299184|FG000|Acute Phase|Protocol Violation|5|||
131185240|NCT00607919|472299185|FG001|Acute Phase|Protocol Violation|1|||
131185241|NCT00607919|472299184|FG000|Acute Phase|Withdrawal by Subject|3|||
131185242|NCT00607919|472299185|FG001|Acute Phase|Withdrawal by Subject|3|||
131185243|NCT00607919|472299184|FG000|Open-Label Phase|Adverse Event|1|||
131185244|NCT00607919|472299185|FG001|Open-Label Phase|Adverse Event|5|||
131185245|NCT00607919|472299184|FG000|Open-Label Phase|Lost to Follow-up|4|||
131185246|NCT00607919|472299185|FG001|Open-Label Phase|Lost to Follow-up|1|||
131185247|NCT00607919|472299184|FG000|Open-Label Phase|Protocol Violation|2|||
131185248|NCT00607919|472299185|FG001|Open-Label Phase|Protocol Violation|2|||
131185249|NCT00607919|472299184|FG000|Open-Label Phase|Withdrawal by Subject|2|||
131185250|NCT00607919|472299185|FG001|Open-Label Phase|Withdrawal by Subject|2|||
131185251|NCT00607919|472299184|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
131185252|NCT00607919|472299185|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
131185253|NCT05441540|472299191|FG000|Overall Study|Withdrawal by Subject|2|||
131185254|NCT03862495|472299192|FG000|Overall Study|Lost to Follow-up|37|||
131185255|NCT03862495|472299193|FG001|Overall Study|Lost to Follow-up|35|||
131185256|NCT00615914|472299194|FG000|Overall Study|Adverse Event|274|||
131185257|NCT00615914|472299194|FG000|Overall Study|Death|20|||
131185258|NCT00615914|472299194|FG000|Overall Study|Lack of Efficacy|59|||
131185259|NCT00615914|472299194|FG000|Overall Study|Lost to Follow-up|187|||
131185260|NCT00615914|472299194|FG000|Overall Study|Withdrawal by Subject|16|||
131185261|NCT00615914|472299194|FG000|Overall Study|Physician Decision|4|||
131185262|NCT00615914|472299194|FG000|Overall Study|No data was collected.|65|||
131185263|NCT00615914|472299194|FG000|Overall Study|No treatment|2|||
131185264|NCT00615914|472299194|FG000|Overall Study|Irregularly enrolled patients|10|||
131185265|NCT00425113|472299195|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
131185266|NCT00425113|472299196|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
131185267|NCT00425113|472299195|FG000|Overall Study|diagnosis of abdominal TB|0|||
131240451|NCT03482635|472504392|FG001|Overall Study|Lack of Efficacy|0|||
131240452|NCT03482635|472504393|FG002|Overall Study|Lack of Efficacy|1|||
131240453|NCT03482635|472504394|FG003|Overall Study|Lack of Efficacy|3|||
131240454|NCT03482635|472504391|FG000|Overall Study|Adverse Event|2|||
131240455|NCT03482635|472504392|FG001|Overall Study|Adverse Event|2|||
131240456|NCT03482635|472504393|FG002|Overall Study|Adverse Event|0|||
131240457|NCT03482635|472504394|FG003|Overall Study|Adverse Event|3|||
131240458|NCT03482635|472504391|FG000|Overall Study|Withdrawal by Subject|2|||
131240459|NCT03482635|472504392|FG001|Overall Study|Withdrawal by Subject|1|||
131240460|NCT03482635|472504393|FG002|Overall Study|Withdrawal by Subject|0|||
131240461|NCT03482635|472504394|FG003|Overall Study|Withdrawal by Subject|1|||
131240462|NCT03482635|472504391|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
131240463|NCT03482635|472504392|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
131240464|NCT03482635|472504393|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
131240465|NCT03482635|472504394|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
131240466|NCT03482635|472504391|FG000|Overall Study|Not treated|0|||
131240467|NCT03482635|472504392|FG001|Overall Study|Not treated|0|||
131240468|NCT03482635|472504393|FG002|Overall Study|Not treated|0|||
131240469|NCT03482635|472504394|FG003|Overall Study|Not treated|1|||
131240470|NCT02159989|472504397|FG000|Overall Study|Adverse Event|1|||
131240471|NCT02159989|472504398|FG001|Overall Study|Adverse Event|0|||
131185268|NCT00425113|472299196|FG001|Overall Study|diagnosis of abdominal TB|1|||
131185269|NCT00425113|472299195|FG000|Overall Study|missing study drug more than 14 days|0|||
131185270|NCT00425113|472299196|FG001|Overall Study|missing study drug more than 14 days|1|||
131185271|NCT00425113|472299195|FG000|Overall Study|Withdrawal by Subject|1|||
131240472|NCT02159989|472504399|FG002|Overall Study|Adverse Event|0|||
131185272|NCT00425113|472299196|FG001|Overall Study|Withdrawal by Subject|0|||
131185273|NCT00879437|472299197|FG000|Overall Study|Protocol Violation|0|||
131185274|NCT00879437|472299198|FG001|Overall Study|Protocol Violation|1|||
131185275|NCT00879437|472299197|FG000|Overall Study|Death|1|||
131240473|NCT02159989|472504400|FG003|Overall Study|Adverse Event|0|||
131240474|NCT02159989|472504401|FG004|Overall Study|Adverse Event|1|||
131185276|NCT00879437|472299198|FG001|Overall Study|Death|0|||
131185277|NCT03000686|472299199|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
131185278|NCT03000686|472299200|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
131185279|NCT03000686|472299201|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
131185280|NCT03000686|472299202|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
131185281|NCT01112982|472299205|FG000|Overall Study|Withdrawal by Subject|1|||
131185282|NCT01112982|472299205|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
131185283|NCT00294684|472299206|FG000|Overall Study|Lost to Follow-up|5|||
131185284|NCT00294684|472299207|FG001|Overall Study|Lost to Follow-up|8|||
131185285|NCT00389441|472299208|FG000|Overall Study|Adverse Event|7|||
131185286|NCT00389441|472299208|FG000|Overall Study|Death|4|||
131185287|NCT00389441|472299208|FG000|Overall Study|Lost to Follow-up|2|||
131185288|NCT00389441|472299208|FG000|Overall Study|Withdrawal by Subject|4|||
131185289|NCT00389441|472299208|FG000|Overall Study|Physician Decision|1|||
131185290|NCT00389441|472299208|FG000|Overall Study|Protocol Violation|1|||
131185291|NCT00389441|472299208|FG000|Overall Study|Global deterioration of health status|4|||
131185292|NCT00389441|472299208|FG000|Overall Study|Objective progression or relapse|26|||
131185293|NCT00389441|472299208|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
131185294|NCT00389441|472299208|FG000|Overall Study|Clinical progression|1|||
131185295|NCT01981109|472299209|FG000|Overall Study|Death|36|||
131185296|NCT01981109|472299209|FG000|Overall Study|Withdrawal by Subject|40|||
131185297|NCT01981109|472299209|FG000|Overall Study|Lost to Follow-up|9|||
131185298|NCT01981109|472299209|FG000|Overall Study|No Discontinuation Documentation|37|||
131185299|NCT01981109|472299209|FG000|Overall Study|Study Termination|100|||
131185300|NCT01981109|472299209|FG000|Overall Study|No data available|2|||
131185301|NCT00126672|472299212|FG000|Overall Study|Adverse Event|4|||
131185302|NCT00126672|472299212|FG000|Overall Study|Lost to Follow-up|4|||
131185303|NCT01001234|472299218|FG000|Overall Study|Withdrawal by Subject|2|||
131185304|NCT01001234|472299219|FG001|Overall Study|Withdrawal by Subject|0|||
131185305|NCT01001234|472299220|FG002|Overall Study|Withdrawal by Subject|3|||
131185306|NCT01001234|472299221|FG003|Overall Study|Withdrawal by Subject|0|||
131185307|NCT01001234|472299222|FG004|Overall Study|Withdrawal by Subject|0|||
131185308|NCT01001234|472299218|FG000|Overall Study|Protocol Violation|34|||
131185309|NCT01001234|472299219|FG001|Overall Study|Protocol Violation|3|||
131185310|NCT01001234|472299220|FG002|Overall Study|Protocol Violation|19|||
131185311|NCT01001234|472299221|FG003|Overall Study|Protocol Violation|18|||
131185312|NCT01001234|472299222|FG004|Overall Study|Protocol Violation|0|||
131185313|NCT01001234|472299218|FG000|Overall Study|Lost to Follow-up|0|||
131185314|NCT01001234|472299219|FG001|Overall Study|Lost to Follow-up|0|||
131185315|NCT01001234|472299220|FG002|Overall Study|Lost to Follow-up|1|||
131185316|NCT01001234|472299221|FG003|Overall Study|Lost to Follow-up|2|||
131185317|NCT01001234|472299222|FG004|Overall Study|Lost to Follow-up|0|||
131185318|NCT01001234|472299218|FG000|Overall Study|Physician Decision|1|||
131185319|NCT01001234|472299219|FG001|Overall Study|Physician Decision|0|||
131185320|NCT01001234|472299220|FG002|Overall Study|Physician Decision|0|||
131185321|NCT01001234|472299221|FG003|Overall Study|Physician Decision|0|||
131185322|NCT01001234|472299222|FG004|Overall Study|Physician Decision|0|||
131185323|NCT01001234|472299218|FG000|Overall Study|Not Treated: Adverse Event|1|||
131185324|NCT01001234|472299219|FG001|Overall Study|Not Treated: Adverse Event|0|||
131185325|NCT01001234|472299220|FG002|Overall Study|Not Treated: Adverse Event|0|||
131185326|NCT01001234|472299221|FG003|Overall Study|Not Treated: Adverse Event|0|||
131185327|NCT01001234|472299222|FG004|Overall Study|Not Treated: Adverse Event|0|||
131185328|NCT01001234|472299218|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
131185329|NCT01001234|472299219|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
131185330|NCT01001234|472299220|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
131185331|NCT01001234|472299221|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
131185332|NCT01001234|472299222|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
131185333|NCT01001234|472299218|FG000|Overall Study|Not Treated: Protocol Violation|3|||
131185334|NCT01001234|472299219|FG001|Overall Study|Not Treated: Protocol Violation|0|||
131185335|NCT01001234|472299220|FG002|Overall Study|Not Treated: Protocol Violation|0|||
131185336|NCT01001234|472299221|FG003|Overall Study|Not Treated: Protocol Violation|0|||
131185337|NCT01001234|472299222|FG004|Overall Study|Not Treated: Protocol Violation|0|||
131185338|NCT01001234|472299218|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
131185339|NCT01001234|472299219|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
131240475|NCT02159989|472504402|FG005|Overall Study|Adverse Event|0|||
131185340|NCT01001234|472299220|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
131185341|NCT01001234|472299221|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
131185342|NCT01001234|472299222|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
131185343|NCT01001234|472299218|FG000|Overall Study|Not Treated: Pregnancy|3|||
131185344|NCT01001234|472299219|FG001|Overall Study|Not Treated: Pregnancy|0|||
131185345|NCT01001234|472299220|FG002|Overall Study|Not Treated: Pregnancy|0|||
131185346|NCT01001234|472299221|FG003|Overall Study|Not Treated: Pregnancy|0|||
131185347|NCT01001234|472299222|FG004|Overall Study|Not Treated: Pregnancy|0|||
131185348|NCT01001234|472299218|FG000|Overall Study|Not Treated: Physician Decision|37|||
131185349|NCT01001234|472299219|FG001|Overall Study|Not Treated: Physician Decision|4|||
131240476|NCT02159989|472504403|FG006|Overall Study|Adverse Event|1|||
131185350|NCT01001234|472299220|FG002|Overall Study|Not Treated: Physician Decision|0|||
131185351|NCT01001234|472299221|FG003|Overall Study|Not Treated: Physician Decision|0|||
131185352|NCT01001234|472299222|FG004|Overall Study|Not Treated: Physician Decision|0|||
131185353|NCT01001234|472299218|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
131185354|NCT01001234|472299219|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
131185355|NCT01001234|472299220|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
131185356|NCT01001234|472299221|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
131185357|NCT01001234|472299222|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
131185358|NCT02076334|472299224|FG000|Overall Study|Protocol Violation|1|||
131185359|NCT02076334|472299225|FG001|Overall Study|Protocol Violation|0|||
131185360|NCT02076334|472299226|FG002|Overall Study|Protocol Violation|0|||
131185361|NCT02076334|472299227|FG003|Overall Study|Protocol Violation|0|||
131185362|NCT02076334|472299224|FG000|Overall Study|Lost to Follow-up|0|||
131185363|NCT02076334|472299225|FG001|Overall Study|Lost to Follow-up|1|||
131185364|NCT02076334|472299226|FG002|Overall Study|Lost to Follow-up|1|||
131185365|NCT02076334|472299227|FG003|Overall Study|Lost to Follow-up|0|||
131185366|NCT02076334|472299224|FG000|Overall Study|muscle soreness|0|||
131185367|NCT02076334|472299225|FG001|Overall Study|muscle soreness|0|||
131185368|NCT02076334|472299226|FG002|Overall Study|muscle soreness|0|||
131240477|NCT02159989|472504404|FG007|Overall Study|Adverse Event|2|||
131185369|NCT02076334|472299227|FG003|Overall Study|muscle soreness|1|||
131185370|NCT03379376|472299228|FG000|Overall Study|Lost to Follow-up|2|||
131185371|NCT03379376|472299228|FG000|Overall Study|Did not wish to complete follow up|1|||
131185372|NCT03379376|472299228|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
131185373|NCT03379376|472299228|FG000|Overall Study|Death|1|||
131240478|NCT02159989|472504405|FG008|Overall Study|Adverse Event|0|||
131240479|NCT02159989|472504406|FG009|Overall Study|Adverse Event|2|||
131240480|NCT02159989|472504407|FG010|Overall Study|Adverse Event|1|||
131240481|NCT02159989|472504397|FG000|Overall Study|Death|0|||
131240482|NCT02159989|472504398|FG001|Overall Study|Death|0|||
131240483|NCT02159989|472504399|FG002|Overall Study|Death|0|||
131240484|NCT02159989|472504400|FG003|Overall Study|Death|0|||
131185374|NCT01611298|472299229|FG000|Overall Study|Relapsed|2|||
131185375|NCT00753623|472299230|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
131185376|NCT00753623|472299231|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
131185377|NCT00753623|472299230|FG000|Phase I (14 Days)|Physician Decision|1|||
131185378|NCT00753623|472299231|FG001|Phase I (14 Days)|Physician Decision|2|||
131185379|NCT00753623|472299230|FG000|Phase I (14 Days)|Adverse Event|0|||
131185380|NCT00753623|472299231|FG001|Phase I (14 Days)|Adverse Event|1|||
131185381|NCT00753623|472299230|FG000|Washout (7 Days)|Physician Decision|1|||
131185382|NCT00753623|472299231|FG001|Washout (7 Days)|Physician Decision|0|||
131185383|NCT00753623|472299230|FG000|Phase II (14 Days)|Physician Decision|0|||
131185384|NCT00753623|472299231|FG001|Phase II (14 Days)|Physician Decision|1|||
131185385|NCT03332303|472299232|FG000|Overall Study|Participant did not dose|1|||
131185386|NCT03332303|472299233|FG001|Overall Study|Participant did not dose|2|||
131185387|NCT03332303|472299234|FG002|Overall Study|Participant did not dose|0|||
131185388|NCT03332303|472299232|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
131185389|NCT03332303|472299233|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
131185390|NCT03332303|472299234|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
131185391|NCT03332303|472299232|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
131185392|NCT03332303|472299233|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
131185393|NCT03332303|472299234|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
131185394|NCT03332303|472299232|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
131185395|NCT03332303|472299233|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
131185396|NCT03332303|472299234|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
131185397|NCT03332303|472299232|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
131185398|NCT03332303|472299233|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
131185399|NCT03332303|472299234|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
131240485|NCT02159989|472504401|FG004|Overall Study|Death|0|||
131185400|NCT03332303|472299232|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
131185401|NCT03332303|472299233|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
131185402|NCT03332303|472299234|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
131240486|NCT02159989|472504402|FG005|Overall Study|Death|0|||
131240487|NCT02159989|472504403|FG006|Overall Study|Death|0|||
131185403|NCT03332303|472299232|FG000|Overall Study|Participant had a significant protocol deviation|0|||
131185404|NCT03332303|472299233|FG001|Overall Study|Participant had a significant protocol deviation|1|||
131240488|NCT02159989|472504404|FG007|Overall Study|Death|0|||
131240489|NCT02159989|472504405|FG008|Overall Study|Death|0|||
131240490|NCT02159989|472504406|FG009|Overall Study|Death|0|||
131240491|NCT02159989|472504407|FG010|Overall Study|Death|1|||
130784530|NCT00113607|470838811|FG000|Overall Study|Lost to Follow-up|0|||
131240492|NCT02159989|472504397|FG000|Overall Study|Lack of Efficacy|2|||
131185405|NCT03332303|472299234|FG002|Overall Study|Participant had a significant protocol deviation|0|||
131185406|NCT01296698|472299235|FG000|Overall Study|Adverse Event|1|||
131185407|NCT01296698|472299236|FG001|Overall Study|Adverse Event|0|||
131185408|NCT01296698|472299235|FG000|Overall Study|Death|1|||
131185409|NCT01296698|472299236|FG001|Overall Study|Death|0|||
131185410|NCT01296698|472299235|FG000|Overall Study|Lost to Follow-up|19|||
131185411|NCT01296698|472299236|FG001|Overall Study|Lost to Follow-up|1|||
131185412|NCT01296698|472299235|FG000|Overall Study|Withdrawal by Subject|12|||
131240493|NCT02159989|472504398|FG001|Overall Study|Lack of Efficacy|3|||
131240494|NCT02159989|472504399|FG002|Overall Study|Lack of Efficacy|3|||
131240495|NCT02159989|472504400|FG003|Overall Study|Lack of Efficacy|0|||
131240496|NCT02159989|472504401|FG004|Overall Study|Lack of Efficacy|2|||
131240497|NCT02159989|472504402|FG005|Overall Study|Lack of Efficacy|3|||
131240498|NCT02159989|472504403|FG006|Overall Study|Lack of Efficacy|3|||
131240499|NCT02159989|472504404|FG007|Overall Study|Lack of Efficacy|1|||
131240500|NCT02159989|472504405|FG008|Overall Study|Lack of Efficacy|3|||
131240501|NCT02159989|472504406|FG009|Overall Study|Lack of Efficacy|6|||
131240502|NCT02159989|472504407|FG010|Overall Study|Lack of Efficacy|7|||
131240503|NCT02159989|472504397|FG000|Overall Study|Lost to Follow-up|0|||
131240504|NCT02159989|472504398|FG001|Overall Study|Lost to Follow-up|0|||
131240505|NCT02159989|472504399|FG002|Overall Study|Lost to Follow-up|0|||
131240506|NCT02159989|472504400|FG003|Overall Study|Lost to Follow-up|1|||
131240507|NCT02159989|472504401|FG004|Overall Study|Lost to Follow-up|0|||
131240508|NCT02159989|472504402|FG005|Overall Study|Lost to Follow-up|0|||
131240509|NCT02159989|472504403|FG006|Overall Study|Lost to Follow-up|0|||
131240510|NCT02159989|472504404|FG007|Overall Study|Lost to Follow-up|0|||
131240511|NCT02159989|472504405|FG008|Overall Study|Lost to Follow-up|0|||
131240512|NCT02159989|472504406|FG009|Overall Study|Lost to Follow-up|0|||
131240513|NCT02159989|472504407|FG010|Overall Study|Lost to Follow-up|1|||
131240514|NCT02159989|472504397|FG000|Overall Study|Withdrawal by Subject|2|||
131240515|NCT02159989|472504398|FG001|Overall Study|Withdrawal by Subject|0|||
131240516|NCT02159989|472504399|FG002|Overall Study|Withdrawal by Subject|0|||
131240517|NCT02159989|472504400|FG003|Overall Study|Withdrawal by Subject|2|||
131240518|NCT02159989|472504401|FG004|Overall Study|Withdrawal by Subject|1|||
131240519|NCT02159989|472504402|FG005|Overall Study|Withdrawal by Subject|0|||
131240520|NCT02159989|472504403|FG006|Overall Study|Withdrawal by Subject|3|||
131240521|NCT02159989|472504404|FG007|Overall Study|Withdrawal by Subject|1|||
131240522|NCT02159989|472504405|FG008|Overall Study|Withdrawal by Subject|0|||
131240523|NCT02159989|472504406|FG009|Overall Study|Withdrawal by Subject|0|||
131240524|NCT02159989|472504407|FG010|Overall Study|Withdrawal by Subject|0|||
131240525|NCT02159989|472504397|FG000|Overall Study|New treatment|0|||
131240526|NCT02159989|472504398|FG001|Overall Study|New treatment|1|||
131240527|NCT02159989|472504399|FG002|Overall Study|New treatment|0|||
131240528|NCT02159989|472504400|FG003|Overall Study|New treatment|0|||
131240529|NCT02159989|472504401|FG004|Overall Study|New treatment|0|||
131240530|NCT02159989|472504402|FG005|Overall Study|New treatment|0|||
131240531|NCT02159989|472504403|FG006|Overall Study|New treatment|0|||
131240532|NCT02159989|472504404|FG007|Overall Study|New treatment|0|||
131240533|NCT02159989|472504405|FG008|Overall Study|New treatment|0|||
131240534|NCT02159989|472504406|FG009|Overall Study|New treatment|0|||
131240535|NCT02159989|472504407|FG010|Overall Study|New treatment|0|||
131240536|NCT02159989|472504397|FG000|Overall Study|Insurance Issues|0|||
131240537|NCT02159989|472504398|FG001|Overall Study|Insurance Issues|0|||
131240538|NCT02159989|472504399|FG002|Overall Study|Insurance Issues|0|||
131240539|NCT02159989|472504400|FG003|Overall Study|Insurance Issues|0|||
131240540|NCT02159989|472504401|FG004|Overall Study|Insurance Issues|0|||
131240541|NCT02159989|472504402|FG005|Overall Study|Insurance Issues|0|||
131240542|NCT02159989|472504403|FG006|Overall Study|Insurance Issues|0|||
131240543|NCT02159989|472504404|FG007|Overall Study|Insurance Issues|0|||
131240544|NCT02159989|472504405|FG008|Overall Study|Insurance Issues|0|||
131240545|NCT02159989|472504406|FG009|Overall Study|Insurance Issues|1|||
131240546|NCT02159989|472504407|FG010|Overall Study|Insurance Issues|0|||
131240547|NCT04745689|472504409|FG000|Overall Study|Death|9|||
131240548|NCT04745689|472504410|FG001|Overall Study|Death|6|||
131240549|NCT04745689|472504409|FG000|Overall Study|Lost to Follow-up|1|||
131240550|NCT04745689|472504410|FG001|Overall Study|Lost to Follow-up|0|||
131240551|NCT04745689|472504409|FG000|Overall Study|Withdrawal by Subject|2|||
131240552|NCT04745689|472504410|FG001|Overall Study|Withdrawal by Subject|0|||
131185413|NCT01296698|472299236|FG001|Overall Study|Withdrawal by Subject|0|||
131240553|NCT04745689|472504409|FG000|Overall Study|Study terminated by sponsor|10|||
131240554|NCT04745689|472504410|FG001|Overall Study|Study terminated by sponsor|3|||
131240555|NCT05338476|472504411|FG000|Period 2|Adverse Event|0|||
131240556|NCT05338476|472504412|FG001|Period 2|Adverse Event|1|||
131240557|NCT04639219|472504415|FG000|Overall Study|Withdrawal by Subject|8|||
131240558|NCT04639219|472504415|FG000|Overall Study|Lost to Follow-up|6|||
131240559|NCT04639219|472504415|FG000|Overall Study|Death|55|||
131240560|NCT03421808|472504416|FG000|Overall Study|COVID related problems|2|||
131240561|NCT03421808|472504417|FG001|Overall Study|COVID related problems|0|||
131240562|NCT03421808|472504416|FG000|Overall Study|Withdrawal by Subject|1|||
131240563|NCT03421808|472504417|FG001|Overall Study|Withdrawal by Subject|0|||
131185414|NCT01296698|472299235|FG000|Overall Study|Difficulty Contacting Subject|2|||
131185415|NCT01296698|472299236|FG001|Overall Study|Difficulty Contacting Subject|0|||
131185416|NCT01296698|472299235|FG000|Overall Study|Study Terminated by Sponsor|209|||
131185417|NCT01296698|472299236|FG001|Overall Study|Study Terminated by Sponsor|12|||
131185418|NCT03639987|472299237|FG000|Overall Study|Study terminated by sponsor|26|||
131185419|NCT03639987|472299238|FG001|Overall Study|Study terminated by sponsor|25|||
131185420|NCT03639987|472299237|FG000|Overall Study|Lost to Follow-up|0|||
131185421|NCT03639987|472299238|FG001|Overall Study|Lost to Follow-up|1|||
131185422|NCT02559713|472299245|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
131185423|NCT02193828|472299250|FG000|Overall Study|Withdrawal by Subject|0|||
131185424|NCT02193828|472299251|FG001|Overall Study|Withdrawal by Subject|0|||
131185425|NCT02193828|472299252|FG002|Overall Study|Withdrawal by Subject|1|||
131185426|NCT02193828|472299253|FG003|Overall Study|Withdrawal by Subject|1|||
131185427|NCT00889681|472299254|FG000|Overall Study|Not meeting qualification Criteria|2|||
131185428|NCT00889681|472299254|FG000|Overall Study|Insurance disapproval|1|||
131185429|NCT01185704|472299255|FG000|Overall Study|Randomized but not treated|3|||
131185430|NCT01185704|472299256|FG001|Overall Study|Randomized but not treated|3|||
131185431|NCT01185704|472299255|FG000|Overall Study|Lack of ovarian response|5|||
131185432|NCT01185704|472299256|FG001|Overall Study|Lack of ovarian response|1|||
131185433|NCT01185704|472299255|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
131185434|NCT01185704|472299256|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
131185435|NCT01185704|472299255|FG000|Overall Study|Ectopic pregnancy|0|||
131185436|NCT01185704|472299256|FG001|Overall Study|Ectopic pregnancy|1|||
131185437|NCT01686958|472299257|FG000|Overall Study|Withdrawal by Subject|1|||
131185438|NCT01151540|472299262|FG000|Overall Study|Other|2|||
131185439|NCT01151540|472299262|FG000|Overall Study|Adverse event, non-fatal|4|||
131185440|NCT01151540|472299262|FG000|Overall Study|Withdrawal by Subject|7|||
131185441|NCT02248857|472299263|FG000|3 Month|Withdrawal by Subject|9|||
131185442|NCT02248857|472299264|FG001|3 Month|Withdrawal by Subject|3|||
131185443|NCT02248857|472299265|FG002|3 Month|Withdrawal by Subject|4|||
131185444|NCT02248857|472299263|FG000|3 Month|Unable to reach for 3 month|35|||
131185445|NCT02248857|472299264|FG001|3 Month|Unable to reach for 3 month|29|||
131185446|NCT02248857|472299265|FG002|3 Month|Unable to reach for 3 month|26|||
131185447|NCT02248857|472299263|FG000|3 Month|Partially completed, unable to finish|2|||
131185448|NCT02248857|472299264|FG001|3 Month|Partially completed, unable to finish|2|||
131185449|NCT02248857|472299265|FG002|3 Month|Partially completed, unable to finish|1|||
131185450|NCT02248857|472299263|FG000|6 Month|Lost to Follow-up|27|||
131185451|NCT02248857|472299264|FG001|6 Month|Lost to Follow-up|26|||
131185452|NCT02248857|472299265|FG002|6 Month|Lost to Follow-up|15|||
131185453|NCT02248857|472299263|FG000|6 Month|Partially completed, unable to finish|0|||
131185454|NCT02248857|472299264|FG001|6 Month|Partially completed, unable to finish|1|||
131185455|NCT02248857|472299265|FG002|6 Month|Partially completed, unable to finish|0|||
131185456|NCT02248857|472299263|FG000|6 Month|Withdrawal by Subject|0|||
131185457|NCT02248857|472299264|FG001|6 Month|Withdrawal by Subject|2|||
131185458|NCT02248857|472299265|FG002|6 Month|Withdrawal by Subject|2|||
131185459|NCT02248857|472299263|FG000|6 Month|Death|1|||
131185460|NCT02248857|472299264|FG001|6 Month|Death|0|||
131185461|NCT02248857|472299265|FG002|6 Month|Death|0|||
131185462|NCT02261883|472299266|FG000|Overall Study|Death|3|||
131185463|NCT02261883|472299267|FG001|Overall Study|Death|2|||
131185464|NCT02261883|472299266|FG000|Overall Study|Physician Decision|1|||
131185465|NCT02261883|472299267|FG001|Overall Study|Physician Decision|0|||
131185466|NCT02261883|472299266|FG000|Overall Study|Protocol Violation|1|||
131185467|NCT02261883|472299267|FG001|Overall Study|Protocol Violation|0|||
131185468|NCT02261883|472299266|FG000|Overall Study|Withdrawal by Subject|0|||
131185469|NCT02261883|472299267|FG001|Overall Study|Withdrawal by Subject|1|||
131185470|NCT02261883|472299266|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
131185471|NCT02261883|472299267|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
131240564|NCT03421808|472504416|FG000|Overall Study|Protocol Violation|0|||
130784531|NCT00113607|470838812|FG001|Overall Study|Lost to Follow-up|2|||
130784532|NCT00113607|470838811|FG000|Overall Study|Disease Progression|180|||
130784533|NCT00113607|470838812|FG001|Overall Study|Disease Progression|142|||
130784534|NCT00113607|470838811|FG000|Overall Study|Complete Response (Confirmed)|14|||
131185472|NCT02177175|472299273|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
131185473|NCT02177175|472299274|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
131185474|NCT00260429|472299275|FG000|Overall Study|failure to follow appointments|1|||
131185475|NCT00260429|472299276|FG001|Overall Study|failure to follow appointments|0|||
131185476|NCT00260429|472299275|FG000|Overall Study|scheduled hand surgery|1|||
131185477|NCT00260429|472299276|FG001|Overall Study|scheduled hand surgery|0|||
131185478|NCT00861380|472299277|FG000|Overall Study|Withdrawal Information not recorded|8427|||
131185479|NCT00861380|472299278|FG001|Overall Study|Withdrawal Information not recorded|9112|||
131185480|NCT00861380|472299279|FG002|Overall Study|Withdrawal Information not recorded|8872|||
131185481|NCT00861380|472299280|FG003|Overall Study|Withdrawal Information not recorded|3689|||
131185482|NCT00861380|472299281|FG004|Overall Study|Withdrawal Information not recorded|1812|||
131185483|NCT00861380|472299282|FG005|Overall Study|Withdrawal Information not recorded|6249|||
131240565|NCT03421808|472504417|FG001|Overall Study|Protocol Violation|1|||
131240566|NCT04681066|472504418|FG000|Overall Study|Lost to Follow-up|3|||
131240567|NCT04681066|472504419|FG001|Overall Study|Lost to Follow-up|1|||
131240568|NCT04681066|472504420|FG002|Overall Study|Lost to Follow-up|2|||
131240569|NCT04681066|472504421|FG003|Overall Study|Lost to Follow-up|1|||
131240570|NCT04681066|472504418|FG000|Overall Study|Withdrawal by Subject|2|||
131240571|NCT04681066|472504419|FG001|Overall Study|Withdrawal by Subject|1|||
131240572|NCT04681066|472504420|FG002|Overall Study|Withdrawal by Subject|0|||
131240573|NCT04681066|472504421|FG003|Overall Study|Withdrawal by Subject|3|||
131240574|NCT04681066|472504418|FG000|Overall Study|Death|0|||
131240575|NCT04681066|472504419|FG001|Overall Study|Death|1|||
131240576|NCT04681066|472504420|FG002|Overall Study|Death|0|||
131240577|NCT04681066|472504421|FG003|Overall Study|Death|0|||
131240578|NCT03907488|472504422|FG000|Overall Study|Adverse Event|20|||
131240579|NCT03907488|472504423|FG001|Overall Study|Adverse Event|20|||
131240580|NCT03907488|472504422|FG000|Overall Study|Withdrawal by Subject|9|||
131185484|NCT00861380|472299283|FG006|Overall Study|Withdrawal Information not recorded|3020|||
131240581|NCT03907488|472504423|FG001|Overall Study|Withdrawal by Subject|13|||
131240582|NCT03907488|472504422|FG000|Overall Study|Lack of Efficacy|0|||
131240583|NCT03907488|472504423|FG001|Overall Study|Lack of Efficacy|9|||
131240584|NCT03907488|472504422|FG000|Overall Study|Death|3|||
131240585|NCT03907488|472504423|FG001|Overall Study|Death|8|||
131240586|NCT03907488|472504422|FG000|Overall Study|not protocol specified|5|||
131240587|NCT03907488|472504423|FG001|Overall Study|not protocol specified|8|||
131240588|NCT03907488|472504422|FG000|Overall Study|Ineligible|9|||
131185485|NCT00628758|472299284|FG000|Overall Study|Adverse Event|2|||
131185486|NCT00628758|472299285|FG001|Overall Study|Adverse Event|3|||
131185487|NCT00628758|472299284|FG000|Overall Study|Withdrawal by Subject|6|||
131240589|NCT03907488|472504423|FG001|Overall Study|Ineligible|15|||
131240590|NCT05289037|472504424|FG000|Overall Study|Withdrawal by Subject|7|||
131240591|NCT05289037|472504425|FG001|Overall Study|Withdrawal by Subject|0|||
131240592|NCT05289037|472504426|FG002|Overall Study|Withdrawal by Subject|3|||
131240593|NCT05289037|472504427|FG003|Overall Study|Withdrawal by Subject|3|||
131240594|NCT05289037|472504428|FG004|Overall Study|Withdrawal by Subject|1|||
131240595|NCT05289037|472504429|FG005|Overall Study|Withdrawal by Subject|5|||
131240596|NCT05289037|472504430|FG006|Overall Study|Withdrawal by Subject|2|||
131240597|NCT05289037|472504431|FG007|Overall Study|Withdrawal by Subject|1|||
131240598|NCT05289037|472504432|FG008|Overall Study|Withdrawal by Subject|2|||
131240599|NCT05289037|472504433|FG009|Overall Study|Withdrawal by Subject|2|||
131240600|NCT05289037|472504434|FG010|Overall Study|Withdrawal by Subject|1|||
131240601|NCT05289037|472504435|FG011|Overall Study|Withdrawal by Subject|0|||
131240602|NCT05289037|472504436|FG012|Overall Study|Withdrawal by Subject|1|||
131240603|NCT05289037|472504437|FG013|Overall Study|Withdrawal by Subject|2|||
131240604|NCT05289037|472504438|FG014|Overall Study|Withdrawal by Subject|0|||
131240605|NCT05289037|472504439|FG015|Overall Study|Withdrawal by Subject|3|||
131240606|NCT05289037|472504440|FG016|Overall Study|Withdrawal by Subject|3|||
131240607|NCT05289037|472504424|FG000|Overall Study|Lost to Follow-up|1|||
131185488|NCT00628758|472299285|FG001|Overall Study|Withdrawal by Subject|3|||
131185489|NCT00628758|472299284|FG000|Overall Study|Death|1|||
131185490|NCT00628758|472299285|FG001|Overall Study|Death|0|||
131185491|NCT00628758|472299284|FG000|Overall Study|Protocol Violation|5|||
131185492|NCT00628758|472299285|FG001|Overall Study|Protocol Violation|1|||
131185493|NCT00628758|472299284|FG000|Overall Study|Lost to Follow-up|25|||
131185494|NCT00628758|472299285|FG001|Overall Study|Lost to Follow-up|31|||
131185495|NCT00628758|472299284|FG000|Overall Study|Pregnancy|2|||
131185496|NCT00628758|472299285|FG001|Overall Study|Pregnancy|2|||
131185497|NCT00628758|472299284|FG000|Overall Study|Investigator Moved|3|||
131185498|NCT00628758|472299285|FG001|Overall Study|Investigator Moved|0|||
131240608|NCT05289037|472504425|FG001|Overall Study|Lost to Follow-up|4|||
131240609|NCT05289037|472504426|FG002|Overall Study|Lost to Follow-up|3|||
131240610|NCT05289037|472504427|FG003|Overall Study|Lost to Follow-up|3|||
131240611|NCT05289037|472504428|FG004|Overall Study|Lost to Follow-up|3|||
131240612|NCT05289037|472504429|FG005|Overall Study|Lost to Follow-up|2|||
130733530|NCT05026177|470642913|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
130733531|NCT05026177|470642911|FG000|Overall Study|Withdrawal by Subject|53|||
130733532|NCT05026177|470642912|FG001|Overall Study|Withdrawal by Subject|51|||
131185499|NCT00628758|472299284|FG000|Overall Study|Treatment Failure|0|||
131185500|NCT00628758|472299285|FG001|Overall Study|Treatment Failure|2|||
131240613|NCT05289037|472504430|FG006|Overall Study|Lost to Follow-up|3|||
131240614|NCT05289037|472504431|FG007|Overall Study|Lost to Follow-up|2|||
131240615|NCT05289037|472504432|FG008|Overall Study|Lost to Follow-up|2|||
131240616|NCT05289037|472504433|FG009|Overall Study|Lost to Follow-up|1|||
131240617|NCT05289037|472504434|FG010|Overall Study|Lost to Follow-up|3|||
131240618|NCT05289037|472504435|FG011|Overall Study|Lost to Follow-up|4|||
131240619|NCT05289037|472504436|FG012|Overall Study|Lost to Follow-up|2|||
131240620|NCT05289037|472504437|FG013|Overall Study|Lost to Follow-up|7|||
131240621|NCT05289037|472504438|FG014|Overall Study|Lost to Follow-up|4|||
131240622|NCT05289037|472504439|FG015|Overall Study|Lost to Follow-up|6|||
131240623|NCT05289037|472504440|FG016|Overall Study|Lost to Follow-up|4|||
131240624|NCT05289037|472504424|FG000|Overall Study|Death|0|||
131240625|NCT05289037|472504425|FG001|Overall Study|Death|0|||
131185501|NCT00637377|472299286|FG000|Overall Study|Adverse Event|2|||
131185502|NCT00637377|472299287|FG001|Overall Study|Adverse Event|6|||
131185503|NCT00637377|472299288|FG002|Overall Study|Adverse Event|8|||
131185504|NCT00637377|472299289|FG003|Overall Study|Adverse Event|9|||
131185505|NCT00637377|472299286|FG000|Overall Study|Death|1|||
131185506|NCT00637377|472299287|FG001|Overall Study|Death|3|||
131185507|NCT00637377|472299288|FG002|Overall Study|Death|2|||
131185508|NCT00637377|472299289|FG003|Overall Study|Death|1|||
131185509|NCT00637377|472299286|FG000|Overall Study|Lack of Efficacy|0|||
131185510|NCT00637377|472299287|FG001|Overall Study|Lack of Efficacy|0|||
131185511|NCT00637377|472299288|FG002|Overall Study|Lack of Efficacy|1|||
131185512|NCT00637377|472299289|FG003|Overall Study|Lack of Efficacy|1|||
131185513|NCT00637377|472299286|FG000|Overall Study|Lost to Follow-up|4|||
131185514|NCT00637377|472299287|FG001|Overall Study|Lost to Follow-up|1|||
131185515|NCT00637377|472299288|FG002|Overall Study|Lost to Follow-up|2|||
131185516|NCT00637377|472299289|FG003|Overall Study|Lost to Follow-up|2|||
131185517|NCT00637377|472299286|FG000|Overall Study|Protocol Violation|2|||
131185518|NCT00637377|472299287|FG001|Overall Study|Protocol Violation|1|||
131185519|NCT00637377|472299288|FG002|Overall Study|Protocol Violation|1|||
131185520|NCT00637377|472299289|FG003|Overall Study|Protocol Violation|0|||
131185521|NCT00637377|472299286|FG000|Overall Study|Withdrawal by Subject|11|||
131185522|NCT00637377|472299287|FG001|Overall Study|Withdrawal by Subject|15|||
131185523|NCT00637377|472299288|FG002|Overall Study|Withdrawal by Subject|13|||
131185524|NCT00637377|472299289|FG003|Overall Study|Withdrawal by Subject|11|||
131185525|NCT00637377|472299286|FG000|Overall Study|Other (no further information available)|7|||
131185526|NCT00637377|472299287|FG001|Overall Study|Other (no further information available)|6|||
131185527|NCT00637377|472299288|FG002|Overall Study|Other (no further information available)|10|||
131185528|NCT00637377|472299289|FG003|Overall Study|Other (no further information available)|5|||
131185529|NCT00994162|472299290|FG000|Overall Study|Withdrawal by Subject|1|||
131185530|NCT00994162|472299290|FG000|Overall Study|Lost to Follow-up|2|||
131185531|NCT00994162|472299290|FG000|Overall Study|Product Complaint|1|||
131185532|NCT00994162|472299290|FG000|Overall Study|Poor Compliance|5|||
131185533|NCT00994162|472299290|FG000|Overall Study|Lack of Response|3|||
131185534|NCT00994162|472299290|FG000|Overall Study|Discharged from Hospital|4|||
131185535|NCT00994162|472299290|FG000|Overall Study|Death|2|||
131185536|NCT00994162|472299290|FG000|Overall Study|Care Transferred to Another Physician|2|||
131185537|NCT00994162|472299290|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
131185538|NCT00994162|472299290|FG000|Overall Study|Physician Decision|2|||
131185539|NCT00994162|472299290|FG000|Overall Study|Surrounding Wound Erythematous|1|||
131185540|NCT00994162|472299290|FG000|Overall Study|Machine Losing Vaccum|1|||
131185541|NCT00994162|472299290|FG000|Overall Study|Patient Lived Too Far Away|1|||
131185542|NCT00994162|472299290|FG000|Overall Study|Above Knee Amputation|1|||
131185543|NCT00994162|472299290|FG000|Overall Study|Reason Not Reported By Site|1|||
131185544|NCT01425749|472299291|FG000|Overall Study|progression of melanoma|0|||
131185545|NCT01425749|472299292|FG001|Overall Study|progression of melanoma|1|||
131185546|NCT01293084|472299293|FG000|Overall Study|Physician Decision|3|||
131185547|NCT01293084|472299293|FG000|Overall Study|Withdrawal by Subject|2|||
131185548|NCT02983799|472299294|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
131240626|NCT05289037|472504426|FG002|Overall Study|Death|0|||
131240627|NCT05289037|472504427|FG003|Overall Study|Death|0|||
131240628|NCT05289037|472504428|FG004|Overall Study|Death|0|||
131240629|NCT05289037|472504429|FG005|Overall Study|Death|1|||
131240630|NCT05289037|472504430|FG006|Overall Study|Death|0|||
131240631|NCT05289037|472504431|FG007|Overall Study|Death|0|||
131240632|NCT05289037|472504432|FG008|Overall Study|Death|0|||
131240633|NCT05289037|472504433|FG009|Overall Study|Death|0|||
131240634|NCT05289037|472504434|FG010|Overall Study|Death|0|||
131240635|NCT05289037|472504435|FG011|Overall Study|Death|0|||
131240636|NCT05289037|472504436|FG012|Overall Study|Death|0|||
131240637|NCT05289037|472504437|FG013|Overall Study|Death|0|||
131240638|NCT05289037|472504438|FG014|Overall Study|Death|1|||
131240639|NCT05289037|472504439|FG015|Overall Study|Death|0|||
131240640|NCT05289037|472504440|FG016|Overall Study|Death|0|||
131240641|NCT05289037|472504424|FG000|Overall Study|Did not receive vaccine|0|||
131240642|NCT05289037|472504425|FG001|Overall Study|Did not receive vaccine|3|||
131185549|NCT02983799|472299295|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
131185550|NCT02983799|472299296|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
131185551|NCT02983799|472299297|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
131185552|NCT02983799|472299298|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
131185553|NCT02983799|472299294|FG000|Overall Study|Death|20|||
131185554|NCT02983799|472299295|FG001|Overall Study|Death|5|||
131185555|NCT02983799|472299296|FG002|Overall Study|Death|23|||
131185556|NCT02983799|472299297|FG003|Overall Study|Death|47|||
131185557|NCT02983799|472299298|FG004|Overall Study|Death|7|||
131240643|NCT05289037|472504426|FG002|Overall Study|Did not receive vaccine|0|||
131240644|NCT05289037|472504427|FG003|Overall Study|Did not receive vaccine|0|||
131240645|NCT05289037|472504428|FG004|Overall Study|Did not receive vaccine|1|||
131240646|NCT05289037|472504429|FG005|Overall Study|Did not receive vaccine|1|||
131240647|NCT05289037|472504430|FG006|Overall Study|Did not receive vaccine|1|||
131185558|NCT02983799|472299294|FG000|Overall Study|Withdrawal by Subject|1|||
131185559|NCT02983799|472299295|FG001|Overall Study|Withdrawal by Subject|0|||
131185560|NCT02983799|472299296|FG002|Overall Study|Withdrawal by Subject|3|||
131185561|NCT02983799|472299297|FG003|Overall Study|Withdrawal by Subject|4|||
131185562|NCT02983799|472299298|FG004|Overall Study|Withdrawal by Subject|1|||
131185563|NCT02983799|472299294|FG000|Overall Study|Protocol Violation|0|||
131185564|NCT02983799|472299295|FG001|Overall Study|Protocol Violation|1|||
131185565|NCT02983799|472299296|FG002|Overall Study|Protocol Violation|0|||
131185566|NCT02983799|472299297|FG003|Overall Study|Protocol Violation|0|||
131240648|NCT05289037|472504431|FG007|Overall Study|Did not receive vaccine|0|||
131240649|NCT05289037|472504432|FG008|Overall Study|Did not receive vaccine|0|||
131240650|NCT05289037|472504433|FG009|Overall Study|Did not receive vaccine|0|||
131240651|NCT05289037|472504434|FG010|Overall Study|Did not receive vaccine|0|||
131240652|NCT05289037|472504435|FG011|Overall Study|Did not receive vaccine|0|||
131240653|NCT05289037|472504436|FG012|Overall Study|Did not receive vaccine|0|||
131240654|NCT05289037|472504437|FG013|Overall Study|Did not receive vaccine|0|||
131240655|NCT05289037|472504438|FG014|Overall Study|Did not receive vaccine|1|||
131240656|NCT05289037|472504439|FG015|Overall Study|Did not receive vaccine|0|||
131240657|NCT05289037|472504440|FG016|Overall Study|Did not receive vaccine|0|||
131240658|NCT05289037|472504424|FG000|Overall Study|Unable to make last visit|0|||
131240659|NCT05289037|472504425|FG001|Overall Study|Unable to make last visit|0|||
131240660|NCT05289037|472504426|FG002|Overall Study|Unable to make last visit|1|||
131240661|NCT05289037|472504427|FG003|Overall Study|Unable to make last visit|0|||
131240662|NCT05289037|472504428|FG004|Overall Study|Unable to make last visit|0|||
131240663|NCT05289037|472504429|FG005|Overall Study|Unable to make last visit|0|||
131240664|NCT05289037|472504430|FG006|Overall Study|Unable to make last visit|0|||
131240665|NCT05289037|472504431|FG007|Overall Study|Unable to make last visit|0|||
131240666|NCT05289037|472504432|FG008|Overall Study|Unable to make last visit|0|||
131240667|NCT05289037|472504433|FG009|Overall Study|Unable to make last visit|0|||
131240668|NCT05289037|472504434|FG010|Overall Study|Unable to make last visit|0|||
131240669|NCT05289037|472504435|FG011|Overall Study|Unable to make last visit|0|||
131240670|NCT05289037|472504436|FG012|Overall Study|Unable to make last visit|0|||
131240671|NCT05289037|472504437|FG013|Overall Study|Unable to make last visit|0|||
131240672|NCT05289037|472504438|FG014|Overall Study|Unable to make last visit|0|||
131240673|NCT05289037|472504439|FG015|Overall Study|Unable to make last visit|0|||
131240674|NCT05289037|472504440|FG016|Overall Study|Unable to make last visit|0|||
131240675|NCT05289037|472504424|FG000|Overall Study|Protocol deviation|0|||
131240676|NCT05289037|472504425|FG001|Overall Study|Protocol deviation|0|||
131240677|NCT05289037|472504426|FG002|Overall Study|Protocol deviation|0|||
131240678|NCT05289037|472504427|FG003|Overall Study|Protocol deviation|0|||
131240679|NCT05289037|472504428|FG004|Overall Study|Protocol deviation|0|||
131240680|NCT05289037|472504429|FG005|Overall Study|Protocol deviation|0|||
131240681|NCT05289037|472504430|FG006|Overall Study|Protocol deviation|0|||
131240682|NCT05289037|472504431|FG007|Overall Study|Protocol deviation|0|||
131240683|NCT05289037|472504432|FG008|Overall Study|Protocol deviation|0|||
131185567|NCT02983799|472299298|FG004|Overall Study|Protocol Violation|1|||
131185568|NCT02983799|472299294|FG000|Overall Study|Lost to Follow-up|1|||
131185569|NCT02983799|472299295|FG001|Overall Study|Lost to Follow-up|0|||
131185570|NCT02983799|472299296|FG002|Overall Study|Lost to Follow-up|1|||
131185571|NCT02983799|472299297|FG003|Overall Study|Lost to Follow-up|0|||
131185572|NCT02983799|472299298|FG004|Overall Study|Lost to Follow-up|0|||
131185573|NCT02688153|472301579|FG000|Overall Study|Death|7|||
131185574|NCT02688153|472301580|FG001|Overall Study|Death|5|||
131185575|NCT02688153|472301579|FG000|Overall Study|Withdrawal by Subject|4|||
131185576|NCT02688153|472301580|FG001|Overall Study|Withdrawal by Subject|2|||
131185577|NCT02688153|472301579|FG000|Overall Study|Valve Explant|1|||
131185578|NCT02688153|472301580|FG001|Overall Study|Valve Explant|0|||
131185579|NCT02688153|472301579|FG000|Overall Study|Conversion to Commercial Valve|3|||
131185580|NCT02688153|472301580|FG001|Overall Study|Conversion to Commercial Valve|0|||
131185581|NCT00107172|472301581|FG000|Overall Study|Withdrawal by Subject|1|||
131185582|NCT00107172|472301582|FG001|Overall Study|Withdrawal by Subject|0|||
131185583|NCT00107172|472301581|FG000|Overall Study|Death|0|||
131185584|NCT00107172|472301582|FG001|Overall Study|Death|2|||
131185585|NCT00107172|472301581|FG000|Overall Study|Other Reason|4|||
131185586|NCT00107172|472301582|FG001|Overall Study|Other Reason|3|||
131185587|NCT01102140|472301583|FG000|Overall Study|Lost to Follow-up|1|||
131185588|NCT01102140|472301584|FG001|Overall Study|Lost to Follow-up|0|||
131185589|NCT01102140|472301583|FG000|Overall Study|Investigator terminated study|2|||
131185590|NCT01102140|472301584|FG001|Overall Study|Investigator terminated study|2|||
131185591|NCT03682055|472301585|FG000|Overall Study|Lack of Efficacy|1|||
131240684|NCT05289037|472504433|FG009|Overall Study|Protocol deviation|0|||
131240685|NCT05289037|472504434|FG010|Overall Study|Protocol deviation|0|||
131240686|NCT05289037|472504435|FG011|Overall Study|Protocol deviation|0|||
131240687|NCT05289037|472504436|FG012|Overall Study|Protocol deviation|0|||
131240688|NCT05289037|472504437|FG013|Overall Study|Protocol deviation|0|||
131240689|NCT05289037|472504438|FG014|Overall Study|Protocol deviation|0|||
131240690|NCT05289037|472504439|FG015|Overall Study|Protocol deviation|1|||
131240691|NCT05289037|472504440|FG016|Overall Study|Protocol deviation|0|||
131185592|NCT03682055|472301586|FG001|Overall Study|Lack of Efficacy|2|||
131185593|NCT03682055|472301587|FG002|Overall Study|Lack of Efficacy|1|||
131185594|NCT03682055|472301588|FG003|Overall Study|Lack of Efficacy|2|||
131185595|NCT03682055|472301589|FG004|Overall Study|Lack of Efficacy|1|||
131185596|NCT03682055|472301590|FG005|Overall Study|Lack of Efficacy|3|||
131185597|NCT03682055|472301585|FG000|Overall Study|Withdrawal by Subject|0|||
131185598|NCT03682055|472301586|FG001|Overall Study|Withdrawal by Subject|0|||
131185599|NCT03682055|472301587|FG002|Overall Study|Withdrawal by Subject|0|||
131185600|NCT03682055|472301588|FG003|Overall Study|Withdrawal by Subject|0|||
131185601|NCT03682055|472301589|FG004|Overall Study|Withdrawal by Subject|0|||
131185602|NCT03682055|472301590|FG005|Overall Study|Withdrawal by Subject|1|||
131185603|NCT03682055|472301585|FG000|Overall Study|Termination of Study by Sponsor|0|||
131185604|NCT03682055|472301586|FG001|Overall Study|Termination of Study by Sponsor|0|||
131185605|NCT03682055|472301587|FG002|Overall Study|Termination of Study by Sponsor|0|||
131185606|NCT03682055|472301588|FG003|Overall Study|Termination of Study by Sponsor|0|||
131185607|NCT03682055|472301589|FG004|Overall Study|Termination of Study by Sponsor|0|||
131185608|NCT03682055|472301590|FG005|Overall Study|Termination of Study by Sponsor|3|||
131185609|NCT02687711|472301591|FG000|Overall Study|Adverse Event|89|||
131185610|NCT02687711|472301591|FG000|Overall Study|Lack of Efficacy|70|||
131185611|NCT02687711|472301591|FG000|Overall Study|Lost to Follow-up|20|||
131185612|NCT02687711|472301591|FG000|Overall Study|Consent withdrawn|15|||
131185613|NCT02687711|472301591|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
131185614|NCT02687711|472301591|FG000|Overall Study|Too expensive|4|||
131185615|NCT02687711|472301591|FG000|Overall Study|Participant moved abroad|1|||
131185616|NCT02687711|472301591|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
131185617|NCT02687711|472301591|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
131185618|NCT02687711|472301591|FG000|Overall Study|Disliked taste|1|||
131185619|NCT02687711|472301591|FG000|Overall Study|Low mood|1|||
131185620|NCT02687711|472301591|FG000|Overall Study|Side effects|1|||
131185621|NCT02687711|472301591|FG000|Overall Study|Change of Hospital|1|||
131185622|NCT02687711|472301591|FG000|Overall Study|Liver Encephalopathy|1|||
131185623|NCT02687711|472301591|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
131185624|NCT02687711|472301591|FG000|Overall Study|Withdrawn due to intake interruption|1|||
131185625|NCT02687711|472301591|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
131185626|NCT02687711|472301591|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
131185627|NCT02687711|472301591|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
131185628|NCT03621189|472301592|FG000|Overall Study|Withdrawal by Subject|0|||
131185629|NCT03621189|472301593|FG001|Overall Study|Withdrawal by Subject|3|||
131185630|NCT03621189|472301592|FG000|Overall Study|Physician Decision|0|||
131185631|NCT03621189|472301593|FG001|Overall Study|Physician Decision|2|||
131185632|NCT01135394|472301594|FG000|Screening|Lost to Follow-up|2|||
131185633|NCT01135394|472301594|FG000|Screening|Withdrawal by Subject|10|||
131185634|NCT01135394|472301594|FG000|Screening|Screening failure|16|||
131185635|NCT01135394|472301594|FG000|Screening|Physician Decision|5|||
131185636|NCT01135394|472301594|FG000|Baseline Assessment|Withdrawal by Subject|9|||
131185637|NCT01135394|472301594|FG000|Baseline Assessment|Physician Decision|3|||
131185638|NCT01135394|472301594|FG000|Baseline Assessment|Lost to Follow-up|2|||
131185639|NCT01135394|472301594|FG000|Baseline Assessment|Adverse Event|1|||
131185640|NCT01135394|472301594|FG000|Study Treatment|Withdrawal by Subject|1|||
131185641|NCT01135394|472301594|FG000|Study Treatment|Physician Decision|1|||
131185642|NCT01135394|472301594|FG000|Study Treatment|Adverse Event|2|||
131185643|NCT00191386|472301595|FG000|Overall Study|Adverse Event|16|||
131185644|NCT00191386|472301595|FG000|Overall Study|Lost to Follow-up|1|||
131185645|NCT00191386|472301595|FG000|Overall Study|Entry Criteria Exclusion|3|||
131185646|NCT00191386|472301595|FG000|Overall Study|Protocol Violation|18|||
131185647|NCT00191386|472301595|FG000|Overall Study|Withdrawal by Subject|96|||
131185648|NCT00191386|472301595|FG000|Overall Study|Physician Decision|11|||
131185649|NCT00191386|472301595|FG000|Overall Study|Lack of Efficacy|15|||
131185650|NCT00462488|472301596|FG000|Overall Study|Protocol Violation|1|||
131185651|NCT00462488|472301597|FG001|Overall Study|Protocol Violation|0|||
131185652|NCT00462488|472301596|FG000|Overall Study|Lack of Efficacy|19|||
131185653|NCT00462488|472301597|FG001|Overall Study|Lack of Efficacy|17|||
131185654|NCT01742091|472301602|FG000|Overall Study|Adverse Event|0|||
131185655|NCT01742091|472301603|FG001|Overall Study|Adverse Event|0|||
131185656|NCT01742091|472301604|FG002|Overall Study|Adverse Event|0|||
131185657|NCT01742091|472301605|FG003|Overall Study|Adverse Event|0|||
131185658|NCT01742091|472301606|FG004|Overall Study|Adverse Event|1|||
131185659|NCT01742091|472301607|FG005|Overall Study|Adverse Event|0|||
131185660|NCT01742091|472301602|FG000|Overall Study|Physician Decision|0|||
131185661|NCT01742091|472301603|FG001|Overall Study|Physician Decision|0|||
131185662|NCT01742091|472301604|FG002|Overall Study|Physician Decision|0|||
131185663|NCT01742091|472301605|FG003|Overall Study|Physician Decision|0|||
131185664|NCT01742091|472301606|FG004|Overall Study|Physician Decision|0|||
131185665|NCT01742091|472301607|FG005|Overall Study|Physician Decision|1|||
131185666|NCT01742091|472301602|FG000|Overall Study|Withdrawal by Subject|0|||
131185667|NCT01742091|472301603|FG001|Overall Study|Withdrawal by Subject|0|||
131185668|NCT01742091|472301604|FG002|Overall Study|Withdrawal by Subject|0|||
131185669|NCT01742091|472301605|FG003|Overall Study|Withdrawal by Subject|1|||
131185670|NCT01742091|472301606|FG004|Overall Study|Withdrawal by Subject|0|||
131185671|NCT01742091|472301607|FG005|Overall Study|Withdrawal by Subject|0|||
131185672|NCT01742091|472301602|FG000|Overall Study|Lost to Follow-up|0|||
131185673|NCT01742091|472301603|FG001|Overall Study|Lost to Follow-up|0|||
131185674|NCT01742091|472301604|FG002|Overall Study|Lost to Follow-up|0|||
131185675|NCT01742091|472301605|FG003|Overall Study|Lost to Follow-up|0|||
131185676|NCT01742091|472301606|FG004|Overall Study|Lost to Follow-up|0|||
131185677|NCT01742091|472301607|FG005|Overall Study|Lost to Follow-up|1|||
131185678|NCT03510910|472301609|FG000|Overall Study|Incomplete Survey|2|||
131185679|NCT03510910|472301610|FG001|Overall Study|Incomplete Survey|3|||
131185680|NCT01105936|472301611|FG000|Period 1|Adverse Event|0|||
131185681|NCT01105936|472301612|FG001|Period 1|Adverse Event|0|||
131185682|NCT01105936|472301613|FG002|Period 1|Adverse Event|0|||
131185683|NCT01105936|472301614|FG003|Period 1|Adverse Event|1|||
131185684|NCT01105936|472301611|FG000|Period 2|Adverse Event|1|||
131185685|NCT01105936|472301612|FG001|Period 2|Adverse Event|0|||
131185686|NCT01105936|472301613|FG002|Period 2|Adverse Event|0|||
131185687|NCT01105936|472301614|FG003|Period 2|Adverse Event|0|||
131185688|NCT01105936|472301611|FG000|Period 3|Protocol Violation|0|||
131185689|NCT01105936|472301612|FG001|Period 3|Protocol Violation|2|||
131185690|NCT01105936|472301613|FG002|Period 3|Protocol Violation|0|||
131185691|NCT01105936|472301614|FG003|Period 3|Protocol Violation|0|||
131185692|NCT00948194|472301615|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
131185693|NCT00948194|472301616|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
131185694|NCT00233324|472301617|FG000|Main Study|Death|68|||
131185695|NCT00233324|472301618|FG001|Main Study|Death|60|||
131185696|NCT00233324|472301619|FG002|Main Study|Death|62|||
131185697|NCT00233324|472301620|FG003|Main Study|Death|47|||
131185698|NCT00233324|472301617|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
131185699|NCT00233324|472301618|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
131185700|NCT00233324|472301619|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
131185701|NCT00233324|472301620|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
131185702|NCT00233324|472301617|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
131185703|NCT00233324|472301618|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
131185704|NCT00233324|472301619|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
131185705|NCT00233324|472301620|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
131185706|NCT03170258|472301623|FG000|Overall Study|Physician Decision|4|||
131185707|NCT03170258|472301624|FG001|Overall Study|Physician Decision|0|||
131185708|NCT03170258|472301623|FG000|Overall Study|Equipment issues|1|||
131185709|NCT03170258|472301624|FG001|Overall Study|Equipment issues|0|||
131185710|NCT03170258|472301623|FG000|Overall Study|Medication|1|||
131185711|NCT03170258|472301624|FG001|Overall Study|Medication|0|||
131185712|NCT03170258|472301623|FG000|Overall Study|Sleep issues|1|||
131185713|NCT03170258|472301624|FG001|Overall Study|Sleep issues|0|||
131185714|NCT01563107|472301625|FG000|Overall Study|Physician Decision|0|||
131185715|NCT01563107|472301626|FG001|Overall Study|Physician Decision|1|||
131185716|NCT01563107|472301627|FG002|Overall Study|Physician Decision|1|||
131185717|NCT01563107|472301628|FG003|Overall Study|Physician Decision|3|||
131185718|NCT01563107|472301625|FG000|Overall Study|Withdrawal by Subject|1|||
131185719|NCT01563107|472301626|FG001|Overall Study|Withdrawal by Subject|2|||
131185720|NCT01563107|472301627|FG002|Overall Study|Withdrawal by Subject|1|||
131185721|NCT01563107|472301628|FG003|Overall Study|Withdrawal by Subject|2|||
131185722|NCT00247273|472301632|FG000|Overall Study|Adverse Event|85|||
131185723|NCT00247273|472301633|FG001|Overall Study|Adverse Event|80|||
131185724|NCT00247273|472301632|FG000|Overall Study|Physician Decision|6|||
131185725|NCT00247273|472301633|FG001|Overall Study|Physician Decision|3|||
131185726|NCT00247273|472301632|FG000|Overall Study|Lost to Follow-up|7|||
131185727|NCT00247273|472301633|FG001|Overall Study|Lost to Follow-up|7|||
131185728|NCT00247273|472301632|FG000|Overall Study|Withdrawal by Subject|46|||
131185729|NCT00247273|472301633|FG001|Overall Study|Withdrawal by Subject|47|||
131185730|NCT00247273|472301632|FG000|Overall Study|Did not take any study drug|2|||
131185731|NCT00247273|472301633|FG001|Overall Study|Did not take any study drug|0|||
131185732|NCT01419015|472301635|FG000|Overall Study|Death|2|||
131185733|NCT02580240|472301649|FG000|Overall Study|Physician Decision|2|||
131185734|NCT02580240|472301650|FG001|Overall Study|Physician Decision|0|||
131185735|NCT02007252|472301651|FG000|Overall Study|Administrative problems|3|||
131185736|NCT02007252|472301652|FG001|Overall Study|Administrative problems|7|||
131185737|NCT02007252|472301651|FG000|Overall Study|Abnormal laboratory value(s)|1|||
131185738|NCT02007252|472301652|FG001|Overall Study|Abnormal laboratory value(s)|0|||
131185739|NCT02007252|472301651|FG000|Overall Study|Adverse Event|7|||
131185740|NCT02007252|472301652|FG001|Overall Study|Adverse Event|4|||
131185741|NCT00527072|472301653|FG000|Overall Study|Adverse Event|13|||
131185742|NCT00527072|472301653|FG000|Overall Study|Lack of Efficacy|11|||
131185743|NCT00527072|472301653|FG000|Overall Study|Lost to Follow-up|3|||
131185744|NCT00527072|472301653|FG000|Overall Study|Protocol Violation|2|||
131185745|NCT00527072|472301653|FG000|Overall Study|Withdrawal by Subject|7|||
131185746|NCT02657434|472301654|FG000|Overall Study|Study Terminated By Sponsor|64|||
131185747|NCT02657434|472301655|FG001|Overall Study|Study Terminated By Sponsor|82|||
131185748|NCT02657434|472301654|FG000|Overall Study|Death|189|||
131185749|NCT02657434|472301655|FG001|Overall Study|Death|190|||
131185750|NCT02657434|472301654|FG000|Overall Study|Lost to Follow-up|2|||
131185751|NCT02657434|472301655|FG001|Overall Study|Lost to Follow-up|2|||
131185752|NCT02657434|472301654|FG000|Overall Study|Randomization by Error|2|||
131185753|NCT02657434|472301655|FG001|Overall Study|Randomization by Error|0|||
131185754|NCT02657434|472301654|FG000|Overall Study|Withdrawal by Subject|28|||
131185755|NCT02657434|472301655|FG001|Overall Study|Withdrawal by Subject|17|||
131185756|NCT02657434|472301654|FG000|Overall Study|Protocol Violation|1|||
131185757|NCT02657434|472301655|FG001|Overall Study|Protocol Violation|0|||
131185758|NCT02657434|472301654|FG000|Overall Study|Physician Decision|0|||
131185759|NCT02657434|472301655|FG001|Overall Study|Physician Decision|1|||
131185760|NCT02001688|472301656|FG000|Overall Study|Withdrawal by Subject|0|||
131185761|NCT02001688|472301657|FG001|Overall Study|Withdrawal by Subject|0|||
131185762|NCT02001688|472301658|FG002|Overall Study|Withdrawal by Subject|1|||
131185763|NCT02001688|472301656|FG000|Overall Study|Adverse Event|0|||
131185764|NCT02001688|472301657|FG001|Overall Study|Adverse Event|1|||
131240692|NCT04266912|472504450|FG000|Overall Study|Withdrawal by Subject|1|||
131185765|NCT02001688|472301658|FG002|Overall Study|Adverse Event|0|||
131185766|NCT01989754|472301659|FG000|Overall Study|Withdrawal by Subject|10|||
131185767|NCT01989754|472301660|FG001|Overall Study|Withdrawal by Subject|14|||
131185768|NCT01989754|472301659|FG000|Overall Study|Lost to Follow-up|28|||
131185769|NCT01989754|472301660|FG001|Overall Study|Lost to Follow-up|20|||
131185770|NCT01989754|472301659|FG000|Overall Study|Closed Site|1|||
131185771|NCT01989754|472301660|FG001|Overall Study|Closed Site|1|||
131185772|NCT00813917|472301664|FG000|Overall Study|Adverse Event|0|||
131185773|NCT00813917|472301665|FG001|Overall Study|Adverse Event|1|||
131185774|NCT00813917|472301664|FG000|Overall Study|Withdrawal by Subject|3|||
131185775|NCT00813917|472301665|FG001|Overall Study|Withdrawal by Subject|4|||
131185776|NCT00813917|472301664|FG000|Overall Study|Lost to Follow-up|3|||
131185777|NCT00813917|472301665|FG001|Overall Study|Lost to Follow-up|1|||
131185778|NCT01369225|472301671|FG000|Overall Study|Withdrawal by Subject|1|||
131185779|NCT01369225|472301672|FG001|Overall Study|Withdrawal by Subject|0|||
131185780|NCT01369225|472301673|FG002|Overall Study|Withdrawal by Subject|2|||
131185781|NCT01369225|472301674|FG003|Overall Study|Withdrawal by Subject|1|||
131185782|NCT01369225|472301675|FG004|Overall Study|Withdrawal by Subject|0|||
131185783|NCT01369225|472301676|FG005|Overall Study|Withdrawal by Subject|0|||
131185784|NCT01369225|472301671|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
131185785|NCT01369225|472301672|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
131185786|NCT01369225|472301673|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
131185787|NCT01369225|472301674|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
131185788|NCT01369225|472301675|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
131185789|NCT01369225|472301676|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
131185790|NCT01369225|472301671|FG000|Overall Study|Other|1|||
131185791|NCT01369225|472301672|FG001|Overall Study|Other|0|||
131185792|NCT01369225|472301673|FG002|Overall Study|Other|0|||
131185793|NCT01369225|472301674|FG003|Overall Study|Other|0|||
131185794|NCT01369225|472301675|FG004|Overall Study|Other|1|||
131185795|NCT01369225|472301676|FG005|Overall Study|Other|0|||
131185796|NCT01369225|472301671|FG000|Overall Study|Adverse Event|0|||
131185797|NCT01369225|472301672|FG001|Overall Study|Adverse Event|0|||
131185798|NCT01369225|472301673|FG002|Overall Study|Adverse Event|0|||
131185799|NCT01369225|472301674|FG003|Overall Study|Adverse Event|1|||
131185800|NCT01369225|472301675|FG004|Overall Study|Adverse Event|1|||
131185801|NCT01369225|472301676|FG005|Overall Study|Adverse Event|0|||
131185802|NCT00105183|472301678|FG000|Overall Study|Death|19|||
131185803|NCT00105183|472301679|FG001|Overall Study|Death|13|||
131185804|NCT00105183|472301680|FG002|Overall Study|Death|15|||
131185805|NCT00105183|472301678|FG000|Overall Study|Withdrawal by Subject|1|||
131185806|NCT00105183|472301679|FG001|Overall Study|Withdrawal by Subject|1|||
131185807|NCT00105183|472301680|FG002|Overall Study|Withdrawal by Subject|4|||
131185808|NCT00105183|472301678|FG000|Overall Study|Physician Decision|1|||
131185809|NCT00105183|472301679|FG001|Overall Study|Physician Decision|2|||
131185810|NCT00105183|472301680|FG002|Overall Study|Physician Decision|3|||
131185811|NCT00105183|472301678|FG000|Overall Study|Lost to Follow-up|0|||
131185812|NCT00105183|472301679|FG001|Overall Study|Lost to Follow-up|1|||
131185813|NCT00105183|472301680|FG002|Overall Study|Lost to Follow-up|1|||
131185814|NCT00105183|472301678|FG000|Overall Study|Other reason|1|||
131185815|NCT00105183|472301679|FG001|Overall Study|Other reason|2|||
131185816|NCT00105183|472301680|FG002|Overall Study|Other reason|0|||
131185817|NCT02980692|472301681|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
131185818|NCT02980692|472301682|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
131185819|NCT02980692|472301683|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
131185820|NCT02980692|472301684|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
131185821|NCT02980692|472301685|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
131240693|NCT04266912|472504451|FG001|Overall Study|Withdrawal by Subject|0|||
131240694|NCT04266912|472504452|FG002|Overall Study|Withdrawal by Subject|0|||
131240695|NCT04266912|472504453|FG003|Overall Study|Withdrawal by Subject|0|||
131240696|NCT04266912|472504450|FG000|Overall Study|Progression|6|||
131240697|NCT04266912|472504451|FG001|Overall Study|Progression|6|||
131185822|NCT02980692|472301681|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
131185823|NCT02980692|472301682|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
131185824|NCT02980692|472301683|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
131185825|NCT02980692|472301684|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
131185826|NCT02980692|472301685|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
131185827|NCT02980692|472301681|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
131185828|NCT02980692|472301682|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
131185829|NCT02980692|472301683|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
131185830|NCT02980692|472301684|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
131185831|NCT02980692|472301685|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
131185832|NCT02980692|472301681|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
131185833|NCT02980692|472301682|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
131185834|NCT02980692|472301683|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
131185835|NCT02980692|472301684|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
131185836|NCT02980692|472301685|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
131185837|NCT02980692|472301681|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
131185838|NCT02980692|472301682|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
131185839|NCT02980692|472301683|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
131185840|NCT02980692|472301684|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
131185841|NCT02980692|472301685|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
131185842|NCT02980692|472301681|FG000|Double Blind Placebo Controlled Period|Other|1|||
131185843|NCT02980692|472301682|FG001|Double Blind Placebo Controlled Period|Other|0|||
131185844|NCT02980692|472301683|FG002|Double Blind Placebo Controlled Period|Other|0|||
131185845|NCT02980692|472301684|FG003|Double Blind Placebo Controlled Period|Other|0|||
131185846|NCT02980692|472301685|FG004|Double Blind Placebo Controlled Period|Other|1|||
131185847|NCT02980692|472301681|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
131185848|NCT02980692|472301682|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
131185849|NCT02980692|472301683|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
131185850|NCT02980692|472301684|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
131185851|NCT02980692|472301685|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
131185852|NCT02980692|472301681|FG000|Double-blind Follow-up Period|Adverse Event|0|||
131185853|NCT02980692|472301682|FG001|Double-blind Follow-up Period|Adverse Event|0|||
131185854|NCT02980692|472301683|FG002|Double-blind Follow-up Period|Adverse Event|0|||
131185855|NCT02980692|472301684|FG003|Double-blind Follow-up Period|Adverse Event|1|||
131185856|NCT02980692|472301685|FG004|Double-blind Follow-up Period|Adverse Event|1|||
131185857|NCT02980692|472301681|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
131185858|NCT02980692|472301682|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
131185859|NCT02980692|472301683|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
131185860|NCT02980692|472301684|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
131185861|NCT02980692|472301685|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
131185862|NCT02980692|472301681|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
131185863|NCT02980692|472301682|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
131185864|NCT02980692|472301683|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
131185865|NCT02980692|472301684|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
131185866|NCT02980692|472301685|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
131240698|NCT04266912|472504452|FG002|Overall Study|Progression|0|||
131240699|NCT04266912|472504453|FG003|Overall Study|Progression|10|||
131240700|NCT04487080|472504454|FG000|Overall Study|Withdrawal by Subject|19|||
131240701|NCT04487080|472504455|FG001|Overall Study|Withdrawal by Subject|18|||
131240702|NCT04487080|472504456|FG002|Overall Study|Withdrawal by Subject|13|||
131240703|NCT04487080|472504454|FG000|Overall Study|Lost to Follow-up|3|||
131240704|NCT04487080|472504455|FG001|Overall Study|Lost to Follow-up|1|||
131240705|NCT04487080|472504456|FG002|Overall Study|Lost to Follow-up|0|||
131240706|NCT04487080|472504454|FG000|Overall Study|Ongoing|313|||
131240707|NCT04487080|472504455|FG001|Overall Study|Ongoing|297|||
131240708|NCT04487080|472504456|FG002|Overall Study|Ongoing|149|||
131240709|NCT03968224|472504457|FG000|Overall Study|Lost to Follow-up|11|||
130733533|NCT05026177|470642913|FG002|Overall Study|Withdrawal by Subject|55|||
131240710|NCT03968224|472504458|FG001|Overall Study|Lost to Follow-up|18|||
131240711|NCT03867201|472504460|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
130733534|NCT05026177|470642911|FG000|Overall Study|Protocol Violation|0|||
131185867|NCT02980692|472301681|FG000|Double-blind Follow-up Period|Pregnancy|0|||
131185868|NCT02980692|472301682|FG001|Double-blind Follow-up Period|Pregnancy|0|||
131185869|NCT02980692|472301683|FG002|Double-blind Follow-up Period|Pregnancy|1|||
131185870|NCT02980692|472301684|FG003|Double-blind Follow-up Period|Pregnancy|1|||
131185871|NCT02980692|472301685|FG004|Double-blind Follow-up Period|Pregnancy|0|||
131185872|NCT02980692|472301681|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
131185873|NCT02980692|472301682|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
131185874|NCT02980692|472301683|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
131185875|NCT02980692|472301684|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
131185876|NCT02980692|472301685|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
131185877|NCT02980692|472301681|FG000|Double-blind Follow-up Period|Other|0|||
131185878|NCT02980692|472301682|FG001|Double-blind Follow-up Period|Other|0|||
131185879|NCT02980692|472301683|FG002|Double-blind Follow-up Period|Other|1|||
131185880|NCT02980692|472301684|FG003|Double-blind Follow-up Period|Other|1|||
131185881|NCT02980692|472301685|FG004|Double-blind Follow-up Period|Other|3|||
131185882|NCT00792701|472301686|FG000|Overall Study|Adverse Event|0|||
131185883|NCT00792701|472301687|FG001|Overall Study|Adverse Event|22|||
131185884|NCT00792701|472301686|FG000|Overall Study|Ineligible|1|||
131185885|NCT00792701|472301687|FG001|Overall Study|Ineligible|3|||
131185886|NCT00792701|472301686|FG000|Overall Study|Withdrawal by Subject|1|||
131185887|NCT00792701|472301687|FG001|Overall Study|Withdrawal by Subject|19|||
131185888|NCT00792701|472301686|FG000|Overall Study|Not protocol specified|17|||
131185889|NCT00792701|472301687|FG001|Overall Study|Not protocol specified|0|||
131185890|NCT02143141|472301697|FG000|Overall Study|pain scores at 24 hours not collected|1|||
131185891|NCT02143141|472301698|FG001|Overall Study|pain scores at 24 hours not collected|0|||
131185892|NCT00064077|472301699|FG000|Overall Study|Improper prior treatment|1|||
131185893|NCT00064077|472301700|FG001|Overall Study|Improper prior treatment|0|||
131185894|NCT00064077|472301701|FG002|Overall Study|Improper prior treatment|0|||
131185895|NCT00064077|472301702|FG003|Overall Study|Improper prior treatment|0|||
131185896|NCT00064077|472301699|FG000|Overall Study|Poor risk|2|||
131185897|NCT00064077|472301700|FG001|Overall Study|Poor risk|0|||
131185898|NCT00064077|472301701|FG002|Overall Study|Poor risk|1|||
131185899|NCT00064077|472301702|FG003|Overall Study|Poor risk|1|||
131185900|NCT00064077|472301699|FG000|Overall Study|Pathology|10|||
131185901|NCT00064077|472301700|FG001|Overall Study|Pathology|7|||
131185902|NCT00064077|472301701|FG002|Overall Study|Pathology|3|||
131185903|NCT00064077|472301702|FG003|Overall Study|Pathology|4|||
131185904|NCT00064077|472301699|FG000|Overall Study|No surgery|0|||
131185905|NCT00064077|472301700|FG001|Overall Study|No surgery|0|||
131185906|NCT00064077|472301701|FG002|Overall Study|No surgery|1|||
131185907|NCT00064077|472301702|FG003|Overall Study|No surgery|0|||
131185908|NCT00064077|472301699|FG000|Overall Study|No tumor|0|||
131185909|NCT00064077|472301700|FG001|Overall Study|No tumor|0|||
131185910|NCT00064077|472301701|FG002|Overall Study|No tumor|1|||
131185911|NCT00064077|472301702|FG003|Overall Study|No tumor|0|||
131185912|NCT00064077|472301699|FG000|Overall Study|Other reasons|2|||
131185913|NCT00064077|472301700|FG001|Overall Study|Other reasons|2|||
131185914|NCT00064077|472301701|FG002|Overall Study|Other reasons|1|||
131185915|NCT00064077|472301702|FG003|Overall Study|Other reasons|2|||
131185916|NCT00563368|472301705|FG000|Overall Study|Lost to Follow-up|14|||
131185917|NCT00563368|472301706|FG001|Overall Study|Lost to Follow-up|14|||
131185918|NCT00563368|472301707|FG002|Overall Study|Lost to Follow-up|12|||
131185919|NCT00563368|472301708|FG003|Overall Study|Lost to Follow-up|6|||
131185920|NCT00563368|472301709|FG004|Overall Study|Lost to Follow-up|9|||
131185921|NCT00563368|472301710|FG005|Overall Study|Lost to Follow-up|8|||
131185922|NCT00563368|472301711|FG006|Overall Study|Lost to Follow-up|9|||
131185923|NCT00563368|472301705|FG000|Overall Study|Adverse Event|3|||
131185924|NCT00563368|472301706|FG001|Overall Study|Adverse Event|4|||
131185925|NCT00563368|472301707|FG002|Overall Study|Adverse Event|5|||
131185926|NCT00563368|472301708|FG003|Overall Study|Adverse Event|9|||
131185927|NCT00563368|472301709|FG004|Overall Study|Adverse Event|6|||
131185928|NCT00563368|472301710|FG005|Overall Study|Adverse Event|10|||
131185929|NCT00563368|472301711|FG006|Overall Study|Adverse Event|17|||
131185930|NCT00563368|472301705|FG000|Overall Study|Withdrawal by Subject|11|||
131185931|NCT00563368|472301706|FG001|Overall Study|Withdrawal by Subject|6|||
131185932|NCT00563368|472301707|FG002|Overall Study|Withdrawal by Subject|5|||
131185933|NCT00563368|472301708|FG003|Overall Study|Withdrawal by Subject|7|||
131185934|NCT00563368|472301709|FG004|Overall Study|Withdrawal by Subject|8|||
131185935|NCT00563368|472301710|FG005|Overall Study|Withdrawal by Subject|5|||
131185936|NCT00563368|472301711|FG006|Overall Study|Withdrawal by Subject|4|||
131185937|NCT00563368|472301705|FG000|Overall Study|protocol non-compliance|1|||
131185938|NCT00563368|472301706|FG001|Overall Study|protocol non-compliance|1|||
131185939|NCT00563368|472301707|FG002|Overall Study|protocol non-compliance|2|||
131185940|NCT00563368|472301708|FG003|Overall Study|protocol non-compliance|1|||
131185941|NCT00563368|472301709|FG004|Overall Study|protocol non-compliance|0|||
131185942|NCT00563368|472301710|FG005|Overall Study|protocol non-compliance|1|||
131185943|NCT00563368|472301711|FG006|Overall Study|protocol non-compliance|3|||
131185944|NCT00563368|472301705|FG000|Overall Study|Pregnancy|1|||
131185945|NCT00563368|472301706|FG001|Overall Study|Pregnancy|0|||
131185946|NCT00563368|472301707|FG002|Overall Study|Pregnancy|1|||
131185947|NCT00563368|472301708|FG003|Overall Study|Pregnancy|2|||
131185948|NCT00563368|472301709|FG004|Overall Study|Pregnancy|1|||
131185949|NCT00563368|472301710|FG005|Overall Study|Pregnancy|2|||
131185950|NCT00563368|472301711|FG006|Overall Study|Pregnancy|0|||
131185951|NCT00563368|472301705|FG000|Overall Study|requirement for restricted medication|0|||
131185952|NCT00563368|472301706|FG001|Overall Study|requirement for restricted medication|0|||
131185953|NCT00563368|472301707|FG002|Overall Study|requirement for restricted medication|2|||
131185954|NCT00563368|472301708|FG003|Overall Study|requirement for restricted medication|0|||
131185955|NCT00563368|472301709|FG004|Overall Study|requirement for restricted medication|0|||
131185956|NCT00563368|472301710|FG005|Overall Study|requirement for restricted medication|0|||
131185957|NCT00563368|472301711|FG006|Overall Study|requirement for restricted medication|0|||
131185958|NCT00563368|472301705|FG000|Overall Study|Other|5|||
131185959|NCT00563368|472301706|FG001|Overall Study|Other|5|||
131185960|NCT00563368|472301707|FG002|Overall Study|Other|3|||
131185961|NCT00563368|472301708|FG003|Overall Study|Other|4|||
131185962|NCT00563368|472301709|FG004|Overall Study|Other|4|||
131185963|NCT00563368|472301710|FG005|Overall Study|Other|4|||
131185964|NCT00563368|472301711|FG006|Overall Study|Other|0|||
131185965|NCT01156532|472301712|FG000|Overall Study|Family Reasons|1|||
131185966|NCT01156532|472301712|FG000|Overall Study|Lost to Follow-up|1|||
131185967|NCT01819506|472301713|FG000|Overall Study|Physician Decision|5|||
131185968|NCT01819506|472301714|FG001|Overall Study|Physician Decision|2|||
131185969|NCT01819506|472301713|FG000|Overall Study|Withdrawal by Subject|3|||
131185970|NCT01819506|472301714|FG001|Overall Study|Withdrawal by Subject|3|||
131185971|NCT01963780|472301715|FG000|Overall Study|Death|7|||
131185972|NCT04153929|472301716|FG000|Overall Study|Other than listed|2|||
131185973|NCT04153929|472301717|FG001|Overall Study|Other than listed|2|||
131185974|NCT04153929|472301718|FG002|Overall Study|Other than listed|0|||
131185975|NCT04153929|472301719|FG003|Overall Study|Other than listed|1|||
131185976|NCT04153929|472301720|FG004|Overall Study|Other than listed|0|||
131185977|NCT04153929|472301721|FG005|Overall Study|Other than listed|2|||
131185978|NCT04153929|472301722|FG006|Overall Study|Other than listed|2|||
131185979|NCT04153929|472301723|FG007|Overall Study|Other than listed|1|||
131185980|NCT04153929|472301716|FG000|Overall Study|Lost to Follow-up|2|||
131185981|NCT04153929|472301717|FG001|Overall Study|Lost to Follow-up|1|||
131185982|NCT04153929|472301718|FG002|Overall Study|Lost to Follow-up|0|||
131185983|NCT04153929|472301719|FG003|Overall Study|Lost to Follow-up|1|||
131185984|NCT04153929|472301720|FG004|Overall Study|Lost to Follow-up|1|||
131185985|NCT04153929|472301721|FG005|Overall Study|Lost to Follow-up|0|||
131185986|NCT04153929|472301722|FG006|Overall Study|Lost to Follow-up|0|||
131185987|NCT04153929|472301723|FG007|Overall Study|Lost to Follow-up|0|||
131185988|NCT04153929|472301716|FG000|Overall Study|Withdrawal by Subject|3|||
131185989|NCT04153929|472301717|FG001|Overall Study|Withdrawal by Subject|1|||
131185990|NCT04153929|472301718|FG002|Overall Study|Withdrawal by Subject|0|||
131185991|NCT04153929|472301719|FG003|Overall Study|Withdrawal by Subject|3|||
131185992|NCT04153929|472301720|FG004|Overall Study|Withdrawal by Subject|1|||
131185993|NCT04153929|472301721|FG005|Overall Study|Withdrawal by Subject|0|||
131185994|NCT04153929|472301722|FG006|Overall Study|Withdrawal by Subject|1|||
131185995|NCT04153929|472301723|FG007|Overall Study|Withdrawal by Subject|0|||
131185996|NCT04153929|472301716|FG000|Overall Study|Protocol Violation|0|||
131185997|NCT04153929|472301717|FG001|Overall Study|Protocol Violation|0|||
131185998|NCT04153929|472301718|FG002|Overall Study|Protocol Violation|0|||
131185999|NCT04153929|472301719|FG003|Overall Study|Protocol Violation|0|||
131186000|NCT04153929|472301720|FG004|Overall Study|Protocol Violation|0|||
131186001|NCT04153929|472301721|FG005|Overall Study|Protocol Violation|0|||
131186002|NCT04153929|472301722|FG006|Overall Study|Protocol Violation|1|||
131186003|NCT04153929|472301723|FG007|Overall Study|Protocol Violation|2|||
131186004|NCT04153929|472301716|FG000|Overall Study|Adverse Event|3|||
131186005|NCT04153929|472301717|FG001|Overall Study|Adverse Event|5|||
131186006|NCT04153929|472301718|FG002|Overall Study|Adverse Event|5|||
131186007|NCT04153929|472301719|FG003|Overall Study|Adverse Event|11|||
131186008|NCT04153929|472301720|FG004|Overall Study|Adverse Event|15|||
131186009|NCT04153929|472301721|FG005|Overall Study|Adverse Event|4|||
131186010|NCT04153929|472301722|FG006|Overall Study|Adverse Event|8|||
130733535|NCT05026177|470642912|FG001|Overall Study|Protocol Violation|1|||
131186011|NCT04153929|472301723|FG007|Overall Study|Adverse Event|2|||
131186012|NCT04153929|472301716|FG000|Overall Study|Not treated|1|||
131186013|NCT04153929|472301717|FG001|Overall Study|Not treated|0|||
131186014|NCT04153929|472301718|FG002|Overall Study|Not treated|0|||
131186015|NCT04153929|472301719|FG003|Overall Study|Not treated|0|||
131186016|NCT04153929|472301720|FG004|Overall Study|Not treated|0|||
131186017|NCT04153929|472301721|FG005|Overall Study|Not treated|0|||
131186018|NCT04153929|472301722|FG006|Overall Study|Not treated|1|||
131186019|NCT04153929|472301723|FG007|Overall Study|Not treated|0|||
131186020|NCT04083794|472301724|FG000|Overall Study|Lost to Follow-up|9|||
131186021|NCT01235728|472301728|FG000|Overall Study|Protocol Violation|0|||
131186022|NCT01235728|472301729|FG001|Overall Study|Protocol Violation|0|||
131186023|NCT01235728|472301730|FG002|Overall Study|Protocol Violation|0|||
131186024|NCT01235728|472301731|FG003|Overall Study|Protocol Violation|1|||
131186025|NCT01235728|472301732|FG004|Overall Study|Protocol Violation|0|||
131186026|NCT01235728|472301733|FG005|Overall Study|Protocol Violation|0|||
131186027|NCT01235728|472301734|FG006|Overall Study|Protocol Violation|0|||
131186028|NCT01235728|472301735|FG007|Overall Study|Protocol Violation|0|||
131186029|NCT01202760|472301736|FG000|Overall Study|Entry Criteria Not Met|0|||
131186030|NCT01202760|472301737|FG001|Overall Study|Entry Criteria Not Met|3|||
131186031|NCT01202760|472301738|FG002|Overall Study|Entry Criteria Not Met|1|||
131186032|NCT01202760|472301736|FG000|Overall Study|Adverse Event|11|||
131186033|NCT01202760|472301737|FG001|Overall Study|Adverse Event|9|||
131186034|NCT01202760|472301738|FG002|Overall Study|Adverse Event|10|||
131186035|NCT01202760|472301736|FG000|Overall Study|Death|2|||
131186036|NCT01202760|472301737|FG001|Overall Study|Death|1|||
131186037|NCT01202760|472301738|FG002|Overall Study|Death|0|||
131186038|NCT01202760|472301736|FG000|Overall Study|Lack of Efficacy|6|||
131186039|NCT01202760|472301737|FG001|Overall Study|Lack of Efficacy|8|||
131186040|NCT01202760|472301738|FG002|Overall Study|Lack of Efficacy|7|||
131186041|NCT01202760|472301736|FG000|Overall Study|Lost to Follow-up|0|||
131186042|NCT01202760|472301737|FG001|Overall Study|Lost to Follow-up|2|||
131186043|NCT01202760|472301738|FG002|Overall Study|Lost to Follow-up|1|||
131186044|NCT01202760|472301736|FG000|Overall Study|Parent / Caregiver Decision|0|||
131186045|NCT01202760|472301737|FG001|Overall Study|Parent / Caregiver Decision|1|||
131186046|NCT01202760|472301738|FG002|Overall Study|Parent / Caregiver Decision|0|||
131186047|NCT01202760|472301736|FG000|Overall Study|Withdrawal by Subject|17|||
131186048|NCT01202760|472301737|FG001|Overall Study|Withdrawal by Subject|18|||
131186049|NCT01202760|472301738|FG002|Overall Study|Withdrawal by Subject|14|||
131186050|NCT01202760|472301736|FG000|Overall Study|Physician Decision|0|||
131186051|NCT01202760|472301737|FG001|Overall Study|Physician Decision|1|||
131186052|NCT01202760|472301738|FG002|Overall Study|Physician Decision|0|||
131186053|NCT01202760|472301736|FG000|Overall Study|Protocol Violation|7|||
131186054|NCT01202760|472301737|FG001|Overall Study|Protocol Violation|5|||
131186055|NCT01202760|472301738|FG002|Overall Study|Protocol Violation|2|||
131186056|NCT01202760|472301736|FG000|Overall Study|Sponsor Decision|4|||
131186057|NCT01202760|472301737|FG001|Overall Study|Sponsor Decision|4|||
131186058|NCT01202760|472301738|FG002|Overall Study|Sponsor Decision|0|||
131186059|NCT00871572|472301739|FG000|Overall Study|Adverse Event|0|||
131186060|NCT00871572|472301740|FG001|Overall Study|Adverse Event|2|||
131186061|NCT00871572|472301741|FG002|Overall Study|Adverse Event|0|||
131186062|NCT00871572|472301742|FG003|Overall Study|Adverse Event|3|||
131186063|NCT00871572|472301739|FG000|Overall Study|Investigator Decision|0|||
131186064|NCT00871572|472301740|FG001|Overall Study|Investigator Decision|1|||
131186065|NCT00871572|472301741|FG002|Overall Study|Investigator Decision|0|||
131186066|NCT00871572|472301742|FG003|Overall Study|Investigator Decision|1|||
131186067|NCT00871572|472301739|FG000|Overall Study|Lost to Follow-up|0|||
131186068|NCT00871572|472301740|FG001|Overall Study|Lost to Follow-up|1|||
131186069|NCT00871572|472301741|FG002|Overall Study|Lost to Follow-up|0|||
131186070|NCT00871572|472301742|FG003|Overall Study|Lost to Follow-up|1|||
131186071|NCT00871572|472301739|FG000|Overall Study|Protocol Violation|0|||
131186072|NCT00871572|472301740|FG001|Overall Study|Protocol Violation|0|||
131186073|NCT00871572|472301741|FG002|Overall Study|Protocol Violation|1|||
131186074|NCT00871572|472301742|FG003|Overall Study|Protocol Violation|1|||
131186075|NCT00871572|472301739|FG000|Overall Study|Sponsor Decision|1|||
131186076|NCT00871572|472301740|FG001|Overall Study|Sponsor Decision|0|||
131186077|NCT00871572|472301741|FG002|Overall Study|Sponsor Decision|0|||
131186078|NCT00871572|472301742|FG003|Overall Study|Sponsor Decision|0|||
131186079|NCT00871572|472301739|FG000|Overall Study|Withdrawal by Subject|1|||
131186080|NCT00871572|472301740|FG001|Overall Study|Withdrawal by Subject|2|||
131186081|NCT00871572|472301741|FG002|Overall Study|Withdrawal by Subject|3|||
131186082|NCT00871572|472301742|FG003|Overall Study|Withdrawal by Subject|1|||
131186083|NCT04354155|472301745|FG000|Overall Study|Withdrawal by Subject|1|||
131186084|NCT04354155|472301745|FG000|Overall Study|Did not meet criteria for study intervention|1|||
131186085|NCT00187889|472301746|FG000|Overall Study|Withdrawal by Subject|6|||
131186086|NCT00187889|472301747|FG001|Overall Study|Withdrawal by Subject|4|||
131186087|NCT01419080|472301748|FG000|Overall Study|Withdrawal by Subject|75|||
131186088|NCT01419080|472301748|FG000|Overall Study|Death|30|||
131186089|NCT01419080|472301748|FG000|Overall Study|Lost to Follow-up|23|||
131186090|NCT01419080|472301748|FG000|Overall Study|Too Ill|3|||
131186091|NCT01575899|472301749|FG000|Overall Study|Lost to Follow-up|3|||
131240712|NCT03867201|472504461|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
131186092|NCT01575899|472301750|FG001|Overall Study|Lost to Follow-up|4|||
131240713|NCT03867201|472504460|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
131186093|NCT01575899|472301751|FG002|Overall Study|Lost to Follow-up|2|||
131186094|NCT01575899|472301749|FG000|Overall Study|Protocol Violation|2|||
131186095|NCT01575899|472301750|FG001|Overall Study|Protocol Violation|1|||
131186096|NCT01575899|472301751|FG002|Overall Study|Protocol Violation|0|||
131186097|NCT04294095|472301752|FG000|Overall Study|Adverse Event|1|||
131186098|NCT04294095|472301753|FG001|Overall Study|Adverse Event|0|||
131186099|NCT03205982|472301758|FG000|Overall Study|Lost to Follow-up|20|||
131186100|NCT03205982|472301759|FG001|Overall Study|Lost to Follow-up|19|||
131186101|NCT03205982|472301758|FG000|Overall Study|Withdrawal by Subject|4|||
131186102|NCT03205982|472301759|FG001|Overall Study|Withdrawal by Subject|3|||
131186103|NCT03205982|472301758|FG000|Overall Study|Withdrawal by PI|0|||
131186104|NCT03205982|472301759|FG001|Overall Study|Withdrawal by PI|1|||
131186105|NCT03136367|472301762|FG000|T1 Consultation|discontinued mistakenly included|2|||
131186106|NCT03136367|472301763|FG001|T1 Consultation|discontinued mistakenly included|6|||
131186107|NCT03136367|472301764|FG002|T1 Consultation|discontinued mistakenly included|1|||
131186108|NCT03136367|472301762|FG000|T1 Consultation|Discontinued other|0|||
131186109|NCT03136367|472301763|FG001|T1 Consultation|Discontinued other|1|||
131186110|NCT03136367|472301764|FG002|T1 Consultation|Discontinued other|0|||
131186111|NCT03136367|472301762|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
131186112|NCT03136367|472301763|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
131186113|NCT03136367|472301764|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
131186114|NCT03136367|472301762|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
131186115|NCT03136367|472301763|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
131186116|NCT03136367|472301764|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
131186117|NCT03136367|472301762|FG000|T2 Post-consultation|Discontinued other|0|||
131186118|NCT03136367|472301763|FG001|T2 Post-consultation|Discontinued other|2|||
131186119|NCT03136367|472301764|FG002|T2 Post-consultation|Discontinued other|6|||
131186120|NCT03136367|472301762|FG000|T2 Post-consultation|Discontinued transferred care|0|||
131186121|NCT03136367|472301763|FG001|T2 Post-consultation|Discontinued transferred care|0|||
131186122|NCT03136367|472301764|FG002|T2 Post-consultation|Discontinued transferred care|3|||
131186123|NCT03136367|472301762|FG000|T2 Post-consultation|Discontinued lost contact|0|||
131186124|NCT03136367|472301763|FG001|T2 Post-consultation|Discontinued lost contact|1|||
131186125|NCT03136367|472301764|FG002|T2 Post-consultation|Discontinued lost contact|0|||
131186126|NCT03136367|472301762|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
131186127|NCT03136367|472301763|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
131186128|NCT03136367|472301764|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
131186129|NCT03136367|472301762|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
131186130|NCT03136367|472301763|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
131186131|NCT03136367|472301764|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
131186132|NCT03136367|472301762|FG000|T3 1 Week After Surgery|other discontinued|2|||
131186133|NCT03136367|472301763|FG001|T3 1 Week After Surgery|other discontinued|4|||
131186134|NCT03136367|472301764|FG002|T3 1 Week After Surgery|other discontinued|3|||
131186135|NCT03136367|472301762|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
131186136|NCT03136367|472301763|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
131186137|NCT03136367|472301764|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
131186138|NCT03136367|472301762|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
131186139|NCT03136367|472301763|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
131186140|NCT03136367|472301764|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
131186141|NCT03136367|472301762|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
131186142|NCT03136367|472301763|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
131186143|NCT03136367|472301764|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
131186144|NCT03136367|472301762|FG000|T4 12 Weeks After Surgery|Death|0|||
131186145|NCT03136367|472301763|FG001|T4 12 Weeks After Surgery|Death|1|||
131186146|NCT03136367|472301764|FG002|T4 12 Weeks After Surgery|Death|3|||
131186147|NCT03136367|472301762|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
131186148|NCT03136367|472301763|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
131240714|NCT03867201|472504461|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
131240715|NCT03867201|472504460|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
131240716|NCT03867201|472504461|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
131240717|NCT03867201|472504460|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
131240718|NCT03867201|472504461|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
131240719|NCT03867201|472504460|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
131240720|NCT03867201|472504461|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
131240721|NCT03867201|472504460|FG000|Open-Label Period From Week 12|Adverse Event|5|||
131240722|NCT03867201|472504461|FG001|Open-Label Period From Week 12|Adverse Event|11|||
131240723|NCT03867201|472504460|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
131240724|NCT03867201|472504461|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
131240725|NCT03867201|472504460|FG000|Open-Label Period From Week 12|Physician Decision|6|||
131240726|NCT03867201|472504461|FG001|Open-Label Period From Week 12|Physician Decision|3|||
131240727|NCT03867201|472504460|FG000|Open-Label Period From Week 12|Pregnancy|2|||
131240728|NCT03867201|472504461|FG001|Open-Label Period From Week 12|Pregnancy|2|||
131240729|NCT03867201|472504460|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
131186149|NCT03136367|472301764|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
131186150|NCT03136367|472301762|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
131240730|NCT03867201|472504461|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
131240731|NCT03867201|472504460|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
131240732|NCT03867201|472504461|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
131240733|NCT03867201|472504460|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
131186151|NCT03136367|472301763|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
131186152|NCT03136367|472301764|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
131186153|NCT03136367|472301762|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
131186154|NCT03136367|472301763|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
131186155|NCT03136367|472301764|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
131186156|NCT03136367|472301762|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
131186157|NCT03136367|472301763|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
131186158|NCT03136367|472301764|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
131186159|NCT03136367|472301762|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
131186160|NCT03136367|472301763|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
131186161|NCT03136367|472301764|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
131186162|NCT03136367|472301762|FG000|T5 1 Year After Surgery|Death|0|||
131186163|NCT03136367|472301763|FG001|T5 1 Year After Surgery|Death|0|||
131186164|NCT03136367|472301764|FG002|T5 1 Year After Surgery|Death|1|||
131186165|NCT03136367|472301762|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
131186166|NCT03136367|472301763|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
131186167|NCT03136367|472301764|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
131186168|NCT03136367|472301762|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
131186169|NCT03136367|472301763|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
131186170|NCT03136367|472301764|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
131186171|NCT03136367|472301762|FG000|T5 1 Year After Surgery|study ended before due|31|||
131186172|NCT03136367|472301763|FG001|T5 1 Year After Surgery|study ended before due|103|||
131186173|NCT03136367|472301764|FG002|T5 1 Year After Surgery|study ended before due|110|||
131186174|NCT03136367|472301762|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
131186175|NCT03136367|472301763|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
131186176|NCT03136367|472301764|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
131186177|NCT05200455|472301767|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
131186178|NCT02483078|472301775|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
131186179|NCT02483078|472301776|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
131186180|NCT02483078|472301775|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
131186181|NCT02483078|472301776|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
131186182|NCT02483078|472301775|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
131186183|NCT02483078|472301776|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
131186184|NCT02483078|472301775|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
131186185|NCT02483078|472301776|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
131186186|NCT02483078|472301775|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
131186187|NCT02483078|472301776|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
131186188|NCT02483078|472301775|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
131186189|NCT02483078|472301776|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
131186190|NCT02853032|472301777|FG000|Overall Study|Adverse Event|4|||
131186191|NCT02853032|472301778|FG001|Overall Study|Adverse Event|0|||
131186192|NCT02853032|472301777|FG000|Overall Study|Withdrawal by Subject|3|||
131186193|NCT02853032|472301778|FG001|Overall Study|Withdrawal by Subject|1|||
131186194|NCT02853032|472301777|FG000|Overall Study|Requested to withdraw from all treatment|2|||
131186195|NCT02853032|472301778|FG001|Overall Study|Requested to withdraw from all treatment|2|||
131186196|NCT00676208|472301781|FG000|Overall Study|Lost to Follow-up|0|||
131186197|NCT00676208|472301782|FG001|Overall Study|Lost to Follow-up|2|||
131186198|NCT00676208|472301781|FG000|Overall Study|Incomplete data|2|||
131186199|NCT00676208|472301782|FG001|Overall Study|Incomplete data|4|||
131186200|NCT03726333|472301783|FG000|Overall Study|Progressive Disease|0|||
131186201|NCT03726333|472301784|FG001|Overall Study|Progressive Disease|0|||
131186202|NCT03726333|472301785|FG002|Overall Study|Progressive Disease|1|||
131186203|NCT03726333|472301786|FG003|Overall Study|Progressive Disease|0|||
131186204|NCT03726333|472301787|FG004|Overall Study|Progressive Disease|0|||
131186205|NCT01410799|472301788|FG000|Overall Study|PI decision|13|||
131186206|NCT01946412|472301789|FG000|Overall Study|Adverse Event|1|||
131186207|NCT01946412|472301789|FG000|Overall Study|Non-Compliance|1|||
131186208|NCT01946412|472301789|FG000|Overall Study|Continued with commercial Kalydeco|2|||
131186209|NCT01946412|472301789|FG000|Overall Study|Difficulty in swallowing|1|||
131186210|NCT03750240|472304401|FG000|Overall Study|Technical Difficulties|2|||
131186211|NCT00927758|472304402|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
131186212|NCT00927758|472304403|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
131186213|NCT00927758|472304404|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
131186214|NCT00927758|472304405|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
131186215|NCT00927758|472304406|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
130733536|NCT05026177|470642913|FG002|Overall Study|Protocol Violation|0|||
131186216|NCT00927758|472304407|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
131186217|NCT00927758|472304402|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
131186218|NCT00927758|472304403|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
131186219|NCT00927758|472304404|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
131186220|NCT00927758|472304405|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
131186221|NCT00927758|472304406|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
131186222|NCT00927758|472304407|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
131186223|NCT00439725|472304409|FG000|Treatment Period|Withdrawal by Subject|22|||
131186224|NCT00439725|472304410|FG001|Treatment Period|Withdrawal by Subject|19|||
131186225|NCT00439725|472304409|FG000|Treatment Period|Study terminated by sponsor|156|||
131186226|NCT00439725|472304410|FG001|Treatment Period|Study terminated by sponsor|148|||
131186227|NCT00439725|472304409|FG000|Treatment Period|Site closed by investigator|1|||
131186228|NCT00439725|472304410|FG001|Treatment Period|Site closed by investigator|2|||
131186229|NCT00439725|472304409|FG000|Treatment Period|Adverse Event|39|||
131186230|NCT00439725|472304410|FG001|Treatment Period|Adverse Event|18|||
131186231|NCT00439725|472304409|FG000|Treatment Period|Physician Decision|1|||
131186232|NCT00439725|472304410|FG001|Treatment Period|Physician Decision|1|||
131186233|NCT00439725|472304409|FG000|Treatment Period|Protocol Violation|2|||
131186234|NCT00439725|472304410|FG001|Treatment Period|Protocol Violation|1|||
131186235|NCT00439725|472304409|FG000|Treatment Period|Clinical endpoint reached|6|||
131186236|NCT00439725|472304410|FG001|Treatment Period|Clinical endpoint reached|50|||
131186237|NCT00439725|472304409|FG000|Treatment Period|Technical problems|1|||
131186238|NCT00439725|472304410|FG001|Treatment Period|Technical problems|0|||
130784535|NCT00113607|470838812|FG001|Overall Study|Complete Response (Confirmed)|24|||
130784536|NCT00113607|470838811|FG000|Overall Study|Other|43|||
130784537|NCT00113607|470838812|FG001|Overall Study|Other|32|||
130784538|NCT01222104|470838813|FG000|Overall Study|Lost to Follow-up|37|||
130784539|NCT01222104|470838813|FG000|Overall Study|Death|10|||
130784540|NCT01418339|470838815|FG000|Overall Study|Adverse Event|5|||
130784541|NCT01418339|470838816|FG001|Overall Study|Adverse Event|2|||
130784542|NCT01418339|470838815|FG000|Overall Study|Subject Withdrew Consent|1|||
131186239|NCT00439725|472304409|FG000|Treatment Period|Lost to Follow-up|1|||
131186240|NCT00439725|472304410|FG001|Treatment Period|Lost to Follow-up|1|||
131186241|NCT00439725|472304409|FG000|Treatment Period|Participant convenience|1|||
131186242|NCT00439725|472304410|FG001|Treatment Period|Participant convenience|0|||
131186243|NCT00439725|472304409|FG000|Treatment Period|Protocol driven decision point|1|||
131186244|NCT00439725|472304410|FG001|Treatment Period|Protocol driven decision point|1|||
131186245|NCT00439725|472304409|FG000|Treatment Period|Death|1|||
131186246|NCT00439725|472304410|FG001|Treatment Period|Death|1|||
131186247|NCT00439725|472304409|FG000|Treatment Period|Participant did not receive treatment|4|||
131186248|NCT00439725|472304410|FG001|Treatment Period|Participant did not receive treatment|4|||
131186249|NCT00439725|472304409|FG000|Observational Period|Withdrawal by Subject|2|||
131186250|NCT00439725|472304410|FG001|Observational Period|Withdrawal by Subject|2|||
131186251|NCT00439725|472304409|FG000|Observational Period|Lost to Follow-up|0|||
131186252|NCT00439725|472304410|FG001|Observational Period|Lost to Follow-up|1|||
131186253|NCT00439725|472304409|FG000|Observational Period|Death|0|||
131186254|NCT00439725|472304410|FG001|Observational Period|Death|2|||
131186255|NCT00439725|472304409|FG000|Observational Period|Study termination by sponsor|1|||
131186256|NCT00439725|472304410|FG001|Observational Period|Study termination by sponsor|1|||
131186257|NCT00439725|472304409|FG000|Observational Period|Clinical endpoint reached|3|||
131186258|NCT00439725|472304410|FG001|Observational Period|Clinical endpoint reached|1|||
131186259|NCT00439725|472304409|FG000|Observational Period|Technical problems|1|||
131186260|NCT00439725|472304410|FG001|Observational Period|Technical problems|0|||
131186261|NCT00439725|472304409|FG000|Observational Period|Participant convenience|1|||
131186262|NCT00439725|472304410|FG001|Observational Period|Participant convenience|0|||
131186263|NCT00379236|472304411|FG000|Double-blind|Adverse Event|11|||
131186264|NCT00379236|472304412|FG001|Double-blind|Adverse Event|6|||
131186265|NCT00379236|472304413|FG002|Double-blind|Adverse Event|0|||
131186266|NCT00379236|472304411|FG000|Double-blind|Protocol Violation|3|||
131186267|NCT00379236|472304412|FG001|Double-blind|Protocol Violation|3|||
131186268|NCT00379236|472304413|FG002|Double-blind|Protocol Violation|0|||
131186269|NCT00379236|472304411|FG000|Double-blind|Withdrawal by Subject|12|||
131186270|NCT00379236|472304412|FG001|Double-blind|Withdrawal by Subject|13|||
131240734|NCT03867201|472504461|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
131240735|NCT03867201|472504460|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
131240736|NCT03867201|472504461|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
131240737|NCT05763875|472504466|FG000|Overall Study|Subject decision|5|||
131240738|NCT05763875|472504467|FG001|Overall Study|Subject decision|2|||
131240739|NCT05763875|472504468|FG002|Overall Study|Subject decision|1|||
131240740|NCT05763875|472504466|FG000|Overall Study|Lost to Follow-up|4|||
131240741|NCT05763875|472504467|FG001|Overall Study|Lost to Follow-up|1|||
131240742|NCT05763875|472504468|FG002|Overall Study|Lost to Follow-up|2|||
130784543|NCT01418339|470838816|FG001|Overall Study|Subject Withdrew Consent|2|||
131186271|NCT00379236|472304413|FG002|Double-blind|Withdrawal by Subject|0|||
131186272|NCT00379236|472304411|FG000|Double-blind|Lost to Follow-up|4|||
131186273|NCT00379236|472304412|FG001|Double-blind|Lost to Follow-up|3|||
131186274|NCT00379236|472304413|FG002|Double-blind|Lost to Follow-up|0|||
131186275|NCT00379236|472304411|FG000|Double-blind|Use of exclusionary medication|1|||
131240743|NCT05763875|472504466|FG000|Overall Study|Adverse Event|1|||
130784544|NCT01418339|470838815|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
131186276|NCT00379236|472304412|FG001|Double-blind|Use of exclusionary medication|2|||
131186277|NCT00379236|472304413|FG002|Double-blind|Use of exclusionary medication|0|||
131186278|NCT00379236|472304411|FG000|Double-blind|Other|3|||
131186279|NCT00379236|472304412|FG001|Double-blind|Other|7|||
131186280|NCT00379236|472304413|FG002|Double-blind|Other|0|||
131186281|NCT00379236|472304411|FG000|Double-blind|Data could not be retrieved|2|||
131186282|NCT00379236|472304412|FG001|Double-blind|Data could not be retrieved|2|||
131186283|NCT00379236|472304413|FG002|Double-blind|Data could not be retrieved|0|||
131186284|NCT00379236|472304411|FG000|Open-label Extension|Adverse Event|0|||
131186285|NCT00379236|472304412|FG001|Open-label Extension|Adverse Event|0|||
131186286|NCT00379236|472304413|FG002|Open-label Extension|Adverse Event|13|||
131186287|NCT00379236|472304411|FG000|Open-label Extension|Protocol Violation|0|||
131186288|NCT00379236|472304412|FG001|Open-label Extension|Protocol Violation|0|||
131186289|NCT00379236|472304413|FG002|Open-label Extension|Protocol Violation|7|||
131186290|NCT00379236|472304411|FG000|Open-label Extension|Withdrawal by Subject|0|||
131186291|NCT00379236|472304412|FG001|Open-label Extension|Withdrawal by Subject|0|||
131186292|NCT00379236|472304413|FG002|Open-label Extension|Withdrawal by Subject|13|||
131186293|NCT00379236|472304411|FG000|Open-label Extension|Lost to Follow-up|0|||
131186294|NCT00379236|472304412|FG001|Open-label Extension|Lost to Follow-up|0|||
131186295|NCT00379236|472304413|FG002|Open-label Extension|Lost to Follow-up|12|||
131186296|NCT00379236|472304411|FG000|Open-label Extension|Use of exclusionary medication|0|||
131186297|NCT00379236|472304412|FG001|Open-label Extension|Use of exclusionary medication|0|||
131186298|NCT00379236|472304413|FG002|Open-label Extension|Use of exclusionary medication|3|||
131186299|NCT00379236|472304411|FG000|Open-label Extension|Other|0|||
131186300|NCT00379236|472304412|FG001|Open-label Extension|Other|0|||
131186301|NCT00379236|472304413|FG002|Open-label Extension|Other|7|||
131186302|NCT04914819|472304414|FG000|Overall Study|Pregnancy|3|||
131186303|NCT04914819|472304415|FG001|Overall Study|Pregnancy|1|||
131186304|NCT04914819|472304414|FG000|Overall Study|Discontinued study|4|||
131186305|NCT04914819|472304415|FG001|Overall Study|Discontinued study|1|||
131186306|NCT04914819|472304414|FG000|Overall Study|Lost to Follow-up|7|||
131186307|NCT04914819|472304415|FG001|Overall Study|Lost to Follow-up|0|||
131186308|NCT04038385|472304416|FG000|Overall Study|Completed baseline assessment only|7|||
131186309|NCT04038385|472304417|FG001|Overall Study|Completed baseline assessment only|4|||
131186310|NCT04038385|472304416|FG000|Overall Study|Moved out of area|4|||
131186311|NCT04038385|472304417|FG001|Overall Study|Moved out of area|2|||
131186312|NCT04038385|472304416|FG000|Overall Study|Discontinued study involvement|6|||
131186313|NCT04038385|472304417|FG001|Overall Study|Discontinued study involvement|1|||
131186314|NCT01625611|472304418|FG000|Overall Study|No adlib drinks Lab 1|3|||
131186315|NCT01625611|472304419|FG001|Overall Study|No adlib drinks Lab 1|0|||
131186316|NCT01625611|472304418|FG000|Overall Study|Technical issues with PET|1|||
131186317|NCT01625611|472304419|FG001|Overall Study|Technical issues with PET|0|||
131186318|NCT01625611|472304418|FG000|Overall Study|Unable to complete study procedures|1|||
131186319|NCT01625611|472304419|FG001|Overall Study|Unable to complete study procedures|0|||
131186320|NCT01625611|472304418|FG000|Overall Study|Withdrawal by Subject|3|||
131186321|NCT01625611|472304419|FG001|Overall Study|Withdrawal by Subject|0|||
131186322|NCT01527110|472304420|FG000|Overall Study|Adverse Event|1|||
131186323|NCT01709708|472304421|FG000|Overall Study|Protocol Violation|1|||
131186324|NCT01709708|472304422|FG001|Overall Study|Protocol Violation|2|||
131186325|NCT00511108|472304425|FG000|Overall Study|Adverse Event|2|||
131186326|NCT00511108|472304426|FG001|Overall Study|Adverse Event|0|||
131186327|NCT00511108|472304427|FG002|Overall Study|Adverse Event|1|||
131186328|NCT00511108|472304428|FG003|Overall Study|Adverse Event|2|||
131186329|NCT00511108|472304425|FG000|Overall Study|Lost to Follow-up|0|||
131186330|NCT00511108|472304426|FG001|Overall Study|Lost to Follow-up|2|||
131186331|NCT00511108|472304427|FG002|Overall Study|Lost to Follow-up|1|||
131186332|NCT00511108|472304428|FG003|Overall Study|Lost to Follow-up|0|||
131186333|NCT00511108|472304425|FG000|Overall Study|Physician Decision|0|||
131186334|NCT00511108|472304426|FG001|Overall Study|Physician Decision|0|||
131186335|NCT00511108|472304427|FG002|Overall Study|Physician Decision|0|||
131186336|NCT00511108|472304428|FG003|Overall Study|Physician Decision|1|||
131186337|NCT00511108|472304425|FG000|Overall Study|Withdrawal by Subject|4|||
131186338|NCT00511108|472304426|FG001|Overall Study|Withdrawal by Subject|0|||
131186339|NCT00511108|472304427|FG002|Overall Study|Withdrawal by Subject|3|||
131186340|NCT00511108|472304428|FG003|Overall Study|Withdrawal by Subject|2|||
131186341|NCT02147691|472304431|FG000|Overall Study|Withdrawal by Subject|2|||
131186342|NCT02147691|472304432|FG001|Overall Study|Withdrawal by Subject|0|||
131186343|NCT02147691|472304431|FG000|Overall Study|Adverse Event|2|||
131186344|NCT02147691|472304432|FG001|Overall Study|Adverse Event|0|||
131186345|NCT02147691|472304431|FG000|Overall Study|Lost to Follow-up|0|||
131186346|NCT02147691|472304432|FG001|Overall Study|Lost to Follow-up|1|||
131186347|NCT02954952|472304433|FG000|Overall Study|Withdrawal by Subject|1|||
131186348|NCT02954952|472304434|FG001|Overall Study|Withdrawal by Subject|0|||
131186349|NCT02954952|472304435|FG002|Overall Study|Withdrawal by Subject|0|||
131186350|NCT02954952|472304433|FG000|Overall Study|No data collected|0|||
131186351|NCT02954952|472304434|FG001|Overall Study|No data collected|1|||
131186352|NCT02954952|472304435|FG002|Overall Study|No data collected|0|||
131186353|NCT01392742|472304436|FG000|Overall Study|Premature study termination|42|||
131186354|NCT01392742|472304436|FG000|Overall Study|Failure to return|35|||
131186355|NCT01392742|472304436|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
131186356|NCT01392742|472304436|FG000|Overall Study|Lost to Follow-up|34|||
131186357|NCT01392742|472304436|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
131186358|NCT01392742|472304436|FG000|Overall Study|ITR and Protocol deviation|1|||
131186359|NCT01392742|472304436|FG000|Overall Study|Adverse event/intercurrent illness|17|||
131186360|NCT01392742|472304436|FG000|Overall Study|Protocol Violation|14|||
131186361|NCT01392742|472304436|FG000|Overall Study|Other|3|||
131186362|NCT01392742|472304436|FG000|Overall Study|Missing information|13|||
131186363|NCT04179032|472304437|FG000|Part B (Up to Week 52)|Adverse Event|1|||
131240744|NCT05763875|472504467|FG001|Overall Study|Adverse Event|0|||
131240745|NCT05763875|472504468|FG002|Overall Study|Adverse Event|0|||
131240746|NCT00336024|472504469|FG000|Overall Study|Death|2|||
131240747|NCT00336024|472504470|FG001|Overall Study|Death|1|||
131240748|NCT00336024|472504469|FG000|Overall Study|Physician Decision|4|||
131186364|NCT04179032|472304437|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
131186365|NCT04179032|472304437|FG000|Access Extension Phase|Ongoing|11|||
131186366|NCT01998958|472304438|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186367|NCT01998958|472304439|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
131186368|NCT01998958|472304440|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186369|NCT01998958|472304441|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186370|NCT01998958|472304442|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186371|NCT01998958|472304443|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186372|NCT01998958|472304444|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186373|NCT01998958|472304445|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186374|NCT01998958|472304446|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186375|NCT01998958|472304447|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186376|NCT01998958|472304448|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186377|NCT01998958|472304449|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186378|NCT01998958|472304450|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186379|NCT01998958|472304451|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186380|NCT01998958|472304452|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186381|NCT01998958|472304453|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186382|NCT01998958|472304454|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186383|NCT01998958|472304455|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186384|NCT01998958|472304456|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186385|NCT01998958|472304457|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186386|NCT01998958|472304458|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186387|NCT01998958|472304459|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186388|NCT01998958|472304460|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186389|NCT01998958|472304461|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186390|NCT01998958|472304462|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186391|NCT01998958|472304463|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186392|NCT01998958|472304464|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186393|NCT01998958|472304465|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186394|NCT01998958|472304466|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186395|NCT01998958|472304467|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186396|NCT01998958|472304468|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186397|NCT01998958|472304469|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
131186398|NCT01998958|472304438|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186399|NCT01998958|472304439|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
131186400|NCT01998958|472304440|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186401|NCT01998958|472304441|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186402|NCT01998958|472304442|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186403|NCT01998958|472304443|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186404|NCT01998958|472304444|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186405|NCT01998958|472304445|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186406|NCT01998958|472304446|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186407|NCT01998958|472304447|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131240749|NCT00336024|472504470|FG001|Overall Study|Physician Decision|1|||
131240750|NCT00336024|472504469|FG000|Overall Study|Protocol Violation|1|||
131240751|NCT00336024|472504470|FG001|Overall Study|Protocol Violation|0|||
131240752|NCT00336024|472504469|FG000|Overall Study|Withdrawal by Subject|1|||
131240753|NCT00336024|472504470|FG001|Overall Study|Withdrawal by Subject|2|||
131240754|NCT00336024|472504469|FG000|Overall Study|Failure to fulfill consolidation|1|||
131240755|NCT00336024|472504470|FG001|Overall Study|Failure to fulfill consolidation|1|||
130733537|NCT05026177|470642911|FG000|Overall Study|Study terminated by sponsor|70|||
131186408|NCT01998958|472304448|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186409|NCT01998958|472304449|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131240756|NCT00336024|472504469|FG000|Overall Study|Progressive Disease|4|||
131240757|NCT00336024|472504470|FG001|Overall Study|Progressive Disease|7|||
131240758|NCT00336024|472504469|FG000|Overall Study|Ineligible|7|||
131240759|NCT00336024|472504470|FG001|Overall Study|Ineligible|7|||
131186410|NCT01998958|472304450|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186411|NCT01998958|472304451|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186412|NCT01998958|472304452|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186413|NCT01998958|472304453|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186414|NCT01998958|472304454|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186415|NCT01998958|472304455|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186416|NCT01998958|472304456|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186417|NCT01998958|472304457|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186418|NCT01998958|472304458|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186419|NCT01998958|472304459|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186420|NCT01998958|472304460|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186421|NCT01998958|472304461|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186422|NCT01998958|472304462|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186423|NCT01998958|472304463|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186424|NCT01998958|472304464|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186425|NCT01998958|472304465|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186426|NCT01998958|472304466|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186427|NCT01998958|472304467|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186428|NCT01998958|472304468|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186429|NCT01998958|472304469|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
131186430|NCT01998958|472304438|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
131186431|NCT01998958|472304439|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
131186432|NCT01998958|472304440|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
131186433|NCT01998958|472304441|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
131186434|NCT01998958|472304442|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
131186435|NCT01998958|472304443|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
131186436|NCT01998958|472304444|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
131186437|NCT01998958|472304445|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
131186438|NCT01998958|472304446|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
131186439|NCT01998958|472304447|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
131186440|NCT01998958|472304448|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
131186441|NCT01998958|472304449|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
131186442|NCT01998958|472304450|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
131186443|NCT01998958|472304451|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
131186444|NCT01998958|472304452|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
131186445|NCT01998958|472304453|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
131186446|NCT01998958|472304454|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
131186447|NCT01998958|472304455|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
131186448|NCT01998958|472304456|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
131186449|NCT01998958|472304457|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
131186450|NCT01998958|472304458|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
131186451|NCT01998958|472304459|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
131186452|NCT01998958|472304460|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
131186453|NCT01998958|472304461|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
131186454|NCT01998958|472304462|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
131186455|NCT01998958|472304463|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
131186456|NCT01998958|472304464|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
131186457|NCT01998958|472304465|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
131186458|NCT01998958|472304466|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
131186459|NCT01998958|472304467|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
131186460|NCT01998958|472304468|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
131186461|NCT01998958|472304469|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
131186462|NCT01998958|472304438|FG000|Period 1 (Panel A and B)|Other|1|||
131186463|NCT01998958|472304439|FG001|Period 1 (Panel A and B)|Other|0|||
131186464|NCT01998958|472304440|FG002|Period 1 (Panel A and B)|Other|0|||
131186465|NCT01998958|472304441|FG003|Period 1 (Panel A and B)|Other|0|||
131186466|NCT01998958|472304442|FG004|Period 1 (Panel A and B)|Other|0|||
131186467|NCT01998958|472304443|FG005|Period 1 (Panel A and B)|Other|0|||
131186468|NCT01998958|472304444|FG006|Period 1 (Panel A and B)|Other|0|||
131186469|NCT01998958|472304445|FG007|Period 1 (Panel A and B)|Other|0|||
131186470|NCT01998958|472304446|FG008|Period 1 (Panel A and B)|Other|0|||
131186471|NCT01998958|472304447|FG009|Period 1 (Panel A and B)|Other|0|||
131186472|NCT01998958|472304448|FG010|Period 1 (Panel A and B)|Other|0|||
131186473|NCT01998958|472304449|FG011|Period 1 (Panel A and B)|Other|0|||
131186474|NCT01998958|472304450|FG012|Period 1 (Panel A and B)|Other|0|||
131186475|NCT01998958|472304451|FG013|Period 1 (Panel A and B)|Other|0|||
131186476|NCT01998958|472304452|FG014|Period 1 (Panel A and B)|Other|0|||
131186477|NCT01998958|472304453|FG015|Period 1 (Panel A and B)|Other|0|||
131186478|NCT01998958|472304454|FG016|Period 1 (Panel A and B)|Other|0|||
131186479|NCT01998958|472304455|FG017|Period 1 (Panel A and B)|Other|0|||
131186480|NCT01998958|472304456|FG018|Period 1 (Panel A and B)|Other|0|||
131186481|NCT01998958|472304457|FG019|Period 1 (Panel A and B)|Other|0|||
131186482|NCT01998958|472304458|FG020|Period 1 (Panel A and B)|Other|0|||
131186483|NCT01998958|472304459|FG021|Period 1 (Panel A and B)|Other|0|||
130733538|NCT05026177|470642912|FG001|Overall Study|Study terminated by sponsor|74|||
131186484|NCT01998958|472304460|FG022|Period 1 (Panel A and B)|Other|0|||
131186485|NCT01998958|472304461|FG023|Period 1 (Panel A and B)|Other|0|||
131186486|NCT01998958|472304462|FG024|Period 1 (Panel A and B)|Other|0|||
131186487|NCT01998958|472304463|FG025|Period 1 (Panel A and B)|Other|0|||
131186488|NCT01998958|472304464|FG026|Period 1 (Panel A and B)|Other|0|||
131186489|NCT01998958|472304465|FG027|Period 1 (Panel A and B)|Other|0|||
131186490|NCT01998958|472304466|FG028|Period 1 (Panel A and B)|Other|0|||
131186491|NCT01998958|472304467|FG029|Period 1 (Panel A and B)|Other|0|||
131186492|NCT01998958|472304468|FG030|Period 1 (Panel A and B)|Other|0|||
131186493|NCT01998958|472304469|FG031|Period 1 (Panel A and B)|Other|0|||
131186494|NCT01998958|472304438|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
131186495|NCT01998958|472304439|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
131186496|NCT01998958|472304440|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
131186497|NCT01998958|472304441|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
131186498|NCT01998958|472304442|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
131186499|NCT01998958|472304443|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
131186500|NCT01998958|472304444|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
131186501|NCT01998958|472304445|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
131186502|NCT01998958|472304446|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
131186503|NCT01998958|472304447|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
131186504|NCT01998958|472304448|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
131186505|NCT01998958|472304449|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
131186506|NCT01998958|472304450|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
131186507|NCT01998958|472304451|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
131186508|NCT01998958|472304452|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
131186509|NCT01998958|472304453|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
131186510|NCT01998958|472304454|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
131186511|NCT01998958|472304455|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
131186512|NCT01998958|472304456|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
131186513|NCT01998958|472304457|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
131186514|NCT01998958|472304458|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
131186515|NCT01998958|472304459|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
131186516|NCT01998958|472304460|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
131186517|NCT01998958|472304461|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
131186518|NCT01998958|472304462|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
131186519|NCT01998958|472304463|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
131186520|NCT01998958|472304464|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
131186521|NCT01998958|472304465|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
131186522|NCT01998958|472304466|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
131186523|NCT01998958|472304467|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
131186524|NCT01998958|472304468|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
131186525|NCT01998958|472304469|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
131186526|NCT01998958|472304438|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186527|NCT01998958|472304439|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186528|NCT01998958|472304440|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186529|NCT01998958|472304441|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186530|NCT01998958|472304442|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186531|NCT01998958|472304443|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186532|NCT01998958|472304444|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186533|NCT01998958|472304445|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186534|NCT01998958|472304446|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186535|NCT01998958|472304447|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186536|NCT01998958|472304448|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186537|NCT01998958|472304449|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186538|NCT01998958|472304450|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186539|NCT01998958|472304451|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186540|NCT01998958|472304452|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
131186541|NCT01998958|472304453|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186542|NCT01998958|472304454|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186543|NCT01998958|472304455|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186544|NCT01998958|472304456|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
131186545|NCT01998958|472304457|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186546|NCT01998958|472304458|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186547|NCT01998958|472304459|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186548|NCT01998958|472304460|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186549|NCT01998958|472304461|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186550|NCT01998958|472304462|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186551|NCT01998958|472304463|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186552|NCT01998958|472304464|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186553|NCT01998958|472304465|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186554|NCT01998958|472304466|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186555|NCT01998958|472304467|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186556|NCT01998958|472304468|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186557|NCT01998958|472304469|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
131186558|NCT01998958|472304438|FG000|Open Label Phase (Optional)|Adverse Event|0|||
131186559|NCT01998958|472304439|FG001|Open Label Phase (Optional)|Adverse Event|0|||
131186560|NCT01998958|472304440|FG002|Open Label Phase (Optional)|Adverse Event|0|||
131186561|NCT01998958|472304441|FG003|Open Label Phase (Optional)|Adverse Event|0|||
131186562|NCT01998958|472304442|FG004|Open Label Phase (Optional)|Adverse Event|0|||
131186563|NCT01998958|472304443|FG005|Open Label Phase (Optional)|Adverse Event|0|||
131186564|NCT01998958|472304444|FG006|Open Label Phase (Optional)|Adverse Event|0|||
131186565|NCT01998958|472304445|FG007|Open Label Phase (Optional)|Adverse Event|0|||
131186566|NCT01998958|472304446|FG008|Open Label Phase (Optional)|Adverse Event|0|||
131186567|NCT01998958|472304447|FG009|Open Label Phase (Optional)|Adverse Event|0|||
131186568|NCT01998958|472304448|FG010|Open Label Phase (Optional)|Adverse Event|0|||
131186569|NCT01998958|472304449|FG011|Open Label Phase (Optional)|Adverse Event|0|||
131186570|NCT01998958|472304450|FG012|Open Label Phase (Optional)|Adverse Event|0|||
131186571|NCT01998958|472304451|FG013|Open Label Phase (Optional)|Adverse Event|0|||
131186572|NCT01998958|472304452|FG014|Open Label Phase (Optional)|Adverse Event|0|||
131186573|NCT01998958|472304453|FG015|Open Label Phase (Optional)|Adverse Event|0|||
131186574|NCT01998958|472304454|FG016|Open Label Phase (Optional)|Adverse Event|0|||
131186575|NCT01998958|472304455|FG017|Open Label Phase (Optional)|Adverse Event|0|||
131186576|NCT01998958|472304456|FG018|Open Label Phase (Optional)|Adverse Event|0|||
131186577|NCT01998958|472304457|FG019|Open Label Phase (Optional)|Adverse Event|0|||
131186578|NCT01998958|472304458|FG020|Open Label Phase (Optional)|Adverse Event|0|||
131186579|NCT01998958|472304459|FG021|Open Label Phase (Optional)|Adverse Event|0|||
131186580|NCT01998958|472304460|FG022|Open Label Phase (Optional)|Adverse Event|0|||
131186581|NCT01998958|472304461|FG023|Open Label Phase (Optional)|Adverse Event|1|||
131186582|NCT01998958|472304462|FG024|Open Label Phase (Optional)|Adverse Event|0|||
131186583|NCT01998958|472304463|FG025|Open Label Phase (Optional)|Adverse Event|0|||
131186584|NCT01998958|472304464|FG026|Open Label Phase (Optional)|Adverse Event|0|||
131186585|NCT01998958|472304465|FG027|Open Label Phase (Optional)|Adverse Event|0|||
131186586|NCT01998958|472304466|FG028|Open Label Phase (Optional)|Adverse Event|0|||
131186587|NCT01998958|472304467|FG029|Open Label Phase (Optional)|Adverse Event|0|||
131186588|NCT01998958|472304468|FG030|Open Label Phase (Optional)|Adverse Event|0|||
131186589|NCT01998958|472304469|FG031|Open Label Phase (Optional)|Adverse Event|0|||
131186590|NCT01998958|472304438|FG000|Open Label Phase (Optional)|Other|0|||
131186591|NCT01998958|472304439|FG001|Open Label Phase (Optional)|Other|0|||
131186592|NCT01998958|472304440|FG002|Open Label Phase (Optional)|Other|0|||
131186593|NCT01998958|472304441|FG003|Open Label Phase (Optional)|Other|0|||
131186594|NCT01998958|472304442|FG004|Open Label Phase (Optional)|Other|0|||
131186595|NCT01998958|472304443|FG005|Open Label Phase (Optional)|Other|0|||
131186596|NCT01998958|472304444|FG006|Open Label Phase (Optional)|Other|0|||
131186597|NCT01998958|472304445|FG007|Open Label Phase (Optional)|Other|0|||
131186598|NCT01998958|472304446|FG008|Open Label Phase (Optional)|Other|0|||
131186599|NCT01998958|472304447|FG009|Open Label Phase (Optional)|Other|0|||
131186600|NCT01998958|472304448|FG010|Open Label Phase (Optional)|Other|0|||
131186601|NCT01998958|472304449|FG011|Open Label Phase (Optional)|Other|0|||
131186602|NCT01998958|472304450|FG012|Open Label Phase (Optional)|Other|0|||
131186603|NCT01998958|472304451|FG013|Open Label Phase (Optional)|Other|0|||
131186604|NCT01998958|472304452|FG014|Open Label Phase (Optional)|Other|0|||
131186605|NCT01998958|472304453|FG015|Open Label Phase (Optional)|Other|0|||
131186606|NCT01998958|472304454|FG016|Open Label Phase (Optional)|Other|0|||
131240760|NCT03978637|472504471|FG000|Overall Study|Death|0|||
131240761|NCT03978637|472504472|FG001|Overall Study|Death|2|||
131240762|NCT03978637|472504473|FG002|Overall Study|Death|2|||
131240763|NCT03978637|472504474|FG003|Overall Study|Death|0|||
131240764|NCT03978637|472504471|FG000|Overall Study|Withdrawal by Subject|0|||
131240765|NCT03978637|472504472|FG001|Overall Study|Withdrawal by Subject|0|||
131240766|NCT03978637|472504473|FG002|Overall Study|Withdrawal by Subject|1|||
131186607|NCT01998958|472304455|FG017|Open Label Phase (Optional)|Other|0|||
131186608|NCT01998958|472304456|FG018|Open Label Phase (Optional)|Other|0|||
131186609|NCT01998958|472304457|FG019|Open Label Phase (Optional)|Other|0|||
131186610|NCT01998958|472304458|FG020|Open Label Phase (Optional)|Other|0|||
131186611|NCT01998958|472304459|FG021|Open Label Phase (Optional)|Other|0|||
131240767|NCT03978637|472504474|FG003|Overall Study|Withdrawal by Subject|0|||
130733539|NCT05026177|470642913|FG002|Overall Study|Study terminated by sponsor|67|||
131186612|NCT01998958|472304460|FG022|Open Label Phase (Optional)|Other|5|||
131186613|NCT01998958|472304461|FG023|Open Label Phase (Optional)|Other|1|||
131186614|NCT01998958|472304462|FG024|Open Label Phase (Optional)|Other|0|||
131186615|NCT01998958|472304463|FG025|Open Label Phase (Optional)|Other|0|||
131186616|NCT01998958|472304464|FG026|Open Label Phase (Optional)|Other|0|||
131186617|NCT01998958|472304465|FG027|Open Label Phase (Optional)|Other|0|||
131186618|NCT01998958|472304466|FG028|Open Label Phase (Optional)|Other|0|||
131186619|NCT01998958|472304467|FG029|Open Label Phase (Optional)|Other|0|||
131186620|NCT01998958|472304468|FG030|Open Label Phase (Optional)|Other|0|||
131186621|NCT01998958|472304469|FG031|Open Label Phase (Optional)|Other|0|||
131186622|NCT01998958|472304438|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
130733540|NCT05026177|470642911|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
131186623|NCT01998958|472304439|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
131240768|NCT03978637|472504471|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
131240769|NCT03978637|472504472|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
131186624|NCT01998958|472304440|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186625|NCT01998958|472304441|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186626|NCT01998958|472304442|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186627|NCT01998958|472304443|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186628|NCT01998958|472304444|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186629|NCT01998958|472304445|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186630|NCT01998958|472304446|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186631|NCT01998958|472304447|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186632|NCT01998958|472304448|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186633|NCT01998958|472304449|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186634|NCT01998958|472304450|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186635|NCT01998958|472304451|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186636|NCT01998958|472304452|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186637|NCT01998958|472304453|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186638|NCT01998958|472304454|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186639|NCT01998958|472304455|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186640|NCT01998958|472304456|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186641|NCT01998958|472304457|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186642|NCT01998958|472304458|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186643|NCT01998958|472304459|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186644|NCT01998958|472304460|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
131186645|NCT01998958|472304461|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186646|NCT01998958|472304462|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186647|NCT01998958|472304463|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186648|NCT01998958|472304464|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186649|NCT01998958|472304465|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186650|NCT01998958|472304466|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186651|NCT01998958|472304467|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186652|NCT01998958|472304468|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186653|NCT01998958|472304469|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
131186654|NCT01998958|472304438|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186655|NCT01998958|472304439|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186656|NCT01998958|472304440|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186657|NCT01998958|472304441|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186658|NCT01998958|472304442|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186659|NCT01998958|472304443|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186660|NCT01998958|472304444|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186661|NCT01998958|472304445|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186662|NCT01998958|472304446|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186663|NCT01998958|472304447|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186664|NCT01998958|472304448|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186665|NCT01998958|472304449|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186666|NCT01998958|472304450|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186667|NCT01998958|472304451|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186668|NCT01998958|472304452|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186669|NCT01998958|472304453|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186670|NCT01998958|472304454|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186671|NCT01998958|472304455|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186672|NCT01998958|472304456|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186673|NCT01998958|472304457|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186674|NCT01998958|472304458|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186675|NCT01998958|472304459|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
131186676|NCT01998958|472304460|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
131186677|NCT01998958|472304461|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186678|NCT01998958|472304462|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186679|NCT01998958|472304463|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186680|NCT01998958|472304464|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186681|NCT01998958|472304465|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186682|NCT01998958|472304466|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186683|NCT01998958|472304467|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186684|NCT01998958|472304468|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186685|NCT01998958|472304469|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
131186686|NCT01998958|472304438|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186687|NCT01998958|472304439|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186688|NCT01998958|472304440|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186689|NCT01998958|472304441|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186690|NCT01998958|472304442|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186691|NCT01998958|472304443|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186692|NCT01998958|472304444|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186693|NCT01998958|472304445|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186694|NCT01998958|472304446|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186695|NCT01998958|472304447|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186696|NCT01998958|472304448|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186697|NCT01998958|472304449|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186698|NCT01998958|472304450|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186699|NCT01998958|472304451|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186700|NCT01998958|472304452|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186701|NCT01998958|472304453|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186702|NCT01998958|472304454|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186703|NCT01998958|472304455|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186704|NCT01998958|472304456|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186705|NCT01998958|472304457|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186706|NCT01998958|472304458|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186707|NCT01998958|472304459|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
131186708|NCT01998958|472304460|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
131186709|NCT01998958|472304461|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
131186710|NCT01998958|472304462|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186711|NCT01998958|472304463|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186712|NCT01998958|472304464|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186713|NCT01998958|472304465|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186714|NCT01998958|472304466|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186715|NCT01998958|472304467|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186716|NCT01998958|472304468|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186717|NCT01998958|472304469|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
131186718|NCT02432703|472304470|FG000|Overall Study|Adverse Event|1|||
131186719|NCT02432703|472304471|FG001|Overall Study|Adverse Event|4|||
131186720|NCT02432703|472304470|FG000|Overall Study|Lack of Efficacy|1|||
131186721|NCT02432703|472304471|FG001|Overall Study|Lack of Efficacy|0|||
131186722|NCT02432703|472304470|FG000|Overall Study|Lost to Follow-up|5|||
131186723|NCT02432703|472304471|FG001|Overall Study|Lost to Follow-up|3|||
131186724|NCT02432703|472304470|FG000|Overall Study|Withdrawal by Subject|9|||
131186725|NCT02432703|472304471|FG001|Overall Study|Withdrawal by Subject|6|||
131186726|NCT02432703|472304470|FG000|Overall Study|Other|6|||
131186727|NCT02432703|472304471|FG001|Overall Study|Other|5|||
131186728|NCT01628393|472304472|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
131186729|NCT01628393|472304473|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131186730|NCT01628393|472304474|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131186731|NCT01628393|472304475|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131186732|NCT01628393|472304476|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
131186733|NCT01628393|472304472|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
131186734|NCT01628393|472304473|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
131186735|NCT01628393|472304474|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
131186736|NCT01628393|472304475|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
131186737|NCT01628393|472304476|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
131186738|NCT01628393|472304472|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
131186739|NCT01628393|472304473|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
131186740|NCT01628393|472304474|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
131186741|NCT01628393|472304475|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
131186742|NCT01628393|472304476|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
131186743|NCT01628393|472304472|FG000|Blinded Active Extension Period|Adverse Event|0|||
131186744|NCT01628393|472304473|FG001|Blinded Active Extension Period|Adverse Event|1|||
131186745|NCT01628393|472304474|FG002|Blinded Active Extension Period|Adverse Event|0|||
131186746|NCT01628393|472304475|FG003|Blinded Active Extension Period|Adverse Event|2|||
131186747|NCT01628393|472304476|FG004|Blinded Active Extension Period|Adverse Event|2|||
131186748|NCT01628393|472304472|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
131186749|NCT01628393|472304473|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
131186750|NCT01628393|472304474|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
131186751|NCT01628393|472304475|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
131186752|NCT01628393|472304476|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
131186753|NCT01628393|472304472|FG000|Blinded Active Extension Period|Physician Decision|0|||
131186754|NCT01628393|472304473|FG001|Blinded Active Extension Period|Physician Decision|3|||
131186755|NCT01628393|472304474|FG002|Blinded Active Extension Period|Physician Decision|0|||
131186756|NCT01628393|472304475|FG003|Blinded Active Extension Period|Physician Decision|1|||
131186757|NCT01628393|472304476|FG004|Blinded Active Extension Period|Physician Decision|0|||
131186758|NCT01628393|472304472|FG000|Blinded Active Extension Period|Protocol Violation|0|||
131186759|NCT01628393|472304473|FG001|Blinded Active Extension Period|Protocol Violation|0|||
131186760|NCT01628393|472304474|FG002|Blinded Active Extension Period|Protocol Violation|2|||
131186761|NCT01628393|472304475|FG003|Blinded Active Extension Period|Protocol Violation|1|||
131186762|NCT01628393|472304476|FG004|Blinded Active Extension Period|Protocol Violation|0|||
131186763|NCT01628393|472304472|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
131186764|NCT01628393|472304473|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
131186765|NCT01628393|472304474|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
131186766|NCT01628393|472304475|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
131186767|NCT01628393|472304476|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
131186768|NCT00445341|472304477|FG000|Overall Study|refused further treatment|1|||
131186769|NCT00445341|472304477|FG000|Overall Study|taken off treatment too early|1|||
131186770|NCT01831804|472304480|FG000|Overall Study|Adverse Event|0|||
131186771|NCT01831804|472304481|FG001|Overall Study|Adverse Event|0|||
131186772|NCT01831804|472304482|FG002|Overall Study|Adverse Event|0|||
131186773|NCT01831804|472304483|FG003|Overall Study|Adverse Event|0|||
131186774|NCT01831804|472304484|FG004|Overall Study|Adverse Event|0|||
131186775|NCT01831804|472304485|FG005|Overall Study|Adverse Event|0|||
131186776|NCT01831804|472304486|FG006|Overall Study|Adverse Event|1|||
131186777|NCT01831804|472304487|FG007|Overall Study|Adverse Event|0|||
131186778|NCT01831804|472304488|FG008|Overall Study|Adverse Event|1|||
131186779|NCT01831804|472304480|FG000|Overall Study|Protocol Violation|0|||
131186780|NCT01831804|472304481|FG001|Overall Study|Protocol Violation|0|||
131186781|NCT01831804|472304482|FG002|Overall Study|Protocol Violation|2|||
131186782|NCT01831804|472304483|FG003|Overall Study|Protocol Violation|0|||
131186783|NCT01831804|472304484|FG004|Overall Study|Protocol Violation|0|||
131186784|NCT01831804|472304485|FG005|Overall Study|Protocol Violation|0|||
131186785|NCT01831804|472304486|FG006|Overall Study|Protocol Violation|0|||
131186786|NCT01831804|472304487|FG007|Overall Study|Protocol Violation|0|||
131186787|NCT01831804|472304488|FG008|Overall Study|Protocol Violation|0|||
131186788|NCT01831804|472304480|FG000|Overall Study|Protocol defined stopping criteria|1|||
131186789|NCT01831804|472304481|FG001|Overall Study|Protocol defined stopping criteria|1|||
131186790|NCT01831804|472304482|FG002|Overall Study|Protocol defined stopping criteria|3|||
131186791|NCT01831804|472304483|FG003|Overall Study|Protocol defined stopping criteria|0|||
131186792|NCT01831804|472304484|FG004|Overall Study|Protocol defined stopping criteria|1|||
131186793|NCT01831804|472304485|FG005|Overall Study|Protocol defined stopping criteria|0|||
131186794|NCT01831804|472304486|FG006|Overall Study|Protocol defined stopping criteria|0|||
131186795|NCT01831804|472304487|FG007|Overall Study|Protocol defined stopping criteria|0|||
131186796|NCT01831804|472304488|FG008|Overall Study|Protocol defined stopping criteria|0|||
131186797|NCT01831804|472304480|FG000|Overall Study|Lost to Follow-up|0|||
131186798|NCT01831804|472304481|FG001|Overall Study|Lost to Follow-up|0|||
131186799|NCT01831804|472304482|FG002|Overall Study|Lost to Follow-up|1|||
131186800|NCT01831804|472304483|FG003|Overall Study|Lost to Follow-up|0|||
131186801|NCT01831804|472304484|FG004|Overall Study|Lost to Follow-up|0|||
131186802|NCT01831804|472304485|FG005|Overall Study|Lost to Follow-up|0|||
131186803|NCT01831804|472304486|FG006|Overall Study|Lost to Follow-up|0|||
131186804|NCT01831804|472304487|FG007|Overall Study|Lost to Follow-up|0|||
131186805|NCT01831804|472304488|FG008|Overall Study|Lost to Follow-up|1|||
131186806|NCT01831804|472304480|FG000|Overall Study|Investigator discretion|0|||
131186807|NCT01831804|472304481|FG001|Overall Study|Investigator discretion|0|||
131186808|NCT01831804|472304482|FG002|Overall Study|Investigator discretion|0|||
131186809|NCT01831804|472304483|FG003|Overall Study|Investigator discretion|0|||
131186810|NCT01831804|472304484|FG004|Overall Study|Investigator discretion|1|||
131186811|NCT01831804|472304485|FG005|Overall Study|Investigator discretion|0|||
131186812|NCT01831804|472304486|FG006|Overall Study|Investigator discretion|0|||
131186813|NCT01831804|472304487|FG007|Overall Study|Investigator discretion|1|||
131186814|NCT01831804|472304488|FG008|Overall Study|Investigator discretion|0|||
131186815|NCT01831804|472304480|FG000|Overall Study|Withdrew Consent|0|||
131186816|NCT01831804|472304481|FG001|Overall Study|Withdrew Consent|1|||
131186817|NCT01831804|472304482|FG002|Overall Study|Withdrew Consent|0|||
131186818|NCT01831804|472304483|FG003|Overall Study|Withdrew Consent|0|||
131186819|NCT01831804|472304484|FG004|Overall Study|Withdrew Consent|0|||
131186820|NCT01831804|472304485|FG005|Overall Study|Withdrew Consent|0|||
131186821|NCT01831804|472304486|FG006|Overall Study|Withdrew Consent|0|||
131186822|NCT01831804|472304487|FG007|Overall Study|Withdrew Consent|2|||
131186823|NCT01831804|472304488|FG008|Overall Study|Withdrew Consent|0|||
131186824|NCT00968708|472304490|FG000|Overall Study|Adverse Event|169|||
131186825|NCT00968708|472304491|FG001|Overall Study|Adverse Event|150|||
131186826|NCT00968708|472304490|FG000|Overall Study|Major Protocol Deviation|0|||
131186827|NCT00968708|472304491|FG001|Overall Study|Major Protocol Deviation|1|||
131186828|NCT00968708|472304490|FG000|Overall Study|Lost to Follow-up|19|||
131186829|NCT00968708|472304491|FG001|Overall Study|Lost to Follow-up|11|||
131186830|NCT00968708|472304490|FG000|Overall Study|Voluntary Withdrawal|104|||
131186831|NCT00968708|472304491|FG001|Overall Study|Voluntary Withdrawal|101|||
131186832|NCT00968708|472304490|FG000|Overall Study|Investigator Discretion|0|||
131186833|NCT00968708|472304491|FG001|Overall Study|Investigator Discretion|1|||
131186834|NCT00968708|472304490|FG000|Overall Study|Other|26|||
131186835|NCT00968708|472304491|FG001|Overall Study|Other|34|||
131186836|NCT02023268|472304492|FG000|Overall Study|Lack of Efficacy|0|||
131186837|NCT02023268|472304493|FG001|Overall Study|Lack of Efficacy|1|||
131186838|NCT02023268|472304492|FG000|Overall Study|Adverse Event|0|||
131186839|NCT02023268|472304493|FG001|Overall Study|Adverse Event|2|||
131186840|NCT02023268|472304492|FG000|Overall Study|Withdrawal by Subject|0|||
131186841|NCT02023268|472304493|FG001|Overall Study|Withdrawal by Subject|1|||
131186842|NCT03407170|472304494|FG000|Overall Study|Adverse Event|1|||
131186843|NCT00615459|472304497|FG000|Period I|Adverse Event|2|||
131186844|NCT00615459|472304498|FG001|Period I|Adverse Event|0|||
131186845|NCT00615459|472304499|FG002|Period I|Adverse Event|1|||
131186846|NCT00615459|472304500|FG003|Period I|Adverse Event|0|||
131186847|NCT00615459|472304497|FG000|Period I|Subject withdrew consent|1|||
131186848|NCT00615459|472304498|FG001|Period I|Subject withdrew consent|0|||
131186849|NCT00615459|472304499|FG002|Period I|Subject withdrew consent|0|||
131186850|NCT00615459|472304500|FG003|Period I|Subject withdrew consent|1|||
131186851|NCT00615459|472304497|FG000|Period I|Abnormal test procedure results|1|||
131186852|NCT00615459|472304498|FG001|Period I|Abnormal test procedure results|1|||
131186853|NCT00615459|472304499|FG002|Period I|Abnormal test procedure results|1|||
131186854|NCT00615459|472304500|FG003|Period I|Abnormal test procedure results|0|||
131186855|NCT00615459|472304497|FG000|Period II|Adverse Event|1|||
131186856|NCT00615459|472304498|FG001|Period II|Adverse Event|0|||
131186857|NCT00615459|472304499|FG002|Period II|Adverse Event|0|||
131186858|NCT00615459|472304500|FG003|Period II|Adverse Event|0|||
131186859|NCT00615459|472304497|FG000|Period II|Lost to Follow-up|0|||
131186860|NCT00615459|472304498|FG001|Period II|Lost to Follow-up|0|||
131186861|NCT00615459|472304499|FG002|Period II|Lost to Follow-up|0|||
131186862|NCT00615459|472304500|FG003|Period II|Lost to Follow-up|1|||
131186863|NCT00615459|472304497|FG000|Period III|Adverse Event|0|||
131186864|NCT00615459|472304498|FG001|Period III|Adverse Event|1|||
131186865|NCT00615459|472304499|FG002|Period III|Adverse Event|0|||
131186866|NCT00615459|472304500|FG003|Period III|Adverse Event|0|||
131186867|NCT00615459|472304497|FG000|Period III|Administrative problems|0|||
131186868|NCT00615459|472304498|FG001|Period III|Administrative problems|1|||
131186869|NCT00615459|472304499|FG002|Period III|Administrative problems|1|||
131186870|NCT00615459|472304500|FG003|Period III|Administrative problems|0|||
131186871|NCT00615459|472304497|FG000|Period III|Unsatisfactory therapeutic effect|0|||
131186872|NCT00615459|472304498|FG001|Period III|Unsatisfactory therapeutic effect|1|||
131186873|NCT00615459|472304499|FG002|Period III|Unsatisfactory therapeutic effect|0|||
131186874|NCT00615459|472304500|FG003|Period III|Unsatisfactory therapeutic effect|0|||
131186875|NCT01851863|472304503|FG000|Overall Study|Did not receive study medication|2|||
131186876|NCT01851863|472304504|FG001|Overall Study|Did not receive study medication|5|||
131186877|NCT01851863|472304505|FG002|Overall Study|Did not receive study medication|3|||
131186878|NCT01851863|472304506|FG003|Overall Study|Did not receive study medication|0|||
131186879|NCT01851863|472304503|FG000|Overall Study|Lost to Follow-up|3|||
131186880|NCT01851863|472304504|FG001|Overall Study|Lost to Follow-up|4|||
131186881|NCT01851863|472304505|FG002|Overall Study|Lost to Follow-up|2|||
131186882|NCT01851863|472304506|FG003|Overall Study|Lost to Follow-up|3|||
131186883|NCT03238352|472304507|FG000|Overall Study|Lost to Follow-up|0|||
131186884|NCT03238352|472304508|FG001|Overall Study|Lost to Follow-up|2|||
131186885|NCT03238352|472304509|FG002|Overall Study|Lost to Follow-up|1|||
131186886|NCT03238352|472304507|FG000|Overall Study|Withdrawal by Subject|0|||
131186887|NCT03238352|472304508|FG001|Overall Study|Withdrawal by Subject|1|||
131186888|NCT03238352|472304509|FG002|Overall Study|Withdrawal by Subject|0|||
131186889|NCT00928512|472304510|FG000|Overall Study|Adverse Event|4|||
131186890|NCT00928512|472304511|FG001|Overall Study|Adverse Event|3|||
131186891|NCT00928512|472304512|FG002|Overall Study|Adverse Event|2|||
131186892|NCT00928512|472304513|FG003|Overall Study|Adverse Event|8|||
131186893|NCT00928512|472304514|FG004|Overall Study|Adverse Event|6|||
131186894|NCT00928512|472304510|FG000|Overall Study|Lack of Efficacy|2|||
131186895|NCT00928512|472304511|FG001|Overall Study|Lack of Efficacy|0|||
131186896|NCT00928512|472304512|FG002|Overall Study|Lack of Efficacy|4|||
131186897|NCT00928512|472304513|FG003|Overall Study|Lack of Efficacy|7|||
131186898|NCT00928512|472304514|FG004|Overall Study|Lack of Efficacy|3|||
131186899|NCT00928512|472304510|FG000|Overall Study|Protocol Violation|0|||
131186900|NCT00928512|472304511|FG001|Overall Study|Protocol Violation|1|||
131186901|NCT00928512|472304512|FG002|Overall Study|Protocol Violation|0|||
131186902|NCT00928512|472304513|FG003|Overall Study|Protocol Violation|1|||
131186903|NCT00928512|472304514|FG004|Overall Study|Protocol Violation|3|||
131186904|NCT00928512|472304510|FG000|Overall Study|Withdrawal by Subject|3|||
131186905|NCT00928512|472304511|FG001|Overall Study|Withdrawal by Subject|0|||
131186906|NCT00928512|472304512|FG002|Overall Study|Withdrawal by Subject|3|||
131186907|NCT00928512|472304513|FG003|Overall Study|Withdrawal by Subject|4|||
131186908|NCT00928512|472304514|FG004|Overall Study|Withdrawal by Subject|0|||
131186909|NCT00928512|472304510|FG000|Overall Study|Lost to Follow-up|1|||
131186910|NCT00928512|472304511|FG001|Overall Study|Lost to Follow-up|1|||
131186911|NCT00928512|472304512|FG002|Overall Study|Lost to Follow-up|2|||
131186912|NCT00928512|472304513|FG003|Overall Study|Lost to Follow-up|1|||
131186913|NCT00928512|472304514|FG004|Overall Study|Lost to Follow-up|3|||
131186914|NCT00928512|472304510|FG000|Overall Study|Administrative Problems|0|||
131240770|NCT03978637|472504473|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
131186915|NCT00928512|472304511|FG001|Overall Study|Administrative Problems|1|||
131186916|NCT00928512|472304512|FG002|Overall Study|Administrative Problems|0|||
131186917|NCT00928512|472304513|FG003|Overall Study|Administrative Problems|0|||
131186918|NCT00928512|472304514|FG004|Overall Study|Administrative Problems|0|||
131186919|NCT03383614|472304515|FG000|Overall Study|Withdrawal by Subject|0|||
131186920|NCT03383614|472304516|FG001|Overall Study|Withdrawal by Subject|1|||
131186921|NCT03383614|472304517|FG002|Overall Study|Withdrawal by Subject|0|||
131186922|NCT03383614|472304518|FG003|Overall Study|Withdrawal by Subject|0|||
131186923|NCT01975675|472304521|FG000|Overall Study|Death|0|||
131186924|NCT01975675|472304522|FG001|Overall Study|Death|1|||
131186925|NCT01975675|472304523|FG002|Overall Study|Death|0|||
131186926|NCT01975675|472304524|FG003|Overall Study|Death|0|||
131186927|NCT00224003|472304525|FG000|Overall Study|Adverse Event|1|||
131186928|NCT00224003|472304525|FG000|Overall Study|Protocol Violation|2|||
131186929|NCT00224003|472304525|FG000|Overall Study|Withdrawal by Subject|1|||
131186930|NCT00224003|472304525|FG000|Overall Study|unk|3|||
131186931|NCT00729326|472304528|FG000|Overall Study|Lost to Follow-up|2|||
131186932|NCT00729326|472304529|FG001|Overall Study|Lost to Follow-up|0|||
131186933|NCT00729326|472304528|FG000|Overall Study|Physician Decision|0|||
131186934|NCT00729326|472304529|FG001|Overall Study|Physician Decision|1|||
131186935|NCT00729326|472304528|FG000|Overall Study|Protocol Violation|3|||
131186936|NCT00729326|472304529|FG001|Overall Study|Protocol Violation|2|||
131186937|NCT00729326|472304528|FG000|Overall Study|Subject Decision|4|||
131186938|NCT00729326|472304529|FG001|Overall Study|Subject Decision|4|||
131186939|NCT00729326|472304528|FG000|Overall Study|Sponsor Decision|1|||
131186940|NCT00729326|472304529|FG001|Overall Study|Sponsor Decision|2|||
131186941|NCT03199638|472304539|FG000|Overall Study|inability to drink glutamine during regularly|0|||
131186942|NCT03199638|472304540|FG001|Overall Study|inability to drink glutamine during regularly|2|||
131186943|NCT03097029|472304541|FG000|Overall Study|Withdrawal by Subject|1|||
131186944|NCT02807844|472304542|FG000|Overall Study|Physician Decision|0|||
131186945|NCT02807844|472304543|FG001|Overall Study|Physician Decision|0|||
131186946|NCT02807844|472304544|FG002|Overall Study|Physician Decision|0|||
131186947|NCT02807844|472304545|FG003|Overall Study|Physician Decision|0|||
131186948|NCT02807844|472304546|FG004|Overall Study|Physician Decision|0|||
131186949|NCT02807844|472304547|FG005|Overall Study|Physician Decision|0|||
131186950|NCT02807844|472304548|FG006|Overall Study|Physician Decision|3|||
131186951|NCT02807844|472304549|FG007|Overall Study|Physician Decision|0|||
131186952|NCT02807844|472304550|FG008|Overall Study|Physician Decision|1|||
131186953|NCT02807844|472304551|FG009|Overall Study|Physician Decision|2|||
131186954|NCT02807844|472304542|FG000|Overall Study|Death|0|||
131186955|NCT02807844|472304543|FG001|Overall Study|Death|0|||
131186956|NCT02807844|472304544|FG002|Overall Study|Death|2|||
131186957|NCT02807844|472304545|FG003|Overall Study|Death|4|||
131186958|NCT02807844|472304546|FG004|Overall Study|Death|1|||
131186959|NCT02807844|472304547|FG005|Overall Study|Death|2|||
131186960|NCT02807844|472304548|FG006|Overall Study|Death|1|||
131186961|NCT02807844|472304549|FG007|Overall Study|Death|2|||
131186962|NCT02807844|472304550|FG008|Overall Study|Death|0|||
131186963|NCT02807844|472304551|FG009|Overall Study|Death|1|||
131186964|NCT02807844|472304542|FG000|Overall Study|Withdrawal by Subject|0|||
131186965|NCT02807844|472304543|FG001|Overall Study|Withdrawal by Subject|0|||
131186966|NCT02807844|472304544|FG002|Overall Study|Withdrawal by Subject|2|||
131186967|NCT02807844|472304545|FG003|Overall Study|Withdrawal by Subject|1|||
131186968|NCT02807844|472304546|FG004|Overall Study|Withdrawal by Subject|1|||
131186969|NCT02807844|472304547|FG005|Overall Study|Withdrawal by Subject|0|||
131186970|NCT02807844|472304548|FG006|Overall Study|Withdrawal by Subject|1|||
131186971|NCT02807844|472304549|FG007|Overall Study|Withdrawal by Subject|0|||
131186972|NCT02807844|472304550|FG008|Overall Study|Withdrawal by Subject|0|||
131186973|NCT02807844|472304551|FG009|Overall Study|Withdrawal by Subject|0|||
131186974|NCT02807844|472304542|FG000|Overall Study|Progressive disease|5|||
131186975|NCT02807844|472304543|FG001|Overall Study|Progressive disease|12|||
131186976|NCT02807844|472304544|FG002|Overall Study|Progressive disease|8|||
131186977|NCT02807844|472304545|FG003|Overall Study|Progressive disease|8|||
131186978|NCT02807844|472304546|FG004|Overall Study|Progressive disease|3|||
131186979|NCT02807844|472304547|FG005|Overall Study|Progressive disease|8|||
131186980|NCT02807844|472304548|FG006|Overall Study|Progressive disease|14|||
131186981|NCT02807844|472304549|FG007|Overall Study|Progressive disease|17|||
131186982|NCT02807844|472304550|FG008|Overall Study|Progressive disease|19|||
131186983|NCT02807844|472304551|FG009|Overall Study|Progressive disease|15|||
131186984|NCT02807844|472304542|FG000|Overall Study|Adverse Event|1|||
131186985|NCT02807844|472304543|FG001|Overall Study|Adverse Event|0|||
131186986|NCT02807844|472304544|FG002|Overall Study|Adverse Event|0|||
131186987|NCT02807844|472304545|FG003|Overall Study|Adverse Event|0|||
131186988|NCT02807844|472304546|FG004|Overall Study|Adverse Event|1|||
131186989|NCT02807844|472304547|FG005|Overall Study|Adverse Event|1|||
131186990|NCT02807844|472304548|FG006|Overall Study|Adverse Event|1|||
131186991|NCT02807844|472304549|FG007|Overall Study|Adverse Event|1|||
131186992|NCT02807844|472304550|FG008|Overall Study|Adverse Event|1|||
131186993|NCT02807844|472304551|FG009|Overall Study|Adverse Event|2|||
131186994|NCT00709124|472304553|FG000|Overall Study|Death|3|||
131186995|NCT00709124|472304554|FG001|Overall Study|Death|1|||
131186996|NCT00709124|472304553|FG000|Overall Study|encephalopathy; can't do assessment|1|||
131186997|NCT00709124|472304554|FG001|Overall Study|encephalopathy; can't do assessment|0|||
131186998|NCT00373490|472304555|FG000|Overall Study|Adverse Event|0|||
131186999|NCT00373490|472304556|FG001|Overall Study|Adverse Event|1|||
131187000|NCT00373490|472304555|FG000|Overall Study|Lack of Efficacy|9|||
131187001|NCT00373490|472304556|FG001|Overall Study|Lack of Efficacy|4|||
131187002|NCT00373490|472304555|FG000|Overall Study|Withdrawal by Subject|0|||
131187003|NCT00373490|472304556|FG001|Overall Study|Withdrawal by Subject|1|||
131187004|NCT00108953|472304563|FG000|Follow-up|Death|18|||
131187005|NCT00108953|472304564|FG001|Follow-up|Death|26|||
131187006|NCT00108953|472304563|FG000|Follow-up|Lost to Follow-up|1|||
131187007|NCT00108953|472304564|FG001|Follow-up|Lost to Follow-up|1|||
131187008|NCT00108953|472304563|FG000|Follow-up|Study terminated by sponsor|10|||
131187009|NCT00108953|472304564|FG001|Follow-up|Study terminated by sponsor|6|||
131187010|NCT02999100|472304570|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
131187011|NCT02999100|472304571|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
131187012|NCT02999100|472304572|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
131187013|NCT02999100|472304573|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
131187014|NCT02999100|472304574|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
131187015|NCT02999100|472304575|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
131187016|NCT02999100|472304570|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
131187017|NCT02999100|472304571|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
131187018|NCT02999100|472304572|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
131187019|NCT02999100|472304573|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
131187020|NCT02999100|472304574|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
131187021|NCT02999100|472304575|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
131187022|NCT02999100|472304570|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
131187023|NCT02999100|472304571|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
131187024|NCT02999100|472304572|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
131187025|NCT02999100|472304573|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
131187026|NCT02999100|472304574|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
131187027|NCT02999100|472304575|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
131187028|NCT03803202|472304576|FG000|Overall Study|Other|0|||
131187029|NCT03803202|472304577|FG001|Overall Study|Other|1|||
131187030|NCT03803202|472304578|FG002|Overall Study|Other|0|||
131187031|NCT03803202|472304579|FG003|Overall Study|Other|0|||
131187032|NCT03803202|472304580|FG004|Overall Study|Other|0|||
131187033|NCT03803202|472304581|FG005|Overall Study|Other|0|||
131187034|NCT03803202|472304582|FG006|Overall Study|Other|0|||
131187035|NCT03803202|472304583|FG007|Overall Study|Other|0|||
131187036|NCT03803202|472304584|FG008|Overall Study|Other|0|||
131187037|NCT03803202|472304576|FG000|Overall Study|Death|0|||
131187038|NCT03803202|472304577|FG001|Overall Study|Death|0|||
131187039|NCT03803202|472304578|FG002|Overall Study|Death|0|||
131187040|NCT03803202|472304579|FG003|Overall Study|Death|0|||
131187041|NCT03803202|472304580|FG004|Overall Study|Death|0|||
131187042|NCT03803202|472304581|FG005|Overall Study|Death|1|||
131187043|NCT03803202|472304582|FG006|Overall Study|Death|0|||
131187044|NCT03803202|472304583|FG007|Overall Study|Death|0|||
131187045|NCT03803202|472304584|FG008|Overall Study|Death|0|||
131187046|NCT03803202|472304576|FG000|Overall Study|Withdrawal by Subject|0|||
131187047|NCT03803202|472304577|FG001|Overall Study|Withdrawal by Subject|0|||
131187048|NCT03803202|472304578|FG002|Overall Study|Withdrawal by Subject|1|||
131187049|NCT03803202|472304579|FG003|Overall Study|Withdrawal by Subject|0|||
131187050|NCT03803202|472304580|FG004|Overall Study|Withdrawal by Subject|0|||
131187051|NCT03803202|472304581|FG005|Overall Study|Withdrawal by Subject|0|||
131187052|NCT03803202|472304582|FG006|Overall Study|Withdrawal by Subject|0|||
131187053|NCT03803202|472304583|FG007|Overall Study|Withdrawal by Subject|1|||
131187054|NCT03803202|472304584|FG008|Overall Study|Withdrawal by Subject|0|||
131187055|NCT03803202|472304576|FG000|Overall Study|Lost to Follow-up|0|||
131187056|NCT03803202|472304577|FG001|Overall Study|Lost to Follow-up|0|||
131187057|NCT03803202|472304578|FG002|Overall Study|Lost to Follow-up|0|||
131187058|NCT03803202|472304579|FG003|Overall Study|Lost to Follow-up|1|||
131187059|NCT03803202|472304580|FG004|Overall Study|Lost to Follow-up|1|||
131187060|NCT03803202|472304581|FG005|Overall Study|Lost to Follow-up|0|||
131187061|NCT03803202|472304582|FG006|Overall Study|Lost to Follow-up|1|||
131187062|NCT03803202|472304583|FG007|Overall Study|Lost to Follow-up|0|||
131187063|NCT03803202|472304584|FG008|Overall Study|Lost to Follow-up|0|||
131187064|NCT00293241|472304585|FG000|Overall Study|Lost to Follow-up|9|||
131187065|NCT00293241|472304586|FG001|Overall Study|Lost to Follow-up|16|||
131187066|NCT00293241|472304585|FG000|Overall Study|Physician Decision|23|||
131187067|NCT00293241|472304586|FG001|Overall Study|Physician Decision|17|||
131187068|NCT00293241|472304585|FG000|Overall Study|Withdrawal by Subject|4|||
131187069|NCT00293241|472304586|FG001|Overall Study|Withdrawal by Subject|8|||
131187070|NCT03595384|472304587|FG000|Overall Study|Other time commitments|8|||
131187071|NCT03595384|472304587|FG000|Overall Study|Changes to session time|7|||
131187072|NCT03595384|472304587|FG000|Overall Study|Relocation out of country|1|||
131187073|NCT01125293|472304588|FG000|Overall Study|Disease Progression|1|||
131187074|NCT01125293|472304589|FG001|Overall Study|Disease Progression|3|||
131187075|NCT01125293|472304590|FG002|Overall Study|Disease Progression|4|||
131187076|NCT01125293|472304591|FG003|Overall Study|Disease Progression|3|||
131187077|NCT01125293|472304592|FG004|Overall Study|Disease Progression|5|||
131187078|NCT01125293|472304593|FG005|Overall Study|Disease Progression|12|||
131187079|NCT01125293|472304588|FG000|Overall Study|Adverse Event|1|||
131187080|NCT01125293|472304589|FG001|Overall Study|Adverse Event|0|||
131187081|NCT01125293|472304590|FG002|Overall Study|Adverse Event|0|||
131187082|NCT01125293|472304591|FG003|Overall Study|Adverse Event|0|||
131187083|NCT01125293|472304592|FG004|Overall Study|Adverse Event|2|||
131187084|NCT01125293|472304593|FG005|Overall Study|Adverse Event|8|||
131187085|NCT01125293|472304588|FG000|Overall Study|Symptomatic Deterioration|1|||
131187086|NCT01125293|472304589|FG001|Overall Study|Symptomatic Deterioration|0|||
131187087|NCT01125293|472304590|FG002|Overall Study|Symptomatic Deterioration|0|||
131187088|NCT01125293|472304591|FG003|Overall Study|Symptomatic Deterioration|0|||
131187089|NCT01125293|472304592|FG004|Overall Study|Symptomatic Deterioration|0|||
131187090|NCT01125293|472304593|FG005|Overall Study|Symptomatic Deterioration|0|||
131187091|NCT01125293|472304588|FG000|Overall Study|Death|0|||
131187092|NCT01125293|472304589|FG001|Overall Study|Death|0|||
131187093|NCT01125293|472304590|FG002|Overall Study|Death|0|||
131187094|NCT01125293|472304591|FG003|Overall Study|Death|0|||
131187095|NCT01125293|472304592|FG004|Overall Study|Death|1|||
131187096|NCT01125293|472304593|FG005|Overall Study|Death|0|||
131187097|NCT01125293|472304588|FG000|Overall Study|Withdrawal by Subject|0|||
131187098|NCT01125293|472304589|FG001|Overall Study|Withdrawal by Subject|0|||
131187099|NCT01125293|472304590|FG002|Overall Study|Withdrawal by Subject|0|||
131187100|NCT01125293|472304591|FG003|Overall Study|Withdrawal by Subject|0|||
131187101|NCT01125293|472304592|FG004|Overall Study|Withdrawal by Subject|2|||
131187102|NCT01125293|472304593|FG005|Overall Study|Withdrawal by Subject|1|||
131187103|NCT01125293|472304588|FG000|Overall Study|Physician Decision|0|||
131187104|NCT01125293|472304589|FG001|Overall Study|Physician Decision|0|||
131187105|NCT01125293|472304590|FG002|Overall Study|Physician Decision|0|||
131187106|NCT01125293|472304591|FG003|Overall Study|Physician Decision|0|||
131187107|NCT01125293|472304592|FG004|Overall Study|Physician Decision|0|||
131187108|NCT01125293|472304593|FG005|Overall Study|Physician Decision|2|||
131187109|NCT02224638|472304594|FG000|Overall Study|Adverse Event|1|||
131187110|NCT02224638|472304595|FG001|Overall Study|Adverse Event|1|||
131187111|NCT01270958|472304598|FG000|Overall Study|Lost to Follow-up|2|||
131187112|NCT01270958|472304598|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
131187113|NCT02096042|472304607|FG000|Overall Study|Disease Progression|1|||
131187114|NCT02096042|472304608|FG001|Overall Study|Disease Progression|0|||
131187115|NCT02096042|472304609|FG002|Overall Study|Disease Progression|0|||
131187116|NCT00631540|472304622|FG000|Overall Study|Withdrawal by Subject|5|||
131187117|NCT00631540|472304622|FG000|Overall Study|Death|4|||
131187118|NCT00631540|472304622|FG000|Overall Study|Lost to Follow-up|2|||
131187119|NCT00631540|472304622|FG000|Overall Study|Core Lab Data Unavailable|3|||
131187120|NCT00970268|472304623|FG000|Overall Study|Withdrawal by Subject|12|||
131187121|NCT00970268|472304624|FG001|Overall Study|Withdrawal by Subject|19|||
131187122|NCT00970268|472304623|FG000|Overall Study|Adverse Event|15|||
131187123|NCT00970268|472304624|FG001|Overall Study|Adverse Event|12|||
131187124|NCT00970268|472304623|FG000|Overall Study|Lack of Efficacy|3|||
131187125|NCT00970268|472304624|FG001|Overall Study|Lack of Efficacy|6|||
131187126|NCT00970268|472304623|FG000|Overall Study|Protocol Violation|4|||
131187127|NCT00970268|472304624|FG001|Overall Study|Protocol Violation|7|||
131187128|NCT00970268|472304623|FG000|Overall Study|Other Reason|3|||
131187129|NCT00970268|472304624|FG001|Overall Study|Other Reason|1|||
131187130|NCT00970268|472304623|FG000|Overall Study|COPD Exacerbation|4|||
131187131|NCT00970268|472304624|FG001|Overall Study|COPD Exacerbation|2|||
131187132|NCT00970268|472304623|FG000|Overall Study|Lost to Follow-up|1|||
131187133|NCT00970268|472304624|FG001|Overall Study|Lost to Follow-up|2|||
131187134|NCT00970268|472304623|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
131187135|NCT00970268|472304624|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
131187136|NCT01602549|472304626|FG000|Overall Study|Protocol Violation|0|||
131187137|NCT01602549|472304627|FG001|Overall Study|Protocol Violation|1|||
131187138|NCT01602549|472304626|FG000|Overall Study|Withdrawal by Subject|1|||
131187139|NCT01602549|472304627|FG001|Overall Study|Withdrawal by Subject|0|||
131187140|NCT03907969|472306632|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
131187141|NCT03907969|472306633|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
131187142|NCT03907969|472306634|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
131187143|NCT03907969|472306635|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
131187144|NCT03907969|472306636|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
131187145|NCT03907969|472306637|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
131187146|NCT03907969|472306638|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
131187147|NCT03907969|472306639|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
131187148|NCT03907969|472306640|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
131187149|NCT03907969|472306641|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
131187150|NCT03907969|472306642|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
131187151|NCT03907969|472306632|FG000|Monotherapy Part A|Progressive Disease|0|||
131187152|NCT03907969|472306633|FG001|Monotherapy Part A|Progressive Disease|1|||
131187153|NCT03907969|472306634|FG002|Monotherapy Part A|Progressive Disease|0|||
131187154|NCT03907969|472306635|FG003|Monotherapy Part A|Progressive Disease|0|||
131187155|NCT03907969|472306636|FG004|Monotherapy Part A|Progressive Disease|0|||
131187156|NCT03907969|472306637|FG005|Monotherapy Part A|Progressive Disease|1|||
131187157|NCT03907969|472306638|FG006|Monotherapy Part A|Progressive Disease|2|||
131187158|NCT03907969|472306639|FG007|Monotherapy Part A|Progressive Disease|0|||
131187159|NCT03907969|472306640|FG008|Monotherapy Part A|Progressive Disease|0|||
131187160|NCT03907969|472306641|FG009|Monotherapy Part A|Progressive Disease|0|||
131187161|NCT03907969|472306642|FG010|Monotherapy Part A|Progressive Disease|0|||
131187162|NCT03907969|472306632|FG000|Monotherapy Part A|Death|0|||
131187163|NCT03907969|472306633|FG001|Monotherapy Part A|Death|0|||
131187164|NCT03907969|472306634|FG002|Monotherapy Part A|Death|1|||
131187165|NCT03907969|472306635|FG003|Monotherapy Part A|Death|1|||
131187166|NCT03907969|472306636|FG004|Monotherapy Part A|Death|0|||
131187167|NCT03907969|472306637|FG005|Monotherapy Part A|Death|1|||
131187168|NCT03907969|472306638|FG006|Monotherapy Part A|Death|0|||
131187169|NCT03907969|472306639|FG007|Monotherapy Part A|Death|0|||
131187170|NCT03907969|472306640|FG008|Monotherapy Part A|Death|0|||
131187171|NCT03907969|472306641|FG009|Monotherapy Part A|Death|0|||
131187172|NCT03907969|472306642|FG010|Monotherapy Part A|Death|0|||
131187173|NCT03907969|472306632|FG000|Combination Therapy Part A|Adverse Event|0|||
131187174|NCT03907969|472306633|FG001|Combination Therapy Part A|Adverse Event|0|||
131187175|NCT03907969|472306634|FG002|Combination Therapy Part A|Adverse Event|0|||
131187176|NCT03907969|472306635|FG003|Combination Therapy Part A|Adverse Event|0|||
131187177|NCT03907969|472306636|FG004|Combination Therapy Part A|Adverse Event|0|||
131187178|NCT03907969|472306637|FG005|Combination Therapy Part A|Adverse Event|0|||
131187179|NCT03907969|472306638|FG006|Combination Therapy Part A|Adverse Event|0|||
131187180|NCT03907969|472306639|FG007|Combination Therapy Part A|Adverse Event|0|||
131187181|NCT03907969|472306640|FG008|Combination Therapy Part A|Adverse Event|0|||
131187182|NCT03907969|472306641|FG009|Combination Therapy Part A|Adverse Event|1|||
131187183|NCT03907969|472306642|FG010|Combination Therapy Part A|Adverse Event|1|||
131187184|NCT03907969|472306632|FG000|Combination Therapy Part A|Progressive disease|0|||
131187185|NCT03907969|472306633|FG001|Combination Therapy Part A|Progressive disease|0|||
131187186|NCT03907969|472306634|FG002|Combination Therapy Part A|Progressive disease|0|||
131187187|NCT03907969|472306635|FG003|Combination Therapy Part A|Progressive disease|0|||
131187188|NCT03907969|472306636|FG004|Combination Therapy Part A|Progressive disease|0|||
131187189|NCT03907969|472306637|FG005|Combination Therapy Part A|Progressive disease|0|||
131187190|NCT03907969|472306638|FG006|Combination Therapy Part A|Progressive disease|0|||
131187191|NCT03907969|472306639|FG007|Combination Therapy Part A|Progressive disease|1|||
131187192|NCT03907969|472306640|FG008|Combination Therapy Part A|Progressive disease|0|||
131187193|NCT03907969|472306641|FG009|Combination Therapy Part A|Progressive disease|2|||
131187194|NCT03907969|472306642|FG010|Combination Therapy Part A|Progressive disease|3|||
131187195|NCT03907969|472306632|FG000|Combination Therapy Part A|Death|0|||
131187196|NCT03907969|472306633|FG001|Combination Therapy Part A|Death|0|||
131187197|NCT03907969|472306634|FG002|Combination Therapy Part A|Death|0|||
131187198|NCT03907969|472306635|FG003|Combination Therapy Part A|Death|0|||
131187199|NCT03907969|472306636|FG004|Combination Therapy Part A|Death|0|||
131187200|NCT03907969|472306637|FG005|Combination Therapy Part A|Death|0|||
131187201|NCT03907969|472306638|FG006|Combination Therapy Part A|Death|0|||
131187202|NCT03907969|472306639|FG007|Combination Therapy Part A|Death|0|||
131187203|NCT03907969|472306640|FG008|Combination Therapy Part A|Death|1|||
131187204|NCT03907969|472306641|FG009|Combination Therapy Part A|Death|0|||
131187205|NCT03907969|472306642|FG010|Combination Therapy Part A|Death|1|||
131187206|NCT03907969|472306632|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
131187207|NCT03907969|472306633|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
131187208|NCT03907969|472306634|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
131187209|NCT03907969|472306635|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
131187210|NCT03907969|472306636|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
131187211|NCT03907969|472306637|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
131187212|NCT03907969|472306638|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
131187213|NCT03907969|472306639|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
131187214|NCT03907969|472306640|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
131187215|NCT03907969|472306641|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
131187216|NCT03907969|472306642|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
131187217|NCT03907969|472306632|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
131240771|NCT03978637|472504474|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
131240772|NCT04015518|472504475|FG000|Overall Study|Adverse Event|6|||
131187218|NCT03907969|472306633|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
131187219|NCT03907969|472306634|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
131187220|NCT03907969|472306635|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
131187221|NCT03907969|472306636|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
131187222|NCT03907969|472306637|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
131187223|NCT03907969|472306638|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
131187224|NCT03907969|472306639|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
131187225|NCT03907969|472306640|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
131240773|NCT04015518|472504476|FG001|Overall Study|Adverse Event|1|||
131240774|NCT04015518|472504477|FG002|Overall Study|Adverse Event|1|||
131240775|NCT04015518|472504478|FG003|Overall Study|Adverse Event|3|||
131240776|NCT04015518|472504479|FG004|Overall Study|Adverse Event|3|||
131240777|NCT04015518|472504475|FG000|Overall Study|Lack of Efficacy|1|||
131240778|NCT04015518|472504476|FG001|Overall Study|Lack of Efficacy|0|||
131240779|NCT04015518|472504477|FG002|Overall Study|Lack of Efficacy|1|||
131240780|NCT04015518|472504478|FG003|Overall Study|Lack of Efficacy|0|||
131240781|NCT04015518|472504479|FG004|Overall Study|Lack of Efficacy|4|||
131240782|NCT04015518|472504475|FG000|Overall Study|Lost to Follow-up|0|||
131240783|NCT04015518|472504476|FG001|Overall Study|Lost to Follow-up|0|||
131240784|NCT04015518|472504477|FG002|Overall Study|Lost to Follow-up|0|||
131240785|NCT04015518|472504478|FG003|Overall Study|Lost to Follow-up|0|||
131240786|NCT04015518|472504479|FG004|Overall Study|Lost to Follow-up|1|||
131240787|NCT04015518|472504475|FG000|Overall Study|Withdrawal by Subject|0|||
131240788|NCT04015518|472504476|FG001|Overall Study|Withdrawal by Subject|1|||
131240789|NCT04015518|472504477|FG002|Overall Study|Withdrawal by Subject|0|||
131240790|NCT04015518|472504478|FG003|Overall Study|Withdrawal by Subject|1|||
131240791|NCT04015518|472504479|FG004|Overall Study|Withdrawal by Subject|1|||
131240792|NCT04015518|472504475|FG000|Overall Study|Patient did not come for consecutive visits|0|||
131240793|NCT04015518|472504476|FG001|Overall Study|Patient did not come for consecutive visits|1|||
131240794|NCT04015518|472504477|FG002|Overall Study|Patient did not come for consecutive visits|0|||
131240795|NCT04015518|472504478|FG003|Overall Study|Patient did not come for consecutive visits|0|||
131240796|NCT04015518|472504479|FG004|Overall Study|Patient did not come for consecutive visits|0|||
131240797|NCT04015518|472504475|FG000|Overall Study|not willing to travel due to Covid-19|0|||
131240798|NCT04015518|472504476|FG001|Overall Study|not willing to travel due to Covid-19|0|||
131240799|NCT04015518|472504477|FG002|Overall Study|not willing to travel due to Covid-19|1|||
131240800|NCT04015518|472504478|FG003|Overall Study|not willing to travel due to Covid-19|0|||
131240801|NCT04015518|472504479|FG004|Overall Study|not willing to travel due to Covid-19|0|||
131240802|NCT04015518|472504475|FG000|Overall Study|Patient wants to discontinue treatment|0|||
131240803|NCT04015518|472504476|FG001|Overall Study|Patient wants to discontinue treatment|0|||
131240804|NCT04015518|472504477|FG002|Overall Study|Patient wants to discontinue treatment|0|||
131240805|NCT04015518|472504478|FG003|Overall Study|Patient wants to discontinue treatment|1|||
131240806|NCT04015518|472504479|FG004|Overall Study|Patient wants to discontinue treatment|0|||
131240807|NCT04015518|472504475|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
131240808|NCT04015518|472504476|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
131240809|NCT04015518|472504477|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
131240810|NCT04015518|472504478|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
131240811|NCT04015518|472504479|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
131240812|NCT04015518|472504475|FG000|Overall Study|Pregnancy|0|||
131240813|NCT04015518|472504476|FG001|Overall Study|Pregnancy|0|||
131240814|NCT04015518|472504477|FG002|Overall Study|Pregnancy|0|||
131240815|NCT04015518|472504478|FG003|Overall Study|Pregnancy|0|||
131240816|NCT04015518|472504479|FG004|Overall Study|Pregnancy|1|||
131240817|NCT04015518|472504475|FG000|Overall Study|Personal reasons|1|||
131240818|NCT04015518|472504476|FG001|Overall Study|Personal reasons|0|||
131240819|NCT04015518|472504477|FG002|Overall Study|Personal reasons|0|||
131240820|NCT04015518|472504478|FG003|Overall Study|Personal reasons|0|||
131240821|NCT04015518|472504479|FG004|Overall Study|Personal reasons|1|||
131240822|NCT04015518|472504475|FG000|Overall Study|Withdrew consent|1|||
131240823|NCT04015518|472504476|FG001|Overall Study|Withdrew consent|0|||
131240824|NCT04015518|472504477|FG002|Overall Study|Withdrew consent|0|||
131240825|NCT04015518|472504478|FG003|Overall Study|Withdrew consent|0|||
131240826|NCT04015518|472504479|FG004|Overall Study|Withdrew consent|0|||
131240827|NCT04015518|472504475|FG000|Overall Study|Prostate carcinoma|1|||
131240828|NCT04015518|472504476|FG001|Overall Study|Prostate carcinoma|0|||
131240829|NCT04015518|472504477|FG002|Overall Study|Prostate carcinoma|0|||
131240830|NCT04015518|472504478|FG003|Overall Study|Prostate carcinoma|0|||
131240831|NCT04015518|472504479|FG004|Overall Study|Prostate carcinoma|0|||
131240832|NCT04015518|472504475|FG000|Overall Study|Could not keep appointments due to work|1|||
131240833|NCT04015518|472504476|FG001|Overall Study|Could not keep appointments due to work|0|||
131240834|NCT04015518|472504477|FG002|Overall Study|Could not keep appointments due to work|0|||
131240835|NCT04015518|472504478|FG003|Overall Study|Could not keep appointments due to work|0|||
131240836|NCT04015518|472504479|FG004|Overall Study|Could not keep appointments due to work|0|||
131240837|NCT05809596|472504480|FG000|Overall Study|Death|16|||
131240838|NCT05809596|472504480|FG000|Overall Study|Withdrawal by Subject|4|||
131240839|NCT05809596|472504480|FG000|Overall Study|Physician Decision|1|||
131240840|NCT05809596|472504480|FG000|Overall Study|Missed Visit|2|||
131240841|NCT05809596|472504480|FG000|Overall Study|Other|3|||
131240842|NCT03451851|472504481|FG000|PCP: Week 0 -16|Adverse Event|1|||
131240843|NCT03451851|472504482|FG001|PCP: Week 0 -16|Adverse Event|0|||
131240844|NCT03451851|472504483|FG002|PCP: Week 0 -16|Adverse Event|0|||
131240845|NCT03451851|472504484|FG003|PCP: Week 0 -16|Adverse Event|0|||
131240846|NCT03451851|472504485|FG004|PCP: Week 0 -16|Adverse Event|0|||
131240847|NCT03451851|472504486|FG005|PCP: Week 0 -16|Adverse Event|0|||
131240848|NCT03451851|472504487|FG006|PCP: Week 0 -16|Adverse Event|1|||
131240849|NCT03451851|472504488|FG007|PCP: Week 0 -16|Adverse Event|0|||
131240850|NCT03451851|472504481|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
131240851|NCT03451851|472504482|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
131240852|NCT03451851|472504483|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
131240853|NCT03451851|472504484|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
131240854|NCT03451851|472504485|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
131240855|NCT03451851|472504486|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
131240856|NCT03451851|472504487|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
131240857|NCT03451851|472504488|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
131240858|NCT03451851|472504481|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131240859|NCT03451851|472504482|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131240860|NCT03451851|472504483|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
131240861|NCT03451851|472504484|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131240862|NCT03451851|472504485|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131240863|NCT03451851|472504486|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131240864|NCT03451851|472504487|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131240865|NCT03451851|472504488|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
131240866|NCT03451851|472504481|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131240867|NCT03451851|472504482|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131240868|NCT03451851|472504483|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131240869|NCT03451851|472504484|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131240870|NCT03451851|472504485|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
131240871|NCT03451851|472504486|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
131240872|NCT03451851|472504487|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131240873|NCT03451851|472504488|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
131240874|NCT03451851|472504481|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131240875|NCT03451851|472504482|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131240876|NCT03451851|472504483|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131187226|NCT03907969|472306641|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
131187227|NCT03907969|472306642|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
131187228|NCT03907969|472306632|FG000|Combination Therapy Part A|Physician Decision|0|||
131187229|NCT03907969|472306633|FG001|Combination Therapy Part A|Physician Decision|0|||
131187230|NCT03907969|472306634|FG002|Combination Therapy Part A|Physician Decision|0|||
131187231|NCT03907969|472306635|FG003|Combination Therapy Part A|Physician Decision|0|||
131187232|NCT03907969|472306636|FG004|Combination Therapy Part A|Physician Decision|0|||
131187233|NCT03907969|472306637|FG005|Combination Therapy Part A|Physician Decision|0|||
131187234|NCT03907969|472306638|FG006|Combination Therapy Part A|Physician Decision|0|||
131187235|NCT03907969|472306639|FG007|Combination Therapy Part A|Physician Decision|1|||
131187236|NCT03907969|472306640|FG008|Combination Therapy Part A|Physician Decision|0|||
131187237|NCT03907969|472306641|FG009|Combination Therapy Part A|Physician Decision|0|||
131187238|NCT03907969|472306642|FG010|Combination Therapy Part A|Physician Decision|1|||
131187239|NCT00063986|472306646|FG000|Overall Study|Withdrawal by Subject|1|||
131187240|NCT00063986|472306646|FG000|Overall Study|Ineligible|1|||
131187241|NCT00063986|472306646|FG000|Overall Study|Intra-operatively ineligible|4|||
131187242|NCT00724815|472306649|FG000|Overall Study|Randomized, not treated|31|||
131187243|NCT00724815|472306650|FG001|Overall Study|Randomized, not treated|30|||
131187244|NCT00724815|472306649|FG000|Overall Study|Adverse Event|5|||
131187245|NCT00724815|472306650|FG001|Overall Study|Adverse Event|3|||
131187246|NCT00724815|472306649|FG000|Overall Study|Lost to Follow-up|4|||
131187247|NCT00724815|472306650|FG001|Overall Study|Lost to Follow-up|1|||
131187248|NCT00724815|472306649|FG000|Overall Study|Other Various|3|||
131187249|NCT00724815|472306650|FG001|Overall Study|Other Various|5|||
131187250|NCT00810043|472306651|FG000|Overall Study|Withdrawal by Subject|1|||
131187251|NCT00810043|472306652|FG001|Overall Study|Withdrawal by Subject|0|||
131187252|NCT00810043|472306653|FG002|Overall Study|Withdrawal by Subject|2|||
131187253|NCT00810043|472306651|FG000|Overall Study|Lost to Follow-up|1|||
131187254|NCT00810043|472306652|FG001|Overall Study|Lost to Follow-up|0|||
131187255|NCT00810043|472306653|FG002|Overall Study|Lost to Follow-up|0|||
131187256|NCT00810043|472306651|FG000|Overall Study|Physician Decision|0|||
131187257|NCT00810043|472306652|FG001|Overall Study|Physician Decision|0|||
131187258|NCT00810043|472306653|FG002|Overall Study|Physician Decision|2|||
131187259|NCT00810043|472306651|FG000|Overall Study|Death|2|||
131240877|NCT03451851|472504484|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131240878|NCT03451851|472504485|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
131240879|NCT03451851|472504486|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131240880|NCT03451851|472504487|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131240881|NCT03451851|472504488|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
131187260|NCT00810043|472306652|FG001|Overall Study|Death|0|||
131187261|NCT00810043|472306653|FG002|Overall Study|Death|0|||
131187262|NCT00810043|472306651|FG000|Overall Study|Unrelated medical problem|0|||
131187263|NCT00810043|472306652|FG001|Overall Study|Unrelated medical problem|1|||
131187264|NCT00810043|472306653|FG002|Overall Study|Unrelated medical problem|0|||
131187265|NCT00810043|472306651|FG000|Overall Study|Non-medical problem|0|||
131187266|NCT00810043|472306652|FG001|Overall Study|Non-medical problem|0|||
131187267|NCT00810043|472306653|FG002|Overall Study|Non-medical problem|1|||
131187268|NCT00810043|472306651|FG000|Overall Study|No longer met enrollment criteria|0|||
131187269|NCT00810043|472306652|FG001|Overall Study|No longer met enrollment criteria|0|||
131187270|NCT00810043|472306653|FG002|Overall Study|No longer met enrollment criteria|3|||
131187271|NCT01359046|472306654|FG000|Overall Study|Did not receive allocated intervention|6|||
131187272|NCT01359046|472306655|FG001|Overall Study|Did not receive allocated intervention|6|||
131187273|NCT01359046|472306654|FG000|Overall Study|Physician Decision|1|||
131187274|NCT01359046|472306655|FG001|Overall Study|Physician Decision|11|||
131187275|NCT04539262|472306659|FG000|Overall Study|Adverse Event|0|||
131187276|NCT04539262|472306660|FG001|Overall Study|Adverse Event|0|||
131187277|NCT04539262|472306661|FG002|Overall Study|Adverse Event|1|||
131187278|NCT04539262|472306662|FG003|Overall Study|Adverse Event|0|||
131187279|NCT04539262|472306663|FG004|Overall Study|Adverse Event|0|||
131187280|NCT04539262|472306664|FG005|Overall Study|Adverse Event|0|||
131187281|NCT04539262|472306665|FG006|Overall Study|Adverse Event|0|||
131187282|NCT04539262|472306666|FG007|Overall Study|Adverse Event|0|||
131187283|NCT04539262|472306659|FG000|Overall Study|Withdrew Consent|0|||
131187284|NCT04539262|472306660|FG001|Overall Study|Withdrew Consent|0|||
131187285|NCT04539262|472306661|FG002|Overall Study|Withdrew Consent|0|||
131187286|NCT04539262|472306662|FG003|Overall Study|Withdrew Consent|1|||
131187287|NCT04539262|472306663|FG004|Overall Study|Withdrew Consent|0|||
131187288|NCT04539262|472306664|FG005|Overall Study|Withdrew Consent|0|||
131187289|NCT04539262|472306665|FG006|Overall Study|Withdrew Consent|0|||
131187290|NCT04539262|472306666|FG007|Overall Study|Withdrew Consent|0|||
131187291|NCT04539262|472306659|FG000|Overall Study|Randomized, Not treated|0|||
131187292|NCT04539262|472306660|FG001|Overall Study|Randomized, Not treated|1|||
131187293|NCT04539262|472306661|FG002|Overall Study|Randomized, Not treated|0|||
131187294|NCT04539262|472306662|FG003|Overall Study|Randomized, Not treated|0|||
131187295|NCT04539262|472306663|FG004|Overall Study|Randomized, Not treated|0|||
131187296|NCT04539262|472306664|FG005|Overall Study|Randomized, Not treated|0|||
131187297|NCT04539262|472306665|FG006|Overall Study|Randomized, Not treated|1|||
131187298|NCT04539262|472306666|FG007|Overall Study|Randomized, Not treated|0|||
131187299|NCT01061567|472306673|FG000|Overall Study|Adverse Event|32|||
131187300|NCT01061567|472306673|FG000|Overall Study|Death|2|||
131187301|NCT01061567|472306673|FG000|Overall Study|Lack of Efficacy|3|||
131187302|NCT01061567|472306673|FG000|Overall Study|Lost to Follow-up|24|||
131187303|NCT01061567|472306673|FG000|Overall Study|Protocol Violation|1|||
131187304|NCT01061567|472306673|FG000|Overall Study|Withdrawal by Subject|11|||
131187305|NCT01061567|472306673|FG000|Overall Study|Other reason than stated above|3|||
131187306|NCT02255760|472306674|FG000|Overall Study|Lost to Follow-up|0|||
131187307|NCT02255760|472306675|FG001|Overall Study|Lost to Follow-up|1|||
131187308|NCT02255760|472306676|FG002|Overall Study|Lost to Follow-up|0|||
131187309|NCT02255760|472306677|FG003|Overall Study|Lost to Follow-up|0|||
131187310|NCT02255760|472306678|FG004|Overall Study|Lost to Follow-up|0|||
131187311|NCT00618813|472306679|FG000|Overall Study|Lack of Efficacy|1|||
131187312|NCT00618813|472306679|FG000|Overall Study|Physician Decision|2|||
131187313|NCT00618813|472306679|FG000|Overall Study|Withdrawal by Subject|1|||
131187314|NCT00003838|472306680|FG000|Overall Study|Death|0|||
131187315|NCT00003838|472306681|FG001|Overall Study|Death|12|||
131187316|NCT00003838|472306682|FG002|Overall Study|Death|7|||
131187317|NCT00003838|472306680|FG000|Overall Study|Lost to Follow-up|0|||
131187318|NCT00003838|472306681|FG001|Overall Study|Lost to Follow-up|1|||
131187319|NCT00003838|472306682|FG002|Overall Study|Lost to Follow-up|1|||
131187320|NCT00003838|472306680|FG000|Overall Study|Disease Progression|0|||
131187321|NCT00003838|472306681|FG001|Overall Study|Disease Progression|12|||
131187322|NCT00003838|472306682|FG002|Overall Study|Disease Progression|0|||
131187323|NCT01809197|472306683|FG000|Overall Study|Lost to Follow-up|4|||
131187324|NCT01809197|472306684|FG001|Overall Study|Lost to Follow-up|2|||
131187325|NCT01809197|472306683|FG000|Overall Study|Adverse Event|2|||
131187326|NCT01809197|472306684|FG001|Overall Study|Adverse Event|3|||
131187327|NCT01809197|472306683|FG000|Overall Study|Failed slit lamp exam|1|||
131187328|NCT01809197|472306684|FG001|Overall Study|Failed slit lamp exam|0|||
131187329|NCT01809197|472306683|FG000|Overall Study|Non-Compliance|1|||
131187330|NCT01809197|472306684|FG001|Overall Study|Non-Compliance|1|||
131187331|NCT01809197|472306683|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
131187332|NCT01809197|472306684|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
131187333|NCT01809197|472306683|FG000|Overall Study|Withdrawal by Subject|1|||
131187334|NCT01809197|472306684|FG001|Overall Study|Withdrawal by Subject|1|||
131187335|NCT01809197|472306683|FG000|Overall Study|Product not available|0|||
131187336|NCT01809197|472306684|FG001|Overall Study|Product not available|1|||
131187337|NCT00268463|472306687|FG000|Overall Study|study terminated due to low accrual|10|||
131187338|NCT00268463|472306688|FG001|Overall Study|study terminated due to low accrual|12|||
131187339|NCT02920450|472306689|FG000|Overall Study|Death|1|||
131187340|NCT02920450|472306690|FG001|Overall Study|Death|0|||
131187341|NCT02920450|472306691|FG002|Overall Study|Death|0|||
131187342|NCT02920450|472306692|FG003|Overall Study|Death|0|||
131187343|NCT02920450|472306689|FG000|Overall Study|Withdrawal by Subject|1|||
131187344|NCT02920450|472306690|FG001|Overall Study|Withdrawal by Subject|0|||
131187345|NCT02920450|472306691|FG002|Overall Study|Withdrawal by Subject|0|||
131187346|NCT02920450|472306692|FG003|Overall Study|Withdrawal by Subject|0|||
131187347|NCT00291187|472306693|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
131187348|NCT00291187|472306694|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
131187349|NCT00291187|472306695|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
131187350|NCT00291187|472306696|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
131187351|NCT02443805|472306702|FG000|Overall Study|Adverse Event|100|||
131187352|NCT02443805|472306703|FG001|Overall Study|Adverse Event|18|||
131187353|NCT02443805|472306702|FG000|Overall Study|Withdrawal by Subject|73|||
131187354|NCT02443805|472306703|FG001|Overall Study|Withdrawal by Subject|74|||
131187355|NCT02443805|472306702|FG000|Overall Study|Lost to Follow-up|19|||
131187356|NCT02443805|472306703|FG001|Overall Study|Lost to Follow-up|14|||
131187357|NCT02443805|472306702|FG000|Overall Study|Pregnancy|6|||
131187358|NCT02443805|472306703|FG001|Overall Study|Pregnancy|5|||
131187359|NCT02443805|472306702|FG000|Overall Study|Protocol Violation|2|||
131187360|NCT02443805|472306703|FG001|Overall Study|Protocol Violation|4|||
131187361|NCT02443805|472306702|FG000|Overall Study|Lack of Efficacy|1|||
131187362|NCT02443805|472306703|FG001|Overall Study|Lack of Efficacy|1|||
131187363|NCT02443805|472306702|FG000|Overall Study|Non-compliance with study drug|6|||
131187364|NCT02443805|472306703|FG001|Overall Study|Non-compliance with study drug|4|||
131187365|NCT02443805|472306702|FG000|Overall Study|Withdrawal by parent/guardian|3|||
131187366|NCT02443805|472306703|FG001|Overall Study|Withdrawal by parent/guardian|5|||
131187367|NCT02443805|472306702|FG000|Overall Study|Any other reason not above-mentioned|3|||
131187368|NCT02443805|472306703|FG001|Overall Study|Any other reason not above-mentioned|2|||
131187369|NCT04362813|472306704|FG000|Overall Study|Death|12|||
131187370|NCT04362813|472306705|FG001|Overall Study|Death|16|||
131187371|NCT04362813|472306704|FG000|Overall Study|Withdrawal by Subject|3|||
131187372|NCT04362813|472306705|FG001|Overall Study|Withdrawal by Subject|1|||
131187373|NCT04362813|472306704|FG000|Overall Study|Protocol Violation|0|||
131187374|NCT04362813|472306705|FG001|Overall Study|Protocol Violation|3|||
131187375|NCT04362813|472306704|FG000|Overall Study|Lost to Follow-up|1|||
131187376|NCT04362813|472306705|FG001|Overall Study|Lost to Follow-up|1|||
131187377|NCT04362813|472306704|FG000|Overall Study|Enrolled but did not receive treatment|2|||
131187378|NCT04362813|472306705|FG001|Overall Study|Enrolled but did not receive treatment|4|||
131187379|NCT00961116|472306706|FG000|Washout Period of 7 Days|Adverse Event|1|||
131187380|NCT00961116|472306707|FG001|Washout Period of 7 Days|Adverse Event|1|||
131187381|NCT00961116|472306706|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
131187382|NCT00961116|472306707|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
131187383|NCT00961116|472306706|FG000|Washout Period of 7 Days|Protocol Violation|0|||
131187384|NCT00961116|472306707|FG001|Washout Period of 7 Days|Protocol Violation|1|||
131187385|NCT02708966|472306708|FG000|Overall Study|Lost to Follow-up|2|||
131187386|NCT02708966|472306709|FG001|Overall Study|Lost to Follow-up|2|||
131187387|NCT02260388|472306712|FG000|Overall Study|Lost to Follow-up|2|||
131187388|NCT02260388|472306713|FG001|Overall Study|Lost to Follow-up|8|||
131187389|NCT02260388|472306714|FG002|Overall Study|Lost to Follow-up|3|||
131187390|NCT02260388|472306715|FG003|Overall Study|Lost to Follow-up|4|||
131187391|NCT01732107|472306716|FG000|Overall Study|Adverse Event|2|||
131187392|NCT01732107|472306716|FG000|Overall Study|Disease Progression|8|||
131187393|NCT01732107|472306716|FG000|Overall Study|Physician Decision|1|||
131187394|NCT01732107|472306716|FG000|Overall Study|Withdrawal by Subject|2|||
131187395|NCT02959190|472306717|FG000|Open Label|Adverse Event|5|||
131187396|NCT02959190|472306718|FG001|Open Label|Adverse Event|7|||
131187397|NCT02959190|472306719|FG002|Open Label|Adverse Event|3|||
131187398|NCT02959190|472306720|FG003|Open Label|Adverse Event|4|||
131187399|NCT02959190|472306717|FG000|Open Label|Pregnancy|0|||
131187400|NCT02959190|472306718|FG001|Open Label|Pregnancy|1|||
131187401|NCT02959190|472306719|FG002|Open Label|Pregnancy|0|||
131187402|NCT02959190|472306720|FG003|Open Label|Pregnancy|0|||
131187403|NCT02959190|472306717|FG000|Open Label|Withdrawal by Subject|2|||
131187404|NCT02959190|472306718|FG001|Open Label|Withdrawal by Subject|8|||
131187405|NCT02959190|472306719|FG002|Open Label|Withdrawal by Subject|0|||
131187406|NCT02959190|472306720|FG003|Open Label|Withdrawal by Subject|0|||
131187407|NCT02959190|472306717|FG000|Open Label|Physician Decision|0|||
131187408|NCT02959190|472306718|FG001|Open Label|Physician Decision|0|||
131187409|NCT02959190|472306719|FG002|Open Label|Physician Decision|1|||
131187410|NCT02959190|472306720|FG003|Open Label|Physician Decision|0|||
131187411|NCT02959190|472306717|FG000|Open Label|Protocol Violation|0|||
131187412|NCT02959190|472306718|FG001|Open Label|Protocol Violation|0|||
131187413|NCT02959190|472306719|FG002|Open Label|Protocol Violation|0|||
131187414|NCT02959190|472306720|FG003|Open Label|Protocol Violation|2|||
131187415|NCT02959190|472306717|FG000|Post Treatment Follow Up|Adverse Event|1|||
131187416|NCT02959190|472306718|FG001|Post Treatment Follow Up|Adverse Event|1|||
131187417|NCT02959190|472306719|FG002|Post Treatment Follow Up|Adverse Event|0|||
131187418|NCT02959190|472306720|FG003|Post Treatment Follow Up|Adverse Event|0|||
131187419|NCT02959190|472306717|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
131240882|NCT03451851|472504481|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131187420|NCT02959190|472306718|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
131187421|NCT02959190|472306719|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
131187422|NCT02959190|472306720|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
131187423|NCT00753688|472306721|FG000|Overall Study|Death|102|||
131187424|NCT00753688|472306722|FG001|Overall Study|Death|203|||
131187425|NCT00753688|472306721|FG000|Overall Study|Missing|4|||
131187426|NCT00753688|472306722|FG001|Overall Study|Missing|9|||
131187427|NCT00753688|472306721|FG000|Overall Study|Participant Withdrew Consent|2|||
131187428|NCT00753688|472306722|FG001|Overall Study|Participant Withdrew Consent|2|||
131187429|NCT00753688|472306721|FG000|Overall Study|Ongoing - in Follow-up|15|||
131187430|NCT00753688|472306722|FG001|Overall Study|Ongoing - in Follow-up|31|||
131187431|NCT00753688|472306721|FG000|Overall Study|Adverse Event|0|||
131187432|NCT00753688|472306722|FG001|Overall Study|Adverse Event|1|||
131187433|NCT00659126|472306723|FG000|Overall Study|Adverse Event|2|||
131187434|NCT00659126|472306724|FG001|Overall Study|Adverse Event|2|||
131187435|NCT00659126|472306723|FG000|Overall Study|Screen failure|1|||
131187436|NCT00659126|472306724|FG001|Overall Study|Screen failure|1|||
131187437|NCT00659126|472306723|FG000|Overall Study|Technical problems with MRI|0|||
131187438|NCT00659126|472306724|FG001|Overall Study|Technical problems with MRI|1|||
131187439|NCT02633046|472306727|FG000|Overall Study|Adverse Event|8|||
131187440|NCT02633046|472306727|FG000|Overall Study|Physician Decision|7|||
131187441|NCT02633046|472306727|FG000|Overall Study|Withdrawal by Subject|8|||
131187442|NCT02633046|472306727|FG000|Overall Study|Increased proteinuria|2|||
131187443|NCT02633046|472306727|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
131187444|NCT02633046|472306727|FG000|Overall Study|Mutual decision patient and physician|1|||
131187445|NCT02925312|472306728|FG000|Overall Study|Lost to Follow-up|25|||
131187446|NCT02925312|472306729|FG001|Overall Study|Lost to Follow-up|0|||
131187447|NCT02925312|472306728|FG000|Overall Study|Adverse Event|2|||
131187448|NCT02925312|472306729|FG001|Overall Study|Adverse Event|0|||
131187449|NCT01998399|472306738|FG000|Overall Study|Lost to Follow-up|1|||
131187450|NCT01998399|472306739|FG001|Overall Study|Lost to Follow-up|3|||
131187451|NCT01998399|472306738|FG000|Overall Study|Death|4|||
131187452|NCT01998399|472306739|FG001|Overall Study|Death|2|||
131187453|NCT01998399|472306738|FG000|Overall Study|Study stopped before dosing completed|3|||
131187454|NCT01998399|472306739|FG001|Overall Study|Study stopped before dosing completed|3|||
131187455|NCT01998399|472306738|FG000|Overall Study|Withdrawal by Subject|0|||
131187456|NCT01998399|472306739|FG001|Overall Study|Withdrawal by Subject|1|||
131187457|NCT00376246|472306741|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
131187458|NCT00376246|472306742|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
131187459|NCT00376246|472306741|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
131187460|NCT00376246|472306742|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
131187461|NCT00376246|472306741|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
131187462|NCT00376246|472306742|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
131187463|NCT01455415|472306746|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
131187464|NCT01455415|472306747|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
131187465|NCT01455415|472306746|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
131187466|NCT01455415|472306747|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
131187467|NCT01455415|472306746|FG000|Period 1|Drug Error not Associated to AE|0|||
131187468|NCT01455415|472306747|FG001|Period 1|Drug Error not Associated to AE|1|||
131187469|NCT01455415|472306746|FG000|Period 1|AE Not Related to Study Drug|2|||
131187470|NCT01455415|472306747|FG001|Period 1|AE Not Related to Study Drug|6|||
131187471|NCT01455415|472306746|FG000|Period 1|Withdrawal by Subject|4|||
131187472|NCT01455415|472306747|FG001|Period 1|Withdrawal by Subject|5|||
131187473|NCT01455415|472306746|FG000|Period 1|Unspecified Reason|1|||
131187474|NCT01455415|472306747|FG001|Period 1|Unspecified Reason|1|||
131187475|NCT01455415|472306746|FG000|Period 1|Protocol Violation|0|||
131187476|NCT01455415|472306747|FG001|Period 1|Protocol Violation|2|||
131187477|NCT01455415|472306746|FG000|Washout|AE Related to Study Drug|2|||
131187478|NCT01455415|472306747|FG001|Washout|AE Related to Study Drug|0|||
131187479|NCT01455415|472306746|FG000|Washout|Lost to Follow-up|1|||
131240883|NCT03451851|472504482|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131187480|NCT01455415|472306747|FG001|Washout|Lost to Follow-up|0|||
131187481|NCT01455415|472306746|FG000|Washout|Drug Error not Associated to AE|2|||
131240884|NCT03451851|472504483|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131240885|NCT03451851|472504484|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130784545|NCT01418339|470838816|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
131187482|NCT01455415|472306747|FG001|Washout|Drug Error not Associated to AE|1|||
131187483|NCT01455415|472306746|FG000|Washout|AE Not Related to Study Drug|2|||
131187484|NCT01455415|472306747|FG001|Washout|AE Not Related to Study Drug|3|||
131187485|NCT01455415|472306746|FG000|Washout|Unspecified Reason|1|||
131187486|NCT01455415|472306747|FG001|Washout|Unspecified Reason|2|||
131187487|NCT01455415|472306746|FG000|Washout|Protocol Violation|0|||
131187488|NCT01455415|472306747|FG001|Washout|Protocol Violation|1|||
131187489|NCT01455415|472306746|FG000|Period 2|AE Related to Study Drug|1|||
131240886|NCT03451851|472504485|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
131240887|NCT03451851|472504486|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131240888|NCT03451851|472504487|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131240889|NCT03451851|472504488|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
131240890|NCT03213704|472504489|FG000|Overall Study|Physician Decision|3|||
131240891|NCT03213704|472504489|FG000|Overall Study|Protocol Violation|1|||
131240892|NCT03213704|472504489|FG000|Overall Study|Progressive disease|4|||
131240893|NCT05125952|472504490|FG000|Overall Study|Physician Decision|1|||
131240894|NCT03946449|472504492|FG000|Treatment Extension II|Rolled over to another study|0|||
131240895|NCT03946449|472504493|FG001|Treatment Extension II|Rolled over to another study|0|||
131240896|NCT03946449|472504494|FG002|Treatment Extension II|Rolled over to another study|2|||
131240897|NCT03946449|472504492|FG000|Treatment Extension II|Withdrawal by Subject|0|||
131240898|NCT03946449|472504493|FG001|Treatment Extension II|Withdrawal by Subject|0|||
131240899|NCT03946449|472504494|FG002|Treatment Extension II|Withdrawal by Subject|1|||
131240900|NCT04852978|472504497|FG000|Overall Study|Physician Decision|0|||
131240901|NCT04852978|472504498|FG001|Overall Study|Physician Decision|1|||
131240902|NCT04852978|472504499|FG002|Overall Study|Physician Decision|0|||
131240903|NCT04852978|472504500|FG003|Overall Study|Physician Decision|0|||
131240904|NCT04852978|472504501|FG004|Overall Study|Physician Decision|0|||
131240905|NCT04852978|472504502|FG005|Overall Study|Physician Decision|0|||
131240906|NCT04852978|472504503|FG006|Overall Study|Physician Decision|0|||
131240907|NCT04852978|472504504|FG007|Overall Study|Physician Decision|2|||
131240908|NCT04852978|472504505|FG008|Overall Study|Physician Decision|0|||
131240909|NCT04852978|472504497|FG000|Overall Study|Sponsor request|0|||
131240910|NCT04852978|472504498|FG001|Overall Study|Sponsor request|0|||
131240911|NCT04852978|472504499|FG002|Overall Study|Sponsor request|1|||
131240912|NCT04852978|472504500|FG003|Overall Study|Sponsor request|0|||
131240913|NCT04852978|472504501|FG004|Overall Study|Sponsor request|0|||
131240914|NCT04852978|472504502|FG005|Overall Study|Sponsor request|0|||
131240915|NCT04852978|472504503|FG006|Overall Study|Sponsor request|0|||
131240916|NCT04852978|472504504|FG007|Overall Study|Sponsor request|0|||
131240917|NCT04852978|472504505|FG008|Overall Study|Sponsor request|0|||
131240918|NCT04852978|472504497|FG000|Overall Study|Death|0|||
131240919|NCT04852978|472504498|FG001|Overall Study|Death|0|||
131187490|NCT01455415|472306747|FG001|Period 2|AE Related to Study Drug|2|||
131187491|NCT01455415|472306746|FG000|Period 2|Lost to Follow-up|2|||
131187492|NCT01455415|472306747|FG001|Period 2|Lost to Follow-up|1|||
131187493|NCT01455415|472306746|FG000|Period 2|AE Not Related to Study Drug|2|||
131187494|NCT01455415|472306747|FG001|Period 2|AE Not Related to Study Drug|1|||
131187495|NCT01455415|472306746|FG000|Period 2|Lack of Efficacy|2|||
131187496|NCT01455415|472306747|FG001|Period 2|Lack of Efficacy|0|||
131187497|NCT01455415|472306746|FG000|Period 2|Withdrawal by Subject|2|||
131187498|NCT01455415|472306747|FG001|Period 2|Withdrawal by Subject|3|||
131187499|NCT01455415|472306746|FG000|Period 2|Unspecified Reason|2|||
131187500|NCT01455415|472306747|FG001|Period 2|Unspecified Reason|3|||
131187501|NCT01455415|472306746|FG000|Period 2|Protocol Violation|2|||
131187502|NCT01455415|472306747|FG001|Period 2|Protocol Violation|0|||
131187503|NCT01455415|472306746|FG000|Follow-up|AE Related to Study Drug|0|||
131187504|NCT01455415|472306747|FG001|Follow-up|AE Related to Study Drug|1|||
131187505|NCT01455415|472306746|FG000|Follow-up|Lack of Efficacy|0|||
131187506|NCT01455415|472306747|FG001|Follow-up|Lack of Efficacy|1|||
131187507|NCT01455415|472306746|FG000|Follow-up|Withdrawal by Subject|2|||
131187508|NCT01455415|472306747|FG001|Follow-up|Withdrawal by Subject|0|||
131187509|NCT01455415|472306746|FG000|Follow-up|Unspecified Reason|1|||
131187510|NCT01455415|472306747|FG001|Follow-up|Unspecified Reason|0|||
131187511|NCT00587301|472306748|FG000|Overall Study|Screen Failure|9|||
131187512|NCT00587301|472306748|FG000|Overall Study|Lost to Follow-up|22|||
131187513|NCT00587301|472306748|FG000|Overall Study|Withdrawal by Subject|7|||
131187514|NCT00587301|472306748|FG000|Overall Study|Protocol Violation|7|||
131187515|NCT02758613|472306751|FG000|Treatment|Physician and Sponsor Decision|1|||
131187516|NCT02758613|472306752|FG001|Treatment|Physician and Sponsor Decision|0|||
131240920|NCT04852978|472504499|FG002|Overall Study|Death|0|||
131240921|NCT04852978|472504500|FG003|Overall Study|Death|0|||
131240922|NCT04852978|472504501|FG004|Overall Study|Death|0|||
131240923|NCT04852978|472504502|FG005|Overall Study|Death|0|||
131240924|NCT04852978|472504503|FG006|Overall Study|Death|1|||
131240925|NCT04852978|472504504|FG007|Overall Study|Death|0|||
131187517|NCT02758613|472306753|FG002|Treatment|Physician and Sponsor Decision|0|||
130733541|NCT05026177|470642912|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
131187518|NCT02758613|472306754|FG003|Treatment|Physician and Sponsor Decision|0|||
131187519|NCT02758613|472306751|FG000|Treatment|Withdrawal by Subject|1|||
131187520|NCT02758613|472306752|FG001|Treatment|Withdrawal by Subject|0|||
131187521|NCT02758613|472306753|FG002|Treatment|Withdrawal by Subject|1|||
131187522|NCT02758613|472306754|FG003|Treatment|Withdrawal by Subject|0|||
131187523|NCT01496274|472306755|FG000|Overall Study|Protocol Violation|0|||
131187524|NCT01496274|472306756|FG001|Overall Study|Protocol Violation|1|||
131240926|NCT04852978|472504505|FG008|Overall Study|Death|0|||
131240927|NCT04852978|472504497|FG000|Overall Study|Lost to Follow-up|3|||
131240928|NCT04852978|472504498|FG001|Overall Study|Lost to Follow-up|2|||
131240929|NCT04852978|472504499|FG002|Overall Study|Lost to Follow-up|2|||
131240930|NCT04852978|472504500|FG003|Overall Study|Lost to Follow-up|0|||
131240931|NCT04852978|472504501|FG004|Overall Study|Lost to Follow-up|2|||
131240932|NCT04852978|472504502|FG005|Overall Study|Lost to Follow-up|4|||
131240933|NCT04852978|472504503|FG006|Overall Study|Lost to Follow-up|1|||
131240934|NCT04852978|472504504|FG007|Overall Study|Lost to Follow-up|2|||
131240935|NCT04852978|472504505|FG008|Overall Study|Lost to Follow-up|2|||
131240936|NCT04852978|472504497|FG000|Overall Study|Withdrawal by Subject|4|||
131240937|NCT04852978|472504498|FG001|Overall Study|Withdrawal by Subject|2|||
131240938|NCT04852978|472504499|FG002|Overall Study|Withdrawal by Subject|2|||
131240939|NCT04852978|472504500|FG003|Overall Study|Withdrawal by Subject|1|||
131240940|NCT04852978|472504501|FG004|Overall Study|Withdrawal by Subject|5|||
131240941|NCT04852978|472504502|FG005|Overall Study|Withdrawal by Subject|3|||
131240942|NCT04852978|472504503|FG006|Overall Study|Withdrawal by Subject|2|||
131240943|NCT04852978|472504504|FG007|Overall Study|Withdrawal by Subject|2|||
131240944|NCT04852978|472504505|FG008|Overall Study|Withdrawal by Subject|1|||
131240945|NCT03474965|472504506|FG000|Overall Study|Pregnancy|1|||
131240946|NCT03474965|472504507|FG001|Overall Study|Pregnancy|0|||
131240947|NCT03474965|472504508|FG002|Overall Study|Pregnancy|0|||
131240948|NCT03474965|472504509|FG003|Overall Study|Pregnancy|0|||
131240949|NCT03474965|472504506|FG000|Overall Study|Lost to Follow-up|0|||
131240950|NCT03474965|472504507|FG001|Overall Study|Lost to Follow-up|0|||
131240951|NCT03474965|472504508|FG002|Overall Study|Lost to Follow-up|1|||
131240952|NCT03474965|472504509|FG003|Overall Study|Lost to Follow-up|0|||
131240953|NCT03474965|472504506|FG000|Overall Study|Death|1|||
131240954|NCT03474965|472504507|FG001|Overall Study|Death|0|||
131240955|NCT03474965|472504508|FG002|Overall Study|Death|0|||
131240956|NCT03474965|472504509|FG003|Overall Study|Death|0|||
131240957|NCT03474965|472504506|FG000|Overall Study|Adverse Event|1|||
131240958|NCT03474965|472504507|FG001|Overall Study|Adverse Event|0|||
131240959|NCT03474965|472504508|FG002|Overall Study|Adverse Event|0|||
131240960|NCT03474965|472504509|FG003|Overall Study|Adverse Event|1|||
131240961|NCT03474965|472504506|FG000|Overall Study|Physician Decision|3|||
131240962|NCT03474965|472504507|FG001|Overall Study|Physician Decision|1|||
131240963|NCT03474965|472504508|FG002|Overall Study|Physician Decision|2|||
131240964|NCT03474965|472504509|FG003|Overall Study|Physician Decision|0|||
131240965|NCT03474965|472504506|FG000|Overall Study|Participant Decision|7|||
131240966|NCT03474965|472504507|FG001|Overall Study|Participant Decision|0|||
131240967|NCT03474965|472504508|FG002|Overall Study|Participant Decision|1|||
131240968|NCT03474965|472504509|FG003|Overall Study|Participant Decision|0|||
131240969|NCT03474965|472504506|FG000|Overall Study|Guardian Decision|4|||
131240970|NCT03474965|472504507|FG001|Overall Study|Guardian Decision|2|||
131240971|NCT03474965|472504508|FG002|Overall Study|Guardian Decision|7|||
131240972|NCT03474965|472504509|FG003|Overall Study|Guardian Decision|2|||
131240973|NCT05067504|472504940|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
131240974|NCT05067504|472504941|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
131240975|NCT05067504|472504940|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
131240976|NCT05067504|472504941|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
131240977|NCT05067504|472504940|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
131240978|NCT05067504|472504941|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
131240979|NCT02294461|472504944|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
131240980|NCT02294461|472504945|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
131240981|NCT02294461|472504946|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
131240982|NCT02294461|472504944|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
131240983|NCT02294461|472504945|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
131240984|NCT02294461|472504946|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
131240985|NCT02294461|472504944|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
131240986|NCT02294461|472504945|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
131240987|NCT02294461|472504946|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
131240988|NCT02294461|472504944|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
131240989|NCT02294461|472504945|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
131240990|NCT02294461|472504946|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
131240991|NCT02294461|472504944|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
131240992|NCT02294461|472504945|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
131240993|NCT02294461|472504946|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
131240994|NCT02294461|472504944|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
131240995|NCT02294461|472504945|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
131240996|NCT02294461|472504946|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
131240997|NCT02294461|472504944|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
131240998|NCT02294461|472504945|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
131240999|NCT02294461|472504946|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
131241000|NCT02294461|472504944|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
131187525|NCT01496274|472306755|FG000|Overall Study|Adverse Event|1|||
131187526|NCT01496274|472306756|FG001|Overall Study|Adverse Event|1|||
131187527|NCT01496274|472306755|FG000|Overall Study|Withdrawal by Subject|2|||
131187528|NCT01496274|472306756|FG001|Overall Study|Withdrawal by Subject|0|||
131187529|NCT01496274|472306755|FG000|Overall Study|Lost to Follow-up|0|||
131187530|NCT01496274|472306756|FG001|Overall Study|Lost to Follow-up|3|||
131187531|NCT00351819|472306758|FG000|Overall Study|Lost to Follow-up|4|||
131187532|NCT00351819|472306759|FG001|Overall Study|Lost to Follow-up|4|||
131187533|NCT00351819|472306758|FG000|Overall Study|Withdrawal by Subject|0|||
131187534|NCT00351819|472306759|FG001|Overall Study|Withdrawal by Subject|4|||
131187535|NCT00351819|472306758|FG000|Overall Study|Elevated PSA|1|||
131187536|NCT00351819|472306759|FG001|Overall Study|Elevated PSA|1|||
131187537|NCT00351819|472306758|FG000|Overall Study|Traumatic ankle fracture|1|||
131187538|NCT00351819|472306759|FG001|Overall Study|Traumatic ankle fracture|0|||
131187539|NCT00351819|472306758|FG000|Overall Study|Unprofessional behavior|1|||
131187540|NCT00351819|472306759|FG001|Overall Study|Unprofessional behavior|0|||
131187541|NCT00351819|472306758|FG000|Overall Study|Non-compliance|0|||
131187542|NCT00351819|472306759|FG001|Overall Study|Non-compliance|1|||
131187543|NCT00351819|472306758|FG000|Overall Study|Incarcerated|0|||
131187544|NCT00351819|472306759|FG001|Overall Study|Incarcerated|1|||
131187545|NCT00351819|472306758|FG000|Overall Study|Enrolled in another trial|0|||
131187546|NCT00351819|472306759|FG001|Overall Study|Enrolled in another trial|1|||
131187547|NCT00418717|472306762|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
131187548|NCT00418717|472306762|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
131187549|NCT00719537|472306765|FG000|Overall Study|Withdrawal by Subject|1|||
131187550|NCT00719537|472306766|FG001|Overall Study|Withdrawal by Subject|0|||
131187551|NCT00719537|472306765|FG000|Overall Study|Lost to Follow-up|0|||
131187552|NCT00719537|472306766|FG001|Overall Study|Lost to Follow-up|1|||
131187553|NCT01142193|472306767|FG000|Overall Study|Adverse Event|12|||
131187554|NCT01142193|472306768|FG001|Overall Study|Adverse Event|4|||
131187555|NCT01142193|472306767|FG000|Overall Study|Lack of Efficacy|2|||
131187556|NCT01142193|472306768|FG001|Overall Study|Lack of Efficacy|1|||
131187557|NCT01142193|472306767|FG000|Overall Study|Physician Decision|1|||
131187558|NCT01142193|472306768|FG001|Overall Study|Physician Decision|1|||
131187559|NCT01142193|472306767|FG000|Overall Study|Withdrawal by Subject|4|||
131187560|NCT01142193|472306768|FG001|Overall Study|Withdrawal by Subject|3|||
131187561|NCT01142193|472306767|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
131187562|NCT01142193|472306768|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
131187563|NCT01142193|472306767|FG000|Overall Study|Other|1|||
131187564|NCT01142193|472306768|FG001|Overall Study|Other|2|||
131187565|NCT02910219|472306769|FG000|Overall Study|Withdrawal by Subject|1|||
131187566|NCT02910219|472306770|FG001|Overall Study|Withdrawal by Subject|1|||
131187567|NCT01015820|472306771|FG000|Overall Study|Suboptimal measurements|1|||
131187568|NCT01015820|472306772|FG001|Overall Study|Suboptimal measurements|0|||
131187569|NCT00701441|472306773|FG000|Overall Study|failure in cpap compliance|0|||
131187570|NCT00701441|472306774|FG001|Overall Study|failure in cpap compliance|4|||
131187571|NCT01313078|472306776|FG000|Overall Study|Death|1|||
131187572|NCT01313078|472306776|FG000|Overall Study|Discontinued study drug|1|||
131187573|NCT01313078|472306776|FG000|Overall Study|Withdrawal by Subject|1|||
131187574|NCT01225172|472306781|FG000|Overall Study|Subject decision to stop|1|||
131187575|NCT01225172|472306782|FG001|Overall Study|Subject decision to stop|0|||
131187576|NCT01225172|472306781|FG000|Overall Study|Subject request to discontinue treatment|3|||
131187577|NCT01225172|472306782|FG001|Overall Study|Subject request to discontinue treatment|1|||
131187578|NCT01225172|472306781|FG000|Overall Study|Subject no longer meets study criteria|1|||
131187579|NCT01225172|472306782|FG001|Overall Study|Subject no longer meets study criteria|0|||
131187580|NCT01225172|472306781|FG000|Overall Study|Withdrawal by Subject|1|||
131187581|NCT01225172|472306782|FG001|Overall Study|Withdrawal by Subject|0|||
131187582|NCT02679781|472306783|FG000|Overall Study|Lost to Follow-up|1|||
131187583|NCT02679781|472306784|FG001|Overall Study|Lost to Follow-up|2|||
131187584|NCT02679781|472306783|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
131187585|NCT02679781|472306784|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
131187586|NCT04209400|472306785|FG000|Overall Study|Withdrawal by Subject|0|||
131187587|NCT04209400|472306786|FG001|Overall Study|Withdrawal by Subject|1|||
131187588|NCT00795509|472306787|FG000|Overall Study|Protocol Violation|31|||
131187589|NCT00383708|472306791|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
131187590|NCT00383708|472306791|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
131187591|NCT00383708|472306791|FG000|Run-in Period|Protocol Violation|4|||
131187592|NCT00383708|472306791|FG000|Run-in Period|Adverse Event|2|||
131187593|NCT00383708|472306791|FG000|Run-in Period|Claustrophobia|1|||
131187594|NCT00383708|472306791|FG000|Co-administration Period|Adverse Event|5|||
131187595|NCT01576406|472306793|FG000|Overall Study|Lost to Follow-up|1|||
131187596|NCT01576406|472306794|FG001|Overall Study|Lost to Follow-up|2|||
131187597|NCT01576406|472306795|FG002|Overall Study|Lost to Follow-up|0|||
131187598|NCT01576406|472306796|FG003|Overall Study|Lost to Follow-up|0|||
131187599|NCT01576406|472306797|FG004|Overall Study|Lost to Follow-up|0|||
131187600|NCT01576406|472306798|FG005|Overall Study|Lost to Follow-up|0|||
131187601|NCT01576406|472306793|FG000|Overall Study|Death|3|||
131187602|NCT01576406|472306794|FG001|Overall Study|Death|4|||
131187603|NCT01576406|472306795|FG002|Overall Study|Death|8|||
131187604|NCT01576406|472306796|FG003|Overall Study|Death|5|||
131187605|NCT01576406|472306797|FG004|Overall Study|Death|7|||
131187606|NCT01576406|472306798|FG005|Overall Study|Death|9|||
131187607|NCT01576406|472306793|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
131187608|NCT01576406|472306794|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
131187609|NCT01576406|472306795|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
131187610|NCT01576406|472306796|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
131187611|NCT01576406|472306797|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
131187612|NCT01576406|472306798|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
131187613|NCT01576406|472306793|FG000|Overall Study|Withdrawal the consent|2|||
131187614|NCT01576406|472306794|FG001|Overall Study|Withdrawal the consent|2|||
131187615|NCT01576406|472306795|FG002|Overall Study|Withdrawal the consent|5|||
131187616|NCT01576406|472306796|FG003|Overall Study|Withdrawal the consent|1|||
131187617|NCT01576406|472306797|FG004|Overall Study|Withdrawal the consent|1|||
131187618|NCT01576406|472306798|FG005|Overall Study|Withdrawal the consent|3|||
131187619|NCT01576406|472306793|FG000|Overall Study|Other|0|||
131187620|NCT01576406|472306794|FG001|Overall Study|Other|0|||
131187621|NCT01576406|472306795|FG002|Overall Study|Other|2|||
131187622|NCT01576406|472306796|FG003|Overall Study|Other|2|||
131187623|NCT01576406|472306797|FG004|Overall Study|Other|0|||
131187624|NCT01576406|472306798|FG005|Overall Study|Other|0|||
131187625|NCT00669032|472306803|FG000|Overall Study|Lost to Follow-up|6|||
131187626|NCT00669032|472306804|FG001|Overall Study|Lost to Follow-up|5|||
131187627|NCT00669032|472306803|FG000|Overall Study|Lack of Efficacy|8|||
131187628|NCT00669032|472306804|FG001|Overall Study|Lack of Efficacy|19|||
131187629|NCT00669032|472306803|FG000|Overall Study|Withdrawal by Subject|12|||
131187630|NCT00669032|472306804|FG001|Overall Study|Withdrawal by Subject|13|||
131187631|NCT00669032|472306803|FG000|Overall Study|Adverse Event|12|||
131187632|NCT00669032|472306804|FG001|Overall Study|Adverse Event|16|||
131187633|NCT00669032|472306803|FG000|Overall Study|Physician Decision|1|||
131187634|NCT00669032|472306804|FG001|Overall Study|Physician Decision|1|||
131187635|NCT00669032|472306803|FG000|Overall Study|No fulfilment of the selection criteria|5|||
131187636|NCT00669032|472306804|FG001|Overall Study|No fulfilment of the selection criteria|5|||
131187637|NCT01607073|472306805|FG000|Overall Study|Adverse Event|1|||
131187638|NCT01375647|472309030|FG000|Overall Study|Lost to Follow-up|3|||
131187639|NCT01375647|472309031|FG001|Overall Study|Lost to Follow-up|3|||
131187640|NCT01375647|472309032|FG002|Overall Study|Lost to Follow-up|7|||
131187641|NCT01375647|472309033|FG003|Overall Study|Lost to Follow-up|10|||
131187642|NCT01375647|472309030|FG000|Overall Study|Death|1|||
131187643|NCT01375647|472309031|FG001|Overall Study|Death|2|||
131187644|NCT01375647|472309032|FG002|Overall Study|Death|1|||
131187645|NCT01375647|472309033|FG003|Overall Study|Death|0|||
131187646|NCT01375647|472309030|FG000|Overall Study|Withdrawal by Subject|17|||
131187647|NCT01375647|472309031|FG001|Overall Study|Withdrawal by Subject|20|||
131187648|NCT01375647|472309032|FG002|Overall Study|Withdrawal by Subject|26|||
131187649|NCT01375647|472309033|FG003|Overall Study|Withdrawal by Subject|14|||
131187650|NCT01375647|472309030|FG000|Overall Study|Physician Decision|1|||
131187651|NCT01375647|472309031|FG001|Overall Study|Physician Decision|0|||
131187652|NCT01375647|472309032|FG002|Overall Study|Physician Decision|0|||
131187653|NCT01375647|472309033|FG003|Overall Study|Physician Decision|0|||
131187654|NCT03366844|472309034|FG000|Overall Study|Physician Decision|1|||
131187655|NCT03366844|472309034|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
131187656|NCT02088541|472309039|FG000|Overall Study|Adverse Event|3|||
131187657|NCT02088541|472309040|FG001|Overall Study|Adverse Event|0|||
131187658|NCT02088541|472309041|FG002|Overall Study|Adverse Event|3|||
131187659|NCT02088541|472309042|FG003|Overall Study|Adverse Event|3|||
131187660|NCT02088541|472309043|FG004|Overall Study|Adverse Event|0|||
131187661|NCT02088541|472309039|FG000|Overall Study|Death|51|||
131187662|NCT02088541|472309040|FG001|Overall Study|Death|21|||
131187663|NCT02088541|472309041|FG002|Overall Study|Death|85|||
131187664|NCT02088541|472309042|FG003|Overall Study|Death|28|||
131187665|NCT02088541|472309043|FG004|Overall Study|Death|38|||
131187666|NCT02088541|472309039|FG000|Overall Study|Lost to Follow-up|2|||
131187667|NCT02088541|472309040|FG001|Overall Study|Lost to Follow-up|0|||
131187668|NCT02088541|472309041|FG002|Overall Study|Lost to Follow-up|1|||
131187669|NCT02088541|472309042|FG003|Overall Study|Lost to Follow-up|0|||
131187670|NCT02088541|472309043|FG004|Overall Study|Lost to Follow-up|0|||
131187671|NCT02088541|472309039|FG000|Overall Study|Physician Decision|2|||
131187672|NCT02088541|472309040|FG001|Overall Study|Physician Decision|1|||
131187673|NCT02088541|472309041|FG002|Overall Study|Physician Decision|2|||
131187674|NCT02088541|472309042|FG003|Overall Study|Physician Decision|0|||
131187675|NCT02088541|472309043|FG004|Overall Study|Physician Decision|2|||
131187676|NCT02088541|472309039|FG000|Overall Study|Disease progression|7|||
131187677|NCT02088541|472309040|FG001|Overall Study|Disease progression|1|||
131187678|NCT02088541|472309041|FG002|Overall Study|Disease progression|2|||
131187679|NCT02088541|472309042|FG003|Overall Study|Disease progression|3|||
131241001|NCT02294461|472504945|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
131241002|NCT02294461|472504946|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
131241003|NCT02294461|472504944|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
131241004|NCT02294461|472504945|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
131241005|NCT02294461|472504946|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
131241006|NCT02294461|472504944|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
131241007|NCT02294461|472504945|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
131241008|NCT02294461|472504946|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
131241009|NCT02294461|472504944|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
131241010|NCT02294461|472504945|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
131241011|NCT02294461|472504946|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
131241012|NCT02294461|472504944|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
131241013|NCT02294461|472504945|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
131241014|NCT02294461|472504946|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
131241015|NCT02294461|472504944|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
131241016|NCT02294461|472504945|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
131241017|NCT02294461|472504946|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
131241018|NCT02294461|472504944|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
131241019|NCT02294461|472504945|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
131241020|NCT02294461|472504946|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
130733542|NCT05026177|470642913|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
131187680|NCT02088541|472309043|FG004|Overall Study|Disease progression|1|||
131187681|NCT02088541|472309039|FG000|Overall Study|Study terminated by sponsor|1|||
131187682|NCT02088541|472309040|FG001|Overall Study|Study terminated by sponsor|1|||
131187683|NCT02088541|472309041|FG002|Overall Study|Study terminated by sponsor|12|||
131187684|NCT02088541|472309042|FG003|Overall Study|Study terminated by sponsor|2|||
131187685|NCT02088541|472309043|FG004|Overall Study|Study terminated by sponsor|6|||
131187686|NCT02088541|472309039|FG000|Overall Study|Withdrawal by Subject|3|||
131187687|NCT02088541|472309040|FG001|Overall Study|Withdrawal by Subject|2|||
131187688|NCT02088541|472309041|FG002|Overall Study|Withdrawal by Subject|9|||
131187689|NCT02088541|472309042|FG003|Overall Study|Withdrawal by Subject|7|||
131187690|NCT02088541|472309043|FG004|Overall Study|Withdrawal by Subject|10|||
131187691|NCT02088541|472309039|FG000|Overall Study|Other|2|||
131187692|NCT02088541|472309040|FG001|Overall Study|Other|1|||
131187693|NCT02088541|472309041|FG002|Overall Study|Other|3|||
131187694|NCT02088541|472309042|FG003|Overall Study|Other|1|||
131187695|NCT02088541|472309043|FG004|Overall Study|Other|1|||
131187696|NCT00323310|472309045|FG000|Overall Study|Withdrawal by Subject|1|||
131187697|NCT00323310|472309045|FG000|Overall Study|a parent refused blood draw|1|||
131187698|NCT00323310|472309045|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
131187699|NCT03984812|472309046|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131187700|NCT03984812|472309047|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131187701|NCT03984812|472309048|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
131187702|NCT03984812|472309049|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131187703|NCT03984812|472309050|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131187704|NCT03984812|472309051|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131187705|NCT03984812|472309052|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131187706|NCT03984812|472309053|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131187707|NCT03984812|472309054|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131187708|NCT03984812|472309055|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131187709|NCT03984812|472309056|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
131187710|NCT00446641|472309057|FG000|Overall Study|Withdrawal by Subject|8|||
131187711|NCT00446641|472309058|FG001|Overall Study|Withdrawal by Subject|3|||
131187712|NCT00446641|472309057|FG000|Overall Study|poor compliance|8|||
131187713|NCT00446641|472309058|FG001|Overall Study|poor compliance|6|||
131187714|NCT00446641|472309057|FG000|Overall Study|Lost to Follow-up|1|||
131187715|NCT00446641|472309058|FG001|Overall Study|Lost to Follow-up|1|||
131187716|NCT02707601|472309061|FG000|Overall Study|Death|0|||
131187717|NCT02707601|472309062|FG001|Overall Study|Death|1|||
131187718|NCT02707601|472309061|FG000|Overall Study|Lack of Efficacy|0|||
131187719|NCT02707601|472309062|FG001|Overall Study|Lack of Efficacy|1|||
131187720|NCT02707601|472309061|FG000|Overall Study|Investigator's Discretion|1|||
131187721|NCT02707601|472309062|FG001|Overall Study|Investigator's Discretion|0|||
131187722|NCT02707601|472309061|FG000|Overall Study|Withdrew Consent|0|||
131187723|NCT02707601|472309062|FG001|Overall Study|Withdrew Consent|1|||
131187724|NCT02707601|472309061|FG000|Overall Study|Lost to Follow-up|1|||
131187725|NCT02707601|472309062|FG001|Overall Study|Lost to Follow-up|1|||
131187726|NCT02707601|472309061|FG000|Overall Study|Participants Randomized but Not Treated|2|||
131187727|NCT02707601|472309062|FG001|Overall Study|Participants Randomized but Not Treated|0|||
131187728|NCT00666536|472309064|FG000|Overall Study|Adverse Event|9|||
131187729|NCT00666536|472309065|FG001|Overall Study|Adverse Event|19|||
131187730|NCT00666536|472309064|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
131187731|NCT00666536|472309065|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
131187732|NCT00666536|472309064|FG000|Overall Study|Protocol deviation(s)|8|||
131187733|NCT00666536|472309065|FG001|Overall Study|Protocol deviation(s)|6|||
131187734|NCT00666536|472309064|FG000|Overall Study|Withdrawal by Subject|10|||
131187735|NCT00666536|472309065|FG001|Overall Study|Withdrawal by Subject|9|||
131187736|NCT00666536|472309064|FG000|Overall Study|Lost to Follow-up|4|||
131187737|NCT00666536|472309065|FG001|Overall Study|Lost to Follow-up|3|||
131187738|NCT04839393|472309066|FG000|Overall Study|Adverse Event|0|||
131187739|NCT04839393|472309067|FG001|Overall Study|Adverse Event|0|||
131187740|NCT04839393|472309068|FG002|Overall Study|Adverse Event|2|||
131187741|NCT04839393|472309066|FG000|Overall Study|Withdrawal by participant|0|||
131187742|NCT04839393|472309067|FG001|Overall Study|Withdrawal by participant|0|||
131187743|NCT04839393|472309068|FG002|Overall Study|Withdrawal by participant|1|||
131187744|NCT00608881|472309073|FG000|Overall Study|Death|22|||
131187745|NCT00608881|472309074|FG001|Overall Study|Death|13|||
131187746|NCT00608881|472309073|FG000|Overall Study|Adverse Event|5|||
131187747|NCT00608881|472309074|FG001|Overall Study|Adverse Event|3|||
131187748|NCT00608881|472309073|FG000|Overall Study|Lost to Follow-up|28|||
131187749|NCT00608881|472309074|FG001|Overall Study|Lost to Follow-up|14|||
131187750|NCT00608881|472309073|FG000|Overall Study|Withdrawal by Subject|18|||
131187751|NCT00608881|472309074|FG001|Overall Study|Withdrawal by Subject|29|||
131187752|NCT00608881|472309073|FG000|Overall Study|Physician Decision|5|||
131187753|NCT00608881|472309074|FG001|Overall Study|Physician Decision|5|||
131187754|NCT00608881|472309073|FG000|Overall Study|Institutionalized|1|||
131187755|NCT00608881|472309074|FG001|Overall Study|Institutionalized|2|||
131187756|NCT00633893|472309075|FG000|Overall Study|Death|1|||
131187757|NCT00633893|472309076|FG001|Overall Study|Death|3|||
131187758|NCT00633893|472309077|FG002|Overall Study|Death|9|||
131187759|NCT00633893|472309075|FG000|Overall Study|Adverse Event|65|||
131187760|NCT00633893|472309076|FG001|Overall Study|Adverse Event|58|||
131187761|NCT00633893|472309077|FG002|Overall Study|Adverse Event|126|||
131187762|NCT00633893|472309075|FG000|Overall Study|Withdrawal by Subject|7|||
131187763|NCT00633893|472309076|FG001|Overall Study|Withdrawal by Subject|12|||
131187764|NCT00633893|472309077|FG002|Overall Study|Withdrawal by Subject|6|||
131187765|NCT00633893|472309075|FG000|Overall Study|Lost to Follow-up|2|||
131187766|NCT00633893|472309076|FG001|Overall Study|Lost to Follow-up|4|||
131187767|NCT00633893|472309077|FG002|Overall Study|Lost to Follow-up|8|||
131187768|NCT00633893|472309075|FG000|Overall Study|Poor/non-compliance|5|||
131187769|NCT00633893|472309076|FG001|Overall Study|Poor/non-compliance|12|||
131187770|NCT00633893|472309077|FG002|Overall Study|Poor/non-compliance|3|||
131187771|NCT00633893|472309075|FG000|Overall Study|Pregnancy|2|||
131187772|NCT00633893|472309076|FG001|Overall Study|Pregnancy|1|||
131187773|NCT00633893|472309077|FG002|Overall Study|Pregnancy|1|||
131187774|NCT00633893|472309075|FG000|Overall Study|Not meet/no longer meets criteria|4|||
131187775|NCT00633893|472309076|FG001|Overall Study|Not meet/no longer meets criteria|6|||
131187776|NCT00633893|472309077|FG002|Overall Study|Not meet/no longer meets criteria|4|||
131187777|NCT00633893|472309075|FG000|Overall Study|Other|28|||
131187778|NCT00633893|472309076|FG001|Overall Study|Other|33|||
131187779|NCT00633893|472309077|FG002|Overall Study|Other|31|||
131187780|NCT05091918|472309078|FG000|Overall Study|Adverse Event|1|||
131187781|NCT05091918|472309078|FG000|Overall Study|Withdrawal by Subject|81|||
130733543|NCT05026177|470642911|FG000|Overall Study|Starting alternative treatment|0|||
130733544|NCT05026177|470642912|FG001|Overall Study|Starting alternative treatment|1|||
131187782|NCT00239356|472309080|FG000|Overall Study|Lack of Efficacy|1|||
131187783|NCT00239356|472309081|FG001|Overall Study|Lack of Efficacy|0|||
131187784|NCT00239356|472309080|FG000|Overall Study|Adverse Event|6|||
131187785|NCT00239356|472309081|FG001|Overall Study|Adverse Event|0|||
131187786|NCT00239356|472309080|FG000|Overall Study|Withdrawal by Subject|15|||
131187787|NCT00239356|472309081|FG001|Overall Study|Withdrawal by Subject|6|||
131187788|NCT00239356|472309080|FG000|Overall Study|Lost to Follow-up|3|||
131187789|NCT00239356|472309081|FG001|Overall Study|Lost to Follow-up|0|||
131187790|NCT00239356|472309080|FG000|Overall Study|poor/non-compliance|2|||
131187791|NCT00239356|472309081|FG001|Overall Study|poor/non-compliance|0|||
131187792|NCT00239356|472309080|FG000|Overall Study|Pregnancy|1|||
131187793|NCT00239356|472309081|FG001|Overall Study|Pregnancy|0|||
131187794|NCT00239356|472309080|FG000|Overall Study|Administrative reason|0|||
131187795|NCT00239356|472309081|FG001|Overall Study|Administrative reason|1|||
131187796|NCT00239356|472309080|FG000|Overall Study|Drug available on market|11|||
131187797|NCT00239356|472309081|FG001|Overall Study|Drug available on market|2|||
131187798|NCT02044822|472309082|FG000|Overall Study|Study Terminated by Sponsor|77|||
131187799|NCT02044822|472309082|FG000|Overall Study|Investigator's Discretion|10|||
131187800|NCT02044822|472309082|FG000|Overall Study|Withdrew Consent|3|||
131187801|NCT02044822|472309082|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
131187802|NCT02044822|472309082|FG000|Overall Study|Lost to Follow-up|1|||
131187803|NCT03417505|472309083|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
131187804|NCT03417505|472309084|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
131187805|NCT03210220|472309085|FG000|Overall Study|Physician Decision|1|||
131187806|NCT03210220|472309086|FG001|Overall Study|Physician Decision|0|||
131187807|NCT00653328|472309087|FG000|Overall Study|Withdrawal by Subject|1|||
131187808|NCT00653328|472309087|FG000|Overall Study|Adverse Event|2|||
131187809|NCT00653328|472309087|FG000|Overall Study|Disease progression|10|||
131187810|NCT00653328|472309087|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
131187811|NCT02911519|472309088|FG000|Overall Study|Lost to Follow-up|2|||
131187812|NCT02911519|472309089|FG001|Overall Study|Lost to Follow-up|2|||
130733545|NCT05026177|470642913|FG002|Overall Study|Starting alternative treatment|1|||
130733546|NCT05026177|470642911|FG000|Overall Study|Noncompliance with study procedures|0|||
131187813|NCT02911519|472309088|FG000|Overall Study|Death|0|||
131187814|NCT02911519|472309089|FG001|Overall Study|Death|2|||
131187815|NCT01237223|472309098|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
131187816|NCT01237223|472309099|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
131187817|NCT01237223|472309100|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
131187818|NCT01237223|472309101|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
131187819|NCT01237223|472309102|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
131187820|NCT01237223|472309103|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
131187821|NCT01237223|472309098|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
131187822|NCT01237223|472309099|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
131187823|NCT01237223|472309100|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
131187824|NCT01237223|472309101|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
131187825|NCT01237223|472309102|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
131187826|NCT01237223|472309103|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
131187827|NCT01237223|472309098|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
131187828|NCT01237223|472309099|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
131187829|NCT01237223|472309100|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
131187830|NCT01237223|472309101|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
131187831|NCT01237223|472309102|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
131187832|NCT01237223|472309103|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
131187833|NCT01237223|472309098|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
131187834|NCT01237223|472309099|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
131187835|NCT01237223|472309100|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
131187836|NCT01237223|472309101|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
131187837|NCT01237223|472309102|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
131187838|NCT01237223|472309103|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
131187839|NCT01237223|472309098|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
131187840|NCT01237223|472309099|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
131187841|NCT01237223|472309100|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
131187842|NCT01237223|472309101|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
131187843|NCT01237223|472309102|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
131187844|NCT01237223|472309103|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
131187845|NCT01237223|472309098|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
131187846|NCT01237223|472309099|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
131187847|NCT01237223|472309100|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
131187848|NCT01237223|472309101|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
131187849|NCT01237223|472309102|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
131187850|NCT01237223|472309103|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
131187851|NCT01237223|472309098|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
131187852|NCT01237223|472309099|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
131187853|NCT01237223|472309100|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
131187854|NCT01237223|472309101|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
131187855|NCT01237223|472309102|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
131187856|NCT01237223|472309103|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
131187857|NCT01237223|472309098|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
131187858|NCT01237223|472309099|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
131187859|NCT01237223|472309100|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
131187860|NCT01237223|472309101|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
131187861|NCT01237223|472309102|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
131187862|NCT01237223|472309103|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
131187863|NCT01237223|472309098|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
131187864|NCT01237223|472309099|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
131187865|NCT01237223|472309100|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
131187866|NCT01237223|472309101|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
131187867|NCT01237223|472309102|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
131187868|NCT01237223|472309103|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
131187869|NCT01237223|472309098|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
131187870|NCT01237223|472309099|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
131187871|NCT01237223|472309100|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
131187872|NCT01237223|472309101|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
131187873|NCT01237223|472309102|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
131187874|NCT01237223|472309103|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
131187875|NCT00839436|472309104|FG000|Overall Study|Developed exclusionary condition|1|||
131187876|NCT00839436|472309105|FG001|Overall Study|Developed exclusionary condition|0|||
131187877|NCT00839436|472309106|FG002|Overall Study|Developed exclusionary condition|0|||
131187878|NCT00839436|472309104|FG000|Overall Study|Withdrawal by Subject|0|||
131187879|NCT00839436|472309105|FG001|Overall Study|Withdrawal by Subject|1|||
131187880|NCT00839436|472309106|FG002|Overall Study|Withdrawal by Subject|0|||
131187881|NCT00839436|472309104|FG000|Overall Study|Study drug no longer available|0|||
131187882|NCT00839436|472309105|FG001|Overall Study|Study drug no longer available|0|||
131187883|NCT00839436|472309106|FG002|Overall Study|Study drug no longer available|1|||
131187884|NCT00407550|472309111|FG000|Overall Study|Adverse Event|0|||
131187885|NCT00407550|472309112|FG001|Overall Study|Adverse Event|1|||
131187886|NCT00407550|472309111|FG000|Overall Study|Withdrawal by Subject|0|||
131187887|NCT00407550|472309112|FG001|Overall Study|Withdrawal by Subject|2|||
131187888|NCT00407550|472309111|FG000|Overall Study|Death|1|||
131187889|NCT00407550|472309112|FG001|Overall Study|Death|0|||
131187890|NCT00407550|472309111|FG000|Overall Study|Insurance or Other medical condition|2|||
131187891|NCT00407550|472309112|FG001|Overall Study|Insurance or Other medical condition|1|||
131187892|NCT01444898|472309114|FG000|Overall Study|Withdrawal by Subject|1|||
131187893|NCT00443846|472309116|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
131187894|NCT00443846|472309117|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
131187895|NCT00443846|472309116|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
131187896|NCT00443846|472309117|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
131187897|NCT00443846|472309116|FG000|Overall Study|Adverse Event|0|||
131187898|NCT00443846|472309117|FG001|Overall Study|Adverse Event|1|||
131187899|NCT00443846|472309116|FG000|Overall Study|Personal reason|8|||
131187900|NCT00443846|472309117|FG001|Overall Study|Personal reason|3|||
131187901|NCT00443846|472309116|FG000|Overall Study|Lost to Follow-up|1|||
131187902|NCT00443846|472309117|FG001|Overall Study|Lost to Follow-up|2|||
131187903|NCT02580591|472309118|FG000|Overall Study|Adverse Event|0|||
131187904|NCT02580591|472309119|FG001|Overall Study|Adverse Event|1|||
131187905|NCT02580591|472309120|FG002|Overall Study|Adverse Event|2|||
131187906|NCT02580591|472309121|FG003|Overall Study|Adverse Event|5|||
131187907|NCT02580591|472309118|FG000|Overall Study|Protocol Violation|3|||
131187908|NCT02580591|472309119|FG001|Overall Study|Protocol Violation|2|||
131187909|NCT02580591|472309120|FG002|Overall Study|Protocol Violation|1|||
131187910|NCT02580591|472309121|FG003|Overall Study|Protocol Violation|1|||
131187911|NCT02580591|472309118|FG000|Overall Study|Lost to Follow-up|5|||
131187912|NCT02580591|472309119|FG001|Overall Study|Lost to Follow-up|3|||
131187913|NCT02580591|472309120|FG002|Overall Study|Lost to Follow-up|3|||
131187914|NCT02580591|472309121|FG003|Overall Study|Lost to Follow-up|1|||
131187915|NCT02580591|472309118|FG000|Overall Study|Withdrawal by Subject|6|||
131187916|NCT02580591|472309119|FG001|Overall Study|Withdrawal by Subject|1|||
131187917|NCT02580591|472309120|FG002|Overall Study|Withdrawal by Subject|2|||
131187918|NCT02580591|472309121|FG003|Overall Study|Withdrawal by Subject|3|||
131187919|NCT02580591|472309118|FG000|Overall Study|Not treated|1|||
131187920|NCT02580591|472309119|FG001|Overall Study|Not treated|1|||
131187921|NCT02580591|472309120|FG002|Overall Study|Not treated|0|||
131187922|NCT02580591|472309121|FG003|Overall Study|Not treated|0|||
131187923|NCT02580591|472309118|FG000|Overall Study|Other than specified|3|||
131187924|NCT02580591|472309119|FG001|Overall Study|Other than specified|2|||
131187925|NCT02580591|472309120|FG002|Overall Study|Other than specified|5|||
131187926|NCT02580591|472309121|FG003|Overall Study|Other than specified|2|||
131187927|NCT00561340|472309125|FG000|Overall Study|refused to drink pediasure|6|||
131187928|NCT00561340|472309126|FG001|Overall Study|refused to drink pediasure|0|||
131187929|NCT03051217|472309127|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
131187930|NCT03051217|472309128|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131187931|NCT03051217|472309129|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
131187932|NCT03051217|472309130|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131187933|NCT03051217|472309131|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131187934|NCT03051217|472309132|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131187935|NCT03051217|472309133|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
131187936|NCT03051217|472309127|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131187937|NCT03051217|472309128|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
131187938|NCT03051217|472309129|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131187939|NCT03051217|472309130|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131187940|NCT03051217|472309131|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131187941|NCT03051217|472309132|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131187942|NCT03051217|472309133|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
131187943|NCT03051217|472309127|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
131187944|NCT03051217|472309128|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
131187945|NCT03051217|472309129|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
131187946|NCT03051217|472309130|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131187947|NCT03051217|472309131|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131187948|NCT03051217|472309132|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131187949|NCT03051217|472309133|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
131187950|NCT03051217|472309127|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
131187951|NCT03051217|472309128|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
131187952|NCT03051217|472309129|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
131187953|NCT03051217|472309130|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
131187954|NCT03051217|472309131|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
131187955|NCT03051217|472309132|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
131187956|NCT03051217|472309133|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
131187957|NCT03051217|472309127|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131187958|NCT03051217|472309128|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131187959|NCT03051217|472309129|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131187960|NCT03051217|472309130|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
131187961|NCT03051217|472309131|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131187962|NCT03051217|472309132|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131187963|NCT03051217|472309133|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
131187964|NCT03051217|472309127|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131187965|NCT03051217|472309128|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131187966|NCT03051217|472309129|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131187967|NCT03051217|472309130|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
131187968|NCT03051217|472309131|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131187969|NCT03051217|472309132|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131187970|NCT03051217|472309133|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
131187971|NCT03051217|472309127|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131187972|NCT03051217|472309128|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131187973|NCT03051217|472309129|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131187974|NCT03051217|472309130|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131187975|NCT03051217|472309131|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
131187976|NCT03051217|472309132|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131187977|NCT03051217|472309133|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
131187978|NCT03051217|472309127|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131187979|NCT03051217|472309128|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131187980|NCT03051217|472309129|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131187981|NCT03051217|472309130|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131187982|NCT03051217|472309131|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131187983|NCT03051217|472309132|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
131187984|NCT03051217|472309133|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
131187985|NCT00641706|472309134|FG000|Overall Study|Adverse Event|2|||
131187986|NCT00641706|472309135|FG001|Overall Study|Adverse Event|1|||
131187987|NCT00641706|472309134|FG000|Overall Study|Withdrawal by Subject|6|||
131187988|NCT00641706|472309135|FG001|Overall Study|Withdrawal by Subject|1|||
131187989|NCT00641706|472309134|FG000|Overall Study|Clinical Decline|1|||
131187990|NCT00641706|472309135|FG001|Overall Study|Clinical Decline|0|||
131187991|NCT00641706|472309134|FG000|Overall Study|Lead Investigator Decision|0|||
131187992|NCT00641706|472309135|FG001|Overall Study|Lead Investigator Decision|1|||
131187993|NCT00109772|472309136|FG000|Double-blind Treatment|Adverse Event|14|||
131187994|NCT00109772|472309137|FG001|Double-blind Treatment|Adverse Event|5|||
131187995|NCT00109772|472309136|FG000|Double-blind Treatment|Lack of Efficacy|1|||
131187996|NCT00109772|472309137|FG001|Double-blind Treatment|Lack of Efficacy|0|||
131187997|NCT00109772|472309136|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
131187998|NCT00109772|472309137|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
131187999|NCT00109772|472309136|FG000|Double-blind Treatment|Lost to Follow-up|2|||
131188000|NCT00109772|472309137|FG001|Double-blind Treatment|Lost to Follow-up|3|||
131188001|NCT00109772|472309136|FG000|Double-blind Treatment|Protocol Violation|0|||
131188002|NCT00109772|472309137|FG001|Double-blind Treatment|Protocol Violation|1|||
131188003|NCT00109772|472309136|FG000|Double-blind Treatment|Other|0|||
131188004|NCT00109772|472309137|FG001|Double-blind Treatment|Other|4|||
131188005|NCT00109772|472309136|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
131188006|NCT00109772|472309137|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
131188007|NCT00109772|472309136|FG000|Open-label Extension|Adverse Event|10|||
131188008|NCT00109772|472309137|FG001|Open-label Extension|Adverse Event|19|||
131188009|NCT00109772|472309136|FG000|Open-label Extension|Lack of Efficacy|19|||
131188010|NCT00109772|472309137|FG001|Open-label Extension|Lack of Efficacy|11|||
131188011|NCT00109772|472309136|FG000|Open-label Extension|Withdrawal by Subject|9|||
131188012|NCT00109772|472309137|FG001|Open-label Extension|Withdrawal by Subject|6|||
131188013|NCT00109772|472309136|FG000|Open-label Extension|Lost to Follow-up|1|||
131188014|NCT00109772|472309137|FG001|Open-label Extension|Lost to Follow-up|0|||
131188015|NCT00109772|472309136|FG000|Open-label Extension|Death|0|||
131188016|NCT00109772|472309137|FG001|Open-label Extension|Death|1|||
131188017|NCT00109772|472309136|FG000|Open-label Extension|Protocol Violation|2|||
131188018|NCT00109772|472309137|FG001|Open-label Extension|Protocol Violation|2|||
131188019|NCT00109772|472309136|FG000|Open-label Extension|Other|4|||
131188020|NCT00109772|472309137|FG001|Open-label Extension|Other|10|||
131188021|NCT00282568|472309142|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
131188022|NCT00282568|472309142|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
131188023|NCT00282568|472309142|FG000|Extended Treatment Period|Adverse Event|17|||
131188024|NCT00282568|472309142|FG000|Extended Treatment Period|Non-compliance|4|||
131188025|NCT00282568|472309142|FG000|Extended Treatment Period|Physician Decision|1|||
131188026|NCT00282568|472309142|FG000|Extended Treatment Period|Lost to Follow-up|2|||
131188027|NCT03006926|472309143|FG000|Overall Study|Adverse Event|0|||
131188028|NCT03006926|472309144|FG001|Overall Study|Adverse Event|27|||
131188029|NCT03006926|472309143|FG000|Overall Study|Withdrawal by Subject|0|||
131188030|NCT03006926|472309144|FG001|Overall Study|Withdrawal by Subject|1|||
131188031|NCT03006926|472309143|FG000|Overall Study|Radiological Disease Progression|0|||
131188032|NCT03006926|472309144|FG001|Overall Study|Radiological Disease Progression|52|||
131188033|NCT03006926|472309143|FG000|Overall Study|Clinical Disease Progression|0|||
131188034|NCT03006926|472309144|FG001|Overall Study|Clinical Disease Progression|10|||
131188035|NCT03006926|472309143|FG000|Overall Study|Other|0|||
131188036|NCT03006926|472309144|FG001|Overall Study|Other|8|||
131188037|NCT00990249|472309149|FG000|Overall Study|Disease Progression|8|||
131188038|NCT00990249|472309149|FG000|Overall Study|Non-Compliance|1|||
131188039|NCT00990249|472309149|FG000|Overall Study|Death|2|||
131188040|NCT00990249|472309149|FG000|Overall Study|Not treated|2|||
131188041|NCT03725293|472309150|FG000|Overall Study|Physician Decision|9|||
131188042|NCT03725293|472309151|FG001|Overall Study|Physician Decision|6|||
131188043|NCT03725293|472309150|FG000|Overall Study|alternative vascular access needs|1|||
131188044|NCT03725293|472309151|FG001|Overall Study|alternative vascular access needs|2|||
131188045|NCT03725293|472309150|FG000|Overall Study|venous anatomy screen failures|2|||
131188046|NCT03725293|472309151|FG001|Overall Study|venous anatomy screen failures|1|||
131188047|NCT04583969|472309154|FG000|Overall Study|Death|31|||
131188048|NCT04583969|472309155|FG001|Overall Study|Death|38|||
131188049|NCT04583969|472309154|FG000|Overall Study|Lost to Follow-up|16|||
131188050|NCT04583969|472309155|FG001|Overall Study|Lost to Follow-up|13|||
131188051|NCT04583969|472309154|FG000|Overall Study|Protocol Violation|1|||
131188052|NCT04583969|472309155|FG001|Overall Study|Protocol Violation|0|||
131188053|NCT04583969|472309154|FG000|Overall Study|Withdrawal by Subject|3|||
131188054|NCT04583969|472309155|FG001|Overall Study|Withdrawal by Subject|3|||
131188055|NCT04583969|472309154|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
131188056|NCT04583969|472309155|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
131188057|NCT04583969|472309154|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
131188058|NCT04583969|472309155|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
131188059|NCT04583969|472309154|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
131188060|NCT04583969|472309155|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
131188061|NCT04583969|472309154|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
131188062|NCT04583969|472309155|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
131188063|NCT04583969|472309154|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
131188064|NCT04583969|472309155|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
131188065|NCT01057862|472309156|FG000|Overall Study|Withdrawal by Subject|1|||
131188066|NCT01057862|472309157|FG001|Overall Study|Withdrawal by Subject|2|||
131188067|NCT00415584|472309158|FG000|Overall Study|Withdrawal by Subject|1|||
131188068|NCT00802867|472309159|FG000|Overall Study|Lost to Follow-up|6|||
131188069|NCT00802867|472309159|FG000|Overall Study|Protocol Violation|6|||
131188070|NCT00802867|472309159|FG000|Overall Study|Withdrawal by Subject|1|||
131188071|NCT04075396|472309160|FG000|Overall Study|Death|11|||
131188072|NCT04075396|472309161|FG001|Overall Study|Death|9|||
131188073|NCT04075396|472309160|FG000|Overall Study|Withdrawal by Subject|1|||
131188074|NCT04075396|472309161|FG001|Overall Study|Withdrawal by Subject|2|||
131188075|NCT04075396|472309160|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
131188076|NCT04075396|472309161|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
131188077|NCT04075396|472309160|FG000|Overall Study|Enrolled but not-treated|0|||
131188078|NCT04075396|472309161|FG001|Overall Study|Enrolled but not-treated|1|||
131188079|NCT03434041|472309162|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
131188080|NCT03434041|472309163|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
131188081|NCT03434041|472309162|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
131188082|NCT03434041|472309163|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
131188083|NCT03434041|472309162|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
131188084|NCT03434041|472309163|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
131188085|NCT03434041|472309162|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
131188086|NCT03434041|472309163|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
131188087|NCT03434041|472309162|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
131188088|NCT03434041|472309163|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
131188089|NCT03434041|472309162|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
131188090|NCT03434041|472309163|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
131188091|NCT03434041|472309162|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
131188092|NCT03434041|472309163|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
131188093|NCT03434041|472309162|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
131188094|NCT03434041|472309163|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
131188095|NCT03434041|472309162|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
131188096|NCT03434041|472309163|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
131188097|NCT03434041|472309162|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
131188098|NCT03434041|472309163|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
131188099|NCT03434041|472309162|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
131188100|NCT03434041|472309163|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
131188101|NCT03363165|472309170|FG000|3-month Follow-up|Death|0|||
131188102|NCT03363165|472309171|FG001|3-month Follow-up|Death|1|||
131188103|NCT03363165|472309170|FG000|6-month Follow-up|Death|0|||
131188104|NCT03363165|472309171|FG001|6-month Follow-up|Death|1|||
131188105|NCT03363165|472309170|FG000|6-month Follow-up|Withdrawal by Subject|1|||
131188106|NCT03363165|472309171|FG001|6-month Follow-up|Withdrawal by Subject|1|||
131188107|NCT03363165|472309170|FG000|12-month Follow-up|Death|1|||
131188108|NCT03363165|472309171|FG001|12-month Follow-up|Death|1|||
131188109|NCT03363165|472309170|FG000|12-month Follow-up|Withdrawal by Subject|1|||
131188110|NCT03363165|472309171|FG001|12-month Follow-up|Withdrawal by Subject|1|||
131188111|NCT02228564|472309178|FG000|Overall Study|Withdrawal by Subject|10|||
131188112|NCT02228564|472309178|FG000|Overall Study|Death|11|||
131188113|NCT02228564|472309178|FG000|Overall Study|Physician Decision|5|||
131188114|NCT02228564|472309178|FG000|Overall Study|Lost to Follow-up|17|||
131188115|NCT02228564|472309178|FG000|Overall Study|Other|6|||
131188116|NCT02142504|472309179|FG000|Overall Study|Protocol Violation|2|||
131188117|NCT02142504|472309180|FG001|Overall Study|Protocol Violation|1|||
131188118|NCT02142504|472309181|FG002|Overall Study|Protocol Violation|2|||
131188119|NCT02142504|472309179|FG000|Overall Study|Adverse Event|2|||
131188120|NCT02142504|472309180|FG001|Overall Study|Adverse Event|3|||
131188121|NCT02142504|472309181|FG002|Overall Study|Adverse Event|4|||
131188122|NCT02142504|472309179|FG000|Overall Study|Lost to Follow-up|12|||
131188123|NCT02142504|472309180|FG001|Overall Study|Lost to Follow-up|19|||
131188124|NCT02142504|472309181|FG002|Overall Study|Lost to Follow-up|17|||
131188125|NCT02142504|472309179|FG000|Overall Study|Withdrawal by Subject|7|||
131188126|NCT02142504|472309180|FG001|Overall Study|Withdrawal by Subject|9|||
131188127|NCT02142504|472309181|FG002|Overall Study|Withdrawal by Subject|11|||
131188128|NCT02142504|472309179|FG000|Overall Study|Pregnancy|4|||
131188129|NCT02142504|472309180|FG001|Overall Study|Pregnancy|4|||
131188130|NCT02142504|472309181|FG002|Overall Study|Pregnancy|2|||
131188131|NCT02142504|472309179|FG000|Overall Study|Physician Decision|0|||
131188132|NCT02142504|472309180|FG001|Overall Study|Physician Decision|1|||
131188133|NCT02142504|472309181|FG002|Overall Study|Physician Decision|3|||
131188134|NCT02142504|472309179|FG000|Overall Study|Reason Not Specified|4|||
131188135|NCT02142504|472309180|FG001|Overall Study|Reason Not Specified|5|||
131188136|NCT02142504|472309181|FG002|Overall Study|Reason Not Specified|4|||
131188137|NCT00617591|472309185|FG000|Overall Study|Withdrew consent during Induction|4|||
131188138|NCT00617591|472309185|FG000|Overall Study|Withdrew consent during Maintenance|6|||
131188139|NCT01400139|472309190|FG000|HYD Core Study|Adverse Event|210|||
131188140|NCT01400139|472309190|FG000|HYD Core Study|Lack of Efficacy|59|||
131188141|NCT01400139|472309190|FG000|HYD Core Study|Withdrawal by Subject|114|||
131188142|NCT01400139|472309190|FG000|HYD Core Study|Lost to Follow-up|39|||
131188143|NCT01400139|472309190|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
131188144|NCT01400139|472309190|FG000|HYD Core Study|Administrative|56|||
131188145|NCT01400139|472309190|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
131188146|NCT01400139|472309190|FG000|HYD Extension Period|Adverse Event|8|||
131188147|NCT01400139|472309190|FG000|HYD Extension Period|Withdrawal by Subject|5|||
131188148|NCT01400139|472309190|FG000|HYD Extension Period|Administrative|10|||
131188149|NCT00249795|472309191|FG000|Overall Study|Not treated|16|||
131188150|NCT00249795|472309192|FG001|Overall Study|Not treated|14|||
131188151|NCT00249795|472309191|FG000|Overall Study|Symptomatic hypotension|127|||
131188152|NCT00249795|472309192|FG001|Overall Study|Symptomatic hypotension|64|||
131188153|NCT00249795|472309191|FG000|Overall Study|Other Serious Adverse Event|84|||
131188154|NCT00249795|472309192|FG001|Overall Study|Other Serious Adverse Event|93|||
131188155|NCT00249795|472309191|FG000|Overall Study|Qualifying condition not present|26|||
131188156|NCT00249795|472309192|FG001|Overall Study|Qualifying condition not present|29|||
131188157|NCT00249795|472309191|FG000|Overall Study|Withdrawal by Subject|678|||
131188158|NCT00249795|472309192|FG001|Overall Study|Withdrawal by Subject|742|||
131188159|NCT00249795|472309191|FG000|Overall Study|Thromboembolic / outcome event|39|||
131188160|NCT00249795|472309192|FG001|Overall Study|Thromboembolic / outcome event|45|||
131188161|NCT00249795|472309191|FG000|Overall Study|Oral anticoagulant required|2|||
131188162|NCT00249795|472309192|FG001|Overall Study|Oral anticoagulant required|0|||
131188163|NCT00249795|472309191|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
131188164|NCT00249795|472309192|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
131188165|NCT00249795|472309191|FG000|Overall Study|Non-compliance|71|||
131188166|NCT00249795|472309192|FG001|Overall Study|Non-compliance|69|||
131188167|NCT00249795|472309191|FG000|Overall Study|Study drug intolerance|3|||
131188168|NCT00249795|472309192|FG001|Overall Study|Study drug intolerance|3|||
131188169|NCT00249795|472309191|FG000|Overall Study|Other adverse events (non-serious)|188|||
131188170|NCT00249795|472309192|FG001|Overall Study|Other adverse events (non-serious)|159|||
131188171|NCT00249795|472309191|FG000|Overall Study|Physician withdrew consent|71|||
131188172|NCT00249795|472309192|FG001|Overall Study|Physician withdrew consent|63|||
131188173|NCT00249795|472309191|FG000|Overall Study|Surgery / procedure|4|||
131188174|NCT00249795|472309192|FG001|Overall Study|Surgery / procedure|5|||
131188175|NCT00249795|472309191|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
131188176|NCT00249795|472309192|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
131188177|NCT00249795|472309191|FG000|Overall Study|Lightheadedness / dizziness|15|||
131188178|NCT00249795|472309192|FG001|Overall Study|Lightheadedness / dizziness|11|||
131188179|NCT00249795|472309191|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
131188180|NCT00249795|472309192|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
131188181|NCT00249795|472309191|FG000|Overall Study|Other contraindicated medication|1|||
131188182|NCT00249795|472309192|FG001|Overall Study|Other contraindicated medication|1|||
131188183|NCT00249795|472309191|FG000|Overall Study|Event related to cardiac condition|17|||
131188184|NCT00249795|472309192|FG001|Overall Study|Event related to cardiac condition|16|||
131188185|NCT00249795|472309191|FG000|Overall Study|Patient not wish to continue after May08|4|||
131188186|NCT00249795|472309192|FG001|Overall Study|Patient not wish to continue after May08|6|||
131188187|NCT00249795|472309191|FG000|Overall Study|Site not agree to continue after May08|1|||
131188188|NCT00249795|472309192|FG001|Overall Study|Site not agree to continue after May08|1|||
131188189|NCT00249795|472309191|FG000|Overall Study|Lost to Follow-up|0|||
131188190|NCT00249795|472309192|FG001|Overall Study|Lost to Follow-up|2|||
131188191|NCT00249795|472309191|FG000|Overall Study|Missing|0|||
131188192|NCT00249795|472309192|FG001|Overall Study|Missing|1|||
131188193|NCT02460978|472309193|FG000|Overall Study|Adverse Event|17|||
131188194|NCT02460978|472309194|FG001|Overall Study|Adverse Event|11|||
131188195|NCT02460978|472309195|FG002|Overall Study|Adverse Event|11|||
131188196|NCT02460978|472309193|FG000|Overall Study|Withdrawal by Subject|5|||
131188197|NCT02460978|472309194|FG001|Overall Study|Withdrawal by Subject|5|||
131188198|NCT02460978|472309195|FG002|Overall Study|Withdrawal by Subject|14|||
131188199|NCT02460978|472309193|FG000|Overall Study|Lost to Follow-up|2|||
131188200|NCT02460978|472309194|FG001|Overall Study|Lost to Follow-up|3|||
131188201|NCT02460978|472309195|FG002|Overall Study|Lost to Follow-up|1|||
131188202|NCT02460978|472309193|FG000|Overall Study|Protocol Violation|1|||
131188203|NCT02460978|472309194|FG001|Overall Study|Protocol Violation|1|||
131188204|NCT02460978|472309195|FG002|Overall Study|Protocol Violation|1|||
131188205|NCT02460978|472309193|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
131188206|NCT02460978|472309194|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
131188207|NCT02460978|472309195|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
131188208|NCT02460978|472309193|FG000|Overall Study|Pregnancy|0|||
131188209|NCT02460978|472309194|FG001|Overall Study|Pregnancy|0|||
131188210|NCT02460978|472309195|FG002|Overall Study|Pregnancy|2|||
131188211|NCT03549429|472309198|FG000|Overall Study|Protocol Violation|5|||
131188212|NCT03549429|472309199|FG001|Overall Study|Protocol Violation|3|||
131188213|NCT00588523|472309203|FG000|Overall Study|Not treated|3|||
131188214|NCT01459068|472309204|FG000|Overall Study|Withdrawal by Subject|8|||
131188215|NCT01459068|472309205|FG001|Overall Study|Withdrawal by Subject|18|||
131188216|NCT01459068|472309204|FG000|Overall Study|Lost to Follow-up|31|||
131188217|NCT01459068|472309205|FG001|Overall Study|Lost to Follow-up|15|||
131188218|NCT01459068|472309204|FG000|Overall Study|Death|0|||
131188219|NCT01459068|472309205|FG001|Overall Study|Death|1|||
131188220|NCT01203787|472309208|FG000|Overall Study|Death|12|||
131188221|NCT01203787|472309209|FG001|Overall Study|Death|10|||
131188222|NCT01203787|472309208|FG000|Overall Study|Withdrawal by Subject|6|||
131188223|NCT01203787|472309209|FG001|Overall Study|Withdrawal by Subject|2|||
131188224|NCT01203787|472309208|FG000|Overall Study|Lost to Follow-up|2|||
131188225|NCT01203787|472309209|FG001|Overall Study|Lost to Follow-up|0|||
131188226|NCT01203787|472309208|FG000|Overall Study|Adverse Event|11|||
131188227|NCT01203787|472309209|FG001|Overall Study|Adverse Event|15|||
131188228|NCT03404518|472309210|FG000|Overall Study|Lost to Follow-up|28|||
131188229|NCT03404518|472309211|FG001|Overall Study|Lost to Follow-up|30|||
131188230|NCT03404518|472309210|FG000|Overall Study|Protocol Violation|13|||
131188231|NCT03404518|472309211|FG001|Overall Study|Protocol Violation|6|||
131188232|NCT03693404|472309214|FG000|Overall Study|Withdrawal by Subject|1|||
131188233|NCT03693404|472309215|FG001|Overall Study|Withdrawal by Subject|0|||
131188234|NCT03693404|472309214|FG000|Overall Study|Lost to Follow-up|0|||
131188235|NCT03693404|472309215|FG001|Overall Study|Lost to Follow-up|5|||
131188236|NCT03693404|472309214|FG000|Overall Study|Excluded from Analysis|0|||
131188237|NCT03693404|472309215|FG001|Overall Study|Excluded from Analysis|1|||
131188238|NCT01041404|472309218|FG000|Overall Study|Adverse Event|45|||
131188239|NCT01041404|472309219|FG001|Overall Study|Adverse Event|35|||
131188240|NCT01041404|472309218|FG000|Overall Study|Lack of Efficacy|200|||
131188241|NCT01041404|472309219|FG001|Overall Study|Lack of Efficacy|210|||
131188242|NCT01041404|472309218|FG000|Overall Study|Violation of Selection Criteria|0|||
131188243|NCT01041404|472309219|FG001|Overall Study|Violation of Selection Criteria|1|||
131188244|NCT01041404|472309218|FG000|Overall Study|Protocol Violation|4|||
131188245|NCT01041404|472309219|FG001|Overall Study|Protocol Violation|0|||
131188246|NCT01041404|472309218|FG000|Overall Study|Withdrawal by Subject|29|||
131188247|NCT01041404|472309219|FG001|Overall Study|Withdrawal by Subject|23|||
131188248|NCT01041404|472309218|FG000|Overall Study|Failure to Return|1|||
131188249|NCT01041404|472309219|FG001|Overall Study|Failure to Return|2|||
131188250|NCT01041404|472309218|FG000|Overall Study|Other|11|||
131188251|NCT01041404|472309219|FG001|Overall Study|Other|23|||
131188252|NCT03627494|472309220|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
131188253|NCT03627494|472309221|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
131188254|NCT03627494|472309222|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
131188255|NCT03627494|472309223|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
131188256|NCT03627494|472309224|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
131188257|NCT03627494|472309225|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
131188258|NCT03627494|472309226|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
131188259|NCT03627494|472309227|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
131188260|NCT03627494|472309228|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
131188261|NCT03627494|472309229|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
131188262|NCT03627494|472309230|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
131188263|NCT03627494|472309231|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
131188264|NCT03627494|472309220|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188265|NCT03627494|472309221|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188266|NCT03627494|472309222|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188267|NCT03627494|472309223|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188268|NCT03627494|472309224|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188269|NCT03627494|472309225|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188270|NCT03627494|472309226|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188271|NCT03627494|472309227|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188272|NCT03627494|472309228|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
131188273|NCT03627494|472309229|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188274|NCT03627494|472309230|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188275|NCT03627494|472309231|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
131188276|NCT03627494|472309220|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
131188277|NCT03627494|472309221|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
131188278|NCT03627494|472309222|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
131188279|NCT03627494|472309223|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
131188280|NCT03627494|472309224|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
131188281|NCT03627494|472309225|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
131188282|NCT03627494|472309226|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
131188283|NCT03627494|472309227|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
131188284|NCT03627494|472309228|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
131188285|NCT03627494|472309229|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
131188286|NCT03627494|472309230|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
131188287|NCT03627494|472309231|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
131188288|NCT03565991|472310871|FG000|Overall Study|Other|11|||
131188289|NCT03565991|472310872|FG001|Overall Study|Other|0|||
131188290|NCT03565991|472310871|FG000|Overall Study|Global deterioration of health status|14|||
131188291|NCT03565991|472310872|FG001|Overall Study|Global deterioration of health status|4|||
131188292|NCT03565991|472310871|FG000|Overall Study|Withdrawal by Subject|2|||
131188293|NCT03565991|472310872|FG001|Overall Study|Withdrawal by Subject|6|||
131188294|NCT03565991|472310871|FG000|Overall Study|Progressive disease|121|||
131188295|NCT03565991|472310872|FG001|Overall Study|Progressive disease|29|||
131188296|NCT03565991|472310871|FG000|Overall Study|Death|3|||
131188297|NCT03565991|472310872|FG001|Overall Study|Death|0|||
131188298|NCT03565991|472310871|FG000|Overall Study|Adverse Event|7|||
131188299|NCT03565991|472310872|FG001|Overall Study|Adverse Event|2|||
131188300|NCT00784459|472310873|FG000|Overall Study|Adverse Event|0|||
131188301|NCT00784459|472310874|FG001|Overall Study|Adverse Event|2|||
131188302|NCT02741310|472310887|FG000|Overall Study|Sponsor Decision|2|||
131188303|NCT02741310|472310888|FG001|Overall Study|Sponsor Decision|2|||
131188304|NCT03235726|472310891|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131188305|NCT03235726|472310892|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131188306|NCT03235726|472310893|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131188307|NCT03235726|472310894|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131188308|NCT03235726|472310895|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
131188309|NCT03235726|472310896|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131188310|NCT03235726|472310897|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131188311|NCT03235726|472310898|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131188312|NCT03235726|472310899|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131188313|NCT03235726|472310900|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
131188314|NCT03235726|472310891|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131188315|NCT03235726|472310892|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131188316|NCT03235726|472310893|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131188317|NCT03235726|472310894|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131188318|NCT03235726|472310895|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
131188319|NCT03235726|472310896|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131188320|NCT03235726|472310897|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131188321|NCT03235726|472310898|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131188322|NCT03235726|472310899|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131188323|NCT03235726|472310900|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
131188324|NCT01675141|472310904|FG000|Overall Study|Lenalidomide outside NIH|3|||
131188325|NCT01675141|472310904|FG000|Overall Study|Withdrawal by Subject|3|||
131188326|NCT01675141|472310904|FG000|Overall Study|Physician Decision|4|||
131188327|NCT01675141|472310904|FG000|Overall Study|No treatment, per protocol|1|||
131188328|NCT00391807|472310907|FG000|Overall Study|Did not receive study medication|23|||
131188329|NCT00391807|472310907|FG000|Overall Study|Adverse Event|177|||
131188330|NCT00391807|472310907|FG000|Overall Study|Pregnancy|25|||
131188331|NCT00391807|472310907|FG000|Overall Study|Lost to Follow-up|227|||
131188332|NCT00391807|472310907|FG000|Overall Study|Withdrawal by Subject|147|||
131188333|NCT00391807|472310907|FG000|Overall Study|Protocol Violation|20|||
131188334|NCT00391807|472310907|FG000|Overall Study|Various|96|||
131188335|NCT04397796|472310908|FG000|Overall Study|Death|3|||
131188336|NCT04397796|472310909|FG001|Overall Study|Death|1|||
131188337|NCT02640755|472310910|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
131188338|NCT02640755|472310911|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
131188339|NCT02640755|472310910|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
131188340|NCT02640755|472310911|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
131188341|NCT02640755|472310910|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
131188342|NCT02640755|472310911|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
131188343|NCT00770224|472310922|FG000|Step 1: Induction|Adverse Event|3|||
131188344|NCT00770224|472310923|FG001|Step 1: Induction|Adverse Event|0|||
131188345|NCT00770224|472310922|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
131188346|NCT00770224|472310923|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
131188347|NCT00770224|472310922|FG000|Step 1: Induction|Other reason not protocol specified|2|||
131188348|NCT00770224|472310923|FG001|Step 1: Induction|Other reason not protocol specified|0|||
131188349|NCT00770224|472310922|FG000|Step 1: Induction|Ineligible|2|||
131188350|NCT00770224|472310923|FG001|Step 1: Induction|Ineligible|0|||
131188351|NCT00770224|472310922|FG000|Step 1: Induction|No protocol treatment given|1|||
131188352|NCT00770224|472310923|FG001|Step 1: Induction|No protocol treatment given|0|||
131188353|NCT00770224|472310922|FG000|Step 2: Maintenance|Adverse Event|0|||
131188354|NCT00770224|472310923|FG001|Step 2: Maintenance|Adverse Event|10|||
131188355|NCT00770224|472310922|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
131188356|NCT00770224|472310923|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
131188357|NCT00770224|472310922|FG000|Step 2: Maintenance|Progression/relapse|0|||
131188358|NCT00770224|472310923|FG001|Step 2: Maintenance|Progression/relapse|1|||
131188359|NCT00770224|472310922|FG000|Step 2: Maintenance|Death|0|||
131188360|NCT00770224|472310923|FG001|Step 2: Maintenance|Death|2|||
131188361|NCT00770224|472310922|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
131188362|NCT00770224|472310923|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
131188363|NCT00770224|472310922|FG000|Step 2: Maintenance|Ineligible|0|||
131188364|NCT00770224|472310923|FG001|Step 2: Maintenance|Ineligible|2|||
131188365|NCT01484561|472310924|FG000|Overall Study|Lack of Efficacy|3|||
131188366|NCT01484561|472310925|FG001|Overall Study|Lack of Efficacy|1|||
131188367|NCT01484561|472310924|FG000|Overall Study|Lost to Follow-up|1|||
131188368|NCT01484561|472310925|FG001|Overall Study|Lost to Follow-up|0|||
131188369|NCT01484561|472310924|FG000|Overall Study|Withdrawal by Subject|3|||
131188370|NCT01484561|472310925|FG001|Overall Study|Withdrawal by Subject|0|||
131188371|NCT01484561|472310924|FG000|Overall Study|Other|1|||
131188372|NCT01484561|472310925|FG001|Overall Study|Other|1|||
131188373|NCT01484561|472310924|FG000|Overall Study|Adverse Event|1|||
131188374|NCT01484561|472310925|FG001|Overall Study|Adverse Event|4|||
131188375|NCT03371251|472310934|FG000|Overall Study|Withdrawal by Subject|1|||
131188376|NCT03371251|472310935|FG001|Overall Study|Withdrawal by Subject|0|||
131188377|NCT03371251|472310936|FG002|Overall Study|Withdrawal by Subject|1|||
131188378|NCT03371251|472310937|FG003|Overall Study|Withdrawal by Subject|0|||
131188379|NCT03371251|472310938|FG004|Overall Study|Withdrawal by Subject|2|||
131188380|NCT03371251|472310939|FG005|Overall Study|Withdrawal by Subject|2|||
131188381|NCT03371251|472310934|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
131188382|NCT03371251|472310935|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
131188383|NCT03371251|472310936|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
131188384|NCT03371251|472310937|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
131188385|NCT03371251|472310938|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
131188386|NCT03371251|472310939|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
131188387|NCT03371251|472310934|FG000|Overall Study|Adverse Event|0|||
131188388|NCT03371251|472310935|FG001|Overall Study|Adverse Event|0|||
131188389|NCT03371251|472310936|FG002|Overall Study|Adverse Event|0|||
131188390|NCT03371251|472310937|FG003|Overall Study|Adverse Event|0|||
131188391|NCT03371251|472310938|FG004|Overall Study|Adverse Event|1|||
131188392|NCT03371251|472310939|FG005|Overall Study|Adverse Event|0|||
131188393|NCT03371251|472310934|FG000|Overall Study|Decision by Sponsor|0|||
131188394|NCT03371251|472310935|FG001|Overall Study|Decision by Sponsor|0|||
131188395|NCT03371251|472310936|FG002|Overall Study|Decision by Sponsor|0|||
131188396|NCT03371251|472310937|FG003|Overall Study|Decision by Sponsor|0|||
131188397|NCT03371251|472310938|FG004|Overall Study|Decision by Sponsor|2|||
131188398|NCT03371251|472310939|FG005|Overall Study|Decision by Sponsor|0|||
131188399|NCT00114218|472310940|FG000|Overall Study|Wrong Cell Type|2|||
131188400|NCT00114218|472310940|FG000|Overall Study|Wrong Primary|1|||
131188401|NCT00114218|472310940|FG000|Overall Study|Never Treated|1|||
131188402|NCT01505114|472310941|FG000|Overall Study|Withdrawal by Subject|5|||
131188403|NCT01505114|472310942|FG001|Overall Study|Withdrawal by Subject|4|||
131188404|NCT01505114|472310943|FG002|Overall Study|Withdrawal by Subject|4|||
131188405|NCT01505114|472310944|FG003|Overall Study|Withdrawal by Subject|7|||
131188406|NCT01505114|472310941|FG000|Overall Study|Death|1|||
131188407|NCT01505114|472310942|FG001|Overall Study|Death|0|||
131188408|NCT01505114|472310943|FG002|Overall Study|Death|0|||
131188409|NCT01505114|472310944|FG003|Overall Study|Death|1|||
131188410|NCT01505114|472310941|FG000|Overall Study|unable to adhere to visit schedule|3|||
131188411|NCT01505114|472310942|FG001|Overall Study|unable to adhere to visit schedule|2|||
131188412|NCT01505114|472310943|FG002|Overall Study|unable to adhere to visit schedule|3|||
131188413|NCT01505114|472310944|FG003|Overall Study|unable to adhere to visit schedule|3|||
131188414|NCT01505114|472310941|FG000|Overall Study|Lost to Follow-up|11|||
131188415|NCT01505114|472310942|FG001|Overall Study|Lost to Follow-up|5|||
131188416|NCT01505114|472310943|FG002|Overall Study|Lost to Follow-up|8|||
131188417|NCT01505114|472310944|FG003|Overall Study|Lost to Follow-up|7|||
131188418|NCT01505114|472310941|FG000|Overall Study|relocated|4|||
131188419|NCT01505114|472310942|FG001|Overall Study|relocated|2|||
131188420|NCT01505114|472310943|FG002|Overall Study|relocated|2|||
131188421|NCT01505114|472310944|FG003|Overall Study|relocated|3|||
131188422|NCT01505114|472310941|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
131188423|NCT01505114|472310942|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
131188424|NCT01505114|472310943|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
131188425|NCT01505114|472310944|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
131188426|NCT01505114|472310941|FG000|Overall Study|staff safety concerns|0|||
131188427|NCT01505114|472310942|FG001|Overall Study|staff safety concerns|0|||
131188428|NCT01505114|472310943|FG002|Overall Study|staff safety concerns|0|||
131188429|NCT01505114|472310944|FG003|Overall Study|staff safety concerns|1|||
131188430|NCT01505114|472310941|FG000|Overall Study|investigator decision|1|||
131188431|NCT01505114|472310942|FG001|Overall Study|investigator decision|0|||
131188432|NCT01505114|472310943|FG002|Overall Study|investigator decision|1|||
131188433|NCT01505114|472310944|FG003|Overall Study|investigator decision|0|||
131188434|NCT03168555|472310945|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
131188435|NCT03168555|472310945|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
131188436|NCT03168555|472310945|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
131188437|NCT03168555|472310945|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
131188438|NCT01040845|472310946|FG000|Overall Study|Withdrawal by Subject|1|||
131188439|NCT01040845|472310947|FG001|Overall Study|Withdrawal by Subject|1|||
131188440|NCT01040845|472310946|FG000|Overall Study|Physician Decision|1|||
131188441|NCT01040845|472310947|FG001|Overall Study|Physician Decision|0|||
131188442|NCT04445688|472310952|FG000|Washout (One Week)|Adverse Event|2|||
131188443|NCT04445688|472310952|FG000|Washout (One Week)|Withdrawal by Subject|1|||
131188444|NCT01235507|472310954|FG000|Overall Study|Adverse Event|1|||
131188445|NCT01235507|472310954|FG000|Overall Study|Withdrawal by Subject|1|||
131188446|NCT02017704|472310958|FG000|Overall Study|Withdrawal by Subject|2|||
131188447|NCT02017704|472310959|FG001|Overall Study|Withdrawal by Subject|0|||
131188448|NCT01587274|472310960|FG000|Overall Study|Lost to Follow-up|4|||
131188449|NCT01587274|472310961|FG001|Overall Study|Lost to Follow-up|5|||
131188450|NCT01587274|472310962|FG002|Overall Study|Lost to Follow-up|3|||
131188451|NCT00918346|472310963|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
131188452|NCT00918346|472310964|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
131188453|NCT01749800|472310968|FG000|Overall Study|not meeting inclusion criteria|3|||
131188454|NCT01749800|472310969|FG001|Overall Study|not meeting inclusion criteria|0|||
131188455|NCT01749800|472310970|FG002|Overall Study|not meeting inclusion criteria|0|||
131188456|NCT01749800|472310968|FG000|Overall Study|Withdrawal by Subject|0|||
131188457|NCT01749800|472310969|FG001|Overall Study|Withdrawal by Subject|1|||
131188458|NCT01749800|472310970|FG002|Overall Study|Withdrawal by Subject|0|||
131188459|NCT01451398|472310975|FG000|Overall Study|Adverse Event|7|||
131188460|NCT01451398|472310976|FG001|Overall Study|Adverse Event|9|||
131188461|NCT01451398|472310975|FG000|Overall Study|Protocol Violation|1|||
131188462|NCT01451398|472310976|FG001|Overall Study|Protocol Violation|2|||
131188463|NCT01451398|472310975|FG000|Overall Study|Physician Decision|1|||
131188464|NCT01451398|472310976|FG001|Overall Study|Physician Decision|1|||
131188465|NCT01451398|472310975|FG000|Overall Study|Withdrawal by Subject|10|||
131188466|NCT01451398|472310976|FG001|Overall Study|Withdrawal by Subject|14|||
131188467|NCT01451398|472310975|FG000|Overall Study|Lost to Follow-up|6|||
131188468|NCT01451398|472310976|FG001|Overall Study|Lost to Follow-up|4|||
131188469|NCT01451398|472310975|FG000|Overall Study|Non-compliance with study drug|1|||
131188470|NCT01451398|472310976|FG001|Overall Study|Non-compliance with study drug|3|||
131188471|NCT01451398|472310975|FG000|Overall Study|Non-compliance with protocol|1|||
131188472|NCT01451398|472310976|FG001|Overall Study|Non-compliance with protocol|1|||
131188473|NCT01451398|472310975|FG000|Overall Study|Moved out of country|0|||
131188474|NCT01451398|472310976|FG001|Overall Study|Moved out of country|1|||
131188475|NCT01451398|472310975|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
131188476|NCT01451398|472310976|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
131188477|NCT01451398|472310975|FG000|Overall Study|Lack of Efficacy|0|||
131188478|NCT01451398|472310976|FG001|Overall Study|Lack of Efficacy|1|||
131188479|NCT02565615|472310979|FG000|Overall Study|Death|0|||
131188480|NCT02565615|472310980|FG001|Overall Study|Death|1|||
131188481|NCT02565615|472310981|FG002|Overall Study|Death|0|||
131188482|NCT02565615|472310982|FG003|Overall Study|Death|0|||
131188483|NCT02565615|472310983|FG004|Overall Study|Death|4|||
131188484|NCT02565615|472310979|FG000|Overall Study|Not willing to participate in study|2|||
131188485|NCT02565615|472310980|FG001|Overall Study|Not willing to participate in study|21|||
131188486|NCT02565615|472310981|FG002|Overall Study|Not willing to participate in study|0|||
131188487|NCT02565615|472310982|FG003|Overall Study|Not willing to participate in study|1|||
131188488|NCT02565615|472310983|FG004|Overall Study|Not willing to participate in study|169|||
131188489|NCT02565615|472310979|FG000|Overall Study|Lost to Follow-up|0|||
131188490|NCT02565615|472310980|FG001|Overall Study|Lost to Follow-up|4|||
131188491|NCT02565615|472310981|FG002|Overall Study|Lost to Follow-up|0|||
131188492|NCT02565615|472310982|FG003|Overall Study|Lost to Follow-up|1|||
131188493|NCT02565615|472310983|FG004|Overall Study|Lost to Follow-up|765|||
131188494|NCT02565615|472310979|FG000|Overall Study|Not meeting eligibility criteria|0|||
131188495|NCT02565615|472310980|FG001|Overall Study|Not meeting eligibility criteria|7|||
131188496|NCT02565615|472310981|FG002|Overall Study|Not meeting eligibility criteria|0|||
131188497|NCT02565615|472310982|FG003|Overall Study|Not meeting eligibility criteria|0|||
131188498|NCT02565615|472310983|FG004|Overall Study|Not meeting eligibility criteria|25|||
131188499|NCT02565615|472310979|FG000|Overall Study|Reason not defined|0|||
131188500|NCT02565615|472310980|FG001|Overall Study|Reason not defined|2|||
131188501|NCT02565615|472310981|FG002|Overall Study|Reason not defined|0|||
131188502|NCT02565615|472310982|FG003|Overall Study|Reason not defined|1|||
131188503|NCT02565615|472310983|FG004|Overall Study|Reason not defined|62|||
131188504|NCT02565615|472310979|FG000|Overall Study|Adverse Event|1|||
131188505|NCT02565615|472310980|FG001|Overall Study|Adverse Event|1|||
131188506|NCT02565615|472310981|FG002|Overall Study|Adverse Event|0|||
131188507|NCT02565615|472310982|FG003|Overall Study|Adverse Event|0|||
131188508|NCT02565615|472310983|FG004|Overall Study|Adverse Event|9|||
131188509|NCT02565615|472310979|FG000|Overall Study|Untreated|0|||
131188510|NCT02565615|472310980|FG001|Overall Study|Untreated|0|||
131188511|NCT02565615|472310981|FG002|Overall Study|Untreated|0|||
131188512|NCT02565615|472310982|FG003|Overall Study|Untreated|0|||
131188513|NCT02565615|472310983|FG004|Overall Study|Untreated|567|||
131188514|NCT01250756|472310984|FG000|Infant Series|Withdrawal by Subject|4|||
131188515|NCT01250756|472310985|FG001|Infant Series|Withdrawal by Subject|5|||
131188516|NCT01250756|472310984|FG000|Infant Series|Randomized, Not Vaccinated|2|||
131188517|NCT01250756|472310985|FG001|Infant Series|Randomized, Not Vaccinated|2|||
131188518|NCT01250756|472310984|FG000|Infant Series|Other|22|||
131188519|NCT01250756|472310985|FG001|Infant Series|Other|0|||
131188520|NCT01250756|472310984|FG000|After Infant Series|Adverse Event|5|||
131188521|NCT01250756|472310985|FG001|After Infant Series|Adverse Event|2|||
131188522|NCT01250756|472310984|FG000|After Infant Series|Withdrawal by Subject|4|||
131188523|NCT01250756|472310985|FG001|After Infant Series|Withdrawal by Subject|1|||
131188524|NCT01250756|472310984|FG000|After Infant Series|Other|2|||
131188525|NCT01250756|472310985|FG001|After Infant Series|Other|1|||
131188526|NCT01250756|472310984|FG000|Toddler Dose|Adverse Event|0|||
131188527|NCT01250756|472310985|FG001|Toddler Dose|Adverse Event|1|||
131188528|NCT01250756|472310984|FG000|After Toddler Dose|Adverse Event|0|||
131188529|NCT01250756|472310985|FG001|After Toddler Dose|Adverse Event|1|||
131188530|NCT01815580|472310987|FG000|Overall Study|Lost to Follow-up|4|||
131188531|NCT01815580|472310988|FG001|Overall Study|Lost to Follow-up|7|||
131188532|NCT01815580|472310987|FG000|Overall Study|Withdrawal by Subject|3|||
131188533|NCT01815580|472310988|FG001|Overall Study|Withdrawal by Subject|4|||
131188534|NCT01815580|472310987|FG000|Overall Study|Excluded from analysis|5|||
131188535|NCT01815580|472310988|FG001|Overall Study|Excluded from analysis|4|||
131188536|NCT04114539|472310991|FG000|Overall Study|Adverse Event|14|||
131188537|NCT04114539|472310991|FG000|Overall Study|Lost to Follow-up|2|||
131188538|NCT04114539|472310991|FG000|Overall Study|Non-compliance with Protocol|2|||
131188539|NCT04114539|472310991|FG000|Overall Study|Non-compliance with Study Drug|1|||
131188540|NCT04114539|472310991|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
131188541|NCT04114539|472310991|FG000|Overall Study|Withdrew consent|10|||
131188542|NCT04114539|472310991|FG000|Overall Study|Others not specified|5|||
131188543|NCT04114539|472310991|FG000|Overall Study|Investigator Decision|2|||
131188544|NCT01072448|472310994|FG000|Overall Study|Adverse Event|9|||
131188545|NCT01072448|472310995|FG001|Overall Study|Adverse Event|10|||
131188546|NCT01072448|472310994|FG000|Overall Study|Subject withdrew consent|4|||
131188547|NCT01072448|472310995|FG001|Overall Study|Subject withdrew consent|9|||
131188548|NCT01072448|472310994|FG000|Overall Study|Protocol deviation|3|||
131188549|NCT01072448|472310995|FG001|Overall Study|Protocol deviation|4|||
131188550|NCT01072448|472310994|FG000|Overall Study|Abnormal test procedure result(s)|1|||
131188551|NCT01072448|472310995|FG001|Overall Study|Abnormal test procedure result(s)|0|||
131188552|NCT01072448|472310994|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131188553|NCT01072448|472310995|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
131188554|NCT01072448|472310994|FG000|Overall Study|Lost to Follow-up|1|||
131188555|NCT01072448|472310995|FG001|Overall Study|Lost to Follow-up|1|||
131188556|NCT01072448|472310994|FG000|Overall Study|Abnormal laboratory value(s)|0|||
131188557|NCT01072448|472310995|FG001|Overall Study|Abnormal laboratory value(s)|1|||
131188558|NCT01072448|472310994|FG000|Overall Study|Death|0|||
131188559|NCT01072448|472310995|FG001|Overall Study|Death|2|||
131188560|NCT00196196|472310997|FG000|Overall Study|Withdrawal by Subject|2|||
131188561|NCT00196196|472310997|FG000|Overall Study|Did not have required condition (hydroce|5|||
131188562|NCT01601470|472310998|FG000|Period 2 - LCZ696|Physician Decision|1|||
131188563|NCT03032510|472310999|FG000|Overall Study|Adverse Event|5|||
131188564|NCT03032510|472311000|FG001|Overall Study|Adverse Event|2|||
131188565|NCT03032510|472310999|FG000|Overall Study|Lost to Follow-up|8|||
131188566|NCT03032510|472311000|FG001|Overall Study|Lost to Follow-up|7|||
131188567|NCT03032510|472310999|FG000|Overall Study|Withdrawal by Subject|8|||
131188568|NCT03032510|472311000|FG001|Overall Study|Withdrawal by Subject|7|||
131188569|NCT03032510|472310999|FG000|Overall Study|Subject noncompliance|4|||
131188570|NCT03032510|472311000|FG001|Overall Study|Subject noncompliance|2|||
131188571|NCT03032510|472310999|FG000|Overall Study|Physician Decision|2|||
131188572|NCT03032510|472311000|FG001|Overall Study|Physician Decision|0|||
131188573|NCT01079195|472311001|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
131188574|NCT01079195|472311001|FG000|Overall Study|No Documentation Available|437|||
131188575|NCT01079195|472311001|FG000|Overall Study|Adverse Event|157|||
131188576|NCT01079195|472311001|FG000|Overall Study|Reason Unknown|39|||
131188577|NCT01079195|472311001|FG000|Overall Study|Withdrawal by Subject|18|||
131188578|NCT01079195|472311001|FG000|Overall Study|Financial Reasons|15|||
131188579|NCT01079195|472311001|FG000|Overall Study|Lack of Effectiveness|12|||
131188580|NCT01079195|472311001|FG000|Overall Study|Physician Decision|4|||
131188581|NCT01079195|472311001|FG000|Overall Study|Improved Status of Participant|4|||
131188582|NCT01079195|472311001|FG000|Overall Study|No Follow-up Documentation Available|4|||
131188583|NCT01079195|472311001|FG000|Overall Study|Non-compliance|2|||
131188584|NCT02079519|472311005|FG000|Overall Study|Disease Progression|9|||
131188585|NCT02079519|472311005|FG000|Overall Study|Adverse Event|1|||
131188586|NCT01176240|472311011|FG000|Study 306A|Lack of Efficacy|2|||
131188587|NCT01176240|472311012|FG001|Study 306A|Lack of Efficacy|1|||
131188588|NCT01176240|472311011|FG000|Study 306A|Protocol Violation|0|||
131188589|NCT01176240|472311012|FG001|Study 306A|Protocol Violation|1|||
131188590|NCT01176240|472311011|FG000|Study 306A|Withdrawal by Subject|0|||
131188591|NCT01176240|472311012|FG001|Study 306A|Withdrawal by Subject|1|||
131188592|NCT01176240|472311011|FG000|Study 306A|Stop due to diverse problems|1|||
131188593|NCT01176240|472311012|FG001|Study 306A|Stop due to diverse problems|0|||
131188594|NCT01176240|472311011|FG000|Study 306B|Lack of Efficacy|5|||
131188595|NCT01176240|472311012|FG001|Study 306B|Lack of Efficacy|3|||
131188596|NCT01176240|472311011|FG000|Study 306B|Adverse Event|10|||
131188597|NCT01176240|472311012|FG001|Study 306B|Adverse Event|5|||
131188598|NCT01176240|472311011|FG000|Study 306B|Protocol Violation|2|||
131188599|NCT01176240|472311012|FG001|Study 306B|Protocol Violation|3|||
131188600|NCT01176240|472311011|FG000|Study 306B|Withdrawal by Subject|4|||
131188601|NCT01176240|472311012|FG001|Study 306B|Withdrawal by Subject|1|||
131188602|NCT01176240|472311011|FG000|Study 306B|Physician Decision|2|||
131188603|NCT01176240|472311012|FG001|Study 306B|Physician Decision|1|||
131188604|NCT01176240|472311011|FG000|Study 306B|Supine Hypertension|1|||
131188605|NCT01176240|472311012|FG001|Study 306B|Supine Hypertension|2|||
131188606|NCT01176240|472311011|FG000|Study 306B|Lost to Follow-up|0|||
131188607|NCT01176240|472311012|FG001|Study 306B|Lost to Follow-up|1|||
131188608|NCT01176240|472311011|FG000|Study 306B|withdrew prior to dosing|2|||
131188609|NCT01176240|472311012|FG001|Study 306B|withdrew prior to dosing|1|||
131188610|NCT01685203|472311013|FG000|Overall Study|Lost to Follow-up|3|||
131188611|NCT01685203|472311014|FG001|Overall Study|Lost to Follow-up|3|||
131188612|NCT01685203|472311015|FG002|Overall Study|Lost to Follow-up|0|||
131188613|NCT01685203|472311016|FG003|Overall Study|Lost to Follow-up|1|||
131188614|NCT01685203|472311017|FG004|Overall Study|Lost to Follow-up|0|||
131188615|NCT01685203|472311018|FG005|Overall Study|Lost to Follow-up|0|||
131188616|NCT01685203|472311019|FG006|Overall Study|Lost to Follow-up|0|||
131188617|NCT01685203|472311013|FG000|Overall Study|Adverse Event|0|||
131188618|NCT01685203|472311014|FG001|Overall Study|Adverse Event|0|||
131188619|NCT01685203|472311015|FG002|Overall Study|Adverse Event|0|||
131188620|NCT01685203|472311016|FG003|Overall Study|Adverse Event|0|||
131188621|NCT01685203|472311017|FG004|Overall Study|Adverse Event|0|||
131188622|NCT01685203|472311018|FG005|Overall Study|Adverse Event|2|||
131188623|NCT01685203|472311019|FG006|Overall Study|Adverse Event|0|||
131188624|NCT01685203|472311013|FG000|Overall Study|Adverse event and withdrew consent|1|||
131188625|NCT01685203|472311014|FG001|Overall Study|Adverse event and withdrew consent|0|||
131188626|NCT01685203|472311015|FG002|Overall Study|Adverse event and withdrew consent|0|||
131188627|NCT01685203|472311016|FG003|Overall Study|Adverse event and withdrew consent|0|||
131188628|NCT01685203|472311017|FG004|Overall Study|Adverse event and withdrew consent|0|||
131188629|NCT01685203|472311018|FG005|Overall Study|Adverse event and withdrew consent|0|||
131188630|NCT01685203|472311019|FG006|Overall Study|Adverse event and withdrew consent|0|||
131188631|NCT01685203|472311013|FG000|Overall Study|Patient's decision|0|||
131188632|NCT01685203|472311014|FG001|Overall Study|Patient's decision|0|||
131188633|NCT01685203|472311015|FG002|Overall Study|Patient's decision|0|||
131188634|NCT01685203|472311016|FG003|Overall Study|Patient's decision|0|||
131188635|NCT01685203|472311017|FG004|Overall Study|Patient's decision|0|||
131188636|NCT01685203|472311018|FG005|Overall Study|Patient's decision|1|||
131188637|NCT01685203|472311019|FG006|Overall Study|Patient's decision|0|||
131188638|NCT00318370|472311023|FG000|Period 1|Lack of Efficacy|5|||
131188639|NCT00318370|472311024|FG001|Period 1|Lack of Efficacy|0|||
131188640|NCT00318370|472311025|FG002|Period 1|Lack of Efficacy|0|||
131188641|NCT00318370|472311023|FG000|Period 1|Physician Decision|1|||
131188642|NCT00318370|472311024|FG001|Period 1|Physician Decision|0|||
131188643|NCT00318370|472311025|FG002|Period 1|Physician Decision|0|||
131188644|NCT00318370|472311023|FG000|Period 1|Withdrawal by Subject|1|||
131188645|NCT00318370|472311024|FG001|Period 1|Withdrawal by Subject|0|||
131188646|NCT00318370|472311025|FG002|Period 1|Withdrawal by Subject|0|||
131188647|NCT00318370|472311023|FG000|Period 2|Adverse Event|0|||
131188648|NCT00318370|472311024|FG001|Period 2|Adverse Event|3|||
131188649|NCT00318370|472311025|FG002|Period 2|Adverse Event|0|||
131188650|NCT00318370|472311023|FG000|Period 2|Lack of Efficacy|0|||
131188651|NCT00318370|472311024|FG001|Period 2|Lack of Efficacy|5|||
131188652|NCT00318370|472311025|FG002|Period 2|Lack of Efficacy|0|||
131188653|NCT00318370|472311023|FG000|Period 2|Physician Decision|0|||
131188654|NCT00318370|472311024|FG001|Period 2|Physician Decision|1|||
131188655|NCT00318370|472311025|FG002|Period 2|Physician Decision|0|||
131188656|NCT00318370|472311023|FG000|Period 2|Withdrawal by Subject|0|||
131188657|NCT00318370|472311024|FG001|Period 2|Withdrawal by Subject|1|||
131188658|NCT00318370|472311025|FG002|Period 2|Withdrawal by Subject|0|||
131188659|NCT00318370|472311023|FG000|Period 2|Other|0|||
131188660|NCT00318370|472311024|FG001|Period 2|Other|1|||
131188661|NCT00318370|472311025|FG002|Period 2|Other|0|||
131188662|NCT00318370|472311023|FG000|Period 3|Adverse Event|0|||
131188663|NCT00318370|472311024|FG001|Period 3|Adverse Event|0|||
131188664|NCT00318370|472311025|FG002|Period 3|Adverse Event|1|||
131188665|NCT00318370|472311023|FG000|Period 3|Lack of Efficacy|0|||
131188666|NCT00318370|472311024|FG001|Period 3|Lack of Efficacy|0|||
131188667|NCT00318370|472311025|FG002|Period 3|Lack of Efficacy|24|||
131188668|NCT00318370|472311023|FG000|Period 3|Death|0|||
131188669|NCT00318370|472311024|FG001|Period 3|Death|0|||
131188670|NCT00318370|472311025|FG002|Period 3|Death|1|||
131188671|NCT00318370|472311023|FG000|Period 3|Physician Decision|0|||
131188672|NCT00318370|472311024|FG001|Period 3|Physician Decision|0|||
131188673|NCT00318370|472311025|FG002|Period 3|Physician Decision|1|||
131188674|NCT00318370|472311023|FG000|Period 3|Withdrawal by Subject|0|||
131188675|NCT00318370|472311024|FG001|Period 3|Withdrawal by Subject|0|||
131188676|NCT00318370|472311025|FG002|Period 3|Withdrawal by Subject|3|||
131188677|NCT00318370|472311023|FG000|Period 3|Other|0|||
131188678|NCT00318370|472311024|FG001|Period 3|Other|0|||
131188679|NCT00318370|472311025|FG002|Period 3|Other|3|||
131188680|NCT01750840|472311028|FG000|Overall Study|Lost to Follow-up|4|||
131188681|NCT00807014|472311029|FG000|Overall Study|Participant Considered Disease Cured|13|||
131188682|NCT00807014|472311030|FG001|Overall Study|Participant Considered Disease Cured|2|||
131188683|NCT00807014|472311029|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
131188684|NCT00807014|472311030|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
131188685|NCT00807014|472311029|FG000|Overall Study|Protocol Violation|2|||
131188686|NCT00807014|472311030|FG001|Overall Study|Protocol Violation|8|||
131188687|NCT00807014|472311029|FG000|Overall Study|Adverse Event|0|||
131188688|NCT00807014|472311030|FG001|Overall Study|Adverse Event|2|||
131188689|NCT00807014|472311029|FG000|Overall Study|Lost to Follow-up|9|||
131188690|NCT00807014|472311030|FG001|Overall Study|Lost to Follow-up|7|||
131188691|NCT00807014|472311029|FG000|Overall Study|Recovery|1|||
131188692|NCT00807014|472311030|FG001|Overall Study|Recovery|0|||
130733547|NCT05026177|470642912|FG001|Overall Study|Noncompliance with study procedures|1|||
130733548|NCT05026177|470642913|FG002|Overall Study|Noncompliance with study procedures|1|||
131188693|NCT00807014|472311029|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
131188694|NCT00807014|472311030|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
131188695|NCT00651313|472311031|FG000|Overall Study|Adverse Event|0|||
131188696|NCT00651313|472311032|FG001|Overall Study|Adverse Event|1|||
131188697|NCT00651313|472311031|FG000|Overall Study|Withdrawal by Subject|3|||
131188698|NCT00651313|472311032|FG001|Overall Study|Withdrawal by Subject|1|||
131188699|NCT00651313|472311031|FG000|Overall Study|Lost to Follow-up|1|||
131188700|NCT00651313|472311032|FG001|Overall Study|Lost to Follow-up|1|||
131188701|NCT00651313|472311031|FG000|Overall Study|Adminstrative Discontinuation|2|||
131188702|NCT00651313|472311032|FG001|Overall Study|Adminstrative Discontinuation|3|||
131188703|NCT02650895|472311033|FG000|Overall Study|Withdrawal by Subject|0|||
131188704|NCT02650895|472311034|FG001|Overall Study|Withdrawal by Subject|1|||
131188705|NCT02650895|472311035|FG002|Overall Study|Withdrawal by Subject|0|||
131188706|NCT02650895|472311036|FG003|Overall Study|Withdrawal by Subject|0|||
131188707|NCT02650895|472311037|FG004|Overall Study|Withdrawal by Subject|0|||
131188708|NCT02650895|472311038|FG005|Overall Study|Withdrawal by Subject|0|||
131188709|NCT02971007|472313042|FG000|Overall Study|Adverse Event|1|||
131188710|NCT02971007|472313043|FG001|Overall Study|Adverse Event|0|||
131188711|NCT02971007|472313044|FG002|Overall Study|Adverse Event|0|||
131188712|NCT02971007|472313042|FG000|Overall Study|Lost to Follow-up|0|||
131188713|NCT02971007|472313043|FG001|Overall Study|Lost to Follow-up|1|||
131188714|NCT02971007|472313044|FG002|Overall Study|Lost to Follow-up|1|||
131188715|NCT02971007|472313042|FG000|Overall Study|Withdrawal by Subject|0|||
131188716|NCT02971007|472313043|FG001|Overall Study|Withdrawal by Subject|1|||
131188717|NCT02971007|472313044|FG002|Overall Study|Withdrawal by Subject|0|||
131188718|NCT02971007|472313042|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
131188719|NCT02971007|472313043|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
131188720|NCT02971007|472313044|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
131188721|NCT02971007|472313042|FG000|Overall Study|Patient discontinued study drug|0|||
131188722|NCT02971007|472313043|FG001|Overall Study|Patient discontinued study drug|1|||
131188723|NCT02971007|472313044|FG002|Overall Study|Patient discontinued study drug|0|||
131188724|NCT00402285|472313049|FG000|Overall Study|insufficient RNA quality|7|||
131188725|NCT00402285|472313050|FG001|Overall Study|insufficient RNA quality|6|||
131188726|NCT00402285|472313051|FG002|Overall Study|insufficient RNA quality|2|||
131188727|NCT02431702|472313054|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
131188728|NCT02431702|472313055|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131188729|NCT02431702|472313056|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131188730|NCT02431702|472313057|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131188731|NCT02431702|472313058|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131188732|NCT02431702|472313059|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131188733|NCT02431702|472313060|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
131188734|NCT02431702|472313054|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
131188735|NCT02431702|472313055|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
131188736|NCT02431702|472313056|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
131188737|NCT02431702|472313057|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
131188738|NCT02431702|472313058|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
131188739|NCT02431702|472313059|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
131188740|NCT02431702|472313060|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
131188741|NCT02431702|472313054|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
131188742|NCT02431702|472313055|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
131188743|NCT02431702|472313056|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
131188744|NCT02431702|472313057|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
131188745|NCT02431702|472313058|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
131188746|NCT02431702|472313059|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
131188747|NCT02431702|472313060|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
131188748|NCT02431702|472313054|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
131188749|NCT02431702|472313055|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
131188750|NCT02431702|472313056|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
131188751|NCT02431702|472313057|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
131188752|NCT02431702|472313058|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
131188753|NCT02431702|472313059|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
131188754|NCT02431702|472313060|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
131188755|NCT02431702|472313054|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
131188756|NCT02431702|472313055|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131188757|NCT02431702|472313056|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131188758|NCT02431702|472313057|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131188759|NCT02431702|472313058|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131188760|NCT02431702|472313059|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131188761|NCT02431702|472313060|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
131188762|NCT02431702|472313054|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
131188763|NCT02431702|472313055|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
131188764|NCT02431702|472313056|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
131188765|NCT02431702|472313057|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
131188766|NCT02431702|472313058|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
131188767|NCT02431702|472313059|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
131188768|NCT02431702|472313060|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
131188769|NCT02431702|472313054|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
131188770|NCT02431702|472313055|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
131188771|NCT02431702|472313056|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
131188772|NCT02431702|472313057|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
131188773|NCT02431702|472313058|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
131188774|NCT02431702|472313059|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
131188775|NCT02431702|472313060|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
131188776|NCT02431702|472313054|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
131188777|NCT02431702|472313055|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
131188778|NCT02431702|472313056|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
131188779|NCT02431702|472313057|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
131188780|NCT02431702|472313058|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
131188781|NCT02431702|472313059|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
131188782|NCT02431702|472313060|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
131188783|NCT02431702|472313054|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130733549|NCT05026177|470642911|FG000|Overall Study|Met stopping criteria|0|||
131188784|NCT02431702|472313055|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
131188785|NCT02431702|472313056|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131188786|NCT02431702|472313057|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131188787|NCT02431702|472313058|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131188788|NCT02431702|472313059|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131188789|NCT02431702|472313060|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
131188790|NCT02431702|472313054|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
131188791|NCT02431702|472313055|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
131188792|NCT02431702|472313056|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
131188793|NCT02431702|472313057|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
131188794|NCT02431702|472313058|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
131188795|NCT02431702|472313059|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
131188796|NCT02431702|472313060|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
131188797|NCT02431702|472313054|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131188798|NCT02431702|472313055|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131188799|NCT02431702|472313056|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
131188800|NCT02431702|472313057|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131188801|NCT02431702|472313058|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131188802|NCT02431702|472313059|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131188803|NCT02431702|472313060|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
131188804|NCT02431702|472313054|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
131188805|NCT02431702|472313055|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
131188806|NCT02431702|472313056|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
131188807|NCT02431702|472313057|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
131188808|NCT02431702|472313058|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
131188809|NCT02431702|472313059|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
131188810|NCT02431702|472313060|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
131188811|NCT02431702|472313054|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
131188812|NCT02431702|472313055|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
131188813|NCT02431702|472313056|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
131188814|NCT02431702|472313057|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
131188815|NCT02431702|472313058|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
131188816|NCT02431702|472313059|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
131188817|NCT02431702|472313060|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
131188818|NCT02431702|472313054|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
131188819|NCT02431702|472313055|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
131188820|NCT02431702|472313056|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
131188821|NCT02431702|472313057|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
131188822|NCT02431702|472313058|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
131188823|NCT02431702|472313059|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
131188824|NCT02431702|472313060|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
131188825|NCT02431702|472313054|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
131188826|NCT02431702|472313055|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
131188827|NCT02431702|472313056|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
131188828|NCT02431702|472313057|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
131188829|NCT02431702|472313058|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
131188830|NCT02431702|472313059|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
131188831|NCT02431702|472313060|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
131188832|NCT02009930|472313061|FG000|Overall Study|withdrawn|5|||
131188833|NCT02959970|472313065|FG000|Overall Study|Adverse Event|1|||
131188834|NCT02959970|472313066|FG001|Overall Study|Adverse Event|0|||
131188835|NCT02959970|472313065|FG000|Overall Study|Withdrawal by Subject|0|||
131188836|NCT02959970|472313066|FG001|Overall Study|Withdrawal by Subject|2|||
131188837|NCT02959970|472313065|FG000|Overall Study|Lost to Follow-up|1|||
131188838|NCT02959970|472313066|FG001|Overall Study|Lost to Follow-up|5|||
131188839|NCT00693420|472313069|FG000|Overall Study|Adverse Event|4|||
131188840|NCT00693420|472313070|FG001|Overall Study|Adverse Event|4|||
131188841|NCT00693420|472313069|FG000|Overall Study|Lost to Follow-up|0|||
131188842|NCT00693420|472313070|FG001|Overall Study|Lost to Follow-up|3|||
131188843|NCT00693420|472313069|FG000|Overall Study|Withdrawal by Subject|1|||
131188844|NCT00693420|472313070|FG001|Overall Study|Withdrawal by Subject|0|||
131188845|NCT00693420|472313069|FG000|Overall Study|Protocol Violation|0|||
131188846|NCT00693420|472313070|FG001|Overall Study|Protocol Violation|2|||
131188847|NCT00693420|472313069|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
130733550|NCT05026177|470642912|FG001|Overall Study|Met stopping criteria|0|||
130733551|NCT05026177|470642913|FG002|Overall Study|Met stopping criteria|1|||
131188848|NCT00693420|472313070|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
131188849|NCT00693420|472313069|FG000|Overall Study|Personal Reasons|1|||
131188850|NCT00693420|472313070|FG001|Overall Study|Personal Reasons|4|||
131188851|NCT03250624|472313071|FG000|Overall Study|Lack of Efficacy|1|||
131188852|NCT03250624|472313072|FG001|Overall Study|Lack of Efficacy|4|||
131188853|NCT03250624|472313071|FG000|Overall Study|Adverse Event|0|||
131188854|NCT03250624|472313072|FG001|Overall Study|Adverse Event|1|||
131188855|NCT03250624|472313071|FG000|Overall Study|Other|1|||
131188856|NCT03250624|472313072|FG001|Overall Study|Other|2|||
131188857|NCT00948428|472313076|FG000|Overall Study|Withdrawal by Subject|6|||
131188858|NCT00948428|472313077|FG001|Overall Study|Withdrawal by Subject|12|||
131188859|NCT00948428|472313078|FG002|Overall Study|Withdrawal by Subject|7|||
131188860|NCT00948428|472313076|FG000|Overall Study|Adverse Event|6|||
131188861|NCT00948428|472313077|FG001|Overall Study|Adverse Event|3|||
131188862|NCT00948428|472313078|FG002|Overall Study|Adverse Event|0|||
131188863|NCT00948428|472313076|FG000|Overall Study|Lost to Follow-up|2|||
131188864|NCT00948428|472313077|FG001|Overall Study|Lost to Follow-up|1|||
131188865|NCT00948428|472313078|FG002|Overall Study|Lost to Follow-up|1|||
131188866|NCT00948428|472313076|FG000|Overall Study|Death|2|||
131188867|NCT00948428|472313077|FG001|Overall Study|Death|0|||
131188868|NCT00948428|472313078|FG002|Overall Study|Death|0|||
131188869|NCT00948428|472313076|FG000|Overall Study|Intercurrent Illness|1|||
131188870|NCT00948428|472313077|FG001|Overall Study|Intercurrent Illness|0|||
131188871|NCT00948428|472313078|FG002|Overall Study|Intercurrent Illness|0|||
131188872|NCT00948428|472313076|FG000|Overall Study|Non-compliance|1|||
131188873|NCT00948428|472313077|FG001|Overall Study|Non-compliance|2|||
131188874|NCT00948428|472313078|FG002|Overall Study|Non-compliance|0|||
131188875|NCT00509028|472313079|FG000|Overall Study|Adverse Event|2|||
131188876|NCT00509028|472313080|FG001|Overall Study|Adverse Event|0|||
131188877|NCT00509028|472313079|FG000|Overall Study|Withdrawal by Subject|4|||
131188878|NCT00509028|472313080|FG001|Overall Study|Withdrawal by Subject|3|||
131188879|NCT00509028|472313079|FG000|Overall Study|Lost to Follow-up|0|||
131188880|NCT00509028|472313080|FG001|Overall Study|Lost to Follow-up|1|||
131188881|NCT00509028|472313079|FG000|Overall Study|Protocol Violation|4|||
131188882|NCT00509028|472313080|FG001|Overall Study|Protocol Violation|2|||
131188883|NCT00509028|472313079|FG000|Overall Study|Non-compliance|2|||
131188884|NCT00509028|472313080|FG001|Overall Study|Non-compliance|1|||
131188885|NCT02471586|472313081|FG000|Overall Study|Lost to Follow-up|3|||
131188886|NCT02471586|472313082|FG001|Overall Study|Lost to Follow-up|8|||
131188887|NCT02471586|472313083|FG002|Overall Study|Lost to Follow-up|4|||
131188888|NCT02471586|472313081|FG000|Overall Study|Death|2|||
131188889|NCT02471586|472313082|FG001|Overall Study|Death|2|||
131188890|NCT02471586|472313083|FG002|Overall Study|Death|0|||
131188891|NCT00369278|472313086|FG000|Overall Study|Adverse Event|14|||
131188892|NCT00369278|472313087|FG001|Overall Study|Adverse Event|11|||
131188893|NCT00369278|472313086|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
131188894|NCT00369278|472313087|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
131188895|NCT00369278|472313086|FG000|Overall Study|Protocol Violation|2|||
131188896|NCT00369278|472313087|FG001|Overall Study|Protocol Violation|1|||
131188897|NCT00369278|472313086|FG000|Overall Study|Withdrawal by Subject|2|||
131188898|NCT00369278|472313087|FG001|Overall Study|Withdrawal by Subject|2|||
131188899|NCT00369278|472313086|FG000|Overall Study|Lost to Follow-up|1|||
131188900|NCT00369278|472313087|FG001|Overall Study|Lost to Follow-up|0|||
131188901|NCT00369278|472313086|FG000|Overall Study|Graft loss|1|||
131188902|NCT00369278|472313087|FG001|Overall Study|Graft loss|2|||
131188903|NCT01224106|472313088|FG000|Double-Blind Treatment Phase|Death|3|||
131188904|NCT01224106|472313089|FG001|Double-Blind Treatment Phase|Death|0|||
131188905|NCT01224106|472313090|FG002|Double-Blind Treatment Phase|Death|0|||
131188906|NCT01224106|472313091|FG003|Double-Blind Treatment Phase|Death|0|||
131188907|NCT01224106|472313092|FG004|Double-Blind Treatment Phase|Death|0|||
131188908|NCT01224106|472313088|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
131188909|NCT01224106|472313089|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
131188910|NCT01224106|472313090|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
131188911|NCT01224106|472313091|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
131188912|NCT01224106|472313092|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
131188913|NCT01224106|472313088|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
131188914|NCT01224106|472313089|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
131188915|NCT01224106|472313090|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
131188916|NCT01224106|472313091|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
131188917|NCT01224106|472313092|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
131188918|NCT01224106|472313088|FG000|Double-Blind Treatment Phase|Other|0|||
131188919|NCT01224106|472313089|FG001|Double-Blind Treatment Phase|Other|0|||
131188920|NCT01224106|472313090|FG002|Double-Blind Treatment Phase|Other|1|||
131188921|NCT01224106|472313091|FG003|Double-Blind Treatment Phase|Other|0|||
131188922|NCT01224106|472313092|FG004|Double-Blind Treatment Phase|Other|0|||
131188923|NCT01224106|472313088|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
131188924|NCT01224106|472313089|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
131188925|NCT01224106|472313090|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
131188926|NCT01224106|472313091|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
131188927|NCT01224106|472313092|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
131188928|NCT01224106|472313088|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
131188929|NCT01224106|472313089|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
131188930|NCT01224106|472313090|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
131188931|NCT01224106|472313091|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
131188932|NCT01224106|472313092|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
131188933|NCT01224106|472313088|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
131188934|NCT01224106|472313089|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131188935|NCT01224106|472313090|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
131188936|NCT01224106|472313091|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131188937|NCT01224106|472313092|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131188938|NCT01224106|472313088|FG000|Open-Label Extension (OLE) Phase|Death|0|||
131188939|NCT01224106|472313089|FG001|Open-Label Extension (OLE) Phase|Death|0|||
131188940|NCT01224106|472313090|FG002|Open-Label Extension (OLE) Phase|Death|0|||
131188941|NCT01224106|472313091|FG003|Open-Label Extension (OLE) Phase|Death|1|||
131188942|NCT01224106|472313092|FG004|Open-Label Extension (OLE) Phase|Death|3|||
131188943|NCT01224106|472313088|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
131188944|NCT01224106|472313089|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
131188945|NCT01224106|472313090|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
131188946|NCT01224106|472313091|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
131188947|NCT01224106|472313092|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
131188948|NCT01224106|472313088|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
131188949|NCT01224106|472313089|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
131188950|NCT01224106|472313090|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
131188951|NCT01224106|472313091|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
131188952|NCT01224106|472313092|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
131188953|NCT01224106|472313088|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
131188954|NCT01224106|472313089|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
131188955|NCT01224106|472313090|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
131188956|NCT01224106|472313091|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
131188957|NCT01224106|472313092|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
131188958|NCT01224106|472313088|FG000|Open-Label Extension (OLE) Phase|Other|0|||
131188959|NCT01224106|472313089|FG001|Open-Label Extension (OLE) Phase|Other|0|||
131188960|NCT01224106|472313090|FG002|Open-Label Extension (OLE) Phase|Other|0|||
131188961|NCT01224106|472313091|FG003|Open-Label Extension (OLE) Phase|Other|5|||
131188962|NCT01224106|472313092|FG004|Open-Label Extension (OLE) Phase|Other|3|||
131188963|NCT00446797|472313093|FG000|Overall Study|Lack of Efficacy|0|||
131188964|NCT00446797|472313094|FG001|Overall Study|Lack of Efficacy|2|||
131188965|NCT00446797|472313093|FG000|Overall Study|Lost to Follow-up|5|||
131188966|NCT00446797|472313094|FG001|Overall Study|Lost to Follow-up|3|||
131188967|NCT00446797|472313093|FG000|Overall Study|Withdrawal by Subject|2|||
131188968|NCT00446797|472313094|FG001|Overall Study|Withdrawal by Subject|2|||
131188969|NCT00446797|472313093|FG000|Overall Study|Protocol Violation|1|||
131188970|NCT00446797|472313094|FG001|Overall Study|Protocol Violation|3|||
131188971|NCT00446797|472313093|FG000|Overall Study|subject entered at another site|0|||
131188972|NCT00446797|472313094|FG001|Overall Study|subject entered at another site|1|||
131188973|NCT00446797|472313093|FG000|Overall Study|did not meet entrance criteria|0|||
131188974|NCT00446797|472313094|FG001|Overall Study|did not meet entrance criteria|1|||
131188975|NCT00441727|472313097|FG000|Overall Study|Protocol Violation|19|||
131188976|NCT00441727|472313098|FG001|Overall Study|Protocol Violation|28|||
131188977|NCT00441727|472313099|FG002|Overall Study|Protocol Violation|32|||
131188978|NCT00441727|472313097|FG000|Overall Study|Adverse Event|26|||
131188979|NCT00441727|472313098|FG001|Overall Study|Adverse Event|33|||
131188980|NCT00441727|472313099|FG002|Overall Study|Adverse Event|28|||
131188981|NCT00441727|472313097|FG000|Overall Study|Lack of Efficacy|7|||
131188982|NCT00441727|472313098|FG001|Overall Study|Lack of Efficacy|8|||
131188983|NCT00441727|472313099|FG002|Overall Study|Lack of Efficacy|48|||
131188984|NCT00441727|472313097|FG000|Overall Study|Withdrawal by Subject|40|||
131188985|NCT00441727|472313098|FG001|Overall Study|Withdrawal by Subject|34|||
131188986|NCT00441727|472313099|FG002|Overall Study|Withdrawal by Subject|47|||
131188987|NCT00441727|472313097|FG000|Overall Study|Lost to Follow-up|5|||
131188988|NCT00441727|472313098|FG001|Overall Study|Lost to Follow-up|6|||
131188989|NCT00441727|472313099|FG002|Overall Study|Lost to Follow-up|5|||
131188990|NCT00441727|472313097|FG000|Overall Study|Safety Reasons|3|||
131188991|NCT00441727|472313098|FG001|Overall Study|Safety Reasons|1|||
131188992|NCT00441727|472313099|FG002|Overall Study|Safety Reasons|3|||
131188993|NCT00441727|472313097|FG000|Overall Study|Various reason specified|6|||
131188994|NCT00441727|472313098|FG001|Overall Study|Various reason specified|8|||
131188995|NCT00441727|472313099|FG002|Overall Study|Various reason specified|5|||
131188996|NCT03551626|472313104|FG000|Overall Study|Adverse Event|88|||
131188997|NCT03551626|472313104|FG000|Overall Study|Disease relapse|18|||
131188998|NCT03551626|472313104|FG000|Overall Study|Withdrawal of informed consent|6|||
131188999|NCT03551626|472313104|FG000|Overall Study|Patient decision|5|||
131189000|NCT03551626|472313104|FG000|Overall Study|Physician Decision|4|||
131189001|NCT03551626|472313104|FG000|Overall Study|Lost to Follow-up|3|||
131189002|NCT03551626|472313104|FG000|Overall Study|Pregnancy|1|||
131189003|NCT03551626|472313104|FG000|Overall Study|Protocol deviation|1|||
131189004|NCT03551626|472313104|FG000|Overall Study|Technical problems|1|||
131189005|NCT02133001|472313105|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
131189006|NCT02133001|472313106|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
131189007|NCT02133001|472313105|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
131189008|NCT02133001|472313106|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
131189009|NCT02133001|472313105|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
131189010|NCT02133001|472313106|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
131189011|NCT02133001|472313105|FG000|Double Blind (Day 1-25)|Other|2|||
131189012|NCT02133001|472313106|FG001|Double Blind (Day 1-25)|Other|2|||
131189013|NCT02133001|472313105|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
131189014|NCT02133001|472313106|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
131189015|NCT02133001|472313105|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
131189016|NCT02133001|472313106|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
131189017|NCT02133001|472313105|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
131189018|NCT02133001|472313106|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
131189019|NCT02133001|472313105|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
131189020|NCT02133001|472313106|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
131189021|NCT04211961|472313107|FG000|Overall Study|Death|0|||
131189022|NCT04211961|472313108|FG001|Overall Study|Death|1|||
131189023|NCT04211961|472313107|FG000|Overall Study|Lost to Follow-up|0|||
131189024|NCT04211961|472313108|FG001|Overall Study|Lost to Follow-up|1|||
131189025|NCT04211961|472313107|FG000|Overall Study|Withdrawal by Subject|0|||
131189026|NCT04211961|472313108|FG001|Overall Study|Withdrawal by Subject|1|||
131189027|NCT03135262|472313115|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
131189028|NCT03135262|472313116|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
131189029|NCT03135262|472313117|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
131189030|NCT03135262|472313118|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
131189031|NCT03135262|472313119|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
131189032|NCT03135262|472313115|FG000|Overall Study|Progression of disease|0|||
131189033|NCT03135262|472313116|FG001|Overall Study|Progression of disease|0|||
131189034|NCT03135262|472313117|FG002|Overall Study|Progression of disease|0|||
131189035|NCT03135262|472313118|FG003|Overall Study|Progression of disease|1|||
131189036|NCT03135262|472313119|FG004|Overall Study|Progression of disease|0|||
131189037|NCT03135262|472313115|FG000|Overall Study|Death|6|||
131189038|NCT03135262|472313116|FG001|Overall Study|Death|2|||
131189039|NCT03135262|472313117|FG002|Overall Study|Death|2|||
131189040|NCT03135262|472313118|FG003|Overall Study|Death|2|||
131189041|NCT03135262|472313119|FG004|Overall Study|Death|0|||
131189042|NCT03135262|472313115|FG000|Overall Study|Withdrawal by Subject|0|||
131189043|NCT03135262|472313116|FG001|Overall Study|Withdrawal by Subject|0|||
131189044|NCT03135262|472313117|FG002|Overall Study|Withdrawal by Subject|1|||
131189045|NCT03135262|472313118|FG003|Overall Study|Withdrawal by Subject|0|||
131189046|NCT03135262|472313119|FG004|Overall Study|Withdrawal by Subject|1|||
131189047|NCT03135262|472313115|FG000|Overall Study|Study terminated by sponsor|2|||
131189048|NCT03135262|472313116|FG001|Overall Study|Study terminated by sponsor|4|||
131189049|NCT03135262|472313117|FG002|Overall Study|Study terminated by sponsor|4|||
131189050|NCT03135262|472313118|FG003|Overall Study|Study terminated by sponsor|3|||
131189051|NCT03135262|472313119|FG004|Overall Study|Study terminated by sponsor|0|||
131189052|NCT01599806|472313121|FG000|Overall Study|Lost to Follow-up|20|||
131189053|NCT01599806|472313122|FG001|Overall Study|Lost to Follow-up|20|||
131189054|NCT01599806|472313121|FG000|Overall Study|Withdrawal by Subject|12|||
131189055|NCT01599806|472313122|FG001|Overall Study|Withdrawal by Subject|12|||
131189056|NCT01599806|472313121|FG000|Overall Study|Other Eligibility criteria|11|||
131189057|NCT01599806|472313122|FG001|Overall Study|Other Eligibility criteria|9|||
131189058|NCT01266070|472313132|FG000|Overall Study|Adverse Event|3|||
131189059|NCT01266070|472313132|FG000|Overall Study|Protocol Violation|1|||
131189060|NCT03689972|472313133|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
131189061|NCT03689972|472313134|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
131189062|NCT03689972|472313135|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
131189063|NCT03689972|472313136|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
131189064|NCT03689972|472313137|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
131189065|NCT03689972|472313133|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
131189066|NCT03689972|472313134|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
131189067|NCT03689972|472313135|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
131189068|NCT03689972|472313136|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
131189069|NCT03689972|472313137|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
131189070|NCT03689972|472313133|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
131189071|NCT03689972|472313134|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
131189072|NCT03689972|472313135|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
131189073|NCT03689972|472313136|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
131189074|NCT03689972|472313137|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
131189075|NCT03689972|472313133|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
131189076|NCT03689972|472313134|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
131189077|NCT03689972|472313135|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
131189078|NCT03689972|472313136|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
131189079|NCT03689972|472313137|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
131189080|NCT03689972|472313133|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
131189081|NCT03689972|472313134|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
131189082|NCT03689972|472313135|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
131189083|NCT03689972|472313136|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
131189084|NCT03689972|472313137|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
131189085|NCT03689972|472313133|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
131189086|NCT03689972|472313134|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
131189087|NCT03689972|472313135|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
131189088|NCT03689972|472313136|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
131189089|NCT03689972|472313137|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
131189090|NCT03689972|472313133|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
131189091|NCT03689972|472313134|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
131189092|NCT03689972|472313135|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
131189093|NCT03689972|472313136|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
131189094|NCT03689972|472313137|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
131189095|NCT03689972|472313133|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
131189096|NCT03689972|472313134|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
131189097|NCT03689972|472313135|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
131189098|NCT03689972|472313136|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
131189099|NCT03689972|472313137|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
131189100|NCT03689972|472313133|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
131189101|NCT03689972|472313134|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
131189102|NCT03689972|472313135|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
131189103|NCT03689972|472313136|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
131189104|NCT03689972|472313137|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
131189105|NCT03689972|472313133|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
131189106|NCT03689972|472313134|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
131189107|NCT03689972|472313135|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
131189108|NCT03689972|472313136|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
131189109|NCT03689972|472313137|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
131189110|NCT03689972|472313133|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
131189111|NCT03689972|472313134|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
131189112|NCT03689972|472313135|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
131189113|NCT03689972|472313136|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
131189114|NCT03689972|472313137|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
131189115|NCT03689972|472313133|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
131189116|NCT03689972|472313134|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
131189117|NCT03689972|472313135|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
131189118|NCT03689972|472313136|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
131189119|NCT03689972|472313137|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
131189120|NCT03689972|472313133|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
131189121|NCT03689972|472313134|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
131189122|NCT03689972|472313135|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
131189123|NCT03689972|472313136|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
131189124|NCT03689972|472313137|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
131189125|NCT03689972|472313133|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
131189126|NCT03689972|472313134|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
131189127|NCT03689972|472313135|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
131189128|NCT03689972|472313136|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
131189129|NCT03689972|472313137|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
131189130|NCT03689972|472313133|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
131189131|NCT03689972|472313134|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
131189132|NCT03689972|472313135|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
131189133|NCT03689972|472313136|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
131189134|NCT03689972|472313137|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
131189135|NCT03689972|472313133|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
131189136|NCT03689972|472313134|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
131189137|NCT03689972|472313135|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
131189138|NCT03689972|472313136|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
131189139|NCT03689972|472313137|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
131189140|NCT03689972|472313133|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
131189141|NCT03689972|472313134|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
131189142|NCT03689972|472313135|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
131189143|NCT03689972|472313136|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
131189144|NCT03689972|472313137|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
131189145|NCT03689972|472313133|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
131189146|NCT03689972|472313134|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
131189147|NCT03689972|472313135|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
131189148|NCT03689972|472313136|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
131189149|NCT03689972|472313137|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
131189150|NCT03689972|472313133|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
131189151|NCT03689972|472313134|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
131189152|NCT03689972|472313135|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
131189153|NCT03689972|472313136|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
131189154|NCT03689972|472313137|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
131189155|NCT01838213|472313138|FG000|Overall Study|Ineligible|166|||
131189156|NCT01838213|472313139|FG001|Overall Study|Ineligible|191|||
131189157|NCT02417064|472313140|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
131189158|NCT02417064|472313141|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
131189159|NCT02417064|472313142|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
131189160|NCT02417064|472313140|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
131189161|NCT02417064|472313141|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
131189162|NCT02417064|472313142|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
131189163|NCT02417064|472313140|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
131189164|NCT02417064|472313141|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
131189165|NCT02417064|472313142|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
131189166|NCT02417064|472313140|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
131189167|NCT02417064|472313141|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
131189168|NCT02417064|472313142|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
131189169|NCT02417064|472313140|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
131189170|NCT02417064|472313141|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
131189171|NCT02417064|472313142|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
131189172|NCT02417064|472313140|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
131189173|NCT02417064|472313141|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
131189174|NCT02417064|472313142|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
131189175|NCT02417064|472313140|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
131189176|NCT02417064|472313141|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
131189177|NCT02417064|472313142|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
131189178|NCT02417064|472313140|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
131189179|NCT02417064|472313141|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
131189180|NCT02417064|472313142|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
131189181|NCT02417064|472313140|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
131189182|NCT02417064|472313141|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
131189183|NCT02417064|472313142|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
131189184|NCT02417064|472313140|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
131189185|NCT02417064|472313141|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
131189186|NCT02417064|472313142|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
131189187|NCT02417064|472313140|FG000|Follow-up Phase (24 Weeks)|Other|2|||
131189188|NCT02417064|472313141|FG001|Follow-up Phase (24 Weeks)|Other|2|||
131189189|NCT02417064|472313142|FG002|Follow-up Phase (24 Weeks)|Other|3|||
131189190|NCT01548417|472313145|FG000|Overall Study|Withdrawal by Subject|0|||
131189191|NCT01548417|472313146|FG001|Overall Study|Withdrawal by Subject|2|||
131189192|NCT02873208|472313147|FG000|Overall Study|Withdrawal by Subject|36|||
130733552|NCT05026177|470642911|FG000|Overall Study|Health issues preventing continuation|0|||
131189193|NCT02873208|472313147|FG000|Overall Study|Lost to Follow-up|22|||
131189194|NCT02873208|472313147|FG000|Overall Study|Adverse Event|15|||
131189195|NCT02873208|472313147|FG000|Overall Study|Non-compliance with study drug|12|||
131189196|NCT02873208|472313147|FG000|Overall Study|Protocol Violation|8|||
131189197|NCT02873208|472313147|FG000|Overall Study|Pregnancy|2|||
131189198|NCT02873208|472313147|FG000|Overall Study|Incarceration|1|||
131189199|NCT02873208|472313147|FG000|Overall Study|Lack of Efficacy|1|||
131189200|NCT02873208|472313147|FG000|Overall Study|Physician Decision|1|||
131189201|NCT01585168|472313148|FG000|Overall Study|Lost to Follow-up|3|||
131189202|NCT01585168|472313149|FG001|Overall Study|Lost to Follow-up|1|||
131189203|NCT01585168|472313150|FG002|Overall Study|Lost to Follow-up|1|||
131189204|NCT01585168|472313151|FG003|Overall Study|Lost to Follow-up|1|||
131189205|NCT01194414|472313152|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
131189206|NCT01194414|472313153|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
131189207|NCT01194414|472313154|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
131189208|NCT01194414|472313155|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
131189209|NCT01194414|472313152|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
131189210|NCT01194414|472313153|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
131189211|NCT01194414|472313154|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
131189212|NCT01194414|472313155|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
131189213|NCT01194414|472313152|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
131189214|NCT01194414|472313153|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
131189215|NCT01194414|472313154|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
131189216|NCT01194414|472313155|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
131189217|NCT01194414|472313152|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
131189218|NCT01194414|472313153|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
131189219|NCT01194414|472313154|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
131189220|NCT01194414|472313155|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
131189221|NCT01194414|472313152|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
131189222|NCT01194414|472313153|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
131189223|NCT01194414|472313154|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
131189224|NCT01194414|472313155|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
131189225|NCT01194414|472313152|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
131189226|NCT01194414|472313153|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
131189227|NCT01194414|472313154|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
131189228|NCT01194414|472313155|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
131189229|NCT01194414|472313152|FG000|24 Weeks Double Blind Period|Other|0|||
131189230|NCT01194414|472313153|FG001|24 Weeks Double Blind Period|Other|1|||
131189231|NCT01194414|472313154|FG002|24 Weeks Double Blind Period|Other|0|||
131189232|NCT01194414|472313155|FG003|24 Weeks Double Blind Period|Other|0|||
131189233|NCT01194414|472313152|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
131189234|NCT01194414|472313153|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
131189235|NCT01194414|472313154|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
131189236|NCT01194414|472313155|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
131189237|NCT01194414|472313152|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
131189238|NCT01194414|472313153|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
131189239|NCT01194414|472313154|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
131189240|NCT01194414|472313155|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
131189241|NCT01194414|472313152|FG000|24 Weeks Double Blind Period|Death|0|||
131189242|NCT01194414|472313153|FG001|24 Weeks Double Blind Period|Death|1|||
131189243|NCT01194414|472313154|FG002|24 Weeks Double Blind Period|Death|0|||
131189244|NCT01194414|472313155|FG003|24 Weeks Double Blind Period|Death|0|||
131189245|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
131189246|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
131189247|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
131189248|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
131189249|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
131189250|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
131189251|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
131189252|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
131189253|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
131189254|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
131189255|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
131189256|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
131189257|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
131189258|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
131189259|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
131189260|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
131189261|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
131189262|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
130733553|NCT05026177|470642912|FG001|Overall Study|Health issues preventing continuation|0|||
131189263|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
131189264|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
131189265|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
131189266|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
131189267|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
131189268|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
131189269|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Other|2|||
131189270|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Other|1|||
131189271|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Other|0|||
131189272|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Other|0|||
131189273|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
131189274|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
131189275|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
131189276|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
131189277|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
131189278|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
131189279|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
131189280|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
131189281|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
131189282|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
131189283|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
131189284|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
131189285|NCT01194414|472313152|FG000|72 Weeks Open Label Extension|Death|1|||
131189286|NCT01194414|472313153|FG001|72 Weeks Open Label Extension|Death|2|||
131189287|NCT01194414|472313154|FG002|72 Weeks Open Label Extension|Death|0|||
131189288|NCT01194414|472313155|FG003|72 Weeks Open Label Extension|Death|2|||
131189289|NCT04737759|472313158|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
131189290|NCT04737759|472313159|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
131189291|NCT04737759|472313158|FG000|Overall Study|Death|2|||
131189292|NCT04737759|472313159|FG001|Overall Study|Death|0|||
131189293|NCT04737759|472313158|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
131189294|NCT04737759|472313159|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
131189295|NCT04737759|472313158|FG000|Overall Study|Lost to Follow-up|4|||
131189296|NCT04737759|472313159|FG001|Overall Study|Lost to Follow-up|12|||
131189297|NCT02475629|472313163|FG000|Overall Study|Adverse Event|1|||
131189298|NCT02475629|472313163|FG000|Overall Study|Death|4|||
131189299|NCT02475629|472313163|FG000|Overall Study|Physician Decision|1|||
131189300|NCT02475629|472313163|FG000|Overall Study|Withdrawal by Subject|1|||
131189301|NCT02475629|472313163|FG000|Overall Study|Lost to Follow-up|1|||
131189302|NCT02475629|472313163|FG000|Overall Study|Subject non-compliance|1|||
131189303|NCT01421069|472313164|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
131189304|NCT01421069|472313164|FG000|Parent Study|Failed to return|3|||
131189305|NCT01421069|472313164|FG000|Parent Study|Withdrawal by Subject|1|||
131189306|NCT01421069|472313164|FG000|Parent Study|Lost to Follow-up|2|||
131189307|NCT01421069|472313164|FG000|Parent Study|Lack of Efficacy|1|||
131189308|NCT01421069|472313164|FG000|Overall Period for Extension Study|Other|2|||
131189309|NCT01421069|472313164|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
131189310|NCT01421069|472313164|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
131189311|NCT01421069|472313164|FG000|Overall Period for Extension Study|Pregnancy|1|||
131189312|NCT01421069|472313164|FG000|Overall Period for Extension Study|Adverse Event|1|||
131189313|NCT01421069|472313164|FG000|Overall Period for Extension Study|Protocol Violation|1|||
131189314|NCT01421069|472313164|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
131189315|NCT01421069|472313164|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
131189316|NCT01421069|472313164|FG000|Active Treatment Period|Other|1|||
131189317|NCT01421069|472313164|FG000|Active Treatment Period|No longer willing to participate in study|8|||
131189318|NCT01421069|472313164|FG000|Active Treatment Period|Insufficient clinical response|1|||
131189319|NCT01421069|472313164|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
131189320|NCT01421069|472313164|FG000|Active Treatment Period|Pregnancy|1|||
131189321|NCT01421069|472313164|FG000|Active Treatment Period|Adverse Event|1|||
131189322|NCT01421069|472313164|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
131189323|NCT01421069|472313164|FG000|Active Treatment Period|Enrolled in observational period|29|||
131189324|NCT01421069|472313164|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
131189325|NCT01421069|472313164|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
131189326|NCT01421069|472313164|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
131189327|NCT01421069|472313164|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
131189328|NCT01421069|472313164|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
131189329|NCT01421069|472313164|FG000|2b. Retreatment Period|Protocol Violation|1|||
131189330|NCT01421069|472313164|FG000|Observational Period|Other|1|||
131189331|NCT01421069|472313164|FG000|Observational Period|No longer willing to participate in study|4|||
131189332|NCT01421069|472313164|FG000|Observational Period|Lost to Follow-up|3|||
130784546|NCT03885908|470838817|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
131189333|NCT01641081|472313170|FG000|Period 1|Sponsor request (potential unblinding)|0|||
131189334|NCT01641081|472313171|FG001|Period 1|Sponsor request (potential unblinding)|0|||
131189335|NCT01641081|472313172|FG002|Period 1|Sponsor request (potential unblinding)|0|||
131189336|NCT01641081|472313173|FG003|Period 1|Sponsor request (potential unblinding)|0|||
131189337|NCT01641081|472313174|FG004|Period 1|Sponsor request (potential unblinding)|0|||
131189338|NCT01641081|472313175|FG005|Period 1|Sponsor request (potential unblinding)|0|||
131189339|NCT01641081|472313176|FG006|Period 1|Sponsor request (potential unblinding)|1|||
131189340|NCT01641081|472313177|FG007|Period 1|Sponsor request (potential unblinding)|0|||
131189341|NCT01641081|472313178|FG008|Period 1|Sponsor request (potential unblinding)|0|||
131189342|NCT01641081|472313179|FG009|Period 1|Sponsor request (potential unblinding)|0|||
131189343|NCT01641081|472313170|FG000|Period 1|Protocol Violation|0|||
131189344|NCT01641081|472313171|FG001|Period 1|Protocol Violation|0|||
131189345|NCT01641081|472313172|FG002|Period 1|Protocol Violation|0|||
131189346|NCT01641081|472313173|FG003|Period 1|Protocol Violation|0|||
131189347|NCT01641081|472313174|FG004|Period 1|Protocol Violation|1|||
131189348|NCT01641081|472313175|FG005|Period 1|Protocol Violation|0|||
131189349|NCT01641081|472313176|FG006|Period 1|Protocol Violation|0|||
131189350|NCT01641081|472313177|FG007|Period 1|Protocol Violation|1|||
131189351|NCT01641081|472313178|FG008|Period 1|Protocol Violation|0|||
131189352|NCT01641081|472313179|FG009|Period 1|Protocol Violation|0|||
131189353|NCT01641081|472313170|FG000|Period 1|Adverse Event|1|||
131189354|NCT01641081|472313171|FG001|Period 1|Adverse Event|0|||
131189355|NCT01641081|472313172|FG002|Period 1|Adverse Event|0|||
131189356|NCT01641081|472313173|FG003|Period 1|Adverse Event|0|||
131189357|NCT01641081|472313174|FG004|Period 1|Adverse Event|0|||
131189358|NCT01641081|472313175|FG005|Period 1|Adverse Event|0|||
131189359|NCT01641081|472313176|FG006|Period 1|Adverse Event|0|||
131189360|NCT01641081|472313177|FG007|Period 1|Adverse Event|2|||
131189361|NCT01641081|472313178|FG008|Period 1|Adverse Event|0|||
131189362|NCT01641081|472313179|FG009|Period 1|Adverse Event|0|||
131189363|NCT01641081|472313170|FG000|Period 2|Adverse Event|0|||
131189364|NCT01641081|472313171|FG001|Period 2|Adverse Event|0|||
131189365|NCT01641081|472313172|FG002|Period 2|Adverse Event|0|||
131189366|NCT01641081|472313173|FG003|Period 2|Adverse Event|0|||
131189367|NCT01641081|472313174|FG004|Period 2|Adverse Event|0|||
131189368|NCT01641081|472313175|FG005|Period 2|Adverse Event|1|||
131189369|NCT01641081|472313176|FG006|Period 2|Adverse Event|0|||
131189370|NCT01641081|472313177|FG007|Period 2|Adverse Event|0|||
131189371|NCT01641081|472313178|FG008|Period 2|Adverse Event|0|||
131189372|NCT01641081|472313179|FG009|Period 2|Adverse Event|0|||
131189373|NCT01641081|472313170|FG000|Period 2|Withdrawal by Subject|0|||
131189374|NCT01641081|472313171|FG001|Period 2|Withdrawal by Subject|0|||
131189375|NCT01641081|472313172|FG002|Period 2|Withdrawal by Subject|0|||
131189376|NCT01641081|472313173|FG003|Period 2|Withdrawal by Subject|1|||
131189377|NCT01641081|472313174|FG004|Period 2|Withdrawal by Subject|0|||
131189378|NCT01641081|472313175|FG005|Period 2|Withdrawal by Subject|0|||
131189379|NCT01641081|472313176|FG006|Period 2|Withdrawal by Subject|2|||
131189380|NCT01641081|472313177|FG007|Period 2|Withdrawal by Subject|0|||
131189381|NCT01641081|472313178|FG008|Period 2|Withdrawal by Subject|0|||
131189382|NCT01641081|472313179|FG009|Period 2|Withdrawal by Subject|0|||
131189383|NCT01641081|472313170|FG000|Period 2|Protocol Violation|1|||
131189384|NCT01641081|472313171|FG001|Period 2|Protocol Violation|0|||
131189385|NCT01641081|472313172|FG002|Period 2|Protocol Violation|0|||
131189386|NCT01641081|472313173|FG003|Period 2|Protocol Violation|0|||
131189387|NCT01641081|472313174|FG004|Period 2|Protocol Violation|0|||
131189388|NCT01641081|472313175|FG005|Period 2|Protocol Violation|0|||
131189389|NCT01641081|472313176|FG006|Period 2|Protocol Violation|0|||
131189390|NCT01641081|472313177|FG007|Period 2|Protocol Violation|0|||
131189391|NCT01641081|472313178|FG008|Period 2|Protocol Violation|0|||
131189392|NCT01641081|472313179|FG009|Period 2|Protocol Violation|0|||
131189393|NCT01641081|472313170|FG000|Period 3|Adverse Event|0|||
131189394|NCT01641081|472313171|FG001|Period 3|Adverse Event|0|||
131189395|NCT01641081|472313172|FG002|Period 3|Adverse Event|1|||
131189396|NCT01641081|472313173|FG003|Period 3|Adverse Event|0|||
131189397|NCT01641081|472313174|FG004|Period 3|Adverse Event|0|||
131189398|NCT01641081|472313175|FG005|Period 3|Adverse Event|0|||
131189399|NCT01641081|472313176|FG006|Period 3|Adverse Event|0|||
131189400|NCT01641081|472313177|FG007|Period 3|Adverse Event|0|||
131189401|NCT01641081|472313178|FG008|Period 3|Adverse Event|0|||
131189402|NCT01641081|472313179|FG009|Period 3|Adverse Event|0|||
131189403|NCT01641081|472313170|FG000|Period 3|Withdrawal by Subject|0|||
131189404|NCT01641081|472313171|FG001|Period 3|Withdrawal by Subject|0|||
131189405|NCT01641081|472313172|FG002|Period 3|Withdrawal by Subject|0|||
131189406|NCT01641081|472313173|FG003|Period 3|Withdrawal by Subject|0|||
131189407|NCT01641081|472313174|FG004|Period 3|Withdrawal by Subject|0|||
131189408|NCT01641081|472313175|FG005|Period 3|Withdrawal by Subject|0|||
131189409|NCT01641081|472313176|FG006|Period 3|Withdrawal by Subject|0|||
131189410|NCT01641081|472313177|FG007|Period 3|Withdrawal by Subject|0|||
131189411|NCT01641081|472313178|FG008|Period 3|Withdrawal by Subject|1|||
131189412|NCT01641081|472313179|FG009|Period 3|Withdrawal by Subject|0|||
131189413|NCT01641081|472313170|FG000|Period 4|Adverse Event|0|||
131189414|NCT01641081|472313171|FG001|Period 4|Adverse Event|1|||
131189415|NCT01641081|472313172|FG002|Period 4|Adverse Event|0|||
131189416|NCT01641081|472313173|FG003|Period 4|Adverse Event|1|||
131189417|NCT01641081|472313174|FG004|Period 4|Adverse Event|0|||
131189418|NCT01641081|472313175|FG005|Period 4|Adverse Event|0|||
131189419|NCT01641081|472313176|FG006|Period 4|Adverse Event|0|||
131189420|NCT01641081|472313177|FG007|Period 4|Adverse Event|0|||
131189421|NCT01641081|472313178|FG008|Period 4|Adverse Event|0|||
131189422|NCT01641081|472313179|FG009|Period 4|Adverse Event|0|||
131189423|NCT01641081|472313170|FG000|Period 5|Adverse Event|0|||
131189424|NCT01641081|472313171|FG001|Period 5|Adverse Event|0|||
131189425|NCT01641081|472313172|FG002|Period 5|Adverse Event|2|||
131189426|NCT01641081|472313173|FG003|Period 5|Adverse Event|0|||
131189427|NCT01641081|472313174|FG004|Period 5|Adverse Event|0|||
131189428|NCT01641081|472313175|FG005|Period 5|Adverse Event|0|||
131189429|NCT01641081|472313176|FG006|Period 5|Adverse Event|0|||
131189430|NCT01641081|472313177|FG007|Period 5|Adverse Event|0|||
131189431|NCT01641081|472313178|FG008|Period 5|Adverse Event|0|||
131189432|NCT01641081|472313179|FG009|Period 5|Adverse Event|0|||
131189433|NCT01000025|472313182|FG000|Overall Study|Adverse Event|43|||
131189434|NCT01000025|472313183|FG001|Overall Study|Adverse Event|2|||
131189435|NCT01000025|472313182|FG000|Overall Study|Withdrawal by Subject|13|||
131189436|NCT01000025|472313183|FG001|Overall Study|Withdrawal by Subject|8|||
131189437|NCT01000025|472313182|FG000|Overall Study|Death|23|||
131189438|NCT01000025|472313183|FG001|Overall Study|Death|13|||
131189439|NCT01000025|472313182|FG000|Overall Study|Lack of Efficacy|363|||
131189440|NCT01000025|472313183|FG001|Overall Study|Lack of Efficacy|208|||
131189441|NCT01000025|472313182|FG000|Overall Study|Intercurrent Illness|26|||
131189442|NCT01000025|472313183|FG001|Overall Study|Intercurrent Illness|7|||
131189443|NCT00422669|472313184|FG000|Overall Study|The study was terminated early.|98|||
131189444|NCT00422669|472313185|FG001|Overall Study|The study was terminated early.|100|||
131189445|NCT00422669|472313186|FG002|Overall Study|The study was terminated early.|7|||
131189446|NCT04423757|472313187|FG000|Overall Study|Adverse Event|2|||
131189447|NCT04423757|472313188|FG001|Overall Study|Adverse Event|0|||
131189448|NCT04423757|472313187|FG000|Overall Study|Not treated|1|||
131189449|NCT04423757|472313188|FG001|Overall Study|Not treated|1|||
131189450|NCT02709109|472313189|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
131189451|NCT02709109|472313190|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
131189452|NCT02709109|472313191|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
131189453|NCT02709109|472313192|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
131189454|NCT02709109|472313189|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
131189455|NCT02709109|472313190|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
131189456|NCT02709109|472313191|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
131189457|NCT02709109|472313192|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
131189458|NCT02709109|472313189|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
131189459|NCT02709109|472313190|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
131189460|NCT02709109|472313191|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
131189461|NCT02709109|472313192|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
131189462|NCT02709109|472313189|FG000|Washout Period (28 Days)|Other|2|||
131189463|NCT02709109|472313190|FG001|Washout Period (28 Days)|Other|2|||
131189464|NCT02709109|472313191|FG002|Washout Period (28 Days)|Other|3|||
131189465|NCT02709109|472313192|FG003|Washout Period (28 Days)|Other|0|||
131189466|NCT02709109|472313189|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
131189467|NCT02709109|472313190|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
131189468|NCT02709109|472313191|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
131189469|NCT02709109|472313192|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
131189470|NCT02709109|472313189|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
131189471|NCT02709109|472313190|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
131189472|NCT02709109|472313191|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
131189473|NCT02709109|472313192|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
131189474|NCT02709109|472313189|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
131189475|NCT02709109|472313190|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
131189476|NCT02709109|472313191|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
131189477|NCT02709109|472313192|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
131189478|NCT02709109|472313189|FG000|Treatment Period 2 (28 Days)|Other|0|||
131189479|NCT02709109|472313190|FG001|Treatment Period 2 (28 Days)|Other|0|||
131189480|NCT02709109|472313191|FG002|Treatment Period 2 (28 Days)|Other|1|||
131189481|NCT02709109|472313192|FG003|Treatment Period 2 (28 Days)|Other|0|||
131189482|NCT02738580|472313193|FG000|Overall Study|Adverse Event|1|||
131189483|NCT02738580|472313194|FG001|Overall Study|Adverse Event|0|||
131189484|NCT02738580|472313193|FG000|Overall Study|Lack of Efficacy|3|||
131189485|NCT02738580|472313194|FG001|Overall Study|Lack of Efficacy|2|||
131189486|NCT02738580|472313193|FG000|Overall Study|Withdrawal by Subject|0|||
131189487|NCT02738580|472313194|FG001|Overall Study|Withdrawal by Subject|1|||
131189488|NCT02738580|472313193|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
131189489|NCT02738580|472313194|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
131189490|NCT00996593|472313195|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
131189491|NCT00996593|472313195|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
131189492|NCT00996593|472313195|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
131189493|NCT00996593|472313195|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
131189494|NCT00996593|472313195|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
131189495|NCT00996593|472313195|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
131189496|NCT00996593|472313195|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
131189497|NCT00996593|472313195|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
131189498|NCT00996593|472313195|FG000|Long-Term Follow-Up|Site Closed|1|||
131189499|NCT02810951|472313196|FG000|Overall Study|Adverse Event|1|||
131189500|NCT01928082|472313200|FG000|Overall Study|Study terminated.|1|||
131189501|NCT05563714|472313201|FG000|Overall Study|Death|2|||
131189502|NCT05563714|472313202|FG001|Overall Study|Death|2|||
131189503|NCT05563714|472313203|FG002|Overall Study|Death|0|||
131189504|NCT05563714|472313204|FG003|Overall Study|Death|0|||
131189505|NCT05563714|472313201|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
131189506|NCT05563714|472313202|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
131189507|NCT05563714|472313203|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
131189508|NCT05563714|472313204|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
131189509|NCT05563714|472313201|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
131189510|NCT05563714|472313202|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
131189511|NCT05563714|472313203|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
131189512|NCT05563714|472313204|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
131189513|NCT05563714|472313201|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
131189514|NCT05563714|472313202|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
131189515|NCT05563714|472313203|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
131189516|NCT05563714|472313204|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
131189517|NCT05563714|472313201|FG000|Overall Study|Lost to Follow-up|22|||
131189518|NCT05563714|472313202|FG001|Overall Study|Lost to Follow-up|19|||
131189519|NCT05563714|472313203|FG002|Overall Study|Lost to Follow-up|0|||
131189520|NCT05563714|472313204|FG003|Overall Study|Lost to Follow-up|0|||
131189521|NCT01610206|472313210|FG000|Overall Study|Adverse Event|10|||
131189522|NCT01610206|472313211|FG001|Overall Study|Adverse Event|30|||
131189523|NCT00166517|472313212|FG000|Overall Study|Lost to Follow-up|1|||
131189524|NCT00166517|472313213|FG001|Overall Study|Lost to Follow-up|0|||
131189525|NCT00166517|472313212|FG000|Overall Study|Protocol Violation|4|||
131189526|NCT00166517|472313213|FG001|Overall Study|Protocol Violation|1|||
131189527|NCT00166517|472313212|FG000|Overall Study|Withdrawal by Subject|0|||
131189528|NCT00166517|472313213|FG001|Overall Study|Withdrawal by Subject|1|||
131189529|NCT02186561|472313214|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
131189530|NCT02186561|472313214|FG000|Enrollment|Enrollment Cap Reached|5|||
131189531|NCT02186561|472313214|FG000|Enrollment|Insurance Denial|2|||
131189532|NCT02186561|472313214|FG000|Enrollment|Withdrawal by Subject|2|||
131189533|NCT02186561|472313214|FG000|Enrollment|Investigator Withdrew Consent|1|||
131189534|NCT02186561|472313214|FG000|30-Day Post Index Procedure Visit|Death|1|||
131189535|NCT02186561|472313214|FG000|1- Year Post Index Procedure Visit|Death|1|||
131189536|NCT02186561|472313214|FG000|1- Year Post Index Procedure Visit|Missed|1|||
131189537|NCT04285853|472313215|FG000|Overall Study|Withdrawal by Subject|1|||
131189538|NCT04285853|472313216|FG001|Overall Study|Withdrawal by Subject|0|||
131189539|NCT04285853|472313215|FG000|Overall Study|Lost to Follow-up|9|||
131189540|NCT04285853|472313216|FG001|Overall Study|Lost to Follow-up|5|||
131189541|NCT00981682|472313219|FG000|Overall Study|Adverse Event|48|||
131189542|NCT00981682|472313219|FG000|Overall Study|Withdrawal by Subject|52|||
131189543|NCT00981682|472313219|FG000|Overall Study|Lost to Follow-up|14|||
131189544|NCT00981682|472313219|FG000|Overall Study|Lack of Efficacy|13|||
131189545|NCT00981682|472313219|FG000|Overall Study|Protocol Violation|6|||
131189546|NCT00981682|472313219|FG000|Overall Study|administrative|9|||
131189547|NCT03906136|472314796|FG000|Overall Study|Adverse Event|1|||
131189548|NCT03906136|472314797|FG001|Overall Study|Adverse Event|0|||
131189549|NCT03906136|472314796|FG000|Overall Study|Lost to Follow-up|7|||
131189550|NCT03906136|472314797|FG001|Overall Study|Lost to Follow-up|4|||
131189551|NCT03906136|472314796|FG000|Overall Study|Physician Decision|1|||
131189552|NCT03906136|472314797|FG001|Overall Study|Physician Decision|0|||
131189553|NCT03906136|472314796|FG000|Overall Study|Withdrawal by Subject|3|||
131189554|NCT03906136|472314797|FG001|Overall Study|Withdrawal by Subject|7|||
131189555|NCT02371980|472314801|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
131189556|NCT02371980|472314802|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
131189557|NCT02371980|472314803|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
130733554|NCT05026177|470642913|FG002|Overall Study|Health issues preventing continuation|1|||
130733555|NCT05026177|470642911|FG000|Overall Study|Randomized in error, not treated|0|||
130733556|NCT05026177|470642912|FG001|Overall Study|Randomized in error, not treated|0|||
131189558|NCT02371980|472314804|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
131189559|NCT02371980|472314805|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
131189560|NCT02371980|472314801|FG000|Open-label Period|Significant Protocol Deviation|19|||
131189561|NCT02371980|472314802|FG001|Open-label Period|Significant Protocol Deviation|0|||
131189562|NCT02371980|472314803|FG002|Open-label Period|Significant Protocol Deviation|0|||
131189563|NCT02371980|472314804|FG003|Open-label Period|Significant Protocol Deviation|0|||
131189564|NCT02371980|472314805|FG004|Open-label Period|Significant Protocol Deviation|0|||
130733557|NCT05026177|470642913|FG002|Overall Study|Randomized in error, not treated|2|||
130733558|NCT01169337|470642914|FG000|Overall Study|Lack of Efficacy|5|||
131189565|NCT02371980|472314801|FG000|Open-label Period|Noncompliance with Study Drug|10|||
131189566|NCT02371980|472314802|FG001|Open-label Period|Noncompliance with Study Drug|0|||
131189567|NCT02371980|472314803|FG002|Open-label Period|Noncompliance with Study Drug|0|||
131189568|NCT02371980|472314804|FG003|Open-label Period|Noncompliance with Study Drug|0|||
131189569|NCT02371980|472314805|FG004|Open-label Period|Noncompliance with Study Drug|0|||
131189570|NCT02371980|472314801|FG000|Open-label Period|Lost to Follow-up|55|||
130733559|NCT01169337|470642915|FG001|Overall Study|Lack of Efficacy|7|||
130733560|NCT01169337|470642916|FG002|Overall Study|Lack of Efficacy|0|||
130733561|NCT01169337|470642914|FG000|Overall Study|Adverse Event|12|||
131189571|NCT02371980|472314802|FG001|Open-label Period|Lost to Follow-up|0|||
131189572|NCT02371980|472314803|FG002|Open-label Period|Lost to Follow-up|0|||
131189573|NCT02371980|472314804|FG003|Open-label Period|Lost to Follow-up|0|||
131189574|NCT02371980|472314805|FG004|Open-label Period|Lost to Follow-up|0|||
131189575|NCT02371980|472314801|FG000|Open-label Period|Voluntary Withdrawal|91|||
131189576|NCT02371980|472314802|FG001|Open-label Period|Voluntary Withdrawal|0|||
131189577|NCT02371980|472314803|FG002|Open-label Period|Voluntary Withdrawal|0|||
131189578|NCT02371980|472314804|FG003|Open-label Period|Voluntary Withdrawal|0|||
131189579|NCT02371980|472314805|FG004|Open-label Period|Voluntary Withdrawal|0|||
131189580|NCT02371980|472314801|FG000|Open-label Period|Pregnancy|1|||
131189581|NCT02371980|472314802|FG001|Open-label Period|Pregnancy|0|||
131189582|NCT02371980|472314803|FG002|Open-label Period|Pregnancy|0|||
131189583|NCT02371980|472314804|FG003|Open-label Period|Pregnancy|0|||
131189584|NCT02371980|472314805|FG004|Open-label Period|Pregnancy|0|||
131189585|NCT02371980|472314801|FG000|Open-label Period|Lack of Efficacy|116|||
131189586|NCT02371980|472314802|FG001|Open-label Period|Lack of Efficacy|0|||
131189587|NCT02371980|472314803|FG002|Open-label Period|Lack of Efficacy|0|||
131189588|NCT02371980|472314804|FG003|Open-label Period|Lack of Efficacy|0|||
131189589|NCT02371980|472314805|FG004|Open-label Period|Lack of Efficacy|0|||
131189590|NCT02371980|472314801|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
131189591|NCT02371980|472314802|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
131189592|NCT02371980|472314803|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
131189593|NCT02371980|472314804|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
131189594|NCT02371980|472314805|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
131189595|NCT02371980|472314801|FG000|Open-label Period|Reason not Specified|9|||
131189596|NCT02371980|472314802|FG001|Open-label Period|Reason not Specified|0|||
131189597|NCT02371980|472314803|FG002|Open-label Period|Reason not Specified|0|||
131189598|NCT02371980|472314804|FG003|Open-label Period|Reason not Specified|0|||
131189599|NCT02371980|472314805|FG004|Open-label Period|Reason not Specified|0|||
131189600|NCT02371980|472314801|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
131189601|NCT02371980|472314802|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
131189602|NCT02371980|472314803|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
131189603|NCT02371980|472314804|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
131189604|NCT02371980|472314805|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
131189605|NCT02371980|472314801|FG000|Double-blind Period|Significant Protocol Deviation|0|||
131189606|NCT02371980|472314802|FG001|Double-blind Period|Significant Protocol Deviation|2|||
131189607|NCT02371980|472314803|FG002|Double-blind Period|Significant Protocol Deviation|7|||
131189608|NCT02371980|472314804|FG003|Double-blind Period|Significant Protocol Deviation|3|||
131189609|NCT02371980|472314805|FG004|Double-blind Period|Significant Protocol Deviation|3|||
131189610|NCT02371980|472314801|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
131189611|NCT02371980|472314802|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
131189612|NCT02371980|472314803|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
131189613|NCT02371980|472314804|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
131189614|NCT02371980|472314805|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
131189615|NCT02371980|472314801|FG000|Double-blind Period|Lost to Follow-up|0|||
131189616|NCT02371980|472314802|FG001|Double-blind Period|Lost to Follow-up|8|||
131189617|NCT02371980|472314803|FG002|Double-blind Period|Lost to Follow-up|8|||
131189618|NCT02371980|472314804|FG003|Double-blind Period|Lost to Follow-up|6|||
131189619|NCT02371980|472314805|FG004|Double-blind Period|Lost to Follow-up|5|||
131189620|NCT02371980|472314801|FG000|Double-blind Period|Voluntary Withdrawal|0|||
131189621|NCT02371980|472314802|FG001|Double-blind Period|Voluntary Withdrawal|12|||
131189622|NCT02371980|472314803|FG002|Double-blind Period|Voluntary Withdrawal|8|||
131189623|NCT02371980|472314804|FG003|Double-blind Period|Voluntary Withdrawal|9|||
131189624|NCT02371980|472314805|FG004|Double-blind Period|Voluntary Withdrawal|11|||
131189625|NCT02371980|472314801|FG000|Double-blind Period|Relapse|0|||
131189626|NCT02371980|472314802|FG001|Double-blind Period|Relapse|50|||
131189627|NCT02371980|472314803|FG002|Double-blind Period|Relapse|25|||
131189628|NCT02371980|472314804|FG003|Double-blind Period|Relapse|25|||
131189629|NCT02371980|472314805|FG004|Double-blind Period|Relapse|26|||
131189630|NCT02371980|472314801|FG000|Double-blind Period|Reason not Specified|0|||
131189631|NCT02371980|472314802|FG001|Double-blind Period|Reason not Specified|3|||
131189632|NCT02371980|472314803|FG002|Double-blind Period|Reason not Specified|3|||
131189633|NCT02371980|472314804|FG003|Double-blind Period|Reason not Specified|2|||
131189634|NCT02371980|472314805|FG004|Double-blind Period|Reason not Specified|1|||
131189635|NCT02371980|472314801|FG000|Double-blind Period|Missing|0|||
131189636|NCT02371980|472314802|FG001|Double-blind Period|Missing|1|||
131189637|NCT02371980|472314803|FG002|Double-blind Period|Missing|0|||
131189638|NCT02371980|472314804|FG003|Double-blind Period|Missing|0|||
131189639|NCT02371980|472314805|FG004|Double-blind Period|Missing|0|||
131189640|NCT02712008|472314807|FG000|Baseline (Day 1) up to Week 12|Death|3|||
131189641|NCT02712008|472314808|FG001|Baseline (Day 1) up to Week 12|Death|0|||
131189642|NCT02712008|472314809|FG002|Baseline (Day 1) up to Week 12|Death|0|||
131189643|NCT02712008|472314810|FG003|Baseline (Day 1) up to Week 12|Death|0|||
131189644|NCT02712008|472314811|FG004|Baseline (Day 1) up to Week 12|Death|0|||
131189645|NCT02712008|472314812|FG005|Baseline (Day 1) up to Week 12|Death|0|||
131189646|NCT02712008|472314813|FG006|Baseline (Day 1) up to Week 12|Death|0|||
131189647|NCT02712008|472314814|FG007|Baseline (Day 1) up to Week 12|Death|0|||
131189648|NCT02712008|472314807|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131189649|NCT02712008|472314808|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
131189650|NCT02712008|472314809|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
131189651|NCT02712008|472314810|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131189652|NCT02712008|472314811|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131189653|NCT02712008|472314812|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131189654|NCT02712008|472314813|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131189655|NCT02712008|472314814|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
131189656|NCT02712008|472314807|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
131189657|NCT02712008|472314808|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131189658|NCT02712008|472314809|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
131189659|NCT02712008|472314810|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131189660|NCT02712008|472314811|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131189661|NCT02712008|472314812|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131189662|NCT02712008|472314813|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131189663|NCT02712008|472314814|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
131189664|NCT02712008|472314807|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131189665|NCT02712008|472314808|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131189666|NCT02712008|472314809|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
131189667|NCT02712008|472314810|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131189668|NCT02712008|472314811|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131189669|NCT02712008|472314812|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130733562|NCT01169337|470642915|FG001|Overall Study|Adverse Event|18|||
131189670|NCT02712008|472314813|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131189671|NCT02712008|472314814|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
131189672|NCT02712008|472314807|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131189673|NCT02712008|472314808|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
131189674|NCT02712008|472314809|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131189675|NCT02712008|472314810|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131189676|NCT02712008|472314811|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131189677|NCT02712008|472314812|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131189678|NCT02712008|472314813|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131189679|NCT02712008|472314814|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
131189680|NCT02712008|472314807|FG000|From Week 12 up to Week 36|Adverse Event|0|||
131189681|NCT02712008|472314808|FG001|From Week 12 up to Week 36|Adverse Event|0|||
131189682|NCT02712008|472314809|FG002|From Week 12 up to Week 36|Adverse Event|0|||
131189683|NCT02712008|472314810|FG003|From Week 12 up to Week 36|Adverse Event|0|||
131189684|NCT02712008|472314811|FG004|From Week 12 up to Week 36|Adverse Event|1|||
131189685|NCT02712008|472314812|FG005|From Week 12 up to Week 36|Adverse Event|0|||
131189686|NCT02712008|472314813|FG006|From Week 12 up to Week 36|Adverse Event|0|||
131189687|NCT02712008|472314814|FG007|From Week 12 up to Week 36|Adverse Event|2|||
131189688|NCT02712008|472314807|FG000|From Week 12 up to Week 36|Death|1|||
131189689|NCT02712008|472314808|FG001|From Week 12 up to Week 36|Death|0|||
131189690|NCT02712008|472314809|FG002|From Week 12 up to Week 36|Death|0|||
131189691|NCT02712008|472314810|FG003|From Week 12 up to Week 36|Death|0|||
131189692|NCT02712008|472314811|FG004|From Week 12 up to Week 36|Death|0|||
131189693|NCT02712008|472314812|FG005|From Week 12 up to Week 36|Death|0|||
131189694|NCT02712008|472314813|FG006|From Week 12 up to Week 36|Death|1|||
131189695|NCT02712008|472314814|FG007|From Week 12 up to Week 36|Death|0|||
131189696|NCT02712008|472314807|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
131189697|NCT02712008|472314808|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
131189698|NCT02712008|472314809|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
131189699|NCT02712008|472314810|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
131189700|NCT02712008|472314811|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
131189701|NCT02712008|472314812|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
131189702|NCT02712008|472314813|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
131189703|NCT02712008|472314814|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
131189704|NCT02712008|472314807|FG000|From Week 12 up to Week 36|Physician Decision|0|||
131189705|NCT02712008|472314808|FG001|From Week 12 up to Week 36|Physician Decision|0|||
131189706|NCT02712008|472314809|FG002|From Week 12 up to Week 36|Physician Decision|0|||
131189707|NCT02712008|472314810|FG003|From Week 12 up to Week 36|Physician Decision|1|||
131189708|NCT02712008|472314811|FG004|From Week 12 up to Week 36|Physician Decision|1|||
131189709|NCT02712008|472314812|FG005|From Week 12 up to Week 36|Physician Decision|0|||
131189710|NCT02712008|472314813|FG006|From Week 12 up to Week 36|Physician Decision|0|||
131189711|NCT02712008|472314814|FG007|From Week 12 up to Week 36|Physician Decision|0|||
131189712|NCT02712008|472314807|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131189713|NCT02712008|472314808|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131189714|NCT02712008|472314809|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131189715|NCT02712008|472314810|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131189716|NCT02712008|472314811|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131189717|NCT02712008|472314812|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
131189718|NCT02712008|472314813|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
131189719|NCT02712008|472314814|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
131189720|NCT01731990|472314815|FG000|Overall Study|Adverse Event|1|||
131189721|NCT01731990|472314816|FG001|Overall Study|Adverse Event|5|||
131189722|NCT01731990|472314815|FG000|Overall Study|Withdrawal by Subject|1|||
131189723|NCT01731990|472314816|FG001|Overall Study|Withdrawal by Subject|1|||
131189724|NCT01731990|472314815|FG000|Overall Study|Protocol deviation|1|||
131189725|NCT01731990|472314816|FG001|Overall Study|Protocol deviation|2|||
131189726|NCT01731990|472314815|FG000|Overall Study|Death|1|||
131189727|NCT01731990|472314816|FG001|Overall Study|Death|0|||
131189728|NCT01280812|472314817|FG000|Overall Study|Withdrawal by Subject|2|||
131189729|NCT01280812|472314818|FG001|Overall Study|Withdrawal by Subject|1|||
131189730|NCT01280812|472314819|FG002|Overall Study|Withdrawal by Subject|0|||
131189731|NCT01280812|472314817|FG000|Overall Study|Lost to Follow-up|1|||
131189732|NCT01280812|472314818|FG001|Overall Study|Lost to Follow-up|1|||
131189733|NCT01280812|472314819|FG002|Overall Study|Lost to Follow-up|1|||
131189734|NCT04483544|472314820|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
131189735|NCT04483544|472314820|FG000|Post-Treatment|Admitted to hospice|2|||
131189736|NCT04483544|472314820|FG000|Post-Treatment|Study terminated|3|||
131189737|NCT03597503|472314827|FG000|Overall Study|Withdrawal by Subject|0|||
131189738|NCT03597503|472314828|FG001|Overall Study|Withdrawal by Subject|2|||
131189739|NCT03597503|472314827|FG000|Overall Study|Lost to Follow-up|1|||
131189740|NCT03597503|472314828|FG001|Overall Study|Lost to Follow-up|2|||
131189741|NCT03597503|472314827|FG000|Overall Study|Protocol Violation|1|||
131189742|NCT03597503|472314828|FG001|Overall Study|Protocol Violation|0|||
131189743|NCT01826448|472314830|FG000|Overall Study|Adverse Event|1|||
131189744|NCT01826448|472314831|FG001|Overall Study|Adverse Event|3|||
131189745|NCT01826448|472314830|FG000|Overall Study|Disease progression|2|||
131189746|NCT01826448|472314831|FG001|Overall Study|Disease progression|4|||
131189747|NCT01826448|472314830|FG000|Overall Study|Withdrawal by Subject|1|||
131189748|NCT01826448|472314831|FG001|Overall Study|Withdrawal by Subject|0|||
131189749|NCT01826448|472314830|FG000|Overall Study|Physician Decision|0|||
130733563|NCT01169337|470642916|FG002|Overall Study|Adverse Event|0|||
131189750|NCT01826448|472314831|FG001|Overall Study|Physician Decision|1|||
131189751|NCT01826448|472314830|FG000|Overall Study|2 active cancers|0|||
131189752|NCT01826448|472314831|FG001|Overall Study|2 active cancers|1|||
131189753|NCT00790218|472314835|FG000|Overall Study|Death|1|||
131189754|NCT00790218|472314836|FG001|Overall Study|Death|0|||
131189755|NCT00790218|472314837|FG002|Overall Study|Death|0|||
131189756|NCT00086385|472314838|FG000|Overall Study|Death|2|||
131189757|NCT00086385|472314839|FG001|Overall Study|Death|2|||
131189758|NCT00086385|472314840|FG002|Overall Study|Death|1|||
131189759|NCT00086385|472314841|FG003|Overall Study|Death|1|||
131189760|NCT00880100|472314844|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
131189761|NCT00880100|472314844|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
131189762|NCT00880100|472314844|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
131189763|NCT03424044|472314845|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131189764|NCT03424044|472314846|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131189765|NCT03424044|472314847|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
131189766|NCT03424044|472314848|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131189767|NCT03424044|472314849|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131189768|NCT03424044|472314850|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131189769|NCT03424044|472314851|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131189770|NCT03424044|472314852|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131189771|NCT03424044|472314853|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
131189772|NCT03424044|472314845|FG000|First Intervention (76 Hours)|Adverse Event|0|||
131189773|NCT03424044|472314846|FG001|First Intervention (76 Hours)|Adverse Event|0|||
131189774|NCT03424044|472314847|FG002|First Intervention (76 Hours)|Adverse Event|0|||
131189775|NCT03424044|472314848|FG003|First Intervention (76 Hours)|Adverse Event|0|||
131189776|NCT03424044|472314849|FG004|First Intervention (76 Hours)|Adverse Event|1|||
131189777|NCT03424044|472314850|FG005|First Intervention (76 Hours)|Adverse Event|0|||
131189778|NCT03424044|472314851|FG006|First Intervention (76 Hours)|Adverse Event|0|||
131189779|NCT03424044|472314852|FG007|First Intervention (76 Hours)|Adverse Event|0|||
131189780|NCT03424044|472314853|FG008|First Intervention (76 Hours)|Adverse Event|0|||
131189781|NCT03424044|472314845|FG000|First Intervention (76 Hours)|device issues|0|||
131189782|NCT03424044|472314846|FG001|First Intervention (76 Hours)|device issues|0|||
131189783|NCT03424044|472314847|FG002|First Intervention (76 Hours)|device issues|0|||
131189784|NCT03424044|472314848|FG003|First Intervention (76 Hours)|device issues|0|||
131189785|NCT03424044|472314849|FG004|First Intervention (76 Hours)|device issues|0|||
131189786|NCT03424044|472314850|FG005|First Intervention (76 Hours)|device issues|0|||
131189787|NCT03424044|472314851|FG006|First Intervention (76 Hours)|device issues|1|||
131189788|NCT03424044|472314852|FG007|First Intervention (76 Hours)|device issues|1|||
131189789|NCT03424044|472314853|FG008|First Intervention (76 Hours)|device issues|1|||
131189790|NCT03424044|472314845|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
131189791|NCT03424044|472314846|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
131189792|NCT03424044|472314847|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
131189793|NCT03424044|472314848|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
131189794|NCT03424044|472314849|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
131189795|NCT03424044|472314850|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
131189796|NCT03424044|472314851|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
131189797|NCT03424044|472314852|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
131189798|NCT03424044|472314853|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
131189799|NCT03424044|472314845|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131189800|NCT03424044|472314846|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131189801|NCT03424044|472314847|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131189802|NCT03424044|472314848|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
131189803|NCT03424044|472314849|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131189804|NCT03424044|472314850|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131189805|NCT03424044|472314851|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131189806|NCT03424044|472314852|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131189807|NCT03424044|472314853|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
131189808|NCT02408484|472314863|FG000|Overall Study|Withdrawal by Subject|3|||
131189809|NCT02408484|472314863|FG000|Overall Study|Not treated during study period|1|||
131189810|NCT05516134|472314871|FG000|Overall Study|Lost to Follow-up|1|||
131189811|NCT05516134|472314872|FG001|Overall Study|Lost to Follow-up|0|||
131189812|NCT05516134|472314873|FG002|Overall Study|Lost to Follow-up|0|||
131189813|NCT03805971|472314874|FG000|Overall Study|Withdrawal by Subject|1|||
131189814|NCT03805971|472314874|FG000|Overall Study|Protocol Violation|2|||
130733564|NCT01169337|470642914|FG000|Overall Study|Death|2|||
131189815|NCT00254163|472314875|FG000|Overall Study|Adverse Event|29|||
131189816|NCT00254163|472314876|FG001|Overall Study|Adverse Event|26|||
131189817|NCT00254163|472314875|FG000|Overall Study|Patient request/withdrew consent|6|||
131189818|NCT00254163|472314876|FG001|Overall Study|Patient request/withdrew consent|4|||
131189819|NCT00254163|472314875|FG000|Overall Study|Investigator request|1|||
131189820|NCT00254163|472314876|FG001|Overall Study|Investigator request|3|||
131189821|NCT00254163|472314875|FG000|Overall Study|Failed entry|1|||
131189822|NCT00254163|472314876|FG001|Overall Study|Failed entry|3|||
131189823|NCT00254163|472314875|FG000|Overall Study|Progressive disease|0|||
131189824|NCT00254163|472314876|FG001|Overall Study|Progressive disease|1|||
131189825|NCT00254163|472314875|FG000|Overall Study|Death|0|||
131189826|NCT00254163|472314876|FG001|Overall Study|Death|1|||
131189827|NCT00254163|472314875|FG000|Overall Study|Other|8|||
131189828|NCT00254163|472314876|FG001|Overall Study|Other|8|||
131189829|NCT00517413|472314882|FG000|Overall Study|Adverse Event|7|||
131189830|NCT00517413|472314882|FG000|Overall Study|Death|13|||
131189831|NCT00517413|472314882|FG000|Overall Study|Protocol Violation|15|||
131189832|NCT00517413|472314882|FG000|Overall Study|Withdrawal by Subject|2|||
131189833|NCT00517413|472314882|FG000|Overall Study|Failure to return|1|||
131189834|NCT00517413|472314882|FG000|Overall Study|Other-Reasons|23|||
131189835|NCT01510028|472314883|FG000|Overall Study|Lack of Efficacy|1|||
131189836|NCT01510028|472314884|FG001|Overall Study|Lack of Efficacy|0|||
131189837|NCT01510028|472314885|FG002|Overall Study|Lack of Efficacy|0|||
131189838|NCT01510028|472314886|FG003|Overall Study|Lack of Efficacy|0|||
131189839|NCT01355497|472314887|FG000|Overall Study|Death|19|||
131189840|NCT01355497|472314888|FG001|Overall Study|Death|18|||
131189841|NCT01355497|472314887|FG000|Overall Study|Lost to Follow-up|3|||
131189842|NCT01355497|472314888|FG001|Overall Study|Lost to Follow-up|0|||
131189843|NCT01355497|472314887|FG000|Overall Study|Protocol Violation|0|||
131189844|NCT01355497|472314888|FG001|Overall Study|Protocol Violation|1|||
131189845|NCT01355497|472314887|FG000|Overall Study|other-not provided|9|||
131189846|NCT01355497|472314888|FG001|Overall Study|other-not provided|4|||
131189847|NCT01355497|472314887|FG000|Overall Study|Withdrawal by Subject|12|||
131189848|NCT01355497|472314888|FG001|Overall Study|Withdrawal by Subject|20|||
131189849|NCT01355497|472314887|FG000|Overall Study|noncompliance|1|||
131189850|NCT01355497|472314888|FG001|Overall Study|noncompliance|2|||
131189851|NCT01355497|472314887|FG000|Overall Study|progressive disease|11|||
131189852|NCT01355497|472314888|FG001|Overall Study|progressive disease|8|||
131189853|NCT01355497|472314887|FG000|Overall Study|Adverse Event|11|||
131189854|NCT01355497|472314888|FG001|Overall Study|Adverse Event|10|||
131189855|NCT01784211|472314896|FG000|Part A (Days 1-15)|Adverse Event|1|||
131189856|NCT01784211|472314897|FG001|Part A (Days 1-15)|Adverse Event|1|||
131189857|NCT01784211|472314898|FG002|Part A (Days 1-15)|Adverse Event|0|||
131189858|NCT01784211|472314899|FG003|Part A (Days 1-15)|Adverse Event|0|||
131189859|NCT01784211|472314900|FG004|Part A (Days 1-15)|Adverse Event|0|||
131189860|NCT01784211|472314901|FG005|Part A (Days 1-15)|Adverse Event|0|||
131189861|NCT01784211|472314896|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
131189862|NCT01784211|472314897|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
131189863|NCT01784211|472314898|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
131189864|NCT01784211|472314899|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
131189865|NCT01784211|472314900|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
131189866|NCT01784211|472314901|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
131189867|NCT01001572|472314902|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
131189868|NCT01001572|472314903|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
131189869|NCT01001572|472314904|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
131189870|NCT01001572|472314902|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
131189871|NCT01001572|472314903|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
131189872|NCT01001572|472314904|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
131189873|NCT01001572|472314902|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
131189874|NCT01001572|472314903|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
131189875|NCT01001572|472314904|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
131189876|NCT01001572|472314902|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
131189877|NCT01001572|472314903|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
131189878|NCT01001572|472314904|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
131189879|NCT01001572|472314902|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
131189880|NCT01001572|472314903|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
131189881|NCT01001572|472314904|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
130733565|NCT01169337|470642915|FG001|Overall Study|Death|0|||
131189882|NCT01001572|472314902|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
131189883|NCT01001572|472314903|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
131189884|NCT01001572|472314904|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
131189885|NCT01001572|472314902|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
131189886|NCT01001572|472314903|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
130733566|NCT01169337|470642916|FG002|Overall Study|Death|0|||
130733567|NCT01169337|470642914|FG000|Overall Study|Withdrawal by Subject|11|||
130784547|NCT03885908|470838818|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
131189887|NCT01001572|472314904|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
131189888|NCT01001572|472314902|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
131189889|NCT01001572|472314903|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
131189890|NCT01001572|472314904|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
131189891|NCT01001572|472314902|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
131189892|NCT01001572|472314903|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
131189893|NCT01001572|472314904|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
131189894|NCT01001572|472314902|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131189895|NCT01001572|472314903|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
131189896|NCT01001572|472314904|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
131189897|NCT01001572|472314902|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
131189898|NCT01001572|472314903|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
131189899|NCT01001572|472314904|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
131189900|NCT01001572|472314902|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
131189901|NCT01001572|472314903|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
131189902|NCT01001572|472314904|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
131189903|NCT01001572|472314902|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
131189904|NCT01001572|472314903|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
131189905|NCT01001572|472314904|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
131189906|NCT01001572|472314902|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131189907|NCT01001572|472314903|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131189908|NCT01001572|472314904|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
131189909|NCT01094808|472314905|FG000|Overall Study|Withdrawal by Subject|1|||
131189910|NCT01094808|472314906|FG001|Overall Study|Withdrawal by Subject|1|||
131189911|NCT01094808|472314907|FG002|Overall Study|Withdrawal by Subject|0|||
131189912|NCT02498392|472314908|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
131189913|NCT02498392|472314909|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
131189914|NCT02498392|472314908|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
131189915|NCT02498392|472314909|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
131189916|NCT02498392|472314908|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
131189917|NCT02498392|472314909|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
131189918|NCT02498392|472314908|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
131189919|NCT02498392|472314909|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
131189920|NCT02498392|472314908|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
131189921|NCT02498392|472314909|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
131189922|NCT02498392|472314908|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
131189923|NCT02498392|472314909|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
131189924|NCT05784129|472314910|FG000|Overall Study|Study terminated by sponsor|2|||
131189925|NCT05784129|472314911|FG001|Overall Study|Study terminated by sponsor|2|||
131189926|NCT01156363|472314912|FG000|Overall Study|Adverse Event|6|||
131189927|NCT01156363|472314912|FG000|Overall Study|Insufficient Therapeutic Response|5|||
131189928|NCT01156363|472314912|FG000|Overall Study|Failure to Return|1|||
131189929|NCT01156363|472314912|FG000|Overall Study|Refused Treatment|4|||
131189930|NCT01156363|472314912|FG000|Overall Study|Other|6|||
131189931|NCT04080752|472314917|FG000|Overall Study|Adverse Event|2|||
131189932|NCT04080752|472314918|FG001|Overall Study|Adverse Event|3|||
131189933|NCT04080752|472314917|FG000|Overall Study|Lack of Efficacy|1|||
131189934|NCT04080752|472314918|FG001|Overall Study|Lack of Efficacy|0|||
131189935|NCT04080752|472314917|FG000|Overall Study|Lost to Follow-up|1|||
131189936|NCT04080752|472314918|FG001|Overall Study|Lost to Follow-up|0|||
131189937|NCT04080752|472314917|FG000|Overall Study|Pregnancy|0|||
131189938|NCT04080752|472314918|FG001|Overall Study|Pregnancy|1|||
131189939|NCT04080752|472314917|FG000|Overall Study|Withdrawal by Subject|7|||
131189940|NCT04080752|472314918|FG001|Overall Study|Withdrawal by Subject|0|||
131189941|NCT04080752|472314917|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131189942|NCT04080752|472314918|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131189943|NCT04080752|472314917|FG000|Overall Study|Other|2|||
131189944|NCT04080752|472314918|FG001|Overall Study|Other|1|||
131189945|NCT01192100|472314919|FG000|Overall Study|Withdrawal by Subject|0|||
131189946|NCT01192100|472314920|FG001|Overall Study|Withdrawal by Subject|0|||
131189947|NCT01192100|472314921|FG002|Overall Study|Withdrawal by Subject|0|||
131189948|NCT01192100|472314922|FG003|Overall Study|Withdrawal by Subject|0|||
131189949|NCT01192100|472314923|FG004|Overall Study|Withdrawal by Subject|1|||
131189950|NCT01192100|472314924|FG005|Overall Study|Withdrawal by Subject|0|||
131189951|NCT01192100|472314919|FG000|Overall Study|Protocol Violation|0|||
131189952|NCT01192100|472314920|FG001|Overall Study|Protocol Violation|0|||
131189953|NCT01192100|472314921|FG002|Overall Study|Protocol Violation|0|||
131189954|NCT01192100|472314922|FG003|Overall Study|Protocol Violation|1|||
131189955|NCT01192100|472314923|FG004|Overall Study|Protocol Violation|0|||
131189956|NCT01192100|472314924|FG005|Overall Study|Protocol Violation|0|||
131189957|NCT04685538|472314925|FG000|Overall Study|Adverse Event|0|||
131189958|NCT04685538|472314926|FG001|Overall Study|Adverse Event|1|||
131189959|NCT04685538|472314925|FG000|Overall Study|Lost to Follow-up|0|||
131189960|NCT04685538|472314926|FG001|Overall Study|Lost to Follow-up|2|||
131189961|NCT01095666|472314927|FG000|Overall Study|Lack of Efficacy|0|||
131189962|NCT01095666|472314928|FG001|Overall Study|Lack of Efficacy|0|||
131189963|NCT01095666|472314929|FG002|Overall Study|Lack of Efficacy|1|||
131189964|NCT01095666|472314927|FG000|Overall Study|Adverse Event|2|||
131189965|NCT01095666|472314928|FG001|Overall Study|Adverse Event|1|||
131189966|NCT01095666|472314929|FG002|Overall Study|Adverse Event|3|||
131189967|NCT01095666|472314927|FG000|Overall Study|Lost to Follow-up|2|||
131189968|NCT01095666|472314928|FG001|Overall Study|Lost to Follow-up|2|||
131189969|NCT01095666|472314929|FG002|Overall Study|Lost to Follow-up|0|||
131189970|NCT01095666|472314927|FG000|Overall Study|Withdrawal by Subject|6|||
131189971|NCT01095666|472314928|FG001|Overall Study|Withdrawal by Subject|6|||
131189972|NCT01095666|472314929|FG002|Overall Study|Withdrawal by Subject|1|||
131189973|NCT01095666|472314927|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
131189974|NCT01095666|472314928|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
131189975|NCT01095666|472314929|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
131189976|NCT00842361|472314940|FG000|Overall Study|Protocol Violation|1|||
131189977|NCT00842361|472314941|FG001|Overall Study|Protocol Violation|0|||
131189978|NCT00842361|472314940|FG000|Overall Study|Unclassified|0|||
131189979|NCT00842361|472314941|FG001|Overall Study|Unclassified|2|||
131189980|NCT02917629|472314944|FG000|Overall Study|Withdrawal by Subject|0|||
131189981|NCT02917629|472314945|FG001|Overall Study|Withdrawal by Subject|1|||
131189982|NCT00718523|472314946|FG000|Overall Study|Withdrawal by Subject|5|||
131189983|NCT00718523|472314947|FG001|Overall Study|Withdrawal by Subject|7|||
131189984|NCT00718523|472314946|FG000|Overall Study|Death|13|||
131189985|NCT00718523|472314947|FG001|Overall Study|Death|17|||
131189986|NCT03136484|472314948|FG000|Overall Study|Withdrawal by Subject|19|||
131189987|NCT03136484|472314949|FG001|Overall Study|Withdrawal by Subject|14|||
131189988|NCT03136484|472314948|FG000|Overall Study|Lost to Follow-up|7|||
131189989|NCT03136484|472314949|FG001|Overall Study|Lost to Follow-up|8|||
131189990|NCT03136484|472314948|FG000|Overall Study|Death|1|||
131189991|NCT03136484|472314949|FG001|Overall Study|Death|0|||
131189992|NCT05041062|472314952|FG000|Overall Study|Adverse Event|2|||
131189993|NCT01802515|472314957|FG000|Overall Study|Withdrawal by Subject|3|||
131189994|NCT01802515|472314958|FG001|Overall Study|Withdrawal by Subject|0|||
131189995|NCT01802515|472314959|FG002|Overall Study|Withdrawal by Subject|0|||
131189996|NCT03038672|472317456|FG000|Initial Treatment|Unacceptable chemistry|0|||
131189997|NCT03038672|472317457|FG001|Initial Treatment|Unacceptable chemistry|1|||
131189998|NCT03038672|472317456|FG000|Initial Treatment|Progression prior to treatment|1|||
131189999|NCT03038672|472317457|FG001|Initial Treatment|Progression prior to treatment|0|||
131190000|NCT03038672|472317456|FG000|Initial Treatment|No treatment per protocol|1|||
131190001|NCT03038672|472317457|FG001|Initial Treatment|No treatment per protocol|0|||
131190002|NCT01696396|472317458|FG000|Overall Study|Withdrawal by Subject|19|||
131190003|NCT01696396|472317459|FG001|Overall Study|Withdrawal by Subject|5|||
130733568|NCT01169337|470642915|FG001|Overall Study|Withdrawal by Subject|11|||
130733569|NCT01169337|470642916|FG002|Overall Study|Withdrawal by Subject|6|||
131190004|NCT01696396|472317460|FG002|Overall Study|Withdrawal by Subject|19|||
131190005|NCT01696396|472317461|FG003|Overall Study|Withdrawal by Subject|11|||
131190006|NCT01696396|472317458|FG000|Overall Study|Decision by Sponsor|3|||
131190007|NCT01696396|472317459|FG001|Overall Study|Decision by Sponsor|1|||
131190008|NCT01696396|472317460|FG002|Overall Study|Decision by Sponsor|2|||
131190009|NCT01696396|472317461|FG003|Overall Study|Decision by Sponsor|2|||
131190010|NCT01696396|472317458|FG000|Overall Study|Lost to Follow-up|9|||
130733570|NCT01169337|470642914|FG000|Overall Study|Noncompliance|2|||
131190011|NCT01696396|472317459|FG001|Overall Study|Lost to Follow-up|1|||
131190012|NCT01696396|472317460|FG002|Overall Study|Lost to Follow-up|4|||
131190013|NCT01696396|472317461|FG003|Overall Study|Lost to Follow-up|1|||
131190014|NCT01696396|472317458|FG000|Overall Study|Death|0|||
131190015|NCT01696396|472317459|FG001|Overall Study|Death|0|||
131190016|NCT01696396|472317460|FG002|Overall Study|Death|1|||
131190017|NCT01696396|472317461|FG003|Overall Study|Death|0|||
131190018|NCT01131078|472317467|FG000|Overall Study|Adverse Event|22|||
131190019|NCT01131078|472317468|FG001|Overall Study|Adverse Event|12|||
131190020|NCT01131078|472317469|FG002|Overall Study|Adverse Event|17|||
131190021|NCT01131078|472317467|FG000|Overall Study|Progressive Disease|58|||
131190022|NCT01131078|472317468|FG001|Overall Study|Progressive Disease|77|||
131190023|NCT01131078|472317469|FG002|Overall Study|Progressive Disease|71|||
131190024|NCT01131078|472317467|FG000|Overall Study|Protocol Violation|1|||
131190025|NCT01131078|472317468|FG001|Overall Study|Protocol Violation|0|||
131190026|NCT01131078|472317469|FG002|Overall Study|Protocol Violation|0|||
131190027|NCT01131078|472317467|FG000|Overall Study|Lost to Follow-up|1|||
131190028|NCT01131078|472317468|FG001|Overall Study|Lost to Follow-up|1|||
131190029|NCT01131078|472317469|FG002|Overall Study|Lost to Follow-up|1|||
131190030|NCT01131078|472317467|FG000|Overall Study|Withdrawal by Subject|2|||
131190031|NCT01131078|472317468|FG001|Overall Study|Withdrawal by Subject|4|||
131190032|NCT01131078|472317469|FG002|Overall Study|Withdrawal by Subject|3|||
131190033|NCT01131078|472317467|FG000|Overall Study|Non-compliance|3|||
131190034|NCT01131078|472317468|FG001|Overall Study|Non-compliance|0|||
131190035|NCT01131078|472317469|FG002|Overall Study|Non-compliance|0|||
131190036|NCT01131078|472317467|FG000|Overall Study|Physician Decision|10|||
131190037|NCT01131078|472317468|FG001|Overall Study|Physician Decision|6|||
131190038|NCT01131078|472317469|FG002|Overall Study|Physician Decision|8|||
131190039|NCT01131078|472317467|FG000|Overall Study|Death|4|||
131190040|NCT01131078|472317468|FG001|Overall Study|Death|0|||
131190041|NCT01131078|472317469|FG002|Overall Study|Death|2|||
131190042|NCT01131078|472317467|FG000|Overall Study|Other|0|||
131190043|NCT01131078|472317468|FG001|Overall Study|Other|1|||
131190044|NCT01131078|472317469|FG002|Overall Study|Other|0|||
131190045|NCT01199198|472317470|FG000|Overall Study|Adverse Event|3|||
131190046|NCT01199198|472317471|FG001|Overall Study|Adverse Event|0|||
131190047|NCT01199198|472317470|FG000|Overall Study|Lost to Follow-up|1|||
131190048|NCT01199198|472317471|FG001|Overall Study|Lost to Follow-up|5|||
131190049|NCT01199198|472317470|FG000|Overall Study|Withdrawal by Subject|1|||
131190050|NCT01199198|472317471|FG001|Overall Study|Withdrawal by Subject|2|||
131190051|NCT01199198|472317470|FG000|Overall Study|ICU Transfer|1|||
131190052|NCT01199198|472317471|FG001|Overall Study|ICU Transfer|2|||
131190053|NCT01199198|472317470|FG000|Overall Study|Hospice-care transfer|1|||
131190054|NCT01199198|472317471|FG001|Overall Study|Hospice-care transfer|2|||
131190055|NCT00959894|472317473|FG000|Overall Study|Lost to Follow-up|10|||
131190056|NCT00959894|472317473|FG000|Overall Study|Adverse Event|3|||
130733571|NCT01169337|470642915|FG001|Overall Study|Noncompliance|0|||
130733572|NCT01169337|470642916|FG002|Overall Study|Noncompliance|0|||
131190057|NCT00959894|472317473|FG000|Overall Study|Withdrawal by Subject|1|||
131190058|NCT00959894|472317473|FG000|Overall Study|Need for contraindicated medication|1|||
131190059|NCT00959894|472317473|FG000|Overall Study|Subject moved out of town|1|||
131190060|NCT00653068|472317474|FG000|Overall Study|Death|9|||
131190061|NCT00653068|472317474|FG000|Overall Study|Lack of Efficacy|34|||
131190062|NCT00653068|472317474|FG000|Overall Study|Physician Decision|4|||
131190063|NCT00653068|472317474|FG000|Overall Study|Withdrawal by Subject|1|||
131190064|NCT00653068|472317474|FG000|Overall Study|Ineligible|2|||
131190065|NCT01305941|472317475|FG000|Overall Study|Adverse Event|6|||
131190066|NCT01305941|472317475|FG000|Overall Study|Clinical decline|2|||
131190067|NCT01305941|472317475|FG000|Overall Study|Withdrawal by Subject|1|||
131190068|NCT01305941|472317475|FG000|Overall Study|Death|1|||
131190069|NCT02892734|472317476|FG000|Treatment on Study|Progressive Disease|2|||
131190070|NCT02892734|472317476|FG000|Follow up for 2 Years|Death|2|||
131190071|NCT02892734|472317476|FG000|Follow up for 2 Years|Study closed early|1|||
131190072|NCT02043509|472317477|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
131190073|NCT02043509|472317478|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
131190074|NCT02043509|472317477|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
131190075|NCT02043509|472317478|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
131190076|NCT02043509|472317477|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
131190077|NCT02043509|472317478|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
131190078|NCT02043509|472317477|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
131190079|NCT02043509|472317478|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
131190080|NCT00608244|472317483|FG000|Overall Study|Adverse Event|1|||
131190081|NCT00608244|472317483|FG000|Overall Study|Low trough levels|1|||
131190082|NCT01685060|472317492|FG000|Overall Study|Rollover patients|16|||
131190083|NCT01685060|472317492|FG000|Overall Study|Adverse Event|12|||
131190084|NCT01685060|472317492|FG000|Overall Study|Progressive disease|69|||
131190085|NCT01685060|472317492|FG000|Overall Study|Physician Decision|14|||
131190086|NCT01685060|472317492|FG000|Overall Study|Subject/guardian decision|20|||
131190087|NCT01685060|472317492|FG000|Overall Study|Lost to Follow-up|1|||
131190088|NCT01685060|472317492|FG000|Overall Study|Death|8|||
131190089|NCT02944513|472317493|FG000|Overall Study|Withdrawal by Subject|4|||
131190090|NCT02944513|472317494|FG001|Overall Study|Withdrawal by Subject|1|||
131190091|NCT00937326|472317497|FG000|Overall Study|Adverse Event|0|||
131190092|NCT00937326|472317498|FG001|Overall Study|Adverse Event|3|||
131190093|NCT00937326|472317499|FG002|Overall Study|Adverse Event|1|||
131190094|NCT00937326|472317500|FG003|Overall Study|Adverse Event|1|||
131190095|NCT00937326|472317501|FG004|Overall Study|Adverse Event|2|||
131190096|NCT00937326|472317497|FG000|Overall Study|Death|0|||
131190097|NCT00937326|472317498|FG001|Overall Study|Death|0|||
131190098|NCT00937326|472317499|FG002|Overall Study|Death|1|||
131190099|NCT00937326|472317500|FG003|Overall Study|Death|0|||
131190100|NCT00937326|472317501|FG004|Overall Study|Death|0|||
131190101|NCT00937326|472317497|FG000|Overall Study|Withdrawal by Subject|3|||
131190102|NCT00937326|472317498|FG001|Overall Study|Withdrawal by Subject|4|||
131190103|NCT00937326|472317499|FG002|Overall Study|Withdrawal by Subject|1|||
131190104|NCT00937326|472317500|FG003|Overall Study|Withdrawal by Subject|4|||
131190105|NCT00937326|472317501|FG004|Overall Study|Withdrawal by Subject|3|||
131190106|NCT00937326|472317497|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
131190107|NCT00937326|472317498|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
131190108|NCT00937326|472317499|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
131190109|NCT00937326|472317500|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
131190110|NCT00937326|472317501|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
131190111|NCT02578992|472317502|FG000|Overall Study|equipment not available or malfunction|3|||
131190112|NCT02578992|472317503|FG001|Overall Study|equipment not available or malfunction|3|||
131190113|NCT02443155|472317504|FG000|Overall Study|Adverse Event|3|||
131190114|NCT02443155|472317505|FG001|Overall Study|Adverse Event|4|||
131190115|NCT02443155|472317506|FG002|Overall Study|Adverse Event|1|||
131190116|NCT02443155|472317507|FG003|Overall Study|Adverse Event|2|||
131190117|NCT02443155|472317504|FG000|Overall Study|Unclassified|0|||
131190118|NCT02443155|472317505|FG001|Overall Study|Unclassified|0|||
131190119|NCT02443155|472317506|FG002|Overall Study|Unclassified|2|||
131190120|NCT02443155|472317507|FG003|Overall Study|Unclassified|1|||
131190121|NCT02443155|472317504|FG000|Overall Study|Withdrawal by Subject|4|||
131190122|NCT02443155|472317505|FG001|Overall Study|Withdrawal by Subject|7|||
131190123|NCT02443155|472317506|FG002|Overall Study|Withdrawal by Subject|3|||
131190124|NCT02443155|472317507|FG003|Overall Study|Withdrawal by Subject|9|||
131190125|NCT02443155|472317504|FG000|Overall Study|Pregnancy|3|||
131190126|NCT02443155|472317505|FG001|Overall Study|Pregnancy|1|||
131190127|NCT02443155|472317506|FG002|Overall Study|Pregnancy|1|||
131190128|NCT02443155|472317507|FG003|Overall Study|Pregnancy|2|||
131190129|NCT02443155|472317504|FG000|Overall Study|Lost to Follow-up|1|||
131190130|NCT02443155|472317505|FG001|Overall Study|Lost to Follow-up|2|||
131190131|NCT02443155|472317506|FG002|Overall Study|Lost to Follow-up|0|||
131190132|NCT02443155|472317507|FG003|Overall Study|Lost to Follow-up|1|||
131190133|NCT02443155|472317504|FG000|Overall Study|Protocol Violation|1|||
131190134|NCT02443155|472317505|FG001|Overall Study|Protocol Violation|0|||
130733573|NCT01169337|470642914|FG000|Overall Study|Other complicating disease|1|||
130733574|NCT01169337|470642915|FG001|Overall Study|Other complicating disease|1|||
131190135|NCT02443155|472317506|FG002|Overall Study|Protocol Violation|1|||
131190136|NCT02443155|472317507|FG003|Overall Study|Protocol Violation|1|||
131190137|NCT02443155|472317504|FG000|Overall Study|Death|0|||
131190138|NCT02443155|472317505|FG001|Overall Study|Death|0|||
131190139|NCT02443155|472317506|FG002|Overall Study|Death|1|||
131190140|NCT02443155|472317507|FG003|Overall Study|Death|0|||
131190141|NCT00405275|472317511|FG000|Overall Study|Death|1|||
131190142|NCT00405275|472317512|FG001|Overall Study|Death|0|||
131190143|NCT00405275|472317511|FG000|Overall Study|Lost to Follow-up|5|||
131190144|NCT00405275|472317512|FG001|Overall Study|Lost to Follow-up|1|||
131190145|NCT00405275|472317511|FG000|Overall Study|Withdrawal by Subject|7|||
131190146|NCT00405275|472317512|FG001|Overall Study|Withdrawal by Subject|9|||
131190147|NCT00405275|472317511|FG000|Overall Study|Unwilling to continue|10|||
131190148|NCT00405275|472317512|FG001|Overall Study|Unwilling to continue|9|||
131190149|NCT00731666|472317513|FG000|Overall Study|Adverse Event|2|||
131190150|NCT00731666|472317513|FG000|Overall Study|Lost to Follow-up|8|||
131190151|NCT00731666|472317513|FG000|Overall Study|Withdrawal by Subject|2|||
131190152|NCT01376388|472317519|FG000|Overall Study|Adverse Event|13|||
131190153|NCT01376388|472317519|FG000|Overall Study|Lack of Efficacy|2|||
131190154|NCT01376388|472317519|FG000|Overall Study|Withdrawal by Subject|3|||
131190155|NCT02853123|472317527|FG000|Treatment Period 1|Adverse Event|0|||
131190156|NCT02853123|472317528|FG001|Treatment Period 1|Adverse Event|3|||
131190157|NCT02853123|472317527|FG000|Washout Period|Worsening of COPD|0|||
131190158|NCT02853123|472317528|FG001|Washout Period|Worsening of COPD|3|||
131190159|NCT02853123|472317527|FG000|Washout Period|Adverse Event|1|||
131190160|NCT02853123|472317528|FG001|Washout Period|Adverse Event|0|||
131190161|NCT00106249|472317529|FG000|Overall Study|Lost to Follow-up|3|||
131190162|NCT00106249|472317530|FG001|Overall Study|Lost to Follow-up|2|||
131190163|NCT01235338|472317531|FG000|Overall Study|Adverse Event|3|||
131190164|NCT01235338|472317532|FG001|Overall Study|Adverse Event|2|||
131190165|NCT01235338|472317531|FG000|Overall Study|Protocol Violation|1|||
131190166|NCT01235338|472317532|FG001|Overall Study|Protocol Violation|1|||
131190167|NCT01235338|472317531|FG000|Overall Study|Withdrawal by Subject|5|||
131190168|NCT01235338|472317532|FG001|Overall Study|Withdrawal by Subject|0|||
131190169|NCT01235338|472317531|FG000|Overall Study|Exclusion criteria violations|1|||
131190170|NCT01235338|472317532|FG001|Overall Study|Exclusion criteria violations|1|||
131190171|NCT01235338|472317531|FG000|Overall Study|Positive drug screen|0|||
131190172|NCT01235338|472317532|FG001|Overall Study|Positive drug screen|1|||
131190173|NCT01235338|472317531|FG000|Overall Study|Prohibited meds|1|||
131190174|NCT01235338|472317532|FG001|Overall Study|Prohibited meds|0|||
131190175|NCT02809118|472317533|FG000|Overall Study|Withdrawal by Subject|0|||
131190176|NCT02809118|472317534|FG001|Overall Study|Withdrawal by Subject|1|||
131190177|NCT02809118|472317535|FG002|Overall Study|Withdrawal by Subject|1|||
131190178|NCT05283499|472317539|FG000|Overall Study|Did not receive intervention|1|||
131190179|NCT05283499|472317540|FG001|Overall Study|Did not receive intervention|2|||
131190180|NCT00136357|472317543|FG000|Overall Study|Withdrawal by Subject|3|||
131190181|NCT00136357|472317544|FG001|Overall Study|Withdrawal by Subject|2|||
131190182|NCT00216086|472317547|FG000|Overall Study|Protocol Violation|1|||
131190183|NCT00216086|472317547|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
131190184|NCT00216086|472317547|FG000|Overall Study|Social Reasons|2|||
131190185|NCT02025530|472317551|FG000|Overall Study|No longer met elligibility criteria|5|||
131190186|NCT02025530|472317552|FG001|Overall Study|No longer met elligibility criteria|1|||
131190187|NCT01017549|472317555|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
131190188|NCT01017549|472317555|FG000|One-year Follow-up|Lost to Follow-up|2|||
131190189|NCT01017549|472317555|FG000|One-year Follow-up|Withdrawal by Subject|5|||
131190190|NCT01017549|472317555|FG000|5 Year Follow-up|Lost to Follow-up|9|||
131190191|NCT01017549|472317555|FG000|5 Year Follow-up|Mastectomy|3|||
131190192|NCT02728206|472317557|FG000|Overall Study|Death|1|||
131190193|NCT01929018|472317560|FG000|Overall Study|Lost to Follow-up|1|||
131190194|NCT01929018|472317561|FG001|Overall Study|Lost to Follow-up|0|||
131190195|NCT01929018|472317560|FG000|Overall Study|Hospitalization|0|||
131190196|NCT01929018|472317561|FG001|Overall Study|Hospitalization|1|||
131190197|NCT04882072|472317562|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
131190198|NCT04882072|472317563|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
131190199|NCT04882072|472317562|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
131190200|NCT04882072|472317563|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
131190201|NCT04882072|472317562|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
131190202|NCT04882072|472317563|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
131190203|NCT03097133|472317564|FG000|Overall Study|Lost to Follow-up|3|||
131190204|NCT03097133|472317565|FG001|Overall Study|Lost to Follow-up|2|||
131190205|NCT03097133|472317564|FG000|Overall Study|Withdrawal by Subject|2|||
131190206|NCT03097133|472317565|FG001|Overall Study|Withdrawal by Subject|5|||
130733575|NCT01169337|470642916|FG002|Overall Study|Other complicating disease|0|||
131190207|NCT03097133|472317564|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
131190208|NCT03097133|472317565|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
131190209|NCT03097133|472317564|FG000|Overall Study|Other|3|||
131190210|NCT03097133|472317565|FG001|Overall Study|Other|2|||
131190211|NCT03097133|472317564|FG000|Overall Study|Adverse Event|1|||
131190212|NCT03097133|472317565|FG001|Overall Study|Adverse Event|0|||
131190213|NCT00841672|472317571|FG000|Overall Study|Adverse Event|7|||
131190214|NCT00841672|472317572|FG001|Overall Study|Adverse Event|16|||
131190215|NCT00841672|472317571|FG000|Overall Study|Abnormal test procedure result(s)|0|||
131190216|NCT00841672|472317572|FG001|Overall Study|Abnormal test procedure result(s)|1|||
131190217|NCT00841672|472317571|FG000|Overall Study|Subject withdrew consent|2|||
131190218|NCT00841672|472317572|FG001|Overall Study|Subject withdrew consent|4|||
131190219|NCT00841672|472317571|FG000|Overall Study|Lost to Follow-up|1|||
131190220|NCT00841672|472317572|FG001|Overall Study|Lost to Follow-up|1|||
131190221|NCT00841672|472317571|FG000|Overall Study|Administrative problems|9|||
131190222|NCT00841672|472317572|FG001|Overall Study|Administrative problems|9|||
131190223|NCT00841672|472317571|FG000|Overall Study|Misrandomized|1|||
131190224|NCT00841672|472317572|FG001|Overall Study|Misrandomized|0|||
131190225|NCT00841672|472317571|FG000|Overall Study|Protocol Deviation|0|||
131190226|NCT00841672|472317572|FG001|Overall Study|Protocol Deviation|1|||
131190227|NCT00741260|472317574|FG000|Overall Study|Disease Progression|3|||
131190228|NCT00741260|472317575|FG001|Overall Study|Disease Progression|5|||
131190229|NCT00741260|472317576|FG002|Overall Study|Disease Progression|3|||
131190230|NCT00741260|472317577|FG003|Overall Study|Disease Progression|3|||
131190231|NCT00741260|472317578|FG004|Overall Study|Disease Progression|5|||
131190232|NCT00741260|472317579|FG005|Overall Study|Disease Progression|37|||
131190233|NCT00741260|472317580|FG006|Overall Study|Disease Progression|4|||
131190234|NCT00741260|472317574|FG000|Overall Study|Death|0|||
131190235|NCT00741260|472317575|FG001|Overall Study|Death|1|||
131190236|NCT00741260|472317576|FG002|Overall Study|Death|0|||
131190237|NCT00741260|472317577|FG003|Overall Study|Death|1|||
131190238|NCT00741260|472317578|FG004|Overall Study|Death|2|||
131190239|NCT00741260|472317579|FG005|Overall Study|Death|2|||
131190240|NCT00741260|472317580|FG006|Overall Study|Death|1|||
131190241|NCT00741260|472317574|FG000|Overall Study|Withdrawal by Subject|0|||
131190242|NCT00741260|472317575|FG001|Overall Study|Withdrawal by Subject|0|||
131190243|NCT00741260|472317576|FG002|Overall Study|Withdrawal by Subject|0|||
131190244|NCT00741260|472317577|FG003|Overall Study|Withdrawal by Subject|0|||
131190245|NCT00741260|472317578|FG004|Overall Study|Withdrawal by Subject|1|||
131190246|NCT00741260|472317579|FG005|Overall Study|Withdrawal by Subject|3|||
131190247|NCT00741260|472317580|FG006|Overall Study|Withdrawal by Subject|1|||
131190248|NCT00741260|472317574|FG000|Overall Study|Physician Decision|1|||
131190249|NCT00741260|472317575|FG001|Overall Study|Physician Decision|1|||
131190250|NCT00741260|472317576|FG002|Overall Study|Physician Decision|0|||
131190251|NCT00741260|472317577|FG003|Overall Study|Physician Decision|0|||
131190252|NCT00741260|472317578|FG004|Overall Study|Physician Decision|0|||
131190253|NCT00741260|472317579|FG005|Overall Study|Physician Decision|0|||
131190254|NCT00741260|472317580|FG006|Overall Study|Physician Decision|0|||
131190255|NCT00741260|472317574|FG000|Overall Study|Other|2|||
131190256|NCT00741260|472317575|FG001|Overall Study|Other|1|||
131190257|NCT00741260|472317576|FG002|Overall Study|Other|1|||
131190258|NCT00741260|472317577|FG003|Overall Study|Other|2|||
131190259|NCT00741260|472317578|FG004|Overall Study|Other|1|||
131190260|NCT00741260|472317579|FG005|Overall Study|Other|3|||
131190261|NCT00741260|472317580|FG006|Overall Study|Other|1|||
131190262|NCT02427100|472317581|FG000|Overall Study|Lost to Follow-up|0|||
131190263|NCT02427100|472317582|FG001|Overall Study|Lost to Follow-up|2|||
131190264|NCT02120352|472317583|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
131190265|NCT02120352|472317584|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
131190266|NCT02120352|472317585|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
130733576|NCT01169337|470642914|FG000|Overall Study|Physician Decision|1|||
130733577|NCT01169337|470642915|FG001|Overall Study|Physician Decision|5|||
130733578|NCT01169337|470642916|FG002|Overall Study|Physician Decision|0|||
131190267|NCT02120352|472317586|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
131190268|NCT02120352|472317587|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
131190269|NCT02120352|472317588|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
131190270|NCT02120352|472317589|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
131190271|NCT02120352|472317583|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
131190272|NCT02120352|472317584|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131190273|NCT02120352|472317585|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131190274|NCT02120352|472317586|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131190275|NCT02120352|472317587|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131190276|NCT02120352|472317588|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
131190277|NCT02120352|472317589|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130733579|NCT01169337|470642914|FG000|Overall Study|Alternative therapy|0|||
131190278|NCT02120352|472317583|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
131190279|NCT02120352|472317584|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
131190280|NCT02120352|472317585|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
130784548|NCT03885908|470838817|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
130784549|NCT03885908|470838818|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
130784550|NCT03885908|470838817|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
131190281|NCT02120352|472317586|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
131190282|NCT02120352|472317587|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
131190283|NCT02120352|472317588|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
131190284|NCT02120352|472317589|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
131190285|NCT02120352|472317583|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
131190286|NCT02120352|472317584|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131190287|NCT02120352|472317585|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131190288|NCT02120352|472317586|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131190289|NCT02120352|472317587|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131190290|NCT02120352|472317588|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131190291|NCT02120352|472317589|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
131190292|NCT02120352|472317583|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
131190293|NCT02120352|472317584|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131190294|NCT02120352|472317585|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131190295|NCT02120352|472317586|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131190296|NCT02120352|472317587|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131190297|NCT02120352|472317588|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131190298|NCT02120352|472317589|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
131190299|NCT02120352|472317583|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
131190300|NCT02120352|472317584|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131190301|NCT02120352|472317585|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131190302|NCT02120352|472317586|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131190303|NCT02120352|472317587|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131190304|NCT02120352|472317588|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131190305|NCT02120352|472317589|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
131190306|NCT02120352|472317583|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
131190307|NCT02120352|472317584|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
131190308|NCT02120352|472317585|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
131190309|NCT02120352|472317586|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
131190310|NCT02120352|472317587|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
131190311|NCT02120352|472317588|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
131190312|NCT02120352|472317589|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
131190313|NCT02120352|472317583|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
131190314|NCT02120352|472317584|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
131190315|NCT02120352|472317585|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
131190316|NCT02120352|472317586|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
131190317|NCT02120352|472317587|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
131190318|NCT02120352|472317588|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
131190319|NCT02120352|472317589|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
131190320|NCT02120352|472317583|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
131190321|NCT02120352|472317584|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
131190322|NCT02120352|472317585|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
131190323|NCT02120352|472317586|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
131190324|NCT02120352|472317587|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130733580|NCT01169337|470642915|FG001|Overall Study|Alternative therapy|2|||
131190325|NCT02120352|472317588|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
131190326|NCT02120352|472317589|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
131190327|NCT02120352|472317583|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
131190328|NCT02120352|472317584|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
131190329|NCT02120352|472317585|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
131190330|NCT02120352|472317586|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
131190331|NCT02120352|472317587|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
131190332|NCT02120352|472317588|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
131190333|NCT02120352|472317589|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
131190334|NCT02120352|472317583|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
131190335|NCT02120352|472317584|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
131190336|NCT02120352|472317585|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
131190337|NCT02120352|472317586|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
131190338|NCT02120352|472317587|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
131190339|NCT02120352|472317588|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
131190340|NCT02120352|472317589|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
131190341|NCT02120352|472317583|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131190342|NCT02120352|472317584|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131190343|NCT02120352|472317585|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131190344|NCT02120352|472317586|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
131190345|NCT02120352|472317587|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131190346|NCT02120352|472317588|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131190347|NCT02120352|472317589|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
131190348|NCT02120352|472317583|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
131190349|NCT02120352|472317584|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
131190350|NCT02120352|472317585|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
131190351|NCT02120352|472317586|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
131190352|NCT02120352|472317587|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
131190353|NCT02120352|472317588|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
131190354|NCT02120352|472317589|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
131190355|NCT02120352|472317583|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131190356|NCT02120352|472317584|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
131190357|NCT02120352|472317585|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131190358|NCT02120352|472317586|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131190359|NCT02120352|472317587|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131190360|NCT02120352|472317588|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131190361|NCT02120352|472317589|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
131190362|NCT02120352|472317583|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
131190363|NCT02120352|472317584|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
131190364|NCT02120352|472317585|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
131190365|NCT02120352|472317586|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
131190366|NCT02120352|472317587|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
131190367|NCT02120352|472317588|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
131190368|NCT02120352|472317589|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
131190369|NCT02120352|472317583|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131190370|NCT02120352|472317584|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131190371|NCT02120352|472317585|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131190372|NCT02120352|472317586|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131190373|NCT02120352|472317587|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
131190374|NCT02120352|472317588|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131190375|NCT02120352|472317589|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
131190376|NCT02120352|472317583|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
131190377|NCT02120352|472317584|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
131190378|NCT02120352|472317585|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
131190379|NCT02120352|472317586|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
131190380|NCT02120352|472317587|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
131190381|NCT02120352|472317588|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
131190382|NCT02120352|472317589|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
131190383|NCT02120352|472317583|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
131190384|NCT02120352|472317584|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
131190385|NCT02120352|472317585|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
131190386|NCT02120352|472317586|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
131190387|NCT02120352|472317587|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
131190388|NCT02120352|472317588|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
131190389|NCT02120352|472317589|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
131190390|NCT02120352|472317583|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
131190391|NCT02120352|472317584|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
131190392|NCT02120352|472317585|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
131190393|NCT02120352|472317586|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
131190394|NCT02120352|472317587|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
131190395|NCT02120352|472317588|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
131190396|NCT02120352|472317589|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
131190397|NCT02120352|472317583|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
131190398|NCT02120352|472317584|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
131190399|NCT02120352|472317585|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
131190400|NCT02120352|472317586|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
131190401|NCT02120352|472317587|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
131190402|NCT02120352|472317588|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
131190403|NCT02120352|472317589|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
131190404|NCT02120352|472317583|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
131190405|NCT02120352|472317584|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
131190406|NCT02120352|472317585|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
131190407|NCT02120352|472317586|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
131190408|NCT02120352|472317587|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
131190409|NCT02120352|472317588|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
131190410|NCT02120352|472317589|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
131190411|NCT02120352|472317583|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131190412|NCT02120352|472317584|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131190413|NCT02120352|472317585|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131190414|NCT02120352|472317586|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131190415|NCT02120352|472317587|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131190416|NCT02120352|472317588|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
131190417|NCT02120352|472317589|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
131190418|NCT03094611|472317590|FG000|Overall Study|Lack of Efficacy|1|||
131190419|NCT03094611|472317590|FG000|Overall Study|Stem Cell Transplant|1|||
131190420|NCT02023112|472317598|FG000|Overall Study|Withdrawal by Subject|2|||
131190421|NCT02023112|472317599|FG001|Overall Study|Withdrawal by Subject|1|||
131190422|NCT00981747|472317602|FG000|Losartan|Withdrawal by Subject|1|||
131190423|NCT00981747|472317602|FG000|Losartan|Death|1|||
131190424|NCT00981747|472317602|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
131190425|NCT03034057|472317606|FG000|Overall Study|Withdrawal by Subject|10|||
131190426|NCT03034057|472317606|FG000|Overall Study|Protocol Violation|1|||
131190427|NCT03034057|472317606|FG000|Overall Study|Not defined|2|||
131190428|NCT03034057|472317606|FG000|Overall Study|Lost to Follow-up|19|||
131190429|NCT03034057|472317606|FG000|Overall Study|Adverse Event|22|||
131190430|NCT03034057|472317606|FG000|Overall Study|Medication error without associated AE|1|||
131190431|NCT01814826|472317607|FG000|Overall Study|Other|3|||
131190432|NCT01814826|472317608|FG001|Overall Study|Other|5|||
131190433|NCT01814826|472317609|FG002|Overall Study|Other|0|||
131190434|NCT01814826|472317607|FG000|Overall Study|Death|29|||
131190435|NCT01814826|472317608|FG001|Overall Study|Death|24|||
131190436|NCT01814826|472317609|FG002|Overall Study|Death|3|||
131190437|NCT03339401|472317610|FG000|Overall Study|Death|2|||
131190438|NCT03339401|472317611|FG001|Overall Study|Death|1|||
131190439|NCT03339401|472317610|FG000|Overall Study|Withdrawal by Subject|2|||
131190440|NCT03339401|472317611|FG001|Overall Study|Withdrawal by Subject|0|||
131190441|NCT03339401|472317610|FG000|Overall Study|Study terminated|4|||
131190442|NCT03339401|472317611|FG001|Overall Study|Study terminated|3|||
131190443|NCT03339401|472317610|FG000|Overall Study|Investigator Decision|1|||
131190444|NCT03339401|472317611|FG001|Overall Study|Investigator Decision|0|||
131190445|NCT03271307|472317612|FG000|Overall Study|Lost to Follow-up|0|||
131190446|NCT03271307|472317613|FG001|Overall Study|Lost to Follow-up|0|||
131190447|NCT03271307|472317614|FG002|Overall Study|Lost to Follow-up|0|||
131190448|NCT03271307|472317615|FG003|Overall Study|Lost to Follow-up|28|||
131190449|NCT03271307|472317616|FG004|Overall Study|Lost to Follow-up|91|||
131190450|NCT03365947|472317617|FG000|Overall Study|Lost to Follow-up|0|||
131190451|NCT03365947|472317618|FG001|Overall Study|Lost to Follow-up|0|||
131190452|NCT03365947|472317619|FG002|Overall Study|Lost to Follow-up|0|||
131190453|NCT03365947|472317620|FG003|Overall Study|Lost to Follow-up|0|||
131190454|NCT03365947|472317621|FG004|Overall Study|Lost to Follow-up|0|||
131190455|NCT03365947|472317622|FG005|Overall Study|Lost to Follow-up|1|||
131190456|NCT03365947|472317623|FG006|Overall Study|Lost to Follow-up|0|||
131190457|NCT03365947|472317624|FG007|Overall Study|Lost to Follow-up|0|||
131190458|NCT03365947|472317625|FG008|Overall Study|Lost to Follow-up|0|||
131190459|NCT03365947|472317626|FG009|Overall Study|Lost to Follow-up|0|||
131190460|NCT03365947|472317627|FG010|Overall Study|Lost to Follow-up|0|||
131190461|NCT03365947|472317628|FG011|Overall Study|Lost to Follow-up|0|||
131190462|NCT03365947|472317629|FG012|Overall Study|Lost to Follow-up|0|||
131190463|NCT03365947|472317630|FG013|Overall Study|Lost to Follow-up|0|||
131190464|NCT03365947|472317631|FG014|Overall Study|Lost to Follow-up|0|||
131190465|NCT03365947|472317632|FG015|Overall Study|Lost to Follow-up|0|||
131190466|NCT03365947|472317633|FG016|Overall Study|Lost to Follow-up|0|||
131190467|NCT03365947|472317634|FG017|Overall Study|Lost to Follow-up|0|||
131190468|NCT03365947|472317635|FG018|Overall Study|Lost to Follow-up|0|||
131190469|NCT01042938|472317636|FG000|Overall Study|Withdrawal by Subject|1|||
131190470|NCT01042938|472317637|FG001|Overall Study|Withdrawal by Subject|1|||
131190471|NCT01042938|472317636|FG000|Overall Study|Protocol Violation|1|||
131190472|NCT01042938|472317637|FG001|Overall Study|Protocol Violation|1|||
131190473|NCT01042938|472317636|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
131190474|NCT01042938|472317637|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
131190475|NCT03997760|472317640|FG000|Overall Study|Protocol Deviation|0|||
131190476|NCT03997760|472317641|FG001|Overall Study|Protocol Deviation|1|||
131190477|NCT03997760|472317642|FG002|Overall Study|Protocol Deviation|0|||
131190478|NCT03997760|472317643|FG003|Overall Study|Protocol Deviation|0|||
131190479|NCT00856986|472317644|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
131190480|NCT00856986|472317645|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
131190481|NCT00856986|472317646|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
131190482|NCT00856986|472317647|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
131190483|NCT00856986|472317648|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
131190484|NCT00856986|472317644|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
131190485|NCT00856986|472317645|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
131190486|NCT00856986|472317646|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
131190487|NCT00856986|472317647|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
131190488|NCT00856986|472317648|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
131190489|NCT00856986|472317644|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
131190490|NCT00856986|472317645|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
131190491|NCT00856986|472317646|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
131190492|NCT00856986|472317647|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
131190493|NCT00856986|472317648|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
131190494|NCT00856986|472317644|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
131190495|NCT00856986|472317645|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
131190496|NCT00856986|472317646|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
131190497|NCT00856986|472317647|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
131190498|NCT00856986|472317648|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
131190499|NCT00856986|472317644|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
131190500|NCT00856986|472317645|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
131190501|NCT00856986|472317646|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
131190502|NCT00856986|472317647|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
131190503|NCT00856986|472317648|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
131190504|NCT00856986|472317644|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
131190505|NCT00856986|472317645|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
131190506|NCT00856986|472317646|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
131190507|NCT00856986|472317647|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
131190508|NCT00856986|472317648|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
131190509|NCT00856986|472317644|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
131190510|NCT00856986|472317645|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
131190511|NCT00856986|472317646|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
131190512|NCT00856986|472317647|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
131190513|NCT00856986|472317648|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
131190514|NCT00856986|472317644|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
131190515|NCT00856986|472317645|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
131190516|NCT00856986|472317646|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
131190517|NCT00856986|472317647|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
131190518|NCT00856986|472317648|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
131190519|NCT00856986|472317644|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
131190520|NCT00856986|472317645|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
131190521|NCT00856986|472317646|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
131190522|NCT00856986|472317647|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
131190523|NCT00856986|472317648|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
131190524|NCT00856986|472317644|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
131190525|NCT00856986|472317645|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
131190526|NCT00856986|472317646|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
131190527|NCT00856986|472317647|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
131190528|NCT00856986|472317648|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
131190529|NCT00856986|472317644|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
131190530|NCT00856986|472317645|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
131190531|NCT00856986|472317646|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
131190532|NCT00856986|472317647|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
131190533|NCT00856986|472317648|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
131190534|NCT00856986|472317644|FG000|Main Period, Weeks 0-26|Unclassified|7|||
131190535|NCT00856986|472317645|FG001|Main Period, Weeks 0-26|Unclassified|6|||
131190536|NCT00856986|472317646|FG002|Main Period, Weeks 0-26|Unclassified|7|||
131190537|NCT00856986|472317647|FG003|Main Period, Weeks 0-26|Unclassified|0|||
131190538|NCT00856986|472317648|FG004|Main Period, Weeks 0-26|Unclassified|0|||
131190539|NCT00856986|472317644|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
131190540|NCT00856986|472317645|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
131190541|NCT00856986|472317646|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
131190542|NCT00856986|472317647|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
131190543|NCT00856986|472317648|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
131190544|NCT00856986|472317644|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
131190545|NCT00856986|472317645|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
131190546|NCT00856986|472317646|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
131190547|NCT00856986|472317647|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
131190548|NCT00856986|472317648|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
131190549|NCT00856986|472317644|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
131190550|NCT00856986|472317645|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
131190551|NCT00856986|472317646|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
131190552|NCT00856986|472317647|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
131190553|NCT00856986|472317648|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
131190554|NCT00856986|472317644|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
131190555|NCT00856986|472317645|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
131190556|NCT00856986|472317646|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
131190557|NCT00856986|472317647|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
131190558|NCT00856986|472317648|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
131190559|NCT00856986|472317644|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
131190560|NCT00856986|472317645|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
131190561|NCT00856986|472317646|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
131190562|NCT00856986|472317647|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
131190563|NCT00856986|472317648|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
131190564|NCT00856986|472317644|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
131190565|NCT00856986|472317645|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
131190566|NCT00856986|472317646|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
131190567|NCT00856986|472317647|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
131190568|NCT00856986|472317648|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
131190569|NCT02000219|472319176|FG000|14-Week Study Period|Physician Decision|1|||
131190570|NCT02000219|472319176|FG000|14-Week Study Period|Adverse Event|1|||
131190571|NCT02000219|472319176|FG000|14-Week Study Period|Underwent transplantation|1|||
131190572|NCT02000219|472319176|FG000|Continuation Period|Withdrawal by Subject|1|||
131190573|NCT02000219|472319176|FG000|Continuation Period|Had liver transplant|2|||
131190574|NCT02000219|472319176|FG000|Continuation Period|Non-compliance with study drug|2|||
131190575|NCT00608894|472319180|FG000|Overall Study|Withdrawal by Subject|0|||
131190576|NCT00608894|472319181|FG001|Overall Study|Withdrawal by Subject|2|||
131190577|NCT01495689|472319189|FG000|Overall Study|Death|0|||
131190578|NCT01495689|472319190|FG001|Overall Study|Death|1|||
131190579|NCT01495689|472319189|FG000|Overall Study|Withdrawal by Subject|3|||
131190580|NCT01495689|472319190|FG001|Overall Study|Withdrawal by Subject|0|||
131190581|NCT01495689|472319189|FG000|Overall Study|Lost to Follow-up|7|||
131190582|NCT01495689|472319190|FG001|Overall Study|Lost to Follow-up|6|||
131190583|NCT00524043|472319191|FG000|Overall Study|Lack of Efficacy|15|||
131190584|NCT00524043|472319192|FG001|Overall Study|Lack of Efficacy|13|||
131190585|NCT00524043|472319193|FG002|Overall Study|Lack of Efficacy|14|||
131190586|NCT00524043|472319191|FG000|Overall Study|Withdrawal by Subject|5|||
131190587|NCT00524043|472319192|FG001|Overall Study|Withdrawal by Subject|7|||
131190588|NCT00524043|472319193|FG002|Overall Study|Withdrawal by Subject|7|||
131190589|NCT00524043|472319191|FG000|Overall Study|Adverse Event|5|||
131190590|NCT00524043|472319192|FG001|Overall Study|Adverse Event|2|||
131190591|NCT00524043|472319193|FG002|Overall Study|Adverse Event|7|||
131190592|NCT00524043|472319191|FG000|Overall Study|Lost to Follow-up|3|||
131190593|NCT00524043|472319192|FG001|Overall Study|Lost to Follow-up|5|||
131190594|NCT00524043|472319193|FG002|Overall Study|Lost to Follow-up|3|||
131190595|NCT00524043|472319191|FG000|Overall Study|Various (eg, incarceration)|2|||
131190596|NCT00524043|472319192|FG001|Overall Study|Various (eg, incarceration)|1|||
131190597|NCT00524043|472319193|FG002|Overall Study|Various (eg, incarceration)|0|||
131190598|NCT01843205|472319198|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
131190599|NCT01843205|472319199|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
131190600|NCT00606177|472319200|FG000|Overall Study|Adverse Event|9|||
131190601|NCT00606177|472319201|FG001|Overall Study|Adverse Event|5|||
131190602|NCT00606177|472319200|FG000|Overall Study|Lack of Efficacy|3|||
131190603|NCT00606177|472319201|FG001|Overall Study|Lack of Efficacy|7|||
131190604|NCT00606177|472319200|FG000|Overall Study|Physician Decision|1|||
131190605|NCT00606177|472319201|FG001|Overall Study|Physician Decision|0|||
131190606|NCT00606177|472319200|FG000|Overall Study|Protocol Violation|1|||
131190607|NCT00606177|472319201|FG001|Overall Study|Protocol Violation|4|||
131190608|NCT00606177|472319200|FG000|Overall Study|Withdrawal by Subject|5|||
131190609|NCT00606177|472319201|FG001|Overall Study|Withdrawal by Subject|6|||
131190610|NCT00606177|472319200|FG000|Overall Study|Progression to depressive phase|6|||
131190611|NCT00606177|472319201|FG001|Overall Study|Progression to depressive phase|1|||
131190612|NCT00606177|472319200|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
131190613|NCT00606177|472319201|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
131190614|NCT00606177|472319200|FG000|Overall Study|Change of residence or other commitments|1|||
131190615|NCT00606177|472319201|FG001|Overall Study|Change of residence or other commitments|1|||
131190616|NCT02773368|472319202|FG000|Overall Study|Lost to Follow-up|4|||
131190617|NCT02773368|472319203|FG001|Overall Study|Lost to Follow-up|1|||
131190618|NCT02773368|472319202|FG000|Overall Study|Withdrawal by Subject|5|||
131190619|NCT02773368|472319203|FG001|Overall Study|Withdrawal by Subject|1|||
131190620|NCT02773368|472319202|FG000|Overall Study|Unclassified|1|||
131190621|NCT02773368|472319203|FG001|Overall Study|Unclassified|1|||
131190622|NCT02773368|472319202|FG000|Overall Study|Missing|0|||
131190623|NCT02773368|472319203|FG001|Overall Study|Missing|1|||
131190624|NCT02635867|472319206|FG000|Overall Study|Lost to Follow-up|4|||
131190625|NCT02635867|472319207|FG001|Overall Study|Lost to Follow-up|3|||
131190626|NCT02635867|472319208|FG002|Overall Study|Lost to Follow-up|3|||
131190627|NCT02635867|472319209|FG003|Overall Study|Lost to Follow-up|4|||
131190628|NCT02635867|472319210|FG004|Overall Study|Lost to Follow-up|1|||
131190629|NCT01782885|472319211|FG000|Overall Study|Lost to Follow-up|4|||
131190630|NCT01782885|472319212|FG001|Overall Study|Lost to Follow-up|6|||
131190631|NCT02977507|472319216|FG000|Overall Study|Protocol Deviation|1|||
131190632|NCT02977507|472319217|FG001|Overall Study|Protocol Deviation|0|||
131190633|NCT02977507|472319216|FG000|Overall Study|Lost to Follow-up|1|||
131190634|NCT02977507|472319217|FG001|Overall Study|Lost to Follow-up|0|||
131190635|NCT00633360|472319218|FG000|Overall Study|Lost to Follow-up|1|||
131190636|NCT00633360|472319219|FG001|Overall Study|Lost to Follow-up|1|||
131190637|NCT00633360|472319218|FG000|Overall Study|Adverse Event|3|||
131190638|NCT00633360|472319219|FG001|Overall Study|Adverse Event|1|||
131190639|NCT00633360|472319218|FG000|Overall Study|Protocol Violation|0|||
131190640|NCT00633360|472319219|FG001|Overall Study|Protocol Violation|1|||
131190641|NCT00329784|472319220|FG000|Overall Study|Lost to Follow-up|0|||
131190642|NCT00329784|472319221|FG001|Overall Study|Lost to Follow-up|1|||
131190643|NCT00329784|472319222|FG002|Overall Study|Lost to Follow-up|0|||
131190644|NCT00329784|472319223|FG003|Overall Study|Lost to Follow-up|0|||
131190645|NCT00329784|472319220|FG000|Overall Study|Withdrawal by Subject|4|||
131190646|NCT00329784|472319221|FG001|Overall Study|Withdrawal by Subject|2|||
131190647|NCT00329784|472319222|FG002|Overall Study|Withdrawal by Subject|0|||
131190648|NCT00329784|472319223|FG003|Overall Study|Withdrawal by Subject|0|||
131190649|NCT00329784|472319220|FG000|Overall Study|Other|1|||
131190650|NCT00329784|472319221|FG001|Overall Study|Other|2|||
131190651|NCT00329784|472319222|FG002|Overall Study|Other|0|||
131190652|NCT00329784|472319223|FG003|Overall Study|Other|0|||
131190653|NCT00924729|472319228|FG000|Overall Study|insufficient volume for analysis|1|||
131190654|NCT00924729|472319229|FG001|Overall Study|insufficient volume for analysis|0|||
131190655|NCT00924729|472319228|FG000|Overall Study|Protocol Violation|1|||
131190656|NCT00924729|472319229|FG001|Overall Study|Protocol Violation|0|||
131190657|NCT01449955|472319230|FG000|Overall Study|Withdrawal by Subject|1|||
131190658|NCT01449955|472319231|FG001|Overall Study|Withdrawal by Subject|2|||
131190659|NCT01915095|472319232|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
131190660|NCT01915095|472319233|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
131190661|NCT01915095|472319234|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
131190662|NCT01915095|472319235|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
131190663|NCT01915095|472319236|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
131190664|NCT04018612|472319237|FG000|Overall Study|Withdrawal by Subject|1|||
131190665|NCT04018612|472319238|FG001|Overall Study|Withdrawal by Subject|0|||
131190666|NCT04018612|472319239|FG002|Overall Study|Withdrawal by Subject|1|||
131190667|NCT00361218|472319242|FG000|Overall Study|Lost to Follow-up|11|||
131190668|NCT00361218|472319242|FG000|Overall Study|Personal Reasons|7|||
131190669|NCT00361218|472319242|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
131190670|NCT02067533|472319243|FG000|Overall Study|Lost to Follow-up|4|||
131190671|NCT02067533|472319244|FG001|Overall Study|Lost to Follow-up|2|||
131190672|NCT02671760|472319246|FG000|Overall Study|Lost to Follow-up|0|||
131190673|NCT02671760|472319247|FG001|Overall Study|Lost to Follow-up|1|||
131190674|NCT02671760|472319248|FG002|Overall Study|Lost to Follow-up|0|||
131190675|NCT02999191|472319249|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
131190676|NCT02999191|472319250|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
131190677|NCT02999191|472319251|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
131190678|NCT02566109|472319253|FG000|Overall Study|Withdrawal by Subject|1|||
131190679|NCT01906476|472319254|FG000|Overall Study|Lost to Follow-up|17|||
131190680|NCT01906476|472319255|FG001|Overall Study|Lost to Follow-up|16|||
131190681|NCT01993667|472319256|FG000|Overall Study|Insufficient data to analyze|16|||
131190682|NCT01993667|472319257|FG001|Overall Study|Insufficient data to analyze|16|||
131190683|NCT01993667|472319256|FG000|Overall Study|Insufficient altitude reached|3|||
131190684|NCT01993667|472319257|FG001|Overall Study|Insufficient altitude reached|1|||
131190685|NCT01993667|472319256|FG000|Overall Study|Lost to Follow-up|2|||
131190686|NCT01993667|472319257|FG001|Overall Study|Lost to Follow-up|2|||
131190687|NCT01931150|472319258|FG000|Overall Study|Withdrawal by Subject|1|||
131190688|NCT01931150|472319259|FG001|Overall Study|Withdrawal by Subject|2|||
131190689|NCT02896192|472319260|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
131190690|NCT02896192|472319260|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
131190691|NCT02896192|472319260|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
131190692|NCT00479167|472319265|FG000|Overall Study|Withdrawal by Subject|1|||
131190693|NCT01997281|472319268|FG000|Overall Study|Withdrawal by Subject|1|||
131190694|NCT01997281|472319269|FG001|Overall Study|Withdrawal by Subject|0|||
131190695|NCT01570309|472319272|FG000|Overall Study|Withdrawal by Subject|3|||
131190696|NCT01570309|472319273|FG001|Overall Study|Withdrawal by Subject|3|||
131190697|NCT00560794|472319274|FG000|Overall Study|Adverse Event|2|||
131190698|NCT00560794|472319274|FG000|Overall Study|Patient was not Compliant|1|||
131190699|NCT00560794|472319274|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
131190700|NCT00560794|472319274|FG000|Overall Study|Hematological Relapse|1|||
131190701|NCT00560794|472319274|FG000|Overall Study|Received Bone Marrow Transplant|6|||
131190702|NCT04857892|472319275|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
131190703|NCT04857892|472319276|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
131190704|NCT04857892|472319277|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
131190705|NCT04857892|472319278|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
131190706|NCT04857892|472319279|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
131190707|NCT04857892|472319275|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
131190708|NCT04857892|472319276|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
131190709|NCT04857892|472319277|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
131190710|NCT04857892|472319278|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
131190711|NCT04857892|472319279|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
131190712|NCT04857892|472319275|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
131190713|NCT04857892|472319276|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
131190714|NCT04857892|472319277|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
131190715|NCT04857892|472319278|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
131190716|NCT04857892|472319279|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
131190717|NCT01390038|472319280|FG000|Overall Study|Death|1|||
131190718|NCT01390038|472319280|FG000|Overall Study|Lost to Follow-up|1|||
131190719|NCT01390038|472319280|FG000|Overall Study|Withdrawal by Subject|4|||
131190720|NCT01390038|472319280|FG000|Overall Study|Simpliciti System Removal|2|||
131190721|NCT00368472|472319286|FG000|Overall Study|Adverse Event|22|||
131190722|NCT00368472|472319286|FG000|Overall Study|Medication non-compliance|4|||
131190723|NCT00368472|472319286|FG000|Overall Study|Protocol Violation|2|||
131190724|NCT00368472|472319286|FG000|Overall Study|Request of Investigator or Sponsor|3|||
131190725|NCT00368472|472319286|FG000|Overall Study|Withdrawal by Subject|40|||
131190726|NCT00368472|472319286|FG000|Overall Study|Diary non-compliance|1|||
131190727|NCT00368472|472319286|FG000|Overall Study|Other|32|||
131190728|NCT00368472|472319286|FG000|Overall Study|Missing Final Disposition Date|1|||
131190729|NCT03619837|472319290|FG000|Screening|received organs from HCV-negative donors|47|||
131190730|NCT03619837|472319290|FG000|Screening|died on the wait-list|2|||
131190731|NCT03619837|472319290|FG000|Screening|remained on the wait list|40|||
131190732|NCT03619837|472319290|FG000|Screening|didn't meet eligibility criteria|3|||
131190733|NCT03619837|472319290|FG000|Screening|withdrew consent|2|||
131190734|NCT03619837|472319290|FG000|Screening|never listed for HCV-viremic donor|1|||
131190735|NCT03619837|472319290|FG000|Screening|developed exclusion criteria|2|||
131190736|NCT03619837|472319290|FG000|Screening|excluded by the investigator due to non-compliance|1|||
131190737|NCT04095793|472319291|FG000|Overall Study|Adverse Event|3|||
131190738|NCT04095793|472319291|FG000|Overall Study|Study Terminated by Sponsor|103|||
131190739|NCT04095793|472319291|FG000|Overall Study|Withdrawal by Subject|4|||
131190740|NCT02384993|472319292|FG000|Overall Study|Adverse Event|0|||
131190741|NCT02384993|472319293|FG001|Overall Study|Adverse Event|1|||
130733581|NCT01169337|470642916|FG002|Overall Study|Alternative therapy|0|||
131190742|NCT00044213|472319294|FG000|Overall Study|Withdrawal by Subject|50|||
131190743|NCT00044213|472319295|FG001|Overall Study|Withdrawal by Subject|65|||
131190744|NCT00044213|472319296|FG002|Overall Study|Withdrawal by Subject|91|||
131190745|NCT00044213|472319297|FG003|Overall Study|Withdrawal by Subject|83|||
131190746|NCT00044213|472319294|FG000|Overall Study|Death|42|||
131190747|NCT00044213|472319295|FG001|Overall Study|Death|42|||
131190748|NCT00044213|472319296|FG002|Overall Study|Death|42|||
131190749|NCT00044213|472319297|FG003|Overall Study|Death|49|||
131190750|NCT00044213|472319294|FG000|Overall Study|Lost to Follow-up|8|||
131190751|NCT00044213|472319295|FG001|Overall Study|Lost to Follow-up|5|||
131190752|NCT00044213|472319296|FG002|Overall Study|Lost to Follow-up|5|||
131190753|NCT00044213|472319297|FG003|Overall Study|Lost to Follow-up|4|||
131190754|NCT01927068|472319299|FG000|Overall Study|Death|37|||
131190755|NCT01927068|472319300|FG001|Overall Study|Death|3|||
131190756|NCT01927068|472319299|FG000|Overall Study|Withdrawal by Subject|50|||
131190757|NCT01927068|472319300|FG001|Overall Study|Withdrawal by Subject|3|||
131190758|NCT01927068|472319299|FG000|Overall Study|Lost to Follow-up|10|||
131190759|NCT01927068|472319300|FG001|Overall Study|Lost to Follow-up|2|||
131190760|NCT01927068|472319299|FG000|Overall Study|Physician Decision|9|||
131190761|NCT01927068|472319300|FG001|Overall Study|Physician Decision|0|||
131190762|NCT01927068|472319299|FG000|Overall Study|Missed last follow-up visit|2|||
131190763|NCT01927068|472319300|FG001|Overall Study|Missed last follow-up visit|0|||
131190764|NCT00880607|472319301|FG000|Overall Study|Physician Decision|2|||
131190765|NCT00880607|472319302|FG001|Overall Study|Physician Decision|2|||
131190766|NCT00880607|472319301|FG000|Overall Study|Protocol Violation|2|||
131190767|NCT00880607|472319302|FG001|Overall Study|Protocol Violation|1|||
131190768|NCT00880607|472319301|FG000|Overall Study|surgery did not extend past L1 level|3|||
131190769|NCT00880607|472319302|FG001|Overall Study|surgery did not extend past L1 level|0|||
131190770|NCT02963766|472319304|FG000|Double-Blind Period|Adverse Event|1|||
131190771|NCT02963766|472319305|FG001|Double-Blind Period|Adverse Event|0|||
131190772|NCT02963766|472319306|FG002|Double-Blind Period|Adverse Event|1|||
131190773|NCT02963766|472319304|FG000|Double-Blind Period|Physician Decision|1|||
131190774|NCT02963766|472319305|FG001|Double-Blind Period|Physician Decision|0|||
131190775|NCT02963766|472319306|FG002|Double-Blind Period|Physician Decision|0|||
131190776|NCT02963766|472319304|FG000|Double-Blind Period|Withdrawal by Subject|1|||
131190777|NCT02963766|472319305|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131190778|NCT02963766|472319306|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131190779|NCT02963766|472319304|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
131190780|NCT02963766|472319305|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
131190781|NCT02963766|472319306|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
131190782|NCT02963766|472319304|FG000|Double-Blind Period|Protocol Violation|1|||
131190783|NCT02963766|472319305|FG001|Double-Blind Period|Protocol Violation|0|||
131190784|NCT02963766|472319306|FG002|Double-Blind Period|Protocol Violation|0|||
131190785|NCT02963766|472319304|FG000|Double-Blind Period|Lost to Follow-up|0|||
131190786|NCT02963766|472319305|FG001|Double-Blind Period|Lost to Follow-up|1|||
131190787|NCT02963766|472319306|FG002|Double-Blind Period|Lost to Follow-up|0|||
131190788|NCT02963766|472319304|FG000|Open Label Extension (OLE)|Physician Decision|1|||
131190789|NCT02963766|472319305|FG001|Open Label Extension (OLE)|Physician Decision|2|||
131190790|NCT02963766|472319306|FG002|Open Label Extension (OLE)|Physician Decision|2|||
131190791|NCT02963766|472319304|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
131190792|NCT02963766|472319305|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
131190793|NCT02963766|472319306|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
131190794|NCT00634751|472320853|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
131190795|NCT00634751|472320854|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
131190796|NCT00634751|472320855|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
131190797|NCT00634751|472320856|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
131190798|NCT00634751|472320853|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
131190799|NCT00634751|472320854|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
131190800|NCT00634751|472320855|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
131190801|NCT00634751|472320856|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
131190802|NCT00634751|472320853|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
131190803|NCT00634751|472320854|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
131190804|NCT00634751|472320855|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
131190805|NCT00634751|472320856|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
131190806|NCT04402385|472320859|FG000|Overall Study|Withdrawal by Subject|4|||
131190807|NCT04402385|472320860|FG001|Overall Study|Withdrawal by Subject|4|||
131190808|NCT04402385|472320859|FG000|Overall Study|Lost to Follow-up|1|||
131190809|NCT04402385|472320860|FG001|Overall Study|Lost to Follow-up|1|||
131190810|NCT04402385|472320859|FG000|Overall Study|Physician Decision|0|||
131190811|NCT04402385|472320860|FG001|Overall Study|Physician Decision|1|||
131190812|NCT00088595|472320861|FG000|Overall Study|Adverse Event|11|||
131190813|NCT00088595|472320861|FG000|Overall Study|Withdrawal by Subject|8|||
131190814|NCT00088595|472320861|FG000|Overall Study|Ongoing (After Core)|7|||
131190815|NCT00088595|472320861|FG000|Overall Study|New Cancer Therapy|2|||
131190816|NCT01308853|472320867|FG000|Overall Study|Adverse Event|1|||
131190817|NCT01308853|472320867|FG000|Overall Study|Lost to Follow-up|2|||
131190818|NCT01308853|472320867|FG000|Overall Study|Insertion of permanent implants|1|||
131190819|NCT03938636|472320868|FG000|Overall Study|Protocol Violation|0|||
131190820|NCT03938636|472320869|FG001|Overall Study|Protocol Violation|1|||
131190821|NCT03938636|472320870|FG002|Overall Study|Protocol Violation|1|||
131190822|NCT03938636|472320868|FG000|Overall Study|Subject withdrew due to death in family|0|||
131190823|NCT03938636|472320869|FG001|Overall Study|Subject withdrew due to death in family|1|||
131190824|NCT03938636|472320870|FG002|Overall Study|Subject withdrew due to death in family|0|||
131190825|NCT03938636|472320868|FG000|Overall Study|Missed visit|0|||
131190826|NCT03938636|472320869|FG001|Overall Study|Missed visit|1|||
131190827|NCT03938636|472320870|FG002|Overall Study|Missed visit|0|||
131190828|NCT03938636|472320868|FG000|Overall Study|Adverse Event|0|||
131190829|NCT03938636|472320869|FG001|Overall Study|Adverse Event|0|||
130784551|NCT03885908|470838818|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
130784552|NCT03885908|470838817|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
130784553|NCT03885908|470838818|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
130784554|NCT02204917|470838819|FG000|Overall Study|Protocol Violation|1|||
131190830|NCT03938636|472320870|FG002|Overall Study|Adverse Event|1|||
131190831|NCT03938636|472320868|FG000|Overall Study|Lost to Follow-up|0|||
131190832|NCT03938636|472320869|FG001|Overall Study|Lost to Follow-up|0|||
131190833|NCT03938636|472320870|FG002|Overall Study|Lost to Follow-up|1|||
131190834|NCT01100658|472320871|FG000|Overall Study|Withdrawal by Subject|1|||
131190835|NCT00711412|472320872|FG000|Induction Treatment|Death|2|||
131190836|NCT00711412|472320872|FG000|Induction Treatment|Adverse Event|1|||
131190837|NCT00711412|472320872|FG000|Induction Treatment|Other|1|||
131190838|NCT00711412|472320872|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
131190839|NCT00711412|472320872|FG000|Evaluated for Combination Treatment|Death|1|||
131190840|NCT00711412|472320872|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
131190841|NCT00711412|472320872|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
131190842|NCT00711412|472320872|FG000|Combination Treatment|Progressive Disease|1|||
131190843|NCT00711412|472320872|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
131190844|NCT00711412|472320872|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
131190845|NCT00711412|472320872|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
131190846|NCT00711412|472320872|FG000|Evaluation for Response and Surgery|Death|1|||
131190847|NCT00711412|472320872|FG000|Survival Follow up Until Death|Other|12|||
131190848|NCT00420342|472320876|FG000|Overall Study|Lost to Follow-up|1|||
131190849|NCT00420342|472320877|FG001|Overall Study|Lost to Follow-up|0|||
131190850|NCT00420342|472320878|FG002|Overall Study|Lost to Follow-up|1|||
131190851|NCT00420342|472320876|FG000|Overall Study|Withdrawal by Subject|0|||
131190852|NCT00420342|472320877|FG001|Overall Study|Withdrawal by Subject|2|||
131190853|NCT00420342|472320878|FG002|Overall Study|Withdrawal by Subject|0|||
131190854|NCT04072575|472320879|FG000|Overall Study|Physician Decision|1|||
131190855|NCT04072575|472320879|FG000|Overall Study|Adverse Event|7|||
131190856|NCT04072575|472320879|FG000|Overall Study|Withdrawal by Subject|14|||
131190857|NCT04072575|472320879|FG000|Overall Study|Other|2|||
131190858|NCT02473289|472320880|FG000|Overall Study|Adverse Event|2|||
131190859|NCT02473289|472320881|FG001|Overall Study|Adverse Event|3|||
131190860|NCT02473289|472320880|FG000|Overall Study|Lost to Follow-up|1|||
131190861|NCT02473289|472320881|FG001|Overall Study|Lost to Follow-up|1|||
131190862|NCT02473289|472320880|FG000|Overall Study|Protocol Violation|0|||
131190863|NCT02473289|472320881|FG001|Overall Study|Protocol Violation|1|||
131190864|NCT02473289|472320880|FG000|Overall Study|Withdrawal of consent|6|||
131190865|NCT02473289|472320881|FG001|Overall Study|Withdrawal of consent|7|||
131190866|NCT02473289|472320880|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
131190867|NCT02473289|472320881|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
131190868|NCT02473289|472320880|FG000|Overall Study|Other|2|||
131190869|NCT02473289|472320881|FG001|Overall Study|Other|0|||
131190870|NCT02244619|472320882|FG000|Overall Study|Did not receive study intervention|8|||
131190871|NCT02244619|472320883|FG001|Overall Study|Did not receive study intervention|21|||
131190872|NCT03285490|472320885|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
131190873|NCT03285490|472320886|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
131190874|NCT03285490|472320885|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
131190875|NCT03285490|472320886|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
131190876|NCT03745989|472320887|FG000|Overall Study|Death|3|||
131190877|NCT03745989|472320888|FG001|Overall Study|Death|7|||
131190878|NCT03745989|472320889|FG002|Overall Study|Death|4|||
131190879|NCT03745989|472320887|FG000|Overall Study|Lost to Follow-up|0|||
131190880|NCT03745989|472320888|FG001|Overall Study|Lost to Follow-up|2|||
131190881|NCT03745989|472320889|FG002|Overall Study|Lost to Follow-up|0|||
131190882|NCT03745989|472320887|FG000|Overall Study|Sponsor Decision|0|||
131190883|NCT03745989|472320888|FG001|Overall Study|Sponsor Decision|2|||
131190884|NCT03745989|472320889|FG002|Overall Study|Sponsor Decision|8|||
131190885|NCT03745989|472320887|FG000|Overall Study|Withdrawal by Subject|0|||
131190886|NCT03745989|472320888|FG001|Overall Study|Withdrawal by Subject|1|||
131190887|NCT03745989|472320889|FG002|Overall Study|Withdrawal by Subject|3|||
131190888|NCT01291511|472320893|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
131190889|NCT01291511|472320894|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
131190890|NCT01291511|472320893|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
131190891|NCT01291511|472320894|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
131190892|NCT01291511|472320893|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
131190893|NCT01291511|472320894|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
131190894|NCT01291511|472320893|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
131190895|NCT01291511|472320894|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
131190896|NCT01291511|472320893|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
131190897|NCT01291511|472320894|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
131190898|NCT01291511|472320893|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
130733582|NCT01169337|470642914|FG000|Overall Study|Changed hospital|0|||
130733583|NCT01169337|470642915|FG001|Overall Study|Changed hospital|1|||
130733584|NCT01169337|470642916|FG002|Overall Study|Changed hospital|0|||
130733585|NCT01169337|470642914|FG000|Overall Study|Never started treatment|0|||
130733586|NCT01169337|470642915|FG001|Overall Study|Never started treatment|2|||
130733587|NCT01169337|470642916|FG002|Overall Study|Never started treatment|0|||
130733588|NCT01169337|470642914|FG000|Overall Study|Reason not reported|1|||
131190899|NCT01291511|472320894|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
131190900|NCT01291511|472320893|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
131190901|NCT01291511|472320894|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
131190902|NCT01291511|472320893|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
131190903|NCT01291511|472320894|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
131190904|NCT01291511|472320893|FG000|Cross-Titration and Stabilization Phase|Death|1|||
131190905|NCT01291511|472320894|FG001|Cross-Titration and Stabilization Phase|Death|0|||
131190906|NCT01291511|472320893|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
131190907|NCT01291511|472320894|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
131190908|NCT01291511|472320893|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
131190909|NCT01291511|472320894|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
131190910|NCT01291511|472320893|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
131190911|NCT01291511|472320894|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
131190912|NCT01291511|472320893|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
131190913|NCT01291511|472320894|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
131190914|NCT01291511|472320893|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
130733589|NCT01169337|470642915|FG001|Overall Study|Reason not reported|0|||
131190915|NCT01291511|472320894|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
131190916|NCT01291511|472320893|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
131190917|NCT01291511|472320894|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
131190918|NCT01291511|472320893|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
131190919|NCT01291511|472320894|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
131190920|NCT01291511|472320893|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
131190921|NCT01291511|472320894|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
131190922|NCT01291511|472320893|FG000|Double-blind Relapse Prevention Phase|Death|1|||
131190923|NCT01291511|472320894|FG001|Double-blind Relapse Prevention Phase|Death|0|||
131190924|NCT00429572|472320896|FG000|Overall Study|Disease progression|1|||
131190925|NCT01047436|472320899|FG000|Overall Study|Protocol Violation|1|||
131190926|NCT01047436|472320900|FG001|Overall Study|Protocol Violation|0|||
131190927|NCT02565576|472320901|FG000|Overall Study|abnormal lab value|2|||
131190928|NCT02565576|472320902|FG001|Overall Study|abnormal lab value|0|||
131190929|NCT02565576|472320901|FG000|Overall Study|subject / guardian decision|1|||
131190930|NCT02565576|472320902|FG001|Overall Study|subject / guardian decision|3|||
131190931|NCT02565576|472320901|FG000|Overall Study|Lost to Follow-up|1|||
131190932|NCT02565576|472320902|FG001|Overall Study|Lost to Follow-up|0|||
131190933|NCT02565576|472320901|FG000|Overall Study|Death|0|||
131190934|NCT02565576|472320902|FG001|Overall Study|Death|2|||
131190935|NCT02565576|472320901|FG000|Overall Study|Adverse Event|1|||
131190936|NCT02565576|472320902|FG001|Overall Study|Adverse Event|0|||
131190937|NCT00939341|472320903|FG000|Overall Study|Adverse Event|15|||
131190938|NCT00939341|472320903|FG000|Overall Study|Pregnancy|1|||
131190939|NCT00939341|472320903|FG000|Overall Study|Lost to Follow-up|23|||
131190940|NCT00939341|472320903|FG000|Overall Study|Withdrawal by Subject|13|||
131190941|NCT00939341|472320903|FG000|Overall Study|Protocol Violation|6|||
131190942|NCT00939341|472320903|FG000|Overall Study|Incorrect enrolment|8|||
131190943|NCT02918318|472320904|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
131190944|NCT02918318|472320905|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
131190945|NCT02918318|472320906|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
131190946|NCT02918318|472320907|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
131190947|NCT02918318|472320908|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
131190948|NCT02918318|472320904|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
131190949|NCT02918318|472320905|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
131190950|NCT02918318|472320906|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
131190951|NCT02918318|472320907|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
131190952|NCT02918318|472320908|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
131190953|NCT02918318|472320904|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
131190954|NCT02918318|472320905|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
131190955|NCT02918318|472320906|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
131190956|NCT02918318|472320907|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
131190957|NCT02918318|472320908|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
131190958|NCT02918318|472320904|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
131190959|NCT02918318|472320905|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
131190960|NCT02918318|472320906|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
131190961|NCT02918318|472320907|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
131190962|NCT02918318|472320908|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
131190963|NCT02918318|472320904|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
131190964|NCT02918318|472320905|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
131190965|NCT02918318|472320906|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
131190966|NCT02918318|472320907|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
131190967|NCT02918318|472320908|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
131190968|NCT02918318|472320904|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
131190969|NCT02918318|472320905|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
131190970|NCT02918318|472320906|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
131190971|NCT02918318|472320907|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
131190972|NCT02918318|472320908|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
131190973|NCT02918318|472320904|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
131190974|NCT02918318|472320905|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
131190975|NCT02918318|472320906|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
131190976|NCT02918318|472320907|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
131190977|NCT02918318|472320908|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
131190978|NCT02918318|472320904|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
131190979|NCT02918318|472320905|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
131190980|NCT02918318|472320906|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
131190981|NCT02918318|472320907|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
131190982|NCT02918318|472320908|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
131190983|NCT02918318|472320904|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
131190984|NCT02918318|472320905|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
131190985|NCT02918318|472320906|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
131190986|NCT02918318|472320907|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
131190987|NCT02918318|472320908|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
131190988|NCT02918318|472320904|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
131190989|NCT02918318|472320905|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
131190990|NCT02918318|472320906|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
131190991|NCT02918318|472320907|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
131190992|NCT02918318|472320908|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
131190993|NCT02918318|472320904|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
131190994|NCT02918318|472320905|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
131190995|NCT02918318|472320906|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
131190996|NCT02918318|472320907|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
131190997|NCT02918318|472320908|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
131190998|NCT02918318|472320904|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
131190999|NCT02918318|472320905|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
131191000|NCT02918318|472320906|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
131191001|NCT02918318|472320907|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
131191002|NCT02918318|472320908|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
131191003|NCT03981744|472320909|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
131191004|NCT03981744|472320910|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
131191005|NCT03981744|472320911|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
131191006|NCT03981744|472320912|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
131191007|NCT03981744|472320909|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
131191008|NCT03981744|472320910|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
131191009|NCT03981744|472320911|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
131191010|NCT03981744|472320912|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
131191011|NCT03981744|472320909|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
131191012|NCT03981744|472320910|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
131191013|NCT03981744|472320911|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
131191014|NCT03981744|472320912|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
131191015|NCT02782104|472320913|FG000|Overall Study|Other|215|||
131191016|NCT02782104|472320913|FG000|Overall Study|Induction Day 28 Non Responder|9|||
131191017|NCT02782104|472320913|FG000|Overall Study|Non-Compliance with Study Drug|2|||
131191018|NCT02782104|472320913|FG000|Overall Study|Death|8|||
131191019|NCT02782104|472320913|FG000|Overall Study|Pregnancy|6|||
131191020|NCT02782104|472320913|FG000|Overall Study|Withdrawal by Subject|63|||
131191021|NCT02782104|472320913|FG000|Overall Study|Protocol Violation|7|||
131191022|NCT02782104|472320913|FG000|Overall Study|Lack of Efficacy|61|||
131191023|NCT02782104|472320913|FG000|Overall Study|Lost to Follow-up|23|||
131191024|NCT02782104|472320913|FG000|Overall Study|Adverse Event|74|||
131191025|NCT03185819|472320914|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
131191026|NCT03185819|472320915|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
131191027|NCT03185819|472320916|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
131191028|NCT03185819|472320917|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
131191029|NCT03185819|472320914|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
131191030|NCT03185819|472320915|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
131191031|NCT03185819|472320916|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
131191032|NCT03185819|472320917|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
131191033|NCT03185819|472320914|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
131191034|NCT03185819|472320915|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
131191035|NCT03185819|472320916|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
131191036|NCT03185819|472320917|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
131191037|NCT03185819|472320914|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
131191038|NCT03185819|472320915|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
131191039|NCT03185819|472320916|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
131191040|NCT03185819|472320917|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
131191041|NCT03185819|472320914|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
131191042|NCT03185819|472320915|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
131191043|NCT03185819|472320916|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
131191044|NCT03185819|472320917|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
131191045|NCT03185819|472320914|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
131191046|NCT03185819|472320915|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
131191047|NCT03185819|472320916|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
131191048|NCT03185819|472320917|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
131191049|NCT03185819|472320914|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
130733590|NCT01169337|470642916|FG002|Overall Study|Reason not reported|0|||
131191050|NCT03185819|472320915|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
131191051|NCT03185819|472320916|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
131191052|NCT03185819|472320917|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
131191053|NCT03185819|472320914|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
131191054|NCT03185819|472320915|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
131191055|NCT03185819|472320916|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
131191056|NCT03185819|472320917|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
131191057|NCT03185819|472320914|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
131191058|NCT03185819|472320915|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
131191059|NCT03185819|472320916|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
131191060|NCT03185819|472320917|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
131191061|NCT03185819|472320914|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
131191062|NCT03185819|472320915|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
131191063|NCT03185819|472320916|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
131191064|NCT03185819|472320917|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
131191065|NCT03185819|472320914|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
131191066|NCT03185819|472320915|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
131191067|NCT03185819|472320916|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
131191068|NCT03185819|472320917|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
131191069|NCT03185819|472320914|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
131191070|NCT03185819|472320915|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
131191071|NCT03185819|472320916|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
131191072|NCT03185819|472320917|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
131191073|NCT03185819|472320914|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
131191074|NCT03185819|472320915|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
131191075|NCT03185819|472320916|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
131191076|NCT03185819|472320917|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
131191077|NCT02438787|472320918|FG000|Overall Study|Adverse Event|1|||
131191078|NCT02438787|472320919|FG001|Overall Study|Adverse Event|0|||
131191079|NCT02438787|472320920|FG002|Overall Study|Adverse Event|2|||
131191080|NCT02438787|472320918|FG000|Overall Study|Lack of Efficacy|1|||
131191081|NCT02438787|472320919|FG001|Overall Study|Lack of Efficacy|2|||
131191082|NCT02438787|472320920|FG002|Overall Study|Lack of Efficacy|0|||
131191083|NCT02438787|472320918|FG000|Overall Study|Lost to Follow-up|0|||
131191084|NCT02438787|472320919|FG001|Overall Study|Lost to Follow-up|1|||
131191085|NCT02438787|472320920|FG002|Overall Study|Lost to Follow-up|0|||
131191086|NCT02438787|472320918|FG000|Overall Study|Protocol Violation|0|||
131191087|NCT02438787|472320919|FG001|Overall Study|Protocol Violation|0|||
131191088|NCT02438787|472320920|FG002|Overall Study|Protocol Violation|1|||
131191089|NCT02438787|472320918|FG000|Overall Study|Withdrawal by Subject|15|||
131191090|NCT02438787|472320919|FG001|Overall Study|Withdrawal by Subject|7|||
131191091|NCT02438787|472320920|FG002|Overall Study|Withdrawal by Subject|10|||
131191092|NCT02438787|472320918|FG000|Overall Study|Study discontinued by sponsor|64|||
131191093|NCT02438787|472320919|FG001|Overall Study|Study discontinued by sponsor|72|||
131191094|NCT02438787|472320920|FG002|Overall Study|Study discontinued by sponsor|69|||
131191095|NCT02438787|472320918|FG000|Overall Study|Other|0|||
131191096|NCT02438787|472320919|FG001|Overall Study|Other|1|||
131191097|NCT02438787|472320920|FG002|Overall Study|Other|0|||
131191098|NCT02438787|472320918|FG000|Overall Study|Site terminated by sponsor|0|||
131191099|NCT02438787|472320919|FG001|Overall Study|Site terminated by sponsor|0|||
131191100|NCT02438787|472320920|FG002|Overall Study|Site terminated by sponsor|1|||
131191101|NCT00732641|472320921|FG000|Overall Study|Relapse or Progressive Disease|65|||
131191102|NCT00732641|472320922|FG001|Overall Study|Relapse or Progressive Disease|101|||
131191103|NCT00732641|472320921|FG000|Overall Study|Serious Adverse Events|12|||
131191104|NCT00732641|472320922|FG001|Overall Study|Serious Adverse Events|3|||
131191105|NCT00732641|472320921|FG000|Overall Study|Physician Decision|6|||
131191106|NCT00732641|472320922|FG001|Overall Study|Physician Decision|0|||
131191107|NCT00732641|472320921|FG000|Overall Study|Withdrawal by Subject|4|||
131191108|NCT00732641|472320922|FG001|Overall Study|Withdrawal by Subject|2|||
131191109|NCT00732641|472320921|FG000|Overall Study|Unable to Complete|1|||
131191110|NCT00732641|472320922|FG001|Overall Study|Unable to Complete|1|||
131191111|NCT00732641|472320921|FG000|Overall Study|Other|18|||
131191112|NCT00732641|472320922|FG001|Overall Study|Other|5|||
131191113|NCT02910089|472320923|FG000|Overall Study|Lost insurance eligibility|22|||
131191114|NCT02910089|472320924|FG001|Overall Study|Lost insurance eligibility|16|||
131191115|NCT00732238|472320925|FG000|Overall Study|Bacteremia|4|||
131191116|NCT00732238|472320926|FG001|Overall Study|Bacteremia|1|||
131191117|NCT00732238|472320925|FG000|Overall Study|Asymptomatic bacteriuria|1|||
131191118|NCT00732238|472320926|FG001|Overall Study|Asymptomatic bacteriuria|0|||
131191119|NCT02939976|472320929|FG000|Overall Study|Lost to Follow-up|7|||
131191120|NCT02939976|472320930|FG001|Overall Study|Lost to Follow-up|1|||
131191121|NCT02939976|472320931|FG002|Overall Study|Lost to Follow-up|1|||
131191122|NCT02939976|472320932|FG003|Overall Study|Lost to Follow-up|2|||
131191123|NCT02939976|472320929|FG000|Overall Study|Withdrawal by Subject|4|||
131191124|NCT02939976|472320930|FG001|Overall Study|Withdrawal by Subject|0|||
131191125|NCT02939976|472320931|FG002|Overall Study|Withdrawal by Subject|2|||
131191126|NCT02939976|472320932|FG003|Overall Study|Withdrawal by Subject|4|||
131191127|NCT02939976|472320929|FG000|Overall Study|Due to early study closure|4|||
131191128|NCT02939976|472320930|FG001|Overall Study|Due to early study closure|3|||
131191129|NCT02939976|472320931|FG002|Overall Study|Due to early study closure|2|||
131191130|NCT02939976|472320932|FG003|Overall Study|Due to early study closure|3|||
131191131|NCT01872897|472320933|FG000|Overall Study|Withdrawal by Subject|1|||
131191132|NCT01872897|472320934|FG001|Overall Study|Withdrawal by Subject|0|||
131191133|NCT04159701|472320937|FG000|Period 1: Treatment Period|Pregnancy|1|||
131191134|NCT04159701|472320938|FG001|Period 1: Treatment Period|Pregnancy|0|||
131191135|NCT04159701|472320937|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
131191136|NCT04159701|472320938|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
131191137|NCT04159701|472320937|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
131191138|NCT04159701|472320938|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
131191139|NCT04159701|472320937|FG000|Washout Period|site terminated by sponsor|0|||
131191140|NCT04159701|472320938|FG001|Washout Period|site terminated by sponsor|1|||
131191141|NCT04159701|472320937|FG000|Washout Period|study terminated by sponsor|10|||
131191142|NCT04159701|472320938|FG001|Washout Period|study terminated by sponsor|3|||
131191143|NCT04159701|472320937|FG000|Washout Period|Withdrawal by Subject|1|||
131191144|NCT04159701|472320938|FG001|Washout Period|Withdrawal by Subject|0|||
131191145|NCT04159701|472320937|FG000|Washout Period|Inadvertent Enrollment|1|||
131191146|NCT04159701|472320938|FG001|Washout Period|Inadvertent Enrollment|0|||
131191147|NCT04159701|472320937|FG000|Washout Period|Miscellaneous|1|||
130733591|NCT01169337|470642914|FG000|Overall Study|Continuing lenalidomide|9|||
131191148|NCT04159701|472320938|FG001|Washout Period|Miscellaneous|0|||
131191149|NCT04159701|472320937|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
131191150|NCT04159701|472320938|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
131191151|NCT04159701|472320937|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
131191152|NCT04159701|472320938|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
131191153|NCT04159701|472320937|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
131191154|NCT04159701|472320938|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
131191155|NCT04159701|472320937|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
131191156|NCT04159701|472320938|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
131191157|NCT04159701|472320937|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
131191158|NCT04159701|472320938|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
131191159|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
131191160|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
131191161|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
131191162|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
131191163|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
131191164|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
131191165|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
131191166|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
131191167|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
131191168|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
131191169|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
131191170|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
131191171|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
131191172|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
131191173|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
131191174|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
131191175|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
131191176|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
131191177|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
131191178|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
131191179|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
131191180|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
131191181|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
131191182|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
131191183|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
131191184|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
131191185|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
131191186|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
131191187|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
131191188|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
131191189|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
131191190|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
131191191|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
131191192|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
131191193|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
131191194|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
131191195|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
131191196|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
131191197|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
131191198|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
131191199|NCT03605836|472320939|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
131191200|NCT03605836|472320940|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
131191201|NCT03605836|472320941|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
131191202|NCT03605836|472320942|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
131191203|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
131191204|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
131191205|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
131191206|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
131191207|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
131191208|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
131191209|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
131191210|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
131191211|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
131191212|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
130733592|NCT01169337|470642915|FG001|Overall Study|Continuing lenalidomide|43|||
131191213|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
131191214|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
131191215|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
131191216|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
131191217|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
131191218|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
131191219|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
131191220|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
131191221|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
131191222|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
131191223|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
131191224|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
131191225|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
131191226|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
131191227|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
131191228|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
131191229|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
131191230|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
131191231|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
131191232|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
131191233|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
131191234|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
131191235|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
131191236|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
131191237|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
131191238|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
131191239|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
130784555|NCT03669549|470838820|FG000|Overall Study|Adverse Event|4|||
130733593|NCT01169337|470642916|FG002|Overall Study|Continuing lenalidomide|0|||
131191240|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
131191241|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
131191242|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
131191243|NCT03605836|472320939|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
131191244|NCT03605836|472320940|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
131191245|NCT03605836|472320941|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
131191246|NCT03605836|472320942|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
131191247|NCT02057068|472320948|FG000|Overall Study|Withdrawal by Subject|2|||
131191248|NCT02057068|472320949|FG001|Overall Study|Withdrawal by Subject|2|||
131191249|NCT02057068|472320948|FG000|Overall Study|Caregiver (CG) Health|0|||
131191250|NCT02057068|472320949|FG001|Overall Study|Caregiver (CG) Health|2|||
131191251|NCT02057068|472320948|FG000|Overall Study|Carepartner (CP) Health|4|||
131191252|NCT02057068|472320949|FG001|Overall Study|Carepartner (CP) Health|2|||
131191253|NCT02057068|472320948|FG000|Overall Study|Lost to Follow-up|2|||
131191254|NCT02057068|472320949|FG001|Overall Study|Lost to Follow-up|2|||
131191255|NCT00865046|472320950|FG000|Overall Study|Lost to Follow-up|1|||
131191256|NCT00865046|472320951|FG001|Overall Study|Lost to Follow-up|4|||
131191257|NCT00865046|472320952|FG002|Overall Study|Lost to Follow-up|0|||
131191258|NCT00865046|472320950|FG000|Overall Study|Death|0|||
131191259|NCT00865046|472320951|FG001|Overall Study|Death|1|||
131191260|NCT00865046|472320952|FG002|Overall Study|Death|1|||
131191261|NCT00865046|472320950|FG000|Overall Study|Withdrawal by Subject|5|||
131191262|NCT00865046|472320951|FG001|Overall Study|Withdrawal by Subject|0|||
131191263|NCT00865046|472320952|FG002|Overall Study|Withdrawal by Subject|0|||
131191264|NCT03447821|472320953|FG000|Overall Study|Withdrawal by Subject|1|||
131191265|NCT03447821|472320954|FG001|Overall Study|Withdrawal by Subject|1|||
131191266|NCT03447821|472320955|FG002|Overall Study|Withdrawal by Subject|0|||
131191267|NCT03447821|472320953|FG000|Overall Study|Lost to Follow-up|0|||
131191268|NCT03447821|472320954|FG001|Overall Study|Lost to Follow-up|0|||
131191269|NCT03447821|472320955|FG002|Overall Study|Lost to Follow-up|1|||
131191270|NCT00481988|472320959|FG000|Overall Study|Withdrawal by Subject|1|||
131191271|NCT00481988|472320960|FG001|Overall Study|Withdrawal by Subject|1|||
131191272|NCT00654420|472320961|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
131191273|NCT00654420|472320962|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
131191274|NCT00654420|472320963|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
131191275|NCT00654420|472320964|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
131191276|NCT00654420|472320961|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
131191277|NCT00654420|472320962|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
131191278|NCT00654420|472320963|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
131191279|NCT00654420|472320964|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
131191280|NCT00654420|472320961|FG000|Phase II|Adverse Event|0|||
131191281|NCT00654420|472320962|FG001|Phase II|Adverse Event|0|||
131191282|NCT00654420|472320963|FG002|Phase II|Adverse Event|3|||
131191283|NCT00654420|472320964|FG003|Phase II|Adverse Event|3|||
131191284|NCT00654420|472320961|FG000|Phase II|Lost to Follow-up|0|||
131191285|NCT00654420|472320962|FG001|Phase II|Lost to Follow-up|0|||
131191286|NCT00654420|472320963|FG002|Phase II|Lost to Follow-up|0|||
131191287|NCT00654420|472320964|FG003|Phase II|Lost to Follow-up|1|||
131191288|NCT00654420|472320961|FG000|Phase II|Physician Decision|0|||
131191289|NCT00654420|472320962|FG001|Phase II|Physician Decision|0|||
131191290|NCT00654420|472320963|FG002|Phase II|Physician Decision|0|||
131191291|NCT00654420|472320964|FG003|Phase II|Physician Decision|4|||
131191292|NCT00654420|472320961|FG000|Phase II|Progressive Disease|0|||
131191293|NCT00654420|472320962|FG001|Phase II|Progressive Disease|0|||
131191294|NCT00654420|472320963|FG002|Phase II|Progressive Disease|29|||
131191295|NCT00654420|472320964|FG003|Phase II|Progressive Disease|29|||
131191296|NCT00654420|472320961|FG000|Phase II|Withdrawal by Subject|0|||
131191297|NCT00654420|472320962|FG001|Phase II|Withdrawal by Subject|0|||
131191298|NCT00654420|472320963|FG002|Phase II|Withdrawal by Subject|4|||
131191299|NCT00654420|472320964|FG003|Phase II|Withdrawal by Subject|1|||
131191300|NCT00654420|472320961|FG000|Phase II|Missing Disposition Record|0|||
131191301|NCT00654420|472320962|FG001|Phase II|Missing Disposition Record|0|||
131191302|NCT00654420|472320963|FG002|Phase II|Missing Disposition Record|1|||
131191303|NCT00654420|472320964|FG003|Phase II|Missing Disposition Record|0|||
131191304|NCT00610207|472320967|FG000|Overall Study|Lost to Follow-up|3|||
131191305|NCT02465489|472320970|FG000|Overall Study|Adverse Event|5|||
131191306|NCT00045630|472320973|FG000|Overall Study|Adverse Event|1|||
131191307|NCT00045630|472320973|FG000|Overall Study|Refusal unrelated to adverse event|1|||
131191308|NCT00045630|472320973|FG000|Overall Study|Progression/relapse|1|||
131191309|NCT00045630|472320973|FG000|Overall Study|Death|1|||
131191310|NCT00045630|472320973|FG000|Overall Study|Ineligible|2|||
131191311|NCT00701103|472320974|FG000|Overall Study|Adverse Event|0|||
131191312|NCT00701103|472320975|FG001|Overall Study|Adverse Event|0|||
131191313|NCT00701103|472320976|FG002|Overall Study|Adverse Event|1|||
131191314|NCT00701103|472320977|FG003|Overall Study|Adverse Event|1|||
131191315|NCT00701103|472320978|FG004|Overall Study|Adverse Event|0|||
131191316|NCT00701103|472320979|FG005|Overall Study|Adverse Event|1|||
131191317|NCT00701103|472320980|FG006|Overall Study|Adverse Event|1|||
131191318|NCT00701103|472320981|FG007|Overall Study|Adverse Event|0|||
131191319|NCT00701103|472320982|FG008|Overall Study|Adverse Event|0|||
131191320|NCT00701103|472320983|FG009|Overall Study|Adverse Event|2|||
131191321|NCT00701103|472320984|FG010|Overall Study|Adverse Event|0|||
131191322|NCT00701103|472320974|FG000|Overall Study|Progressive Disease|5|||
131191323|NCT00701103|472320975|FG001|Overall Study|Progressive Disease|2|||
131191324|NCT00701103|472320976|FG002|Overall Study|Progressive Disease|6|||
131191325|NCT00701103|472320977|FG003|Overall Study|Progressive Disease|5|||
131191326|NCT00701103|472320978|FG004|Overall Study|Progressive Disease|6|||
131191327|NCT00701103|472320979|FG005|Overall Study|Progressive Disease|5|||
131191328|NCT00701103|472320980|FG006|Overall Study|Progressive Disease|7|||
131191329|NCT00701103|472320981|FG007|Overall Study|Progressive Disease|7|||
131191330|NCT00701103|472320982|FG008|Overall Study|Progressive Disease|8|||
131191331|NCT00701103|472320983|FG009|Overall Study|Progressive Disease|8|||
131191332|NCT00701103|472320984|FG010|Overall Study|Progressive Disease|11|||
131191333|NCT00701103|472320974|FG000|Overall Study|Withdrawal by Subject|0|||
131191334|NCT00701103|472320975|FG001|Overall Study|Withdrawal by Subject|1|||
131191335|NCT00701103|472320976|FG002|Overall Study|Withdrawal by Subject|1|||
131191336|NCT00701103|472320977|FG003|Overall Study|Withdrawal by Subject|0|||
131191337|NCT00701103|472320978|FG004|Overall Study|Withdrawal by Subject|0|||
131191338|NCT00701103|472320979|FG005|Overall Study|Withdrawal by Subject|0|||
131191339|NCT00701103|472320980|FG006|Overall Study|Withdrawal by Subject|0|||
131191340|NCT00701103|472320981|FG007|Overall Study|Withdrawal by Subject|0|||
131191341|NCT00701103|472320982|FG008|Overall Study|Withdrawal by Subject|0|||
131191342|NCT00701103|472320983|FG009|Overall Study|Withdrawal by Subject|0|||
131191343|NCT00701103|472320984|FG010|Overall Study|Withdrawal by Subject|0|||
131191344|NCT00701103|472320974|FG000|Overall Study|Other|0|||
131191345|NCT00701103|472320975|FG001|Overall Study|Other|0|||
131191346|NCT00701103|472320976|FG002|Overall Study|Other|0|||
131191347|NCT00701103|472320977|FG003|Overall Study|Other|0|||
131191348|NCT00701103|472320978|FG004|Overall Study|Other|0|||
131191349|NCT00701103|472320979|FG005|Overall Study|Other|0|||
131191350|NCT00701103|472320980|FG006|Overall Study|Other|0|||
131191351|NCT00701103|472320981|FG007|Overall Study|Other|0|||
131191352|NCT00701103|472320982|FG008|Overall Study|Other|1|||
131191353|NCT00701103|472320983|FG009|Overall Study|Other|1|||
131191354|NCT00701103|472320984|FG010|Overall Study|Other|0|||
131191355|NCT01929707|472320985|FG000|Intervention Period 1|Lost to Follow-up|0|||
131191356|NCT01929707|472320986|FG001|Intervention Period 1|Lost to Follow-up|0|||
131191357|NCT01929707|472320987|FG002|Intervention Period 1|Lost to Follow-up|0|||
131191358|NCT01929707|472320988|FG003|Intervention Period 1|Lost to Follow-up|1|||
131191359|NCT01929707|472320989|FG004|Intervention Period 1|Lost to Follow-up|0|||
131191360|NCT01929707|472320990|FG005|Intervention Period 1|Lost to Follow-up|0|||
131191361|NCT01929707|472320991|FG006|Intervention Period 1|Lost to Follow-up|0|||
131191362|NCT01929707|472320992|FG007|Intervention Period 1|Lost to Follow-up|0|||
131191363|NCT01929707|472320985|FG000|Intervention Period 1|Withdrawal by Subject|0|||
131191364|NCT01929707|472320986|FG001|Intervention Period 1|Withdrawal by Subject|0|||
131191365|NCT01929707|472320987|FG002|Intervention Period 1|Withdrawal by Subject|0|||
131191366|NCT01929707|472320988|FG003|Intervention Period 1|Withdrawal by Subject|2|||
131191367|NCT01929707|472320989|FG004|Intervention Period 1|Withdrawal by Subject|0|||
131191368|NCT01929707|472320990|FG005|Intervention Period 1|Withdrawal by Subject|0|||
131191369|NCT01929707|472320991|FG006|Intervention Period 1|Withdrawal by Subject|0|||
131191370|NCT01929707|472320992|FG007|Intervention Period 1|Withdrawal by Subject|0|||
131191371|NCT01929707|472320985|FG000|Intervention Period 2|Withdrawal by Subject|0|||
131191372|NCT01929707|472320986|FG001|Intervention Period 2|Withdrawal by Subject|0|||
131191373|NCT01929707|472320987|FG002|Intervention Period 2|Withdrawal by Subject|0|||
131191374|NCT01929707|472320988|FG003|Intervention Period 2|Withdrawal by Subject|0|||
131191375|NCT01929707|472320989|FG004|Intervention Period 2|Withdrawal by Subject|0|||
131191376|NCT01929707|472320990|FG005|Intervention Period 2|Withdrawal by Subject|2|||
131191377|NCT01929707|472320991|FG006|Intervention Period 2|Withdrawal by Subject|0|||
131191378|NCT01929707|472320992|FG007|Intervention Period 2|Withdrawal by Subject|0|||
131191379|NCT00179517|472320993|FG000|Overall Study|Withdrawal by Subject|2|||
131191380|NCT00179517|472320994|FG001|Overall Study|Withdrawal by Subject|1|||
131191381|NCT00437203|472320995|FG000|Overall Study|Death|0|||
131191382|NCT00437203|472320996|FG001|Overall Study|Death|0|||
131191383|NCT00437203|472320997|FG002|Overall Study|Death|1|||
131191384|NCT00437203|472320998|FG003|Overall Study|Death|0|||
131191385|NCT00437203|472320999|FG004|Overall Study|Death|0|||
131191386|NCT00437203|472321000|FG005|Overall Study|Death|0|||
131191387|NCT00437203|472321001|FG006|Overall Study|Death|0|||
131191388|NCT00437203|472321002|FG007|Overall Study|Death|1|||
131191389|NCT00437203|472321003|FG008|Overall Study|Death|0|||
131191390|NCT00437203|472321004|FG009|Overall Study|Death|1|||
131191391|NCT00437203|472320995|FG000|Overall Study|Adverse Event|1|||
131191392|NCT00437203|472320996|FG001|Overall Study|Adverse Event|1|||
131191393|NCT00437203|472320997|FG002|Overall Study|Adverse Event|0|||
131191394|NCT00437203|472320998|FG003|Overall Study|Adverse Event|0|||
131191395|NCT00437203|472320999|FG004|Overall Study|Adverse Event|0|||
131191396|NCT00437203|472321000|FG005|Overall Study|Adverse Event|0|||
131191397|NCT00437203|472321001|FG006|Overall Study|Adverse Event|0|||
131191398|NCT00437203|472321002|FG007|Overall Study|Adverse Event|1|||
131191399|NCT00437203|472321003|FG008|Overall Study|Adverse Event|0|||
131191400|NCT00437203|472321004|FG009|Overall Study|Adverse Event|1|||
131191401|NCT00437203|472320995|FG000|Overall Study|Study terminated by sponsor|0|||
131191402|NCT00437203|472320996|FG001|Overall Study|Study terminated by sponsor|0|||
131191403|NCT00437203|472320997|FG002|Overall Study|Study terminated by sponsor|0|||
131191404|NCT00437203|472320998|FG003|Overall Study|Study terminated by sponsor|0|||
131191405|NCT00437203|472320999|FG004|Overall Study|Study terminated by sponsor|0|||
131191406|NCT00437203|472321000|FG005|Overall Study|Study terminated by sponsor|0|||
131191407|NCT00437203|472321001|FG006|Overall Study|Study terminated by sponsor|0|||
131191408|NCT00437203|472321002|FG007|Overall Study|Study terminated by sponsor|0|||
131191409|NCT00437203|472321003|FG008|Overall Study|Study terminated by sponsor|1|||
131191410|NCT00437203|472321004|FG009|Overall Study|Study terminated by sponsor|0|||
131191411|NCT00437203|472320995|FG000|Overall Study|Objective progression or relapse|5|||
131191412|NCT00437203|472320996|FG001|Overall Study|Objective progression or relapse|6|||
131191413|NCT00437203|472320997|FG002|Overall Study|Objective progression or relapse|2|||
131191414|NCT00437203|472320998|FG003|Overall Study|Objective progression or relapse|3|||
130733594|NCT01575548|470642917|FG000|Overall Study|Adverse Event|15|||
131191415|NCT00437203|472320999|FG004|Overall Study|Objective progression or relapse|3|||
130784556|NCT03669549|470838820|FG000|Overall Study|Withdrawal by Subject|1|||
130784557|NCT03669549|470838820|FG000|Overall Study|Study terminated by the Sponsor|1|||
130784558|NCT00909844|470838821|FG000|Overall Study|Adverse Event|1|||
130784559|NCT00909844|470838821|FG000|Overall Study|Withdrawal by Subject|1|||
130784560|NCT00909844|470838821|FG000|Overall Study|Lost to Follow-up|2|||
130784561|NCT00698815|470838822|FG000|Overall Study|Death|1|||
130784562|NCT00698815|470838823|FG001|Overall Study|Death|2|||
130784563|NCT00698815|470838824|FG002|Overall Study|Death|4|||
130784564|NCT00698815|470838822|FG000|Overall Study|Withdrawal by Subject|6|||
130784565|NCT00698815|470838823|FG001|Overall Study|Withdrawal by Subject|3|||
130784566|NCT00698815|470838824|FG002|Overall Study|Withdrawal by Subject|2|||
130784567|NCT00698815|470838822|FG000|Overall Study|MD discretion|2|||
131191416|NCT00437203|472321000|FG005|Overall Study|Objective progression or relapse|3|||
131191417|NCT00437203|472321001|FG006|Overall Study|Objective progression or relapse|6|||
131191418|NCT00437203|472321002|FG007|Overall Study|Objective progression or relapse|1|||
131191419|NCT00437203|472321003|FG008|Overall Study|Objective progression or relapse|2|||
131191420|NCT00437203|472321004|FG009|Overall Study|Objective progression or relapse|2|||
131191421|NCT00437203|472320995|FG000|Overall Study|Other|0|||
131191422|NCT00437203|472320996|FG001|Overall Study|Other|1|||
131191423|NCT00437203|472320997|FG002|Overall Study|Other|0|||
131191424|NCT00437203|472320998|FG003|Overall Study|Other|0|||
131191425|NCT00437203|472320999|FG004|Overall Study|Other|0|||
131191426|NCT00437203|472321000|FG005|Overall Study|Other|0|||
131191427|NCT00437203|472321001|FG006|Overall Study|Other|1|||
131191428|NCT00437203|472321002|FG007|Overall Study|Other|0|||
131191429|NCT00437203|472321003|FG008|Overall Study|Other|0|||
131191430|NCT00437203|472321004|FG009|Overall Study|Other|0|||
131191431|NCT00431496|472321011|FG000|Overall Study|Adverse Event|3|||
131191432|NCT00431496|472321011|FG000|Overall Study|Lost to Follow-up|1|||
131191433|NCT00431496|472321011|FG000|Overall Study|Withdrawal by Subject|2|||
131191434|NCT00431496|472321011|FG000|Overall Study|Protocol-specified criteria|5|||
131191435|NCT00499460|472321017|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
131191436|NCT00499460|472321018|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
131191437|NCT00499460|472321017|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
131191438|NCT00499460|472321018|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
131191439|NCT00499460|472321017|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
131191440|NCT00499460|472321018|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
131191441|NCT02290340|472321020|FG000|Overall Study|Lost to Follow-up|0|||
131191442|NCT02290340|472321021|FG001|Overall Study|Lost to Follow-up|0|||
131191443|NCT02290340|472321022|FG002|Overall Study|Lost to Follow-up|0|||
131191444|NCT02290340|472321023|FG003|Overall Study|Lost to Follow-up|1|||
131191445|NCT02290340|472321020|FG000|Overall Study|Withdrawal by Subject|1|||
131191446|NCT02290340|472321021|FG001|Overall Study|Withdrawal by Subject|0|||
131191447|NCT02290340|472321022|FG002|Overall Study|Withdrawal by Subject|0|||
131191448|NCT02290340|472321023|FG003|Overall Study|Withdrawal by Subject|0|||
131191449|NCT02290340|472321020|FG000|Overall Study|Other|1|||
131191450|NCT02290340|472321021|FG001|Overall Study|Other|0|||
131191451|NCT02290340|472321022|FG002|Overall Study|Other|0|||
131191452|NCT02290340|472321023|FG003|Overall Study|Other|1|||
131191453|NCT04315298|472323524|FG000|Overall Study|Withdrawal by Subject|0|||
131191454|NCT04315298|472323525|FG001|Overall Study|Withdrawal by Subject|0|||
131191455|NCT04315298|472323526|FG002|Overall Study|Withdrawal by Subject|0|||
131191456|NCT04315298|472323527|FG003|Overall Study|Withdrawal by Subject|2|||
131191457|NCT04315298|472323528|FG004|Overall Study|Withdrawal by Subject|2|||
131191458|NCT04315298|472323529|FG005|Overall Study|Withdrawal by Subject|2|||
131191459|NCT04315298|472323530|FG006|Overall Study|Withdrawal by Subject|0|||
131191460|NCT04315298|472323531|FG007|Overall Study|Withdrawal by Subject|1|||
131191461|NCT04315298|472323532|FG008|Overall Study|Withdrawal by Subject|1|||
131191462|NCT04315298|472323533|FG009|Overall Study|Withdrawal by Subject|1|||
131191463|NCT04315298|472323534|FG010|Overall Study|Withdrawal by Subject|0|||
131191464|NCT04315298|472323535|FG011|Overall Study|Withdrawal by Subject|0|||
131191465|NCT04315298|472323536|FG012|Overall Study|Withdrawal by Subject|0|||
131191466|NCT04315298|472323537|FG013|Overall Study|Withdrawal by Subject|0|||
131191467|NCT04315298|472323538|FG014|Overall Study|Withdrawal by Subject|0|||
131191468|NCT04315298|472323539|FG015|Overall Study|Withdrawal by Subject|0|||
131191469|NCT04315298|472323540|FG016|Overall Study|Withdrawal by Subject|0|||
131191470|NCT04315298|472323541|FG017|Overall Study|Withdrawal by Subject|0|||
131191471|NCT04315298|472323542|FG018|Overall Study|Withdrawal by Subject|0|||
131191472|NCT04315298|472323524|FG000|Overall Study|Physician Decision|0|||
131191473|NCT04315298|472323525|FG001|Overall Study|Physician Decision|0|||
131191474|NCT04315298|472323526|FG002|Overall Study|Physician Decision|0|||
131191475|NCT04315298|472323527|FG003|Overall Study|Physician Decision|0|||
131191476|NCT04315298|472323528|FG004|Overall Study|Physician Decision|1|||
131191477|NCT04315298|472323529|FG005|Overall Study|Physician Decision|0|||
131191478|NCT04315298|472323530|FG006|Overall Study|Physician Decision|0|||
131191479|NCT04315298|472323531|FG007|Overall Study|Physician Decision|0|||
131191480|NCT04315298|472323532|FG008|Overall Study|Physician Decision|0|||
131191481|NCT04315298|472323533|FG009|Overall Study|Physician Decision|0|||
131191482|NCT04315298|472323534|FG010|Overall Study|Physician Decision|0|||
131191483|NCT04315298|472323535|FG011|Overall Study|Physician Decision|0|||
131191484|NCT04315298|472323536|FG012|Overall Study|Physician Decision|0|||
131191485|NCT04315298|472323537|FG013|Overall Study|Physician Decision|0|||
131191486|NCT04315298|472323538|FG014|Overall Study|Physician Decision|0|||
131191487|NCT04315298|472323539|FG015|Overall Study|Physician Decision|0|||
131191488|NCT04315298|472323540|FG016|Overall Study|Physician Decision|0|||
131191489|NCT04315298|472323541|FG017|Overall Study|Physician Decision|0|||
131191490|NCT04315298|472323542|FG018|Overall Study|Physician Decision|0|||
131191491|NCT04315298|472323524|FG000|Overall Study|Lost to Follow-up|5|||
131191492|NCT04315298|472323525|FG001|Overall Study|Lost to Follow-up|10|||
131191493|NCT04315298|472323526|FG002|Overall Study|Lost to Follow-up|6|||
131191494|NCT04315298|472323527|FG003|Overall Study|Lost to Follow-up|8|||
131191495|NCT04315298|472323528|FG004|Overall Study|Lost to Follow-up|12|||
131191496|NCT04315298|472323529|FG005|Overall Study|Lost to Follow-up|13|||
131191497|NCT04315298|472323530|FG006|Overall Study|Lost to Follow-up|9|||
131191498|NCT04315298|472323531|FG007|Overall Study|Lost to Follow-up|16|||
131191499|NCT04315298|472323532|FG008|Overall Study|Lost to Follow-up|14|||
131191500|NCT04315298|472323533|FG009|Overall Study|Lost to Follow-up|0|||
131191501|NCT04315298|472323534|FG010|Overall Study|Lost to Follow-up|2|||
131191502|NCT04315298|472323535|FG011|Overall Study|Lost to Follow-up|1|||
131191503|NCT04315298|472323536|FG012|Overall Study|Lost to Follow-up|0|||
131191504|NCT04315298|472323537|FG013|Overall Study|Lost to Follow-up|0|||
131191505|NCT04315298|472323538|FG014|Overall Study|Lost to Follow-up|0|||
131191506|NCT04315298|472323539|FG015|Overall Study|Lost to Follow-up|2|||
131191507|NCT04315298|472323540|FG016|Overall Study|Lost to Follow-up|0|||
131191508|NCT04315298|472323541|FG017|Overall Study|Lost to Follow-up|0|||
131191509|NCT04315298|472323542|FG018|Overall Study|Lost to Follow-up|0|||
131191510|NCT04315298|472323524|FG000|Overall Study|Death|24|||
131191511|NCT04315298|472323525|FG001|Overall Study|Death|60|||
131191512|NCT04315298|472323526|FG002|Overall Study|Death|49|||
131191513|NCT04315298|472323527|FG003|Overall Study|Death|59|||
131191514|NCT04315298|472323528|FG004|Overall Study|Death|70|||
131191515|NCT04315298|472323529|FG005|Overall Study|Death|114|||
131191516|NCT04315298|472323530|FG006|Overall Study|Death|9|||
131191517|NCT04315298|472323531|FG007|Overall Study|Death|12|||
131191518|NCT04315298|472323532|FG008|Overall Study|Death|21|||
131191519|NCT04315298|472323533|FG009|Overall Study|Death|16|||
131191520|NCT04315298|472323534|FG010|Overall Study|Death|40|||
131191521|NCT04315298|472323535|FG011|Overall Study|Death|40|||
131191522|NCT04315298|472323536|FG012|Overall Study|Death|3|||
131191523|NCT04315298|472323537|FG013|Overall Study|Death|4|||
131191524|NCT04315298|472323538|FG014|Overall Study|Death|6|||
131191525|NCT04315298|472323539|FG015|Overall Study|Death|4|||
131191526|NCT04315298|472323540|FG016|Overall Study|Death|3|||
131191527|NCT04315298|472323541|FG017|Overall Study|Death|1|||
131191528|NCT04315298|472323542|FG018|Overall Study|Death|0|||
131191529|NCT00736385|472323543|FG000|Overall Study|Withdrawal by Subject|2|||
131191530|NCT00736385|472323544|FG001|Overall Study|Withdrawal by Subject|2|||
131191531|NCT00736385|472323543|FG000|Overall Study|Adverse Event|0|||
131191532|NCT00736385|472323544|FG001|Overall Study|Adverse Event|1|||
131191533|NCT01183104|472323545|FG000|Overall Study|Adverse Event|8|||
131191534|NCT01183104|472323546|FG001|Overall Study|Adverse Event|6|||
131191535|NCT01183104|472323545|FG000|Overall Study|Death|0|||
131191536|NCT01183104|472323546|FG001|Overall Study|Death|1|||
131191537|NCT01183104|472323545|FG000|Overall Study|Lost to Follow-up|14|||
131191538|NCT01183104|472323546|FG001|Overall Study|Lost to Follow-up|7|||
131191539|NCT01183104|472323545|FG000|Overall Study|Physician Decision|5|||
131191540|NCT01183104|472323546|FG001|Overall Study|Physician Decision|8|||
131191541|NCT01183104|472323545|FG000|Overall Study|Withdrawal by Subject|6|||
131191542|NCT01183104|472323546|FG001|Overall Study|Withdrawal by Subject|11|||
131191543|NCT01183104|472323545|FG000|Overall Study|Nonparticipation in Extension Study|39|||
131191544|NCT01183104|472323546|FG001|Overall Study|Nonparticipation in Extension Study|50|||
131191545|NCT01183104|472323545|FG000|Overall Study|Did not receive study drug|5|||
131191546|NCT01183104|472323546|FG001|Overall Study|Did not receive study drug|9|||
131191547|NCT03267511|472323547|FG000|Overall Study|Lost to Follow-up|0|||
131191548|NCT03267511|472323548|FG001|Overall Study|Lost to Follow-up|0|||
131191549|NCT03267511|472323549|FG002|Overall Study|Lost to Follow-up|0|||
131191550|NCT03267511|472323550|FG003|Overall Study|Lost to Follow-up|1|||
131191551|NCT01594749|472323551|FG000|Overall Study|Adverse Event|2|||
131191552|NCT01594749|472323552|FG001|Overall Study|Adverse Event|1|||
131191553|NCT01594749|472323551|FG000|Overall Study|Withdrawal by Subject|2|||
131191554|NCT01594749|472323552|FG001|Overall Study|Withdrawal by Subject|2|||
131191555|NCT01594749|472323551|FG000|Overall Study|Protocol Violation|2|||
131191556|NCT01594749|472323552|FG001|Overall Study|Protocol Violation|0|||
131191557|NCT01594749|472323551|FG000|Overall Study|Physician Decision|1|||
131191558|NCT01594749|472323552|FG001|Overall Study|Physician Decision|1|||
131191559|NCT01594749|472323551|FG000|Overall Study|Non-compliance with Protocol|0|||
131191560|NCT01594749|472323552|FG001|Overall Study|Non-compliance with Protocol|1|||
131191561|NCT01594749|472323551|FG000|Overall Study|Lost to Follow-up|1|||
131191562|NCT01594749|472323552|FG001|Overall Study|Lost to Follow-up|0|||
131191563|NCT01594749|472323551|FG000|Overall Study|Death|9|||
131191564|NCT01594749|472323552|FG001|Overall Study|Death|3|||
131191565|NCT01594749|472323551|FG000|Overall Study|Not Treated|4|||
131191566|NCT01594749|472323552|FG001|Overall Study|Not Treated|10|||
131191567|NCT01594749|472323551|FG000|Overall Study|Lost Source Documentation|1|||
131191568|NCT01594749|472323552|FG001|Overall Study|Lost Source Documentation|0|||
131191569|NCT00364351|472323553|FG000|Overall Study|Adverse Event|90|||
131191570|NCT00364351|472323554|FG001|Overall Study|Adverse Event|44|||
131191571|NCT00364351|472323553|FG000|Overall Study|Condition under investigation worsened|469|||
131191572|NCT00364351|472323554|FG001|Overall Study|Condition under investigation worsened|497|||
131191573|NCT00364351|472323553|FG000|Overall Study|Prohibited concomitant medication|0|||
131191574|NCT00364351|472323554|FG001|Overall Study|Prohibited concomitant medication|2|||
131191575|NCT00364351|472323553|FG000|Overall Study|Lost to Follow-up|1|||
131191576|NCT00364351|472323554|FG001|Overall Study|Lost to Follow-up|1|||
131191577|NCT00364351|472323553|FG000|Overall Study|Withdrawal by Subject|30|||
131191578|NCT00364351|472323554|FG001|Overall Study|Withdrawal by Subject|29|||
131191579|NCT00364351|472323553|FG000|Overall Study|Incorrect enrollment|1|||
131191580|NCT00364351|472323554|FG001|Overall Study|Incorrect enrollment|1|||
131191581|NCT00364351|472323553|FG000|Overall Study|Sponsor decision|1|||
131191582|NCT00364351|472323554|FG001|Overall Study|Sponsor decision|0|||
131191583|NCT00364351|472323553|FG000|Overall Study|Poor treatment compliance|0|||
131191584|NCT00364351|472323554|FG001|Overall Study|Poor treatment compliance|3|||
131191585|NCT00364351|472323553|FG000|Overall Study|Investigator error|0|||
131191586|NCT00364351|472323554|FG001|Overall Study|Investigator error|2|||
131191587|NCT00364351|472323553|FG000|Overall Study|Patient could not travel to site|0|||
131191588|NCT00364351|472323554|FG001|Overall Study|Patient could not travel to site|1|||
131191589|NCT00364351|472323553|FG000|Overall Study|Randomised treatment not started|0|||
131191590|NCT00364351|472323554|FG001|Overall Study|Randomised treatment not started|3|||
131191591|NCT00922974|472323555|FG000|Phase II Component|Protocol Violation|2|||
131191592|NCT00922974|472323556|FG001|Phase II Component|Protocol Violation|0|||
131191593|NCT00922974|472323555|FG000|Phase II Component|Not evaluable for treatment review|5|||
131191594|NCT00922974|472323556|FG001|Phase II Component|Not evaluable for treatment review|0|||
131191595|NCT00922974|472323555|FG000|Phase III Component|Protocol Violation|8|||
131191596|NCT00922974|472323556|FG001|Phase III Component|Protocol Violation|6|||
131191597|NCT02177786|472323557|FG000|Overall Study|Withdrew Consent|2|||
131191598|NCT02177786|472323558|FG001|Overall Study|Withdrew Consent|6|||
131191599|NCT02177786|472323559|FG002|Overall Study|Withdrew Consent|9|||
131191600|NCT02177786|472323560|FG003|Overall Study|Withdrew Consent|5|||
131191601|NCT02177786|472323557|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
131191602|NCT02177786|472323558|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
131191603|NCT02177786|472323559|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
131191604|NCT02177786|472323560|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
131191605|NCT02177786|472323557|FG000|Overall Study|Adverse Event|1|||
131191606|NCT02177786|472323558|FG001|Overall Study|Adverse Event|1|||
131191607|NCT02177786|472323559|FG002|Overall Study|Adverse Event|2|||
131191608|NCT02177786|472323560|FG003|Overall Study|Adverse Event|3|||
131191609|NCT02177786|472323557|FG000|Overall Study|Death|1|||
131191610|NCT02177786|472323558|FG001|Overall Study|Death|1|||
131191611|NCT02177786|472323559|FG002|Overall Study|Death|1|||
131191612|NCT02177786|472323560|FG003|Overall Study|Death|1|||
131191613|NCT02177786|472323557|FG000|Overall Study|Lost to Follow-up|0|||
131191614|NCT02177786|472323558|FG001|Overall Study|Lost to Follow-up|0|||
131191615|NCT02177786|472323559|FG002|Overall Study|Lost to Follow-up|2|||
131191616|NCT02177786|472323560|FG003|Overall Study|Lost to Follow-up|2|||
131191617|NCT02177786|472323557|FG000|Overall Study|Non-Compliance with Study Drug|0|||
131191618|NCT02177786|472323558|FG001|Overall Study|Non-Compliance with Study Drug|1|||
131191619|NCT02177786|472323559|FG002|Overall Study|Non-Compliance with Study Drug|0|||
131191620|NCT02177786|472323560|FG003|Overall Study|Non-Compliance with Study Drug|1|||
131191621|NCT02177786|472323557|FG000|Overall Study|Protocol Violation|0|||
131191622|NCT02177786|472323558|FG001|Overall Study|Protocol Violation|0|||
131191623|NCT02177786|472323559|FG002|Overall Study|Protocol Violation|2|||
131191624|NCT02177786|472323560|FG003|Overall Study|Protocol Violation|0|||
131191625|NCT02177786|472323557|FG000|Overall Study|Progressive Disease|0|||
131191626|NCT02177786|472323558|FG001|Overall Study|Progressive Disease|1|||
131191627|NCT02177786|472323559|FG002|Overall Study|Progressive Disease|0|||
131191628|NCT02177786|472323560|FG003|Overall Study|Progressive Disease|0|||
131191629|NCT02177786|472323557|FG000|Overall Study|Missing study completion status|0|||
131191630|NCT02177786|472323558|FG001|Overall Study|Missing study completion status|1|||
131191631|NCT02177786|472323559|FG002|Overall Study|Missing study completion status|0|||
131191632|NCT02177786|472323560|FG003|Overall Study|Missing study completion status|0|||
131191633|NCT03950440|472323561|FG000|Overall Study|Death|8|||
131191634|NCT03950440|472323562|FG001|Overall Study|Death|2|||
131191635|NCT03950440|472323563|FG002|Overall Study|Death|1|||
131191636|NCT00439309|472323564|FG000|Follow-Up|Death|1|||
131191637|NCT00439309|472323565|FG001|Follow-Up|Death|0|||
131191638|NCT00439309|472323564|FG000|Follow-Up|Lost to Follow-up|2|||
131191639|NCT00439309|472323565|FG001|Follow-Up|Lost to Follow-up|0|||
131191640|NCT00439309|472323564|FG000|Follow-Up|Withdrawal by Subject|0|||
131191641|NCT00439309|472323565|FG001|Follow-Up|Withdrawal by Subject|1|||
131191642|NCT00439309|472323564|FG000|Follow-Up|Late response by subject|0|||
131191643|NCT00439309|472323565|FG001|Follow-Up|Late response by subject|1|||
131191644|NCT00430027|472323566|FG000|Overall Study|Study terminated|8|||
131191645|NCT01957215|472323567|FG000|Overall Study|Adverse Event|2|||
131191646|NCT01957215|472323568|FG001|Overall Study|Adverse Event|2|||
131191647|NCT01957215|472323567|FG000|Overall Study|Lost to Follow-up|3|||
131191648|NCT01957215|472323568|FG001|Overall Study|Lost to Follow-up|3|||
131191649|NCT01957215|472323567|FG000|Overall Study|Protocol Violation|1|||
131191650|NCT01957215|472323568|FG001|Overall Study|Protocol Violation|2|||
131191651|NCT01957215|472323567|FG000|Overall Study|Withdrawal by Subject|7|||
131191652|NCT01957215|472323568|FG001|Overall Study|Withdrawal by Subject|5|||
130733595|NCT01575548|470642918|FG001|Overall Study|Adverse Event|2|||
131191653|NCT01977040|472323569|FG000|Overall Study|Vasa previa not confirmed|2|||
131191654|NCT00688623|472323570|FG000|Overall Study|Adverse Event|22|||
131191655|NCT00688623|472323570|FG000|Overall Study|abnormal lab value|1|||
131191656|NCT00688623|472323570|FG000|Overall Study|Withdrawal by Subject|4|||
131191657|NCT00688623|472323570|FG000|Overall Study|Death|3|||
131191658|NCT00688623|472323570|FG000|Overall Study|disease progression|23|||
131191659|NCT00688623|472323570|FG000|Overall Study|Protocol Violation|2|||
131191660|NCT02667236|472323571|FG000|Overall Study|Adverse Event|1|||
131191661|NCT02667236|472323572|FG001|Overall Study|Adverse Event|1|||
131191662|NCT02667236|472323571|FG000|Overall Study|Withdrawal by Subject|2|||
131191663|NCT02667236|472323572|FG001|Overall Study|Withdrawal by Subject|0|||
131191664|NCT01473355|472323576|FG000|Overall Study|Protocol Violation|2|||
131191665|NCT01473355|472323576|FG000|Overall Study|Adverse Event|2|||
131191666|NCT01473355|472323576|FG000|Overall Study|Lost to Follow-up|2|||
131191667|NCT01119963|472323577|FG000|Overall Study|Lost to Follow-up|1|||
131191668|NCT01119963|472323578|FG001|Overall Study|Lost to Follow-up|1|||
131191669|NCT02603172|472323579|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131191670|NCT02603172|472323580|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131191671|NCT02603172|472323581|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
131191672|NCT02603172|472323582|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131191673|NCT02603172|472323583|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131191674|NCT02603172|472323584|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131191675|NCT02603172|472323585|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131191676|NCT02603172|472323586|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
131191677|NCT00809614|472323587|FG000|Overall Study|Lack of Efficacy|2|||
131191678|NCT00809614|472323588|FG001|Overall Study|Lack of Efficacy|3|||
131191679|NCT00809614|472323587|FG000|Overall Study|Withdrawal by Subject|1|||
131191680|NCT00809614|472323588|FG001|Overall Study|Withdrawal by Subject|1|||
131191681|NCT01080625|472323589|FG000|Overall Study|Physician Decision|0|||
131191682|NCT01080625|472323590|FG001|Overall Study|Physician Decision|2|||
131191683|NCT01080625|472323591|FG002|Overall Study|Physician Decision|1|||
131191684|NCT00364832|472323592|FG000|Core Period|Early Withdrawals|2|||
131191685|NCT00364832|472323593|FG001|Core Period|Early Withdrawals|2|||
131191686|NCT00364832|472323594|FG002|Core Period|Early Withdrawals|1|||
131191687|NCT00364832|472323595|FG003|Core Period|Early Withdrawals|1|||
131191688|NCT00364832|472323596|FG004|Core Period|Early Withdrawals|0|||
131191689|NCT00364832|472323597|FG005|Core Period|Early Withdrawals|0|||
131191690|NCT00364832|472323598|FG006|Core Period|Early Withdrawals|4|||
131191691|NCT00364832|472323599|FG007|Core Period|Early Withdrawals|1|||
131191692|NCT00364832|472323600|FG008|Core Period|Early Withdrawals|0|||
131191693|NCT00364832|472323601|FG009|Core Period|Early Withdrawals|0|||
131191694|NCT00364832|472323602|FG010|Core Period|Early Withdrawals|0|||
131191695|NCT00364832|472323603|FG011|Core Period|Early Withdrawals|0|||
131191696|NCT00364832|472323592|FG000|Extension Year 1|Early Withdrawals|0|||
131191697|NCT00364832|472323593|FG001|Extension Year 1|Early Withdrawals|0|||
131191698|NCT00364832|472323594|FG002|Extension Year 1|Early Withdrawals|0|||
131191699|NCT00364832|472323595|FG003|Extension Year 1|Early Withdrawals|0|||
131191700|NCT00364832|472323596|FG004|Extension Year 1|Early Withdrawals|0|||
131191701|NCT00364832|472323597|FG005|Extension Year 1|Early Withdrawals|0|||
131191702|NCT00364832|472323598|FG006|Extension Year 1|Early Withdrawals|0|||
131191703|NCT00364832|472323599|FG007|Extension Year 1|Early Withdrawals|0|||
131191704|NCT00364832|472323600|FG008|Extension Year 1|Early Withdrawals|0|||
131191705|NCT00364832|472323601|FG009|Extension Year 1|Early Withdrawals|4|||
131191706|NCT00364832|472323602|FG010|Extension Year 1|Early Withdrawals|2|||
130784568|NCT00698815|470838823|FG001|Overall Study|MD discretion|7|||
130784569|NCT00698815|470838824|FG002|Overall Study|MD discretion|2|||
131191707|NCT00364832|472323603|FG011|Extension Year 1|Early Withdrawals|10|||
131191708|NCT00364832|472323592|FG000|Extension Year 2|Early Withdrawals|0|||
131191709|NCT00364832|472323593|FG001|Extension Year 2|Early Withdrawals|0|||
131191710|NCT00364832|472323594|FG002|Extension Year 2|Early Withdrawals|0|||
131191711|NCT00364832|472323595|FG003|Extension Year 2|Early Withdrawals|0|||
131191712|NCT00364832|472323596|FG004|Extension Year 2|Early Withdrawals|0|||
131191713|NCT00364832|472323597|FG005|Extension Year 2|Early Withdrawals|0|||
131191714|NCT00364832|472323598|FG006|Extension Year 2|Early Withdrawals|0|||
131191715|NCT00364832|472323599|FG007|Extension Year 2|Early Withdrawals|0|||
131191716|NCT00364832|472323600|FG008|Extension Year 2|Early Withdrawals|0|||
131191717|NCT00364832|472323601|FG009|Extension Year 2|Early Withdrawals|5|||
131191718|NCT00364832|472323602|FG010|Extension Year 2|Early Withdrawals|5|||
131191719|NCT00364832|472323603|FG011|Extension Year 2|Early Withdrawals|3|||
131191720|NCT04222673|472323606|FG000|Overall Study|Lost to Follow-up|5|||
131191721|NCT00047008|472323607|FG000|Overall Study|Withdrawn consent|2|||
131191722|NCT00047008|472323608|FG001|Overall Study|Withdrawn consent|3|||
131191723|NCT00047008|472323607|FG000|Overall Study|Ineligible|9|||
131191724|NCT00047008|472323608|FG001|Overall Study|Ineligible|8|||
131191725|NCT01366534|472323609|FG000|Overall Study|Lost to Follow-up|1|||
131191726|NCT01366534|472323610|FG001|Overall Study|Lost to Follow-up|0|||
131191727|NCT01366534|472323611|FG002|Overall Study|Lost to Follow-up|0|||
131191728|NCT01366534|472323609|FG000|Overall Study|Migrated|1|||
131191729|NCT01366534|472323610|FG001|Overall Study|Migrated|1|||
131191730|NCT01366534|472323611|FG002|Overall Study|Migrated|0|||
131191731|NCT01366534|472323609|FG000|Overall Study|Declined challenged|0|||
131191732|NCT01366534|472323610|FG001|Overall Study|Declined challenged|1|||
131191733|NCT01366534|472323611|FG002|Overall Study|Declined challenged|0|||
131191734|NCT01408732|472323612|FG000|Overall Study|Withdrawal by Subject|2|||
131191735|NCT01408732|472323613|FG001|Overall Study|Withdrawal by Subject|2|||
131191736|NCT00424099|472323614|FG000|Overall Study|Adverse Event|0|||
131191737|NCT00424099|472323615|FG001|Overall Study|Adverse Event|1|||
131191738|NCT00424099|472323616|FG002|Overall Study|Adverse Event|1|||
131191739|NCT00424099|472323617|FG003|Overall Study|Adverse Event|0|||
131191740|NCT00424099|472323614|FG000|Overall Study|Death|0|||
131191741|NCT00424099|472323615|FG001|Overall Study|Death|1|||
131191742|NCT00424099|472323616|FG002|Overall Study|Death|0|||
131191743|NCT00424099|472323617|FG003|Overall Study|Death|0|||
131191744|NCT00424099|472323614|FG000|Overall Study|Illness|2|||
131191745|NCT00424099|472323615|FG001|Overall Study|Illness|0|||
131191746|NCT00424099|472323616|FG002|Overall Study|Illness|1|||
131191747|NCT00424099|472323617|FG003|Overall Study|Illness|4|||
131191748|NCT00424099|472323614|FG000|Overall Study|Lost to Follow-up|0|||
131191749|NCT00424099|472323615|FG001|Overall Study|Lost to Follow-up|0|||
131191750|NCT00424099|472323616|FG002|Overall Study|Lost to Follow-up|3|||
131191751|NCT00424099|472323617|FG003|Overall Study|Lost to Follow-up|0|||
131191752|NCT00424099|472323614|FG000|Overall Study|Hospitalized|1|||
131191753|NCT00424099|472323615|FG001|Overall Study|Hospitalized|2|||
131191754|NCT00424099|472323616|FG002|Overall Study|Hospitalized|1|||
131191755|NCT00424099|472323617|FG003|Overall Study|Hospitalized|3|||
131191756|NCT00424099|472323614|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
131191757|NCT00424099|472323615|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
131191758|NCT00424099|472323616|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
131191759|NCT00424099|472323617|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
131191760|NCT00424099|472323614|FG000|Overall Study|Withdrawal by Subject|1|||
131191761|NCT00424099|472323615|FG001|Overall Study|Withdrawal by Subject|9|||
131191762|NCT00424099|472323616|FG002|Overall Study|Withdrawal by Subject|4|||
131191763|NCT00424099|472323617|FG003|Overall Study|Withdrawal by Subject|6|||
131191764|NCT00424099|472323614|FG000|Overall Study|Physician Decision|0|||
131191765|NCT00424099|472323615|FG001|Overall Study|Physician Decision|0|||
131191766|NCT00424099|472323616|FG002|Overall Study|Physician Decision|1|||
131191767|NCT00424099|472323617|FG003|Overall Study|Physician Decision|0|||
131191768|NCT00424099|472323614|FG000|Overall Study|Missing|0|||
131191769|NCT00424099|472323615|FG001|Overall Study|Missing|0|||
131191770|NCT00424099|472323616|FG002|Overall Study|Missing|1|||
131191771|NCT00424099|472323617|FG003|Overall Study|Missing|0|||
131191772|NCT03377452|472323618|FG000|Overall Study|Refused assessment|0|||
131191773|NCT03377452|472323619|FG001|Overall Study|Refused assessment|2|||
131191774|NCT03377452|472323618|FG000|Overall Study|Lost to Follow-up|5|||
131191775|NCT03377452|472323619|FG001|Overall Study|Lost to Follow-up|4|||
131191776|NCT00796003|472323621|FG000|Overall Study|Disease Progression|2|||
131191777|NCT00796003|472323622|FG001|Overall Study|Disease Progression|13|||
131191778|NCT00796003|472323621|FG000|Overall Study|Adverse Event|1|||
131191779|NCT00796003|472323622|FG001|Overall Study|Adverse Event|7|||
131191780|NCT00796003|472323621|FG000|Overall Study|Specified organ function not met|0|||
131191781|NCT00796003|472323622|FG001|Overall Study|Specified organ function not met|1|||
131191782|NCT00796003|472323621|FG000|Overall Study|Physician Decision|0|||
131191783|NCT00796003|472323622|FG001|Overall Study|Physician Decision|4|||
131191784|NCT00796003|472323621|FG000|Overall Study|Withdrawal by Subject|0|||
131191785|NCT00796003|472323622|FG001|Overall Study|Withdrawal by Subject|1|||
131191786|NCT00796003|472323621|FG000|Overall Study|Other|0|||
131191787|NCT00796003|472323622|FG001|Overall Study|Other|1|||
131191788|NCT00796003|472323621|FG000|Overall Study|Participants Not treated|0|||
131191789|NCT00796003|472323622|FG001|Overall Study|Participants Not treated|2|||
131191790|NCT05179057|472323623|FG000|Overall Study|Adverse Event|3|||
131191791|NCT05179057|472323624|FG001|Overall Study|Adverse Event|2|||
131191792|NCT05179057|472323623|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
131191793|NCT05179057|472323624|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
131191794|NCT05179057|472323623|FG000|Overall Study|Study terminated|13|||
131191795|NCT05179057|472323624|FG001|Overall Study|Study terminated|7|||
131191796|NCT05179057|472323623|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
131191797|NCT05179057|472323624|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
131191798|NCT05179057|472323623|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
131191799|NCT05179057|472323624|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
131191800|NCT03345342|472323625|FG000|Open-Label Phase|Adverse Event|30|||
131191801|NCT03345342|472323626|FG001|Open-Label Phase|Adverse Event|0|||
131191802|NCT03345342|472323627|FG002|Open-Label Phase|Adverse Event|0|||
131191803|NCT03345342|472323628|FG003|Open-Label Phase|Adverse Event|0|||
131191804|NCT03345342|472323629|FG004|Open-Label Phase|Adverse Event|0|||
131191805|NCT03345342|472323625|FG000|Open-Label Phase|Death|1|||
131191806|NCT03345342|472323626|FG001|Open-Label Phase|Death|0|||
131191807|NCT03345342|472323627|FG002|Open-Label Phase|Death|0|||
131191808|NCT03345342|472323628|FG003|Open-Label Phase|Death|0|||
131191809|NCT03345342|472323629|FG004|Open-Label Phase|Death|0|||
131191810|NCT03345342|472323625|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
131191811|NCT03345342|472323626|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
131191812|NCT03345342|472323627|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
131191813|NCT03345342|472323628|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
131191814|NCT03345342|472323629|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
131191815|NCT03345342|472323625|FG000|Open-Label Phase|Lack of Efficacy|6|||
131191816|NCT03345342|472323626|FG001|Open-Label Phase|Lack of Efficacy|0|||
131191817|NCT03345342|472323627|FG002|Open-Label Phase|Lack of Efficacy|0|||
131191818|NCT03345342|472323628|FG003|Open-Label Phase|Lack of Efficacy|0|||
131191819|NCT03345342|472323629|FG004|Open-Label Phase|Lack of Efficacy|0|||
131191820|NCT03345342|472323625|FG000|Open-Label Phase|Lost to Follow-up|9|||
131191821|NCT03345342|472323626|FG001|Open-Label Phase|Lost to Follow-up|0|||
131191822|NCT03345342|472323627|FG002|Open-Label Phase|Lost to Follow-up|0|||
131191823|NCT03345342|472323628|FG003|Open-Label Phase|Lost to Follow-up|0|||
131191824|NCT03345342|472323629|FG004|Open-Label Phase|Lost to Follow-up|0|||
131191825|NCT03345342|472323625|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
131191826|NCT03345342|472323626|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
131191827|NCT03345342|472323627|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
131191828|NCT03345342|472323628|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
131191829|NCT03345342|472323629|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
131191830|NCT03345342|472323625|FG000|Open-Label Phase|Physician Decision|4|||
131191831|NCT03345342|472323626|FG001|Open-Label Phase|Physician Decision|0|||
131191832|NCT03345342|472323627|FG002|Open-Label Phase|Physician Decision|0|||
131191833|NCT03345342|472323628|FG003|Open-Label Phase|Physician Decision|0|||
131191834|NCT03345342|472323629|FG004|Open-Label Phase|Physician Decision|0|||
131191835|NCT03345342|472323625|FG000|Open-Label Phase|Protocol Violation|8|||
131191836|NCT03345342|472323626|FG001|Open-Label Phase|Protocol Violation|0|||
131191837|NCT03345342|472323627|FG002|Open-Label Phase|Protocol Violation|0|||
131191838|NCT03345342|472323628|FG003|Open-Label Phase|Protocol Violation|0|||
131191839|NCT03345342|472323629|FG004|Open-Label Phase|Protocol Violation|0|||
131191840|NCT03345342|472323625|FG000|Open-Label Phase|Withdrawal by Subject|57|||
131191841|NCT03345342|472323626|FG001|Open-Label Phase|Withdrawal by Subject|0|||
131191842|NCT03345342|472323627|FG002|Open-Label Phase|Withdrawal by Subject|0|||
131191843|NCT03345342|472323628|FG003|Open-Label Phase|Withdrawal by Subject|0|||
131191844|NCT03345342|472323629|FG004|Open-Label Phase|Withdrawal by Subject|0|||
131191845|NCT03345342|472323625|FG000|Open-Label Phase|Other|15|||
131191846|NCT03345342|472323626|FG001|Open-Label Phase|Other|0|||
131191847|NCT03345342|472323627|FG002|Open-Label Phase|Other|0|||
131191848|NCT03345342|472323628|FG003|Open-Label Phase|Other|0|||
131191849|NCT03345342|472323629|FG004|Open-Label Phase|Other|0|||
131191850|NCT03345342|472323625|FG000|Double-Blind Phase|Adverse Event|0|||
131191851|NCT03345342|472323626|FG001|Double-Blind Phase|Adverse Event|1|||
131191852|NCT03345342|472323627|FG002|Double-Blind Phase|Adverse Event|6|||
131191853|NCT03345342|472323628|FG003|Double-Blind Phase|Adverse Event|0|||
131191854|NCT03345342|472323629|FG004|Double-Blind Phase|Adverse Event|0|||
131191855|NCT03345342|472323625|FG000|Double-Blind Phase|Death|0|||
131191856|NCT03345342|472323626|FG001|Double-Blind Phase|Death|2|||
131191857|NCT03345342|472323627|FG002|Double-Blind Phase|Death|1|||
131191858|NCT03345342|472323628|FG003|Double-Blind Phase|Death|0|||
131191859|NCT03345342|472323629|FG004|Double-Blind Phase|Death|0|||
131191860|NCT03345342|472323625|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
131191861|NCT03345342|472323626|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
131191862|NCT03345342|472323627|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
131191863|NCT03345342|472323628|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
131191864|NCT03345342|472323629|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
131191865|NCT03345342|472323625|FG000|Double-Blind Phase|Lost to Follow-up|0|||
131191866|NCT03345342|472323626|FG001|Double-Blind Phase|Lost to Follow-up|1|||
131191867|NCT03345342|472323627|FG002|Double-Blind Phase|Lost to Follow-up|7|||
131191868|NCT03345342|472323628|FG003|Double-Blind Phase|Lost to Follow-up|0|||
131191869|NCT03345342|472323629|FG004|Double-Blind Phase|Lost to Follow-up|0|||
131191870|NCT03345342|472323625|FG000|Double-Blind Phase|Physician Decision|0|||
131191871|NCT03345342|472323626|FG001|Double-Blind Phase|Physician Decision|1|||
131191872|NCT03345342|472323627|FG002|Double-Blind Phase|Physician Decision|4|||
131191873|NCT03345342|472323628|FG003|Double-Blind Phase|Physician Decision|0|||
131191874|NCT03345342|472323629|FG004|Double-Blind Phase|Physician Decision|0|||
131191875|NCT03345342|472323625|FG000|Double-Blind Phase|Protocol Violation|0|||
131191876|NCT03345342|472323626|FG001|Double-Blind Phase|Protocol Violation|0|||
131191877|NCT03345342|472323627|FG002|Double-Blind Phase|Protocol Violation|1|||
131191878|NCT03345342|472323628|FG003|Double-Blind Phase|Protocol Violation|0|||
131191879|NCT03345342|472323629|FG004|Double-Blind Phase|Protocol Violation|0|||
131191880|NCT03345342|472323625|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
131191881|NCT03345342|472323626|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
131191882|NCT03345342|472323627|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
131191883|NCT03345342|472323628|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
131191884|NCT03345342|472323629|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
131191885|NCT03345342|472323625|FG000|Double-Blind Phase|Other|0|||
131191886|NCT03345342|472323626|FG001|Double-Blind Phase|Other|1|||
131191887|NCT03345342|472323627|FG002|Double-Blind Phase|Other|3|||
131191888|NCT03345342|472323628|FG003|Double-Blind Phase|Other|0|||
131191889|NCT03345342|472323629|FG004|Double-Blind Phase|Other|0|||
131191890|NCT03345342|472323625|FG000|Follow-Up Phase|Adverse Event|0|||
131191891|NCT03345342|472323626|FG001|Follow-Up Phase|Adverse Event|0|||
131191892|NCT03345342|472323627|FG002|Follow-Up Phase|Adverse Event|0|||
131191893|NCT03345342|472323628|FG003|Follow-Up Phase|Adverse Event|0|||
131191894|NCT03345342|472323629|FG004|Follow-Up Phase|Adverse Event|4|||
131191895|NCT03345342|472323625|FG000|Follow-Up Phase|Lost to Follow-up|0|||
131191896|NCT03345342|472323626|FG001|Follow-Up Phase|Lost to Follow-up|0|||
131191897|NCT03345342|472323627|FG002|Follow-Up Phase|Lost to Follow-up|0|||
131191898|NCT03345342|472323628|FG003|Follow-Up Phase|Lost to Follow-up|0|||
131191899|NCT03345342|472323629|FG004|Follow-Up Phase|Lost to Follow-up|6|||
131191900|NCT03345342|472323625|FG000|Follow-Up Phase|Physician Decision|0|||
131191901|NCT03345342|472323626|FG001|Follow-Up Phase|Physician Decision|0|||
131191902|NCT03345342|472323627|FG002|Follow-Up Phase|Physician Decision|0|||
131191903|NCT03345342|472323628|FG003|Follow-Up Phase|Physician Decision|0|||
131191904|NCT03345342|472323629|FG004|Follow-Up Phase|Physician Decision|5|||
131191905|NCT03345342|472323625|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
131191906|NCT03345342|472323626|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
131191907|NCT03345342|472323627|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
131191908|NCT03345342|472323628|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
131191909|NCT03345342|472323629|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
131191910|NCT03345342|472323625|FG000|Follow-Up Phase|Other|0|||
131191911|NCT03345342|472323626|FG001|Follow-Up Phase|Other|0|||
131191912|NCT03345342|472323627|FG002|Follow-Up Phase|Other|0|||
131191913|NCT03345342|472323628|FG003|Follow-Up Phase|Other|3|||
131191914|NCT03345342|472323629|FG004|Follow-Up Phase|Other|1|||
131191915|NCT02437162|472323634|FG000|Overall Study|Protocol Violation|0|||
131191916|NCT02437162|472323635|FG001|Overall Study|Protocol Violation|1|||
131191917|NCT02437162|472323636|FG002|Overall Study|Protocol Violation|0|||
131191918|NCT02437162|472323634|FG000|Overall Study|Randomized but not treated|0|||
131191919|NCT02437162|472323635|FG001|Overall Study|Randomized but not treated|0|||
131191920|NCT02437162|472323636|FG002|Overall Study|Randomized but not treated|1|||
131191921|NCT02437162|472323634|FG000|Overall Study|Study discontinued by Sponsor|93|||
131191922|NCT02437162|472323635|FG001|Overall Study|Study discontinued by Sponsor|98|||
131191923|NCT02437162|472323636|FG002|Overall Study|Study discontinued by Sponsor|97|||
131191924|NCT02437162|472323634|FG000|Overall Study|Withdrawal by Subject|13|||
131191925|NCT02437162|472323635|FG001|Overall Study|Withdrawal by Subject|7|||
131191926|NCT02437162|472323636|FG002|Overall Study|Withdrawal by Subject|9|||
131191927|NCT02437162|472323634|FG000|Overall Study|Adverse Event|0|||
131191928|NCT02437162|472323635|FG001|Overall Study|Adverse Event|1|||
131191929|NCT02437162|472323636|FG002|Overall Study|Adverse Event|0|||
131191930|NCT02437162|472323634|FG000|Overall Study|Lost to Follow-up|1|||
131191931|NCT02437162|472323635|FG001|Overall Study|Lost to Follow-up|0|||
131191932|NCT02437162|472323636|FG002|Overall Study|Lost to Follow-up|1|||
131191933|NCT02437162|472323634|FG000|Overall Study|Death|0|||
131191934|NCT02437162|472323635|FG001|Overall Study|Death|1|||
131191935|NCT02437162|472323636|FG002|Overall Study|Death|0|||
131191936|NCT02437162|472323634|FG000|Overall Study|Other|0|||
131191937|NCT02437162|472323635|FG001|Overall Study|Other|0|||
131191938|NCT02437162|472323636|FG002|Overall Study|Other|1|||
131191939|NCT04338321|472323637|FG000|Overall Study|Adverse Event|4|||
131191940|NCT04338321|472323638|FG001|Overall Study|Adverse Event|10|||
131191941|NCT04338321|472323637|FG000|Overall Study|Death|1|||
131191942|NCT04338321|472323638|FG001|Overall Study|Death|1|||
131191943|NCT04338321|472323637|FG000|Overall Study|Lost to Follow-up|4|||
131191944|NCT04338321|472323638|FG001|Overall Study|Lost to Follow-up|9|||
131191945|NCT04338321|472323637|FG000|Overall Study|Withdrawal by Subject|45|||
131191946|NCT04338321|472323638|FG001|Overall Study|Withdrawal by Subject|69|||
131191947|NCT04338321|472323637|FG000|Overall Study|Physician Decision|5|||
131191948|NCT04338321|472323638|FG001|Overall Study|Physician Decision|9|||
131191949|NCT04338321|472323637|FG000|Overall Study|Other|3|||
131191950|NCT04338321|472323638|FG001|Overall Study|Other|10|||
131191951|NCT03375203|472323639|FG000|Overall Study|Protocol Violation|0|||
131191952|NCT03375203|472323640|FG001|Overall Study|Protocol Violation|0|||
131191953|NCT03375203|472323641|FG002|Overall Study|Protocol Violation|1|||
131191954|NCT03375203|472323642|FG003|Overall Study|Protocol Violation|0|||
131191955|NCT03375203|472323643|FG004|Overall Study|Protocol Violation|0|||
131191956|NCT03375203|472323639|FG000|Overall Study|Adverse Event|2|||
131191957|NCT03375203|472323640|FG001|Overall Study|Adverse Event|3|||
131191958|NCT03375203|472323641|FG002|Overall Study|Adverse Event|0|||
131191959|NCT03375203|472323642|FG003|Overall Study|Adverse Event|2|||
131191960|NCT03375203|472323643|FG004|Overall Study|Adverse Event|2|||
131191961|NCT03375203|472323639|FG000|Overall Study|Withdrawal by Subject|3|||
131191962|NCT03375203|472323640|FG001|Overall Study|Withdrawal by Subject|0|||
131191963|NCT03375203|472323641|FG002|Overall Study|Withdrawal by Subject|1|||
131191964|NCT03375203|472323642|FG003|Overall Study|Withdrawal by Subject|0|||
131191965|NCT03375203|472323643|FG004|Overall Study|Withdrawal by Subject|2|||
131191966|NCT03375203|472323639|FG000|Overall Study|Non-compliance with study drug|1|||
131191967|NCT03375203|472323640|FG001|Overall Study|Non-compliance with study drug|0|||
131191968|NCT03375203|472323641|FG002|Overall Study|Non-compliance with study drug|0|||
131191969|NCT03375203|472323642|FG003|Overall Study|Non-compliance with study drug|0|||
131191970|NCT03375203|472323643|FG004|Overall Study|Non-compliance with study drug|0|||
131191971|NCT03375203|472323639|FG000|Overall Study|Randomized, not treated.|0|||
131191972|NCT03375203|472323640|FG001|Overall Study|Randomized, not treated.|1|||
131191973|NCT03375203|472323641|FG002|Overall Study|Randomized, not treated.|0|||
131191974|NCT03375203|472323642|FG003|Overall Study|Randomized, not treated.|0|||
131191975|NCT03375203|472323643|FG004|Overall Study|Randomized, not treated.|0|||
131191976|NCT03107793|472323644|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
131191977|NCT03107793|472323645|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
131191978|NCT03107793|472323646|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
131191979|NCT03107793|472323647|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
131191980|NCT03107793|472323648|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
131191981|NCT03107793|472323644|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
131191982|NCT03107793|472323645|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
131191983|NCT03107793|472323646|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
131191984|NCT03107793|472323647|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
131191985|NCT03107793|472323648|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
131191986|NCT03107793|472323644|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
131191987|NCT03107793|472323645|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
131191988|NCT03107793|472323646|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
131191989|NCT03107793|472323647|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
131191990|NCT03107793|472323648|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
131191991|NCT03107793|472323644|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
131191992|NCT03107793|472323645|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131191993|NCT03107793|472323646|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131191994|NCT03107793|472323647|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131191995|NCT03107793|472323648|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
131191996|NCT03107793|472323644|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
131191997|NCT03107793|472323645|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
131191998|NCT03107793|472323646|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
131191999|NCT03107793|472323647|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
131192000|NCT03107793|472323648|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
131192001|NCT03107793|472323644|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
131192002|NCT03107793|472323645|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
131192003|NCT03107793|472323646|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
131192004|NCT03107793|472323647|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
131192005|NCT03107793|472323648|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
131192006|NCT03107793|472323644|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
131192007|NCT03107793|472323645|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
131192008|NCT03107793|472323646|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
131192009|NCT03107793|472323647|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
131192010|NCT03107793|472323648|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
131192011|NCT03107793|472323644|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
131192012|NCT03107793|472323645|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
131192013|NCT03107793|472323646|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
131192014|NCT03107793|472323647|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
131192015|NCT03107793|472323648|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
131192016|NCT03107793|472323644|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
131192017|NCT03107793|472323645|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
131192018|NCT03107793|472323646|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
131192019|NCT03107793|472323647|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
131192020|NCT03107793|472323648|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
131192021|NCT03107793|472323644|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
131192022|NCT03107793|472323645|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
131192023|NCT03107793|472323646|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
131192024|NCT03107793|472323647|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
131192025|NCT03107793|472323648|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
131192026|NCT03107793|472323644|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131192027|NCT03107793|472323645|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
131192028|NCT03107793|472323646|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130733596|NCT01575548|470642917|FG000|Overall Study|Disease progression|12|||
130733597|NCT01575548|470642918|FG001|Overall Study|Disease progression|25|||
130733598|NCT01575548|470642917|FG000|Overall Study|Death|1|||
131192029|NCT03107793|472323647|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131192030|NCT03107793|472323648|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
131192031|NCT03107793|472323644|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
131192032|NCT03107793|472323645|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
131192033|NCT03107793|472323646|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
131192034|NCT03107793|472323647|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
131192035|NCT03107793|472323648|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
131192036|NCT03107793|472323644|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
131192037|NCT03107793|472323645|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
131192038|NCT03107793|472323646|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
131192039|NCT03107793|472323647|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
131192040|NCT03107793|472323648|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
131192041|NCT03107793|472323644|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
131192042|NCT03107793|472323645|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
131192043|NCT03107793|472323646|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
131192044|NCT03107793|472323647|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
131192045|NCT03107793|472323648|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
131192046|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
131192047|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
131192048|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
131192049|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
131192050|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
131192051|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
131192052|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
131192053|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
131192054|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
131192055|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
131192056|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
131192057|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
131192058|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
131192059|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
131192060|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
131192061|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Death|0|||
131192062|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Death|0|||
131192063|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Death|0|||
131192064|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Death|0|||
131192065|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Death|1|||
131192066|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
131192067|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
131192068|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
131192069|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
131192070|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
131192071|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
131192072|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
131192073|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
131192074|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
131192075|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
131192076|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
131192077|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
131192078|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
131192079|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
131192080|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
131192081|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
131192082|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
131192083|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
131192084|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
131192085|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
131192086|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
131192087|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
131192088|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
131192089|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
131192090|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
131192091|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Other|0|||
131192092|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Other|0|||
131192093|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Other|0|||
131192094|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Other|1|||
131192095|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Other|3|||
131192096|NCT03107793|472323644|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
131192097|NCT03107793|472323645|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
131192098|NCT03107793|472323646|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
131192099|NCT03107793|472323647|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
131192100|NCT03107793|472323648|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
131192101|NCT03321526|472323649|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
131192102|NCT03321526|472323650|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
131192103|NCT03321526|472323649|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
131192104|NCT03321526|472323650|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
131192105|NCT03321526|472323649|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
131192106|NCT03321526|472323650|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
131192107|NCT03321526|472323649|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
131192108|NCT03321526|472323650|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
131192109|NCT03321526|472323649|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
131192110|NCT03321526|472323650|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
131192111|NCT03321526|472323649|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
131192112|NCT03321526|472323650|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
131192113|NCT03321526|472323649|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
131192114|NCT03321526|472323650|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
131192115|NCT03321526|472323649|FG000|Follow-up Phase (2 Weeks)|Other|24|||
131192116|NCT03321526|472323650|FG001|Follow-up Phase (2 Weeks)|Other|24|||
131192117|NCT01989572|472323654|FG000|Overall Study|Lack of Efficacy|35|||
131192118|NCT01989572|472323655|FG001|Overall Study|Lack of Efficacy|48|||
131192119|NCT01989572|472323656|FG002|Overall Study|Lack of Efficacy|48|||
131192120|NCT01989572|472323657|FG003|Overall Study|Lack of Efficacy|43|||
131192121|NCT01989572|472323658|FG004|Overall Study|Lack of Efficacy|71|||
131192122|NCT01989572|472323659|FG005|Overall Study|Lack of Efficacy|79|||
131192123|NCT01989572|472323654|FG000|Overall Study|Adverse Event|2|||
131192124|NCT01989572|472323655|FG001|Overall Study|Adverse Event|1|||
131192125|NCT01989572|472323656|FG002|Overall Study|Adverse Event|3|||
131192126|NCT01989572|472323657|FG003|Overall Study|Adverse Event|0|||
131192127|NCT01989572|472323658|FG004|Overall Study|Adverse Event|3|||
131192128|NCT01989572|472323659|FG005|Overall Study|Adverse Event|0|||
131192129|NCT01989572|472323654|FG000|Overall Study|Death|0|||
131192130|NCT01989572|472323655|FG001|Overall Study|Death|0|||
131192131|NCT01989572|472323656|FG002|Overall Study|Death|0|||
131192132|NCT01989572|472323657|FG003|Overall Study|Death|0|||
131192133|NCT01989572|472323658|FG004|Overall Study|Death|1|||
131192134|NCT01989572|472323659|FG005|Overall Study|Death|0|||
131192135|NCT01989572|472323654|FG000|Overall Study|Withdrawal by Subject|4|||
131192136|NCT01989572|472323655|FG001|Overall Study|Withdrawal by Subject|1|||
131192137|NCT01989572|472323656|FG002|Overall Study|Withdrawal by Subject|5|||
131192138|NCT01989572|472323657|FG003|Overall Study|Withdrawal by Subject|1|||
131192139|NCT01989572|472323658|FG004|Overall Study|Withdrawal by Subject|12|||
131192140|NCT01989572|472323659|FG005|Overall Study|Withdrawal by Subject|4|||
131192141|NCT01989572|472323654|FG000|Overall Study|complicating disease|1|||
131192142|NCT01989572|472323655|FG001|Overall Study|complicating disease|1|||
131192143|NCT01989572|472323656|FG002|Overall Study|complicating disease|2|||
131192144|NCT01989572|472323657|FG003|Overall Study|complicating disease|0|||
131192145|NCT01989572|472323658|FG004|Overall Study|complicating disease|1|||
131192146|NCT01989572|472323659|FG005|Overall Study|complicating disease|0|||
131192147|NCT01989572|472323654|FG000|Overall Study|error|2|||
131192148|NCT01989572|472323655|FG001|Overall Study|error|1|||
131192149|NCT01989572|472323656|FG002|Overall Study|error|1|||
131192150|NCT01989572|472323657|FG003|Overall Study|error|1|||
131192151|NCT01989572|472323658|FG004|Overall Study|error|1|||
131192152|NCT01989572|472323659|FG005|Overall Study|error|1|||
131192153|NCT01989572|472323654|FG000|Overall Study|maximum dose reached|0|||
131192154|NCT01989572|472323655|FG001|Overall Study|maximum dose reached|1|||
131192155|NCT01989572|472323656|FG002|Overall Study|maximum dose reached|0|||
131192156|NCT01989572|472323657|FG003|Overall Study|maximum dose reached|0|||
131192157|NCT01989572|472323658|FG004|Overall Study|maximum dose reached|1|||
131192158|NCT01989572|472323659|FG005|Overall Study|maximum dose reached|0|||
131192159|NCT01989572|472323654|FG000|Overall Study|unknown/not specify|3|||
131192160|NCT01989572|472323655|FG001|Overall Study|unknown/not specify|4|||
131192161|NCT01989572|472323656|FG002|Overall Study|unknown/not specify|1|||
131192162|NCT01989572|472323657|FG003|Overall Study|unknown/not specify|3|||
131192163|NCT01989572|472323658|FG004|Overall Study|unknown/not specify|3|||
131192164|NCT01989572|472323659|FG005|Overall Study|unknown/not specify|5|||
131192165|NCT01989572|472323654|FG000|Overall Study|not start protocol therapy|5|||
131192166|NCT01989572|472323655|FG001|Overall Study|not start protocol therapy|1|||
131192167|NCT01989572|472323656|FG002|Overall Study|not start protocol therapy|2|||
131192168|NCT01989572|472323657|FG003|Overall Study|not start protocol therapy|3|||
131192169|NCT01989572|472323658|FG004|Overall Study|not start protocol therapy|4|||
131192170|NCT01989572|472323659|FG005|Overall Study|not start protocol therapy|18|||
131192171|NCT01989572|472323654|FG000|Overall Study|alternative therapy|3|||
131192172|NCT01989572|472323655|FG001|Overall Study|alternative therapy|0|||
131192173|NCT01989572|472323656|FG002|Overall Study|alternative therapy|0|||
131192174|NCT01989572|472323657|FG003|Overall Study|alternative therapy|0|||
131192175|NCT01989572|472323658|FG004|Overall Study|alternative therapy|1|||
131192176|NCT01989572|472323659|FG005|Overall Study|alternative therapy|3|||
131192177|NCT02280096|472323660|FG000|Overall Study|Pregnancy|1|||
131192178|NCT02280096|472323661|FG001|Overall Study|Pregnancy|0|||
131192179|NCT02280096|472323660|FG000|Overall Study|Functional neurological disorder|1|||
131192180|NCT02280096|472323661|FG001|Overall Study|Functional neurological disorder|0|||
131192181|NCT02280096|472323660|FG000|Overall Study|Lack of attachment|0|||
131192182|NCT02280096|472323661|FG001|Overall Study|Lack of attachment|1|||
131192183|NCT00246376|472323662|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
131192184|NCT00246376|472323663|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
131192185|NCT00246376|472323664|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
131192186|NCT00246376|472323665|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
131192187|NCT00246376|472323666|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
131192188|NCT00246376|472323662|FG000|Overall Study|Adverse Event|2|||
131192189|NCT00246376|472323663|FG001|Overall Study|Adverse Event|3|||
131192190|NCT00246376|472323664|FG002|Overall Study|Adverse Event|1|||
131192191|NCT00246376|472323665|FG003|Overall Study|Adverse Event|3|||
131192192|NCT00246376|472323666|FG004|Overall Study|Adverse Event|1|||
131192193|NCT00246376|472323662|FG000|Overall Study|Lost to Follow-up|2|||
131192194|NCT00246376|472323663|FG001|Overall Study|Lost to Follow-up|11|||
131192195|NCT00246376|472323664|FG002|Overall Study|Lost to Follow-up|11|||
131192196|NCT00246376|472323665|FG003|Overall Study|Lost to Follow-up|16|||
131192197|NCT00246376|472323666|FG004|Overall Study|Lost to Follow-up|13|||
131192198|NCT02418585|472323667|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
131192199|NCT02418585|472323668|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
131192200|NCT02418585|472323667|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
131192201|NCT02418585|472323668|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
131192202|NCT02418585|472323667|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
131192203|NCT02418585|472323668|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
131192204|NCT02418585|472323667|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
131192205|NCT02418585|472323668|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
131192206|NCT02418585|472323667|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
131192207|NCT02418585|472323668|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
131192208|NCT02418585|472323667|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
131192209|NCT02418585|472323668|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
131192210|NCT02418585|472323667|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
131192211|NCT02418585|472323668|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
131192212|NCT02418585|472323667|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
131192213|NCT02418585|472323668|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
131192214|NCT02418585|472323667|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
131192215|NCT02418585|472323668|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
131192216|NCT02418585|472323667|FG000|Follow-up Phase (24 Weeks)|Other|3|||
131192217|NCT02418585|472323668|FG001|Follow-up Phase (24 Weeks)|Other|2|||
131192218|NCT02040857|472323669|FG000|Overall Study|Adverse Event|14|||
131192219|NCT02040857|472323669|FG000|Overall Study|Physician Decision|5|||
131192220|NCT02040857|472323669|FG000|Overall Study|Withdrawal by Subject|31|||
131192221|NCT02040857|472323669|FG000|Overall Study|patient non-compliance|3|||
131192222|NCT02040857|472323669|FG000|Overall Study|Lost to Follow-up|2|||
130784570|NCT00698815|470838822|FG000|Overall Study|Did not receive protocol treatment|1|||
130784571|NCT00698815|470838823|FG001|Overall Study|Did not receive protocol treatment|2|||
130784572|NCT00698815|470838824|FG002|Overall Study|Did not receive protocol treatment|2|||
130784573|NCT01064479|470838825|FG000|Overall Study|Death|10|||
130784574|NCT01064479|470838826|FG001|Overall Study|Death|11|||
131192223|NCT02040857|472323669|FG000|Overall Study|recurrence|4|||
131192224|NCT02040857|472323669|FG000|Overall Study|ineligible|1|||
131192225|NCT00471276|472323672|FG000|Overall Study|Death|2|||
131192226|NCT00471276|472323672|FG000|Overall Study|Adverse Event|16|||
131192227|NCT00471276|472323672|FG000|Overall Study|Protocol Violation|1|||
131192228|NCT00471276|472323672|FG000|Overall Study|Objective progression or relapse|54|||
131192229|NCT00471276|472323672|FG000|Overall Study|Global deterioration of health status|1|||
131192230|NCT00471276|472323672|FG000|Overall Study|Other|3|||
131192231|NCT00471276|472323672|FG000|Overall Study|Refused treatment|6|||
131192232|NCT01614795|472323673|FG000|Overall Study|Adverse Event|0|||
131192233|NCT01614795|472323674|FG001|Overall Study|Adverse Event|0|||
131192234|NCT01614795|472323675|FG002|Overall Study|Adverse Event|1|||
131192235|NCT01614795|472323676|FG003|Overall Study|Adverse Event|1|||
131192236|NCT01614795|472323673|FG000|Overall Study|Lack of Efficacy|10|||
131192237|NCT01614795|472323674|FG001|Overall Study|Lack of Efficacy|10|||
131192238|NCT01614795|472323675|FG002|Overall Study|Lack of Efficacy|9|||
131192239|NCT01614795|472323676|FG003|Overall Study|Lack of Efficacy|8|||
131192240|NCT01614795|472323673|FG000|Overall Study|Physician Decision|1|||
131192241|NCT01614795|472323674|FG001|Overall Study|Physician Decision|0|||
131192242|NCT01614795|472323675|FG002|Overall Study|Physician Decision|1|||
131192243|NCT01614795|472323676|FG003|Overall Study|Physician Decision|1|||
131192244|NCT01614795|472323673|FG000|Overall Study|Withdrawal by Subject|0|||
131192245|NCT01614795|472323674|FG001|Overall Study|Withdrawal by Subject|1|||
131192246|NCT01614795|472323675|FG002|Overall Study|Withdrawal by Subject|0|||
131192247|NCT01614795|472323676|FG003|Overall Study|Withdrawal by Subject|2|||
131192248|NCT01614795|472323673|FG000|Overall Study|Ineligible|0|||
131192249|NCT01614795|472323674|FG001|Overall Study|Ineligible|1|||
131192250|NCT01614795|472323675|FG002|Overall Study|Ineligible|0|||
131192251|NCT01614795|472323676|FG003|Overall Study|Ineligible|0|||
131192252|NCT00023712|472323677|FG000|Overall Study|Not platinum sensitive|1|||
131192253|NCT00023712|472323678|FG001|Overall Study|Not platinum sensitive|0|||
131192254|NCT00023712|472323677|FG000|Overall Study|Never treated|1|||
131192255|NCT00023712|472323678|FG001|Overall Study|Never treated|1|||
131192256|NCT00565812|472323681|FG000|Overall Study|Death|2|||
131192257|NCT00565812|472323682|FG001|Overall Study|Death|1|||
131192258|NCT00565812|472323683|FG002|Overall Study|Death|3|||
131192259|NCT00565812|472323681|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
131192260|NCT00565812|472323682|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
131192261|NCT00565812|472323683|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
131192262|NCT00565812|472323681|FG000|Overall Study|Lost to Follow-up|10|||
131192263|NCT00565812|472323682|FG001|Overall Study|Lost to Follow-up|8|||
131192264|NCT00565812|472323683|FG002|Overall Study|Lost to Follow-up|8|||
131192265|NCT00565812|472323681|FG000|Overall Study|Withdrawal by Subject|58|||
131192266|NCT00565812|472323682|FG001|Overall Study|Withdrawal by Subject|47|||
131192267|NCT00565812|472323683|FG002|Overall Study|Withdrawal by Subject|48|||
131192268|NCT00565812|472323681|FG000|Overall Study|Work Schedule|5|||
131192269|NCT00565812|472323682|FG001|Overall Study|Work Schedule|3|||
131192270|NCT00565812|472323683|FG002|Overall Study|Work Schedule|1|||
131192271|NCT00565812|472323681|FG000|Overall Study|Protocol Violation|2|||
131192272|NCT00565812|472323682|FG001|Overall Study|Protocol Violation|6|||
131192273|NCT00565812|472323683|FG002|Overall Study|Protocol Violation|4|||
131192274|NCT00565812|472323681|FG000|Overall Study|Adverse Event|41|||
131192275|NCT00565812|472323682|FG001|Overall Study|Adverse Event|54|||
131192276|NCT00565812|472323683|FG002|Overall Study|Adverse Event|40|||
131192277|NCT00565812|472323681|FG000|Overall Study|Jury Duty|1|||
131192278|NCT00565812|472323682|FG001|Overall Study|Jury Duty|0|||
131192279|NCT00565812|472323683|FG002|Overall Study|Jury Duty|0|||
131192280|NCT00565812|472323681|FG000|Overall Study|Relocated Out of Area|5|||
131192281|NCT00565812|472323682|FG001|Overall Study|Relocated Out of Area|8|||
131192282|NCT00565812|472323683|FG002|Overall Study|Relocated Out of Area|9|||
131192283|NCT00565812|472323681|FG000|Overall Study|Sponsor Decision|1|||
131192284|NCT00565812|472323682|FG001|Overall Study|Sponsor Decision|5|||
131192285|NCT00565812|472323683|FG002|Overall Study|Sponsor Decision|1|||
131192286|NCT00565812|472323681|FG000|Overall Study|Domestic Reasons|7|||
131192287|NCT00565812|472323682|FG001|Overall Study|Domestic Reasons|1|||
131192288|NCT00565812|472323683|FG002|Overall Study|Domestic Reasons|3|||
131192289|NCT00565812|472323681|FG000|Overall Study|Research Site Closure|6|||
130733599|NCT01575548|470642918|FG001|Overall Study|Death|0|||
131192290|NCT00565812|472323682|FG001|Overall Study|Research Site Closure|1|||
131192291|NCT00565812|472323683|FG002|Overall Study|Research Site Closure|8|||
131192292|NCT00565812|472323681|FG000|Overall Study|Surgical Intervention|0|||
131192293|NCT00565812|472323682|FG001|Overall Study|Surgical Intervention|1|||
131192294|NCT00565812|472323683|FG002|Overall Study|Surgical Intervention|2|||
131192295|NCT00565812|472323681|FG000|Overall Study|Low Compliance|1|||
131192296|NCT00565812|472323682|FG001|Overall Study|Low Compliance|0|||
131192297|NCT00565812|472323683|FG002|Overall Study|Low Compliance|1|||
131192298|NCT00565812|472323681|FG000|Overall Study|Follow-up Visit Not Completed|2|||
131192299|NCT00565812|472323682|FG001|Overall Study|Follow-up Visit Not Completed|0|||
131192300|NCT00565812|472323683|FG002|Overall Study|Follow-up Visit Not Completed|1|||
131192301|NCT00565812|472323681|FG000|Overall Study|Physician Decision|2|||
131192302|NCT00565812|472323682|FG001|Overall Study|Physician Decision|0|||
131192303|NCT00565812|472323683|FG002|Overall Study|Physician Decision|0|||
131192304|NCT00814307|472323685|FG000|Overall Study|Randomized but not treated|1|||
131192305|NCT00814307|472323686|FG001|Overall Study|Randomized but not treated|0|||
131192306|NCT00814307|472323687|FG002|Overall Study|Randomized but not treated|0|||
131192307|NCT00814307|472323688|FG003|Overall Study|Randomized but not treated|0|||
131192308|NCT00814307|472323685|FG000|Overall Study|Adverse Event|3|||
131192309|NCT00814307|472323686|FG001|Overall Study|Adverse Event|9|||
131192310|NCT00814307|472323687|FG002|Overall Study|Adverse Event|3|||
131192311|NCT00814307|472323688|FG003|Overall Study|Adverse Event|2|||
131192312|NCT00814307|472323685|FG000|Overall Study|Lack of Efficacy|1|||
131192313|NCT00814307|472323686|FG001|Overall Study|Lack of Efficacy|1|||
131192314|NCT00814307|472323687|FG002|Overall Study|Lack of Efficacy|3|||
131192315|NCT00814307|472323688|FG003|Overall Study|Lack of Efficacy|4|||
131192316|NCT00814307|472323685|FG000|Overall Study|Other|1|||
131192317|NCT00814307|472323686|FG001|Overall Study|Other|2|||
131192318|NCT00814307|472323687|FG002|Overall Study|Other|0|||
131192319|NCT00814307|472323688|FG003|Overall Study|Other|1|||
131192320|NCT00814307|472323685|FG000|Overall Study|Protocol Violation|2|||
131192321|NCT00814307|472323686|FG001|Overall Study|Protocol Violation|8|||
131192322|NCT00814307|472323687|FG002|Overall Study|Protocol Violation|1|||
131192323|NCT00814307|472323688|FG003|Overall Study|Protocol Violation|1|||
131192324|NCT00814307|472323685|FG000|Overall Study|Withdrawal by Subject|4|||
131192325|NCT00814307|472323686|FG001|Overall Study|Withdrawal by Subject|6|||
131192326|NCT00814307|472323687|FG002|Overall Study|Withdrawal by Subject|0|||
131192327|NCT00814307|472323688|FG003|Overall Study|Withdrawal by Subject|2|||
131192328|NCT00814307|472323685|FG000|Overall Study|Death|0|||
131192329|NCT00814307|472323686|FG001|Overall Study|Death|1|||
131192330|NCT00814307|472323687|FG002|Overall Study|Death|0|||
131192331|NCT00814307|472323688|FG003|Overall Study|Death|0|||
131192332|NCT03039192|472323691|FG000|Overall Study|Lost to Follow-up|4|||
131192333|NCT03039192|472323692|FG001|Overall Study|Lost to Follow-up|4|||
131192334|NCT03039192|472323691|FG000|Overall Study|Adverse event, serious fatal|0|||
131192335|NCT03039192|472323692|FG001|Overall Study|Adverse event, serious fatal|1|||
131192336|NCT03039192|472323691|FG000|Overall Study|Adverse event, non-fatal|0|||
131192337|NCT03039192|472323692|FG001|Overall Study|Adverse event, non-fatal|2|||
131192338|NCT03039192|472323691|FG000|Overall Study|Withdrawal by Subject|6|||
131192339|NCT03039192|472323692|FG001|Overall Study|Withdrawal by Subject|9|||
131192340|NCT03039192|472323691|FG000|Overall Study|Discontinued from treatment phase|19|||
131192341|NCT03039192|472323692|FG001|Overall Study|Discontinued from treatment phase|12|||
131192342|NCT03039192|472323691|FG000|Overall Study|Other|3|||
131192343|NCT03039192|472323692|FG001|Overall Study|Other|2|||
131192344|NCT00777257|472325803|FG000|Overall Study|Adverse Event|3|||
131192345|NCT00777257|472325804|FG001|Overall Study|Adverse Event|1|||
131192346|NCT00777257|472325805|FG002|Overall Study|Adverse Event|0|||
131192347|NCT00777257|472325803|FG000|Overall Study|Lost to Follow-up|3|||
131192348|NCT00777257|472325804|FG001|Overall Study|Lost to Follow-up|3|||
131192349|NCT00777257|472325805|FG002|Overall Study|Lost to Follow-up|2|||
131192350|NCT00777257|472325803|FG000|Overall Study|Protocol Violation|2|||
131192351|NCT00777257|472325804|FG001|Overall Study|Protocol Violation|2|||
131192352|NCT00777257|472325805|FG002|Overall Study|Protocol Violation|2|||
131192353|NCT00777257|472325803|FG000|Overall Study|Withdrawal by Subject|3|||
131192354|NCT00777257|472325804|FG001|Overall Study|Withdrawal by Subject|6|||
131192355|NCT00777257|472325805|FG002|Overall Study|Withdrawal by Subject|5|||
131192356|NCT00098865|472325806|FG000|Overall Study|Progressive Disease|6|||
131192357|NCT00098865|472325806|FG000|Overall Study|Adverse Event|2|||
131192358|NCT00098865|472325806|FG000|Overall Study|Alternative Therapy|1|||
131192359|NCT00464620|472325808|FG000|Overall Study|Physician Decision|1|||
131192360|NCT00464620|472325809|FG001|Overall Study|Physician Decision|0|||
131192361|NCT00464620|472325810|FG002|Overall Study|Physician Decision|0|||
131192362|NCT00464620|472325808|FG000|Overall Study|Withdrawal by Subject|1|||
131192363|NCT00464620|472325809|FG001|Overall Study|Withdrawal by Subject|0|||
131192364|NCT00464620|472325810|FG002|Overall Study|Withdrawal by Subject|3|||
131192365|NCT00464620|472325808|FG000|Overall Study|Ineligible sarcoma subtype|0|||
131192366|NCT00464620|472325809|FG001|Overall Study|Ineligible sarcoma subtype|2|||
131192367|NCT00464620|472325810|FG002|Overall Study|Ineligible sarcoma subtype|2|||
131192368|NCT00464620|472325808|FG000|Overall Study|Use of prohibited concomitant medication|0|||
131192369|NCT00464620|472325809|FG001|Overall Study|Use of prohibited concomitant medication|0|||
131192370|NCT00464620|472325810|FG002|Overall Study|Use of prohibited concomitant medication|2|||
131192371|NCT04984876|472325811|FG000|Overall Study|Subject decision|2|||
131192372|NCT04984876|472325812|FG001|Overall Study|Subject decision|10|||
131192373|NCT04984876|472325813|FG002|Overall Study|Subject decision|3|||
131192374|NCT04984876|472325814|FG003|Overall Study|Subject decision|3|||
131192375|NCT04984876|472325815|FG004|Overall Study|Subject decision|3|||
131192376|NCT04984876|472325816|FG005|Overall Study|Subject decision|0|||
131192377|NCT04984876|472325811|FG000|Overall Study|Guardian decision|0|||
131192378|NCT04984876|472325812|FG001|Overall Study|Guardian decision|1|||
131192379|NCT04984876|472325813|FG002|Overall Study|Guardian decision|0|||
131192380|NCT04984876|472325814|FG003|Overall Study|Guardian decision|2|||
131192381|NCT04984876|472325815|FG004|Overall Study|Guardian decision|0|||
131192382|NCT04984876|472325816|FG005|Overall Study|Guardian decision|1|||
131192383|NCT04984876|472325811|FG000|Overall Study|Lost to Follow-up|0|||
131192384|NCT04984876|472325812|FG001|Overall Study|Lost to Follow-up|0|||
131192385|NCT04984876|472325813|FG002|Overall Study|Lost to Follow-up|1|||
131192386|NCT04984876|472325814|FG003|Overall Study|Lost to Follow-up|1|||
131192387|NCT04984876|472325815|FG004|Overall Study|Lost to Follow-up|0|||
131192388|NCT04984876|472325816|FG005|Overall Study|Lost to Follow-up|0|||
131192389|NCT04984876|472325811|FG000|Overall Study|Physician Decision|1|||
131192390|NCT04984876|472325812|FG001|Overall Study|Physician Decision|0|||
131192391|NCT04984876|472325813|FG002|Overall Study|Physician Decision|0|||
131192392|NCT04984876|472325814|FG003|Overall Study|Physician Decision|1|||
131192393|NCT04984876|472325815|FG004|Overall Study|Physician Decision|0|||
131192394|NCT04984876|472325816|FG005|Overall Study|Physician Decision|0|||
131192395|NCT04984876|472325811|FG000|Overall Study|Adverse Event|0|||
131192396|NCT04984876|472325812|FG001|Overall Study|Adverse Event|0|||
131192397|NCT04984876|472325813|FG002|Overall Study|Adverse Event|1|||
131192398|NCT04984876|472325814|FG003|Overall Study|Adverse Event|0|||
131192399|NCT04984876|472325815|FG004|Overall Study|Adverse Event|0|||
131192400|NCT04984876|472325816|FG005|Overall Study|Adverse Event|0|||
131192401|NCT02204410|472325817|FG000|Overall Study|Lost to Follow-up|5|||
131192402|NCT02204410|472325817|FG000|Overall Study|Physician Decision|2|||
131192403|NCT02204410|472325817|FG000|Overall Study|Protocol Violation|1|||
131192404|NCT02204410|472325817|FG000|Overall Study|Withdrawal by Subject|3|||
131192405|NCT03654560|472325820|FG000|Overall Study|Death|3|||
131192406|NCT03654560|472325821|FG001|Overall Study|Death|1|||
131192407|NCT03654560|472325820|FG000|Overall Study|Lost to Follow-up|1|||
131192408|NCT03654560|472325821|FG001|Overall Study|Lost to Follow-up|0|||
131192409|NCT00209092|472325822|FG000|Overall Study|Progression of disease|7|||
131192410|NCT00209092|472325823|FG001|Overall Study|Progression of disease|1|||
131192411|NCT00209092|472325822|FG000|Overall Study|Adverse Event|0|||
131192412|NCT00209092|472325823|FG001|Overall Study|Adverse Event|1|||
131192413|NCT00209092|472325822|FG000|Overall Study|Withdrawal by Subject|1|||
131192414|NCT00209092|472325823|FG001|Overall Study|Withdrawal by Subject|0|||
131192415|NCT02436915|472325826|FG000|Overall Study|Withdrawal by Subject|0|||
131192416|NCT02436915|472325827|FG001|Overall Study|Withdrawal by Subject|1|||
131192417|NCT01117181|472325834|FG000|Overall Study|Lost to Follow-up|1|||
131192418|NCT01117181|472325835|FG001|Overall Study|Lost to Follow-up|0|||
131192419|NCT01117181|472325834|FG000|Overall Study|Withdrawal by Subject|0|||
131192420|NCT01117181|472325835|FG001|Overall Study|Withdrawal by Subject|2|||
131192421|NCT01518309|472325836|FG000|Overall Study|Adverse Event|6|||
131192422|NCT01518309|472325836|FG000|Overall Study|Death|6|||
131192423|NCT01518309|472325836|FG000|Overall Study|Lack of Efficacy|7|||
131192424|NCT01518309|472325836|FG000|Overall Study|Withdrawal by Subject|6|||
131192425|NCT01518309|472325836|FG000|Overall Study|Physician Decision|3|||
131192426|NCT01518309|472325836|FG000|Overall Study|Sponsor Decision|2|||
131192427|NCT01518309|472325836|FG000|Overall Study|Not in Predefined Categories|9|||
131192428|NCT00863317|472325837|FG000|Overall Study|Lost to Follow-up|8|||
131192429|NCT00863317|472325838|FG001|Overall Study|Lost to Follow-up|9|||
131192430|NCT00038142|472325841|FG000|Overall Study|Ineligible|1|||
131192431|NCT00038142|472325842|FG001|Overall Study|Ineligible|0|||
131192432|NCT00038142|472325841|FG000|Overall Study|Progressive Disease|11|||
131192433|NCT00038142|472325842|FG001|Overall Study|Progressive Disease|7|||
131192434|NCT00038142|472325841|FG000|Overall Study|Death|1|||
131192435|NCT00038142|472325842|FG001|Overall Study|Death|0|||
131192436|NCT00038142|472325841|FG000|Overall Study|Adverse Event|1|||
131192437|NCT00038142|472325842|FG001|Overall Study|Adverse Event|0|||
131192438|NCT00038142|472325841|FG000|Overall Study|Unknown Reason|8|||
131192439|NCT00038142|472325842|FG001|Overall Study|Unknown Reason|0|||
131192440|NCT01440972|472325852|FG000|Overall Study|Withdrawal by Subject|3|||
131192441|NCT01440972|472325853|FG001|Overall Study|Withdrawal by Subject|2|||
131192442|NCT00068822|472325854|FG000|First Randomized Intervention|Lost to Follow-up|1|||
131192443|NCT00068822|472325855|FG001|First Randomized Intervention|Lost to Follow-up|2|||
131192444|NCT00735072|472325859|FG000|Overall Study|interrupted study med during ARV change|1|||
130784575|NCT01064479|470838825|FG000|Overall Study|Withdrawal by Subject|2|||
131192445|NCT00735072|472325860|FG001|Overall Study|interrupted study med during ARV change|0|||
131192446|NCT00735072|472325859|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
131192447|NCT00735072|472325860|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
131192448|NCT01678313|472325865|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
131192449|NCT01678313|472325866|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
131192450|NCT01678313|472325865|FG000|Completed the 3-month Therapy|Physician Decision|3|||
131192451|NCT01678313|472325866|FG001|Completed the 3-month Therapy|Physician Decision|4|||
131192452|NCT01678313|472325865|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
130784576|NCT01064479|470838826|FG001|Overall Study|Withdrawal by Subject|2|||
131192453|NCT01678313|472325866|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
131192454|NCT01678313|472325865|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
131192455|NCT01678313|472325866|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
131192456|NCT03464136|472325867|FG000|Overall Study|Lost to Follow-up|5|||
131192457|NCT03464136|472325868|FG001|Overall Study|Lost to Follow-up|8|||
131192458|NCT03464136|472325867|FG000|Overall Study|Withdrawal by Subject|16|||
131192459|NCT03464136|472325868|FG001|Overall Study|Withdrawal by Subject|13|||
131192460|NCT03464136|472325867|FG000|Overall Study|Death|1|||
131192461|NCT03464136|472325868|FG001|Overall Study|Death|0|||
131192462|NCT03464136|472325867|FG000|Overall Study|Other|8|||
131192463|NCT03464136|472325868|FG001|Overall Study|Other|4|||
131192464|NCT03412565|472325869|FG000|Overall Study|Lost to Follow-up|0|||
131192465|NCT03412565|472325870|FG001|Overall Study|Lost to Follow-up|0|||
131192466|NCT03412565|472325871|FG002|Overall Study|Lost to Follow-up|1|||
131192467|NCT03412565|472325872|FG003|Overall Study|Lost to Follow-up|0|||
131192468|NCT03412565|472325869|FG000|Overall Study|Physician Decision|0|||
131192469|NCT03412565|472325870|FG001|Overall Study|Physician Decision|0|||
131192470|NCT03412565|472325871|FG002|Overall Study|Physician Decision|0|||
131192471|NCT03412565|472325872|FG003|Overall Study|Physician Decision|1|||
131192472|NCT03412565|472325869|FG000|Overall Study|Withdrawal by Subject|0|||
131192473|NCT03412565|472325870|FG001|Overall Study|Withdrawal by Subject|4|||
131192474|NCT03412565|472325871|FG002|Overall Study|Withdrawal by Subject|5|||
131192475|NCT03412565|472325872|FG003|Overall Study|Withdrawal by Subject|5|||
131192476|NCT03412565|472325869|FG000|Overall Study|Death|1|||
131192477|NCT03412565|472325870|FG001|Overall Study|Death|3|||
131192478|NCT03412565|472325871|FG002|Overall Study|Death|4|||
131192479|NCT03412565|472325872|FG003|Overall Study|Death|5|||
131192480|NCT03412565|472325869|FG000|Overall Study|Data collection ended|0|||
131192481|NCT03412565|472325870|FG001|Overall Study|Data collection ended|41|||
131192482|NCT03412565|472325871|FG002|Overall Study|Data collection ended|41|||
131192483|NCT03412565|472325872|FG003|Overall Study|Data collection ended|40|||
131192484|NCT03146403|472325875|FG000|Overall Study|Withdrawal by Subject|0|||
131192485|NCT03146403|472325876|FG001|Overall Study|Withdrawal by Subject|3|||
131192486|NCT03146403|472325875|FG000|Overall Study|Lost to Follow-up|2|||
131192487|NCT03146403|472325876|FG001|Overall Study|Lost to Follow-up|0|||
131192488|NCT01024920|472325877|FG000|Overall Study|Progressive disease|47|||
131192489|NCT01024920|472325878|FG001|Overall Study|Progressive disease|25|||
131192490|NCT01024920|472325877|FG000|Overall Study|Adverse Event|8|||
131192491|NCT01024920|472325878|FG001|Overall Study|Adverse Event|4|||
131192492|NCT01024920|472325877|FG000|Overall Study|Lost to Follow-up|0|||
131192493|NCT01024920|472325878|FG001|Overall Study|Lost to Follow-up|1|||
131192494|NCT01024920|472325877|FG000|Overall Study|Patient refusal to continue|4|||
131192495|NCT01024920|472325878|FG001|Overall Study|Patient refusal to continue|0|||
131192496|NCT01024920|472325877|FG000|Overall Study|Other than listed|5|||
131192497|NCT01024920|472325878|FG001|Overall Study|Other than listed|1|||
131192498|NCT01024920|472325877|FG000|Overall Study|Not treated|3|||
131192499|NCT01024920|472325878|FG001|Overall Study|Not treated|0|||
131192500|NCT01024920|472325877|FG000|Overall Study|Protocol Violation|0|||
131192501|NCT01024920|472325878|FG001|Overall Study|Protocol Violation|1|||
131192502|NCT02972593|472325884|FG000|Overall Study|Lost to Follow-up|19|||
131192503|NCT02972593|472325885|FG001|Overall Study|Lost to Follow-up|15|||
131192504|NCT02972593|472325884|FG000|Overall Study|Protocol Violation|1|||
131192505|NCT02972593|472325885|FG001|Overall Study|Protocol Violation|0|||
131192506|NCT00693693|472325886|FG000|Overall Study|Lost to Follow-up|1|||
131192507|NCT00693693|472325887|FG001|Overall Study|Lost to Follow-up|1|||
131192508|NCT00693693|472325888|FG002|Overall Study|Lost to Follow-up|2|||
131192509|NCT04599972|472325893|FG000|Overall Study|Withdrawal by Subject|6|||
131192510|NCT04599972|472325894|FG001|Overall Study|Withdrawal by Subject|1|||
131192511|NCT04599972|472325893|FG000|Overall Study|Adverse Event|1|||
131192512|NCT04599972|472325894|FG001|Overall Study|Adverse Event|1|||
131192513|NCT04599972|472325893|FG000|Overall Study|Lost to Follow-up|1|||
131192514|NCT04599972|472325894|FG001|Overall Study|Lost to Follow-up|6|||
130784577|NCT01064479|470838825|FG000|Overall Study|Disease progression|1|||
131192515|NCT04599972|472325893|FG000|Overall Study|Protocol Violation|1|||
131192516|NCT04599972|472325894|FG001|Overall Study|Protocol Violation|0|||
131192517|NCT04599972|472325893|FG000|Overall Study|Other reason|1|||
131192518|NCT04599972|472325894|FG001|Overall Study|Other reason|0|||
131192519|NCT00638690|472325901|FG000|Overall Study|Death|655|||
131192520|NCT00638690|472325902|FG001|Overall Study|Death|335|||
131192521|NCT00638690|472325901|FG000|Overall Study|Withdrawal by Subject|22|||
131192522|NCT00638690|472325902|FG001|Overall Study|Withdrawal by Subject|5|||
131192523|NCT00638690|472325901|FG000|Overall Study|Lost to Follow-up|4|||
131192524|NCT00638690|472325902|FG001|Overall Study|Lost to Follow-up|2|||
131192525|NCT01594411|472325909|FG000|Overall Study|Lost to Follow-up|2|||
131192526|NCT04449276|472325915|FG000|Overall Study|Adverse Event|1|||
131192527|NCT04449276|472325916|FG001|Overall Study|Adverse Event|2|||
131192528|NCT04449276|472325917|FG002|Overall Study|Adverse Event|0|||
131192529|NCT04449276|472325918|FG003|Overall Study|Adverse Event|0|||
131192530|NCT04449276|472325919|FG004|Overall Study|Adverse Event|2|||
131192531|NCT04449276|472325920|FG005|Overall Study|Adverse Event|0|||
131192532|NCT04449276|472325921|FG006|Overall Study|Adverse Event|0|||
131192533|NCT04449276|472325922|FG007|Overall Study|Adverse Event|1|||
131192534|NCT04449276|472325915|FG000|Overall Study|Withdrawal by Subject|2|||
131192535|NCT04449276|472325916|FG001|Overall Study|Withdrawal by Subject|0|||
131192536|NCT04449276|472325917|FG002|Overall Study|Withdrawal by Subject|0|||
131192537|NCT04449276|472325918|FG003|Overall Study|Withdrawal by Subject|1|||
131192538|NCT04449276|472325919|FG004|Overall Study|Withdrawal by Subject|0|||
131192539|NCT04449276|472325920|FG005|Overall Study|Withdrawal by Subject|0|||
131192540|NCT04449276|472325921|FG006|Overall Study|Withdrawal by Subject|0|||
131192541|NCT04449276|472325922|FG007|Overall Study|Withdrawal by Subject|0|||
131192542|NCT04449276|472325915|FG000|Overall Study|Other|0|||
131192543|NCT04449276|472325916|FG001|Overall Study|Other|2|||
131192544|NCT04449276|472325917|FG002|Overall Study|Other|3|||
131192545|NCT04449276|472325918|FG003|Overall Study|Other|2|||
131192546|NCT04449276|472325919|FG004|Overall Study|Other|0|||
131192547|NCT04449276|472325920|FG005|Overall Study|Other|0|||
131192548|NCT04449276|472325921|FG006|Overall Study|Other|0|||
131192549|NCT04449276|472325922|FG007|Overall Study|Other|1|||
131192550|NCT00910728|472325926|FG000|Overall Study|Lack of Efficacy|2|||
131192551|NCT00910728|472325927|FG001|Overall Study|Lack of Efficacy|3|||
131192552|NCT00910728|472325928|FG002|Overall Study|Lack of Efficacy|1|||
131192553|NCT00910728|472325929|FG003|Overall Study|Lack of Efficacy|2|||
131192554|NCT00910728|472325930|FG004|Overall Study|Lack of Efficacy|1|||
131192555|NCT00910728|472325931|FG005|Overall Study|Lack of Efficacy|0|||
131192556|NCT00910728|472325932|FG006|Overall Study|Lack of Efficacy|2|||
131192557|NCT00910728|472325933|FG007|Overall Study|Lack of Efficacy|2|||
131192558|NCT00910728|472325934|FG008|Overall Study|Lack of Efficacy|2|||
131192559|NCT00910728|472325926|FG000|Overall Study|Withdrawal by Subject|0|||
131192560|NCT00910728|472325927|FG001|Overall Study|Withdrawal by Subject|0|||
131192561|NCT00910728|472325928|FG002|Overall Study|Withdrawal by Subject|0|||
131192562|NCT00910728|472325929|FG003|Overall Study|Withdrawal by Subject|0|||
131192563|NCT00910728|472325930|FG004|Overall Study|Withdrawal by Subject|3|||
131192564|NCT00910728|472325931|FG005|Overall Study|Withdrawal by Subject|1|||
131192565|NCT00910728|472325932|FG006|Overall Study|Withdrawal by Subject|2|||
131192566|NCT00910728|472325933|FG007|Overall Study|Withdrawal by Subject|0|||
131192567|NCT00910728|472325934|FG008|Overall Study|Withdrawal by Subject|0|||
131192568|NCT00910728|472325926|FG000|Overall Study|(not specified)|2|||
131192569|NCT00910728|472325927|FG001|Overall Study|(not specified)|0|||
131192570|NCT00910728|472325928|FG002|Overall Study|(not specified)|1|||
131192571|NCT00910728|472325929|FG003|Overall Study|(not specified)|0|||
131192572|NCT00910728|472325930|FG004|Overall Study|(not specified)|1|||
131192573|NCT00910728|472325931|FG005|Overall Study|(not specified)|0|||
131192574|NCT00910728|472325932|FG006|Overall Study|(not specified)|0|||
131192575|NCT00910728|472325933|FG007|Overall Study|(not specified)|0|||
131192576|NCT00910728|472325934|FG008|Overall Study|(not specified)|0|||
131192577|NCT00910728|472325926|FG000|Overall Study|Adverse Event|2|||
131192578|NCT00910728|472325927|FG001|Overall Study|Adverse Event|0|||
131192579|NCT00910728|472325928|FG002|Overall Study|Adverse Event|1|||
131192580|NCT00910728|472325929|FG003|Overall Study|Adverse Event|1|||
131192581|NCT00910728|472325930|FG004|Overall Study|Adverse Event|0|||
131192582|NCT00910728|472325931|FG005|Overall Study|Adverse Event|0|||
131192583|NCT00910728|472325932|FG006|Overall Study|Adverse Event|2|||
131192584|NCT00910728|472325933|FG007|Overall Study|Adverse Event|1|||
131192585|NCT00910728|472325934|FG008|Overall Study|Adverse Event|1|||
131192586|NCT04968353|472325935|FG000|Overall Study|Non-compliance|1|||
131192587|NCT04968353|472325936|FG001|Overall Study|Non-compliance|0|||
131192588|NCT04968353|472325937|FG002|Overall Study|Non-compliance|2|||
131192589|NCT04968353|472325938|FG003|Overall Study|Non-compliance|0|||
131192590|NCT03215667|472325943|FG000|Overall Study|Physician Decision|4|||
131192591|NCT01810380|472325946|FG000|Overall Study|Randomised not treated|2|||
131192592|NCT01810380|472325947|FG001|Overall Study|Randomised not treated|1|||
131192593|NCT01810380|472325948|FG002|Overall Study|Randomised not treated|1|||
131192594|NCT01810380|472325946|FG000|Overall Study|Adverse Event|11|||
131192595|NCT01810380|472325947|FG001|Overall Study|Adverse Event|14|||
131192596|NCT01810380|472325948|FG002|Overall Study|Adverse Event|4|||
131192597|NCT01810380|472325946|FG000|Overall Study|Lack of Efficacy|24|||
131192598|NCT01810380|472325947|FG001|Overall Study|Lack of Efficacy|10|||
131192599|NCT01810380|472325948|FG002|Overall Study|Lack of Efficacy|11|||
131192600|NCT01810380|472325946|FG000|Overall Study|Protocol Violation|1|||
131192601|NCT01810380|472325947|FG001|Overall Study|Protocol Violation|0|||
131192602|NCT01810380|472325948|FG002|Overall Study|Protocol Violation|1|||
131192603|NCT01810380|472325946|FG000|Overall Study|Withdrawal by Subject|6|||
131192604|NCT01810380|472325947|FG001|Overall Study|Withdrawal by Subject|0|||
131192605|NCT01810380|472325948|FG002|Overall Study|Withdrawal by Subject|6|||
131192606|NCT01810380|472325946|FG000|Overall Study|Administrative or other reasons|11|||
131192607|NCT01810380|472325947|FG001|Overall Study|Administrative or other reasons|13|||
131192608|NCT01810380|472325948|FG002|Overall Study|Administrative or other reasons|9|||
131192609|NCT00614991|472325949|FG000|Overall Study|Adverse Event|3|||
131192610|NCT00614991|472325950|FG001|Overall Study|Adverse Event|3|||
131192611|NCT00614991|472325951|FG002|Overall Study|Adverse Event|0|||
131192612|NCT00614991|472325952|FG003|Overall Study|Adverse Event|0|||
131192613|NCT00614991|472325953|FG004|Overall Study|Adverse Event|1|||
131192614|NCT00614991|472325954|FG005|Overall Study|Adverse Event|0|||
131192615|NCT03209362|472325961|FG000|Overall Study|Adverse Event|0|||
131192616|NCT03209362|472325962|FG001|Overall Study|Adverse Event|1|||
131192617|NCT03209362|472325961|FG000|Overall Study|Lost to Follow-up|0|||
131192618|NCT03209362|472325962|FG001|Overall Study|Lost to Follow-up|1|||
131192619|NCT03209362|472325961|FG000|Overall Study|Withdrawal by Subject|2|||
131192620|NCT03209362|472325962|FG001|Overall Study|Withdrawal by Subject|0|||
131192621|NCT03209362|472325961|FG000|Overall Study|Other|0|||
131192622|NCT03209362|472325962|FG001|Overall Study|Other|1|||
131192623|NCT00251589|472325965|FG000|Overall Study|Adverse Event|5|||
131192624|NCT00251589|472325966|FG001|Overall Study|Adverse Event|1|||
131192625|NCT00251589|472325967|FG002|Overall Study|Adverse Event|2|||
131192626|NCT00251589|472325968|FG003|Overall Study|Adverse Event|1|||
131192627|NCT00251589|472325965|FG000|Overall Study|Withdrawal by Subject|1|||
131192628|NCT00251589|472325966|FG001|Overall Study|Withdrawal by Subject|1|||
131192629|NCT00251589|472325967|FG002|Overall Study|Withdrawal by Subject|0|||
131192630|NCT00251589|472325968|FG003|Overall Study|Withdrawal by Subject|0|||
131192631|NCT00251589|472325965|FG000|Overall Study|Discontinued due to progressive disease|9|||
131192632|NCT00251589|472325966|FG001|Overall Study|Discontinued due to progressive disease|1|||
131192633|NCT00251589|472325967|FG002|Overall Study|Discontinued due to progressive disease|0|||
131192634|NCT00251589|472325968|FG003|Overall Study|Discontinued due to progressive disease|1|||
131192635|NCT02571972|472325971|FG000|Overall Study|Protocol Violation|2|||
131192636|NCT02571972|472325971|FG000|Overall Study|Withdrawal by Subject|2|||
131192637|NCT02493868|472325974|FG000|Induction Phase: DE Participants|Adverse Event|22|||
131192638|NCT02493868|472325975|FG001|Induction Phase: DE Participants|Adverse Event|0|||
131192639|NCT02493868|472325974|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
131192640|NCT02493868|472325975|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
131192641|NCT02493868|472325974|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
131192642|NCT02493868|472325975|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
131192643|NCT02493868|472325974|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
131192644|NCT02493868|472325975|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
131192645|NCT02493868|472325974|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
131192646|NCT02493868|472325975|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
131192647|NCT02493868|472325974|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
131192648|NCT02493868|472325975|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
131192649|NCT02493868|472325974|FG000|Induction Phase: DE Participants|Other|8|||
131192650|NCT02493868|472325975|FG001|Induction Phase: DE Participants|Other|0|||
131192651|NCT02493868|472325974|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
131192652|NCT02493868|472325975|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
131192653|NCT02493868|472325974|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
131192654|NCT02493868|472325975|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
131192655|NCT02493868|472325974|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
131192656|NCT02493868|472325975|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
131192657|NCT02493868|472325974|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
131192658|NCT02493868|472325975|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
131192659|NCT02493868|472325974|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
131192660|NCT02493868|472325975|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
131192661|NCT02493868|472325974|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
131192662|NCT02493868|472325975|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
131192663|NCT02493868|472325974|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
131192664|NCT02493868|472325975|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
131192665|NCT02493868|472325974|FG000|Optimization Phase: DE+TE Participants|Other|10|||
131192666|NCT02493868|472325975|FG001|Optimization Phase: DE+TE Participants|Other|2|||
131192667|NCT02493868|472325974|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
131192668|NCT02493868|472325975|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
131192669|NCT02493868|472325974|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
131192670|NCT02493868|472325975|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
131192671|NCT02493868|472325974|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
131192672|NCT02493868|472325975|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
131192673|NCT02493868|472325974|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
131192674|NCT02493868|472325975|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
131192675|NCT02493868|472325974|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
131192676|NCT02493868|472325975|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
131192677|NCT02493868|472325974|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
131192678|NCT02493868|472325975|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
130784578|NCT01064479|470838826|FG001|Overall Study|Disease progression|1|||
131192679|NCT02493868|472325974|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
131192680|NCT02493868|472325975|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
131192681|NCT02493868|472325974|FG000|Follow-up Phase|Lost to Follow-up|1|||
131192682|NCT02493868|472325975|FG001|Follow-up Phase|Lost to Follow-up|0|||
131192683|NCT02493868|472325974|FG000|Follow-up Phase|Withdrawal by Subject|3|||
131192684|NCT02493868|472325975|FG001|Follow-up Phase|Withdrawal by Subject|0|||
131192685|NCT02493868|472325974|FG000|Follow-up Phase|Investigator Decision|5|||
131192686|NCT02493868|472325975|FG001|Follow-up Phase|Investigator Decision|1|||
131192687|NCT02493868|472325974|FG000|Follow-up Phase|Other|2|||
131192688|NCT02493868|472325975|FG001|Follow-up Phase|Other|1|||
131192689|NCT02407236|472325976|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
131192690|NCT02407236|472325977|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
131192691|NCT02407236|472325978|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
131192692|NCT02407236|472325979|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
130733600|NCT01575548|470642917|FG000|Overall Study|Other complicating disease|1|||
130733601|NCT01575548|470642918|FG001|Overall Study|Other complicating disease|0|||
130733602|NCT01575548|470642917|FG000|Overall Study|Withdrawal by Subject|7|||
131192693|NCT02407236|472325980|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
130733603|NCT01575548|470642918|FG001|Overall Study|Withdrawal by Subject|3|||
131192694|NCT02407236|472325981|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
131192695|NCT02407236|472325982|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
131192696|NCT02407236|472325983|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
131192697|NCT02407236|472325984|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
131192698|NCT02407236|472325985|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
131192699|NCT02407236|472325986|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
131192700|NCT02407236|472325987|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
131192701|NCT02407236|472325988|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
131192702|NCT02407236|472325976|FG000|Induction Study (8 Weeks)|Death|0|||
131192703|NCT02407236|472325977|FG001|Induction Study (8 Weeks)|Death|0|||
131192704|NCT02407236|472325978|FG002|Induction Study (8 Weeks)|Death|1|||
131192705|NCT02407236|472325979|FG003|Induction Study (8 Weeks)|Death|0|||
131192706|NCT02407236|472325980|FG004|Induction Study (8 Weeks)|Death|0|||
130784579|NCT01064479|470838825|FG000|Overall Study|Toxicity|1|||
131192707|NCT02407236|472325981|FG005|Induction Study (8 Weeks)|Death|0|||
131192708|NCT02407236|472325982|FG006|Induction Study (8 Weeks)|Death|0|||
131192709|NCT02407236|472325983|FG007|Induction Study (8 Weeks)|Death|0|||
131192710|NCT02407236|472325984|FG008|Induction Study (8 Weeks)|Death|0|||
130784580|NCT01064479|470838826|FG001|Overall Study|Toxicity|1|||
131192711|NCT02407236|472325985|FG009|Induction Study (8 Weeks)|Death|0|||
131192712|NCT02407236|472325986|FG010|Induction Study (8 Weeks)|Death|0|||
131192713|NCT02407236|472325987|FG011|Induction Study (8 Weeks)|Death|0|||
131192714|NCT02407236|472325988|FG012|Induction Study (8 Weeks)|Death|0|||
131192715|NCT02407236|472325976|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
131192716|NCT02407236|472325977|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
131192717|NCT02407236|472325978|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
131192718|NCT02407236|472325979|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131192719|NCT02407236|472325980|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131192720|NCT02407236|472325981|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131192721|NCT02407236|472325982|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131192722|NCT02407236|472325983|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131192723|NCT02407236|472325984|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131192724|NCT02407236|472325985|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131192725|NCT02407236|472325986|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131192726|NCT02407236|472325987|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131192727|NCT02407236|472325988|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
131192728|NCT02407236|472325976|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192729|NCT02407236|472325977|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192730|NCT02407236|472325978|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
131192731|NCT02407236|472325979|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192732|NCT02407236|472325980|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192733|NCT02407236|472325981|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192734|NCT02407236|472325982|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192735|NCT02407236|472325983|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192736|NCT02407236|472325984|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192737|NCT02407236|472325985|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192738|NCT02407236|472325986|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192739|NCT02407236|472325987|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192740|NCT02407236|472325988|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
131192741|NCT02407236|472325976|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
131192742|NCT02407236|472325977|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
131192743|NCT02407236|472325978|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
131192744|NCT02407236|472325979|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
131192745|NCT02407236|472325980|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
131192746|NCT02407236|472325981|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
131192747|NCT02407236|472325982|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
131192748|NCT02407236|472325983|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
131192749|NCT02407236|472325984|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
131192750|NCT02407236|472325985|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
131192751|NCT02407236|472325986|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
131192752|NCT02407236|472325987|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
131192753|NCT02407236|472325988|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
131192754|NCT02407236|472325976|FG000|Induction Study (8 Weeks)|Other|2|||
131192755|NCT02407236|472325977|FG001|Induction Study (8 Weeks)|Other|1|||
131192756|NCT02407236|472325978|FG002|Induction Study (8 Weeks)|Other|5|||
131192757|NCT02407236|472325979|FG003|Induction Study (8 Weeks)|Other|0|||
131192758|NCT02407236|472325980|FG004|Induction Study (8 Weeks)|Other|0|||
131192759|NCT02407236|472325981|FG005|Induction Study (8 Weeks)|Other|0|||
131192760|NCT02407236|472325982|FG006|Induction Study (8 Weeks)|Other|0|||
131192761|NCT02407236|472325983|FG007|Induction Study (8 Weeks)|Other|0|||
131192762|NCT02407236|472325984|FG008|Induction Study (8 Weeks)|Other|0|||
131192763|NCT02407236|472325985|FG009|Induction Study (8 Weeks)|Other|0|||
131192764|NCT02407236|472325986|FG010|Induction Study (8 Weeks)|Other|0|||
131192765|NCT02407236|472325987|FG011|Induction Study (8 Weeks)|Other|0|||
131192766|NCT02407236|472325988|FG012|Induction Study (8 Weeks)|Other|0|||
131192767|NCT02407236|472325976|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
131192768|NCT02407236|472325977|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
131192769|NCT02407236|472325978|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
131192770|NCT02407236|472325979|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
131192771|NCT02407236|472325980|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
131192772|NCT02407236|472325981|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
131192773|NCT02407236|472325982|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
131192774|NCT02407236|472325983|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
131192775|NCT02407236|472325984|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
131192776|NCT02407236|472325985|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
131192777|NCT02407236|472325986|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
131192778|NCT02407236|472325987|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
131192779|NCT02407236|472325988|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
131192780|NCT02407236|472325976|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131192781|NCT02407236|472325977|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131192782|NCT02407236|472325978|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131192783|NCT02407236|472325979|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
131192784|NCT02407236|472325980|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
131192785|NCT02407236|472325981|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
131192786|NCT02407236|472325982|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
131192787|NCT02407236|472325983|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
131192788|NCT02407236|472325984|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131192789|NCT02407236|472325985|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131192790|NCT02407236|472325986|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131192791|NCT02407236|472325987|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131192792|NCT02407236|472325988|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
131192793|NCT02407236|472325976|FG000|Maintenance Study (44 Weeks)|Other|0|||
131192794|NCT02407236|472325977|FG001|Maintenance Study (44 Weeks)|Other|0|||
131192795|NCT02407236|472325978|FG002|Maintenance Study (44 Weeks)|Other|0|||
131192796|NCT02407236|472325979|FG003|Maintenance Study (44 Weeks)|Other|5|||
131192797|NCT02407236|472325980|FG004|Maintenance Study (44 Weeks)|Other|7|||
131192798|NCT02407236|472325981|FG005|Maintenance Study (44 Weeks)|Other|8|||
131192799|NCT02407236|472325982|FG006|Maintenance Study (44 Weeks)|Other|4|||
131192800|NCT02407236|472325983|FG007|Maintenance Study (44 Weeks)|Other|6|||
131192801|NCT02407236|472325984|FG008|Maintenance Study (44 Weeks)|Other|0|||
131192802|NCT02407236|472325985|FG009|Maintenance Study (44 Weeks)|Other|0|||
131192803|NCT02407236|472325986|FG010|Maintenance Study (44 Weeks)|Other|0|||
131192804|NCT02407236|472325987|FG011|Maintenance Study (44 Weeks)|Other|0|||
131192805|NCT02407236|472325988|FG012|Maintenance Study (44 Weeks)|Other|0|||
131192806|NCT02407236|472325976|FG000|Maintenance Study (44 Weeks)|Death|0|||
131192807|NCT02407236|472325977|FG001|Maintenance Study (44 Weeks)|Death|0|||
131192808|NCT02407236|472325978|FG002|Maintenance Study (44 Weeks)|Death|0|||
131192809|NCT02407236|472325979|FG003|Maintenance Study (44 Weeks)|Death|0|||
131192810|NCT02407236|472325980|FG004|Maintenance Study (44 Weeks)|Death|0|||
131192811|NCT02407236|472325981|FG005|Maintenance Study (44 Weeks)|Death|0|||
131192812|NCT02407236|472325982|FG006|Maintenance Study (44 Weeks)|Death|0|||
131192813|NCT02407236|472325983|FG007|Maintenance Study (44 Weeks)|Death|1|||
131192814|NCT02407236|472325984|FG008|Maintenance Study (44 Weeks)|Death|0|||
131192815|NCT02407236|472325985|FG009|Maintenance Study (44 Weeks)|Death|0|||
131192816|NCT02407236|472325986|FG010|Maintenance Study (44 Weeks)|Death|0|||
131192817|NCT02407236|472325987|FG011|Maintenance Study (44 Weeks)|Death|0|||
131192818|NCT02407236|472325988|FG012|Maintenance Study (44 Weeks)|Death|0|||
131192819|NCT02407236|472325976|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131192820|NCT02407236|472325977|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131192821|NCT02407236|472325978|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131192822|NCT02407236|472325979|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131192823|NCT02407236|472325980|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131192824|NCT02407236|472325981|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131192825|NCT02407236|472325982|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131192826|NCT02407236|472325983|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
131192827|NCT02407236|472325984|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
131192828|NCT02407236|472325985|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
131192829|NCT02407236|472325986|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
131192830|NCT02407236|472325987|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
131192831|NCT02407236|472325988|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
131192832|NCT02407236|472325976|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192833|NCT02407236|472325977|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192834|NCT02407236|472325978|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192835|NCT02407236|472325979|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192836|NCT02407236|472325980|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192837|NCT02407236|472325981|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192838|NCT02407236|472325982|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192839|NCT02407236|472325983|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192840|NCT02407236|472325984|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192841|NCT02407236|472325985|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192842|NCT02407236|472325986|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
131192843|NCT02407236|472325987|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192844|NCT02407236|472325988|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
131192845|NCT02407236|472325976|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131192846|NCT02407236|472325977|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131192847|NCT02407236|472325978|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131192848|NCT02407236|472325979|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131192849|NCT02407236|472325980|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131192850|NCT02407236|472325981|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131192851|NCT02407236|472325982|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131192852|NCT02407236|472325983|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
131192853|NCT02407236|472325984|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
131192854|NCT02407236|472325985|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
131192855|NCT02407236|472325986|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
131192856|NCT02407236|472325987|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
131192857|NCT02407236|472325988|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
131192858|NCT02407236|472325976|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
131192859|NCT02407236|472325977|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
131192860|NCT02407236|472325978|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
131192861|NCT02407236|472325979|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
131192862|NCT02407236|472325980|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
131192863|NCT02407236|472325981|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
131192864|NCT02407236|472325982|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
131192865|NCT02407236|472325983|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
131192866|NCT02407236|472325984|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
131192867|NCT02407236|472325985|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
131192868|NCT02407236|472325986|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
131192869|NCT02407236|472325987|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
131192870|NCT02407236|472325988|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
131192871|NCT03074318|472325989|FG000|Overall Study|Adverse Event|0|||
131192872|NCT03074318|472325990|FG001|Overall Study|Adverse Event|1|||
131192873|NCT03074318|472325991|FG002|Overall Study|Adverse Event|1|||
131192874|NCT03074318|472325992|FG003|Overall Study|Adverse Event|1|||
131192875|NCT03074318|472325989|FG000|Overall Study|Death|1|||
131192876|NCT03074318|472325990|FG001|Overall Study|Death|0|||
131192877|NCT03074318|472325991|FG002|Overall Study|Death|0|||
131192878|NCT03074318|472325992|FG003|Overall Study|Death|0|||
131192879|NCT03074318|472325989|FG000|Overall Study|Withdrawal by Subject|1|||
131192880|NCT03074318|472325990|FG001|Overall Study|Withdrawal by Subject|2|||
131192881|NCT03074318|472325991|FG002|Overall Study|Withdrawal by Subject|2|||
131192882|NCT03074318|472325992|FG003|Overall Study|Withdrawal by Subject|4|||
131192883|NCT03074318|472325989|FG000|Overall Study|Trial Closure|2|||
131192884|NCT03074318|472325990|FG001|Overall Study|Trial Closure|2|||
131192885|NCT03074318|472325991|FG002|Overall Study|Trial Closure|3|||
131192886|NCT03074318|472325992|FG003|Overall Study|Trial Closure|11|||
131192887|NCT01627782|472325995|FG000|Overall Study|Adverse Event|1|||
131192888|NCT01627782|472325996|FG001|Overall Study|Adverse Event|2|||
131192889|NCT01627782|472325997|FG002|Overall Study|Adverse Event|0|||
131192890|NCT01627782|472325998|FG003|Overall Study|Adverse Event|1|||
131192891|NCT01627782|472325995|FG000|Overall Study|Lack of Efficacy|11|||
131192892|NCT01627782|472325996|FG001|Overall Study|Lack of Efficacy|1|||
131192893|NCT01627782|472325997|FG002|Overall Study|Lack of Efficacy|15|||
131192894|NCT01627782|472325998|FG003|Overall Study|Lack of Efficacy|2|||
131192895|NCT01627782|472325995|FG000|Overall Study|Protocol Violation|1|||
131192896|NCT01627782|472325996|FG001|Overall Study|Protocol Violation|0|||
131192897|NCT01627782|472325997|FG002|Overall Study|Protocol Violation|0|||
131192898|NCT01627782|472325998|FG003|Overall Study|Protocol Violation|0|||
131192899|NCT01627782|472325995|FG000|Overall Study|Withdrawal by Subject|2|||
131192900|NCT01627782|472325996|FG001|Overall Study|Withdrawal by Subject|1|||
131192901|NCT01627782|472325997|FG002|Overall Study|Withdrawal by Subject|0|||
131192902|NCT01627782|472325998|FG003|Overall Study|Withdrawal by Subject|0|||
131192903|NCT01627782|472325995|FG000|Overall Study|Other|0|||
131192904|NCT01627782|472325996|FG001|Overall Study|Other|2|||
131192905|NCT01627782|472325997|FG002|Overall Study|Other|0|||
131192906|NCT01627782|472325998|FG003|Overall Study|Other|3|||
131192907|NCT01627782|472325995|FG000|Overall Study|Randomized But Not Treated|1|||
131192908|NCT01627782|472325996|FG001|Overall Study|Randomized But Not Treated|0|||
131192909|NCT01627782|472325997|FG002|Overall Study|Randomized But Not Treated|0|||
131192910|NCT01627782|472325998|FG003|Overall Study|Randomized But Not Treated|0|||
131192911|NCT00643448|472325999|FG000|Overall Study|Lack of Efficacy|2|||
131192912|NCT00643448|472326000|FG001|Overall Study|Lack of Efficacy|0|||
131192913|NCT00643448|472326001|FG002|Overall Study|Lack of Efficacy|4|||
131192914|NCT00643448|472325999|FG000|Overall Study|Adverse Event|2|||
131192915|NCT00643448|472326000|FG001|Overall Study|Adverse Event|2|||
131192916|NCT00643448|472326001|FG002|Overall Study|Adverse Event|2|||
131192917|NCT00643448|472325999|FG000|Overall Study|QTcF>550 ms|0|||
131192918|NCT00643448|472326000|FG001|Overall Study|QTcF>550 ms|3|||
131192919|NCT00643448|472326001|FG002|Overall Study|QTcF>550 ms|0|||
131192920|NCT02177812|472326003|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131192921|NCT02177812|472326004|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131192922|NCT02177812|472326005|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131192923|NCT02177812|472326006|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131192924|NCT02177812|472326007|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131192925|NCT02177812|472326008|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
131192926|NCT02177812|472326009|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
131192927|NCT02177812|472326010|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
131192928|NCT02177812|472326011|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
131192929|NCT02177812|472326003|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131192930|NCT02177812|472326004|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131192931|NCT02177812|472326005|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131192932|NCT02177812|472326006|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131192933|NCT02177812|472326007|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131192934|NCT02177812|472326008|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
131192935|NCT02177812|472326009|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
131192936|NCT02177812|472326010|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131192937|NCT02177812|472326011|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
131192938|NCT02177812|472326003|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
131192939|NCT02177812|472326004|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
131192940|NCT02177812|472326005|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
131192941|NCT02177812|472326006|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
131192942|NCT02177812|472326007|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
131192943|NCT02177812|472326008|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
131192944|NCT02177812|472326009|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
131192945|NCT02177812|472326010|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
131192946|NCT02177812|472326011|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
131192947|NCT00089999|472326012|FG000|Overall Study|Adverse Event|4|||
131192948|NCT00089999|472326013|FG001|Overall Study|Adverse Event|7|||
131192949|NCT00089999|472326012|FG000|Overall Study|Withdrawal by Subject|0|||
131192950|NCT00089999|472326013|FG001|Overall Study|Withdrawal by Subject|4|||
131192951|NCT00089999|472326012|FG000|Overall Study|Lost to Follow-up|2|||
131192952|NCT00089999|472326013|FG001|Overall Study|Lost to Follow-up|1|||
131192953|NCT00089999|472326012|FG000|Overall Study|Radiological Progression of Cancer|52|||
131192954|NCT00089999|472326013|FG001|Overall Study|Radiological Progression of Cancer|44|||
131192955|NCT00089999|472326012|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
131192956|NCT00089999|472326013|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
131192957|NCT00089999|472326012|FG000|Overall Study|Death|3|||
131192958|NCT00089999|472326013|FG001|Overall Study|Death|3|||
131192959|NCT00089999|472326012|FG000|Overall Study|Poor General Condition|1|||
131192960|NCT00089999|472326013|FG001|Overall Study|Poor General Condition|0|||
131192961|NCT00089999|472326012|FG000|Overall Study|Clinical Progression|1|||
131192962|NCT00089999|472326013|FG001|Overall Study|Clinical Progression|2|||
131192963|NCT00089999|472326012|FG000|Overall Study|Physician Decision|2|||
131192964|NCT00089999|472326013|FG001|Overall Study|Physician Decision|2|||
131192965|NCT00089999|472326012|FG000|Overall Study|Patient Underwent Surgery|2|||
131192966|NCT00089999|472326013|FG001|Overall Study|Patient Underwent Surgery|0|||
131192967|NCT00089999|472326012|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
131192968|NCT00089999|472326013|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
131192969|NCT05166603|472326016|FG000|Overall Study|Withdrawal by Subject|68|||
131192970|NCT05166603|472326017|FG001|Overall Study|Withdrawal by Subject|0|||
131192971|NCT01462045|472327751|FG000|Overall Study|Family matter|0|||
130733604|NCT01575548|470642917|FG000|Overall Study|Noncompliance|1|||
130733605|NCT01575548|470642918|FG001|Overall Study|Noncompliance|0|||
130733606|NCT01575548|470642917|FG000|Overall Study|Anticipated surgery|0|||
131192972|NCT01462045|472327752|FG001|Overall Study|Family matter|1|||
131192973|NCT01462045|472327753|FG002|Overall Study|Family matter|0|||
131192974|NCT02579863|472327754|FG000|Overall Study|Final Disposition Unknown|2|||
131192975|NCT02579863|472327755|FG001|Overall Study|Final Disposition Unknown|1|||
131192976|NCT02579863|472327754|FG000|Overall Study|Adverse Event|18|||
131192977|NCT02579863|472327755|FG001|Overall Study|Adverse Event|11|||
131192978|NCT02579863|472327754|FG000|Overall Study|Death|31|||
131192979|NCT02579863|472327755|FG001|Overall Study|Death|29|||
131192980|NCT02579863|472327754|FG000|Overall Study|Lost to Follow-up|2|||
131192981|NCT02579863|472327755|FG001|Overall Study|Lost to Follow-up|1|||
131192982|NCT02579863|472327754|FG000|Overall Study|Physician Decision|1|||
131192983|NCT02579863|472327755|FG001|Overall Study|Physician Decision|2|||
131192984|NCT02579863|472327754|FG000|Overall Study|Screen Failure|0|||
131192985|NCT02579863|472327755|FG001|Overall Study|Screen Failure|2|||
131192986|NCT02579863|472327754|FG000|Overall Study|Study Terminated at Selected Sites|82|||
131192987|NCT02579863|472327755|FG001|Overall Study|Study Terminated at Selected Sites|88|||
131192988|NCT02579863|472327754|FG000|Overall Study|Withdrawal by Subject|20|||
131192989|NCT02579863|472327755|FG001|Overall Study|Withdrawal by Subject|20|||
131192990|NCT02658149|472327757|FG000|Overall Study|Physician Decision|1|||
131192991|NCT02658149|472327758|FG001|Overall Study|Physician Decision|0|||
131192992|NCT03933215|472327766|FG000|Overall Study|Other|6|||
131192993|NCT03933215|472327766|FG000|Overall Study|Sponsor decision|5|||
131192994|NCT03933215|472327766|FG000|Overall Study|Protocol Violation|5|||
131192995|NCT03933215|472327766|FG000|Overall Study|Withdrawal by Subject|6|||
131192996|NCT03933215|472327766|FG000|Overall Study|Lost to Follow-up|6|||
131192997|NCT03933215|472327766|FG000|Overall Study|Enrolled but not treated|38|||
131192998|NCT02352090|472327767|FG000|Overall Study|general malaise|1|||
131192999|NCT02352090|472327768|FG001|Overall Study|general malaise|0|||
131193000|NCT02352090|472327769|FG002|Overall Study|general malaise|0|||
131193001|NCT02352090|472327767|FG000|Overall Study|non-specified mild side-effects|0|||
131193002|NCT02352090|472327768|FG001|Overall Study|non-specified mild side-effects|0|||
131193003|NCT02352090|472327769|FG002|Overall Study|non-specified mild side-effects|2|||
131193004|NCT00911144|472327770|FG000|Overall Study|Withdrawal by Subject|16|||
131193005|NCT00911144|472327771|FG001|Overall Study|Withdrawal by Subject|5|||
131193006|NCT00981292|472327772|FG000|Day 1|Protocol Violation|1|||
131193007|NCT00981292|472327773|FG001|Day 1|Protocol Violation|0|||
131193008|NCT00981292|472327774|FG002|Day 1|Protocol Violation|0|||
131193009|NCT00981292|472327775|FG003|Day 1|Protocol Violation|0|||
131193010|NCT00981292|472327776|FG004|Day 1|Protocol Violation|0|||
131193011|NCT00981292|472327777|FG005|Day 1|Protocol Violation|2|||
131193012|NCT00981292|472327772|FG000|Day 2|Protocol Violation|2|||
131193013|NCT00981292|472327773|FG001|Day 2|Protocol Violation|0|||
131193014|NCT00981292|472327774|FG002|Day 2|Protocol Violation|0|||
131193015|NCT00981292|472327775|FG003|Day 2|Protocol Violation|0|||
131193016|NCT00981292|472327776|FG004|Day 2|Protocol Violation|0|||
131193017|NCT00981292|472327777|FG005|Day 2|Protocol Violation|0|||
131193018|NCT00981292|472327772|FG000|Day 3|Protocol Violation|0|||
131193019|NCT00981292|472327773|FG001|Day 3|Protocol Violation|0|||
131193020|NCT00981292|472327774|FG002|Day 3|Protocol Violation|0|||
131193021|NCT00981292|472327775|FG003|Day 3|Protocol Violation|0|||
131193022|NCT00981292|472327776|FG004|Day 3|Protocol Violation|0|||
131193023|NCT00981292|472327777|FG005|Day 3|Protocol Violation|1|||
131193024|NCT01131130|472327778|FG000|Period 1 - Baseline|Pregnancy|1|||
131193025|NCT01131130|472327778|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
131193026|NCT01849562|472327779|FG000|Overall Study|Lost to Follow-up|1|||
131193027|NCT01849562|472327780|FG001|Overall Study|Lost to Follow-up|0|||
131193028|NCT01849562|472327781|FG002|Overall Study|Lost to Follow-up|0|||
131193029|NCT01849562|472327779|FG000|Overall Study|Non-compliance with Study Drug|1|||
131193030|NCT01849562|472327780|FG001|Overall Study|Non-compliance with Study Drug|0|||
131193031|NCT01849562|472327781|FG002|Overall Study|Non-compliance with Study Drug|0|||
131193032|NCT01098032|472327782|FG000|Overall Study|Withdrawal by Subject|1|||
131193033|NCT01098032|472327783|FG001|Overall Study|Withdrawal by Subject|1|||
131193034|NCT02182999|472327785|FG000|Overall Study|Adverse Event|4|||
131193035|NCT02182999|472327786|FG001|Overall Study|Adverse Event|3|||
130733607|NCT01575548|470642918|FG001|Overall Study|Anticipated surgery|1|||
131193036|NCT02182999|472327785|FG000|Overall Study|Physician Decision|1|||
131193037|NCT02182999|472327786|FG001|Overall Study|Physician Decision|0|||
131193038|NCT02252588|472327788|FG000|Overall Study|Withdrawal by Subject|4|||
131193039|NCT02252588|472327789|FG001|Overall Study|Withdrawal by Subject|0|||
130733608|NCT01575548|470642917|FG000|Overall Study|Never started protocol therapy|3|||
131193040|NCT03039790|472327790|FG000|Overall Study|Lost to Follow-up|2|||
131193041|NCT03039790|472327791|FG001|Overall Study|Lost to Follow-up|0|||
131193042|NCT03039790|472327792|FG002|Overall Study|Lost to Follow-up|1|||
131193043|NCT03039790|472327793|FG003|Overall Study|Lost to Follow-up|1|||
131193044|NCT03039790|472327794|FG004|Overall Study|Lost to Follow-up|0|||
131193045|NCT03039790|472327795|FG005|Overall Study|Lost to Follow-up|1|||
131193046|NCT03039790|472327796|FG006|Overall Study|Lost to Follow-up|1|||
131193047|NCT03039790|472327797|FG007|Overall Study|Lost to Follow-up|1|||
131193048|NCT03039790|472327798|FG008|Overall Study|Lost to Follow-up|0|||
131193049|NCT03039790|472327799|FG009|Overall Study|Lost to Follow-up|1|||
131193050|NCT03039790|472327800|FG010|Overall Study|Lost to Follow-up|1|||
131193051|NCT03039790|472327801|FG011|Overall Study|Lost to Follow-up|0|||
131193052|NCT03039790|472327802|FG012|Overall Study|Lost to Follow-up|1|||
131193053|NCT03039790|472327803|FG013|Overall Study|Lost to Follow-up|0|||
131193054|NCT03039790|472327804|FG014|Overall Study|Lost to Follow-up|3|||
131193055|NCT03039790|472327805|FG015|Overall Study|Lost to Follow-up|1|||
131193056|NCT03039790|472327806|FG016|Overall Study|Lost to Follow-up|2|||
131193057|NCT03039790|472327807|FG017|Overall Study|Lost to Follow-up|2|||
131193058|NCT03039790|472327808|FG018|Overall Study|Lost to Follow-up|1|||
131193059|NCT03039790|472327809|FG019|Overall Study|Lost to Follow-up|3|||
131193060|NCT03039790|472327790|FG000|Overall Study|Withdrawal of Consent|1|||
131193061|NCT03039790|472327791|FG001|Overall Study|Withdrawal of Consent|0|||
131193062|NCT03039790|472327792|FG002|Overall Study|Withdrawal of Consent|0|||
131193063|NCT03039790|472327793|FG003|Overall Study|Withdrawal of Consent|1|||
131193064|NCT03039790|472327794|FG004|Overall Study|Withdrawal of Consent|0|||
131193065|NCT03039790|472327795|FG005|Overall Study|Withdrawal of Consent|0|||
131193066|NCT03039790|472327796|FG006|Overall Study|Withdrawal of Consent|0|||
131193067|NCT03039790|472327797|FG007|Overall Study|Withdrawal of Consent|0|||
131193068|NCT03039790|472327798|FG008|Overall Study|Withdrawal of Consent|0|||
131193069|NCT03039790|472327799|FG009|Overall Study|Withdrawal of Consent|1|||
130733609|NCT01575548|470642918|FG001|Overall Study|Never started protocol therapy|2|||
130733610|NCT04175912|470642919|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
130733611|NCT04175912|470642920|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
130733612|NCT04175912|470642919|FG000|Overall Study|Adverse Event|0|||
130733613|NCT04175912|470642920|FG001|Overall Study|Adverse Event|3|||
130733614|NCT04175912|470642919|FG000|Overall Study|Never started treatment|3|||
130733615|NCT04175912|470642920|FG001|Overall Study|Never started treatment|3|||
131193070|NCT03039790|472327800|FG010|Overall Study|Withdrawal of Consent|0|||
131193071|NCT03039790|472327801|FG011|Overall Study|Withdrawal of Consent|0|||
131193072|NCT03039790|472327802|FG012|Overall Study|Withdrawal of Consent|2|||
131193073|NCT03039790|472327803|FG013|Overall Study|Withdrawal of Consent|0|||
131193074|NCT03039790|472327804|FG014|Overall Study|Withdrawal of Consent|1|||
131193075|NCT03039790|472327805|FG015|Overall Study|Withdrawal of Consent|5|||
131193076|NCT03039790|472327806|FG016|Overall Study|Withdrawal of Consent|3|||
131193077|NCT03039790|472327807|FG017|Overall Study|Withdrawal of Consent|0|||
131193078|NCT03039790|472327808|FG018|Overall Study|Withdrawal of Consent|2|||
131193079|NCT03039790|472327809|FG019|Overall Study|Withdrawal of Consent|5|||
131193080|NCT03039790|472327790|FG000|Overall Study|Death|0|||
131193081|NCT03039790|472327791|FG001|Overall Study|Death|0|||
131193082|NCT03039790|472327792|FG002|Overall Study|Death|0|||
131193083|NCT03039790|472327793|FG003|Overall Study|Death|0|||
131193084|NCT03039790|472327794|FG004|Overall Study|Death|0|||
131193085|NCT03039790|472327795|FG005|Overall Study|Death|0|||
131193086|NCT03039790|472327796|FG006|Overall Study|Death|0|||
131193087|NCT03039790|472327797|FG007|Overall Study|Death|0|||
131193088|NCT03039790|472327798|FG008|Overall Study|Death|0|||
131193089|NCT03039790|472327799|FG009|Overall Study|Death|0|||
131193090|NCT03039790|472327800|FG010|Overall Study|Death|0|||
131193091|NCT03039790|472327801|FG011|Overall Study|Death|0|||
131193092|NCT03039790|472327802|FG012|Overall Study|Death|0|||
131193093|NCT03039790|472327803|FG013|Overall Study|Death|0|||
131193094|NCT03039790|472327804|FG014|Overall Study|Death|0|||
131193095|NCT03039790|472327805|FG015|Overall Study|Death|1|||
131193096|NCT03039790|472327806|FG016|Overall Study|Death|3|||
131193097|NCT03039790|472327807|FG017|Overall Study|Death|0|||
131193098|NCT03039790|472327808|FG018|Overall Study|Death|2|||
131193099|NCT03039790|472327809|FG019|Overall Study|Death|0|||
131193100|NCT03039790|472327790|FG000|Overall Study|Reason, not Specified|1|||
131193101|NCT03039790|472327791|FG001|Overall Study|Reason, not Specified|0|||
131193102|NCT03039790|472327792|FG002|Overall Study|Reason, not Specified|0|||
131193103|NCT03039790|472327793|FG003|Overall Study|Reason, not Specified|0|||
131193104|NCT03039790|472327794|FG004|Overall Study|Reason, not Specified|0|||
131193105|NCT03039790|472327795|FG005|Overall Study|Reason, not Specified|0|||
131193106|NCT03039790|472327796|FG006|Overall Study|Reason, not Specified|0|||
131193107|NCT03039790|472327797|FG007|Overall Study|Reason, not Specified|0|||
131193108|NCT03039790|472327798|FG008|Overall Study|Reason, not Specified|0|||
131193109|NCT03039790|472327799|FG009|Overall Study|Reason, not Specified|0|||
131193110|NCT03039790|472327800|FG010|Overall Study|Reason, not Specified|0|||
131193111|NCT03039790|472327801|FG011|Overall Study|Reason, not Specified|0|||
131193112|NCT03039790|472327802|FG012|Overall Study|Reason, not Specified|0|||
131193113|NCT03039790|472327803|FG013|Overall Study|Reason, not Specified|0|||
131193114|NCT03039790|472327804|FG014|Overall Study|Reason, not Specified|0|||
131193115|NCT03039790|472327805|FG015|Overall Study|Reason, not Specified|0|||
131193116|NCT03039790|472327806|FG016|Overall Study|Reason, not Specified|2|||
131193117|NCT03039790|472327807|FG017|Overall Study|Reason, not Specified|0|||
131193118|NCT03039790|472327808|FG018|Overall Study|Reason, not Specified|1|||
131193119|NCT03039790|472327809|FG019|Overall Study|Reason, not Specified|0|||
131193120|NCT00498368|472327817|FG000|Overall Study|Withdrawal by Subject|3|||
131193121|NCT00498368|472327818|FG001|Overall Study|Withdrawal by Subject|2|||
131193122|NCT02266004|472327819|FG000|Overall Study|unrelated adverse event|1|||
131193123|NCT02266004|472327819|FG000|Overall Study|Physician Decision|1|||
131193124|NCT00537771|472327824|FG000|Overall Study|Withdrawal by Subject|6|||
131193125|NCT00537771|472327825|FG001|Overall Study|Withdrawal by Subject|23|||
131193126|NCT00537771|472327824|FG000|Overall Study|Adverse Event|8|||
131193127|NCT00537771|472327825|FG001|Overall Study|Adverse Event|15|||
131193128|NCT00537771|472327824|FG000|Overall Study|Lost to Follow-up|9|||
131193129|NCT00537771|472327825|FG001|Overall Study|Lost to Follow-up|15|||
131193130|NCT00537771|472327824|FG000|Overall Study|Protocol Violation|2|||
131193131|NCT00537771|472327825|FG001|Overall Study|Protocol Violation|6|||
131193132|NCT00537771|472327824|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
131193133|NCT00537771|472327825|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
131193134|NCT00621244|472327836|FG000|Overall Study|Withdrawal by Subject|7|||
131193135|NCT00621244|472327837|FG001|Overall Study|Withdrawal by Subject|3|||
131193136|NCT00621244|472327838|FG002|Overall Study|Withdrawal by Subject|3|||
131193137|NCT00621244|472327839|FG003|Overall Study|Withdrawal by Subject|3|||
131193138|NCT00621244|472327836|FG000|Overall Study|Disease progression|44|||
131193139|NCT00621244|472327837|FG001|Overall Study|Disease progression|20|||
131193140|NCT00621244|472327838|FG002|Overall Study|Disease progression|20|||
130733616|NCT04175912|470642919|FG000|Overall Study|Death|0|||
131193141|NCT00621244|472327839|FG003|Overall Study|Disease progression|15|||
131193142|NCT00621244|472327836|FG000|Overall Study|Death|3|||
131193143|NCT00621244|472327837|FG001|Overall Study|Death|3|||
131193144|NCT00621244|472327838|FG002|Overall Study|Death|1|||
131193145|NCT00621244|472327839|FG003|Overall Study|Death|1|||
131193146|NCT00621244|472327836|FG000|Overall Study|Adverse Event|27|||
131193147|NCT00621244|472327837|FG001|Overall Study|Adverse Event|7|||
131193148|NCT00621244|472327838|FG002|Overall Study|Adverse Event|9|||
130733617|NCT04175912|470642920|FG001|Overall Study|Death|1|||
130733618|NCT01708954|470642921|FG000|Step 1|Disease progression|26|||
130733619|NCT01708954|470642922|FG001|Step 1|Disease progression|17|||
130733620|NCT01708954|470642923|FG002|Step 1|Disease progression|14|||
131193149|NCT00621244|472327839|FG003|Overall Study|Adverse Event|2|||
131193150|NCT00621244|472327836|FG000|Overall Study|Administrative problems|5|||
131193151|NCT00621244|472327837|FG001|Overall Study|Administrative problems|1|||
131193152|NCT00621244|472327838|FG002|Overall Study|Administrative problems|0|||
131193153|NCT00621244|472327839|FG003|Overall Study|Administrative problems|2|||
131193154|NCT01662986|472327840|FG000|Overall Study|Adverse Event|5|||
131193155|NCT01662986|472327841|FG001|Overall Study|Adverse Event|4|||
131193156|NCT01662986|472327840|FG000|Overall Study|Protocol Violation|2|||
131193157|NCT01662986|472327841|FG001|Overall Study|Protocol Violation|3|||
131193158|NCT01662986|472327840|FG000|Overall Study|Lost to Follow-up|5|||
131193159|NCT01662986|472327841|FG001|Overall Study|Lost to Follow-up|4|||
131193160|NCT01662986|472327840|FG000|Overall Study|Withdrawal by Subject|2|||
131193161|NCT01662986|472327841|FG001|Overall Study|Withdrawal by Subject|2|||
131193162|NCT01662986|472327840|FG000|Overall Study|Not Treated|1|||
131193163|NCT01662986|472327841|FG001|Overall Study|Not Treated|0|||
131193164|NCT01662986|472327840|FG000|Overall Study|Other than stated above|3|||
131193165|NCT01662986|472327841|FG001|Overall Study|Other than stated above|0|||
131193166|NCT02343952|472327846|FG000|Study Treatment|Disease Progression|23|||
131193167|NCT02343952|472327846|FG000|Study Treatment|Death|3|||
131193168|NCT02343952|472327846|FG000|Study Treatment|Adverse Event|19|||
131193169|NCT02343952|472327846|FG000|Study Treatment|Withdrawal by Subject|7|||
131193170|NCT02343952|472327846|FG000|Study Treatment|other complicating Diseases|1|||
131193171|NCT02343952|472327846|FG000|Follow up|Withdrawal by Subject|3|||
130733621|NCT01708954|470642921|FG000|Step 1|Adverse Event|3|||
131193172|NCT02343952|472327846|FG000|Follow up|Death|33|||
131193173|NCT02343952|472327846|FG000|Follow up|Patient does not meet eligibility for study.|1|||
131193174|NCT02343952|472327846|FG000|Follow up|Research department closed by the practice.|5|||
130733622|NCT01708954|470642922|FG001|Step 1|Adverse Event|11|||
131193175|NCT02343952|472327846|FG000|Follow up|Patient went home to Russia|1|||
131193176|NCT02343952|472327846|FG000|Follow up|Disease Progression|1|||
131193177|NCT02343952|472327846|FG000|Follow up|study terminated|1|||
131193178|NCT00845845|472327850|FG000|Overall Study|Lost to Follow-up|0|||
131193179|NCT00845845|472327851|FG001|Overall Study|Lost to Follow-up|4|||
131193180|NCT02033850|472327853|FG000|Overall Study|Death|1|||
131193181|NCT02033850|472327854|FG001|Overall Study|Death|0|||
131193182|NCT02033850|472327853|FG000|Overall Study|unrelated medical reason|1|||
131193183|NCT02033850|472327854|FG001|Overall Study|unrelated medical reason|1|||
131193184|NCT02820038|472327855|FG000|Overall Study|Lost to Follow-up|7|||
131193185|NCT02820038|472327856|FG001|Overall Study|Lost to Follow-up|11|||
131193186|NCT02820038|472327857|FG002|Overall Study|Lost to Follow-up|2|||
131193187|NCT02820038|472327858|FG003|Overall Study|Lost to Follow-up|9|||
131193188|NCT02820038|472327855|FG000|Overall Study|Withdrawal by Subject|3|||
131193189|NCT02820038|472327856|FG001|Overall Study|Withdrawal by Subject|14|||
131193190|NCT02820038|472327857|FG002|Overall Study|Withdrawal by Subject|3|||
131193191|NCT02820038|472327858|FG003|Overall Study|Withdrawal by Subject|13|||
131193192|NCT00033371|472327859|FG000|Overall Study|Adverse Event|1|||
131193193|NCT00033371|472327860|FG001|Overall Study|Adverse Event|5|||
131193194|NCT00033371|472327859|FG000|Overall Study|Lost to Follow-up|2|||
131193195|NCT00033371|472327860|FG001|Overall Study|Lost to Follow-up|1|||
131193196|NCT00033371|472327859|FG000|Overall Study|Withdrawal by Subject|3|||
131193197|NCT00033371|472327860|FG001|Overall Study|Withdrawal by Subject|3|||
131193198|NCT00033371|472327859|FG000|Overall Study|Disease Progression|0|||
131193199|NCT00033371|472327860|FG001|Overall Study|Disease Progression|1|||
131193200|NCT03799627|472327865|FG000|Overall Study|Adverse Event|1|||
131193201|NCT03799627|472327866|FG001|Overall Study|Adverse Event|2|||
131193202|NCT03799627|472327867|FG002|Overall Study|Adverse Event|0|||
131193203|NCT03799627|472327868|FG003|Overall Study|Adverse Event|0|||
131193204|NCT03799627|472327869|FG004|Overall Study|Adverse Event|2|||
131193205|NCT03799627|472327870|FG005|Overall Study|Adverse Event|5|||
131193206|NCT03799627|472327871|FG006|Overall Study|Adverse Event|0|||
131193207|NCT03799627|472327872|FG007|Overall Study|Adverse Event|2|||
131193208|NCT03799627|472327873|FG008|Overall Study|Adverse Event|0|||
131193209|NCT03799627|472327865|FG000|Overall Study|Physician Decision|2|||
131193210|NCT03799627|472327866|FG001|Overall Study|Physician Decision|2|||
131193211|NCT03799627|472327867|FG002|Overall Study|Physician Decision|0|||
131193212|NCT03799627|472327868|FG003|Overall Study|Physician Decision|0|||
131193213|NCT03799627|472327869|FG004|Overall Study|Physician Decision|2|||
131193214|NCT03799627|472327870|FG005|Overall Study|Physician Decision|2|||
131193215|NCT03799627|472327871|FG006|Overall Study|Physician Decision|0|||
131193216|NCT03799627|472327872|FG007|Overall Study|Physician Decision|0|||
131193217|NCT03799627|472327873|FG008|Overall Study|Physician Decision|0|||
131193218|NCT03799627|472327865|FG000|Overall Study|Withdrawal by Subject|1|||
131193219|NCT03799627|472327866|FG001|Overall Study|Withdrawal by Subject|1|||
131193220|NCT03799627|472327867|FG002|Overall Study|Withdrawal by Subject|0|||
131193221|NCT03799627|472327868|FG003|Overall Study|Withdrawal by Subject|2|||
131193222|NCT03799627|472327869|FG004|Overall Study|Withdrawal by Subject|0|||
131193223|NCT03799627|472327870|FG005|Overall Study|Withdrawal by Subject|3|||
131193224|NCT03799627|472327871|FG006|Overall Study|Withdrawal by Subject|0|||
131193225|NCT03799627|472327872|FG007|Overall Study|Withdrawal by Subject|0|||
131193226|NCT03799627|472327873|FG008|Overall Study|Withdrawal by Subject|0|||
131193227|NCT03799627|472327865|FG000|Overall Study|Lack of Efficacy|0|||
131193228|NCT03799627|472327866|FG001|Overall Study|Lack of Efficacy|0|||
131193229|NCT03799627|472327867|FG002|Overall Study|Lack of Efficacy|0|||
131193230|NCT03799627|472327868|FG003|Overall Study|Lack of Efficacy|1|||
131193231|NCT03799627|472327869|FG004|Overall Study|Lack of Efficacy|0|||
131193232|NCT03799627|472327870|FG005|Overall Study|Lack of Efficacy|0|||
131193233|NCT03799627|472327871|FG006|Overall Study|Lack of Efficacy|0|||
131193234|NCT03799627|472327872|FG007|Overall Study|Lack of Efficacy|0|||
131193235|NCT03799627|472327873|FG008|Overall Study|Lack of Efficacy|0|||
131193236|NCT03799627|472327865|FG000|Overall Study|Lost to Follow-up|0|||
131193237|NCT03799627|472327866|FG001|Overall Study|Lost to Follow-up|0|||
131193238|NCT03799627|472327867|FG002|Overall Study|Lost to Follow-up|0|||
131193239|NCT03799627|472327868|FG003|Overall Study|Lost to Follow-up|0|||
131193240|NCT03799627|472327869|FG004|Overall Study|Lost to Follow-up|0|||
131193241|NCT03799627|472327870|FG005|Overall Study|Lost to Follow-up|0|||
131193242|NCT03799627|472327871|FG006|Overall Study|Lost to Follow-up|1|||
131193243|NCT03799627|472327872|FG007|Overall Study|Lost to Follow-up|0|||
131193244|NCT03799627|472327873|FG008|Overall Study|Lost to Follow-up|1|||
131193245|NCT03799627|472327865|FG000|Overall Study|Death|0|||
131193246|NCT03799627|472327866|FG001|Overall Study|Death|0|||
131193247|NCT03799627|472327867|FG002|Overall Study|Death|0|||
131193248|NCT03799627|472327868|FG003|Overall Study|Death|1|||
131193249|NCT03799627|472327869|FG004|Overall Study|Death|0|||
131193250|NCT03799627|472327870|FG005|Overall Study|Death|0|||
131193251|NCT03799627|472327871|FG006|Overall Study|Death|0|||
131193252|NCT03799627|472327872|FG007|Overall Study|Death|0|||
131193253|NCT03799627|472327873|FG008|Overall Study|Death|0|||
131193254|NCT03799627|472327865|FG000|Overall Study|Study Drug Put on Hold|1|||
130733623|NCT01708954|470642923|FG002|Step 1|Adverse Event|13|||
130733624|NCT01708954|470642921|FG000|Step 1|Death|3|||
130733625|NCT01708954|470642922|FG001|Step 1|Death|2|||
130733626|NCT01708954|470642923|FG002|Step 1|Death|3|||
131193255|NCT03799627|472327866|FG001|Overall Study|Study Drug Put on Hold|0|||
131193256|NCT03799627|472327867|FG002|Overall Study|Study Drug Put on Hold|0|||
131193257|NCT03799627|472327868|FG003|Overall Study|Study Drug Put on Hold|0|||
131193258|NCT03799627|472327869|FG004|Overall Study|Study Drug Put on Hold|0|||
131193259|NCT03799627|472327870|FG005|Overall Study|Study Drug Put on Hold|0|||
131193260|NCT03799627|472327871|FG006|Overall Study|Study Drug Put on Hold|0|||
131193261|NCT03799627|472327872|FG007|Overall Study|Study Drug Put on Hold|0|||
131193262|NCT03799627|472327873|FG008|Overall Study|Study Drug Put on Hold|0|||
131193263|NCT03799627|472327865|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
131193264|NCT03799627|472327866|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
131193265|NCT03799627|472327867|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
131193266|NCT03799627|472327868|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
131193267|NCT03799627|472327869|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
131193268|NCT03799627|472327870|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
131193269|NCT03799627|472327871|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
131193270|NCT03799627|472327872|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
131193271|NCT03799627|472327873|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
131193272|NCT03799627|472327865|FG000|Overall Study|Kidney Transplantation|1|||
131193273|NCT03799627|472327866|FG001|Overall Study|Kidney Transplantation|0|||
131193274|NCT03799627|472327867|FG002|Overall Study|Kidney Transplantation|0|||
131193275|NCT03799627|472327868|FG003|Overall Study|Kidney Transplantation|1|||
131193276|NCT03799627|472327869|FG004|Overall Study|Kidney Transplantation|1|||
131193277|NCT03799627|472327870|FG005|Overall Study|Kidney Transplantation|0|||
131193278|NCT03799627|472327871|FG006|Overall Study|Kidney Transplantation|0|||
131193279|NCT03799627|472327872|FG007|Overall Study|Kidney Transplantation|0|||
131193280|NCT03799627|472327873|FG008|Overall Study|Kidney Transplantation|0|||
131193281|NCT03799627|472327865|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
131193282|NCT03799627|472327866|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
131193283|NCT03799627|472327867|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
131193284|NCT03799627|472327868|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
131193285|NCT03799627|472327869|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
131193286|NCT03799627|472327870|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
131193287|NCT03799627|472327871|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
131193288|NCT03799627|472327872|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
131193289|NCT03799627|472327873|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
131193290|NCT03799627|472327865|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131193291|NCT03799627|472327866|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
131193292|NCT03799627|472327867|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131193293|NCT03799627|472327868|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131193294|NCT03799627|472327869|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131193295|NCT03799627|472327870|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131193296|NCT03799627|472327871|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131193297|NCT03799627|472327872|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131193298|NCT03799627|472327873|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
131193299|NCT03799627|472327865|FG000|Overall Study|Met Exclusion Criteria|0|||
131193300|NCT03799627|472327866|FG001|Overall Study|Met Exclusion Criteria|0|||
131193301|NCT03799627|472327867|FG002|Overall Study|Met Exclusion Criteria|0|||
131193302|NCT03799627|472327868|FG003|Overall Study|Met Exclusion Criteria|1|||
131193303|NCT03799627|472327869|FG004|Overall Study|Met Exclusion Criteria|0|||
131193304|NCT03799627|472327870|FG005|Overall Study|Met Exclusion Criteria|0|||
131193305|NCT03799627|472327871|FG006|Overall Study|Met Exclusion Criteria|0|||
131193306|NCT03799627|472327872|FG007|Overall Study|Met Exclusion Criteria|0|||
131193307|NCT03799627|472327873|FG008|Overall Study|Met Exclusion Criteria|0|||
131193308|NCT03799627|472327865|FG000|Overall Study|Investigational Product Noncompliance|0|||
131193309|NCT03799627|472327866|FG001|Overall Study|Investigational Product Noncompliance|0|||
131193310|NCT03799627|472327867|FG002|Overall Study|Investigational Product Noncompliance|0|||
131193311|NCT03799627|472327868|FG003|Overall Study|Investigational Product Noncompliance|1|||
131193312|NCT03799627|472327869|FG004|Overall Study|Investigational Product Noncompliance|0|||
131193313|NCT03799627|472327870|FG005|Overall Study|Investigational Product Noncompliance|0|||
131193314|NCT03799627|472327871|FG006|Overall Study|Investigational Product Noncompliance|0|||
131193315|NCT03799627|472327872|FG007|Overall Study|Investigational Product Noncompliance|0|||
131193316|NCT03799627|472327873|FG008|Overall Study|Investigational Product Noncompliance|0|||
131193317|NCT03799627|472327865|FG000|Overall Study|Participant Relocation|0|||
131193318|NCT03799627|472327866|FG001|Overall Study|Participant Relocation|0|||
131193319|NCT03799627|472327867|FG002|Overall Study|Participant Relocation|0|||
131193320|NCT03799627|472327868|FG003|Overall Study|Participant Relocation|1|||
131193321|NCT03799627|472327869|FG004|Overall Study|Participant Relocation|0|||
131193322|NCT03799627|472327870|FG005|Overall Study|Participant Relocation|1|||
131193323|NCT03799627|472327871|FG006|Overall Study|Participant Relocation|0|||
131193324|NCT03799627|472327872|FG007|Overall Study|Participant Relocation|0|||
131193325|NCT03799627|472327873|FG008|Overall Study|Participant Relocation|0|||
131193326|NCT03799627|472327865|FG000|Overall Study|Eurofin Issue|0|||
131193327|NCT03799627|472327866|FG001|Overall Study|Eurofin Issue|0|||
131193328|NCT03799627|472327867|FG002|Overall Study|Eurofin Issue|0|||
131193329|NCT03799627|472327868|FG003|Overall Study|Eurofin Issue|0|||
131193330|NCT03799627|472327869|FG004|Overall Study|Eurofin Issue|1|||
131193331|NCT03799627|472327870|FG005|Overall Study|Eurofin Issue|0|||
131193332|NCT03799627|472327871|FG006|Overall Study|Eurofin Issue|0|||
131193333|NCT03799627|472327872|FG007|Overall Study|Eurofin Issue|0|||
131193334|NCT03799627|472327873|FG008|Overall Study|Eurofin Issue|0|||
131193335|NCT03799627|472327865|FG000|Overall Study|Noncompliance with Site Instructions|0|||
131193336|NCT03799627|472327866|FG001|Overall Study|Noncompliance with Site Instructions|0|||
131193337|NCT03799627|472327867|FG002|Overall Study|Noncompliance with Site Instructions|0|||
131193338|NCT03799627|472327868|FG003|Overall Study|Noncompliance with Site Instructions|0|||
131193339|NCT03799627|472327869|FG004|Overall Study|Noncompliance with Site Instructions|1|||
131193340|NCT03799627|472327870|FG005|Overall Study|Noncompliance with Site Instructions|0|||
131193341|NCT03799627|472327871|FG006|Overall Study|Noncompliance with Site Instructions|0|||
131193342|NCT03799627|472327872|FG007|Overall Study|Noncompliance with Site Instructions|0|||
131193343|NCT03799627|472327873|FG008|Overall Study|Noncompliance with Site Instructions|0|||
131193344|NCT03799627|472327865|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131193345|NCT03799627|472327866|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131193346|NCT03799627|472327867|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131193347|NCT03799627|472327868|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131193348|NCT03799627|472327869|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
131193349|NCT03799627|472327870|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131193350|NCT03799627|472327871|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131193351|NCT03799627|472327872|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131193352|NCT03799627|472327873|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
131193353|NCT03799627|472327865|FG000|Overall Study|Changes In Hemoglobin Values|1|||
131193354|NCT03799627|472327866|FG001|Overall Study|Changes In Hemoglobin Values|2|||
131193355|NCT03799627|472327867|FG002|Overall Study|Changes In Hemoglobin Values|1|||
131193356|NCT03799627|472327868|FG003|Overall Study|Changes In Hemoglobin Values|0|||
131193357|NCT03799627|472327869|FG004|Overall Study|Changes In Hemoglobin Values|0|||
131193358|NCT03799627|472327870|FG005|Overall Study|Changes In Hemoglobin Values|2|||
131193359|NCT03799627|472327871|FG006|Overall Study|Changes In Hemoglobin Values|1|||
131193360|NCT03799627|472327872|FG007|Overall Study|Changes In Hemoglobin Values|0|||
131193361|NCT03799627|472327873|FG008|Overall Study|Changes In Hemoglobin Values|1|||
131193362|NCT02092324|472327874|FG000|Overall Study|Adverse Event|1|||
131193363|NCT02092324|472327874|FG000|Overall Study|Lack of Efficacy|6|||
131193364|NCT02092324|472327874|FG000|Overall Study|Proceed to Transplant|3|||
131193365|NCT02092324|472327874|FG000|Overall Study|Physician Decision|7|||
131193366|NCT02092324|472327874|FG000|Overall Study|Misdiagnosis|2|||
131193367|NCT01922739|472327875|FG000|Titration/Adjustment Period|Adverse Event|3|||
131193368|NCT01922739|472327875|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
131193369|NCT01922739|472327875|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
131193370|NCT01922739|472327875|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
131193371|NCT01922739|472327875|FG000|Open-label Treatment Period|Adverse Event|6|||
131193372|NCT01922739|472327875|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
131193373|NCT01922739|472327875|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
131193374|NCT01922739|472327875|FG000|Open-label Treatment Period|Protocol Violation|5|||
131193375|NCT01922739|472327875|FG000|Open-label Treatment Period|Pregnancy|1|||
131193376|NCT01922739|472327875|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
131193377|NCT01922739|472327875|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
131193378|NCT01922739|472327875|FG000|Open-label Treatment Period|Physician Decision|1|||
131193379|NCT01922739|472327875|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
131193380|NCT03148795|472327878|FG000|Overall Study|Progressive Disease|1|||
131193381|NCT04489940|472327879|FG000|Overall Study|Other|2|||
131193382|NCT04489940|472327879|FG000|Overall Study|Withdrawal by Subject|2|||
131193383|NCT04489940|472327879|FG000|Overall Study|Death|5|||
131193384|NCT04489940|472327879|FG000|Overall Study|Lost to Follow-up|1|||
131193385|NCT02725268|472327880|FG000|Overall Study|Death|58|||
131193386|NCT02725268|472327881|FG001|Overall Study|Death|59|||
131193387|NCT02725268|472327882|FG002|Overall Study|Death|30|||
131193388|NCT02725268|472327883|FG003|Overall Study|Death|16|||
131193389|NCT02725268|472327880|FG000|Overall Study|Lost to Follow-up|4|||
131193390|NCT02725268|472327881|FG001|Overall Study|Lost to Follow-up|3|||
131193391|NCT02725268|472327882|FG002|Overall Study|Lost to Follow-up|0|||
131193392|NCT02725268|472327883|FG003|Overall Study|Lost to Follow-up|1|||
131193393|NCT02725268|472327880|FG000|Overall Study|Site Terminated by Sponsor|0|||
131193394|NCT02725268|472327881|FG001|Overall Study|Site Terminated by Sponsor|1|||
131193395|NCT02725268|472327882|FG002|Overall Study|Site Terminated by Sponsor|0|||
131193396|NCT02725268|472327883|FG003|Overall Study|Site Terminated by Sponsor|0|||
131193397|NCT02725268|472327880|FG000|Overall Study|Withdrawal by Subject|8|||
131193398|NCT02725268|472327881|FG001|Overall Study|Withdrawal by Subject|6|||
131193399|NCT02725268|472327882|FG002|Overall Study|Withdrawal by Subject|8|||
131193400|NCT02725268|472327883|FG003|Overall Study|Withdrawal by Subject|1|||
131193401|NCT02725268|472327880|FG000|Overall Study|Reason not Specified|2|||
131193402|NCT02725268|472327881|FG001|Overall Study|Reason not Specified|1|||
131193403|NCT02725268|472327882|FG002|Overall Study|Reason not Specified|0|||
131193404|NCT02725268|472327883|FG003|Overall Study|Reason not Specified|0|||
131193405|NCT04498468|472327884|FG000|Overall Study|Lost to Follow-up|3|||
131193406|NCT00398138|472327885|FG000|Overall Study|Adverse Event|2|||
131193407|NCT04973085|472327893|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
131193408|NCT04973085|472327894|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
131193409|NCT02224274|472327895|FG000|Overall Study|Death|1|||
131193410|NCT02224274|472327896|FG001|Overall Study|Death|0|||
131193411|NCT00887068|472327897|FG000|Overall Study|Withdrawal by Subject|2|||
131193412|NCT00887068|472327898|FG001|Overall Study|Withdrawal by Subject|0|||
131193413|NCT00887068|472327897|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
131193414|NCT00887068|472327898|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
131193415|NCT01976624|472327899|FG000|Overall Study|Participants contraindicated|2|||
131193416|NCT01976624|472327899|FG000|Overall Study|Participants age less than 19 years|12|||
131193417|NCT01387594|472327900|FG000|Overall Study|Withdrawal by Subject|0|||
131193418|NCT01387594|472327901|FG001|Overall Study|Withdrawal by Subject|2|||
131193419|NCT01387594|472327900|FG000|Overall Study|Lost to Follow-up|0|||
131193420|NCT01387594|472327901|FG001|Overall Study|Lost to Follow-up|1|||
131193421|NCT03277794|472327913|FG000|Overall Study|Lost to Follow-up|2|||
131193422|NCT03277794|472327914|FG001|Overall Study|Lost to Follow-up|4|||
131193423|NCT03277794|472327913|FG000|Overall Study|Withdrew due to high acuity|1|||
131193424|NCT03277794|472327914|FG001|Overall Study|Withdrew due to high acuity|0|||
131193425|NCT01167153|472327919|FG000|Overall Study|Non-effective therapy|1|||
131193426|NCT01167153|472327920|FG001|Overall Study|Non-effective therapy|4|||
131193427|NCT01167153|472327919|FG000|Overall Study|AE including clinical laboratory AE|2|||
131193428|NCT01167153|472327920|FG001|Overall Study|AE including clinical laboratory AE|8|||
131193429|NCT01167153|472327919|FG000|Overall Study|Hypotension|1|||
131193430|NCT01167153|472327920|FG001|Overall Study|Hypotension|0|||
131193431|NCT01167153|472327919|FG000|Overall Study|Lost to Follow-up|7|||
131193432|NCT01167153|472327920|FG001|Overall Study|Lost to Follow-up|9|||
131193433|NCT01167153|472327919|FG000|Overall Study|Non-compliance to concomitant medication|0|||
131193434|NCT01167153|472327920|FG001|Overall Study|Non-compliance to concomitant medication|2|||
131193435|NCT01167153|472327919|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
131193436|NCT01167153|472327920|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
131193437|NCT01167153|472327919|FG000|Overall Study|Withdrawal consent|1|||
131193438|NCT01167153|472327920|FG001|Overall Study|Withdrawal consent|1|||
131193439|NCT01167153|472327919|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
131193440|NCT01167153|472327920|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
131193441|NCT04507360|472329560|FG000|Week 1|Lost to Follow-up|0|||
131193442|NCT04507360|472329561|FG001|Week 1|Lost to Follow-up|0|||
131193443|NCT04507360|472329562|FG002|Week 1|Lost to Follow-up|0|||
131193444|NCT04507360|472329563|FG003|Week 1|Lost to Follow-up|0|||
131193445|NCT04507360|472329564|FG004|Week 1|Lost to Follow-up|0|||
131193446|NCT04507360|472329565|FG005|Week 1|Lost to Follow-up|0|||
131193447|NCT04507360|472329566|FG006|Week 1|Lost to Follow-up|0|||
131193448|NCT04507360|472329567|FG007|Week 1|Lost to Follow-up|0|||
131193449|NCT04507360|472329568|FG008|Week 1|Lost to Follow-up|72|||
131193450|NCT04507360|472329569|FG009|Week 1|Lost to Follow-up|22|||
131193451|NCT04507360|472329570|FG010|Week 1|Lost to Follow-up|10|||
131193452|NCT04507360|472329560|FG000|Week 2|Lost to Follow-up|0|||
131193453|NCT04507360|472329561|FG001|Week 2|Lost to Follow-up|0|||
131193454|NCT04507360|472329562|FG002|Week 2|Lost to Follow-up|0|||
131193455|NCT04507360|472329563|FG003|Week 2|Lost to Follow-up|0|||
131193456|NCT04507360|472329564|FG004|Week 2|Lost to Follow-up|0|||
131193457|NCT04507360|472329565|FG005|Week 2|Lost to Follow-up|0|||
131193458|NCT04507360|472329566|FG006|Week 2|Lost to Follow-up|0|||
131193459|NCT04507360|472329567|FG007|Week 2|Lost to Follow-up|0|||
131193460|NCT04507360|472329568|FG008|Week 2|Lost to Follow-up|121|||
131193461|NCT04507360|472329569|FG009|Week 2|Lost to Follow-up|85|||
131193462|NCT04507360|472329570|FG010|Week 2|Lost to Follow-up|82|||
131193463|NCT04507360|472329560|FG000|Week 3|Lost to Follow-up|0|||
131193464|NCT04507360|472329561|FG001|Week 3|Lost to Follow-up|0|||
131193465|NCT04507360|472329562|FG002|Week 3|Lost to Follow-up|0|||
131193466|NCT04507360|472329563|FG003|Week 3|Lost to Follow-up|0|||
131193467|NCT04507360|472329564|FG004|Week 3|Lost to Follow-up|0|||
131193468|NCT04507360|472329565|FG005|Week 3|Lost to Follow-up|0|||
131193469|NCT04507360|472329566|FG006|Week 3|Lost to Follow-up|0|||
131193470|NCT04507360|472329567|FG007|Week 3|Lost to Follow-up|0|||
131193471|NCT04507360|472329568|FG008|Week 3|Lost to Follow-up|123|||
131193472|NCT04507360|472329569|FG009|Week 3|Lost to Follow-up|92|||
131193473|NCT04507360|472329570|FG010|Week 3|Lost to Follow-up|84|||
131193474|NCT04507360|472329560|FG000|Week 4|Lost to Follow-up|0|||
131193475|NCT04507360|472329561|FG001|Week 4|Lost to Follow-up|0|||
131193476|NCT04507360|472329562|FG002|Week 4|Lost to Follow-up|0|||
131193477|NCT04507360|472329563|FG003|Week 4|Lost to Follow-up|0|||
131193478|NCT04507360|472329564|FG004|Week 4|Lost to Follow-up|0|||
131193479|NCT04507360|472329565|FG005|Week 4|Lost to Follow-up|0|||
131193480|NCT04507360|472329566|FG006|Week 4|Lost to Follow-up|0|||
131193481|NCT04507360|472329567|FG007|Week 4|Lost to Follow-up|0|||
131193482|NCT04507360|472329568|FG008|Week 4|Lost to Follow-up|131|||
131193483|NCT04507360|472329569|FG009|Week 4|Lost to Follow-up|115|||
131193484|NCT04507360|472329570|FG010|Week 4|Lost to Follow-up|102|||
131193485|NCT04507360|472329560|FG000|Week 5|Lost to Follow-up|0|||
131193486|NCT04507360|472329561|FG001|Week 5|Lost to Follow-up|0|||
131193487|NCT04507360|472329562|FG002|Week 5|Lost to Follow-up|0|||
131193488|NCT04507360|472329563|FG003|Week 5|Lost to Follow-up|0|||
131193489|NCT04507360|472329564|FG004|Week 5|Lost to Follow-up|0|||
131193490|NCT04507360|472329565|FG005|Week 5|Lost to Follow-up|0|||
131193491|NCT04507360|472329566|FG006|Week 5|Lost to Follow-up|0|||
131193492|NCT04507360|472329567|FG007|Week 5|Lost to Follow-up|0|||
131193493|NCT04507360|472329568|FG008|Week 5|Lost to Follow-up|103|||
131193494|NCT04507360|472329569|FG009|Week 5|Lost to Follow-up|135|||
131193495|NCT04507360|472329570|FG010|Week 5|Lost to Follow-up|143|||
131193496|NCT04507360|472329560|FG000|Week 8|Lost to Follow-up|0|||
131193497|NCT04507360|472329561|FG001|Week 8|Lost to Follow-up|0|||
131193498|NCT04507360|472329562|FG002|Week 8|Lost to Follow-up|0|||
131193499|NCT04507360|472329563|FG003|Week 8|Lost to Follow-up|0|||
131193500|NCT04507360|472329564|FG004|Week 8|Lost to Follow-up|0|||
131193501|NCT04507360|472329565|FG005|Week 8|Lost to Follow-up|0|||
131193502|NCT04507360|472329566|FG006|Week 8|Lost to Follow-up|0|||
131193503|NCT04507360|472329567|FG007|Week 8|Lost to Follow-up|0|||
131193504|NCT04507360|472329568|FG008|Week 8|Lost to Follow-up|139|||
131193505|NCT04507360|472329569|FG009|Week 8|Lost to Follow-up|145|||
131193506|NCT04507360|472329570|FG010|Week 8|Lost to Follow-up|152|||
131193507|NCT01004159|472329571|FG000|Overall Study|Adverse Event|2|||
131193508|NCT01004159|472329571|FG000|Overall Study|Disease Progression|18|||
131193509|NCT03050307|472329575|FG000|Overall Study|Adverse Event|4|||
131193510|NCT03050307|472329576|FG001|Overall Study|Adverse Event|2|||
131193511|NCT03050307|472329575|FG000|Overall Study|Significant Protocol Deviation|0|||
131193512|NCT03050307|472329576|FG001|Overall Study|Significant Protocol Deviation|1|||
131193513|NCT03050307|472329575|FG000|Overall Study|Lost to Follow-up|0|||
131193514|NCT03050307|472329576|FG001|Overall Study|Lost to Follow-up|1|||
131193515|NCT03050307|472329575|FG000|Overall Study|Voluntary Withdrawal|3|||
131193516|NCT03050307|472329576|FG001|Overall Study|Voluntary Withdrawal|4|||
131193517|NCT03050307|472329575|FG000|Overall Study|Reason not Specified|1|||
131193518|NCT03050307|472329576|FG001|Overall Study|Reason not Specified|1|||
131193519|NCT02828644|472329579|FG000|Overall Study|Lost to Follow-up|23|||
131193520|NCT02828644|472329580|FG001|Overall Study|Lost to Follow-up|22|||
131193521|NCT01938391|472329581|FG000|6 Month Follow up|Withdrawal by Subject|1|||
131193522|NCT01938391|472329581|FG000|12 Month Follow up|Physician Decision|1|||
131193523|NCT01938391|472329581|FG000|12 Month Follow up|Withdrawal by Subject|1|||
131193524|NCT01077193|472329582|FG000|Overall Study|Lost to Follow-up|1|||
131193525|NCT01077193|472329582|FG000|Overall Study|Withdrawal by Subject|2|||
131193526|NCT01077193|472329582|FG000|Overall Study|Lack of Efficacy|1|||
131193527|NCT01077193|472329582|FG000|Overall Study|Study Terminated by Sponsor|40|||
131193528|NCT06048809|472329587|FG000|Overall Study|Adverse Event|2|||
131193529|NCT06048809|472329588|FG001|Overall Study|Adverse Event|0|||
131193530|NCT06048809|472329587|FG000|Overall Study|Withdrawal by Subject|1|||
131193531|NCT06048809|472329588|FG001|Overall Study|Withdrawal by Subject|1|||
131193532|NCT02158728|472329589|FG000|Overall Study|no procedure according to CIP done|3|||
131193533|NCT02158728|472329589|FG000|Overall Study|no qualified dataset|24|||
131193534|NCT03878160|472329595|FG000|Overall Study|Lost to Follow-up|1|||
131193535|NCT03878160|472329596|FG001|Overall Study|Lost to Follow-up|1|||
131193536|NCT03878160|472329597|FG002|Overall Study|Lost to Follow-up|1|||
131193537|NCT03878160|472329595|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
131193538|NCT03878160|472329596|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
131193539|NCT03878160|472329597|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
131193540|NCT03887052|472329605|FG000|Overall Study|Adverse Event|2|||
131193541|NCT03887052|472329605|FG000|Overall Study|Physician Decision|2|||
131193542|NCT03887052|472329605|FG000|Overall Study|Withdrawal by Subject|3|||
131193543|NCT03887052|472329605|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
131193544|NCT03887052|472329605|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
131193545|NCT01804842|472329606|FG000|Overall Study|Adverse Event|1|||
131193546|NCT01804842|472329607|FG001|Overall Study|Adverse Event|1|||
131193547|NCT01804842|472329608|FG002|Overall Study|Adverse Event|0|||
131193548|NCT01804842|472329606|FG000|Overall Study|Lost to Follow-up|1|||
131193549|NCT01804842|472329607|FG001|Overall Study|Lost to Follow-up|0|||
131193550|NCT01804842|472329608|FG002|Overall Study|Lost to Follow-up|0|||
131193551|NCT01804842|472329606|FG000|Overall Study|Non-Compliance|1|||
131193552|NCT01804842|472329607|FG001|Overall Study|Non-Compliance|1|||
131193553|NCT01804842|472329608|FG002|Overall Study|Non-Compliance|0|||
131193554|NCT01804842|472329606|FG000|Overall Study|Personal Reason|0|||
131193555|NCT01804842|472329607|FG001|Overall Study|Personal Reason|0|||
131193556|NCT01804842|472329608|FG002|Overall Study|Personal Reason|1|||
131193557|NCT04097028|472329611|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
131193558|NCT04097028|472329611|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
131193559|NCT04097028|472329611|FG000|Overall Study|Disease Progression prior to Surgery|2|||
131193560|NCT04097028|472329611|FG000|Overall Study|Adverse Event prior to Surgery|1|||
131193561|NCT03687827|472329612|FG000|Treatment Period 1|Death|0|||
131193562|NCT03687827|472329613|FG001|Treatment Period 1|Death|1|||
131193563|NCT03687827|472329612|FG000|Treatment Period 1|Lost to Follow-up|2|||
131193564|NCT03687827|472329613|FG001|Treatment Period 1|Lost to Follow-up|2|||
131193565|NCT03687827|472329612|FG000|Treatment Period 1|Physician Decision|5|||
131193566|NCT03687827|472329613|FG001|Treatment Period 1|Physician Decision|2|||
131193567|NCT03687827|472329612|FG000|Treatment Period 1|Withdrawal by Subject|7|||
131193568|NCT03687827|472329613|FG001|Treatment Period 1|Withdrawal by Subject|3|||
131193569|NCT03687827|472329612|FG000|Treatment Period 2|Physician Decision|4|||
131193570|NCT03687827|472329613|FG001|Treatment Period 2|Physician Decision|1|||
131193571|NCT03687827|472329612|FG000|Treatment Period 2|Withdrawal by Subject|1|||
131193572|NCT03687827|472329613|FG001|Treatment Period 2|Withdrawal by Subject|2|||
131193573|NCT03277105|472329616|FG000|Overall Study|Death|129|||
131193574|NCT03277105|472329617|FG001|Overall Study|Death|124|||
131193575|NCT03277105|472329616|FG000|Overall Study|Lost to Follow-up|2|||
131193576|NCT03277105|472329617|FG001|Overall Study|Lost to Follow-up|4|||
131193577|NCT03277105|472329616|FG000|Overall Study|Withdrawal by Subject|10|||
131193578|NCT03277105|472329617|FG001|Overall Study|Withdrawal by Subject|10|||
131193579|NCT03277105|472329616|FG000|Overall Study|Other|118|||
131193580|NCT03277105|472329617|FG001|Overall Study|Other|125|||
131193581|NCT02736929|472329625|FG000|Main Study|Lost to Follow-up|7|||
131193582|NCT02736929|472329626|FG001|Main Study|Lost to Follow-up|1|||
131193583|NCT02736929|472329627|FG002|Main Study|Lost to Follow-up|0|||
131193584|NCT02736929|472329625|FG000|Main Study|Withdrawal by Subject|1|||
131193585|NCT02736929|472329626|FG001|Main Study|Withdrawal by Subject|1|||
131193586|NCT02736929|472329627|FG002|Main Study|Withdrawal by Subject|0|||
131193587|NCT02736929|472329625|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
131193588|NCT02736929|472329626|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
131193589|NCT02736929|472329627|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
131193590|NCT01347073|472329628|FG000|Overall Study|Adverse Event|1|||
131193591|NCT01347073|472329628|FG000|Overall Study|Liver Transplant|1|||
131193592|NCT03236506|472329629|FG000|Overall Study|Death|1|||
131193593|NCT03236506|472329630|FG001|Overall Study|Death|1|||
131193594|NCT03236506|472329631|FG002|Overall Study|Death|1|||
131193595|NCT03236506|472329629|FG000|Overall Study|Withdrawal by Subject|3|||
131193596|NCT03236506|472329630|FG001|Overall Study|Withdrawal by Subject|3|||
131193597|NCT03236506|472329631|FG002|Overall Study|Withdrawal by Subject|4|||
131193598|NCT03236506|472329629|FG000|Overall Study|Did not initiate treatment|2|||
130733627|NCT01708954|470642921|FG000|Step 1|Withdrawal by Subject|2|||
130733628|NCT01708954|470642922|FG001|Step 1|Withdrawal by Subject|5|||
130733629|NCT01708954|470642923|FG002|Step 1|Withdrawal by Subject|3|||
130733630|NCT01708954|470642921|FG000|Step 1|Other complicating disease|0|||
130733631|NCT01708954|470642922|FG001|Step 1|Other complicating disease|2|||
131193599|NCT03236506|472329630|FG001|Overall Study|Did not initiate treatment|1|||
131193600|NCT03236506|472329631|FG002|Overall Study|Did not initiate treatment|2|||
131193601|NCT01690988|472329632|FG000|Overall Study|Withdrawal by Subject|2|||
131193602|NCT01690988|472329633|FG001|Overall Study|Withdrawal by Subject|2|||
131193603|NCT01690988|472329634|FG002|Overall Study|Withdrawal by Subject|3|||
131193604|NCT01690988|472329632|FG000|Overall Study|Physician Decision|0|||
131193605|NCT01690988|472329633|FG001|Overall Study|Physician Decision|0|||
131193606|NCT01690988|472329634|FG002|Overall Study|Physician Decision|1|||
131193607|NCT01690988|472329632|FG000|Overall Study|Operation Cancelled|1|||
131193608|NCT01690988|472329633|FG001|Overall Study|Operation Cancelled|1|||
131193609|NCT01690988|472329634|FG002|Overall Study|Operation Cancelled|0|||
131193610|NCT01690988|472329632|FG000|Overall Study|Determined ineligible|1|||
131193611|NCT01690988|472329633|FG001|Overall Study|Determined ineligible|0|||
131193612|NCT01690988|472329634|FG002|Overall Study|Determined ineligible|0|||
131193613|NCT01690988|472329632|FG000|Overall Study|Death|1|||
131193614|NCT01690988|472329633|FG001|Overall Study|Death|1|||
130733632|NCT01708954|470642923|FG002|Step 1|Other complicating disease|0|||
130733633|NCT01708954|470642921|FG000|Step 1|Crossed over to Step 2|2|||
130733634|NCT01708954|470642922|FG001|Step 1|Crossed over to Step 2|0|||
130733635|NCT01708954|470642923|FG002|Step 1|Crossed over to Step 2|0|||
130733636|NCT01708954|470642921|FG000|Step 1|Symptomatic deterioration|1|||
130733637|NCT01708954|470642922|FG001|Step 1|Symptomatic deterioration|0|||
130733638|NCT01708954|470642923|FG002|Step 1|Symptomatic deterioration|1|||
130784581|NCT01064479|470838825|FG000|Overall Study|Other|1|||
131193615|NCT01690988|472329634|FG002|Overall Study|Death|1|||
131193616|NCT01690988|472329632|FG000|Overall Study|Sedated|1|||
131193617|NCT01690988|472329633|FG001|Overall Study|Sedated|1|||
130733639|NCT01708954|470642921|FG000|Step 1|Off-treatment reason not submitted|1|||
130733640|NCT01708954|470642922|FG001|Step 1|Off-treatment reason not submitted|1|||
130733641|NCT01708954|470642923|FG002|Step 1|Off-treatment reason not submitted|1|||
130733642|NCT01708954|470642921|FG000|Step 1|Ineligible or never received treatment|4|||
131193618|NCT01690988|472329634|FG002|Overall Study|Sedated|2|||
131193619|NCT00372489|472329639|FG000|Overall Study|Adverse Event|18|||
131193620|NCT00372489|472329639|FG000|Overall Study|Lack of Efficacy|1|||
131193621|NCT00372489|472329639|FG000|Overall Study|Lost to Follow-up|3|||
131193622|NCT00372489|472329639|FG000|Overall Study|Physician Decision|3|||
131193623|NCT00372489|472329639|FG000|Overall Study|Withdrawal by Subject|5|||
131193624|NCT00372489|472329639|FG000|Overall Study|Patient Relocation|2|||
131193625|NCT00372489|472329639|FG000|Overall Study|Renal transplant|6|||
131193626|NCT00372489|472329639|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
131193627|NCT03696576|472329644|FG000|Overall Study|Soreness of throat after therapy|1|||
131193628|NCT03696576|472329645|FG001|Overall Study|Soreness of throat after therapy|1|||
130733643|NCT01708954|470642922|FG001|Step 1|Ineligible or never received treatment|2|||
130733644|NCT01708954|470642923|FG002|Step 1|Ineligible or never received treatment|8|||
130733645|NCT01708954|470642921|FG000|Step 2|Disease progression|9|||
130733646|NCT01708954|470642922|FG001|Step 2|Disease progression|4|||
130784582|NCT01064479|470838826|FG001|Overall Study|Other|2|||
131193629|NCT03696576|472329644|FG000|Overall Study|Lost to Follow-up|2|||
130733647|NCT01708954|470642923|FG002|Step 2|Disease progression|0|||
130733648|NCT01708954|470642921|FG000|Step 2|Adverse Event|3|||
130733649|NCT01708954|470642922|FG001|Step 2|Adverse Event|2|||
130733650|NCT01708954|470642923|FG002|Step 2|Adverse Event|0|||
130733651|NCT01708954|470642921|FG000|Step 2|Withdrawal by Subject|1|||
130733652|NCT01708954|470642922|FG001|Step 2|Withdrawal by Subject|1|||
130784583|NCT01663402|470838831|FG000|Overall Study|Randomized but not treated|19|||
130784584|NCT01663402|470838832|FG001|Overall Study|Randomized but not treated|11|||
131193630|NCT03696576|472329645|FG001|Overall Study|Lost to Follow-up|4|||
131193631|NCT01634100|472329655|FG000|Overall Study|Withdrawal by Subject|1|||
131193632|NCT01634100|472329656|FG001|Overall Study|Withdrawal by Subject|0|||
131193633|NCT01634100|472329657|FG002|Overall Study|Withdrawal by Subject|1|||
131193634|NCT01634100|472329658|FG003|Overall Study|Withdrawal by Subject|0|||
131193635|NCT01634100|472329659|FG004|Overall Study|Withdrawal by Subject|0|||
131193636|NCT01634100|472329660|FG005|Overall Study|Withdrawal by Subject|0|||
131193637|NCT00552344|472329661|FG000|Overall Study|Lack of Efficacy|55|||
131193638|NCT00552344|472329661|FG000|Overall Study|Loss of efficacy|75|||
131193639|NCT00552344|472329661|FG000|Overall Study|Lost to Follow-up|8|||
131193640|NCT00552344|472329661|FG000|Overall Study|Withdrawal by Subject|48|||
131193641|NCT00552344|472329661|FG000|Overall Study|SAE, non-fatal|6|||
131193642|NCT00552344|472329661|FG000|Overall Study|AE, non-serious non-fatal|38|||
131193643|NCT00552344|472329661|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
131193644|NCT00552344|472329661|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
131193645|NCT00552344|472329661|FG000|Overall Study|Other Reason|22|||
131193646|NCT01487863|472329669|FG000|Overall Study|Death|19|||
131193647|NCT01487863|472329670|FG001|Overall Study|Death|19|||
131193648|NCT00486889|472329671|FG000|Overall Study|Death|3|||
131193649|NCT00486889|472329671|FG000|Overall Study|Non-compliant|2|||
131193650|NCT00486889|472329671|FG000|Overall Study|Withdrawal by Subject|6|||
131193651|NCT00893763|472329672|FG000|Overall Study|extubated|110|||
131193652|NCT00893763|472329673|FG001|Overall Study|extubated|110|||
131193653|NCT01512693|472329674|FG000|Overall Study|Withdrawal by Subject|0|||
131193654|NCT01512693|472329675|FG001|Overall Study|Withdrawal by Subject|1|||
131193655|NCT01975376|472329676|FG000|Overall Study|Adverse Event|5|||
131193656|NCT01975376|472329677|FG001|Overall Study|Adverse Event|5|||
131193657|NCT01975376|472329676|FG000|Overall Study|Death|65|||
131193658|NCT01975376|472329677|FG001|Overall Study|Death|72|||
131193659|NCT01975376|472329676|FG000|Overall Study|Lost to Follow-up|70|||
131193660|NCT01975376|472329677|FG001|Overall Study|Lost to Follow-up|66|||
131193661|NCT01975376|472329676|FG000|Overall Study|Withdrew consent|68|||
131193662|NCT01975376|472329677|FG001|Overall Study|Withdrew consent|62|||
131193663|NCT01975376|472329676|FG000|Overall Study|Other|2|||
131193664|NCT01975376|472329677|FG001|Overall Study|Other|4|||
131193665|NCT01975376|472329676|FG000|Overall Study|Randomized, Not Treated|16|||
131193666|NCT01975376|472329677|FG001|Overall Study|Randomized, Not Treated|8|||
131193667|NCT04731922|472329681|FG000|Overall Study|Adverse Event|0|||
131193668|NCT04731922|472329682|FG001|Overall Study|Adverse Event|0|||
131193669|NCT04731922|472329683|FG002|Overall Study|Adverse Event|0|||
131193670|NCT04731922|472329684|FG003|Overall Study|Adverse Event|0|||
131193671|NCT04731922|472329685|FG004|Overall Study|Adverse Event|0|||
131193672|NCT04731922|472329686|FG005|Overall Study|Adverse Event|0|||
131193673|NCT04731922|472329687|FG006|Overall Study|Adverse Event|0|||
131193674|NCT04731922|472329688|FG007|Overall Study|Adverse Event|0|||
131193675|NCT04731922|472329689|FG008|Overall Study|Adverse Event|0|||
131193676|NCT04731922|472329690|FG009|Overall Study|Adverse Event|0|||
131193677|NCT04731922|472329691|FG010|Overall Study|Adverse Event|1|||
131193678|NCT04731922|472329692|FG011|Overall Study|Adverse Event|0|||
131193679|NCT04731922|472329693|FG012|Overall Study|Adverse Event|0|||
131193680|NCT04731922|472329694|FG013|Overall Study|Adverse Event|0|||
131193681|NCT04731922|472329695|FG014|Overall Study|Adverse Event|0|||
131193682|NCT04731922|472329696|FG015|Overall Study|Adverse Event|0|||
131193683|NCT04731922|472329697|FG016|Overall Study|Adverse Event|0|||
131193684|NCT04731922|472329681|FG000|Overall Study|Lost to Follow-up|0|||
131193685|NCT04731922|472329682|FG001|Overall Study|Lost to Follow-up|0|||
131193686|NCT04731922|472329683|FG002|Overall Study|Lost to Follow-up|0|||
131193687|NCT04731922|472329684|FG003|Overall Study|Lost to Follow-up|1|||
131193688|NCT04731922|472329685|FG004|Overall Study|Lost to Follow-up|0|||
131193689|NCT04731922|472329686|FG005|Overall Study|Lost to Follow-up|1|||
130784585|NCT01663402|470838831|FG000|Overall Study|Adverse Event|347|||
131193690|NCT04731922|472329687|FG006|Overall Study|Lost to Follow-up|0|||
131193691|NCT04731922|472329688|FG007|Overall Study|Lost to Follow-up|0|||
131193692|NCT04731922|472329689|FG008|Overall Study|Lost to Follow-up|0|||
131193693|NCT04731922|472329690|FG009|Overall Study|Lost to Follow-up|0|||
131193694|NCT04731922|472329691|FG010|Overall Study|Lost to Follow-up|0|||
131193695|NCT04731922|472329692|FG011|Overall Study|Lost to Follow-up|0|||
131193696|NCT04731922|472329693|FG012|Overall Study|Lost to Follow-up|0|||
131193697|NCT04731922|472329694|FG013|Overall Study|Lost to Follow-up|0|||
131193698|NCT04731922|472329695|FG014|Overall Study|Lost to Follow-up|0|||
131193699|NCT04731922|472329696|FG015|Overall Study|Lost to Follow-up|0|||
131193700|NCT04731922|472329697|FG016|Overall Study|Lost to Follow-up|0|||
131193701|NCT04731922|472329681|FG000|Overall Study|Withdrawal by Subject|1|||
131193702|NCT04731922|472329682|FG001|Overall Study|Withdrawal by Subject|0|||
131193703|NCT04731922|472329683|FG002|Overall Study|Withdrawal by Subject|0|||
131193704|NCT04731922|472329684|FG003|Overall Study|Withdrawal by Subject|0|||
130784586|NCT01663402|470838832|FG001|Overall Study|Adverse Event|362|||
131193705|NCT04731922|472329685|FG004|Overall Study|Withdrawal by Subject|1|||
131193706|NCT04731922|472329686|FG005|Overall Study|Withdrawal by Subject|0|||
131193707|NCT04731922|472329687|FG006|Overall Study|Withdrawal by Subject|1|||
131193708|NCT04731922|472329688|FG007|Overall Study|Withdrawal by Subject|0|||
131193709|NCT04731922|472329689|FG008|Overall Study|Withdrawal by Subject|0|||
131193710|NCT04731922|472329690|FG009|Overall Study|Withdrawal by Subject|0|||
131193711|NCT04731922|472329691|FG010|Overall Study|Withdrawal by Subject|0|||
131193712|NCT04731922|472329692|FG011|Overall Study|Withdrawal by Subject|0|||
131193713|NCT04731922|472329693|FG012|Overall Study|Withdrawal by Subject|0|||
131193714|NCT04731922|472329694|FG013|Overall Study|Withdrawal by Subject|1|||
131193715|NCT04731922|472329695|FG014|Overall Study|Withdrawal by Subject|0|||
131193716|NCT04731922|472329696|FG015|Overall Study|Withdrawal by Subject|0|||
131193717|NCT04731922|472329697|FG016|Overall Study|Withdrawal by Subject|0|||
131193718|NCT04731922|472329681|FG000|Overall Study|Other|0|||
131193719|NCT04731922|472329682|FG001|Overall Study|Other|0|||
131193720|NCT04731922|472329683|FG002|Overall Study|Other|0|||
131193721|NCT04731922|472329684|FG003|Overall Study|Other|0|||
131193722|NCT04731922|472329685|FG004|Overall Study|Other|0|||
131193723|NCT04731922|472329686|FG005|Overall Study|Other|0|||
131193724|NCT04731922|472329687|FG006|Overall Study|Other|1|||
131193725|NCT04731922|472329688|FG007|Overall Study|Other|0|||
131193726|NCT04731922|472329689|FG008|Overall Study|Other|0|||
131193727|NCT04731922|472329690|FG009|Overall Study|Other|0|||
131193728|NCT04731922|472329691|FG010|Overall Study|Other|0|||
131193729|NCT04731922|472329692|FG011|Overall Study|Other|0|||
131193730|NCT04731922|472329693|FG012|Overall Study|Other|0|||
131193731|NCT04731922|472329694|FG013|Overall Study|Other|0|||
131193732|NCT04731922|472329695|FG014|Overall Study|Other|0|||
131193733|NCT04731922|472329696|FG015|Overall Study|Other|0|||
131193734|NCT04731922|472329697|FG016|Overall Study|Other|0|||
131193735|NCT01819194|472329699|FG000|Overall Study|Loss of study articles|2|||
131193736|NCT01448707|472329700|FG000|Overall Study|Adverse Event|3|||
131193737|NCT01448707|472329701|FG001|Overall Study|Adverse Event|1|||
131193738|NCT01448707|472329700|FG000|Overall Study|Lost to Follow-up|2|||
131193739|NCT01448707|472329701|FG001|Overall Study|Lost to Follow-up|6|||
131193740|NCT01448707|472329700|FG000|Overall Study|Withdrawal by Subject|6|||
131193741|NCT01448707|472329701|FG001|Overall Study|Withdrawal by Subject|7|||
131193742|NCT01448707|472329700|FG000|Overall Study|Other|7|||
131193743|NCT01448707|472329701|FG001|Overall Study|Other|4|||
131193744|NCT00441480|472329704|FG000|Overall Study|Protocol Violation|1|||
131193745|NCT00441480|472329705|FG001|Overall Study|Protocol Violation|1|||
131193746|NCT00441480|472329704|FG000|Overall Study|Withdrawal by Subject|2|||
131193747|NCT00441480|472329705|FG001|Overall Study|Withdrawal by Subject|3|||
131193748|NCT02623699|472329706|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193749|NCT02623699|472329707|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
131193750|NCT02623699|472329708|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193751|NCT02623699|472329709|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193752|NCT02623699|472329710|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193753|NCT02623699|472329711|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193754|NCT02623699|472329712|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193755|NCT02623699|472329713|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193756|NCT02623699|472329714|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193757|NCT02623699|472329715|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193758|NCT02623699|472329716|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193759|NCT02623699|472329717|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
131193760|NCT02623699|472329706|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193761|NCT02623699|472329707|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193762|NCT02623699|472329708|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193763|NCT02623699|472329709|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193764|NCT02623699|472329710|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193765|NCT02623699|472329711|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193766|NCT02623699|472329712|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
131193767|NCT02623699|472329713|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193768|NCT02623699|472329714|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193769|NCT02623699|472329715|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193770|NCT02623699|472329716|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193771|NCT02623699|472329717|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
131193772|NCT02623699|472329706|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193773|NCT02623699|472329707|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193774|NCT02623699|472329708|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193775|NCT02623699|472329709|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193776|NCT02623699|472329710|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193777|NCT02623699|472329711|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
131193778|NCT02623699|472329712|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193779|NCT02623699|472329713|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193780|NCT02623699|472329714|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193781|NCT02623699|472329715|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193782|NCT02623699|472329716|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193783|NCT02623699|472329717|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
131193784|NCT02623699|472329706|FG000|Part B (Up to 289 Days)|Death|0|||
131193785|NCT02623699|472329707|FG001|Part B (Up to 289 Days)|Death|0|||
131193786|NCT02623699|472329708|FG002|Part B (Up to 289 Days)|Death|0|||
131193787|NCT02623699|472329709|FG003|Part B (Up to 289 Days)|Death|0|||
131193788|NCT02623699|472329710|FG004|Part B (Up to 289 Days)|Death|0|||
131193789|NCT02623699|472329711|FG005|Part B (Up to 289 Days)|Death|1|||
131193790|NCT02623699|472329712|FG006|Part B (Up to 289 Days)|Death|1|||
131193791|NCT02623699|472329713|FG007|Part B (Up to 289 Days)|Death|0|||
131193792|NCT02623699|472329714|FG008|Part B (Up to 289 Days)|Death|1|||
131193793|NCT02623699|472329715|FG009|Part B (Up to 289 Days)|Death|0|||
131193794|NCT02623699|472329716|FG010|Part B (Up to 289 Days)|Death|0|||
131193795|NCT02623699|472329717|FG011|Part B (Up to 289 Days)|Death|0|||
131193796|NCT02623699|472329706|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
131193797|NCT02623699|472329707|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
131193798|NCT02623699|472329708|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
131193799|NCT02623699|472329709|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
131193800|NCT02623699|472329710|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
131193801|NCT02623699|472329711|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
131193802|NCT02623699|472329712|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
131193803|NCT02623699|472329713|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
131193804|NCT02623699|472329714|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
131193805|NCT02623699|472329715|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
131193806|NCT02623699|472329716|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
131193807|NCT02623699|472329717|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
131193808|NCT02623699|472329706|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131193809|NCT02623699|472329707|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131193810|NCT02623699|472329708|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131193811|NCT02623699|472329709|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131193812|NCT02623699|472329710|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131193813|NCT02623699|472329711|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131193814|NCT02623699|472329712|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131193815|NCT02623699|472329713|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131193816|NCT02623699|472329714|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131193817|NCT02623699|472329715|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
131193818|NCT02623699|472329716|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
131193819|NCT02623699|472329717|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
131193820|NCT02623699|472329706|FG000|Part C (Up to 236 Days)|Death|0|||
131193821|NCT02623699|472329707|FG001|Part C (Up to 236 Days)|Death|0|||
131193822|NCT02623699|472329708|FG002|Part C (Up to 236 Days)|Death|0|||
131193823|NCT02623699|472329709|FG003|Part C (Up to 236 Days)|Death|0|||
131193824|NCT02623699|472329710|FG004|Part C (Up to 236 Days)|Death|0|||
131193825|NCT02623699|472329711|FG005|Part C (Up to 236 Days)|Death|0|||
131193826|NCT02623699|472329712|FG006|Part C (Up to 236 Days)|Death|0|||
131193827|NCT02623699|472329713|FG007|Part C (Up to 236 Days)|Death|0|||
131193828|NCT02623699|472329714|FG008|Part C (Up to 236 Days)|Death|0|||
131193829|NCT02623699|472329715|FG009|Part C (Up to 236 Days)|Death|0|||
131193830|NCT02623699|472329716|FG010|Part C (Up to 236 Days)|Death|0|||
131193831|NCT02623699|472329717|FG011|Part C (Up to 236 Days)|Death|1|||
131193832|NCT02623699|472329706|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
131193833|NCT02623699|472329707|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
131193834|NCT02623699|472329708|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
131193835|NCT02623699|472329709|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
131193836|NCT02623699|472329710|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
131193837|NCT02623699|472329711|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
131193838|NCT02623699|472329712|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
131193839|NCT02623699|472329713|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
131193840|NCT02623699|472329714|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
131193841|NCT02623699|472329715|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
131193842|NCT02623699|472329716|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
131193843|NCT02623699|472329717|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
131193844|NCT00899678|472329718|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
131193845|NCT00899678|472329719|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
131193846|NCT00899678|472329720|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
131193847|NCT00899678|472329718|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
131193848|NCT00899678|472329719|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
131193849|NCT00899678|472329720|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
131193850|NCT00899678|472329718|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
130733653|NCT01708954|470642923|FG002|Step 2|Withdrawal by Subject|0|||
131193851|NCT00899678|472329719|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
131193852|NCT00899678|472329720|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
131193853|NCT00899678|472329718|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
131193854|NCT00899678|472329719|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
131193855|NCT00899678|472329720|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
131193856|NCT00899678|472329718|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
131193857|NCT00899678|472329719|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
130733654|NCT06400251|470642924|FG000|Overall Study|Never Start Protocol Therapy|1|||
130733655|NCT06400251|470642924|FG000|Overall Study|Ineligible|2|||
130733656|NCT06400251|470642924|FG000|Overall Study|Mutation Status Not Confirmed|3|||
130733657|NCT06400251|470642924|FG000|Overall Study|Disease Progression|25|||
130733658|NCT06400251|470642924|FG000|Overall Study|Adverse Event|1|||
130733659|NCT06400251|470642924|FG000|Overall Study|Complicating Disease|1|||
131193858|NCT00899678|472329720|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
131193859|NCT00899678|472329718|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
131193860|NCT00899678|472329719|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
131193861|NCT00899678|472329720|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
131193862|NCT00899678|472329718|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
131193863|NCT00899678|472329719|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
131193864|NCT00899678|472329720|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
131193865|NCT00899678|472329718|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
131193866|NCT00899678|472329719|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
131193867|NCT00899678|472329720|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
131193868|NCT00899678|472329718|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
131193869|NCT00899678|472329719|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
131193870|NCT00899678|472329720|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
131193871|NCT02699125|472329723|FG000|Placebo|Lost to Follow-up|2|||
131193872|NCT02699125|472329724|FG001|Placebo|Lost to Follow-up|0|||
131193873|NCT02699125|472329723|FG000|Placebo|Protocol Violation|1|||
131193874|NCT02699125|472329724|FG001|Placebo|Protocol Violation|0|||
131193875|NCT02699125|472329723|FG000|Placebo|Withdrawal by Subject|0|||
131193876|NCT02699125|472329724|FG001|Placebo|Withdrawal by Subject|4|||
131193877|NCT02699125|472329723|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
131193878|NCT02699125|472329724|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
131193879|NCT03796195|472329725|FG000|Overall Study|Study closed early|1|||
131193880|NCT01039428|472329730|FG000|Overall Study|Protocol Violation|1|||
131193881|NCT01039428|472329731|FG001|Overall Study|Protocol Violation|0|||
131193882|NCT01039428|472329730|FG000|Overall Study|Withdrawal by Subject|1|||
131193883|NCT01039428|472329731|FG001|Overall Study|Withdrawal by Subject|0|||
131193884|NCT00441012|472329732|FG000|Overall Study|Adverse Event|0|||
131193885|NCT00441012|472329733|FG001|Overall Study|Adverse Event|1|||
131193886|NCT00441012|472329732|FG000|Overall Study|Lost to Follow-up|3|||
131193887|NCT00441012|472329733|FG001|Overall Study|Lost to Follow-up|3|||
131193888|NCT00441012|472329732|FG000|Overall Study|Protocol Violation|10|||
131193889|NCT00441012|472329733|FG001|Overall Study|Protocol Violation|9|||
131193890|NCT00441012|472329732|FG000|Overall Study|Withdrawal by Subject|4|||
131193891|NCT00441012|472329733|FG001|Overall Study|Withdrawal by Subject|0|||
131193892|NCT00441012|472329732|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
131193893|NCT00441012|472329733|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
131193894|NCT00262314|472329738|FG000|Overall Study|Changing physicians|38|||
131193895|NCT00262314|472329738|FG000|Overall Study|Death|12|||
131193896|NCT00262314|472329738|FG000|Overall Study|Patient's decision|92|||
131193897|NCT00262314|472329738|FG000|Overall Study|Other|95|||
131193898|NCT00262314|472329738|FG000|Overall Study|Lost to Follow-up|70|||
131193899|NCT00262314|472329738|FG000|Overall Study|Administrative withdrawal|30|||
131193900|NCT05104749|472329739|FG000|Overall Study|Lost to Follow-up|2|||
131193901|NCT05104749|472329740|FG001|Overall Study|Lost to Follow-up|3|||
131193902|NCT03964493|472329741|FG000|Overall Study|Withdrawal by Subject|4|||
131193903|NCT03964493|472329742|FG001|Overall Study|Withdrawal by Subject|1|||
131193904|NCT03964493|472329741|FG000|Overall Study|Lost to Follow-up|13|||
131193905|NCT03964493|472329742|FG001|Overall Study|Lost to Follow-up|4|||
131193906|NCT02470429|472329743|FG000|Overall Study|Adverse Event|1|||
131193907|NCT02470429|472329744|FG001|Overall Study|Adverse Event|0|||
131193908|NCT02470429|472329743|FG000|Overall Study|Withdrawal by Subject|1|||
131193909|NCT02470429|472329744|FG001|Overall Study|Withdrawal by Subject|0|||
131193910|NCT01300767|472329745|FG000|Overall Study|Discomfort|2|||
131193911|NCT01300767|472329745|FG000|Overall Study|Biomicroscopy|1|||
131193912|NCT01300767|472329745|FG000|Overall Study|Unacceptable fit|1|||
131193913|NCT00117572|472329746|FG000|Overall Study|Site withdrew before starting treatment|2|||
131193914|NCT00117572|472329747|FG001|Overall Study|Site withdrew before starting treatment|3|||
131193915|NCT00117572|472329746|FG000|Overall Study|Withdrawal by Subject|3|||
131193916|NCT00117572|472329747|FG001|Overall Study|Withdrawal by Subject|3|||
131193917|NCT00117572|472329746|FG000|Overall Study|Protocol Violation|1|||
131193918|NCT00117572|472329747|FG001|Overall Study|Protocol Violation|0|||
131193919|NCT00901394|472329748|FG000|Overall Study|Physician Decision|1|||
130733660|NCT06400251|470642924|FG000|Overall Study|Physician Decision|2|||
130733661|NCT01625988|470642931|FG000|Overall Study|Lost to Follow-up|5|||
130733662|NCT01625988|470642932|FG001|Overall Study|Lost to Follow-up|6|||
131193920|NCT00901394|472329749|FG001|Overall Study|Physician Decision|1|||
131193921|NCT00901394|472329750|FG002|Overall Study|Physician Decision|2|||
131193922|NCT03039569|472329754|FG000|Overall Study|Lost to Follow-up|5|||
131193923|NCT03039569|472329755|FG001|Overall Study|Lost to Follow-up|4|||
131193924|NCT02254304|472329756|FG000|Overall Study|Adverse Event|2|||
130733663|NCT01625988|470642931|FG000|Overall Study|Withdrawal by Subject|8|||
130733664|NCT01625988|470642932|FG001|Overall Study|Withdrawal by Subject|3|||
130733665|NCT01625988|470642931|FG000|Overall Study|Adverse Event|0|||
130733666|NCT01625988|470642932|FG001|Overall Study|Adverse Event|1|||
130733667|NCT01625988|470642931|FG000|Overall Study|Lack of Efficacy|0|||
130733668|NCT01625988|470642932|FG001|Overall Study|Lack of Efficacy|1|||
130733669|NCT01625988|470642931|FG000|Overall Study|Randomized Inappropriately|1|||
130733670|NCT01625988|470642932|FG001|Overall Study|Randomized Inappropriately|0|||
130733671|NCT01625988|470642931|FG000|Overall Study|Protocol Violation|0|||
130733672|NCT01625988|470642932|FG001|Overall Study|Protocol Violation|2|||
130733673|NCT01644617|470642933|FG000|Overall Study|Withdrawal by Subject|3|||
131193925|NCT02254304|472329757|FG001|Overall Study|Adverse Event|1|||
131193926|NCT02254304|472329756|FG000|Overall Study|Lost to Follow-up|2|||
131193927|NCT02254304|472329757|FG001|Overall Study|Lost to Follow-up|2|||
131193928|NCT02254304|472329756|FG000|Overall Study|Protocol Violation|1|||
131193929|NCT02254304|472329757|FG001|Overall Study|Protocol Violation|0|||
131193930|NCT02254304|472329756|FG000|Overall Study|Withdrawal by Subject|3|||
131193931|NCT02254304|472329757|FG001|Overall Study|Withdrawal by Subject|0|||
131193932|NCT02254304|472329756|FG000|Overall Study|Injection site pain and Injection fear|1|||
131193933|NCT02254304|472329757|FG001|Overall Study|Injection site pain and Injection fear|0|||
131193934|NCT02254304|472329756|FG000|Overall Study|Personal causes|4|||
131193935|NCT02254304|472329757|FG001|Overall Study|Personal causes|1|||
131193936|NCT02254304|472329756|FG000|Overall Study|Personal decision|1|||
131193937|NCT02254304|472329757|FG001|Overall Study|Personal decision|0|||
131193938|NCT02973997|472331475|FG000|Overall Study|Withdrawal by Subject|4|||
131193939|NCT02973997|472331476|FG001|Overall Study|Withdrawal by Subject|0|||
131193940|NCT02973997|472331475|FG000|Overall Study|Adverse Event|4|||
131193941|NCT02973997|472331476|FG001|Overall Study|Adverse Event|1|||
131193942|NCT02973997|472331475|FG000|Overall Study|Disease Progression|11|||
131193943|NCT02973997|472331476|FG001|Overall Study|Disease Progression|20|||
131193944|NCT02973997|472331475|FG000|Overall Study|Alternative Therapy|3|||
131193945|NCT02973997|472331476|FG001|Overall Study|Alternative Therapy|0|||
131193946|NCT02973997|472331475|FG000|Overall Study|Other complicating disease|0|||
131193947|NCT02973997|472331476|FG001|Overall Study|Other complicating disease|1|||
131193948|NCT02973997|472331475|FG000|Overall Study|Death|0|||
131193949|NCT02973997|472331476|FG001|Overall Study|Death|1|||
131193950|NCT00444951|472331477|FG000|Overall Study|Lost to Follow-up|1|||
131193951|NCT00444951|472331478|FG001|Overall Study|Lost to Follow-up|1|||
131193952|NCT00444951|472331479|FG002|Overall Study|Lost to Follow-up|0|||
131193953|NCT00444951|472331477|FG000|Overall Study|Withdrawal by Subject|4|||
131193954|NCT00444951|472331478|FG001|Overall Study|Withdrawal by Subject|5|||
131193955|NCT00444951|472331479|FG002|Overall Study|Withdrawal by Subject|3|||
131193956|NCT01998906|472331480|FG000|Overall Study|Participants ongoing in follow-up|77|||
131193957|NCT01998906|472331481|FG001|Overall Study|Participants ongoing in follow-up|60|||
131193958|NCT01998906|472331482|FG002|Overall Study|Participants ongoing in follow-up|58|||
131193959|NCT01998906|472331480|FG000|Overall Study|Death|21|||
131193960|NCT01998906|472331481|FG001|Overall Study|Death|30|||
131193961|NCT01998906|472331482|FG002|Overall Study|Death|17|||
131193962|NCT01998906|472331480|FG000|Overall Study|Lack of Efficacy|10|||
131193963|NCT01998906|472331481|FG001|Overall Study|Lack of Efficacy|9|||
131193964|NCT01998906|472331482|FG002|Overall Study|Lack of Efficacy|8|||
131193965|NCT01998906|472331480|FG000|Overall Study|Failure to return|0|||
131193966|NCT01998906|472331481|FG001|Overall Study|Failure to return|2|||
131193967|NCT01998906|472331482|FG002|Overall Study|Failure to return|4|||
131193968|NCT01998906|472331480|FG000|Overall Study|Violation of Selection Criteria|0|||
131193969|NCT01998906|472331481|FG001|Overall Study|Violation of Selection Criteria|0|||
131193970|NCT01998906|472331482|FG002|Overall Study|Violation of Selection Criteria|1|||
131193971|NCT01998906|472331480|FG000|Overall Study|Withdrawal by Subject|1|||
131193972|NCT01998906|472331481|FG001|Overall Study|Withdrawal by Subject|4|||
131193973|NCT01998906|472331482|FG002|Overall Study|Withdrawal by Subject|3|||
131193974|NCT01998906|472331480|FG000|Overall Study|Administrative/Other|2|||
131193975|NCT01998906|472331481|FG001|Overall Study|Administrative/Other|1|||
131193976|NCT01998906|472331482|FG002|Overall Study|Administrative/Other|3|||
131193977|NCT01998906|472331480|FG000|Overall Study|Other|3|||
131193978|NCT01998906|472331481|FG001|Overall Study|Other|8|||
131193979|NCT01998906|472331482|FG002|Overall Study|Other|4|||
131193980|NCT02996110|472331491|FG000|Pre-Treatment|Other Reasons|0|||
131193981|NCT02996110|472331492|FG001|Pre-Treatment|Other Reasons|1|||
131193982|NCT02996110|472331493|FG002|Pre-Treatment|Other Reasons|0|||
131193983|NCT02996110|472331494|FG003|Pre-Treatment|Other Reasons|0|||
131193984|NCT02996110|472331495|FG004|Pre-Treatment|Other Reasons|1|||
131193985|NCT02996110|472331491|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
131193986|NCT02996110|472331492|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
131193987|NCT02996110|472331493|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
131193988|NCT02996110|472331494|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
131193989|NCT02996110|472331495|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
131193990|NCT02996110|472331491|FG000|Track 1|Disease Progression|15|||
131193991|NCT02996110|472331492|FG001|Track 1|Disease Progression|17|||
131193992|NCT02996110|472331493|FG002|Track 1|Disease Progression|0|||
131193993|NCT02996110|472331494|FG003|Track 1|Disease Progression|0|||
131193994|NCT02996110|472331495|FG004|Track 1|Disease Progression|0|||
131193995|NCT02996110|472331491|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
131193996|NCT02996110|472331492|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
131193997|NCT02996110|472331493|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
131193998|NCT02996110|472331494|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
131193999|NCT02996110|472331495|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
131194000|NCT02996110|472331491|FG000|Track 1|Study Drug Toxicity|5|||
131194001|NCT02996110|472331492|FG001|Track 1|Study Drug Toxicity|3|||
131194002|NCT02996110|472331493|FG002|Track 1|Study Drug Toxicity|0|||
131194003|NCT02996110|472331494|FG003|Track 1|Study Drug Toxicity|0|||
131194004|NCT02996110|472331495|FG004|Track 1|Study Drug Toxicity|0|||
131194005|NCT02996110|472331491|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
131194006|NCT02996110|472331492|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
131194007|NCT02996110|472331493|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
131194008|NCT02996110|472331494|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
131194009|NCT02996110|472331495|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
131194010|NCT02996110|472331491|FG000|Track 1|Administrative Reason by Sponsor|0|||
131194011|NCT02996110|472331492|FG001|Track 1|Administrative Reason by Sponsor|1|||
131194012|NCT02996110|472331493|FG002|Track 1|Administrative Reason by Sponsor|0|||
131194013|NCT02996110|472331494|FG003|Track 1|Administrative Reason by Sponsor|0|||
131194014|NCT02996110|472331495|FG004|Track 1|Administrative Reason by Sponsor|0|||
131194015|NCT02996110|472331491|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
131194016|NCT02996110|472331492|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
131194017|NCT02996110|472331493|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
131194018|NCT02996110|472331494|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
131194019|NCT02996110|472331495|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
131194020|NCT02996110|472331491|FG000|Track 2|Disease Progression|33|||
131194021|NCT02996110|472331492|FG001|Track 2|Disease Progression|26|||
131194022|NCT02996110|472331493|FG002|Track 2|Disease Progression|19|||
131194023|NCT02996110|472331494|FG003|Track 2|Disease Progression|16|||
131194024|NCT02996110|472331495|FG004|Track 2|Disease Progression|15|||
131194025|NCT02996110|472331491|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
131194026|NCT02996110|472331492|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
131194027|NCT02996110|472331493|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
131194028|NCT02996110|472331494|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
131194029|NCT02996110|472331495|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
131194030|NCT02996110|472331491|FG000|Track 2|Death|0|||
131194031|NCT02996110|472331492|FG001|Track 2|Death|0|||
131194032|NCT02996110|472331493|FG002|Track 2|Death|1|||
131194033|NCT02996110|472331494|FG003|Track 2|Death|0|||
131194034|NCT02996110|472331495|FG004|Track 2|Death|1|||
131194035|NCT02996110|472331491|FG000|Track 2|Study Drug Toxicity|4|||
131194036|NCT02996110|472331492|FG001|Track 2|Study Drug Toxicity|1|||
131194037|NCT02996110|472331493|FG002|Track 2|Study Drug Toxicity|4|||
131194038|NCT02996110|472331494|FG003|Track 2|Study Drug Toxicity|1|||
131194039|NCT02996110|472331495|FG004|Track 2|Study Drug Toxicity|0|||
131194040|NCT02996110|472331491|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
131194041|NCT02996110|472331492|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
131194042|NCT02996110|472331493|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
131194043|NCT02996110|472331494|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
131194044|NCT02996110|472331495|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
131194045|NCT02996110|472331491|FG000|Track 2|Participant Withdrew Consent|1|||
131194046|NCT02996110|472331492|FG001|Track 2|Participant Withdrew Consent|2|||
131194047|NCT02996110|472331493|FG002|Track 2|Participant Withdrew Consent|3|||
131194048|NCT02996110|472331494|FG003|Track 2|Participant Withdrew Consent|1|||
131194049|NCT02996110|472331495|FG004|Track 2|Participant Withdrew Consent|1|||
131194050|NCT02996110|472331491|FG000|Track 2|Other Reasons|0|||
131194051|NCT02996110|472331492|FG001|Track 2|Other Reasons|0|||
131194052|NCT02996110|472331493|FG002|Track 2|Other Reasons|1|||
131194053|NCT02996110|472331494|FG003|Track 2|Other Reasons|0|||
131194054|NCT02996110|472331495|FG004|Track 2|Other Reasons|1|||
131194055|NCT00589602|472331507|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
131194056|NCT01536418|472331510|FG000|Overall Study|Protocol Violation|2|||
131194057|NCT01536418|472331511|FG001|Overall Study|Protocol Violation|3|||
131194058|NCT01536418|472331510|FG000|Overall Study|Physician Decision|1|||
131194059|NCT01536418|472331511|FG001|Overall Study|Physician Decision|3|||
131194060|NCT01536418|472331510|FG000|Overall Study|Study closed/terminated|41|||
131194061|NCT01536418|472331511|FG001|Overall Study|Study closed/terminated|37|||
131194062|NCT01536418|472331510|FG000|Overall Study|Lack of Efficacy|10|||
131194063|NCT01536418|472331511|FG001|Overall Study|Lack of Efficacy|16|||
131194064|NCT01536418|472331510|FG000|Overall Study|Adverse Event|9|||
130733674|NCT01644617|470642934|FG001|Overall Study|Withdrawal by Subject|4|||
130733675|NCT01644617|470642935|FG002|Overall Study|Withdrawal by Subject|1|||
130733676|NCT01644617|470642933|FG000|Overall Study|Lost to Follow-up|0|||
130733677|NCT01644617|470642934|FG001|Overall Study|Lost to Follow-up|1|||
130733678|NCT01644617|470642935|FG002|Overall Study|Lost to Follow-up|0|||
130733679|NCT01644617|470642933|FG000|Overall Study|Adverse Event|3|||
130733680|NCT01644617|470642934|FG001|Overall Study|Adverse Event|0|||
130733681|NCT01644617|470642935|FG002|Overall Study|Adverse Event|6|||
131194065|NCT01536418|472331511|FG001|Overall Study|Adverse Event|4|||
131194066|NCT01536418|472331510|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
131194067|NCT01536418|472331511|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
131194068|NCT01536418|472331510|FG000|Overall Study|Withdrawal by Subject|5|||
131194069|NCT01536418|472331511|FG001|Overall Study|Withdrawal by Subject|3|||
131194070|NCT00285649|472331514|FG000|Overall Study|Lost to Follow-up|6|||
131194071|NCT00285649|472331515|FG001|Overall Study|Lost to Follow-up|4|||
131194072|NCT00285649|472331516|FG002|Overall Study|Lost to Follow-up|4|||
131194073|NCT00285649|472331514|FG000|Overall Study|Withdrawal by Subject|3|||
131194074|NCT00285649|472331515|FG001|Overall Study|Withdrawal by Subject|2|||
131194075|NCT00285649|472331516|FG002|Overall Study|Withdrawal by Subject|2|||
131194076|NCT03342404|472331517|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
131194077|NCT03342404|472331518|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
131194078|NCT03342404|472331517|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
131194079|NCT03342404|472331518|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
131194080|NCT03342404|472331517|FG000|Blinded Treatment Phase|Adverse Event|5|||
131194081|NCT03342404|472331518|FG001|Blinded Treatment Phase|Adverse Event|4|||
131194082|NCT03342404|472331517|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
131194083|NCT03342404|472331518|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
131194084|NCT03342404|472331517|FG000|Blinded Treatment Phase|Other reasons|1|||
131194085|NCT03342404|472331518|FG001|Blinded Treatment Phase|Other reasons|0|||
131194086|NCT03342404|472331517|FG000|Blinded Treatment Phase|Physician Decision|1|||
130733682|NCT05223920|470642939|FG000|Overall Study|Adverse Event|6|||
130733683|NCT05223920|470642940|FG001|Overall Study|Adverse Event|3|||
131194087|NCT03342404|472331518|FG001|Blinded Treatment Phase|Physician Decision|0|||
131194088|NCT03342404|472331517|FG000|Blinded Treatment Phase|Death|1|||
130733684|NCT05223920|470642939|FG000|Overall Study|Death|2|||
130733685|NCT05223920|470642940|FG001|Overall Study|Death|0|||
131194089|NCT03342404|472331518|FG001|Blinded Treatment Phase|Death|0|||
131194090|NCT03342404|472331517|FG000|Open-Label Phase|Lost to Follow-up|0|||
131194091|NCT03342404|472331518|FG001|Open-Label Phase|Lost to Follow-up|1|||
131194092|NCT03342404|472331517|FG000|Open-Label Phase|Other reasons|0|||
131194093|NCT03342404|472331518|FG001|Open-Label Phase|Other reasons|1|||
131194094|NCT03342404|472331517|FG000|Open-Label Phase|Adverse Event|0|||
131194095|NCT03342404|472331518|FG001|Open-Label Phase|Adverse Event|3|||
131194096|NCT03342404|472331517|FG000|Open-Label Phase|Withdrawal by Subject|0|||
131194097|NCT03342404|472331518|FG001|Open-Label Phase|Withdrawal by Subject|6|||
131194098|NCT01855425|472331519|FG000|Overall Study|Physician Decision|20|||
131194099|NCT03748420|472331521|FG000|Overall Study|No 12 month medication adherence data available|0|||
131194100|NCT03748420|472331522|FG001|Overall Study|No 12 month medication adherence data available|1|||
131194101|NCT03748420|472331521|FG000|Overall Study|Death|24|||
131194102|NCT03748420|472331522|FG001|Overall Study|Death|28|||
131194103|NCT03748420|472331521|FG000|Overall Study|Lost to Follow-up|231|||
131194104|NCT03748420|472331522|FG001|Overall Study|Lost to Follow-up|230|||
131194105|NCT00373880|472331523|FG000|Overall Study|Physician Decision|3|||
131194106|NCT00373880|472331523|FG000|Overall Study|Arrested|1|||
131194107|NCT00373880|472331523|FG000|Overall Study|Protocol Violation|14|||
131194108|NCT01899768|472331525|FG000|Part A|Adverse Event|2|||
131194109|NCT01899768|472331525|FG000|Part A|Withdrawal by Subject|1|||
131194110|NCT01899768|472331525|FG000|Part B|Adverse Event|1|||
131194111|NCT01899768|472331525|FG000|Part B|Withdrawal by Subject|1|||
131194112|NCT04043416|472331526|FG000|Washout|Change in health condition|0|||
131194113|NCT04043416|472331527|FG001|Washout|Change in health condition|1|||
131194114|NCT02865928|472331528|FG000|Overall Study|Withdrawal by Subject|1|||
131194115|NCT02865928|472331529|FG001|Overall Study|Withdrawal by Subject|0|||
131194116|NCT02865928|472331528|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
131194117|NCT02865928|472331529|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
131194118|NCT02865928|472331528|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
131194119|NCT02865928|472331529|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
131194120|NCT01925014|472331532|FG000|Overall Study|Inappropriate enrollment|4|||
131194121|NCT01925014|472331533|FG001|Overall Study|Inappropriate enrollment|6|||
131194122|NCT01925014|472331532|FG000|Overall Study|Withdrawal by Subject|5|||
131194123|NCT01925014|472331533|FG001|Overall Study|Withdrawal by Subject|13|||
131194124|NCT00312728|472331534|FG000|Overall Study|Progressive disease|53|||
131194125|NCT00312728|472331534|FG000|Overall Study|Adverse Event|32|||
131194126|NCT00312728|472331534|FG000|Overall Study|Withdrawal by Subject|10|||
131194127|NCT00312728|472331534|FG000|Overall Study|Required non-protocol cancer treatment|2|||
131194128|NCT00312728|472331534|FG000|Overall Study|Protocol Violation|2|||
131194129|NCT00312728|472331534|FG000|Overall Study|Other|10|||
131194130|NCT00312728|472331534|FG000|Overall Study|Other|1|||
131194131|NCT01437267|472331543|FG000|Overall Study|Withdrawal by Subject|0|||
131194132|NCT01437267|472331544|FG001|Overall Study|Withdrawal by Subject|0|||
131194133|NCT01437267|472331545|FG002|Overall Study|Withdrawal by Subject|0|||
131194134|NCT01437267|472331546|FG003|Overall Study|Withdrawal by Subject|1|||
131194135|NCT01437267|472331547|FG004|Overall Study|Withdrawal by Subject|0|||
131194136|NCT01437267|472331548|FG005|Overall Study|Withdrawal by Subject|0|||
131194137|NCT01437267|472331543|FG000|Overall Study|Protocol Violation|0|||
131194138|NCT01437267|472331544|FG001|Overall Study|Protocol Violation|1|||
131194139|NCT01437267|472331545|FG002|Overall Study|Protocol Violation|0|||
131194140|NCT01437267|472331546|FG003|Overall Study|Protocol Violation|0|||
131194141|NCT01437267|472331547|FG004|Overall Study|Protocol Violation|0|||
131194142|NCT01437267|472331548|FG005|Overall Study|Protocol Violation|0|||
131194143|NCT00333970|472331549|FG000|Overall Study|Withdrawal by Subject|13|||
131194144|NCT00333970|472331550|FG001|Overall Study|Withdrawal by Subject|7|||
131194145|NCT00422240|472331558|FG000|Overall Study|Lack of Efficacy|1|||
131194146|NCT00422240|472331559|FG001|Overall Study|Lack of Efficacy|2|||
131194147|NCT00422240|472331560|FG002|Overall Study|Lack of Efficacy|0|||
131194148|NCT00422240|472331561|FG003|Overall Study|Lack of Efficacy|1|||
131194149|NCT00422240|472331558|FG000|Overall Study|Adverse Event|11|||
131194150|NCT00422240|472331559|FG001|Overall Study|Adverse Event|4|||
131194151|NCT00422240|472331560|FG002|Overall Study|Adverse Event|5|||
131194152|NCT00422240|472331561|FG003|Overall Study|Adverse Event|2|||
131194153|NCT00422240|472331558|FG000|Overall Study|Subject request|21|||
131194154|NCT00422240|472331559|FG001|Overall Study|Subject request|17|||
131194155|NCT00422240|472331560|FG002|Overall Study|Subject request|18|||
131194156|NCT00422240|472331561|FG003|Overall Study|Subject request|30|||
131194157|NCT00422240|472331558|FG000|Overall Study|Protocol Violation|0|||
131194158|NCT00422240|472331559|FG001|Overall Study|Protocol Violation|1|||
131194159|NCT00422240|472331560|FG002|Overall Study|Protocol Violation|0|||
131194160|NCT00422240|472331561|FG003|Overall Study|Protocol Violation|1|||
131194161|NCT00422240|472331558|FG000|Overall Study|Lost to Follow-up|31|||
131194162|NCT00422240|472331559|FG001|Overall Study|Lost to Follow-up|32|||
131194163|NCT00422240|472331560|FG002|Overall Study|Lost to Follow-up|19|||
131194164|NCT00422240|472331561|FG003|Overall Study|Lost to Follow-up|34|||
131194165|NCT00422240|472331558|FG000|Overall Study|Other|1|||
131194166|NCT00422240|472331559|FG001|Overall Study|Other|0|||
131194167|NCT00422240|472331560|FG002|Overall Study|Other|0|||
131194168|NCT00422240|472331561|FG003|Overall Study|Other|1|||
131194169|NCT00422240|472331558|FG000|Overall Study|Pregnancy|3|||
131194170|NCT00422240|472331559|FG001|Overall Study|Pregnancy|1|||
131194171|NCT00422240|472331560|FG002|Overall Study|Pregnancy|1|||
131194172|NCT00422240|472331561|FG003|Overall Study|Pregnancy|2|||
131194173|NCT01624467|472331562|FG000|Overall Study|Withdrawal by Subject|2|||
131194174|NCT01624467|472331562|FG000|Overall Study|Lost to Follow-up|1|||
131194175|NCT01624467|472331562|FG000|Overall Study|Adverse Event|7|||
131194176|NCT01624467|472331562|FG000|Overall Study|Progressive Disease|19|||
131194177|NCT01624467|472331562|FG000|Overall Study|Per Sponsor Requirement|1|||
131194178|NCT01624467|472331562|FG000|Overall Study|Subject Withdrew from Treatment|1|||
131194179|NCT02201472|472331563|FG000|Overall Study|Lack of Efficacy|2|||
131194180|NCT01602744|472331573|FG000|Overall Study|Death|17|||
131194181|NCT01602744|472331574|FG001|Overall Study|Death|15|||
131194182|NCT01602744|472331573|FG000|Overall Study|Lost to Follow-up|13|||
131194183|NCT01602744|472331574|FG001|Overall Study|Lost to Follow-up|8|||
131194184|NCT03418376|472331575|FG000|Overall Study|Musculoskeletal injury|1|||
131194185|NCT03418376|472331576|FG001|Overall Study|Musculoskeletal injury|2|||
131194186|NCT03418376|472331577|FG002|Overall Study|Musculoskeletal injury|1|||
131194187|NCT03418376|472331578|FG003|Overall Study|Musculoskeletal injury|0|||
131194188|NCT03418376|472331575|FG000|Overall Study|Personal reasons|0|||
131194189|NCT03418376|472331576|FG001|Overall Study|Personal reasons|2|||
131194190|NCT03418376|472331577|FG002|Overall Study|Personal reasons|2|||
131194191|NCT03418376|472331578|FG003|Overall Study|Personal reasons|1|||
131194192|NCT03418376|472331575|FG000|Overall Study|Exacerbation|0|||
131194193|NCT03418376|472331576|FG001|Overall Study|Exacerbation|1|||
131194194|NCT03418376|472331577|FG002|Overall Study|Exacerbation|0|||
131194195|NCT03418376|472331578|FG003|Overall Study|Exacerbation|0|||
131194196|NCT03864627|472331581|FG000|Overall Study|Adverse Event|0|||
131194197|NCT03864627|472331582|FG001|Overall Study|Adverse Event|1|||
131194198|NCT03864627|472331581|FG000|Overall Study|Lack of Efficacy|0|||
131194199|NCT03864627|472331582|FG001|Overall Study|Lack of Efficacy|1|||
131194200|NCT03864627|472331581|FG000|Overall Study|Lost to Follow-up|0|||
131194201|NCT03864627|472331582|FG001|Overall Study|Lost to Follow-up|1|||
131194202|NCT03864627|472331581|FG000|Overall Study|Withdrawal by Subject|4|||
131194203|NCT03864627|472331582|FG001|Overall Study|Withdrawal by Subject|8|||
131194204|NCT03864627|472331581|FG000|Overall Study|Study terminated by sponsor|0|||
131194205|NCT03864627|472331582|FG001|Overall Study|Study terminated by sponsor|1|||
131194206|NCT01388491|472331583|FG000|Overall Study|Adverse Event|10|||
131194207|NCT01388491|472331584|FG001|Overall Study|Adverse Event|9|||
131194208|NCT01388491|472331583|FG000|Overall Study|Sponsor Request|9|||
131194209|NCT01388491|472331584|FG001|Overall Study|Sponsor Request|7|||
131194210|NCT01388491|472331583|FG000|Overall Study|Withdrawal by Subject|6|||
131194211|NCT01388491|472331584|FG001|Overall Study|Withdrawal by Subject|10|||
131194212|NCT01388491|472331583|FG000|Overall Study|Lost to Follow-up|4|||
131194213|NCT01388491|472331584|FG001|Overall Study|Lost to Follow-up|3|||
131194214|NCT01388491|472331583|FG000|Overall Study|Protocol Violation|2|||
131194215|NCT01388491|472331584|FG001|Overall Study|Protocol Violation|0|||
131194216|NCT01388491|472331583|FG000|Overall Study|Noncompliance|2|||
131194217|NCT01388491|472331584|FG001|Overall Study|Noncompliance|0|||
131194218|NCT01388491|472331583|FG000|Overall Study|Pregnancy|1|||
131194219|NCT01388491|472331584|FG001|Overall Study|Pregnancy|0|||
131194220|NCT00412113|472331586|FG000|Overall Study|Adverse Event|11|||
131194221|NCT00412113|472331587|FG001|Overall Study|Adverse Event|15|||
131194222|NCT00412113|472331586|FG000|Overall Study|did not receive treatment|1|||
131194223|NCT00412113|472331587|FG001|Overall Study|did not receive treatment|0|||
131194224|NCT01190020|472331590|FG000|Overall Study|Adverse Event|2|||
131194225|NCT01190020|472331591|FG001|Overall Study|Adverse Event|0|||
131194226|NCT01190020|472331590|FG000|Overall Study|Lost to Follow-up|2|||
131194227|NCT01190020|472331591|FG001|Overall Study|Lost to Follow-up|0|||
131194228|NCT01190020|472331590|FG000|Overall Study|Withdrawal by Subject|3|||
131194229|NCT01190020|472331591|FG001|Overall Study|Withdrawal by Subject|0|||
131194230|NCT00796224|472331592|FG000|Overall Study|Adverse Event|1|||
131194231|NCT00796224|472331593|FG001|Overall Study|Adverse Event|0|||
131194232|NCT00796224|472331592|FG000|Overall Study|Protocol Violation|0|||
131194233|NCT00796224|472331593|FG001|Overall Study|Protocol Violation|1|||
131194234|NCT02569398|472331594|FG000|Overall Study|Adverse Event|0|||
131194235|NCT02569398|472331595|FG001|Overall Study|Adverse Event|1|||
131194236|NCT02569398|472331596|FG002|Overall Study|Adverse Event|6|||
131194237|NCT02569398|472331594|FG000|Overall Study|Withdrawal by Subject|43|||
131194238|NCT02569398|472331595|FG001|Overall Study|Withdrawal by Subject|43|||
131194239|NCT02569398|472331596|FG002|Overall Study|Withdrawal by Subject|30|||
131194240|NCT02569398|472331594|FG000|Overall Study|Study terminated by sponsor|130|||
131194241|NCT02569398|472331595|FG001|Overall Study|Study terminated by sponsor|131|||
131194242|NCT02569398|472331596|FG002|Overall Study|Study terminated by sponsor|134|||
131194243|NCT02569398|472331594|FG000|Overall Study|Other|12|||
131194244|NCT02569398|472331595|FG001|Overall Study|Other|14|||
131194245|NCT02569398|472331596|FG002|Overall Study|Other|13|||
131194246|NCT02116361|472331599|FG000|Overall Study|Pregnancy|0|||
131194247|NCT02116361|472331600|FG001|Overall Study|Pregnancy|0|||
131194248|NCT02116361|472331601|FG002|Overall Study|Pregnancy|0|||
131194249|NCT02116361|472331602|FG003|Overall Study|Pregnancy|1|||
131194250|NCT02116361|472331599|FG000|Overall Study|Protocol Violation|1|||
131194251|NCT02116361|472331600|FG001|Overall Study|Protocol Violation|0|||
131194252|NCT02116361|472331601|FG002|Overall Study|Protocol Violation|0|||
131194253|NCT02116361|472331602|FG003|Overall Study|Protocol Violation|2|||
131194254|NCT02116361|472331599|FG000|Overall Study|Physician Decision|2|||
131194255|NCT02116361|472331600|FG001|Overall Study|Physician Decision|3|||
131194256|NCT02116361|472331601|FG002|Overall Study|Physician Decision|0|||
131194257|NCT02116361|472331602|FG003|Overall Study|Physician Decision|0|||
131194258|NCT02116361|472331599|FG000|Overall Study|Adverse Event|1|||
131194259|NCT02116361|472331600|FG001|Overall Study|Adverse Event|0|||
131194260|NCT02116361|472331601|FG002|Overall Study|Adverse Event|0|||
131194261|NCT02116361|472331602|FG003|Overall Study|Adverse Event|3|||
131194262|NCT02116361|472331599|FG000|Overall Study|Other Reasons|3|||
131194263|NCT02116361|472331600|FG001|Overall Study|Other Reasons|3|||
131194264|NCT02116361|472331601|FG002|Overall Study|Other Reasons|3|||
131194265|NCT02116361|472331602|FG003|Overall Study|Other Reasons|3|||
131194266|NCT02116361|472331599|FG000|Overall Study|Lack of Efficacy|5|||
131194267|NCT02116361|472331600|FG001|Overall Study|Lack of Efficacy|7|||
131194268|NCT02116361|472331601|FG002|Overall Study|Lack of Efficacy|4|||
131194269|NCT02116361|472331602|FG003|Overall Study|Lack of Efficacy|3|||
131194270|NCT02116361|472331599|FG000|Overall Study|Lost to Follow-up|4|||
131194271|NCT02116361|472331600|FG001|Overall Study|Lost to Follow-up|5|||
131194272|NCT02116361|472331601|FG002|Overall Study|Lost to Follow-up|7|||
131194273|NCT02116361|472331602|FG003|Overall Study|Lost to Follow-up|5|||
131194274|NCT02116361|472331599|FG000|Overall Study|Personal Reasons|6|||
131194275|NCT02116361|472331600|FG001|Overall Study|Personal Reasons|6|||
131194276|NCT02116361|472331601|FG002|Overall Study|Personal Reasons|4|||
131194277|NCT02116361|472331602|FG003|Overall Study|Personal Reasons|9|||
131194278|NCT02116361|472331599|FG000|Overall Study|Investigator Decision - Relapse|9|||
131194279|NCT02116361|472331600|FG001|Overall Study|Investigator Decision - Relapse|7|||
131194280|NCT02116361|472331601|FG002|Overall Study|Investigator Decision - Relapse|8|||
131194281|NCT02116361|472331602|FG003|Overall Study|Investigator Decision - Relapse|5|||
131194282|NCT03227224|472331603|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
131194283|NCT03227224|472331604|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
131194284|NCT03227224|472331605|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
131194285|NCT03227224|472331606|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
131194286|NCT03227224|472331603|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
131194287|NCT03227224|472331604|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
131194288|NCT03227224|472331605|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
131194289|NCT03227224|472331606|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
131194290|NCT03227224|472331603|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
131194291|NCT03227224|472331604|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
131194292|NCT03227224|472331605|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
131194293|NCT03227224|472331606|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
131194294|NCT03227224|472331603|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
131194295|NCT03227224|472331604|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131194296|NCT03227224|472331605|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131194297|NCT03227224|472331606|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
131194298|NCT03227224|472331603|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
131194299|NCT03227224|472331604|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
131194300|NCT03227224|472331605|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
131194301|NCT03227224|472331606|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
131194302|NCT03227224|472331603|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
131194303|NCT03227224|472331604|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
131194304|NCT03227224|472331605|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
131194305|NCT03227224|472331606|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
131194306|NCT03227224|472331603|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
131194307|NCT03227224|472331604|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
131194308|NCT03227224|472331605|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
131194309|NCT03227224|472331606|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130733686|NCT05223920|470642939|FG000|Overall Study|Disease Progression|1|||
131194310|NCT03227224|472331603|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
131194311|NCT03227224|472331604|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
131194312|NCT03227224|472331605|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
131194313|NCT03227224|472331606|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
131194314|NCT03227224|472331603|FG000|Follow-up Phase (2 Weeks)|Other|4|||
131194315|NCT03227224|472331604|FG001|Follow-up Phase (2 Weeks)|Other|4|||
131194316|NCT03227224|472331605|FG002|Follow-up Phase (2 Weeks)|Other|6|||
131194317|NCT03227224|472331606|FG003|Follow-up Phase (2 Weeks)|Other|3|||
131194318|NCT04195750|472331607|FG000|Overall Study|Death|245|||
131194319|NCT04195750|472331608|FG001|Overall Study|Death|253|||
131194320|NCT04195750|472331609|FG002|Overall Study|Death|5|||
131194321|NCT04195750|472331607|FG000|Overall Study|Physician Decision|0|||
131194322|NCT04195750|472331608|FG001|Overall Study|Physician Decision|1|||
131194323|NCT04195750|472331609|FG002|Overall Study|Physician Decision|0|||
131194324|NCT04195750|472331607|FG000|Overall Study|Withdrawal by Subject|9|||
131194325|NCT04195750|472331608|FG001|Overall Study|Withdrawal by Subject|8|||
131194326|NCT04195750|472331609|FG002|Overall Study|Withdrawal by Subject|0|||
131194327|NCT04195750|472331607|FG000|Overall Study|Ongoing|120|||
131194328|NCT04195750|472331608|FG001|Overall Study|Ongoing|110|||
131194329|NCT04195750|472331609|FG002|Overall Study|Ongoing|4|||
131194330|NCT02406027|472331610|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
131194331|NCT02406027|472331611|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
131194332|NCT02406027|472331612|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
131194333|NCT02406027|472331613|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
131194334|NCT02406027|472331614|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
131194335|NCT02406027|472331615|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
131194336|NCT02406027|472331616|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
131194337|NCT02406027|472331610|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
131194338|NCT02406027|472331611|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
131194339|NCT02406027|472331612|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
131194340|NCT02406027|472331613|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
131194341|NCT02406027|472331614|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
131194342|NCT02406027|472331615|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
131194343|NCT02406027|472331616|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
131194344|NCT02406027|472331610|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
131194345|NCT02406027|472331611|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
131194346|NCT02406027|472331612|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
131194347|NCT02406027|472331613|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
131194348|NCT02406027|472331614|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
131194349|NCT02406027|472331615|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
131194350|NCT02406027|472331616|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
131194351|NCT02406027|472331610|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
131194352|NCT02406027|472331611|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
131194353|NCT02406027|472331612|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
131194354|NCT02406027|472331613|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
131194355|NCT02406027|472331614|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
131194356|NCT02406027|472331615|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
131194357|NCT02406027|472331616|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
131194358|NCT02406027|472331610|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
131194359|NCT02406027|472331611|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
131194360|NCT02406027|472331612|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
131194361|NCT02406027|472331613|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
131194362|NCT02406027|472331614|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
131194363|NCT02406027|472331615|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
131194364|NCT02406027|472331616|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
131194365|NCT02406027|472331610|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
131194366|NCT02406027|472331611|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
131194367|NCT02406027|472331612|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
131194368|NCT02406027|472331613|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
131194369|NCT02406027|472331614|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
131194370|NCT02406027|472331615|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
131194371|NCT02406027|472331616|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
131194372|NCT02406027|472331610|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
131194373|NCT02406027|472331611|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
131194374|NCT02406027|472331612|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
131194375|NCT02406027|472331613|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
131194376|NCT02406027|472331614|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
131194377|NCT02406027|472331615|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
131194378|NCT02406027|472331616|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
131194379|NCT02406027|472331610|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
131194380|NCT02406027|472331611|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
131194381|NCT02406027|472331612|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
131194382|NCT02406027|472331613|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
131194383|NCT02406027|472331614|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
131194384|NCT02406027|472331615|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
131194385|NCT02406027|472331616|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
131194386|NCT02406027|472331610|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131194387|NCT02406027|472331611|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131194388|NCT02406027|472331612|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131194389|NCT02406027|472331613|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131194390|NCT02406027|472331614|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131194391|NCT02406027|472331615|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
131194392|NCT02406027|472331616|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
131194393|NCT02406027|472331610|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131194394|NCT02406027|472331611|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131194395|NCT02406027|472331612|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131194396|NCT02406027|472331613|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131194397|NCT02406027|472331614|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
131194398|NCT02406027|472331615|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131194399|NCT02406027|472331616|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
131194400|NCT02497287|472331617|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
131194401|NCT02497287|472331617|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
131194402|NCT02497287|472331617|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
131194403|NCT02497287|472331617|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
131194404|NCT02497287|472331617|FG000|Induction Phase (4 Weeks)|Other|13|||
131194405|NCT02497287|472331617|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
131194406|NCT02497287|472331617|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
131194407|NCT02497287|472331617|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
131194408|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
131194409|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
131194410|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
131194411|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
131194412|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
131194413|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
131194414|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
131194415|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
131194416|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
131194417|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
131194418|NCT02497287|472331617|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
131194419|NCT02497287|472331617|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
131194420|NCT02497287|472331617|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
131194421|NCT02497287|472331617|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
131194422|NCT02497287|472331617|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
131194423|NCT02497287|472331617|FG000|Follow-up Phase (4 Week)|Other|1|||
131194424|NCT03782376|472331618|FG000|Overall Study|Lost to Follow-up|2|||
131194425|NCT03782376|472331619|FG001|Overall Study|Lost to Follow-up|2|||
131194426|NCT03782376|472331618|FG000|Overall Study|Withdrawal by Subject|7|||
131194427|NCT03782376|472331619|FG001|Overall Study|Withdrawal by Subject|11|||
131194428|NCT03782376|472331618|FG000|Overall Study|Death|1|||
131194429|NCT03782376|472331619|FG001|Overall Study|Death|0|||
131194430|NCT03782376|472331618|FG000|Overall Study|Other|16|||
131194431|NCT03782376|472331619|FG001|Overall Study|Other|17|||
131194432|NCT03559192|472331620|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
131194433|NCT03559192|472331621|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
131194434|NCT03559192|472331622|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
131194435|NCT03559192|472331620|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
131194436|NCT03559192|472331621|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
131194437|NCT03559192|472331622|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
131194438|NCT03559192|472331620|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
131194439|NCT03559192|472331621|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
131194440|NCT03559192|472331622|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
131194441|NCT03559192|472331620|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
131194442|NCT03559192|472331621|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
131194443|NCT03559192|472331622|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
131194444|NCT03559192|472331620|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
131194445|NCT03559192|472331621|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
131194446|NCT03559192|472331622|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
131194447|NCT03559192|472331620|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
131194448|NCT03559192|472331621|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
131194449|NCT03559192|472331622|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
131194450|NCT03559192|472331620|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
131194451|NCT03559192|472331621|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
131194452|NCT03559192|472331622|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
131194453|NCT03559192|472331620|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
131194454|NCT03559192|472331621|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
131194455|NCT03559192|472331622|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
131194456|NCT03559192|472331620|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
131194457|NCT03559192|472331621|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
131194458|NCT03559192|472331622|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
131194459|NCT03517722|472331623|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
131194460|NCT03517722|472331624|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
131194461|NCT03517722|472331623|FG000|Double Blind Period: Week 0-52|Death|0|||
131194462|NCT03517722|472331624|FG001|Double Blind Period: Week 0-52|Death|4|||
131194463|NCT03517722|472331623|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
131194464|NCT03517722|472331624|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
131194465|NCT03517722|472331623|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
131194466|NCT03517722|472331624|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
131194467|NCT03517722|472331623|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
131194468|NCT03517722|472331624|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
131194469|NCT03517722|472331623|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
131194470|NCT03517722|472331624|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
131194471|NCT03517722|472331623|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
131194472|NCT03517722|472331624|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
131194473|NCT03517722|472331623|FG000|Double Blind Period: Week 0-52|Other|4|||
131194474|NCT03517722|472331624|FG001|Double Blind Period: Week 0-52|Other|3|||
131194475|NCT03517722|472331623|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
131194476|NCT03517722|472331624|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
131194477|NCT03517722|472331623|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
131194478|NCT03517722|472331624|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
131194479|NCT03517722|472331623|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
131194480|NCT03517722|472331624|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
131194481|NCT03517722|472331623|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
131194482|NCT03517722|472331624|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
131194483|NCT03517722|472331623|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
131194484|NCT03517722|472331624|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
131194485|NCT02422186|472331625|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
131194486|NCT02422186|472331626|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
131194487|NCT02422186|472331625|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
131194488|NCT02422186|472331626|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
131194489|NCT02422186|472331625|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
131194490|NCT02422186|472331626|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
131194491|NCT02422186|472331625|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
131194492|NCT02422186|472331626|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
131194493|NCT02422186|472331625|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
131194494|NCT02422186|472331626|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
131194495|NCT02422186|472331625|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
131194496|NCT02422186|472331626|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
131194497|NCT02422186|472331625|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
131194498|NCT02422186|472331626|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
131194499|NCT02422186|472331625|FG000|Follow-up Phase (2 Weeks)|Other|3|||
131194500|NCT02422186|472331626|FG001|Follow-up Phase (2 Weeks)|Other|0|||
131194501|NCT01226472|472331627|FG000|Overall Study|Progressive Disease|1|||
131194502|NCT03573804|472331628|FG000|Overall Study|claustrophobia or MRI table problems|10|||
131194503|NCT00952419|472331631|FG000|Overall Study|Adverse Event|2|||
131194504|NCT00952419|472331632|FG001|Overall Study|Adverse Event|0|||
131194505|NCT00952419|472331633|FG002|Overall Study|Adverse Event|0|||
131194506|NCT00952419|472331631|FG000|Overall Study|Protocol Violation|3|||
131194507|NCT00952419|472331632|FG001|Overall Study|Protocol Violation|7|||
131194508|NCT00952419|472331633|FG002|Overall Study|Protocol Violation|0|||
131194509|NCT00952419|472331631|FG000|Overall Study|Withdrawal by Subject|1|||
131194510|NCT00952419|472331632|FG001|Overall Study|Withdrawal by Subject|3|||
131194511|NCT00952419|472331633|FG002|Overall Study|Withdrawal by Subject|0|||
131194512|NCT03399786|472331634|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
131194513|NCT03399786|472331635|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131194514|NCT03399786|472331636|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131194515|NCT03399786|472331637|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
131194516|NCT03399786|472331634|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
131194517|NCT03399786|472331635|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
131194518|NCT03399786|472331636|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
131194519|NCT03399786|472331637|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
131194520|NCT03399786|472331634|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
131194521|NCT03399786|472331635|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
131194522|NCT03399786|472331636|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
131194523|NCT03399786|472331637|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
130784587|NCT01663402|470838831|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
130784588|NCT01663402|470838832|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
130784589|NCT01663402|470838831|FG000|Overall Study|Poor compliance to protocol|529|||
130784590|NCT01663402|470838832|FG001|Overall Study|Poor compliance to protocol|454|||
130784591|NCT01663402|470838831|FG000|Overall Study|Physician Decision|77|||
130784592|NCT01663402|470838832|FG001|Overall Study|Physician Decision|62|||
130784593|NCT01663402|470838831|FG000|Overall Study|Site terminated by sponsor|1|||
130784594|NCT01663402|470838832|FG001|Overall Study|Site terminated by sponsor|3|||
130784595|NCT01663402|470838831|FG000|Overall Study|Participant moved|139|||
130784596|NCT01663402|470838832|FG001|Overall Study|Participant moved|104|||
130784597|NCT01663402|470838831|FG000|Overall Study|Withdrawal by Subject|118|||
130784598|NCT01663402|470838832|FG001|Overall Study|Withdrawal by Subject|91|||
130784599|NCT01663402|470838831|FG000|Overall Study|Related to study drug administration|96|||
131194524|NCT01673373|472333384|FG000|Overall Study|Death|2|||
131194525|NCT01431521|472333388|FG000|Overall Study|Withdrawal by Subject|0|||
131194526|NCT01431521|472333389|FG001|Overall Study|Withdrawal by Subject|0|||
131194527|NCT01431521|472333390|FG002|Overall Study|Withdrawal by Subject|1|||
131194528|NCT01431521|472333391|FG003|Overall Study|Withdrawal by Subject|0|||
131194529|NCT01572844|472333392|FG000|Overall Study|Physician Decision|1|||
131194530|NCT01572844|472333393|FG001|Overall Study|Physician Decision|1|||
131194531|NCT00366444|472333395|FG000|Overall Study|Withdrawal by Subject|1|||
131194532|NCT00366444|472333396|FG001|Overall Study|Withdrawal by Subject|1|||
131194533|NCT00366444|472333395|FG000|Overall Study|Lack of Efficacy|0|||
131194534|NCT00366444|472333396|FG001|Overall Study|Lack of Efficacy|1|||
131194535|NCT05171816|472333397|FG000|Overall Study|Death|18|||
131194536|NCT05171816|472333398|FG001|Overall Study|Death|16|||
131194537|NCT04667949|472333399|FG000|Overall Study|Adverse Event|0|||
131194538|NCT04667949|472333400|FG001|Overall Study|Adverse Event|2|||
131194539|NCT04667949|472333399|FG000|Overall Study|Lost to Follow-up|0|||
131194540|NCT04667949|472333400|FG001|Overall Study|Lost to Follow-up|1|||
131194541|NCT04667949|472333399|FG000|Overall Study|Physician Decision|0|||
131194542|NCT04667949|472333400|FG001|Overall Study|Physician Decision|2|||
131194543|NCT04667949|472333399|FG000|Overall Study|Subject decision|1|||
131194544|NCT04667949|472333400|FG001|Overall Study|Subject decision|7|||
131194545|NCT03671148|472333403|FG000|Overall Study|Adverse Event|3|||
131194546|NCT03671148|472333404|FG001|Overall Study|Adverse Event|2|||
131194547|NCT03671148|472333403|FG000|Overall Study|Withdrawal by Subject|8|||
131194548|NCT03671148|472333404|FG001|Overall Study|Withdrawal by Subject|2|||
131194549|NCT03671148|472333403|FG000|Overall Study|Lost to Follow-up|1|||
130784600|NCT01663402|470838832|FG001|Overall Study|Related to study drug administration|105|||
130784601|NCT01663402|470838831|FG000|Overall Study|Lost to Follow-up|17|||
130784602|NCT01663402|470838832|FG001|Overall Study|Lost to Follow-up|15|||
130784603|NCT01663402|470838831|FG000|Overall Study|Other than specified above|172|||
131194550|NCT03671148|472333404|FG001|Overall Study|Lost to Follow-up|2|||
131194551|NCT03671148|472333403|FG000|Overall Study|Lack of Efficacy|7|||
131194552|NCT03671148|472333404|FG001|Overall Study|Lack of Efficacy|2|||
131194553|NCT03671148|472333403|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
130784604|NCT01663402|470838832|FG001|Overall Study|Other than specified above|147|||
130784605|NCT02984982|470838846|FG000|Overall Study|Adverse Event|2|||
131194554|NCT03671148|472333404|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
131194555|NCT03671148|472333403|FG000|Overall Study|Other|1|||
131194556|NCT03671148|472333404|FG001|Overall Study|Other|0|||
131194557|NCT03671148|472333403|FG000|Overall Study|Incomplete Randomization Visit|1|||
131194558|NCT03671148|472333404|FG001|Overall Study|Incomplete Randomization Visit|0|||
131194559|NCT00673816|472333405|FG000|Overall Study|Adverse Event|1|||
131194560|NCT00673816|472333405|FG000|Overall Study|Withdrawal by Subject|1|||
131194561|NCT02234050|472333406|FG000|Overall Study|Lack of Efficacy|38|||
131194562|NCT02234050|472333407|FG001|Overall Study|Lack of Efficacy|22|||
131194563|NCT02234050|472333406|FG000|Overall Study|Adverse Event|13|||
131194564|NCT02234050|472333407|FG001|Overall Study|Adverse Event|1|||
131194565|NCT02234050|472333406|FG000|Overall Study|Withdrawal by Subject|4|||
131194566|NCT02234050|472333407|FG001|Overall Study|Withdrawal by Subject|2|||
131194567|NCT02234050|472333406|FG000|Overall Study|Sponsor's decision|6|||
131194568|NCT02234050|472333407|FG001|Overall Study|Sponsor's decision|0|||
131194569|NCT01680991|472333409|FG000|Overall Study|Adverse Event|1|||
131194570|NCT01680991|472333410|FG001|Overall Study|Adverse Event|0|||
131194571|NCT01680991|472333411|FG002|Overall Study|Adverse Event|0|||
131194572|NCT01680991|472333409|FG000|Overall Study|Death|1|||
131194573|NCT01680991|472333410|FG001|Overall Study|Death|0|||
131194574|NCT01680991|472333411|FG002|Overall Study|Death|1|||
131194575|NCT01680991|472333409|FG000|Overall Study|Protocol Violation|0|||
131194576|NCT01680991|472333410|FG001|Overall Study|Protocol Violation|1|||
131194577|NCT01680991|472333411|FG002|Overall Study|Protocol Violation|0|||
131194578|NCT01680991|472333409|FG000|Overall Study|Withdrawal by Subject|5|||
131194579|NCT01680991|472333410|FG001|Overall Study|Withdrawal by Subject|1|||
131194580|NCT01680991|472333411|FG002|Overall Study|Withdrawal by Subject|0|||
131194581|NCT01680991|472333409|FG000|Overall Study|Progressive disease (PD)|0|||
131194582|NCT01680991|472333410|FG001|Overall Study|Progressive disease (PD)|10|||
131194583|NCT01680991|472333411|FG002|Overall Study|Progressive disease (PD)|0|||
131194584|NCT01680991|472333409|FG000|Overall Study|Physician Decision|0|||
131194585|NCT01680991|472333410|FG001|Overall Study|Physician Decision|7|||
131194586|NCT01680991|472333411|FG002|Overall Study|Physician Decision|2|||
131194587|NCT01680991|472333409|FG000|Overall Study|Bad physical condition|0|||
131194588|NCT01680991|472333410|FG001|Overall Study|Bad physical condition|0|||
131194589|NCT01680991|472333411|FG002|Overall Study|Bad physical condition|1|||
131194590|NCT01680991|472333409|FG000|Overall Study|PD confirmed in other hospital|1|||
131194591|NCT01680991|472333410|FG001|Overall Study|PD confirmed in other hospital|0|||
131194592|NCT01680991|472333411|FG002|Overall Study|PD confirmed in other hospital|0|||
131194593|NCT06073054|472333412|FG000|Overall Study|Withdrawal by Subject|2|||
131194594|NCT03149029|472333413|FG000|Overall Study|Adverse Event|2|||
131194595|NCT03149029|472333414|FG001|Overall Study|Adverse Event|0|||
131194596|NCT00413777|472333419|FG000|Fixed-dose Period|Lost to Follow-up|1|||
131194597|NCT00413777|472333420|FG001|Fixed-dose Period|Lost to Follow-up|1|||
131194598|NCT00413777|472333419|FG000|Fixed-dose Period|Adverse Event|2|||
131194599|NCT00413777|472333420|FG001|Fixed-dose Period|Adverse Event|1|||
131194600|NCT00413777|472333419|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
131194601|NCT00413777|472333420|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
131194602|NCT00413777|472333419|FG000|Fixed-dose Period|Withdrew Consent|0|||
131194603|NCT00413777|472333420|FG001|Fixed-dose Period|Withdrew Consent|1|||
131194604|NCT05505734|472333421|FG000|Overall Study|Withdrawal by Subject|51|||
131194605|NCT05505734|472333422|FG001|Overall Study|Withdrawal by Subject|64|||
131194606|NCT05505734|472333421|FG000|Overall Study|Adverse Event|6|||
131194607|NCT05505734|472333422|FG001|Overall Study|Adverse Event|20|||
131194608|NCT05505734|472333421|FG000|Overall Study|Protocol Violation|8|||
131194609|NCT05505734|472333422|FG001|Overall Study|Protocol Violation|15|||
131194610|NCT05505734|472333421|FG000|Overall Study|Lack of therapeutic response|0|||
131194611|NCT05505734|472333422|FG001|Overall Study|Lack of therapeutic response|1|||
131194612|NCT05505734|472333421|FG000|Overall Study|Lost to Follow-up|247|||
131194613|NCT05505734|472333422|FG001|Overall Study|Lost to Follow-up|237|||
131194614|NCT05505734|472333421|FG000|Overall Study|Physician Decision|22|||
131194615|NCT05505734|472333422|FG001|Overall Study|Physician Decision|13|||
130733687|NCT05223920|470642940|FG001|Overall Study|Disease Progression|2|||
130733688|NCT05223920|470642939|FG000|Overall Study|Physician Decision|1|||
131194616|NCT05505734|472333421|FG000|Overall Study|Death|2|||
131194617|NCT05505734|472333422|FG001|Overall Study|Death|1|||
131194618|NCT05505734|472333421|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131194619|NCT05505734|472333422|FG001|Overall Study|Withdrawal by parent/guardian|1|||
131194620|NCT05505734|472333421|FG000|Overall Study|Pregnancy|1|||
131194621|NCT05505734|472333422|FG001|Overall Study|Pregnancy|0|||
131194622|NCT05505734|472333421|FG000|Overall Study|Other|17|||
131194623|NCT05505734|472333422|FG001|Overall Study|Other|13|||
131194624|NCT00764322|472333423|FG000|Overall Study|Withdrawal by Subject|11|||
131194625|NCT00764322|472333423|FG000|Overall Study|No CYP2D6 genotyping|9|||
131194626|NCT02348840|472333445|FG000|Overall Study|Withdrawal by Subject|2|||
131194627|NCT02348840|472333446|FG001|Overall Study|Withdrawal by Subject|1|||
131194628|NCT02348840|472333447|FG002|Overall Study|Withdrawal by Subject|0|||
131194629|NCT02348840|472333448|FG003|Overall Study|Withdrawal by Subject|0|||
130733689|NCT05223920|470642940|FG001|Overall Study|Physician Decision|2|||
131194630|NCT02203916|472333449|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
131194631|NCT02203916|472333450|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
131194632|NCT02203916|472333451|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
131194633|NCT02203916|472333449|FG000|Overall Study|Major Protocol Deviation|1|||
131194634|NCT02203916|472333450|FG001|Overall Study|Major Protocol Deviation|1|||
131194635|NCT02203916|472333451|FG002|Overall Study|Major Protocol Deviation|0|||
131194636|NCT02203916|472333449|FG000|Overall Study|Lost to Follow-up|0|||
131194637|NCT02203916|472333450|FG001|Overall Study|Lost to Follow-up|1|||
131194638|NCT02203916|472333451|FG002|Overall Study|Lost to Follow-up|0|||
131194639|NCT02203916|472333449|FG000|Overall Study|Voluntary Withdrawal|3|||
131194640|NCT02203916|472333450|FG001|Overall Study|Voluntary Withdrawal|3|||
131194641|NCT02203916|472333451|FG002|Overall Study|Voluntary Withdrawal|8|||
131194642|NCT02203916|472333449|FG000|Overall Study|Lack of Efficacy|3|||
131194643|NCT02203916|472333450|FG001|Overall Study|Lack of Efficacy|0|||
131194644|NCT02203916|472333451|FG002|Overall Study|Lack of Efficacy|0|||
131194645|NCT02203916|472333449|FG000|Overall Study|Reason Not Specified|0|||
131194646|NCT02203916|472333450|FG001|Overall Study|Reason Not Specified|2|||
131194647|NCT02203916|472333451|FG002|Overall Study|Reason Not Specified|1|||
131194648|NCT00414973|472333453|FG000|Overall Study|Withdrawal by Subject|14|||
131194649|NCT00414973|472333454|FG001|Overall Study|Withdrawal by Subject|4|||
131194650|NCT00414973|472333455|FG002|Overall Study|Withdrawal by Subject|1|||
131194651|NCT00414973|472333456|FG003|Overall Study|Withdrawal by Subject|0|||
131194652|NCT00414973|472333453|FG000|Overall Study|Adverse Event|10|||
131194653|NCT00414973|472333454|FG001|Overall Study|Adverse Event|0|||
131194654|NCT00414973|472333455|FG002|Overall Study|Adverse Event|1|||
131194655|NCT00414973|472333456|FG003|Overall Study|Adverse Event|0|||
131194656|NCT00414973|472333453|FG000|Overall Study|Protocol Violation|3|||
131194657|NCT00414973|472333454|FG001|Overall Study|Protocol Violation|4|||
131194658|NCT00414973|472333455|FG002|Overall Study|Protocol Violation|0|||
131194659|NCT00414973|472333456|FG003|Overall Study|Protocol Violation|0|||
131194660|NCT00414973|472333453|FG000|Overall Study|Lost to Follow-up|0|||
131194661|NCT00414973|472333454|FG001|Overall Study|Lost to Follow-up|2|||
131194662|NCT00414973|472333455|FG002|Overall Study|Lost to Follow-up|0|||
131194663|NCT00414973|472333456|FG003|Overall Study|Lost to Follow-up|0|||
131194664|NCT00414973|472333453|FG000|Overall Study|Sponsor Decision|1|||
131194665|NCT00414973|472333454|FG001|Overall Study|Sponsor Decision|0|||
131194666|NCT00414973|472333455|FG002|Overall Study|Sponsor Decision|0|||
131194667|NCT00414973|472333456|FG003|Overall Study|Sponsor Decision|0|||
131194668|NCT00414973|472333453|FG000|Overall Study|Death|0|||
131194669|NCT00414973|472333454|FG001|Overall Study|Death|0|||
131194670|NCT00414973|472333455|FG002|Overall Study|Death|1|||
131194671|NCT00414973|472333456|FG003|Overall Study|Death|0|||
131194672|NCT01466062|472333457|FG000|Overall Study|Adverse Event|1|||
131194673|NCT01466062|472333457|FG000|Overall Study|Withdrawal by Subject|1|||
131194674|NCT03152110|472333464|FG000|Overall Study|Withdrawal by Subject|3|||
131194675|NCT00850135|472333468|FG000|Overall Study|Physician Decision|1|||
131194676|NCT00338806|472333469|FG000|Acute Phase|Withdrawal by Subject|0|||
131194677|NCT00338806|472333470|FG001|Acute Phase|Withdrawal by Subject|1|||
131194678|NCT00338806|472333469|FG000|Follow-up|Lost to Follow-up|1|||
131194679|NCT00338806|472333470|FG001|Follow-up|Lost to Follow-up|3|||
131194680|NCT00744991|472333471|FG000|Overall Study|Progressive Disease|11|||
131194681|NCT00744991|472333471|FG000|Overall Study|Withdrawal by Subject|8|||
131194682|NCT00744991|472333471|FG000|Overall Study|Physician Decision|3|||
131194683|NCT00744991|472333471|FG000|Overall Study|Adverse Event|2|||
131194684|NCT00744991|472333471|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
131194685|NCT00085644|472333477|FG000|Double-Blind Period|Adverse Event|5|||
131194686|NCT00085644|472333478|FG001|Double-Blind Period|Adverse Event|2|||
131194687|NCT00085644|472333479|FG002|Double-Blind Period|Adverse Event|0|||
131194688|NCT00085644|472333477|FG000|Double-Blind Period|Withdrawal by Subject|3|||
131194689|NCT00085644|472333478|FG001|Double-Blind Period|Withdrawal by Subject|0|||
131194690|NCT00085644|472333479|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131194691|NCT00085644|472333477|FG000|Double-Blind Period|Lost to Follow-up|2|||
131194692|NCT00085644|472333478|FG001|Double-Blind Period|Lost to Follow-up|1|||
131194693|NCT00085644|472333479|FG002|Double-Blind Period|Lost to Follow-up|0|||
131194694|NCT00085644|472333477|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
130733690|NCT05223920|470642939|FG000|Overall Study|Sponsor decision|11|||
131194695|NCT00085644|472333478|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
131194696|NCT00085644|472333479|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
131194697|NCT00085644|472333477|FG000|Double-Blind Period|Contemplating pregnancy|1|||
131194698|NCT00085644|472333478|FG001|Double-Blind Period|Contemplating pregnancy|0|||
131194699|NCT00085644|472333479|FG002|Double-Blind Period|Contemplating pregnancy|0|||
131194700|NCT00085644|472333477|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
131194701|NCT00085644|472333478|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
131194702|NCT00085644|472333479|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
131194703|NCT00085644|472333477|FG000|Open-Label Period|Adverse Event|0|||
131194704|NCT00085644|472333478|FG001|Open-Label Period|Adverse Event|0|||
131194705|NCT00085644|472333479|FG002|Open-Label Period|Adverse Event|38|||
131194706|NCT00085644|472333477|FG000|Open-Label Period|Withdrawal by Subject|0|||
131194707|NCT00085644|472333478|FG001|Open-Label Period|Withdrawal by Subject|0|||
131194708|NCT00085644|472333479|FG002|Open-Label Period|Withdrawal by Subject|29|||
131194709|NCT00085644|472333477|FG000|Open-Label Period|Lost to Follow-up|0|||
131194710|NCT00085644|472333478|FG001|Open-Label Period|Lost to Follow-up|0|||
131194711|NCT00085644|472333479|FG002|Open-Label Period|Lost to Follow-up|13|||
131194712|NCT00085644|472333477|FG000|Open-Label Period|Lack of Efficacy|0|||
131194713|NCT00085644|472333478|FG001|Open-Label Period|Lack of Efficacy|0|||
131194714|NCT00085644|472333479|FG002|Open-Label Period|Lack of Efficacy|15|||
131194715|NCT00085644|472333477|FG000|Open-Label Period|Pregnancy|0|||
131194716|NCT00085644|472333478|FG001|Open-Label Period|Pregnancy|0|||
131194717|NCT00085644|472333479|FG002|Open-Label Period|Pregnancy|3|||
131194718|NCT00085644|472333477|FG000|Open-Label Period|Contemplating pregnancy|0|||
131194719|NCT00085644|472333478|FG001|Open-Label Period|Contemplating pregnancy|0|||
131194720|NCT00085644|472333479|FG002|Open-Label Period|Contemplating pregnancy|3|||
131194721|NCT00085644|472333477|FG000|Open-Label Period|Protocol Violation|0|||
131194722|NCT00085644|472333478|FG001|Open-Label Period|Protocol Violation|0|||
131194723|NCT00085644|472333479|FG002|Open-Label Period|Protocol Violation|4|||
131194724|NCT00085644|472333477|FG000|Open-Label Period|Personal reason|0|||
131194725|NCT00085644|472333478|FG001|Open-Label Period|Personal reason|0|||
131194726|NCT00085644|472333479|FG002|Open-Label Period|Personal reason|4|||
131194727|NCT04259346|472333480|FG000|Overall Study|Lost to Follow-up|1|||
131194728|NCT04259346|472333481|FG001|Overall Study|Lost to Follow-up|3|||
131194729|NCT04259346|472333480|FG000|Overall Study|Protocol Violation|1|||
131194730|NCT04259346|472333481|FG001|Overall Study|Protocol Violation|0|||
131194731|NCT04259346|472333480|FG000|Overall Study|Withdrawal by Subject|1|||
131194732|NCT04259346|472333481|FG001|Overall Study|Withdrawal by Subject|0|||
131194733|NCT04259346|472333480|FG000|Overall Study|Adverse Event|1|||
131194734|NCT04259346|472333481|FG001|Overall Study|Adverse Event|1|||
131194735|NCT03330106|472333482|FG000|Part A|Withdrawal by Subject|1|||
131194736|NCT03330106|472333483|FG001|Part A|Withdrawal by Subject|1|||
131194737|NCT03330106|472333484|FG002|Part A|Withdrawal by Subject|0|||
131194738|NCT03330106|472333485|FG003|Part A|Withdrawal by Subject|0|||
131194739|NCT03330106|472333482|FG000|Part A|Death|2|||
131194740|NCT03330106|472333483|FG001|Part A|Death|1|||
131194741|NCT03330106|472333484|FG002|Part A|Death|0|||
131194742|NCT03330106|472333485|FG003|Part A|Death|0|||
131194743|NCT03330106|472333482|FG000|Part A|Adverse Event|0|||
131194744|NCT03330106|472333483|FG001|Part A|Adverse Event|1|||
131194745|NCT03330106|472333484|FG002|Part A|Adverse Event|0|||
131194746|NCT03330106|472333485|FG003|Part A|Adverse Event|0|||
131194747|NCT03330106|472333482|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
131194748|NCT03330106|472333483|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
131194749|NCT03330106|472333484|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
131194750|NCT03330106|472333485|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
131194751|NCT03330106|472333482|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
131194752|NCT03330106|472333483|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
131194753|NCT03330106|472333484|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
131194754|NCT03330106|472333485|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
131194755|NCT03330106|472333482|FG000|Part A|Progressive Disease|0|||
131194756|NCT03330106|472333483|FG001|Part A|Progressive Disease|1|||
131194757|NCT03330106|472333484|FG002|Part A|Progressive Disease|0|||
131194758|NCT03330106|472333485|FG003|Part A|Progressive Disease|0|||
131194759|NCT03330106|472333482|FG000|Part B|Lost to Follow-up|0|||
131194760|NCT03330106|472333483|FG001|Part B|Lost to Follow-up|0|||
131194761|NCT03330106|472333484|FG002|Part B|Lost to Follow-up|0|||
131194762|NCT03330106|472333485|FG003|Part B|Lost to Follow-up|1|||
131194763|NCT03330106|472333482|FG000|Part B|Withdrawal by Subject|0|||
131194764|NCT03330106|472333483|FG001|Part B|Withdrawal by Subject|0|||
131194765|NCT03330106|472333484|FG002|Part B|Withdrawal by Subject|4|||
131194766|NCT03330106|472333485|FG003|Part B|Withdrawal by Subject|0|||
131194767|NCT03330106|472333482|FG000|Part B|Death|0|||
131194768|NCT03330106|472333483|FG001|Part B|Death|0|||
131194769|NCT03330106|472333484|FG002|Part B|Death|2|||
131194770|NCT03330106|472333485|FG003|Part B|Death|0|||
131194771|NCT03330106|472333482|FG000|Part B|Clinical Progression|0|||
131194772|NCT03330106|472333483|FG001|Part B|Clinical Progression|0|||
131194773|NCT03330106|472333484|FG002|Part B|Clinical Progression|1|||
131194774|NCT03330106|472333485|FG003|Part B|Clinical Progression|1|||
131194775|NCT03330106|472333482|FG000|Part B|Symptomatic Deterioration|0|||
131194776|NCT03330106|472333483|FG001|Part B|Symptomatic Deterioration|0|||
131194777|NCT03330106|472333484|FG002|Part B|Symptomatic Deterioration|0|||
131194778|NCT03330106|472333485|FG003|Part B|Symptomatic Deterioration|1|||
131194779|NCT03330106|472333482|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
131194780|NCT03330106|472333483|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
131194781|NCT03330106|472333484|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
131194782|NCT03330106|472333485|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
131194783|NCT03330106|472333482|FG000|Part B|Progressive Disease|0|||
131194784|NCT03330106|472333483|FG001|Part B|Progressive Disease|0|||
131194785|NCT03330106|472333484|FG002|Part B|Progressive Disease|11|||
131194786|NCT03330106|472333485|FG003|Part B|Progressive Disease|4|||
131194787|NCT00623766|472333486|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
131194788|NCT00623766|472333487|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
130733691|NCT05223920|470642940|FG001|Overall Study|Sponsor decision|9|||
130733692|NCT05223920|470642939|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
131194789|NCT00623766|472333486|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
131194790|NCT00623766|472333487|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
131194791|NCT00623766|472333486|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
131194792|NCT00623766|472333487|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
131194793|NCT00623766|472333486|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
131194794|NCT00623766|472333487|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
131194795|NCT00623766|472333486|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
131194796|NCT00623766|472333487|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
131194797|NCT03198728|472333491|FG000|Overall Study|Adverse Event|10|||
131194798|NCT03198728|472333492|FG001|Overall Study|Adverse Event|5|||
131194799|NCT03198728|472333491|FG000|Overall Study|Lost to Follow-up|21|||
131194800|NCT03198728|472333492|FG001|Overall Study|Lost to Follow-up|7|||
131194801|NCT03198728|472333491|FG000|Overall Study|Physician Decision|7|||
131194802|NCT03198728|472333492|FG001|Overall Study|Physician Decision|2|||
131194803|NCT03198728|472333491|FG000|Overall Study|Withdrawal by Subject|14|||
131194804|NCT03198728|472333492|FG001|Overall Study|Withdrawal by Subject|10|||
131194805|NCT04051944|472333496|FG000|Overall Study|Study ending|1|||
131194806|NCT04051944|472333497|FG001|Overall Study|Study ending|1|||
131194807|NCT04051944|472333496|FG000|Overall Study|Early study termination by participant|1|||
131194808|NCT04051944|472333497|FG001|Overall Study|Early study termination by participant|0|||
131194809|NCT04051944|472333496|FG000|Overall Study|Withdrawal by Subject|2|||
131194810|NCT04051944|472333497|FG001|Overall Study|Withdrawal by Subject|2|||
131194811|NCT04051944|472333496|FG000|Overall Study|Lack of Efficacy|3|||
131194812|NCT04051944|472333497|FG001|Overall Study|Lack of Efficacy|0|||
131194813|NCT04051944|472333496|FG000|Overall Study|Adverse event, non- fatal|1|||
131194814|NCT04051944|472333497|FG001|Overall Study|Adverse event, non- fatal|1|||
131194815|NCT02139280|472333498|FG000|Overall Study|No longer eligible|2|||
131194816|NCT02139280|472333499|FG001|Overall Study|No longer eligible|0|||
131194817|NCT00736450|472333500|FG000|Overall Study|Not ABC gene eligible|19|||
131194818|NCT00736450|472333500|FG000|Overall Study|Withdrawal by Subject|5|||
131194819|NCT00736450|472333500|FG000|Overall Study|Physician Decision|1|||
131194820|NCT04157751|472333501|FG000|Overall Study|Withdrawal by Subject|12|||
131194821|NCT04157751|472333502|FG001|Overall Study|Withdrawal by Subject|17|||
131194822|NCT04157751|472333501|FG000|Overall Study|Lost to Follow-up|6|||
131194823|NCT04157751|472333502|FG001|Overall Study|Lost to Follow-up|2|||
131194824|NCT04157751|472333501|FG000|Overall Study|Adverse Event|34|||
131194825|NCT04157751|472333502|FG001|Overall Study|Adverse Event|23|||
131194826|NCT04157751|472333501|FG000|Overall Study|Not treated|1|||
131194827|NCT04157751|472333502|FG001|Overall Study|Not treated|5|||
131194828|NCT04157751|472333501|FG000|Overall Study|Other reason not stated above|10|||
131194829|NCT04157751|472333502|FG001|Overall Study|Other reason not stated above|10|||
131194830|NCT00422903|472333511|FG000|Overall Study|Disease Progression|3|||
131194831|NCT00422903|472333512|FG001|Overall Study|Disease Progression|1|||
131194832|NCT00422903|472333511|FG000|Overall Study|Adverse Event|0|||
131194833|NCT00422903|472333512|FG001|Overall Study|Adverse Event|2|||
131194834|NCT00422903|472333511|FG000|Overall Study|Informed Consent Withdrawn|1|||
131194835|NCT00422903|472333512|FG001|Overall Study|Informed Consent Withdrawn|2|||
131194836|NCT01947894|472333517|FG000|Overall Study|Other|3|||
131194837|NCT01947894|472333518|FG001|Overall Study|Other|4|||
131194838|NCT01947894|472333519|FG002|Overall Study|Other|3|||
131194839|NCT01947894|472333517|FG000|Overall Study|Withdrawal by Subject|12|||
130733693|NCT05223920|470642940|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
131194840|NCT01947894|472333518|FG001|Overall Study|Withdrawal by Subject|4|||
131194841|NCT01947894|472333519|FG002|Overall Study|Withdrawal by Subject|1|||
131194842|NCT01947894|472333517|FG000|Overall Study|Death|12|||
131194843|NCT01947894|472333518|FG001|Overall Study|Death|1|||
131194844|NCT01947894|472333519|FG002|Overall Study|Death|0|||
131194845|NCT01947894|472333517|FG000|Overall Study|Physician Decision|2|||
131194846|NCT01947894|472333518|FG001|Overall Study|Physician Decision|0|||
131194847|NCT01947894|472333519|FG002|Overall Study|Physician Decision|0|||
131194848|NCT01947894|472333517|FG000|Overall Study|Adverse Event|5|||
131194849|NCT01947894|472333518|FG001|Overall Study|Adverse Event|1|||
131194850|NCT01947894|472333519|FG002|Overall Study|Adverse Event|0|||
131194851|NCT01947894|472333517|FG000|Overall Study|Switched to other growth hormone brand|53|||
130733694|NCT05223920|470642939|FG000|Overall Study|Subject decision|1|||
131194852|NCT01947894|472333518|FG001|Overall Study|Switched to other growth hormone brand|8|||
131194853|NCT01947894|472333519|FG002|Overall Study|Switched to other growth hormone brand|23|||
131194854|NCT01302691|472333520|FG000|Overall Study|Adverse Event|2|||
131194855|NCT01302691|472333521|FG001|Overall Study|Adverse Event|0|||
131194856|NCT01302691|472333520|FG000|Overall Study|Death|0|||
131194857|NCT01302691|472333521|FG001|Overall Study|Death|1|||
131194858|NCT01302691|472333520|FG000|Overall Study|Lost to Follow-up|1|||
131194859|NCT01302691|472333521|FG001|Overall Study|Lost to Follow-up|0|||
131194860|NCT01302691|472333520|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
131194861|NCT01302691|472333521|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
131194862|NCT01302691|472333520|FG000|Overall Study|Physician Decision|0|||
131194863|NCT01302691|472333521|FG001|Overall Study|Physician Decision|1|||
131194864|NCT01302691|472333520|FG000|Overall Study|Protocol Violation|1|||
131194865|NCT01302691|472333521|FG001|Overall Study|Protocol Violation|0|||
131194866|NCT03446612|472333522|FG000|Overall Study|Protocol defined stopping criteria|0|||
131194867|NCT03446612|472333523|FG001|Overall Study|Protocol defined stopping criteria|1|||
131194868|NCT03934203|472333527|FG000|Overall Study|Adverse Event|0|||
131194869|NCT03934203|472333528|FG001|Overall Study|Adverse Event|0|||
131194870|NCT03934203|472333529|FG002|Overall Study|Adverse Event|1|||
131194871|NCT03934203|472333530|FG003|Overall Study|Adverse Event|0|||
131194872|NCT03934203|472333531|FG004|Overall Study|Adverse Event|1|||
131194873|NCT03934203|472333532|FG005|Overall Study|Adverse Event|0|||
131194874|NCT03934203|472333533|FG006|Overall Study|Adverse Event|2|||
131194875|NCT03934203|472333534|FG007|Overall Study|Adverse Event|0|||
131194876|NCT03934203|472333535|FG008|Overall Study|Adverse Event|0|||
131194877|NCT03934203|472333536|FG009|Overall Study|Adverse Event|0|||
131194878|NCT03934203|472333537|FG010|Overall Study|Adverse Event|0|||
131194879|NCT03934203|472333538|FG011|Overall Study|Adverse Event|0|||
131194880|NCT03934203|472333539|FG012|Overall Study|Adverse Event|0|||
131194881|NCT03934203|472333540|FG013|Overall Study|Adverse Event|1|||
131194882|NCT03934203|472333541|FG014|Overall Study|Adverse Event|0|||
131194883|NCT00608842|472333542|FG000|Overall Study|Participant's Request|0|||
131194884|NCT00608842|472333543|FG001|Overall Study|Participant's Request|1|||
131194885|NCT00608842|472333544|FG002|Overall Study|Participant's Request|2|||
131194886|NCT00608842|472333545|FG003|Overall Study|Participant's Request|1|||
131194887|NCT00608842|472333542|FG000|Overall Study|Lost to Follow-up|1|||
131194888|NCT00608842|472333543|FG001|Overall Study|Lost to Follow-up|0|||
131194889|NCT00608842|472333544|FG002|Overall Study|Lost to Follow-up|0|||
131194890|NCT00608842|472333545|FG003|Overall Study|Lost to Follow-up|0|||
131194891|NCT04445051|472333547|FG000|Overall Study|Adverse Event|0|||
131194892|NCT04445051|472333548|FG001|Overall Study|Adverse Event|0|||
131194893|NCT04445051|472333549|FG002|Overall Study|Adverse Event|1|||
131194894|NCT04445051|472333550|FG003|Overall Study|Adverse Event|0|||
131194895|NCT04445051|472333551|FG004|Overall Study|Adverse Event|0|||
131194896|NCT04445051|472333552|FG005|Overall Study|Adverse Event|0|||
131194897|NCT01188811|472333555|FG000|Overall Study|Withdrawal by Subject|0|||
131194898|NCT01188811|472333556|FG001|Overall Study|Withdrawal by Subject|2|||
131194899|NCT01188811|472333555|FG000|Overall Study|Adverse Event|6|||
131194900|NCT01188811|472333556|FG001|Overall Study|Adverse Event|0|||
131194901|NCT03924427|472333557|FG000|Overall Study|Adverse Event|4|||
131194902|NCT03924427|472333557|FG000|Overall Study|Lack of Efficacy|1|||
131194903|NCT03924427|472333557|FG000|Overall Study|Withdrawal by Subject|1|||
131194904|NCT04350372|472333562|FG000|Overall Study|Death|1|||
131194905|NCT04757376|472333563|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
131194906|NCT04757376|472333564|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
131194907|NCT04757376|472333565|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
131194908|NCT04757376|472333566|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
131194909|NCT04757376|472333567|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
131194910|NCT04757376|472333563|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
131194911|NCT04757376|472333564|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
131194912|NCT04757376|472333565|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
131194913|NCT04757376|472333566|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
131194914|NCT04757376|472333567|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
131194915|NCT04757376|472333563|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
131194916|NCT04757376|472333564|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
131194917|NCT04757376|472333565|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
131194918|NCT04757376|472333566|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
131194919|NCT04757376|472333567|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
131194920|NCT04757376|472333563|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
131194921|NCT04757376|472333564|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
131194922|NCT04757376|472333565|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
131194923|NCT04757376|472333566|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
131194924|NCT04757376|472333567|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
131194925|NCT04757376|472333563|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
131194926|NCT04757376|472333564|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
131194927|NCT04757376|472333565|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
131194928|NCT04757376|472333566|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
131194929|NCT04757376|472333567|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
131194930|NCT04757376|472333563|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
131194931|NCT04757376|472333564|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
131194932|NCT04757376|472333565|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
131194933|NCT04757376|472333566|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
131194934|NCT04757376|472333567|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
131194935|NCT04757376|472333563|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
131194936|NCT04757376|472333564|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
131194937|NCT04757376|472333565|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
131194938|NCT04757376|472333566|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
131194939|NCT04757376|472333567|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
131194940|NCT04757376|472333563|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
131194941|NCT04757376|472333564|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
131194942|NCT04757376|472333565|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
131194943|NCT04757376|472333566|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
131194944|NCT04757376|472333567|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
131194945|NCT01307046|472333568|FG000|Overall Study|Adverse Event|3|||
131194946|NCT01307046|472333569|FG001|Overall Study|Adverse Event|3|||
131194947|NCT01307046|472333568|FG000|Overall Study|Lack of Efficacy|0|||
131194948|NCT01307046|472333569|FG001|Overall Study|Lack of Efficacy|2|||
131194949|NCT01307046|472333568|FG000|Overall Study|Physician Decision|2|||
131194950|NCT01307046|472333569|FG001|Overall Study|Physician Decision|0|||
131194951|NCT01307046|472333568|FG000|Overall Study|Withdrawal by Subject|1|||
131194952|NCT01307046|472333569|FG001|Overall Study|Withdrawal by Subject|1|||
131194953|NCT01307046|472333568|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
131194954|NCT01307046|472333569|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
131194955|NCT01307046|472333568|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
131194956|NCT01307046|472333569|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
131194957|NCT01365091|472333572|FG000|Period 1|Adverse Event|1|||
131194958|NCT01365091|472333573|FG001|Period 1|Adverse Event|0|||
131194959|NCT01365091|472333574|FG002|Period 1|Adverse Event|2|||
131194960|NCT01365091|472333575|FG003|Period 1|Adverse Event|3|||
131194961|NCT01365091|472333572|FG000|Period 1|Positive test result for drugs of abuse|1|||
131194962|NCT01365091|472333573|FG001|Period 1|Positive test result for drugs of abuse|0|||
131194963|NCT01365091|472333574|FG002|Period 1|Positive test result for drugs of abuse|0|||
131194964|NCT01365091|472333575|FG003|Period 1|Positive test result for drugs of abuse|0|||
131194965|NCT01365091|472333572|FG000|Period 1|No longer met study criteria|0|||
131194966|NCT01365091|472333573|FG001|Period 1|No longer met study criteria|1|||
131194967|NCT01365091|472333574|FG002|Period 1|No longer met study criteria|0|||
131194968|NCT01365091|472333575|FG003|Period 1|No longer met study criteria|0|||
131194969|NCT01365091|472333572|FG000|Period 1|Withdrawal by Subject|0|||
131194970|NCT01365091|472333573|FG001|Period 1|Withdrawal by Subject|1|||
131194971|NCT01365091|472333574|FG002|Period 1|Withdrawal by Subject|0|||
131194972|NCT01365091|472333575|FG003|Period 1|Withdrawal by Subject|0|||
131194973|NCT01365091|472333572|FG000|Period 1|Personal reasons|0|||
131194974|NCT01365091|472333573|FG001|Period 1|Personal reasons|0|||
131194975|NCT01365091|472333574|FG002|Period 1|Personal reasons|1|||
131194976|NCT01365091|472333575|FG003|Period 1|Personal reasons|0|||
131194977|NCT01365091|472333572|FG000|Period 2|Withdrawal by Subject|1|||
131194978|NCT01365091|472333573|FG001|Period 2|Withdrawal by Subject|0|||
131194979|NCT01365091|472333574|FG002|Period 2|Withdrawal by Subject|0|||
131194980|NCT01365091|472333575|FG003|Period 2|Withdrawal by Subject|0|||
131194981|NCT01365091|472333572|FG000|Period 2|Adverse Event|0|||
131194982|NCT01365091|472333573|FG001|Period 2|Adverse Event|0|||
131194983|NCT01365091|472333574|FG002|Period 2|Adverse Event|1|||
131194984|NCT01365091|472333575|FG003|Period 2|Adverse Event|0|||
131194985|NCT00400946|472335250|FG000|Overall Study|Ineligible|0|||
131194986|NCT00400946|472335251|FG001|Overall Study|Ineligible|0|||
131194987|NCT00400946|472335252|FG002|Overall Study|Ineligible|0|||
131194988|NCT00400946|472335253|FG003|Overall Study|Ineligible|5|||
131194989|NCT00400946|472335254|FG004|Overall Study|Ineligible|1|||
131194990|NCT00400946|472335250|FG000|Overall Study|Induction Failure|0|||
131194991|NCT00400946|472335251|FG001|Overall Study|Induction Failure|0|||
131194992|NCT00400946|472335252|FG002|Overall Study|Induction Failure|0|||
131194993|NCT00400946|472335253|FG003|Overall Study|Induction Failure|11|||
131194994|NCT00400946|472335254|FG004|Overall Study|Induction Failure|8|||
131194995|NCT00400946|472335250|FG000|Overall Study|Induction Death|0|||
131194996|NCT00400946|472335251|FG001|Overall Study|Induction Death|0|||
131194997|NCT00400946|472335252|FG002|Overall Study|Induction Death|0|||
131194998|NCT00400946|472335253|FG003|Overall Study|Induction Death|13|||
131194999|NCT00400946|472335254|FG004|Overall Study|Induction Death|3|||
131195000|NCT00400946|472335250|FG000|Overall Study|Lost to Follow-up|1|||
131195001|NCT00400946|472335251|FG001|Overall Study|Lost to Follow-up|1|||
131195002|NCT00400946|472335252|FG002|Overall Study|Lost to Follow-up|0|||
131195003|NCT00400946|472335253|FG003|Overall Study|Lost to Follow-up|0|||
131195004|NCT00400946|472335254|FG004|Overall Study|Lost to Follow-up|1|||
131195005|NCT00400946|472335250|FG000|Overall Study|Remission Death|1|||
131195006|NCT00400946|472335251|FG001|Overall Study|Remission Death|1|||
131195007|NCT00400946|472335252|FG002|Overall Study|Remission Death|0|||
131195008|NCT00400946|472335253|FG003|Overall Study|Remission Death|0|||
131195009|NCT00400946|472335254|FG004|Overall Study|Remission Death|1|||
131195010|NCT00400946|472335250|FG000|Overall Study|Relapse|9|||
131195011|NCT00400946|472335251|FG001|Overall Study|Relapse|2|||
131195012|NCT00400946|472335252|FG002|Overall Study|Relapse|1|||
131195013|NCT00400946|472335253|FG003|Overall Study|Relapse|1|||
131195014|NCT00400946|472335254|FG004|Overall Study|Relapse|5|||
131195015|NCT00400946|472335250|FG000|Overall Study|Transplant in CR1|0|||
131195016|NCT00400946|472335251|FG001|Overall Study|Transplant in CR1|0|||
131195017|NCT00400946|472335252|FG002|Overall Study|Transplant in CR1|0|||
131195018|NCT00400946|472335253|FG003|Overall Study|Transplant in CR1|10|||
131195019|NCT00400946|472335254|FG004|Overall Study|Transplant in CR1|1|||
131195020|NCT00400946|472335250|FG000|Overall Study|Withdrawal by Subject|2|||
131195021|NCT00400946|472335251|FG001|Overall Study|Withdrawal by Subject|5|||
131195022|NCT00400946|472335252|FG002|Overall Study|Withdrawal by Subject|1|||
131195023|NCT00400946|472335253|FG003|Overall Study|Withdrawal by Subject|5|||
131195024|NCT00400946|472335254|FG004|Overall Study|Withdrawal by Subject|8|||
131195025|NCT00400946|472335250|FG000|Overall Study|Clinical|1|||
131195026|NCT00400946|472335251|FG001|Overall Study|Clinical|2|||
131195027|NCT00400946|472335252|FG002|Overall Study|Clinical|0|||
131195028|NCT00400946|472335253|FG003|Overall Study|Clinical|2|||
131195029|NCT00400946|472335254|FG004|Overall Study|Clinical|9|||
131195030|NCT00400946|472335250|FG000|Overall Study|Other|0|||
131195031|NCT00400946|472335251|FG001|Overall Study|Other|0|||
131195032|NCT00400946|472335252|FG002|Overall Study|Other|0|||
131195033|NCT00400946|472335253|FG003|Overall Study|Other|0|||
131195034|NCT00400946|472335254|FG004|Overall Study|Other|1|||
131195035|NCT05643170|472335255|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
131195036|NCT05643170|472335255|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
131195037|NCT01432756|472335256|FG000|Overall Study|Lost to Follow-up|1|||
131195038|NCT01432756|472335257|FG001|Overall Study|Lost to Follow-up|0|||
131195039|NCT01432756|472335258|FG002|Overall Study|Lost to Follow-up|2|||
131195040|NCT01432756|472335259|FG003|Overall Study|Lost to Follow-up|1|||
131195041|NCT05426460|472335269|FG000|Overall Study|Protocol Violation|1|||
131195042|NCT05426460|472335270|FG001|Overall Study|Protocol Violation|1|||
131195043|NCT05426460|472335271|FG002|Overall Study|Protocol Violation|1|||
131195044|NCT05426460|472335272|FG003|Overall Study|Protocol Violation|0|||
131195045|NCT02000622|472335273|FG000|Overall Study|Withdrawal by Subject|5|||
131195046|NCT02000622|472335274|FG001|Overall Study|Withdrawal by Subject|7|||
131195047|NCT02000622|472335273|FG000|Overall Study|Lost to Follow-up|4|||
131195048|NCT02000622|472335274|FG001|Overall Study|Lost to Follow-up|0|||
131195049|NCT02000622|472335273|FG000|Overall Study|Death|159|||
131195050|NCT02000622|472335274|FG001|Overall Study|Death|73|||
131195051|NCT02000622|472335273|FG000|Overall Study|Withdrawn due to site closure|1|||
131195052|NCT02000622|472335274|FG001|Overall Study|Withdrawn due to site closure|0|||
131195053|NCT01405027|472335278|FG000|Overall Study|Withdrawn consent|3|||
131195054|NCT01405027|472335279|FG001|Overall Study|Withdrawn consent|0|||
131195055|NCT01405027|472335278|FG000|Overall Study|Lost to Follow-up|16|||
131195056|NCT01405027|472335279|FG001|Overall Study|Lost to Follow-up|24|||
131195057|NCT01405027|472335278|FG000|Overall Study|Investigator judgement|0|||
131195058|NCT01405027|472335279|FG001|Overall Study|Investigator judgement|2|||
131195059|NCT01405027|472335278|FG000|Overall Study|Death|1|||
131195060|NCT01405027|472335279|FG001|Overall Study|Death|0|||
131195061|NCT01405027|472335278|FG000|Overall Study|Other or Unknown|12|||
131195062|NCT01405027|472335279|FG001|Overall Study|Other or Unknown|25|||
131195063|NCT01320033|472335281|FG000|Overall Study|Lack of Efficacy|0|||
130733695|NCT05223920|470642940|FG001|Overall Study|Subject decision|0|||
130733696|NCT05223920|470642939|FG000|Overall Study|Withdrawal by Subject|1|||
131195064|NCT01320033|472335282|FG001|Overall Study|Lack of Efficacy|0|||
131195065|NCT01320033|472335283|FG002|Overall Study|Lack of Efficacy|1|||
131195066|NCT01320033|472335281|FG000|Overall Study|Adverse Event|9|||
131195067|NCT01320033|472335282|FG001|Overall Study|Adverse Event|7|||
131195068|NCT01320033|472335283|FG002|Overall Study|Adverse Event|8|||
131195069|NCT01320033|472335281|FG000|Overall Study|Withdrawal by Subject|22|||
131195070|NCT01320033|472335282|FG001|Overall Study|Withdrawal by Subject|23|||
131195071|NCT01320033|472335283|FG002|Overall Study|Withdrawal by Subject|23|||
131195072|NCT01320033|472335281|FG000|Overall Study|Protocol Violation|3|||
131195073|NCT01320033|472335282|FG001|Overall Study|Protocol Violation|5|||
131195074|NCT01320033|472335283|FG002|Overall Study|Protocol Violation|3|||
131195075|NCT01320033|472335281|FG000|Overall Study|Lost to Follow-up|22|||
131195076|NCT01320033|472335282|FG001|Overall Study|Lost to Follow-up|26|||
131195077|NCT01320033|472335283|FG002|Overall Study|Lost to Follow-up|17|||
131195078|NCT01320033|472335281|FG000|Overall Study|Other|2|||
131195079|NCT01320033|472335282|FG001|Overall Study|Other|3|||
131195080|NCT01320033|472335283|FG002|Overall Study|Other|1|||
131195081|NCT00963469|472335284|FG000|Overall Study|Adverse Event|15|||
131195082|NCT00963469|472335285|FG001|Overall Study|Adverse Event|11|||
131195083|NCT00963469|472335286|FG002|Overall Study|Adverse Event|1|||
131195084|NCT00963469|472335284|FG000|Overall Study|Lack of Efficacy|10|||
131195085|NCT00963469|472335285|FG001|Overall Study|Lack of Efficacy|7|||
131195086|NCT00963469|472335286|FG002|Overall Study|Lack of Efficacy|2|||
131195087|NCT00963469|472335284|FG000|Overall Study|Lost to Follow-up|1|||
131195088|NCT00963469|472335285|FG001|Overall Study|Lost to Follow-up|1|||
131195089|NCT00963469|472335286|FG002|Overall Study|Lost to Follow-up|0|||
131195090|NCT00963469|472335284|FG000|Overall Study|Protocol Violation|5|||
131195091|NCT00963469|472335285|FG001|Overall Study|Protocol Violation|5|||
131195092|NCT00963469|472335286|FG002|Overall Study|Protocol Violation|3|||
131195093|NCT00963469|472335284|FG000|Overall Study|Withdrawal by Subject|4|||
131195094|NCT00963469|472335285|FG001|Overall Study|Withdrawal by Subject|1|||
131195095|NCT00963469|472335286|FG002|Overall Study|Withdrawal by Subject|1|||
131195096|NCT00963469|472335284|FG000|Overall Study|Pre-randomization Adverse Event|1|||
131195097|NCT00963469|472335285|FG001|Overall Study|Pre-randomization Adverse Event|2|||
131195098|NCT00963469|472335286|FG002|Overall Study|Pre-randomization Adverse Event|0|||
131195099|NCT00963469|472335284|FG000|Overall Study|Moved|1|||
131195100|NCT00963469|472335285|FG001|Overall Study|Moved|0|||
131195101|NCT00963469|472335286|FG002|Overall Study|Moved|0|||
131195102|NCT00963469|472335284|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
131195103|NCT00963469|472335285|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
131195104|NCT00963469|472335286|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
131195105|NCT00378534|472335300|FG000|Overall Study|Participants did not receive transplant|3|||
131195106|NCT00378534|472335301|FG001|Overall Study|Participants did not receive transplant|0|||
131195107|NCT04969900|472335302|FG000|Overall Study|Physician Decision|1|||
131195108|NCT04969900|472335303|FG001|Overall Study|Physician Decision|1|||
131195109|NCT04969900|472335302|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
131195110|NCT04969900|472335303|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
131195111|NCT02365506|472335312|FG000|Overall Study|Investigator's Discretion|0|||
131195112|NCT02365506|472335313|FG001|Overall Study|Investigator's Discretion|0|||
131195113|NCT02365506|472335314|FG002|Overall Study|Investigator's Discretion|1|||
131195114|NCT03774875|472335315|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
131195115|NCT03774875|472335316|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
131195116|NCT03774875|472335315|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
131195117|NCT03774875|472335316|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
131195118|NCT03774875|472335315|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
131195119|NCT03774875|472335316|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
131195120|NCT03774875|472335315|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
131195121|NCT03774875|472335316|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
131195122|NCT03774875|472335315|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
131195123|NCT03774875|472335316|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
131195124|NCT03774875|472335315|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
131195125|NCT03774875|472335316|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
131195126|NCT03774875|472335315|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
131195127|NCT03774875|472335316|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
131195128|NCT03774875|472335315|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
131195129|NCT03774875|472335316|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
130733697|NCT05223920|470642940|FG001|Overall Study|Withdrawal by Subject|6|||
131195130|NCT03774875|472335315|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
131195131|NCT03774875|472335316|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
130733698|NCT03154125|470642948|FG000|Overall Study|Lost to Follow-up|11|||
131195132|NCT03774875|472335315|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
131195133|NCT03774875|472335316|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
131195134|NCT03774875|472335315|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
131195135|NCT03774875|472335316|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
131195136|NCT03774875|472335315|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
131195137|NCT03774875|472335316|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
131195138|NCT03774875|472335315|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
131195139|NCT03774875|472335316|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
131195140|NCT03728881|472335319|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
131195141|NCT03728881|472335320|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
131195142|NCT03728881|472335319|FG000|Enrolled and Received 1st Vaccination|Death|1|||
131195143|NCT03728881|472335320|FG001|Enrolled and Received 1st Vaccination|Death|1|||
131195144|NCT03728881|472335319|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
131195145|NCT03728881|472335320|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
131195146|NCT03728881|472335319|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
131195147|NCT03728881|472335320|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
131195148|NCT03728881|472335319|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
131195149|NCT03728881|472335320|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
131195150|NCT03728881|472335319|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
131195151|NCT03728881|472335320|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
131195152|NCT03728881|472335319|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
131195153|NCT03728881|472335320|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
131195154|NCT03728881|472335319|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
131195155|NCT03728881|472335320|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
131195156|NCT03728881|472335319|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
131195157|NCT03728881|472335320|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
131195158|NCT03728881|472335319|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
131195159|NCT03728881|472335320|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
131195160|NCT03728881|472335319|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
131195161|NCT03728881|472335320|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
131195162|NCT04088331|472335321|FG000|Overall Study|Lost to Follow-up|3|||
131195163|NCT04088331|472335321|FG000|Overall Study|Withdrawal by Subject|7|||
131195164|NCT04088331|472335321|FG000|Overall Study|Adverse Event|4|||
131195165|NCT03233308|472335326|FG000|Overall Study|Adverse Event|1|||
131195166|NCT03233308|472335326|FG000|Overall Study|Protocol Violation|1|||
131195167|NCT02155712|472335332|FG000|Overall Study|Death|12|||
131195168|NCT02155712|472335333|FG001|Overall Study|Death|0|||
131195169|NCT02155712|472335332|FG000|Overall Study|Lost to Follow-up|37|||
131195170|NCT02155712|472335333|FG001|Overall Study|Lost to Follow-up|22|||
131195171|NCT02155712|472335332|FG000|Overall Study|Revision of device|4|||
131195172|NCT02155712|472335333|FG001|Overall Study|Revision of device|3|||
131195173|NCT02155712|472335332|FG000|Overall Study|Withdrawal by Subject|39|||
131195174|NCT02155712|472335333|FG001|Overall Study|Withdrawal by Subject|21|||
131195175|NCT02155712|472335332|FG000|Overall Study|Site termination|77|||
131195176|NCT02155712|472335333|FG001|Overall Study|Site termination|19|||
131195177|NCT02155712|472335332|FG000|Overall Study|Sponsor terminated study early|150|||
131195178|NCT02155712|472335333|FG001|Overall Study|Sponsor terminated study early|0|||
131195179|NCT02155712|472335332|FG000|Overall Study|Missed final 5-year protocol visit|0|||
131195180|NCT02155712|472335333|FG001|Overall Study|Missed final 5-year protocol visit|32|||
131195181|NCT02155712|472335332|FG000|Overall Study|Censored because surgery cancelled|6|||
131195182|NCT02155712|472335333|FG001|Overall Study|Censored because surgery cancelled|10|||
131195183|NCT02155712|472335332|FG000|Overall Study|Censored because study device was not implanted|61|||
131195184|NCT02155712|472335333|FG001|Overall Study|Censored because study device was not implanted|66|||
131195185|NCT02155712|472335332|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
131195186|NCT02155712|472335333|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
131195187|NCT05016037|472335334|FG000|Overall Study|Lost to Follow-up|2|||
131195188|NCT00976963|472335335|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
131195189|NCT00976963|472335336|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
131195190|NCT00976963|472335335|FG000|Overall Study|administrative error|1|||
131195191|NCT00976963|472335336|FG001|Overall Study|administrative error|0|||
131195192|NCT00976963|472335335|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
131195193|NCT00976963|472335336|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
131195194|NCT01688999|472335344|FG000|Overall Study|Withdrawal by Subject|5|||
131195195|NCT01688999|472335345|FG001|Overall Study|Withdrawal by Subject|1|||
131195196|NCT01688999|472335346|FG002|Overall Study|Withdrawal by Subject|1|||
131195197|NCT01688999|472335344|FG000|Overall Study|Adverse Event|2|||
131195198|NCT01688999|472335345|FG001|Overall Study|Adverse Event|0|||
131195199|NCT01688999|472335346|FG002|Overall Study|Adverse Event|2|||
131195200|NCT01688999|472335344|FG000|Overall Study|Ineligible/Not treated|1|||
131195201|NCT01688999|472335345|FG001|Overall Study|Ineligible/Not treated|0|||
131195202|NCT01688999|472335346|FG002|Overall Study|Ineligible/Not treated|0|||
131195203|NCT02768103|472335347|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
131195204|NCT02148952|472335349|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
131195205|NCT02148952|472335350|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
131195206|NCT02148952|472335349|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
131195207|NCT02148952|472335350|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
131195208|NCT02148952|472335349|FG000|Follow-Up|Lost to Follow-up|219|||
131195209|NCT02148952|472335350|FG001|Follow-Up|Lost to Follow-up|231|||
131195210|NCT02148952|472335349|FG000|Follow-Up|Withdrawal by Subject|46|||
131195211|NCT02148952|472335350|FG001|Follow-Up|Withdrawal by Subject|48|||
131195212|NCT01025232|472335351|FG000|Overall Study|Study drug no longer available|3|||
131195213|NCT01025232|472335352|FG001|Overall Study|Study drug no longer available|6|||
131195214|NCT01600105|472335353|FG000|Total Participants|Withdrawal by Subject|1|||
131195215|NCT01600105|472335354|FG001|Total Participants|Withdrawal by Subject|0|||
131195216|NCT01600105|472335353|FG000|Total Participants|No images in PACS|10|||
131195217|NCT01600105|472335354|FG001|Total Participants|No images in PACS|0|||
131195218|NCT01600105|472335353|FG000|Total Participants|Insufficient image quality|30|||
131195219|NCT01600105|472335354|FG001|Total Participants|Insufficient image quality|10|||
131195220|NCT01600105|472335353|FG000|Sub Study I|Insufficient image quality|0|||
131195221|NCT01600105|472335354|FG001|Sub Study I|Insufficient image quality|10|||
131195222|NCT01600105|472335353|FG000|Sub Study II|Withdrawal by Subject|1|||
131195223|NCT01600105|472335354|FG001|Sub Study II|Withdrawal by Subject|0|||
131195224|NCT01600105|472335353|FG000|Sub Study II|No images in PACS|1|||
131195225|NCT01600105|472335354|FG001|Sub Study II|No images in PACS|0|||
131195226|NCT01600105|472335353|FG000|Sub Study II|Insufficient image quality|3|||
131195227|NCT01600105|472335354|FG001|Sub Study II|Insufficient image quality|0|||
131195228|NCT01600105|472335353|FG000|Sub Study III|Insufficient image quality|5|||
131195229|NCT01600105|472335354|FG001|Sub Study III|Insufficient image quality|0|||
131195230|NCT01600105|472335353|FG000|Sub Study V|Poor Image Quality|2|||
131195231|NCT01600105|472335354|FG001|Sub Study V|Poor Image Quality|0|||
131195232|NCT01263444|472335355|FG000|Overall Study|Adverse Event|8|||
131195233|NCT01263444|472335355|FG000|Overall Study|Withdrawal by Subject|1|||
131195234|NCT01263444|472335355|FG000|Overall Study|Protocol Violation|1|||
131195235|NCT04007367|472335357|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
131195236|NCT04007367|472335358|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
131195237|NCT04007367|472335359|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
131195238|NCT04007367|472335357|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
131195239|NCT04007367|472335358|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
131195240|NCT04007367|472335359|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
131195241|NCT04007367|472335357|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
131195242|NCT04007367|472335358|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
131195243|NCT04007367|472335359|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
131195244|NCT04007367|472335357|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
131195245|NCT04007367|472335358|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
131195246|NCT04007367|472335359|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
131195247|NCT04007367|472335357|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
131195248|NCT04007367|472335358|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
131195249|NCT04007367|472335359|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
131195250|NCT01764022|472335360|FG000|Overall Study|Death|3|||
131195251|NCT01764022|472335361|FG001|Overall Study|Death|5|||
131195252|NCT01764022|472335360|FG000|Overall Study|Withdrawal by Subject|2|||
131195253|NCT01764022|472335361|FG001|Overall Study|Withdrawal by Subject|6|||
131195254|NCT01764022|472335360|FG000|Overall Study|Lack of Efficacy|0|||
131195255|NCT01764022|472335361|FG001|Overall Study|Lack of Efficacy|1|||
131195256|NCT01764022|472335360|FG000|Overall Study|Physician Decision|0|||
131195257|NCT01764022|472335361|FG001|Overall Study|Physician Decision|2|||
131195258|NCT01764022|472335360|FG000|Overall Study|Lost to Follow-up|2|||
131195259|NCT01764022|472335361|FG001|Overall Study|Lost to Follow-up|0|||
131195260|NCT01764022|472335360|FG000|Overall Study|Protocol Violation|1|||
131195261|NCT01764022|472335361|FG001|Overall Study|Protocol Violation|0|||
131195262|NCT02324049|472335364|FG000|Part C|Study terminated|11|||
131195263|NCT03083470|472335366|FG000|Overall Study|Lost to Follow-up|0|||
131195264|NCT03083470|472335367|FG001|Overall Study|Lost to Follow-up|0|||
131195265|NCT03083470|472335368|FG002|Overall Study|Lost to Follow-up|0|||
131195266|NCT03083470|472335369|FG003|Overall Study|Lost to Follow-up|0|||
131195267|NCT03083470|472335370|FG004|Overall Study|Lost to Follow-up|1|||
131195268|NCT03083470|472335366|FG000|Overall Study|Withdrawal by Subject|0|||
131195269|NCT03083470|472335367|FG001|Overall Study|Withdrawal by Subject|0|||
131195270|NCT03083470|472335368|FG002|Overall Study|Withdrawal by Subject|0|||
131195271|NCT03083470|472335369|FG003|Overall Study|Withdrawal by Subject|0|||
131195272|NCT03083470|472335370|FG004|Overall Study|Withdrawal by Subject|1|||
131195273|NCT03077711|472335371|FG000|Overall Study|Lost to Follow-up|2|||
131195274|NCT03077711|472335372|FG001|Overall Study|Lost to Follow-up|2|||
131195275|NCT03077711|472335371|FG000|Overall Study|noncompliant taking medication|2|||
130733699|NCT03154125|470642949|FG001|Overall Study|Lost to Follow-up|11|||
131195276|NCT03077711|472335372|FG001|Overall Study|noncompliant taking medication|0|||
131195277|NCT00423592|472335375|FG000|Overall Study|Adverse Event (through Week 12)|2|||
131195278|NCT00423592|472335375|FG000|Overall Study|Adverse Event (post Week 12)|5|||
131195279|NCT00149890|472335379|FG000|Overall Study|Adverse Event|1|||
131195280|NCT00149890|472335380|FG001|Overall Study|Adverse Event|8|||
131195281|NCT00149890|472335379|FG000|Overall Study|Lack of Efficacy|8|||
131195282|NCT00149890|472335380|FG001|Overall Study|Lack of Efficacy|9|||
131195283|NCT00149890|472335379|FG000|Overall Study|Protocol Violation|1|||
131195284|NCT00149890|472335380|FG001|Overall Study|Protocol Violation|0|||
131195285|NCT00149890|472335379|FG000|Overall Study|Lost to Follow-up|1|||
131195286|NCT00149890|472335380|FG001|Overall Study|Lost to Follow-up|0|||
131195287|NCT00149890|472335379|FG000|Overall Study|Graft Loss|2|||
131195288|NCT00149890|472335380|FG001|Overall Study|Graft Loss|1|||
131195289|NCT01894776|472335381|FG000|Overall Study|Withdrawal by Subject|1|||
131195290|NCT02485860|472335382|FG000|Overall Study|Lost to Follow-up|4|||
131195291|NCT02485860|472335383|FG001|Overall Study|Lost to Follow-up|1|||
131195292|NCT02485860|472335382|FG000|Overall Study|Physician Decision|1|||
131195293|NCT02485860|472335383|FG001|Overall Study|Physician Decision|2|||
131195294|NCT02485860|472335382|FG000|Overall Study|Health context (COVID-19)|1|||
131195295|NCT02485860|472335383|FG001|Overall Study|Health context (COVID-19)|0|||
131195296|NCT03325010|472335387|FG000|Overall Study|Adverse Event|3|||
130784606|NCT02984982|470838847|FG001|Overall Study|Adverse Event|5|||
131195297|NCT03325010|472335388|FG001|Overall Study|Adverse Event|8|||
131195298|NCT03325010|472335387|FG000|Overall Study|Protocol Violation|1|||
131195299|NCT03325010|472335388|FG001|Overall Study|Protocol Violation|8|||
131195300|NCT03325010|472335387|FG000|Overall Study|Withdrawal by Subject|1|||
131195301|NCT03325010|472335388|FG001|Overall Study|Withdrawal by Subject|3|||
131195302|NCT03325010|472335387|FG000|Overall Study|Lost to Follow-up|1|||
131195303|NCT03325010|472335388|FG001|Overall Study|Lost to Follow-up|0|||
131195304|NCT03325010|472335387|FG000|Overall Study|Physician Decision|1|||
131195305|NCT03325010|472335388|FG001|Overall Study|Physician Decision|1|||
131195306|NCT03325010|472335387|FG000|Overall Study|Lack of Efficacy|2|||
131195307|NCT03325010|472335388|FG001|Overall Study|Lack of Efficacy|0|||
131195308|NCT03073200|472335393|FG000|Double Blind Treatment Period|Protocol Violation|1|||
131195309|NCT03073200|472335394|FG001|Double Blind Treatment Period|Protocol Violation|0|||
131195310|NCT03073200|472335395|FG002|Double Blind Treatment Period|Protocol Violation|0|||
131195311|NCT03073200|472335396|FG003|Double Blind Treatment Period|Protocol Violation|0|||
131195312|NCT03073200|472335397|FG004|Double Blind Treatment Period|Protocol Violation|0|||
131195313|NCT03073200|472335398|FG005|Double Blind Treatment Period|Protocol Violation|0|||
131195314|NCT03073200|472335399|FG006|Double Blind Treatment Period|Protocol Violation|0|||
131195315|NCT03073200|472335400|FG007|Double Blind Treatment Period|Protocol Violation|0|||
131195316|NCT03073200|472335401|FG008|Double Blind Treatment Period|Protocol Violation|0|||
131195317|NCT03073200|472335402|FG009|Double Blind Treatment Period|Protocol Violation|0|||
131195318|NCT03073200|472335403|FG010|Double Blind Treatment Period|Protocol Violation|0|||
131195319|NCT03073200|472335404|FG011|Double Blind Treatment Period|Protocol Violation|0|||
131195320|NCT03073200|472335405|FG012|Double Blind Treatment Period|Protocol Violation|0|||
131195321|NCT03073200|472335406|FG013|Double Blind Treatment Period|Protocol Violation|0|||
131195322|NCT03073200|472335407|FG014|Double Blind Treatment Period|Protocol Violation|0|||
131195323|NCT03073200|472335393|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195324|NCT03073200|472335394|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
131195325|NCT03073200|472335395|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195326|NCT03073200|472335396|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195327|NCT03073200|472335397|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195328|NCT03073200|472335398|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195329|NCT03073200|472335399|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195330|NCT03073200|472335400|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195331|NCT03073200|472335401|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195332|NCT03073200|472335402|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195333|NCT03073200|472335403|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195334|NCT03073200|472335404|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195335|NCT03073200|472335405|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195336|NCT03073200|472335406|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195337|NCT03073200|472335407|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
131195338|NCT03073200|472335393|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
131195339|NCT03073200|472335394|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195340|NCT03073200|472335395|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195341|NCT03073200|472335396|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195342|NCT03073200|472335397|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195343|NCT03073200|472335398|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195344|NCT03073200|472335399|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195345|NCT03073200|472335400|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195346|NCT03073200|472335401|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195347|NCT03073200|472335402|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195348|NCT03073200|472335403|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195349|NCT03073200|472335404|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195350|NCT03073200|472335405|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195351|NCT03073200|472335406|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195352|NCT03073200|472335407|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
131195353|NCT03073200|472335393|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195354|NCT03073200|472335394|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195355|NCT03073200|472335395|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195356|NCT03073200|472335396|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
131195357|NCT03073200|472335397|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
131195358|NCT03073200|472335398|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195359|NCT03073200|472335399|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195360|NCT03073200|472335400|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195361|NCT03073200|472335401|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
130784607|NCT02984982|470838846|FG000|Overall Study|Poor Compliance to Protocol|4|||
130784608|NCT02984982|470838847|FG001|Overall Study|Poor Compliance to Protocol|4|||
131195362|NCT03073200|472335402|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195363|NCT03073200|472335403|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195364|NCT03073200|472335404|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195365|NCT03073200|472335405|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195366|NCT03073200|472335406|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195367|NCT03073200|472335407|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
131195368|NCT03073200|472335393|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
131195369|NCT03073200|472335394|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
130733700|NCT03154125|470642950|FG002|Overall Study|Lost to Follow-up|0|||
131195370|NCT03073200|472335395|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
131195371|NCT03073200|472335396|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
131195372|NCT03073200|472335397|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
130733701|NCT03154125|470642948|FG000|Overall Study|Withdrawal by Subject|49|||
131195373|NCT03073200|472335398|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
131195374|NCT03073200|472335399|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
131195375|NCT03073200|472335400|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
131195376|NCT03073200|472335401|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
131195377|NCT03073200|472335402|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
131195378|NCT03073200|472335403|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
131195379|NCT03073200|472335404|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
131195380|NCT03073200|472335405|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
131195381|NCT03073200|472335406|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
131195382|NCT03073200|472335407|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
131195383|NCT03073200|472335393|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195384|NCT03073200|472335394|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195385|NCT03073200|472335395|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195386|NCT03073200|472335396|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195387|NCT03073200|472335397|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
131195388|NCT03073200|472335398|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195389|NCT03073200|472335399|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195390|NCT03073200|472335400|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195391|NCT03073200|472335401|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195392|NCT03073200|472335402|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195393|NCT03073200|472335403|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195394|NCT03073200|472335404|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195395|NCT03073200|472335405|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195396|NCT03073200|472335406|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195397|NCT03073200|472335407|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
131195398|NCT03073200|472335393|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195399|NCT03073200|472335394|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195400|NCT03073200|472335395|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195401|NCT03073200|472335396|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
131195402|NCT03073200|472335397|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
131195403|NCT03073200|472335398|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195404|NCT03073200|472335399|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195405|NCT03073200|472335400|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195406|NCT03073200|472335401|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195407|NCT03073200|472335402|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195408|NCT03073200|472335403|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195409|NCT03073200|472335404|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195410|NCT03073200|472335405|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195411|NCT03073200|472335406|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195412|NCT03073200|472335407|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
131195413|NCT03073200|472335393|FG000|Extension Period|Lost to Follow-up|0|||
131195414|NCT03073200|472335394|FG001|Extension Period|Lost to Follow-up|0|||
131195415|NCT03073200|472335395|FG002|Extension Period|Lost to Follow-up|0|||
131195416|NCT03073200|472335396|FG003|Extension Period|Lost to Follow-up|0|||
131195417|NCT03073200|472335397|FG004|Extension Period|Lost to Follow-up|0|||
131195418|NCT03073200|472335398|FG005|Extension Period|Lost to Follow-up|0|||
131195419|NCT03073200|472335399|FG006|Extension Period|Lost to Follow-up|1|||
131195420|NCT03073200|472335400|FG007|Extension Period|Lost to Follow-up|1|||
131195421|NCT03073200|472335401|FG008|Extension Period|Lost to Follow-up|0|||
131195422|NCT03073200|472335402|FG009|Extension Period|Lost to Follow-up|0|||
131195423|NCT03073200|472335403|FG010|Extension Period|Lost to Follow-up|0|||
131195424|NCT03073200|472335404|FG011|Extension Period|Lost to Follow-up|0|||
131195425|NCT03073200|472335405|FG012|Extension Period|Lost to Follow-up|0|||
131195426|NCT03073200|472335406|FG013|Extension Period|Lost to Follow-up|0|||
131195427|NCT03073200|472335407|FG014|Extension Period|Lost to Follow-up|0|||
131195428|NCT03073200|472335393|FG000|Extension Period|Sponsor Decision|0|||
131195429|NCT03073200|472335394|FG001|Extension Period|Sponsor Decision|0|||
131195430|NCT03073200|472335395|FG002|Extension Period|Sponsor Decision|0|||
131195431|NCT03073200|472335396|FG003|Extension Period|Sponsor Decision|0|||
131195432|NCT03073200|472335397|FG004|Extension Period|Sponsor Decision|0|||
131195433|NCT03073200|472335398|FG005|Extension Period|Sponsor Decision|0|||
131195434|NCT03073200|472335399|FG006|Extension Period|Sponsor Decision|0|||
131195435|NCT03073200|472335400|FG007|Extension Period|Sponsor Decision|0|||
131195436|NCT03073200|472335401|FG008|Extension Period|Sponsor Decision|1|||
131195437|NCT03073200|472335402|FG009|Extension Period|Sponsor Decision|0|||
131195438|NCT03073200|472335403|FG010|Extension Period|Sponsor Decision|0|||
131195439|NCT03073200|472335404|FG011|Extension Period|Sponsor Decision|0|||
131195440|NCT03073200|472335405|FG012|Extension Period|Sponsor Decision|0|||
131195441|NCT03073200|472335406|FG013|Extension Period|Sponsor Decision|0|||
131195442|NCT03073200|472335407|FG014|Extension Period|Sponsor Decision|0|||
131195443|NCT03073200|472335393|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
130733702|NCT03154125|470642949|FG001|Overall Study|Withdrawal by Subject|55|||
130733703|NCT03154125|470642950|FG002|Overall Study|Withdrawal by Subject|8|||
130733704|NCT03154125|470642948|FG000|Overall Study|Physician Decision|13|||
130733705|NCT03154125|470642949|FG001|Overall Study|Physician Decision|6|||
130733706|NCT03154125|470642950|FG002|Overall Study|Physician Decision|0|||
130733707|NCT03154125|470642948|FG000|Overall Study|Protocol Violation|3|||
130733708|NCT03154125|470642949|FG001|Overall Study|Protocol Violation|5|||
130733709|NCT03154125|470642950|FG002|Overall Study|Protocol Violation|0|||
131195444|NCT03073200|472335394|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
131195445|NCT03073200|472335395|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
131195446|NCT03073200|472335396|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
131195447|NCT03073200|472335397|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
131195448|NCT03073200|472335398|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
131195449|NCT03073200|472335399|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
131195450|NCT03073200|472335400|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
130733710|NCT00810511|470642951|FG000|Overall Study|Protocol Violation|0|||
131195451|NCT03073200|472335401|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
131195452|NCT03073200|472335402|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
130784609|NCT02984982|470838846|FG000|Overall Study|Withdrawal by Subject|2|||
130784610|NCT02984982|470838847|FG001|Overall Study|Withdrawal by Subject|0|||
130784611|NCT02984982|470838846|FG000|Overall Study|Randomized but not treated|0|||
130784612|NCT02984982|470838847|FG001|Overall Study|Randomized but not treated|1|||
130784613|NCT01103323|470838848|FG000|Without/Before Drug Switch|Adverse Event|50|||
130784614|NCT01103323|470838849|FG001|Without/Before Drug Switch|Adverse Event|7|||
130784615|NCT01103323|470838848|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
130784616|NCT01103323|470838849|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
130784617|NCT01103323|470838848|FG000|Without/Before Drug Switch|Protocol Violation|2|||
131195453|NCT03073200|472335403|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
131195454|NCT03073200|472335404|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
131195455|NCT03073200|472335405|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
131195456|NCT03073200|472335406|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
131195457|NCT03073200|472335407|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
131195458|NCT03073200|472335393|FG000|Extension Period|Withdrawal by Subject|0|||
131195459|NCT03073200|472335394|FG001|Extension Period|Withdrawal by Subject|0|||
131195460|NCT03073200|472335395|FG002|Extension Period|Withdrawal by Subject|0|||
131195461|NCT03073200|472335396|FG003|Extension Period|Withdrawal by Subject|0|||
131195462|NCT03073200|472335397|FG004|Extension Period|Withdrawal by Subject|0|||
131195463|NCT03073200|472335398|FG005|Extension Period|Withdrawal by Subject|0|||
131195464|NCT03073200|472335399|FG006|Extension Period|Withdrawal by Subject|1|||
131195465|NCT03073200|472335400|FG007|Extension Period|Withdrawal by Subject|2|||
131195466|NCT03073200|472335401|FG008|Extension Period|Withdrawal by Subject|0|||
131195467|NCT03073200|472335402|FG009|Extension Period|Withdrawal by Subject|0|||
131195468|NCT03073200|472335403|FG010|Extension Period|Withdrawal by Subject|0|||
131195469|NCT03073200|472335404|FG011|Extension Period|Withdrawal by Subject|0|||
131195470|NCT03073200|472335405|FG012|Extension Period|Withdrawal by Subject|0|||
131195471|NCT03073200|472335406|FG013|Extension Period|Withdrawal by Subject|0|||
131195472|NCT03073200|472335407|FG014|Extension Period|Withdrawal by Subject|0|||
131195473|NCT03073200|472335393|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195474|NCT03073200|472335394|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195475|NCT03073200|472335395|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195476|NCT03073200|472335396|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195477|NCT03073200|472335397|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195478|NCT03073200|472335398|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195479|NCT03073200|472335399|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195480|NCT03073200|472335400|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195481|NCT03073200|472335401|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195482|NCT03073200|472335402|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195483|NCT03073200|472335403|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195484|NCT03073200|472335404|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
131195485|NCT03073200|472335405|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195486|NCT03073200|472335406|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195487|NCT03073200|472335407|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
131195488|NCT03073200|472335393|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195489|NCT03073200|472335394|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195490|NCT03073200|472335395|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195491|NCT03073200|472335396|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195492|NCT03073200|472335397|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195493|NCT03073200|472335398|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195494|NCT03073200|472335399|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195495|NCT03073200|472335400|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195496|NCT03073200|472335401|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195497|NCT03073200|472335402|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195498|NCT03073200|472335403|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195499|NCT03073200|472335404|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
131195500|NCT03073200|472335405|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195501|NCT03073200|472335406|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195502|NCT03073200|472335407|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
131195503|NCT03073200|472335393|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195504|NCT03073200|472335394|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195505|NCT03073200|472335395|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195506|NCT03073200|472335396|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195507|NCT03073200|472335397|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195508|NCT03073200|472335398|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195509|NCT03073200|472335399|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195510|NCT03073200|472335400|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195511|NCT03073200|472335401|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195512|NCT03073200|472335402|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195513|NCT03073200|472335403|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
131195514|NCT03073200|472335404|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
131195515|NCT03073200|472335405|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195516|NCT03073200|472335406|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195517|NCT03073200|472335407|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
131195518|NCT03073200|472335393|FG000|Randomized Withdrawal Period|Adverse Event|0|||
131195519|NCT03073200|472335394|FG001|Randomized Withdrawal Period|Adverse Event|0|||
131195520|NCT03073200|472335395|FG002|Randomized Withdrawal Period|Adverse Event|0|||
131195521|NCT03073200|472335396|FG003|Randomized Withdrawal Period|Adverse Event|0|||
131195522|NCT03073200|472335397|FG004|Randomized Withdrawal Period|Adverse Event|0|||
131195523|NCT03073200|472335398|FG005|Randomized Withdrawal Period|Adverse Event|0|||
131195524|NCT03073200|472335399|FG006|Randomized Withdrawal Period|Adverse Event|0|||
131195525|NCT03073200|472335400|FG007|Randomized Withdrawal Period|Adverse Event|0|||
131195526|NCT03073200|472335401|FG008|Randomized Withdrawal Period|Adverse Event|0|||
131195527|NCT03073200|472335402|FG009|Randomized Withdrawal Period|Adverse Event|0|||
131195528|NCT03073200|472335403|FG010|Randomized Withdrawal Period|Adverse Event|1|||
131195529|NCT03073200|472335404|FG011|Randomized Withdrawal Period|Adverse Event|0|||
131195530|NCT03073200|472335405|FG012|Randomized Withdrawal Period|Adverse Event|0|||
131195531|NCT03073200|472335406|FG013|Randomized Withdrawal Period|Adverse Event|0|||
131195532|NCT03073200|472335407|FG014|Randomized Withdrawal Period|Adverse Event|0|||
131195533|NCT03073200|472335393|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195534|NCT03073200|472335394|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195535|NCT03073200|472335395|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195536|NCT03073200|472335396|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195537|NCT03073200|472335397|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195538|NCT03073200|472335398|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195539|NCT03073200|472335399|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195540|NCT03073200|472335400|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195541|NCT03073200|472335401|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195542|NCT03073200|472335402|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195543|NCT03073200|472335403|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195544|NCT03073200|472335404|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195545|NCT03073200|472335405|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195546|NCT03073200|472335406|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
131195547|NCT03073200|472335407|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
131195548|NCT03073200|472335393|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195549|NCT03073200|472335394|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195550|NCT03073200|472335395|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195551|NCT03073200|472335396|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195552|NCT03073200|472335397|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195553|NCT03073200|472335398|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195554|NCT03073200|472335399|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195555|NCT03073200|472335400|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195556|NCT03073200|472335401|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195557|NCT03073200|472335402|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195558|NCT03073200|472335403|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195559|NCT03073200|472335404|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195560|NCT03073200|472335405|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195561|NCT03073200|472335406|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
131195562|NCT03073200|472335407|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
131195563|NCT03073200|472335393|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195564|NCT03073200|472335394|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195565|NCT03073200|472335395|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195566|NCT03073200|472335396|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195567|NCT03073200|472335397|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195568|NCT03073200|472335398|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195569|NCT03073200|472335399|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195570|NCT03073200|472335400|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195571|NCT03073200|472335401|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195572|NCT03073200|472335402|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195573|NCT03073200|472335403|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195574|NCT03073200|472335404|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195575|NCT03073200|472335405|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195576|NCT03073200|472335406|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
131195577|NCT03073200|472335407|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
131195578|NCT03073200|472335393|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195579|NCT03073200|472335394|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195580|NCT03073200|472335395|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195581|NCT03073200|472335396|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195582|NCT03073200|472335397|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195583|NCT03073200|472335398|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195584|NCT03073200|472335399|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195585|NCT03073200|472335400|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195586|NCT03073200|472335401|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195587|NCT03073200|472335402|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195588|NCT03073200|472335403|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195589|NCT03073200|472335404|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195590|NCT03073200|472335405|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195591|NCT03073200|472335406|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
131195592|NCT03073200|472335407|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
131195593|NCT03073200|472335393|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195594|NCT03073200|472335394|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195595|NCT03073200|472335395|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195596|NCT03073200|472335396|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195597|NCT03073200|472335397|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195598|NCT03073200|472335398|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195599|NCT03073200|472335399|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195600|NCT03073200|472335400|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195601|NCT03073200|472335401|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195602|NCT03073200|472335402|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195603|NCT03073200|472335403|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195604|NCT03073200|472335404|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195605|NCT03073200|472335405|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195606|NCT03073200|472335406|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
131195607|NCT03073200|472335407|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
131195608|NCT03073200|472335393|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195609|NCT03073200|472335394|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195610|NCT03073200|472335395|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195611|NCT03073200|472335396|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195612|NCT03073200|472335397|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195613|NCT03073200|472335398|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195614|NCT03073200|472335399|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195615|NCT03073200|472335400|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195616|NCT03073200|472335401|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195617|NCT03073200|472335402|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195618|NCT03073200|472335403|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195619|NCT03073200|472335404|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195620|NCT03073200|472335405|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195621|NCT03073200|472335406|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
131195622|NCT03073200|472335407|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
131195623|NCT03073200|472335393|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195624|NCT03073200|472335394|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195625|NCT03073200|472335395|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195626|NCT03073200|472335396|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195627|NCT03073200|472335397|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195628|NCT03073200|472335398|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195629|NCT03073200|472335399|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195630|NCT03073200|472335400|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195631|NCT03073200|472335401|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195632|NCT03073200|472335402|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195633|NCT03073200|472335403|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195634|NCT03073200|472335404|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195635|NCT03073200|472335405|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195636|NCT03073200|472335406|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
131195637|NCT03073200|472335407|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
131195638|NCT03073200|472335393|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195639|NCT03073200|472335394|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195640|NCT03073200|472335395|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195641|NCT03073200|472335396|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195642|NCT03073200|472335397|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195643|NCT03073200|472335398|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195644|NCT03073200|472335399|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195645|NCT03073200|472335400|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195646|NCT03073200|472335401|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195647|NCT03073200|472335402|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195648|NCT03073200|472335403|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195649|NCT03073200|472335404|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195650|NCT03073200|472335405|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195651|NCT03073200|472335406|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
131195652|NCT03073200|472335407|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
131195653|NCT05116683|472335411|FG000|Overall Study|Physician Decision|4|||
131195654|NCT01474889|472335412|FG000|Overall Study|Physician Decision|1|||
131195655|NCT01474889|472335413|FG001|Overall Study|Physician Decision|0|||
131195656|NCT01474889|472335414|FG002|Overall Study|Physician Decision|0|||
131195657|NCT01474889|472335412|FG000|Overall Study|Did not meet inclusion|1|||
131195658|NCT01474889|472335413|FG001|Overall Study|Did not meet inclusion|0|||
131195659|NCT01474889|472335414|FG002|Overall Study|Did not meet inclusion|0|||
131195660|NCT01474889|472335412|FG000|Overall Study|Withdrawal by Subject|0|||
131195661|NCT01474889|472335413|FG001|Overall Study|Withdrawal by Subject|1|||
131195662|NCT01474889|472335414|FG002|Overall Study|Withdrawal by Subject|0|||
131195663|NCT03935594|472335418|FG000|Overall Study|Physician Decision|3|||
131195664|NCT01435122|472335419|FG000|Overall Study|Early withdrawal due to toxicity|8|||
131195665|NCT04412668|472335420|FG000|Overall Study|Death - multiple comorbidities|2|||
131195666|NCT04412668|472335421|FG001|Overall Study|Death - multiple comorbidities|0|||
131195667|NCT04412668|472335422|FG002|Overall Study|Death - multiple comorbidities|0|||
131195668|NCT04412668|472335420|FG000|Overall Study|Withdrawal by Subject|3|||
131195669|NCT04412668|472335421|FG001|Overall Study|Withdrawal by Subject|0|||
131195670|NCT04412668|472335422|FG002|Overall Study|Withdrawal by Subject|0|||
131195671|NCT04412668|472335420|FG000|Overall Study|Other than Specified|2|||
131195672|NCT04412668|472335421|FG001|Overall Study|Other than Specified|0|||
131195673|NCT04412668|472335422|FG002|Overall Study|Other than Specified|0|||
131195674|NCT03954704|472335425|FG000|Overall Study|Death|1|||
131195675|NCT03954704|472335426|FG001|Overall Study|Death|1|||
131195676|NCT03954704|472335427|FG002|Overall Study|Death|1|||
131195677|NCT03954704|472335428|FG003|Overall Study|Death|3|||
131195678|NCT03954704|472335429|FG004|Overall Study|Death|2|||
131195679|NCT03954704|472335430|FG005|Overall Study|Death|2|||
131195680|NCT03954704|472335431|FG006|Overall Study|Death|0|||
131195681|NCT03954704|472335425|FG000|Overall Study|Withdrew Consent|0|||
131195682|NCT03954704|472335426|FG001|Overall Study|Withdrew Consent|0|||
131195683|NCT03954704|472335427|FG002|Overall Study|Withdrew Consent|1|||
131195684|NCT03954704|472335428|FG003|Overall Study|Withdrew Consent|0|||
131195685|NCT03954704|472335429|FG004|Overall Study|Withdrew Consent|0|||
131195686|NCT03954704|472335430|FG005|Overall Study|Withdrew Consent|1|||
131195687|NCT03954704|472335431|FG006|Overall Study|Withdrew Consent|0|||
131195688|NCT03954704|472335425|FG000|Overall Study|Lost to Follow-up|0|||
131195689|NCT03954704|472335426|FG001|Overall Study|Lost to Follow-up|0|||
131195690|NCT03954704|472335427|FG002|Overall Study|Lost to Follow-up|0|||
131195691|NCT03954704|472335428|FG003|Overall Study|Lost to Follow-up|0|||
131195692|NCT03954704|472335429|FG004|Overall Study|Lost to Follow-up|0|||
131195693|NCT03954704|472335430|FG005|Overall Study|Lost to Follow-up|0|||
131195694|NCT03954704|472335431|FG006|Overall Study|Lost to Follow-up|1|||
131195695|NCT03954704|472335425|FG000|Overall Study|Study Terminated by Sponsor|0|||
131195696|NCT03954704|472335426|FG001|Overall Study|Study Terminated by Sponsor|0|||
131195697|NCT03954704|472335427|FG002|Overall Study|Study Terminated by Sponsor|1|||
131195698|NCT03954704|472335428|FG003|Overall Study|Study Terminated by Sponsor|0|||
131195699|NCT03954704|472335429|FG004|Overall Study|Study Terminated by Sponsor|1|||
131195700|NCT03954704|472335430|FG005|Overall Study|Study Terminated by Sponsor|4|||
131195701|NCT03954704|472335431|FG006|Overall Study|Study Terminated by Sponsor|2|||
131195702|NCT03954704|472335425|FG000|Overall Study|Enrolled but not Treated|0|||
131195703|NCT03954704|472335426|FG001|Overall Study|Enrolled but not Treated|0|||
131195704|NCT03954704|472335427|FG002|Overall Study|Enrolled but not Treated|0|||
131195705|NCT03954704|472335428|FG003|Overall Study|Enrolled but not Treated|0|||
131195706|NCT03954704|472335429|FG004|Overall Study|Enrolled but not Treated|0|||
131195707|NCT03954704|472335430|FG005|Overall Study|Enrolled but not Treated|1|||
131195708|NCT03954704|472335431|FG006|Overall Study|Enrolled but not Treated|0|||
131195709|NCT03695471|472337732|FG000|Overall Study|Cancellation|1|||
131195710|NCT02859558|472337733|FG000|Step 1|Not Eligible|0|||
131195711|NCT02859558|472337734|FG001|Step 1|Not Eligible|0|||
131195712|NCT02859558|472337735|FG002|Step 1|Not Eligible|0|||
131195713|NCT02859558|472337736|FG003|Step 1|Not Eligible|0|||
131195714|NCT02859558|472337737|FG004|Step 1|Not Eligible|3|||
131195715|NCT02859558|472337733|FG000|Step 1|Lost to Follow-up|1|||
131195716|NCT02859558|472337734|FG001|Step 1|Lost to Follow-up|3|||
131195717|NCT02859558|472337735|FG002|Step 1|Lost to Follow-up|3|||
131195718|NCT02859558|472337736|FG003|Step 1|Lost to Follow-up|0|||
131195719|NCT02859558|472337737|FG004|Step 1|Lost to Follow-up|0|||
131195720|NCT02859558|472337733|FG000|Step 1|Did Not Return to Clinic|2|||
130733711|NCT00810511|470642952|FG001|Overall Study|Protocol Violation|1|||
131195721|NCT02859558|472337734|FG001|Step 1|Did Not Return to Clinic|3|||
131195722|NCT02859558|472337735|FG002|Step 1|Did Not Return to Clinic|4|||
131195723|NCT02859558|472337736|FG003|Step 1|Did Not Return to Clinic|0|||
131195724|NCT02859558|472337737|FG004|Step 1|Did Not Return to Clinic|0|||
131195725|NCT02859558|472337733|FG000|Step 1|Moved|0|||
131195726|NCT02859558|472337734|FG001|Step 1|Moved|1|||
131195727|NCT02859558|472337735|FG002|Step 1|Moved|1|||
131195728|NCT02859558|472337736|FG003|Step 1|Moved|0|||
131195729|NCT02859558|472337737|FG004|Step 1|Moved|0|||
131195730|NCT02859558|472337733|FG000|Step 1|Withdrawal By Participant|1|||
131195731|NCT02859558|472337734|FG001|Step 1|Withdrawal By Participant|2|||
131195732|NCT02859558|472337735|FG002|Step 1|Withdrawal By Participant|1|||
131195733|NCT02859558|472337736|FG003|Step 1|Withdrawal By Participant|0|||
131195734|NCT02859558|472337737|FG004|Step 1|Withdrawal By Participant|0|||
131195735|NCT02859558|472337733|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
131195736|NCT02859558|472337734|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
131195737|NCT02859558|472337735|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
131195738|NCT02859558|472337736|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
131195739|NCT02859558|472337737|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
131195740|NCT02859558|472337733|FG000|Step 1|Incarceration|0|||
131195741|NCT02859558|472337734|FG001|Step 1|Incarceration|1|||
131195742|NCT02859558|472337735|FG002|Step 1|Incarceration|0|||
131195743|NCT02859558|472337736|FG003|Step 1|Incarceration|0|||
131195744|NCT02859558|472337737|FG004|Step 1|Incarceration|0|||
131195745|NCT02859558|472337733|FG000|Step 1|Non-Adherence to Study Drug|2|||
131195746|NCT02859558|472337734|FG001|Step 1|Non-Adherence to Study Drug|0|||
131195747|NCT02859558|472337735|FG002|Step 1|Non-Adherence to Study Drug|1|||
131195748|NCT02859558|472337736|FG003|Step 1|Non-Adherence to Study Drug|0|||
131195749|NCT02859558|472337737|FG004|Step 1|Non-Adherence to Study Drug|0|||
131195750|NCT02859558|472337733|FG000|Step 1|Non-Adherence to Study Requirements|3|||
131195751|NCT02859558|472337734|FG001|Step 1|Non-Adherence to Study Requirements|1|||
131195752|NCT02859558|472337735|FG002|Step 1|Non-Adherence to Study Requirements|0|||
131195753|NCT02859558|472337736|FG003|Step 1|Non-Adherence to Study Requirements|0|||
131195754|NCT02859558|472337737|FG004|Step 1|Non-Adherence to Study Requirements|0|||
131195755|NCT02859558|472337733|FG000|Step 1|Virologic Failure|2|||
131195756|NCT02859558|472337734|FG001|Step 1|Virologic Failure|1|||
131195757|NCT02859558|472337735|FG002|Step 1|Virologic Failure|1|||
131195758|NCT02859558|472337736|FG003|Step 1|Virologic Failure|0|||
131195759|NCT02859558|472337737|FG004|Step 1|Virologic Failure|0|||
131195760|NCT02859558|472337733|FG000|Step 2|Lost to Follow-up|3|||
131195761|NCT02859558|472337734|FG001|Step 2|Lost to Follow-up|3|||
131195762|NCT02859558|472337735|FG002|Step 2|Lost to Follow-up|1|||
131195763|NCT02859558|472337736|FG003|Step 2|Lost to Follow-up|0|||
131195764|NCT02859558|472337737|FG004|Step 2|Lost to Follow-up|0|||
131195765|NCT02859558|472337733|FG000|Step 2|Withdrawal by Subject|0|||
131195766|NCT02859558|472337734|FG001|Step 2|Withdrawal by Subject|1|||
131195767|NCT02859558|472337735|FG002|Step 2|Withdrawal by Subject|1|||
131195768|NCT02859558|472337736|FG003|Step 2|Withdrawal by Subject|0|||
131195769|NCT02859558|472337737|FG004|Step 2|Withdrawal by Subject|0|||
131195770|NCT02859558|472337733|FG000|Step 2|Unexpected Closure of Site|0|||
131195771|NCT02859558|472337734|FG001|Step 2|Unexpected Closure of Site|1|||
131195772|NCT02859558|472337735|FG002|Step 2|Unexpected Closure of Site|1|||
131195773|NCT02859558|472337736|FG003|Step 2|Unexpected Closure of Site|0|||
131195774|NCT02859558|472337737|FG004|Step 2|Unexpected Closure of Site|0|||
131195775|NCT02859558|472337733|FG000|Step 2|Death|1|||
131195776|NCT02859558|472337734|FG001|Step 2|Death|0|||
131195777|NCT02859558|472337735|FG002|Step 2|Death|0|||
131195778|NCT02859558|472337736|FG003|Step 2|Death|0|||
131195779|NCT02859558|472337737|FG004|Step 2|Death|0|||
131195780|NCT02859558|472337733|FG000|Step 2|Incarceration|0|||
131195781|NCT02859558|472337734|FG001|Step 2|Incarceration|0|||
131195782|NCT02859558|472337735|FG002|Step 2|Incarceration|1|||
131195783|NCT02859558|472337736|FG003|Step 2|Incarceration|0|||
131195784|NCT02859558|472337737|FG004|Step 2|Incarceration|0|||
131195785|NCT04888507|472337738|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
131195786|NCT00636155|472337739|FG000|Overall Study|Adverse Event|8|||
131195787|NCT00636155|472337739|FG000|Overall Study|Lack of Efficacy|1|||
131195788|NCT00636155|472337739|FG000|Overall Study|Withdrawal by Subject|3|||
131195789|NCT00636155|472337739|FG000|Overall Study|Stem cell transplant|1|||
131195790|NCT00636155|472337739|FG000|Overall Study|Physician Decision|5|||
131195791|NCT00766142|472337740|FG000|Overall Study|Protocol Violation|4|||
131195792|NCT02358863|472337746|FG000|Overall Study|Physician Decision|3|||
131195793|NCT02531633|472337765|FG000|Part A (52 Weeks)|Sponsor request|24|||
131195794|NCT02531633|472337766|FG001|Part A (52 Weeks)|Sponsor request|24|||
131195795|NCT02531633|472337767|FG002|Part A (52 Weeks)|Sponsor request|18|||
131195796|NCT02531633|472337768|FG003|Part A (52 Weeks)|Sponsor request|18|||
131195797|NCT02531633|472337769|FG004|Part A (52 Weeks)|Sponsor request|19|||
131195798|NCT02531633|472337770|FG005|Part A (52 Weeks)|Sponsor request|0|||
131195799|NCT02531633|472337771|FG006|Part A (52 Weeks)|Sponsor request|0|||
131195800|NCT02531633|472337772|FG007|Part A (52 Weeks)|Sponsor request|0|||
131195801|NCT02531633|472337773|FG008|Part A (52 Weeks)|Sponsor request|0|||
131195802|NCT02531633|472337774|FG009|Part A (52 Weeks)|Sponsor request|0|||
131195803|NCT02531633|472337765|FG000|Part A (52 Weeks)|Protocol Violation|1|||
131195804|NCT02531633|472337766|FG001|Part A (52 Weeks)|Protocol Violation|0|||
131195805|NCT02531633|472337767|FG002|Part A (52 Weeks)|Protocol Violation|0|||
131195806|NCT02531633|472337768|FG003|Part A (52 Weeks)|Protocol Violation|0|||
131195807|NCT02531633|472337769|FG004|Part A (52 Weeks)|Protocol Violation|0|||
131195808|NCT02531633|472337770|FG005|Part A (52 Weeks)|Protocol Violation|0|||
131195809|NCT02531633|472337771|FG006|Part A (52 Weeks)|Protocol Violation|0|||
131195810|NCT02531633|472337772|FG007|Part A (52 Weeks)|Protocol Violation|0|||
131195811|NCT02531633|472337773|FG008|Part A (52 Weeks)|Protocol Violation|0|||
131195812|NCT02531633|472337774|FG009|Part A (52 Weeks)|Protocol Violation|0|||
131195813|NCT02531633|472337765|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
131195814|NCT02531633|472337766|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
131195815|NCT02531633|472337767|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
131195816|NCT02531633|472337768|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
131195817|NCT02531633|472337769|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
131195818|NCT02531633|472337770|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
131195819|NCT02531633|472337771|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
131195820|NCT02531633|472337772|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
131195821|NCT02531633|472337773|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
131195822|NCT02531633|472337774|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
131195823|NCT02531633|472337765|FG000|Part A (52 Weeks)|Physician Decision|1|||
131195824|NCT02531633|472337766|FG001|Part A (52 Weeks)|Physician Decision|4|||
131195825|NCT02531633|472337767|FG002|Part A (52 Weeks)|Physician Decision|3|||
131195826|NCT02531633|472337768|FG003|Part A (52 Weeks)|Physician Decision|1|||
131195827|NCT02531633|472337769|FG004|Part A (52 Weeks)|Physician Decision|0|||
131195828|NCT02531633|472337770|FG005|Part A (52 Weeks)|Physician Decision|0|||
131195829|NCT02531633|472337771|FG006|Part A (52 Weeks)|Physician Decision|0|||
131195830|NCT02531633|472337772|FG007|Part A (52 Weeks)|Physician Decision|0|||
131195831|NCT02531633|472337773|FG008|Part A (52 Weeks)|Physician Decision|0|||
131195832|NCT02531633|472337774|FG009|Part A (52 Weeks)|Physician Decision|0|||
131195833|NCT02531633|472337765|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
131195834|NCT02531633|472337766|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
131195835|NCT02531633|472337767|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
131195836|NCT02531633|472337768|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
131195837|NCT02531633|472337769|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
131195838|NCT02531633|472337770|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
131195839|NCT02531633|472337771|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
131195840|NCT02531633|472337772|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
131195841|NCT02531633|472337773|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
131195842|NCT02531633|472337774|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
131195843|NCT02531633|472337765|FG000|Part A (52 Weeks)|Other|2|||
131195844|NCT02531633|472337766|FG001|Part A (52 Weeks)|Other|0|||
131195845|NCT02531633|472337767|FG002|Part A (52 Weeks)|Other|0|||
131195846|NCT02531633|472337768|FG003|Part A (52 Weeks)|Other|0|||
131195847|NCT02531633|472337769|FG004|Part A (52 Weeks)|Other|0|||
131195848|NCT02531633|472337770|FG005|Part A (52 Weeks)|Other|0|||
131195849|NCT02531633|472337771|FG006|Part A (52 Weeks)|Other|0|||
131195850|NCT02531633|472337772|FG007|Part A (52 Weeks)|Other|0|||
131195851|NCT02531633|472337773|FG008|Part A (52 Weeks)|Other|0|||
131195852|NCT02531633|472337774|FG009|Part A (52 Weeks)|Other|0|||
131195853|NCT02531633|472337765|FG000|Part B (104 Weeks)|Sponsor request|0|||
131195854|NCT02531633|472337766|FG001|Part B (104 Weeks)|Sponsor request|0|||
131195855|NCT02531633|472337767|FG002|Part B (104 Weeks)|Sponsor request|0|||
131195856|NCT02531633|472337768|FG003|Part B (104 Weeks)|Sponsor request|0|||
131195857|NCT02531633|472337769|FG004|Part B (104 Weeks)|Sponsor request|0|||
131195858|NCT02531633|472337770|FG005|Part B (104 Weeks)|Sponsor request|8|||
131195859|NCT02531633|472337771|FG006|Part B (104 Weeks)|Sponsor request|5|||
131195860|NCT02531633|472337772|FG007|Part B (104 Weeks)|Sponsor request|3|||
131195861|NCT02531633|472337773|FG008|Part B (104 Weeks)|Sponsor request|5|||
131195862|NCT02531633|472337774|FG009|Part B (104 Weeks)|Sponsor request|4|||
131195863|NCT02531633|472337765|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
131195864|NCT02531633|472337766|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
131195865|NCT02531633|472337767|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
131195866|NCT02531633|472337768|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
131195867|NCT02531633|472337769|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
131195868|NCT02531633|472337770|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
131195869|NCT02531633|472337771|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
131195870|NCT02531633|472337772|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
131195871|NCT02531633|472337773|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
131195872|NCT02531633|472337774|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
131195873|NCT04960202|472337782|FG000|Overall Study|Other|5|||
131195874|NCT04960202|472337783|FG001|Overall Study|Other|0|||
131195875|NCT04960202|472337782|FG000|Overall Study|Withdrawal by Subject|37|||
131195876|NCT04960202|472337783|FG001|Overall Study|Withdrawal by Subject|43|||
131195877|NCT04960202|472337782|FG000|Overall Study|Lost to Follow-up|20|||
131195878|NCT04960202|472337783|FG001|Overall Study|Lost to Follow-up|16|||
131195879|NCT04960202|472337782|FG000|Overall Study|Death|0|||
131195880|NCT04960202|472337783|FG001|Overall Study|Death|15|||
131195881|NCT03558828|472337785|FG000|Overall Study|Lost to Follow-up|4|||
131195882|NCT03558828|472337786|FG001|Overall Study|Lost to Follow-up|3|||
131195883|NCT03558828|472337787|FG002|Overall Study|Lost to Follow-up|3|||
131195884|NCT03558828|472337788|FG003|Overall Study|Lost to Follow-up|5|||
131195885|NCT03558828|472337789|FG004|Overall Study|Lost to Follow-up|2|||
131195886|NCT03558828|472337790|FG005|Overall Study|Lost to Follow-up|3|||
131195887|NCT03558828|472337785|FG000|Overall Study|dropped before the intervention|1|||
131195888|NCT03558828|472337786|FG001|Overall Study|dropped before the intervention|1|||
131195889|NCT03558828|472337787|FG002|Overall Study|dropped before the intervention|0|||
131195890|NCT03558828|472337788|FG003|Overall Study|dropped before the intervention|0|||
131195891|NCT03558828|472337789|FG004|Overall Study|dropped before the intervention|0|||
131195892|NCT03558828|472337790|FG005|Overall Study|dropped before the intervention|0|||
131195893|NCT01852591|472337791|FG000|Overall Study|Withdrawal by Subject|2|||
131195894|NCT01852591|472337791|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
131195895|NCT02974621|472337793|FG000|Overall Study|Didn't receive study treatment|1|||
131195896|NCT02974621|472337794|FG001|Overall Study|Didn't receive study treatment|10|||
131195897|NCT02756845|472337799|FG000|Overall Study|Death|12|||
131195898|NCT02756845|472337800|FG001|Overall Study|Death|2|||
131195899|NCT02756845|472337799|FG000|Overall Study|Withdrawal by Subject|1|||
131195900|NCT02756845|472337800|FG001|Overall Study|Withdrawal by Subject|0|||
131195901|NCT00557323|472337801|FG000|Overall Study|Death|3|||
131195902|NCT00557323|472337801|FG000|Overall Study|Withdrawal by Subject|2|||
131195903|NCT00557323|472337801|FG000|Overall Study|Administrative change|2|||
131195904|NCT03369704|472337807|FG000|Treatment Epoch|technical problems|1|||
131195905|NCT03369704|472337808|FG001|Treatment Epoch|technical problems|0|||
131195906|NCT03369704|472337807|FG000|Treatment Epoch|Protocol Violation|1|||
131195907|NCT03369704|472337808|FG001|Treatment Epoch|Protocol Violation|0|||
131195908|NCT03369704|472337807|FG000|Treatment Epoch|Lost to Follow-up|0|||
131195909|NCT03369704|472337808|FG001|Treatment Epoch|Lost to Follow-up|1|||
131195910|NCT03369704|472337807|FG000|Treatment Epoch|Lack of Efficacy|0|||
131195911|NCT03369704|472337808|FG001|Treatment Epoch|Lack of Efficacy|2|||
131195912|NCT03369704|472337807|FG000|Treatment Epoch|Adverse Event|2|||
131195913|NCT03369704|472337808|FG001|Treatment Epoch|Adverse Event|0|||
131195914|NCT03369704|472337807|FG000|Follow-up Epoch|Lost to Follow-up|1|||
131195915|NCT03369704|472337808|FG001|Follow-up Epoch|Lost to Follow-up|0|||
131195916|NCT01196091|472337809|FG000|Overall Study|Adverse Event|22|||
131195917|NCT01196091|472337810|FG001|Overall Study|Adverse Event|27|||
131195918|NCT01196091|472337811|FG002|Overall Study|Adverse Event|26|||
131195919|NCT01196091|472337809|FG000|Overall Study|Death|3|||
131195920|NCT01196091|472337810|FG001|Overall Study|Death|2|||
131195921|NCT01196091|472337811|FG002|Overall Study|Death|2|||
131195922|NCT01196091|472337809|FG000|Overall Study|Entry Criteria Not Met|11|||
131195923|NCT01196091|472337810|FG001|Overall Study|Entry Criteria Not Met|11|||
131195924|NCT01196091|472337811|FG002|Overall Study|Entry Criteria Not Met|10|||
131195925|NCT01196091|472337809|FG000|Overall Study|Lack of Efficacy|15|||
131195926|NCT01196091|472337810|FG001|Overall Study|Lack of Efficacy|12|||
131195927|NCT01196091|472337811|FG002|Overall Study|Lack of Efficacy|17|||
131195928|NCT01196091|472337809|FG000|Overall Study|Lost to Follow-up|5|||
131195929|NCT01196091|472337810|FG001|Overall Study|Lost to Follow-up|5|||
131195930|NCT01196091|472337811|FG002|Overall Study|Lost to Follow-up|6|||
131195931|NCT01196091|472337809|FG000|Overall Study|Parent/Caregiver Decision|0|||
131195932|NCT01196091|472337810|FG001|Overall Study|Parent/Caregiver Decision|0|||
131195933|NCT01196091|472337811|FG002|Overall Study|Parent/Caregiver Decision|1|||
131195934|NCT01196091|472337809|FG000|Overall Study|Withdrawal by Subject|16|||
131195935|NCT01196091|472337810|FG001|Overall Study|Withdrawal by Subject|19|||
131195936|NCT01196091|472337811|FG002|Overall Study|Withdrawal by Subject|22|||
131195937|NCT01196091|472337809|FG000|Overall Study|Physician Decision|3|||
131195938|NCT01196091|472337810|FG001|Overall Study|Physician Decision|3|||
131195939|NCT01196091|472337811|FG002|Overall Study|Physician Decision|4|||
131195940|NCT01196091|472337809|FG000|Overall Study|Protocol Violation|1|||
131195941|NCT01196091|472337810|FG001|Overall Study|Protocol Violation|3|||
131195942|NCT01196091|472337811|FG002|Overall Study|Protocol Violation|3|||
131195943|NCT01196091|472337809|FG000|Overall Study|Sponsor Decision|6|||
131195944|NCT01196091|472337810|FG001|Overall Study|Sponsor Decision|5|||
131195945|NCT01196091|472337811|FG002|Overall Study|Sponsor Decision|4|||
131195946|NCT01196091|472337809|FG000|Overall Study|Excluded Site|5|||
131195947|NCT01196091|472337810|FG001|Overall Study|Excluded Site|11|||
131195948|NCT01196091|472337811|FG002|Overall Study|Excluded Site|8|||
131195949|NCT01196091|472337809|FG000|Overall Study|Randomized, No Study Drug Received|1|||
131195950|NCT01196091|472337810|FG001|Overall Study|Randomized, No Study Drug Received|0|||
130784618|NCT01103323|470838849|FG001|Without/Before Drug Switch|Protocol Violation|0|||
131195951|NCT01196091|472337811|FG002|Overall Study|Randomized, No Study Drug Received|1|||
131195952|NCT03733249|472337812|FG000|Overall Study|Death|7|||
131195953|NCT03733249|472337812|FG000|Overall Study|Disease relapse|16|||
131195954|NCT03733249|472337812|FG000|Overall Study|Lost to Follow-up|4|||
131195955|NCT03733249|472337812|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
131195956|NCT03733249|472337812|FG000|Overall Study|Withdrawal by Subject|1|||
131195957|NCT04247828|472337821|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
131195958|NCT03797144|472337822|FG000|Enrollment|Protocol Violation|4|||
131195959|NCT03797144|472337823|FG001|Enrollment|Protocol Violation|1|||
131195960|NCT03797144|472337822|FG000|Surgery|Protocol Violation|1|||
131195961|NCT03797144|472337823|FG001|Surgery|Protocol Violation|0|||
131195962|NCT03797144|472337822|FG000|3 Month|Early termination cut-off date|2|||
131195963|NCT03797144|472337823|FG001|3 Month|Early termination cut-off date|0|||
131195964|NCT03797144|472337822|FG000|12 Month|Early termination cut-off date|8|||
131195965|NCT03797144|472337823|FG001|12 Month|Early termination cut-off date|9|||
131195966|NCT03797144|472337822|FG000|24 Month|Early termination cut-off date|1|||
131195967|NCT03797144|472337823|FG001|24 Month|Early termination cut-off date|1|||
131195968|NCT00606229|472337824|FG000|Overall Study|Adverse Event|11|||
131195969|NCT00606229|472337824|FG000|Overall Study|Lack of Efficacy|1|||
131195970|NCT00606229|472337824|FG000|Overall Study|Withdrawal by Subject|4|||
131195971|NCT00606229|472337824|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
131195972|NCT00606229|472337824|FG000|Overall Study|change of residence or other commitments|2|||
131195973|NCT01526928|472337825|FG000|Overall Study|Progressive Disease|35|||
131195974|NCT01526928|472337826|FG001|Overall Study|Progressive Disease|17|||
131195975|NCT01526928|472337827|FG002|Overall Study|Progressive Disease|150|||
131195976|NCT01526928|472337828|FG003|Overall Study|Progressive Disease|182|||
131195977|NCT01526928|472337829|FG004|Overall Study|Progressive Disease|76|||
131195978|NCT01526928|472337830|FG005|Overall Study|Progressive Disease|4|||
131195979|NCT01526928|472337825|FG000|Overall Study|Adverse Event|2|||
131195980|NCT01526928|472337826|FG001|Overall Study|Adverse Event|1|||
131195981|NCT01526928|472337827|FG002|Overall Study|Adverse Event|29|||
131195982|NCT01526928|472337828|FG003|Overall Study|Adverse Event|40|||
131195983|NCT01526928|472337829|FG004|Overall Study|Adverse Event|13|||
131195984|NCT01526928|472337830|FG005|Overall Study|Adverse Event|2|||
131195985|NCT01526928|472337825|FG000|Overall Study|Death|0|||
131195986|NCT01526928|472337826|FG001|Overall Study|Death|0|||
131195987|NCT01526928|472337827|FG002|Overall Study|Death|3|||
131195988|NCT01526928|472337828|FG003|Overall Study|Death|0|||
131195989|NCT01526928|472337829|FG004|Overall Study|Death|0|||
131195990|NCT01526928|472337830|FG005|Overall Study|Death|0|||
131195991|NCT01526928|472337825|FG000|Overall Study|Withdrawal by Subject|1|||
131195992|NCT01526928|472337826|FG001|Overall Study|Withdrawal by Subject|0|||
131195993|NCT01526928|472337827|FG002|Overall Study|Withdrawal by Subject|13|||
131195994|NCT01526928|472337828|FG003|Overall Study|Withdrawal by Subject|11|||
131195995|NCT01526928|472337829|FG004|Overall Study|Withdrawal by Subject|3|||
131195996|NCT01526928|472337830|FG005|Overall Study|Withdrawal by Subject|0|||
131195997|NCT01526928|472337825|FG000|Overall Study|Physician Decision|0|||
131195998|NCT01526928|472337826|FG001|Overall Study|Physician Decision|0|||
131195999|NCT01526928|472337827|FG002|Overall Study|Physician Decision|2|||
131196000|NCT01526928|472337828|FG003|Overall Study|Physician Decision|5|||
131196001|NCT01526928|472337829|FG004|Overall Study|Physician Decision|0|||
131196002|NCT01526928|472337830|FG005|Overall Study|Physician Decision|0|||
131196003|NCT01526928|472337825|FG000|Overall Study|Other Reason|0|||
131196004|NCT01526928|472337826|FG001|Overall Study|Other Reason|1|||
131196005|NCT01526928|472337827|FG002|Overall Study|Other Reason|11|||
131196006|NCT01526928|472337828|FG003|Overall Study|Other Reason|4|||
131196007|NCT01526928|472337829|FG004|Overall Study|Other Reason|1|||
131196008|NCT01526928|472337830|FG005|Overall Study|Other Reason|0|||
131196009|NCT01526928|472337825|FG000|Overall Study|Lost to Follow-up|0|||
131196010|NCT01526928|472337826|FG001|Overall Study|Lost to Follow-up|0|||
131196011|NCT01526928|472337827|FG002|Overall Study|Lost to Follow-up|0|||
131196012|NCT01526928|472337828|FG003|Overall Study|Lost to Follow-up|1|||
131196013|NCT01526928|472337829|FG004|Overall Study|Lost to Follow-up|0|||
131196014|NCT01526928|472337830|FG005|Overall Study|Lost to Follow-up|0|||
131196015|NCT01526928|472337825|FG000|Overall Study|Protocol Deviation|0|||
131196016|NCT01526928|472337826|FG001|Overall Study|Protocol Deviation|0|||
131196017|NCT01526928|472337827|FG002|Overall Study|Protocol Deviation|0|||
131196018|NCT01526928|472337828|FG003|Overall Study|Protocol Deviation|2|||
131196019|NCT01526928|472337829|FG004|Overall Study|Protocol Deviation|0|||
130733712|NCT00810511|470642951|FG000|Overall Study|Lack of Efficacy|9|||
130733713|NCT00810511|470642952|FG001|Overall Study|Lack of Efficacy|1|||
131196020|NCT01526928|472337830|FG005|Overall Study|Protocol Deviation|0|||
131196021|NCT01526928|472337825|FG000|Overall Study|Missing|0|||
131196022|NCT01526928|472337826|FG001|Overall Study|Missing|0|||
131196023|NCT01526928|472337827|FG002|Overall Study|Missing|1|||
131196024|NCT01526928|472337828|FG003|Overall Study|Missing|0|||
131196025|NCT01526928|472337829|FG004|Overall Study|Missing|2|||
131196026|NCT01526928|472337830|FG005|Overall Study|Missing|0|||
131196027|NCT01108068|472337831|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
131196028|NCT01108068|472337832|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
131196029|NCT00836953|472337833|FG000|Overall Study|Withdrawal by Subject|1|||
131196030|NCT00836953|472337833|FG000|Overall Study|Lost to Follow-up|1|||
131196031|NCT00376675|472337834|FG000|Overall Study|Withdrawal by Subject|9|||
131196032|NCT00376675|472337835|FG001|Overall Study|Withdrawal by Subject|2|||
131196033|NCT00376675|472337834|FG000|Overall Study|Adverse Event|10|||
130733714|NCT00810511|470642951|FG000|Overall Study|death in the family|0|||
131196034|NCT00376675|472337835|FG001|Overall Study|Adverse Event|5|||
131196035|NCT00376675|472337834|FG000|Overall Study|Other Reason|1|||
131196036|NCT00376675|472337835|FG001|Overall Study|Other Reason|7|||
131196037|NCT02943668|472337837|FG000|Overall Study|Disease Progression|1|||
131196038|NCT02829775|472337838|FG000|Overall Study|Death|1|||
131196039|NCT02829775|472337838|FG000|Overall Study|Withdrawal by Subject|3|||
131196040|NCT02829775|472337838|FG000|Overall Study|Disease remission|1|||
131196041|NCT01249157|472337839|FG000|Overall Study|Withdrawal by Subject|1|||
131196042|NCT00062647|472337840|FG000|Overall Study|Death|2|||
131196043|NCT00062647|472337841|FG001|Overall Study|Death|2|||
131196044|NCT00062647|472337840|FG000|Overall Study|Adverse Event|1|||
131196045|NCT00062647|472337841|FG001|Overall Study|Adverse Event|1|||
131196046|NCT00062647|472337840|FG000|Overall Study|Withdrawal by Subject|2|||
131196047|NCT00062647|472337841|FG001|Overall Study|Withdrawal by Subject|1|||
131196048|NCT00062647|472337840|FG000|Overall Study|Protocol Violation|1|||
131196049|NCT00062647|472337841|FG001|Overall Study|Protocol Violation|0|||
131196050|NCT00062647|472337840|FG000|Overall Study|Lost to Follow-up|1|||
131196051|NCT00062647|472337841|FG001|Overall Study|Lost to Follow-up|2|||
131196052|NCT00062647|472337840|FG000|Overall Study|Failed continuation criteria|4|||
131196053|NCT00062647|472337841|FG001|Overall Study|Failed continuation criteria|2|||
131196054|NCT00062647|472337840|FG000|Overall Study|Other|4|||
131196055|NCT00062647|472337841|FG001|Overall Study|Other|4|||
131196056|NCT00062647|472337840|FG000|Overall Study|Never received study treatment|1|||
131196057|NCT00062647|472337841|FG001|Overall Study|Never received study treatment|1|||
131196058|NCT02392468|472337849|FG000|Overall Study|Adverse Event|0|||
131196059|NCT02392468|472337850|FG001|Overall Study|Adverse Event|1|||
131196060|NCT02392468|472337851|FG002|Overall Study|Adverse Event|0|||
131196061|NCT02392468|472337852|FG003|Overall Study|Adverse Event|0|||
131196062|NCT02392468|472337853|FG004|Overall Study|Adverse Event|0|||
131196063|NCT02392468|472337854|FG005|Overall Study|Adverse Event|1|||
131196064|NCT01313039|472337855|FG000|Overall Study|Physician Decision|1|||
131196065|NCT01313039|472337855|FG000|Overall Study|Adverse Event|1|||
131196066|NCT05083949|472337858|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
131196067|NCT05083949|472337859|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
131196068|NCT05083949|472337858|FG000|Period 1|Adverse Event|1|||
131196069|NCT05083949|472337859|FG001|Period 1|Adverse Event|1|||
131196070|NCT05083949|472337858|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
131196071|NCT05083949|472337859|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
131196072|NCT05083949|472337858|FG000|Period 2|Adverse Event|0|||
131196073|NCT05083949|472337859|FG001|Period 2|Adverse Event|2|||
131196074|NCT02996500|472337863|FG000|Overall Study|Adverse Event|1|||
131196075|NCT02996500|472337864|FG001|Overall Study|Adverse Event|1|||
131196076|NCT02996500|472337865|FG002|Overall Study|Adverse Event|4|||
131196077|NCT02996500|472337866|FG003|Overall Study|Adverse Event|3|||
131196078|NCT02996500|472337867|FG004|Overall Study|Adverse Event|1|||
131196079|NCT02996500|472337868|FG005|Overall Study|Adverse Event|2|||
131196080|NCT02996500|472337863|FG000|Overall Study|Lack of Efficacy|0|||
131196081|NCT02996500|472337864|FG001|Overall Study|Lack of Efficacy|0|||
131196082|NCT02996500|472337865|FG002|Overall Study|Lack of Efficacy|0|||
131196083|NCT02996500|472337866|FG003|Overall Study|Lack of Efficacy|0|||
131196084|NCT02996500|472337867|FG004|Overall Study|Lack of Efficacy|2|||
131196085|NCT02996500|472337868|FG005|Overall Study|Lack of Efficacy|0|||
131196086|NCT02996500|472337863|FG000|Overall Study|Lost to Follow-up|1|||
131196087|NCT02996500|472337864|FG001|Overall Study|Lost to Follow-up|0|||
131196088|NCT02996500|472337865|FG002|Overall Study|Lost to Follow-up|0|||
131196089|NCT02996500|472337866|FG003|Overall Study|Lost to Follow-up|0|||
131196090|NCT02996500|472337867|FG004|Overall Study|Lost to Follow-up|0|||
131196091|NCT02996500|472337868|FG005|Overall Study|Lost to Follow-up|1|||
131196092|NCT02996500|472337863|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
131196093|NCT02996500|472337864|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
131196094|NCT02996500|472337865|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
130733715|NCT00810511|470642952|FG001|Overall Study|death in the family|1|||
130733716|NCT00810511|470642951|FG000|Overall Study|Lost to Follow-up|1|||
131196095|NCT02996500|472337866|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
131196096|NCT02996500|472337867|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
131196097|NCT02996500|472337868|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
131196098|NCT02996500|472337863|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131196099|NCT02996500|472337864|FG001|Overall Study|Non-Compliance With Study Drug|0|||
131196100|NCT02996500|472337865|FG002|Overall Study|Non-Compliance With Study Drug|0|||
131196101|NCT02996500|472337866|FG003|Overall Study|Non-Compliance With Study Drug|0|||
131196102|NCT02996500|472337867|FG004|Overall Study|Non-Compliance With Study Drug|0|||
131196103|NCT02996500|472337868|FG005|Overall Study|Non-Compliance With Study Drug|1|||
131196104|NCT02996500|472337863|FG000|Overall Study|Progressive Disease|1|||
131196105|NCT02996500|472337864|FG001|Overall Study|Progressive Disease|0|||
131196106|NCT02996500|472337865|FG002|Overall Study|Progressive Disease|0|||
131196107|NCT02996500|472337866|FG003|Overall Study|Progressive Disease|0|||
131196108|NCT02996500|472337867|FG004|Overall Study|Progressive Disease|0|||
131196109|NCT02996500|472337868|FG005|Overall Study|Progressive Disease|0|||
131196110|NCT02996500|472337863|FG000|Overall Study|Other|2|||
131196111|NCT02996500|472337864|FG001|Overall Study|Other|0|||
131196112|NCT02996500|472337865|FG002|Overall Study|Other|2|||
131196113|NCT02996500|472337866|FG003|Overall Study|Other|0|||
131196114|NCT02996500|472337867|FG004|Overall Study|Other|0|||
131196115|NCT02996500|472337868|FG005|Overall Study|Other|0|||
131196116|NCT02996500|472337863|FG000|Overall Study|Protocol Violation|0|||
131196117|NCT02996500|472337864|FG001|Overall Study|Protocol Violation|0|||
131196118|NCT02996500|472337865|FG002|Overall Study|Protocol Violation|0|||
131196119|NCT02996500|472337866|FG003|Overall Study|Protocol Violation|1|||
131196120|NCT02996500|472337867|FG004|Overall Study|Protocol Violation|0|||
131196121|NCT02996500|472337868|FG005|Overall Study|Protocol Violation|0|||
131196122|NCT02996500|472337863|FG000|Overall Study|Withdrawal by Subject|3|||
131196123|NCT02996500|472337864|FG001|Overall Study|Withdrawal by Subject|0|||
131196124|NCT02996500|472337865|FG002|Overall Study|Withdrawal by Subject|3|||
131196125|NCT02996500|472337866|FG003|Overall Study|Withdrawal by Subject|0|||
131196126|NCT02996500|472337867|FG004|Overall Study|Withdrawal by Subject|2|||
131196127|NCT02996500|472337868|FG005|Overall Study|Withdrawal by Subject|0|||
131196128|NCT01678560|472337869|FG000|Overall Study|Physician Decision|4|||
131196129|NCT01678560|472337870|FG001|Overall Study|Physician Decision|4|||
131196130|NCT01678560|472337869|FG000|Overall Study|Death|0|||
131196131|NCT01678560|472337870|FG001|Overall Study|Death|1|||
131196132|NCT01678560|472337869|FG000|Overall Study|Withdrawal by Subject|0|||
131196133|NCT01678560|472337870|FG001|Overall Study|Withdrawal by Subject|1|||
131196134|NCT00322387|472337871|FG000|Treatment Period|Adverse Event|0|||
131196135|NCT00322387|472337872|FG001|Treatment Period|Adverse Event|1|||
131196136|NCT00322387|472337871|FG000|Follow-up Period|Final assessment not done|1|||
131196137|NCT00322387|472337872|FG001|Follow-up Period|Final assessment not done|3|||
131196138|NCT00322387|472337871|FG000|Follow-up Period|Death|1|||
131196139|NCT00322387|472337872|FG001|Follow-up Period|Death|0|||
131196140|NCT00090766|472337873|FG000|Overall Study|Nephrectomy Planned|0|||
131196141|NCT00090766|472337874|FG001|Overall Study|Nephrectomy Planned|0|||
131196142|NCT00090766|472337875|FG002|Overall Study|Nephrectomy Planned|1|||
131196143|NCT00090766|472337873|FG000|Overall Study|Death|1|||
131196144|NCT00090766|472337874|FG001|Overall Study|Death|0|||
131196145|NCT00090766|472337875|FG002|Overall Study|Death|0|||
131196146|NCT00090766|472337873|FG000|Overall Study|Admin|0|||
131196147|NCT00090766|472337874|FG001|Overall Study|Admin|2|||
131196148|NCT00090766|472337875|FG002|Overall Study|Admin|0|||
131196149|NCT00090766|472337873|FG000|Overall Study|Lost to Follow-up|2|||
131196150|NCT00090766|472337874|FG001|Overall Study|Lost to Follow-up|0|||
131196151|NCT00090766|472337875|FG002|Overall Study|Lost to Follow-up|2|||
131196152|NCT00654368|472337882|FG000|Overall Study|Ineligibility determined|6|||
131196153|NCT00654368|472337883|FG001|Overall Study|Ineligibility determined|0|||
131196154|NCT00654368|472337884|FG002|Overall Study|Ineligibility determined|0|||
131196155|NCT00654368|472337882|FG000|Overall Study|Protocol deviation|3|||
131196156|NCT00654368|472337883|FG001|Overall Study|Protocol deviation|2|||
131196157|NCT00654368|472337884|FG002|Overall Study|Protocol deviation|1|||
131196158|NCT00654368|472337882|FG000|Overall Study|Non-compliance|2|||
131196159|NCT00654368|472337883|FG001|Overall Study|Non-compliance|1|||
131196160|NCT00654368|472337884|FG002|Overall Study|Non-compliance|2|||
131196161|NCT00654368|472337882|FG000|Overall Study|Withdrawal by Subject|5|||
131196162|NCT00654368|472337883|FG001|Overall Study|Withdrawal by Subject|2|||
131196163|NCT00654368|472337884|FG002|Overall Study|Withdrawal by Subject|2|||
131196164|NCT00654368|472337882|FG000|Overall Study|Disease progression|21|||
131196165|NCT00654368|472337883|FG001|Overall Study|Disease progression|31|||
131196166|NCT00654368|472337884|FG002|Overall Study|Disease progression|13|||
131196167|NCT00654368|472337882|FG000|Overall Study|Requirement for alternative therapy|1|||
131196168|NCT00654368|472337883|FG001|Overall Study|Requirement for alternative therapy|1|||
131196169|NCT00654368|472337884|FG002|Overall Study|Requirement for alternative therapy|1|||
131196170|NCT00654368|472337882|FG000|Overall Study|Physician Decision|0|||
131196171|NCT00654368|472337883|FG001|Overall Study|Physician Decision|0|||
131196172|NCT00654368|472337884|FG002|Overall Study|Physician Decision|2|||
131196173|NCT00654368|472337882|FG000|Overall Study|Death|1|||
131196174|NCT00654368|472337883|FG001|Overall Study|Death|0|||
131196175|NCT00654368|472337884|FG002|Overall Study|Death|0|||
131196176|NCT00654368|472337882|FG000|Overall Study|Pregnancy|0|||
131196177|NCT00654368|472337883|FG001|Overall Study|Pregnancy|0|||
131196178|NCT00654368|472337884|FG002|Overall Study|Pregnancy|2|||
131196179|NCT00654368|472337882|FG000|Overall Study|Other|0|||
131196180|NCT00654368|472337883|FG001|Overall Study|Other|2|||
131196181|NCT00654368|472337884|FG002|Overall Study|Other|3|||
131196182|NCT00654368|472337882|FG000|Overall Study|Adverse Event|14|||
131196183|NCT00654368|472337883|FG001|Overall Study|Adverse Event|9|||
131196184|NCT00654368|472337884|FG002|Overall Study|Adverse Event|6|||
131196185|NCT00804986|472337885|FG000|Overall Study|Adverse Event|0|||
131196186|NCT00804986|472337886|FG001|Overall Study|Adverse Event|1|||
131196187|NCT00804986|472337887|FG002|Overall Study|Adverse Event|2|||
131196188|NCT00804986|472337888|FG003|Overall Study|Adverse Event|1|||
131196189|NCT00804986|472337889|FG004|Overall Study|Adverse Event|3|||
131196190|NCT00804986|472337890|FG005|Overall Study|Adverse Event|0|||
131196191|NCT00804986|472337885|FG000|Overall Study|Lack of Efficacy|0|||
131196192|NCT00804986|472337886|FG001|Overall Study|Lack of Efficacy|0|||
131196193|NCT00804986|472337887|FG002|Overall Study|Lack of Efficacy|0|||
131196194|NCT00804986|472337888|FG003|Overall Study|Lack of Efficacy|1|||
131196195|NCT00804986|472337889|FG004|Overall Study|Lack of Efficacy|0|||
131196196|NCT00804986|472337890|FG005|Overall Study|Lack of Efficacy|3|||
131196197|NCT00804986|472337885|FG000|Overall Study|Lost to Follow-up|0|||
131196198|NCT00804986|472337886|FG001|Overall Study|Lost to Follow-up|0|||
131196199|NCT00804986|472337887|FG002|Overall Study|Lost to Follow-up|0|||
131196200|NCT00804986|472337888|FG003|Overall Study|Lost to Follow-up|1|||
131196201|NCT00804986|472337889|FG004|Overall Study|Lost to Follow-up|1|||
131196202|NCT00804986|472337890|FG005|Overall Study|Lost to Follow-up|3|||
131196203|NCT00804986|472337885|FG000|Overall Study|Protocol Violation|0|||
131196204|NCT00804986|472337886|FG001|Overall Study|Protocol Violation|1|||
131196205|NCT00804986|472337887|FG002|Overall Study|Protocol Violation|0|||
131196206|NCT00804986|472337888|FG003|Overall Study|Protocol Violation|1|||
131196207|NCT00804986|472337889|FG004|Overall Study|Protocol Violation|0|||
131196208|NCT00804986|472337890|FG005|Overall Study|Protocol Violation|0|||
131196209|NCT00804986|472337885|FG000|Overall Study|Withdrawal by Subject|0|||
131196210|NCT00804986|472337886|FG001|Overall Study|Withdrawal by Subject|3|||
131196211|NCT00804986|472337887|FG002|Overall Study|Withdrawal by Subject|0|||
131196212|NCT00804986|472337888|FG003|Overall Study|Withdrawal by Subject|3|||
131196213|NCT00804986|472337889|FG004|Overall Study|Withdrawal by Subject|5|||
131196214|NCT00804986|472337890|FG005|Overall Study|Withdrawal by Subject|3|||
131196215|NCT00804986|472337885|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
131196216|NCT00804986|472337886|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
130733717|NCT00810511|470642952|FG001|Overall Study|Lost to Follow-up|0|||
130733718|NCT00810511|470642951|FG000|Overall Study|deposits on contact lens|0|||
131196217|NCT00804986|472337887|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
131196218|NCT00804986|472337888|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
131196219|NCT00804986|472337889|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
131196220|NCT00804986|472337890|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
131196221|NCT00804986|472337885|FG000|Overall Study|Sponsor Decision|0|||
131196222|NCT00804986|472337886|FG001|Overall Study|Sponsor Decision|1|||
131196223|NCT00804986|472337887|FG002|Overall Study|Sponsor Decision|0|||
131196224|NCT00804986|472337888|FG003|Overall Study|Sponsor Decision|0|||
131196225|NCT00804986|472337889|FG004|Overall Study|Sponsor Decision|0|||
131196226|NCT00804986|472337890|FG005|Overall Study|Sponsor Decision|0|||
131196227|NCT00804986|472337885|FG000|Overall Study|Physician Decision|1|||
131196228|NCT00804986|472337886|FG001|Overall Study|Physician Decision|0|||
131196229|NCT00804986|472337887|FG002|Overall Study|Physician Decision|0|||
131196230|NCT00804986|472337888|FG003|Overall Study|Physician Decision|0|||
131196231|NCT00804986|472337889|FG004|Overall Study|Physician Decision|0|||
131196232|NCT00804986|472337890|FG005|Overall Study|Physician Decision|0|||
131196233|NCT00959699|472337895|FG000|Treatment Period|Adverse Event|3|||
131196234|NCT00959699|472337896|FG001|Treatment Period|Adverse Event|13|||
131196235|NCT00959699|472337895|FG000|Treatment Period|Lack of Efficacy|15|||
131196236|NCT00959699|472337896|FG001|Treatment Period|Lack of Efficacy|6|||
131196237|NCT00959699|472337895|FG000|Treatment Period|Lost to Follow-up|0|||
131196238|NCT00959699|472337896|FG001|Treatment Period|Lost to Follow-up|1|||
131196239|NCT00959699|472337895|FG000|Treatment Period|Withdrawal by Subject|1|||
131196240|NCT00959699|472337896|FG001|Treatment Period|Withdrawal by Subject|3|||
131196241|NCT00959699|472337895|FG000|Treatment Period|Non-Compliance with Protocol|0|||
131196242|NCT00959699|472337896|FG001|Treatment Period|Non-Compliance with Protocol|1|||
131196243|NCT00959699|472337895|FG000|Treatment Period|Did not receive treatment|0|||
131196244|NCT00959699|472337896|FG001|Treatment Period|Did not receive treatment|1|||
131196245|NCT00959699|472337895|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
131196246|NCT00959699|472337896|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
131196247|NCT00959699|472337895|FG000|Follow-up Period|Lost to Follow-up|3|||
131196248|NCT00959699|472337896|FG001|Follow-up Period|Lost to Follow-up|2|||
131196249|NCT00959699|472337895|FG000|Follow-up Period|Withdrawal by Subject|3|||
131196250|NCT00959699|472337896|FG001|Follow-up Period|Withdrawal by Subject|4|||
131196251|NCT04228445|472337899|FG000|Overall Study|Lost to Follow-up|1|||
131196252|NCT04228445|472337900|FG001|Overall Study|Lost to Follow-up|1|||
131196253|NCT04228445|472337899|FG000|Overall Study|Physician Decision|1|||
131196254|NCT04228445|472337900|FG001|Overall Study|Physician Decision|2|||
131196255|NCT04228445|472337899|FG000|Overall Study|Withdrawal by Subject|0|||
131196256|NCT04228445|472337900|FG001|Overall Study|Withdrawal by Subject|1|||
131196257|NCT04228445|472337899|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
131196258|NCT04228445|472337900|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
131196259|NCT00606294|472337901|FG000|Overall Study|Withdrawal by Subject|36|||
131196260|NCT00606294|472337902|FG001|Overall Study|Withdrawal by Subject|0|||
131196261|NCT01316380|472337903|FG000|Overall Study|Adverse Event|0|||
131196262|NCT01316380|472337904|FG001|Overall Study|Adverse Event|2|||
131196263|NCT01316380|472337905|FG002|Overall Study|Adverse Event|1|||
131196264|NCT01316380|472337903|FG000|Overall Study|Protocol Violation|0|||
131196265|NCT01316380|472337904|FG001|Overall Study|Protocol Violation|0|||
131196266|NCT01316380|472337905|FG002|Overall Study|Protocol Violation|1|||
131196267|NCT01316380|472337903|FG000|Overall Study|Withdrawal by Subject|1|||
131196268|NCT01316380|472337904|FG001|Overall Study|Withdrawal by Subject|2|||
131196269|NCT01316380|472337905|FG002|Overall Study|Withdrawal by Subject|0|||
131196270|NCT01316380|472337903|FG000|Overall Study|Other|0|||
131196271|NCT01316380|472337904|FG001|Overall Study|Other|1|||
131196272|NCT01316380|472337905|FG002|Overall Study|Other|1|||
131196273|NCT01316380|472337903|FG000|Overall Study|Not treated|1|||
131196274|NCT01316380|472337904|FG001|Overall Study|Not treated|0|||
131196275|NCT01316380|472337905|FG002|Overall Study|Not treated|0|||
131196276|NCT00112840|472337906|FG000|Overall Study|Physician Decision|1|||
131196277|NCT00112840|472337907|FG001|Overall Study|Physician Decision|0|||
131196278|NCT00112840|472337908|FG002|Overall Study|Physician Decision|0|||
131196279|NCT00112840|472337906|FG000|Overall Study|Withdrawal by Subject|1|||
131196280|NCT00112840|472337907|FG001|Overall Study|Withdrawal by Subject|0|||
131196281|NCT00112840|472337908|FG002|Overall Study|Withdrawal by Subject|1|||
131196282|NCT00112840|472337906|FG000|Overall Study|Protocol Violation|0|||
131196283|NCT00112840|472337907|FG001|Overall Study|Protocol Violation|0|||
131196284|NCT00112840|472337908|FG002|Overall Study|Protocol Violation|5|||
131196285|NCT00397891|472337909|FG000|Overall Study|Withdrawal by Subject|1|||
131196286|NCT00397891|472337910|FG001|Overall Study|Withdrawal by Subject|0|||
131196287|NCT00397891|472337911|FG002|Overall Study|Withdrawal by Subject|0|||
131196288|NCT00397891|472337912|FG003|Overall Study|Withdrawal by Subject|0|||
131196289|NCT00397891|472337913|FG004|Overall Study|Withdrawal by Subject|1|||
131196290|NCT02632344|472339273|FG000|Overall Study|Adverse Event|3|||
131196291|NCT02632344|472339273|FG000|Overall Study|Lack of Efficacy|3|||
131196292|NCT02632344|472339273|FG000|Overall Study|Withdrawal by Subject|2|||
131196293|NCT04076579|472339275|FG000|Overall Study|Adverse Event|2|||
131196294|NCT04076579|472339276|FG001|Overall Study|Adverse Event|0|||
131196295|NCT04076579|472339275|FG000|Overall Study|discontinued due to toxicity|1|||
131196296|NCT04076579|472339276|FG001|Overall Study|discontinued due to toxicity|0|||
131196297|NCT04076579|472339275|FG000|Overall Study|Physician Decision|1|||
131196298|NCT04076579|472339276|FG001|Overall Study|Physician Decision|0|||
131196299|NCT04076579|472339275|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
131196300|NCT04076579|472339276|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
131196301|NCT04076579|472339275|FG000|Overall Study|Noncompliance|0|||
131196302|NCT04076579|472339276|FG001|Overall Study|Noncompliance|1|||
131196303|NCT04076579|472339275|FG000|Overall Study|Withdrawal by Subject|0|||
131196304|NCT04076579|472339276|FG001|Overall Study|Withdrawal by Subject|2|||
131196305|NCT03793010|472339277|FG000|Overall Study|Withdrawal by Subject|5|||
131196306|NCT03793010|472339278|FG001|Overall Study|Withdrawal by Subject|7|||
131196307|NCT03793010|472339277|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
131196308|NCT03793010|472339278|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
131196309|NCT03793010|472339277|FG000|Overall Study|Lost to Follow-up|1|||
131196310|NCT03793010|472339278|FG001|Overall Study|Lost to Follow-up|2|||
131196311|NCT03793010|472339277|FG000|Overall Study|Patient couldn't sit still for injection|1|||
131196312|NCT03793010|472339278|FG001|Overall Study|Patient couldn't sit still for injection|0|||
131196313|NCT03793010|472339277|FG000|Overall Study|Withdrew to pursue other treatment|1|||
131196314|NCT03793010|472339278|FG001|Overall Study|Withdrew to pursue other treatment|0|||
131196315|NCT03793010|472339277|FG000|Overall Study|Did not meet eligibility criteria|1|||
131196316|NCT03793010|472339278|FG001|Overall Study|Did not meet eligibility criteria|0|||
131196317|NCT02903966|472339279|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
131196318|NCT02903966|472339280|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
131196319|NCT02903966|472339279|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
131196320|NCT02903966|472339280|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
131196321|NCT02903966|472339279|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
131196322|NCT02903966|472339280|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
131196323|NCT04924114|472339281|FG000|Overall Study|Withdrawal by Subject|0|||
131196324|NCT04924114|472339282|FG001|Overall Study|Withdrawal by Subject|2|||
131196325|NCT04924114|472339283|FG002|Overall Study|Withdrawal by Subject|2|||
131196326|NCT04924114|472339284|FG003|Overall Study|Withdrawal by Subject|0|||
131196327|NCT04924114|472339285|FG004|Overall Study|Withdrawal by Subject|2|||
131196328|NCT04423718|472339286|FG000|Main Study|Adverse Event|9|||
131196329|NCT04423718|472339287|FG001|Main Study|Adverse Event|5|||
131196330|NCT04423718|472339288|FG002|Main Study|Adverse Event|8|||
131196331|NCT04423718|472339286|FG000|Main Study|Physician Decision|3|||
131196332|NCT04423718|472339287|FG001|Main Study|Physician Decision|3|||
131196333|NCT04423718|472339288|FG002|Main Study|Physician Decision|2|||
131196334|NCT04423718|472339286|FG000|Main Study|Protocol Violation|0|||
131196335|NCT04423718|472339287|FG001|Main Study|Protocol Violation|0|||
131196336|NCT04423718|472339288|FG002|Main Study|Protocol Violation|1|||
131196337|NCT04423718|472339286|FG000|Main Study|Lost to Follow-up|3|||
131196338|NCT04423718|472339287|FG001|Main Study|Lost to Follow-up|3|||
131196339|NCT04423718|472339288|FG002|Main Study|Lost to Follow-up|4|||
131196340|NCT04423718|472339286|FG000|Main Study|Lack of Efficacy|2|||
131196341|NCT04423718|472339287|FG001|Main Study|Lack of Efficacy|1|||
131196342|NCT04423718|472339288|FG002|Main Study|Lack of Efficacy|0|||
131196343|NCT04423718|472339286|FG000|Main Study|Withdrawal by Subject|14|||
131196344|NCT04423718|472339287|FG001|Main Study|Withdrawal by Subject|20|||
131196345|NCT04423718|472339288|FG002|Main Study|Withdrawal by Subject|20|||
131196346|NCT04423718|472339286|FG000|Main Study|Death|10|||
131196347|NCT04423718|472339287|FG001|Main Study|Death|7|||
131196348|NCT04423718|472339288|FG002|Main Study|Death|7|||
131196349|NCT04423718|472339286|FG000|Main Study|COVID-19 pandemic|2|||
131196350|NCT04423718|472339287|FG001|Main Study|COVID-19 pandemic|2|||
131196351|NCT04423718|472339288|FG002|Main Study|COVID-19 pandemic|2|||
131196352|NCT04423718|472339286|FG000|Main Study|Other|7|||
131196353|NCT04423718|472339287|FG001|Main Study|Other|3|||
131196354|NCT04423718|472339288|FG002|Main Study|Other|2|||
131196355|NCT04423718|472339286|FG000|Extension Phase|Other|1|||
131196356|NCT04423718|472339287|FG001|Extension Phase|Other|0|||
131196357|NCT04423718|472339288|FG002|Extension Phase|Other|0|||
131196358|NCT04423718|472339286|FG000|Extension Phase|Logistical problems|0|||
131196359|NCT04423718|472339287|FG001|Extension Phase|Logistical problems|1|||
131196360|NCT04423718|472339288|FG002|Extension Phase|Logistical problems|1|||
131196361|NCT04423718|472339286|FG000|Extension Phase|Physician Decision|1|||
131196362|NCT04423718|472339287|FG001|Extension Phase|Physician Decision|0|||
131196363|NCT04423718|472339288|FG002|Extension Phase|Physician Decision|1|||
131196364|NCT04423718|472339286|FG000|Extension Phase|Lack of Efficacy|2|||
131196365|NCT04423718|472339287|FG001|Extension Phase|Lack of Efficacy|0|||
131196366|NCT04423718|472339288|FG002|Extension Phase|Lack of Efficacy|1|||
130733719|NCT00810511|470642952|FG001|Overall Study|deposits on contact lens|1|||
131196367|NCT04423718|472339286|FG000|Extension Phase|Lost to Follow-up|0|||
131196368|NCT04423718|472339287|FG001|Extension Phase|Lost to Follow-up|2|||
131196369|NCT04423718|472339288|FG002|Extension Phase|Lost to Follow-up|3|||
131196370|NCT04423718|472339286|FG000|Extension Phase|Adverse Event|2|||
130733720|NCT04759703|470642958|FG000|Overall Study|Withdrawal by Subject|4|||
130733721|NCT04759703|470642959|FG001|Overall Study|Withdrawal by Subject|9|||
130733722|NCT04759703|470642958|FG000|Overall Study|Adverse Event|1|||
130733723|NCT04759703|470642959|FG001|Overall Study|Adverse Event|0|||
131196371|NCT04423718|472339287|FG001|Extension Phase|Adverse Event|3|||
131196372|NCT04423718|472339288|FG002|Extension Phase|Adverse Event|1|||
131196373|NCT04423718|472339286|FG000|Extension Phase|Death|4|||
131196374|NCT04423718|472339287|FG001|Extension Phase|Death|7|||
131196375|NCT04423718|472339288|FG002|Extension Phase|Death|2|||
131196376|NCT04423718|472339286|FG000|Extension Phase|Withdrawal by Subject|11|||
131196377|NCT04423718|472339287|FG001|Extension Phase|Withdrawal by Subject|11|||
131196378|NCT04423718|472339288|FG002|Extension Phase|Withdrawal by Subject|7|||
131196379|NCT00425945|472339289|FG000|Overall Study|Concern about Supplement|2|||
131196380|NCT00425945|472339290|FG001|Overall Study|Concern about Supplement|0|||
131196381|NCT00425945|472339289|FG000|Overall Study|Inconvenience|0|||
131196382|NCT00425945|472339290|FG001|Overall Study|Inconvenience|2|||
131196383|NCT00425945|472339289|FG000|Overall Study|Lost to Follow-up|0|||
131196384|NCT00425945|472339290|FG001|Overall Study|Lost to Follow-up|2|||
131196385|NCT00425945|472339289|FG000|Overall Study|Began hypertension medication|1|||
131196386|NCT00425945|472339290|FG001|Overall Study|Began hypertension medication|0|||
131196387|NCT00425945|472339289|FG000|Overall Study|Began cancer treatments|1|||
131196388|NCT00425945|472339290|FG001|Overall Study|Began cancer treatments|0|||
131196389|NCT00425945|472339289|FG000|Overall Study|Moved from area|0|||
131196390|NCT00425945|472339290|FG001|Overall Study|Moved from area|1|||
131196391|NCT02881151|472339291|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
131196392|NCT04284787|472339292|FG000|Overall Study|Disease Progression|9|||
131196393|NCT04284787|472339293|FG001|Overall Study|Disease Progression|12|||
131196394|NCT04284787|472339292|FG000|Overall Study|Physician Decision|12|||
131196395|NCT04284787|472339293|FG001|Overall Study|Physician Decision|7|||
131196396|NCT04284787|472339292|FG000|Overall Study|Transplant|5|||
131196397|NCT04284787|472339293|FG001|Overall Study|Transplant|4|||
131196398|NCT04284787|472339292|FG000|Overall Study|Death|1|||
131196399|NCT04284787|472339293|FG001|Overall Study|Death|2|||
131196400|NCT04284787|472339292|FG000|Overall Study|Adverse Event|0|||
131196401|NCT04284787|472339293|FG001|Overall Study|Adverse Event|4|||
131196402|NCT04284787|472339292|FG000|Overall Study|Non-adherence|2|||
131196403|NCT04284787|472339293|FG001|Overall Study|Non-adherence|0|||
131196404|NCT04284787|472339292|FG000|Overall Study|Lack of Efficacy|2|||
131196405|NCT04284787|472339293|FG001|Overall Study|Lack of Efficacy|0|||
131196406|NCT04992507|472339296|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
131196407|NCT04992507|472339297|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
131196408|NCT04992507|472339296|FG000|Overall Study|Death|0|||
131196409|NCT04992507|472339297|FG001|Overall Study|Death|1|||
131196410|NCT03287830|472339298|FG000|Overall Study|Withdrawal by Subject|1|||
131196411|NCT03287830|472339299|FG001|Overall Study|Withdrawal by Subject|1|||
131196412|NCT03287830|472339298|FG000|Overall Study|not meeting inclusion criteria|5|||
131196413|NCT03287830|472339299|FG001|Overall Study|not meeting inclusion criteria|12|||
131196414|NCT02136134|472339300|FG000|Overall Study|Death|170|||
131196415|NCT02136134|472339301|FG001|Overall Study|Death|148|||
131196416|NCT02136134|472339300|FG000|Overall Study|Withdrawal by Subject|19|||
131196417|NCT02136134|472339301|FG001|Overall Study|Withdrawal by Subject|10|||
131196418|NCT02136134|472339300|FG000|Overall Study|Lost to Follow-up|3|||
131196419|NCT02136134|472339301|FG001|Overall Study|Lost to Follow-up|3|||
131196420|NCT02136134|472339300|FG000|Overall Study|Uspecified|55|||
131196421|NCT02136134|472339301|FG001|Overall Study|Uspecified|90|||
131196422|NCT03070119|472339304|FG000|Overall Study|Adverse Event|0|||
131196423|NCT03070119|472339305|FG001|Overall Study|Adverse Event|0|||
131196424|NCT03070119|472339306|FG002|Overall Study|Adverse Event|1|||
131196425|NCT03070119|472339304|FG000|Overall Study|Lost to Follow-up|0|||
131196426|NCT03070119|472339305|FG001|Overall Study|Lost to Follow-up|1|||
131196427|NCT03070119|472339306|FG002|Overall Study|Lost to Follow-up|0|||
131196428|NCT03070119|472339304|FG000|Overall Study|Consent Withdrawn|6|||
131196429|NCT03070119|472339305|FG001|Overall Study|Consent Withdrawn|5|||
131196430|NCT03070119|472339306|FG002|Overall Study|Consent Withdrawn|3|||
131196431|NCT03070119|472339304|FG000|Overall Study|Investigator Decision|0|||
131196432|NCT03070119|472339305|FG001|Overall Study|Investigator Decision|0|||
131196433|NCT03070119|472339306|FG002|Overall Study|Investigator Decision|1|||
131196434|NCT03070119|472339304|FG000|Overall Study|Death|7|||
131196435|NCT03070119|472339305|FG001|Overall Study|Death|14|||
131196436|NCT03070119|472339306|FG002|Overall Study|Death|5|||
131196437|NCT03070119|472339304|FG000|Overall Study|Disease Progression|5|||
131196438|NCT03070119|472339305|FG001|Overall Study|Disease Progression|7|||
130733724|NCT04759703|470642958|FG000|Overall Study|Lost to Follow-up|2|||
131196439|NCT03070119|472339306|FG002|Overall Study|Disease Progression|7|||
131196440|NCT03070119|472339304|FG000|Overall Study|Reason not Specified|2|||
131196441|NCT03070119|472339305|FG001|Overall Study|Reason not Specified|2|||
131196442|NCT03070119|472339306|FG002|Overall Study|Reason not Specified|1|||
131196443|NCT00732472|472339307|FG000|Overall Study|Adverse Event|0|||
131196444|NCT00732472|472339308|FG001|Overall Study|Adverse Event|1|||
131196445|NCT00732472|472339309|FG002|Overall Study|Adverse Event|1|||
131196446|NCT00732472|472339310|FG003|Overall Study|Adverse Event|1|||
131196447|NCT00732472|472339307|FG000|Overall Study|Protocol Violation|0|||
131196448|NCT00732472|472339308|FG001|Overall Study|Protocol Violation|0|||
131196449|NCT00732472|472339309|FG002|Overall Study|Protocol Violation|0|||
131196450|NCT00732472|472339310|FG003|Overall Study|Protocol Violation|1|||
131196451|NCT00732472|472339307|FG000|Overall Study|Withdrawal by Subject|0|||
131196452|NCT00732472|472339308|FG001|Overall Study|Withdrawal by Subject|2|||
131196453|NCT00732472|472339309|FG002|Overall Study|Withdrawal by Subject|0|||
131196454|NCT00732472|472339310|FG003|Overall Study|Withdrawal by Subject|1|||
131196455|NCT00772889|472339312|FG000|Overall Study|Adverse Event|7|||
131196456|NCT00772889|472339313|FG001|Overall Study|Adverse Event|4|||
131196457|NCT00772889|472339314|FG002|Overall Study|Adverse Event|0|||
131196458|NCT00772889|472339312|FG000|Overall Study|Withdrawal by Subject|9|||
131196459|NCT00772889|472339313|FG001|Overall Study|Withdrawal by Subject|8|||
131196460|NCT00772889|472339314|FG002|Overall Study|Withdrawal by Subject|9|||
131196461|NCT00772889|472339312|FG000|Overall Study|Lost to Follow-up|6|||
131196462|NCT00772889|472339313|FG001|Overall Study|Lost to Follow-up|6|||
131196463|NCT00772889|472339314|FG002|Overall Study|Lost to Follow-up|7|||
131196464|NCT03323086|472339315|FG000|Overall Study|Lost to Follow-up|3|||
131196465|NCT03323086|472339316|FG001|Overall Study|Lost to Follow-up|2|||
131196466|NCT00355615|472339317|FG000|Randomized Double Blind Period|Adverse Event|1|||
131196467|NCT00355615|472339318|FG001|Randomized Double Blind Period|Adverse Event|0|||
131196468|NCT00355615|472339319|FG002|Randomized Double Blind Period|Adverse Event|0|||
131196469|NCT00355615|472339320|FG003|Randomized Double Blind Period|Adverse Event|0|||
131196470|NCT00355615|472339321|FG004|Randomized Double Blind Period|Adverse Event|0|||
131196471|NCT00355615|472339317|FG000|Randomized Double Blind Period|Protocol Violation|0|||
131196472|NCT00355615|472339318|FG001|Randomized Double Blind Period|Protocol Violation|0|||
131196473|NCT00355615|472339319|FG002|Randomized Double Blind Period|Protocol Violation|1|||
131196474|NCT00355615|472339320|FG003|Randomized Double Blind Period|Protocol Violation|1|||
131196475|NCT00355615|472339321|FG004|Randomized Double Blind Period|Protocol Violation|0|||
131196476|NCT00355615|472339317|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
131196477|NCT00355615|472339318|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
131196478|NCT00355615|472339319|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
131196479|NCT00355615|472339320|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
131196480|NCT00355615|472339321|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
131196481|NCT00355615|472339317|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
131196482|NCT00355615|472339318|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
131196483|NCT00355615|472339319|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
131196484|NCT00355615|472339320|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
131196485|NCT00355615|472339321|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
131196486|NCT00355615|472339317|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
131196487|NCT00355615|472339318|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
131196488|NCT00355615|472339319|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
131196489|NCT00355615|472339320|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
131196490|NCT00355615|472339321|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
131196491|NCT00355615|472339317|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
131196492|NCT00355615|472339318|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
131196493|NCT00355615|472339319|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
131196494|NCT00355615|472339320|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
131196495|NCT00355615|472339321|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
131196496|NCT02159365|472339322|FG000|Overall Study|Disease Progression|23|||
131196497|NCT02159365|472339322|FG000|Overall Study|Other reasons|11|||
131196498|NCT02159365|472339322|FG000|Overall Study|Administrative reason by Sponsor|9|||
131196499|NCT02159365|472339322|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
131196500|NCT02159365|472339322|FG000|Overall Study|Study drug toxicity|7|||
131196501|NCT02159365|472339322|FG000|Overall Study|Maximum clinical benefit|3|||
131196502|NCT02159365|472339322|FG000|Overall Study|Subject request to discontinue treatment|3|||
131196503|NCT02159365|472339322|FG000|Overall Study|Subject withdrew consent|3|||
131196504|NCT02159365|472339322|FG000|Overall Study|Death|1|||
131196505|NCT02159365|472339322|FG000|Overall Study|Lost to Follow-up|1|||
131196506|NCT00796549|472339323|FG000|Overall Study|Adverse Event|11|||
131196507|NCT00796549|472339323|FG000|Overall Study|not entered|149|||
131196508|NCT00796549|472339323|FG000|Overall Study|Other|2|||
131196509|NCT00796549|472339323|FG000|Overall Study|Progressive disease|56|||
131196510|NCT01878175|472339325|FG000|Overall Study|Developed contraindicated health problem|2|||
131196511|NCT03523715|472339326|FG000|Overall Study|Lost to Follow-up|11|||
131196512|NCT03523715|472339327|FG001|Overall Study|Lost to Follow-up|14|||
131196513|NCT03523715|472339326|FG000|Overall Study|Did not meet inclusion criteria|1|||
131196514|NCT03523715|472339327|FG001|Overall Study|Did not meet inclusion criteria|0|||
131196515|NCT03523715|472339326|FG000|Overall Study|Internally inconsistent reporting|0|||
131196516|NCT03523715|472339327|FG001|Overall Study|Internally inconsistent reporting|2|||
131196517|NCT04430036|472339328|FG000|Safety Run in Phase|Progression of disease|2|||
131196518|NCT01842334|472339329|FG000|Overall Study|Withdrawal by Subject|3|||
131196519|NCT01842334|472339330|FG001|Overall Study|Withdrawal by Subject|3|||
131196520|NCT01842334|472339329|FG000|Overall Study|Moved away mid-study|0|||
131196521|NCT01842334|472339330|FG001|Overall Study|Moved away mid-study|1|||
131196522|NCT00707486|472339339|FG000|Overall Study|Withdrawal by Subject|1|||
131196523|NCT02774291|472339347|FG000|Overall Study|Lost to Follow-up|1|||
131196524|NCT02332876|472339348|FG000|Overall Study|Lost to Follow-up|1|||
131196525|NCT02332876|472339349|FG001|Overall Study|Lost to Follow-up|1|||
131196526|NCT02415595|472339350|FG000|Overall Study|Administrative reason by sponsor|39|||
131196527|NCT02415595|472339351|FG001|Overall Study|Administrative reason by sponsor|40|||
131196528|NCT02415595|472339352|FG002|Overall Study|Administrative reason by sponsor|41|||
131196529|NCT02415595|472339353|FG003|Overall Study|Administrative reason by sponsor|39|||
131196530|NCT02415595|472339350|FG000|Overall Study|Adverse Event|1|||
131196531|NCT02415595|472339351|FG001|Overall Study|Adverse Event|3|||
131196532|NCT02415595|472339352|FG002|Overall Study|Adverse Event|5|||
131196533|NCT02415595|472339353|FG003|Overall Study|Adverse Event|10|||
131196534|NCT02415595|472339350|FG000|Overall Study|Lack of Efficacy|4|||
131196535|NCT02415595|472339351|FG001|Overall Study|Lack of Efficacy|4|||
131196536|NCT02415595|472339352|FG002|Overall Study|Lack of Efficacy|0|||
131196537|NCT02415595|472339353|FG003|Overall Study|Lack of Efficacy|0|||
131196538|NCT02415595|472339350|FG000|Overall Study|Lost to Follow-up|1|||
131196539|NCT02415595|472339351|FG001|Overall Study|Lost to Follow-up|3|||
131196540|NCT02415595|472339352|FG002|Overall Study|Lost to Follow-up|1|||
131196541|NCT02415595|472339353|FG003|Overall Study|Lost to Follow-up|1|||
131196542|NCT02415595|472339350|FG000|Overall Study|Poor/Non-compliance|1|||
131196543|NCT02415595|472339351|FG001|Overall Study|Poor/Non-compliance|0|||
131196544|NCT02415595|472339352|FG002|Overall Study|Poor/Non-compliance|1|||
131196545|NCT02415595|472339353|FG003|Overall Study|Poor/Non-compliance|0|||
131196546|NCT02415595|472339350|FG000|Overall Study|Reached stopping criteria|0|||
131196547|NCT02415595|472339351|FG001|Overall Study|Reached stopping criteria|1|||
131196548|NCT02415595|472339352|FG002|Overall Study|Reached stopping criteria|1|||
131196549|NCT02415595|472339353|FG003|Overall Study|Reached stopping criteria|0|||
131196550|NCT02415595|472339350|FG000|Overall Study|Withdrawal by Subject|4|||
131196551|NCT02415595|472339351|FG001|Overall Study|Withdrawal by Subject|0|||
131196552|NCT02415595|472339352|FG002|Overall Study|Withdrawal by Subject|1|||
131196553|NCT02415595|472339353|FG003|Overall Study|Withdrawal by Subject|3|||
131196554|NCT02415595|472339350|FG000|Overall Study|Other|0|||
131196555|NCT02415595|472339351|FG001|Overall Study|Other|1|||
131196556|NCT02415595|472339352|FG002|Overall Study|Other|1|||
131196557|NCT02415595|472339353|FG003|Overall Study|Other|0|||
131196558|NCT00471315|472339354|FG000|Overall Study|Adverse Event|7|||
131196559|NCT00471315|472339354|FG000|Overall Study|Withdrawal by Subject|1|||
131196560|NCT02614261|472339355|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
131196561|NCT02614261|472339356|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
131196562|NCT02614261|472339357|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
131196563|NCT02614261|472339358|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
131196564|NCT02614261|472339355|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
131196565|NCT02614261|472339356|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
131196566|NCT02614261|472339357|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
131196567|NCT02614261|472339358|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
131196568|NCT02614261|472339355|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
131196569|NCT02614261|472339356|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
131196570|NCT02614261|472339357|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
131196571|NCT02614261|472339358|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
131196572|NCT02614261|472339355|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
131196573|NCT02614261|472339356|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
131196574|NCT02614261|472339357|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
131196575|NCT02614261|472339358|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
131196576|NCT02614261|472339355|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
131196577|NCT02614261|472339356|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
131196578|NCT02614261|472339357|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
131196579|NCT02614261|472339358|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
131196580|NCT02614261|472339355|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
131196581|NCT02614261|472339356|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
131196582|NCT02614261|472339357|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
130784619|NCT01103323|470838848|FG000|Without/Before Drug Switch|Physician Decision|2|||
130784620|NCT01103323|470838849|FG001|Without/Before Drug Switch|Physician Decision|0|||
130784621|NCT01103323|470838848|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
131196583|NCT02614261|472339358|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
131196584|NCT02614261|472339355|FG000|Double-Blind Treatment Phase|Screen failure|0|||
131196585|NCT02614261|472339356|FG001|Double-Blind Treatment Phase|Screen failure|1|||
131196586|NCT02614261|472339357|FG002|Double-Blind Treatment Phase|Screen failure|2|||
131196587|NCT02614261|472339358|FG003|Double-Blind Treatment Phase|Screen failure|0|||
131196588|NCT02614261|472339355|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
131196589|NCT02614261|472339356|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
131196590|NCT02614261|472339357|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
131196591|NCT02614261|472339358|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
131196592|NCT02614261|472339355|FG000|Open-Label Extension Phase|Adverse Event|23|||
131196593|NCT02614261|472339356|FG001|Open-Label Extension Phase|Adverse Event|12|||
131196594|NCT02614261|472339357|FG002|Open-Label Extension Phase|Adverse Event|11|||
131196595|NCT02614261|472339358|FG003|Open-Label Extension Phase|Adverse Event|0|||
131196596|NCT02614261|472339355|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
131196597|NCT02614261|472339356|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
131196598|NCT02614261|472339357|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
131196599|NCT02614261|472339358|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
131196600|NCT02614261|472339355|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
131196601|NCT02614261|472339356|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
131196602|NCT02614261|472339357|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
131196603|NCT02614261|472339358|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
131196604|NCT02614261|472339355|FG000|Open-Label Extension Phase|Physician Decision|2|||
131196605|NCT02614261|472339356|FG001|Open-Label Extension Phase|Physician Decision|0|||
131196606|NCT02614261|472339357|FG002|Open-Label Extension Phase|Physician Decision|0|||
131196607|NCT02614261|472339358|FG003|Open-Label Extension Phase|Physician Decision|0|||
131196608|NCT02614261|472339355|FG000|Open-Label Extension Phase|Pregnancy|1|||
131196609|NCT02614261|472339356|FG001|Open-Label Extension Phase|Pregnancy|2|||
131196610|NCT02614261|472339357|FG002|Open-Label Extension Phase|Pregnancy|1|||
131196611|NCT02614261|472339358|FG003|Open-Label Extension Phase|Pregnancy|0|||
131196612|NCT02614261|472339355|FG000|Open-Label Extension Phase|Protocol Violation|3|||
131196613|NCT02614261|472339356|FG001|Open-Label Extension Phase|Protocol Violation|4|||
131196614|NCT02614261|472339357|FG002|Open-Label Extension Phase|Protocol Violation|1|||
131196615|NCT02614261|472339358|FG003|Open-Label Extension Phase|Protocol Violation|0|||
131196616|NCT02614261|472339355|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
131196617|NCT02614261|472339356|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
131196618|NCT02614261|472339357|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
131196619|NCT02614261|472339358|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
131196620|NCT02614261|472339355|FG000|Follow-up Phase|Adverse Event|2|||
131196621|NCT02614261|472339356|FG001|Follow-up Phase|Adverse Event|0|||
131196622|NCT02614261|472339357|FG002|Follow-up Phase|Adverse Event|1|||
131196623|NCT02614261|472339358|FG003|Follow-up Phase|Adverse Event|0|||
131196624|NCT02614261|472339355|FG000|Follow-up Phase|Lost to Follow-up|12|||
131196625|NCT02614261|472339356|FG001|Follow-up Phase|Lost to Follow-up|5|||
131196626|NCT02614261|472339357|FG002|Follow-up Phase|Lost to Follow-up|2|||
131196627|NCT02614261|472339358|FG003|Follow-up Phase|Lost to Follow-up|0|||
131196628|NCT02614261|472339355|FG000|Follow-up Phase|Physician Decision|5|||
131196629|NCT02614261|472339356|FG001|Follow-up Phase|Physician Decision|1|||
131196630|NCT02614261|472339357|FG002|Follow-up Phase|Physician Decision|0|||
131196631|NCT02614261|472339358|FG003|Follow-up Phase|Physician Decision|0|||
131196632|NCT02614261|472339355|FG000|Follow-up Phase|Pregnancy|0|||
131196633|NCT02614261|472339356|FG001|Follow-up Phase|Pregnancy|1|||
131196634|NCT02614261|472339357|FG002|Follow-up Phase|Pregnancy|0|||
131196635|NCT02614261|472339358|FG003|Follow-up Phase|Pregnancy|0|||
131196636|NCT02614261|472339355|FG000|Follow-up Phase|Protocol Violation|1|||
131196637|NCT02614261|472339356|FG001|Follow-up Phase|Protocol Violation|0|||
131196638|NCT02614261|472339357|FG002|Follow-up Phase|Protocol Violation|0|||
131196639|NCT02614261|472339358|FG003|Follow-up Phase|Protocol Violation|0|||
131196640|NCT02614261|472339355|FG000|Follow-up Phase|Withdrawal by Subject|12|||
131196641|NCT02614261|472339356|FG001|Follow-up Phase|Withdrawal by Subject|4|||
131196642|NCT02614261|472339357|FG002|Follow-up Phase|Withdrawal by Subject|11|||
131196643|NCT02614261|472339358|FG003|Follow-up Phase|Withdrawal by Subject|0|||
131196644|NCT02614261|472339355|FG000|Israel Addendum|Withdrawal by Subject|0|||
131196645|NCT02614261|472339356|FG001|Israel Addendum|Withdrawal by Subject|0|||
131196646|NCT02614261|472339357|FG002|Israel Addendum|Withdrawal by Subject|0|||
131196647|NCT02614261|472339358|FG003|Israel Addendum|Withdrawal by Subject|4|||
131196648|NCT03512275|472339363|FG000|Overall Study|Withdrawal by Subject|1|||
131196649|NCT03512275|472339364|FG001|Overall Study|Withdrawal by Subject|3|||
131196650|NCT03512275|472339363|FG000|Overall Study|Physician Decision|0|||
131196651|NCT03512275|472339364|FG001|Overall Study|Physician Decision|1|||
131196652|NCT03512275|472339363|FG000|Overall Study|Lost to Follow-up|0|||
131196653|NCT03512275|472339364|FG001|Overall Study|Lost to Follow-up|3|||
131196654|NCT03512275|472339363|FG000|Overall Study|Other|1|||
131196655|NCT03512275|472339364|FG001|Overall Study|Other|0|||
131196656|NCT00609167|472339365|FG000|Overall Study|Withdrawal by Subject|1|||
131196657|NCT00609167|472339366|FG001|Overall Study|Withdrawal by Subject|0|||
131196658|NCT00609167|472339365|FG000|Overall Study|Lack of Efficacy|1|||
131196659|NCT00609167|472339366|FG001|Overall Study|Lack of Efficacy|0|||
131196660|NCT00609167|472339365|FG000|Overall Study|Adverse Event|5|||
131196661|NCT00609167|472339366|FG001|Overall Study|Adverse Event|1|||
131196662|NCT00609167|472339365|FG000|Overall Study|Disease Progression|1|||
131196663|NCT00609167|472339366|FG001|Overall Study|Disease Progression|0|||
131196664|NCT00609167|472339365|FG000|Overall Study|Stem Cell Transplant|0|||
131196665|NCT00609167|472339366|FG001|Overall Study|Stem Cell Transplant|6|||
131196666|NCT03898323|472339367|FG000|Overall Study|Physician Decision|1|||
131196667|NCT00712270|472339369|FG000|Overall Study|Withdrawal by Subject|11|||
131196668|NCT00712270|472339369|FG000|Overall Study|Screen Failure|3|||
131196669|NCT02574520|472339370|FG000|Overall Study|Not dosed|2|||
131196670|NCT02574520|472339371|FG001|Overall Study|Not dosed|0|||
131196671|NCT02574520|472339372|FG002|Overall Study|Not dosed|5|||
131196672|NCT02574520|472339373|FG003|Overall Study|Not dosed|4|||
131196673|NCT02574520|472339370|FG000|Overall Study|Adverse Event|0|||
131196674|NCT02574520|472339371|FG001|Overall Study|Adverse Event|0|||
131196675|NCT02574520|472339372|FG002|Overall Study|Adverse Event|0|||
131196676|NCT02574520|472339373|FG003|Overall Study|Adverse Event|1|||
131196677|NCT02574520|472339370|FG000|Overall Study|Withdrawal by Subject|0|||
131196678|NCT02574520|472339371|FG001|Overall Study|Withdrawal by Subject|0|||
131196679|NCT02574520|472339372|FG002|Overall Study|Withdrawal by Subject|0|||
131196680|NCT02574520|472339373|FG003|Overall Study|Withdrawal by Subject|1|||
131196681|NCT02574520|472339370|FG000|Overall Study|Other|0|||
131196682|NCT02574520|472339371|FG001|Overall Study|Other|0|||
131196683|NCT02574520|472339372|FG002|Overall Study|Other|0|||
131196684|NCT02574520|472339373|FG003|Overall Study|Other|2|||
131196685|NCT00691054|472339381|FG000|Overall Study|Withdrawal by Subject|1|||
131196686|NCT03595176|472339382|FG000|Overall Study|Death|0|||
131196687|NCT03595176|472339383|FG001|Overall Study|Death|2|||
131196688|NCT03595176|472339382|FG000|Overall Study|Lost to Follow-up|0|||
131196689|NCT03595176|472339383|FG001|Overall Study|Lost to Follow-up|1|||
131196690|NCT01868594|472339384|FG000|Overall Study|Do not meet inclusion criteria|4|||
131196691|NCT01868594|472339385|FG001|Overall Study|Do not meet inclusion criteria|3|||
131196692|NCT04964557|472339388|FG000|Overall Study|Withdrawal by Subject|3|||
131196693|NCT04964557|472339389|FG001|Overall Study|Withdrawal by Subject|2|||
131196694|NCT04964557|472339388|FG000|Overall Study|Lost to Follow-up|1|||
131196695|NCT04964557|472339389|FG001|Overall Study|Lost to Follow-up|2|||
131196696|NCT04964557|472339388|FG000|Overall Study|Physician Decision|2|||
131196697|NCT04964557|472339389|FG001|Overall Study|Physician Decision|0|||
131196698|NCT04964557|472339388|FG000|Overall Study|Death|3|||
131196699|NCT04964557|472339389|FG001|Overall Study|Death|0|||
131196700|NCT04964557|472339388|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
131196701|NCT04964557|472339389|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
131196702|NCT02659098|472339390|FG000|Overall Study|Withdrawal by Subject|7|||
131196703|NCT04363944|472339391|FG000|Overall Study|Withdrawal by Subject|2|||
131196704|NCT04363944|472339392|FG001|Overall Study|Withdrawal by Subject|0|||
131196705|NCT03258593|472341286|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
131196706|NCT03258593|472341287|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
131196707|NCT03258593|472341288|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
131196708|NCT03258593|472341289|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
131196709|NCT03258593|472341286|FG000|Run-In Maintenance Phase|Disease progression|3|||
131196710|NCT03258593|472341287|FG001|Run-In Maintenance Phase|Disease progression|0|||
131196711|NCT03258593|472341288|FG002|Run-In Maintenance Phase|Disease progression|0|||
131196712|NCT03258593|472341289|FG003|Run-In Maintenance Phase|Disease progression|0|||
131196713|NCT03258593|472341286|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
131196714|NCT03258593|472341287|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
131196715|NCT03258593|472341288|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
131196716|NCT03258593|472341289|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
131196717|NCT03258593|472341286|FG000|Expansion Maintenance Phase|Physician Decision|0|||
131196718|NCT03258593|472341287|FG001|Expansion Maintenance Phase|Physician Decision|1|||
131196719|NCT03258593|472341288|FG002|Expansion Maintenance Phase|Physician Decision|0|||
131196720|NCT03258593|472341289|FG003|Expansion Maintenance Phase|Physician Decision|0|||
131196721|NCT05318183|472341293|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
131196722|NCT05318183|472341294|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
131196723|NCT05318183|472341293|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
131196724|NCT05318183|472341294|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
131196725|NCT03657576|472341295|FG000|Overall Study|Death|0|||
131196726|NCT03657576|472341296|FG001|Overall Study|Death|1|||
131196727|NCT03657576|472341297|FG002|Overall Study|Death|1|||
131196728|NCT03657576|472341298|FG003|Overall Study|Death|0|||
131196729|NCT03657576|472341299|FG004|Overall Study|Death|0|||
131196730|NCT03657576|472341300|FG005|Overall Study|Death|0|||
131196731|NCT03657576|472341295|FG000|Overall Study|Withdrawal by Subject|0|||
131196732|NCT03657576|472341296|FG001|Overall Study|Withdrawal by Subject|0|||
131196733|NCT03657576|472341297|FG002|Overall Study|Withdrawal by Subject|0|||
131196734|NCT03657576|472341298|FG003|Overall Study|Withdrawal by Subject|1|||
131196735|NCT03657576|472341299|FG004|Overall Study|Withdrawal by Subject|0|||
131196736|NCT03657576|472341300|FG005|Overall Study|Withdrawal by Subject|0|||
131196737|NCT03657576|472341295|FG000|Overall Study|Screen Fail|0|||
131196738|NCT03657576|472341296|FG001|Overall Study|Screen Fail|0|||
130733725|NCT04759703|470642959|FG001|Overall Study|Lost to Follow-up|0|||
130733726|NCT04186845|470642960|FG000|Overall Study|Death|2|||
131196739|NCT03657576|472341297|FG002|Overall Study|Screen Fail|0|||
131196740|NCT03657576|472341298|FG003|Overall Study|Screen Fail|0|||
131196741|NCT03657576|472341299|FG004|Overall Study|Screen Fail|0|||
131196742|NCT03657576|472341300|FG005|Overall Study|Screen Fail|5|||
131196743|NCT03657576|472341295|FG000|Overall Study|Disease Progression|1|||
130733727|NCT04186845|470642960|FG000|Overall Study|Lost to Follow-up|1|||
131196744|NCT03657576|472341296|FG001|Overall Study|Disease Progression|1|||
131196745|NCT03657576|472341297|FG002|Overall Study|Disease Progression|0|||
131196746|NCT03657576|472341298|FG003|Overall Study|Disease Progression|5|||
131196747|NCT03657576|472341299|FG004|Overall Study|Disease Progression|0|||
131196748|NCT03657576|472341300|FG005|Overall Study|Disease Progression|0|||
131196749|NCT03657576|472341295|FG000|Overall Study|Insurance Coverage|0|||
131196750|NCT03657576|472341296|FG001|Overall Study|Insurance Coverage|0|||
131196751|NCT03657576|472341297|FG002|Overall Study|Insurance Coverage|0|||
131196752|NCT03657576|472341298|FG003|Overall Study|Insurance Coverage|1|||
131196753|NCT03657576|472341299|FG004|Overall Study|Insurance Coverage|0|||
131196754|NCT03657576|472341300|FG005|Overall Study|Insurance Coverage|0|||
131196755|NCT03381274|472341303|FG000|Overall Study|Death|2|||
131196756|NCT03381274|472341304|FG001|Overall Study|Death|9|||
131196757|NCT03381274|472341305|FG002|Overall Study|Death|3|||
131196758|NCT03381274|472341306|FG003|Overall Study|Death|2|||
131196759|NCT03381274|472341307|FG004|Overall Study|Death|3|||
131196760|NCT03381274|472341303|FG000|Overall Study|Lost to Follow-up|0|||
131196761|NCT03381274|472341304|FG001|Overall Study|Lost to Follow-up|0|||
131196762|NCT03381274|472341305|FG002|Overall Study|Lost to Follow-up|0|||
131196763|NCT03381274|472341306|FG003|Overall Study|Lost to Follow-up|1|||
131196764|NCT03381274|472341307|FG004|Overall Study|Lost to Follow-up|0|||
131196765|NCT03381274|472341303|FG000|Overall Study|Withdrawal by Subject|2|||
131196766|NCT03381274|472341304|FG001|Overall Study|Withdrawal by Subject|1|||
131196767|NCT03381274|472341305|FG002|Overall Study|Withdrawal by Subject|3|||
131196768|NCT03381274|472341306|FG003|Overall Study|Withdrawal by Subject|1|||
131196769|NCT03381274|472341307|FG004|Overall Study|Withdrawal by Subject|0|||
131196770|NCT03381274|472341303|FG000|Overall Study|Other|1|||
131196771|NCT03381274|472341304|FG001|Overall Study|Other|11|||
131196772|NCT03381274|472341305|FG002|Overall Study|Other|0|||
131196773|NCT03381274|472341306|FG003|Overall Study|Other|2|||
131196774|NCT03381274|472341307|FG004|Overall Study|Other|2|||
131196775|NCT01874353|472341308|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
131196776|NCT01874353|472341309|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
131196777|NCT01874353|472341310|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
131196778|NCT01874353|472341311|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
131196779|NCT01874353|472341308|FG000|Overall Study|Lost to Follow-up|2|||
131196780|NCT01874353|472341309|FG001|Overall Study|Lost to Follow-up|2|||
131196781|NCT01874353|472341310|FG002|Overall Study|Lost to Follow-up|2|||
131196782|NCT01874353|472341311|FG003|Overall Study|Lost to Follow-up|0|||
130733728|NCT04186845|470642960|FG000|Overall Study|Physician Decision|1|||
131196783|NCT01874353|472341308|FG000|Overall Study|Death|110|||
131196784|NCT01874353|472341309|FG001|Overall Study|Death|60|||
131196785|NCT01874353|472341310|FG002|Overall Study|Death|13|||
131196786|NCT01874353|472341311|FG003|Overall Study|Death|7|||
131196787|NCT01874353|472341308|FG000|Overall Study|Withdrawal by Subject|13|||
131196788|NCT01874353|472341309|FG001|Overall Study|Withdrawal by Subject|11|||
131196789|NCT01874353|472341310|FG002|Overall Study|Withdrawal by Subject|0|||
131196790|NCT01874353|472341311|FG003|Overall Study|Withdrawal by Subject|0|||
131196791|NCT04392154|472341312|FG000|Overall Study|Adverse Event|3|||
131196792|NCT04392154|472341313|FG001|Overall Study|Adverse Event|46|||
130733729|NCT04186845|470642960|FG000|Overall Study|Protocol Violation|1|||
130733730|NCT04186845|470642960|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
131196793|NCT04392154|472341312|FG000|Overall Study|Due to epidemic/pandemic|0|||
131196794|NCT04392154|472341313|FG001|Overall Study|Due to epidemic/pandemic|1|||
131196795|NCT04392154|472341312|FG000|Overall Study|Lack of Efficacy|1|||
131196796|NCT04392154|472341313|FG001|Overall Study|Lack of Efficacy|47|||
131196797|NCT04392154|472341312|FG000|Overall Study|Lost to Follow-up|11|||
131196798|NCT04392154|472341313|FG001|Overall Study|Lost to Follow-up|61|||
131196799|NCT04392154|472341312|FG000|Overall Study|Geopolitical conflict|1|||
131196800|NCT04392154|472341313|FG001|Overall Study|Geopolitical conflict|1|||
131196801|NCT04392154|472341312|FG000|Overall Study|Physician Decision|1|||
131196802|NCT04392154|472341313|FG001|Overall Study|Physician Decision|5|||
131196803|NCT04392154|472341312|FG000|Overall Study|Pregnancy|1|||
131196804|NCT04392154|472341313|FG001|Overall Study|Pregnancy|8|||
131196805|NCT04392154|472341312|FG000|Overall Study|Protocol deviation|1|||
131196806|NCT04392154|472341313|FG001|Overall Study|Protocol deviation|12|||
131196807|NCT04392154|472341312|FG000|Overall Study|Withdrawal by Subject|18|||
131196808|NCT04392154|472341313|FG001|Overall Study|Withdrawal by Subject|138|||
131196809|NCT04392154|472341312|FG000|Overall Study|Sponsor Decision|1|||
131196810|NCT04392154|472341313|FG001|Overall Study|Sponsor Decision|14|||
131196811|NCT04392154|472341312|FG000|Overall Study|Site Closure|0|||
131196812|NCT04392154|472341313|FG001|Overall Study|Site Closure|4|||
131196813|NCT04517253|472341316|FG000|Primary Treatment Period|Adverse Event|1|||
131196814|NCT04517253|472341317|FG001|Primary Treatment Period|Adverse Event|0|||
131196815|NCT04517253|472341318|FG002|Primary Treatment Period|Adverse Event|0|||
131196816|NCT04517253|472341316|FG000|Primary Treatment Period|Death|0|||
131196817|NCT04517253|472341317|FG001|Primary Treatment Period|Death|1|||
131196818|NCT04517253|472341318|FG002|Primary Treatment Period|Death|0|||
131196819|NCT04517253|472341316|FG000|Maintenance Period|Withdrawal by Subject|1|||
131196820|NCT04517253|472341317|FG001|Maintenance Period|Withdrawal by Subject|0|||
131196821|NCT04517253|472341318|FG002|Maintenance Period|Withdrawal by Subject|0|||
131196822|NCT04517253|472341316|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
131196823|NCT04517253|472341317|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
131196824|NCT04517253|472341318|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
131196825|NCT06048367|472341323|FG000|Overall Study|Withdrawal by Subject|0|||
131196826|NCT06048367|472341324|FG001|Overall Study|Withdrawal by Subject|1|||
131196827|NCT06048367|472341325|FG002|Overall Study|Withdrawal by Subject|0|||
131196828|NCT06048367|472341326|FG003|Overall Study|Withdrawal by Subject|0|||
131196829|NCT06048367|472341327|FG004|Overall Study|Withdrawal by Subject|0|||
131196830|NCT06048367|472341323|FG000|Overall Study|Withdrawal by Subject|0|||
131196831|NCT06048367|472341324|FG001|Overall Study|Withdrawal by Subject|0|||
131196832|NCT06048367|472341325|FG002|Overall Study|Withdrawal by Subject|1|||
131196833|NCT06048367|472341326|FG003|Overall Study|Withdrawal by Subject|0|||
131196834|NCT06048367|472341327|FG004|Overall Study|Withdrawal by Subject|0|||
131196835|NCT06048367|472341323|FG000|Overall Study|Withdrawal by Subject|0|||
131196836|NCT06048367|472341324|FG001|Overall Study|Withdrawal by Subject|0|||
131196837|NCT06048367|472341325|FG002|Overall Study|Withdrawal by Subject|0|||
131196838|NCT06048367|472341326|FG003|Overall Study|Withdrawal by Subject|1|||
131196839|NCT06048367|472341327|FG004|Overall Study|Withdrawal by Subject|0|||
131196840|NCT06048367|472341323|FG000|Overall Study|Withdrawal by Subject|0|||
131196841|NCT06048367|472341324|FG001|Overall Study|Withdrawal by Subject|0|||
131196842|NCT06048367|472341325|FG002|Overall Study|Withdrawal by Subject|0|||
131196843|NCT06048367|472341326|FG003|Overall Study|Withdrawal by Subject|1|||
131196844|NCT06048367|472341327|FG004|Overall Study|Withdrawal by Subject|0|||
131196845|NCT01327573|472341328|FG000|Overall Study|Physician Decision|3|||
131196846|NCT01327573|472341329|FG001|Overall Study|Physician Decision|1|||
131196847|NCT01058395|472341330|FG000|Overall Study|Death|2|||
131196848|NCT01058395|472341331|FG001|Overall Study|Death|1|||
131196849|NCT01058395|472341330|FG000|Overall Study|Lost to Follow-up|1|||
131196850|NCT01058395|472341331|FG001|Overall Study|Lost to Follow-up|0|||
131196851|NCT01266876|472341332|FG000|Overall Study|Adverse Event|0|||
131196852|NCT01266876|472341333|FG001|Overall Study|Adverse Event|0|||
131196853|NCT01266876|472341334|FG002|Overall Study|Adverse Event|0|||
131196854|NCT01266876|472341335|FG003|Overall Study|Adverse Event|1|||
131196855|NCT01266876|472341336|FG004|Overall Study|Adverse Event|0|||
131196856|NCT05180721|472341337|FG000|Overall Study|Lost to Follow-up|4|||
130733731|NCT04186845|470642960|FG000|Overall Study|Biopsy ordered but not done|1|||
131196857|NCT01996865|472341339|FG000|Induction Period|Protocol Violation|1|||
131196858|NCT01996865|472341340|FG001|Induction Period|Protocol Violation|0|||
131196859|NCT01996865|472341341|FG002|Induction Period|Protocol Violation|0|||
131196860|NCT01996865|472341339|FG000|Induction Period|Progressive Disease|4|||
131196861|NCT01996865|472341340|FG001|Induction Period|Progressive Disease|0|||
131196862|NCT01996865|472341341|FG002|Induction Period|Progressive Disease|0|||
131196863|NCT01996865|472341339|FG000|Induction Period|Lost to Follow-up|10|||
131196864|NCT01996865|472341340|FG001|Induction Period|Lost to Follow-up|0|||
131196865|NCT01996865|472341341|FG002|Induction Period|Lost to Follow-up|0|||
131196866|NCT01996865|472341339|FG000|Induction Period|Other Reasons|13|||
131196867|NCT01996865|472341340|FG001|Induction Period|Other Reasons|0|||
131196868|NCT01996865|472341341|FG002|Induction Period|Other Reasons|0|||
131196869|NCT01996865|472341339|FG000|Induction Period|Adverse Event|20|||
131196870|NCT01996865|472341340|FG001|Induction Period|Adverse Event|0|||
131196871|NCT01996865|472341341|FG002|Induction Period|Adverse Event|0|||
131196872|NCT01996865|472341339|FG000|Induction Period|Withdrawal by Subject|60|||
131196873|NCT01996865|472341340|FG001|Induction Period|Withdrawal by Subject|0|||
131196874|NCT01996865|472341341|FG002|Induction Period|Withdrawal by Subject|0|||
131196875|NCT01996865|472341339|FG000|Induction Period|Death|111|||
131196876|NCT01996865|472341340|FG001|Induction Period|Death|0|||
131196877|NCT01996865|472341341|FG002|Induction Period|Death|0|||
131196878|NCT01996865|472341339|FG000|Maintenance Period|Protocol Violation|0|||
131196879|NCT01996865|472341340|FG001|Maintenance Period|Protocol Violation|1|||
131196880|NCT01996865|472341341|FG002|Maintenance Period|Protocol Violation|1|||
131196881|NCT01996865|472341339|FG000|Maintenance Period|Other reasons|0|||
131196882|NCT01996865|472341340|FG001|Maintenance Period|Other reasons|8|||
131196883|NCT01996865|472341341|FG002|Maintenance Period|Other reasons|5|||
131196884|NCT01996865|472341339|FG000|Maintenance Period|Progressive Disease|0|||
131196885|NCT01996865|472341340|FG001|Maintenance Period|Progressive Disease|6|||
131196886|NCT01996865|472341341|FG002|Maintenance Period|Progressive Disease|23|||
131196887|NCT01996865|472341339|FG000|Maintenance Period|Withdrawal by Subject|0|||
131196888|NCT01996865|472341340|FG001|Maintenance Period|Withdrawal by Subject|18|||
131196889|NCT01996865|472341341|FG002|Maintenance Period|Withdrawal by Subject|4|||
131196890|NCT01996865|472341339|FG000|Maintenance Period|Adverse Event|0|||
131196891|NCT01996865|472341340|FG001|Maintenance Period|Adverse Event|7|||
131196892|NCT01996865|472341341|FG002|Maintenance Period|Adverse Event|7|||
131196893|NCT01996865|472341339|FG000|Maintenance Period|Death|0|||
131196894|NCT01996865|472341340|FG001|Maintenance Period|Death|15|||
131196895|NCT01996865|472341341|FG002|Maintenance Period|Death|3|||
131196896|NCT01996865|472341339|FG000|Maintenance Period|Lost to Follow-up|0|||
131196897|NCT01996865|472341340|FG001|Maintenance Period|Lost to Follow-up|2|||
131196898|NCT01996865|472341341|FG002|Maintenance Period|Lost to Follow-up|0|||
131196927|NCT03575351|472341348|FG000|Overall Study|Adverse Event|1|||
131196928|NCT03575351|472341349|FG001|Overall Study|Adverse Event|0|||
131196929|NCT03575351|472341348|FG000|Overall Study|Death|2|||
131196930|NCT03575351|472341349|FG001|Overall Study|Death|2|||
131196931|NCT03575351|472341348|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
131196932|NCT03575351|472341349|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
131196933|NCT03575351|472341348|FG000|Overall Study|Lack of Efficacy|28|||
131196934|NCT03575351|472341349|FG001|Overall Study|Lack of Efficacy|0|||
131196935|NCT03575351|472341348|FG000|Overall Study|Withdrawal by Subject|1|||
131196936|NCT03575351|472341349|FG001|Overall Study|Withdrawal by Subject|1|||
131196937|NCT03575351|472341348|FG000|Overall Study|Physician Decision|3|||
131196938|NCT03575351|472341349|FG001|Overall Study|Physician Decision|0|||
131196939|NCT03575351|472341348|FG000|Overall Study|Disease relapse|15|||
131196940|NCT03575351|472341349|FG001|Overall Study|Disease relapse|6|||
131196941|NCT03575351|472341348|FG000|Overall Study|Study drug manufacturing failure|0|||
131196942|NCT03575351|472341349|FG001|Overall Study|Study drug manufacturing failure|1|||
131196943|NCT03575351|472341348|FG000|Overall Study|other reasons|5|||
131196944|NCT03575351|472341349|FG001|Overall Study|other reasons|0|||
131196945|NCT04288089|472341355|FG000|Overall Study|Ongoing Treatment|2|||
131196946|NCT04288089|472341356|FG001|Overall Study|Ongoing Treatment|1|||
131196947|NCT04288089|472341357|FG002|Overall Study|Ongoing Treatment|1|||
131196948|NCT04288089|472341358|FG003|Overall Study|Ongoing Treatment|4|||
131196949|NCT03715205|472341359|FG000|Overall Study|Death|13|||
131196950|NCT03715205|472341359|FG000|Overall Study|Lost to Follow-up|2|||
131196951|NCT03715205|472341359|FG000|Overall Study|Physician Decision|93|||
131196952|NCT03715205|472341359|FG000|Overall Study|Withdrawal by Subject|26|||
131196953|NCT05245071|472341360|FG000|Overall Study|Progressive disease|18|||
131196954|NCT05245071|472341360|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
131196955|NCT05245071|472341360|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
131196956|NCT05304611|472341361|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
131196957|NCT05304611|472341362|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
131196958|NCT05304611|472341363|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
131196959|NCT05304611|472341364|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
131196960|NCT05304611|472341365|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
131196961|NCT05304611|472341366|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
131196962|NCT05304611|472341367|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
131196963|NCT05304611|472341368|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
131196964|NCT05304611|472341369|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
131196965|NCT05304611|472341370|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
131196966|NCT05304611|472341371|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
131196967|NCT05304611|472341372|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
131196968|NCT05304611|472341361|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
131196969|NCT05304611|472341362|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
131196970|NCT05304611|472341363|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
131196971|NCT05304611|472341364|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
131196972|NCT05304611|472341365|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
131196973|NCT05304611|472341366|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
131196974|NCT05304611|472341367|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
131196975|NCT05304611|472341368|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
131196976|NCT05304611|472341369|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
131196977|NCT05304611|472341370|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
131196978|NCT05304611|472341371|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
131196979|NCT05304611|472341372|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
131196980|NCT05304611|472341361|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
131196981|NCT05304611|472341362|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
131196982|NCT05304611|472341363|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
131196983|NCT05304611|472341364|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
131196984|NCT05304611|472341365|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
131196985|NCT05304611|472341366|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
131196986|NCT05304611|472341367|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
131196987|NCT05304611|472341368|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
131196988|NCT05304611|472341369|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
131196989|NCT05304611|472341370|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
131196990|NCT05304611|472341371|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
131196991|NCT05304611|472341372|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
131196992|NCT02354690|472341373|FG000|Overall Study|Physician Decision|1|||
131196993|NCT00963820|472341374|FG000|Dose Escalation Phase|Progressive Disease|3|||
131196994|NCT00963820|472341375|FG001|Dose Escalation Phase|Progressive Disease|3|||
131196995|NCT00963820|472341376|FG002|Dose Escalation Phase|Progressive Disease|3|||
131196996|NCT00963820|472341377|FG003|Dose Escalation Phase|Progressive Disease|3|||
131196997|NCT00963820|472341378|FG004|Dose Escalation Phase|Progressive Disease|4|||
131196998|NCT00963820|472341379|FG005|Dose Escalation Phase|Progressive Disease|3|||
131196999|NCT00963820|472341380|FG006|Dose Escalation Phase|Progressive Disease|3|||
131197000|NCT00963820|472341381|FG007|Dose Escalation Phase|Progressive Disease|2|||
131197001|NCT00963820|472341382|FG008|Dose Escalation Phase|Progressive Disease|0|||
131197002|NCT00963820|472341383|FG009|Dose Escalation Phase|Progressive Disease|0|||
131197003|NCT00963820|472341384|FG010|Dose Escalation Phase|Progressive Disease|0|||
131197004|NCT00963820|472341385|FG011|Dose Escalation Phase|Progressive Disease|0|||
131197005|NCT00963820|472341374|FG000|Dose Escalation Phase|Adverse Event|0|||
131197006|NCT00963820|472341375|FG001|Dose Escalation Phase|Adverse Event|0|||
131197007|NCT00963820|472341376|FG002|Dose Escalation Phase|Adverse Event|0|||
130733732|NCT04186845|470642960|FG000|Overall Study|It was previously confirmed|1|||
131197008|NCT00963820|472341377|FG003|Dose Escalation Phase|Adverse Event|0|||
131197009|NCT00963820|472341378|FG004|Dose Escalation Phase|Adverse Event|0|||
131197010|NCT00963820|472341379|FG005|Dose Escalation Phase|Adverse Event|0|||
131197011|NCT00963820|472341380|FG006|Dose Escalation Phase|Adverse Event|3|||
131197012|NCT00963820|472341381|FG007|Dose Escalation Phase|Adverse Event|1|||
131197013|NCT00963820|472341382|FG008|Dose Escalation Phase|Adverse Event|0|||
131197014|NCT00963820|472341383|FG009|Dose Escalation Phase|Adverse Event|0|||
131197015|NCT00963820|472341384|FG010|Dose Escalation Phase|Adverse Event|0|||
130733733|NCT04186845|470642960|FG000|Overall Study|Patient cancelled scheduled scans|2|||
130733734|NCT04186845|470642960|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
131197016|NCT00963820|472341385|FG011|Dose Escalation Phase|Adverse Event|0|||
131197017|NCT00963820|472341374|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
131197018|NCT00963820|472341375|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
131197019|NCT00963820|472341376|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
131197020|NCT00963820|472341377|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
131197021|NCT00963820|472341378|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
131197022|NCT00963820|472341379|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
131197023|NCT00963820|472341380|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
131197024|NCT00963820|472341381|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
131197025|NCT00963820|472341382|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
131197026|NCT00963820|472341383|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
131197027|NCT00963820|472341384|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
131197028|NCT00963820|472341385|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
131197029|NCT00963820|472341374|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197030|NCT00963820|472341375|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197031|NCT00963820|472341376|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197032|NCT00963820|472341377|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197033|NCT00963820|472341378|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197034|NCT00963820|472341379|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197035|NCT00963820|472341380|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
131197036|NCT00963820|472341381|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197037|NCT00963820|472341382|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197038|NCT00963820|472341383|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197039|NCT00963820|472341384|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197040|NCT00963820|472341385|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
131197041|NCT00963820|472341374|FG000|Expansion Phase|Progressive Disease|0|||
131197042|NCT00963820|472341375|FG001|Expansion Phase|Progressive Disease|0|||
131197043|NCT00963820|472341376|FG002|Expansion Phase|Progressive Disease|0|||
131197044|NCT00963820|472341377|FG003|Expansion Phase|Progressive Disease|0|||
131197045|NCT00963820|472341378|FG004|Expansion Phase|Progressive Disease|0|||
131197046|NCT00963820|472341379|FG005|Expansion Phase|Progressive Disease|0|||
131197047|NCT00963820|472341380|FG006|Expansion Phase|Progressive Disease|0|||
131197048|NCT00963820|472341381|FG007|Expansion Phase|Progressive Disease|0|||
131197049|NCT00963820|472341382|FG008|Expansion Phase|Progressive Disease|8|||
131197050|NCT00963820|472341383|FG009|Expansion Phase|Progressive Disease|6|||
131197051|NCT00963820|472341384|FG010|Expansion Phase|Progressive Disease|4|||
131197052|NCT00963820|472341385|FG011|Expansion Phase|Progressive Disease|2|||
131197053|NCT00963820|472341374|FG000|Expansion Phase|Adverse Event|0|||
131197054|NCT00963820|472341375|FG001|Expansion Phase|Adverse Event|0|||
131197055|NCT00963820|472341376|FG002|Expansion Phase|Adverse Event|0|||
131197056|NCT00963820|472341377|FG003|Expansion Phase|Adverse Event|0|||
131197057|NCT00963820|472341378|FG004|Expansion Phase|Adverse Event|0|||
131197058|NCT00963820|472341379|FG005|Expansion Phase|Adverse Event|0|||
131197059|NCT00963820|472341380|FG006|Expansion Phase|Adverse Event|0|||
131197060|NCT00963820|472341381|FG007|Expansion Phase|Adverse Event|0|||
131197061|NCT00963820|472341382|FG008|Expansion Phase|Adverse Event|1|||
131197062|NCT00963820|472341383|FG009|Expansion Phase|Adverse Event|3|||
131197063|NCT00963820|472341384|FG010|Expansion Phase|Adverse Event|0|||
131197064|NCT00963820|472341385|FG011|Expansion Phase|Adverse Event|0|||
131197065|NCT00963820|472341374|FG000|Expansion Phase|Withdrawal by Subject|0|||
131197066|NCT00963820|472341375|FG001|Expansion Phase|Withdrawal by Subject|0|||
131197067|NCT00963820|472341376|FG002|Expansion Phase|Withdrawal by Subject|0|||
131197068|NCT00963820|472341377|FG003|Expansion Phase|Withdrawal by Subject|0|||
131197069|NCT00963820|472341378|FG004|Expansion Phase|Withdrawal by Subject|0|||
131197070|NCT00963820|472341379|FG005|Expansion Phase|Withdrawal by Subject|0|||
131197071|NCT00963820|472341380|FG006|Expansion Phase|Withdrawal by Subject|0|||
131197072|NCT00963820|472341381|FG007|Expansion Phase|Withdrawal by Subject|0|||
131197073|NCT00963820|472341382|FG008|Expansion Phase|Withdrawal by Subject|1|||
131197074|NCT00963820|472341383|FG009|Expansion Phase|Withdrawal by Subject|0|||
131197075|NCT00963820|472341384|FG010|Expansion Phase|Withdrawal by Subject|1|||
131197076|NCT00963820|472341385|FG011|Expansion Phase|Withdrawal by Subject|1|||
131197077|NCT00963820|472341374|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197078|NCT00963820|472341375|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197079|NCT00963820|472341376|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197080|NCT00963820|472341377|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197081|NCT00963820|472341378|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197082|NCT00963820|472341379|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197083|NCT00963820|472341380|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197084|NCT00963820|472341381|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197085|NCT00963820|472341382|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197086|NCT00963820|472341383|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197087|NCT00963820|472341384|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
131197088|NCT00963820|472341385|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
131197089|NCT02253992|472341396|FG000|Overall Study|Study drug toxicity|1|||
131197090|NCT02253992|472341397|FG001|Overall Study|Study drug toxicity|0|||
131197091|NCT02253992|472341398|FG002|Overall Study|Study drug toxicity|10|||
131197092|NCT02253992|472341396|FG000|Overall Study|Disease progression|4|||
131197093|NCT02253992|472341397|FG001|Overall Study|Disease progression|3|||
131197094|NCT02253992|472341398|FG002|Overall Study|Disease progression|98|||
131197095|NCT02253992|472341396|FG000|Overall Study|Withdrawal by Subject|0|||
131197096|NCT02253992|472341397|FG001|Overall Study|Withdrawal by Subject|0|||
131197097|NCT02253992|472341398|FG002|Overall Study|Withdrawal by Subject|3|||
131197098|NCT02253992|472341396|FG000|Overall Study|Adverse Event|0|||
131197099|NCT02253992|472341397|FG001|Overall Study|Adverse Event|0|||
131197100|NCT02253992|472341398|FG002|Overall Study|Adverse Event|8|||
131197101|NCT02253992|472341396|FG000|Overall Study|Death|0|||
131197102|NCT02253992|472341397|FG001|Overall Study|Death|0|||
131197103|NCT02253992|472341398|FG002|Overall Study|Death|1|||
131197104|NCT02253992|472341396|FG000|Overall Study|Subject discontinued study drug|1|||
131197105|NCT02253992|472341397|FG001|Overall Study|Subject discontinued study drug|0|||
131197106|NCT02253992|472341398|FG002|Overall Study|Subject discontinued study drug|1|||
131197107|NCT02253992|472341396|FG000|Overall Study|Completed treatment as per protocol|0|||
131197108|NCT02253992|472341397|FG001|Overall Study|Completed treatment as per protocol|1|||
131197109|NCT02253992|472341398|FG002|Overall Study|Completed treatment as per protocol|22|||
131197110|NCT02253992|472341396|FG000|Overall Study|Other|0|||
131197111|NCT02253992|472341397|FG001|Overall Study|Other|0|||
131197112|NCT02253992|472341398|FG002|Overall Study|Other|1|||
131197113|NCT02201251|472341399|FG000|Overall Study|Adverse Event|1|||
131197114|NCT02201251|472341400|FG001|Overall Study|Adverse Event|1|||
131197115|NCT02201251|472341399|FG000|Overall Study|Protocol Violation|1|||
131197116|NCT02201251|472341400|FG001|Overall Study|Protocol Violation|0|||
131197117|NCT02201251|472341399|FG000|Overall Study|Noncompliance with Study Drug|0|||
131197118|NCT02201251|472341400|FG001|Overall Study|Noncompliance with Study Drug|1|||
131197119|NCT02201251|472341399|FG000|Overall Study|Withdrawal by Subject|2|||
131197120|NCT02201251|472341400|FG001|Overall Study|Withdrawal by Subject|1|||
131197121|NCT02877134|472341404|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
131197122|NCT02877134|472341405|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
131197123|NCT02877134|472341406|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
131197124|NCT02877134|472341407|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
131197125|NCT02877134|472341408|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
131197126|NCT02877134|472341409|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
131197127|NCT02877134|472341410|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
131197128|NCT02877134|472341411|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
131197129|NCT02877134|472341412|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
131197130|NCT02877134|472341413|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
131197131|NCT02877134|472341414|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
131197132|NCT02877134|472341415|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
131197133|NCT02877134|472341404|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131197134|NCT02877134|472341405|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
131197135|NCT02877134|472341406|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131197136|NCT02877134|472341407|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
131197137|NCT02877134|472341408|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131197138|NCT02877134|472341409|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131197139|NCT02877134|472341410|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
131197140|NCT02877134|472341411|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131197141|NCT02877134|472341412|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131197142|NCT02877134|472341413|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131197143|NCT02877134|472341414|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131197144|NCT02877134|472341415|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
131197145|NCT02877134|472341404|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
131197146|NCT02877134|472341405|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
131197147|NCT02877134|472341406|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
131197148|NCT02877134|472341407|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
131197149|NCT02877134|472341408|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
131197150|NCT02877134|472341409|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
131197151|NCT02877134|472341410|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
131197152|NCT02877134|472341411|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
131197153|NCT02877134|472341412|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
131197154|NCT02877134|472341413|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
131197155|NCT02877134|472341414|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
131197156|NCT02877134|472341415|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
131197157|NCT02877134|472341404|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
131197158|NCT02877134|472341405|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
131197159|NCT02877134|472341406|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
131197160|NCT02877134|472341407|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
131197161|NCT02877134|472341408|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
131197162|NCT02877134|472341409|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
131197163|NCT02877134|472341410|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
131197164|NCT02877134|472341411|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
131197165|NCT02877134|472341412|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
131197166|NCT02877134|472341413|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
131197167|NCT02877134|472341414|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
131197168|NCT02877134|472341415|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
131197169|NCT02877134|472341404|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197170|NCT02877134|472341405|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197171|NCT02877134|472341406|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197172|NCT02877134|472341407|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197173|NCT02877134|472341408|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197174|NCT02877134|472341409|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197175|NCT02877134|472341410|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197176|NCT02877134|472341411|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197177|NCT02877134|472341412|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
131197178|NCT02877134|472341413|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197179|NCT02877134|472341414|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197180|NCT02877134|472341415|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
131197181|NCT02877134|472341404|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131197182|NCT02877134|472341405|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131197183|NCT02877134|472341406|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131197184|NCT02877134|472341407|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131197185|NCT02877134|472341408|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131197186|NCT02877134|472341409|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131197187|NCT02877134|472341410|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
131197188|NCT02877134|472341411|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
131197189|NCT02877134|472341412|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
131197190|NCT02877134|472341413|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
131197191|NCT02877134|472341414|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
131197192|NCT02877134|472341415|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
131197193|NCT02877134|472341404|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131197194|NCT02877134|472341405|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131197195|NCT02877134|472341406|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131197196|NCT02877134|472341407|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131197197|NCT02877134|472341408|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131197198|NCT02877134|472341409|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131197199|NCT02877134|472341410|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131197200|NCT02877134|472341411|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
131197201|NCT02877134|472341412|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
131197202|NCT02877134|472341413|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
131197203|NCT02877134|472341414|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131197204|NCT02877134|472341415|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
131197205|NCT02877134|472341404|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
131197206|NCT02877134|472341405|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
131197207|NCT02877134|472341406|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
131197208|NCT02877134|472341407|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
131197209|NCT02877134|472341408|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
131197210|NCT02877134|472341409|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
131197211|NCT02877134|472341410|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
131197212|NCT02877134|472341411|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
131197213|NCT02877134|472341412|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
131197214|NCT02877134|472341413|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
131197215|NCT02877134|472341414|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
131197216|NCT02877134|472341415|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
131197217|NCT01332851|472341420|FG000|Overall Study|Withdrawal by Subject|4|||
131197218|NCT01332851|472341421|FG001|Overall Study|Withdrawal by Subject|2|||
131197219|NCT01332851|472341420|FG000|Overall Study|Lost to Follow-up|7|||
131197220|NCT01332851|472341421|FG001|Overall Study|Lost to Follow-up|11|||
131197221|NCT03299166|472341424|FG000|Overall Study|Adverse Event|9|||
131197222|NCT03299166|472341425|FG001|Overall Study|Adverse Event|4|||
131197223|NCT03299166|472341424|FG000|Overall Study|Withdrawal by Subject|6|||
131197224|NCT03299166|472341425|FG001|Overall Study|Withdrawal by Subject|5|||
131197225|NCT03299166|472341424|FG000|Overall Study|Physician Decision|1|||
131197226|NCT03299166|472341425|FG001|Overall Study|Physician Decision|1|||
131197227|NCT03299166|472341424|FG000|Overall Study|Sponsor Decision|3|||
131197228|NCT03299166|472341425|FG001|Overall Study|Sponsor Decision|0|||
131197229|NCT03299166|472341424|FG000|Overall Study|Lost to Follow-up|2|||
131197230|NCT03299166|472341425|FG001|Overall Study|Lost to Follow-up|4|||
131197231|NCT03299166|472341424|FG000|Overall Study|Randomization Error|0|||
131197232|NCT03299166|472341425|FG001|Overall Study|Randomization Error|1|||
131197233|NCT03299166|472341424|FG000|Overall Study|Subject unable to return due to COVID|1|||
131197234|NCT03299166|472341425|FG001|Overall Study|Subject unable to return due to COVID|0|||
131197235|NCT03299166|472341424|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
131197236|NCT03299166|472341425|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
131197237|NCT03630016|472341426|FG000|Overall Study|Poor Sensor Placement|1|||
131197238|NCT00002981|472341427|FG000|Overall Study|Inevaluable|6|||
131197239|NCT00255008|472341430|FG000|Overall Study|Adverse Event|1|||
131197240|NCT00255008|472341431|FG001|Overall Study|Adverse Event|1|||
131197241|NCT00255008|472341432|FG002|Overall Study|Adverse Event|2|||
131197242|NCT00255008|472341433|FG003|Overall Study|Adverse Event|0|||
131197243|NCT00255008|472341430|FG000|Overall Study|Lost to Follow-up|1|||
131197244|NCT00255008|472341431|FG001|Overall Study|Lost to Follow-up|0|||
131197245|NCT00255008|472341432|FG002|Overall Study|Lost to Follow-up|1|||
131197246|NCT00255008|472341433|FG003|Overall Study|Lost to Follow-up|2|||
131197247|NCT00255008|472341430|FG000|Overall Study|Did not meet viral reduction criteria|4|||
131197248|NCT00255008|472341431|FG001|Overall Study|Did not meet viral reduction criteria|5|||
131197249|NCT00255008|472341432|FG002|Overall Study|Did not meet viral reduction criteria|0|||
131197250|NCT00255008|472341433|FG003|Overall Study|Did not meet viral reduction criteria|1|||
131197251|NCT00255008|472341430|FG000|Overall Study|Withdrew consent|0|||
131197252|NCT00255008|472341431|FG001|Overall Study|Withdrew consent|0|||
131197253|NCT00255008|472341432|FG002|Overall Study|Withdrew consent|2|||
131197254|NCT00255008|472341433|FG003|Overall Study|Withdrew consent|0|||
131197255|NCT00255008|472341430|FG000|Overall Study|Sponsor request|18|||
131197256|NCT00255008|472341431|FG001|Overall Study|Sponsor request|3|||
131197257|NCT00255008|472341432|FG002|Overall Study|Sponsor request|8|||
131197258|NCT00255008|472341433|FG003|Overall Study|Sponsor request|17|||
131197259|NCT00255008|472341430|FG000|Overall Study|Adverse lab experience|1|||
131197260|NCT00255008|472341431|FG001|Overall Study|Adverse lab experience|0|||
131197261|NCT00255008|472341432|FG002|Overall Study|Adverse lab experience|0|||
131197262|NCT00255008|472341433|FG003|Overall Study|Adverse lab experience|0|||
131197263|NCT00255008|472341430|FG000|Overall Study|Other|7|||
131197264|NCT00255008|472341431|FG001|Overall Study|Other|0|||
131197265|NCT00255008|472341432|FG002|Overall Study|Other|3|||
131197266|NCT00255008|472341433|FG003|Overall Study|Other|2|||
131197267|NCT03457636|472341434|FG000|Overall Study|Lost to Follow-up|2|||
131197268|NCT01833806|472341435|FG000|Overall Study|Alternative treatment|2|||
131197269|NCT01833806|472341435|FG000|Overall Study|Death|5|||
131197270|NCT01833806|472341435|FG000|Overall Study|Physician Decision|1|||
131197271|NCT01833806|472341435|FG000|Overall Study|Lost to Follow-up|1|||
131197272|NCT02724111|472341436|FG000|Overall Study|Protocol Violation|2|||
131197273|NCT02724111|472341437|FG001|Overall Study|Protocol Violation|5|||
131197274|NCT01828567|472341438|FG000|Overall Study|Lost to Follow-up|27|||
131197275|NCT01828567|472341439|FG001|Overall Study|Lost to Follow-up|9|||
131197276|NCT01828567|472341438|FG000|Overall Study|Excluded - did not meet criteria|4|||
131197277|NCT01828567|472341439|FG001|Overall Study|Excluded - did not meet criteria|1|||
131197278|NCT01885104|472341440|FG000|Overall Study|Withdrawal of Consent|1|||
131197279|NCT01885104|472341441|FG001|Overall Study|Withdrawal of Consent|0|||
131197280|NCT01885104|472341440|FG000|Overall Study|Lost to Follow-up|0|||
131197281|NCT01885104|472341441|FG001|Overall Study|Lost to Follow-up|1|||
131197282|NCT01885104|472341440|FG000|Overall Study|Physician Decision|1|||
131197283|NCT01885104|472341441|FG001|Overall Study|Physician Decision|0|||
131197284|NCT00126425|472341445|FG000|Overall Study|Withdrawal by Subject|17|||
131197285|NCT00126425|472341446|FG001|Overall Study|Withdrawal by Subject|1|||
131197286|NCT00126425|472341445|FG000|Overall Study|Lost to Follow-up|8|||
131197287|NCT00126425|472341446|FG001|Overall Study|Lost to Follow-up|4|||
131197288|NCT00126425|472341445|FG000|Overall Study|Protocol Violation|9|||
131197289|NCT00126425|472341446|FG001|Overall Study|Protocol Violation|6|||
131197290|NCT00126425|472341445|FG000|Overall Study|Adverse Event|1|||
131197291|NCT00126425|472341446|FG001|Overall Study|Adverse Event|0|||
131197292|NCT00126425|472341445|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
131197293|NCT00126425|472341446|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
131197294|NCT00126425|472341445|FG000|Overall Study|Other|5|||
131197295|NCT00126425|472341446|FG001|Overall Study|Other|0|||
131197296|NCT00113555|472341447|FG000|Overall Study|Baseline Failure|59|||
131197297|NCT00113555|472341447|FG000|Overall Study|Permanently Explanted|7|||
131197298|NCT00113555|472341447|FG000|Overall Study|Death|1|||
131197299|NCT00113555|472341447|FG000|Overall Study|Missed Followup|4|||
131197300|NCT00113555|472341447|FG000|Overall Study|Lost to Follow-up|8|||
131197301|NCT04474366|472341448|FG000|Overall Study|Lost to Follow-up|2|||
131197302|NCT04474366|472341449|FG001|Overall Study|Lost to Follow-up|5|||
131197303|NCT04063865|472341450|FG000|Overall Study|Physician Decision|1|||
131197304|NCT04063865|472341451|FG001|Overall Study|Physician Decision|3|||
131197305|NCT04063865|472341450|FG000|Overall Study|Study Closed Prior to Completion|4|||
131197306|NCT04063865|472341451|FG001|Overall Study|Study Closed Prior to Completion|4|||
131197307|NCT04063865|472341450|FG000|Overall Study|Withdrawal by Subject|1|||
131197308|NCT04063865|472341451|FG001|Overall Study|Withdrawal by Subject|1|||
131197309|NCT00320190|472341452|FG000|First 12 Months|Completed but did not enter extension|5|||
131197310|NCT00320190|472341453|FG001|First 12 Months|Completed but did not enter extension|3|||
131197311|NCT00320190|472341452|FG000|First 12 Months|Sponsor terminated study|2|||
131197312|NCT00320190|472341453|FG001|First 12 Months|Sponsor terminated study|2|||
131197313|NCT00320190|472341452|FG000|First 12 Months|Lost to Follow-up|0|||
131197314|NCT00320190|472341453|FG001|First 12 Months|Lost to Follow-up|1|||
131197315|NCT00320190|472341452|FG000|First 12 Months|Enrollment failure|0|||
131197316|NCT00320190|472341453|FG001|First 12 Months|Enrollment failure|1|||
131197317|NCT00320190|472341452|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
131197318|NCT00320190|472341453|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
131197319|NCT00320190|472341452|FG000|First 12 Months|Investigator request|0|||
131197320|NCT00320190|472341453|FG001|First 12 Months|Investigator request|1|||
131197321|NCT00320190|472341452|FG000|First 12 Months|Study drug toxicity|0|||
131197322|NCT00320190|472341453|FG001|First 12 Months|Study drug toxicity|1|||
131197323|NCT00320190|472341452|FG000|First 12 Months|Withdrawal by Subject|0|||
131197324|NCT00320190|472341453|FG001|First 12 Months|Withdrawal by Subject|1|||
131197325|NCT00320190|472341452|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
131197326|NCT00320190|472341453|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
131197327|NCT00320190|472341452|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
131197328|NCT00320190|472341453|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
131197329|NCT00320190|472341452|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
131197330|NCT00320190|472341453|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
131197331|NCT05307523|472341460|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
131197332|NCT05307523|472341461|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
131197333|NCT05307523|472341460|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
131197334|NCT05307523|472341461|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
131197335|NCT00102804|472341468|FG000|Overall Study|Progressive Disease (PD)|307|||
131197336|NCT00102804|472341469|FG001|Overall Study|Progressive Disease (PD)|196|||
131197337|NCT00102804|472341468|FG000|Overall Study|Withdrawal by Subject|46|||
131197338|NCT00102804|472341469|FG001|Overall Study|Withdrawal by Subject|7|||
131197339|NCT00102804|472341468|FG000|Overall Study|Adverse Event|37|||
131197340|NCT00102804|472341469|FG001|Overall Study|Adverse Event|3|||
131197341|NCT00102804|472341468|FG000|Overall Study|Physician Decision|24|||
131197342|NCT00102804|472341469|FG001|Overall Study|Physician Decision|6|||
131197343|NCT00102804|472341468|FG000|Overall Study|Death|5|||
131197344|NCT00102804|472341469|FG001|Overall Study|Death|6|||
131197345|NCT00102804|472341468|FG000|Overall Study|Enrollment Criteria Not Met|6|||
131197346|NCT00102804|472341469|FG001|Overall Study|Enrollment Criteria Not Met|0|||
131197347|NCT00102804|472341468|FG000|Overall Study|Lost to Follow-up|4|||
131197348|NCT00102804|472341469|FG001|Overall Study|Lost to Follow-up|1|||
131197349|NCT00102804|472341468|FG000|Overall Study|Protocol Violation|2|||
131197350|NCT00102804|472341469|FG001|Overall Study|Protocol Violation|1|||
131197351|NCT00102804|472341468|FG000|Overall Study|Satisfactory Response|2|||
131197352|NCT00102804|472341469|FG001|Overall Study|Satisfactory Response|0|||
131197353|NCT00102804|472341468|FG000|Overall Study|Sponsor Decision|1|||
131197354|NCT00102804|472341469|FG001|Overall Study|Sponsor Decision|0|||
131197355|NCT00102804|472341468|FG000|Overall Study|Alive, Receiving Treatment|7|||
131197356|NCT00102804|472341469|FG001|Overall Study|Alive, Receiving Treatment|2|||
131197357|NCT04035473|472341470|FG000|Screening/Baseline|Death|0|||
131197358|NCT04035473|472341471|FG001|Screening/Baseline|Death|1|||
131197359|NCT04035473|472341470|FG000|Screening/Baseline|Adverse Event|0|||
131197360|NCT04035473|472341471|FG001|Screening/Baseline|Adverse Event|1|||
131197361|NCT04035473|472341470|FG000|Follow-up Period|Adverse Event|2|||
131197362|NCT04035473|472341471|FG001|Follow-up Period|Adverse Event|0|||
131197363|NCT00683774|472341472|FG000|Overall Study|Withdrawal by Subject|0|||
131197364|NCT00683774|472341473|FG001|Overall Study|Withdrawal by Subject|1|||
131197365|NCT00683774|472341472|FG000|Overall Study|Physician Decision|3|||
131197366|NCT00683774|472341473|FG001|Overall Study|Physician Decision|0|||
131197367|NCT02735044|472341474|FG000|Overall Study|Adverse Event|3|||
131197368|NCT02735044|472341475|FG001|Overall Study|Adverse Event|3|||
131197369|NCT02735044|472341474|FG000|Overall Study|Lack of Efficacy|1|||
131197370|NCT02735044|472341475|FG001|Overall Study|Lack of Efficacy|0|||
131197371|NCT02735044|472341474|FG000|Overall Study|Poor compliance to protocol|7|||
131197372|NCT02735044|472341475|FG001|Overall Study|Poor compliance to protocol|7|||
131197373|NCT02735044|472341474|FG000|Overall Study|Randomized and not treated|0|||
131197374|NCT02735044|472341475|FG001|Overall Study|Randomized and not treated|2|||
131197375|NCT02735044|472341474|FG000|Overall Study|Other, not specified above|5|||
131197376|NCT02735044|472341475|FG001|Overall Study|Other, not specified above|11|||
131197377|NCT02141854|472341478|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
131197378|NCT02141854|472341479|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131197379|NCT02141854|472341480|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131197380|NCT02141854|472341481|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131197381|NCT02141854|472341482|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131197382|NCT02141854|472341483|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
131197383|NCT02141854|472341478|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
131197384|NCT02141854|472341479|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131197385|NCT02141854|472341480|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131197386|NCT02141854|472341481|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131197387|NCT02141854|472341482|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131197388|NCT02141854|472341483|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
131197389|NCT02141854|472341478|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
131197390|NCT02141854|472341479|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131197391|NCT02141854|472341480|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131197392|NCT02141854|472341481|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131197393|NCT02141854|472341482|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131197394|NCT02141854|472341483|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
131197395|NCT02141854|472341478|FG000|Run-In Period (Pre-assignment)|Other|14|||
131197396|NCT02141854|472341479|FG001|Run-In Period (Pre-assignment)|Other|0|||
131197397|NCT02141854|472341480|FG002|Run-In Period (Pre-assignment)|Other|0|||
131197398|NCT02141854|472341481|FG003|Run-In Period (Pre-assignment)|Other|0|||
131197399|NCT02141854|472341482|FG004|Run-In Period (Pre-assignment)|Other|0|||
131197400|NCT02141854|472341483|FG005|Run-In Period (Pre-assignment)|Other|0|||
131197401|NCT02141854|472341478|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
131197402|NCT02141854|472341479|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
131197403|NCT02141854|472341480|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
131197404|NCT02141854|472341481|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
131197405|NCT02141854|472341482|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
131197406|NCT02141854|472341483|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
131197407|NCT02141854|472341478|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
131197408|NCT02141854|472341479|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131197409|NCT02141854|472341480|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131197410|NCT02141854|472341481|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131197411|NCT02141854|472341482|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131197412|NCT02141854|472341483|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
131197413|NCT02141854|472341478|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
131197414|NCT02141854|472341479|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131197415|NCT02141854|472341480|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131197416|NCT02141854|472341481|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131197417|NCT02141854|472341482|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131197418|NCT02141854|472341483|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
131197419|NCT02141854|472341478|FG000|Treatment Period|Protocol Violation|0|||
131197420|NCT02141854|472341479|FG001|Treatment Period|Protocol Violation|1|||
131197421|NCT02141854|472341480|FG002|Treatment Period|Protocol Violation|0|||
131197422|NCT02141854|472341481|FG003|Treatment Period|Protocol Violation|2|||
131197423|NCT02141854|472341482|FG004|Treatment Period|Protocol Violation|2|||
131197424|NCT02141854|472341483|FG005|Treatment Period|Protocol Violation|1|||
131197425|NCT02141854|472341478|FG000|Treatment Period|Noncompliance|0|||
131197426|NCT02141854|472341479|FG001|Treatment Period|Noncompliance|0|||
131197427|NCT02141854|472341480|FG002|Treatment Period|Noncompliance|0|||
131197428|NCT02141854|472341481|FG003|Treatment Period|Noncompliance|1|||
131197429|NCT02141854|472341482|FG004|Treatment Period|Noncompliance|0|||
131197430|NCT02141854|472341483|FG005|Treatment Period|Noncompliance|0|||
131197431|NCT02141854|472341478|FG000|Treatment Period|Lack of Efficacy|0|||
131197432|NCT02141854|472341479|FG001|Treatment Period|Lack of Efficacy|0|||
131197433|NCT02141854|472341480|FG002|Treatment Period|Lack of Efficacy|0|||
131197434|NCT02141854|472341481|FG003|Treatment Period|Lack of Efficacy|1|||
131197435|NCT02141854|472341482|FG004|Treatment Period|Lack of Efficacy|1|||
131197436|NCT02141854|472341483|FG005|Treatment Period|Lack of Efficacy|7|||
131197437|NCT02141854|472341478|FG000|Treatment Period|Pregnancy|0|||
131197438|NCT02141854|472341479|FG001|Treatment Period|Pregnancy|1|||
131197439|NCT02141854|472341480|FG002|Treatment Period|Pregnancy|0|||
131197440|NCT02141854|472341481|FG003|Treatment Period|Pregnancy|0|||
131197441|NCT02141854|472341482|FG004|Treatment Period|Pregnancy|0|||
131197442|NCT02141854|472341483|FG005|Treatment Period|Pregnancy|0|||
131197443|NCT02141854|472341478|FG000|Treatment Period|Other|0|||
131197444|NCT02141854|472341479|FG001|Treatment Period|Other|1|||
131197445|NCT02141854|472341480|FG002|Treatment Period|Other|2|||
131197446|NCT02141854|472341481|FG003|Treatment Period|Other|0|||
131197447|NCT02141854|472341482|FG004|Treatment Period|Other|1|||
131197448|NCT02141854|472341483|FG005|Treatment Period|Other|2|||
131197449|NCT02141854|472341478|FG000|Treatment Period|Adverse Event|0|||
131197450|NCT02141854|472341479|FG001|Treatment Period|Adverse Event|2|||
131197451|NCT02141854|472341480|FG002|Treatment Period|Adverse Event|2|||
131197452|NCT02141854|472341481|FG003|Treatment Period|Adverse Event|0|||
131197453|NCT02141854|472341482|FG004|Treatment Period|Adverse Event|2|||
131197454|NCT02141854|472341483|FG005|Treatment Period|Adverse Event|2|||
131197455|NCT02141854|472341478|FG000|Treatment Period|Withdrawal by Subject|0|||
131197456|NCT02141854|472341479|FG001|Treatment Period|Withdrawal by Subject|2|||
131197457|NCT02141854|472341480|FG002|Treatment Period|Withdrawal by Subject|3|||
131197458|NCT02141854|472341481|FG003|Treatment Period|Withdrawal by Subject|3|||
131197459|NCT02141854|472341482|FG004|Treatment Period|Withdrawal by Subject|4|||
131197460|NCT02141854|472341483|FG005|Treatment Period|Withdrawal by Subject|7|||
131197461|NCT02141854|472341478|FG000|Treatment Period|Disease progression|0|||
131197462|NCT02141854|472341479|FG001|Treatment Period|Disease progression|2|||
131197463|NCT02141854|472341480|FG002|Treatment Period|Disease progression|1|||
131197464|NCT02141854|472341481|FG003|Treatment Period|Disease progression|3|||
131197465|NCT02141854|472341482|FG004|Treatment Period|Disease progression|0|||
131197466|NCT02141854|472341483|FG005|Treatment Period|Disease progression|18|||
131197467|NCT02141854|472341478|FG000|Treatment Period|Lost to Follow-up|0|||
131197468|NCT02141854|472341479|FG001|Treatment Period|Lost to Follow-up|1|||
131197469|NCT02141854|472341480|FG002|Treatment Period|Lost to Follow-up|1|||
131197470|NCT02141854|472341481|FG003|Treatment Period|Lost to Follow-up|1|||
131197471|NCT02141854|472341482|FG004|Treatment Period|Lost to Follow-up|0|||
131197472|NCT02141854|472341483|FG005|Treatment Period|Lost to Follow-up|1|||
131197473|NCT03128307|472341486|FG000|Overall Study|Lost to Follow-up|29|||
131197474|NCT03128307|472341486|FG000|Overall Study|Withdrawal by Subject|5|||
131197475|NCT03991936|472343357|FG000|Overall Study|Lost to Follow-up|1|||
131197476|NCT03991936|472343358|FG001|Overall Study|Lost to Follow-up|1|||
131197477|NCT03991936|472343359|FG002|Overall Study|Lost to Follow-up|1|||
131197478|NCT03991936|472343360|FG003|Overall Study|Lost to Follow-up|1|||
131197479|NCT03991936|472343361|FG004|Overall Study|Lost to Follow-up|1|||
131197480|NCT00939055|472343362|FG000|Overall Study|Discontinuation prior to procedure|4|||
131197481|NCT00939055|472343363|FG001|Overall Study|Discontinuation prior to procedure|0|||
131197482|NCT00584987|472343366|FG000|Overall Study|Protocol Violation|1|||
131197483|NCT00584987|472343367|FG001|Overall Study|Protocol Violation|1|||
131197484|NCT00584987|472343368|FG002|Overall Study|Protocol Violation|1|||
131197485|NCT00584987|472343369|FG003|Overall Study|Protocol Violation|0|||
131197486|NCT00584987|472343366|FG000|Overall Study|Adverse Event|0|||
131197487|NCT00584987|472343367|FG001|Overall Study|Adverse Event|0|||
131197488|NCT00584987|472343368|FG002|Overall Study|Adverse Event|0|||
131197489|NCT00584987|472343369|FG003|Overall Study|Adverse Event|1|||
131197490|NCT03225833|472343370|FG000|Overall Study|Adverse Event|0|||
131197491|NCT03225833|472343371|FG001|Overall Study|Adverse Event|1|||
131197492|NCT03225833|472343372|FG002|Overall Study|Adverse Event|2|||
131197493|NCT03225833|472343373|FG003|Overall Study|Adverse Event|0|||
131197494|NCT03225833|472343374|FG004|Overall Study|Adverse Event|0|||
131197495|NCT03225833|472343375|FG005|Overall Study|Adverse Event|2|||
131197496|NCT03225833|472343370|FG000|Overall Study|Withdrawal by Subject|1|||
131197497|NCT03225833|472343371|FG001|Overall Study|Withdrawal by Subject|0|||
131197498|NCT03225833|472343372|FG002|Overall Study|Withdrawal by Subject|0|||
131197499|NCT03225833|472343373|FG003|Overall Study|Withdrawal by Subject|0|||
131197500|NCT03225833|472343374|FG004|Overall Study|Withdrawal by Subject|1|||
131197501|NCT03225833|472343375|FG005|Overall Study|Withdrawal by Subject|0|||
131197502|NCT03225833|472343370|FG000|Overall Study|Termination of Study by Sponsor|4|||
131197503|NCT03225833|472343371|FG001|Overall Study|Termination of Study by Sponsor|0|||
131197504|NCT03225833|472343372|FG002|Overall Study|Termination of Study by Sponsor|0|||
131197505|NCT03225833|472343373|FG003|Overall Study|Termination of Study by Sponsor|0|||
131197506|NCT03225833|472343374|FG004|Overall Study|Termination of Study by Sponsor|0|||
131197507|NCT03225833|472343375|FG005|Overall Study|Termination of Study by Sponsor|7|||
131197508|NCT03225833|472343370|FG000|Overall Study|Sponsor Decision|0|||
131197509|NCT03225833|472343371|FG001|Overall Study|Sponsor Decision|0|||
131197510|NCT03225833|472343372|FG002|Overall Study|Sponsor Decision|0|||
131197511|NCT03225833|472343373|FG003|Overall Study|Sponsor Decision|0|||
131197512|NCT03225833|472343374|FG004|Overall Study|Sponsor Decision|0|||
131197513|NCT03225833|472343375|FG005|Overall Study|Sponsor Decision|1|||
131197514|NCT00081263|472343378|FG000|Overall Study|clerical error|1|||
131197515|NCT00081263|472343379|FG001|Overall Study|clerical error|0|||
131197516|NCT00081263|472343378|FG000|Overall Study|wrong cell type|7|||
131197517|NCT00081263|472343379|FG001|Overall Study|wrong cell type|5|||
131197518|NCT00081263|472343378|FG000|Overall Study|improper pre-protocol therapy|0|||
131197519|NCT00081263|472343379|FG001|Overall Study|improper pre-protocol therapy|1|||
131197520|NCT00081263|472343378|FG000|Overall Study|Inadequate pathology|0|||
131197521|NCT00081263|472343379|FG001|Overall Study|Inadequate pathology|1|||
131197522|NCT00081263|472343378|FG000|Overall Study|Never treated|4|||
131197523|NCT00081263|472343379|FG001|Overall Study|Never treated|5|||
131197524|NCT00081263|472343378|FG000|Overall Study|Inadequate data|5|||
131197525|NCT00081263|472343379|FG001|Overall Study|Inadequate data|10|||
131197526|NCT04564027|472343394|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
131197527|NCT04564027|472343395|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
131197528|NCT04564027|472343396|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
131197529|NCT04564027|472343397|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
131197530|NCT01267955|472343400|FG000|Stage 1 (6 Months)|Death|3|||
131197531|NCT01267955|472343400|FG000|Stage 2 (6 Months)|Death|5|||
131197532|NCT01267955|472343400|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
131197533|NCT05827978|472343401|FG000|Overall Study|Adverse Event|1|||
131197534|NCT05827978|472343402|FG001|Overall Study|Adverse Event|0|||
131197535|NCT05827978|472343403|FG002|Overall Study|Adverse Event|0|||
131197536|NCT05827978|472343404|FG003|Overall Study|Adverse Event|1|||
131197537|NCT05827978|472343405|FG004|Overall Study|Adverse Event|0|||
131197538|NCT05827978|472343406|FG005|Overall Study|Adverse Event|0|||
131197539|NCT05827978|472343401|FG000|Overall Study|Death|1|||
131197540|NCT05827978|472343402|FG001|Overall Study|Death|5|||
131197541|NCT05827978|472343403|FG002|Overall Study|Death|2|||
131197542|NCT05827978|472343404|FG003|Overall Study|Death|3|||
131197543|NCT05827978|472343405|FG004|Overall Study|Death|1|||
131197544|NCT05827978|472343406|FG005|Overall Study|Death|3|||
131197545|NCT05827978|472343401|FG000|Overall Study|Lost to Follow-up|57|||
131197546|NCT05827978|472343402|FG001|Overall Study|Lost to Follow-up|88|||
131197547|NCT05827978|472343403|FG002|Overall Study|Lost to Follow-up|54|||
131197548|NCT05827978|472343404|FG003|Overall Study|Lost to Follow-up|47|||
131197549|NCT05827978|472343405|FG004|Overall Study|Lost to Follow-up|25|||
131197550|NCT05827978|472343406|FG005|Overall Study|Lost to Follow-up|10|||
131197551|NCT05827978|472343401|FG000|Overall Study|Noncompliance with Study Procedures|0|||
131197552|NCT05827978|472343402|FG001|Overall Study|Noncompliance with Study Procedures|1|||
131197553|NCT05827978|472343403|FG002|Overall Study|Noncompliance with Study Procedures|1|||
131197554|NCT05827978|472343404|FG003|Overall Study|Noncompliance with Study Procedures|1|||
131197555|NCT05827978|472343405|FG004|Overall Study|Noncompliance with Study Procedures|1|||
131197556|NCT05827978|472343406|FG005|Overall Study|Noncompliance with Study Procedures|0|||
131197557|NCT05827978|472343401|FG000|Overall Study|Physician Decision|2|||
131197558|NCT05827978|472343402|FG001|Overall Study|Physician Decision|0|||
131197559|NCT05827978|472343403|FG002|Overall Study|Physician Decision|1|||
131197560|NCT05827978|472343404|FG003|Overall Study|Physician Decision|2|||
131197561|NCT05827978|472343405|FG004|Overall Study|Physician Decision|1|||
131197562|NCT05827978|472343406|FG005|Overall Study|Physician Decision|1|||
131197563|NCT05827978|472343401|FG000|Overall Study|Protocol Violation|5|||
131197564|NCT05827978|472343402|FG001|Overall Study|Protocol Violation|2|||
131197565|NCT05827978|472343403|FG002|Overall Study|Protocol Violation|0|||
131197566|NCT05827978|472343404|FG003|Overall Study|Protocol Violation|0|||
131197567|NCT05827978|472343405|FG004|Overall Study|Protocol Violation|0|||
131197568|NCT05827978|472343406|FG005|Overall Study|Protocol Violation|0|||
131197569|NCT05827978|472343401|FG000|Overall Study|Withdrawal by Subject|17|||
131197570|NCT05827978|472343402|FG001|Overall Study|Withdrawal by Subject|16|||
131197571|NCT05827978|472343403|FG002|Overall Study|Withdrawal by Subject|10|||
131197572|NCT05827978|472343404|FG003|Overall Study|Withdrawal by Subject|12|||
131197573|NCT05827978|472343405|FG004|Overall Study|Withdrawal by Subject|10|||
131197574|NCT05827978|472343406|FG005|Overall Study|Withdrawal by Subject|9|||
131197575|NCT05827978|472343401|FG000|Overall Study|Other Than Specified|0|||
131197576|NCT05827978|472343402|FG001|Overall Study|Other Than Specified|0|||
131197577|NCT05827978|472343403|FG002|Overall Study|Other Than Specified|1|||
131197578|NCT05827978|472343404|FG003|Overall Study|Other Than Specified|0|||
131197579|NCT05827978|472343405|FG004|Overall Study|Other Than Specified|2|||
131197580|NCT05827978|472343406|FG005|Overall Study|Other Than Specified|0|||
131197581|NCT04651777|472343407|FG000|Overall Study|Adverse Event|1|||
131197582|NCT04651777|472343407|FG000|Overall Study|Withdrawal by Subject|2|||
131197583|NCT04566445|472343408|FG000|Overall Study|Death|4|||
131197584|NCT04566445|472343409|FG001|Overall Study|Death|1|||
131197585|NCT04566445|472343410|FG002|Overall Study|Death|1|||
131197586|NCT04566445|472343408|FG000|Overall Study|Lost to Follow-up|3|||
131197587|NCT04566445|472343409|FG001|Overall Study|Lost to Follow-up|1|||
131197588|NCT04566445|472343410|FG002|Overall Study|Lost to Follow-up|1|||
131197589|NCT04566445|472343408|FG000|Overall Study|Study terminated by sponsor|11|||
131197590|NCT04566445|472343409|FG001|Overall Study|Study terminated by sponsor|17|||
131197591|NCT04566445|472343410|FG002|Overall Study|Study terminated by sponsor|32|||
131197592|NCT04566445|472343408|FG000|Overall Study|Withdrawal by Subject|12|||
131197593|NCT04566445|472343409|FG001|Overall Study|Withdrawal by Subject|14|||
131197594|NCT04566445|472343410|FG002|Overall Study|Withdrawal by Subject|13|||
131197595|NCT04566445|472343408|FG000|Overall Study|Randomized but not treated due to AE|2|||
131197596|NCT04566445|472343409|FG001|Overall Study|Randomized but not treated due to AE|1|||
131197597|NCT04566445|472343410|FG002|Overall Study|Randomized but not treated due to AE|0|||
131197598|NCT04566445|472343408|FG000|Overall Study|Adverse Event|1|||
131197599|NCT04566445|472343409|FG001|Overall Study|Adverse Event|1|||
131197600|NCT04566445|472343410|FG002|Overall Study|Adverse Event|0|||
131197601|NCT04785144|472343411|FG000|Overall Study|Withdrawal by Subject|4|||
131197602|NCT04785144|472343412|FG001|Overall Study|Withdrawal by Subject|1|||
131197603|NCT04785144|472343413|FG002|Overall Study|Withdrawal by Subject|0|||
131197604|NCT04785144|472343414|FG003|Overall Study|Withdrawal by Subject|0|||
131197605|NCT04785144|472343415|FG004|Overall Study|Withdrawal by Subject|0|||
131197606|NCT04785144|472343416|FG005|Overall Study|Withdrawal by Subject|2|||
131197607|NCT04785144|472343417|FG006|Overall Study|Withdrawal by Subject|2|||
131197608|NCT04785144|472343418|FG007|Overall Study|Withdrawal by Subject|0|||
131197609|NCT04785144|472343419|FG008|Overall Study|Withdrawal by Subject|1|||
131197610|NCT04785144|472343420|FG009|Overall Study|Withdrawal by Subject|0|||
131197611|NCT04785144|472343411|FG000|Overall Study|Lost to Follow-up|1|||
131197612|NCT04785144|472343412|FG001|Overall Study|Lost to Follow-up|0|||
131197613|NCT04785144|472343413|FG002|Overall Study|Lost to Follow-up|0|||
131197614|NCT04785144|472343414|FG003|Overall Study|Lost to Follow-up|0|||
131197615|NCT04785144|472343415|FG004|Overall Study|Lost to Follow-up|1|||
131197616|NCT04785144|472343416|FG005|Overall Study|Lost to Follow-up|2|||
131197617|NCT04785144|472343417|FG006|Overall Study|Lost to Follow-up|1|||
131197618|NCT04785144|472343418|FG007|Overall Study|Lost to Follow-up|2|||
131197619|NCT04785144|472343419|FG008|Overall Study|Lost to Follow-up|4|||
131197620|NCT04785144|472343420|FG009|Overall Study|Lost to Follow-up|1|||
131197621|NCT04785144|472343411|FG000|Overall Study|Protocol Violation|0|||
130733735|NCT04186845|470642960|FG000|Overall Study|Subject refused confirmatory imaging|1|||
130733736|NCT04186845|470642960|FG000|Overall Study|Too small to biopsy|1|||
130733737|NCT01814553|470642963|FG000|Overall Study|PD per clinical progression|6|||
131197622|NCT04785144|472343412|FG001|Overall Study|Protocol Violation|0|||
131197623|NCT04785144|472343413|FG002|Overall Study|Protocol Violation|0|||
131197624|NCT04785144|472343414|FG003|Overall Study|Protocol Violation|0|||
131197625|NCT04785144|472343415|FG004|Overall Study|Protocol Violation|0|||
131197626|NCT04785144|472343416|FG005|Overall Study|Protocol Violation|0|||
131197627|NCT04785144|472343417|FG006|Overall Study|Protocol Violation|1|||
131197628|NCT04785144|472343418|FG007|Overall Study|Protocol Violation|0|||
131197629|NCT04785144|472343419|FG008|Overall Study|Protocol Violation|0|||
131197630|NCT04785144|472343420|FG009|Overall Study|Protocol Violation|0|||
131197631|NCT04785144|472343411|FG000|Overall Study|Physician Decision|0|||
131197632|NCT04785144|472343412|FG001|Overall Study|Physician Decision|0|||
131197633|NCT04785144|472343413|FG002|Overall Study|Physician Decision|0|||
131197634|NCT04785144|472343414|FG003|Overall Study|Physician Decision|0|||
131197635|NCT04785144|472343415|FG004|Overall Study|Physician Decision|0|||
131197636|NCT04785144|472343416|FG005|Overall Study|Physician Decision|0|||
131197637|NCT04785144|472343417|FG006|Overall Study|Physician Decision|0|||
131197638|NCT04785144|472343418|FG007|Overall Study|Physician Decision|0|||
131197639|NCT04785144|472343419|FG008|Overall Study|Physician Decision|0|||
131197640|NCT04785144|472343420|FG009|Overall Study|Physician Decision|1|||
131197641|NCT04785144|472343411|FG000|Overall Study|Unable to continue due to work schedule|0|||
131197642|NCT04785144|472343412|FG001|Overall Study|Unable to continue due to work schedule|0|||
131197643|NCT04785144|472343413|FG002|Overall Study|Unable to continue due to work schedule|0|||
131197644|NCT04785144|472343414|FG003|Overall Study|Unable to continue due to work schedule|0|||
131197645|NCT04785144|472343415|FG004|Overall Study|Unable to continue due to work schedule|0|||
131197646|NCT04785144|472343416|FG005|Overall Study|Unable to continue due to work schedule|0|||
131197647|NCT04785144|472343417|FG006|Overall Study|Unable to continue due to work schedule|0|||
131197648|NCT04785144|472343418|FG007|Overall Study|Unable to continue due to work schedule|0|||
131197649|NCT04785144|472343419|FG008|Overall Study|Unable to continue due to work schedule|0|||
131197650|NCT04785144|472343420|FG009|Overall Study|Unable to continue due to work schedule|1|||
131197651|NCT00610714|472343421|FG000|Overall Study|Adverse Event|3|||
131197652|NCT00610714|472343422|FG001|Overall Study|Adverse Event|1|||
131197653|NCT00610714|472343421|FG000|Overall Study|Death|12|||
131197654|NCT00610714|472343422|FG001|Overall Study|Death|18|||
131197655|NCT00610714|472343421|FG000|Overall Study|Withdrawal by Subject|9|||
131197656|NCT00610714|472343422|FG001|Overall Study|Withdrawal by Subject|3|||
131197657|NCT00610714|472343421|FG000|Overall Study|Study completion at 120 PFS events|2|||
131197658|NCT00610714|472343422|FG001|Overall Study|Study completion at 120 PFS events|2|||
131197659|NCT00712712|472343423|FG000|Overall Study|Protocol Violation|11|||
131197660|NCT00712712|472343423|FG000|Overall Study|Radiofrequency not done|3|||
131197661|NCT00712712|472343423|FG000|Overall Study|Death|8|||
131197662|NCT00712712|472343423|FG000|Overall Study|Withdrawal by Subject|1|||
131197663|NCT05549505|472343424|FG000|Overall Study|Lost to Follow-up|2|||
131197664|NCT05549505|472343425|FG001|Overall Study|Lost to Follow-up|0|||
131197665|NCT05549505|472343424|FG000|Overall Study|Withdrawal by Subject|3|||
131197666|NCT05549505|472343425|FG001|Overall Study|Withdrawal by Subject|3|||
131197667|NCT05549505|472343424|FG000|Overall Study|Other: Miscellaneous|3|||
131197668|NCT05549505|472343425|FG001|Overall Study|Other: Miscellaneous|6|||
131197669|NCT01602822|472343428|FG000|Overall Study|Adverse Event|11|||
131197670|NCT05492877|472343432|FG000|Overall Study|Adverse Event|11|||
131197671|NCT05492877|472343433|FG001|Overall Study|Adverse Event|7|||
131197672|NCT05492877|472343432|FG000|Overall Study|Death|1|||
131197673|NCT05492877|472343433|FG001|Overall Study|Death|0|||
131197674|NCT05492877|472343432|FG000|Overall Study|Lost to Follow-up|1|||
131197675|NCT05492877|472343433|FG001|Overall Study|Lost to Follow-up|1|||
131197676|NCT05492877|472343432|FG000|Overall Study|Physician Decision|1|||
131197677|NCT05492877|472343433|FG001|Overall Study|Physician Decision|2|||
131197678|NCT05492877|472343432|FG000|Overall Study|Protocol Violation|1|||
131197679|NCT05492877|472343433|FG001|Overall Study|Protocol Violation|1|||
131197680|NCT05492877|472343432|FG000|Overall Study|Withdrawal by Subject|3|||
131197681|NCT05492877|472343433|FG001|Overall Study|Withdrawal by Subject|7|||
131197682|NCT05492877|472343432|FG000|Overall Study|Reason not specified|6|||
131197683|NCT05492877|472343433|FG001|Overall Study|Reason not specified|4|||
131197684|NCT02286089|472343434|FG000|Overall Study|Ongoing in Study|1|||
131197685|NCT02286089|472343435|FG001|Overall Study|Ongoing in Study|1|||
131197686|NCT02286089|472343436|FG002|Overall Study|Ongoing in Study|4|||
131197687|NCT02286089|472343437|FG003|Overall Study|Ongoing in Study|10|||
131197688|NCT02286089|472343434|FG000|Overall Study|Withdrawal by Subject|0|||
131197689|NCT02286089|472343435|FG001|Overall Study|Withdrawal by Subject|0|||
131197690|NCT02286089|472343436|FG002|Overall Study|Withdrawal by Subject|2|||
131197691|NCT02286089|472343437|FG003|Overall Study|Withdrawal by Subject|2|||
131197692|NCT00129376|472343438|FG000|Overall Study|Adverse Event|1|||
131197693|NCT00129376|472343438|FG000|Overall Study|Lack of Efficacy|1|||
131197694|NCT03218826|472343439|FG000|Overall Study|Non-compliance with protocol|1|||
130733738|NCT01814553|470642964|FG001|Overall Study|PD per clinical progression|8|||
131197695|NCT03218826|472343440|FG001|Overall Study|Non-compliance with protocol|0|||
131197696|NCT03218826|472343441|FG002|Overall Study|Non-compliance with protocol|2|||
131197697|NCT03218826|472343442|FG003|Overall Study|Non-compliance with protocol|1|||
131197698|NCT03218826|472343443|FG004|Overall Study|Non-compliance with protocol|1|||
131197699|NCT01426009|472343444|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
131197700|NCT01426009|472343444|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
131197701|NCT01426009|472343444|FG000|Washout 1|Withdrawal by Subject|1|||
131197702|NCT01426009|472343444|FG000|Washout 1|Personal Reasons|1|||
131197703|NCT01426009|472343444|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
131197704|NCT01426009|472343444|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
131197705|NCT01426009|472343444|FG000|Washout 2|electrive surgery|1|||
131197706|NCT01426009|472343444|FG000|Washout 3|personal reasons|1|||
131197707|NCT01426009|472343444|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
131197708|NCT01426009|472343444|FG000|Washout 4|Lost to Follow-up|1|||
131197709|NCT02723019|472343447|FG000|Overall Study|Death|17|||
131197710|NCT02723019|472343448|FG001|Overall Study|Death|13|||
131197711|NCT02723019|472343447|FG000|Overall Study|Withdrawal by Subject|11|||
131197712|NCT02723019|472343448|FG001|Overall Study|Withdrawal by Subject|7|||
131197713|NCT02723019|472343447|FG000|Overall Study|Lost to Follow-up|57|||
131197714|NCT02723019|472343448|FG001|Overall Study|Lost to Follow-up|70|||
131197715|NCT00515099|472343455|FG000|Overall Study|Lost to Follow-up|0|||
131197716|NCT00515099|472343456|FG001|Overall Study|Lost to Follow-up|4|||
131197717|NCT00515099|472343455|FG000|Overall Study|Withdrawal by Subject|2|||
131197718|NCT00515099|472343456|FG001|Overall Study|Withdrawal by Subject|0|||
131197719|NCT00515099|472343455|FG000|Overall Study|IRB Recommendation|1|||
131197720|NCT00515099|472343456|FG001|Overall Study|IRB Recommendation|0|||
131197721|NCT00592072|472343457|FG000|Wash Out Period|Lost to Follow-up|1|||
131197722|NCT00592072|472343458|FG001|Wash Out Period|Lost to Follow-up|1|||
131197723|NCT05333289|472343460|FG000|Overall Study|Other|1|||
131197724|NCT05333289|472343461|FG001|Overall Study|Other|0|||
131197725|NCT05333289|472343462|FG002|Overall Study|Other|0|||
131197726|NCT05333289|472343463|FG003|Overall Study|Other|1|||
131197727|NCT05333289|472343464|FG004|Overall Study|Other|1|||
131197728|NCT05333289|472343465|FG005|Overall Study|Other|2|||
131197729|NCT05333289|472343466|FG006|Overall Study|Other|2|||
131197730|NCT05333289|472343467|FG007|Overall Study|Other|0|||
131197731|NCT05333289|472343460|FG000|Overall Study|Withdrawal by Subject|1|||
131197732|NCT05333289|472343461|FG001|Overall Study|Withdrawal by Subject|2|||
131197733|NCT05333289|472343462|FG002|Overall Study|Withdrawal by Subject|2|||
131197734|NCT05333289|472343463|FG003|Overall Study|Withdrawal by Subject|1|||
131197735|NCT05333289|472343464|FG004|Overall Study|Withdrawal by Subject|1|||
131197736|NCT05333289|472343465|FG005|Overall Study|Withdrawal by Subject|2|||
131197737|NCT05333289|472343466|FG006|Overall Study|Withdrawal by Subject|1|||
131197738|NCT05333289|472343467|FG007|Overall Study|Withdrawal by Subject|3|||
131197739|NCT05333289|472343460|FG000|Overall Study|Protocol Violation|1|||
131197740|NCT05333289|472343461|FG001|Overall Study|Protocol Violation|0|||
131197741|NCT05333289|472343462|FG002|Overall Study|Protocol Violation|0|||
131197742|NCT05333289|472343463|FG003|Overall Study|Protocol Violation|0|||
131197743|NCT05333289|472343464|FG004|Overall Study|Protocol Violation|0|||
131197744|NCT05333289|472343465|FG005|Overall Study|Protocol Violation|0|||
131197745|NCT05333289|472343466|FG006|Overall Study|Protocol Violation|0|||
131197746|NCT05333289|472343467|FG007|Overall Study|Protocol Violation|0|||
131197747|NCT05333289|472343460|FG000|Overall Study|Physician Decision|0|||
131197748|NCT05333289|472343461|FG001|Overall Study|Physician Decision|0|||
131197749|NCT05333289|472343462|FG002|Overall Study|Physician Decision|1|||
131197750|NCT05333289|472343463|FG003|Overall Study|Physician Decision|0|||
131197751|NCT05333289|472343464|FG004|Overall Study|Physician Decision|0|||
131197752|NCT05333289|472343465|FG005|Overall Study|Physician Decision|2|||
131197753|NCT05333289|472343466|FG006|Overall Study|Physician Decision|0|||
131197754|NCT05333289|472343467|FG007|Overall Study|Physician Decision|0|||
131197755|NCT05333289|472343460|FG000|Overall Study|Lost to Follow-up|6|||
131197756|NCT05333289|472343461|FG001|Overall Study|Lost to Follow-up|0|||
131197757|NCT05333289|472343462|FG002|Overall Study|Lost to Follow-up|1|||
131197758|NCT05333289|472343463|FG003|Overall Study|Lost to Follow-up|6|||
131197759|NCT05333289|472343464|FG004|Overall Study|Lost to Follow-up|3|||
131197760|NCT05333289|472343465|FG005|Overall Study|Lost to Follow-up|3|||
131197761|NCT05333289|472343466|FG006|Overall Study|Lost to Follow-up|2|||
131197762|NCT05333289|472343467|FG007|Overall Study|Lost to Follow-up|1|||
131197763|NCT05333289|472343460|FG000|Overall Study|Death|1|||
131197764|NCT05333289|472343461|FG001|Overall Study|Death|0|||
131197765|NCT05333289|472343462|FG002|Overall Study|Death|0|||
131197766|NCT05333289|472343463|FG003|Overall Study|Death|0|||
131197767|NCT05333289|472343464|FG004|Overall Study|Death|0|||
131197768|NCT05333289|472343465|FG005|Overall Study|Death|0|||
131197769|NCT05333289|472343466|FG006|Overall Study|Death|0|||
131197770|NCT05333289|472343467|FG007|Overall Study|Death|0|||
131197771|NCT04476108|472343468|FG000|Overall Study|Adverse Event|4|||
131197772|NCT04476108|472343469|FG001|Overall Study|Adverse Event|1|||
131197773|NCT04476108|472343468|FG000|Overall Study|Lost to Follow-up|1|||
131197774|NCT04476108|472343469|FG001|Overall Study|Lost to Follow-up|0|||
131197775|NCT04476108|472343468|FG000|Overall Study|Inadvertent Enrollment|1|||
131197776|NCT04476108|472343469|FG001|Overall Study|Inadvertent Enrollment|0|||
130733739|NCT01814553|470642963|FG000|Overall Study|Other Adverse Event|4|||
130733740|NCT01814553|470642964|FG001|Overall Study|Other Adverse Event|5|||
130733741|NCT01814553|470642963|FG000|Overall Study|Withdrawal by Subject|1|||
130733742|NCT01814553|470642964|FG001|Overall Study|Withdrawal by Subject|1|||
131197777|NCT04476108|472343468|FG000|Overall Study|Protocol Violation|1|||
131197778|NCT04476108|472343469|FG001|Overall Study|Protocol Violation|1|||
131197779|NCT04476108|472343468|FG000|Overall Study|Withdrawal by Subject|1|||
131197780|NCT04476108|472343469|FG001|Overall Study|Withdrawal by Subject|1|||
131197781|NCT03685643|472343472|FG000|Overall Study|Lost to Follow-up|14|||
131197782|NCT03685643|472343473|FG001|Overall Study|Lost to Follow-up|22|||
131197783|NCT01197794|472343476|FG000|Overall Study|Adverse Event|3|||
131197784|NCT01197794|472343477|FG001|Overall Study|Adverse Event|2|||
131197785|NCT01197794|472343478|FG002|Overall Study|Adverse Event|4|||
131197786|NCT01197794|472343479|FG003|Overall Study|Adverse Event|4|||
131197787|NCT01197794|472343480|FG004|Overall Study|Adverse Event|4|||
131197788|NCT01197794|472343481|FG005|Overall Study|Adverse Event|2|||
131197789|NCT01197794|472343482|FG006|Overall Study|Adverse Event|3|||
131197790|NCT01197794|472343476|FG000|Overall Study|Protocol Violation|0|||
131197791|NCT01197794|472343477|FG001|Overall Study|Protocol Violation|0|||
131197792|NCT01197794|472343478|FG002|Overall Study|Protocol Violation|0|||
131197793|NCT01197794|472343479|FG003|Overall Study|Protocol Violation|0|||
131197794|NCT01197794|472343480|FG004|Overall Study|Protocol Violation|2|||
131197795|NCT01197794|472343481|FG005|Overall Study|Protocol Violation|0|||
131197796|NCT01197794|472343482|FG006|Overall Study|Protocol Violation|1|||
131197797|NCT01197794|472343476|FG000|Overall Study|Development of study withdrawal criteria|3|||
131197798|NCT01197794|472343477|FG001|Overall Study|Development of study withdrawal criteria|0|||
131197799|NCT01197794|472343478|FG002|Overall Study|Development of study withdrawal criteria|0|||
131197800|NCT01197794|472343479|FG003|Overall Study|Development of study withdrawal criteria|1|||
131197801|NCT01197794|472343480|FG004|Overall Study|Development of study withdrawal criteria|0|||
131197802|NCT01197794|472343481|FG005|Overall Study|Development of study withdrawal criteria|0|||
131197803|NCT01197794|472343482|FG006|Overall Study|Development of study withdrawal criteria|1|||
131197804|NCT01197794|472343476|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
131197805|NCT01197794|472343477|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
131197806|NCT01197794|472343478|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
131197807|NCT01197794|472343479|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
131197808|NCT01197794|472343480|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
131197809|NCT01197794|472343481|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
131197810|NCT01197794|472343482|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
131197811|NCT01197794|472343476|FG000|Overall Study|Withdrawal by Subject|3|||
131197812|NCT01197794|472343477|FG001|Overall Study|Withdrawal by Subject|3|||
131197813|NCT01197794|472343478|FG002|Overall Study|Withdrawal by Subject|4|||
131197814|NCT01197794|472343479|FG003|Overall Study|Withdrawal by Subject|1|||
131197815|NCT01197794|472343480|FG004|Overall Study|Withdrawal by Subject|1|||
131197816|NCT01197794|472343481|FG005|Overall Study|Withdrawal by Subject|5|||
131197817|NCT01197794|472343482|FG006|Overall Study|Withdrawal by Subject|6|||
131197818|NCT01197794|472343476|FG000|Overall Study|Lost to Follow-up|1|||
131197819|NCT01197794|472343477|FG001|Overall Study|Lost to Follow-up|1|||
131197820|NCT01197794|472343478|FG002|Overall Study|Lost to Follow-up|0|||
131197821|NCT01197794|472343479|FG003|Overall Study|Lost to Follow-up|1|||
131197822|NCT01197794|472343480|FG004|Overall Study|Lost to Follow-up|0|||
131197823|NCT01197794|472343481|FG005|Overall Study|Lost to Follow-up|1|||
131197824|NCT01197794|472343482|FG006|Overall Study|Lost to Follow-up|0|||
131197825|NCT01197794|472343476|FG000|Overall Study|Other|1|||
131197826|NCT01197794|472343477|FG001|Overall Study|Other|1|||
131197827|NCT01197794|472343478|FG002|Overall Study|Other|3|||
131197828|NCT01197794|472343479|FG003|Overall Study|Other|0|||
131197829|NCT01197794|472343480|FG004|Overall Study|Other|2|||
131197830|NCT01197794|472343481|FG005|Overall Study|Other|2|||
131197831|NCT01197794|472343482|FG006|Overall Study|Other|4|||
131197832|NCT01055457|472343483|FG000|Overall Study|Lost to Follow-up|0|||
131197833|NCT01055457|472343484|FG001|Overall Study|Lost to Follow-up|1|||
131197834|NCT01055457|472343485|FG002|Overall Study|Lost to Follow-up|0|||
131197835|NCT01055457|472343486|FG003|Overall Study|Lost to Follow-up|0|||
131197836|NCT01055457|472343487|FG004|Overall Study|Lost to Follow-up|0|||
131197837|NCT01055457|472343488|FG005|Overall Study|Lost to Follow-up|1|||
131197838|NCT01055457|472343489|FG006|Overall Study|Lost to Follow-up|0|||
130733743|NCT01814553|470642963|FG000|Overall Study|Other than stated|7|||
131197839|NCT01055457|472343490|FG007|Overall Study|Lost to Follow-up|0|||
131197840|NCT01055457|472343491|FG008|Overall Study|Lost to Follow-up|0|||
131197841|NCT01055457|472343492|FG009|Overall Study|Lost to Follow-up|0|||
131197842|NCT01055457|472343483|FG000|Overall Study|Protocol Violation|0|||
130733744|NCT01814553|470642964|FG001|Overall Study|Other than stated|8|||
130733745|NCT04138823|470642965|FG000|Overall Study|Clinical disease progression|0|||
131197843|NCT01055457|472343484|FG001|Overall Study|Protocol Violation|0|||
131197844|NCT01055457|472343485|FG002|Overall Study|Protocol Violation|1|||
131197845|NCT01055457|472343486|FG003|Overall Study|Protocol Violation|1|||
131197846|NCT01055457|472343487|FG004|Overall Study|Protocol Violation|1|||
131197847|NCT01055457|472343488|FG005|Overall Study|Protocol Violation|2|||
131197848|NCT01055457|472343489|FG006|Overall Study|Protocol Violation|1|||
131197849|NCT01055457|472343490|FG007|Overall Study|Protocol Violation|0|||
131197850|NCT01055457|472343491|FG008|Overall Study|Protocol Violation|0|||
131197851|NCT01055457|472343492|FG009|Overall Study|Protocol Violation|1|||
131197852|NCT01055457|472343483|FG000|Overall Study|Subject Disinterest|0|||
131197853|NCT01055457|472343484|FG001|Overall Study|Subject Disinterest|0|||
131197854|NCT01055457|472343485|FG002|Overall Study|Subject Disinterest|0|||
131197855|NCT01055457|472343486|FG003|Overall Study|Subject Disinterest|0|||
131197856|NCT01055457|472343487|FG004|Overall Study|Subject Disinterest|0|||
131197857|NCT01055457|472343488|FG005|Overall Study|Subject Disinterest|0|||
131197858|NCT01055457|472343489|FG006|Overall Study|Subject Disinterest|0|||
131197859|NCT01055457|472343490|FG007|Overall Study|Subject Disinterest|1|||
131197860|NCT01055457|472343491|FG008|Overall Study|Subject Disinterest|0|||
131197861|NCT01055457|472343492|FG009|Overall Study|Subject Disinterest|0|||
131197862|NCT01055457|472343483|FG000|Overall Study|Subject Ineligible|1|||
131197863|NCT01055457|472343484|FG001|Overall Study|Subject Ineligible|0|||
131197864|NCT01055457|472343485|FG002|Overall Study|Subject Ineligible|1|||
131197865|NCT01055457|472343486|FG003|Overall Study|Subject Ineligible|0|||
131197866|NCT01055457|472343487|FG004|Overall Study|Subject Ineligible|1|||
131197867|NCT01055457|472343488|FG005|Overall Study|Subject Ineligible|0|||
131197868|NCT01055457|472343489|FG006|Overall Study|Subject Ineligible|0|||
131197869|NCT01055457|472343490|FG007|Overall Study|Subject Ineligible|0|||
131197870|NCT01055457|472343491|FG008|Overall Study|Subject Ineligible|0|||
131197871|NCT01055457|472343492|FG009|Overall Study|Subject Ineligible|0|||
131197872|NCT01055457|472343483|FG000|Overall Study|Discomfort|0|||
131197873|NCT01055457|472343484|FG001|Overall Study|Discomfort|0|||
131197874|NCT01055457|472343485|FG002|Overall Study|Discomfort|0|||
131197875|NCT01055457|472343486|FG003|Overall Study|Discomfort|0|||
131197876|NCT01055457|472343487|FG004|Overall Study|Discomfort|1|||
131197877|NCT01055457|472343488|FG005|Overall Study|Discomfort|0|||
131197878|NCT01055457|472343489|FG006|Overall Study|Discomfort|0|||
131197879|NCT01055457|472343490|FG007|Overall Study|Discomfort|0|||
131197880|NCT01055457|472343491|FG008|Overall Study|Discomfort|0|||
131197881|NCT01055457|472343492|FG009|Overall Study|Discomfort|0|||
131197882|NCT01055457|472343483|FG000|Overall Study|Pregnancy|0|||
131197883|NCT01055457|472343484|FG001|Overall Study|Pregnancy|0|||
131197884|NCT01055457|472343485|FG002|Overall Study|Pregnancy|0|||
131197885|NCT01055457|472343486|FG003|Overall Study|Pregnancy|1|||
131197886|NCT01055457|472343487|FG004|Overall Study|Pregnancy|0|||
131197887|NCT01055457|472343488|FG005|Overall Study|Pregnancy|0|||
131197888|NCT01055457|472343489|FG006|Overall Study|Pregnancy|0|||
131197889|NCT01055457|472343490|FG007|Overall Study|Pregnancy|0|||
131197890|NCT01055457|472343491|FG008|Overall Study|Pregnancy|0|||
131197891|NCT01055457|472343492|FG009|Overall Study|Pregnancy|0|||
131197892|NCT01055457|472343483|FG000|Overall Study|Adverse Event|0|||
131197893|NCT01055457|472343484|FG001|Overall Study|Adverse Event|0|||
131197894|NCT01055457|472343485|FG002|Overall Study|Adverse Event|0|||
131197895|NCT01055457|472343486|FG003|Overall Study|Adverse Event|1|||
131197896|NCT01055457|472343487|FG004|Overall Study|Adverse Event|0|||
131197897|NCT01055457|472343488|FG005|Overall Study|Adverse Event|0|||
131197898|NCT01055457|472343489|FG006|Overall Study|Adverse Event|0|||
131197899|NCT01055457|472343490|FG007|Overall Study|Adverse Event|0|||
131197900|NCT01055457|472343491|FG008|Overall Study|Adverse Event|0|||
131197901|NCT01055457|472343492|FG009|Overall Study|Adverse Event|0|||
131197902|NCT04055844|472343493|FG000|Overall Study|Adverse Event|12|||
131197903|NCT04055844|472343493|FG000|Overall Study|Poor Performance|1|||
131197904|NCT04055844|472343493|FG000|Overall Study|Death|1|||
131197905|NCT00572728|472343498|FG000|Overall Study|Withdrawal by Subject|10|||
131197906|NCT00572728|472343498|FG000|Overall Study|Ineligible|3|||
131197907|NCT00572728|472343498|FG000|Overall Study|Enrolled under Amendment 4|5|||
131197908|NCT00572728|472343498|FG000|Overall Study|Offstudy due to complicating disease|1|||
131197909|NCT00572728|472343498|FG000|Overall Study|FLT1 not completed|4|||
131197910|NCT00572728|472343498|FG000|Overall Study|First Chemotherapy not initiated|2|||
131197911|NCT00572728|472343498|FG000|Overall Study|FLT2 not completed|5|||
131197912|NCT00572728|472343498|FG000|Overall Study|Second chemotherapy not initiated|1|||
131197913|NCT00572728|472343498|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
131197914|NCT00572728|472343498|FG000|Overall Study|Pathology missing|1|||
131197915|NCT00374127|472343503|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
131197916|NCT00374127|472343503|FG000|Overall Study|Blood could not be drawn.|2|||
131197917|NCT00374127|472343503|FG000|Overall Study|Protocol Violation|5|||
131197918|NCT00374127|472343503|FG000|Overall Study|Pregnancy|1|||
131197919|NCT02875366|472343504|FG000|Overall Study|Adverse Event|0|||
131197920|NCT02875366|472343505|FG001|Overall Study|Adverse Event|2|||
131197921|NCT02875366|472343504|FG000|Overall Study|Noncompliance|0|||
131197922|NCT02875366|472343505|FG001|Overall Study|Noncompliance|1|||
131197923|NCT01201967|472343508|FG000|Overall Study|Lost to Follow-up|6|||
131197924|NCT01201967|472343509|FG001|Overall Study|Lost to Follow-up|5|||
131197925|NCT04191096|472343513|FG000|Overall Study|Death|102|||
131197926|NCT04191096|472343514|FG001|Overall Study|Death|89|||
131197927|NCT04191096|472343513|FG000|Overall Study|Lost to Follow-up|1|||
131197928|NCT04191096|472343514|FG001|Overall Study|Lost to Follow-up|1|||
131197929|NCT04191096|472343513|FG000|Overall Study|Withdrawal by Subject|5|||
131197930|NCT04191096|472343514|FG001|Overall Study|Withdrawal by Subject|5|||
131197931|NCT04191096|472343513|FG000|Overall Study|Participants Ongoing|518|||
131197932|NCT04191096|472343514|FG001|Overall Study|Participants Ongoing|530|||
131197933|NCT01888965|472345398|FG000|Overall Study|Adverse Event|5|||
131197934|NCT01888965|472345398|FG000|Overall Study|Lack of Efficacy|4|||
131197935|NCT01693562|472345399|FG000|Escalation Phase|Withdrawal by Subject|0|||
131197936|NCT01693562|472345400|FG001|Escalation Phase|Withdrawal by Subject|1|||
131197937|NCT01693562|472345401|FG002|Escalation Phase|Withdrawal by Subject|0|||
131197938|NCT01693562|472345402|FG003|Escalation Phase|Withdrawal by Subject|0|||
131197939|NCT01693562|472345403|FG004|Escalation Phase|Withdrawal by Subject|0|||
131197940|NCT01693562|472345404|FG005|Escalation Phase|Withdrawal by Subject|2|||
131197941|NCT01693562|472345405|FG006|Escalation Phase|Withdrawal by Subject|0|||
131197942|NCT01693562|472345406|FG007|Escalation Phase|Withdrawal by Subject|0|||
131197943|NCT01693562|472345407|FG008|Escalation Phase|Withdrawal by Subject|0|||
131197944|NCT01693562|472345408|FG009|Escalation Phase|Withdrawal by Subject|0|||
131197945|NCT01693562|472345409|FG010|Escalation Phase|Withdrawal by Subject|0|||
131197946|NCT01693562|472345410|FG011|Escalation Phase|Withdrawal by Subject|0|||
131197947|NCT01693562|472345411|FG012|Escalation Phase|Withdrawal by Subject|0|||
131197948|NCT01693562|472345412|FG013|Escalation Phase|Withdrawal by Subject|0|||
131197949|NCT01693562|472345413|FG014|Escalation Phase|Withdrawal by Subject|0|||
131197950|NCT01693562|472345414|FG015|Escalation Phase|Withdrawal by Subject|0|||
131197951|NCT01693562|472345415|FG016|Escalation Phase|Withdrawal by Subject|0|||
131197952|NCT01693562|472345416|FG017|Escalation Phase|Withdrawal by Subject|0|||
131197953|NCT01693562|472345417|FG018|Escalation Phase|Withdrawal by Subject|0|||
131197954|NCT01693562|472345418|FG019|Escalation Phase|Withdrawal by Subject|0|||
131197955|NCT01693562|472345419|FG020|Escalation Phase|Withdrawal by Subject|0|||
131197956|NCT01693562|472345420|FG021|Escalation Phase|Withdrawal by Subject|0|||
131197957|NCT01693562|472345421|FG022|Escalation Phase|Withdrawal by Subject|0|||
131197958|NCT01693562|472345399|FG000|Escalation Phase|Death|4|||
131197959|NCT01693562|472345400|FG001|Escalation Phase|Death|2|||
131197960|NCT01693562|472345401|FG002|Escalation Phase|Death|0|||
131197961|NCT01693562|472345402|FG003|Escalation Phase|Death|3|||
131197962|NCT01693562|472345403|FG004|Escalation Phase|Death|6|||
131197963|NCT01693562|472345404|FG005|Escalation Phase|Death|4|||
131197964|NCT01693562|472345405|FG006|Escalation Phase|Death|0|||
131197965|NCT01693562|472345406|FG007|Escalation Phase|Death|0|||
131197966|NCT01693562|472345407|FG008|Escalation Phase|Death|0|||
131197967|NCT01693562|472345408|FG009|Escalation Phase|Death|0|||
131197968|NCT01693562|472345409|FG010|Escalation Phase|Death|0|||
131197969|NCT01693562|472345410|FG011|Escalation Phase|Death|0|||
131197970|NCT01693562|472345411|FG012|Escalation Phase|Death|0|||
131197971|NCT01693562|472345412|FG013|Escalation Phase|Death|0|||
131197972|NCT01693562|472345413|FG014|Escalation Phase|Death|0|||
131197973|NCT01693562|472345414|FG015|Escalation Phase|Death|0|||
131197974|NCT01693562|472345415|FG016|Escalation Phase|Death|0|||
131197975|NCT01693562|472345416|FG017|Escalation Phase|Death|0|||
131197976|NCT01693562|472345417|FG018|Escalation Phase|Death|0|||
131197977|NCT01693562|472345418|FG019|Escalation Phase|Death|0|||
131197978|NCT01693562|472345419|FG020|Escalation Phase|Death|0|||
131197979|NCT01693562|472345420|FG021|Escalation Phase|Death|0|||
131197980|NCT01693562|472345421|FG022|Escalation Phase|Death|0|||
131197981|NCT01693562|472345399|FG000|Escalation Phase|Lost to Follow-up|0|||
131197982|NCT01693562|472345400|FG001|Escalation Phase|Lost to Follow-up|1|||
131197983|NCT01693562|472345401|FG002|Escalation Phase|Lost to Follow-up|1|||
131197984|NCT01693562|472345402|FG003|Escalation Phase|Lost to Follow-up|0|||
131197985|NCT01693562|472345403|FG004|Escalation Phase|Lost to Follow-up|0|||
131197986|NCT01693562|472345404|FG005|Escalation Phase|Lost to Follow-up|0|||
131197987|NCT01693562|472345405|FG006|Escalation Phase|Lost to Follow-up|0|||
131197988|NCT01693562|472345406|FG007|Escalation Phase|Lost to Follow-up|0|||
131197989|NCT01693562|472345407|FG008|Escalation Phase|Lost to Follow-up|0|||
131197990|NCT01693562|472345408|FG009|Escalation Phase|Lost to Follow-up|0|||
131197991|NCT01693562|472345409|FG010|Escalation Phase|Lost to Follow-up|0|||
131197992|NCT01693562|472345410|FG011|Escalation Phase|Lost to Follow-up|0|||
131197993|NCT01693562|472345411|FG012|Escalation Phase|Lost to Follow-up|0|||
131197994|NCT01693562|472345412|FG013|Escalation Phase|Lost to Follow-up|0|||
131197995|NCT01693562|472345413|FG014|Escalation Phase|Lost to Follow-up|0|||
131197996|NCT01693562|472345414|FG015|Escalation Phase|Lost to Follow-up|0|||
131197997|NCT01693562|472345415|FG016|Escalation Phase|Lost to Follow-up|0|||
131197998|NCT01693562|472345416|FG017|Escalation Phase|Lost to Follow-up|0|||
131197999|NCT01693562|472345417|FG018|Escalation Phase|Lost to Follow-up|0|||
131198000|NCT01693562|472345418|FG019|Escalation Phase|Lost to Follow-up|0|||
131198001|NCT01693562|472345419|FG020|Escalation Phase|Lost to Follow-up|0|||
131198002|NCT01693562|472345420|FG021|Escalation Phase|Lost to Follow-up|0|||
131198003|NCT01693562|472345421|FG022|Escalation Phase|Lost to Follow-up|0|||
131198004|NCT01693562|472345399|FG000|Escalation Phase|Other|0|||
131198005|NCT01693562|472345400|FG001|Escalation Phase|Other|0|||
131198006|NCT01693562|472345401|FG002|Escalation Phase|Other|2|||
131198007|NCT01693562|472345402|FG003|Escalation Phase|Other|0|||
131198008|NCT01693562|472345403|FG004|Escalation Phase|Other|0|||
131198009|NCT01693562|472345404|FG005|Escalation Phase|Other|1|||
131198010|NCT01693562|472345405|FG006|Escalation Phase|Other|0|||
131198011|NCT01693562|472345406|FG007|Escalation Phase|Other|0|||
131198012|NCT01693562|472345407|FG008|Escalation Phase|Other|0|||
131198013|NCT01693562|472345408|FG009|Escalation Phase|Other|0|||
131198014|NCT01693562|472345409|FG010|Escalation Phase|Other|0|||
131198015|NCT01693562|472345410|FG011|Escalation Phase|Other|0|||
131198016|NCT01693562|472345411|FG012|Escalation Phase|Other|0|||
131198017|NCT01693562|472345412|FG013|Escalation Phase|Other|0|||
131198018|NCT01693562|472345413|FG014|Escalation Phase|Other|0|||
131198019|NCT01693562|472345414|FG015|Escalation Phase|Other|0|||
131198020|NCT01693562|472345415|FG016|Escalation Phase|Other|0|||
131198021|NCT01693562|472345416|FG017|Escalation Phase|Other|0|||
131198022|NCT01693562|472345417|FG018|Escalation Phase|Other|0|||
131198023|NCT01693562|472345418|FG019|Escalation Phase|Other|0|||
131198024|NCT01693562|472345419|FG020|Escalation Phase|Other|0|||
131198025|NCT01693562|472345420|FG021|Escalation Phase|Other|0|||
131198026|NCT01693562|472345421|FG022|Escalation Phase|Other|0|||
131198027|NCT01693562|472345399|FG000|Exploration Phase|Withdrawal by Subject|0|||
131198028|NCT01693562|472345400|FG001|Exploration Phase|Withdrawal by Subject|0|||
131198029|NCT01693562|472345401|FG002|Exploration Phase|Withdrawal by Subject|0|||
131198030|NCT01693562|472345402|FG003|Exploration Phase|Withdrawal by Subject|0|||
131198031|NCT01693562|472345403|FG004|Exploration Phase|Withdrawal by Subject|0|||
131198032|NCT01693562|472345404|FG005|Exploration Phase|Withdrawal by Subject|0|||
131198033|NCT01693562|472345405|FG006|Exploration Phase|Withdrawal by Subject|2|||
131198034|NCT01693562|472345406|FG007|Exploration Phase|Withdrawal by Subject|0|||
131198035|NCT01693562|472345407|FG008|Exploration Phase|Withdrawal by Subject|0|||
131198036|NCT01693562|472345408|FG009|Exploration Phase|Withdrawal by Subject|0|||
131198037|NCT01693562|472345409|FG010|Exploration Phase|Withdrawal by Subject|0|||
131198038|NCT01693562|472345410|FG011|Exploration Phase|Withdrawal by Subject|0|||
131198039|NCT01693562|472345411|FG012|Exploration Phase|Withdrawal by Subject|0|||
131198040|NCT01693562|472345412|FG013|Exploration Phase|Withdrawal by Subject|0|||
131198041|NCT01693562|472345413|FG014|Exploration Phase|Withdrawal by Subject|0|||
131198042|NCT01693562|472345414|FG015|Exploration Phase|Withdrawal by Subject|0|||
131198043|NCT01693562|472345415|FG016|Exploration Phase|Withdrawal by Subject|0|||
131198044|NCT01693562|472345416|FG017|Exploration Phase|Withdrawal by Subject|0|||
131198045|NCT01693562|472345417|FG018|Exploration Phase|Withdrawal by Subject|0|||
131198046|NCT01693562|472345418|FG019|Exploration Phase|Withdrawal by Subject|0|||
131198047|NCT01693562|472345419|FG020|Exploration Phase|Withdrawal by Subject|0|||
131198048|NCT01693562|472345420|FG021|Exploration Phase|Withdrawal by Subject|0|||
131198049|NCT01693562|472345421|FG022|Exploration Phase|Withdrawal by Subject|0|||
131198050|NCT01693562|472345399|FG000|Exploration Phase|Death|0|||
131198051|NCT01693562|472345400|FG001|Exploration Phase|Death|0|||
131198052|NCT01693562|472345401|FG002|Exploration Phase|Death|0|||
131198053|NCT01693562|472345402|FG003|Exploration Phase|Death|0|||
131198054|NCT01693562|472345403|FG004|Exploration Phase|Death|0|||
131198055|NCT01693562|472345404|FG005|Exploration Phase|Death|0|||
131198056|NCT01693562|472345405|FG006|Exploration Phase|Death|17|||
131198057|NCT01693562|472345406|FG007|Exploration Phase|Death|0|||
131198058|NCT01693562|472345407|FG008|Exploration Phase|Death|0|||
131198059|NCT01693562|472345408|FG009|Exploration Phase|Death|0|||
131198060|NCT01693562|472345409|FG010|Exploration Phase|Death|0|||
131198061|NCT01693562|472345410|FG011|Exploration Phase|Death|0|||
131198062|NCT01693562|472345411|FG012|Exploration Phase|Death|0|||
131198063|NCT01693562|472345412|FG013|Exploration Phase|Death|0|||
131198064|NCT01693562|472345413|FG014|Exploration Phase|Death|0|||
131198065|NCT01693562|472345414|FG015|Exploration Phase|Death|0|||
131198066|NCT01693562|472345415|FG016|Exploration Phase|Death|0|||
131198067|NCT01693562|472345416|FG017|Exploration Phase|Death|0|||
131198068|NCT01693562|472345417|FG018|Exploration Phase|Death|0|||
131198069|NCT01693562|472345418|FG019|Exploration Phase|Death|0|||
131198070|NCT01693562|472345419|FG020|Exploration Phase|Death|0|||
131198071|NCT01693562|472345420|FG021|Exploration Phase|Death|0|||
131198072|NCT01693562|472345421|FG022|Exploration Phase|Death|0|||
131198073|NCT01693562|472345399|FG000|Exploration Phase|Other|0|||
131198074|NCT01693562|472345400|FG001|Exploration Phase|Other|0|||
131198075|NCT01693562|472345401|FG002|Exploration Phase|Other|0|||
131198076|NCT01693562|472345402|FG003|Exploration Phase|Other|0|||
131198077|NCT01693562|472345403|FG004|Exploration Phase|Other|0|||
131198078|NCT01693562|472345404|FG005|Exploration Phase|Other|0|||
131198079|NCT01693562|472345405|FG006|Exploration Phase|Other|2|||
131198080|NCT01693562|472345406|FG007|Exploration Phase|Other|0|||
131198081|NCT01693562|472345407|FG008|Exploration Phase|Other|0|||
131198082|NCT01693562|472345408|FG009|Exploration Phase|Other|0|||
131198083|NCT01693562|472345409|FG010|Exploration Phase|Other|0|||
131198084|NCT01693562|472345410|FG011|Exploration Phase|Other|0|||
131198085|NCT01693562|472345411|FG012|Exploration Phase|Other|0|||
131198086|NCT01693562|472345412|FG013|Exploration Phase|Other|0|||
131198087|NCT01693562|472345413|FG014|Exploration Phase|Other|0|||
131198088|NCT01693562|472345414|FG015|Exploration Phase|Other|0|||
131198089|NCT01693562|472345415|FG016|Exploration Phase|Other|0|||
131198090|NCT01693562|472345416|FG017|Exploration Phase|Other|0|||
131198091|NCT01693562|472345417|FG018|Exploration Phase|Other|0|||
131198092|NCT01693562|472345418|FG019|Exploration Phase|Other|0|||
131198093|NCT01693562|472345419|FG020|Exploration Phase|Other|0|||
131198094|NCT01693562|472345420|FG021|Exploration Phase|Other|0|||
131198095|NCT01693562|472345421|FG022|Exploration Phase|Other|0|||
131198096|NCT01693562|472345399|FG000|Expansion Phase|Withdrawal by Subject|0|||
131198097|NCT01693562|472345400|FG001|Expansion Phase|Withdrawal by Subject|0|||
131198098|NCT01693562|472345401|FG002|Expansion Phase|Withdrawal by Subject|0|||
131198099|NCT01693562|472345402|FG003|Expansion Phase|Withdrawal by Subject|0|||
131198100|NCT01693562|472345403|FG004|Expansion Phase|Withdrawal by Subject|0|||
131198101|NCT01693562|472345404|FG005|Expansion Phase|Withdrawal by Subject|0|||
131198102|NCT01693562|472345405|FG006|Expansion Phase|Withdrawal by Subject|0|||
131198103|NCT01693562|472345406|FG007|Expansion Phase|Withdrawal by Subject|16|||
131198104|NCT01693562|472345407|FG008|Expansion Phase|Withdrawal by Subject|2|||
131198105|NCT01693562|472345408|FG009|Expansion Phase|Withdrawal by Subject|54|||
131198106|NCT01693562|472345409|FG010|Expansion Phase|Withdrawal by Subject|2|||
131198107|NCT01693562|472345410|FG011|Expansion Phase|Withdrawal by Subject|2|||
131198108|NCT01693562|472345411|FG012|Expansion Phase|Withdrawal by Subject|3|||
131198109|NCT01693562|472345412|FG013|Expansion Phase|Withdrawal by Subject|5|||
131198110|NCT01693562|472345413|FG014|Expansion Phase|Withdrawal by Subject|16|||
131198111|NCT01693562|472345414|FG015|Expansion Phase|Withdrawal by Subject|7|||
131198112|NCT01693562|472345415|FG016|Expansion Phase|Withdrawal by Subject|40|||
131198113|NCT01693562|472345416|FG017|Expansion Phase|Withdrawal by Subject|4|||
131198114|NCT01693562|472345417|FG018|Expansion Phase|Withdrawal by Subject|8|||
131198115|NCT01693562|472345418|FG019|Expansion Phase|Withdrawal by Subject|3|||
131198116|NCT01693562|472345419|FG020|Expansion Phase|Withdrawal by Subject|1|||
131198117|NCT01693562|472345420|FG021|Expansion Phase|Withdrawal by Subject|8|||
131198118|NCT01693562|472345421|FG022|Expansion Phase|Withdrawal by Subject|1|||
131198119|NCT01693562|472345399|FG000|Expansion Phase|Death|0|||
131198120|NCT01693562|472345400|FG001|Expansion Phase|Death|0|||
131198121|NCT01693562|472345401|FG002|Expansion Phase|Death|0|||
131198122|NCT01693562|472345402|FG003|Expansion Phase|Death|0|||
131198123|NCT01693562|472345403|FG004|Expansion Phase|Death|0|||
131198124|NCT01693562|472345404|FG005|Expansion Phase|Death|0|||
131198125|NCT01693562|472345405|FG006|Expansion Phase|Death|0|||
131198126|NCT01693562|472345406|FG007|Expansion Phase|Death|42|||
131198127|NCT01693562|472345407|FG008|Expansion Phase|Death|17|||
131198128|NCT01693562|472345408|FG009|Expansion Phase|Death|208|||
131198129|NCT01693562|472345409|FG010|Expansion Phase|Death|30|||
131198130|NCT01693562|472345410|FG011|Expansion Phase|Death|8|||
131198131|NCT01693562|472345411|FG012|Expansion Phase|Death|19|||
131198132|NCT01693562|472345412|FG013|Expansion Phase|Death|42|||
131198133|NCT01693562|472345413|FG014|Expansion Phase|Death|23|||
131198134|NCT01693562|472345414|FG015|Expansion Phase|Death|23|||
131198135|NCT01693562|472345415|FG016|Expansion Phase|Death|128|||
131198136|NCT01693562|472345416|FG017|Expansion Phase|Death|16|||
131198137|NCT01693562|472345417|FG018|Expansion Phase|Death|36|||
131198138|NCT01693562|472345418|FG019|Expansion Phase|Death|16|||
131198139|NCT01693562|472345419|FG020|Expansion Phase|Death|17|||
131198140|NCT01693562|472345420|FG021|Expansion Phase|Death|35|||
131198141|NCT01693562|472345421|FG022|Expansion Phase|Death|7|||
131198142|NCT01693562|472345399|FG000|Expansion Phase|Lost to Follow-up|0|||
131198143|NCT01693562|472345400|FG001|Expansion Phase|Lost to Follow-up|0|||
131198144|NCT01693562|472345401|FG002|Expansion Phase|Lost to Follow-up|0|||
131198145|NCT01693562|472345402|FG003|Expansion Phase|Lost to Follow-up|0|||
131198146|NCT01693562|472345403|FG004|Expansion Phase|Lost to Follow-up|0|||
131198147|NCT01693562|472345404|FG005|Expansion Phase|Lost to Follow-up|0|||
131198148|NCT01693562|472345405|FG006|Expansion Phase|Lost to Follow-up|0|||
131198149|NCT01693562|472345406|FG007|Expansion Phase|Lost to Follow-up|1|||
131198150|NCT01693562|472345407|FG008|Expansion Phase|Lost to Follow-up|2|||
131198151|NCT01693562|472345408|FG009|Expansion Phase|Lost to Follow-up|10|||
131198152|NCT01693562|472345409|FG010|Expansion Phase|Lost to Follow-up|4|||
131198153|NCT01693562|472345410|FG011|Expansion Phase|Lost to Follow-up|4|||
131198154|NCT01693562|472345411|FG012|Expansion Phase|Lost to Follow-up|1|||
131198155|NCT01693562|472345412|FG013|Expansion Phase|Lost to Follow-up|3|||
131198156|NCT01693562|472345413|FG014|Expansion Phase|Lost to Follow-up|0|||
131198157|NCT01693562|472345414|FG015|Expansion Phase|Lost to Follow-up|1|||
131198158|NCT01693562|472345415|FG016|Expansion Phase|Lost to Follow-up|1|||
131198159|NCT01693562|472345416|FG017|Expansion Phase|Lost to Follow-up|0|||
131198160|NCT01693562|472345417|FG018|Expansion Phase|Lost to Follow-up|2|||
131198161|NCT01693562|472345418|FG019|Expansion Phase|Lost to Follow-up|1|||
131198162|NCT01693562|472345419|FG020|Expansion Phase|Lost to Follow-up|2|||
131198163|NCT01693562|472345420|FG021|Expansion Phase|Lost to Follow-up|2|||
131198164|NCT01693562|472345421|FG022|Expansion Phase|Lost to Follow-up|1|||
131198165|NCT01693562|472345399|FG000|Expansion Phase|Other|0|||
131198166|NCT01693562|472345400|FG001|Expansion Phase|Other|0|||
131198167|NCT01693562|472345401|FG002|Expansion Phase|Other|0|||
131198168|NCT01693562|472345402|FG003|Expansion Phase|Other|0|||
131198169|NCT01693562|472345403|FG004|Expansion Phase|Other|0|||
131198170|NCT01693562|472345404|FG005|Expansion Phase|Other|0|||
131198171|NCT01693562|472345405|FG006|Expansion Phase|Other|0|||
131198172|NCT01693562|472345406|FG007|Expansion Phase|Other|3|||
131198173|NCT01693562|472345407|FG008|Expansion Phase|Other|1|||
131198174|NCT01693562|472345408|FG009|Expansion Phase|Other|28|||
131198175|NCT01693562|472345409|FG010|Expansion Phase|Other|4|||
131198176|NCT01693562|472345410|FG011|Expansion Phase|Other|7|||
131198177|NCT01693562|472345411|FG012|Expansion Phase|Other|0|||
131198178|NCT01693562|472345412|FG013|Expansion Phase|Other|1|||
131198179|NCT01693562|472345413|FG014|Expansion Phase|Other|1|||
131198180|NCT01693562|472345414|FG015|Expansion Phase|Other|0|||
131198181|NCT01693562|472345415|FG016|Expansion Phase|Other|28|||
131198182|NCT01693562|472345416|FG017|Expansion Phase|Other|0|||
131198183|NCT01693562|472345417|FG018|Expansion Phase|Other|1|||
131198184|NCT01693562|472345418|FG019|Expansion Phase|Other|0|||
131198185|NCT01693562|472345419|FG020|Expansion Phase|Other|1|||
131198186|NCT01693562|472345420|FG021|Expansion Phase|Other|17|||
131198187|NCT01693562|472345421|FG022|Expansion Phase|Other|1|||
131198188|NCT00887822|472345427|FG000|Overall Study|Insufficient therapeutic response|53|||
131198189|NCT00887822|472345428|FG001|Overall Study|Insufficient therapeutic response|55|||
131198190|NCT00887822|472345427|FG000|Overall Study|Adverse Event|14|||
131198191|NCT00887822|472345428|FG001|Overall Study|Adverse Event|17|||
131198192|NCT00887822|472345427|FG000|Overall Study|Failure to return|11|||
131198193|NCT00887822|472345428|FG001|Overall Study|Failure to return|11|||
131198194|NCT00887822|472345427|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
131198195|NCT00887822|472345428|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
131198196|NCT00887822|472345427|FG000|Overall Study|Administrative/Other than specified|5|||
131198197|NCT00887822|472345428|FG001|Overall Study|Administrative/Other than specified|4|||
131198198|NCT00887822|472345427|FG000|Overall Study|Death|2|||
131198199|NCT00887822|472345428|FG001|Overall Study|Death|3|||
131198200|NCT00887822|472345427|FG000|Overall Study|Protocol Violation|0|||
131198201|NCT00887822|472345428|FG001|Overall Study|Protocol Violation|1|||
131198202|NCT00887822|472345427|FG000|Overall Study|Randomized but not treated|0|||
131198203|NCT00887822|472345428|FG001|Overall Study|Randomized but not treated|1|||
131198204|NCT02045979|472345429|FG000|Overall Study|Informed Consent Withdrawn|2|||
131198205|NCT02045979|472345430|FG001|Overall Study|Informed Consent Withdrawn|0|||
131198206|NCT02045979|472345431|FG002|Overall Study|Informed Consent Withdrawn|1|||
131198207|NCT02045979|472345429|FG000|Overall Study|not specified above|0|||
131198208|NCT02045979|472345430|FG001|Overall Study|not specified above|1|||
131198209|NCT02045979|472345431|FG002|Overall Study|not specified above|0|||
131198210|NCT02987205|472345433|FG000|Overall Study|Adverse Event|1|||
131198211|NCT02987205|472345433|FG000|Overall Study|Withdrawal by Subject|3|||
131198212|NCT02145429|472345434|FG000|Overall Study|Death|4|||
131198213|NCT02145429|472345435|FG001|Overall Study|Death|5|||
131198214|NCT02145429|472345434|FG000|Overall Study|Lost to Follow-up|4|||
131198215|NCT02145429|472345435|FG001|Overall Study|Lost to Follow-up|3|||
131198216|NCT02145429|472345434|FG000|Overall Study|Withdrawal by Subject|8|||
131198217|NCT02145429|472345435|FG001|Overall Study|Withdrawal by Subject|3|||
131198218|NCT02094612|472345436|FG000|Overall Study|Lost to Follow-up|47|||
131198219|NCT02094612|472345437|FG001|Overall Study|Lost to Follow-up|47|||
131198220|NCT02094612|472345436|FG000|Overall Study|Never started ADHD medication|32|||
131198221|NCT02094612|472345437|FG001|Overall Study|Never started ADHD medication|23|||
131198222|NCT04167514|472345438|FG000|Overall Study|Adverse event, not serious|0|||
131198223|NCT04167514|472345439|FG001|Overall Study|Adverse event, not serious|1|||
131198224|NCT04167514|472345438|FG000|Overall Study|Lost to Follow-up|1|||
131198225|NCT04167514|472345439|FG001|Overall Study|Lost to Follow-up|0|||
131198226|NCT04167514|472345438|FG000|Overall Study|Participant Decision|2|||
131198227|NCT04167514|472345439|FG001|Overall Study|Participant Decision|4|||
131198228|NCT04167514|472345438|FG000|Overall Study|Physician Decision|3|||
131198229|NCT04167514|472345439|FG001|Overall Study|Physician Decision|2|||
131198230|NCT04167514|472345438|FG000|Overall Study|Death|14|||
131198231|NCT04167514|472345439|FG001|Overall Study|Death|18|||
131198232|NCT04167514|472345438|FG000|Overall Study|Enrolled but treatment not administered|2|||
131198233|NCT04167514|472345439|FG001|Overall Study|Enrolled but treatment not administered|0|||
131198234|NCT04167514|472345438|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
131198235|NCT04167514|472345439|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
131198236|NCT04167514|472345438|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
131198237|NCT04167514|472345439|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
131198238|NCT03345849|472345440|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
131198239|NCT03345849|472345441|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
131198240|NCT03345849|472345442|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
131198241|NCT03345849|472345443|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
131198242|NCT03345849|472345440|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
131198243|NCT03345849|472345441|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
131198244|NCT03345849|472345442|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
131198245|NCT03345849|472345443|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
131198246|NCT03345849|472345440|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
131198247|NCT03345849|472345441|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
131198248|NCT03345849|472345442|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
131198249|NCT03345849|472345443|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
131198250|NCT03345849|472345440|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
131198251|NCT03345849|472345441|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
131198252|NCT03345849|472345442|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
131198253|NCT03345849|472345443|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
131198254|NCT03345849|472345440|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
131198255|NCT03345849|472345441|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
131198256|NCT03345849|472345442|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
131198257|NCT03345849|472345443|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
131198258|NCT03345849|472345440|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
131198259|NCT03345849|472345441|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
131198260|NCT03345849|472345442|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
131198261|NCT03345849|472345443|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
131198262|NCT03345849|472345440|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
131198263|NCT03345849|472345441|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
131198264|NCT03345849|472345442|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
131198265|NCT03345849|472345443|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
131198266|NCT03345849|472345440|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
131198267|NCT03345849|472345441|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
131198268|NCT03345849|472345442|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
131198269|NCT03345849|472345443|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
131198270|NCT03345849|472345440|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
131198271|NCT03345849|472345441|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
131198272|NCT03345849|472345442|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
131198273|NCT03345849|472345443|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
131198274|NCT03345849|472345440|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
131198275|NCT03345849|472345441|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
131198276|NCT03345849|472345442|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
131198277|NCT03345849|472345443|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
131198278|NCT03345849|472345440|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
131198279|NCT03345849|472345441|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
131198280|NCT03345849|472345442|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
131198281|NCT03345849|472345443|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
131198282|NCT03261037|472345444|FG000|Overall Study|Withdrawal by Subject|2|||
131198283|NCT03261037|472345445|FG001|Overall Study|Withdrawal by Subject|13|||
131198284|NCT03261037|472345446|FG002|Overall Study|Withdrawal by Subject|0|||
131198285|NCT03261037|472345447|FG003|Overall Study|Withdrawal by Subject|18|||
131198286|NCT03261037|472345444|FG000|Overall Study|Non-compliance with study procedures|0|||
131198287|NCT03261037|472345445|FG001|Overall Study|Non-compliance with study procedures|2|||
131198288|NCT03261037|472345446|FG002|Overall Study|Non-compliance with study procedures|0|||
131198289|NCT03261037|472345447|FG003|Overall Study|Non-compliance with study procedures|6|||
131198290|NCT03261037|472345444|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
131198291|NCT03261037|472345445|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
131198292|NCT03261037|472345446|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
131198293|NCT03261037|472345447|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
131198294|NCT03261037|472345444|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
131198295|NCT03261037|472345445|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
131198296|NCT03261037|472345446|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
131198297|NCT03261037|472345447|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
131198298|NCT03261037|472345444|FG000|Overall Study|Diagnosed but protocol deviation|1|||
131198299|NCT03261037|472345445|FG001|Overall Study|Diagnosed but protocol deviation|0|||
131198300|NCT03261037|472345446|FG002|Overall Study|Diagnosed but protocol deviation|0|||
131198301|NCT03261037|472345447|FG003|Overall Study|Diagnosed but protocol deviation|0|||
131198302|NCT03261037|472345444|FG000|Overall Study|Participant did not want to continue the study|0|||
131198303|NCT03261037|472345445|FG001|Overall Study|Participant did not want to continue the study|1|||
131198304|NCT03261037|472345446|FG002|Overall Study|Participant did not want to continue the study|0|||
131198305|NCT03261037|472345447|FG003|Overall Study|Participant did not want to continue the study|0|||
131198306|NCT03261037|472345444|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
131198307|NCT03261037|472345445|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
131198308|NCT03261037|472345446|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
131198309|NCT03261037|472345447|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
131198310|NCT03261037|472345444|FG000|Overall Study|Participant presented clinical improvement|0|||
131198311|NCT03261037|472345445|FG001|Overall Study|Participant presented clinical improvement|2|||
131198312|NCT03261037|472345446|FG002|Overall Study|Participant presented clinical improvement|0|||
131198313|NCT03261037|472345447|FG003|Overall Study|Participant presented clinical improvement|0|||
131198314|NCT03261037|472345444|FG000|Overall Study|Technical difficulties|0|||
131198315|NCT03261037|472345445|FG001|Overall Study|Technical difficulties|0|||
131198316|NCT03261037|472345446|FG002|Overall Study|Technical difficulties|0|||
131198317|NCT03261037|472345447|FG003|Overall Study|Technical difficulties|1|||
131198318|NCT03261037|472345444|FG000|Overall Study|Equipment failed to work|0|||
131198319|NCT03261037|472345445|FG001|Overall Study|Equipment failed to work|0|||
131198320|NCT03261037|472345446|FG002|Overall Study|Equipment failed to work|0|||
131198321|NCT03261037|472345447|FG003|Overall Study|Equipment failed to work|1|||
131198322|NCT03261037|472345444|FG000|Overall Study|End of study for participant and no follow up|0|||
131198323|NCT03261037|472345445|FG001|Overall Study|End of study for participant and no follow up|0|||
131198324|NCT03261037|472345446|FG002|Overall Study|End of study for participant and no follow up|0|||
131198325|NCT03261037|472345447|FG003|Overall Study|End of study for participant and no follow up|1|||
131198326|NCT03261037|472345444|FG000|Overall Study|Participant was too weak to continue in study|1|||
131198327|NCT03261037|472345445|FG001|Overall Study|Participant was too weak to continue in study|0|||
131198328|NCT03261037|472345446|FG002|Overall Study|Participant was too weak to continue in study|0|||
131198329|NCT03261037|472345447|FG003|Overall Study|Participant was too weak to continue in study|0|||
131198330|NCT05618808|472345450|FG000|Overall Study|Withdrawal by Subject|3|||
131198331|NCT05618808|472345451|FG001|Overall Study|Withdrawal by Subject|1|||
131198332|NCT05618808|472345452|FG002|Overall Study|Withdrawal by Subject|3|||
131198333|NCT05298774|472345459|FG000|Overall Study|Physician Decision|3|||
131198334|NCT05298774|472345459|FG000|Overall Study|Withdrawal by Subject|2|||
131198335|NCT05298774|472345459|FG000|Overall Study|Lost to Follow-up|3|||
131198336|NCT05298774|472345459|FG000|Overall Study|Screen failure|1|||
131198337|NCT00777036|472345466|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
131198338|NCT00777036|472345467|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
131198339|NCT00777036|472345468|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
131198340|NCT00777036|472345469|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
131198341|NCT00777036|472345466|FG000|On Treatment|Administrative Reason By Sponsor|1|||
131198342|NCT00777036|472345467|FG001|On Treatment|Administrative Reason By Sponsor|0|||
131198343|NCT00777036|472345468|FG002|On Treatment|Administrative Reason By Sponsor|9|||
131198344|NCT00777036|472345469|FG003|On Treatment|Administrative Reason By Sponsor|0|||
131198345|NCT00777036|472345466|FG000|On Treatment|Failure to Meet Study Criteria|0|||
131198346|NCT00777036|472345467|FG001|On Treatment|Failure to Meet Study Criteria|1|||
131198347|NCT00777036|472345468|FG002|On Treatment|Failure to Meet Study Criteria|4|||
131198348|NCT00777036|472345469|FG003|On Treatment|Failure to Meet Study Criteria|0|||
131198349|NCT00777036|472345466|FG000|On Treatment|Pregnancy|1|||
131198350|NCT00777036|472345467|FG001|On Treatment|Pregnancy|0|||
131198351|NCT00777036|472345468|FG002|On Treatment|Pregnancy|1|||
131198352|NCT00777036|472345469|FG003|On Treatment|Pregnancy|0|||
131198353|NCT00777036|472345466|FG000|On Treatment|Non-compliance with Study Drug|1|||
131198354|NCT00777036|472345467|FG001|On Treatment|Non-compliance with Study Drug|0|||
131198355|NCT00777036|472345468|FG002|On Treatment|Non-compliance with Study Drug|1|||
131198356|NCT00777036|472345469|FG003|On Treatment|Non-compliance with Study Drug|0|||
131198357|NCT00777036|472345466|FG000|On Treatment|Maximum Clinical Benefit|2|||
131198358|NCT00777036|472345467|FG001|On Treatment|Maximum Clinical Benefit|0|||
131198359|NCT00777036|472345468|FG002|On Treatment|Maximum Clinical Benefit|5|||
131198360|NCT00777036|472345469|FG003|On Treatment|Maximum Clinical Benefit|0|||
131198361|NCT00777036|472345466|FG000|On Treatment|Withdrawal by Subject|0|||
131198362|NCT00777036|472345467|FG001|On Treatment|Withdrawal by Subject|2|||
131198363|NCT00777036|472345468|FG002|On Treatment|Withdrawal by Subject|2|||
131198364|NCT00777036|472345469|FG003|On Treatment|Withdrawal by Subject|0|||
131198365|NCT00777036|472345466|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
131198366|NCT00777036|472345467|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
131198367|NCT00777036|472345468|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
131198368|NCT00777036|472345469|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
131198369|NCT00777036|472345466|FG000|On Treatment|Death|0|||
131198370|NCT00777036|472345467|FG001|On Treatment|Death|2|||
131198371|NCT00777036|472345468|FG002|On Treatment|Death|0|||
131198372|NCT00777036|472345469|FG003|On Treatment|Death|0|||
131198373|NCT00777036|472345466|FG000|On Treatment|Study Drug Toxicity|1|||
131198374|NCT00777036|472345467|FG001|On Treatment|Study Drug Toxicity|0|||
131198375|NCT00777036|472345468|FG002|On Treatment|Study Drug Toxicity|4|||
131198376|NCT00777036|472345469|FG003|On Treatment|Study Drug Toxicity|0|||
131198377|NCT00777036|472345466|FG000|On Treatment|Progressive Disease|6|||
131198378|NCT00777036|472345467|FG001|On Treatment|Progressive Disease|4|||
131198379|NCT00777036|472345468|FG002|On Treatment|Progressive Disease|7|||
131198380|NCT00777036|472345469|FG003|On Treatment|Progressive Disease|0|||
131198381|NCT00777036|472345466|FG000|On Treatment|Not Reported|0|||
131198382|NCT00777036|472345467|FG001|On Treatment|Not Reported|0|||
131198383|NCT00777036|472345468|FG002|On Treatment|Not Reported|2|||
131198384|NCT00777036|472345469|FG003|On Treatment|Not Reported|0|||
131198385|NCT00777036|472345466|FG000|On Treatment|Site Closed|0|||
131198386|NCT00777036|472345467|FG001|On Treatment|Site Closed|1|||
131198387|NCT00777036|472345468|FG002|On Treatment|Site Closed|1|||
131198388|NCT00777036|472345469|FG003|On Treatment|Site Closed|0|||
131198389|NCT00777036|472345466|FG000|Follow-Up|Withdrawal by Subject|0|||
131198390|NCT00777036|472345467|FG001|Follow-Up|Withdrawal by Subject|0|||
131198391|NCT00777036|472345468|FG002|Follow-Up|Withdrawal by Subject|5|||
131198392|NCT00777036|472345469|FG003|Follow-Up|Withdrawal by Subject|0|||
131198393|NCT00777036|472345466|FG000|Follow-Up|Death|1|||
131198394|NCT00777036|472345467|FG001|Follow-Up|Death|9|||
131198395|NCT00777036|472345468|FG002|Follow-Up|Death|0|||
131198396|NCT00777036|472345469|FG003|Follow-Up|Death|0|||
131198397|NCT00777036|472345466|FG000|Follow-Up|Lost to Follow-up|3|||
131198398|NCT00777036|472345467|FG001|Follow-Up|Lost to Follow-up|0|||
131198399|NCT00777036|472345468|FG002|Follow-Up|Lost to Follow-up|0|||
131198400|NCT00777036|472345469|FG003|Follow-Up|Lost to Follow-up|0|||
131198401|NCT00777036|472345466|FG000|Follow-Up|Reason Not Specified|4|||
131198402|NCT00777036|472345467|FG001|Follow-Up|Reason Not Specified|0|||
131198403|NCT00777036|472345468|FG002|Follow-Up|Reason Not Specified|13|||
131198404|NCT00777036|472345469|FG003|Follow-Up|Reason Not Specified|0|||
131198405|NCT00777036|472345466|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
131198406|NCT00777036|472345467|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
131198407|NCT00777036|472345468|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
131198408|NCT00777036|472345469|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
131198409|NCT01263470|472345470|FG000|Overall Study|Adverse Event|2|||
131198410|NCT01263470|472345471|FG001|Overall Study|Adverse Event|2|||
131198411|NCT01263470|472345472|FG002|Overall Study|Adverse Event|1|||
131198412|NCT01263470|472345473|FG003|Overall Study|Adverse Event|1|||
131198413|NCT01263470|472345474|FG004|Overall Study|Adverse Event|2|||
131198414|NCT01263470|472345475|FG005|Overall Study|Adverse Event|2|||
131198415|NCT01263470|472345470|FG000|Overall Study|Protocol Violation|0|||
131198416|NCT01263470|472345471|FG001|Overall Study|Protocol Violation|1|||
131198417|NCT01263470|472345472|FG002|Overall Study|Protocol Violation|0|||
131198418|NCT01263470|472345473|FG003|Overall Study|Protocol Violation|0|||
131198419|NCT01263470|472345474|FG004|Overall Study|Protocol Violation|0|||
131198420|NCT01263470|472345475|FG005|Overall Study|Protocol Violation|1|||
131198421|NCT01263470|472345470|FG000|Overall Study|Withdrawal by Subject|0|||
131198422|NCT01263470|472345471|FG001|Overall Study|Withdrawal by Subject|1|||
131198423|NCT01263470|472345472|FG002|Overall Study|Withdrawal by Subject|1|||
131198424|NCT01263470|472345473|FG003|Overall Study|Withdrawal by Subject|2|||
131198425|NCT01263470|472345474|FG004|Overall Study|Withdrawal by Subject|0|||
131198426|NCT01263470|472345475|FG005|Overall Study|Withdrawal by Subject|2|||
131198427|NCT01263470|472345470|FG000|Overall Study|Lack of Efficacy|0|||
131198428|NCT01263470|472345471|FG001|Overall Study|Lack of Efficacy|0|||
131198429|NCT01263470|472345472|FG002|Overall Study|Lack of Efficacy|2|||
131198430|NCT01263470|472345473|FG003|Overall Study|Lack of Efficacy|0|||
131198431|NCT01263470|472345474|FG004|Overall Study|Lack of Efficacy|0|||
131198432|NCT01263470|472345475|FG005|Overall Study|Lack of Efficacy|0|||
131198433|NCT01263470|472345470|FG000|Overall Study|Participant Unavailability|0|||
131198434|NCT01263470|472345471|FG001|Overall Study|Participant Unavailability|1|||
131198435|NCT01263470|472345472|FG002|Overall Study|Participant Unavailability|0|||
131198436|NCT01263470|472345473|FG003|Overall Study|Participant Unavailability|0|||
131198437|NCT01263470|472345474|FG004|Overall Study|Participant Unavailability|0|||
131198438|NCT01263470|472345475|FG005|Overall Study|Participant Unavailability|0|||
131198439|NCT01263470|472345470|FG000|Overall Study|Study Drug Non-compliance|0|||
131198440|NCT01263470|472345471|FG001|Overall Study|Study Drug Non-compliance|0|||
131198441|NCT01263470|472345472|FG002|Overall Study|Study Drug Non-compliance|0|||
131198442|NCT01263470|472345473|FG003|Overall Study|Study Drug Non-compliance|0|||
131198443|NCT01263470|472345474|FG004|Overall Study|Study Drug Non-compliance|1|||
131198444|NCT01263470|472345475|FG005|Overall Study|Study Drug Non-compliance|0|||
131198445|NCT03598140|472345476|FG000|Overall Study|enrolled but didn't start|1|||
131198446|NCT03598140|472345477|FG001|Overall Study|enrolled but didn't start|0|||
131198447|NCT01029691|472345478|FG000|Continued APAP to Delivery|Death|0|||
131198448|NCT01029691|472345479|FG001|Continued APAP to Delivery|Death|0|||
131198449|NCT01029691|472345480|FG002|Continued APAP to Delivery|Death|1|||
131198450|NCT02871791|472345486|FG000|Phase 1b|Death|0|||
131198451|NCT02871791|472345487|FG001|Phase 1b|Death|1|||
131198452|NCT02871791|472345486|FG000|Phase 1b|progressive disease|6|||
131198453|NCT02871791|472345487|FG001|Phase 1b|progressive disease|2|||
131198454|NCT02871791|472345486|FG000|Phase 2|Death|1|||
131198455|NCT02871791|472345487|FG001|Phase 2|Death|0|||
131198456|NCT02871791|472345486|FG000|Phase 2|Lost to Follow-up|2|||
131198457|NCT02871791|472345487|FG001|Phase 2|Lost to Follow-up|0|||
131198458|NCT02750501|472345494|FG000|Overall Study|Adverse Event|4|||
131198459|NCT02750501|472345494|FG000|Overall Study|Physician Decision|1|||
131198460|NCT02750501|472345494|FG000|Overall Study|Protocol Violation|1|||
131198461|NCT02750501|472345494|FG000|Overall Study|G-tube came out|1|||
131198462|NCT02750501|472345494|FG000|Overall Study|Non-compliant use of PERT|1|||
131198463|NCT00403390|472345495|FG000|Overall Study|Withdrawal by Subject|1|||
131198464|NCT00403390|472345496|FG001|Overall Study|Withdrawal by Subject|0|||
131198465|NCT00403390|472345495|FG000|Overall Study|samples lost|1|||
131198466|NCT00403390|472345496|FG001|Overall Study|samples lost|0|||
131198467|NCT00403390|472345495|FG000|Overall Study|non-compliant|1|||
131198468|NCT00403390|472345496|FG001|Overall Study|non-compliant|0|||
131198469|NCT00942422|472345497|FG000|Overall Study|Withdrawal by Subject|1|||
131198470|NCT00942422|472345497|FG000|Overall Study|Death|1|||
131198471|NCT00942422|472345497|FG000|Overall Study|Progressive diease|1|||
131198472|NCT02711553|472345500|FG000|Overall Study|Withdrawal by Subject|2|||
131198473|NCT02711553|472345501|FG001|Overall Study|Withdrawal by Subject|1|||
131198474|NCT02711553|472345502|FG002|Overall Study|Withdrawal by Subject|1|||
131198475|NCT02711553|472345503|FG003|Overall Study|Withdrawal by Subject|0|||
131198476|NCT02711553|472345500|FG000|Overall Study|Lost to Follow-up|3|||
131198477|NCT02711553|472345501|FG001|Overall Study|Lost to Follow-up|3|||
131198478|NCT02711553|472345502|FG002|Overall Study|Lost to Follow-up|6|||
131198479|NCT02711553|472345503|FG003|Overall Study|Lost to Follow-up|3|||
131198480|NCT02711553|472345500|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
131198481|NCT02711553|472345501|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
131198482|NCT02711553|472345502|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
131198483|NCT02711553|472345503|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
131198484|NCT05559203|472345504|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
131198485|NCT04048876|472345505|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
131198486|NCT04048876|472345506|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
131198487|NCT04048876|472345507|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
131198488|NCT04048876|472345508|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
131198489|NCT04048876|472345505|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
131198490|NCT04048876|472345506|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
131198491|NCT04048876|472345507|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
131198492|NCT04048876|472345508|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
131198493|NCT04048876|472345505|FG000|Placebo Controlled Phase|Adverse Event|0|||
131198494|NCT04048876|472345506|FG001|Placebo Controlled Phase|Adverse Event|1|||
131198495|NCT04048876|472345507|FG002|Placebo Controlled Phase|Adverse Event|0|||
131198496|NCT04048876|472345508|FG003|Placebo Controlled Phase|Adverse Event|0|||
131198497|NCT04048876|472345505|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
131198498|NCT04048876|472345506|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
131198499|NCT04048876|472345507|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
131198500|NCT04048876|472345508|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
131198501|NCT02187224|472345509|FG000|Overall Study|Did not show up for test day|1|||
131198502|NCT02187224|472345510|FG001|Overall Study|Did not show up for test day|0|||
131198503|NCT01347840|472345515|FG000|Overall Study|Withdrawal by Subject|1|||
131198504|NCT03858686|472345522|FG000|Period 1|Adverse Event|1|||
131198505|NCT03858686|472345523|FG001|Period 1|Adverse Event|1|||
131198506|NCT03858686|472345522|FG000|Period 1|Lack of compliance|0|||
131198507|NCT03858686|472345523|FG001|Period 1|Lack of compliance|1|||
131198508|NCT03858686|472345522|FG000|Period 1|Adverse Event|0|||
131198509|NCT03858686|472345523|FG001|Period 1|Adverse Event|1|||
131198510|NCT03858686|472345522|FG000|Period 2|Adverse Event|0|||
131198511|NCT03858686|472345523|FG001|Period 2|Adverse Event|1|||
131198512|NCT03231228|472345525|FG000|Overall Study|Lost to Follow-up|2|||
131198513|NCT03231228|472345526|FG001|Overall Study|Lost to Follow-up|0|||
131198514|NCT03231228|472345525|FG000|Overall Study|Physician Decision|1|||
131198515|NCT03231228|472345526|FG001|Overall Study|Physician Decision|0|||
131198516|NCT02299206|472345527|FG000|Overall Study|Lost to Follow-up|1|||
131198517|NCT02299206|472345527|FG000|Overall Study|Withdrawal by Subject|1|||
131198518|NCT01682759|472345531|FG000|Overall Study|Death|2|||
131198519|NCT01682759|472345532|FG001|Overall Study|Death|1|||
131198520|NCT01682759|472345531|FG000|Overall Study|Lost to Follow-up|10|||
131198521|NCT01682759|472345532|FG001|Overall Study|Lost to Follow-up|13|||
131198522|NCT01682759|472345531|FG000|Overall Study|Physician Decision|1|||
131198523|NCT01682759|472345532|FG001|Overall Study|Physician Decision|1|||
131198524|NCT01682759|472345531|FG000|Overall Study|Withdrawal by Subject|56|||
131198525|NCT01682759|472345532|FG001|Overall Study|Withdrawal by Subject|55|||
131198526|NCT02683668|472345536|FG000|Period 2|Withdrawal by Subject|0|||
131198527|NCT02683668|472345537|FG001|Period 2|Withdrawal by Subject|1|||
131198528|NCT02683668|472345538|FG002|Period 2|Withdrawal by Subject|0|||
131198529|NCT03893630|472345539|FG000|Overall Study|Lost to Follow-up|5|||
131198530|NCT03893630|472345540|FG001|Overall Study|Lost to Follow-up|4|||
131198531|NCT03893630|472345541|FG002|Overall Study|Lost to Follow-up|2|||
131198532|NCT03893630|472345539|FG000|Overall Study|Withdrawal by Subject|3|||
131198533|NCT03893630|472345540|FG001|Overall Study|Withdrawal by Subject|6|||
130733746|NCT04138823|470642966|FG001|Overall Study|Clinical disease progression|0|||
130733747|NCT04138823|470642967|FG002|Overall Study|Clinical disease progression|1|||
130733748|NCT04138823|470642965|FG000|Overall Study|Objective disease progression|3|||
130733749|NCT04138823|470642966|FG001|Overall Study|Objective disease progression|2|||
130733750|NCT04138823|470642967|FG002|Overall Study|Objective disease progression|5|||
130733751|NCT02859142|470642968|FG000|Overall Study|Adverse Event|1|||
131198534|NCT03893630|472345541|FG002|Overall Study|Withdrawal by Subject|3|||
131198535|NCT03893630|472345539|FG000|Overall Study|Discontinued Intervention|0|||
131198536|NCT03893630|472345540|FG001|Overall Study|Discontinued Intervention|4|||
131198537|NCT03893630|472345541|FG002|Overall Study|Discontinued Intervention|2|||
131198538|NCT01855919|472347067|FG000|Overall Study|Adverse Event|16|||
131198539|NCT01855919|472347068|FG001|Overall Study|Adverse Event|8|||
131198540|NCT01855919|472347067|FG000|Overall Study|Lack of Efficacy|1|||
131198541|NCT01855919|472347068|FG001|Overall Study|Lack of Efficacy|3|||
131198542|NCT01855919|472347067|FG000|Overall Study|Withdrawal by Subject|4|||
131198543|NCT01855919|472347068|FG001|Overall Study|Withdrawal by Subject|10|||
131198544|NCT01855919|472347067|FG000|Overall Study|Entry Criteria Not Met|1|||
131198545|NCT01855919|472347068|FG001|Overall Study|Entry Criteria Not Met|1|||
131198546|NCT01855919|472347067|FG000|Overall Study|Protocol Violation|1|||
131198547|NCT01855919|472347068|FG001|Overall Study|Protocol Violation|4|||
131198548|NCT00186121|472347074|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
131198549|NCT00186121|472347074|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
131198550|NCT00186121|472347074|FG000|Overall Study|Not eligible (no treatment)|1|||
131198551|NCT03650387|472347075|FG000|Overall Study|Withdrawal by Subject|13|||
131198552|NCT03650387|472347075|FG000|Overall Study|Lost to Follow-up|12|||
131198553|NCT03650387|472347075|FG000|Overall Study|Adverse Event (Not related)|1|||
131198554|NCT03650387|472347075|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
131198555|NCT01569568|472347076|FG000|Overall Study|Physician Decision|0|||
131198556|NCT01569568|472347077|FG001|Overall Study|Physician Decision|2|||
131198557|NCT05815758|472347078|FG000|Overall Study|Adverse Event|6|||
131198558|NCT05815758|472347079|FG001|Overall Study|Adverse Event|2|||
131198559|NCT05815758|472347078|FG000|Overall Study|Lost to Follow-up|14|||
131198560|NCT05815758|472347079|FG001|Overall Study|Lost to Follow-up|1|||
131198561|NCT05815758|472347078|FG000|Overall Study|Withdrawal by Subject|6|||
131198562|NCT05815758|472347079|FG001|Overall Study|Withdrawal by Subject|6|||
131198563|NCT05815758|472347078|FG000|Overall Study|Protocol Violation|1|||
131198564|NCT05815758|472347079|FG001|Overall Study|Protocol Violation|1|||
131198565|NCT05815758|472347078|FG000|Overall Study|Discontinued|4|||
131198566|NCT05815758|472347079|FG001|Overall Study|Discontinued|4|||
131198567|NCT03661983|472347080|FG000|Open Label Stabilization Phase|Adverse Event|5|||
131198568|NCT03661983|472347081|FG001|Open Label Stabilization Phase|Adverse Event|0|||
131198569|NCT03661983|472347082|FG002|Open Label Stabilization Phase|Adverse Event|0|||
131198570|NCT03661983|472347083|FG003|Open Label Stabilization Phase|Adverse Event|0|||
131198571|NCT03661983|472347080|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
131198572|NCT03661983|472347081|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
131198573|NCT03661983|472347082|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
131198574|NCT03661983|472347083|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
131198575|NCT03661983|472347080|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
131198576|NCT03661983|472347081|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
131198577|NCT03661983|472347082|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
131198578|NCT03661983|472347083|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
131198579|NCT03661983|472347080|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
131198580|NCT03661983|472347081|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
130733752|NCT02859142|470642969|FG001|Overall Study|Adverse Event|2|||
131198581|NCT03661983|472347082|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
131198582|NCT03661983|472347083|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
131198583|NCT03661983|472347080|FG000|Double-blind Randomized Phase|Adverse Event|0|||
130733753|NCT02859142|470642968|FG000|Overall Study|Lost to Follow-up|1|||
131198584|NCT03661983|472347081|FG001|Double-blind Randomized Phase|Adverse Event|1|||
131198585|NCT03661983|472347082|FG002|Double-blind Randomized Phase|Adverse Event|0|||
131198586|NCT03661983|472347083|FG003|Double-blind Randomized Phase|Adverse Event|0|||
131198587|NCT03661983|472347080|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
131198588|NCT03661983|472347081|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
131198589|NCT03661983|472347082|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
131198590|NCT03661983|472347083|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
131198591|NCT03661983|472347080|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
131198592|NCT03661983|472347081|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
131198593|NCT03661983|472347082|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
131198594|NCT03661983|472347083|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
131198595|NCT03661983|472347080|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
130733754|NCT02859142|470642969|FG001|Overall Study|Lost to Follow-up|4|||
131198596|NCT03661983|472347081|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
131198597|NCT03661983|472347082|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
131198598|NCT03661983|472347083|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
131198599|NCT02425891|472347085|FG000|Overall Study|Death|333|||
131198600|NCT02425891|472347086|FG001|Overall Study|Death|314|||
131198601|NCT02425891|472347085|FG000|Overall Study|Lost to Follow-up|4|||
131198602|NCT02425891|472347086|FG001|Overall Study|Lost to Follow-up|6|||
131198603|NCT02425891|472347085|FG000|Overall Study|Non-Compliance|1|||
131198604|NCT02425891|472347086|FG001|Overall Study|Non-Compliance|1|||
131198605|NCT02425891|472347085|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
131198606|NCT02425891|472347086|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
131198607|NCT02425891|472347085|FG000|Overall Study|Physician Decision|0|||
131198608|NCT02425891|472347086|FG001|Overall Study|Physician Decision|1|||
131198609|NCT02425891|472347085|FG000|Overall Study|Protocol Violation|1|||
131198610|NCT02425891|472347086|FG001|Overall Study|Protocol Violation|1|||
131198611|NCT02425891|472347085|FG000|Overall Study|Study Terminated By Sponsor|85|||
131198612|NCT02425891|472347086|FG001|Overall Study|Study Terminated By Sponsor|95|||
131198613|NCT02425891|472347085|FG000|Overall Study|Withdrawal by Subject|27|||
131198614|NCT02425891|472347086|FG001|Overall Study|Withdrawal by Subject|32|||
131198615|NCT04124952|472347087|FG000|Overall Study|Lost to Follow-up|1|||
131198616|NCT01654224|472347091|FG000|Overall Study|Lost to Follow-up|2|||
131198617|NCT01654224|472347092|FG001|Overall Study|Lost to Follow-up|2|||
131198618|NCT01654224|472347091|FG000|Overall Study|Did not receive allocation|1|||
131198619|NCT01654224|472347092|FG001|Overall Study|Did not receive allocation|8|||
131198620|NCT01654224|472347091|FG000|Overall Study|Insufficient blood sample|3|||
131198621|NCT01654224|472347092|FG001|Overall Study|Insufficient blood sample|2|||
131198622|NCT00166504|472347093|FG000|Overall Study|Adverse Event|3|||
131198623|NCT00166504|472347094|FG001|Overall Study|Adverse Event|3|||
131198624|NCT00166504|472347093|FG000|Overall Study|Lost to Follow-up|1|||
131198625|NCT00166504|472347094|FG001|Overall Study|Lost to Follow-up|1|||
131198626|NCT00166504|472347093|FG000|Overall Study|Withdrawal by Subject|1|||
131198627|NCT00166504|472347094|FG001|Overall Study|Withdrawal by Subject|0|||
131198628|NCT03558503|472347095|FG000|Overall Study|Adverse Event|1|||
131198629|NCT03558503|472347095|FG000|Overall Study|Death|1|||
131198630|NCT03558503|472347095|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
131198631|NCT02943577|472347096|FG000|Overall Study|Protocol Violation|0|||
131198632|NCT02943577|472347097|FG001|Overall Study|Protocol Violation|1|||
131198633|NCT02943577|472347096|FG000|Overall Study|Adverse Event|3|||
131198634|NCT02943577|472347097|FG001|Overall Study|Adverse Event|2|||
131198635|NCT02943577|472347096|FG000|Overall Study|Lost to Follow-up|0|||
131198636|NCT02943577|472347097|FG001|Overall Study|Lost to Follow-up|1|||
131198637|NCT02943577|472347096|FG000|Overall Study|Withdrawal by Subject|1|||
131198638|NCT02943577|472347097|FG001|Overall Study|Withdrawal by Subject|1|||
131198639|NCT02943577|472347096|FG000|Overall Study|Pregnancy|1|||
131198640|NCT02943577|472347097|FG001|Overall Study|Pregnancy|0|||
131198641|NCT01944462|472347102|FG000|PPPP Educational Program|Lost to Follow-up|60|||
131198642|NCT01222767|472347103|FG000|Overall Study|Progressive disease|13|||
131198643|NCT01222767|472347103|FG000|Overall Study|Adverse Event|2|||
131198644|NCT01222767|472347103|FG000|Overall Study|Surgical resection|1|||
131198645|NCT01222767|472347103|FG000|Overall Study|Never treated|1|||
131198646|NCT00723489|472347104|FG000|Overall Study|Physician Decision|0|||
131198647|NCT00723489|472347105|FG001|Overall Study|Physician Decision|1|||
131198648|NCT00723489|472347106|FG002|Overall Study|Physician Decision|0|||
131198649|NCT00723489|472347107|FG003|Overall Study|Physician Decision|0|||
131198650|NCT00723489|472347104|FG000|Overall Study|Pregnancy|0|||
131198651|NCT00723489|472347105|FG001|Overall Study|Pregnancy|0|||
131198652|NCT00723489|472347106|FG002|Overall Study|Pregnancy|0|||
131198653|NCT00723489|472347107|FG003|Overall Study|Pregnancy|1|||
131198654|NCT00723489|472347104|FG000|Overall Study|Withdrawal by Subject|0|||
131198655|NCT00723489|472347105|FG001|Overall Study|Withdrawal by Subject|0|||
131198656|NCT00723489|472347106|FG002|Overall Study|Withdrawal by Subject|0|||
131198657|NCT00723489|472347107|FG003|Overall Study|Withdrawal by Subject|1|||
131198658|NCT00723489|472347104|FG000|Overall Study|Seropositive at baseline|1|||
131198659|NCT00723489|472347105|FG001|Overall Study|Seropositive at baseline|0|||
131198660|NCT00723489|472347106|FG002|Overall Study|Seropositive at baseline|0|||
131198661|NCT00723489|472347107|FG003|Overall Study|Seropositive at baseline|0|||
131198662|NCT00723489|472347104|FG000|Overall Study|Prohibited Medication|0|||
131198663|NCT00723489|472347105|FG001|Overall Study|Prohibited Medication|0|||
131198664|NCT00723489|472347106|FG002|Overall Study|Prohibited Medication|0|||
131198665|NCT00723489|472347107|FG003|Overall Study|Prohibited Medication|1|||
131198666|NCT00723489|472347104|FG000|Overall Study|Samples Collected Out of Window|0|||
131198667|NCT00723489|472347105|FG001|Overall Study|Samples Collected Out of Window|3|||
131198668|NCT00723489|472347106|FG002|Overall Study|Samples Collected Out of Window|0|||
131198669|NCT00723489|472347107|FG003|Overall Study|Samples Collected Out of Window|0|||
131198670|NCT04437511|472347108|FG000|Overall Study|Adverse Event|50|||
131198671|NCT04437511|472347109|FG001|Overall Study|Adverse Event|21|||
130733755|NCT02859142|470642968|FG000|Overall Study|Withdrawal by Subject|2|||
131198672|NCT04437511|472347108|FG000|Overall Study|Death|15|||
131198673|NCT04437511|472347109|FG001|Overall Study|Death|10|||
131198674|NCT04437511|472347108|FG000|Overall Study|Lost to Follow-up|11|||
131198675|NCT04437511|472347109|FG001|Overall Study|Lost to Follow-up|11|||
131198676|NCT04437511|472347108|FG000|Overall Study|Physician Decision|19|||
131198677|NCT04437511|472347109|FG001|Overall Study|Physician Decision|10|||
131198678|NCT04437511|472347108|FG000|Overall Study|Progressive Disease|4|||
131198679|NCT04437511|472347109|FG001|Overall Study|Progressive Disease|7|||
131198680|NCT04437511|472347108|FG000|Overall Study|Withdrawal by Subject|111|||
131198681|NCT04437511|472347109|FG001|Overall Study|Withdrawal by Subject|94|||
131198682|NCT04437511|472347108|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
131198683|NCT04437511|472347109|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
131198684|NCT04437511|472347108|FG000|Overall Study|Continuing Study|7|||
131198685|NCT04437511|472347109|FG001|Overall Study|Continuing Study|5|||
131198686|NCT04654468|472347112|FG000|Overall Study|Death|1|||
131198687|NCT04654468|472347112|FG000|Overall Study|Ongoing in the Study|50|||
131198688|NCT03093350|472347113|FG000|Overall Study|Death|1|||
131198689|NCT03093350|472347113|FG000|Overall Study|Signed consent, never began treartment|1|||
131198690|NCT05564039|472347114|FG000|Overall Study|Adverse Event|1|||
131198691|NCT05564039|472347115|FG001|Overall Study|Adverse Event|0|||
131198692|NCT05564039|472347114|FG000|Overall Study|Death|1|||
131198693|NCT05564039|472347115|FG001|Overall Study|Death|1|||
131198694|NCT05564039|472347114|FG000|Overall Study|Lost to Follow-up|3|||
131198695|NCT05564039|472347115|FG001|Overall Study|Lost to Follow-up|2|||
131198696|NCT05564039|472347114|FG000|Overall Study|Withdrawal by Subject|2|||
131198697|NCT05564039|472347115|FG001|Overall Study|Withdrawal by Subject|0|||
131198698|NCT05564039|472347114|FG000|Overall Study|Inadvertent enrollment|3|||
131198699|NCT05564039|472347115|FG001|Overall Study|Inadvertent enrollment|6|||
131198700|NCT02421939|472347116|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
131198701|NCT02421939|472347117|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
131198702|NCT02421939|472347116|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
131198703|NCT02421939|472347117|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
131198704|NCT02421939|472347116|FG000|Randomization Period: Up to 3 Years|Death|38|||
131198705|NCT02421939|472347117|FG001|Randomization Period: Up to 3 Years|Death|10|||
131198706|NCT02421939|472347116|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
131198707|NCT02421939|472347117|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
131198708|NCT02421939|472347116|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
131198709|NCT02421939|472347117|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
131198710|NCT02421939|472347116|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
131198711|NCT02421939|472347117|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
131198712|NCT02421939|472347116|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
131198713|NCT02421939|472347117|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
131198714|NCT02421939|472347116|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
131198715|NCT02421939|472347117|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
131198716|NCT02421939|472347116|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
131198717|NCT02421939|472347117|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
131198718|NCT02421939|472347116|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
131198719|NCT02421939|472347117|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
131198720|NCT02421939|472347116|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
131198721|NCT02421939|472347117|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
131198722|NCT02421939|472347116|FG000|Long Term Follow up: up to 3 Years|Death|118|||
131198723|NCT02421939|472347117|FG001|Long Term Follow up: up to 3 Years|Death|65|||
131198724|NCT02421939|472347116|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
131198725|NCT02421939|472347117|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
131198726|NCT00729560|472347120|FG000|Overall Study|Withdrawal by Subject|3|||
131198727|NCT00103207|472347121|FG000|Overall Study|Adverse Event|3|||
131198728|NCT00103207|472347121|FG000|Overall Study|Death|1|||
131198729|NCT00103207|472347121|FG000|Overall Study|Withdrawal by Subject|2|||
131198730|NCT00103207|472347121|FG000|Overall Study|Other complicating disease|1|||
131198731|NCT00103207|472347121|FG000|Overall Study|Ineligible|4|||
131198732|NCT00103207|472347121|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
131198733|NCT03662789|472347122|FG000|Overall Study|Lost to Follow-up|1|||
131198734|NCT03662789|472347123|FG001|Overall Study|Lost to Follow-up|2|||
131198735|NCT03662789|472347122|FG000|Overall Study|Could not perform treadmill test|4|||
131198736|NCT03662789|472347123|FG001|Overall Study|Could not perform treadmill test|4|||
131198737|NCT03662789|472347122|FG000|Overall Study|Death|0|||
131198738|NCT03662789|472347123|FG001|Overall Study|Death|1|||
131198739|NCT01023516|472347125|FG000|Overall Study|Voluntary discontinuation|7|||
131198740|NCT01023516|472347126|FG001|Overall Study|Voluntary discontinuation|5|||
131198741|NCT01023516|472347125|FG000|Overall Study|Adverse Event|9|||
131198742|NCT01023516|472347126|FG001|Overall Study|Adverse Event|6|||
131198743|NCT01023516|472347125|FG000|Overall Study|Safety reason|0|||
131198744|NCT01023516|472347126|FG001|Overall Study|Safety reason|3|||
131198745|NCT01023516|472347125|FG000|Overall Study|Study-specific criteria|4|||
131198746|NCT01023516|472347126|FG001|Overall Study|Study-specific criteria|2|||
131198747|NCT01023516|472347125|FG000|Overall Study|Incorrect enrolment|4|||
131198748|NCT01023516|472347126|FG001|Overall Study|Incorrect enrolment|2|||
131198749|NCT02559115|472347127|FG000|Overall Study|Withdrawal by Subject|3|||
131198750|NCT02060903|472347132|FG000|Overall Study|Lost to Follow-up|4|||
131198751|NCT02060903|472347133|FG001|Overall Study|Lost to Follow-up|0|||
131198752|NCT02060903|472347132|FG000|Overall Study|Withdrawal by Subject|0|||
131198753|NCT02060903|472347133|FG001|Overall Study|Withdrawal by Subject|7|||
131198754|NCT00137267|472347134|FG000|Overall Study|Lost to Follow-up|15|||
131198755|NCT00137267|472347135|FG001|Overall Study|Lost to Follow-up|21|||
131198756|NCT00638989|472347136|FG000|Overall Study|Lost to Follow-up|0|||
131198757|NCT00638989|472347137|FG001|Overall Study|Lost to Follow-up|0|||
131198758|NCT00638989|472347138|FG002|Overall Study|Lost to Follow-up|1|||
131198759|NCT04556175|472347140|FG000|Overall Study|Study terminated due to COVID-19|8|||
131198760|NCT04556175|472347141|FG001|Overall Study|Study terminated due to COVID-19|8|||
131198761|NCT01553591|472347142|FG000|Overall Study|Voluntarily withdrew|94|||
131198762|NCT01553591|472347143|FG001|Overall Study|Voluntarily withdrew|79|||
131198763|NCT01553591|472347144|FG002|Overall Study|Voluntarily withdrew|96|||
131198764|NCT01553591|472347142|FG000|Overall Study|Adverse Event|36|||
131198765|NCT01553591|472347143|FG001|Overall Study|Adverse Event|45|||
131198766|NCT01553591|472347144|FG002|Overall Study|Adverse Event|16|||
131198767|NCT01553591|472347142|FG000|Overall Study|Lost to Follow-up|25|||
131198768|NCT01553591|472347143|FG001|Overall Study|Lost to Follow-up|23|||
131198769|NCT01553591|472347144|FG002|Overall Study|Lost to Follow-up|16|||
131198770|NCT01553591|472347142|FG000|Overall Study|Physician decision: other|11|||
131198771|NCT01553591|472347143|FG001|Overall Study|Physician decision: other|14|||
131198772|NCT01553591|472347144|FG002|Overall Study|Physician decision: other|16|||
131198773|NCT01553591|472347142|FG000|Overall Study|Physician decision: lack of efficacy|2|||
131198774|NCT01553591|472347143|FG001|Overall Study|Physician decision: lack of efficacy|3|||
131198775|NCT01553591|472347144|FG002|Overall Study|Physician decision: lack of efficacy|7|||
131198776|NCT01553591|472347142|FG000|Overall Study|Protocol Violation|3|||
131198777|NCT01553591|472347143|FG001|Overall Study|Protocol Violation|4|||
131198778|NCT01553591|472347144|FG002|Overall Study|Protocol Violation|4|||
131198779|NCT01553591|472347142|FG000|Overall Study|Sponsor decision|1|||
131198780|NCT01553591|472347143|FG001|Overall Study|Sponsor decision|0|||
131198781|NCT01553591|472347144|FG002|Overall Study|Sponsor decision|3|||
131198782|NCT01553591|472347142|FG000|Overall Study|Randomized and never dispensed drug|0|||
131198783|NCT01553591|472347143|FG001|Overall Study|Randomized and never dispensed drug|1|||
131198784|NCT01553591|472347144|FG002|Overall Study|Randomized and never dispensed drug|0|||
131198785|NCT04005755|472347145|FG000|Overall Study|Adverse Event|6|||
131198786|NCT04005755|472347145|FG000|Overall Study|Physician Decision|3|||
131198787|NCT04005755|472347145|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
131198788|NCT04005755|472347145|FG000|Overall Study|Withdrawal by Subject|3|||
131198789|NCT04005755|472347145|FG000|Overall Study|Lost to Follow-up|1|||
131198790|NCT00611767|472347146|FG000|Overall Study|Withdrawal by Subject|4|||
131198791|NCT00611767|472347147|FG001|Overall Study|Withdrawal by Subject|1|||
131198792|NCT00611767|472347146|FG000|Overall Study|Thiopental not available|3|||
131198793|NCT00611767|472347147|FG001|Overall Study|Thiopental not available|0|||
131198794|NCT00611767|472347146|FG000|Overall Study|didn't like the medication|1|||
131198795|NCT00611767|472347147|FG001|Overall Study|didn't like the medication|1|||
131198796|NCT00611767|472347146|FG000|Overall Study|Physician Decision|1|||
131198797|NCT00611767|472347147|FG001|Overall Study|Physician Decision|0|||
131198798|NCT00397631|472347151|FG000|Overall Study|Adverse Event|5|||
131198799|NCT00397631|472347152|FG001|Overall Study|Adverse Event|6|||
131198800|NCT00397631|472347151|FG000|Overall Study|Lack of Efficacy|7|||
131198801|NCT00397631|472347152|FG001|Overall Study|Lack of Efficacy|10|||
131198802|NCT00397631|472347151|FG000|Overall Study|Lost to Follow-up|8|||
131198803|NCT00397631|472347152|FG001|Overall Study|Lost to Follow-up|9|||
131198804|NCT00397631|472347151|FG000|Overall Study|Physician Decision|2|||
131198805|NCT00397631|472347152|FG001|Overall Study|Physician Decision|0|||
131198806|NCT00397631|472347151|FG000|Overall Study|Protocol Violation|0|||
131198807|NCT00397631|472347152|FG001|Overall Study|Protocol Violation|1|||
131198808|NCT00397631|472347151|FG000|Overall Study|Withdrawal by Subject|7|||
131198809|NCT00397631|472347152|FG001|Overall Study|Withdrawal by Subject|14|||
131198810|NCT00397631|472347151|FG000|Overall Study|protocol discontinuation criteria|1|||
131198811|NCT00397631|472347152|FG001|Overall Study|protocol discontinuation criteria|4|||
131198812|NCT02202161|472347153|FG000|Overall Study|Adverse Event|1|||
131198813|NCT02202161|472347154|FG001|Overall Study|Adverse Event|1|||
131198814|NCT02202161|472347155|FG002|Overall Study|Adverse Event|0|||
131198815|NCT02202161|472347156|FG003|Overall Study|Adverse Event|0|||
131198816|NCT02202161|472347157|FG004|Overall Study|Adverse Event|0|||
131198817|NCT02202161|472347158|FG005|Overall Study|Adverse Event|1|||
131198818|NCT02202161|472347159|FG006|Overall Study|Adverse Event|0|||
131198819|NCT02202161|472347160|FG007|Overall Study|Adverse Event|0|||
131198820|NCT02202161|472347153|FG000|Overall Study|Did not meet continuation criteria|0|||
131198821|NCT02202161|472347154|FG001|Overall Study|Did not meet continuation criteria|0|||
131198822|NCT02202161|472347155|FG002|Overall Study|Did not meet continuation criteria|0|||
131198823|NCT02202161|472347156|FG003|Overall Study|Did not meet continuation criteria|0|||
131198824|NCT02202161|472347157|FG004|Overall Study|Did not meet continuation criteria|0|||
131198825|NCT02202161|472347158|FG005|Overall Study|Did not meet continuation criteria|0|||
131198826|NCT02202161|472347159|FG006|Overall Study|Did not meet continuation criteria|0|||
131198827|NCT02202161|472347160|FG007|Overall Study|Did not meet continuation criteria|3|||
131198828|NCT02202161|472347153|FG000|Overall Study|Physician Decision|0|||
131198829|NCT02202161|472347154|FG001|Overall Study|Physician Decision|0|||
131198830|NCT02202161|472347155|FG002|Overall Study|Physician Decision|0|||
131198831|NCT02202161|472347156|FG003|Overall Study|Physician Decision|0|||
131198832|NCT02202161|472347157|FG004|Overall Study|Physician Decision|0|||
131198833|NCT02202161|472347158|FG005|Overall Study|Physician Decision|0|||
131198834|NCT02202161|472347159|FG006|Overall Study|Physician Decision|0|||
131198835|NCT02202161|472347160|FG007|Overall Study|Physician Decision|3|||
131198836|NCT02202161|472347153|FG000|Overall Study|Withdrawal by Subject|0|||
131198837|NCT02202161|472347154|FG001|Overall Study|Withdrawal by Subject|0|||
131198838|NCT02202161|472347155|FG002|Overall Study|Withdrawal by Subject|0|||
131198839|NCT02202161|472347156|FG003|Overall Study|Withdrawal by Subject|0|||
131198840|NCT02202161|472347157|FG004|Overall Study|Withdrawal by Subject|1|||
131198841|NCT02202161|472347158|FG005|Overall Study|Withdrawal by Subject|0|||
131198842|NCT02202161|472347159|FG006|Overall Study|Withdrawal by Subject|0|||
131198843|NCT02202161|472347160|FG007|Overall Study|Withdrawal by Subject|0|||
131198844|NCT00832091|472347161|FG000|Overall Study|Adverse Event|1|||
131198845|NCT00832091|472347162|FG001|Overall Study|Adverse Event|1|||
131198846|NCT00832091|472347161|FG000|Overall Study|Protocol Violation|1|||
131198847|NCT00832091|472347162|FG001|Overall Study|Protocol Violation|0|||
131198848|NCT00832091|472347161|FG000|Overall Study|Withdrawal by Subject|2|||
131198849|NCT00832091|472347162|FG001|Overall Study|Withdrawal by Subject|1|||
131198850|NCT00832091|472347161|FG000|Overall Study|Prohibited Medication|1|||
131198851|NCT00832091|472347162|FG001|Overall Study|Prohibited Medication|0|||
131198852|NCT01738594|472347163|FG000|Registration and Treatment Start|Adverse Event|0|||
131198853|NCT01738594|472347164|FG001|Registration and Treatment Start|Adverse Event|1|||
131198854|NCT01738594|472347165|FG002|Registration and Treatment Start|Adverse Event|0|||
131198855|NCT01738594|472347166|FG003|Registration and Treatment Start|Adverse Event|0|||
131198856|NCT01738594|472347167|FG004|Registration and Treatment Start|Adverse Event|0|||
131198857|NCT01738594|472347168|FG005|Registration and Treatment Start|Adverse Event|0|||
131198858|NCT01738594|472347169|FG006|Registration and Treatment Start|Adverse Event|0|||
131198859|NCT01738594|472347170|FG007|Registration and Treatment Start|Adverse Event|0|||
131198860|NCT01738594|472347163|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131198861|NCT01738594|472347164|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131198862|NCT01738594|472347165|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131198863|NCT01738594|472347166|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131198864|NCT01738594|472347167|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131198865|NCT01738594|472347168|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
131198866|NCT01738594|472347169|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131198867|NCT01738594|472347170|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
131198868|NCT01738594|472347163|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
131198869|NCT01738594|472347164|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
131198870|NCT01738594|472347165|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
131198871|NCT01738594|472347166|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
131198872|NCT01738594|472347167|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
131198873|NCT01738594|472347168|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
131198874|NCT01738594|472347169|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
131198875|NCT01738594|472347170|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
131198876|NCT01738594|472347163|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131198877|NCT01738594|472347164|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131198878|NCT01738594|472347165|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131198879|NCT01738594|472347166|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131198880|NCT01738594|472347167|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131198881|NCT01738594|472347168|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
131198882|NCT01738594|472347169|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131198883|NCT01738594|472347170|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
131198884|NCT01738594|472347163|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131198885|NCT01738594|472347164|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131198886|NCT01738594|472347165|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131198887|NCT01738594|472347166|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131198888|NCT01738594|472347167|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130784622|NCT01103323|470838849|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
131198889|NCT01738594|472347168|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
130784623|NCT01103323|470838848|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
131198890|NCT01738594|472347169|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131198891|NCT01738594|472347170|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
131198892|NCT01738594|472347163|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131198893|NCT01738594|472347164|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131198894|NCT01738594|472347165|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131198895|NCT01738594|472347166|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131198896|NCT01738594|472347167|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
131198897|NCT01738594|472347168|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131198898|NCT01738594|472347169|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131198899|NCT01738594|472347170|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
131198900|NCT01738594|472347163|FG000|Follow up for 1 Year|Death|0|||
131198901|NCT01738594|472347164|FG001|Follow up for 1 Year|Death|0|||
131198902|NCT01738594|472347165|FG002|Follow up for 1 Year|Death|0|||
131198903|NCT01738594|472347166|FG003|Follow up for 1 Year|Death|0|||
131198904|NCT01738594|472347167|FG004|Follow up for 1 Year|Death|0|||
131198905|NCT01738594|472347168|FG005|Follow up for 1 Year|Death|1|||
131198906|NCT01738594|472347169|FG006|Follow up for 1 Year|Death|0|||
131198907|NCT01738594|472347170|FG007|Follow up for 1 Year|Death|0|||
131198908|NCT01738594|472347163|FG000|Follow up for 1 Year|Other|0|||
131198909|NCT01738594|472347164|FG001|Follow up for 1 Year|Other|0|||
131198910|NCT01738594|472347165|FG002|Follow up for 1 Year|Other|0|||
131198911|NCT01738594|472347166|FG003|Follow up for 1 Year|Other|0|||
131198912|NCT01738594|472347167|FG004|Follow up for 1 Year|Other|0|||
131198913|NCT01738594|472347168|FG005|Follow up for 1 Year|Other|2|||
131198914|NCT01738594|472347169|FG006|Follow up for 1 Year|Other|0|||
131198915|NCT01738594|472347170|FG007|Follow up for 1 Year|Other|0|||
131198916|NCT03117309|472347171|FG000|Overall Study|Not meeting inclusion criteria|0|||
131198917|NCT03117309|472347172|FG001|Overall Study|Not meeting inclusion criteria|1|||
131198918|NCT01010776|472347176|FG000|Main Phase|Withdrawal by Subject|14|||
131198919|NCT01010776|472347176|FG000|Main Phase|Lack of Efficacy|8|||
131198920|NCT01010776|472347176|FG000|Main Phase|Adverse Event|7|||
131198921|NCT01010776|472347176|FG000|Main Phase|Lost to Follow-up|6|||
131198922|NCT01010776|472347176|FG000|Main Phase|Non-compliance to study medication|5|||
131198923|NCT01010776|472347176|FG000|Main Phase|Selection failure|2|||
131198924|NCT01010776|472347176|FG000|Main Phase|Inform consent withdrawal|1|||
131198925|NCT01010776|472347176|FG000|Main Phase|Other|1|||
131198926|NCT01010776|472347176|FG000|Main Phase|Did not received study medication|5|||
131198927|NCT01010776|472347176|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
131198928|NCT01010776|472347176|FG000|Extension Phase|Other|3|||
131198929|NCT01012037|472347181|FG000|Overall Study|Adverse Event|0|||
131198930|NCT01012037|472347182|FG001|Overall Study|Adverse Event|8|||
131198931|NCT01012037|472347183|FG002|Overall Study|Adverse Event|3|||
131198932|NCT01012037|472347181|FG000|Overall Study|Protocol Violation|0|||
131198933|NCT01012037|472347182|FG001|Overall Study|Protocol Violation|3|||
131198934|NCT01012037|472347183|FG002|Overall Study|Protocol Violation|5|||
131198935|NCT01012037|472347181|FG000|Overall Study|Withdrawal by Subject|0|||
131198936|NCT01012037|472347182|FG001|Overall Study|Withdrawal by Subject|4|||
131198937|NCT01012037|472347183|FG002|Overall Study|Withdrawal by Subject|1|||
131198938|NCT01012037|472347181|FG000|Overall Study|Other reason (not specified)|1|||
131198939|NCT01012037|472347182|FG001|Overall Study|Other reason (not specified)|1|||
131198940|NCT01012037|472347183|FG002|Overall Study|Other reason (not specified)|1|||
131198941|NCT02583711|472347184|FG000|Overall Study|Withdrawal by Subject|0|||
131198942|NCT02583711|472347185|FG001|Overall Study|Withdrawal by Subject|10|||
131198943|NCT02583711|472347186|FG002|Overall Study|Withdrawal by Subject|0|||
131198944|NCT01060124|472347190|FG000|Overall Study|Other|16|||
131198945|NCT01060124|472347190|FG000|Overall Study|Adverse Event|14|||
131198946|NCT01060124|472347190|FG000|Overall Study|Withdrawal by Subject|7|||
131198947|NCT00415623|472347191|FG000|Overall Study|Adverse Event|3|||
131198948|NCT00415623|472347192|FG001|Overall Study|Adverse Event|4|||
131198949|NCT00415623|472347191|FG000|Overall Study|Death|1|||
131198950|NCT00415623|472347192|FG001|Overall Study|Death|0|||
131198951|NCT00415623|472347191|FG000|Overall Study|Withdrawal by Subject|1|||
131198952|NCT00415623|472347192|FG001|Overall Study|Withdrawal by Subject|1|||
131198959|NCT03455530|472348555|FG000|Overall Study|Withdrawal by Subject|9|||
131198960|NCT03455530|472348556|FG001|Overall Study|Withdrawal by Subject|1|||
131198961|NCT03455530|472348557|FG002|Overall Study|Withdrawal by Subject|3|||
131198962|NCT03455530|472348558|FG003|Overall Study|Withdrawal by Subject|3|||
131198963|NCT01592773|472348563|FG000|Overall Study|Study Terminated by Sponsor|582|||
131198964|NCT01592773|472348563|FG000|Overall Study|Withdrawal by Subject|35|||
131198965|NCT01592773|472348563|FG000|Overall Study|Lost to Follow-up|19|||
131198966|NCT01592773|472348563|FG000|Overall Study|Adverse Event|17|||
131198967|NCT01592773|472348563|FG000|Overall Study|Lack of Efficacy|9|||
131198968|NCT01592773|472348563|FG000|Overall Study|Protocol Violation|2|||
131198969|NCT01592773|472348563|FG000|Overall Study|Inclusion/exclusion not meet|1|||
131198970|NCT01592773|472348563|FG000|Overall Study|Other Reason|1|||
131198971|NCT04418427|472348565|FG000|Overall Study|Death|0|||
131198972|NCT04418427|472348566|FG001|Overall Study|Death|1|||
131198973|NCT04418427|472348567|FG002|Overall Study|Death|0|||
131198974|NCT04418427|472348565|FG000|Overall Study|Lost to Follow-up|0|||
131198975|NCT04418427|472348566|FG001|Overall Study|Lost to Follow-up|2|||
131198976|NCT04418427|472348567|FG002|Overall Study|Lost to Follow-up|2|||
131198977|NCT04418427|472348565|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
131198978|NCT04418427|472348566|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
131198979|NCT04418427|472348567|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
131198980|NCT04418427|472348565|FG000|Overall Study|Pre-existing medical condition|0|||
131198981|NCT04418427|472348566|FG001|Overall Study|Pre-existing medical condition|1|||
131198982|NCT04418427|472348567|FG002|Overall Study|Pre-existing medical condition|0|||
131198983|NCT01004861|472348568|FG000|Overall Study|Disease progression|3|||
131198984|NCT01004861|472348569|FG001|Overall Study|Disease progression|4|||
131198985|NCT01004861|472348570|FG002|Overall Study|Disease progression|5|||
131198986|NCT01004861|472348571|FG003|Overall Study|Disease progression|4|||
131198987|NCT01004861|472348572|FG004|Overall Study|Disease progression|4|||
131198988|NCT01004861|472348573|FG005|Overall Study|Disease progression|4|||
131198989|NCT01004861|472348574|FG006|Overall Study|Disease progression|5|||
131198990|NCT01004861|472348575|FG007|Overall Study|Disease progression|1|||
131198991|NCT01004861|472348576|FG008|Overall Study|Disease progression|4|||
131198992|NCT01004861|472348577|FG009|Overall Study|Disease progression|7|||
131198993|NCT01004861|472348578|FG010|Overall Study|Disease progression|6|||
131198994|NCT01004861|472348579|FG011|Overall Study|Disease progression|3|||
131198995|NCT01004861|472348580|FG012|Overall Study|Disease progression|8|||
131198996|NCT01004861|472348568|FG000|Overall Study|Physician Decision|0|||
131198997|NCT01004861|472348569|FG001|Overall Study|Physician Decision|2|||
131198998|NCT01004861|472348570|FG002|Overall Study|Physician Decision|1|||
131198999|NCT01004861|472348571|FG003|Overall Study|Physician Decision|1|||
131199000|NCT01004861|472348572|FG004|Overall Study|Physician Decision|1|||
131199001|NCT01004861|472348573|FG005|Overall Study|Physician Decision|0|||
131199002|NCT01004861|472348574|FG006|Overall Study|Physician Decision|0|||
131199003|NCT01004861|472348575|FG007|Overall Study|Physician Decision|1|||
131199004|NCT01004861|472348576|FG008|Overall Study|Physician Decision|0|||
131199005|NCT01004861|472348577|FG009|Overall Study|Physician Decision|0|||
131199006|NCT01004861|472348578|FG010|Overall Study|Physician Decision|0|||
131199007|NCT01004861|472348579|FG011|Overall Study|Physician Decision|0|||
131199008|NCT01004861|472348580|FG012|Overall Study|Physician Decision|3|||
131199009|NCT01004861|472348568|FG000|Overall Study|Adverse Event|0|||
131199010|NCT01004861|472348569|FG001|Overall Study|Adverse Event|0|||
131199011|NCT01004861|472348570|FG002|Overall Study|Adverse Event|0|||
131199012|NCT01004861|472348571|FG003|Overall Study|Adverse Event|1|||
131199013|NCT01004861|472348572|FG004|Overall Study|Adverse Event|0|||
131199014|NCT01004861|472348573|FG005|Overall Study|Adverse Event|2|||
131199015|NCT01004861|472348574|FG006|Overall Study|Adverse Event|1|||
131199016|NCT01004861|472348575|FG007|Overall Study|Adverse Event|1|||
131199017|NCT01004861|472348576|FG008|Overall Study|Adverse Event|13|||
131199018|NCT01004861|472348577|FG009|Overall Study|Adverse Event|1|||
131199019|NCT01004861|472348578|FG010|Overall Study|Adverse Event|1|||
131199020|NCT01004861|472348579|FG011|Overall Study|Adverse Event|0|||
131199021|NCT01004861|472348580|FG012|Overall Study|Adverse Event|2|||
131199022|NCT01004861|472348568|FG000|Overall Study|Protocol Violation|0|||
131199023|NCT01004861|472348569|FG001|Overall Study|Protocol Violation|0|||
131199024|NCT01004861|472348570|FG002|Overall Study|Protocol Violation|0|||
131199025|NCT01004861|472348571|FG003|Overall Study|Protocol Violation|0|||
131199026|NCT01004861|472348572|FG004|Overall Study|Protocol Violation|1|||
131199027|NCT01004861|472348573|FG005|Overall Study|Protocol Violation|0|||
131199028|NCT01004861|472348574|FG006|Overall Study|Protocol Violation|0|||
131199029|NCT01004861|472348575|FG007|Overall Study|Protocol Violation|0|||
131199030|NCT01004861|472348576|FG008|Overall Study|Protocol Violation|0|||
131199031|NCT01004861|472348577|FG009|Overall Study|Protocol Violation|0|||
131199032|NCT01004861|472348578|FG010|Overall Study|Protocol Violation|0|||
131199033|NCT01004861|472348579|FG011|Overall Study|Protocol Violation|0|||
131199034|NCT01004861|472348580|FG012|Overall Study|Protocol Violation|0|||
131199035|NCT01004861|472348568|FG000|Overall Study|Lost to Follow-up|0|||
131199036|NCT01004861|472348569|FG001|Overall Study|Lost to Follow-up|0|||
131199037|NCT01004861|472348570|FG002|Overall Study|Lost to Follow-up|0|||
131199038|NCT01004861|472348571|FG003|Overall Study|Lost to Follow-up|0|||
131199039|NCT01004861|472348572|FG004|Overall Study|Lost to Follow-up|0|||
131199040|NCT01004861|472348573|FG005|Overall Study|Lost to Follow-up|0|||
131199041|NCT01004861|472348574|FG006|Overall Study|Lost to Follow-up|0|||
131199042|NCT01004861|472348575|FG007|Overall Study|Lost to Follow-up|1|||
131199043|NCT01004861|472348576|FG008|Overall Study|Lost to Follow-up|3|||
131199044|NCT01004861|472348577|FG009|Overall Study|Lost to Follow-up|0|||
131199045|NCT01004861|472348578|FG010|Overall Study|Lost to Follow-up|0|||
131199046|NCT01004861|472348579|FG011|Overall Study|Lost to Follow-up|1|||
131199047|NCT01004861|472348580|FG012|Overall Study|Lost to Follow-up|0|||
131199048|NCT01004861|472348568|FG000|Overall Study|Non-compliance|0|||
131199049|NCT01004861|472348569|FG001|Overall Study|Non-compliance|0|||
131199050|NCT01004861|472348570|FG002|Overall Study|Non-compliance|0|||
131199051|NCT01004861|472348571|FG003|Overall Study|Non-compliance|0|||
131199052|NCT01004861|472348572|FG004|Overall Study|Non-compliance|0|||
131199053|NCT01004861|472348573|FG005|Overall Study|Non-compliance|0|||
131199054|NCT01004861|472348574|FG006|Overall Study|Non-compliance|0|||
131199055|NCT01004861|472348575|FG007|Overall Study|Non-compliance|0|||
131199056|NCT01004861|472348576|FG008|Overall Study|Non-compliance|5|||
131199057|NCT01004861|472348577|FG009|Overall Study|Non-compliance|0|||
131199058|NCT01004861|472348578|FG010|Overall Study|Non-compliance|0|||
131199059|NCT01004861|472348579|FG011|Overall Study|Non-compliance|0|||
131199060|NCT01004861|472348580|FG012|Overall Study|Non-compliance|1|||
131199061|NCT01004861|472348568|FG000|Overall Study|Other|0|||
131199062|NCT01004861|472348569|FG001|Overall Study|Other|0|||
131199063|NCT01004861|472348570|FG002|Overall Study|Other|0|||
131199064|NCT01004861|472348571|FG003|Overall Study|Other|0|||
131199065|NCT01004861|472348572|FG004|Overall Study|Other|0|||
131199066|NCT01004861|472348573|FG005|Overall Study|Other|0|||
131199067|NCT01004861|472348574|FG006|Overall Study|Other|0|||
131199068|NCT01004861|472348575|FG007|Overall Study|Other|0|||
131199069|NCT01004861|472348576|FG008|Overall Study|Other|0|||
131199070|NCT01004861|472348577|FG009|Overall Study|Other|2|||
131199071|NCT01004861|472348578|FG010|Overall Study|Other|1|||
131199072|NCT01004861|472348579|FG011|Overall Study|Other|2|||
131199073|NCT01004861|472348580|FG012|Overall Study|Other|3|||
131199074|NCT01004861|472348568|FG000|Overall Study|Patient decision|0|||
131199075|NCT01004861|472348569|FG001|Overall Study|Patient decision|0|||
131199076|NCT01004861|472348570|FG002|Overall Study|Patient decision|0|||
131199077|NCT01004861|472348571|FG003|Overall Study|Patient decision|0|||
131199078|NCT01004861|472348572|FG004|Overall Study|Patient decision|1|||
131199079|NCT01004861|472348573|FG005|Overall Study|Patient decision|0|||
131199080|NCT01004861|472348574|FG006|Overall Study|Patient decision|1|||
131199081|NCT01004861|472348575|FG007|Overall Study|Patient decision|0|||
131199082|NCT01004861|472348576|FG008|Overall Study|Patient decision|7|||
131199083|NCT01004861|472348577|FG009|Overall Study|Patient decision|1|||
131199084|NCT01004861|472348578|FG010|Overall Study|Patient decision|1|||
131199085|NCT01004861|472348579|FG011|Overall Study|Patient decision|2|||
131199086|NCT01004861|472348580|FG012|Overall Study|Patient decision|3|||
131199087|NCT01004861|472348568|FG000|Overall Study|Transitioned to Phase 4 study|0|||
131199088|NCT01004861|472348569|FG001|Overall Study|Transitioned to Phase 4 study|0|||
131199089|NCT01004861|472348570|FG002|Overall Study|Transitioned to Phase 4 study|0|||
131199090|NCT01004861|472348571|FG003|Overall Study|Transitioned to Phase 4 study|0|||
131199091|NCT01004861|472348572|FG004|Overall Study|Transitioned to Phase 4 study|0|||
131199092|NCT01004861|472348573|FG005|Overall Study|Transitioned to Phase 4 study|0|||
131199093|NCT01004861|472348574|FG006|Overall Study|Transitioned to Phase 4 study|0|||
131199094|NCT01004861|472348575|FG007|Overall Study|Transitioned to Phase 4 study|0|||
131199095|NCT01004861|472348576|FG008|Overall Study|Transitioned to Phase 4 study|2|||
131199096|NCT01004861|472348577|FG009|Overall Study|Transitioned to Phase 4 study|0|||
131199097|NCT01004861|472348578|FG010|Overall Study|Transitioned to Phase 4 study|0|||
131199098|NCT01004861|472348579|FG011|Overall Study|Transitioned to Phase 4 study|0|||
131199099|NCT01004861|472348580|FG012|Overall Study|Transitioned to Phase 4 study|0|||
131199100|NCT01004861|472348568|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199101|NCT01004861|472348569|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199102|NCT01004861|472348570|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199103|NCT01004861|472348571|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199104|NCT01004861|472348572|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199105|NCT01004861|472348573|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199106|NCT01004861|472348574|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199107|NCT01004861|472348575|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199108|NCT01004861|472348576|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
131199109|NCT01004861|472348577|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199110|NCT01004861|472348578|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199111|NCT01004861|472348579|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199112|NCT01004861|472348580|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
131199113|NCT01004861|472348568|FG000|Overall Study|Patient withdrew|0|||
131199114|NCT01004861|472348569|FG001|Overall Study|Patient withdrew|0|||
131199115|NCT01004861|472348570|FG002|Overall Study|Patient withdrew|0|||
131199116|NCT01004861|472348571|FG003|Overall Study|Patient withdrew|0|||
131199117|NCT01004861|472348572|FG004|Overall Study|Patient withdrew|0|||
131199118|NCT01004861|472348573|FG005|Overall Study|Patient withdrew|0|||
131199119|NCT01004861|472348574|FG006|Overall Study|Patient withdrew|0|||
131199120|NCT01004861|472348575|FG007|Overall Study|Patient withdrew|0|||
131199121|NCT01004861|472348576|FG008|Overall Study|Patient withdrew|1|||
131199122|NCT01004861|472348577|FG009|Overall Study|Patient withdrew|0|||
131199123|NCT01004861|472348578|FG010|Overall Study|Patient withdrew|0|||
131199124|NCT01004861|472348579|FG011|Overall Study|Patient withdrew|0|||
131199125|NCT01004861|472348580|FG012|Overall Study|Patient withdrew|0|||
131199126|NCT01004861|472348568|FG000|Overall Study|Surgical resection|0|||
131199127|NCT01004861|472348569|FG001|Overall Study|Surgical resection|0|||
131199128|NCT01004861|472348570|FG002|Overall Study|Surgical resection|0|||
131199129|NCT01004861|472348571|FG003|Overall Study|Surgical resection|0|||
131199130|NCT01004861|472348572|FG004|Overall Study|Surgical resection|0|||
131199131|NCT01004861|472348573|FG005|Overall Study|Surgical resection|0|||
131199132|NCT01004861|472348574|FG006|Overall Study|Surgical resection|0|||
131199133|NCT01004861|472348575|FG007|Overall Study|Surgical resection|0|||
131199134|NCT01004861|472348576|FG008|Overall Study|Surgical resection|1|||
131199135|NCT01004861|472348577|FG009|Overall Study|Surgical resection|0|||
131199136|NCT01004861|472348578|FG010|Overall Study|Surgical resection|0|||
131199137|NCT01004861|472348579|FG011|Overall Study|Surgical resection|0|||
131199138|NCT01004861|472348580|FG012|Overall Study|Surgical resection|0|||
131199139|NCT01004861|472348568|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199140|NCT01004861|472348569|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199141|NCT01004861|472348570|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199142|NCT01004861|472348571|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199143|NCT01004861|472348572|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199144|NCT01004861|472348573|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199145|NCT01004861|472348574|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199146|NCT01004861|472348575|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199147|NCT01004861|472348576|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
131199148|NCT01004861|472348577|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199149|NCT01004861|472348578|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199150|NCT01004861|472348579|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199151|NCT01004861|472348580|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
131199152|NCT01004861|472348568|FG000|Overall Study|Study termination by Sponsor|0|||
131199153|NCT01004861|472348569|FG001|Overall Study|Study termination by Sponsor|0|||
131199154|NCT01004861|472348570|FG002|Overall Study|Study termination by Sponsor|0|||
131199155|NCT01004861|472348571|FG003|Overall Study|Study termination by Sponsor|0|||
131199156|NCT01004861|472348572|FG004|Overall Study|Study termination by Sponsor|0|||
131199157|NCT01004861|472348573|FG005|Overall Study|Study termination by Sponsor|0|||
131199158|NCT01004861|472348574|FG006|Overall Study|Study termination by Sponsor|0|||
131199159|NCT01004861|472348575|FG007|Overall Study|Study termination by Sponsor|0|||
131199160|NCT01004861|472348576|FG008|Overall Study|Study termination by Sponsor|1|||
131199161|NCT01004861|472348577|FG009|Overall Study|Study termination by Sponsor|0|||
131199162|NCT01004861|472348578|FG010|Overall Study|Study termination by Sponsor|0|||
131199163|NCT01004861|472348579|FG011|Overall Study|Study termination by Sponsor|0|||
131199164|NCT01004861|472348580|FG012|Overall Study|Study termination by Sponsor|0|||
131199165|NCT02554721|472348582|FG000|Overall Study|Adverse Event|1|||
131199166|NCT02554721|472348583|FG001|Overall Study|Adverse Event|0|||
131199167|NCT02554721|472348584|FG002|Overall Study|Adverse Event|0|||
131199168|NCT02554721|472348585|FG003|Overall Study|Adverse Event|0|||
131199169|NCT02554721|472348586|FG004|Overall Study|Adverse Event|1|||
131199170|NCT02554721|472348582|FG000|Overall Study|Noncompliance|0|||
131199171|NCT02554721|472348583|FG001|Overall Study|Noncompliance|0|||
131199172|NCT02554721|472348584|FG002|Overall Study|Noncompliance|0|||
131199173|NCT02554721|472348585|FG003|Overall Study|Noncompliance|0|||
131199174|NCT02554721|472348586|FG004|Overall Study|Noncompliance|1|||
131199175|NCT00686699|472348587|FG000|Treatment Period 1|Adverse Event|0|||
131199176|NCT00686699|472348588|FG001|Treatment Period 1|Adverse Event|2|||
131199177|NCT04610827|472348589|FG000|Overall Study|Withdrawal by Subject|1|||
131199178|NCT04610827|472348590|FG001|Overall Study|Withdrawal by Subject|1|||
131199179|NCT04610827|472348591|FG002|Overall Study|Withdrawal by Subject|0|||
131199180|NCT00908895|472348592|FG000|Overall Study|Lost to Follow-up|1|||
131199181|NCT00908895|472348593|FG001|Overall Study|Lost to Follow-up|3|||
131199182|NCT00908895|472348592|FG000|Overall Study|algodystrophy|2|||
131199183|NCT00908895|472348593|FG001|Overall Study|algodystrophy|2|||
131199184|NCT00908895|472348592|FG000|Overall Study|Adverse Event|1|||
131199185|NCT00908895|472348593|FG001|Overall Study|Adverse Event|1|||
131199186|NCT01997892|472348597|FG000|Overall Study|Physician Decision|2|||
131199187|NCT01997892|472348597|FG000|Overall Study|Lost to Follow-up|6|||
131199188|NCT01997892|472348597|FG000|Overall Study|Death|14|||
131199189|NCT01997892|472348597|FG000|Overall Study|Renal transplant|8|||
131199190|NCT01997892|472348597|FG000|Overall Study|Other|3|||
131199191|NCT01997892|472348597|FG000|Overall Study|Study completion data not recorded|35|||
131199192|NCT02710422|472348598|FG000|Overall Study|Termination of study|9|||
131199193|NCT02710422|472348599|FG001|Overall Study|Termination of study|9|||
131199194|NCT02059174|472348619|FG000|Period 1|Withdrawal by Subject|0|||
131199195|NCT02059174|472348620|FG001|Period 1|Withdrawal by Subject|2|||
131199196|NCT02059174|472348619|FG000|Period 2|Withdrawal by Subject|0|||
131199197|NCT02059174|472348620|FG001|Period 2|Withdrawal by Subject|2|||
131199198|NCT02059174|472348619|FG000|Period 2|Protocol Violation|1|||
131199199|NCT02059174|472348620|FG001|Period 2|Protocol Violation|0|||
131199200|NCT02059174|472348619|FG000|Period 3|Physician Decision|1|||
131199201|NCT02059174|472348620|FG001|Period 3|Physician Decision|0|||
131199202|NCT02306148|472348621|FG000|Overall Study|Adverse Event|12|||
131199203|NCT02306148|472348622|FG001|Overall Study|Adverse Event|6|||
131199204|NCT02306148|472348621|FG000|Overall Study|Lost to Follow-up|1|||
131199205|NCT02306148|472348622|FG001|Overall Study|Lost to Follow-up|4|||
131199206|NCT02608099|472348623|FG000|Overall Study|Ablation procedure not initiated|3|||
131199207|NCT02608099|472348624|FG001|Overall Study|Ablation procedure not initiated|2|||
131199208|NCT00087594|472348629|FG000|Overall Study|Adverse Event|2|||
131199209|NCT00087594|472348630|FG001|Overall Study|Adverse Event|3|||
131199210|NCT00087594|472348629|FG000|Overall Study|Lost to Follow-up|0|||
131199211|NCT00087594|472348630|FG001|Overall Study|Lost to Follow-up|2|||
131199212|NCT00087594|472348629|FG000|Overall Study|Withdrawal by Subject|4|||
131199213|NCT00087594|472348630|FG001|Overall Study|Withdrawal by Subject|2|||
131199214|NCT00087594|472348629|FG000|Overall Study|Lack of Efficacy|2|||
131199215|NCT00087594|472348630|FG001|Overall Study|Lack of Efficacy|5|||
131199216|NCT04657003|472348636|FG000|Overall Study|Adverse Event|5|||
131199217|NCT04657003|472348637|FG001|Overall Study|Adverse Event|1|||
131199218|NCT04657003|472348638|FG002|Overall Study|Adverse Event|5|||
131199219|NCT04657003|472348636|FG000|Overall Study|Death|0|||
131199220|NCT04657003|472348637|FG001|Overall Study|Death|2|||
131199221|NCT04657003|472348638|FG002|Overall Study|Death|0|||
131199222|NCT04657003|472348636|FG000|Overall Study|Lost to Follow-up|8|||
131199223|NCT04657003|472348637|FG001|Overall Study|Lost to Follow-up|4|||
131199224|NCT04657003|472348638|FG002|Overall Study|Lost to Follow-up|10|||
131199225|NCT04657003|472348636|FG000|Overall Study|Other - As Reported by Investigator|3|||
131199226|NCT04657003|472348637|FG001|Overall Study|Other - As Reported by Investigator|2|||
131199227|NCT04657003|472348638|FG002|Overall Study|Other - As Reported by Investigator|2|||
131199228|NCT04657003|472348636|FG000|Overall Study|Pregnancy|2|||
131199229|NCT04657003|472348637|FG001|Overall Study|Pregnancy|0|||
131199230|NCT04657003|472348638|FG002|Overall Study|Pregnancy|2|||
131199231|NCT04657003|472348636|FG000|Overall Study|Withdrawal by Subject|16|||
131199232|NCT04657003|472348637|FG001|Overall Study|Withdrawal by Subject|7|||
131199233|NCT04657003|472348638|FG002|Overall Study|Withdrawal by Subject|10|||
131199234|NCT01952041|472348639|FG000|Overall Study|Lost to Follow-up|9|||
131199235|NCT01952041|472348640|FG001|Overall Study|Lost to Follow-up|16|||
131199236|NCT01952041|472348639|FG000|Overall Study|Withdrawal by Subject|7|||
131199237|NCT01952041|472348640|FG001|Overall Study|Withdrawal by Subject|5|||
131199238|NCT01952041|472348639|FG000|Overall Study|Death|1|||
131199239|NCT01952041|472348640|FG001|Overall Study|Death|0|||
131199240|NCT01736176|472348641|FG000|Overall Study|Adverse Event|3|||
131199241|NCT01736176|472348641|FG000|Overall Study|Withdrawal by Subject|4|||
131199242|NCT01736176|472348641|FG000|Overall Study|Lack of Efficacy|3|||
131199243|NCT01736176|472348641|FG000|Overall Study|Unable to Complete PEG Placement|1|||
131199244|NCT00417248|472348642|FG000|Overall Study|Study Terminated|6|||
131199245|NCT00417248|472348642|FG000|Overall Study|Death|1|||
131199246|NCT00417248|472348642|FG000|Overall Study|Lack of Efficacy|1|||
131199247|NCT01370499|472348643|FG000|Overall Study|Adverse Event|38|||
131199248|NCT01370499|472348644|FG001|Overall Study|Adverse Event|12|||
131199249|NCT01370499|472348643|FG000|Overall Study|Lack of Efficacy|4|||
131199250|NCT01370499|472348644|FG001|Overall Study|Lack of Efficacy|2|||
131199251|NCT01370499|472348643|FG000|Overall Study|Lost to Follow-up|2|||
131199252|NCT01370499|472348644|FG001|Overall Study|Lost to Follow-up|1|||
131199253|NCT01370499|472348643|FG000|Overall Study|Physician Decision|3|||
131199254|NCT01370499|472348644|FG001|Overall Study|Physician Decision|3|||
131199255|NCT01370499|472348643|FG000|Overall Study|Protocol Violation|5|||
131199256|NCT01370499|472348644|FG001|Overall Study|Protocol Violation|4|||
131199257|NCT01370499|472348643|FG000|Overall Study|Withdrawal by Subject|18|||
131199258|NCT01370499|472348644|FG001|Overall Study|Withdrawal by Subject|7|||
131199259|NCT01370499|472348643|FG000|Overall Study|Sponsor Decision|41|||
131199260|NCT01370499|472348644|FG001|Overall Study|Sponsor Decision|15|||
131199261|NCT00934791|472348645|FG000|Overall Study|Withdrawal by Subject|1|||
131199262|NCT00934791|472348646|FG001|Overall Study|Withdrawal by Subject|0|||
131199263|NCT03763942|472348647|FG000|Overall Study|Lost to Follow-up|114|||
131199264|NCT03763942|472348648|FG001|Overall Study|Lost to Follow-up|54|||
131199265|NCT03763942|472348647|FG000|Overall Study|Protocol Violation|1|||
131199266|NCT03763942|472348648|FG001|Overall Study|Protocol Violation|0|||
131199267|NCT03763942|472348647|FG000|Overall Study|Withdrawal by Subject|2|||
131199268|NCT03763942|472348648|FG001|Overall Study|Withdrawal by Subject|0|||
131199269|NCT03763942|472348647|FG000|Overall Study|Other|2|||
131199270|NCT03763942|472348648|FG001|Overall Study|Other|3|||
131199271|NCT02274311|472348649|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
131199272|NCT00853112|472348651|FG000|Overall Study|Randomized but not treated|0|||
131199273|NCT00853112|472348652|FG001|Overall Study|Randomized but not treated|1|||
131199274|NCT00853112|472348653|FG002|Overall Study|Randomized but not treated|0|||
131199275|NCT00853112|472348654|FG003|Overall Study|Randomized but not treated|2|||
131199276|NCT00853112|472348655|FG004|Overall Study|Randomized but not treated|0|||
131199277|NCT00853112|472348656|FG005|Overall Study|Randomized but not treated|0|||
131199278|NCT00853112|472348657|FG006|Overall Study|Randomized but not treated|1|||
131199279|NCT02477800|472348660|FG000|Placebo-Controlled Period|Adverse Event|16|||
131199280|NCT02477800|472348661|FG001|Placebo-Controlled Period|Adverse Event|25|||
131199281|NCT02477800|472348662|FG002|Placebo-Controlled Period|Adverse Event|28|||
131199282|NCT02477800|472348663|FG003|Placebo-Controlled Period|Adverse Event|0|||
131199283|NCT02477800|472348664|FG004|Placebo-Controlled Period|Adverse Event|0|||
131199284|NCT02477800|472348665|FG005|Placebo-Controlled Period|Adverse Event|0|||
131199285|NCT02477800|472348666|FG006|Placebo-Controlled Period|Adverse Event|0|||
131199286|NCT02477800|472348660|FG000|Placebo-Controlled Period|Change of Treatment|1|||
131199287|NCT02477800|472348661|FG001|Placebo-Controlled Period|Change of Treatment|2|||
131199288|NCT02477800|472348662|FG002|Placebo-Controlled Period|Change of Treatment|1|||
131199289|NCT02477800|472348663|FG003|Placebo-Controlled Period|Change of Treatment|0|||
131199290|NCT02477800|472348664|FG004|Placebo-Controlled Period|Change of Treatment|0|||
131199291|NCT02477800|472348665|FG005|Placebo-Controlled Period|Change of Treatment|0|||
131199292|NCT02477800|472348666|FG006|Placebo-Controlled Period|Change of Treatment|0|||
131199293|NCT02477800|472348660|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
131199294|NCT02477800|472348661|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
131199295|NCT02477800|472348662|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
131199296|NCT02477800|472348663|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
131199297|NCT02477800|472348664|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
131199298|NCT02477800|472348665|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
131199299|NCT02477800|472348666|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
131199300|NCT02477800|472348660|FG000|Placebo-Controlled Period|Death|0|||
131199301|NCT02477800|472348661|FG001|Placebo-Controlled Period|Death|3|||
131199302|NCT02477800|472348662|FG002|Placebo-Controlled Period|Death|2|||
131199303|NCT02477800|472348663|FG003|Placebo-Controlled Period|Death|0|||
131199304|NCT02477800|472348664|FG004|Placebo-Controlled Period|Death|0|||
131199305|NCT02477800|472348665|FG005|Placebo-Controlled Period|Death|0|||
131199306|NCT02477800|472348666|FG006|Placebo-Controlled Period|Death|0|||
131199307|NCT02477800|472348660|FG000|Placebo-Controlled Period|Disease Progression|1|||
131199308|NCT02477800|472348661|FG001|Placebo-Controlled Period|Disease Progression|0|||
131199309|NCT02477800|472348662|FG002|Placebo-Controlled Period|Disease Progression|1|||
131199310|NCT02477800|472348663|FG003|Placebo-Controlled Period|Disease Progression|0|||
131199311|NCT02477800|472348664|FG004|Placebo-Controlled Period|Disease Progression|0|||
131199312|NCT02477800|472348665|FG005|Placebo-Controlled Period|Disease Progression|0|||
131199313|NCT02477800|472348666|FG006|Placebo-Controlled Period|Disease Progression|0|||
131199314|NCT02477800|472348660|FG000|Placebo-Controlled Period|Investigator Decision|3|||
131199315|NCT02477800|472348661|FG001|Placebo-Controlled Period|Investigator Decision|2|||
131199316|NCT02477800|472348662|FG002|Placebo-Controlled Period|Investigator Decision|1|||
131199317|NCT02477800|472348663|FG003|Placebo-Controlled Period|Investigator Decision|0|||
131199318|NCT02477800|472348664|FG004|Placebo-Controlled Period|Investigator Decision|0|||
131199319|NCT02477800|472348665|FG005|Placebo-Controlled Period|Investigator Decision|0|||
131199320|NCT02477800|472348666|FG006|Placebo-Controlled Period|Investigator Decision|0|||
131199321|NCT02477800|472348660|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
131199322|NCT02477800|472348661|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
131199323|NCT02477800|472348662|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
131199324|NCT02477800|472348663|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
131199325|NCT02477800|472348664|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
131199326|NCT02477800|472348665|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
131199327|NCT02477800|472348666|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
131199328|NCT02477800|472348660|FG000|Placebo-Controlled Period|Relocation|2|||
131199329|NCT02477800|472348661|FG001|Placebo-Controlled Period|Relocation|0|||
131199330|NCT02477800|472348662|FG002|Placebo-Controlled Period|Relocation|0|||
131199331|NCT02477800|472348663|FG003|Placebo-Controlled Period|Relocation|0|||
131199332|NCT02477800|472348664|FG004|Placebo-Controlled Period|Relocation|0|||
131199333|NCT02477800|472348665|FG005|Placebo-Controlled Period|Relocation|0|||
131199334|NCT02477800|472348666|FG006|Placebo-Controlled Period|Relocation|0|||
131199335|NCT02477800|472348660|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
131199336|NCT02477800|472348661|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
131199337|NCT02477800|472348662|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
131199338|NCT02477800|472348663|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
131199339|NCT02477800|472348664|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
131199340|NCT02477800|472348665|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
131199341|NCT02477800|472348666|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
131199342|NCT02477800|472348660|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
131199343|NCT02477800|472348661|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
131199344|NCT02477800|472348662|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
131199345|NCT02477800|472348663|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
131199346|NCT02477800|472348664|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
131199347|NCT02477800|472348665|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
131199348|NCT02477800|472348666|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
131199349|NCT02477800|472348660|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
131199350|NCT02477800|472348661|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
131199351|NCT02477800|472348662|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
131199352|NCT02477800|472348663|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
131199353|NCT02477800|472348664|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
131199354|NCT02477800|472348665|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
131199355|NCT02477800|472348666|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
131199356|NCT02477800|472348660|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
131199357|NCT02477800|472348661|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
131199358|NCT02477800|472348662|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
131199359|NCT02477800|472348663|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131199360|NCT02477800|472348664|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131199361|NCT02477800|472348665|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131199362|NCT02477800|472348666|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
131199363|NCT02477800|472348660|FG000|Placebo-Controlled Period|Reason not Specified|161|||
131199364|NCT02477800|472348661|FG001|Placebo-Controlled Period|Reason not Specified|161|||
131199365|NCT02477800|472348662|FG002|Placebo-Controlled Period|Reason not Specified|189|||
131199366|NCT02477800|472348663|FG003|Placebo-Controlled Period|Reason not Specified|0|||
131199367|NCT02477800|472348664|FG004|Placebo-Controlled Period|Reason not Specified|0|||
131199368|NCT02477800|472348665|FG005|Placebo-Controlled Period|Reason not Specified|0|||
131199369|NCT02477800|472348666|FG006|Placebo-Controlled Period|Reason not Specified|0|||
131199370|NCT02477800|472348660|FG000|Long Term Extension Period|Adverse Event|0|||
131199371|NCT02477800|472348661|FG001|Long Term Extension Period|Adverse Event|0|||
131199372|NCT02477800|472348662|FG002|Long Term Extension Period|Adverse Event|0|||
131199373|NCT02477800|472348663|FG003|Long Term Extension Period|Adverse Event|6|||
131199374|NCT02477800|472348664|FG004|Long Term Extension Period|Adverse Event|2|||
131199375|NCT02477800|472348665|FG005|Long Term Extension Period|Adverse Event|4|||
131199376|NCT02477800|472348666|FG006|Long Term Extension Period|Adverse Event|3|||
131199377|NCT02477800|472348660|FG000|Long Term Extension Period|Death|0|||
131199378|NCT02477800|472348661|FG001|Long Term Extension Period|Death|0|||
131199379|NCT02477800|472348662|FG002|Long Term Extension Period|Death|0|||
131199380|NCT02477800|472348663|FG003|Long Term Extension Period|Death|1|||
131199381|NCT02477800|472348664|FG004|Long Term Extension Period|Death|1|||
131199382|NCT02477800|472348665|FG005|Long Term Extension Period|Death|1|||
131199383|NCT02477800|472348666|FG006|Long Term Extension Period|Death|2|||
131199384|NCT02477800|472348660|FG000|Long Term Extension Period|Consent Withdrawn|0|||
131199385|NCT02477800|472348661|FG001|Long Term Extension Period|Consent Withdrawn|0|||
131199386|NCT02477800|472348662|FG002|Long Term Extension Period|Consent Withdrawn|0|||
131199387|NCT02477800|472348663|FG003|Long Term Extension Period|Consent Withdrawn|10|||
131199388|NCT02477800|472348664|FG004|Long Term Extension Period|Consent Withdrawn|4|||
131199389|NCT02477800|472348665|FG005|Long Term Extension Period|Consent Withdrawn|13|||
131199390|NCT02477800|472348666|FG006|Long Term Extension Period|Consent Withdrawn|16|||
130733756|NCT02859142|470642969|FG001|Overall Study|Withdrawal by Subject|0|||
130733757|NCT02859142|470642968|FG000|Overall Study|Scheduling difficulties|0|||
130733758|NCT02859142|470642969|FG001|Overall Study|Scheduling difficulties|3|||
130733759|NCT03290079|470642970|FG000|Overall Study|Death|2|||
131199391|NCT02477800|472348660|FG000|Long Term Extension Period|Disease Progression|0|||
131199392|NCT02477800|472348661|FG001|Long Term Extension Period|Disease Progression|0|||
130733760|NCT02676765|470642971|FG000|Overall Study|Lost to Follow-up|0|||
131199393|NCT02477800|472348662|FG002|Long Term Extension Period|Disease Progression|0|||
131199394|NCT02477800|472348663|FG003|Long Term Extension Period|Disease Progression|3|||
131199395|NCT02477800|472348664|FG004|Long Term Extension Period|Disease Progression|1|||
131199396|NCT02477800|472348665|FG005|Long Term Extension Period|Disease Progression|1|||
130733761|NCT02676765|470642972|FG001|Overall Study|Lost to Follow-up|1|||
130733762|NCT01941498|470642975|FG000|Overall Study|Relocated out of state|1|||
130733763|NCT04877457|470642976|FG000|Overall Study|Early termination of study due to low enrollment|2|||
130733764|NCT04877457|470642977|FG001|Overall Study|Early termination of study due to low enrollment|1|||
131199397|NCT02477800|472348666|FG006|Long Term Extension Period|Disease Progression|0|||
131199398|NCT02477800|472348660|FG000|Long Term Extension Period|Investigator Decision|0|||
131199399|NCT02477800|472348661|FG001|Long Term Extension Period|Investigator Decision|0|||
131199400|NCT02477800|472348662|FG002|Long Term Extension Period|Investigator Decision|0|||
131199401|NCT02477800|472348663|FG003|Long Term Extension Period|Investigator Decision|0|||
131199402|NCT02477800|472348664|FG004|Long Term Extension Period|Investigator Decision|0|||
131199403|NCT02477800|472348665|FG005|Long Term Extension Period|Investigator Decision|0|||
131199404|NCT02477800|472348666|FG006|Long Term Extension Period|Investigator Decision|2|||
131199405|NCT02477800|472348660|FG000|Long Term Extension Period|Lost to Follow-up|0|||
131199406|NCT02477800|472348661|FG001|Long Term Extension Period|Lost to Follow-up|0|||
131199407|NCT02477800|472348662|FG002|Long Term Extension Period|Lost to Follow-up|0|||
131199408|NCT02477800|472348663|FG003|Long Term Extension Period|Lost to Follow-up|0|||
131199409|NCT02477800|472348664|FG004|Long Term Extension Period|Lost to Follow-up|1|||
131199410|NCT02477800|472348665|FG005|Long Term Extension Period|Lost to Follow-up|3|||
131199411|NCT02477800|472348666|FG006|Long Term Extension Period|Lost to Follow-up|0|||
131199412|NCT02477800|472348660|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
131199413|NCT02477800|472348661|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
131199414|NCT02477800|472348662|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
131199415|NCT02477800|472348663|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
131199416|NCT02477800|472348664|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
131199417|NCT02477800|472348665|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
131199418|NCT02477800|472348666|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
131199419|NCT02477800|472348660|FG000|Long Term Extension Period|Study Visit Burden|0|||
131199420|NCT02477800|472348661|FG001|Long Term Extension Period|Study Visit Burden|0|||
131199421|NCT02477800|472348662|FG002|Long Term Extension Period|Study Visit Burden|0|||
131199422|NCT02477800|472348663|FG003|Long Term Extension Period|Study Visit Burden|3|||
131199423|NCT02477800|472348664|FG004|Long Term Extension Period|Study Visit Burden|0|||
131199424|NCT02477800|472348665|FG005|Long Term Extension Period|Study Visit Burden|2|||
131199425|NCT02477800|472348666|FG006|Long Term Extension Period|Study Visit Burden|2|||
131199426|NCT02477800|472348660|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
131199427|NCT02477800|472348661|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
131199428|NCT02477800|472348662|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
131199429|NCT02477800|472348663|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
131199430|NCT02477800|472348664|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
131199431|NCT02477800|472348665|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
131199432|NCT02477800|472348666|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
131199433|NCT02477800|472348660|FG000|Long Term Extension Period|Reason not Specified|0|||
131199434|NCT02477800|472348661|FG001|Long Term Extension Period|Reason not Specified|0|||
131199435|NCT02477800|472348662|FG002|Long Term Extension Period|Reason not Specified|0|||
131199436|NCT02477800|472348663|FG003|Long Term Extension Period|Reason not Specified|126|||
131199437|NCT02477800|472348664|FG004|Long Term Extension Period|Reason not Specified|140|||
131199438|NCT02477800|472348665|FG005|Long Term Extension Period|Reason not Specified|270|||
131199439|NCT02477800|472348666|FG006|Long Term Extension Period|Reason not Specified|224|||
131199440|NCT00958191|472348668|FG000|Overall Study|Death|4|||
131199441|NCT00958191|472348668|FG000|Overall Study|Lost to Follow-up|5|||
131199442|NCT00958191|472348668|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
131199443|NCT00958191|472348668|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
131199444|NCT00958191|472348668|FG000|Overall Study|Revision of study device|4|||
131199445|NCT00958191|472348668|FG000|Overall Study|Site termination|11|||
131199446|NCT00958191|472348668|FG000|Overall Study|No 5 yr x-rays|56|||
131199447|NCT01818765|472348669|FG000|Overall Study|Death|2|||
131199448|NCT02010567|472348670|FG000|Overall Study|Adverse Event|0|||
131199449|NCT02010567|472348671|FG001|Overall Study|Adverse Event|0|||
131199450|NCT02010567|472348672|FG002|Overall Study|Adverse Event|1|||
131199451|NCT02010567|472348673|FG003|Overall Study|Adverse Event|0|||
131199452|NCT02010567|472348674|FG004|Overall Study|Adverse Event|1|||
131199453|NCT02005211|472348675|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131199454|NCT02005211|472348676|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131199455|NCT02005211|472348677|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131199456|NCT02005211|472348678|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131199457|NCT02005211|472348679|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
131199458|NCT02005211|472348680|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131199459|NCT02005211|472348681|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
131199460|NCT00935701|472348683|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
131199461|NCT01700140|472348684|FG000|Overall Study|Use of rescue drugs|3|||
131199462|NCT01700140|472348685|FG001|Overall Study|Use of rescue drugs|3|||
131199463|NCT01700140|472348686|FG002|Overall Study|Use of rescue drugs|1|||
131199464|NCT01700140|472348684|FG000|Overall Study|Discontinuation of radiotherapy|1|||
131199465|NCT01700140|472348685|FG001|Overall Study|Discontinuation of radiotherapy|0|||
131199466|NCT01700140|472348686|FG002|Overall Study|Discontinuation of radiotherapy|0|||
131199467|NCT01700140|472348684|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
131199468|NCT01700140|472348685|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
131199469|NCT01700140|472348686|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
131199470|NCT01700140|472348684|FG000|Overall Study|Aggravation of symptoms|1|||
131199471|NCT01700140|472348685|FG001|Overall Study|Aggravation of symptoms|0|||
131199472|NCT01700140|472348686|FG002|Overall Study|Aggravation of symptoms|0|||
131199473|NCT01700140|472348684|FG000|Overall Study|Adverse Event|0|||
131199474|NCT01700140|472348685|FG001|Overall Study|Adverse Event|1|||
131199475|NCT01700140|472348686|FG002|Overall Study|Adverse Event|0|||
131199476|NCT01700140|472348684|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
131199477|NCT01700140|472348685|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
131199478|NCT01700140|472348686|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
131199479|NCT01708915|472348688|FG000|Overall Study|Adverse Event|1|||
131199480|NCT01708915|472348689|FG001|Overall Study|Adverse Event|0|||
131199481|NCT01708915|472348690|FG002|Overall Study|Adverse Event|9|||
131199482|NCT01708915|472348691|FG003|Overall Study|Adverse Event|13|||
131199483|NCT01708915|472348688|FG000|Overall Study|Lack of Efficacy|84|||
131199484|NCT01708915|472348689|FG001|Overall Study|Lack of Efficacy|60|||
131199485|NCT01708915|472348690|FG002|Overall Study|Lack of Efficacy|35|||
131199486|NCT01708915|472348691|FG003|Overall Study|Lack of Efficacy|15|||
131199487|NCT01708915|472348688|FG000|Overall Study|Protocol Violation|0|||
131199488|NCT01708915|472348689|FG001|Overall Study|Protocol Violation|0|||
131199489|NCT01708915|472348690|FG002|Overall Study|Protocol Violation|0|||
131199490|NCT01708915|472348691|FG003|Overall Study|Protocol Violation|1|||
131199491|NCT01708915|472348688|FG000|Overall Study|Withdrawal by Subject|0|||
131199492|NCT01708915|472348689|FG001|Overall Study|Withdrawal by Subject|1|||
131199493|NCT01708915|472348690|FG002|Overall Study|Withdrawal by Subject|2|||
131199494|NCT01708915|472348691|FG003|Overall Study|Withdrawal by Subject|2|||
131199495|NCT01708915|472348688|FG000|Overall Study|Other reasons than stated above|1|||
131199496|NCT01708915|472348689|FG001|Overall Study|Other reasons than stated above|1|||
131199497|NCT01708915|472348690|FG002|Overall Study|Other reasons than stated above|0|||
131199498|NCT01708915|472348691|FG003|Overall Study|Other reasons than stated above|2|||
131199499|NCT01432938|472348692|FG000|First Intervention|Protocol Violation|1|||
131199500|NCT01432938|472348693|FG001|First Intervention|Protocol Violation|0|||
131199501|NCT01432938|472348692|FG000|First Intervention|Physician Decision|1|||
131199502|NCT01432938|472348693|FG001|First Intervention|Physician Decision|0|||
131199503|NCT01432938|472348692|FG000|Second Intervention|Adverse Event|1|||
131199504|NCT01432938|472348693|FG001|Second Intervention|Adverse Event|0|||
131199505|NCT01601873|472348694|FG000|Overall Study|Lost to Follow-up|2|||
131199506|NCT01601873|472348695|FG001|Overall Study|Lost to Follow-up|3|||
131199507|NCT02096471|472348696|FG000|Overall Study|Adverse Event|1|||
131199508|NCT02096471|472348696|FG000|Overall Study|Lack of Efficacy|7|||
131199509|NCT02096471|472348696|FG000|Overall Study|Withdrawal by Subject|3|||
131199510|NCT02096471|472348696|FG000|Overall Study|Non-Compliant|2|||
131199511|NCT02382276|472348697|FG000|Overall Study|Withdrawal by Subject|4|||
131199512|NCT02382276|472348698|FG001|Overall Study|Withdrawal by Subject|8|||
131199513|NCT02382276|472348699|FG002|Overall Study|Withdrawal by Subject|5|||
131199514|NCT02382276|472348697|FG000|Overall Study|Adverse Event|7|||
131199515|NCT02382276|472348698|FG001|Overall Study|Adverse Event|2|||
131199516|NCT02382276|472348699|FG002|Overall Study|Adverse Event|32|||
131199517|NCT02382276|472348697|FG000|Overall Study|Physician Decision|0|||
131199518|NCT02382276|472348698|FG001|Overall Study|Physician Decision|0|||
131199519|NCT02382276|472348699|FG002|Overall Study|Physician Decision|2|||
131199520|NCT00518336|472348700|FG000|Year 7|Lost to Follow-up|2|||
131199521|NCT00518336|472348701|FG001|Year 7|Lost to Follow-up|0|||
131199522|NCT00518336|472348700|FG000|Year 7|Could not attend in time|0|||
131199523|NCT00518336|472348701|FG001|Year 7|Could not attend in time|3|||
131199524|NCT00518336|472348700|FG000|Year 8|Lost to Follow-up|1|||
131199525|NCT00518336|472348701|FG001|Year 8|Lost to Follow-up|1|||
131199526|NCT00518336|472348700|FG000|Year 8|Could not attend in time|0|||
131199527|NCT00518336|472348701|FG001|Year 8|Could not attend in time|1|||
131199528|NCT00518336|472348700|FG000|Year 9|Migrated/moved from study area|1|||
131199529|NCT00518336|472348701|FG001|Year 9|Migrated/moved from study area|1|||
131199530|NCT00518336|472348700|FG000|Year 9|Lost to Follow-up|3|||
131199531|NCT00518336|472348701|FG001|Year 9|Lost to Follow-up|0|||
131199532|NCT00518336|472348700|FG000|Year 9|Personal reasons|1|||
131199533|NCT00518336|472348701|FG001|Year 9|Personal reasons|0|||
131199534|NCT00125268|472348702|FG000|Overall Study|Withdrawal by Subject|1|||
131199535|NCT00125268|472348703|FG001|Overall Study|Withdrawal by Subject|1|||
131199536|NCT02449915|472348704|FG000|Overall Study|Exclusion criteria - drug use|1|||
131199537|NCT02449915|472348705|FG001|Overall Study|Exclusion criteria - drug use|0|||
131199538|NCT02449915|472348704|FG000|Overall Study|Withdrawal by Subject|0|||
130733765|NCT04697069|470642979|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
131199539|NCT02449915|472348705|FG001|Overall Study|Withdrawal by Subject|2|||
131199540|NCT02449915|472348704|FG000|Overall Study|Intraoperative surgical findings|1|||
131199541|NCT02449915|472348705|FG001|Overall Study|Intraoperative surgical findings|1|||
131199542|NCT02449915|472348704|FG000|Overall Study|Abnormal preop lab|0|||
131199543|NCT02449915|472348705|FG001|Overall Study|Abnormal preop lab|1|||
131199544|NCT04223778|472348706|FG000|Overall Study|Death|1|||
131199545|NCT04223778|472348707|FG001|Overall Study|Death|1|||
131199546|NCT04223778|472348706|FG000|Overall Study|Lost to Follow-up|4|||
131199547|NCT04223778|472348707|FG001|Overall Study|Lost to Follow-up|5|||
131199548|NCT04223778|472348706|FG000|Overall Study|Physician Decision|10|||
131199549|NCT04223778|472348707|FG001|Overall Study|Physician Decision|6|||
131199550|NCT04223778|472348706|FG000|Overall Study|Withdrawal by Subject|35|||
131199551|NCT04223778|472348707|FG001|Overall Study|Withdrawal by Subject|17|||
131199552|NCT04223778|472348706|FG000|Overall Study|Not Reported|7|||
131199553|NCT04223778|472348707|FG001|Overall Study|Not Reported|8|||
131199554|NCT00740116|472350236|FG000|Overall Study|Withdrawal by Subject|1|||
131199555|NCT00740116|472350237|FG001|Overall Study|Withdrawal by Subject|1|||
131199556|NCT00740116|472350236|FG000|Overall Study|Protocol Violation|1|||
131199557|NCT00740116|472350237|FG001|Overall Study|Protocol Violation|4|||
131199558|NCT03037489|472350238|FG000|Overall Study|Adverse Event|4|||
131199559|NCT03037489|472350239|FG001|Overall Study|Adverse Event|0|||
131199560|NCT03037489|472350238|FG000|Overall Study|Withdrawal by Subject|3|||
131199561|NCT03037489|472350239|FG001|Overall Study|Withdrawal by Subject|0|||
131199562|NCT00621764|472350240|FG000|Overall Study|Protocol Violation|0|||
131199563|NCT00621764|472350241|FG001|Overall Study|Protocol Violation|0|||
131199564|NCT00621764|472350242|FG002|Overall Study|Protocol Violation|0|||
131199565|NCT00621764|472350243|FG003|Overall Study|Protocol Violation|1|||
131199566|NCT02499172|472350244|FG000|Overall Study|Financial reason|0|||
131199567|NCT02499172|472350245|FG001|Overall Study|Financial reason|0|||
131199568|NCT02499172|472350246|FG002|Overall Study|Financial reason|523|||
131199569|NCT02499172|472350247|FG003|Overall Study|Financial reason|436|||
131199570|NCT02499172|472350244|FG000|Overall Study|Lost to Follow-up|65|||
131199571|NCT02499172|472350245|FG001|Overall Study|Lost to Follow-up|64|||
131199572|NCT02499172|472350246|FG002|Overall Study|Lost to Follow-up|0|||
131199573|NCT02499172|472350247|FG003|Overall Study|Lost to Follow-up|0|||
131199574|NCT01293123|472350248|FG000|Overall Study|Lost to Follow-up|0|||
131199575|NCT01293123|472350249|FG001|Overall Study|Lost to Follow-up|1|||
131199576|NCT00121485|472350250|FG000|Overall Study|Not implanted|1|||
131199577|NCT00121485|472350251|FG001|Overall Study|Not implanted|5|||
131199578|NCT00121485|472350250|FG000|Overall Study|Crossover|0|||
131199579|NCT00121485|472350251|FG001|Overall Study|Crossover|2|||
131199580|NCT00724243|472350256|FG000|Overall Study|Lack of Efficacy|10|||
131199581|NCT00724243|472350256|FG000|Overall Study|Adverse Event|5|||
131199582|NCT03031327|472350259|FG000|Overall Study|Withdrawal by Subject|0|||
131199583|NCT03031327|472350260|FG001|Overall Study|Withdrawal by Subject|1|||
131199584|NCT03031327|472350261|FG002|Overall Study|Withdrawal by Subject|1|||
131199585|NCT00211536|472350262|FG000|Overall Study|Withdrawal by Subject|2|||
131199586|NCT00211536|472350263|FG001|Overall Study|Withdrawal by Subject|2|||
131199587|NCT00211536|472350262|FG000|Overall Study|Physician Decision|0|||
131199588|NCT00211536|472350263|FG001|Overall Study|Physician Decision|5|||
131199589|NCT00211536|472350262|FG000|Overall Study|Adverse Event|2|||
131199590|NCT00211536|472350263|FG001|Overall Study|Adverse Event|0|||
131199591|NCT00003389|472350264|FG000|Overall Study|Disease progression|6|||
131199592|NCT00003389|472350265|FG001|Overall Study|Disease progression|1|||
131199593|NCT00003389|472350264|FG000|Overall Study|Adverse Event|13|||
131199594|NCT00003389|472350265|FG001|Overall Study|Adverse Event|2|||
131199595|NCT00003389|472350264|FG000|Overall Study|Death|0|||
131199596|NCT00003389|472350265|FG001|Overall Study|Death|3|||
131199597|NCT00003389|472350264|FG000|Overall Study|Withdrawal by Subject|12|||
131199598|NCT00003389|472350265|FG001|Overall Study|Withdrawal by Subject|5|||
130733766|NCT04697069|470642980|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
130733767|NCT04697069|470642979|FG000|Overall Study|Study termination|2|||
130733768|NCT04697069|470642980|FG001|Overall Study|Study termination|1|||
130733769|NCT04597632|470642983|FG000|Overall Study|Withdrawal by Subject|10|||
131199599|NCT00003389|472350264|FG000|Overall Study|Alternative therapy|2|||
131199600|NCT00003389|472350265|FG001|Overall Study|Alternative therapy|1|||
131199601|NCT00003389|472350264|FG000|Overall Study|Complicating disease|1|||
131199602|NCT00003389|472350265|FG001|Overall Study|Complicating disease|0|||
131199603|NCT00003389|472350264|FG000|Overall Study|Off-treatment reason missing|31|||
131199604|NCT00003389|472350265|FG001|Overall Study|Off-treatment reason missing|21|||
131199605|NCT00003389|472350264|FG000|Overall Study|Ineligible|33|||
131199606|NCT00003389|472350265|FG001|Overall Study|Ineligible|27|||
131199607|NCT02646891|472350266|FG000|Overall Study|Adverse Event|0|||
131199608|NCT02646891|472350267|FG001|Overall Study|Adverse Event|1|||
131199609|NCT02646891|472350268|FG002|Overall Study|Adverse Event|0|||
131199610|NCT02646891|472350269|FG003|Overall Study|Adverse Event|0|||
131199611|NCT02646891|472350270|FG004|Overall Study|Adverse Event|0|||
131199612|NCT02646891|472350271|FG005|Overall Study|Adverse Event|0|||
130733770|NCT04597632|470642983|FG000|Overall Study|Lost to Follow-up|1|||
130733771|NCT04597632|470642983|FG000|Overall Study|Death|1|||
130733772|NCT04597632|470642983|FG000|Overall Study|Adverse Event|5|||
131199613|NCT02646891|472350272|FG006|Overall Study|Adverse Event|0|||
131199614|NCT02646891|472350273|FG007|Overall Study|Adverse Event|0|||
131199615|NCT02646891|472350274|FG008|Overall Study|Adverse Event|0|||
131199616|NCT02646891|472350275|FG009|Overall Study|Adverse Event|0|||
131199617|NCT02646891|472350266|FG000|Overall Study|Lost to Follow-up|0|||
131199618|NCT02646891|472350267|FG001|Overall Study|Lost to Follow-up|0|||
131199619|NCT02646891|472350268|FG002|Overall Study|Lost to Follow-up|0|||
131199620|NCT02646891|472350269|FG003|Overall Study|Lost to Follow-up|0|||
131199621|NCT02646891|472350270|FG004|Overall Study|Lost to Follow-up|0|||
131199622|NCT02646891|472350271|FG005|Overall Study|Lost to Follow-up|0|||
131199623|NCT02646891|472350272|FG006|Overall Study|Lost to Follow-up|2|||
131199624|NCT02646891|472350273|FG007|Overall Study|Lost to Follow-up|2|||
131199625|NCT02646891|472350274|FG008|Overall Study|Lost to Follow-up|2|||
131199626|NCT02646891|472350275|FG009|Overall Study|Lost to Follow-up|2|||
131199627|NCT02646891|472350266|FG000|Overall Study|Protocol Violation|0|||
131199628|NCT02646891|472350267|FG001|Overall Study|Protocol Violation|0|||
131199629|NCT02646891|472350268|FG002|Overall Study|Protocol Violation|0|||
131199630|NCT02646891|472350269|FG003|Overall Study|Protocol Violation|0|||
131199631|NCT02646891|472350270|FG004|Overall Study|Protocol Violation|0|||
131199632|NCT02646891|472350271|FG005|Overall Study|Protocol Violation|0|||
131199633|NCT02646891|472350272|FG006|Overall Study|Protocol Violation|1|||
131199634|NCT02646891|472350273|FG007|Overall Study|Protocol Violation|1|||
131199635|NCT02646891|472350274|FG008|Overall Study|Protocol Violation|0|||
131199636|NCT02646891|472350275|FG009|Overall Study|Protocol Violation|0|||
131199637|NCT02646891|472350266|FG000|Overall Study|Withdrawal by Subject|2|||
131199638|NCT02646891|472350267|FG001|Overall Study|Withdrawal by Subject|0|||
131199639|NCT02646891|472350268|FG002|Overall Study|Withdrawal by Subject|1|||
131199640|NCT02646891|472350269|FG003|Overall Study|Withdrawal by Subject|0|||
131199641|NCT02646891|472350270|FG004|Overall Study|Withdrawal by Subject|0|||
131199642|NCT02646891|472350271|FG005|Overall Study|Withdrawal by Subject|0|||
131199643|NCT02646891|472350272|FG006|Overall Study|Withdrawal by Subject|5|||
131199644|NCT02646891|472350273|FG007|Overall Study|Withdrawal by Subject|9|||
131199645|NCT02646891|472350274|FG008|Overall Study|Withdrawal by Subject|7|||
131199646|NCT02646891|472350275|FG009|Overall Study|Withdrawal by Subject|3|||
131199647|NCT02646891|472350266|FG000|Overall Study|Death|0|||
131199648|NCT02646891|472350267|FG001|Overall Study|Death|0|||
131199649|NCT02646891|472350268|FG002|Overall Study|Death|0|||
131199650|NCT02646891|472350269|FG003|Overall Study|Death|0|||
131199651|NCT02646891|472350270|FG004|Overall Study|Death|0|||
131199652|NCT02646891|472350271|FG005|Overall Study|Death|0|||
131199653|NCT02646891|472350272|FG006|Overall Study|Death|1|||
131199654|NCT02646891|472350273|FG007|Overall Study|Death|1|||
131199655|NCT02646891|472350274|FG008|Overall Study|Death|1|||
131199656|NCT02646891|472350275|FG009|Overall Study|Death|0|||
131199657|NCT01599585|472350276|FG000|Overall Study|Withdrawal by Subject|16|||
131199658|NCT01599585|472350277|FG001|Overall Study|Withdrawal by Subject|9|||
131199659|NCT01599585|472350276|FG000|Overall Study|Lost to Follow-up|3|||
131199660|NCT01599585|472350277|FG001|Overall Study|Lost to Follow-up|5|||
131199661|NCT01599585|472350276|FG000|Overall Study|randomized did not start treatment|3|||
131199662|NCT01599585|472350277|FG001|Overall Study|randomized did not start treatment|3|||
131199663|NCT01108263|472350278|FG000|Overall Study|Adverse Event|0|||
131199664|NCT01108263|472350279|FG001|Overall Study|Adverse Event|1|||
131199665|NCT01685372|472350280|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
131199666|NCT01685372|472350281|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
131199667|NCT00829010|472350284|FG000|Overall Study|Adverse Event|1|||
131199668|NCT00829010|472350285|FG001|Overall Study|Adverse Event|0|||
131199669|NCT00829010|472350286|FG002|Overall Study|Adverse Event|0|||
131199670|NCT00829010|472350287|FG003|Overall Study|Adverse Event|0|||
131199671|NCT00829010|472350288|FG004|Overall Study|Adverse Event|0|||
130733773|NCT01893346|470642986|FG000|Overall Study|Lost to Follow-up|0|||
130733774|NCT01893346|470642987|FG001|Overall Study|Lost to Follow-up|1|||
131199672|NCT00829010|472350284|FG000|Overall Study|Withdrawal by Subject|0|||
131199673|NCT00829010|472350285|FG001|Overall Study|Withdrawal by Subject|1|||
131199674|NCT00829010|472350286|FG002|Overall Study|Withdrawal by Subject|1|||
131199675|NCT00829010|472350287|FG003|Overall Study|Withdrawal by Subject|0|||
131199676|NCT00829010|472350288|FG004|Overall Study|Withdrawal by Subject|2|||
131199677|NCT00829010|472350284|FG000|Overall Study|Lost to Follow-up|1|||
131199678|NCT00829010|472350285|FG001|Overall Study|Lost to Follow-up|0|||
130733775|NCT01893346|470642988|FG002|Overall Study|Lost to Follow-up|0|||
131199679|NCT00829010|472350286|FG002|Overall Study|Lost to Follow-up|2|||
131199680|NCT00829010|472350287|FG003|Overall Study|Lost to Follow-up|0|||
131199681|NCT00829010|472350288|FG004|Overall Study|Lost to Follow-up|0|||
131199682|NCT00829010|472350284|FG000|Overall Study|Fatality|5|||
131199683|NCT00829010|472350285|FG001|Overall Study|Fatality|4|||
131199684|NCT00829010|472350286|FG002|Overall Study|Fatality|0|||
131199685|NCT00829010|472350287|FG003|Overall Study|Fatality|3|||
131199686|NCT00829010|472350288|FG004|Overall Study|Fatality|0|||
131199687|NCT00829010|472350284|FG000|Overall Study|Migrated/Moved from study area|3|||
131199688|NCT00829010|472350285|FG001|Overall Study|Migrated/Moved from study area|4|||
131199689|NCT00829010|472350286|FG002|Overall Study|Migrated/Moved from study area|0|||
131199690|NCT00829010|472350287|FG003|Overall Study|Migrated/Moved from study area|5|||
131199691|NCT00829010|472350288|FG004|Overall Study|Migrated/Moved from study area|0|||
131199692|NCT02289833|472350293|FG000|Overall Study|Study discontinuation|0|||
131199693|NCT02289833|472350294|FG001|Overall Study|Study discontinuation|1|||
131199694|NCT02289833|472350293|FG000|Overall Study|Lost to Follow-up|4|||
131199695|NCT02289833|472350294|FG001|Overall Study|Lost to Follow-up|0|||
131199696|NCT02289833|472350293|FG000|Overall Study|Death|23|||
131199697|NCT02289833|472350294|FG001|Overall Study|Death|16|||
131199698|NCT03442595|472350295|FG000|Overall Study|Lost to Follow-up|94|||
131199699|NCT03442595|472350296|FG001|Overall Study|Lost to Follow-up|0|||
131199700|NCT00811395|472350299|FG000|Extension Treatment|Adverse Event|1|||
131199701|NCT00811395|472350300|FG001|Extension Treatment|Adverse Event|2|||
131199702|NCT00811395|472350301|FG002|Extension Treatment|Adverse Event|2|||
131199703|NCT00811395|472350302|FG003|Extension Treatment|Adverse Event|2|||
131199704|NCT00811395|472350303|FG004|Extension Treatment|Adverse Event|0|||
131199705|NCT00811395|472350304|FG005|Extension Treatment|Adverse Event|1|||
131199706|NCT00811395|472350299|FG000|Extension Treatment|Progressive disease|1|||
131199707|NCT00811395|472350300|FG001|Extension Treatment|Progressive disease|1|||
131199708|NCT00811395|472350301|FG002|Extension Treatment|Progressive disease|0|||
131199709|NCT00811395|472350302|FG003|Extension Treatment|Progressive disease|0|||
131199710|NCT00811395|472350303|FG004|Extension Treatment|Progressive disease|0|||
131199711|NCT00811395|472350304|FG005|Extension Treatment|Progressive disease|0|||
131199712|NCT00811395|472350299|FG000|Extension Treatment|Participant did not wish to continue|0|||
131199713|NCT00811395|472350300|FG001|Extension Treatment|Participant did not wish to continue|3|||
131199714|NCT00811395|472350301|FG002|Extension Treatment|Participant did not wish to continue|0|||
131199715|NCT00811395|472350302|FG003|Extension Treatment|Participant did not wish to continue|1|||
131199716|NCT00811395|472350303|FG004|Extension Treatment|Participant did not wish to continue|0|||
131199717|NCT00811395|472350304|FG005|Extension Treatment|Participant did not wish to continue|1|||
131199718|NCT00811395|472350299|FG000|Extension Treatment|Other than above|0|||
131199719|NCT00811395|472350300|FG001|Extension Treatment|Other than above|0|||
131199720|NCT00811395|472350301|FG002|Extension Treatment|Other than above|1|||
131199721|NCT00811395|472350302|FG003|Extension Treatment|Other than above|0|||
131199722|NCT00811395|472350303|FG004|Extension Treatment|Other than above|0|||
131199723|NCT00811395|472350304|FG005|Extension Treatment|Other than above|0|||
131199724|NCT00170846|472350311|FG000|Overall Study|Subject withdrew Informed Consent|5|||
131199725|NCT00170846|472350312|FG001|Overall Study|Subject withdrew Informed Consent|12|||
131199726|NCT00170846|472350313|FG002|Overall Study|Subject withdrew Informed Consent|8|||
131199727|NCT00170846|472350311|FG000|Overall Study|Lost to Follow-up|6|||
131199728|NCT00170846|472350312|FG001|Overall Study|Lost to Follow-up|3|||
131199729|NCT00170846|472350313|FG002|Overall Study|Lost to Follow-up|2|||
131199730|NCT00170846|472350311|FG000|Overall Study|Death|0|||
131199731|NCT00170846|472350312|FG001|Overall Study|Death|3|||
131199732|NCT00170846|472350313|FG002|Overall Study|Death|3|||
131199733|NCT00170846|472350311|FG000|Overall Study|Reason Missing|0|||
131199734|NCT00170846|472350312|FG001|Overall Study|Reason Missing|1|||
131199735|NCT00170846|472350313|FG002|Overall Study|Reason Missing|0|||
131199736|NCT00118040|472350314|FG000|Overall Study|Adverse Event|0|||
131199737|NCT00118040|472350315|FG001|Overall Study|Adverse Event|1|||
131199738|NCT00118040|472350316|FG002|Overall Study|Adverse Event|0|||
131199739|NCT00118040|472350314|FG000|Overall Study|Withdrawal by Subject|0|||
131199740|NCT00118040|472350315|FG001|Overall Study|Withdrawal by Subject|0|||
131199741|NCT00118040|472350316|FG002|Overall Study|Withdrawal by Subject|2|||
131199742|NCT00118040|472350314|FG000|Overall Study|Medical Contraindication|0|||
131199743|NCT00118040|472350315|FG001|Overall Study|Medical Contraindication|0|||
131199744|NCT00118040|472350316|FG002|Overall Study|Medical Contraindication|1|||
131199745|NCT00118040|472350314|FG000|Overall Study|Non-Compliant Participant|1|||
131199746|NCT00118040|472350315|FG001|Overall Study|Non-Compliant Participant|1|||
131199747|NCT00118040|472350316|FG002|Overall Study|Non-Compliant Participant|2|||
131199748|NCT00118040|472350314|FG000|Overall Study|Other|0|||
131199749|NCT00118040|472350315|FG001|Overall Study|Other|0|||
131199750|NCT00118040|472350316|FG002|Overall Study|Other|1|||
131199751|NCT01970540|472350319|FG000|Overall Study|Non-treatment-related AE|0|||
130733776|NCT01893346|470642989|FG003|Overall Study|Lost to Follow-up|0|||
130733777|NCT01893346|470642986|FG000|Overall Study|Protocol Violation|1|||
130733778|NCT01893346|470642987|FG001|Overall Study|Protocol Violation|0|||
130733779|NCT01893346|470642988|FG002|Overall Study|Protocol Violation|0|||
131199752|NCT01970540|472350320|FG001|Overall Study|Non-treatment-related AE|0|||
131199753|NCT01970540|472350321|FG002|Overall Study|Non-treatment-related AE|1|||
131199754|NCT01970540|472350319|FG000|Overall Study|Progressive disease|55|||
131199755|NCT01970540|472350320|FG001|Overall Study|Progressive disease|23|||
131199756|NCT01970540|472350321|FG002|Overall Study|Progressive disease|10|||
131199757|NCT01970540|472350319|FG000|Overall Study|Treatment delay over protocol|0|||
131199758|NCT01970540|472350320|FG001|Overall Study|Treatment delay over protocol|0|||
131199759|NCT01970540|472350321|FG002|Overall Study|Treatment delay over protocol|1|||
131199760|NCT01970540|472350319|FG000|Overall Study|Physician Decision|7|||
130733780|NCT01893346|470642989|FG003|Overall Study|Protocol Violation|0|||
130733781|NCT01893346|470642986|FG000|Overall Study|Withdrawal by Subject|2|||
131199761|NCT01970540|472350320|FG001|Overall Study|Physician Decision|2|||
131199762|NCT01970540|472350321|FG002|Overall Study|Physician Decision|0|||
131199763|NCT01970540|472350319|FG000|Overall Study|Clinical progression|0|||
131199764|NCT01970540|472350320|FG001|Overall Study|Clinical progression|1|||
131199765|NCT01970540|472350321|FG002|Overall Study|Clinical progression|1|||
131199766|NCT01970540|472350319|FG000|Overall Study|End of study|2|||
131199767|NCT01970540|472350320|FG001|Overall Study|End of study|0|||
131199768|NCT01970540|472350321|FG002|Overall Study|End of study|2|||
131199769|NCT01970540|472350319|FG000|Overall Study|Adverse Event|0|||
131199770|NCT01970540|472350320|FG001|Overall Study|Adverse Event|2|||
131199771|NCT01970540|472350321|FG002|Overall Study|Adverse Event|1|||
131199772|NCT01970540|472350319|FG000|Overall Study|Treatment-related AE|4|||
131199773|NCT01970540|472350320|FG001|Overall Study|Treatment-related AE|0|||
131199774|NCT01970540|472350321|FG002|Overall Study|Treatment-related AE|2|||
131199775|NCT01970540|472350319|FG000|Overall Study|Withdrawal by Subject|4|||
131199776|NCT01970540|472350320|FG001|Overall Study|Withdrawal by Subject|0|||
131199777|NCT01970540|472350321|FG002|Overall Study|Withdrawal by Subject|1|||
131199778|NCT01970540|472350319|FG000|Overall Study|Clinical deterioration|1|||
131199779|NCT01970540|472350320|FG001|Overall Study|Clinical deterioration|0|||
131199780|NCT01970540|472350321|FG002|Overall Study|Clinical deterioration|0|||
131199781|NCT00952588|472350326|FG000|Overall Study|Death|28|||
131199782|NCT00952588|472350327|FG001|Overall Study|Death|13|||
131199783|NCT00952588|472350326|FG000|Overall Study|Withdrawal by Subject|2|||
131199784|NCT00952588|472350327|FG001|Overall Study|Withdrawal by Subject|5|||
131199785|NCT00952588|472350326|FG000|Overall Study|Adverse Event|2|||
131199786|NCT00952588|472350327|FG001|Overall Study|Adverse Event|3|||
131199787|NCT00952588|472350326|FG000|Overall Study|Lost to Follow-up|2|||
131199788|NCT00952588|472350327|FG001|Overall Study|Lost to Follow-up|0|||
131199789|NCT00952588|472350326|FG000|Overall Study|Physician Decision|0|||
131199790|NCT00952588|472350327|FG001|Overall Study|Physician Decision|1|||
131199791|NCT00952588|472350326|FG000|Overall Study|Lack of Efficacy|2|||
131199792|NCT00952588|472350327|FG001|Overall Study|Lack of Efficacy|2|||
131199793|NCT01796106|472350328|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
131199794|NCT01796106|472350329|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
131199795|NCT01766401|472350330|FG000|Overall Study|Adverse Event|7|||
131199796|NCT01766401|472350331|FG001|Overall Study|Adverse Event|22|||
131199797|NCT01766401|472350330|FG000|Overall Study|Lack of Efficacy|1|||
131199798|NCT01766401|472350331|FG001|Overall Study|Lack of Efficacy|2|||
131199799|NCT01766401|472350330|FG000|Overall Study|Protocol Violation|3|||
131199800|NCT01766401|472350331|FG001|Overall Study|Protocol Violation|8|||
131199801|NCT01766401|472350330|FG000|Overall Study|Withdrawal by Subject|15|||
131199802|NCT01766401|472350331|FG001|Overall Study|Withdrawal by Subject|12|||
131199803|NCT01766401|472350330|FG000|Overall Study|Lost to Follow-up|10|||
131199804|NCT01766401|472350331|FG001|Overall Study|Lost to Follow-up|11|||
131199805|NCT01766401|472350330|FG000|Overall Study|Pregnancy|1|||
131199806|NCT01766401|472350331|FG001|Overall Study|Pregnancy|1|||
131199807|NCT01021553|472350336|FG000|Overall Study|Adverse Event|1|||
131199808|NCT01021553|472350337|FG001|Overall Study|Adverse Event|0|||
131199809|NCT01021553|472350338|FG002|Overall Study|Adverse Event|0|||
131199810|NCT01021553|472350336|FG000|Overall Study|Lack of Efficacy|2|||
131199811|NCT01021553|472350337|FG001|Overall Study|Lack of Efficacy|2|||
131199812|NCT01021553|472350338|FG002|Overall Study|Lack of Efficacy|0|||
131199813|NCT01021553|472350336|FG000|Overall Study|Protocol Violation|0|||
131199814|NCT01021553|472350337|FG001|Overall Study|Protocol Violation|2|||
131199815|NCT01021553|472350338|FG002|Overall Study|Protocol Violation|2|||
131199816|NCT01021553|472350336|FG000|Overall Study|Lost to Follow-up|0|||
131199817|NCT01021553|472350337|FG001|Overall Study|Lost to Follow-up|0|||
131199818|NCT01021553|472350338|FG002|Overall Study|Lost to Follow-up|1|||
131199819|NCT01021553|472350336|FG000|Overall Study|Withdrawal by Subject|1|||
131199820|NCT01021553|472350337|FG001|Overall Study|Withdrawal by Subject|1|||
131199821|NCT01021553|472350338|FG002|Overall Study|Withdrawal by Subject|0|||
131199822|NCT01950364|472350339|FG000|Overall Study|Adverse Event|3|||
131199823|NCT01950364|472350340|FG001|Overall Study|Adverse Event|0|||
131199824|NCT01950364|472350339|FG000|Overall Study|Stem Cell Transplant|2|||
131199825|NCT01950364|472350340|FG001|Overall Study|Stem Cell Transplant|6|||
131199826|NCT01950364|472350339|FG000|Overall Study|Disease Progression|5|||
131199827|NCT01950364|472350340|FG001|Overall Study|Disease Progression|2|||
131199828|NCT01950364|472350339|FG000|Overall Study|Withdrawal by Subject|0|||
131199829|NCT01950364|472350340|FG001|Overall Study|Withdrawal by Subject|1|||
131199830|NCT01950364|472350339|FG000|Overall Study|Protocol Violation|0|||
131199831|NCT01950364|472350340|FG001|Overall Study|Protocol Violation|1|||
131199832|NCT00033293|472350341|FG000|Overall Study|Death|0|||
131199833|NCT00033293|472350342|FG001|Overall Study|Death|1|||
131199834|NCT00033293|472350341|FG000|Overall Study|Lack of Efficacy|5|||
131199835|NCT00033293|472350342|FG001|Overall Study|Lack of Efficacy|8|||
131199836|NCT00033293|472350341|FG000|Overall Study|Lost to Follow-up|0|||
131199837|NCT00033293|472350342|FG001|Overall Study|Lost to Follow-up|1|||
131199838|NCT00033293|472350341|FG000|Overall Study|Physician Decision|3|||
131199839|NCT00033293|472350342|FG001|Overall Study|Physician Decision|1|||
131199840|NCT00033293|472350341|FG000|Overall Study|Withdrawal by Subject|1|||
131199841|NCT00033293|472350342|FG001|Overall Study|Withdrawal by Subject|0|||
131199842|NCT00033293|472350341|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
131199843|NCT00033293|472350342|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
131199844|NCT00033293|472350341|FG000|Overall Study|Treatment refused|0|||
131199845|NCT00033293|472350342|FG001|Overall Study|Treatment refused|6|||
131199846|NCT00542425|472350343|FG000|Initial 24 Weeks|Administrative reasons|0|||
131199847|NCT00542425|472350344|FG001|Initial 24 Weeks|Administrative reasons|0|||
131199848|NCT00542425|472350345|FG002|Initial 24 Weeks|Administrative reasons|1|||
131199849|NCT00542425|472350346|FG003|Initial 24 Weeks|Administrative reasons|1|||
131199850|NCT00542425|472350347|FG004|Initial 24 Weeks|Administrative reasons|0|||
131199851|NCT00542425|472350343|FG000|Initial 24 Weeks|Adverse Event|0|||
131199852|NCT00542425|472350344|FG001|Initial 24 Weeks|Adverse Event|1|||
131199853|NCT00542425|472350345|FG002|Initial 24 Weeks|Adverse Event|1|||
131199854|NCT00542425|472350346|FG003|Initial 24 Weeks|Adverse Event|3|||
131199855|NCT00542425|472350347|FG004|Initial 24 Weeks|Adverse Event|2|||
131199856|NCT00542425|472350343|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
131199857|NCT00542425|472350344|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
131199858|NCT00542425|472350345|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
131199859|NCT00542425|472350346|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
131199860|NCT00542425|472350347|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
131199861|NCT00542425|472350343|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
131199862|NCT00542425|472350344|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
131199863|NCT00542425|472350345|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
131199864|NCT00542425|472350346|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
131199865|NCT00542425|472350347|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
131199866|NCT00542425|472350343|FG000|Initial 24 Weeks|Non-compliance|0|||
131199867|NCT00542425|472350344|FG001|Initial 24 Weeks|Non-compliance|0|||
131199868|NCT00542425|472350345|FG002|Initial 24 Weeks|Non-compliance|0|||
131199869|NCT00542425|472350346|FG003|Initial 24 Weeks|Non-compliance|1|||
131199870|NCT00542425|472350347|FG004|Initial 24 Weeks|Non-compliance|1|||
131199871|NCT00542425|472350343|FG000|Initial 24 Weeks|Protocol Violation|0|||
131199872|NCT00542425|472350344|FG001|Initial 24 Weeks|Protocol Violation|0|||
131199873|NCT00542425|472350345|FG002|Initial 24 Weeks|Protocol Violation|0|||
131199874|NCT00542425|472350346|FG003|Initial 24 Weeks|Protocol Violation|1|||
131199875|NCT00542425|472350347|FG004|Initial 24 Weeks|Protocol Violation|0|||
131199876|NCT00542425|472350343|FG000|Initial 24 Weeks|Refusal of treatment|2|||
131199877|NCT00542425|472350344|FG001|Initial 24 Weeks|Refusal of treatment|2|||
131199878|NCT00542425|472350345|FG002|Initial 24 Weeks|Refusal of treatment|1|||
131199879|NCT00542425|472350346|FG003|Initial 24 Weeks|Refusal of treatment|4|||
131199880|NCT00542425|472350347|FG004|Initial 24 Weeks|Refusal of treatment|1|||
131199881|NCT00542425|472350343|FG000|Initial 24 Weeks|Other|0|||
131199882|NCT00542425|472350344|FG001|Initial 24 Weeks|Other|2|||
131199883|NCT00542425|472350345|FG002|Initial 24 Weeks|Other|1|||
131199884|NCT00542425|472350346|FG003|Initial 24 Weeks|Other|0|||
131199885|NCT00542425|472350347|FG004|Initial 24 Weeks|Other|0|||
131199886|NCT00542425|472350343|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
131199887|NCT00542425|472350344|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
131199888|NCT00542425|472350345|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
131199889|NCT00542425|472350346|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
131199890|NCT00542425|472350347|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
131199891|NCT00542425|472350343|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
131199892|NCT00542425|472350344|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
131199893|NCT00542425|472350345|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
131199894|NCT00542425|472350346|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
131199895|NCT00542425|472350347|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
131199896|NCT00542425|472350343|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
131199897|NCT00542425|472350344|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
131199898|NCT00542425|472350345|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
131199899|NCT00542425|472350346|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
131199900|NCT00542425|472350347|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
131199901|NCT00542425|472350343|FG000|Extended 24 Weeks of Treatment|Other|1|||
131199902|NCT00542425|472350344|FG001|Extended 24 Weeks of Treatment|Other|1|||
130733782|NCT01893346|470642987|FG001|Overall Study|Withdrawal by Subject|0|||
131199903|NCT00542425|472350345|FG002|Extended 24 Weeks of Treatment|Other|0|||
131199904|NCT00542425|472350346|FG003|Extended 24 Weeks of Treatment|Other|0|||
131199905|NCT00542425|472350347|FG004|Extended 24 Weeks of Treatment|Other|1|||
131199906|NCT01610414|472350348|FG000|Study Start - Month 13|Serious Adverse Event|65|||
130733783|NCT01893346|470642988|FG002|Overall Study|Withdrawal by Subject|0|||
130733784|NCT01893346|470642989|FG003|Overall Study|Withdrawal by Subject|0|||
130733785|NCT01954745|470642993|FG000|Overall Study|Radiological Progression|11|||
130733786|NCT01954745|470642993|FG000|Overall Study|Clinical Progression|5|||
130733787|NCT01954745|470642993|FG000|Overall Study|Adverse Event|2|||
130733788|NCT01954745|470642993|FG000|Overall Study|Death|1|||
130733789|NCT02839707|470642994|FG000|Phase I|Not eligible for analysis|9|||
130733790|NCT02839707|470642995|FG001|Phase I|Not eligible for analysis|0|||
130733791|NCT02839707|470642996|FG002|Phase I|Not eligible for analysis|0|||
130733792|NCT02839707|470642994|FG000|Phase II|Not treated according to protocol|4|||
131199907|NCT01610414|472350349|FG001|Study Start - Month 13|Serious Adverse Event|67|||
131199908|NCT01610414|472350348|FG000|Study Start - Month 13|Adverse Event|14|||
131199909|NCT01610414|472350349|FG001|Study Start - Month 13|Adverse Event|14|||
131199910|NCT01610414|472350348|FG000|Study Start - Month 13|Protocol Violation|3|||
131199911|NCT01610414|472350349|FG001|Study Start - Month 13|Protocol Violation|1|||
131199912|NCT01610414|472350348|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
131199913|NCT01610414|472350349|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
131199914|NCT01610414|472350348|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
131199915|NCT01610414|472350349|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
131199916|NCT01610414|472350348|FG000|Study Start - Month 13|Lost to Follow-up|4|||
131199917|NCT01610414|472350349|FG001|Study Start - Month 13|Lost to Follow-up|6|||
131199918|NCT01610414|472350348|FG000|Study Start - Month 13|Suspected HZ episode|1|||
131199919|NCT01610414|472350349|FG001|Study Start - Month 13|Suspected HZ episode|3|||
131199920|NCT01610414|472350348|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
131199921|NCT01610414|472350349|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
131199922|NCT01610414|472350348|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
131199923|NCT01610414|472350349|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
131199924|NCT01610414|472350348|FG000|Month 13 - Month 25|Adverse Event|8|||
131199925|NCT01610414|472350349|FG001|Month 13 - Month 25|Adverse Event|4|||
131199926|NCT01610414|472350348|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
131199927|NCT01610414|472350349|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
131199928|NCT01610414|472350348|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
131199929|NCT01610414|472350349|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
131199930|NCT01610414|472350348|FG000|Month 13 - Month 25|Protocol Violation|0|||
131199931|NCT01610414|472350349|FG001|Month 13 - Month 25|Protocol Violation|2|||
131199932|NCT01610414|472350348|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
131199933|NCT01610414|472350349|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
131199934|NCT01610414|472350348|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
131199935|NCT01610414|472350349|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
131199936|NCT01610414|472350348|FG000|After Month 25|Study end not reached|48|||
131199937|NCT01610414|472350349|FG001|After Month 25|Study end not reached|53|||
131199938|NCT02520141|472350354|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
131199939|NCT00703781|472350355|FG000|Overall Study|Withdrawal by Subject|1|||
131199940|NCT00703781|472350356|FG001|Overall Study|Withdrawal by Subject|2|||
131199941|NCT00703781|472350355|FG000|Overall Study|Cancelled surgery|1|||
131199942|NCT00703781|472350356|FG001|Overall Study|Cancelled surgery|0|||
131199943|NCT03452397|472350359|FG000|Overall Study|Adverse Event|1|||
131199944|NCT03452397|472350360|FG001|Overall Study|Adverse Event|0|||
131199945|NCT03452397|472350361|FG002|Overall Study|Adverse Event|0|||
131199946|NCT03452397|472350362|FG003|Overall Study|Adverse Event|0|||
131199947|NCT03452397|472350359|FG000|Overall Study|Administrative reason|0|||
131199948|NCT03452397|472350360|FG001|Overall Study|Administrative reason|0|||
131199949|NCT03452397|472350361|FG002|Overall Study|Administrative reason|1|||
131199950|NCT03452397|472350362|FG003|Overall Study|Administrative reason|1|||
131199951|NCT03452397|472350359|FG000|Overall Study|Withdrawal by Subject|0|||
131199952|NCT03452397|472350360|FG001|Overall Study|Withdrawal by Subject|0|||
131199953|NCT03452397|472350361|FG002|Overall Study|Withdrawal by Subject|1|||
131199954|NCT03452397|472350362|FG003|Overall Study|Withdrawal by Subject|0|||
131199955|NCT02691468|472350363|FG000|Overall Study|Bronchial blocker use|2|||
131199956|NCT02691468|472350364|FG001|Overall Study|Bronchial blocker use|1|||
131199957|NCT02691468|472350363|FG000|Overall Study|Lost to Follow-up|2|||
131199958|NCT02691468|472350364|FG001|Overall Study|Lost to Follow-up|1|||
131199959|NCT02691468|472350363|FG000|Overall Study|Failure to advance FOB|2|||
131199960|NCT02691468|472350364|FG001|Overall Study|Failure to advance FOB|0|||
131199961|NCT00286156|472350366|FG000|Overall Study|Missed 12 month visit|0|||
131199962|NCT00286156|472350367|FG001|Overall Study|Missed 12 month visit|0|||
131199963|NCT00286156|472350368|FG002|Overall Study|Missed 12 month visit|1|||
131199964|NCT00286156|472350366|FG000|Overall Study|AE: pulmonary embolus|0|||
131199965|NCT00286156|472350367|FG001|Overall Study|AE: pulmonary embolus|1|||
131199966|NCT00286156|472350368|FG002|Overall Study|AE: pulmonary embolus|0|||
131199967|NCT00286156|472350366|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
131199968|NCT00286156|472350367|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
131199969|NCT00286156|472350368|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
131199970|NCT00286156|472350366|FG000|Overall Study|AE: pneumonia|1|||
131199971|NCT00286156|472350367|FG001|Overall Study|AE: pneumonia|0|||
131199972|NCT00286156|472350368|FG002|Overall Study|AE: pneumonia|0|||
131199973|NCT06334055|472350372|FG000|Overall Study|Adverse Event|4|||
131199974|NCT06334055|472350372|FG000|Overall Study|Disqualified|72|||
131199975|NCT02545049|472350373|FG000|Overall Study|Withdrawal by Subject|1|||
131199976|NCT02545049|472350374|FG001|Overall Study|Withdrawal by Subject|7|||
131199977|NCT02545049|472350373|FG000|Overall Study|Lost to Follow-up|4|||
131199978|NCT02545049|472350374|FG001|Overall Study|Lost to Follow-up|6|||
131199979|NCT02545049|472350373|FG000|Overall Study|GCP violations|37|||
131199980|NCT02545049|472350374|FG001|Overall Study|GCP violations|48|||
131199981|NCT02200510|472351754|FG000|Overall Study|Death|1|||
131199982|NCT02200510|472351755|FG001|Overall Study|Death|1|||
131199983|NCT02200510|472351754|FG000|Overall Study|Protocol Violation|0|||
131199984|NCT02200510|472351755|FG001|Overall Study|Protocol Violation|1|||
131199985|NCT02200510|472351754|FG000|Overall Study|Lost to Follow-up|7|||
131199986|NCT02200510|472351755|FG001|Overall Study|Lost to Follow-up|1|||
131199987|NCT02200510|472351754|FG000|Overall Study|potential COI - joined study team|1|||
131199988|NCT02200510|472351755|FG001|Overall Study|potential COI - joined study team|0|||
131199989|NCT00290355|472351756|FG000|Overall Study|Serious adverse event|7|||
131199990|NCT00290355|472351757|FG001|Overall Study|Serious adverse event|4|||
131199991|NCT00290355|472351756|FG000|Overall Study|Study product reactogenicity|1|||
131199992|NCT00290355|472351757|FG001|Overall Study|Study product reactogenicity|0|||
131199993|NCT00290355|472351756|FG000|Overall Study|Protocol Violation|1|||
131199994|NCT00290355|472351757|FG001|Overall Study|Protocol Violation|0|||
131199995|NCT00290355|472351756|FG000|Overall Study|Withdrawal by Subject|2|||
131199996|NCT00290355|472351757|FG001|Overall Study|Withdrawal by Subject|0|||
131199997|NCT00290355|472351756|FG000|Overall Study|Migrated / moved from the study area|1|||
131199998|NCT00290355|472351757|FG001|Overall Study|Migrated / moved from the study area|0|||
131199999|NCT00290355|472351756|FG000|Overall Study|Lost to Follow-up|3|||
131200000|NCT00290355|472351757|FG001|Overall Study|Lost to Follow-up|1|||
131200001|NCT00290355|472351756|FG000|Overall Study|Other|2|||
131200002|NCT00290355|472351757|FG001|Overall Study|Other|0|||
131200003|NCT01542632|472351758|FG000|Overall Study|Withdrawal of Consent|0|||
131200004|NCT01542632|472351759|FG001|Overall Study|Withdrawal of Consent|0|||
131200005|NCT01542632|472351760|FG002|Overall Study|Withdrawal of Consent|0|||
131200006|NCT01542632|472351761|FG003|Overall Study|Withdrawal of Consent|2|||
131200007|NCT01542632|472351762|FG004|Overall Study|Withdrawal of Consent|3|||
131200008|NCT01542632|472351763|FG005|Overall Study|Withdrawal of Consent|0|||
131200009|NCT01542632|472351758|FG000|Overall Study|Adverse Event|0|||
131200010|NCT01542632|472351759|FG001|Overall Study|Adverse Event|0|||
131200011|NCT01542632|472351760|FG002|Overall Study|Adverse Event|1|||
131200012|NCT01542632|472351761|FG003|Overall Study|Adverse Event|0|||
131200013|NCT01542632|472351762|FG004|Overall Study|Adverse Event|0|||
131200014|NCT01542632|472351763|FG005|Overall Study|Adverse Event|0|||
131200015|NCT01542632|472351758|FG000|Overall Study|Lost to Follow-up|0|||
131200016|NCT01542632|472351759|FG001|Overall Study|Lost to Follow-up|1|||
131200017|NCT01542632|472351760|FG002|Overall Study|Lost to Follow-up|0|||
131200018|NCT01542632|472351761|FG003|Overall Study|Lost to Follow-up|0|||
131200019|NCT01542632|472351762|FG004|Overall Study|Lost to Follow-up|0|||
131200020|NCT01542632|472351763|FG005|Overall Study|Lost to Follow-up|0|||
131200021|NCT01542632|472351758|FG000|Overall Study|Sponsor/Investigator Decision|0|||
131200022|NCT01542632|472351759|FG001|Overall Study|Sponsor/Investigator Decision|0|||
131200023|NCT01542632|472351760|FG002|Overall Study|Sponsor/Investigator Decision|0|||
131200024|NCT01542632|472351761|FG003|Overall Study|Sponsor/Investigator Decision|0|||
131200025|NCT01542632|472351762|FG004|Overall Study|Sponsor/Investigator Decision|1|||
131200026|NCT01542632|472351763|FG005|Overall Study|Sponsor/Investigator Decision|0|||
131200027|NCT00033514|472351764|FG000|Overall Study|Lost to Follow-up|1|||
131200028|NCT00033514|472351765|FG001|Overall Study|Lost to Follow-up|1|||
131200029|NCT00033514|472351764|FG000|Overall Study|Withdrawal by Subject|0|||
131200030|NCT00033514|472351765|FG001|Overall Study|Withdrawal by Subject|3|||
131200031|NCT02607865|472351777|FG000|Overall Study|Lost to Follow-up|9|||
131200032|NCT02607865|472351778|FG001|Overall Study|Lost to Follow-up|7|||
131200033|NCT02607865|472351779|FG002|Overall Study|Lost to Follow-up|7|||
131200034|NCT02607865|472351780|FG003|Overall Study|Lost to Follow-up|5|||
131200035|NCT02607865|472351777|FG000|Overall Study|Withdrawal by Subject|18|||
131200036|NCT02607865|472351778|FG001|Overall Study|Withdrawal by Subject|18|||
131200037|NCT02607865|472351779|FG002|Overall Study|Withdrawal by Subject|17|||
131200038|NCT02607865|472351780|FG003|Overall Study|Withdrawal by Subject|8|||
131200039|NCT02607865|472351777|FG000|Overall Study|Death|5|||
131200040|NCT02607865|472351778|FG001|Overall Study|Death|4|||
131200041|NCT02607865|472351779|FG002|Overall Study|Death|1|||
131200042|NCT02607865|472351780|FG003|Overall Study|Death|3|||
131200043|NCT02607865|472351777|FG000|Overall Study|Unclassified|1|||
131200044|NCT02607865|472351778|FG001|Overall Study|Unclassified|1|||
131200045|NCT02607865|472351779|FG002|Overall Study|Unclassified|2|||
131200046|NCT02607865|472351780|FG003|Overall Study|Unclassified|0|||
131200047|NCT00528840|472351781|FG000|Overall Study|Lost to Follow-up|10|||
131200048|NCT00528840|472351781|FG000|Overall Study|Adverse Event|1|||
131200049|NCT00528840|472351781|FG000|Overall Study|Withdrawal by Subject|17|||
131200050|NCT00528840|472351781|FG000|Overall Study|Death|2|||
131200051|NCT00528840|472351781|FG000|Overall Study|Administrative Reasons|1|||
131200052|NCT00528840|472351781|FG000|Overall Study|Other|2|||
131200053|NCT01657253|472351782|FG000|Overall Study|Lost to Follow-up|6|||
131200054|NCT01657253|472351783|FG001|Overall Study|Lost to Follow-up|5|||
131200055|NCT01657253|472351782|FG000|Overall Study|Withdrawal by Subject|11|||
131200056|NCT01657253|472351783|FG001|Overall Study|Withdrawal by Subject|12|||
131200057|NCT01657253|472351782|FG000|Overall Study|Adverse Event|0|||
131200058|NCT01657253|472351783|FG001|Overall Study|Adverse Event|1|||
131200059|NCT01603628|472351784|FG000|Overall Study|Personal Reasons|1|||
131200060|NCT01603628|472351785|FG001|Overall Study|Personal Reasons|1|||
131200061|NCT01603628|472351786|FG002|Overall Study|Personal Reasons|2|||
131200062|NCT01603628|472351784|FG000|Overall Study|Protocol Violation|1|||
131200063|NCT01603628|472351785|FG001|Overall Study|Protocol Violation|1|||
131200064|NCT01603628|472351786|FG002|Overall Study|Protocol Violation|0|||
131200065|NCT01603628|472351784|FG000|Overall Study|Lost to Follow-up|0|||
131200066|NCT01603628|472351785|FG001|Overall Study|Lost to Follow-up|1|||
131200067|NCT01603628|472351786|FG002|Overall Study|Lost to Follow-up|0|||
131200068|NCT01603628|472351784|FG000|Overall Study|Other Miscellaneous Reason|1|||
131200069|NCT01603628|472351785|FG001|Overall Study|Other Miscellaneous Reason|0|||
131200070|NCT01603628|472351786|FG002|Overall Study|Other Miscellaneous Reason|0|||
131200071|NCT01756833|472351792|FG000|Overall Study|Withdrawal by Subject|4|||
131200072|NCT01756833|472351793|FG001|Overall Study|Withdrawal by Subject|3|||
131200073|NCT00886587|472351794|FG000|Overall Study|Adverse Event|2|||
131200074|NCT00886587|472351795|FG001|Overall Study|Adverse Event|1|||
131200075|NCT00886587|472351794|FG000|Overall Study|Protocol Violation|2|||
131200076|NCT00886587|472351795|FG001|Overall Study|Protocol Violation|0|||
131200077|NCT00886587|472351794|FG000|Overall Study|Withdrawal by Subject|0|||
131200078|NCT00886587|472351795|FG001|Overall Study|Withdrawal by Subject|1|||
131200079|NCT02795182|472351796|FG000|Overall Study|Death|5|||
131200080|NCT02795182|472351797|FG001|Overall Study|Death|4|||
131200081|NCT02795182|472351798|FG002|Overall Study|Death|4|||
131200082|NCT02795182|472351799|FG003|Overall Study|Death|18|||
131200083|NCT02795182|472351796|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
131200084|NCT02795182|472351797|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
131200085|NCT02795182|472351798|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
131200086|NCT02795182|472351799|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
131200087|NCT02795182|472351796|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
131200088|NCT02795182|472351797|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
131200089|NCT02795182|472351798|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
131200090|NCT02795182|472351799|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
131200091|NCT02795182|472351796|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
131200092|NCT02795182|472351797|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
131200093|NCT02795182|472351798|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
131200094|NCT02795182|472351799|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
131200095|NCT02795182|472351796|FG000|Overall Study|Withdrawal by Subject|4|||
131200096|NCT02795182|472351797|FG001|Overall Study|Withdrawal by Subject|0|||
131200097|NCT02795182|472351798|FG002|Overall Study|Withdrawal by Subject|0|||
131200098|NCT02795182|472351799|FG003|Overall Study|Withdrawal by Subject|3|||
131200099|NCT02795182|472351796|FG000|Overall Study|Lost to Follow-up|0|||
131200100|NCT02795182|472351797|FG001|Overall Study|Lost to Follow-up|0|||
131200101|NCT02795182|472351798|FG002|Overall Study|Lost to Follow-up|1|||
131200102|NCT02795182|472351799|FG003|Overall Study|Lost to Follow-up|1|||
131200103|NCT02795182|472351796|FG000|Overall Study|Roll Over to Long Term Extension|3|||
131200104|NCT02795182|472351797|FG001|Overall Study|Roll Over to Long Term Extension|3|||
131200105|NCT02795182|472351798|FG002|Overall Study|Roll Over to Long Term Extension|2|||
131200106|NCT02795182|472351799|FG003|Overall Study|Roll Over to Long Term Extension|5|||
131200107|NCT02795182|472351796|FG000|Overall Study|Progressive Disease|0|||
131200108|NCT02795182|472351797|FG001|Overall Study|Progressive Disease|1|||
131200109|NCT02795182|472351798|FG002|Overall Study|Progressive Disease|0|||
131200110|NCT02795182|472351799|FG003|Overall Study|Progressive Disease|4|||
131200111|NCT02795182|472351796|FG000|Overall Study|Physician Decision|0|||
131200112|NCT02795182|472351797|FG001|Overall Study|Physician Decision|0|||
131200113|NCT02795182|472351798|FG002|Overall Study|Physician Decision|0|||
131200114|NCT02795182|472351799|FG003|Overall Study|Physician Decision|1|||
131200115|NCT04107935|472351800|FG000|Overall Study|Death|1|||
131200116|NCT04107935|472351801|FG001|Overall Study|Death|0|||
130733793|NCT02839707|470642995|FG001|Phase II|Not treated according to protocol|0|||
130733794|NCT02839707|470642996|FG002|Phase II|Not treated according to protocol|2|||
130733795|NCT02839707|470642994|FG000|Phase III|Not treated according to protocol|0|||
130733796|NCT02839707|470642995|FG001|Phase III|Not treated according to protocol|0|||
131200117|NCT00398086|472351802|FG000|Overall Study|Unacceptable Toxicity|2|||
131200118|NCT00398086|472351803|FG001|Overall Study|Unacceptable Toxicity|8|||
131200119|NCT00398086|472351804|FG002|Overall Study|Unacceptable Toxicity|2|||
131200120|NCT00398086|472351802|FG000|Overall Study|Adverse Event|1|||
131200121|NCT00398086|472351803|FG001|Overall Study|Adverse Event|4|||
131200122|NCT00398086|472351804|FG002|Overall Study|Adverse Event|0|||
131200123|NCT00398086|472351802|FG000|Overall Study|Physician Decision|1|||
131200124|NCT00398086|472351803|FG001|Overall Study|Physician Decision|4|||
131200125|NCT00398086|472351804|FG002|Overall Study|Physician Decision|0|||
131200126|NCT00398086|472351802|FG000|Overall Study|Withdrawal by Subject|5|||
131200127|NCT00398086|472351803|FG001|Overall Study|Withdrawal by Subject|7|||
131200128|NCT00398086|472351804|FG002|Overall Study|Withdrawal by Subject|0|||
131200129|NCT02087241|472351805|FG000|Overall Study|Death|2|||
131200130|NCT02087241|472351806|FG001|Overall Study|Death|1|||
131200131|NCT02087241|472351807|FG002|Overall Study|Death|1|||
131200132|NCT02087241|472351808|FG003|Overall Study|Death|1|||
131200133|NCT02087241|472351805|FG000|Overall Study|Withdrawal by Subject|1|||
131200134|NCT02087241|472351806|FG001|Overall Study|Withdrawal by Subject|0|||
131200135|NCT02087241|472351807|FG002|Overall Study|Withdrawal by Subject|0|||
131200136|NCT02087241|472351808|FG003|Overall Study|Withdrawal by Subject|1|||
131200137|NCT02087241|472351805|FG000|Overall Study|Progressive Disease|0|||
131200138|NCT02087241|472351806|FG001|Overall Study|Progressive Disease|0|||
131200139|NCT02087241|472351807|FG002|Overall Study|Progressive Disease|0|||
131200140|NCT02087241|472351808|FG003|Overall Study|Progressive Disease|1|||
131200141|NCT02087241|472351805|FG000|Overall Study|Study Terminated by Sponsor|0|||
131200142|NCT02087241|472351806|FG001|Overall Study|Study Terminated by Sponsor|2|||
131200143|NCT02087241|472351807|FG002|Overall Study|Study Terminated by Sponsor|0|||
131200144|NCT02087241|472351808|FG003|Overall Study|Study Terminated by Sponsor|4|||
131200145|NCT00374452|472351811|FG000|Overall Study|Left clinic before intervention started|4|||
131200146|NCT00374452|472351812|FG001|Overall Study|Left clinic before intervention started|1|||
131200147|NCT00374452|472351811|FG000|Overall Study|Change in job role before intervention|0|||
131200148|NCT00374452|472351812|FG001|Overall Study|Change in job role before intervention|1|||
131200149|NCT00374452|472351811|FG000|Overall Study|Left clinic after intervention started|1|||
130733797|NCT02839707|470642996|FG002|Phase III|Not treated according to protocol|4|||
131200150|NCT00374452|472351812|FG001|Overall Study|Left clinic after intervention started|1|||
131200151|NCT00374452|472351811|FG000|Overall Study|Withdrawal by Subject|0|||
131200152|NCT00374452|472351812|FG001|Overall Study|Withdrawal by Subject|2|||
131200153|NCT01289028|472351813|FG000|Overall Study|Progressive Disease|49|||
131200154|NCT01289028|472351813|FG000|Overall Study|Adverse Event|14|||
130733798|NCT01290302|470645270|FG000|Overall Study|Adverse Event|2|||
131200155|NCT01289028|472351813|FG000|Overall Study|Withdrawal by Subject|6|||
130733799|NCT01290302|470645271|FG001|Overall Study|Adverse Event|0|||
130733800|NCT01290302|470645270|FG000|Overall Study|Withdrawal by Subject|1|||
130733801|NCT01290302|470645271|FG001|Overall Study|Withdrawal by Subject|0|||
130733802|NCT01290302|470645270|FG000|Overall Study|Physician Decision|0|||
130733803|NCT01290302|470645271|FG001|Overall Study|Physician Decision|2|||
130733804|NCT01290302|470645270|FG000|Overall Study|Expiration of time for screening window|1|||
130733805|NCT01290302|470645271|FG001|Overall Study|Expiration of time for screening window|0|||
131200156|NCT01289028|472351813|FG000|Overall Study|Death|4|||
131200157|NCT01289028|472351813|FG000|Overall Study|Lack of Efficacy|2|||
131200158|NCT01289028|472351813|FG000|Overall Study|No longer required|2|||
131200159|NCT01289028|472351813|FG000|Overall Study|Lost to Follow-up|2|||
131200160|NCT01289028|472351813|FG000|Overall Study|New Cancer Therapy|2|||
131200161|NCT01289028|472351813|FG000|Overall Study|Abnormal Lab Value|1|||
131200162|NCT01289028|472351813|FG000|Overall Study|Missing reason for discon|1|||
131200163|NCT02120469|472351816|FG000|Overall Study|HER-2/neu-amplified|1|||
131200164|NCT02120469|472351817|FG001|Overall Study|HER-2/neu-amplified|0|||
131200165|NCT02120469|472351818|FG002|Overall Study|HER-2/neu-amplified|1|||
131200166|NCT00998985|472351820|FG000|Overall Study|Withdrawal by Subject|0|||
131200167|NCT00998985|472351821|FG001|Overall Study|Withdrawal by Subject|0|||
131200168|NCT00998985|472351822|FG002|Overall Study|Withdrawal by Subject|0|||
131200169|NCT00998985|472351823|FG003|Overall Study|Withdrawal by Subject|0|||
131200170|NCT00998985|472351824|FG004|Overall Study|Withdrawal by Subject|0|||
131200171|NCT00998985|472351825|FG005|Overall Study|Withdrawal by Subject|0|||
131200172|NCT00998985|472351826|FG006|Overall Study|Withdrawal by Subject|0|||
131200173|NCT00998985|472351827|FG007|Overall Study|Withdrawal by Subject|0|||
131200174|NCT00998985|472351828|FG008|Overall Study|Withdrawal by Subject|1|||
131200175|NCT00998985|472351829|FG009|Overall Study|Withdrawal by Subject|0|||
131200176|NCT00998985|472351830|FG010|Overall Study|Withdrawal by Subject|0|||
131200177|NCT00998985|472351831|FG011|Overall Study|Withdrawal by Subject|0|||
131200178|NCT00998985|472351832|FG012|Overall Study|Withdrawal by Subject|0|||
131200179|NCT00998985|472351833|FG013|Overall Study|Withdrawal by Subject|0|||
131200180|NCT00998985|472351820|FG000|Overall Study|Protocol Violation|0|||
131200181|NCT00998985|472351821|FG001|Overall Study|Protocol Violation|0|||
131200182|NCT00998985|472351822|FG002|Overall Study|Protocol Violation|0|||
131200183|NCT00998985|472351823|FG003|Overall Study|Protocol Violation|0|||
131200184|NCT00998985|472351824|FG004|Overall Study|Protocol Violation|0|||
131200185|NCT00998985|472351825|FG005|Overall Study|Protocol Violation|1|||
131200186|NCT00998985|472351826|FG006|Overall Study|Protocol Violation|0|||
131200187|NCT00998985|472351827|FG007|Overall Study|Protocol Violation|0|||
131200188|NCT00998985|472351828|FG008|Overall Study|Protocol Violation|0|||
131200189|NCT00998985|472351829|FG009|Overall Study|Protocol Violation|0|||
131200190|NCT00998985|472351830|FG010|Overall Study|Protocol Violation|0|||
131200191|NCT00998985|472351831|FG011|Overall Study|Protocol Violation|0|||
131200192|NCT00998985|472351832|FG012|Overall Study|Protocol Violation|0|||
131200193|NCT00998985|472351833|FG013|Overall Study|Protocol Violation|0|||
131200194|NCT01040728|472351835|FG000|Overall Study|Adverse Event|4|||
131200195|NCT01040728|472351836|FG001|Overall Study|Adverse Event|8|||
131200196|NCT01040728|472351837|FG002|Overall Study|Adverse Event|0|||
131200197|NCT01040728|472351838|FG003|Overall Study|Adverse Event|4|||
131200198|NCT01040728|472351835|FG000|Overall Study|Withdrawal by Subject|0|||
131200199|NCT01040728|472351836|FG001|Overall Study|Withdrawal by Subject|1|||
131200200|NCT01040728|472351837|FG002|Overall Study|Withdrawal by Subject|1|||
131200201|NCT01040728|472351838|FG003|Overall Study|Withdrawal by Subject|0|||
131200202|NCT01040728|472351835|FG000|Overall Study|Protocol Violation|0|||
131200203|NCT01040728|472351836|FG001|Overall Study|Protocol Violation|0|||
131200204|NCT01040728|472351837|FG002|Overall Study|Protocol Violation|0|||
131200205|NCT01040728|472351838|FG003|Overall Study|Protocol Violation|1|||
131200206|NCT01040728|472351835|FG000|Overall Study|Lack of Efficacy|0|||
131200207|NCT01040728|472351836|FG001|Overall Study|Lack of Efficacy|1|||
131200208|NCT01040728|472351837|FG002|Overall Study|Lack of Efficacy|0|||
131200209|NCT01040728|472351838|FG003|Overall Study|Lack of Efficacy|1|||
131200210|NCT01040728|472351835|FG000|Overall Study|Other reasons not listed above|0|||
131200211|NCT01040728|472351836|FG001|Overall Study|Other reasons not listed above|1|||
131200212|NCT01040728|472351837|FG002|Overall Study|Other reasons not listed above|0|||
131200213|NCT01040728|472351838|FG003|Overall Study|Other reasons not listed above|0|||
131200214|NCT02573012|472351840|FG000|Overall Study|Adverse Event|5|||
131200215|NCT02573012|472351841|FG001|Overall Study|Adverse Event|5|||
131200216|NCT02573012|472351840|FG000|Overall Study|Lack of Efficacy|5|||
131200217|NCT02573012|472351841|FG001|Overall Study|Lack of Efficacy|4|||
131200218|NCT02573012|472351840|FG000|Overall Study|Non-compliance|1|||
131200219|NCT02573012|472351841|FG001|Overall Study|Non-compliance|2|||
131200220|NCT02573012|472351840|FG000|Overall Study|Withdrawal by Subject|2|||
131200221|NCT02573012|472351841|FG001|Overall Study|Withdrawal by Subject|2|||
131200222|NCT02573012|472351840|FG000|Overall Study|Study Ended per Protocol|1|||
131200223|NCT02573012|472351841|FG001|Overall Study|Study Ended per Protocol|0|||
131200224|NCT02573012|472351840|FG000|Overall Study|Physician Decision|1|||
131200225|NCT02573012|472351841|FG001|Overall Study|Physician Decision|2|||
131200226|NCT01875874|472351847|FG000|Overall Study|Death|3|||
131200227|NCT00590031|472351848|FG000|Overall Study|Adverse Event|3|||
130784624|NCT01103323|470838849|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
131200228|NCT00590031|472351848|FG000|Overall Study|Withdrawal by Subject|1|||
131200229|NCT00590031|472351848|FG000|Overall Study|Metastatic Disease|1|||
131200230|NCT00590031|472351848|FG000|Overall Study|Admin Hold|1|||
131200231|NCT01809327|472351851|FG000|Overall Study|Lost to Follow-up|5|||
131200232|NCT01809327|472351852|FG001|Overall Study|Lost to Follow-up|2|||
131200233|NCT01809327|472351853|FG002|Overall Study|Lost to Follow-up|4|||
131200234|NCT01809327|472351854|FG003|Overall Study|Lost to Follow-up|2|||
131200235|NCT01809327|472351855|FG004|Overall Study|Lost to Follow-up|3|||
131200236|NCT01809327|472351851|FG000|Overall Study|Withdrawal by Subject|6|||
131200237|NCT01809327|472351852|FG001|Overall Study|Withdrawal by Subject|4|||
131200238|NCT01809327|472351853|FG002|Overall Study|Withdrawal by Subject|4|||
131200239|NCT01809327|472351854|FG003|Overall Study|Withdrawal by Subject|2|||
131200240|NCT01809327|472351855|FG004|Overall Study|Withdrawal by Subject|5|||
131200241|NCT01809327|472351851|FG000|Overall Study|Adverse Event|4|||
131200242|NCT01809327|472351852|FG001|Overall Study|Adverse Event|3|||
131200243|NCT01809327|472351853|FG002|Overall Study|Adverse Event|7|||
131200244|NCT01809327|472351854|FG003|Overall Study|Adverse Event|4|||
131200245|NCT01809327|472351855|FG004|Overall Study|Adverse Event|8|||
131200246|NCT01809327|472351851|FG000|Overall Study|Death|1|||
131200247|NCT01809327|472351852|FG001|Overall Study|Death|0|||
131200248|NCT01809327|472351853|FG002|Overall Study|Death|0|||
131200249|NCT01809327|472351854|FG003|Overall Study|Death|0|||
131200250|NCT01809327|472351855|FG004|Overall Study|Death|0|||
131200251|NCT01809327|472351851|FG000|Overall Study|Protocol Violation|0|||
131200252|NCT01809327|472351852|FG001|Overall Study|Protocol Violation|1|||
131200253|NCT01809327|472351853|FG002|Overall Study|Protocol Violation|0|||
131200254|NCT01809327|472351854|FG003|Overall Study|Protocol Violation|0|||
131200255|NCT01809327|472351855|FG004|Overall Study|Protocol Violation|0|||
131200256|NCT01809327|472351851|FG000|Overall Study|Physician Decision|1|||
131200257|NCT01809327|472351852|FG001|Overall Study|Physician Decision|1|||
131200258|NCT01809327|472351853|FG002|Overall Study|Physician Decision|0|||
131200259|NCT01809327|472351854|FG003|Overall Study|Physician Decision|0|||
131200260|NCT01809327|472351855|FG004|Overall Study|Physician Decision|0|||
131200261|NCT01809327|472351851|FG000|Overall Study|Pregnancy|1|||
131200262|NCT01809327|472351852|FG001|Overall Study|Pregnancy|0|||
131200263|NCT01809327|472351853|FG002|Overall Study|Pregnancy|0|||
131200264|NCT01809327|472351854|FG003|Overall Study|Pregnancy|0|||
131200265|NCT01809327|472351855|FG004|Overall Study|Pregnancy|0|||
131200266|NCT01809327|472351851|FG000|Overall Study|Other|14|||
131200267|NCT01809327|472351852|FG001|Overall Study|Other|15|||
131200268|NCT01809327|472351853|FG002|Overall Study|Other|7|||
131200269|NCT01809327|472351854|FG003|Overall Study|Other|4|||
131200270|NCT01809327|472351855|FG004|Overall Study|Other|9|||
131200271|NCT03196973|472351856|FG000|Overall Study|Adverse Event|1|||
131200272|NCT03196973|472351857|FG001|Overall Study|Adverse Event|1|||
131200273|NCT03196973|472351858|FG002|Overall Study|Adverse Event|2|||
131200274|NCT03196973|472351856|FG000|Overall Study|Lack of Efficacy|2|||
131200275|NCT03196973|472351857|FG001|Overall Study|Lack of Efficacy|6|||
131200276|NCT03196973|472351858|FG002|Overall Study|Lack of Efficacy|1|||
131200277|NCT03196973|472351856|FG000|Overall Study|Lost to Follow-up|4|||
131200278|NCT03196973|472351857|FG001|Overall Study|Lost to Follow-up|3|||
131200279|NCT03196973|472351858|FG002|Overall Study|Lost to Follow-up|2|||
131200280|NCT03196973|472351856|FG000|Overall Study|Consent withdrawn|2|||
131200281|NCT03196973|472351857|FG001|Overall Study|Consent withdrawn|1|||
131200282|NCT03196973|472351858|FG002|Overall Study|Consent withdrawn|0|||
131200283|NCT03196973|472351856|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
131200284|NCT03196973|472351857|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
131200285|NCT03196973|472351858|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
130784625|NCT01103323|470838848|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
131200286|NCT03344562|472351859|FG000|Overall Study|Withdrawal by Subject|2|||
131200287|NCT03344562|472351860|FG001|Overall Study|Withdrawal by Subject|0|||
131200288|NCT02736474|472351867|FG000|Overall Study|Lost to Follow-up|0|||
131200289|NCT02736474|472351868|FG001|Overall Study|Lost to Follow-up|1|||
131200290|NCT02463331|472351869|FG000|Overall Study|Adverse Event|4|||
131200291|NCT02463331|472351870|FG001|Overall Study|Adverse Event|2|||
131200292|NCT02463331|472351869|FG000|Overall Study|Lost to Follow-up|1|||
131200293|NCT02463331|472351870|FG001|Overall Study|Lost to Follow-up|1|||
131200294|NCT02463331|472351869|FG000|Overall Study|Pregnancy|2|||
131200295|NCT02463331|472351870|FG001|Overall Study|Pregnancy|3|||
131200296|NCT02463331|472351869|FG000|Overall Study|Lack of Efficacy|6|||
131200297|NCT02463331|472351870|FG001|Overall Study|Lack of Efficacy|0|||
131200298|NCT02463331|472351869|FG000|Overall Study|Physician Decision|3|||
131200299|NCT02463331|472351870|FG001|Overall Study|Physician Decision|0|||
130784626|NCT01103323|470838849|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
131200300|NCT00826540|472351871|FG000|Overall Study|ineligible|3|||
131200301|NCT00826540|472351871|FG000|Overall Study|Withdrawal by Subject|1|||
131200302|NCT01166386|472351872|FG000|Overall Study|Withdrawal by Subject|3|||
131200303|NCT01166386|472351873|FG001|Overall Study|Withdrawal by Subject|5|||
131200304|NCT02483611|472351874|FG000|Overall Study|Protocol Violation|0|||
131200305|NCT02483611|472351875|FG001|Overall Study|Protocol Violation|0|||
131200306|NCT02483611|472351876|FG002|Overall Study|Protocol Violation|1|||
131200307|NCT01222416|472351877|FG000|Overall Study|ineligible;metastasis|3|||
131200308|NCT01222416|472351878|FG001|Overall Study|ineligible;metastasis|0|||
131200309|NCT01222416|472351877|FG000|Overall Study|Adverse Event|4|||
131200310|NCT01222416|472351878|FG001|Overall Study|Adverse Event|0|||
131200311|NCT01222416|472351877|FG000|Overall Study|Withdrawal by Subject|5|||
131200312|NCT01222416|472351878|FG001|Overall Study|Withdrawal by Subject|0|||
131200313|NCT01222416|472351877|FG000|Overall Study|scheduling|6|||
131200314|NCT01222416|472351878|FG001|Overall Study|scheduling|0|||
131200315|NCT01222416|472351877|FG000|Overall Study|missed view/scan|1|||
131200316|NCT01222416|472351878|FG001|Overall Study|missed view/scan|0|||
131200317|NCT01222416|472351877|FG000|Overall Study|Death|1|||
131200318|NCT01222416|472351878|FG001|Overall Study|Death|0|||
131200319|NCT02178592|472351879|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
131200320|NCT02178592|472351880|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
131200321|NCT02178592|472351879|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
131200322|NCT02178592|472351880|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
131200323|NCT02178592|472351879|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
131200324|NCT02178592|472351880|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
131200325|NCT02178592|472351879|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
131200326|NCT02178592|472351880|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
131200327|NCT02178592|472351879|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
131200328|NCT02178592|472351880|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
131200329|NCT02178592|472351879|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
131200330|NCT02178592|472351880|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
131200331|NCT02178592|472351879|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
131200332|NCT02178592|472351880|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
131200333|NCT02178592|472351879|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
131200334|NCT02178592|472351880|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
131200335|NCT02178592|472351879|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
131200336|NCT02178592|472351880|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
131200337|NCT02178592|472351879|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
131200338|NCT02178592|472351880|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
131200339|NCT02178592|472351879|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
131200340|NCT02178592|472351880|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
131200341|NCT02178592|472351879|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
131200342|NCT02178592|472351880|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
131200343|NCT02036476|472351883|FG000|Overall Study|Withdrawal by Subject|2|||
131200344|NCT02036476|472351883|FG000|Overall Study|Progressive Disease|4|||
131200345|NCT02036476|472351883|FG000|Overall Study|Unacceptable Toxicity|2|||
131200346|NCT02168816|472351884|FG000|Overall Study|Lost to Follow-up|2|||
131200347|NCT02168816|472351885|FG001|Overall Study|Lost to Follow-up|2|||
131200348|NCT00424463|472351886|FG000|Overall Study|Adverse Event|2|||
131200349|NCT00424463|472351887|FG001|Overall Study|Adverse Event|3|||
131200350|NCT00424463|472351888|FG002|Overall Study|Adverse Event|2|||
131200351|NCT00424463|472351886|FG000|Overall Study|Physician Decision|0|||
131200352|NCT00424463|472351887|FG001|Overall Study|Physician Decision|2|||
131200353|NCT00424463|472351888|FG002|Overall Study|Physician Decision|2|||
131200354|NCT00424463|472351886|FG000|Overall Study|Withdrawal by Subject|4|||
131200355|NCT00424463|472351887|FG001|Overall Study|Withdrawal by Subject|2|||
131200356|NCT00424463|472351888|FG002|Overall Study|Withdrawal by Subject|5|||
131200357|NCT00424463|472351886|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
131200358|NCT00424463|472351887|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
131200359|NCT00424463|472351888|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
131200360|NCT00424463|472351886|FG000|Overall Study|Patient's convenience|0|||
131200361|NCT00424463|472351887|FG001|Overall Study|Patient's convenience|0|||
131200362|NCT00424463|472351888|FG002|Overall Study|Patient's convenience|1|||
131200363|NCT01436357|472351891|FG000|Overall Study|Death|5|||
131200364|NCT01436357|472351892|FG001|Overall Study|Death|1|||
131200365|NCT01436357|472351891|FG000|Overall Study|Enrolled but not vaccinated|1|||
131200366|NCT01436357|472351892|FG001|Overall Study|Enrolled but not vaccinated|1|||
131200367|NCT01436357|472351891|FG000|Overall Study|Incarceration|18|||
131200368|NCT01436357|472351892|FG001|Overall Study|Incarceration|20|||
131200369|NCT01436357|472351891|FG000|Overall Study|Lost to Follow-up|67|||
131200370|NCT01436357|472351892|FG001|Overall Study|Lost to Follow-up|61|||
131200371|NCT01436357|472351891|FG000|Overall Study|Protocol Violation|1|||
131200372|NCT01436357|472351892|FG001|Overall Study|Protocol Violation|0|||
130733806|NCT06419907|470645274|FG000|Overall Study|Protocol Violation|0|||
130733807|NCT06419907|470645275|FG001|Overall Study|Protocol Violation|3|||
130733808|NCT06419907|470645276|FG002|Overall Study|Protocol Violation|0|||
130733809|NCT06419907|470645277|FG003|Overall Study|Protocol Violation|1|||
130733810|NCT06419907|470645274|FG000|Overall Study|Lost to Follow-up|0|||
130733811|NCT06419907|470645275|FG001|Overall Study|Lost to Follow-up|0|||
130733812|NCT06419907|470645276|FG002|Overall Study|Lost to Follow-up|2|||
130733813|NCT06419907|470645277|FG003|Overall Study|Lost to Follow-up|1|||
130733814|NCT02586688|470645280|FG000|Overall Study|Lost to Follow-up|2|||
131200373|NCT01436357|472351891|FG000|Overall Study|Withdrawal by Subject|26|||
131200374|NCT01436357|472351892|FG001|Overall Study|Withdrawal by Subject|38|||
131200375|NCT01436357|472351891|FG000|Overall Study|Physician Decision|3|||
131200376|NCT01436357|472351892|FG001|Overall Study|Physician Decision|4|||
131200377|NCT01436357|472351891|FG000|Overall Study|Moved out of area|1|||
131200378|NCT01436357|472351892|FG001|Overall Study|Moved out of area|2|||
131200379|NCT01436357|472351891|FG000|Overall Study|Subject in rehab|0|||
131200380|NCT01436357|472351892|FG001|Overall Study|Subject in rehab|1|||
131200381|NCT00768040|472353635|FG000|Overall Study|Adverse Event|3|||
131200382|NCT00768040|472353636|FG001|Overall Study|Adverse Event|2|||
131200383|NCT00768040|472353635|FG000|Overall Study|Abnormal laboratory value|1|||
131200384|NCT00768040|472353636|FG001|Overall Study|Abnormal laboratory value|1|||
131200385|NCT03557801|472353637|FG000|Overall Study|Protocol Violation|1|||
131200386|NCT03557801|472353638|FG001|Overall Study|Protocol Violation|0|||
131200387|NCT03557801|472353639|FG002|Overall Study|Protocol Violation|0|||
131200388|NCT03557801|472353637|FG000|Overall Study|Withdrawal by Subject|1|||
131200389|NCT03557801|472353638|FG001|Overall Study|Withdrawal by Subject|0|||
131200390|NCT03557801|472353639|FG002|Overall Study|Withdrawal by Subject|3|||
130733815|NCT02586688|470645281|FG001|Overall Study|Lost to Follow-up|1|||
130733816|NCT02586688|470645280|FG000|Overall Study|Withdrawal by Subject|1|||
131200391|NCT03557801|472353637|FG000|Overall Study|Lost to Follow-up|0|||
131200392|NCT03557801|472353638|FG001|Overall Study|Lost to Follow-up|1|||
131200393|NCT03557801|472353639|FG002|Overall Study|Lost to Follow-up|0|||
131200394|NCT00141297|472353640|FG000|Overall Study|Adverse Event|0|||
131200395|NCT00141297|472353641|FG001|Overall Study|Adverse Event|0|||
131200396|NCT00141297|472353642|FG002|Overall Study|Adverse Event|1|||
131200397|NCT00141297|472353643|FG003|Overall Study|Adverse Event|0|||
131200398|NCT00141297|472353644|FG004|Overall Study|Adverse Event|1|||
131200399|NCT00141297|472353645|FG005|Overall Study|Adverse Event|1|||
131200400|NCT00141297|472353646|FG006|Overall Study|Adverse Event|0|||
131200401|NCT00141297|472353647|FG007|Overall Study|Adverse Event|1|||
131200402|NCT00141297|472353648|FG008|Overall Study|Adverse Event|1|||
131200403|NCT00141297|472353649|FG009|Overall Study|Adverse Event|0|||
131200404|NCT00141297|472353640|FG000|Overall Study|Death|1|||
130733817|NCT02586688|470645281|FG001|Overall Study|Withdrawal by Subject|1|||
130733818|NCT02586688|470645280|FG000|Overall Study|Adverse Event|3|||
130733819|NCT02586688|470645281|FG001|Overall Study|Adverse Event|1|||
130733820|NCT04856917|470645282|FG000|Overall Study|Withdrawal by Subject|4|||
130733821|NCT04856917|470645283|FG001|Overall Study|Withdrawal by Subject|3|||
130733822|NCT04856917|470645284|FG002|Overall Study|Withdrawal by Subject|1|||
131200405|NCT00141297|472353641|FG001|Overall Study|Death|0|||
131200406|NCT00141297|472353642|FG002|Overall Study|Death|0|||
131200407|NCT00141297|472353643|FG003|Overall Study|Death|0|||
131200408|NCT00141297|472353644|FG004|Overall Study|Death|0|||
131200409|NCT00141297|472353645|FG005|Overall Study|Death|0|||
131200410|NCT00141297|472353646|FG006|Overall Study|Death|0|||
130733823|NCT04856917|470645282|FG000|Overall Study|Lost to Follow-up|3|||
130733824|NCT04856917|470645283|FG001|Overall Study|Lost to Follow-up|1|||
130733825|NCT04856917|470645284|FG002|Overall Study|Lost to Follow-up|1|||
131200411|NCT00141297|472353647|FG007|Overall Study|Death|0|||
131200412|NCT00141297|472353648|FG008|Overall Study|Death|1|||
131200413|NCT00141297|472353649|FG009|Overall Study|Death|0|||
131200414|NCT00141297|472353640|FG000|Overall Study|Withdrawal by Subject|0|||
131200415|NCT00141297|472353641|FG001|Overall Study|Withdrawal by Subject|0|||
131200416|NCT00141297|472353642|FG002|Overall Study|Withdrawal by Subject|0|||
131200417|NCT00141297|472353643|FG003|Overall Study|Withdrawal by Subject|0|||
131200418|NCT00141297|472353644|FG004|Overall Study|Withdrawal by Subject|0|||
131200419|NCT00141297|472353645|FG005|Overall Study|Withdrawal by Subject|0|||
131200420|NCT00141297|472353646|FG006|Overall Study|Withdrawal by Subject|0|||
131200421|NCT00141297|472353647|FG007|Overall Study|Withdrawal by Subject|0|||
131200422|NCT00141297|472353648|FG008|Overall Study|Withdrawal by Subject|1|||
131200423|NCT00141297|472353649|FG009|Overall Study|Withdrawal by Subject|0|||
131200424|NCT00141297|472353640|FG000|Overall Study|Other|0|||
131200425|NCT00141297|472353641|FG001|Overall Study|Other|0|||
131200426|NCT00141297|472353642|FG002|Overall Study|Other|0|||
131200427|NCT00141297|472353643|FG003|Overall Study|Other|1|||
131200428|NCT00141297|472353644|FG004|Overall Study|Other|5|||
131200429|NCT00141297|472353645|FG005|Overall Study|Other|0|||
131200430|NCT00141297|472353646|FG006|Overall Study|Other|0|||
131200431|NCT00141297|472353647|FG007|Overall Study|Other|0|||
131200432|NCT00141297|472353648|FG008|Overall Study|Other|2|||
131200433|NCT00141297|472353649|FG009|Overall Study|Other|0|||
131200434|NCT00141297|472353640|FG000|Overall Study|Progressive Disease|2|||
131200435|NCT00141297|472353641|FG001|Overall Study|Progressive Disease|3|||
131200436|NCT00141297|472353642|FG002|Overall Study|Progressive Disease|6|||
131200437|NCT00141297|472353643|FG003|Overall Study|Progressive Disease|2|||
131200438|NCT00141297|472353644|FG004|Overall Study|Progressive Disease|15|||
131200439|NCT00141297|472353645|FG005|Overall Study|Progressive Disease|2|||
131200440|NCT00141297|472353646|FG006|Overall Study|Progressive Disease|3|||
131200441|NCT00141297|472353647|FG007|Overall Study|Progressive Disease|3|||
131200442|NCT00141297|472353648|FG008|Overall Study|Progressive Disease|15|||
131200443|NCT00141297|472353649|FG009|Overall Study|Progressive Disease|6|||
131200444|NCT00141297|472353640|FG000|Overall Study|Transitioned|0|||
131200445|NCT00141297|472353641|FG001|Overall Study|Transitioned|0|||
131200446|NCT00141297|472353642|FG002|Overall Study|Transitioned|0|||
131200447|NCT00141297|472353643|FG003|Overall Study|Transitioned|0|||
131200448|NCT00141297|472353644|FG004|Overall Study|Transitioned|1|||
131200449|NCT00141297|472353645|FG005|Overall Study|Transitioned|0|||
131200450|NCT00141297|472353646|FG006|Overall Study|Transitioned|0|||
131200451|NCT00141297|472353647|FG007|Overall Study|Transitioned|0|||
131200452|NCT00141297|472353648|FG008|Overall Study|Transitioned|0|||
131200453|NCT00141297|472353649|FG009|Overall Study|Transitioned|0|||
131200454|NCT01488994|472353651|FG000|Overall Study|Withdrawal by Subject|0|||
131200455|NCT01488994|472353652|FG001|Overall Study|Withdrawal by Subject|1|||
131200456|NCT01072500|472353653|FG000|Overall Study|Death|2|||
131200457|NCT01072500|472353654|FG001|Overall Study|Death|2|||
131200458|NCT01072500|472353653|FG000|Overall Study|Lost to Follow-up|5|||
131200459|NCT01072500|472353654|FG001|Overall Study|Lost to Follow-up|2|||
131200460|NCT01072500|472353653|FG000|Overall Study|Withdrawal by Subject|17|||
131200461|NCT01072500|472353654|FG001|Overall Study|Withdrawal by Subject|10|||
131200462|NCT03798366|472353664|FG000|Overall Study|Lost to Follow-up|0|||
131200463|NCT03798366|472353665|FG001|Overall Study|Lost to Follow-up|1|||
131200464|NCT00474539|472353668|FG000|Infant Series|Withdrawal by Subject|3|||
131200465|NCT00474539|472353669|FG001|Infant Series|Withdrawal by Subject|4|||
131200466|NCT00474539|472353668|FG000|Infant Series|Randomization error|5|||
131200467|NCT00474539|472353669|FG001|Infant Series|Randomization error|0|||
131200468|NCT00474539|472353668|FG000|Infant Series|Lost to Follow-up|2|||
131200469|NCT00474539|472353669|FG001|Infant Series|Lost to Follow-up|1|||
131200470|NCT00474539|472353668|FG000|Infant Series|Protocol Violation|0|||
131200471|NCT00474539|472353669|FG001|Infant Series|Protocol Violation|1|||
131200472|NCT00474539|472353668|FG000|After Infant Series|Lost to Follow-up|3|||
131200473|NCT00474539|472353669|FG001|After Infant Series|Lost to Follow-up|0|||
131200474|NCT00474539|472353668|FG000|After Infant Series|Withdrawal by Subject|1|||
131200475|NCT00474539|472353669|FG001|After Infant Series|Withdrawal by Subject|0|||
131200476|NCT00474539|472353668|FG000|Toddler Dose|Protocol Violation|1|||
131200477|NCT00474539|472353669|FG001|Toddler Dose|Protocol Violation|0|||
131200478|NCT02061540|472353670|FG000|Overall Study|Adverse Event|2|||
131200479|NCT02061540|472353670|FG000|Overall Study|Withdrawal by Subject|2|||
131200480|NCT01227252|472353671|FG000|Overall Study|Sponsor Decision|0|||
131200481|NCT01227252|472353672|FG001|Overall Study|Sponsor Decision|1|||
131200482|NCT01227252|472353673|FG002|Overall Study|Sponsor Decision|0|||
131200483|NCT01227252|472353674|FG003|Overall Study|Sponsor Decision|0|||
131200484|NCT01227252|472353671|FG000|Overall Study|Lost to Follow-up|0|||
131200485|NCT01227252|472353672|FG001|Overall Study|Lost to Follow-up|1|||
131200486|NCT01227252|472353673|FG002|Overall Study|Lost to Follow-up|0|||
131200487|NCT01227252|472353674|FG003|Overall Study|Lost to Follow-up|0|||
131200488|NCT01227252|472353671|FG000|Overall Study|Withdrawal by Subject|0|||
131200489|NCT01227252|472353672|FG001|Overall Study|Withdrawal by Subject|1|||
131200490|NCT01227252|472353673|FG002|Overall Study|Withdrawal by Subject|0|||
131200491|NCT01227252|472353674|FG003|Overall Study|Withdrawal by Subject|0|||
131200492|NCT02561273|472353681|FG000|Overall Study|Protocol Violation|1|||
131200493|NCT02561273|472353682|FG001|Overall Study|Protocol Violation|0|||
131200494|NCT01642004|472353683|FG000|Randomization|Adverse Event unrelated to study drug|1|||
131200495|NCT01642004|472353684|FG001|Randomization|Adverse Event unrelated to study drug|0|||
131200496|NCT01642004|472353683|FG000|Randomization|Participant withdrew consent|1|||
131200497|NCT01642004|472353684|FG001|Randomization|Participant withdrew consent|6|||
131200498|NCT01642004|472353683|FG000|Randomization|No longer meets study criteria|2|||
131200499|NCT01642004|472353684|FG001|Randomization|No longer meets study criteria|2|||
131200500|NCT01642004|472353683|FG000|Treatment|Disease progression|95|||
131200501|NCT01642004|472353684|FG001|Treatment|Disease progression|79|||
131200502|NCT01642004|472353683|FG000|Treatment|Study drug toxicity|10|||
131200503|NCT01642004|472353684|FG001|Treatment|Study drug toxicity|13|||
131200504|NCT01642004|472353683|FG000|Treatment|Death|1|||
131200505|NCT01642004|472353684|FG001|Treatment|Death|1|||
131200506|NCT01642004|472353683|FG000|Treatment|Adverse event unrelated to study drug|9|||
131200507|NCT01642004|472353684|FG001|Treatment|Adverse event unrelated to study drug|13|||
131200508|NCT01642004|472353683|FG000|Treatment|Maximum clinical benefit|1|||
131200509|NCT01642004|472353684|FG001|Treatment|Maximum clinical benefit|9|||
131200510|NCT01642004|472353683|FG000|Treatment|Poor/non-compliance|1|||
131200511|NCT01642004|472353684|FG001|Treatment|Poor/non-compliance|0|||
131200512|NCT01642004|472353683|FG000|Treatment|No longer meets study criteria|1|||
131200513|NCT01642004|472353684|FG001|Treatment|No longer meets study criteria|2|||
131200514|NCT01642004|472353683|FG000|Treatment|Other reasons|2|||
131200515|NCT01642004|472353684|FG001|Treatment|Other reasons|0|||
131200516|NCT01642004|472353683|FG000|Treatment|Not reported|0|||
131200517|NCT01642004|472353684|FG001|Treatment|Not reported|3|||
131200518|NCT01642004|472353683|FG000|Treatment|Participant request to discontinue study treatment|6|||
131200519|NCT01642004|472353684|FG001|Treatment|Participant request to discontinue study treatment|4|||
131200520|NCT01642004|472353683|FG000|Treatment|Participant withdrew consent|5|||
131200521|NCT01642004|472353684|FG001|Treatment|Participant withdrew consent|5|||
131200522|NCT02192190|472353689|FG000|Overall Study|Adverse Event|1|||
131200523|NCT02192190|472353690|FG001|Overall Study|Adverse Event|1|||
131200524|NCT02192190|472353691|FG002|Overall Study|Adverse Event|0|||
131200525|NCT02192190|472353692|FG003|Overall Study|Adverse Event|0|||
131200526|NCT02192190|472353693|FG004|Overall Study|Adverse Event|0|||
131200527|NCT02192190|472353694|FG005|Overall Study|Adverse Event|0|||
131200528|NCT02192190|472353689|FG000|Overall Study|Lost to Follow-up|3|||
131200529|NCT02192190|472353690|FG001|Overall Study|Lost to Follow-up|3|||
131200530|NCT02192190|472353691|FG002|Overall Study|Lost to Follow-up|2|||
131200531|NCT02192190|472353692|FG003|Overall Study|Lost to Follow-up|1|||
131200532|NCT02192190|472353693|FG004|Overall Study|Lost to Follow-up|4|||
131200533|NCT02192190|472353694|FG005|Overall Study|Lost to Follow-up|3|||
131200534|NCT02192190|472353689|FG000|Overall Study|Physician Decision|2|||
131200535|NCT02192190|472353690|FG001|Overall Study|Physician Decision|0|||
131200536|NCT02192190|472353691|FG002|Overall Study|Physician Decision|0|||
131200537|NCT02192190|472353692|FG003|Overall Study|Physician Decision|0|||
131200538|NCT02192190|472353693|FG004|Overall Study|Physician Decision|0|||
131200539|NCT02192190|472353694|FG005|Overall Study|Physician Decision|0|||
131200540|NCT02192190|472353689|FG000|Overall Study|Terminated by Sponsor|43|||
131200541|NCT02192190|472353690|FG001|Overall Study|Terminated by Sponsor|23|||
131200542|NCT02192190|472353691|FG002|Overall Study|Terminated by Sponsor|20|||
131200543|NCT02192190|472353692|FG003|Overall Study|Terminated by Sponsor|23|||
131200544|NCT02192190|472353693|FG004|Overall Study|Terminated by Sponsor|21|||
131200545|NCT02192190|472353694|FG005|Overall Study|Terminated by Sponsor|23|||
131200546|NCT02192190|472353689|FG000|Overall Study|Withdrawal by Subject|4|||
131200547|NCT02192190|472353690|FG001|Overall Study|Withdrawal by Subject|1|||
131200548|NCT02192190|472353691|FG002|Overall Study|Withdrawal by Subject|2|||
131200549|NCT02192190|472353692|FG003|Overall Study|Withdrawal by Subject|1|||
131200550|NCT02192190|472353693|FG004|Overall Study|Withdrawal by Subject|5|||
131200551|NCT02192190|472353694|FG005|Overall Study|Withdrawal by Subject|3|||
131200552|NCT02192190|472353689|FG000|Overall Study|Could not Keep Visit Schedule|1|||
131200553|NCT02192190|472353690|FG001|Overall Study|Could not Keep Visit Schedule|0|||
131200554|NCT02192190|472353691|FG002|Overall Study|Could not Keep Visit Schedule|0|||
131200555|NCT02192190|472353692|FG003|Overall Study|Could not Keep Visit Schedule|0|||
131200556|NCT02192190|472353693|FG004|Overall Study|Could not Keep Visit Schedule|0|||
131200557|NCT02192190|472353694|FG005|Overall Study|Could not Keep Visit Schedule|0|||
131200558|NCT02192190|472353689|FG000|Overall Study|Positive Drug Screen|0|||
131200559|NCT02192190|472353690|FG001|Overall Study|Positive Drug Screen|0|||
131200560|NCT02192190|472353691|FG002|Overall Study|Positive Drug Screen|0|||
131200561|NCT02192190|472353692|FG003|Overall Study|Positive Drug Screen|1|||
131200562|NCT02192190|472353693|FG004|Overall Study|Positive Drug Screen|0|||
131200563|NCT02192190|472353694|FG005|Overall Study|Positive Drug Screen|0|||
131200564|NCT02192190|472353689|FG000|Overall Study|Inadequate Pain Relief|0|||
131200565|NCT02192190|472353690|FG001|Overall Study|Inadequate Pain Relief|1|||
131200566|NCT02192190|472353691|FG002|Overall Study|Inadequate Pain Relief|1|||
131200567|NCT02192190|472353692|FG003|Overall Study|Inadequate Pain Relief|0|||
131200568|NCT02192190|472353693|FG004|Overall Study|Inadequate Pain Relief|0|||
131200569|NCT02192190|472353694|FG005|Overall Study|Inadequate Pain Relief|0|||
131200570|NCT03227692|472353695|FG000|Overall Study|Protocol Violation|1|||
131200571|NCT03227692|472353696|FG001|Overall Study|Protocol Violation|1|||
131200572|NCT03227692|472353695|FG000|Overall Study|Lost to Follow-up|4|||
131200573|NCT03227692|472353696|FG001|Overall Study|Lost to Follow-up|2|||
131200574|NCT03227692|472353695|FG000|Overall Study|Adverse Event|0|||
131200575|NCT03227692|472353696|FG001|Overall Study|Adverse Event|2|||
131200576|NCT02447952|472353697|FG000|Overall Study|Adverse Event|2|||
131200577|NCT02447952|472353697|FG000|Overall Study|Physician Decision|1|||
131200578|NCT02447952|472353697|FG000|Overall Study|Withdrawal by Subject|4|||
131200579|NCT04554394|472353700|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
131200580|NCT04554394|472353701|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
131200581|NCT04554394|472353700|FG000|Overall Study|Withdrawal by Subject|2|||
131200582|NCT04554394|472353701|FG001|Overall Study|Withdrawal by Subject|2|||
131200583|NCT04554394|472353700|FG000|Overall Study|Lost to Follow-up|2|||
131200584|NCT04554394|472353701|FG001|Overall Study|Lost to Follow-up|2|||
131200585|NCT04554394|472353700|FG000|Overall Study|Physician Decision|1|||
131200586|NCT04554394|472353701|FG001|Overall Study|Physician Decision|1|||
131200587|NCT00890201|472353702|FG000|Overall Study|Protocol Violation|5|||
131200588|NCT00890201|472353703|FG001|Overall Study|Protocol Violation|56|||
131200589|NCT02181504|472353704|FG000|Overall Study|Adverse Event|1|||
131200590|NCT02181504|472353705|FG001|Overall Study|Adverse Event|1|||
131200591|NCT02181504|472353706|FG002|Overall Study|Adverse Event|1|||
131200592|NCT03267576|472353717|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
131200593|NCT03267576|472353718|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
131200594|NCT03267576|472353717|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
131200595|NCT03267576|472353718|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
131200596|NCT01369069|472353719|FG000|Overall Study|Lost to Follow-up|8|||
131200597|NCT01369069|472353720|FG001|Overall Study|Lost to Follow-up|9|||
131200598|NCT01369069|472353719|FG000|Overall Study|Withdrawal by Subject|9|||
131200599|NCT01369069|472353720|FG001|Overall Study|Withdrawal by Subject|7|||
131200600|NCT00882362|472353721|FG000|Overall Study|Adverse Event|13|||
131200601|NCT00882362|472353722|FG001|Overall Study|Adverse Event|10|||
131200602|NCT00882362|472353721|FG000|Overall Study|Withdrawal by Subject|13|||
131200603|NCT00882362|472353722|FG001|Overall Study|Withdrawal by Subject|10|||
131200604|NCT00882362|472353721|FG000|Overall Study|Lack of Efficacy|3|||
131200605|NCT00882362|472353722|FG001|Overall Study|Lack of Efficacy|0|||
131200606|NCT00882362|472353721|FG000|Overall Study|Protocol Violation|7|||
131200607|NCT00882362|472353722|FG001|Overall Study|Protocol Violation|2|||
131200608|NCT00882362|472353721|FG000|Overall Study|Pregnancy|1|||
131200609|NCT00882362|472353722|FG001|Overall Study|Pregnancy|0|||
131200610|NCT00882362|472353721|FG000|Overall Study|Physician Decision|5|||
131200611|NCT00882362|472353722|FG001|Overall Study|Physician Decision|1|||
131200612|NCT00882362|472353721|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
131200613|NCT00882362|472353722|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
131200614|NCT00882362|472353721|FG000|Overall Study|change of residence or other commitments|5|||
131200615|NCT00882362|472353722|FG001|Overall Study|change of residence or other commitments|0|||
131200616|NCT01268514|472353723|FG000|Overall Study|Adverse Event|20|||
131200617|NCT01268514|472353723|FG000|Overall Study|Death|8|||
131200618|NCT01268514|472353723|FG000|Overall Study|Lost to Follow-up|5|||
131200619|NCT01268514|472353723|FG000|Overall Study|Withdrawal by Subject|3|||
131200620|NCT01268514|472353723|FG000|Overall Study|Withdrawal by Surgeon|5|||
131200621|NCT01846208|472353724|FG000|Overall Study|Withdrew prior to treatment|1|||
131200622|NCT01846208|472353725|FG001|Overall Study|Withdrew prior to treatment|1|||
131200623|NCT01846208|472353726|FG002|Overall Study|Withdrew prior to treatment|1|||
131200624|NCT01846208|472353724|FG000|Overall Study|Dosing Symptoms|1|||
130784627|NCT03160716|470838850|FG000|Overall Study|Lost to Follow-up|1|||
130784628|NCT00875810|470838851|FG000|Overall Study|Withdrawal by Subject|1|||
131200625|NCT01846208|472353725|FG001|Overall Study|Dosing Symptoms|2|||
131200626|NCT01846208|472353726|FG002|Overall Study|Dosing Symptoms|6|||
131200627|NCT01846208|472353724|FG000|Overall Study|Withdrawal by Subject|5|||
131200628|NCT01846208|472353725|FG001|Overall Study|Withdrawal by Subject|0|||
131200629|NCT01846208|472353726|FG002|Overall Study|Withdrawal by Subject|0|||
131200630|NCT01846208|472353724|FG000|Overall Study|Non-compliance|1|||
131200631|NCT01846208|472353725|FG001|Overall Study|Non-compliance|1|||
130784629|NCT00875810|470838851|FG000|Overall Study|Physician Decision|3|||
131200632|NCT01846208|472353726|FG002|Overall Study|Non-compliance|0|||
131200633|NCT01846208|472353724|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
131200634|NCT01846208|472353725|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
131200635|NCT01846208|472353726|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
131200636|NCT01846208|472353724|FG000|Overall Study|Refused SU OFC|0|||
131200637|NCT01846208|472353725|FG001|Overall Study|Refused SU OFC|0|||
131200638|NCT01846208|472353726|FG002|Overall Study|Refused SU OFC|1|||
131200639|NCT01424306|472353727|FG000|Overall Study|Protocol Violation|0|||
131200640|NCT01424306|472353728|FG001|Overall Study|Protocol Violation|0|||
131200641|NCT01424306|472353729|FG002|Overall Study|Protocol Violation|0|||
131200642|NCT01424306|472353730|FG003|Overall Study|Protocol Violation|0|||
131200643|NCT01424306|472353731|FG004|Overall Study|Protocol Violation|1|||
131200644|NCT01424306|472353732|FG005|Overall Study|Protocol Violation|0|||
131200645|NCT02390362|472353746|FG000|Overall Study|Withdrawal by Subject|0|||
131200646|NCT02390362|472353747|FG001|Overall Study|Withdrawal by Subject|1|||
131200647|NCT04009824|472353748|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
131200648|NCT04009824|472353749|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
131200649|NCT04009824|472353750|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
131200650|NCT04009824|472353751|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
131200651|NCT04009824|472353752|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
131200652|NCT01024946|472353753|FG000|Overall Study|Screen Failure|3|||
131200653|NCT01024946|472353753|FG000|Overall Study|Withdrawal by Subject|1|||
131200654|NCT01024946|472353753|FG000|Overall Study|Adverse Event|1|||
131200655|NCT02274766|472353754|FG000|Overall Study|Withdrawal by Subject|3|||
131200656|NCT02274766|472353755|FG001|Overall Study|Withdrawal by Subject|6|||
131200657|NCT02274766|472353754|FG000|Overall Study|Did Not Receive Study Drug|1|||
131200658|NCT02274766|472353755|FG001|Overall Study|Did Not Receive Study Drug|1|||
131200659|NCT02274766|472353754|FG000|Overall Study|Subject Unwilling to Proceed|0|||
131200660|NCT02274766|472353755|FG001|Overall Study|Subject Unwilling to Proceed|1|||
131200661|NCT02274766|472353754|FG000|Overall Study|Adverse Event|0|||
131200662|NCT02274766|472353755|FG001|Overall Study|Adverse Event|1|||
131200663|NCT01142791|472353765|FG000|Overall Study|Alternative Treatment|1|||
131200664|NCT01142791|472353766|FG001|Overall Study|Alternative Treatment|0|||
131200665|NCT01142791|472353765|FG000|Overall Study|Lost to Follow-up|1|||
131200666|NCT01142791|472353766|FG001|Overall Study|Lost to Follow-up|0|||
131200667|NCT01142791|472353765|FG000|Overall Study|Withdrawal by Subject|5|||
131200668|NCT01142791|472353766|FG001|Overall Study|Withdrawal by Subject|0|||
131200669|NCT01142791|472353765|FG000|Overall Study|Received only 1 sonication|0|||
131200670|NCT01142791|472353766|FG001|Overall Study|Received only 1 sonication|6|||
131200671|NCT02608892|472353767|FG000|Overall Study|Lost to Follow-up|1|||
131200672|NCT02608892|472353768|FG001|Overall Study|Lost to Follow-up|0|||
131200673|NCT02590406|472353771|FG000|Overall Study|Adverse Event|1|||
131200674|NCT02590406|472353772|FG001|Overall Study|Adverse Event|0|||
131200675|NCT02590406|472353771|FG000|Overall Study|Saturometer malfunction|0|||
131200676|NCT02590406|472353772|FG001|Overall Study|Saturometer malfunction|1|||
131200677|NCT03032523|472353773|FG000|Overall Study|Withdrawal by Subject|2|||
131200678|NCT03032523|472353774|FG001|Overall Study|Withdrawal by Subject|2|||
131200679|NCT03032523|472353773|FG000|Overall Study|Physician Decision|1|||
131200680|NCT03032523|472353774|FG001|Overall Study|Physician Decision|0|||
131200681|NCT05375838|472353775|FG000|Overall Study|Other|0|||
131200682|NCT05375838|472353776|FG001|Overall Study|Other|0|||
131200683|NCT05375838|472353777|FG002|Overall Study|Other|0|||
131200684|NCT05375838|472353778|FG003|Overall Study|Other|1|||
131200685|NCT05375838|472353779|FG004|Overall Study|Other|1|||
131200686|NCT05375838|472353780|FG005|Overall Study|Other|0|||
131200687|NCT05375838|472353775|FG000|Overall Study|Withdrawal by Subject|2|||
131200688|NCT05375838|472353776|FG001|Overall Study|Withdrawal by Subject|1|||
131200689|NCT05375838|472353777|FG002|Overall Study|Withdrawal by Subject|3|||
131200690|NCT05375838|472353778|FG003|Overall Study|Withdrawal by Subject|2|||
131200691|NCT05375838|472353779|FG004|Overall Study|Withdrawal by Subject|2|||
131200692|NCT05375838|472353780|FG005|Overall Study|Withdrawal by Subject|0|||
131200693|NCT05375838|472353775|FG000|Overall Study|Protocol Violation|0|||
131200694|NCT05375838|472353776|FG001|Overall Study|Protocol Violation|0|||
131200695|NCT05375838|472353777|FG002|Overall Study|Protocol Violation|0|||
131200696|NCT05375838|472353778|FG003|Overall Study|Protocol Violation|0|||
131200697|NCT05375838|472353779|FG004|Overall Study|Protocol Violation|1|||
131200698|NCT05375838|472353780|FG005|Overall Study|Protocol Violation|0|||
131200699|NCT05375838|472353775|FG000|Overall Study|Physician Decision|0|||
131200700|NCT05375838|472353776|FG001|Overall Study|Physician Decision|1|||
131200701|NCT05375838|472353777|FG002|Overall Study|Physician Decision|0|||
131200702|NCT05375838|472353778|FG003|Overall Study|Physician Decision|0|||
131200703|NCT05375838|472353779|FG004|Overall Study|Physician Decision|0|||
131200704|NCT05375838|472353780|FG005|Overall Study|Physician Decision|1|||
131200705|NCT05375838|472353775|FG000|Overall Study|Lost to Follow-up|2|||
131200706|NCT05375838|472353776|FG001|Overall Study|Lost to Follow-up|7|||
131200707|NCT05375838|472353777|FG002|Overall Study|Lost to Follow-up|0|||
131200708|NCT05375838|472353778|FG003|Overall Study|Lost to Follow-up|4|||
131200709|NCT05375838|472353779|FG004|Overall Study|Lost to Follow-up|2|||
131200710|NCT05375838|472353780|FG005|Overall Study|Lost to Follow-up|3|||
131200711|NCT00984009|472353781|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
131200712|NCT00281528|472353782|FG000|Overall Study|Progressive Disease|28|||
131200713|NCT00281528|472353783|FG001|Overall Study|Progressive Disease|18|||
131200714|NCT00281528|472353784|FG002|Overall Study|Progressive Disease|27|||
131200715|NCT00281528|472353782|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
131200716|NCT00281528|472353783|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
131200717|NCT00281528|472353784|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
131200718|NCT00281528|472353782|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
131200719|NCT00281528|472353783|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
131200720|NCT00281528|472353784|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
131200721|NCT00281528|472353782|FG000|Overall Study|Physician Decision|11|||
131200722|NCT00281528|472353783|FG001|Overall Study|Physician Decision|4|||
131200723|NCT00281528|472353784|FG002|Overall Study|Physician Decision|5|||
131200724|NCT00281528|472353782|FG000|Overall Study|Protocol Violation|1|||
131200725|NCT00281528|472353783|FG001|Overall Study|Protocol Violation|0|||
131200726|NCT00281528|472353784|FG002|Overall Study|Protocol Violation|1|||
131200727|NCT00281528|472353782|FG000|Overall Study|Withdrawal by Subject|5|||
131200728|NCT00281528|472353783|FG001|Overall Study|Withdrawal by Subject|5|||
131200729|NCT00281528|472353784|FG002|Overall Study|Withdrawal by Subject|7|||
131200730|NCT00281528|472353782|FG000|Overall Study|Other|6|||
131200731|NCT00281528|472353783|FG001|Overall Study|Other|3|||
131200732|NCT00281528|472353784|FG002|Overall Study|Other|5|||
131200733|NCT05281094|472353794|FG000|Overall Study|Adverse Event|1|||
131200734|NCT05281094|472353795|FG001|Overall Study|Adverse Event|0|||
131200735|NCT05281094|472353794|FG000|Overall Study|Lost to Follow-up|29|||
131200736|NCT05281094|472353795|FG001|Overall Study|Lost to Follow-up|22|||
131200737|NCT05281094|472353794|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
131200738|NCT05281094|472353795|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
131200739|NCT05281094|472353794|FG000|Overall Study|Death|1|||
131200740|NCT05281094|472353795|FG001|Overall Study|Death|2|||
131200741|NCT05281094|472353794|FG000|Overall Study|Not pre-specified reason|8|||
131200742|NCT05281094|472353795|FG001|Overall Study|Not pre-specified reason|5|||
131200743|NCT00631969|472353800|FG000|Overall Study|Adverse Event|3|||
131200744|NCT00631969|472353801|FG001|Overall Study|Adverse Event|1|||
131200745|NCT00631969|472353800|FG000|Overall Study|Lack of Efficacy|2|||
131200746|NCT00631969|472353801|FG001|Overall Study|Lack of Efficacy|8|||
131200747|NCT00631969|472353800|FG000|Overall Study|Lost to Follow-up|2|||
131200748|NCT00631969|472353801|FG001|Overall Study|Lost to Follow-up|1|||
131200749|NCT00631969|472353800|FG000|Overall Study|Protocol Violation|1|||
131200750|NCT00631969|472353801|FG001|Overall Study|Protocol Violation|1|||
131200751|NCT00631969|472353800|FG000|Overall Study|Consent Withdrawn|5|||
131200752|NCT00631969|472353801|FG001|Overall Study|Consent Withdrawn|7|||
131200753|NCT00631969|472353800|FG000|Overall Study|Noncompliant With Study Medication|0|||
131200754|NCT00631969|472353801|FG001|Overall Study|Noncompliant With Study Medication|1|||
131200755|NCT00631969|472353800|FG000|Overall Study|No Drug Exposure|2|||
131200756|NCT00631969|472353801|FG001|Overall Study|No Drug Exposure|2|||
131200757|NCT03053180|472355634|FG000|Overall Study|Failure to Return|1|||
131200758|NCT04144140|472355637|FG000|Overall Study|Other|0|||
131200759|NCT04144140|472355638|FG001|Overall Study|Other|0|||
131200760|NCT04144140|472355639|FG002|Overall Study|Other|0|||
131200761|NCT04144140|472355640|FG003|Overall Study|Other|0|||
131200762|NCT04144140|472355641|FG004|Overall Study|Other|0|||
131200763|NCT04144140|472355642|FG005|Overall Study|Other|1|||
131200764|NCT04144140|472355643|FG006|Overall Study|Other|0|||
131200765|NCT01465958|472355644|FG000|Run-in Phase|Protocol Violation|1|||
131200766|NCT01465958|472355645|FG001|Run-in Phase|Protocol Violation|0|||
131200767|NCT01465958|472355644|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
131200768|NCT01465958|472355645|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
131200769|NCT02972658|472355646|FG000|Overall Study|Adverse Event|0|||
131200770|NCT02972658|472355647|FG001|Overall Study|Adverse Event|3|||
131200771|NCT02972658|472355648|FG002|Overall Study|Adverse Event|0|||
131200772|NCT02972658|472355649|FG003|Overall Study|Adverse Event|2|||
131200773|NCT02972658|472355646|FG000|Overall Study|Other-determined by Investigator|1|||
131200774|NCT02972658|472355647|FG001|Overall Study|Other-determined by Investigator|1|||
131200775|NCT02972658|472355648|FG002|Overall Study|Other-determined by Investigator|0|||
131200776|NCT02972658|472355649|FG003|Overall Study|Other-determined by Investigator|0|||
131200777|NCT02972658|472355646|FG000|Overall Study|Death|0|||
131200778|NCT02972658|472355647|FG001|Overall Study|Death|0|||
131200779|NCT02972658|472355648|FG002|Overall Study|Death|0|||
131200780|NCT02972658|472355649|FG003|Overall Study|Death|1|||
131200781|NCT02972658|472355646|FG000|Overall Study|Lost to Follow-up|0|||
131200782|NCT02972658|472355647|FG001|Overall Study|Lost to Follow-up|1|||
131200783|NCT02972658|472355648|FG002|Overall Study|Lost to Follow-up|1|||
131200784|NCT02972658|472355649|FG003|Overall Study|Lost to Follow-up|2|||
131200785|NCT02972658|472355646|FG000|Overall Study|Progressive Disease|0|||
131200786|NCT02972658|472355647|FG001|Overall Study|Progressive Disease|1|||
131200787|NCT02972658|472355648|FG002|Overall Study|Progressive Disease|0|||
131200788|NCT02972658|472355649|FG003|Overall Study|Progressive Disease|1|||
131200789|NCT02972658|472355646|FG000|Overall Study|Withdrawal by Subject|4|||
131200790|NCT02972658|472355647|FG001|Overall Study|Withdrawal by Subject|4|||
131200791|NCT02972658|472355648|FG002|Overall Study|Withdrawal by Subject|1|||
131200792|NCT02972658|472355649|FG003|Overall Study|Withdrawal by Subject|6|||
131200793|NCT02972658|472355646|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
131200794|NCT02972658|472355647|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
131200795|NCT02972658|472355648|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
131200796|NCT02972658|472355649|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
131200797|NCT02972658|472355646|FG000|Overall Study|Sponsor Decision|70|||
131200798|NCT02972658|472355647|FG001|Overall Study|Sponsor Decision|127|||
131200799|NCT02972658|472355648|FG002|Overall Study|Sponsor Decision|72|||
131200800|NCT02972658|472355649|FG003|Overall Study|Sponsor Decision|119|||
131200801|NCT03958149|472355650|FG000|Overall Study|Withdrawal by Subject|0|||
131200802|NCT03958149|472355651|FG001|Overall Study|Withdrawal by Subject|1|||
131200803|NCT02785588|472355652|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
131200804|NCT02785588|472355652|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
131200805|NCT02583399|472355654|FG000|Overall Study|Able to be discharged|3|||
131200806|NCT02583399|472355654|FG000|Overall Study|Wanted to use a restricted medication|3|||
131200807|NCT00364611|472355655|FG000|Overall Study|Did not receive study medication|0|||
131200808|NCT00364611|472355656|FG001|Overall Study|Did not receive study medication|1|||
131200809|NCT00364611|472355655|FG000|Overall Study|Adverse Event|7|||
131200810|NCT00364611|472355656|FG001|Overall Study|Adverse Event|4|||
131200811|NCT00364611|472355655|FG000|Overall Study|Participant's Request|3|||
131200812|NCT00364611|472355656|FG001|Overall Study|Participant's Request|4|||
131200813|NCT00364611|472355655|FG000|Overall Study|Disease Progression|38|||
131200814|NCT00364611|472355656|FG001|Overall Study|Disease Progression|8|||
131200815|NCT00364611|472355655|FG000|Overall Study|Investigator decision|2|||
131200816|NCT00364611|472355656|FG001|Overall Study|Investigator decision|2|||
131200817|NCT00364611|472355655|FG000|Overall Study|Found Ineligible|1|||
131200818|NCT00364611|472355656|FG001|Overall Study|Found Ineligible|0|||
131200819|NCT00364611|472355655|FG000|Overall Study|Presumed CR on Study|0|||
131200820|NCT00364611|472355656|FG001|Overall Study|Presumed CR on Study|1|||
131200821|NCT00364611|472355655|FG000|Overall Study|Receiving Liver Ablation|0|||
131200822|NCT00364611|472355656|FG001|Overall Study|Receiving Liver Ablation|1|||
131200823|NCT02759939|472355661|FG000|Overall Study|Missing data on first outcome assessed|11|||
131200824|NCT02759939|472355662|FG001|Overall Study|Missing data on first outcome assessed|2|||
131200825|NCT02759939|472355663|FG002|Overall Study|Missing data on first outcome assessed|5|||
131200826|NCT02759939|472355664|FG003|Overall Study|Missing data on first outcome assessed|2|||
131200827|NCT02759939|472355661|FG000|Overall Study|Ineligible for T2 and T3|310|||
131200828|NCT02759939|472355662|FG001|Overall Study|Ineligible for T2 and T3|179|||
131200829|NCT02759939|472355663|FG002|Overall Study|Ineligible for T2 and T3|366|||
131200830|NCT02759939|472355664|FG003|Overall Study|Ineligible for T2 and T3|391|||
131200831|NCT02759939|472355661|FG000|Overall Study|Lost to Follow-up|735|||
131200832|NCT02759939|472355662|FG001|Overall Study|Lost to Follow-up|791|||
131200833|NCT02759939|472355663|FG002|Overall Study|Lost to Follow-up|783|||
131200834|NCT02759939|472355664|FG003|Overall Study|Lost to Follow-up|650|||
131200835|NCT04397757|472355666|FG000|Overall Study|Death|3|||
131200836|NCT04397757|472355667|FG001|Overall Study|Death|11|||
131200837|NCT04397757|472355666|FG000|Overall Study|Withdrawal by Subject|2|||
131200838|NCT04397757|472355667|FG001|Overall Study|Withdrawal by Subject|0|||
131200839|NCT04397757|472355666|FG000|Overall Study|Lost to Follow-up|4|||
131200840|NCT04397757|472355667|FG001|Overall Study|Lost to Follow-up|3|||
131200841|NCT02185040|472355671|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
131200842|NCT02185040|472355672|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
131200843|NCT02185040|472355673|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
131200844|NCT02185040|472355674|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
131200845|NCT02185040|472355675|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
131200846|NCT02185040|472355676|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
131200847|NCT02185040|472355677|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
131200848|NCT02185040|472355671|FG000|Part 1 Treatment Phase|Adverse Event|1|||
131200849|NCT02185040|472355672|FG001|Part 1 Treatment Phase|Adverse Event|0|||
131200850|NCT02185040|472355673|FG002|Part 1 Treatment Phase|Adverse Event|0|||
131200851|NCT02185040|472355674|FG003|Part 1 Treatment Phase|Adverse Event|2|||
131200852|NCT02185040|472355675|FG004|Part 1 Treatment Phase|Adverse Event|3|||
131200853|NCT02185040|472355676|FG005|Part 1 Treatment Phase|Adverse Event|0|||
131200854|NCT02185040|472355677|FG006|Part 1 Treatment Phase|Adverse Event|0|||
131200855|NCT02185040|472355671|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131200856|NCT02185040|472355672|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
131200857|NCT02185040|472355673|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131200858|NCT02185040|472355674|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131200859|NCT02185040|472355675|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131200860|NCT02185040|472355676|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131200861|NCT02185040|472355677|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
131200862|NCT02185040|472355671|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
131200863|NCT02185040|472355672|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
131200864|NCT02185040|472355673|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
130784630|NCT00875810|470838851|FG000|Overall Study|Lost to Follow-up|39|||
131200865|NCT02185040|472355674|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
131200866|NCT02185040|472355675|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
131200867|NCT02185040|472355676|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
131200868|NCT02185040|472355677|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
131200869|NCT02185040|472355671|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
131200870|NCT02185040|472355672|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
131200871|NCT02185040|472355673|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
131200872|NCT02185040|472355674|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
131200873|NCT02185040|472355675|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
131200874|NCT02185040|472355676|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
131200875|NCT02185040|472355677|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
131200876|NCT02185040|472355671|FG000|Active Treatment Extension Phase|Adverse Event|0|||
131200877|NCT02185040|472355672|FG001|Active Treatment Extension Phase|Adverse Event|0|||
131200878|NCT02185040|472355673|FG002|Active Treatment Extension Phase|Adverse Event|0|||
131200879|NCT02185040|472355674|FG003|Active Treatment Extension Phase|Adverse Event|0|||
131200880|NCT02185040|472355675|FG004|Active Treatment Extension Phase|Adverse Event|0|||
131200881|NCT02185040|472355676|FG005|Active Treatment Extension Phase|Adverse Event|1|||
131200882|NCT02185040|472355677|FG006|Active Treatment Extension Phase|Adverse Event|4|||
131200883|NCT02185040|472355671|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
131200884|NCT02185040|472355672|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
131200885|NCT02185040|472355673|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
131200886|NCT02185040|472355674|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
131200887|NCT02185040|472355675|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
131200888|NCT02185040|472355676|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
131200889|NCT02185040|472355677|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
131200890|NCT02185040|472355671|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
131200891|NCT02185040|472355672|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
131200892|NCT02185040|472355673|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
131200893|NCT02185040|472355674|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
131200894|NCT02185040|472355675|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
131200895|NCT02185040|472355676|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
131200896|NCT02185040|472355677|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
131200897|NCT03347279|472355678|FG000|Overall Study|Withdrawal by Subject|8|||
131200898|NCT03347279|472355679|FG001|Overall Study|Withdrawal by Subject|15|||
131200899|NCT03347279|472355678|FG000|Overall Study|Death|0|||
131200900|NCT03347279|472355679|FG001|Overall Study|Death|2|||
131200901|NCT03347279|472355678|FG000|Overall Study|Lost to Follow-up|5|||
131200902|NCT03347279|472355679|FG001|Overall Study|Lost to Follow-up|2|||
131200903|NCT03347279|472355678|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
131200904|NCT03347279|472355679|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
131200905|NCT03818399|472355684|FG000|Overall Study|Lost to Follow-up|11|||
131200906|NCT03818399|472355684|FG000|Overall Study|Withdrawal by Subject|1|||
131200907|NCT03818399|472355684|FG000|Overall Study|Protocol Violation|2|||
131200908|NCT00535236|472355687|FG000|Overall Study|Adverse Event|1|||
131200909|NCT00535236|472355688|FG001|Overall Study|Adverse Event|0|||
131200910|NCT00535236|472355689|FG002|Overall Study|Adverse Event|9|||
131200911|NCT00535236|472355690|FG003|Overall Study|Adverse Event|3|||
131200912|NCT00535236|472355691|FG004|Overall Study|Adverse Event|3|||
131200913|NCT00535236|472355692|FG005|Overall Study|Adverse Event|0|||
131200914|NCT00535236|472355693|FG006|Overall Study|Adverse Event|5|||
131200915|NCT00535236|472355694|FG007|Overall Study|Adverse Event|1|||
131200916|NCT00535236|472355695|FG008|Overall Study|Adverse Event|2|||
131200917|NCT00535236|472355696|FG009|Overall Study|Adverse Event|1|||
131200918|NCT00535236|472355687|FG000|Overall Study|Lost to Follow-up|1|||
131200919|NCT00535236|472355688|FG001|Overall Study|Lost to Follow-up|2|||
131200920|NCT00535236|472355689|FG002|Overall Study|Lost to Follow-up|0|||
131200921|NCT00535236|472355690|FG003|Overall Study|Lost to Follow-up|0|||
131200922|NCT00535236|472355691|FG004|Overall Study|Lost to Follow-up|2|||
131200923|NCT00535236|472355692|FG005|Overall Study|Lost to Follow-up|0|||
131200924|NCT00535236|472355693|FG006|Overall Study|Lost to Follow-up|0|||
131200925|NCT00535236|472355694|FG007|Overall Study|Lost to Follow-up|0|||
131200926|NCT00535236|472355695|FG008|Overall Study|Lost to Follow-up|6|||
131200927|NCT00535236|472355696|FG009|Overall Study|Lost to Follow-up|1|||
131200928|NCT00535236|472355687|FG000|Overall Study|Physician Decision|0|||
131200929|NCT00535236|472355688|FG001|Overall Study|Physician Decision|0|||
131200930|NCT00535236|472355689|FG002|Overall Study|Physician Decision|0|||
131200931|NCT00535236|472355690|FG003|Overall Study|Physician Decision|0|||
131200932|NCT00535236|472355691|FG004|Overall Study|Physician Decision|1|||
131200933|NCT00535236|472355692|FG005|Overall Study|Physician Decision|0|||
131200934|NCT00535236|472355693|FG006|Overall Study|Physician Decision|1|||
131200935|NCT00535236|472355694|FG007|Overall Study|Physician Decision|0|||
131200936|NCT00535236|472355695|FG008|Overall Study|Physician Decision|0|||
131200937|NCT00535236|472355696|FG009|Overall Study|Physician Decision|0|||
131200938|NCT00535236|472355687|FG000|Overall Study|Protocol Violation|2|||
131200939|NCT00535236|472355688|FG001|Overall Study|Protocol Violation|0|||
131200940|NCT00535236|472355689|FG002|Overall Study|Protocol Violation|1|||
131200941|NCT00535236|472355690|FG003|Overall Study|Protocol Violation|0|||
131200942|NCT00535236|472355691|FG004|Overall Study|Protocol Violation|0|||
131200943|NCT00535236|472355692|FG005|Overall Study|Protocol Violation|0|||
131200944|NCT00535236|472355693|FG006|Overall Study|Protocol Violation|0|||
131200945|NCT00535236|472355694|FG007|Overall Study|Protocol Violation|0|||
131200946|NCT00535236|472355695|FG008|Overall Study|Protocol Violation|1|||
131200947|NCT00535236|472355696|FG009|Overall Study|Protocol Violation|0|||
131200948|NCT00535236|472355687|FG000|Overall Study|Withdrawal by Subject|3|||
131200949|NCT00535236|472355688|FG001|Overall Study|Withdrawal by Subject|0|||
131200950|NCT00535236|472355689|FG002|Overall Study|Withdrawal by Subject|2|||
131200951|NCT00535236|472355690|FG003|Overall Study|Withdrawal by Subject|1|||
131200952|NCT00535236|472355691|FG004|Overall Study|Withdrawal by Subject|6|||
131200953|NCT00535236|472355692|FG005|Overall Study|Withdrawal by Subject|1|||
131200954|NCT00535236|472355693|FG006|Overall Study|Withdrawal by Subject|5|||
131200955|NCT00535236|472355694|FG007|Overall Study|Withdrawal by Subject|0|||
131200956|NCT00535236|472355695|FG008|Overall Study|Withdrawal by Subject|4|||
131200957|NCT00535236|472355696|FG009|Overall Study|Withdrawal by Subject|2|||
131200958|NCT03288987|472355698|FG000|Overall Study|Protocol Violation|10|||
131200959|NCT03288987|472355699|FG001|Overall Study|Protocol Violation|4|||
131200960|NCT04905563|472355702|FG000|Overall Study|Withdrawal by Subject|1|||
131200961|NCT04905563|472355703|FG001|Overall Study|Withdrawal by Subject|0|||
131200962|NCT04905563|472355702|FG000|Overall Study|Standard of care orders entered by resident|1|||
131200963|NCT04905563|472355703|FG001|Overall Study|Standard of care orders entered by resident|0|||
131200964|NCT04905563|472355702|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
131200965|NCT04905563|472355703|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
131200966|NCT04905563|472355702|FG000|Overall Study|Withdrawal by Subject|0|||
131200967|NCT04905563|472355703|FG001|Overall Study|Withdrawal by Subject|1|||
131200968|NCT02718625|472355706|FG000|Overall Study|Adverse Event|0|||
131200969|NCT02718625|472355707|FG001|Overall Study|Adverse Event|1|||
131200970|NCT02718625|472355706|FG000|Overall Study|Termination of Study by Sponsor|0|||
131200971|NCT02718625|472355707|FG001|Overall Study|Termination of Study by Sponsor|1|||
131200972|NCT01947127|472355712|FG000|Overall Study|Protocol Violation|18|||
131200973|NCT01947127|472355713|FG001|Overall Study|Protocol Violation|38|||
131200974|NCT01947127|472355712|FG000|Overall Study|Withdrawal by Subject|1|||
131200975|NCT01947127|472355713|FG001|Overall Study|Withdrawal by Subject|1|||
131200976|NCT01947127|472355712|FG000|Overall Study|Data loss|4|||
131200977|NCT01947127|472355713|FG001|Overall Study|Data loss|4|||
131200978|NCT01836549|472355714|FG000|Overall Study|Did not receive study drug|0|||
131200979|NCT01836549|472355715|FG001|Overall Study|Did not receive study drug|0|||
131200980|NCT01836549|472355716|FG002|Overall Study|Did not receive study drug|1|||
131200981|NCT01836549|472355717|FG003|Overall Study|Did not receive study drug|0|||
131200982|NCT01836549|472355718|FG004|Overall Study|Did not receive study drug|0|||
131200983|NCT01836549|472355719|FG005|Overall Study|Did not receive study drug|0|||
131200984|NCT01836549|472355720|FG006|Overall Study|Did not receive study drug|0|||
131200985|NCT01836549|472355714|FG000|Overall Study|Patient declared ineligible|0|||
131200986|NCT01836549|472355715|FG001|Overall Study|Patient declared ineligible|0|||
131200987|NCT01836549|472355716|FG002|Overall Study|Patient declared ineligible|0|||
131200988|NCT01836549|472355717|FG003|Overall Study|Patient declared ineligible|1|||
131200989|NCT01836549|472355718|FG004|Overall Study|Patient declared ineligible|0|||
131200990|NCT01836549|472355719|FG005|Overall Study|Patient declared ineligible|0|||
131200991|NCT01836549|472355720|FG006|Overall Study|Patient declared ineligible|0|||
131200992|NCT01836549|472355714|FG000|Overall Study|Patient inevaluable to start therapy|0|||
131200993|NCT01836549|472355715|FG001|Overall Study|Patient inevaluable to start therapy|0|||
131200994|NCT01836549|472355716|FG002|Overall Study|Patient inevaluable to start therapy|0|||
131200995|NCT01836549|472355717|FG003|Overall Study|Patient inevaluable to start therapy|0|||
131200996|NCT01836549|472355718|FG004|Overall Study|Patient inevaluable to start therapy|0|||
131200997|NCT01836549|472355719|FG005|Overall Study|Patient inevaluable to start therapy|0|||
131200998|NCT01836549|472355720|FG006|Overall Study|Patient inevaluable to start therapy|1|||
131200999|NCT04652102|472355721|FG000|Overall Study|Adverse Event|14|||
131201000|NCT04652102|472355722|FG001|Overall Study|Adverse Event|13|||
131201001|NCT04652102|472355721|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
131201002|NCT04652102|472355722|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
131201003|NCT04652102|472355721|FG000|Overall Study|Physician Decision|78|||
131201004|NCT04652102|472355722|FG001|Overall Study|Physician Decision|40|||
131201005|NCT04652102|472355721|FG000|Overall Study|Study Ended by Sponsor|64|||
131201006|NCT04652102|472355722|FG001|Overall Study|Study Ended by Sponsor|17|||
131201007|NCT04652102|472355721|FG000|Overall Study|Withdrawal by Subject|4625|||
131201008|NCT04652102|472355722|FG001|Overall Study|Withdrawal by Subject|5594|||
131201009|NCT04652102|472355721|FG000|Overall Study|Lost to Follow-up|2019|||
131201010|NCT04652102|472355722|FG001|Overall Study|Lost to Follow-up|1082|||
131201011|NCT04652102|472355721|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
131201012|NCT04652102|472355722|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
131201013|NCT04652102|472355721|FG000|Overall Study|Miscellaneous|80|||
131201014|NCT04652102|472355722|FG001|Overall Study|Miscellaneous|64|||
131201015|NCT01969565|472355725|FG000|Overall Study|Withdrawal by Subject|1|||
131201016|NCT00696774|472355726|FG000|Period II|Adverse Event|0|||
131201017|NCT00696774|472355727|FG001|Period II|Adverse Event|0|||
131201018|NCT00696774|472355728|FG002|Period II|Adverse Event|15|||
131201019|NCT00696774|472355726|FG000|Period II|Lost to Follow-up|0|||
131201020|NCT00696774|472355727|FG001|Period II|Lost to Follow-up|0|||
131201021|NCT00696774|472355728|FG002|Period II|Lost to Follow-up|4|||
131201022|NCT00696774|472355726|FG000|Period II|Protocol Violation|0|||
131201023|NCT00696774|472355727|FG001|Period II|Protocol Violation|0|||
131201024|NCT00696774|472355728|FG002|Period II|Protocol Violation|11|||
131201025|NCT00696774|472355726|FG000|Period II|Withdrawal by Subject|0|||
131201026|NCT00696774|472355727|FG001|Period II|Withdrawal by Subject|0|||
131201027|NCT00696774|472355728|FG002|Period II|Withdrawal by Subject|4|||
131201028|NCT00696774|472355726|FG000|Period II|Sponsor Decision|0|||
131201029|NCT00696774|472355727|FG001|Period II|Sponsor Decision|0|||
131201030|NCT00696774|472355728|FG002|Period II|Sponsor Decision|0|||
131201031|NCT00696774|472355726|FG000|Period II|Lack of Efficacy|0|||
131201032|NCT00696774|472355727|FG001|Period II|Lack of Efficacy|0|||
131201033|NCT00696774|472355728|FG002|Period II|Lack of Efficacy|2|||
131201034|NCT00696774|472355726|FG000|Period III|Adverse Event|1|||
131201035|NCT00696774|472355727|FG001|Period III|Adverse Event|1|||
131201036|NCT00696774|472355728|FG002|Period III|Adverse Event|0|||
131201037|NCT00696774|472355726|FG000|Period III|Lost to Follow-up|2|||
131201038|NCT00696774|472355727|FG001|Period III|Lost to Follow-up|1|||
131201039|NCT00696774|472355728|FG002|Period III|Lost to Follow-up|0|||
131201040|NCT00696774|472355726|FG000|Period III|Protocol Violation|1|||
131201041|NCT00696774|472355727|FG001|Period III|Protocol Violation|1|||
131201042|NCT00696774|472355728|FG002|Period III|Protocol Violation|0|||
131201043|NCT00696774|472355726|FG000|Period III|Withdrawal by Subject|1|||
131201044|NCT00696774|472355727|FG001|Period III|Withdrawal by Subject|2|||
131201045|NCT00696774|472355728|FG002|Period III|Withdrawal by Subject|0|||
131201046|NCT00696774|472355726|FG000|Period III|Sponsor Decision|2|||
131201047|NCT00696774|472355727|FG001|Period III|Sponsor Decision|0|||
131201048|NCT00696774|472355728|FG002|Period III|Sponsor Decision|0|||
131201049|NCT00696774|472355726|FG000|Period III|Lack of Efficacy|0|||
131201050|NCT00696774|472355727|FG001|Period III|Lack of Efficacy|2|||
131201051|NCT00696774|472355728|FG002|Period III|Lack of Efficacy|0|||
131201052|NCT02442765|472355729|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
131201053|NCT02442765|472355730|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
131201054|NCT02442765|472355731|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
131201055|NCT02442765|472355732|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
131201056|NCT02442765|472355733|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
131201057|NCT02442765|472355734|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
131201058|NCT02442765|472355735|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
131201059|NCT02442765|472355736|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
131201060|NCT02442765|472355729|FG000|Stage 2- (Days 43 to 85)|Death|0|||
131201061|NCT02442765|472355730|FG001|Stage 2- (Days 43 to 85)|Death|0|||
131201062|NCT02442765|472355731|FG002|Stage 2- (Days 43 to 85)|Death|0|||
131201063|NCT02442765|472355732|FG003|Stage 2- (Days 43 to 85)|Death|1|||
131201064|NCT02442765|472355733|FG004|Stage 2- (Days 43 to 85)|Death|1|||
131201065|NCT02442765|472355734|FG005|Stage 2- (Days 43 to 85)|Death|0|||
131201066|NCT02442765|472355735|FG006|Stage 2- (Days 43 to 85)|Death|2|||
131201067|NCT02442765|472355736|FG007|Stage 2- (Days 43 to 85)|Death|0|||
131201068|NCT02442765|472355729|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131201069|NCT02442765|472355730|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131201070|NCT02442765|472355731|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131201071|NCT02442765|472355732|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
131201072|NCT02442765|472355733|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131201073|NCT02442765|472355734|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131201074|NCT02442765|472355735|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131201075|NCT02442765|472355736|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
131201076|NCT02442765|472355729|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131201077|NCT02442765|472355730|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131201078|NCT02442765|472355731|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131201079|NCT02442765|472355732|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
130784631|NCT00875810|470838851|FG000|Overall Study|Patient enroled but not implanted|2|||
131201080|NCT02442765|472355733|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131201081|NCT02442765|472355734|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131201082|NCT02442765|472355735|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131201083|NCT02442765|472355736|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
131201084|NCT02442765|472355729|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
131201085|NCT02442765|472355730|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
131201086|NCT02442765|472355731|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
131201087|NCT02442765|472355732|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
131201088|NCT02442765|472355733|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
131201089|NCT02442765|472355734|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
131201090|NCT02442765|472355735|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
131201091|NCT02442765|472355736|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
131201092|NCT02442765|472355729|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
131201093|NCT02442765|472355730|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
131201094|NCT02442765|472355731|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
131201095|NCT02442765|472355732|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
131201096|NCT02442765|472355733|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
131201097|NCT02442765|472355734|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
131201098|NCT02442765|472355735|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
131201099|NCT02442765|472355736|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
131201100|NCT02442765|472355729|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
131201101|NCT02442765|472355730|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
131201102|NCT02442765|472355731|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
131201103|NCT02442765|472355732|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
131201104|NCT02442765|472355733|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
131201105|NCT02442765|472355734|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
131201106|NCT02442765|472355735|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
131201107|NCT02442765|472355736|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
131201108|NCT02442765|472355729|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131201109|NCT02442765|472355730|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131201110|NCT02442765|472355731|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131201111|NCT02442765|472355732|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131201112|NCT02442765|472355733|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
131201113|NCT02442765|472355734|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131201114|NCT02442765|472355735|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
131201115|NCT02442765|472355736|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
131201116|NCT01200758|472355739|FG000|Stage I|Death|0|||
131201117|NCT01200758|472355740|FG001|Stage I|Death|1|||
131201118|NCT01200758|472355741|FG002|Stage I|Death|0|||
131201119|NCT01200758|472355742|FG003|Stage I|Death|0|||
131201120|NCT01200758|472355739|FG000|Stage I|Physician Decision|1|||
131201121|NCT01200758|472355740|FG001|Stage I|Physician Decision|1|||
131201122|NCT01200758|472355741|FG002|Stage I|Physician Decision|0|||
131201123|NCT01200758|472355742|FG003|Stage I|Physician Decision|0|||
131201124|NCT01200758|472355739|FG000|Stage I|Lack of Efficacy|2|||
131201125|NCT01200758|472355740|FG001|Stage I|Lack of Efficacy|1|||
131201126|NCT01200758|472355741|FG002|Stage I|Lack of Efficacy|0|||
131201127|NCT01200758|472355742|FG003|Stage I|Lack of Efficacy|0|||
131201128|NCT01200758|472355739|FG000|Stage I|Adverse Event|5|||
131201129|NCT01200758|472355740|FG001|Stage I|Adverse Event|5|||
131201130|NCT01200758|472355741|FG002|Stage I|Adverse Event|0|||
131201131|NCT01200758|472355742|FG003|Stage I|Adverse Event|0|||
131201132|NCT01200758|472355739|FG000|Stage I|Withdrawal by Subject|1|||
131201133|NCT01200758|472355740|FG001|Stage I|Withdrawal by Subject|2|||
131201134|NCT01200758|472355741|FG002|Stage I|Withdrawal by Subject|0|||
131201135|NCT01200758|472355742|FG003|Stage I|Withdrawal by Subject|0|||
131201136|NCT01200758|472355739|FG000|Stage I|Disease Progression|9|||
131201137|NCT01200758|472355740|FG001|Stage I|Disease Progression|7|||
131201138|NCT01200758|472355741|FG002|Stage I|Disease Progression|0|||
131201139|NCT01200758|472355742|FG003|Stage I|Disease Progression|0|||
131201140|NCT01200758|472355739|FG000|Stage 2|Disease Progression|0|||
131201141|NCT01200758|472355740|FG001|Stage 2|Disease Progression|0|||
131201142|NCT01200758|472355741|FG002|Stage 2|Disease Progression|16|||
131201143|NCT01200758|472355742|FG003|Stage 2|Disease Progression|21|||
131201144|NCT01200758|472355739|FG000|Stage 2|Lack of Efficacy|0|||
131201145|NCT01200758|472355740|FG001|Stage 2|Lack of Efficacy|0|||
131201146|NCT01200758|472355741|FG002|Stage 2|Lack of Efficacy|4|||
131201147|NCT01200758|472355742|FG003|Stage 2|Lack of Efficacy|2|||
131201148|NCT01200758|472355739|FG000|Stage 2|Physician Decision|0|||
131201149|NCT01200758|472355740|FG001|Stage 2|Physician Decision|0|||
131201150|NCT01200758|472355741|FG002|Stage 2|Physician Decision|5|||
131201151|NCT01200758|472355742|FG003|Stage 2|Physician Decision|7|||
131201152|NCT01200758|472355739|FG000|Stage 2|Adverse Event|0|||
131201153|NCT01200758|472355740|FG001|Stage 2|Adverse Event|0|||
131201154|NCT01200758|472355741|FG002|Stage 2|Adverse Event|5|||
131201155|NCT01200758|472355742|FG003|Stage 2|Adverse Event|9|||
131201156|NCT01200758|472355739|FG000|Stage 2|Withdrawal by Subject|0|||
131201157|NCT01200758|472355740|FG001|Stage 2|Withdrawal by Subject|0|||
131201158|NCT01200758|472355741|FG002|Stage 2|Withdrawal by Subject|4|||
131201159|NCT01200758|472355742|FG003|Stage 2|Withdrawal by Subject|1|||
131201160|NCT01200758|472355739|FG000|Stage 2|Lost to Follow-up|0|||
131201161|NCT01200758|472355740|FG001|Stage 2|Lost to Follow-up|0|||
131201162|NCT01200758|472355741|FG002|Stage 2|Lost to Follow-up|3|||
131201163|NCT01200758|472355742|FG003|Stage 2|Lost to Follow-up|1|||
131201164|NCT01200758|472355739|FG000|Stage 2|Protocol Violation|0|||
131201165|NCT01200758|472355740|FG001|Stage 2|Protocol Violation|0|||
131201166|NCT01200758|472355741|FG002|Stage 2|Protocol Violation|1|||
131201167|NCT01200758|472355742|FG003|Stage 2|Protocol Violation|4|||
131201168|NCT01200758|472355739|FG000|Stage 2|Death|0|||
131201169|NCT01200758|472355740|FG001|Stage 2|Death|0|||
131201170|NCT01200758|472355741|FG002|Stage 2|Death|3|||
131201171|NCT01200758|472355742|FG003|Stage 2|Death|5|||
131201172|NCT00545584|472355743|FG000|Overall Study|Only one reason for discontinuation|62|||
131201173|NCT00545584|472355744|FG001|Overall Study|Only one reason for discontinuation|61|||
131201174|NCT00545584|472355745|FG002|Overall Study|Only one reason for discontinuation|48|||
131201175|NCT00545584|472355743|FG000|Overall Study|Two or more reasons for discontinuation|17|||
131201176|NCT00545584|472355744|FG001|Overall Study|Two or more reasons for discontinuation|19|||
131201177|NCT00545584|472355745|FG002|Overall Study|Two or more reasons for discontinuation|8|||
131201178|NCT03525613|472355748|FG000|Overall Study|Adverse Event|11|||
131201179|NCT03525613|472355749|FG001|Overall Study|Adverse Event|8|||
131201180|NCT03525613|472355750|FG002|Overall Study|Adverse Event|3|||
131201181|NCT03525613|472355751|FG003|Overall Study|Adverse Event|3|||
131201182|NCT03525613|472355748|FG000|Overall Study|Lost to Follow-up|4|||
131201183|NCT03525613|472355749|FG001|Overall Study|Lost to Follow-up|5|||
131201184|NCT03525613|472355750|FG002|Overall Study|Lost to Follow-up|3|||
131201185|NCT03525613|472355751|FG003|Overall Study|Lost to Follow-up|2|||
131201186|NCT03525613|472355748|FG000|Overall Study|Physician Decision|0|||
131201187|NCT03525613|472355749|FG001|Overall Study|Physician Decision|1|||
131201188|NCT03525613|472355750|FG002|Overall Study|Physician Decision|0|||
131201189|NCT03525613|472355751|FG003|Overall Study|Physician Decision|1|||
131201190|NCT03525613|472355748|FG000|Overall Study|Consent Withdrawal|25|||
131201191|NCT03525613|472355749|FG001|Overall Study|Consent Withdrawal|16|||
130733826|NCT04856917|470645282|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
130784632|NCT00875810|470838851|FG000|Overall Study|Device explanted|1|||
131201192|NCT03525613|472355750|FG002|Overall Study|Consent Withdrawal|12|||
131201193|NCT03525613|472355751|FG003|Overall Study|Consent Withdrawal|9|||
131201194|NCT03525613|472355748|FG000|Overall Study|Death|20|||
131201195|NCT03525613|472355749|FG001|Overall Study|Death|9|||
131201196|NCT03525613|472355750|FG002|Overall Study|Death|7|||
131201197|NCT03525613|472355751|FG003|Overall Study|Death|1|||
131201198|NCT03525613|472355748|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
131201199|NCT03525613|472355749|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
131201200|NCT03525613|472355750|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
131201201|NCT03525613|472355751|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
131201202|NCT02584660|472355752|FG000|Overall Study|Adverse Event|4|||
131201203|NCT02584660|472355753|FG001|Overall Study|Adverse Event|0|||
131201204|NCT02584660|472355752|FG000|Overall Study|Lost to Follow-up|3|||
131201205|NCT02584660|472355753|FG001|Overall Study|Lost to Follow-up|4|||
131201206|NCT02584660|472355752|FG000|Overall Study|Protocol Violation|0|||
131201207|NCT02584660|472355753|FG001|Overall Study|Protocol Violation|1|||
131201208|NCT02584660|472355752|FG000|Overall Study|Withdrawal by Subject|0|||
131201209|NCT02584660|472355753|FG001|Overall Study|Withdrawal by Subject|2|||
131201210|NCT02584660|472355752|FG000|Overall Study|Other|0|||
131201211|NCT02584660|472355753|FG001|Overall Study|Other|1|||
131201212|NCT00461552|472355754|FG000|Overall Study|Drug Dispensing error|0|||
131201213|NCT00461552|472355755|FG001|Overall Study|Drug Dispensing error|2|||
131201214|NCT00523744|472355756|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
131201215|NCT00523744|472355756|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
131201216|NCT00523744|472355756|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
131201217|NCT00523744|472355756|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
131201218|NCT00523744|472355756|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
131201219|NCT00523744|472355756|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
131201220|NCT03099304|472355759|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
131201221|NCT03099304|472355760|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
131201222|NCT03099304|472355761|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
131201223|NCT03099304|472355762|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
131201224|NCT03099304|472355763|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
131201225|NCT03099304|472355764|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
131201226|NCT03099304|472355759|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
131201227|NCT03099304|472355760|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
131201228|NCT03099304|472355761|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
131201229|NCT03099304|472355762|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
131201230|NCT03099304|472355763|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
131201231|NCT03099304|472355764|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
131201232|NCT03099304|472355759|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
131201233|NCT03099304|472355760|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
131201234|NCT03099304|472355761|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
131201235|NCT03099304|472355762|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
131201236|NCT03099304|472355763|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
131201237|NCT03099304|472355764|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
131201238|NCT03099304|472355759|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
131201239|NCT03099304|472355760|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
131201240|NCT03099304|472355761|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
131201241|NCT03099304|472355762|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
131201242|NCT03099304|472355763|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
131201243|NCT03099304|472355764|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
131201244|NCT03099304|472355759|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
131201245|NCT03099304|472355760|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
131201246|NCT03099304|472355761|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
131201247|NCT03099304|472355762|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
131201248|NCT03099304|472355763|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
131201249|NCT03099304|472355764|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
131201250|NCT03099304|472355759|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
131201251|NCT03099304|472355760|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
131201252|NCT03099304|472355761|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
131201253|NCT03099304|472355762|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
131201254|NCT03099304|472355763|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
131201255|NCT03099304|472355764|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
131201256|NCT03099304|472355759|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
131201257|NCT03099304|472355760|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
131201258|NCT03099304|472355761|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
131201259|NCT03099304|472355762|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
131201260|NCT03099304|472355763|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
131201261|NCT03099304|472355764|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
131201262|NCT03099304|472355759|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
131201263|NCT03099304|472355760|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
131201264|NCT03099304|472355761|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
131201265|NCT03099304|472355762|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
131201266|NCT03099304|472355763|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
131201267|NCT03099304|472355764|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
131201268|NCT03099304|472355759|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
131201269|NCT03099304|472355760|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
131201270|NCT03099304|472355761|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
131201271|NCT03099304|472355762|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
131201272|NCT03099304|472355763|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
131201273|NCT03099304|472355764|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
131201274|NCT03099304|472355759|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
131201275|NCT03099304|472355760|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
131201276|NCT03099304|472355761|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
131201277|NCT03099304|472355762|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
131201278|NCT03099304|472355763|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
131201279|NCT03099304|472355764|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
130733827|NCT04856917|470645283|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
130733828|NCT04856917|470645284|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
130733829|NCT04856917|470645282|FG000|Overall Study|Other|1|||
130733830|NCT04856917|470645283|FG001|Overall Study|Other|1|||
130733831|NCT04856917|470645284|FG002|Overall Study|Other|0|||
130733832|NCT03560037|470645285|FG000|Overall Study|Protocol Violation|1|||
131201280|NCT03099304|472355759|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
131201281|NCT03099304|472355760|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
131201282|NCT03099304|472355761|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
131201283|NCT03099304|472355762|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
131201284|NCT03099304|472355763|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
131201285|NCT03099304|472355764|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
131201286|NCT03099304|472355759|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
131201287|NCT03099304|472355760|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
131201288|NCT03099304|472355761|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
131201289|NCT03099304|472355762|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
131201290|NCT03099304|472355763|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
131201291|NCT03099304|472355764|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
131201292|NCT03099304|472355759|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
131201293|NCT03099304|472355760|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
131201294|NCT03099304|472355761|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
131201295|NCT03099304|472355762|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
131201296|NCT03099304|472355763|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
131201297|NCT03099304|472355764|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
131201298|NCT03099304|472355759|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
131201299|NCT03099304|472355760|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
131201300|NCT03099304|472355761|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
131201301|NCT03099304|472355762|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
131201302|NCT03099304|472355763|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
131201303|NCT03099304|472355764|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
130733833|NCT03560037|470645286|FG001|Overall Study|Protocol Violation|0|||
131201304|NCT03099304|472355759|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
131201305|NCT03099304|472355760|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
131201306|NCT03099304|472355761|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
130733834|NCT03560037|470645285|FG000|Overall Study|Physician Decision|0|||
131201307|NCT03099304|472355762|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
131201308|NCT03099304|472355763|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
131201309|NCT03099304|472355764|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
131201310|NCT03099304|472355759|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
131201311|NCT03099304|472355760|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
131201312|NCT03099304|472355761|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
131201313|NCT03099304|472355762|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
131201314|NCT03099304|472355763|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
131201315|NCT03099304|472355764|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
131201316|NCT03099304|472355759|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
131201317|NCT03099304|472355760|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
131201318|NCT03099304|472355761|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
131201319|NCT03099304|472355762|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
131201320|NCT03099304|472355763|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
131201321|NCT03099304|472355764|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
131201322|NCT00715949|472355768|FG000|Overall Study|could not finish first test|4|||
131201323|NCT00957723|472355771|FG000|Overall Study|Death|3|||
131201324|NCT00957723|472355771|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
131201325|NCT00957723|472355771|FG000|Overall Study|Lost to Follow-up|8|||
131201326|NCT00957723|472355771|FG000|Overall Study|Withdrawal by Subject|24|||
131201327|NCT00957723|472355771|FG000|Overall Study|Investigative Site Terminated|61|||
131201328|NCT00957723|472355771|FG000|Overall Study|Intercurrent Illness|2|||
131201329|NCT00957723|472355771|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
131201330|NCT01984294|472355774|FG000|Overall Study|Randomized but Never Treated|0|||
131201331|NCT01984294|472355775|FG001|Overall Study|Randomized but Never Treated|0|||
131201332|NCT01984294|472355776|FG002|Overall Study|Randomized but Never Treated|1|||
131201333|NCT01984294|472355774|FG000|Overall Study|Lack of Efficacy|4|||
131201334|NCT01984294|472355775|FG001|Overall Study|Lack of Efficacy|2|||
131201335|NCT01984294|472355776|FG002|Overall Study|Lack of Efficacy|6|||
131201336|NCT01984294|472355774|FG000|Overall Study|Adverse Event|0|||
131201337|NCT01984294|472355775|FG001|Overall Study|Adverse Event|1|||
131201338|NCT01984294|472355776|FG002|Overall Study|Adverse Event|0|||
131201339|NCT01987609|472355777|FG000|Overall Study|Adverse Event|1|||
131201340|NCT02709889|472355778|FG000|Overall Study|Withdrawal by Subject|11|||
131201341|NCT02709889|472355779|FG001|Overall Study|Withdrawal by Subject|10|||
131201342|NCT02709889|472355780|FG002|Overall Study|Withdrawal by Subject|2|||
131201343|NCT02709889|472355781|FG003|Overall Study|Withdrawal by Subject|12|||
131201344|NCT02709889|472355778|FG000|Overall Study|Death|25|||
131201345|NCT02709889|472355779|FG001|Overall Study|Death|38|||
131201346|NCT02709889|472355780|FG002|Overall Study|Death|4|||
131201347|NCT02709889|472355781|FG003|Overall Study|Death|44|||
131201348|NCT02709889|472355778|FG000|Overall Study|Physician Decision|1|||
131201349|NCT02709889|472355779|FG001|Overall Study|Physician Decision|2|||
131201350|NCT02709889|472355780|FG002|Overall Study|Physician Decision|3|||
131201351|NCT02709889|472355781|FG003|Overall Study|Physician Decision|5|||
131201352|NCT02709889|472355778|FG000|Overall Study|Lost to Follow-up|2|||
131201353|NCT02709889|472355779|FG001|Overall Study|Lost to Follow-up|0|||
131201354|NCT02709889|472355780|FG002|Overall Study|Lost to Follow-up|0|||
131201355|NCT02709889|472355781|FG003|Overall Study|Lost to Follow-up|4|||
131201356|NCT02709889|472355778|FG000|Overall Study|Study Terminated by Sponsor|4|||
131201357|NCT02709889|472355779|FG001|Overall Study|Study Terminated by Sponsor|6|||
131201358|NCT02709889|472355780|FG002|Overall Study|Study Terminated by Sponsor|2|||
131201359|NCT02709889|472355781|FG003|Overall Study|Study Terminated by Sponsor|17|||
131201360|NCT02709889|472355778|FG000|Overall Study|Other, Not Specified|0|||
131201361|NCT02709889|472355779|FG001|Overall Study|Other, Not Specified|1|||
131201362|NCT02709889|472355780|FG002|Overall Study|Other, Not Specified|1|||
131201363|NCT02709889|472355781|FG003|Overall Study|Other, Not Specified|6|||
131201364|NCT01066546|472355782|FG000|Overall Study|Study terminated by sponsor|5|||
131201365|NCT00925522|472355787|FG000|Overall Study|study closed -- business decision|20|||
131201366|NCT02561572|472355788|FG000|Overall Study|Inadequate time before surgery|2|||
131201367|NCT02561572|472355789|FG001|Overall Study|Inadequate time before surgery|1|||
131201368|NCT02561572|472355788|FG000|Overall Study|Protocol Violation|0|||
131201369|NCT02561572|472355789|FG001|Overall Study|Protocol Violation|1|||
131201370|NCT00795717|472355790|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
131201371|NCT00795717|472355791|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
131201372|NCT00795717|472355790|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
131201373|NCT00795717|472355791|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
131201374|NCT00795717|472355790|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
131201375|NCT00795717|472355791|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
131201376|NCT00795717|472355790|FG000|Phase II|too busy|0|||
131201377|NCT00795717|472355791|FG001|Phase II|too busy|1|||
131201378|NCT00656799|472355794|FG000|Overall Study|Death|2|||
131201379|NCT05315297|472355795|FG000|Overall Study|Lost to Follow-up|6|||
131201380|NCT05315297|472355796|FG001|Overall Study|Lost to Follow-up|4|||
131201381|NCT05315297|472355795|FG000|Overall Study|Withdrawal by Subject|0|||
131201382|NCT05315297|472355796|FG001|Overall Study|Withdrawal by Subject|1|||
131201383|NCT00669240|472358120|FG000|Overall Study|Lack of Efficacy|33|||
131201384|NCT00669240|472358120|FG000|Overall Study|Withdrawal by Subject|42|||
131201385|NCT00669240|472358120|FG000|Overall Study|Lost to Follow-up|34|||
131201386|NCT00669240|472358120|FG000|Overall Study|Adverse Event|21|||
131201387|NCT00669240|472358120|FG000|Overall Study|Other|19|||
131201388|NCT00669240|472358120|FG000|Overall Study|Enrolled but not treated|15|||
131201389|NCT00669240|472358120|FG000|Overall Study|Enrolled but no dosing record|1|||
131201390|NCT00959192|472358125|FG000|Overall Study|Adverse Event|1|||
131201391|NCT00959192|472358126|FG001|Overall Study|Adverse Event|1|||
131201392|NCT00959192|472358127|FG002|Overall Study|Adverse Event|1|||
131201393|NCT00959192|472358128|FG003|Overall Study|Adverse Event|0|||
131201394|NCT00959192|472358125|FG000|Overall Study|Investigator Request|1|||
131201395|NCT00959192|472358126|FG001|Overall Study|Investigator Request|0|||
131201396|NCT00959192|472358127|FG002|Overall Study|Investigator Request|0|||
131201397|NCT00959192|472358128|FG003|Overall Study|Investigator Request|0|||
131201398|NCT00959192|472358125|FG000|Overall Study|Caregiver Request|0|||
131201399|NCT00959192|472358126|FG001|Overall Study|Caregiver Request|0|||
131201400|NCT00959192|472358127|FG002|Overall Study|Caregiver Request|2|||
131201401|NCT00959192|472358128|FG003|Overall Study|Caregiver Request|1|||
131201402|NCT00532441|472358129|FG000|Overall Study|Death|1|||
131201403|NCT00532441|472358130|FG001|Overall Study|Death|0|||
131201404|NCT01967134|472358131|FG000|Overall Study|Lost to Follow-up|0|||
131201405|NCT01967134|472358132|FG001|Overall Study|Lost to Follow-up|1|||
131201406|NCT01967134|472358133|FG002|Overall Study|Lost to Follow-up|0|||
131201407|NCT00443534|472358134|FG000|Overall Study|Lack of Efficacy|67|||
131201408|NCT00443534|472358134|FG000|Overall Study|Adverse Event|16|||
131201409|NCT00443534|472358134|FG000|Overall Study|Death|9|||
131201410|NCT00443534|472358134|FG000|Overall Study|Withdrawal by Subject|8|||
131201411|NCT00443534|472358134|FG000|Overall Study|Study Terminated by Sponsor|12|||
131201412|NCT00443534|472358134|FG000|Overall Study|Other|10|||
131201413|NCT00443534|472358134|FG000|Overall Study|Enrolled, Not Treated|1|||
131201414|NCT04097925|472358136|FG000|Overall Study|Withdrawal by Subject|1|||
131201415|NCT04735432|472358140|FG000|Overall Study|Other - due to personal reason|1|||
131201416|NCT04735432|472358141|FG001|Overall Study|Other - due to personal reason|0|||
131201417|NCT04735432|472358140|FG000|Overall Study|Adverse Event|2|||
131201418|NCT04735432|472358141|FG001|Overall Study|Adverse Event|0|||
131201419|NCT00626327|472358142|FG000|Overall Study|Withdrawal by Subject|21|||
131201420|NCT00626327|472358143|FG001|Overall Study|Withdrawal by Subject|29|||
131201421|NCT00626327|472358144|FG002|Overall Study|Withdrawal by Subject|30|||
131201422|NCT00626327|472358142|FG000|Overall Study|Adverse Event|1|||
131201423|NCT00626327|472358143|FG001|Overall Study|Adverse Event|0|||
131201424|NCT00626327|472358144|FG002|Overall Study|Adverse Event|0|||
131201425|NCT00626327|472358142|FG000|Overall Study|Lost to Follow-up|24|||
131201426|NCT00626327|472358143|FG001|Overall Study|Lost to Follow-up|21|||
131201427|NCT00626327|472358144|FG002|Overall Study|Lost to Follow-up|23|||
131201428|NCT00626327|472358142|FG000|Overall Study|Inappropriate enrollment|4|||
131201429|NCT00626327|472358143|FG001|Overall Study|Inappropriate enrollment|5|||
131201430|NCT00626327|472358144|FG002|Overall Study|Inappropriate enrollment|3|||
131201431|NCT00626327|472358142|FG000|Overall Study|Administrative Reason|2|||
131201432|NCT00626327|472358143|FG001|Overall Study|Administrative Reason|0|||
131201433|NCT00626327|472358144|FG002|Overall Study|Administrative Reason|6|||
131201434|NCT00626327|472358142|FG000|Overall Study|Protocol Violation|26|||
131201435|NCT00626327|472358143|FG001|Overall Study|Protocol Violation|4|||
131201436|NCT00626327|472358144|FG002|Overall Study|Protocol Violation|26|||
131201437|NCT01823991|472358145|FG000|Overall Study|Withdrawal by Subject|8|||
131201438|NCT01823991|472358146|FG001|Overall Study|Withdrawal by Subject|5|||
131201439|NCT05158244|472358147|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
131201440|NCT05158244|472358148|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
131201441|NCT05158244|472358149|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
131201442|NCT05158244|472358150|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
131201443|NCT05158244|472358151|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
131201444|NCT05158244|472358147|FG000|Overall Study|Withdrawal by Subject|0|||
130733835|NCT03560037|470645286|FG001|Overall Study|Physician Decision|1|||
131201445|NCT05158244|472358148|FG001|Overall Study|Withdrawal by Subject|0|||
131201446|NCT05158244|472358149|FG002|Overall Study|Withdrawal by Subject|1|||
131201447|NCT05158244|472358150|FG003|Overall Study|Withdrawal by Subject|0|||
131201448|NCT05158244|472358151|FG004|Overall Study|Withdrawal by Subject|0|||
131201449|NCT01066819|472358152|FG000|Overall Study|Adverse Event|18|||
131201450|NCT01066819|472358153|FG001|Overall Study|Adverse Event|1|||
131201451|NCT01066819|472358154|FG002|Overall Study|Adverse Event|6|||
131201452|NCT01066819|472358155|FG003|Overall Study|Adverse Event|0|||
131201453|NCT01066819|472358156|FG004|Overall Study|Adverse Event|0|||
131201454|NCT01066819|472358157|FG005|Overall Study|Adverse Event|0|||
131201455|NCT01066819|472358152|FG000|Overall Study|Death|5|||
131201456|NCT01066819|472358153|FG001|Overall Study|Death|0|||
131201457|NCT01066819|472358154|FG002|Overall Study|Death|1|||
130733836|NCT03816878|470645289|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
130733837|NCT03816878|470645290|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
130733838|NCT03816878|470645289|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
130733839|NCT03816878|470645290|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
130733840|NCT03355469|470645291|FG000|Overall Study|COVID-19|3|||
130733841|NCT03355469|470645292|FG001|Overall Study|COVID-19|2|||
130733842|NCT03355469|470645293|FG002|Overall Study|COVID-19|3|||
131201458|NCT01066819|472358155|FG003|Overall Study|Death|0|||
131201459|NCT01066819|472358156|FG004|Overall Study|Death|0|||
131201460|NCT01066819|472358157|FG005|Overall Study|Death|0|||
131201461|NCT01066819|472358152|FG000|Overall Study|Lack of Efficacy|22|||
131201462|NCT01066819|472358153|FG001|Overall Study|Lack of Efficacy|1|||
131201463|NCT01066819|472358154|FG002|Overall Study|Lack of Efficacy|2|||
131201464|NCT01066819|472358155|FG003|Overall Study|Lack of Efficacy|1|||
131201465|NCT01066819|472358156|FG004|Overall Study|Lack of Efficacy|0|||
131201466|NCT01066819|472358157|FG005|Overall Study|Lack of Efficacy|0|||
131201467|NCT01066819|472358152|FG000|Overall Study|Physician Decision|6|||
131201468|NCT01066819|472358153|FG001|Overall Study|Physician Decision|2|||
131201469|NCT01066819|472358154|FG002|Overall Study|Physician Decision|3|||
131201470|NCT01066819|472358155|FG003|Overall Study|Physician Decision|0|||
131201471|NCT01066819|472358156|FG004|Overall Study|Physician Decision|0|||
131201472|NCT01066819|472358157|FG005|Overall Study|Physician Decision|0|||
131201473|NCT01066819|472358152|FG000|Overall Study|Protocol Violation|12|||
131201474|NCT01066819|472358153|FG001|Overall Study|Protocol Violation|6|||
131201475|NCT01066819|472358154|FG002|Overall Study|Protocol Violation|0|||
131201476|NCT01066819|472358155|FG003|Overall Study|Protocol Violation|0|||
131201477|NCT01066819|472358156|FG004|Overall Study|Protocol Violation|0|||
131201478|NCT01066819|472358157|FG005|Overall Study|Protocol Violation|0|||
131201479|NCT01066819|472358152|FG000|Overall Study|Withdrawal by Subject|29|||
131201480|NCT01066819|472358153|FG001|Overall Study|Withdrawal by Subject|11|||
131201481|NCT01066819|472358154|FG002|Overall Study|Withdrawal by Subject|6|||
131201482|NCT01066819|472358155|FG003|Overall Study|Withdrawal by Subject|0|||
131201483|NCT01066819|472358156|FG004|Overall Study|Withdrawal by Subject|0|||
131201484|NCT01066819|472358157|FG005|Overall Study|Withdrawal by Subject|0|||
131201485|NCT01066819|472358152|FG000|Overall Study|Administrative|6|||
131201486|NCT01066819|472358153|FG001|Overall Study|Administrative|4|||
131201487|NCT01066819|472358154|FG002|Overall Study|Administrative|2|||
131201488|NCT01066819|472358155|FG003|Overall Study|Administrative|0|||
131201489|NCT01066819|472358156|FG004|Overall Study|Administrative|0|||
131201490|NCT01066819|472358157|FG005|Overall Study|Administrative|0|||
131201491|NCT01066819|472358152|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
131201492|NCT01066819|472358153|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
131201493|NCT01066819|472358154|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
131201494|NCT01066819|472358155|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
131201495|NCT01066819|472358156|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
131201496|NCT01066819|472358157|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
131201497|NCT01066819|472358152|FG000|Overall Study|Early termination|2|||
131201498|NCT01066819|472358153|FG001|Overall Study|Early termination|0|||
131201499|NCT01066819|472358154|FG002|Overall Study|Early termination|0|||
131201500|NCT01066819|472358155|FG003|Overall Study|Early termination|0|||
131201501|NCT01066819|472358156|FG004|Overall Study|Early termination|0|||
131201502|NCT01066819|472358157|FG005|Overall Study|Early termination|0|||
131201503|NCT01066819|472358152|FG000|Overall Study|Failed to return|298|||
131201504|NCT01066819|472358153|FG001|Overall Study|Failed to return|107|||
131201505|NCT01066819|472358154|FG002|Overall Study|Failed to return|68|||
131201506|NCT01066819|472358155|FG003|Overall Study|Failed to return|7|||
131201507|NCT01066819|472358156|FG004|Overall Study|Failed to return|2|||
131201508|NCT01066819|472358157|FG005|Overall Study|Failed to return|3|||
131201509|NCT01066819|472358152|FG000|Overall Study|Lab test not done|9|||
131201510|NCT01066819|472358153|FG001|Overall Study|Lab test not done|0|||
131201511|NCT01066819|472358154|FG002|Overall Study|Lab test not done|2|||
131201512|NCT01066819|472358155|FG003|Overall Study|Lab test not done|1|||
131201513|NCT01066819|472358156|FG004|Overall Study|Lab test not done|0|||
131201514|NCT01066819|472358157|FG005|Overall Study|Lab test not done|0|||
131201515|NCT01066819|472358152|FG000|Overall Study|Miscellaneous|28|||
131201516|NCT01066819|472358153|FG001|Overall Study|Miscellaneous|10|||
131201517|NCT01066819|472358154|FG002|Overall Study|Miscellaneous|18|||
131201518|NCT01066819|472358155|FG003|Overall Study|Miscellaneous|1|||
131201519|NCT01066819|472358156|FG004|Overall Study|Miscellaneous|0|||
131201520|NCT01066819|472358157|FG005|Overall Study|Miscellaneous|0|||
131201521|NCT01066819|472358152|FG000|Overall Study|Non responders|123|||
131201522|NCT01066819|472358153|FG001|Overall Study|Non responders|2|||
131201523|NCT01066819|472358154|FG002|Overall Study|Non responders|7|||
131201524|NCT01066819|472358155|FG003|Overall Study|Non responders|2|||
131201525|NCT01066819|472358156|FG004|Overall Study|Non responders|0|||
131201526|NCT01066819|472358157|FG005|Overall Study|Non responders|1|||
130733843|NCT03355469|470645294|FG003|Overall Study|COVID-19|3|||
131201527|NCT01066819|472358152|FG000|Overall Study|Not categorised|9|||
131201528|NCT01066819|472358153|FG001|Overall Study|Not categorised|2|||
131201529|NCT01066819|472358154|FG002|Overall Study|Not categorised|6|||
131201530|NCT01066819|472358155|FG003|Overall Study|Not categorised|1|||
131201531|NCT01066819|472358156|FG004|Overall Study|Not categorised|0|||
131201532|NCT01066819|472358157|FG005|Overall Study|Not categorised|0|||
131201533|NCT01066819|472358152|FG000|Overall Study|Relapse|16|||
131201534|NCT01066819|472358153|FG001|Overall Study|Relapse|4|||
131201535|NCT01066819|472358154|FG002|Overall Study|Relapse|3|||
131201536|NCT01066819|472358155|FG003|Overall Study|Relapse|0|||
131201537|NCT01066819|472358156|FG004|Overall Study|Relapse|0|||
131201538|NCT01066819|472358157|FG005|Overall Study|Relapse|0|||
131201539|NCT01066819|472358152|FG000|Overall Study|Results not available|1|||
131201540|NCT01066819|472358153|FG001|Overall Study|Results not available|0|||
131201541|NCT01066819|472358154|FG002|Overall Study|Results not available|0|||
131201542|NCT01066819|472358155|FG003|Overall Study|Results not available|0|||
131201543|NCT01066819|472358156|FG004|Overall Study|Results not available|0|||
131201544|NCT01066819|472358157|FG005|Overall Study|Results not available|0|||
131201545|NCT01066819|472358152|FG000|Overall Study|Screen failure|1|||
131201546|NCT01066819|472358153|FG001|Overall Study|Screen failure|0|||
131201547|NCT01066819|472358154|FG002|Overall Study|Screen failure|0|||
131201548|NCT01066819|472358155|FG003|Overall Study|Screen failure|0|||
131201549|NCT01066819|472358156|FG004|Overall Study|Screen failure|0|||
131201550|NCT01066819|472358157|FG005|Overall Study|Screen failure|0|||
131201551|NCT01066819|472358152|FG000|Overall Study|Spontaneous cure|1|||
131201552|NCT01066819|472358153|FG001|Overall Study|Spontaneous cure|0|||
131201553|NCT01066819|472358154|FG002|Overall Study|Spontaneous cure|0|||
131201554|NCT01066819|472358155|FG003|Overall Study|Spontaneous cure|0|||
131201555|NCT01066819|472358156|FG004|Overall Study|Spontaneous cure|0|||
131201556|NCT01066819|472358157|FG005|Overall Study|Spontaneous cure|0|||
131201557|NCT01066819|472358152|FG000|Overall Study|Treatment never started|85|||
131201558|NCT01066819|472358153|FG001|Overall Study|Treatment never started|19|||
131201559|NCT01066819|472358154|FG002|Overall Study|Treatment never started|19|||
131201560|NCT01066819|472358155|FG003|Overall Study|Treatment never started|3|||
131201561|NCT01066819|472358156|FG004|Overall Study|Treatment never started|2|||
131201562|NCT01066819|472358157|FG005|Overall Study|Treatment never started|2|||
131201563|NCT01066819|472358152|FG000|Overall Study|Treatment stopped|12|||
131201564|NCT01066819|472358153|FG001|Overall Study|Treatment stopped|1|||
131201565|NCT01066819|472358154|FG002|Overall Study|Treatment stopped|2|||
131201566|NCT01066819|472358155|FG003|Overall Study|Treatment stopped|1|||
131201567|NCT01066819|472358156|FG004|Overall Study|Treatment stopped|0|||
131201568|NCT01066819|472358157|FG005|Overall Study|Treatment stopped|0|||
131201569|NCT01066819|472358152|FG000|Overall Study|Other|5|||
131201570|NCT01066819|472358153|FG001|Overall Study|Other|1|||
131201571|NCT01066819|472358154|FG002|Overall Study|Other|1|||
131201572|NCT01066819|472358155|FG003|Overall Study|Other|0|||
131201573|NCT01066819|472358156|FG004|Overall Study|Other|0|||
131201574|NCT01066819|472358157|FG005|Overall Study|Other|0|||
131201575|NCT02807376|472358158|FG000|Overall Study|Intra-operative exclusion criteria|3|||
131201576|NCT02807376|472358159|FG001|Overall Study|Intra-operative exclusion criteria|0|||
131201577|NCT02807376|472358158|FG000|Overall Study|Lost to Follow-up|0|||
131201578|NCT02807376|472358159|FG001|Overall Study|Lost to Follow-up|1|||
131201579|NCT00808028|472358160|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
131201580|NCT00808028|472358161|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
131201581|NCT00808028|472358162|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
131201582|NCT00808028|472358163|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
131201583|NCT00808028|472358160|FG000|Stage 1 (6 Months)|Other|1|||
131201584|NCT00808028|472358161|FG001|Stage 1 (6 Months)|Other|0|||
131201585|NCT00808028|472358162|FG002|Stage 1 (6 Months)|Other|2|||
131201586|NCT00808028|472358163|FG003|Stage 1 (6 Months)|Other|4|||
131201587|NCT00808028|472358160|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
131201588|NCT00808028|472358161|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
131201589|NCT00808028|472358162|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
131201590|NCT00808028|472358163|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
131201591|NCT00808028|472358160|FG000|Stage 1 (6 Months)|Adverse Event|0|||
131201592|NCT00808028|472358161|FG001|Stage 1 (6 Months)|Adverse Event|0|||
131201593|NCT00808028|472358162|FG002|Stage 1 (6 Months)|Adverse Event|1|||
131201594|NCT00808028|472358163|FG003|Stage 1 (6 Months)|Adverse Event|2|||
131201595|NCT00808028|472358160|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
131201596|NCT00808028|472358161|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
131201597|NCT00808028|472358162|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
131201598|NCT00808028|472358163|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
131201599|NCT00808028|472358160|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
131201600|NCT00808028|472358161|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
131201601|NCT00808028|472358162|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
131201602|NCT00808028|472358163|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
131201603|NCT00808028|472358160|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
131201604|NCT00808028|472358161|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
131201605|NCT00808028|472358162|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
131201606|NCT00808028|472358163|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
131201607|NCT00808028|472358160|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
131201608|NCT00808028|472358161|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
131201609|NCT00808028|472358162|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
131201610|NCT00808028|472358163|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
131201611|NCT00808028|472358160|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
131201612|NCT00808028|472358161|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
131201613|NCT00808028|472358162|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
131201614|NCT00808028|472358163|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
131201615|NCT00808028|472358160|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
131201616|NCT00808028|472358161|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
131201617|NCT00808028|472358162|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
131201618|NCT00808028|472358163|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
131201619|NCT00808028|472358160|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
131201620|NCT00808028|472358161|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
131201621|NCT00808028|472358162|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
131201622|NCT00808028|472358163|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
131201623|NCT00808028|472358160|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
131201624|NCT00808028|472358161|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
131201625|NCT00808028|472358162|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
131201626|NCT00808028|472358163|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
131201627|NCT00808028|472358160|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
131201628|NCT00808028|472358161|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
131201629|NCT00808028|472358162|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
131201630|NCT00808028|472358163|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
131201631|NCT00808028|472358160|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
131201632|NCT00808028|472358161|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
131201633|NCT00808028|472358162|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
131201634|NCT00808028|472358163|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
131201635|NCT00808028|472358160|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
131201636|NCT00808028|472358161|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
131201637|NCT00808028|472358162|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
131201638|NCT00808028|472358163|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
131201639|NCT00948389|472358164|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
131201640|NCT00948389|472358165|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
131201641|NCT00948389|472358166|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
131201642|NCT00948389|472358167|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
131201643|NCT00948389|472358168|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
131201644|NCT00948389|472358164|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
131201645|NCT00948389|472358165|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
131201646|NCT00948389|472358166|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
131201647|NCT00948389|472358167|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
131201648|NCT00948389|472358168|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
131201649|NCT00948389|472358164|FG000|Overall Study|Both Progression and Toxicity|1|||
131201650|NCT00948389|472358165|FG001|Overall Study|Both Progression and Toxicity|0|||
131201651|NCT00948389|472358166|FG002|Overall Study|Both Progression and Toxicity|0|||
131201652|NCT00948389|472358167|FG003|Overall Study|Both Progression and Toxicity|0|||
131201653|NCT00948389|472358168|FG004|Overall Study|Both Progression and Toxicity|0|||
131201654|NCT00508001|472358169|FG000|Overall Study|Adverse Event|2|||
131201655|NCT00508001|472358170|FG001|Overall Study|Adverse Event|0|||
131201656|NCT00508001|472358171|FG002|Overall Study|Adverse Event|4|||
131201657|NCT00508001|472358169|FG000|Overall Study|condition under investigation worsened|13|||
131201658|NCT00508001|472358170|FG001|Overall Study|condition under investigation worsened|7|||
131201659|NCT00508001|472358171|FG002|Overall Study|condition under investigation worsened|1|||
131201660|NCT00508001|472358169|FG000|Overall Study|Death|0|||
131201661|NCT00508001|472358170|FG001|Overall Study|Death|1|||
131201662|NCT00508001|472358171|FG002|Overall Study|Death|1|||
131201663|NCT00508001|472358169|FG000|Overall Study|Withdrawal by Subject|4|||
131201664|NCT00508001|472358170|FG001|Overall Study|Withdrawal by Subject|4|||
131201665|NCT00508001|472358171|FG002|Overall Study|Withdrawal by Subject|1|||
131201666|NCT00732199|472358174|FG000|Overall Study|Withdrawal by Subject|25|||
131201667|NCT00732199|472358175|FG001|Overall Study|Withdrawal by Subject|18|||
131201668|NCT00732199|472358174|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
131201669|NCT00732199|472358175|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
131201670|NCT02870348|472358189|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
131201671|NCT01051856|472358190|FG000|Overall Study|Withdrawal by Subject|1|||
131201672|NCT01051856|472358191|FG001|Overall Study|Withdrawal by Subject|0|||
131201673|NCT02381795|472358192|FG000|Overall Study|Withdrawal by Subject|1|||
131201674|NCT02381795|472358192|FG000|Overall Study|Study Terminated|2|||
131201675|NCT02176226|472358193|FG000|Overall Study|Lost to Follow-up|3|||
131201676|NCT02176226|472358193|FG000|Overall Study|Withdrew prior to treatment|6|||
131201677|NCT02908841|472358200|FG000|Overall Study|Physician Decision|4|||
131201678|NCT02908841|472358201|FG001|Overall Study|Physician Decision|0|||
131201679|NCT01611558|472358202|FG000|Induction Phase|Study drug toxicity|15|||
131201680|NCT01611558|472358202|FG000|Induction Phase|Disease progression|18|||
131201681|NCT01611558|472358202|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
131201682|NCT01611558|472358202|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
131201683|NCT01611558|472358202|FG000|Induction Phase|Death|1|||
131201684|NCT01611558|472358202|FG000|Maintenance Phase|Withdrawal by Subject|1|||
131201685|NCT01611558|472358202|FG000|Maintenance Phase|Elevated Uric acid|1|||
131201686|NCT04005885|472358208|FG000|First Intervention|Withdrawal by Subject|1|||
131201687|NCT04005885|472358209|FG001|First Intervention|Withdrawal by Subject|1|||
131201688|NCT04005885|472358208|FG000|Second Intervention|Withdrawal by Subject|0|||
131201689|NCT04005885|472358209|FG001|Second Intervention|Withdrawal by Subject|2|||
131201690|NCT00808132|472358211|FG000|Overall Study|Adverse Event|34|||
131201691|NCT00808132|472358212|FG001|Overall Study|Adverse Event|33|||
131201692|NCT00808132|472358213|FG002|Overall Study|Adverse Event|16|||
131201693|NCT00808132|472358214|FG003|Overall Study|Adverse Event|31|||
131201694|NCT00808132|472358215|FG004|Overall Study|Adverse Event|33|||
131201695|NCT00808132|472358211|FG000|Overall Study|Death|0|||
131201696|NCT00808132|472358212|FG001|Overall Study|Death|0|||
131201697|NCT00808132|472358213|FG002|Overall Study|Death|0|||
131201698|NCT00808132|472358214|FG003|Overall Study|Death|0|||
131201699|NCT00808132|472358215|FG004|Overall Study|Death|1|||
131201700|NCT00808132|472358211|FG000|Overall Study|Physician Decision|0|||
131201701|NCT00808132|472358212|FG001|Overall Study|Physician Decision|1|||
131201702|NCT00808132|472358213|FG002|Overall Study|Physician Decision|0|||
131201703|NCT00808132|472358214|FG003|Overall Study|Physician Decision|0|||
131201704|NCT00808132|472358215|FG004|Overall Study|Physician Decision|0|||
131201705|NCT00808132|472358211|FG000|Overall Study|Lost to Follow-up|8|||
131201706|NCT00808132|472358212|FG001|Overall Study|Lost to Follow-up|10|||
131201707|NCT00808132|472358213|FG002|Overall Study|Lost to Follow-up|11|||
131201708|NCT00808132|472358214|FG003|Overall Study|Lost to Follow-up|8|||
131201709|NCT00808132|472358215|FG004|Overall Study|Lost to Follow-up|9|||
131201710|NCT00808132|472358211|FG000|Overall Study|Protocol Violation|8|||
131201711|NCT00808132|472358212|FG001|Overall Study|Protocol Violation|9|||
131201712|NCT00808132|472358213|FG002|Overall Study|Protocol Violation|4|||
131201713|NCT00808132|472358214|FG003|Overall Study|Protocol Violation|9|||
131201714|NCT00808132|472358215|FG004|Overall Study|Protocol Violation|5|||
131201715|NCT00808132|472358211|FG000|Overall Study|Withdrawal by Subject|27|||
131201716|NCT00808132|472358212|FG001|Overall Study|Withdrawal by Subject|18|||
131201717|NCT00808132|472358213|FG002|Overall Study|Withdrawal by Subject|2|||
131201718|NCT00808132|472358214|FG003|Overall Study|Withdrawal by Subject|7|||
131201719|NCT00808132|472358215|FG004|Overall Study|Withdrawal by Subject|16|||
131201720|NCT00808132|472358211|FG000|Overall Study|Other|6|||
131201721|NCT00808132|472358212|FG001|Overall Study|Other|4|||
130733844|NCT03355469|470645291|FG000|Overall Study|Lost to Follow-up|1|||
130733845|NCT03355469|470645292|FG001|Overall Study|Lost to Follow-up|0|||
130733846|NCT03355469|470645293|FG002|Overall Study|Lost to Follow-up|1|||
130733847|NCT03355469|470645294|FG003|Overall Study|Lost to Follow-up|0|||
130733848|NCT03355469|470645291|FG000|Overall Study|Withdrawal by Subject|2|||
130733849|NCT03355469|470645292|FG001|Overall Study|Withdrawal by Subject|1|||
130733850|NCT03355469|470645293|FG002|Overall Study|Withdrawal by Subject|0|||
130733851|NCT03355469|470645294|FG003|Overall Study|Withdrawal by Subject|3|||
130733852|NCT01708941|470645295|FG000|Overall Study|Adverse Event|4|||
130733853|NCT01708941|470645296|FG001|Overall Study|Adverse Event|6|||
130733854|NCT01708941|470645297|FG002|Overall Study|Adverse Event|1|||
130733855|NCT01708941|470645298|FG003|Overall Study|Adverse Event|0|||
130733856|NCT01708941|470645295|FG000|Overall Study|Death|1|||
130733857|NCT01708941|470645296|FG001|Overall Study|Death|1|||
130733858|NCT01708941|470645297|FG002|Overall Study|Death|2|||
130733859|NCT01708941|470645298|FG003|Overall Study|Death|14|||
130733860|NCT01708941|470645295|FG000|Overall Study|Withdrawal by Subject|1|||
130733861|NCT01708941|470645296|FG001|Overall Study|Withdrawal by Subject|0|||
130733862|NCT01708941|470645297|FG002|Overall Study|Withdrawal by Subject|3|||
130733863|NCT01708941|470645298|FG003|Overall Study|Withdrawal by Subject|4|||
130733864|NCT01708941|470645295|FG000|Overall Study|Disease progression|9|||
130733865|NCT01708941|470645296|FG001|Overall Study|Disease progression|10|||
130733866|NCT01708941|470645297|FG002|Overall Study|Disease progression|8|||
130733867|NCT01708941|470645298|FG003|Overall Study|Disease progression|0|||
130733868|NCT01708941|470645295|FG000|Overall Study|Alternative therapy|0|||
130733869|NCT01708941|470645296|FG001|Overall Study|Alternative therapy|0|||
130733870|NCT01708941|470645297|FG002|Overall Study|Alternative therapy|2|||
130733871|NCT01708941|470645298|FG003|Overall Study|Alternative therapy|0|||
131201722|NCT00808132|472358213|FG002|Overall Study|Other|6|||
131201723|NCT00808132|472358214|FG003|Overall Study|Other|2|||
131201724|NCT00808132|472358215|FG004|Overall Study|Other|15|||
131201725|NCT00808132|472358211|FG000|Overall Study|Randomized, but not treated|10|||
131201726|NCT00808132|472358212|FG001|Overall Study|Randomized, but not treated|7|||
131201727|NCT00808132|472358213|FG002|Overall Study|Randomized, but not treated|9|||
131201728|NCT00808132|472358214|FG003|Overall Study|Randomized, but not treated|8|||
131201729|NCT00808132|472358215|FG004|Overall Study|Randomized, but not treated|9|||
131201730|NCT00808132|472358211|FG000|Overall Study|Unsatisfactory response|5|||
131201731|NCT00808132|472358212|FG001|Overall Study|Unsatisfactory response|6|||
131201732|NCT00808132|472358213|FG002|Overall Study|Unsatisfactory response|6|||
131201733|NCT00808132|472358214|FG003|Overall Study|Unsatisfactory response|4|||
131201734|NCT00808132|472358215|FG004|Overall Study|Unsatisfactory response|12|||
131201735|NCT01948791|472358216|FG000|Overall Study|Adverse Event|12|||
131201736|NCT01948791|472358216|FG000|Overall Study|Lack of Efficacy|3|||
131201737|NCT01948791|472358216|FG000|Overall Study|Protocol Violation|2|||
131201738|NCT01948791|472358216|FG000|Overall Study|Withdrawal by Subject|5|||
131201739|NCT01948791|472358216|FG000|Overall Study|Lost to Follow-up|6|||
131201740|NCT01948791|472358216|FG000|Overall Study|Management issues|1|||
131201741|NCT01948791|472358216|FG000|Overall Study|Others|7|||
131201742|NCT01948791|472358216|FG000|Overall Study|Screening failure|35|||
131201743|NCT00702949|472358224|FG000|Overall Study|Refusal|3|||
131201744|NCT00702949|472358225|FG001|Overall Study|Refusal|2|||
131201745|NCT00702949|472358226|FG002|Overall Study|Refusal|2|||
131201746|NCT00702949|472358224|FG000|Overall Study|Adverse Event|1|||
131201747|NCT00702949|472358225|FG001|Overall Study|Adverse Event|6|||
131201748|NCT00702949|472358226|FG002|Overall Study|Adverse Event|3|||
131201749|NCT00702949|472358224|FG000|Overall Study|Other Medical Reason/unknown|1|||
131201750|NCT00702949|472358225|FG001|Overall Study|Other Medical Reason/unknown|1|||
131201751|NCT00702949|472358226|FG002|Overall Study|Other Medical Reason/unknown|3|||
131201752|NCT01371721|472358227|FG000|Overall Study|Adverse Event|5|||
131201753|NCT01371721|472358228|FG001|Overall Study|Adverse Event|4|||
131201754|NCT01371721|472358229|FG002|Overall Study|Adverse Event|5|||
131201755|NCT01371721|472358227|FG000|Overall Study|Protocol Violation|6|||
131201756|NCT01371721|472358228|FG001|Overall Study|Protocol Violation|4|||
131201757|NCT01371721|472358229|FG002|Overall Study|Protocol Violation|5|||
131201758|NCT01371721|472358227|FG000|Overall Study|Lost to Follow-up|8|||
131201759|NCT01371721|472358228|FG001|Overall Study|Lost to Follow-up|2|||
131201760|NCT01371721|472358229|FG002|Overall Study|Lost to Follow-up|6|||
131201761|NCT01371721|472358227|FG000|Overall Study|Withdrawal by Subject|5|||
131201762|NCT01371721|472358228|FG001|Overall Study|Withdrawal by Subject|7|||
131201763|NCT01371721|472358229|FG002|Overall Study|Withdrawal by Subject|11|||
131201764|NCT01371721|472358227|FG000|Overall Study|Other|2|||
131201765|NCT01371721|472358228|FG001|Overall Study|Other|3|||
131201766|NCT01371721|472358229|FG002|Overall Study|Other|0|||
131201767|NCT01371721|472358227|FG000|Overall Study|Lack of Efficacy|2|||
131201768|NCT01371721|472358228|FG001|Overall Study|Lack of Efficacy|4|||
131201769|NCT01371721|472358229|FG002|Overall Study|Lack of Efficacy|3|||
131201770|NCT01371721|472358227|FG000|Overall Study|Randomized but not treated|1|||
131201771|NCT01371721|472358228|FG001|Overall Study|Randomized but not treated|0|||
131201772|NCT01371721|472358229|FG002|Overall Study|Randomized but not treated|0|||
131201773|NCT00472043|472358230|FG000|Overall Study|Withdrawal by Subject|1|||
131201774|NCT00472043|472358231|FG001|Overall Study|Withdrawal by Subject|0|||
131201775|NCT00472043|472358230|FG000|Overall Study|Death|1|||
131201776|NCT00472043|472358231|FG001|Overall Study|Death|0|||
131201777|NCT02802735|472358232|FG000|Overall Study|Withdrawal by Subject|0|||
131201778|NCT02802735|472358233|FG001|Overall Study|Withdrawal by Subject|1|||
131201779|NCT02802735|472358234|FG002|Overall Study|Withdrawal by Subject|0|||
131201780|NCT02802735|472358235|FG003|Overall Study|Withdrawal by Subject|0|||
131201781|NCT02802735|472358236|FG004|Overall Study|Withdrawal by Subject|0|||
131201782|NCT00877890|472358239|FG000|Overall Study|Adverse Event|6|||
131201783|NCT00877890|472358240|FG001|Overall Study|Adverse Event|6|||
131201784|NCT00877890|472358239|FG000|Overall Study|Lost to Follow-up|5|||
130733872|NCT01708941|470645295|FG000|Overall Study|Ineligible and never started treatment|1|||
131201785|NCT00877890|472358240|FG001|Overall Study|Lost to Follow-up|5|||
131201786|NCT00877890|472358239|FG000|Overall Study|Protocol Violation|0|||
131201787|NCT00877890|472358240|FG001|Overall Study|Protocol Violation|1|||
131201788|NCT00877890|472358239|FG000|Overall Study|Withdrawal of Consent|6|||
131201789|NCT00877890|472358240|FG001|Overall Study|Withdrawal of Consent|12|||
131201790|NCT00877890|472358239|FG000|Overall Study|Investigator Decision|0|||
131201791|NCT00877890|472358240|FG001|Overall Study|Investigator Decision|2|||
131201792|NCT00877890|472358239|FG000|Overall Study|Loss of Glucose Control|3|||
131201793|NCT00877890|472358240|FG001|Overall Study|Loss of Glucose Control|4|||
131201794|NCT02993783|472358243|FG000|Overall Study|Reason not Specified|6|||
131201795|NCT02993783|472358244|FG001|Overall Study|Reason not Specified|9|||
131201796|NCT03049852|472358252|FG000|Overall Study|Lost to Follow-up|0|||
131201797|NCT03049852|472358253|FG001|Overall Study|Lost to Follow-up|1|||
130733873|NCT01708941|470645296|FG001|Overall Study|Ineligible and never started treatment|0|||
130733874|NCT01708941|470645297|FG002|Overall Study|Ineligible and never started treatment|1|||
130733875|NCT01708941|470645298|FG003|Overall Study|Ineligible and never started treatment|0|||
130733876|NCT01708941|470645295|FG000|Overall Study|Never started treatment|2|||
130733877|NCT01708941|470645296|FG001|Overall Study|Never started treatment|1|||
130733878|NCT01708941|470645297|FG002|Overall Study|Never started treatment|0|||
130733879|NCT01708941|470645298|FG003|Overall Study|Never started treatment|0|||
131201798|NCT03049852|472358254|FG002|Overall Study|Lost to Follow-up|0|||
131201799|NCT00806494|472358255|FG000|Overall Study|Adverse Event|29|||
131201800|NCT00806494|472358255|FG000|Overall Study|Lack of Efficacy|6|||
131201801|NCT00806494|472358255|FG000|Overall Study|Lost to Follow-up|10|||
131201802|NCT00806494|472358255|FG000|Overall Study|Other|30|||
131201803|NCT00806494|472358255|FG000|Overall Study|Withdrawal by Subject|5|||
131201804|NCT02610231|472358256|FG000|Overall Study|Withdrawal by Subject|27|||
131201805|NCT02610231|472358256|FG000|Overall Study|Adverse Event|20|||
131201806|NCT02610231|472358256|FG000|Overall Study|Death|5|||
131201807|NCT02610231|472358256|FG000|Overall Study|Surgery|2|||
131201808|NCT02610231|472358256|FG000|Overall Study|Physician Decision|1|||
131201809|NCT02610231|472358256|FG000|Overall Study|Non Compliance|2|||
131201810|NCT02610231|472358256|FG000|Overall Study|Other|3|||
131201811|NCT01279954|472358257|FG000|Overall Study|Lack of Efficacy|3|||
131201812|NCT01279954|472358258|FG001|Overall Study|Lack of Efficacy|4|||
131201813|NCT00537810|472358259|FG000|Overall Study|Withdrawal by Subject|4|||
131201814|NCT00537810|472358260|FG001|Overall Study|Withdrawal by Subject|11|||
131201815|NCT00537810|472358261|FG002|Overall Study|Withdrawal by Subject|4|||
131201816|NCT00537810|472358262|FG003|Overall Study|Withdrawal by Subject|3|||
131201817|NCT00537810|472358259|FG000|Overall Study|Medically withdrawn|2|||
131201818|NCT00537810|472358260|FG001|Overall Study|Medically withdrawn|2|||
131201819|NCT00537810|472358261|FG002|Overall Study|Medically withdrawn|0|||
131201820|NCT00537810|472358262|FG003|Overall Study|Medically withdrawn|1|||
131201821|NCT03258762|472358267|FG000|Overall Study|Lost to Follow-up|0|||
131201822|NCT03258762|472358268|FG001|Overall Study|Lost to Follow-up|1|||
131201823|NCT01711359|472358269|FG000|Treatment Period|Withdrawal by Subject|18|||
131201824|NCT01711359|472358270|FG001|Treatment Period|Withdrawal by Subject|7|||
131201825|NCT01711359|472358271|FG002|Treatment Period|Withdrawal by Subject|13|||
131201826|NCT01711359|472358269|FG000|Treatment Period|Lack of Efficacy|13|||
131201827|NCT01711359|472358270|FG001|Treatment Period|Lack of Efficacy|2|||
131201828|NCT01711359|472358271|FG002|Treatment Period|Lack of Efficacy|2|||
131201829|NCT01711359|472358269|FG000|Treatment Period|Adverse Event|8|||
131201830|NCT01711359|472358270|FG001|Treatment Period|Adverse Event|10|||
131201831|NCT01711359|472358271|FG002|Treatment Period|Adverse Event|24|||
131201832|NCT01711359|472358269|FG000|Treatment Period|Physician Decision|4|||
131201833|NCT01711359|472358270|FG001|Treatment Period|Physician Decision|3|||
131201834|NCT01711359|472358271|FG002|Treatment Period|Physician Decision|2|||
131201835|NCT01711359|472358269|FG000|Treatment Period|Death|3|||
131201836|NCT01711359|472358270|FG001|Treatment Period|Death|0|||
131201837|NCT01711359|472358271|FG002|Treatment Period|Death|0|||
131201838|NCT01711359|472358269|FG000|Treatment Period|Entry Criteria Not Met|1|||
131201839|NCT01711359|472358270|FG001|Treatment Period|Entry Criteria Not Met|0|||
131201840|NCT01711359|472358271|FG002|Treatment Period|Entry Criteria Not Met|0|||
131201841|NCT01711359|472358269|FG000|Treatment Period|Sponsor Decision|1|||
131201842|NCT01711359|472358270|FG001|Treatment Period|Sponsor Decision|0|||
131201843|NCT01711359|472358271|FG002|Treatment Period|Sponsor Decision|0|||
131201844|NCT01711359|472358269|FG000|Treatment Period|Lost to Follow-up|1|||
131201845|NCT01711359|472358270|FG001|Treatment Period|Lost to Follow-up|1|||
131201846|NCT01711359|472358271|FG002|Treatment Period|Lost to Follow-up|1|||
131201847|NCT01711359|472358269|FG000|Treatment Period|Randomized, Not Treated|3|||
131201848|NCT01711359|472358270|FG001|Treatment Period|Randomized, Not Treated|1|||
131201849|NCT01711359|472358271|FG002|Treatment Period|Randomized, Not Treated|0|||
131201850|NCT01385098|472358272|FG000|Overall Study|Adverse Event|10|||
131201851|NCT01385098|472358272|FG000|Overall Study|Lost to Follow-up|4|||
131201852|NCT00554840|472358273|FG000|Overall Study|Physician Decision|0|||
131201853|NCT00554840|472358274|FG001|Overall Study|Physician Decision|1|||
131201854|NCT02698176|472358275|FG000|Overall Study|Progressive disease|4|||
131201855|NCT02698176|472358276|FG001|Overall Study|Progressive disease|3|||
131201856|NCT02698176|472358277|FG002|Overall Study|Progressive disease|1|||
131201857|NCT02698176|472358278|FG003|Overall Study|Progressive disease|0|||
131201858|NCT02698176|472358275|FG000|Overall Study|Adverse Event|2|||
131201859|NCT02698176|472358276|FG001|Overall Study|Adverse Event|0|||
131201860|NCT02698176|472358277|FG002|Overall Study|Adverse Event|0|||
131201861|NCT02698176|472358278|FG003|Overall Study|Adverse Event|0|||
131201862|NCT02698176|472358275|FG000|Overall Study|Clinical progression|3|||
131201863|NCT02698176|472358276|FG001|Overall Study|Clinical progression|0|||
131201864|NCT02698176|472358277|FG002|Overall Study|Clinical progression|0|||
131201865|NCT02698176|472358278|FG003|Overall Study|Clinical progression|0|||
131201866|NCT00410514|472358285|FG000|Overall Study|Adverse Event|2|||
131201867|NCT00410514|472358286|FG001|Overall Study|Adverse Event|2|||
131201868|NCT00410514|472358287|FG002|Overall Study|Adverse Event|2|||
131201869|NCT00410514|472358285|FG000|Overall Study|Protocol Violation|0|||
131201870|NCT00410514|472358286|FG001|Overall Study|Protocol Violation|1|||
131201871|NCT00410514|472358287|FG002|Overall Study|Protocol Violation|1|||
131201872|NCT00410514|472358285|FG000|Overall Study|Lost to Follow-up|0|||
131201873|NCT00410514|472358286|FG001|Overall Study|Lost to Follow-up|0|||
131201874|NCT00410514|472358287|FG002|Overall Study|Lost to Follow-up|2|||
131201875|NCT00410514|472358285|FG000|Overall Study|Non-compliant with study procedures|0|||
131201876|NCT00410514|472358286|FG001|Overall Study|Non-compliant with study procedures|0|||
131201877|NCT00410514|472358287|FG002|Overall Study|Non-compliant with study procedures|2|||
131201878|NCT01021423|472358288|FG000|Overall Study|Study terminated|4|||
131201879|NCT01021423|472358289|FG001|Overall Study|Study terminated|5|||
131201880|NCT02985684|472358293|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
131201881|NCT02985684|472358293|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
131201882|NCT02985684|472358293|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
131201883|NCT04728815|472358297|FG000|Overall Study|Lost to Follow-up|3|||
131201884|NCT04728815|472358298|FG001|Overall Study|Lost to Follow-up|0|||
131201885|NCT04728815|472358299|FG002|Overall Study|Lost to Follow-up|0|||
131201886|NCT04728815|472358300|FG003|Overall Study|Lost to Follow-up|1|||
131201887|NCT04728815|472358301|FG004|Overall Study|Lost to Follow-up|1|||
131201888|NCT04728815|472358302|FG005|Overall Study|Lost to Follow-up|0|||
131201889|NCT04728815|472358303|FG006|Overall Study|Lost to Follow-up|2|||
131201890|NCT04728815|472358304|FG007|Overall Study|Lost to Follow-up|0|||
131201891|NCT04728815|472358297|FG000|Overall Study|Physician Decision|0|||
131201892|NCT04728815|472358298|FG001|Overall Study|Physician Decision|0|||
131201893|NCT04728815|472358299|FG002|Overall Study|Physician Decision|1|||
131201894|NCT04728815|472358300|FG003|Overall Study|Physician Decision|0|||
131201895|NCT04728815|472358301|FG004|Overall Study|Physician Decision|0|||
131201896|NCT04728815|472358302|FG005|Overall Study|Physician Decision|0|||
131201897|NCT04728815|472358303|FG006|Overall Study|Physician Decision|0|||
131201898|NCT04728815|472358304|FG007|Overall Study|Physician Decision|0|||
131201899|NCT04728815|472358297|FG000|Overall Study|Treatment drop|0|||
131201900|NCT04728815|472358298|FG001|Overall Study|Treatment drop|2|||
131201901|NCT04728815|472358299|FG002|Overall Study|Treatment drop|1|||
131201902|NCT04728815|472358300|FG003|Overall Study|Treatment drop|0|||
131201903|NCT04728815|472358301|FG004|Overall Study|Treatment drop|3|||
131201904|NCT04728815|472358302|FG005|Overall Study|Treatment drop|1|||
131201905|NCT04728815|472358303|FG006|Overall Study|Treatment drop|3|||
131201906|NCT04728815|472358304|FG007|Overall Study|Treatment drop|0|||
131201907|NCT04728815|472358297|FG000|Overall Study|Study drop|0|||
131201908|NCT04728815|472358298|FG001|Overall Study|Study drop|3|||
131201909|NCT04728815|472358299|FG002|Overall Study|Study drop|3|||
131201910|NCT04728815|472358300|FG003|Overall Study|Study drop|0|||
131201911|NCT04728815|472358301|FG004|Overall Study|Study drop|0|||
131201912|NCT04728815|472358302|FG005|Overall Study|Study drop|0|||
131201913|NCT04728815|472358303|FG006|Overall Study|Study drop|7|||
131201914|NCT04728815|472358304|FG007|Overall Study|Study drop|0|||
131201915|NCT00957034|472358305|FG000|Overall Study|Adverse Event|0|||
131201916|NCT00957034|472358306|FG001|Overall Study|Adverse Event|1|||
131201917|NCT00957034|472358307|FG002|Overall Study|Adverse Event|1|||
131201918|NCT00957034|472358305|FG000|Overall Study|Sponsor Terminated Study|6|||
131201919|NCT00957034|472358306|FG001|Overall Study|Sponsor Terminated Study|1|||
131201920|NCT00957034|472358307|FG002|Overall Study|Sponsor Terminated Study|5|||
131201921|NCT00957034|472358305|FG000|Overall Study|Withdrawal by Subject|0|||
131201922|NCT00957034|472358306|FG001|Overall Study|Withdrawal by Subject|2|||
131201923|NCT00957034|472358307|FG002|Overall Study|Withdrawal by Subject|0|||
131201924|NCT02390167|472360258|FG000|Overall Study|Lost to Follow-up|1|||
131201925|NCT00027846|472360259|FG000|Overall Study|Lost to Follow-up|0|||
131201926|NCT00027846|472360260|FG001|Overall Study|Lost to Follow-up|41|||
131201927|NCT00027846|472360261|FG002|Overall Study|Lost to Follow-up|9|||
131201928|NCT00027846|472360259|FG000|Overall Study|Withdrawal by Subject|0|||
131201929|NCT00027846|472360260|FG001|Overall Study|Withdrawal by Subject|14|||
131201930|NCT00027846|472360261|FG002|Overall Study|Withdrawal by Subject|7|||
131201931|NCT00027846|472360259|FG000|Overall Study|Ineligible for study|2|||
131201932|NCT00027846|472360260|FG001|Overall Study|Ineligible for study|6|||
131201933|NCT00027846|472360261|FG002|Overall Study|Ineligible for study|14|||
131201934|NCT00027846|472360259|FG000|Overall Study|Entry into another COG therapeutic study|0|||
131201935|NCT00027846|472360260|FG001|Overall Study|Entry into another COG therapeutic study|5|||
131201936|NCT00027846|472360261|FG002|Overall Study|Entry into another COG therapeutic study|2|||
131201937|NCT00027846|472360259|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
131201938|NCT00027846|472360260|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
131201939|NCT00027846|472360261|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
131201940|NCT02033369|472360262|FG000|Overall Study|Physician Decision|1|||
131201941|NCT02033369|472360263|FG001|Overall Study|Physician Decision|2|||
131201942|NCT02033369|472360262|FG000|Overall Study|Not a good demographic match|0|||
131201943|NCT02033369|472360263|FG001|Overall Study|Not a good demographic match|2|||
131201944|NCT02033369|472360262|FG000|Overall Study|Withdrawal by Subject|1|||
131201945|NCT02033369|472360263|FG001|Overall Study|Withdrawal by Subject|1|||
131201946|NCT02033369|472360262|FG000|Overall Study|Lost to Follow-up|1|||
131201947|NCT02033369|472360263|FG001|Overall Study|Lost to Follow-up|0|||
130733880|NCT01708941|470645295|FG000|Overall Study|Ineligible|0|||
130733881|NCT01708941|470645296|FG001|Overall Study|Ineligible|0|||
130733882|NCT01708941|470645297|FG002|Overall Study|Ineligible|2|||
130733883|NCT01708941|470645298|FG003|Overall Study|Ineligible|0|||
130733884|NCT02048813|470645299|FG000|Overall Study|Still on treatment|279|||
130733885|NCT02048813|470645300|FG001|Overall Study|Still on treatment|0|||
130733886|NCT02048813|470645299|FG000|Overall Study|Adverse Event|40|||
130733887|NCT02048813|470645300|FG001|Overall Study|Adverse Event|38|||
131201948|NCT02033369|472360262|FG000|Overall Study|Protocol Violation|2|||
131201949|NCT02033369|472360263|FG001|Overall Study|Protocol Violation|0|||
131201950|NCT01265719|472360264|FG000|Overall Study|Does not meet entrance criteria|0|||
131201951|NCT01265719|472360265|FG001|Overall Study|Does not meet entrance criteria|3|||
131201952|NCT01265719|472360264|FG000|Overall Study|Other reasons|2|||
131201953|NCT01265719|472360265|FG001|Overall Study|Other reasons|0|||
131201954|NCT01265719|472360264|FG000|Overall Study|Withdrawal by Subject|8|||
131201955|NCT01265719|472360265|FG001|Overall Study|Withdrawal by Subject|3|||
131201956|NCT01265719|472360264|FG000|Overall Study|Lost to Follow-up|2|||
131201957|NCT01265719|472360265|FG001|Overall Study|Lost to Follow-up|7|||
131201958|NCT01265719|472360264|FG000|Overall Study|Adverse Event|2|||
131201959|NCT01265719|472360265|FG001|Overall Study|Adverse Event|0|||
131201960|NCT04335929|472360266|FG000|Overall Study|Lost to Follow-up|10|||
131201961|NCT05604781|472360268|FG000|Overall Study|Lost to Follow-up|3|||
131201962|NCT05604781|472360268|FG000|Overall Study|Adverse Event|1|||
131201963|NCT01005966|472360269|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
131201964|NCT01005966|472360270|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
131201965|NCT01005966|472360271|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
131201966|NCT01005966|472360272|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
131201967|NCT01005966|472360273|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
131201968|NCT01005966|472360269|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
131201969|NCT01005966|472360270|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
131201970|NCT01005966|472360271|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
131201971|NCT01005966|472360272|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
131201972|NCT01005966|472360273|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
131201973|NCT01005966|472360269|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
131201974|NCT01005966|472360270|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
131201975|NCT01005966|472360271|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
131201976|NCT01005966|472360272|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
131201977|NCT01005966|472360273|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
131201978|NCT01005966|472360269|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
131201979|NCT01005966|472360270|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
131201980|NCT01005966|472360271|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
131201981|NCT01005966|472360272|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
130733888|NCT02048813|470645299|FG000|Overall Study|Disease progression|13|||
131201982|NCT01005966|472360273|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
131201983|NCT01005966|472360269|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131201984|NCT01005966|472360270|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131201985|NCT01005966|472360271|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130733889|NCT02048813|470645300|FG001|Overall Study|Disease progression|3|||
130733890|NCT02048813|470645299|FG000|Overall Study|Withdrawal by Subject|7|||
131201986|NCT01005966|472360272|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
131201987|NCT01005966|472360273|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
131201988|NCT01005966|472360269|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131201989|NCT01005966|472360270|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131201990|NCT01005966|472360271|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
131201991|NCT01005966|472360272|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131201992|NCT01005966|472360273|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
131201993|NCT01005966|472360269|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
131201994|NCT01005966|472360270|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
131201995|NCT01005966|472360271|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
131201996|NCT01005966|472360272|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
131201997|NCT01005966|472360273|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
131201998|NCT01005966|472360269|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
131201999|NCT01005966|472360270|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
131202000|NCT01005966|472360271|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
131202001|NCT01005966|472360272|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
131202002|NCT01005966|472360273|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
131202003|NCT01005966|472360269|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
131202004|NCT01005966|472360270|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
130733891|NCT02048813|470645300|FG001|Overall Study|Withdrawal by Subject|8|||
130733892|NCT02048813|470645299|FG000|Overall Study|Death|2|||
130733893|NCT02048813|470645300|FG001|Overall Study|Death|1|||
130733894|NCT02048813|470645299|FG000|Overall Study|Complication|2|||
130733895|NCT02048813|470645300|FG001|Overall Study|Complication|2|||
130733896|NCT02048813|470645299|FG000|Overall Study|Non-protocol therapy|0|||
130733897|NCT02048813|470645300|FG001|Overall Study|Non-protocol therapy|1|||
130733898|NCT02048813|470645299|FG000|Overall Study|Second primary cancer|2|||
130733899|NCT02048813|470645300|FG001|Overall Study|Second primary cancer|0|||
130733900|NCT02048813|470645299|FG000|Overall Study|Insurance|2|||
130733901|NCT02048813|470645300|FG001|Overall Study|Insurance|0|||
130733902|NCT02048813|470645299|FG000|Overall Study|Wound infection/healing|2|||
130733903|NCT02048813|470645300|FG001|Overall Study|Wound infection/healing|0|||
130733904|NCT02048813|470645299|FG000|Overall Study|Missed appointment|3|||
130733905|NCT02048813|470645300|FG001|Overall Study|Missed appointment|0|||
130733906|NCT02048813|470645299|FG000|Overall Study|Never started treatment|2|||
130733907|NCT02048813|470645300|FG001|Overall Study|Never started treatment|17|||
130733908|NCT02454608|470645301|FG000|Double-Blind Period|Lack of Efficacy|0|||
130733909|NCT02454608|470645302|FG001|Double-Blind Period|Lack of Efficacy|2|||
130733910|NCT02454608|470645303|FG002|Double-Blind Period|Lack of Efficacy|0|||
130733911|NCT02454608|470645301|FG000|Open Label Period|Lost to Follow-up|0|||
130733912|NCT02454608|470645302|FG001|Open Label Period|Lost to Follow-up|0|||
130733913|NCT02454608|470645303|FG002|Open Label Period|Lost to Follow-up|11|||
130733914|NCT02454608|470645301|FG000|Open Label Period|Withdrawal by Subject|0|||
130733915|NCT02454608|470645302|FG001|Open Label Period|Withdrawal by Subject|0|||
130733916|NCT02454608|470645303|FG002|Open Label Period|Withdrawal by Subject|8|||
130733917|NCT03573830|470645304|FG000|Overall Study|Dropped without completing treatment|0|||
130733918|NCT03573830|470645305|FG001|Overall Study|Dropped without completing treatment|7|||
130733919|NCT03573830|470645304|FG000|Overall Study|Lost to Follow-up|4|||
130733920|NCT03573830|470645305|FG001|Overall Study|Lost to Follow-up|0|||
130733921|NCT01769456|470645306|FG000|Overall Study|Lost to Follow-up|19|||
130733922|NCT01769456|470645306|FG000|Overall Study|Withdrawal by Subject|3|||
130733923|NCT01769456|470645306|FG000|Overall Study|Did not receive PCC intervention|6|||
130733924|NCT01769456|470645306|FG000|Overall Study|Moved out of the area|3|||
130733925|NCT01769456|470645306|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
130733926|NCT01769456|470645306|FG000|Overall Study|Parental request to youth to withdraw|1|||
130733927|NCT02465398|470645313|FG000|Overall Study|Death|7|||
130733928|NCT02465398|470645313|FG000|Overall Study|Revision|7|||
130784633|NCT00794664|470838855|FG000|Treatment Period|Withdrawal by Subject|0|||
130784634|NCT00794664|470838856|FG001|Treatment Period|Withdrawal by Subject|2|||
130784635|NCT00794664|470838855|FG000|Treatment Period|Protocol non-compliance|0|||
131202005|NCT01005966|472360271|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
131202006|NCT01005966|472360272|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
131202007|NCT01005966|472360273|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
131202008|NCT01451203|472360274|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
131202009|NCT01451203|472360275|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
131202010|NCT01451203|472360274|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
131202011|NCT01451203|472360275|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
131202012|NCT01451203|472360274|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
131202013|NCT01451203|472360275|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
131202014|NCT01451203|472360274|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
131202015|NCT01451203|472360275|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
131202016|NCT01451203|472360274|FG000|Double-blind Treatment Period|Adverse Event|6|||
131202017|NCT01451203|472360275|FG001|Double-blind Treatment Period|Adverse Event|9|||
131202018|NCT01451203|472360274|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
131202019|NCT01451203|472360275|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
131202020|NCT01451203|472360274|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
131202021|NCT01451203|472360275|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
131202022|NCT01451203|472360274|FG000|Double-blind Treatment Period|Investigator decision|2|||
131202023|NCT01451203|472360275|FG001|Double-blind Treatment Period|Investigator decision|0|||
131202024|NCT01451203|472360274|FG000|Post-treatment Period|Consent withdrawn|2|||
131202025|NCT01451203|472360275|FG001|Post-treatment Period|Consent withdrawn|4|||
131202026|NCT01451203|472360274|FG000|Post-treatment Period|Lack of Efficacy|12|||
131202027|NCT01451203|472360275|FG001|Post-treatment Period|Lack of Efficacy|28|||
131202028|NCT01451203|472360274|FG000|Post-treatment Period|Adverse Event|0|||
131202029|NCT01451203|472360275|FG001|Post-treatment Period|Adverse Event|1|||
131202030|NCT01451203|472360274|FG000|Post-treatment Period|Investigator decision|0|||
131202031|NCT01451203|472360275|FG001|Post-treatment Period|Investigator decision|1|||
131202032|NCT00027027|472360276|FG000|Overall Study|Adverse Event|0|||
131202033|NCT00027027|472360277|FG001|Overall Study|Adverse Event|0|||
131202034|NCT00027027|472360278|FG002|Overall Study|Adverse Event|1|||
131202035|NCT00027027|472360279|FG003|Overall Study|Adverse Event|0|||
131202036|NCT00027027|472360280|FG004|Overall Study|Adverse Event|1|||
131202037|NCT00027027|472360276|FG000|Overall Study|Admitted for Signs of PD|0|||
131202038|NCT00027027|472360277|FG001|Overall Study|Admitted for Signs of PD|0|||
131202039|NCT00027027|472360278|FG002|Overall Study|Admitted for Signs of PD|0|||
131202040|NCT00027027|472360279|FG003|Overall Study|Admitted for Signs of PD|0|||
131202041|NCT00027027|472360280|FG004|Overall Study|Admitted for Signs of PD|1|||
131202042|NCT00027027|472360276|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
131202043|NCT00027027|472360277|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
131202044|NCT00027027|472360278|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
131202045|NCT00027027|472360279|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
131202046|NCT00027027|472360280|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
131202047|NCT00027027|472360276|FG000|Overall Study|PD Requiring Surgery|0|||
131202048|NCT00027027|472360277|FG001|Overall Study|PD Requiring Surgery|0|||
131202049|NCT00027027|472360278|FG002|Overall Study|PD Requiring Surgery|1|||
131202050|NCT00027027|472360279|FG003|Overall Study|PD Requiring Surgery|0|||
131202051|NCT00027027|472360280|FG004|Overall Study|PD Requiring Surgery|0|||
131202052|NCT00027027|472360276|FG000|Overall Study|Physician Decision Due To PD|2|||
131202053|NCT00027027|472360277|FG001|Overall Study|Physician Decision Due To PD|3|||
131202054|NCT00027027|472360278|FG002|Overall Study|Physician Decision Due To PD|2|||
131202055|NCT00027027|472360279|FG003|Overall Study|Physician Decision Due To PD|3|||
131202056|NCT00027027|472360280|FG004|Overall Study|Physician Decision Due To PD|5|||
131202057|NCT00027027|472360276|FG000|Overall Study|Withdrawal by Subject|0|||
131202058|NCT00027027|472360277|FG001|Overall Study|Withdrawal by Subject|0|||
131202059|NCT00027027|472360278|FG002|Overall Study|Withdrawal by Subject|0|||
131202060|NCT00027027|472360279|FG003|Overall Study|Withdrawal by Subject|0|||
131202061|NCT00027027|472360280|FG004|Overall Study|Withdrawal by Subject|1|||
131202062|NCT05466240|472360284|FG000|Overall Study|Adverse Event|1|||
131202063|NCT05466240|472360285|FG001|Overall Study|Adverse Event|0|||
131202064|NCT05466240|472360284|FG000|Overall Study|Withdrawal by Subject|1|||
131202065|NCT05466240|472360285|FG001|Overall Study|Withdrawal by Subject|0|||
131202066|NCT00305773|472360286|FG000|Overall Study|Death|3|||
131202067|NCT00305773|472360287|FG001|Overall Study|Death|2|||
130784636|NCT00794664|470838856|FG001|Treatment Period|Protocol non-compliance|1|||
131202068|NCT00305773|472360286|FG000|Overall Study|Adverse Event|1|||
131202069|NCT00305773|472360287|FG001|Overall Study|Adverse Event|2|||
131202070|NCT00305773|472360286|FG000|Overall Study|Alternative Treatment|4|||
131202071|NCT00305773|472360287|FG001|Overall Study|Alternative Treatment|4|||
130784637|NCT00794664|470838855|FG000|Treatment Period|Other|0|||
131202072|NCT00305773|472360286|FG000|Overall Study|Physician Decision|1|||
131202073|NCT00305773|472360287|FG001|Overall Study|Physician Decision|1|||
131202074|NCT00305773|472360286|FG000|Overall Study|Withdrawal by Subject|1|||
131202075|NCT00305773|472360287|FG001|Overall Study|Withdrawal by Subject|4|||
130733929|NCT02465398|470645313|FG000|Overall Study|did not receive study device|1|||
130733930|NCT02465398|470645313|FG000|Overall Study|Withdrawal by Subject|1|||
130733931|NCT02465398|470645313|FG000|Overall Study|Lost to Follow-up|14|||
130733932|NCT05244122|470645318|FG000|Overall Study|Withdrawal by Subject|318|||
130733933|NCT00064987|470645323|FG000|Overall Study|Physician Decision|3|||
130733934|NCT00064987|470645324|FG001|Overall Study|Physician Decision|0|||
130733935|NCT02969382|470645325|FG000|Overall Study|Adverse Event|8|||
130733936|NCT02969382|470645326|FG001|Overall Study|Adverse Event|10|||
130733937|NCT02969382|470645325|FG000|Overall Study|Lack of Efficacy|4|||
130784638|NCT00794664|470838856|FG001|Treatment Period|Other|1|||
130784639|NCT00794664|470838855|FG000|Treatment Period|Adverse Event|1|||
130733938|NCT02969382|470645326|FG001|Overall Study|Lack of Efficacy|5|||
130784640|NCT00794664|470838856|FG001|Treatment Period|Adverse Event|8|||
130733939|NCT02969382|470645325|FG000|Overall Study|Death|0|||
130733940|NCT02969382|470645326|FG001|Overall Study|Death|1|||
131202076|NCT00305773|472360286|FG000|Overall Study|Disease Progression|1|||
131202077|NCT00305773|472360287|FG001|Overall Study|Disease Progression|3|||
131202078|NCT00305773|472360286|FG000|Overall Study|All other reasons|3|||
131202079|NCT00305773|472360287|FG001|Overall Study|All other reasons|2|||
131202080|NCT02679222|472360288|FG000|Overall Study|No time for project|1|||
131202081|NCT00413231|472360289|FG000|0 to 30-day Post Treatment|Death|5|||
131202082|NCT00413231|472360289|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
131202083|NCT00413231|472360289|FG000|30-day to 365-day Post Treatment|Death|13|||
131202084|NCT00413231|472360289|FG000|365-day to 60-month Post Treatment|Death|36|||
131202085|NCT00413231|472360289|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
131202086|NCT00413231|472360289|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
131202087|NCT00413231|472360289|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
131202088|NCT00945945|472360294|FG000|Overall Study|Adverse Event|15|||
131202089|NCT00945945|472360295|FG001|Overall Study|Adverse Event|35|||
131202090|NCT00945945|472360294|FG000|Overall Study|Withdrawal by Subject|7|||
131202091|NCT00945945|472360295|FG001|Overall Study|Withdrawal by Subject|10|||
131202092|NCT00945945|472360294|FG000|Overall Study|Lost to Follow-up|4|||
131202093|NCT00945945|472360295|FG001|Overall Study|Lost to Follow-up|5|||
131202094|NCT00945945|472360294|FG000|Overall Study|Lack of Efficacy|6|||
131202095|NCT00945945|472360295|FG001|Overall Study|Lack of Efficacy|2|||
131202096|NCT00945945|472360294|FG000|Overall Study|Protocol Violation|4|||
131202097|NCT00945945|472360295|FG001|Overall Study|Protocol Violation|2|||
131202098|NCT00945945|472360294|FG000|Overall Study|Entry Criteria Not Met|0|||
131202099|NCT00945945|472360295|FG001|Overall Study|Entry Criteria Not Met|1|||
131202100|NCT02408016|472360297|FG000|Overall Study|Death|6|||
131202101|NCT02408016|472360298|FG001|Overall Study|Death|1|||
131202102|NCT02408016|472360299|FG002|Overall Study|Death|0|||
131202103|NCT02408016|472360297|FG000|Overall Study|Physician Decision|0|||
131202104|NCT02408016|472360298|FG001|Overall Study|Physician Decision|2|||
131202105|NCT02408016|472360299|FG002|Overall Study|Physician Decision|0|||
131202106|NCT00805194|472360300|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
131202107|NCT00805194|472360301|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
131202108|NCT00805194|472360300|FG000|Overall Study|Worsening or AE of underlying disease|64|||
131202109|NCT00805194|472360301|FG001|Overall Study|Worsening or AE of underlying disease|70|||
131202110|NCT00805194|472360300|FG000|Overall Study|Other AE|84|||
131202111|NCT00805194|472360301|FG001|Overall Study|Other AE|73|||
131202112|NCT00805194|472360300|FG000|Overall Study|Protocol Violation|9|||
131202113|NCT00805194|472360301|FG001|Overall Study|Protocol Violation|9|||
131202114|NCT00805194|472360300|FG000|Overall Study|Lost to Follow-up|5|||
131202115|NCT00805194|472360301|FG001|Overall Study|Lost to Follow-up|5|||
131202116|NCT00805194|472360300|FG000|Overall Study|Withdrawal by Subject|60|||
131202117|NCT00805194|472360301|FG001|Overall Study|Withdrawal by Subject|42|||
131202118|NCT00805194|472360300|FG000|Overall Study|Not treated|3|||
131202119|NCT00805194|472360301|FG001|Overall Study|Not treated|4|||
131202120|NCT00805194|472360300|FG000|Overall Study|Reasons other than stated above|20|||
131202121|NCT00805194|472360301|FG001|Overall Study|Reasons other than stated above|16|||
131202122|NCT02275052|472360306|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131202123|NCT02275052|472360307|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
131202124|NCT02275052|472360308|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131202125|NCT02275052|472360309|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
131202126|NCT02275052|472360306|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
131202127|NCT02275052|472360307|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
131202128|NCT02275052|472360308|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
131202129|NCT02275052|472360309|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
131202130|NCT02275052|472360306|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
131202131|NCT02275052|472360307|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
131202132|NCT02275052|472360308|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131202133|NCT02275052|472360309|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
131202134|NCT02275052|472360306|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
131202135|NCT02275052|472360307|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
131202136|NCT02275052|472360308|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
131202137|NCT02275052|472360309|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
131202138|NCT02275052|472360306|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
131202139|NCT02275052|472360307|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
131202140|NCT02275052|472360308|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
130733941|NCT02969382|470645325|FG000|Overall Study|PROTOCOL DEVIATION|0|||
130733942|NCT02969382|470645326|FG001|Overall Study|PROTOCOL DEVIATION|1|||
130733943|NCT02969382|470645325|FG000|Overall Study|Withdrawal by Subject|14|||
130733944|NCT02969382|470645326|FG001|Overall Study|Withdrawal by Subject|9|||
130733945|NCT00764881|470645327|FG000|Overall Study|Adverse Event|5|||
130733946|NCT00764881|470645328|FG001|Overall Study|Adverse Event|1|||
130733947|NCT00764881|470645327|FG000|Overall Study|Withdrawal by Subject|1|||
130733948|NCT00764881|470645328|FG001|Overall Study|Withdrawal by Subject|3|||
130733949|NCT00764881|470645327|FG000|Overall Study|Protocol Violation|2|||
130733950|NCT00764881|470645328|FG001|Overall Study|Protocol Violation|2|||
130733951|NCT00764881|470645327|FG000|Overall Study|Lost to Follow-up|2|||
130733952|NCT00764881|470645328|FG001|Overall Study|Lost to Follow-up|0|||
131202141|NCT02275052|472360309|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
131202142|NCT02275052|472360306|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
131202143|NCT02275052|472360307|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
131202144|NCT02275052|472360308|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
131202145|NCT02275052|472360309|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
131202146|NCT02275052|472360306|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
131202147|NCT02275052|472360307|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
131202148|NCT02275052|472360308|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
131202149|NCT02275052|472360309|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
131202150|NCT02275052|472360306|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
131202151|NCT02275052|472360307|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
131202152|NCT02275052|472360308|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
131202153|NCT02275052|472360309|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
131202154|NCT02275052|472360306|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131202155|NCT02275052|472360307|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
131202156|NCT02275052|472360308|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
131202157|NCT02275052|472360309|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
131202158|NCT02275052|472360306|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
131202159|NCT02275052|472360307|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
131202160|NCT02275052|472360308|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
131202161|NCT02275052|472360309|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
131202162|NCT02275052|472360306|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131202163|NCT02275052|472360307|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131202164|NCT02275052|472360308|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
131202165|NCT02275052|472360309|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
131202166|NCT00846027|472360312|FG000|Overall Study|Death|3|||
131202167|NCT00846027|472360312|FG000|Overall Study|Disease Progression|30|||
131202168|NCT00846027|472360312|FG000|Overall Study|Toxicity|12|||
131202169|NCT00846027|472360312|FG000|Overall Study|Patient Decision|7|||
131202170|NCT00846027|472360312|FG000|Overall Study|Investigator Discretion|29|||
131202171|NCT00846027|472360312|FG000|Overall Study|Protocol Violation|2|||
131202172|NCT00846027|472360312|FG000|Overall Study|Subject Not Treated|7|||
131202173|NCT01797302|472360313|FG000|Overall Study|Lost to Follow-up|16|||
131202174|NCT01797302|472360314|FG001|Overall Study|Lost to Follow-up|23|||
131202175|NCT01797302|472360315|FG002|Overall Study|Lost to Follow-up|22|||
131202176|NCT01797302|472360313|FG000|Overall Study|Withdrawal by Subject|1|||
131202177|NCT01797302|472360314|FG001|Overall Study|Withdrawal by Subject|3|||
131202178|NCT01797302|472360315|FG002|Overall Study|Withdrawal by Subject|4|||
131202179|NCT03228836|472360316|FG000|Overall Study|Adverse Event|3|||
131202180|NCT03228836|472360316|FG000|Overall Study|Withdrawal by Subject|1|||
131202181|NCT03228836|472360316|FG000|Overall Study|Death|1|||
131202182|NCT03228836|472360316|FG000|Overall Study|Physician Decision|1|||
131202183|NCT03228836|472360316|FG000|Overall Study|Disease Progression|7|||
131202184|NCT03228836|472360316|FG000|Overall Study|Other|4|||
131202185|NCT02773849|472360318|FG000|Overall Study|Lost to Follow-up|11|||
131202186|NCT02773849|472360318|FG000|Overall Study|Death|26|||
130733953|NCT00764881|470645327|FG000|Overall Study|Noncompliant|1|||
130733954|NCT00764881|470645328|FG001|Overall Study|Noncompliant|0|||
130733955|NCT00764881|470645327|FG000|Overall Study|Accidentally discontinued study drug|1|||
131202187|NCT02773849|472360318|FG000|Overall Study|Withdrawal by Subject|5|||
131202188|NCT02773849|472360318|FG000|Overall Study|Withdrawal of Consent|9|||
130733956|NCT00764881|470645328|FG001|Overall Study|Accidentally discontinued study drug|0|||
130733957|NCT00764881|470645327|FG000|Overall Study|Wished to become pregnant|1|||
131202189|NCT02773849|472360318|FG000|Overall Study|Other: not due to lack of tolerability|11|||
131202190|NCT02418000|472360323|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
131202191|NCT02418000|472360324|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
131202192|NCT02418000|472360325|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
131202193|NCT02418000|472360326|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
131202194|NCT02418000|472360327|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
130733958|NCT00764881|470645328|FG001|Overall Study|Wished to become pregnant|0|||
130733959|NCT00764881|470645327|FG000|Overall Study|Carcinoma detected|1|||
130733960|NCT00764881|470645328|FG001|Overall Study|Carcinoma detected|0|||
130733961|NCT00764881|470645327|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
130784641|NCT00794664|470838855|FG000|Follow-up Period|Other|1|||
130784642|NCT00794664|470838856|FG001|Follow-up Period|Other|2|||
130733962|NCT00764881|470645328|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
130733963|NCT00764881|470645327|FG000|Overall Study|no treatment or no observation|2|||
130733964|NCT00764881|470645328|FG001|Overall Study|no treatment or no observation|2|||
130733965|NCT01567462|470645329|FG000|Overall Study|Withdrawal by Subject|4|||
130733966|NCT01567462|470645330|FG001|Overall Study|Withdrawal by Subject|7|||
130733967|NCT01977417|470645338|FG000|Overall Study|Adverse Event|1|||
130733968|NCT01977417|470645339|FG001|Overall Study|Adverse Event|0|||
130733969|NCT01977417|470645338|FG000|Overall Study|Withdrawal by Subject|2|||
130733970|NCT01977417|470645339|FG001|Overall Study|Withdrawal by Subject|4|||
130733971|NCT01977417|470645338|FG000|Overall Study|Female enrollment goal met|0|||
130784643|NCT00794664|470838855|FG000|Follow-up Period|Withdrawal by Subject|0|||
131202195|NCT02418000|472360323|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
131202196|NCT02418000|472360324|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
131202197|NCT02418000|472360325|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
131202198|NCT02418000|472360326|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
131202199|NCT02418000|472360327|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
131202200|NCT02418000|472360323|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
131202201|NCT02418000|472360324|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
131202202|NCT02418000|472360325|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
131202203|NCT02418000|472360326|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
131202204|NCT02418000|472360327|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
131202205|NCT02418000|472360323|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
131202206|NCT02418000|472360324|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
131202207|NCT02418000|472360325|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
131202208|NCT02418000|472360326|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
131202209|NCT02418000|472360327|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
131202210|NCT02418000|472360323|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
131202211|NCT02418000|472360324|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
131202212|NCT02418000|472360325|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
131202213|NCT02418000|472360326|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
131202214|NCT02418000|472360327|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
131202215|NCT02418000|472360323|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202216|NCT02418000|472360324|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202217|NCT02418000|472360325|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
131202218|NCT02418000|472360326|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202219|NCT02418000|472360327|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202220|NCT02418000|472360323|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202221|NCT02418000|472360324|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202222|NCT02418000|472360325|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202223|NCT02418000|472360326|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
131202224|NCT02418000|472360327|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202225|NCT02418000|472360323|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
131202226|NCT02418000|472360324|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
131202227|NCT02418000|472360325|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
131202228|NCT02418000|472360326|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
131202229|NCT02418000|472360327|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
131202230|NCT02418000|472360323|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202231|NCT02418000|472360324|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202232|NCT02418000|472360325|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202233|NCT02418000|472360326|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
131202234|NCT02418000|472360327|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
131202235|NCT01412333|472360336|FG000|Overall Study|Adverse Event|40|||
131202236|NCT01412333|472360337|FG001|Overall Study|Adverse Event|42|||
131202237|NCT01412333|472360336|FG000|Overall Study|Death|5|||
131202238|NCT01412333|472360337|FG001|Overall Study|Death|6|||
131202239|NCT01412333|472360336|FG000|Overall Study|Lack of Efficacy|22|||
131202240|NCT01412333|472360337|FG001|Overall Study|Lack of Efficacy|10|||
131202241|NCT01412333|472360336|FG000|Overall Study|Lost to Follow-up|15|||
131202242|NCT01412333|472360337|FG001|Overall Study|Lost to Follow-up|12|||
131202243|NCT01412333|472360336|FG000|Overall Study|Non-Compliance|3|||
131202244|NCT01412333|472360337|FG001|Overall Study|Non-Compliance|7|||
131202245|NCT01412333|472360336|FG000|Overall Study|Non-Compliance With Study Drug|1|||
131202246|NCT01412333|472360337|FG001|Overall Study|Non-Compliance With Study Drug|1|||
131202247|NCT01412333|472360336|FG000|Overall Study|Other|30|||
130733972|NCT01977417|470645339|FG001|Overall Study|Female enrollment goal met|2|||
130733973|NCT01692626|470645340|FG000|Overall Study|Death|0|||
131202248|NCT01412333|472360337|FG001|Overall Study|Other|33|||
131202249|NCT01412333|472360336|FG000|Overall Study|Physician Decision|11|||
131202250|NCT01412333|472360337|FG001|Overall Study|Physician Decision|16|||
131202251|NCT01412333|472360336|FG000|Overall Study|Pregnancy|6|||
131202252|NCT01412333|472360337|FG001|Overall Study|Pregnancy|4|||
130733974|NCT01692626|470645341|FG001|Overall Study|Death|1|||
130733975|NCT01692626|470645340|FG000|Overall Study|Adverse Event|2|||
130733976|NCT01692626|470645341|FG001|Overall Study|Adverse Event|3|||
130733977|NCT01692626|470645340|FG000|Overall Study|Protocol Violation|1|||
130733978|NCT01692626|470645341|FG001|Overall Study|Protocol Violation|2|||
130733979|NCT01692626|470645340|FG000|Overall Study|Withdrawal by Subject|1|||
130733980|NCT01692626|470645341|FG001|Overall Study|Withdrawal by Subject|0|||
130733981|NCT00855894|470645344|FG000|Overall Study|Death|31|||
130733982|NCT00855894|470645344|FG000|Overall Study|Patient's decision|1|||
130733983|NCT00855894|470645344|FG000|Overall Study|Disease progression|1|||
130733984|NCT02422797|470645345|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
130733985|NCT02422797|470645346|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
130733986|NCT02422797|470645345|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
130733987|NCT02422797|470645346|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
130733988|NCT02422797|470645345|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
130733989|NCT02422797|470645346|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
130733990|NCT02422797|470645345|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
130733991|NCT02422797|470645346|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
130733992|NCT02422797|470645345|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
130733993|NCT02422797|470645346|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
130733994|NCT02422797|470645345|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
130733995|NCT02422797|470645346|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
130733996|NCT02422797|470645345|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
130733997|NCT02422797|470645346|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
130733998|NCT02422797|470645345|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
130733999|NCT02422797|470645346|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
130734000|NCT02422797|470645345|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
130734001|NCT02422797|470645346|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
130734002|NCT02422797|470645345|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
130734003|NCT02422797|470645346|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
130734004|NCT02422797|470645345|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
130734005|NCT02422797|470645346|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
130734006|NCT02422797|470645345|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
130734007|NCT02422797|470645346|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
130734008|NCT02422797|470645345|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
130734009|NCT02422797|470645346|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
130734010|NCT02422797|470645345|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
130734011|NCT02422797|470645346|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
130734012|NCT02422797|470645345|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
130734013|NCT02422797|470645346|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
130734014|NCT02422797|470645345|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
130734015|NCT02422797|470645346|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
130734016|NCT02422797|470645345|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
130734017|NCT02422797|470645346|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
130734018|NCT02422797|470645345|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
130734019|NCT02422797|470645346|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
130734020|NCT02422797|470645345|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
130734021|NCT02422797|470645346|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
130734022|NCT02422797|470645345|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
130734023|NCT02422797|470645346|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
130734024|NCT02422797|470645345|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
130734025|NCT02422797|470645346|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
130734026|NCT04071405|470645347|FG000|Overall Study|Protocol Violation|3|||
130734027|NCT00369941|470645348|FG000|Overall Study|Never Treated|1|||
130734028|NCT00369941|470645349|FG001|Overall Study|Never Treated|2|||
130734029|NCT00369941|470645348|FG000|Overall Study|Adverse Event|14|||
130734030|NCT00369941|470645349|FG001|Overall Study|Adverse Event|28|||
130734031|NCT00369941|470645348|FG000|Overall Study|Lack of Efficacy|6|||
130734032|NCT00369941|470645349|FG001|Overall Study|Lack of Efficacy|10|||
130734033|NCT00369941|470645348|FG000|Overall Study|Lost to Follow-up|12|||
130734034|NCT00369941|470645349|FG001|Overall Study|Lost to Follow-up|22|||
130734035|NCT00369941|470645348|FG000|Overall Study|Protocol Violation|5|||
130734036|NCT00369941|470645349|FG001|Overall Study|Protocol Violation|3|||
130734037|NCT00369941|470645348|FG000|Overall Study|Withdrawal by Subject|5|||
130734038|NCT00369941|470645349|FG001|Overall Study|Withdrawal by Subject|18|||
130734039|NCT00369941|470645348|FG000|Overall Study|Pregnancy|4|||
130734040|NCT00369941|470645349|FG001|Overall Study|Pregnancy|2|||
130734041|NCT00369941|470645348|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
130734042|NCT00369941|470645349|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
130734043|NCT00369941|470645348|FG000|Overall Study|Moved|11|||
130734044|NCT00369941|470645349|FG001|Overall Study|Moved|5|||
130734045|NCT00369941|470645348|FG000|Overall Study|Treatment with Prohibited Medication|3|||
130734046|NCT00369941|470645349|FG001|Overall Study|Treatment with Prohibited Medication|1|||
130734047|NCT00369941|470645348|FG000|Overall Study|Employment Interfered with Study Visits|1|||
130734048|NCT00369941|470645349|FG001|Overall Study|Employment Interfered with Study Visits|0|||
130734049|NCT00369941|470645348|FG000|Overall Study|Study Site Terminated|2|||
131202253|NCT01412333|472360336|FG000|Overall Study|Protocol Violation|1|||
131202254|NCT01412333|472360337|FG001|Overall Study|Protocol Violation|2|||
131202255|NCT01412333|472360336|FG000|Overall Study|Study Terminated By Sponsor|3|||
131202256|NCT01412333|472360337|FG001|Overall Study|Study Terminated By Sponsor|2|||
131202257|NCT01412333|472360336|FG000|Overall Study|Withdrawal by Subject|51|||
131202258|NCT01412333|472360337|FG001|Overall Study|Withdrawal by Subject|54|||
131202259|NCT01412333|472360336|FG000|Overall Study|Missing|1|||
131202260|NCT01412333|472360337|FG001|Overall Study|Missing|3|||
131202261|NCT00750867|472360338|FG000|Overall Study|Adverse Event|2|||
131202262|NCT02516306|472360339|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
131202263|NCT02516306|472360340|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
131202264|NCT00242710|472360342|FG000|Core Study (up to Year 1)|Adverse Event|30|||
131202265|NCT00242710|472360343|FG001|Core Study (up to Year 1)|Adverse Event|25|||
131202266|NCT00242710|472360344|FG002|Core Study (up to Year 1)|Adverse Event|23|||
131202267|NCT00242710|472360345|FG003|Core Study (up to Year 1)|Adverse Event|14|||
131202268|NCT00242710|472360342|FG000|Core Study (up to Year 1)|Death|0|||
131202269|NCT00242710|472360343|FG001|Core Study (up to Year 1)|Death|0|||
131202270|NCT00242710|472360344|FG002|Core Study (up to Year 1)|Death|1|||
131202271|NCT00242710|472360345|FG003|Core Study (up to Year 1)|Death|0|||
131202272|NCT00242710|472360342|FG000|Core Study (up to Year 1)|Physician Decision|0|||
131202273|NCT00242710|472360343|FG001|Core Study (up to Year 1)|Physician Decision|1|||
131202274|NCT00242710|472360344|FG002|Core Study (up to Year 1)|Physician Decision|0|||
131202275|NCT00242710|472360345|FG003|Core Study (up to Year 1)|Physician Decision|1|||
131202276|NCT00242710|472360342|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
131202277|NCT00242710|472360343|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
131202278|NCT00242710|472360344|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
131202279|NCT00242710|472360345|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
131202280|NCT00242710|472360342|FG000|Core Study (up to Year 1)|Other|6|||
131202281|NCT00242710|472360343|FG001|Core Study (up to Year 1)|Other|1|||
131202282|NCT00242710|472360344|FG002|Core Study (up to Year 1)|Other|0|||
131202283|NCT00242710|472360345|FG003|Core Study (up to Year 1)|Other|2|||
131202284|NCT00242710|472360342|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
131202285|NCT00242710|472360343|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
131202286|NCT00242710|472360344|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
131202287|NCT00242710|472360345|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
131202288|NCT00242710|472360342|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
131202289|NCT00242710|472360343|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
131202290|NCT00242710|472360344|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
131202291|NCT00242710|472360345|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
131202292|NCT00242710|472360342|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
131202293|NCT00242710|472360343|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
131202294|NCT00242710|472360344|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
131202295|NCT00242710|472360345|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
131202296|NCT00242710|472360342|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
131202297|NCT00242710|472360343|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
131202298|NCT00242710|472360344|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
131202299|NCT00242710|472360345|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
131202300|NCT00242710|472360342|FG000|Period Between Core Study and Extension|Adverse Event|2|||
131202301|NCT00242710|472360343|FG001|Period Between Core Study and Extension|Adverse Event|3|||
131202302|NCT00242710|472360344|FG002|Period Between Core Study and Extension|Adverse Event|5|||
131202303|NCT00242710|472360345|FG003|Period Between Core Study and Extension|Adverse Event|2|||
131202304|NCT00242710|472360342|FG000|Period Between Core Study and Extension|Physician Decision|1|||
131202305|NCT00242710|472360343|FG001|Period Between Core Study and Extension|Physician Decision|1|||
131202306|NCT00242710|472360344|FG002|Period Between Core Study and Extension|Physician Decision|0|||
131202307|NCT00242710|472360345|FG003|Period Between Core Study and Extension|Physician Decision|0|||
131202308|NCT00242710|472360342|FG000|Period Between Core Study and Extension|Other|24|||
131202309|NCT00242710|472360343|FG001|Period Between Core Study and Extension|Other|24|||
131202310|NCT00242710|472360344|FG002|Period Between Core Study and Extension|Other|9|||
131202311|NCT00242710|472360345|FG003|Period Between Core Study and Extension|Other|11|||
131202312|NCT00242710|472360342|FG000|Period Between Core Study and Extension|Extension not Available|17|||
131202313|NCT00242710|472360343|FG001|Period Between Core Study and Extension|Extension not Available|21|||
131202314|NCT00242710|472360344|FG002|Period Between Core Study and Extension|Extension not Available|8|||
131202315|NCT00242710|472360345|FG003|Period Between Core Study and Extension|Extension not Available|7|||
131202316|NCT00242710|472360342|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
131202317|NCT00242710|472360343|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
131202318|NCT00242710|472360344|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
131202319|NCT00242710|472360345|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
131202320|NCT00242710|472360342|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
131202321|NCT00242710|472360343|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
130734050|NCT00369941|470645349|FG001|Overall Study|Study Site Terminated|0|||
130734051|NCT00369941|470645348|FG000|Overall Study|Miscellaneous|3|||
130734052|NCT00369941|470645349|FG001|Overall Study|Miscellaneous|3|||
130734053|NCT00403585|470645350|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
130734054|NCT00403585|470645350|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
130734055|NCT00403585|470645350|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
131202322|NCT00242710|472360344|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
131202323|NCT00242710|472360345|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
131202324|NCT00242710|472360342|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
131202325|NCT00242710|472360343|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
131202326|NCT00242710|472360344|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
131202327|NCT00242710|472360345|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
131202328|NCT00242710|472360342|FG000|Study Extension (up to Year 2)|Death|0|||
131202329|NCT00242710|472360343|FG001|Study Extension (up to Year 2)|Death|0|||
131202330|NCT00242710|472360344|FG002|Study Extension (up to Year 2)|Death|0|||
131202331|NCT00242710|472360345|FG003|Study Extension (up to Year 2)|Death|1|||
131202332|NCT00242710|472360342|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
131202333|NCT00242710|472360343|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
131202334|NCT00242710|472360344|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
131202335|NCT00242710|472360345|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
131202336|NCT00242710|472360342|FG000|Study Extension (up to Year 2)|Other|3|||
131202337|NCT00242710|472360343|FG001|Study Extension (up to Year 2)|Other|5|||
131202338|NCT00242710|472360344|FG002|Study Extension (up to Year 2)|Other|4|||
131202339|NCT00242710|472360345|FG003|Study Extension (up to Year 2)|Other|3|||
131202340|NCT00242710|472360342|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
131202341|NCT00242710|472360343|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
131202342|NCT00242710|472360344|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
131202343|NCT00242710|472360345|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
131202344|NCT00242710|472360342|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
131202345|NCT00242710|472360343|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
131202346|NCT00242710|472360344|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
131202347|NCT00242710|472360345|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
131202348|NCT00579527|472360346|FG000|Overall Study|Death|4|||
131202349|NCT03490734|472360357|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
131202350|NCT03490734|472360358|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
131202351|NCT03490734|472360359|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
131202352|NCT03490734|472360360|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
131202353|NCT03490734|472360357|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
131202354|NCT03490734|472360358|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
131202355|NCT03490734|472360359|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
130734056|NCT02276807|470645351|FG000|Overall Study|Withdrawal by Subject|8|||
131202356|NCT03490734|472360360|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
131202357|NCT03490734|472360357|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
131202358|NCT03490734|472360358|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
131202359|NCT03490734|472360359|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
131202360|NCT03490734|472360360|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
131202361|NCT03490734|472360357|FG000|Post-intervention Scan Visit|Adverse Event|2|||
131202362|NCT03490734|472360358|FG001|Post-intervention Scan Visit|Adverse Event|0|||
131202363|NCT03490734|472360359|FG002|Post-intervention Scan Visit|Adverse Event|0|||
131202364|NCT03490734|472360360|FG003|Post-intervention Scan Visit|Adverse Event|0|||
131202365|NCT03490734|472360357|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
131202366|NCT03490734|472360358|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
131202367|NCT03490734|472360359|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
131202368|NCT03490734|472360360|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
131202369|NCT03490734|472360357|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
131202370|NCT03490734|472360358|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
131202371|NCT03490734|472360359|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
131202372|NCT03490734|472360360|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
131202373|NCT01955005|472360367|FG000|Overall Study|Withdrawal by Subject|3|||
131202374|NCT01955005|472360368|FG001|Overall Study|Withdrawal by Subject|5|||
131202375|NCT00887913|472360369|FG000|Overall Study|Withdrawal by Subject|6|||
131202376|NCT04491591|472360371|FG000|Overall Study|Accidently randomized|3|||
131202377|NCT04491591|472360372|FG001|Overall Study|Accidently randomized|1|||
131202378|NCT04491591|472360373|FG002|Overall Study|Accidently randomized|0|||
131202379|NCT04491591|472360371|FG000|Overall Study|Did not complete survey|28|||
131202380|NCT04491591|472360372|FG001|Overall Study|Did not complete survey|20|||
131202381|NCT04491591|472360373|FG002|Overall Study|Did not complete survey|3|||
131202382|NCT00135694|472360374|FG000|Overall Study|Adverse Event|17|||
131202383|NCT00135694|472360375|FG001|Overall Study|Adverse Event|4|||
130784644|NCT00794664|470838856|FG001|Follow-up Period|Withdrawal by Subject|2|||
130784645|NCT00794664|470838855|FG000|Follow-up Period|Protocol non-compliance|0|||
130784646|NCT00794664|470838856|FG001|Follow-up Period|Protocol non-compliance|1|||
130784647|NCT01305564|470838859|FG000|Overall Study|Death|21|||
130734057|NCT02276807|470645352|FG001|Overall Study|Withdrawal by Subject|7|||
130734058|NCT02276807|470645351|FG000|Overall Study|Lost to Follow-up|10|||
130734059|NCT02276807|470645352|FG001|Overall Study|Lost to Follow-up|10|||
130734060|NCT03971474|470645353|FG000|Overall Study|Adverse Event|11|||
130734061|NCT03971474|470645354|FG001|Overall Study|Adverse Event|7|||
130734062|NCT03971474|470645353|FG000|Overall Study|Refusal unrelated to adverse event|5|||
130734063|NCT03971474|470645354|FG001|Overall Study|Refusal unrelated to adverse event|1|||
130734064|NCT03971474|470645353|FG000|Overall Study|Progression/relapse|40|||
130734065|NCT03971474|470645354|FG001|Overall Study|Progression/relapse|47|||
130734066|NCT03971474|470645353|FG000|Overall Study|Death|6|||
130734067|NCT03971474|470645354|FG001|Overall Study|Death|3|||
130734068|NCT03971474|470645353|FG000|Overall Study|Other - not protocol specified|5|||
130734069|NCT03971474|470645354|FG001|Overall Study|Other - not protocol specified|4|||
130734070|NCT03971474|470645353|FG000|Overall Study|On treatment|0|||
130734071|NCT03971474|470645354|FG001|Overall Study|On treatment|7|||
130734072|NCT00261950|470645361|FG000|Overall Study|Lost to Follow-up|2|||
130734073|NCT00261950|470645361|FG000|Overall Study|Death|6|||
130734074|NCT00261950|470645361|FG000|Overall Study|Withdrawal by Subject|5|||
130734075|NCT00261950|470645361|FG000|Overall Study|Other|1|||
130734076|NCT00261950|470645361|FG000|Overall Study|Physician Decision|1|||
130734077|NCT00261950|470645361|FG000|Overall Study|Protocol specified Criteria|11|||
130734078|NCT01937871|470645362|FG000|Overall Study|Adverse Event|6|||
130734079|NCT01937871|470645363|FG001|Overall Study|Adverse Event|6|||
130734080|NCT01937871|470645364|FG002|Overall Study|Adverse Event|2|||
130734081|NCT01937871|470645362|FG000|Overall Study|Lost to Follow-up|8|||
130734082|NCT01937871|470645363|FG001|Overall Study|Lost to Follow-up|2|||
130734083|NCT01937871|470645364|FG002|Overall Study|Lost to Follow-up|4|||
130734084|NCT01937871|470645362|FG000|Overall Study|Withdrawal by Subject|9|||
130734085|NCT01937871|470645363|FG001|Overall Study|Withdrawal by Subject|6|||
130734086|NCT01937871|470645364|FG002|Overall Study|Withdrawal by Subject|4|||
130734087|NCT01937871|470645362|FG000|Overall Study|Physician Decision|0|||
130734088|NCT01937871|470645363|FG001|Overall Study|Physician Decision|1|||
130734089|NCT01937871|470645364|FG002|Overall Study|Physician Decision|0|||
130734090|NCT01937871|470645362|FG000|Overall Study|Entry Criteria Not Met|1|||
130734091|NCT01937871|470645363|FG001|Overall Study|Entry Criteria Not Met|2|||
130734092|NCT01937871|470645364|FG002|Overall Study|Entry Criteria Not Met|1|||
130734093|NCT00577863|470645371|FG000|Overall Study|Adverse Event|4|||
130734094|NCT00577863|470645372|FG001|Overall Study|Adverse Event|2|||
130734095|NCT00577863|470645371|FG000|Overall Study|Death|1|||
130734096|NCT00577863|470645372|FG001|Overall Study|Death|0|||
130734097|NCT00577863|470645371|FG000|Overall Study|Lost to Follow-up|2|||
130734098|NCT00577863|470645372|FG001|Overall Study|Lost to Follow-up|2|||
130734099|NCT00577863|470645371|FG000|Overall Study|Entry Criteria Exclusion|1|||
130734100|NCT00577863|470645372|FG001|Overall Study|Entry Criteria Exclusion|0|||
130734101|NCT00577863|470645371|FG000|Overall Study|Withdrawal by Subject|0|||
130734102|NCT00577863|470645372|FG001|Overall Study|Withdrawal by Subject|2|||
130734103|NCT00577863|470645371|FG000|Overall Study|Sponsor Decision|2|||
130734104|NCT00577863|470645372|FG001|Overall Study|Sponsor Decision|7|||
131202384|NCT00135694|472360376|FG002|Overall Study|Adverse Event|0|||
131202385|NCT00135694|472360374|FG000|Overall Study|Death|14|||
131202386|NCT00135694|472360375|FG001|Overall Study|Death|1|||
131202387|NCT00135694|472360376|FG002|Overall Study|Death|2|||
131202388|NCT00135694|472360374|FG000|Overall Study|Lost to Follow-up|8|||
131202389|NCT00135694|472360375|FG001|Overall Study|Lost to Follow-up|7|||
131202390|NCT00135694|472360376|FG002|Overall Study|Lost to Follow-up|1|||
131202391|NCT00135694|472360374|FG000|Overall Study|Withdrawal by Subject|41|||
131202392|NCT00135694|472360375|FG001|Overall Study|Withdrawal by Subject|7|||
131202393|NCT00135694|472360376|FG002|Overall Study|Withdrawal by Subject|4|||
131202394|NCT00135694|472360374|FG000|Overall Study|Protocol Violation|19|||
131202395|NCT00135694|472360375|FG001|Overall Study|Protocol Violation|1|||
131202396|NCT00135694|472360376|FG002|Overall Study|Protocol Violation|0|||
131202397|NCT00135694|472360374|FG000|Overall Study|Hepatitis C related reasons|39|||
131202398|NCT00135694|472360375|FG001|Overall Study|Hepatitis C related reasons|1|||
131202399|NCT00135694|472360376|FG002|Overall Study|Hepatitis C related reasons|0|||
131202400|NCT00135694|472360374|FG000|Overall Study|Ineligible for Random assignment|42|||
131202401|NCT00135694|472360375|FG001|Overall Study|Ineligible for Random assignment|0|||
131202402|NCT00135694|472360376|FG002|Overall Study|Ineligible for Random assignment|0|||
131202403|NCT00420212|472360377|FG000|Overall Study|Adverse Event|22|||
131202404|NCT00420212|472360378|FG001|Overall Study|Adverse Event|40|||
131202405|NCT00420212|472360379|FG002|Overall Study|Adverse Event|36|||
131202406|NCT00420212|472360377|FG000|Overall Study|Lost to Follow-up|9|||
131202407|NCT00420212|472360378|FG001|Overall Study|Lost to Follow-up|11|||
131202408|NCT00420212|472360379|FG002|Overall Study|Lost to Follow-up|11|||
131202409|NCT00420212|472360377|FG000|Overall Study|Withdrawal by Subject|31|||
131202410|NCT00420212|472360378|FG001|Overall Study|Withdrawal by Subject|22|||
130734105|NCT00577863|470645371|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
131202411|NCT00420212|472360379|FG002|Overall Study|Withdrawal by Subject|19|||
131202412|NCT00420212|472360377|FG000|Overall Study|Physician Decision|4|||
131202413|NCT00420212|472360378|FG001|Overall Study|Physician Decision|4|||
130734106|NCT00577863|470645372|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
130734107|NCT00668317|470645377|FG000|Overall Study|Adverse Event|2|||
130734108|NCT05211726|470645386|FG000|Overall Study|Withdrawal by Subject|2|||
130734109|NCT05211726|470645387|FG001|Overall Study|Withdrawal by Subject|3|||
130734110|NCT05211726|470645386|FG000|Overall Study|Protocol Violation|0|||
130734111|NCT05211726|470645387|FG001|Overall Study|Protocol Violation|1|||
130734112|NCT03509467|470645388|FG000|Overall Study|Withdrawal by Subject|5|||
130734113|NCT03509467|470645389|FG001|Overall Study|Withdrawal by Subject|1|||
130734114|NCT03509467|470645390|FG002|Overall Study|Withdrawal by Subject|6|||
130734115|NCT03509467|470645391|FG003|Overall Study|Withdrawal by Subject|7|||
130734116|NCT03509467|470645392|FG004|Overall Study|Withdrawal by Subject|10|||
130734117|NCT03509467|470645393|FG005|Overall Study|Withdrawal by Subject|10|||
130734118|NCT03509467|470645394|FG006|Overall Study|Withdrawal by Subject|10|||
130734119|NCT03509467|470645395|FG007|Overall Study|Withdrawal by Subject|10|||
130734120|NCT03509467|470645388|FG000|Overall Study|Death|0|||
130734121|NCT03509467|470645389|FG001|Overall Study|Death|0|||
130734122|NCT03509467|470645390|FG002|Overall Study|Death|2|||
130734123|NCT03509467|470645391|FG003|Overall Study|Death|2|||
130734124|NCT03509467|470645392|FG004|Overall Study|Death|1|||
130734125|NCT03509467|470645393|FG005|Overall Study|Death|0|||
130734126|NCT03509467|470645394|FG006|Overall Study|Death|1|||
130734127|NCT03509467|470645395|FG007|Overall Study|Death|0|||
130734128|NCT03509467|470645388|FG000|Overall Study|Proxy Withdrawal|0|||
130734129|NCT03509467|470645389|FG001|Overall Study|Proxy Withdrawal|0|||
130734130|NCT03509467|470645390|FG002|Overall Study|Proxy Withdrawal|0|||
130734131|NCT03509467|470645391|FG003|Overall Study|Proxy Withdrawal|0|||
130734132|NCT03509467|470645392|FG004|Overall Study|Proxy Withdrawal|0|||
130734133|NCT03509467|470645393|FG005|Overall Study|Proxy Withdrawal|0|||
130734134|NCT03509467|470645394|FG006|Overall Study|Proxy Withdrawal|0|||
130734135|NCT03509467|470645395|FG007|Overall Study|Proxy Withdrawal|1|||
130734136|NCT02829918|470645397|FG000|Overall Study|Death|2|||
130734137|NCT02829918|470645397|FG000|Overall Study|Withdrawal by Subject|4|||
130734138|NCT02829918|470645397|FG000|Overall Study|Adverse Event|1|||
130734139|NCT02829918|470645397|FG000|Overall Study|Progression|1|||
130734140|NCT03340974|470645404|FG000|Completion of Study -Long Term Follow up|Death|8|||
130734141|NCT03340974|470645405|FG001|Completion of Study -Long Term Follow up|Death|5|||
130734142|NCT03340974|470645406|FG002|Completion of Study -Long Term Follow up|Death|5|||
130734143|NCT03340974|470645407|FG003|Completion of Study -Long Term Follow up|Death|7|||
130734144|NCT03340974|470645404|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
130734145|NCT03340974|470645405|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
130734146|NCT03340974|470645406|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
130734147|NCT03340974|470645407|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
130734148|NCT03340974|470645404|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
131202414|NCT00420212|472360379|FG002|Overall Study|Physician Decision|3|||
131202415|NCT00420212|472360377|FG000|Overall Study|Protocol Violation|4|||
131202416|NCT00420212|472360378|FG001|Overall Study|Protocol Violation|4|||
131202417|NCT00420212|472360379|FG002|Overall Study|Protocol Violation|8|||
131202418|NCT00420212|472360377|FG000|Overall Study|Death|0|||
131202419|NCT00420212|472360378|FG001|Overall Study|Death|0|||
131202420|NCT00420212|472360379|FG002|Overall Study|Death|1|||
131202421|NCT00420212|472360377|FG000|Overall Study|Other-Unspecified|21|||
130734149|NCT03340974|470645405|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
130734150|NCT03340974|470645406|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
130734151|NCT03340974|470645407|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
130734152|NCT03340974|470645404|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
130734153|NCT03340974|470645405|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
130734154|NCT03340974|470645406|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
130784648|NCT01305564|470838859|FG000|Overall Study|Lost to Follow-up|12|||
131202422|NCT00420212|472360378|FG001|Overall Study|Other-Unspecified|14|||
131202423|NCT00420212|472360379|FG002|Overall Study|Other-Unspecified|18|||
131202424|NCT01225211|472360381|FG000|Overall Study|Adverse Event|0|||
131202425|NCT01225211|472360382|FG001|Overall Study|Adverse Event|0|||
130734155|NCT03340974|470645407|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
130734156|NCT02466685|470645408|FG000|Overall Study|Adverse Event|5|||
130734157|NCT02466685|470645409|FG001|Overall Study|Adverse Event|2|||
130734158|NCT02466685|470645408|FG000|Overall Study|Lost to Follow-up|1|||
130734159|NCT02466685|470645409|FG001|Overall Study|Lost to Follow-up|1|||
130734160|NCT02466685|470645408|FG000|Overall Study|Withdrawal by Subject|1|||
130734161|NCT02466685|470645409|FG001|Overall Study|Withdrawal by Subject|0|||
130734162|NCT02466685|470645408|FG000|Overall Study|Physician Decision|1|||
130734163|NCT02466685|470645409|FG001|Overall Study|Physician Decision|1|||
130734164|NCT02374346|470645410|FG000|Overall Study|operated or discharged during weekend|48|||
131202426|NCT01225211|472360383|FG002|Overall Study|Adverse Event|1|||
130734165|NCT05299528|470645413|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130784649|NCT01305564|470838859|FG000|Overall Study|Withdrawal by Subject|1|||
131202427|NCT01225211|472360384|FG003|Overall Study|Adverse Event|0|||
131202428|NCT01225211|472360385|FG004|Overall Study|Adverse Event|0|||
131202429|NCT01225211|472360386|FG005|Overall Study|Adverse Event|0|||
131202430|NCT01225211|472360387|FG006|Overall Study|Adverse Event|0|||
131202431|NCT01225211|472360388|FG007|Overall Study|Adverse Event|0|||
131202432|NCT01225211|472360389|FG008|Overall Study|Adverse Event|0|||
131202433|NCT01225211|472360390|FG009|Overall Study|Adverse Event|1|||
131202434|NCT01225211|472360381|FG000|Overall Study|Withdrawal by Subject|0|||
131202435|NCT01225211|472360382|FG001|Overall Study|Withdrawal by Subject|0|||
131202436|NCT01225211|472360383|FG002|Overall Study|Withdrawal by Subject|0|||
131202437|NCT01225211|472360384|FG003|Overall Study|Withdrawal by Subject|0|||
131202438|NCT01225211|472360385|FG004|Overall Study|Withdrawal by Subject|0|||
131202439|NCT01225211|472360386|FG005|Overall Study|Withdrawal by Subject|0|||
131202440|NCT01225211|472360387|FG006|Overall Study|Withdrawal by Subject|1|||
131202441|NCT01225211|472360388|FG007|Overall Study|Withdrawal by Subject|0|||
131202442|NCT01225211|472360389|FG008|Overall Study|Withdrawal by Subject|1|||
131202443|NCT01225211|472360390|FG009|Overall Study|Withdrawal by Subject|3|||
131202444|NCT01225211|472360381|FG000|Overall Study|Other|0|||
131202445|NCT01225211|472360382|FG001|Overall Study|Other|0|||
131202446|NCT01225211|472360383|FG002|Overall Study|Other|0|||
131202447|NCT01225211|472360384|FG003|Overall Study|Other|0|||
131202448|NCT01225211|472360385|FG004|Overall Study|Other|0|||
131202449|NCT01225211|472360386|FG005|Overall Study|Other|0|||
131202450|NCT01225211|472360387|FG006|Overall Study|Other|0|||
131202451|NCT01225211|472360388|FG007|Overall Study|Other|0|||
131202452|NCT01225211|472360389|FG008|Overall Study|Other|0|||
131202453|NCT01225211|472360390|FG009|Overall Study|Other|1|||
131202454|NCT00392210|472360398|FG000|First Voiding Trial|Physician Decision|2|||
131202455|NCT00392210|472360399|FG001|First Voiding Trial|Physician Decision|2|||
131202456|NCT00606021|472360400|FG000|Induction Phase|Death|73|||
131202457|NCT00606021|472360401|FG001|Induction Phase|Death|0|||
131202458|NCT00606021|472360402|FG002|Induction Phase|Death|0|||
131202459|NCT00606021|472360400|FG000|Induction Phase|Physician Decision|2|||
131202460|NCT00606021|472360401|FG001|Induction Phase|Physician Decision|0|||
131202461|NCT00606021|472360402|FG002|Induction Phase|Physician Decision|0|||
131202462|NCT00606021|472360400|FG000|Induction Phase|Withdrawal by Subject|2|||
131202463|NCT00606021|472360401|FG001|Induction Phase|Withdrawal by Subject|0|||
131202464|NCT00606021|472360402|FG002|Induction Phase|Withdrawal by Subject|0|||
131202465|NCT00606021|472360400|FG000|Induction Phase|Lost to Follow-up|10|||
131202466|NCT00606021|472360401|FG001|Induction Phase|Lost to Follow-up|0|||
131202467|NCT00606021|472360402|FG002|Induction Phase|Lost to Follow-up|0|||
131202468|NCT00606021|472360400|FG000|Maintenance Phase|Death|0|||
131202469|NCT00606021|472360401|FG001|Maintenance Phase|Death|17|||
131202470|NCT00606021|472360402|FG002|Maintenance Phase|Death|15|||
131202471|NCT00606021|472360400|FG000|Maintenance Phase|Physician Decision|0|||
131202472|NCT00606021|472360401|FG001|Maintenance Phase|Physician Decision|1|||
131202473|NCT00606021|472360402|FG002|Maintenance Phase|Physician Decision|0|||
131202474|NCT00606021|472360400|FG000|Maintenance Phase|Lost to Follow-up|0|||
131202475|NCT00606021|472360401|FG001|Maintenance Phase|Lost to Follow-up|5|||
131202476|NCT00606021|472360402|FG002|Maintenance Phase|Lost to Follow-up|2|||
131202477|NCT04815291|472360403|FG000|Overall Study|Lost to Follow-up|1|||
131202478|NCT04815291|472360403|FG000|Overall Study|Physician Decision|4|||
131202479|NCT04815291|472360403|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
131202480|NCT02140762|472360404|FG000|Overall Study|Adverse Event|1|||
131202481|NCT02140762|472360405|FG001|Overall Study|Adverse Event|1|||
131202482|NCT02140762|472360404|FG000|Overall Study|Lost to Follow-up|9|||
131202483|NCT02140762|472360405|FG001|Overall Study|Lost to Follow-up|5|||
131202484|NCT02140762|472360404|FG000|Overall Study|Protocol Violation|1|||
131202485|NCT02140762|472360405|FG001|Overall Study|Protocol Violation|1|||
131202486|NCT02140762|472360404|FG000|Overall Study|Withdrawal by Subject|6|||
131202487|NCT02140762|472360405|FG001|Overall Study|Withdrawal by Subject|4|||
131202488|NCT02140762|472360404|FG000|Overall Study|Other|0|||
131202489|NCT02140762|472360405|FG001|Overall Study|Other|1|||
131202490|NCT02055976|472360406|FG000|Overall Study|Other|0|||
131202491|NCT02055976|472360407|FG001|Overall Study|Other|0|||
131202492|NCT02055976|472360408|FG002|Overall Study|Other|1|||
131202493|NCT02055976|472360409|FG003|Overall Study|Other|0|||
131202494|NCT02055976|472360410|FG004|Overall Study|Other|0|||
131202495|NCT02055976|472360411|FG005|Overall Study|Other|0|||
131202496|NCT02055976|472360412|FG006|Overall Study|Other|0|||
131202497|NCT02055976|472360413|FG007|Overall Study|Other|0|||
131202498|NCT02055976|472360414|FG008|Overall Study|Other|0|||
131202499|NCT02055976|472360406|FG000|Overall Study|Adverse Event|0|||
131202500|NCT02055976|472360407|FG001|Overall Study|Adverse Event|0|||
131202501|NCT02055976|472360408|FG002|Overall Study|Adverse Event|0|||
131202502|NCT02055976|472360409|FG003|Overall Study|Adverse Event|0|||
131202503|NCT02055976|472360410|FG004|Overall Study|Adverse Event|0|||
131202504|NCT02055976|472360411|FG005|Overall Study|Adverse Event|1|||
131202505|NCT02055976|472360412|FG006|Overall Study|Adverse Event|1|||
131202506|NCT02055976|472360413|FG007|Overall Study|Adverse Event|0|||
131202507|NCT02055976|472360414|FG008|Overall Study|Adverse Event|0|||
131202508|NCT02055976|472360406|FG000|Overall Study|Does not meet entrance criteria|0|||
131202509|NCT02055976|472360407|FG001|Overall Study|Does not meet entrance criteria|0|||
131202510|NCT02055976|472360408|FG002|Overall Study|Does not meet entrance criteria|0|||
131202511|NCT02055976|472360409|FG003|Overall Study|Does not meet entrance criteria|0|||
131202512|NCT02055976|472360410|FG004|Overall Study|Does not meet entrance criteria|0|||
131202513|NCT02055976|472360411|FG005|Overall Study|Does not meet entrance criteria|0|||
131202514|NCT02055976|472360412|FG006|Overall Study|Does not meet entrance criteria|1|||
131202515|NCT02055976|472360413|FG007|Overall Study|Does not meet entrance criteria|0|||
131202516|NCT02055976|472360414|FG008|Overall Study|Does not meet entrance criteria|0|||
131202517|NCT02055976|472360406|FG000|Overall Study|Lost to Follow-up|0|||
131202518|NCT02055976|472360407|FG001|Overall Study|Lost to Follow-up|0|||
131202519|NCT02055976|472360408|FG002|Overall Study|Lost to Follow-up|0|||
131202520|NCT02055976|472360409|FG003|Overall Study|Lost to Follow-up|1|||
131202521|NCT02055976|472360410|FG004|Overall Study|Lost to Follow-up|0|||
131202522|NCT02055976|472360411|FG005|Overall Study|Lost to Follow-up|0|||
131202523|NCT02055976|472360412|FG006|Overall Study|Lost to Follow-up|0|||
131202524|NCT02055976|472360413|FG007|Overall Study|Lost to Follow-up|0|||
131202525|NCT02055976|472360414|FG008|Overall Study|Lost to Follow-up|0|||
131202526|NCT01230827|472360415|FG000|Overall Study|Lost to Follow-up|0|||
131202527|NCT01230827|472360416|FG001|Overall Study|Lost to Follow-up|0|||
131202528|NCT01230827|472360417|FG002|Overall Study|Lost to Follow-up|1|||
131202529|NCT01230827|472360418|FG003|Overall Study|Lost to Follow-up|3|||
131202530|NCT01230827|472360415|FG000|Overall Study|Withdrawal by Subject|1|||
131202531|NCT01230827|472360416|FG001|Overall Study|Withdrawal by Subject|0|||
131202532|NCT01230827|472360417|FG002|Overall Study|Withdrawal by Subject|3|||
131202533|NCT01230827|472360418|FG003|Overall Study|Withdrawal by Subject|2|||
131202534|NCT01230827|472360415|FG000|Overall Study|Lack of Efficacy|14|||
131202535|NCT01230827|472360416|FG001|Overall Study|Lack of Efficacy|1|||
131202536|NCT01230827|472360417|FG002|Overall Study|Lack of Efficacy|2|||
131202537|NCT01230827|472360418|FG003|Overall Study|Lack of Efficacy|3|||
131202538|NCT01230827|472360415|FG000|Overall Study|Adverse Event|4|||
131202539|NCT01230827|472360416|FG001|Overall Study|Adverse Event|2|||
131202540|NCT01230827|472360417|FG002|Overall Study|Adverse Event|3|||
131202541|NCT01230827|472360418|FG003|Overall Study|Adverse Event|7|||
131202542|NCT01230827|472360415|FG000|Overall Study|Recovery|0|||
131202543|NCT01230827|472360416|FG001|Overall Study|Recovery|6|||
131202544|NCT01230827|472360417|FG002|Overall Study|Recovery|0|||
131202545|NCT01230827|472360418|FG003|Overall Study|Recovery|0|||
131202546|NCT01230827|472360415|FG000|Overall Study|Study terminated by Sponsor|0|||
131202547|NCT01230827|472360416|FG001|Overall Study|Study terminated by Sponsor|2|||
131202548|NCT01230827|472360417|FG002|Overall Study|Study terminated by Sponsor|56|||
131202549|NCT01230827|472360418|FG003|Overall Study|Study terminated by Sponsor|63|||
131202550|NCT00805142|472360419|FG000|Titration Period|Adverse Event|3|||
131202551|NCT00805142|472360420|FG001|Titration Period|Adverse Event|3|||
131202552|NCT00805142|472360419|FG000|Titration Period|Lack of Efficacy|1|||
131202553|NCT00805142|472360420|FG001|Titration Period|Lack of Efficacy|1|||
131202554|NCT00805142|472360419|FG000|Titration Period|Lost to Follow-up|0|||
131202555|NCT00805142|472360420|FG001|Titration Period|Lost to Follow-up|1|||
131202556|NCT00805142|472360419|FG000|Titration Period|Disease Progression|2|||
131202557|NCT00805142|472360420|FG001|Titration Period|Disease Progression|1|||
131202558|NCT00805142|472360419|FG000|Titration Period|Withdrawal of consent|0|||
131202559|NCT00805142|472360420|FG001|Titration Period|Withdrawal of consent|1|||
131202560|NCT00805142|472360419|FG000|Titration Period|Other|0|||
131202561|NCT00805142|472360420|FG001|Titration Period|Other|3|||
131202562|NCT00805142|472360419|FG000|Maintenance Period|Adverse Event|0|||
131202563|NCT00805142|472360420|FG001|Maintenance Period|Adverse Event|1|||
131202564|NCT00805142|472360419|FG000|Maintenance Period|Other|0|||
131202565|NCT00805142|472360420|FG001|Maintenance Period|Other|1|||
131202566|NCT00122317|472360422|FG000|Overall Study|Death|3|||
131202567|NCT00122317|472360422|FG000|Overall Study|Adverse Event|4|||
131202568|NCT00122317|472360422|FG000|Overall Study|Physician Decision|2|||
131202569|NCT00122317|472360422|FG000|Overall Study|patient non-compliance|1|||
131202570|NCT00122317|472360422|FG000|Overall Study|Withdrawal by Subject|1|||
131202571|NCT00394654|472360423|FG000|Overall Study|Lost to Follow-up|1|||
131202572|NCT00394654|472360424|FG001|Overall Study|Lost to Follow-up|0|||
131202573|NCT00394654|472360423|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
131202574|NCT00394654|472360424|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
131202575|NCT02886338|472360425|FG000|Overall Study|Withdrawal by Subject|1|||
131202576|NCT03756285|472360427|FG000|Overall Study|Lost to Follow-up|0|||
131202577|NCT03756285|472360428|FG001|Overall Study|Lost to Follow-up|1|||
131202578|NCT03756285|472360427|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
131202579|NCT03756285|472360428|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
131202580|NCT03756285|472360427|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
131202581|NCT03756285|472360428|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
131202582|NCT03890731|472362464|FG000|Overall Study|Progressive disease|1|||
131202583|NCT03890731|472362464|FG000|Overall Study|Patient's decision|1|||
131202584|NCT03890731|472362464|FG000|Overall Study|Adverse Event|4|||
131202585|NCT00348686|472362478|FG000|Overall Study|Withdrawal by Subject|45|||
131202586|NCT00348686|472362478|FG000|Overall Study|Adverse Event|5|||
131202587|NCT00348686|472362478|FG000|Overall Study|Protocol Violation|6|||
131202588|NCT00348686|472362478|FG000|Overall Study|Lost to Follow-up|2|||
131202589|NCT00348686|472362478|FG000|Overall Study|Multiple Reasons|8|||
131202590|NCT01258738|472362479|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
131202591|NCT01258738|472362480|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
131202592|NCT01258738|472362479|FG000|Double-blind Period|Withdrawal by Subject|2|||
131202593|NCT01258738|472362480|FG001|Double-blind Period|Withdrawal by Subject|2|||
131202594|NCT01258738|472362479|FG000|Double-blind Period|Protocol Violation|1|||
131202595|NCT01258738|472362480|FG001|Double-blind Period|Protocol Violation|1|||
131202596|NCT01258738|472362479|FG000|Double-blind Period|Adverse Event|3|||
131202597|NCT01258738|472362480|FG001|Double-blind Period|Adverse Event|1|||
131202598|NCT01258738|472362479|FG000|Open-label Period|Did not meet inclusion criteria|0|||
131202599|NCT01258738|472362480|FG001|Open-label Period|Did not meet inclusion criteria|1|||
131202600|NCT01258738|472362479|FG000|Open-label Period|Insufficient clinical response|5|||
131202601|NCT01258738|472362480|FG001|Open-label Period|Insufficient clinical response|3|||
131202602|NCT01258738|472362479|FG000|Open-label Period|Lost to Follow-up|0|||
131202603|NCT01258738|472362480|FG001|Open-label Period|Lost to Follow-up|2|||
131202604|NCT01258738|472362479|FG000|Open-label Period|Withdrawal by Subject|5|||
131202605|NCT01258738|472362480|FG001|Open-label Period|Withdrawal by Subject|6|||
131202606|NCT01258738|472362479|FG000|Open-label Period|Protocol Violation|2|||
131202607|NCT01258738|472362480|FG001|Open-label Period|Protocol Violation|2|||
131202608|NCT01258738|472362479|FG000|Open-label Period|Adverse Event|4|||
131202609|NCT01258738|472362480|FG001|Open-label Period|Adverse Event|5|||
131202610|NCT01258738|472362479|FG000|Open-label Period|Other Reasons|0|||
131202611|NCT01258738|472362480|FG001|Open-label Period|Other Reasons|1|||
131202612|NCT01258738|472362479|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
131202613|NCT01258738|472362480|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
131202614|NCT00689611|472362481|FG000|Overall Study|Death|6|||
131202615|NCT00689611|472362482|FG001|Overall Study|Death|9|||
131202616|NCT00689611|472362481|FG000|Overall Study|Withdrawal by Subject|8|||
131202617|NCT00689611|472362482|FG001|Overall Study|Withdrawal by Subject|9|||
131202618|NCT00689611|472362481|FG000|Overall Study|Lost to Follow-up|27|||
131202619|NCT00689611|472362482|FG001|Overall Study|Lost to Follow-up|28|||
131202620|NCT00568399|472362483|FG000|Overall Study|Death|2|||
131202621|NCT00568399|472362483|FG000|Overall Study|Adverse Event|5|||
131202622|NCT00568399|472362483|FG000|Overall Study|Withdrawal by Subject|8|||
131202623|NCT02967562|472362484|FG000|Overall Study|Consent not obtained|1|||
131202624|NCT02967562|472362485|FG001|Overall Study|Consent not obtained|0|||
131202625|NCT02967562|472362484|FG000|Overall Study|High leak precluding analysis|1|||
131202626|NCT02967562|472362485|FG001|Overall Study|High leak precluding analysis|1|||
131202627|NCT00672139|472362486|FG000|Overall Study|Death|14|||
131202628|NCT00672139|472362487|FG001|Overall Study|Death|23|||
131202629|NCT00672139|472362486|FG000|Overall Study|Withdrawal by Subject|2|||
131202630|NCT00672139|472362487|FG001|Overall Study|Withdrawal by Subject|11|||
131202631|NCT00672139|472362486|FG000|Overall Study|Adverse Event|4|||
131202632|NCT00672139|472362487|FG001|Overall Study|Adverse Event|7|||
131202633|NCT00672139|472362486|FG000|Overall Study|Physician Decision|2|||
131202634|NCT00672139|472362487|FG001|Overall Study|Physician Decision|0|||
131202635|NCT00672139|472362486|FG000|Overall Study|Lack of Efficacy|4|||
131202636|NCT00672139|472362487|FG001|Overall Study|Lack of Efficacy|1|||
131202637|NCT00672139|472362486|FG000|Overall Study|Protocol Violation|1|||
131202638|NCT00672139|472362487|FG001|Overall Study|Protocol Violation|1|||
131202639|NCT00672139|472362486|FG000|Overall Study|hospice discharge, caregiver requests|3|||
131202640|NCT00672139|472362487|FG001|Overall Study|hospice discharge, caregiver requests|2|||
131202641|NCT01038635|472362488|FG000|Overall Study|Disease Progression|2|||
131202642|NCT01038635|472362489|FG001|Overall Study|Disease Progression|0|||
131202643|NCT01038635|472362490|FG002|Overall Study|Disease Progression|0|||
131202644|NCT01038635|472362491|FG003|Overall Study|Disease Progression|0|||
131202645|NCT01038635|472362492|FG004|Overall Study|Disease Progression|0|||
131202646|NCT01038635|472362493|FG005|Overall Study|Disease Progression|0|||
131202647|NCT01038635|472362494|FG006|Overall Study|Disease Progression|1|||
131202648|NCT01038635|472362495|FG007|Overall Study|Disease Progression|4|||
131202649|NCT01038635|472362496|FG008|Overall Study|Disease Progression|0|||
131202650|NCT01038635|472362488|FG000|Overall Study|Death|0|||
131202651|NCT01038635|472362489|FG001|Overall Study|Death|0|||
131202652|NCT01038635|472362490|FG002|Overall Study|Death|0|||
131202653|NCT01038635|472362491|FG003|Overall Study|Death|0|||
131202654|NCT01038635|472362492|FG004|Overall Study|Death|1|||
131202655|NCT01038635|472362493|FG005|Overall Study|Death|0|||
131202656|NCT01038635|472362494|FG006|Overall Study|Death|1|||
131202657|NCT01038635|472362495|FG007|Overall Study|Death|1|||
131202658|NCT01038635|472362496|FG008|Overall Study|Death|2|||
131202659|NCT01060150|472362497|FG000|Overall Study|Adverse Event|6|||
131202660|NCT01060150|472362497|FG000|Overall Study|Lost to Follow-up|1|||
131202661|NCT01060150|472362497|FG000|Overall Study|Protocol Violation|6|||
131202662|NCT01060150|472362497|FG000|Overall Study|Withdrawal by Subject|8|||
131202663|NCT01060150|472362497|FG000|Overall Study|Enrolled, but not treated|2|||
131202664|NCT01562327|472362498|FG000|Overall Study|Adverse Event|2|||
131202665|NCT01562327|472362498|FG000|Overall Study|Lack of Efficacy|1|||
131202666|NCT01562327|472362498|FG000|Overall Study|Participant drop-out|1|||
131202667|NCT01562327|472362498|FG000|Overall Study|Infusion not received at 6 month window|4|||
131202668|NCT03018340|472362499|FG000|Overall Study|Adverse Event|1|||
131202669|NCT03018340|472362500|FG001|Overall Study|Adverse Event|2|||
131202670|NCT03018340|472362499|FG000|Overall Study|Withdrawal by Subject|0|||
131202671|NCT03018340|472362500|FG001|Overall Study|Withdrawal by Subject|8|||
131202672|NCT03018340|472362499|FG000|Overall Study|Lack of Efficacy|0|||
131202673|NCT03018340|472362500|FG001|Overall Study|Lack of Efficacy|1|||
131202674|NCT03018340|472362499|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
131202675|NCT03018340|472362500|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
131202676|NCT03018340|472362499|FG000|Overall Study|Lost to Follow-up|1|||
131202677|NCT03018340|472362500|FG001|Overall Study|Lost to Follow-up|7|||
131202678|NCT03018340|472362499|FG000|Overall Study|Protocol Violation|3|||
131202679|NCT03018340|472362500|FG001|Overall Study|Protocol Violation|7|||
131202680|NCT03018340|472362499|FG000|Overall Study|Not further specified|0|||
131202681|NCT03018340|472362500|FG001|Overall Study|Not further specified|1|||
131202682|NCT01195636|472362501|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
131202683|NCT01195636|472362502|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
131202684|NCT01195636|472362501|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
131202685|NCT01195636|472362502|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
131202686|NCT01195636|472362501|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131202687|NCT01195636|472362502|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
131202688|NCT01195636|472362501|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
131202689|NCT01195636|472362502|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
131202690|NCT01195636|472362501|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
131202691|NCT01195636|472362502|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
131202692|NCT01195636|472362501|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
131202693|NCT01195636|472362502|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
131202694|NCT01195636|472362501|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
131202695|NCT01195636|472362502|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
131202696|NCT01195636|472362501|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
131202697|NCT01195636|472362502|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
131202698|NCT03961529|472362503|FG000|Overall Study|Adverse Event|13|||
131202699|NCT03961529|472362504|FG001|Overall Study|Adverse Event|5|||
131202700|NCT03961529|472362505|FG002|Overall Study|Adverse Event|2|||
131202701|NCT03961529|472362503|FG000|Overall Study|Withdrawal by Subject|17|||
131202702|NCT03961529|472362504|FG001|Overall Study|Withdrawal by Subject|2|||
131202703|NCT03961529|472362505|FG002|Overall Study|Withdrawal by Subject|1|||
131202704|NCT03961529|472362503|FG000|Overall Study|Withdrawal by parent/guardian|0|||
131202705|NCT03961529|472362504|FG001|Overall Study|Withdrawal by parent/guardian|7|||
131202706|NCT03961529|472362505|FG002|Overall Study|Withdrawal by parent/guardian|0|||
131202707|NCT03961529|472362503|FG000|Overall Study|Physician Decision|2|||
131202708|NCT03961529|472362504|FG001|Overall Study|Physician Decision|1|||
131202709|NCT03961529|472362505|FG002|Overall Study|Physician Decision|1|||
131202710|NCT03961529|472362503|FG000|Overall Study|Lost to Follow-up|2|||
131202711|NCT03961529|472362504|FG001|Overall Study|Lost to Follow-up|1|||
131202712|NCT03961529|472362505|FG002|Overall Study|Lost to Follow-up|0|||
131202713|NCT03961529|472362503|FG000|Overall Study|Lack of Efficacy|2|||
131202714|NCT03961529|472362504|FG001|Overall Study|Lack of Efficacy|0|||
131202715|NCT03961529|472362505|FG002|Overall Study|Lack of Efficacy|1|||
131202716|NCT03961529|472362503|FG000|Overall Study|Other|6|||
131202717|NCT03961529|472362504|FG001|Overall Study|Other|1|||
131202718|NCT03961529|472362505|FG002|Overall Study|Other|0|||
131202719|NCT03644173|472362506|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
131202720|NCT03644173|472362506|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
131202721|NCT03644173|472362506|FG000|Participants at the 1-month Follow up|Death|2|||
131202722|NCT03644173|472362506|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
131202723|NCT00381706|472362509|FG000|Overall Study|Never treated|7|||
131202724|NCT00381706|472362510|FG001|Overall Study|Never treated|2|||
131202725|NCT00381706|472362511|FG002|Overall Study|Never treated|1|||
131202726|NCT00203294|472362513|FG000|Overall Study|Withdrawal by Subject|8|||
131202727|NCT00203294|472362514|FG001|Overall Study|Withdrawal by Subject|13|||
131202728|NCT00256204|472362518|FG000|Overall Study|Adverse Event|10|||
131202729|NCT00256204|472362519|FG001|Overall Study|Adverse Event|14|||
131202730|NCT00256204|472362520|FG002|Overall Study|Adverse Event|16|||
131202731|NCT00256204|472362521|FG003|Overall Study|Adverse Event|14|||
131202732|NCT00256204|472362518|FG000|Overall Study|Death|0|||
131202733|NCT00256204|472362519|FG001|Overall Study|Death|1|||
131202734|NCT00256204|472362520|FG002|Overall Study|Death|0|||
131202735|NCT00256204|472362521|FG003|Overall Study|Death|0|||
131202736|NCT00256204|472362518|FG000|Overall Study|Lost to Follow-up|1|||
130734166|NCT05299528|470645414|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
130734167|NCT05299528|470645415|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130734168|NCT05299528|470645416|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130734169|NCT05299528|470645417|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130734170|NCT05299528|470645418|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130734171|NCT05299528|470645419|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130734172|NCT05299528|470645413|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130734173|NCT05299528|470645414|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130784650|NCT01305564|470838859|FG000|Overall Study|Physician Decision|3|||
131202737|NCT00256204|472362519|FG001|Overall Study|Lost to Follow-up|1|||
131202738|NCT00256204|472362520|FG002|Overall Study|Lost to Follow-up|1|||
131202739|NCT00256204|472362521|FG003|Overall Study|Lost to Follow-up|2|||
131202740|NCT00256204|472362518|FG000|Overall Study|Protocol Violation|1|||
131202741|NCT00256204|472362519|FG001|Overall Study|Protocol Violation|0|||
131202742|NCT00256204|472362520|FG002|Overall Study|Protocol Violation|2|||
131202743|NCT00256204|472362521|FG003|Overall Study|Protocol Violation|1|||
131202744|NCT00256204|472362518|FG000|Overall Study|Physician Decision|0|||
131202745|NCT00256204|472362519|FG001|Overall Study|Physician Decision|0|||
131202746|NCT00256204|472362520|FG002|Overall Study|Physician Decision|1|||
131202747|NCT00256204|472362521|FG003|Overall Study|Physician Decision|2|||
131202748|NCT00256204|472362518|FG000|Overall Study|Withdrawal by Subject|17|||
131202749|NCT00256204|472362519|FG001|Overall Study|Withdrawal by Subject|6|||
131202750|NCT00256204|472362520|FG002|Overall Study|Withdrawal by Subject|7|||
131202751|NCT00256204|472362521|FG003|Overall Study|Withdrawal by Subject|5|||
131202752|NCT00256204|472362518|FG000|Overall Study|Need for additional prohibited treatment|38|||
131202753|NCT00256204|472362519|FG001|Overall Study|Need for additional prohibited treatment|28|||
131202754|NCT00256204|472362520|FG002|Overall Study|Need for additional prohibited treatment|27|||
131202755|NCT00256204|472362521|FG003|Overall Study|Need for additional prohibited treatment|25|||
131202756|NCT00550615|472362523|FG000|Overall Study|Withdrawal by Subject|0|||
131202757|NCT00550615|472362524|FG001|Overall Study|Withdrawal by Subject|0|||
131202758|NCT00550615|472362525|FG002|Overall Study|Withdrawal by Subject|2|||
131202759|NCT00550615|472362526|FG003|Overall Study|Withdrawal by Subject|3|||
131202760|NCT00550615|472362523|FG000|Overall Study|Not evaluable|0|||
131202761|NCT00550615|472362524|FG001|Overall Study|Not evaluable|0|||
131202762|NCT00550615|472362525|FG002|Overall Study|Not evaluable|2|||
131202763|NCT00550615|472362526|FG003|Overall Study|Not evaluable|7|||
131202764|NCT02405091|472362529|FG000|Overall Study|Adverse Event|16|||
131202765|NCT02405091|472362530|FG001|Overall Study|Adverse Event|10|||
131202766|NCT02405091|472362531|FG002|Overall Study|Adverse Event|0|||
131202767|NCT02405091|472362529|FG000|Overall Study|Protocol Violation|1|||
131202768|NCT02405091|472362530|FG001|Overall Study|Protocol Violation|0|||
131202769|NCT02405091|472362531|FG002|Overall Study|Protocol Violation|0|||
131202770|NCT02405091|472362529|FG000|Overall Study|Noncompliance|1|||
131202771|NCT02405091|472362530|FG001|Overall Study|Noncompliance|6|||
131202772|NCT02405091|472362531|FG002|Overall Study|Noncompliance|2|||
131202773|NCT02405091|472362529|FG000|Overall Study|Withdrawal by Subject|4|||
131202774|NCT02405091|472362530|FG001|Overall Study|Withdrawal by Subject|8|||
131202775|NCT02405091|472362531|FG002|Overall Study|Withdrawal by Subject|0|||
131202776|NCT02405091|472362529|FG000|Overall Study|Death|0|||
131202777|NCT02405091|472362530|FG001|Overall Study|Death|1|||
131202778|NCT02405091|472362531|FG002|Overall Study|Death|0|||
131202779|NCT02405091|472362529|FG000|Overall Study|Lost to Follow-up|5|||
131202780|NCT02405091|472362530|FG001|Overall Study|Lost to Follow-up|6|||
131202781|NCT02405091|472362531|FG002|Overall Study|Lost to Follow-up|0|||
131202782|NCT02405091|472362529|FG000|Overall Study|Physician Decision|2|||
131202783|NCT02405091|472362530|FG001|Overall Study|Physician Decision|2|||
131202784|NCT02405091|472362531|FG002|Overall Study|Physician Decision|0|||
131202785|NCT01234337|472362535|FG000|Overall Study|Adverse Event|58|||
131202786|NCT01234337|472362536|FG001|Overall Study|Adverse Event|21|||
131202787|NCT01234337|472362535|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
131202788|NCT01234337|472362536|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
131202789|NCT01234337|472362535|FG000|Overall Study|Investi. decision not protocol driven|5|||
131202790|NCT01234337|472362536|FG001|Overall Study|Investi. decision not protocol driven|6|||
131202791|NCT01234337|472362535|FG000|Overall Study|Non-compliant with study medication|3|||
131202792|NCT01234337|472362536|FG001|Overall Study|Non-compliant with study medication|2|||
131202793|NCT01234337|472362535|FG000|Overall Study|Randomized but not treated|6|||
131202794|NCT01234337|472362536|FG001|Overall Study|Randomized but not treated|4|||
131202795|NCT01234337|472362535|FG000|Overall Study|Lost to Follow-up|0|||
131202796|NCT01234337|472362536|FG001|Overall Study|Lost to Follow-up|1|||
131202797|NCT01234337|472362535|FG000|Overall Study|Protocol Violation|2|||
131202798|NCT01234337|472362536|FG001|Overall Study|Protocol Violation|3|||
131202799|NCT01234337|472362535|FG000|Overall Study|Withdrawal by Subject|11|||
131202800|NCT01234337|472362536|FG001|Overall Study|Withdrawal by Subject|9|||
131202801|NCT01234337|472362535|FG000|Overall Study|Death|0|||
131202802|NCT01234337|472362536|FG001|Overall Study|Death|1|||
131202803|NCT01234337|472362535|FG000|Overall Study|Switch to commercial drug|0|||
131202804|NCT01234337|472362536|FG001|Overall Study|Switch to commercial drug|1|||
131202805|NCT03481634|472362543|FG000|Overall Study|Withdrawal by Subject|16|||
131202806|NCT03481634|472362544|FG001|Overall Study|Withdrawal by Subject|19|||
131202807|NCT03481634|472362545|FG002|Overall Study|Withdrawal by Subject|14|||
131202808|NCT03481634|472362543|FG000|Overall Study|Protocol Violation|1|||
131202809|NCT03481634|472362544|FG001|Overall Study|Protocol Violation|0|||
131202810|NCT03481634|472362545|FG002|Overall Study|Protocol Violation|1|||
131202811|NCT03481634|472362543|FG000|Overall Study|Progressive disease|0|||
131202812|NCT03481634|472362544|FG001|Overall Study|Progressive disease|1|||
131202813|NCT03481634|472362545|FG002|Overall Study|Progressive disease|0|||
131202814|NCT03481634|472362543|FG000|Overall Study|Physician Decision|3|||
131202815|NCT03481634|472362544|FG001|Overall Study|Physician Decision|0|||
131202816|NCT03481634|472362545|FG002|Overall Study|Physician Decision|1|||
131202817|NCT03481634|472362543|FG000|Overall Study|Lost to Follow-up|3|||
131202818|NCT03481634|472362544|FG001|Overall Study|Lost to Follow-up|4|||
131202819|NCT03481634|472362545|FG002|Overall Study|Lost to Follow-up|4|||
131202820|NCT03481634|472362543|FG000|Overall Study|Death|4|||
131202821|NCT03481634|472362544|FG001|Overall Study|Death|8|||
131202822|NCT03481634|472362545|FG002|Overall Study|Death|7|||
131202823|NCT03481634|472362543|FG000|Overall Study|Adverse Event|6|||
131202824|NCT03481634|472362544|FG001|Overall Study|Adverse Event|3|||
131202825|NCT03481634|472362545|FG002|Overall Study|Adverse Event|7|||
131202826|NCT00994890|472362549|FG000|Overall Study|Adverse Event|13|||
131202827|NCT00994890|472362550|FG001|Overall Study|Adverse Event|9|||
131202828|NCT00994890|472362551|FG002|Overall Study|Adverse Event|11|||
131202829|NCT00994890|472362549|FG000|Overall Study|Lack of Efficacy|0|||
131202830|NCT00994890|472362550|FG001|Overall Study|Lack of Efficacy|0|||
131202831|NCT00994890|472362551|FG002|Overall Study|Lack of Efficacy|1|||
131202832|NCT00994890|472362549|FG000|Overall Study|Lost to Follow-up|6|||
131202833|NCT00994890|472362550|FG001|Overall Study|Lost to Follow-up|1|||
131202834|NCT00994890|472362551|FG002|Overall Study|Lost to Follow-up|3|||
131202835|NCT00994890|472362549|FG000|Overall Study|No longer willing to participate|8|||
131202836|NCT00994890|472362550|FG001|Overall Study|No longer willing to participate|5|||
131202837|NCT00994890|472362551|FG002|Overall Study|No longer willing to participate|13|||
131202838|NCT00994890|472362549|FG000|Overall Study|Protocol Violation|2|||
131202839|NCT00994890|472362550|FG001|Overall Study|Protocol Violation|4|||
131202840|NCT00994890|472362551|FG002|Overall Study|Protocol Violation|0|||
131202841|NCT00994890|472362549|FG000|Overall Study|Study terminated by sponsor|199|||
131202842|NCT00994890|472362550|FG001|Overall Study|Study terminated by sponsor|201|||
131202843|NCT00994890|472362551|FG002|Overall Study|Study terminated by sponsor|197|||
131202844|NCT00994890|472362549|FG000|Overall Study|Randomized, but not treated|1|||
131202845|NCT00994890|472362550|FG001|Overall Study|Randomized, but not treated|0|||
131202846|NCT00994890|472362551|FG002|Overall Study|Randomized, but not treated|0|||
131202847|NCT00994890|472362549|FG000|Overall Study|Other|2|||
131202848|NCT00994890|472362550|FG001|Overall Study|Other|2|||
131202849|NCT00994890|472362551|FG002|Overall Study|Other|1|||
131202850|NCT00247962|472362552|FG000|Overall Study|Adverse Event|15|||
131202851|NCT00247962|472362553|FG001|Overall Study|Adverse Event|12|||
131202852|NCT00247962|472362552|FG000|Overall Study|Lost to Follow-up|3|||
131202853|NCT00247962|472362553|FG001|Overall Study|Lost to Follow-up|1|||
131202854|NCT00247962|472362552|FG000|Overall Study|Physician Decision|0|||
131202855|NCT00247962|472362553|FG001|Overall Study|Physician Decision|1|||
131202856|NCT00247962|472362552|FG000|Overall Study|Protocol Violation|1|||
131202857|NCT00247962|472362553|FG001|Overall Study|Protocol Violation|1|||
131202858|NCT00247962|472362552|FG000|Overall Study|Withdrawal by Subject|3|||
131202859|NCT00247962|472362553|FG001|Overall Study|Withdrawal by Subject|2|||
131202860|NCT00247962|472362552|FG000|Overall Study|Lack of Efficacy|4|||
131202861|NCT00247962|472362553|FG001|Overall Study|Lack of Efficacy|2|||
131202862|NCT03323385|472362554|FG000|Overall Study|Withdrawal by Subject|1|||
131202863|NCT03323385|472362555|FG001|Overall Study|Withdrawal by Subject|2|||
131202864|NCT03323385|472362554|FG000|Overall Study|Noncompliance|0|||
131202865|NCT03323385|472362555|FG001|Overall Study|Noncompliance|1|||
131202866|NCT01849289|472362556|FG000|Overall Study|Adverse Event|3|||
131202867|NCT01849289|472362557|FG001|Overall Study|Adverse Event|3|||
131202868|NCT01849289|472362556|FG000|Overall Study|Protocol Violation|3|||
131202869|NCT01849289|472362557|FG001|Overall Study|Protocol Violation|3|||
131202870|NCT01849289|472362556|FG000|Overall Study|Withdrawal criteria|1|||
131202871|NCT01849289|472362557|FG001|Overall Study|Withdrawal criteria|0|||
131202872|NCT01849289|472362556|FG000|Overall Study|Unclassified|25|||
131202873|NCT01849289|472362557|FG001|Overall Study|Unclassified|18|||
131202874|NCT02555722|472362558|FG000|Week 2|Adverse Event|0|||
131202875|NCT02555722|472362559|FG001|Week 2|Adverse Event|1|||
131202876|NCT02555722|472362558|FG000|Week 2|Withdrawal by Subject|1|||
131202877|NCT02555722|472362559|FG001|Week 2|Withdrawal by Subject|0|||
131202878|NCT02555722|472362558|FG000|Month 1|Lens Discomfort|1|||
131202879|NCT02555722|472362559|FG001|Month 1|Lens Discomfort|0|||
131202880|NCT02555722|472362558|FG000|Month 2|Withdrawal by Subject|3|||
131202881|NCT02555722|472362559|FG001|Month 2|Withdrawal by Subject|0|||
131202882|NCT02555722|472362558|FG000|Month 2|Lost to Follow-up|1|||
131202883|NCT02555722|472362559|FG001|Month 2|Lost to Follow-up|0|||
131202884|NCT00352027|472362560|FG000|Overall Study|Progressive disease|3|||
131202885|NCT01469637|472362561|FG000|First Intervention|Unacceptable behavior|0|||
131202886|NCT01469637|472362562|FG001|First Intervention|Unacceptable behavior|1|||
131202887|NCT01469637|472362561|FG000|Second Intervention|Incarcerated|1|||
131202888|NCT01469637|472362562|FG001|Second Intervention|Incarcerated|0|||
131202889|NCT00598585|472362563|FG000|Overall Study|Lost to Follow-up|1|||
131202890|NCT00598585|472362564|FG001|Overall Study|Lost to Follow-up|0|||
131202891|NCT03922711|472362571|FG000|Overall Study|Adverse Event|3|||
131202892|NCT03922711|472362572|FG001|Overall Study|Adverse Event|2|||
131202893|NCT03922711|472362573|FG002|Overall Study|Adverse Event|2|||
131202894|NCT03922711|472362571|FG000|Overall Study|Protocol Violation|1|||
131202895|NCT03922711|472362572|FG001|Overall Study|Protocol Violation|0|||
131202896|NCT03922711|472362573|FG002|Overall Study|Protocol Violation|0|||
131202897|NCT03922711|472362571|FG000|Overall Study|Withdrawal by Subject|0|||
131202898|NCT03922711|472362572|FG001|Overall Study|Withdrawal by Subject|3|||
131202899|NCT03922711|472362573|FG002|Overall Study|Withdrawal by Subject|1|||
131202900|NCT03922711|472362571|FG000|Overall Study|Not further specified|0|||
131202901|NCT03922711|472362572|FG001|Overall Study|Not further specified|0|||
131202902|NCT03922711|472362573|FG002|Overall Study|Not further specified|1|||
131202903|NCT03147495|472362574|FG000|Overall Study|Physician Decision|0|||
131202904|NCT03147495|472362575|FG001|Overall Study|Physician Decision|6|||
131202905|NCT00742391|472362582|FG000|Overall Study|Adverse Event|2|||
131202906|NCT00742391|472362583|FG001|Overall Study|Adverse Event|1|||
131202907|NCT00742391|472362582|FG000|Overall Study|Lost to Follow-up|1|||
131202908|NCT00742391|472362583|FG001|Overall Study|Lost to Follow-up|0|||
131202909|NCT00742391|472362582|FG000|Overall Study|Protocol Violation|1|||
131202910|NCT00742391|472362583|FG001|Overall Study|Protocol Violation|0|||
131202911|NCT02975206|472362590|FG000|Overall Study|Withdrawal by Subject|14|||
131202912|NCT02975206|472362591|FG001|Overall Study|Withdrawal by Subject|11|||
131202913|NCT02975206|472362592|FG002|Overall Study|Withdrawal by Subject|11|||
131202914|NCT02975206|472362590|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
131202915|NCT02975206|472362591|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
131202916|NCT02975206|472362592|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
131202917|NCT01981096|472362593|FG000|Overall Study|Parent illness|1|||
131202918|NCT01981096|472362594|FG001|Overall Study|Parent illness|0|||
131202919|NCT01981096|472362593|FG000|Overall Study|Withdrawal by Subject|0|||
131202920|NCT01981096|472362594|FG001|Overall Study|Withdrawal by Subject|1|||
131202921|NCT01981096|472362593|FG000|Overall Study|Lost to Follow-up|2|||
131202922|NCT01981096|472362594|FG001|Overall Study|Lost to Follow-up|0|||
131202923|NCT00866606|472362595|FG000|Overall Study|Lost to Follow-up|3|||
131202924|NCT00866606|472362595|FG000|Overall Study|Adverse Event|1|||
131202925|NCT01058356|472362611|FG000|Overall Study|Adverse Event|5|||
131202926|NCT01058356|472362611|FG000|Overall Study|Administration of contraindicated drugs|12|||
131202927|NCT01058356|472362611|FG000|Overall Study|Withdrawal by Subject|21|||
131202928|NCT01058356|472362611|FG000|Overall Study|Lost to Follow-up|4|||
131202929|NCT02067104|472362612|FG000|Overall Study|Study termination due to low accrual|4|||
131202930|NCT02067104|472362613|FG001|Overall Study|Study termination due to low accrual|5|||
131202931|NCT00095836|472362626|FG000|Overall Study|Lost to Follow-up|1|||
131202932|NCT00095836|472362626|FG000|Overall Study|Adverse Event|1|||
131202933|NCT00095836|472362626|FG000|Overall Study|Death|2|||
131202934|NCT00989664|472362629|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
131202935|NCT00989664|472362629|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
131202936|NCT00989664|472362629|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
131202937|NCT00989664|472362629|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
131202938|NCT00989664|472362629|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
131202939|NCT00989664|472362629|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
131202940|NCT00989664|472362629|FG000|Long-Term Follow-Up|Death|3|||
131202941|NCT00962780|472362631|FG000|Overall Study|Death|0|||
131202942|NCT00962780|472362632|FG001|Overall Study|Death|1|||
131202943|NCT00962780|472362631|FG000|Overall Study|Protocol Violation|9|||
131202944|NCT00962780|472362632|FG001|Overall Study|Protocol Violation|4|||
131202945|NCT00962780|472362631|FG000|Overall Study|Withdrawal by Subject|1|||
130784651|NCT05630196|470841135|FG000|Overall Study|Adverse Event|2|||
131202946|NCT00962780|472362632|FG001|Overall Study|Withdrawal by Subject|8|||
131202947|NCT00962780|472362631|FG000|Overall Study|Other|0|||
131202948|NCT00962780|472362632|FG001|Overall Study|Other|1|||
131202949|NCT02363322|472362633|FG000|Overall Study|Lost to Follow-up|1|||
131202950|NCT02363322|472362634|FG001|Overall Study|Lost to Follow-up|0|||
131202951|NCT03458234|472362637|FG000|Overall Study|Withdrawal by Subject|1|||
131202952|NCT01021293|472362639|FG000|Overall Study|Serious Adverse Event|2|||
131202953|NCT01021293|472362640|FG001|Overall Study|Serious Adverse Event|1|||
131202954|NCT01021293|472362639|FG000|Overall Study|Adverse Event|2|||
130734174|NCT05299528|470645415|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130734175|NCT05299528|470645416|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130734176|NCT05299528|470645417|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130734177|NCT05299528|470645418|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
130734178|NCT05299528|470645419|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130734179|NCT05299528|470645413|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
130734180|NCT05299528|470645414|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
130734181|NCT05299528|470645415|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
130734182|NCT05299528|470645416|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
130734183|NCT05299528|470645417|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
130734184|NCT05299528|470645418|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
130734185|NCT05299528|470645419|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
130734186|NCT05180227|470645423|FG000|Overall Study|Hypertension at screening|1|||
130734187|NCT05180227|470645423|FG000|Overall Study|Lost to Follow-up|1|||
130734188|NCT03548337|470645424|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
130734189|NCT03548337|470645425|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
130734190|NCT03548337|470645424|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
130734191|NCT03548337|470645425|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
130734192|NCT03548337|470645424|FG000|Infant Series|Lost to Follow-up|2|||
130734193|NCT03548337|470645425|FG001|Infant Series|Lost to Follow-up|1|||
130734194|NCT03548337|470645424|FG000|Infant Series|Adverse Event|0|||
130734195|NCT03548337|470645425|FG001|Infant Series|Adverse Event|2|||
130734196|NCT03548337|470645424|FG000|Infant Series|Randomized but Not Vaccinated|1|||
130734197|NCT03548337|470645425|FG001|Infant Series|Randomized but Not Vaccinated|0|||
130734198|NCT03548337|470645424|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
130734199|NCT03548337|470645425|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
130734200|NCT01911273|470645428|FG000|Overall Study|Progression of Disease|1|||
130734201|NCT01911273|470645429|FG001|Overall Study|Progression of Disease|0|||
130734202|NCT01911273|470645428|FG000|Overall Study|Withdrawal by Subject|0|||
130734203|NCT01911273|470645429|FG001|Overall Study|Withdrawal by Subject|2|||
130734204|NCT01070953|470645430|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
130734205|NCT01070953|470645430|FG000|Participants for Safety Evaluation|Off-label use|283|||
130734206|NCT01070953|470645430|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
130734207|NCT01070953|470645430|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
130734208|NCT01070953|470645430|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
130734209|NCT01070953|470645430|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
130734210|NCT01070953|470645430|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
130734211|NCT01070953|470645430|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
130734212|NCT01070953|470645430|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
130734213|NCT01070953|470645430|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
130734214|NCT01957176|470645431|FG000|Overall Study|Adverse Event|2|||
130734215|NCT01957176|470645432|FG001|Overall Study|Adverse Event|0|||
130734216|NCT01957176|470645431|FG000|Overall Study|Physician Decision|2|||
130734217|NCT01957176|470645432|FG001|Overall Study|Physician Decision|1|||
130734218|NCT01957176|470645431|FG000|Overall Study|Withdrawal by Subject|1|||
130734219|NCT01957176|470645432|FG001|Overall Study|Withdrawal by Subject|0|||
130734220|NCT02359994|470645433|FG000|Overall Population Study|Adverse Event|1|||
130734221|NCT02359994|470645434|FG001|Overall Population Study|Adverse Event|1|||
130734222|NCT02359994|470645433|FG000|Overall Population Study|Death|1|||
130734223|NCT02359994|470645434|FG001|Overall Population Study|Death|5|||
130734224|NCT02359994|470645433|FG000|Overall Population Study|Lost to Follow-up|1|||
130734225|NCT02359994|470645434|FG001|Overall Population Study|Lost to Follow-up|1|||
130734226|NCT02359994|470645433|FG000|Overall Population Study|Withdrawal by Subject|1|||
130734227|NCT02359994|470645434|FG001|Overall Population Study|Withdrawal by Subject|0|||
130734228|NCT02359994|470645433|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
130734229|NCT02359994|470645434|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
130734230|NCT02359994|470645433|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
130734231|NCT02359994|470645434|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
130734232|NCT02359994|470645433|FG000|Extended Oncology 24-Month Survival|Death|19|||
130734233|NCT02359994|470645434|FG001|Extended Oncology 24-Month Survival|Death|21|||
130734234|NCT02359994|470645433|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
130734235|NCT02359994|470645434|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
130734236|NCT03017612|470645437|FG000|Overall Study|Adverse Event|2|||
131202955|NCT01021293|472362640|FG001|Overall Study|Adverse Event|1|||
131202956|NCT01021293|472362639|FG000|Overall Study|Withdrawal by Subject|1|||
130734237|NCT04895982|470645438|FG000|Overall Study|Withdrawal by Subject|0|||
130734238|NCT04895982|470645439|FG001|Overall Study|Withdrawal by Subject|0|||
130734239|NCT04895982|470645440|FG002|Overall Study|Withdrawal by Subject|0|||
130734240|NCT04895982|470645441|FG003|Overall Study|Withdrawal by Subject|0|||
130734241|NCT04895982|470645442|FG004|Overall Study|Withdrawal by Subject|0|||
130734242|NCT04895982|470645443|FG005|Overall Study|Withdrawal by Subject|1|||
130734243|NCT04895982|470645444|FG006|Overall Study|Withdrawal by Subject|1|||
130734244|NCT04895982|470645445|FG007|Overall Study|Withdrawal by Subject|0|||
130734245|NCT04895982|470645446|FG008|Overall Study|Withdrawal by Subject|0|||
130734246|NCT04895982|470645447|FG009|Overall Study|Withdrawal by Subject|1|||
130734247|NCT04895982|470645448|FG010|Overall Study|Withdrawal by Subject|0|||
131202957|NCT01021293|472362640|FG001|Overall Study|Withdrawal by Subject|3|||
131202958|NCT01021293|472362639|FG000|Overall Study|Migrated/moved from study area|6|||
131202959|NCT01021293|472362640|FG001|Overall Study|Migrated/moved from study area|18|||
131202960|NCT01021293|472362639|FG000|Overall Study|Lost to Follow-up|1|||
131202961|NCT01021293|472362640|FG001|Overall Study|Lost to Follow-up|1|||
131202962|NCT02889861|472364841|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
131202963|NCT01864746|472364842|FG000|Overall Study|Disease recurrence|25|||
131202964|NCT01864746|472364843|FG001|Overall Study|Disease recurrence|40|||
131202965|NCT01864746|472364842|FG000|Overall Study|Second primary invasive nonbreast|2|||
131202966|NCT01864746|472364843|FG001|Overall Study|Second primary invasive nonbreast|3|||
131202967|NCT01864746|472364842|FG000|Overall Study|Death|2|||
131202968|NCT01864746|472364843|FG001|Overall Study|Death|1|||
131202969|NCT01864746|472364842|FG000|Overall Study|Adverse Event|33|||
131202970|NCT01864746|472364843|FG001|Overall Study|Adverse Event|5|||
131202971|NCT01864746|472364842|FG000|Overall Study|Withdrawal by Subject|56|||
131202972|NCT01864746|472364843|FG001|Overall Study|Withdrawal by Subject|41|||
131202973|NCT01864746|472364842|FG000|Overall Study|Physician Decision|5|||
131202974|NCT01864746|472364843|FG001|Overall Study|Physician Decision|6|||
131202975|NCT02039687|472364849|FG000|Overall Study|Adverse Event|0|||
131202976|NCT02039687|472364850|FG001|Overall Study|Adverse Event|0|||
131202977|NCT02039687|472364851|FG002|Overall Study|Adverse Event|1|||
131202978|NCT02039687|472364852|FG003|Overall Study|Adverse Event|0|||
131202979|NCT02039687|472364849|FG000|Overall Study|Withdrawal by Subject|0|||
131202980|NCT02039687|472364850|FG001|Overall Study|Withdrawal by Subject|1|||
131202981|NCT02039687|472364851|FG002|Overall Study|Withdrawal by Subject|0|||
131202982|NCT02039687|472364852|FG003|Overall Study|Withdrawal by Subject|0|||
131202983|NCT02039687|472364849|FG000|Overall Study|treatment assignment could not be confir|0|||
131202984|NCT02039687|472364850|FG001|Overall Study|treatment assignment could not be confir|0|||
131202985|NCT02039687|472364851|FG002|Overall Study|treatment assignment could not be confir|2|||
131202986|NCT02039687|472364852|FG003|Overall Study|treatment assignment could not be confir|0|||
131202987|NCT00303329|472364857|FG000|Overall Study|Adverse Event|7|||
131202988|NCT00303329|472364858|FG001|Overall Study|Adverse Event|14|||
131202989|NCT00303329|472364857|FG000|Overall Study|Abnormal Laboratory Values|0|||
131202990|NCT00303329|472364858|FG001|Overall Study|Abnormal Laboratory Values|1|||
131202991|NCT00303329|472364857|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
131202992|NCT00303329|472364858|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
131202993|NCT00303329|472364857|FG000|Overall Study|Condition no longer requires study drug|0|||
131202994|NCT00303329|472364858|FG001|Overall Study|Condition no longer requires study drug|8|||
131202995|NCT00303329|472364857|FG000|Overall Study|Protocol Violation|3|||
131202996|NCT00303329|472364858|FG001|Overall Study|Protocol Violation|0|||
131202997|NCT00303329|472364857|FG000|Overall Study|Withdrawal by Subject|9|||
131202998|NCT00303329|472364858|FG001|Overall Study|Withdrawal by Subject|15|||
131202999|NCT00303329|472364857|FG000|Overall Study|Lost to Follow-up|0|||
131203000|NCT00303329|472364858|FG001|Overall Study|Lost to Follow-up|1|||
131203001|NCT00303329|472364857|FG000|Overall Study|Administrative problems|1|||
131203002|NCT00303329|472364858|FG001|Overall Study|Administrative problems|0|||
131203003|NCT00303329|472364857|FG000|Overall Study|Death|2|||
131203004|NCT00303329|472364858|FG001|Overall Study|Death|12|||
131203005|NCT00303329|472364857|FG000|Overall Study|Stopped at end of core|3|||
131203006|NCT00303329|472364858|FG001|Overall Study|Stopped at end of core|9|||
131203007|NCT00303329|472364857|FG000|Overall Study|Stopped at end of extension 1|1|||
131203008|NCT00303329|472364858|FG001|Overall Study|Stopped at end of extension 1|0|||
131203009|NCT00542321|472364859|FG000|Overall Study|Death|0|||
131203010|NCT00542321|472364860|FG001|Overall Study|Death|1|||
131203011|NCT00253747|472364866|FG000|Overall Study|Lost to Follow-up|13|||
131203012|NCT00253747|472364867|FG001|Overall Study|Lost to Follow-up|14|||
131203013|NCT00253747|472364866|FG000|Overall Study|Withdrawal by Subject|10|||
131203014|NCT00253747|472364867|FG001|Overall Study|Withdrawal by Subject|11|||
131203015|NCT00253747|472364866|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
131203016|NCT00253747|472364867|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
130734248|NCT04895982|470645449|FG011|Overall Study|Withdrawal by Subject|1|||
131203017|NCT00718887|472364869|FG000|Overall Study|Withdrawal by Subject|3|||
131203018|NCT00718887|472364870|FG001|Overall Study|Withdrawal by Subject|2|||
130734249|NCT04895982|470645438|FG000|Overall Study|Withdrawal by parent/guardian|2|||
131203019|NCT00718887|472364869|FG000|Overall Study|Not identified|2|||
130734250|NCT04895982|470645439|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130734251|NCT04895982|470645440|FG002|Overall Study|Withdrawal by parent/guardian|3|||
130734252|NCT04895982|470645441|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130734253|NCT04895982|470645442|FG004|Overall Study|Withdrawal by parent/guardian|3|||
130734254|NCT04895982|470645443|FG005|Overall Study|Withdrawal by parent/guardian|2|||
130734255|NCT04895982|470645444|FG006|Overall Study|Withdrawal by parent/guardian|1|||
130734256|NCT04895982|470645445|FG007|Overall Study|Withdrawal by parent/guardian|0|||
130734257|NCT04895982|470645446|FG008|Overall Study|Withdrawal by parent/guardian|3|||
130734258|NCT04895982|470645447|FG009|Overall Study|Withdrawal by parent/guardian|0|||
130734259|NCT04895982|470645448|FG010|Overall Study|Withdrawal by parent/guardian|0|||
130734260|NCT04895982|470645449|FG011|Overall Study|Withdrawal by parent/guardian|0|||
130734261|NCT04895982|470645438|FG000|Overall Study|Other|0|||
130734262|NCT04895982|470645439|FG001|Overall Study|Other|0|||
130734263|NCT04895982|470645440|FG002|Overall Study|Other|1|||
130734264|NCT04895982|470645441|FG003|Overall Study|Other|1|||
130734265|NCT04895982|470645442|FG004|Overall Study|Other|0|||
130734266|NCT04895982|470645443|FG005|Overall Study|Other|0|||
130734267|NCT04895982|470645444|FG006|Overall Study|Other|0|||
130734268|NCT04895982|470645445|FG007|Overall Study|Other|0|||
130734269|NCT04895982|470645446|FG008|Overall Study|Other|0|||
130734270|NCT04895982|470645447|FG009|Overall Study|Other|1|||
130734271|NCT04895982|470645448|FG010|Overall Study|Other|0|||
130734272|NCT04895982|470645449|FG011|Overall Study|Other|0|||
130734273|NCT04895982|470645438|FG000|Overall Study|Protocol Violation|0|||
130734274|NCT04895982|470645439|FG001|Overall Study|Protocol Violation|0|||
130734275|NCT04895982|470645440|FG002|Overall Study|Protocol Violation|1|||
130734276|NCT04895982|470645441|FG003|Overall Study|Protocol Violation|1|||
130734277|NCT04895982|470645442|FG004|Overall Study|Protocol Violation|1|||
130734278|NCT04895982|470645443|FG005|Overall Study|Protocol Violation|0|||
130734279|NCT04895982|470645444|FG006|Overall Study|Protocol Violation|0|||
130734280|NCT04895982|470645445|FG007|Overall Study|Protocol Violation|1|||
130734281|NCT04895982|470645446|FG008|Overall Study|Protocol Violation|0|||
130734282|NCT04895982|470645447|FG009|Overall Study|Protocol Violation|0|||
130734283|NCT04895982|470645448|FG010|Overall Study|Protocol Violation|0|||
130734284|NCT04895982|470645449|FG011|Overall Study|Protocol Violation|0|||
130734285|NCT04895982|470645438|FG000|Overall Study|Lost to Follow-up|0|||
130734286|NCT04895982|470645439|FG001|Overall Study|Lost to Follow-up|0|||
130734287|NCT04895982|470645440|FG002|Overall Study|Lost to Follow-up|1|||
130734288|NCT04895982|470645441|FG003|Overall Study|Lost to Follow-up|0|||
130734289|NCT04895982|470645442|FG004|Overall Study|Lost to Follow-up|0|||
130734290|NCT04895982|470645443|FG005|Overall Study|Lost to Follow-up|1|||
130734291|NCT04895982|470645444|FG006|Overall Study|Lost to Follow-up|0|||
130734292|NCT04895982|470645445|FG007|Overall Study|Lost to Follow-up|0|||
130734293|NCT04895982|470645446|FG008|Overall Study|Lost to Follow-up|1|||
130734294|NCT04895982|470645447|FG009|Overall Study|Lost to Follow-up|0|||
130734295|NCT04895982|470645448|FG010|Overall Study|Lost to Follow-up|0|||
130734296|NCT04895982|470645449|FG011|Overall Study|Lost to Follow-up|0|||
130734297|NCT04895982|470645438|FG000|Overall Study|Refused further study procedures|0|||
130734298|NCT04895982|470645439|FG001|Overall Study|Refused further study procedures|0|||
130734299|NCT04895982|470645440|FG002|Overall Study|Refused further study procedures|1|||
130734300|NCT04895982|470645441|FG003|Overall Study|Refused further study procedures|0|||
130734301|NCT04895982|470645442|FG004|Overall Study|Refused further study procedures|0|||
130734302|NCT04895982|470645443|FG005|Overall Study|Refused further study procedures|0|||
130734303|NCT04895982|470645444|FG006|Overall Study|Refused further study procedures|0|||
130734304|NCT04895982|470645445|FG007|Overall Study|Refused further study procedures|0|||
130734305|NCT04895982|470645446|FG008|Overall Study|Refused further study procedures|0|||
131203020|NCT00718887|472364870|FG001|Overall Study|Not identified|7|||
131203021|NCT05102734|472364872|FG000|Overall Study|Did not require vasopressors|1|||
131203022|NCT05102734|472364873|FG001|Overall Study|Did not require vasopressors|0|||
131203023|NCT05102734|472364872|FG000|Overall Study|Did not have functioning PA catheter|1|||
130734306|NCT04895982|470645447|FG009|Overall Study|Refused further study procedures|0|||
130734307|NCT04895982|470645448|FG010|Overall Study|Refused further study procedures|0|||
130734308|NCT04895982|470645449|FG011|Overall Study|Refused further study procedures|0|||
130734309|NCT01449812|470645450|FG000|Overall Study|Migrated/moved from study area|1|||
130734310|NCT01449812|470645451|FG001|Overall Study|Migrated/moved from study area|0|||
130734311|NCT01449812|470645452|FG002|Overall Study|Migrated/moved from study area|0|||
130734312|NCT01449812|470645450|FG000|Overall Study|Withdrawal by Subject|0|||
130734313|NCT01449812|470645451|FG001|Overall Study|Withdrawal by Subject|0|||
130734314|NCT01449812|470645452|FG002|Overall Study|Withdrawal by Subject|1|||
130734315|NCT01449812|470645450|FG000|Overall Study|Lost to Follow-up|1|||
130734316|NCT01449812|470645451|FG001|Overall Study|Lost to Follow-up|0|||
130734317|NCT01449812|470645452|FG002|Overall Study|Lost to Follow-up|0|||
130734318|NCT04239027|470645453|FG000|Overall Study|Adverse Event|4|||
130734319|NCT04239027|470645453|FG000|Overall Study|Withdrawal by Subject|9|||
130734320|NCT04239027|470645453|FG000|Overall Study|Death|1|||
130734321|NCT04239027|470645453|FG000|Overall Study|Physician Decision|9|||
130734322|NCT04239027|470645453|FG000|Overall Study|Lost to Follow-up|2|||
130734323|NCT04239027|470645453|FG000|Overall Study|Lack of Efficacy|1|||
130734324|NCT01059786|470647238|FG000|Overall Study|Did not receive 6 cycles.|0|||
130734325|NCT01059786|470647239|FG001|Overall Study|Did not receive 6 cycles.|0|||
130734326|NCT01059786|470647240|FG002|Overall Study|Did not receive 6 cycles.|4|||
131203024|NCT05102734|472364873|FG001|Overall Study|Did not have functioning PA catheter|0|||
131203025|NCT05102734|472364872|FG000|Overall Study|Inadequate video quality|2|||
131203026|NCT05102734|472364873|FG001|Overall Study|Inadequate video quality|0|||
131203027|NCT04235959|472364874|FG000|Overall Study|Protocol Violation|0|||
131203028|NCT04235959|472364875|FG001|Overall Study|Protocol Violation|1|||
131203029|NCT04235959|472364876|FG002|Overall Study|Protocol Violation|0|||
131203030|NCT04235959|472364874|FG000|Overall Study|Adverse Event|1|||
131203031|NCT04235959|472364875|FG001|Overall Study|Adverse Event|0|||
131203032|NCT04235959|472364876|FG002|Overall Study|Adverse Event|0|||
131203033|NCT00608426|472364877|FG000|Overall Study|Death|32|||
131203034|NCT00608426|472364878|FG001|Overall Study|Death|36|||
131203035|NCT00608426|472364877|FG000|Overall Study|Lost to Follow-up|485|||
131203036|NCT00608426|472364878|FG001|Overall Study|Lost to Follow-up|521|||
131203037|NCT00608426|472364877|FG000|Overall Study|refused, health issues, wrong address|319|||
131203038|NCT00608426|472364878|FG001|Overall Study|refused, health issues, wrong address|348|||
131203039|NCT03055806|472364882|FG000|Overall Study|Adverse Event|0|||
131203040|NCT03055806|472364883|FG001|Overall Study|Adverse Event|0|||
131203041|NCT03055806|472364884|FG002|Overall Study|Adverse Event|1|||
131203042|NCT03055806|472364885|FG003|Overall Study|Adverse Event|1|||
131203043|NCT03055806|472364882|FG000|Overall Study|Lost to Follow-up|0|||
131203044|NCT03055806|472364883|FG001|Overall Study|Lost to Follow-up|3|||
131203045|NCT03055806|472364884|FG002|Overall Study|Lost to Follow-up|6|||
131203046|NCT03055806|472364885|FG003|Overall Study|Lost to Follow-up|7|||
131203047|NCT03055806|472364882|FG000|Overall Study|Physician Decision|1|||
131203048|NCT03055806|472364883|FG001|Overall Study|Physician Decision|0|||
131203049|NCT03055806|472364884|FG002|Overall Study|Physician Decision|0|||
131203050|NCT03055806|472364885|FG003|Overall Study|Physician Decision|1|||
131203051|NCT03055806|472364882|FG000|Overall Study|Protocol Violation|1|||
131203052|NCT03055806|472364883|FG001|Overall Study|Protocol Violation|0|||
131203053|NCT03055806|472364884|FG002|Overall Study|Protocol Violation|0|||
131203054|NCT03055806|472364885|FG003|Overall Study|Protocol Violation|0|||
131203055|NCT03055806|472364882|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
131203056|NCT03055806|472364883|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
131203057|NCT03055806|472364884|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
131203058|NCT03055806|472364885|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
131203059|NCT03055806|472364882|FG000|Overall Study|Withdrawal of consent to continue study|2|||
131203060|NCT03055806|472364883|FG001|Overall Study|Withdrawal of consent to continue study|3|||
131203061|NCT03055806|472364884|FG002|Overall Study|Withdrawal of consent to continue study|4|||
131203062|NCT03055806|472364885|FG003|Overall Study|Withdrawal of consent to continue study|6|||
131203063|NCT03055806|472364882|FG000|Overall Study|Partner not willing to try intercourse|1|||
131203064|NCT03055806|472364883|FG001|Overall Study|Partner not willing to try intercourse|0|||
131203065|NCT03055806|472364884|FG002|Overall Study|Partner not willing to try intercourse|0|||
131203066|NCT03055806|472364885|FG003|Overall Study|Partner not willing to try intercourse|0|||
131203067|NCT04601194|472364886|FG000|Overall Study|Lost to Follow-up|7|||
131203068|NCT02630459|472364887|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131203069|NCT02630459|472364888|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
131203070|NCT02630459|472364889|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131203071|NCT02630459|472364890|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
131203072|NCT02630459|472364891|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131203073|NCT02630459|472364892|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131203074|NCT02630459|472364893|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131203075|NCT02630459|472364894|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
131203076|NCT02630459|472364887|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131203077|NCT02630459|472364888|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131203078|NCT02630459|472364889|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
131203079|NCT02630459|472364890|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131203080|NCT02630459|472364891|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131203081|NCT02630459|472364892|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131203082|NCT02630459|472364893|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131203083|NCT02630459|472364894|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
131203084|NCT02630459|472364887|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
131203085|NCT02630459|472364888|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
131203086|NCT02630459|472364889|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
131203087|NCT02630459|472364890|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
131203088|NCT02630459|472364891|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
131203089|NCT02630459|472364892|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
131203090|NCT02630459|472364893|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
131203091|NCT02630459|472364894|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
131203092|NCT02630459|472364887|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
131203093|NCT02630459|472364888|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131203094|NCT02630459|472364889|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131203095|NCT02630459|472364890|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131203096|NCT02630459|472364891|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131203097|NCT02630459|472364892|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131203098|NCT02630459|472364893|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131203099|NCT02630459|472364894|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
131203100|NCT02630459|472364887|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131203101|NCT02630459|472364888|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131203102|NCT02630459|472364889|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131203103|NCT02630459|472364890|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131203104|NCT02630459|472364891|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
131203105|NCT02630459|472364892|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
131203106|NCT02630459|472364893|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131203107|NCT02630459|472364894|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
131203108|NCT02630459|472364887|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131203109|NCT02630459|472364888|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131203110|NCT02630459|472364889|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131203111|NCT02630459|472364890|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131203112|NCT02630459|472364891|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
131203113|NCT02630459|472364892|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
131203114|NCT02630459|472364893|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130734327|NCT01059786|470647241|FG003|Overall Study|Did not receive 6 cycles.|1|||
130734328|NCT01059786|470647242|FG004|Overall Study|Did not receive 6 cycles.|0|||
130734329|NCT04460885|470647243|FG000|Overall Study|Withdrawal by Subject|6|||
130734330|NCT04460885|470647244|FG001|Overall Study|Withdrawal by Subject|8|||
130734331|NCT04460885|470647243|FG000|Overall Study|Site closure|1|||
130734332|NCT04460885|470647244|FG001|Overall Study|Site closure|0|||
130734333|NCT04460885|470647243|FG000|Overall Study|Death|5|||
130734334|NCT04460885|470647244|FG001|Overall Study|Death|4|||
130734335|NCT04460885|470647243|FG000|Overall Study|Physician Decision|2|||
130734336|NCT04460885|470647244|FG001|Overall Study|Physician Decision|1|||
130734337|NCT04460885|470647243|FG000|Overall Study|Lost to Follow-up|4|||
130734338|NCT04460885|470647244|FG001|Overall Study|Lost to Follow-up|4|||
130734339|NCT04559347|470647245|FG000|Overall Study|Death|1|||
130734340|NCT04559347|470647246|FG001|Overall Study|Death|0|||
130734341|NCT04559347|470647245|FG000|Overall Study|Thoracotomy conversion|1|||
130734342|NCT04559347|470647246|FG001|Overall Study|Thoracotomy conversion|1|||
130734343|NCT04559347|470647245|FG000|Overall Study|Provider unavailable|2|||
130734344|NCT04559347|470647246|FG001|Overall Study|Provider unavailable|1|||
131203115|NCT02630459|472364894|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
131203116|NCT02630459|472364887|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131203117|NCT02630459|472364888|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131203118|NCT02630459|472364889|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131203119|NCT02630459|472364890|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131203120|NCT02630459|472364891|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
131203121|NCT02630459|472364892|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130734345|NCT04559347|470647245|FG000|Overall Study|Other|2|||
130734346|NCT04559347|470647246|FG001|Overall Study|Other|1|||
131203122|NCT02630459|472364893|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131203123|NCT02630459|472364894|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
131203124|NCT00125138|472364895|FG000|Overall Study|Adverse Event|1|||
131203125|NCT00125138|472364896|FG001|Overall Study|Adverse Event|0|||
131203126|NCT00125138|472364897|FG002|Overall Study|Adverse Event|3|||
131203127|NCT00125138|472364898|FG003|Overall Study|Adverse Event|2|||
131203128|NCT00125138|472364895|FG000|Overall Study|Withdrawal by Subject|2|||
131203129|NCT00125138|472364896|FG001|Overall Study|Withdrawal by Subject|3|||
131203130|NCT00125138|472364897|FG002|Overall Study|Withdrawal by Subject|1|||
131203131|NCT00125138|472364898|FG003|Overall Study|Withdrawal by Subject|1|||
131203132|NCT00125138|472364895|FG000|Overall Study|Lack of Efficacy|0|||
131203133|NCT00125138|472364896|FG001|Overall Study|Lack of Efficacy|0|||
131203134|NCT00125138|472364897|FG002|Overall Study|Lack of Efficacy|0|||
131203135|NCT00125138|472364898|FG003|Overall Study|Lack of Efficacy|1|||
131203136|NCT00125138|472364895|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
131203137|NCT00125138|472364896|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
131203138|NCT00125138|472364897|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
131203139|NCT00125138|472364898|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
131203140|NCT01904760|472364905|FG000|Overall Study|Protocol Violation|1|||
131203141|NCT01904760|472364906|FG001|Overall Study|Protocol Violation|0|||
131203142|NCT04249076|472364916|FG000|Overall Study|Adverse Event|1|||
131203143|NCT04249076|472364917|FG001|Overall Study|Adverse Event|1|||
131203144|NCT04249076|472364916|FG000|Overall Study|Protocol Violation|1|||
131203145|NCT04249076|472364917|FG001|Overall Study|Protocol Violation|2|||
131203146|NCT04249076|472364916|FG000|Overall Study|Lack of Efficacy|0|||
131203147|NCT04249076|472364917|FG001|Overall Study|Lack of Efficacy|1|||
131203148|NCT04249076|472364916|FG000|Overall Study|Withdrawal by Subject|0|||
131203149|NCT04249076|472364917|FG001|Overall Study|Withdrawal by Subject|1|||
131203150|NCT00783263|472364918|FG000|Overall Study|Adverse Event|3|||
131203151|NCT00783263|472364919|FG001|Overall Study|Adverse Event|0|||
131203152|NCT00783263|472364920|FG002|Overall Study|Adverse Event|2|||
131203153|NCT00783263|472364921|FG003|Overall Study|Adverse Event|1|||
131203154|NCT00783263|472364918|FG000|Overall Study|Lost to Follow-up|1|||
131203155|NCT00783263|472364919|FG001|Overall Study|Lost to Follow-up|1|||
131203156|NCT00783263|472364920|FG002|Overall Study|Lost to Follow-up|0|||
131203157|NCT00783263|472364921|FG003|Overall Study|Lost to Follow-up|0|||
131203158|NCT00783263|472364918|FG000|Overall Study|Withdrawal by Subject|0|||
131203159|NCT00783263|472364919|FG001|Overall Study|Withdrawal by Subject|1|||
131203160|NCT00783263|472364920|FG002|Overall Study|Withdrawal by Subject|1|||
131203161|NCT00783263|472364921|FG003|Overall Study|Withdrawal by Subject|2|||
131203162|NCT00106626|472364922|FG000|Overall Study|Adverse Event|5|||
131203163|NCT00106626|472364923|FG001|Overall Study|Adverse Event|4|||
131203164|NCT00106626|472364924|FG002|Overall Study|Adverse Event|3|||
131203165|NCT00106626|472364925|FG003|Overall Study|Adverse Event|3|||
131203166|NCT00106626|472364922|FG000|Overall Study|Progressive Disease|4|||
131203167|NCT00106626|472364923|FG001|Overall Study|Progressive Disease|1|||
131203168|NCT00106626|472364924|FG002|Overall Study|Progressive Disease|9|||
131203169|NCT00106626|472364925|FG003|Overall Study|Progressive Disease|10|||
131203170|NCT00106626|472364922|FG000|Overall Study|Received radiation on new therapy|1|||
131203171|NCT00106626|472364923|FG001|Overall Study|Received radiation on new therapy|0|||
131203172|NCT00106626|472364924|FG002|Overall Study|Received radiation on new therapy|0|||
131203173|NCT00106626|472364925|FG003|Overall Study|Received radiation on new therapy|0|||
131203174|NCT00106626|472364922|FG000|Overall Study|> 14 day delay in therapy start|0|||
131203175|NCT00106626|472364923|FG001|Overall Study|> 14 day delay in therapy start|1|||
131203176|NCT00106626|472364924|FG002|Overall Study|> 14 day delay in therapy start|0|||
131203177|NCT00106626|472364925|FG003|Overall Study|> 14 day delay in therapy start|0|||
131203178|NCT00405756|472364930|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
131203179|NCT00405756|472364931|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
131203180|NCT00405756|472364932|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
131203181|NCT00405756|472364930|FG000|Double-blind Treatment|Adverse Event|31|||
131203182|NCT00405756|472364931|FG001|Double-blind Treatment|Adverse Event|27|||
131203183|NCT00405756|472364932|FG002|Double-blind Treatment|Adverse Event|12|||
131203184|NCT00405756|472364930|FG000|Double-blind Treatment|Disease Progression|47|||
131203185|NCT00405756|472364931|FG001|Double-blind Treatment|Disease Progression|81|||
131203186|NCT00405756|472364932|FG002|Double-blind Treatment|Disease Progression|102|||
131203187|NCT00405756|472364930|FG000|Double-blind Treatment|Lack of Efficacy|1|||
130734347|NCT02717455|470647248|FG000|Overall Study|Adverse Event|1|||
130734348|NCT02717455|470647249|FG001|Overall Study|Adverse Event|0|||
130734349|NCT02717455|470647250|FG002|Overall Study|Adverse Event|0|||
130734350|NCT02717455|470647251|FG003|Overall Study|Adverse Event|2|||
130734351|NCT02717455|470647252|FG004|Overall Study|Adverse Event|2|||
130734352|NCT02717455|470647253|FG005|Overall Study|Adverse Event|2|||
130734353|NCT02717455|470647248|FG000|Overall Study|Withdrawal by Subject|1|||
130734354|NCT02717455|470647249|FG001|Overall Study|Withdrawal by Subject|1|||
130734355|NCT02717455|470647250|FG002|Overall Study|Withdrawal by Subject|0|||
130734356|NCT02717455|470647251|FG003|Overall Study|Withdrawal by Subject|2|||
130734357|NCT02717455|470647252|FG004|Overall Study|Withdrawal by Subject|2|||
130734358|NCT02717455|470647253|FG005|Overall Study|Withdrawal by Subject|1|||
130734359|NCT02717455|470647248|FG000|Overall Study|Death|1|||
130734360|NCT02717455|470647249|FG001|Overall Study|Death|0|||
130734361|NCT02717455|470647250|FG002|Overall Study|Death|0|||
130734362|NCT02717455|470647251|FG003|Overall Study|Death|0|||
130734363|NCT02717455|470647252|FG004|Overall Study|Death|1|||
130734364|NCT02717455|470647253|FG005|Overall Study|Death|0|||
130734365|NCT02717455|470647248|FG000|Overall Study|Did not receive study drug|0|||
130734366|NCT02717455|470647249|FG001|Overall Study|Did not receive study drug|0|||
130734367|NCT02717455|470647250|FG002|Overall Study|Did not receive study drug|0|||
130734368|NCT02717455|470647251|FG003|Overall Study|Did not receive study drug|1|||
130734369|NCT02717455|470647252|FG004|Overall Study|Did not receive study drug|0|||
130734370|NCT02717455|470647253|FG005|Overall Study|Did not receive study drug|1|||
130734371|NCT02717455|470647248|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130734372|NCT02717455|470647249|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130734373|NCT02717455|470647250|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130734374|NCT02717455|470647251|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130734375|NCT02717455|470647252|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130734376|NCT02717455|470647253|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
130734377|NCT02717455|470647248|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
130734378|NCT02717455|470647249|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
130734379|NCT02717455|470647250|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
130734380|NCT02717455|470647251|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
130784652|NCT05630196|470841136|FG001|Overall Study|Adverse Event|1|||
130734381|NCT02717455|470647252|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
130734382|NCT02717455|470647253|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
130734383|NCT01433055|470647254|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
130734384|NCT01433055|470647255|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
130734385|NCT01433055|470647254|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
130734386|NCT01433055|470647255|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
130734387|NCT00233948|470647259|FG000|Overall Study|Adverse Event|1|||
130734388|NCT00233948|470647260|FG001|Overall Study|Adverse Event|0|||
130734389|NCT00233948|470647261|FG002|Overall Study|Adverse Event|0|||
130734390|NCT00233948|470647262|FG003|Overall Study|Adverse Event|0|||
130734391|NCT00233948|470647263|FG004|Overall Study|Adverse Event|0|||
130734392|NCT00233948|470647264|FG005|Overall Study|Adverse Event|0|||
130734393|NCT01214655|470647272|FG000|Part A|Progressive Disease|7|||
130734394|NCT01214655|470647273|FG001|Part A|Progressive Disease|0|||
130734395|NCT01214655|470647274|FG002|Part A|Progressive Disease|0|||
130734396|NCT01214655|470647272|FG000|Part A|Physician Decision|1|||
130734397|NCT01214655|470647273|FG001|Part A|Physician Decision|0|||
130734398|NCT01214655|470647274|FG002|Part A|Physician Decision|0|||
130734399|NCT01214655|470647272|FG000|Part B|Progressive disease|0|||
130734400|NCT01214655|470647273|FG001|Part B|Progressive disease|10|||
130734401|NCT01214655|470647274|FG002|Part B|Progressive disease|0|||
130734402|NCT01214655|470647272|FG000|Part B|Death|0|||
130734403|NCT01214655|470647273|FG001|Part B|Death|1|||
130734404|NCT01214655|470647274|FG002|Part B|Death|0|||
130734405|NCT01214655|470647272|FG000|Part B|Withdrawal by Subject|0|||
130734406|NCT01214655|470647273|FG001|Part B|Withdrawal by Subject|2|||
130734407|NCT01214655|470647274|FG002|Part B|Withdrawal by Subject|0|||
130734408|NCT01214655|470647272|FG000|Part C|Progressive Disease|0|||
130734409|NCT01214655|470647273|FG001|Part C|Progressive Disease|0|||
130734410|NCT01214655|470647274|FG002|Part C|Progressive Disease|5|||
130734411|NCT01214655|470647272|FG000|Part C|Death|0|||
130734412|NCT01214655|470647273|FG001|Part C|Death|0|||
130734413|NCT01214655|470647274|FG002|Part C|Death|1|||
130734414|NCT01214655|470647272|FG000|Part C|Physician Decision|0|||
130734415|NCT01214655|470647273|FG001|Part C|Physician Decision|0|||
130734416|NCT01214655|470647274|FG002|Part C|Physician Decision|1|||
130734417|NCT05256134|470647275|FG000|Overall Study|Study Terminated by Sponsor|11|||
130734418|NCT05256134|470647276|FG001|Overall Study|Study Terminated by Sponsor|10|||
130734419|NCT05256134|470647275|FG000|Overall Study|Withdrawal by Subject|1|||
130734420|NCT05256134|470647276|FG001|Overall Study|Withdrawal by Subject|3|||
130734421|NCT00886015|470647279|FG000|Overall Study|Death|0|||
130734422|NCT00886015|470647280|FG001|Overall Study|Death|2|||
130734423|NCT05490771|470647286|FG000|Overall Study|Disease progression|18|||
130734424|NCT05490771|470647286|FG000|Overall Study|Adverse Event|3|||
130734425|NCT05490771|470647286|FG000|Overall Study|Other complicating disease|1|||
130734426|NCT05490771|470647286|FG000|Overall Study|Withdrawal by Subject|3|||
130734427|NCT05490771|470647286|FG000|Overall Study|Physician Decision|1|||
130734428|NCT05490771|470647286|FG000|Overall Study|Still on treatment|2|||
130734429|NCT05490771|470647286|FG000|Overall Study|Never start protocol therapy|5|||
130734430|NCT05490771|470647286|FG000|Overall Study|Ineligible|2|||
130734431|NCT01720225|470647287|FG000|Overall Study|Withdrawal by Subject|0|||
130734432|NCT01720225|470647288|FG001|Overall Study|Withdrawal by Subject|1|||
130734433|NCT01720225|470647287|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
130734434|NCT01720225|470647288|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
130734435|NCT00661193|470647292|FG000|Overall Study|Adverse Event|2|||
130734436|NCT00661193|470647293|FG001|Overall Study|Adverse Event|1|||
130734437|NCT00661193|470647292|FG000|Overall Study|Withdrawal by Subject|3|||
130734438|NCT00661193|470647293|FG001|Overall Study|Withdrawal by Subject|1|||
130734439|NCT00661193|470647292|FG000|Overall Study|Progression|27|||
130734440|NCT00661193|470647293|FG001|Overall Study|Progression|24|||
130734441|NCT00661193|470647292|FG000|Overall Study|Not protocol specified|1|||
130734442|NCT00661193|470647293|FG001|Overall Study|Not protocol specified|0|||
130734443|NCT02964312|470647294|FG000|Overall Study|Lost to Follow-up|28|||
130734444|NCT02964312|470647294|FG000|Overall Study|Withdrawal by Subject|11|||
130734445|NCT02964312|470647294|FG000|Overall Study|Lack of Efficacy|10|||
130734446|NCT02964312|470647294|FG000|Overall Study|Did not consent to long-term FU|14|||
130734447|NCT02964312|470647294|FG000|Overall Study|Death|1|||
130734448|NCT02862730|470647303|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130734449|NCT02862730|470647304|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130734450|NCT02862730|470647305|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
130734451|NCT02862730|470647306|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
131203188|NCT00405756|472364931|FG001|Double-blind Treatment|Lack of Efficacy|4|||
131203189|NCT00405756|472364932|FG002|Double-blind Treatment|Lack of Efficacy|2|||
131203190|NCT00405756|472364930|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
131203191|NCT00405756|472364931|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
131203192|NCT00405756|472364932|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
131203193|NCT00405756|472364930|FG000|Double-blind Treatment|Lost to Follow-up|1|||
131203194|NCT00405756|472364931|FG001|Double-blind Treatment|Lost to Follow-up|0|||
131203195|NCT00405756|472364932|FG002|Double-blind Treatment|Lost to Follow-up|0|||
131203196|NCT00405756|472364930|FG000|Double-blind Treatment|Death|4|||
131203197|NCT00405756|472364931|FG001|Double-blind Treatment|Death|4|||
131203198|NCT00405756|472364932|FG002|Double-blind Treatment|Death|4|||
131203199|NCT00405756|472364930|FG000|Double-blind Treatment|Protocol Violation|1|||
131203200|NCT00405756|472364931|FG001|Double-blind Treatment|Protocol Violation|0|||
131203201|NCT00405756|472364932|FG002|Double-blind Treatment|Protocol Violation|2|||
131203202|NCT00405756|472364930|FG000|Double-blind Treatment|Other|7|||
131203203|NCT00405756|472364931|FG001|Double-blind Treatment|Other|4|||
131203204|NCT00405756|472364932|FG002|Double-blind Treatment|Other|4|||
131203205|NCT00405756|472364930|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
131203206|NCT00405756|472364931|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
131203207|NCT00405756|472364932|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
131203208|NCT00405756|472364930|FG000|Open-label Extension|Adverse Event|1|||
131203209|NCT00405756|472364931|FG001|Open-label Extension|Adverse Event|3|||
131203210|NCT00405756|472364932|FG002|Open-label Extension|Adverse Event|7|||
131203211|NCT00405756|472364930|FG000|Open-label Extension|Disease Progression|8|||
131203212|NCT00405756|472364931|FG001|Open-label Extension|Disease Progression|23|||
131203213|NCT00405756|472364932|FG002|Open-label Extension|Disease Progression|26|||
131203214|NCT00405756|472364930|FG000|Open-label Extension|Withdrawal by Subject|2|||
131203215|NCT00405756|472364931|FG001|Open-label Extension|Withdrawal by Subject|3|||
131203216|NCT00405756|472364932|FG002|Open-label Extension|Withdrawal by Subject|3|||
131203217|NCT00405756|472364930|FG000|Open-label Extension|Death|1|||
131203218|NCT00405756|472364931|FG001|Open-label Extension|Death|2|||
131203219|NCT00405756|472364932|FG002|Open-label Extension|Death|4|||
131203220|NCT00405756|472364930|FG000|Open-label Extension|Other|0|||
131203221|NCT00405756|472364931|FG001|Open-label Extension|Other|1|||
131203222|NCT00405756|472364932|FG002|Open-label Extension|Other|7|||
131203223|NCT00405756|472364930|FG000|Follow-up|Ongoing in Follow-up Period|52|||
131203224|NCT00405756|472364931|FG001|Follow-up|Ongoing in Follow-up Period|51|||
131203225|NCT00405756|472364932|FG002|Follow-up|Ongoing in Follow-up Period|60|||
131203226|NCT00405756|472364930|FG000|Follow-up|Death|21|||
131203227|NCT00405756|472364931|FG001|Follow-up|Death|31|||
131203228|NCT00405756|472364932|FG002|Follow-up|Death|24|||
131203229|NCT00405756|472364930|FG000|Follow-up|Lost to Follow-up|2|||
131203230|NCT00405756|472364931|FG001|Follow-up|Lost to Follow-up|8|||
131203231|NCT00405756|472364932|FG002|Follow-up|Lost to Follow-up|4|||
131203232|NCT01117428|472364938|FG000|Overall Study|Lack of Efficacy|1|||
131203233|NCT01117428|472364939|FG001|Overall Study|Lack of Efficacy|0|||
131203234|NCT01117428|472364940|FG002|Overall Study|Lack of Efficacy|0|||
131203235|NCT01117428|472364941|FG003|Overall Study|Lack of Efficacy|0|||
131203236|NCT01117428|472364942|FG004|Overall Study|Lack of Efficacy|0|||
131203237|NCT01117428|472364943|FG005|Overall Study|Lack of Efficacy|0|||
131203238|NCT01117428|472364938|FG000|Overall Study|Adverse Event|4|||
131203239|NCT01117428|472364939|FG001|Overall Study|Adverse Event|0|||
131203240|NCT01117428|472364940|FG002|Overall Study|Adverse Event|0|||
131203241|NCT01117428|472364941|FG003|Overall Study|Adverse Event|0|||
131203242|NCT01117428|472364942|FG004|Overall Study|Adverse Event|1|||
131203243|NCT01117428|472364943|FG005|Overall Study|Adverse Event|2|||
130734452|NCT02862730|470647307|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
131203244|NCT01117428|472364938|FG000|Overall Study|Death|0|||
131203245|NCT01117428|472364939|FG001|Overall Study|Death|1|||
131203246|NCT01117428|472364940|FG002|Overall Study|Death|2|||
131203247|NCT01117428|472364941|FG003|Overall Study|Death|0|||
131203248|NCT01117428|472364942|FG004|Overall Study|Death|0|||
131203249|NCT01117428|472364943|FG005|Overall Study|Death|1|||
131203250|NCT01117428|472364938|FG000|Overall Study|Physician Decision|0|||
131203251|NCT01117428|472364939|FG001|Overall Study|Physician Decision|1|||
131203252|NCT01117428|472364940|FG002|Overall Study|Physician Decision|0|||
131203253|NCT01117428|472364941|FG003|Overall Study|Physician Decision|0|||
131203254|NCT01117428|472364942|FG004|Overall Study|Physician Decision|0|||
131203255|NCT01117428|472364943|FG005|Overall Study|Physician Decision|0|||
131203256|NCT01117428|472364938|FG000|Overall Study|Withdrawal by Subject|0|||
130734453|NCT02862730|470647308|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130734454|NCT02862730|470647309|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130734455|NCT02862730|470647303|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
130734456|NCT02862730|470647304|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130734457|NCT02862730|470647305|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130734458|NCT02862730|470647306|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130734459|NCT02862730|470647307|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130734460|NCT02862730|470647308|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130734461|NCT02862730|470647309|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130784653|NCT05630196|470841135|FG000|Overall Study|Lost to Follow-up|1|||
130734462|NCT02862730|470647303|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130734463|NCT02862730|470647304|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130734464|NCT02862730|470647305|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
130734465|NCT02862730|470647306|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
131203257|NCT01117428|472364939|FG001|Overall Study|Withdrawal by Subject|0|||
131203258|NCT01117428|472364940|FG002|Overall Study|Withdrawal by Subject|1|||
131203259|NCT01117428|472364941|FG003|Overall Study|Withdrawal by Subject|0|||
131203260|NCT01117428|472364942|FG004|Overall Study|Withdrawal by Subject|0|||
131203261|NCT01117428|472364943|FG005|Overall Study|Withdrawal by Subject|0|||
131203262|NCT01117428|472364938|FG000|Overall Study|Progressive disease|15|||
131203263|NCT01117428|472364939|FG001|Overall Study|Progressive disease|27|||
131203264|NCT01117428|472364940|FG002|Overall Study|Progressive disease|10|||
131203265|NCT01117428|472364941|FG003|Overall Study|Progressive disease|12|||
131203266|NCT01117428|472364942|FG004|Overall Study|Progressive disease|16|||
131203267|NCT01117428|472364943|FG005|Overall Study|Progressive disease|17|||
131203268|NCT03018028|472364944|FG000|Overall Study|Withdrawal by Subject|3|||
131203269|NCT03018028|472364945|FG001|Overall Study|Withdrawal by Subject|0|||
131203270|NCT03018028|472364946|FG002|Overall Study|Withdrawal by Subject|1|||
131203271|NCT03018028|472364947|FG003|Overall Study|Withdrawal by Subject|2|||
131203272|NCT03018028|472364948|FG004|Overall Study|Withdrawal by Subject|0|||
131203273|NCT02519777|472364951|FG000|Overall Study|Death|1|||
131203274|NCT02519777|472364952|FG001|Overall Study|Death|0|||
131203275|NCT02519777|472364953|FG002|Overall Study|Death|0|||
131203276|NCT02519777|472364951|FG000|Overall Study|Lost to Follow-up|0|||
131203277|NCT02519777|472364952|FG001|Overall Study|Lost to Follow-up|4|||
131203278|NCT02519777|472364953|FG002|Overall Study|Lost to Follow-up|2|||
131203279|NCT02519777|472364951|FG000|Overall Study|Withdrawal by Subject|3|||
131203280|NCT02519777|472364952|FG001|Overall Study|Withdrawal by Subject|1|||
131203281|NCT02519777|472364953|FG002|Overall Study|Withdrawal by Subject|0|||
131203282|NCT02519777|472364951|FG000|Overall Study|Severe Debilitation|1|||
131203283|NCT02519777|472364952|FG001|Overall Study|Severe Debilitation|1|||
131203284|NCT02519777|472364953|FG002|Overall Study|Severe Debilitation|1|||
131203285|NCT02519777|472364951|FG000|Overall Study|Not able to get to clinic|1|||
131203286|NCT02519777|472364952|FG001|Overall Study|Not able to get to clinic|2|||
131203287|NCT02519777|472364953|FG002|Overall Study|Not able to get to clinic|1|||
131203288|NCT01683058|472364955|FG000|Overall Study|Lost to Follow-up|9|||
131203289|NCT01683058|472364955|FG000|Overall Study|Adverse Event|6|||
131203290|NCT01683058|472364955|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
131203291|NCT01683058|472364955|FG000|Overall Study|Withdrawal by Subject|7|||
131203292|NCT01683058|472364955|FG000|Overall Study|Lack of Efficacy|2|||
131203293|NCT04062240|472364959|FG000|Overall Study|equipment malfunction|1|||
131203294|NCT01957111|472364960|FG000|Overall Study|Withdrawal by Subject|1|||
131203295|NCT01957111|472364961|FG001|Overall Study|Withdrawal by Subject|1|||
131203296|NCT01057394|472364962|FG000|Overall Study|Not eligible|0|||
131203297|NCT01057394|472364963|FG001|Overall Study|Not eligible|2|||
131203298|NCT03500419|472364964|FG000|Overall Study|Withdrawal by Subject|2|||
131203299|NCT03500419|472364965|FG001|Overall Study|Withdrawal by Subject|25|||
131203300|NCT00082628|472364966|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
131203301|NCT00082628|472364967|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
131203302|NCT00082628|472364968|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
131203303|NCT00082628|472364969|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
131203304|NCT00082628|472364970|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
131203305|NCT00082628|472364966|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
131203306|NCT00082628|472364967|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
131203307|NCT00082628|472364968|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
131203308|NCT00082628|472364969|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
131203309|NCT00082628|472364970|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
131203310|NCT00082628|472364966|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
131203311|NCT00082628|472364967|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
131203312|NCT00082628|472364968|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
131203313|NCT00082628|472364969|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
131203314|NCT00082628|472364970|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
131203315|NCT00082628|472364966|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
131203316|NCT00082628|472364967|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
131203317|NCT00082628|472364968|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
131203318|NCT00082628|472364969|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
131203319|NCT00082628|472364970|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
130734466|NCT02862730|470647307|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
130734467|NCT02862730|470647308|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
131203320|NCT00082628|472364966|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
131203321|NCT00082628|472364967|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
131203322|NCT00082628|472364968|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
130734468|NCT02862730|470647309|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130734469|NCT02862730|470647303|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130734470|NCT02862730|470647304|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130734471|NCT02862730|470647305|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130734472|NCT02862730|470647306|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
130734473|NCT02862730|470647307|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130734474|NCT02862730|470647308|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130734475|NCT02862730|470647309|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130734476|NCT03685344|470647310|FG000|Overall Study|Withdrawal by Subject|1|||
131203323|NCT00082628|472364969|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
131203324|NCT00082628|472364970|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
131203325|NCT00082628|472364966|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
131203326|NCT00082628|472364967|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
131203327|NCT00082628|472364968|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
131203328|NCT00082628|472364969|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
131203329|NCT00082628|472364970|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
131203330|NCT00082628|472364966|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
131203331|NCT00082628|472364967|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
131203332|NCT00082628|472364968|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
131203333|NCT00082628|472364969|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
131203334|NCT00082628|472364970|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
131203335|NCT01566981|472364973|FG000|Overall Study|Lost to Follow-up|5|||
131203336|NCT01566981|472364974|FG001|Overall Study|Lost to Follow-up|8|||
131203337|NCT03480360|472364981|FG000|Overall Study|Death|2|||
131203338|NCT01326910|472364984|FG000|Overall Study|Withdrawal by Subject|3|||
131203339|NCT01326910|472364985|FG001|Overall Study|Withdrawal by Subject|2|||
131203340|NCT01326910|472364984|FG000|Overall Study|Protocol Violation|1|||
131203341|NCT01326910|472364985|FG001|Overall Study|Protocol Violation|1|||
131203342|NCT02607735|472364986|FG000|Primary Study|Randomized but Never Treated|1|||
131203343|NCT02607735|472364987|FG001|Primary Study|Randomized but Never Treated|0|||
131203344|NCT02607735|472364988|FG002|Primary Study|Randomized but Never Treated|0|||
131203345|NCT02607735|472364986|FG000|Primary Study|Lost to Follow-up|4|||
131203346|NCT02607735|472364987|FG001|Primary Study|Lost to Follow-up|0|||
131203347|NCT02607735|472364988|FG002|Primary Study|Lost to Follow-up|0|||
131203348|NCT02607735|472364986|FG000|Primary Study|Withdrew Consent|2|||
131203349|NCT02607735|472364987|FG001|Primary Study|Withdrew Consent|0|||
131203350|NCT02607735|472364988|FG002|Primary Study|Withdrew Consent|0|||
131203351|NCT02607735|472364986|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
131203352|NCT02607735|472364987|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
131203353|NCT02607735|472364988|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
131203354|NCT02607735|472364986|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
131203355|NCT02607735|472364987|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
131203356|NCT02607735|472364988|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
131203357|NCT01681836|472364991|FG000|Second Intervention|Withdrawal by Subject|0|||
131203358|NCT01681836|472364992|FG001|Second Intervention|Withdrawal by Subject|1|||
131203359|NCT01241318|472364997|FG000|Overall Study|Woman: false pregnancies|27|||
131203360|NCT01241318|472364998|FG001|Overall Study|Woman: false pregnancies|15|||
131203361|NCT01241318|472364997|FG000|Overall Study|Woman: miscarriage/abortion|46|||
131203362|NCT01241318|472364998|FG001|Overall Study|Woman: miscarriage/abortion|38|||
131203363|NCT01241318|472364997|FG000|Overall Study|Withdrawal by Subject|175|||
131203364|NCT01241318|472364998|FG001|Overall Study|Withdrawal by Subject|46|||
131203365|NCT01241318|472364997|FG000|Overall Study|Lost to Follow-up|740|||
131203366|NCT01241318|472364998|FG001|Overall Study|Lost to Follow-up|455|||
131203367|NCT01241318|472364997|FG000|Overall Study|Death|2|||
131203368|NCT01241318|472364998|FG001|Overall Study|Death|4|||
131203369|NCT01241318|472364997|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
131203370|NCT01241318|472364998|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
131203371|NCT01241318|472364997|FG000|Overall Study|Woman: Stillborn infant|129|||
131203372|NCT01241318|472364998|FG001|Overall Study|Woman: Stillborn infant|146|||
131203373|NCT02355665|472364999|FG000|Overall Study|Adverse Event|16|||
130734477|NCT03685344|470647311|FG001|Overall Study|Withdrawal by Subject|1|||
131203374|NCT02355665|472365000|FG001|Overall Study|Adverse Event|24|||
131203375|NCT02355665|472364999|FG000|Overall Study|Protocol Violation|2|||
131203376|NCT02355665|472365000|FG001|Overall Study|Protocol Violation|0|||
131203377|NCT02355665|472364999|FG000|Overall Study|Withdrawal by Subject|90|||
131203378|NCT02355665|472365000|FG001|Overall Study|Withdrawal by Subject|100|||
130734478|NCT03685344|470647312|FG002|Overall Study|Withdrawal by Subject|2|||
130734479|NCT03685344|470647313|FG003|Overall Study|Withdrawal by Subject|0|||
130734480|NCT03685344|470647310|FG000|Overall Study|Physician Decision|1|||
131203379|NCT02355665|472364999|FG000|Overall Study|Lost to Follow-up|131|||
131203380|NCT02355665|472365000|FG001|Overall Study|Lost to Follow-up|103|||
131203381|NCT02355665|472364999|FG000|Overall Study|Death|4|||
131203382|NCT02355665|472365000|FG001|Overall Study|Death|2|||
130734481|NCT03685344|470647311|FG001|Overall Study|Physician Decision|1|||
131203383|NCT02355665|472364999|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
131203384|NCT02355665|472365000|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
131203385|NCT01454531|472365001|FG000|Overall Study|Adverse Event|14|||
131203386|NCT01454531|472365001|FG000|Overall Study|Withdrawal by Subject|5|||
131203387|NCT01454531|472365001|FG000|Overall Study|Lost to Follow-up|1|||
131203388|NCT01454531|472365001|FG000|Overall Study|Physician Decision|1|||
131203389|NCT01454531|472365001|FG000|Overall Study|Delay in IMP administration|1|||
131203390|NCT01454531|472365001|FG000|Overall Study|Other|1|||
131203391|NCT01084096|472366789|FG000|Overall Study|Lost to Follow-up|1501|||
131203392|NCT01084096|472366790|FG001|Overall Study|Lost to Follow-up|1833|||
131203393|NCT01084096|472366789|FG000|Overall Study|Withdrawal by Subject|3|||
131203394|NCT01084096|472366790|FG001|Overall Study|Withdrawal by Subject|0|||
131203395|NCT01084096|472366789|FG000|Overall Study|Woman had a miscarriage|21|||
131203396|NCT01084096|472366790|FG001|Overall Study|Woman had a miscarriage|17|||
131203397|NCT01354964|472366791|FG000|Overall Study|Lost to Follow-up|2|||
131203398|NCT01354964|472366792|FG001|Overall Study|Lost to Follow-up|0|||
131203399|NCT01354964|472366791|FG000|Overall Study|IV access issues|1|||
131203400|NCT01354964|472366792|FG001|Overall Study|IV access issues|1|||
131203401|NCT01354964|472366791|FG000|Overall Study|Physician Decision|1|||
131203402|NCT01354964|472366792|FG001|Overall Study|Physician Decision|0|||
131203403|NCT02551874|472366793|FG000|Overall Study|Lost to Follow-up|0|||
131203404|NCT02551874|472366794|FG001|Overall Study|Lost to Follow-up|2|||
131203405|NCT02551874|472366793|FG000|Overall Study|Pregnancy|0|||
131203406|NCT02551874|472366794|FG001|Overall Study|Pregnancy|1|||
131203407|NCT02551874|472366793|FG000|Overall Study|Reason not reported|10|||
131203408|NCT02551874|472366794|FG001|Overall Study|Reason not reported|4|||
131203409|NCT02551874|472366793|FG000|Overall Study|Did not receive randomized treatment|0|||
131203410|NCT02551874|472366794|FG001|Overall Study|Did not receive randomized treatment|7|||
131203411|NCT02551874|472366793|FG000|Overall Study|Did not enter long-term study|18|||
131203412|NCT02551874|472366794|FG001|Overall Study|Did not enter long-term study|25|||
131203413|NCT01640353|472366805|FG000|Overall Study|Withdrew prior to treatment|10|||
131203414|NCT01640353|472366805|FG000|Overall Study|Withdrawn from analysis at term site|12|||
131203415|NCT01640353|472366805|FG000|Overall Study|Withdrawal by Subject|5|||
131203416|NCT01640353|472366805|FG000|Overall Study|Death|2|||
131203417|NCT01640353|472366805|FG000|Overall Study|Early site termination|3|||
131203418|NCT01640353|472366805|FG000|Overall Study|Lost to Follow-up|12|||
131203419|NCT01640353|472366805|FG000|Overall Study|Physician Decision|1|||
131203420|NCT04450394|472366806|FG000|Overall Study|Adverse Event|2|||
131203421|NCT04450394|472366807|FG001|Overall Study|Adverse Event|0|||
131203422|NCT04450394|472366808|FG002|Overall Study|Adverse Event|0|||
131203423|NCT04450394|472366806|FG000|Overall Study|Death|0|||
131203424|NCT04450394|472366807|FG001|Overall Study|Death|1|||
131203425|NCT04450394|472366808|FG002|Overall Study|Death|0|||
131203426|NCT04450394|472366806|FG000|Overall Study|Lost to Follow-up|0|||
131203427|NCT04450394|472366807|FG001|Overall Study|Lost to Follow-up|3|||
131203428|NCT04450394|472366808|FG002|Overall Study|Lost to Follow-up|0|||
131203429|NCT04450394|472366806|FG000|Overall Study|Physician Decision|0|||
131203430|NCT04450394|472366807|FG001|Overall Study|Physician Decision|1|||
131203431|NCT04450394|472366808|FG002|Overall Study|Physician Decision|0|||
131203432|NCT04450394|472366806|FG000|Overall Study|Protocol Violation|2|||
131203433|NCT04450394|472366807|FG001|Overall Study|Protocol Violation|0|||
131203434|NCT04450394|472366808|FG002|Overall Study|Protocol Violation|0|||
131203435|NCT04450394|472366806|FG000|Overall Study|Withdrawal by Subject|6|||
131203436|NCT04450394|472366807|FG001|Overall Study|Withdrawal by Subject|9|||
131203437|NCT04450394|472366808|FG002|Overall Study|Withdrawal by Subject|0|||
131203438|NCT02155660|472366813|FG000|Overall Study|Other Reason|8|||
131203439|NCT02155660|472366814|FG001|Overall Study|Other Reason|6|||
131203440|NCT02155660|472366815|FG002|Overall Study|Other Reason|10|||
131203441|NCT02155660|472366816|FG003|Overall Study|Other Reason|10|||
131203442|NCT02155660|472366813|FG000|Overall Study|Study-specific withdrawal criteria|0|||
131203443|NCT02155660|472366814|FG001|Overall Study|Study-specific withdrawal criteria|1|||
131203444|NCT02155660|472366815|FG002|Overall Study|Study-specific withdrawal criteria|1|||
131203445|NCT02155660|472366816|FG003|Overall Study|Study-specific withdrawal criteria|1|||
131203446|NCT02155660|472366813|FG000|Overall Study|Severe non-compliance|0|||
131203447|NCT02155660|472366814|FG001|Overall Study|Severe non-compliance|4|||
131203448|NCT02155660|472366815|FG002|Overall Study|Severe non-compliance|0|||
131203449|NCT02155660|472366816|FG003|Overall Study|Severe non-compliance|1|||
131203450|NCT02155660|472366813|FG000|Overall Study|Adverse Event|2|||
130734482|NCT03685344|470647312|FG002|Overall Study|Physician Decision|5|||
131203451|NCT02155660|472366814|FG001|Overall Study|Adverse Event|6|||
131203452|NCT02155660|472366815|FG002|Overall Study|Adverse Event|3|||
131203453|NCT02155660|472366816|FG003|Overall Study|Adverse Event|1|||
131203454|NCT02155660|472366813|FG000|Overall Study|Lost to Follow-up|3|||
130734483|NCT03685344|470647313|FG003|Overall Study|Physician Decision|0|||
131203455|NCT02155660|472366814|FG001|Overall Study|Lost to Follow-up|6|||
131203456|NCT02155660|472366815|FG002|Overall Study|Lost to Follow-up|5|||
131203457|NCT02155660|472366816|FG003|Overall Study|Lost to Follow-up|8|||
131203458|NCT02155660|472366813|FG000|Overall Study|Death|17|||
131203459|NCT02155660|472366814|FG001|Overall Study|Death|19|||
131203460|NCT02155660|472366815|FG002|Overall Study|Death|17|||
131203461|NCT02155660|472366816|FG003|Overall Study|Death|19|||
131203462|NCT02155660|472366813|FG000|Overall Study|Withdrawal by Subject|28|||
131203463|NCT02155660|472366814|FG001|Overall Study|Withdrawal by Subject|31|||
131203464|NCT02155660|472366815|FG002|Overall Study|Withdrawal by Subject|24|||
131203465|NCT02155660|472366816|FG003|Overall Study|Withdrawal by Subject|21|||
131203466|NCT03812224|472366823|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
131203467|NCT03812224|472366824|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
131203468|NCT03812224|472366823|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
131203469|NCT03812224|472366824|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
131203470|NCT03812224|472366823|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
131203471|NCT03812224|472366824|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
131203472|NCT03812224|472366823|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
131203473|NCT03812224|472366824|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
131203474|NCT00303719|472366825|FG000|Overall Study|Not evaluable, prior therapies|0|||
131203475|NCT00303719|472366826|FG001|Overall Study|Not evaluable, prior therapies|30|||
131203476|NCT00303719|472366825|FG000|Overall Study|Lost to Follow-up|0|||
131203477|NCT00303719|472366826|FG001|Overall Study|Lost to Follow-up|7|||
131203478|NCT01641952|472366827|FG000|Overall Study|Lost to Follow-up|28|||
131203479|NCT01641952|472366827|FG000|Overall Study|Adverse Event|6|||
131203480|NCT02500901|472366828|FG000|Overall Study|Disease ProgressionDD|2|||
131203481|NCT00561912|472366839|FG000|Overall Study|ineligible|1|||
131203482|NCT02577107|472366841|FG000|Overall Study|Protocol deviation|0|||
131203483|NCT02577107|472366842|FG001|Overall Study|Protocol deviation|1|||
131203484|NCT02516605|472366843|FG000|Overall Study|Protocol Violation|0|||
131203485|NCT02516605|472366844|FG001|Overall Study|Protocol Violation|0|||
131203486|NCT02516605|472366845|FG002|Overall Study|Protocol Violation|0|||
131203487|NCT02516605|472366846|FG003|Overall Study|Protocol Violation|0|||
131203488|NCT02516605|472366847|FG004|Overall Study|Protocol Violation|1|||
131203489|NCT02516605|472366843|FG000|Overall Study|Withdrawal by Subject|0|||
131203490|NCT02516605|472366844|FG001|Overall Study|Withdrawal by Subject|0|||
131203491|NCT02516605|472366845|FG002|Overall Study|Withdrawal by Subject|0|||
131203492|NCT02516605|472366846|FG003|Overall Study|Withdrawal by Subject|1|||
131203493|NCT02516605|472366847|FG004|Overall Study|Withdrawal by Subject|0|||
131203494|NCT00577382|472366848|FG000|Overall Study|Adverse Event|0|||
131203495|NCT00577382|472366849|FG001|Overall Study|Adverse Event|6|||
131203496|NCT00577382|472366848|FG000|Overall Study|Withdrawal by Subject|0|||
131203497|NCT00577382|472366849|FG001|Overall Study|Withdrawal by Subject|1|||
131203498|NCT00577382|472366848|FG000|Overall Study|Progressive Disease|17|||
131203499|NCT00577382|472366849|FG001|Overall Study|Progressive Disease|19|||
131203500|NCT00577382|472366848|FG000|Overall Study|Intercurrent Illness|1|||
131203501|NCT00577382|472366849|FG001|Overall Study|Intercurrent Illness|2|||
131203502|NCT00577382|472366848|FG000|Overall Study|Death|1|||
131203503|NCT00577382|472366849|FG001|Overall Study|Death|1|||
131203504|NCT00577382|472366848|FG000|Overall Study|Lost to Follow-up|2|||
131203505|NCT00577382|472366849|FG001|Overall Study|Lost to Follow-up|2|||
131203506|NCT02643420|472366850|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
131203507|NCT02643420|472366851|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
131203508|NCT02643420|472366850|FG000|Overall Study|Withdrawal by Subject|25|||
131203509|NCT02643420|472366851|FG001|Overall Study|Withdrawal by Subject|19|||
131203510|NCT02643420|472366850|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
131203511|NCT02643420|472366851|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
131203512|NCT02643420|472366850|FG000|Overall Study|Lost to Follow-up|6|||
131203513|NCT02643420|472366851|FG001|Overall Study|Lost to Follow-up|10|||
131203514|NCT02643420|472366850|FG000|Overall Study|Investigator Decision|2|||
131203515|NCT02643420|472366851|FG001|Overall Study|Investigator Decision|4|||
131203516|NCT02643420|472366850|FG000|Overall Study|Sponsor decision|1|||
131203517|NCT02643420|472366851|FG001|Overall Study|Sponsor decision|1|||
131203518|NCT02643420|472366850|FG000|Overall Study|Death|0|||
131203519|NCT02643420|472366851|FG001|Overall Study|Death|2|||
131203520|NCT02643420|472366850|FG000|Overall Study|Reason not Specified|8|||
131203521|NCT02643420|472366851|FG001|Overall Study|Reason not Specified|7|||
131203522|NCT02127970|472366852|FG000|Overall Study|Adverse Event|2|||
131203523|NCT02127970|472366853|FG001|Overall Study|Adverse Event|1|||
131203524|NCT02127970|472366852|FG000|Overall Study|Death|1|||
131203525|NCT02127970|472366853|FG001|Overall Study|Death|1|||
131203526|NCT02127970|472366852|FG000|Overall Study|Lost to Follow-up|14|||
131203527|NCT02127970|472366853|FG001|Overall Study|Lost to Follow-up|14|||
131203528|NCT02127970|472366852|FG000|Overall Study|Reason not Specified|4|||
131203529|NCT02127970|472366853|FG001|Overall Study|Reason not Specified|7|||
131203530|NCT02127970|472366852|FG000|Overall Study|Pregnancy|0|||
131203531|NCT02127970|472366853|FG001|Overall Study|Pregnancy|1|||
131203532|NCT02127970|472366852|FG000|Overall Study|Subject Withdrew Consent|5|||
131203533|NCT02127970|472366853|FG001|Overall Study|Subject Withdrew Consent|3|||
131203534|NCT01710709|472366854|FG000|Overall Study|Lost to Follow-up|29|||
130784654|NCT05630196|470841136|FG001|Overall Study|Lost to Follow-up|1|||
130784655|NCT05630196|470841135|FG000|Overall Study|Protocol Violation|2|||
130784656|NCT05630196|470841136|FG001|Overall Study|Protocol Violation|3|||
130784657|NCT05630196|470841135|FG000|Overall Study|Physician Decision|1|||
130784658|NCT05630196|470841136|FG001|Overall Study|Physician Decision|0|||
131203535|NCT01710709|472366854|FG000|Overall Study|Adverse Event|48|||
131203536|NCT01710709|472366854|FG000|Overall Study|Participant met withdrawal criteria|33|||
131203537|NCT01710709|472366854|FG000|Overall Study|Participant withdrawn by investigator|2|||
131203538|NCT01710709|472366854|FG000|Overall Study|Withdrawal by Subject|53|||
131203539|NCT01710709|472366854|FG000|Overall Study|Protocol Violation|5|||
131203540|NCT01710709|472366854|FG000|Overall Study|Lack of Efficacy|3|||
131203541|NCT01398176|472366856|FG000|Overall Study|Lost to Follow-up|1|||
131203542|NCT01398176|472366857|FG001|Overall Study|Lost to Follow-up|3|||
131203543|NCT01398176|472366856|FG000|Overall Study|Physician Decision|2|||
131203544|NCT01398176|472366857|FG001|Overall Study|Physician Decision|3|||
131203545|NCT02988115|472366859|FG000|Overall Study|Adverse Event|6|||
131203546|NCT02988115|472366860|FG001|Overall Study|Adverse Event|1|||
131203547|NCT02988115|472366859|FG000|Overall Study|Sponsor Decision|5|||
131203548|NCT02988115|472366860|FG001|Overall Study|Sponsor Decision|2|||
131203549|NCT02988115|472366859|FG000|Overall Study|Withdrawal by Subject|1|||
131203550|NCT02988115|472366860|FG001|Overall Study|Withdrawal by Subject|1|||
131203551|NCT02988115|472366859|FG000|Overall Study|Withdrawn by Mistake|1|||
131203552|NCT02988115|472366860|FG001|Overall Study|Withdrawn by Mistake|0|||
131203553|NCT02988115|472366859|FG000|Overall Study|Lost to Follow-up|1|||
131203554|NCT02988115|472366860|FG001|Overall Study|Lost to Follow-up|0|||
131203555|NCT01731951|472366861|FG000|Overall Study|Documented Disease Progression|1|||
131203556|NCT01731951|472366862|FG001|Overall Study|Documented Disease Progression|0|||
131203557|NCT01731951|472366863|FG002|Overall Study|Documented Disease Progression|0|||
131203558|NCT01731951|472366864|FG003|Overall Study|Documented Disease Progression|0|||
131203559|NCT01731951|472366865|FG004|Overall Study|Documented Disease Progression|0|||
131203560|NCT01731951|472366866|FG005|Overall Study|Documented Disease Progression|0|||
131203561|NCT01731951|472366861|FG000|Overall Study|Lost to Follow-up|2|||
131203562|NCT01731951|472366862|FG001|Overall Study|Lost to Follow-up|0|||
131203563|NCT01731951|472366863|FG002|Overall Study|Lost to Follow-up|0|||
131203564|NCT01731951|472366864|FG003|Overall Study|Lost to Follow-up|1|||
131203565|NCT01731951|472366865|FG004|Overall Study|Lost to Follow-up|3|||
131203566|NCT01731951|472366866|FG005|Overall Study|Lost to Follow-up|1|||
131203567|NCT01731951|472366861|FG000|Overall Study|Withdrawal of Consent|1|||
131203568|NCT01731951|472366862|FG001|Overall Study|Withdrawal of Consent|0|||
131203569|NCT01731951|472366863|FG002|Overall Study|Withdrawal of Consent|0|||
131203570|NCT01731951|472366864|FG003|Overall Study|Withdrawal of Consent|0|||
131203571|NCT01731951|472366865|FG004|Overall Study|Withdrawal of Consent|0|||
131203572|NCT01731951|472366866|FG005|Overall Study|Withdrawal of Consent|2|||
131203573|NCT01731951|472366861|FG000|Overall Study|Death|13|||
131203574|NCT01731951|472366862|FG001|Overall Study|Death|15|||
131203575|NCT01731951|472366863|FG002|Overall Study|Death|9|||
130784659|NCT05630196|470841135|FG000|Overall Study|Withdrawal by Subject|3|||
130784660|NCT05630196|470841136|FG001|Overall Study|Withdrawal by Subject|4|||
131203576|NCT01731951|472366864|FG003|Overall Study|Death|8|||
131203577|NCT01731951|472366865|FG004|Overall Study|Death|9|||
131203578|NCT01731951|472366866|FG005|Overall Study|Death|6|||
131203579|NCT03287089|472366867|FG000|Overall Study|Lost to Follow-up|0|||
131203580|NCT03287089|472366868|FG001|Overall Study|Lost to Follow-up|2|||
131203581|NCT03287089|472366867|FG000|Overall Study|Physician Decision|0|||
131203582|NCT03287089|472366868|FG001|Overall Study|Physician Decision|2|||
131203583|NCT03287089|472366867|FG000|Overall Study|Withdrawal by Subject|0|||
131203584|NCT03287089|472366868|FG001|Overall Study|Withdrawal by Subject|2|||
131203585|NCT00775138|472366869|FG000|Overall Study|Withdrawal by Subject|0|||
131203586|NCT00775138|472366870|FG001|Overall Study|Withdrawal by Subject|0|||
131203587|NCT00775138|472366871|FG002|Overall Study|Withdrawal by Subject|2|||
131203588|NCT00775138|472366872|FG003|Overall Study|Withdrawal by Subject|2|||
131203589|NCT00775138|472366869|FG000|Overall Study|Adverse Event|0|||
131203590|NCT00775138|472366870|FG001|Overall Study|Adverse Event|0|||
131203591|NCT00775138|472366871|FG002|Overall Study|Adverse Event|1|||
131203592|NCT00775138|472366872|FG003|Overall Study|Adverse Event|0|||
131203593|NCT04880642|472366873|FG000|Randomization|Withdrawal by Subject|2|||
131203594|NCT04880642|472366874|FG001|Randomization|Withdrawal by Subject|3|||
131203595|NCT04880642|472366873|FG000|Treatment Period|Adverse Event|0|||
131203596|NCT04880642|472366874|FG001|Treatment Period|Adverse Event|1|||
131203597|NCT04880642|472366873|FG000|Treatment Period|Death|6|||
131203598|NCT04880642|472366874|FG001|Treatment Period|Death|6|||
131203599|NCT04880642|472366873|FG000|Treatment Period|Lost to Follow-up|1|||
131203600|NCT04880642|472366874|FG001|Treatment Period|Lost to Follow-up|0|||
131203601|NCT04880642|472366873|FG000|Treatment Period|Protocol Violation|0|||
131203602|NCT04880642|472366874|FG001|Treatment Period|Protocol Violation|1|||
131203603|NCT04880642|472366873|FG000|Treatment Period|Withdrawal by Subject|5|||
131203604|NCT04880642|472366874|FG001|Treatment Period|Withdrawal by Subject|3|||
131203605|NCT04880642|472366873|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
131203606|NCT04880642|472366874|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
131203607|NCT04880642|472366873|FG000|Follow-up|Death|4|||
131203608|NCT04880642|472366874|FG001|Follow-up|Death|3|||
131203609|NCT04880642|472366873|FG000|Follow-up|Withdrawal by Subject|1|||
131203610|NCT04880642|472366874|FG001|Follow-up|Withdrawal by Subject|0|||
131203611|NCT00104299|472366875|FG000|Overall Study|Adverse Event|3|||
131203612|NCT00104299|472366876|FG001|Overall Study|Adverse Event|1|||
131203613|NCT00104299|472366875|FG000|Overall Study|Death|2|||
131203614|NCT00104299|472366876|FG001|Overall Study|Death|2|||
131203615|NCT00104299|472366875|FG000|Overall Study|Withdrawal by Subject|2|||
131203616|NCT00104299|472366876|FG001|Overall Study|Withdrawal by Subject|6|||
131203617|NCT00104299|472366875|FG000|Overall Study|Physician Decision|1|||
131203618|NCT00104299|472366876|FG001|Overall Study|Physician Decision|1|||
131203619|NCT00104299|472366875|FG000|Overall Study|To have renal transplant|1|||
131203620|NCT00104299|472366876|FG001|Overall Study|To have renal transplant|0|||
131203621|NCT02452034|472366877|FG000|Overall Study|Adverse Event|0|||
131203622|NCT02452034|472366878|FG001|Overall Study|Adverse Event|0|||
131203623|NCT02452034|472366879|FG002|Overall Study|Adverse Event|0|||
131203624|NCT02452034|472366880|FG003|Overall Study|Adverse Event|0|||
131203625|NCT02452034|472366881|FG004|Overall Study|Adverse Event|0|||
131203626|NCT02452034|472366882|FG005|Overall Study|Adverse Event|1|||
131203627|NCT02452034|472366877|FG000|Overall Study|Death|0|||
131203628|NCT02452034|472366878|FG001|Overall Study|Death|0|||
131203629|NCT02452034|472366879|FG002|Overall Study|Death|0|||
130734484|NCT03685344|470647310|FG000|Overall Study|Death|1|||
130734485|NCT03685344|470647311|FG001|Overall Study|Death|1|||
130734486|NCT03685344|470647312|FG002|Overall Study|Death|0|||
131203630|NCT02452034|472366880|FG003|Overall Study|Death|0|||
131203631|NCT02452034|472366881|FG004|Overall Study|Death|1|||
131203632|NCT02452034|472366882|FG005|Overall Study|Death|1|||
131203633|NCT02452034|472366877|FG000|Overall Study|Physician Decision|0|||
131203634|NCT02452034|472366878|FG001|Overall Study|Physician Decision|1|||
131203635|NCT02452034|472366879|FG002|Overall Study|Physician Decision|1|||
131203636|NCT02452034|472366880|FG003|Overall Study|Physician Decision|0|||
131203637|NCT02452034|472366881|FG004|Overall Study|Physician Decision|0|||
131203638|NCT02452034|472366882|FG005|Overall Study|Physician Decision|0|||
131203639|NCT02452034|472366877|FG000|Overall Study|Protocol Violation|0|||
131203640|NCT02452034|472366878|FG001|Overall Study|Protocol Violation|0|||
131203641|NCT02452034|472366879|FG002|Overall Study|Protocol Violation|0|||
131203642|NCT02452034|472366880|FG003|Overall Study|Protocol Violation|0|||
131203643|NCT02452034|472366881|FG004|Overall Study|Protocol Violation|0|||
131203644|NCT02452034|472366882|FG005|Overall Study|Protocol Violation|1|||
131203645|NCT02452034|472366877|FG000|Overall Study|Screen Failure|1|||
131203646|NCT02452034|472366878|FG001|Overall Study|Screen Failure|0|||
131203647|NCT02452034|472366879|FG002|Overall Study|Screen Failure|0|||
131203648|NCT02452034|472366880|FG003|Overall Study|Screen Failure|1|||
131203649|NCT02452034|472366881|FG004|Overall Study|Screen Failure|0|||
131203650|NCT02452034|472366882|FG005|Overall Study|Screen Failure|0|||
131203651|NCT02452034|472366877|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
131203652|NCT02452034|472366878|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
131203653|NCT02452034|472366879|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
131203654|NCT02452034|472366880|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
131203655|NCT02452034|472366881|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
131203656|NCT02452034|472366882|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
131203657|NCT00561795|472366884|FG000|Overall Study|Adverse Event|3|||
131203658|NCT00561795|472366885|FG001|Overall Study|Adverse Event|3|||
131203659|NCT00561795|472366886|FG002|Overall Study|Adverse Event|0|||
131203660|NCT00561795|472366887|FG003|Overall Study|Adverse Event|0|||
131203661|NCT00561795|472366884|FG000|Overall Study|Study Closed/Terminated|0|||
131203662|NCT00561795|472366885|FG001|Overall Study|Study Closed/Terminated|3|||
131203663|NCT00561795|472366886|FG002|Overall Study|Study Closed/Terminated|0|||
131203664|NCT00561795|472366887|FG003|Overall Study|Study Closed/Terminated|0|||
131203665|NCT00561795|472366884|FG000|Overall Study|Physician Decision|1|||
131203666|NCT00561795|472366885|FG001|Overall Study|Physician Decision|0|||
131203667|NCT00561795|472366886|FG002|Overall Study|Physician Decision|0|||
131203668|NCT00561795|472366887|FG003|Overall Study|Physician Decision|0|||
131203669|NCT00490815|472366892|FG000|Overall Study|Adverse Event|2|||
131203670|NCT00490815|472366893|FG001|Overall Study|Adverse Event|3|||
131203671|NCT00490815|472366892|FG000|Overall Study|Withdrawal by Subject|4|||
131203672|NCT00490815|472366893|FG001|Overall Study|Withdrawal by Subject|0|||
131203673|NCT00490815|472366892|FG000|Overall Study|Lost to Follow-up|1|||
131203674|NCT00490815|472366893|FG001|Overall Study|Lost to Follow-up|3|||
131203675|NCT00490815|472366892|FG000|Overall Study|Death|1|||
131203676|NCT00490815|472366893|FG001|Overall Study|Death|3|||
131203677|NCT02195531|472366896|FG000|Overall Study|Withdrawal by Subject|1|||
131203678|NCT02195531|472366897|FG001|Overall Study|Withdrawal by Subject|1|||
130734487|NCT03685344|470647313|FG003|Overall Study|Death|0|||
131203679|NCT02195531|472366898|FG002|Overall Study|Withdrawal by Subject|1|||
131203680|NCT02543801|472366900|FG000|Overall Study|Protocol Violation|1|||
131203681|NCT02543801|472366901|FG001|Overall Study|Protocol Violation|2|||
131203682|NCT02543801|472366902|FG002|Overall Study|Protocol Violation|0|||
131203683|NCT02543801|472366903|FG003|Overall Study|Protocol Violation|0|||
131203684|NCT01034709|472366906|FG000|Overall Study|Protocol Violation|9|||
131203685|NCT01034709|472366907|FG001|Overall Study|Protocol Violation|16|||
130734488|NCT03126435|470647315|FG000|Overall Study|Death|90|||
130734489|NCT03126435|470647316|FG001|Overall Study|Death|84|||
131203686|NCT02364999|472366910|FG000|Overall Study|Death|136|||
130734490|NCT03126435|470647315|FG000|Overall Study|Lost to Follow-up|4|||
131203687|NCT02364999|472366911|FG001|Overall Study|Death|138|||
131203688|NCT02364999|472366910|FG000|Overall Study|Lost to Follow-up|10|||
131203689|NCT02364999|472366911|FG001|Overall Study|Lost to Follow-up|15|||
131203690|NCT02364999|472366910|FG000|Overall Study|Protocol Violation|3|||
131203691|NCT02364999|472366911|FG001|Overall Study|Protocol Violation|2|||
131203692|NCT02364999|472366910|FG000|Overall Study|Withdrawal by Subject|14|||
131203693|NCT02364999|472366911|FG001|Overall Study|Withdrawal by Subject|14|||
131203694|NCT02364999|472366910|FG000|Overall Study|Other|0|||
130734491|NCT03126435|470647316|FG001|Overall Study|Lost to Follow-up|3|||
130734492|NCT03126435|470647315|FG000|Overall Study|Physician Decision|0|||
130734493|NCT03126435|470647316|FG001|Overall Study|Physician Decision|1|||
130734494|NCT03126435|470647315|FG000|Overall Study|Withdrawal by Subject|6|||
130734495|NCT03126435|470647316|FG001|Overall Study|Withdrawal by Subject|12|||
131203695|NCT02364999|472366911|FG001|Overall Study|Other|1|||
131203696|NCT02364999|472366910|FG000|Overall Study|Randomized but did not receive treatment|2|||
130734496|NCT03126435|470647315|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
130734497|NCT03126435|470647316|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
130734498|NCT01023035|470647318|FG000|Treatment Period|Adverse Event|27|||
130784661|NCT01655901|470841137|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
131203697|NCT02364999|472366911|FG001|Overall Study|Randomized but did not receive treatment|3|||
131203698|NCT02177942|472366912|FG000|Overall Study|Adverse Event|1|||
131203699|NCT02177942|472366913|FG001|Overall Study|Adverse Event|0|||
131203700|NCT02177942|472366912|FG000|Overall Study|Lost to Follow-up|1|||
131203701|NCT02177942|472366913|FG001|Overall Study|Lost to Follow-up|1|||
131203702|NCT02177942|472366912|FG000|Overall Study|Protocol Violation|4|||
131203703|NCT02177942|472366913|FG001|Overall Study|Protocol Violation|6|||
131203704|NCT02177942|472366912|FG000|Overall Study|Withdrawal by Subject|71|||
131203705|NCT02177942|472366913|FG001|Overall Study|Withdrawal by Subject|81|||
131203706|NCT00699582|472366916|FG000|Overall Study|Adverse Event|4|||
131203707|NCT00699582|472366917|FG001|Overall Study|Adverse Event|11|||
131203708|NCT00699582|472366918|FG002|Overall Study|Adverse Event|23|||
131203709|NCT00699582|472366916|FG000|Overall Study|Withdrawal by Subject|6|||
131203710|NCT00699582|472366917|FG001|Overall Study|Withdrawal by Subject|7|||
131203711|NCT00699582|472366918|FG002|Overall Study|Withdrawal by Subject|4|||
131203712|NCT00699582|472366916|FG000|Overall Study|Lack of Efficacy|1|||
131203713|NCT00699582|472366917|FG001|Overall Study|Lack of Efficacy|0|||
131203714|NCT00699582|472366918|FG002|Overall Study|Lack of Efficacy|1|||
131203715|NCT00699582|472366916|FG000|Overall Study|Progressive Disease|1|||
131203716|NCT00699582|472366917|FG001|Overall Study|Progressive Disease|0|||
131203717|NCT00699582|472366918|FG002|Overall Study|Progressive Disease|0|||
131203718|NCT00699582|472366916|FG000|Overall Study|Administrative/Other|4|||
131203719|NCT00699582|472366917|FG001|Overall Study|Administrative/Other|3|||
131203720|NCT00699582|472366918|FG002|Overall Study|Administrative/Other|0|||
131203721|NCT00699582|472366916|FG000|Overall Study|Randomized, Not Treated|2|||
131203722|NCT00699582|472366917|FG001|Overall Study|Randomized, Not Treated|1|||
131203723|NCT00699582|472366918|FG002|Overall Study|Randomized, Not Treated|0|||
131203724|NCT02692560|472366921|FG000|Overall Study|Withdrawal by Subject|0|||
131203725|NCT02692560|472366922|FG001|Overall Study|Withdrawal by Subject|6|||
131203726|NCT02394028|472366923|FG000|Induction Phase|Adverse Event|2|||
131203727|NCT02394028|472366924|FG001|Induction Phase|Adverse Event|4|||
131203728|NCT02394028|472366925|FG002|Induction Phase|Adverse Event|1|||
131203729|NCT02394028|472366926|FG003|Induction Phase|Adverse Event|2|||
131203730|NCT02394028|472366927|FG004|Induction Phase|Adverse Event|5|||
131203731|NCT02394028|472366928|FG005|Induction Phase|Adverse Event|2|||
131203732|NCT02394028|472366929|FG006|Induction Phase|Adverse Event|0|||
131203733|NCT02394028|472366930|FG007|Induction Phase|Adverse Event|0|||
131203734|NCT02394028|472366931|FG008|Induction Phase|Adverse Event|0|||
131203735|NCT02394028|472366932|FG009|Induction Phase|Adverse Event|0|||
131203736|NCT02394028|472366933|FG010|Induction Phase|Adverse Event|0|||
131203737|NCT02394028|472366923|FG000|Induction Phase|Lack of Efficacy|3|||
131203738|NCT02394028|472366924|FG001|Induction Phase|Lack of Efficacy|6|||
131203739|NCT02394028|472366925|FG002|Induction Phase|Lack of Efficacy|2|||
131203740|NCT02394028|472366926|FG003|Induction Phase|Lack of Efficacy|17|||
131203741|NCT02394028|472366927|FG004|Induction Phase|Lack of Efficacy|14|||
131203742|NCT02394028|472366928|FG005|Induction Phase|Lack of Efficacy|8|||
131203743|NCT02394028|472366929|FG006|Induction Phase|Lack of Efficacy|17|||
131203744|NCT02394028|472366930|FG007|Induction Phase|Lack of Efficacy|23|||
131203745|NCT02394028|472366931|FG008|Induction Phase|Lack of Efficacy|0|||
131203746|NCT02394028|472366932|FG009|Induction Phase|Lack of Efficacy|0|||
131203747|NCT02394028|472366933|FG010|Induction Phase|Lack of Efficacy|0|||
131203748|NCT02394028|472366923|FG000|Induction Phase|Lost to Follow-up|1|||
131203749|NCT02394028|472366924|FG001|Induction Phase|Lost to Follow-up|0|||
131203750|NCT02394028|472366925|FG002|Induction Phase|Lost to Follow-up|0|||
131203751|NCT02394028|472366926|FG003|Induction Phase|Lost to Follow-up|1|||
131203752|NCT02394028|472366927|FG004|Induction Phase|Lost to Follow-up|0|||
131203753|NCT02394028|472366928|FG005|Induction Phase|Lost to Follow-up|0|||
131203754|NCT02394028|472366929|FG006|Induction Phase|Lost to Follow-up|1|||
131203755|NCT02394028|472366930|FG007|Induction Phase|Lost to Follow-up|0|||
131203756|NCT02394028|472366931|FG008|Induction Phase|Lost to Follow-up|0|||
131203757|NCT02394028|472366932|FG009|Induction Phase|Lost to Follow-up|0|||
131203758|NCT02394028|472366933|FG010|Induction Phase|Lost to Follow-up|0|||
131203759|NCT02394028|472366923|FG000|Induction Phase|Non-compliance|0|||
131203760|NCT02394028|472366924|FG001|Induction Phase|Non-compliance|1|||
131203761|NCT02394028|472366925|FG002|Induction Phase|Non-compliance|3|||
131203762|NCT02394028|472366926|FG003|Induction Phase|Non-compliance|1|||
131203763|NCT02394028|472366927|FG004|Induction Phase|Non-compliance|3|||
131203764|NCT02394028|472366928|FG005|Induction Phase|Non-compliance|0|||
130734499|NCT01023035|470647319|FG001|Treatment Period|Adverse Event|32|||
130734500|NCT01023035|470647320|FG002|Treatment Period|Adverse Event|50|||
130734501|NCT01023035|470647318|FG000|Treatment Period|Non-Medical Reasons|19|||
130734502|NCT01023035|470647319|FG001|Treatment Period|Non-Medical Reasons|22|||
130734503|NCT01023035|470647320|FG002|Treatment Period|Non-Medical Reasons|44|||
130734504|NCT01023035|470647318|FG000|Treatment Period|Treatment Failure|26|||
130734505|NCT01023035|470647319|FG001|Treatment Period|Treatment Failure|31|||
130734506|NCT01023035|470647320|FG002|Treatment Period|Treatment Failure|24|||
130734507|NCT01023035|470647318|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
130734508|NCT01023035|470647319|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
130734509|NCT01023035|470647320|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
130734510|NCT01023035|470647318|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
130734511|NCT01023035|470647319|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
130734512|NCT01023035|470647320|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
130734513|NCT00524420|470647324|FG000|Overall Study|Lack of Efficacy|1|||
130734514|NCT00524420|470647325|FG001|Overall Study|Lack of Efficacy|0|||
130734515|NCT01090414|470647326|FG000|Study 101-99|Progressive Disease|28|||
130734516|NCT01090414|470647327|FG001|Study 101-99|Progressive Disease|48|||
130734517|NCT01090414|470647328|FG002|Study 101-99|Progressive Disease|10|||
130734518|NCT01090414|470647329|FG003|Study 101-99|Progressive Disease|4|||
130734519|NCT01090414|470647326|FG000|Study 101-99|Adverse Event|10|||
130734520|NCT01090414|470647327|FG001|Study 101-99|Adverse Event|28|||
130734521|NCT01090414|470647328|FG002|Study 101-99|Adverse Event|18|||
130734522|NCT01090414|470647329|FG003|Study 101-99|Adverse Event|0|||
130734523|NCT01090414|470647326|FG000|Study 101-99|Investigator Request|1|||
130734524|NCT01090414|470647327|FG001|Study 101-99|Investigator Request|11|||
130734525|NCT01090414|470647328|FG002|Study 101-99|Investigator Request|4|||
130734526|NCT01090414|470647329|FG003|Study 101-99|Investigator Request|0|||
130734527|NCT01090414|470647326|FG000|Study 101-99|Death|3|||
130734528|NCT01090414|470647327|FG001|Study 101-99|Death|8|||
130734529|NCT01090414|470647328|FG002|Study 101-99|Death|1|||
130734530|NCT01090414|470647329|FG003|Study 101-99|Death|0|||
130734531|NCT01090414|470647326|FG000|Study 101-99|Sponsor Discontinued Study|0|||
130734532|NCT01090414|470647327|FG001|Study 101-99|Sponsor Discontinued Study|7|||
130734533|NCT01090414|470647328|FG002|Study 101-99|Sponsor Discontinued Study|5|||
130734534|NCT01090414|470647329|FG003|Study 101-99|Sponsor Discontinued Study|0|||
130734535|NCT01090414|470647326|FG000|Study 101-99|Other (Unknown Reasons)|3|||
130734536|NCT01090414|470647327|FG001|Study 101-99|Other (Unknown Reasons)|3|||
130734537|NCT01090414|470647328|FG002|Study 101-99|Other (Unknown Reasons)|0|||
130734538|NCT01090414|470647329|FG003|Study 101-99|Other (Unknown Reasons)|0|||
130734539|NCT01090414|470647326|FG000|Study 101-99|Withdrew Consent|0|||
130734540|NCT01090414|470647327|FG001|Study 101-99|Withdrew Consent|2|||
130734541|NCT01090414|470647328|FG002|Study 101-99|Withdrew Consent|3|||
130784662|NCT01655901|470841138|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
131203765|NCT02394028|472366929|FG006|Induction Phase|Non-compliance|1|||
131203766|NCT02394028|472366930|FG007|Induction Phase|Non-compliance|1|||
131203767|NCT02394028|472366931|FG008|Induction Phase|Non-compliance|0|||
131203768|NCT02394028|472366932|FG009|Induction Phase|Non-compliance|0|||
131203769|NCT02394028|472366933|FG010|Induction Phase|Non-compliance|0|||
131203770|NCT02394028|472366923|FG000|Induction Phase|Physician Decision|0|||
131203771|NCT02394028|472366924|FG001|Induction Phase|Physician Decision|0|||
131203772|NCT02394028|472366925|FG002|Induction Phase|Physician Decision|1|||
131203773|NCT02394028|472366926|FG003|Induction Phase|Physician Decision|4|||
131203774|NCT02394028|472366927|FG004|Induction Phase|Physician Decision|0|||
131203775|NCT02394028|472366928|FG005|Induction Phase|Physician Decision|2|||
131203776|NCT02394028|472366929|FG006|Induction Phase|Physician Decision|1|||
131203777|NCT02394028|472366930|FG007|Induction Phase|Physician Decision|0|||
131203778|NCT02394028|472366931|FG008|Induction Phase|Physician Decision|0|||
131203779|NCT02394028|472366932|FG009|Induction Phase|Physician Decision|0|||
130734542|NCT01090414|470647329|FG003|Study 101-99|Withdrew Consent|1|||
130734543|NCT01090414|470647326|FG000|Study 101-99|Participant Request|3|||
130734544|NCT01090414|470647327|FG001|Study 101-99|Participant Request|1|||
130734545|NCT01090414|470647328|FG002|Study 101-99|Participant Request|0|||
130734546|NCT01090414|470647329|FG003|Study 101-99|Participant Request|0|||
130734547|NCT02413229|470647335|FG000|Overall Study|Adverse Event|0|||
130734548|NCT02413229|470647336|FG001|Overall Study|Adverse Event|0|||
130734549|NCT02413229|470647337|FG002|Overall Study|Adverse Event|0|||
130734550|NCT02413229|470647338|FG003|Overall Study|Adverse Event|1|||
130734551|NCT02413229|470647339|FG004|Overall Study|Adverse Event|0|||
130734552|NCT02413229|470647340|FG005|Overall Study|Adverse Event|0|||
130734553|NCT02413229|470647341|FG006|Overall Study|Adverse Event|0|||
130734554|NCT02413229|470647342|FG007|Overall Study|Adverse Event|1|||
131203780|NCT02394028|472366933|FG010|Induction Phase|Physician Decision|0|||
131203781|NCT02394028|472366923|FG000|Induction Phase|Protocol Violation|0|||
130734555|NCT02413229|470647335|FG000|Overall Study|Lost to Follow-up|0|||
130734556|NCT02413229|470647336|FG001|Overall Study|Lost to Follow-up|0|||
130734557|NCT02413229|470647337|FG002|Overall Study|Lost to Follow-up|1|||
130734558|NCT02413229|470647338|FG003|Overall Study|Lost to Follow-up|0|||
130734559|NCT02413229|470647339|FG004|Overall Study|Lost to Follow-up|2|||
130734560|NCT02413229|470647340|FG005|Overall Study|Lost to Follow-up|0|||
130734561|NCT02413229|470647341|FG006|Overall Study|Lost to Follow-up|0|||
130734562|NCT02413229|470647342|FG007|Overall Study|Lost to Follow-up|0|||
130734563|NCT02413229|470647335|FG000|Overall Study|Withdrawal by Subject|1|||
130734564|NCT02413229|470647336|FG001|Overall Study|Withdrawal by Subject|1|||
130734565|NCT02413229|470647337|FG002|Overall Study|Withdrawal by Subject|0|||
130734566|NCT02413229|470647338|FG003|Overall Study|Withdrawal by Subject|0|||
130734567|NCT02413229|470647339|FG004|Overall Study|Withdrawal by Subject|1|||
130734568|NCT02413229|470647340|FG005|Overall Study|Withdrawal by Subject|0|||
130734569|NCT02413229|470647341|FG006|Overall Study|Withdrawal by Subject|0|||
130734570|NCT02413229|470647342|FG007|Overall Study|Withdrawal by Subject|2|||
130734571|NCT02413229|470647335|FG000|Overall Study|Progressive Disease|0|||
130734572|NCT02413229|470647336|FG001|Overall Study|Progressive Disease|0|||
130734573|NCT02413229|470647337|FG002|Overall Study|Progressive Disease|0|||
130734574|NCT02413229|470647338|FG003|Overall Study|Progressive Disease|0|||
130734575|NCT02413229|470647339|FG004|Overall Study|Progressive Disease|0|||
130734576|NCT02413229|470647340|FG005|Overall Study|Progressive Disease|0|||
130734577|NCT02413229|470647341|FG006|Overall Study|Progressive Disease|0|||
130734578|NCT02413229|470647342|FG007|Overall Study|Progressive Disease|1|||
130734579|NCT03594071|470647343|FG000|Overall Study|Re-operation|3|||
130734580|NCT03594071|470647343|FG000|Overall Study|Missed visit|2|||
130734581|NCT03022370|470647344|FG000|Overall Study|Death|6|||
130734582|NCT03022370|470647345|FG001|Overall Study|Death|12|||
130734583|NCT03022370|470647344|FG000|Overall Study|Lost to Follow-up|174|||
130734584|NCT03022370|470647345|FG001|Overall Study|Lost to Follow-up|109|||
130734585|NCT00699816|470647348|FG000|Overall Study|Protocol Violation|1|||
130734586|NCT00699816|470647349|FG001|Overall Study|Protocol Violation|3|||
130734587|NCT02454933|470647350|FG000|Overall Study|Progressive disease|10|||
130734588|NCT02454933|470647351|FG001|Overall Study|Progressive disease|7|||
130734589|NCT02454933|470647350|FG000|Overall Study|Adverse Event|1|||
130734590|NCT02454933|470647351|FG001|Overall Study|Adverse Event|1|||
130734591|NCT02454933|470647350|FG000|Overall Study|Withdrawal by Subject|0|||
130734592|NCT02454933|470647351|FG001|Overall Study|Withdrawal by Subject|3|||
130734593|NCT02454933|470647350|FG000|Overall Study|Lost to Follow-up|1|||
130734594|NCT02454933|470647351|FG001|Overall Study|Lost to Follow-up|0|||
130734595|NCT03668808|470647354|FG000|First Intervention|Withdrawal by Subject|2|||
130734596|NCT03668808|470647355|FG001|First Intervention|Withdrawal by Subject|2|||
130734597|NCT01526655|470647356|FG000|Overall Study|Withdrawal by Subject|0|||
130734598|NCT01526655|470647357|FG001|Overall Study|Withdrawal by Subject|1|||
130734599|NCT02288325|470647361|FG000|Run-in Period|Adverse Event|48|||
130734600|NCT02288325|470647362|FG001|Run-in Period|Adverse Event|0|||
130734601|NCT02288325|470647363|FG002|Run-in Period|Adverse Event|0|||
130734602|NCT02288325|470647361|FG000|Run-in Period|Lack of Efficacy|16|||
130734603|NCT02288325|470647362|FG001|Run-in Period|Lack of Efficacy|0|||
130734604|NCT02288325|470647363|FG002|Run-in Period|Lack of Efficacy|0|||
130734605|NCT02288325|470647361|FG000|Run-in Period|Withdrawal of Consent|28|||
130734606|NCT02288325|470647362|FG001|Run-in Period|Withdrawal of Consent|0|||
130734607|NCT02288325|470647363|FG002|Run-in Period|Withdrawal of Consent|0|||
130734608|NCT02288325|470647361|FG000|Run-in Period|Lost to Follow-up|25|||
130734609|NCT02288325|470647362|FG001|Run-in Period|Lost to Follow-up|0|||
130734610|NCT02288325|470647363|FG002|Run-in Period|Lost to Follow-up|0|||
130734611|NCT02288325|470647361|FG000|Run-in Period|Protocol Violation|17|||
130734612|NCT02288325|470647362|FG001|Run-in Period|Protocol Violation|0|||
130734613|NCT02288325|470647363|FG002|Run-in Period|Protocol Violation|0|||
130734614|NCT02288325|470647361|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
130734615|NCT02288325|470647362|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
130734616|NCT02288325|470647363|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
130734617|NCT02288325|470647361|FG000|Run-in Period|Reason not Specified|8|||
130734618|NCT02288325|470647362|FG001|Run-in Period|Reason not Specified|0|||
131203782|NCT02394028|472366924|FG001|Induction Phase|Protocol Violation|2|||
131203783|NCT02394028|472366925|FG002|Induction Phase|Protocol Violation|0|||
131203784|NCT02394028|472366926|FG003|Induction Phase|Protocol Violation|3|||
131203785|NCT02394028|472366927|FG004|Induction Phase|Protocol Violation|0|||
131203786|NCT02394028|472366928|FG005|Induction Phase|Protocol Violation|1|||
131203787|NCT02394028|472366929|FG006|Induction Phase|Protocol Violation|1|||
131203788|NCT02394028|472366930|FG007|Induction Phase|Protocol Violation|0|||
131203789|NCT02394028|472366931|FG008|Induction Phase|Protocol Violation|0|||
131203790|NCT02394028|472366932|FG009|Induction Phase|Protocol Violation|0|||
131203791|NCT02394028|472366933|FG010|Induction Phase|Protocol Violation|0|||
131203792|NCT02394028|472366923|FG000|Induction Phase|Withdrawal by Subject|1|||
131203793|NCT02394028|472366924|FG001|Induction Phase|Withdrawal by Subject|2|||
131203794|NCT02394028|472366925|FG002|Induction Phase|Withdrawal by Subject|4|||
131203795|NCT02394028|472366926|FG003|Induction Phase|Withdrawal by Subject|6|||
131203796|NCT02394028|472366927|FG004|Induction Phase|Withdrawal by Subject|7|||
131203797|NCT02394028|472366928|FG005|Induction Phase|Withdrawal by Subject|4|||
131203798|NCT02394028|472366929|FG006|Induction Phase|Withdrawal by Subject|3|||
131203799|NCT02394028|472366930|FG007|Induction Phase|Withdrawal by Subject|6|||
131203800|NCT02394028|472366931|FG008|Induction Phase|Withdrawal by Subject|0|||
131203801|NCT02394028|472366932|FG009|Induction Phase|Withdrawal by Subject|0|||
131203802|NCT02394028|472366933|FG010|Induction Phase|Withdrawal by Subject|0|||
131203803|NCT02394028|472366923|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
131203804|NCT02394028|472366924|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
131203805|NCT02394028|472366925|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
131203806|NCT02394028|472366926|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
131203807|NCT02394028|472366927|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
131203808|NCT02394028|472366928|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
131203809|NCT02394028|472366929|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
131203810|NCT02394028|472366930|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
131203811|NCT02394028|472366931|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
131203812|NCT02394028|472366932|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
131203813|NCT02394028|472366933|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
131203814|NCT02394028|472366923|FG000|Induction Phase|Sponsor decision|0|||
131203815|NCT02394028|472366924|FG001|Induction Phase|Sponsor decision|1|||
131203816|NCT02394028|472366925|FG002|Induction Phase|Sponsor decision|2|||
131203817|NCT02394028|472366926|FG003|Induction Phase|Sponsor decision|0|||
131203818|NCT02394028|472366927|FG004|Induction Phase|Sponsor decision|0|||
131203819|NCT02394028|472366928|FG005|Induction Phase|Sponsor decision|0|||
131203820|NCT02394028|472366929|FG006|Induction Phase|Sponsor decision|0|||
131203821|NCT02394028|472366930|FG007|Induction Phase|Sponsor decision|0|||
131203822|NCT02394028|472366931|FG008|Induction Phase|Sponsor decision|0|||
131203823|NCT02394028|472366932|FG009|Induction Phase|Sponsor decision|0|||
131203824|NCT02394028|472366933|FG010|Induction Phase|Sponsor decision|0|||
131203825|NCT02394028|472366923|FG000|Induction Phase|Technical reason|0|||
131203826|NCT02394028|472366924|FG001|Induction Phase|Technical reason|0|||
131203827|NCT02394028|472366925|FG002|Induction Phase|Technical reason|0|||
131203828|NCT02394028|472366926|FG003|Induction Phase|Technical reason|1|||
131203829|NCT02394028|472366927|FG004|Induction Phase|Technical reason|0|||
131203830|NCT02394028|472366928|FG005|Induction Phase|Technical reason|0|||
131203831|NCT02394028|472366929|FG006|Induction Phase|Technical reason|0|||
131203832|NCT02394028|472366930|FG007|Induction Phase|Technical reason|0|||
131203833|NCT02394028|472366931|FG008|Induction Phase|Technical reason|0|||
131203834|NCT02394028|472366932|FG009|Induction Phase|Technical reason|0|||
131203835|NCT02394028|472366933|FG010|Induction Phase|Technical reason|0|||
131203836|NCT02394028|472366923|FG000|Induction Phase|:ack of calculation|0|||
131203837|NCT02394028|472366924|FG001|Induction Phase|:ack of calculation|0|||
131203838|NCT02394028|472366925|FG002|Induction Phase|:ack of calculation|0|||
131203839|NCT02394028|472366926|FG003|Induction Phase|:ack of calculation|0|||
131203840|NCT02394028|472366927|FG004|Induction Phase|:ack of calculation|0|||
131203841|NCT02394028|472366928|FG005|Induction Phase|:ack of calculation|0|||
131203842|NCT02394028|472366929|FG006|Induction Phase|:ack of calculation|0|||
131203843|NCT02394028|472366930|FG007|Induction Phase|:ack of calculation|1|||
131203844|NCT02394028|472366931|FG008|Induction Phase|:ack of calculation|0|||
131203845|NCT02394028|472366932|FG009|Induction Phase|:ack of calculation|0|||
131203846|NCT02394028|472366933|FG010|Induction Phase|:ack of calculation|0|||
131203847|NCT02394028|472366923|FG000|Maintenance Phase|Protocol Violation|0|||
131203848|NCT02394028|472366924|FG001|Maintenance Phase|Protocol Violation|0|||
131203849|NCT02394028|472366925|FG002|Maintenance Phase|Protocol Violation|0|||
131203850|NCT02394028|472366926|FG003|Maintenance Phase|Protocol Violation|0|||
131203851|NCT02394028|472366927|FG004|Maintenance Phase|Protocol Violation|0|||
131203852|NCT02394028|472366928|FG005|Maintenance Phase|Protocol Violation|0|||
131203853|NCT02394028|472366929|FG006|Maintenance Phase|Protocol Violation|0|||
131203854|NCT02394028|472366930|FG007|Maintenance Phase|Protocol Violation|0|||
130734619|NCT02288325|470647363|FG002|Run-in Period|Reason not Specified|0|||
130734620|NCT02288325|470647361|FG000|Stabilization Period|Adverse Event|13|||
130734621|NCT02288325|470647362|FG001|Stabilization Period|Adverse Event|0|||
130734622|NCT02288325|470647363|FG002|Stabilization Period|Adverse Event|0|||
130734623|NCT02288325|470647361|FG000|Stabilization Period|Lack of Efficacy|22|||
130734624|NCT02288325|470647362|FG001|Stabilization Period|Lack of Efficacy|0|||
130734625|NCT02288325|470647363|FG002|Stabilization Period|Lack of Efficacy|0|||
130734626|NCT02288325|470647361|FG000|Stabilization Period|Withdrawal of Consent|23|||
130734627|NCT02288325|470647362|FG001|Stabilization Period|Withdrawal of Consent|0|||
130734628|NCT02288325|470647363|FG002|Stabilization Period|Withdrawal of Consent|0|||
130734629|NCT02288325|470647361|FG000|Stabilization Period|Lost to Follow-up|12|||
130734630|NCT02288325|470647362|FG001|Stabilization Period|Lost to Follow-up|0|||
130734631|NCT02288325|470647363|FG002|Stabilization Period|Lost to Follow-up|0|||
130734632|NCT02288325|470647361|FG000|Stabilization Period|Protocol Violation|8|||
130734633|NCT02288325|470647362|FG001|Stabilization Period|Protocol Violation|0|||
130734634|NCT02288325|470647363|FG002|Stabilization Period|Protocol Violation|0|||
130734635|NCT02288325|470647361|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
130734636|NCT02288325|470647362|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
130784663|NCT01655901|470841139|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
130784664|NCT01655901|470841140|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
130784665|NCT01655901|470841141|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
130784666|NCT01655901|470841142|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
130784667|NCT00922636|470841143|FG000|Overall Study|Adverse Event|3|||
130784668|NCT00922636|470841144|FG001|Overall Study|Adverse Event|3|||
130784669|NCT00922636|470841145|FG002|Overall Study|Adverse Event|2|||
130784670|NCT00922636|470841146|FG003|Overall Study|Adverse Event|3|||
130784671|NCT00922636|470841147|FG004|Overall Study|Adverse Event|2|||
130784672|NCT00922636|470841143|FG000|Overall Study|Lack of Efficacy|1|||
130784673|NCT00922636|470841144|FG001|Overall Study|Lack of Efficacy|7|||
130784674|NCT00922636|470841145|FG002|Overall Study|Lack of Efficacy|3|||
130784675|NCT00922636|470841146|FG003|Overall Study|Lack of Efficacy|2|||
130784676|NCT00922636|470841147|FG004|Overall Study|Lack of Efficacy|4|||
130784677|NCT00922636|470841143|FG000|Overall Study|Sponsor Decision|0|||
130784678|NCT00922636|470841144|FG001|Overall Study|Sponsor Decision|0|||
130784679|NCT00922636|470841145|FG002|Overall Study|Sponsor Decision|2|||
130784680|NCT00922636|470841146|FG003|Overall Study|Sponsor Decision|0|||
130784681|NCT00922636|470841147|FG004|Overall Study|Sponsor Decision|0|||
130784682|NCT00922636|470841143|FG000|Overall Study|Withdrawal by Subject|0|||
130784683|NCT00922636|470841144|FG001|Overall Study|Withdrawal by Subject|0|||
130784684|NCT00922636|470841145|FG002|Overall Study|Withdrawal by Subject|5|||
130784685|NCT00922636|470841146|FG003|Overall Study|Withdrawal by Subject|2|||
130784686|NCT00922636|470841147|FG004|Overall Study|Withdrawal by Subject|4|||
130784687|NCT00922636|470841143|FG000|Overall Study|Protocol Violation|0|||
130784688|NCT00922636|470841144|FG001|Overall Study|Protocol Violation|0|||
130784689|NCT00922636|470841145|FG002|Overall Study|Protocol Violation|2|||
130784690|NCT00922636|470841146|FG003|Overall Study|Protocol Violation|2|||
130784691|NCT00922636|470841147|FG004|Overall Study|Protocol Violation|0|||
130784692|NCT00922636|470841143|FG000|Overall Study|Entry Criteria Not Met|0|||
131203855|NCT02394028|472366931|FG008|Maintenance Phase|Protocol Violation|0|||
131203856|NCT02394028|472366932|FG009|Maintenance Phase|Protocol Violation|0|||
131203857|NCT02394028|472366933|FG010|Maintenance Phase|Protocol Violation|1|||
131203858|NCT02394028|472366923|FG000|Maintenance Phase|Physician Decision|0|||
131203859|NCT02394028|472366924|FG001|Maintenance Phase|Physician Decision|0|||
131203860|NCT02394028|472366925|FG002|Maintenance Phase|Physician Decision|0|||
131203861|NCT02394028|472366926|FG003|Maintenance Phase|Physician Decision|0|||
131203862|NCT02394028|472366927|FG004|Maintenance Phase|Physician Decision|0|||
131203863|NCT02394028|472366928|FG005|Maintenance Phase|Physician Decision|0|||
131203864|NCT02394028|472366929|FG006|Maintenance Phase|Physician Decision|0|||
131203865|NCT02394028|472366930|FG007|Maintenance Phase|Physician Decision|0|||
131203866|NCT02394028|472366931|FG008|Maintenance Phase|Physician Decision|1|||
131203867|NCT02394028|472366932|FG009|Maintenance Phase|Physician Decision|3|||
131203868|NCT02394028|472366933|FG010|Maintenance Phase|Physician Decision|2|||
131203869|NCT02394028|472366923|FG000|Maintenance Phase|Lack of Efficacy|0|||
131203870|NCT02394028|472366924|FG001|Maintenance Phase|Lack of Efficacy|0|||
131203871|NCT02394028|472366925|FG002|Maintenance Phase|Lack of Efficacy|0|||
131203872|NCT02394028|472366926|FG003|Maintenance Phase|Lack of Efficacy|0|||
131203873|NCT02394028|472366927|FG004|Maintenance Phase|Lack of Efficacy|0|||
131203874|NCT02394028|472366928|FG005|Maintenance Phase|Lack of Efficacy|0|||
131203875|NCT02394028|472366929|FG006|Maintenance Phase|Lack of Efficacy|0|||
131203876|NCT02394028|472366930|FG007|Maintenance Phase|Lack of Efficacy|0|||
131203877|NCT02394028|472366931|FG008|Maintenance Phase|Lack of Efficacy|7|||
131203878|NCT02394028|472366932|FG009|Maintenance Phase|Lack of Efficacy|25|||
131203879|NCT02394028|472366933|FG010|Maintenance Phase|Lack of Efficacy|33|||
130784693|NCT00922636|470841144|FG001|Overall Study|Entry Criteria Not Met|0|||
131203880|NCT02394028|472366923|FG000|Maintenance Phase|Death|0|||
131203881|NCT02394028|472366924|FG001|Maintenance Phase|Death|0|||
131203882|NCT02394028|472366925|FG002|Maintenance Phase|Death|0|||
130784694|NCT00922636|470841145|FG002|Overall Study|Entry Criteria Not Met|1|||
130784695|NCT00922636|470841146|FG003|Overall Study|Entry Criteria Not Met|1|||
130784696|NCT00922636|470841147|FG004|Overall Study|Entry Criteria Not Met|0|||
130784697|NCT00922636|470841143|FG000|Overall Study|Parent/Caregiver Decision|2|||
131203883|NCT02394028|472366926|FG003|Maintenance Phase|Death|0|||
131203884|NCT02394028|472366927|FG004|Maintenance Phase|Death|0|||
131203885|NCT02394028|472366928|FG005|Maintenance Phase|Death|0|||
131203886|NCT02394028|472366929|FG006|Maintenance Phase|Death|0|||
130734637|NCT02288325|470647363|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
130734638|NCT02288325|470647361|FG000|Stabilization Period|Reason not Specified|15|||
130734639|NCT02288325|470647362|FG001|Stabilization Period|Reason not Specified|0|||
130734640|NCT02288325|470647363|FG002|Stabilization Period|Reason not Specified|0|||
130734641|NCT02288325|470647361|FG000|Double-blind Treatment Period|Adverse Event|0|||
130734642|NCT02288325|470647362|FG001|Double-blind Treatment Period|Adverse Event|2|||
130734643|NCT02288325|470647363|FG002|Double-blind Treatment Period|Adverse Event|5|||
130734644|NCT02288325|470647361|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
130734645|NCT02288325|470647362|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
130734646|NCT02288325|470647363|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
130734647|NCT02288325|470647361|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130734648|NCT02288325|470647362|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
130734649|NCT02288325|470647363|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
130734650|NCT02288325|470647361|FG000|Double-blind Treatment Period|Protocol Violation|0|||
130734651|NCT02288325|470647362|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130734652|NCT02288325|470647363|FG002|Double-blind Treatment Period|Protocol Violation|2|||
130734653|NCT02288325|470647361|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
130734654|NCT02288325|470647362|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
130734655|NCT02288325|470647363|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
130734656|NCT02288325|470647361|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
131203887|NCT02394028|472366930|FG007|Maintenance Phase|Death|0|||
131203888|NCT02394028|472366931|FG008|Maintenance Phase|Death|0|||
131203889|NCT02394028|472366932|FG009|Maintenance Phase|Death|0|||
131203890|NCT02394028|472366933|FG010|Maintenance Phase|Death|1|||
131203891|NCT02394028|472366923|FG000|Maintenance Phase|Adverse Event|0|||
131203892|NCT02394028|472366924|FG001|Maintenance Phase|Adverse Event|0|||
131203893|NCT02394028|472366925|FG002|Maintenance Phase|Adverse Event|0|||
131203894|NCT02394028|472366926|FG003|Maintenance Phase|Adverse Event|0|||
131203895|NCT02394028|472366927|FG004|Maintenance Phase|Adverse Event|0|||
131203896|NCT02394028|472366928|FG005|Maintenance Phase|Adverse Event|0|||
131203897|NCT02394028|472366929|FG006|Maintenance Phase|Adverse Event|0|||
131203898|NCT02394028|472366930|FG007|Maintenance Phase|Adverse Event|0|||
131203899|NCT02394028|472366931|FG008|Maintenance Phase|Adverse Event|1|||
131203900|NCT02394028|472366932|FG009|Maintenance Phase|Adverse Event|1|||
131203901|NCT02394028|472366933|FG010|Maintenance Phase|Adverse Event|3|||
131203902|NCT02394028|472366923|FG000|Maintenance Phase|Site closure|0|||
131203903|NCT02394028|472366924|FG001|Maintenance Phase|Site closure|0|||
131203904|NCT02394028|472366925|FG002|Maintenance Phase|Site closure|0|||
131203905|NCT02394028|472366926|FG003|Maintenance Phase|Site closure|0|||
131203906|NCT02394028|472366927|FG004|Maintenance Phase|Site closure|0|||
131203907|NCT02394028|472366928|FG005|Maintenance Phase|Site closure|0|||
131203908|NCT02394028|472366929|FG006|Maintenance Phase|Site closure|0|||
131203909|NCT02394028|472366930|FG007|Maintenance Phase|Site closure|0|||
131203910|NCT02394028|472366931|FG008|Maintenance Phase|Site closure|0|||
131203911|NCT02394028|472366932|FG009|Maintenance Phase|Site closure|1|||
131203912|NCT02394028|472366933|FG010|Maintenance Phase|Site closure|0|||
131203913|NCT02394028|472366923|FG000|Maintenance Phase|Withdrawal by Subject|0|||
131203914|NCT02394028|472366924|FG001|Maintenance Phase|Withdrawal by Subject|0|||
131203915|NCT02394028|472366925|FG002|Maintenance Phase|Withdrawal by Subject|0|||
131203916|NCT02394028|472366926|FG003|Maintenance Phase|Withdrawal by Subject|0|||
131203917|NCT02394028|472366927|FG004|Maintenance Phase|Withdrawal by Subject|0|||
131203918|NCT02394028|472366928|FG005|Maintenance Phase|Withdrawal by Subject|0|||
131203919|NCT02394028|472366929|FG006|Maintenance Phase|Withdrawal by Subject|0|||
131203920|NCT02394028|472366930|FG007|Maintenance Phase|Withdrawal by Subject|0|||
131203921|NCT02394028|472366931|FG008|Maintenance Phase|Withdrawal by Subject|3|||
131203922|NCT02394028|472366932|FG009|Maintenance Phase|Withdrawal by Subject|12|||
131203923|NCT02394028|472366933|FG010|Maintenance Phase|Withdrawal by Subject|12|||
131203924|NCT04129242|472366934|FG000|Overall Study|Physician Decision|1|||
131203925|NCT04129242|472366935|FG001|Overall Study|Physician Decision|1|||
131203926|NCT04129242|472366934|FG000|Overall Study|Protocol Violation|0|||
131203927|NCT04129242|472366935|FG001|Overall Study|Protocol Violation|1|||
131203928|NCT01775995|472366938|FG000|Overall Study|Lost to Follow-up|1|||
131203929|NCT01775995|472366939|FG001|Overall Study|Lost to Follow-up|1|||
131203930|NCT00440232|472366940|FG000|Overall Study|Lost to Follow-up|1|||
131203931|NCT00440232|472366941|FG001|Overall Study|Lost to Follow-up|1|||
131203932|NCT00440232|472366940|FG000|Overall Study|Unable to treat within allowed time|0|||
131203933|NCT00440232|472366941|FG001|Overall Study|Unable to treat within allowed time|1|||
131203934|NCT00440232|472366940|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
131203935|NCT00440232|472366941|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
131203936|NCT00426842|472366942|FG000|Overall Study|Lost to Follow-up|1|||
131203937|NCT01277666|472366945|FG000|Overall Study|Adverse Event|26|||
131203938|NCT01277666|472366946|FG001|Overall Study|Adverse Event|25|||
131203939|NCT01277666|472366947|FG002|Overall Study|Adverse Event|20|||
131203940|NCT01277666|472366945|FG000|Overall Study|Lack of Efficacy|8|||
131203941|NCT01277666|472366946|FG001|Overall Study|Lack of Efficacy|20|||
131203942|NCT01277666|472366947|FG002|Overall Study|Lack of Efficacy|12|||
131203943|NCT01277666|472366945|FG000|Overall Study|Protocol Violation|2|||
131203944|NCT01277666|472366946|FG001|Overall Study|Protocol Violation|3|||
131203945|NCT01277666|472366947|FG002|Overall Study|Protocol Violation|2|||
131203946|NCT01277666|472366945|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
131203947|NCT01277666|472366946|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
131203948|NCT01277666|472366947|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
131203949|NCT01277666|472366945|FG000|Overall Study|Lost to Follow-up|1|||
131203950|NCT01277666|472366946|FG001|Overall Study|Lost to Follow-up|1|||
131203951|NCT01277666|472366947|FG002|Overall Study|Lost to Follow-up|2|||
131203952|NCT01277666|472366945|FG000|Overall Study|Withdrawal by Subject|7|||
131203953|NCT01277666|472366946|FG001|Overall Study|Withdrawal by Subject|8|||
131203954|NCT01277666|472366947|FG002|Overall Study|Withdrawal by Subject|6|||
131203955|NCT01277666|472366945|FG000|Overall Study|Death|0|||
131203956|NCT01277666|472366946|FG001|Overall Study|Death|0|||
131203957|NCT01277666|472366947|FG002|Overall Study|Death|1|||
131203958|NCT02728804|472366955|FG000|Overall Study|Ineligible|3|||
131203959|NCT02728804|472366955|FG000|Overall Study|Did not complete baseline questionnaire|9|||
131203960|NCT02728804|472366955|FG000|Overall Study|Death|99|||
131203961|NCT02918006|472366961|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
131203962|NCT02918006|472366962|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
131203963|NCT02918006|472366963|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
131203964|NCT02918006|472366961|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
131203965|NCT02918006|472366962|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
131203966|NCT02918006|472366963|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
131203967|NCT02918006|472366961|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
131203968|NCT02918006|472366962|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
131203969|NCT02918006|472366963|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
131203970|NCT02918006|472366961|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
131203971|NCT02918006|472366962|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
131203972|NCT02918006|472366963|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
131203973|NCT02918006|472366961|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
131203974|NCT02918006|472366962|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
131203975|NCT02918006|472366963|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
131203976|NCT02918006|472366961|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
131203977|NCT02918006|472366962|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
131203978|NCT02918006|472366963|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
131203979|NCT02918006|472366961|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
131203980|NCT02918006|472366962|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
131203981|NCT02918006|472366963|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
131203982|NCT02918006|472366961|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
131203983|NCT02918006|472366962|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
131203984|NCT02918006|472366963|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
131203985|NCT02918006|472366961|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
131203986|NCT02918006|472366962|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
131203987|NCT02918006|472366963|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
131203988|NCT01156012|472366967|FG000|Overall Study|Adverse Event|3|||
131203989|NCT01156012|472366968|FG001|Overall Study|Adverse Event|1|||
131203990|NCT01156012|472366967|FG000|Overall Study|Lost to Follow-up|1|||
131203991|NCT01156012|472366968|FG001|Overall Study|Lost to Follow-up|0|||
131203992|NCT01156012|472366967|FG000|Overall Study|Withdrawal by Subject|1|||
131203993|NCT01156012|472366968|FG001|Overall Study|Withdrawal by Subject|0|||
131203994|NCT01156012|472366967|FG000|Overall Study|use of commercial drug instead of study|0|||
131203995|NCT01156012|472366968|FG001|Overall Study|use of commercial drug instead of study|1|||
131203996|NCT01156012|472366967|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
131203997|NCT01156012|472366968|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
131203998|NCT02475564|472366969|FG000|Overall Study|Withdrawal by Subject|1|||
131203999|NCT02475564|472366970|FG001|Overall Study|Withdrawal by Subject|0|||
131204000|NCT02475564|472366969|FG000|Overall Study|Lost to Follow-up|2|||
131204001|NCT02475564|472366970|FG001|Overall Study|Lost to Follow-up|1|||
131204002|NCT02475564|472366969|FG000|Overall Study|Intense Menstrual bleeding|1|||
131204003|NCT02475564|472366970|FG001|Overall Study|Intense Menstrual bleeding|0|||
131204004|NCT02705755|472366972|FG000|Part A (6 Days)|Adverse Event|1|||
131204005|NCT02705755|472366973|FG001|Part A (6 Days)|Adverse Event|0|||
131204006|NCT02705755|472366974|FG002|Part A (6 Days)|Adverse Event|0|||
131204007|NCT02705755|472366975|FG003|Part A (6 Days)|Adverse Event|0|||
131204008|NCT02705755|472366972|FG000|Part A (6 Days)|Physician Decision|3|||
131204009|NCT02705755|472366973|FG001|Part A (6 Days)|Physician Decision|0|||
131204010|NCT02705755|472366974|FG002|Part A (6 Days)|Physician Decision|0|||
131204011|NCT02705755|472366975|FG003|Part A (6 Days)|Physician Decision|0|||
131204012|NCT02705755|472366972|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
131204013|NCT02705755|472366973|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
131204014|NCT02705755|472366974|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
131204015|NCT02705755|472366975|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
131204016|NCT02705755|472366972|FG000|Part C (20 Weeks)|Physician Decision|0|||
131204017|NCT02705755|472366973|FG001|Part C (20 Weeks)|Physician Decision|0|||
131204018|NCT02705755|472366974|FG002|Part C (20 Weeks)|Physician Decision|0|||
131204019|NCT02705755|472366975|FG003|Part C (20 Weeks)|Physician Decision|2|||
131204020|NCT02705755|472366972|FG000|Part C (20 Weeks)|Adverse Event|0|||
131204021|NCT02705755|472366973|FG001|Part C (20 Weeks)|Adverse Event|0|||
131204022|NCT02705755|472366974|FG002|Part C (20 Weeks)|Adverse Event|0|||
131204023|NCT02705755|472366975|FG003|Part C (20 Weeks)|Adverse Event|6|||
131204024|NCT02705755|472366972|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
131204025|NCT02705755|472366973|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
131204026|NCT02705755|472366974|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
131204027|NCT02705755|472366975|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
131204028|NCT01524900|472368719|FG000|Overall Study|Lost to Follow-up|3|||
131204029|NCT01524900|472368720|FG001|Overall Study|Lost to Follow-up|12|||
131204030|NCT01524900|472368721|FG002|Overall Study|Lost to Follow-up|1|||
131204031|NCT01524900|472368722|FG003|Overall Study|Lost to Follow-up|0|||
131204032|NCT01524900|472368723|FG004|Overall Study|Lost to Follow-up|0|||
131204033|NCT01524900|472368719|FG000|Overall Study|Other reason than stated above|1|||
131204034|NCT01524900|472368720|FG001|Overall Study|Other reason than stated above|1|||
131204035|NCT01524900|472368721|FG002|Overall Study|Other reason than stated above|0|||
131204036|NCT01524900|472368722|FG003|Overall Study|Other reason than stated above|0|||
131204037|NCT01524900|472368723|FG004|Overall Study|Other reason than stated above|0|||
131204038|NCT01524900|472368719|FG000|Overall Study|No reason documented|2|||
131204039|NCT01524900|472368720|FG001|Overall Study|No reason documented|1|||
131204040|NCT01524900|472368721|FG002|Overall Study|No reason documented|0|||
131204041|NCT01524900|472368722|FG003|Overall Study|No reason documented|1|||
131204042|NCT01524900|472368723|FG004|Overall Study|No reason documented|0|||
131204043|NCT03758612|472368724|FG000|Washout Period|Withdrawal by Subject|0|||
131204044|NCT03758612|472368725|FG001|Washout Period|Withdrawal by Subject|0|||
131204045|NCT03758612|472368726|FG002|Washout Period|Withdrawal by Subject|2|||
131204046|NCT03758612|472368727|FG003|Washout Period|Withdrawal by Subject|0|||
131204047|NCT03758612|472368728|FG004|Washout Period|Withdrawal by Subject|0|||
131204048|NCT03758612|472368729|FG005|Washout Period|Withdrawal by Subject|0|||
131204049|NCT03758612|472368730|FG006|Washout Period|Withdrawal by Subject|0|||
131204050|NCT03758612|472368731|FG007|Washout Period|Withdrawal by Subject|0|||
131204051|NCT03758612|472368732|FG008|Washout Period|Withdrawal by Subject|0|||
131204052|NCT03758612|472368733|FG009|Washout Period|Withdrawal by Subject|0|||
131204053|NCT03758612|472368734|FG010|Washout Period|Withdrawal by Subject|0|||
131204054|NCT03758612|472368735|FG011|Washout Period|Withdrawal by Subject|0|||
131204055|NCT03758612|472368724|FG000|Period 2|Protocol Violation|0|||
131204056|NCT03758612|472368725|FG001|Period 2|Protocol Violation|0|||
131204057|NCT03758612|472368726|FG002|Period 2|Protocol Violation|0|||
131204058|NCT03758612|472368727|FG003|Period 2|Protocol Violation|0|||
131204059|NCT03758612|472368728|FG004|Period 2|Protocol Violation|1|||
131204060|NCT03758612|472368729|FG005|Period 2|Protocol Violation|0|||
131204061|NCT03758612|472368730|FG006|Period 2|Protocol Violation|0|||
131204062|NCT03758612|472368731|FG007|Period 2|Protocol Violation|0|||
131204063|NCT03758612|472368732|FG008|Period 2|Protocol Violation|0|||
131204064|NCT03758612|472368733|FG009|Period 2|Protocol Violation|0|||
131204065|NCT03758612|472368734|FG010|Period 2|Protocol Violation|0|||
131204066|NCT03758612|472368735|FG011|Period 2|Protocol Violation|0|||
131204067|NCT01603615|472368737|FG000|Overall Study|Did not Receive Treatment|7|||
131204068|NCT01603615|472368737|FG000|Overall Study|Lost to Follow-up|9|||
131204069|NCT01603615|472368737|FG000|Overall Study|Personal Reasons|17|||
131204070|NCT01603615|472368737|FG000|Overall Study|Other Miscellaneous|1|||
131204071|NCT03419741|472368738|FG000|Overall Study|Adverse Event|1|||
131204072|NCT03419741|472368739|FG001|Overall Study|Adverse Event|0|||
131204073|NCT03419741|472368738|FG000|Overall Study|Withdrawal by Subject|1|||
131204074|NCT03419741|472368739|FG001|Overall Study|Withdrawal by Subject|2|||
131204075|NCT04354870|472368740|FG000|Overall Study|Lost to Follow-up|32|||
131204076|NCT04354870|472368741|FG001|Overall Study|Lost to Follow-up|12|||
131204077|NCT04354870|472368740|FG000|Overall Study|Withdrawal by Subject|10|||
131204078|NCT04354870|472368741|FG001|Overall Study|Withdrawal by Subject|16|||
131204079|NCT04354870|472368740|FG000|Overall Study|Did not complete all study visits|6|||
131204080|NCT04354870|472368741|FG001|Overall Study|Did not complete all study visits|5|||
131204081|NCT03384316|472368742|FG000|Overall Study|Screen failure|0|||
131204082|NCT03384316|472368743|FG001|Overall Study|Screen failure|1|||
131204083|NCT02194699|472368754|FG000|Randomised|Did not receive treatment|1|||
131204084|NCT02194699|472368755|FG001|Randomised|Did not receive treatment|5|||
131204085|NCT02194699|472368754|FG000|Randomised|Without potential for 52 weeks of IP|5|||
131204086|NCT02194699|472368755|FG001|Randomised|Without potential for 52 weeks of IP|5|||
131204087|NCT02194699|472368754|FG000|Randomised|Duplicate patient|2|||
131204088|NCT02194699|472368755|FG001|Randomised|Duplicate patient|1|||
131204089|NCT02194699|472368754|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
131204090|NCT02194699|472368755|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
131204091|NCT02194699|472368754|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
131204092|NCT02194699|472368755|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
131204093|NCT02194699|472368754|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
131204094|NCT02194699|472368755|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
131204095|NCT02194699|472368754|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
131204096|NCT02194699|472368755|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
131204097|NCT02194699|472368754|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
131204098|NCT02194699|472368755|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
131204099|NCT02194699|472368754|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
131204100|NCT02194699|472368755|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
131204101|NCT02719028|472368756|FG000|Overall Study|Adverse Event|2|||
131204102|NCT02719028|472368757|FG001|Overall Study|Adverse Event|1|||
131204103|NCT02719028|472368758|FG002|Overall Study|Adverse Event|4|||
131204104|NCT02719028|472368759|FG003|Overall Study|Adverse Event|8|||
131204105|NCT02719028|472368756|FG000|Overall Study|Physician Decision|0|||
131204106|NCT02719028|472368757|FG001|Overall Study|Physician Decision|1|||
131204107|NCT02719028|472368758|FG002|Overall Study|Physician Decision|1|||
131204108|NCT02719028|472368759|FG003|Overall Study|Physician Decision|1|||
131204109|NCT02719028|472368756|FG000|Overall Study|Use of prohibited medication|0|||
131204110|NCT02719028|472368757|FG001|Overall Study|Use of prohibited medication|0|||
131204111|NCT02719028|472368758|FG002|Overall Study|Use of prohibited medication|1|||
131204112|NCT02719028|472368759|FG003|Overall Study|Use of prohibited medication|0|||
131204113|NCT02719028|472368756|FG000|Overall Study|Protocol Violation|0|||
131204114|NCT02719028|472368757|FG001|Overall Study|Protocol Violation|0|||
131204115|NCT02719028|472368758|FG002|Overall Study|Protocol Violation|0|||
131204116|NCT02719028|472368759|FG003|Overall Study|Protocol Violation|1|||
131204117|NCT01539720|472368760|FG000|Overall Study|Screen Fail|15|||
130734657|NCT02288325|470647362|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
130734658|NCT02288325|470647363|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
130734659|NCT05061420|470647376|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
130734660|NCT05061420|470647377|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
130734661|NCT05061420|470647378|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
130734662|NCT05061420|470647376|FG000|Overall Study|Progressive disease|11|||
130734663|NCT05061420|470647377|FG001|Overall Study|Progressive disease|15|||
130734664|NCT05061420|470647378|FG002|Overall Study|Progressive disease|14|||
130734665|NCT05061420|470647376|FG000|Overall Study|Withdrawal by Subject|2|||
130734666|NCT05061420|470647377|FG001|Overall Study|Withdrawal by Subject|0|||
130734667|NCT05061420|470647378|FG002|Overall Study|Withdrawal by Subject|1|||
130734668|NCT05061420|470647376|FG000|Overall Study|Not related to COVID-19|2|||
130734669|NCT05061420|470647377|FG001|Overall Study|Not related to COVID-19|0|||
130734670|NCT05061420|470647378|FG002|Overall Study|Not related to COVID-19|0|||
130734671|NCT04868500|470647379|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
130734672|NCT04868500|470647380|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
130734673|NCT04868500|470647379|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
130734674|NCT04868500|470647380|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
130734675|NCT04807400|470647382|FG000|Overall Study|Adverse Event|2|||
130734676|NCT04807400|470647383|FG001|Overall Study|Adverse Event|3|||
130734677|NCT04807400|470647384|FG002|Overall Study|Adverse Event|3|||
130734678|NCT04807400|470647382|FG000|Overall Study|Death|2|||
130734679|NCT04807400|470647383|FG001|Overall Study|Death|0|||
130734680|NCT04807400|470647384|FG002|Overall Study|Death|0|||
130734681|NCT04807400|470647382|FG000|Overall Study|Lost to Follow-up|8|||
130734682|NCT04807400|470647383|FG001|Overall Study|Lost to Follow-up|6|||
130734683|NCT04807400|470647384|FG002|Overall Study|Lost to Follow-up|6|||
130734684|NCT04807400|470647382|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130734685|NCT04807400|470647383|FG001|Overall Study|Non-Compliance With Study Drug|4|||
130734686|NCT04807400|470647384|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130734687|NCT04807400|470647382|FG000|Overall Study|Participant Decision|20|||
130734688|NCT04807400|470647383|FG001|Overall Study|Participant Decision|19|||
130734689|NCT04807400|470647384|FG002|Overall Study|Participant Decision|26|||
130734690|NCT04807400|470647382|FG000|Overall Study|Physician Decision|0|||
130734691|NCT04807400|470647383|FG001|Overall Study|Physician Decision|1|||
130734692|NCT04807400|470647384|FG002|Overall Study|Physician Decision|0|||
131204118|NCT01539720|472368761|FG001|Overall Study|Screen Fail|3|||
131204119|NCT01539720|472368760|FG000|Overall Study|Lost to Follow-up|14|||
131204120|NCT01539720|472368761|FG001|Overall Study|Lost to Follow-up|7|||
131204121|NCT00298766|472368762|FG000|Overall Study|Adverse Event|18|||
131204122|NCT00298766|472368762|FG000|Overall Study|Death|2|||
131204123|NCT00298766|472368762|FG000|Overall Study|Withdrawal by Subject|9|||
130734693|NCT04807400|470647382|FG000|Overall Study|Protocol Violation|4|||
130734694|NCT04807400|470647383|FG001|Overall Study|Protocol Violation|3|||
130734695|NCT04807400|470647384|FG002|Overall Study|Protocol Violation|7|||
130734696|NCT04807400|470647382|FG000|Overall Study|Withdrawal by Subject|13|||
130734697|NCT04807400|470647383|FG001|Overall Study|Withdrawal by Subject|9|||
130734698|NCT04807400|470647384|FG002|Overall Study|Withdrawal by Subject|20|||
130734699|NCT04807400|470647382|FG000|Overall Study|Mis-randomized|1|||
130734700|NCT04807400|470647383|FG001|Overall Study|Mis-randomized|0|||
130734701|NCT04807400|470647384|FG002|Overall Study|Mis-randomized|0|||
130734702|NCT01332292|470647389|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
130784698|NCT00922636|470841144|FG001|Overall Study|Parent/Caregiver Decision|4|||
131204124|NCT00298766|472368762|FG000|Overall Study|Treatment ongoing|4|||
131204125|NCT00298766|472368762|FG000|Overall Study|Progression of amyloid markers|4|||
131204126|NCT00298766|472368762|FG000|Overall Study|Deterioration in KPS and organ function|1|||
131204127|NCT00298766|472368762|FG000|Overall Study|Subjects overall condition deterioration|4|||
131204128|NCT00298766|472368762|FG000|Overall Study|Other|4|||
131204129|NCT00386152|472368763|FG000|Overall Study|Adverse Event|6|||
131204130|NCT00386152|472368764|FG001|Overall Study|Adverse Event|5|||
131204131|NCT00386152|472368765|FG002|Overall Study|Adverse Event|4|||
131204132|NCT00386152|472368763|FG000|Overall Study|Chang from original chemo stratification|4|||
131204133|NCT00386152|472368764|FG001|Overall Study|Chang from original chemo stratification|5|||
131204134|NCT00386152|472368765|FG002|Overall Study|Chang from original chemo stratification|6|||
131204135|NCT00386152|472368763|FG000|Overall Study|Death|3|||
131204136|NCT00386152|472368764|FG001|Overall Study|Death|0|||
131204137|NCT00386152|472368765|FG002|Overall Study|Death|1|||
131204138|NCT00386152|472368763|FG000|Overall Study|Disease progression|7|||
131204139|NCT00386152|472368764|FG001|Overall Study|Disease progression|4|||
131204140|NCT00386152|472368765|FG002|Overall Study|Disease progression|5|||
131204141|NCT00386152|472368763|FG000|Overall Study|Physician Decision|13|||
131204142|NCT00386152|472368764|FG001|Overall Study|Physician Decision|10|||
131204143|NCT00386152|472368765|FG002|Overall Study|Physician Decision|4|||
131204144|NCT00386152|472368763|FG000|Overall Study|Lost to Follow-up|1|||
131204145|NCT00386152|472368764|FG001|Overall Study|Lost to Follow-up|0|||
131204146|NCT00386152|472368765|FG002|Overall Study|Lost to Follow-up|0|||
131204147|NCT00386152|472368763|FG000|Overall Study|Completed chemotherapy|4|||
131204148|NCT00386152|472368764|FG001|Overall Study|Completed chemotherapy|5|||
131204149|NCT00386152|472368765|FG002|Overall Study|Completed chemotherapy|1|||
131204150|NCT00386152|472368763|FG000|Overall Study|Protocol Violation|3|||
131204151|NCT00386152|472368764|FG001|Overall Study|Protocol Violation|5|||
131204152|NCT00386152|472368765|FG002|Overall Study|Protocol Violation|2|||
131204153|NCT00386152|472368763|FG000|Overall Study|Withdrawal by Subject|3|||
131204154|NCT00386152|472368764|FG001|Overall Study|Withdrawal by Subject|6|||
131204155|NCT00386152|472368765|FG002|Overall Study|Withdrawal by Subject|10|||
131204156|NCT03633461|472368780|FG000|Overall Study|Lost to Follow-up|0|||
131204157|NCT03633461|472368781|FG001|Overall Study|Lost to Follow-up|1|||
131204158|NCT03938857|472368784|FG000|Overall Study|Physician Decision|1|||
131204159|NCT03938857|472368785|FG001|Overall Study|Physician Decision|0|||
131204160|NCT03938857|472368786|FG002|Overall Study|Physician Decision|0|||
131204161|NCT03938857|472368787|FG003|Overall Study|Physician Decision|0|||
131204162|NCT01977651|472368788|FG000|4 Month Treatment Period|Adverse Event|34|||
131204163|NCT01977651|472368788|FG000|4 Month Treatment Period|Death|3|||
131204164|NCT01977651|472368788|FG000|4 Month Treatment Period|Progressive Disease|43|||
131204165|NCT01977651|472368788|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
131204166|NCT01977651|472368788|FG000|4 Month Treatment Period|Physician Decision|4|||
131204167|NCT01977651|472368788|FG000|1 Year Extension Period|Adverse Event|14|||
131204168|NCT01977651|472368788|FG000|1 Year Extension Period|Death|10|||
131204169|NCT01977651|472368788|FG000|1 Year Extension Period|Lost to Follow-up|2|||
131204170|NCT01977651|472368788|FG000|1 Year Extension Period|Progressive Disease|86|||
131204171|NCT01977651|472368788|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
131204172|NCT01977651|472368788|FG000|1 Year Extension Period|Physician Decision|6|||
131204173|NCT01977651|472368788|FG000|1 Year Extension Period|Miscellaneous|1|||
131204174|NCT01977651|472368788|FG000|Post 1 Year Extension Period|Adverse Event|5|||
131204175|NCT01977651|472368788|FG000|Post 1 Year Extension Period|Death|13|||
131204176|NCT01977651|472368788|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
131204177|NCT01977651|472368788|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
131204178|NCT01977651|472368788|FG000|Post 1 Year Extension Period|Physician Decision|4|||
131204179|NCT01977651|472368788|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
131204180|NCT00661362|472368789|FG000|Overall Study|Adverse Event|5|||
131204181|NCT00661362|472368790|FG001|Overall Study|Adverse Event|4|||
131204182|NCT00661362|472368789|FG000|Overall Study|Incorrect enrollment|2|||
130784699|NCT00922636|470841145|FG002|Overall Study|Parent/Caregiver Decision|3|||
131204183|NCT00661362|472368790|FG001|Overall Study|Incorrect enrollment|0|||
131204184|NCT00661362|472368789|FG000|Overall Study|Study specific discontinuation criteria|4|||
131204185|NCT00661362|472368790|FG001|Overall Study|Study specific discontinuation criteria|11|||
131204186|NCT00661362|472368789|FG000|Overall Study|Withdrawal by Subject|13|||
131204187|NCT00661362|472368790|FG001|Overall Study|Withdrawal by Subject|23|||
130734703|NCT01332292|470647390|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
130734704|NCT01332292|470647389|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
131204188|NCT00661362|472368789|FG000|Overall Study|Lost to Follow-up|3|||
131204189|NCT00661362|472368790|FG001|Overall Study|Lost to Follow-up|1|||
131204190|NCT00661362|472368789|FG000|Overall Study|Severe non-compliance to protocol|0|||
131204191|NCT00661362|472368790|FG001|Overall Study|Severe non-compliance to protocol|1|||
131204192|NCT00661362|472368789|FG000|Overall Study|Safety reasons|1|||
131204193|NCT00661362|472368790|FG001|Overall Study|Safety reasons|0|||
131204194|NCT00661362|472368789|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
131204195|NCT00661362|472368790|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
131204196|NCT02906644|472368791|FG000|First 2 Weeks|Withdrawal by Subject|0|||
131204197|NCT02906644|472368792|FG001|First 2 Weeks|Withdrawal by Subject|2|||
131204198|NCT02906644|472368791|FG000|First 2 Weeks|Physician Decision|1|||
131204199|NCT02906644|472368792|FG001|First 2 Weeks|Physician Decision|1|||
131204200|NCT02906644|472368791|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
131204201|NCT02906644|472368792|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
131204202|NCT02906644|472368791|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
131204203|NCT02906644|472368792|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
131204204|NCT01351415|472368804|FG000|Overall Study|Withdrawal by Subject|15|||
131204205|NCT01351415|472368805|FG001|Overall Study|Withdrawal by Subject|17|||
131204206|NCT01351415|472368804|FG000|Overall Study|Trial termination by the Sponsor|28|||
131204207|NCT01351415|472368805|FG001|Overall Study|Trial termination by the Sponsor|19|||
131204208|NCT01351415|472368804|FG000|Overall Study|Lost to Follow-up|5|||
131204209|NCT01351415|472368805|FG001|Overall Study|Lost to Follow-up|7|||
131204210|NCT01351415|472368804|FG000|Overall Study|Death|190|||
131204211|NCT01351415|472368805|FG001|Overall Study|Death|187|||
131204212|NCT01351415|472368804|FG000|Overall Study|Physician Decision|2|||
131204213|NCT01351415|472368805|FG001|Overall Study|Physician Decision|3|||
131204214|NCT01351415|472368804|FG000|Overall Study|Reason unknown|0|||
131204215|NCT01351415|472368805|FG001|Overall Study|Reason unknown|2|||
131204216|NCT01351415|472368804|FG000|Overall Study|Never Started|5|||
131204217|NCT01351415|472368805|FG001|Overall Study|Never Started|5|||
131204218|NCT04118127|472368810|FG000|Overall Study|Trial terminated by sponsor|0|||
131204219|NCT04118127|472368811|FG001|Overall Study|Trial terminated by sponsor|12|||
131204220|NCT04118127|472368810|FG000|Overall Study|Adverse Event|1|||
131204221|NCT04118127|472368811|FG001|Overall Study|Adverse Event|2|||
131204222|NCT04118127|472368810|FG000|Overall Study|Physician Decision|0|||
131204223|NCT04118127|472368811|FG001|Overall Study|Physician Decision|1|||
131204224|NCT04118127|472368810|FG000|Overall Study|Withdrawal by Subject|2|||
131204225|NCT04118127|472368811|FG001|Overall Study|Withdrawal by Subject|1|||
131204226|NCT00660816|472368812|FG000|Overall Study|Adverse Event|1|||
131204227|NCT00660816|472368813|FG001|Overall Study|Adverse Event|2|||
131204228|NCT00660816|472368812|FG000|Overall Study|Withdrawal by Subject|1|||
131204229|NCT00660816|472368813|FG001|Overall Study|Withdrawal by Subject|0|||
131204230|NCT00660816|472368812|FG000|Overall Study|Death|0|||
131204231|NCT00660816|472368813|FG001|Overall Study|Death|2|||
131204232|NCT00660816|472368812|FG000|Overall Study|Lack of Efficacy|1|||
131204233|NCT00660816|472368813|FG001|Overall Study|Lack of Efficacy|0|||
131204234|NCT00660816|472368812|FG000|Overall Study|Physician Decision|0|||
131204235|NCT00660816|472368813|FG001|Overall Study|Physician Decision|2|||
131204236|NCT00660816|472368812|FG000|Overall Study|Protocol Violation|1|||
131204237|NCT00660816|472368813|FG001|Overall Study|Protocol Violation|0|||
131204238|NCT00660816|472368812|FG000|Overall Study|Disease Progression|16|||
131204239|NCT00660816|472368813|FG001|Overall Study|Disease Progression|12|||
131204240|NCT00660816|472368812|FG000|Overall Study|Complicating Disease|0|||
131204241|NCT00660816|472368813|FG001|Overall Study|Complicating Disease|1|||
131204242|NCT01646255|472368814|FG000|Overall Study|Adverse Event|7|||
131204243|NCT01646255|472368815|FG001|Overall Study|Adverse Event|8|||
131204244|NCT01646255|472368814|FG000|Overall Study|Lack of Efficacy|2|||
131204245|NCT01646255|472368815|FG001|Overall Study|Lack of Efficacy|0|||
131204246|NCT01646255|472368814|FG000|Overall Study|Withdrawal by Subject|10|||
131204247|NCT01646255|472368815|FG001|Overall Study|Withdrawal by Subject|6|||
131204248|NCT01646255|472368814|FG000|Overall Study|Compliance is not well|1|||
131204249|NCT01646255|472368815|FG001|Overall Study|Compliance is not well|0|||
131204250|NCT01646255|472368814|FG000|Overall Study|Inclusion Criteria Deviation|1|||
131204251|NCT01646255|472368815|FG001|Overall Study|Inclusion Criteria Deviation|0|||
131204252|NCT02142712|472368816|FG000|Overall Study|Lost to Follow-up|1|||
131204253|NCT02142712|472368817|FG001|Overall Study|Lost to Follow-up|1|||
131204254|NCT02142712|472368818|FG002|Overall Study|Lost to Follow-up|1|||
131204255|NCT02142712|472368819|FG003|Overall Study|Lost to Follow-up|0|||
131204256|NCT03480841|472368822|FG000|Overall Study|Lost to Follow-up|2|||
131204257|NCT02380703|472368823|FG000|Overall Study|Withdrawal by Subject|12|||
131204258|NCT02380703|472368824|FG001|Overall Study|Withdrawal by Subject|9|||
131204259|NCT02380703|472368823|FG000|Overall Study|Lost to Follow-up|12|||
131204260|NCT02380703|472368824|FG001|Overall Study|Lost to Follow-up|12|||
131204261|NCT02380703|472368823|FG000|Overall Study|Caregiver death|1|||
131204262|NCT02380703|472368824|FG001|Overall Study|Caregiver death|0|||
131204263|NCT02380703|472368823|FG000|Overall Study|Person with dementia (PWD) death|7|||
131204264|NCT02380703|472368824|FG001|Overall Study|Person with dementia (PWD) death|8|||
131204265|NCT02380703|472368823|FG000|Overall Study|Entered Long-term Care|4|||
130734705|NCT01332292|470647390|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
130734706|NCT01332292|470647389|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
130734707|NCT01332292|470647390|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
130734708|NCT04650204|470647391|FG000|Overall Study|Study was Terminated|2|||
130734709|NCT04650204|470647392|FG001|Overall Study|Study was Terminated|1|||
130734710|NCT01330303|470647393|FG000|Period 1|Adverse Event|1|||
130734711|NCT01330303|470647394|FG001|Period 1|Adverse Event|0|||
130734712|NCT01330303|470647393|FG000|Period 1|Protocol Violation|0|||
130734713|NCT01330303|470647394|FG001|Period 1|Protocol Violation|1|||
130734714|NCT01330303|470647393|FG000|Period 1|Withdrawal by Subject|0|||
130734715|NCT01330303|470647394|FG001|Period 1|Withdrawal by Subject|1|||
130734716|NCT01107197|470647395|FG000|Overall Study|Death|12|||
130734717|NCT01107197|470647396|FG001|Overall Study|Death|10|||
130734718|NCT01107197|470647395|FG000|Overall Study|Lost to Follow-up|5|||
130734719|NCT01107197|470647396|FG001|Overall Study|Lost to Follow-up|8|||
130734720|NCT01107197|470647395|FG000|Overall Study|Withdrawal by Subject|3|||
131204266|NCT02380703|472368824|FG001|Overall Study|Entered Long-term Care|7|||
131204267|NCT01362049|472368825|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
131204268|NCT01362049|472368826|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
131204269|NCT01362049|472368827|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
131204270|NCT01362049|472368828|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
131204271|NCT01362049|472368825|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
131204272|NCT01362049|472368826|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
131204273|NCT01362049|472368827|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
131204274|NCT01362049|472368828|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
131204275|NCT03607994|472368829|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
131204276|NCT03607994|472368830|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
131204277|NCT02850276|472368835|FG000|Overall Study|screen failure|43|||
131204278|NCT02850276|472368835|FG000|Overall Study|Withdrawal by Subject|14|||
131204279|NCT02850276|472368835|FG000|Overall Study|Physician Decision|2|||
131204280|NCT02850276|472368835|FG000|Overall Study|Lost to Follow-up|2|||
131204281|NCT02853318|472368839|FG000|Overall Study|Withdrawal by Subject|1|||
131204282|NCT00252499|472368845|FG000|Overall Study|Lost to Follow-up|1|||
131204283|NCT00252499|472368846|FG001|Overall Study|Lost to Follow-up|0|||
131204284|NCT00252499|472368847|FG002|Overall Study|Lost to Follow-up|0|||
131204285|NCT01882439|472368850|FG000|Overall Study|Adverse event related to study drug|3|||
131204286|NCT01882439|472368851|FG001|Overall Study|Adverse event related to study drug|8|||
131204287|NCT01882439|472368852|FG002|Overall Study|Adverse event related to study drug|1|||
131204288|NCT01882439|472368853|FG003|Overall Study|Adverse event related to study drug|2|||
131204289|NCT01882439|472368850|FG000|Overall Study|Pregnancy|0|||
131204290|NCT01882439|472368851|FG001|Overall Study|Pregnancy|1|||
131204291|NCT01882439|472368852|FG002|Overall Study|Pregnancy|0|||
131204292|NCT01882439|472368853|FG003|Overall Study|Pregnancy|0|||
131204293|NCT01882439|472368850|FG000|Overall Study|Protocol Violation|2|||
131204294|NCT01882439|472368851|FG001|Overall Study|Protocol Violation|2|||
131204295|NCT01882439|472368852|FG002|Overall Study|Protocol Violation|0|||
131204296|NCT01882439|472368853|FG003|Overall Study|Protocol Violation|1|||
131204297|NCT01882439|472368850|FG000|Overall Study|No longer willing to participate|1|||
131204298|NCT01882439|472368851|FG001|Overall Study|No longer willing to participate|4|||
131204299|NCT01882439|472368852|FG002|Overall Study|No longer willing to participate|2|||
131204300|NCT01882439|472368853|FG003|Overall Study|No longer willing to participate|3|||
131204301|NCT01882439|472368850|FG000|Overall Study|Medication error with no associated AE|0|||
131204302|NCT01882439|472368851|FG001|Overall Study|Medication error with no associated AE|0|||
131204303|NCT01882439|472368852|FG002|Overall Study|Medication error with no associated AE|2|||
131204304|NCT01882439|472368853|FG003|Overall Study|Medication error with no associated AE|0|||
131204305|NCT01882439|472368850|FG000|Overall Study|Insufficient clinical response|1|||
131204306|NCT01882439|472368851|FG001|Overall Study|Insufficient clinical response|4|||
131204307|NCT01882439|472368852|FG002|Overall Study|Insufficient clinical response|4|||
131204308|NCT01882439|472368853|FG003|Overall Study|Insufficient clinical response|2|||
131204309|NCT01882439|472368850|FG000|Overall Study|Adverse event unrelated to study drug|2|||
131204310|NCT01882439|472368851|FG001|Overall Study|Adverse event unrelated to study drug|2|||
131204311|NCT01882439|472368852|FG002|Overall Study|Adverse event unrelated to study drug|1|||
131204312|NCT01882439|472368853|FG003|Overall Study|Adverse event unrelated to study drug|1|||
131204313|NCT01997333|472368856|FG000|Randomization and Treatment|Disease Progression|70|||
131204314|NCT01997333|472368857|FG001|Randomization and Treatment|Disease Progression|159|||
131204315|NCT01997333|472368856|FG000|Randomization and Treatment|Adverse Event|10|||
131204316|NCT01997333|472368857|FG001|Randomization and Treatment|Adverse Event|32|||
130734721|NCT01107197|470647396|FG001|Overall Study|Withdrawal by Subject|5|||
130734722|NCT02445963|470647397|FG000|Overall Study|Lost to Follow-up|1|||
131204317|NCT01997333|472368856|FG000|Randomization and Treatment|Physician Decision|0|||
131204318|NCT01997333|472368857|FG001|Randomization and Treatment|Physician Decision|4|||
131204319|NCT01997333|472368856|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
131204320|NCT01997333|472368857|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
130734723|NCT02445963|470647398|FG001|Overall Study|Lost to Follow-up|0|||
130734724|NCT02445963|470647399|FG002|Overall Study|Lost to Follow-up|0|||
130734725|NCT02445963|470647400|FG003|Overall Study|Lost to Follow-up|0|||
130734726|NCT02445963|470647397|FG000|Overall Study|Change in employment|1|||
130784700|NCT00922636|470841146|FG003|Overall Study|Parent/Caregiver Decision|5|||
130784701|NCT00922636|470841147|FG004|Overall Study|Parent/Caregiver Decision|2|||
131204321|NCT01997333|472368856|FG000|Randomization and Treatment|Did not receive treatment|17|||
131204322|NCT01997333|472368857|FG001|Randomization and Treatment|Did not receive treatment|5|||
131204323|NCT01997333|472368856|FG000|Survival Follow up|Withdrawal by Subject|15|||
131204324|NCT01997333|472368857|FG001|Survival Follow up|Withdrawal by Subject|6|||
131204325|NCT01997333|472368856|FG000|Survival Follow up|Lost to Follow-up|0|||
131204326|NCT01997333|472368857|FG001|Survival Follow up|Lost to Follow-up|6|||
131204327|NCT01997333|472368856|FG000|Survival Follow up|Various|1|||
131204328|NCT01997333|472368857|FG001|Survival Follow up|Various|2|||
131204329|NCT02269709|472368858|FG000|Time of Enrollment|Withdrawal by Subject|3|||
131204330|NCT02269709|472368858|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
131204331|NCT02269709|472368858|FG000|Six Month Follow-up|Lost to Follow-up|12|||
131204332|NCT02909504|472368859|FG000|Overall Study|Adverse Event|2|||
131204333|NCT02909504|472368859|FG000|Overall Study|Lack of Efficacy|3|||
131204334|NCT02909504|472368859|FG000|Overall Study|Withdrawal by Subject|4|||
131204335|NCT02909504|472368859|FG000|Overall Study|Pregnancy|1|||
131204336|NCT02909504|472368859|FG000|Overall Study|Subject moved|1|||
131204337|NCT02909504|472368859|FG000|Overall Study|Lost to Follow-up|1|||
131204338|NCT04411472|472368862|FG000|Overall Study|Adverse Event|5|||
131204339|NCT04411472|472368863|FG001|Overall Study|Adverse Event|10|||
131204340|NCT04411472|472368864|FG002|Overall Study|Adverse Event|1|||
131204341|NCT04411472|472368865|FG003|Overall Study|Adverse Event|0|||
131204342|NCT04411472|472368866|FG004|Overall Study|Adverse Event|0|||
131204343|NCT04411472|472368867|FG005|Overall Study|Adverse Event|0|||
131204344|NCT04411472|472368862|FG000|Overall Study|Protocol Violation|1|||
131204345|NCT04411472|472368863|FG001|Overall Study|Protocol Violation|0|||
131204346|NCT04411472|472368864|FG002|Overall Study|Protocol Violation|0|||
131204347|NCT04411472|472368865|FG003|Overall Study|Protocol Violation|0|||
131204348|NCT04411472|472368866|FG004|Overall Study|Protocol Violation|0|||
131204349|NCT04411472|472368867|FG005|Overall Study|Protocol Violation|0|||
131204350|NCT04411472|472368862|FG000|Overall Study|Withdrawal by Subject|0|||
131204351|NCT04411472|472368863|FG001|Overall Study|Withdrawal by Subject|1|||
131204352|NCT04411472|472368864|FG002|Overall Study|Withdrawal by Subject|0|||
131204353|NCT04411472|472368865|FG003|Overall Study|Withdrawal by Subject|1|||
131204354|NCT04411472|472368866|FG004|Overall Study|Withdrawal by Subject|0|||
131204355|NCT04411472|472368867|FG005|Overall Study|Withdrawal by Subject|0|||
131204356|NCT04411472|472368862|FG000|Overall Study|Physician Decision|1|||
131204357|NCT04411472|472368863|FG001|Overall Study|Physician Decision|0|||
131204358|NCT04411472|472368864|FG002|Overall Study|Physician Decision|0|||
131204359|NCT04411472|472368865|FG003|Overall Study|Physician Decision|0|||
131204360|NCT04411472|472368866|FG004|Overall Study|Physician Decision|0|||
131204361|NCT04411472|472368867|FG005|Overall Study|Physician Decision|0|||
131204362|NCT04411472|472368862|FG000|Overall Study|Study terminated by sponsor|17|||
131204363|NCT04411472|472368863|FG001|Overall Study|Study terminated by sponsor|20|||
131204364|NCT04411472|472368864|FG002|Overall Study|Study terminated by sponsor|3|||
131204365|NCT04411472|472368865|FG003|Overall Study|Study terminated by sponsor|0|||
131204366|NCT04411472|472368866|FG004|Overall Study|Study terminated by sponsor|0|||
131204367|NCT04411472|472368867|FG005|Overall Study|Study terminated by sponsor|0|||
131204368|NCT02504424|472368868|FG000|Overall Study|Withdrawal by Subject|2|||
131204369|NCT05060003|472368872|FG000|Overall Study|ctDNA negative|7|||
131204370|NCT00819052|472368873|FG000|Overall Study|Adverse Event|0|||
131204371|NCT00819052|472368874|FG001|Overall Study|Adverse Event|5|||
131204372|NCT00819052|472368873|FG000|Overall Study|Protocol Violation|1|||
131204373|NCT00819052|472368874|FG001|Overall Study|Protocol Violation|2|||
131204374|NCT00819052|472368873|FG000|Overall Study|Lost to Follow-up|1|||
131204375|NCT00819052|472368874|FG001|Overall Study|Lost to Follow-up|2|||
131204376|NCT00819052|472368873|FG000|Overall Study|Withdrawal by Subject|1|||
131204377|NCT00819052|472368874|FG001|Overall Study|Withdrawal by Subject|2|||
131204378|NCT00819052|472368873|FG000|Overall Study|Lack of Efficacy|1|||
131204379|NCT00819052|472368874|FG001|Overall Study|Lack of Efficacy|1|||
131204380|NCT00819052|472368873|FG000|Overall Study|Pregnancy|1|||
131204381|NCT00819052|472368874|FG001|Overall Study|Pregnancy|2|||
131204382|NCT00819052|472368873|FG000|Overall Study|Death or events leading to death|1|||
131204383|NCT00819052|472368874|FG001|Overall Study|Death or events leading to death|0|||
131204384|NCT00362297|472368875|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
131204385|NCT00362297|472368876|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
131204386|NCT01747655|472368879|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
131204387|NCT01747655|472368880|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
131204388|NCT01747655|472368879|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
131204389|NCT01747655|472368880|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
131204390|NCT01747655|472368879|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
131204391|NCT01747655|472368880|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
131204392|NCT00982111|472368881|FG000|Overall Study|Adverse Event|1|||
131204393|NCT00982111|472368882|FG001|Overall Study|Adverse Event|1|||
131204394|NCT00982111|472368881|FG000|Overall Study|Progressive Disease|46|||
131204395|NCT00982111|472368882|FG001|Overall Study|Progressive Disease|39|||
131204396|NCT00982111|472368881|FG000|Overall Study|Lost to Follow-up|9|||
131204397|NCT00982111|472368882|FG001|Overall Study|Lost to Follow-up|6|||
130734727|NCT02445963|470647398|FG001|Overall Study|Change in employment|0|||
130734728|NCT02445963|470647399|FG002|Overall Study|Change in employment|0|||
130734729|NCT02445963|470647400|FG003|Overall Study|Change in employment|0|||
130734730|NCT02445963|470647397|FG000|Overall Study|Symptoms post-vaccination|0|||
130734731|NCT02445963|470647398|FG001|Overall Study|Symptoms post-vaccination|0|||
131204398|NCT00982111|472368881|FG000|Overall Study|New Anti-Cancer Therapy|5|||
131204399|NCT00982111|472368882|FG001|Overall Study|New Anti-Cancer Therapy|5|||
131204400|NCT00982111|472368881|FG000|Overall Study|Medical Decision|1|||
131204401|NCT00982111|472368882|FG001|Overall Study|Medical Decision|0|||
131204402|NCT00982111|472368881|FG000|Overall Study|Withdrawal by Subject|17|||
131204403|NCT00982111|472368882|FG001|Overall Study|Withdrawal by Subject|19|||
131204404|NCT00982111|472368881|FG000|Overall Study|Global Study End|0|||
131204405|NCT00982111|472368882|FG001|Overall Study|Global Study End|1|||
131204406|NCT00982111|472368881|FG000|Overall Study|Sponsor's Decision|0|||
131204407|NCT00982111|472368882|FG001|Overall Study|Sponsor's Decision|1|||
131204408|NCT03769753|472368883|FG000|Overall Study|Not Treated|6|||
131204409|NCT03769753|472368883|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
131204410|NCT03702166|472368884|FG000|Overall Study|Lost to Follow-up|1|||
131204411|NCT03702166|472368884|FG000|Overall Study|Withdrawal by Subject|1|||
131204412|NCT01070381|472368885|FG000|Period 2, 1 Week of Wear|Handling|0|||
131204413|NCT01070381|472368886|FG001|Period 2, 1 Week of Wear|Handling|1|||
131204414|NCT01070381|472368885|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
131204415|NCT01070381|472368886|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
131204416|NCT00684073|472368887|FG000|Selection|Selection/non-selection criteria|3|||
131204417|NCT00684073|472368887|FG000|Selection|Death|1|||
131204418|NCT00684073|472368887|FG000|Selection|noncompliance|1|||
131204419|NCT00684073|472368887|FG000|Selection|Lost to Follow-up|1|||
131204420|NCT00684073|472368887|FG000|Selection|request of the sponsor|1|||
131204421|NCT00684073|472368887|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
131204422|NCT03512028|472368891|FG000|Overall Study|Withdrawal by Subject|2|||
131204423|NCT03512028|472368892|FG001|Overall Study|Withdrawal by Subject|0|||
131204424|NCT03512028|472368891|FG000|Overall Study|Protocol Violation|2|||
131204425|NCT03512028|472368892|FG001|Overall Study|Protocol Violation|0|||
131204426|NCT03529162|472368893|FG000|Overall Study|Lost to Follow-up|2|||
131204427|NCT03529162|472368894|FG001|Overall Study|Lost to Follow-up|2|||
131204428|NCT01503229|472370499|FG000|Overall Study|Withdrew consent|1|||
131204429|NCT03824704|472370502|FG000|Overall Study|Study Terminated by Sponsor|1|||
131204430|NCT03287960|472370503|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
131204431|NCT03287960|472370503|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
131204432|NCT01667731|472370508|FG000|Overall Study|Enrolled but not treated|0|||
131204433|NCT01667731|472370509|FG001|Overall Study|Enrolled but not treated|0|||
131204434|NCT01667731|472370510|FG002|Overall Study|Enrolled but not treated|0|||
131204435|NCT01667731|472370511|FG003|Overall Study|Enrolled but not treated|0|||
131204436|NCT01667731|472370512|FG004|Overall Study|Enrolled but not treated|1|||
131204437|NCT01667731|472370508|FG000|Overall Study|Efficacy Failure|1|||
131204438|NCT01667731|472370509|FG001|Overall Study|Efficacy Failure|12|||
131204439|NCT01667731|472370510|FG002|Overall Study|Efficacy Failure|0|||
131204440|NCT01667731|472370511|FG003|Overall Study|Efficacy Failure|1|||
131204441|NCT01667731|472370512|FG004|Overall Study|Efficacy Failure|24|||
131204442|NCT01667731|472370508|FG000|Overall Study|Lost to Follow-up|2|||
131204443|NCT01667731|472370509|FG001|Overall Study|Lost to Follow-up|3|||
131204444|NCT01667731|472370510|FG002|Overall Study|Lost to Follow-up|1|||
131204445|NCT01667731|472370511|FG003|Overall Study|Lost to Follow-up|1|||
131204446|NCT01667731|472370512|FG004|Overall Study|Lost to Follow-up|2|||
131204447|NCT01667731|472370508|FG000|Overall Study|Subject Withdrew Consent|2|||
131204448|NCT01667731|472370509|FG001|Overall Study|Subject Withdrew Consent|0|||
131204449|NCT01667731|472370510|FG002|Overall Study|Subject Withdrew Consent|1|||
131204450|NCT01667731|472370511|FG003|Overall Study|Subject Withdrew Consent|0|||
131204451|NCT01667731|472370512|FG004|Overall Study|Subject Withdrew Consent|1|||
131204452|NCT01667731|472370508|FG000|Overall Study|Death|0|||
131204453|NCT01667731|472370509|FG001|Overall Study|Death|1|||
131204454|NCT01667731|472370510|FG002|Overall Study|Death|0|||
131204455|NCT01667731|472370511|FG003|Overall Study|Death|0|||
131204456|NCT01667731|472370512|FG004|Overall Study|Death|0|||
131204457|NCT01425268|472370513|FG000|Overall Study|Withdrawal by Subject|2|||
131204458|NCT01425268|472370514|FG001|Overall Study|Withdrawal by Subject|0|||
131204459|NCT01425268|472370513|FG000|Overall Study|Sponsor Decision|5|||
131204460|NCT01425268|472370514|FG001|Overall Study|Sponsor Decision|0|||
131204461|NCT01425268|472370513|FG000|Overall Study|Physician Decision|1|||
131204462|NCT01425268|472370514|FG001|Overall Study|Physician Decision|0|||
131204463|NCT02839330|472370515|FG000|Overall Study|Adverse Event|0|||
131204464|NCT02839330|472370516|FG001|Overall Study|Adverse Event|1|||
131204465|NCT02839330|472370517|FG002|Overall Study|Adverse Event|2|||
131204466|NCT02839330|472370518|FG003|Overall Study|Adverse Event|2|||
131204467|NCT02839330|472370515|FG000|Overall Study|Death|4|||
131204468|NCT02839330|472370516|FG001|Overall Study|Death|6|||
131204469|NCT02839330|472370517|FG002|Overall Study|Death|1|||
131204470|NCT02839330|472370518|FG003|Overall Study|Death|1|||
131204471|NCT02839330|472370515|FG000|Overall Study|Withdrawal by Subject|27|||
131204472|NCT02839330|472370516|FG001|Overall Study|Withdrawal by Subject|19|||
131204473|NCT02839330|472370517|FG002|Overall Study|Withdrawal by Subject|11|||
131204474|NCT02839330|472370518|FG003|Overall Study|Withdrawal by Subject|13|||
131204475|NCT02839330|472370515|FG000|Overall Study|Lost to Follow-up|22|||
131204476|NCT02839330|472370516|FG001|Overall Study|Lost to Follow-up|27|||
131204477|NCT02839330|472370517|FG002|Overall Study|Lost to Follow-up|29|||
131204478|NCT02839330|472370518|FG003|Overall Study|Lost to Follow-up|25|||
131204479|NCT02839330|472370515|FG000|Overall Study|Administrative Reason|0|||
131204480|NCT02839330|472370516|FG001|Overall Study|Administrative Reason|0|||
131204481|NCT02839330|472370517|FG002|Overall Study|Administrative Reason|0|||
131204482|NCT02839330|472370518|FG003|Overall Study|Administrative Reason|1|||
131204483|NCT02839330|472370515|FG000|Overall Study|Protocol Violation|1|||
130784702|NCT00922636|470841143|FG000|Overall Study|Lost to Follow-up|1|||
131204484|NCT02839330|472370516|FG001|Overall Study|Protocol Violation|2|||
131204485|NCT02839330|472370517|FG002|Overall Study|Protocol Violation|2|||
131204486|NCT02839330|472370518|FG003|Overall Study|Protocol Violation|3|||
131204487|NCT02839330|472370515|FG000|Overall Study|Other reason, not specified|4|||
131204488|NCT02839330|472370516|FG001|Overall Study|Other reason, not specified|3|||
131204489|NCT02839330|472370517|FG002|Overall Study|Other reason, not specified|3|||
131204490|NCT02839330|472370518|FG003|Overall Study|Other reason, not specified|6|||
131204491|NCT01345162|472370519|FG000|Overall Study|Protocol Violation|2|||
131204492|NCT01345162|472370520|FG001|Overall Study|Protocol Violation|4|||
131204493|NCT00508872|472370521|FG000|Overall Study|Lost to Follow-up|1|||
131204494|NCT00508872|472370521|FG000|Overall Study|Physician Decision|1|||
131204495|NCT01871870|472370522|FG000|Overall Study|Hardware issues|7|||
131204496|NCT01871870|472370522|FG000|Overall Study|hyperglycemia|2|||
131204497|NCT03007472|472370524|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
131204498|NCT03007472|472370524|FG000|Overall Study|Death|2|||
131204499|NCT03007472|472370524|FG000|Overall Study|Loss to Follow Up|1|||
131204500|NCT00883896|472370525|FG000|Overall Study|Lost to Follow-up|0|||
131204501|NCT00883896|472370526|FG001|Overall Study|Lost to Follow-up|0|||
131204502|NCT00883896|472370527|FG002|Overall Study|Lost to Follow-up|0|||
131204503|NCT00883896|472370528|FG003|Overall Study|Lost to Follow-up|2|||
131204504|NCT00883896|472370525|FG000|Overall Study|Withdrawal by Subject|5|||
131204505|NCT00883896|472370526|FG001|Overall Study|Withdrawal by Subject|0|||
131204506|NCT00883896|472370527|FG002|Overall Study|Withdrawal by Subject|1|||
131204507|NCT00883896|472370528|FG003|Overall Study|Withdrawal by Subject|3|||
131204508|NCT00883896|472370525|FG000|Overall Study|Lack of Efficacy|0|||
131204509|NCT00883896|472370526|FG001|Overall Study|Lack of Efficacy|0|||
131204510|NCT00883896|472370527|FG002|Overall Study|Lack of Efficacy|0|||
131204511|NCT00883896|472370528|FG003|Overall Study|Lack of Efficacy|2|||
131204512|NCT00883896|472370525|FG000|Overall Study|Other|1|||
131204513|NCT00883896|472370526|FG001|Overall Study|Other|0|||
131204514|NCT00883896|472370527|FG002|Overall Study|Other|0|||
131204515|NCT00883896|472370528|FG003|Overall Study|Other|0|||
131204516|NCT01716585|472370539|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
131204517|NCT01716585|472370540|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
131204518|NCT01716585|472370539|FG000|Double-blind Treatment|Adverse Event|2|||
131204519|NCT01716585|472370540|FG001|Double-blind Treatment|Adverse Event|1|||
131204520|NCT01716585|472370539|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
131204521|NCT01716585|472370540|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
131204522|NCT01716585|472370539|FG000|Double-blind Treatment|Lost to Follow-up|2|||
131204523|NCT01716585|472370540|FG001|Double-blind Treatment|Lost to Follow-up|0|||
131204524|NCT01716585|472370539|FG000|Double-blind Treatment|Subject Noncompliant|1|||
131204525|NCT01716585|472370540|FG001|Double-blind Treatment|Subject Noncompliant|0|||
131204526|NCT01716585|472370539|FG000|Double-blind Treatment|Other|1|||
131204527|NCT01716585|472370540|FG001|Double-blind Treatment|Other|0|||
131204528|NCT01716585|472370539|FG000|Open-label Treatment|Adverse Event|0|||
131204529|NCT01716585|472370540|FG001|Open-label Treatment|Adverse Event|2|||
131204530|NCT01716585|472370539|FG000|Open-label Treatment|Virologic Failure|0|||
131204531|NCT01716585|472370540|FG001|Open-label Treatment|Virologic Failure|2|||
131204532|NCT01716585|472370539|FG000|Open-label Treatment|Withdrawal by Subject|0|||
131204533|NCT01716585|472370540|FG001|Open-label Treatment|Withdrawal by Subject|3|||
131204534|NCT03672006|472370541|FG000|Overall Study|exclusion criteria met|0|||
131204535|NCT03672006|472370542|FG001|Overall Study|exclusion criteria met|1|||
131204536|NCT01453439|472370543|FG000|Treatment Phase|Withdrawal by Subject|13|||
131204537|NCT01453439|472370544|FG001|Treatment Phase|Withdrawal by Subject|10|||
131204538|NCT01453439|472370543|FG000|Treatment Phase|Suicidal Ideation|2|||
131204539|NCT01453439|472370544|FG001|Treatment Phase|Suicidal Ideation|0|||
131204540|NCT01453439|472370543|FG000|Treatment Phase|Need for higher level of care|1|||
131204541|NCT01453439|472370544|FG001|Treatment Phase|Need for higher level of care|1|||
131204542|NCT01453439|472370543|FG000|Treatment Phase|Therapist conflict of interest|1|||
131204543|NCT01453439|472370544|FG001|Treatment Phase|Therapist conflict of interest|0|||
131204544|NCT01453439|472370543|FG000|Follow-up|Withdrawal by Subject|0|||
131204545|NCT01453439|472370544|FG001|Follow-up|Withdrawal by Subject|1|||
131204546|NCT01453439|472370543|FG000|Follow-up|Lost to Follow-up|5|||
131204547|NCT01453439|472370544|FG001|Follow-up|Lost to Follow-up|10|||
131204548|NCT01014442|472370545|FG000|Overall Study|Adverse Event|0|||
131204549|NCT01014442|472370546|FG001|Overall Study|Adverse Event|8|||
131204550|NCT01014442|472370545|FG000|Overall Study|Withdrawal by Subject|4|||
131204551|NCT01014442|472370546|FG001|Overall Study|Withdrawal by Subject|4|||
131204552|NCT01014442|472370545|FG000|Overall Study|Protocol Violation|2|||
131204553|NCT01014442|472370546|FG001|Overall Study|Protocol Violation|5|||
131204554|NCT01014442|472370545|FG000|Overall Study|Lack of Compliance|0|||
131204555|NCT01014442|472370546|FG001|Overall Study|Lack of Compliance|1|||
131204556|NCT01014442|472370545|FG000|Overall Study|Unspecified Reason|1|||
131204557|NCT01014442|472370546|FG001|Overall Study|Unspecified Reason|1|||
131204558|NCT02135848|472370554|FG000|Overall Study|Adverse Event|2|||
131204559|NCT02135848|472370555|FG001|Overall Study|Adverse Event|0|||
131204560|NCT02135848|472370554|FG000|Overall Study|Withdrawal by Subject|1|||
131204561|NCT02135848|472370555|FG001|Overall Study|Withdrawal by Subject|1|||
131204562|NCT00089505|472370556|FG000|Overall Study|Death|4|||
131204563|NCT00089505|472370557|FG001|Overall Study|Death|1|||
131204564|NCT00089505|472370558|FG002|Overall Study|Death|5|||
131204565|NCT00089505|472370559|FG003|Overall Study|Death|8|||
131204566|NCT00089505|472370556|FG000|Overall Study|Withdrawal by Subject|3|||
131204567|NCT00089505|472370557|FG001|Overall Study|Withdrawal by Subject|0|||
131204568|NCT00089505|472370558|FG002|Overall Study|Withdrawal by Subject|6|||
131204569|NCT00089505|472370559|FG003|Overall Study|Withdrawal by Subject|6|||
131204570|NCT00089505|472370556|FG000|Overall Study|Lost to Follow-up|1|||
131204571|NCT00089505|472370557|FG001|Overall Study|Lost to Follow-up|1|||
131204572|NCT00089505|472370558|FG002|Overall Study|Lost to Follow-up|9|||
131204573|NCT00089505|472370559|FG003|Overall Study|Lost to Follow-up|7|||
131204574|NCT00089505|472370556|FG000|Overall Study|Physician Decision|1|||
131204575|NCT00089505|472370557|FG001|Overall Study|Physician Decision|0|||
131204576|NCT00089505|472370558|FG002|Overall Study|Physician Decision|0|||
131204577|NCT00089505|472370559|FG003|Overall Study|Physician Decision|0|||
131204578|NCT00089505|472370556|FG000|Overall Study|Protocol Violation|0|||
131204579|NCT00089505|472370557|FG001|Overall Study|Protocol Violation|0|||
131204580|NCT00089505|472370558|FG002|Overall Study|Protocol Violation|1|||
131204581|NCT00089505|472370559|FG003|Overall Study|Protocol Violation|0|||
131204582|NCT01284127|472370561|FG000|Overall Study|Adverse Event|2|||
131204583|NCT01284127|472370561|FG000|Overall Study|Withdrawal by Subject|4|||
131204584|NCT01284127|472370561|FG000|Overall Study|Physician Decision|1|||
131204585|NCT04212221|472370566|FG000|Overall Study|Remained on Treatment|0|||
131204586|NCT04212221|472370567|FG001|Overall Study|Remained on Treatment|0|||
131204587|NCT04212221|472370568|FG002|Overall Study|Remained on Treatment|0|||
131204588|NCT04212221|472370569|FG003|Overall Study|Remained on Treatment|1|||
131204589|NCT04212221|472370570|FG004|Overall Study|Remained on Treatment|0|||
131204590|NCT04212221|472370571|FG005|Overall Study|Remained on Treatment|0|||
131204591|NCT04212221|472370572|FG006|Overall Study|Remained on Treatment|3|||
131204592|NCT04212221|472370573|FG007|Overall Study|Remained on Treatment|9|||
131204593|NCT04212221|472370566|FG000|Overall Study|Adverse Event|0|||
131204594|NCT04212221|472370567|FG001|Overall Study|Adverse Event|0|||
131204595|NCT04212221|472370568|FG002|Overall Study|Adverse Event|0|||
131204596|NCT04212221|472370569|FG003|Overall Study|Adverse Event|0|||
131204597|NCT04212221|472370570|FG004|Overall Study|Adverse Event|0|||
131204598|NCT04212221|472370571|FG005|Overall Study|Adverse Event|0|||
131204599|NCT04212221|472370572|FG006|Overall Study|Adverse Event|2|||
131204600|NCT04212221|472370573|FG007|Overall Study|Adverse Event|3|||
131204601|NCT04212221|472370566|FG000|Overall Study|Death|0|||
131204602|NCT04212221|472370567|FG001|Overall Study|Death|0|||
131204603|NCT04212221|472370568|FG002|Overall Study|Death|0|||
131204604|NCT04212221|472370569|FG003|Overall Study|Death|0|||
131204605|NCT04212221|472370570|FG004|Overall Study|Death|0|||
131204606|NCT04212221|472370571|FG005|Overall Study|Death|0|||
131204607|NCT04212221|472370572|FG006|Overall Study|Death|0|||
131204608|NCT04212221|472370573|FG007|Overall Study|Death|2|||
131204609|NCT04212221|472370566|FG000|Overall Study|Disease progression according to irRECIST|1|||
131204610|NCT04212221|472370567|FG001|Overall Study|Disease progression according to irRECIST|2|||
131204611|NCT04212221|472370568|FG002|Overall Study|Disease progression according to irRECIST|3|||
131204612|NCT04212221|472370569|FG003|Overall Study|Disease progression according to irRECIST|3|||
131204613|NCT04212221|472370570|FG004|Overall Study|Disease progression according to irRECIST|2|||
131204614|NCT04212221|472370571|FG005|Overall Study|Disease progression according to irRECIST|2|||
131204615|NCT04212221|472370572|FG006|Overall Study|Disease progression according to irRECIST|21|||
131204616|NCT04212221|472370573|FG007|Overall Study|Disease progression according to irRECIST|17|||
131204617|NCT04212221|472370566|FG000|Overall Study|Global Deterioration of Health Status|0|||
131204618|NCT04212221|472370567|FG001|Overall Study|Global Deterioration of Health Status|0|||
131204619|NCT04212221|472370568|FG002|Overall Study|Global Deterioration of Health Status|0|||
131204620|NCT04212221|472370569|FG003|Overall Study|Global Deterioration of Health Status|0|||
131204621|NCT04212221|472370570|FG004|Overall Study|Global Deterioration of Health Status|0|||
131204622|NCT04212221|472370571|FG005|Overall Study|Global Deterioration of Health Status|0|||
131204623|NCT04212221|472370572|FG006|Overall Study|Global Deterioration of Health Status|0|||
131204624|NCT04212221|472370573|FG007|Overall Study|Global Deterioration of Health Status|2|||
131204625|NCT04212221|472370566|FG000|Overall Study|Investigator's Decision|0|||
131204626|NCT04212221|472370567|FG001|Overall Study|Investigator's Decision|0|||
131204627|NCT04212221|472370568|FG002|Overall Study|Investigator's Decision|0|||
131204628|NCT04212221|472370569|FG003|Overall Study|Investigator's Decision|1|||
131204629|NCT04212221|472370570|FG004|Overall Study|Investigator's Decision|0|||
131204630|NCT04212221|472370571|FG005|Overall Study|Investigator's Decision|0|||
131204631|NCT04212221|472370572|FG006|Overall Study|Investigator's Decision|3|||
130734732|NCT02445963|470647399|FG002|Overall Study|Symptoms post-vaccination|1|||
130734733|NCT02445963|470647400|FG003|Overall Study|Symptoms post-vaccination|0|||
130734734|NCT01823835|470647404|FG000|Overall Study|Adverse Event|0|||
130734735|NCT01823835|470647405|FG001|Overall Study|Adverse Event|0|||
130734736|NCT01823835|470647406|FG002|Overall Study|Adverse Event|0|||
131204632|NCT04212221|472370573|FG007|Overall Study|Investigator's Decision|0|||
131204633|NCT04212221|472370566|FG000|Overall Study|Participant refused to continue treatment|0|||
131204634|NCT04212221|472370567|FG001|Overall Study|Participant refused to continue treatment|1|||
131204635|NCT04212221|472370568|FG002|Overall Study|Participant refused to continue treatment|0|||
131204636|NCT04212221|472370569|FG003|Overall Study|Participant refused to continue treatment|1|||
131204637|NCT04212221|472370570|FG004|Overall Study|Participant refused to continue treatment|1|||
131204638|NCT04212221|472370571|FG005|Overall Study|Participant refused to continue treatment|2|||
131204639|NCT04212221|472370572|FG006|Overall Study|Participant refused to continue treatment|4|||
131204640|NCT04212221|472370573|FG007|Overall Study|Participant refused to continue treatment|2|||
131204641|NCT04212221|472370566|FG000|Overall Study|Protocol Violation|0|||
131204642|NCT04212221|472370567|FG001|Overall Study|Protocol Violation|0|||
131204643|NCT04212221|472370568|FG002|Overall Study|Protocol Violation|0|||
131204644|NCT04212221|472370569|FG003|Overall Study|Protocol Violation|0|||
131204645|NCT04212221|472370570|FG004|Overall Study|Protocol Violation|0|||
131204646|NCT04212221|472370571|FG005|Overall Study|Protocol Violation|0|||
131204647|NCT04212221|472370572|FG006|Overall Study|Protocol Violation|0|||
131204648|NCT04212221|472370573|FG007|Overall Study|Protocol Violation|1|||
131204649|NCT01624974|472370579|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
131204650|NCT01624974|472370580|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
131204651|NCT01624974|472370579|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
131204652|NCT01624974|472370580|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
131204653|NCT01624974|472370579|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
131204654|NCT01624974|472370580|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
131204655|NCT01624974|472370579|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
131204656|NCT01624974|472370580|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
131204657|NCT01624974|472370579|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
131204658|NCT01624974|472370580|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
131204659|NCT01624974|472370579|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
131204660|NCT01624974|472370580|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
131204661|NCT01624974|472370579|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
131204662|NCT01624974|472370580|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
131204663|NCT01624974|472370579|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
131204664|NCT01624974|472370580|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
131204665|NCT01624974|472370579|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
131204666|NCT01624974|472370580|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
131204667|NCT01624974|472370579|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
131204668|NCT01624974|472370580|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
131204669|NCT01624974|472370579|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
131204670|NCT01624974|472370580|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
131204671|NCT01624974|472370579|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
131204672|NCT01624974|472370580|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
131204673|NCT01376908|472370581|FG000|Overall Study|Protocol Violation|1|||
131204674|NCT01376908|472370582|FG001|Overall Study|Protocol Violation|1|||
131204675|NCT01376908|472370581|FG000|Overall Study|Withdrawal by Subject|1|||
131204676|NCT01376908|472370582|FG001|Overall Study|Withdrawal by Subject|2|||
131204677|NCT01468844|472370583|FG000|Overall Study|Adverse Event|1|||
131204678|NCT01468844|472370584|FG001|Overall Study|Adverse Event|0|||
131204679|NCT01468844|472370583|FG000|Overall Study|Withdrawal by Subject|1|||
131204680|NCT01468844|472370584|FG001|Overall Study|Withdrawal by Subject|0|||
131204681|NCT00266695|472370585|FG000|Overall Study|Adverse Event|1|||
130734737|NCT01823835|470647407|FG003|Overall Study|Adverse Event|0|||
131204682|NCT00266695|472370585|FG000|Overall Study|Death|9|||
131204683|NCT00266695|472370585|FG000|Overall Study|Physician Decision|1|||
131204684|NCT00266695|472370585|FG000|Overall Study|Lost to Follow-up|3|||
131204685|NCT00266695|472370585|FG000|Overall Study|Withdrawal by Subject|15|||
131204686|NCT02417935|472370586|FG000|Treatment Period|Adverse Event|12|||
131204687|NCT02417935|472370587|FG001|Treatment Period|Adverse Event|10|||
131204688|NCT02417935|472370586|FG000|Treatment Period|Lost to Follow-up|1|||
131204689|NCT02417935|472370587|FG001|Treatment Period|Lost to Follow-up|0|||
131204690|NCT02417935|472370586|FG000|Treatment Period|Entry Criteria not met|0|||
131204691|NCT02417935|472370587|FG001|Treatment Period|Entry Criteria not met|1|||
131204692|NCT02417935|472370586|FG000|Treatment Period|Protocol Violation|2|||
131204693|NCT02417935|472370587|FG001|Treatment Period|Protocol Violation|1|||
131204694|NCT02417935|472370586|FG000|Treatment Period|Withdrawal by Subject|3|||
131204695|NCT02417935|472370587|FG001|Treatment Period|Withdrawal by Subject|3|||
131204696|NCT02417935|472370586|FG000|Treatment Period|Physician Decision|3|||
131204697|NCT02417935|472370587|FG001|Treatment Period|Physician Decision|1|||
131204698|NCT01899729|472370588|FG000|Overall Study|Adverse Event|1|||
131204699|NCT01899729|472370589|FG001|Overall Study|Adverse Event|0|||
131204700|NCT01899729|472370590|FG002|Overall Study|Adverse Event|0|||
131204701|NCT01899729|472370591|FG003|Overall Study|Adverse Event|0|||
131204702|NCT01899729|472370592|FG004|Overall Study|Adverse Event|1|||
131204703|NCT01899729|472370588|FG000|Overall Study|Withdrawal by Subject|1|||
131204704|NCT01899729|472370589|FG001|Overall Study|Withdrawal by Subject|2|||
131204705|NCT01899729|472370590|FG002|Overall Study|Withdrawal by Subject|0|||
131204706|NCT01899729|472370591|FG003|Overall Study|Withdrawal by Subject|0|||
131204707|NCT01899729|472370592|FG004|Overall Study|Withdrawal by Subject|0|||
131204708|NCT01899729|472370588|FG000|Overall Study|Lack of Efficacy|0|||
131204709|NCT01899729|472370589|FG001|Overall Study|Lack of Efficacy|0|||
131204710|NCT01899729|472370590|FG002|Overall Study|Lack of Efficacy|2|||
131204711|NCT01899729|472370591|FG003|Overall Study|Lack of Efficacy|0|||
131204712|NCT01899729|472370592|FG004|Overall Study|Lack of Efficacy|1|||
131204713|NCT02646332|472370595|FG000|Overall Study|Lost to Follow-up|0|||
131204714|NCT02646332|472370596|FG001|Overall Study|Lost to Follow-up|3|||
131204715|NCT04490499|472370597|FG000|Overall Study|Withdrawal by Subject|2|||
131204716|NCT03125902|472370598|FG000|Overall Study|Adverse Event|0|||
131204717|NCT03125902|472370599|FG001|Overall Study|Adverse Event|1|||
131204718|NCT03125902|472370598|FG000|Overall Study|Death|119|||
131204719|NCT03125902|472370599|FG001|Overall Study|Death|229|||
131204720|NCT03125902|472370598|FG000|Overall Study|Lost to Follow-up|4|||
131204721|NCT03125902|472370599|FG001|Overall Study|Lost to Follow-up|13|||
131204722|NCT03125902|472370598|FG000|Overall Study|Other|0|||
131204723|NCT03125902|472370599|FG001|Overall Study|Other|4|||
131204724|NCT03125902|472370598|FG000|Overall Study|Physician Decision|2|||
131204725|NCT03125902|472370599|FG001|Overall Study|Physician Decision|1|||
131204726|NCT03125902|472370598|FG000|Overall Study|Progressive Disease|0|||
131204727|NCT03125902|472370599|FG001|Overall Study|Progressive Disease|3|||
131204728|NCT03125902|472370598|FG000|Overall Study|Study Terminated By Sponsor|74|||
131204729|NCT03125902|472370599|FG001|Overall Study|Study Terminated By Sponsor|143|||
131204730|NCT03125902|472370598|FG000|Overall Study|Withdrawal by Subject|21|||
131204731|NCT03125902|472370599|FG001|Overall Study|Withdrawal by Subject|37|||
131204732|NCT01657903|472370600|FG000|Overall Study|Lost to Follow-up|1|||
131204733|NCT01657903|472370600|FG000|Overall Study|Withdrawal by Subject|1|||
131204734|NCT01259388|472370602|FG000|Overall Study|Adverse Event|3|||
131204735|NCT01259388|472370603|FG001|Overall Study|Adverse Event|0|||
131204736|NCT01259388|472370602|FG000|Overall Study|Withdrawal by Subject|1|||
131204737|NCT01259388|472370603|FG001|Overall Study|Withdrawal by Subject|1|||
131204738|NCT01259388|472370602|FG000|Overall Study|Physician Decision|1|||
131204739|NCT01259388|472370603|FG001|Overall Study|Physician Decision|0|||
131204740|NCT02743494|472370604|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
131204741|NCT02743494|472370605|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
131204742|NCT02743494|472370604|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
131204743|NCT02743494|472370605|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
131204744|NCT02743494|472370604|FG000|Treatment Period|Completed treatment|229|||
131204745|NCT02743494|472370605|FG001|Treatment Period|Completed treatment|99|||
131204746|NCT02743494|472370604|FG000|Treatment Period|Disease recurrence|149|||
131204747|NCT02743494|472370605|FG001|Treatment Period|Disease recurrence|113|||
131204748|NCT02743494|472370604|FG000|Treatment Period|Study drug toxicity|57|||
131204749|NCT02743494|472370605|FG001|Treatment Period|Study drug toxicity|8|||
131204750|NCT02743494|472370604|FG000|Treatment Period|Death|1|||
131204751|NCT02743494|472370605|FG001|Treatment Period|Death|0|||
131204752|NCT02743494|472370604|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
131204753|NCT02743494|472370605|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
131204754|NCT02743494|472370604|FG000|Treatment Period|Participant request to discontinue treatment|30|||
131204755|NCT02743494|472370605|FG001|Treatment Period|Participant request to discontinue treatment|5|||
130734738|NCT01823835|470647408|FG004|Overall Study|Adverse Event|1|||
131204756|NCT02743494|472370604|FG000|Treatment Period|Participant withdrew consent|12|||
130734739|NCT01823835|470647409|FG005|Overall Study|Adverse Event|0|||
130734740|NCT01823835|470647410|FG006|Overall Study|Adverse Event|1|||
130734741|NCT01823835|470647411|FG007|Overall Study|Adverse Event|0|||
131204757|NCT02743494|472370605|FG001|Treatment Period|Participant withdrew consent|4|||
131204758|NCT02743494|472370604|FG000|Treatment Period|Lost to Follow-up|0|||
131204759|NCT02743494|472370605|FG001|Treatment Period|Lost to Follow-up|1|||
131204760|NCT02743494|472370604|FG000|Treatment Period|Poor/Non-compliance|1|||
131204761|NCT02743494|472370605|FG001|Treatment Period|Poor/Non-compliance|0|||
131204762|NCT02743494|472370604|FG000|Treatment Period|Other reasons|7|||
131204763|NCT02743494|472370605|FG001|Treatment Period|Other reasons|2|||
131204764|NCT00983827|472370608|FG000|Overall Study|Withdrawal by Subject|1|||
131204765|NCT01521494|472370609|FG000|Overall Study|Adverse Event|1|||
131204766|NCT01521494|472370610|FG001|Overall Study|Adverse Event|2|||
131204767|NCT01521494|472370611|FG002|Overall Study|Adverse Event|9|||
131204768|NCT01521494|472370612|FG003|Overall Study|Adverse Event|6|||
131204769|NCT01521494|472370613|FG004|Overall Study|Adverse Event|2|||
131204770|NCT01521494|472370609|FG000|Overall Study|Lack of Efficacy|0|||
131204771|NCT01521494|472370610|FG001|Overall Study|Lack of Efficacy|0|||
131204772|NCT01521494|472370611|FG002|Overall Study|Lack of Efficacy|0|||
131204773|NCT01521494|472370612|FG003|Overall Study|Lack of Efficacy|0|||
131204774|NCT01521494|472370613|FG004|Overall Study|Lack of Efficacy|2|||
131204775|NCT01521494|472370609|FG000|Overall Study|Withdrawal by Subject|1|||
131204776|NCT01521494|472370610|FG001|Overall Study|Withdrawal by Subject|1|||
131204777|NCT01521494|472370611|FG002|Overall Study|Withdrawal by Subject|0|||
131204778|NCT01521494|472370612|FG003|Overall Study|Withdrawal by Subject|2|||
131204779|NCT01521494|472370613|FG004|Overall Study|Withdrawal by Subject|0|||
131204780|NCT01521494|472370609|FG000|Overall Study|Decrease in serum phosphate|0|||
131204781|NCT01521494|472370610|FG001|Overall Study|Decrease in serum phosphate|2|||
131204782|NCT01521494|472370611|FG002|Overall Study|Decrease in serum phosphate|3|||
131204783|NCT01521494|472370612|FG003|Overall Study|Decrease in serum phosphate|12|||
131204784|NCT01521494|472370613|FG004|Overall Study|Decrease in serum phosphate|0|||
131204785|NCT01521494|472370609|FG000|Overall Study|Decrease in serum calcium|0|||
131204786|NCT01521494|472370610|FG001|Overall Study|Decrease in serum calcium|0|||
131204787|NCT01521494|472370611|FG002|Overall Study|Decrease in serum calcium|0|||
131204788|NCT01521494|472370612|FG003|Overall Study|Decrease in serum calcium|1|||
131204789|NCT01521494|472370613|FG004|Overall Study|Decrease in serum calcium|1|||
131204790|NCT01521494|472370609|FG000|Overall Study|Physician Decision|0|||
131204791|NCT01521494|472370610|FG001|Overall Study|Physician Decision|0|||
131204792|NCT01521494|472370611|FG002|Overall Study|Physician Decision|0|||
131204793|NCT01521494|472370612|FG003|Overall Study|Physician Decision|0|||
131204794|NCT01521494|472370613|FG004|Overall Study|Physician Decision|2|||
131204795|NCT01888367|472370614|FG000|Overall Study|Physician Decision|3|||
131204796|NCT01888367|472370615|FG001|Overall Study|Physician Decision|4|||
131204797|NCT01888367|472370616|FG002|Overall Study|Physician Decision|2|||
131204798|NCT01888367|472370614|FG000|Overall Study|Death|2|||
131204799|NCT01888367|472370615|FG001|Overall Study|Death|0|||
131204800|NCT01888367|472370616|FG002|Overall Study|Death|1|||
131204801|NCT01888367|472370614|FG000|Overall Study|Withdrawal by Subject|1|||
131204802|NCT01888367|472370615|FG001|Overall Study|Withdrawal by Subject|0|||
131204803|NCT01888367|472370616|FG002|Overall Study|Withdrawal by Subject|1|||
131204804|NCT01888367|472370614|FG000|Overall Study|Lost to Follow-up|1|||
131204805|NCT01888367|472370615|FG001|Overall Study|Lost to Follow-up|1|||
131204806|NCT01888367|472370616|FG002|Overall Study|Lost to Follow-up|0|||
131204807|NCT01888367|472370614|FG000|Overall Study|Protocol Violation|0|||
131204808|NCT01888367|472370615|FG001|Overall Study|Protocol Violation|0|||
131204809|NCT01888367|472370616|FG002|Overall Study|Protocol Violation|1|||
131204810|NCT01888367|472370614|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
131204811|NCT01888367|472370615|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
131204812|NCT01888367|472370616|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
131204813|NCT01854918|472370617|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
131204814|NCT01854918|472370618|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
131204815|NCT01854918|472370617|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
131204816|NCT01854918|472370618|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
131204817|NCT01854918|472370617|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
131204818|NCT01854918|472370618|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
131204819|NCT01854918|472370617|FG000|SOC-controlled Period (Year 1)|Death|5|||
131204820|NCT01854918|472370618|FG001|SOC-controlled Period (Year 1)|Death|5|||
131204821|NCT01854918|472370617|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
131204822|NCT01854918|472370618|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
131204823|NCT01854918|472370617|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
131204824|NCT01854918|472370618|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
131204825|NCT01854918|472370617|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
131204826|NCT01854918|472370618|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
131204827|NCT01854918|472370617|FG000|All-IP Period (Years 2 and 3)|Death|5|||
131204828|NCT01854918|472370618|FG001|All-IP Period (Years 2 and 3)|Death|16|||
131204829|NCT02146352|472370619|FG000|Overall Study|Death|1|||
131204830|NCT02146352|472370619|FG000|Overall Study|Patient entered hospice care|1|||
131204831|NCT03969589|472370622|FG000|Overall Study|Lost to Follow-up|3|||
131204832|NCT03969589|472370623|FG001|Overall Study|Lost to Follow-up|2|||
131204833|NCT03969589|472370622|FG000|Overall Study|Declined Follow-Up|0|||
131204834|NCT03969589|472370623|FG001|Overall Study|Declined Follow-Up|1|||
131204835|NCT00517634|472370624|FG000|Second Treatment Period|Withdrawal by Subject|0|||
131204836|NCT00517634|472370625|FG001|Second Treatment Period|Withdrawal by Subject|0|||
131204837|NCT00517634|472370626|FG002|Second Treatment Period|Withdrawal by Subject|0|||
131204838|NCT00517634|472370627|FG003|Second Treatment Period|Withdrawal by Subject|0|||
131204839|NCT00517634|472370628|FG004|Second Treatment Period|Withdrawal by Subject|1|||
131204840|NCT00517634|472370629|FG005|Second Treatment Period|Withdrawal by Subject|0|||
131204841|NCT03091920|472370632|FG000|Overall Study|Adverse Event|0|||
131204842|NCT03091920|472370633|FG001|Overall Study|Adverse Event|1|||
131204843|NCT03091920|472370634|FG002|Overall Study|Adverse Event|0|||
131204844|NCT03143855|472370635|FG000|Overall Study|Withdrawal by Subject|4|||
131204845|NCT03143855|472370636|FG001|Overall Study|Withdrawal by Subject|3|||
131204846|NCT03143855|472370635|FG000|Overall Study|Protocol Violation|1|||
131204847|NCT03143855|472370636|FG001|Overall Study|Protocol Violation|0|||
131204848|NCT03143855|472370635|FG000|Overall Study|Participant experienced withdrawal|0|||
131204849|NCT03143855|472370636|FG001|Overall Study|Participant experienced withdrawal|1|||
131204850|NCT00453349|472370637|FG000|Randomized|Adverse Event|12|||
131204851|NCT00453349|472370638|FG001|Randomized|Adverse Event|11|||
131204852|NCT00453349|472370637|FG000|Randomized|Lack of Efficacy|2|||
131204853|NCT00453349|472370638|FG001|Randomized|Lack of Efficacy|1|||
131204854|NCT00453349|472370637|FG000|Randomized|Lost to Follow-up|7|||
131204855|NCT00453349|472370638|FG001|Randomized|Lost to Follow-up|5|||
131204856|NCT00453349|472370637|FG000|Randomized|Protocol Violation|1|||
131204857|NCT00453349|472370638|FG001|Randomized|Protocol Violation|1|||
131204858|NCT00453349|472370637|FG000|Randomized|Withdrawal by Subject|3|||
131204859|NCT00453349|472370638|FG001|Randomized|Withdrawal by Subject|5|||
131204860|NCT00453349|472370637|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
131204861|NCT00453349|472370638|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
131204862|NCT00453349|472370637|FG000|Completed Study|Adverse Event|12|||
131204863|NCT00453349|472370638|FG001|Completed Study|Adverse Event|11|||
131204864|NCT00453349|472370637|FG000|Completed Study|Lack of Efficacy|2|||
131204865|NCT00453349|472370638|FG001|Completed Study|Lack of Efficacy|1|||
131204866|NCT00453349|472370637|FG000|Completed Study|Lost to Follow-up|7|||
131204867|NCT00453349|472370638|FG001|Completed Study|Lost to Follow-up|5|||
131204868|NCT00453349|472370637|FG000|Completed Study|Protocol Violation|1|||
131204869|NCT00453349|472370638|FG001|Completed Study|Protocol Violation|1|||
131204870|NCT00453349|472370637|FG000|Completed Study|Withdrawal by Subject|3|||
131204871|NCT00453349|472370638|FG001|Completed Study|Withdrawal by Subject|5|||
131204872|NCT00453349|472370637|FG000|Completed Study|Lost to follow up after study treatment|2|||
131204873|NCT00453349|472370638|FG001|Completed Study|Lost to follow up after study treatment|11|||
131204874|NCT01513460|472370641|FG000|Overall Study|Death|0|||
131204875|NCT01513460|472370642|FG001|Overall Study|Death|0|||
131204876|NCT01513460|472370643|FG002|Overall Study|Death|1|||
131204877|NCT01513460|472370641|FG000|Overall Study|Lost to Follow-up|0|||
131204878|NCT01513460|472370642|FG001|Overall Study|Lost to Follow-up|0|||
131204879|NCT01513460|472370643|FG002|Overall Study|Lost to Follow-up|2|||
131204880|NCT01513460|472370641|FG000|Overall Study|Abnormal laboratory value|1|||
131204881|NCT01513460|472370642|FG001|Overall Study|Abnormal laboratory value|0|||
131204882|NCT01513460|472370643|FG002|Overall Study|Abnormal laboratory value|1|||
131204883|NCT01513460|472370641|FG000|Overall Study|Lack of Efficacy|1|||
131204884|NCT01513460|472370642|FG001|Overall Study|Lack of Efficacy|2|||
131204885|NCT01513460|472370643|FG002|Overall Study|Lack of Efficacy|5|||
131204886|NCT01513460|472370641|FG000|Overall Study|Protocol deviations|3|||
131204887|NCT01513460|472370642|FG001|Overall Study|Protocol deviations|4|||
131204888|NCT01513460|472370643|FG002|Overall Study|Protocol deviations|3|||
131204889|NCT01513460|472370641|FG000|Overall Study|Withdrawal by Subject|7|||
131204890|NCT01513460|472370642|FG001|Overall Study|Withdrawal by Subject|8|||
131204891|NCT01513460|472370643|FG002|Overall Study|Withdrawal by Subject|21|||
131204892|NCT01513460|472370641|FG000|Overall Study|Adverse Event|16|||
131204893|NCT01513460|472370642|FG001|Overall Study|Adverse Event|18|||
131204894|NCT01513460|472370643|FG002|Overall Study|Adverse Event|23|||
131204895|NCT01513460|472370641|FG000|Overall Study|Abnormal test procedure|1|||
131204896|NCT01513460|472370642|FG001|Overall Study|Abnormal test procedure|0|||
131204897|NCT01513460|472370643|FG002|Overall Study|Abnormal test procedure|0|||
131204898|NCT00489216|472370647|FG000|Overall Study|Adverse Event|1|||
131204899|NCT00939094|472370648|FG000|Overall Study|Adverse Event|9|||
131204900|NCT00939094|472370649|FG001|Overall Study|Adverse Event|0|||
131204901|NCT00939094|472370648|FG000|Overall Study|Withdrawal by Subject|1|||
131204902|NCT00939094|472370649|FG001|Overall Study|Withdrawal by Subject|6|||
131204903|NCT00939094|472370648|FG000|Overall Study|Lost to Follow-up|1|||
131204904|NCT00939094|472370649|FG001|Overall Study|Lost to Follow-up|1|||
131204905|NCT00939094|472370648|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
131204906|NCT00939094|472370649|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130734742|NCT01823835|470647412|FG008|Overall Study|Adverse Event|0|||
131204907|NCT00939094|472370648|FG000|Overall Study|Severe non-compliance to protocol|0|||
131204908|NCT00939094|472370649|FG001|Overall Study|Severe non-compliance to protocol|1|||
131204909|NCT00939094|472370648|FG000|Overall Study|Study stopped by sponsor|0|||
131204910|NCT00939094|472370649|FG001|Overall Study|Study stopped by sponsor|2|||
131204911|NCT00939094|472370648|FG000|Overall Study|Abnormal ECG findings|1|||
131204912|NCT00939094|472370649|FG001|Overall Study|Abnormal ECG findings|0|||
131204913|NCT01906489|472370650|FG000|Overall Study|Adverse Event|10|||
131204914|NCT01906489|472370651|FG001|Overall Study|Adverse Event|3|||
131204915|NCT01906489|472370650|FG000|Overall Study|Worsening of CKD|6|||
131204916|NCT01906489|472370651|FG001|Overall Study|Worsening of CKD|4|||
131204917|NCT01906489|472370650|FG000|Overall Study|Withdrawal by Subject|5|||
131204918|NCT01906489|472370651|FG001|Overall Study|Withdrawal by Subject|0|||
131204919|NCT01906489|472370650|FG000|Overall Study|Worsening of Anemia|1|||
131204920|NCT01906489|472370651|FG001|Overall Study|Worsening of Anemia|0|||
131204921|NCT01906489|472370650|FG000|Overall Study|Protocol Violation|0|||
131204922|NCT01906489|472370651|FG001|Overall Study|Protocol Violation|1|||
131204923|NCT01906489|472370650|FG000|Overall Study|Non- Compliance|1|||
131204924|NCT01906489|472370651|FG001|Overall Study|Non- Compliance|0|||
131204925|NCT01906489|472370650|FG000|Overall Study|Sponsor Decision|1|||
131204926|NCT01906489|472370651|FG001|Overall Study|Sponsor Decision|0|||
131204927|NCT01906489|472370650|FG000|Overall Study|Lost to Follow-up|1|||
131204928|NCT01906489|472370651|FG001|Overall Study|Lost to Follow-up|1|||
131204929|NCT01906489|472370650|FG000|Overall Study|Other|1|||
131204930|NCT01906489|472370651|FG001|Overall Study|Other|0|||
131204931|NCT01884675|472372392|FG000|Overall Study|Study closed/terminated|3|||
131204932|NCT01884675|472372393|FG001|Overall Study|Study closed/terminated|2|||
131204933|NCT02361307|472372394|FG000|Overall Study|Unstable medical condition.|0|||
131204934|NCT02361307|472372395|FG001|Overall Study|Unstable medical condition.|1|||
131204935|NCT01682876|472372397|FG000|Overall Study|Administrative reason|4|||
131204936|NCT01682876|472372398|FG001|Overall Study|Administrative reason|4|||
131204937|NCT01682876|472372399|FG002|Overall Study|Administrative reason|0|||
131204938|NCT01682876|472372400|FG003|Overall Study|Administrative reason|3|||
131204939|NCT01682876|472372397|FG000|Overall Study|Adverse Event|0|||
131204940|NCT01682876|472372398|FG001|Overall Study|Adverse Event|0|||
131204941|NCT01682876|472372399|FG002|Overall Study|Adverse Event|0|||
131204942|NCT01682876|472372400|FG003|Overall Study|Adverse Event|1|||
131204943|NCT01682876|472372397|FG000|Overall Study|Lost to Follow-up|11|||
131204944|NCT01682876|472372398|FG001|Overall Study|Lost to Follow-up|15|||
131204945|NCT01682876|472372399|FG002|Overall Study|Lost to Follow-up|9|||
131204946|NCT01682876|472372400|FG003|Overall Study|Lost to Follow-up|11|||
131204947|NCT01682876|472372397|FG000|Overall Study|Protocol Violation|1|||
131204948|NCT01682876|472372398|FG001|Overall Study|Protocol Violation|1|||
131204949|NCT01682876|472372399|FG002|Overall Study|Protocol Violation|1|||
131204950|NCT01682876|472372400|FG003|Overall Study|Protocol Violation|1|||
131204951|NCT01682876|472372397|FG000|Overall Study|Withdrawal by Subject|4|||
131204952|NCT01682876|472372398|FG001|Overall Study|Withdrawal by Subject|0|||
131204953|NCT01682876|472372399|FG002|Overall Study|Withdrawal by Subject|0|||
131204954|NCT01682876|472372400|FG003|Overall Study|Withdrawal by Subject|2|||
131204955|NCT01682876|472372397|FG000|Overall Study|Other|1|||
131204956|NCT01682876|472372398|FG001|Overall Study|Other|0|||
131204957|NCT01682876|472372399|FG002|Overall Study|Other|1|||
131204958|NCT01682876|472372400|FG003|Overall Study|Other|1|||
131204959|NCT02534324|472372404|FG000|Overall Study|Protocol Violation|4|||
131204960|NCT02534324|472372405|FG001|Overall Study|Protocol Violation|1|||
131204961|NCT02534324|472372404|FG000|Overall Study|Lost to Follow-up|20|||
131204962|NCT02534324|472372405|FG001|Overall Study|Lost to Follow-up|7|||
131204963|NCT02534324|472372404|FG000|Overall Study|Adverse Event|1|||
131204964|NCT02534324|472372405|FG001|Overall Study|Adverse Event|0|||
131204965|NCT01459016|472372408|FG000|Overall Study|Withdrawal by Subject|11|||
131204966|NCT01459016|472372408|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
131204967|NCT00303602|472372412|FG000|Overall Study|Adverse Event|2|||
131204968|NCT00303602|472372413|FG001|Overall Study|Adverse Event|2|||
131204969|NCT00303602|472372412|FG000|Overall Study|Withdrawal by Subject|5|||
130734743|NCT01823835|470647413|FG009|Overall Study|Adverse Event|0|||
130734744|NCT01823835|470647414|FG010|Overall Study|Adverse Event|1|||
131204970|NCT00303602|472372413|FG001|Overall Study|Withdrawal by Subject|6|||
131204971|NCT00303602|472372412|FG000|Overall Study|Lost to Follow-up|5|||
131204972|NCT00303602|472372413|FG001|Overall Study|Lost to Follow-up|2|||
131204973|NCT00303602|472372412|FG000|Overall Study|Protocol entry criteria not met|2|||
131204974|NCT00303602|472372413|FG001|Overall Study|Protocol entry criteria not met|2|||
131204975|NCT00303602|472372412|FG000|Overall Study|Physician Decision|2|||
131204976|NCT00303602|472372413|FG001|Overall Study|Physician Decision|1|||
131204977|NCT00303602|472372412|FG000|Overall Study|Noncompliance|2|||
131204978|NCT00303602|472372413|FG001|Overall Study|Noncompliance|2|||
131204979|NCT00303602|472372412|FG000|Overall Study|Protocol Violation|1|||
131204980|NCT00303602|472372413|FG001|Overall Study|Protocol Violation|0|||
131204981|NCT00240331|472372414|FG000|Overall Study|Withdrawal by Subject|125|||
130734745|NCT01823835|470647415|FG011|Overall Study|Adverse Event|2|||
130734746|NCT01823835|470647416|FG012|Overall Study|Adverse Event|0|||
130734747|NCT01823835|470647417|FG013|Overall Study|Adverse Event|0|||
130734748|NCT01823835|470647418|FG014|Overall Study|Adverse Event|0|||
130734749|NCT01823835|470647404|FG000|Overall Study|Physician Decision|0|||
130734750|NCT01823835|470647405|FG001|Overall Study|Physician Decision|0|||
130734751|NCT01823835|470647406|FG002|Overall Study|Physician Decision|0|||
130734752|NCT01823835|470647407|FG003|Overall Study|Physician Decision|0|||
130734753|NCT01823835|470647408|FG004|Overall Study|Physician Decision|0|||
130734754|NCT01823835|470647409|FG005|Overall Study|Physician Decision|0|||
130734755|NCT01823835|470647410|FG006|Overall Study|Physician Decision|0|||
130734756|NCT01823835|470647411|FG007|Overall Study|Physician Decision|0|||
130734757|NCT01823835|470647412|FG008|Overall Study|Physician Decision|0|||
130734758|NCT01823835|470647413|FG009|Overall Study|Physician Decision|0|||
130734759|NCT01823835|470647414|FG010|Overall Study|Physician Decision|0|||
130734760|NCT01823835|470647415|FG011|Overall Study|Physician Decision|2|||
130734761|NCT01823835|470647416|FG012|Overall Study|Physician Decision|0|||
130734762|NCT01823835|470647417|FG013|Overall Study|Physician Decision|0|||
130734763|NCT01823835|470647418|FG014|Overall Study|Physician Decision|0|||
130734764|NCT01823835|470647404|FG000|Overall Study|Progressive Disease|3|||
130734765|NCT01823835|470647405|FG001|Overall Study|Progressive Disease|4|||
130734766|NCT01823835|470647406|FG002|Overall Study|Progressive Disease|3|||
130734767|NCT01823835|470647407|FG003|Overall Study|Progressive Disease|6|||
130734768|NCT01823835|470647408|FG004|Overall Study|Progressive Disease|4|||
130734769|NCT01823835|470647409|FG005|Overall Study|Progressive Disease|6|||
131204982|NCT00240331|472372415|FG001|Overall Study|Withdrawal by Subject|132|||
131204983|NCT00240331|472372414|FG000|Overall Study|Option selected by investigator|1|||
131204984|NCT00240331|472372415|FG001|Overall Study|Option selected by investigator|2|||
131204985|NCT00313716|472372422|FG000|Overall Study|Death|3|||
131204986|NCT00313716|472372423|FG001|Overall Study|Death|2|||
131204987|NCT00313716|472372424|FG002|Overall Study|Death|9|||
131204988|NCT00313716|472372425|FG003|Overall Study|Death|3|||
131204989|NCT00313716|472372426|FG004|Overall Study|Death|5|||
131204990|NCT00313716|472372427|FG005|Overall Study|Death|9|||
131204991|NCT00313716|472372422|FG000|Overall Study|Lost to Follow-up|2|||
131204992|NCT00313716|472372423|FG001|Overall Study|Lost to Follow-up|5|||
131204993|NCT00313716|472372424|FG002|Overall Study|Lost to Follow-up|2|||
131204994|NCT00313716|472372425|FG003|Overall Study|Lost to Follow-up|1|||
131204995|NCT00313716|472372426|FG004|Overall Study|Lost to Follow-up|0|||
131204996|NCT00313716|472372427|FG005|Overall Study|Lost to Follow-up|4|||
131204997|NCT00313716|472372422|FG000|Overall Study|Withdrawal by Subject|0|||
131204998|NCT00313716|472372423|FG001|Overall Study|Withdrawal by Subject|1|||
131204999|NCT00313716|472372424|FG002|Overall Study|Withdrawal by Subject|1|||
131205000|NCT00313716|472372425|FG003|Overall Study|Withdrawal by Subject|0|||
131205001|NCT00313716|472372426|FG004|Overall Study|Withdrawal by Subject|1|||
131205002|NCT00313716|472372427|FG005|Overall Study|Withdrawal by Subject|0|||
131205003|NCT01491802|472372428|FG000|Overall Study|Adverse Event|1|||
130734770|NCT01823835|470647410|FG006|Overall Study|Progressive Disease|5|||
130734771|NCT01823835|470647411|FG007|Overall Study|Progressive Disease|3|||
130734772|NCT01823835|470647412|FG008|Overall Study|Progressive Disease|3|||
130734773|NCT01823835|470647413|FG009|Overall Study|Progressive Disease|18|||
130734774|NCT01823835|470647414|FG010|Overall Study|Progressive Disease|8|||
130734775|NCT01823835|470647415|FG011|Overall Study|Progressive Disease|46|||
131205004|NCT01491802|472372429|FG001|Overall Study|Adverse Event|1|||
131205005|NCT01491802|472372428|FG000|Overall Study|Withdrawal by Subject|0|||
131205006|NCT01491802|472372429|FG001|Overall Study|Withdrawal by Subject|1|||
130734776|NCT01823835|470647416|FG012|Overall Study|Progressive Disease|18|||
130734777|NCT01823835|470647417|FG013|Overall Study|Progressive Disease|4|||
131205007|NCT00663208|472372432|FG000|Treatment Period|Lost to Follow-up|0|||
131205008|NCT00663208|472372433|FG001|Treatment Period|Lost to Follow-up|1|||
131205009|NCT00663208|472372434|FG002|Treatment Period|Lost to Follow-up|0|||
131205010|NCT00663208|472372435|FG003|Treatment Period|Lost to Follow-up|0|||
131205011|NCT00663208|472372436|FG004|Treatment Period|Lost to Follow-up|0|||
131205012|NCT00663208|472372437|FG005|Treatment Period|Lost to Follow-up|0|||
131205013|NCT00663208|472372438|FG006|Treatment Period|Lost to Follow-up|0|||
131205014|NCT00663208|472372432|FG000|Follow-up Period|Lost to Follow-up|2|||
131205015|NCT00663208|472372433|FG001|Follow-up Period|Lost to Follow-up|0|||
131205016|NCT00663208|472372434|FG002|Follow-up Period|Lost to Follow-up|3|||
131205017|NCT00663208|472372435|FG003|Follow-up Period|Lost to Follow-up|2|||
131205018|NCT00663208|472372436|FG004|Follow-up Period|Lost to Follow-up|0|||
131205019|NCT00663208|472372437|FG005|Follow-up Period|Lost to Follow-up|0|||
131205020|NCT00663208|472372438|FG006|Follow-up Period|Lost to Follow-up|0|||
131205021|NCT00663208|472372432|FG000|Follow-up Period|Other reason|1|||
131205022|NCT00663208|472372433|FG001|Follow-up Period|Other reason|0|||
131205023|NCT00663208|472372434|FG002|Follow-up Period|Other reason|0|||
131205024|NCT00663208|472372435|FG003|Follow-up Period|Other reason|0|||
131205025|NCT00663208|472372436|FG004|Follow-up Period|Other reason|0|||
131205026|NCT00663208|472372437|FG005|Follow-up Period|Other reason|0|||
131205027|NCT00663208|472372438|FG006|Follow-up Period|Other reason|1|||
131205028|NCT04067310|472372441|FG000|Overall Study|Physician Decision|2|||
131205029|NCT04067310|472372442|FG001|Overall Study|Physician Decision|6|||
131205030|NCT04067310|472372441|FG000|Overall Study|Lost to Follow-up|0|||
131205031|NCT04067310|472372442|FG001|Overall Study|Lost to Follow-up|1|||
131205032|NCT04067310|472372441|FG000|Overall Study|Withdrawal by Subject|3|||
131205033|NCT04067310|472372442|FG001|Overall Study|Withdrawal by Subject|0|||
131205034|NCT01041027|472372443|FG000|Overall Study|Withdrawal by Subject|2|||
131205035|NCT01041027|472372443|FG000|Overall Study|Protocol Violation|1|||
131205036|NCT01041027|472372443|FG000|Overall Study|Delayed Radiation Therapy|1|||
131205037|NCT01041027|472372443|FG000|Overall Study|Adverse Event|4|||
131205038|NCT01249404|472372444|FG000|Overall Study|Study treatment not received|0|||
131205039|NCT01249404|472372445|FG001|Overall Study|Study treatment not received|1|||
131205040|NCT01249404|472372446|FG002|Overall Study|Study treatment not received|2|||
131205041|NCT01249404|472372444|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
131205042|NCT01249404|472372445|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
131205043|NCT01249404|472372446|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
131205044|NCT01249404|472372444|FG000|Overall Study|Adverse Event|2|||
131205045|NCT01249404|472372445|FG001|Overall Study|Adverse Event|2|||
131205046|NCT01249404|472372446|FG002|Overall Study|Adverse Event|2|||
131205047|NCT01249404|472372444|FG000|Overall Study|Withdrawal by Subject|2|||
131205048|NCT01249404|472372445|FG001|Overall Study|Withdrawal by Subject|2|||
131205049|NCT01249404|472372446|FG002|Overall Study|Withdrawal by Subject|0|||
131205050|NCT01249404|472372444|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
131205051|NCT01249404|472372445|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
131205052|NCT01249404|472372446|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
131205053|NCT01249404|472372444|FG000|Overall Study|Non compliance to visit schedule|0|||
131205054|NCT01249404|472372445|FG001|Overall Study|Non compliance to visit schedule|1|||
131205055|NCT01249404|472372446|FG002|Overall Study|Non compliance to visit schedule|0|||
131205056|NCT02927990|472372447|FG000|Overall Study|Protocol Violation|4|||
131205057|NCT02927990|472372447|FG000|Overall Study|Physician Decision|9|||
131205058|NCT02927990|472372447|FG000|Overall Study|Room switched and therefore no study device available|15|||
131205059|NCT02927990|472372447|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
131205060|NCT00960323|472372448|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
130734778|NCT01823835|470647418|FG014|Overall Study|Progressive Disease|6|||
131205061|NCT02146274|472372449|FG000|Overall Study|Protocol Violation|73|||
131205062|NCT03730987|472372456|FG000|Overall Study|Lost to Follow-up|2|||
131205063|NCT03730987|472372457|FG001|Overall Study|Lost to Follow-up|0|||
131205064|NCT03730987|472372458|FG002|Overall Study|Lost to Follow-up|2|||
131205065|NCT03730987|472372459|FG003|Overall Study|Lost to Follow-up|0|||
131205066|NCT01191190|472372460|FG000|Overall Study|Withdrawal by Subject|1|||
131205067|NCT01856920|472372478|FG000|Overall Study|Disease Progression On Study|3|||
131205068|NCT01856920|472372479|FG001|Overall Study|Disease Progression On Study|4|||
130734779|NCT01823835|470647404|FG000|Overall Study|Study Termination|0|||
130784703|NCT00922636|470841144|FG001|Overall Study|Lost to Follow-up|2|||
130784704|NCT00922636|470841145|FG002|Overall Study|Lost to Follow-up|2|||
130784705|NCT00922636|470841146|FG003|Overall Study|Lost to Follow-up|2|||
130784706|NCT00922636|470841147|FG004|Overall Study|Lost to Follow-up|4|||
130784707|NCT00557466|470841148|FG000|Overall Study|Adverse Event|3|||
130784708|NCT00557466|470841149|FG001|Overall Study|Adverse Event|1|||
130784709|NCT00557466|470841150|FG002|Overall Study|Adverse Event|4|||
130784710|NCT00557466|470841151|FG003|Overall Study|Adverse Event|1|||
130784711|NCT00557466|470841152|FG004|Overall Study|Adverse Event|2|||
130784712|NCT00557466|470841153|FG005|Overall Study|Adverse Event|4|||
130784713|NCT00557466|470841148|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130784714|NCT00557466|470841149|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130784715|NCT00557466|470841150|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130784716|NCT00557466|470841151|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130784717|NCT00557466|470841152|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130784718|NCT00557466|470841153|FG005|Overall Study|Abnormal laboratory value(s)|0|||
130784719|NCT00557466|470841148|FG000|Overall Study|Protocol deviation|0|||
130784720|NCT00557466|470841149|FG001|Overall Study|Protocol deviation|1|||
130784721|NCT00557466|470841150|FG002|Overall Study|Protocol deviation|0|||
130784722|NCT00557466|470841151|FG003|Overall Study|Protocol deviation|2|||
130784723|NCT00557466|470841152|FG004|Overall Study|Protocol deviation|0|||
130784724|NCT00557466|470841153|FG005|Overall Study|Protocol deviation|0|||
130784725|NCT00557466|470841148|FG000|Overall Study|Subject withdrew consent|0|||
130784726|NCT00557466|470841149|FG001|Overall Study|Subject withdrew consent|0|||
131205069|NCT01856920|472372478|FG000|Overall Study|Disease Progression before Treatment|1|||
131205070|NCT01856920|472372479|FG001|Overall Study|Disease Progression before Treatment|0|||
131205071|NCT01856920|472372478|FG000|Overall Study|Ineligible|0|||
131205072|NCT01856920|472372479|FG001|Overall Study|Ineligible|1|||
131205073|NCT01856920|472372478|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
131205074|NCT01856920|472372479|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
131205075|NCT01856920|472372478|FG000|Overall Study|Refused further Treatment|5|||
131205076|NCT01856920|472372479|FG001|Overall Study|Refused further Treatment|1|||
131205077|NCT01856920|472372478|FG000|Overall Study|Other Reasons|0|||
131205078|NCT01856920|472372479|FG001|Overall Study|Other Reasons|1|||
131205079|NCT01856920|472372478|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
131205080|NCT01856920|472372479|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
131205081|NCT02545270|472372480|FG000|Overall Study|technical difficulties|0|||
131205082|NCT02545270|472372481|FG001|Overall Study|technical difficulties|1|||
131205083|NCT02545270|472372482|FG002|Overall Study|technical difficulties|0|||
131205084|NCT02545270|472372480|FG000|Overall Study|Videos being too similar to other|0|||
131205085|NCT02545270|472372481|FG001|Overall Study|Videos being too similar to other|0|||
131205086|NCT02545270|472372482|FG002|Overall Study|Videos being too similar to other|2|||
131205087|NCT01220024|472372489|FG000|Overall Study|Lost to Follow-up|1|||
131205088|NCT01220024|472372490|FG001|Overall Study|Lost to Follow-up|1|||
131205089|NCT00174460|472372491|FG000|Overall Study|Withdrawal by Subject|0|||
131205090|NCT00174460|472372492|FG001|Overall Study|Withdrawal by Subject|1|||
131205091|NCT00579059|472372495|FG000|Overall Study|Study Canceled at 1 Year|21|||
131205092|NCT00579059|472372496|FG001|Overall Study|Study Canceled at 1 Year|10|||
131205093|NCT00779506|472372498|FG000|Overall Study|Screening Failed|2|||
131205094|NCT00779506|472372498|FG000|Overall Study|Adverse Event|4|||
131205095|NCT00779506|472372498|FG000|Overall Study|Lack of Efficacy|11|||
131205096|NCT00779506|472372498|FG000|Overall Study|Protocol Violation|5|||
131205097|NCT00779506|472372498|FG000|Overall Study|Withdrawal by Subject|6|||
130734780|NCT01823835|470647405|FG001|Overall Study|Study Termination|0|||
130734781|NCT01823835|470647406|FG002|Overall Study|Study Termination|0|||
130734782|NCT01823835|470647407|FG003|Overall Study|Study Termination|0|||
130734783|NCT01823835|470647408|FG004|Overall Study|Study Termination|1|||
130734784|NCT01823835|470647409|FG005|Overall Study|Study Termination|0|||
131205098|NCT00779506|472372498|FG000|Overall Study|Lost to Follow-up|1|||
131205099|NCT04047472|472372499|FG000|Overall Study|Adverse Event|3|||
131205100|NCT04047472|472372500|FG001|Overall Study|Adverse Event|3|||
131205101|NCT04047472|472372499|FG000|Overall Study|Death|0|||
131205102|NCT04047472|472372500|FG001|Overall Study|Death|1|||
131205103|NCT04047472|472372499|FG000|Overall Study|Lost to Follow-up|1|||
131205104|NCT04047472|472372500|FG001|Overall Study|Lost to Follow-up|0|||
131205105|NCT04047472|472372499|FG000|Overall Study|Physician Decision|1|||
131205106|NCT04047472|472372500|FG001|Overall Study|Physician Decision|2|||
131205107|NCT04047472|472372499|FG000|Overall Study|Protocol Violation|1|||
131205108|NCT04047472|472372500|FG001|Overall Study|Protocol Violation|0|||
131205109|NCT04047472|472372499|FG000|Overall Study|Withdrawal by Subject|10|||
131205110|NCT04047472|472372500|FG001|Overall Study|Withdrawal by Subject|10|||
131205111|NCT02030067|472372501|FG000|Overall Study|Disease Progression|1|||
131205112|NCT02030067|472372502|FG001|Overall Study|Disease Progression|1|||
131205113|NCT02030067|472372503|FG002|Overall Study|Disease Progression|2|||
131205114|NCT02030067|472372504|FG003|Overall Study|Disease Progression|2|||
131205115|NCT02030067|472372505|FG004|Overall Study|Disease Progression|3|||
131205116|NCT02030067|472372506|FG005|Overall Study|Disease Progression|2|||
131205117|NCT02030067|472372507|FG006|Overall Study|Disease Progression|3|||
131205118|NCT02030067|472372508|FG007|Overall Study|Disease Progression|3|||
131205119|NCT02030067|472372509|FG008|Overall Study|Disease Progression|4|||
131205120|NCT02030067|472372510|FG009|Overall Study|Disease Progression|3|||
131205121|NCT02030067|472372511|FG010|Overall Study|Disease Progression|7|||
131205122|NCT02030067|472372512|FG011|Overall Study|Disease Progression|2|||
131205123|NCT02030067|472372513|FG012|Overall Study|Disease Progression|59|||
131205124|NCT02030067|472372501|FG000|Overall Study|Withdrawal by Subject|0|||
131205125|NCT02030067|472372502|FG001|Overall Study|Withdrawal by Subject|0|||
131205126|NCT02030067|472372503|FG002|Overall Study|Withdrawal by Subject|0|||
131205127|NCT02030067|472372504|FG003|Overall Study|Withdrawal by Subject|1|||
131205128|NCT02030067|472372505|FG004|Overall Study|Withdrawal by Subject|0|||
131205129|NCT02030067|472372506|FG005|Overall Study|Withdrawal by Subject|0|||
131205130|NCT02030067|472372507|FG006|Overall Study|Withdrawal by Subject|0|||
131205131|NCT02030067|472372508|FG007|Overall Study|Withdrawal by Subject|1|||
131205132|NCT02030067|472372509|FG008|Overall Study|Withdrawal by Subject|0|||
131205133|NCT02030067|472372510|FG009|Overall Study|Withdrawal by Subject|0|||
131205134|NCT02030067|472372511|FG010|Overall Study|Withdrawal by Subject|3|||
131205135|NCT02030067|472372512|FG011|Overall Study|Withdrawal by Subject|0|||
131205136|NCT02030067|472372513|FG012|Overall Study|Withdrawal by Subject|6|||
131205137|NCT02030067|472372501|FG000|Overall Study|Physician Decision|0|||
131205138|NCT02030067|472372502|FG001|Overall Study|Physician Decision|0|||
131205139|NCT02030067|472372503|FG002|Overall Study|Physician Decision|0|||
131205140|NCT02030067|472372504|FG003|Overall Study|Physician Decision|0|||
131205141|NCT02030067|472372505|FG004|Overall Study|Physician Decision|0|||
131205142|NCT02030067|472372506|FG005|Overall Study|Physician Decision|0|||
131205143|NCT02030067|472372507|FG006|Overall Study|Physician Decision|0|||
131205144|NCT02030067|472372508|FG007|Overall Study|Physician Decision|0|||
131205145|NCT02030067|472372509|FG008|Overall Study|Physician Decision|0|||
131205146|NCT02030067|472372510|FG009|Overall Study|Physician Decision|0|||
131205147|NCT02030067|472372511|FG010|Overall Study|Physician Decision|1|||
131205148|NCT02030067|472372512|FG011|Overall Study|Physician Decision|0|||
131205149|NCT02030067|472372513|FG012|Overall Study|Physician Decision|3|||
131205150|NCT02030067|472372501|FG000|Overall Study|other reasons|0|||
131205151|NCT02030067|472372502|FG001|Overall Study|other reasons|0|||
131205152|NCT02030067|472372503|FG002|Overall Study|other reasons|0|||
131205153|NCT02030067|472372504|FG003|Overall Study|other reasons|0|||
131205154|NCT02030067|472372505|FG004|Overall Study|other reasons|0|||
131205155|NCT02030067|472372506|FG005|Overall Study|other reasons|1|||
131205156|NCT02030067|472372507|FG006|Overall Study|other reasons|0|||
131205157|NCT02030067|472372508|FG007|Overall Study|other reasons|0|||
131205158|NCT02030067|472372509|FG008|Overall Study|other reasons|2|||
131205159|NCT02030067|472372510|FG009|Overall Study|other reasons|0|||
131205160|NCT02030067|472372511|FG010|Overall Study|other reasons|0|||
131205161|NCT02030067|472372512|FG011|Overall Study|other reasons|0|||
131205162|NCT02030067|472372513|FG012|Overall Study|other reasons|4|||
131205163|NCT02030067|472372501|FG000|Overall Study|Adverse Event|0|||
131205164|NCT02030067|472372502|FG001|Overall Study|Adverse Event|0|||
130734785|NCT01823835|470647410|FG006|Overall Study|Study Termination|0|||
131205165|NCT02030067|472372503|FG002|Overall Study|Adverse Event|0|||
131205166|NCT02030067|472372504|FG003|Overall Study|Adverse Event|0|||
131205167|NCT02030067|472372505|FG004|Overall Study|Adverse Event|0|||
131205168|NCT02030067|472372506|FG005|Overall Study|Adverse Event|0|||
131205169|NCT02030067|472372507|FG006|Overall Study|Adverse Event|0|||
131205170|NCT02030067|472372508|FG007|Overall Study|Adverse Event|0|||
131205171|NCT02030067|472372509|FG008|Overall Study|Adverse Event|0|||
131205172|NCT02030067|472372510|FG009|Overall Study|Adverse Event|0|||
131205173|NCT02030067|472372511|FG010|Overall Study|Adverse Event|0|||
131205174|NCT02030067|472372512|FG011|Overall Study|Adverse Event|1|||
131205175|NCT02030067|472372513|FG012|Overall Study|Adverse Event|8|||
131205176|NCT01632345|472372514|FG000|Treatment: Part I|Adverse Event|1|||
131205177|NCT01632345|472372515|FG001|Treatment: Part I|Adverse Event|4|||
131205178|NCT01632345|472372516|FG002|Treatment: Part I|Adverse Event|2|||
131205179|NCT01632345|472372517|FG003|Treatment: Part I|Adverse Event|1|||
131205180|NCT01632345|472372518|FG004|Treatment: Part I|Adverse Event|3|||
131205181|NCT01632345|472372519|FG005|Treatment: Part I|Adverse Event|0|||
131205182|NCT01632345|472372520|FG006|Treatment: Part I|Adverse Event|0|||
131205183|NCT01632345|472372514|FG000|Treatment: Part I|Lack of Efficacy|0|||
131205184|NCT01632345|472372515|FG001|Treatment: Part I|Lack of Efficacy|1|||
131205185|NCT01632345|472372516|FG002|Treatment: Part I|Lack of Efficacy|0|||
131205186|NCT01632345|472372517|FG003|Treatment: Part I|Lack of Efficacy|1|||
131205187|NCT01632345|472372518|FG004|Treatment: Part I|Lack of Efficacy|1|||
131205188|NCT01632345|472372519|FG005|Treatment: Part I|Lack of Efficacy|0|||
131205189|NCT01632345|472372520|FG006|Treatment: Part I|Lack of Efficacy|0|||
131205190|NCT01632345|472372514|FG000|Treatment: Part I|Lost to Follow-up|3|||
131205191|NCT01632345|472372515|FG001|Treatment: Part I|Lost to Follow-up|2|||
131205192|NCT01632345|472372516|FG002|Treatment: Part I|Lost to Follow-up|1|||
131205193|NCT01632345|472372517|FG003|Treatment: Part I|Lost to Follow-up|3|||
131205194|NCT01632345|472372518|FG004|Treatment: Part I|Lost to Follow-up|4|||
131205195|NCT01632345|472372519|FG005|Treatment: Part I|Lost to Follow-up|0|||
131205196|NCT01632345|472372520|FG006|Treatment: Part I|Lost to Follow-up|0|||
131205197|NCT01632345|472372514|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
131205198|NCT01632345|472372515|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
131205199|NCT01632345|472372516|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
131205200|NCT01632345|472372517|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
131205201|NCT01632345|472372518|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
131205202|NCT01632345|472372519|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
131205203|NCT01632345|472372520|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
131205204|NCT01632345|472372514|FG000|Treatment: Part I|Physician Decision|2|||
131205205|NCT01632345|472372515|FG001|Treatment: Part I|Physician Decision|1|||
131205206|NCT01632345|472372516|FG002|Treatment: Part I|Physician Decision|0|||
131205207|NCT01632345|472372517|FG003|Treatment: Part I|Physician Decision|0|||
131205208|NCT01632345|472372518|FG004|Treatment: Part I|Physician Decision|1|||
131205209|NCT01632345|472372519|FG005|Treatment: Part I|Physician Decision|0|||
131205210|NCT01632345|472372520|FG006|Treatment: Part I|Physician Decision|0|||
131205211|NCT01632345|472372514|FG000|Treatment: Part I|Pregnancy|0|||
131205212|NCT01632345|472372515|FG001|Treatment: Part I|Pregnancy|1|||
131205213|NCT01632345|472372516|FG002|Treatment: Part I|Pregnancy|0|||
131205214|NCT01632345|472372517|FG003|Treatment: Part I|Pregnancy|0|||
131205215|NCT01632345|472372518|FG004|Treatment: Part I|Pregnancy|0|||
131205216|NCT01632345|472372519|FG005|Treatment: Part I|Pregnancy|0|||
131205217|NCT01632345|472372520|FG006|Treatment: Part I|Pregnancy|0|||
131205218|NCT01632345|472372514|FG000|Treatment: Part I|Protocol Deviation|0|||
131205219|NCT01632345|472372515|FG001|Treatment: Part I|Protocol Deviation|0|||
131205220|NCT01632345|472372516|FG002|Treatment: Part I|Protocol Deviation|1|||
131205221|NCT01632345|472372517|FG003|Treatment: Part I|Protocol Deviation|1|||
131205222|NCT01632345|472372518|FG004|Treatment: Part I|Protocol Deviation|0|||
131205223|NCT01632345|472372519|FG005|Treatment: Part I|Protocol Deviation|0|||
131205224|NCT01632345|472372520|FG006|Treatment: Part I|Protocol Deviation|0|||
131205225|NCT01632345|472372514|FG000|Treatment: Part I|Withdrawal by Subject|3|||
131205226|NCT01632345|472372515|FG001|Treatment: Part I|Withdrawal by Subject|4|||
131205227|NCT01632345|472372516|FG002|Treatment: Part I|Withdrawal by Subject|4|||
131205228|NCT01632345|472372517|FG003|Treatment: Part I|Withdrawal by Subject|1|||
131205229|NCT01632345|472372518|FG004|Treatment: Part I|Withdrawal by Subject|4|||
131205230|NCT01632345|472372519|FG005|Treatment: Part I|Withdrawal by Subject|0|||
131205231|NCT01632345|472372520|FG006|Treatment: Part I|Withdrawal by Subject|0|||
131205232|NCT01632345|472372514|FG000|Treatment: Part II|Adverse Event|0|||
131205233|NCT01632345|472372515|FG001|Treatment: Part II|Adverse Event|0|||
131205234|NCT01632345|472372516|FG002|Treatment: Part II|Adverse Event|0|||
131205235|NCT01632345|472372517|FG003|Treatment: Part II|Adverse Event|0|||
131205236|NCT01632345|472372518|FG004|Treatment: Part II|Adverse Event|0|||
131205237|NCT01632345|472372519|FG005|Treatment: Part II|Adverse Event|3|||
131205238|NCT01632345|472372520|FG006|Treatment: Part II|Adverse Event|8|||
131205239|NCT01632345|472372514|FG000|Treatment: Part II|Lost to Follow-up|0|||
131205240|NCT01632345|472372515|FG001|Treatment: Part II|Lost to Follow-up|0|||
131205241|NCT01632345|472372516|FG002|Treatment: Part II|Lost to Follow-up|0|||
131205242|NCT01632345|472372517|FG003|Treatment: Part II|Lost to Follow-up|0|||
131205243|NCT01632345|472372518|FG004|Treatment: Part II|Lost to Follow-up|0|||
131205244|NCT01632345|472372519|FG005|Treatment: Part II|Lost to Follow-up|3|||
131205245|NCT01632345|472372520|FG006|Treatment: Part II|Lost to Follow-up|1|||
131205246|NCT01632345|472372514|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
131205247|NCT01632345|472372515|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
131205248|NCT01632345|472372516|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
131205249|NCT01632345|472372517|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
131205250|NCT01632345|472372518|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
131205251|NCT01632345|472372519|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
131205252|NCT01632345|472372520|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
131205253|NCT01632345|472372514|FG000|Treatment: Part II|Withdrawal by Subject|0|||
131205254|NCT01632345|472372515|FG001|Treatment: Part II|Withdrawal by Subject|0|||
131205255|NCT01632345|472372516|FG002|Treatment: Part II|Withdrawal by Subject|0|||
131205256|NCT01632345|472372517|FG003|Treatment: Part II|Withdrawal by Subject|0|||
131205257|NCT01632345|472372518|FG004|Treatment: Part II|Withdrawal by Subject|0|||
131205258|NCT01632345|472372519|FG005|Treatment: Part II|Withdrawal by Subject|2|||
131205259|NCT01632345|472372520|FG006|Treatment: Part II|Withdrawal by Subject|2|||
131205260|NCT01756846|472372521|FG000|Overall Study|Lost to Follow-up|5|||
131205261|NCT01756846|472372522|FG001|Overall Study|Lost to Follow-up|10|||
131205262|NCT01756846|472372521|FG000|Overall Study|Withdrawal by Subject|1|||
131205263|NCT01756846|472372522|FG001|Overall Study|Withdrawal by Subject|2|||
131205264|NCT00545740|472372525|FG000|Overall Study|Lack of Efficacy|34|||
131205265|NCT00545740|472372526|FG001|Overall Study|Lack of Efficacy|35|||
131205266|NCT00545740|472372527|FG002|Overall Study|Lack of Efficacy|47|||
131205267|NCT00545740|472372528|FG003|Overall Study|Lack of Efficacy|36|||
131205268|NCT00545740|472372525|FG000|Overall Study|Withdrawal by Subject|17|||
131205269|NCT00545740|472372526|FG001|Overall Study|Withdrawal by Subject|15|||
131205270|NCT00545740|472372527|FG002|Overall Study|Withdrawal by Subject|16|||
131205271|NCT00545740|472372528|FG003|Overall Study|Withdrawal by Subject|18|||
131205272|NCT00545740|472372525|FG000|Overall Study|Adverse Event|10|||
131205273|NCT00545740|472372526|FG001|Overall Study|Adverse Event|18|||
131205274|NCT00545740|472372527|FG002|Overall Study|Adverse Event|19|||
131205275|NCT00545740|472372528|FG003|Overall Study|Adverse Event|9|||
131205276|NCT00545740|472372525|FG000|Overall Study|Lost to Follow-up|7|||
131205277|NCT00545740|472372526|FG001|Overall Study|Lost to Follow-up|5|||
131205278|NCT00545740|472372527|FG002|Overall Study|Lost to Follow-up|5|||
131205279|NCT00545740|472372528|FG003|Overall Study|Lost to Follow-up|6|||
131205280|NCT00545740|472372525|FG000|Overall Study|Protocol Violation|1|||
131205281|NCT00545740|472372526|FG001|Overall Study|Protocol Violation|3|||
131205282|NCT00545740|472372527|FG002|Overall Study|Protocol Violation|1|||
131205283|NCT00545740|472372528|FG003|Overall Study|Protocol Violation|0|||
131205284|NCT00545740|472372525|FG000|Overall Study|Non-compliance|0|||
131205285|NCT00545740|472372526|FG001|Overall Study|Non-compliance|2|||
131205286|NCT00545740|472372527|FG002|Overall Study|Non-compliance|1|||
131205287|NCT00545740|472372528|FG003|Overall Study|Non-compliance|0|||
131205288|NCT00545740|472372525|FG000|Overall Study|Moved|2|||
131205289|NCT00545740|472372526|FG001|Overall Study|Moved|0|||
131205290|NCT00545740|472372527|FG002|Overall Study|Moved|1|||
131205291|NCT00545740|472372528|FG003|Overall Study|Moved|0|||
131205292|NCT00545740|472372525|FG000|Overall Study|Diverticulitis attack|0|||
131205293|NCT00545740|472372526|FG001|Overall Study|Diverticulitis attack|0|||
131205294|NCT00545740|472372527|FG002|Overall Study|Diverticulitis attack|1|||
131205295|NCT00545740|472372528|FG003|Overall Study|Diverticulitis attack|1|||
131205296|NCT00545740|472372525|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
131205297|NCT00545740|472372526|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
131205298|NCT00545740|472372527|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
131205299|NCT00545740|472372528|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
131205300|NCT00545740|472372525|FG000|Overall Study|Site closure|1|||
131205301|NCT00545740|472372526|FG001|Overall Study|Site closure|0|||
131205302|NCT00545740|472372527|FG002|Overall Study|Site closure|0|||
131205303|NCT00545740|472372528|FG003|Overall Study|Site closure|0|||
131205304|NCT00545740|472372525|FG000|Overall Study|Missed visit|1|||
131205305|NCT00545740|472372526|FG001|Overall Study|Missed visit|0|||
131205306|NCT00545740|472372527|FG002|Overall Study|Missed visit|0|||
131205307|NCT00545740|472372528|FG003|Overall Study|Missed visit|0|||
131205308|NCT00545740|472372525|FG000|Overall Study|Physician Decision|0|||
131205309|NCT00545740|472372526|FG001|Overall Study|Physician Decision|0|||
131205310|NCT00545740|472372527|FG002|Overall Study|Physician Decision|3|||
131205311|NCT00545740|472372528|FG003|Overall Study|Physician Decision|0|||
131205312|NCT00545740|472372525|FG000|Overall Study|Accepted only monthly telephone calls|1|||
130734786|NCT01823835|470647411|FG007|Overall Study|Study Termination|0|||
130734787|NCT01823835|470647412|FG008|Overall Study|Study Termination|0|||
130734788|NCT01823835|470647413|FG009|Overall Study|Study Termination|0|||
131205313|NCT00545740|472372526|FG001|Overall Study|Accepted only monthly telephone calls|0|||
130734789|NCT01823835|470647414|FG010|Overall Study|Study Termination|0|||
130734790|NCT01823835|470647415|FG011|Overall Study|Study Termination|1|||
130734791|NCT01823835|470647416|FG012|Overall Study|Study Termination|0|||
130734792|NCT01823835|470647417|FG013|Overall Study|Study Termination|0|||
130734793|NCT01823835|470647418|FG014|Overall Study|Study Termination|0|||
130734794|NCT01823835|470647404|FG000|Overall Study|Withdrawal by Subject|0|||
130734795|NCT01823835|470647405|FG001|Overall Study|Withdrawal by Subject|0|||
130734796|NCT01823835|470647406|FG002|Overall Study|Withdrawal by Subject|1|||
130734797|NCT01823835|470647407|FG003|Overall Study|Withdrawal by Subject|0|||
130734798|NCT01823835|470647408|FG004|Overall Study|Withdrawal by Subject|0|||
130734799|NCT01823835|470647409|FG005|Overall Study|Withdrawal by Subject|0|||
130734800|NCT01823835|470647410|FG006|Overall Study|Withdrawal by Subject|0|||
130734801|NCT01823835|470647411|FG007|Overall Study|Withdrawal by Subject|0|||
130734802|NCT01823835|470647412|FG008|Overall Study|Withdrawal by Subject|0|||
130734803|NCT01823835|470647413|FG009|Overall Study|Withdrawal by Subject|1|||
130734804|NCT01823835|470647414|FG010|Overall Study|Withdrawal by Subject|1|||
130734805|NCT01823835|470647415|FG011|Overall Study|Withdrawal by Subject|2|||
130734806|NCT01823835|470647416|FG012|Overall Study|Withdrawal by Subject|1|||
130734807|NCT01823835|470647417|FG013|Overall Study|Withdrawal by Subject|0|||
130734808|NCT01823835|470647418|FG014|Overall Study|Withdrawal by Subject|0|||
130734809|NCT03999996|470648941|FG000|Prior to Booster|Adverse Event|2|||
130734810|NCT03999996|470648942|FG001|Prior to Booster|Adverse Event|0|||
130734811|NCT03999996|470648943|FG002|Prior to Booster|Adverse Event|0|||
130734812|NCT03999996|470648944|FG003|Prior to Booster|Adverse Event|0|||
130734813|NCT03999996|470648941|FG000|Prior to Booster|Lost to Follow-up|17|||
130734814|NCT03999996|470648942|FG001|Prior to Booster|Lost to Follow-up|22|||
130734815|NCT03999996|470648943|FG002|Prior to Booster|Lost to Follow-up|0|||
130734816|NCT03999996|470648944|FG003|Prior to Booster|Lost to Follow-up|0|||
130734817|NCT03999996|470648941|FG000|Prior to Booster|Withdrawal of Consent|51|||
130734818|NCT03999996|470648942|FG001|Prior to Booster|Withdrawal of Consent|8|||
130734819|NCT03999996|470648943|FG002|Prior to Booster|Withdrawal of Consent|0|||
130734820|NCT03999996|470648944|FG003|Prior to Booster|Withdrawal of Consent|0|||
130734821|NCT03999996|470648941|FG000|Prior to Booster|Death|0|||
130734822|NCT03999996|470648942|FG001|Prior to Booster|Death|1|||
130734823|NCT03999996|470648943|FG002|Prior to Booster|Death|0|||
130734824|NCT03999996|470648944|FG003|Prior to Booster|Death|0|||
130734825|NCT03999996|470648941|FG000|Prior to Booster|Reason Not Specified|27|||
130734826|NCT03999996|470648942|FG001|Prior to Booster|Reason Not Specified|4|||
130734827|NCT03999996|470648943|FG002|Prior to Booster|Reason Not Specified|0|||
130784727|NCT00557466|470841150|FG002|Overall Study|Subject withdrew consent|0|||
130784728|NCT00557466|470841151|FG003|Overall Study|Subject withdrew consent|0|||
131205314|NCT00545740|472372527|FG002|Overall Study|Accepted only monthly telephone calls|0|||
131205315|NCT00545740|472372528|FG003|Overall Study|Accepted only monthly telephone calls|0|||
131205316|NCT00545740|472372525|FG000|Overall Study|Sponsor decision|0|||
131205317|NCT00545740|472372526|FG001|Overall Study|Sponsor decision|1|||
131205318|NCT00545740|472372527|FG002|Overall Study|Sponsor decision|0|||
131205319|NCT00545740|472372528|FG003|Overall Study|Sponsor decision|0|||
131205320|NCT00545740|472372525|FG000|Overall Study|Lack of time|0|||
131205321|NCT00545740|472372526|FG001|Overall Study|Lack of time|1|||
131205322|NCT00545740|472372527|FG002|Overall Study|Lack of time|0|||
131205323|NCT00545740|472372528|FG003|Overall Study|Lack of time|0|||
131205324|NCT00545740|472372525|FG000|Overall Study|Non-adherence to visits|0|||
131205325|NCT00545740|472372526|FG001|Overall Study|Non-adherence to visits|1|||
131205326|NCT00545740|472372527|FG002|Overall Study|Non-adherence to visits|0|||
131205327|NCT00545740|472372528|FG003|Overall Study|Non-adherence to visits|0|||
131205328|NCT00545740|472372525|FG000|Overall Study|Patient difficulties|0|||
131205329|NCT00545740|472372526|FG001|Overall Study|Patient difficulties|1|||
131205330|NCT00545740|472372527|FG002|Overall Study|Patient difficulties|0|||
131205331|NCT00545740|472372528|FG003|Overall Study|Patient difficulties|0|||
131205332|NCT00545740|472372525|FG000|Overall Study|Husband against study|0|||
131205333|NCT00545740|472372526|FG001|Overall Study|Husband against study|0|||
130734828|NCT03999996|470648944|FG003|Prior to Booster|Reason Not Specified|0|||
130784729|NCT00557466|470841152|FG004|Overall Study|Subject withdrew consent|1|||
130784730|NCT00557466|470841153|FG005|Overall Study|Subject withdrew consent|2|||
130734829|NCT03999996|470648941|FG000|Booster Phase|Lost to Follow-up|0|||
130734830|NCT03999996|470648942|FG001|Booster Phase|Lost to Follow-up|0|||
130734831|NCT03999996|470648943|FG002|Booster Phase|Lost to Follow-up|3|||
130784731|NCT00557466|470841148|FG000|Overall Study|Administrative problems|0|||
130734832|NCT03999996|470648944|FG003|Booster Phase|Lost to Follow-up|3|||
130734833|NCT03999996|470648941|FG000|Booster Phase|Withdrawal of Consent|0|||
130734834|NCT03999996|470648942|FG001|Booster Phase|Withdrawal of Consent|0|||
130734835|NCT03999996|470648943|FG002|Booster Phase|Withdrawal of Consent|0|||
130784732|NCT00557466|470841149|FG001|Overall Study|Administrative problems|1|||
131205334|NCT00545740|472372527|FG002|Overall Study|Husband against study|1|||
131205335|NCT00545740|472372528|FG003|Overall Study|Husband against study|0|||
131205336|NCT03370133|472372538|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
131205337|NCT03370133|472372539|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
131205338|NCT03370133|472372540|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
131205339|NCT03370133|472372541|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
131205340|NCT03370133|472372542|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
131205341|NCT03370133|472372543|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
131205342|NCT03370133|472372538|FG000|Initial Treatment Period (WK 16)|Death|1|||
131205343|NCT03370133|472372539|FG001|Initial Treatment Period (WK 16)|Death|1|||
131205344|NCT03370133|472372540|FG002|Initial Treatment Period (WK 16)|Death|1|||
131205345|NCT03370133|472372541|FG003|Initial Treatment Period (WK 16)|Death|0|||
131205346|NCT03370133|472372542|FG004|Initial Treatment Period (WK 16)|Death|0|||
131205347|NCT03370133|472372543|FG005|Initial Treatment Period (WK 16)|Death|0|||
131205348|NCT03370133|472372538|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
131205349|NCT03370133|472372539|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
131205350|NCT03370133|472372540|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
131205351|NCT03370133|472372541|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
131205352|NCT03370133|472372542|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
131205353|NCT03370133|472372543|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
131205354|NCT03370133|472372538|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
131205355|NCT03370133|472372539|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
131205356|NCT03370133|472372540|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
131205357|NCT03370133|472372541|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
131205358|NCT03370133|472372542|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
131205359|NCT03370133|472372543|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
131205360|NCT03370133|472372538|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
131205361|NCT03370133|472372539|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
131205362|NCT03370133|472372540|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
131205363|NCT03370133|472372541|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
131205364|NCT03370133|472372542|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
131205365|NCT03370133|472372543|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
131205366|NCT03370133|472372538|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
131205367|NCT03370133|472372539|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
131205368|NCT03370133|472372540|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
131205369|NCT03370133|472372541|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
131205370|NCT03370133|472372542|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
131205371|NCT03370133|472372543|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
131205372|NCT03370133|472372538|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
131205373|NCT03370133|472372539|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
131205374|NCT03370133|472372540|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
131205375|NCT03370133|472372541|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
131205376|NCT03370133|472372542|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
131205377|NCT03370133|472372543|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
131205378|NCT03370133|472372538|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
131205379|NCT03370133|472372539|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
131205380|NCT03370133|472372540|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
131205381|NCT03370133|472372541|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
131205382|NCT03370133|472372542|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
131205383|NCT03370133|472372543|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
131205384|NCT03370133|472372538|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
131205385|NCT03370133|472372539|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
131205386|NCT03370133|472372540|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
131205387|NCT03370133|472372541|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
131205388|NCT03370133|472372542|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
131205389|NCT03370133|472372543|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
131205390|NCT03370133|472372538|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
131205391|NCT03370133|472372539|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
131205392|NCT03370133|472372540|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
131205393|NCT03370133|472372541|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
131205394|NCT03370133|472372542|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
131205395|NCT03370133|472372543|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
131205396|NCT03370133|472372538|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
131205397|NCT03370133|472372539|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
131205398|NCT03370133|472372540|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
131205399|NCT03370133|472372541|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
131205400|NCT03370133|472372542|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
131205401|NCT03370133|472372543|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
131205402|NCT03370133|472372538|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
131205403|NCT03370133|472372539|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
131205404|NCT03370133|472372540|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
131205405|NCT03370133|472372541|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
131205406|NCT03370133|472372542|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
131205407|NCT03370133|472372543|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
131205408|NCT03370133|472372538|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
131205409|NCT03370133|472372539|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
131205410|NCT03370133|472372540|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
131205411|NCT03370133|472372541|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
131205412|NCT03370133|472372542|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
131205413|NCT03370133|472372543|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
131205414|NCT03370133|472372538|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
131205415|NCT03370133|472372539|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
131205416|NCT03370133|472372540|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
131205417|NCT03370133|472372541|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
131205418|NCT03370133|472372542|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
131205419|NCT03370133|472372543|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
131205420|NCT03370133|472372538|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
131205421|NCT03370133|472372539|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
131205422|NCT03370133|472372540|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
131205423|NCT03370133|472372541|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
131205424|NCT03370133|472372542|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
131205425|NCT03370133|472372543|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
131205426|NCT00636506|472372544|FG000|Overall Study|Lost to Follow-up|8|||
131205427|NCT00636506|472372544|FG000|Overall Study|Explanted|1|||
131205428|NCT00636506|472372544|FG000|Overall Study|Withdrawal by Subject|6|||
131205429|NCT00636506|472372544|FG000|Overall Study|Procedure aborted|1|||
131205430|NCT03742271|472372545|FG000|Overall Study|Unsatisfactory Visual Response|1|||
131205431|NCT03742271|472372545|FG000|Overall Study|Withdrawal by Subject|3|||
131205432|NCT03742271|472372545|FG000|Overall Study|Lost to Follow-up|4|||
131205433|NCT03742271|472372545|FG000|Overall Study|Failed Insertion & removal|3|||
131205434|NCT03742271|472372545|FG000|Overall Study|Protocol Violation|1|||
131205435|NCT02539160|472372546|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
131205436|NCT02539160|472372547|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
131205437|NCT02539160|472372548|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
131205438|NCT02539160|472372549|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
131205439|NCT02539160|472372546|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
131205440|NCT02539160|472372547|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
131205441|NCT02539160|472372548|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
131205442|NCT02539160|472372549|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
131205443|NCT02539160|472372546|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
131205444|NCT02539160|472372547|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
131205445|NCT02539160|472372548|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
131205446|NCT02539160|472372549|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
131205447|NCT01681004|472372550|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
131205448|NCT01681004|472372551|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
131205449|NCT01681004|472372550|FG000|Study Completion|Lost to Follow-up|8|||
131205450|NCT01681004|472372551|FG001|Study Completion|Lost to Follow-up|3|||
131205451|NCT01681004|472372550|FG000|Study Completion|Physician Decision|1|||
131205452|NCT01681004|472372551|FG001|Study Completion|Physician Decision|3|||
131205453|NCT01681004|472372550|FG000|Study Completion|Site Termination|2|||
131205454|NCT01681004|472372551|FG001|Study Completion|Site Termination|1|||
131205455|NCT01681004|472372550|FG000|Study Completion|Death|1|||
131205456|NCT01681004|472372551|FG001|Study Completion|Death|1|||
131205457|NCT02828982|472372552|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131205458|NCT02828982|472372553|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
131205459|NCT00701064|472372554|FG000|Overall Study|Protocol Violation|1|||
131205460|NCT00701064|472372555|FG001|Overall Study|Protocol Violation|1|||
131205461|NCT00701064|472372554|FG000|Overall Study|Withdrawal by Subject|1|||
131205462|NCT00701064|472372555|FG001|Overall Study|Withdrawal by Subject|1|||
131205463|NCT00701064|472372554|FG000|Overall Study|initiated other PTSD treatment|2|||
131205464|NCT00701064|472372555|FG001|Overall Study|initiated other PTSD treatment|2|||
131205465|NCT00695318|472372556|FG000|Overall Study|Lost to Follow-up|1|||
131205466|NCT00695318|472372557|FG001|Overall Study|Lost to Follow-up|0|||
131205467|NCT00695318|472372556|FG000|Overall Study|Withdrawal by Subject|2|||
131205468|NCT00695318|472372557|FG001|Overall Study|Withdrawal by Subject|0|||
131205469|NCT00695318|472372556|FG000|Overall Study|Death|1|||
131205470|NCT00695318|472372557|FG001|Overall Study|Death|1|||
131205471|NCT00695318|472372556|FG000|Overall Study|Study Terminated|1|||
131205472|NCT00695318|472372557|FG001|Overall Study|Study Terminated|0|||
131205473|NCT00758394|472372558|FG000|2nd Intervention Order|Lost to Follow-up|0|||
131205474|NCT00758394|472372559|FG001|2nd Intervention Order|Lost to Follow-up|1|||
131205475|NCT00758394|472372560|FG002|2nd Intervention Order|Lost to Follow-up|0|||
131205476|NCT00758394|472372561|FG003|2nd Intervention Order|Lost to Follow-up|0|||
131205477|NCT00758394|472372558|FG000|3rd Intervention|Lost to Follow-up|1|||
131205478|NCT00758394|472372559|FG001|3rd Intervention|Lost to Follow-up|0|||
131205479|NCT00758394|472372560|FG002|3rd Intervention|Lost to Follow-up|0|||
131205480|NCT00758394|472372561|FG003|3rd Intervention|Lost to Follow-up|1|||
131205481|NCT01078389|472374534|FG000|Overall Study|Adverse Event|10|||
131205482|NCT01078389|472374535|FG001|Overall Study|Adverse Event|6|||
131205483|NCT01078389|472374534|FG000|Overall Study|Major Protocol Deviation|2|||
131205484|NCT01078389|472374535|FG001|Overall Study|Major Protocol Deviation|0|||
131205485|NCT01078389|472374534|FG000|Overall Study|Lost to Follow-up|23|||
131205486|NCT01078389|472374535|FG001|Overall Study|Lost to Follow-up|23|||
131205487|NCT01078389|472374534|FG000|Overall Study|Voluntary Withdrawal|20|||
131205488|NCT01078389|472374535|FG001|Overall Study|Voluntary Withdrawal|36|||
131205489|NCT01078389|472374534|FG000|Overall Study|Other|9|||
131205490|NCT01078389|472374535|FG001|Overall Study|Other|2|||
131205491|NCT01002573|472374536|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
131205492|NCT01002573|472374537|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
131205493|NCT04823494|472374538|FG000|Overall Study|Programming software malfunction.|1|||
131205494|NCT04823494|472374539|FG001|Overall Study|Programming software malfunction.|0|||
131205495|NCT04823494|472374538|FG000|Overall Study|Withdrawal by Subject|1|||
131205496|NCT04823494|472374539|FG001|Overall Study|Withdrawal by Subject|0|||
131205497|NCT04823494|472374538|FG000|Overall Study|Devices lost|0|||
131205498|NCT04823494|472374539|FG001|Overall Study|Devices lost|1|||
131205499|NCT03726320|472374540|FG000|Overall Study|Lost to Follow-up|2|||
131205500|NCT03726320|472374541|FG001|Overall Study|Lost to Follow-up|4|||
131205501|NCT03726320|472374542|FG002|Overall Study|Lost to Follow-up|0|||
131205502|NCT03726320|472374540|FG000|Overall Study|Time Constraints|4|||
131205503|NCT03726320|472374541|FG001|Overall Study|Time Constraints|1|||
131205504|NCT03726320|472374542|FG002|Overall Study|Time Constraints|0|||
131205505|NCT03726320|472374540|FG000|Overall Study|Ineligible after enrollment|3|||
131205506|NCT03726320|472374541|FG001|Overall Study|Ineligible after enrollment|3|||
131205507|NCT03726320|472374542|FG002|Overall Study|Ineligible after enrollment|0|||
131205508|NCT03726320|472374540|FG000|Overall Study|Clinic / insurance issue|2|||
131205509|NCT03726320|472374541|FG001|Overall Study|Clinic / insurance issue|0|||
131205510|NCT03726320|472374542|FG002|Overall Study|Clinic / insurance issue|0|||
131205511|NCT03726320|472374540|FG000|Overall Study|Language barrier|1|||
131205512|NCT03726320|472374541|FG001|Overall Study|Language barrier|0|||
131205513|NCT03726320|472374542|FG002|Overall Study|Language barrier|0|||
131205514|NCT03726320|472374540|FG000|Overall Study|Provider left the clinic|0|||
131205515|NCT03726320|472374541|FG001|Overall Study|Provider left the clinic|0|||
131205516|NCT03726320|472374542|FG002|Overall Study|Provider left the clinic|1|||
131205517|NCT03691831|472374545|FG000|Overall Study|Lost to Follow-up|16|||
130734836|NCT03999996|470648944|FG003|Booster Phase|Withdrawal of Consent|1|||
130734837|NCT03999996|470648941|FG000|Booster Phase|Reason Not Specified|0|||
130734838|NCT03999996|470648942|FG001|Booster Phase|Reason Not Specified|0|||
130734839|NCT03999996|470648943|FG002|Booster Phase|Reason Not Specified|0|||
131205518|NCT03691831|472374546|FG001|Overall Study|Lost to Follow-up|12|||
131205519|NCT03691831|472374545|FG000|Overall Study|Withdrawal by Subject|9|||
131205520|NCT03691831|472374546|FG001|Overall Study|Withdrawal by Subject|17|||
131205521|NCT03691831|472374545|FG000|Overall Study|Investigator Decision|2|||
131205522|NCT03691831|472374546|FG001|Overall Study|Investigator Decision|2|||
131205523|NCT02028182|472374547|FG000|Overall Study|Protocol Violation|2|||
131205524|NCT01684930|472374550|FG000|Overall Study|Withdrawal by Subject|3|||
131205525|NCT01684930|472374551|FG001|Overall Study|Withdrawal by Subject|1|||
131205526|NCT02198040|472374552|FG000|Overall Study|Work reasons|0|||
131205527|NCT02198040|472374553|FG001|Overall Study|Work reasons|1|||
131205528|NCT02198040|472374554|FG002|Overall Study|Work reasons|0|||
131205529|NCT02198040|472374552|FG000|Overall Study|Withdrawal by Subject|0|||
131205530|NCT02198040|472374553|FG001|Overall Study|Withdrawal by Subject|0|||
131205531|NCT02198040|472374554|FG002|Overall Study|Withdrawal by Subject|1|||
131205532|NCT04524663|472374555|FG000|Overall Study|Withdrawal by Subject|0|||
131205533|NCT04524663|472374556|FG001|Overall Study|Withdrawal by Subject|2|||
131205534|NCT00337935|472374557|FG000|Overall Study|Adverse Event|2|||
131205535|NCT00337935|472374558|FG001|Overall Study|Adverse Event|5|||
131205536|NCT00337935|472374557|FG000|Overall Study|Death|2|||
131205537|NCT00337935|472374558|FG001|Overall Study|Death|8|||
131205538|NCT00337935|472374557|FG000|Overall Study|Physician Decision|1|||
131205539|NCT00337935|472374558|FG001|Overall Study|Physician Decision|1|||
131205540|NCT00337935|472374557|FG000|Overall Study|Lost to Follow-up|0|||
131205541|NCT00337935|472374558|FG001|Overall Study|Lost to Follow-up|1|||
131205542|NCT00337935|472374557|FG000|Overall Study|Protocol Violation|4|||
131205543|NCT00337935|472374558|FG001|Overall Study|Protocol Violation|3|||
131205544|NCT00337935|472374557|FG000|Overall Study|Withdrawal by Subject|1|||
131205545|NCT00337935|472374558|FG001|Overall Study|Withdrawal by Subject|7|||
131205546|NCT00337935|472374557|FG000|Overall Study|Other|0|||
131205547|NCT00337935|472374558|FG001|Overall Study|Other|1|||
131205548|NCT00337935|472374557|FG000|Overall Study|Lack of Efficacy|0|||
131205549|NCT00337935|472374558|FG001|Overall Study|Lack of Efficacy|1|||
131205550|NCT00711009|472374559|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
131205551|NCT00711009|472374560|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
131205552|NCT00711009|472374559|FG000|Overall Study|Withdrawal by Subject|4|||
131205553|NCT00711009|472374560|FG001|Overall Study|Withdrawal by Subject|2|||
131205554|NCT00711009|472374559|FG000|Overall Study|Lost to Follow-up|3|||
131205555|NCT00711009|472374560|FG001|Overall Study|Lost to Follow-up|9|||
131205556|NCT00711009|472374559|FG000|Overall Study|Participant Noncompliant|0|||
131205557|NCT00711009|472374560|FG001|Overall Study|Participant Noncompliant|1|||
131205558|NCT00711009|472374559|FG000|Overall Study|Virologic Failure|2|||
131205559|NCT00711009|472374560|FG001|Overall Study|Virologic Failure|1|||
131205560|NCT00711009|472374559|FG000|Overall Study|Pregnancy|1|||
131205561|NCT00711009|472374560|FG001|Overall Study|Pregnancy|0|||
131205562|NCT00711009|472374559|FG000|Overall Study|Site closing|0|||
131205563|NCT00711009|472374560|FG001|Overall Study|Site closing|1|||
131205564|NCT00711009|472374559|FG000|Overall Study|Dose adjustment|1|||
131205565|NCT00711009|472374560|FG001|Overall Study|Dose adjustment|0|||
131205566|NCT03359811|472374561|FG000|Overall Study|Protocol Violation|2|||
131205567|NCT03359811|472374562|FG001|Overall Study|Protocol Violation|0|||
131205568|NCT03922945|472374563|FG000|Overall Study|Adverse Event|1|||
131205569|NCT03922945|472374564|FG001|Overall Study|Adverse Event|1|||
131205570|NCT03922945|472374565|FG002|Overall Study|Adverse Event|2|||
131205571|NCT03922945|472374563|FG000|Overall Study|Lost to Follow-up|13|||
131205572|NCT03922945|472374564|FG001|Overall Study|Lost to Follow-up|9|||
131205573|NCT03922945|472374565|FG002|Overall Study|Lost to Follow-up|20|||
131205574|NCT03922945|472374563|FG000|Overall Study|Lack of Efficacy|2|||
131205575|NCT03922945|472374564|FG001|Overall Study|Lack of Efficacy|0|||
131205576|NCT03922945|472374565|FG002|Overall Study|Lack of Efficacy|1|||
131205577|NCT03922945|472374563|FG000|Overall Study|Protocol Non-Compliance|0|||
131205578|NCT03922945|472374564|FG001|Overall Study|Protocol Non-Compliance|0|||
131205579|NCT03922945|472374565|FG002|Overall Study|Protocol Non-Compliance|1|||
131205580|NCT03922945|472374563|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
131205581|NCT03922945|472374564|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
130734840|NCT03999996|470648944|FG003|Booster Phase|Reason Not Specified|1|||
130734841|NCT00733005|470648947|FG000|Overall Study|Adverse Event|0|||
131205582|NCT03922945|472374565|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
131205583|NCT03922945|472374563|FG000|Overall Study|All Other Personal Reasons|1|||
131205584|NCT03922945|472374564|FG001|Overall Study|All Other Personal Reasons|1|||
131205585|NCT03922945|472374565|FG002|Overall Study|All Other Personal Reasons|2|||
131205586|NCT02491463|472374566|FG000|Overall Study|Withdrawal by Subject|1|||
131205587|NCT02491463|472374567|FG001|Overall Study|Withdrawal by Subject|2|||
131205588|NCT02491463|472374568|FG002|Overall Study|Withdrawal by Subject|0|||
131205589|NCT02491463|472374569|FG003|Overall Study|Withdrawal by Subject|0|||
130734842|NCT00733005|470648948|FG001|Overall Study|Adverse Event|1|||
130734843|NCT00733005|470648947|FG000|Overall Study|Treatment Failure|0|||
130734844|NCT00733005|470648948|FG001|Overall Study|Treatment Failure|1|||
130734845|NCT00733005|470648947|FG000|Overall Study|Withdrawal by Subject|0|||
130734846|NCT00733005|470648948|FG001|Overall Study|Withdrawal by Subject|1|||
130734847|NCT00733005|470648947|FG000|Overall Study|Protocol Violation|2|||
130734848|NCT00733005|470648948|FG001|Overall Study|Protocol Violation|0|||
130734849|NCT00266630|470648949|FG000|Overall Study|Adverse Event|8|||
131205590|NCT02491463|472374566|FG000|Overall Study|Migrated/moved from study area|1|||
131205591|NCT02491463|472374567|FG001|Overall Study|Migrated/moved from study area|5|||
131205592|NCT02491463|472374568|FG002|Overall Study|Migrated/moved from study area|1|||
131205593|NCT02491463|472374569|FG003|Overall Study|Migrated/moved from study area|1|||
131205594|NCT02491463|472374566|FG000|Overall Study|Lost to Follow-up|0|||
131205595|NCT02491463|472374567|FG001|Overall Study|Lost to Follow-up|3|||
131205596|NCT02491463|472374568|FG002|Overall Study|Lost to Follow-up|3|||
131205597|NCT02491463|472374569|FG003|Overall Study|Lost to Follow-up|0|||
131205598|NCT00039377|472374570|FG000|Initial Registration|Adverse Event|2|||
131205599|NCT00039377|472374571|FG001|Initial Registration|Adverse Event|0|||
131205600|NCT00039377|472374572|FG002|Initial Registration|Adverse Event|0|||
131205601|NCT00039377|472374573|FG003|Initial Registration|Adverse Event|0|||
131205602|NCT00039377|472374570|FG000|Initial Registration|Relapsed|6|||
131205603|NCT00039377|472374571|FG001|Initial Registration|Relapsed|0|||
131205604|NCT00039377|472374572|FG002|Initial Registration|Relapsed|0|||
131205605|NCT00039377|472374573|FG003|Initial Registration|Relapsed|0|||
131205606|NCT00039377|472374570|FG000|Initial Registration|Received non-protocol therapy|11|||
131205607|NCT00039377|472374571|FG001|Initial Registration|Received non-protocol therapy|0|||
131205608|NCT00039377|472374572|FG002|Initial Registration|Received non-protocol therapy|0|||
131205609|NCT00039377|472374573|FG003|Initial Registration|Received non-protocol therapy|0|||
131205610|NCT00039377|472374570|FG000|Initial Registration|Withdrawal by Subject|3|||
131205611|NCT00039377|472374571|FG001|Initial Registration|Withdrawal by Subject|0|||
131205612|NCT00039377|472374572|FG002|Initial Registration|Withdrawal by Subject|0|||
131205613|NCT00039377|472374573|FG003|Initial Registration|Withdrawal by Subject|0|||
131205614|NCT01347931|472374577|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
131205615|NCT02493712|472374578|FG000|Overall Study|Withdrawal by Subject|1|||
131205616|NCT02493712|472374579|FG001|Overall Study|Withdrawal by Subject|0|||
131205617|NCT02493712|472374580|FG002|Overall Study|Withdrawal by Subject|2|||
131205618|NCT02493712|472374578|FG000|Overall Study|Protocol Violation|0|||
131205619|NCT02493712|472374579|FG001|Overall Study|Protocol Violation|0|||
131205620|NCT02493712|472374580|FG002|Overall Study|Protocol Violation|1|||
131205621|NCT02493712|472374578|FG000|Overall Study|Lost to Follow-up|1|||
131205622|NCT02493712|472374579|FG001|Overall Study|Lost to Follow-up|0|||
131205623|NCT02493712|472374580|FG002|Overall Study|Lost to Follow-up|0|||
131205624|NCT02493712|472374578|FG000|Overall Study|Physician Decision|0|||
131205625|NCT02493712|472374579|FG001|Overall Study|Physician Decision|1|||
131205626|NCT02493712|472374580|FG002|Overall Study|Physician Decision|0|||
131205627|NCT02493712|472374578|FG000|Overall Study|Lack of Efficacy|0|||
131205628|NCT02493712|472374579|FG001|Overall Study|Lack of Efficacy|5|||
131205629|NCT02493712|472374580|FG002|Overall Study|Lack of Efficacy|3|||
131205630|NCT04563845|472374581|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205631|NCT04563845|472374582|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205632|NCT04563845|472374583|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205633|NCT04563845|472374584|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205634|NCT04563845|472374585|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205635|NCT04563845|472374586|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205636|NCT04563845|472374587|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205637|NCT04563845|472374588|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
131205638|NCT04563845|472374589|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205639|NCT04563845|472374590|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130734850|NCT00266630|470648950|FG001|Overall Study|Adverse Event|6|||
130734851|NCT00266630|470648949|FG000|Overall Study|Lack of Efficacy|1|||
130734852|NCT00266630|470648950|FG001|Overall Study|Lack of Efficacy|4|||
131205640|NCT04563845|472374591|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205641|NCT04563845|472374592|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205642|NCT04563845|472374593|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205643|NCT04563845|472374594|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
131205644|NCT04563845|472374581|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205645|NCT04563845|472374582|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205646|NCT04563845|472374583|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205647|NCT04563845|472374584|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205648|NCT04563845|472374585|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
131205649|NCT04563845|472374586|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205650|NCT04563845|472374587|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205651|NCT04563845|472374588|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205652|NCT04563845|472374589|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205653|NCT04563845|472374590|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205654|NCT04563845|472374591|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205655|NCT04563845|472374592|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205656|NCT04563845|472374593|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205657|NCT04563845|472374594|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
131205658|NCT01020812|472374595|FG000|Overall Study|Physician Decision|1|||
131205659|NCT01020812|472374595|FG000|Overall Study|Withdrawal by Subject|1|||
131205660|NCT01020812|472374595|FG000|Overall Study|Protocol Violation|1|||
131205661|NCT02528643|472374596|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
131205662|NCT02528643|472374597|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
131205663|NCT02528643|472374596|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
131205664|NCT02528643|472374597|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
131205665|NCT02528643|472374596|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
131205666|NCT02528643|472374597|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
131205667|NCT02528643|472374596|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
131205668|NCT02528643|472374597|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
131205669|NCT02528643|472374596|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
131205670|NCT02528643|472374597|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
131205671|NCT02528643|472374596|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
131205672|NCT02528643|472374597|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
131205673|NCT02528643|472374596|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
131205674|NCT02528643|472374597|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
131205675|NCT01729559|472374599|FG000|Overall Study|Protocol Violation|31|||
131205676|NCT01729559|472374600|FG001|Overall Study|Protocol Violation|28|||
131205677|NCT03764813|472374601|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
131205678|NCT03764813|472374602|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
131205679|NCT03764813|472374603|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
131205680|NCT03764813|472374604|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
131205681|NCT00761891|472374605|FG000|Overall Study|Withdrawal by Subject|10|||
131205682|NCT01707667|472374606|FG000|Period 1|expulsion of colonic sensor catheter|1|||
131205683|NCT01707667|472374607|FG001|Period 1|expulsion of colonic sensor catheter|0|||
131205684|NCT02074059|472374613|FG000|Overall Study|Death|0|||
131205685|NCT02074059|472374614|FG001|Overall Study|Death|0|||
131205686|NCT02074059|472374615|FG002|Overall Study|Death|0|||
131205687|NCT02074059|472374616|FG003|Overall Study|Death|0|||
131205688|NCT02074059|472374617|FG004|Overall Study|Death|1|||
131205689|NCT02074059|472374618|FG005|Overall Study|Death|1|||
131205690|NCT03432819|472374620|FG000|Overall Study|Lost to Follow-up|2|||
131205691|NCT03432819|472374621|FG001|Overall Study|Lost to Follow-up|2|||
131205692|NCT03432819|472374620|FG000|Overall Study|Withdrawal by Subject|5|||
131205693|NCT03432819|472374621|FG001|Overall Study|Withdrawal by Subject|3|||
131205694|NCT02764229|472374628|FG000|Overall Study|Withdrawal by Subject|15|||
131205695|NCT02764229|472374628|FG000|Overall Study|Adverse Event|9|||
131205696|NCT02764229|472374628|FG000|Overall Study|Physician Decision|5|||
131205697|NCT02764229|472374628|FG000|Overall Study|Lost to Follow-up|3|||
131205698|NCT02764229|472374628|FG000|Overall Study|Lack of Efficacy|1|||
130734853|NCT00266630|470648949|FG000|Overall Study|Entry Criteria not met|1|||
130734854|NCT00266630|470648950|FG001|Overall Study|Entry Criteria not met|0|||
130734855|NCT00266630|470648949|FG000|Overall Study|Protocol Violation|1|||
131205699|NCT02764229|472374628|FG000|Overall Study|Study Stopped by Sponsor|69|||
131205700|NCT00779142|472374629|FG000|Overall Study|Screen Failures|3|||
131205701|NCT00265382|472374632|FG000|Overall Study|Adverse Event|21|||
131205702|NCT00265382|472374632|FG000|Overall Study|Laboratory Abnormality|1|||
130734856|NCT00266630|470648950|FG001|Overall Study|Protocol Violation|3|||
131205703|NCT00265382|472374632|FG000|Overall Study|Lost to Follow-up|3|||
131205704|NCT00265382|472374632|FG000|Overall Study|Lack of Efficacy|6|||
131205705|NCT00265382|472374632|FG000|Overall Study|Miscellaneous|6|||
131205706|NCT00265382|472374632|FG000|Overall Study|Withdrawal by Subject|13|||
131205707|NCT00265382|472374632|FG000|Overall Study|Study terminated by sponsor|94|||
131205708|NCT00265382|472374632|FG000|Overall Study|Death|1|||
131205709|NCT00529152|472374635|FG000|Overall Study|Adverse Event|2|||
131205710|NCT00529152|472374635|FG000|Overall Study|Withdrawal by Subject|2|||
131205711|NCT00529152|472374635|FG000|Overall Study|Lost to Follow-up|1|||
131205712|NCT01843933|472374639|FG000|Overall Study|Data lost|6|||
131205713|NCT01843933|472374640|FG001|Overall Study|Data lost|4|||
131205714|NCT01535638|472374641|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
131205715|NCT01535638|472374642|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
131205716|NCT01535638|472374643|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
131205717|NCT01535638|472374644|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
131205718|NCT01535638|472374645|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
131205719|NCT01535638|472374646|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
131205720|NCT01535638|472374641|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
131205721|NCT01535638|472374642|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
131205722|NCT01535638|472374643|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
131205723|NCT01535638|472374644|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
131205724|NCT01535638|472374645|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
131205725|NCT01535638|472374646|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
131205726|NCT01482598|472374647|FG000|Overall Study|Death|7|||
131205727|NCT01482598|472374648|FG001|Overall Study|Death|10|||
131205728|NCT01482598|472374647|FG000|Overall Study|Physician Decision|0|||
131205729|NCT01482598|472374648|FG001|Overall Study|Physician Decision|3|||
131205730|NCT01482598|472374647|FG000|Overall Study|Withdrawal by Subject|4|||
131205731|NCT01482598|472374648|FG001|Overall Study|Withdrawal by Subject|5|||
131205732|NCT01482598|472374647|FG000|Overall Study|Lost to Follow-up|5|||
131205733|NCT01482598|472374648|FG001|Overall Study|Lost to Follow-up|4|||
131205734|NCT01373294|472374649|FG000|Overall Study|Adverse Event|1|||
131205735|NCT01373294|472374650|FG001|Overall Study|Adverse Event|0|||
131205736|NCT02694562|472374651|FG000|Overall Study|Death|8|||
131205737|NCT02694562|472374651|FG000|Overall Study|Protocol Violation|4|||
131205738|NCT02694562|472374651|FG000|Overall Study|Lost to Follow-up|3|||
131205739|NCT02694562|472374651|FG000|Overall Study|Screen Failure|2|||
131205740|NCT02694562|472374651|FG000|Overall Study|Physician Decision|1|||
131205741|NCT01333865|472374652|FG000|Overall Study|Adverse Event|2|||
131205742|NCT00620815|472374655|FG000|Overall Study|Adverse Event|1|||
131205743|NCT00620815|472374656|FG001|Overall Study|Adverse Event|1|||
131205744|NCT00620815|472374657|FG002|Overall Study|Adverse Event|2|||
130734857|NCT00266630|470648949|FG000|Overall Study|Physician Decision|1|||
131205745|NCT00620815|472374655|FG000|Overall Study|Withdrawal by Subject|1|||
131205746|NCT00620815|472374656|FG001|Overall Study|Withdrawal by Subject|2|||
131205747|NCT00620815|472374657|FG002|Overall Study|Withdrawal by Subject|0|||
131205748|NCT00620815|472374655|FG000|Overall Study|Lost to Follow-up|1|||
131205749|NCT00620815|472374656|FG001|Overall Study|Lost to Follow-up|6|||
131205750|NCT00620815|472374657|FG002|Overall Study|Lost to Follow-up|3|||
131205751|NCT00620815|472374655|FG000|Overall Study|Inappropriate enrolment|0|||
131205752|NCT00620815|472374656|FG001|Overall Study|Inappropriate enrolment|0|||
131205753|NCT00620815|472374657|FG002|Overall Study|Inappropriate enrolment|1|||
131205754|NCT00620815|472374655|FG000|Overall Study|Protocol Violation|1|||
131205755|NCT00620815|472374656|FG001|Overall Study|Protocol Violation|2|||
131205756|NCT00620815|472374657|FG002|Overall Study|Protocol Violation|1|||
131205757|NCT00877929|472374659|FG000|Overall Study|Adverse Event|11|||
130734858|NCT00266630|470648950|FG001|Overall Study|Physician Decision|2|||
131205758|NCT00877929|472374660|FG001|Overall Study|Adverse Event|20|||
131205759|NCT00877929|472374659|FG000|Overall Study|Protocol Violation|3|||
131205760|NCT00877929|472374660|FG001|Overall Study|Protocol Violation|3|||
130734859|NCT00266630|470648949|FG000|Overall Study|Withdrawal by Subject|10|||
130734860|NCT00266630|470648950|FG001|Overall Study|Withdrawal by Subject|2|||
130734861|NCT00266630|470648949|FG000|Overall Study|Lost to Follow-up|1|||
130734862|NCT00266630|470648950|FG001|Overall Study|Lost to Follow-up|0|||
130734863|NCT00266630|470648949|FG000|Overall Study|Other|19|||
130734864|NCT00266630|470648950|FG001|Overall Study|Other|11|||
130734865|NCT03410056|470648951|FG000|Overall Study|Decision by Sponsor|0|||
130734866|NCT03410056|470648952|FG001|Overall Study|Decision by Sponsor|0|||
130734867|NCT03410056|470648953|FG002|Overall Study|Decision by Sponsor|3|||
130734868|NCT03410056|470648954|FG003|Overall Study|Decision by Sponsor|0|||
130734869|NCT03410056|470648955|FG004|Overall Study|Decision by Sponsor|0|||
130734870|NCT03410056|470648956|FG005|Overall Study|Decision by Sponsor|0|||
130734871|NCT03410056|470648957|FG006|Overall Study|Decision by Sponsor|0|||
131205761|NCT00877929|472374659|FG000|Overall Study|Lost to Follow-up|0|||
131205762|NCT00877929|472374660|FG001|Overall Study|Lost to Follow-up|1|||
131205763|NCT00877929|472374659|FG000|Overall Study|Withdrawal by Subject|4|||
131205764|NCT00877929|472374660|FG001|Overall Study|Withdrawal by Subject|4|||
131205765|NCT00877929|472374659|FG000|Overall Study|Lack of Efficacy|0|||
131205766|NCT00877929|472374660|FG001|Overall Study|Lack of Efficacy|1|||
131205767|NCT00877929|472374659|FG000|Overall Study|Other reason (not specified)|2|||
131205768|NCT00877929|472374660|FG001|Overall Study|Other reason (not specified)|6|||
131205769|NCT00689728|472374661|FG000|Double-Blind Treatment|Adverse Event|1|||
131205770|NCT00689728|472374662|FG001|Double-Blind Treatment|Adverse Event|0|||
131205771|NCT00689728|472374663|FG002|Double-Blind Treatment|Adverse Event|0|||
131205772|NCT00689728|472374661|FG000|Double-Blind Treatment|Protocol Violation|0|||
131205773|NCT00689728|472374662|FG001|Double-Blind Treatment|Protocol Violation|0|||
131205774|NCT00689728|472374663|FG002|Double-Blind Treatment|Protocol Violation|1|||
131205775|NCT00689728|472374661|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
131205776|NCT00689728|472374662|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
131205777|NCT00689728|472374663|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
131205778|NCT00689728|472374661|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
131205779|NCT00689728|472374662|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
131205780|NCT00689728|472374663|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
131205781|NCT00689728|472374661|FG000|Rescue|Adverse Event|0|||
131205782|NCT00689728|472374662|FG001|Rescue|Adverse Event|1|||
131205783|NCT00689728|472374663|FG002|Rescue|Adverse Event|0|||
131205784|NCT00689728|472374661|FG000|Rescue|Withdrawal by Subject|1|||
131205785|NCT00689728|472374662|FG001|Rescue|Withdrawal by Subject|1|||
131205786|NCT00689728|472374663|FG002|Rescue|Withdrawal by Subject|1|||
131205787|NCT00689728|472374661|FG000|Optional Follow-Up|Adverse Event|1|||
131205788|NCT00689728|472374662|FG001|Optional Follow-Up|Adverse Event|0|||
131205789|NCT00689728|472374663|FG002|Optional Follow-Up|Adverse Event|0|||
131205790|NCT00689728|472374661|FG000|Optional Follow-Up|Lack of Efficacy|0|||
131205791|NCT00689728|472374662|FG001|Optional Follow-Up|Lack of Efficacy|1|||
131205792|NCT00689728|472374663|FG002|Optional Follow-Up|Lack of Efficacy|1|||
131205793|NCT00689728|472374661|FG000|Optional Follow-Up|Lost to Follow-up|0|||
131205794|NCT00689728|472374662|FG001|Optional Follow-Up|Lost to Follow-up|1|||
131205795|NCT00689728|472374663|FG002|Optional Follow-Up|Lost to Follow-up|1|||
131205796|NCT00689728|472374661|FG000|Optional Follow-Up|Protocol Violation|0|||
131205797|NCT00689728|472374662|FG001|Optional Follow-Up|Protocol Violation|0|||
131205798|NCT00689728|472374663|FG002|Optional Follow-Up|Protocol Violation|1|||
131205799|NCT00689728|472374661|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
131205800|NCT00689728|472374662|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
131205801|NCT00689728|472374663|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
131205802|NCT03590613|472374665|FG000|Period 2, 4 Days|Physician Decision|0|||
131205803|NCT03590613|472374666|FG001|Period 2, 4 Days|Physician Decision|0|||
131205804|NCT03590613|472374667|FG002|Period 2, 4 Days|Physician Decision|0|||
131205805|NCT03590613|472374668|FG003|Period 2, 4 Days|Physician Decision|1|||
131205806|NCT04369742|472374669|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
131205807|NCT04369742|472374670|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
131205808|NCT04369742|472374669|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
131205809|NCT04369742|472374670|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
131205810|NCT00280059|472374671|FG000|Efficacy Assessment Phase|Death|2|||
131205811|NCT00280059|472374672|FG001|Efficacy Assessment Phase|Death|0|||
131205812|NCT00280059|472374671|FG000|Efficacy Assessment Phase|Adverse Event|33|||
131205813|NCT00280059|472374672|FG001|Efficacy Assessment Phase|Adverse Event|31|||
131205814|NCT00280059|472374671|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
131205815|NCT00280059|472374672|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
131205816|NCT00280059|472374671|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
131205817|NCT00280059|472374672|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
131205818|NCT00280059|472374671|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
131205819|NCT00280059|472374672|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
131205820|NCT00280059|472374671|FG000|Efficacy Assessment Phase|Other|7|||
131205821|NCT00280059|472374672|FG001|Efficacy Assessment Phase|Other|8|||
131205822|NCT00280059|472374671|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
131205823|NCT00280059|472374672|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
131205824|NCT01130831|472374677|FG000|Overall Study|Withdrawal by Subject|7|||
131205825|NCT01130831|472374677|FG000|Overall Study|Death|4|||
131205826|NCT01130831|472374677|FG000|Overall Study|Information was missing|3|||
131205827|NCT00951912|472374678|FG000|Overall Study|Lack of Efficacy|1|||
131205828|NCT00951912|472374679|FG001|Overall Study|Lack of Efficacy|0|||
131205829|NCT00951912|472374680|FG002|Overall Study|Lack of Efficacy|0|||
131205830|NCT00951912|472374678|FG000|Overall Study|Adverse Event|0|||
131205831|NCT00951912|472374679|FG001|Overall Study|Adverse Event|1|||
131205832|NCT00951912|472374680|FG002|Overall Study|Adverse Event|1|||
131205833|NCT00951912|472374678|FG000|Overall Study|Lost to Follow-up|2|||
131205834|NCT00951912|472374679|FG001|Overall Study|Lost to Follow-up|2|||
131205835|NCT00951912|472374680|FG002|Overall Study|Lost to Follow-up|0|||
131205836|NCT00951912|472374678|FG000|Overall Study|Physician Decision|1|||
131205837|NCT00951912|472374679|FG001|Overall Study|Physician Decision|0|||
131205838|NCT00951912|472374680|FG002|Overall Study|Physician Decision|1|||
131205839|NCT00951912|472374678|FG000|Overall Study|Withdrawal by Subject|1|||
131205840|NCT00951912|472374679|FG001|Overall Study|Withdrawal by Subject|1|||
131205841|NCT00951912|472374680|FG002|Overall Study|Withdrawal by Subject|0|||
131205842|NCT00951912|472374678|FG000|Overall Study|Other:Depression|1|||
131205843|NCT00951912|472374679|FG001|Overall Study|Other:Depression|0|||
131205844|NCT00951912|472374680|FG002|Overall Study|Other:Depression|0|||
131205845|NCT00951912|472374678|FG000|Overall Study|Other: Colon cancer|1|||
131205846|NCT00951912|472374679|FG001|Overall Study|Other: Colon cancer|0|||
131205847|NCT00951912|472374680|FG002|Overall Study|Other: Colon cancer|0|||
131205848|NCT00951912|472374678|FG000|Overall Study|Other: Stroke|0|||
131205849|NCT00951912|472374679|FG001|Overall Study|Other: Stroke|1|||
131205850|NCT00951912|472374680|FG002|Overall Study|Other: Stroke|0|||
131205851|NCT03417999|472374681|FG000|Overall Study|Withdrawal by Subject|1|||
131205852|NCT03417999|472374682|FG001|Overall Study|Withdrawal by Subject|0|||
131205853|NCT03417999|472374683|FG002|Overall Study|Withdrawal by Subject|0|||
131205854|NCT03417999|472374681|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
131205855|NCT03417999|472374682|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
131205856|NCT03417999|472374683|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
131205857|NCT03417999|472374681|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
131205858|NCT03417999|472374682|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
131205859|NCT03417999|472374683|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
131205860|NCT03417999|472374681|FG000|Overall Study|Inadequate study staff available to process samples|0|||
131205861|NCT03417999|472374682|FG001|Overall Study|Inadequate study staff available to process samples|0|||
131205862|NCT03417999|472374683|FG002|Overall Study|Inadequate study staff available to process samples|1|||
131205863|NCT00422942|472374689|FG000|Overall Study|Study terminated by Sponsor|3|||
131205864|NCT02612194|472374690|FG000|Overall Study|Death|5|||
131205865|NCT02612194|472374691|FG001|Overall Study|Death|0|||
131205866|NCT02612194|472374692|FG002|Overall Study|Death|2|||
131205867|NCT02612194|472374690|FG000|Overall Study|Early Study Termination|1|||
131205868|NCT02612194|472374691|FG001|Overall Study|Early Study Termination|0|||
131205869|NCT02612194|472374692|FG002|Overall Study|Early Study Termination|0|||
131205870|NCT00372905|472374695|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
131205871|NCT00372905|472374696|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
131205872|NCT00372905|472374697|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
131205873|NCT00372905|472374698|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
131205874|NCT00372905|472374695|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
131205875|NCT00372905|472374696|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
131205876|NCT00372905|472374697|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
131205877|NCT00372905|472374698|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
131205878|NCT00372905|472374695|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
131205879|NCT00372905|472374696|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
131205880|NCT00372905|472374697|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
131205881|NCT00372905|472374698|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
131205882|NCT00372905|472374695|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
131205883|NCT00372905|472374696|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
131205884|NCT00372905|472374697|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
131205885|NCT00372905|472374698|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
131205886|NCT00372905|472374695|FG000|Follow up Until Relapse or Progression|Study closed|0|||
131205887|NCT00372905|472374696|FG001|Follow up Until Relapse or Progression|Study closed|0|||
131205888|NCT00372905|472374697|FG002|Follow up Until Relapse or Progression|Study closed|0|||
131205889|NCT00372905|472374698|FG003|Follow up Until Relapse or Progression|Study closed|3|||
131205890|NCT00372905|472374695|FG000|Follow up Until Relapse or Progression|Other|0|||
131205891|NCT00372905|472374696|FG001|Follow up Until Relapse or Progression|Other|1|||
131205892|NCT00372905|472374697|FG002|Follow up Until Relapse or Progression|Other|0|||
131205893|NCT00372905|472374698|FG003|Follow up Until Relapse or Progression|Other|0|||
131205894|NCT02312934|472374699|FG000|Overall Study|Lost to Follow-up|1|||
131205895|NCT02312934|472374700|FG001|Overall Study|Lost to Follow-up|0|||
131205896|NCT02312934|472374699|FG000|Overall Study|Physician Decision|1|||
131205897|NCT02312934|472374700|FG001|Overall Study|Physician Decision|0|||
131205898|NCT00689299|472374702|FG000|Overall Study|Adverse Event|2|||
131205899|NCT00689299|472374703|FG001|Overall Study|Adverse Event|1|||
131205900|NCT00689299|472374704|FG002|Overall Study|Adverse Event|1|||
131205901|NCT00689299|472374702|FG000|Overall Study|Lost to Follow-up|0|||
131205902|NCT00689299|472374703|FG001|Overall Study|Lost to Follow-up|1|||
131205903|NCT00689299|472374704|FG002|Overall Study|Lost to Follow-up|1|||
131205904|NCT00689299|472374702|FG000|Overall Study|Withdrawal by Subject|4|||
131205905|NCT00689299|472374703|FG001|Overall Study|Withdrawal by Subject|1|||
131205906|NCT00689299|472374704|FG002|Overall Study|Withdrawal by Subject|3|||
131205907|NCT00689299|472374702|FG000|Overall Study|Protocol Violation|1|||
131205908|NCT00689299|472374703|FG001|Overall Study|Protocol Violation|0|||
131205909|NCT00689299|472374704|FG002|Overall Study|Protocol Violation|0|||
131205910|NCT02613910|472374707|FG000|Overall Study|Termination of study|1|||
131205911|NCT02098733|472374708|FG000|Overall Study|Data Not Available|5|||
131205912|NCT02098733|472374708|FG000|Overall Study|Lost to Follow-up|5|||
131205913|NCT03395704|472374709|FG000|Overall Study|Adverse Event|2|||
131205914|NCT03395704|472374710|FG001|Overall Study|Adverse Event|1|||
131205915|NCT03395704|472374709|FG000|Overall Study|Withdrawal by Subject|2|||
131205916|NCT03395704|472374710|FG001|Overall Study|Withdrawal by Subject|1|||
131205917|NCT03395704|472374709|FG000|Overall Study|Physician Decision|0|||
131205918|NCT03395704|472374710|FG001|Overall Study|Physician Decision|1|||
131205919|NCT00434876|472374713|FG000|Overall Study|Lost to Follow-up|1|||
131205920|NCT00434876|472374714|FG001|Overall Study|Lost to Follow-up|1|||
131205921|NCT03044730|472374715|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
131205922|NCT03044730|472374715|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
131205923|NCT03044730|472374715|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
131205924|NCT03044730|472374715|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
131205925|NCT03044730|472374715|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
131205926|NCT03044730|472374715|FG000|Cycles 4 and Beyond|Adverse Event|1|||
131205927|NCT03044730|472374715|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
131205928|NCT03044730|472374715|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
131205929|NCT03044730|472374715|FG000|On Follow-up for 2 Years|Death|17|||
131205930|NCT01786707|472377033|FG000|Overall Study|Lost to Follow-up|1|||
131205931|NCT01786707|472377034|FG001|Overall Study|Lost to Follow-up|1|||
131205932|NCT02058940|472377035|FG000|Overall Study|Discharged from Critical Care Unit|1|||
131205933|NCT01519700|472377036|FG000|Overall Study|Death|1|||
131205934|NCT01519700|472377037|FG001|Overall Study|Death|0|||
131205935|NCT01519700|472377038|FG002|Overall Study|Death|0|||
131205936|NCT01519700|472377039|FG003|Overall Study|Death|0|||
131205937|NCT01519700|472377036|FG000|Overall Study|Lost to Follow-up|0|||
131205938|NCT01519700|472377037|FG001|Overall Study|Lost to Follow-up|0|||
131205939|NCT01519700|472377038|FG002|Overall Study|Lost to Follow-up|1|||
131205940|NCT01519700|472377039|FG003|Overall Study|Lost to Follow-up|1|||
131205941|NCT01519700|472377036|FG000|Overall Study|Physician Decision|1|||
131205942|NCT01519700|472377037|FG001|Overall Study|Physician Decision|1|||
131205943|NCT01519700|472377038|FG002|Overall Study|Physician Decision|3|||
131205944|NCT01519700|472377039|FG003|Overall Study|Physician Decision|0|||
131205945|NCT01519700|472377036|FG000|Overall Study|Withdrawal by Subject|5|||
131205946|NCT01519700|472377037|FG001|Overall Study|Withdrawal by Subject|3|||
131205947|NCT01519700|472377038|FG002|Overall Study|Withdrawal by Subject|3|||
131205948|NCT01519700|472377039|FG003|Overall Study|Withdrawal by Subject|2|||
131205949|NCT01519700|472377036|FG000|Overall Study|Other Reason|2|||
131205950|NCT01519700|472377037|FG001|Overall Study|Other Reason|2|||
131205951|NCT01519700|472377038|FG002|Overall Study|Other Reason|0|||
131205952|NCT01519700|472377039|FG003|Overall Study|Other Reason|4|||
131205953|NCT02079077|472377040|FG000|Overall Study|Lost to Follow-up|5|||
131205954|NCT02079077|472377041|FG001|Overall Study|Lost to Follow-up|7|||
131205955|NCT02079077|472377040|FG000|Overall Study|Became STIs Positive|1|||
131205956|NCT02079077|472377041|FG001|Overall Study|Became STIs Positive|2|||
131205957|NCT00772031|472377042|FG000|Overall Study|Early termination of trial|12|||
131205958|NCT00772031|472377043|FG001|Overall Study|Early termination of trial|10|||
131205959|NCT00772031|472377042|FG000|Overall Study|Lost to Follow-up|20|||
131205960|NCT00772031|472377043|FG001|Overall Study|Lost to Follow-up|33|||
131205961|NCT00656136|472377044|FG000|Overall Study|Progressive disease|177|||
131205962|NCT00656136|472377045|FG001|Overall Study|Progressive disease|322|||
131205963|NCT00656136|472377044|FG000|Overall Study|Other Adverse Event|5|||
131205964|NCT00656136|472377045|FG001|Overall Study|Other Adverse Event|51|||
131205965|NCT00656136|472377044|FG000|Overall Study|Protocol Violation|2|||
131205966|NCT00656136|472377045|FG001|Overall Study|Protocol Violation|3|||
131205967|NCT00656136|472377044|FG000|Overall Study|Patient refused to take study medication|7|||
131205968|NCT00656136|472377045|FG001|Overall Study|Patient refused to take study medication|10|||
131205969|NCT00656136|472377044|FG000|Overall Study|Unknown and others|4|||
131205970|NCT00656136|472377045|FG001|Overall Study|Unknown and others|4|||
131205971|NCT02406586|472377046|FG000|Overall Study|Lost to Follow-up|0|||
131205972|NCT02406586|472377047|FG001|Overall Study|Lost to Follow-up|4|||
131205973|NCT02406586|472377048|FG002|Overall Study|Lost to Follow-up|2|||
131205974|NCT02406586|472377046|FG000|Overall Study|Withdrawal by Subject|1|||
131205975|NCT02406586|472377047|FG001|Overall Study|Withdrawal by Subject|0|||
131205976|NCT02406586|472377048|FG002|Overall Study|Withdrawal by Subject|0|||
131205977|NCT00682539|472377049|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
131205978|NCT00682539|472377050|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
131205979|NCT00682539|472377051|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
131205980|NCT00682539|472377049|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
131205981|NCT00682539|472377050|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
131205982|NCT00682539|472377051|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
131205983|NCT03339999|472377054|FG000|Overall Study|Adverse Event|1|||
131205984|NCT03339999|472377055|FG001|Overall Study|Adverse Event|2|||
131205985|NCT03339999|472377056|FG002|Overall Study|Adverse Event|2|||
131205986|NCT03339999|472377057|FG003|Overall Study|Adverse Event|1|||
131205987|NCT03339999|472377054|FG000|Overall Study|Lack of Efficacy|0|||
131205988|NCT03339999|472377055|FG001|Overall Study|Lack of Efficacy|1|||
131205989|NCT03339999|472377056|FG002|Overall Study|Lack of Efficacy|0|||
131205990|NCT03339999|472377057|FG003|Overall Study|Lack of Efficacy|0|||
131205991|NCT03339999|472377054|FG000|Overall Study|Lost to Follow-up|0|||
131205992|NCT03339999|472377055|FG001|Overall Study|Lost to Follow-up|0|||
131205993|NCT03339999|472377056|FG002|Overall Study|Lost to Follow-up|0|||
131205994|NCT03339999|472377057|FG003|Overall Study|Lost to Follow-up|1|||
131205995|NCT03339999|472377054|FG000|Overall Study|Study Terminated by Sponsor|6|||
131205996|NCT03339999|472377055|FG001|Overall Study|Study Terminated by Sponsor|3|||
131205997|NCT03339999|472377056|FG002|Overall Study|Study Terminated by Sponsor|4|||
131205998|NCT03339999|472377057|FG003|Overall Study|Study Terminated by Sponsor|3|||
131205999|NCT04738123|472377070|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
131206000|NCT04738123|472377071|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
131206001|NCT04738123|472377070|FG000|Overall Study|Progressive Disease|0|||
131206002|NCT04738123|472377071|FG001|Overall Study|Progressive Disease|4|||
131206003|NCT04738123|472377070|FG000|Overall Study|Adverse Event|8|||
131206004|NCT04738123|472377071|FG001|Overall Study|Adverse Event|7|||
131206005|NCT04738123|472377070|FG000|Overall Study|Other Reasons|0|||
131206006|NCT04738123|472377071|FG001|Overall Study|Other Reasons|1|||
131206007|NCT04738123|472377070|FG000|Overall Study|Suicidal or assaultive behavior|0|||
131206008|NCT04738123|472377071|FG001|Overall Study|Suicidal or assaultive behavior|2|||
131206009|NCT04738123|472377070|FG000|Overall Study|Protocol Violation|2|||
131206010|NCT04738123|472377071|FG001|Overall Study|Protocol Violation|2|||
131206011|NCT04738123|472377070|FG000|Overall Study|Consent Withdrawn|35|||
131206012|NCT04738123|472377071|FG001|Overall Study|Consent Withdrawn|22|||
131206013|NCT03982069|472377073|FG000|Overall Study|Lost to Follow-up|5|||
131206014|NCT03982069|472377074|FG001|Overall Study|Lost to Follow-up|5|||
131206015|NCT03982069|472377075|FG002|Overall Study|Lost to Follow-up|3|||
131206016|NCT03982069|472377076|FG003|Overall Study|Lost to Follow-up|5|||
131206017|NCT03982069|472377073|FG000|Overall Study|Physician Decision|0|||
131206018|NCT03982069|472377074|FG001|Overall Study|Physician Decision|1|||
131206019|NCT03982069|472377075|FG002|Overall Study|Physician Decision|0|||
131206020|NCT03982069|472377076|FG003|Overall Study|Physician Decision|0|||
131206021|NCT03982069|472377073|FG000|Overall Study|Withdrawal by Subject|2|||
131206022|NCT03982069|472377074|FG001|Overall Study|Withdrawal by Subject|1|||
131206023|NCT03982069|472377075|FG002|Overall Study|Withdrawal by Subject|5|||
131206024|NCT03982069|472377076|FG003|Overall Study|Withdrawal by Subject|2|||
131206025|NCT03982069|472377073|FG000|Overall Study|Specimen loss|3|||
131206026|NCT03982069|472377074|FG001|Overall Study|Specimen loss|3|||
131206027|NCT03982069|472377075|FG002|Overall Study|Specimen loss|1|||
131206028|NCT03982069|472377076|FG003|Overall Study|Specimen loss|1|||
131206029|NCT00787527|472377079|FG000|Overall Study|Toxicity|3|||
131206030|NCT03137433|472377080|FG000|Overall Study|Withdrawal by Subject|11|||
131206031|NCT03137433|472377081|FG001|Overall Study|Withdrawal by Subject|11|||
131206032|NCT03137433|472377080|FG000|Overall Study|Lost to Follow-up|5|||
131206033|NCT03137433|472377081|FG001|Overall Study|Lost to Follow-up|6|||
131206034|NCT03137433|472377080|FG000|Overall Study|Physician Decision|2|||
131206035|NCT03137433|472377081|FG001|Overall Study|Physician Decision|0|||
131206036|NCT03137433|472377080|FG000|Overall Study|Moved out of study area|1|||
131206037|NCT03137433|472377081|FG001|Overall Study|Moved out of study area|0|||
131206038|NCT03137433|472377080|FG000|Overall Study|Too far out of window due to COVID|0|||
131206039|NCT03137433|472377081|FG001|Overall Study|Too far out of window due to COVID|1|||
131206040|NCT00083616|472377082|FG000|Overall Study|Disease Progression|16|||
131206041|NCT00083616|472377082|FG000|Overall Study|Lost to Follow-up|1|||
131206042|NCT00083616|472377082|FG000|Overall Study|Physician Decision|2|||
131206043|NCT00083616|472377082|FG000|Overall Study|Withdrawal by Subject|3|||
131206044|NCT00083616|472377082|FG000|Overall Study|Ineligibility determined|2|||
131206045|NCT00083616|472377082|FG000|Overall Study|Non-compliance|1|||
131206046|NCT00083616|472377082|FG000|Overall Study|Other|6|||
131206047|NCT01474993|472377084|FG000|Overall Study|Lost to Follow-up|1|||
131206048|NCT01474993|472377085|FG001|Overall Study|Lost to Follow-up|2|||
131206049|NCT01474993|472377084|FG000|Overall Study|Adverse Event|0|||
131206050|NCT01474993|472377085|FG001|Overall Study|Adverse Event|1|||
131206051|NCT01853397|472377086|FG000|Overall Study|Withdrawal by Subject|0|||
131206052|NCT01853397|472377087|FG001|Overall Study|Withdrawal by Subject|0|||
131206053|NCT01853397|472377088|FG002|Overall Study|Withdrawal by Subject|0|||
131206054|NCT01853397|472377089|FG003|Overall Study|Withdrawal by Subject|1|||
131206055|NCT01853397|472377086|FG000|Overall Study|Subject Noncompliance|0|||
131206056|NCT01853397|472377087|FG001|Overall Study|Subject Noncompliance|0|||
131206057|NCT01853397|472377088|FG002|Overall Study|Subject Noncompliance|0|||
131206058|NCT01853397|472377089|FG003|Overall Study|Subject Noncompliance|1|||
131206059|NCT03258710|472377090|FG000|Overall Study|Adverse Event|1|||
131206060|NCT03258710|472377090|FG000|Overall Study|Protocol-defined stopping criteria|1|||
131206061|NCT03258710|472377090|FG000|Overall Study|Physician Decision|1|||
131206062|NCT02242305|472377091|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
131206063|NCT02242305|472377092|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
131206064|NCT02242305|472377091|FG000|Overall Study|Adverse Event|1|||
131206065|NCT02242305|472377092|FG001|Overall Study|Adverse Event|0|||
131206066|NCT02242305|472377091|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
131206067|NCT02242305|472377092|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
131206068|NCT02242305|472377091|FG000|Overall Study|Subject withdraws inform consent|0|||
131206069|NCT02242305|472377092|FG001|Overall Study|Subject withdraws inform consent|4|||
131206070|NCT02242305|472377091|FG000|Overall Study|Lost to Follow-up|2|||
131206071|NCT02242305|472377092|FG001|Overall Study|Lost to Follow-up|0|||
131206072|NCT03451630|472377093|FG000|Overall Study|Death|15|||
131206073|NCT03451630|472377094|FG001|Overall Study|Death|16|||
131206074|NCT03451630|472377095|FG002|Overall Study|Death|11|||
131206075|NCT03451630|472377093|FG000|Overall Study|Lost to Follow-up|9|||
131206076|NCT03451630|472377094|FG001|Overall Study|Lost to Follow-up|0|||
131206077|NCT03451630|472377095|FG002|Overall Study|Lost to Follow-up|4|||
131206078|NCT03451630|472377093|FG000|Overall Study|Withdrawal by Subject|0|||
131206079|NCT03451630|472377094|FG001|Overall Study|Withdrawal by Subject|3|||
131206080|NCT03451630|472377095|FG002|Overall Study|Withdrawal by Subject|0|||
130734872|NCT03410056|470648951|FG000|Overall Study|Withdrawal by Subject|0|||
131206081|NCT03451630|472377093|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
131206082|NCT03451630|472377094|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
131206083|NCT03451630|472377095|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
131206084|NCT01724021|472377096|FG000|Overall Study|Adverse Event|11|||
130734873|NCT03410056|470648952|FG001|Overall Study|Withdrawal by Subject|2|||
130734874|NCT03410056|470648953|FG002|Overall Study|Withdrawal by Subject|5|||
130734875|NCT03410056|470648954|FG003|Overall Study|Withdrawal by Subject|5|||
130734876|NCT03410056|470648955|FG004|Overall Study|Withdrawal by Subject|0|||
131206085|NCT01724021|472377097|FG001|Overall Study|Adverse Event|6|||
131206086|NCT01724021|472377096|FG000|Overall Study|Death|46|||
131206087|NCT01724021|472377097|FG001|Overall Study|Death|58|||
131206088|NCT01724021|472377096|FG000|Overall Study|Participant request/ Withdrew consent|18|||
131206089|NCT01724021|472377097|FG001|Overall Study|Participant request/ Withdrew consent|14|||
131206090|NCT01724021|472377096|FG000|Overall Study|Lost to Follow-up|15|||
131206091|NCT01724021|472377097|FG001|Overall Study|Lost to Follow-up|15|||
131206092|NCT01724021|472377096|FG000|Overall Study|Reason Not Specified|36|||
131206093|NCT01724021|472377097|FG001|Overall Study|Reason Not Specified|39|||
131206094|NCT01724021|472377096|FG000|Overall Study|Missing|1|||
131206095|NCT01724021|472377097|FG001|Overall Study|Missing|1|||
131206096|NCT02452892|472377100|FG000|Week 1 Initial Randommization|Adverse Event|1|||
131206097|NCT02452892|472377101|FG001|Week 1 Initial Randommization|Adverse Event|0|||
131206098|NCT02452892|472377102|FG002|Week 1 Initial Randommization|Adverse Event|0|||
131206099|NCT02452892|472377103|FG003|Week 1 Initial Randommization|Adverse Event|0|||
131206100|NCT02452892|472377100|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
131206101|NCT02452892|472377101|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
131206102|NCT02452892|472377102|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
131206103|NCT02452892|472377103|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
131206104|NCT02452892|472377100|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
131206105|NCT02452892|472377101|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
131206106|NCT02452892|472377102|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
131206107|NCT02452892|472377103|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
131206108|NCT02452892|472377100|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
131206109|NCT02452892|472377101|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
131206110|NCT02452892|472377102|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
131206111|NCT02452892|472377103|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
131206112|NCT02452892|472377100|FG000|Follow-up|Withdrawal by Subject|0|||
131206113|NCT02452892|472377101|FG001|Follow-up|Withdrawal by Subject|0|||
131206114|NCT02452892|472377102|FG002|Follow-up|Withdrawal by Subject|0|||
131206115|NCT02452892|472377103|FG003|Follow-up|Withdrawal by Subject|1|||
131206116|NCT02452892|472377100|FG000|Follow-up|Subject left town on Day 42|1|||
131206117|NCT02452892|472377101|FG001|Follow-up|Subject left town on Day 42|0|||
131206118|NCT02452892|472377102|FG002|Follow-up|Subject left town on Day 42|0|||
131206119|NCT02452892|472377103|FG003|Follow-up|Subject left town on Day 42|0|||
131206120|NCT02041533|472377105|FG000|Pre-Treatment Period|Disease Progression|1|||
131206121|NCT02041533|472377106|FG001|Pre-Treatment Period|Disease Progression|1|||
131206122|NCT02041533|472377105|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
131206123|NCT02041533|472377106|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
131206124|NCT02041533|472377105|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
131206125|NCT02041533|472377106|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
131206126|NCT02041533|472377105|FG000|Treatment Period|Disease progression|189|||
131206127|NCT02041533|472377106|FG001|Treatment Period|Disease progression|146|||
131206128|NCT02041533|472377105|FG000|Treatment Period|Study drug toxicity|30|||
131206129|NCT02041533|472377106|FG001|Treatment Period|Study drug toxicity|34|||
131206130|NCT02041533|472377105|FG000|Treatment Period|Death|1|||
131206131|NCT02041533|472377106|FG001|Treatment Period|Death|0|||
131206132|NCT02041533|472377105|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
131206133|NCT02041533|472377106|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
131206134|NCT02041533|472377105|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
131206135|NCT02041533|472377106|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
131206136|NCT02041533|472377105|FG000|Treatment Period|Participant withdrew consent|2|||
131206137|NCT02041533|472377106|FG001|Treatment Period|Participant withdrew consent|2|||
131206138|NCT02041533|472377105|FG000|Treatment Period|Maximum clinical benefit|0|||
131206139|NCT02041533|472377106|FG001|Treatment Period|Maximum clinical benefit|18|||
131206140|NCT02041533|472377105|FG000|Treatment Period|Poor/Non-compliance|1|||
131206141|NCT02041533|472377106|FG001|Treatment Period|Poor/Non-compliance|0|||
131206142|NCT02041533|472377105|FG000|Treatment Period|Administrative reason by sponsor|1|||
131206143|NCT02041533|472377106|FG001|Treatment Period|Administrative reason by sponsor|0|||
131206144|NCT02041533|472377105|FG000|Treatment Period|Other reasons|9|||
131206145|NCT02041533|472377106|FG001|Treatment Period|Other reasons|2|||
131206146|NCT02041533|472377105|FG000|Treatment Period|Not Reported|0|||
131206147|NCT02041533|472377106|FG001|Treatment Period|Not Reported|1|||
131206148|NCT00565721|472377109|FG000|Overall Study|Screen Failure|2|||
131206149|NCT00565721|472377109|FG000|Overall Study|Lost to Follow-up|6|||
131206150|NCT00565721|472377109|FG000|Overall Study|Technical Problems|1|||
131206151|NCT00565721|472377109|FG000|Overall Study|Physician Decision|2|||
131206152|NCT00565721|472377109|FG000|Overall Study|Other reasons|6|||
131206153|NCT02813681|472377110|FG000|Overall Study|Physician Decision|5|||
131206154|NCT02813681|472377111|FG001|Overall Study|Physician Decision|5|||
131206155|NCT02813681|472377112|FG002|Overall Study|Physician Decision|0|||
131206156|NCT02813681|472377110|FG000|Overall Study|Lost to Follow-up|0|||
131206157|NCT02813681|472377111|FG001|Overall Study|Lost to Follow-up|1|||
131206158|NCT02813681|472377112|FG002|Overall Study|Lost to Follow-up|0|||
131206159|NCT02500706|472377113|FG000|Overall Study|Adverse Event|0|||
131206160|NCT02500706|472377114|FG001|Overall Study|Adverse Event|0|||
131206161|NCT02500706|472377115|FG002|Overall Study|Adverse Event|1|||
131206162|NCT02500706|472377113|FG000|Overall Study|Lost to Follow-up|0|||
131206163|NCT02500706|472377114|FG001|Overall Study|Lost to Follow-up|1|||
131206164|NCT02500706|472377115|FG002|Overall Study|Lost to Follow-up|1|||
131206165|NCT02500706|472377113|FG000|Overall Study|Withdrawal by Subject|4|||
131206166|NCT02500706|472377114|FG001|Overall Study|Withdrawal by Subject|6|||
131206167|NCT02500706|472377115|FG002|Overall Study|Withdrawal by Subject|4|||
131206168|NCT02500706|472377113|FG000|Overall Study|Unclassified|0|||
131206169|NCT02500706|472377114|FG001|Overall Study|Unclassified|0|||
131206170|NCT02500706|472377115|FG002|Overall Study|Unclassified|1|||
131206171|NCT01497899|472377120|FG000|Double-Blind Phase|Randomized but not Treated|1|||
131206172|NCT01497899|472377121|FG001|Double-Blind Phase|Randomized but not Treated|0|||
131206173|NCT01497899|472377122|FG002|Double-Blind Phase|Randomized but not Treated|0|||
131206174|NCT01497899|472377123|FG003|Double-Blind Phase|Randomized but not Treated|0|||
131206175|NCT01497899|472377120|FG000|Double-Blind Phase|Adverse Event|1|||
131206176|NCT01497899|472377121|FG001|Double-Blind Phase|Adverse Event|0|||
131206177|NCT01497899|472377122|FG002|Double-Blind Phase|Adverse Event|0|||
131206178|NCT01497899|472377123|FG003|Double-Blind Phase|Adverse Event|0|||
131206179|NCT01497899|472377120|FG000|Double-Blind Phase|Lack of Efficacy|0|||
131206180|NCT01497899|472377121|FG001|Double-Blind Phase|Lack of Efficacy|1|||
131206181|NCT01497899|472377122|FG002|Double-Blind Phase|Lack of Efficacy|0|||
131206182|NCT01497899|472377123|FG003|Double-Blind Phase|Lack of Efficacy|0|||
131206183|NCT01497899|472377120|FG000|Double-Blind Phase|Investigator's Discretion|1|||
131206184|NCT01497899|472377121|FG001|Double-Blind Phase|Investigator's Discretion|0|||
131206185|NCT01497899|472377122|FG002|Double-Blind Phase|Investigator's Discretion|0|||
131206186|NCT01497899|472377123|FG003|Double-Blind Phase|Investigator's Discretion|0|||
131206187|NCT01497899|472377120|FG000|Double-Blind Phase|Withdrew Consent|0|||
131206188|NCT01497899|472377121|FG001|Double-Blind Phase|Withdrew Consent|1|||
131206189|NCT01497899|472377122|FG002|Double-Blind Phase|Withdrew Consent|0|||
131206190|NCT01497899|472377123|FG003|Double-Blind Phase|Withdrew Consent|0|||
131206191|NCT01497899|472377120|FG000|Double-Blind Phase|Lost to Follow-up|3|||
131206192|NCT01497899|472377121|FG001|Double-Blind Phase|Lost to Follow-up|2|||
131206193|NCT01497899|472377122|FG002|Double-Blind Phase|Lost to Follow-up|0|||
131206194|NCT01497899|472377123|FG003|Double-Blind Phase|Lost to Follow-up|0|||
131206195|NCT01497899|472377120|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
131206196|NCT01497899|472377121|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
131206197|NCT01497899|472377122|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
131206198|NCT01497899|472377123|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
131206199|NCT01497899|472377120|FG000|Open-Label Extension Phase|Adverse Event|1|||
131206200|NCT01497899|472377121|FG001|Open-Label Extension Phase|Adverse Event|0|||
131206201|NCT01497899|472377122|FG002|Open-Label Extension Phase|Adverse Event|0|||
131206202|NCT01497899|472377123|FG003|Open-Label Extension Phase|Adverse Event|0|||
131206203|NCT01497899|472377120|FG000|Open-Label Extension Phase|Death|1|||
131206204|NCT01497899|472377121|FG001|Open-Label Extension Phase|Death|0|||
131206205|NCT01497899|472377122|FG002|Open-Label Extension Phase|Death|0|||
131206206|NCT01497899|472377123|FG003|Open-Label Extension Phase|Death|0|||
131206207|NCT01497899|472377120|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
131206208|NCT01497899|472377121|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
131206209|NCT01497899|472377122|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
131206210|NCT01497899|472377123|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
131206211|NCT01497899|472377120|FG000|Open-Label Extension Phase|Pregnancy|0|||
131206212|NCT01497899|472377121|FG001|Open-Label Extension Phase|Pregnancy|1|||
131206213|NCT01497899|472377122|FG002|Open-Label Extension Phase|Pregnancy|1|||
131206214|NCT01497899|472377123|FG003|Open-Label Extension Phase|Pregnancy|0|||
131206215|NCT01497899|472377120|FG000|Open-Label Extension Phase|Protocol Violation|0|||
131206216|NCT01497899|472377121|FG001|Open-Label Extension Phase|Protocol Violation|0|||
131206217|NCT01497899|472377122|FG002|Open-Label Extension Phase|Protocol Violation|1|||
131206218|NCT01497899|472377123|FG003|Open-Label Extension Phase|Protocol Violation|0|||
131206219|NCT01497899|472377120|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
131206220|NCT01497899|472377121|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
131206221|NCT01497899|472377122|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
131206222|NCT01497899|472377123|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
131206223|NCT05047601|472377127|FG000|Overall Study|Lost to Follow-up|9|||
131206224|NCT05047601|472377128|FG001|Overall Study|Lost to Follow-up|11|||
131206225|NCT05047601|472377129|FG002|Overall Study|Lost to Follow-up|7|||
131206226|NCT05047601|472377127|FG000|Overall Study|Withdrawal by Subject|25|||
131206227|NCT05047601|472377128|FG001|Overall Study|Withdrawal by Subject|36|||
131206228|NCT05047601|472377129|FG002|Overall Study|Withdrawal by Subject|23|||
131206229|NCT05047601|472377127|FG000|Overall Study|Other|10|||
131206230|NCT05047601|472377128|FG001|Overall Study|Other|6|||
131206231|NCT05047601|472377129|FG002|Overall Study|Other|5|||
131206232|NCT00286234|472377130|FG000|Overall Study|Protocol Violation|1|||
131206233|NCT00286234|472377131|FG001|Overall Study|Protocol Violation|2|||
131206234|NCT00286234|472377132|FG002|Overall Study|Protocol Violation|0|||
131206235|NCT00286234|472377133|FG003|Overall Study|Protocol Violation|1|||
131206236|NCT00286234|472377130|FG000|Overall Study|Physician Decision|1|||
131206237|NCT00286234|472377131|FG001|Overall Study|Physician Decision|0|||
131206238|NCT00286234|472377132|FG002|Overall Study|Physician Decision|0|||
131206239|NCT00286234|472377133|FG003|Overall Study|Physician Decision|1|||
131206240|NCT00286234|472377130|FG000|Overall Study|Adverse Event|0|||
131206241|NCT00286234|472377131|FG001|Overall Study|Adverse Event|0|||
131206242|NCT00286234|472377132|FG002|Overall Study|Adverse Event|0|||
131206243|NCT00286234|472377133|FG003|Overall Study|Adverse Event|1|||
131206244|NCT00286234|472377130|FG000|Overall Study|Adverse Event|0|||
131206245|NCT00286234|472377131|FG001|Overall Study|Adverse Event|0|||
131206246|NCT00286234|472377132|FG002|Overall Study|Adverse Event|0|||
131206247|NCT00286234|472377133|FG003|Overall Study|Adverse Event|1|||
131206248|NCT01874288|472377137|FG000|Overall Study|Withdrawal by Subject|1|||
131206249|NCT01874288|472377138|FG001|Overall Study|Withdrawal by Subject|0|||
131206250|NCT01874288|472377139|FG002|Overall Study|Withdrawal by Subject|2|||
131206251|NCT01874288|472377140|FG003|Overall Study|Withdrawal by Subject|1|||
131206252|NCT01874288|472377141|FG004|Overall Study|Withdrawal by Subject|1|||
131206253|NCT01874288|472377137|FG000|Overall Study|Physician Decision|0|||
131206254|NCT01874288|472377138|FG001|Overall Study|Physician Decision|0|||
131206255|NCT01874288|472377139|FG002|Overall Study|Physician Decision|0|||
131206256|NCT01874288|472377140|FG003|Overall Study|Physician Decision|1|||
131206257|NCT01874288|472377141|FG004|Overall Study|Physician Decision|0|||
131206258|NCT01874288|472377137|FG000|Overall Study|Progressive disease|2|||
131206259|NCT01874288|472377138|FG001|Overall Study|Progressive disease|0|||
131206260|NCT01874288|472377139|FG002|Overall Study|Progressive disease|3|||
131206261|NCT01874288|472377140|FG003|Overall Study|Progressive disease|5|||
131206262|NCT01874288|472377141|FG004|Overall Study|Progressive disease|1|||
131206263|NCT00283062|472377142|FG000|Overall Study|Did not receive any study medication|5|||
131206264|NCT00283062|472377143|FG001|Overall Study|Did not receive any study medication|4|||
131206265|NCT00283062|472377144|FG002|Overall Study|Did not receive any study medication|36|||
131206266|NCT00283062|472377145|FG003|Overall Study|Did not receive any study medication|45|||
131206267|NCT00283062|472377142|FG000|Overall Study|Adverse Event|2|||
131206268|NCT00283062|472377143|FG001|Overall Study|Adverse Event|0|||
131206269|NCT00283062|472377144|FG002|Overall Study|Adverse Event|1|||
131206270|NCT00283062|472377145|FG003|Overall Study|Adverse Event|0|||
131206271|NCT00283062|472377142|FG000|Overall Study|Lost to Follow-up|1|||
131206272|NCT00283062|472377143|FG001|Overall Study|Lost to Follow-up|0|||
131206273|NCT00283062|472377144|FG002|Overall Study|Lost to Follow-up|1|||
131206274|NCT00283062|472377145|FG003|Overall Study|Lost to Follow-up|0|||
131206275|NCT00283062|472377142|FG000|Overall Study|Progressive disease|0|||
131206276|NCT00283062|472377143|FG001|Overall Study|Progressive disease|0|||
131206277|NCT00283062|472377144|FG002|Overall Study|Progressive disease|1|||
131206278|NCT00283062|472377145|FG003|Overall Study|Progressive disease|0|||
131206279|NCT00283062|472377142|FG000|Overall Study|Participant did not wish to continue|3|||
131206280|NCT00283062|472377143|FG001|Overall Study|Participant did not wish to continue|2|||
131206281|NCT00283062|472377144|FG002|Overall Study|Participant did not wish to continue|1|||
131206282|NCT00283062|472377145|FG003|Overall Study|Participant did not wish to continue|0|||
131206283|NCT00283062|472377142|FG000|Overall Study|Undefined|0|||
131206284|NCT00283062|472377143|FG001|Overall Study|Undefined|1|||
131206285|NCT00283062|472377144|FG002|Overall Study|Undefined|1|||
131206286|NCT00283062|472377145|FG003|Overall Study|Undefined|4|||
131206287|NCT00283062|472377142|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
131206288|NCT00283062|472377143|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
131206289|NCT00283062|472377144|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
131206290|NCT00283062|472377145|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
131206291|NCT03137173|472377146|FG000|Overall Study|Withdrawal by Subject|8|||
131206292|NCT03137173|472377147|FG001|Overall Study|Withdrawal by Subject|13|||
131206293|NCT03137173|472377146|FG000|Overall Study|Death|1|||
131206294|NCT03137173|472377147|FG001|Overall Study|Death|3|||
131206295|NCT03137173|472377146|FG000|Overall Study|Physician Decision|1|||
131206296|NCT03137173|472377147|FG001|Overall Study|Physician Decision|0|||
131206297|NCT03137173|472377146|FG000|Overall Study|Lost to Follow-up|13|||
131206298|NCT03137173|472377147|FG001|Overall Study|Lost to Follow-up|18|||
131206299|NCT03137173|472377146|FG000|Overall Study|Other reasons|3|||
131206300|NCT03137173|472377147|FG001|Overall Study|Other reasons|2|||
131206301|NCT01365468|472377148|FG000|Overall Study|Physician Decision|1|||
131206302|NCT01365468|472377149|FG001|Overall Study|Physician Decision|0|||
131206303|NCT01365468|472377148|FG000|Overall Study|Disease progression|1|||
131206304|NCT01365468|472377149|FG001|Overall Study|Disease progression|0|||
131206305|NCT01365468|472377148|FG000|Overall Study|Lost to Follow-up|2|||
131206306|NCT01365468|472377149|FG001|Overall Study|Lost to Follow-up|0|||
131206307|NCT03524664|472377150|FG000|Overall Study|Withdrawal by Subject|1|||
131206308|NCT03524664|472377151|FG001|Overall Study|Withdrawal by Subject|2|||
131206309|NCT03524664|472377150|FG000|Overall Study|Lost to Follow-up|4|||
131206310|NCT03524664|472377151|FG001|Overall Study|Lost to Follow-up|13|||
131206311|NCT00423267|472377152|FG000|Period A|Withdrawal by Subject|0|||
131206312|NCT00423267|472377153|FG001|Period A|Withdrawal by Subject|1|||
131206313|NCT00423267|472377152|FG000|Period A|Non-compliance with protocol|1|||
131206314|NCT00423267|472377153|FG001|Period A|Non-compliance with protocol|0|||
131206315|NCT00423267|472377152|FG000|Period A|Administrative|1|||
131206316|NCT00423267|472377153|FG001|Period A|Administrative|0|||
131206317|NCT00827112|472377154|FG000|Overall Study|Adverse Event|2|||
131206318|NCT00827112|472377155|FG001|Overall Study|Adverse Event|0|||
131206319|NCT00827112|472377154|FG000|Overall Study|Lack of Efficacy|2|||
131206320|NCT00827112|472377155|FG001|Overall Study|Lack of Efficacy|0|||
131206321|NCT00827112|472377154|FG000|Overall Study|Lost to Follow-up|3|||
131206322|NCT00827112|472377155|FG001|Overall Study|Lost to Follow-up|2|||
131206323|NCT00827112|472377154|FG000|Overall Study|Pregnancy|0|||
131206324|NCT00827112|472377155|FG001|Overall Study|Pregnancy|1|||
131206325|NCT00827112|472377154|FG000|Overall Study|Protocol Violation|0|||
131206326|NCT00827112|472377155|FG001|Overall Study|Protocol Violation|2|||
131206327|NCT00827112|472377154|FG000|Overall Study|Withdrawal by Subject|2|||
131206328|NCT00827112|472377155|FG001|Overall Study|Withdrawal by Subject|1|||
131206329|NCT00827112|472377154|FG000|Overall Study|Randomized but not treated|5|||
131206330|NCT00827112|472377155|FG001|Overall Study|Randomized but not treated|3|||
131206331|NCT00827112|472377154|FG000|Overall Study|Other|1|||
131206332|NCT00827112|472377155|FG001|Overall Study|Other|3|||
131206333|NCT00591786|472377160|FG000|Overall Study|Withdrawal of Informed Consent|0|||
131206334|NCT00591786|472377161|FG001|Overall Study|Withdrawal of Informed Consent|0|||
131206335|NCT00591786|472377162|FG002|Overall Study|Withdrawal of Informed Consent|1|||
131206336|NCT00591786|472377163|FG003|Overall Study|Withdrawal of Informed Consent|0|||
131206337|NCT00591786|472377164|FG004|Overall Study|Withdrawal of Informed Consent|0|||
131206338|NCT00591786|472377165|FG005|Overall Study|Withdrawal of Informed Consent|0|||
131206339|NCT00591786|472377166|FG006|Overall Study|Withdrawal of Informed Consent|0|||
131206340|NCT00591786|472377167|FG007|Overall Study|Withdrawal of Informed Consent|0|||
131206341|NCT00591786|472377168|FG008|Overall Study|Withdrawal of Informed Consent|0|||
131206342|NCT00591786|472377169|FG009|Overall Study|Withdrawal of Informed Consent|0|||
131206343|NCT01920061|472377170|FG000|Overall Study|Death|1|||
131206344|NCT01920061|472377171|FG001|Overall Study|Death|1|||
131206345|NCT01920061|472377172|FG002|Overall Study|Death|0|||
131206346|NCT01920061|472377173|FG003|Overall Study|Death|1|||
131206347|NCT01920061|472377174|FG004|Overall Study|Death|1|||
131206348|NCT01920061|472377175|FG005|Overall Study|Death|0|||
131206349|NCT01920061|472377176|FG006|Overall Study|Death|0|||
131206350|NCT01920061|472377177|FG007|Overall Study|Death|1|||
131206351|NCT01920061|472377178|FG008|Overall Study|Death|0|||
131206352|NCT01920061|472377179|FG009|Overall Study|Death|1|||
131206353|NCT01920061|472377180|FG010|Overall Study|Death|0|||
131206354|NCT01920061|472377181|FG011|Overall Study|Death|1|||
131206355|NCT01920061|472377182|FG012|Overall Study|Death|0|||
131206356|NCT01920061|472377183|FG013|Overall Study|Death|2|||
131206357|NCT01920061|472377184|FG014|Overall Study|Death|0|||
131206358|NCT01920061|472377185|FG015|Overall Study|Death|0|||
131206359|NCT01920061|472377186|FG016|Overall Study|Death|0|||
131206360|NCT01920061|472377187|FG017|Overall Study|Death|0|||
131206361|NCT01920061|472377188|FG018|Overall Study|Death|1|||
131206362|NCT01920061|472377189|FG019|Overall Study|Death|0|||
130734877|NCT03410056|470648956|FG005|Overall Study|Withdrawal by Subject|0|||
130734878|NCT03410056|470648957|FG006|Overall Study|Withdrawal by Subject|0|||
130734879|NCT02548156|470648963|FG000|Washout Period 1|Lost to Follow-up|0|||
130734880|NCT02548156|470648964|FG001|Washout Period 1|Lost to Follow-up|0|||
130734881|NCT02548156|470648965|FG002|Washout Period 1|Lost to Follow-up|0|||
130734882|NCT02548156|470648966|FG003|Washout Period 1|Lost to Follow-up|0|||
130734883|NCT02548156|470648967|FG004|Washout Period 1|Lost to Follow-up|1|||
130734884|NCT02548156|470648968|FG005|Washout Period 1|Lost to Follow-up|0|||
130734885|NCT01068262|470648973|FG000|Overall Study|Adverse Event|2|||
130734886|NCT01068262|470648974|FG001|Overall Study|Adverse Event|0|||
130734887|NCT01068262|470648975|FG002|Overall Study|Adverse Event|1|||
130734888|NCT01068262|470648976|FG003|Overall Study|Adverse Event|0|||
130734889|NCT01068262|470648973|FG000|Overall Study|Protocol Violation|1|||
130734890|NCT01068262|470648974|FG001|Overall Study|Protocol Violation|0|||
130734891|NCT01068262|470648975|FG002|Overall Study|Protocol Violation|0|||
130734892|NCT01068262|470648976|FG003|Overall Study|Protocol Violation|0|||
130734893|NCT01068262|470648973|FG000|Overall Study|Withdrawal by Subject|0|||
130734894|NCT01068262|470648974|FG001|Overall Study|Withdrawal by Subject|1|||
130734895|NCT01068262|470648975|FG002|Overall Study|Withdrawal by Subject|0|||
130734896|NCT01068262|470648976|FG003|Overall Study|Withdrawal by Subject|0|||
130734897|NCT00444587|470648979|FG000|Overall Study|Death|2|||
130734898|NCT00444587|470648980|FG001|Overall Study|Death|1|||
130734899|NCT00444587|470648979|FG000|Overall Study|Progression of the disease|73|||
130734900|NCT00444587|470648980|FG001|Overall Study|Progression of the disease|8|||
130734901|NCT00444587|470648979|FG000|Overall Study|Refused treatment/did not cooperate|4|||
130734902|NCT00444587|470648980|FG001|Overall Study|Refused treatment/did not cooperate|1|||
130734903|NCT00444587|470648979|FG000|Overall Study|Investigator decision|3|||
130734904|NCT00444587|470648980|FG001|Overall Study|Investigator decision|0|||
130734905|NCT00444587|470648979|FG000|Overall Study|Protocol Violation|1|||
130734906|NCT00444587|470648980|FG001|Overall Study|Protocol Violation|0|||
130734907|NCT00444587|470648979|FG000|Overall Study|Missing|0|||
130734908|NCT00444587|470648980|FG001|Overall Study|Missing|5|||
130734909|NCT01473407|470648989|FG000|Overall Study|Physician Decision|1|||
130734910|NCT01473407|470648990|FG001|Overall Study|Physician Decision|4|||
130734911|NCT01473407|470648989|FG000|Overall Study|Lost to Follow-up|10|||
130734912|NCT01473407|470648990|FG001|Overall Study|Lost to Follow-up|4|||
130734913|NCT01473407|470648989|FG000|Overall Study|Adverse Event|8|||
130734914|NCT01473407|470648990|FG001|Overall Study|Adverse Event|8|||
130734915|NCT01473407|470648989|FG000|Overall Study|Randomization Error|3|||
130734916|NCT01473407|470648990|FG001|Overall Study|Randomization Error|1|||
130734917|NCT01473407|470648989|FG000|Overall Study|Withdrawal by Subject|4|||
130734918|NCT01473407|470648990|FG001|Overall Study|Withdrawal by Subject|7|||
130734919|NCT01473407|470648989|FG000|Overall Study|Kidney Transplant|7|||
130734920|NCT01473407|470648990|FG001|Overall Study|Kidney Transplant|6|||
130734921|NCT01473407|470648989|FG000|Overall Study|Vacation/Travel|1|||
130734922|NCT01473407|470648990|FG001|Overall Study|Vacation/Travel|1|||
130734923|NCT01473407|470648989|FG000|Overall Study|Elevated Hemoglobin|1|||
130734924|NCT01473407|470648990|FG001|Overall Study|Elevated Hemoglobin|0|||
130734925|NCT01473407|470648989|FG000|Overall Study|Patient Received Aranesp|1|||
130734926|NCT01473407|470648990|FG001|Overall Study|Patient Received Aranesp|0|||
130734927|NCT01473407|470648989|FG000|Overall Study|Patient Lost Green Card Status|1|||
130734928|NCT01473407|470648990|FG001|Overall Study|Patient Lost Green Card Status|0|||
131206363|NCT01920061|472377170|FG000|Overall Study|Lost to Follow-up|0|||
131206364|NCT01920061|472377171|FG001|Overall Study|Lost to Follow-up|2|||
131206365|NCT01920061|472377172|FG002|Overall Study|Lost to Follow-up|0|||
131206366|NCT01920061|472377173|FG003|Overall Study|Lost to Follow-up|0|||
131206367|NCT01920061|472377174|FG004|Overall Study|Lost to Follow-up|0|||
131206368|NCT01920061|472377175|FG005|Overall Study|Lost to Follow-up|0|||
131206369|NCT01920061|472377176|FG006|Overall Study|Lost to Follow-up|1|||
131206370|NCT01920061|472377177|FG007|Overall Study|Lost to Follow-up|0|||
131206371|NCT01920061|472377178|FG008|Overall Study|Lost to Follow-up|0|||
131206372|NCT01920061|472377179|FG009|Overall Study|Lost to Follow-up|0|||
131206373|NCT01920061|472377180|FG010|Overall Study|Lost to Follow-up|3|||
131206374|NCT01920061|472377181|FG011|Overall Study|Lost to Follow-up|0|||
131206375|NCT01920061|472377182|FG012|Overall Study|Lost to Follow-up|0|||
131206376|NCT01920061|472377183|FG013|Overall Study|Lost to Follow-up|0|||
131206377|NCT01920061|472377184|FG014|Overall Study|Lost to Follow-up|0|||
131206378|NCT01920061|472377185|FG015|Overall Study|Lost to Follow-up|0|||
131206379|NCT01920061|472377186|FG016|Overall Study|Lost to Follow-up|0|||
131206380|NCT01920061|472377187|FG017|Overall Study|Lost to Follow-up|1|||
131206381|NCT01920061|472377188|FG018|Overall Study|Lost to Follow-up|4|||
131206382|NCT01920061|472377189|FG019|Overall Study|Lost to Follow-up|3|||
131206383|NCT01920061|472377170|FG000|Overall Study|Other|1|||
131206384|NCT01920061|472377171|FG001|Overall Study|Other|1|||
131206385|NCT01920061|472377172|FG002|Overall Study|Other|2|||
131206386|NCT01920061|472377173|FG003|Overall Study|Other|1|||
131206387|NCT01920061|472377174|FG004|Overall Study|Other|0|||
131206388|NCT01920061|472377175|FG005|Overall Study|Other|1|||
131206389|NCT01920061|472377176|FG006|Overall Study|Other|0|||
131206390|NCT01920061|472377177|FG007|Overall Study|Other|0|||
131206391|NCT01920061|472377178|FG008|Overall Study|Other|0|||
131206392|NCT01920061|472377179|FG009|Overall Study|Other|1|||
131206393|NCT01920061|472377180|FG010|Overall Study|Other|1|||
131206394|NCT01920061|472377181|FG011|Overall Study|Other|2|||
131206395|NCT01920061|472377182|FG012|Overall Study|Other|1|||
131206396|NCT01920061|472377183|FG013|Overall Study|Other|4|||
131206397|NCT01920061|472377184|FG014|Overall Study|Other|0|||
131206398|NCT01920061|472377185|FG015|Overall Study|Other|1|||
131206399|NCT01920061|472377186|FG016|Overall Study|Other|1|||
131206400|NCT01920061|472377187|FG017|Overall Study|Other|0|||
131206401|NCT01920061|472377188|FG018|Overall Study|Other|1|||
131206402|NCT01920061|472377189|FG019|Overall Study|Other|1|||
131206403|NCT01920061|472377170|FG000|Overall Study|Participant refused further follow-up|0|||
131206404|NCT01920061|472377171|FG001|Overall Study|Participant refused further follow-up|0|||
131206405|NCT01920061|472377172|FG002|Overall Study|Participant refused further follow-up|0|||
131206406|NCT01920061|472377173|FG003|Overall Study|Participant refused further follow-up|0|||
131206407|NCT01920061|472377174|FG004|Overall Study|Participant refused further follow-up|1|||
131206408|NCT01920061|472377175|FG005|Overall Study|Participant refused further follow-up|1|||
131206409|NCT01920061|472377176|FG006|Overall Study|Participant refused further follow-up|0|||
131206410|NCT01920061|472377177|FG007|Overall Study|Participant refused further follow-up|0|||
131206411|NCT01920061|472377178|FG008|Overall Study|Participant refused further follow-up|1|||
131206412|NCT01920061|472377179|FG009|Overall Study|Participant refused further follow-up|0|||
131206413|NCT01920061|472377180|FG010|Overall Study|Participant refused further follow-up|1|||
131206414|NCT01920061|472377181|FG011|Overall Study|Participant refused further follow-up|0|||
131206415|NCT01920061|472377182|FG012|Overall Study|Participant refused further follow-up|1|||
131206416|NCT01920061|472377183|FG013|Overall Study|Participant refused further follow-up|0|||
131206417|NCT01920061|472377184|FG014|Overall Study|Participant refused further follow-up|1|||
131206418|NCT01920061|472377185|FG015|Overall Study|Participant refused further follow-up|2|||
131206419|NCT01920061|472377186|FG016|Overall Study|Participant refused further follow-up|1|||
131206420|NCT01920061|472377187|FG017|Overall Study|Participant refused further follow-up|1|||
131206421|NCT01920061|472377188|FG018|Overall Study|Participant refused further follow-up|0|||
131206422|NCT01920061|472377189|FG019|Overall Study|Participant refused further follow-up|0|||
131206423|NCT00554229|472377190|FG000|Overall Study|Lost to Follow-up|3|||
131206424|NCT00554229|472377191|FG001|Overall Study|Lost to Follow-up|6|||
131206425|NCT00554229|472377190|FG000|Overall Study|Withdrawal by Subject|29|||
131206426|NCT00554229|472377191|FG001|Overall Study|Withdrawal by Subject|37|||
131206427|NCT00554229|472377190|FG000|Overall Study|Adverse Event|71|||
131206428|NCT00554229|472377191|FG001|Overall Study|Adverse Event|39|||
131206429|NCT00554229|472377190|FG000|Overall Study|Protocol Violation|3|||
131206430|NCT00554229|472377191|FG001|Overall Study|Protocol Violation|3|||
131206431|NCT00554229|472377190|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
131206432|NCT00554229|472377191|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
131206433|NCT00554229|472377190|FG000|Overall Study|Randomised but no treatment received|1|||
131206434|NCT00554229|472377191|FG001|Overall Study|Randomised but no treatment received|0|||
131206435|NCT01140646|472377192|FG000|Overall Study|Adverse Event|4|||
131206436|NCT01140646|472377192|FG000|Overall Study|Refused Further Treatment|5|||
131206437|NCT00842829|472377198|FG000|Dose Titration Period|Adverse Event|11|||
131206438|NCT00842829|472377199|FG001|Dose Titration Period|Adverse Event|10|||
131206439|NCT00842829|472377200|FG002|Dose Titration Period|Adverse Event|0|||
131206440|NCT00842829|472377198|FG000|Dose Titration Period|Lack of Efficacy|4|||
131206441|NCT00842829|472377199|FG001|Dose Titration Period|Lack of Efficacy|1|||
131206442|NCT00842829|472377200|FG002|Dose Titration Period|Lack of Efficacy|0|||
131206443|NCT00842829|472377198|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
131206444|NCT00842829|472377199|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
131206445|NCT00842829|472377200|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
131206446|NCT00842829|472377198|FG000|Dose Titration Period|Withdrawal by Subject|2|||
131206447|NCT00842829|472377199|FG001|Dose Titration Period|Withdrawal by Subject|6|||
131206448|NCT00842829|472377200|FG002|Dose Titration Period|Withdrawal by Subject|0|||
131206449|NCT00842829|472377198|FG000|Dose Titration Period|Other|5|||
131206450|NCT00842829|472377199|FG001|Dose Titration Period|Other|4|||
131206451|NCT00842829|472377200|FG002|Dose Titration Period|Other|0|||
131206452|NCT00842829|472377198|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
131206453|NCT00842829|472377199|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
131206454|NCT00842829|472377200|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
131206455|NCT00842829|472377198|FG000|Dose Titration Period|Non-compliance to study drug|2|||
131206456|NCT00842829|472377199|FG001|Dose Titration Period|Non-compliance to study drug|1|||
131206457|NCT00842829|472377200|FG002|Dose Titration Period|Non-compliance to study drug|0|||
131206458|NCT00842829|472377198|FG000|Treatment Period|Adverse Event|0|||
131206459|NCT00842829|472377199|FG001|Treatment Period|Adverse Event|0|||
131206460|NCT00842829|472377200|FG002|Treatment Period|Adverse Event|15|||
131206461|NCT00842829|472377198|FG000|Treatment Period|Lack of Efficacy|0|||
131206462|NCT00842829|472377199|FG001|Treatment Period|Lack of Efficacy|0|||
131206463|NCT00842829|472377200|FG002|Treatment Period|Lack of Efficacy|6|||
131206464|NCT00842829|472377198|FG000|Treatment Period|Unstable persistent cancer pain|0|||
131206465|NCT00842829|472377199|FG001|Treatment Period|Unstable persistent cancer pain|0|||
131206466|NCT00842829|472377200|FG002|Treatment Period|Unstable persistent cancer pain|5|||
131206467|NCT00842829|472377198|FG000|Treatment Period|Withdrawal by Subject|0|||
131206468|NCT00842829|472377199|FG001|Treatment Period|Withdrawal by Subject|0|||
131206469|NCT00842829|472377200|FG002|Treatment Period|Withdrawal by Subject|11|||
131206470|NCT00842829|472377198|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
131206471|NCT00842829|472377199|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
131206472|NCT00842829|472377200|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
131206473|NCT00842829|472377198|FG000|Treatment Period|Protocol Violation|0|||
131206474|NCT00842829|472377199|FG001|Treatment Period|Protocol Violation|0|||
131206475|NCT00842829|472377200|FG002|Treatment Period|Protocol Violation|2|||
131206476|NCT00842829|472377198|FG000|Treatment Period|Other|0|||
131206477|NCT00842829|472377199|FG001|Treatment Period|Other|0|||
131206478|NCT00842829|472377200|FG002|Treatment Period|Other|18|||
131206479|NCT00842829|472377198|FG000|Treatment Period|Non-compliance to study procedures|0|||
131206480|NCT00842829|472377199|FG001|Treatment Period|Non-compliance to study procedures|0|||
131206481|NCT00842829|472377200|FG002|Treatment Period|Non-compliance to study procedures|4|||
131206482|NCT00842829|472377198|FG000|Treatment Period|Unclear completion status|0|||
131206483|NCT00842829|472377199|FG001|Treatment Period|Unclear completion status|0|||
131206484|NCT00842829|472377200|FG002|Treatment Period|Unclear completion status|1|||
131206485|NCT00842829|472377198|FG000|Continuation Period|Adverse Event|0|||
131206486|NCT00842829|472377199|FG001|Continuation Period|Adverse Event|0|||
131206487|NCT00842829|472377200|FG002|Continuation Period|Adverse Event|32|||
131206488|NCT00842829|472377198|FG000|Continuation Period|Lack of Efficacy|0|||
131206489|NCT00842829|472377199|FG001|Continuation Period|Lack of Efficacy|0|||
131206490|NCT00842829|472377200|FG002|Continuation Period|Lack of Efficacy|6|||
131206491|NCT00842829|472377198|FG000|Continuation Period|Unstable persistent cancer pain|0|||
131206492|NCT00842829|472377199|FG001|Continuation Period|Unstable persistent cancer pain|0|||
131206493|NCT00842829|472377200|FG002|Continuation Period|Unstable persistent cancer pain|3|||
131206494|NCT00842829|472377198|FG000|Continuation Period|Withdrawal by Subject|0|||
131206495|NCT00842829|472377199|FG001|Continuation Period|Withdrawal by Subject|0|||
131206496|NCT00842829|472377200|FG002|Continuation Period|Withdrawal by Subject|10|||
131206497|NCT00842829|472377198|FG000|Continuation Period|Other|0|||
131206498|NCT00842829|472377199|FG001|Continuation Period|Other|0|||
131206499|NCT00842829|472377200|FG002|Continuation Period|Other|7|||
131206500|NCT00842829|472377198|FG000|Continuation Period|Non-compliance to study procedures|0|||
131206501|NCT00842829|472377199|FG001|Continuation Period|Non-compliance to study procedures|0|||
131206502|NCT00842829|472377200|FG002|Continuation Period|Non-compliance to study procedures|2|||
131206503|NCT00842829|472377198|FG000|Continuation Period|Non-compliance to study drug|0|||
131206504|NCT00842829|472377199|FG001|Continuation Period|Non-compliance to study drug|0|||
131206505|NCT00842829|472377200|FG002|Continuation Period|Non-compliance to study drug|1|||
131206506|NCT00784836|472377203|FG000|Overall Study|Early Study Termination|3|||
131206507|NCT00660829|472377204|FG000|Overall Study|Adverse Event|3|||
131206508|NCT00660829|472377205|FG001|Overall Study|Adverse Event|4|||
131206509|NCT00660829|472377204|FG000|Overall Study|Lack of Efficacy|2|||
131206510|NCT00660829|472377205|FG001|Overall Study|Lack of Efficacy|3|||
131206511|NCT00660829|472377204|FG000|Overall Study|Non-Compliance|0|||
131206512|NCT00660829|472377205|FG001|Overall Study|Non-Compliance|4|||
130784733|NCT00557466|470841150|FG002|Overall Study|Administrative problems|1|||
131206513|NCT00660829|472377204|FG000|Overall Study|Withdrawal by Subject|1|||
131206514|NCT00660829|472377205|FG001|Overall Study|Withdrawal by Subject|2|||
131206515|NCT00660829|472377204|FG000|Overall Study|Lost to Follow-up|3|||
131206516|NCT00660829|472377205|FG001|Overall Study|Lost to Follow-up|2|||
131206517|NCT00660829|472377204|FG000|Overall Study|Other|9|||
131206518|NCT00660829|472377205|FG001|Overall Study|Other|4|||
131206519|NCT02127931|472377206|FG000|Overall Study|Glitch in Game|1|||
131206520|NCT00690612|472378509|FG000|Overall Study|Adverse Event|1|||
131206521|NCT00690612|472378509|FG000|Overall Study|Withdrawal by Subject|2|||
131206522|NCT01233076|472378510|FG000|Period 2, One Week|Lost to Follow-up|1|||
131206523|NCT01233076|472378511|FG001|Period 2, One Week|Lost to Follow-up|0|||
131206524|NCT04120116|472378513|FG000|Overall Study|Lost to Follow-up|0|||
131206525|NCT04120116|472378514|FG001|Overall Study|Lost to Follow-up|1|||
131206526|NCT04120116|472378515|FG002|Overall Study|Lost to Follow-up|0|||
131206527|NCT04120116|472378516|FG003|Overall Study|Lost to Follow-up|2|||
131206528|NCT04120116|472378513|FG000|Overall Study|Withdrawal by Subject|1|||
131206529|NCT04120116|472378514|FG001|Overall Study|Withdrawal by Subject|0|||
131206530|NCT04120116|472378515|FG002|Overall Study|Withdrawal by Subject|1|||
131206531|NCT04120116|472378516|FG003|Overall Study|Withdrawal by Subject|1|||
131206532|NCT04120116|472378513|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
131206533|NCT04120116|472378514|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
131206534|NCT04120116|472378515|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
131206535|NCT04120116|472378516|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
131206536|NCT05637515|472378517|FG000|Overall Study|Withdrawal by Subject|17|||
131206537|NCT05637515|472378518|FG001|Overall Study|Withdrawal by Subject|17|||
131206538|NCT02087085|472378520|FG000|Overall Study|Adverse Event|10|||
131206539|NCT02087085|472378521|FG001|Overall Study|Adverse Event|14|||
131206540|NCT02087085|472378520|FG000|Overall Study|Lack of Efficacy|4|||
131206541|NCT02087085|472378521|FG001|Overall Study|Lack of Efficacy|3|||
131206542|NCT02087085|472378520|FG000|Overall Study|Lost to Follow-up|6|||
131206543|NCT02087085|472378521|FG001|Overall Study|Lost to Follow-up|4|||
131206544|NCT02087085|472378520|FG000|Overall Study|Withdrawal by Subject|9|||
131206545|NCT02087085|472378521|FG001|Overall Study|Withdrawal by Subject|11|||
131206546|NCT02087085|472378520|FG000|Overall Study|Protocol Violation|1|||
131206547|NCT02087085|472378521|FG001|Overall Study|Protocol Violation|0|||
131206548|NCT02087085|472378520|FG000|Overall Study|Study Terminated by Sponsor|87|||
131206549|NCT02087085|472378521|FG001|Overall Study|Study Terminated by Sponsor|80|||
131206550|NCT02087085|472378520|FG000|Overall Study|Other Miscellaneous Reasons|3|||
131206551|NCT02087085|472378521|FG001|Overall Study|Other Miscellaneous Reasons|4|||
131206552|NCT02505945|472378522|FG000|Overall Study|Withdrawal by Subject|13|||
131206553|NCT02505945|472378523|FG001|Overall Study|Withdrawal by Subject|2|||
131206554|NCT02505945|472378522|FG000|Overall Study|Adverse Event|1|||
131206555|NCT02505945|472378523|FG001|Overall Study|Adverse Event|0|||
131206556|NCT02505945|472378522|FG000|Overall Study|Physician Decision|2|||
131206557|NCT02505945|472378523|FG001|Overall Study|Physician Decision|1|||
131206558|NCT02505945|472378522|FG000|Overall Study|Lost to Follow-up|6|||
131206559|NCT02505945|472378523|FG001|Overall Study|Lost to Follow-up|1|||
131206560|NCT00635804|472378524|FG000|Overall Study|Adverse Event|0|||
131206561|NCT00635804|472378525|FG001|Overall Study|Adverse Event|0|||
131206562|NCT00635804|472378526|FG002|Overall Study|Adverse Event|0|||
131206563|NCT00635804|472378527|FG003|Overall Study|Adverse Event|0|||
131206564|NCT00635804|472378528|FG004|Overall Study|Adverse Event|0|||
131206565|NCT00635804|472378529|FG005|Overall Study|Adverse Event|1|||
131206566|NCT00635804|472378530|FG006|Overall Study|Adverse Event|0|||
131206567|NCT00635804|472378531|FG007|Overall Study|Adverse Event|0|||
131206568|NCT00635804|472378524|FG000|Overall Study|Withdrawal by Subject|1|||
131206569|NCT00635804|472378525|FG001|Overall Study|Withdrawal by Subject|0|||
131206570|NCT00635804|472378526|FG002|Overall Study|Withdrawal by Subject|0|||
131206571|NCT00635804|472378527|FG003|Overall Study|Withdrawal by Subject|0|||
131206572|NCT00635804|472378528|FG004|Overall Study|Withdrawal by Subject|0|||
131206573|NCT00635804|472378529|FG005|Overall Study|Withdrawal by Subject|0|||
131206574|NCT00635804|472378530|FG006|Overall Study|Withdrawal by Subject|0|||
131206575|NCT00635804|472378531|FG007|Overall Study|Withdrawal by Subject|0|||
131206576|NCT02718131|472378538|FG000|Overall Study|Withdrawal by Subject|1|||
131206577|NCT02718131|472378539|FG001|Overall Study|Withdrawal by Subject|0|||
131206578|NCT02718131|472378538|FG000|Overall Study|Adverse Event|1|||
131206579|NCT02718131|472378539|FG001|Overall Study|Adverse Event|0|||
131206580|NCT02718131|472378538|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
131206581|NCT02718131|472378539|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
131206582|NCT01097057|472378541|FG000|Overall Study|Physician Decision|3|||
131206583|NCT01101321|472378542|FG000|Period 1|Withdrawal by Subject|1|||
131206584|NCT01101321|472378543|FG001|Period 1|Withdrawal by Subject|1|||
131206585|NCT01101321|472378542|FG000|Period 1|Adverse Event|3|||
131206586|NCT01101321|472378543|FG001|Period 1|Adverse Event|3|||
131206587|NCT02681094|472378544|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
131206588|NCT02681094|472378545|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
131206589|NCT02681094|472378546|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
131206590|NCT02681094|472378544|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
131206591|NCT02681094|472378545|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
131206592|NCT02681094|472378546|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
131206593|NCT02681094|472378544|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
131206594|NCT02681094|472378545|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
131206595|NCT02681094|472378546|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
131206596|NCT02681094|472378544|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
131206597|NCT02681094|472378545|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
131206598|NCT02681094|472378546|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
131206599|NCT02681094|472378544|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
131206600|NCT02681094|472378545|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
131206601|NCT02681094|472378546|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
131206602|NCT02681094|472378544|FG000|1 -Modified Enrolled Participants Set|Other|6|||
131206603|NCT02681094|472378545|FG001|1 -Modified Enrolled Participants Set|Other|6|||
131206604|NCT02681094|472378546|FG002|1 -Modified Enrolled Participants Set|Other|7|||
131206605|NCT02681094|472378544|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
131206606|NCT02681094|472378545|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
131206607|NCT02681094|472378546|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
131206608|NCT02681094|472378544|FG000|2 - Enrolled Participants Set|Participant decision|7|||
131206609|NCT02681094|472378545|FG001|2 - Enrolled Participants Set|Participant decision|10|||
131206610|NCT02681094|472378546|FG002|2 - Enrolled Participants Set|Participant decision|9|||
131206611|NCT02681094|472378544|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
131206612|NCT02681094|472378545|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
131206613|NCT02681094|472378546|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
131206614|NCT02681094|472378544|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
131206615|NCT02681094|472378545|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
131206616|NCT02681094|472378546|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
131206617|NCT02681094|472378544|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
131206618|NCT02681094|472378545|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
131206619|NCT02681094|472378546|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
131206620|NCT02681094|472378544|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
131206621|NCT02681094|472378545|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
131206622|NCT02681094|472378546|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
131206623|NCT02681094|472378544|FG000|2 - Enrolled Participants Set|Other|6|||
131206624|NCT02681094|472378545|FG001|2 - Enrolled Participants Set|Other|6|||
131206625|NCT02681094|472378546|FG002|2 - Enrolled Participants Set|Other|7|||
131206626|NCT02681094|472378544|FG000|2 - Enrolled Participants Set|No treatment given|0|||
131206627|NCT02681094|472378545|FG001|2 - Enrolled Participants Set|No treatment given|1|||
131206628|NCT02681094|472378546|FG002|2 - Enrolled Participants Set|No treatment given|1|||
131206629|NCT01270139|472378549|FG000|Overall Study|Adverse Event|8|||
131206630|NCT01270139|472378550|FG001|Overall Study|Adverse Event|17|||
131206631|NCT01270139|472378551|FG002|Overall Study|Adverse Event|18|||
131206632|NCT01270139|472378549|FG000|Overall Study|Lost to Follow-up|10|||
131206633|NCT01270139|472378550|FG001|Overall Study|Lost to Follow-up|9|||
131206634|NCT01270139|472378551|FG002|Overall Study|Lost to Follow-up|2|||
131206635|NCT00134563|472378552|FG000|Overall Study|Not treated due to protocol violation|0|||
131206636|NCT00134563|472378553|FG001|Overall Study|Not treated due to protocol violation|1|||
131206637|NCT00134563|472378554|FG002|Overall Study|Not treated due to protocol violation|1|||
131206638|NCT00134563|472378552|FG000|Overall Study|Adverse Event|29|||
131206639|NCT00134563|472378553|FG001|Overall Study|Adverse Event|37|||
130734929|NCT01473407|470648989|FG000|Overall Study|Temperature Excursion|2|||
130734930|NCT01473407|470648990|FG001|Overall Study|Temperature Excursion|3|||
130734931|NCT01473407|470648989|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
130734932|NCT01473407|470648990|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
130734933|NCT01473407|470648989|FG000|Overall Study|Sponsor's Decision|10|||
130734934|NCT01473407|470648990|FG001|Overall Study|Sponsor's Decision|10|||
130734935|NCT01473407|470648989|FG000|Overall Study|Site Closure|1|||
130734936|NCT01473407|470648990|FG001|Overall Study|Site Closure|0|||
130734937|NCT02301390|470648993|FG000|Overall Study|Withdrawal by Subject|3|||
130734938|NCT02301390|470648994|FG001|Overall Study|Withdrawal by Subject|5|||
130734939|NCT02301390|470648993|FG000|Overall Study|Protocol Violation|1|||
130734940|NCT02301390|470648994|FG001|Overall Study|Protocol Violation|0|||
130734941|NCT02301390|470648993|FG000|Overall Study|Physician Decision|1|||
130734942|NCT02301390|470648994|FG001|Overall Study|Physician Decision|0|||
130734943|NCT02301390|470648993|FG000|Overall Study|Lost to Follow-up|0|||
131206640|NCT00134563|472378554|FG002|Overall Study|Adverse Event|38|||
131206641|NCT00134563|472378552|FG000|Overall Study|Lack of Efficacy|24|||
130734944|NCT02301390|470648994|FG001|Overall Study|Lost to Follow-up|1|||
130734945|NCT02301390|470648993|FG000|Overall Study|Death|2|||
130784734|NCT00557466|470841151|FG003|Overall Study|Administrative problems|0|||
130784735|NCT00557466|470841152|FG004|Overall Study|Administrative problems|0|||
131206642|NCT00134563|472378553|FG001|Overall Study|Lack of Efficacy|14|||
131206643|NCT00134563|472378554|FG002|Overall Study|Lack of Efficacy|17|||
131206644|NCT00134563|472378552|FG000|Overall Study|Protocol Violation|3|||
130734946|NCT02301390|470648994|FG001|Overall Study|Death|2|||
130734947|NCT02301390|470648993|FG000|Overall Study|Procedure not completed|0|||
130734948|NCT02301390|470648994|FG001|Overall Study|Procedure not completed|4|||
131206645|NCT00134563|472378553|FG001|Overall Study|Protocol Violation|2|||
131206646|NCT00134563|472378554|FG002|Overall Study|Protocol Violation|5|||
131206647|NCT00134563|472378552|FG000|Overall Study|Lost to Follow-up|4|||
131206648|NCT00134563|472378553|FG001|Overall Study|Lost to Follow-up|0|||
131206649|NCT00134563|472378554|FG002|Overall Study|Lost to Follow-up|2|||
131206650|NCT00134563|472378552|FG000|Overall Study|progressive disease|11|||
131206651|NCT00134563|472378553|FG001|Overall Study|progressive disease|4|||
131206652|NCT00134563|472378554|FG002|Overall Study|progressive disease|2|||
131206653|NCT00134563|472378552|FG000|Overall Study|did not wish to continue|33|||
131206654|NCT00134563|472378553|FG001|Overall Study|did not wish to continue|32|||
131206655|NCT00134563|472378554|FG002|Overall Study|did not wish to continue|26|||
131206656|NCT00134563|472378552|FG000|Overall Study|Reason other than above|0|||
131206657|NCT00134563|472378553|FG001|Overall Study|Reason other than above|2|||
131206658|NCT00134563|472378554|FG002|Overall Study|Reason other than above|5|||
131206659|NCT03382639|472378555|FG000|Overall Study|Adverse Event|2|||
131206660|NCT03382639|472378556|FG001|Overall Study|Adverse Event|0|||
131206661|NCT03382639|472378557|FG002|Overall Study|Adverse Event|1|||
131206662|NCT03382639|472378558|FG003|Overall Study|Adverse Event|1|||
131206663|NCT03382639|472378555|FG000|Overall Study|Lost to Follow-up|1|||
131206664|NCT03382639|472378556|FG001|Overall Study|Lost to Follow-up|0|||
131206665|NCT03382639|472378557|FG002|Overall Study|Lost to Follow-up|0|||
131206666|NCT03382639|472378558|FG003|Overall Study|Lost to Follow-up|0|||
131206667|NCT03382639|472378555|FG000|Overall Study|Withdrawal by Subject|4|||
130734949|NCT02301390|470648993|FG000|Overall Study|Missed multiple visits|1|||
130734950|NCT02301390|470648994|FG001|Overall Study|Missed multiple visits|1|||
130734951|NCT02301390|470648993|FG000|Overall Study|study terminated|2|||
130734952|NCT02301390|470648994|FG001|Overall Study|study terminated|0|||
130734953|NCT01027702|470648995|FG000|Overall Study|Received subsequent therapy|1|||
130734954|NCT01027702|470648996|FG001|Overall Study|Received subsequent therapy|2|||
130734955|NCT01027702|470648997|FG002|Overall Study|Received subsequent therapy|0|||
130734956|NCT01027702|470648998|FG003|Overall Study|Received subsequent therapy|4|||
130734957|NCT01027702|470648999|FG004|Overall Study|Received subsequent therapy|1|||
130734958|NCT01027702|470649000|FG005|Overall Study|Received subsequent therapy|0|||
130734959|NCT01027702|470649001|FG006|Overall Study|Received subsequent therapy|1|||
130734960|NCT01027702|470648995|FG000|Overall Study|Death|0|||
130734961|NCT01027702|470648996|FG001|Overall Study|Death|0|||
130734962|NCT01027702|470648997|FG002|Overall Study|Death|1|||
130734963|NCT01027702|470648998|FG003|Overall Study|Death|0|||
130734964|NCT01027702|470648999|FG004|Overall Study|Death|0|||
130734965|NCT01027702|470649000|FG005|Overall Study|Death|0|||
130734966|NCT01027702|470649001|FG006|Overall Study|Death|0|||
130734967|NCT02121652|470649004|FG000|Overall Study|Lost to Follow-up|2|||
130734968|NCT02121652|470649005|FG001|Overall Study|Lost to Follow-up|1|||
130734969|NCT02121652|470649004|FG000|Overall Study|Death|1|||
131206668|NCT03382639|472378556|FG001|Overall Study|Withdrawal by Subject|3|||
131206669|NCT03382639|472378557|FG002|Overall Study|Withdrawal by Subject|2|||
131206670|NCT03382639|472378558|FG003|Overall Study|Withdrawal by Subject|3|||
131206671|NCT03382639|472378555|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
131206672|NCT03382639|472378556|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
131206673|NCT03382639|472378557|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
131206674|NCT03382639|472378558|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
131206675|NCT03382639|472378555|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
131206676|NCT03382639|472378556|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
131206677|NCT03382639|472378557|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
130734970|NCT02121652|470649005|FG001|Overall Study|Death|0|||
131206678|NCT03382639|472378558|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
131206679|NCT03382639|472378555|FG000|Overall Study|Other|2|||
131206680|NCT03382639|472378556|FG001|Overall Study|Other|0|||
131206681|NCT03382639|472378557|FG002|Overall Study|Other|0|||
131206682|NCT03382639|472378558|FG003|Overall Study|Other|3|||
131206683|NCT02477215|472378561|FG000|Dose Escalation Phase|Physician Decision|1|||
131206684|NCT02477215|472378562|FG001|Dose Escalation Phase|Physician Decision|2|||
131206685|NCT02477215|472378563|FG002|Dose Escalation Phase|Physician Decision|0|||
130734971|NCT02121652|470649004|FG000|Overall Study|Withdrawal by Subject|3|||
130734972|NCT02121652|470649005|FG001|Overall Study|Withdrawal by Subject|3|||
131206686|NCT02477215|472378561|FG000|Fixed Dose Phase|Physician Decision|0|||
131206687|NCT02477215|472378562|FG001|Fixed Dose Phase|Physician Decision|7|||
131206688|NCT02477215|472378563|FG002|Fixed Dose Phase|Physician Decision|0|||
131206689|NCT01911546|472378566|FG000|Overall Study|Lost to Follow-up|1|||
131206690|NCT01911546|472378566|FG000|Overall Study|Everolimus was discontinued|5|||
131206691|NCT02210559|472378567|FG000|Overall Study|Progressive Disease|3|||
130734973|NCT01153425|470649006|FG000|Overall Study|Withdrawal by Subject|3|||
131206692|NCT02210559|472378568|FG001|Overall Study|Progressive Disease|2|||
131206693|NCT02210559|472378567|FG000|Overall Study|Adverse Event|2|||
130734974|NCT01153425|470649007|FG001|Overall Study|Withdrawal by Subject|3|||
130734975|NCT02932462|470649008|FG000|Overall Study|Adverse Event|1|||
130734976|NCT02932462|470649009|FG001|Overall Study|Adverse Event|2|||
130734977|NCT02932462|470649008|FG000|Overall Study|Lost to Follow-up|4|||
130734978|NCT02932462|470649009|FG001|Overall Study|Lost to Follow-up|1|||
130734979|NCT02932462|470649008|FG000|Overall Study|Protocol Violation|0|||
131206694|NCT02210559|472378568|FG001|Overall Study|Adverse Event|2|||
131206695|NCT02210559|472378567|FG000|Overall Study|Physician Decision|1|||
131206696|NCT02210559|472378568|FG001|Overall Study|Physician Decision|0|||
131206697|NCT02210559|472378567|FG000|Overall Study|Withdrawal by Subject|0|||
131206698|NCT02210559|472378568|FG001|Overall Study|Withdrawal by Subject|1|||
131206699|NCT02210559|472378567|FG000|Overall Study|Other than specified|0|||
131206700|NCT02210559|472378568|FG001|Overall Study|Other than specified|1|||
131206701|NCT01474291|472378569|FG000|Overall Study|Not Evaluable for Efficacy|26|||
131206702|NCT01474291|472378569|FG000|Overall Study|Lack of Treatment Efficacy|88|||
131206703|NCT01474291|472378569|FG000|Overall Study|Adverse Event|53|||
131206704|NCT01474291|472378569|FG000|Overall Study|Lost to Follow-up|29|||
131206705|NCT01474291|472378569|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
131206706|NCT01474291|472378569|FG000|Overall Study|No Reason Reported|10|||
131206707|NCT01474291|472378569|FG000|Overall Study|Death|2|||
131206708|NCT00310440|472378570|FG000|Overall Study|Lost to Follow-up|17|||
131206709|NCT00310440|472378571|FG001|Overall Study|Lost to Follow-up|8|||
131206710|NCT00310440|472378570|FG000|Overall Study|Withdrawal by Subject|2|||
131206711|NCT00310440|472378571|FG001|Overall Study|Withdrawal by Subject|1|||
131206712|NCT00310440|472378570|FG000|Overall Study|Missed 12 Month Visit|7|||
131206713|NCT00310440|472378571|FG001|Overall Study|Missed 12 Month Visit|4|||
131206714|NCT01287403|472378572|FG000|1st Intervention (1 Day)|Adverse Event|1|||
131206715|NCT00148109|472378573|FG000|Overall Study|Lack of Efficacy|10|||
131206716|NCT00148109|472378574|FG001|Overall Study|Lack of Efficacy|18|||
131206717|NCT00148109|472378573|FG000|Overall Study|Adverse Event|0|||
131206718|NCT00148109|472378574|FG001|Overall Study|Adverse Event|2|||
131206719|NCT00148109|472378573|FG000|Overall Study|Withdrawal by Subject|2|||
131206720|NCT00148109|472378574|FG001|Overall Study|Withdrawal by Subject|0|||
131206721|NCT01098266|472378575|FG000|Overall Study|Physician Decision|1|||
131206722|NCT01098266|472378576|FG001|Overall Study|Physician Decision|0|||
131206723|NCT01098266|472378575|FG000|Overall Study|Death|3|||
131206724|NCT01098266|472378576|FG001|Overall Study|Death|2|||
131206725|NCT01098266|472378575|FG000|Overall Study|Withdrawal by Subject|3|||
131206726|NCT01098266|472378576|FG001|Overall Study|Withdrawal by Subject|5|||
131206727|NCT00649220|472378580|FG000|Overall Study|Adverse Event|2|||
131206728|NCT00649220|472378580|FG000|Overall Study|Withdrawal by Subject|1|||
131206729|NCT00525499|472378581|FG000|Overall Study|Lost to Follow-up|2|||
131206730|NCT00525499|472378582|FG001|Overall Study|Lost to Follow-up|4|||
131206731|NCT00525499|472378583|FG002|Overall Study|Lost to Follow-up|1|||
131206732|NCT00525499|472378584|FG003|Overall Study|Lost to Follow-up|4|||
131206733|NCT00525499|472378581|FG000|Overall Study|Adverse Event|0|||
131206734|NCT00525499|472378582|FG001|Overall Study|Adverse Event|1|||
131206735|NCT00525499|472378583|FG002|Overall Study|Adverse Event|0|||
131206736|NCT00525499|472378584|FG003|Overall Study|Adverse Event|1|||
131206737|NCT00525499|472378581|FG000|Overall Study|Withdrawal by Subject|5|||
131206738|NCT00525499|472378582|FG001|Overall Study|Withdrawal by Subject|1|||
131206739|NCT00525499|472378583|FG002|Overall Study|Withdrawal by Subject|5|||
131206740|NCT00525499|472378584|FG003|Overall Study|Withdrawal by Subject|2|||
131206741|NCT00525499|472378581|FG000|Overall Study|Protocol Violation|0|||
131206742|NCT00525499|472378582|FG001|Overall Study|Protocol Violation|1|||
131206743|NCT00525499|472378583|FG002|Overall Study|Protocol Violation|1|||
131206744|NCT00525499|472378584|FG003|Overall Study|Protocol Violation|0|||
131206745|NCT00438815|472378585|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
131206746|NCT00438815|472378585|FG000|Overall Study|3-month follow-up no longer required|12|||
131206747|NCT00438815|472378585|FG000|Overall Study|Noncompliance with protocol requirements|9|||
131206748|NCT00438815|472378585|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
131206749|NCT00438815|472378585|FG000|Overall Study|Lost to Follow-up|6|||
131206750|NCT00438815|472378585|FG000|Overall Study|Withdrawal by Subject|6|||
131206751|NCT00438815|472378585|FG000|Overall Study|Death|1|||
131206752|NCT03380091|472378588|FG000|Overall Study|Withdrawal by Subject|2|||
131206753|NCT03380091|472378589|FG001|Overall Study|Withdrawal by Subject|1|||
131206754|NCT05602818|472378590|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
131206755|NCT05602818|472378591|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
130734980|NCT02932462|470649009|FG001|Overall Study|Protocol Violation|5|||
131206756|NCT05602818|472378592|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
131206757|NCT05602818|472378593|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
131206758|NCT05602818|472378594|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
131206759|NCT05602818|472378595|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
131206760|NCT05602818|472378596|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
131206761|NCT05602818|472378597|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
131206762|NCT05602818|472378598|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
131206763|NCT05602818|472378599|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
130734981|NCT02932462|470649008|FG000|Overall Study|Withdrawal by Subject|1|||
131206764|NCT05602818|472378600|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
130734982|NCT02932462|470649009|FG001|Overall Study|Withdrawal by Subject|4|||
131206765|NCT05602818|472378601|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
130734983|NCT02932462|470649008|FG000|Overall Study|Non-Compliance With Study Drug|0|||
131206766|NCT05602818|472378590|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
131206767|NCT05602818|472378591|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
131206768|NCT05602818|472378592|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131206769|NCT05602818|472378593|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131206770|NCT05602818|472378594|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131206771|NCT05602818|472378595|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131206772|NCT05602818|472378596|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131206773|NCT05602818|472378597|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131206774|NCT05602818|472378598|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131206775|NCT05602818|472378599|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131206776|NCT05602818|472378600|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131206777|NCT05602818|472378601|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
131206778|NCT05602818|472378590|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
131206779|NCT05602818|472378591|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206780|NCT05602818|472378592|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206781|NCT05602818|472378593|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206782|NCT05602818|472378594|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206783|NCT05602818|472378595|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206784|NCT05602818|472378596|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206785|NCT05602818|472378597|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206786|NCT05602818|472378598|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206787|NCT05602818|472378599|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206788|NCT05602818|472378600|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206789|NCT05602818|472378601|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
131206790|NCT05602818|472378590|FG000|Qualification Phase (3 Days)|Other|1|||
131206791|NCT05602818|472378591|FG001|Qualification Phase (3 Days)|Other|0|||
131206792|NCT05602818|472378592|FG002|Qualification Phase (3 Days)|Other|0|||
131206793|NCT05602818|472378593|FG003|Qualification Phase (3 Days)|Other|0|||
131206794|NCT05602818|472378594|FG004|Qualification Phase (3 Days)|Other|0|||
131206795|NCT05602818|472378595|FG005|Qualification Phase (3 Days)|Other|0|||
131206796|NCT05602818|472378596|FG006|Qualification Phase (3 Days)|Other|0|||
131206797|NCT05602818|472378597|FG007|Qualification Phase (3 Days)|Other|0|||
131206798|NCT05602818|472378598|FG008|Qualification Phase (3 Days)|Other|0|||
131206799|NCT05602818|472378599|FG009|Qualification Phase (3 Days)|Other|0|||
131206800|NCT05602818|472378600|FG010|Qualification Phase (3 Days)|Other|0|||
131206801|NCT05602818|472378601|FG011|Qualification Phase (3 Days)|Other|0|||
131206802|NCT05602818|472378590|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131206803|NCT05602818|472378591|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
131206804|NCT05602818|472378592|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131206805|NCT05602818|472378593|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130734984|NCT02932462|470649009|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130734985|NCT02932462|470649008|FG000|Overall Study|Progressive Disease|1|||
131206806|NCT05602818|472378594|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131206807|NCT05602818|472378595|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130734986|NCT02932462|470649009|FG001|Overall Study|Progressive Disease|0|||
130734987|NCT02652949|470649010|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
130734988|NCT02652949|470649010|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
131206808|NCT05602818|472378596|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131206809|NCT05602818|472378597|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131206810|NCT05602818|472378598|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131206811|NCT05602818|472378599|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131206812|NCT05602818|472378600|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131206813|NCT05602818|472378601|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
131206814|NCT05602818|472378590|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
131206815|NCT05602818|472378591|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
131206816|NCT05602818|472378592|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
131206817|NCT05602818|472378593|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
131206818|NCT05602818|472378594|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
131206819|NCT05602818|472378595|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
131206820|NCT05602818|472378596|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
131206821|NCT05602818|472378597|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
131206822|NCT05602818|472378598|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
131206823|NCT05602818|472378599|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
131206824|NCT05602818|472378600|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
131206825|NCT05602818|472378601|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
131206826|NCT05602818|472378590|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131206827|NCT05602818|472378591|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131206828|NCT05602818|472378592|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131206829|NCT05602818|472378593|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131206830|NCT05602818|472378594|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131206831|NCT05602818|472378595|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131206832|NCT05602818|472378596|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131206833|NCT05602818|472378597|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131206834|NCT05602818|472378598|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131206835|NCT05602818|472378599|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
131206836|NCT05602818|472378600|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
131206837|NCT05602818|472378601|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
131206838|NCT05602818|472378590|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
131206839|NCT05602818|472378591|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
131206840|NCT05602818|472378592|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
131206841|NCT05602818|472378593|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
131206842|NCT05602818|472378594|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
131206843|NCT05602818|472378595|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
131206844|NCT05602818|472378596|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
131206845|NCT05602818|472378597|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
131206846|NCT05602818|472378598|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
131206847|NCT05602818|472378599|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
131206848|NCT05602818|472378600|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
131206849|NCT05602818|472378601|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
131206850|NCT00679354|472378608|FG000|Overall Study|Death|3|||
131206851|NCT00679354|472378608|FG000|Overall Study|Lack of Efficacy|22|||
131206852|NCT00679354|472378608|FG000|Overall Study|Physician Decision|4|||
131206853|NCT00679354|472378608|FG000|Overall Study|Ineligible|1|||
131206854|NCT00535262|472378613|FG000|Overall Study|No funding|3|||
131206855|NCT02898662|472378614|FG000|Overall Study|Adverse Event|1|||
131206856|NCT02898662|472378615|FG001|Overall Study|Adverse Event|0|||
131206857|NCT02898662|472378614|FG000|Overall Study|Loss of asthma control|23|||
131206858|NCT02898662|472378615|FG001|Overall Study|Loss of asthma control|24|||
131206859|NCT02898662|472378614|FG000|Overall Study|Withdrawal by Subject|4|||
131206860|NCT02898662|472378615|FG001|Overall Study|Withdrawal by Subject|1|||
131206861|NCT02898662|472378614|FG000|Overall Study|Technical issue|0|||
131206862|NCT02898662|472378615|FG001|Overall Study|Technical issue|1|||
131206863|NCT02898662|472378614|FG000|Overall Study|Randomized in error|0|||
131206864|NCT02898662|472378615|FG001|Overall Study|Randomized in error|1|||
131206865|NCT02898662|472378614|FG000|Overall Study|Subject decision|1|||
131206866|NCT02898662|472378615|FG001|Overall Study|Subject decision|0|||
131206867|NCT02898662|472378614|FG000|Overall Study|Other|0|||
131206868|NCT02898662|472378615|FG001|Overall Study|Other|1|||
131206869|NCT03802331|472378616|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
131206870|NCT03802331|472378617|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
131206871|NCT00917553|472378618|FG000|Overall Study|Lost to Follow-up|2|||
131206872|NCT00917553|472378619|FG001|Overall Study|Lost to Follow-up|1|||
131206873|NCT01616173|472378620|FG000|Overall Study|Lost to Follow-up|0|||
131206874|NCT01616173|472378621|FG001|Overall Study|Lost to Follow-up|2|||
131206875|NCT01616173|472378622|FG002|Overall Study|Lost to Follow-up|0|||
131206876|NCT04382066|472378625|FG000|Overall Study|Adverse Event|1|||
131206877|NCT04382066|472378626|FG001|Overall Study|Adverse Event|0|||
131206878|NCT04382066|472378627|FG002|Overall Study|Adverse Event|0|||
131206879|NCT04382066|472378625|FG000|Overall Study|Death|1|||
131206880|NCT04382066|472378626|FG001|Overall Study|Death|0|||
131206881|NCT04382066|472378627|FG002|Overall Study|Death|1|||
131206882|NCT00504595|472378628|FG000|Overall Study|Lack of Efficacy|1|||
131206883|NCT00504595|472378629|FG001|Overall Study|Lack of Efficacy|0|||
131206884|NCT00504595|472378630|FG002|Overall Study|Lack of Efficacy|0|||
131206885|NCT00504595|472378631|FG003|Overall Study|Lack of Efficacy|0|||
131206886|NCT00504595|472378628|FG000|Overall Study|Other|0|||
131206887|NCT00504595|472378629|FG001|Overall Study|Other|0|||
131206888|NCT00504595|472378630|FG002|Overall Study|Other|2|||
131206889|NCT00504595|472378631|FG003|Overall Study|Other|0|||
131206890|NCT03326323|472378632|FG000|Overall Study|Unable to receive ANH protocol|3|||
131206891|NCT04225026|472378633|FG000|Overall Study|Withdrawal by Subject|4|||
131206892|NCT04225026|472378633|FG000|Overall Study|Adverse Event|1|||
131206893|NCT04225026|472378633|FG000|Overall Study|Other|1|||
131206894|NCT04225026|472378633|FG000|Overall Study|Death|11|||
131206895|NCT04225026|472378633|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
131206896|NCT00851721|472378634|FG000|Overall Study|planned surgery|1|||
131206897|NCT00851721|472378635|FG001|Overall Study|planned surgery|0|||
131206898|NCT00851721|472378634|FG000|Overall Study|Death|1|||
131206899|NCT00851721|472378635|FG001|Overall Study|Death|0|||
131206900|NCT00851721|472378634|FG000|Overall Study|Adverse Event|0|||
131206901|NCT00851721|472378635|FG001|Overall Study|Adverse Event|1|||
131206902|NCT01218477|472378638|FG000|Overall Study|Disease progression|2|||
131206903|NCT01218477|472378639|FG001|Overall Study|Disease progression|3|||
131206904|NCT01218477|472378640|FG002|Overall Study|Disease progression|6|||
131206905|NCT01218477|472378641|FG003|Overall Study|Disease progression|2|||
131206906|NCT01218477|472378638|FG000|Overall Study|Study drug toxicity|0|||
131206907|NCT01218477|472378639|FG001|Overall Study|Study drug toxicity|2|||
131206908|NCT01218477|472378640|FG002|Overall Study|Study drug toxicity|5|||
131206909|NCT01218477|472378641|FG003|Overall Study|Study drug toxicity|0|||
131206910|NCT01218477|472378638|FG000|Overall Study|No longer meets study criteria|1|||
131206911|NCT01218477|472378639|FG001|Overall Study|No longer meets study criteria|0|||
131206912|NCT01218477|472378640|FG002|Overall Study|No longer meets study criteria|0|||
131206913|NCT01218477|472378641|FG003|Overall Study|No longer meets study criteria|0|||
131206914|NCT01218477|472378638|FG000|Overall Study|Withdrawal by Subject|0|||
131206915|NCT01218477|472378639|FG001|Overall Study|Withdrawal by Subject|0|||
131206916|NCT01218477|472378640|FG002|Overall Study|Withdrawal by Subject|1|||
131206917|NCT01218477|472378641|FG003|Overall Study|Withdrawal by Subject|0|||
131206918|NCT01218477|472378638|FG000|Overall Study|Prepared for cell transplantation|0|||
131206919|NCT01218477|472378639|FG001|Overall Study|Prepared for cell transplantation|1|||
131206920|NCT01218477|472378640|FG002|Overall Study|Prepared for cell transplantation|1|||
131206921|NCT01218477|472378641|FG003|Overall Study|Prepared for cell transplantation|0|||
131206922|NCT01218477|472378638|FG000|Overall Study|Administrative reason by sponsor|0|||
131206923|NCT01218477|472378639|FG001|Overall Study|Administrative reason by sponsor|0|||
131206924|NCT01218477|472378640|FG002|Overall Study|Administrative reason by sponsor|1|||
131206925|NCT01218477|472378641|FG003|Overall Study|Administrative reason by sponsor|0|||
131206926|NCT01218477|472378638|FG000|Overall Study|Maximum clinical benefit|0|||
131206927|NCT01218477|472378639|FG001|Overall Study|Maximum clinical benefit|2|||
131206928|NCT01218477|472378640|FG002|Overall Study|Maximum clinical benefit|0|||
131206929|NCT01218477|472378641|FG003|Overall Study|Maximum clinical benefit|0|||
131206930|NCT00760994|472378644|FG000|Overall Study|Lost to Follow-up|4|||
131206931|NCT00760994|472378645|FG001|Overall Study|Lost to Follow-up|4|||
131206932|NCT00760994|472378646|FG002|Overall Study|Lost to Follow-up|3|||
131206933|NCT02132312|472378647|FG000|Overall Study|Adverse Event|2|||
131206934|NCT02132312|472378648|FG001|Overall Study|Adverse Event|0|||
131206935|NCT02132312|472378647|FG000|Overall Study|Physician Decision|1|||
131206936|NCT02132312|472378648|FG001|Overall Study|Physician Decision|1|||
131206937|NCT02132312|472378647|FG000|Overall Study|Protocol Violation|0|||
131206938|NCT02132312|472378648|FG001|Overall Study|Protocol Violation|1|||
131206939|NCT02132312|472378647|FG000|Overall Study|Withdrawal by Subject|1|||
131206940|NCT02132312|472378648|FG001|Overall Study|Withdrawal by Subject|0|||
131206941|NCT02132312|472378647|FG000|Overall Study|Lost to Follow-up|2|||
131206942|NCT02132312|472378648|FG001|Overall Study|Lost to Follow-up|1|||
131206943|NCT00486720|472378649|FG000|Overall Study|Adverse Event|1|||
131206944|NCT00486720|472378650|FG001|Overall Study|Adverse Event|2|||
131206945|NCT00486720|472378649|FG000|Overall Study|Lack of Efficacy|4|||
131206946|NCT00486720|472378650|FG001|Overall Study|Lack of Efficacy|6|||
131206947|NCT00486720|472378649|FG000|Overall Study|Physician Decision|1|||
131206948|NCT00486720|472378650|FG001|Overall Study|Physician Decision|2|||
131206949|NCT00486720|472378649|FG000|Overall Study|Protocol Violation|1|||
131206950|NCT00486720|472378650|FG001|Overall Study|Protocol Violation|0|||
131206951|NCT00486720|472378649|FG000|Overall Study|Withdrawal by Subject|3|||
131206952|NCT00486720|472378650|FG001|Overall Study|Withdrawal by Subject|1|||
131206953|NCT00486720|472378649|FG000|Overall Study|Progressive Disease|0|||
131206954|NCT00486720|472378650|FG001|Overall Study|Progressive Disease|1|||
131206955|NCT02117024|472378651|FG000|Overall Study|Progressive Disease|26|||
131206956|NCT02117024|472378652|FG001|Overall Study|Progressive Disease|9|||
130734989|NCT02652949|470649010|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
130734990|NCT02652949|470649010|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
130734991|NCT02652949|470649010|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
130734992|NCT02652949|470649010|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
130734993|NCT02652949|470649010|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
130734994|NCT02652949|470649010|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
130734995|NCT02652949|470649010|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
130734996|NCT02652949|470649010|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
130734997|NCT02652949|470649010|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
130734998|NCT02652949|470649010|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
130734999|NCT02652949|470649010|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
130735000|NCT02652949|470649010|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
130735001|NCT02652949|470649010|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
130735002|NCT02652949|470649010|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
130735003|NCT02652949|470649010|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
130735004|NCT00280735|470649020|FG000|Overall Study|Adverse Event|5|||
130735005|NCT00280735|470649020|FG000|Overall Study|Lack of Efficacy|3|||
130735006|NCT00280735|470649020|FG000|Overall Study|Withdrawal by Subject|8|||
130735007|NCT00280735|470649020|FG000|Overall Study|Intercurrent Illness|2|||
130735008|NCT04753216|470649021|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
130735009|NCT04753216|470649021|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
130735010|NCT04753216|470649021|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
130735011|NCT02001987|470649023|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
130735012|NCT02001987|470649023|FG000|Core Study Period (24 Weeks)|Death|1|||
130735013|NCT02001987|470649023|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
130735014|NCT02001987|470649023|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
131206957|NCT02117024|472378651|FG000|Overall Study|Significant Clinical Progression|7|||
131206958|NCT02117024|472378652|FG001|Overall Study|Significant Clinical Progression|4|||
131206959|NCT02117024|472378651|FG000|Overall Study|Death|5|||
131206960|NCT02117024|472378652|FG001|Overall Study|Death|0|||
131206961|NCT02117024|472378651|FG000|Overall Study|Withdrawal by Subject|3|||
131206962|NCT02117024|472378652|FG001|Overall Study|Withdrawal by Subject|1|||
131206963|NCT02117024|472378651|FG000|Overall Study|Protocol Violation|1|||
131206964|NCT02117024|472378652|FG001|Overall Study|Protocol Violation|0|||
131206965|NCT02117024|472378651|FG000|Overall Study|Adverse Event|1|||
131206966|NCT02117024|472378652|FG001|Overall Study|Adverse Event|2|||
131206967|NCT02117024|472378651|FG000|Overall Study|Randomized in Error|1|||
131206968|NCT02117024|472378652|FG001|Overall Study|Randomized in Error|0|||
131206969|NCT02117024|472378651|FG000|Overall Study|Patient returned to primary oncologist|0|||
131206970|NCT02117024|472378652|FG001|Overall Study|Patient returned to primary oncologist|1|||
131206971|NCT02117024|472378651|FG000|Overall Study|Patient took treatment break|0|||
131206972|NCT02117024|472378652|FG001|Overall Study|Patient took treatment break|1|||
131206973|NCT02117024|472378651|FG000|Overall Study|Physician Decision|0|||
131206974|NCT02117024|472378652|FG001|Overall Study|Physician Decision|2|||
131206975|NCT01475214|472378658|FG000|Overall Study|Lost to Follow-up|1|||
131206976|NCT01475214|472378659|FG001|Overall Study|Lost to Follow-up|0|||
131206977|NCT01475214|472378660|FG002|Overall Study|Lost to Follow-up|1|||
131206978|NCT01475214|472378658|FG000|Overall Study|Physician Decision|2|||
131206979|NCT01475214|472378659|FG001|Overall Study|Physician Decision|0|||
131206980|NCT01475214|472378660|FG002|Overall Study|Physician Decision|0|||
131206981|NCT01475214|472378658|FG000|Overall Study|Withdrawal by Subject|2|||
131206982|NCT01475214|472378659|FG001|Overall Study|Withdrawal by Subject|4|||
131206983|NCT01475214|472378660|FG002|Overall Study|Withdrawal by Subject|1|||
131206984|NCT02926833|472380732|FG000|Overall Study|Death|1|||
131206985|NCT02926833|472380733|FG001|Overall Study|Death|1|||
131206986|NCT02926833|472380734|FG002|Overall Study|Death|2|||
131206987|NCT02926833|472380735|FG003|Overall Study|Death|13|||
131206988|NCT02926833|472380732|FG000|Overall Study|Lost to Follow-up|1|||
131206989|NCT02926833|472380733|FG001|Overall Study|Lost to Follow-up|2|||
131206990|NCT02926833|472380734|FG002|Overall Study|Lost to Follow-up|0|||
131206991|NCT02926833|472380735|FG003|Overall Study|Lost to Follow-up|3|||
131206992|NCT02926833|472380732|FG000|Overall Study|Full Consent Withdrawal|0|||
131206993|NCT02926833|472380733|FG001|Overall Study|Full Consent Withdrawal|0|||
131206994|NCT02926833|472380734|FG002|Overall Study|Full Consent Withdrawal|0|||
130735015|NCT02001987|470649023|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
130735016|NCT02001987|470649023|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
130735017|NCT02001987|470649023|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
130735018|NCT02001987|470649023|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
130735019|NCT02001987|470649023|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
130735020|NCT02001987|470649023|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
131206995|NCT02926833|472380735|FG003|Overall Study|Full Consent Withdrawal|2|||
131206996|NCT02926833|472380732|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
131206997|NCT02926833|472380733|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
130735021|NCT02001987|470649023|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
131206998|NCT02926833|472380734|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
131206999|NCT02926833|472380735|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
131207000|NCT02926833|472380732|FG000|Overall Study|Investigator Decision|0|||
131207001|NCT02926833|472380733|FG001|Overall Study|Investigator Decision|1|||
131207002|NCT02926833|472380734|FG002|Overall Study|Investigator Decision|0|||
131207003|NCT02926833|472380735|FG003|Overall Study|Investigator Decision|0|||
131207004|NCT02926833|472380732|FG000|Overall Study|Adverse Event|0|||
131207005|NCT02926833|472380733|FG001|Overall Study|Adverse Event|0|||
131207006|NCT02926833|472380734|FG002|Overall Study|Adverse Event|1|||
131207007|NCT02926833|472380735|FG003|Overall Study|Adverse Event|0|||
131207008|NCT02926833|472380732|FG000|Overall Study|Partial Withdrawal of Consent|0|||
131207009|NCT02926833|472380733|FG001|Overall Study|Partial Withdrawal of Consent|0|||
131207010|NCT02926833|472380734|FG002|Overall Study|Partial Withdrawal of Consent|0|||
131207011|NCT02926833|472380735|FG003|Overall Study|Partial Withdrawal of Consent|1|||
131207012|NCT01189201|472380742|FG000|Overall Study|Adverse Event|1|||
131207013|NCT01277757|472380743|FG000|Overall Study|Disease Progression|1|||
131207014|NCT01277757|472380743|FG000|Overall Study|Withdrawal by Subject|1|||
131207015|NCT00911508|472380744|FG000|Overall Study|Lost to Follow-up|27|||
131207016|NCT00911508|472380745|FG001|Overall Study|Lost to Follow-up|18|||
131207017|NCT00911508|472380744|FG000|Overall Study|Withdrawal by Subject|79|||
131207018|NCT00911508|472380745|FG001|Overall Study|Withdrawal by Subject|112|||
131207019|NCT01409382|472380746|FG000|Overall Study|Lost to Follow-up|1|||
131207020|NCT01409382|472380747|FG001|Overall Study|Lost to Follow-up|1|||
131207021|NCT01409382|472380746|FG000|Overall Study|Protocol Violation|0|||
131207022|NCT01409382|472380747|FG001|Overall Study|Protocol Violation|3|||
131207023|NCT01409382|472380746|FG000|Overall Study|Multiple pregnancy|2|||
131207024|NCT01409382|472380747|FG001|Overall Study|Multiple pregnancy|4|||
131207025|NCT01409382|472380746|FG000|Overall Study|Still pregnant when study ended|13|||
131207026|NCT01409382|472380747|FG001|Overall Study|Still pregnant when study ended|2|||
131207027|NCT01409382|472380746|FG000|Overall Study|Did not manage to get pregnant|64|||
131207028|NCT01409382|472380747|FG001|Overall Study|Did not manage to get pregnant|70|||
131207029|NCT01409382|472380746|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
131207030|NCT01409382|472380747|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
131207031|NCT04308668|472380748|FG000|Overall Study|Lost to Follow-up|32|||
131207032|NCT04308668|472380749|FG001|Overall Study|Lost to Follow-up|38|||
131207033|NCT04308668|472380748|FG000|Overall Study|Withdrawal by Subject|4|||
131207034|NCT04308668|472380749|FG001|Overall Study|Withdrawal by Subject|4|||
131207035|NCT01336647|472380750|FG000|Overall Study|Lost to Follow-up|4|||
131207036|NCT01336647|472380751|FG001|Overall Study|Lost to Follow-up|1|||
131207037|NCT01336647|472380752|FG002|Overall Study|Lost to Follow-up|3|||
131207038|NCT03808298|472380753|FG000|Overall Study|Adverse Event|3|||
131207039|NCT03808298|472380753|FG000|Overall Study|Physician Decision|1|||
131207040|NCT03808298|472380753|FG000|Overall Study|Withdrawal by Subject|1|||
131207041|NCT03808298|472380753|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
131207042|NCT01004822|472380754|FG000|Overall Study|Objective progression or relapse|3|||
131207043|NCT01004822|472380755|FG001|Overall Study|Objective progression or relapse|3|||
131207044|NCT01004822|472380756|FG002|Overall Study|Objective progression or relapse|0|||
131207045|NCT01004822|472380757|FG003|Overall Study|Objective progression or relapse|1|||
131207046|NCT01004822|472380758|FG004|Overall Study|Objective progression or relapse|2|||
131207047|NCT01004822|472380759|FG005|Overall Study|Objective progression or relapse|2|||
131207048|NCT01004822|472380760|FG006|Overall Study|Objective progression or relapse|1|||
131207049|NCT01004822|472380761|FG007|Overall Study|Objective progression or relapse|4|||
131207050|NCT01004822|472380754|FG000|Overall Study|Global deterioration of health status|0|||
131207051|NCT01004822|472380755|FG001|Overall Study|Global deterioration of health status|0|||
131207052|NCT01004822|472380756|FG002|Overall Study|Global deterioration of health status|0|||
131207053|NCT01004822|472380757|FG003|Overall Study|Global deterioration of health status|1|||
131207054|NCT01004822|472380758|FG004|Overall Study|Global deterioration of health status|0|||
131207055|NCT01004822|472380759|FG005|Overall Study|Global deterioration of health status|0|||
131207056|NCT01004822|472380760|FG006|Overall Study|Global deterioration of health status|1|||
131207057|NCT01004822|472380761|FG007|Overall Study|Global deterioration of health status|0|||
131207058|NCT01004822|472380754|FG000|Overall Study|No longer willing to continue|0|||
131207059|NCT01004822|472380755|FG001|Overall Study|No longer willing to continue|0|||
131207060|NCT01004822|472380756|FG002|Overall Study|No longer willing to continue|0|||
131207061|NCT01004822|472380757|FG003|Overall Study|No longer willing to continue|1|||
130735022|NCT02001987|470649023|FG000|LTE Period (52 Weeks)|Other|3|||
131207062|NCT01004822|472380758|FG004|Overall Study|No longer willing to continue|2|||
131207063|NCT01004822|472380759|FG005|Overall Study|No longer willing to continue|1|||
131207064|NCT01004822|472380760|FG006|Overall Study|No longer willing to continue|1|||
131207065|NCT01004822|472380761|FG007|Overall Study|No longer willing to continue|0|||
131207066|NCT01004822|472380754|FG000|Overall Study|Adverse Event|0|||
130735023|NCT01965860|470649024|FG000|Overall Study|Pregnancy|1|||
130735024|NCT01965860|470649025|FG001|Overall Study|Pregnancy|0|||
130735025|NCT01965860|470649026|FG002|Overall Study|Pregnancy|1|||
131207067|NCT01004822|472380755|FG001|Overall Study|Adverse Event|0|||
131207068|NCT01004822|472380756|FG002|Overall Study|Adverse Event|0|||
131207069|NCT01004822|472380757|FG003|Overall Study|Adverse Event|0|||
131207070|NCT01004822|472380758|FG004|Overall Study|Adverse Event|0|||
131207071|NCT01004822|472380759|FG005|Overall Study|Adverse Event|0|||
131207072|NCT01004822|472380760|FG006|Overall Study|Adverse Event|1|||
131207073|NCT01004822|472380761|FG007|Overall Study|Adverse Event|1|||
131207074|NCT01004822|472380754|FG000|Overall Study|Other|0|||
131207075|NCT01004822|472380755|FG001|Overall Study|Other|0|||
131207076|NCT01004822|472380756|FG002|Overall Study|Other|4|||
131207077|NCT01004822|472380757|FG003|Overall Study|Other|1|||
131207078|NCT01004822|472380758|FG004|Overall Study|Other|0|||
131207079|NCT01004822|472380759|FG005|Overall Study|Other|1|||
131207080|NCT01004822|472380760|FG006|Overall Study|Other|0|||
131207081|NCT01004822|472380761|FG007|Overall Study|Other|0|||
131207082|NCT01858701|472380762|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
131207083|NCT01858701|472380763|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
131207084|NCT01858701|472380762|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
131207085|NCT01858701|472380763|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
131207086|NCT01858701|472380762|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
131207087|NCT01858701|472380763|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
131207088|NCT01858701|472380762|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
131207089|NCT01858701|472380763|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
131207090|NCT01801475|472380764|FG000|Overall Study|Withdrawal by Subject|0|||
131207091|NCT01801475|472380765|FG001|Overall Study|Withdrawal by Subject|0|||
131207092|NCT01801475|472380766|FG002|Overall Study|Withdrawal by Subject|0|||
131207093|NCT01801475|472380767|FG003|Overall Study|Withdrawal by Subject|0|||
131207094|NCT01801475|472380768|FG004|Overall Study|Withdrawal by Subject|1|||
131207095|NCT00421928|472380769|FG000|Overall Study|Adverse Event|61|||
131207096|NCT00421928|472380770|FG001|Overall Study|Adverse Event|140|||
131207097|NCT00421928|472380771|FG002|Overall Study|Adverse Event|22|||
131207098|NCT00421928|472380769|FG000|Overall Study|Lost to Follow-up|5|||
131207099|NCT00421928|472380770|FG001|Overall Study|Lost to Follow-up|0|||
131207100|NCT00421928|472380771|FG002|Overall Study|Lost to Follow-up|3|||
131207101|NCT00421928|472380769|FG000|Overall Study|Withdrawal by Subject|50|||
131207102|NCT00421928|472380770|FG001|Overall Study|Withdrawal by Subject|48|||
131207103|NCT00421928|472380771|FG002|Overall Study|Withdrawal by Subject|43|||
131207104|NCT00421928|472380769|FG000|Overall Study|Lack of Efficacy|15|||
131207105|NCT00421928|472380770|FG001|Overall Study|Lack of Efficacy|7|||
131207106|NCT00421928|472380771|FG002|Overall Study|Lack of Efficacy|35|||
131207107|NCT00421928|472380769|FG000|Overall Study|Study drug non-compliant|6|||
131207108|NCT00421928|472380770|FG001|Overall Study|Study drug non-compliant|7|||
131207109|NCT00421928|472380771|FG002|Overall Study|Study drug non-compliant|4|||
131207110|NCT00421928|472380769|FG000|Overall Study|All other|26|||
131207111|NCT00421928|472380770|FG001|Overall Study|All other|21|||
131207112|NCT00421928|472380771|FG002|Overall Study|All other|27|||
131207113|NCT00421928|472380769|FG000|Overall Study|Death|0|||
131207114|NCT00421928|472380770|FG001|Overall Study|Death|1|||
131207115|NCT00421928|472380771|FG002|Overall Study|Death|0|||
131207116|NCT01789476|472380792|FG000|Overall Study|Lack of Efficacy|6|||
131207117|NCT01789476|472380793|FG001|Overall Study|Lack of Efficacy|2|||
131207118|NCT01789476|472380792|FG000|Overall Study|Adverse Event|1|||
130735026|NCT01965860|470649024|FG000|Overall Study|Logistics|1|||
130735027|NCT01965860|470649025|FG001|Overall Study|Logistics|0|||
130735028|NCT01965860|470649026|FG002|Overall Study|Logistics|0|||
130735029|NCT01895777|470649027|FG000|Overall Study|Adverse Event|1|||
130735030|NCT01895777|470649028|FG001|Overall Study|Adverse Event|2|||
131207119|NCT01789476|472380793|FG001|Overall Study|Adverse Event|0|||
131207120|NCT01789476|472380792|FG000|Overall Study|Unable to get IV access|1|||
131207121|NCT01789476|472380793|FG001|Overall Study|Unable to get IV access|0|||
131207122|NCT00501969|472380794|FG000|Overall Study|Major Protocol Violation|4|||
131207123|NCT00501969|472380794|FG000|Overall Study|Lack of Efficacy|29|||
131207124|NCT00501969|472380794|FG000|Overall Study|Adverse Event|76|||
131207125|NCT00501969|472380794|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
131207126|NCT00501969|472380794|FG000|Overall Study|Subject withdrew consent|51|||
131207127|NCT00501969|472380794|FG000|Overall Study|Lost to Follow-up|4|||
130735031|NCT01895777|470649027|FG000|Overall Study|Lost to Follow-up|2|||
130735032|NCT01895777|470649028|FG001|Overall Study|Lost to Follow-up|0|||
130735033|NCT01895777|470649027|FG000|Overall Study|Not treated|1|||
130735034|NCT01895777|470649028|FG001|Overall Study|Not treated|0|||
130735035|NCT01895777|470649027|FG000|Overall Study|Other reasons|3|||
130735036|NCT01895777|470649028|FG001|Overall Study|Other reasons|2|||
130735037|NCT01895777|470649027|FG000|Overall Study|Non-compliance with the CTP|2|||
130735038|NCT01895777|470649028|FG001|Overall Study|Non-compliance with the CTP|1|||
130735039|NCT03735121|470649032|FG000|Overall Study|Death|3|||
130735040|NCT03735121|470649033|FG001|Overall Study|Death|6|||
130735041|NCT03735121|470649034|FG002|Overall Study|Death|8|||
130735042|NCT03735121|470649035|FG003|Overall Study|Death|37|||
130735043|NCT03735121|470649036|FG004|Overall Study|Death|86|||
130735044|NCT03735121|470649032|FG000|Overall Study|Withdrawal by Subject|1|||
130735045|NCT03735121|470649033|FG001|Overall Study|Withdrawal by Subject|1|||
130735046|NCT03735121|470649034|FG002|Overall Study|Withdrawal by Subject|3|||
130735047|NCT03735121|470649035|FG003|Overall Study|Withdrawal by Subject|4|||
130735048|NCT03735121|470649036|FG004|Overall Study|Withdrawal by Subject|2|||
130735049|NCT03735121|470649032|FG000|Overall Study|Progressive Disease|0|||
130735050|NCT03735121|470649033|FG001|Overall Study|Progressive Disease|0|||
130735051|NCT03735121|470649034|FG002|Overall Study|Progressive Disease|1|||
130735052|NCT03735121|470649035|FG003|Overall Study|Progressive Disease|0|||
130735053|NCT03735121|470649036|FG004|Overall Study|Progressive Disease|0|||
130735054|NCT03735121|470649032|FG000|Overall Study|Lost to Follow-up|0|||
130735055|NCT03735121|470649033|FG001|Overall Study|Lost to Follow-up|0|||
130735056|NCT03735121|470649034|FG002|Overall Study|Lost to Follow-up|0|||
130735057|NCT03735121|470649035|FG003|Overall Study|Lost to Follow-up|0|||
130735058|NCT03735121|470649036|FG004|Overall Study|Lost to Follow-up|1|||
130735059|NCT03735121|470649032|FG000|Overall Study|Ongoing|3|||
130735060|NCT03735121|470649033|FG001|Overall Study|Ongoing|3|||
130735061|NCT03735121|470649034|FG002|Overall Study|Ongoing|26|||
130735062|NCT03735121|470649035|FG003|Overall Study|Ongoing|83|||
130735063|NCT03735121|470649036|FG004|Overall Study|Ongoing|158|||
130735064|NCT00344448|470649037|FG000|Screening|Withdrawal by Subject|0|||
130735065|NCT00344448|470649038|FG001|Screening|Withdrawal by Subject|1|||
130735066|NCT00344448|470649037|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
130735067|NCT00344448|470649038|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
130735068|NCT00344448|470649037|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
130735069|NCT00344448|470649038|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
130735070|NCT00344448|470649037|FG000|Open Label|Withdrawal by Subject|1|||
130735071|NCT00344448|470649038|FG001|Open Label|Withdrawal by Subject|1|||
130735072|NCT00344448|470649037|FG000|Open Label|Study terminated|1|||
130735073|NCT00344448|470649038|FG001|Open Label|Study terminated|0|||
130735074|NCT03138655|470649039|FG000|Overall Study|Adverse Event|2|||
130735075|NCT03138655|470649040|FG001|Overall Study|Adverse Event|1|||
131207128|NCT00501969|472380794|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
131207129|NCT00501969|472380794|FG000|Overall Study|Other: Sponsors Request|10|||
131207130|NCT00501969|472380794|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
131207131|NCT00501969|472380794|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
131207132|NCT00501969|472380794|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
131207133|NCT00501969|472380794|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
131207134|NCT00501969|472380794|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
131207135|NCT00501969|472380794|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
131207136|NCT00501969|472380794|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
131207137|NCT00501969|472380794|FG000|Overall Study|Other: As Required by Local EC|2|||
131207138|NCT00501969|472380794|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
131207139|NCT00501969|472380794|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
131207140|NCT00965458|472380795|FG000|Overall Study|Adverse Event|1|||
131207141|NCT00965458|472380796|FG001|Overall Study|Adverse Event|0|||
131207142|NCT00965458|472380795|FG000|Overall Study|Lost to Follow-up|1|||
131207143|NCT00965458|472380796|FG001|Overall Study|Lost to Follow-up|3|||
130735076|NCT03138655|470649041|FG002|Overall Study|Adverse Event|2|||
130735077|NCT03138655|470649042|FG003|Overall Study|Adverse Event|1|||
130735078|NCT03138655|470649043|FG004|Overall Study|Adverse Event|1|||
130735079|NCT03138655|470649044|FG005|Overall Study|Adverse Event|4|||
130735080|NCT03138655|470649045|FG006|Overall Study|Adverse Event|2|||
130735081|NCT03138655|470649046|FG007|Overall Study|Adverse Event|2|||
130735082|NCT03138655|470649039|FG000|Overall Study|Withdrawal by Subject|0|||
130735083|NCT03138655|470649040|FG001|Overall Study|Withdrawal by Subject|1|||
130735084|NCT03138655|470649041|FG002|Overall Study|Withdrawal by Subject|0|||
130735085|NCT03138655|470649042|FG003|Overall Study|Withdrawal by Subject|0|||
130735086|NCT03138655|470649043|FG004|Overall Study|Withdrawal by Subject|0|||
130735087|NCT03138655|470649044|FG005|Overall Study|Withdrawal by Subject|0|||
130735088|NCT03138655|470649045|FG006|Overall Study|Withdrawal by Subject|1|||
131207144|NCT00965458|472380795|FG000|Overall Study|Withdrawal by Subject|0|||
131207145|NCT00965458|472380796|FG001|Overall Study|Withdrawal by Subject|1|||
130735089|NCT03138655|470649046|FG007|Overall Study|Withdrawal by Subject|0|||
130735090|NCT03138655|470649039|FG000|Overall Study|Reason not Specified|1|||
131207146|NCT05111548|472380803|FG000|Overall Study|Withdrawal by Subject|2|||
130735091|NCT03138655|470649040|FG001|Overall Study|Reason not Specified|0|||
130735092|NCT03138655|470649041|FG002|Overall Study|Reason not Specified|0|||
130735093|NCT03138655|470649042|FG003|Overall Study|Reason not Specified|2|||
130735094|NCT03138655|470649043|FG004|Overall Study|Reason not Specified|1|||
131207147|NCT05111548|472380804|FG001|Overall Study|Withdrawal by Subject|1|||
131207148|NCT05111548|472380803|FG000|Overall Study|Adverse Event|1|||
131207149|NCT05111548|472380804|FG001|Overall Study|Adverse Event|0|||
131207150|NCT00379639|472380805|FG000|Overall Study|Disease Progression|3|||
131207151|NCT00379639|472380806|FG001|Overall Study|Disease Progression|3|||
131207152|NCT00379639|472380807|FG002|Overall Study|Disease Progression|3|||
131207153|NCT00379639|472380808|FG003|Overall Study|Disease Progression|4|||
131207154|NCT00379639|472380809|FG004|Overall Study|Disease Progression|4|||
131207155|NCT00379639|472380805|FG000|Overall Study|Physician Decision|0|||
131207156|NCT00379639|472380806|FG001|Overall Study|Physician Decision|2|||
131207157|NCT00379639|472380807|FG002|Overall Study|Physician Decision|1|||
131207158|NCT00379639|472380808|FG003|Overall Study|Physician Decision|1|||
131207159|NCT00379639|472380809|FG004|Overall Study|Physician Decision|0|||
131207160|NCT00379639|472380805|FG000|Overall Study|Symptomatic Deterioration|0|||
131207161|NCT00379639|472380806|FG001|Overall Study|Symptomatic Deterioration|0|||
131207162|NCT00379639|472380807|FG002|Overall Study|Symptomatic Deterioration|1|||
131207163|NCT00379639|472380808|FG003|Overall Study|Symptomatic Deterioration|0|||
131207164|NCT00379639|472380809|FG004|Overall Study|Symptomatic Deterioration|1|||
131207165|NCT00379639|472380805|FG000|Overall Study|Adverse Event|0|||
131207166|NCT00379639|472380806|FG001|Overall Study|Adverse Event|0|||
130735095|NCT03138655|470649044|FG005|Overall Study|Reason not Specified|1|||
131207167|NCT00379639|472380807|FG002|Overall Study|Adverse Event|1|||
131207168|NCT00379639|472380808|FG003|Overall Study|Adverse Event|0|||
131207169|NCT00379639|472380809|FG004|Overall Study|Adverse Event|1|||
131207170|NCT00379639|472380805|FG000|Overall Study|Lost to Follow-up|0|||
131207171|NCT00379639|472380806|FG001|Overall Study|Lost to Follow-up|0|||
131207172|NCT00379639|472380807|FG002|Overall Study|Lost to Follow-up|0|||
131207173|NCT00379639|472380808|FG003|Overall Study|Lost to Follow-up|1|||
131207174|NCT00379639|472380809|FG004|Overall Study|Lost to Follow-up|0|||
131207175|NCT00379639|472380805|FG000|Overall Study|Other|0|||
131207176|NCT00379639|472380806|FG001|Overall Study|Other|0|||
131207177|NCT00379639|472380807|FG002|Overall Study|Other|3|||
131207178|NCT00379639|472380808|FG003|Overall Study|Other|0|||
131207179|NCT00379639|472380809|FG004|Overall Study|Other|0|||
131207180|NCT00594958|472380810|FG000|Overall Study|Withdrawal by Subject|1|||
131207181|NCT00594958|472380811|FG001|Overall Study|Withdrawal by Subject|0|||
131207182|NCT00594958|472380812|FG002|Overall Study|Withdrawal by Subject|1|||
131207183|NCT00594958|472380810|FG000|Overall Study|Adverse Event|4|||
131207184|NCT00594958|472380811|FG001|Overall Study|Adverse Event|1|||
131207185|NCT00594958|472380812|FG002|Overall Study|Adverse Event|2|||
131207186|NCT00594958|472380810|FG000|Overall Study|Pregnancy|0|||
131207187|NCT00594958|472380811|FG001|Overall Study|Pregnancy|2|||
131207188|NCT00594958|472380812|FG002|Overall Study|Pregnancy|0|||
131207189|NCT00594958|472380810|FG000|Overall Study|Protocol Violation|1|||
131207190|NCT00594958|472380811|FG001|Overall Study|Protocol Violation|0|||
131207191|NCT00594958|472380812|FG002|Overall Study|Protocol Violation|2|||
131207192|NCT00594958|472380810|FG000|Overall Study|Lost to Follow-up|5|||
131207193|NCT00594958|472380811|FG001|Overall Study|Lost to Follow-up|0|||
131207194|NCT00594958|472380812|FG002|Overall Study|Lost to Follow-up|3|||
131207195|NCT00594958|472380810|FG000|Overall Study|administrative|3|||
131207196|NCT00594958|472380811|FG001|Overall Study|administrative|0|||
131207197|NCT00594958|472380812|FG002|Overall Study|administrative|2|||
131207198|NCT00151775|472380825|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
131207199|NCT00151775|472380826|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
131207200|NCT00151775|472380827|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131207201|NCT00151775|472380828|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131207202|NCT00151775|472380829|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131207203|NCT00151775|472380830|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131207204|NCT00151775|472380831|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131207205|NCT00151775|472380832|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131207206|NCT00151775|472380833|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131207207|NCT00151775|472380834|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131207208|NCT00151775|472380835|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131207209|NCT00151775|472380836|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
131207210|NCT00151775|472380825|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
131207211|NCT00151775|472380826|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131207212|NCT00151775|472380827|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131207213|NCT00151775|472380828|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131207214|NCT00151775|472380829|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131207215|NCT00151775|472380830|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131207216|NCT00151775|472380831|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
131207217|NCT00151775|472380832|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131207218|NCT00151775|472380833|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131207219|NCT00151775|472380834|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131207220|NCT00151775|472380835|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
131207221|NCT00151775|472380836|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
131207222|NCT00151775|472380825|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207223|NCT00151775|472380826|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
131207224|NCT00151775|472380827|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207225|NCT00151775|472380828|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207226|NCT00151775|472380829|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207227|NCT00151775|472380830|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207228|NCT00151775|472380831|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207229|NCT00151775|472380832|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207230|NCT00151775|472380833|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207231|NCT00151775|472380834|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207232|NCT00151775|472380835|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207233|NCT00151775|472380836|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
131207234|NCT00151775|472380825|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
131207235|NCT00151775|472380826|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
131207236|NCT00151775|472380827|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
131207237|NCT00151775|472380828|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
131207238|NCT00151775|472380829|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
131207239|NCT00151775|472380830|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
131207240|NCT00151775|472380831|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
131207241|NCT00151775|472380832|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
131207242|NCT00151775|472380833|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
130735096|NCT03138655|470649045|FG006|Overall Study|Reason not Specified|0|||
131207243|NCT00151775|472380834|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
131207244|NCT00151775|472380835|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
131207245|NCT00151775|472380836|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
131207246|NCT00151775|472380825|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207247|NCT00151775|472380826|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207248|NCT00151775|472380827|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207249|NCT00151775|472380828|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207250|NCT00151775|472380829|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207251|NCT00151775|472380830|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
131207252|NCT00151775|472380831|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207253|NCT00151775|472380832|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207254|NCT00151775|472380833|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207255|NCT00151775|472380834|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207256|NCT00151775|472380835|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207257|NCT00151775|472380836|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
131207258|NCT00151775|472380825|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207259|NCT00151775|472380826|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207260|NCT00151775|472380827|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207261|NCT00151775|472380828|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207262|NCT00151775|472380829|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207263|NCT00151775|472380830|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
131207264|NCT00151775|472380831|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207265|NCT00151775|472380832|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207266|NCT00151775|472380833|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207267|NCT00151775|472380834|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207268|NCT00151775|472380835|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207269|NCT00151775|472380836|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
131207270|NCT00151775|472380825|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207271|NCT00151775|472380826|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207272|NCT00151775|472380827|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207273|NCT00151775|472380828|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207274|NCT00151775|472380829|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207275|NCT00151775|472380830|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207276|NCT00151775|472380831|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
131207277|NCT00151775|472380832|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207278|NCT00151775|472380833|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207279|NCT00151775|472380834|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207280|NCT00151775|472380835|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207281|NCT00151775|472380836|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
131207282|NCT00151775|472380825|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207283|NCT00151775|472380826|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207284|NCT00151775|472380827|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207285|NCT00151775|472380828|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207286|NCT00151775|472380829|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207287|NCT00151775|472380830|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
131207288|NCT00151775|472380831|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207289|NCT00151775|472380832|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207290|NCT00151775|472380833|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207291|NCT00151775|472380834|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207292|NCT00151775|472380835|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207293|NCT00151775|472380836|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
131207294|NCT00151775|472380825|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
131207295|NCT00151775|472380826|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
131207296|NCT00151775|472380827|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
131207297|NCT00151775|472380828|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
131207298|NCT00151775|472380829|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
131207299|NCT00151775|472380830|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
131207300|NCT00151775|472380831|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
131207301|NCT00151775|472380832|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
131207302|NCT00151775|472380833|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
131207303|NCT00151775|472380834|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
131207304|NCT00151775|472380835|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
131207305|NCT00151775|472380836|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
130735097|NCT03138655|470649046|FG007|Overall Study|Reason not Specified|0|||
130735098|NCT02565511|470649047|FG000|Overall Study|Study terminated by Sponsor|35|||
130735099|NCT02565511|470649048|FG001|Overall Study|Study terminated by Sponsor|22|||
130735100|NCT02565511|470649049|FG002|Overall Study|Study terminated by Sponsor|235|||
130735101|NCT02565511|470649050|FG003|Overall Study|Study terminated by Sponsor|156|||
130735102|NCT02565511|470649047|FG000|Overall Study|Withdrawal by Subject|3|||
131207306|NCT00151775|472380825|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207307|NCT00151775|472380826|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207308|NCT00151775|472380827|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207309|NCT00151775|472380828|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207310|NCT00151775|472380829|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207311|NCT00151775|472380830|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207312|NCT00151775|472380831|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
131207313|NCT00151775|472380832|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207314|NCT00151775|472380833|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207315|NCT00151775|472380834|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207316|NCT00151775|472380835|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207317|NCT00151775|472380836|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
131207318|NCT00151775|472380825|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207319|NCT00151775|472380826|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207320|NCT00151775|472380827|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
131207321|NCT00151775|472380828|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207322|NCT00151775|472380829|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207323|NCT00151775|472380830|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207324|NCT00151775|472380831|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207325|NCT00151775|472380832|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207326|NCT00151775|472380833|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207327|NCT00151775|472380834|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207328|NCT00151775|472380835|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207329|NCT00151775|472380836|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
131207330|NCT00151775|472380825|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207331|NCT00151775|472380826|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207332|NCT00151775|472380827|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
131207333|NCT00151775|472380828|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207334|NCT00151775|472380829|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207335|NCT00151775|472380830|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207336|NCT00151775|472380831|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207337|NCT00151775|472380832|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207338|NCT00151775|472380833|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207339|NCT00151775|472380834|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207340|NCT00151775|472380835|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207341|NCT00151775|472380836|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
131207342|NCT00151775|472380825|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207343|NCT00151775|472380826|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207344|NCT00151775|472380827|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207345|NCT00151775|472380828|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207346|NCT00151775|472380829|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207347|NCT00151775|472380830|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207348|NCT00151775|472380831|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207349|NCT00151775|472380832|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207350|NCT00151775|472380833|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207351|NCT00151775|472380834|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207352|NCT00151775|472380835|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
131207353|NCT00151775|472380836|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
131207354|NCT00151775|472380825|FG000|Period 4: Open Label|Increased blood pressure|0|||
131207355|NCT00151775|472380826|FG001|Period 4: Open Label|Increased blood pressure|0|||
131207356|NCT00151775|472380827|FG002|Period 4: Open Label|Increased blood pressure|0|||
131207357|NCT00151775|472380828|FG003|Period 4: Open Label|Increased blood pressure|0|||
131207358|NCT00151775|472380829|FG004|Period 4: Open Label|Increased blood pressure|1|||
131207359|NCT00151775|472380830|FG005|Period 4: Open Label|Increased blood pressure|0|||
131207360|NCT00151775|472380831|FG006|Period 4: Open Label|Increased blood pressure|0|||
131207361|NCT00151775|472380832|FG007|Period 4: Open Label|Increased blood pressure|0|||
131207362|NCT00151775|472380833|FG008|Period 4: Open Label|Increased blood pressure|0|||
131207363|NCT00151775|472380834|FG009|Period 4: Open Label|Increased blood pressure|1|||
131207364|NCT00151775|472380835|FG010|Period 4: Open Label|Increased blood pressure|0|||
131207365|NCT00151775|472380836|FG011|Period 4: Open Label|Increased blood pressure|0|||
131207366|NCT00151775|472380825|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
131207367|NCT00151775|472380826|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
131207368|NCT00151775|472380827|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
131207369|NCT00151775|472380828|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
131207370|NCT00151775|472380829|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
131207371|NCT00151775|472380830|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
131207372|NCT00151775|472380831|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
131207373|NCT00151775|472380832|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
131207374|NCT00151775|472380833|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
131207375|NCT00151775|472380834|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
131207376|NCT00151775|472380835|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
131207377|NCT00151775|472380836|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
131207378|NCT00151775|472380825|FG000|Period 4: Open Label|Adverse Event|0|||
131207379|NCT00151775|472380826|FG001|Period 4: Open Label|Adverse Event|0|||
131207380|NCT00151775|472380827|FG002|Period 4: Open Label|Adverse Event|0|||
131207381|NCT00151775|472380828|FG003|Period 4: Open Label|Adverse Event|0|||
131207382|NCT00151775|472380829|FG004|Period 4: Open Label|Adverse Event|1|||
131207383|NCT00151775|472380830|FG005|Period 4: Open Label|Adverse Event|0|||
131207384|NCT00151775|472380831|FG006|Period 4: Open Label|Adverse Event|0|||
131207385|NCT00151775|472380832|FG007|Period 4: Open Label|Adverse Event|0|||
131207386|NCT00151775|472380833|FG008|Period 4: Open Label|Adverse Event|0|||
131207387|NCT00151775|472380834|FG009|Period 4: Open Label|Adverse Event|2|||
131207388|NCT00151775|472380835|FG010|Period 4: Open Label|Adverse Event|0|||
131207389|NCT00151775|472380836|FG011|Period 4: Open Label|Adverse Event|0|||
130735103|NCT02565511|470649048|FG001|Overall Study|Withdrawal by Subject|0|||
130735104|NCT02565511|470649049|FG002|Overall Study|Withdrawal by Subject|12|||
130735105|NCT02565511|470649050|FG003|Overall Study|Withdrawal by Subject|5|||
130735106|NCT02565511|470649047|FG000|Overall Study|Adverse Event|0|||
130735107|NCT02565511|470649048|FG001|Overall Study|Adverse Event|0|||
130735108|NCT02565511|470649049|FG002|Overall Study|Adverse Event|1|||
130735109|NCT02565511|470649050|FG003|Overall Study|Adverse Event|1|||
130735110|NCT02565511|470649047|FG000|Overall Study|Lost to Follow-up|4|||
130784736|NCT00557466|470841153|FG005|Overall Study|Administrative problems|0|||
130735111|NCT02565511|470649048|FG001|Overall Study|Lost to Follow-up|1|||
130784737|NCT00557466|470841148|FG000|Overall Study|Abnormal test procedure results|0|||
131207390|NCT00151775|472380825|FG000|Period 4: Open Label|Lost to Follow-up|0|||
131207391|NCT00151775|472380826|FG001|Period 4: Open Label|Lost to Follow-up|0|||
131207392|NCT00151775|472380827|FG002|Period 4: Open Label|Lost to Follow-up|0|||
131207393|NCT00151775|472380828|FG003|Period 4: Open Label|Lost to Follow-up|0|||
131207394|NCT00151775|472380829|FG004|Period 4: Open Label|Lost to Follow-up|17|||
131207395|NCT00151775|472380830|FG005|Period 4: Open Label|Lost to Follow-up|0|||
131207396|NCT00151775|472380831|FG006|Period 4: Open Label|Lost to Follow-up|0|||
131207397|NCT00151775|472380832|FG007|Period 4: Open Label|Lost to Follow-up|0|||
131207398|NCT00151775|472380833|FG008|Period 4: Open Label|Lost to Follow-up|0|||
131207399|NCT00151775|472380834|FG009|Period 4: Open Label|Lost to Follow-up|7|||
131207400|NCT00151775|472380835|FG010|Period 4: Open Label|Lost to Follow-up|0|||
131207401|NCT00151775|472380836|FG011|Period 4: Open Label|Lost to Follow-up|0|||
131207402|NCT00151775|472380825|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
131207403|NCT00151775|472380826|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
131207404|NCT00151775|472380827|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
131207405|NCT00151775|472380828|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
131207406|NCT00151775|472380829|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
131207407|NCT00151775|472380830|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
131207408|NCT00151775|472380831|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
131207409|NCT00151775|472380832|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
131207410|NCT00151775|472380833|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
131207411|NCT00151775|472380834|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
131207412|NCT00151775|472380835|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
131207413|NCT00151775|472380836|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
131207414|NCT00151775|472380825|FG000|Period 4: Open Label|Other|0|||
131207415|NCT00151775|472380826|FG001|Period 4: Open Label|Other|0|||
131207416|NCT00151775|472380827|FG002|Period 4: Open Label|Other|0|||
131207417|NCT00151775|472380828|FG003|Period 4: Open Label|Other|0|||
131207418|NCT00151775|472380829|FG004|Period 4: Open Label|Other|1|||
131207419|NCT00151775|472380830|FG005|Period 4: Open Label|Other|0|||
131207420|NCT00151775|472380831|FG006|Period 4: Open Label|Other|0|||
131207421|NCT00151775|472380832|FG007|Period 4: Open Label|Other|0|||
131207422|NCT00151775|472380833|FG008|Period 4: Open Label|Other|0|||
131207423|NCT00151775|472380834|FG009|Period 4: Open Label|Other|3|||
131207424|NCT00151775|472380835|FG010|Period 4: Open Label|Other|0|||
131207425|NCT00151775|472380836|FG011|Period 4: Open Label|Other|0|||
131207426|NCT00151775|472380825|FG000|Period 4: Open Label|Physician Decision|0|||
131207427|NCT00151775|472380826|FG001|Period 4: Open Label|Physician Decision|0|||
131207428|NCT00151775|472380827|FG002|Period 4: Open Label|Physician Decision|0|||
131207429|NCT00151775|472380828|FG003|Period 4: Open Label|Physician Decision|0|||
131207430|NCT00151775|472380829|FG004|Period 4: Open Label|Physician Decision|0|||
131207431|NCT00151775|472380830|FG005|Period 4: Open Label|Physician Decision|0|||
131207432|NCT00151775|472380831|FG006|Period 4: Open Label|Physician Decision|0|||
131207433|NCT00151775|472380832|FG007|Period 4: Open Label|Physician Decision|0|||
131207434|NCT00151775|472380833|FG008|Period 4: Open Label|Physician Decision|0|||
131207435|NCT00151775|472380834|FG009|Period 4: Open Label|Physician Decision|2|||
131207436|NCT00151775|472380835|FG010|Period 4: Open Label|Physician Decision|0|||
131207437|NCT00151775|472380836|FG011|Period 4: Open Label|Physician Decision|0|||
131207438|NCT00151775|472380825|FG000|Period 4: Open Label|Protocol Violation|0|||
131207439|NCT00151775|472380826|FG001|Period 4: Open Label|Protocol Violation|0|||
131207440|NCT00151775|472380827|FG002|Period 4: Open Label|Protocol Violation|0|||
131207441|NCT00151775|472380828|FG003|Period 4: Open Label|Protocol Violation|0|||
131207442|NCT00151775|472380829|FG004|Period 4: Open Label|Protocol Violation|1|||
131207443|NCT00151775|472380830|FG005|Period 4: Open Label|Protocol Violation|0|||
131207444|NCT00151775|472380831|FG006|Period 4: Open Label|Protocol Violation|0|||
131207445|NCT00151775|472380832|FG007|Period 4: Open Label|Protocol Violation|0|||
131207446|NCT00151775|472380833|FG008|Period 4: Open Label|Protocol Violation|0|||
131207447|NCT00151775|472380834|FG009|Period 4: Open Label|Protocol Violation|0|||
131207448|NCT00151775|472380835|FG010|Period 4: Open Label|Protocol Violation|0|||
131207449|NCT00151775|472380836|FG011|Period 4: Open Label|Protocol Violation|0|||
131207450|NCT04516291|472380837|FG000|Treatment Period (24 Weeks)|Other|1|||
131207451|NCT04516291|472380838|FG001|Treatment Period (24 Weeks)|Other|0|||
131207452|NCT04516291|472380839|FG002|Treatment Period (24 Weeks)|Other|0|||
131207453|NCT04516291|472380840|FG003|Treatment Period (24 Weeks)|Other|2|||
131207454|NCT04516291|472380841|FG004|Treatment Period (24 Weeks)|Other|2|||
131207455|NCT04516291|472380842|FG005|Treatment Period (24 Weeks)|Other|4|||
131207456|NCT04516291|472380843|FG006|Treatment Period (24 Weeks)|Other|2|||
131207457|NCT04516291|472380844|FG007|Treatment Period (24 Weeks)|Other|0|||
131207458|NCT04516291|472380837|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131207459|NCT04516291|472380838|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
131207460|NCT04516291|472380839|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
131207461|NCT04516291|472380840|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131207462|NCT04516291|472380841|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
131207463|NCT04516291|472380842|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131207464|NCT04516291|472380843|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130735112|NCT02565511|470649049|FG002|Overall Study|Lost to Follow-up|0|||
130735113|NCT02565511|470649050|FG003|Overall Study|Lost to Follow-up|1|||
130735114|NCT02565511|470649047|FG000|Overall Study|Physician Decision|0|||
130735115|NCT02565511|470649048|FG001|Overall Study|Physician Decision|0|||
130735116|NCT02565511|470649049|FG002|Overall Study|Physician Decision|0|||
130735117|NCT02565511|470649050|FG003|Overall Study|Physician Decision|1|||
130735118|NCT02565511|470649047|FG000|Overall Study|Protocol deviation|0|||
130735119|NCT02565511|470649048|FG001|Overall Study|Protocol deviation|0|||
130735120|NCT02565511|470649049|FG002|Overall Study|Protocol deviation|3|||
130735121|NCT02565511|470649050|FG003|Overall Study|Protocol deviation|0|||
130735122|NCT03656744|470649051|FG000|Overall Study|Adverse Event|1|||
130735123|NCT03656744|470649052|FG001|Overall Study|Adverse Event|4|||
130735124|NCT03656744|470649053|FG002|Overall Study|Adverse Event|1|||
130735125|NCT03656744|470649051|FG000|Overall Study|Protocol Violation|1|||
130735126|NCT03656744|470649052|FG001|Overall Study|Protocol Violation|0|||
130735127|NCT03656744|470649053|FG002|Overall Study|Protocol Violation|0|||
130735128|NCT03656744|470649051|FG000|Overall Study|Lost to Follow-up|2|||
130735129|NCT03656744|470649052|FG001|Overall Study|Lost to Follow-up|2|||
130735130|NCT03656744|470649053|FG002|Overall Study|Lost to Follow-up|0|||
130735131|NCT03656744|470649051|FG000|Overall Study|Withdrawal by Subject|0|||
130735132|NCT03656744|470649052|FG001|Overall Study|Withdrawal by Subject|1|||
130735133|NCT03656744|470649053|FG002|Overall Study|Withdrawal by Subject|0|||
130735134|NCT03656744|470649051|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
130735135|NCT03656744|470649052|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
130735136|NCT03656744|470649053|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
130735137|NCT03910673|470649059|FG000|Overall Study|Adverse Event|0|||
130735138|NCT03910673|470649060|FG001|Overall Study|Adverse Event|0|||
130735139|NCT03910673|470649061|FG002|Overall Study|Adverse Event|0|||
130735140|NCT03910673|470649062|FG003|Overall Study|Adverse Event|2|||
130735141|NCT03910673|470649063|FG004|Overall Study|Adverse Event|0|||
130735142|NCT00796757|470649064|FG000|Overall Study|Withdrawal by Subject|14|||
130735143|NCT00796757|470649064|FG000|Overall Study|Death|61|||
130735144|NCT00796757|470649064|FG000|Overall Study|Protocol Violation|1|||
130735145|NCT00796757|470649064|FG000|Overall Study|Participant noncompliance|1|||
130735146|NCT00796757|470649064|FG000|Overall Study|Investigator's decision|2|||
130735147|NCT00796757|470649064|FG000|Overall Study|Other|7|||
130735148|NCT01277211|470649065|FG000|Overall Study|Adverse Event|60|||
130735149|NCT01277211|470649066|FG001|Overall Study|Adverse Event|22|||
130735150|NCT01277211|470649065|FG000|Overall Study|Pregnancy|9|||
130735151|NCT01277211|470649066|FG001|Overall Study|Pregnancy|4|||
130735152|NCT01277211|470649065|FG000|Overall Study|Lost to Follow-up|14|||
130735153|NCT01277211|470649066|FG001|Overall Study|Lost to Follow-up|9|||
130735154|NCT01277211|470649065|FG000|Overall Study|Did not wish to continue|17|||
130735155|NCT01277211|470649066|FG001|Overall Study|Did not wish to continue|0|||
130735156|NCT01277211|470649065|FG000|Overall Study|Withdrew Consent|9|||
130735157|NCT01277211|470649066|FG001|Overall Study|Withdrew Consent|9|||
130735158|NCT01277211|470649065|FG000|Overall Study|Non-compliance with protocol|13|||
130735159|NCT01277211|470649066|FG001|Overall Study|Non-compliance with protocol|4|||
130735160|NCT01277211|470649065|FG000|Overall Study|Did not meet protocol eligibility|1|||
130735161|NCT01277211|470649066|FG001|Overall Study|Did not meet protocol eligibility|0|||
130735162|NCT01277211|470649065|FG000|Overall Study|Administrative|3|||
130735163|NCT01277211|470649066|FG001|Overall Study|Administrative|0|||
130735164|NCT01277211|470649065|FG000|Overall Study|Pregnancy wish|0|||
130735165|NCT01277211|470649066|FG001|Overall Study|Pregnancy wish|2|||
130735166|NCT01277211|470649065|FG000|Overall Study|Discontinued prior to treatment|24|||
130735167|NCT01277211|470649066|FG001|Overall Study|Discontinued prior to treatment|13|||
130735168|NCT00879086|470649067|FG000|Overall Study|Adverse Event|3|||
130735169|NCT00879086|470649068|FG001|Overall Study|Adverse Event|15|||
130735170|NCT00879086|470649067|FG000|Overall Study|Participant choice|2|||
130735171|NCT00879086|470649068|FG001|Overall Study|Participant choice|2|||
130735172|NCT00879086|470649067|FG000|Overall Study|Progression of disease|40|||
131207465|NCT04516291|472380844|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
131207466|NCT04516291|472380837|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
131207467|NCT04516291|472380838|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
131207468|NCT04516291|472380839|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
131207469|NCT04516291|472380840|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
131207470|NCT04516291|472380841|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
131207471|NCT04516291|472380842|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
131207472|NCT04516291|472380843|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
131207473|NCT04516291|472380844|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
131207474|NCT04516291|472380837|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131207475|NCT04516291|472380838|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
131207476|NCT04516291|472380839|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131207477|NCT04516291|472380840|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131207478|NCT04516291|472380841|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131207479|NCT04516291|472380842|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131207480|NCT04516291|472380843|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131207481|NCT04516291|472380844|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
131207482|NCT04516291|472380837|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
131207483|NCT04516291|472380838|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
131207484|NCT04516291|472380839|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
131207485|NCT04516291|472380840|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
131207486|NCT04516291|472380841|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
131207487|NCT04516291|472380842|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
131207488|NCT04516291|472380843|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
131207489|NCT04516291|472380844|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
131207490|NCT04516291|472380837|FG000|Follow-up Period (12 Weeks)|Other|0|||
131207491|NCT04516291|472380838|FG001|Follow-up Period (12 Weeks)|Other|1|||
130735173|NCT00879086|470649068|FG001|Overall Study|Progression of disease|26|||
130735174|NCT00879086|470649067|FG000|Overall Study|Withdrawal of consent|2|||
130735175|NCT00879086|470649068|FG001|Overall Study|Withdrawal of consent|1|||
130735176|NCT00879086|470649067|FG000|Overall Study|Other|4|||
130735177|NCT00879086|470649068|FG001|Overall Study|Other|6|||
131207492|NCT04516291|472380839|FG002|Follow-up Period (12 Weeks)|Other|0|||
131207493|NCT04516291|472380840|FG003|Follow-up Period (12 Weeks)|Other|2|||
131207494|NCT04516291|472380841|FG004|Follow-up Period (12 Weeks)|Other|0|||
131207495|NCT04516291|472380842|FG005|Follow-up Period (12 Weeks)|Other|0|||
131207496|NCT04516291|472380843|FG006|Follow-up Period (12 Weeks)|Other|0|||
131207497|NCT04516291|472380844|FG007|Follow-up Period (12 Weeks)|Other|0|||
131207498|NCT04516291|472380837|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131207499|NCT04516291|472380838|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131207500|NCT04516291|472380839|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131207501|NCT04516291|472380840|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131207502|NCT04516291|472380841|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
131207503|NCT04516291|472380842|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
131207504|NCT04516291|472380843|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130735178|NCT00879086|470649067|FG000|Overall Study|Death|1|||
130735179|NCT00879086|470649068|FG001|Overall Study|Death|2|||
131207505|NCT04516291|472380844|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130735180|NCT01855828|470649069|FG000|Overall Study|Adverse Event|1|||
130735181|NCT01855828|470649069|FG000|Overall Study|Withdrawal by Subject|1|||
130735182|NCT01866098|470649074|FG000|Overall Study|Lost to Follow-up|11|||
130735183|NCT01866098|470649075|FG001|Overall Study|Lost to Follow-up|18|||
130735184|NCT01866098|470649076|FG002|Overall Study|Lost to Follow-up|13|||
130735185|NCT01866098|470649074|FG000|Overall Study|Physician Decision|0|||
130735186|NCT01866098|470649075|FG001|Overall Study|Physician Decision|1|||
130735187|NCT01866098|470649076|FG002|Overall Study|Physician Decision|2|||
130735188|NCT01866098|470649074|FG000|Overall Study|Adverse Event|1|||
130735189|NCT01866098|470649075|FG001|Overall Study|Adverse Event|5|||
130735190|NCT01866098|470649076|FG002|Overall Study|Adverse Event|4|||
130735191|NCT01866098|470649074|FG000|Overall Study|Protocol Violation|1|||
130735192|NCT01866098|470649075|FG001|Overall Study|Protocol Violation|0|||
130735193|NCT01866098|470649076|FG002|Overall Study|Protocol Violation|0|||
130735194|NCT01866098|470649074|FG000|Overall Study|Withdrawal by Subject|1|||
130735195|NCT01866098|470649075|FG001|Overall Study|Withdrawal by Subject|2|||
130735196|NCT01866098|470649076|FG002|Overall Study|Withdrawal by Subject|0|||
131207506|NCT04516291|472380837|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
131207507|NCT04516291|472380838|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
131207508|NCT04516291|472380839|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
131207509|NCT04516291|472380840|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
131207510|NCT04516291|472380841|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
131207511|NCT04516291|472380842|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
131207512|NCT04516291|472380843|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
131207513|NCT04516291|472380844|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
131207514|NCT03039686|472380845|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
131207515|NCT03039686|472380846|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
131207516|NCT03039686|472380847|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
131207517|NCT03039686|472380845|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
131207518|NCT03039686|472380846|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
131207519|NCT03039686|472380847|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
131207520|NCT03039686|472380845|FG000|Double-blind Period|Withdrawal by Subject|2|||
131207521|NCT03039686|472380846|FG001|Double-blind Period|Withdrawal by Subject|2|||
131207522|NCT03039686|472380847|FG002|Double-blind Period|Withdrawal by Subject|1|||
131207523|NCT03039686|472380845|FG000|Double-blind Period|Death|0|||
131207524|NCT03039686|472380846|FG001|Double-blind Period|Death|0|||
131207525|NCT03039686|472380847|FG002|Double-blind Period|Death|1|||
131207526|NCT03039686|472380845|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
131207527|NCT03039686|472380846|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
131207528|NCT03039686|472380847|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
131207529|NCT03039686|472380845|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
131207530|NCT03039686|472380846|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
131207531|NCT03039686|472380847|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
131207532|NCT03039686|472380845|FG000|Open Label Period|Withdrawal by Subject|0|||
131207533|NCT03039686|472380846|FG001|Open Label Period|Withdrawal by Subject|3|||
131207534|NCT03039686|472380847|FG002|Open Label Period|Withdrawal by Subject|1|||
131207535|NCT02158949|472380848|FG000|Overall Study|Withdrawal by Subject|1|||
131207536|NCT02158949|472380849|FG001|Overall Study|Withdrawal by Subject|0|||
131207537|NCT02158949|472380848|FG000|Overall Study|Lost to Follow-up|5|||
131207538|NCT02158949|472380849|FG001|Overall Study|Lost to Follow-up|11|||
131207539|NCT02181634|472380850|FG000|Overall Study|Lack of Efficacy|33|||
131207540|NCT02181634|472380850|FG000|Overall Study|Adverse Event|17|||
131207541|NCT02181634|472380850|FG000|Overall Study|Physician Decision|8|||
131207542|NCT02181634|472380850|FG000|Overall Study|Withdrawal by Subject|5|||
131207543|NCT02181634|472380850|FG000|Overall Study|Death|2|||
131207544|NCT02181634|472380850|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
131207545|NCT02181634|472380850|FG000|Overall Study|Ineligible|1|||
131207546|NCT02181634|472380850|FG000|Overall Study|Max number of dose reduction|1|||
131207547|NCT02181634|472380850|FG000|Overall Study|Symptomatic progression|1|||
130735197|NCT01866098|470649074|FG000|Overall Study|Unrelated Hospitalization|2|||
130735198|NCT01866098|470649075|FG001|Overall Study|Unrelated Hospitalization|0|||
130735199|NCT01866098|470649076|FG002|Overall Study|Unrelated Hospitalization|1|||
130735200|NCT01866098|470649074|FG000|Overall Study|Non-compliance|1|||
131207548|NCT02181634|472380850|FG000|Overall Study|Patient opted to proceed to surgery|1|||
131207549|NCT02546193|472380860|FG000|Overall Study|Withdrawal by Subject|2|||
131207550|NCT02546193|472380861|FG001|Overall Study|Withdrawal by Subject|0|||
131207551|NCT02546193|472380862|FG002|Overall Study|Withdrawal by Subject|1|||
131207552|NCT02546193|472380863|FG003|Overall Study|Withdrawal by Subject|0|||
131207553|NCT02546193|472380860|FG000|Overall Study|Not eligible at time of induction|4|||
130735201|NCT01866098|470649075|FG001|Overall Study|Non-compliance|0|||
131207554|NCT02546193|472380861|FG001|Overall Study|Not eligible at time of induction|6|||
131207555|NCT02546193|472380862|FG002|Overall Study|Not eligible at time of induction|1|||
130735202|NCT01866098|470649076|FG002|Overall Study|Non-compliance|1|||
130735203|NCT01866098|470649074|FG000|Overall Study|Pregnancy|2|||
130735204|NCT01866098|470649075|FG001|Overall Study|Pregnancy|0|||
130735205|NCT01866098|470649076|FG002|Overall Study|Pregnancy|0|||
130735206|NCT01866098|470649074|FG000|Overall Study|Death|0|||
130735207|NCT01866098|470649075|FG001|Overall Study|Death|1|||
130735208|NCT01866098|470649076|FG002|Overall Study|Death|0|||
130735209|NCT03449446|470649077|FG000|Overall Study|Randomized but Never Treated|0|||
130735210|NCT03449446|470649078|FG001|Overall Study|Randomized but Never Treated|0|||
130735211|NCT03449446|470649079|FG002|Overall Study|Randomized but Never Treated|1|||
130735212|NCT03449446|470649080|FG003|Overall Study|Randomized but Never Treated|1|||
130735213|NCT03449446|470649081|FG004|Overall Study|Randomized but Never Treated|1|||
130735214|NCT03449446|470649082|FG005|Overall Study|Randomized but Never Treated|0|||
130735215|NCT03449446|470649083|FG006|Overall Study|Randomized but Never Treated|0|||
130735216|NCT03449446|470649077|FG000|Overall Study|Unknown Reason|33|||
130735217|NCT03449446|470649078|FG001|Overall Study|Unknown Reason|1|||
130784738|NCT00557466|470841149|FG001|Overall Study|Abnormal test procedure results|0|||
131207556|NCT02546193|472380863|FG003|Overall Study|Not eligible at time of induction|0|||
131207557|NCT01733758|472380864|FG000|Overall Study|Adverse Event|5|||
131207558|NCT01733758|472380865|FG001|Overall Study|Adverse Event|7|||
131207559|NCT01733758|472380866|FG002|Overall Study|Adverse Event|8|||
131207560|NCT01733758|472380867|FG003|Overall Study|Adverse Event|1|||
131207561|NCT01733758|472380864|FG000|Overall Study|Withdrawal by Subject|1|||
131207562|NCT01733758|472380865|FG001|Overall Study|Withdrawal by Subject|1|||
131207563|NCT01733758|472380866|FG002|Overall Study|Withdrawal by Subject|5|||
131207564|NCT01733758|472380867|FG003|Overall Study|Withdrawal by Subject|3|||
131207565|NCT01733758|472380864|FG000|Overall Study|Persistent Hyperglycemia|3|||
131207566|NCT01733758|472380865|FG001|Overall Study|Persistent Hyperglycemia|2|||
131207567|NCT01733758|472380866|FG002|Overall Study|Persistent Hyperglycemia|0|||
131207568|NCT01733758|472380867|FG003|Overall Study|Persistent Hyperglycemia|0|||
131207569|NCT01733758|472380864|FG000|Overall Study|Protocol Violation|0|||
130735218|NCT03449446|470649079|FG002|Overall Study|Unknown Reason|1|||
130735219|NCT03449446|470649080|FG003|Overall Study|Unknown Reason|1|||
130735220|NCT03449446|470649081|FG004|Overall Study|Unknown Reason|2|||
130735221|NCT03449446|470649082|FG005|Overall Study|Unknown Reason|2|||
130735222|NCT03449446|470649083|FG006|Overall Study|Unknown Reason|0|||
130735223|NCT03449446|470649077|FG000|Overall Study|Withdrew Consent|1|||
130735224|NCT03449446|470649078|FG001|Overall Study|Withdrew Consent|3|||
130735225|NCT03449446|470649079|FG002|Overall Study|Withdrew Consent|1|||
130735226|NCT03449446|470649080|FG003|Overall Study|Withdrew Consent|4|||
130735227|NCT03449446|470649081|FG004|Overall Study|Withdrew Consent|4|||
130735228|NCT03449446|470649082|FG005|Overall Study|Withdrew Consent|4|||
130735229|NCT03449446|470649083|FG006|Overall Study|Withdrew Consent|1|||
130735230|NCT03449446|470649077|FG000|Overall Study|Adverse Event|1|||
130735231|NCT03449446|470649078|FG001|Overall Study|Adverse Event|2|||
130735232|NCT03449446|470649079|FG002|Overall Study|Adverse Event|1|||
130735233|NCT03449446|470649080|FG003|Overall Study|Adverse Event|0|||
130735234|NCT03449446|470649081|FG004|Overall Study|Adverse Event|0|||
130735235|NCT03449446|470649082|FG005|Overall Study|Adverse Event|2|||
130735236|NCT03449446|470649083|FG006|Overall Study|Adverse Event|0|||
130735237|NCT03449446|470649077|FG000|Overall Study|Lost to Follow-up|0|||
130735238|NCT03449446|470649078|FG001|Overall Study|Lost to Follow-up|0|||
130735239|NCT03449446|470649079|FG002|Overall Study|Lost to Follow-up|2|||
130735240|NCT03449446|470649080|FG003|Overall Study|Lost to Follow-up|1|||
130735241|NCT03449446|470649081|FG004|Overall Study|Lost to Follow-up|3|||
130735242|NCT03449446|470649082|FG005|Overall Study|Lost to Follow-up|0|||
130735243|NCT03449446|470649083|FG006|Overall Study|Lost to Follow-up|0|||
130735244|NCT03449446|470649077|FG000|Overall Study|Investigator's Discretion|0|||
130735245|NCT03449446|470649078|FG001|Overall Study|Investigator's Discretion|1|||
130735246|NCT03449446|470649079|FG002|Overall Study|Investigator's Discretion|1|||
130735247|NCT03449446|470649080|FG003|Overall Study|Investigator's Discretion|2|||
130735248|NCT03449446|470649081|FG004|Overall Study|Investigator's Discretion|0|||
130735249|NCT03449446|470649082|FG005|Overall Study|Investigator's Discretion|0|||
130735250|NCT03449446|470649083|FG006|Overall Study|Investigator's Discretion|0|||
130735251|NCT03449446|470649077|FG000|Overall Study|Non Compliance with Study Drug|1|||
130735252|NCT03449446|470649078|FG001|Overall Study|Non Compliance with Study Drug|0|||
130735253|NCT03449446|470649079|FG002|Overall Study|Non Compliance with Study Drug|0|||
130735254|NCT03449446|470649080|FG003|Overall Study|Non Compliance with Study Drug|0|||
130735255|NCT03449446|470649081|FG004|Overall Study|Non Compliance with Study Drug|0|||
130735256|NCT03449446|470649082|FG005|Overall Study|Non Compliance with Study Drug|0|||
131207570|NCT01733758|472380865|FG001|Overall Study|Protocol Violation|1|||
131207571|NCT01733758|472380866|FG002|Overall Study|Protocol Violation|2|||
131207572|NCT01733758|472380867|FG003|Overall Study|Protocol Violation|2|||
131207573|NCT01733758|472380864|FG000|Overall Study|Non-compliance|1|||
131207574|NCT01733758|472380865|FG001|Overall Study|Non-compliance|0|||
131207575|NCT01733758|472380866|FG002|Overall Study|Non-compliance|0|||
131207576|NCT01733758|472380867|FG003|Overall Study|Non-compliance|0|||
131207577|NCT01733758|472380864|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
131207578|NCT01733758|472380865|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
131207579|NCT01733758|472380866|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
131207580|NCT01733758|472380867|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
131207581|NCT01733758|472380864|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
130735257|NCT03449446|470649083|FG006|Overall Study|Non Compliance with Study Drug|0|||
130735258|NCT03449446|470649077|FG000|Overall Study|Protocol Violation|0|||
130735259|NCT03449446|470649078|FG001|Overall Study|Protocol Violation|0|||
130735260|NCT03449446|470649079|FG002|Overall Study|Protocol Violation|0|||
130735261|NCT03449446|470649080|FG003|Overall Study|Protocol Violation|0|||
131207582|NCT01733758|472380865|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
131207583|NCT01733758|472380866|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
130735262|NCT03449446|470649081|FG004|Overall Study|Protocol Violation|1|||
130735263|NCT03449446|470649082|FG005|Overall Study|Protocol Violation|1|||
130735264|NCT03449446|470649083|FG006|Overall Study|Protocol Violation|0|||
131207584|NCT01733758|472380867|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
131207585|NCT02557308|472380868|FG000|Overall Study|Withdrawal by Subject|11|||
130735265|NCT03449446|470649077|FG000|Overall Study|Death|0|||
130735266|NCT03449446|470649078|FG001|Overall Study|Death|0|||
131207586|NCT02557308|472380869|FG001|Overall Study|Withdrawal by Subject|3|||
131207587|NCT02557308|472380870|FG002|Overall Study|Withdrawal by Subject|2|||
131207588|NCT02557308|472380871|FG003|Overall Study|Withdrawal by Subject|0|||
131207589|NCT02557308|472380872|FG004|Overall Study|Withdrawal by Subject|1|||
131207590|NCT02557308|472380873|FG005|Overall Study|Withdrawal by Subject|0|||
131207591|NCT02557308|472380874|FG006|Overall Study|Withdrawal by Subject|10|||
131207592|NCT02557308|472380875|FG007|Overall Study|Withdrawal by Subject|1|||
131207593|NCT02557308|472380868|FG000|Overall Study|Disease Progression|0|||
131207594|NCT02557308|472380869|FG001|Overall Study|Disease Progression|1|||
131207595|NCT02557308|472380870|FG002|Overall Study|Disease Progression|0|||
131207596|NCT02557308|472380871|FG003|Overall Study|Disease Progression|0|||
131207597|NCT02557308|472380872|FG004|Overall Study|Disease Progression|0|||
131207598|NCT02557308|472380873|FG005|Overall Study|Disease Progression|0|||
131207599|NCT02557308|472380874|FG006|Overall Study|Disease Progression|0|||
131207600|NCT02557308|472380875|FG007|Overall Study|Disease Progression|0|||
131207601|NCT02557308|472380868|FG000|Overall Study|Lack of Efficacy|3|||
131207602|NCT02557308|472380869|FG001|Overall Study|Lack of Efficacy|0|||
131207603|NCT02557308|472380870|FG002|Overall Study|Lack of Efficacy|0|||
131207604|NCT02557308|472380871|FG003|Overall Study|Lack of Efficacy|0|||
131207605|NCT02557308|472380872|FG004|Overall Study|Lack of Efficacy|0|||
131207606|NCT02557308|472380873|FG005|Overall Study|Lack of Efficacy|0|||
131207607|NCT02557308|472380874|FG006|Overall Study|Lack of Efficacy|1|||
131207608|NCT02557308|472380875|FG007|Overall Study|Lack of Efficacy|0|||
131207609|NCT02557308|472380868|FG000|Overall Study|Adverse Event|4|||
131207610|NCT02557308|472380869|FG001|Overall Study|Adverse Event|1|||
131207611|NCT02557308|472380870|FG002|Overall Study|Adverse Event|2|||
131207612|NCT02557308|472380871|FG003|Overall Study|Adverse Event|0|||
131207613|NCT02557308|472380872|FG004|Overall Study|Adverse Event|0|||
131207614|NCT02557308|472380873|FG005|Overall Study|Adverse Event|0|||
131207615|NCT02557308|472380874|FG006|Overall Study|Adverse Event|4|||
131207616|NCT02557308|472380875|FG007|Overall Study|Adverse Event|1|||
131207617|NCT02557308|472380868|FG000|Overall Study|Lost to Follow-up|2|||
131207618|NCT02557308|472380869|FG001|Overall Study|Lost to Follow-up|0|||
131207619|NCT02557308|472380870|FG002|Overall Study|Lost to Follow-up|1|||
131207620|NCT02557308|472380871|FG003|Overall Study|Lost to Follow-up|0|||
131207621|NCT02557308|472380872|FG004|Overall Study|Lost to Follow-up|0|||
131207622|NCT02557308|472380873|FG005|Overall Study|Lost to Follow-up|0|||
131207623|NCT02557308|472380874|FG006|Overall Study|Lost to Follow-up|2|||
131207624|NCT02557308|472380875|FG007|Overall Study|Lost to Follow-up|0|||
131207625|NCT02557308|472380868|FG000|Overall Study|Death|1|||
131207626|NCT02557308|472380869|FG001|Overall Study|Death|0|||
131207627|NCT02557308|472380870|FG002|Overall Study|Death|0|||
131207628|NCT02557308|472380871|FG003|Overall Study|Death|0|||
131207629|NCT02557308|472380872|FG004|Overall Study|Death|0|||
131207630|NCT02557308|472380873|FG005|Overall Study|Death|0|||
131207631|NCT02557308|472380874|FG006|Overall Study|Death|0|||
131207632|NCT02557308|472380875|FG007|Overall Study|Death|0|||
131207633|NCT02557308|472380868|FG000|Overall Study|Study Close|98|||
131207634|NCT02557308|472380869|FG001|Overall Study|Study Close|18|||
131207635|NCT02557308|472380870|FG002|Overall Study|Study Close|5|||
131207636|NCT02557308|472380871|FG003|Overall Study|Study Close|3|||
131207637|NCT02557308|472380872|FG004|Overall Study|Study Close|1|||
131207638|NCT02557308|472380873|FG005|Overall Study|Study Close|0|||
131207639|NCT02557308|472380874|FG006|Overall Study|Study Close|123|||
131207640|NCT02557308|472380875|FG007|Overall Study|Study Close|5|||
131207641|NCT02557308|472380868|FG000|Overall Study|Except for study close|5|||
131207642|NCT02557308|472380869|FG001|Overall Study|Except for study close|0|||
131207643|NCT02557308|472380870|FG002|Overall Study|Except for study close|0|||
131207644|NCT02557308|472380871|FG003|Overall Study|Except for study close|0|||
131207645|NCT02557308|472380872|FG004|Overall Study|Except for study close|3|||
131207646|NCT02557308|472380873|FG005|Overall Study|Except for study close|0|||
131207647|NCT02557308|472380874|FG006|Overall Study|Except for study close|6|||
131207648|NCT02557308|472380875|FG007|Overall Study|Except for study close|10|||
131207649|NCT04594213|472380878|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
131207650|NCT04594213|472380879|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
131207651|NCT04594213|472380880|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
131207652|NCT04594213|472380881|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
131207653|NCT04594213|472380882|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
131207654|NCT04594213|472380883|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130735267|NCT03449446|470649079|FG002|Overall Study|Death|0|||
131207655|NCT04594213|472380878|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
131207656|NCT04594213|472380879|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
130735268|NCT03449446|470649080|FG003|Overall Study|Death|0|||
131207657|NCT04594213|472380880|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
131207658|NCT04594213|472380881|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
131207659|NCT04594213|472380882|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130735269|NCT03449446|470649081|FG004|Overall Study|Death|1|||
130735270|NCT03449446|470649082|FG005|Overall Study|Death|0|||
130735271|NCT03449446|470649083|FG006|Overall Study|Death|0|||
130735272|NCT01450683|470649104|FG000|Overall Study|Adverse Event|2|||
130735273|NCT02108912|470649106|FG000|Overall Study|Lost to Follow-up|1|||
131207660|NCT04594213|472380883|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
131207661|NCT04594213|472380878|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
131207662|NCT04594213|472380879|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131207663|NCT04594213|472380880|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
131207664|NCT04594213|472380881|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131207665|NCT04594213|472380882|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131207666|NCT04594213|472380883|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
131207667|NCT04594213|472380878|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131207668|NCT04594213|472380879|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131207669|NCT04594213|472380880|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131207670|NCT04594213|472380881|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131207671|NCT04594213|472380882|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
131207672|NCT04594213|472380883|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
131207673|NCT04594213|472380878|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131207674|NCT04594213|472380879|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131207675|NCT04594213|472380880|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
131207676|NCT04594213|472380881|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
131207677|NCT04594213|472380882|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
131207678|NCT04594213|472380883|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
131207679|NCT04594213|472380878|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131207680|NCT04594213|472380879|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131207681|NCT04594213|472380880|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131207682|NCT04594213|472380881|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131207683|NCT04594213|472380882|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
131207684|NCT04594213|472380883|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
131207685|NCT04594213|472380878|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131207686|NCT04594213|472380879|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131207687|NCT04594213|472380880|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131207688|NCT04594213|472380881|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
131207689|NCT04594213|472380882|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131207690|NCT04594213|472380883|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
131207691|NCT04594213|472380878|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
131207692|NCT04594213|472380879|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
131207693|NCT04594213|472380880|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
131207694|NCT04594213|472380881|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
131207695|NCT04594213|472380882|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
131207696|NCT04594213|472380883|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
131207697|NCT04594213|472380878|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
131207698|NCT04594213|472380879|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
131207699|NCT04594213|472380880|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
131207700|NCT04594213|472380881|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
130735274|NCT02108912|470649107|FG001|Overall Study|Lost to Follow-up|1|||
130735275|NCT02108912|470649106|FG000|Overall Study|lack of transportation|1|||
130735276|NCT02108912|470649107|FG001|Overall Study|lack of transportation|0|||
131207701|NCT04594213|472380882|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
131207702|NCT04594213|472380883|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
131207703|NCT04594213|472380878|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
131207704|NCT04594213|472380879|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
131207705|NCT04594213|472380880|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
131207706|NCT04594213|472380881|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
131207707|NCT04594213|472380882|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
130735277|NCT02108912|470649106|FG000|Overall Study|high blood pressure|1|||
130735278|NCT02108912|470649107|FG001|Overall Study|high blood pressure|0|||
130735279|NCT01950390|470649113|FG000|Overall Study|Never started treatment|3|||
130735280|NCT01950390|470649114|FG001|Overall Study|Never started treatment|2|||
130735281|NCT01950390|470649113|FG000|Overall Study|Disease progression|45|||
130735282|NCT01950390|470649114|FG001|Overall Study|Disease progression|52|||
130735283|NCT01950390|470649113|FG000|Overall Study|Adverse Event|22|||
130735284|NCT01950390|470649114|FG001|Overall Study|Adverse Event|16|||
130735285|NCT01950390|470649113|FG000|Overall Study|Death|5|||
130735286|NCT01950390|470649114|FG001|Overall Study|Death|3|||
130735287|NCT01950390|470649113|FG000|Overall Study|Withdrawal by Subject|5|||
130735288|NCT01950390|470649114|FG001|Overall Study|Withdrawal by Subject|1|||
130735289|NCT01950390|470649113|FG000|Overall Study|Alternative therapy|0|||
130735290|NCT01950390|470649114|FG001|Overall Study|Alternative therapy|3|||
130735291|NCT01950390|470649113|FG000|Overall Study|Complicating disease|1|||
130735292|NCT01950390|470649114|FG001|Overall Study|Complicating disease|0|||
130735293|NCT01950390|470649113|FG000|Overall Study|On treatment|1|||
130735294|NCT01950390|470649114|FG001|Overall Study|On treatment|0|||
131207708|NCT04594213|472380883|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
131207709|NCT04594213|472380878|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
131207710|NCT04594213|472380879|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
131207711|NCT04594213|472380880|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
131207712|NCT04594213|472380881|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
131207713|NCT04594213|472380882|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
131207714|NCT04594213|472380883|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
131207715|NCT03814499|472380889|FG000|Overall Study|Lost to Follow-up|3|||
131207716|NCT02046993|472380890|FG000|Overall Study|Withdrawal by Subject|2|||
131207717|NCT02046993|472380891|FG001|Overall Study|Withdrawal by Subject|10|||
131207718|NCT02046993|472380890|FG000|Overall Study|Lost to Follow-up|1|||
131207719|NCT02046993|472380891|FG001|Overall Study|Lost to Follow-up|1|||
131207720|NCT01589185|472380892|FG000|Overall Study|Death|1|||
131207721|NCT01589185|472380893|FG001|Overall Study|Death|2|||
131207722|NCT01589185|472380894|FG002|Overall Study|Death|2|||
131207723|NCT01589185|472380895|FG003|Overall Study|Death|0|||
131207724|NCT01589185|472380896|FG004|Overall Study|Death|1|||
131207725|NCT01589185|472380892|FG000|Overall Study|Lost to Follow-up|1|||
131207726|NCT01589185|472380893|FG001|Overall Study|Lost to Follow-up|0|||
131207727|NCT01589185|472380894|FG002|Overall Study|Lost to Follow-up|2|||
131207728|NCT01589185|472380895|FG003|Overall Study|Lost to Follow-up|3|||
131207729|NCT01589185|472380896|FG004|Overall Study|Lost to Follow-up|0|||
131207730|NCT00598442|472380899|FG000|Overall Study|Adverse Event|3|||
131207731|NCT00598442|472380900|FG001|Overall Study|Adverse Event|0|||
131207732|NCT00598442|472380901|FG002|Overall Study|Adverse Event|0|||
131207733|NCT00598442|472380899|FG000|Overall Study|Death|19|||
131207734|NCT00598442|472380900|FG001|Overall Study|Death|11|||
131207735|NCT00598442|472380901|FG002|Overall Study|Death|11|||
131207736|NCT00598442|472380899|FG000|Overall Study|Lost to Follow-up|4|||
131207737|NCT00598442|472380900|FG001|Overall Study|Lost to Follow-up|3|||
131207738|NCT00598442|472380901|FG002|Overall Study|Lost to Follow-up|3|||
131207739|NCT00598442|472380899|FG000|Overall Study|Physician Decision|2|||
131207740|NCT00598442|472380900|FG001|Overall Study|Physician Decision|1|||
131207741|NCT00598442|472380901|FG002|Overall Study|Physician Decision|1|||
131207742|NCT00598442|472380899|FG000|Overall Study|Withdrawal by Subject|8|||
131207743|NCT00598442|472380900|FG001|Overall Study|Withdrawal by Subject|16|||
131207744|NCT00598442|472380901|FG002|Overall Study|Withdrawal by Subject|6|||
131207745|NCT00598442|472380899|FG000|Overall Study|Noncompliance|0|||
131207746|NCT00598442|472380900|FG001|Overall Study|Noncompliance|2|||
131207747|NCT00598442|472380901|FG002|Overall Study|Noncompliance|1|||
131207748|NCT00598442|472380899|FG000|Overall Study|Relocation|1|||
131207749|NCT00598442|472380900|FG001|Overall Study|Relocation|4|||
131207750|NCT00598442|472380901|FG002|Overall Study|Relocation|0|||
131207751|NCT00598442|472380899|FG000|Overall Study|Renal transplant|0|||
131207752|NCT00598442|472380900|FG001|Overall Study|Renal transplant|0|||
131207753|NCT00598442|472380901|FG002|Overall Study|Renal transplant|1|||
131207754|NCT00598442|472380899|FG000|Overall Study|Site closed by sponsor|5|||
131207755|NCT00598442|472380900|FG001|Overall Study|Site closed by sponsor|2|||
131207756|NCT00598442|472380901|FG002|Overall Study|Site closed by sponsor|1|||
131207757|NCT00598442|472380899|FG000|Overall Study|Started dialysis|1|||
131207758|NCT00598442|472380900|FG001|Overall Study|Started dialysis|0|||
131207759|NCT00598442|472380901|FG002|Overall Study|Started dialysis|0|||
131207760|NCT01654666|472380902|FG000|Overall Study|Protocol Violation|7|||
131207761|NCT01654666|472380903|FG001|Overall Study|Protocol Violation|4|||
131207762|NCT01654666|472380904|FG002|Overall Study|Protocol Violation|8|||
131207763|NCT01654666|472380902|FG000|Overall Study|Lost to Follow-up|4|||
130735295|NCT01950390|470649113|FG000|Overall Study|Symptomatic deterioration|2|||
130735296|NCT01950390|470649114|FG001|Overall Study|Symptomatic deterioration|1|||
130735297|NCT01950390|470649113|FG000|Overall Study|Physician Decision|0|||
130735298|NCT01950390|470649114|FG001|Overall Study|Physician Decision|4|||
131207764|NCT01654666|472380903|FG001|Overall Study|Lost to Follow-up|5|||
131207765|NCT01654666|472380904|FG002|Overall Study|Lost to Follow-up|5|||
131207766|NCT01654666|472380902|FG000|Overall Study|Withdrawal by Subject|4|||
131207767|NCT01654666|472380903|FG001|Overall Study|Withdrawal by Subject|4|||
131207768|NCT01654666|472380904|FG002|Overall Study|Withdrawal by Subject|1|||
131207769|NCT00368069|472380907|FG000|Overall Study|Adverse Event|5|||
131207770|NCT00368069|472380908|FG001|Overall Study|Adverse Event|2|||
131207771|NCT00368069|472380907|FG000|Overall Study|Lack of Efficacy|0|||
131207772|NCT00368069|472380908|FG001|Overall Study|Lack of Efficacy|1|||
130784739|NCT00557466|470841150|FG002|Overall Study|Abnormal test procedure results|1|||
131207773|NCT00368069|472380907|FG000|Overall Study|Lost to Follow-up|1|||
131207774|NCT00368069|472380908|FG001|Overall Study|Lost to Follow-up|0|||
131207775|NCT00368069|472380907|FG000|Overall Study|Protocol Violation|0|||
131207776|NCT00368069|472380908|FG001|Overall Study|Protocol Violation|2|||
131207777|NCT00368069|472380907|FG000|Overall Study|Withdrawal of Consent|2|||
131207778|NCT00368069|472380908|FG001|Overall Study|Withdrawal of Consent|1|||
131207779|NCT00368069|472380907|FG000|Overall Study|no blood sampling possible|0|||
131207780|NCT00368069|472380908|FG001|Overall Study|no blood sampling possible|1|||
131207781|NCT03907072|472380912|FG000|Overall Study|Study Terminated by Sponsor|2|||
131207782|NCT03907072|472380913|FG001|Overall Study|Study Terminated by Sponsor|2|||
131207783|NCT03907072|472380914|FG002|Overall Study|Study Terminated by Sponsor|2|||
131207784|NCT01430559|472380917|FG000|Overall Study|Adverse Event|7|||
131207785|NCT01430559|472380918|FG001|Overall Study|Adverse Event|3|||
131207786|NCT01430559|472380917|FG000|Overall Study|Entry criteria not met|1|||
131207787|NCT01430559|472380918|FG001|Overall Study|Entry criteria not met|1|||
131207788|NCT01430559|472380917|FG000|Overall Study|Lost to Follow-up|1|||
131207789|NCT01430559|472380918|FG001|Overall Study|Lost to Follow-up|0|||
131207790|NCT01430559|472380917|FG000|Overall Study|Medication error|1|||
131207791|NCT01430559|472380918|FG001|Overall Study|Medication error|0|||
131207792|NCT01430559|472380917|FG000|Overall Study|Withdrawal by Subject|3|||
131207793|NCT01430559|472380918|FG001|Overall Study|Withdrawal by Subject|2|||
131207794|NCT01430559|472380917|FG000|Overall Study|Protocol Violation|1|||
131207795|NCT01430559|472380918|FG001|Overall Study|Protocol Violation|0|||
131207796|NCT01430559|472380917|FG000|Overall Study|Other|3|||
131207797|NCT01430559|472380918|FG001|Overall Study|Other|3|||
131207798|NCT01430559|472380917|FG000|Overall Study|Randomized, Not Treated|3|||
131207799|NCT01430559|472380918|FG001|Overall Study|Randomized, Not Treated|3|||
131207800|NCT01177943|472380920|FG000|First Intervention|Withdrawal by Subject|2|||
131207801|NCT01177943|472380921|FG001|First Intervention|Withdrawal by Subject|0|||
131207802|NCT00672490|472380922|FG000|Overall Study|Withdrawal by Subject|8|||
131207803|NCT00672490|472380923|FG001|Overall Study|Withdrawal by Subject|8|||
131207804|NCT00672490|472380922|FG000|Overall Study|Lack of Compliance|2|||
131207805|NCT00672490|472380923|FG001|Overall Study|Lack of Compliance|7|||
131207806|NCT00672490|472380922|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
131207807|NCT00672490|472380923|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
131207808|NCT00672490|472380922|FG000|Overall Study|Adverse Event|5|||
131207809|NCT00672490|472380923|FG001|Overall Study|Adverse Event|8|||
131207810|NCT00672490|472380922|FG000|Overall Study|Violation of Concomitant Medicine|1|||
131207811|NCT00672490|472380923|FG001|Overall Study|Violation of Concomitant Medicine|0|||
131207812|NCT00672490|472380922|FG000|Overall Study|Intolerance|0|||
131207813|NCT00672490|472380923|FG001|Overall Study|Intolerance|2|||
131207814|NCT00672490|472380922|FG000|Overall Study|Lost to Follow-up|1|||
131207815|NCT00672490|472380923|FG001|Overall Study|Lost to Follow-up|5|||
131207816|NCT00672490|472380922|FG000|Overall Study|No reason was provided|6|||
131207817|NCT00672490|472380923|FG001|Overall Study|No reason was provided|2|||
131207818|NCT03319160|472380926|FG000|Overall Study|Data not available.|7|||
131207819|NCT03604159|472380927|FG000|Overall Study|Lost to Follow-up|6|||
131207820|NCT03604159|472380928|FG001|Overall Study|Lost to Follow-up|7|||
131207821|NCT04533204|472380931|FG000|Overall Study|Unable to understand training instructions|1|||
131207822|NCT04533204|472380932|FG001|Overall Study|Unable to understand training instructions|1|||
131207823|NCT00697255|472380933|FG000|Stage 1a|Insufficient ovarian response|1|||
131207824|NCT00697255|472380934|FG001|Stage 1a|Insufficient ovarian response|0|||
131207825|NCT00697255|472380933|FG000|Stage 1a|Multifollicular growth|1|||
131207826|NCT00697255|472380934|FG001|Stage 1a|Multifollicular growth|0|||
131207827|NCT00697255|472380933|FG000|Stage 1a|Not growing of dominant follicle|1|||
131207828|NCT00697255|472380934|FG001|Stage 1a|Not growing of dominant follicle|0|||
131207829|NCT00697255|472380933|FG000|Stage 1b|Not growing of dominant follicle|0|||
131207830|NCT00697255|472380934|FG001|Stage 1b|Not growing of dominant follicle|1|||
131207831|NCT00697255|472380933|FG000|Stage 1b|Insufficient ovarian response|0|||
131207832|NCT00697255|472380934|FG001|Stage 1b|Insufficient ovarian response|1|||
131207833|NCT01303159|472380938|FG000|Overall Study|Death|16|||
131207834|NCT01303159|472380938|FG000|Overall Study|Study Termination|7|||
131207835|NCT02431559|472380939|FG000|Overall Study|Adverse Event|0|||
131207836|NCT02431559|472380940|FG001|Overall Study|Adverse Event|1|||
131207837|NCT02431559|472380941|FG002|Overall Study|Adverse Event|0|||
131207838|NCT02431559|472380942|FG003|Overall Study|Adverse Event|4|||
131207839|NCT02431559|472380939|FG000|Overall Study|Progressive disease|2|||
131207840|NCT02431559|472380940|FG001|Overall Study|Progressive disease|1|||
131207841|NCT02431559|472380941|FG002|Overall Study|Progressive disease|4|||
131207842|NCT02431559|472380942|FG003|Overall Study|Progressive disease|22|||
131207843|NCT02431559|472380939|FG000|Overall Study|Withdrawal by Subject|0|||
131207844|NCT02431559|472380940|FG001|Overall Study|Withdrawal by Subject|1|||
131207845|NCT02431559|472380941|FG002|Overall Study|Withdrawal by Subject|0|||
131207846|NCT02431559|472380942|FG003|Overall Study|Withdrawal by Subject|4|||
131207847|NCT02431559|472380939|FG000|Overall Study|Physician Decision|0|||
131207848|NCT02431559|472380940|FG001|Overall Study|Physician Decision|0|||
131207849|NCT02431559|472380941|FG002|Overall Study|Physician Decision|0|||
131207850|NCT02431559|472380942|FG003|Overall Study|Physician Decision|1|||
131207851|NCT02543918|472380943|FG000|Overall Study|Never treated|0|||
131207852|NCT02543918|472380944|FG001|Overall Study|Never treated|1|||
131207853|NCT02543918|472380943|FG000|Overall Study|Lost to Follow-up|1|||
131207854|NCT02543918|472380944|FG001|Overall Study|Lost to Follow-up|1|||
131207855|NCT02543918|472380943|FG000|Overall Study|Withdrawal by Subject|1|||
131207856|NCT02543918|472380944|FG001|Overall Study|Withdrawal by Subject|1|||
131207857|NCT02543918|472380943|FG000|Overall Study|Adverse Event|1|||
131207858|NCT02543918|472380944|FG001|Overall Study|Adverse Event|1|||
131207859|NCT00955682|472380947|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
131207860|NCT00955682|472380948|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
131207861|NCT01266967|472382886|FG000|Overall Study|Death|69|||
131207862|NCT01266967|472382887|FG001|Overall Study|Death|61|||
131207863|NCT01266967|472382886|FG000|Overall Study|Study Closed/Terminated|15|||
131207864|NCT01266967|472382887|FG001|Overall Study|Study Closed/Terminated|17|||
131207865|NCT01266967|472382886|FG000|Overall Study|Lost to Follow-up|2|||
131207866|NCT01266967|472382887|FG001|Overall Study|Lost to Follow-up|1|||
131207867|NCT01266967|472382886|FG000|Overall Study|Physician Decision|0|||
131207868|NCT01266967|472382887|FG001|Overall Study|Physician Decision|1|||
131207869|NCT01266967|472382886|FG000|Overall Study|Withdrawal by Subject|3|||
131207870|NCT01266967|472382887|FG001|Overall Study|Withdrawal by Subject|3|||
131207871|NCT04398030|472382888|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
131207872|NCT04398030|472382889|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
131207873|NCT04398030|472382888|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
131207874|NCT04398030|472382889|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
131207875|NCT01928758|472382890|FG000|Overall Study|Lost to Follow-up|14|||
131207876|NCT01928758|472382891|FG001|Overall Study|Lost to Follow-up|9|||
131207877|NCT01928758|472382890|FG000|Overall Study|Withdrawal by Subject|5|||
131207878|NCT01928758|472382891|FG001|Overall Study|Withdrawal by Subject|2|||
131207879|NCT01928758|472382890|FG000|Overall Study|Adverse Event|3|||
131207880|NCT01928758|472382891|FG001|Overall Study|Adverse Event|5|||
131207881|NCT01928758|472382890|FG000|Overall Study|Protocol Violation|3|||
131207882|NCT01928758|472382891|FG001|Overall Study|Protocol Violation|4|||
131207883|NCT00719706|472382892|FG000|Overall Study|Adverse Event|5|||
131207884|NCT00719706|472382893|FG001|Overall Study|Adverse Event|4|||
131207885|NCT00719706|472382892|FG000|Overall Study|Withdrawal by Subject|1|||
131207886|NCT00719706|472382893|FG001|Overall Study|Withdrawal by Subject|2|||
131207887|NCT00719706|472382892|FG000|Overall Study|Protocol Violation|3|||
131207888|NCT00719706|472382893|FG001|Overall Study|Protocol Violation|0|||
131207889|NCT02452320|472382897|FG000|Overall Study|Adverse Event|0|||
131207890|NCT02452320|472382898|FG001|Overall Study|Adverse Event|1|||
131207891|NCT03198559|472382899|FG000|Overall Study|Adverse Event|2|||
131207892|NCT01072175|472382900|FG000|Part A (Drug-Drug Interaction)|Death|1|||
131207893|NCT01072175|472382901|FG001|Part A (Drug-Drug Interaction)|Death|0|||
131207894|NCT01072175|472382902|FG002|Part A (Drug-Drug Interaction)|Death|0|||
131207895|NCT01072175|472382903|FG003|Part A (Drug-Drug Interaction)|Death|0|||
131207896|NCT01072175|472382904|FG004|Part A (Drug-Drug Interaction)|Death|0|||
131207897|NCT01072175|472382905|FG005|Part A (Drug-Drug Interaction)|Death|0|||
131207898|NCT01072175|472382906|FG006|Part A (Drug-Drug Interaction)|Death|0|||
131207899|NCT01072175|472382907|FG007|Part A (Drug-Drug Interaction)|Death|0|||
131207900|NCT01072175|472382908|FG008|Part A (Drug-Drug Interaction)|Death|0|||
131207901|NCT01072175|472382909|FG009|Part A (Drug-Drug Interaction)|Death|0|||
131207902|NCT01072175|472382910|FG010|Part A (Drug-Drug Interaction)|Death|0|||
131207903|NCT01072175|472382911|FG011|Part A (Drug-Drug Interaction)|Death|0|||
131207904|NCT01072175|472382912|FG012|Part A (Drug-Drug Interaction)|Death|0|||
131207905|NCT01072175|472382900|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
131207906|NCT01072175|472382901|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207907|NCT01072175|472382902|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207908|NCT01072175|472382903|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207909|NCT01072175|472382904|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207910|NCT01072175|472382905|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207911|NCT01072175|472382906|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207912|NCT01072175|472382907|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207913|NCT01072175|472382908|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130735299|NCT01950390|470649113|FG000|Overall Study|Lack of clinical benefit|0|||
131207914|NCT01072175|472382909|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207915|NCT01072175|472382910|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207916|NCT01072175|472382911|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207917|NCT01072175|472382912|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
131207918|NCT01072175|472382900|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
131207919|NCT01072175|472382901|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207920|NCT01072175|472382902|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207921|NCT01072175|472382903|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130735300|NCT01950390|470649114|FG001|Overall Study|Lack of clinical benefit|1|||
131207922|NCT01072175|472382904|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207923|NCT01072175|472382905|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207924|NCT01072175|472382906|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207925|NCT01072175|472382907|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207926|NCT01072175|472382908|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207927|NCT01072175|472382909|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207928|NCT01072175|472382910|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207929|NCT01072175|472382911|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207930|NCT01072175|472382912|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
131207931|NCT01072175|472382900|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
131207932|NCT01072175|472382901|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
131207933|NCT01072175|472382902|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
131207934|NCT01072175|472382903|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
131207935|NCT01072175|472382904|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
131207936|NCT01072175|472382905|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
131207937|NCT01072175|472382906|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
131207938|NCT01072175|472382907|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
131207939|NCT01072175|472382908|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
131207940|NCT01072175|472382909|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
131207941|NCT01072175|472382910|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
131207942|NCT01072175|472382911|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
131207943|NCT01072175|472382912|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
131207944|NCT01072175|472382900|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207945|NCT01072175|472382901|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207946|NCT01072175|472382902|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
131207947|NCT01072175|472382903|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207948|NCT01072175|472382904|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
131207949|NCT01072175|472382905|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207950|NCT01072175|472382906|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207951|NCT01072175|472382907|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207952|NCT01072175|472382908|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207953|NCT01072175|472382909|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207954|NCT01072175|472382910|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207955|NCT01072175|472382911|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207956|NCT01072175|472382912|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
131207957|NCT01072175|472382900|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131207958|NCT01072175|472382901|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
131207959|NCT01072175|472382902|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131207960|NCT01072175|472382903|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
131207961|NCT01072175|472382904|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
131207962|NCT01072175|472382905|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131207963|NCT01072175|472382906|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131207964|NCT01072175|472382907|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131207965|NCT01072175|472382908|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131207966|NCT01072175|472382909|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131207967|NCT01072175|472382910|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131207968|NCT01072175|472382911|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131207969|NCT01072175|472382912|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
131207970|NCT01072175|472382900|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131207971|NCT01072175|472382901|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131207972|NCT01072175|472382902|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
131207973|NCT01072175|472382903|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
131207974|NCT01072175|472382904|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
131207975|NCT01072175|472382905|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131207976|NCT01072175|472382906|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131207977|NCT01072175|472382907|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131207978|NCT01072175|472382908|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131207979|NCT01072175|472382909|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131207980|NCT01072175|472382910|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131207981|NCT01072175|472382911|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131207982|NCT01072175|472382912|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
131207983|NCT01072175|472382900|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131207984|NCT01072175|472382901|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
131207985|NCT01072175|472382902|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131207986|NCT01072175|472382903|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
130735301|NCT01950390|470649113|FG000|Overall Study|Maintained PR and moved to observation only|0|||
130735302|NCT01950390|470649114|FG001|Overall Study|Maintained PR and moved to observation only|1|||
131207987|NCT01072175|472382904|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
131207988|NCT01072175|472382905|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131207989|NCT01072175|472382906|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131207990|NCT01072175|472382907|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131207991|NCT01072175|472382908|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131207992|NCT01072175|472382909|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131207993|NCT01072175|472382910|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131207994|NCT01072175|472382911|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131207995|NCT01072175|472382912|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
131207996|NCT01072175|472382900|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
131207997|NCT01072175|472382901|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
131207998|NCT01072175|472382902|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
131207999|NCT01072175|472382903|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
131208000|NCT01072175|472382904|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
131208001|NCT01072175|472382905|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
131208002|NCT01072175|472382906|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
131208003|NCT01072175|472382907|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
131208004|NCT01072175|472382908|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
131208005|NCT01072175|472382909|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
131208006|NCT01072175|472382910|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
131208007|NCT01072175|472382911|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
131208008|NCT01072175|472382912|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
131208009|NCT01072175|472382900|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131208010|NCT01072175|472382901|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131208011|NCT01072175|472382902|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131208012|NCT01072175|472382903|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131208013|NCT01072175|472382904|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131208014|NCT01072175|472382905|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
131208015|NCT01072175|472382906|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
131208016|NCT01072175|472382907|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
131208017|NCT01072175|472382908|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131208018|NCT01072175|472382909|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131208019|NCT01072175|472382910|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131208020|NCT01072175|472382911|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131208021|NCT01072175|472382912|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
131208022|NCT01072175|472382900|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208023|NCT01072175|472382901|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208024|NCT01072175|472382902|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208025|NCT01072175|472382903|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208026|NCT01072175|472382904|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208027|NCT01072175|472382905|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208028|NCT01072175|472382906|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
131208029|NCT01072175|472382907|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
131208030|NCT01072175|472382908|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208031|NCT01072175|472382909|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208032|NCT01072175|472382910|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208033|NCT01072175|472382911|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208034|NCT01072175|472382912|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
131208035|NCT01072175|472382900|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131208036|NCT01072175|472382901|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131208037|NCT01072175|472382902|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131208038|NCT01072175|472382903|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131208039|NCT01072175|472382904|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131208040|NCT01072175|472382905|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
131208041|NCT01072175|472382906|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
131208042|NCT01072175|472382907|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
131208043|NCT01072175|472382908|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131208044|NCT01072175|472382909|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131208045|NCT01072175|472382910|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131208046|NCT01072175|472382911|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131208047|NCT01072175|472382912|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
131208048|NCT01072175|472382900|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208049|NCT01072175|472382901|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208050|NCT01072175|472382902|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208051|NCT01072175|472382903|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208052|NCT01072175|472382904|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208053|NCT01072175|472382905|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
131208054|NCT01072175|472382906|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
131208055|NCT01072175|472382907|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208056|NCT01072175|472382908|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208057|NCT01072175|472382909|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208058|NCT01072175|472382910|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208059|NCT01072175|472382911|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208060|NCT01072175|472382912|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
131208061|NCT01072175|472382900|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208062|NCT01072175|472382901|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208063|NCT01072175|472382902|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208064|NCT01072175|472382903|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208065|NCT01072175|472382904|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208066|NCT01072175|472382905|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208067|NCT01072175|472382906|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208068|NCT01072175|472382907|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208069|NCT01072175|472382908|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
131208070|NCT01072175|472382909|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208071|NCT01072175|472382910|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208072|NCT01072175|472382911|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208073|NCT01072175|472382912|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
131208074|NCT01072175|472382900|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208075|NCT01072175|472382901|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208076|NCT01072175|472382902|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208077|NCT01072175|472382903|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208078|NCT01072175|472382904|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208079|NCT01072175|472382905|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208080|NCT01072175|472382906|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208081|NCT01072175|472382907|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208082|NCT01072175|472382908|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
131208083|NCT01072175|472382909|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208084|NCT01072175|472382910|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208085|NCT01072175|472382911|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208086|NCT01072175|472382912|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
131208087|NCT01072175|472382900|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208088|NCT01072175|472382901|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208089|NCT01072175|472382902|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208090|NCT01072175|472382903|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208091|NCT01072175|472382904|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130784740|NCT00557466|470841151|FG003|Overall Study|Abnormal test procedure results|0|||
131208092|NCT01072175|472382905|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208093|NCT01072175|472382906|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208094|NCT01072175|472382907|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208095|NCT01072175|472382908|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
131208096|NCT01072175|472382909|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208097|NCT01072175|472382910|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208098|NCT01072175|472382911|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208099|NCT01072175|472382912|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
131208100|NCT01072175|472382900|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131208101|NCT01072175|472382901|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131208102|NCT01072175|472382902|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131208103|NCT01072175|472382903|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130735303|NCT02731638|470651172|FG000|Overall Study|Lost to Follow-up|6|||
130735304|NCT02731638|470651173|FG001|Overall Study|Lost to Follow-up|9|||
130735305|NCT03284723|470651174|FG000|Overall Study|Death|0|||
130735306|NCT03284723|470651175|FG001|Overall Study|Death|0|||
130735307|NCT03284723|470651176|FG002|Overall Study|Death|0|||
130735308|NCT03284723|470651177|FG003|Overall Study|Death|1|||
130735309|NCT03284723|470651178|FG004|Overall Study|Death|0|||
131208104|NCT01072175|472382904|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130735310|NCT03284723|470651179|FG005|Overall Study|Death|0|||
130735311|NCT03284723|470651180|FG006|Overall Study|Death|1|||
130735312|NCT03284723|470651181|FG007|Overall Study|Death|0|||
130735313|NCT03284723|470651182|FG008|Overall Study|Death|0|||
130735314|NCT03284723|470651183|FG009|Overall Study|Death|2|||
130735315|NCT03284723|470651184|FG010|Overall Study|Death|1|||
131208105|NCT01072175|472382905|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131208106|NCT01072175|472382906|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131208107|NCT01072175|472382907|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131208108|NCT01072175|472382908|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
131208109|NCT01072175|472382909|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131208110|NCT01072175|472382910|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131208111|NCT01072175|472382911|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131208112|NCT01072175|472382912|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
131208113|NCT01072175|472382900|FG000|Part D (HPMC Capsules)|Death|0|||
131208114|NCT01072175|472382901|FG001|Part D (HPMC Capsules)|Death|0|||
131208115|NCT01072175|472382902|FG002|Part D (HPMC Capsules)|Death|0|||
131208116|NCT01072175|472382903|FG003|Part D (HPMC Capsules)|Death|0|||
131208117|NCT01072175|472382904|FG004|Part D (HPMC Capsules)|Death|0|||
131208118|NCT01072175|472382905|FG005|Part D (HPMC Capsules)|Death|0|||
131208119|NCT01072175|472382906|FG006|Part D (HPMC Capsules)|Death|0|||
131208120|NCT01072175|472382907|FG007|Part D (HPMC Capsules)|Death|0|||
131208121|NCT01072175|472382908|FG008|Part D (HPMC Capsules)|Death|0|||
131208122|NCT01072175|472382909|FG009|Part D (HPMC Capsules)|Death|10|||
131208123|NCT01072175|472382910|FG010|Part D (HPMC Capsules)|Death|12|||
131208124|NCT01072175|472382911|FG011|Part D (HPMC Capsules)|Death|28|||
131208125|NCT01072175|472382912|FG012|Part D (HPMC Capsules)|Death|26|||
131208126|NCT01072175|472382900|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
131208127|NCT01072175|472382901|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
131208128|NCT01072175|472382902|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
131208129|NCT01072175|472382903|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
131208130|NCT01072175|472382904|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
131208131|NCT01072175|472382905|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
131208132|NCT01072175|472382906|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
131208133|NCT01072175|472382907|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
131208134|NCT01072175|472382908|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
131208135|NCT01072175|472382909|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
131208136|NCT01072175|472382910|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
131208137|NCT01072175|472382911|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
131208138|NCT01072175|472382912|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
131208139|NCT01072175|472382900|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131208140|NCT01072175|472382901|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131208141|NCT01072175|472382902|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131208142|NCT01072175|472382903|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131208143|NCT01072175|472382904|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131208144|NCT01072175|472382905|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131208145|NCT01072175|472382906|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131208146|NCT01072175|472382907|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131208147|NCT01072175|472382908|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131208148|NCT01072175|472382909|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
131208149|NCT01072175|472382910|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
131208150|NCT01072175|472382911|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
131208151|NCT01072175|472382912|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
131208152|NCT01072175|472382900|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
131208153|NCT01072175|472382901|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
131208154|NCT01072175|472382902|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
131208155|NCT01072175|472382903|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
130735316|NCT03284723|470651185|FG011|Overall Study|Death|0|||
130735317|NCT03284723|470651174|FG000|Overall Study|Lost to Follow-up|0|||
130735318|NCT03284723|470651175|FG001|Overall Study|Lost to Follow-up|0|||
130735319|NCT03284723|470651176|FG002|Overall Study|Lost to Follow-up|0|||
130735320|NCT03284723|470651177|FG003|Overall Study|Lost to Follow-up|0|||
131208156|NCT01072175|472382904|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
131208157|NCT01072175|472382905|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
131208158|NCT01072175|472382906|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
131208159|NCT01072175|472382907|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
131208160|NCT01072175|472382908|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
131208161|NCT01072175|472382909|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
131208162|NCT01072175|472382910|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
131208163|NCT01072175|472382911|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
131208164|NCT01072175|472382912|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
131208165|NCT01072175|472382900|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208166|NCT01072175|472382901|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208167|NCT01072175|472382902|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208168|NCT01072175|472382903|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208169|NCT01072175|472382904|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208170|NCT01072175|472382905|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208171|NCT01072175|472382906|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208172|NCT01072175|472382907|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208173|NCT01072175|472382908|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208174|NCT01072175|472382909|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208175|NCT01072175|472382910|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
131208176|NCT01072175|472382911|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
131208177|NCT01072175|472382912|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
131208178|NCT01980056|472382913|FG000|Overall Study|Death|1|||
131208179|NCT01980056|472382914|FG001|Overall Study|Death|1|||
131208180|NCT01980056|472382915|FG002|Overall Study|Death|0|||
131208181|NCT00351611|472382916|FG000|Overall Study|Adverse Event|11|||
131208182|NCT00351611|472382917|FG001|Overall Study|Adverse Event|3|||
131208183|NCT00351611|472382916|FG000|Overall Study|Death|1|||
131208184|NCT00351611|472382917|FG001|Overall Study|Death|0|||
131208185|NCT00351611|472382916|FG000|Overall Study|Lost to Follow-up|1|||
131208186|NCT00351611|472382917|FG001|Overall Study|Lost to Follow-up|0|||
131208187|NCT00351611|472382916|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
131208188|NCT00351611|472382917|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
131208189|NCT00351611|472382916|FG000|Overall Study|Other|1|||
131208190|NCT00351611|472382917|FG001|Overall Study|Other|0|||
131208191|NCT00351611|472382916|FG000|Overall Study|Protocol Violation|0|||
131208192|NCT00351611|472382917|FG001|Overall Study|Protocol Violation|2|||
131208193|NCT00808665|472382918|FG000|Overall Study|Withdrawal by Subject|1|||
131208194|NCT00808665|472382919|FG001|Overall Study|Withdrawal by Subject|0|||
131208195|NCT00808665|472382918|FG000|Overall Study|only required minimally invasive surgery|1|||
131208196|NCT00808665|472382919|FG001|Overall Study|only required minimally invasive surgery|0|||
131208197|NCT00808665|472382918|FG000|Overall Study|surgery cancelled|1|||
131208198|NCT00808665|472382919|FG001|Overall Study|surgery cancelled|0|||
131208199|NCT00808665|472382918|FG000|Overall Study|required an additional procedure|0|||
131208200|NCT00808665|472382919|FG001|Overall Study|required an additional procedure|1|||
131208201|NCT00808665|472382918|FG000|Overall Study|Physician Decision|3|||
131208202|NCT00808665|472382919|FG001|Overall Study|Physician Decision|1|||
131208203|NCT00808665|472382918|FG000|Overall Study|Medication stopped by resident|0|||
131208204|NCT00808665|472382919|FG001|Overall Study|Medication stopped by resident|1|||
131208205|NCT00665002|472382920|FG000|Overall Study|Progression/relapse during treatment|11|||
131208206|NCT00665002|472382920|FG000|Overall Study|Cytogenetic resistance|1|||
131208207|NCT00496782|472382931|FG000|Overall Study|Protocol Violation|1|||
130735321|NCT03284723|470651178|FG004|Overall Study|Lost to Follow-up|0|||
130735322|NCT03284723|470651179|FG005|Overall Study|Lost to Follow-up|2|||
130735323|NCT03284723|470651180|FG006|Overall Study|Lost to Follow-up|1|||
130735324|NCT03284723|470651181|FG007|Overall Study|Lost to Follow-up|0|||
130735325|NCT03284723|470651182|FG008|Overall Study|Lost to Follow-up|0|||
130735326|NCT03284723|470651183|FG009|Overall Study|Lost to Follow-up|2|||
130735327|NCT03284723|470651184|FG010|Overall Study|Lost to Follow-up|0|||
130735328|NCT03284723|470651185|FG011|Overall Study|Lost to Follow-up|0|||
130735329|NCT03284723|470651174|FG000|Overall Study|Study Terminated By Sponsor|0|||
130735330|NCT03284723|470651175|FG001|Overall Study|Study Terminated By Sponsor|0|||
130735331|NCT03284723|470651176|FG002|Overall Study|Study Terminated By Sponsor|0|||
130735332|NCT03284723|470651177|FG003|Overall Study|Study Terminated By Sponsor|0|||
130735333|NCT03284723|470651178|FG004|Overall Study|Study Terminated By Sponsor|1|||
131208208|NCT00496782|472382932|FG001|Overall Study|Protocol Violation|2|||
131208209|NCT01288911|472382937|FG000|Double-blind Period|Death|11|||
131208210|NCT01288911|472382938|FG001|Double-blind Period|Death|7|||
131208211|NCT01288911|472382937|FG000|Double-blind Period|Lost to Follow-up|0|||
131208212|NCT01288911|472382938|FG001|Double-blind Period|Lost to Follow-up|2|||
131208213|NCT01288911|472382937|FG000|Double-blind Period|Progressive Disease|75|||
131208214|NCT01288911|472382938|FG001|Double-blind Period|Progressive Disease|103|||
131208215|NCT01288911|472382937|FG000|Double-blind Period|Protocol Violation|1|||
131208216|NCT01288911|472382938|FG001|Double-blind Period|Protocol Violation|0|||
131208217|NCT01288911|472382937|FG000|Double-blind Period|Withdrawal by Subject|25|||
131208218|NCT01288911|472382938|FG001|Double-blind Period|Withdrawal by Subject|26|||
131208219|NCT01288911|472382937|FG000|Double-blind Period|Miscellaneous Reason|29|||
131208220|NCT01288911|472382938|FG001|Double-blind Period|Miscellaneous Reason|42|||
131208221|NCT01288911|472382937|FG000|Double-blind Period|Randomized but never received study drug|1|||
131208222|NCT01288911|472382938|FG001|Double-blind Period|Randomized but never received study drug|2|||
131208223|NCT01288911|472382937|FG000|Open-label Period (All Enzalutamide)|Death|0|||
131208224|NCT01288911|472382938|FG001|Open-label Period (All Enzalutamide)|Death|1|||
131208225|NCT01288911|472382937|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
131208226|NCT01288911|472382938|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
131208227|NCT01288911|472382937|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
131208228|NCT01288911|472382938|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
131208229|NCT01288911|472382937|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
131208230|NCT01288911|472382938|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
131208231|NCT01288911|472382937|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
131208232|NCT01288911|472382938|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
131208233|NCT01288911|472382937|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
131208234|NCT01288911|472382938|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
131208235|NCT01005875|472382941|FG000|Overall Study|Death|3|||
131208236|NCT02924129|472382957|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
131208237|NCT02924129|472382958|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
131208238|NCT02924129|472382957|FG000|Overall Study|Withdrawal by Subject|2|||
131208239|NCT02924129|472382958|FG001|Overall Study|Withdrawal by Subject|2|||
131208240|NCT02924129|472382957|FG000|Overall Study|Physician Decision|1|||
131208241|NCT02924129|472382958|FG001|Overall Study|Physician Decision|0|||
131208242|NCT02924129|472382957|FG000|Overall Study|Missed Visit|0|||
131208243|NCT02924129|472382958|FG001|Overall Study|Missed Visit|1|||
131208244|NCT01348828|472382963|FG000|Overall Study|Death|20|||
131208245|NCT01348828|472382963|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
131208246|NCT01348828|472382963|FG000|Overall Study|Conversion|2|||
131208247|NCT01348828|472382963|FG000|Overall Study|missed visit|1|||
131208248|NCT00302731|472382966|FG000|Overall Study|Lost to Follow-up|1|||
131208249|NCT00302731|472382967|FG001|Overall Study|Lost to Follow-up|2|||
131208250|NCT00302731|472382968|FG002|Overall Study|Lost to Follow-up|0|||
131208251|NCT00302731|472382969|FG003|Overall Study|Lost to Follow-up|0|||
131208252|NCT00302731|472382966|FG000|Overall Study|Adverse Event|0|||
131208253|NCT00302731|472382967|FG001|Overall Study|Adverse Event|2|||
131208254|NCT00302731|472382968|FG002|Overall Study|Adverse Event|2|||
131208255|NCT00302731|472382969|FG003|Overall Study|Adverse Event|0|||
131208256|NCT00302731|472382966|FG000|Overall Study|Withdrawal by Subject|1|||
131208257|NCT00302731|472382967|FG001|Overall Study|Withdrawal by Subject|1|||
131208258|NCT00302731|472382968|FG002|Overall Study|Withdrawal by Subject|0|||
131208259|NCT00302731|472382969|FG003|Overall Study|Withdrawal by Subject|0|||
131208260|NCT00302731|472382966|FG000|Overall Study|Protocol Violation|1|||
131208261|NCT00302731|472382967|FG001|Overall Study|Protocol Violation|0|||
131208262|NCT00302731|472382968|FG002|Overall Study|Protocol Violation|0|||
131208263|NCT00302731|472382969|FG003|Overall Study|Protocol Violation|0|||
131208264|NCT00302731|472382966|FG000|Overall Study|cancer unrelated to study discovered|1|||
131208265|NCT00302731|472382967|FG001|Overall Study|cancer unrelated to study discovered|0|||
131208266|NCT00302731|472382968|FG002|Overall Study|cancer unrelated to study discovered|1|||
131208267|NCT00302731|472382969|FG003|Overall Study|cancer unrelated to study discovered|0|||
131208268|NCT01000311|472382970|FG000|Overall Study|Adverse Event|2|||
131208269|NCT01000311|472382971|FG001|Overall Study|Adverse Event|5|||
131208270|NCT01000311|472382970|FG000|Overall Study|Withdrawal by Subject|16|||
131208271|NCT01000311|472382971|FG001|Overall Study|Withdrawal by Subject|24|||
131208272|NCT01000311|472382970|FG000|Overall Study|Lost to Follow-up|15|||
131208273|NCT01000311|472382971|FG001|Overall Study|Lost to Follow-up|24|||
131208274|NCT01000311|472382970|FG000|Overall Study|Protocol Violation|1|||
131208275|NCT01000311|472382971|FG001|Overall Study|Protocol Violation|2|||
131208276|NCT01000311|472382970|FG000|Overall Study|Inappropriate enrollment|2|||
131208277|NCT01000311|472382971|FG001|Overall Study|Inappropriate enrollment|0|||
131208278|NCT01000311|472382970|FG000|Overall Study|Administrative reason|9|||
131208279|NCT01000311|472382971|FG001|Overall Study|Administrative reason|15|||
131208280|NCT01610752|472382974|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
131208281|NCT01610752|472382975|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
131208282|NCT01610752|472382976|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
131208283|NCT02815670|472382977|FG000|Overall Study|Prematurely discontinued of the trial|1|||
131208284|NCT01411917|472382978|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
131208285|NCT01411917|472382979|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
131208286|NCT00242658|472382985|FG000|Overall Study|Lost to Follow-up|22|||
131208287|NCT00242658|472382986|FG001|Overall Study|Lost to Follow-up|19|||
131208288|NCT01815099|472382987|FG000|Overall Study|Lack of Efficacy|1|||
131208289|NCT01815099|472382987|FG000|Overall Study|unable to attend study visits|1|||
131208290|NCT00643851|472382988|FG000|Overall Study|Death|0|||
131208291|NCT00643851|472382989|FG001|Overall Study|Death|1|||
131208292|NCT00643851|472382990|FG002|Overall Study|Death|0|||
131208293|NCT00643851|472382988|FG000|Overall Study|Lack of Efficacy|0|||
131208294|NCT00643851|472382989|FG001|Overall Study|Lack of Efficacy|1|||
131208295|NCT00643851|472382990|FG002|Overall Study|Lack of Efficacy|0|||
131208296|NCT00643851|472382988|FG000|Overall Study|Adverse Event|2|||
131208297|NCT00643851|472382989|FG001|Overall Study|Adverse Event|6|||
131208298|NCT00643851|472382990|FG002|Overall Study|Adverse Event|6|||
131208299|NCT00643851|472382988|FG000|Overall Study|Lost to Follow-up|4|||
131208300|NCT00643851|472382989|FG001|Overall Study|Lost to Follow-up|6|||
131208301|NCT00643851|472382990|FG002|Overall Study|Lost to Follow-up|9|||
131208302|NCT00643851|472382988|FG000|Overall Study|Withdrawal by Subject|8|||
131208303|NCT00643851|472382989|FG001|Overall Study|Withdrawal by Subject|15|||
131208304|NCT00643851|472382990|FG002|Overall Study|Withdrawal by Subject|9|||
131208305|NCT00643851|472382988|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
131208306|NCT00643851|472382989|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
131208307|NCT00643851|472382990|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
131208308|NCT04806334|472382993|FG000|Overall Study|Withdrawal by Subject|1|||
131208309|NCT04557189|472382994|FG000|Overall Study|Adverse Event|0|||
131208310|NCT04557189|472382995|FG001|Overall Study|Adverse Event|1|||
131208311|NCT04557189|472382994|FG000|Overall Study|Lost to Follow-up|1|||
131208312|NCT04557189|472382995|FG001|Overall Study|Lost to Follow-up|1|||
131208313|NCT04557189|472382994|FG000|Overall Study|Withdrawal by Subject|2|||
131208314|NCT04557189|472382995|FG001|Overall Study|Withdrawal by Subject|1|||
131208315|NCT04557189|472382994|FG000|Overall Study|Reason not Specified|3|||
131208316|NCT04557189|472382995|FG001|Overall Study|Reason not Specified|6|||
131208317|NCT01731600|472382998|FG000|Overall Study|Adverse Event|2|||
131208318|NCT01731600|472382999|FG001|Overall Study|Adverse Event|0|||
131208319|NCT01731600|472382998|FG000|Overall Study|Withdrawal criteria|1|||
131208320|NCT01731600|472382999|FG001|Overall Study|Withdrawal criteria|0|||
131208321|NCT01731600|472382998|FG000|Overall Study|Other reasons|3|||
131208322|NCT01731600|472382999|FG001|Overall Study|Other reasons|0|||
131208323|NCT00465894|472383000|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
131208324|NCT00465894|472383001|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
131208325|NCT00465894|472383000|FG000|Treatment For 12 Weeks|Family Issues|1|||
131208326|NCT00465894|472383001|FG001|Treatment For 12 Weeks|Family Issues|1|||
131208327|NCT00465894|472383000|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
130735334|NCT03284723|470651179|FG005|Overall Study|Study Terminated By Sponsor|0|||
131208328|NCT00465894|472383001|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
131208329|NCT01636076|472383002|FG000|Overall Study|Terminated by sponsor|1|||
131208330|NCT01636076|472383003|FG001|Overall Study|Terminated by sponsor|1|||
131208331|NCT01636076|472383002|FG000|Overall Study|Lack of Efficacy|0|||
131208332|NCT01636076|472383003|FG001|Overall Study|Lack of Efficacy|1|||
131208333|NCT01636076|472383002|FG000|Overall Study|Lost to Follow-up|1|||
131208334|NCT01636076|472383003|FG001|Overall Study|Lost to Follow-up|0|||
131208335|NCT01636076|472383002|FG000|Overall Study|Physician Decision|1|||
131208336|NCT01636076|472383003|FG001|Overall Study|Physician Decision|1|||
131208337|NCT01636076|472383002|FG000|Overall Study|Non-compliance with study treatment|1|||
131208338|NCT01636076|472383003|FG001|Overall Study|Non-compliance with study treatment|1|||
131208339|NCT01636076|472383002|FG000|Overall Study|Adverse Event|6|||
131208340|NCT01636076|472383003|FG001|Overall Study|Adverse Event|11|||
131208341|NCT01636076|472383002|FG000|Overall Study|Withdrawal by Subject|7|||
131208342|NCT01636076|472383003|FG001|Overall Study|Withdrawal by Subject|10|||
131208343|NCT02173158|472383005|FG000|Efficacy Phase|Adverse Event|1|||
130735335|NCT03284723|470651180|FG006|Overall Study|Study Terminated By Sponsor|0|||
131208344|NCT01728454|472383017|FG000|Stage 1 and 2|Pregnancy|1|||
131208345|NCT01728454|472383018|FG001|Stage 1 and 2|Pregnancy|0|||
131208346|NCT01728454|472383019|FG002|Stage 1 and 2|Pregnancy|0|||
131208347|NCT01728454|472383017|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
131208348|NCT01728454|472383018|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
131208349|NCT01728454|472383019|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
131208350|NCT01728454|472383017|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
131208351|NCT01728454|472383018|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
131208352|NCT01728454|472383019|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
131208353|NCT01728454|472383017|FG000|Stage 1 and 2|Lost to Follow-up|1|||
131208354|NCT01728454|472383018|FG001|Stage 1 and 2|Lost to Follow-up|1|||
131208355|NCT01728454|472383019|FG002|Stage 1 and 2|Lost to Follow-up|0|||
131208356|NCT01728454|472383017|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
131208357|NCT01728454|472383018|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
131208358|NCT01728454|472383019|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
131208359|NCT01728454|472383017|FG000|Stage 3|Reason Missing|0|||
131208360|NCT01728454|472383018|FG001|Stage 3|Reason Missing|0|||
131208361|NCT01728454|472383019|FG002|Stage 3|Reason Missing|1|||
131208362|NCT01728454|472383017|FG000|Stage 3|Subject Required Other Treatment|0|||
131208363|NCT01728454|472383018|FG001|Stage 3|Subject Required Other Treatment|1|||
131208364|NCT01728454|472383019|FG002|Stage 3|Subject Required Other Treatment|0|||
131208365|NCT01728454|472383017|FG000|Stage 3|Pregnancy|1|||
131208366|NCT01728454|472383018|FG001|Stage 3|Pregnancy|0|||
131208367|NCT01728454|472383019|FG002|Stage 3|Pregnancy|0|||
131208368|NCT01728454|472383017|FG000|Stage 3|Withdrew Consent|1|||
131208369|NCT01728454|472383018|FG001|Stage 3|Withdrew Consent|0|||
131208370|NCT01728454|472383019|FG002|Stage 3|Withdrew Consent|1|||
131208371|NCT01728454|472383017|FG000|Stage 3|Non-compliance with Protocol|0|||
131208372|NCT01728454|472383018|FG001|Stage 3|Non-compliance with Protocol|0|||
131208373|NCT01728454|472383019|FG002|Stage 3|Non-compliance with Protocol|1|||
131208374|NCT01728454|472383017|FG000|Stage 3|Lost to Follow-up|0|||
131208375|NCT01728454|472383018|FG001|Stage 3|Lost to Follow-up|3|||
131208376|NCT01728454|472383019|FG002|Stage 3|Lost to Follow-up|1|||
131208377|NCT01728454|472383017|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
131208378|NCT01728454|472383018|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
131208379|NCT01728454|472383019|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
131208380|NCT01190839|472383020|FG000|Overall Study|Adverse Event|32|||
131208381|NCT01190839|472383021|FG001|Overall Study|Adverse Event|41|||
131208382|NCT01190839|472383020|FG000|Overall Study|Protocol Violation|2|||
131208383|NCT01190839|472383021|FG001|Overall Study|Protocol Violation|2|||
131208384|NCT01190839|472383020|FG000|Overall Study|Lost to Follow-up|7|||
131208385|NCT01190839|472383021|FG001|Overall Study|Lost to Follow-up|1|||
130735336|NCT03284723|470651181|FG007|Overall Study|Study Terminated By Sponsor|0|||
130735337|NCT03284723|470651182|FG008|Overall Study|Study Terminated By Sponsor|1|||
130735338|NCT03284723|470651183|FG009|Overall Study|Study Terminated By Sponsor|1|||
131208386|NCT01190839|472383020|FG000|Overall Study|Death|1|||
131208387|NCT01190839|472383021|FG001|Overall Study|Death|0|||
131208388|NCT01190839|472383020|FG000|Overall Study|Trial stopped by Sponsor|71|||
131208389|NCT01190839|472383021|FG001|Overall Study|Trial stopped by Sponsor|68|||
131208390|NCT01190839|472383020|FG000|Overall Study|Undefined|35|||
131208391|NCT01190839|472383021|FG001|Overall Study|Undefined|31|||
131208392|NCT01190839|472383020|FG000|Overall Study|Randomized but not treated|2|||
131208393|NCT01190839|472383021|FG001|Overall Study|Randomized but not treated|4|||
131208394|NCT03077646|472383025|FG000|Overall Study|Lost to Follow-up|29|||
131208395|NCT03077646|472383026|FG001|Overall Study|Lost to Follow-up|30|||
131208396|NCT03077646|472383027|FG002|Overall Study|Lost to Follow-up|31|||
131208397|NCT00765726|472383028|FG000|Overall Study|Withdrawal by Subject|1|||
131208398|NCT00765726|472383028|FG000|Overall Study|Discontinuation of study by sponsor|8|||
131208399|NCT02058966|472383029|FG000|Open-Label Methamphetamine|Adverse Event|1|||
131208400|NCT02058966|472383029|FG000|First Intervention|Withdrawal by Subject|1|||
131208401|NCT02993731|472383030|FG000|Overall Study|Study Termination|101|||
131208402|NCT02993731|472383031|FG001|Overall Study|Study Termination|105|||
131208403|NCT01265511|472383032|FG000|Overall Study|Lack of Efficacy|2|||
131208404|NCT01265511|472383033|FG001|Overall Study|Lack of Efficacy|1|||
131208405|NCT01265511|472383032|FG000|Overall Study|Met stopping rules|0|||
131208406|NCT01265511|472383033|FG001|Overall Study|Met stopping rules|2|||
131208407|NCT00323479|472383034|FG000|Overall Study|Adverse Event|2|||
131208408|NCT00323479|472383034|FG000|Overall Study|Withdrawal by Subject|2|||
130735339|NCT03284723|470651184|FG010|Overall Study|Study Terminated By Sponsor|1|||
130735340|NCT03284723|470651185|FG011|Overall Study|Study Terminated By Sponsor|1|||
131208409|NCT00323479|472383034|FG000|Overall Study|Protocol Violation|3|||
131208410|NCT00323479|472383034|FG000|Overall Study|house moving|1|||
131208411|NCT01362062|472383037|FG000|Overall Study|Adverse Event|1|||
131208412|NCT01362062|472383038|FG001|Overall Study|Adverse Event|0|||
131208413|NCT01362062|472383037|FG000|Overall Study|Lost to Follow-up|11|||
131208414|NCT01362062|472383038|FG001|Overall Study|Lost to Follow-up|0|||
131208415|NCT01362062|472383037|FG000|Overall Study|Withdrawal by Subject|2|||
131208416|NCT01362062|472383038|FG001|Overall Study|Withdrawal by Subject|0|||
131208417|NCT01362062|472383037|FG000|Overall Study|Non-compliant participant|2|||
131208418|NCT01362062|472383038|FG001|Overall Study|Non-compliant participant|0|||
131208419|NCT01362062|472383037|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
131208420|NCT01362062|472383038|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
131208421|NCT01362062|472383037|FG000|Overall Study|Had significant improvement|9|||
131208422|NCT01362062|472383038|FG001|Overall Study|Had significant improvement|0|||
131208423|NCT02545504|472383041|FG000|Overall Study|Death|174|||
131208424|NCT02545504|472383042|FG001|Overall Study|Death|168|||
131208425|NCT02545504|472383041|FG000|Overall Study|Unknown reason|30|||
131208426|NCT02545504|472383042|FG001|Overall Study|Unknown reason|32|||
131208427|NCT02545504|472383041|FG000|Overall Study|Withdrew consent|9|||
131208428|NCT02545504|472383042|FG001|Overall Study|Withdrew consent|11|||
131208429|NCT02545504|472383041|FG000|Overall Study|Investigator's discretion|3|||
131208430|NCT02545504|472383042|FG001|Overall Study|Investigator's discretion|1|||
131208431|NCT02545504|472383041|FG000|Overall Study|Lost to Follow-up|2|||
131208432|NCT02545504|472383042|FG001|Overall Study|Lost to Follow-up|2|||
131208433|NCT00967343|472383043|FG000|Overall Study|Study termination by sponsor|12|||
131208434|NCT00967343|472383043|FG000|Overall Study|Death|24|||
131208435|NCT00967343|472383043|FG000|Overall Study|Relapse|1|||
131208436|NCT00967343|472383043|FG000|Overall Study|Lost to Follow-up|1|||
131208437|NCT00950755|472383045|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
131208438|NCT00950755|472383045|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
131208439|NCT00950755|472383045|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
131208440|NCT00950755|472383045|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
131208441|NCT00950755|472383045|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
131208442|NCT00950755|472383045|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
131208443|NCT00950755|472383045|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
131208444|NCT00950755|472383045|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
131208445|NCT00950755|472383045|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
131208446|NCT00950755|472383045|FG000|Long-Term Follow-Up|Death|8|||
131208447|NCT00508820|472383047|FG000|Overall Study|Adverse Event|6|||
131208448|NCT00508820|472383048|FG001|Overall Study|Adverse Event|10|||
131208449|NCT00508820|472383047|FG000|Overall Study|Death|6|||
131208450|NCT00508820|472383048|FG001|Overall Study|Death|8|||
131208451|NCT00508820|472383047|FG000|Overall Study|Lost to Follow-up|1|||
131208452|NCT00508820|472383048|FG001|Overall Study|Lost to Follow-up|1|||
131208453|NCT00508820|472383047|FG000|Overall Study|Physician Decision|8|||
131208454|NCT00508820|472383048|FG001|Overall Study|Physician Decision|2|||
131208455|NCT00508820|472383047|FG000|Overall Study|Pregnancy|0|||
131208456|NCT00508820|472383048|FG001|Overall Study|Pregnancy|2|||
131208457|NCT00508820|472383047|FG000|Overall Study|Protocol Violation|2|||
131208458|NCT00508820|472383048|FG001|Overall Study|Protocol Violation|0|||
131208459|NCT00508820|472383047|FG000|Overall Study|Withdrawal by Subject|10|||
131208460|NCT00508820|472383048|FG001|Overall Study|Withdrawal by Subject|12|||
131208461|NCT00508820|472383047|FG000|Overall Study|Other|11|||
131208462|NCT00508820|472383048|FG001|Overall Study|Other|2|||
131208463|NCT00508820|472383047|FG000|Overall Study|Noncompliance|1|||
131208464|NCT00508820|472383048|FG001|Overall Study|Noncompliance|0|||
131208465|NCT00508820|472383047|FG000|Overall Study|Requirement for alternative therapy|7|||
131208466|NCT00508820|472383048|FG001|Overall Study|Requirement for alternative therapy|15|||
131208467|NCT00508820|472383047|FG000|Overall Study|Protocol-specified Criteria|3|||
131208468|NCT00508820|472383048|FG001|Overall Study|Protocol-specified Criteria|12|||
131208469|NCT01945866|472384626|FG000|Overall Study|Eyes did not complete or were dropped|2|||
131208470|NCT01945866|472384627|FG001|Overall Study|Eyes did not complete or were dropped|0|||
131208471|NCT01674010|472384628|FG000|Open Treatment Phase 1|Adverse Event|10|||
131208472|NCT01674010|472384629|FG001|Open Treatment Phase 1|Adverse Event|0|||
131208473|NCT01674010|472384630|FG002|Open Treatment Phase 1|Adverse Event|0|||
131208474|NCT01674010|472384628|FG000|Open Treatment Phase 1|Death|1|||
131208475|NCT01674010|472384629|FG001|Open Treatment Phase 1|Death|0|||
130735341|NCT03284723|470651174|FG000|Overall Study|Withdrawal by Subject|0|||
131208476|NCT01674010|472384630|FG002|Open Treatment Phase 1|Death|0|||
131208477|NCT01674010|472384628|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
131208478|NCT01674010|472384629|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
131208479|NCT01674010|472384630|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
131208480|NCT01674010|472384628|FG000|Open Treatment Phase 1|Physician Decision|9|||
131208481|NCT01674010|472384629|FG001|Open Treatment Phase 1|Physician Decision|0|||
131208482|NCT01674010|472384630|FG002|Open Treatment Phase 1|Physician Decision|0|||
131208483|NCT01674010|472384628|FG000|Open Treatment Phase 1|Protocol Violation|7|||
131208484|NCT01674010|472384629|FG001|Open Treatment Phase 1|Protocol Violation|0|||
131208485|NCT01674010|472384630|FG002|Open Treatment Phase 1|Protocol Violation|0|||
130735342|NCT03284723|470651175|FG001|Overall Study|Withdrawal by Subject|0|||
131208486|NCT01674010|472384628|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
131208487|NCT01674010|472384629|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
131208488|NCT01674010|472384630|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
131208489|NCT01674010|472384628|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
131208490|NCT01674010|472384629|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
131208491|NCT01674010|472384630|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
131208492|NCT01674010|472384628|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
131208493|NCT01674010|472384629|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
131208494|NCT01674010|472384630|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
131208495|NCT01674010|472384628|FG000|Randomization Phase 2|Adverse Event|0|||
131208496|NCT01674010|472384629|FG001|Randomization Phase 2|Adverse Event|1|||
131208497|NCT01674010|472384630|FG002|Randomization Phase 2|Adverse Event|1|||
131208498|NCT01674010|472384628|FG000|Randomization Phase 2|Lost to Follow-up|0|||
131208499|NCT01674010|472384629|FG001|Randomization Phase 2|Lost to Follow-up|1|||
131208500|NCT01674010|472384630|FG002|Randomization Phase 2|Lost to Follow-up|2|||
131208501|NCT01674010|472384628|FG000|Randomization Phase 2|Mood episode recurrence|0|||
131208502|NCT01674010|472384629|FG001|Randomization Phase 2|Mood episode recurrence|8|||
131208503|NCT01674010|472384630|FG002|Randomization Phase 2|Mood episode recurrence|2|||
131208504|NCT01674010|472384628|FG000|Randomization Phase 2|Physician Decision|0|||
131208505|NCT01674010|472384629|FG001|Randomization Phase 2|Physician Decision|0|||
131208506|NCT01674010|472384630|FG002|Randomization Phase 2|Physician Decision|2|||
131208507|NCT01674010|472384628|FG000|Randomization Phase 2|Pregnancy|0|||
131208508|NCT01674010|472384629|FG001|Randomization Phase 2|Pregnancy|1|||
131208509|NCT01674010|472384630|FG002|Randomization Phase 2|Pregnancy|1|||
131208510|NCT01674010|472384628|FG000|Randomization Phase 2|Protocol Violation|0|||
131208511|NCT01674010|472384629|FG001|Randomization Phase 2|Protocol Violation|1|||
131208512|NCT01674010|472384630|FG002|Randomization Phase 2|Protocol Violation|1|||
131208513|NCT01674010|472384628|FG000|Randomization Phase 2|Sponsor Decision|0|||
131208514|NCT01674010|472384629|FG001|Randomization Phase 2|Sponsor Decision|42|||
131208515|NCT01674010|472384630|FG002|Randomization Phase 2|Sponsor Decision|45|||
131208516|NCT01674010|472384628|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
131208517|NCT01674010|472384629|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
131208518|NCT01674010|472384630|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
131208519|NCT03159455|472384633|FG000|Overall Study|Adverse Event|0|||
131208520|NCT03159455|472384634|FG001|Overall Study|Adverse Event|0|||
131208521|NCT03159455|472384635|FG002|Overall Study|Adverse Event|0|||
131208522|NCT03159455|472384636|FG003|Overall Study|Adverse Event|0|||
131208523|NCT03159455|472384637|FG004|Overall Study|Adverse Event|0|||
131208524|NCT03159455|472384638|FG005|Overall Study|Adverse Event|1|||
131208525|NCT05056311|472384648|FG000|Overall Study|Lost to Follow-up|14|||
131208526|NCT05056311|472384648|FG000|Overall Study|Withdrawal by Subject|1|||
131208527|NCT05056311|472384648|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
131208528|NCT02713490|472384650|FG000|Overall Study|Withdrawal by Subject|2|||
131208529|NCT02713490|472384651|FG001|Overall Study|Withdrawal by Subject|1|||
131208530|NCT02713490|472384650|FG000|Overall Study|Did not receive study drug|1|||
131208531|NCT02713490|472384651|FG001|Overall Study|Did not receive study drug|0|||
131208532|NCT02713490|472384650|FG000|Overall Study|Met exclusion criteria|0|||
131208533|NCT02713490|472384651|FG001|Overall Study|Met exclusion criteria|1|||
131208534|NCT00346775|472384652|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
131208535|NCT00346775|472384653|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
131208536|NCT00346775|472384652|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
131208537|NCT00346775|472384653|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
131208538|NCT00346775|472384652|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
131208539|NCT00346775|472384653|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
131208540|NCT02946515|472384654|FG000|Overall Study|Lost to Follow-up|2|||
131208541|NCT02946515|472384655|FG001|Overall Study|Lost to Follow-up|1|||
131208542|NCT03799198|472384656|FG000|Overall Study|Lost to Follow-up|4|||
131208543|NCT03799198|472384657|FG001|Overall Study|Lost to Follow-up|8|||
131208544|NCT03799198|472384656|FG000|Overall Study|Death|0|||
131208545|NCT03799198|472384657|FG001|Overall Study|Death|1|||
131208546|NCT00960869|472384658|FG000|Overall Study|Adverse Event|17|||
131208547|NCT00960869|472384659|FG001|Overall Study|Adverse Event|26|||
131208548|NCT00960869|472384658|FG000|Overall Study|Withdrawal by Subject|16|||
131208549|NCT00960869|472384659|FG001|Overall Study|Withdrawal by Subject|14|||
131208550|NCT00960869|472384658|FG000|Overall Study|Lost to Follow-up|1|||
131208551|NCT00960869|472384659|FG001|Overall Study|Lost to Follow-up|4|||
131208552|NCT00960869|472384658|FG000|Overall Study|Misc|19|||
131208553|NCT00960869|472384659|FG001|Overall Study|Misc|18|||
131208554|NCT01714726|472384660|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
131208555|NCT01714726|472384661|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
131208556|NCT01714726|472384662|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
131208557|NCT01714726|472384663|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
131208558|NCT01714726|472384660|FG000|Double-Blinded Induction Period|Adverse Event|0|||
131208559|NCT01714726|472384661|FG001|Double-Blinded Induction Period|Adverse Event|1|||
131208560|NCT01714726|472384662|FG002|Double-Blinded Induction Period|Adverse Event|0|||
131208561|NCT01714726|472384663|FG003|Double-Blinded Induction Period|Adverse Event|0|||
131208562|NCT01714726|472384660|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
131208563|NCT01714726|472384661|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
131208564|NCT01714726|472384662|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
131208565|NCT01714726|472384663|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
131208566|NCT01714726|472384660|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
131208567|NCT01714726|472384661|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
131208568|NCT01714726|472384662|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
131208569|NCT01714726|472384663|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
131208570|NCT01714726|472384660|FG000|Open-Label Period|Other|0|||
131208571|NCT01714726|472384661|FG001|Open-Label Period|Other|0|||
131208572|NCT01714726|472384662|FG002|Open-Label Period|Other|1|||
131208573|NCT01714726|472384663|FG003|Open-Label Period|Other|3|||
131208574|NCT01714726|472384660|FG000|Open-Label Period|Adverse Event|0|||
131208575|NCT01714726|472384661|FG001|Open-Label Period|Adverse Event|0|||
131208576|NCT01714726|472384662|FG002|Open-Label Period|Adverse Event|1|||
131208577|NCT01714726|472384663|FG003|Open-Label Period|Adverse Event|0|||
131208578|NCT01714726|472384660|FG000|Open-Label Period|Withdrawal by Subject|0|||
131208579|NCT01714726|472384661|FG001|Open-Label Period|Withdrawal by Subject|0|||
131208580|NCT01714726|472384662|FG002|Open-Label Period|Withdrawal by Subject|9|||
131208581|NCT01714726|472384663|FG003|Open-Label Period|Withdrawal by Subject|19|||
131208582|NCT01714726|472384660|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
131208583|NCT01714726|472384661|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
131208584|NCT01714726|472384662|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
131208585|NCT01714726|472384663|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
131208586|NCT01714726|472384660|FG000|Open-Label Period|Lost to Follow-up|0|||
131208587|NCT01714726|472384661|FG001|Open-Label Period|Lost to Follow-up|0|||
131208588|NCT01714726|472384662|FG002|Open-Label Period|Lost to Follow-up|3|||
131208589|NCT01714726|472384663|FG003|Open-Label Period|Lost to Follow-up|4|||
131208590|NCT01096017|472384666|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
131208591|NCT01096017|472384667|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
131208592|NCT01846442|472384668|FG000|Overall Study|Adverse Event|2|||
131208593|NCT01846442|472384669|FG001|Overall Study|Adverse Event|4|||
131208594|NCT01846442|472384670|FG002|Overall Study|Adverse Event|2|||
131208595|NCT01846442|472384671|FG003|Overall Study|Adverse Event|1|||
131208596|NCT01846442|472384668|FG000|Overall Study|Lost to Follow-up|0|||
131208597|NCT01846442|472384669|FG001|Overall Study|Lost to Follow-up|0|||
131208598|NCT01846442|472384670|FG002|Overall Study|Lost to Follow-up|1|||
131208599|NCT01846442|472384671|FG003|Overall Study|Lost to Follow-up|0|||
131208600|NCT01846442|472384668|FG000|Overall Study|Withdrawal by Subject|3|||
131208601|NCT01846442|472384669|FG001|Overall Study|Withdrawal by Subject|2|||
131208602|NCT01846442|472384670|FG002|Overall Study|Withdrawal by Subject|0|||
131208603|NCT01846442|472384671|FG003|Overall Study|Withdrawal by Subject|1|||
131208604|NCT01846442|472384668|FG000|Overall Study|Left the city/Lost medication|1|||
131208605|NCT01846442|472384669|FG001|Overall Study|Left the city/Lost medication|0|||
131208606|NCT01846442|472384670|FG002|Overall Study|Left the city/Lost medication|1|||
131208607|NCT01846442|472384671|FG003|Overall Study|Left the city/Lost medication|1|||
131208608|NCT00665366|472384674|FG000|Overall Study|Lack of Efficacy|11|||
131208609|NCT00665366|472384675|FG001|Overall Study|Lack of Efficacy|10|||
131208610|NCT00665366|472384674|FG000|Overall Study|Adverse Event|25|||
131208611|NCT00665366|472384675|FG001|Overall Study|Adverse Event|23|||
131208612|NCT00665366|472384674|FG000|Overall Study|Withdrawal by Subject|11|||
131208613|NCT00665366|472384675|FG001|Overall Study|Withdrawal by Subject|14|||
131208614|NCT00665366|472384674|FG000|Overall Study|Lost to Follow-up|3|||
131208615|NCT00665366|472384675|FG001|Overall Study|Lost to Follow-up|5|||
131208616|NCT00665366|472384674|FG000|Overall Study|Poor compliance/noncompliance|3|||
131208617|NCT00665366|472384675|FG001|Overall Study|Poor compliance/noncompliance|5|||
131208618|NCT00665366|472384674|FG000|Overall Study|Pregnancy|1|||
131208619|NCT00665366|472384675|FG001|Overall Study|Pregnancy|0|||
131208620|NCT00665366|472384674|FG000|Overall Study|No longer meets study criteria|0|||
131208621|NCT00665366|472384675|FG001|Overall Study|No longer meets study criteria|1|||
131208622|NCT00665366|472384674|FG000|Overall Study|Other reasons|4|||
131208623|NCT00665366|472384675|FG001|Overall Study|Other reasons|1|||
131208624|NCT02687815|472384678|FG000|Overall Study|Lost to Follow-up|2|||
131208625|NCT02687815|472384679|FG001|Overall Study|Lost to Follow-up|4|||
131208626|NCT02687815|472384678|FG000|Overall Study|Withdrawal by Subject|2|||
131208627|NCT02687815|472384679|FG001|Overall Study|Withdrawal by Subject|4|||
131208628|NCT04177862|472384680|FG000|Overall Study|Protocol Violation|2|||
131208629|NCT04177862|472384681|FG001|Overall Study|Protocol Violation|7|||
131208630|NCT03233009|472384682|FG000|Overall Study|Lost to Follow-up|1|||
131208631|NCT00474994|472384692|FG000|Overall Study|Patient Not treated|1|||
131208632|NCT00474994|472384692|FG000|Overall Study|Patient evaluable for toxicity only|3|||
131208633|NCT00474994|472384692|FG000|Overall Study|Patient found to be ineligible|1|||
131208634|NCT00278473|472384693|FG000|Overall Study|drop out|4|||
130735343|NCT03284723|470651176|FG002|Overall Study|Withdrawal by Subject|0|||
131208635|NCT00278473|472384694|FG001|Overall Study|drop out|3|||
131208636|NCT02322866|472384696|FG000|Overall Study|Adverse Event|6|||
131208637|NCT02322866|472384697|FG001|Overall Study|Adverse Event|11|||
131208638|NCT02322866|472384696|FG000|Overall Study|Withdrawal of Consent|16|||
131208639|NCT02322866|472384697|FG001|Overall Study|Withdrawal of Consent|25|||
131208640|NCT02322866|472384696|FG000|Overall Study|Lost to Follow-up|36|||
131208641|NCT02322866|472384697|FG001|Overall Study|Lost to Follow-up|39|||
131208642|NCT02322866|472384696|FG000|Overall Study|Protocol Violation|1|||
131208643|NCT02322866|472384697|FG001|Overall Study|Protocol Violation|0|||
130735344|NCT03284723|470651177|FG003|Overall Study|Withdrawal by Subject|0|||
130735345|NCT03284723|470651178|FG004|Overall Study|Withdrawal by Subject|5|||
130735346|NCT03284723|470651179|FG005|Overall Study|Withdrawal by Subject|3|||
130735347|NCT03284723|470651180|FG006|Overall Study|Withdrawal by Subject|1|||
130735348|NCT03284723|470651181|FG007|Overall Study|Withdrawal by Subject|0|||
130735349|NCT03284723|470651182|FG008|Overall Study|Withdrawal by Subject|6|||
130735350|NCT03284723|470651183|FG009|Overall Study|Withdrawal by Subject|0|||
130735351|NCT03284723|470651184|FG010|Overall Study|Withdrawal by Subject|3|||
130735352|NCT03284723|470651185|FG011|Overall Study|Withdrawal by Subject|1|||
130735353|NCT03284723|470651174|FG000|Overall Study|Other|1|||
130735354|NCT03284723|470651175|FG001|Overall Study|Other|0|||
131208644|NCT02322866|472384696|FG000|Overall Study|Noncompliance with Treatment|3|||
131208645|NCT02322866|472384697|FG001|Overall Study|Noncompliance with Treatment|4|||
131208646|NCT02322866|472384696|FG000|Overall Study|Lack of Efficacy|3|||
131208647|NCT02322866|472384697|FG001|Overall Study|Lack of Efficacy|1|||
131208648|NCT02322866|472384696|FG000|Overall Study|Other Miscellaneous Reasons|6|||
131208649|NCT02322866|472384697|FG001|Overall Study|Other Miscellaneous Reasons|6|||
131208650|NCT06045026|472384706|FG000|Overall Study|Lost to Follow-up|60|||
131208651|NCT06045026|472384706|FG000|Overall Study|Adverse Event|12|||
131208652|NCT06045026|472384706|FG000|Overall Study|Withdrawal by Subject|3|||
131208653|NCT06045026|472384706|FG000|Overall Study|Enrollment closed|1|||
131208654|NCT00408408|472384712|FG000|Overall Study|No follow up data|2|||
131208655|NCT00408408|472384713|FG001|Overall Study|No follow up data|3|||
131208656|NCT00408408|472384714|FG002|Overall Study|No follow up data|0|||
131208657|NCT00408408|472384715|FG003|Overall Study|No follow up data|7|||
131208658|NCT00408408|472384716|FG004|Overall Study|No follow up data|5|||
131208659|NCT00408408|472384717|FG005|Overall Study|No follow up data|3|||
131208660|NCT00267202|472384718|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
131208661|NCT00267202|472384719|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
131208662|NCT00267202|472384718|FG000|Overall Study|Withdrawal by Subject|12|||
131208663|NCT00267202|472384719|FG001|Overall Study|Withdrawal by Subject|15|||
131208664|NCT00267202|472384718|FG000|Overall Study|Adverse Event|13|||
131208665|NCT00267202|472384719|FG001|Overall Study|Adverse Event|7|||
131208666|NCT00267202|472384718|FG000|Overall Study|Protocol Violation|2|||
131208667|NCT00267202|472384719|FG001|Overall Study|Protocol Violation|3|||
131208668|NCT00267202|472384718|FG000|Overall Study|Administrative problems|2|||
131208669|NCT00267202|472384719|FG001|Overall Study|Administrative problems|1|||
131208670|NCT00267202|472384718|FG000|Overall Study|Lost to Follow-up|3|||
131208671|NCT00267202|472384719|FG001|Overall Study|Lost to Follow-up|0|||
131208672|NCT00399542|472384720|FG000|Overall Study|Adverse Event|18|||
131208673|NCT00399542|472384721|FG001|Overall Study|Adverse Event|15|||
131208674|NCT00399542|472384720|FG000|Overall Study|Protocol Violation|13|||
131208675|NCT00399542|472384721|FG001|Overall Study|Protocol Violation|3|||
131208676|NCT00399542|472384720|FG000|Overall Study|Withdrawal by Subject|28|||
131208677|NCT00399542|472384721|FG001|Overall Study|Withdrawal by Subject|10|||
131208678|NCT00399542|472384720|FG000|Overall Study|Lack of Efficacy|18|||
131208679|NCT00399542|472384721|FG001|Overall Study|Lack of Efficacy|8|||
131208680|NCT00399542|472384720|FG000|Overall Study|Lost to Follow-up|6|||
131208681|NCT00399542|472384721|FG001|Overall Study|Lost to Follow-up|6|||
131208682|NCT00399542|472384720|FG000|Overall Study|Other|1|||
131208683|NCT00399542|472384721|FG001|Overall Study|Other|0|||
131208684|NCT00399542|472384720|FG000|Overall Study|Physician Decision|0|||
131208685|NCT00399542|472384721|FG001|Overall Study|Physician Decision|1|||
131208686|NCT03172026|472384722|FG000|Overall Study|Withdrawal by Subject|1|||
131208687|NCT03172026|472384723|FG001|Overall Study|Withdrawal by Subject|0|||
131208688|NCT03172026|472384722|FG000|Overall Study|COVID restrictions|1|||
131208689|NCT03172026|472384723|FG001|Overall Study|COVID restrictions|0|||
131208690|NCT00612456|472384724|FG000|Overall Study|Adverse Event|1|||
131208691|NCT00612456|472384725|FG001|Overall Study|Adverse Event|0|||
131208692|NCT00612456|472384726|FG002|Overall Study|Adverse Event|0|||
131208693|NCT00612456|472384724|FG000|Overall Study|Lack of Efficacy|1|||
131208694|NCT00612456|472384725|FG001|Overall Study|Lack of Efficacy|1|||
131208695|NCT00612456|472384726|FG002|Overall Study|Lack of Efficacy|0|||
131208696|NCT00612456|472384724|FG000|Overall Study|Withdrawal by Subject|0|||
130735355|NCT03284723|470651176|FG002|Overall Study|Other|1|||
130735356|NCT03284723|470651177|FG003|Overall Study|Other|0|||
130735357|NCT03284723|470651178|FG004|Overall Study|Other|1|||
130735358|NCT03284723|470651179|FG005|Overall Study|Other|0|||
130735359|NCT03284723|470651180|FG006|Overall Study|Other|0|||
130735360|NCT03284723|470651181|FG007|Overall Study|Other|0|||
131208697|NCT00612456|472384725|FG001|Overall Study|Withdrawal by Subject|1|||
131208698|NCT00612456|472384726|FG002|Overall Study|Withdrawal by Subject|0|||
131208699|NCT02463097|472384727|FG000|Overall Study|Withdrawal by Subject|1|||
131208700|NCT01757821|472384728|FG000|Overall Study|Adverse Event|1|||
131208701|NCT01552408|472384729|FG000|Overall Study|Lost to Follow-up|2|||
131208702|NCT01552408|472384730|FG001|Overall Study|Lost to Follow-up|0|||
131208703|NCT01552408|472384729|FG000|Overall Study|Relocation|0|||
131208704|NCT01552408|472384730|FG001|Overall Study|Relocation|1|||
131208705|NCT01552408|472384729|FG000|Overall Study|Withdrawal by Subject|2|||
131208706|NCT01552408|472384730|FG001|Overall Study|Withdrawal by Subject|1|||
131208707|NCT00606931|472384734|FG000|Overall Study|Withdrawal by Subject|3|||
131208708|NCT02354599|472384735|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
131208709|NCT02354599|472384736|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
131208710|NCT02354599|472384737|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
131208711|NCT02354599|472384738|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
131208712|NCT02354599|472384739|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
131208713|NCT02354599|472384740|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
131208714|NCT02354599|472384735|FG000|Overall Study|Withdrawal by Subject|1|||
131208715|NCT02354599|472384736|FG001|Overall Study|Withdrawal by Subject|1|||
131208716|NCT02354599|472384737|FG002|Overall Study|Withdrawal by Subject|0|||
131208717|NCT02354599|472384738|FG003|Overall Study|Withdrawal by Subject|0|||
131208718|NCT02354599|472384739|FG004|Overall Study|Withdrawal by Subject|0|||
131208719|NCT02354599|472384740|FG005|Overall Study|Withdrawal by Subject|0|||
131208720|NCT01087944|472384760|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
131208721|NCT01087944|472384761|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
131208722|NCT01087944|472384760|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
131208723|NCT01087944|472384761|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
131208724|NCT01159665|472384762|FG000|Overall Study|Withdrawal by Subject|0|||
131208725|NCT01159665|472384763|FG001|Overall Study|Withdrawal by Subject|1|||
131208726|NCT01159665|472384764|FG002|Overall Study|Withdrawal by Subject|0|||
131208727|NCT01159665|472384765|FG003|Overall Study|Withdrawal by Subject|0|||
131208728|NCT01159665|472384766|FG004|Overall Study|Withdrawal by Subject|0|||
131208729|NCT01159665|472384767|FG005|Overall Study|Withdrawal by Subject|0|||
131208730|NCT00540228|472384769|FG000|Overall Study|Adverse Event|2|||
131208731|NCT00540228|472384770|FG001|Overall Study|Adverse Event|0|||
131208732|NCT00540228|472384771|FG002|Overall Study|Adverse Event|0|||
131208733|NCT00540228|472384772|FG003|Overall Study|Adverse Event|0|||
131208734|NCT00540228|472384773|FG004|Overall Study|Adverse Event|0|||
131208735|NCT00540228|472384769|FG000|Overall Study|Lost to Follow-up|1|||
131208736|NCT00540228|472384770|FG001|Overall Study|Lost to Follow-up|1|||
131208737|NCT00540228|472384771|FG002|Overall Study|Lost to Follow-up|0|||
131208738|NCT00540228|472384772|FG003|Overall Study|Lost to Follow-up|0|||
131208739|NCT00540228|472384773|FG004|Overall Study|Lost to Follow-up|0|||
131208740|NCT01377194|472384774|FG000|Overall Study|Adverse Event|3|||
131208741|NCT01377194|472384775|FG001|Overall Study|Adverse Event|12|||
131208742|NCT01377194|472384776|FG002|Overall Study|Adverse Event|19|||
131208743|NCT01377194|472384774|FG000|Overall Study|Lack of Efficacy|3|||
131208744|NCT01377194|472384775|FG001|Overall Study|Lack of Efficacy|3|||
131208745|NCT01377194|472384776|FG002|Overall Study|Lack of Efficacy|3|||
131208746|NCT01377194|472384774|FG000|Overall Study|Protocol Violation|4|||
131208747|NCT01377194|472384775|FG001|Overall Study|Protocol Violation|10|||
131208748|NCT01377194|472384776|FG002|Overall Study|Protocol Violation|6|||
131208749|NCT01377194|472384774|FG000|Overall Study|Withdrawal by Subject|8|||
130735361|NCT03284723|470651182|FG008|Overall Study|Other|0|||
130735362|NCT03284723|470651183|FG009|Overall Study|Other|0|||
130735363|NCT03284723|470651184|FG010|Overall Study|Other|1|||
130735364|NCT03284723|470651185|FG011|Overall Study|Other|0|||
130735365|NCT03284723|470651174|FG000|Overall Study|Adverse Event|0|||
130735366|NCT03284723|470651175|FG001|Overall Study|Adverse Event|0|||
130735367|NCT03284723|470651176|FG002|Overall Study|Adverse Event|0|||
130735368|NCT03284723|470651177|FG003|Overall Study|Adverse Event|0|||
130735369|NCT03284723|470651178|FG004|Overall Study|Adverse Event|0|||
130735370|NCT03284723|470651179|FG005|Overall Study|Adverse Event|0|||
130735371|NCT03284723|470651180|FG006|Overall Study|Adverse Event|0|||
130735372|NCT03284723|470651181|FG007|Overall Study|Adverse Event|0|||
130784741|NCT00557466|470841152|FG004|Overall Study|Abnormal test procedure results|0|||
130784742|NCT00557466|470841153|FG005|Overall Study|Abnormal test procedure results|0|||
131208750|NCT01377194|472384775|FG001|Overall Study|Withdrawal by Subject|10|||
131208751|NCT01377194|472384776|FG002|Overall Study|Withdrawal by Subject|7|||
131208752|NCT01377194|472384774|FG000|Overall Study|Lost to Follow-up|14|||
131208753|NCT01377194|472384775|FG001|Overall Study|Lost to Follow-up|8|||
131208754|NCT01377194|472384776|FG002|Overall Study|Lost to Follow-up|11|||
131208755|NCT02451137|472384779|FG000|Overall Study|Randomized but not treated|19|||
131208756|NCT02451137|472384780|FG001|Overall Study|Randomized but not treated|27|||
131208757|NCT02451137|472384779|FG000|Overall Study|Adverse Event|43|||
131208758|NCT02451137|472384780|FG001|Overall Study|Adverse Event|42|||
131208759|NCT02451137|472384779|FG000|Overall Study|Lack of Efficacy|4|||
131208760|NCT02451137|472384780|FG001|Overall Study|Lack of Efficacy|9|||
131208761|NCT02451137|472384779|FG000|Overall Study|Participant decision:discontinue insulin|41|||
131208762|NCT02451137|472384780|FG001|Overall Study|Participant decision:discontinue insulin|43|||
131208763|NCT02451137|472384779|FG000|Overall Study|Hypoglycemia|2|||
131208764|NCT02451137|472384780|FG001|Overall Study|Hypoglycemia|1|||
131208765|NCT02451137|472384779|FG000|Overall Study|Investigator's decision|23|||
131208766|NCT02451137|472384780|FG001|Overall Study|Investigator's decision|19|||
131208767|NCT02451137|472384779|FG000|Overall Study|Lost to Follow-up|53|||
131208768|NCT02451137|472384780|FG001|Overall Study|Lost to Follow-up|61|||
131208769|NCT02451137|472384779|FG000|Overall Study|Physician Decision|6|||
131208770|NCT02451137|472384780|FG001|Overall Study|Physician Decision|5|||
131208771|NCT02451137|472384779|FG000|Overall Study|Sponsor decision|13|||
131208772|NCT02451137|472384780|FG001|Overall Study|Sponsor decision|25|||
131208773|NCT02451137|472384779|FG000|Overall Study|Withdrawal by Subject|40|||
131208774|NCT02451137|472384780|FG001|Overall Study|Withdrawal by Subject|63|||
131208775|NCT02451137|472384779|FG000|Overall Study|Other than specified above|2|||
131208776|NCT02451137|472384780|FG001|Overall Study|Other than specified above|3|||
131208777|NCT01977573|472384783|FG000|Overall Study|Adverse Event|7|||
131208778|NCT01977573|472384784|FG001|Overall Study|Adverse Event|0|||
131208779|NCT01977573|472384785|FG002|Overall Study|Adverse Event|2|||
131208780|NCT01977573|472384786|FG003|Overall Study|Adverse Event|1|||
131208781|NCT01977573|472384783|FG000|Overall Study|Lost to Follow-up|1|||
131208782|NCT01977573|472384784|FG001|Overall Study|Lost to Follow-up|0|||
131208783|NCT01977573|472384785|FG002|Overall Study|Lost to Follow-up|0|||
131208784|NCT01977573|472384786|FG003|Overall Study|Lost to Follow-up|1|||
131208785|NCT01977573|472384783|FG000|Overall Study|Physician Decision|1|||
131208786|NCT01977573|472384784|FG001|Overall Study|Physician Decision|0|||
131208787|NCT01977573|472384785|FG002|Overall Study|Physician Decision|0|||
131208788|NCT01977573|472384786|FG003|Overall Study|Physician Decision|0|||
131208789|NCT01977573|472384783|FG000|Overall Study|Protocol Violation|3|||
131208790|NCT01977573|472384784|FG001|Overall Study|Protocol Violation|1|||
131208791|NCT01977573|472384785|FG002|Overall Study|Protocol Violation|0|||
131208792|NCT01977573|472384786|FG003|Overall Study|Protocol Violation|0|||
131208793|NCT01977573|472384783|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
131208794|NCT01977573|472384784|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
131208795|NCT01977573|472384785|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
131208796|NCT01977573|472384786|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
131208797|NCT01977573|472384783|FG000|Overall Study|Withdrawal by Subject|6|||
131208798|NCT01977573|472384784|FG001|Overall Study|Withdrawal by Subject|1|||
131208799|NCT01977573|472384785|FG002|Overall Study|Withdrawal by Subject|1|||
131208800|NCT01977573|472384786|FG003|Overall Study|Withdrawal by Subject|1|||
131208801|NCT02501642|472386455|FG000|Overall Study|Lost to Follow-up|7|||
131208802|NCT02501642|472386456|FG001|Overall Study|Lost to Follow-up|11|||
131208803|NCT00548340|472386457|FG000|Overall Study|Protocol Violation|2|||
131208804|NCT00548340|472386458|FG001|Overall Study|Protocol Violation|3|||
131208805|NCT00548340|472386459|FG002|Overall Study|Protocol Violation|3|||
131208806|NCT00548340|472386457|FG000|Overall Study|Adverse Event|2|||
130735373|NCT03284723|470651182|FG008|Overall Study|Adverse Event|1|||
130735374|NCT03284723|470651183|FG009|Overall Study|Adverse Event|0|||
130735375|NCT03284723|470651184|FG010|Overall Study|Adverse Event|0|||
131208807|NCT00548340|472386458|FG001|Overall Study|Adverse Event|2|||
131208808|NCT00548340|472386459|FG002|Overall Study|Adverse Event|2|||
131208809|NCT00548340|472386457|FG000|Overall Study|Lost to Follow-up|1|||
131208810|NCT00548340|472386458|FG001|Overall Study|Lost to Follow-up|1|||
131208811|NCT00548340|472386459|FG002|Overall Study|Lost to Follow-up|0|||
131208812|NCT00548340|472386457|FG000|Overall Study|Withdrawal by Subject|2|||
131208813|NCT00548340|472386458|FG001|Overall Study|Withdrawal by Subject|4|||
131208814|NCT00548340|472386459|FG002|Overall Study|Withdrawal by Subject|3|||
131208815|NCT00548340|472386457|FG000|Overall Study|Other|1|||
131208816|NCT00548340|472386458|FG001|Overall Study|Other|1|||
131208817|NCT00548340|472386459|FG002|Overall Study|Other|1|||
131208818|NCT02600559|472386471|FG000|Overall Study|Withdrawal by Subject|3|||
131208819|NCT02600559|472386471|FG000|Overall Study|Lost to Follow-up|20|||
131208820|NCT01153971|472386474|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
131208821|NCT01153971|472386474|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
131208822|NCT01153971|472386474|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
131208823|NCT01153971|472386474|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
131208824|NCT01153971|472386474|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
131208825|NCT01153971|472386474|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
130735376|NCT03284723|470651185|FG011|Overall Study|Adverse Event|0|||
130735377|NCT00615199|470651186|FG000|Overall Study|Adverse Event|3|||
130735378|NCT00615199|470651187|FG001|Overall Study|Adverse Event|1|||
130735379|NCT00615199|470651188|FG002|Overall Study|Adverse Event|1|||
130735380|NCT00615199|470651189|FG003|Overall Study|Adverse Event|0|||
130735381|NCT00615199|470651186|FG000|Overall Study|Lack of Efficacy|2|||
130735382|NCT00615199|470651187|FG001|Overall Study|Lack of Efficacy|0|||
130735383|NCT00615199|470651188|FG002|Overall Study|Lack of Efficacy|0|||
130735384|NCT00615199|470651189|FG003|Overall Study|Lack of Efficacy|1|||
130735385|NCT00615199|470651186|FG000|Overall Study|Lost to Follow-up|1|||
130735386|NCT00615199|470651187|FG001|Overall Study|Lost to Follow-up|0|||
130735387|NCT00615199|470651188|FG002|Overall Study|Lost to Follow-up|0|||
130735388|NCT00615199|470651189|FG003|Overall Study|Lost to Follow-up|0|||
130735389|NCT00615199|470651186|FG000|Overall Study|Other|0|||
130735390|NCT00615199|470651187|FG001|Overall Study|Other|0|||
130735391|NCT00615199|470651188|FG002|Overall Study|Other|0|||
130735392|NCT00615199|470651189|FG003|Overall Study|Other|1|||
130735393|NCT00615199|470651186|FG000|Overall Study|Withdrawal by Subject|2|||
130735394|NCT00615199|470651187|FG001|Overall Study|Withdrawal by Subject|1|||
130735395|NCT00615199|470651188|FG002|Overall Study|Withdrawal by Subject|0|||
130735396|NCT00615199|470651189|FG003|Overall Study|Withdrawal by Subject|0|||
130735397|NCT01499095|470651190|FG000|Overall Study|Randomized But Not Treated|1|||
130735398|NCT01499095|470651191|FG001|Overall Study|Randomized But Not Treated|1|||
130735399|NCT01499095|470651190|FG000|Overall Study|Adverse Event|12|||
130735400|NCT01499095|470651191|FG001|Overall Study|Adverse Event|7|||
130735401|NCT01499095|470651190|FG000|Overall Study|Lack of Efficacy|2|||
130735402|NCT01499095|470651191|FG001|Overall Study|Lack of Efficacy|1|||
130735403|NCT01499095|470651190|FG000|Overall Study|Protocol Violation|6|||
130784743|NCT00557466|470841148|FG000|Overall Study|Lost to Follow-up|0|||
131208826|NCT01153971|472386474|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
131208827|NCT03410693|472386475|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
131208828|NCT03410693|472386476|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
131208829|NCT03410693|472386475|FG000|Overall Study|Disc trt: Lost to follow up|0|||
131208830|NCT03410693|472386476|FG001|Overall Study|Disc trt: Lost to follow up|1|||
131208831|NCT03410693|472386475|FG000|Overall Study|Disc trt: radiological progression|58|||
131208832|NCT03410693|472386476|FG001|Overall Study|Disc trt: radiological progression|50|||
131208833|NCT03410693|472386475|FG000|Overall Study|Disc trt: Other|1|||
131208834|NCT03410693|472386476|FG001|Overall Study|Disc trt: Other|0|||
131208835|NCT03410693|472386475|FG000|Overall Study|Study drug never administered|1|||
131208836|NCT03410693|472386476|FG001|Overall Study|Study drug never administered|6|||
131208837|NCT03410693|472386475|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
131208838|NCT03410693|472386476|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
131208839|NCT03410693|472386475|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
131208840|NCT03410693|472386476|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
131208841|NCT03410693|472386475|FG000|Overall Study|Disc trt: Physician decision|0|||
131208842|NCT03410693|472386476|FG001|Overall Study|Disc trt: Physician decision|5|||
131208843|NCT03410693|472386475|FG000|Overall Study|Disc trt: clinical progression|1|||
131208844|NCT03410693|472386476|FG001|Overall Study|Disc trt: clinical progression|5|||
131208845|NCT03410693|472386475|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
131208846|NCT03410693|472386476|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
131208847|NCT00953576|472386477|FG000|Overall Study|Adverse Event|0|||
131208848|NCT00953576|472386478|FG001|Overall Study|Adverse Event|1|||
131208849|NCT00953576|472386477|FG000|Overall Study|Ineligible after Consent|2|||
131208850|NCT00953576|472386478|FG001|Overall Study|Ineligible after Consent|0|||
131208851|NCT03628781|472386483|FG000|Overall Study|Lost to Follow-up|16|||
130735404|NCT01499095|470651191|FG001|Overall Study|Protocol Violation|7|||
130735405|NCT01499095|470651190|FG000|Overall Study|Received Rescue Therapy|32|||
130735406|NCT01499095|470651191|FG001|Overall Study|Received Rescue Therapy|40|||
130735407|NCT01499095|470651190|FG000|Overall Study|Diverse Reasons|22|||
130735408|NCT01499095|470651191|FG001|Overall Study|Diverse Reasons|25|||
131208852|NCT03628781|472386484|FG001|Overall Study|Lost to Follow-up|8|||
131208853|NCT03628781|472386483|FG000|Overall Study|Withdrawal by Subject|16|||
130735409|NCT01499095|470651190|FG000|Overall Study|Lost to Follow-up|6|||
130735410|NCT01499095|470651191|FG001|Overall Study|Lost to Follow-up|4|||
130735411|NCT01499095|470651190|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
130735412|NCT01499095|470651191|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
130735413|NCT01499095|470651190|FG000|Overall Study|Hypoglycemia|3|||
130735414|NCT01499095|470651191|FG001|Overall Study|Hypoglycemia|1|||
130735415|NCT01499095|470651190|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
130735416|NCT01499095|470651191|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
130735417|NCT01499095|470651190|FG000|Overall Study|Change in Injection Schedule|2|||
130735418|NCT01499095|470651191|FG001|Overall Study|Change in Injection Schedule|0|||
130735419|NCT01499095|470651190|FG000|Overall Study|Perceived Lack of Efficacy|1|||
130735420|NCT01499095|470651191|FG001|Overall Study|Perceived Lack of Efficacy|1|||
130735421|NCT01811472|470651197|FG000|Overall Study|Adverse Event|1|||
130735422|NCT01811472|470651198|FG001|Overall Study|Adverse Event|0|||
130735423|NCT01811472|470651199|FG002|Overall Study|Adverse Event|4|||
130735424|NCT01811472|470651197|FG000|Overall Study|Lost to Follow-up|0|||
130735425|NCT01811472|470651198|FG001|Overall Study|Lost to Follow-up|0|||
130735426|NCT01811472|470651199|FG002|Overall Study|Lost to Follow-up|1|||
130735427|NCT01811472|470651197|FG000|Overall Study|Subject/guardian decision|1|||
130735428|NCT01811472|470651198|FG001|Overall Study|Subject/guardian decision|0|||
130735429|NCT01811472|470651199|FG002|Overall Study|Subject/guardian decision|0|||
130735430|NCT03280264|470651200|FG000|Overall Study|Adverse Event|1|||
130735431|NCT03280264|470651200|FG000|Overall Study|Physician Decision|1|||
130735432|NCT03280264|470651200|FG000|Overall Study|Withdrawal by Subject|1|||
130735433|NCT02738138|470651201|FG000|Overall Study|Adverse Event|0|||
130784744|NCT00557466|470841149|FG001|Overall Study|Lost to Follow-up|0|||
130784745|NCT00557466|470841150|FG002|Overall Study|Lost to Follow-up|0|||
130784746|NCT00557466|470841151|FG003|Overall Study|Lost to Follow-up|1|||
130784747|NCT00557466|470841152|FG004|Overall Study|Lost to Follow-up|0|||
131208854|NCT03628781|472386484|FG001|Overall Study|Withdrawal by Subject|1|||
131208855|NCT00656669|472386485|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
131208856|NCT00656669|472386485|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
131208857|NCT00656669|472386485|FG000|AC (Cycles 6-9)|Adverse Event|1|||
131208858|NCT00656669|472386485|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
131208859|NCT03778021|472386488|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
131208860|NCT03778021|472386489|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
131208861|NCT01545375|472386490|FG000|Overall Study|Adverse Event|2|||
131208862|NCT01545375|472386491|FG001|Overall Study|Adverse Event|1|||
131208863|NCT01545375|472386490|FG000|Overall Study|Lost to Follow-up|34|||
131208864|NCT01545375|472386491|FG001|Overall Study|Lost to Follow-up|31|||
131208865|NCT01545375|472386490|FG000|Overall Study|Protocol Violation|3|||
131208866|NCT01545375|472386491|FG001|Overall Study|Protocol Violation|3|||
131208867|NCT01545375|472386490|FG000|Overall Study|Withdrawal by Subject|58|||
131208868|NCT01545375|472386491|FG001|Overall Study|Withdrawal by Subject|55|||
131208869|NCT00679042|472386492|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
131208870|NCT00679042|472386492|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
131208871|NCT00679042|472386492|FG000|5-Year Follow Up|Death|1|||
131208872|NCT00679042|472386492|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
131208873|NCT00679042|472386492|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
131208874|NCT01846039|472386493|FG000|Overall Study|Protocol Violation|1|||
131208875|NCT01846039|472386493|FG000|Overall Study|Subject Withdrew Consent|1|||
130735434|NCT02738138|470651202|FG001|Overall Study|Adverse Event|1|||
130735435|NCT02738138|470651201|FG000|Overall Study|Lost to Follow-up|2|||
130735436|NCT02738138|470651202|FG001|Overall Study|Lost to Follow-up|0|||
130735437|NCT02738138|470651201|FG000|Overall Study|Other - not further specified|1|||
130735438|NCT02738138|470651202|FG001|Overall Study|Other - not further specified|0|||
130735439|NCT01995513|470651208|FG000|Period 1: First Open Label Treatment|Other|34|||
130735440|NCT01995513|470651209|FG001|Period 1: First Open Label Treatment|Other|0|||
130735441|NCT01995513|470651210|FG002|Period 1: First Open Label Treatment|Other|0|||
130735442|NCT01995513|470651211|FG003|Period 1: First Open Label Treatment|Other|0|||
130735443|NCT01995513|470651208|FG000|Period 1: First Open Label Treatment|Death|14|||
130735444|NCT01995513|470651209|FG001|Period 1: First Open Label Treatment|Death|0|||
130735445|NCT01995513|470651210|FG002|Period 1: First Open Label Treatment|Death|0|||
130735446|NCT01995513|470651211|FG003|Period 1: First Open Label Treatment|Death|0|||
130735447|NCT01995513|470651208|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
130735448|NCT01995513|470651209|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
130735449|NCT01995513|470651210|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
130735450|NCT01995513|470651211|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
130735451|NCT01995513|470651208|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
130735452|NCT01995513|470651209|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
130735453|NCT01995513|470651210|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
130735454|NCT01995513|470651211|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
130735455|NCT01995513|470651208|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
130735456|NCT01995513|470651209|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
130735457|NCT01995513|470651210|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
130735458|NCT01995513|470651211|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
130735459|NCT01995513|470651208|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
130735460|NCT01995513|470651209|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
130735461|NCT01995513|470651210|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
130735462|NCT01995513|470651211|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
130735463|NCT01995513|470651208|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
130735464|NCT01995513|470651209|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
130735465|NCT01995513|470651210|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
130735466|NCT01995513|470651211|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
130735467|NCT01995513|470651208|FG000|Period 1: Second Open Label Treatment|Other|0|||
130735468|NCT01995513|470651209|FG001|Period 1: Second Open Label Treatment|Other|2|||
130735469|NCT01995513|470651210|FG002|Period 1: Second Open Label Treatment|Other|0|||
130735470|NCT01995513|470651211|FG003|Period 1: Second Open Label Treatment|Other|0|||
130735471|NCT01995513|470651208|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
130735472|NCT01995513|470651209|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
130735473|NCT01995513|470651210|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
130735474|NCT01995513|470651211|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
130735475|NCT01995513|470651208|FG000|Period 2: Double Blind Treatment|Death|0|||
130735476|NCT01995513|470651209|FG001|Period 2: Double Blind Treatment|Death|0|||
130735477|NCT01995513|470651210|FG002|Period 2: Double Blind Treatment|Death|0|||
130735478|NCT01995513|470651211|FG003|Period 2: Double Blind Treatment|Death|1|||
130735479|NCT01995513|470651208|FG000|Period 2: Double Blind Treatment|Other|0|||
130735480|NCT01995513|470651209|FG001|Period 2: Double Blind Treatment|Other|0|||
130735481|NCT01995513|470651210|FG002|Period 2: Double Blind Treatment|Other|3|||
130735482|NCT01995513|470651211|FG003|Period 2: Double Blind Treatment|Other|3|||
130735483|NCT01995513|470651208|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
130735484|NCT01995513|470651209|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
130735485|NCT01995513|470651210|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
130735486|NCT01995513|470651211|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
131208876|NCT00247416|472386496|FG000|Overall Study|3 patients were found to be ineligible|1|||
131208877|NCT00247416|472386497|FG001|Overall Study|3 patients were found to be ineligible|2|||
131208878|NCT04854421|472386498|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
131208879|NCT04854421|472386499|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
131208880|NCT00798161|472386500|FG000|Overall Study|Adverse Event|3|||
131208881|NCT00798161|472386501|FG001|Overall Study|Adverse Event|4|||
131208882|NCT00798161|472386502|FG002|Overall Study|Adverse Event|6|||
131208883|NCT00798161|472386503|FG003|Overall Study|Adverse Event|6|||
131208884|NCT00798161|472386504|FG004|Overall Study|Adverse Event|5|||
131208885|NCT00798161|472386505|FG005|Overall Study|Adverse Event|2|||
131208886|NCT00798161|472386506|FG006|Overall Study|Adverse Event|4|||
131208887|NCT00798161|472386500|FG000|Overall Study|Protocol Violation|2|||
130735487|NCT01995513|470651208|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
130735488|NCT01995513|470651209|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
130735489|NCT01995513|470651210|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
130735490|NCT01995513|470651211|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
131208888|NCT00798161|472386501|FG001|Overall Study|Protocol Violation|1|||
131208889|NCT00798161|472386502|FG002|Overall Study|Protocol Violation|3|||
131208890|NCT00798161|472386503|FG003|Overall Study|Protocol Violation|3|||
131208891|NCT00798161|472386504|FG004|Overall Study|Protocol Violation|3|||
131208892|NCT00798161|472386505|FG005|Overall Study|Protocol Violation|2|||
131208893|NCT00798161|472386506|FG006|Overall Study|Protocol Violation|0|||
131208894|NCT00798161|472386500|FG000|Overall Study|Lost to Follow-up|1|||
131208895|NCT00798161|472386501|FG001|Overall Study|Lost to Follow-up|3|||
131208896|NCT00798161|472386502|FG002|Overall Study|Lost to Follow-up|4|||
131208897|NCT00798161|472386503|FG003|Overall Study|Lost to Follow-up|3|||
131208898|NCT00798161|472386504|FG004|Overall Study|Lost to Follow-up|4|||
131208899|NCT00798161|472386505|FG005|Overall Study|Lost to Follow-up|0|||
131208900|NCT00798161|472386506|FG006|Overall Study|Lost to Follow-up|0|||
131208901|NCT00798161|472386500|FG000|Overall Study|Withdrawal by Subject|5|||
131208902|NCT00798161|472386501|FG001|Overall Study|Withdrawal by Subject|4|||
131208903|NCT00798161|472386502|FG002|Overall Study|Withdrawal by Subject|5|||
131208904|NCT00798161|472386503|FG003|Overall Study|Withdrawal by Subject|4|||
131208905|NCT00798161|472386504|FG004|Overall Study|Withdrawal by Subject|2|||
131208906|NCT00798161|472386505|FG005|Overall Study|Withdrawal by Subject|3|||
131208907|NCT00798161|472386506|FG006|Overall Study|Withdrawal by Subject|1|||
131208908|NCT00798161|472386500|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
131208909|NCT00798161|472386501|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
131208910|NCT00798161|472386502|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
131208911|NCT00798161|472386503|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
131208912|NCT00798161|472386504|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
131208913|NCT00798161|472386505|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
131208914|NCT00798161|472386506|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
131208915|NCT01399619|472386507|FG000|Overall Study|Adverse Event|10|||
131208916|NCT01399619|472386508|FG001|Overall Study|Adverse Event|0|||
130784748|NCT00557466|470841153|FG005|Overall Study|Lost to Follow-up|0|||
130784749|NCT01251952|470841156|FG000|Overall Study|Adverse Event|1|||
130784750|NCT00496769|470841157|FG000|Double Blind|>=1 reason assigned per patient|558|||
131208917|NCT01399619|472386509|FG002|Overall Study|Adverse Event|4|||
131208918|NCT01399619|472386510|FG003|Overall Study|Adverse Event|10|||
130735491|NCT01995513|470651208|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
130735492|NCT01995513|470651209|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
130735493|NCT01995513|470651210|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
130735494|NCT01995513|470651211|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
130735495|NCT01995513|470651208|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
130735496|NCT01995513|470651209|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
130735497|NCT01995513|470651210|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
130735498|NCT01995513|470651211|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
131208919|NCT01399619|472386507|FG000|Overall Study|Lack of Efficacy|9|||
131208920|NCT01399619|472386508|FG001|Overall Study|Lack of Efficacy|0|||
131208921|NCT01399619|472386509|FG002|Overall Study|Lack of Efficacy|5|||
131208922|NCT01399619|472386510|FG003|Overall Study|Lack of Efficacy|0|||
131208923|NCT01399619|472386507|FG000|Overall Study|Withdrawal by Subject|6|||
131208924|NCT01399619|472386508|FG001|Overall Study|Withdrawal by Subject|0|||
131208925|NCT01399619|472386509|FG002|Overall Study|Withdrawal by Subject|3|||
131208926|NCT01399619|472386510|FG003|Overall Study|Withdrawal by Subject|4|||
131208927|NCT01399619|472386507|FG000|Overall Study|Protocol Violation|0|||
131208928|NCT01399619|472386508|FG001|Overall Study|Protocol Violation|0|||
131208929|NCT01399619|472386509|FG002|Overall Study|Protocol Violation|0|||
131208930|NCT01399619|472386510|FG003|Overall Study|Protocol Violation|1|||
131208931|NCT01399619|472386507|FG000|Overall Study|Not treated|0|||
131208932|NCT01399619|472386508|FG001|Overall Study|Not treated|0|||
131208933|NCT01399619|472386509|FG002|Overall Study|Not treated|0|||
131208934|NCT01399619|472386510|FG003|Overall Study|Not treated|2|||
131208935|NCT00462501|472386511|FG000|Overall Study|Not treated|3|||
131208936|NCT00462501|472386511|FG000|Overall Study|Adverse Event|2|||
131208937|NCT00998166|472386512|FG000|Overall Study|Early Study Termination|8|||
131208938|NCT04626947|472386526|FG000|Overall Study|Study terminated|14|||
131208939|NCT00265109|472386529|FG000|Overall Study|Withdrawal by Subject|5|||
131208940|NCT00265109|472386529|FG000|Overall Study|Adverse Event|1|||
131208941|NCT00920582|472386530|FG000|Overall Study|Lost to Follow-up|5|||
131208942|NCT00920582|472386531|FG001|Overall Study|Lost to Follow-up|1|||
131208943|NCT00920582|472386532|FG002|Overall Study|Lost to Follow-up|2|||
131208944|NCT00920582|472386533|FG003|Overall Study|Lost to Follow-up|0|||
131208945|NCT00920582|472386530|FG000|Overall Study|Withdrawal by Subject|5|||
131208946|NCT00920582|472386531|FG001|Overall Study|Withdrawal by Subject|4|||
131208947|NCT00920582|472386532|FG002|Overall Study|Withdrawal by Subject|6|||
131208948|NCT00920582|472386533|FG003|Overall Study|Withdrawal by Subject|3|||
131208949|NCT00920582|472386530|FG000|Overall Study|Protocol Violation|1|||
131208950|NCT00920582|472386531|FG001|Overall Study|Protocol Violation|0|||
131208951|NCT00920582|472386532|FG002|Overall Study|Protocol Violation|0|||
131208952|NCT00920582|472386533|FG003|Overall Study|Protocol Violation|0|||
131208953|NCT00920582|472386530|FG000|Overall Study|Other|2|||
131208954|NCT00920582|472386531|FG001|Overall Study|Other|1|||
131208955|NCT00920582|472386532|FG002|Overall Study|Other|3|||
131208956|NCT00920582|472386533|FG003|Overall Study|Other|2|||
131208957|NCT00383292|472386536|FG000|Overall Study|Adverse Event|4|||
131208958|NCT00383292|472386537|FG001|Overall Study|Adverse Event|1|||
131208959|NCT00383292|472386538|FG002|Overall Study|Adverse Event|2|||
131208960|NCT00383292|472386536|FG000|Overall Study|Death|3|||
131208961|NCT00383292|472386537|FG001|Overall Study|Death|3|||
131208962|NCT00383292|472386538|FG002|Overall Study|Death|3|||
131208963|NCT00383292|472386536|FG000|Overall Study|Physician Decision|4|||
131208964|NCT00383292|472386537|FG001|Overall Study|Physician Decision|0|||
131208965|NCT00383292|472386538|FG002|Overall Study|Physician Decision|1|||
131208966|NCT00383292|472386536|FG000|Overall Study|Withdrawal by Subject|3|||
131208967|NCT00383292|472386537|FG001|Overall Study|Withdrawal by Subject|2|||
131208968|NCT00383292|472386538|FG002|Overall Study|Withdrawal by Subject|2|||
131208969|NCT00383292|472386536|FG000|Overall Study|Other|1|||
131208970|NCT00383292|472386537|FG001|Overall Study|Other|0|||
131208971|NCT00383292|472386538|FG002|Overall Study|Other|0|||
131208972|NCT03457701|472386541|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
131208973|NCT03457701|472386542|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
131208974|NCT03457701|472386541|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
130735499|NCT01232452|470651213|FG000|Overall Study|Adverse Event|17|||
131208975|NCT03457701|472386542|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
131208976|NCT02243306|472386543|FG000|Overall Study|Adverse Event|0|||
131208977|NCT02243306|472386544|FG001|Overall Study|Adverse Event|1|||
131208978|NCT02243306|472386543|FG000|Overall Study|Other: Reached stopping criteria|0|||
131208979|NCT02243306|472386544|FG001|Overall Study|Other: Reached stopping criteria|1|||
131208980|NCT02243306|472386543|FG000|Overall Study|Physician Decision|0|||
131208981|NCT02243306|472386544|FG001|Overall Study|Physician Decision|1|||
131208982|NCT01016912|472386545|FG000|End of Treatment Period|Lack of Efficacy|0|||
131208983|NCT01016912|472386546|FG001|End of Treatment Period|Lack of Efficacy|1|||
131208984|NCT01016912|472386547|FG002|End of Treatment Period|Lack of Efficacy|0|||
130735500|NCT01232452|470651214|FG001|Overall Study|Adverse Event|15|||
130735501|NCT01232452|470651213|FG000|Overall Study|Withdrawal by Subject|11|||
130735502|NCT01232452|470651214|FG001|Overall Study|Withdrawal by Subject|8|||
130735503|NCT01232452|470651213|FG000|Overall Study|Physician Decision|8|||
130735504|NCT01232452|470651214|FG001|Overall Study|Physician Decision|12|||
130735505|NCT01232452|470651213|FG000|Overall Study|Protocol entry criterion not met|0|||
130735506|NCT01232452|470651214|FG001|Overall Study|Protocol entry criterion not met|2|||
130735507|NCT01232452|470651213|FG000|Overall Study|Sponsor Decision|3|||
130735508|NCT01232452|470651214|FG001|Overall Study|Sponsor Decision|1|||
130735509|NCT01232452|470651213|FG000|Overall Study|Protocol Violation|0|||
130735510|NCT01232452|470651214|FG001|Overall Study|Protocol Violation|1|||
130735511|NCT04108299|470651215|FG000|Overall Study|Not interested in participating|2|||
130735512|NCT04108299|470651216|FG001|Overall Study|Not interested in participating|1|||
130784751|NCT00496769|470841158|FG001|Double Blind|>=1 reason assigned per patient|649|||
131208985|NCT01016912|472386548|FG003|End of Treatment Period|Lack of Efficacy|4|||
131208986|NCT01016912|472386549|FG004|End of Treatment Period|Lack of Efficacy|4|||
131208987|NCT01016912|472386545|FG000|End of Treatment Period|Adverse Event|0|||
131208988|NCT01016912|472386546|FG001|End of Treatment Period|Adverse Event|1|||
131208989|NCT01016912|472386547|FG002|End of Treatment Period|Adverse Event|1|||
131208990|NCT01016912|472386548|FG003|End of Treatment Period|Adverse Event|0|||
131208991|NCT01016912|472386549|FG004|End of Treatment Period|Adverse Event|0|||
131208992|NCT01016912|472386545|FG000|End of Treatment Period|Completed double-blind period only|0|||
131208993|NCT01016912|472386546|FG001|End of Treatment Period|Completed double-blind period only|1|||
131208994|NCT01016912|472386547|FG002|End of Treatment Period|Completed double-blind period only|0|||
131208995|NCT01016912|472386548|FG003|End of Treatment Period|Completed double-blind period only|0|||
131208996|NCT01016912|472386549|FG004|End of Treatment Period|Completed double-blind period only|0|||
131208997|NCT01016912|472386545|FG000|Follow-up Period|Other reason|0|||
131208998|NCT01016912|472386546|FG001|Follow-up Period|Other reason|0|||
131208999|NCT01016912|472386547|FG002|Follow-up Period|Other reason|1|||
131209000|NCT01016912|472386548|FG003|Follow-up Period|Other reason|1|||
131209001|NCT01016912|472386549|FG004|Follow-up Period|Other reason|0|||
131209002|NCT02370173|472386556|FG000|Overall Study|Protocol Violation|1|||
131209003|NCT02370173|472386557|FG001|Overall Study|Protocol Violation|1|||
131209004|NCT02370173|472386556|FG000|Overall Study|Withdrawal by Subject|2|||
131209005|NCT02370173|472386557|FG001|Overall Study|Withdrawal by Subject|2|||
131209006|NCT01326481|472386563|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
131209007|NCT00307736|472386564|FG000|Overall Study|Adverse Event|0|||
131209008|NCT00307736|472386565|FG001|Overall Study|Adverse Event|0|||
131209009|NCT00307736|472386566|FG002|Overall Study|Adverse Event|1|||
131209010|NCT00307736|472386567|FG003|Overall Study|Adverse Event|3|||
131209011|NCT00307736|472386564|FG000|Overall Study|Withdrawal by Subject|0|||
131209012|NCT00307736|472386565|FG001|Overall Study|Withdrawal by Subject|0|||
131209013|NCT00307736|472386566|FG002|Overall Study|Withdrawal by Subject|2|||
131209014|NCT00307736|472386567|FG003|Overall Study|Withdrawal by Subject|0|||
131209015|NCT02260791|472386570|FG000|Overall Study|Lost to Follow-up|4|||
131209016|NCT02260791|472386571|FG001|Overall Study|Lost to Follow-up|4|||
131209017|NCT02260791|472386570|FG000|Overall Study|Lack of Efficacy|2|||
131209018|NCT02260791|472386571|FG001|Overall Study|Lack of Efficacy|1|||
131209019|NCT02260791|472386570|FG000|Overall Study|Adverse Event|13|||
131209020|NCT02260791|472386571|FG001|Overall Study|Adverse Event|9|||
131209021|NCT02260791|472386570|FG000|Overall Study|Death|1|||
131209022|NCT02260791|472386571|FG001|Overall Study|Death|0|||
131209023|NCT02260791|472386570|FG000|Overall Study|Withdrawal by Subject|11|||
131209024|NCT02260791|472386571|FG001|Overall Study|Withdrawal by Subject|16|||
131209025|NCT02260791|472386570|FG000|Overall Study|Screen failure|0|||
131209026|NCT02260791|472386571|FG001|Overall Study|Screen failure|1|||
131209027|NCT02260791|472386570|FG000|Overall Study|Protocol deviation|2|||
131209028|NCT02260791|472386571|FG001|Overall Study|Protocol deviation|3|||
131209029|NCT04246996|472386573|FG000|Overall Study|Physician Decision|1|||
131209030|NCT04246996|472386574|FG001|Overall Study|Physician Decision|1|||
131209031|NCT04246996|472386573|FG000|Overall Study|Did not meet eligibility criteria|1|||
131209032|NCT04246996|472386574|FG001|Overall Study|Did not meet eligibility criteria|4|||
131209033|NCT02442284|472386575|FG000|Overall Study|Adverse Event|1|||
131209034|NCT02442284|472386575|FG000|Overall Study|Withdrew Consent|2|||
131209035|NCT02442284|472386575|FG000|Overall Study|Lost to Follow-up|3|||
130735513|NCT04108299|470651217|FG002|Overall Study|Not interested in participating|2|||
130735514|NCT04108299|470651218|FG003|Overall Study|Not interested in participating|1|||
130735515|NCT00247676|470651219|FG000|Overall Study|Death|5|||
131209036|NCT02442284|472386575|FG000|Overall Study|Other|1|||
131209037|NCT01018680|472388269|FG000|Overall Study|Adverse Event|23|||
131209038|NCT01018680|472388270|FG001|Overall Study|Adverse Event|40|||
131209039|NCT01018680|472388269|FG000|Overall Study|Withdrawal by Subject|10|||
131209040|NCT01018680|472388270|FG001|Overall Study|Withdrawal by Subject|10|||
131209041|NCT01018680|472388269|FG000|Overall Study|Protocol Violation|5|||
131209042|NCT01018680|472388270|FG001|Overall Study|Protocol Violation|8|||
131209043|NCT01018680|472388269|FG000|Overall Study|Sponsor Decision|6|||
131209044|NCT01018680|472388270|FG001|Overall Study|Sponsor Decision|7|||
130735516|NCT00247676|470651219|FG000|Overall Study|Adverse Event|11|||
130735517|NCT00247676|470651219|FG000|Overall Study|Lack of Efficacy|15|||
130735518|NCT00247676|470651219|FG000|Overall Study|Other|3|||
130735519|NCT00247676|470651219|FG000|Overall Study|Withdrawal by Subject|2|||
131209045|NCT01018680|472388269|FG000|Overall Study|Lack of Efficacy|8|||
131209046|NCT01018680|472388270|FG001|Overall Study|Lack of Efficacy|2|||
131209047|NCT01018680|472388269|FG000|Overall Study|Lost to Follow-up|5|||
131209048|NCT01018680|472388270|FG001|Overall Study|Lost to Follow-up|3|||
131209049|NCT01018680|472388269|FG000|Overall Study|Entry Criteria Not Met|1|||
131209050|NCT01018680|472388270|FG001|Overall Study|Entry Criteria Not Met|4|||
131209051|NCT01018680|472388269|FG000|Overall Study|Physician Decision|3|||
131209052|NCT01018680|472388270|FG001|Overall Study|Physician Decision|1|||
131209053|NCT02930889|472388271|FG000|Overall Study|Lost to Follow-up|2|||
131209054|NCT02930889|472388271|FG000|Overall Study|Withdrawal by Subject|6|||
131209055|NCT02930889|472388271|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
131209056|NCT00761761|472388272|FG000|Overall Study|Lost to Follow-up|3|||
131209057|NCT00761761|472388273|FG001|Overall Study|Lost to Follow-up|1|||
131209058|NCT00761761|472388272|FG000|Overall Study|Withdrawal by Subject|3|||
131209059|NCT00761761|472388273|FG001|Overall Study|Withdrawal by Subject|0|||
131209060|NCT03472586|472388279|FG000|Overall Study|Physician Decision|6|||
131209061|NCT03472586|472388279|FG000|Overall Study|Death|6|||
131209062|NCT03472586|472388279|FG000|Overall Study|Adverse Event|1|||
131209063|NCT02528331|472388281|FG000|Overall Study|Withdrawal by Subject|2|||
131209064|NCT01224171|472388282|FG000|Overall Study|Adverse Event|8|||
131209065|NCT01224171|472388283|FG001|Overall Study|Adverse Event|4|||
131209066|NCT01224171|472388282|FG000|Overall Study|Protocol Violation|0|||
131209067|NCT01224171|472388283|FG001|Overall Study|Protocol Violation|1|||
131209068|NCT01224171|472388282|FG000|Overall Study|Lack of Efficacy|5|||
131209069|NCT01224171|472388283|FG001|Overall Study|Lack of Efficacy|1|||
131209070|NCT01224171|472388282|FG000|Overall Study|Withdrawal of Consent|2|||
131209071|NCT01224171|472388283|FG001|Overall Study|Withdrawal of Consent|4|||
131209072|NCT01224171|472388282|FG000|Overall Study|Lost to Follow-up|0|||
131209073|NCT01224171|472388283|FG001|Overall Study|Lost to Follow-up|3|||
131209074|NCT03737812|472388284|FG000|Overall Study|Withdrawal by Subject|1|||
131209075|NCT03737812|472388285|FG001|Overall Study|Withdrawal by Subject|2|||
131209076|NCT03737812|472388286|FG002|Overall Study|Withdrawal by Subject|1|||
131209077|NCT03737812|472388284|FG000|Overall Study|Sponsor Discontinued the Study|4|||
131209078|NCT03737812|472388285|FG001|Overall Study|Sponsor Discontinued the Study|3|||
131209079|NCT03737812|472388286|FG002|Overall Study|Sponsor Discontinued the Study|2|||
131209080|NCT03737812|472388284|FG000|Overall Study|Adverse Event|0|||
131209081|NCT03737812|472388285|FG001|Overall Study|Adverse Event|1|||
131209082|NCT03737812|472388286|FG002|Overall Study|Adverse Event|0|||
131209083|NCT03737812|472388284|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
131209084|NCT03737812|472388285|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
131209085|NCT03737812|472388286|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
131209086|NCT02624713|472388287|FG000|Overall Study|Lost to Follow-up|14|||
131209087|NCT02624713|472388288|FG001|Overall Study|Lost to Follow-up|0|||
131209088|NCT00285857|472388292|FG000|Overall Study|Withdrawal by Subject|2|||
131209089|NCT00285857|472388292|FG000|Overall Study|Inadequate initial breast cytology|1|||
131209090|NCT00285857|472388292|FG000|Overall Study|Adverse Event|1|||
131209091|NCT01161173|472388298|FG000|Overall Study|Protocol Violation|13|||
131209092|NCT01161173|472388298|FG000|Overall Study|Lost to Follow-up|7|||
131209093|NCT01161173|472388298|FG000|Overall Study|Progressive Disease|82|||
131209094|NCT01161173|472388298|FG000|Overall Study|Withdrawal of Consent|5|||
131209095|NCT01161173|472388298|FG000|Overall Study|Unacceptable Toxicity|21|||
131209096|NCT01161173|472388298|FG000|Overall Study|Death|194|||
131209097|NCT01161173|472388298|FG000|Overall Study|End of Study|2|||
131209098|NCT01161173|472388298|FG000|Overall Study|Reasons Not Specified|23|||
131209099|NCT00792467|472388301|FG000|Overall Study|progression of disease|17|||
131209100|NCT00792467|472388301|FG000|Overall Study|Adverse Event|1|||
131209101|NCT00792467|472388301|FG000|Overall Study|patient request|1|||
131209102|NCT00792467|472388301|FG000|Overall Study|Lost to Follow-up|1|||
131209103|NCT00792467|472388301|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
131209104|NCT00792467|472388301|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
130735520|NCT00662649|470651220|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
130735521|NCT00662649|470651221|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
130735522|NCT00662649|470651222|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
131209105|NCT03911401|472388302|FG000|Overall Study|Adverse Event|1|||
131209106|NCT03911401|472388303|FG001|Overall Study|Adverse Event|2|||
131209107|NCT03911401|472388304|FG002|Overall Study|Adverse Event|5|||
131209108|NCT03911401|472388302|FG000|Overall Study|Lack of Efficacy|1|||
131209109|NCT03911401|472388303|FG001|Overall Study|Lack of Efficacy|1|||
131209110|NCT03911401|472388304|FG002|Overall Study|Lack of Efficacy|8|||
131209111|NCT03911401|472388302|FG000|Overall Study|Physician Decision|0|||
131209112|NCT03911401|472388303|FG001|Overall Study|Physician Decision|0|||
131209113|NCT03911401|472388304|FG002|Overall Study|Physician Decision|1|||
131209114|NCT03911401|472388302|FG000|Overall Study|Withdrawal by Subject|1|||
130735523|NCT00662649|470651223|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
130735524|NCT00662649|470651224|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
130735525|NCT00662649|470651220|FG000|Core Study (24 Months)|Adverse Event|22|||
130735526|NCT00662649|470651221|FG001|Core Study (24 Months)|Adverse Event|13|||
130735527|NCT00662649|470651222|FG002|Core Study (24 Months)|Adverse Event|18|||
130735528|NCT00662649|470651223|FG003|Core Study (24 Months)|Adverse Event|0|||
130735529|NCT00662649|470651224|FG004|Core Study (24 Months)|Adverse Event|0|||
130735530|NCT00662649|470651220|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
130735531|NCT00662649|470651221|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
130735532|NCT00662649|470651222|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
130735533|NCT00662649|470651223|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
130735534|NCT00662649|470651224|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
130735535|NCT00662649|470651220|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
130735536|NCT00662649|470651221|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
130735537|NCT00662649|470651222|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
130735538|NCT00662649|470651223|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
130735539|NCT00662649|470651224|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
130735540|NCT00662649|470651220|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
130735541|NCT00662649|470651221|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
130735542|NCT00662649|470651222|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
130735543|NCT00662649|470651223|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
130735544|NCT00662649|470651224|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
130735545|NCT00662649|470651220|FG000|Core Study (24 Months)|Protocol Violation|5|||
130735546|NCT00662649|470651221|FG001|Core Study (24 Months)|Protocol Violation|5|||
130735547|NCT00662649|470651222|FG002|Core Study (24 Months)|Protocol Violation|4|||
130735548|NCT00662649|470651223|FG003|Core Study (24 Months)|Protocol Violation|0|||
130735549|NCT00662649|470651224|FG004|Core Study (24 Months)|Protocol Violation|0|||
130735550|NCT00662649|470651220|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
130735551|NCT00662649|470651221|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
130735552|NCT00662649|470651222|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
130735553|NCT00662649|470651223|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
130735554|NCT00662649|470651224|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
130735555|NCT00662649|470651220|FG000|Core Study (24 Months)|Death|1|||
130735556|NCT00662649|470651221|FG001|Core Study (24 Months)|Death|0|||
131209115|NCT03911401|472388303|FG001|Overall Study|Withdrawal by Subject|2|||
131209116|NCT03911401|472388304|FG002|Overall Study|Withdrawal by Subject|0|||
131209117|NCT03911401|472388302|FG000|Overall Study|Withdrawal by parent/guardian|4|||
131209118|NCT03911401|472388303|FG001|Overall Study|Withdrawal by parent/guardian|4|||
131209119|NCT03911401|472388304|FG002|Overall Study|Withdrawal by parent/guardian|11|||
131209120|NCT02918968|472388305|FG000|1st Line AAT|Progressive disease|9|||
131209121|NCT02918968|472388306|FG001|1st Line AAT|Progressive disease|4|||
131209122|NCT02918968|472388305|FG000|1st Line AAT|Adverse Event|12|||
131209123|NCT02918968|472388306|FG001|1st Line AAT|Adverse Event|3|||
131209124|NCT02918968|472388305|FG000|1st Line AAT|Physician Decision|4|||
131209125|NCT02918968|472388306|FG001|1st Line AAT|Physician Decision|2|||
131209126|NCT02918968|472388305|FG000|1st Line AAT|Withdrawal by Subject|2|||
131209127|NCT02918968|472388306|FG001|1st Line AAT|Withdrawal by Subject|1|||
131209128|NCT02918968|472388305|FG000|1st Line AAT|Lost to Follow-up|0|||
131209129|NCT02918968|472388306|FG001|1st Line AAT|Lost to Follow-up|1|||
131209130|NCT02918968|472388305|FG000|1st Line AAT|Death|1|||
131209131|NCT02918968|472388306|FG001|1st Line AAT|Death|0|||
131209132|NCT02918968|472388305|FG000|1st Line AAT|Miscellaneous|1|||
131209133|NCT02918968|472388306|FG001|1st Line AAT|Miscellaneous|0|||
131209134|NCT02918968|472388305|FG000|2nd Line AAT|Progressive disease|21|||
131209135|NCT02918968|472388306|FG001|2nd Line AAT|Progressive disease|3|||
131209136|NCT02918968|472388305|FG000|2nd Line AAT|Adverse Event|2|||
131209137|NCT02918968|472388306|FG001|2nd Line AAT|Adverse Event|5|||
131209138|NCT02918968|472388305|FG000|2nd Line AAT|Physician Decision|0|||
131209139|NCT02918968|472388306|FG001|2nd Line AAT|Physician Decision|1|||
131209140|NCT02918968|472388305|FG000|2nd Line AAT|Withdrawal by Subject|2|||
131209141|NCT02918968|472388306|FG001|2nd Line AAT|Withdrawal by Subject|2|||
131209142|NCT02918968|472388305|FG000|2nd Line AAT|Death|0|||
131209143|NCT02918968|472388306|FG001|2nd Line AAT|Death|1|||
131209144|NCT03781167|472388316|FG000|Overall Study|Adverse Event|23|||
130735557|NCT00662649|470651222|FG002|Core Study (24 Months)|Death|2|||
130735558|NCT00662649|470651223|FG003|Core Study (24 Months)|Death|0|||
130735559|NCT00662649|470651224|FG004|Core Study (24 Months)|Death|0|||
130735560|NCT00662649|470651220|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
130735561|NCT00662649|470651221|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
131209145|NCT03781167|472388317|FG001|Overall Study|Adverse Event|25|||
131209146|NCT03781167|472388316|FG000|Overall Study|Withdrew consent|16|||
131209147|NCT03781167|472388317|FG001|Overall Study|Withdrew consent|12|||
131209148|NCT03781167|472388316|FG000|Overall Study|Lost to Follow-up|0|||
131209149|NCT03781167|472388317|FG001|Overall Study|Lost to Follow-up|1|||
131209150|NCT03781167|472388316|FG000|Overall Study|Lack of Efficacy|4|||
131209151|NCT03781167|472388317|FG001|Overall Study|Lack of Efficacy|5|||
131209152|NCT03781167|472388316|FG000|Overall Study|Difficulty with drug delivery system|2|||
131209153|NCT03781167|472388317|FG001|Overall Study|Difficulty with drug delivery system|3|||
131209154|NCT03781167|472388316|FG000|Overall Study|Other, not specified|2|||
131209155|NCT03781167|472388317|FG001|Overall Study|Other, not specified|2|||
131209156|NCT01590628|472388319|FG000|Overall Study|Death|2|||
131209157|NCT01590628|472388320|FG001|Overall Study|Death|0|||
131209158|NCT00475657|472388321|FG000|Overall Study|Death|1|||
131209159|NCT00475657|472388321|FG000|Overall Study|Sponsor's Decision|3|||
131209160|NCT00381680|472388324|FG000|Overall Study|Adverse Event|9|||
131209161|NCT00381680|472388325|FG001|Overall Study|Adverse Event|3|||
131209162|NCT00381680|472388324|FG000|Overall Study|Death|10|||
131209163|NCT00381680|472388325|FG001|Overall Study|Death|7|||
131209164|NCT00381680|472388324|FG000|Overall Study|Lost to Follow-up|3|||
131209165|NCT00381680|472388325|FG001|Overall Study|Lost to Follow-up|2|||
131209166|NCT00381680|472388324|FG000|Overall Study|Physician Decision|25|||
131209167|NCT00381680|472388325|FG001|Overall Study|Physician Decision|6|||
131209168|NCT00381680|472388324|FG000|Overall Study|Withdrawal by Subject|3|||
131209169|NCT00381680|472388325|FG001|Overall Study|Withdrawal by Subject|1|||
131209170|NCT00381680|472388324|FG000|Overall Study|Entry onto another COG Trial|1|||
131209171|NCT00381680|472388325|FG001|Overall Study|Entry onto another COG Trial|2|||
131209172|NCT00381680|472388324|FG000|Overall Study|Alternative Therapy|11|||
131209173|NCT00381680|472388325|FG001|Overall Study|Alternative Therapy|5|||
131209174|NCT00381680|472388324|FG000|Overall Study|Secondary Malignancy|3|||
131209175|NCT00381680|472388325|FG001|Overall Study|Secondary Malignancy|0|||
131209176|NCT00381680|472388324|FG000|Overall Study|Delay initiation|1|||
131209177|NCT00381680|472388325|FG001|Overall Study|Delay initiation|0|||
131209178|NCT00381680|472388324|FG000|Overall Study|Stem Cell Transplant|26|||
131209179|NCT00381680|472388325|FG001|Overall Study|Stem Cell Transplant|10|||
131209180|NCT00381680|472388324|FG000|Overall Study|Relapse|18|||
131209181|NCT00381680|472388325|FG001|Overall Study|Relapse|9|||
131209182|NCT00381680|472388324|FG000|Overall Study|Induction Failure|4|||
131209183|NCT00381680|472388325|FG001|Overall Study|Induction Failure|1|||
131209184|NCT00381680|472388324|FG000|Overall Study|Progression|1|||
131209185|NCT00381680|472388325|FG001|Overall Study|Progression|1|||
131209186|NCT00381680|472388324|FG000|Overall Study|Other not otherwise specified|7|||
131209187|NCT00381680|472388325|FG001|Overall Study|Other not otherwise specified|2|||
131209188|NCT00381680|472388324|FG000|Overall Study|Ineligible|3|||
131209189|NCT00381680|472388325|FG001|Overall Study|Ineligible|1|||
131209190|NCT00933543|472388330|FG000|Overall Study|Adverse Event|2|||
131209191|NCT00933543|472388331|FG001|Overall Study|Adverse Event|1|||
131209192|NCT00933543|472388330|FG000|Overall Study|Lost to Follow-up|0|||
131209193|NCT00933543|472388331|FG001|Overall Study|Lost to Follow-up|1|||
131209194|NCT00933543|472388330|FG000|Overall Study|Withdrawal by Subject|0|||
131209195|NCT00933543|472388331|FG001|Overall Study|Withdrawal by Subject|1|||
131209196|NCT00933543|472388330|FG000|Overall Study|Lack of Efficacy|0|||
131209197|NCT00933543|472388331|FG001|Overall Study|Lack of Efficacy|3|||
131209198|NCT00933543|472388330|FG000|Overall Study|Other|1|||
131209199|NCT00933543|472388331|FG001|Overall Study|Other|1|||
131209200|NCT04988035|472388332|FG000|Overall Study|Death|19|||
131209201|NCT04988035|472388333|FG001|Overall Study|Death|13|||
131209202|NCT04988035|472388332|FG000|Overall Study|Lost to Follow-up|12|||
131209203|NCT04988035|472388333|FG001|Overall Study|Lost to Follow-up|6|||
131209204|NCT04988035|472388332|FG000|Overall Study|Protocol Violation|0|||
131209205|NCT04988035|472388333|FG001|Overall Study|Protocol Violation|1|||
131209206|NCT04988035|472388332|FG000|Overall Study|Withdrawal by Subject|2|||
131209207|NCT04988035|472388333|FG001|Overall Study|Withdrawal by Subject|4|||
131209208|NCT04988035|472388332|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
131209209|NCT04988035|472388333|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
131209210|NCT03831282|472388334|FG000|Overall Study|Could not place sensor|1|||
131209211|NCT00334893|472388335|FG000|Overall Study|Not Treated|1|||
131209212|NCT00334893|472388336|FG001|Overall Study|Not Treated|0|||
131209213|NCT01258803|472388337|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
131209214|NCT01258803|472388338|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
131209215|NCT01258803|472388339|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
131209216|NCT01258803|472388340|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
131209217|NCT01258803|472388341|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
131209218|NCT01258803|472388342|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
131209219|NCT01258803|472388337|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
131209220|NCT01258803|472388338|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
131209221|NCT01258803|472388339|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
131209222|NCT01258803|472388340|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
131209223|NCT01258803|472388341|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
131209224|NCT01258803|472388342|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
131209225|NCT01258803|472388337|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
131209226|NCT01258803|472388338|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
131209227|NCT01258803|472388339|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
131209228|NCT01258803|472388340|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
131209229|NCT01258803|472388341|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
131209230|NCT01258803|472388342|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
131209231|NCT04652245|472388349|FG000|Wash-Out Period|Adverse Event|0|||
131209232|NCT04652245|472388350|FG001|Wash-Out Period|Adverse Event|2|||
131209233|NCT04652245|472388349|FG000|Wash-Out Period|Withdrawal by Subject|0|||
131209234|NCT04652245|472388350|FG001|Wash-Out Period|Withdrawal by Subject|2|||
131209235|NCT03556202|472388353|FG000|Extension Treatment Period|Adverse Event|18|||
131209236|NCT03556202|472388354|FG001|Extension Treatment Period|Adverse Event|14|||
131209237|NCT03556202|472388355|FG002|Extension Treatment Period|Adverse Event|9|||
131209238|NCT03556202|472388353|FG000|Extension Treatment Period|Death|2|||
131209239|NCT03556202|472388354|FG001|Extension Treatment Period|Death|6|||
131209240|NCT03556202|472388355|FG002|Extension Treatment Period|Death|0|||
131209241|NCT03556202|472388353|FG000|Extension Treatment Period|Lack of Efficacy|5|||
131209242|NCT03556202|472388354|FG001|Extension Treatment Period|Lack of Efficacy|12|||
131209243|NCT03556202|472388355|FG002|Extension Treatment Period|Lack of Efficacy|18|||
131209244|NCT03556202|472388353|FG000|Extension Treatment Period|Lost to Follow-up|9|||
131209245|NCT03556202|472388354|FG001|Extension Treatment Period|Lost to Follow-up|20|||
131209246|NCT03556202|472388355|FG002|Extension Treatment Period|Lost to Follow-up|2|||
131209247|NCT03556202|472388353|FG000|Extension Treatment Period|Pregnancy|2|||
131209248|NCT03556202|472388354|FG001|Extension Treatment Period|Pregnancy|4|||
131209249|NCT03556202|472388355|FG002|Extension Treatment Period|Pregnancy|3|||
131209250|NCT03556202|472388353|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
131209251|NCT03556202|472388354|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
131209252|NCT03556202|472388355|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
131209253|NCT03556202|472388353|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
131209254|NCT03556202|472388354|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
131209255|NCT03556202|472388355|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
131209256|NCT03556202|472388353|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
131209257|NCT03556202|472388354|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
131209258|NCT03556202|472388355|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
131209259|NCT03556202|472388353|FG000|Extension Treatment Period|Physician Decision|0|||
131209260|NCT03556202|472388354|FG001|Extension Treatment Period|Physician Decision|8|||
131209261|NCT03556202|472388355|FG002|Extension Treatment Period|Physician Decision|2|||
131209262|NCT03556202|472388353|FG000|Extension Treatment Period|Protocol Violation|0|||
131209263|NCT03556202|472388354|FG001|Extension Treatment Period|Protocol Violation|1|||
131209264|NCT03556202|472388355|FG002|Extension Treatment Period|Protocol Violation|1|||
131209265|NCT03556202|472388353|FG000|Extension Treatment Period|Sponsor Decision|0|||
131209266|NCT03556202|472388354|FG001|Extension Treatment Period|Sponsor Decision|1|||
131209267|NCT03556202|472388355|FG002|Extension Treatment Period|Sponsor Decision|0|||
131209268|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
131209269|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
131209270|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
131209271|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Death|1|||
131209272|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Death|0|||
131209273|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Death|0|||
131209274|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
131209275|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
131209276|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
131209277|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
131209278|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
131209279|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
131209280|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
131209281|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
131209282|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
131209283|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
131209284|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
131209285|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
131209286|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
131209287|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
131209288|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
131209289|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
131209290|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
131209291|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
131209292|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
131209293|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
131209294|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
131209295|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
131209296|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
131209297|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
131209298|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
131209299|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
131209300|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
131209301|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
131209302|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
131209303|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
131209304|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
131209305|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
131209306|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
131209307|NCT03556202|472388353|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
131209308|NCT03556202|472388354|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
131209309|NCT03556202|472388355|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
131209310|NCT04419558|472388356|FG000|DB Period (48 Weeks)|Adverse Event|6|||
131209311|NCT04419558|472388357|FG001|DB Period (48 Weeks)|Adverse Event|6|||
131209312|NCT04419558|472388356|FG000|DB Period (48 Weeks)|Death|14|||
131209313|NCT04419558|472388357|FG001|DB Period (48 Weeks)|Death|11|||
131209314|NCT04419558|472388356|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
131209315|NCT04419558|472388357|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
131209316|NCT04419558|472388356|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
131209317|NCT04419558|472388357|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
131209318|NCT04419558|472388356|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
131209319|NCT04419558|472388357|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
131209320|NCT04419558|472388356|FG000|DB Period (48 Weeks)|Disease Progression|1|||
131209321|NCT04419558|472388357|FG001|DB Period (48 Weeks)|Disease Progression|0|||
131209322|NCT04419558|472388356|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
131209323|NCT04419558|472388357|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
131209324|NCT04419558|472388356|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
131209325|NCT04419558|472388357|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
131209326|NCT04419558|472388356|FG000|DB Period (48 Weeks)|Participant Decision|4|||
131209327|NCT04419558|472388357|FG001|DB Period (48 Weeks)|Participant Decision|3|||
131209328|NCT04419558|472388356|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
131209329|NCT04419558|472388357|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
131209330|NCT04419558|472388356|FG000|OLE Period (48 Weeks)|Death|4|||
131209331|NCT04419558|472388357|FG001|OLE Period (48 Weeks)|Death|6|||
131209332|NCT04419558|472388356|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
131209333|NCT04419558|472388357|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
131209334|NCT04419558|472388356|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
131209335|NCT04419558|472388357|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
131209336|NCT00903357|472388358|FG000|First Intervention|Withdrawal by Subject|5|||
131209337|NCT00903357|472388359|FG001|First Intervention|Withdrawal by Subject|3|||
131209338|NCT00903357|472388358|FG000|First Intervention|Flu|0|||
131209339|NCT00903357|472388359|FG001|First Intervention|Flu|1|||
131209340|NCT00903357|472388358|FG000|Wash Out Period of 2 Weeks|Flu|0|||
131209341|NCT00903357|472388359|FG001|Wash Out Period of 2 Weeks|Flu|1|||
131209342|NCT00903357|472388358|FG000|Second Intervention|Lost to Follow-up|1|||
131209343|NCT00903357|472388359|FG001|Second Intervention|Lost to Follow-up|0|||
131209344|NCT05146999|472388360|FG000|Overall Study|Withdrew consent|6|||
131209345|NCT05146999|472388361|FG001|Overall Study|Withdrew consent|1|||
131209346|NCT05146999|472388360|FG000|Overall Study|Lost to Follow-up|3|||
131209347|NCT05146999|472388361|FG001|Overall Study|Lost to Follow-up|2|||
131209348|NCT05146999|472388360|FG000|Overall Study|Other|1|||
131209349|NCT05146999|472388361|FG001|Overall Study|Other|3|||
131209350|NCT02221882|472388362|FG000|Overall Study|Withdrawal by Subject|0|||
131209351|NCT02221882|472388363|FG001|Overall Study|Withdrawal by Subject|0|||
131209352|NCT02221882|472388364|FG002|Overall Study|Withdrawal by Subject|4|||
131209353|NCT02221882|472388365|FG003|Overall Study|Withdrawal by Subject|2|||
131209354|NCT02221882|472388366|FG004|Overall Study|Withdrawal by Subject|2|||
131209355|NCT02221882|472388367|FG005|Overall Study|Withdrawal by Subject|2|||
131209356|NCT02221882|472388362|FG000|Overall Study|Death|0|||
131209357|NCT02221882|472388363|FG001|Overall Study|Death|1|||
131209358|NCT02221882|472388364|FG002|Overall Study|Death|0|||
131209359|NCT02221882|472388365|FG003|Overall Study|Death|0|||
131209360|NCT02221882|472388366|FG004|Overall Study|Death|0|||
131209361|NCT02221882|472388367|FG005|Overall Study|Death|0|||
131209362|NCT05664672|472388368|FG000|Overall Study|Adverse Event|0|||
131209363|NCT05664672|472388369|FG001|Overall Study|Adverse Event|0|||
131209364|NCT05664672|472388370|FG002|Overall Study|Adverse Event|0|||
131209365|NCT05664672|472388371|FG003|Overall Study|Adverse Event|0|||
131209366|NCT05664672|472388372|FG004|Overall Study|Adverse Event|0|||
131209367|NCT05664672|472388373|FG005|Overall Study|Adverse Event|1|||
131209368|NCT05664672|472388368|FG000|Overall Study|Withdrawal by Subject|0|||
131209369|NCT05664672|472388369|FG001|Overall Study|Withdrawal by Subject|1|||
131209370|NCT05664672|472388370|FG002|Overall Study|Withdrawal by Subject|3|||
131209371|NCT05664672|472388371|FG003|Overall Study|Withdrawal by Subject|0|||
131209372|NCT05664672|472388372|FG004|Overall Study|Withdrawal by Subject|5|||
131209373|NCT05664672|472388373|FG005|Overall Study|Withdrawal by Subject|6|||
131209374|NCT05664672|472388368|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
131209375|NCT05664672|472388369|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
131209376|NCT05664672|472388370|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
131209377|NCT05664672|472388371|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
131209378|NCT05664672|472388372|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
131209379|NCT05664672|472388373|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
131209380|NCT05664672|472388368|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
131209381|NCT05664672|472388369|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
131209382|NCT05664672|472388370|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
131209383|NCT05664672|472388371|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
131209384|NCT05664672|472388372|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
131209385|NCT05664672|472388373|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
131209386|NCT04236986|472388378|FG000|Overall Study|Withdrawal by Subject|3|||
131209387|NCT04236986|472388379|FG001|Overall Study|Withdrawal by Subject|1|||
131209388|NCT04034225|472388380|FG000|Overall Study|Death|3|||
131209389|NCT04034225|472388380|FG000|Overall Study|Withdrawal by Subject|2|||
131209390|NCT04034225|472388380|FG000|Overall Study|Study termination by Sponsor|18|||
131209391|NCT04034225|472388380|FG000|Overall Study|Physician Decision|1|||
131209392|NCT04034225|472388380|FG000|Overall Study|Lack of Efficacy|1|||
131209393|NCT02129192|472388381|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
131209394|NCT02129192|472388382|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
131209395|NCT01231620|472388383|FG000|Overall Study|Physician Decision|3|||
130735562|NCT00662649|470651222|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
130735563|NCT00662649|470651223|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
130735564|NCT00662649|470651224|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
130735565|NCT00662649|470651220|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
131209396|NCT01231620|472388384|FG001|Overall Study|Physician Decision|5|||
131209397|NCT01231620|472388385|FG002|Overall Study|Physician Decision|10|||
131209398|NCT01231620|472388383|FG000|Overall Study|Death|12|||
131209399|NCT01231620|472388384|FG001|Overall Study|Death|14|||
131209400|NCT01231620|472388385|FG002|Overall Study|Death|11|||
131209401|NCT01231620|472388383|FG000|Overall Study|Adverse Event|2|||
131209402|NCT01231620|472388384|FG001|Overall Study|Adverse Event|2|||
131209403|NCT01231620|472388385|FG002|Overall Study|Adverse Event|1|||
131209404|NCT01231620|472388383|FG000|Overall Study|Withdrawal by Subject|6|||
131209405|NCT01231620|472388384|FG001|Overall Study|Withdrawal by Subject|6|||
131209406|NCT01231620|472388385|FG002|Overall Study|Withdrawal by Subject|8|||
131209407|NCT01231620|472388383|FG000|Overall Study|Lost to Follow-up|3|||
131209408|NCT01231620|472388384|FG001|Overall Study|Lost to Follow-up|4|||
131209409|NCT01231620|472388385|FG002|Overall Study|Lost to Follow-up|9|||
131209410|NCT02400281|472388387|FG000|Overall Study|Adverse Event|0|||
131209411|NCT02400281|472388388|FG001|Overall Study|Adverse Event|0|||
131209412|NCT02400281|472388389|FG002|Overall Study|Adverse Event|1|||
131209413|NCT02400281|472388390|FG003|Overall Study|Adverse Event|0|||
131209414|NCT02400281|472388391|FG004|Overall Study|Adverse Event|1|||
131209415|NCT02400281|472388392|FG005|Overall Study|Adverse Event|0|||
131209416|NCT02400281|472388387|FG000|Overall Study|Physician Decision|0|||
131209417|NCT02400281|472388388|FG001|Overall Study|Physician Decision|0|||
131209418|NCT02400281|472388389|FG002|Overall Study|Physician Decision|1|||
131209419|NCT02400281|472388390|FG003|Overall Study|Physician Decision|0|||
131209420|NCT02400281|472388391|FG004|Overall Study|Physician Decision|0|||
131209421|NCT02400281|472388392|FG005|Overall Study|Physician Decision|0|||
131209422|NCT01078974|472388395|FG000|Overall Study|Adverse Event|3|||
131209423|NCT03575975|472388396|FG000|Overall Study|Lost to Follow-up|1|||
131209424|NCT03575975|472388397|FG001|Overall Study|Lost to Follow-up|0|||
131209425|NCT03575975|472388398|FG002|Overall Study|Lost to Follow-up|0|||
131209426|NCT00495794|472388399|FG000|Overall Study|Pharmacist did not activate patient|522|||
131209427|NCT00495794|472388400|FG001|Overall Study|Pharmacist did not activate patient|0|||
131209428|NCT02441517|472388401|FG000|Overall Study|Lost to Follow-up|1|||
131209429|NCT02441517|472388401|FG000|Overall Study|Withdrawal by Subject|2|||
131209430|NCT02441517|472388401|FG000|Overall Study|Study Terminated by Sponsor|1|||
131209431|NCT01393444|472388402|FG000|Overall Study|Withdrawal by Subject|1|||
131209432|NCT01393444|472388402|FG000|Overall Study|Determined ineligible during screening.|2|||
131209433|NCT03039699|472388404|FG000|Overall Study|Incorrect inclusion|5|||
131209434|NCT03039699|472388405|FG001|Overall Study|Incorrect inclusion|4|||
131209435|NCT03039699|472388404|FG000|Overall Study|Lack of data to assess study endpoint|5|||
131209436|NCT03039699|472388405|FG001|Overall Study|Lack of data to assess study endpoint|3|||
131209437|NCT03039699|472388404|FG000|Overall Study|Bacterial infection|12|||
131209438|NCT03039699|472388405|FG001|Overall Study|Bacterial infection|28|||
131209439|NCT00129220|472388406|FG000|Study Period II|Adverse Event|9|||
131209440|NCT00129220|472388407|FG001|Study Period II|Adverse Event|5|||
131209441|NCT00129220|472388408|FG002|Study Period II|Adverse Event|7|||
131209442|NCT00129220|472388406|FG000|Study Period II|Lack of Efficacy|15|||
131209443|NCT00129220|472388407|FG001|Study Period II|Lack of Efficacy|1|||
131209444|NCT00129220|472388408|FG002|Study Period II|Lack of Efficacy|28|||
131209445|NCT00129220|472388406|FG000|Study Period II|Entry Criteria Not Met|2|||
131209446|NCT00129220|472388407|FG001|Study Period II|Entry Criteria Not Met|0|||
131209447|NCT00129220|472388408|FG002|Study Period II|Entry Criteria Not Met|2|||
131209448|NCT00129220|472388406|FG000|Study Period II|Protocol Violation|4|||
131209449|NCT00129220|472388407|FG001|Study Period II|Protocol Violation|2|||
131209450|NCT00129220|472388408|FG002|Study Period II|Protocol Violation|1|||
131209451|NCT00129220|472388406|FG000|Study Period II|Physician Decision|0|||
131209452|NCT00129220|472388407|FG001|Study Period II|Physician Decision|1|||
131209453|NCT00129220|472388408|FG002|Study Period II|Physician Decision|0|||
131209454|NCT00129220|472388406|FG000|Study Period II|Withdrawal by Subject|1|||
131209455|NCT00129220|472388407|FG001|Study Period II|Withdrawal by Subject|3|||
131209456|NCT00129220|472388408|FG002|Study Period II|Withdrawal by Subject|4|||
131209457|NCT00129220|472388406|FG000|Study Period II|Reason Not Specified|2|||
131209458|NCT00129220|472388407|FG001|Study Period II|Reason Not Specified|0|||
131209459|NCT00129220|472388408|FG002|Study Period II|Reason Not Specified|5|||
131209460|NCT00129220|472388406|FG000|Study Period III|Adverse Event|1|||
131209461|NCT00129220|472388407|FG001|Study Period III|Adverse Event|0|||
131209462|NCT00129220|472388408|FG002|Study Period III|Adverse Event|3|||
131209463|NCT00129220|472388406|FG000|Study Period III|Protocol Violation|1|||
131209464|NCT00129220|472388407|FG001|Study Period III|Protocol Violation|1|||
131209465|NCT00129220|472388408|FG002|Study Period III|Protocol Violation|2|||
131209466|NCT00129220|472388406|FG000|Study Period III|Withdrawal by Subject|1|||
131209467|NCT00129220|472388407|FG001|Study Period III|Withdrawal by Subject|0|||
131209468|NCT00129220|472388408|FG002|Study Period III|Withdrawal by Subject|3|||
131209469|NCT00129220|472388406|FG000|Study Period III|Sponsor Decision|1|||
131209470|NCT00129220|472388407|FG001|Study Period III|Sponsor Decision|0|||
131209471|NCT00129220|472388408|FG002|Study Period III|Sponsor Decision|0|||
131209472|NCT00129220|472388406|FG000|Study Period III|Reason Not Specified|9|||
131209473|NCT00129220|472388407|FG001|Study Period III|Reason Not Specified|0|||
131209474|NCT00129220|472388408|FG002|Study Period III|Reason Not Specified|2|||
131209475|NCT01883362|472388409|FG000|Treatment|Adverse Event|1|||
131209476|NCT01883362|472388410|FG001|Treatment|Adverse Event|8|||
131209477|NCT01883362|472388409|FG000|Treatment|Withdrawal by Subject|6|||
131209478|NCT01883362|472388410|FG001|Treatment|Withdrawal by Subject|2|||
131209479|NCT01883362|472388409|FG000|Treatment|Administrative problems|4|||
131209480|NCT01883362|472388410|FG001|Treatment|Administrative problems|1|||
131209481|NCT01883362|472388409|FG000|Treatment|Relapse|4|||
131209482|NCT01883362|472388410|FG001|Treatment|Relapse|2|||
131209483|NCT01883362|472388409|FG000|Treatment|Randomized, not treated|1|||
131209484|NCT01883362|472388410|FG001|Treatment|Randomized, not treated|1|||
131209485|NCT01883362|472388409|FG000|Post Treatment Follow-up|Protocol Violation|0|||
131209486|NCT01883362|472388410|FG001|Post Treatment Follow-up|Protocol Violation|1|||
131209487|NCT01883362|472388409|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
131209488|NCT01883362|472388410|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
131209489|NCT01883362|472388409|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
131209490|NCT01883362|472388410|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
131209491|NCT01883362|472388409|FG000|Post Treatment Follow-up|Administrative problems|2|||
131209492|NCT01883362|472388410|FG001|Post Treatment Follow-up|Administrative problems|0|||
131209493|NCT01883362|472388409|FG000|Post Treatment Follow-up|Death|8|||
131209494|NCT01883362|472388410|FG001|Post Treatment Follow-up|Death|4|||
131209495|NCT01883362|472388409|FG000|Post Treatment Follow-up|Relapse|1|||
131209496|NCT01883362|472388410|FG001|Post Treatment Follow-up|Relapse|2|||
131209497|NCT02911285|472388414|FG000|Overall Study|Lost to Follow-up|8|||
131209498|NCT02911285|472388415|FG001|Overall Study|Lost to Follow-up|5|||
131209499|NCT02911285|472388414|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
131209500|NCT02911285|472388415|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
131209501|NCT03053102|472389821|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
131209502|NCT03053102|472389821|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
131209503|NCT01238861|472389822|FG000|Overall Study|Lost to Follow-up|4|||
131209504|NCT01238861|472389823|FG001|Overall Study|Lost to Follow-up|2|||
131209505|NCT01238861|472389824|FG002|Overall Study|Lost to Follow-up|3|||
131209506|NCT01238861|472389825|FG003|Overall Study|Lost to Follow-up|1|||
131209507|NCT01238861|472389826|FG004|Overall Study|Lost to Follow-up|1|||
131209508|NCT01238861|472389827|FG005|Overall Study|Lost to Follow-up|2|||
131209509|NCT01238861|472389822|FG000|Overall Study|Unplanned surgery|1|||
131209510|NCT01238861|472389823|FG001|Overall Study|Unplanned surgery|0|||
131209511|NCT01238861|472389824|FG002|Overall Study|Unplanned surgery|0|||
131209512|NCT01238861|472389825|FG003|Overall Study|Unplanned surgery|0|||
131209513|NCT01238861|472389826|FG004|Overall Study|Unplanned surgery|0|||
131209514|NCT01238861|472389827|FG005|Overall Study|Unplanned surgery|0|||
131209515|NCT01238861|472389822|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
131209516|NCT01238861|472389823|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
131209517|NCT01238861|472389824|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
131209518|NCT01238861|472389825|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
131209519|NCT01238861|472389826|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
131209520|NCT01238861|472389827|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
131209521|NCT01238861|472389822|FG000|Overall Study|Incorrect enrollment/randomization|0|||
131209522|NCT01238861|472389823|FG001|Overall Study|Incorrect enrollment/randomization|0|||
131209523|NCT01238861|472389824|FG002|Overall Study|Incorrect enrollment/randomization|1|||
131209524|NCT01238861|472389825|FG003|Overall Study|Incorrect enrollment/randomization|0|||
131209525|NCT01238861|472389826|FG004|Overall Study|Incorrect enrollment/randomization|1|||
131209526|NCT01238861|472389827|FG005|Overall Study|Incorrect enrollment/randomization|0|||
131209527|NCT01238861|472389822|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
131209528|NCT01238861|472389823|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
131209529|NCT01238861|472389824|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
131209530|NCT01238861|472389825|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
131209531|NCT01238861|472389826|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
131209532|NCT01238861|472389827|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
131209533|NCT01238861|472389822|FG000|Overall Study|Subject moved out of state/area|0|||
131209534|NCT01238861|472389823|FG001|Overall Study|Subject moved out of state/area|0|||
131209535|NCT01238861|472389824|FG002|Overall Study|Subject moved out of state/area|1|||
131209536|NCT01238861|472389825|FG003|Overall Study|Subject moved out of state/area|1|||
131209537|NCT01238861|472389826|FG004|Overall Study|Subject moved out of state/area|0|||
131209538|NCT01238861|472389827|FG005|Overall Study|Subject moved out of state/area|0|||
131209539|NCT01238861|472389822|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
131209540|NCT01238861|472389823|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
131209541|NCT01238861|472389824|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
131209542|NCT01238861|472389825|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
131209543|NCT01238861|472389826|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
131209544|NCT01238861|472389827|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
131209545|NCT01238861|472389822|FG000|Overall Study|Personal problems|0|||
131209546|NCT01238861|472389823|FG001|Overall Study|Personal problems|0|||
131209547|NCT01238861|472389824|FG002|Overall Study|Personal problems|0|||
131209548|NCT01238861|472389825|FG003|Overall Study|Personal problems|1|||
131209549|NCT01238861|472389826|FG004|Overall Study|Personal problems|0|||
131209550|NCT01238861|472389827|FG005|Overall Study|Personal problems|0|||
131209551|NCT01238861|472389822|FG000|Overall Study|Unable to continue visits|0|||
131209552|NCT01238861|472389823|FG001|Overall Study|Unable to continue visits|0|||
131209553|NCT01238861|472389824|FG002|Overall Study|Unable to continue visits|0|||
131209554|NCT01238861|472389825|FG003|Overall Study|Unable to continue visits|1|||
131209555|NCT01238861|472389826|FG004|Overall Study|Unable to continue visits|0|||
131209556|NCT01238861|472389827|FG005|Overall Study|Unable to continue visits|1|||
131209557|NCT01238861|472389822|FG000|Overall Study|Serious adverse event|0|||
131209558|NCT01238861|472389823|FG001|Overall Study|Serious adverse event|0|||
131209559|NCT01238861|472389824|FG002|Overall Study|Serious adverse event|0|||
131209560|NCT01238861|472389825|FG003|Overall Study|Serious adverse event|0|||
131209561|NCT01238861|472389826|FG004|Overall Study|Serious adverse event|0|||
131209562|NCT01238861|472389827|FG005|Overall Study|Serious adverse event|1|||
131209563|NCT01238861|472389822|FG000|Overall Study|Lack of compliance|0|||
131209564|NCT01238861|472389823|FG001|Overall Study|Lack of compliance|0|||
131209565|NCT01238861|472389824|FG002|Overall Study|Lack of compliance|0|||
131209566|NCT01238861|472389825|FG003|Overall Study|Lack of compliance|0|||
131209567|NCT01238861|472389826|FG004|Overall Study|Lack of compliance|0|||
131209568|NCT01238861|472389827|FG005|Overall Study|Lack of compliance|1|||
131209569|NCT01238861|472389822|FG000|Overall Study|Adverse Event|0|||
131209570|NCT01238861|472389823|FG001|Overall Study|Adverse Event|1|||
131209571|NCT01238861|472389824|FG002|Overall Study|Adverse Event|0|||
131209572|NCT01238861|472389825|FG003|Overall Study|Adverse Event|0|||
131209573|NCT01238861|472389826|FG004|Overall Study|Adverse Event|0|||
131209574|NCT01238861|472389827|FG005|Overall Study|Adverse Event|0|||
131209575|NCT01238861|472389822|FG000|Overall Study|Withdrawal by Subject|6|||
131209576|NCT01238861|472389823|FG001|Overall Study|Withdrawal by Subject|5|||
131209577|NCT01238861|472389824|FG002|Overall Study|Withdrawal by Subject|4|||
131209578|NCT01238861|472389825|FG003|Overall Study|Withdrawal by Subject|8|||
131209579|NCT01238861|472389826|FG004|Overall Study|Withdrawal by Subject|10|||
131209580|NCT01238861|472389827|FG005|Overall Study|Withdrawal by Subject|9|||
131209581|NCT01269346|472389828|FG000|Treatment Phase|Disease progression|3|||
131209582|NCT01269346|472389828|FG000|Treatment Phase|Adverse Event|3|||
131209583|NCT01269346|472389828|FG000|Treatment Phase|Withdrawal by Subject|1|||
131209584|NCT01269346|472389828|FG000|Treatment Phase|Other|2|||
131209585|NCT01269346|472389828|FG000|Extension Phase|Adverse Event|6|||
131209586|NCT01269346|472389828|FG000|Extension Phase|Withdrawal by Subject|4|||
131209587|NCT01269346|472389828|FG000|Extension Phase|Disease progression|22|||
131209588|NCT01269346|472389828|FG000|Extension Phase|Physician decision or participant choice|9|||
131209589|NCT01269346|472389828|FG000|Extension Phase|Clinical progression|1|||
131209590|NCT01269346|472389828|FG000|Extension Phase|Started a prohibited con med|1|||
131209591|NCT01855607|472389829|FG000|Overall Study|Withdrawal by Subject|1|||
131209592|NCT01855607|472389829|FG000|Overall Study|Study was terminated|11|||
131209593|NCT04963231|472389835|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
131209594|NCT04963231|472389836|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
131209595|NCT04963231|472389837|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
131209596|NCT04963231|472389835|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
131209597|NCT04963231|472389836|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
131209598|NCT04963231|472389837|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
131209599|NCT04963231|472389835|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
131209600|NCT04963231|472389836|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
131209601|NCT04963231|472389837|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
131209602|NCT04963231|472389835|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
131209603|NCT04963231|472389836|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
131209604|NCT04963231|472389837|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
131209605|NCT04963231|472389835|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
131209606|NCT04963231|472389836|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
131209607|NCT04963231|472389837|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
131209608|NCT04963231|472389835|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
131209609|NCT04963231|472389836|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
131209610|NCT04963231|472389837|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
131209611|NCT04963231|472389835|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
131209612|NCT04963231|472389836|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
131209613|NCT04963231|472389837|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
131209614|NCT04511533|472389838|FG000|Treatment|Other|2|||
131209615|NCT04511533|472389838|FG000|Treatment|Withdrawal by Subject|11|||
131209616|NCT04511533|472389838|FG000|Treatment|Death|5|||
131209617|NCT04511533|472389838|FG000|Treatment|Physician Decision|1|||
131209618|NCT04511533|472389838|FG000|Treatment|Progressive Disease|61|||
131209619|NCT04511533|472389838|FG000|Follow-Up|Other|7|||
131209620|NCT04511533|472389838|FG000|Follow-Up|Withdrawal by Subject|5|||
131209621|NCT04511533|472389838|FG000|Follow-Up|Lost to Follow-up|2|||
131209622|NCT04511533|472389838|FG000|Follow-Up|Death|4|||
131209623|NCT04576702|472389839|FG000|Overall Study|Death|1|||
131209624|NCT04576702|472389840|FG001|Overall Study|Death|0|||
131209625|NCT04576702|472389841|FG002|Overall Study|Death|0|||
131209626|NCT04576702|472389842|FG003|Overall Study|Death|0|||
131209627|NCT04576702|472389839|FG000|Overall Study|Withdrawal by Subject|0|||
131209628|NCT04576702|472389840|FG001|Overall Study|Withdrawal by Subject|2|||
131209629|NCT04576702|472389841|FG002|Overall Study|Withdrawal by Subject|1|||
131209630|NCT04576702|472389842|FG003|Overall Study|Withdrawal by Subject|0|||
131209631|NCT04576702|472389839|FG000|Overall Study|Lost to Follow-up|3|||
131209632|NCT04576702|472389840|FG001|Overall Study|Lost to Follow-up|3|||
131209633|NCT04576702|472389841|FG002|Overall Study|Lost to Follow-up|3|||
131209634|NCT04576702|472389842|FG003|Overall Study|Lost to Follow-up|4|||
131209635|NCT01319422|472389845|FG000|Overall Study|Withdrawal by Subject|1|||
131209636|NCT01319422|472389846|FG001|Overall Study|Withdrawal by Subject|0|||
131209637|NCT06104423|472389849|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
131209638|NCT06104423|472389850|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
131209639|NCT06104423|472389851|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
131209640|NCT06104423|472389849|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
131209641|NCT06104423|472389850|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
131209642|NCT06104423|472389851|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
131209643|NCT00727246|472389852|FG000|Overall Study|could not complete MRI|0|||
131209644|NCT00727246|472389853|FG001|Overall Study|could not complete MRI|1|||
131209645|NCT00727246|472389854|FG002|Overall Study|could not complete MRI|0|||
130735566|NCT00662649|470651221|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
130735567|NCT00662649|470651222|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
131209646|NCT00727246|472389855|FG003|Overall Study|could not complete MRI|1|||
131209647|NCT00727246|472389852|FG000|Overall Study|incidental finding|0|||
131209648|NCT00727246|472389853|FG001|Overall Study|incidental finding|0|||
131209649|NCT00727246|472389854|FG002|Overall Study|incidental finding|0|||
131209650|NCT00727246|472389855|FG003|Overall Study|incidental finding|1|||
130735568|NCT00662649|470651223|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
130735569|NCT00662649|470651224|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
130735570|NCT00662649|470651220|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
130735571|NCT00662649|470651221|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
130735572|NCT00662649|470651222|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
130735573|NCT00662649|470651223|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
130735574|NCT00662649|470651224|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
130735575|NCT00662649|470651220|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
130735576|NCT00662649|470651221|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
130735577|NCT00662649|470651222|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
130735578|NCT00662649|470651223|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
130735579|NCT00662649|470651224|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
130735580|NCT00662649|470651220|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
130735581|NCT00662649|470651221|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
130735582|NCT00662649|470651222|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
130735583|NCT00662649|470651223|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
130735584|NCT00662649|470651224|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
130735585|NCT00662649|470651220|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
130735586|NCT00662649|470651221|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
130735587|NCT00662649|470651222|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
130735588|NCT00662649|470651223|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
130735589|NCT00662649|470651224|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
130735590|NCT00662649|470651220|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
130735591|NCT00662649|470651221|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
130735592|NCT00662649|470651222|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
130735593|NCT00662649|470651223|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
130735594|NCT00662649|470651224|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
130735595|NCT00662649|470651220|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130735596|NCT00662649|470651221|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
130735597|NCT00662649|470651222|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130735598|NCT00662649|470651223|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130735599|NCT00662649|470651224|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130735600|NCT00662649|470651220|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
130735601|NCT00662649|470651221|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
130735602|NCT00662649|470651222|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
130735603|NCT00662649|470651223|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
130735604|NCT00662649|470651224|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
130735605|NCT00560391|470651237|FG000|Overall Study|Still on treatment|0|||
130735606|NCT00560391|470651238|FG001|Overall Study|Still on treatment|0|||
130735607|NCT00560391|470651239|FG002|Overall Study|Still on treatment|0|||
130735608|NCT00560391|470651240|FG003|Overall Study|Still on treatment|1|||
130735609|NCT00560391|470651241|FG004|Overall Study|Still on treatment|2|||
130735610|NCT02071225|470651242|FG000|Overall Study|Withdrawal of Consent|2|||
130735611|NCT02071225|470651242|FG000|Overall Study|Protocol Deviation|1|||
130735612|NCT02071225|470651242|FG000|Overall Study|Lost to Follow-up|2|||
130735613|NCT02071225|470651242|FG000|Overall Study|Death|25|||
130735614|NCT02064296|470651243|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
130735615|NCT02064296|470651244|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
130735616|NCT02064296|470651245|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
130735617|NCT02064296|470651243|FG000|Intervention|Withdrawal by Subject|0|||
130735618|NCT02064296|470651244|FG001|Intervention|Withdrawal by Subject|1|||
130735619|NCT02064296|470651245|FG002|Intervention|Withdrawal by Subject|2|||
130735620|NCT03519087|470651251|FG000|Clinic Evaluation|Physician Decision|15|||
130735621|NCT03519087|470651252|FG001|Clinic Evaluation|Physician Decision|18|||
130735622|NCT03519087|470651253|FG002|Clinic Evaluation|Physician Decision|0|||
130735623|NCT03519087|470651254|FG003|Clinic Evaluation|Physician Decision|0|||
130735624|NCT03519087|470651255|FG004|Clinic Evaluation|Physician Decision|0|||
130735625|NCT03519087|470651251|FG000|Clinic Evaluation|Protocol Violation|1|||
130735626|NCT03519087|470651252|FG001|Clinic Evaluation|Protocol Violation|0|||
130735627|NCT03519087|470651253|FG002|Clinic Evaluation|Protocol Violation|0|||
130735628|NCT03519087|470651254|FG003|Clinic Evaluation|Protocol Violation|0|||
130735629|NCT03519087|470651255|FG004|Clinic Evaluation|Protocol Violation|0|||
130735630|NCT03519087|470651251|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
130735631|NCT03519087|470651252|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
130735632|NCT03519087|470651253|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
130735633|NCT03519087|470651254|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
130735634|NCT03519087|470651255|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
131209651|NCT00727246|472389852|FG000|Overall Study|withdrawn|0|||
130735635|NCT03519087|470651251|FG000|Re-randomization for Treatment|Not appropriate|2|||
130735636|NCT03519087|470651252|FG001|Re-randomization for Treatment|Not appropriate|3|||
130735637|NCT03519087|470651253|FG002|Re-randomization for Treatment|Not appropriate|0|||
130735638|NCT03519087|470651254|FG003|Re-randomization for Treatment|Not appropriate|0|||
130735639|NCT03519087|470651255|FG004|Re-randomization for Treatment|Not appropriate|0|||
130735640|NCT03519087|470651251|FG000|Laboratory Testing|Lost to Follow-up|0|||
130735641|NCT03519087|470651252|FG001|Laboratory Testing|Lost to Follow-up|0|||
130735642|NCT03519087|470651253|FG002|Laboratory Testing|Lost to Follow-up|2|||
130735643|NCT03519087|470651254|FG003|Laboratory Testing|Lost to Follow-up|3|||
130735644|NCT03519087|470651255|FG004|Laboratory Testing|Lost to Follow-up|6|||
130735645|NCT03519087|470651251|FG000|Laboratory Testing|Protocol Violation|0|||
130735646|NCT03519087|470651252|FG001|Laboratory Testing|Protocol Violation|0|||
130735647|NCT03519087|470651253|FG002|Laboratory Testing|Protocol Violation|0|||
130735648|NCT03519087|470651254|FG003|Laboratory Testing|Protocol Violation|1|||
130735649|NCT03519087|470651255|FG004|Laboratory Testing|Protocol Violation|0|||
130735650|NCT01137071|470651256|FG000|Overall Study|Disease Progression|11|||
130735651|NCT01137071|470651256|FG000|Overall Study|Withdrawal by Subject|2|||
131209652|NCT00727246|472389853|FG001|Overall Study|withdrawn|0|||
131209653|NCT00727246|472389854|FG002|Overall Study|withdrawn|1|||
131209654|NCT00727246|472389855|FG003|Overall Study|withdrawn|0|||
131209655|NCT00229931|472389868|FG000|Overall Study|Death|1|||
131209656|NCT00229931|472389869|FG001|Overall Study|Death|0|||
131209657|NCT00229931|472389868|FG000|Overall Study|Lost to Follow-up|3|||
131209658|NCT00229931|472389869|FG001|Overall Study|Lost to Follow-up|2|||
131209659|NCT02992743|472389870|FG000|Overall Study|Withdrawal by Subject|1|||
131209660|NCT02992743|472389871|FG001|Overall Study|Withdrawal by Subject|1|||
130735652|NCT01137071|470651256|FG000|Overall Study|Wrongly Included|1|||
130735653|NCT00098774|470651257|FG000|Overall Study|Adverse Event|2|||
130735654|NCT00098774|470651257|FG000|Overall Study|Disease Progression|9|||
130735655|NCT00098774|470651257|FG000|Overall Study|Withdrawal by Subject|1|||
130735656|NCT00098774|470651257|FG000|Overall Study|Failed (to respond) during induction|4|||
131209661|NCT02992743|472389870|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
131209662|NCT02992743|472389871|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
131209663|NCT02992743|472389870|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
131209664|NCT02992743|472389871|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
131209665|NCT02992743|472389870|FG000|Overall Study|No measurable disease|1|||
131209666|NCT02992743|472389871|FG001|Overall Study|No measurable disease|0|||
131209667|NCT02992743|472389870|FG000|Overall Study|Lost to Follow-up|0|||
131209668|NCT02992743|472389871|FG001|Overall Study|Lost to Follow-up|1|||
131209669|NCT02067728|472389872|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
131209670|NCT02067728|472389873|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
131209671|NCT02067728|472389872|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
131209672|NCT02067728|472389873|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
131209673|NCT02067728|472389872|FG000|6 Month Measurements|Unable to attend|114|||
131209674|NCT02067728|472389873|FG001|6 Month Measurements|Unable to attend|97|||
131209675|NCT01428882|472389878|FG000|Overall Study|Lack of Efficacy|2|||
131209676|NCT01428882|472389879|FG001|Overall Study|Lack of Efficacy|7|||
131209677|NCT01428882|472389878|FG000|Overall Study|Protocol Violation|4|||
131209678|NCT01428882|472389879|FG001|Overall Study|Protocol Violation|3|||
131209679|NCT01539512|472389886|FG000|Overall Study|Adverse Event|9|||
131209680|NCT01539512|472389887|FG001|Overall Study|Adverse Event|7|||
131209681|NCT01539512|472389886|FG000|Overall Study|Physician Decision|1|||
131209682|NCT01539512|472389887|FG001|Overall Study|Physician Decision|1|||
131209683|NCT01539512|472389886|FG000|Overall Study|Withdrawal by Subject|12|||
131209684|NCT01539512|472389887|FG001|Overall Study|Withdrawal by Subject|5|||
131209685|NCT01539512|472389886|FG000|Overall Study|Richter's Transformation|1|||
131209686|NCT01539512|472389887|FG001|Overall Study|Richter's Transformation|0|||
131209687|NCT04668157|472389888|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
131209688|NCT04668157|472389889|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
131209689|NCT04668157|472389888|FG000|Treatment Period (52 Weeks)|Other|0|||
131209690|NCT04668157|472389889|FG001|Treatment Period (52 Weeks)|Other|2|||
131209691|NCT04479358|472389896|FG000|Overall Study|Withdrawal by Subject|0|||
131209692|NCT04479358|472389897|FG001|Overall Study|Withdrawal by Subject|0|||
131209693|NCT04479358|472389898|FG002|Overall Study|Withdrawal by Subject|1|||
130735657|NCT00098774|470651257|FG000|Overall Study|Physician Decision|2|||
130735658|NCT02324582|470651258|FG000|Overall Study|Screen Failures|0|||
130735659|NCT02324582|470651259|FG001|Overall Study|Screen Failures|5|||
130735660|NCT01487525|470651262|FG000|Overall Study|Withdrawal by Subject|0|||
131209694|NCT04479358|472389899|FG003|Overall Study|Withdrawal by Subject|0|||
131209695|NCT04479358|472389900|FG004|Overall Study|Withdrawal by Subject|0|||
131209696|NCT04479358|472389901|FG005|Overall Study|Withdrawal by Subject|1|||
131209697|NCT00764465|472389902|FG000|Overall Study|Adverse Event|2|||
131209698|NCT00764465|472389903|FG001|Overall Study|Adverse Event|0|||
131209699|NCT00764465|472389904|FG002|Overall Study|Adverse Event|0|||
130735661|NCT01487525|470651263|FG001|Overall Study|Withdrawal by Subject|1|||
130735662|NCT04388553|470651264|FG000|Overall Study|Protocol Violation|1|||
131209700|NCT00764465|472389905|FG003|Overall Study|Adverse Event|1|||
131209701|NCT00764465|472389906|FG004|Overall Study|Adverse Event|1|||
131209702|NCT00764465|472389907|FG005|Overall Study|Adverse Event|1|||
131209703|NCT00764465|472389902|FG000|Overall Study|Withdrawal by Subject|0|||
131209704|NCT00764465|472389903|FG001|Overall Study|Withdrawal by Subject|1|||
131209705|NCT00764465|472389904|FG002|Overall Study|Withdrawal by Subject|1|||
131209706|NCT00764465|472389905|FG003|Overall Study|Withdrawal by Subject|0|||
131209707|NCT00764465|472389906|FG004|Overall Study|Withdrawal by Subject|0|||
131209708|NCT00764465|472389907|FG005|Overall Study|Withdrawal by Subject|0|||
131209709|NCT01333501|472389908|FG000|Overall Study|Adverse Event|3|||
131209710|NCT01333501|472389909|FG001|Overall Study|Adverse Event|1|||
131209711|NCT01333501|472389908|FG000|Overall Study|Abnormal laboratory value|2|||
131209712|NCT01333501|472389909|FG001|Overall Study|Abnormal laboratory value|1|||
131209713|NCT01333501|472389908|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
131209714|NCT01333501|472389909|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
131209715|NCT01333501|472389908|FG000|Overall Study|Withdrawn consent|3|||
131209716|NCT01333501|472389909|FG001|Overall Study|Withdrawn consent|12|||
131209717|NCT00674440|472389910|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
131209718|NCT00674440|472389910|FG000|Overall Study|did not have surgery, so unevaluable|7|||
131209719|NCT00674440|472389910|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
131209720|NCT03329404|472389911|FG000|Overall Study|The study was suspended.|1|||
131209721|NCT03329404|472389912|FG001|Overall Study|The study was suspended.|4|||
131209722|NCT00914940|472389913|FG000|D0 to D100 Post-transplant|Death|2|||
131209723|NCT00914940|472389913|FG000|D101 to 2 Years Post-transplant|Death|8|||
131209724|NCT00914940|472389913|FG000|2 Years to 5 Years Post-transplant|Death|3|||
131209725|NCT00796367|472389914|FG000|Overall Study|Adverse Event|6|||
131209726|NCT00796367|472389915|FG001|Overall Study|Adverse Event|4|||
131209727|NCT00796367|472389916|FG002|Overall Study|Adverse Event|7|||
131209728|NCT00796367|472389914|FG000|Overall Study|Lost to Follow-up|5|||
131209729|NCT00796367|472389915|FG001|Overall Study|Lost to Follow-up|4|||
131209730|NCT00796367|472389916|FG002|Overall Study|Lost to Follow-up|21|||
131209731|NCT00796367|472389914|FG000|Overall Study|Withdrawal by Subject|9|||
131209732|NCT00796367|472389915|FG001|Overall Study|Withdrawal by Subject|11|||
131209733|NCT00796367|472389916|FG002|Overall Study|Withdrawal by Subject|12|||
130735663|NCT04388553|470651265|FG001|Overall Study|Protocol Violation|0|||
130735664|NCT02123446|470651266|FG000|Washout Period (1 Day)|Physician Decision|1|||
130735665|NCT02123446|470651267|FG001|Washout Period (1 Day)|Physician Decision|0|||
130735666|NCT04604795|470651268|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
130735667|NCT04604795|470651269|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
130735668|NCT04604795|470651270|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130735669|NCT04604795|470651271|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130735670|NCT04604795|470651272|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131209734|NCT00796367|472389914|FG000|Overall Study|Lack of Efficacy|2|||
131209735|NCT00796367|472389915|FG001|Overall Study|Lack of Efficacy|1|||
131209736|NCT00796367|472389916|FG002|Overall Study|Lack of Efficacy|0|||
131209737|NCT00796367|472389914|FG000|Overall Study|non compliance|3|||
131209738|NCT00796367|472389915|FG001|Overall Study|non compliance|1|||
130735671|NCT04604795|470651273|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130735672|NCT04604795|470651274|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131209739|NCT00796367|472389916|FG002|Overall Study|non compliance|1|||
131209740|NCT00796367|472389914|FG000|Overall Study|Pregnancy|1|||
131209741|NCT00796367|472389915|FG001|Overall Study|Pregnancy|0|||
131209742|NCT00796367|472389916|FG002|Overall Study|Pregnancy|1|||
131209743|NCT00796367|472389914|FG000|Overall Study|Requirement for restricted medication|2|||
131209744|NCT00796367|472389915|FG001|Overall Study|Requirement for restricted medication|0|||
131209745|NCT00796367|472389916|FG002|Overall Study|Requirement for restricted medication|2|||
131209746|NCT00796367|472389914|FG000|Overall Study|other|2|||
131209747|NCT00796367|472389915|FG001|Overall Study|other|4|||
131209748|NCT00796367|472389916|FG002|Overall Study|other|3|||
130735673|NCT04604795|470651275|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130735674|NCT04604795|470651276|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131209749|NCT01365182|472389919|FG000|Overall Study|Withdrawal by Subject|10|||
131209750|NCT01365182|472389920|FG001|Overall Study|Withdrawal by Subject|13|||
131209751|NCT01365182|472389921|FG002|Overall Study|Withdrawal by Subject|12|||
131209752|NCT01728194|472389928|FG000|Overall Study|Lost to Follow-up|4|||
130735675|NCT04604795|470651277|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
131209753|NCT01728194|472389929|FG001|Overall Study|Lost to Follow-up|3|||
131209754|NCT01728194|472389928|FG000|Overall Study|Physician Decision|4|||
131209755|NCT01728194|472389929|FG001|Overall Study|Physician Decision|0|||
130735676|NCT04604795|470651268|FG000|Part B: Up to Day 14|Adverse Event|0|||
130735677|NCT04604795|470651269|FG001|Part B: Up to Day 14|Adverse Event|0|||
130735678|NCT04604795|470651270|FG002|Part B: Up to Day 14|Adverse Event|0|||
130735679|NCT04604795|470651271|FG003|Part B: Up to Day 14|Adverse Event|0|||
130735680|NCT04604795|470651272|FG004|Part B: Up to Day 14|Adverse Event|2|||
130735681|NCT04604795|470651273|FG005|Part B: Up to Day 14|Adverse Event|1|||
130735682|NCT04604795|470651274|FG006|Part B: Up to Day 14|Adverse Event|0|||
130735683|NCT04604795|470651275|FG007|Part B: Up to Day 14|Adverse Event|0|||
130735684|NCT04604795|470651276|FG008|Part B: Up to Day 14|Adverse Event|0|||
130735685|NCT04604795|470651277|FG009|Part B: Up to Day 14|Adverse Event|0|||
130735686|NCT04604795|470651268|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130735687|NCT04604795|470651269|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130735688|NCT04604795|470651270|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130735689|NCT04604795|470651271|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130735690|NCT04604795|470651272|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130735691|NCT04604795|470651273|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130735692|NCT04604795|470651274|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130735693|NCT04604795|470651275|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130735694|NCT04604795|470651276|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130735695|NCT04604795|470651277|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
130735696|NCT04604795|470651268|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131209756|NCT01728194|472389928|FG000|Overall Study|Withdrawal by Subject|7|||
131209757|NCT01728194|472389929|FG001|Overall Study|Withdrawal by Subject|3|||
131209758|NCT01728194|472389928|FG000|Overall Study|Perceived Medication Side Effects|4|||
131209759|NCT01728194|472389929|FG001|Overall Study|Perceived Medication Side Effects|0|||
131209760|NCT01728194|472389928|FG000|Overall Study|Family Member Request|1|||
131209761|NCT01728194|472389929|FG001|Overall Study|Family Member Request|0|||
131209762|NCT02309372|472389930|FG000|Overall Study|Lost to Follow-up|3|||
131209763|NCT02309372|472389931|FG001|Overall Study|Lost to Follow-up|2|||
131209764|NCT01590810|472389934|FG000|Overall Study|Physician Decision|0|||
131209765|NCT01590810|472389935|FG001|Overall Study|Physician Decision|1|||
131209766|NCT01590810|472389936|FG002|Overall Study|Physician Decision|1|||
131209767|NCT01590810|472389937|FG003|Overall Study|Physician Decision|0|||
131209768|NCT01590810|472389938|FG004|Overall Study|Physician Decision|0|||
131209769|NCT04604015|472389939|FG000|Overall Study|Incomplete Data Collection|33|||
131209770|NCT02576652|472389941|FG000|Overall Study|Withdrawal by Subject|2|||
131209771|NCT00553319|472389949|FG000|Overall Study|Lost to Follow-up|10|||
131209772|NCT00553319|472389950|FG001|Overall Study|Lost to Follow-up|9|||
131209773|NCT00553319|472389951|FG002|Overall Study|Lost to Follow-up|5|||
131209774|NCT00553319|472389949|FG000|Overall Study|wanted treatment elsewhere|2|||
131209775|NCT00553319|472389950|FG001|Overall Study|wanted treatment elsewhere|1|||
131209776|NCT00553319|472389951|FG002|Overall Study|wanted treatment elsewhere|1|||
131209777|NCT00553319|472389949|FG000|Overall Study|non-compliance|0|||
131209778|NCT00553319|472389950|FG001|Overall Study|non-compliance|0|||
131209779|NCT00553319|472389951|FG002|Overall Study|non-compliance|2|||
131209780|NCT00553319|472389949|FG000|Overall Study|incarceration|1|||
131209781|NCT00553319|472389950|FG001|Overall Study|incarceration|0|||
131209782|NCT00553319|472389951|FG002|Overall Study|incarceration|0|||
131209783|NCT00553319|472389949|FG000|Overall Study|moved|1|||
131209784|NCT00553319|472389950|FG001|Overall Study|moved|0|||
131209785|NCT00553319|472389951|FG002|Overall Study|moved|1|||
131209786|NCT01349816|472389953|FG000|Overall Study|Withdrawal by Subject|4|||
131209787|NCT01349816|472389953|FG000|Overall Study|Physician Decision|1|||
131209788|NCT01349816|472389953|FG000|Overall Study|Adverse Event|14|||
131209789|NCT01349816|472389953|FG000|Overall Study|Lost to Follow-up|2|||
131209790|NCT01349816|472389953|FG000|Overall Study|Protocol Violation|1|||
131209791|NCT01349816|472389953|FG000|Overall Study|Protocol-specified criteria|8|||
131209792|NCT01230489|472389954|FG000|Overall Study|Death|2|||
131209793|NCT01230489|472389954|FG000|Overall Study|Adverse Event|2|||
130735697|NCT04604795|470651269|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130735698|NCT04604795|470651270|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130735699|NCT04604795|470651271|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130735700|NCT04604795|470651272|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130735701|NCT04604795|470651273|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131209794|NCT01230489|472389954|FG000|Overall Study|Treatment modality changed|1|||
131209795|NCT01791543|472389955|FG000|Overall Study|Lost to Follow-up|1|||
131209796|NCT01791543|472389955|FG000|Overall Study|Adverse Event|1|||
131209797|NCT00198107|472391703|FG000|Double-Blind Period|Adverse Event|1|||
131209798|NCT00198107|472391704|FG001|Double-Blind Period|Adverse Event|1|||
131209799|NCT00198107|472391705|FG002|Double-Blind Period|Adverse Event|0|||
131209800|NCT00198107|472391703|FG000|Double-Blind Period|Lack of Efficacy|2|||
131209801|NCT00198107|472391704|FG001|Double-Blind Period|Lack of Efficacy|0|||
131209802|NCT00198107|472391705|FG002|Double-Blind Period|Lack of Efficacy|0|||
131209803|NCT00198107|472391703|FG000|Double-Blind Period|Lost to Follow-up|2|||
131209804|NCT00198107|472391704|FG001|Double-Blind Period|Lost to Follow-up|1|||
130735702|NCT04604795|470651274|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130735703|NCT04604795|470651275|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
131209805|NCT00198107|472391705|FG002|Double-Blind Period|Lost to Follow-up|0|||
131209806|NCT00198107|472391703|FG000|Double-Blind Period|Physician Decision|1|||
131209807|NCT00198107|472391704|FG001|Double-Blind Period|Physician Decision|0|||
131209808|NCT00198107|472391705|FG002|Double-Blind Period|Physician Decision|0|||
131209809|NCT00198107|472391703|FG000|Double-Blind Period|Withdrawal by Subject|0|||
131209810|NCT00198107|472391704|FG001|Double-Blind Period|Withdrawal by Subject|1|||
131209811|NCT00198107|472391705|FG002|Double-Blind Period|Withdrawal by Subject|0|||
131209812|NCT00198107|472391703|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
131209813|NCT00198107|472391704|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
131209814|NCT00198107|472391705|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
131209815|NCT02985541|472391710|FG000|Overall Study|Withdrawal by Subject|33|||
131209816|NCT02985541|472391710|FG000|Overall Study|Lost to Follow-up|26|||
131209817|NCT02985541|472391710|FG000|Overall Study|Adverse Event|27|||
131209818|NCT02985541|472391710|FG000|Overall Study|Physician Decision|2|||
131209819|NCT02985541|472391710|FG000|Overall Study|Pregnancy|2|||
131209820|NCT02985541|472391710|FG000|Overall Study|Wish for pregnancy|44|||
131209821|NCT02985541|472391710|FG000|Overall Study|Other reason|5|||
131209822|NCT02985541|472391710|FG000|Overall Study|Not valid for analysis|2|||
131209823|NCT02383966|472391711|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
131209824|NCT02383966|472391712|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
131209825|NCT02383966|472391711|FG000|Overall Study|Randomized, but not treated|1|||
131209826|NCT02383966|472391712|FG001|Overall Study|Randomized, but not treated|3|||
131209827|NCT02163759|472391713|FG000|Overall Study|Withdrawal by Subject|1|||
131209828|NCT02163759|472391714|FG001|Overall Study|Withdrawal by Subject|5|||
131209829|NCT02163759|472391715|FG002|Overall Study|Withdrawal by Subject|1|||
131209830|NCT02163759|472391713|FG000|Overall Study|Adverse Event|0|||
131209831|NCT02163759|472391714|FG001|Overall Study|Adverse Event|0|||
131209832|NCT02163759|472391715|FG002|Overall Study|Adverse Event|1|||
131209833|NCT02163759|472391713|FG000|Overall Study|Death|0|||
131209834|NCT02163759|472391714|FG001|Overall Study|Death|0|||
131209835|NCT02163759|472391715|FG002|Overall Study|Death|1|||
131209836|NCT03996694|472391718|FG000|First Washout (7 Days)|positive urine drug screen|0|||
131209837|NCT03996694|472391719|FG001|First Washout (7 Days)|positive urine drug screen|0|||
131209838|NCT03996694|472391720|FG002|First Washout (7 Days)|positive urine drug screen|1|||
131209839|NCT03996694|472391721|FG003|First Washout (7 Days)|positive urine drug screen|0|||
131209840|NCT03996694|472391722|FG004|First Washout (7 Days)|positive urine drug screen|0|||
131209841|NCT03996694|472391723|FG005|First Washout (7 Days)|positive urine drug screen|0|||
131209842|NCT03996694|472391718|FG000|First Washout (7 Days)|Adverse Event|0|||
131209843|NCT03996694|472391719|FG001|First Washout (7 Days)|Adverse Event|1|||
131209844|NCT03996694|472391720|FG002|First Washout (7 Days)|Adverse Event|0|||
131209845|NCT03996694|472391721|FG003|First Washout (7 Days)|Adverse Event|0|||
131209846|NCT03996694|472391722|FG004|First Washout (7 Days)|Adverse Event|0|||
131209847|NCT03996694|472391723|FG005|First Washout (7 Days)|Adverse Event|0|||
131209848|NCT03996694|472391718|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
131209849|NCT03996694|472391719|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
131209850|NCT03996694|472391720|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
131209851|NCT03996694|472391721|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
131209852|NCT03996694|472391722|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
131209853|NCT03996694|472391723|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
131209854|NCT03996694|472391718|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
131209855|NCT03996694|472391719|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
131209856|NCT03996694|472391720|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
131209857|NCT03996694|472391721|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
131209858|NCT03996694|472391722|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
131209859|NCT03996694|472391723|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
131209860|NCT02777554|472391724|FG000|Overall Study|Adverse Event|4|||
131209861|NCT02777554|472391725|FG001|Overall Study|Adverse Event|4|||
131209862|NCT02777554|472391726|FG002|Overall Study|Adverse Event|0|||
131209863|NCT02777554|472391727|FG003|Overall Study|Adverse Event|1|||
131209864|NCT02777554|472391728|FG004|Overall Study|Adverse Event|0|||
131209865|NCT02777554|472391729|FG005|Overall Study|Adverse Event|0|||
131209866|NCT02777554|472391724|FG000|Overall Study|Withdrawal by Subject|3|||
131209867|NCT02777554|472391725|FG001|Overall Study|Withdrawal by Subject|1|||
131209868|NCT02777554|472391726|FG002|Overall Study|Withdrawal by Subject|1|||
131209869|NCT02777554|472391727|FG003|Overall Study|Withdrawal by Subject|0|||
131209870|NCT02777554|472391728|FG004|Overall Study|Withdrawal by Subject|0|||
131209871|NCT02777554|472391729|FG005|Overall Study|Withdrawal by Subject|0|||
131209872|NCT02777554|472391724|FG000|Overall Study|Discharged early due to hurricane|22|||
131209873|NCT02777554|472391725|FG001|Overall Study|Discharged early due to hurricane|20|||
131209874|NCT02777554|472391726|FG002|Overall Study|Discharged early due to hurricane|0|||
131209875|NCT02777554|472391727|FG003|Overall Study|Discharged early due to hurricane|0|||
131209876|NCT02777554|472391728|FG004|Overall Study|Discharged early due to hurricane|0|||
131209877|NCT02777554|472391729|FG005|Overall Study|Discharged early due to hurricane|0|||
131209878|NCT02777554|472391724|FG000|Overall Study|Other - Miscellaneous|1|||
131209879|NCT02777554|472391725|FG001|Overall Study|Other - Miscellaneous|0|||
131209880|NCT02777554|472391726|FG002|Overall Study|Other - Miscellaneous|0|||
131209881|NCT02777554|472391727|FG003|Overall Study|Other - Miscellaneous|0|||
131209882|NCT02777554|472391728|FG004|Overall Study|Other - Miscellaneous|0|||
131209883|NCT02777554|472391729|FG005|Overall Study|Other - Miscellaneous|0|||
130784752|NCT00496769|470841159|FG002|Double Blind|>=1 reason assigned per patient|0|||
131209884|NCT00066573|472391730|FG000|Overall Study|Did not received protocol treatment|28|||
131209885|NCT00066573|472391731|FG001|Overall Study|Did not received protocol treatment|28|||
131209886|NCT01458535|472391732|FG000|Overall Study|Other|0|||
131209887|NCT01458535|472391733|FG001|Overall Study|Other|0|||
131209888|NCT01458535|472391734|FG002|Overall Study|Other|0|||
131209889|NCT01458535|472391735|FG003|Overall Study|Other|0|||
131209890|NCT01458535|472391736|FG004|Overall Study|Other|1|||
131209891|NCT01458535|472391737|FG005|Overall Study|Other|1|||
131209892|NCT01458535|472391732|FG000|Overall Study|Withdrawal by Subject|0|||
131209893|NCT01458535|472391733|FG001|Overall Study|Withdrawal by Subject|0|||
131209894|NCT01458535|472391734|FG002|Overall Study|Withdrawal by Subject|2|||
131209895|NCT01458535|472391735|FG003|Overall Study|Withdrawal by Subject|0|||
131209896|NCT01458535|472391736|FG004|Overall Study|Withdrawal by Subject|1|||
131209897|NCT01458535|472391737|FG005|Overall Study|Withdrawal by Subject|1|||
131209898|NCT01458535|472391732|FG000|Overall Study|Lost to Follow-up|0|||
131209899|NCT01458535|472391733|FG001|Overall Study|Lost to Follow-up|2|||
131209900|NCT01458535|472391734|FG002|Overall Study|Lost to Follow-up|0|||
131209901|NCT01458535|472391735|FG003|Overall Study|Lost to Follow-up|3|||
131209902|NCT01458535|472391736|FG004|Overall Study|Lost to Follow-up|2|||
131209903|NCT01458535|472391737|FG005|Overall Study|Lost to Follow-up|2|||
131209904|NCT01458535|472391732|FG000|Overall Study|Adverse Event|0|||
131209905|NCT01458535|472391733|FG001|Overall Study|Adverse Event|0|||
131209906|NCT01458535|472391734|FG002|Overall Study|Adverse Event|0|||
131209907|NCT01458535|472391735|FG003|Overall Study|Adverse Event|1|||
131209908|NCT01458535|472391736|FG004|Overall Study|Adverse Event|0|||
131209909|NCT01458535|472391737|FG005|Overall Study|Adverse Event|0|||
131209910|NCT04001790|472391738|FG000|Overall Study|Withdrawal by Subject|1|||
131209911|NCT04001790|472391739|FG001|Overall Study|Withdrawal by Subject|2|||
131209912|NCT02706327|472391740|FG000|Overall Study|Lost to Follow-up|1|||
131209913|NCT02706327|472391741|FG001|Overall Study|Lost to Follow-up|1|||
131209914|NCT02706327|472391742|FG002|Overall Study|Lost to Follow-up|2|||
131209915|NCT01982942|472391748|FG000|Overall Study|Adverse Event|10|||
131209916|NCT01982942|472391749|FG001|Overall Study|Adverse Event|5|||
131209917|NCT01982942|472391748|FG000|Overall Study|Lost to Follow-up|4|||
131209918|NCT01982942|472391749|FG001|Overall Study|Lost to Follow-up|3|||
130735704|NCT04604795|470651276|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
130735705|NCT04604795|470651277|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130735706|NCT04604795|470651268|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130735707|NCT04604795|470651269|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130735708|NCT04604795|470651270|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130735709|NCT04604795|470651271|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130735710|NCT04604795|470651272|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130735711|NCT04604795|470651273|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130735712|NCT04604795|470651274|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130735713|NCT04604795|470651275|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130735714|NCT04604795|470651276|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
130735715|NCT04604795|470651277|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130735716|NCT04604795|470651268|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
130735717|NCT04604795|470651269|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
130735718|NCT04604795|470651270|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
130735719|NCT04604795|470651271|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
130735720|NCT04604795|470651272|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
130735721|NCT04604795|470651273|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
130735722|NCT04604795|470651274|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
130735723|NCT04604795|470651275|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
130735724|NCT04604795|470651276|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
130735725|NCT04604795|470651277|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
130735726|NCT00111241|470651285|FG000|Overall Study|Lost to Follow-up|1|||
130735727|NCT00111241|470651286|FG001|Overall Study|Lost to Follow-up|0|||
130735728|NCT00111241|470651285|FG000|Overall Study|Withdrawal by Subject|4|||
130735729|NCT00111241|470651286|FG001|Overall Study|Withdrawal by Subject|0|||
130735730|NCT00111241|470651285|FG000|Overall Study|Protocol Violation|9|||
130735731|NCT00111241|470651286|FG001|Overall Study|Protocol Violation|8|||
130735732|NCT00111241|470651285|FG000|Overall Study|Adverse Event|1|||
130735733|NCT00111241|470651286|FG001|Overall Study|Adverse Event|0|||
130735734|NCT00952731|470651292|FG000|Overall Study|Drug supply expired|1|||
130735735|NCT00952731|470651293|FG001|Overall Study|Drug supply expired|0|||
130735736|NCT02517463|470651301|FG000|Overall Study|Lost to Follow-up|5|||
130735737|NCT02517463|470651302|FG001|Overall Study|Lost to Follow-up|2|||
130735738|NCT03172494|470651307|FG000|Overall Study|Adverse Event|5|||
130735739|NCT03172494|470651308|FG001|Overall Study|Adverse Event|1|||
130735740|NCT03172494|470651309|FG002|Overall Study|Adverse Event|15|||
130735741|NCT03172494|470651307|FG000|Overall Study|Protocol Violation|3|||
130735742|NCT03172494|470651308|FG001|Overall Study|Protocol Violation|2|||
130735743|NCT03172494|470651309|FG002|Overall Study|Protocol Violation|1|||
130735744|NCT03172494|470651307|FG000|Overall Study|Lack of Efficacy|0|||
130735745|NCT03172494|470651308|FG001|Overall Study|Lack of Efficacy|0|||
130735746|NCT03172494|470651309|FG002|Overall Study|Lack of Efficacy|4|||
130735747|NCT03172494|470651307|FG000|Overall Study|Pregnancy|0|||
130735748|NCT03172494|470651308|FG001|Overall Study|Pregnancy|1|||
130735749|NCT03172494|470651309|FG002|Overall Study|Pregnancy|0|||
130735750|NCT03172494|470651307|FG000|Overall Study|Withdrawal by Subject|10|||
130735751|NCT03172494|470651308|FG001|Overall Study|Withdrawal by Subject|8|||
130735752|NCT03172494|470651309|FG002|Overall Study|Withdrawal by Subject|8|||
130735753|NCT03172494|470651307|FG000|Overall Study|Severe hypoglycaemic episode|0|||
130735754|NCT03172494|470651308|FG001|Overall Study|Severe hypoglycaemic episode|0|||
130735755|NCT03172494|470651309|FG002|Overall Study|Severe hypoglycaemic episode|1|||
130735756|NCT03172494|470651307|FG000|Overall Study|Non-compliance towards treatment|2|||
130735757|NCT03172494|470651308|FG001|Overall Study|Non-compliance towards treatment|0|||
130735758|NCT03172494|470651309|FG002|Overall Study|Non-compliance towards treatment|0|||
131209919|NCT01982942|472391748|FG000|Overall Study|Multiple sclerosis progression|3|||
131209920|NCT01982942|472391749|FG001|Overall Study|Multiple sclerosis progression|2|||
131209921|NCT01982942|472391748|FG000|Overall Study|Wanted to try therapy not permitted|1|||
131209922|NCT01982942|472391749|FG001|Overall Study|Wanted to try therapy not permitted|0|||
131209923|NCT01982942|472391748|FG000|Overall Study|Subject declined future visits|0|||
130735759|NCT02764151|470651310|FG000|Overall Study|Subject refused further follow-up|0|||
130735760|NCT02764151|470651311|FG001|Overall Study|Subject refused further follow-up|0|||
130735761|NCT02764151|470651312|FG002|Overall Study|Subject refused further follow-up|0|||
130735762|NCT02764151|470651313|FG003|Overall Study|Subject refused further follow-up|1|||
130735763|NCT02764151|470651310|FG000|Overall Study|Other|0|||
130735764|NCT02764151|470651311|FG001|Overall Study|Other|0|||
130735765|NCT02764151|470651312|FG002|Overall Study|Other|0|||
130735766|NCT02764151|470651313|FG003|Overall Study|Other|2|||
130735767|NCT00852202|470651314|FG000|Overall Study|Adverse Event|2|||
130735768|NCT00852202|470651315|FG001|Overall Study|Adverse Event|3|||
130735769|NCT00852202|470651316|FG002|Overall Study|Adverse Event|7|||
130735770|NCT00852202|470651314|FG000|Overall Study|Lack of Efficacy|4|||
130735771|NCT00852202|470651315|FG001|Overall Study|Lack of Efficacy|1|||
130735772|NCT00852202|470651316|FG002|Overall Study|Lack of Efficacy|2|||
131209924|NCT01982942|472391749|FG001|Overall Study|Subject declined future visits|1|||
131209925|NCT01982942|472391748|FG000|Overall Study|Left geographical area|2|||
131209926|NCT01982942|472391749|FG001|Overall Study|Left geographical area|0|||
131209927|NCT01982942|472391748|FG000|Overall Study|Too many pills|1|||
131209928|NCT01982942|472391749|FG001|Overall Study|Too many pills|0|||
131209929|NCT01982942|472391748|FG000|Overall Study|MS Relapse|0|||
131209930|NCT01982942|472391749|FG001|Overall Study|MS Relapse|1|||
131209931|NCT01982942|472391748|FG000|Overall Study|Chose to join a stem cell trial|0|||
131209932|NCT01982942|472391749|FG001|Overall Study|Chose to join a stem cell trial|1|||
131209933|NCT01982942|472391748|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
131209934|NCT01982942|472391749|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
131209935|NCT03471507|472391750|FG000|Overall Study|Lost to Follow-up|1|||
131209936|NCT03471507|472391751|FG001|Overall Study|Lost to Follow-up|3|||
131209937|NCT03471507|472391750|FG000|Overall Study|Physician Decision|0|||
131209938|NCT03471507|472391751|FG001|Overall Study|Physician Decision|1|||
131209939|NCT03471507|472391750|FG000|Overall Study|Withdrawal by Subject|2|||
131209940|NCT03471507|472391751|FG001|Overall Study|Withdrawal by Subject|1|||
131209941|NCT02213666|472391752|FG000|Overall Study|Withdrawal by Subject|1|||
131209942|NCT00750061|472391756|FG000|Overall Study|Adverse Event|2|||
131209943|NCT00750061|472391757|FG001|Overall Study|Adverse Event|0|||
131209944|NCT00750061|472391756|FG000|Overall Study|Withdrawal by Subject|0|||
131209945|NCT00750061|472391757|FG001|Overall Study|Withdrawal by Subject|1|||
131209946|NCT00750061|472391756|FG000|Overall Study|Physician Decision|0|||
131209947|NCT00750061|472391757|FG001|Overall Study|Physician Decision|1|||
131209948|NCT02696382|472391758|FG000|Overall Study|Death|7|||
131209949|NCT02696382|472391759|FG001|Overall Study|Death|2|||
131209950|NCT02696382|472391758|FG000|Overall Study|Withdrawal by Subject|5|||
131209951|NCT02696382|472391759|FG001|Overall Study|Withdrawal by Subject|12|||
131209952|NCT02696382|472391758|FG000|Overall Study|Lost to Follow-up|4|||
131209953|NCT02696382|472391759|FG001|Overall Study|Lost to Follow-up|7|||
131209954|NCT03417245|472391760|FG000|Overall Study|Adverse Event|1|||
131209955|NCT03417245|472391761|FG001|Overall Study|Adverse Event|0|||
131209956|NCT03417245|472391760|FG000|Overall Study|Protocol Violation|1|||
131209957|NCT03417245|472391761|FG001|Overall Study|Protocol Violation|0|||
131209958|NCT03417245|472391760|FG000|Overall Study|Withdrawal by Subject|1|||
131209959|NCT03417245|472391761|FG001|Overall Study|Withdrawal by Subject|1|||
131209960|NCT02708524|472391765|FG000|Overall Study|Adverse Event|0|||
131209961|NCT02708524|472391766|FG001|Overall Study|Adverse Event|1|||
131209962|NCT02708524|472391767|FG002|Overall Study|Adverse Event|0|||
131209963|NCT02708524|472391768|FG003|Overall Study|Adverse Event|0|||
131209964|NCT02708524|472391765|FG000|Overall Study|Lens Discomfort|1|||
131209965|NCT02708524|472391766|FG001|Overall Study|Lens Discomfort|0|||
131209966|NCT02708524|472391767|FG002|Overall Study|Lens Discomfort|1|||
131209967|NCT02708524|472391768|FG003|Overall Study|Lens Discomfort|0|||
131209968|NCT02708524|472391765|FG000|Overall Study|Lost to Follow-up|1|||
131209969|NCT02708524|472391766|FG001|Overall Study|Lost to Follow-up|1|||
131209970|NCT02708524|472391767|FG002|Overall Study|Lost to Follow-up|1|||
131209971|NCT02708524|472391768|FG003|Overall Study|Lost to Follow-up|0|||
131209972|NCT02708524|472391765|FG000|Overall Study|Protocol Violation|0|||
131209973|NCT02708524|472391766|FG001|Overall Study|Protocol Violation|1|||
131209974|NCT02708524|472391767|FG002|Overall Study|Protocol Violation|0|||
131209975|NCT02708524|472391768|FG003|Overall Study|Protocol Violation|0|||
131209976|NCT02708524|472391765|FG000|Overall Study|Withdrawal by Subject|1|||
131209977|NCT02708524|472391766|FG001|Overall Study|Withdrawal by Subject|1|||
131209978|NCT02708524|472391767|FG002|Overall Study|Withdrawal by Subject|0|||
131209979|NCT02708524|472391768|FG003|Overall Study|Withdrawal by Subject|0|||
131209980|NCT02708524|472391765|FG000|Overall Study|Dispensed incorrect study lens|0|||
131209981|NCT02708524|472391766|FG001|Overall Study|Dispensed incorrect study lens|1|||
131209982|NCT02708524|472391767|FG002|Overall Study|Dispensed incorrect study lens|1|||
131209983|NCT02708524|472391768|FG003|Overall Study|Dispensed incorrect study lens|0|||
131209984|NCT02708524|472391765|FG000|Overall Study|Did not wear lens at final visit|0|||
131209985|NCT02708524|472391766|FG001|Overall Study|Did not wear lens at final visit|1|||
131209986|NCT02708524|472391767|FG002|Overall Study|Did not wear lens at final visit|0|||
131209987|NCT02708524|472391768|FG003|Overall Study|Did not wear lens at final visit|0|||
131209988|NCT02708524|472391765|FG000|Overall Study|Subject lost study lens|1|||
131209989|NCT02708524|472391766|FG001|Overall Study|Subject lost study lens|0|||
131209990|NCT02708524|472391767|FG002|Overall Study|Subject lost study lens|0|||
131209991|NCT02708524|472391768|FG003|Overall Study|Subject lost study lens|0|||
131209992|NCT03246152|472391769|FG000|Overall Study|Lost to Follow-up|2|||
131209993|NCT03246152|472391769|FG000|Overall Study|Protocol Violation|1|||
131209994|NCT00761735|472391770|FG000|Overall Study|Lost to Follow-up|6|||
130735773|NCT00852202|470651314|FG000|Overall Study|Protocol Violation|2|||
130735774|NCT00852202|470651315|FG001|Overall Study|Protocol Violation|2|||
131209995|NCT00761735|472391770|FG000|Overall Study|Withdrawal by Subject|6|||
131209996|NCT00761735|472391770|FG000|Overall Study|Non-compliance with protocol|1|||
131209997|NCT00761735|472391770|FG000|Overall Study|Administrative|1|||
131209998|NCT03290131|472391771|FG000|Overall Study|Adverse Event|22|||
131209999|NCT03290131|472391772|FG001|Overall Study|Adverse Event|57|||
130735775|NCT00852202|470651316|FG002|Overall Study|Protocol Violation|7|||
130735776|NCT00852202|470651314|FG000|Overall Study|Withdrawal by Subject|3|||
130735777|NCT00852202|470651315|FG001|Overall Study|Withdrawal by Subject|1|||
130735778|NCT00852202|470651316|FG002|Overall Study|Withdrawal by Subject|2|||
130735779|NCT00852202|470651314|FG000|Overall Study|Lost to Follow-up|5|||
130735780|NCT00852202|470651315|FG001|Overall Study|Lost to Follow-up|5|||
130735781|NCT00852202|470651316|FG002|Overall Study|Lost to Follow-up|6|||
130735782|NCT00852202|470651314|FG000|Overall Study|pregnancy,moving away and surgery|1|||
130735783|NCT00852202|470651315|FG001|Overall Study|pregnancy,moving away and surgery|0|||
131210000|NCT03290131|472391773|FG002|Overall Study|Adverse Event|11|||
131210001|NCT03290131|472391771|FG000|Overall Study|Withdrawal by Subject|18|||
131210002|NCT03290131|472391772|FG001|Overall Study|Withdrawal by Subject|13|||
131210003|NCT03290131|472391773|FG002|Overall Study|Withdrawal by Subject|8|||
131210004|NCT03290131|472391771|FG000|Overall Study|MS Relapse|2|||
131210005|NCT03290131|472391772|FG001|Overall Study|MS Relapse|1|||
131210006|NCT03290131|472391773|FG002|Overall Study|MS Relapse|0|||
131210007|NCT03290131|472391771|FG000|Overall Study|Unknown reason|0|||
131210008|NCT03290131|472391772|FG001|Overall Study|Unknown reason|1|||
131210009|NCT03290131|472391773|FG002|Overall Study|Unknown reason|0|||
131210010|NCT00483574|472391774|FG000|Overall Study|Adverse Event|6|||
131210011|NCT00483574|472391775|FG001|Overall Study|Adverse Event|0|||
131210012|NCT00483574|472391774|FG000|Overall Study|Protocol Violation|28|||
131210013|NCT00483574|472391775|FG001|Overall Study|Protocol Violation|9|||
131210014|NCT00483574|472391774|FG000|Overall Study|Lost to Follow-up|16|||
131210015|NCT00483574|472391775|FG001|Overall Study|Lost to Follow-up|4|||
131210016|NCT00483574|472391774|FG000|Overall Study|Withdrawal by Subject|52|||
131210017|NCT00483574|472391775|FG001|Overall Study|Withdrawal by Subject|0|||
131210018|NCT00465101|472391776|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
131210019|NCT00465101|472391776|FG000|Overall Study|Change in health precluded follow up|4|||
131210020|NCT00465101|472391776|FG000|Overall Study|Did not meet study criteria|4|||
131210021|NCT00465101|472391776|FG000|Overall Study|Lost to Follow-up|5|||
131210022|NCT00465101|472391776|FG000|Overall Study|Other|6|||
131210023|NCT00465101|472391776|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
131210024|NCT00465101|472391776|FG000|Overall Study|Patient postponed procedure|1|||
131210025|NCT00465101|472391776|FG000|Overall Study|Site closed due to IRB expiration|1|||
131210026|NCT00465101|472391776|FG000|Overall Study|Unable to obtain IRB approval|1|||
131210027|NCT00465101|472391776|FG000|Overall Study|Death|3|||
131210028|NCT00465101|472391776|FG000|Overall Study|Withdrawal by Subject|25|||
131210029|NCT00465101|472391776|FG000|Overall Study|Physician Decision|1|||
131210030|NCT00465101|472391776|FG000|Overall Study|Withdrew consent prior to procedure|3|||
131210031|NCT03099096|472391779|FG000|Overall Study|Adverse Event|1|||
131210032|NCT03099096|472391779|FG000|Overall Study|Physician Decision|1|||
131210033|NCT00361504|472391782|FG000|Overall Study|Withdrawal by Subject|94|||
131210034|NCT00361504|472391783|FG001|Overall Study|Withdrawal by Subject|31|||
131210035|NCT00361504|472391782|FG000|Overall Study|Lost to Follow-up|40|||
131210036|NCT00361504|472391783|FG001|Overall Study|Lost to Follow-up|7|||
131210037|NCT00361504|472391782|FG000|Overall Study|Adverse Event|203|||
131210038|NCT00361504|472391783|FG001|Overall Study|Adverse Event|82|||
131210039|NCT00361504|472391782|FG000|Overall Study|Lack of Efficacy|72|||
131210040|NCT00361504|472391783|FG001|Overall Study|Lack of Efficacy|7|||
131210041|NCT00361504|472391782|FG000|Overall Study|Resolution of Pain|2|||
131210042|NCT00361504|472391783|FG001|Overall Study|Resolution of Pain|0|||
130735784|NCT00852202|470651316|FG002|Overall Study|pregnancy,moving away and surgery|2|||
130735785|NCT05022212|470651319|FG000|Overall Study|Lost to Follow-up|0|||
131210043|NCT00361504|472391782|FG000|Overall Study|Study medication non compliant|42|||
131210044|NCT00361504|472391783|FG001|Overall Study|Study medication non compliant|15|||
131210045|NCT00361504|472391782|FG000|Overall Study|All other|28|||
130735786|NCT05022212|470651320|FG001|Overall Study|Lost to Follow-up|2|||
130735787|NCT02890355|470651321|FG000|Overall Study|Adverse Event|5|||
131210046|NCT00361504|472391783|FG001|Overall Study|All other|3|||
131210047|NCT01374516|472391787|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
131210048|NCT01374516|472391788|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
131210049|NCT01374516|472391787|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
131210050|NCT01374516|472391788|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
131210051|NCT01374516|472391787|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
131210052|NCT01374516|472391788|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
131210053|NCT01374516|472391787|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
131210054|NCT01374516|472391788|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
131210055|NCT01374516|472391787|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
131210056|NCT01374516|472391788|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
131210057|NCT01374516|472391787|FG000|Surveillance Expansion Period|Protocol Violation|386|||
131210058|NCT01374516|472391788|FG001|Surveillance Expansion Period|Protocol Violation|217|||
131210059|NCT01374516|472391787|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
131210060|NCT01374516|472391788|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
131210061|NCT01374516|472391787|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
131210062|NCT01374516|472391788|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
131210063|NCT01374516|472391787|FG000|Surveillance Expansion Period|Serious adverse event|20|||
131210064|NCT01374516|472391788|FG001|Surveillance Expansion Period|Serious adverse event|5|||
131210065|NCT03219372|472391796|FG000|Overall Study|Withdrawal by Subject|1|||
131210066|NCT03219372|472391797|FG001|Overall Study|Withdrawal by Subject|0|||
131210067|NCT00450814|472391798|FG000|Overall Study|Failed to complete the initial therapy|0|||
131210068|NCT00450814|472391799|FG001|Overall Study|Failed to complete the initial therapy|0|||
131210069|NCT00450814|472391800|FG002|Overall Study|Failed to complete the initial therapy|0|||
131210070|NCT00450814|472391801|FG003|Overall Study|Failed to complete the initial therapy|1|||
131210071|NCT00450814|472391802|FG004|Overall Study|Failed to complete the initial therapy|1|||
131210072|NCT00450814|472391803|FG005|Overall Study|Failed to complete the initial therapy|1|||
131210073|NCT00450814|472391804|FG006|Overall Study|Failed to complete the initial therapy|0|||
131210074|NCT00450814|472391805|FG007|Overall Study|Failed to complete the initial therapy|0|||
131210075|NCT00450814|472391806|FG008|Overall Study|Failed to complete the initial therapy|0|||
131210076|NCT00450814|472391807|FG009|Overall Study|Failed to complete the initial therapy|0|||
131210077|NCT00450814|472391808|FG010|Overall Study|Failed to complete the initial therapy|0|||
131210078|NCT00450814|472391798|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
131210079|NCT00450814|472391799|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
131210080|NCT00450814|472391800|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
131210081|NCT00450814|472391801|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
131210082|NCT00450814|472391802|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
131210083|NCT00450814|472391803|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
131210084|NCT00450814|472391804|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
131210085|NCT00450814|472391805|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
131210086|NCT00450814|472391806|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
131210087|NCT00450814|472391807|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
131210088|NCT00450814|472391808|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
131210089|NCT04145531|472391809|FG000|Part A|Adverse Event|2|||
131210090|NCT04145531|472391810|FG001|Part A|Adverse Event|12|||
131210091|NCT04145531|472391811|FG002|Part A|Adverse Event|6|||
131210092|NCT04145531|472391812|FG003|Part A|Adverse Event|0|||
131210093|NCT04145531|472391809|FG000|Part A|Death|1|||
131210094|NCT04145531|472391810|FG001|Part A|Death|2|||
131210095|NCT04145531|472391811|FG002|Part A|Death|0|||
131210096|NCT04145531|472391812|FG003|Part A|Death|0|||
131210097|NCT04145531|472391809|FG000|Part A|Physician Decision|2|||
131210098|NCT04145531|472391810|FG001|Part A|Physician Decision|5|||
131210099|NCT04145531|472391811|FG002|Part A|Physician Decision|2|||
131210100|NCT04145531|472391812|FG003|Part A|Physician Decision|0|||
131210101|NCT04145531|472391809|FG000|Part A|Progressive disease|0|||
131210102|NCT04145531|472391810|FG001|Part A|Progressive disease|2|||
131210103|NCT04145531|472391811|FG002|Part A|Progressive disease|1|||
131210104|NCT04145531|472391812|FG003|Part A|Progressive disease|0|||
131210105|NCT04145531|472391809|FG000|Part A|Protocol deviation|0|||
131210106|NCT04145531|472391810|FG001|Part A|Protocol deviation|0|||
131210107|NCT04145531|472391811|FG002|Part A|Protocol deviation|1|||
131210108|NCT04145531|472391812|FG003|Part A|Protocol deviation|0|||
131210109|NCT04145531|472391809|FG000|Part A|Withdrawal by parent or guardian|1|||
131210110|NCT04145531|472391810|FG001|Part A|Withdrawal by parent or guardian|0|||
131210111|NCT04145531|472391811|FG002|Part A|Withdrawal by parent or guardian|0|||
131210112|NCT04145531|472391812|FG003|Part A|Withdrawal by parent or guardian|0|||
131210113|NCT04145531|472391809|FG000|Part A|Withdrawal by participant|0|||
131210114|NCT04145531|472391810|FG001|Part A|Withdrawal by participant|0|||
131210115|NCT04145531|472391811|FG002|Part A|Withdrawal by participant|1|||
131210116|NCT04145531|472391812|FG003|Part A|Withdrawal by participant|0|||
131210117|NCT04145531|472391809|FG000|Part A|Other|0|||
131210118|NCT04145531|472391810|FG001|Part A|Other|0|||
131210119|NCT04145531|472391811|FG002|Part A|Other|1|||
131210120|NCT04145531|472391812|FG003|Part A|Other|0|||
130735788|NCT02890355|470651322|FG001|Overall Study|Adverse Event|5|||
130735789|NCT02890355|470651321|FG000|Overall Study|Refusal unrelated to adverse event|5|||
131210121|NCT04145531|472391809|FG000|Part B|Adverse Event|0|||
131210122|NCT04145531|472391810|FG001|Part B|Adverse Event|0|||
131210123|NCT04145531|472391811|FG002|Part B|Adverse Event|0|||
131210124|NCT04145531|472391812|FG003|Part B|Adverse Event|21|||
131210125|NCT04145531|472391809|FG000|Part B|Physician Decision|0|||
131210126|NCT04145531|472391810|FG001|Part B|Physician Decision|0|||
131210127|NCT04145531|472391811|FG002|Part B|Physician Decision|0|||
131210128|NCT04145531|472391812|FG003|Part B|Physician Decision|7|||
131210129|NCT04145531|472391809|FG000|Part B|Progressive disease|0|||
131210130|NCT04145531|472391810|FG001|Part B|Progressive disease|0|||
131210131|NCT04145531|472391811|FG002|Part B|Progressive disease|0|||
131210132|NCT04145531|472391812|FG003|Part B|Progressive disease|1|||
131210133|NCT04145531|472391809|FG000|Part B|Recurrent disease|0|||
131210134|NCT04145531|472391810|FG001|Part B|Recurrent disease|0|||
131210135|NCT04145531|472391811|FG002|Part B|Recurrent disease|0|||
131210136|NCT04145531|472391812|FG003|Part B|Recurrent disease|1|||
131210137|NCT04145531|472391809|FG000|Part B|Withdrawal by parent or guardian|0|||
131210138|NCT04145531|472391810|FG001|Part B|Withdrawal by parent or guardian|0|||
131210139|NCT04145531|472391811|FG002|Part B|Withdrawal by parent or guardian|0|||
131210140|NCT04145531|472391812|FG003|Part B|Withdrawal by parent or guardian|3|||
131210141|NCT04145531|472391809|FG000|Part B|Withdrawal by participant|0|||
131210142|NCT04145531|472391810|FG001|Part B|Withdrawal by participant|0|||
131210143|NCT04145531|472391811|FG002|Part B|Withdrawal by participant|0|||
131210144|NCT04145531|472391812|FG003|Part B|Withdrawal by participant|1|||
131210145|NCT04145531|472391809|FG000|Part B|Other|0|||
131210146|NCT04145531|472391810|FG001|Part B|Other|0|||
131210147|NCT04145531|472391811|FG002|Part B|Other|0|||
131210148|NCT04145531|472391812|FG003|Part B|Other|1|||
131210149|NCT03602976|472391816|FG000|Overall Study|Withdrawal by Subject|1|||
131210150|NCT04837807|472391817|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
131210151|NCT04837807|472391818|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
131210152|NCT04629534|472391819|FG000|Overall Study|Physician Decision|1|||
131210153|NCT04629534|472391820|FG001|Overall Study|Physician Decision|0|||
131210154|NCT04629534|472391819|FG000|Overall Study|Protocol Violation|0|||
131210155|NCT04629534|472391820|FG001|Overall Study|Protocol Violation|2|||
131210156|NCT03732534|472391821|FG000|Overall Study|Study terminated by Sponsor|6|||
131210157|NCT02190604|472391822|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210158|NCT02190604|472391823|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210159|NCT02190604|472391824|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210160|NCT02190604|472391825|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210161|NCT02190604|472391826|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210162|NCT02190604|472391827|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210163|NCT02190604|472391828|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210164|NCT02190604|472391829|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210165|NCT02190604|472391830|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210166|NCT02190604|472391831|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210167|NCT02190604|472391832|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210168|NCT02190604|472391833|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210169|NCT02190604|472391834|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210170|NCT02190604|472391835|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210171|NCT02190604|472391836|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
131210172|NCT02190604|472391837|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210173|NCT02190604|472391838|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210174|NCT02190604|472391839|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210175|NCT02190604|472391840|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
131210176|NCT02190604|472391822|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210177|NCT02190604|472391823|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210178|NCT02190604|472391824|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210179|NCT02190604|472391825|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210180|NCT02190604|472391826|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210181|NCT02190604|472391827|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210182|NCT02190604|472391828|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210183|NCT02190604|472391829|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210184|NCT02190604|472391830|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210185|NCT02190604|472391831|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210186|NCT02190604|472391832|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210187|NCT02190604|472391833|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210188|NCT02190604|472391834|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210189|NCT02190604|472391835|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
131210190|NCT02190604|472391836|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210191|NCT02190604|472391837|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210192|NCT02190604|472391838|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210193|NCT02190604|472391839|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210194|NCT02190604|472391840|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
131210195|NCT02797951|472391841|FG000|Overall Study|Adverse Event|4|||
131210196|NCT02797951|472391841|FG000|Overall Study|Death|1|||
130735790|NCT02890355|470651322|FG001|Overall Study|Refusal unrelated to adverse event|10|||
130735791|NCT02890355|470651321|FG000|Overall Study|Progression/relapse|46|||
130735792|NCT02890355|470651322|FG001|Overall Study|Progression/relapse|39|||
130735793|NCT02890355|470651321|FG000|Overall Study|Not protocol specified|3|||
130735794|NCT02890355|470651322|FG001|Overall Study|Not protocol specified|4|||
130735795|NCT01128179|470651323|FG000|Overall Study|Death|1|||
130735796|NCT01128179|470651324|FG001|Overall Study|Death|0|||
130735797|NCT01128179|470651323|FG000|Overall Study|Protocol Violation|1|||
130735798|NCT01128179|470651324|FG001|Overall Study|Protocol Violation|0|||
130735799|NCT01682811|470651325|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130735800|NCT01682811|470651326|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
131210197|NCT02797951|472391841|FG000|Overall Study|Lack of Efficacy|19|||
131210198|NCT02797951|472391841|FG000|Overall Study|Lost to Follow-up|4|||
131210199|NCT02797951|472391841|FG000|Overall Study|Physician Decision|6|||
131210200|NCT02797951|472391841|FG000|Overall Study|Withdrawal by Subject|15|||
131210201|NCT00814502|472391842|FG000|Overall Study|Adverse Event|1|||
131210202|NCT00814502|472391843|FG001|Overall Study|Adverse Event|0|||
131210203|NCT00814502|472391842|FG000|Overall Study|Withdrawal by Subject|0|||
131210204|NCT00814502|472391843|FG001|Overall Study|Withdrawal by Subject|2|||
131210205|NCT03735849|472391845|FG000|Overall Study|Lost to Follow-up|1|||
131210206|NCT03735849|472391846|FG001|Overall Study|Lost to Follow-up|0|||
131210207|NCT03735849|472391847|FG002|Overall Study|Lost to Follow-up|0|||
131210208|NCT03735849|472391845|FG000|Overall Study|Participant unable to adhere to visit|1|||
131210209|NCT03735849|472391846|FG001|Overall Study|Participant unable to adhere to visit|0|||
131210210|NCT03735849|472391847|FG002|Overall Study|Participant unable to adhere to visit|0|||
131210211|NCT03735849|472391845|FG000|Overall Study|Not Randomized|0|||
131210212|NCT03735849|472391846|FG001|Overall Study|Not Randomized|0|||
131210213|NCT03735849|472391847|FG002|Overall Study|Not Randomized|4|||
131210214|NCT04585906|472391850|FG000|Overall Study|Lost to Follow-up|8|||
131210215|NCT04585906|472391851|FG001|Overall Study|Lost to Follow-up|5|||
131210216|NCT00429026|472391856|FG000|Overall Study|Inevaluable for response.|40|||
131210217|NCT02219477|472391857|FG000|Overall Study|Adverse Event|0|||
131210218|NCT02219477|472391858|FG001|Overall Study|Adverse Event|1|||
131210219|NCT02219477|472391859|FG002|Overall Study|Adverse Event|1|||
131210220|NCT02219477|472391857|FG000|Overall Study|Withdrawal by Subject|0|||
131210221|NCT02219477|472391858|FG001|Overall Study|Withdrawal by Subject|1|||
131210222|NCT02219477|472391859|FG002|Overall Study|Withdrawal by Subject|0|||
131210223|NCT00234533|472391868|FG000|Overall Study|Withdrawal by Subject|6|||
131210224|NCT00234533|472391868|FG000|Overall Study|Adverse Event|2|||
131210225|NCT00234533|472391868|FG000|Overall Study|Enrolled but not treated|3|||
131210226|NCT00976989|472391869|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
131210227|NCT00976989|472391870|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
131210228|NCT00976989|472391871|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
131210229|NCT00976989|472391869|FG000|Overall Study|Death|5|||
131210230|NCT00976989|472391870|FG001|Overall Study|Death|7|||
131210231|NCT00976989|472391871|FG002|Overall Study|Death|10|||
131210232|NCT00976989|472391869|FG000|Overall Study|Refused Treatment|4|||
131210233|NCT00976989|472391870|FG001|Overall Study|Refused Treatment|3|||
131210234|NCT00976989|472391871|FG002|Overall Study|Refused Treatment|5|||
131210235|NCT00976989|472391869|FG000|Overall Study|Failure to Return|2|||
131210236|NCT00976989|472391870|FG001|Overall Study|Failure to Return|1|||
131210237|NCT00976989|472391871|FG002|Overall Study|Failure to Return|0|||
131210238|NCT00976989|472391869|FG000|Overall Study|Recurrence of Disease|0|||
131210239|NCT00976989|472391870|FG001|Overall Study|Recurrence of Disease|1|||
131210240|NCT00976989|472391871|FG002|Overall Study|Recurrence of Disease|0|||
131210241|NCT00976989|472391869|FG000|Overall Study|Other|1|||
131210242|NCT00976989|472391870|FG001|Overall Study|Other|0|||
131210243|NCT00976989|472391871|FG002|Overall Study|Other|1|||
131210244|NCT01484691|472391872|FG000|Overall Study|Withdrawal by Subject|1|||
131210245|NCT01484691|472391873|FG001|Overall Study|Withdrawal by Subject|1|||
131210246|NCT01484691|472391874|FG002|Overall Study|Withdrawal by Subject|1|||
131210247|NCT01484691|472391872|FG000|Overall Study|Physician Decision|0|||
131210248|NCT01484691|472391873|FG001|Overall Study|Physician Decision|2|||
131210249|NCT01484691|472391874|FG002|Overall Study|Physician Decision|1|||
131210250|NCT04095039|472391879|FG000|Overall Study|Withdrawal by Subject|2|||
130735801|NCT01682811|470651327|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130735802|NCT01682811|470651328|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
131210251|NCT04095039|472391880|FG001|Overall Study|Withdrawal by Subject|16|||
131210252|NCT04095039|472391879|FG000|Overall Study|Transplanted|21|||
131210253|NCT04095039|472391880|FG001|Overall Study|Transplanted|24|||
131210254|NCT04095039|472391879|FG000|Overall Study|Transferred to Non-study Facility|47|||
131210255|NCT04095039|472391880|FG001|Overall Study|Transferred to Non-study Facility|44|||
131210256|NCT04095039|472391879|FG000|Overall Study|Withdrawal from internvention target|0|||
131210257|NCT04095039|472391880|FG001|Overall Study|Withdrawal from internvention target|2|||
131210258|NCT04095039|472391879|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
131210259|NCT04095039|472391880|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
131210260|NCT04095039|472391879|FG000|Overall Study|Cacliphylaxis|0|||
130735803|NCT01682811|470651329|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
131210261|NCT04095039|472391880|FG001|Overall Study|Cacliphylaxis|1|||
131210262|NCT04095039|472391879|FG000|Overall Study|Pregnancy|1|||
131210263|NCT04095039|472391880|FG001|Overall Study|Pregnancy|0|||
131210264|NCT03655951|472391882|FG000|Overall Study|Lost to Follow-up|39|||
131210265|NCT03655951|472391883|FG001|Overall Study|Lost to Follow-up|20|||
131210266|NCT03655951|472391882|FG000|Overall Study|Withdrawal by Subject|0|||
130735804|NCT01682811|470651330|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
131210267|NCT03655951|472391883|FG001|Overall Study|Withdrawal by Subject|1|||
131210268|NCT02811640|472391884|FG000|Overall Study|Technology malfunction|2|||
130735805|NCT01682811|470651331|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130735806|NCT01682811|470651325|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
130735807|NCT01682811|470651326|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
130735808|NCT01682811|470651327|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
130735809|NCT01682811|470651328|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
130735810|NCT01682811|470651329|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
130735811|NCT01682811|470651330|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
130735812|NCT01682811|470651331|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
130735813|NCT01682811|470651325|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
130735814|NCT01682811|470651326|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
130735815|NCT01682811|470651327|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
130735816|NCT01682811|470651328|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
130735817|NCT01682811|470651329|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
130784753|NCT00496769|470841157|FG000|Open Label|>=1 reason assigned per patient|0|||
130784754|NCT00496769|470841158|FG001|Open Label|>=1 reason assigned per patient|0|||
130784755|NCT00496769|470841159|FG002|Open Label|>=1 reason assigned per patient|1011|||
130784756|NCT02486692|470841160|FG000|Overall Study|did not login for randomization|4|||
130784757|NCT02486692|470841161|FG001|Overall Study|did not login for randomization|7|||
130784758|NCT02812186|470841164|FG000|Period 1|Post randomization screen failure|5|||
130784759|NCT02812186|470841165|FG001|Period 1|Post randomization screen failure|9|||
130784760|NCT02812186|470841164|FG000|Period 1|nonevaluable data sets|6|||
130784761|NCT02812186|470841165|FG001|Period 1|nonevaluable data sets|6|||
130784762|NCT01307787|470841166|FG000|Overall Study|Withdrawal by Subject|2|||
130784763|NCT01307787|470841167|FG001|Overall Study|Withdrawal by Subject|0|||
130784764|NCT01573000|470841168|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
130784765|NCT01573000|470841169|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
130784766|NCT01573000|470841168|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
130784767|NCT01573000|470841169|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
130784768|NCT01573000|470841168|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
130784769|NCT01573000|470841169|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
130784770|NCT01573000|470841168|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
130784771|NCT01573000|470841169|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
130784772|NCT01573000|470841168|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
130784773|NCT01573000|470841169|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
130784774|NCT01573000|470841168|FG000|Crossover Phase|Lack of Efficacy|0|||
130784775|NCT01573000|470841169|FG001|Crossover Phase|Lack of Efficacy|13|||
130784776|NCT01573000|470841168|FG000|Crossover Phase|Lost to Follow-up|0|||
130784777|NCT01573000|470841169|FG001|Crossover Phase|Lost to Follow-up|2|||
130784778|NCT01573000|470841168|FG000|Crossover Phase|Death|0|||
130784779|NCT01573000|470841169|FG001|Crossover Phase|Death|3|||
130784780|NCT01573000|470841168|FG000|Long-Term Follow-Up|Death|3|||
130784781|NCT01573000|470841169|FG001|Long-Term Follow-Up|Death|0|||
130784782|NCT01573000|470841168|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
130784783|NCT01573000|470841169|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
130784784|NCT03353792|470841170|FG000|Overall Study|Lost to Follow-up|1|||
130784785|NCT03353792|470841171|FG001|Overall Study|Lost to Follow-up|0|||
130784786|NCT03353792|470841170|FG000|Overall Study|Participant Unable to Manage Device|1|||
130784787|NCT03353792|470841171|FG001|Overall Study|Participant Unable to Manage Device|0|||
130784788|NCT03342001|470841174|FG000|Overall Study|Adverse Event|1|||
130784789|NCT03342001|470841174|FG000|Overall Study|Lost to Follow-up|1|||
130784790|NCT01433159|470841176|FG000|Overall Study|Adverse Event|1|||
130784791|NCT01433159|470841177|FG001|Overall Study|Adverse Event|0|||
130784792|NCT01433159|470841176|FG000|Overall Study|Physician Decision|1|||
130784793|NCT01433159|470841177|FG001|Overall Study|Physician Decision|0|||
130784794|NCT01433159|470841176|FG000|Overall Study|Protocol Violation|0|||
130784795|NCT01433159|470841177|FG001|Overall Study|Protocol Violation|1|||
130784796|NCT04161391|470841180|FG000|Overall Study|Adverse Event|0|||
130784797|NCT04161391|470841181|FG001|Overall Study|Adverse Event|1|||
130784798|NCT04161391|470841182|FG002|Overall Study|Adverse Event|0|||
130784799|NCT04161391|470841183|FG003|Overall Study|Adverse Event|1|||
130784800|NCT04161391|470841184|FG004|Overall Study|Adverse Event|0|||
130784801|NCT04161391|470841185|FG005|Overall Study|Adverse Event|0|||
130784802|NCT04161391|470841186|FG006|Overall Study|Adverse Event|0|||
130784803|NCT04161391|470841187|FG007|Overall Study|Adverse Event|3|||
130784804|NCT04161391|470841188|FG008|Overall Study|Adverse Event|0|||
130784805|NCT04161391|470841180|FG000|Overall Study|Death|0|||
130784806|NCT04161391|470841181|FG001|Overall Study|Death|0|||
130784807|NCT04161391|470841182|FG002|Overall Study|Death|0|||
130784808|NCT04161391|470841183|FG003|Overall Study|Death|0|||
130784809|NCT04161391|470841184|FG004|Overall Study|Death|0|||
130784810|NCT04161391|470841185|FG005|Overall Study|Death|0|||
130784811|NCT04161391|470841186|FG006|Overall Study|Death|0|||
130784812|NCT04161391|470841187|FG007|Overall Study|Death|1|||
130784813|NCT04161391|470841188|FG008|Overall Study|Death|0|||
130784814|NCT04161391|470841180|FG000|Overall Study|Physician Decision|0|||
130784815|NCT04161391|470841181|FG001|Overall Study|Physician Decision|0|||
130784816|NCT04161391|470841182|FG002|Overall Study|Physician Decision|1|||
130735818|NCT01682811|470651330|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
130735819|NCT01682811|470651331|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
130735820|NCT01682811|470651325|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
130735821|NCT01682811|470651326|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
130735822|NCT01682811|470651327|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
130735823|NCT01682811|470651328|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
130735824|NCT01682811|470651329|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
130735825|NCT01682811|470651330|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
130735826|NCT01682811|470651331|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
130735827|NCT02694328|470651332|FG000|Overall Study|Adverse Event|27|||
130735828|NCT02694328|470651333|FG001|Overall Study|Adverse Event|33|||
130735829|NCT02694328|470651332|FG000|Overall Study|Withdrawal by Subject|27|||
130735830|NCT02694328|470651333|FG001|Overall Study|Withdrawal by Subject|23|||
130735831|NCT02694328|470651332|FG000|Overall Study|Lost to Follow-up|26|||
130735832|NCT02694328|470651333|FG001|Overall Study|Lost to Follow-up|22|||
130735833|NCT02694328|470651332|FG000|Overall Study|Noncompliant with study drug|11|||
130735834|NCT02694328|470651333|FG001|Overall Study|Noncompliant with study drug|8|||
130735835|NCT02694328|470651332|FG000|Overall Study|Incarceration|1|||
130735836|NCT02694328|470651333|FG001|Overall Study|Incarceration|1|||
130735837|NCT02694328|470651332|FG000|Overall Study|Lack of Efficacy|1|||
130735838|NCT02694328|470651333|FG001|Overall Study|Lack of Efficacy|2|||
130735839|NCT02694328|470651332|FG000|Overall Study|Pregnancy|1|||
130735840|NCT02694328|470651333|FG001|Overall Study|Pregnancy|1|||
130735841|NCT02694328|470651332|FG000|Overall Study|Protocol Violation|6|||
130735842|NCT02694328|470651333|FG001|Overall Study|Protocol Violation|5|||
130735843|NCT02694328|470651332|FG000|Overall Study|Abnormal Laboratory Value|0|||
130735844|NCT02694328|470651333|FG001|Overall Study|Abnormal Laboratory Value|3|||
130735845|NCT01260701|470651335|FG000|Overall Study|Adverse Event|9|||
130735846|NCT01260701|470651335|FG000|Overall Study|Withdrawal by Subject|2|||
130735847|NCT01260701|470651335|FG000|Overall Study|Progression|53|||
130735848|NCT01260701|470651335|FG000|Overall Study|Death|2|||
130735849|NCT01260701|470651335|FG000|Overall Study|Not protocol specified|3|||
130735850|NCT01260701|470651335|FG000|Overall Study|Under review|1|||
130735851|NCT01260701|470651335|FG000|Overall Study|Ineligible|4|||
130735852|NCT01260701|470651335|FG000|Overall Study|Did not begin protocol therapy|1|||
130735853|NCT00720382|470651336|FG000|Overall Study|Adverse Event|54|||
130735854|NCT00720382|470651337|FG001|Overall Study|Adverse Event|17|||
130735855|NCT00720382|470651336|FG000|Overall Study|Lack of Efficacy|18|||
130735856|NCT00720382|470651337|FG001|Overall Study|Lack of Efficacy|7|||
130735857|NCT00720382|470651336|FG000|Overall Study|Non-Compliance|15|||
130735858|NCT00720382|470651337|FG001|Overall Study|Non-Compliance|5|||
130735859|NCT00720382|470651336|FG000|Overall Study|Withdrawal by Subject|47|||
130735860|NCT00720382|470651337|FG001|Overall Study|Withdrawal by Subject|11|||
130735861|NCT00720382|470651336|FG000|Overall Study|Lost to Follow-up|28|||
130735862|NCT00720382|470651337|FG001|Overall Study|Lost to Follow-up|14|||
130735863|NCT00720382|470651336|FG000|Overall Study|administrative|14|||
130735864|NCT00720382|470651337|FG001|Overall Study|administrative|5|||
130735865|NCT05192889|470651338|FG000|Block 1: All Eligible Patients|Death|2|||
130735866|NCT05192889|470651339|FG001|Block 1: All Eligible Patients|Death|0|||
130735867|NCT05192889|470651340|FG002|Block 1: All Eligible Patients|Death|0|||
130735868|NCT05192889|470651338|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
130735869|NCT05192889|470651339|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
130735870|NCT05192889|470651340|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
130735871|NCT05192889|470651338|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
130735872|NCT05192889|470651339|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
130735873|NCT05192889|470651340|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
130735874|NCT04205812|470653061|FG000|Randomized Treatment Period|Ongoing|28|||
130735875|NCT04205812|470653062|FG001|Randomized Treatment Period|Ongoing|138|||
130735876|NCT04205812|470653061|FG000|Randomized Treatment Period|Death|94|||
130735877|NCT04205812|470653062|FG001|Randomized Treatment Period|Death|226|||
130735878|NCT04205812|470653061|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
130735879|NCT04205812|470653062|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
130735880|NCT04205812|470653061|FG000|Randomized Treatment Period|Physician Decision|1|||
130735881|NCT04205812|470653062|FG001|Randomized Treatment Period|Physician Decision|4|||
130784817|NCT04161391|470841183|FG003|Overall Study|Physician Decision|2|||
130735882|NCT04205812|470653061|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
130735883|NCT04205812|470653062|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
130735884|NCT04205812|470653061|FG000|Randomized Treatment Period|Progressive Disease|0|||
130735885|NCT04205812|470653062|FG001|Randomized Treatment Period|Progressive Disease|1|||
130735886|NCT04205812|470653061|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
130735887|NCT04205812|470653062|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
130735888|NCT04205812|470653061|FG000|Monotherapy Treatment Period|Ongoing|17|||
130735889|NCT04205812|470653062|FG001|Monotherapy Treatment Period|Ongoing|0|||
130735890|NCT04205812|470653061|FG000|Monotherapy Treatment Period|Death|39|||
130735891|NCT04205812|470653062|FG001|Monotherapy Treatment Period|Death|0|||
130735892|NCT04205812|470653061|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
130784818|NCT04161391|470841184|FG004|Overall Study|Physician Decision|0|||
130735893|NCT04205812|470653062|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
130735894|NCT04205812|470653061|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
130735895|NCT04205812|470653062|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
130735896|NCT05221320|470653063|FG000|Overall Study|Lack of Efficacy|3|||
130735897|NCT05221320|470653064|FG001|Overall Study|Lack of Efficacy|7|||
130735898|NCT05221320|470653065|FG002|Overall Study|Lack of Efficacy|10|||
130735899|NCT05221320|470653066|FG003|Overall Study|Lack of Efficacy|1|||
130735900|NCT05221320|470653067|FG004|Overall Study|Lack of Efficacy|0|||
130735901|NCT05221320|470653068|FG005|Overall Study|Lack of Efficacy|0|||
130735902|NCT05221320|470653063|FG000|Overall Study|Physician Decision|1|||
130735903|NCT05221320|470653064|FG001|Overall Study|Physician Decision|0|||
130735904|NCT05221320|470653065|FG002|Overall Study|Physician Decision|3|||
130735905|NCT05221320|470653066|FG003|Overall Study|Physician Decision|1|||
130735906|NCT05221320|470653067|FG004|Overall Study|Physician Decision|0|||
130735907|NCT05221320|470653068|FG005|Overall Study|Physician Decision|0|||
130735908|NCT05221320|470653063|FG000|Overall Study|Withdrawal by Subject|0|||
130735909|NCT05221320|470653064|FG001|Overall Study|Withdrawal by Subject|3|||
130735910|NCT05221320|470653065|FG002|Overall Study|Withdrawal by Subject|1|||
130735911|NCT05221320|470653066|FG003|Overall Study|Withdrawal by Subject|0|||
130735912|NCT05221320|470653067|FG004|Overall Study|Withdrawal by Subject|0|||
130735913|NCT05221320|470653068|FG005|Overall Study|Withdrawal by Subject|0|||
130735914|NCT05221320|470653063|FG000|Overall Study|Death|0|||
130735915|NCT05221320|470653064|FG001|Overall Study|Death|5|||
130735916|NCT05221320|470653065|FG002|Overall Study|Death|6|||
130735917|NCT05221320|470653066|FG003|Overall Study|Death|0|||
130735918|NCT05221320|470653067|FG004|Overall Study|Death|1|||
130735919|NCT05221320|470653068|FG005|Overall Study|Death|0|||
130735920|NCT06473519|470653069|FG000|Overall Study|Lost to Follow-up|2|||
130735921|NCT06473519|470653070|FG001|Overall Study|Lost to Follow-up|5|||
130735922|NCT06473519|470653069|FG000|Overall Study|Withdrawal by Subject|1|||
130735923|NCT06473519|470653070|FG001|Overall Study|Withdrawal by Subject|4|||
130735924|NCT06473519|470653069|FG000|Overall Study|Randomized but not vaccinated|1|||
130735925|NCT06473519|470653070|FG001|Overall Study|Randomized but not vaccinated|2|||
130735926|NCT02514447|470653072|FG000|Overall Study|Withdrawal by Subject|3|||
130735927|NCT02514447|470653073|FG001|Overall Study|Withdrawal by Subject|1|||
130735928|NCT02514447|470653074|FG002|Overall Study|Withdrawal by Subject|1|||
130735929|NCT02514447|470653075|FG003|Overall Study|Withdrawal by Subject|0|||
130735930|NCT02514447|470653076|FG004|Overall Study|Withdrawal by Subject|0|||
130735931|NCT02514447|470653077|FG005|Overall Study|Withdrawal by Subject|0|||
130735932|NCT02514447|470653078|FG006|Overall Study|Withdrawal by Subject|0|||
130735933|NCT02514447|470653079|FG007|Overall Study|Withdrawal by Subject|1|||
130735934|NCT02514447|470653080|FG008|Overall Study|Withdrawal by Subject|1|||
130735935|NCT02514447|470653072|FG000|Overall Study|Death|24|||
130735936|NCT02514447|470653073|FG001|Overall Study|Death|28|||
130735937|NCT02514447|470653074|FG002|Overall Study|Death|29|||
130735938|NCT02514447|470653075|FG003|Overall Study|Death|0|||
130735939|NCT02514447|470653076|FG004|Overall Study|Death|3|||
130735940|NCT02514447|470653077|FG005|Overall Study|Death|4|||
130735941|NCT02514447|470653078|FG006|Overall Study|Death|8|||
130735942|NCT02514447|470653079|FG007|Overall Study|Death|6|||
130735943|NCT02514447|470653080|FG008|Overall Study|Death|5|||
130735944|NCT02514447|470653072|FG000|Overall Study|Lost to Follow-up|1|||
130735945|NCT02514447|470653073|FG001|Overall Study|Lost to Follow-up|0|||
130735946|NCT02514447|470653074|FG002|Overall Study|Lost to Follow-up|0|||
130735947|NCT02514447|470653075|FG003|Overall Study|Lost to Follow-up|0|||
130735948|NCT02514447|470653076|FG004|Overall Study|Lost to Follow-up|0|||
130735949|NCT02514447|470653077|FG005|Overall Study|Lost to Follow-up|0|||
130735950|NCT02514447|470653078|FG006|Overall Study|Lost to Follow-up|0|||
130735951|NCT02514447|470653079|FG007|Overall Study|Lost to Follow-up|0|||
130735952|NCT02514447|470653080|FG008|Overall Study|Lost to Follow-up|1|||
130735953|NCT02514447|470653072|FG000|Overall Study|Sponsor Termination of Study|0|||
130735954|NCT02514447|470653073|FG001|Overall Study|Sponsor Termination of Study|1|||
130735955|NCT02514447|470653074|FG002|Overall Study|Sponsor Termination of Study|1|||
130735956|NCT02514447|470653075|FG003|Overall Study|Sponsor Termination of Study|0|||
130735957|NCT02514447|470653076|FG004|Overall Study|Sponsor Termination of Study|0|||
130735958|NCT02514447|470653077|FG005|Overall Study|Sponsor Termination of Study|0|||
130735959|NCT02514447|470653078|FG006|Overall Study|Sponsor Termination of Study|0|||
130735960|NCT02514447|470653079|FG007|Overall Study|Sponsor Termination of Study|0|||
130735961|NCT02514447|470653080|FG008|Overall Study|Sponsor Termination of Study|0|||
130735962|NCT02514447|470653072|FG000|Overall Study|Study completion per Investigator|1|||
130735963|NCT02514447|470653073|FG001|Overall Study|Study completion per Investigator|0|||
130735964|NCT02514447|470653074|FG002|Overall Study|Study completion per Investigator|1|||
130735965|NCT02514447|470653075|FG003|Overall Study|Study completion per Investigator|2|||
130735966|NCT02514447|470653076|FG004|Overall Study|Study completion per Investigator|0|||
130735967|NCT02514447|470653077|FG005|Overall Study|Study completion per Investigator|0|||
130735968|NCT02514447|470653078|FG006|Overall Study|Study completion per Investigator|0|||
130735969|NCT02514447|470653079|FG007|Overall Study|Study completion per Investigator|0|||
130735970|NCT02514447|470653080|FG008|Overall Study|Study completion per Investigator|1|||
130735971|NCT05626231|470653081|FG000|Provider Enrollment|Worked part-time|4|||
130735972|NCT05626231|470653081|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
130735973|NCT05626231|470653081|FG000|Provider Enrollment|Non-clinical employee|1|||
130735974|NCT05626231|470653081|FG000|Provider Enrollment|Provider does not see clients|3|||
130735975|NCT05626231|470653081|FG000|Provider Enrollment|Other|5|||
130735976|NCT02653625|470653084|FG000|Overall Study|Adverse Event|1|||
130735977|NCT02653625|470653084|FG000|Overall Study|Non-compliance with Study Drug|1|||
130735978|NCT02653625|470653084|FG000|Overall Study|Protocol Violation|1|||
130735979|NCT02653625|470653084|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
130735980|NCT05377749|470653085|FG000|3 Weeks|Lost to Follow-up|2|||
130735981|NCT05377749|470653086|FG001|3 Weeks|Lost to Follow-up|4|||
130735982|NCT05377749|470653085|FG000|3 Weeks|Withdrawal by Subject|1|||
130735983|NCT05377749|470653086|FG001|3 Weeks|Withdrawal by Subject|1|||
130735984|NCT02762929|470653087|FG000|Overall Study|Adverse Event|0|||
130735985|NCT02762929|470653088|FG001|Overall Study|Adverse Event|0|||
130735986|NCT02762929|470653089|FG002|Overall Study|Adverse Event|0|||
130735987|NCT02762929|470653090|FG003|Overall Study|Adverse Event|1|||
130735988|NCT02762929|470653091|FG004|Overall Study|Adverse Event|0|||
130735989|NCT02762929|470653092|FG005|Overall Study|Adverse Event|0|||
130735990|NCT02762929|470653087|FG000|Overall Study|Lost to Follow-up|1|||
130735991|NCT02762929|470653088|FG001|Overall Study|Lost to Follow-up|2|||
130735992|NCT02762929|470653089|FG002|Overall Study|Lost to Follow-up|0|||
130735993|NCT02762929|470653090|FG003|Overall Study|Lost to Follow-up|1|||
130735994|NCT02762929|470653091|FG004|Overall Study|Lost to Follow-up|0|||
130735995|NCT02762929|470653092|FG005|Overall Study|Lost to Follow-up|0|||
130735996|NCT02762929|470653087|FG000|Overall Study|Withdrawal by Subject|0|||
130735997|NCT02762929|470653088|FG001|Overall Study|Withdrawal by Subject|1|||
130735998|NCT02762929|470653089|FG002|Overall Study|Withdrawal by Subject|0|||
130735999|NCT02762929|470653090|FG003|Overall Study|Withdrawal by Subject|0|||
130736000|NCT02762929|470653091|FG004|Overall Study|Withdrawal by Subject|0|||
130736001|NCT02762929|470653092|FG005|Overall Study|Withdrawal by Subject|0|||
130736002|NCT02762929|470653087|FG000|Overall Study|exclusionary medication disclosed late|0|||
130736003|NCT02762929|470653088|FG001|Overall Study|exclusionary medication disclosed late|0|||
130736004|NCT02762929|470653089|FG002|Overall Study|exclusionary medication disclosed late|0|||
130736005|NCT02762929|470653090|FG003|Overall Study|exclusionary medication disclosed late|1|||
130784819|NCT04161391|470841185|FG005|Overall Study|Physician Decision|0|||
130784820|NCT04161391|470841186|FG006|Overall Study|Physician Decision|2|||
130736006|NCT02762929|470653091|FG004|Overall Study|exclusionary medication disclosed late|0|||
130736007|NCT02762929|470653092|FG005|Overall Study|exclusionary medication disclosed late|0|||
130736008|NCT05024747|470653098|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
130736009|NCT05024747|470653099|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
130736010|NCT05024747|470653098|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
130736011|NCT05024747|470653099|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
130736012|NCT05024747|470653098|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
130736013|NCT05024747|470653099|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
130736014|NCT04123405|470653100|FG000|Overall Study|Adverse Event|1|||
130736015|NCT04123405|470653101|FG001|Overall Study|Adverse Event|2|||
130736016|NCT04123405|470653102|FG002|Overall Study|Adverse Event|3|||
130736017|NCT04123405|470653103|FG003|Overall Study|Adverse Event|3|||
130736018|NCT04123405|470653100|FG000|Overall Study|Exclusion criteria met|1|||
130736019|NCT04123405|470653101|FG001|Overall Study|Exclusion criteria met|2|||
130736020|NCT04123405|470653102|FG002|Overall Study|Exclusion criteria met|0|||
130736021|NCT04123405|470653103|FG003|Overall Study|Exclusion criteria met|2|||
130736022|NCT04123405|470653100|FG000|Overall Study|Withdrawal by Subject|1|||
130736023|NCT04123405|470653101|FG001|Overall Study|Withdrawal by Subject|3|||
130736024|NCT04123405|470653102|FG002|Overall Study|Withdrawal by Subject|0|||
130736025|NCT04123405|470653103|FG003|Overall Study|Withdrawal by Subject|2|||
130736026|NCT04123405|470653100|FG000|Overall Study|Contact to subject lost|0|||
130736027|NCT04123405|470653101|FG001|Overall Study|Contact to subject lost|0|||
130736028|NCT04123405|470653102|FG002|Overall Study|Contact to subject lost|0|||
130736029|NCT04123405|470653103|FG003|Overall Study|Contact to subject lost|1|||
130736030|NCT04123405|470653100|FG000|Overall Study|screening failure|1|||
130736031|NCT04123405|470653101|FG001|Overall Study|screening failure|0|||
130736032|NCT04123405|470653102|FG002|Overall Study|screening failure|0|||
130736033|NCT04123405|470653103|FG003|Overall Study|screening failure|0|||
130736034|NCT01750190|470653104|FG000|Overall Study|Adverse Event|47|||
130736035|NCT01750190|470653105|FG001|Overall Study|Adverse Event|19|||
130736036|NCT01750190|470653104|FG000|Overall Study|Death|38|||
130736037|NCT01750190|470653105|FG001|Overall Study|Death|11|||
130736038|NCT01750190|470653104|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
130736039|NCT01750190|470653105|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
130736040|NCT01750190|470653104|FG000|Overall Study|Lost to Follow-up|28|||
130736041|NCT01750190|470653105|FG001|Overall Study|Lost to Follow-up|7|||
130736042|NCT01750190|470653104|FG000|Overall Study|Physician Decision|16|||
130736043|NCT01750190|470653105|FG001|Overall Study|Physician Decision|17|||
130736044|NCT01750190|470653104|FG000|Overall Study|Protocol Violation|6|||
130736045|NCT01750190|470653105|FG001|Overall Study|Protocol Violation|5|||
130736046|NCT01750190|470653104|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
130736047|NCT01750190|470653105|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
130736048|NCT01750190|470653104|FG000|Overall Study|Withdrawal by Subject|83|||
130736049|NCT01750190|470653105|FG001|Overall Study|Withdrawal by Subject|89|||
130736050|NCT01750190|470653104|FG000|Overall Study|Kidney Transplant|8|||
130736051|NCT01750190|470653105|FG001|Overall Study|Kidney Transplant|4|||
130736052|NCT01750190|470653104|FG000|Overall Study|Dialysis|22|||
130736053|NCT01750190|470653105|FG001|Overall Study|Dialysis|8|||
130736054|NCT01750190|470653104|FG000|Overall Study|Other than Specified|13|||
130736055|NCT01750190|470653105|FG001|Overall Study|Other than Specified|4|||
130736056|NCT02009722|470653106|FG000|Overall Study|Protocol Violation|1|||
130736057|NCT02009722|470653107|FG001|Overall Study|Protocol Violation|2|||
130736058|NCT02009722|470653106|FG000|Overall Study|Did not receive intervention|0|||
130736059|NCT02009722|470653107|FG001|Overall Study|Did not receive intervention|1|||
130736060|NCT02955212|470653108|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
130736061|NCT02955212|470653109|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
130736062|NCT02955212|470653108|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
130736063|NCT02955212|470653109|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
130736064|NCT02955212|470653108|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
130736065|NCT02955212|470653109|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
130736066|NCT02955212|470653108|FG000|Period 1: Double-blind Treatment Period|Other|3|||
130736067|NCT02955212|470653109|FG001|Period 1: Double-blind Treatment Period|Other|2|||
130736068|NCT02955212|470653108|FG000|Period 2: Open-label Extension|Adverse Event|11|||
130736069|NCT02955212|470653109|FG001|Period 2: Open-label Extension|Adverse Event|7|||
130736070|NCT02955212|470653108|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
130736071|NCT02955212|470653109|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
130736072|NCT02955212|470653108|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
130736073|NCT02955212|470653109|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
130736074|NCT02955212|470653108|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
130736075|NCT02955212|470653109|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
130736076|NCT02955212|470653108|FG000|Period 2: Open-label Extension|Other|2|||
130736077|NCT02955212|470653109|FG001|Period 2: Open-label Extension|Other|4|||
130784821|NCT04161391|470841187|FG007|Overall Study|Physician Decision|0|||
130736078|NCT00545714|470653114|FG000|Induction Phase (6 Months)|Physician Decision|3|||
130784822|NCT04161391|470841188|FG008|Overall Study|Physician Decision|0|||
130736079|NCT00545714|470653114|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
130736080|NCT00545714|470653114|FG000|Induction Phase (6 Months)|Disease Progression|1|||
130736081|NCT00545714|470653114|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
130736082|NCT00545714|470653114|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
130736083|NCT00545714|470653114|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
130736084|NCT00545714|470653114|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
130736085|NCT00545714|470653114|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
130736086|NCT00545714|470653114|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
130736087|NCT00545714|470653114|FG000|Maintenance Phase (36 Months)|Death|2|||
130736088|NCT04428034|470653115|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
130736089|NCT02556801|470653116|FG000|Overall Study|Lost to Follow-up|1|||
130736090|NCT02556801|470653117|FG001|Overall Study|Lost to Follow-up|0|||
130736091|NCT02556801|470653118|FG002|Overall Study|Lost to Follow-up|2|||
130784823|NCT04161391|470841180|FG000|Overall Study|Progressive Disease|4|||
130784824|NCT04161391|470841181|FG001|Overall Study|Progressive Disease|3|||
130784825|NCT04161391|470841182|FG002|Overall Study|Progressive Disease|3|||
130784826|NCT04161391|470841183|FG003|Overall Study|Progressive Disease|5|||
130784827|NCT04161391|470841184|FG004|Overall Study|Progressive Disease|3|||
130784828|NCT04161391|470841185|FG005|Overall Study|Progressive Disease|3|||
130784829|NCT04161391|470841186|FG006|Overall Study|Progressive Disease|5|||
130784830|NCT04161391|470841187|FG007|Overall Study|Progressive Disease|2|||
130784831|NCT04161391|470841188|FG008|Overall Study|Progressive Disease|2|||
130784832|NCT01190891|470841191|FG000|Overall Study|Protocol Violation|1|||
130784833|NCT01190891|470841192|FG001|Overall Study|Protocol Violation|0|||
130784834|NCT01190891|470841191|FG000|Overall Study|Withdrawal by Subject|5|||
130784835|NCT01190891|470841192|FG001|Overall Study|Withdrawal by Subject|0|||
130784836|NCT01130272|470841193|FG000|Overall Study|Adverse Event|2|||
130784837|NCT01130272|470841194|FG001|Overall Study|Adverse Event|5|||
130784838|NCT01130272|470841195|FG002|Overall Study|Adverse Event|6|||
130784839|NCT01130272|470841196|FG003|Overall Study|Adverse Event|22|||
130784840|NCT01130272|470841197|FG004|Overall Study|Adverse Event|7|||
130784841|NCT01130272|470841193|FG000|Overall Study|IVRS-confirmed constipation|0|||
130784842|NCT01130272|470841194|FG001|Overall Study|IVRS-confirmed constipation|1|||
130784843|NCT01130272|470841195|FG002|Overall Study|IVRS-confirmed constipation|1|||
130784844|NCT01130272|470841196|FG003|Overall Study|IVRS-confirmed constipation|2|||
130784845|NCT01130272|470841197|FG004|Overall Study|IVRS-confirmed constipation|0|||
130784846|NCT01130272|470841193|FG000|Overall Study|Rescue medications due to diarrhea|3|||
130784847|NCT01130272|470841194|FG001|Overall Study|Rescue medications due to diarrhea|5|||
130784848|NCT01130272|470841195|FG002|Overall Study|Rescue medications due to diarrhea|8|||
130736092|NCT02556801|470653119|FG003|Overall Study|Lost to Follow-up|0|||
130736093|NCT02556801|470653116|FG000|Overall Study|Withdrawal by Subject|1|||
130736094|NCT02556801|470653117|FG001|Overall Study|Withdrawal by Subject|1|||
130736095|NCT02556801|470653118|FG002|Overall Study|Withdrawal by Subject|1|||
130736096|NCT02556801|470653119|FG003|Overall Study|Withdrawal by Subject|0|||
130736097|NCT02556801|470653116|FG000|Overall Study|Protocol Violation|0|||
130736098|NCT02556801|470653117|FG001|Overall Study|Protocol Violation|3|||
130736099|NCT02556801|470653118|FG002|Overall Study|Protocol Violation|1|||
130736100|NCT02556801|470653119|FG003|Overall Study|Protocol Violation|1|||
130736101|NCT02556801|470653116|FG000|Overall Study|Adverse Event|0|||
130736102|NCT02556801|470653117|FG001|Overall Study|Adverse Event|2|||
130736103|NCT02556801|470653118|FG002|Overall Study|Adverse Event|0|||
130736104|NCT02556801|470653119|FG003|Overall Study|Adverse Event|3|||
130736105|NCT02556801|470653116|FG000|Overall Study|Pregnancy|0|||
130736106|NCT02556801|470653117|FG001|Overall Study|Pregnancy|1|||
130736107|NCT02556801|470653118|FG002|Overall Study|Pregnancy|0|||
130736108|NCT02556801|470653119|FG003|Overall Study|Pregnancy|0|||
130736109|NCT02556801|470653116|FG000|Overall Study|Personal reasons patient|0|||
130736110|NCT02556801|470653117|FG001|Overall Study|Personal reasons patient|0|||
130736111|NCT02556801|470653118|FG002|Overall Study|Personal reasons patient|0|||
130736112|NCT02556801|470653119|FG003|Overall Study|Personal reasons patient|1|||
130736113|NCT03934541|470653127|FG000|Overall Study|Study Terminated by Sponsor|0|||
130736114|NCT03934541|470653128|FG001|Overall Study|Study Terminated by Sponsor|1|||
130736115|NCT03934541|470653129|FG002|Overall Study|Study Terminated by Sponsor|0|||
130736116|NCT03934541|470653130|FG003|Overall Study|Study Terminated by Sponsor|0|||
130736117|NCT02673775|470653131|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
130784849|NCT01130272|470841196|FG003|Overall Study|Rescue medications due to diarrhea|8|||
130784850|NCT01130272|470841197|FG004|Overall Study|Rescue medications due to diarrhea|6|||
130736118|NCT02673775|470653132|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
130736119|NCT02673775|470653131|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
130736120|NCT02673775|470653132|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
130736121|NCT02673775|470653131|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
130736122|NCT02673775|470653132|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
130736123|NCT02673775|470653131|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
130736124|NCT02673775|470653132|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
130736125|NCT04194645|470653135|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736126|NCT04194645|470653136|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736127|NCT04194645|470653137|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736128|NCT04194645|470653138|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736129|NCT04194645|470653139|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736130|NCT04194645|470653140|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736131|NCT04194645|470653141|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736132|NCT04194645|470653142|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736133|NCT04194645|470653143|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736134|NCT04194645|470653144|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
130736135|NCT04194645|470653145|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736136|NCT04194645|470653146|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736137|NCT04194645|470653147|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736138|NCT04194645|470653148|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736139|NCT04194645|470653149|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130736140|NCT03076775|470653150|FG000|Overall Study|Lost to Follow-up|1|||
130736141|NCT03076775|470653151|FG001|Overall Study|Lost to Follow-up|0|||
130736142|NCT01783886|470653152|FG000|Overall Study|Lost to Follow-up|0|||
130736143|NCT01783886|470653153|FG001|Overall Study|Lost to Follow-up|3|||
130736144|NCT01783886|470653154|FG002|Overall Study|Lost to Follow-up|0|||
130736145|NCT01783886|470653152|FG000|Overall Study|Protocol deviation|0|||
130736146|NCT01783886|470653153|FG001|Overall Study|Protocol deviation|0|||
130736147|NCT01783886|470653154|FG002|Overall Study|Protocol deviation|2|||
130736148|NCT01783886|470653152|FG000|Overall Study|Withdrawal of consent by participant|1|||
130736149|NCT01783886|470653153|FG001|Overall Study|Withdrawal of consent by participant|3|||
130736150|NCT01783886|470653154|FG002|Overall Study|Withdrawal of consent by participant|4|||
130736151|NCT01783886|470653152|FG000|Overall Study|Adverse Event|4|||
130736152|NCT01783886|470653153|FG001|Overall Study|Adverse Event|5|||
130736153|NCT01783886|470653154|FG002|Overall Study|Adverse Event|4|||
130736154|NCT04542057|470653155|FG000|Overall Study|Death|3|||
130736155|NCT04542057|470653156|FG001|Overall Study|Death|1|||
130736156|NCT04542057|470653155|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
130736157|NCT04542057|470653156|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
130784851|NCT01130272|470841193|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
130736158|NCT04542057|470653155|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
130736159|NCT04542057|470653156|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
130736160|NCT04542057|470653155|FG000|Overall Study|Adverse Event|15|||
130736161|NCT04542057|470653156|FG001|Overall Study|Adverse Event|6|||
130784852|NCT01130272|470841194|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
130736162|NCT04542057|470653155|FG000|Overall Study|COVID-19 adverse event|6|||
130736163|NCT04542057|470653156|FG001|Overall Study|COVID-19 adverse event|4|||
130736164|NCT04542057|470653155|FG000|Overall Study|Lack of Efficacy|2|||
130736165|NCT04542057|470653156|FG001|Overall Study|Lack of Efficacy|5|||
130736166|NCT04542057|470653155|FG000|Overall Study|Study terminated by sponsor|1|||
130736167|NCT04542057|470653156|FG001|Overall Study|Study terminated by sponsor|0|||
130736168|NCT04542057|470653155|FG000|Overall Study|Investigator discretion|2|||
130736169|NCT04542057|470653156|FG001|Overall Study|Investigator discretion|1|||
130736170|NCT04542057|470653155|FG000|Overall Study|Withdrawal by Subject|52|||
130736171|NCT04542057|470653156|FG001|Overall Study|Withdrawal by Subject|30|||
130736172|NCT04542057|470653155|FG000|Overall Study|Lost to Follow-up|8|||
130736173|NCT04542057|470653156|FG001|Overall Study|Lost to Follow-up|11|||
130736174|NCT04542057|470653155|FG000|Overall Study|Other|2|||
130736175|NCT04542057|470653156|FG001|Overall Study|Other|2|||
130736176|NCT00104572|470653157|FG000|Overall Study|Withdrawal by Subject|3|||
130736177|NCT00104572|470653158|FG001|Overall Study|Withdrawal by Subject|3|||
130736178|NCT00104572|470653159|FG002|Overall Study|Withdrawal by Subject|0|||
130736179|NCT00940316|470653162|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
130736180|NCT00940316|470653163|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
130736181|NCT00940316|470653164|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
130736182|NCT00940316|470653162|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
130736183|NCT00940316|470653163|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
130736184|NCT00940316|470653164|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
130736185|NCT00940316|470653162|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
130736186|NCT00940316|470653163|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
130736187|NCT00940316|470653164|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
130736188|NCT00940316|470653162|FG000|Treated After Cycle 5|Adverse Event|0|||
130736189|NCT00940316|470653163|FG001|Treated After Cycle 5|Adverse Event|0|||
130736190|NCT00940316|470653164|FG002|Treated After Cycle 5|Adverse Event|1|||
130736191|NCT00940316|470653162|FG000|Treated After Cycle 5|Progressive disease|0|||
130736192|NCT00940316|470653163|FG001|Treated After Cycle 5|Progressive disease|1|||
130736193|NCT00940316|470653164|FG002|Treated After Cycle 5|Progressive disease|0|||
130736194|NCT02290405|470653168|FG000|Overall Study|Withdrawal by Subject|1|||
130736195|NCT02290405|470653169|FG001|Overall Study|Withdrawal by Subject|0|||
130736196|NCT02016183|470653170|FG000|Overall Study|Case Report Forms Uncollected|13|||
130736197|NCT02016183|470653170|FG000|Overall Study|Protocol Violation|52|||
130736198|NCT00996489|470653171|FG000|Overall Study|Device failure|45|||
130736199|NCT00996489|470653171|FG000|Overall Study|Discontinued|116|||
130736200|NCT03142191|470653172|FG000|Placebo Controlled Period|Death|0|||
130736201|NCT03142191|470653173|FG001|Placebo Controlled Period|Death|1|||
130736202|NCT03142191|470653174|FG002|Placebo Controlled Period|Death|1|||
130736203|NCT03142191|470653175|FG003|Placebo Controlled Period|Death|0|||
130736204|NCT03142191|470653176|FG004|Placebo Controlled Period|Death|0|||
130736205|NCT03142191|470653172|FG000|Placebo Controlled Period|Adverse Event|4|||
130736206|NCT03142191|470653173|FG001|Placebo Controlled Period|Adverse Event|5|||
130736207|NCT03142191|470653174|FG002|Placebo Controlled Period|Adverse Event|1|||
130736208|NCT03142191|470653175|FG003|Placebo Controlled Period|Adverse Event|0|||
130736209|NCT03142191|470653176|FG004|Placebo Controlled Period|Adverse Event|0|||
130736210|NCT03142191|470653172|FG000|Placebo Controlled Period|Progressive Disease|1|||
130736211|NCT03142191|470653173|FG001|Placebo Controlled Period|Progressive Disease|0|||
130736212|NCT03142191|470653174|FG002|Placebo Controlled Period|Progressive Disease|1|||
130736213|NCT03142191|470653175|FG003|Placebo Controlled Period|Progressive Disease|0|||
130736214|NCT03142191|470653176|FG004|Placebo Controlled Period|Progressive Disease|0|||
130736215|NCT03142191|470653172|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
130736216|NCT03142191|470653173|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
130736217|NCT03142191|470653174|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
130736218|NCT03142191|470653175|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
130736219|NCT03142191|470653176|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
130736220|NCT03142191|470653172|FG000|Placebo Controlled Period|Other Reasons|1|||
130736221|NCT03142191|470653173|FG001|Placebo Controlled Period|Other Reasons|0|||
130736222|NCT03142191|470653174|FG002|Placebo Controlled Period|Other Reasons|0|||
130736223|NCT03142191|470653175|FG003|Placebo Controlled Period|Other Reasons|0|||
130736224|NCT03142191|470653176|FG004|Placebo Controlled Period|Other Reasons|0|||
130736225|NCT03142191|470653172|FG000|Active Treatment Extension Period|Death|2|||
130736226|NCT03142191|470653173|FG001|Active Treatment Extension Period|Death|1|||
130736227|NCT03142191|470653174|FG002|Active Treatment Extension Period|Death|1|||
130736228|NCT03142191|470653175|FG003|Active Treatment Extension Period|Death|1|||
130736229|NCT03142191|470653176|FG004|Active Treatment Extension Period|Death|0|||
130736230|NCT03142191|470653172|FG000|Active Treatment Extension Period|Adverse Event|6|||
130736231|NCT03142191|470653173|FG001|Active Treatment Extension Period|Adverse Event|5|||
130736232|NCT03142191|470653174|FG002|Active Treatment Extension Period|Adverse Event|4|||
130736233|NCT03142191|470653175|FG003|Active Treatment Extension Period|Adverse Event|1|||
130736234|NCT03142191|470653176|FG004|Active Treatment Extension Period|Adverse Event|0|||
130736235|NCT03142191|470653172|FG000|Active Treatment Extension Period|Progressive Disease|10|||
130736236|NCT03142191|470653173|FG001|Active Treatment Extension Period|Progressive Disease|5|||
130736237|NCT03142191|470653174|FG002|Active Treatment Extension Period|Progressive Disease|4|||
130736238|NCT03142191|470653175|FG003|Active Treatment Extension Period|Progressive Disease|1|||
130736239|NCT03142191|470653176|FG004|Active Treatment Extension Period|Progressive Disease|2|||
130736240|NCT03142191|470653172|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
130736241|NCT03142191|470653173|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
130736242|NCT03142191|470653174|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
130736243|NCT03142191|470653175|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
130736244|NCT03142191|470653176|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
130736245|NCT03142191|470653172|FG000|Active Treatment Extension Period|Physician Decision|2|||
130736246|NCT03142191|470653173|FG001|Active Treatment Extension Period|Physician Decision|0|||
130736247|NCT03142191|470653174|FG002|Active Treatment Extension Period|Physician Decision|0|||
130736248|NCT03142191|470653175|FG003|Active Treatment Extension Period|Physician Decision|0|||
130736249|NCT03142191|470653176|FG004|Active Treatment Extension Period|Physician Decision|0|||
130736250|NCT03142191|470653172|FG000|Active Treatment Extension Period|Other Reasons|3|||
130736251|NCT03142191|470653173|FG001|Active Treatment Extension Period|Other Reasons|3|||
130736252|NCT03142191|470653174|FG002|Active Treatment Extension Period|Other Reasons|3|||
130736253|NCT03142191|470653175|FG003|Active Treatment Extension Period|Other Reasons|8|||
130736254|NCT03142191|470653176|FG004|Active Treatment Extension Period|Other Reasons|3|||
130736255|NCT03142191|470653172|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
130736256|NCT03142191|470653173|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
130736257|NCT03142191|470653174|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
130736258|NCT03142191|470653175|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
130736259|NCT03142191|470653176|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
130736260|NCT00770328|470653179|FG000|Overall Study|Adverse Event|11|||
130736261|NCT00770328|470653180|FG001|Overall Study|Adverse Event|2|||
130736262|NCT00770328|470653179|FG000|Overall Study|Lost to Follow-up|2|||
130736263|NCT00770328|470653180|FG001|Overall Study|Lost to Follow-up|2|||
130736264|NCT03452943|470653181|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
130736265|NCT03452943|470653182|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
130736266|NCT03452943|470653181|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
130736267|NCT03452943|470653182|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
130736268|NCT03452943|470653181|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
130736269|NCT03452943|470653182|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
130736270|NCT03452943|470653181|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
130736271|NCT03452943|470653182|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
130736272|NCT03452943|470653181|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
130736273|NCT03452943|470653182|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
130736274|NCT03452943|470653181|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
130736275|NCT03452943|470653182|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
130736276|NCT04502212|470653185|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
130736277|NCT04502212|470653185|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
130736278|NCT02096744|470653186|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
130736279|NCT02096744|470653187|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
130736280|NCT02096744|470653186|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
130736281|NCT02096744|470653187|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
130736282|NCT02096744|470653186|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
130736283|NCT02096744|470653187|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
130736284|NCT03086551|470653188|FG000|First Intervention|Failure to meet inclusion criterion|1|||
130736285|NCT03086551|470653189|FG001|First Intervention|Failure to meet inclusion criterion|0|||
130736286|NCT03086551|470653188|FG000|First Intervention|Lost to Follow-up|0|||
130736287|NCT03086551|470653189|FG001|First Intervention|Lost to Follow-up|1|||
130736288|NCT03086551|470653188|FG000|Washout|Lost to Follow-up|1|||
130736289|NCT03086551|470653189|FG001|Washout|Lost to Follow-up|2|||
130736290|NCT03086551|470653188|FG000|Washout|Withdrawal by Subject|2|||
130736291|NCT03086551|470653189|FG001|Washout|Withdrawal by Subject|1|||
130736292|NCT00625872|470653192|FG000|Overall Study|Withdrawal by Subject|1|||
130736293|NCT00625872|470653193|FG001|Overall Study|Withdrawal by Subject|0|||
130736294|NCT00625872|470653192|FG000|Overall Study|Does not meet inclusion criteria|1|||
130736295|NCT00625872|470653193|FG001|Overall Study|Does not meet inclusion criteria|0|||
130736296|NCT00625872|470653192|FG000|Overall Study|Terminated by sponsor|2|||
130736297|NCT00625872|470653193|FG001|Overall Study|Terminated by sponsor|5|||
130736298|NCT00625872|470653192|FG000|Overall Study|Randomized but not treated|0|||
130736299|NCT00625872|470653193|FG001|Overall Study|Randomized but not treated|1|||
130736300|NCT04208750|470653194|FG000|Overall Study|Lost to Follow-up|16|||
130736301|NCT04208750|470653195|FG001|Overall Study|Lost to Follow-up|15|||
130736302|NCT02201277|470653196|FG000|Overall Study|Death|3|||
130736303|NCT02201277|470653197|FG001|Overall Study|Death|4|||
130736304|NCT02201277|470653196|FG000|Overall Study|Lost to Follow-up|2|||
130736305|NCT02201277|470653197|FG001|Overall Study|Lost to Follow-up|1|||
130736306|NCT02201277|470653196|FG000|Overall Study|Failed retrieval|1|||
130736307|NCT02201277|470653197|FG001|Overall Study|Failed retrieval|0|||
130736308|NCT02201277|470653196|FG000|Overall Study|Physician Decision|1|||
130736309|NCT02201277|470653197|FG001|Overall Study|Physician Decision|0|||
130736310|NCT03485352|470653198|FG000|Overall Study|Lost to Follow-up|9|||
130736311|NCT01512160|470653199|FG000|Overall Study|Lost to Follow-up|1|||
130736312|NCT01512160|470653200|FG001|Overall Study|Lost to Follow-up|0|||
130736313|NCT01512160|470653201|FG002|Overall Study|Lost to Follow-up|0|||
130736314|NCT01512160|470653202|FG003|Overall Study|Lost to Follow-up|0|||
130736315|NCT01512160|470653199|FG000|Overall Study|Withdrawal by Subject|1|||
130736316|NCT01512160|470653200|FG001|Overall Study|Withdrawal by Subject|0|||
130736317|NCT01512160|470653201|FG002|Overall Study|Withdrawal by Subject|0|||
130736318|NCT01512160|470653202|FG003|Overall Study|Withdrawal by Subject|1|||
130736319|NCT02163057|470653204|FG000|Overall Study|Participant Refusal to Continue|2|||
130736320|NCT02163057|470653205|FG001|Overall Study|Participant Refusal to Continue|2|||
130736321|NCT02163057|470653204|FG000|Overall Study|Participant Significant Noncompliance|0|||
130736322|NCT02163057|470653205|FG001|Overall Study|Participant Significant Noncompliance|1|||
130736323|NCT02163057|470653204|FG000|Overall Study|Progression of Disease|1|||
130736324|NCT02163057|470653205|FG001|Overall Study|Progression of Disease|2|||
130736325|NCT01959295|470653206|FG000|Overall Study|Adverse Event|2|||
130736326|NCT01959295|470653207|FG001|Overall Study|Adverse Event|0|||
130736327|NCT01959295|470653206|FG000|Overall Study|Lost to Follow-up|0|||
130736328|NCT01959295|470653207|FG001|Overall Study|Lost to Follow-up|2|||
130736329|NCT01959295|470653206|FG000|Overall Study|Physician Decision|2|||
130736330|NCT01959295|470653207|FG001|Overall Study|Physician Decision|3|||
130736331|NCT01959295|470653206|FG000|Overall Study|Protocol Violation|16|||
130736332|NCT01959295|470653207|FG001|Overall Study|Protocol Violation|5|||
130736333|NCT01959295|470653206|FG000|Overall Study|Withdrawal by Subject|3|||
130736334|NCT01959295|470653207|FG001|Overall Study|Withdrawal by Subject|1|||
130736335|NCT01959295|470653206|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
130736336|NCT01959295|470653207|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
130736337|NCT04903288|470654590|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
130736338|NCT04903288|470654590|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
130736339|NCT04903288|470654590|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
130736340|NCT04903288|470654590|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
130736341|NCT02498613|470654595|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
130736342|NCT02498613|470654596|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
130736343|NCT02498613|470654597|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
130736344|NCT02498613|470654598|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
130736345|NCT02498613|470654595|FG000|Overall Study|Withdrawal by Subject|3|||
130736346|NCT02498613|470654596|FG001|Overall Study|Withdrawal by Subject|1|||
130736347|NCT02498613|470654597|FG002|Overall Study|Withdrawal by Subject|0|||
130736348|NCT02498613|470654598|FG003|Overall Study|Withdrawal by Subject|0|||
130736349|NCT05168202|470654599|FG000|Overall Study|Progressive Disease|4|||
130736350|NCT05168202|470654600|FG001|Overall Study|Progressive Disease|4|||
130736351|NCT05168202|470654601|FG002|Overall Study|Progressive Disease|2|||
130736352|NCT05168202|470654602|FG003|Overall Study|Progressive Disease|3|||
130736353|NCT05168202|470654603|FG004|Overall Study|Progressive Disease|2|||
130736354|NCT05168202|470654604|FG005|Overall Study|Progressive Disease|3|||
130736355|NCT05168202|470654605|FG006|Overall Study|Progressive Disease|2|||
130736356|NCT05168202|470654599|FG000|Overall Study|Adverse Event|2|||
130736357|NCT05168202|470654600|FG001|Overall Study|Adverse Event|1|||
130736358|NCT05168202|470654601|FG002|Overall Study|Adverse Event|4|||
130736359|NCT05168202|470654602|FG003|Overall Study|Adverse Event|4|||
130736360|NCT05168202|470654603|FG004|Overall Study|Adverse Event|3|||
130736361|NCT05168202|470654604|FG005|Overall Study|Adverse Event|2|||
130736362|NCT05168202|470654605|FG006|Overall Study|Adverse Event|0|||
130736363|NCT05168202|470654599|FG000|Overall Study|Lack of Efficacy|0|||
130736364|NCT05168202|470654600|FG001|Overall Study|Lack of Efficacy|1|||
130736365|NCT05168202|470654601|FG002|Overall Study|Lack of Efficacy|1|||
130736366|NCT05168202|470654602|FG003|Overall Study|Lack of Efficacy|0|||
130736367|NCT05168202|470654603|FG004|Overall Study|Lack of Efficacy|1|||
130736368|NCT05168202|470654604|FG005|Overall Study|Lack of Efficacy|2|||
130736369|NCT05168202|470654605|FG006|Overall Study|Lack of Efficacy|2|||
130736370|NCT05168202|470654599|FG000|Overall Study|Withdrawal by Subject|0|||
130736371|NCT05168202|470654600|FG001|Overall Study|Withdrawal by Subject|0|||
130736372|NCT05168202|470654601|FG002|Overall Study|Withdrawal by Subject|1|||
130736373|NCT05168202|470654602|FG003|Overall Study|Withdrawal by Subject|1|||
130736374|NCT05168202|470654603|FG004|Overall Study|Withdrawal by Subject|1|||
130736375|NCT05168202|470654604|FG005|Overall Study|Withdrawal by Subject|1|||
130736376|NCT05168202|470654605|FG006|Overall Study|Withdrawal by Subject|0|||
130736377|NCT05168202|470654599|FG000|Overall Study|Disease Relapse|0|||
130736378|NCT05168202|470654600|FG001|Overall Study|Disease Relapse|1|||
130736379|NCT05168202|470654601|FG002|Overall Study|Disease Relapse|0|||
130736380|NCT05168202|470654602|FG003|Overall Study|Disease Relapse|1|||
130736381|NCT05168202|470654603|FG004|Overall Study|Disease Relapse|1|||
130736382|NCT05168202|470654604|FG005|Overall Study|Disease Relapse|0|||
130736383|NCT05168202|470654605|FG006|Overall Study|Disease Relapse|0|||
130736384|NCT05168202|470654599|FG000|Overall Study|Other Reasons|0|||
130736385|NCT05168202|470654600|FG001|Overall Study|Other Reasons|0|||
130736386|NCT05168202|470654601|FG002|Overall Study|Other Reasons|0|||
130736387|NCT05168202|470654602|FG003|Overall Study|Other Reasons|0|||
130736388|NCT05168202|470654603|FG004|Overall Study|Other Reasons|0|||
130736389|NCT05168202|470654604|FG005|Overall Study|Other Reasons|2|||
130736390|NCT05168202|470654605|FG006|Overall Study|Other Reasons|1|||
130736391|NCT05168202|470654599|FG000|Overall Study|Physician Decision|0|||
130736392|NCT05168202|470654600|FG001|Overall Study|Physician Decision|1|||
130736393|NCT05168202|470654601|FG002|Overall Study|Physician Decision|1|||
130736394|NCT05168202|470654602|FG003|Overall Study|Physician Decision|0|||
130736395|NCT05168202|470654603|FG004|Overall Study|Physician Decision|0|||
130736396|NCT05168202|470654604|FG005|Overall Study|Physician Decision|0|||
130736397|NCT05168202|470654605|FG006|Overall Study|Physician Decision|0|||
130736398|NCT05168202|470654599|FG000|Overall Study|Study Terminated by Sponsor|0|||
130736399|NCT05168202|470654600|FG001|Overall Study|Study Terminated by Sponsor|0|||
130736400|NCT05168202|470654601|FG002|Overall Study|Study Terminated by Sponsor|0|||
130736401|NCT05168202|470654602|FG003|Overall Study|Study Terminated by Sponsor|1|||
130736402|NCT05168202|470654603|FG004|Overall Study|Study Terminated by Sponsor|0|||
130736403|NCT05168202|470654604|FG005|Overall Study|Study Terminated by Sponsor|0|||
130736404|NCT05168202|470654605|FG006|Overall Study|Study Terminated by Sponsor|0|||
130736405|NCT05878093|470654606|FG000|Overall Study|Withdrawal by Subject|3|||
130736406|NCT05878093|470654607|FG001|Overall Study|Withdrawal by Subject|1|||
130736407|NCT03690388|470654610|FG000|Overall Study|Adverse Event|8|||
130736408|NCT03690388|470654611|FG001|Overall Study|Adverse Event|1|||
130736409|NCT03690388|470654610|FG000|Overall Study|Radiographic Progression|14|||
130736410|NCT03690388|470654611|FG001|Overall Study|Radiographic Progression|29|||
130736411|NCT03690388|470654610|FG000|Overall Study|Clinical deterioration|10|||
130736412|NCT03690388|470654611|FG001|Overall Study|Clinical deterioration|6|||
130736413|NCT03690388|470654610|FG000|Overall Study|Withdrawal by Subject|2|||
130736414|NCT03690388|470654611|FG001|Overall Study|Withdrawal by Subject|0|||
130736415|NCT03690388|470654610|FG000|Overall Study|Lack of Efficacy|1|||
130736416|NCT03690388|470654611|FG001|Overall Study|Lack of Efficacy|0|||
130736417|NCT03690388|470654610|FG000|Overall Study|Lost to Follow-up|1|||
130736418|NCT03690388|470654611|FG001|Overall Study|Lost to Follow-up|0|||
130736419|NCT04100018|470654613|FG000|Pre-Treatment Period|Not Reported|0|||
130736420|NCT04100018|470654614|FG001|Pre-Treatment Period|Not Reported|4|||
130736421|NCT04100018|470654613|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
130736422|NCT04100018|470654614|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
130736423|NCT04100018|470654613|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
130736424|NCT04100018|470654614|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
130736425|NCT04100018|470654613|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
130736426|NCT04100018|470654614|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130736427|NCT04100018|470654613|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130736428|NCT04100018|470654614|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
130736429|NCT04100018|470654613|FG000|Treatment Period|Ongoing Treatment|1|||
130736430|NCT04100018|470654614|FG001|Treatment Period|Ongoing Treatment|0|||
130736431|NCT04100018|470654613|FG000|Treatment Period|Other Reason|26|||
130736432|NCT04100018|470654614|FG001|Treatment Period|Other Reason|37|||
130736433|NCT04100018|470654613|FG000|Treatment Period|Completed treatment as per protocol|1|||
130736434|NCT04100018|470654614|FG001|Treatment Period|Completed treatment as per protocol|2|||
130736435|NCT04100018|470654613|FG000|Treatment Period|Maximum clinical benefit|3|||
130736436|NCT04100018|470654614|FG001|Treatment Period|Maximum clinical benefit|0|||
130736437|NCT04100018|470654613|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
130736438|NCT04100018|470654614|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
130736439|NCT04100018|470654613|FG000|Treatment Period|Study drug toxicity|67|||
130736440|NCT04100018|470654614|FG001|Treatment Period|Study drug toxicity|28|||
130736441|NCT04100018|470654613|FG000|Treatment Period|Disease Progression|284|||
130736442|NCT04100018|470654614|FG001|Treatment Period|Disease Progression|327|||
130736443|NCT04100018|470654613|FG000|Treatment Period|Administrative reasons by sponsor|16|||
130736444|NCT04100018|470654614|FG001|Treatment Period|Administrative reasons by sponsor|30|||
130736445|NCT04100018|470654613|FG000|Treatment Period|Poor/Non-Compliance|1|||
130736446|NCT04100018|470654614|FG001|Treatment Period|Poor/Non-Compliance|0|||
130736447|NCT04100018|470654613|FG000|Treatment Period|Lost to Follow-up|2|||
130736448|NCT04100018|470654614|FG001|Treatment Period|Lost to Follow-up|2|||
130736449|NCT04100018|470654613|FG000|Treatment Period|Death|16|||
130736450|NCT04100018|470654614|FG001|Treatment Period|Death|11|||
130736451|NCT04100018|470654613|FG000|Treatment Period|Participant withdrew consent|10|||
130736452|NCT04100018|470654614|FG001|Treatment Period|Participant withdrew consent|10|||
130736453|NCT04100018|470654613|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
130736454|NCT04100018|470654614|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
130736455|NCT04100018|470654613|FG000|Treatment Period|Adverse Event|14|||
130736456|NCT04100018|470654614|FG001|Treatment Period|Adverse Event|6|||
130736457|NCT04100018|470654613|FG000|Treatment Period|Lack of Efficacy|4|||
130736458|NCT04100018|470654614|FG001|Treatment Period|Lack of Efficacy|2|||
130736459|NCT02090725|470654619|FG000|Overall Study|Withdrawal by Subject|1|||
130736460|NCT02090725|470654619|FG000|Overall Study|participants moved from area|3|||
130736461|NCT04358081|470654620|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
130736462|NCT04358081|470654621|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
130736463|NCT04358081|470654622|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
130736464|NCT04358081|470654620|FG000|Treatment Phase of Study|Adverse Event|1|||
130736465|NCT04358081|470654621|FG001|Treatment Phase of Study|Adverse Event|0|||
130736466|NCT04358081|470654622|FG002|Treatment Phase of Study|Adverse Event|1|||
130736467|NCT04358081|470654620|FG000|Treatment Phase of Study|Physician Decision|2|||
130736468|NCT04358081|470654621|FG001|Treatment Phase of Study|Physician Decision|0|||
130736469|NCT04358081|470654622|FG002|Treatment Phase of Study|Physician Decision|1|||
130736470|NCT04358081|470654620|FG000|Treatment Phase of Study|Protocol Violation|1|||
130736471|NCT04358081|470654621|FG001|Treatment Phase of Study|Protocol Violation|0|||
130736472|NCT04358081|470654622|FG002|Treatment Phase of Study|Protocol Violation|0|||
130736473|NCT04358081|470654620|FG000|Study Completion Phase|Death|0|||
130736474|NCT04358081|470654621|FG001|Study Completion Phase|Death|0|||
130736475|NCT04358081|470654622|FG002|Study Completion Phase|Death|1|||
130736476|NCT04358081|470654620|FG000|Study Completion Phase|Lost to Follow-up|1|||
130736477|NCT04358081|470654621|FG001|Study Completion Phase|Lost to Follow-up|0|||
130736478|NCT04358081|470654622|FG002|Study Completion Phase|Lost to Follow-up|1|||
130736479|NCT01130532|470654623|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
130736480|NCT01130532|470654624|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
130736481|NCT01130532|470654625|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
130736482|NCT01130532|470654626|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
130736483|NCT01130532|470654623|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
130736484|NCT01130532|470654624|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
130736485|NCT01130532|470654625|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
130736486|NCT01130532|470654626|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
130736487|NCT01130532|470654623|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
130736488|NCT01130532|470654624|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
130736489|NCT01130532|470654625|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
130736490|NCT01130532|470654626|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
130736491|NCT01130532|470654623|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
130736492|NCT01130532|470654624|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
130736493|NCT01130532|470654625|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
130736494|NCT01130532|470654626|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
130736495|NCT01130532|470654623|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
130736496|NCT01130532|470654624|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
130736497|NCT01130532|470654625|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
130736498|NCT01130532|470654626|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
130736499|NCT01130532|470654623|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
130736500|NCT01130532|470654624|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
130736501|NCT01130532|470654625|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
130736502|NCT01130532|470654626|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
130736503|NCT01130532|470654623|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
130736504|NCT01130532|470654624|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
130736505|NCT01130532|470654625|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
130736506|NCT01130532|470654626|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
130736507|NCT01130532|470654623|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
130736508|NCT01130532|470654624|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
130736509|NCT01130532|470654625|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
130736510|NCT01130532|470654626|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
130736511|NCT01130532|470654623|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
130736512|NCT01130532|470654624|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
130736513|NCT01130532|470654625|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
130736514|NCT01130532|470654626|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
130736515|NCT01130532|470654623|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
130736516|NCT01130532|470654624|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
130736517|NCT01130532|470654625|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
130736518|NCT01130532|470654626|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
130784853|NCT01130272|470841195|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
130736519|NCT01130532|470654623|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
130736520|NCT01130532|470654624|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
130736521|NCT01130532|470654625|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
130736522|NCT01130532|470654626|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
130736523|NCT02656303|470654627|FG000|Overall Study|Adverse Event|3|||
130736524|NCT02656303|470654628|FG001|Overall Study|Adverse Event|2|||
130736525|NCT02656303|470654629|FG002|Overall Study|Adverse Event|0|||
130736526|NCT02656303|470654627|FG000|Overall Study|Death|12|||
130736527|NCT02656303|470654628|FG001|Overall Study|Death|4|||
130736528|NCT02656303|470654629|FG002|Overall Study|Death|1|||
130736529|NCT02656303|470654627|FG000|Overall Study|Lack of Efficacy|1|||
130736530|NCT02656303|470654628|FG001|Overall Study|Lack of Efficacy|0|||
130736531|NCT02656303|470654629|FG002|Overall Study|Lack of Efficacy|0|||
130736532|NCT02656303|470654627|FG000|Overall Study|Non-Compliance with Study|1|||
130736533|NCT02656303|470654628|FG001|Overall Study|Non-Compliance with Study|1|||
130736534|NCT02656303|470654629|FG002|Overall Study|Non-Compliance with Study|0|||
130736535|NCT02656303|470654627|FG000|Overall Study|Investigator Decision|2|||
130736536|NCT02656303|470654628|FG001|Overall Study|Investigator Decision|1|||
130736537|NCT02656303|470654629|FG002|Overall Study|Investigator Decision|0|||
130736538|NCT02656303|470654627|FG000|Overall Study|Progressive Disease|25|||
130736539|NCT02656303|470654628|FG001|Overall Study|Progressive Disease|14|||
130736540|NCT02656303|470654629|FG002|Overall Study|Progressive Disease|10|||
130736541|NCT02656303|470654627|FG000|Overall Study|Study Terminated by Sponsor|20|||
130736542|NCT02656303|470654628|FG001|Overall Study|Study Terminated by Sponsor|7|||
130736543|NCT02656303|470654629|FG002|Overall Study|Study Terminated by Sponsor|5|||
130736544|NCT02656303|470654627|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
130736545|NCT02656303|470654628|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
130736546|NCT02656303|470654629|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
130736547|NCT02656303|470654627|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
130736548|NCT02656303|470654628|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
130736549|NCT02656303|470654629|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
130736550|NCT02656303|470654627|FG000|Overall Study|Reason not Specified|1|||
130736551|NCT02656303|470654628|FG001|Overall Study|Reason not Specified|1|||
130736552|NCT02656303|470654629|FG002|Overall Study|Reason not Specified|2|||
130736553|NCT03041311|470654630|FG000|Overall Study|Death|39|||
130736554|NCT03041311|470654631|FG001|Overall Study|Death|42|||
130736555|NCT03041311|470654630|FG000|Overall Study|Lost to Follow-up|0|||
130736556|NCT03041311|470654631|FG001|Overall Study|Lost to Follow-up|1|||
130736557|NCT03041311|470654630|FG000|Overall Study|Withdrawal by Subject|8|||
130736558|NCT03041311|470654631|FG001|Overall Study|Withdrawal by Subject|5|||
130736559|NCT03041311|470654630|FG000|Overall Study|Sponsor Terminated Study|2|||
130784854|NCT01130272|470841196|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
130784855|NCT01130272|470841197|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
130736560|NCT03041311|470654631|FG001|Overall Study|Sponsor Terminated Study|4|||
130736561|NCT03041311|470654630|FG000|Overall Study|Disease Progression|3|||
130784856|NCT01130272|470841193|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130784857|NCT01130272|470841194|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130784858|NCT01130272|470841195|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130784859|NCT01130272|470841196|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
130736562|NCT03041311|470654631|FG001|Overall Study|Disease Progression|1|||
130736563|NCT03041311|470654630|FG000|Overall Study|Randomized in error, did not receive drug|2|||
130736564|NCT03041311|470654631|FG001|Overall Study|Randomized in error, did not receive drug|0|||
130736565|NCT01842438|470654632|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
130736566|NCT01842438|470654633|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
130736567|NCT01842438|470654632|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
130736568|NCT01842438|470654633|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
130736569|NCT01842438|470654632|FG000|T2: 6month Follow-up|Death|0|||
130736570|NCT01842438|470654633|FG001|T2: 6month Follow-up|Death|1|||
130736571|NCT00782626|470654637|FG000|Overall Study|Adverse Event|1|||
130736572|NCT00782626|470654637|FG000|Overall Study|Progressive Disease|5|||
130736573|NCT00782626|470654637|FG000|Overall Study|Other Complicating Disease|1|||
130736574|NCT04909853|470654638|FG000|Part 1|Assigned but not treated|0|||
130736575|NCT04909853|470654639|FG001|Part 1|Assigned but not treated|0|||
130736576|NCT04909853|470654640|FG002|Part 1|Assigned but not treated|1|||
130736577|NCT04909853|470654641|FG003|Part 1|Assigned but not treated|0|||
130736578|NCT04909853|470654638|FG000|Part 2|Adverse Event|0|||
130736579|NCT04909853|470654639|FG001|Part 2|Adverse Event|0|||
130736580|NCT04909853|470654640|FG002|Part 2|Adverse Event|0|||
130736581|NCT04909853|470654641|FG003|Part 2|Adverse Event|1|||
130736582|NCT04054765|470654642|FG000|Baseline|Withdrawal by Subject|5|||
130736583|NCT04054765|470654643|FG001|Baseline|Withdrawal by Subject|3|||
130736584|NCT04054765|470654642|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
130736585|NCT04054765|470654643|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
130736586|NCT04054765|470654642|FG000|3-month Follow up|Withdrawal by Subject|0|||
130736587|NCT04054765|470654643|FG001|3-month Follow up|Withdrawal by Subject|3|||
130784860|NCT01130272|470841197|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130784861|NCT01130272|470841193|FG000|Overall Study|Protocol Violation|0|||
130784862|NCT01130272|470841194|FG001|Overall Study|Protocol Violation|0|||
130784863|NCT01130272|470841195|FG002|Overall Study|Protocol Violation|3|||
130784864|NCT01130272|470841196|FG003|Overall Study|Protocol Violation|5|||
130784865|NCT01130272|470841197|FG004|Overall Study|Protocol Violation|5|||
130784866|NCT01130272|470841193|FG000|Overall Study|Lost to Follow-up|4|||
130784867|NCT01130272|470841194|FG001|Overall Study|Lost to Follow-up|3|||
130784868|NCT01130272|470841195|FG002|Overall Study|Lost to Follow-up|4|||
130784869|NCT01130272|470841196|FG003|Overall Study|Lost to Follow-up|7|||
130784870|NCT01130272|470841197|FG004|Overall Study|Lost to Follow-up|6|||
130784871|NCT01130272|470841193|FG000|Overall Study|Withdrawal by Subject|4|||
130784872|NCT01130272|470841194|FG001|Overall Study|Withdrawal by Subject|11|||
130784873|NCT01130272|470841195|FG002|Overall Study|Withdrawal by Subject|10|||
130784874|NCT01130272|470841196|FG003|Overall Study|Withdrawal by Subject|9|||
130784875|NCT01130272|470841197|FG004|Overall Study|Withdrawal by Subject|8|||
130784876|NCT01130272|470841193|FG000|Overall Study|Physician Decision|1|||
130736588|NCT04054765|470654642|FG000|6-month Follow up|Lost to Follow-up|32|||
130736589|NCT04054765|470654643|FG001|6-month Follow up|Lost to Follow-up|32|||
130736590|NCT00077207|470654645|FG000|Overall Study|Adverse Event|5|||
130736591|NCT00077207|470654645|FG000|Overall Study|Lack of Efficacy|12|||
130736592|NCT00077207|470654645|FG000|Overall Study|Physician Decision|6|||
130736593|NCT00077207|470654645|FG000|Overall Study|Withdrawal by Subject|6|||
130736594|NCT00077207|470654645|FG000|Overall Study|Ineligible|1|||
130736595|NCT04182490|470654646|FG000|Overall Study|Withdrawal by Subject|3|||
130736596|NCT04182490|470654647|FG001|Overall Study|Withdrawal by Subject|3|||
130736597|NCT04182490|470654646|FG000|Overall Study|Lost to Follow-up|0|||
130736598|NCT04182490|470654647|FG001|Overall Study|Lost to Follow-up|1|||
130736599|NCT04182490|470654646|FG000|Overall Study|Physician Decision|0|||
130736600|NCT04182490|470654647|FG001|Overall Study|Physician Decision|1|||
130736601|NCT00853099|470654648|FG000|Double-blind Period|Adverse Event|7|||
130736602|NCT00853099|470654649|FG001|Double-blind Period|Adverse Event|9|||
130736603|NCT00853099|470654650|FG002|Double-blind Period|Adverse Event|13|||
130736604|NCT00853099|470654651|FG003|Double-blind Period|Adverse Event|0|||
130736605|NCT00853099|470654648|FG000|Double-blind Period|Withdrawal by Subject|2|||
130736606|NCT00853099|470654649|FG001|Double-blind Period|Withdrawal by Subject|3|||
130736607|NCT00853099|470654650|FG002|Double-blind Period|Withdrawal by Subject|0|||
130736608|NCT00853099|470654651|FG003|Double-blind Period|Withdrawal by Subject|0|||
130736609|NCT00853099|470654648|FG000|Double-blind Period|Lack of Efficacy|14|||
130736610|NCT00853099|470654649|FG001|Double-blind Period|Lack of Efficacy|17|||
130736611|NCT00853099|470654650|FG002|Double-blind Period|Lack of Efficacy|16|||
130736612|NCT00853099|470654651|FG003|Double-blind Period|Lack of Efficacy|0|||
130736613|NCT00853099|470654648|FG000|Double-blind Period|Other|0|||
130736614|NCT00853099|470654649|FG001|Double-blind Period|Other|0|||
130736615|NCT00853099|470654650|FG002|Double-blind Period|Other|1|||
130736616|NCT00853099|470654651|FG003|Double-blind Period|Other|0|||
130736617|NCT00853099|470654648|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
130736618|NCT00853099|470654649|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
130736619|NCT00853099|470654650|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
130736620|NCT00853099|470654651|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
130784877|NCT01130272|470841194|FG001|Overall Study|Physician Decision|1|||
130784878|NCT01130272|470841195|FG002|Overall Study|Physician Decision|0|||
130784879|NCT01130272|470841196|FG003|Overall Study|Physician Decision|1|||
130784880|NCT01130272|470841197|FG004|Overall Study|Physician Decision|2|||
130784881|NCT01130272|470841193|FG000|Overall Study|Sponsor decision|6|||
130784882|NCT01130272|470841194|FG001|Overall Study|Sponsor decision|15|||
130784883|NCT01130272|470841195|FG002|Overall Study|Sponsor decision|16|||
130784884|NCT01130272|470841196|FG003|Overall Study|Sponsor decision|13|||
130736621|NCT00853099|470654648|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
130736622|NCT00853099|470654649|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
130736623|NCT00853099|470654650|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
130736624|NCT00853099|470654651|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
130736625|NCT00853099|470654648|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
130736626|NCT00853099|470654649|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
130736627|NCT00853099|470654650|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
130736628|NCT00853099|470654651|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
130736629|NCT00853099|470654648|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
130736630|NCT00853099|470654649|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
130736631|NCT00853099|470654650|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
130736632|NCT00853099|470654651|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
130736633|NCT00853099|470654648|FG000|Double-blind + Open-label Periods|Other|0|||
130736634|NCT00853099|470654649|FG001|Double-blind + Open-label Periods|Other|0|||
130736635|NCT00853099|470654650|FG002|Double-blind + Open-label Periods|Other|0|||
130736636|NCT00853099|470654651|FG003|Double-blind + Open-label Periods|Other|6|||
130736637|NCT01026194|470654654|FG000|Period 1：Double Blind Period|Adverse Event|2|||
130736638|NCT01026194|470654655|FG001|Period 1：Double Blind Period|Adverse Event|1|||
130736639|NCT01026194|470654654|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
130736640|NCT01026194|470654655|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
130736641|NCT01026194|470654654|FG000|Period 1：Double Blind Period|Physician Decision|0|||
130736642|NCT01026194|470654655|FG001|Period 1：Double Blind Period|Physician Decision|4|||
130736643|NCT01026194|470654654|FG000|Period 2：Open-label Period|Adverse Event|4|||
130736644|NCT01026194|470654655|FG001|Period 2：Open-label Period|Adverse Event|5|||
130736645|NCT01026194|470654654|FG000|Period 2：Open-label Period|Physician Decision|3|||
130736646|NCT01026194|470654655|FG001|Period 2：Open-label Period|Physician Decision|1|||
130736647|NCT01026194|470654654|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
130736648|NCT01026194|470654655|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
130736649|NCT01342081|470654664|FG000|Overall Study|Did not receive allocated intervention|0|||
130736650|NCT01342081|470654665|FG001|Overall Study|Did not receive allocated intervention|0|||
130736651|NCT01342081|470654666|FG002|Overall Study|Did not receive allocated intervention|1|||
130736652|NCT01342081|470654664|FG000|Overall Study|Adverse Event|1|||
130736653|NCT01342081|470654665|FG001|Overall Study|Adverse Event|0|||
130736654|NCT01342081|470654666|FG002|Overall Study|Adverse Event|0|||
130736655|NCT01342081|470654664|FG000|Overall Study|Physician Decision|0|||
130736656|NCT01342081|470654665|FG001|Overall Study|Physician Decision|1|||
130736657|NCT01342081|470654666|FG002|Overall Study|Physician Decision|0|||
130736658|NCT01342081|470654664|FG000|Overall Study|Withdrawal by Subject|1|||
130736659|NCT01342081|470654665|FG001|Overall Study|Withdrawal by Subject|1|||
130736660|NCT01342081|470654666|FG002|Overall Study|Withdrawal by Subject|0|||
130736661|NCT02790437|470654667|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
130736662|NCT02790437|470654668|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
130736663|NCT02790437|470654667|FG000|Overall Study|Adverse Event|1|||
130736664|NCT02790437|470654668|FG001|Overall Study|Adverse Event|0|||
130736665|NCT02790437|470654667|FG000|Overall Study|Withdrawal by Subject|1|||
130736666|NCT02790437|470654668|FG001|Overall Study|Withdrawal by Subject|0|||
130736667|NCT03908125|470654673|FG000|Overall Study|Withdrawal by Subject|92|||
130736668|NCT03908125|470654673|FG000|Overall Study|Lost to Follow-up|8|||
130736669|NCT01071915|470654674|FG000|Overall Study|Adverse Event|3|||
130736670|NCT01071915|470654674|FG000|Overall Study|Physician Decision|2|||
130736671|NCT01071915|470654674|FG000|Overall Study|Withdrawal by Subject|2|||
130736672|NCT01071915|470654674|FG000|Overall Study|Miscellaneous Reasons|2|||
130736673|NCT00114140|470654675|FG000|Overall Study|Protocol Violation|7|||
130736674|NCT00666328|470654679|FG000|Overall Study|Death|2|||
130736675|NCT00666328|470654679|FG000|Overall Study|Lost to Follow-up|2|||
130736676|NCT00666328|470654679|FG000|Overall Study|No longer met eligibility criteria|1|||
130736677|NCT03885661|470654682|FG000|Overall Study|Withdrawal by Subject|0|||
130736678|NCT03885661|470654683|FG001|Overall Study|Withdrawal by Subject|1|||
130736679|NCT03885661|470654682|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
130736680|NCT03885661|470654683|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
130736681|NCT05064397|470654684|FG000|Overall Study|Adverse Event|4|||
130736682|NCT05064397|470654684|FG000|Overall Study|Lack of Efficacy|12|||
130736683|NCT05064397|470654684|FG000|Overall Study|Withdrawal by Subject|3|||
130736684|NCT05064397|470654684|FG000|Overall Study|Lost to Follow-up|1|||
130736685|NCT05064397|470654684|FG000|Overall Study|Other reasons|3|||
130736686|NCT02232984|470654685|FG000|Overall Study|Withdrawal by Subject|5|||
130736687|NCT02232984|470654685|FG000|Overall Study|Death|1|||
130736688|NCT02232984|470654685|FG000|Overall Study|Investigator withdrawal|10|||
130736689|NCT02232984|470654685|FG000|Overall Study|Device implant unsuccessful|53|||
130736690|NCT02232984|470654685|FG000|Overall Study|not disclosed by site|7|||
130736691|NCT02232984|470654685|FG000|Overall Study|Protocol Violation|1|||
130736692|NCT02441686|470654688|FG000|Induction|Adverse Event|4|||
130736693|NCT02441686|470654688|FG000|Induction|Complicating disease|1|||
130736694|NCT02441686|470654688|FG000|Induction|Physician Decision|1|||
130736695|NCT02441686|470654688|FG000|Induction|Withdrawal by Subject|1|||
130736696|NCT02441686|470654688|FG000|Induction|Did not receive treatment|1|||
130736697|NCT02441686|470654688|FG000|Maintenance|Remaining on Treatment|23|||
130736698|NCT02441686|470654688|FG000|Maintenance|Physician Decision|1|||
130736699|NCT02441686|470654688|FG000|Maintenance|Adverse Event|3|||
130736700|NCT02441686|470654688|FG000|Maintenance|Progressive Disease|10|||
130736701|NCT02441686|470654688|FG000|Maintenance|Withdrawal by Subject|1|||
130736702|NCT00535405|470654691|FG000|Overall Study|Adverse Event|6|||
130736703|NCT00535405|470654692|FG001|Overall Study|Adverse Event|8|||
130736704|NCT00535405|470654693|FG002|Overall Study|Adverse Event|3|||
130736705|NCT00535405|470654694|FG003|Overall Study|Adverse Event|8|||
130736706|NCT00535405|470654695|FG004|Overall Study|Adverse Event|6|||
130736707|NCT00535405|470654691|FG000|Overall Study|Lost to Follow-up|1|||
130736708|NCT00535405|470654692|FG001|Overall Study|Lost to Follow-up|3|||
130736709|NCT00535405|470654693|FG002|Overall Study|Lost to Follow-up|3|||
130736710|NCT00535405|470654694|FG003|Overall Study|Lost to Follow-up|2|||
130736711|NCT00535405|470654695|FG004|Overall Study|Lost to Follow-up|1|||
130736712|NCT00535405|470654691|FG000|Overall Study|Physician Decision|3|||
130736713|NCT00535405|470654692|FG001|Overall Study|Physician Decision|2|||
130736714|NCT00535405|470654693|FG002|Overall Study|Physician Decision|0|||
130736715|NCT00535405|470654694|FG003|Overall Study|Physician Decision|1|||
130736716|NCT00535405|470654695|FG004|Overall Study|Physician Decision|1|||
130736717|NCT00535405|470654691|FG000|Overall Study|Protocol Violation|2|||
130736718|NCT00535405|470654692|FG001|Overall Study|Protocol Violation|2|||
130736719|NCT00535405|470654693|FG002|Overall Study|Protocol Violation|2|||
130736720|NCT00535405|470654694|FG003|Overall Study|Protocol Violation|1|||
130736721|NCT00535405|470654695|FG004|Overall Study|Protocol Violation|0|||
130736722|NCT00535405|470654691|FG000|Overall Study|Withdrawal by Subject|5|||
130736723|NCT00535405|470654692|FG001|Overall Study|Withdrawal by Subject|11|||
130736724|NCT00535405|470654693|FG002|Overall Study|Withdrawal by Subject|10|||
130736725|NCT00535405|470654694|FG003|Overall Study|Withdrawal by Subject|10|||
130736726|NCT00535405|470654695|FG004|Overall Study|Withdrawal by Subject|8|||
130736727|NCT03151304|470654696|FG000|Overall Study|Termination of study by Sponsor|23|||
130736728|NCT03151304|470654696|FG000|Overall Study|missing|3|||
130736729|NCT03151304|470654696|FG000|Overall Study|Withdrawal by Subject|8|||
130736730|NCT03151304|470654696|FG000|Overall Study|multiple reasons|30|||
130736731|NCT01130493|470654697|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
130736732|NCT01130493|470654698|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
130736733|NCT01130493|470654699|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
130736734|NCT01130493|470654697|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
130736735|NCT01130493|470654698|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
130736736|NCT01130493|470654699|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
130736737|NCT01130493|470654697|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
130736738|NCT01130493|470654698|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
130736739|NCT01130493|470654699|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
130736740|NCT01130493|470654697|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
130736741|NCT01130493|470654698|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
130736742|NCT01130493|470654699|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
130736743|NCT01130493|470654697|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
130736744|NCT01130493|470654698|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
130736745|NCT01130493|470654699|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
130736746|NCT01130493|470654697|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
130736747|NCT01130493|470654698|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
130736748|NCT01130493|470654699|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
130736749|NCT01130493|470654697|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
130736750|NCT01130493|470654698|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
130784885|NCT01130272|470841197|FG004|Overall Study|Sponsor decision|16|||
130784886|NCT01130272|470841193|FG000|Overall Study|Study arm discontinued|38|||
130736751|NCT01130493|470654699|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
130736752|NCT01130493|470654697|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
130736753|NCT01130493|470654698|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
130736754|NCT01130493|470654699|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
130736755|NCT01130493|470654697|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
130736756|NCT01130493|470654698|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
130736757|NCT01130493|470654699|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
130736758|NCT01130493|470654697|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
130736759|NCT01130493|470654698|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
130736760|NCT01130493|470654699|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
130736761|NCT01130493|470654697|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
130736762|NCT01130493|470654698|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
130736763|NCT01130493|470654699|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
130736764|NCT01130493|470654697|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
130736765|NCT01130493|470654698|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
130736766|NCT01130493|470654699|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
130736767|NCT01130493|470654697|FG000|Part 2: OLE|Adverse Event|0|||
130736768|NCT01130493|470654698|FG001|Part 2: OLE|Adverse Event|2|||
130736769|NCT01130493|470654699|FG002|Part 2: OLE|Adverse Event|1|||
130736770|NCT01130493|470654697|FG000|Part 2: OLE|Withdrawal by Subject|0|||
130736771|NCT01130493|470654698|FG001|Part 2: OLE|Withdrawal by Subject|1|||
130736772|NCT01130493|470654699|FG002|Part 2: OLE|Withdrawal by Subject|4|||
130736773|NCT03541317|470654700|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
130736774|NCT03541317|470654701|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130736775|NCT03541317|470654702|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130736776|NCT03541317|470654703|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130736777|NCT03541317|470654704|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130736778|NCT03541317|470654705|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130736779|NCT02969044|470654708|FG000|Overall Study|Withdrawal by Subject|2|||
130736780|NCT02969044|470654709|FG001|Overall Study|Withdrawal by Subject|6|||
130736781|NCT02969044|470654708|FG000|Overall Study|Adverse Event|3|||
130736782|NCT02969044|470654709|FG001|Overall Study|Adverse Event|0|||
130736783|NCT04728802|470654710|FG000|Overall Study|Withdrawal by Subject|4|||
130736784|NCT04728802|470654711|FG001|Overall Study|Withdrawal by Subject|20|||
130736785|NCT04728802|470654710|FG000|Overall Study|Physician Decision|7|||
130736786|NCT04728802|470654711|FG001|Overall Study|Physician Decision|7|||
130736787|NCT04728802|470654710|FG000|Overall Study|Protocol Violation|10|||
130736788|NCT04728802|470654711|FG001|Overall Study|Protocol Violation|4|||
130736789|NCT04728802|470654710|FG000|Overall Study|Transfer|1|||
130736790|NCT04728802|470654711|FG001|Overall Study|Transfer|0|||
130736791|NCT04728802|470654710|FG000|Overall Study|Death|4|||
130736792|NCT04728802|470654711|FG001|Overall Study|Death|5|||
130736793|NCT04728802|470654710|FG000|Overall Study|Other|3|||
130736794|NCT04728802|470654711|FG001|Overall Study|Other|0|||
130736795|NCT01176513|470654712|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
130736796|NCT02286843|470654713|FG000|Overall Study|Not Treated|4|||
130736797|NCT02286843|470654713|FG000|Overall Study|Protocol Violation|1|||
130736798|NCT02286843|470654713|FG000|Overall Study|Withdrawal by Subject|1|||
130736799|NCT02536846|470654714|FG000|Overall Study|Withdrawal by Subject|1|||
130736800|NCT03164616|470654716|FG000|Overall Study|Death|250|||
130736801|NCT03164616|470654717|FG001|Overall Study|Death|264|||
130736802|NCT03164616|470654718|FG002|Overall Study|Death|279|||
130784887|NCT01130272|470841194|FG001|Overall Study|Study arm discontinued|0|||
130784888|NCT01130272|470841195|FG002|Overall Study|Study arm discontinued|0|||
130784889|NCT01130272|470841196|FG003|Overall Study|Study arm discontinued|0|||
130784890|NCT01130272|470841197|FG004|Overall Study|Study arm discontinued|0|||
130784891|NCT01548404|470841198|FG000|Overall Study|Adverse Event|3|||
130784892|NCT01548404|470841199|FG001|Overall Study|Adverse Event|1|||
130784893|NCT01548404|470841198|FG000|Overall Study|Physician Decision|2|||
130784894|NCT01548404|470841199|FG001|Overall Study|Physician Decision|1|||
130784895|NCT01548404|470841198|FG000|Overall Study|Inadequate response to study treatment|23|||
130784896|NCT01548404|470841199|FG001|Overall Study|Inadequate response to study treatment|7|||
130784897|NCT01548404|470841198|FG000|Overall Study|Lost to Follow-up|2|||
130784898|NCT01548404|470841199|FG001|Overall Study|Lost to Follow-up|0|||
130784899|NCT01548404|470841198|FG000|Overall Study|Withdrawal by Subject|0|||
130784900|NCT01548404|470841199|FG001|Overall Study|Withdrawal by Subject|3|||
130784901|NCT01548404|470841198|FG000|Overall Study|Other than specified above|0|||
130784902|NCT01548404|470841199|FG001|Overall Study|Other than specified above|2|||
130784903|NCT00641056|470841200|FG000|Overall Study|Adverse Event|12|||
130784904|NCT00641056|470841201|FG001|Overall Study|Adverse Event|2|||
130784905|NCT00641056|470841200|FG000|Overall Study|Lost to Follow-up|2|||
130784906|NCT00641056|470841201|FG001|Overall Study|Lost to Follow-up|1|||
130784907|NCT00641056|470841200|FG000|Overall Study|Physician Decision|3|||
130784908|NCT00641056|470841201|FG001|Overall Study|Physician Decision|1|||
130784909|NCT00641056|470841200|FG000|Overall Study|Protocol Violation|2|||
130784910|NCT00641056|470841201|FG001|Overall Study|Protocol Violation|0|||
130784911|NCT00641056|470841200|FG000|Overall Study|Entry Criteria Not Met|3|||
130784912|NCT00641056|470841201|FG001|Overall Study|Entry Criteria Not Met|0|||
130784913|NCT00641056|470841200|FG000|Overall Study|Subject Decision|6|||
130784914|NCT00641056|470841201|FG001|Overall Study|Subject Decision|19|||
130784915|NCT00641056|470841200|FG000|Overall Study|Sponsor Decision|1|||
130784916|NCT00641056|470841201|FG001|Overall Study|Sponsor Decision|2|||
130784917|NCT00737048|470841202|FG000|Overall Study|Physician Decision|0|||
130784918|NCT00737048|470841203|FG001|Overall Study|Physician Decision|0|||
130784919|NCT00737048|470841204|FG002|Overall Study|Physician Decision|1|||
130784920|NCT00737048|470841202|FG000|Overall Study|Adverse Event|0|||
130784921|NCT00737048|470841203|FG001|Overall Study|Adverse Event|1|||
130784922|NCT00737048|470841204|FG002|Overall Study|Adverse Event|0|||
130784923|NCT00737048|470841202|FG000|Overall Study|Worsening of the symptoms|3|||
130784924|NCT00737048|470841203|FG001|Overall Study|Worsening of the symptoms|5|||
130784925|NCT00737048|470841204|FG002|Overall Study|Worsening of the symptoms|3|||
130784926|NCT02351934|470841205|FG000|Allocation|POD weight<pre-op weight|3|||
130784927|NCT02351934|470841206|FG001|Allocation|POD weight<pre-op weight|0|||
130784928|NCT02351934|470841205|FG000|Allocation|Hypotension preventing administration|2|||
130784929|NCT02351934|470841206|FG001|Allocation|Hypotension preventing administration|0|||
130784930|NCT02351934|470841205|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
130784931|NCT02351934|470841206|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
130784932|NCT02351934|470841205|FG000|Follow-Up|POD weight<pre-op weight|3|||
130784933|NCT02351934|470841206|FG001|Follow-Up|POD weight<pre-op weight|0|||
130784934|NCT02351934|470841205|FG000|Follow-Up|Acute Kidney Injury|1|||
130784935|NCT02351934|470841206|FG001|Follow-Up|Acute Kidney Injury|0|||
130784936|NCT02351934|470841205|FG000|Follow-Up|Early dismissal|3|||
130784937|NCT02351934|470841206|FG001|Follow-Up|Early dismissal|0|||
130784938|NCT02351934|470841205|FG000|Follow-Up|Hypotension|3|||
130784939|NCT02351934|470841206|FG001|Follow-Up|Hypotension|0|||
130784940|NCT02351934|470841205|FG000|Follow-Up|No documentation|2|||
130784941|NCT02351934|470841206|FG001|Follow-Up|No documentation|0|||
130784942|NCT02351934|470841205|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
130736803|NCT03164616|470654716|FG000|Overall Study|Lost to Follow-up|2|||
130736804|NCT03164616|470654717|FG001|Overall Study|Lost to Follow-up|2|||
130784943|NCT02351934|470841206|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
130784944|NCT02351934|470841205|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
130784945|NCT02351934|470841206|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
130784946|NCT00896493|470841207|FG000|Overall Study|Early disease relapse|3|||
130736805|NCT03164616|470654718|FG002|Overall Study|Lost to Follow-up|2|||
130784947|NCT01739335|470841209|FG000|Overall Study|Lost to Follow-up|7|||
130784948|NCT01739335|470841210|FG001|Overall Study|Lost to Follow-up|4|||
130784949|NCT01739335|470841209|FG000|Overall Study|Ineligible patient randomized|0|||
130784950|NCT01739335|470841210|FG001|Overall Study|Ineligible patient randomized|1|||
130736806|NCT03164616|470654716|FG000|Overall Study|Withdrawal by Subject|6|||
130736807|NCT03164616|470654717|FG001|Overall Study|Withdrawal by Subject|7|||
130736808|NCT03164616|470654718|FG002|Overall Study|Withdrawal by Subject|16|||
130736809|NCT02593110|470654719|FG000|Overall Study|Withdrawal by Subject|0|||
130736810|NCT02593110|470654720|FG001|Overall Study|Withdrawal by Subject|3|||
130736811|NCT02593110|470654721|FG002|Overall Study|Withdrawal by Subject|3|||
130736812|NCT02593110|470654722|FG003|Overall Study|Withdrawal by Subject|2|||
130736813|NCT02593110|470654719|FG000|Overall Study|Death|0|||
130736814|NCT02593110|470654720|FG001|Overall Study|Death|0|||
130736815|NCT02593110|470654721|FG002|Overall Study|Death|1|||
130736816|NCT02593110|470654722|FG003|Overall Study|Death|0|||
130736817|NCT01625091|470654724|FG000|Intervention|Death|1|||
130736818|NCT01625091|470654725|FG001|Intervention|Death|1|||
130736819|NCT01625091|470654724|FG000|Intervention|Withdrawal by Subject|4|||
130736820|NCT01625091|470654725|FG001|Intervention|Withdrawal by Subject|1|||
130736821|NCT01625091|470654724|FG000|Intervention|Adverse Event|0|||
130736822|NCT01625091|470654725|FG001|Intervention|Adverse Event|2|||
130736823|NCT01625091|470654724|FG000|Intervention|Lost to Follow-up|4|||
130736824|NCT01625091|470654725|FG001|Intervention|Lost to Follow-up|4|||
130736825|NCT01625091|470654724|FG000|Intervention|Study termination|2|||
130736826|NCT01625091|470654725|FG001|Intervention|Study termination|3|||
130736827|NCT01625091|470654724|FG000|Post-intervention|Death|0|||
130736828|NCT01625091|470654725|FG001|Post-intervention|Death|1|||
130736829|NCT01625091|470654724|FG000|Post-intervention|Lost to Follow-up|2|||
130736830|NCT01625091|470654725|FG001|Post-intervention|Lost to Follow-up|0|||
130736831|NCT01625091|470654724|FG000|Post-intervention|Study termination|2|||
130736832|NCT01625091|470654725|FG001|Post-intervention|Study termination|1|||
130784951|NCT02062437|470841216|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
130784952|NCT02062437|470841216|FG000|Overall Study|Patient not available for the 2y visit|18|||
130784953|NCT02062437|470841216|FG000|Overall Study|Death|2|||
130784954|NCT02062437|470841216|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
130784955|NCT00752089|470841217|FG000|Overall Study|Adverse Event|1|||
130784956|NCT00752089|470841217|FG000|Overall Study|Protocol Deviation|2|||
130784957|NCT00752089|470841217|FG000|Overall Study|Could not attend visit 9|1|||
130784958|NCT00752089|470841217|FG000|Overall Study|Not capable of wearing partial denture|1|||
130784959|NCT00752089|470841217|FG000|Overall Study|Cannot continue the study|1|||
130784960|NCT01324102|470841218|FG000|Overall Study|illness|1|||
130784961|NCT01324102|470841219|FG001|Overall Study|illness|6|||
130784962|NCT00386334|470841224|FG000|Double Blind Period|Adverse Event|9|||
130784963|NCT00386334|470841225|FG001|Double Blind Period|Adverse Event|14|||
130784964|NCT00386334|470841224|FG000|Double Blind Period|Protocol Violation|1|||
130736833|NCT03130777|470656610|FG000|Overall Study|Death|0|||
130736834|NCT03130777|470656611|FG001|Overall Study|Death|1|||
130736835|NCT03130777|470656610|FG000|Overall Study|Did not meet eligibility criteria|1|||
130736836|NCT03130777|470656611|FG001|Overall Study|Did not meet eligibility criteria|0|||
130736837|NCT06195930|470656614|FG000|Overall Study|Adverse Event|4|||
130736838|NCT00970593|470656617|FG000|Overall Study|Adverse Event|1|||
130736839|NCT00970593|470656618|FG001|Overall Study|Adverse Event|1|||
130736840|NCT00970593|470656619|FG002|Overall Study|Adverse Event|0|||
130736841|NCT00970593|470656620|FG003|Overall Study|Adverse Event|0|||
130736842|NCT00970593|470656621|FG004|Overall Study|Adverse Event|0|||
130736843|NCT00970593|470656622|FG005|Overall Study|Adverse Event|0|||
130736844|NCT00970593|470656623|FG006|Overall Study|Adverse Event|0|||
130736845|NCT00970593|470656617|FG000|Overall Study|Discontinuation of study by sponsor|0|||
130736846|NCT00970593|470656618|FG001|Overall Study|Discontinuation of study by sponsor|0|||
130736847|NCT00970593|470656619|FG002|Overall Study|Discontinuation of study by sponsor|5|||
130736848|NCT00970593|470656620|FG003|Overall Study|Discontinuation of study by sponsor|0|||
130736849|NCT00970593|470656621|FG004|Overall Study|Discontinuation of study by sponsor|0|||
130736850|NCT00970593|470656622|FG005|Overall Study|Discontinuation of study by sponsor|0|||
130736851|NCT00970593|470656623|FG006|Overall Study|Discontinuation of study by sponsor|2|||
130736852|NCT00970593|470656617|FG000|Overall Study|Withdrawal by Subject|0|||
130736853|NCT00970593|470656618|FG001|Overall Study|Withdrawal by Subject|0|||
130736854|NCT00970593|470656619|FG002|Overall Study|Withdrawal by Subject|1|||
130736855|NCT00970593|470656620|FG003|Overall Study|Withdrawal by Subject|0|||
130736856|NCT00970593|470656621|FG004|Overall Study|Withdrawal by Subject|0|||
130736857|NCT00970593|470656622|FG005|Overall Study|Withdrawal by Subject|0|||
130736858|NCT00970593|470656623|FG006|Overall Study|Withdrawal by Subject|0|||
130736859|NCT03889886|470656624|FG000|Overall Study|Other|0|||
130736860|NCT03889886|470656625|FG001|Overall Study|Other|1|||
130736861|NCT03889886|470656626|FG002|Overall Study|Other|0|||
130736862|NCT03889886|470656627|FG003|Overall Study|Other|1|||
130736863|NCT03889886|470656624|FG000|Overall Study|Withdrawal by Subject|0|||
130736864|NCT03889886|470656625|FG001|Overall Study|Withdrawal by Subject|0|||
130736865|NCT03889886|470656626|FG002|Overall Study|Withdrawal by Subject|1|||
130736866|NCT03889886|470656627|FG003|Overall Study|Withdrawal by Subject|0|||
130736867|NCT03889886|470656624|FG000|Overall Study|Adverse Event|0|||
130736868|NCT03889886|470656625|FG001|Overall Study|Adverse Event|0|||
130736869|NCT03889886|470656626|FG002|Overall Study|Adverse Event|0|||
130736870|NCT03889886|470656627|FG003|Overall Study|Adverse Event|6|||
130736871|NCT04176250|470656628|FG000|Overall Study|Adverse Event|0|||
130736872|NCT04176250|470656629|FG001|Overall Study|Adverse Event|1|||
130736873|NCT04176250|470656630|FG002|Overall Study|Adverse Event|0|||
130736874|NCT04176250|470656631|FG003|Overall Study|Adverse Event|1|||
130736875|NCT04176250|470656632|FG004|Overall Study|Adverse Event|0|||
130736876|NCT04176250|470656633|FG005|Overall Study|Adverse Event|1|||
130736877|NCT04176250|470656628|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130736878|NCT04176250|470656629|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130736879|NCT04176250|470656630|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
130736880|NCT04176250|470656631|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
130736881|NCT04176250|470656632|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130736882|NCT04176250|470656633|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130736883|NCT04176250|470656628|FG000|Overall Study|Withdrawal by Subject|0|||
130736884|NCT04176250|470656629|FG001|Overall Study|Withdrawal by Subject|0|||
130736885|NCT04176250|470656630|FG002|Overall Study|Withdrawal by Subject|0|||
130736886|NCT04176250|470656631|FG003|Overall Study|Withdrawal by Subject|0|||
130736887|NCT04176250|470656632|FG004|Overall Study|Withdrawal by Subject|0|||
130736888|NCT04176250|470656633|FG005|Overall Study|Withdrawal by Subject|1|||
130736889|NCT04176250|470656628|FG000|Overall Study|Randomized in error|0|||
130736890|NCT04176250|470656629|FG001|Overall Study|Randomized in error|0|||
130736891|NCT04176250|470656630|FG002|Overall Study|Randomized in error|0|||
130736892|NCT04176250|470656631|FG003|Overall Study|Randomized in error|0|||
130736893|NCT04176250|470656632|FG004|Overall Study|Randomized in error|1|||
130736894|NCT04176250|470656633|FG005|Overall Study|Randomized in error|0|||
130736895|NCT01202175|470656642|FG000|Overall Study|Lost to Follow-up|2|||
130736896|NCT01202175|470656642|FG000|Overall Study|Withdrawal by Subject|1|||
130736897|NCT01202175|470656642|FG000|Overall Study|Adverse Event|2|||
130736898|NCT04747470|470656643|FG000|Overall Study|Death|0|||
130736899|NCT04747470|470656644|FG001|Overall Study|Death|3|||
130736900|NCT04747470|470656645|FG002|Overall Study|Death|2|||
130736901|NCT04747470|470656646|FG003|Overall Study|Death|2|||
130736902|NCT04747470|470656647|FG004|Overall Study|Death|2|||
130736903|NCT04747470|470656648|FG005|Overall Study|Death|0|||
130736904|NCT04747470|470656649|FG006|Overall Study|Death|0|||
130736905|NCT04747470|470656650|FG007|Overall Study|Death|0|||
130736906|NCT04747470|470656651|FG008|Overall Study|Death|0|||
130736907|NCT04747470|470656652|FG009|Overall Study|Death|0|||
130736908|NCT04747470|470656653|FG010|Overall Study|Death|0|||
130736909|NCT04747470|470656643|FG000|Overall Study|Withdrew Consent|0|||
130736910|NCT04747470|470656644|FG001|Overall Study|Withdrew Consent|0|||
130736911|NCT04747470|470656645|FG002|Overall Study|Withdrew Consent|0|||
130736912|NCT04747470|470656646|FG003|Overall Study|Withdrew Consent|1|||
130736913|NCT04747470|470656647|FG004|Overall Study|Withdrew Consent|0|||
130736914|NCT04747470|470656648|FG005|Overall Study|Withdrew Consent|0|||
130736915|NCT04747470|470656649|FG006|Overall Study|Withdrew Consent|0|||
130736916|NCT04747470|470656650|FG007|Overall Study|Withdrew Consent|0|||
130736917|NCT04747470|470656651|FG008|Overall Study|Withdrew Consent|0|||
130736918|NCT04747470|470656652|FG009|Overall Study|Withdrew Consent|0|||
130736919|NCT04747470|470656653|FG010|Overall Study|Withdrew Consent|0|||
130736920|NCT04747470|470656643|FG000|Overall Study|Study Terminated by Sponsor|0|||
130736921|NCT04747470|470656644|FG001|Overall Study|Study Terminated by Sponsor|0|||
130736922|NCT04747470|470656645|FG002|Overall Study|Study Terminated by Sponsor|1|||
130736923|NCT04747470|470656646|FG003|Overall Study|Study Terminated by Sponsor|0|||
130736924|NCT04747470|470656647|FG004|Overall Study|Study Terminated by Sponsor|2|||
130736925|NCT04747470|470656648|FG005|Overall Study|Study Terminated by Sponsor|0|||
130736926|NCT04747470|470656649|FG006|Overall Study|Study Terminated by Sponsor|0|||
130736927|NCT04747470|470656650|FG007|Overall Study|Study Terminated by Sponsor|0|||
130736928|NCT04747470|470656651|FG008|Overall Study|Study Terminated by Sponsor|0|||
130736929|NCT04747470|470656652|FG009|Overall Study|Study Terminated by Sponsor|0|||
130736930|NCT04747470|470656653|FG010|Overall Study|Study Terminated by Sponsor|0|||
130736931|NCT04688671|470656657|FG000|Overall Study|Adverse Event|3|||
130736932|NCT04688671|470656658|FG001|Overall Study|Adverse Event|1|||
130736933|NCT04688671|470656657|FG000|Overall Study|Withdrawal by Subject|3|||
130736934|NCT04688671|470656658|FG001|Overall Study|Withdrawal by Subject|1|||
130736935|NCT04688671|470656657|FG000|Overall Study|Lack of Efficacy|1|||
130736936|NCT04688671|470656658|FG001|Overall Study|Lack of Efficacy|1|||
130736937|NCT04688671|470656657|FG000|Overall Study|Protocol Violation|1|||
130736938|NCT04688671|470656658|FG001|Overall Study|Protocol Violation|0|||
130736939|NCT04688671|470656657|FG000|Overall Study|Lost to Follow-up|0|||
130736940|NCT04688671|470656658|FG001|Overall Study|Lost to Follow-up|1|||
130736941|NCT04720053|470656659|FG000|Overall Study|Lost to Follow-up|12|||
130736942|NCT01942993|470656660|FG000|Overall Study|Lost to Follow-up|1|||
130736943|NCT01942993|470656660|FG000|Overall Study|Physician Decision|1|||
130736944|NCT01350271|470656661|FG000|Overall Study|Lost to Follow-up|21|||
130736945|NCT01350271|470656662|FG001|Overall Study|Lost to Follow-up|17|||
130736946|NCT01350271|470656663|FG002|Overall Study|Lost to Follow-up|26|||
130736947|NCT02906670|470656667|FG000|Cohort 1, QW|Radiological Progression|1|||
130736948|NCT02906670|470656668|FG001|Cohort 1, QW|Radiological Progression|0|||
130736949|NCT02906670|470656669|FG002|Cohort 1, QW|Radiological Progression|0|||
130736950|NCT02906670|470656670|FG003|Cohort 1, QW|Radiological Progression|0|||
130736951|NCT02906670|470656671|FG004|Cohort 1, QW|Radiological Progression|0|||
130736952|NCT02906670|470656672|FG005|Cohort 1, QW|Radiological Progression|0|||
130736953|NCT02906670|470656673|FG006|Cohort 1, QW|Radiological Progression|0|||
130736954|NCT02906670|470656674|FG007|Cohort 1, QW|Radiological Progression|0|||
130736955|NCT02906670|470656675|FG008|Cohort 1, QW|Radiological Progression|0|||
130736956|NCT02906670|470656676|FG009|Cohort 1, QW|Radiological Progression|0|||
130736957|NCT02906670|470656667|FG000|Cohort 2, QW|Radiological Progression|0|||
130736958|NCT02906670|470656668|FG001|Cohort 2, QW|Radiological Progression|1|||
130736959|NCT02906670|470656669|FG002|Cohort 2, QW|Radiological Progression|0|||
130736960|NCT02906670|470656670|FG003|Cohort 2, QW|Radiological Progression|0|||
130736961|NCT02906670|470656671|FG004|Cohort 2, QW|Radiological Progression|0|||
130736962|NCT02906670|470656672|FG005|Cohort 2, QW|Radiological Progression|0|||
130784965|NCT00386334|470841225|FG001|Double Blind Period|Protocol Violation|1|||
130736963|NCT02906670|470656673|FG006|Cohort 2, QW|Radiological Progression|0|||
130736964|NCT02906670|470656674|FG007|Cohort 2, QW|Radiological Progression|0|||
130736965|NCT02906670|470656675|FG008|Cohort 2, QW|Radiological Progression|0|||
130736966|NCT02906670|470656676|FG009|Cohort 2, QW|Radiological Progression|0|||
130736967|NCT02906670|470656667|FG000|Cohort 3, QW|Radiological Progression|0|||
130736968|NCT02906670|470656668|FG001|Cohort 3, QW|Radiological Progression|0|||
130736969|NCT02906670|470656669|FG002|Cohort 3, QW|Radiological Progression|2|||
130736970|NCT02906670|470656670|FG003|Cohort 3, QW|Radiological Progression|0|||
130736971|NCT02906670|470656671|FG004|Cohort 3, QW|Radiological Progression|0|||
130736972|NCT02906670|470656672|FG005|Cohort 3, QW|Radiological Progression|0|||
130736973|NCT02906670|470656673|FG006|Cohort 3, QW|Radiological Progression|0|||
130736974|NCT02906670|470656674|FG007|Cohort 3, QW|Radiological Progression|0|||
130736975|NCT02906670|470656675|FG008|Cohort 3, QW|Radiological Progression|0|||
130736976|NCT02906670|470656676|FG009|Cohort 3, QW|Radiological Progression|0|||
130736977|NCT02906670|470656667|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
130736978|NCT02906670|470656668|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
130736979|NCT02906670|470656669|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
130736980|NCT02906670|470656670|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
130736981|NCT02906670|470656671|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
130736982|NCT02906670|470656672|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
130736983|NCT02906670|470656673|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
130736984|NCT02906670|470656674|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
130736985|NCT02906670|470656675|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
130736986|NCT02906670|470656676|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
130736987|NCT02906670|470656667|FG000|Cohort 4, Q2W|Radiological Progression|0|||
130736988|NCT02906670|470656668|FG001|Cohort 4, Q2W|Radiological Progression|0|||
130736989|NCT02906670|470656669|FG002|Cohort 4, Q2W|Radiological Progression|0|||
130736990|NCT02906670|470656670|FG003|Cohort 4, Q2W|Radiological Progression|0|||
130736991|NCT02906670|470656671|FG004|Cohort 4, Q2W|Radiological Progression|0|||
130736992|NCT02906670|470656672|FG005|Cohort 4, Q2W|Radiological Progression|1|||
130736993|NCT02906670|470656673|FG006|Cohort 4, Q2W|Radiological Progression|0|||
130736994|NCT02906670|470656674|FG007|Cohort 4, Q2W|Radiological Progression|0|||
130736995|NCT02906670|470656675|FG008|Cohort 4, Q2W|Radiological Progression|0|||
130736996|NCT02906670|470656676|FG009|Cohort 4, Q2W|Radiological Progression|0|||
130736997|NCT02906670|470656667|FG000|Cohort 4, Q2W|Clinical Progression|0|||
130736998|NCT02906670|470656668|FG001|Cohort 4, Q2W|Clinical Progression|0|||
130736999|NCT02906670|470656669|FG002|Cohort 4, Q2W|Clinical Progression|0|||
130737000|NCT02906670|470656670|FG003|Cohort 4, Q2W|Clinical Progression|0|||
130737001|NCT02906670|470656671|FG004|Cohort 4, Q2W|Clinical Progression|0|||
130737002|NCT02906670|470656672|FG005|Cohort 4, Q2W|Clinical Progression|2|||
130737003|NCT02906670|470656673|FG006|Cohort 4, Q2W|Clinical Progression|0|||
130737004|NCT02906670|470656674|FG007|Cohort 4, Q2W|Clinical Progression|0|||
130737005|NCT02906670|470656675|FG008|Cohort 4, Q2W|Clinical Progression|0|||
130737006|NCT02906670|470656676|FG009|Cohort 4, Q2W|Clinical Progression|0|||
130737007|NCT02906670|470656667|FG000|Cohort 5, Q2W|Radiological Progression|0|||
130737008|NCT02906670|470656668|FG001|Cohort 5, Q2W|Radiological Progression|0|||
130737009|NCT02906670|470656669|FG002|Cohort 5, Q2W|Radiological Progression|0|||
130737010|NCT02906670|470656670|FG003|Cohort 5, Q2W|Radiological Progression|0|||
130737011|NCT02906670|470656671|FG004|Cohort 5, Q2W|Radiological Progression|0|||
130737012|NCT02906670|470656672|FG005|Cohort 5, Q2W|Radiological Progression|0|||
130737013|NCT02906670|470656673|FG006|Cohort 5, Q2W|Radiological Progression|4|||
130737014|NCT02906670|470656674|FG007|Cohort 5, Q2W|Radiological Progression|0|||
130737015|NCT02906670|470656675|FG008|Cohort 5, Q2W|Radiological Progression|0|||
130737016|NCT02906670|470656676|FG009|Cohort 5, Q2W|Radiological Progression|0|||
130737017|NCT02906670|470656667|FG000|Cohort 5, Q2W|Clinical Progression|0|||
130737018|NCT02906670|470656668|FG001|Cohort 5, Q2W|Clinical Progression|0|||
130737019|NCT02906670|470656669|FG002|Cohort 5, Q2W|Clinical Progression|0|||
130737020|NCT02906670|470656670|FG003|Cohort 5, Q2W|Clinical Progression|0|||
130737021|NCT02906670|470656671|FG004|Cohort 5, Q2W|Clinical Progression|0|||
130737022|NCT02906670|470656672|FG005|Cohort 5, Q2W|Clinical Progression|0|||
130737023|NCT02906670|470656673|FG006|Cohort 5, Q2W|Clinical Progression|1|||
130737024|NCT02906670|470656674|FG007|Cohort 5, Q2W|Clinical Progression|0|||
130737025|NCT02906670|470656675|FG008|Cohort 5, Q2W|Clinical Progression|0|||
130737026|NCT02906670|470656676|FG009|Cohort 5, Q2W|Clinical Progression|0|||
130737027|NCT02906670|470656667|FG000|Cohort 5, Q2W|Adverse Event|0|||
130737028|NCT02906670|470656668|FG001|Cohort 5, Q2W|Adverse Event|0|||
130737029|NCT02906670|470656669|FG002|Cohort 5, Q2W|Adverse Event|0|||
130737030|NCT02906670|470656670|FG003|Cohort 5, Q2W|Adverse Event|0|||
130737031|NCT02906670|470656671|FG004|Cohort 5, Q2W|Adverse Event|0|||
130737032|NCT02906670|470656672|FG005|Cohort 5, Q2W|Adverse Event|0|||
130737033|NCT02906670|470656673|FG006|Cohort 5, Q2W|Adverse Event|1|||
130737034|NCT02906670|470656674|FG007|Cohort 5, Q2W|Adverse Event|0|||
130737035|NCT02906670|470656675|FG008|Cohort 5, Q2W|Adverse Event|0|||
130737036|NCT02906670|470656676|FG009|Cohort 5, Q2W|Adverse Event|0|||
130737037|NCT02906670|470656667|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130737038|NCT02906670|470656668|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130737039|NCT02906670|470656669|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130737040|NCT02906670|470656670|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130737041|NCT02906670|470656671|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130737042|NCT02906670|470656672|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130737043|NCT02906670|470656673|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
130737044|NCT02906670|470656674|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130737045|NCT02906670|470656675|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130737046|NCT02906670|470656676|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130737047|NCT02906670|470656667|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
130737048|NCT02906670|470656668|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
130784966|NCT00386334|470841224|FG000|Double Blind Period|Withdrawal by Subject|9|||
130784967|NCT00386334|470841225|FG001|Double Blind Period|Withdrawal by Subject|13|||
130784968|NCT00386334|470841224|FG000|Double Blind Period|Lack of Efficacy|20|||
130784969|NCT00386334|470841225|FG001|Double Blind Period|Lack of Efficacy|11|||
130784970|NCT00386334|470841224|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
130784971|NCT00386334|470841225|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
130784972|NCT00386334|470841224|FG000|Double Blind Period|Other|3|||
130784973|NCT00386334|470841225|FG001|Double Blind Period|Other|3|||
130784974|NCT00386334|470841224|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
130784975|NCT00386334|470841225|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
130784976|NCT00902577|470841228|FG000|Overall Study|Withdrawal by Subject|6|||
130784977|NCT00902577|470841228|FG000|Overall Study|FMISO production failure|2|||
130784978|NCT00785356|470841231|FG000|Overall Study|Study prematurely terminated|8|||
130784979|NCT03238417|470841233|FG000|Overall|non-response|955|||
130784980|NCT03238417|470841234|FG001|Overall|non-response|1920|||
130784981|NCT03238417|470841233|FG000|Overall|partial completion|48|||
130784982|NCT03238417|470841234|FG001|Overall|partial completion|68|||
130737049|NCT02906670|470656669|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
130737050|NCT02906670|470656670|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
130737051|NCT02906670|470656671|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
130737052|NCT02906670|470656672|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
130737053|NCT02906670|470656673|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
130737054|NCT02906670|470656674|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
130737055|NCT02906670|470656675|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
130737056|NCT02906670|470656676|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
130737057|NCT02906670|470656667|FG000|Cohort 5P, Q2W|Adverse Event|0|||
130737058|NCT02906670|470656668|FG001|Cohort 5P, Q2W|Adverse Event|0|||
130737059|NCT02906670|470656669|FG002|Cohort 5P, Q2W|Adverse Event|0|||
130737060|NCT02906670|470656670|FG003|Cohort 5P, Q2W|Adverse Event|0|||
130737061|NCT02906670|470656671|FG004|Cohort 5P, Q2W|Adverse Event|0|||
130737062|NCT02906670|470656672|FG005|Cohort 5P, Q2W|Adverse Event|0|||
130737063|NCT02906670|470656673|FG006|Cohort 5P, Q2W|Adverse Event|0|||
130737064|NCT02906670|470656674|FG007|Cohort 5P, Q2W|Adverse Event|1|||
130737065|NCT02906670|470656675|FG008|Cohort 5P, Q2W|Adverse Event|0|||
130737066|NCT02906670|470656676|FG009|Cohort 5P, Q2W|Adverse Event|0|||
130737067|NCT02906670|470656667|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
130737068|NCT02906670|470656668|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
130737069|NCT02906670|470656669|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
130737070|NCT02906670|470656670|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
130737071|NCT02906670|470656671|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
130737072|NCT02906670|470656672|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
130737073|NCT02906670|470656673|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
130737074|NCT02906670|470656674|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
130737075|NCT02906670|470656675|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
130737076|NCT02906670|470656676|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
130737077|NCT02906670|470656667|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
130737078|NCT02906670|470656668|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
130737079|NCT02906670|470656669|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
130737080|NCT02906670|470656670|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
130737081|NCT02906670|470656671|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
130737082|NCT02906670|470656672|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
130737083|NCT02906670|470656673|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
130737084|NCT02906670|470656674|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
130737085|NCT02906670|470656675|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
130737086|NCT02906670|470656676|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
130737087|NCT02906670|470656667|FG000|Cohort 4P, QW|Radiological Progression|0|||
130737088|NCT02906670|470656668|FG001|Cohort 4P, QW|Radiological Progression|0|||
130737089|NCT02906670|470656669|FG002|Cohort 4P, QW|Radiological Progression|0|||
130737090|NCT02906670|470656670|FG003|Cohort 4P, QW|Radiological Progression|3|||
130737091|NCT02906670|470656671|FG004|Cohort 4P, QW|Radiological Progression|0|||
130737092|NCT02906670|470656672|FG005|Cohort 4P, QW|Radiological Progression|0|||
130737093|NCT02906670|470656673|FG006|Cohort 4P, QW|Radiological Progression|0|||
130737094|NCT02906670|470656674|FG007|Cohort 4P, QW|Radiological Progression|0|||
130737095|NCT02906670|470656675|FG008|Cohort 4P, QW|Radiological Progression|0|||
130737096|NCT02906670|470656676|FG009|Cohort 4P, QW|Radiological Progression|0|||
130737097|NCT02906670|470656667|FG000|Cohort 7P, Q2W|Adverse Event|0|||
130737098|NCT02906670|470656668|FG001|Cohort 7P, Q2W|Adverse Event|0|||
130737099|NCT02906670|470656669|FG002|Cohort 7P, Q2W|Adverse Event|0|||
130737100|NCT02906670|470656670|FG003|Cohort 7P, Q2W|Adverse Event|0|||
130737101|NCT02906670|470656671|FG004|Cohort 7P, Q2W|Adverse Event|0|||
130737102|NCT02906670|470656672|FG005|Cohort 7P, Q2W|Adverse Event|0|||
130737103|NCT02906670|470656673|FG006|Cohort 7P, Q2W|Adverse Event|0|||
130737104|NCT02906670|470656674|FG007|Cohort 7P, Q2W|Adverse Event|0|||
130737105|NCT02906670|470656675|FG008|Cohort 7P, Q2W|Adverse Event|0|||
130737106|NCT02906670|470656676|FG009|Cohort 7P, Q2W|Adverse Event|1|||
130737107|NCT02906670|470656667|FG000|Cohort 7P, Q2W|Physician Decision|0|||
130737108|NCT02906670|470656668|FG001|Cohort 7P, Q2W|Physician Decision|0|||
130737109|NCT02906670|470656669|FG002|Cohort 7P, Q2W|Physician Decision|0|||
130737110|NCT02906670|470656670|FG003|Cohort 7P, Q2W|Physician Decision|0|||
130737111|NCT02906670|470656671|FG004|Cohort 7P, Q2W|Physician Decision|0|||
130737112|NCT02906670|470656672|FG005|Cohort 7P, Q2W|Physician Decision|0|||
130737113|NCT02906670|470656673|FG006|Cohort 7P, Q2W|Physician Decision|0|||
130737114|NCT02906670|470656674|FG007|Cohort 7P, Q2W|Physician Decision|0|||
130737115|NCT02906670|470656675|FG008|Cohort 7P, Q2W|Physician Decision|0|||
130737116|NCT02906670|470656676|FG009|Cohort 7P, Q2W|Physician Decision|1|||
130737117|NCT02906670|470656667|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130737118|NCT02906670|470656668|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130737119|NCT02906670|470656669|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130737120|NCT02906670|470656670|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130737121|NCT02906670|470656671|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130737122|NCT02906670|470656672|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130737123|NCT02906670|470656673|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130737124|NCT02906670|470656674|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130737125|NCT02906670|470656675|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130737126|NCT02906670|470656676|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
130737127|NCT02906670|470656667|FG000|Cohort 5P, QW|Radiological Progression|0|||
130737128|NCT02906670|470656668|FG001|Cohort 5P, QW|Radiological Progression|0|||
130737129|NCT02906670|470656669|FG002|Cohort 5P, QW|Radiological Progression|0|||
130737130|NCT02906670|470656670|FG003|Cohort 5P, QW|Radiological Progression|0|||
130737131|NCT02906670|470656671|FG004|Cohort 5P, QW|Radiological Progression|3|||
130737132|NCT02906670|470656672|FG005|Cohort 5P, QW|Radiological Progression|0|||
130737133|NCT02906670|470656673|FG006|Cohort 5P, QW|Radiological Progression|0|||
130737134|NCT02906670|470656674|FG007|Cohort 5P, QW|Radiological Progression|0|||
130737135|NCT02906670|470656675|FG008|Cohort 5P, QW|Radiological Progression|0|||
130737136|NCT02906670|470656676|FG009|Cohort 5P, QW|Radiological Progression|0|||
130737137|NCT01349192|470656677|FG000|Overall Study|Protocol Violation|0|||
130737138|NCT01349192|470656678|FG001|Overall Study|Protocol Violation|1|||
130737139|NCT01349192|470656677|FG000|Overall Study|Withdrawal by Subject|0|||
130737140|NCT01349192|470656678|FG001|Overall Study|Withdrawal by Subject|2|||
130737141|NCT01349192|470656677|FG000|Overall Study|Lost to Follow-up|1|||
130737142|NCT01349192|470656678|FG001|Overall Study|Lost to Follow-up|3|||
130737143|NCT01349192|470656677|FG000|Overall Study|Failure to adhere to Protocol|2|||
130737144|NCT01349192|470656678|FG001|Overall Study|Failure to adhere to Protocol|0|||
130737145|NCT03749330|470656679|FG000|Overall Study|Clinicians left work in the CICU|0|||
130737146|NCT03749330|470656680|FG001|Overall Study|Clinicians left work in the CICU|2|||
130737147|NCT03749330|470656681|FG002|Overall Study|Clinicians left work in the CICU|0|||
130737148|NCT03749330|470656682|FG003|Overall Study|Clinicians left work in the CICU|0|||
130737149|NCT03749330|470656683|FG004|Overall Study|Clinicians left work in the CICU|0|||
130737150|NCT03749330|470656684|FG005|Overall Study|Clinicians left work in the CICU|0|||
130737151|NCT01973439|470656685|FG000|Overall Study|Lost samples from one PK Day|2|||
130737152|NCT01973439|470656685|FG000|Overall Study|Vomiting after commencing once daily|1|||
130737153|NCT01973439|470656685|FG000|Overall Study|PK curve incomplete|2|||
130737154|NCT02262325|470656687|FG000|Overall Study|Death|16|||
130737155|NCT02262325|470656687|FG000|Overall Study|Lost to Follow-up|1|||
130737156|NCT02815995|470656688|FG000|Overall Study|Disease Progression|3|||
130737157|NCT02815995|470656689|FG001|Overall Study|Disease Progression|7|||
130737158|NCT02815995|470656690|FG002|Overall Study|Disease Progression|2|||
130737159|NCT02815995|470656691|FG003|Overall Study|Disease Progression|4|||
130737160|NCT02815995|470656692|FG004|Overall Study|Disease Progression|3|||
130737161|NCT02815995|470656693|FG005|Overall Study|Disease Progression|9|||
130737162|NCT02815995|470656694|FG006|Overall Study|Disease Progression|3|||
130737163|NCT02815995|470656695|FG007|Overall Study|Disease Progression|1|||
130737164|NCT02815995|470656688|FG000|Overall Study|Adverse Event|1|||
130737165|NCT02815995|470656689|FG001|Overall Study|Adverse Event|2|||
130737166|NCT02815995|470656690|FG002|Overall Study|Adverse Event|2|||
130737167|NCT02815995|470656691|FG003|Overall Study|Adverse Event|0|||
130737168|NCT02815995|470656692|FG004|Overall Study|Adverse Event|0|||
130737169|NCT02815995|470656693|FG005|Overall Study|Adverse Event|1|||
130737170|NCT02815995|470656694|FG006|Overall Study|Adverse Event|0|||
130737171|NCT02815995|470656695|FG007|Overall Study|Adverse Event|0|||
130737172|NCT02815995|470656688|FG000|Overall Study|Pregnancy|0|||
130737173|NCT02815995|470656689|FG001|Overall Study|Pregnancy|0|||
130737174|NCT02815995|470656690|FG002|Overall Study|Pregnancy|0|||
130737175|NCT02815995|470656691|FG003|Overall Study|Pregnancy|0|||
130737176|NCT02815995|470656692|FG004|Overall Study|Pregnancy|0|||
130737177|NCT02815995|470656693|FG005|Overall Study|Pregnancy|0|||
130737178|NCT02815995|470656694|FG006|Overall Study|Pregnancy|1|||
130737179|NCT02815995|470656695|FG007|Overall Study|Pregnancy|0|||
130737180|NCT03571828|470656700|FG000|Overall Study|Withdrawal by Subject|1|||
130737181|NCT03571828|470656701|FG001|Overall Study|Withdrawal by Subject|0|||
130737182|NCT03571828|470656700|FG000|Overall Study|Decision by sponsor|5|||
130737183|NCT03571828|470656701|FG001|Overall Study|Decision by sponsor|1|||
130737184|NCT03571828|470656700|FG000|Overall Study|Death|2|||
130737185|NCT03571828|470656701|FG001|Overall Study|Death|0|||
130737186|NCT00769379|470656702|FG000|Overall Study|No follow up data mapped to Other.|3|||
130737187|NCT00769379|470656703|FG001|Overall Study|No follow up data mapped to Other.|13|||
130737188|NCT03404674|470656704|FG000|Overall Study|Inability to Attend Future Visits|0|||
130737189|NCT03404674|470656705|FG001|Overall Study|Inability to Attend Future Visits|1|||
130737190|NCT03404674|470656706|FG002|Overall Study|Inability to Attend Future Visits|1|||
130737191|NCT03404674|470656707|FG003|Overall Study|Inability to Attend Future Visits|0|||
130737192|NCT03404674|470656708|FG004|Overall Study|Inability to Attend Future Visits|0|||
130737193|NCT03404674|470656709|FG005|Overall Study|Inability to Attend Future Visits|0|||
130737194|NCT03404674|470656704|FG000|Overall Study|Behavioral Problems|0|||
130737195|NCT03404674|470656705|FG001|Overall Study|Behavioral Problems|0|||
130737196|NCT03404674|470656706|FG002|Overall Study|Behavioral Problems|1|||
130737197|NCT03404674|470656707|FG003|Overall Study|Behavioral Problems|0|||
130737198|NCT03404674|470656708|FG004|Overall Study|Behavioral Problems|0|||
130737199|NCT03404674|470656709|FG005|Overall Study|Behavioral Problems|0|||
130737200|NCT03404674|470656704|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
130737201|NCT03404674|470656705|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
130737202|NCT03404674|470656706|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
130737203|NCT03404674|470656707|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
130737204|NCT03404674|470656708|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
130737205|NCT03404674|470656709|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
130737206|NCT00143390|470656730|FG000|Overall Study|Death|2|||
130737207|NCT00143390|470656731|FG001|Overall Study|Death|0|||
130737208|NCT00143390|470656730|FG000|Overall Study|Not meeting entry criteria|2|||
130737209|NCT00143390|470656731|FG001|Overall Study|Not meeting entry criteria|5|||
130737210|NCT00143390|470656730|FG000|Overall Study|Withdrawal by Subject|4|||
130737211|NCT00143390|470656731|FG001|Overall Study|Withdrawal by Subject|4|||
130737212|NCT00143390|470656730|FG000|Overall Study|Progressive disease|119|||
130737213|NCT00143390|470656731|FG001|Overall Study|Progressive disease|115|||
130737214|NCT00143390|470656730|FG000|Overall Study|Protocol Violation|2|||
130737215|NCT00143390|470656731|FG001|Overall Study|Protocol Violation|0|||
130737216|NCT00143390|470656730|FG000|Overall Study|Study termination|10|||
130737217|NCT00143390|470656731|FG001|Overall Study|Study termination|15|||
130737218|NCT00143390|470656730|FG000|Overall Study|Adverse Event|9|||
130737219|NCT00143390|470656731|FG001|Overall Study|Adverse Event|8|||
130737220|NCT00143390|470656730|FG000|Overall Study|Other|1|||
130737221|NCT00143390|470656731|FG001|Overall Study|Other|2|||
130737222|NCT00041132|470656734|FG000|Overall Study|Adverse Event|19|||
130737223|NCT00041132|470656734|FG000|Overall Study|Death|1|||
130737224|NCT00041132|470656734|FG000|Overall Study|Not Eligible|7|||
130737225|NCT00041132|470656734|FG000|Overall Study|Withdrawal by Subject|1|||
130737226|NCT00041132|470656734|FG000|Overall Study|Physician Decision|2|||
130737227|NCT03180645|470656735|FG000|Overall Study|Adverse Event|0|||
130737228|NCT03180645|470656736|FG001|Overall Study|Adverse Event|1|||
130737229|NCT03180645|470656737|FG002|Overall Study|Adverse Event|2|||
130737230|NCT00489255|470656738|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
130737231|NCT00489255|470656739|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
130737232|NCT00489255|470656738|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
130737233|NCT00489255|470656739|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
130737234|NCT00489255|470656738|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
130737235|NCT00489255|470656739|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
130737236|NCT00489255|470656738|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
130737237|NCT00489255|470656739|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
130737238|NCT00489255|470656738|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
130737239|NCT00489255|470656739|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
130737240|NCT00489255|470656738|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
130737241|NCT00489255|470656739|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
130737242|NCT00489255|470656738|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
130737243|NCT00489255|470656739|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
130737244|NCT00489255|470656738|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
130737245|NCT00489255|470656739|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
130737246|NCT00489255|470656738|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
130737247|NCT00489255|470656739|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
130737248|NCT00489255|470656738|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
130737249|NCT00489255|470656739|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
130737250|NCT02729909|470656741|FG000|Overall Study|Lost to Follow-up|0|||
130737251|NCT02729909|470656742|FG001|Overall Study|Lost to Follow-up|1|||
130737252|NCT02729909|470656741|FG000|Overall Study|Lack of Efficacy|0|||
130737253|NCT02729909|470656742|FG001|Overall Study|Lack of Efficacy|2|||
130737254|NCT02729909|470656741|FG000|Overall Study|Significant Protocol Deviation|0|||
130737255|NCT02729909|470656742|FG001|Overall Study|Significant Protocol Deviation|2|||
130737256|NCT02729909|470656741|FG000|Overall Study|Voluntary Withdrawal|1|||
130737257|NCT02729909|470656742|FG001|Overall Study|Voluntary Withdrawal|0|||
130737258|NCT00866359|470656743|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
130737259|NCT00866359|470656744|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
130737260|NCT00866359|470656745|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
130737261|NCT00866359|470656746|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
130737262|NCT00866359|470656743|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
130737263|NCT00866359|470656744|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
130737264|NCT00866359|470656745|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
130737265|NCT00866359|470656746|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
130737266|NCT00866359|470656743|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
130737267|NCT00866359|470656744|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
130737268|NCT00866359|470656745|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
130737269|NCT00866359|470656746|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
130737270|NCT00866359|470656743|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
130737271|NCT00866359|470656744|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
130737272|NCT00866359|470656745|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
130737273|NCT00866359|470656746|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
130737274|NCT00866359|470656743|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
130737275|NCT00866359|470656744|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
130737276|NCT00866359|470656745|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
130737277|NCT00866359|470656746|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
130737278|NCT00866359|470656743|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
130737279|NCT00866359|470656744|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
130737280|NCT00866359|470656745|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
130737281|NCT00866359|470656746|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
130737282|NCT00768248|470656751|FG000|Overall Study|Research coordinator didn't collect data|1|||
130737283|NCT00768248|470656752|FG001|Overall Study|Research coordinator didn't collect data|1|||
130737284|NCT01547390|470656753|FG000|Overall Study|Withdrawal by Subject|10|||
130737285|NCT01547390|470656754|FG001|Overall Study|Withdrawal by Subject|7|||
130737286|NCT01547390|470656753|FG000|Overall Study|termination of pregnancy|0|||
130737287|NCT01547390|470656754|FG001|Overall Study|termination of pregnancy|1|||
130737288|NCT01547390|470656753|FG000|Overall Study|Lost to Follow-up|0|||
130737289|NCT01547390|470656754|FG001|Overall Study|Lost to Follow-up|2|||
130737290|NCT01547390|470656753|FG000|Overall Study|Adverse Event|3|||
130737291|NCT01547390|470656754|FG001|Overall Study|Adverse Event|0|||
130737292|NCT01459783|470656755|FG000|Baseline to 6 Months|Death|1|||
130737293|NCT01459783|470656756|FG001|Baseline to 6 Months|Death|0|||
130737294|NCT01459783|470656755|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
130737295|NCT01459783|470656756|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
130737296|NCT01459783|470656755|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
130737297|NCT01459783|470656756|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
130737298|NCT01459783|470656755|FG000|6 Months to 12 Months|Death|0|||
130737299|NCT01459783|470656756|FG001|6 Months to 12 Months|Death|1|||
130737300|NCT01459783|470656755|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
130737301|NCT01459783|470656756|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
130737302|NCT01459783|470656755|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
130737303|NCT01459783|470656756|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
130737304|NCT01459783|470656755|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
130737305|NCT01459783|470656756|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
130737306|NCT06018129|470656758|FG000|Overall Study|Death|1|||
130737307|NCT06018129|470656759|FG001|Overall Study|Death|1|||
130737308|NCT06018129|470656760|FG002|Overall Study|Death|2|||
130737309|NCT06018129|470656758|FG000|Overall Study|Sponsor Decision|2|||
130737310|NCT06018129|470656759|FG001|Overall Study|Sponsor Decision|2|||
130737311|NCT06018129|470656760|FG002|Overall Study|Sponsor Decision|1|||
130737312|NCT04917861|470656761|FG000|Main Study (196 Days)|Adverse Event|0|||
130737313|NCT04917861|470656762|FG001|Main Study (196 Days)|Adverse Event|1|||
130737314|NCT04917861|470656763|FG002|Main Study (196 Days)|Adverse Event|0|||
130737315|NCT04917861|470656764|FG003|Main Study (196 Days)|Adverse Event|0|||
130737316|NCT04917861|470656761|FG000|Main Study (196 Days)|Death|0|||
130737317|NCT04917861|470656762|FG001|Main Study (196 Days)|Death|0|||
130737318|NCT04917861|470656763|FG002|Main Study (196 Days)|Death|0|||
130737319|NCT04917861|470656764|FG003|Main Study (196 Days)|Death|1|||
130737320|NCT04917861|470656761|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
130737321|NCT04917861|470656762|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
130737322|NCT04917861|470656763|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
130737323|NCT04917861|470656764|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
130737324|NCT04917861|470656761|FG000|Main Study (196 Days)|Physician Decision|0|||
130737325|NCT04917861|470656762|FG001|Main Study (196 Days)|Physician Decision|0|||
130784983|NCT03238417|470841233|FG000|Baseline|Partial completion|17|||
130737326|NCT04917861|470656763|FG002|Main Study (196 Days)|Physician Decision|0|||
130737327|NCT04917861|470656764|FG003|Main Study (196 Days)|Physician Decision|1|||
130737328|NCT04917861|470656761|FG000|Main Study (196 Days)|Pregnancy|1|||
130737329|NCT04917861|470656762|FG001|Main Study (196 Days)|Pregnancy|1|||
130737330|NCT04917861|470656763|FG002|Main Study (196 Days)|Pregnancy|0|||
130737331|NCT04917861|470656764|FG003|Main Study (196 Days)|Pregnancy|0|||
130784984|NCT03238417|470841234|FG001|Baseline|Partial completion|48|||
130784985|NCT03238417|470841233|FG000|Baseline|non-response|372|||
130784986|NCT03238417|470841234|FG001|Baseline|non-response|669|||
130784987|NCT03238417|470841233|FG000|12-month|non-response|296|||
130784988|NCT03238417|470841234|FG001|12-month|non-response|669|||
130784989|NCT03238417|470841233|FG000|12-month|partial completion|23|||
130784990|NCT03238417|470841234|FG001|12-month|partial completion|37|||
130784991|NCT03238417|470841233|FG000|24-month|non-response|287|||
130784992|NCT03238417|470841234|FG001|24-month|non-response|594|||
130784993|NCT03238417|470841233|FG000|24-month|partial completion|8|||
130784994|NCT03238417|470841234|FG001|24-month|partial completion|31|||
130784995|NCT01232790|470841235|FG000|Randomization|Withdrawal by Subject|2|||
130784996|NCT01232790|470841236|FG001|Randomization|Withdrawal by Subject|0|||
130784997|NCT01232790|470841235|FG000|Randomization|Protocol Violation|0|||
130784998|NCT01232790|470841236|FG001|Randomization|Protocol Violation|1|||
130784999|NCT01232790|470841235|FG000|Randomization|Physician Decision|0|||
130785000|NCT01232790|470841236|FG001|Randomization|Physician Decision|1|||
130785001|NCT01232790|470841235|FG000|Initial Assessment|Withdrawal by Subject|0|||
130785002|NCT01232790|470841236|FG001|Initial Assessment|Withdrawal by Subject|1|||
130785003|NCT01232790|470841235|FG000|First Crossover|Withdrawal by Subject|1|||
130785004|NCT01232790|470841236|FG001|First Crossover|Withdrawal by Subject|0|||
130785005|NCT01232790|470841235|FG000|Second Crossover|Withdrawal by Subject|1|||
130785006|NCT01232790|470841236|FG001|Second Crossover|Withdrawal by Subject|2|||
130785007|NCT02914834|470841239|FG000|Overall Study|Study halted due to COVID|1|||
130785008|NCT02914834|470841240|FG001|Overall Study|Study halted due to COVID|1|||
130785009|NCT02914834|470841239|FG000|Overall Study|1 subject withdrew|0|||
130785010|NCT02914834|470841240|FG001|Overall Study|1 subject withdrew|1|||
130785011|NCT00106002|470841241|FG000|Overall Study|Did not take any study drug|1|||
130785012|NCT00106002|470841241|FG000|Overall Study|Ineligible after Registration|1|||
130785013|NCT01245101|470841244|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
130785014|NCT01245101|470841245|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
130785015|NCT01245101|470841244|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
130785016|NCT01245101|470841245|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
130785017|NCT01245101|470841244|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
130785018|NCT01245101|470841245|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
130785019|NCT04456686|470841248|FG000|Overall Study|Adverse Event|2|||
130785020|NCT04456686|470841249|FG001|Overall Study|Adverse Event|1|||
130785021|NCT04456686|470841248|FG000|Overall Study|Lack of Efficacy|3|||
130785022|NCT04456686|470841249|FG001|Overall Study|Lack of Efficacy|1|||
130785023|NCT04456686|470841248|FG000|Overall Study|Withdrew consent|3|||
130785024|NCT04456686|470841249|FG001|Overall Study|Withdrew consent|1|||
130785025|NCT04456686|470841248|FG000|Overall Study|Physician Decision|2|||
130785026|NCT04456686|470841249|FG001|Overall Study|Physician Decision|2|||
130785027|NCT04456686|470841248|FG000|Overall Study|Withdrawal by Subject|5|||
130785028|NCT04456686|470841249|FG001|Overall Study|Withdrawal by Subject|1|||
130785029|NCT04456686|470841248|FG000|Overall Study|Protocol Violation|0|||
130785030|NCT04456686|470841249|FG001|Overall Study|Protocol Violation|1|||
130785031|NCT01225549|470841250|FG000|Period 4 - Washout|Disallowed medication|0|||
130785032|NCT01225549|470841251|FG001|Period 4 - Washout|Disallowed medication|1|||
130785033|NCT01225549|470841252|FG002|Period 4 - Washout|Disallowed medication|0|||
130737332|NCT04917861|470656761|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
130737333|NCT04917861|470656762|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
130737334|NCT04917861|470656763|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
130737335|NCT04917861|470656764|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
130737336|NCT04917861|470656761|FG000|Main Study (196 Days)|Other Than Specified|1|||
130737337|NCT04917861|470656762|FG001|Main Study (196 Days)|Other Than Specified|0|||
130737338|NCT04917861|470656763|FG002|Main Study (196 Days)|Other Than Specified|1|||
130737339|NCT04917861|470656764|FG003|Main Study (196 Days)|Other Than Specified|2|||
130737340|NCT04917861|470656761|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
130737341|NCT04917861|470656762|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
130737342|NCT04917861|470656763|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
130737343|NCT04917861|470656764|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
130737344|NCT04917861|470656761|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
130737345|NCT04917861|470656762|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
130737346|NCT04917861|470656763|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
130737347|NCT04917861|470656764|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
130737348|NCT04917861|470656761|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
130737349|NCT04917861|470656762|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
130737350|NCT04917861|470656763|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
130737351|NCT04917861|470656764|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
130737352|NCT04917861|470656761|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
130737353|NCT04917861|470656762|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
130737354|NCT04917861|470656763|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
130737355|NCT04917861|470656764|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
130737356|NCT04917861|470656761|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
130737357|NCT04917861|470656762|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
130737358|NCT04917861|470656763|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
130737359|NCT04917861|470656764|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
130737360|NCT04917861|470656761|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
130737361|NCT04917861|470656762|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
130737362|NCT04917861|470656763|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
130737363|NCT04917861|470656764|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
130737364|NCT06389487|470656765|FG000|Overall Study|Lost to Follow-up|9|||
130737365|NCT06389487|470656766|FG001|Overall Study|Lost to Follow-up|5|||
130737366|NCT06389487|470656767|FG002|Overall Study|Lost to Follow-up|13|||
130737367|NCT06389487|470656765|FG000|Overall Study|Protocol Violation|0|||
130737368|NCT06389487|470656766|FG001|Overall Study|Protocol Violation|0|||
130737369|NCT06389487|470656767|FG002|Overall Study|Protocol Violation|2|||
130737370|NCT06389487|470656765|FG000|Overall Study|Withdrawal by Subject|2|||
130737371|NCT06389487|470656766|FG001|Overall Study|Withdrawal by Subject|2|||
130737372|NCT06389487|470656767|FG002|Overall Study|Withdrawal by Subject|1|||
130737373|NCT06389487|470656765|FG000|Overall Study|Other|1|||
130737374|NCT06389487|470656766|FG001|Overall Study|Other|0|||
130737375|NCT06389487|470656767|FG002|Overall Study|Other|1|||
130737376|NCT03493685|470658457|FG000|Overall Study|Death|4|||
130737377|NCT03493685|470658458|FG001|Overall Study|Death|3|||
130737378|NCT03493685|470658457|FG000|Overall Study|Lost to Follow-up|3|||
130737379|NCT03493685|470658458|FG001|Overall Study|Lost to Follow-up|2|||
130737380|NCT03493685|470658457|FG000|Overall Study|Physician Decision|2|||
130737381|NCT03493685|470658458|FG001|Overall Study|Physician Decision|0|||
130737382|NCT03493685|470658457|FG000|Overall Study|Withdrawal by Subject|7|||
130737383|NCT03493685|470658458|FG001|Overall Study|Withdrawal by Subject|11|||
130737384|NCT04452669|470658459|FG000|Overall Study|Death|1|||
130737385|NCT04452669|470658460|FG001|Overall Study|Death|4|||
130737386|NCT03300817|470658461|FG000|Overall Study|Withdrawal by Subject|1|||
130737387|NCT03300817|470658461|FG000|Overall Study|Adverse Event|1|||
130737388|NCT03300817|470658461|FG000|Overall Study|Subject Found to be Ineligible|2|||
130737389|NCT03729596|470658464|FG000|Overall Study|Death|3|||
130737390|NCT03729596|470658465|FG001|Overall Study|Death|5|||
130737391|NCT03729596|470658466|FG002|Overall Study|Death|4|||
130737392|NCT03729596|470658467|FG003|Overall Study|Death|1|||
130737393|NCT03729596|470658468|FG004|Overall Study|Death|0|||
130737394|NCT03729596|470658469|FG005|Overall Study|Death|34|||
130737395|NCT03729596|470658470|FG006|Overall Study|Death|18|||
130737396|NCT03729596|470658471|FG007|Overall Study|Death|14|||
130737397|NCT03729596|470658472|FG008|Overall Study|Death|19|||
130737398|NCT03729596|470658473|FG009|Overall Study|Death|9|||
130737399|NCT03729596|470658464|FG000|Overall Study|Lost to Follow-up|0|||
130737400|NCT03729596|470658465|FG001|Overall Study|Lost to Follow-up|0|||
130737401|NCT03729596|470658466|FG002|Overall Study|Lost to Follow-up|0|||
130737402|NCT03729596|470658467|FG003|Overall Study|Lost to Follow-up|0|||
130737403|NCT03729596|470658468|FG004|Overall Study|Lost to Follow-up|0|||
130737404|NCT03729596|470658469|FG005|Overall Study|Lost to Follow-up|0|||
130737405|NCT03729596|470658470|FG006|Overall Study|Lost to Follow-up|1|||
130737406|NCT03729596|470658471|FG007|Overall Study|Lost to Follow-up|0|||
130737407|NCT03729596|470658472|FG008|Overall Study|Lost to Follow-up|0|||
130737408|NCT03729596|470658473|FG009|Overall Study|Lost to Follow-up|1|||
130737409|NCT03729596|470658464|FG000|Overall Study|protocol amendment|0|||
130737410|NCT03729596|470658465|FG001|Overall Study|protocol amendment|1|||
130737411|NCT03729596|470658466|FG002|Overall Study|protocol amendment|3|||
130737412|NCT03729596|470658467|FG003|Overall Study|protocol amendment|6|||
130737413|NCT03729596|470658468|FG004|Overall Study|protocol amendment|5|||
130737414|NCT03729596|470658469|FG005|Overall Study|protocol amendment|0|||
130737415|NCT03729596|470658470|FG006|Overall Study|protocol amendment|0|||
130737416|NCT03729596|470658471|FG007|Overall Study|protocol amendment|0|||
130785034|NCT01225549|470841253|FG003|Period 4 - Washout|Disallowed medication|0|||
130785035|NCT01225549|470841254|FG004|Period 4 - Washout|Disallowed medication|0|||
130785036|NCT01225549|470841255|FG005|Period 4 - Washout|Disallowed medication|0|||
130785037|NCT01225549|470841256|FG006|Period 4 - Washout|Disallowed medication|0|||
130785038|NCT01225549|470841257|FG007|Period 4 - Washout|Disallowed medication|0|||
130785039|NCT01225549|470841258|FG008|Period 4 - Washout|Disallowed medication|0|||
130785040|NCT01225549|470841259|FG009|Period 4 - Washout|Disallowed medication|0|||
130785041|NCT01225549|470841250|FG000|Period 6 - Washout|Disallowed medication|0|||
130785042|NCT01225549|470841251|FG001|Period 6 - Washout|Disallowed medication|0|||
130785043|NCT01225549|470841252|FG002|Period 6 - Washout|Disallowed medication|0|||
130785044|NCT01225549|470841253|FG003|Period 6 - Washout|Disallowed medication|1|||
130785045|NCT01225549|470841254|FG004|Period 6 - Washout|Disallowed medication|0|||
130785046|NCT01225549|470841255|FG005|Period 6 - Washout|Disallowed medication|0|||
130785047|NCT01225549|470841256|FG006|Period 6 - Washout|Disallowed medication|0|||
130785048|NCT01225549|470841257|FG007|Period 6 - Washout|Disallowed medication|0|||
130785049|NCT01225549|470841258|FG008|Period 6 - Washout|Disallowed medication|0|||
130785050|NCT01225549|470841259|FG009|Period 6 - Washout|Disallowed medication|0|||
130785051|NCT00891813|470841261|FG000|Overall Study|Adverse Event|3|||
130785052|NCT00891813|470841261|FG000|Overall Study|Withdrawal by Subject|1|||
130785053|NCT00891813|470841261|FG000|Overall Study|Patient Noncompliance|6|||
130785054|NCT00891813|470841261|FG000|Overall Study|Protocol Violation|2|||
130785055|NCT00473083|470841266|FG000|Overall Study|Adverse Event|1|||
130785056|NCT00473083|470841267|FG001|Overall Study|Adverse Event|0|||
130785057|NCT00473083|470841268|FG002|Overall Study|Adverse Event|0|||
130785058|NCT02858401|470841269|FG000|Overall Study|Withdrew Consent|0|||
130785059|NCT02858401|470841270|FG001|Overall Study|Withdrew Consent|0|||
130785060|NCT02858401|470841271|FG002|Overall Study|Withdrew Consent|0|||
130785061|NCT02858401|470841272|FG003|Overall Study|Withdrew Consent|0|||
130785062|NCT02858401|470841273|FG004|Overall Study|Withdrew Consent|0|||
130785063|NCT02858401|470841274|FG005|Overall Study|Withdrew Consent|1|||
130785064|NCT02858401|470841275|FG006|Overall Study|Withdrew Consent|0|||
130785065|NCT02858401|470841269|FG000|Overall Study|Lost to Follow-up|0|||
130785066|NCT02858401|470841270|FG001|Overall Study|Lost to Follow-up|1|||
130785067|NCT02858401|470841271|FG002|Overall Study|Lost to Follow-up|0|||
130785068|NCT02858401|470841272|FG003|Overall Study|Lost to Follow-up|0|||
130785069|NCT02858401|470841273|FG004|Overall Study|Lost to Follow-up|0|||
130785070|NCT02858401|470841274|FG005|Overall Study|Lost to Follow-up|0|||
130785071|NCT02858401|470841275|FG006|Overall Study|Lost to Follow-up|0|||
130785072|NCT00749398|470841276|FG000|Overall Study|Lack of Efficacy|7|||
130785073|NCT00749398|470841276|FG000|Overall Study|Adverse Event|4|||
130785074|NCT00749398|470841276|FG000|Overall Study|Serious adverse event|11|||
130785075|NCT00749398|470841276|FG000|Overall Study|Withdrawal by Subject|17|||
130785076|NCT00749398|470841276|FG000|Overall Study|Lost to Follow-up|11|||
130785077|NCT00749398|470841276|FG000|Overall Study|Reason not specified|2|||
130785078|NCT00749398|470841276|FG000|Overall Study|Unknown reason|1|||
130785079|NCT03093181|470841277|FG000|Overall Study|Withdrawal by Subject|2|||
130785080|NCT03093181|470841278|FG001|Overall Study|Withdrawal by Subject|1|||
130785081|NCT03093181|470841279|FG002|Overall Study|Withdrawal by Subject|2|||
130785082|NCT03093181|470841277|FG000|Overall Study|Other (Not specified)|1|||
130785083|NCT03093181|470841278|FG001|Overall Study|Other (Not specified)|0|||
130785084|NCT03093181|470841279|FG002|Overall Study|Other (Not specified)|0|||
130737417|NCT03729596|470658472|FG008|Overall Study|protocol amendment|0|||
130737418|NCT03729596|470658473|FG009|Overall Study|protocol amendment|0|||
130737419|NCT03729596|470658464|FG000|Overall Study|Withdrawal by Subject|0|||
130737420|NCT03729596|470658465|FG001|Overall Study|Withdrawal by Subject|0|||
130737421|NCT03729596|470658466|FG002|Overall Study|Withdrawal by Subject|0|||
130737422|NCT03729596|470658467|FG003|Overall Study|Withdrawal by Subject|0|||
130737423|NCT03729596|470658468|FG004|Overall Study|Withdrawal by Subject|0|||
130737424|NCT03729596|470658469|FG005|Overall Study|Withdrawal by Subject|4|||
130737425|NCT03729596|470658470|FG006|Overall Study|Withdrawal by Subject|2|||
130737426|NCT03729596|470658471|FG007|Overall Study|Withdrawal by Subject|3|||
130737427|NCT03729596|470658472|FG008|Overall Study|Withdrawal by Subject|2|||
130737428|NCT03729596|470658473|FG009|Overall Study|Withdrawal by Subject|3|||
130737429|NCT03729596|470658464|FG000|Overall Study|study terminated by sponsor|0|||
130737430|NCT03729596|470658465|FG001|Overall Study|study terminated by sponsor|0|||
130737431|NCT03729596|470658466|FG002|Overall Study|study terminated by sponsor|0|||
130737432|NCT03729596|470658467|FG003|Overall Study|study terminated by sponsor|0|||
130737433|NCT03729596|470658468|FG004|Overall Study|study terminated by sponsor|1|||
130737434|NCT03729596|470658469|FG005|Overall Study|study terminated by sponsor|3|||
130737435|NCT03729596|470658470|FG006|Overall Study|study terminated by sponsor|0|||
130737436|NCT03729596|470658471|FG007|Overall Study|study terminated by sponsor|1|||
130737437|NCT03729596|470658472|FG008|Overall Study|study terminated by sponsor|0|||
130737438|NCT03729596|470658473|FG009|Overall Study|study terminated by sponsor|0|||
130737439|NCT03713593|470658474|FG000|Overall Study|Sponsor Decision|73|||
130737440|NCT03713593|470658475|FG001|Overall Study|Sponsor Decision|41|||
130737441|NCT03713593|470658474|FG000|Overall Study|Lost to Follow-up|2|||
130737442|NCT03713593|470658475|FG001|Overall Study|Lost to Follow-up|1|||
130737443|NCT03713593|470658474|FG000|Overall Study|Death|314|||
130737444|NCT03713593|470658475|FG001|Overall Study|Death|349|||
130737445|NCT03713593|470658474|FG000|Overall Study|Withdrawal by Subject|6|||
130737446|NCT03713593|470658475|FG001|Overall Study|Withdrawal by Subject|8|||
130737447|NCT04653454|470658476|FG000|Overall Study|Withdrawal by Subject|1|||
130737448|NCT04653454|470658476|FG000|Overall Study|Physician Decision|40|||
130737449|NCT03620708|470658477|FG000|Overall Study|Lost to Follow-up|1|||
130737450|NCT03620708|470658478|FG001|Overall Study|Lost to Follow-up|1|||
130737451|NCT03620708|470658479|FG002|Overall Study|Lost to Follow-up|2|||
130737452|NCT03620708|470658477|FG000|Overall Study|Withdrawal by Subject|0|||
130737453|NCT03620708|470658478|FG001|Overall Study|Withdrawal by Subject|0|||
130737454|NCT03620708|470658479|FG002|Overall Study|Withdrawal by Subject|1|||
130737455|NCT05126693|470658480|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
130737456|NCT05126693|470658481|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
130737457|NCT05126693|470658480|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
130737458|NCT05126693|470658481|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
130737459|NCT05126693|470658480|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
130737460|NCT05126693|470658481|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
130737461|NCT04011722|470658485|FG000|30 Days|Death|5|||
130737462|NCT04011722|470658486|FG001|30 Days|Death|1|||
130737463|NCT04011722|470658485|FG000|1 Year|Death|13|||
130737464|NCT04011722|470658486|FG001|1 Year|Death|5|||
130737465|NCT04011722|470658485|FG000|1 Year|Withdrawal by Subject|8|||
130737466|NCT04011722|470658486|FG001|1 Year|Withdrawal by Subject|2|||
130737467|NCT04011722|470658485|FG000|1 Year|Missed Visit|6|||
130737468|NCT04011722|470658486|FG001|1 Year|Missed Visit|1|||
130737469|NCT04011722|470658485|FG000|1 Year|Pending Visit|0|||
130737470|NCT04011722|470658486|FG001|1 Year|Pending Visit|11|||
130737471|NCT04011722|470658485|FG000|1 Year|Not Yet Due|0|||
130737472|NCT04011722|470658486|FG001|1 Year|Not Yet Due|9|||
130737473|NCT04011722|470658485|FG000|2 Year|Death|16|||
130737474|NCT04011722|470658486|FG001|2 Year|Death|1|||
130785085|NCT03093181|470841277|FG000|Overall Study|Adverse Event|0|||
130785086|NCT03093181|470841278|FG001|Overall Study|Adverse Event|1|||
130785087|NCT03093181|470841279|FG002|Overall Study|Adverse Event|0|||
130785088|NCT03093181|470841277|FG000|Overall Study|Other (Protocol violation)|0|||
130785089|NCT03093181|470841278|FG001|Overall Study|Other (Protocol violation)|0|||
130785090|NCT03093181|470841279|FG002|Overall Study|Other (Protocol violation)|1|||
130785091|NCT04210986|470841280|FG000|Overall Study|Lost to Follow-up|5|||
130785092|NCT04210986|470841281|FG001|Overall Study|Lost to Follow-up|2|||
130785093|NCT04210986|470841280|FG000|Overall Study|Withdrawal by Subject|3|||
130785094|NCT04210986|470841281|FG001|Overall Study|Withdrawal by Subject|1|||
130785095|NCT04210986|470841280|FG000|Overall Study|Protocol Violation|1|||
130785096|NCT04210986|470841281|FG001|Overall Study|Protocol Violation|1|||
130785097|NCT04210986|470841280|FG000|Overall Study|Physician Decision|0|||
130785098|NCT04210986|470841281|FG001|Overall Study|Physician Decision|1|||
130785099|NCT02666222|470841282|FG000|Overall Study|Death|2|||
130785100|NCT04233879|470841283|FG000|Overall Study|Death|2|||
130785101|NCT04233879|470841284|FG001|Overall Study|Death|0|||
130785102|NCT04233879|470841283|FG000|Overall Study|Lost to Follow-up|3|||
130785103|NCT04233879|470841284|FG001|Overall Study|Lost to Follow-up|8|||
130785104|NCT04233879|470841283|FG000|Overall Study|Physician Decision|4|||
130785105|NCT04233879|470841284|FG001|Overall Study|Physician Decision|4|||
130785106|NCT04233879|470841283|FG000|Overall Study|Withdrawal by Subject|7|||
130785107|NCT04233879|470841284|FG001|Overall Study|Withdrawal by Subject|10|||
130785108|NCT04233879|470841283|FG000|Overall Study|Other|281|||
130785109|NCT04233879|470841284|FG001|Overall Study|Other|279|||
130785110|NCT03585270|470841287|FG000|Overall Study|Withdrawal by Subject|2|||
130785111|NCT03585270|470841288|FG001|Overall Study|Withdrawal by Subject|6|||
130785112|NCT03585270|470841287|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
130785113|NCT03585270|470841288|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
130785114|NCT03585270|470841287|FG000|Overall Study|Adverse Event|5|||
130785115|NCT03585270|470841288|FG001|Overall Study|Adverse Event|2|||
130785116|NCT03585270|470841287|FG000|Overall Study|Lost to Follow-up|1|||
130785117|NCT03585270|470841288|FG001|Overall Study|Lost to Follow-up|4|||
130785118|NCT03585270|470841287|FG000|Overall Study|Death|5|||
130785119|NCT03585270|470841288|FG001|Overall Study|Death|3|||
130785120|NCT03585270|470841287|FG000|Overall Study|Other reasons|2|||
130785121|NCT03585270|470841288|FG001|Overall Study|Other reasons|2|||
130785122|NCT01664091|470841289|FG000|Overall Study|Death|1|||
130785123|NCT01664091|470841289|FG000|Overall Study|Disease Progression|2|||
130785124|NCT01664091|470841289|FG000|Overall Study|Lost to Follow-up|2|||
130785125|NCT01664091|470841289|FG000|Overall Study|Withdrawal by Subject|1|||
130785126|NCT01076543|470841292|FG000|Overall Study|Withdrawal by Subject|2|||
130785127|NCT01076543|470841293|FG001|Overall Study|Withdrawal by Subject|0|||
130785128|NCT01076543|470841294|FG002|Overall Study|Withdrawal by Subject|0|||
130785129|NCT01076543|470841295|FG003|Overall Study|Withdrawal by Subject|0|||
130785130|NCT01076543|470841296|FG004|Overall Study|Withdrawal by Subject|0|||
130785131|NCT01076543|470841297|FG005|Overall Study|Withdrawal by Subject|0|||
130785132|NCT05222880|470841298|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130785133|NCT05222880|470841298|FG000|Overall Study|Withdrew Consent during Study|1|||
130785134|NCT05222880|470841298|FG000|Overall Study|COVID-19 Related|1|||
130785135|NCT01791985|470841299|FG000|Overall Study|Adverse Event|7|||
130785136|NCT01791985|470841299|FG000|Overall Study|Withdrawal by Subject|1|||
130785137|NCT01614470|470841305|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
130785138|NCT01614470|470841306|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130785139|NCT01614470|470841307|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130785140|NCT01614470|470841305|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
130785141|NCT01614470|470841306|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
130785142|NCT01614470|470841307|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
130785143|NCT03217591|470841318|FG000|Overall Study|Adverse Event|1|||
130785144|NCT03217591|470841319|FG001|Overall Study|Adverse Event|2|||
130785145|NCT03217591|470841320|FG002|Overall Study|Adverse Event|6|||
130785146|NCT03217591|470841318|FG000|Overall Study|Withdrawal by Subject|0|||
130785147|NCT03217591|470841319|FG001|Overall Study|Withdrawal by Subject|1|||
130785148|NCT03217591|470841320|FG002|Overall Study|Withdrawal by Subject|3|||
130785149|NCT03217591|470841318|FG000|Overall Study|Lost to Follow-up|1|||
130785150|NCT03217591|470841319|FG001|Overall Study|Lost to Follow-up|0|||
130785151|NCT03217591|470841320|FG002|Overall Study|Lost to Follow-up|0|||
130785152|NCT03217591|470841318|FG000|Overall Study|Protocol Violation|1|||
130785153|NCT03217591|470841319|FG001|Overall Study|Protocol Violation|0|||
130785154|NCT03217591|470841320|FG002|Overall Study|Protocol Violation|1|||
130737475|NCT04011722|470658485|FG000|2 Year|Withdrawal by Subject|10|||
130737476|NCT04011722|470658486|FG001|2 Year|Withdrawal by Subject|1|||
130737477|NCT04011722|470658485|FG000|2 Year|Missed Visit|9|||
130737478|NCT04011722|470658486|FG001|2 Year|Missed Visit|0|||
130737479|NCT04011722|470658485|FG000|2 Year|Visit Pending|1|||
130737480|NCT04011722|470658486|FG001|2 Year|Visit Pending|3|||
130737481|NCT04011722|470658485|FG000|2 Year|Not Yet Due|43|||
130737482|NCT04011722|470658486|FG001|2 Year|Not Yet Due|54|||
130737483|NCT04011722|470658485|FG000|3 Year|Death|10|||
130737484|NCT04011722|470658486|FG001|3 Year|Death|0|||
130737485|NCT04011722|470658485|FG000|3 Year|Withdrawal by Subject|2|||
130737486|NCT04011722|470658486|FG001|3 Year|Withdrawal by Subject|0|||
130737487|NCT04011722|470658485|FG000|3 Year|Missed Visit|2|||
130737488|NCT04011722|470658486|FG001|3 Year|Missed Visit|0|||
130737489|NCT04011722|470658485|FG000|3 Year|Pending Visit|34|||
130737490|NCT04011722|470658486|FG001|3 Year|Pending Visit|0|||
130737491|NCT04011722|470658485|FG000|3 Year|Not Yet Due|99|||
130737492|NCT04011722|470658486|FG001|3 Year|Not Yet Due|0|||
130737493|NCT05109611|470658487|FG000|Overall Study|Adverse Event|13|||
130737494|NCT05109611|470658488|FG001|Overall Study|Adverse Event|10|||
130737495|NCT05109611|470658487|FG000|Overall Study|Withdrawal by Subject|1|||
130737496|NCT05109611|470658488|FG001|Overall Study|Withdrawal by Subject|0|||
130737497|NCT05109611|470658487|FG000|Overall Study|Lost to Follow-up|1|||
130737498|NCT05109611|470658488|FG001|Overall Study|Lost to Follow-up|2|||
130737499|NCT05109611|470658487|FG000|Overall Study|Protocol Violation|0|||
130737500|NCT05109611|470658488|FG001|Overall Study|Protocol Violation|4|||
130737501|NCT05109611|470658487|FG000|Overall Study|Information unavailable|1|||
130737502|NCT05109611|470658488|FG001|Overall Study|Information unavailable|1|||
130737503|NCT05061134|470658489|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
130737504|NCT05061134|470658490|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
130737505|NCT05061134|470658491|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
130737506|NCT05061134|470658489|FG000|Overall Study|Subject not treated|0|||
130737507|NCT05061134|470658490|FG001|Overall Study|Subject not treated|0|||
130737508|NCT05061134|470658491|FG002|Overall Study|Subject not treated|2|||
130737509|NCT05061134|470658489|FG000|Overall Study|Other|0|||
130737510|NCT05061134|470658490|FG001|Overall Study|Other|0|||
130737511|NCT05061134|470658491|FG002|Overall Study|Other|9|||
130737512|NCT05061134|470658489|FG000|Overall Study|Withdrawal by Subject|9|||
130737513|NCT05061134|470658490|FG001|Overall Study|Withdrawal by Subject|8|||
130737514|NCT05061134|470658491|FG002|Overall Study|Withdrawal by Subject|5|||
130737515|NCT05061134|470658489|FG000|Overall Study|Study Terminated by Sponsor|22|||
130737516|NCT05061134|470658490|FG001|Overall Study|Study Terminated by Sponsor|14|||
130737517|NCT05061134|470658491|FG002|Overall Study|Study Terminated by Sponsor|7|||
130737518|NCT05061134|470658489|FG000|Overall Study|Progressive Disease|1|||
130737519|NCT05061134|470658490|FG001|Overall Study|Progressive Disease|2|||
130737520|NCT05061134|470658491|FG002|Overall Study|Progressive Disease|0|||
130737521|NCT05061134|470658489|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
130737522|NCT05061134|470658490|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
130737523|NCT05061134|470658491|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
130737524|NCT05061134|470658489|FG000|Overall Study|Lost to Follow-up|1|||
130737525|NCT05061134|470658490|FG001|Overall Study|Lost to Follow-up|0|||
130737526|NCT05061134|470658491|FG002|Overall Study|Lost to Follow-up|0|||
130737527|NCT05061134|470658489|FG000|Overall Study|Physician Decision|1|||
130737528|NCT05061134|470658490|FG001|Overall Study|Physician Decision|1|||
130737529|NCT05061134|470658491|FG002|Overall Study|Physician Decision|0|||
130737530|NCT05061134|470658489|FG000|Overall Study|Disease progression|1|||
130737531|NCT05061134|470658490|FG001|Overall Study|Disease progression|0|||
130737532|NCT05061134|470658491|FG002|Overall Study|Disease progression|0|||
130737533|NCT05061134|470658489|FG000|Overall Study|Death|43|||
130737534|NCT05061134|470658490|FG001|Overall Study|Death|23|||
130737535|NCT05061134|470658491|FG002|Overall Study|Death|14|||
130737536|NCT05061134|470658489|FG000|Overall Study|Database lock|2|||
130737537|NCT05061134|470658490|FG001|Overall Study|Database lock|0|||
130737538|NCT05061134|470658491|FG002|Overall Study|Database lock|0|||
130737539|NCT02366689|470658503|FG000|Overall Study|Withdrawal by Subject|1|||
130737540|NCT02366689|470658504|FG001|Overall Study|Withdrawal by Subject|0|||
130737541|NCT02366689|470658505|FG002|Overall Study|Withdrawal by Subject|1|||
130737542|NCT02366689|470658503|FG000|Overall Study|Lost to Follow-up|3|||
130737543|NCT02366689|470658504|FG001|Overall Study|Lost to Follow-up|2|||
130737544|NCT02366689|470658505|FG002|Overall Study|Lost to Follow-up|0|||
130737545|NCT02366689|470658503|FG000|Overall Study|Pregnancy|0|||
130737546|NCT02366689|470658504|FG001|Overall Study|Pregnancy|1|||
130737547|NCT02366689|470658505|FG002|Overall Study|Pregnancy|1|||
130737548|NCT03283566|470658506|FG000|Overall Study|Lost to Follow-up|1|||
130737549|NCT03283566|470658507|FG001|Overall Study|Lost to Follow-up|2|||
130737550|NCT03288714|470658512|FG000|Overall Study|Lost to Follow-up|2|||
130737551|NCT03288714|470658513|FG001|Overall Study|Lost to Follow-up|1|||
130737552|NCT03288714|470658512|FG000|Overall Study|Non-compliance with study schedule|2|||
130737553|NCT03288714|470658513|FG001|Overall Study|Non-compliance with study schedule|0|||
130737554|NCT03288714|470658512|FG000|Overall Study|Withdrawal by Subject|3|||
130737555|NCT03288714|470658513|FG001|Overall Study|Withdrawal by Subject|1|||
130737556|NCT03288714|470658512|FG000|Overall Study|Clinical Worsening|2|||
130737557|NCT03288714|470658513|FG001|Overall Study|Clinical Worsening|1|||
130737558|NCT03288714|470658512|FG000|Overall Study|Adverse Event|1|||
130737559|NCT03288714|470658513|FG001|Overall Study|Adverse Event|0|||
130737560|NCT04882241|470658515|FG000|Overall Study|Ongoing in study|46|||
130737561|NCT04882241|470658516|FG001|Overall Study|Ongoing in study|48|||
130737562|NCT04882241|470658517|FG002|Overall Study|Ongoing in study|0|||
130737563|NCT04882241|470658518|FG003|Overall Study|Ongoing in study|0|||
130737564|NCT04882241|470658515|FG000|Overall Study|Death|13|||
130737565|NCT04882241|470658516|FG001|Overall Study|Death|13|||
130737566|NCT04882241|470658517|FG002|Overall Study|Death|0|||
130737567|NCT04882241|470658518|FG003|Overall Study|Death|0|||
130737568|NCT00470535|470658536|FG000|Overall Study|Disease Progression|13|||
130737569|NCT00470535|470658536|FG000|Overall Study|Withdrawal by Subject|1|||
130737570|NCT00470535|470658536|FG000|Overall Study|Adverse Event|1|||
130737571|NCT00470535|470658536|FG000|Overall Study|Death|1|||
130737572|NCT00470535|470658536|FG000|Overall Study|Other|2|||
130737573|NCT02070965|470658541|FG000|Overall Study|Lost to Follow-up|0|||
130737574|NCT02070965|470658542|FG001|Overall Study|Lost to Follow-up|1|||
130737575|NCT02070965|470658543|FG002|Overall Study|Lost to Follow-up|0|||
130737576|NCT02070965|470658541|FG000|Overall Study|Withdrawal by Subject|1|||
130737577|NCT02070965|470658542|FG001|Overall Study|Withdrawal by Subject|1|||
130737578|NCT02070965|470658543|FG002|Overall Study|Withdrawal by Subject|1|||
130737579|NCT02070965|470658541|FG000|Overall Study|Subject moved|1|||
130737580|NCT02070965|470658542|FG001|Overall Study|Subject moved|0|||
130737581|NCT02070965|470658543|FG002|Overall Study|Subject moved|0|||
130737582|NCT02515331|470658544|FG000|Overall Study|Withdrawal by Subject|0|||
130737583|NCT02515331|470658545|FG001|Overall Study|Withdrawal by Subject|0|||
130737584|NCT02515331|470658546|FG002|Overall Study|Withdrawal by Subject|1|||
130737585|NCT02515331|470658544|FG000|Overall Study|Protocol deviation|0|||
130737586|NCT02515331|470658545|FG001|Overall Study|Protocol deviation|0|||
130737587|NCT02515331|470658546|FG002|Overall Study|Protocol deviation|3|||
130737588|NCT02515331|470658544|FG000|Overall Study|Adverse Event|2|||
130737589|NCT02515331|470658545|FG001|Overall Study|Adverse Event|0|||
130737590|NCT02515331|470658546|FG002|Overall Study|Adverse Event|0|||
130737591|NCT00124748|470658547|FG000|Overall Study|Adverse Event|8|||
130737592|NCT00124748|470658548|FG001|Overall Study|Adverse Event|39|||
130737593|NCT00124748|470658547|FG000|Overall Study|Abnormal laboratory Value|2|||
130737594|NCT00124748|470658548|FG001|Overall Study|Abnormal laboratory Value|2|||
130737595|NCT00124748|470658547|FG000|Overall Study|Abnormal Procedure|0|||
130737596|NCT00124748|470658548|FG001|Overall Study|Abnormal Procedure|1|||
130737597|NCT00124748|470658547|FG000|Overall Study|Lack of Efficacy|20|||
130737598|NCT00124748|470658548|FG001|Overall Study|Lack of Efficacy|41|||
130737599|NCT00124748|470658547|FG000|Overall Study|No longer requires study drug|1|||
130737600|NCT00124748|470658548|FG001|Overall Study|No longer requires study drug|1|||
130737601|NCT00124748|470658547|FG000|Overall Study|Protocol Violation|3|||
130737602|NCT00124748|470658548|FG001|Overall Study|Protocol Violation|1|||
130737603|NCT00124748|470658547|FG000|Overall Study|Withdrawal by Subject|5|||
130737604|NCT00124748|470658548|FG001|Overall Study|Withdrawal by Subject|15|||
130737605|NCT00124748|470658547|FG000|Overall Study|Lost to Follow-up|2|||
130737606|NCT00124748|470658548|FG001|Overall Study|Lost to Follow-up|7|||
130737607|NCT00124748|470658547|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
130737608|NCT00124748|470658548|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
130737609|NCT00124748|470658547|FG000|Overall Study|Death|1|||
130737610|NCT00124748|470658548|FG001|Overall Study|Death|3|||
130737611|NCT00322712|470658549|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
130737612|NCT00758524|470658550|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
130737613|NCT00758524|470658551|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
130737614|NCT00758524|470658552|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
130737615|NCT00758524|470658553|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737616|NCT00758524|470658554|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
130737617|NCT00758524|470658555|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
130737618|NCT00758524|470658556|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737619|NCT00758524|470658557|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737620|NCT00758524|470658558|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737621|NCT00758524|470658559|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737622|NCT00758524|470658560|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737623|NCT00758524|470658561|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737624|NCT00758524|470658562|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737625|NCT00758524|470658563|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737626|NCT00758524|470658564|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737627|NCT00758524|470658565|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737628|NCT00758524|470658566|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130737629|NCT00758524|470658550|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
130737630|NCT00758524|470658551|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130785155|NCT02895347|470841322|FG000|Overall Study|Withdrawal by Subject|3|||
130785156|NCT02895347|470841323|FG001|Overall Study|Withdrawal by Subject|1|||
130785157|NCT03177148|470841327|FG000|Overall Study|Lost to Follow-up|50|||
130785158|NCT03177148|470841328|FG001|Overall Study|Lost to Follow-up|1|||
130785159|NCT03177148|470841327|FG000|Overall Study|Death|1|||
130785160|NCT03177148|470841328|FG001|Overall Study|Death|0|||
130785161|NCT01204671|470841329|FG000|Overall Study|Adverse Event|4|||
130785162|NCT01204671|470841330|FG001|Overall Study|Adverse Event|3|||
130785163|NCT01204671|470841331|FG002|Overall Study|Adverse Event|3|||
130785164|NCT01204671|470841332|FG003|Overall Study|Adverse Event|3|||
130785165|NCT01204671|470841333|FG004|Overall Study|Adverse Event|1|||
130785166|NCT01204671|470841329|FG000|Overall Study|Withdrawal by Subject|2|||
130785167|NCT01204671|470841330|FG001|Overall Study|Withdrawal by Subject|3|||
130785168|NCT01204671|470841331|FG002|Overall Study|Withdrawal by Subject|4|||
130785169|NCT01204671|470841332|FG003|Overall Study|Withdrawal by Subject|5|||
130785170|NCT01204671|470841333|FG004|Overall Study|Withdrawal by Subject|3|||
130785171|NCT01204671|470841329|FG000|Overall Study|Lost to Follow-up|7|||
130785172|NCT01204671|470841330|FG001|Overall Study|Lost to Follow-up|8|||
130785173|NCT01204671|470841331|FG002|Overall Study|Lost to Follow-up|6|||
130785174|NCT01204671|470841332|FG003|Overall Study|Lost to Follow-up|4|||
130785175|NCT01204671|470841333|FG004|Overall Study|Lost to Follow-up|0|||
130785176|NCT01204671|470841329|FG000|Overall Study|Unknown Completion Status|1|||
130785177|NCT01204671|470841330|FG001|Overall Study|Unknown Completion Status|1|||
130785178|NCT01204671|470841331|FG002|Overall Study|Unknown Completion Status|0|||
130785179|NCT01204671|470841332|FG003|Overall Study|Unknown Completion Status|0|||
130785180|NCT01204671|470841333|FG004|Overall Study|Unknown Completion Status|0|||
130785181|NCT01204671|470841329|FG000|Overall Study|Physician Decision|0|||
130785182|NCT01204671|470841330|FG001|Overall Study|Physician Decision|0|||
130785183|NCT01204671|470841331|FG002|Overall Study|Physician Decision|0|||
130785184|NCT01204671|470841332|FG003|Overall Study|Physician Decision|1|||
130785185|NCT01204671|470841333|FG004|Overall Study|Physician Decision|0|||
130785186|NCT02357459|470843063|FG000|Overall Study|Adverse Event|0|||
130785187|NCT02357459|470843064|FG001|Overall Study|Adverse Event|1|||
130785188|NCT02357459|470843065|FG002|Overall Study|Adverse Event|1|||
130785189|NCT02357459|470843063|FG000|Overall Study|Withdrawal by Subject|5|||
130785190|NCT02357459|470843064|FG001|Overall Study|Withdrawal by Subject|3|||
130785191|NCT02357459|470843065|FG002|Overall Study|Withdrawal by Subject|3|||
130785192|NCT02357459|470843063|FG000|Overall Study|Physician Decision|0|||
130785193|NCT02357459|470843064|FG001|Overall Study|Physician Decision|2|||
130785194|NCT02357459|470843065|FG002|Overall Study|Physician Decision|0|||
130785195|NCT02357459|470843063|FG000|Overall Study|Protocol Violation|1|||
130785196|NCT02357459|470843064|FG001|Overall Study|Protocol Violation|1|||
130785197|NCT02357459|470843065|FG002|Overall Study|Protocol Violation|0|||
130785198|NCT02357459|470843063|FG000|Overall Study|Lost to Follow-up|1|||
130785199|NCT02357459|470843064|FG001|Overall Study|Lost to Follow-up|3|||
130785200|NCT02357459|470843065|FG002|Overall Study|Lost to Follow-up|0|||
130785201|NCT02357459|470843063|FG000|Overall Study|Lack of Efficacy|7|||
130785202|NCT02357459|470843064|FG001|Overall Study|Lack of Efficacy|4|||
130785203|NCT02357459|470843065|FG002|Overall Study|Lack of Efficacy|4|||
130785204|NCT02357459|470843063|FG000|Overall Study|Patient Relocated|2|||
130785205|NCT02357459|470843064|FG001|Overall Study|Patient Relocated|0|||
130785206|NCT02357459|470843065|FG002|Overall Study|Patient Relocated|0|||
130785207|NCT02357459|470843063|FG000|Overall Study|Instruction from PCP|1|||
130785208|NCT02357459|470843064|FG001|Overall Study|Instruction from PCP|0|||
130785209|NCT02357459|470843065|FG002|Overall Study|Instruction from PCP|0|||
130785210|NCT02357459|470843063|FG000|Overall Study|Incarceration|0|||
130785211|NCT02357459|470843064|FG001|Overall Study|Incarceration|0|||
130785212|NCT02357459|470843065|FG002|Overall Study|Incarceration|1|||
130785213|NCT02357459|470843063|FG000|Overall Study|Pre-planned Knee surgery|0|||
130785214|NCT02357459|470843064|FG001|Overall Study|Pre-planned Knee surgery|0|||
130785215|NCT02357459|470843065|FG002|Overall Study|Pre-planned Knee surgery|2|||
130785216|NCT02357459|470843063|FG000|Overall Study|Job Commitments|0|||
130785217|NCT02357459|470843064|FG001|Overall Study|Job Commitments|0|||
130785218|NCT02357459|470843065|FG002|Overall Study|Job Commitments|1|||
130785219|NCT01548599|470843066|FG000|Overall Study|Lost to Follow-up|0|||
130785220|NCT01548599|470843067|FG001|Overall Study|Lost to Follow-up|1|||
130785221|NCT01548599|470843066|FG000|Overall Study|Withdrawal by Subject|4|||
130785222|NCT01548599|470843067|FG001|Overall Study|Withdrawal by Subject|0|||
130785223|NCT01548599|470843066|FG000|Overall Study|Death|2|||
130785224|NCT01548599|470843067|FG001|Overall Study|Death|1|||
130785225|NCT00352118|470843069|FG000|Overall Study|Physician Decision|4|||
130785226|NCT02990000|470843070|FG000|Overall Study|Failed to provide data beyond baseline|36|||
130785227|NCT02990000|470843071|FG001|Overall Study|Failed to provide data beyond baseline|34|||
130737631|NCT00758524|470658552|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
130737632|NCT00758524|470658553|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
130737633|NCT00758524|470658554|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
130737634|NCT00758524|470658555|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
130737635|NCT00758524|470658556|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737636|NCT00758524|470658557|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737637|NCT00758524|470658558|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737638|NCT00758524|470658559|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737639|NCT00758524|470658560|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737640|NCT00758524|470658561|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737641|NCT00758524|470658562|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737642|NCT00758524|470658563|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737643|NCT00758524|470658564|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737644|NCT00758524|470658565|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737645|NCT00758524|470658566|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130737646|NCT00758524|470658550|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
130737647|NCT00758524|470658551|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
130737648|NCT00758524|470658552|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
130737649|NCT00758524|470658553|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
130737650|NCT00758524|470658554|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
130737651|NCT00758524|470658555|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
130737652|NCT00758524|470658556|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737653|NCT00758524|470658557|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737654|NCT00758524|470658558|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737655|NCT00758524|470658559|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737656|NCT00758524|470658560|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737657|NCT00758524|470658561|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737658|NCT00758524|470658562|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737659|NCT00758524|470658563|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737660|NCT00758524|470658564|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737661|NCT00758524|470658565|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737662|NCT00758524|470658566|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130737663|NCT00758524|470658550|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737664|NCT00758524|470658551|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
130737665|NCT00758524|470658552|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
130737666|NCT00758524|470658553|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737667|NCT00758524|470658554|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
130737668|NCT00758524|470658555|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
130737669|NCT00758524|470658556|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737670|NCT00758524|470658557|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737671|NCT00758524|470658558|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737672|NCT00758524|470658559|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737673|NCT00758524|470658560|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737674|NCT00758524|470658561|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737675|NCT00758524|470658562|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737676|NCT00758524|470658563|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737677|NCT00758524|470658564|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737678|NCT00758524|470658565|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737679|NCT00758524|470658566|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130737680|NCT00758524|470658550|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130785228|NCT02308046|470843072|FG000|Overall Study|Negative yeast culture at Baseline|32|||
130785229|NCT02308046|470843073|FG001|Overall Study|Negative yeast culture at Baseline|33|||
130785230|NCT02308046|470843072|FG000|Overall Study|Positive for STD at Baseline|1|||
130785231|NCT02308046|470843073|FG001|Overall Study|Positive for STD at Baseline|2|||
130785232|NCT02308046|470843072|FG000|Overall Study|Lost to Follow-up|1|||
130737681|NCT00758524|470658551|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737682|NCT00758524|470658552|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
130737683|NCT00758524|470658553|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
130737684|NCT00758524|470658554|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737685|NCT00758524|470658555|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737686|NCT00758524|470658556|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737687|NCT00758524|470658557|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737688|NCT00758524|470658558|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737689|NCT00758524|470658559|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737690|NCT00758524|470658560|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737691|NCT00758524|470658561|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737692|NCT00758524|470658562|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737693|NCT00758524|470658563|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737694|NCT00758524|470658564|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737695|NCT00758524|470658565|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737696|NCT00758524|470658566|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130737697|NCT00758524|470658550|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737698|NCT00758524|470658551|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737699|NCT00758524|470658552|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737700|NCT00758524|470658553|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737701|NCT00758524|470658554|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
130737702|NCT00758524|470658555|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737703|NCT00758524|470658556|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737704|NCT00758524|470658557|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737705|NCT00758524|470658558|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737706|NCT00758524|470658559|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737707|NCT00758524|470658560|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737708|NCT00758524|470658561|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737709|NCT00758524|470658562|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737710|NCT00758524|470658563|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737711|NCT00758524|470658564|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737712|NCT00758524|470658565|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737713|NCT00758524|470658566|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130737714|NCT00758524|470658550|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737715|NCT00758524|470658551|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
130737716|NCT00758524|470658552|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737717|NCT00758524|470658553|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737718|NCT00758524|470658554|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737719|NCT00758524|470658555|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737720|NCT00758524|470658556|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737721|NCT00758524|470658557|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737722|NCT00758524|470658558|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737723|NCT00758524|470658559|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737724|NCT00758524|470658560|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737725|NCT00758524|470658561|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737726|NCT00758524|470658562|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737727|NCT00758524|470658563|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737728|NCT00758524|470658564|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737729|NCT00758524|470658565|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737730|NCT00758524|470658566|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130737731|NCT00758524|470658550|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737732|NCT00758524|470658551|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
130737733|NCT00758524|470658552|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737734|NCT00758524|470658553|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737735|NCT00758524|470658554|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737736|NCT00758524|470658555|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737737|NCT00758524|470658556|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130785233|NCT02308046|470843073|FG001|Overall Study|Lost to Follow-up|3|||
130737738|NCT00758524|470658557|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130785234|NCT00883181|470843074|FG000|Overall Study|Hematological Adverse Event|26|||
130785235|NCT00883181|470843074|FG000|Overall Study|Non-hematological Adverse Event|55|||
130737739|NCT00758524|470658558|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737740|NCT00758524|470658559|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737741|NCT00758524|470658560|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737742|NCT00758524|470658561|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737743|NCT00758524|470658562|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737744|NCT00758524|470658563|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737745|NCT00758524|470658564|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737746|NCT00758524|470658565|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737747|NCT00758524|470658566|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130737748|NCT00758524|470658550|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737749|NCT00758524|470658551|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737750|NCT00758524|470658552|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737751|NCT00758524|470658553|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737752|NCT00758524|470658554|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737753|NCT00758524|470658555|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737754|NCT00758524|470658556|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737755|NCT00758524|470658557|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737756|NCT00758524|470658558|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
130737757|NCT00758524|470658559|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737758|NCT00758524|470658560|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737759|NCT00758524|470658561|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737760|NCT00758524|470658562|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737761|NCT00758524|470658563|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737762|NCT00758524|470658564|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737763|NCT00758524|470658565|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737764|NCT00758524|470658566|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130737765|NCT00758524|470658550|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737766|NCT00758524|470658551|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737767|NCT00758524|470658552|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737768|NCT00758524|470658553|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737769|NCT00758524|470658554|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737770|NCT00758524|470658555|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737771|NCT00758524|470658556|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
130737772|NCT00758524|470658557|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737773|NCT00758524|470658558|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737774|NCT00758524|470658559|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737775|NCT00758524|470658560|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737776|NCT00758524|470658561|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737777|NCT00758524|470658562|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737778|NCT00758524|470658563|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737779|NCT00758524|470658564|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737780|NCT00758524|470658565|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737781|NCT00758524|470658566|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130737782|NCT01928472|470658574|FG000|Overall Study|Death|0|||
130737783|NCT01928472|470658575|FG001|Overall Study|Death|0|||
130737784|NCT01928472|470658576|FG002|Overall Study|Death|1|||
130737785|NCT01928472|470658577|FG003|Overall Study|Death|0|||
130737786|NCT01928472|470658574|FG000|Overall Study|Withdrawal by Subject|4|||
130737787|NCT01928472|470658575|FG001|Overall Study|Withdrawal by Subject|4|||
130737788|NCT01928472|470658576|FG002|Overall Study|Withdrawal by Subject|1|||
130737789|NCT01928472|470658577|FG003|Overall Study|Withdrawal by Subject|2|||
130737790|NCT01928472|470658574|FG000|Overall Study|Lost to Follow-up|2|||
130737791|NCT01928472|470658575|FG001|Overall Study|Lost to Follow-up|3|||
130737792|NCT01928472|470658576|FG002|Overall Study|Lost to Follow-up|4|||
130737793|NCT01928472|470658577|FG003|Overall Study|Lost to Follow-up|0|||
130737794|NCT01928472|470658574|FG000|Overall Study|Administrative Reason|2|||
130737795|NCT01928472|470658575|FG001|Overall Study|Administrative Reason|1|||
130737796|NCT01928472|470658576|FG002|Overall Study|Administrative Reason|0|||
130737797|NCT01928472|470658577|FG003|Overall Study|Administrative Reason|0|||
130737798|NCT01928472|470658574|FG000|Overall Study|Unclassified|0|||
130737799|NCT01928472|470658575|FG001|Overall Study|Unclassified|0|||
130737800|NCT01928472|470658576|FG002|Overall Study|Unclassified|1|||
130737801|NCT01928472|470658577|FG003|Overall Study|Unclassified|0|||
130737802|NCT00129545|470658583|FG000|Overall Study|Death|5|||
130737803|NCT00129545|470658584|FG001|Overall Study|Death|60|||
130737804|NCT00129545|470658585|FG002|Overall Study|Death|44|||
130737805|NCT00129545|470658583|FG000|Overall Study|Withdrawal by Subject|3|||
130737806|NCT00129545|470658584|FG001|Overall Study|Withdrawal by Subject|18|||
130737807|NCT00129545|470658585|FG002|Overall Study|Withdrawal by Subject|44|||
130785236|NCT00883181|470843074|FG000|Overall Study|Disease Progression|94|||
130785237|NCT00883181|470843074|FG000|Overall Study|Administrative Reason|24|||
130785238|NCT00883181|470843074|FG000|Overall Study|Withdrawal by Subject|4|||
130785239|NCT00883181|470843074|FG000|Overall Study|Death|31|||
130785240|NCT00883181|470843074|FG000|Overall Study|Other|38|||
130785241|NCT00883181|470843074|FG000|Overall Study|Protocol Deviation|3|||
130737808|NCT00129545|470658583|FG000|Overall Study|Lost to Follow-up|2|||
130737809|NCT00129545|470658584|FG001|Overall Study|Lost to Follow-up|22|||
130737810|NCT00129545|470658585|FG002|Overall Study|Lost to Follow-up|13|||
130737811|NCT00129545|470658583|FG000|Overall Study|Physician Decision|0|||
130737812|NCT00129545|470658584|FG001|Overall Study|Physician Decision|3|||
130737813|NCT00129545|470658585|FG002|Overall Study|Physician Decision|10|||
130737814|NCT00129545|470658583|FG000|Overall Study|Device not implanted|16|||
130737815|NCT00129545|470658584|FG001|Overall Study|Device not implanted|61|||
130737816|NCT00129545|470658585|FG002|Overall Study|Device not implanted|0|||
130737817|NCT01841593|470658586|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
130737818|NCT01841593|470658587|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
130737819|NCT01841593|470658586|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
130737820|NCT01841593|470658587|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
130737821|NCT00307086|470658588|FG000|Overall Study|ineligible|5|||
130737822|NCT01870778|470658592|FG000|Overall Study|Withdrawal by Subject|8|||
130737823|NCT01870778|470658593|FG001|Overall Study|Withdrawal by Subject|7|||
130737824|NCT01870778|470658592|FG000|Overall Study|Lost to Follow-up|0|||
130737825|NCT01870778|470658593|FG001|Overall Study|Lost to Follow-up|2|||
130737826|NCT00312338|470658594|FG000|Overall Study|Adverse Event|7|||
130737827|NCT00312338|470658595|FG001|Overall Study|Adverse Event|2|||
130737828|NCT00312338|470658594|FG000|Overall Study|Lost to Follow-up|9|||
130737829|NCT00312338|470658595|FG001|Overall Study|Lost to Follow-up|1|||
130737830|NCT00312338|470658594|FG000|Overall Study|Withdrawal by Subject|4|||
130737831|NCT00312338|470658595|FG001|Overall Study|Withdrawal by Subject|0|||
130737832|NCT00312338|470658594|FG000|Overall Study|Subsequent infection|2|||
130737833|NCT00312338|470658595|FG001|Overall Study|Subsequent infection|0|||
130737834|NCT00262028|470658596|FG000|Overall Study|Withdrawal by Subject|6|||
130737835|NCT00262028|470658597|FG001|Overall Study|Withdrawal by Subject|3|||
130737836|NCT00262028|470658598|FG002|Overall Study|Withdrawal by Subject|6|||
130737837|NCT00262028|470658599|FG003|Overall Study|Withdrawal by Subject|5|||
130737838|NCT00262028|470658600|FG004|Overall Study|Withdrawal by Subject|2|||
130737839|NCT00262028|470658601|FG005|Overall Study|Withdrawal by Subject|3|||
130737840|NCT00262028|470658602|FG006|Overall Study|Withdrawal by Subject|5|||
130737841|NCT00262028|470658603|FG007|Overall Study|Withdrawal by Subject|7|||
130737842|NCT00262028|470658604|FG008|Overall Study|Withdrawal by Subject|2|||
130737843|NCT00262028|470658596|FG000|Overall Study|Lost to Follow-up|7|||
130737844|NCT00262028|470658597|FG001|Overall Study|Lost to Follow-up|7|||
130737845|NCT00262028|470658598|FG002|Overall Study|Lost to Follow-up|5|||
130737846|NCT00262028|470658599|FG003|Overall Study|Lost to Follow-up|5|||
130737847|NCT00262028|470658600|FG004|Overall Study|Lost to Follow-up|4|||
130737848|NCT00262028|470658601|FG005|Overall Study|Lost to Follow-up|3|||
130737849|NCT00262028|470658602|FG006|Overall Study|Lost to Follow-up|3|||
130737850|NCT00262028|470658603|FG007|Overall Study|Lost to Follow-up|5|||
130737851|NCT00262028|470658604|FG008|Overall Study|Lost to Follow-up|6|||
130737852|NCT00262028|470658596|FG000|Overall Study|Administrative Reason|11|||
130737853|NCT00262028|470658597|FG001|Overall Study|Administrative Reason|14|||
130737854|NCT00262028|470658598|FG002|Overall Study|Administrative Reason|9|||
130737855|NCT00262028|470658599|FG003|Overall Study|Administrative Reason|12|||
130737856|NCT00262028|470658600|FG004|Overall Study|Administrative Reason|6|||
130737857|NCT00262028|470658601|FG005|Overall Study|Administrative Reason|7|||
130737858|NCT00262028|470658602|FG006|Overall Study|Administrative Reason|4|||
130737859|NCT00262028|470658603|FG007|Overall Study|Administrative Reason|6|||
130737860|NCT00262028|470658604|FG008|Overall Study|Administrative Reason|10|||
130737861|NCT00262028|470658596|FG000|Overall Study|Protocol Violation|0|||
130737862|NCT00262028|470658597|FG001|Overall Study|Protocol Violation|0|||
130737863|NCT00262028|470658598|FG002|Overall Study|Protocol Violation|0|||
130737864|NCT00262028|470658599|FG003|Overall Study|Protocol Violation|1|||
130737865|NCT00262028|470658600|FG004|Overall Study|Protocol Violation|0|||
130737866|NCT00262028|470658601|FG005|Overall Study|Protocol Violation|0|||
130737867|NCT00262028|470658602|FG006|Overall Study|Protocol Violation|0|||
130737868|NCT00262028|470658603|FG007|Overall Study|Protocol Violation|0|||
130785242|NCT00883181|470843074|FG000|Overall Study|Noncompliance|3|||
130785243|NCT01587885|470843077|FG000|Treatment Period 1|Failure to Return|0|||
130785244|NCT01587885|470843078|FG001|Treatment Period 1|Failure to Return|1|||
130785245|NCT01587885|470843077|FG000|Treatment Period 1|Protocol Violation|0|||
130785246|NCT01587885|470843078|FG001|Treatment Period 1|Protocol Violation|2|||
130785247|NCT00001566|470843083|FG000|Overall Study|patients' choice to discontinue protocol|3|||
130785248|NCT00001566|470843083|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
130785249|NCT00001566|470843083|FG000|Overall Study|Death|13|||
130785250|NCT00001566|470843083|FG000|Overall Study|Lost to Follow-up|1|||
130785251|NCT00001566|470843083|FG000|Overall Study|unable to complete initial apheresis|1|||
130785252|NCT00975416|470843086|FG000|Overall Study|early discharge from tx|3|||
130785253|NCT00975416|470843087|FG001|Overall Study|early discharge from tx|5|||
130785254|NCT01249131|470843092|FG000|Washout Period of 10 Days|Adverse Event|0|||
130785255|NCT01249131|470843093|FG001|Washout Period of 10 Days|Adverse Event|0|||
130785256|NCT01249131|470843094|FG002|Washout Period of 10 Days|Adverse Event|0|||
130785257|NCT01249131|470843095|FG003|Washout Period of 10 Days|Adverse Event|0|||
130785258|NCT01249131|470843096|FG004|Washout Period of 10 Days|Adverse Event|1|||
130785259|NCT01249131|470843097|FG005|Washout Period of 10 Days|Adverse Event|0|||
130785260|NCT02674516|470843098|FG000|Overall Study|Lost to Follow-up|3|||
130785261|NCT02674516|470843099|FG001|Overall Study|Lost to Follow-up|0|||
130737869|NCT00262028|470658604|FG008|Overall Study|Protocol Violation|0|||
130737870|NCT00262028|470658596|FG000|Overall Study|Unable to classify|0|||
130737871|NCT00262028|470658597|FG001|Overall Study|Unable to classify|3|||
130737872|NCT00262028|470658598|FG002|Overall Study|Unable to classify|0|||
130737873|NCT00262028|470658599|FG003|Overall Study|Unable to classify|0|||
130737874|NCT00262028|470658600|FG004|Overall Study|Unable to classify|0|||
130737875|NCT00262028|470658601|FG005|Overall Study|Unable to classify|0|||
130737876|NCT00262028|470658602|FG006|Overall Study|Unable to classify|0|||
130737877|NCT00262028|470658603|FG007|Overall Study|Unable to classify|0|||
130737878|NCT00262028|470658604|FG008|Overall Study|Unable to classify|1|||
130737879|NCT02308124|470658605|FG000|Overall Study|Lost to Follow-up|6|||
130737880|NCT02308124|470658606|FG001|Overall Study|Lost to Follow-up|6|||
130737881|NCT02308124|470658607|FG002|Overall Study|Lost to Follow-up|6|||
130737882|NCT02308124|470658605|FG000|Overall Study|Adverse Event|0|||
130737883|NCT02308124|470658606|FG001|Overall Study|Adverse Event|2|||
130737884|NCT02308124|470658607|FG002|Overall Study|Adverse Event|2|||
130737885|NCT02553772|470658609|FG000|Overall Study|Adverse Event|2|||
130737886|NCT02553772|470658610|FG001|Overall Study|Adverse Event|3|||
130737887|NCT02553772|470658609|FG000|Overall Study|Lost to Follow-up|2|||
130737888|NCT02553772|470658610|FG001|Overall Study|Lost to Follow-up|1|||
130737889|NCT02553772|470658609|FG000|Overall Study|Withdrawal of Consent|1|||
130737890|NCT02553772|470658610|FG001|Overall Study|Withdrawal of Consent|1|||
130737891|NCT02553772|470658609|FG000|Overall Study|Lack of Efficacy|1|||
130737892|NCT02553772|470658610|FG001|Overall Study|Lack of Efficacy|0|||
130785262|NCT02674516|470843098|FG000|Overall Study|Protocol Violation|0|||
130785263|NCT02674516|470843099|FG001|Overall Study|Protocol Violation|4|||
130785264|NCT02674516|470843098|FG000|Overall Study|Knowledge of study hypothesis|1|||
130785265|NCT02674516|470843099|FG001|Overall Study|Knowledge of study hypothesis|0|||
130785266|NCT02662569|470843101|FG000|Overall Study|Withdrawal by Subject|6|||
130785267|NCT02662569|470843102|FG001|Overall Study|Withdrawal by Subject|1|||
130785268|NCT02662569|470843103|FG002|Overall Study|Withdrawal by Subject|6|||
130785269|NCT02662569|470843104|FG003|Overall Study|Withdrawal by Subject|4|||
130785270|NCT02662569|470843101|FG000|Overall Study|Lost to Follow-up|1|||
130785271|NCT02662569|470843102|FG001|Overall Study|Lost to Follow-up|0|||
130785272|NCT02662569|470843103|FG002|Overall Study|Lost to Follow-up|0|||
130785273|NCT02662569|470843104|FG003|Overall Study|Lost to Follow-up|0|||
130785274|NCT04076917|470843105|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
130785275|NCT04076917|470843105|FG000|Overall Study|Study closure|13|||
130785276|NCT04076917|470843105|FG000|Overall Study|Physician Decision|3|||
130785277|NCT04076917|470843105|FG000|Overall Study|Death|1|||
130785278|NCT04076917|470843105|FG000|Overall Study|Lost to Follow-up|1|||
130785279|NCT04076917|470843105|FG000|Overall Study|Withdrawal by Subject|1|||
130785280|NCT04076917|470843105|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
130785281|NCT02378662|470843106|FG000|Overall Study|Early Discontinuation|2|||
130785282|NCT02378662|470843107|FG001|Overall Study|Early Discontinuation|0|||
130785283|NCT01701245|470843108|FG000|Overall Study|Protocol Violation|1|||
130785284|NCT01701245|470843109|FG001|Overall Study|Protocol Violation|3|||
130785285|NCT01701245|470843108|FG000|Overall Study|Did not complete the open label period|11|||
130785286|NCT01701245|470843109|FG001|Overall Study|Did not complete the open label period|12|||
130785287|NCT01774591|470843110|FG000|Overall Study|Physician Decision|1|||
130785288|NCT01774591|470843111|FG001|Overall Study|Physician Decision|1|||
130785289|NCT01774591|470843110|FG000|Overall Study|Withdrawal by Subject|0|||
130785290|NCT01774591|470843111|FG001|Overall Study|Withdrawal by Subject|1|||
130785291|NCT01774591|470843110|FG000|Overall Study|Adverse Event|0|||
130785292|NCT01774591|470843111|FG001|Overall Study|Adverse Event|2|||
130785293|NCT01159574|470843112|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
130785294|NCT01159574|470843112|FG000|Treatment Phase|Adverse Event|3|||
130785295|NCT01159574|470843112|FG000|Treatment Phase|Death|6|||
130785296|NCT01159574|470843112|FG000|Treatment Phase|Physician Decision|2|||
130785297|NCT01159574|470843112|FG000|Treatment Phase|Withdrawal by Subject|7|||
130785298|NCT01159574|470843112|FG000|Treatment Phase|still on treatment|2|||
130785299|NCT01159574|470843112|FG000|Follow Up Phase|Lost to Follow-up|2|||
130785300|NCT01159574|470843112|FG000|Follow Up Phase|still being followed for overall surviva|18|||
130785301|NCT03555149|470843117|FG000|Overall Study|Death|18|||
130785302|NCT03555149|470843118|FG001|Overall Study|Death|15|||
130785303|NCT03555149|470843119|FG002|Overall Study|Death|15|||
130785304|NCT03555149|470843120|FG003|Overall Study|Death|4|||
130785305|NCT03555149|470843121|FG004|Overall Study|Death|4|||
130785306|NCT03555149|470843122|FG005|Overall Study|Death|11|||
130785307|NCT03555149|470843123|FG006|Overall Study|Death|12|||
130785308|NCT03555149|470843124|FG007|Overall Study|Death|1|||
130785309|NCT03555149|470843117|FG000|Overall Study|Lost to Follow-up|1|||
130785310|NCT03555149|470843118|FG001|Overall Study|Lost to Follow-up|0|||
130785311|NCT03555149|470843119|FG002|Overall Study|Lost to Follow-up|0|||
130785312|NCT03555149|470843120|FG003|Overall Study|Lost to Follow-up|0|||
130785313|NCT03555149|470843121|FG004|Overall Study|Lost to Follow-up|0|||
130785314|NCT03555149|470843122|FG005|Overall Study|Lost to Follow-up|1|||
130785315|NCT03555149|470843123|FG006|Overall Study|Lost to Follow-up|0|||
130785316|NCT03555149|470843124|FG007|Overall Study|Lost to Follow-up|0|||
130785317|NCT03555149|470843117|FG000|Overall Study|Physician Decision|1|||
130785318|NCT03555149|470843118|FG001|Overall Study|Physician Decision|0|||
130785319|NCT03555149|470843119|FG002|Overall Study|Physician Decision|0|||
130785320|NCT03555149|470843120|FG003|Overall Study|Physician Decision|0|||
130785321|NCT03555149|470843121|FG004|Overall Study|Physician Decision|0|||
130785322|NCT03555149|470843122|FG005|Overall Study|Physician Decision|0|||
130785323|NCT03555149|470843123|FG006|Overall Study|Physician Decision|0|||
130785324|NCT03555149|470843124|FG007|Overall Study|Physician Decision|0|||
130785325|NCT03555149|470843117|FG000|Overall Study|Study Terminated By Sponsor|1|||
130785326|NCT03555149|470843118|FG001|Overall Study|Study Terminated By Sponsor|0|||
130785327|NCT03555149|470843119|FG002|Overall Study|Study Terminated By Sponsor|0|||
130785328|NCT03555149|470843120|FG003|Overall Study|Study Terminated By Sponsor|0|||
130785329|NCT03555149|470843121|FG004|Overall Study|Study Terminated By Sponsor|0|||
130785330|NCT03555149|470843122|FG005|Overall Study|Study Terminated By Sponsor|2|||
130785331|NCT03555149|470843123|FG006|Overall Study|Study Terminated By Sponsor|3|||
130785332|NCT03555149|470843124|FG007|Overall Study|Study Terminated By Sponsor|1|||
130785333|NCT03555149|470843117|FG000|Overall Study|Withdrawal by Subject|3|||
130785334|NCT03555149|470843118|FG001|Overall Study|Withdrawal by Subject|0|||
130785335|NCT03555149|470843119|FG002|Overall Study|Withdrawal by Subject|0|||
130785336|NCT03555149|470843120|FG003|Overall Study|Withdrawal by Subject|2|||
130785337|NCT03555149|470843121|FG004|Overall Study|Withdrawal by Subject|0|||
130785338|NCT03555149|470843122|FG005|Overall Study|Withdrawal by Subject|1|||
130785339|NCT03555149|470843123|FG006|Overall Study|Withdrawal by Subject|0|||
130785340|NCT03555149|470843124|FG007|Overall Study|Withdrawal by Subject|0|||
130785341|NCT01474486|470843127|FG000|Overall Study|Death|2|||
130785342|NCT01474486|470843127|FG000|Overall Study|Withdrawal by Subject|4|||
130785343|NCT01474486|470843127|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
130737893|NCT02553772|470658609|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130737894|NCT02553772|470658610|FG001|Overall Study|Other Miscellaneous Reasons|1|||
130737895|NCT05724589|470658611|FG000|Overall Study|Lost to Follow-up|1|||
130737896|NCT00786409|470658612|FG000|Overall Study|Withdrawal by Subject|2|||
130737897|NCT00786409|470658612|FG000|Overall Study|Adverse Event|2|||
130737898|NCT00786409|470658612|FG000|Overall Study|Pregnancy|2|||
130737899|NCT00786409|470658612|FG000|Overall Study|Lost to Follow-up|1|||
130737900|NCT00610129|470658613|FG000|Overall Study|Not treated since patients ineligible|3|||
130737901|NCT02273388|470658616|FG000|Overall Study|Adverse Event|0|||
130737902|NCT02273388|470658617|FG001|Overall Study|Adverse Event|0|||
130737903|NCT02273388|470658618|FG002|Overall Study|Adverse Event|0|||
130737904|NCT02273388|470658619|FG003|Overall Study|Adverse Event|0|||
130737905|NCT02273388|470658620|FG004|Overall Study|Adverse Event|0|||
130737906|NCT02273388|470658621|FG005|Overall Study|Adverse Event|0|||
130737907|NCT02273388|470658622|FG006|Overall Study|Adverse Event|1|||
130737908|NCT02273388|470658623|FG007|Overall Study|Adverse Event|2|||
130737909|NCT02273388|470658624|FG008|Overall Study|Adverse Event|0|||
130737910|NCT02273388|470658625|FG009|Overall Study|Adverse Event|0|||
130737911|NCT02273388|470658626|FG010|Overall Study|Adverse Event|0|||
130737912|NCT02273388|470658627|FG011|Overall Study|Adverse Event|0|||
130737913|NCT02273388|470658616|FG000|Overall Study|Adverse Event study disease worse|4|||
130737914|NCT02273388|470658617|FG001|Overall Study|Adverse Event study disease worse|3|||
130737915|NCT02273388|470658618|FG002|Overall Study|Adverse Event study disease worse|3|||
130737916|NCT02273388|470658619|FG003|Overall Study|Adverse Event study disease worse|2|||
130737917|NCT02273388|470658620|FG004|Overall Study|Adverse Event study disease worse|4|||
130737918|NCT02273388|470658621|FG005|Overall Study|Adverse Event study disease worse|3|||
130737919|NCT02273388|470658622|FG006|Overall Study|Adverse Event study disease worse|14|||
130737920|NCT02273388|470658623|FG007|Overall Study|Adverse Event study disease worse|6|||
130737921|NCT02273388|470658624|FG008|Overall Study|Adverse Event study disease worse|6|||
130737922|NCT02273388|470658625|FG009|Overall Study|Adverse Event study disease worse|5|||
130737923|NCT02273388|470658626|FG010|Overall Study|Adverse Event study disease worse|10|||
130737924|NCT02273388|470658627|FG011|Overall Study|Adverse Event study disease worse|1|||
130737925|NCT02273388|470658616|FG000|Overall Study|Sponsor decision|0|||
130737926|NCT02273388|470658617|FG001|Overall Study|Sponsor decision|0|||
130737927|NCT02273388|470658618|FG002|Overall Study|Sponsor decision|0|||
130737928|NCT02273388|470658619|FG003|Overall Study|Sponsor decision|0|||
130737929|NCT02273388|470658620|FG004|Overall Study|Sponsor decision|0|||
130737930|NCT02273388|470658621|FG005|Overall Study|Sponsor decision|0|||
130737931|NCT02273388|470658622|FG006|Overall Study|Sponsor decision|0|||
130737932|NCT02273388|470658623|FG007|Overall Study|Sponsor decision|0|||
130737933|NCT02273388|470658624|FG008|Overall Study|Sponsor decision|0|||
130737934|NCT02273388|470658625|FG009|Overall Study|Sponsor decision|0|||
130737935|NCT02273388|470658626|FG010|Overall Study|Sponsor decision|0|||
130737936|NCT02273388|470658627|FG011|Overall Study|Sponsor decision|1|||
130737937|NCT01042093|470658628|FG000|Overall Study|Protocol Violation|2|||
130737938|NCT01042093|470658629|FG001|Overall Study|Protocol Violation|2|||
130737939|NCT01042093|470658630|FG002|Overall Study|Protocol Violation|2|||
130737940|NCT01042093|470658631|FG003|Overall Study|Protocol Violation|3|||
130737941|NCT01042093|470658628|FG000|Overall Study|Withdrawal by Subject|0|||
130737942|NCT01042093|470658629|FG001|Overall Study|Withdrawal by Subject|0|||
130737943|NCT01042093|470658630|FG002|Overall Study|Withdrawal by Subject|0|||
130737944|NCT01042093|470658631|FG003|Overall Study|Withdrawal by Subject|1|||
130737945|NCT04331808|470658632|FG000|Overall Study|Withdrew consent|1|||
130737946|NCT04331808|470658633|FG001|Overall Study|Withdrew consent|0|||
130737947|NCT04331808|470658634|FG002|Overall Study|Withdrew consent|2|||
130737948|NCT04331808|470658635|FG003|Overall Study|Withdrew consent|3|||
130737949|NCT01184079|470658639|FG000|Overall Study|Lost to Follow-up|14|||
130737950|NCT01184079|470658640|FG001|Overall Study|Lost to Follow-up|2|||
130737951|NCT04233073|470658641|FG000|Overall Study|Death|5|||
130737952|NCT02198963|470658642|FG000|Overall Study|Adverse Event|1|||
130737953|NCT02198963|470658642|FG000|Overall Study|Withdrawal by Subject|6|||
130737954|NCT02905032|470658649|FG000|Overall Study|Withdrawal by Subject|2|||
130737955|NCT02905032|470658650|FG001|Overall Study|Withdrawal by Subject|0|||
130737956|NCT02905032|470658651|FG002|Overall Study|Withdrawal by Subject|0|||
130737957|NCT02905032|470658649|FG000|Overall Study|Protocol Violation|6|||
130737958|NCT02905032|470658650|FG001|Overall Study|Protocol Violation|12|||
130737959|NCT02905032|470658651|FG002|Overall Study|Protocol Violation|0|||
130737960|NCT02603146|470660410|FG000|Overall Study|Lost to Follow-up|5|||
130737961|NCT02603146|470660411|FG001|Overall Study|Lost to Follow-up|6|||
130737962|NCT02603146|470660410|FG000|Overall Study|Withdrawal by Subject|8|||
130737963|NCT02603146|470660411|FG001|Overall Study|Withdrawal by Subject|10|||
130737964|NCT02603146|470660410|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
130737965|NCT02603146|470660411|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
130737966|NCT02603146|470660410|FG000|Overall Study|Participant moved|2|||
130737967|NCT02603146|470660411|FG001|Overall Study|Participant moved|0|||
130737968|NCT02603146|470660410|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
130737969|NCT02603146|470660411|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
130737970|NCT00265759|470660412|FG000|Overall Study|Withdrawal by Subject|0|||
130737971|NCT00265759|470660413|FG001|Overall Study|Withdrawal by Subject|1|||
130737972|NCT00265759|470660414|FG002|Overall Study|Withdrawal by Subject|2|||
130737973|NCT00265759|470660415|FG003|Overall Study|Withdrawal by Subject|2|||
130737974|NCT00265759|470660412|FG000|Overall Study|Cancel|0|||
130737975|NCT00265759|470660413|FG001|Overall Study|Cancel|0|||
130737976|NCT00265759|470660414|FG002|Overall Study|Cancel|0|||
130737977|NCT00265759|470660415|FG003|Overall Study|Cancel|3|||
130737978|NCT00265759|470660412|FG000|Overall Study|Ineligible|0|||
130737979|NCT00265759|470660413|FG001|Overall Study|Ineligible|0|||
130737980|NCT00265759|470660414|FG002|Overall Study|Ineligible|0|||
130785344|NCT03504917|470843131|FG000|Blinded Treatment Period|Protocol Violation|1|||
130785345|NCT03504917|470843132|FG001|Blinded Treatment Period|Protocol Violation|0|||
130785346|NCT03504917|470843131|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
130737981|NCT00265759|470660415|FG003|Overall Study|Ineligible|1|||
130737982|NCT00265759|470660412|FG000|Overall Study|Bilateral disease|0|||
130737983|NCT00265759|470660413|FG001|Overall Study|Bilateral disease|0|||
130737984|NCT00265759|470660414|FG002|Overall Study|Bilateral disease|0|||
130737985|NCT00265759|470660415|FG003|Overall Study|Bilateral disease|2|||
130737986|NCT00265759|470660412|FG000|Overall Study|Discontinued due to intolerability|0|||
130737987|NCT00265759|470660413|FG001|Overall Study|Discontinued due to intolerability|0|||
130737988|NCT00265759|470660414|FG002|Overall Study|Discontinued due to intolerability|0|||
130737989|NCT00265759|470660415|FG003|Overall Study|Discontinued due to intolerability|1|||
130785347|NCT03504917|470843132|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
130785348|NCT03504917|470843131|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
130737990|NCT04467840|470660416|FG000|Overall Study|Death|35|||
130737991|NCT04467840|470660417|FG001|Overall Study|Death|39|||
130737992|NCT04467840|470660416|FG000|Overall Study|Withdrawal by Subject|8|||
130737993|NCT04467840|470660417|FG001|Overall Study|Withdrawal by Subject|4|||
130737994|NCT04467840|470660416|FG000|Overall Study|Adverse Event|2|||
130737995|NCT04467840|470660417|FG001|Overall Study|Adverse Event|0|||
130737996|NCT04467840|470660416|FG000|Overall Study|Lost to Follow-up|1|||
130737997|NCT04467840|470660417|FG001|Overall Study|Lost to Follow-up|3|||
130737998|NCT04467840|470660416|FG000|Overall Study|Physician Decision|1|||
130737999|NCT04467840|470660417|FG001|Overall Study|Physician Decision|0|||
130738000|NCT04467840|470660416|FG000|Overall Study|Other|1|||
130738001|NCT04467840|470660417|FG001|Overall Study|Other|5|||
130738002|NCT04467840|470660416|FG000|Overall Study|Missing study completion status|3|||
130738003|NCT04467840|470660417|FG001|Overall Study|Missing study completion status|1|||
130738004|NCT05201794|470660420|FG000|Overall Study|Withdrawal by Subject|13|||
130738005|NCT05201794|470660421|FG001|Overall Study|Withdrawal by Subject|12|||
130738006|NCT05201794|470660422|FG002|Overall Study|Withdrawal by Subject|14|||
130738007|NCT05201794|470660423|FG003|Overall Study|Withdrawal by Subject|0|||
130738008|NCT05201794|470660420|FG000|Overall Study|Adverse Event|5|||
130738009|NCT05201794|470660421|FG001|Overall Study|Adverse Event|5|||
130738010|NCT05201794|470660422|FG002|Overall Study|Adverse Event|4|||
130738011|NCT05201794|470660423|FG003|Overall Study|Adverse Event|0|||
130738012|NCT05201794|470660420|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
130738013|NCT05201794|470660421|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130738014|NCT05201794|470660422|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
130738015|NCT05201794|470660423|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130738016|NCT05201794|470660420|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130738017|NCT05201794|470660421|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130738018|NCT05201794|470660422|FG002|Overall Study|Non-Compliance With Study Drug|3|||
130738019|NCT05201794|470660423|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130738020|NCT05201794|470660420|FG000|Overall Study|Physician Decision|1|||
130738021|NCT05201794|470660421|FG001|Overall Study|Physician Decision|3|||
130738022|NCT05201794|470660422|FG002|Overall Study|Physician Decision|2|||
130738023|NCT05201794|470660423|FG003|Overall Study|Physician Decision|0|||
130738024|NCT05201794|470660420|FG000|Overall Study|Lost to Follow-up|2|||
130738025|NCT05201794|470660421|FG001|Overall Study|Lost to Follow-up|2|||
130738026|NCT05201794|470660422|FG002|Overall Study|Lost to Follow-up|0|||
130738027|NCT05201794|470660423|FG003|Overall Study|Lost to Follow-up|0|||
130738028|NCT05201794|470660420|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
130738029|NCT05201794|470660421|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
130738030|NCT05201794|470660422|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
130738031|NCT05201794|470660423|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
130738032|NCT05201794|470660420|FG000|Overall Study|Protocol Violation|2|||
130738033|NCT05201794|470660421|FG001|Overall Study|Protocol Violation|0|||
130738034|NCT05201794|470660422|FG002|Overall Study|Protocol Violation|1|||
130738035|NCT05201794|470660423|FG003|Overall Study|Protocol Violation|0|||
130738036|NCT05201794|470660420|FG000|Overall Study|Death|1|||
130738037|NCT05201794|470660421|FG001|Overall Study|Death|0|||
130738038|NCT05201794|470660422|FG002|Overall Study|Death|0|||
130738039|NCT05201794|470660423|FG003|Overall Study|Death|0|||
130738040|NCT05201794|470660420|FG000|Overall Study|Site Terminated By Sponsor|0|||
130738041|NCT05201794|470660421|FG001|Overall Study|Site Terminated By Sponsor|1|||
130738042|NCT05201794|470660422|FG002|Overall Study|Site Terminated By Sponsor|0|||
130738043|NCT05201794|470660423|FG003|Overall Study|Site Terminated By Sponsor|0|||
130738044|NCT05201794|470660420|FG000|Overall Study|Other|3|||
130738045|NCT05201794|470660421|FG001|Overall Study|Other|3|||
130738046|NCT05201794|470660422|FG002|Overall Study|Other|3|||
130738047|NCT05201794|470660423|FG003|Overall Study|Other|0|||
130738048|NCT05201794|470660420|FG000|Overall Study|Randomized But Not Treated|1|||
130738049|NCT05201794|470660421|FG001|Overall Study|Randomized But Not Treated|2|||
130738050|NCT05201794|470660422|FG002|Overall Study|Randomized But Not Treated|1|||
130738051|NCT05201794|470660423|FG003|Overall Study|Randomized But Not Treated|0|||
130738052|NCT06082843|470660429|FG000|Overall Study|Withdrawal by Subject|0|||
130738053|NCT06082843|470660430|FG001|Overall Study|Withdrawal by Subject|2|||
130738054|NCT06082843|470660429|FG000|Overall Study|Study terminated by sponsor|12|||
130785349|NCT03504917|470843132|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
130785350|NCT03504917|470843131|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
130785351|NCT03504917|470843132|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
130785352|NCT03504917|470843131|FG000|Blinded Treatment Period|Adverse Event|4|||
130785353|NCT03504917|470843132|FG001|Blinded Treatment Period|Adverse Event|4|||
130785354|NCT03504917|470843131|FG000|Blinded Treatment Period|Physician Decision|1|||
130785355|NCT03504917|470843132|FG001|Blinded Treatment Period|Physician Decision|0|||
130785356|NCT03504917|470843131|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
130738055|NCT06082843|470660430|FG001|Overall Study|Study terminated by sponsor|8|||
130738056|NCT00001521|470660434|FG000|Overall Study|Withdrawal by Subject|3|||
130738057|NCT00001521|470660435|FG001|Overall Study|Withdrawal by Subject|3|||
130738058|NCT00001521|470660434|FG000|Overall Study|Physician Decision|1|||
130738059|NCT00001521|470660435|FG001|Overall Study|Physician Decision|1|||
130738060|NCT00001521|470660434|FG000|Overall Study|Noncompliant|6|||
130738061|NCT00001521|470660435|FG001|Overall Study|Noncompliant|3|||
130738062|NCT04848480|470660436|FG000|Main Phase (26 Weeks)|Death|1|||
130738063|NCT04848480|470660437|FG001|Main Phase (26 Weeks)|Death|0|||
130738064|NCT04848480|470660436|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
130738065|NCT04848480|470660437|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
130738066|NCT04848480|470660436|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
130738067|NCT04848480|470660437|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
130738068|NCT04848480|470660436|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
130738069|NCT04848480|470660437|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
130738070|NCT04848480|470660436|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
130738071|NCT04848480|470660437|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
130738072|NCT04848480|470660436|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
130785357|NCT03504917|470843132|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
130785358|NCT03504917|470843131|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
130785359|NCT03504917|470843132|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
130738073|NCT04848480|470660437|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
130738074|NCT03176134|470660438|FG000|Overall Study|Lost to Follow-up|0|||
130738075|NCT03176134|470660439|FG001|Overall Study|Lost to Follow-up|2|||
130738076|NCT03176134|470660440|FG002|Overall Study|Lost to Follow-up|0|||
130738077|NCT03176134|470660441|FG003|Overall Study|Lost to Follow-up|0|||
130738078|NCT03176134|470660442|FG004|Overall Study|Lost to Follow-up|0|||
130738079|NCT03176134|470660443|FG005|Overall Study|Lost to Follow-up|0|||
130738080|NCT03176134|470660444|FG006|Overall Study|Lost to Follow-up|0|||
130738081|NCT03176134|470660445|FG007|Overall Study|Lost to Follow-up|0|||
130738082|NCT03176134|470660438|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130738083|NCT03176134|470660439|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130738084|NCT03176134|470660440|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130785360|NCT03504917|470843131|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
130785361|NCT03504917|470843132|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
130785362|NCT03504917|470843131|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
130785363|NCT03504917|470843132|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
130785364|NCT03504917|470843131|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
130785365|NCT03504917|470843132|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
130785366|NCT03504917|470843131|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
130785367|NCT03504917|470843132|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
130785368|NCT03504917|470843131|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
130785369|NCT03504917|470843132|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
130785370|NCT03504917|470843131|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
130785371|NCT03504917|470843132|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
130785372|NCT03504917|470843131|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
130785373|NCT03504917|470843132|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
130785374|NCT03504917|470843131|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
130785375|NCT03504917|470843132|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
130785376|NCT04219189|470843133|FG000|Overall Study|Withdrawal by Subject|1|||
130785377|NCT04219189|470843134|FG001|Overall Study|Withdrawal by Subject|2|||
130785378|NCT04219189|470843133|FG000|Overall Study|Protocol Violation|0|||
130785379|NCT04219189|470843134|FG001|Overall Study|Protocol Violation|1|||
130785380|NCT04219189|470843133|FG000|Overall Study|Lost to Follow-up|0|||
130785381|NCT04219189|470843134|FG001|Overall Study|Lost to Follow-up|1|||
130785382|NCT04219189|470843133|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
130785383|NCT04219189|470843134|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
130785384|NCT03101020|470843135|FG000|Overall Study|Lack of time to participate|1|||
130785385|NCT03101020|470843136|FG001|Overall Study|Lack of time to participate|0|||
130785386|NCT03101020|470843135|FG000|Overall Study|Ran over by a car|0|||
130785387|NCT03101020|470843136|FG001|Overall Study|Ran over by a car|1|||
130785388|NCT03101020|470843135|FG000|Overall Study|Withdrawal by Subject|0|||
130785389|NCT03101020|470843136|FG001|Overall Study|Withdrawal by Subject|2|||
130785390|NCT05817669|470843137|FG000|Overall Study|Prohibited medication used|1|||
130785391|NCT05817669|470843138|FG001|Overall Study|Prohibited medication used|2|||
130785392|NCT05817669|470843137|FG000|Overall Study|Adverse Event|1|||
130785393|NCT05817669|470843138|FG001|Overall Study|Adverse Event|0|||
130785394|NCT05817669|470843137|FG000|Overall Study|Withdrawal by Subject|1|||
130785395|NCT05817669|470843138|FG001|Overall Study|Withdrawal by Subject|2|||
130785396|NCT03292016|470843139|FG000|Second Washout|Adverse Event|0|||
130785397|NCT03292016|470843140|FG001|Second Washout|Adverse Event|1|||
130785398|NCT03292016|470843141|FG002|Second Washout|Adverse Event|0|||
130785399|NCT03292016|470843142|FG003|Second Washout|Adverse Event|0|||
130785400|NCT03292016|470843143|FG004|Second Washout|Adverse Event|0|||
130785401|NCT03292016|470843144|FG005|Second Washout|Adverse Event|0|||
130785402|NCT03786380|470843145|FG000|Overall Study|Adverse Event|1|||
130785403|NCT03786380|470843146|FG001|Overall Study|Adverse Event|0|||
130785404|NCT03786380|470843147|FG002|Overall Study|Adverse Event|0|||
130785405|NCT03786380|470843148|FG003|Overall Study|Adverse Event|3|||
130785406|NCT03786380|470843149|FG004|Overall Study|Adverse Event|1|||
130785407|NCT03786380|470843145|FG000|Overall Study|Lack of Efficacy|0|||
130785408|NCT03786380|470843146|FG001|Overall Study|Lack of Efficacy|0|||
130785409|NCT03786380|470843147|FG002|Overall Study|Lack of Efficacy|0|||
130785410|NCT03786380|470843148|FG003|Overall Study|Lack of Efficacy|0|||
130785411|NCT03786380|470843149|FG004|Overall Study|Lack of Efficacy|1|||
130785412|NCT03786380|470843145|FG000|Overall Study|Withdrawal by Subject|1|||
130785413|NCT03786380|470843146|FG001|Overall Study|Withdrawal by Subject|2|||
130785414|NCT03786380|470843147|FG002|Overall Study|Withdrawal by Subject|2|||
130785415|NCT03786380|470843148|FG003|Overall Study|Withdrawal by Subject|1|||
130785416|NCT03786380|470843149|FG004|Overall Study|Withdrawal by Subject|2|||
130785417|NCT03786380|470843145|FG000|Overall Study|Lost to Follow-up|3|||
130785418|NCT03786380|470843146|FG001|Overall Study|Lost to Follow-up|0|||
130785419|NCT03786380|470843147|FG002|Overall Study|Lost to Follow-up|1|||
130785420|NCT03786380|470843148|FG003|Overall Study|Lost to Follow-up|2|||
130785421|NCT03786380|470843149|FG004|Overall Study|Lost to Follow-up|0|||
130785422|NCT03786380|470843145|FG000|Overall Study|Physician Decision|0|||
130785423|NCT03786380|470843146|FG001|Overall Study|Physician Decision|0|||
130785424|NCT03786380|470843147|FG002|Overall Study|Physician Decision|1|||
130785425|NCT03786380|470843148|FG003|Overall Study|Physician Decision|0|||
130785426|NCT03786380|470843149|FG004|Overall Study|Physician Decision|0|||
130785427|NCT03786380|470843145|FG000|Overall Study|Study Terminated by the Sponsor|30|||
130785428|NCT03786380|470843146|FG001|Overall Study|Study Terminated by the Sponsor|20|||
130785429|NCT03786380|470843147|FG002|Overall Study|Study Terminated by the Sponsor|50|||
130785430|NCT03786380|470843148|FG003|Overall Study|Study Terminated by the Sponsor|57|||
130785431|NCT03786380|470843149|FG004|Overall Study|Study Terminated by the Sponsor|23|||
130785432|NCT03786380|470843145|FG000|Overall Study|Reason Not Specified|0|||
130785433|NCT03786380|470843146|FG001|Overall Study|Reason Not Specified|0|||
130785434|NCT03786380|470843147|FG002|Overall Study|Reason Not Specified|0|||
130785435|NCT03786380|470843148|FG003|Overall Study|Reason Not Specified|0|||
130785436|NCT03786380|470843149|FG004|Overall Study|Reason Not Specified|1|||
130785437|NCT01909804|470843154|FG000|Overall Study|Randomized but Never Treated|0|||
130785438|NCT01909804|470843155|FG001|Overall Study|Randomized but Never Treated|0|||
130785439|NCT01909804|470843156|FG002|Overall Study|Randomized but Never Treated|0|||
130785440|NCT01909804|470843157|FG003|Overall Study|Randomized but Never Treated|0|||
130785441|NCT01909804|470843158|FG004|Overall Study|Randomized but Never Treated|0|||
130785442|NCT01909804|470843159|FG005|Overall Study|Randomized but Never Treated|0|||
130785443|NCT01909804|470843160|FG006|Overall Study|Randomized but Never Treated|1|||
130785444|NCT01909804|470843161|FG007|Overall Study|Randomized but Never Treated|0|||
130785445|NCT01909804|470843162|FG008|Overall Study|Randomized but Never Treated|0|||
130785446|NCT01909804|470843163|FG009|Overall Study|Randomized but Never Treated|0|||
130785447|NCT01909804|470843164|FG010|Overall Study|Randomized but Never Treated|0|||
130785448|NCT01909804|470843165|FG011|Overall Study|Randomized but Never Treated|1|||
130785449|NCT01909804|470843154|FG000|Overall Study|Death|0|||
130785450|NCT01909804|470843155|FG001|Overall Study|Death|0|||
130785451|NCT01909804|470843156|FG002|Overall Study|Death|0|||
130785452|NCT01909804|470843157|FG003|Overall Study|Death|0|||
130785453|NCT01909804|470843158|FG004|Overall Study|Death|0|||
130785454|NCT01909804|470843159|FG005|Overall Study|Death|0|||
130785455|NCT01909804|470843160|FG006|Overall Study|Death|0|||
130785456|NCT01909804|470843161|FG007|Overall Study|Death|0|||
130785457|NCT01909804|470843162|FG008|Overall Study|Death|0|||
130785458|NCT01909804|470843163|FG009|Overall Study|Death|0|||
130785459|NCT01909804|470843164|FG010|Overall Study|Death|1|||
130785460|NCT01909804|470843165|FG011|Overall Study|Death|0|||
130785461|NCT01909804|470843154|FG000|Overall Study|Lack of Efficacy|4|||
130785462|NCT01909804|470843155|FG001|Overall Study|Lack of Efficacy|1|||
130785463|NCT01909804|470843156|FG002|Overall Study|Lack of Efficacy|0|||
130785464|NCT01909804|470843157|FG003|Overall Study|Lack of Efficacy|0|||
130785465|NCT01909804|470843158|FG004|Overall Study|Lack of Efficacy|7|||
130785466|NCT01909804|470843159|FG005|Overall Study|Lack of Efficacy|3|||
130785467|NCT01909804|470843160|FG006|Overall Study|Lack of Efficacy|1|||
130785468|NCT01909804|470843161|FG007|Overall Study|Lack of Efficacy|1|||
130785469|NCT01909804|470843162|FG008|Overall Study|Lack of Efficacy|0|||
130785470|NCT01909804|470843163|FG009|Overall Study|Lack of Efficacy|1|||
130785471|NCT01909804|470843164|FG010|Overall Study|Lack of Efficacy|0|||
130785472|NCT01909804|470843165|FG011|Overall Study|Lack of Efficacy|1|||
130785473|NCT01909804|470843154|FG000|Overall Study|Withdrew Consent|0|||
130785474|NCT01909804|470843155|FG001|Overall Study|Withdrew Consent|0|||
130785475|NCT01909804|470843156|FG002|Overall Study|Withdrew Consent|0|||
130785476|NCT01909804|470843157|FG003|Overall Study|Withdrew Consent|0|||
130785477|NCT01909804|470843158|FG004|Overall Study|Withdrew Consent|1|||
130785478|NCT01909804|470843159|FG005|Overall Study|Withdrew Consent|1|||
130785479|NCT01909804|470843160|FG006|Overall Study|Withdrew Consent|0|||
130785480|NCT01909804|470843161|FG007|Overall Study|Withdrew Consent|0|||
130785481|NCT01909804|470843162|FG008|Overall Study|Withdrew Consent|0|||
130785482|NCT01909804|470843163|FG009|Overall Study|Withdrew Consent|0|||
130785483|NCT01909804|470843164|FG010|Overall Study|Withdrew Consent|0|||
130785484|NCT01909804|470843165|FG011|Overall Study|Withdrew Consent|0|||
130785485|NCT01909804|470843154|FG000|Overall Study|Protocol Violation|0|||
130785486|NCT01909804|470843155|FG001|Overall Study|Protocol Violation|0|||
130785487|NCT01909804|470843156|FG002|Overall Study|Protocol Violation|0|||
130785488|NCT01909804|470843157|FG003|Overall Study|Protocol Violation|0|||
130785489|NCT01909804|470843158|FG004|Overall Study|Protocol Violation|0|||
130785490|NCT01909804|470843159|FG005|Overall Study|Protocol Violation|0|||
130785491|NCT01909804|470843160|FG006|Overall Study|Protocol Violation|0|||
130785492|NCT01909804|470843161|FG007|Overall Study|Protocol Violation|0|||
130785493|NCT01909804|470843162|FG008|Overall Study|Protocol Violation|0|||
130785494|NCT01909804|470843163|FG009|Overall Study|Protocol Violation|0|||
130785495|NCT01909804|470843164|FG010|Overall Study|Protocol Violation|0|||
130785496|NCT01909804|470843165|FG011|Overall Study|Protocol Violation|1|||
130785497|NCT01038687|470843166|FG000|Overall Study|Adverse Event|0|||
130785498|NCT01038687|470843167|FG001|Overall Study|Adverse Event|2|||
130785499|NCT01038687|470843168|FG002|Overall Study|Adverse Event|1|||
130785500|NCT00338741|470843170|FG000|Overall Study|Lost to Follow-up|2|||
130785501|NCT00338741|470843171|FG001|Overall Study|Lost to Follow-up|0|||
130785502|NCT02144701|470843172|FG000|Overall Study|development of relapse, GVHD or death|9|||
130785503|NCT02144701|470843173|FG001|Overall Study|development of relapse, GVHD or death|3|||
130785504|NCT01218802|470843175|FG000|Overall Study|Lost to Follow-up|5|||
130785505|NCT01218802|470843176|FG001|Overall Study|Lost to Follow-up|6|||
130785506|NCT01218802|470843175|FG000|Overall Study|Withdrawal by Subject|3|||
130785507|NCT01218802|470843176|FG001|Overall Study|Withdrawal by Subject|10|||
130785508|NCT01218802|470843175|FG000|Overall Study|Adverse Event|0|||
130785509|NCT01218802|470843176|FG001|Overall Study|Adverse Event|2|||
130785510|NCT01218802|470843175|FG000|Overall Study|Incarcerated|2|||
130785511|NCT01218802|470843176|FG001|Overall Study|Incarcerated|0|||
130785512|NCT03327324|470843177|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130738085|NCT03176134|470660441|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130738086|NCT03176134|470660442|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130738087|NCT03176134|470660443|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130738088|NCT03176134|470660444|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
130738089|NCT03176134|470660445|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
130738090|NCT01368497|470660446|FG000|Overall Study|Lost to Follow-up|2|||
130738091|NCT05989672|470660448|FG000|Overall Study|Adverse Event|3|||
130738092|NCT05989672|470660449|FG001|Overall Study|Adverse Event|0|||
130738093|NCT05989672|470660450|FG002|Overall Study|Adverse Event|0|||
130738094|NCT00443729|470660451|FG000|Overall Study|Never Treated|0|||
130785513|NCT03327324|470843178|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130785514|NCT03327324|470843179|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130785515|NCT03327324|470843180|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130785516|NCT03327324|470843181|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130822733|NCT00887159|470980583|FG000|Overall Study|Never started assigned therapy|3|||
130738095|NCT00443729|470660452|FG001|Overall Study|Never Treated|1|||
130738096|NCT00443729|470660451|FG000|Overall Study|Lack of Efficacy|4|||
130738097|NCT00443729|470660452|FG001|Overall Study|Lack of Efficacy|2|||
130738098|NCT00443729|470660451|FG000|Overall Study|Lost to Follow-up|0|||
130738099|NCT00443729|470660452|FG001|Overall Study|Lost to Follow-up|1|||
130738100|NCT00443729|470660451|FG000|Overall Study|Physician Decision|2|||
130738101|NCT00443729|470660452|FG001|Overall Study|Physician Decision|1|||
130738102|NCT00443729|470660451|FG000|Overall Study|Protocol Violation|1|||
130738103|NCT00443729|470660452|FG001|Overall Study|Protocol Violation|1|||
130738104|NCT00443729|470660451|FG000|Overall Study|Withdrawal by Subject|3|||
130738105|NCT00443729|470660452|FG001|Overall Study|Withdrawal by Subject|1|||
130738106|NCT03718832|470660455|FG000|Analysis Sample|Withdrawal by Subject|18|||
130738107|NCT03718832|470660456|FG001|Analysis Sample|Withdrawal by Subject|15|||
130738108|NCT03718832|470660455|FG000|Analysis Sample|Legal hold on data|1|||
130738109|NCT03718832|470660456|FG001|Analysis Sample|Legal hold on data|0|||
130738110|NCT03718832|470660455|FG000|Analysis Sample|Participant from treated household|0|||
130738111|NCT03718832|470660456|FG001|Analysis Sample|Participant from treated household|1|||
130738112|NCT03718832|470660455|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
130738113|NCT03718832|470660456|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
130738114|NCT00276484|470660462|FG000|Overall Study|Adverse Event|4|||
130738115|NCT00276484|470660463|FG001|Overall Study|Adverse Event|7|||
130738116|NCT00276484|470660462|FG000|Overall Study|Lost to Follow-up|1|||
130738117|NCT00276484|470660463|FG001|Overall Study|Lost to Follow-up|1|||
130738118|NCT00276484|470660462|FG000|Overall Study|Protocol Violation|0|||
130738119|NCT00276484|470660463|FG001|Overall Study|Protocol Violation|1|||
130738120|NCT00276484|470660462|FG000|Overall Study|Withdrawal by Subject|4|||
130738121|NCT00276484|470660463|FG001|Overall Study|Withdrawal by Subject|3|||
130738122|NCT00276484|470660462|FG000|Overall Study|Could not take time off work|0|||
130738123|NCT00276484|470660463|FG001|Overall Study|Could not take time off work|1|||
130738124|NCT01626690|470660464|FG000|Overall Study|Protocol Violation|1|||
130738125|NCT01626690|470660465|FG001|Overall Study|Protocol Violation|0|||
130738126|NCT01626690|470660464|FG000|Overall Study|Adverse Event|1|||
130738127|NCT01626690|470660465|FG001|Overall Study|Adverse Event|0|||
130738128|NCT01269918|470660466|FG000|Overall Study|Did not receive study drug|0|||
130738129|NCT01269918|470660467|FG001|Overall Study|Did not receive study drug|3|||
130738130|NCT01308424|470660468|FG000|Baseline Eligibility|Screen Failures|71|||
130738131|NCT01308424|470660469|FG001|Baseline Eligibility|Screen Failures|0|||
130738132|NCT01308424|470660470|FG002|Baseline Eligibility|Screen Failures|0|||
130738133|NCT01308424|470660468|FG000|Randomization|Adverse Event|0|||
130738134|NCT01308424|470660469|FG001|Randomization|Adverse Event|1|||
130738135|NCT01308424|470660470|FG002|Randomization|Adverse Event|1|||
130738136|NCT01308424|470660468|FG000|Randomization|Lost to Follow-up|0|||
130738137|NCT01308424|470660469|FG001|Randomization|Lost to Follow-up|1|||
130738138|NCT01308424|470660470|FG002|Randomization|Lost to Follow-up|0|||
130738139|NCT01308424|470660468|FG000|Randomization|Physician Decision|0|||
130738140|NCT01308424|470660469|FG001|Randomization|Physician Decision|1|||
130738141|NCT01308424|470660470|FG002|Randomization|Physician Decision|1|||
130738142|NCT04471428|470660471|FG000|Overall Study|Withdrawal by Subject|29|||
130738143|NCT04471428|470660472|FG001|Overall Study|Withdrawal by Subject|1|||
130738144|NCT04471428|470660471|FG000|Overall Study|Physician Decision|0|||
130738145|NCT04471428|470660472|FG001|Overall Study|Physician Decision|1|||
130738146|NCT04471428|470660471|FG000|Overall Study|Reason Not Specified|0|||
130738147|NCT04471428|470660472|FG001|Overall Study|Reason Not Specified|2|||
130738148|NCT04471428|470660471|FG000|Overall Study|Death|106|||
130738149|NCT04471428|470660472|FG001|Overall Study|Death|114|||
130738150|NCT04471428|470660471|FG000|Overall Study|Ongoing in the study|45|||
130738151|NCT04471428|470660472|FG001|Overall Study|Ongoing in the study|68|||
130738152|NCT00995774|470660475|FG000|Training Period 2|Withdrawal by Subject|2|||
130738153|NCT00995774|470660476|FG001|Training Period 2|Withdrawal by Subject|0|||
130738154|NCT01808573|470660477|FG000|Overall Study|Death|212|||
130738155|NCT01808573|470660478|FG001|Overall Study|Death|240|||
130738156|NCT01808573|470660477|FG000|Overall Study|Withdrawal by Subject|12|||
130738157|NCT01808573|470660478|FG001|Overall Study|Withdrawal by Subject|10|||
130738158|NCT01808573|470660477|FG000|Overall Study|Lost to Follow-up|3|||
130738159|NCT01808573|470660478|FG001|Overall Study|Lost to Follow-up|0|||
130738160|NCT01808573|470660477|FG000|Overall Study|Discontinuation of study by sponsor|79|||
130738161|NCT01808573|470660478|FG001|Overall Study|Discontinuation of study by sponsor|64|||
130738162|NCT01808573|470660477|FG000|Overall Study|Randomized in Error|1|||
130738163|NCT01808573|470660478|FG001|Overall Study|Randomized in Error|0|||
130738164|NCT01523002|470660481|FG000|Period 1|Withdrawal by Subject|1|||
130738165|NCT01523002|470660482|FG001|Period 1|Withdrawal by Subject|3|||
130738166|NCT01523002|470660481|FG000|Period 1|Lost to Follow-up|1|||
130738167|NCT01523002|470660482|FG001|Period 1|Lost to Follow-up|0|||
130738168|NCT01523002|470660481|FG000|Period 1|Adverse Event|0|||
130738169|NCT01523002|470660482|FG001|Period 1|Adverse Event|8|||
130738170|NCT01523002|470660481|FG000|Period 2|Withdrawal by Subject|4|||
130738171|NCT01523002|470660482|FG001|Period 2|Withdrawal by Subject|1|||
130738172|NCT01523002|470660481|FG000|Period 2|Adverse Event|2|||
130738173|NCT01523002|470660482|FG001|Period 2|Adverse Event|5|||
130738174|NCT01523002|470660481|FG000|Period 3|Withdrawal by Subject|1|||
130738175|NCT01523002|470660482|FG001|Period 3|Withdrawal by Subject|0|||
130738176|NCT01523002|470660481|FG000|Period 3|Adverse Event|3|||
130738177|NCT01523002|470660482|FG001|Period 3|Adverse Event|0|||
130738178|NCT01256502|470660484|FG000|Overall Study|Had scaffold removed|4|||
130738179|NCT01256502|470660484|FG000|Overall Study|Personal reasons|5|||
130738180|NCT01256502|470660484|FG000|Overall Study|Protocol deviation|1|||
130738181|NCT03953612|470660485|FG000|Overall Study|Randomized but did not start|1|||
130738182|NCT03953612|470660486|FG001|Overall Study|Randomized but did not start|1|||
130738183|NCT03953612|470660487|FG002|Overall Study|Randomized but did not start|1|||
130738184|NCT03953612|470660485|FG000|Overall Study|Withdrawal by Subject|2|||
130785517|NCT03327324|470843182|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
130785518|NCT03327324|470843177|FG000|Baseline (Month 0-Month 3)|Refused|0|||
130785519|NCT03327324|470843178|FG001|Baseline (Month 0-Month 3)|Refused|0|||
130785520|NCT03327324|470843179|FG002|Baseline (Month 0-Month 3)|Refused|0|||
130785521|NCT03327324|470843180|FG003|Baseline (Month 0-Month 3)|Refused|0|||
130785522|NCT03327324|470843181|FG004|Baseline (Month 0-Month 3)|Refused|1|||
130785523|NCT03327324|470843182|FG005|Baseline (Month 0-Month 3)|Refused|0|||
130785524|NCT03327324|470843177|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130785525|NCT03327324|470843178|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
130785526|NCT03327324|470843179|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130785527|NCT03327324|470843180|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130785528|NCT03327324|470843181|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130785529|NCT03327324|470843182|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130785530|NCT03327324|470843177|FG000|Baseline (Month 0-Month 3)|Death|0|||
130785531|NCT03327324|470843178|FG001|Baseline (Month 0-Month 3)|Death|0|||
130785532|NCT03327324|470843179|FG002|Baseline (Month 0-Month 3)|Death|0|||
130785533|NCT03327324|470843180|FG003|Baseline (Month 0-Month 3)|Death|0|||
130785534|NCT03327324|470843181|FG004|Baseline (Month 0-Month 3)|Death|1|||
130785535|NCT03327324|470843182|FG005|Baseline (Month 0-Month 3)|Death|0|||
130785536|NCT03327324|470843177|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785537|NCT03327324|470843178|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785538|NCT03327324|470843179|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785539|NCT03327324|470843180|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785540|NCT03327324|470843181|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785541|NCT03327324|470843182|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
130785542|NCT03327324|470843177|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130785543|NCT03327324|470843178|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130785544|NCT03327324|470843179|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130785545|NCT03327324|470843180|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130785546|NCT03327324|470843181|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130785547|NCT03327324|470843182|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130785548|NCT03327324|470843177|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
130785549|NCT03327324|470843178|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
130785550|NCT03327324|470843179|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
130785551|NCT03327324|470843180|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
130785552|NCT03327324|470843181|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
130785553|NCT03327324|470843182|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
130785554|NCT03327324|470843177|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
130785555|NCT03327324|470843178|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130785556|NCT03327324|470843179|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130785557|NCT03327324|470843180|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130785558|NCT03327324|470843181|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130785559|NCT03327324|470843182|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130785560|NCT03327324|470843177|FG000|Intervention (Month 3-Month 6)|Death|1|||
130785561|NCT03327324|470843178|FG001|Intervention (Month 3-Month 6)|Death|0|||
130785562|NCT03327324|470843179|FG002|Intervention (Month 3-Month 6)|Death|1|||
130785563|NCT03327324|470843180|FG003|Intervention (Month 3-Month 6)|Death|1|||
130785564|NCT03327324|470843181|FG004|Intervention (Month 3-Month 6)|Death|1|||
130785565|NCT03327324|470843182|FG005|Intervention (Month 3-Month 6)|Death|0|||
130785566|NCT03327324|470843177|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785567|NCT03327324|470843178|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785568|NCT03327324|470843179|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785569|NCT03327324|470843180|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785570|NCT03327324|470843181|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785571|NCT03327324|470843182|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
130738185|NCT03953612|470660486|FG001|Overall Study|Withdrawal by Subject|1|||
130738186|NCT03953612|470660487|FG002|Overall Study|Withdrawal by Subject|0|||
130738187|NCT03200717|470660503|FG000|Overall Study|Progressive disease|24|||
130738188|NCT03200717|470660504|FG001|Overall Study|Progressive disease|5|||
130738189|NCT03200717|470660503|FG000|Overall Study|Adverse Event|11|||
130738190|NCT03200717|470660504|FG001|Overall Study|Adverse Event|8|||
130738191|NCT03200717|470660503|FG000|Overall Study|Physician Decision|3|||
130738192|NCT03200717|470660504|FG001|Overall Study|Physician Decision|2|||
130738193|NCT03200717|470660503|FG000|Overall Study|Death|2|||
130738194|NCT03200717|470660504|FG001|Overall Study|Death|0|||
130738195|NCT03200717|470660503|FG000|Overall Study|Subject/Guardian Decision|1|||
130738196|NCT03200717|470660504|FG001|Overall Study|Subject/Guardian Decision|0|||
130738197|NCT01461538|470660505|FG000|Overall Study|Death|15|||
130738198|NCT01461538|470660506|FG001|Overall Study|Death|6|||
130738199|NCT01461538|470660507|FG002|Overall Study|Death|2|||
130738200|NCT01461538|470660505|FG000|Overall Study|Study Stopped by Sponsor|2|||
130738201|NCT01461538|470660506|FG001|Overall Study|Study Stopped by Sponsor|1|||
130738202|NCT01461538|470660507|FG002|Overall Study|Study Stopped by Sponsor|0|||
130738203|NCT01461538|470660505|FG000|Overall Study|Withdrawal by Subject|1|||
130738204|NCT01461538|470660506|FG001|Overall Study|Withdrawal by Subject|1|||
130738205|NCT01461538|470660507|FG002|Overall Study|Withdrawal by Subject|0|||
130738206|NCT00141778|470660508|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
130738207|NCT00141778|470660509|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
130738208|NCT00141778|470660510|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
130738209|NCT00141778|470660508|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
130738210|NCT00141778|470660509|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
130738211|NCT00141778|470660510|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
130738212|NCT00141778|470660508|FG000|Started Study Medication|Withdrawal by Subject|0|||
130738213|NCT00141778|470660509|FG001|Started Study Medication|Withdrawal by Subject|2|||
130738214|NCT00141778|470660510|FG002|Started Study Medication|Withdrawal by Subject|0|||
130738215|NCT00141778|470660508|FG000|Started Study Medication|Difficulty Swallowing|0|||
130738216|NCT00141778|470660509|FG001|Started Study Medication|Difficulty Swallowing|1|||
130738217|NCT00141778|470660510|FG002|Started Study Medication|Difficulty Swallowing|0|||
130738218|NCT00141778|470660508|FG000|Started Study Medication|Chest Discomfort|0|||
130738219|NCT00141778|470660509|FG001|Started Study Medication|Chest Discomfort|0|||
130738220|NCT00141778|470660510|FG002|Started Study Medication|Chest Discomfort|1|||
130738221|NCT01245283|470660515|FG000|Overall Study|Lost to Follow-up|14|||
130738222|NCT01245283|470660516|FG001|Overall Study|Lost to Follow-up|11|||
130738223|NCT01245283|470660517|FG002|Overall Study|Lost to Follow-up|11|||
130738224|NCT01610492|470660520|FG000|Overall Study|Adverse Event|1|||
130738225|NCT01610492|470660520|FG000|Overall Study|Lack of Efficacy|3|||
130738226|NCT01610492|470660520|FG000|Overall Study|Other: Reached stopping criteria|1|||
130738227|NCT01610492|470660520|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
130738228|NCT01982955|470660521|FG000|Overall Study|Randomized but not treated|0|||
130738229|NCT01982955|470660522|FG001|Overall Study|Randomized but not treated|0|||
130738230|NCT01982955|470660523|FG002|Overall Study|Randomized but not treated|0|||
130738231|NCT01982955|470660524|FG003|Overall Study|Randomized but not treated|1|||
130738232|NCT01982955|470660525|FG004|Overall Study|Randomized but not treated|0|||
130738233|NCT04211831|470660528|FG000|Overall Study|Withdrawal by Subject|4|||
130738234|NCT04211831|470660529|FG001|Overall Study|Withdrawal by Subject|1|||
130738235|NCT04211831|470660530|FG002|Overall Study|Withdrawal by Subject|1|||
130738236|NCT04211831|470660528|FG000|Overall Study|Protocol Violation|0|||
130738237|NCT04211831|470660529|FG001|Overall Study|Protocol Violation|0|||
130738238|NCT04211831|470660530|FG002|Overall Study|Protocol Violation|1|||
130738239|NCT04211831|470660528|FG000|Overall Study|Adverse Event|0|||
130738240|NCT04211831|470660529|FG001|Overall Study|Adverse Event|1|||
130738241|NCT04211831|470660530|FG002|Overall Study|Adverse Event|0|||
130738242|NCT04211831|470660528|FG000|Overall Study|Lack of Efficacy|0|||
130738243|NCT04211831|470660529|FG001|Overall Study|Lack of Efficacy|0|||
130738244|NCT04211831|470660530|FG002|Overall Study|Lack of Efficacy|1|||
130738245|NCT04211831|470660528|FG000|Overall Study|Lost to Follow-up|0|||
130738246|NCT04211831|470660529|FG001|Overall Study|Lost to Follow-up|0|||
130738247|NCT04211831|470660530|FG002|Overall Study|Lost to Follow-up|2|||
130738248|NCT04211831|470660528|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
130738249|NCT04211831|470660529|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
130738250|NCT04211831|470660530|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
130738251|NCT04211831|470660528|FG000|Overall Study|Other|0|||
130738252|NCT04211831|470660529|FG001|Overall Study|Other|1|||
130738253|NCT04211831|470660530|FG002|Overall Study|Other|0|||
130738254|NCT00640315|470660531|FG000|Overall Study|Withdrawal by Subject|0|||
130738255|NCT00640315|470660532|FG001|Overall Study|Withdrawal by Subject|1|||
130738256|NCT01256879|470660533|FG000|Overall Study|Withdrawal by Subject|1|||
130738257|NCT00397514|470660534|FG000|Overall Study|Withdrawal by Subject|1|||
130738258|NCT00397514|470660534|FG000|Overall Study|Pacing wire malfunction|1|||
130738259|NCT00397514|470660534|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
130785572|NCT03327324|470843177|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130822734|NCT00887159|470980584|FG001|Overall Study|Never started assigned therapy|3|||
130785573|NCT03327324|470843178|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130785574|NCT03327324|470843179|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130738260|NCT00397514|470660534|FG000|Overall Study|early extubation|2|||
130738261|NCT00397514|470660534|FG000|Overall Study|poor echocardiographic windows|1|||
130785575|NCT03327324|470843180|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130785576|NCT03327324|470843181|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130822735|NCT00887159|470980585|FG002|Overall Study|Never started assigned therapy|4|||
130785577|NCT03327324|470843182|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130785578|NCT03327324|470843177|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
130785579|NCT03327324|470843178|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
130785580|NCT03327324|470843179|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130785581|NCT03327324|470843180|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130785582|NCT03327324|470843181|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130785583|NCT03327324|470843182|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130785584|NCT03327324|470843177|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
130785585|NCT03327324|470843178|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
130785586|NCT03327324|470843179|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
130785587|NCT03327324|470843180|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
130785588|NCT03327324|470843181|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
130785589|NCT03327324|470843182|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
130785590|NCT03327324|470843177|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785591|NCT03327324|470843178|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785592|NCT03327324|470843179|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785593|NCT03327324|470843180|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
130785594|NCT03327324|470843181|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
130785595|NCT03327324|470843182|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130785596|NCT03327324|470843177|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
130785597|NCT03327324|470843178|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130785598|NCT03327324|470843179|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130785599|NCT03327324|470843180|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130785600|NCT03327324|470843181|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130785601|NCT03327324|470843182|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130785602|NCT03327324|470843177|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
130785603|NCT03327324|470843178|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130785604|NCT03327324|470843179|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130785605|NCT03327324|470843180|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130785606|NCT03327324|470843181|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130785607|NCT03327324|470843182|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130785608|NCT02314728|470843186|FG000|Overall Study|Protocol Violation|1|||
130785609|NCT02314728|470843187|FG001|Overall Study|Protocol Violation|0|||
130785610|NCT02314728|470843186|FG000|Overall Study|Lost to Follow-up|0|||
130785611|NCT02314728|470843187|FG001|Overall Study|Lost to Follow-up|1|||
130785612|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
130785613|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130785614|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130785615|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130785616|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130785617|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130785618|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130785619|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
130785620|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130785621|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130785622|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130785623|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130785624|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130785625|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130785626|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130785627|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
130785628|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130785629|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130785630|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130785631|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130785632|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130785633|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130785634|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130785635|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
130738262|NCT00118157|470662121|FG000|Overall Study|Adverse Event|2|||
130785636|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130785637|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130785638|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130785639|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130785640|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130785641|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130785642|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
130785643|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130785644|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130785645|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130785646|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130785647|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130785648|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130785649|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
130785650|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130785651|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130785652|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130785653|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130785654|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130785655|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130785656|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130785657|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
130785658|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130785659|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130785660|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130785661|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130785662|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130785663|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130785664|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
130785665|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130785666|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130785667|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130785668|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130785669|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130785670|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130785671|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130785672|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
130785673|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130785674|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130785675|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130785676|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130785677|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130785678|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130785679|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
130785680|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130785681|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130785682|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130785683|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130785684|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130785685|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130785686|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
130785687|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130785688|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130785689|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130785690|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130785691|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130785692|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130785693|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
130785694|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130785695|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130785696|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130785697|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130785698|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130785699|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130785700|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130785701|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
130785702|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130822736|NCT00812955|470980589|FG000|Overall Study|Adverse Event|7|||
130738263|NCT00118157|470662121|FG000|Overall Study|Death|8|||
130738264|NCT00118157|470662121|FG000|Overall Study|Withdrawal by Subject|2|||
130738265|NCT03989102|470662122|FG000|Year 1|Withdrawal by Subject|6|||
130738266|NCT03989102|470662123|FG001|Year 1|Withdrawal by Subject|2|||
130738267|NCT03989102|470662124|FG002|Year 1|Withdrawal by Subject|7|||
130738268|NCT03989102|470662122|FG000|Year 1|Lost to Follow-up|5|||
130738269|NCT03989102|470662123|FG001|Year 1|Lost to Follow-up|2|||
130738270|NCT03989102|470662124|FG002|Year 1|Lost to Follow-up|5|||
130738271|NCT03989102|470662122|FG000|Year 1|Subject met withdrawal criteria|1|||
130738272|NCT03989102|470662123|FG001|Year 1|Subject met withdrawal criteria|0|||
130738273|NCT03989102|470662124|FG002|Year 1|Subject met withdrawal criteria|1|||
130738274|NCT03989102|470662122|FG000|Year 2|Lost to Follow-up|7|||
130738275|NCT03989102|470662123|FG001|Year 2|Lost to Follow-up|3|||
130738276|NCT03989102|470662124|FG002|Year 2|Lost to Follow-up|4|||
130738277|NCT03989102|470662122|FG000|Year 2|Withdrawal by Subject|3|||
130738278|NCT03989102|470662123|FG001|Year 2|Withdrawal by Subject|1|||
130738279|NCT03989102|470662124|FG002|Year 2|Withdrawal by Subject|2|||
130738280|NCT03989102|470662122|FG000|Year 2|Subject non-compliant|3|||
130738281|NCT03989102|470662123|FG001|Year 2|Subject non-compliant|2|||
130738282|NCT03989102|470662124|FG002|Year 2|Subject non-compliant|0|||
130738283|NCT03989102|470662122|FG000|Year 2|Travel|1|||
130738284|NCT03989102|470662123|FG001|Year 2|Travel|0|||
130738285|NCT03989102|470662124|FG002|Year 2|Travel|1|||
130738286|NCT03989102|470662122|FG000|Year 2|P16 missing|4|||
130738287|NCT03989102|470662123|FG001|Year 2|P16 missing|2|||
130738288|NCT03989102|470662124|FG002|Year 2|P16 missing|1|||
130738289|NCT03989102|470662122|FG000|Year 2|P11 missing|1|||
130738290|NCT03989102|470662123|FG001|Year 2|P11 missing|3|||
130738291|NCT03989102|470662124|FG002|Year 2|P11 missing|7|||
130738292|NCT03989102|470662122|FG000|Year 2|Definitive displacement outside the study site|0|||
130738293|NCT03989102|470662123|FG001|Year 2|Definitive displacement outside the study site|1|||
130738294|NCT03989102|470662124|FG002|Year 2|Definitive displacement outside the study site|0|||
130738295|NCT03989102|470662122|FG000|Year 2|Subject missed last study visit|0|||
130738296|NCT03989102|470662123|FG001|Year 2|Subject missed last study visit|1|||
130738297|NCT03989102|470662124|FG002|Year 2|Subject missed last study visit|0|||
130738298|NCT03989102|470662122|FG000|Year 2|Death|0|||
130738299|NCT03989102|470662123|FG001|Year 2|Death|1|||
130738300|NCT03989102|470662124|FG002|Year 2|Death|0|||
130738301|NCT03989102|470662122|FG000|Year 2|Subject not reachable|0|||
130738302|NCT03989102|470662123|FG001|Year 2|Subject not reachable|0|||
130738303|NCT03989102|470662124|FG002|Year 2|Subject not reachable|1|||
130738304|NCT03989102|470662122|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
130738305|NCT03989102|470662123|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
130738306|NCT03989102|470662124|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
130738307|NCT03989102|470662122|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
130738308|NCT03989102|470662123|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
130738309|NCT03989102|470662124|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
130738310|NCT03989102|470662122|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
130738311|NCT03989102|470662123|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
130738312|NCT03989102|470662124|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
130738313|NCT03989102|470662122|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
130738314|NCT03989102|470662123|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
130738315|NCT03989102|470662124|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
130738316|NCT03989102|470662122|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
130738317|NCT03989102|470662123|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
130738318|NCT03989102|470662124|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
130738319|NCT03989102|470662122|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
130738320|NCT03989102|470662123|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
130738321|NCT03989102|470662124|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
130738322|NCT03642262|470662125|FG000|Period 1|Withdrawal by Subject|1|||
130738323|NCT03642262|470662126|FG001|Period 1|Withdrawal by Subject|1|||
130738324|NCT03642262|470662125|FG000|Period 1|Adverse Event|0|||
130738325|NCT03642262|470662126|FG001|Period 1|Adverse Event|1|||
130738326|NCT02760004|470662129|FG000|Overall Study|Lost to Follow-up|13|||
130738327|NCT02760004|470662130|FG001|Overall Study|Lost to Follow-up|22|||
130738328|NCT02203357|470662133|FG000|Overall Study|Lost to Follow-up|58|||
130738329|NCT02203357|470662134|FG001|Overall Study|Lost to Follow-up|66|||
130738330|NCT02203357|470662135|FG002|Overall Study|Lost to Follow-up|70|||
130738331|NCT01431079|470662136|FG000|Overall Study|Lost to Follow-up|35|||
130738332|NCT01431079|470662137|FG001|Overall Study|Lost to Follow-up|39|||
130738333|NCT02038010|470662141|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
130785703|NCT01791595|470843188|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130785704|NCT01791595|470843189|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130822737|NCT00812955|470980590|FG001|Overall Study|Adverse Event|6|||
130785705|NCT01791595|470843190|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130785706|NCT01791595|470843191|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130785707|NCT01791595|470843192|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130785708|NCT01791595|470843193|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
130785709|NCT01791595|470843194|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130785710|NCT01791595|470843188|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130785711|NCT01791595|470843189|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130785712|NCT01791595|470843190|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130785713|NCT01791595|470843191|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130785714|NCT01791595|470843192|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130785715|NCT01791595|470843193|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130785716|NCT01791595|470843194|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
130785717|NCT01791595|470843188|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130785718|NCT01791595|470843189|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130785719|NCT01791595|470843190|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130785720|NCT01791595|470843191|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130785721|NCT01791595|470843192|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130785722|NCT01791595|470843193|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130785723|NCT01791595|470843194|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
130785724|NCT01791595|470843188|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130785725|NCT01791595|470843189|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130785726|NCT01791595|470843190|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130785727|NCT01791595|470843191|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130785728|NCT01791595|470843192|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130785729|NCT01791595|470843193|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130785730|NCT01791595|470843194|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
130785731|NCT01791595|470843188|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130785732|NCT01791595|470843189|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130822738|NCT00812955|470980591|FG002|Overall Study|Adverse Event|3|||
130785733|NCT01791595|470843190|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130785734|NCT01791595|470843191|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130785735|NCT01791595|470843192|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130785736|NCT01791595|470843193|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130785737|NCT01791595|470843194|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
130785738|NCT03118934|470843195|FG000|Overall Study|Adverse Event|0|||
130785739|NCT03118934|470843196|FG001|Overall Study|Adverse Event|0|||
130785740|NCT03118934|470843197|FG002|Overall Study|Adverse Event|0|||
130785741|NCT03118934|470843198|FG003|Overall Study|Adverse Event|0|||
130785742|NCT03118934|470843199|FG004|Overall Study|Adverse Event|0|||
130785743|NCT03118934|470843200|FG005|Overall Study|Adverse Event|1|||
130785744|NCT03118934|470843195|FG000|Overall Study|Physician Decision|0|||
130785745|NCT03118934|470843196|FG001|Overall Study|Physician Decision|0|||
130785746|NCT03118934|470843197|FG002|Overall Study|Physician Decision|0|||
130785747|NCT03118934|470843198|FG003|Overall Study|Physician Decision|0|||
130785748|NCT03118934|470843199|FG004|Overall Study|Physician Decision|0|||
130785749|NCT03118934|470843200|FG005|Overall Study|Physician Decision|1|||
130785750|NCT03118934|470843195|FG000|Overall Study|Discontinued prior to exposure|0|||
130785751|NCT03118934|470843196|FG001|Overall Study|Discontinued prior to exposure|1|||
130785752|NCT03118934|470843197|FG002|Overall Study|Discontinued prior to exposure|1|||
130785753|NCT03118934|470843198|FG003|Overall Study|Discontinued prior to exposure|1|||
130785754|NCT03118934|470843199|FG004|Overall Study|Discontinued prior to exposure|2|||
130785755|NCT03118934|470843200|FG005|Overall Study|Discontinued prior to exposure|0|||
130785756|NCT00249834|470843201|FG000|Overall Study|Ovarian stimulation failed|1|||
130785757|NCT00249834|470843202|FG001|Overall Study|Ovarian stimulation failed|0|||
130785758|NCT00249834|470843203|FG002|Overall Study|Ovarian stimulation failed|0|||
130785759|NCT00249834|470843204|FG003|Overall Study|Ovarian stimulation failed|0|||
130785760|NCT00249834|470843205|FG004|Overall Study|Ovarian stimulation failed|0|||
130785761|NCT00249834|470843206|FG005|Overall Study|Ovarian stimulation failed|0|||
130785762|NCT00249834|470843207|FG006|Overall Study|Ovarian stimulation failed|0|||
130785763|NCT00249834|470843208|FG007|Overall Study|Ovarian stimulation failed|0|||
130785764|NCT00249834|470843201|FG000|Overall Study|Failure of down-regulation|0|||
130785765|NCT00249834|470843202|FG001|Overall Study|Failure of down-regulation|0|||
130785766|NCT00249834|470843203|FG002|Overall Study|Failure of down-regulation|0|||
130785767|NCT00249834|470843204|FG003|Overall Study|Failure of down-regulation|0|||
130785768|NCT00249834|470843205|FG004|Overall Study|Failure of down-regulation|0|||
130785769|NCT00249834|470843206|FG005|Overall Study|Failure of down-regulation|0|||
130785770|NCT00249834|470843207|FG006|Overall Study|Failure of down-regulation|1|||
130785771|NCT00249834|470843208|FG007|Overall Study|Failure of down-regulation|0|||
130785772|NCT00249834|470843201|FG000|Overall Study|Protocol Violation|0|||
130785773|NCT00249834|470843202|FG001|Overall Study|Protocol Violation|19|||
130785774|NCT00249834|470843203|FG002|Overall Study|Protocol Violation|14|||
130785775|NCT00249834|470843204|FG003|Overall Study|Protocol Violation|8|||
130785776|NCT00249834|470843205|FG004|Overall Study|Protocol Violation|5|||
130785777|NCT00249834|470843206|FG005|Overall Study|Protocol Violation|2|||
130785778|NCT00249834|470843207|FG006|Overall Study|Protocol Violation|0|||
130785779|NCT00249834|470843208|FG007|Overall Study|Protocol Violation|0|||
130785780|NCT02848664|470843211|FG000|Overall Study|Withdrawal by Subject|2|||
130785781|NCT02848664|470843211|FG000|Overall Study|Adverse Event|1|||
130785782|NCT02848664|470843211|FG000|Overall Study|no assistance for device training|1|||
130785783|NCT00887484|470843212|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
130785784|NCT00887484|470843212|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
130785785|NCT00887484|470843212|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
130785786|NCT03044314|470843213|FG000|Overall Study|Physician Decision|2|||
130785787|NCT03044314|470843213|FG000|Overall Study|Withdrawal by Subject|1|||
130785788|NCT03044314|470843213|FG000|Overall Study|Connector tubing not available|1|||
130785789|NCT01316224|470843214|FG000|Overall Study|Protocol Violation|3|||
130785790|NCT01316224|470843214|FG000|Overall Study|Adverse Event|3|||
130785791|NCT01316224|470843214|FG000|Overall Study|Lack of Efficacy|1|||
130785792|NCT01316224|470843214|FG000|Overall Study|Withdrawal by Subject|1|||
130785793|NCT01316224|470843214|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
130785794|NCT01316224|470843214|FG000|Overall Study|Other|1|||
130785795|NCT03106077|470843215|FG000|Overall Study|Screen Failure|94|||
130785796|NCT03106077|470843216|FG001|Overall Study|Screen Failure|0|||
130785797|NCT00449163|470843217|FG000|Overall Study|Physician Decision|3|||
130785798|NCT00606307|470843220|FG000|Overall Study|Adverse Event|2|||
130785799|NCT00606307|470843220|FG000|Overall Study|Withdrawal by Subject|2|||
130785800|NCT00606307|470843220|FG000|Overall Study|Disease progression|6|||
130785801|NCT00606307|470843220|FG000|Overall Study|QTc prolongation|1|||
130785802|NCT01274533|470843221|FG000|Overall Study|Withdrawal by Subject|1|||
130785803|NCT01274533|470843221|FG000|Overall Study|Non-compliance|1|||
130785804|NCT01274533|470843221|FG000|Overall Study|Disease progression|2|||
130785805|NCT02008526|470843235|FG000|Overall Study|Death|0|||
130785806|NCT02008526|470843236|FG001|Overall Study|Death|2|||
130785807|NCT02008526|470843237|FG002|Overall Study|Death|1|||
130785808|NCT02008526|470843235|FG000|Overall Study|Withdrawal by Subject|3|||
130785809|NCT02008526|470843236|FG001|Overall Study|Withdrawal by Subject|3|||
130785810|NCT02008526|470843237|FG002|Overall Study|Withdrawal by Subject|2|||
130785811|NCT02008526|470843235|FG000|Overall Study|Lost to Follow-up|5|||
130785812|NCT02008526|470843236|FG001|Overall Study|Lost to Follow-up|9|||
130785813|NCT02008526|470843237|FG002|Overall Study|Lost to Follow-up|6|||
130785814|NCT00492726|470843238|FG000|Overall Study|Adverse Event|10|||
130785815|NCT00492726|470843239|FG001|Overall Study|Adverse Event|6|||
130785816|NCT00492726|470843238|FG000|Overall Study|Death|7|||
130785817|NCT00492726|470843239|FG001|Overall Study|Death|2|||
130785818|NCT00492726|470843238|FG000|Overall Study|Lack of Efficacy|0|||
130785819|NCT00492726|470843239|FG001|Overall Study|Lack of Efficacy|2|||
130785820|NCT00492726|470843238|FG000|Overall Study|Lost to Follow-up|27|||
130785821|NCT00492726|470843239|FG001|Overall Study|Lost to Follow-up|19|||
130785822|NCT00492726|470843238|FG000|Overall Study|Physician Decision|0|||
130785823|NCT00492726|470843239|FG001|Overall Study|Physician Decision|1|||
130785824|NCT00492726|470843238|FG000|Overall Study|Withdrawal by Subject|6|||
130785825|NCT00492726|470843239|FG001|Overall Study|Withdrawal by Subject|3|||
130785826|NCT00492726|470843238|FG000|Overall Study|Non compliant with study medication|0|||
130785827|NCT00492726|470843239|FG001|Overall Study|Non compliant with study medication|3|||
130785828|NCT04386902|470843240|FG000|Overall Study|Withdrawal by Subject|5|||
130785829|NCT04386902|470843240|FG000|Overall Study|Technical problems in the recording|5|||
130785830|NCT02404545|470843241|FG000|Overall Study|Sponsor Termination|6|||
130785831|NCT02404545|470843242|FG001|Overall Study|Sponsor Termination|6|||
130785832|NCT01712516|470844761|FG000|Overall Study|Technical problems|0|||
130785833|NCT01712516|470844762|FG001|Overall Study|Technical problems|0|||
130785834|NCT01712516|470844763|FG002|Overall Study|Technical problems|0|||
130785835|NCT01712516|470844764|FG003|Overall Study|Technical problems|2|||
130785836|NCT01712516|470844761|FG000|Overall Study|Lost to Follow-up|0|||
130785837|NCT01712516|470844762|FG001|Overall Study|Lost to Follow-up|0|||
130785838|NCT01712516|470844763|FG002|Overall Study|Lost to Follow-up|2|||
130785839|NCT01712516|470844764|FG003|Overall Study|Lost to Follow-up|1|||
130785840|NCT01712516|470844761|FG000|Overall Study|Death|0|||
130785841|NCT01712516|470844762|FG001|Overall Study|Death|1|||
130785842|NCT01712516|470844763|FG002|Overall Study|Death|0|||
130785843|NCT01712516|470844764|FG003|Overall Study|Death|0|||
130785844|NCT01712516|470844761|FG000|Overall Study|Protocol deviation|1|||
130785845|NCT01712516|470844762|FG001|Overall Study|Protocol deviation|0|||
130785846|NCT01712516|470844763|FG002|Overall Study|Protocol deviation|1|||
130785847|NCT01712516|470844764|FG003|Overall Study|Protocol deviation|0|||
130785848|NCT01712516|470844761|FG000|Overall Study|Physician Decision|2|||
130785849|NCT01712516|470844762|FG001|Overall Study|Physician Decision|0|||
130785850|NCT01712516|470844763|FG002|Overall Study|Physician Decision|0|||
130785851|NCT01712516|470844764|FG003|Overall Study|Physician Decision|1|||
130785852|NCT01712516|470844761|FG000|Overall Study|Withdrawal by Subject|3|||
130785853|NCT01712516|470844762|FG001|Overall Study|Withdrawal by Subject|9|||
130785854|NCT01712516|470844763|FG002|Overall Study|Withdrawal by Subject|3|||
130785855|NCT01712516|470844764|FG003|Overall Study|Withdrawal by Subject|9|||
130785856|NCT01181167|470844765|FG000|Overall Study|Adverse Event|11|||
130785857|NCT01181167|470844766|FG001|Overall Study|Adverse Event|21|||
130738334|NCT02038010|470662142|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
130738335|NCT02038010|470662143|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
130738336|NCT02038010|470662144|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
130738337|NCT02038010|470662141|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
130738338|NCT02038010|470662142|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
130738339|NCT02038010|470662143|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
130738340|NCT02038010|470662144|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
130785858|NCT01181167|470844765|FG000|Overall Study|Lost to Follow-up|1|||
130785859|NCT01181167|470844766|FG001|Overall Study|Lost to Follow-up|0|||
130785860|NCT01181167|470844765|FG000|Overall Study|Physician Decision|2|||
130738341|NCT02038010|470662141|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
130738342|NCT02038010|470662142|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
130738343|NCT02038010|470662143|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
130738344|NCT02038010|470662144|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
130738345|NCT02038010|470662141|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
130738346|NCT02038010|470662142|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
130738347|NCT02038010|470662143|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
130738348|NCT02038010|470662144|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
130738349|NCT02038010|470662141|FG000|Follow Up|Death|4|||
130738350|NCT02038010|470662142|FG001|Follow Up|Death|3|||
130738351|NCT02038010|470662143|FG002|Follow Up|Death|0|||
130738352|NCT02038010|470662144|FG003|Follow Up|Death|0|||
130738353|NCT02038010|470662141|FG000|Follow Up|Other|3|||
130738354|NCT02038010|470662142|FG001|Follow Up|Other|0|||
130738355|NCT02038010|470662143|FG002|Follow Up|Other|0|||
130738356|NCT02038010|470662144|FG003|Follow Up|Other|0|||
130738357|NCT00110396|470662145|FG000|Overall Study|Adverse Event|15|||
130738358|NCT00110396|470662145|FG000|Overall Study|Lost to Follow-up|1|||
130738359|NCT00110396|470662145|FG000|Overall Study|Administration of plasmapheresis|1|||
130738360|NCT00110396|470662145|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
130738361|NCT00110396|470662145|FG000|Overall Study|Lack of Efficacy|1|||
130738362|NCT00110396|470662145|FG000|Overall Study|Decided not to continue treatment|1|||
130738363|NCT00110396|470662145|FG000|Overall Study|Patient non-compliance|1|||
130738364|NCT00110396|470662145|FG000|Overall Study|Patient refused to continue|1|||
130738365|NCT00110396|470662145|FG000|Overall Study|Patient refused to participate|1|||
130738366|NCT00110396|470662145|FG000|Overall Study|Patient will|1|||
130738367|NCT00110396|470662145|FG000|Overall Study|Patient's decision|1|||
130738368|NCT00110396|470662145|FG000|Overall Study|Participation in MS vaccine study|1|||
130738369|NCT00110396|470662145|FG000|Overall Study|Pregnancy|1|||
130738370|NCT00110396|470662145|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
130738371|NCT00110396|470662145|FG000|Overall Study|Protocol Violation|2|||
130738372|NCT00110396|470662145|FG000|Overall Study|Patient refused to come back|1|||
130738373|NCT00110396|470662145|FG000|Overall Study|The patient has refused|2|||
130738374|NCT00110396|470662145|FG000|Overall Study|The patient has refused to visit site|1|||
130738375|NCT00110396|470662145|FG000|Overall Study|Patient is to be administered copaxone|1|||
130738376|NCT02414958|470662146|FG000|Overall Study|Adverse Event|6|||
130738377|NCT02414958|470662147|FG001|Overall Study|Adverse Event|6|||
130738378|NCT02414958|470662148|FG002|Overall Study|Adverse Event|3|||
130738379|NCT02414958|470662146|FG000|Overall Study|Protocol Violation|10|||
130738380|NCT02414958|470662147|FG001|Overall Study|Protocol Violation|3|||
130738381|NCT02414958|470662148|FG002|Overall Study|Protocol Violation|1|||
130738382|NCT02414958|470662146|FG000|Overall Study|Lost to Follow-up|7|||
130738383|NCT02414958|470662147|FG001|Overall Study|Lost to Follow-up|4|||
130738384|NCT02414958|470662148|FG002|Overall Study|Lost to Follow-up|0|||
130738385|NCT02414958|470662146|FG000|Overall Study|Withdrawal by Subject|5|||
130738386|NCT02414958|470662147|FG001|Overall Study|Withdrawal by Subject|3|||
130738387|NCT02414958|470662148|FG002|Overall Study|Withdrawal by Subject|5|||
130738388|NCT02414958|470662146|FG000|Overall Study|Other than specified|4|||
130738389|NCT02414958|470662147|FG001|Overall Study|Other than specified|4|||
130738390|NCT02414958|470662148|FG002|Overall Study|Other than specified|5|||
130738391|NCT00245466|470662150|FG000|Overall Study|Adverse Event|2|||
130738392|NCT00245466|470662151|FG001|Overall Study|Adverse Event|8|||
130738393|NCT00245466|470662152|FG002|Overall Study|Adverse Event|4|||
130738394|NCT00245466|470662150|FG000|Overall Study|Low prostate specific antigen suppr|16|||
130738395|NCT00245466|470662151|FG001|Overall Study|Low prostate specific antigen suppr|14|||
130738396|NCT00245466|470662152|FG002|Overall Study|Low prostate specific antigen suppr|5|||
130738397|NCT00245466|470662150|FG000|Overall Study|Insufficient testosterone suppr|12|||
130785861|NCT01181167|470844766|FG001|Overall Study|Physician Decision|3|||
130785862|NCT01181167|470844765|FG000|Overall Study|Protocol Violation|3|||
130785863|NCT01181167|470844766|FG001|Overall Study|Protocol Violation|0|||
130785864|NCT01181167|470844765|FG000|Overall Study|Withdrawal by Subject|6|||
130785865|NCT01181167|470844766|FG001|Overall Study|Withdrawal by Subject|8|||
130785866|NCT00161213|470844767|FG000|Overall Study|Withdrawal by Subject|1|||
130785867|NCT00161213|470844767|FG000|Overall Study|Evaluable for toxicity but not response|1|||
130785868|NCT03103503|470844768|FG000|Overall Study|Death|64|||
130785869|NCT03103503|470844768|FG000|Overall Study|Physician Decision|57|||
130785870|NCT03103503|470844768|FG000|Overall Study|Withdrawal by Subject|10|||
130785871|NCT03103503|470844768|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
130785872|NCT03103503|470844768|FG000|Overall Study|Lost to Follow-up|3|||
130785873|NCT03103503|470844768|FG000|Overall Study|Study Closure|757|||
130785874|NCT01384877|470844769|FG000|Treatment 2|Lost to Follow-up|2|||
130785875|NCT01384877|470844770|FG001|Treatment 2|Lost to Follow-up|2|||
130785876|NCT03630393|470844771|FG000|Overall Study|Death|1|||
130785877|NCT03630393|470844772|FG001|Overall Study|Death|0|||
130785878|NCT00408499|470844773|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130785879|NCT00408499|470844774|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130785880|NCT00408499|470844775|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
130785881|NCT00408499|470844776|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130785882|NCT00408499|470844777|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130785883|NCT00408499|470844773|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
130785884|NCT00408499|470844774|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
130785885|NCT00408499|470844775|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
130785886|NCT00408499|470844776|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
130785887|NCT00408499|470844777|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
130785888|NCT00408499|470844773|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
130785889|NCT00408499|470844774|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
130785890|NCT00408499|470844775|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
130785891|NCT00408499|470844776|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
130785892|NCT00408499|470844777|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
130785893|NCT00408499|470844773|FG000|Phase II- MTD Expansion|Adverse Event|0|||
130785894|NCT00408499|470844774|FG001|Phase II- MTD Expansion|Adverse Event|0|||
130785895|NCT00408499|470844775|FG002|Phase II- MTD Expansion|Adverse Event|0|||
130785896|NCT00408499|470844776|FG003|Phase II- MTD Expansion|Adverse Event|0|||
130785897|NCT00408499|470844777|FG004|Phase II- MTD Expansion|Adverse Event|9|||
130785898|NCT00408499|470844773|FG000|Phase II- MTD Expansion|Death|0|||
130785899|NCT00408499|470844774|FG001|Phase II- MTD Expansion|Death|0|||
130785900|NCT00408499|470844775|FG002|Phase II- MTD Expansion|Death|0|||
130785901|NCT00408499|470844776|FG003|Phase II- MTD Expansion|Death|0|||
130785902|NCT00408499|470844777|FG004|Phase II- MTD Expansion|Death|2|||
130785903|NCT00408499|470844773|FG000|Phase II- MTD Expansion|Physician Decision|0|||
130785904|NCT00408499|470844774|FG001|Phase II- MTD Expansion|Physician Decision|0|||
130785905|NCT00408499|470844775|FG002|Phase II- MTD Expansion|Physician Decision|0|||
130785906|NCT00408499|470844776|FG003|Phase II- MTD Expansion|Physician Decision|0|||
130785907|NCT00408499|470844777|FG004|Phase II- MTD Expansion|Physician Decision|1|||
130785908|NCT00408499|470844773|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130785909|NCT00408499|470844774|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130785910|NCT00408499|470844775|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130785911|NCT00408499|470844776|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130785912|NCT00408499|470844777|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
130785913|NCT00408499|470844773|FG000|Phase II- MTD Expansion|treatment delay|0|||
130785914|NCT00408499|470844774|FG001|Phase II- MTD Expansion|treatment delay|0|||
130738398|NCT00245466|470662151|FG001|Overall Study|Insufficient testosterone suppr|12|||
130738399|NCT00245466|470662152|FG002|Overall Study|Insufficient testosterone suppr|21|||
130738400|NCT00245466|470662150|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
130738401|NCT00245466|470662151|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
130738402|NCT00245466|470662152|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
130738403|NCT00245466|470662150|FG000|Overall Study|Withdrawal by Subject|2|||
130738404|NCT00245466|470662151|FG001|Overall Study|Withdrawal by Subject|2|||
130738405|NCT00245466|470662152|FG002|Overall Study|Withdrawal by Subject|1|||
130738406|NCT00245466|470662150|FG000|Overall Study|Lost to Follow-up|3|||
130738407|NCT00245466|470662151|FG001|Overall Study|Lost to Follow-up|0|||
130738408|NCT00245466|470662152|FG002|Overall Study|Lost to Follow-up|0|||
130738409|NCT00245466|470662150|FG000|Overall Study|Disease progression|0|||
130738410|NCT00245466|470662151|FG001|Overall Study|Disease progression|3|||
130738411|NCT00245466|470662152|FG002|Overall Study|Disease progression|1|||
130738412|NCT00245466|470662150|FG000|Overall Study|Protocol Violation|1|||
130738413|NCT00245466|470662151|FG001|Overall Study|Protocol Violation|2|||
130738414|NCT00245466|470662152|FG002|Overall Study|Protocol Violation|2|||
130738415|NCT00245466|470662150|FG000|Overall Study|Death|0|||
130738416|NCT00245466|470662151|FG001|Overall Study|Death|2|||
130738417|NCT00245466|470662152|FG002|Overall Study|Death|0|||
130738418|NCT00245466|470662150|FG000|Overall Study|Administrative reasons|0|||
130738419|NCT00245466|470662151|FG001|Overall Study|Administrative reasons|1|||
130738420|NCT00245466|470662152|FG002|Overall Study|Administrative reasons|0|||
130738421|NCT01958437|470662153|FG000|Overall Study|Incidental MRI findings|0|||
130738422|NCT01958437|470662154|FG001|Overall Study|Incidental MRI findings|0|||
130738423|NCT01958437|470662155|FG002|Overall Study|Incidental MRI findings|1|||
130738424|NCT01958437|470662156|FG003|Overall Study|Incidental MRI findings|1|||
130738425|NCT04886596|470662159|FG000|Overall Study|Adverse Event|442|||
130738426|NCT04886596|470662160|FG001|Overall Study|Adverse Event|441|||
130738427|NCT04886596|470662159|FG000|Overall Study|Lost to Follow-up|448|||
130738428|NCT04886596|470662160|FG001|Overall Study|Lost to Follow-up|465|||
130738429|NCT04886596|470662159|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
130738430|NCT04886596|470662160|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
130738431|NCT04886596|470662159|FG000|Overall Study|Migrated/moved from the study area|201|||
130738432|NCT04886596|470662160|FG001|Overall Study|Migrated/moved from the study area|184|||
130738433|NCT04886596|470662159|FG000|Overall Study|Other|298|||
130738434|NCT04886596|470662160|FG001|Overall Study|Other|326|||
130738435|NCT00948155|470662163|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
130738436|NCT00948155|470662164|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
130738437|NCT00948155|470662163|FG000|Washout 14 Days|Lost to Follow-up|1|||
130738438|NCT00948155|470662164|FG001|Washout 14 Days|Lost to Follow-up|2|||
130738439|NCT03473925|470662165|FG000|Overall Study|Death|48|||
130738440|NCT03473925|470662166|FG001|Overall Study|Death|44|||
130785915|NCT00408499|470844775|FG002|Phase II- MTD Expansion|treatment delay|0|||
130738441|NCT03473925|470662165|FG000|Overall Study|Sponsor Decision|2|||
130738442|NCT03473925|470662166|FG001|Overall Study|Sponsor Decision|7|||
130738443|NCT03473925|470662165|FG000|Overall Study|Withdrawal by Subject|1|||
130738444|NCT03473925|470662166|FG001|Overall Study|Withdrawal by Subject|3|||
130738445|NCT03473925|470662165|FG000|Overall Study|Not Treated|1|||
130738446|NCT03473925|470662166|FG001|Overall Study|Not Treated|1|||
130738447|NCT04661150|470662171|FG000|Overall Study|Ongoing in study|19|||
130785916|NCT00408499|470844776|FG003|Phase II- MTD Expansion|treatment delay|0|||
130785917|NCT00408499|470844777|FG004|Phase II- MTD Expansion|treatment delay|3|||
130785918|NCT02683109|470844779|FG000|Overall Study|Adverse Event|1|||
130738448|NCT04661150|470662172|FG001|Overall Study|Ongoing in study|20|||
130738449|NCT04661150|470662171|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
130738450|NCT04661150|470662172|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
130738451|NCT04661150|470662171|FG000|Overall Study|Death|2|||
130738452|NCT04661150|470662172|FG001|Overall Study|Death|0|||
130738453|NCT05767905|470662173|FG000|Overall Study|Adverse Event|0|||
130738454|NCT05767905|470662174|FG001|Overall Study|Adverse Event|0|||
130738455|NCT05767905|470662175|FG002|Overall Study|Adverse Event|1|||
130738456|NCT03762239|470662176|FG000|Overall Study|Appointment to the doctor|1|||
130738457|NCT03762239|470662177|FG001|Overall Study|Appointment to the doctor|1|||
130738458|NCT04660331|470662187|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
130738459|NCT04660331|470662188|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
130738460|NCT04660331|470662189|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
130738461|NCT03624192|470662190|FG000|Overall Study|Lost to Follow-up|1|||
130738462|NCT03624192|470662191|FG001|Overall Study|Lost to Follow-up|1|||
130738463|NCT02635984|470662196|FG000|Overall Study|Lost to Follow-up|2|||
130738464|NCT02635984|470662197|FG001|Overall Study|Lost to Follow-up|4|||
130785919|NCT02683109|470844780|FG001|Overall Study|Adverse Event|0|||
130785920|NCT00183430|470844781|FG000|Overall Study|Adverse Event|1|||
130785921|NCT00183430|470844782|FG001|Overall Study|Adverse Event|0|||
130785922|NCT00183430|470844781|FG000|Overall Study|Lost to Follow-up|3|||
130785923|NCT00183430|470844782|FG001|Overall Study|Lost to Follow-up|0|||
130785924|NCT00183430|470844781|FG000|Overall Study|did not meet inclusion criteria|1|||
130785925|NCT00183430|470844782|FG001|Overall Study|did not meet inclusion criteria|0|||
130785926|NCT00183430|470844781|FG000|Overall Study|Withdrawal by Subject|1|||
130785927|NCT00183430|470844782|FG001|Overall Study|Withdrawal by Subject|0|||
130785928|NCT01248455|470844789|FG000|Overall Study|switched to alternate treatment|1|||
130785929|NCT00426270|470844790|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
130785930|NCT00426270|470844790|FG000|Overall Study|Adverse Event|5|||
130785931|NCT01117870|470844792|FG000|Overall Study|Inability to place needle|1|||
130785932|NCT01117870|470844793|FG001|Overall Study|Inability to place needle|0|||
130785933|NCT03102762|470844794|FG000|Overall Study|Lost to Follow-up|1|||
130785934|NCT03102762|470844795|FG001|Overall Study|Lost to Follow-up|0|||
130785935|NCT00958074|470844796|FG000|Overall Study|Withdrawal by Subject|0|||
130785936|NCT00958074|470844797|FG001|Overall Study|Withdrawal by Subject|1|||
130785937|NCT02709746|470844798|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
130785938|NCT02709746|470844799|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130785939|NCT02709746|470844800|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130785940|NCT02709746|470844801|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130785941|NCT02709746|470844802|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130785942|NCT02709746|470844798|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
130785943|NCT02709746|470844799|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130785944|NCT02709746|470844800|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130785945|NCT02709746|470844801|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130785946|NCT02709746|470844802|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130785947|NCT02709746|470844798|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
130785948|NCT02709746|470844799|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130785949|NCT02709746|470844800|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130785950|NCT02709746|470844801|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130785951|NCT02709746|470844802|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130785952|NCT02709746|470844798|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
130785953|NCT02709746|470844799|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130785954|NCT02709746|470844800|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130785955|NCT02709746|470844801|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130785956|NCT02709746|470844802|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130785957|NCT02709746|470844798|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
130785958|NCT02709746|470844799|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130785959|NCT02709746|470844800|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130785960|NCT02709746|470844801|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130785961|NCT02709746|470844802|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130785962|NCT02709746|470844798|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
130785963|NCT02709746|470844799|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130785964|NCT02709746|470844800|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130785965|NCT02709746|470844801|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130785966|NCT02709746|470844802|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130785967|NCT02709746|470844798|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
130738465|NCT02635984|470662196|FG000|Overall Study|Study Arm Closed|1|||
130738466|NCT02635984|470662197|FG001|Overall Study|Study Arm Closed|0|||
130738467|NCT01640249|470662198|FG000|Period 1|Withdrawal by Subject|1|||
130738468|NCT01640249|470662199|FG001|Period 1|Withdrawal by Subject|0|||
130738469|NCT01640249|470662200|FG002|Period 1|Withdrawal by Subject|0|||
130738470|NCT01640249|470662201|FG003|Period 1|Withdrawal by Subject|0|||
130738471|NCT01640249|470662202|FG004|Period 1|Withdrawal by Subject|0|||
130738472|NCT01640249|470662203|FG005|Period 1|Withdrawal by Subject|1|||
130738473|NCT01640249|470662204|FG006|Period 1|Withdrawal by Subject|0|||
130738474|NCT00065156|470662208|FG000|Overall Study|Adverse Event|37|||
130738475|NCT00065156|470662208|FG000|Overall Study|Lack of Efficacy|52|||
130738476|NCT00065156|470662208|FG000|Overall Study|Withdrawal by Subject|8|||
130738477|NCT00065156|470662208|FG000|Overall Study|Lost to Follow-up|1|||
130738478|NCT00065156|470662208|FG000|Overall Study|Death|11|||
130738479|NCT00065156|470662208|FG000|Overall Study|Study Closed by Sponsor|2|||
130738480|NCT00065156|470662208|FG000|Overall Study|Disease Progression|7|||
130738481|NCT00065156|470662208|FG000|Overall Study|Investigator Decision|2|||
130738482|NCT00065156|470662208|FG000|Overall Study|Non-Compliance|2|||
130738483|NCT00065156|470662208|FG000|Overall Study|Loss of Response|1|||
130738484|NCT00065156|470662208|FG000|Overall Study|Secondary Malign Disease|1|||
130738485|NCT03518008|470662209|FG000|Period 2, Second Week of Wear|Family emergency|0|||
130738486|NCT03518008|470662210|FG001|Period 2, Second Week of Wear|Family emergency|1|||
130738487|NCT01215136|470662211|FG000|Overall Study|Adverse Event|2|||
130738488|NCT01215136|470662212|FG001|Overall Study|Adverse Event|9|||
130738489|NCT01215136|470662211|FG000|Overall Study|Disease Progression|3|||
130738490|NCT01215136|470662212|FG001|Overall Study|Disease Progression|14|||
130738491|NCT01215136|470662211|FG000|Overall Study|Symptomatic Deterioration|1|||
130738492|NCT01215136|470662212|FG001|Overall Study|Symptomatic Deterioration|1|||
130738493|NCT01215136|470662211|FG000|Overall Study|Death|0|||
130738494|NCT01215136|470662212|FG001|Overall Study|Death|2|||
130738495|NCT01215136|470662211|FG000|Overall Study|Withdrawal by Subject|0|||
130738496|NCT01215136|470662212|FG001|Overall Study|Withdrawal by Subject|1|||
130738497|NCT00951496|470662217|FG000|Overall Study|Did not initiate study treatment|10|||
130738498|NCT00951496|470662218|FG001|Overall Study|Did not initiate study treatment|8|||
130738499|NCT00951496|470662219|FG002|Overall Study|Did not initiate study treatment|13|||
130738500|NCT01526057|470662221|FG000|Overall Study|Withdrawal by Subject|3|||
130738501|NCT01526057|470662222|FG001|Overall Study|Withdrawal by Subject|2|||
130738502|NCT01526057|470662223|FG002|Overall Study|Withdrawal by Subject|2|||
130738503|NCT01526057|470662221|FG000|Overall Study|Adverse Event|3|||
130738504|NCT01526057|470662222|FG001|Overall Study|Adverse Event|1|||
130738505|NCT01526057|470662223|FG002|Overall Study|Adverse Event|1|||
130738506|NCT01526057|470662221|FG000|Overall Study|Death|1|||
130738507|NCT01526057|470662222|FG001|Overall Study|Death|0|||
130738508|NCT01526057|470662223|FG002|Overall Study|Death|0|||
130738509|NCT01526057|470662221|FG000|Overall Study|Lost to Follow-up|1|||
130738510|NCT01526057|470662222|FG001|Overall Study|Lost to Follow-up|0|||
130738511|NCT01526057|470662223|FG002|Overall Study|Lost to Follow-up|1|||
130785968|NCT02709746|470844799|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130738512|NCT01526057|470662221|FG000|Overall Study|Other|1|||
130738513|NCT01526057|470662222|FG001|Overall Study|Other|0|||
130738514|NCT01526057|470662223|FG002|Overall Study|Other|1|||
130738515|NCT01526057|470662221|FG000|Overall Study|Protocol Violation|0|||
130738516|NCT01526057|470662222|FG001|Overall Study|Protocol Violation|0|||
130738517|NCT01526057|470662223|FG002|Overall Study|Protocol Violation|1|||
130738518|NCT02289729|470662234|FG000|Overall Study|Lack of Efficacy|3|||
130738519|NCT02289729|470662234|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
130738520|NCT02289729|470662234|FG000|Overall Study|Withdrawal by Subject|1|||
130738521|NCT02289729|470662234|FG000|Overall Study|Death|1|||
130738522|NCT04870710|470662238|FG000|Overall Study|Lost to Follow-up|3|||
130738523|NCT00476190|470662239|FG000|Overall Study|Ineligible|1|||
130738524|NCT00476190|470662240|FG001|Overall Study|Ineligible|1|||
130738525|NCT00476190|470662239|FG000|Overall Study|Induction Death|2|||
130738526|NCT00476190|470662240|FG001|Overall Study|Induction Death|0|||
130738527|NCT00476190|470662239|FG000|Overall Study|Induction Failure|2|||
130738528|NCT00476190|470662240|FG001|Overall Study|Induction Failure|4|||
130738529|NCT00476190|470662239|FG000|Overall Study|Lost to Follow-up|1|||
130738530|NCT00476190|470662240|FG001|Overall Study|Lost to Follow-up|0|||
130738531|NCT00476190|470662239|FG000|Overall Study|Relapse/Progression|5|||
130738532|NCT00476190|470662240|FG001|Overall Study|Relapse/Progression|2|||
130738533|NCT00476190|470662239|FG000|Overall Study|Remission Death|0|||
130738534|NCT00476190|470662240|FG001|Overall Study|Remission Death|1|||
130738535|NCT00476190|470662239|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
130738536|NCT00476190|470662240|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
130738537|NCT00476190|470662239|FG000|Overall Study|Withdrawal by Subject|6|||
130738538|NCT00476190|470662240|FG001|Overall Study|Withdrawal by Subject|2|||
130738539|NCT00476190|470662239|FG000|Overall Study|Other|9|||
130738540|NCT00476190|470662240|FG001|Overall Study|Other|10|||
130738541|NCT01329900|470662251|FG000|Overall Study|Elevated creatinine/renal function|1|||
130738542|NCT00281957|470662259|FG000|Overall Study|Adverse Event|7|||
130738543|NCT00281957|470662260|FG001|Overall Study|Adverse Event|2|||
130738544|NCT00281957|470662259|FG000|Overall Study|Death|1|||
130738545|NCT00281957|470662260|FG001|Overall Study|Death|0|||
130738546|NCT00281957|470662259|FG000|Overall Study|Progression/relapse|47|||
130738547|NCT00281957|470662260|FG001|Overall Study|Progression/relapse|35|||
130738548|NCT00281957|470662259|FG000|Overall Study|Not protocol specified|8|||
130738549|NCT00281957|470662260|FG001|Overall Study|Not protocol specified|1|||
130738550|NCT00281957|470662259|FG000|Overall Study|Not eligible|1|||
130738551|NCT00281957|470662260|FG001|Overall Study|Not eligible|2|||
130738552|NCT00281957|470662259|FG000|Overall Study|Did not start treatment|3|||
130738553|NCT00281957|470662260|FG001|Overall Study|Did not start treatment|1|||
130738554|NCT00281957|470662259|FG000|Overall Study|Refusal unrelated to adverse events|0|||
130738555|NCT00281957|470662260|FG001|Overall Study|Refusal unrelated to adverse events|1|||
130738556|NCT01876446|470662261|FG000|Overall Study|Death|0|||
130738557|NCT01876446|470662262|FG001|Overall Study|Death|1|||
130738558|NCT01876446|470662261|FG000|Overall Study|Withdrawal by Subject|1|||
130738559|NCT01876446|470662262|FG001|Overall Study|Withdrawal by Subject|2|||
130738560|NCT01876446|470662261|FG000|Overall Study|Physician Decision|1|||
130738561|NCT01876446|470662262|FG001|Overall Study|Physician Decision|3|||
130738562|NCT00822692|470662265|FG000|Overall Study|Lost to Follow-up|17|||
130738563|NCT00822692|470662266|FG001|Overall Study|Lost to Follow-up|25|||
130738564|NCT03629184|470662267|FG000|Overall Study|Withdrawal by Subject|2|||
130738565|NCT03629184|470662268|FG001|Overall Study|Withdrawal by Subject|1|||
130738566|NCT03629184|470662267|FG000|Overall Study|Physician Decision|1|||
130738567|NCT03629184|470662268|FG001|Overall Study|Physician Decision|0|||
130738568|NCT02548143|470662270|FG000|Overall Study|Adverse Event|1|||
130738569|NCT02548143|470662271|FG001|Overall Study|Adverse Event|0|||
130738570|NCT02548143|470662270|FG000|Overall Study|Withdrawal by Subject|0|||
130738571|NCT02548143|470662271|FG001|Overall Study|Withdrawal by Subject|1|||
130738572|NCT05620082|470662275|FG000|Overall Study|Discharged before study end|1|||
130738573|NCT05620082|470662276|FG001|Overall Study|Discharged before study end|4|||
130738574|NCT05620082|470662277|FG002|Overall Study|Discharged before study end|0|||
130738575|NCT05620082|470662275|FG000|Overall Study|Moved to a different ward|1|||
130738576|NCT05620082|470662276|FG001|Overall Study|Moved to a different ward|0|||
130738577|NCT05620082|470662277|FG002|Overall Study|Moved to a different ward|0|||
130738578|NCT05620082|470662275|FG000|Overall Study|Feeling too unwell|1|||
130738579|NCT05620082|470662276|FG001|Overall Study|Feeling too unwell|0|||
130738580|NCT05620082|470662277|FG002|Overall Study|Feeling too unwell|0|||
130738581|NCT05525520|470664207|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
130738582|NCT05525520|470664208|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
130738583|NCT05525520|470664207|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
130738584|NCT05525520|470664208|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
130738585|NCT02721732|470664209|FG000|Overall Study|Adverse Event|2|||
130785969|NCT02709746|470844800|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130785970|NCT02709746|470844801|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130785971|NCT02709746|470844802|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130785972|NCT02709746|470844798|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
130785973|NCT02709746|470844799|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130785974|NCT02709746|470844800|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130785975|NCT02709746|470844801|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130785976|NCT02709746|470844802|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130785977|NCT02709746|470844798|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
130785978|NCT02709746|470844799|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130785979|NCT02709746|470844800|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130785980|NCT02709746|470844801|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130785981|NCT02709746|470844802|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130785982|NCT02709746|470844798|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
130785983|NCT02709746|470844799|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
130785984|NCT02709746|470844800|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
130785985|NCT02709746|470844801|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
130785986|NCT02709746|470844802|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
130785987|NCT02709746|470844798|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
130785988|NCT02709746|470844799|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
130785989|NCT02709746|470844800|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
130785990|NCT02709746|470844801|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
130785991|NCT02709746|470844802|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
130785992|NCT02709746|470844798|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
130785993|NCT02709746|470844799|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
130785994|NCT02709746|470844800|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
130785995|NCT02709746|470844801|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
130785996|NCT02709746|470844802|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
130785997|NCT02709746|470844798|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
130785998|NCT02709746|470844799|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
130785999|NCT02709746|470844800|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
130786000|NCT02709746|470844801|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
130786001|NCT02709746|470844802|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
130786002|NCT02709746|470844798|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
130786003|NCT02709746|470844799|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
130786004|NCT02709746|470844800|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
130786005|NCT02709746|470844801|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
130786006|NCT02709746|470844802|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
130786007|NCT02709746|470844798|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
130786008|NCT02709746|470844799|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
130786009|NCT02709746|470844800|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
130786010|NCT02709746|470844801|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
130786011|NCT02709746|470844802|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
130786012|NCT02709746|470844798|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130786013|NCT02709746|470844799|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130786014|NCT02709746|470844800|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
130786015|NCT02709746|470844801|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130786016|NCT02709746|470844802|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130786017|NCT02709746|470844798|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
130786018|NCT02709746|470844799|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
130786019|NCT02709746|470844800|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
130786020|NCT02709746|470844801|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
130786021|NCT02709746|470844802|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
130786022|NCT03322293|470844808|FG000|Overall Study|Lost to Follow-up|0|||
130786023|NCT03322293|470844809|FG001|Overall Study|Lost to Follow-up|0|||
130786024|NCT03322293|470844810|FG002|Overall Study|Lost to Follow-up|1|||
130786025|NCT01178294|470844811|FG000|Overall Study|Adverse Event|4|||
130786026|NCT01178294|470844811|FG000|Overall Study|Lost to Follow-up|2|||
130786027|NCT01178294|470844811|FG000|Overall Study|Lack of Efficacy|1|||
130786028|NCT01178294|470844811|FG000|Overall Study|Death|1|||
130786029|NCT01178294|470844811|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
130786030|NCT01178294|470844811|FG000|Overall Study|Subject status is terminal|1|||
130786031|NCT01178294|470844811|FG000|Overall Study|Completion status could not be verified|1|||
130786032|NCT02089347|470844812|FG000|Overall Study|Protocol Violation|1|||
130786033|NCT02089347|470844813|FG001|Overall Study|Protocol Violation|0|||
130738586|NCT02721732|470664210|FG001|Overall Study|Adverse Event|0|||
130738587|NCT02721732|470664211|FG002|Overall Study|Adverse Event|2|||
130738588|NCT02721732|470664212|FG003|Overall Study|Adverse Event|0|||
130738589|NCT02721732|470664213|FG004|Overall Study|Adverse Event|1|||
130738590|NCT02721732|470664214|FG005|Overall Study|Adverse Event|0|||
130738591|NCT02721732|470664215|FG006|Overall Study|Adverse Event|1|||
130738592|NCT02721732|470664216|FG007|Overall Study|Adverse Event|0|||
130738593|NCT02721732|470664217|FG008|Overall Study|Adverse Event|1|||
130738594|NCT02721732|470664218|FG009|Overall Study|Adverse Event|1|||
130738595|NCT02721732|470664209|FG000|Overall Study|Death|0|||
130738596|NCT02721732|470664210|FG001|Overall Study|Death|0|||
130738597|NCT02721732|470664211|FG002|Overall Study|Death|0|||
130738598|NCT02721732|470664212|FG003|Overall Study|Death|0|||
130738599|NCT02721732|470664213|FG004|Overall Study|Death|1|||
130738600|NCT02721732|470664214|FG005|Overall Study|Death|0|||
130738601|NCT02721732|470664215|FG006|Overall Study|Death|1|||
130738602|NCT02721732|470664216|FG007|Overall Study|Death|0|||
130738603|NCT02721732|470664217|FG008|Overall Study|Death|0|||
130738604|NCT02721732|470664218|FG009|Overall Study|Death|1|||
130738605|NCT02721732|470664209|FG000|Overall Study|Lack of Efficacy|12|||
130738606|NCT02721732|470664210|FG001|Overall Study|Lack of Efficacy|11|||
130738607|NCT02721732|470664211|FG002|Overall Study|Lack of Efficacy|18|||
130738608|NCT02721732|470664212|FG003|Overall Study|Lack of Efficacy|5|||
130738609|NCT02721732|470664213|FG004|Overall Study|Lack of Efficacy|21|||
130738610|NCT02721732|470664214|FG005|Overall Study|Lack of Efficacy|2|||
130738611|NCT02721732|470664215|FG006|Overall Study|Lack of Efficacy|8|||
130738612|NCT02721732|470664216|FG007|Overall Study|Lack of Efficacy|11|||
130738613|NCT02721732|470664217|FG008|Overall Study|Lack of Efficacy|10|||
130738614|NCT02721732|470664218|FG009|Overall Study|Lack of Efficacy|20|||
130738615|NCT02721732|470664209|FG000|Overall Study|Physician Decision|0|||
130738616|NCT02721732|470664210|FG001|Overall Study|Physician Decision|0|||
130738617|NCT02721732|470664211|FG002|Overall Study|Physician Decision|1|||
130738618|NCT02721732|470664212|FG003|Overall Study|Physician Decision|0|||
130738619|NCT02721732|470664213|FG004|Overall Study|Physician Decision|0|||
130738620|NCT02721732|470664214|FG005|Overall Study|Physician Decision|0|||
130738621|NCT02721732|470664215|FG006|Overall Study|Physician Decision|0|||
130738622|NCT02721732|470664216|FG007|Overall Study|Physician Decision|0|||
130738623|NCT02721732|470664217|FG008|Overall Study|Physician Decision|0|||
130738624|NCT02721732|470664218|FG009|Overall Study|Physician Decision|0|||
130738625|NCT02721732|470664209|FG000|Overall Study|Withdrawal by Subject|1|||
130738626|NCT02721732|470664210|FG001|Overall Study|Withdrawal by Subject|0|||
130738627|NCT02721732|470664211|FG002|Overall Study|Withdrawal by Subject|0|||
130738628|NCT02721732|470664212|FG003|Overall Study|Withdrawal by Subject|0|||
130738629|NCT02721732|470664213|FG004|Overall Study|Withdrawal by Subject|3|||
130738630|NCT02721732|470664214|FG005|Overall Study|Withdrawal by Subject|0|||
130738631|NCT02721732|470664215|FG006|Overall Study|Withdrawal by Subject|1|||
130738632|NCT02721732|470664216|FG007|Overall Study|Withdrawal by Subject|1|||
130738633|NCT02721732|470664217|FG008|Overall Study|Withdrawal by Subject|0|||
130738634|NCT02721732|470664218|FG009|Overall Study|Withdrawal by Subject|1|||
130738635|NCT02721732|470664209|FG000|Overall Study|Participant Choice|1|||
130738636|NCT02721732|470664210|FG001|Overall Study|Participant Choice|0|||
130738637|NCT02721732|470664211|FG002|Overall Study|Participant Choice|0|||
130738638|NCT02721732|470664212|FG003|Overall Study|Participant Choice|0|||
130738639|NCT02721732|470664213|FG004|Overall Study|Participant Choice|0|||
130738640|NCT02721732|470664214|FG005|Overall Study|Participant Choice|0|||
130738641|NCT02721732|470664215|FG006|Overall Study|Participant Choice|0|||
130738642|NCT02721732|470664216|FG007|Overall Study|Participant Choice|0|||
130738643|NCT02721732|470664217|FG008|Overall Study|Participant Choice|0|||
130738644|NCT02721732|470664218|FG009|Overall Study|Participant Choice|1|||
130738645|NCT02721732|470664209|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130738646|NCT02721732|470664210|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130738647|NCT02721732|470664211|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
130738648|NCT02721732|470664212|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130738649|NCT02721732|470664213|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130738650|NCT02721732|470664214|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130738651|NCT02721732|470664215|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130738652|NCT02721732|470664216|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130738653|NCT02721732|470664217|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130738654|NCT02721732|470664218|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130738655|NCT02721732|470664209|FG000|Overall Study|Progression and withdrew consent|1|||
130738656|NCT02721732|470664210|FG001|Overall Study|Progression and withdrew consent|1|||
130738657|NCT02721732|470664211|FG002|Overall Study|Progression and withdrew consent|0|||
130786034|NCT00551369|470844814|FG000|Overall Study|Protocol Violation|5|||
130786035|NCT00551369|470844814|FG000|Overall Study|Withdrawal by Subject|1|||
130738658|NCT02721732|470664212|FG003|Overall Study|Progression and withdrew consent|0|||
130738659|NCT02721732|470664213|FG004|Overall Study|Progression and withdrew consent|0|||
130738660|NCT02721732|470664214|FG005|Overall Study|Progression and withdrew consent|0|||
130738661|NCT02721732|470664215|FG006|Overall Study|Progression and withdrew consent|0|||
130738662|NCT02721732|470664216|FG007|Overall Study|Progression and withdrew consent|0|||
130738663|NCT02721732|470664217|FG008|Overall Study|Progression and withdrew consent|0|||
130786036|NCT00551369|470844814|FG000|Overall Study|Not treated per protocol and re|1|||
130786037|NCT00719901|470844819|FG000|Overall Study|Adverse Event|5|||
130786038|NCT00719901|470844819|FG000|Overall Study|Withdrawal by Subject|1|||
130738664|NCT02721732|470664218|FG009|Overall Study|Progression and withdrew consent|1|||
130738665|NCT02721732|470664209|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
130738666|NCT02721732|470664210|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
130738667|NCT02721732|470664211|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
130738668|NCT02721732|470664212|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
130738669|NCT02721732|470664213|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
130738670|NCT02721732|470664214|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
130738671|NCT02721732|470664215|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
130738672|NCT02721732|470664216|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
130738673|NCT02721732|470664217|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
130738674|NCT02721732|470664218|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
130786039|NCT00719901|470844819|FG000|Overall Study|Alternate Treatment|1|||
130786040|NCT00719901|470844819|FG000|Overall Study|Disease Progression|3|||
130786041|NCT00719901|470844819|FG000|Overall Study|Availability of Study Drug|1|||
130786042|NCT01122173|470844820|FG000|Overall Study|Lost to Follow-up|3|||
130786043|NCT01122173|470844820|FG000|Overall Study|Withdrawal by Subject|3|||
130786044|NCT01122173|470844820|FG000|Overall Study|Left study for other reasons|3|||
130786045|NCT01184872|470844821|FG000|Overall Study|Adverse Event|3|||
130786046|NCT01184872|470844822|FG001|Overall Study|Adverse Event|4|||
130786047|NCT01184872|470844821|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130786048|NCT01184872|470844822|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130786049|NCT01184872|470844821|FG000|Overall Study|Withdrawal by Subject|2|||
130786050|NCT01184872|470844822|FG001|Overall Study|Withdrawal by Subject|0|||
130786051|NCT01184872|470844821|FG000|Overall Study|Lost to Follow-up|0|||
130786052|NCT01184872|470844822|FG001|Overall Study|Lost to Follow-up|1|||
130786053|NCT01184872|470844821|FG000|Overall Study|Administrative problems|1|||
130786054|NCT01184872|470844822|FG001|Overall Study|Administrative problems|1|||
130786055|NCT01184872|470844821|FG000|Overall Study|Protocol deviation|1|||
130786056|NCT01184872|470844822|FG001|Overall Study|Protocol deviation|0|||
130786057|NCT03863353|470844826|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
130786058|NCT03863353|470844827|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
130786059|NCT01299584|470844828|FG000|Overall Study|Protocol Violation|9|||
130786060|NCT02747927|470844829|FG000|Overall Study|Adverse Event|5|||
130786061|NCT02747927|470844830|FG001|Overall Study|Adverse Event|14|||
130786062|NCT02747927|470844829|FG000|Overall Study|Lost to Follow-up|22|||
130786063|NCT02747927|470844830|FG001|Overall Study|Lost to Follow-up|43|||
130786064|NCT02747927|470844829|FG000|Overall Study|Pregnancy|34|||
130786065|NCT02747927|470844830|FG001|Overall Study|Pregnancy|66|||
130786066|NCT02747927|470844829|FG000|Overall Study|Protocol Violation|2|||
130786067|NCT02747927|470844830|FG001|Overall Study|Protocol Violation|4|||
130786068|NCT02747927|470844829|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
130786069|NCT02747927|470844830|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
130786070|NCT02747927|470844829|FG000|Overall Study|Reason not Specified|11|||
130786071|NCT02747927|470844830|FG001|Overall Study|Reason not Specified|27|||
130786072|NCT03810183|470844834|FG000|Overall Study|Study terminated by Sponsor|2|||
130786073|NCT03810183|470844835|FG001|Overall Study|Study terminated by Sponsor|1|||
130786074|NCT00323063|470844836|FG000|Overall Study|Adverse Event|1|||
130786075|NCT00323063|470844837|FG001|Overall Study|Adverse Event|0|||
130786076|NCT00323063|470844836|FG000|Overall Study|brain mets discovered prior to treatment|1|||
130786077|NCT00323063|470844837|FG001|Overall Study|brain mets discovered prior to treatment|0|||
130786078|NCT00423046|470844838|FG000|Overall Study|Other|340|||
130786079|NCT00423046|470844839|FG001|Overall Study|Other|345|||
130786080|NCT00830128|470844840|FG000|Overall Study|Adverse Event|5|||
130786081|NCT00830128|470844840|FG000|Overall Study|Lack of Efficacy|7|||
130786082|NCT00830128|470844840|FG000|Overall Study|Protocol Violation|1|||
130786083|NCT00830128|470844840|FG000|Overall Study|Withdrawal by Subject|2|||
130786084|NCT00830128|470844840|FG000|Overall Study|Family obligation|1|||
130786085|NCT00830128|470844840|FG000|Overall Study|Relocation|1|||
130786086|NCT00830128|470844840|FG000|Overall Study|Work obligation|1|||
130786087|NCT00830128|470844840|FG000|Overall Study|Operating a vehicle|1|||
130786088|NCT04249427|470844845|FG000|Overall Study|Adverse Event|3|||
130786089|NCT04249427|470844846|FG001|Overall Study|Adverse Event|1|||
130786090|NCT04249427|470844845|FG000|Overall Study|Lack of Efficacy|0|||
130786091|NCT04249427|470844846|FG001|Overall Study|Lack of Efficacy|1|||
130786092|NCT04249427|470844845|FG000|Overall Study|Withdrawal by Subject|1|||
130786093|NCT04249427|470844846|FG001|Overall Study|Withdrawal by Subject|2|||
130786094|NCT01673178|470844847|FG000|Overall Study|Lost to Follow-up|0|||
130786095|NCT01673178|470844848|FG001|Overall Study|Lost to Follow-up|1|||
130786096|NCT01673178|470844849|FG002|Overall Study|Lost to Follow-up|0|||
130786097|NCT01673178|470844850|FG003|Overall Study|Lost to Follow-up|0|||
130786098|NCT01673178|470844851|FG004|Overall Study|Lost to Follow-up|0|||
130786099|NCT01673178|470844847|FG000|Overall Study|Withdrawal by Subject|0|||
130786100|NCT01673178|470844848|FG001|Overall Study|Withdrawal by Subject|0|||
130786101|NCT01673178|470844849|FG002|Overall Study|Withdrawal by Subject|1|||
130786102|NCT01673178|470844850|FG003|Overall Study|Withdrawal by Subject|4|||
130786103|NCT01673178|470844851|FG004|Overall Study|Withdrawal by Subject|2|||
130786104|NCT01673178|470844847|FG000|Overall Study|Protocol Violation|1|||
130786105|NCT01673178|470844848|FG001|Overall Study|Protocol Violation|1|||
130786106|NCT01673178|470844849|FG002|Overall Study|Protocol Violation|0|||
130786107|NCT01673178|470844850|FG003|Overall Study|Protocol Violation|1|||
130786108|NCT01673178|470844851|FG004|Overall Study|Protocol Violation|0|||
130786109|NCT01673178|470844847|FG000|Overall Study|Adverse Event|1|||
130786110|NCT01673178|470844848|FG001|Overall Study|Adverse Event|0|||
130786111|NCT01673178|470844849|FG002|Overall Study|Adverse Event|0|||
130786112|NCT01673178|470844850|FG003|Overall Study|Adverse Event|2|||
130786113|NCT01673178|470844851|FG004|Overall Study|Adverse Event|0|||
130786114|NCT01673178|470844847|FG000|Overall Study|Other|1|||
130738675|NCT03657797|470664219|FG000|Overall Study|Lost to Follow-up|0|||
130738676|NCT03657797|470664220|FG001|Overall Study|Lost to Follow-up|1|||
130738677|NCT03657797|470664221|FG002|Overall Study|Lost to Follow-up|1|||
130738678|NCT03657797|470664222|FG003|Overall Study|Lost to Follow-up|0|||
130738679|NCT03657797|470664219|FG000|Overall Study|Physician Decision|0|||
130738680|NCT03657797|470664220|FG001|Overall Study|Physician Decision|1|||
130738681|NCT03657797|470664221|FG002|Overall Study|Physician Decision|0|||
130738682|NCT03657797|470664222|FG003|Overall Study|Physician Decision|0|||
130738683|NCT03657797|470664219|FG000|Overall Study|Withdrawal by Subject|0|||
130738684|NCT03657797|470664220|FG001|Overall Study|Withdrawal by Subject|1|||
130738685|NCT03657797|470664221|FG002|Overall Study|Withdrawal by Subject|2|||
130738686|NCT03657797|470664222|FG003|Overall Study|Withdrawal by Subject|0|||
130738687|NCT03657797|470664219|FG000|Overall Study|Adverse Event|0|||
130738688|NCT03657797|470664220|FG001|Overall Study|Adverse Event|0|||
130738689|NCT03657797|470664221|FG002|Overall Study|Adverse Event|2|||
130738690|NCT03657797|470664222|FG003|Overall Study|Adverse Event|0|||
130738691|NCT00725283|470664223|FG000|Overall Study|Missing Code|3|||
130738692|NCT00725283|470664223|FG000|Overall Study|Death|5|||
130738693|NCT00725283|470664223|FG000|Overall Study|Other|6|||
130738694|NCT00725283|470664223|FG000|Overall Study|Withdrawal by Subject|10|||
130738695|NCT00696423|470664224|FG000|Overall Study|Lost to Follow-up|0|||
130738696|NCT00696423|470664225|FG001|Overall Study|Lost to Follow-up|5|||
130738697|NCT01996241|470664229|FG000|Overall Study|Lost to Follow-up|252|||
130738698|NCT01996241|470664230|FG001|Overall Study|Lost to Follow-up|235|||
130738699|NCT04515147|470664231|FG000|Overall Study|Withdrawal by Subject|1|||
130738700|NCT04515147|470664232|FG001|Overall Study|Withdrawal by Subject|0|||
130738701|NCT04515147|470664233|FG002|Overall Study|Withdrawal by Subject|10|||
130738702|NCT04515147|470664234|FG003|Overall Study|Withdrawal by Subject|18|||
130738703|NCT04515147|470664235|FG004|Overall Study|Withdrawal by Subject|1|||
130786115|NCT01673178|470844848|FG001|Overall Study|Other|0|||
130786116|NCT01673178|470844849|FG002|Overall Study|Other|2|||
130786117|NCT01673178|470844850|FG003|Overall Study|Other|1|||
130786118|NCT01673178|470844851|FG004|Overall Study|Other|0|||
130786119|NCT01419314|470844852|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
130786120|NCT01419314|470844853|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
130786121|NCT01419314|470844852|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
130786122|NCT01419314|470844853|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
130786123|NCT01419314|470844852|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
130786124|NCT01419314|470844853|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
130786125|NCT00402727|470844857|FG000|Overall Study|Adverse Event|10|||
130786126|NCT00402727|470844858|FG001|Overall Study|Adverse Event|6|||
130786127|NCT00402727|470844857|FG000|Overall Study|Death|1|||
130738704|NCT04515147|470664236|FG005|Overall Study|Withdrawal by Subject|8|||
130738705|NCT04515147|470664231|FG000|Overall Study|Lost to Follow-up|0|||
130738706|NCT04515147|470664232|FG001|Overall Study|Lost to Follow-up|1|||
130738707|NCT04515147|470664233|FG002|Overall Study|Lost to Follow-up|5|||
130738708|NCT04515147|470664234|FG003|Overall Study|Lost to Follow-up|6|||
130738709|NCT04515147|470664235|FG004|Overall Study|Lost to Follow-up|2|||
130738710|NCT04515147|470664236|FG005|Overall Study|Lost to Follow-up|1|||
130738711|NCT04515147|470664231|FG000|Overall Study|Adverse Event|0|||
130738712|NCT04515147|470664232|FG001|Overall Study|Adverse Event|0|||
130738713|NCT04515147|470664233|FG002|Overall Study|Adverse Event|0|||
130738714|NCT04515147|470664234|FG003|Overall Study|Adverse Event|2|||
130738715|NCT04515147|470664235|FG004|Overall Study|Adverse Event|0|||
130738716|NCT04515147|470664236|FG005|Overall Study|Adverse Event|0|||
130738717|NCT04515147|470664231|FG000|Overall Study|Miscellaneous|0|||
130738718|NCT04515147|470664232|FG001|Overall Study|Miscellaneous|0|||
130738719|NCT04515147|470664233|FG002|Overall Study|Miscellaneous|0|||
130738720|NCT04515147|470664234|FG003|Overall Study|Miscellaneous|1|||
130738721|NCT04515147|470664235|FG004|Overall Study|Miscellaneous|0|||
130738722|NCT04515147|470664236|FG005|Overall Study|Miscellaneous|1|||
130738723|NCT03052751|470664237|FG000|Dosing Period 1|Adverse Event|0|||
130738724|NCT03052751|470664238|FG001|Dosing Period 1|Adverse Event|1|||
130738725|NCT03052751|470664239|FG002|Dosing Period 1|Adverse Event|0|||
130738726|NCT03052751|470664240|FG003|Dosing Period 1|Adverse Event|0|||
130738727|NCT03052751|470664241|FG004|Dosing Period 1|Adverse Event|0|||
130738728|NCT03052751|470664242|FG005|Dosing Period 1|Adverse Event|0|||
130738729|NCT03052751|470664237|FG000|Dosing Period 2|Adverse Event|0|||
130738730|NCT03052751|470664238|FG001|Dosing Period 2|Adverse Event|0|||
130738731|NCT03052751|470664239|FG002|Dosing Period 2|Adverse Event|3|||
130738732|NCT03052751|470664240|FG003|Dosing Period 2|Adverse Event|0|||
130738733|NCT03052751|470664241|FG004|Dosing Period 2|Adverse Event|0|||
130738734|NCT03052751|470664242|FG005|Dosing Period 2|Adverse Event|0|||
130738735|NCT03052751|470664237|FG000|Observation Period|Adverse Event|0|||
130738736|NCT03052751|470664238|FG001|Observation Period|Adverse Event|0|||
130738737|NCT03052751|470664239|FG002|Observation Period|Adverse Event|0|||
130738738|NCT03052751|470664240|FG003|Observation Period|Adverse Event|0|||
130738739|NCT03052751|470664241|FG004|Observation Period|Adverse Event|1|||
130738740|NCT03052751|470664242|FG005|Observation Period|Adverse Event|0|||
130738741|NCT02719184|470664243|FG000|Overall Study|Other than listed|1|||
130738742|NCT02719184|470664244|FG001|Overall Study|Other than listed|12|||
130738743|NCT02719184|470664245|FG002|Overall Study|Other than listed|13|||
130738744|NCT02719184|470664246|FG003|Overall Study|Other than listed|22|||
130738745|NCT02719184|470664247|FG004|Overall Study|Other than listed|9|||
130738746|NCT02719184|470664243|FG000|Overall Study|Withdrawal by Subject|5|||
130738747|NCT02719184|470664244|FG001|Overall Study|Withdrawal by Subject|3|||
130738748|NCT02719184|470664245|FG002|Overall Study|Withdrawal by Subject|6|||
130738749|NCT02719184|470664246|FG003|Overall Study|Withdrawal by Subject|6|||
130738750|NCT02719184|470664247|FG004|Overall Study|Withdrawal by Subject|0|||
130738751|NCT02719184|470664243|FG000|Overall Study|Lost to Follow-up|0|||
130738752|NCT02719184|470664244|FG001|Overall Study|Lost to Follow-up|4|||
130738753|NCT02719184|470664245|FG002|Overall Study|Lost to Follow-up|1|||
130738754|NCT02719184|470664246|FG003|Overall Study|Lost to Follow-up|3|||
130738755|NCT02719184|470664247|FG004|Overall Study|Lost to Follow-up|0|||
130738756|NCT02719184|470664243|FG000|Overall Study|Protocol Violation|0|||
130786128|NCT00402727|470844858|FG001|Overall Study|Death|0|||
130786129|NCT00402727|470844857|FG000|Overall Study|Lack of Efficacy|1|||
130786130|NCT00402727|470844858|FG001|Overall Study|Lack of Efficacy|3|||
130738757|NCT02719184|470664244|FG001|Overall Study|Protocol Violation|3|||
130738758|NCT02719184|470664245|FG002|Overall Study|Protocol Violation|0|||
130738759|NCT02719184|470664246|FG003|Overall Study|Protocol Violation|2|||
130738760|NCT02719184|470664247|FG004|Overall Study|Protocol Violation|0|||
130738761|NCT02719184|470664243|FG000|Overall Study|Adverse Event|0|||
130786131|NCT00402727|470844857|FG000|Overall Study|Lost to Follow-up|24|||
130786132|NCT00402727|470844858|FG001|Overall Study|Lost to Follow-up|11|||
130786133|NCT00402727|470844857|FG000|Overall Study|Physician Decision|1|||
130786134|NCT00402727|470844858|FG001|Overall Study|Physician Decision|1|||
130786135|NCT00402727|470844857|FG000|Overall Study|Protocol Violation|0|||
130786136|NCT00402727|470844858|FG001|Overall Study|Protocol Violation|4|||
130786137|NCT00402727|470844857|FG000|Overall Study|Withdrawal by Subject|3|||
130786138|NCT00402727|470844858|FG001|Overall Study|Withdrawal by Subject|7|||
130786139|NCT00402727|470844857|FG000|Overall Study|supply problems|2|||
130786140|NCT00402727|470844858|FG001|Overall Study|supply problems|1|||
130786141|NCT00402727|470844857|FG000|Overall Study|non-compliance|0|||
130786142|NCT00402727|470844858|FG001|Overall Study|non-compliance|1|||
130786143|NCT01405898|470844859|FG000|Overall Study|Withdrawal by Subject|2|||
130786144|NCT01405898|470844860|FG001|Overall Study|Withdrawal by Subject|2|||
130786145|NCT03188055|470844861|FG000|Overall Study|Unavailable for training|0|||
130786146|NCT03188055|470844862|FG001|Overall Study|Unavailable for training|0|||
130786147|NCT03188055|470844863|FG002|Overall Study|Unavailable for training|19|||
130786148|NCT03188055|470844864|FG003|Overall Study|Unavailable for training|0|||
130786149|NCT03188055|470844865|FG004|Overall Study|Unavailable for training|0|||
130786150|NCT03188055|470844866|FG005|Overall Study|Unavailable for training|0|||
130786151|NCT03188055|470844861|FG000|Overall Study|Lost to Follow-up|0|||
130786152|NCT03188055|470844862|FG001|Overall Study|Lost to Follow-up|18|||
130786153|NCT03188055|470844863|FG002|Overall Study|Lost to Follow-up|0|||
130786154|NCT03188055|470844864|FG003|Overall Study|Lost to Follow-up|11|||
130786155|NCT03188055|470844865|FG004|Overall Study|Lost to Follow-up|0|||
130786156|NCT03188055|470844866|FG005|Overall Study|Lost to Follow-up|0|||
130786157|NCT03188055|470844861|FG000|Overall Study|Withdrawal by Subject|0|||
130786158|NCT03188055|470844862|FG001|Overall Study|Withdrawal by Subject|1|||
130786159|NCT03188055|470844863|FG002|Overall Study|Withdrawal by Subject|0|||
130786160|NCT03188055|470844864|FG003|Overall Study|Withdrawal by Subject|1|||
130786161|NCT03188055|470844865|FG004|Overall Study|Withdrawal by Subject|0|||
130786162|NCT03188055|470844866|FG005|Overall Study|Withdrawal by Subject|0|||
130786163|NCT00264147|470844879|FG000|Treatment I Period|Adverse Event|3|||
130786164|NCT00264147|470844880|FG001|Treatment I Period|Adverse Event|6|||
130786165|NCT00264147|470844881|FG002|Treatment I Period|Adverse Event|3|||
130786166|NCT00264147|470844882|FG003|Treatment I Period|Adverse Event|5|||
130786167|NCT00264147|470844883|FG004|Treatment I Period|Adverse Event|7|||
130786168|NCT00264147|470844884|FG005|Treatment I Period|Adverse Event|0|||
130786169|NCT00264147|470844879|FG000|Treatment I Period|Laboratory Adverse Event|0|||
130786170|NCT00264147|470844880|FG001|Treatment I Period|Laboratory Adverse Event|0|||
130786171|NCT00264147|470844881|FG002|Treatment I Period|Laboratory Adverse Event|0|||
130786172|NCT00264147|470844882|FG003|Treatment I Period|Laboratory Adverse Event|1|||
130786173|NCT00264147|470844883|FG004|Treatment I Period|Laboratory Adverse Event|0|||
130786174|NCT00264147|470844884|FG005|Treatment I Period|Laboratory Adverse Event|0|||
130786175|NCT00264147|470844879|FG000|Treatment I Period|Lack of Efficacy|6|||
130786176|NCT00264147|470844880|FG001|Treatment I Period|Lack of Efficacy|2|||
130786177|NCT00264147|470844881|FG002|Treatment I Period|Lack of Efficacy|8|||
130786178|NCT00264147|470844882|FG003|Treatment I Period|Lack of Efficacy|0|||
130786179|NCT00264147|470844883|FG004|Treatment I Period|Lack of Efficacy|1|||
130786180|NCT00264147|470844884|FG005|Treatment I Period|Lack of Efficacy|0|||
130786181|NCT00264147|470844879|FG000|Treatment I Period|Lost to Follow-up|1|||
130786182|NCT00264147|470844880|FG001|Treatment I Period|Lost to Follow-up|0|||
130786183|NCT00264147|470844881|FG002|Treatment I Period|Lost to Follow-up|0|||
130786184|NCT00264147|470844882|FG003|Treatment I Period|Lost to Follow-up|1|||
130786185|NCT00264147|470844883|FG004|Treatment I Period|Lost to Follow-up|1|||
130786186|NCT00264147|470844884|FG005|Treatment I Period|Lost to Follow-up|0|||
130786187|NCT00264147|470844879|FG000|Treatment I Period|Protocol Violation|2|||
130786188|NCT00264147|470844880|FG001|Treatment I Period|Protocol Violation|2|||
130786189|NCT00264147|470844881|FG002|Treatment I Period|Protocol Violation|0|||
130786190|NCT00264147|470844882|FG003|Treatment I Period|Protocol Violation|0|||
130786191|NCT00264147|470844883|FG004|Treatment I Period|Protocol Violation|0|||
130786192|NCT00264147|470844884|FG005|Treatment I Period|Protocol Violation|0|||
130786193|NCT00264147|470844879|FG000|Treatment I Period|Withdrawal by Subject|2|||
130786194|NCT00264147|470844880|FG001|Treatment I Period|Withdrawal by Subject|0|||
130786195|NCT00264147|470844881|FG002|Treatment I Period|Withdrawal by Subject|0|||
130786196|NCT00264147|470844882|FG003|Treatment I Period|Withdrawal by Subject|2|||
130786197|NCT00264147|470844883|FG004|Treatment I Period|Withdrawal by Subject|2|||
130738762|NCT02719184|470664244|FG001|Overall Study|Adverse Event|0|||
130738763|NCT02719184|470664245|FG002|Overall Study|Adverse Event|0|||
130738764|NCT02719184|470664246|FG003|Overall Study|Adverse Event|3|||
130738765|NCT02719184|470664247|FG004|Overall Study|Adverse Event|0|||
130738766|NCT02439216|470664248|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
130738767|NCT02439216|470664249|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130738768|NCT02439216|470664250|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130738769|NCT02439216|470664251|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130738770|NCT02439216|470664252|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130738771|NCT02439216|470664253|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130738772|NCT02439216|470664254|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130738773|NCT02439216|470664255|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130738774|NCT02439216|470664256|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130738775|NCT02439216|470664248|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130738776|NCT02439216|470664249|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130738777|NCT02439216|470664250|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130738778|NCT02439216|470664251|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130738779|NCT02439216|470664252|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130738780|NCT02439216|470664253|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130738781|NCT02439216|470664254|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130738782|NCT02439216|470664255|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
130738783|NCT02439216|470664256|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130738784|NCT02439216|470664248|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130738785|NCT02439216|470664249|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130738786|NCT02439216|470664250|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130738787|NCT02439216|470664251|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130738788|NCT02439216|470664252|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130738789|NCT02439216|470664253|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130738790|NCT02439216|470664254|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130738791|NCT02439216|470664255|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
130738792|NCT02439216|470664256|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
130738793|NCT02439216|470664248|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130738794|NCT02439216|470664249|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130738795|NCT02439216|470664250|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130738796|NCT02439216|470664251|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130738797|NCT02439216|470664252|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130738798|NCT02439216|470664253|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130738799|NCT02439216|470664254|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130738800|NCT02439216|470664255|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130738801|NCT02439216|470664256|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
130738802|NCT02439216|470664248|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130822739|NCT00812955|470980592|FG003|Overall Study|Adverse Event|4|||
130738803|NCT02439216|470664249|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130738804|NCT02439216|470664250|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130738805|NCT02439216|470664251|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130738806|NCT02439216|470664252|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130738807|NCT02439216|470664253|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130786198|NCT00264147|470844884|FG005|Treatment I Period|Withdrawal by Subject|0|||
130786199|NCT00264147|470844879|FG000|Treatment I Period|Patient out of town for an extended time|0|||
130786200|NCT00264147|470844880|FG001|Treatment I Period|Patient out of town for an extended time|1|||
130786201|NCT00264147|470844881|FG002|Treatment I Period|Patient out of town for an extended time|0|||
130786202|NCT00264147|470844882|FG003|Treatment I Period|Patient out of town for an extended time|0|||
130786203|NCT00264147|470844883|FG004|Treatment I Period|Patient out of town for an extended time|0|||
130786204|NCT00264147|470844884|FG005|Treatment I Period|Patient out of town for an extended time|0|||
130786205|NCT00264147|470844879|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130786206|NCT00264147|470844880|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130786207|NCT00264147|470844881|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
130786208|NCT00264147|470844882|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130786209|NCT00264147|470844883|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130786210|NCT00264147|470844884|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130786211|NCT00264147|470844879|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
130786212|NCT00264147|470844880|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
130786213|NCT00264147|470844881|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
130786214|NCT00264147|470844882|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
130786215|NCT00264147|470844883|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
130786216|NCT00264147|470844884|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
130786217|NCT00264147|470844879|FG000|Treatment II Period|Adverse Event|0|||
130786218|NCT00264147|470844880|FG001|Treatment II Period|Adverse Event|0|||
130786219|NCT00264147|470844881|FG002|Treatment II Period|Adverse Event|0|||
130786220|NCT00264147|470844882|FG003|Treatment II Period|Adverse Event|0|||
130786221|NCT00264147|470844883|FG004|Treatment II Period|Adverse Event|9|||
130786222|NCT00264147|470844884|FG005|Treatment II Period|Adverse Event|9|||
130786223|NCT00264147|470844879|FG000|Treatment II Period|Laboratory Adverse Event|0|||
130786224|NCT00264147|470844880|FG001|Treatment II Period|Laboratory Adverse Event|0|||
130786225|NCT00264147|470844881|FG002|Treatment II Period|Laboratory Adverse Event|0|||
130786226|NCT00264147|470844882|FG003|Treatment II Period|Laboratory Adverse Event|0|||
130786227|NCT00264147|470844883|FG004|Treatment II Period|Laboratory Adverse Event|0|||
130786228|NCT00264147|470844884|FG005|Treatment II Period|Laboratory Adverse Event|1|||
130786229|NCT00264147|470844879|FG000|Treatment II Period|Lack of Efficacy|0|||
130786230|NCT00264147|470844880|FG001|Treatment II Period|Lack of Efficacy|0|||
130786231|NCT00264147|470844881|FG002|Treatment II Period|Lack of Efficacy|0|||
130786232|NCT00264147|470844882|FG003|Treatment II Period|Lack of Efficacy|0|||
130786233|NCT00264147|470844883|FG004|Treatment II Period|Lack of Efficacy|20|||
130786234|NCT00264147|470844884|FG005|Treatment II Period|Lack of Efficacy|19|||
130786235|NCT00264147|470844879|FG000|Treatment II Period|Lost to Follow-up|0|||
130786236|NCT00264147|470844880|FG001|Treatment II Period|Lost to Follow-up|0|||
130786237|NCT00264147|470844881|FG002|Treatment II Period|Lost to Follow-up|0|||
130786238|NCT00264147|470844882|FG003|Treatment II Period|Lost to Follow-up|0|||
130786239|NCT00264147|470844883|FG004|Treatment II Period|Lost to Follow-up|1|||
130786240|NCT00264147|470844884|FG005|Treatment II Period|Lost to Follow-up|1|||
130786241|NCT00264147|470844879|FG000|Treatment II Period|Withdrawal by Subject|0|||
130786242|NCT00264147|470844880|FG001|Treatment II Period|Withdrawal by Subject|0|||
130786243|NCT00264147|470844881|FG002|Treatment II Period|Withdrawal by Subject|0|||
130786244|NCT00264147|470844882|FG003|Treatment II Period|Withdrawal by Subject|0|||
130786245|NCT00264147|470844883|FG004|Treatment II Period|Withdrawal by Subject|3|||
130786246|NCT00264147|470844884|FG005|Treatment II Period|Withdrawal by Subject|2|||
130786247|NCT00264147|470844879|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
130786248|NCT00264147|470844880|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
130786249|NCT00264147|470844881|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
130786250|NCT00264147|470844882|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
130786251|NCT00264147|470844883|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
130786252|NCT00264147|470844884|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
130786253|NCT03234465|470844885|FG000|Overall Study|Adverse Event|4|||
130786254|NCT03234465|470844886|FG001|Overall Study|Adverse Event|2|||
130786255|NCT03234465|470844885|FG000|Overall Study|Death|0|||
130786256|NCT03234465|470844886|FG001|Overall Study|Death|1|||
130786257|NCT03234465|470844885|FG000|Overall Study|Lost to Follow-up|1|||
130786258|NCT03234465|470844886|FG001|Overall Study|Lost to Follow-up|1|||
130786259|NCT03234465|470844885|FG000|Overall Study|Withdrawal by Subject|12|||
130786260|NCT03234465|470844886|FG001|Overall Study|Withdrawal by Subject|27|||
130786261|NCT03234465|470844885|FG000|Overall Study|Symptomatic deterioration|0|||
130786262|NCT03234465|470844886|FG001|Overall Study|Symptomatic deterioration|1|||
130786263|NCT03234465|470844885|FG000|Overall Study|Non-compliance|2|||
130786264|NCT03234465|470844886|FG001|Overall Study|Non-compliance|0|||
130786265|NCT03234465|470844885|FG000|Overall Study|Other|14|||
130786266|NCT03234465|470844886|FG001|Overall Study|Other|8|||
130786267|NCT01118052|470844887|FG000|Overall Study|Never treated|2|||
130738808|NCT02439216|470664254|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130738809|NCT02439216|470664255|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
130738810|NCT02439216|470664256|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
130738811|NCT02094300|470664257|FG000|Overall Study|Death|7|||
130738812|NCT02094300|470664257|FG000|Overall Study|Lost to Follow-up|10|||
130738813|NCT02094300|470664257|FG000|Overall Study|Still be eligible for follow-up|3|||
130738814|NCT01050530|470664261|FG000|Overall Study|Adverse Event|6|||
130738815|NCT01050530|470664262|FG001|Overall Study|Adverse Event|3|||
130738816|NCT01050530|470664261|FG000|Overall Study|Lack of Efficacy|1|||
130738817|NCT01050530|470664262|FG001|Overall Study|Lack of Efficacy|4|||
130738818|NCT01050530|470664261|FG000|Overall Study|Withdrawal by Subject|0|||
130738819|NCT01050530|470664262|FG001|Overall Study|Withdrawal by Subject|3|||
130738820|NCT01050530|470664261|FG000|Overall Study|Protocol Violation|1|||
130738821|NCT01050530|470664262|FG001|Overall Study|Protocol Violation|0|||
130738822|NCT02288312|470664265|FG000|Overall Study|Pregnancy|1|||
130738823|NCT02288312|470664266|FG001|Overall Study|Pregnancy|0|||
130738824|NCT02288312|470664267|FG002|Overall Study|Pregnancy|0|||
130738825|NCT01276041|470664268|FG000|Overall Study|Adverse Event|2|||
130738826|NCT01276041|470664268|FG000|Overall Study|Protocol Violation|1|||
130738827|NCT00485264|470664275|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
130738828|NCT00485264|470664276|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
130738829|NCT00485264|470664277|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
130738830|NCT00485264|470664278|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
130738831|NCT00485264|470664279|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
130738832|NCT00485264|470664280|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
130738833|NCT00485264|470664275|FG000|Overall Study|Death|1|||
130738834|NCT00485264|470664276|FG001|Overall Study|Death|0|||
130738835|NCT00485264|470664277|FG002|Overall Study|Death|0|||
130738836|NCT00485264|470664278|FG003|Overall Study|Death|0|||
130738837|NCT00485264|470664279|FG004|Overall Study|Death|1|||
130738838|NCT00485264|470664280|FG005|Overall Study|Death|0|||
130738839|NCT00485264|470664275|FG000|Overall Study|Adverse Event|1|||
130738840|NCT00485264|470664276|FG001|Overall Study|Adverse Event|0|||
130738841|NCT00485264|470664277|FG002|Overall Study|Adverse Event|2|||
130738842|NCT00485264|470664278|FG003|Overall Study|Adverse Event|3|||
130738843|NCT00485264|470664279|FG004|Overall Study|Adverse Event|1|||
130738844|NCT00485264|470664280|FG005|Overall Study|Adverse Event|3|||
130738845|NCT00485264|470664275|FG000|Overall Study|Pregnancy|4|||
130738846|NCT00485264|470664276|FG001|Overall Study|Pregnancy|0|||
130738847|NCT00485264|470664277|FG002|Overall Study|Pregnancy|0|||
130738848|NCT00485264|470664278|FG003|Overall Study|Pregnancy|0|||
130738849|NCT00485264|470664279|FG004|Overall Study|Pregnancy|0|||
130738850|NCT00485264|470664280|FG005|Overall Study|Pregnancy|0|||
130738851|NCT00485264|470664275|FG000|Overall Study|Disallowed Medication|0|||
130738852|NCT00485264|470664276|FG001|Overall Study|Disallowed Medication|0|||
130738853|NCT00485264|470664277|FG002|Overall Study|Disallowed Medication|0|||
130738854|NCT00485264|470664278|FG003|Overall Study|Disallowed Medication|0|||
130738855|NCT00485264|470664279|FG004|Overall Study|Disallowed Medication|0|||
130738856|NCT00485264|470664280|FG005|Overall Study|Disallowed Medication|1|||
130738857|NCT00485264|470664275|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
130738858|NCT00485264|470664276|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
130738859|NCT00485264|470664277|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
130738860|NCT00485264|470664278|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
130738861|NCT00485264|470664279|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
130738862|NCT00485264|470664280|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
130738863|NCT00485264|470664275|FG000|Overall Study|Lack of Efficacy|0|||
130738864|NCT00485264|470664276|FG001|Overall Study|Lack of Efficacy|1|||
130738865|NCT00485264|470664277|FG002|Overall Study|Lack of Efficacy|0|||
130738866|NCT00485264|470664278|FG003|Overall Study|Lack of Efficacy|0|||
130738867|NCT00485264|470664279|FG004|Overall Study|Lack of Efficacy|0|||
130738868|NCT00485264|470664280|FG005|Overall Study|Lack of Efficacy|0|||
130738869|NCT00485264|470664275|FG000|Overall Study|Guardian Consent Withdrawn|1|||
130738870|NCT00485264|470664276|FG001|Overall Study|Guardian Consent Withdrawn|0|||
130738871|NCT00485264|470664277|FG002|Overall Study|Guardian Consent Withdrawn|0|||
130738872|NCT00485264|470664278|FG003|Overall Study|Guardian Consent Withdrawn|0|||
130738873|NCT00485264|470664279|FG004|Overall Study|Guardian Consent Withdrawn|1|||
130738874|NCT00485264|470664280|FG005|Overall Study|Guardian Consent Withdrawn|0|||
130738875|NCT00485264|470664275|FG000|Overall Study|Physician Decision|0|||
130738876|NCT00485264|470664276|FG001|Overall Study|Physician Decision|2|||
130738877|NCT00485264|470664277|FG002|Overall Study|Physician Decision|0|||
130738878|NCT00485264|470664278|FG003|Overall Study|Physician Decision|0|||
130738879|NCT00485264|470664279|FG004|Overall Study|Physician Decision|0|||
130738880|NCT00485264|470664280|FG005|Overall Study|Physician Decision|0|||
130738881|NCT00485264|470664275|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130738882|NCT00485264|470664276|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130738883|NCT00485264|470664277|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
130738884|NCT00485264|470664278|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130738885|NCT00485264|470664279|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130786268|NCT02949947|470844888|FG000|Overall Study|Non Compliance|0|||
130786269|NCT02949947|470844889|FG001|Overall Study|Non Compliance|1|||
130786270|NCT02949947|470844888|FG000|Overall Study|Insurance change|1|||
130786271|NCT02949947|470844889|FG001|Overall Study|Insurance change|0|||
130786272|NCT00828711|470844891|FG000|Overall Study|Lost to Follow-up|1|||
130786273|NCT00828711|470844892|FG001|Overall Study|Lost to Follow-up|0|||
130786274|NCT00828711|470844893|FG002|Overall Study|Lost to Follow-up|0|||
130786275|NCT01618968|470844894|FG000|Overall Study|Adverse Event|1|||
130786276|NCT01618968|470844895|FG001|Overall Study|Adverse Event|0|||
130786277|NCT01618968|470844896|FG002|Overall Study|Adverse Event|0|||
130786278|NCT01618968|470844897|FG003|Overall Study|Adverse Event|0|||
130786279|NCT01618968|470844894|FG000|Overall Study|Death|0|||
130786280|NCT01618968|470844895|FG001|Overall Study|Death|0|||
130786281|NCT01618968|470844896|FG002|Overall Study|Death|0|||
130786282|NCT01618968|470844897|FG003|Overall Study|Death|1|||
130786283|NCT02230891|470844898|FG000|Baseline|Did not meet inclusion|0|||
130786284|NCT02230891|470844899|FG001|Baseline|Did not meet inclusion|1|||
130786285|NCT02230891|470844900|FG002|Baseline|Did not meet inclusion|1|||
130786286|NCT02230891|470844898|FG000|2 Week|Withdrawal by Subject|2|||
130786287|NCT02230891|470844899|FG001|2 Week|Withdrawal by Subject|2|||
130786288|NCT02230891|470844900|FG002|2 Week|Withdrawal by Subject|0|||
130786289|NCT02230891|470844898|FG000|2 Week|Consent withdrawn|1|||
130786290|NCT02230891|470844899|FG001|2 Week|Consent withdrawn|0|||
130786291|NCT02230891|470844900|FG002|2 Week|Consent withdrawn|0|||
130786292|NCT02230891|470844898|FG000|6 Month|Withdrawal by Subject|1|||
130786293|NCT02230891|470844899|FG001|6 Month|Withdrawal by Subject|1|||
130786294|NCT02230891|470844900|FG002|6 Month|Withdrawal by Subject|1|||
130786295|NCT02230891|470844898|FG000|6 Month|Physician Decision|0|||
130786296|NCT02230891|470844899|FG001|6 Month|Physician Decision|2|||
130786297|NCT02230891|470844900|FG002|6 Month|Physician Decision|0|||
130786298|NCT02230891|470844898|FG000|12 Month|Death|1|||
130786299|NCT02230891|470844899|FG001|12 Month|Death|0|||
130786300|NCT02230891|470844900|FG002|12 Month|Death|0|||
130786301|NCT02230891|470844898|FG000|12 Month|Lost to Follow-up|0|||
130786302|NCT02230891|470844899|FG001|12 Month|Lost to Follow-up|1|||
130786303|NCT02230891|470844900|FG002|12 Month|Lost to Follow-up|0|||
130786304|NCT02230891|470844898|FG000|12 Month|Withdrawal by Subject|0|||
130786305|NCT02230891|470844899|FG001|12 Month|Withdrawal by Subject|2|||
130786306|NCT02230891|470844900|FG002|12 Month|Withdrawal by Subject|0|||
130786307|NCT02230891|470844898|FG000|18 Month End of Study|Death|0|||
130786308|NCT02230891|470844899|FG001|18 Month End of Study|Death|0|||
130786309|NCT02230891|470844900|FG002|18 Month End of Study|Death|1|||
130786310|NCT02230891|470844898|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
130786311|NCT02230891|470844899|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
130786312|NCT02230891|470844900|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
130786313|NCT02370511|470844903|FG000|Overall Study|Death|10|||
130786314|NCT02370511|470844904|FG001|Overall Study|Death|7|||
130786315|NCT02370511|470844905|FG002|Overall Study|Death|1|||
130786316|NCT02370511|470844903|FG000|Overall Study|Withdrawal by Subject|2|||
130786317|NCT02370511|470844904|FG001|Overall Study|Withdrawal by Subject|0|||
130786318|NCT02370511|470844905|FG002|Overall Study|Withdrawal by Subject|0|||
130786319|NCT02370511|470844903|FG000|Overall Study|Lost to Follow-up|0|||
130786320|NCT02370511|470844904|FG001|Overall Study|Lost to Follow-up|4|||
130786321|NCT02370511|470844905|FG002|Overall Study|Lost to Follow-up|0|||
130786322|NCT03882918|470844913|FG000|Overall Study|Study terminated by sponsor|98|||
130786323|NCT03882918|470844913|FG000|Overall Study|Protocol Violation|1|||
130786324|NCT03882918|470844913|FG000|Overall Study|Other|9|||
130786325|NCT03882918|470844913|FG000|Overall Study|Lack of Efficacy|14|||
130786326|NCT03882918|470844913|FG000|Overall Study|Adverse Event|13|||
130786327|NCT03882918|470844913|FG000|Overall Study|Withdrawal by Subject|5|||
130786328|NCT02100124|470844919|FG000|Overall Study|Lost to Follow-up|5|||
130786329|NCT02100124|470844920|FG001|Overall Study|Lost to Follow-up|11|||
130786330|NCT02100124|470844921|FG002|Overall Study|Lost to Follow-up|3|||
130786331|NCT02100124|470844919|FG000|Overall Study|Withdrawal by Subject|1|||
130786332|NCT02100124|470844920|FG001|Overall Study|Withdrawal by Subject|0|||
130786333|NCT02100124|470844921|FG002|Overall Study|Withdrawal by Subject|0|||
130786334|NCT00870727|470846958|FG000|Overall Study|Lost to Follow-up|0|||
130786335|NCT00870727|470846959|FG001|Overall Study|Lost to Follow-up|1|||
130786336|NCT00870727|470846958|FG000|Overall Study|Lack of Efficacy|1|||
130786337|NCT00870727|470846959|FG001|Overall Study|Lack of Efficacy|3|||
130786338|NCT00870727|470846958|FG000|Overall Study|Adverse Event|0|||
130786339|NCT00870727|470846959|FG001|Overall Study|Adverse Event|1|||
130786340|NCT01586195|470846963|FG000|Overall Study|Death|11|||
130786341|NCT01586195|470846963|FG000|Overall Study|Withdrawal of Consent|5|||
130786342|NCT01586195|470846963|FG000|Overall Study|Started new anti-melanoma therapy|1|||
130786343|NCT01586195|470846963|FG000|Overall Study|Reason not specified|9|||
130786344|NCT00997334|470846964|FG000|Overall Study|still on therapy|12|||
130786345|NCT00997334|470846964|FG000|Overall Study|Adverse Event|3|||
130786346|NCT00997334|470846964|FG000|Overall Study|Patient non-compliance|1|||
130786347|NCT00997334|470846964|FG000|Overall Study|Withdrawal by Subject|3|||
130786348|NCT00997334|470846964|FG000|Overall Study|Death|2|||
130786349|NCT00997334|470846964|FG000|Overall Study|Urgent Palliative Care|2|||
130786350|NCT00997334|470846964|FG000|Overall Study|No lesion amenable|1|||
130786351|NCT00997334|470846964|FG000|Overall Study|Ineligible|1|||
130786352|NCT04745351|470846976|FG000|Overall Study|Death|51|||
130786353|NCT04745351|470846977|FG001|Overall Study|Death|25|||
130786354|NCT04745351|470846976|FG000|Overall Study|Lost to Follow-up|9|||
130786355|NCT04745351|470846977|FG001|Overall Study|Lost to Follow-up|3|||
130786356|NCT04745351|470846976|FG000|Overall Study|Randomized but Never Treated|3|||
130786357|NCT04745351|470846977|FG001|Overall Study|Randomized but Never Treated|3|||
130786358|NCT04745351|470846976|FG000|Overall Study|Adverse Event|4|||
130786359|NCT04745351|470846977|FG001|Overall Study|Adverse Event|0|||
130786360|NCT04745351|470846976|FG000|Overall Study|Withdrew Consent|1|||
130786361|NCT04745351|470846977|FG001|Overall Study|Withdrew Consent|2|||
130786362|NCT04745351|470846976|FG000|Overall Study|Investigator's Discretion|2|||
130786363|NCT04745351|470846977|FG001|Overall Study|Investigator's Discretion|0|||
130786364|NCT04745351|470846976|FG000|Overall Study|Protocol Violation|1|||
130786365|NCT04745351|470846977|FG001|Overall Study|Protocol Violation|0|||
130786366|NCT01863771|470846980|FG000|Induction Phase|Adverse Event|9|||
130786367|NCT01863771|470846981|FG001|Induction Phase|Adverse Event|0|||
130786368|NCT01863771|470846982|FG002|Induction Phase|Adverse Event|0|||
130786369|NCT01863771|470846983|FG003|Induction Phase|Adverse Event|0|||
130786370|NCT01863771|470846980|FG000|Induction Phase|Lack of Efficacy|10|||
130786371|NCT01863771|470846981|FG001|Induction Phase|Lack of Efficacy|0|||
130786372|NCT01863771|470846982|FG002|Induction Phase|Lack of Efficacy|0|||
130786373|NCT01863771|470846983|FG003|Induction Phase|Lack of Efficacy|0|||
130786374|NCT01863771|470846980|FG000|Induction Phase|Withdrawal by Subject|2|||
130786375|NCT01863771|470846981|FG001|Induction Phase|Withdrawal by Subject|0|||
130786376|NCT01863771|470846982|FG002|Induction Phase|Withdrawal by Subject|0|||
130786377|NCT01863771|470846983|FG003|Induction Phase|Withdrawal by Subject|0|||
130738886|NCT00485264|470664280|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130738887|NCT00485264|470664275|FG000|Overall Study|Not Able to Attend Clinic|5|||
130738888|NCT00485264|470664276|FG001|Overall Study|Not Able to Attend Clinic|0|||
130738889|NCT00485264|470664277|FG002|Overall Study|Not Able to Attend Clinic|0|||
130738890|NCT00485264|470664278|FG003|Overall Study|Not Able to Attend Clinic|1|||
130738891|NCT00485264|470664279|FG004|Overall Study|Not Able to Attend Clinic|1|||
130738892|NCT00485264|470664280|FG005|Overall Study|Not Able to Attend Clinic|2|||
130738893|NCT00485264|470664275|FG000|Overall Study|Non-Compliant|17|||
130738894|NCT00485264|470664276|FG001|Overall Study|Non-Compliant|2|||
130738895|NCT00485264|470664277|FG002|Overall Study|Non-Compliant|1|||
130738896|NCT00485264|470664278|FG003|Overall Study|Non-Compliant|0|||
130738897|NCT00485264|470664279|FG004|Overall Study|Non-Compliant|1|||
130738898|NCT00485264|470664280|FG005|Overall Study|Non-Compliant|0|||
130738899|NCT00485264|470664275|FG000|Overall Study|Lost to Follow-up|2|||
130738900|NCT00485264|470664276|FG001|Overall Study|Lost to Follow-up|1|||
130738901|NCT00485264|470664277|FG002|Overall Study|Lost to Follow-up|1|||
130738902|NCT00485264|470664278|FG003|Overall Study|Lost to Follow-up|0|||
130738903|NCT00485264|470664279|FG004|Overall Study|Lost to Follow-up|0|||
130738904|NCT00485264|470664280|FG005|Overall Study|Lost to Follow-up|1|||
130738905|NCT00485264|470664275|FG000|Overall Study|Other Reason|3|||
130738906|NCT00485264|470664276|FG001|Overall Study|Other Reason|0|||
130738907|NCT00485264|470664277|FG002|Overall Study|Other Reason|0|||
130738908|NCT00485264|470664278|FG003|Overall Study|Other Reason|0|||
130738909|NCT00485264|470664279|FG004|Overall Study|Other Reason|0|||
130738910|NCT00485264|470664280|FG005|Overall Study|Other Reason|0|||
130738911|NCT00654095|470664282|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
130738912|NCT00654095|470664282|FG000|Overall Study|Elevated triglyceride level (2)|1|||
130738913|NCT00654095|470664282|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
130738914|NCT00654095|470664282|FG000|Overall Study|Adverse Event|11|||
130738915|NCT00654095|470664282|FG000|Overall Study|Withdrawal by Subject|5|||
130738916|NCT00654095|470664282|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
130738917|NCT00654095|470664282|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
130738918|NCT00654095|470664282|FG000|Overall Study|Did not meet inclusion criteria|1|||
130738919|NCT02440464|470664283|FG000|Overall Study|Withdrawal by Subject|3|||
130738920|NCT02440464|470664284|FG001|Overall Study|Withdrawal by Subject|2|||
130738921|NCT04620746|470664300|FG000|Overall Study|Adverse Event|2|||
130738922|NCT04620746|470664301|FG001|Overall Study|Adverse Event|0|||
130786378|NCT01863771|470846980|FG000|Maintenance Phase|Adverse Event|0|||
130786379|NCT01863771|470846981|FG001|Maintenance Phase|Adverse Event|0|||
130786380|NCT01863771|470846982|FG002|Maintenance Phase|Adverse Event|1|||
130786381|NCT01863771|470846983|FG003|Maintenance Phase|Adverse Event|1|||
130738923|NCT04620746|470664300|FG000|Overall Study|Uniterpretable skin test|1|||
130738924|NCT04620746|470664301|FG001|Overall Study|Uniterpretable skin test|0|||
130786382|NCT01863771|470846980|FG000|Maintenance Phase|Lack of Efficacy|0|||
130786383|NCT01863771|470846981|FG001|Maintenance Phase|Lack of Efficacy|3|||
130738925|NCT04620746|470664300|FG000|Overall Study|Withdrawal by Subject|0|||
130738926|NCT04620746|470664301|FG001|Overall Study|Withdrawal by Subject|1|||
130738927|NCT03411863|470664302|FG000|Overall Study|Withdrawal by Subject|3|||
130738928|NCT03411863|470664303|FG001|Overall Study|Withdrawal by Subject|1|||
130786384|NCT01863771|470846982|FG002|Maintenance Phase|Lack of Efficacy|7|||
130786385|NCT01863771|470846983|FG003|Maintenance Phase|Lack of Efficacy|38|||
130786386|NCT01863771|470846980|FG000|Maintenance Phase|Physician Decision|0|||
130786387|NCT01863771|470846981|FG001|Maintenance Phase|Physician Decision|0|||
130786388|NCT01863771|470846982|FG002|Maintenance Phase|Physician Decision|2|||
130786389|NCT01863771|470846983|FG003|Maintenance Phase|Physician Decision|1|||
130786390|NCT01863771|470846980|FG000|Maintenance Phase|Pregnancy|0|||
130786391|NCT01863771|470846981|FG001|Maintenance Phase|Pregnancy|1|||
130786392|NCT01863771|470846982|FG002|Maintenance Phase|Pregnancy|0|||
130786393|NCT01863771|470846983|FG003|Maintenance Phase|Pregnancy|0|||
130786394|NCT01863771|470846980|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130786395|NCT01863771|470846981|FG001|Maintenance Phase|Withdrawal by Subject|1|||
130786396|NCT01863771|470846982|FG002|Maintenance Phase|Withdrawal by Subject|2|||
130786397|NCT01863771|470846983|FG003|Maintenance Phase|Withdrawal by Subject|3|||
130786398|NCT03426345|470846984|FG000|Overall Study|Adverse Event|4|||
130786399|NCT03426345|470846985|FG001|Overall Study|Adverse Event|4|||
130786400|NCT03426345|470846984|FG000|Overall Study|Lack of Efficacy|1|||
130786401|NCT03426345|470846985|FG001|Overall Study|Lack of Efficacy|0|||
130786402|NCT03426345|470846984|FG000|Overall Study|Withdrawal by Subject|5|||
130786403|NCT03426345|470846985|FG001|Overall Study|Withdrawal by Subject|6|||
130786404|NCT03426345|470846984|FG000|Overall Study|Lost to Follow-up|3|||
130786405|NCT03426345|470846985|FG001|Overall Study|Lost to Follow-up|1|||
130786406|NCT03426345|470846984|FG000|Overall Study|Protocol Deviation|3|||
130786407|NCT03426345|470846985|FG001|Overall Study|Protocol Deviation|4|||
130786408|NCT03426345|470846984|FG000|Overall Study|Reason Not Specified|1|||
130786409|NCT03426345|470846985|FG001|Overall Study|Reason Not Specified|2|||
130786410|NCT03426345|470846984|FG000|Overall Study|Missing Completion Status|1|||
130786411|NCT03426345|470846985|FG001|Overall Study|Missing Completion Status|0|||
130786412|NCT02446691|470846986|FG000|Overall Study|Withdrawal by Subject|2|||
130786413|NCT02446691|470846986|FG000|Overall Study|Lost to Follow-up|8|||
130786414|NCT02446691|470846986|FG000|Overall Study|Protocol Violation|1|||
130786415|NCT02497469|470846987|FG000|Overall Study|Randomized but not Treated|0|||
130786416|NCT02497469|470846988|FG001|Overall Study|Randomized but not Treated|2|||
130786417|NCT02497469|470846987|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
130786418|NCT02497469|470846988|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
130786419|NCT02497469|470846987|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
130786420|NCT02497469|470846988|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
130786421|NCT02497469|470846987|FG000|Overall Study|Significant Protocol Deviation|4|||
130786422|NCT02497469|470846988|FG001|Overall Study|Significant Protocol Deviation|5|||
130786423|NCT02497469|470846987|FG000|Overall Study|Lost to Follow-up|14|||
130786424|NCT02497469|470846988|FG001|Overall Study|Lost to Follow-up|4|||
130786425|NCT02497469|470846987|FG000|Overall Study|Voluntary Withdrawal|39|||
130786426|NCT02497469|470846988|FG001|Overall Study|Voluntary Withdrawal|41|||
130786427|NCT02497469|470846987|FG000|Overall Study|Pregnancy|1|||
130786428|NCT02497469|470846988|FG001|Overall Study|Pregnancy|1|||
130786429|NCT02497469|470846987|FG000|Overall Study|Lack of Efficacy|86|||
130786430|NCT02497469|470846988|FG001|Overall Study|Lack of Efficacy|40|||
130786431|NCT02497469|470846987|FG000|Overall Study|Reason not Specified|6|||
130786432|NCT02497469|470846988|FG001|Overall Study|Reason not Specified|6|||
130786433|NCT01026493|470846990|FG000|Overall Study|Protocol Violation|0|||
130786434|NCT01026493|470846991|FG001|Overall Study|Protocol Violation|1|||
130786435|NCT01026493|470846992|FG002|Overall Study|Protocol Violation|0|||
130786436|NCT01026493|470846993|FG003|Overall Study|Protocol Violation|0|||
130786437|NCT01026493|470846994|FG004|Overall Study|Protocol Violation|2|||
130786438|NCT01026493|470846995|FG005|Overall Study|Protocol Violation|3|||
130786439|NCT01026493|470846996|FG006|Overall Study|Protocol Violation|4|||
130786440|NCT01026493|470846997|FG007|Overall Study|Protocol Violation|1|||
130786441|NCT01787552|470847003|FG000|Overall Study|Withdrawal by Subject|2|||
130786442|NCT01787552|470847004|FG001|Overall Study|Withdrawal by Subject|0|||
130786443|NCT01787552|470847005|FG002|Overall Study|Withdrawal by Subject|0|||
130786444|NCT01787552|470847006|FG003|Overall Study|Withdrawal by Subject|4|||
130786445|NCT01787552|470847003|FG000|Overall Study|Physician Decision|2|||
130786446|NCT01787552|470847004|FG001|Overall Study|Physician Decision|2|||
130786447|NCT01787552|470847005|FG002|Overall Study|Physician Decision|1|||
130786448|NCT01787552|470847006|FG003|Overall Study|Physician Decision|2|||
130786449|NCT01787552|470847003|FG000|Overall Study|Death|0|||
130786450|NCT01787552|470847004|FG001|Overall Study|Death|0|||
130786451|NCT01787552|470847005|FG002|Overall Study|Death|0|||
130786452|NCT01787552|470847006|FG003|Overall Study|Death|1|||
130786453|NCT01787552|470847003|FG000|Overall Study|Adverse Event|2|||
130786454|NCT01787552|470847004|FG001|Overall Study|Adverse Event|5|||
130786455|NCT01787552|470847005|FG002|Overall Study|Adverse Event|2|||
130786456|NCT01787552|470847006|FG003|Overall Study|Adverse Event|16|||
130786457|NCT01787552|470847003|FG000|Overall Study|Study terminated by Sponsor|0|||
130786458|NCT01787552|470847004|FG001|Overall Study|Study terminated by Sponsor|0|||
130786459|NCT01787552|470847005|FG002|Overall Study|Study terminated by Sponsor|1|||
130786460|NCT01787552|470847006|FG003|Overall Study|Study terminated by Sponsor|3|||
130786461|NCT01787552|470847003|FG000|Overall Study|Progressive Disease|2|||
130786462|NCT01787552|470847004|FG001|Overall Study|Progressive Disease|2|||
130786463|NCT01787552|470847005|FG002|Overall Study|Progressive Disease|1|||
130786464|NCT01787552|470847006|FG003|Overall Study|Progressive Disease|1|||
130786465|NCT00630916|470847007|FG000|Overall Study|Death|110|||
130786466|NCT00630916|470847007|FG000|Overall Study|Explant|8|||
130786467|NCT00630916|470847007|FG000|Overall Study|Lost to Follow-up|5|||
130786468|NCT00630916|470847007|FG000|Overall Study|Withdrawal by Subject|30|||
130786469|NCT00630916|470847007|FG000|Overall Study|Protocol Violation|7|||
130786470|NCT00630916|470847007|FG000|Overall Study|Physician Decision|47|||
130786471|NCT00630916|470847007|FG000|Overall Study|Lack of Efficacy|3|||
130786472|NCT02295644|470847015|FG000|Overall Study|Did not meet inclusion criterion|0|||
130786473|NCT02295644|470847016|FG001|Overall Study|Did not meet inclusion criterion|0|||
130786474|NCT02295644|470847017|FG002|Overall Study|Did not meet inclusion criterion|1|||
130786475|NCT02295644|470847018|FG003|Overall Study|Did not meet inclusion criterion|2|||
130786476|NCT04079790|470847019|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
130786477|NCT04079790|470847020|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
130786478|NCT04079790|470847021|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
130786479|NCT04079790|470847022|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
130786480|NCT04079790|470847019|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
130786481|NCT04079790|470847020|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
130786482|NCT04079790|470847021|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
130786483|NCT04079790|470847022|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
130786484|NCT04079790|470847019|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
130786485|NCT04079790|470847020|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
130786486|NCT04079790|470847021|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
130786487|NCT04079790|470847022|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
130786488|NCT00324155|470847023|FG000|Enrolled and Randomized|No longer met study criteria|3|||
130786489|NCT00324155|470847024|FG001|Enrolled and Randomized|No longer met study criteria|0|||
130786490|NCT00324155|470847023|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
130786491|NCT00324155|470847024|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
130786492|NCT00324155|470847023|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
130786493|NCT00324155|470847024|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
130786494|NCT00324155|470847023|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
130786495|NCT00324155|470847024|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
130786496|NCT00324155|470847023|FG000|Received Treatment in Induction Phase|Death|8|||
130786497|NCT00324155|470847024|FG001|Received Treatment in Induction Phase|Death|15|||
130786498|NCT00324155|470847023|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
130786499|NCT00324155|470847024|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
130786500|NCT00324155|470847023|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
130786501|NCT00324155|470847024|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
130786502|NCT00324155|470847023|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
130786503|NCT00324155|470847024|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
130786504|NCT00324155|470847023|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
130786505|NCT00324155|470847024|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
130786506|NCT00324155|470847023|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
130786507|NCT00324155|470847024|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
130786508|NCT00324155|470847023|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
130786509|NCT00324155|470847024|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
130786510|NCT00324155|470847023|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
130786511|NCT00324155|470847024|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
130786512|NCT00324155|470847023|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
130786513|NCT00324155|470847024|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
130786514|NCT00324155|470847023|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
130786515|NCT00324155|470847024|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
130786516|NCT00324155|470847023|FG000|Follow-up Phase|On-going participants still on drug|11|||
130786517|NCT00324155|470847024|FG001|Follow-up Phase|On-going participants still on drug|6|||
130786518|NCT00390689|470847025|FG000|Overall Study|Adverse Event|2|||
130786519|NCT00390689|470847026|FG001|Overall Study|Adverse Event|5|||
130786520|NCT00390689|470847027|FG002|Overall Study|Adverse Event|2|||
130786521|NCT00390689|470847025|FG000|Overall Study|Lack of Efficacy|0|||
130786522|NCT00390689|470847026|FG001|Overall Study|Lack of Efficacy|0|||
130786523|NCT00390689|470847027|FG002|Overall Study|Lack of Efficacy|1|||
130786524|NCT00390689|470847025|FG000|Overall Study|Protocol Violation|1|||
130786525|NCT00390689|470847026|FG001|Overall Study|Protocol Violation|0|||
130786526|NCT00390689|470847027|FG002|Overall Study|Protocol Violation|0|||
130786527|NCT00390689|470847025|FG000|Overall Study|Investigator's judgement|2|||
130786528|NCT00390689|470847026|FG001|Overall Study|Investigator's judgement|0|||
130786529|NCT00390689|470847027|FG002|Overall Study|Investigator's judgement|0|||
130786530|NCT01253161|470847028|FG000|Overall Study|Adverse Event|1|||
130786531|NCT05412134|470847029|FG000|Overall Study|Lost to Follow-up|2|||
130786532|NCT05412134|470847030|FG001|Overall Study|Lost to Follow-up|0|||
130786533|NCT03167242|470847031|FG000|Overall Study|Patient/Guardian Decision|0|||
130786534|NCT03167242|470847032|FG001|Overall Study|Patient/Guardian Decision|1|||
130786535|NCT03167242|470847033|FG002|Overall Study|Patient/Guardian Decision|2|||
130786536|NCT03167242|470847034|FG003|Overall Study|Patient/Guardian Decision|1|||
130786537|NCT03167242|470847035|FG004|Overall Study|Patient/Guardian Decision|1|||
130738929|NCT03411863|470664302|FG000|Overall Study|Physician Decision|0|||
130738930|NCT03411863|470664303|FG001|Overall Study|Physician Decision|1|||
130738931|NCT03535740|470664304|FG000|Overall Study|Death|44|||
130738932|NCT03535740|470664304|FG000|Overall Study|Lost to Follow-up|1|||
130738933|NCT03535740|470664304|FG000|Overall Study|Withdrawal by Subject|13|||
130738934|NCT03535740|470664304|FG000|Overall Study|Site terminated by Sponsor|45|||
130738935|NCT05198518|470664309|FG000|Screening Visit|Deemed unable to participate|58|||
130738936|NCT05198518|470664310|FG001|Screening Visit|Deemed unable to participate|0|||
130738937|NCT05198518|470664311|FG002|Screening Visit|Deemed unable to participate|0|||
130738938|NCT03645863|470664312|FG000|Overall Study|Withdrawal by Subject|1|||
130738939|NCT03645863|470664313|FG001|Overall Study|Withdrawal by Subject|0|||
130786538|NCT03167242|470847036|FG005|Overall Study|Patient/Guardian Decision|1|||
130738940|NCT03645863|470664314|FG002|Overall Study|Withdrawal by Subject|0|||
130738941|NCT02756611|470664317|FG000|Overall Study|Death|70|||
130738942|NCT02756611|470664317|FG000|Overall Study|Withdrawal by Subject|2|||
130738943|NCT02756611|470664317|FG000|Overall Study|Lost to Follow-up|3|||
130738944|NCT02756611|470664317|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
130738945|NCT02756611|470664317|FG000|Overall Study|Other|10|||
130738946|NCT03125798|470664319|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
130738947|NCT03125798|470664320|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
130738948|NCT03125798|470664319|FG000|Overall Study|Conversion to thoracotomy|7|||
130738949|NCT03125798|470664320|FG001|Overall Study|Conversion to thoracotomy|7|||
130738950|NCT00100828|470664324|FG000|Overall Study|Physician Decision|6|||
130738951|NCT04583735|470664325|FG000|Double-masked Treatment Period|Adverse Event|0|||
130738952|NCT04583735|470664326|FG001|Double-masked Treatment Period|Adverse Event|1|||
130738953|NCT04583735|470664325|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
130738954|NCT04583735|470664326|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
130738955|NCT04583735|470664325|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
130738956|NCT04583735|470664326|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
130738957|NCT04583735|470664325|FG000|Open-label Treatment Period|Adverse Event|1|||
130738958|NCT04583735|470664326|FG001|Open-label Treatment Period|Adverse Event|1|||
130738959|NCT04583735|470664325|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
130738960|NCT04583735|470664326|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130738961|NCT04583735|470664325|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130738962|NCT04583735|470664326|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
130738963|NCT00124917|470664327|FG000|Overall Study|Physician Decision|3|||
130738964|NCT00613171|470664328|FG000|Overall Study|Adverse Event|7|||
130738965|NCT00613171|470664328|FG000|Overall Study|Withdrawal by Subject|3|||
130738966|NCT00613171|470664328|FG000|Overall Study|Reason not Specified|4|||
130738967|NCT01197911|470664329|FG000|Overall Study|Adverse Event|0|||
130738968|NCT01197911|470664330|FG001|Overall Study|Adverse Event|0|||
130738969|NCT01197911|470664331|FG002|Overall Study|Adverse Event|1|||
130738970|NCT01169350|470664332|FG000|Overall Study|Physician Decision|3|||
130738971|NCT01169350|470664332|FG000|Overall Study|Lost to Follow-up|2|||
130738972|NCT04338022|470664333|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
130738973|NCT04338022|470664334|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
130738974|NCT04338022|470664333|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
130738975|NCT04338022|470664334|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
130738976|NCT04338022|470664333|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
130738977|NCT04338022|470664334|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
130738978|NCT04338022|470664333|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
130738979|NCT04338022|470664334|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
130738980|NCT04338022|470664333|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
130738981|NCT04338022|470664334|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
130738982|NCT04338022|470664333|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
130738983|NCT04338022|470664334|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
130738984|NCT04338022|470664333|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
130738985|NCT04338022|470664334|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
130738986|NCT04338022|470664333|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
130738987|NCT04338022|470664334|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
130738988|NCT04338022|470664333|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
130738989|NCT04338022|470664334|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
130738990|NCT04338022|470664333|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
130738991|NCT04338022|470664334|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
130738992|NCT04338022|470664333|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
130738993|NCT04338022|470664334|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
130738994|NCT04338022|470664333|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
130786539|NCT03167242|470847037|FG006|Overall Study|Patient/Guardian Decision|0|||
130786540|NCT03167242|470847038|FG007|Overall Study|Patient/Guardian Decision|0|||
130786541|NCT03167242|470847039|FG008|Overall Study|Patient/Guardian Decision|0|||
130786542|NCT03167242|470847040|FG009|Overall Study|Patient/Guardian Decision|0|||
130786543|NCT03167242|470847041|FG010|Overall Study|Patient/Guardian Decision|1|||
130786544|NCT03167242|470847042|FG011|Overall Study|Patient/Guardian Decision|0|||
130786545|NCT03167242|470847031|FG000|Overall Study|Lost to Follow-up|0|||
130786546|NCT03167242|470847032|FG001|Overall Study|Lost to Follow-up|0|||
130786547|NCT03167242|470847033|FG002|Overall Study|Lost to Follow-up|1|||
130786548|NCT03167242|470847034|FG003|Overall Study|Lost to Follow-up|0|||
130786549|NCT03167242|470847035|FG004|Overall Study|Lost to Follow-up|0|||
130786550|NCT03167242|470847036|FG005|Overall Study|Lost to Follow-up|1|||
130786551|NCT03167242|470847037|FG006|Overall Study|Lost to Follow-up|2|||
130786552|NCT03167242|470847038|FG007|Overall Study|Lost to Follow-up|1|||
130786553|NCT03167242|470847039|FG008|Overall Study|Lost to Follow-up|0|||
130786554|NCT03167242|470847040|FG009|Overall Study|Lost to Follow-up|0|||
130786555|NCT03167242|470847041|FG010|Overall Study|Lost to Follow-up|1|||
130786556|NCT03167242|470847042|FG011|Overall Study|Lost to Follow-up|1|||
130786557|NCT03167242|470847031|FG000|Overall Study|Reason not provided|0|||
130786558|NCT03167242|470847032|FG001|Overall Study|Reason not provided|0|||
130786559|NCT03167242|470847033|FG002|Overall Study|Reason not provided|0|||
130786560|NCT03167242|470847034|FG003|Overall Study|Reason not provided|0|||
130786561|NCT03167242|470847035|FG004|Overall Study|Reason not provided|0|||
130786562|NCT03167242|470847036|FG005|Overall Study|Reason not provided|0|||
130786563|NCT03167242|470847037|FG006|Overall Study|Reason not provided|0|||
130786564|NCT03167242|470847038|FG007|Overall Study|Reason not provided|0|||
130786565|NCT03167242|470847039|FG008|Overall Study|Reason not provided|1|||
130786566|NCT03167242|470847040|FG009|Overall Study|Reason not provided|0|||
130786567|NCT03167242|470847041|FG010|Overall Study|Reason not provided|0|||
130786568|NCT03167242|470847042|FG011|Overall Study|Reason not provided|0|||
130786569|NCT05401565|470847047|FG000|Overall Study|Lost to Follow-up|1|||
130786570|NCT05401565|470847048|FG001|Overall Study|Lost to Follow-up|0|||
130786571|NCT05401565|470847047|FG000|Overall Study|Adverse Event|2|||
130786572|NCT05401565|470847048|FG001|Overall Study|Adverse Event|0|||
130786573|NCT00726609|470847051|FG000|Overall Study|Adverse Event|10|||
130786574|NCT00726609|470847051|FG000|Overall Study|Withdrawal by Subject|2|||
130786575|NCT00726609|470847051|FG000|Overall Study|Lack of Efficacy|25|||
130786576|NCT00726609|470847051|FG000|Overall Study|Other|16|||
130786577|NCT00726609|470847051|FG000|Overall Study|Missing|42|||
130786578|NCT00726609|470847051|FG000|Overall Study|Other|3|||
130786579|NCT03080935|470847061|FG000|Overall Study|Death|34|||
130786580|NCT03080935|470847062|FG001|Overall Study|Death|50|||
130786581|NCT03080935|470847061|FG000|Overall Study|Lost to Follow-up|5|||
130786582|NCT03080935|470847062|FG001|Overall Study|Lost to Follow-up|4|||
130786583|NCT03080935|470847061|FG000|Overall Study|Withdrawal by Subject|11|||
130786584|NCT03080935|470847062|FG001|Overall Study|Withdrawal by Subject|15|||
130786585|NCT02175121|470847063|FG000|Overall Study|Lack of Efficacy|1|||
130786586|NCT02175121|470847064|FG001|Overall Study|Lack of Efficacy|0|||
130786587|NCT02175121|470847065|FG002|Overall Study|Lack of Efficacy|0|||
130786588|NCT02175121|470847066|FG003|Overall Study|Lack of Efficacy|0|||
130786589|NCT02175121|470847067|FG004|Overall Study|Lack of Efficacy|0|||
130786590|NCT02175121|470847063|FG000|Overall Study|Lost to Follow-up|0|||
130786591|NCT02175121|470847064|FG001|Overall Study|Lost to Follow-up|1|||
130786592|NCT02175121|470847065|FG002|Overall Study|Lost to Follow-up|0|||
130786593|NCT02175121|470847066|FG003|Overall Study|Lost to Follow-up|1|||
130786594|NCT02175121|470847067|FG004|Overall Study|Lost to Follow-up|0|||
130786595|NCT02175121|470847063|FG000|Overall Study|Personal emergency|0|||
130786596|NCT02175121|470847064|FG001|Overall Study|Personal emergency|0|||
130786597|NCT02175121|470847065|FG002|Overall Study|Personal emergency|0|||
130786598|NCT02175121|470847066|FG003|Overall Study|Personal emergency|0|||
130786599|NCT02175121|470847067|FG004|Overall Study|Personal emergency|1|||
130786600|NCT02175121|470847063|FG000|Overall Study|Schedule conflict|0|||
130786601|NCT02175121|470847064|FG001|Overall Study|Schedule conflict|0|||
130786602|NCT02175121|470847065|FG002|Overall Study|Schedule conflict|1|||
130786603|NCT02175121|470847066|FG003|Overall Study|Schedule conflict|0|||
130786604|NCT02175121|470847067|FG004|Overall Study|Schedule conflict|0|||
130786605|NCT02175121|470847063|FG000|Overall Study|Time issues|0|||
130786606|NCT02175121|470847064|FG001|Overall Study|Time issues|0|||
130786607|NCT02175121|470847065|FG002|Overall Study|Time issues|1|||
130786608|NCT02175121|470847066|FG003|Overall Study|Time issues|0|||
130786609|NCT02175121|470847067|FG004|Overall Study|Time issues|0|||
130786610|NCT03329885|470847068|FG000|Overall Study|Sponsor discontinued the study early|0|||
130786611|NCT03329885|470847069|FG001|Overall Study|Sponsor discontinued the study early|0|||
130786612|NCT03329885|470847070|FG002|Overall Study|Sponsor discontinued the study early|0|||
130786613|NCT03329885|470847071|FG003|Overall Study|Sponsor discontinued the study early|0|||
130786614|NCT03329885|470847072|FG004|Overall Study|Sponsor discontinued the study early|0|||
130786615|NCT03329885|470847073|FG005|Overall Study|Sponsor discontinued the study early|0|||
130786616|NCT03329885|470847074|FG006|Overall Study|Sponsor discontinued the study early|1|||
130786617|NCT03329885|470847075|FG007|Overall Study|Sponsor discontinued the study early|1|||
130738995|NCT04338022|470664334|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
130738996|NCT04338022|470664333|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
130738997|NCT04338022|470664334|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
130738998|NCT04338022|470664333|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
130738999|NCT04338022|470664334|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
130739000|NCT02860546|470664336|FG000|Overall Study|Clinical Progression|6|||
130786618|NCT03329885|470847076|FG008|Overall Study|Sponsor discontinued the study early|0|||
130786619|NCT00269152|470847083|FG000|Overall Study|Adverse Event|9|||
130786620|NCT00269152|470847084|FG001|Overall Study|Adverse Event|3|||
130786621|NCT00269152|470847083|FG000|Overall Study|Withdrawal by Subject|7|||
130786622|NCT00269152|470847084|FG001|Overall Study|Withdrawal by Subject|3|||
130786623|NCT00269152|470847083|FG000|Overall Study|Physician Decision|2|||
130786624|NCT00269152|470847084|FG001|Overall Study|Physician Decision|3|||
130786625|NCT00269152|470847083|FG000|Overall Study|Protocol Violation|0|||
130786626|NCT00269152|470847084|FG001|Overall Study|Protocol Violation|1|||
130786627|NCT03886272|470847085|FG000|Period 1|Withdrawal by Subject|0|||
130786628|NCT03886272|470847086|FG001|Period 1|Withdrawal by Subject|0|||
130786629|NCT03886272|470847087|FG002|Period 1|Withdrawal by Subject|0|||
130786630|NCT03886272|470847088|FG003|Period 1|Withdrawal by Subject|0|||
130786631|NCT03886272|470847089|FG004|Period 1|Withdrawal by Subject|0|||
130786632|NCT03886272|470847090|FG005|Period 1|Withdrawal by Subject|1|||
130786633|NCT03886272|470847091|FG006|Period 1|Withdrawal by Subject|0|||
130786634|NCT02557399|470847092|FG000|Overall Study|Adverse Event|6|||
130786635|NCT02557399|470847093|FG001|Overall Study|Adverse Event|5|||
130786636|NCT02557399|470847092|FG000|Overall Study|Protocol Violation|0|||
130786637|NCT02557399|470847093|FG001|Overall Study|Protocol Violation|1|||
130786638|NCT02557399|470847092|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130786639|NCT02557399|470847093|FG001|Overall Study|Protocol-defined stopping criteria|1|||
130786640|NCT02557399|470847092|FG000|Overall Study|Withdrawal by Subject|1|||
130786641|NCT02557399|470847093|FG001|Overall Study|Withdrawal by Subject|1|||
130786642|NCT00931632|470847094|FG000|Overall Study|Withdrawal by Subject|2|||
130786643|NCT00931632|470847095|FG001|Overall Study|Withdrawal by Subject|3|||
130786644|NCT00931632|470847094|FG000|Overall Study|Adverse Event|19|||
130786645|NCT00931632|470847095|FG001|Overall Study|Adverse Event|15|||
130786646|NCT01687218|470847098|FG000|Overall Study|Withdrawal by Subject|2|||
130786647|NCT01687218|470847099|FG001|Overall Study|Withdrawal by Subject|3|||
130786648|NCT01687218|470847100|FG002|Overall Study|Withdrawal by Subject|0|||
130786649|NCT01687218|470847101|FG003|Overall Study|Withdrawal by Subject|1|||
130786650|NCT01687218|470847102|FG004|Overall Study|Withdrawal by Subject|1|||
130786651|NCT01687218|470847103|FG005|Overall Study|Withdrawal by Subject|0|||
130786652|NCT01687218|470847098|FG000|Overall Study|Relocated, no follow-up planned|1|||
130786653|NCT01687218|470847099|FG001|Overall Study|Relocated, no follow-up planned|0|||
130786654|NCT01687218|470847100|FG002|Overall Study|Relocated, no follow-up planned|1|||
130786655|NCT01687218|470847101|FG003|Overall Study|Relocated, no follow-up planned|1|||
130786656|NCT01687218|470847102|FG004|Overall Study|Relocated, no follow-up planned|0|||
130786657|NCT01687218|470847103|FG005|Overall Study|Relocated, no follow-up planned|0|||
130786658|NCT03139552|470847109|FG000|Overall Study|unable to attend tasting due to schedule|3|||
130786659|NCT03368807|470847124|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
130786660|NCT03368807|470847124|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
130786661|NCT03368807|470847124|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
130786662|NCT03368807|470847124|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
130786663|NCT01973218|470847129|FG000|Overall Study|Adverse Event|1|||
130786664|NCT01973218|470847130|FG001|Overall Study|Adverse Event|0|||
130786665|NCT01973218|470847129|FG000|Overall Study|Withdrawal by Subject|1|||
130786666|NCT01973218|470847130|FG001|Overall Study|Withdrawal by Subject|0|||
130786667|NCT02247466|470847131|FG000|Overall Study|Procedure changed to open surgery|0|||
130786668|NCT02247466|470847132|FG001|Overall Study|Procedure changed to open surgery|3|||
130786669|NCT00721799|470847135|FG000|Overall Study|Withdrawal by Subject|7|||
130786670|NCT00721799|470847135|FG000|Overall Study|withdraw by subject after scan 1|1|||
130786671|NCT02033759|470847136|FG000|Overall Study|Withdrawal by Subject|2|||
130786672|NCT02033759|470847137|FG001|Overall Study|Withdrawal by Subject|1|||
130786673|NCT02033759|470847136|FG000|Overall Study|Protocol Violation|1|||
130786674|NCT02033759|470847137|FG001|Overall Study|Protocol Violation|1|||
130786675|NCT04356937|470847140|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
130786676|NCT04356937|470847141|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
130786677|NCT03533751|470847142|FG000|Overall Study|Withdrawal by Subject|12|||
130739001|NCT02860546|470664336|FG000|Overall Study|Radiological Progression|12|||
130739002|NCT02466321|470664337|FG000|Overall Study|Death|26|||
130739003|NCT02466321|470664337|FG000|Overall Study|Revision|6|||
130739004|NCT02466321|470664337|FG000|Overall Study|Lost to Follow-up|60|||
130739005|NCT02466321|470664337|FG000|Overall Study|Did not receive study device|1|||
130739006|NCT06071754|470664338|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
130739007|NCT02189837|470664342|FG000|Overall Study|Withdrawal by Subject|2|||
130739008|NCT02189837|470664343|FG001|Overall Study|Withdrawal by Subject|1|||
130739009|NCT02189837|470664344|FG002|Overall Study|Withdrawal by Subject|3|||
130739010|NCT02189837|470664345|FG003|Overall Study|Withdrawal by Subject|1|||
130739011|NCT02189837|470664342|FG000|Overall Study|Sponsor Decision|0|||
130739012|NCT02189837|470664343|FG001|Overall Study|Sponsor Decision|0|||
130739013|NCT02189837|470664344|FG002|Overall Study|Sponsor Decision|0|||
130739014|NCT02189837|470664345|FG003|Overall Study|Sponsor Decision|1|||
130739015|NCT02443740|470664349|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
130739016|NCT02443740|470664350|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
130739017|NCT02443740|470664351|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
130739018|NCT02443740|470664352|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
130739019|NCT02443740|470664353|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
130739020|NCT02443740|470664354|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
130786678|NCT03533751|470847143|FG001|Overall Study|Withdrawal by Subject|6|||
130786679|NCT03533751|470847144|FG002|Overall Study|Withdrawal by Subject|11|||
130786680|NCT03533751|470847145|FG003|Overall Study|Withdrawal by Subject|9|||
130786681|NCT03533751|470847146|FG004|Overall Study|Withdrawal by Subject|10|||
130786682|NCT03533751|470847142|FG000|Overall Study|Adverse Event|4|||
130786683|NCT03533751|470847143|FG001|Overall Study|Adverse Event|7|||
130786684|NCT03533751|470847144|FG002|Overall Study|Adverse Event|2|||
130786685|NCT03533751|470847145|FG003|Overall Study|Adverse Event|4|||
130786686|NCT03533751|470847146|FG004|Overall Study|Adverse Event|5|||
130786687|NCT03533751|470847142|FG000|Overall Study|Physician Decision|0|||
130786688|NCT03533751|470847143|FG001|Overall Study|Physician Decision|2|||
130786689|NCT03533751|470847144|FG002|Overall Study|Physician Decision|1|||
130786690|NCT03533751|470847145|FG003|Overall Study|Physician Decision|2|||
130786691|NCT03533751|470847146|FG004|Overall Study|Physician Decision|1|||
130786692|NCT03533751|470847142|FG000|Overall Study|Sponsor Decision|0|||
130786693|NCT03533751|470847143|FG001|Overall Study|Sponsor Decision|0|||
130786694|NCT03533751|470847144|FG002|Overall Study|Sponsor Decision|1|||
130786695|NCT03533751|470847145|FG003|Overall Study|Sponsor Decision|1|||
130786696|NCT03533751|470847146|FG004|Overall Study|Sponsor Decision|0|||
130786697|NCT03533751|470847142|FG000|Overall Study|Lost to Follow-up|3|||
130786698|NCT03533751|470847143|FG001|Overall Study|Lost to Follow-up|7|||
130786699|NCT03533751|470847144|FG002|Overall Study|Lost to Follow-up|6|||
130786700|NCT03533751|470847145|FG003|Overall Study|Lost to Follow-up|4|||
130786701|NCT03533751|470847146|FG004|Overall Study|Lost to Follow-up|3|||
130786702|NCT03533751|470847142|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
130786703|NCT03533751|470847143|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
130786704|NCT03533751|470847144|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
130786705|NCT03533751|470847145|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
130786706|NCT03533751|470847146|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
130786707|NCT03533751|470847142|FG000|Overall Study|Other|0|||
130786708|NCT03533751|470847143|FG001|Overall Study|Other|2|||
130786709|NCT03533751|470847144|FG002|Overall Study|Other|1|||
130786710|NCT03533751|470847145|FG003|Overall Study|Other|0|||
130786711|NCT03533751|470847146|FG004|Overall Study|Other|3|||
130786712|NCT05117060|470847147|FG000|Overall Study|Adverse Event|3|||
130786713|NCT05117060|470847148|FG001|Overall Study|Adverse Event|5|||
130786714|NCT05117060|470847149|FG002|Overall Study|Adverse Event|6|||
130786715|NCT05117060|470847150|FG003|Overall Study|Adverse Event|1|||
130786716|NCT05117060|470847147|FG000|Overall Study|Lost to Follow-up|0|||
130786717|NCT05117060|470847148|FG001|Overall Study|Lost to Follow-up|0|||
130786718|NCT05117060|470847149|FG002|Overall Study|Lost to Follow-up|0|||
130786719|NCT05117060|470847150|FG003|Overall Study|Lost to Follow-up|1|||
130786720|NCT05117060|470847147|FG000|Overall Study|Lack of Efficacy|4|||
130786721|NCT05117060|470847148|FG001|Overall Study|Lack of Efficacy|5|||
130786722|NCT05117060|470847149|FG002|Overall Study|Lack of Efficacy|2|||
130786723|NCT05117060|470847150|FG003|Overall Study|Lack of Efficacy|6|||
130786724|NCT05117060|470847147|FG000|Overall Study|Withdrawal by Subject|8|||
130786725|NCT05117060|470847148|FG001|Overall Study|Withdrawal by Subject|5|||
130786726|NCT05117060|470847149|FG002|Overall Study|Withdrawal by Subject|5|||
130786727|NCT05117060|470847150|FG003|Overall Study|Withdrawal by Subject|6|||
130786728|NCT05117060|470847147|FG000|Overall Study|Other|2|||
130786729|NCT05117060|470847148|FG001|Overall Study|Other|1|||
130786730|NCT05117060|470847149|FG002|Overall Study|Other|3|||
130786731|NCT05117060|470847150|FG003|Overall Study|Other|1|||
130786732|NCT03141359|470847151|FG000|Overall Study|Death|32|||
130786733|NCT03141359|470847151|FG000|Overall Study|Still On Study (in follow up)|29|||
130786734|NCT01081626|470847152|FG000|Overall Study|Dosing error|1|||
130786735|NCT01081626|470847153|FG001|Overall Study|Dosing error|1|||
130786736|NCT01081626|470847152|FG000|Overall Study|Missing Estradiol|25|||
130786737|NCT01081626|470847153|FG001|Overall Study|Missing Estradiol|28|||
130786738|NCT01081626|470847152|FG000|Overall Study|Low antral follicle count|1|||
130786739|NCT01081626|470847153|FG001|Overall Study|Low antral follicle count|0|||
130786740|NCT01081626|470847152|FG000|Overall Study|Overstimulation|0|||
130786741|NCT01081626|470847153|FG001|Overall Study|Overstimulation|1|||
130786742|NCT01081626|470847152|FG000|Overall Study|Lost to Follow-up|0|||
130786743|NCT01081626|470847153|FG001|Overall Study|Lost to Follow-up|1|||
130786744|NCT01081626|470847152|FG000|Overall Study|Other|33|||
130786745|NCT01081626|470847153|FG001|Overall Study|Other|30|||
130739021|NCT02443740|470664355|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
130739022|NCT02443740|470664356|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
130786746|NCT04158219|470847154|FG000|Overall Study|Lost to Follow-up|1|||
130786747|NCT01419535|470847155|FG000|Overall Study|could not maintain iv line|1|||
130786748|NCT01419535|470847156|FG001|Overall Study|could not maintain iv line|1|||
130786749|NCT01419535|470847155|FG000|Overall Study|Withdrawal by Subject|0|||
130786750|NCT01419535|470847156|FG001|Overall Study|Withdrawal by Subject|1|||
130786751|NCT02074514|470847159|FG000|Overall Study|Lack of Efficacy|3|||
130786752|NCT02074514|470847160|FG001|Overall Study|Lack of Efficacy|2|||
130786753|NCT02074514|470847159|FG000|Overall Study|Lost to Follow-up|0|||
130786754|NCT02074514|470847160|FG001|Overall Study|Lost to Follow-up|1|||
130786755|NCT02074514|470847159|FG000|Overall Study|Withdrew Consent|0|||
130786756|NCT02074514|470847160|FG001|Overall Study|Withdrew Consent|1|||
130786757|NCT02873689|470848900|FG000|Overall Study|Lack of Efficacy|1|||
130786758|NCT02873689|470848901|FG001|Overall Study|Lack of Efficacy|0|||
130786759|NCT02873689|470848900|FG000|Overall Study|Withdrawal by Subject|2|||
130786760|NCT02873689|470848901|FG001|Overall Study|Withdrawal by Subject|2|||
130786761|NCT02873689|470848900|FG000|Overall Study|Protocol Violation|1|||
130786762|NCT02873689|470848901|FG001|Overall Study|Protocol Violation|0|||
130786763|NCT02873689|470848900|FG000|Overall Study|Adverse Event|2|||
130786764|NCT02873689|470848901|FG001|Overall Study|Adverse Event|2|||
130786765|NCT02873689|470848900|FG000|Overall Study|Randomized but not Treated|1|||
130786766|NCT02873689|470848901|FG001|Overall Study|Randomized but not Treated|1|||
130786767|NCT00350545|470848902|FG000|Overall Study|Withdrawal by Subject|2|||
130786768|NCT02337764|470848912|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
130786769|NCT02337764|470848912|FG000|Overall Study|Voluntary Withdrawal|12|||
130786770|NCT02337764|470848912|FG000|Overall Study|Lack of Efficacy|2|||
130786771|NCT00720278|470848914|FG000|Overall Study|Adverse Event|5|||
130786772|NCT00720278|470848915|FG001|Overall Study|Adverse Event|3|||
130786773|NCT00720278|470848916|FG002|Overall Study|Adverse Event|4|||
130786774|NCT00720278|470848914|FG000|Overall Study|Withdrawal by Subject|0|||
130786775|NCT00720278|470848915|FG001|Overall Study|Withdrawal by Subject|1|||
130786776|NCT00720278|470848916|FG002|Overall Study|Withdrawal by Subject|0|||
130786777|NCT00720278|470848914|FG000|Overall Study|Lost to Follow-up|0|||
130786778|NCT00720278|470848915|FG001|Overall Study|Lost to Follow-up|0|||
130786779|NCT00720278|470848916|FG002|Overall Study|Lost to Follow-up|1|||
130786780|NCT00720278|470848914|FG000|Overall Study|Non-compliance|1|||
130786781|NCT00720278|470848915|FG001|Overall Study|Non-compliance|0|||
130786782|NCT00720278|470848916|FG002|Overall Study|Non-compliance|0|||
130786783|NCT00720278|470848914|FG000|Overall Study|eligibility criteria violation|1|||
130786784|NCT00720278|470848915|FG001|Overall Study|eligibility criteria violation|0|||
130786785|NCT00720278|470848916|FG002|Overall Study|eligibility criteria violation|1|||
130786786|NCT00368251|470848919|FG000|Overall Study|SAE, non-fatal|1|||
130786787|NCT00368251|470848920|FG001|Overall Study|SAE, non-fatal|0|||
130786788|NCT00368251|470848921|FG002|Overall Study|SAE, non-fatal|0|||
130786789|NCT00368251|470848919|FG000|Overall Study|AE, non-serious non-fatal|0|||
130786790|NCT00368251|470848920|FG001|Overall Study|AE, non-serious non-fatal|0|||
130786791|NCT00368251|470848921|FG002|Overall Study|AE, non-serious non-fatal|1|||
130786792|NCT03312738|470848922|FG000|Overall Study|Progressive disease|58|||
130786793|NCT03312738|470848923|FG001|Overall Study|Progressive disease|67|||
130786794|NCT03312738|470848922|FG000|Overall Study|Patient/guardian decision|13|||
130786795|NCT03312738|470848923|FG001|Overall Study|Patient/guardian decision|5|||
130786796|NCT03312738|470848922|FG000|Overall Study|Adverse Event|5|||
130786797|NCT03312738|470848923|FG001|Overall Study|Adverse Event|3|||
130786798|NCT03312738|470848922|FG000|Overall Study|Protocol deviation|2|||
130786799|NCT03312738|470848923|FG001|Overall Study|Protocol deviation|0|||
130786800|NCT03312738|470848922|FG000|Overall Study|Technical problems|0|||
130786801|NCT03312738|470848923|FG001|Overall Study|Technical problems|1|||
130786802|NCT03312738|470848922|FG000|Overall Study|Physician Decision|2|||
130786803|NCT03312738|470848923|FG001|Overall Study|Physician Decision|3|||
130786804|NCT02466399|470848927|FG000|Overall Study|Adverse Event|1|||
130786805|NCT02466399|470848928|FG001|Overall Study|Adverse Event|0|||
130786806|NCT02466399|470848927|FG000|Overall Study|Early exit due to family emergency|1|||
130786807|NCT02466399|470848928|FG001|Overall Study|Early exit due to family emergency|0|||
130786808|NCT00607893|470848929|FG000|Overall Study|Lost to Follow-up|4|||
130786809|NCT00607893|470848930|FG001|Overall Study|Lost to Follow-up|0|||
130786810|NCT00607893|470848929|FG000|Overall Study|withdrew due to loss of interest|0|||
130786811|NCT00607893|470848930|FG001|Overall Study|withdrew due to loss of interest|1|||
130786812|NCT00607893|470848929|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
130786813|NCT00607893|470848930|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
130786814|NCT00607893|470848929|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
130786815|NCT00607893|470848930|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
130786816|NCT00607893|470848929|FG000|Overall Study|Declined to be treated|1|||
130786817|NCT00607893|470848930|FG001|Overall Study|Declined to be treated|0|||
130786818|NCT00607893|470848929|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
130786819|NCT00607893|470848930|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
130786820|NCT02669849|470848931|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130786821|NCT02669849|470848932|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130822740|NCT00812955|470980589|FG000|Overall Study|Lost to Follow-up|2|||
130739023|NCT02443740|470664357|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
130739024|NCT02443740|470664358|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
130739025|NCT02443740|470664359|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
130739026|NCT02443740|470664349|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
130739027|NCT02443740|470664350|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130739028|NCT02443740|470664351|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130739029|NCT02443740|470664352|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130739030|NCT02443740|470664353|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130739031|NCT02443740|470664354|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130739032|NCT02443740|470664355|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
130739033|NCT02443740|470664356|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130739034|NCT02443740|470664357|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130739035|NCT02443740|470664358|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130739036|NCT02443740|470664359|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130739037|NCT02443740|470664349|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130822741|NCT00812955|470980590|FG001|Overall Study|Lost to Follow-up|1|||
130822742|NCT00812955|470980591|FG002|Overall Study|Lost to Follow-up|1|||
130739038|NCT02443740|470664350|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130739039|NCT02443740|470664351|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130739040|NCT02443740|470664352|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130739041|NCT02443740|470664353|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130739042|NCT02443740|470664354|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
130739043|NCT02443740|470664355|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130739044|NCT02443740|470664356|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130739045|NCT02443740|470664357|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130822743|NCT00812955|470980592|FG003|Overall Study|Lost to Follow-up|2|||
130739046|NCT02443740|470664358|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130739047|NCT02443740|470664359|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130739048|NCT00456300|470664360|FG000|Overall Study|Adverse Event|1|||
130739049|NCT00456300|470664361|FG001|Overall Study|Adverse Event|0|||
130739050|NCT01478373|470664363|FG000|Treatment Phase|Protocol Violation|1|||
130739051|NCT01478373|470664363|FG000|Survival Phase|Adverse Event|8|||
130739052|NCT01478373|470664363|FG000|Survival Phase|Protocol Violation|1|||
130739053|NCT01478373|470664363|FG000|Survival Phase|crossover to another study|2|||
130739054|NCT01478373|470664363|FG000|Survival Phase|Progressive Disease|27|||
130739055|NCT01074944|470664366|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
130739056|NCT01074944|470664367|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130739057|NCT01074944|470664368|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130739058|NCT01074944|470664369|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130739059|NCT01074944|470664370|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130739060|NCT01074944|470664366|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
130739061|NCT01074944|470664367|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130739062|NCT01074944|470664368|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130739063|NCT01074944|470664369|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130739064|NCT01074944|470664370|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130739065|NCT01074944|470664366|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
130739066|NCT01074944|470664367|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130739067|NCT01074944|470664368|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130739068|NCT01074944|470664369|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130739069|NCT01074944|470664370|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130739070|NCT01074944|470664366|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
130739071|NCT01074944|470664367|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130739072|NCT01074944|470664368|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130739073|NCT01074944|470664369|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130739074|NCT01074944|470664370|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130739075|NCT01074944|470664366|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
130739076|NCT01074944|470664367|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
130739077|NCT01074944|470664368|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
130739078|NCT01074944|470664369|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
130739079|NCT01074944|470664370|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
130739080|NCT01074944|470664366|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
130739081|NCT01074944|470664367|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
130739082|NCT01074944|470664368|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
130739083|NCT01074944|470664369|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
130739084|NCT01074944|470664370|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
130739085|NCT01074944|470664366|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130739086|NCT01074944|470664367|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
130739087|NCT01074944|470664368|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
130739088|NCT01074944|470664369|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130739089|NCT01074944|470664370|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130739090|NCT01074944|470664366|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130739091|NCT01074944|470664367|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
130739092|NCT01074944|470664368|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130739093|NCT01074944|470664369|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130739094|NCT01074944|470664370|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130739095|NCT01074944|470664366|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
130739096|NCT01074944|470664367|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
130739097|NCT01074944|470664368|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
130739098|NCT01074944|470664369|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
130739099|NCT01074944|470664370|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
130739100|NCT01074944|470664366|FG000|Long Term Treatment|Adverse Event|0|||
130739101|NCT01074944|470664367|FG001|Long Term Treatment|Adverse Event|0|||
130739102|NCT01074944|470664368|FG002|Long Term Treatment|Adverse Event|0|||
130739103|NCT01074944|470664369|FG003|Long Term Treatment|Adverse Event|3|||
130739104|NCT01074944|470664370|FG004|Long Term Treatment|Adverse Event|0|||
130739105|NCT01074944|470664366|FG000|Long Term Treatment|Lost to Follow-up|0|||
130739106|NCT01074944|470664367|FG001|Long Term Treatment|Lost to Follow-up|0|||
130739107|NCT01074944|470664368|FG002|Long Term Treatment|Lost to Follow-up|0|||
130739108|NCT01074944|470664369|FG003|Long Term Treatment|Lost to Follow-up|2|||
130739109|NCT01074944|470664370|FG004|Long Term Treatment|Lost to Follow-up|0|||
130739110|NCT01074944|470664366|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130739111|NCT01074944|470664367|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130739112|NCT01074944|470664368|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130739113|NCT01074944|470664369|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
130739114|NCT01074944|470664370|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130739115|NCT01074944|470664366|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
130739116|NCT01074944|470664367|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
130739117|NCT01074944|470664368|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
130739118|NCT01074944|470664369|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
130739119|NCT01074944|470664370|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
130739120|NCT01074944|470664366|FG000|Long Term Treatment|Withdrawal by Subject|0|||
130739121|NCT01074944|470664367|FG001|Long Term Treatment|Withdrawal by Subject|0|||
130739122|NCT01074944|470664368|FG002|Long Term Treatment|Withdrawal by Subject|0|||
130739123|NCT01074944|470664369|FG003|Long Term Treatment|Withdrawal by Subject|2|||
130739124|NCT01074944|470664370|FG004|Long Term Treatment|Withdrawal by Subject|0|||
130739125|NCT01074944|470664366|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130739126|NCT01074944|470664367|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130739127|NCT01074944|470664368|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130739128|NCT01074944|470664369|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130739129|NCT01074944|470664370|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
130739130|NCT01074944|470664366|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130739131|NCT01074944|470664367|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130739132|NCT01074944|470664368|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130739133|NCT01074944|470664369|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130739134|NCT01074944|470664370|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
130739135|NCT02348112|470664372|FG000|Overall Study|Withdrawal by Subject|32|||
130739136|NCT02348112|470664373|FG001|Overall Study|Withdrawal by Subject|29|||
130739137|NCT02348112|470664372|FG000|Overall Study|Lost to Follow-up|24|||
130739138|NCT02348112|470664373|FG001|Overall Study|Lost to Follow-up|20|||
130739139|NCT02348112|470664372|FG000|Overall Study|Physician Decision|17|||
130739140|NCT02348112|470664373|FG001|Overall Study|Physician Decision|15|||
130739141|NCT02348112|470664372|FG000|Overall Study|Site closed due to PI leaving|0|||
130739142|NCT02348112|470664373|FG001|Overall Study|Site closed due to PI leaving|30|||
130739143|NCT02348112|470664372|FG000|Overall Study|Sponsor withdrawal|0|||
130739144|NCT02348112|470664373|FG001|Overall Study|Sponsor withdrawal|7|||
130739145|NCT02348112|470664372|FG000|Overall Study|Death|0|||
130739146|NCT02348112|470664373|FG001|Overall Study|Death|1|||
130739147|NCT01998841|470664379|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
130739148|NCT01998841|470664380|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
130739149|NCT01998841|470664381|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
130739150|NCT01998841|470664382|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130739151|NCT01998841|470664383|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130739152|NCT01998841|470664379|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130739153|NCT01998841|470664380|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130739154|NCT01998841|470664381|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130739155|NCT01998841|470664382|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
130739156|NCT01998841|470664383|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
130739157|NCT02046603|470664384|FG000|Overall Study|Other|11|||
130739158|NCT02046603|470664385|FG001|Overall Study|Other|66|||
130739159|NCT02046603|470664384|FG000|Overall Study|Protocol Violation|0|||
130739160|NCT02046603|470664385|FG001|Overall Study|Protocol Violation|1|||
130739161|NCT02046603|470664384|FG000|Overall Study|Participant/legal guardian decision|1|||
130739162|NCT02046603|470664385|FG001|Overall Study|Participant/legal guardian decision|3|||
130739163|NCT02046603|470664384|FG000|Overall Study|Physician Decision|2|||
130739164|NCT02046603|470664385|FG001|Overall Study|Physician Decision|1|||
130739165|NCT02046603|470664384|FG000|Overall Study|Lost to Follow-up|1|||
130739166|NCT02046603|470664385|FG001|Overall Study|Lost to Follow-up|2|||
130739167|NCT02046603|470664384|FG000|Overall Study|Death|0|||
130739168|NCT02046603|470664385|FG001|Overall Study|Death|1|||
130739169|NCT02046603|470664384|FG000|Overall Study|Adverse Event|0|||
130739170|NCT02046603|470664385|FG001|Overall Study|Adverse Event|1|||
130739171|NCT05101343|470664386|FG000|Overall Study|Withdrawal by Subject|2|||
130739172|NCT05101343|470664387|FG001|Overall Study|Withdrawal by Subject|1|||
130739173|NCT03447743|470664388|FG000|Overall Study|Withdrawal by Subject|2|||
130786822|NCT02669849|470848933|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
130786823|NCT02669849|470848931|FG000|Overall Study|Lost to Follow-up|1|||
130739174|NCT03447743|470664388|FG000|Overall Study|Lost to Follow-up|3|||
130739175|NCT03447743|470664388|FG000|Overall Study|Adverse Event|1|||
130739176|NCT03447743|470664388|FG000|Overall Study|Did not meet criteria to continue|1|||
130739177|NCT00193050|470664389|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
130739178|NCT00193050|470664389|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
130786824|NCT02669849|470848932|FG001|Overall Study|Lost to Follow-up|0|||
130786825|NCT02669849|470848933|FG002|Overall Study|Lost to Follow-up|3|||
130786826|NCT02669849|470848931|FG000|Overall Study|Death|1|||
130786827|NCT02669849|470848932|FG001|Overall Study|Death|1|||
130786828|NCT02669849|470848933|FG002|Overall Study|Death|2|||
130786829|NCT02669849|470848931|FG000|Overall Study|Study terminated by sponsor|16|||
130786830|NCT02669849|470848932|FG001|Overall Study|Study terminated by sponsor|1|||
130786831|NCT02669849|470848933|FG002|Overall Study|Study terminated by sponsor|14|||
130786832|NCT02669849|470848931|FG000|Overall Study|Other|0|||
130786833|NCT02669849|470848932|FG001|Overall Study|Other|0|||
130786834|NCT02669849|470848933|FG002|Overall Study|Other|2|||
130786835|NCT03408899|470848934|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
130786836|NCT00606008|470848935|FG000|Overall Study|Adverse Event|1|||
130786837|NCT00606008|470848935|FG000|Overall Study|Withdrawal by Subject|4|||
130786838|NCT02014272|470848939|FG000|Intervention Period 1|Withdrawal by Subject|1|||
130786839|NCT02014272|470848940|FG001|Intervention Period 1|Withdrawal by Subject|0|||
130786840|NCT02014272|470848939|FG000|Intervention Period 1|Adverse Event|0|||
130786841|NCT02014272|470848940|FG001|Intervention Period 1|Adverse Event|1|||
130786842|NCT03499795|470848941|FG000|Overall Study|Adverse Event|1|||
130786843|NCT03499795|470848941|FG000|Overall Study|Lost to Follow-up|1|||
130786844|NCT03636256|470848944|FG000|Overall Study|Lost to Follow-up|3|||
130786845|NCT03636256|470848945|FG001|Overall Study|Lost to Follow-up|0|||
130786846|NCT03636256|470848946|FG002|Overall Study|Lost to Follow-up|2|||
130786847|NCT03636256|470848947|FG003|Overall Study|Lost to Follow-up|1|||
130786848|NCT03636256|470848948|FG004|Overall Study|Lost to Follow-up|0|||
130786849|NCT03636256|470848949|FG005|Overall Study|Lost to Follow-up|4|||
130786850|NCT03636256|470848950|FG006|Overall Study|Lost to Follow-up|2|||
130739179|NCT00193050|470664389|FG000|Neoadjuvant Treatment|Physician Decision|2|||
130739180|NCT00193050|470664389|FG000|Neoadjuvant Treatment|Adverse Event|2|||
130739181|NCT00193050|470664389|FG000|Adjuvant|Physician Decision|5|||
130739182|NCT00193050|470664389|FG000|Adjuvant|Intercurrent Hospitalization|3|||
130739183|NCT00193050|470664389|FG000|Adjuvant|Lack of Efficacy|2|||
130739184|NCT00061932|470664390|FG000|Overall Study|Withdrawal by Subject|13|||
130739185|NCT00061932|470664391|FG001|Overall Study|Withdrawal by Subject|4|||
130739186|NCT03567980|470664392|FG000|Overall Study|Adverse Event|1|||
130739187|NCT02848001|470667029|FG000|Overall Study|other reasons|0|||
130739188|NCT02848001|470667030|FG001|Overall Study|other reasons|0|||
130739189|NCT02848001|470667031|FG002|Overall Study|other reasons|1|||
130739190|NCT02848001|470667032|FG003|Overall Study|other reasons|0|||
130739191|NCT02848001|470667033|FG004|Overall Study|other reasons|4|||
130739192|NCT02848001|470667034|FG005|Overall Study|other reasons|1|||
130739193|NCT02848001|470667035|FG006|Overall Study|other reasons|0|||
130739194|NCT02848001|470667036|FG007|Overall Study|other reasons|2|||
130739195|NCT02848001|470667037|FG008|Overall Study|other reasons|2|||
130739196|NCT02848001|470667038|FG009|Overall Study|other reasons|3|||
130739197|NCT02848001|470667039|FG010|Overall Study|other reasons|0|||
130739198|NCT02848001|470667040|FG011|Overall Study|other reasons|1|||
130739199|NCT02848001|470667041|FG012|Overall Study|other reasons|1|||
130739200|NCT02848001|470667042|FG013|Overall Study|other reasons|0|||
130739201|NCT02848001|470667043|FG014|Overall Study|other reasons|0|||
130739202|NCT02848001|470667044|FG015|Overall Study|other reasons|2|||
130739203|NCT02848001|470667045|FG016|Overall Study|other reasons|1|||
130739204|NCT02848001|470667029|FG000|Overall Study|Lack of Efficacy|0|||
130739205|NCT02848001|470667030|FG001|Overall Study|Lack of Efficacy|1|||
130739206|NCT02848001|470667031|FG002|Overall Study|Lack of Efficacy|1|||
130739207|NCT02848001|470667032|FG003|Overall Study|Lack of Efficacy|2|||
130739208|NCT02848001|470667033|FG004|Overall Study|Lack of Efficacy|3|||
130739209|NCT02848001|470667034|FG005|Overall Study|Lack of Efficacy|0|||
130739210|NCT02848001|470667035|FG006|Overall Study|Lack of Efficacy|1|||
130739211|NCT02848001|470667036|FG007|Overall Study|Lack of Efficacy|0|||
130739212|NCT02848001|470667037|FG008|Overall Study|Lack of Efficacy|0|||
130739213|NCT02848001|470667038|FG009|Overall Study|Lack of Efficacy|1|||
130739214|NCT02848001|470667039|FG010|Overall Study|Lack of Efficacy|0|||
130739215|NCT02848001|470667040|FG011|Overall Study|Lack of Efficacy|2|||
130739216|NCT02848001|470667041|FG012|Overall Study|Lack of Efficacy|0|||
130739217|NCT02848001|470667042|FG013|Overall Study|Lack of Efficacy|2|||
130739218|NCT02848001|470667043|FG014|Overall Study|Lack of Efficacy|2|||
130739219|NCT02848001|470667044|FG015|Overall Study|Lack of Efficacy|0|||
130739220|NCT02848001|470667045|FG016|Overall Study|Lack of Efficacy|0|||
130739221|NCT02848001|470667029|FG000|Overall Study|Progressive Disease|2|||
130739222|NCT02848001|470667030|FG001|Overall Study|Progressive Disease|1|||
130739223|NCT02848001|470667031|FG002|Overall Study|Progressive Disease|0|||
130739224|NCT02848001|470667032|FG003|Overall Study|Progressive Disease|4|||
130739225|NCT02848001|470667033|FG004|Overall Study|Progressive Disease|3|||
130739226|NCT02848001|470667034|FG005|Overall Study|Progressive Disease|0|||
130739227|NCT02848001|470667035|FG006|Overall Study|Progressive Disease|4|||
130739228|NCT02848001|470667036|FG007|Overall Study|Progressive Disease|1|||
130739229|NCT02848001|470667037|FG008|Overall Study|Progressive Disease|0|||
130739230|NCT02848001|470667038|FG009|Overall Study|Progressive Disease|2|||
130739231|NCT02848001|470667039|FG010|Overall Study|Progressive Disease|3|||
130739232|NCT02848001|470667040|FG011|Overall Study|Progressive Disease|2|||
130739233|NCT02848001|470667041|FG012|Overall Study|Progressive Disease|1|||
130739234|NCT02848001|470667042|FG013|Overall Study|Progressive Disease|0|||
130739235|NCT02848001|470667043|FG014|Overall Study|Progressive Disease|2|||
130739236|NCT02848001|470667044|FG015|Overall Study|Progressive Disease|4|||
130739237|NCT02848001|470667045|FG016|Overall Study|Progressive Disease|0|||
130739238|NCT02848001|470667029|FG000|Overall Study|Adverse Event|0|||
130739239|NCT02848001|470667030|FG001|Overall Study|Adverse Event|0|||
130739240|NCT02848001|470667031|FG002|Overall Study|Adverse Event|0|||
130739241|NCT02848001|470667032|FG003|Overall Study|Adverse Event|0|||
130739242|NCT02848001|470667033|FG004|Overall Study|Adverse Event|2|||
130739243|NCT02848001|470667034|FG005|Overall Study|Adverse Event|0|||
130739244|NCT02848001|470667035|FG006|Overall Study|Adverse Event|0|||
130739245|NCT02848001|470667036|FG007|Overall Study|Adverse Event|0|||
130739246|NCT02848001|470667037|FG008|Overall Study|Adverse Event|0|||
130739247|NCT02848001|470667038|FG009|Overall Study|Adverse Event|1|||
130739248|NCT02848001|470667039|FG010|Overall Study|Adverse Event|0|||
130739249|NCT02848001|470667040|FG011|Overall Study|Adverse Event|1|||
130739250|NCT02848001|470667041|FG012|Overall Study|Adverse Event|1|||
130739251|NCT02848001|470667042|FG013|Overall Study|Adverse Event|0|||
130786851|NCT03636256|470848951|FG007|Overall Study|Lost to Follow-up|0|||
130786852|NCT03636256|470848952|FG008|Overall Study|Lost to Follow-up|4|||
130786853|NCT03636256|470848944|FG000|Overall Study|Withdrawal by Subject|0|||
130786854|NCT03636256|470848945|FG001|Overall Study|Withdrawal by Subject|0|||
130786855|NCT03636256|470848946|FG002|Overall Study|Withdrawal by Subject|0|||
130786856|NCT03636256|470848947|FG003|Overall Study|Withdrawal by Subject|0|||
130739252|NCT02848001|470667043|FG014|Overall Study|Adverse Event|2|||
130739253|NCT02848001|470667044|FG015|Overall Study|Adverse Event|0|||
130739254|NCT02848001|470667045|FG016|Overall Study|Adverse Event|0|||
130739255|NCT02848001|470667029|FG000|Overall Study|Death|0|||
130739256|NCT02848001|470667030|FG001|Overall Study|Death|0|||
130739257|NCT02848001|470667031|FG002|Overall Study|Death|0|||
130739258|NCT02848001|470667032|FG003|Overall Study|Death|1|||
130739259|NCT02848001|470667033|FG004|Overall Study|Death|3|||
130739260|NCT02848001|470667034|FG005|Overall Study|Death|1|||
130739261|NCT02848001|470667035|FG006|Overall Study|Death|2|||
130739262|NCT02848001|470667036|FG007|Overall Study|Death|3|||
130739263|NCT02848001|470667037|FG008|Overall Study|Death|4|||
130786857|NCT03636256|470848948|FG004|Overall Study|Withdrawal by Subject|0|||
130786858|NCT03636256|470848949|FG005|Overall Study|Withdrawal by Subject|0|||
130786859|NCT03636256|470848950|FG006|Overall Study|Withdrawal by Subject|0|||
130786860|NCT03636256|470848951|FG007|Overall Study|Withdrawal by Subject|0|||
130786861|NCT03636256|470848952|FG008|Overall Study|Withdrawal by Subject|1|||
130786862|NCT01218308|470848953|FG000|Overall Study|Adverse Event|1|||
130786863|NCT01218308|470848954|FG001|Overall Study|Adverse Event|2|||
130786864|NCT01218308|470848953|FG000|Overall Study|Protocol Violation|0|||
130786865|NCT01218308|470848954|FG001|Overall Study|Protocol Violation|2|||
130786866|NCT01218308|470848953|FG000|Overall Study|Withdrawal by Subject|61|||
130786867|NCT01218308|470848954|FG001|Overall Study|Withdrawal by Subject|64|||
130786868|NCT01218308|470848953|FG000|Overall Study|Lost to Follow-up|27|||
130786869|NCT01218308|470848954|FG001|Overall Study|Lost to Follow-up|31|||
130786870|NCT01218308|470848953|FG000|Overall Study|Other|14|||
130786871|NCT01218308|470848954|FG001|Overall Study|Other|21|||
130786872|NCT00547339|470848957|FG000|Overall Study|Physician Decision|0|||
130786873|NCT00547339|470848958|FG001|Overall Study|Physician Decision|0|||
130786874|NCT00547339|470848959|FG002|Overall Study|Physician Decision|1|||
130786875|NCT00547339|470848960|FG003|Overall Study|Physician Decision|0|||
130786876|NCT01516216|470848961|FG000|Overall Study|Adverse Event|2|||
130786877|NCT01516216|470848962|FG001|Overall Study|Adverse Event|4|||
130786878|NCT01516216|470848961|FG000|Overall Study|Disease Progression|38|||
130786879|NCT01516216|470848962|FG001|Overall Study|Disease Progression|34|||
130786880|NCT01516216|470848961|FG000|Overall Study|Withdrawal by Subject|9|||
130786881|NCT01516216|470848962|FG001|Overall Study|Withdrawal by Subject|11|||
130786882|NCT01516216|470848961|FG000|Overall Study|Potentially Curative Resection|6|||
130786883|NCT01516216|470848962|FG001|Overall Study|Potentially Curative Resection|12|||
130786884|NCT01516216|470848961|FG000|Overall Study|Nonadherence|2|||
130786885|NCT01516216|470848962|FG001|Overall Study|Nonadherence|3|||
130786886|NCT01516216|470848961|FG000|Overall Study|Physician Decision|6|||
130786887|NCT01516216|470848962|FG001|Overall Study|Physician Decision|3|||
130786888|NCT01516216|470848961|FG000|Overall Study|Prolonged Treatment Delay|5|||
130786889|NCT01516216|470848962|FG001|Overall Study|Prolonged Treatment Delay|1|||
130786890|NCT01516216|470848961|FG000|Overall Study|Intercurrent Illness|1|||
130786891|NCT01516216|470848962|FG001|Overall Study|Intercurrent Illness|0|||
130786892|NCT01516216|470848961|FG000|Overall Study|Death|1|||
130786893|NCT01516216|470848962|FG001|Overall Study|Death|1|||
130786894|NCT01458587|470848963|FG000|Overall Study|Withdrawal by Subject|1|||
130786895|NCT01458587|470848964|FG001|Overall Study|Withdrawal by Subject|0|||
130786896|NCT01603602|470848965|FG000|Overall Study|Adverse Event|1|||
130786897|NCT01603602|470848966|FG001|Overall Study|Adverse Event|0|||
130786898|NCT01603602|470848967|FG002|Overall Study|Adverse Event|0|||
130786899|NCT01603602|470848965|FG000|Overall Study|Personal Reasons|1|||
130786900|NCT01603602|470848966|FG001|Overall Study|Personal Reasons|0|||
130786901|NCT01603602|470848967|FG002|Overall Study|Personal Reasons|1|||
130786902|NCT04748718|470848970|FG000|Overall Study|Lost to Follow-up|50|||
130786903|NCT01065818|470848971|FG000|Overall Study|Withdrawal by Subject|1|||
130786904|NCT01065818|470848971|FG000|Overall Study|Not a candidate for surgery|1|||
130786905|NCT01450813|470848972|FG000|Overall Study|Physician Decision|1|||
130786906|NCT01450813|470848973|FG001|Overall Study|Physician Decision|1|||
130786907|NCT01450813|470848974|FG002|Overall Study|Physician Decision|0|||
130786908|NCT01450813|470848975|FG003|Overall Study|Physician Decision|3|||
130786909|NCT01935089|470848977|FG000|Overall Study|Adverse Event|2|||
130786910|NCT01935089|470848977|FG000|Overall Study|Withdrawal by Subject|1|||
130786911|NCT02337491|470848981|FG000|Overall Study|Death|1|||
130786912|NCT02337491|470848982|FG001|Overall Study|Death|1|||
130786913|NCT02337491|470848981|FG000|Overall Study|Adverse Event|0|||
130786914|NCT02337491|470848982|FG001|Overall Study|Adverse Event|1|||
130786915|NCT02337491|470848981|FG000|Overall Study|Withdrawal by Subject|3|||
130786916|NCT02337491|470848982|FG001|Overall Study|Withdrawal by Subject|0|||
130786917|NCT02337491|470848981|FG000|Overall Study|Progressive Disease|44|||
130786918|NCT02337491|470848982|FG001|Overall Study|Progressive Disease|28|||
130786919|NCT02337491|470848981|FG000|Overall Study|On Treatment|2|||
130786920|NCT02337491|470848982|FG001|Overall Study|On Treatment|0|||
130786921|NCT00723229|470848983|FG000|First Intervention|Lost to Follow-up|7|||
130786922|NCT00723229|470848984|FG001|First Intervention|Lost to Follow-up|3|||
130786923|NCT01079780|470848985|FG000|Overall Study|Disease progression|43|||
130786924|NCT01079780|470848986|FG001|Overall Study|Disease progression|7|||
130786925|NCT01079780|470848987|FG002|Overall Study|Disease progression|31|||
130786926|NCT01079780|470848985|FG000|Overall Study|Adverse Event|13|||
130786927|NCT01079780|470848986|FG001|Overall Study|Adverse Event|5|||
130786928|NCT01079780|470848987|FG002|Overall Study|Adverse Event|7|||
130786929|NCT01079780|470848985|FG000|Overall Study|Death|2|||
130786930|NCT01079780|470848986|FG001|Overall Study|Death|0|||
130786931|NCT01079780|470848987|FG002|Overall Study|Death|2|||
130786932|NCT01079780|470848985|FG000|Overall Study|Withdrawal by Subject|6|||
130786933|NCT01079780|470848986|FG001|Overall Study|Withdrawal by Subject|4|||
130786934|NCT01079780|470848987|FG002|Overall Study|Withdrawal by Subject|4|||
130786935|NCT01079780|470848985|FG000|Overall Study|Alternative therapy|2|||
130786936|NCT01079780|470848986|FG001|Overall Study|Alternative therapy|0|||
130739264|NCT02848001|470667038|FG009|Overall Study|Death|1|||
130739265|NCT02848001|470667039|FG010|Overall Study|Death|0|||
130739266|NCT02848001|470667040|FG011|Overall Study|Death|1|||
130739267|NCT02848001|470667041|FG012|Overall Study|Death|3|||
130739268|NCT02848001|470667042|FG013|Overall Study|Death|0|||
130739269|NCT02848001|470667043|FG014|Overall Study|Death|2|||
130739270|NCT02848001|470667044|FG015|Overall Study|Death|3|||
130739271|NCT02848001|470667045|FG016|Overall Study|Death|0|||
130739272|NCT02848001|470667029|FG000|Overall Study|Physician Decision|0|||
130739273|NCT02848001|470667030|FG001|Overall Study|Physician Decision|0|||
130739274|NCT02848001|470667031|FG002|Overall Study|Physician Decision|0|||
130739275|NCT02848001|470667032|FG003|Overall Study|Physician Decision|0|||
130739276|NCT02848001|470667033|FG004|Overall Study|Physician Decision|0|||
130739277|NCT02848001|470667034|FG005|Overall Study|Physician Decision|0|||
130739278|NCT02848001|470667035|FG006|Overall Study|Physician Decision|0|||
130739279|NCT02848001|470667036|FG007|Overall Study|Physician Decision|0|||
130739280|NCT02848001|470667037|FG008|Overall Study|Physician Decision|1|||
130739281|NCT02848001|470667038|FG009|Overall Study|Physician Decision|1|||
130739282|NCT02848001|470667039|FG010|Overall Study|Physician Decision|0|||
130739283|NCT02848001|470667040|FG011|Overall Study|Physician Decision|0|||
130739284|NCT02848001|470667041|FG012|Overall Study|Physician Decision|2|||
130739285|NCT02848001|470667042|FG013|Overall Study|Physician Decision|0|||
130739286|NCT02848001|470667043|FG014|Overall Study|Physician Decision|0|||
130739287|NCT02848001|470667044|FG015|Overall Study|Physician Decision|0|||
130739288|NCT02848001|470667045|FG016|Overall Study|Physician Decision|0|||
130739289|NCT02848001|470667029|FG000|Overall Study|Withdrawal by Subject|0|||
130739290|NCT02848001|470667030|FG001|Overall Study|Withdrawal by Subject|0|||
130739291|NCT02848001|470667031|FG002|Overall Study|Withdrawal by Subject|0|||
130739292|NCT02848001|470667032|FG003|Overall Study|Withdrawal by Subject|0|||
130739293|NCT02848001|470667033|FG004|Overall Study|Withdrawal by Subject|0|||
130739294|NCT02848001|470667034|FG005|Overall Study|Withdrawal by Subject|1|||
130739295|NCT02848001|470667035|FG006|Overall Study|Withdrawal by Subject|1|||
130739296|NCT02848001|470667036|FG007|Overall Study|Withdrawal by Subject|1|||
130739297|NCT02848001|470667037|FG008|Overall Study|Withdrawal by Subject|0|||
130739298|NCT02848001|470667038|FG009|Overall Study|Withdrawal by Subject|0|||
130739299|NCT02848001|470667039|FG010|Overall Study|Withdrawal by Subject|0|||
130739300|NCT02848001|470667040|FG011|Overall Study|Withdrawal by Subject|0|||
130739301|NCT02848001|470667041|FG012|Overall Study|Withdrawal by Subject|0|||
130739302|NCT02848001|470667042|FG013|Overall Study|Withdrawal by Subject|0|||
130739303|NCT02848001|470667043|FG014|Overall Study|Withdrawal by Subject|0|||
130739304|NCT02848001|470667044|FG015|Overall Study|Withdrawal by Subject|0|||
130739305|NCT02848001|470667045|FG016|Overall Study|Withdrawal by Subject|0|||
130739306|NCT00711243|470667051|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
130739307|NCT00711243|470667052|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
130739308|NCT00711243|470667053|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
130739309|NCT00711243|470667054|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
130739310|NCT00711243|470667055|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
130739311|NCT00711243|470667056|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
130739312|NCT00711243|470667051|FG000|Reached First Response/4 Cycles|Death|0|||
130739313|NCT00711243|470667052|FG001|Reached First Response/4 Cycles|Death|0|||
130739314|NCT00711243|470667053|FG002|Reached First Response/4 Cycles|Death|0|||
130739315|NCT00711243|470667054|FG003|Reached First Response/4 Cycles|Death|0|||
130739316|NCT00711243|470667055|FG004|Reached First Response/4 Cycles|Death|0|||
130739317|NCT00711243|470667056|FG005|Reached First Response/4 Cycles|Death|2|||
130739318|NCT00711243|470667051|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
130739319|NCT00711243|470667052|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
130739320|NCT00711243|470667053|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
130739321|NCT00711243|470667054|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
130739322|NCT00711243|470667055|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
130739323|NCT00711243|470667056|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
130739324|NCT00711243|470667051|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
130786937|NCT01079780|470848987|FG002|Overall Study|Alternative therapy|2|||
130786938|NCT01079780|470848985|FG000|Overall Study|Physician Decision|1|||
130786939|NCT01079780|470848986|FG001|Overall Study|Physician Decision|0|||
130786940|NCT01079780|470848987|FG002|Overall Study|Physician Decision|1|||
130786941|NCT01079780|470848985|FG000|Overall Study|Error made in lesion measurement|1|||
130786942|NCT01079780|470848986|FG001|Overall Study|Error made in lesion measurement|0|||
130786943|NCT01079780|470848987|FG002|Overall Study|Error made in lesion measurement|0|||
130786944|NCT01079780|470848985|FG000|Overall Study|Patient had surgery|1|||
130786945|NCT01079780|470848986|FG001|Overall Study|Patient had surgery|0|||
130786946|NCT01079780|470848987|FG002|Overall Study|Patient had surgery|0|||
130786947|NCT01079780|470848985|FG000|Overall Study|Treatment cycle delay|0|||
130786948|NCT01079780|470848986|FG001|Overall Study|Treatment cycle delay|0|||
130786949|NCT01079780|470848987|FG002|Overall Study|Treatment cycle delay|1|||
130786950|NCT01079780|470848985|FG000|Overall Study|Never started treatment|1|||
130786951|NCT01079780|470848986|FG001|Overall Study|Never started treatment|0|||
130786952|NCT01079780|470848987|FG002|Overall Study|Never started treatment|2|||
130786953|NCT02783066|470848988|FG000|Overall Study|Withdrawal by Subject|13|||
130786954|NCT05379920|470848993|FG000|Overall Study|Lost to Follow-up|0|||
130786955|NCT05379920|470848994|FG001|Overall Study|Lost to Follow-up|5|||
130786956|NCT05379920|470848995|FG002|Overall Study|Lost to Follow-up|0|||
130786957|NCT05379920|470848996|FG003|Overall Study|Lost to Follow-up|0|||
130786958|NCT03176771|470848997|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
130786959|NCT03176771|470848998|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
130786960|NCT03176771|470848999|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
130786961|NCT03176771|470849000|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
130786962|NCT03176771|470849001|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
130786963|NCT03176771|470848997|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130786964|NCT03176771|470848998|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
130786965|NCT03176771|470848999|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130786966|NCT03176771|470849000|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130786967|NCT03176771|470849001|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130786968|NCT03176771|470848997|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
130786969|NCT03176771|470848998|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
130786970|NCT03176771|470848999|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
130786971|NCT03176771|470849000|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
130786972|NCT03176771|470849001|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
130786973|NCT03176771|470848997|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130786974|NCT03176771|470848998|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130786975|NCT03176771|470848999|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
130786976|NCT03176771|470849000|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130786977|NCT03176771|470849001|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130786978|NCT03176771|470848997|FG000|Double-Blind Extension Period|Adverse Event|0|||
130786979|NCT03176771|470848998|FG001|Double-Blind Extension Period|Adverse Event|0|||
130786980|NCT03176771|470848999|FG002|Double-Blind Extension Period|Adverse Event|0|||
130786981|NCT03176771|470849000|FG003|Double-Blind Extension Period|Adverse Event|15|||
130786982|NCT03176771|470849001|FG004|Double-Blind Extension Period|Adverse Event|18|||
130786983|NCT03176771|470848997|FG000|Double-Blind Extension Period|Death|0|||
130786984|NCT03176771|470848998|FG001|Double-Blind Extension Period|Death|0|||
130786985|NCT03176771|470848999|FG002|Double-Blind Extension Period|Death|0|||
130786986|NCT03176771|470849000|FG003|Double-Blind Extension Period|Death|3|||
130786987|NCT03176771|470849001|FG004|Double-Blind Extension Period|Death|4|||
130786988|NCT03176771|470848997|FG000|Double-Blind Extension Period|Physician Decision|0|||
130786989|NCT03176771|470848998|FG001|Double-Blind Extension Period|Physician Decision|0|||
130786990|NCT03176771|470848999|FG002|Double-Blind Extension Period|Physician Decision|0|||
130786991|NCT03176771|470849000|FG003|Double-Blind Extension Period|Physician Decision|3|||
130786992|NCT03176771|470849001|FG004|Double-Blind Extension Period|Physician Decision|1|||
130786993|NCT03176771|470848997|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
130786994|NCT03176771|470848998|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
130786995|NCT03176771|470848999|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
130786996|NCT03176771|470849000|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
130739325|NCT00711243|470667052|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
130739326|NCT00711243|470667053|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
130739327|NCT00711243|470667054|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
130739328|NCT00711243|470667055|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
130739329|NCT00711243|470667056|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
130739330|NCT00711243|470667051|FG000|Treated Cycle 5 After First Response|Death|0|||
130739331|NCT00711243|470667052|FG001|Treated Cycle 5 After First Response|Death|0|||
130786997|NCT03176771|470849001|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
130739332|NCT00711243|470667053|FG002|Treated Cycle 5 After First Response|Death|0|||
130739333|NCT00711243|470667054|FG003|Treated Cycle 5 After First Response|Death|0|||
130739334|NCT00711243|470667055|FG004|Treated Cycle 5 After First Response|Death|0|||
130739335|NCT00711243|470667056|FG005|Treated Cycle 5 After First Response|Death|2|||
130739336|NCT00711243|470667051|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
130739337|NCT00711243|470667052|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
130739338|NCT00711243|470667053|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
130786998|NCT03530293|470849002|FG000|Pre-randomization|Adverse Event|12|||
130786999|NCT03530293|470849003|FG001|Pre-randomization|Adverse Event|0|||
130787000|NCT03530293|470849004|FG002|Pre-randomization|Adverse Event|0|||
130787001|NCT03530293|470849002|FG000|Pre-randomization|Protocol Violation|2|||
130787002|NCT03530293|470849003|FG001|Pre-randomization|Protocol Violation|0|||
130787003|NCT03530293|470849004|FG002|Pre-randomization|Protocol Violation|0|||
130787004|NCT03530293|470849002|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
130787005|NCT03530293|470849003|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
130787006|NCT03530293|470849004|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
130787007|NCT03530293|470849002|FG000|Pre-randomization|Withdrawal by Subject|5|||
130787008|NCT03530293|470849003|FG001|Pre-randomization|Withdrawal by Subject|0|||
130739339|NCT00711243|470667054|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
130739340|NCT00711243|470667055|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
130739341|NCT00711243|470667056|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
130739342|NCT00711243|470667051|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130739343|NCT00711243|470667052|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130739344|NCT00711243|470667053|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130739345|NCT00711243|470667054|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130739346|NCT00711243|470667055|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130739347|NCT00711243|470667056|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
130739348|NCT01402570|470667057|FG000|Overall Study|Adverse Event|1|||
130739349|NCT01962103|470667061|FG000|Phase 1|Adverse Event|4|||
130739350|NCT01962103|470667062|FG001|Phase 1|Adverse Event|0|||
130739351|NCT01962103|470667063|FG002|Phase 1|Adverse Event|2|||
130739352|NCT01962103|470667064|FG003|Phase 1|Adverse Event|1|||
130739353|NCT01962103|470667065|FG004|Phase 1|Adverse Event|2|||
130739354|NCT01962103|470667066|FG005|Phase 1|Adverse Event|2|||
130739355|NCT01962103|470667067|FG006|Phase 1|Adverse Event|0|||
130787009|NCT03530293|470849004|FG002|Pre-randomization|Withdrawal by Subject|0|||
130787010|NCT03530293|470849002|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
130739356|NCT01962103|470667068|FG007|Phase 1|Adverse Event|0|||
130787011|NCT03530293|470849003|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
130739357|NCT01962103|470667069|FG008|Phase 1|Adverse Event|0|||
130739358|NCT01962103|470667061|FG000|Phase 1|Progressive Disease|8|||
130739359|NCT01962103|470667062|FG001|Phase 1|Progressive Disease|6|||
130787012|NCT03530293|470849004|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
130739360|NCT01962103|470667063|FG002|Phase 1|Progressive Disease|8|||
130787013|NCT03530293|470849002|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
130787014|NCT03530293|470849003|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
130787015|NCT03530293|470849004|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
130739361|NCT01962103|470667064|FG003|Phase 1|Progressive Disease|4|||
130787016|NCT03530293|470849002|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
130787017|NCT03530293|470849003|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
130787018|NCT03530293|470849004|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
130787019|NCT03530293|470849002|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
130787020|NCT03530293|470849003|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
130787021|NCT03530293|470849004|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
130787022|NCT03530293|470849002|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
130739362|NCT01962103|470667065|FG004|Phase 1|Progressive Disease|5|||
130739363|NCT01962103|470667066|FG005|Phase 1|Progressive Disease|4|||
130739364|NCT01962103|470667067|FG006|Phase 1|Progressive Disease|0|||
130739365|NCT01962103|470667068|FG007|Phase 1|Progressive Disease|0|||
130739366|NCT01962103|470667069|FG008|Phase 1|Progressive Disease|0|||
130739367|NCT01962103|470667061|FG000|Phase 1|Withdrawal by Subject|0|||
130739368|NCT01962103|470667062|FG001|Phase 1|Withdrawal by Subject|0|||
130739369|NCT01962103|470667063|FG002|Phase 1|Withdrawal by Subject|0|||
130739370|NCT01962103|470667064|FG003|Phase 1|Withdrawal by Subject|2|||
130739371|NCT01962103|470667065|FG004|Phase 1|Withdrawal by Subject|0|||
130739372|NCT01962103|470667066|FG005|Phase 1|Withdrawal by Subject|0|||
130739373|NCT01962103|470667067|FG006|Phase 1|Withdrawal by Subject|0|||
130739374|NCT01962103|470667068|FG007|Phase 1|Withdrawal by Subject|0|||
130739375|NCT01962103|470667069|FG008|Phase 1|Withdrawal by Subject|0|||
130739376|NCT01962103|470667061|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
130739377|NCT01962103|470667062|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
130739378|NCT01962103|470667063|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
130739379|NCT01962103|470667064|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
130739380|NCT01962103|470667065|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
130739381|NCT01962103|470667066|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
130739382|NCT01962103|470667067|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
130739383|NCT01962103|470667068|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
130739384|NCT01962103|470667069|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
130739385|NCT01962103|470667061|FG000|Phase 1|Physician Decision|0|||
130739386|NCT01962103|470667062|FG001|Phase 1|Physician Decision|0|||
130739387|NCT01962103|470667063|FG002|Phase 1|Physician Decision|0|||
130739388|NCT01962103|470667064|FG003|Phase 1|Physician Decision|1|||
130739389|NCT01962103|470667065|FG004|Phase 1|Physician Decision|0|||
130739390|NCT01962103|470667066|FG005|Phase 1|Physician Decision|0|||
130739391|NCT01962103|470667067|FG006|Phase 1|Physician Decision|0|||
130739392|NCT01962103|470667068|FG007|Phase 1|Physician Decision|0|||
130739393|NCT01962103|470667069|FG008|Phase 1|Physician Decision|0|||
130739394|NCT01962103|470667061|FG000|Phase 1|Symptomatic Deterioration|3|||
130739395|NCT01962103|470667062|FG001|Phase 1|Symptomatic Deterioration|2|||
130739396|NCT01962103|470667063|FG002|Phase 1|Symptomatic Deterioration|2|||
130739397|NCT01962103|470667064|FG003|Phase 1|Symptomatic Deterioration|2|||
130739398|NCT01962103|470667065|FG004|Phase 1|Symptomatic Deterioration|1|||
130739399|NCT01962103|470667066|FG005|Phase 1|Symptomatic Deterioration|1|||
130739400|NCT01962103|470667067|FG006|Phase 1|Symptomatic Deterioration|0|||
130739401|NCT01962103|470667068|FG007|Phase 1|Symptomatic Deterioration|0|||
130739402|NCT01962103|470667069|FG008|Phase 1|Symptomatic Deterioration|0|||
130739403|NCT01962103|470667061|FG000|Phase 1|Miscellaneous|1|||
130739404|NCT01962103|470667062|FG001|Phase 1|Miscellaneous|0|||
130739405|NCT01962103|470667063|FG002|Phase 1|Miscellaneous|0|||
130739406|NCT01962103|470667064|FG003|Phase 1|Miscellaneous|0|||
130739407|NCT01962103|470667065|FG004|Phase 1|Miscellaneous|0|||
130739408|NCT01962103|470667066|FG005|Phase 1|Miscellaneous|0|||
130739409|NCT01962103|470667067|FG006|Phase 1|Miscellaneous|0|||
130739410|NCT01962103|470667068|FG007|Phase 1|Miscellaneous|0|||
130739411|NCT01962103|470667069|FG008|Phase 1|Miscellaneous|0|||
130739412|NCT01962103|470667061|FG000|Phase 2|Adverse Event|0|||
130739413|NCT01962103|470667062|FG001|Phase 2|Adverse Event|0|||
130739414|NCT01962103|470667063|FG002|Phase 2|Adverse Event|0|||
130739415|NCT01962103|470667064|FG003|Phase 2|Adverse Event|0|||
130739416|NCT01962103|470667065|FG004|Phase 2|Adverse Event|0|||
130739417|NCT01962103|470667066|FG005|Phase 2|Adverse Event|0|||
130739418|NCT01962103|470667067|FG006|Phase 2|Adverse Event|1|||
130739419|NCT01962103|470667068|FG007|Phase 2|Adverse Event|0|||
130739420|NCT01962103|470667069|FG008|Phase 2|Adverse Event|3|||
130739421|NCT01962103|470667061|FG000|Phase 2|Progressive Disease|0|||
130739422|NCT01962103|470667062|FG001|Phase 2|Progressive Disease|0|||
130739423|NCT01962103|470667063|FG002|Phase 2|Progressive Disease|0|||
130739424|NCT01962103|470667064|FG003|Phase 2|Progressive Disease|0|||
130739425|NCT01962103|470667065|FG004|Phase 2|Progressive Disease|0|||
130739426|NCT01962103|470667066|FG005|Phase 2|Progressive Disease|0|||
130739427|NCT01962103|470667067|FG006|Phase 2|Progressive Disease|11|||
130739428|NCT01962103|470667068|FG007|Phase 2|Progressive Disease|12|||
130739429|NCT01962103|470667069|FG008|Phase 2|Progressive Disease|11|||
130739430|NCT01962103|470667061|FG000|Phase 2|Symptomatic Deterioration|0|||
130739431|NCT01962103|470667062|FG001|Phase 2|Symptomatic Deterioration|0|||
130739432|NCT01962103|470667063|FG002|Phase 2|Symptomatic Deterioration|0|||
130739433|NCT01962103|470667064|FG003|Phase 2|Symptomatic Deterioration|0|||
130739434|NCT01962103|470667065|FG004|Phase 2|Symptomatic Deterioration|0|||
130739435|NCT01962103|470667066|FG005|Phase 2|Symptomatic Deterioration|0|||
130739436|NCT01962103|470667067|FG006|Phase 2|Symptomatic Deterioration|2|||
130739437|NCT01962103|470667068|FG007|Phase 2|Symptomatic Deterioration|2|||
130739438|NCT01962103|470667069|FG008|Phase 2|Symptomatic Deterioration|0|||
130739439|NCT01321749|470667070|FG000|Overall Study|Lost to Follow-up|4|||
130739440|NCT01321749|470667071|FG001|Overall Study|Lost to Follow-up|11|||
130739441|NCT01321749|470667070|FG000|Overall Study|Protocol Violation|4|||
130739442|NCT01321749|470667071|FG001|Overall Study|Protocol Violation|7|||
130739443|NCT01321749|470667070|FG000|Overall Study|Withdrawal by Subject|5|||
130739444|NCT01321749|470667071|FG001|Overall Study|Withdrawal by Subject|4|||
130739445|NCT04179838|470667075|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
130739446|NCT04179838|470667076|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
130739447|NCT04179838|470667075|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
130739448|NCT04179838|470667076|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
130739449|NCT01290068|470667081|FG000|Overall Study|Adverse Event|1|||
130739450|NCT01290068|470667082|FG001|Overall Study|Adverse Event|3|||
130739451|NCT01290068|470667081|FG000|Overall Study|Lost to Follow-up|3|||
130739452|NCT01290068|470667082|FG001|Overall Study|Lost to Follow-up|0|||
130739453|NCT01290068|470667081|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
130739454|NCT01290068|470667082|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
130739455|NCT01290068|470667081|FG000|Overall Study|Other|3|||
130739456|NCT01290068|470667082|FG001|Overall Study|Other|1|||
130739457|NCT00513695|470667083|FG000|Overall Study|Discontinued therapy|2|||
130739458|NCT00513695|470667083|FG000|Overall Study|Progression prior to surgery|3|||
130739459|NCT01417156|470667090|FG000|Overall Study|Adverse Event|12|||
130739460|NCT01417156|470667090|FG000|Overall Study|Protocol Violation|2|||
130739461|NCT00818766|470667093|FG000|Overall Study|Could not be Contacted on Day 28|11|||
130739462|NCT00818766|470667094|FG001|Overall Study|Could not be Contacted on Day 28|10|||
130739463|NCT00818766|470667093|FG000|Overall Study|Death|1|||
130739464|NCT00818766|470667094|FG001|Overall Study|Death|0|||
130739465|NCT00818766|470667093|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
130739466|NCT00818766|470667094|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
130739467|NCT00725491|470667100|FG000|Overall Study|Adverse Event|3|||
130739468|NCT00725491|470667101|FG001|Overall Study|Adverse Event|2|||
130739469|NCT00725491|470667100|FG000|Overall Study|Pregnancy|0|||
130739470|NCT00725491|470667101|FG001|Overall Study|Pregnancy|3|||
130739471|NCT00725491|470667100|FG000|Overall Study|Risk for hyperstimulation|2|||
130739472|NCT00725491|470667101|FG001|Overall Study|Risk for hyperstimulation|9|||
130739473|NCT00725491|470667100|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
130739474|NCT00725491|470667101|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
130739475|NCT00725491|470667100|FG000|Overall Study|Fertilization failure|0|||
130739476|NCT00725491|470667101|FG001|Overall Study|Fertilization failure|1|||
130739477|NCT00725491|470667100|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
130739478|NCT00725491|470667101|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
130739479|NCT00942357|470667113|FG000|Overall Study|Ineligible|37|||
130739480|NCT00942357|470667114|FG001|Overall Study|Ineligible|40|||
130739481|NCT00882518|470667115|FG000|Overall Study|Adverse Event|9|||
130739482|NCT00882518|470667116|FG001|Overall Study|Adverse Event|18|||
130739483|NCT00882518|470667115|FG000|Overall Study|Withdrawal by Subject|9|||
130739484|NCT00882518|470667116|FG001|Overall Study|Withdrawal by Subject|13|||
130739485|NCT00882518|470667115|FG000|Overall Study|Lack of Efficacy|12|||
130739486|NCT00882518|470667116|FG001|Overall Study|Lack of Efficacy|9|||
130739487|NCT00882518|470667115|FG000|Overall Study|Severe non-compliance to protocol|3|||
130739488|NCT00882518|470667116|FG001|Overall Study|Severe non-compliance to protocol|1|||
130739489|NCT00882518|470667115|FG000|Overall Study|Incorrect enrolment|4|||
130739490|NCT00882518|470667116|FG001|Overall Study|Incorrect enrolment|2|||
130739491|NCT00882518|470667115|FG000|Overall Study|Central lab closure for National day|1|||
130739492|NCT00882518|470667116|FG001|Overall Study|Central lab closure for National day|0|||
130739493|NCT00882518|470667115|FG000|Overall Study|Allocating random number by mistake|0|||
130739494|NCT00882518|470667116|FG001|Overall Study|Allocating random number by mistake|1|||
130739495|NCT02137252|470667117|FG000|Overall Study|trial terminated early|2|||
130739496|NCT02137252|470667118|FG001|Overall Study|trial terminated early|1|||
130739497|NCT00729937|470667119|FG000|Overall Study|Lost to Follow-up|49|||
130739498|NCT00729937|470667120|FG001|Overall Study|Lost to Follow-up|58|||
130739499|NCT00729937|470667121|FG002|Overall Study|Lost to Follow-up|18|||
130739500|NCT00729937|470667122|FG003|Overall Study|Lost to Follow-up|33|||
130739501|NCT00729937|470667123|FG004|Overall Study|Lost to Follow-up|18|||
130739502|NCT00729937|470667124|FG005|Overall Study|Lost to Follow-up|23|||
130739503|NCT00729937|470667119|FG000|Overall Study|Physician Decision|7|||
130739504|NCT00729937|470667120|FG001|Overall Study|Physician Decision|16|||
130739505|NCT00729937|470667121|FG002|Overall Study|Physician Decision|2|||
130739506|NCT00729937|470667122|FG003|Overall Study|Physician Decision|0|||
130739507|NCT00729937|470667123|FG004|Overall Study|Physician Decision|5|||
130739508|NCT00729937|470667124|FG005|Overall Study|Physician Decision|8|||
130739509|NCT00729937|470667119|FG000|Overall Study|Death|1|||
130739510|NCT00729937|470667120|FG001|Overall Study|Death|0|||
130739511|NCT00729937|470667121|FG002|Overall Study|Death|1|||
130739512|NCT00729937|470667122|FG003|Overall Study|Death|0|||
130739513|NCT00729937|470667123|FG004|Overall Study|Death|0|||
130739514|NCT00729937|470667124|FG005|Overall Study|Death|1|||
130739515|NCT00729937|470667119|FG000|Overall Study|Withdrawal by Subject|3|||
130739516|NCT00729937|470667120|FG001|Overall Study|Withdrawal by Subject|5|||
130739517|NCT00729937|470667121|FG002|Overall Study|Withdrawal by Subject|6|||
130739518|NCT00729937|470667122|FG003|Overall Study|Withdrawal by Subject|0|||
130739519|NCT00729937|470667123|FG004|Overall Study|Withdrawal by Subject|4|||
130739520|NCT00729937|470667124|FG005|Overall Study|Withdrawal by Subject|2|||
130739521|NCT00729937|470667119|FG000|Overall Study|Randomized but not treated|12|||
130739522|NCT00729937|470667120|FG001|Overall Study|Randomized but not treated|6|||
130739523|NCT00729937|470667121|FG002|Overall Study|Randomized but not treated|1|||
130739524|NCT00729937|470667122|FG003|Overall Study|Randomized but not treated|0|||
130739525|NCT00729937|470667123|FG004|Overall Study|Randomized but not treated|1|||
130739526|NCT00729937|470667124|FG005|Overall Study|Randomized but not treated|3|||
130739527|NCT00729937|470667119|FG000|Overall Study|Did not meet eligibility criteria|2|||
130739528|NCT00729937|470667120|FG001|Overall Study|Did not meet eligibility criteria|1|||
130739529|NCT00729937|470667121|FG002|Overall Study|Did not meet eligibility criteria|0|||
130739530|NCT00729937|470667122|FG003|Overall Study|Did not meet eligibility criteria|0|||
130739531|NCT00729937|470667123|FG004|Overall Study|Did not meet eligibility criteria|0|||
130739532|NCT00729937|470667124|FG005|Overall Study|Did not meet eligibility criteria|0|||
130739533|NCT00729937|470667119|FG000|Overall Study|Incarcerated|0|||
130739534|NCT00729937|470667120|FG001|Overall Study|Incarcerated|2|||
130739535|NCT00729937|470667121|FG002|Overall Study|Incarcerated|1|||
130739536|NCT00729937|470667122|FG003|Overall Study|Incarcerated|1|||
130739537|NCT00729937|470667123|FG004|Overall Study|Incarcerated|0|||
130739538|NCT00729937|470667124|FG005|Overall Study|Incarcerated|0|||
130739539|NCT00243412|470667125|FG000|Overall Study|Death|0|||
130739540|NCT00243412|470667126|FG001|Overall Study|Death|1|||
130739541|NCT00243412|470667125|FG000|Overall Study|Adverse Event|4|||
130739542|NCT00243412|470667126|FG001|Overall Study|Adverse Event|2|||
130739543|NCT00243412|470667125|FG000|Overall Study|Lost to Follow-up|0|||
130739544|NCT00243412|470667126|FG001|Overall Study|Lost to Follow-up|1|||
130739545|NCT00243412|470667125|FG000|Overall Study|Physician Decision|1|||
130739546|NCT00243412|470667126|FG001|Overall Study|Physician Decision|1|||
130739547|NCT00243412|470667125|FG000|Overall Study|Withdrawal by Subject|4|||
130739548|NCT00243412|470667126|FG001|Overall Study|Withdrawal by Subject|5|||
130739549|NCT00243412|470667125|FG000|Overall Study|Other|1|||
130739550|NCT00243412|470667126|FG001|Overall Study|Other|1|||
130739551|NCT03281876|470667135|FG000|Overall Study|Adverse Event|4|||
130739552|NCT03281876|470667136|FG001|Overall Study|Adverse Event|15|||
130739553|NCT03281876|470667135|FG000|Overall Study|Lost to Follow-up|1|||
130739554|NCT03281876|470667136|FG001|Overall Study|Lost to Follow-up|4|||
130739555|NCT03281876|470667135|FG000|Overall Study|Withdrawal by Subject|11|||
130739556|NCT03281876|470667136|FG001|Overall Study|Withdrawal by Subject|15|||
130739557|NCT03281876|470667135|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130739558|NCT03281876|470667136|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130739559|NCT03281876|470667135|FG000|Overall Study|OTHER|5|||
130739560|NCT03281876|470667136|FG001|Overall Study|OTHER|5|||
130739561|NCT02208089|470667137|FG000|Overall Study|Withdrawal by Subject|1|||
130739562|NCT02208089|470667138|FG001|Overall Study|Withdrawal by Subject|0|||
130739563|NCT02208089|470667137|FG000|Overall Study|Lost to Follow-up|6|||
130739564|NCT02208089|470667138|FG001|Overall Study|Lost to Follow-up|0|||
130739565|NCT00683657|470667144|FG000|Overall Study|Adverse Event|0|||
130739566|NCT00683657|470667145|FG001|Overall Study|Adverse Event|1|||
130739567|NCT00683657|470667144|FG000|Overall Study|Subject Withdrew Consent|1|||
130739568|NCT00683657|470667145|FG001|Overall Study|Subject Withdrew Consent|0|||
130739569|NCT01408043|470667148|FG000|Overall Study|unable to collect cells|1|||
130739570|NCT00972595|470667149|FG000|Period 1|Adverse Event|1|||
130739571|NCT00972595|470667150|FG001|Period 1|Adverse Event|0|||
130739572|NCT02552121|470667151|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
130739573|NCT02552121|470667152|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130739574|NCT02552121|470667153|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130739575|NCT02552121|470667154|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130739576|NCT02552121|470667155|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130739577|NCT02552121|470667156|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130739578|NCT02552121|470667157|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130739579|NCT02552121|470667158|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130739580|NCT02552121|470667151|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
130739581|NCT02552121|470667152|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130739582|NCT02552121|470667153|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130739583|NCT02552121|470667154|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130739584|NCT02552121|470667155|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130739585|NCT02552121|470667156|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130739586|NCT02552121|470667157|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130739587|NCT02552121|470667158|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130739588|NCT02552121|470667151|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130739589|NCT02552121|470667152|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
130739590|NCT02552121|470667153|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130739591|NCT02552121|470667154|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130822744|NCT00812955|470980589|FG000|Overall Study|Withdrawal by Subject|1|||
130739592|NCT02552121|470667155|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130739593|NCT02552121|470667156|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130739594|NCT02552121|470667157|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130739595|NCT02552121|470667158|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130739596|NCT02552121|470667151|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130739597|NCT02552121|470667152|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
130739598|NCT02552121|470667153|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130739599|NCT02552121|470667154|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130739600|NCT02552121|470667155|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130739601|NCT02552121|470667156|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130739602|NCT02552121|470667157|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130739603|NCT02552121|470667158|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130739604|NCT02552121|470667151|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130739605|NCT02552121|470667152|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
130739606|NCT02552121|470667153|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130739607|NCT02552121|470667154|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130739608|NCT02552121|470667155|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130739609|NCT02552121|470667156|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130739610|NCT02552121|470667157|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130739611|NCT02552121|470667158|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130739612|NCT02552121|470667151|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130739613|NCT02552121|470667152|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
130739614|NCT02552121|470667153|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130739615|NCT02552121|470667154|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130739616|NCT02552121|470667155|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130739617|NCT02552121|470667156|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130739618|NCT02552121|470667157|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130739619|NCT02552121|470667158|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130739620|NCT02552121|470667151|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
130739621|NCT02552121|470667152|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
130739622|NCT02552121|470667153|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
130739623|NCT02552121|470667154|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
130739624|NCT02552121|470667155|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
130739625|NCT02552121|470667156|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
130739626|NCT02552121|470667157|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
130739627|NCT02552121|470667158|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
130739628|NCT02552121|470667151|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
130739629|NCT02552121|470667152|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
130739630|NCT02552121|470667153|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
130739631|NCT02552121|470667154|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
130739632|NCT02552121|470667155|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
130739633|NCT02552121|470667156|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
130739634|NCT02552121|470667157|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
130739635|NCT02552121|470667158|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
130739636|NCT02552121|470667151|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
130739637|NCT02552121|470667152|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
130739638|NCT02552121|470667153|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
130739639|NCT02552121|470667154|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
130739640|NCT02552121|470667155|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
130739641|NCT02552121|470667156|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
130739642|NCT02552121|470667157|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
130739643|NCT02552121|470667158|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
130739644|NCT02552121|470667151|FG000|Part 2: Cohort Expansion|Death|0|||
130739645|NCT02552121|470667152|FG001|Part 2: Cohort Expansion|Death|0|||
130739646|NCT02552121|470667153|FG002|Part 2: Cohort Expansion|Death|1|||
130739647|NCT02552121|470667154|FG003|Part 2: Cohort Expansion|Death|0|||
130739648|NCT02552121|470667155|FG004|Part 2: Cohort Expansion|Death|0|||
130739649|NCT02552121|470667156|FG005|Part 2: Cohort Expansion|Death|0|||
130739650|NCT02552121|470667157|FG006|Part 2: Cohort Expansion|Death|0|||
130739651|NCT02552121|470667158|FG007|Part 2: Cohort Expansion|Death|0|||
130739652|NCT02586155|470667159|FG000|Overall Study|Adverse Event|2|||
130739653|NCT02586155|470667160|FG001|Overall Study|Adverse Event|3|||
130739654|NCT02586155|470667159|FG000|Overall Study|Withdrawal by Subject|31|||
130739655|NCT02586155|470667160|FG001|Overall Study|Withdrawal by Subject|24|||
130739656|NCT02586155|470667159|FG000|Overall Study|Lost to Follow-up|7|||
130739657|NCT02586155|470667160|FG001|Overall Study|Lost to Follow-up|13|||
130739658|NCT02586155|470667159|FG000|Overall Study|Death|61|||
130739659|NCT02586155|470667160|FG001|Overall Study|Death|72|||
130739660|NCT02586155|470667159|FG000|Overall Study|Other reasons|26|||
130787023|NCT03530293|470849003|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
130787024|NCT03530293|470849004|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
130739661|NCT02586155|470667160|FG001|Overall Study|Other reasons|15|||
130739662|NCT00739063|470667163|FG000|Overall Study|Screen failures|8|||
130739663|NCT04779879|470667164|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130739664|NCT04779879|470667165|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130739665|NCT04779879|470667166|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130739666|NCT04779879|470667167|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
130739667|NCT04779879|470667168|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130739668|NCT04779879|470667169|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130739669|NCT04779879|470667164|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
130739670|NCT04779879|470667165|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
130739671|NCT04779879|470667166|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
130739672|NCT04779879|470667167|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
130739673|NCT04779879|470667168|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
130739674|NCT04779879|470667169|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
130739675|NCT04779879|470667164|FG000|Part C: Up to Week 36|Death|0|||
130739676|NCT04779879|470667165|FG001|Part C: Up to Week 36|Death|0|||
130739677|NCT04779879|470667166|FG002|Part C: Up to Week 36|Death|0|||
130739678|NCT04779879|470667167|FG003|Part C: Up to Week 36|Death|0|||
130739679|NCT04779879|470667168|FG004|Part C: Up to Week 36|Death|0|||
130739680|NCT04779879|470667169|FG005|Part C: Up to Week 36|Death|1|||
130739681|NCT04779879|470667164|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
130739682|NCT04779879|470667165|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
130739683|NCT04779879|470667166|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
130739684|NCT04779879|470667167|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
130739685|NCT04779879|470667168|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
130739686|NCT04779879|470667169|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
130739687|NCT02461160|470667170|FG000|Overall Study|Lost to Follow-up|0|||
130739688|NCT02461160|470667171|FG001|Overall Study|Lost to Follow-up|0|||
130739689|NCT02461160|470667172|FG002|Overall Study|Lost to Follow-up|0|||
130739690|NCT02461160|470667173|FG003|Overall Study|Lost to Follow-up|0|||
130739691|NCT02461160|470667174|FG004|Overall Study|Lost to Follow-up|0|||
130739692|NCT02461160|470667175|FG005|Overall Study|Lost to Follow-up|0|||
130739693|NCT02461160|470667176|FG006|Overall Study|Lost to Follow-up|0|||
130739694|NCT02461160|470667177|FG007|Overall Study|Lost to Follow-up|1|||
130739695|NCT02461160|470667178|FG008|Overall Study|Lost to Follow-up|0|||
130739696|NCT02461160|470667179|FG009|Overall Study|Lost to Follow-up|0|||
130739697|NCT02461160|470667180|FG010|Overall Study|Lost to Follow-up|0|||
130739698|NCT02461160|470667181|FG011|Overall Study|Lost to Follow-up|0|||
130739699|NCT02461160|470667182|FG012|Overall Study|Lost to Follow-up|0|||
130739700|NCT02854527|470667183|FG000|Overall Study|Adverse Event|0|||
130739701|NCT02854527|470667184|FG001|Overall Study|Adverse Event|0|||
130739702|NCT02854527|470667185|FG002|Overall Study|Adverse Event|0|||
130739703|NCT02854527|470667186|FG003|Overall Study|Adverse Event|0|||
130739704|NCT02854527|470667187|FG004|Overall Study|Adverse Event|1|||
130739705|NCT02854527|470667188|FG005|Overall Study|Adverse Event|0|||
130739706|NCT02854527|470667189|FG006|Overall Study|Adverse Event|0|||
130739707|NCT02854527|470667190|FG007|Overall Study|Adverse Event|0|||
130739708|NCT02854527|470667191|FG008|Overall Study|Adverse Event|0|||
130739709|NCT02854527|470667192|FG009|Overall Study|Adverse Event|0|||
130739710|NCT02854527|470667183|FG000|Overall Study|Lost to Follow-up|0|||
130739711|NCT02854527|470667184|FG001|Overall Study|Lost to Follow-up|0|||
130739712|NCT02854527|470667185|FG002|Overall Study|Lost to Follow-up|0|||
130739713|NCT02854527|470667186|FG003|Overall Study|Lost to Follow-up|1|||
130739714|NCT02854527|470667187|FG004|Overall Study|Lost to Follow-up|0|||
130739715|NCT02854527|470667188|FG005|Overall Study|Lost to Follow-up|0|||
130739716|NCT02854527|470667189|FG006|Overall Study|Lost to Follow-up|0|||
130739717|NCT02854527|470667190|FG007|Overall Study|Lost to Follow-up|0|||
130739718|NCT02854527|470667191|FG008|Overall Study|Lost to Follow-up|0|||
130739719|NCT02854527|470667192|FG009|Overall Study|Lost to Follow-up|0|||
130739720|NCT02899962|470667193|FG000|Open-label Phase|Adverse Event|2|||
130739721|NCT02899962|470667194|FG001|Open-label Phase|Adverse Event|0|||
130739722|NCT02899962|470667195|FG002|Open-label Phase|Adverse Event|0|||
130739723|NCT02899962|470667193|FG000|Open-label Phase|Lost to Follow-up|9|||
130739724|NCT02899962|470667194|FG001|Open-label Phase|Lost to Follow-up|0|||
130739725|NCT02899962|470667195|FG002|Open-label Phase|Lost to Follow-up|0|||
130739726|NCT02899962|470667193|FG000|Open-label Phase|Other reasons|9|||
130739727|NCT02899962|470667194|FG001|Open-label Phase|Other reasons|0|||
130739728|NCT02899962|470667195|FG002|Open-label Phase|Other reasons|0|||
130739729|NCT02899962|470667193|FG000|Open-label Phase|Withdrawal by Subject|7|||
130739730|NCT02899962|470667194|FG001|Open-label Phase|Withdrawal by Subject|0|||
130739731|NCT02899962|470667195|FG002|Open-label Phase|Withdrawal by Subject|0|||
130739732|NCT02899962|470667193|FG000|Maintenance Phase|Adverse Event|0|||
130739733|NCT02899962|470667194|FG001|Maintenance Phase|Adverse Event|2|||
130739734|NCT02899962|470667195|FG002|Maintenance Phase|Adverse Event|1|||
130739735|NCT02899962|470667193|FG000|Maintenance Phase|Death|0|||
130739736|NCT02899962|470667194|FG001|Maintenance Phase|Death|0|||
130739737|NCT02899962|470667195|FG002|Maintenance Phase|Death|1|||
130739738|NCT02899962|470667193|FG000|Maintenance Phase|Lack of Efficacy|0|||
130739739|NCT02899962|470667194|FG001|Maintenance Phase|Lack of Efficacy|20|||
130739740|NCT02899962|470667195|FG002|Maintenance Phase|Lack of Efficacy|16|||
130739741|NCT02899962|470667193|FG000|Maintenance Phase|Lost to Follow-up|0|||
130739742|NCT02899962|470667194|FG001|Maintenance Phase|Lost to Follow-up|12|||
130739743|NCT02899962|470667195|FG002|Maintenance Phase|Lost to Follow-up|14|||
130739744|NCT02899962|470667193|FG000|Maintenance Phase|Other reasons|0|||
130739745|NCT02899962|470667194|FG001|Maintenance Phase|Other reasons|9|||
130739746|NCT02899962|470667195|FG002|Maintenance Phase|Other reasons|13|||
130739747|NCT02899962|470667193|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
130739748|NCT02899962|470667194|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
130739749|NCT02899962|470667195|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
130739750|NCT02899962|470667193|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
130739751|NCT02899962|470667194|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
130739752|NCT02899962|470667195|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
130739753|NCT02899962|470667193|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130739754|NCT02899962|470667194|FG001|Maintenance Phase|Withdrawal by Subject|30|||
130739755|NCT02899962|470667195|FG002|Maintenance Phase|Withdrawal by Subject|36|||
130739756|NCT02575833|470667203|FG000|Overall Study|Withdrawal by Subject|0|||
130787025|NCT02732639|470849006|FG000|Overall Study|Lost to Follow-up|1|||
130739757|NCT02575833|470667204|FG001|Overall Study|Withdrawal by Subject|1|||
130739758|NCT02575833|470667203|FG000|Overall Study|Lost to Follow-up|1|||
130739759|NCT02575833|470667204|FG001|Overall Study|Lost to Follow-up|0|||
130739760|NCT03093259|470667205|FG000|Overall Study|Adverse Event|1|||
130739761|NCT03093259|470667206|FG001|Overall Study|Adverse Event|0|||
130739762|NCT03093259|470667205|FG000|Overall Study|Withdrawal by Subject|1|||
130739763|NCT03093259|470667206|FG001|Overall Study|Withdrawal by Subject|0|||
130739764|NCT01821807|470667207|FG000|Overall Study|Lost to Follow-up|3|||
130739765|NCT01821807|470667208|FG001|Overall Study|Lost to Follow-up|1|||
130739766|NCT00550459|470667210|FG000|Overall Study|Adverse Event|0|||
130739767|NCT00550459|470667211|FG001|Overall Study|Adverse Event|2|||
130739768|NCT00550459|470667210|FG000|Overall Study|Withdrawal by Subject|1|||
130739769|NCT00550459|470667211|FG001|Overall Study|Withdrawal by Subject|1|||
130739770|NCT02633787|470667212|FG000|Overall Study|Withdrawal by Subject|1|||
130787026|NCT02265510|470849009|FG000|Overall Study|Withdrawal by Subject|1|||
130787027|NCT02265510|470849010|FG001|Overall Study|Withdrawal by Subject|1|||
130787028|NCT02265510|470849011|FG002|Overall Study|Withdrawal by Subject|2|||
130787029|NCT02265510|470849012|FG003|Overall Study|Withdrawal by Subject|1|||
130787030|NCT02265510|470849013|FG004|Overall Study|Withdrawal by Subject|0|||
130787031|NCT02265510|470849014|FG005|Overall Study|Withdrawal by Subject|2|||
130787032|NCT02265510|470849015|FG006|Overall Study|Withdrawal by Subject|0|||
130787033|NCT02265510|470849016|FG007|Overall Study|Withdrawal by Subject|2|||
130787034|NCT02265510|470849017|FG008|Overall Study|Withdrawal by Subject|0|||
130787035|NCT02265510|470849018|FG009|Overall Study|Withdrawal by Subject|0|||
130787036|NCT02265510|470849019|FG010|Overall Study|Withdrawal by Subject|0|||
130787037|NCT02265510|470849020|FG011|Overall Study|Withdrawal by Subject|0|||
130787038|NCT02265510|470849021|FG012|Overall Study|Withdrawal by Subject|1|||
130787039|NCT02265510|470849022|FG013|Overall Study|Withdrawal by Subject|0|||
130787040|NCT02265510|470849009|FG000|Overall Study|Disease Progression|0|||
130787041|NCT02265510|470849010|FG001|Overall Study|Disease Progression|1|||
130787042|NCT02265510|470849011|FG002|Overall Study|Disease Progression|2|||
130739771|NCT01742897|470667213|FG000|Overall Study|Adverse Event|3|||
130739772|NCT01742897|470667213|FG000|Overall Study|Withdrawal by Subject|1|||
130739773|NCT01742897|470667213|FG000|Overall Study|Other|1|||
130739774|NCT02404805|470667214|FG000|Overall Study|Withdrawal by Subject|1|||
130739775|NCT02404805|470667215|FG001|Overall Study|Withdrawal by Subject|0|||
130739776|NCT02404805|470667216|FG002|Overall Study|Withdrawal by Subject|0|||
130739777|NCT02404805|470667217|FG003|Overall Study|Withdrawal by Subject|0|||
130739778|NCT02404805|470667218|FG004|Overall Study|Withdrawal by Subject|0|||
130739779|NCT02404805|470667219|FG005|Overall Study|Withdrawal by Subject|0|||
130739780|NCT00625820|470667221|FG000|Overall Study|Withdrawal by Subject|1|||
130739781|NCT00445146|470667222|FG000|Overall Study|Withdrew Consent|29|||
130739782|NCT00445146|470667222|FG000|Overall Study|Lack of Efficacy|28|||
130739783|NCT00445146|470667222|FG000|Overall Study|Investigator's Discretion|22|||
130739784|NCT00445146|470667222|FG000|Overall Study|Adverse Event|13|||
130739785|NCT00445146|470667222|FG000|Overall Study|Lost to Follow-up|13|||
130739786|NCT00445146|470667222|FG000|Overall Study|Death|9|||
130739787|NCT00445146|470667222|FG000|Overall Study|Protocol Violation|4|||
130739788|NCT00445146|470667222|FG000|Overall Study|Pregnancy|1|||
130739789|NCT02456740|470667224|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
130739790|NCT02456740|470667225|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
130787043|NCT02265510|470849012|FG003|Overall Study|Disease Progression|1|||
130787044|NCT02265510|470849013|FG004|Overall Study|Disease Progression|1|||
130739791|NCT02456740|470667226|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
130739792|NCT02456740|470667227|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130739793|NCT02456740|470667228|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130739794|NCT02456740|470667229|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130739795|NCT02456740|470667230|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130739796|NCT02456740|470667231|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130739797|NCT02456740|470667232|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130739798|NCT02456740|470667224|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
130739799|NCT02456740|470667225|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
130739800|NCT02456740|470667226|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
130739801|NCT02456740|470667227|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130739802|NCT02456740|470667228|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130739803|NCT02456740|470667229|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130739804|NCT02456740|470667230|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130739805|NCT02456740|470667231|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130739806|NCT02456740|470667232|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130739807|NCT02456740|470667224|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
130739808|NCT02456740|470667225|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
130739809|NCT02456740|470667226|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
130739810|NCT02456740|470667227|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130739811|NCT02456740|470667228|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130739812|NCT02456740|470667229|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130739813|NCT02456740|470667230|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130739814|NCT02456740|470667231|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130739815|NCT02456740|470667232|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130739816|NCT02456740|470667224|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130739817|NCT02456740|470667225|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130739818|NCT02456740|470667226|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130739819|NCT02456740|470667227|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
130739820|NCT02456740|470667228|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
130739821|NCT02456740|470667229|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130739822|NCT02456740|470667230|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130739823|NCT02456740|470667231|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130739824|NCT02456740|470667232|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
130739825|NCT02456740|470667224|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130739826|NCT02456740|470667225|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130739827|NCT02456740|470667226|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130739828|NCT02456740|470667227|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
130739829|NCT02456740|470667228|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
130739830|NCT02456740|470667229|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
130739831|NCT02456740|470667230|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
130739832|NCT02456740|470667231|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
130739833|NCT02456740|470667232|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
130739834|NCT02456740|470667224|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130739835|NCT02456740|470667225|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130739836|NCT02456740|470667226|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130739837|NCT02456740|470667227|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130739838|NCT02456740|470667228|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130739839|NCT02456740|470667229|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130739840|NCT02456740|470667230|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130739841|NCT02456740|470667231|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
130739842|NCT02456740|470667232|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130739843|NCT02456740|470667224|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130739844|NCT02456740|470667225|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130739845|NCT02456740|470667226|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130739846|NCT02456740|470667227|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
130739847|NCT02456740|470667228|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
130739848|NCT02456740|470667229|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
130739849|NCT02456740|470667230|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
130739850|NCT02456740|470667231|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
130739851|NCT02456740|470667232|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
130739852|NCT03759392|470667233|FG000|Overall Study|Adverse Event|12|||
130739853|NCT03759392|470667234|FG001|Overall Study|Adverse Event|4|||
130739854|NCT03759392|470667233|FG000|Overall Study|Death|2|||
130739855|NCT03759392|470667234|FG001|Overall Study|Death|1|||
130739856|NCT03759392|470667233|FG000|Overall Study|Withdrawal by Subject|2|||
130739857|NCT03759392|470667234|FG001|Overall Study|Withdrawal by Subject|0|||
130739858|NCT03759392|470667233|FG000|Overall Study|Protocol Violation|2|||
130739859|NCT03759392|470667234|FG001|Overall Study|Protocol Violation|0|||
130739860|NCT03759392|470667233|FG000|Overall Study|Physician Decision|0|||
130739861|NCT03759392|470667234|FG001|Overall Study|Physician Decision|1|||
130739862|NCT03759392|470667233|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
130739863|NCT03759392|470667234|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
130739864|NCT03759392|470667233|FG000|Overall Study|No longer able to take medicines|1|||
130739865|NCT03759392|470667234|FG001|Overall Study|No longer able to take medicines|0|||
130739866|NCT03759392|470667233|FG000|Overall Study|Stopped taking study drug|1|||
130739867|NCT03759392|470667234|FG001|Overall Study|Stopped taking study drug|0|||
130739868|NCT02623725|470667235|FG000|Overall Study|Non compliance with protocol|9|||
130739869|NCT02623725|470667236|FG001|Overall Study|Non compliance with protocol|3|||
130739870|NCT02623725|470667235|FG000|Overall Study|Serious adverse event|0|||
130739871|NCT02623725|470667236|FG001|Overall Study|Serious adverse event|2|||
130739872|NCT02623725|470667235|FG000|Overall Study|Withdrawal by Subject|7|||
130739873|NCT02623725|470667236|FG001|Overall Study|Withdrawal by Subject|1|||
130739874|NCT00967330|470667237|FG000|Overall Study|Protocol Violation|3|||
130739875|NCT00967330|470667238|FG001|Overall Study|Protocol Violation|4|||
130739876|NCT00967330|470667237|FG000|Overall Study|Regular|10|||
130739877|NCT00967330|470667238|FG001|Overall Study|Regular|3|||
130739878|NCT00967330|470667237|FG000|Overall Study|Withdrawal by Subject|6|||
130739879|NCT00967330|470667238|FG001|Overall Study|Withdrawal by Subject|0|||
130739880|NCT00967330|470667237|FG000|Overall Study|Lost to Follow-up|1|||
130739881|NCT00967330|470667238|FG001|Overall Study|Lost to Follow-up|1|||
130739882|NCT00967330|470667237|FG000|Overall Study|Death|102|||
130739883|NCT00967330|470667238|FG001|Overall Study|Death|51|||
130739884|NCT00967330|470667237|FG000|Overall Study|Severe protocol deviation|0|||
130739885|NCT00967330|470667238|FG001|Overall Study|Severe protocol deviation|1|||
130739886|NCT04720105|470667239|FG000|Overall Study|Lack of Efficacy|1|||
130739887|NCT04720105|470667239|FG000|Overall Study|Lost to Follow-up|1|||
130739888|NCT04720105|470667239|FG000|Overall Study|Withdrawal by Subject|3|||
130739889|NCT04871776|470667243|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
130739890|NCT04871776|470667244|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
130739891|NCT04871776|470667245|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
130739892|NCT04871776|470667243|FG000|Overall Study|Did not meet eligibility criteria|1|||
130739893|NCT04871776|470667244|FG001|Overall Study|Did not meet eligibility criteria|1|||
130739894|NCT04871776|470667245|FG002|Overall Study|Did not meet eligibility criteria|1|||
130739895|NCT04075487|470668770|FG000|Overall Study|Withdrawal by Subject|1|||
130739896|NCT02750618|470668775|FG000|Overall Study|Withdrawal by Subject|1|||
130739897|NCT02572570|470668781|FG000|Overall Study|Study Terminated|27|||
130739898|NCT02763046|470668782|FG000|Overall Study|Adverse Event|5|||
130739899|NCT02763046|470668783|FG001|Overall Study|Adverse Event|4|||
130739900|NCT02763046|470668784|FG002|Overall Study|Adverse Event|0|||
130739901|NCT02763046|470668782|FG000|Overall Study|Lack of Efficacy|1|||
130739902|NCT02763046|470668783|FG001|Overall Study|Lack of Efficacy|1|||
130739903|NCT02763046|470668784|FG002|Overall Study|Lack of Efficacy|3|||
130739904|NCT02763046|470668782|FG000|Overall Study|Physician Decision|1|||
130739905|NCT02763046|470668783|FG001|Overall Study|Physician Decision|0|||
130739906|NCT02763046|470668784|FG002|Overall Study|Physician Decision|1|||
130739907|NCT02763046|470668782|FG000|Overall Study|Subject/guardian decision|2|||
130739908|NCT02763046|470668783|FG001|Overall Study|Subject/guardian decision|0|||
130739909|NCT02763046|470668784|FG002|Overall Study|Subject/guardian decision|4|||
130787045|NCT02265510|470849014|FG005|Overall Study|Disease Progression|0|||
130739910|NCT00086684|470668785|FG000|Overall Study|Adverse Event|12|||
130739911|NCT00086684|470668786|FG001|Overall Study|Adverse Event|17|||
130739912|NCT00086684|470668787|FG002|Overall Study|Adverse Event|14|||
130739913|NCT00086684|470668785|FG000|Overall Study|Lack of Efficacy|6|||
130739914|NCT00086684|470668786|FG001|Overall Study|Lack of Efficacy|6|||
130739915|NCT00086684|470668787|FG002|Overall Study|Lack of Efficacy|5|||
130739916|NCT00086684|470668785|FG000|Overall Study|Lost to Follow-up|15|||
130739917|NCT00086684|470668786|FG001|Overall Study|Lost to Follow-up|8|||
130739918|NCT00086684|470668787|FG002|Overall Study|Lost to Follow-up|10|||
130739919|NCT00086684|470668785|FG000|Overall Study|Protocol Violation|8|||
130739920|NCT00086684|470668786|FG001|Overall Study|Protocol Violation|3|||
130739921|NCT00086684|470668787|FG002|Overall Study|Protocol Violation|0|||
130739922|NCT00086684|470668785|FG000|Overall Study|Withdrawal by Subject|0|||
130739923|NCT00086684|470668786|FG001|Overall Study|Withdrawal by Subject|4|||
130739924|NCT00086684|470668787|FG002|Overall Study|Withdrawal by Subject|10|||
130739925|NCT00086684|470668785|FG000|Overall Study|NONCOMPLIANCE|5|||
130739926|NCT00086684|470668786|FG001|Overall Study|NONCOMPLIANCE|7|||
130739927|NCT00086684|470668787|FG002|Overall Study|NONCOMPLIANCE|6|||
130739928|NCT00086684|470668785|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130739929|NCT00086684|470668786|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
130739930|NCT00086684|470668787|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130739931|NCT00086684|470668785|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
130739932|NCT00086684|470668786|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
130739933|NCT00086684|470668787|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
130739934|NCT00086684|470668785|FG000|Overall Study|Other|4|||
130739935|NCT00086684|470668786|FG001|Overall Study|Other|2|||
130739936|NCT00086684|470668787|FG002|Overall Study|Other|3|||
130739937|NCT01067105|470668788|FG000|Overall Study|Adverse Event|14|||
130739938|NCT01067105|470668788|FG000|Overall Study|Protocol Violation|48|||
130739939|NCT01067105|470668788|FG000|Overall Study|Withdrawal by Subject|36|||
130739940|NCT01067105|470668788|FG000|Overall Study|Lost to Follow-up|6|||
130739941|NCT01067105|470668788|FG000|Overall Study|Physician Decision|6|||
130739942|NCT01067105|470668788|FG000|Overall Study|Other|31|||
130739943|NCT02302833|470668791|FG000|Overall Study|Lost to Follow-up|3|||
130739951|NCT05017246|470668793|FG000|Overall Study|Withdrawal by Subject|5|||
130739952|NCT05017246|470668794|FG001|Overall Study|Withdrawal by Subject|3|||
130739953|NCT05017246|470668793|FG000|Overall Study|Determined to be ineligible|0|||
130739954|NCT05017246|470668794|FG001|Overall Study|Determined to be ineligible|1|||
130739955|NCT05017246|470668793|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
130739956|NCT05017246|470668794|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
130739957|NCT05017246|470668793|FG000|Overall Study|Technical failure|1|||
130739958|NCT05017246|470668794|FG001|Overall Study|Technical failure|3|||
130739959|NCT01495000|470668799|FG000|Overall Study|Lost to Follow-up|2|||
130739960|NCT01495000|470668800|FG001|Overall Study|Lost to Follow-up|2|||
130739961|NCT01495000|470668799|FG000|Overall Study|Protocol Violation|1|||
130739962|NCT01495000|470668800|FG001|Overall Study|Protocol Violation|0|||
130739963|NCT01495000|470668799|FG000|Overall Study|Withdrawal by Subject|10|||
130739964|NCT01495000|470668800|FG001|Overall Study|Withdrawal by Subject|10|||
130739965|NCT01514461|470668801|FG000|Overall Study|Adverse Event|2|||
130739966|NCT01514461|470668802|FG001|Overall Study|Adverse Event|1|||
130739967|NCT01514461|470668803|FG002|Overall Study|Adverse Event|3|||
130739968|NCT01514461|470668801|FG000|Overall Study|Physician Decision|1|||
130739969|NCT01514461|470668802|FG001|Overall Study|Physician Decision|1|||
130739970|NCT01514461|470668803|FG002|Overall Study|Physician Decision|0|||
130739971|NCT01514461|470668801|FG000|Overall Study|Patient/guardian decision|1|||
130739972|NCT01514461|470668802|FG001|Overall Study|Patient/guardian decision|1|||
130739973|NCT01514461|470668803|FG002|Overall Study|Patient/guardian decision|1|||
130739974|NCT01514461|470668801|FG000|Overall Study|Death|1|||
130739975|NCT01514461|470668802|FG001|Overall Study|Death|0|||
130739976|NCT01514461|470668803|FG002|Overall Study|Death|0|||
130739977|NCT03499067|470668804|FG000|First Intervention|Physician Decision|2|||
130739978|NCT03499067|470668805|FG001|First Intervention|Physician Decision|1|||
130739979|NCT03499067|470668804|FG000|First Intervention|Withdrawal by Subject|3|||
130739980|NCT03499067|470668805|FG001|First Intervention|Withdrawal by Subject|6|||
130739981|NCT02548832|470668806|FG000|Overall Study|Lost to Follow-up|2|||
130739982|NCT02548832|470668807|FG001|Overall Study|Lost to Follow-up|2|||
130787046|NCT02265510|470849015|FG006|Overall Study|Disease Progression|0|||
130787047|NCT02265510|470849016|FG007|Overall Study|Disease Progression|0|||
130787048|NCT02265510|470849017|FG008|Overall Study|Disease Progression|0|||
130787049|NCT02265510|470849018|FG009|Overall Study|Disease Progression|0|||
130787050|NCT02265510|470849019|FG010|Overall Study|Disease Progression|0|||
130787051|NCT02265510|470849020|FG011|Overall Study|Disease Progression|0|||
130787052|NCT02265510|470849021|FG012|Overall Study|Disease Progression|0|||
130787053|NCT02265510|470849022|FG013|Overall Study|Disease Progression|0|||
130787054|NCT02265510|470849009|FG000|Overall Study|Death|2|||
130787055|NCT02265510|470849010|FG001|Overall Study|Death|0|||
130787056|NCT02265510|470849011|FG002|Overall Study|Death|2|||
130787057|NCT02265510|470849012|FG003|Overall Study|Death|2|||
130787058|NCT02265510|470849013|FG004|Overall Study|Death|1|||
130787059|NCT02265510|470849014|FG005|Overall Study|Death|3|||
130787060|NCT02265510|470849015|FG006|Overall Study|Death|2|||
130787061|NCT02265510|470849016|FG007|Overall Study|Death|1|||
130787062|NCT02265510|470849017|FG008|Overall Study|Death|3|||
130787063|NCT02265510|470849018|FG009|Overall Study|Death|3|||
130787064|NCT02265510|470849019|FG010|Overall Study|Death|4|||
130787065|NCT02265510|470849020|FG011|Overall Study|Death|12|||
130787066|NCT02265510|470849021|FG012|Overall Study|Death|7|||
130787067|NCT02265510|470849022|FG013|Overall Study|Death|6|||
130787068|NCT02265510|470849009|FG000|Overall Study|Lost to Follow-up|0|||
130787069|NCT02265510|470849010|FG001|Overall Study|Lost to Follow-up|0|||
130787070|NCT02265510|470849011|FG002|Overall Study|Lost to Follow-up|0|||
130787071|NCT02265510|470849012|FG003|Overall Study|Lost to Follow-up|0|||
130787072|NCT02265510|470849013|FG004|Overall Study|Lost to Follow-up|1|||
130787073|NCT02265510|470849014|FG005|Overall Study|Lost to Follow-up|0|||
130787074|NCT02265510|470849015|FG006|Overall Study|Lost to Follow-up|0|||
130787075|NCT02265510|470849016|FG007|Overall Study|Lost to Follow-up|0|||
130787076|NCT02265510|470849017|FG008|Overall Study|Lost to Follow-up|0|||
130787077|NCT02265510|470849018|FG009|Overall Study|Lost to Follow-up|2|||
130787078|NCT02265510|470849019|FG010|Overall Study|Lost to Follow-up|0|||
130787079|NCT02265510|470849020|FG011|Overall Study|Lost to Follow-up|0|||
130787080|NCT02265510|470849021|FG012|Overall Study|Lost to Follow-up|0|||
130787081|NCT02265510|470849022|FG013|Overall Study|Lost to Follow-up|2|||
130787082|NCT02265510|470849009|FG000|Overall Study|Other|0|||
130787083|NCT02265510|470849010|FG001|Overall Study|Other|1|||
130787084|NCT02265510|470849011|FG002|Overall Study|Other|0|||
130787085|NCT02265510|470849012|FG003|Overall Study|Other|0|||
130787086|NCT02265510|470849013|FG004|Overall Study|Other|0|||
130787087|NCT02265510|470849014|FG005|Overall Study|Other|0|||
130787088|NCT02265510|470849015|FG006|Overall Study|Other|0|||
130787089|NCT02265510|470849016|FG007|Overall Study|Other|0|||
130787090|NCT02265510|470849017|FG008|Overall Study|Other|0|||
130787091|NCT02265510|470849018|FG009|Overall Study|Other|0|||
130787092|NCT02265510|470849019|FG010|Overall Study|Other|0|||
130787093|NCT02265510|470849020|FG011|Overall Study|Other|0|||
130787094|NCT02265510|470849021|FG012|Overall Study|Other|0|||
130787095|NCT02265510|470849022|FG013|Overall Study|Other|0|||
130787096|NCT02265510|470849009|FG000|Overall Study|Study Terminated by Sponsor|0|||
130787097|NCT02265510|470849010|FG001|Overall Study|Study Terminated by Sponsor|0|||
130787098|NCT02265510|470849011|FG002|Overall Study|Study Terminated by Sponsor|0|||
130787099|NCT02265510|470849012|FG003|Overall Study|Study Terminated by Sponsor|0|||
130787100|NCT02265510|470849013|FG004|Overall Study|Study Terminated by Sponsor|0|||
130787101|NCT02265510|470849014|FG005|Overall Study|Study Terminated by Sponsor|1|||
130787102|NCT02265510|470849015|FG006|Overall Study|Study Terminated by Sponsor|1|||
130787103|NCT02265510|470849016|FG007|Overall Study|Study Terminated by Sponsor|1|||
130787104|NCT02265510|470849017|FG008|Overall Study|Study Terminated by Sponsor|1|||
130787105|NCT02265510|470849018|FG009|Overall Study|Study Terminated by Sponsor|2|||
130787106|NCT02265510|470849019|FG010|Overall Study|Study Terminated by Sponsor|1|||
130787107|NCT02265510|470849020|FG011|Overall Study|Study Terminated by Sponsor|4|||
130787108|NCT02265510|470849021|FG012|Overall Study|Study Terminated by Sponsor|1|||
130787109|NCT02265510|470849022|FG013|Overall Study|Study Terminated by Sponsor|2|||
130787110|NCT01668797|470849023|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
130787111|NCT01668797|470849024|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
130787112|NCT01668797|470849025|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
130787113|NCT01668797|470849026|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
130787114|NCT01668797|470849023|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
130787115|NCT01668797|470849024|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
130787116|NCT01668797|470849025|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
130787117|NCT01668797|470849026|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
130739983|NCT02548832|470668808|FG002|Overall Study|Lost to Follow-up|2|||
130739984|NCT03565900|470668809|FG000|Overall Study|Disposition Unknown|4|||
130739985|NCT03565900|470668810|FG001|Overall Study|Disposition Unknown|1|||
130787118|NCT01668797|470849023|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
130787119|NCT01668797|470849024|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
130787120|NCT01668797|470849025|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
130787121|NCT01668797|470849026|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
130787122|NCT01668797|470849023|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
130787123|NCT01668797|470849024|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
130787124|NCT01668797|470849025|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
130787125|NCT01668797|470849026|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
130787126|NCT01668797|470849023|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
130787127|NCT01668797|470849024|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
130787128|NCT01668797|470849025|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
130787129|NCT01668797|470849026|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
130787130|NCT01668797|470849023|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
130787131|NCT01668797|470849024|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
130787132|NCT01668797|470849025|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
130787133|NCT01668797|470849026|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
130787134|NCT01668797|470849023|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
130787135|NCT01668797|470849024|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
130787136|NCT01668797|470849025|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
130787137|NCT01668797|470849026|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
130787138|NCT01668797|470849023|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
130787139|NCT01668797|470849024|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
130787140|NCT01668797|470849025|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
130787141|NCT01668797|470849026|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
130787142|NCT01668797|470849023|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
130787143|NCT01668797|470849024|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
130787144|NCT01668797|470849025|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
130787145|NCT01668797|470849026|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
130787146|NCT01668797|470849023|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
130787147|NCT01668797|470849024|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
130787148|NCT01668797|470849025|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
130787149|NCT01668797|470849026|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
130787150|NCT01668797|470849023|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
130787151|NCT01668797|470849024|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
130787152|NCT01668797|470849025|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
130787153|NCT01668797|470849026|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
130787154|NCT01668797|470849023|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
130739986|NCT03565900|470668809|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130739987|NCT03565900|470668810|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
130739988|NCT03565900|470668809|FG000|Overall Study|Withdrawal by Subject|4|||
130739989|NCT03565900|470668810|FG001|Overall Study|Withdrawal by Subject|5|||
130739990|NCT03565900|470668809|FG000|Overall Study|Randomized By Mistake|0|||
130739991|NCT03565900|470668810|FG001|Overall Study|Randomized By Mistake|2|||
130739992|NCT03565900|470668809|FG000|Overall Study|Physician Decision|7|||
130739993|NCT03565900|470668810|FG001|Overall Study|Physician Decision|11|||
130739994|NCT03565900|470668809|FG000|Overall Study|Death|9|||
130739995|NCT03565900|470668810|FG001|Overall Study|Death|7|||
130739996|NCT03359850|470668814|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
130739997|NCT03359850|470668815|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
130739998|NCT03359850|470668814|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
130739999|NCT03359850|470668815|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
130740000|NCT03359850|470668814|FG000|Extension Phase (Up to 28 Months)|Death|2|||
130740001|NCT03359850|470668815|FG001|Extension Phase (Up to 28 Months)|Death|4|||
130740002|NCT03359850|470668814|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
130787155|NCT01668797|470849024|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
130787156|NCT01668797|470849025|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
130787157|NCT01668797|470849026|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
130787158|NCT01668797|470849023|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
130787159|NCT01668797|470849024|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
130787160|NCT01668797|470849025|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
130787161|NCT01668797|470849026|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
130787162|NCT01668797|470849023|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
130787163|NCT01668797|470849024|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
130787164|NCT01668797|470849025|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
130787165|NCT01668797|470849026|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
130787166|NCT01668797|470849023|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
130787167|NCT01668797|470849024|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
130787168|NCT01668797|470849025|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
130787169|NCT01668797|470849026|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
130787170|NCT01668797|470849023|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
130787171|NCT01668797|470849024|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
130787172|NCT01668797|470849025|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
130787173|NCT01668797|470849026|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
130787174|NCT01668797|470849023|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
130787175|NCT01668797|470849024|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
130787176|NCT01668797|470849025|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
130787177|NCT01668797|470849026|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
130787178|NCT01668797|470849023|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
130787179|NCT01668797|470849024|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
130787180|NCT01668797|470849025|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
130787181|NCT01668797|470849026|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
130787182|NCT01668797|470849023|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
130787183|NCT01668797|470849024|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
130787184|NCT01668797|470849025|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
130787185|NCT01668797|470849026|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
130787186|NCT01668797|470849023|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
130787187|NCT01668797|470849024|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
130787188|NCT01668797|470849025|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
130787189|NCT01668797|470849026|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
130787190|NCT01668797|470849023|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
130787191|NCT01668797|470849024|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
130740003|NCT03359850|470668815|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
130740004|NCT03359850|470668814|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
130740005|NCT03359850|470668815|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
130740006|NCT01960257|470668818|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
130740007|NCT01960257|470668819|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
130740008|NCT01960257|470668820|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
130740009|NCT01960257|470668818|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
130740010|NCT01960257|470668819|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
130740011|NCT01960257|470668820|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
130740012|NCT01960257|470668818|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
130740013|NCT01960257|470668819|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
130740014|NCT01960257|470668820|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
130740015|NCT02002221|470668821|FG000|Overall Study|Adverse Event|2|||
130740016|NCT02002221|470668822|FG001|Overall Study|Adverse Event|1|||
130740017|NCT02002221|470668821|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130740018|NCT02002221|470668822|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130740019|NCT02002221|470668821|FG000|Overall Study|Patient withdrew consent|0|||
130740020|NCT02002221|470668822|FG001|Overall Study|Patient withdrew consent|1|||
130740021|NCT03347110|470668823|FG000|Overall Study|Other (Participant is incarcerated)|1|||
130740022|NCT03347110|470668823|FG000|Overall Study|Withdrawal by Subject|9|||
130740023|NCT03347110|470668823|FG000|Overall Study|Lost to Follow-up|1|||
130740024|NCT03347110|470668823|FG000|Overall Study|Lack of Efficacy|2|||
130740025|NCT03347110|470668823|FG000|Overall Study|Adverse Event, non-fatal|9|||
130740026|NCT02105467|470668826|FG000|Period 1|Lost to Follow-up|1|||
130740027|NCT02105467|470668827|FG001|Period 1|Lost to Follow-up|0|||
130740028|NCT02105467|470668826|FG000|Period 1|Death|1|||
130740029|NCT02105467|470668827|FG001|Period 1|Death|0|||
130740030|NCT02105467|470668826|FG000|Period 2|Lost to Follow-up|1|||
130740031|NCT02105467|470668827|FG001|Period 2|Lost to Follow-up|0|||
130740032|NCT02105467|470668826|FG000|Period 2|Death|1|||
130740033|NCT02105467|470668827|FG001|Period 2|Death|0|||
130740034|NCT02105467|470668826|FG000|Period 2|Withdrawal by Subject|0|||
130740035|NCT02105467|470668827|FG001|Period 2|Withdrawal by Subject|2|||
130740036|NCT02105467|470668826|FG000|Period 3|Lost to Follow-up|0|||
130740037|NCT02105467|470668827|FG001|Period 3|Lost to Follow-up|1|||
130740038|NCT01518322|470668829|FG000|Overall Study|FeNO measurement was missing|13|||
130740039|NCT02792517|470668834|FG000|Overall Study|Withdrawal by Subject|10|||
130740040|NCT02792517|470668834|FG000|Overall Study|Decision by Sponsor|7|||
130740041|NCT02792517|470668834|FG000|Overall Study|Lost to Follow-up|3|||
130740042|NCT00856193|470668837|FG000|Period 2|Abnormal test procedure results|0|||
130740043|NCT00856193|470668838|FG001|Period 2|Abnormal test procedure results|1|||
130740044|NCT00856193|470668837|FG000|Period 2|Lost to Follow-up|0|||
130740045|NCT00856193|470668838|FG001|Period 2|Lost to Follow-up|1|||
130740046|NCT02766335|470668840|FG000|Initial Registration|Adverse Event|6|||
130740047|NCT02766335|470668841|FG001|Initial Registration|Adverse Event|3|||
130740048|NCT02766335|470668842|FG002|Initial Registration|Adverse Event|0|||
130740049|NCT02766335|470668840|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
130740050|NCT02766335|470668841|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
130740051|NCT02766335|470668842|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
130740052|NCT02766335|470668840|FG000|Initial Registration|Progression/relapse|49|||
130740053|NCT02766335|470668841|FG001|Initial Registration|Progression/relapse|15|||
130740054|NCT02766335|470668842|FG002|Initial Registration|Progression/relapse|0|||
130740055|NCT02766335|470668840|FG000|Initial Registration|Death|1|||
130740056|NCT02766335|470668841|FG001|Initial Registration|Death|3|||
130740057|NCT02766335|470668842|FG002|Initial Registration|Death|0|||
130740058|NCT02766335|470668840|FG000|Initial Registration|not protocol specified|1|||
130740059|NCT02766335|470668841|FG001|Initial Registration|not protocol specified|9|||
130740060|NCT02766335|470668842|FG002|Initial Registration|not protocol specified|0|||
130740061|NCT02766335|470668840|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
130740062|NCT02766335|470668841|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
130740063|NCT02766335|470668842|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
130740064|NCT02766335|470668840|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
130740065|NCT02766335|470668841|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
130740066|NCT02766335|470668842|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
130740067|NCT03164551|470668856|FG000|Overall Study|Imaging discontinued prior completion|8|||
130740068|NCT03164551|470668857|FG001|Overall Study|Imaging discontinued prior completion|0|||
130740069|NCT03164551|470668856|FG000|Overall Study|Participant was non-compliant|1|||
130740070|NCT03164551|470668857|FG001|Overall Study|Participant was non-compliant|0|||
130740071|NCT03164551|470668856|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
130740072|NCT03164551|470668857|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
130740073|NCT03164551|470668856|FG000|Overall Study|Other|8|||
130740074|NCT03164551|470668857|FG001|Overall Study|Other|2|||
130740075|NCT01125917|470668862|FG000|Overall Study|Adverse Event|43|||
130740076|NCT01125917|470668862|FG000|Overall Study|Lost to Follow-up|23|||
130740077|NCT01125917|470668862|FG000|Overall Study|Withdrawal by Subject|31|||
130740078|NCT01125917|470668862|FG000|Overall Study|Administrative|223|||
130740079|NCT01125917|470668862|FG000|Overall Study|Lack of Efficacy|19|||
130740080|NCT04421131|470668865|FG000|Overall Study|Lost to Follow-up|1|||
130740081|NCT04421131|470668865|FG000|Overall Study|Protocol Violation|2|||
130740082|NCT04421131|470668865|FG000|Overall Study|App crashed|5|||
130740083|NCT02501928|470668866|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130740084|NCT02501928|470668867|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
130740085|NCT02501928|470668868|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
130740086|NCT02501928|470668869|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
130740087|NCT02501928|470668870|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
130740088|NCT02501928|470668871|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
130740089|NCT01320293|470668879|FG000|Overall Study|Lack of Efficacy|1|||
130740090|NCT01320293|470668879|FG000|Overall Study|Adverse Event|1|||
130740091|NCT03483012|470668882|FG000|Overall Study|Lack of Efficacy|6|||
130740092|NCT04782076|470668883|FG000|Overall Study|Family Emergency|1|||
130740093|NCT01949662|470668886|FG000|Overall Study|Death|9|||
130740094|NCT01949662|470668887|FG001|Overall Study|Death|7|||
130740095|NCT01949662|470668886|FG000|Overall Study|Discharged before an agitation event|8|||
130740096|NCT01949662|470668887|FG001|Overall Study|Discharged before an agitation event|3|||
130740097|NCT01949662|470668886|FG000|Overall Study|Dropped out|1|||
130740098|NCT01949662|470668887|FG001|Overall Study|Dropped out|3|||
130740099|NCT01949662|470668886|FG000|Overall Study|Ineligible|0|||
130740100|NCT01949662|470668887|FG001|Overall Study|Ineligible|1|||
130740101|NCT04135937|470668889|FG000|Overall Study|Lost to Follow-up|2|||
130740102|NCT04135937|470668889|FG000|Overall Study|Withdrawal by Subject|1|||
130740103|NCT00856492|470668892|FG000|Overall Study|Ineligible or withdrew consent|1|||
130740104|NCT00856492|470668893|FG001|Overall Study|Ineligible or withdrew consent|1|||
130740105|NCT00856492|470668894|FG002|Overall Study|Ineligible or withdrew consent|2|||
130740106|NCT00955617|470668897|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
130740107|NCT00955617|470668898|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
130740108|NCT00955617|470668897|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
130740109|NCT00955617|470668898|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
130740110|NCT00955617|470668897|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
130740111|NCT00955617|470668898|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
130740112|NCT00955617|470668897|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
130740113|NCT00955617|470668898|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
130740114|NCT00070564|470669943|FG000|Overall Study|Progression|2|||
130740115|NCT00070564|470669944|FG001|Overall Study|Progression|4|||
130740116|NCT00070564|470669945|FG002|Overall Study|Progression|7|||
130740117|NCT00070564|470669946|FG003|Overall Study|Progression|7|||
130740118|NCT00070564|470669947|FG004|Overall Study|Progression|1|||
130740119|NCT00070564|470669948|FG005|Overall Study|Progression|0|||
130740120|NCT00070564|470669943|FG000|Overall Study|Delinquent|1|||
130740121|NCT00070564|470669944|FG001|Overall Study|Delinquent|4|||
130740122|NCT00070564|470669945|FG002|Overall Study|Delinquent|2|||
130740123|NCT00070564|470669946|FG003|Overall Study|Delinquent|0|||
130740124|NCT00070564|470669947|FG004|Overall Study|Delinquent|0|||
130740125|NCT00070564|470669948|FG005|Overall Study|Delinquent|0|||
130740126|NCT00070564|470669943|FG000|Overall Study|Adverse Event|150|||
130740127|NCT00070564|470669944|FG001|Overall Study|Adverse Event|142|||
130740128|NCT00070564|470669945|FG002|Overall Study|Adverse Event|120|||
130740129|NCT00070564|470669946|FG003|Overall Study|Adverse Event|108|||
130740130|NCT00070564|470669947|FG004|Overall Study|Adverse Event|63|||
130740131|NCT00070564|470669948|FG005|Overall Study|Adverse Event|36|||
130740132|NCT00070564|470669943|FG000|Overall Study|Death|4|||
130740133|NCT00070564|470669944|FG001|Overall Study|Death|1|||
130740134|NCT00070564|470669945|FG002|Overall Study|Death|5|||
130740135|NCT00070564|470669946|FG003|Overall Study|Death|3|||
130740136|NCT00070564|470669947|FG004|Overall Study|Death|0|||
130740137|NCT00070564|470669948|FG005|Overall Study|Death|1|||
130740138|NCT00070564|470669943|FG000|Overall Study|Other, not protocol specified|17|||
130740139|NCT00070564|470669944|FG001|Overall Study|Other, not protocol specified|15|||
130740140|NCT00070564|470669945|FG002|Overall Study|Other, not protocol specified|14|||
130740141|NCT00070564|470669946|FG003|Overall Study|Other, not protocol specified|19|||
130740142|NCT00070564|470669947|FG004|Overall Study|Other, not protocol specified|6|||
130740143|NCT00070564|470669948|FG005|Overall Study|Other, not protocol specified|7|||
130740144|NCT00070564|470669943|FG000|Overall Study|Withdrawal by Subject|26|||
130740145|NCT00070564|470669944|FG001|Overall Study|Withdrawal by Subject|37|||
130740146|NCT00070564|470669945|FG002|Overall Study|Withdrawal by Subject|23|||
130740147|NCT00070564|470669946|FG003|Overall Study|Withdrawal by Subject|30|||
130740148|NCT00070564|470669947|FG004|Overall Study|Withdrawal by Subject|8|||
130740149|NCT00070564|470669948|FG005|Overall Study|Withdrawal by Subject|8|||
130740150|NCT00070564|470669943|FG000|Overall Study|Not reported|0|||
130740151|NCT00070564|470669944|FG001|Overall Study|Not reported|0|||
130740152|NCT00070564|470669945|FG002|Overall Study|Not reported|0|||
130740153|NCT00070564|470669946|FG003|Overall Study|Not reported|0|||
130740154|NCT00070564|470669947|FG004|Overall Study|Not reported|1|||
130740155|NCT00070564|470669948|FG005|Overall Study|Not reported|0|||
130740156|NCT00931528|470669949|FG000|Overall Study|Protocol Violation|9|||
130740157|NCT00931528|470669950|FG001|Overall Study|Protocol Violation|12|||
130740158|NCT00931528|470669949|FG000|Overall Study|Withdrawal by Subject|4|||
130740159|NCT00931528|470669950|FG001|Overall Study|Withdrawal by Subject|12|||
130740160|NCT00931528|470669949|FG000|Overall Study|Lost to Follow-up|6|||
130787192|NCT01668797|470849025|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
130787193|NCT01668797|470849026|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
130787194|NCT01668797|470849023|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
130787195|NCT01668797|470849024|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
130787196|NCT01668797|470849025|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
130787197|NCT01668797|470849026|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
130787198|NCT01668797|470849023|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
130787199|NCT01668797|470849024|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
130787200|NCT01668797|470849025|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
130787201|NCT01668797|470849026|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
130740161|NCT00931528|470669950|FG001|Overall Study|Lost to Follow-up|13|||
130740162|NCT00931528|470669949|FG000|Overall Study|Assessment outside of Time Frame|22|||
130740163|NCT00931528|470669950|FG001|Overall Study|Assessment outside of Time Frame|23|||
130740164|NCT02115269|470669951|FG000|Overall Study|Lost to Follow-up|43|||
130740165|NCT02115269|470669951|FG000|Overall Study|Did not complete patient diary|3|||
130740166|NCT02115269|470669951|FG000|Overall Study|Moved to another city|7|||
130740167|NCT02115269|470669951|FG000|Overall Study|Withdrawal by Subject|2|||
130740168|NCT02115269|470669951|FG000|Overall Study|Didn't take study drug|2|||
130740169|NCT01557504|470669952|FG000|Overall Study|Physician Decision|1|||
130740170|NCT01557504|470669953|FG001|Overall Study|Physician Decision|0|||
130740171|NCT02058069|470669954|FG000|Overall Study|Exclusion due to implant size|5|||
130740172|NCT02058069|470669954|FG000|Overall Study|Withdrawal by Subject|6|||
130740173|NCT02676882|470669955|FG000|Overall Study|Adverse Event|1|||
130740174|NCT02676882|470669956|FG001|Overall Study|Adverse Event|0|||
130740175|NCT02676882|470669955|FG000|Overall Study|Lost to Follow-up|1|||
130740176|NCT02676882|470669956|FG001|Overall Study|Lost to Follow-up|0|||
130740177|NCT02676882|470669955|FG000|Overall Study|Withdrawal by Subject|1|||
130740178|NCT02676882|470669956|FG001|Overall Study|Withdrawal by Subject|2|||
130740179|NCT02568072|470669960|FG000|Overall Study|Unavailable for appointment|23|||
130740180|NCT02568072|470669960|FG000|Overall Study|Unable to contact|3|||
130740181|NCT02568072|470669960|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
130740182|NCT02568072|470669960|FG000|Overall Study|Withdrawal by Subject|1|||
130740183|NCT02568072|470669960|FG000|Overall Study|Sustained injury, marathon not run|24|||
130740184|NCT00958828|470669962|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
130740185|NCT00958828|470669963|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
130740186|NCT00958828|470669962|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
130740187|NCT00958828|470669963|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
130740188|NCT02687451|470669970|FG000|Overall Study|Withdrawal by Subject|1|||
130740189|NCT02687451|470669971|FG001|Overall Study|Withdrawal by Subject|0|||
130740190|NCT02687451|470669972|FG002|Overall Study|Withdrawal by Subject|0|||
130740191|NCT02687451|470669973|FG003|Overall Study|Withdrawal by Subject|0|||
130740192|NCT02687451|470669974|FG004|Overall Study|Withdrawal by Subject|0|||
130740193|NCT02687451|470669975|FG005|Overall Study|Withdrawal by Subject|1|||
130740194|NCT00927589|470669976|FG000|Overall Study|Death|1|||
130740195|NCT00927589|470669976|FG000|Overall Study|Physician Decision|1|||
130740196|NCT00927589|470669976|FG000|Overall Study|Withdrawal by Subject|3|||
130740197|NCT00927589|470669976|FG000|Overall Study|Adverse Event|2|||
130740198|NCT00927589|470669976|FG000|Overall Study|Disease Progression|8|||
130740199|NCT00927589|470669976|FG000|Overall Study|Non-compliance|1|||
130740200|NCT01125189|470669977|FG000|Treatment Period|Lack of Efficacy|15|||
130740201|NCT01125189|470669978|FG001|Treatment Period|Lack of Efficacy|18|||
130740202|NCT01125189|470669979|FG002|Treatment Period|Lack of Efficacy|25|||
130740203|NCT01125189|470669977|FG000|Treatment Period|Adverse Event|7|||
130740204|NCT01125189|470669978|FG001|Treatment Period|Adverse Event|8|||
130740205|NCT01125189|470669979|FG002|Treatment Period|Adverse Event|8|||
130740206|NCT01125189|470669977|FG000|Treatment Period|Withdrawal by Subject|3|||
130740207|NCT01125189|470669978|FG001|Treatment Period|Withdrawal by Subject|1|||
130740208|NCT01125189|470669979|FG002|Treatment Period|Withdrawal by Subject|1|||
130740209|NCT01125189|470669977|FG000|Treatment Period|Death|1|||
130740210|NCT01125189|470669978|FG001|Treatment Period|Death|0|||
130740211|NCT01125189|470669979|FG002|Treatment Period|Death|0|||
130740212|NCT01125189|470669977|FG000|Treatment Period|Lost to Follow-up|1|||
130740213|NCT01125189|470669978|FG001|Treatment Period|Lost to Follow-up|2|||
130740214|NCT01125189|470669979|FG002|Treatment Period|Lost to Follow-up|1|||
130740215|NCT01125189|470669977|FG000|Treatment Period|Poor compliance/noncompliance|0|||
130740216|NCT01125189|470669978|FG001|Treatment Period|Poor compliance/noncompliance|1|||
130740217|NCT01125189|470669979|FG002|Treatment Period|Poor compliance/noncompliance|0|||
130740218|NCT01125189|470669977|FG000|Treatment Period|Participants requested to discontinue|1|||
130740219|NCT01125189|470669978|FG001|Treatment Period|Participants requested to discontinue|3|||
130740220|NCT01125189|470669979|FG002|Treatment Period|Participants requested to discontinue|4|||
130740221|NCT01125189|470669977|FG000|Treatment Period|Other reasons|1|||
130740222|NCT01125189|470669978|FG001|Treatment Period|Other reasons|1|||
130740223|NCT01125189|470669979|FG002|Treatment Period|Other reasons|0|||
130740224|NCT01125189|470669977|FG000|Treatment Period|Completed 24 week treatment period only|2|||
130740225|NCT01125189|470669978|FG001|Treatment Period|Completed 24 week treatment period only|1|||
130740226|NCT01125189|470669979|FG002|Treatment Period|Completed 24 week treatment period only|2|||
130740227|NCT01125189|470669977|FG000|Follow up Period|Withdrawal by Subject|3|||
130787202|NCT01668797|470849023|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
130787203|NCT01668797|470849024|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
130787204|NCT01668797|470849025|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
130787205|NCT01668797|470849026|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
130787206|NCT01668797|470849023|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
130787207|NCT01668797|470849024|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
130787208|NCT01668797|470849025|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
130787209|NCT01668797|470849026|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
130787210|NCT01004614|470849027|FG000|Washout|Withdrawal by Subject|0|||
130787211|NCT01004614|470849028|FG001|Washout|Withdrawal by Subject|1|||
130787212|NCT01004614|470849029|FG002|Washout|Withdrawal by Subject|0|||
130787213|NCT01004614|470849030|FG003|Washout|Withdrawal by Subject|0|||
130787214|NCT02530385|470849031|FG000|Overall Study|Withdrawal by Subject|0|||
130787215|NCT02530385|470849032|FG001|Overall Study|Withdrawal by Subject|1|||
130787216|NCT01569022|470849034|FG000|First Intervention|Lost to Follow-up|2|||
130787217|NCT01569022|470849035|FG001|First Intervention|Lost to Follow-up|1|||
130787218|NCT01569022|470849034|FG000|Second Intervention|Lost to Follow-up|2|||
130787219|NCT01569022|470849035|FG001|Second Intervention|Lost to Follow-up|2|||
130787220|NCT02111083|470849040|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
130787221|NCT02111083|470849041|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
130787222|NCT00116142|470849042|FG000|Overall Study|Adverse Event|8|||
130787223|NCT00116142|470849043|FG001|Overall Study|Adverse Event|7|||
130787224|NCT00116142|470849042|FG000|Overall Study|Protocol Violation|2|||
130787225|NCT00116142|470849043|FG001|Overall Study|Protocol Violation|1|||
130787226|NCT00116142|470849042|FG000|Overall Study|Withdrawal by Subject|5|||
130787227|NCT00116142|470849043|FG001|Overall Study|Withdrawal by Subject|5|||
130787228|NCT00116142|470849042|FG000|Overall Study|Physician Decision|3|||
130787229|NCT00116142|470849043|FG001|Overall Study|Physician Decision|1|||
130787230|NCT00116142|470849042|FG000|Overall Study|Delayed Radiation Therapy|1|||
130787231|NCT00116142|470849043|FG001|Overall Study|Delayed Radiation Therapy|0|||
130787232|NCT00116142|470849042|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
130787233|NCT00116142|470849043|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
130787234|NCT00116142|470849042|FG000|Overall Study|Patient stopped due to depression|0|||
130787235|NCT00116142|470849043|FG001|Overall Study|Patient stopped due to depression|1|||
130787236|NCT00116142|470849042|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
130787237|NCT00116142|470849043|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
130787238|NCT00116142|470849042|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
130787239|NCT00116142|470849043|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
130787240|NCT00116142|470849042|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
130787241|NCT00116142|470849043|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
130787242|NCT00433836|470849044|FG000|Overall Study|Adverse Event|7|||
130787243|NCT00433836|470849045|FG001|Overall Study|Adverse Event|0|||
130787244|NCT00433836|470849044|FG000|Overall Study|Lost to Follow-up|3|||
130787245|NCT00433836|470849045|FG001|Overall Study|Lost to Follow-up|0|||
130787246|NCT00433836|470849044|FG000|Overall Study|Withdrawal by Subject|2|||
130787247|NCT00433836|470849045|FG001|Overall Study|Withdrawal by Subject|1|||
130787248|NCT00433836|470849044|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130787249|NCT00433836|470849045|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130787250|NCT00433836|470849044|FG000|Overall Study|Protocol Violation|0|||
130787251|NCT00433836|470849045|FG001|Overall Study|Protocol Violation|2|||
130787252|NCT00433836|470849044|FG000|Overall Study|Condition no longer requires study drug|0|||
130787253|NCT00433836|470849045|FG001|Overall Study|Condition no longer requires study drug|1|||
130787254|NCT00433836|470849044|FG000|Overall Study|Abnormal laboratory values|0|||
130787255|NCT00433836|470849045|FG001|Overall Study|Abnormal laboratory values|1|||
130787256|NCT00644059|470849046|FG000|Overall Study|Lost to Follow-up|37|||
130787257|NCT00644059|470849047|FG001|Overall Study|Lost to Follow-up|34|||
130787258|NCT00644059|470849048|FG002|Overall Study|Lost to Follow-up|16|||
130787259|NCT00644059|470849046|FG000|Overall Study|Withdrawal by Subject|52|||
130787260|NCT00644059|470849047|FG001|Overall Study|Withdrawal by Subject|60|||
130787261|NCT00644059|470849048|FG002|Overall Study|Withdrawal by Subject|30|||
130787262|NCT00644059|470849046|FG000|Overall Study|Adverse Event|8|||
130787263|NCT00644059|470849047|FG001|Overall Study|Adverse Event|5|||
130787264|NCT00644059|470849048|FG002|Overall Study|Adverse Event|1|||
130787265|NCT00644059|470849046|FG000|Overall Study|Inappropriate Enrollment|1|||
130787266|NCT00644059|470849047|FG001|Overall Study|Inappropriate Enrollment|3|||
130787267|NCT00644059|470849048|FG002|Overall Study|Inappropriate Enrollment|0|||
130740228|NCT01125189|470669978|FG001|Follow up Period|Withdrawal by Subject|2|||
130740229|NCT01125189|470669979|FG002|Follow up Period|Withdrawal by Subject|5|||
130740230|NCT01125189|470669977|FG000|Follow up Period|Death|1|||
130740231|NCT01125189|470669978|FG001|Follow up Period|Death|0|||
130740232|NCT01125189|470669979|FG002|Follow up Period|Death|0|||
130740233|NCT01125189|470669977|FG000|Follow up Period|Lost to Follow-up|12|||
130740234|NCT01125189|470669978|FG001|Follow up Period|Lost to Follow-up|9|||
130787268|NCT00644059|470849046|FG000|Overall Study|Protocol Deviation/violation|20|||
130787269|NCT00644059|470849047|FG001|Overall Study|Protocol Deviation/violation|19|||
130787270|NCT00644059|470849048|FG002|Overall Study|Protocol Deviation/violation|15|||
130787271|NCT00644059|470849046|FG000|Overall Study|Unable to classify|6|||
130787272|NCT00644059|470849047|FG001|Overall Study|Unable to classify|2|||
130787273|NCT00644059|470849048|FG002|Overall Study|Unable to classify|3|||
130787274|NCT02133508|470849049|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
130787275|NCT02133508|470849049|FG000|Overall Study|Death|12|||
130787276|NCT02133508|470849049|FG000|Overall Study|Lost to Follow-up|2|||
130787277|NCT00472420|470849056|FG000|Induction Treatment Period|Physician Decision|9|||
130787278|NCT00472420|470849056|FG000|Induction Treatment Period|Adverse Event|3|||
130787279|NCT00472420|470849056|FG000|Induction Treatment Period|Non-compliance|1|||
130787280|NCT00472420|470849056|FG000|Induction Treatment Period|Death|3|||
130787281|NCT00472420|470849056|FG000|Follow-up Period|Death|5|||
130787282|NCT00472420|470849056|FG000|Follow-up Period|Physician Decision|9|||
130787283|NCT00472420|470849056|FG000|Follow-up Period|Lost to Follow-up|2|||
130787284|NCT00472420|470849056|FG000|Follow-up Period|Protocol Violation|1|||
130787285|NCT01924533|470849061|FG000|Overall Study|Death|181|||
130787286|NCT01924533|470849062|FG001|Overall Study|Death|200|||
130787287|NCT01924533|470849061|FG000|Overall Study|Lost to Follow-up|0|||
130787288|NCT01924533|470849062|FG001|Overall Study|Lost to Follow-up|1|||
130787289|NCT01924533|470849061|FG000|Overall Study|Withdrawal by Subject|7|||
130787290|NCT01924533|470849062|FG001|Overall Study|Withdrawal by Subject|3|||
130787291|NCT01924533|470849061|FG000|Overall Study|Other Eligibility criteria|1|||
130787292|NCT01924533|470849062|FG001|Overall Study|Other Eligibility criteria|1|||
130787293|NCT03307174|470849064|FG000|Overall Study|Unplanned ICU Administrion|5|||
130787294|NCT03307174|470849065|FG001|Overall Study|Unplanned ICU Administrion|3|||
130787295|NCT03307174|470849064|FG000|Overall Study|Aborted Surgery|1|||
130787296|NCT03307174|470849065|FG001|Overall Study|Aborted Surgery|2|||
130787297|NCT03307174|470849064|FG000|Overall Study|Hypotension|6|||
130787298|NCT03307174|470849065|FG001|Overall Study|Hypotension|0|||
130787299|NCT03307174|470849064|FG000|Overall Study|Nonfunctional epidural|1|||
130787300|NCT03307174|470849065|FG001|Overall Study|Nonfunctional epidural|1|||
130787301|NCT03307174|470849064|FG000|Overall Study|Planned epidural removal|1|||
130787302|NCT03307174|470849065|FG001|Overall Study|Planned epidural removal|0|||
130787303|NCT03307174|470849064|FG000|Overall Study|Intrathecal catheter placement|0|||
130787304|NCT03307174|470849065|FG001|Overall Study|Intrathecal catheter placement|1|||
130787305|NCT04275336|470849066|FG000|Overall Study|First venipuncture failed|4|||
130787306|NCT04275336|470849067|FG001|Overall Study|First venipuncture failed|6|||
130787307|NCT04275336|470849068|FG002|Overall Study|First venipuncture failed|5|||
130787308|NCT04275336|470849066|FG000|Overall Study|Unscheduled venipuncture|9|||
130787309|NCT04275336|470849067|FG001|Overall Study|Unscheduled venipuncture|13|||
130787310|NCT04275336|470849068|FG002|Overall Study|Unscheduled venipuncture|7|||
130787311|NCT04275336|470849066|FG000|Overall Study|Failed specimen of saliva|4|||
130787312|NCT04275336|470849067|FG001|Overall Study|Failed specimen of saliva|3|||
130787313|NCT04275336|470849068|FG002|Overall Study|Failed specimen of saliva|4|||
130787314|NCT03055936|470849069|FG000|Overall Study|Adverse Event|0|||
130787315|NCT03055936|470849070|FG001|Overall Study|Adverse Event|1|||
130787316|NCT03055936|470849071|FG002|Overall Study|Adverse Event|1|||
130787317|NCT03055936|470849072|FG003|Overall Study|Adverse Event|1|||
130787318|NCT03055936|470849069|FG000|Overall Study|Personal reason|2|||
130787319|NCT03055936|470849070|FG001|Overall Study|Personal reason|0|||
130787320|NCT03055936|470849071|FG002|Overall Study|Personal reason|1|||
130787321|NCT03055936|470849072|FG003|Overall Study|Personal reason|0|||
130787322|NCT03372798|470849081|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
130787323|NCT03372798|470849082|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
130787324|NCT03372798|470849081|FG000|Overall Study|Failure of imaging probe|0|||
130787325|NCT03372798|470849082|FG001|Overall Study|Failure of imaging probe|1|||
130787326|NCT01373164|470850557|FG000|Overall Study|Lost to Follow-up|0|||
130787327|NCT01373164|470850558|FG001|Overall Study|Lost to Follow-up|0|||
130787328|NCT01373164|470850559|FG002|Overall Study|Lost to Follow-up|1|||
130787329|NCT01373164|470850560|FG003|Overall Study|Lost to Follow-up|2|||
130787330|NCT01373164|470850561|FG004|Overall Study|Lost to Follow-up|0|||
130787331|NCT01373164|470850557|FG000|Overall Study|Withdrawal by Subject|0|||
130787332|NCT01373164|470850558|FG001|Overall Study|Withdrawal by Subject|1|||
130787333|NCT01373164|470850559|FG002|Overall Study|Withdrawal by Subject|0|||
130787334|NCT01373164|470850560|FG003|Overall Study|Withdrawal by Subject|10|||
130787335|NCT01373164|470850561|FG004|Overall Study|Withdrawal by Subject|2|||
130787336|NCT03736967|470850570|FG000|Overall Study|Withdrawal by Subject|26|||
130787337|NCT03736967|470850571|FG001|Overall Study|Withdrawal by Subject|25|||
130787338|NCT03736967|470850572|FG002|Overall Study|Withdrawal by Subject|23|||
130787339|NCT03736967|470850573|FG003|Overall Study|Withdrawal by Subject|26|||
130787340|NCT03736967|470850570|FG000|Overall Study|Lost to Follow-up|3|||
130787341|NCT03736967|470850571|FG001|Overall Study|Lost to Follow-up|2|||
130787342|NCT03736967|470850572|FG002|Overall Study|Lost to Follow-up|1|||
130787343|NCT03736967|470850573|FG003|Overall Study|Lost to Follow-up|1|||
130787344|NCT03736967|470850570|FG000|Overall Study|Physician Decision|1|||
130740235|NCT01125189|470669979|FG002|Follow up Period|Lost to Follow-up|6|||
130740236|NCT01125189|470669977|FG000|Follow up Period|Other reasons|4|||
130740237|NCT01125189|470669978|FG001|Follow up Period|Other reasons|4|||
130740238|NCT01125189|470669979|FG002|Follow up Period|Other reasons|5|||
130740239|NCT00707239|470669980|FG000|Overall Study|Adverse Event|5|||
130740240|NCT00707239|470669981|FG001|Overall Study|Adverse Event|3|||
130740241|NCT00707239|470669982|FG002|Overall Study|Adverse Event|2|||
130740242|NCT00707239|470669980|FG000|Overall Study|Death|3|||
130740243|NCT00707239|470669981|FG001|Overall Study|Death|1|||
130740244|NCT00707239|470669982|FG002|Overall Study|Death|3|||
130740245|NCT00707239|470669980|FG000|Overall Study|Physician Decision|1|||
130740246|NCT00707239|470669981|FG001|Overall Study|Physician Decision|1|||
130740247|NCT00707239|470669982|FG002|Overall Study|Physician Decision|2|||
130740248|NCT00707239|470669980|FG000|Overall Study|Protocol Violation|0|||
130740249|NCT00707239|470669981|FG001|Overall Study|Protocol Violation|0|||
130740250|NCT00707239|470669982|FG002|Overall Study|Protocol Violation|1|||
130740251|NCT00707239|470669980|FG000|Overall Study|Lack of Efficacy|1|||
130740252|NCT00707239|470669981|FG001|Overall Study|Lack of Efficacy|2|||
130740253|NCT00707239|470669982|FG002|Overall Study|Lack of Efficacy|0|||
130740254|NCT00707239|470669980|FG000|Overall Study|Randomized, but not treated|1|||
130740255|NCT00707239|470669981|FG001|Overall Study|Randomized, but not treated|1|||
130740256|NCT00707239|470669982|FG002|Overall Study|Randomized, but not treated|1|||
130740257|NCT00707239|470669980|FG000|Overall Study|Other|8|||
130740258|NCT00707239|470669981|FG001|Overall Study|Other|3|||
130740259|NCT00707239|470669982|FG002|Overall Study|Other|5|||
130740260|NCT02088177|470669983|FG000|Overall Study|Lost to Follow-up|3|||
130740261|NCT01778530|470669984|FG000|Overall Study|Progression on study|1|||
130740262|NCT01778530|470669984|FG000|Overall Study|Adverse event/side effect|1|||
130740263|NCT03472014|470669985|FG000|Overall Study|Lost to Follow-up|4|||
130740264|NCT01894919|470669986|FG000|Overall Study|Withdrawal by Subject|1|||
130740265|NCT01894919|470669987|FG001|Overall Study|Withdrawal by Subject|0|||
130740266|NCT01894919|470669988|FG002|Overall Study|Withdrawal by Subject|0|||
130740267|NCT01894919|470669989|FG003|Overall Study|Withdrawal by Subject|0|||
130740268|NCT01894919|470669990|FG004|Overall Study|Withdrawal by Subject|1|||
130740269|NCT01894919|470669991|FG005|Overall Study|Withdrawal by Subject|0|||
130740270|NCT01894919|470669992|FG006|Overall Study|Withdrawal by Subject|0|||
130740271|NCT01894919|470669993|FG007|Overall Study|Withdrawal by Subject|0|||
130740272|NCT01894919|470669994|FG008|Overall Study|Withdrawal by Subject|0|||
130740273|NCT01894919|470669995|FG009|Overall Study|Withdrawal by Subject|1|||
130740274|NCT01894919|470669996|FG010|Overall Study|Withdrawal by Subject|1|||
130740275|NCT01894919|470669997|FG011|Overall Study|Withdrawal by Subject|0|||
130740276|NCT01894919|470669998|FG012|Overall Study|Withdrawal by Subject|0|||
130740277|NCT01894919|470669986|FG000|Overall Study|Adverse Event|0|||
130740278|NCT01894919|470669987|FG001|Overall Study|Adverse Event|0|||
130740279|NCT01894919|470669988|FG002|Overall Study|Adverse Event|0|||
130740280|NCT01894919|470669989|FG003|Overall Study|Adverse Event|0|||
130740281|NCT01894919|470669990|FG004|Overall Study|Adverse Event|0|||
130740282|NCT01894919|470669991|FG005|Overall Study|Adverse Event|0|||
130740283|NCT01894919|470669992|FG006|Overall Study|Adverse Event|0|||
130740284|NCT01894919|470669993|FG007|Overall Study|Adverse Event|0|||
130740285|NCT01894919|470669994|FG008|Overall Study|Adverse Event|0|||
130740286|NCT01894919|470669995|FG009|Overall Study|Adverse Event|0|||
130740287|NCT01894919|470669996|FG010|Overall Study|Adverse Event|1|||
130740288|NCT01894919|470669997|FG011|Overall Study|Adverse Event|0|||
130740289|NCT01894919|470669998|FG012|Overall Study|Adverse Event|0|||
130740290|NCT01894919|470669986|FG000|Overall Study|Other-Unspecified|1|||
130787345|NCT03736967|470850571|FG001|Overall Study|Physician Decision|0|||
130787346|NCT03736967|470850572|FG002|Overall Study|Physician Decision|0|||
130787347|NCT03736967|470850573|FG003|Overall Study|Physician Decision|1|||
130787348|NCT03736967|470850570|FG000|Overall Study|Adverse Event|0|||
130787349|NCT03736967|470850571|FG001|Overall Study|Adverse Event|1|||
130787350|NCT03736967|470850572|FG002|Overall Study|Adverse Event|0|||
130787351|NCT03736967|470850573|FG003|Overall Study|Adverse Event|1|||
130787352|NCT03736967|470850570|FG000|Overall Study|Death|0|||
130787353|NCT03736967|470850571|FG001|Overall Study|Death|0|||
130787354|NCT03736967|470850572|FG002|Overall Study|Death|0|||
130787355|NCT03736967|470850573|FG003|Overall Study|Death|1|||
130787356|NCT03736967|470850570|FG000|Overall Study|Randomized but never treated|1|||
130787357|NCT03736967|470850571|FG001|Overall Study|Randomized but never treated|0|||
130787358|NCT03736967|470850572|FG002|Overall Study|Randomized but never treated|0|||
130787359|NCT03736967|470850573|FG003|Overall Study|Randomized but never treated|0|||
130787360|NCT02419807|470850574|FG000|Overall Study|Withdrawal by Subject|4|||
130787361|NCT02419807|470850574|FG000|Overall Study|Physician Decision|1|||
130787362|NCT02419807|470850574|FG000|Overall Study|Protocol Violation|5|||
130787363|NCT01006629|470850575|FG000|Overall Study|Adverse Event|1|||
130787364|NCT01006629|470850575|FG000|Overall Study|Parent refused to continue participation|1|||
130787365|NCT01006629|470850575|FG000|Overall Study|Parent unable to perform site visit|4|||
130787366|NCT03157089|470850576|FG000|Overall Study|Treated only with pembrolizumab|1|||
130787367|NCT03157089|470850577|FG001|Overall Study|Treated only with pembrolizumab|0|||
130787368|NCT03157089|470850576|FG000|Overall Study|Adverse Event|5|||
130787369|NCT03157089|470850577|FG001|Overall Study|Adverse Event|4|||
130787370|NCT03157089|470850576|FG000|Overall Study|Progressive disease|6|||
130787371|NCT03157089|470850577|FG001|Overall Study|Progressive disease|8|||
130787372|NCT02932943|470850578|FG000|Overall Study|Lost to Follow-up|0|||
130787373|NCT02932943|470850579|FG001|Overall Study|Lost to Follow-up|2|||
130787374|NCT02932943|470850578|FG000|Overall Study|Adverse Event|2|||
130787375|NCT02932943|470850579|FG001|Overall Study|Adverse Event|2|||
130787376|NCT02932943|470850578|FG000|Overall Study|Withdrawal by Subject|3|||
130787377|NCT02932943|470850579|FG001|Overall Study|Withdrawal by Subject|3|||
130787378|NCT02300610|470850584|FG000|Overall Study|Withdrawal by Subject|1|||
130787379|NCT02300610|470850585|FG001|Overall Study|Withdrawal by Subject|0|||
130787380|NCT02300610|470850586|FG002|Overall Study|Withdrawal by Subject|1|||
130787381|NCT00095979|470850587|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
130787382|NCT01483118|470850588|FG000|Overall Study|Lost to Follow-up|12|||
130787383|NCT01483118|470850589|FG001|Overall Study|Lost to Follow-up|16|||
130787384|NCT03435055|470850591|FG000|Screening|Physician Decision|2|||
130787385|NCT03435055|470850591|FG000|Received Intervention|Did not complete nitrous administration|3|||
130787386|NCT03712280|470850592|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
130787387|NCT03712280|470850593|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
130787388|NCT03712280|470850594|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
130787389|NCT03712280|470850595|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
130787390|NCT03712280|470850592|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
130787391|NCT03712280|470850593|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
130787392|NCT03712280|470850594|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
130787393|NCT03712280|470850595|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
130787394|NCT03712280|470850592|FG000|Overall Study|Adverse Event|0|||
130787395|NCT03712280|470850593|FG001|Overall Study|Adverse Event|0|||
130787396|NCT03712280|470850594|FG002|Overall Study|Adverse Event|1|||
130787397|NCT03712280|470850595|FG003|Overall Study|Adverse Event|0|||
130787398|NCT01302899|470850598|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
130787399|NCT01302899|470850599|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
130787400|NCT01302899|470850598|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
130787401|NCT01302899|470850599|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
130787402|NCT02834975|470850600|FG000|Overall Study|Physician Decision|2|||
130787403|NCT02834975|470850600|FG000|Overall Study|Adverse Event|1|||
130787404|NCT02834975|470850600|FG000|Overall Study|Withdrawal by Subject|1|||
130787405|NCT02834975|470850600|FG000|Overall Study|Lack of Efficacy|1|||
130787406|NCT03558516|470850601|FG000|Overall Study|Protocol Violation|2|||
130787407|NCT03558516|470850602|FG001|Overall Study|Protocol Violation|2|||
130787408|NCT00929669|470850603|FG000|Overall Study|elevated glucose levels|1|||
130787409|NCT04494646|470850608|FG000|Overall Study|Adverse Event|0|||
130787410|NCT04494646|470850609|FG001|Overall Study|Adverse Event|1|||
130787411|NCT04494646|470850608|FG000|Overall Study|Withdrawal by Subject|0|||
130787412|NCT04494646|470850609|FG001|Overall Study|Withdrawal by Subject|1|||
130787413|NCT02785939|470850612|FG000|Overall Study|Progression|25|||
130787414|NCT02785939|470850613|FG001|Overall Study|Progression|8|||
130787415|NCT02785939|470850612|FG000|Overall Study|Adverse Event|3|||
130787416|NCT02785939|470850613|FG001|Overall Study|Adverse Event|1|||
130787417|NCT02785939|470850612|FG000|Overall Study|Death|1|||
130787418|NCT02785939|470850613|FG001|Overall Study|Death|0|||
130787419|NCT02785939|470850612|FG000|Overall Study|Refusal|1|||
130787420|NCT02785939|470850613|FG001|Overall Study|Refusal|0|||
130787421|NCT02785939|470850612|FG000|Overall Study|Deteriorating health|1|||
130787422|NCT02785939|470850613|FG001|Overall Study|Deteriorating health|0|||
130787423|NCT02785939|470850612|FG000|Overall Study|Not protocol specified|0|||
130740291|NCT01894919|470669987|FG001|Overall Study|Other-Unspecified|0|||
130740292|NCT01894919|470669988|FG002|Overall Study|Other-Unspecified|0|||
130740293|NCT01894919|470669989|FG003|Overall Study|Other-Unspecified|0|||
130787424|NCT02785939|470850613|FG001|Overall Study|Not protocol specified|1|||
130787425|NCT02147626|470850616|FG000|Overall Study|Lost to Follow-up|4|||
130787426|NCT02147626|470850617|FG001|Overall Study|Lost to Follow-up|4|||
130787427|NCT02147626|470850616|FG000|Overall Study|Pregnancy|1|||
130787428|NCT02147626|470850617|FG001|Overall Study|Pregnancy|2|||
130787429|NCT02147626|470850616|FG000|Overall Study|Withdrawal by Subject|0|||
130787430|NCT02147626|470850617|FG001|Overall Study|Withdrawal by Subject|1|||
130740294|NCT01894919|470669990|FG004|Overall Study|Other-Unspecified|0|||
130740295|NCT01894919|470669991|FG005|Overall Study|Other-Unspecified|0|||
130740296|NCT01894919|470669992|FG006|Overall Study|Other-Unspecified|0|||
130740297|NCT01894919|470669993|FG007|Overall Study|Other-Unspecified|0|||
130740298|NCT01894919|470669994|FG008|Overall Study|Other-Unspecified|0|||
130740299|NCT01894919|470669995|FG009|Overall Study|Other-Unspecified|0|||
130740300|NCT01894919|470669996|FG010|Overall Study|Other-Unspecified|0|||
130740301|NCT01894919|470669997|FG011|Overall Study|Other-Unspecified|0|||
130740302|NCT01894919|470669998|FG012|Overall Study|Other-Unspecified|0|||
130740303|NCT01894919|470669986|FG000|Overall Study|Lost to Follow-up|0|||
130740304|NCT01894919|470669987|FG001|Overall Study|Lost to Follow-up|0|||
130740305|NCT01894919|470669988|FG002|Overall Study|Lost to Follow-up|0|||
130740306|NCT01894919|470669989|FG003|Overall Study|Lost to Follow-up|0|||
130740307|NCT01894919|470669990|FG004|Overall Study|Lost to Follow-up|2|||
130740308|NCT01894919|470669991|FG005|Overall Study|Lost to Follow-up|0|||
130740309|NCT01894919|470669992|FG006|Overall Study|Lost to Follow-up|0|||
130740310|NCT01894919|470669993|FG007|Overall Study|Lost to Follow-up|0|||
130740311|NCT01894919|470669994|FG008|Overall Study|Lost to Follow-up|0|||
130740312|NCT01894919|470669995|FG009|Overall Study|Lost to Follow-up|0|||
130740313|NCT01894919|470669996|FG010|Overall Study|Lost to Follow-up|0|||
130740314|NCT01894919|470669997|FG011|Overall Study|Lost to Follow-up|0|||
130740315|NCT01894919|470669998|FG012|Overall Study|Lost to Follow-up|0|||
130740316|NCT03711188|470669999|FG000|Overall Study|Disease progression|11|||
130740317|NCT03711188|470669999|FG000|Overall Study|Adverse Event|1|||
130740318|NCT01433471|470670000|FG000|Overall Study|Withdrawal by Subject|0|||
130740319|NCT01433471|470670001|FG001|Overall Study|Withdrawal by Subject|1|||
130740320|NCT03743051|470670004|FG000|Overall Study|Adverse Event|5|||
130740321|NCT03743051|470670005|FG001|Overall Study|Adverse Event|9|||
130740322|NCT03743051|470670004|FG000|Overall Study|Death|27|||
130740323|NCT03743051|470670005|FG001|Overall Study|Death|26|||
130740324|NCT03743051|470670004|FG000|Overall Study|Lost to Follow-up|4|||
130740325|NCT03743051|470670005|FG001|Overall Study|Lost to Follow-up|8|||
130740326|NCT03743051|470670004|FG000|Overall Study|Withdrawal by Subject|32|||
130740327|NCT03743051|470670005|FG001|Overall Study|Withdrawal by Subject|19|||
130740328|NCT03743051|470670004|FG000|Overall Study|Physician Decision|10|||
130740329|NCT03743051|470670005|FG001|Overall Study|Physician Decision|15|||
130740330|NCT03743051|470670004|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
130740331|NCT03743051|470670005|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
130740332|NCT00711087|470670010|FG000|Overall Study|Lost to Follow-up|1|||
130740333|NCT00711087|470670011|FG001|Overall Study|Lost to Follow-up|0|||
130740334|NCT00811733|470670012|FG000|Overall Study|Investigator Discretion|10|||
130740335|NCT00811733|470670013|FG001|Overall Study|Investigator Discretion|8|||
130740336|NCT00811733|470670012|FG000|Overall Study|Withdrawal by Subject|1|||
130740337|NCT00811733|470670013|FG001|Overall Study|Withdrawal by Subject|2|||
130740338|NCT00793871|470670014|FG000|Overall Study|Death|50|||
130740339|NCT00793871|470670014|FG000|Overall Study|Lost to Follow-up|3|||
130740340|NCT00793871|470670014|FG000|Overall Study|Study terminated by the Sponsor|7|||
130740341|NCT02500589|470670015|FG000|Overall Study|Withdrawal by Subject|11|||
130740342|NCT02500589|470670016|FG001|Overall Study|Withdrawal by Subject|14|||
130740343|NCT02500589|470670015|FG000|Overall Study|Lost to Follow-up|10|||
130740344|NCT02500589|470670016|FG001|Overall Study|Lost to Follow-up|12|||
130740345|NCT02500589|470670015|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
130740346|NCT02500589|470670016|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
130740347|NCT02500589|470670015|FG000|Overall Study|Death|7|||
130740348|NCT02500589|470670016|FG001|Overall Study|Death|5|||
130740349|NCT01113892|470670023|FG000|Overall Study|Lost to Follow-up|2|||
130740350|NCT01113892|470670024|FG001|Overall Study|Lost to Follow-up|2|||
130740351|NCT01113892|470670023|FG000|Overall Study|Withdrawal by Subject|1|||
130740352|NCT01113892|470670024|FG001|Overall Study|Withdrawal by Subject|1|||
130740353|NCT01113892|470670023|FG000|Overall Study|Death|2|||
130740354|NCT01113892|470670024|FG001|Overall Study|Death|4|||
130740355|NCT01113892|470670023|FG000|Overall Study|Graft no longer evaluable|9|||
130740356|NCT01113892|470670024|FG001|Overall Study|Graft no longer evaluable|9|||
130740357|NCT02569801|470670025|FG000|Overall Study|Withdrawal by Subject|9|||
130740358|NCT02569801|470670026|FG001|Overall Study|Withdrawal by Subject|9|||
130740359|NCT02569801|470670025|FG000|Overall Study|Sponsor Decision|13|||
130740360|NCT02569801|470670026|FG001|Overall Study|Sponsor Decision|14|||
130740361|NCT02569801|470670025|FG000|Overall Study|Progressive Disease|2|||
130740362|NCT02569801|470670026|FG001|Overall Study|Progressive Disease|7|||
130740363|NCT02569801|470670025|FG000|Overall Study|Lost to Follow-up|0|||
130787431|NCT00572832|470850618|FG000|Overall Study|Lost to Follow-up|0|||
130740364|NCT02569801|470670026|FG001|Overall Study|Lost to Follow-up|1|||
130740365|NCT02569801|470670025|FG000|Overall Study|Death|12|||
130740366|NCT02569801|470670026|FG001|Overall Study|Death|4|||
130740367|NCT00428246|470670027|FG000|Overall Study|Withdrawal by Subject|0|||
130740368|NCT00428246|470670028|FG001|Overall Study|Withdrawal by Subject|0|||
130740369|NCT00428246|470670029|FG002|Overall Study|Withdrawal by Subject|1|||
130740370|NCT00428246|470670027|FG000|Overall Study|Adverse Event|1|||
130740371|NCT00428246|470670028|FG001|Overall Study|Adverse Event|0|||
130740372|NCT00428246|470670029|FG002|Overall Study|Adverse Event|0|||
130740373|NCT03442751|470670031|FG000|Overall Study|Withdrawal by Subject|3|||
130740374|NCT03442751|470670032|FG001|Overall Study|Withdrawal by Subject|1|||
130740375|NCT03442751|470670031|FG000|Overall Study|Lost to Follow-up|3|||
130740376|NCT03442751|470670032|FG001|Overall Study|Lost to Follow-up|0|||
130740377|NCT02603887|470670033|FG000|Stage 1|Adverse Event|4|||
130740378|NCT02603887|470670033|FG000|Stage 1|Disease progression|1|||
130740379|NCT02603887|470670033|FG000|Stage 2|FDA guidance|1|||
130740380|NCT01515423|470670034|FG000|Open Label Phase|Adverse Event|57|||
130740381|NCT01515423|470670035|FG001|Open Label Phase|Adverse Event|0|||
130740382|NCT01515423|470670036|FG002|Open Label Phase|Adverse Event|0|||
130740383|NCT01515423|470670034|FG000|Open Label Phase|Death|2|||
130740384|NCT01515423|470670035|FG001|Open Label Phase|Death|0|||
130740385|NCT01515423|470670036|FG002|Open Label Phase|Death|0|||
130740386|NCT01515423|470670034|FG000|Open Label Phase|Lack of Efficacy|117|||
130740387|NCT01515423|470670035|FG001|Open Label Phase|Lack of Efficacy|0|||
130740388|NCT01515423|470670036|FG002|Open Label Phase|Lack of Efficacy|0|||
130740389|NCT01515423|470670034|FG000|Open Label Phase|Lost to Follow-up|21|||
130740390|NCT01515423|470670035|FG001|Open Label Phase|Lost to Follow-up|0|||
130740391|NCT01515423|470670036|FG002|Open Label Phase|Lost to Follow-up|0|||
130740392|NCT01515423|470670034|FG000|Open Label Phase|Withdrawal by Subject|118|||
130740393|NCT01515423|470670035|FG001|Open Label Phase|Withdrawal by Subject|0|||
130740394|NCT01515423|470670036|FG002|Open Label Phase|Withdrawal by Subject|0|||
130740395|NCT01515423|470670034|FG000|Open Label Phase|excluded from DB Phase|70|||
130740396|NCT01515423|470670035|FG001|Open Label Phase|excluded from DB Phase|0|||
130740397|NCT01515423|470670036|FG002|Open Label Phase|excluded from DB Phase|0|||
130740398|NCT01515423|470670034|FG000|Open Label Phase|Other|28|||
130740399|NCT01515423|470670035|FG001|Open Label Phase|Other|0|||
130740400|NCT01515423|470670036|FG002|Open Label Phase|Other|0|||
130740401|NCT01515423|470670034|FG000|DOUBLE BLIND|Adverse Event|0|||
130740402|NCT01515423|470670035|FG001|DOUBLE BLIND|Adverse Event|15|||
130740403|NCT01515423|470670036|FG002|DOUBLE BLIND|Adverse Event|13|||
130740404|NCT01515423|470670034|FG000|DOUBLE BLIND|Death|0|||
130740405|NCT01515423|470670035|FG001|DOUBLE BLIND|Death|1|||
130740406|NCT01515423|470670036|FG002|DOUBLE BLIND|Death|2|||
130740407|NCT01515423|470670034|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
130740408|NCT01515423|470670035|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
130740409|NCT01515423|470670036|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
130740410|NCT01515423|470670034|FG000|DOUBLE BLIND|Pregnancy|0|||
130740411|NCT01515423|470670035|FG001|DOUBLE BLIND|Pregnancy|2|||
130740412|NCT01515423|470670036|FG002|DOUBLE BLIND|Pregnancy|0|||
130740413|NCT01515423|470670034|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
130740414|NCT01515423|470670035|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
130740415|NCT01515423|470670036|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
130740416|NCT01515423|470670034|FG000|DOUBLE BLIND|Other|0|||
130740417|NCT01515423|470670035|FG001|DOUBLE BLIND|Other|6|||
130740418|NCT01515423|470670036|FG002|DOUBLE BLIND|Other|12|||
130740419|NCT01515423|470670034|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
130740420|NCT01515423|470670035|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
130740421|NCT01515423|470670036|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
130740422|NCT00838526|470670043|FG000|Overall Study|Adverse Event|3|||
130740423|NCT00838526|470670044|FG001|Overall Study|Adverse Event|12|||
130740424|NCT00838526|470670043|FG000|Overall Study|Lost to Follow-up|4|||
130740425|NCT00838526|470670044|FG001|Overall Study|Lost to Follow-up|12|||
130740426|NCT00838526|470670043|FG000|Overall Study|Withdrawal by Subject|4|||
130740427|NCT00838526|470670044|FG001|Overall Study|Withdrawal by Subject|5|||
130740428|NCT00838526|470670043|FG000|Overall Study|Lack of Efficacy|2|||
130740429|NCT00838526|470670044|FG001|Overall Study|Lack of Efficacy|3|||
130740430|NCT00838526|470670043|FG000|Overall Study|Other|11|||
130740431|NCT00838526|470670044|FG001|Overall Study|Other|7|||
130740432|NCT00931411|470670045|FG000|First Intervention - 42 Days|Adverse Event|2|||
130740433|NCT00931411|470670046|FG001|First Intervention - 42 Days|Adverse Event|3|||
130740434|NCT00931411|470670045|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
130787432|NCT00572832|470850619|FG001|Overall Study|Lost to Follow-up|11|||
130787433|NCT00572832|470850618|FG000|Overall Study|Pregnancy|0|||
130787434|NCT00572832|470850619|FG001|Overall Study|Pregnancy|1|||
130787435|NCT01704261|470850623|FG000|Overall Study|Withdrawal by Subject|12|||
130787436|NCT01704261|470850624|FG001|Overall Study|Withdrawal by Subject|15|||
130787437|NCT01704261|470850623|FG000|Overall Study|Lost to Follow-up|1|||
130787438|NCT01704261|470850624|FG001|Overall Study|Lost to Follow-up|0|||
130787439|NCT02722967|470850625|FG000|Overall Study|Adverse Event|1|||
130787440|NCT02722967|470850626|FG001|Overall Study|Adverse Event|0|||
130787441|NCT02722967|470850627|FG002|Overall Study|Adverse Event|0|||
130787442|NCT02722967|470850625|FG000|Overall Study|Lost to Follow-up|0|||
130787443|NCT02722967|470850626|FG001|Overall Study|Lost to Follow-up|1|||
130787444|NCT02722967|470850627|FG002|Overall Study|Lost to Follow-up|0|||
130787445|NCT02722967|470850625|FG000|Overall Study|Non-compliance with patch wearing|2|||
130787446|NCT02722967|470850626|FG001|Overall Study|Non-compliance with patch wearing|1|||
130787447|NCT02722967|470850627|FG002|Overall Study|Non-compliance with patch wearing|1|||
130787448|NCT02722967|470850625|FG000|Overall Study|Withdrawal by Subject|1|||
130787449|NCT02722967|470850626|FG001|Overall Study|Withdrawal by Subject|0|||
130787450|NCT02722967|470850627|FG002|Overall Study|Withdrawal by Subject|1|||
130787451|NCT02722967|470850625|FG000|Overall Study|Physician Decision|1|||
130787452|NCT02722967|470850626|FG001|Overall Study|Physician Decision|0|||
130787453|NCT02722967|470850627|FG002|Overall Study|Physician Decision|0|||
130787454|NCT02722967|470850625|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
130787455|NCT02722967|470850626|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
130787456|NCT02722967|470850627|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
130787457|NCT00846053|470850630|FG000|Overall Study|Physician Decision|3|||
130787458|NCT00846053|470850631|FG001|Overall Study|Physician Decision|0|||
130787459|NCT00111761|470850632|FG000|Part 1|Physician Decision|0|||
130787460|NCT00111761|470850633|FG001|Part 1|Physician Decision|1|||
130787461|NCT00111761|470850632|FG000|Part 1|Death|0|||
130787462|NCT00111761|470850633|FG001|Part 1|Death|2|||
130787463|NCT00111761|470850632|FG000|Part 1|Other|0|||
130787464|NCT00111761|470850633|FG001|Part 1|Other|1|||
130787465|NCT00111761|470850632|FG000|Part 1|Withdrawal by Subject|0|||
130787466|NCT00111761|470850633|FG001|Part 1|Withdrawal by Subject|1|||
130787467|NCT00111761|470850632|FG000|Part 2|Adverse Event|1|||
130787468|NCT00111761|470850633|FG001|Part 2|Adverse Event|0|||
130787469|NCT00111761|470850632|FG000|Part 2|Physician Decision|1|||
130787470|NCT00111761|470850633|FG001|Part 2|Physician Decision|0|||
130787471|NCT00111761|470850632|FG000|Part 2|Death|1|||
130787472|NCT00111761|470850633|FG001|Part 2|Death|0|||
130787473|NCT00111761|470850632|FG000|Part 2|Disease progression|3|||
130787474|NCT00111761|470850633|FG001|Part 2|Disease progression|0|||
130787475|NCT00111761|470850632|FG000|Part 2|Protocol-specified criteria|1|||
130787476|NCT00111761|470850633|FG001|Part 2|Protocol-specified criteria|0|||
130787477|NCT00111761|470850632|FG000|Part 2|Other|1|||
130787478|NCT00111761|470850633|FG001|Part 2|Other|0|||
130787479|NCT00467519|470850637|FG000|Overall Study|Protocol Violation|8|||
130787480|NCT00467519|470850638|FG001|Overall Study|Protocol Violation|4|||
130787481|NCT00467519|470850637|FG000|Overall Study|Lost to Follow-up|2|||
130787482|NCT00467519|470850638|FG001|Overall Study|Lost to Follow-up|9|||
130787483|NCT00467519|470850637|FG000|Overall Study|Withdrawal by Subject|4|||
130787484|NCT00467519|470850638|FG001|Overall Study|Withdrawal by Subject|10|||
130787485|NCT00843492|470850644|FG000|Overall Study|Adverse Event|0|||
130787486|NCT00843492|470850645|FG001|Overall Study|Adverse Event|3|||
130787487|NCT00843492|470850644|FG000|Overall Study|Lost to Follow-up|4|||
130787488|NCT00843492|470850645|FG001|Overall Study|Lost to Follow-up|4|||
130787489|NCT00843492|470850644|FG000|Overall Study|Withdrawal by Subject|0|||
130787490|NCT00843492|470850645|FG001|Overall Study|Withdrawal by Subject|4|||
130787491|NCT00843492|470850644|FG000|Overall Study|Immobilization Stopped|1|||
130787492|NCT00843492|470850645|FG001|Overall Study|Immobilization Stopped|0|||
130787493|NCT00843492|470850644|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
130787494|NCT00843492|470850645|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
130787495|NCT00843492|470850644|FG000|Overall Study|Orthopedic Surgery|0|||
130787496|NCT00843492|470850645|FG001|Overall Study|Orthopedic Surgery|2|||
130787497|NCT00843492|470850644|FG000|Overall Study|Visit Not Performed|1|||
130787498|NCT00843492|470850645|FG001|Overall Study|Visit Not Performed|0|||
130787499|NCT00843492|470850644|FG000|Overall Study|Deep-vein Thrombosis|1|||
130787500|NCT00843492|470850645|FG001|Overall Study|Deep-vein Thrombosis|0|||
130787501|NCT01677741|470850647|FG000|Overall Study|Death|0|||
130787502|NCT01677741|470850648|FG001|Overall Study|Death|0|||
130787503|NCT01677741|470850649|FG002|Overall Study|Death|0|||
130787504|NCT01677741|470850650|FG003|Overall Study|Death|1|||
130787505|NCT01677741|470850651|FG004|Overall Study|Death|0|||
130787506|NCT01677741|470850652|FG005|Overall Study|Death|1|||
130787507|NCT01677741|470850653|FG006|Overall Study|Death|0|||
130787508|NCT01677741|470850654|FG007|Overall Study|Death|0|||
130787509|NCT01677741|470850647|FG000|Overall Study|Withdrawal by Subject|2|||
130787510|NCT01677741|470850648|FG001|Overall Study|Withdrawal by Subject|7|||
130787511|NCT01677741|470850649|FG002|Overall Study|Withdrawal by Subject|5|||
130787512|NCT01677741|470850650|FG003|Overall Study|Withdrawal by Subject|4|||
130787513|NCT01677741|470850651|FG004|Overall Study|Withdrawal by Subject|11|||
130787514|NCT01677741|470850652|FG005|Overall Study|Withdrawal by Subject|20|||
130787515|NCT01677741|470850653|FG006|Overall Study|Withdrawal by Subject|4|||
130787516|NCT01677741|470850654|FG007|Overall Study|Withdrawal by Subject|2|||
130787517|NCT01677741|470850647|FG000|Overall Study|Enrolled in a rollover study|0|||
130787518|NCT01677741|470850648|FG001|Overall Study|Enrolled in a rollover study|3|||
130787519|NCT01677741|470850649|FG002|Overall Study|Enrolled in a rollover study|2|||
130787520|NCT01677741|470850650|FG003|Overall Study|Enrolled in a rollover study|1|||
130787521|NCT01677741|470850651|FG004|Overall Study|Enrolled in a rollover study|6|||
130787522|NCT01677741|470850652|FG005|Overall Study|Enrolled in a rollover study|6|||
130787523|NCT01677741|470850653|FG006|Overall Study|Enrolled in a rollover study|7|||
130787524|NCT01677741|470850654|FG007|Overall Study|Enrolled in a rollover study|0|||
130787525|NCT01677741|470850647|FG000|Overall Study|Progressive disease|1|||
130787526|NCT01677741|470850648|FG001|Overall Study|Progressive disease|0|||
130787527|NCT01677741|470850649|FG002|Overall Study|Progressive disease|1|||
130787528|NCT01677741|470850650|FG003|Overall Study|Progressive disease|0|||
130787529|NCT01677741|470850651|FG004|Overall Study|Progressive disease|0|||
130787530|NCT01677741|470850652|FG005|Overall Study|Progressive disease|1|||
130787531|NCT01677741|470850653|FG006|Overall Study|Progressive disease|0|||
130787532|NCT01677741|470850654|FG007|Overall Study|Progressive disease|0|||
130787533|NCT00720499|470850655|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
130787534|NCT00720499|470850656|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130787535|NCT00720499|470850655|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
130787536|NCT00720499|470850656|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
130787537|NCT00720499|470850655|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
130787538|NCT00720499|470850656|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
130787539|NCT03642990|470850668|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
130787540|NCT03642990|470850668|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
130787541|NCT03641508|470850669|FG000|First Injection|Lost to Follow-up|2|||
130787542|NCT03641508|470850670|FG001|First Injection|Lost to Follow-up|0|||
130787543|NCT00855218|470850671|FG000|Overall Study|Adverse Event|43|||
130787544|NCT00855218|470850672|FG001|Overall Study|Adverse Event|27|||
130787545|NCT00855218|470850671|FG000|Overall Study|Withdrawal by Subject|10|||
130787546|NCT00855218|470850672|FG001|Overall Study|Withdrawal by Subject|6|||
130787547|NCT00855218|470850671|FG000|Overall Study|Physician Decision|18|||
130787548|NCT00855218|470850672|FG001|Overall Study|Physician Decision|11|||
130787549|NCT00855218|470850671|FG000|Overall Study|Lost to Follow-up|0|||
130787550|NCT00855218|470850672|FG001|Overall Study|Lost to Follow-up|1|||
130787551|NCT00855218|470850671|FG000|Overall Study|Protocol Violation|5|||
130787552|NCT00855218|470850672|FG001|Overall Study|Protocol Violation|9|||
130787553|NCT00855218|470850671|FG000|Overall Study|non-compliant with study drug|3|||
130787554|NCT00855218|470850672|FG001|Overall Study|non-compliant with study drug|1|||
130787555|NCT00855218|470850671|FG000|Overall Study|patient convenience|2|||
130787556|NCT00855218|470850672|FG001|Overall Study|patient convenience|0|||
130787557|NCT00855218|470850671|FG000|Overall Study|technical problems|2|||
130787558|NCT00855218|470850672|FG001|Overall Study|technical problems|1|||
130787559|NCT00855218|470850671|FG000|Overall Study|Still treated with study medication|0|||
130787560|NCT00855218|470850672|FG001|Overall Study|Still treated with study medication|1|||
130787561|NCT00855218|470850671|FG000|Overall Study|Untreatable disease progression|54|||
130787562|NCT00855218|470850672|FG001|Overall Study|Untreatable disease progression|67|||
130787563|NCT00855218|470850671|FG000|Overall Study|Second malignancy|0|||
130787564|NCT00855218|470850672|FG001|Overall Study|Second malignancy|1|||
130787565|NCT00855218|470850671|FG000|Overall Study|Progression measurement proven|7|||
130740435|NCT00931411|470670046|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
130740436|NCT00931411|470670045|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
130740437|NCT00931411|470670046|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
130740438|NCT00470470|470670047|FG000|Overall Study|Adverse Event|2|||
130740439|NCT00470470|470670047|FG000|Overall Study|Death|2|||
130740440|NCT00470470|470670047|FG000|Overall Study|Not treated|1|||
130740441|NCT02452476|470670060|FG000|Overall Study|Death|4|||
130740442|NCT02452476|470670061|FG001|Overall Study|Death|7|||
130740443|NCT02452476|470670060|FG000|Overall Study|Lost to Follow-up|1|||
130740444|NCT02452476|470670061|FG001|Overall Study|Lost to Follow-up|1|||
130740445|NCT02452476|470670060|FG000|Overall Study|Physician Decision|1|||
130740446|NCT02452476|470670061|FG001|Overall Study|Physician Decision|1|||
130740447|NCT02452476|470670060|FG000|Overall Study|Not treated|5|||
130740448|NCT02452476|470670061|FG001|Overall Study|Not treated|1|||
130740449|NCT03552380|470670062|FG000|Study Treatment|Disease Progression|3|||
130740450|NCT03552380|470670063|FG001|Study Treatment|Disease Progression|4|||
130740451|NCT03552380|470670062|FG000|Study Treatment|Adverse Event|2|||
130740452|NCT03552380|470670063|FG001|Study Treatment|Adverse Event|2|||
130787566|NCT00855218|470850672|FG001|Overall Study|Progression measurement proven|15|||
130787567|NCT00855218|470850671|FG000|Overall Study|Clinical endpoint reached|10|||
130787568|NCT00855218|470850672|FG001|Overall Study|Clinical endpoint reached|13|||
130787569|NCT00764790|470850673|FG000|Overall Study|Protocol Violation|0|||
130787570|NCT00764790|470850674|FG001|Overall Study|Protocol Violation|0|||
130787571|NCT00764790|470850675|FG002|Overall Study|Protocol Violation|1|||
130787572|NCT00764790|470850673|FG000|Overall Study|Withdrawal by Subject|10|||
130787573|NCT00764790|470850674|FG001|Overall Study|Withdrawal by Subject|12|||
130787574|NCT00764790|470850675|FG002|Overall Study|Withdrawal by Subject|6|||
130787575|NCT00764790|470850673|FG000|Overall Study|Lost to Follow-up|28|||
130787576|NCT00764790|470850674|FG001|Overall Study|Lost to Follow-up|29|||
130787577|NCT00764790|470850675|FG002|Overall Study|Lost to Follow-up|23|||
130787578|NCT03191552|470850676|FG000|Overall Study|Lost to Follow-up|1|||
130787579|NCT03191552|470850677|FG001|Overall Study|Lost to Follow-up|0|||
130787580|NCT03191552|470850678|FG002|Overall Study|Lost to Follow-up|0|||
130787581|NCT03191552|470850676|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
130787582|NCT03191552|470850677|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
130787583|NCT03191552|470850678|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
130787584|NCT01441973|470850679|FG000|Overall Study|Disease progression|8|||
130787585|NCT01441973|470850680|FG001|Overall Study|Disease progression|6|||
130787586|NCT01441973|470850679|FG000|Overall Study|Adverse event unrelated to study drug|3|||
130787587|NCT01441973|470850680|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130787588|NCT01441973|470850679|FG000|Overall Study|Participant request to discontinue|1|||
130787589|NCT01441973|470850680|FG001|Overall Study|Participant request to discontinue|1|||
130787590|NCT01441973|470850679|FG000|Overall Study|Poor compliance/noncompliance|0|||
130787591|NCT01441973|470850680|FG001|Overall Study|Poor compliance/noncompliance|1|||
130787592|NCT01441973|470850679|FG000|Overall Study|Administrative reason by sponsor|3|||
130787593|NCT01441973|470850680|FG001|Overall Study|Administrative reason by sponsor|5|||
130787594|NCT01441973|470850679|FG000|Overall Study|Participant withdrew consent|0|||
130787595|NCT01441973|470850680|FG001|Overall Study|Participant withdrew consent|1|||
130787596|NCT01149655|470850681|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
130787597|NCT01149655|470850682|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
130787598|NCT01149655|470850683|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
130787599|NCT01149655|470850684|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
130787600|NCT01149655|470850681|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
130787601|NCT01149655|470850682|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
130787602|NCT01149655|470850683|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
130787603|NCT01149655|470850684|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
130787604|NCT01149655|470850681|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
130787605|NCT01149655|470850682|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130787606|NCT01149655|470850683|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130787607|NCT01149655|470850684|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130787608|NCT01149655|470850681|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
130787609|NCT01149655|470850682|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
130787610|NCT01149655|470850683|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
130787611|NCT01149655|470850684|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
130787612|NCT01149655|470850681|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
130787613|NCT01149655|470850682|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130787614|NCT01149655|470850683|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130787615|NCT01149655|470850684|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130787616|NCT01149655|470850681|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
130787617|NCT01149655|470850682|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
130787618|NCT01149655|470850683|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
130787619|NCT01149655|470850684|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
130787620|NCT01149655|470850681|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
130787621|NCT01149655|470850682|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
130787622|NCT01149655|470850683|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
130787623|NCT01149655|470850684|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
130787624|NCT01149655|470850681|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
130787625|NCT01149655|470850682|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
130787626|NCT01149655|470850683|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
130740453|NCT03552380|470670062|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
130740454|NCT03552380|470670063|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
130740455|NCT03552380|470670062|FG000|Follow up|Death|3|||
130740456|NCT03552380|470670063|FG001|Follow up|Death|4|||
130740457|NCT03552380|470670062|FG000|Follow up|Site IRB terminated|0|||
130740458|NCT03552380|470670063|FG001|Follow up|Site IRB terminated|1|||
130740459|NCT01401452|470670064|FG000|Overall Study|Adverse reaction|9|||
130740460|NCT01401452|470670064|FG000|Overall Study|Lost to Follow-up|12|||
130740461|NCT01401452|470670064|FG000|Overall Study|Lack of Efficacy|30|||
130740462|NCT01401452|470670064|FG000|Overall Study|Participant developed breast cancer|1|||
130740463|NCT01401452|470670064|FG000|Overall Study|Tx stopped due to financial reasons|1|||
130740464|NCT01401452|470670064|FG000|Overall Study|Tx stopped by psychiatrist|1|||
130740465|NCT01401452|470670064|FG000|Overall Study|No more visits within the 36 wk followup|4|||
130740466|NCT01401452|470670064|FG000|Overall Study|Subject did not come to follow up visits|2|||
130740467|NCT01401452|470670064|FG000|Overall Study|Subject didn't return for routine visits|1|||
130740468|NCT01401452|470670064|FG000|Overall Study|Subject moved to another city|1|||
130740469|NCT01401452|470670064|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
130740470|NCT01401452|470670064|FG000|Overall Study|Psoriatic arthritis|1|||
130740471|NCT01401452|470670064|FG000|Overall Study|Participant stopped Tx|2|||
130740472|NCT01401452|470670064|FG000|Overall Study|Discontinuation for personal reasons|1|||
130740473|NCT01401452|470670064|FG000|Overall Study|Treatment failure|1|||
130740474|NCT01401452|470670064|FG000|Overall Study|Unsatisfactory output|1|||
130740475|NCT01401452|470670064|FG000|Overall Study|Subject withdrew because of Tx success|1|||
130740476|NCT01401452|470670064|FG000|Overall Study|Subject chose to discontinue treatment|1|||
130740477|NCT01401452|470670064|FG000|Overall Study|Participant withdrew consent|1|||
130740478|NCT01133067|470670067|FG000|Overall Study|Death|136|||
130740479|NCT01133067|470670067|FG000|Overall Study|Lost to Follow-up|3|||
130740480|NCT02654054|470670069|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
130740481|NCT02654054|470670070|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
130740482|NCT02654054|470670071|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
130740483|NCT02654054|470670069|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130740484|NCT02654054|470670070|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130740485|NCT02654054|470670071|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
130740486|NCT02654054|470670069|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
130740487|NCT02654054|470670070|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
130740488|NCT02654054|470670071|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
130740489|NCT02654054|470670069|FG000|Post-Treatment Follow-Up Period|Other|1|||
130740490|NCT02654054|470670070|FG001|Post-Treatment Follow-Up Period|Other|0|||
130740491|NCT02654054|470670071|FG002|Post-Treatment Follow-Up Period|Other|4|||
130740492|NCT02654054|470670069|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130740493|NCT02654054|470670070|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130740494|NCT02654054|470670071|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
130740495|NCT00273182|470670072|FG000|Overall Study|Death|450|||
130740496|NCT00273182|470670072|FG000|Overall Study|Lost to Follow-up|88|||
130740497|NCT00273182|470670072|FG000|Overall Study|Withdrawal by Subject|257|||
130740498|NCT00273182|470670072|FG000|Overall Study|Device/System Explant|154|||
130740499|NCT00273182|470670072|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
130740500|NCT03641469|470670073|FG000|Overall Study|Ineligible|2|||
130740501|NCT03641469|470670073|FG000|Overall Study|Withdrawal by Subject|5|||
130740502|NCT03641469|470670073|FG000|Overall Study|Physician Decision|1|||
130740503|NCT03641469|470670073|FG000|Overall Study|Protocol Violation|1|||
130740504|NCT03641469|470670073|FG000|Overall Study|Lost to Follow-up|2|||
130740505|NCT00868530|470670074|FG000|Overall Study|Adverse Event|3|||
130740506|NCT00868530|470670074|FG000|Overall Study|Lost to Follow-up|1|||
130740507|NCT00858273|470670075|FG000|Overall Study|Protocol Violation|3|||
130740508|NCT00858273|470670076|FG001|Overall Study|Protocol Violation|5|||
130740509|NCT04199104|470672011|FG000|Overall Study|Death|148|||
130740510|NCT04199104|470672012|FG001|Overall Study|Death|134|||
130740511|NCT04199104|470672011|FG000|Overall Study|Lost to Follow-up|1|||
130740512|NCT04199104|470672012|FG001|Overall Study|Lost to Follow-up|1|||
130740513|NCT04199104|470672011|FG000|Overall Study|Withdrawal by Subject|4|||
130740514|NCT04199104|470672012|FG001|Overall Study|Withdrawal by Subject|4|||
130740515|NCT04199104|470672011|FG000|Overall Study|Participants Ongoing|103|||
130740516|NCT04199104|470672012|FG001|Overall Study|Participants Ongoing|116|||
130740517|NCT02562235|470672015|FG000|Overall Study|Adverse Event|3|||
130740518|NCT05655546|470672018|FG000|Overall Study|Withdrawal by Subject|2|||
130740519|NCT05655546|470672019|FG001|Overall Study|Withdrawal by Subject|4|||
130740520|NCT01168232|470672020|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
130740521|NCT01168232|470672020|FG000|Overall Study|Ineligible- Wrong cell type|6|||
130740522|NCT01168232|470672020|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
130740523|NCT04576507|470672024|FG000|Overall Study|Adverse Event|4|||
130740524|NCT04576507|470672024|FG000|Overall Study|Withdrawal by Subject|1|||
130740525|NCT05012098|470672029|FG000|Overall Study|Disease progression|5|||
130740526|NCT05012098|470672030|FG001|Overall Study|Disease progression|2|||
130740527|NCT05012098|470672029|FG000|Overall Study|Adverse Event|1|||
130740528|NCT05012098|470672030|FG001|Overall Study|Adverse Event|0|||
130740529|NCT05012098|470672029|FG000|Overall Study|Withdrawal by Subject|1|||
130740530|NCT05012098|470672030|FG001|Overall Study|Withdrawal by Subject|0|||
130740531|NCT05012098|470672029|FG000|Overall Study|Discontinuation per protocol|1|||
130740532|NCT05012098|470672030|FG001|Overall Study|Discontinuation per protocol|0|||
130740533|NCT02493660|470672041|FG000|Overall Study|Physician Decision|0|||
130740534|NCT02493660|470672042|FG001|Overall Study|Physician Decision|1|||
130740535|NCT02493660|470672041|FG000|Overall Study|Adverse Event|4|||
130740536|NCT02493660|470672042|FG001|Overall Study|Adverse Event|2|||
130740537|NCT02493660|470672041|FG000|Overall Study|Withdrawal by Subject|2|||
130740538|NCT02493660|470672042|FG001|Overall Study|Withdrawal by Subject|3|||
130740539|NCT02493660|470672041|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
130740540|NCT02493660|470672042|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
130740541|NCT02493660|470672041|FG000|Overall Study|Protocol Violation|0|||
130740542|NCT02493660|470672042|FG001|Overall Study|Protocol Violation|1|||
130740543|NCT02493660|470672041|FG000|Overall Study|Death|0|||
130740544|NCT02493660|470672042|FG001|Overall Study|Death|1|||
130740545|NCT02493660|470672041|FG000|Overall Study|Lost to Follow-up|2|||
130740546|NCT02493660|470672042|FG001|Overall Study|Lost to Follow-up|4|||
130740547|NCT02392481|470672044|FG000|Overall Study|Adverse Event|0|||
130740548|NCT02392481|470672045|FG001|Overall Study|Adverse Event|0|||
130740549|NCT02392481|470672046|FG002|Overall Study|Adverse Event|1|||
130740550|NCT02392481|470672047|FG003|Overall Study|Adverse Event|2|||
130740551|NCT02392481|470672044|FG000|Overall Study|Withdrawal by Subject|0|||
130740552|NCT02392481|470672045|FG001|Overall Study|Withdrawal by Subject|0|||
130787627|NCT01149655|470850684|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
130787628|NCT01149655|470850681|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
130787629|NCT01149655|470850682|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
130740553|NCT02392481|470672046|FG002|Overall Study|Withdrawal by Subject|1|||
130740554|NCT02392481|470672047|FG003|Overall Study|Withdrawal by Subject|0|||
130740555|NCT02502149|470672049|FG000|Intermediate|Discontinued prematurely|1|||
130787630|NCT01149655|470850683|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
130787631|NCT01149655|470850684|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
130787632|NCT01149655|470850681|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
130787633|NCT01149655|470850682|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
130787634|NCT01149655|470850683|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
130787635|NCT01149655|470850684|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
130787636|NCT01149655|470850681|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
130787637|NCT01149655|470850682|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
130787638|NCT01149655|470850683|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
130787639|NCT01149655|470850684|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
130787640|NCT01149655|470850681|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
130787641|NCT01149655|470850682|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
130787642|NCT01149655|470850683|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
130787643|NCT01149655|470850684|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
130787644|NCT01149655|470850681|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
130787645|NCT01149655|470850682|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
130787646|NCT01149655|470850683|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
130787647|NCT01149655|470850684|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
130787648|NCT01149655|470850681|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
130787649|NCT01149655|470850682|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
130787650|NCT01149655|470850683|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
130787651|NCT01149655|470850684|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
130787652|NCT01149655|470850681|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
130787653|NCT01149655|470850682|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
130787654|NCT01149655|470850683|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
130787655|NCT01149655|470850684|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
130787656|NCT01149655|470850681|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
130787657|NCT01149655|470850682|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
130787658|NCT01149655|470850683|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
130787659|NCT01149655|470850684|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
130787660|NCT05079321|470850685|FG000|Overall Study|Withdrawal by Subject|2|||
130787661|NCT05079321|470850686|FG001|Overall Study|Withdrawal by Subject|2|||
130787662|NCT05079321|470850685|FG000|Overall Study|Lost to Follow-up|0|||
130787663|NCT05079321|470850686|FG001|Overall Study|Lost to Follow-up|1|||
130787664|NCT02003144|470850687|FG000|Open Label Maintenance Phase|Other than specified|2|||
130787665|NCT02003144|470850688|FG001|Open Label Maintenance Phase|Other than specified|4|||
130787666|NCT02003144|470850687|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
130787667|NCT02003144|470850688|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
130787668|NCT02003144|470850687|FG000|Open Label Maintenance Phase|Pregnancy|0|||
130787669|NCT02003144|470850688|FG001|Open Label Maintenance Phase|Pregnancy|2|||
130787670|NCT02003144|470850687|FG000|Open Label Maintenance Phase|Physician Decision|1|||
130787671|NCT02003144|470850688|FG001|Open Label Maintenance Phase|Physician Decision|1|||
130787672|NCT02003144|470850687|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
130787673|NCT02003144|470850688|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
130787674|NCT02003144|470850687|FG000|Open Label Maintenance Phase|Adverse Event|2|||
130787675|NCT02003144|470850688|FG001|Open Label Maintenance Phase|Adverse Event|1|||
130787676|NCT05965752|470850689|FG000|Overall Study|Adverse Event|0|||
130787677|NCT05965752|470850690|FG001|Overall Study|Adverse Event|1|||
130787678|NCT05965752|470850691|FG002|Overall Study|Adverse Event|0|||
130787679|NCT05965752|470850692|FG003|Overall Study|Adverse Event|1|||
130787680|NCT05965752|470850693|FG004|Overall Study|Adverse Event|3|||
130787681|NCT05965752|470850689|FG000|Overall Study|Lost to Follow-up|2|||
130787682|NCT05965752|470850690|FG001|Overall Study|Lost to Follow-up|0|||
130787683|NCT05965752|470850691|FG002|Overall Study|Lost to Follow-up|1|||
130787684|NCT05965752|470850692|FG003|Overall Study|Lost to Follow-up|1|||
130787685|NCT05965752|470850693|FG004|Overall Study|Lost to Follow-up|1|||
130787686|NCT05965752|470850689|FG000|Overall Study|Withdrawal by Subject|2|||
130787687|NCT05965752|470850690|FG001|Overall Study|Withdrawal by Subject|2|||
130787688|NCT05965752|470850691|FG002|Overall Study|Withdrawal by Subject|1|||
130787689|NCT05965752|470850692|FG003|Overall Study|Withdrawal by Subject|5|||
130787690|NCT05965752|470850693|FG004|Overall Study|Withdrawal by Subject|0|||
130787691|NCT05965752|470850689|FG000|Overall Study|Disease Relapse|1|||
130787692|NCT05965752|470850690|FG001|Overall Study|Disease Relapse|0|||
130787693|NCT05965752|470850691|FG002|Overall Study|Disease Relapse|1|||
130787694|NCT05965752|470850692|FG003|Overall Study|Disease Relapse|0|||
130787695|NCT05965752|470850693|FG004|Overall Study|Disease Relapse|0|||
130787696|NCT05965752|470850689|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130787697|NCT05965752|470850690|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
130787698|NCT05965752|470850691|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
130787699|NCT05965752|470850692|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
130787700|NCT05965752|470850693|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
130787701|NCT05965752|470850689|FG000|Overall Study|Unable to Return for Study Visits|0|||
130787702|NCT05965752|470850690|FG001|Overall Study|Unable to Return for Study Visits|1|||
130787703|NCT05965752|470850691|FG002|Overall Study|Unable to Return for Study Visits|0|||
130740556|NCT02502149|470672050|FG001|Intermediate|Discontinued prematurely|0|||
130740557|NCT02502149|470672051|FG002|Intermediate|Discontinued prematurely|0|||
130740558|NCT02502149|470672052|FG003|Intermediate|Discontinued prematurely|0|||
130740559|NCT02502149|470672053|FG004|Intermediate|Discontinued prematurely|0|||
130740560|NCT02968576|470672054|FG000|Overall Study|Pregnancy|0|||
130740561|NCT02968576|470672055|FG001|Overall Study|Pregnancy|1|||
130740562|NCT02222922|470672056|FG000|Overall Study|Death|0|||
130740563|NCT02222922|470672057|FG001|Overall Study|Death|0|||
130740564|NCT02222922|470672058|FG002|Overall Study|Death|0|||
130740565|NCT02222922|470672059|FG003|Overall Study|Death|0|||
130787704|NCT05965752|470850692|FG003|Overall Study|Unable to Return for Study Visits|3|||
130787705|NCT05965752|470850693|FG004|Overall Study|Unable to Return for Study Visits|1|||
130787706|NCT05965752|470850689|FG000|Overall Study|Early Termination|0|||
130787707|NCT05965752|470850690|FG001|Overall Study|Early Termination|0|||
130787708|NCT05965752|470850691|FG002|Overall Study|Early Termination|1|||
130787709|NCT05965752|470850692|FG003|Overall Study|Early Termination|0|||
130787710|NCT05965752|470850693|FG004|Overall Study|Early Termination|0|||
130787711|NCT05965752|470850689|FG000|Overall Study|Reported Unwanted Symptoms|0|||
130787712|NCT05965752|470850690|FG001|Overall Study|Reported Unwanted Symptoms|0|||
130787713|NCT05965752|470850691|FG002|Overall Study|Reported Unwanted Symptoms|0|||
130787714|NCT05965752|470850692|FG003|Overall Study|Reported Unwanted Symptoms|0|||
130787715|NCT05965752|470850693|FG004|Overall Study|Reported Unwanted Symptoms|1|||
130787716|NCT05965752|470850689|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130787717|NCT05965752|470850690|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130787718|NCT05965752|470850691|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130787719|NCT05965752|470850692|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130787720|NCT05965752|470850693|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
130787721|NCT01324947|470850694|FG000|Overall Study|Adverse Event|7|||
130787722|NCT01324947|470850694|FG000|Overall Study|Death|10|||
130787723|NCT01324947|470850694|FG000|Overall Study|Other|3|||
130787724|NCT01324947|470850694|FG000|Overall Study|Progressive Disease|50|||
130787725|NCT01324947|470850694|FG000|Overall Study|Withdrawal by Subject|3|||
130787726|NCT01324947|470850694|FG000|Overall Study|1 discontinued before starting drug|1|||
130787727|NCT01274351|470850695|FG000|Overall Study|Lost to Follow-up|1|||
130787728|NCT01274351|470850695|FG000|Overall Study|patient not compliant with the protocol|1|||
130787729|NCT01274351|470850695|FG000|Overall Study|Pregnancy|1|||
130787730|NCT01274351|470850695|FG000|Overall Study|Death|2|||
130787731|NCT01274351|470850695|FG000|Overall Study|Withdrawal by Subject|3|||
130787732|NCT01274351|470850695|FG000|Overall Study|Adverse Event|8|||
130787733|NCT01274351|470850695|FG000|Overall Study|progression of disease|3|||
130787734|NCT01274351|470850695|FG000|Overall Study|hospitalization|1|||
130740566|NCT02222922|470672060|FG004|Overall Study|Death|13|||
130740567|NCT02222922|470672061|FG005|Overall Study|Death|0|||
130740568|NCT02222922|470672062|FG006|Overall Study|Death|0|||
130740569|NCT02222922|470672063|FG007|Overall Study|Death|0|||
130740570|NCT02222922|470672064|FG008|Overall Study|Death|2|||
130740571|NCT02222922|470672056|FG000|Overall Study|Lost to Follow-up|0|||
130740572|NCT02222922|470672057|FG001|Overall Study|Lost to Follow-up|0|||
130740573|NCT02222922|470672058|FG002|Overall Study|Lost to Follow-up|1|||
130740574|NCT02222922|470672059|FG003|Overall Study|Lost to Follow-up|0|||
130740575|NCT02222922|470672060|FG004|Overall Study|Lost to Follow-up|9|||
130740576|NCT02222922|470672061|FG005|Overall Study|Lost to Follow-up|1|||
130740577|NCT02222922|470672062|FG006|Overall Study|Lost to Follow-up|0|||
130740578|NCT02222922|470672063|FG007|Overall Study|Lost to Follow-up|0|||
130740579|NCT02222922|470672064|FG008|Overall Study|Lost to Follow-up|0|||
130740580|NCT02222922|470672056|FG000|Overall Study|Other|0|||
130740581|NCT02222922|470672057|FG001|Overall Study|Other|0|||
130740582|NCT02222922|470672058|FG002|Overall Study|Other|0|||
130740583|NCT02222922|470672059|FG003|Overall Study|Other|2|||
130740584|NCT02222922|470672060|FG004|Overall Study|Other|10|||
130787735|NCT01296412|470850698|FG000|Overall Study|Adverse Event|8|||
130787736|NCT01296412|470850699|FG001|Overall Study|Adverse Event|29|||
130787737|NCT01296412|470850698|FG000|Overall Study|Lack of Efficacy|1|||
130787738|NCT01296412|470850699|FG001|Overall Study|Lack of Efficacy|0|||
130787739|NCT01296412|470850698|FG000|Overall Study|Lost to Follow-up|10|||
130787740|NCT01296412|470850699|FG001|Overall Study|Lost to Follow-up|7|||
130787741|NCT01296412|470850698|FG000|Overall Study|Non-compliance with study drug|1|||
130787742|NCT01296412|470850699|FG001|Overall Study|Non-compliance with study drug|2|||
130787743|NCT01296412|470850698|FG000|Overall Study|Other reason not specified|20|||
130787744|NCT01296412|470850699|FG001|Overall Study|Other reason not specified|15|||
130787745|NCT01296412|470850698|FG000|Overall Study|Physician Decision|1|||
130787746|NCT01296412|470850699|FG001|Overall Study|Physician Decision|3|||
130787747|NCT01296412|470850698|FG000|Overall Study|Pregnancy|0|||
130787748|NCT01296412|470850699|FG001|Overall Study|Pregnancy|1|||
130787749|NCT01296412|470850698|FG000|Overall Study|Withdrawal by Subject|10|||
130787750|NCT01296412|470850699|FG001|Overall Study|Withdrawal by Subject|13|||
130787751|NCT02160626|470850701|FG000|Overall Study|Adverse Event|1|||
130787752|NCT02160626|470850702|FG001|Overall Study|Adverse Event|0|||
130787753|NCT02160626|470850703|FG002|Overall Study|Adverse Event|0|||
130787754|NCT02160626|470850701|FG000|Overall Study|Schedule not conducive to study visits|0|||
130787755|NCT02160626|470850702|FG001|Overall Study|Schedule not conducive to study visits|0|||
130787756|NCT02160626|470850703|FG002|Overall Study|Schedule not conducive to study visits|1|||
130787757|NCT02160626|470850701|FG000|Overall Study|Withdrawal by Subject|0|||
130787758|NCT02160626|470850702|FG001|Overall Study|Withdrawal by Subject|1|||
130787759|NCT02160626|470850703|FG002|Overall Study|Withdrawal by Subject|0|||
130787760|NCT04239924|470850706|FG000|Overall Study|Lost to Follow-up|2|||
130787761|NCT00434252|470852622|FG000|Overall Study|Lack of Efficacy|50|||
130787762|NCT00434252|470852623|FG001|Overall Study|Lack of Efficacy|100|||
130787763|NCT00434252|470852622|FG000|Overall Study|Adverse Event|6|||
130787764|NCT00434252|470852623|FG001|Overall Study|Adverse Event|13|||
130787765|NCT00434252|470852622|FG000|Overall Study|Death|1|||
130740585|NCT02222922|470672061|FG005|Overall Study|Other|2|||
130740586|NCT02222922|470672062|FG006|Overall Study|Other|2|||
130740587|NCT02222922|470672063|FG007|Overall Study|Other|4|||
130740588|NCT02222922|470672064|FG008|Overall Study|Other|1|||
130740589|NCT02222922|470672056|FG000|Overall Study|Participant refused further follow-up|1|||
130740590|NCT02222922|470672057|FG001|Overall Study|Participant refused further follow-up|0|||
130740591|NCT02222922|470672058|FG002|Overall Study|Participant refused further follow-up|0|||
130740592|NCT02222922|470672059|FG003|Overall Study|Participant refused further follow-up|1|||
130740593|NCT02222922|470672060|FG004|Overall Study|Participant refused further follow-up|6|||
130740594|NCT02222922|470672061|FG005|Overall Study|Participant refused further follow-up|0|||
130740595|NCT02222922|470672062|FG006|Overall Study|Participant refused further follow-up|0|||
130740596|NCT02222922|470672063|FG007|Overall Study|Participant refused further follow-up|0|||
130740597|NCT02222922|470672064|FG008|Overall Study|Participant refused further follow-up|3|||
130740598|NCT01254643|470672065|FG000|Overall Study|Withdrawal by Subject|1|||
130740599|NCT00116779|470672071|FG000|Overall Study|Adverse Event|4|||
130740600|NCT00116779|470672072|FG001|Overall Study|Adverse Event|2|||
130740601|NCT00116779|470672071|FG000|Overall Study|Protocol Violation|1|||
130740602|NCT00116779|470672072|FG001|Overall Study|Protocol Violation|4|||
130740603|NCT00116779|470672071|FG000|Overall Study|Withdrawal by Subject|4|||
130740604|NCT00116779|470672072|FG001|Overall Study|Withdrawal by Subject|1|||
130740605|NCT00116779|470672071|FG000|Overall Study|Inadequate testosterone suppression|7|||
130740606|NCT00116779|470672072|FG001|Overall Study|Inadequate testosterone suppression|9|||
130740607|NCT00116779|470672071|FG000|Overall Study|Physician Decision|3|||
130740608|NCT00116779|470672072|FG001|Overall Study|Physician Decision|1|||
130740609|NCT00116779|470672071|FG000|Overall Study|Elevated PSA levels|2|||
130740610|NCT00116779|470672072|FG001|Overall Study|Elevated PSA levels|2|||
130740611|NCT01037218|470672077|FG000|Overall Study|Adverse Event|4|||
130740612|NCT01037218|470672078|FG001|Overall Study|Adverse Event|2|||
130740613|NCT01037218|470672079|FG002|Overall Study|Adverse Event|2|||
130740614|NCT01037218|470672080|FG003|Overall Study|Adverse Event|1|||
130740615|NCT01037218|470672077|FG000|Overall Study|Lack of Efficacy|0|||
130740616|NCT01037218|470672078|FG001|Overall Study|Lack of Efficacy|2|||
130740617|NCT01037218|470672079|FG002|Overall Study|Lack of Efficacy|1|||
130740618|NCT01037218|470672080|FG003|Overall Study|Lack of Efficacy|5|||
130740619|NCT01037218|470672077|FG000|Overall Study|Lost to Follow-up|3|||
130740620|NCT01037218|470672078|FG001|Overall Study|Lost to Follow-up|5|||
130740621|NCT01037218|470672079|FG002|Overall Study|Lost to Follow-up|4|||
130740622|NCT01037218|470672080|FG003|Overall Study|Lost to Follow-up|2|||
130740623|NCT01037218|470672077|FG000|Overall Study|Withdrawal by Subject|6|||
130740624|NCT01037218|470672078|FG001|Overall Study|Withdrawal by Subject|7|||
130787766|NCT00434252|470852623|FG001|Overall Study|Death|2|||
130740625|NCT01037218|470672079|FG002|Overall Study|Withdrawal by Subject|7|||
130740626|NCT01037218|470672080|FG003|Overall Study|Withdrawal by Subject|4|||
130740627|NCT01037218|470672077|FG000|Overall Study|Partner Withdrew Consent|0|||
130740628|NCT01037218|470672078|FG001|Overall Study|Partner Withdrew Consent|3|||
130740629|NCT01037218|470672079|FG002|Overall Study|Partner Withdrew Consent|2|||
130740630|NCT01037218|470672080|FG003|Overall Study|Partner Withdrew Consent|1|||
130740631|NCT01037218|470672077|FG000|Overall Study|Protocol Violation|0|||
130740632|NCT01037218|470672078|FG001|Overall Study|Protocol Violation|0|||
130740633|NCT01037218|470672079|FG002|Overall Study|Protocol Violation|2|||
130740634|NCT01037218|470672080|FG003|Overall Study|Protocol Violation|2|||
130740635|NCT01037218|470672077|FG000|Overall Study|Various|3|||
130740636|NCT01037218|470672078|FG001|Overall Study|Various|2|||
130740637|NCT01037218|470672079|FG002|Overall Study|Various|3|||
130740638|NCT01037218|470672080|FG003|Overall Study|Various|1|||
130740639|NCT01651117|470672086|FG000|Overall Study|Death|2|||
130740640|NCT01651117|470672087|FG001|Overall Study|Death|3|||
130740641|NCT01651117|470672088|FG002|Overall Study|Death|2|||
130740642|NCT01651117|470672089|FG003|Overall Study|Death|2|||
130740643|NCT02714218|470672090|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130740644|NCT02714218|470672091|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130740645|NCT02714218|470672092|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130740646|NCT02714218|470672090|FG000|Pre-Treatment Period|Other reasons|0|||
130740647|NCT02714218|470672091|FG001|Pre-Treatment Period|Other reasons|1|||
130740648|NCT02714218|470672092|FG002|Pre-Treatment Period|Other reasons|0|||
130740649|NCT02714218|470672090|FG000|Treatment Period|Disease Progression|55|||
130740650|NCT02714218|470672091|FG001|Treatment Period|Disease Progression|52|||
130740651|NCT02714218|470672092|FG002|Treatment Period|Disease Progression|14|||
130740652|NCT02714218|470672090|FG000|Treatment Period|Study drug toxicity|46|||
130740653|NCT02714218|470672091|FG001|Treatment Period|Study drug toxicity|70|||
130740654|NCT02714218|470672092|FG002|Treatment Period|Study drug toxicity|6|||
130740655|NCT02714218|470672090|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
130740656|NCT02714218|470672091|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
130740657|NCT02714218|470672092|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
130740658|NCT02714218|470672090|FG000|Treatment Period|Request to discontinue treatment|1|||
130740659|NCT02714218|470672091|FG001|Treatment Period|Request to discontinue treatment|4|||
130740660|NCT02714218|470672092|FG002|Treatment Period|Request to discontinue treatment|1|||
130740661|NCT02714218|470672090|FG000|Treatment Period|Participant withdrew consent|2|||
130740662|NCT02714218|470672091|FG001|Treatment Period|Participant withdrew consent|2|||
130740663|NCT02714218|470672092|FG002|Treatment Period|Participant withdrew consent|0|||
130740664|NCT02714218|470672090|FG000|Treatment Period|Maximum clinical benefit|4|||
130740665|NCT02714218|470672091|FG001|Treatment Period|Maximum clinical benefit|2|||
130740666|NCT02714218|470672092|FG002|Treatment Period|Maximum clinical benefit|0|||
130740667|NCT02714218|470672090|FG000|Treatment Period|Administrative reason by sponsor|2|||
130740668|NCT02714218|470672091|FG001|Treatment Period|Administrative reason by sponsor|1|||
130740669|NCT02714218|470672092|FG002|Treatment Period|Administrative reason by sponsor|0|||
130740670|NCT02714218|470672090|FG000|Treatment Period|Other reasons|6|||
130740671|NCT02714218|470672091|FG001|Treatment Period|Other reasons|6|||
130740672|NCT02714218|470672092|FG002|Treatment Period|Other reasons|0|||
130787767|NCT00434252|470852622|FG000|Overall Study|Lost to Follow-up|0|||
130740673|NCT02714218|470672090|FG000|Treatment Period|Completed treatment as per protocol|36|||
130740674|NCT02714218|470672091|FG001|Treatment Period|Completed treatment as per protocol|27|||
130787768|NCT00434252|470852623|FG001|Overall Study|Lost to Follow-up|1|||
130787769|NCT00434252|470852622|FG000|Overall Study|Physician Decision|4|||
130787770|NCT00434252|470852623|FG001|Overall Study|Physician Decision|8|||
130787771|NCT00434252|470852622|FG000|Overall Study|Withdrawal by Subject|3|||
130787772|NCT00434252|470852623|FG001|Overall Study|Withdrawal by Subject|7|||
130787773|NCT02997163|470852625|FG000|Overall Study|Adverse Event|1|||
130787774|NCT02997163|470852626|FG001|Overall Study|Adverse Event|0|||
130740675|NCT02714218|470672092|FG002|Treatment Period|Completed treatment as per protocol|3|||
130740676|NCT02714218|470672090|FG000|Treatment Period|Not reported|9|||
130740677|NCT02714218|470672091|FG001|Treatment Period|Not reported|6|||
130787775|NCT02997163|470852627|FG002|Overall Study|Adverse Event|0|||
130787776|NCT02997163|470852628|FG003|Overall Study|Adverse Event|1|||
130787777|NCT01855958|470852643|FG000|Overall Study|Withdrawal by Subject|1|||
130740678|NCT02714218|470672092|FG002|Treatment Period|Not reported|0|||
130740679|NCT01199939|470672096|FG000|Overall Study|Adverse Event|4|||
130740680|NCT01199939|470672096|FG000|Overall Study|Protocol Violation|3|||
130740681|NCT01199939|470672096|FG000|Overall Study|Lost to Follow-up|2|||
130740682|NCT01199939|470672096|FG000|Overall Study|Reached a virologic endpoint|4|||
130740683|NCT03238651|470672099|FG000|Overall Study|Other|0|||
130740684|NCT03238651|470672100|FG001|Overall Study|Other|0|||
130740685|NCT03238651|470672101|FG002|Overall Study|Other|0|||
130740686|NCT03238651|470672102|FG003|Overall Study|Other|0|||
130740687|NCT03238651|470672103|FG004|Overall Study|Other|1|||
130740688|NCT03238651|470672099|FG000|Overall Study|Progressive Disease|2|||
130740689|NCT03238651|470672100|FG001|Overall Study|Progressive Disease|2|||
130740690|NCT03238651|470672101|FG002|Overall Study|Progressive Disease|2|||
130787778|NCT01855958|470852644|FG001|Overall Study|Withdrawal by Subject|0|||
130787779|NCT00296244|470852645|FG000|Overall Study|Underwent retransplant|0|||
130787780|NCT00296244|470852646|FG001|Overall Study|Underwent retransplant|1|||
130787781|NCT00427934|470852647|FG000|Overall Study|Adverse Event|1|||
130787782|NCT00427934|470852648|FG001|Overall Study|Adverse Event|0|||
130787783|NCT00427934|470852649|FG002|Overall Study|Adverse Event|5|||
130740691|NCT03238651|470672102|FG003|Overall Study|Progressive Disease|2|||
130740692|NCT03238651|470672103|FG004|Overall Study|Progressive Disease|0|||
130740693|NCT03238651|470672099|FG000|Overall Study|Withdrawal by Subject|0|||
130787784|NCT00427934|470852650|FG003|Overall Study|Adverse Event|4|||
130740694|NCT03238651|470672100|FG001|Overall Study|Withdrawal by Subject|1|||
130740695|NCT03238651|470672101|FG002|Overall Study|Withdrawal by Subject|0|||
130787785|NCT00427934|470852647|FG000|Overall Study|Lack of Efficacy|0|||
130787786|NCT00427934|470852648|FG001|Overall Study|Lack of Efficacy|0|||
130787787|NCT00427934|470852649|FG002|Overall Study|Lack of Efficacy|5|||
130787788|NCT00427934|470852650|FG003|Overall Study|Lack of Efficacy|2|||
130787789|NCT00427934|470852647|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
130787790|NCT00427934|470852648|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
130740696|NCT03238651|470672102|FG003|Overall Study|Withdrawal by Subject|1|||
130740697|NCT03238651|470672103|FG004|Overall Study|Withdrawal by Subject|0|||
130740698|NCT03238651|470672099|FG000|Overall Study|Adverse Event|1|||
130740699|NCT03238651|470672100|FG001|Overall Study|Adverse Event|3|||
130740700|NCT03238651|470672101|FG002|Overall Study|Adverse Event|2|||
130740701|NCT03238651|470672102|FG003|Overall Study|Adverse Event|0|||
130740702|NCT03238651|470672103|FG004|Overall Study|Adverse Event|0|||
130740703|NCT03875508|470672104|FG000|Overall Study|Adverse Event|1|||
130740704|NCT03875508|470672104|FG000|Overall Study|Lost to Follow-up|8|||
130787791|NCT00427934|470852649|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
130787792|NCT00427934|470852650|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
130787793|NCT00427934|470852647|FG000|Overall Study|Other|0|||
130787794|NCT00427934|470852648|FG001|Overall Study|Other|0|||
130787795|NCT00427934|470852649|FG002|Overall Study|Other|11|||
130787796|NCT00427934|470852650|FG003|Overall Study|Other|5|||
130787797|NCT00427934|470852647|FG000|Overall Study|Withdrawal by Subject|0|||
130787798|NCT00427934|470852648|FG001|Overall Study|Withdrawal by Subject|0|||
130787799|NCT00427934|470852649|FG002|Overall Study|Withdrawal by Subject|1|||
130787800|NCT00427934|470852650|FG003|Overall Study|Withdrawal by Subject|3|||
130787801|NCT00499122|470852651|FG000|Overall Study|Withdrawal by Subject|2|||
130787802|NCT04539275|470852654|FG000|Overall Study|Death|2|||
130787803|NCT04539275|470852655|FG001|Overall Study|Death|4|||
130740705|NCT03875508|470672104|FG000|Overall Study|Lack of Efficacy|1|||
130740706|NCT03875508|470672104|FG000|Overall Study|Other, not specified|2|||
130740707|NCT03652051|470672106|FG000|Stage 1|Adverse Event|0|||
130740708|NCT03652051|470672107|FG001|Stage 1|Adverse Event|5|||
130740709|NCT03652051|470672108|FG002|Stage 1|Adverse Event|7|||
130740710|NCT03652051|470672109|FG003|Stage 1|Adverse Event|1|||
130740711|NCT03652051|470672106|FG000|Stage 1|Withdrawal by Subject|0|||
130740712|NCT03652051|470672107|FG001|Stage 1|Withdrawal by Subject|0|||
130740713|NCT03652051|470672108|FG002|Stage 1|Withdrawal by Subject|1|||
130740714|NCT03652051|470672109|FG003|Stage 1|Withdrawal by Subject|0|||
130740715|NCT03652051|470672106|FG000|Stage 2|Adverse Event|0|||
130740716|NCT03652051|470672107|FG001|Stage 2|Adverse Event|2|||
130740717|NCT03652051|470672108|FG002|Stage 2|Adverse Event|1|||
130740718|NCT03652051|470672109|FG003|Stage 2|Adverse Event|0|||
130740719|NCT03652051|470672106|FG000|Stage 2|Protocol Violation|0|||
130740720|NCT03652051|470672107|FG001|Stage 2|Protocol Violation|1|||
130740721|NCT03652051|470672108|FG002|Stage 2|Protocol Violation|6|||
130740722|NCT03652051|470672109|FG003|Stage 2|Protocol Violation|0|||
130740723|NCT03652051|470672106|FG000|Stage 2|Lost to Follow-up|0|||
130740724|NCT03652051|470672107|FG001|Stage 2|Lost to Follow-up|2|||
130740725|NCT03652051|470672108|FG002|Stage 2|Lost to Follow-up|0|||
130740726|NCT03652051|470672109|FG003|Stage 2|Lost to Follow-up|3|||
130740727|NCT03652051|470672106|FG000|Stage 2|Withdrawal by Subject|0|||
130740728|NCT03652051|470672107|FG001|Stage 2|Withdrawal by Subject|11|||
130740729|NCT03652051|470672108|FG002|Stage 2|Withdrawal by Subject|9|||
130740730|NCT03652051|470672109|FG003|Stage 2|Withdrawal by Subject|3|||
130740731|NCT02550561|470672110|FG000|Overall Study|Lost to Follow-up|5|||
130740732|NCT02550561|470672110|FG000|Overall Study|Withdrawal by Subject|1|||
130740733|NCT02394600|470672111|FG000|Overall Study|Adverse Event|3|||
130740734|NCT02394600|470672112|FG001|Overall Study|Adverse Event|0|||
130740735|NCT02394600|470672111|FG000|Overall Study|Lost to Follow-up|0|||
130740736|NCT02394600|470672112|FG001|Overall Study|Lost to Follow-up|1|||
130740737|NCT02394600|470672111|FG000|Overall Study|Withdrawal by Subject|0|||
130740738|NCT02394600|470672112|FG001|Overall Study|Withdrawal by Subject|1|||
130740739|NCT02394600|470672111|FG000|Overall Study|Protocol Violation|1|||
130740740|NCT02394600|470672112|FG001|Overall Study|Protocol Violation|0|||
130740741|NCT01686373|470672113|FG000|Overall Study|Lost to Follow-up|3|||
130740742|NCT01686373|470672114|FG001|Overall Study|Lost to Follow-up|0|||
130740743|NCT01686373|470672113|FG000|Overall Study|Withdrawal by Subject|0|||
130740744|NCT01686373|470672114|FG001|Overall Study|Withdrawal by Subject|1|||
130787804|NCT04539275|470852654|FG000|Overall Study|Lost to Follow-up|1|||
130787805|NCT04539275|470852655|FG001|Overall Study|Lost to Follow-up|1|||
130740745|NCT01686373|470672113|FG000|Overall Study|Adverse Event|0|||
130740746|NCT01686373|470672114|FG001|Overall Study|Adverse Event|1|||
130740747|NCT04052620|470672118|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
130787806|NCT04539275|470852654|FG000|Overall Study|Withdrawal by Subject|3|||
130787807|NCT04539275|470852655|FG001|Overall Study|Withdrawal by Subject|0|||
130787808|NCT00903968|470852656|FG000|Overall Study|Adverse Event|0|||
130740748|NCT04052620|470672119|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
130740749|NCT04052620|470672118|FG000|Overall Study|Withdrawal by Subject|1|||
130740750|NCT04052620|470672119|FG001|Overall Study|Withdrawal by Subject|0|||
130740751|NCT04052620|470672118|FG000|Overall Study|Lost to Follow-up|1|||
130740752|NCT04052620|470672119|FG001|Overall Study|Lost to Follow-up|1|||
130740753|NCT04052620|470672118|FG000|Overall Study|Adverse Event|1|||
130740754|NCT04052620|470672119|FG001|Overall Study|Adverse Event|0|||
130740755|NCT04052620|470672118|FG000|Overall Study|Subject did not meet study Criteria|0|||
130740756|NCT04052620|470672119|FG001|Overall Study|Subject did not meet study Criteria|1|||
130740757|NCT04052620|470672118|FG000|Overall Study|Screened failure, randomized by mistake|0|||
130740758|NCT04052620|470672119|FG001|Overall Study|Screened failure, randomized by mistake|1|||
130740759|NCT04052620|470672118|FG000|Overall Study|Personal reasons|2|||
130740760|NCT04052620|470672119|FG001|Overall Study|Personal reasons|4|||
130787809|NCT00903968|470852657|FG001|Overall Study|Adverse Event|0|||
130787810|NCT00903968|470852658|FG002|Overall Study|Adverse Event|0|||
130787811|NCT00903968|470852659|FG003|Overall Study|Adverse Event|0|||
130787812|NCT00903968|470852660|FG004|Overall Study|Adverse Event|0|||
130787813|NCT00903968|470852661|FG005|Overall Study|Adverse Event|0|||
130787814|NCT00903968|470852662|FG006|Overall Study|Adverse Event|1|||
130787815|NCT00903968|470852663|FG007|Overall Study|Adverse Event|8|||
130787816|NCT00903968|470852656|FG000|Overall Study|DLT|0|||
130787817|NCT00903968|470852657|FG001|Overall Study|DLT|0|||
130787818|NCT00903968|470852658|FG002|Overall Study|DLT|0|||
130787819|NCT00903968|470852659|FG003|Overall Study|DLT|0|||
130787820|NCT00903968|470852660|FG004|Overall Study|DLT|0|||
130787821|NCT00903968|470852661|FG005|Overall Study|DLT|0|||
130787822|NCT00903968|470852662|FG006|Overall Study|DLT|2|||
130740761|NCT04052620|470672118|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
130740762|NCT04052620|470672119|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
130787823|NCT00903968|470852663|FG007|Overall Study|DLT|0|||
130740763|NCT02201784|470672120|FG000|Overall Study|Failure to achieve adequate block|2|||
130787824|NCT00903968|470852656|FG000|Overall Study|Withdrawal by Subject|1|||
130787825|NCT00903968|470852657|FG001|Overall Study|Withdrawal by Subject|0|||
130787826|NCT00903968|470852658|FG002|Overall Study|Withdrawal by Subject|1|||
130787827|NCT00903968|470852659|FG003|Overall Study|Withdrawal by Subject|0|||
130787828|NCT00903968|470852660|FG004|Overall Study|Withdrawal by Subject|1|||
130787829|NCT00903968|470852661|FG005|Overall Study|Withdrawal by Subject|1|||
130787830|NCT00903968|470852662|FG006|Overall Study|Withdrawal by Subject|0|||
130787831|NCT00903968|470852663|FG007|Overall Study|Withdrawal by Subject|4|||
130787832|NCT00903968|470852656|FG000|Overall Study|Non-Compliance|0|||
130787833|NCT00903968|470852657|FG001|Overall Study|Non-Compliance|0|||
130787834|NCT00903968|470852658|FG002|Overall Study|Non-Compliance|0|||
130787835|NCT00903968|470852659|FG003|Overall Study|Non-Compliance|0|||
130787836|NCT00903968|470852660|FG004|Overall Study|Non-Compliance|0|||
130787837|NCT00903968|470852661|FG005|Overall Study|Non-Compliance|1|||
130787838|NCT00903968|470852662|FG006|Overall Study|Non-Compliance|0|||
130787839|NCT00903968|470852663|FG007|Overall Study|Non-Compliance|0|||
130787840|NCT00903968|470852656|FG000|Overall Study|Physician Decision|0|||
130787841|NCT00903968|470852657|FG001|Overall Study|Physician Decision|0|||
130787842|NCT00903968|470852658|FG002|Overall Study|Physician Decision|0|||
130787843|NCT00903968|470852659|FG003|Overall Study|Physician Decision|0|||
130787844|NCT00903968|470852660|FG004|Overall Study|Physician Decision|0|||
130787845|NCT00903968|470852661|FG005|Overall Study|Physician Decision|1|||
130787846|NCT00903968|470852662|FG006|Overall Study|Physician Decision|0|||
130787847|NCT00903968|470852663|FG007|Overall Study|Physician Decision|0|||
130787848|NCT00903968|470852656|FG000|Overall Study|Progressive Disease|2|||
130787849|NCT00903968|470852657|FG001|Overall Study|Progressive Disease|3|||
130787850|NCT00903968|470852658|FG002|Overall Study|Progressive Disease|2|||
130787851|NCT00903968|470852659|FG003|Overall Study|Progressive Disease|3|||
130787852|NCT00903968|470852660|FG004|Overall Study|Progressive Disease|3|||
130787853|NCT00903968|470852661|FG005|Overall Study|Progressive Disease|3|||
130787854|NCT00903968|470852662|FG006|Overall Study|Progressive Disease|0|||
130787855|NCT00903968|470852663|FG007|Overall Study|Progressive Disease|18|||
130787856|NCT00903968|470852656|FG000|Overall Study|Lack of Efficacy|0|||
130787857|NCT00903968|470852657|FG001|Overall Study|Lack of Efficacy|0|||
130787858|NCT00903968|470852658|FG002|Overall Study|Lack of Efficacy|0|||
130787859|NCT00903968|470852659|FG003|Overall Study|Lack of Efficacy|0|||
130787860|NCT00903968|470852660|FG004|Overall Study|Lack of Efficacy|0|||
130787861|NCT00903968|470852661|FG005|Overall Study|Lack of Efficacy|0|||
130787862|NCT00903968|470852662|FG006|Overall Study|Lack of Efficacy|0|||
130787863|NCT00903968|470852663|FG007|Overall Study|Lack of Efficacy|3|||
130787864|NCT01799941|470852664|FG000|Overall Study|Adverse Event|34|||
130787865|NCT01799941|470852664|FG000|Overall Study|Withdrawal by Subject|21|||
130787866|NCT01799941|470852664|FG000|Overall Study|Death|2|||
130787867|NCT01799941|470852664|FG000|Overall Study|Investigator Decision|4|||
130787868|NCT01799941|470852664|FG000|Overall Study|Lack of Efficacy|3|||
130787869|NCT01799941|470852664|FG000|Overall Study|Lost to Follow-up|17|||
130787870|NCT01799941|470852664|FG000|Overall Study|Other|15|||
130787871|NCT01663623|470852676|FG000|Overall Study|Adverse Event|3|||
130787872|NCT01663623|470852677|FG001|Overall Study|Adverse Event|7|||
130787873|NCT01663623|470852676|FG000|Overall Study|Lack of Efficacy|5|||
130787874|NCT01663623|470852677|FG001|Overall Study|Lack of Efficacy|6|||
130787875|NCT01663623|470852676|FG000|Overall Study|Protocol Violation|0|||
130787876|NCT01663623|470852677|FG001|Overall Study|Protocol Violation|1|||
130787877|NCT01663623|470852676|FG000|Overall Study|Other-Study closed/terminated|1|||
130787878|NCT01663623|470852677|FG001|Overall Study|Other-Study closed/terminated|1|||
130787879|NCT01663623|470852676|FG000|Overall Study|Physician Decision|1|||
130787880|NCT01663623|470852677|FG001|Overall Study|Physician Decision|4|||
130787881|NCT01663623|470852676|FG000|Overall Study|Withdrawal by Subject|2|||
130787882|NCT01663623|470852677|FG001|Overall Study|Withdrawal by Subject|1|||
130787883|NCT02251275|470852678|FG000|Overall Study|Adverse Event|23|||
130787884|NCT02251275|470852679|FG001|Overall Study|Adverse Event|60|||
130787885|NCT02251275|470852680|FG002|Overall Study|Adverse Event|28|||
130787886|NCT02251275|470852681|FG003|Overall Study|Adverse Event|0|||
130787887|NCT02251275|470852682|FG004|Overall Study|Adverse Event|0|||
130787888|NCT02251275|470852678|FG000|Overall Study|Lost to Follow-up|5|||
130787889|NCT02251275|470852679|FG001|Overall Study|Lost to Follow-up|6|||
130787890|NCT02251275|470852680|FG002|Overall Study|Lost to Follow-up|4|||
130787891|NCT02251275|470852681|FG003|Overall Study|Lost to Follow-up|0|||
130787892|NCT02251275|470852682|FG004|Overall Study|Lost to Follow-up|0|||
130787893|NCT02251275|470852678|FG000|Overall Study|Physician Decision|19|||
130787894|NCT02251275|470852679|FG001|Overall Study|Physician Decision|30|||
130787895|NCT02251275|470852680|FG002|Overall Study|Physician Decision|26|||
130787896|NCT02251275|470852681|FG003|Overall Study|Physician Decision|0|||
130787897|NCT02251275|470852682|FG004|Overall Study|Physician Decision|1|||
130787898|NCT02251275|470852678|FG000|Overall Study|Protocol Deviation|0|||
130787899|NCT02251275|470852679|FG001|Overall Study|Protocol Deviation|0|||
130787900|NCT02251275|470852680|FG002|Overall Study|Protocol Deviation|1|||
130787901|NCT02251275|470852681|FG003|Overall Study|Protocol Deviation|0|||
130787902|NCT02251275|470852682|FG004|Overall Study|Protocol Deviation|0|||
130787903|NCT02251275|470852678|FG000|Overall Study|Withdrawal by Subject|25|||
130787904|NCT02251275|470852679|FG001|Overall Study|Withdrawal by Subject|51|||
130787905|NCT02251275|470852680|FG002|Overall Study|Withdrawal by Subject|35|||
130787906|NCT02251275|470852681|FG003|Overall Study|Withdrawal by Subject|1|||
130787907|NCT02251275|470852682|FG004|Overall Study|Withdrawal by Subject|0|||
130787908|NCT00856180|470852686|FG000|Overall Study|Adverse Event|4|||
130787909|NCT00856180|470852686|FG000|Overall Study|Progressive Disease|16|||
130787910|NCT00671749|470852687|FG000|Overall Study|Adverse Event|2|||
130787911|NCT00671749|470852687|FG000|Overall Study|Withdrawal by Subject|4|||
130787912|NCT00671749|470852687|FG000|Overall Study|Protocol Violation|1|||
130787913|NCT00671749|470852687|FG000|Overall Study|Lost to Follow-up|1|||
130787914|NCT02515227|470852688|FG000|Overall Study|Adverse Event|0|||
130787915|NCT02515227|470852689|FG001|Overall Study|Adverse Event|2|||
130787916|NCT02515227|470852688|FG000|Overall Study|Progressive disease|2|||
130787917|NCT02515227|470852689|FG001|Overall Study|Progressive disease|9|||
130787918|NCT03363906|470852699|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
130787919|NCT03363906|470852700|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
130787920|NCT03363906|470852699|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
130787921|NCT03363906|470852700|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
130787922|NCT03363906|470852699|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
130787923|NCT03363906|470852700|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
130787924|NCT03363906|470852699|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
130787925|NCT03363906|470852700|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
130787926|NCT02714153|470852702|FG000|Overall Study|Death|1|||
130787927|NCT00686972|470852703|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
130787928|NCT01462942|470852708|FG000|Overall Study|Adverse Event|7|||
130787929|NCT01462942|470852709|FG001|Overall Study|Adverse Event|12|||
130787930|NCT01462942|470852710|FG002|Overall Study|Adverse Event|10|||
130787931|NCT01462942|470852711|FG003|Overall Study|Adverse Event|11|||
130787932|NCT01462942|470852712|FG004|Overall Study|Adverse Event|11|||
130787933|NCT01462942|470852708|FG000|Overall Study|Other, including COPD exacerbation|3|||
130787934|NCT01462942|470852709|FG001|Overall Study|Other, including COPD exacerbation|5|||
130787935|NCT01462942|470852710|FG002|Overall Study|Other, including COPD exacerbation|2|||
130787936|NCT01462942|470852711|FG003|Overall Study|Other, including COPD exacerbation|8|||
130787937|NCT01462942|470852712|FG004|Overall Study|Other, including COPD exacerbation|5|||
130787938|NCT01462942|470852708|FG000|Overall Study|Withdrawal by Subject|14|||
130787939|NCT01462942|470852709|FG001|Overall Study|Withdrawal by Subject|10|||
130787940|NCT01462942|470852710|FG002|Overall Study|Withdrawal by Subject|14|||
130787941|NCT01462942|470852711|FG003|Overall Study|Withdrawal by Subject|16|||
130787942|NCT01462942|470852712|FG004|Overall Study|Withdrawal by Subject|19|||
130787943|NCT01462942|470852708|FG000|Overall Study|Lack of Efficacy|6|||
130787944|NCT01462942|470852709|FG001|Overall Study|Lack of Efficacy|0|||
130787945|NCT01462942|470852710|FG002|Overall Study|Lack of Efficacy|4|||
130787946|NCT01462942|470852711|FG003|Overall Study|Lack of Efficacy|5|||
130787947|NCT01462942|470852712|FG004|Overall Study|Lack of Efficacy|3|||
130787948|NCT01462942|470852708|FG000|Overall Study|Lost to Follow-up|0|||
130787949|NCT01462942|470852709|FG001|Overall Study|Lost to Follow-up|1|||
130787950|NCT01462942|470852710|FG002|Overall Study|Lost to Follow-up|1|||
130787951|NCT01462942|470852711|FG003|Overall Study|Lost to Follow-up|1|||
130787952|NCT01462942|470852712|FG004|Overall Study|Lost to Follow-up|1|||
130787953|NCT01462942|470852708|FG000|Overall Study|Protocol Violation|4|||
130787954|NCT01462942|470852709|FG001|Overall Study|Protocol Violation|6|||
130787955|NCT01462942|470852710|FG002|Overall Study|Protocol Violation|9|||
130787956|NCT01462942|470852711|FG003|Overall Study|Protocol Violation|9|||
130787957|NCT01462942|470852712|FG004|Overall Study|Protocol Violation|6|||
130787958|NCT01027845|470852713|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
130787959|NCT01027845|470852714|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
130787960|NCT01027845|470852715|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
130787961|NCT01027845|470852716|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
130787962|NCT01027845|470852713|FG000|Primary Vaccination Phase|Adverse Event|1|||
130787963|NCT01027845|470852714|FG001|Primary Vaccination Phase|Adverse Event|0|||
130787964|NCT01027845|470852715|FG002|Primary Vaccination Phase|Adverse Event|0|||
130787965|NCT01027845|470852716|FG003|Primary Vaccination Phase|Adverse Event|0|||
130787966|NCT01027845|470852713|FG000|Primary Vaccination Phase|Protocol Violation|1|||
130787967|NCT01027845|470852714|FG001|Primary Vaccination Phase|Protocol Violation|0|||
130787968|NCT01027845|470852715|FG002|Primary Vaccination Phase|Protocol Violation|0|||
130787969|NCT01027845|470852716|FG003|Primary Vaccination Phase|Protocol Violation|0|||
130787970|NCT01027845|470852713|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
130787971|NCT01027845|470852714|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
130787972|NCT01027845|470852715|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
130740764|NCT02201784|470672121|FG001|Overall Study|Failure to achieve adequate block|0|||
130740765|NCT02072980|470672122|FG000|Period 2, Second Wear|Adverse Event|0|||
130787973|NCT01027845|470852716|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
130787974|NCT01027845|470852713|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
130787975|NCT01027845|470852714|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
130787976|NCT01027845|470852715|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
130787977|NCT01027845|470852716|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
130787978|NCT01027845|470852713|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
130787979|NCT01027845|470852714|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
130787980|NCT01027845|470852715|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
130787981|NCT01027845|470852716|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
130787982|NCT00368550|470852717|FG000|Overall Study|Adverse Event|7|||
130787983|NCT00368550|470852718|FG001|Overall Study|Adverse Event|4|||
130787984|NCT00368550|470852717|FG000|Overall Study|Lack of Efficacy|4|||
130787985|NCT00368550|470852718|FG001|Overall Study|Lack of Efficacy|9|||
130787986|NCT00368550|470852717|FG000|Overall Study|Withdrawal by Subject|17|||
130787987|NCT00368550|470852718|FG001|Overall Study|Withdrawal by Subject|10|||
130787988|NCT00486044|470852719|FG000|Overall Study|Withdrawal by Subject|2|||
130787989|NCT00486044|470852720|FG001|Overall Study|Withdrawal by Subject|1|||
130740766|NCT02072980|470672123|FG001|Period 2, Second Wear|Adverse Event|1|||
130740767|NCT02431364|470672124|FG000|Overall Study|Adverse Event|0|||
130740768|NCT02431364|470672125|FG001|Overall Study|Adverse Event|1|||
130740769|NCT02431364|470672126|FG002|Overall Study|Adverse Event|0|||
130740770|NCT02431364|470672127|FG003|Overall Study|Adverse Event|0|||
130740771|NCT02431364|470672128|FG004|Overall Study|Adverse Event|0|||
130740772|NCT02431364|470672124|FG000|Overall Study|Randomized but never treated|0|||
130740773|NCT02431364|470672125|FG001|Overall Study|Randomized but never treated|0|||
130740774|NCT02431364|470672126|FG002|Overall Study|Randomized but never treated|0|||
130740775|NCT02431364|470672127|FG003|Overall Study|Randomized but never treated|1|||
130740776|NCT02431364|470672128|FG004|Overall Study|Randomized but never treated|0|||
130740777|NCT00916383|470672129|FG000|Overall Study|Adverse Event|1|||
130740778|NCT00916383|470672129|FG000|Overall Study|Death|1|||
130740779|NCT00916383|470672129|FG000|Overall Study|Protocol Violation|1|||
130787990|NCT00486044|470852719|FG000|Overall Study|Adverse Event|0|||
130787991|NCT00486044|470852720|FG001|Overall Study|Adverse Event|1|||
130787992|NCT00486044|470852719|FG000|Overall Study|Lost to Follow-up|0|||
130787993|NCT00486044|470852720|FG001|Overall Study|Lost to Follow-up|1|||
130787994|NCT01670292|470852724|FG000|Overall Study|Lost to Follow-up|14|||
130787995|NCT03154086|470852730|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130787996|NCT03154086|470852731|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130787997|NCT03154086|470852732|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130787998|NCT03154086|470852733|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
130787999|NCT03154086|470852734|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788000|NCT03154086|470852735|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788001|NCT03154086|470852736|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788002|NCT03154086|470852737|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788003|NCT03154086|470852738|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788004|NCT03154086|470852739|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788005|NCT03154086|470852740|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788006|NCT03154086|470852741|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788007|NCT03154086|470852742|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788008|NCT03154086|470852743|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788009|NCT03154086|470852744|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130788010|NCT03154086|470852730|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130740780|NCT00258960|470672130|FG000|Overall Study|Death|2|||
130740781|NCT00258960|470672130|FG000|Overall Study|Disease Progression|7|||
130740782|NCT00258960|470672130|FG000|Overall Study|Adverse Event|4|||
130740783|NCT00258960|470672130|FG000|Overall Study|Physician Decision|1|||
130740784|NCT00258960|470672130|FG000|Overall Study|Withdrawal by Subject|1|||
130740785|NCT00258960|470672130|FG000|Overall Study|Mistake|2|||
130740786|NCT01112059|470672131|FG000|Overall Study|Withdrawal by Subject|1|||
130740787|NCT01112059|470672132|FG001|Overall Study|Withdrawal by Subject|0|||
130740788|NCT01757275|470672135|FG000|Overall Study|Lost to Follow-up|1|||
130740789|NCT01757275|470672136|FG001|Overall Study|Lost to Follow-up|2|||
130740790|NCT01757275|470672135|FG000|Overall Study|Adverse Event|3|||
130740791|NCT01757275|470672136|FG001|Overall Study|Adverse Event|3|||
130740792|NCT01757275|470672135|FG000|Overall Study|Withdrawal by Subject|2|||
130740793|NCT01757275|470672136|FG001|Overall Study|Withdrawal by Subject|4|||
130740794|NCT01757275|470672135|FG000|Overall Study|Not treated|3|||
130740795|NCT01757275|470672136|FG001|Overall Study|Not treated|4|||
130740796|NCT02601014|470672139|FG000|Overall Study|Adverse Event|3|||
130740797|NCT02601014|470672140|FG001|Overall Study|Adverse Event|3|||
130740798|NCT02601014|470672139|FG000|Overall Study|Death|3|||
130740799|NCT02601014|470672140|FG001|Overall Study|Death|1|||
130788011|NCT03154086|470852731|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
130788012|NCT03154086|470852732|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130788013|NCT03154086|470852733|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130788014|NCT03154086|470852734|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130788015|NCT03154086|470852735|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130788016|NCT03154086|470852736|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130788017|NCT03154086|470852737|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130740800|NCT02601014|470672139|FG000|Overall Study|Disease progression|4|||
130740801|NCT02601014|470672140|FG001|Overall Study|Disease progression|8|||
130740802|NCT01168427|470672141|FG000|Overall Study|Patient exited prior to implant|1|||
130740803|NCT00420420|470672144|FG000|Overall Study|Adverse Event|5|||
130740804|NCT00420420|470672145|FG001|Overall Study|Adverse Event|3|||
130740805|NCT00420420|470672144|FG000|Overall Study|Protocol Violation|1|||
130740806|NCT00420420|470672145|FG001|Overall Study|Protocol Violation|1|||
130740807|NCT00420420|470672144|FG000|Overall Study|Withdrawal by Subject|1|||
130740808|NCT00420420|470672145|FG001|Overall Study|Withdrawal by Subject|0|||
130740809|NCT00420420|470672144|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
130740810|NCT00420420|470672145|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
130740811|NCT02235454|470672146|FG000|Overall Study|Withdrawal by Subject|2|||
130740812|NCT03323398|470672147|FG000|Overall Study|Other than Specified|0|||
130740813|NCT03323398|470672148|FG001|Overall Study|Other than Specified|1|||
130740814|NCT03323398|470672149|FG002|Overall Study|Other than Specified|2|||
130740815|NCT03323398|470672150|FG003|Overall Study|Other than Specified|0|||
130740816|NCT03323398|470672151|FG004|Overall Study|Other than Specified|0|||
130740817|NCT03323398|470672152|FG005|Overall Study|Other than Specified|0|||
130740818|NCT03323398|470672153|FG006|Overall Study|Other than Specified|1|||
130740819|NCT03323398|470672154|FG007|Overall Study|Other than Specified|0|||
130740820|NCT03323398|470672155|FG008|Overall Study|Other than Specified|2|||
130740821|NCT03323398|470672147|FG000|Overall Study|Lost to Follow-up|1|||
130740822|NCT03323398|470672148|FG001|Overall Study|Lost to Follow-up|2|||
130740823|NCT03323398|470672149|FG002|Overall Study|Lost to Follow-up|1|||
130740824|NCT03323398|470672150|FG003|Overall Study|Lost to Follow-up|0|||
130740825|NCT03323398|470672151|FG004|Overall Study|Lost to Follow-up|0|||
130788018|NCT03154086|470852738|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130740826|NCT03323398|470672152|FG005|Overall Study|Lost to Follow-up|0|||
130740827|NCT03323398|470672153|FG006|Overall Study|Lost to Follow-up|0|||
130740828|NCT03323398|470672154|FG007|Overall Study|Lost to Follow-up|0|||
130740829|NCT03323398|470672155|FG008|Overall Study|Lost to Follow-up|0|||
130740830|NCT03323398|470672147|FG000|Overall Study|Death|4|||
130740831|NCT03323398|470672148|FG001|Overall Study|Death|6|||
130740832|NCT03323398|470672149|FG002|Overall Study|Death|2|||
130740833|NCT03323398|470672150|FG003|Overall Study|Death|2|||
130740834|NCT03323398|470672151|FG004|Overall Study|Death|1|||
130740835|NCT03323398|470672152|FG005|Overall Study|Death|2|||
130740836|NCT03323398|470672153|FG006|Overall Study|Death|0|||
130740837|NCT03323398|470672154|FG007|Overall Study|Death|0|||
130740838|NCT03323398|470672155|FG008|Overall Study|Death|6|||
130740839|NCT03323398|470672147|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
130740840|NCT03323398|470672148|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
130740841|NCT03323398|470672149|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
130740842|NCT03323398|470672150|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
130740843|NCT03323398|470672151|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
130740844|NCT03323398|470672152|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
130740845|NCT03323398|470672153|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
130740846|NCT03323398|470672154|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
130740847|NCT03323398|470672155|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
130740848|NCT03323398|470672147|FG000|Overall Study|Withdrawal by Subject|2|||
130740849|NCT03323398|470672148|FG001|Overall Study|Withdrawal by Subject|1|||
130740850|NCT03323398|470672149|FG002|Overall Study|Withdrawal by Subject|3|||
130740851|NCT03323398|470672150|FG003|Overall Study|Withdrawal by Subject|0|||
130740852|NCT03323398|470672151|FG004|Overall Study|Withdrawal by Subject|0|||
130740853|NCT03323398|470672152|FG005|Overall Study|Withdrawal by Subject|1|||
130740854|NCT03323398|470672153|FG006|Overall Study|Withdrawal by Subject|0|||
130740855|NCT03323398|470672154|FG007|Overall Study|Withdrawal by Subject|0|||
130740856|NCT03323398|470672155|FG008|Overall Study|Withdrawal by Subject|0|||
130740857|NCT03323398|470672147|FG000|Overall Study|Participant was Put on Hospice|0|||
130740858|NCT03323398|470672148|FG001|Overall Study|Participant was Put on Hospice|0|||
130740859|NCT03323398|470672149|FG002|Overall Study|Participant was Put on Hospice|0|||
130740860|NCT03323398|470672150|FG003|Overall Study|Participant was Put on Hospice|0|||
130740861|NCT03323398|470672151|FG004|Overall Study|Participant was Put on Hospice|0|||
130740862|NCT03323398|470672152|FG005|Overall Study|Participant was Put on Hospice|0|||
130740863|NCT03323398|470672153|FG006|Overall Study|Participant was Put on Hospice|1|||
130740864|NCT03323398|470672154|FG007|Overall Study|Participant was Put on Hospice|0|||
130740865|NCT03323398|470672155|FG008|Overall Study|Participant was Put on Hospice|0|||
130740866|NCT03323398|470672147|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
130788019|NCT03154086|470852739|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130788020|NCT03154086|470852740|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130740867|NCT03323398|470672148|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
130740868|NCT03323398|470672149|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
130740869|NCT03323398|470672150|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
130740870|NCT03323398|470672151|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
130740871|NCT03323398|470672152|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
130740872|NCT03323398|470672153|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
130740873|NCT03323398|470672154|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
130740874|NCT03323398|470672155|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
130740875|NCT01490086|470673428|FG000|Overall Study|Consent withdrawn|4|||
130740876|NCT01490086|470673429|FG001|Overall Study|Consent withdrawn|4|||
130740877|NCT01490086|470673430|FG002|Overall Study|Consent withdrawn|3|||
130740878|NCT01490086|470673431|FG003|Overall Study|Consent withdrawn|0|||
130740879|NCT01490086|470673432|FG004|Overall Study|Consent withdrawn|1|||
130740880|NCT01490086|470673428|FG000|Overall Study|Non-compliance|0|||
130740881|NCT01490086|470673429|FG001|Overall Study|Non-compliance|1|||
130740882|NCT01490086|470673430|FG002|Overall Study|Non-compliance|0|||
130740883|NCT01490086|470673431|FG003|Overall Study|Non-compliance|0|||
130740884|NCT01490086|470673432|FG004|Overall Study|Non-compliance|0|||
130740885|NCT01490086|470673428|FG000|Overall Study|Abnormal laboratory findings|1|||
130740886|NCT01490086|470673429|FG001|Overall Study|Abnormal laboratory findings|0|||
130740887|NCT01490086|470673430|FG002|Overall Study|Abnormal laboratory findings|0|||
130740888|NCT01490086|470673431|FG003|Overall Study|Abnormal laboratory findings|0|||
130740889|NCT01490086|470673432|FG004|Overall Study|Abnormal laboratory findings|0|||
130740890|NCT01490086|470673428|FG000|Overall Study|Lost to Follow-up|0|||
130740891|NCT01490086|470673429|FG001|Overall Study|Lost to Follow-up|0|||
130740892|NCT01490086|470673430|FG002|Overall Study|Lost to Follow-up|0|||
130740893|NCT01490086|470673431|FG003|Overall Study|Lost to Follow-up|0|||
130740894|NCT01490086|470673432|FG004|Overall Study|Lost to Follow-up|1|||
130740895|NCT01490086|470673428|FG000|Overall Study|Physician Decision|3|||
130740896|NCT01490086|470673429|FG001|Overall Study|Physician Decision|4|||
130740897|NCT01490086|470673430|FG002|Overall Study|Physician Decision|2|||
130740898|NCT01490086|470673431|FG003|Overall Study|Physician Decision|3|||
130740899|NCT01490086|470673432|FG004|Overall Study|Physician Decision|1|||
130740900|NCT01490086|470673428|FG000|Overall Study|Adverse Event|0|||
130740901|NCT01490086|470673429|FG001|Overall Study|Adverse Event|0|||
130740902|NCT01490086|470673430|FG002|Overall Study|Adverse Event|1|||
130740903|NCT01490086|470673431|FG003|Overall Study|Adverse Event|2|||
130740904|NCT01490086|470673432|FG004|Overall Study|Adverse Event|0|||
130740905|NCT01490086|470673428|FG000|Overall Study|Lack of Efficacy|0|||
130740906|NCT01490086|470673429|FG001|Overall Study|Lack of Efficacy|3|||
130740907|NCT01490086|470673430|FG002|Overall Study|Lack of Efficacy|1|||
130740908|NCT01490086|470673431|FG003|Overall Study|Lack of Efficacy|0|||
130740909|NCT01490086|470673432|FG004|Overall Study|Lack of Efficacy|8|||
130740910|NCT01490086|470673428|FG000|Overall Study|Worsening of symptoms|0|||
130740911|NCT01490086|470673429|FG001|Overall Study|Worsening of symptoms|1|||
130788021|NCT03154086|470852741|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130788022|NCT03154086|470852742|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130788023|NCT03154086|470852743|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130740912|NCT01490086|470673430|FG002|Overall Study|Worsening of symptoms|0|||
130740913|NCT01490086|470673431|FG003|Overall Study|Worsening of symptoms|1|||
130740914|NCT01490086|470673432|FG004|Overall Study|Worsening of symptoms|0|||
130740915|NCT01490086|470673428|FG000|Overall Study|Subject uncontrollable and abusive|0|||
130740916|NCT01490086|470673429|FG001|Overall Study|Subject uncontrollable and abusive|1|||
130740917|NCT01490086|470673430|FG002|Overall Study|Subject uncontrollable and abusive|0|||
130740918|NCT01490086|470673431|FG003|Overall Study|Subject uncontrollable and abusive|0|||
130740919|NCT01490086|470673432|FG004|Overall Study|Subject uncontrollable and abusive|0|||
130788024|NCT03154086|470852744|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130788025|NCT03154086|470852730|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788026|NCT03154086|470852731|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788027|NCT03154086|470852732|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
130788028|NCT03154086|470852733|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788029|NCT03154086|470852734|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788030|NCT03154086|470852735|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788031|NCT03154086|470852736|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788032|NCT03154086|470852737|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788033|NCT03154086|470852738|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788034|NCT03154086|470852739|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788035|NCT03154086|470852740|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788036|NCT03154086|470852741|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788037|NCT03154086|470852742|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788038|NCT03154086|470852743|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788039|NCT03154086|470852744|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130788040|NCT03154086|470852730|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
130788041|NCT03154086|470852731|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788042|NCT03154086|470852732|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788043|NCT03154086|470852733|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788044|NCT03154086|470852734|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788045|NCT03154086|470852735|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788046|NCT03154086|470852736|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788047|NCT03154086|470852737|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788048|NCT03154086|470852738|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788049|NCT03154086|470852739|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788050|NCT03154086|470852740|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788051|NCT03154086|470852741|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788052|NCT03154086|470852742|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788053|NCT03154086|470852743|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788054|NCT03154086|470852744|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130788055|NCT03154086|470852730|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788056|NCT03154086|470852731|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788057|NCT03154086|470852732|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788058|NCT03154086|470852733|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788059|NCT03154086|470852734|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788060|NCT03154086|470852735|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788061|NCT03154086|470852736|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788062|NCT03154086|470852737|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788063|NCT03154086|470852738|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
130788064|NCT03154086|470852739|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788065|NCT03154086|470852740|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788066|NCT03154086|470852741|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788067|NCT03154086|470852742|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788068|NCT03154086|470852743|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788069|NCT03154086|470852744|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130788070|NCT03154086|470852730|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788071|NCT03154086|470852731|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788072|NCT03154086|470852732|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788073|NCT03154086|470852733|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788074|NCT03154086|470852734|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788075|NCT03154086|470852735|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788076|NCT03154086|470852736|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788077|NCT03154086|470852737|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
130788078|NCT03154086|470852738|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788079|NCT03154086|470852739|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130740920|NCT01490086|470673428|FG000|Overall Study|Subject left hospital|0|||
130740921|NCT01490086|470673429|FG001|Overall Study|Subject left hospital|1|||
130740922|NCT01490086|470673430|FG002|Overall Study|Subject left hospital|0|||
130740923|NCT01490086|470673431|FG003|Overall Study|Subject left hospital|1|||
130740924|NCT01490086|470673432|FG004|Overall Study|Subject left hospital|0|||
130740925|NCT06025721|470673433|FG000|Overall Study|Physician Decision|1|||
130740926|NCT06025721|470673433|FG000|Overall Study|Protocol Violation|1|||
130740927|NCT06025721|470673433|FG000|Overall Study|Incarceration|1|||
130740928|NCT04510090|470673434|FG000|FE-HS|Withdrawal by Subject|0|||
130740929|NCT04510090|470673435|FG001|FE-HS|Withdrawal by Subject|0|||
130788080|NCT03154086|470852740|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788081|NCT03154086|470852741|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130740930|NCT04510090|470673436|FG002|FE-HS|Withdrawal by Subject|0|||
130740931|NCT04510090|470673437|FG003|FE-HS|Withdrawal by Subject|0|||
130740932|NCT04510090|470673438|FG004|FE-HS|Withdrawal by Subject|1|||
130740933|NCT04510090|470673439|FG005|FE-HS|Withdrawal by Subject|0|||
130740934|NCT04510090|470673440|FG006|FE-HS|Withdrawal by Subject|0|||
130740935|NCT04510090|470673441|FG007|FE-HS|Withdrawal by Subject|0|||
130740936|NCT05825404|470673442|FG000|First Intervention (Weeks 2-5)|Death|0|||
130740937|NCT05825404|470673443|FG001|First Intervention (Weeks 2-5)|Death|1|||
130740938|NCT05825404|470673442|FG000|Second Intervention (Weeks 8-11)|Death|0|||
130740939|NCT05825404|470673443|FG001|Second Intervention (Weeks 8-11)|Death|1|||
130740940|NCT01749826|470673444|FG000|Overall Study|Study Terminated|20|||
130740941|NCT01749826|470673445|FG001|Overall Study|Study Terminated|0|||
130740942|NCT05085834|470673446|FG000|Overall Study|Lost to Follow-up|9|||
130740943|NCT05085834|470673447|FG001|Overall Study|Lost to Follow-up|2|||
130740944|NCT05085834|470673446|FG000|Overall Study|Adverse Event|6|||
130740945|NCT05085834|470673447|FG001|Overall Study|Adverse Event|0|||
130740946|NCT05085834|470673446|FG000|Overall Study|Death|1|||
130740947|NCT05085834|470673447|FG001|Overall Study|Death|0|||
130740948|NCT05085834|470673446|FG000|Overall Study|Inability to swallow the pill|0|||
130740949|NCT05085834|470673447|FG001|Overall Study|Inability to swallow the pill|1|||
130740950|NCT05842967|470673448|FG000|Period 1: SSA|Adverse Event|1|||
130740951|NCT05842967|470673449|FG001|Period 1: SSA|Adverse Event|1|||
130740952|NCT05842967|470673450|FG002|Period 1: SSA|Adverse Event|0|||
130740953|NCT05842967|470673451|FG003|Period 1: SSA|Adverse Event|0|||
130740954|NCT05842967|470673448|FG000|Period 1: SSA|Death|1|||
130788082|NCT03154086|470852742|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788083|NCT03154086|470852743|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788084|NCT03154086|470852744|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130788085|NCT03154086|470852730|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
130788086|NCT03154086|470852731|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
130788087|NCT03154086|470852732|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
130788088|NCT03154086|470852733|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
130788089|NCT03154086|470852734|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
130788090|NCT03154086|470852735|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
130788091|NCT03154086|470852736|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
130788092|NCT03154086|470852737|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
130788093|NCT03154086|470852738|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
130788094|NCT03154086|470852739|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
130788095|NCT03154086|470852740|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
130788096|NCT03154086|470852741|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
130788097|NCT03154086|470852742|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
130788098|NCT03154086|470852743|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
130740955|NCT05842967|470673449|FG001|Period 1: SSA|Death|0|||
130740956|NCT05842967|470673450|FG002|Period 1: SSA|Death|0|||
130740957|NCT05842967|470673451|FG003|Period 1: SSA|Death|0|||
130740958|NCT05842967|470673448|FG000|Period 1: SSA|Lost to Follow-up|16|||
130740959|NCT05842967|470673449|FG001|Period 1: SSA|Lost to Follow-up|4|||
130740960|NCT05842967|470673450|FG002|Period 1: SSA|Lost to Follow-up|0|||
130788099|NCT03154086|470852744|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
130740961|NCT05842967|470673451|FG003|Period 1: SSA|Lost to Follow-up|0|||
130740962|NCT05842967|470673448|FG000|Period 1: SSA|Physician Decision|1|||
130740963|NCT05842967|470673449|FG001|Period 1: SSA|Physician Decision|0|||
130740964|NCT05842967|470673450|FG002|Period 1: SSA|Physician Decision|0|||
130740965|NCT05842967|470673451|FG003|Period 1: SSA|Physician Decision|0|||
130740966|NCT05842967|470673448|FG000|Period 1: SSA|Withdrawal by Subject|2|||
130740967|NCT05842967|470673449|FG001|Period 1: SSA|Withdrawal by Subject|2|||
130740968|NCT05842967|470673450|FG002|Period 1: SSA|Withdrawal by Subject|0|||
130740969|NCT05842967|470673451|FG003|Period 1: SSA|Withdrawal by Subject|0|||
130740970|NCT05842967|470673448|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
130740971|NCT05842967|470673449|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
130740972|NCT05842967|470673450|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
130740973|NCT05842967|470673451|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
130740974|NCT05842967|470673448|FG000|Period 2: SSB|Adverse Event|0|||
130740975|NCT05842967|470673449|FG001|Period 2: SSB|Adverse Event|0|||
130740976|NCT05842967|470673450|FG002|Period 2: SSB|Adverse Event|2|||
130740977|NCT05842967|470673451|FG003|Period 2: SSB|Adverse Event|0|||
130740978|NCT05842967|470673448|FG000|Period 2: SSB|Lost to Follow-up|0|||
130740979|NCT05842967|470673449|FG001|Period 2: SSB|Lost to Follow-up|0|||
130740980|NCT05842967|470673450|FG002|Period 2: SSB|Lost to Follow-up|4|||
130740981|NCT05842967|470673451|FG003|Period 2: SSB|Lost to Follow-up|3|||
130740982|NCT05842967|470673448|FG000|Period 2: SSB|Withdrawal by Subject|0|||
130740983|NCT05842967|470673449|FG001|Period 2: SSB|Withdrawal by Subject|0|||
130740984|NCT05842967|470673450|FG002|Period 2: SSB|Withdrawal by Subject|1|||
130740985|NCT05842967|470673451|FG003|Period 2: SSB|Withdrawal by Subject|0|||
130740986|NCT05842967|470673448|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
130740987|NCT05842967|470673449|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
130740988|NCT05842967|470673450|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
130740989|NCT05842967|470673451|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
130740990|NCT05842967|470673448|FG000|Period 2: SSB|Protocol Violation|0|||
130740991|NCT05842967|470673449|FG001|Period 2: SSB|Protocol Violation|0|||
130740992|NCT05842967|470673450|FG002|Period 2: SSB|Protocol Violation|0|||
130740993|NCT05842967|470673451|FG003|Period 2: SSB|Protocol Violation|1|||
130740994|NCT01823328|470673453|FG000|Overall Study|Withdrawal by Subject|8|||
130740995|NCT01823328|470673454|FG001|Overall Study|Withdrawal by Subject|6|||
130740996|NCT02157935|470673455|FG000|Overall Study|Withdrawal by Subject|25|||
130740997|NCT02157935|470673456|FG001|Overall Study|Withdrawal by Subject|39|||
130740998|NCT02157935|470673455|FG000|Overall Study|Screen failure|1|||
130740999|NCT02157935|470673456|FG001|Overall Study|Screen failure|2|||
130741000|NCT02157935|470673455|FG000|Overall Study|Protocol Violation|1|||
130741001|NCT02157935|470673456|FG001|Overall Study|Protocol Violation|0|||
130741002|NCT02157935|470673455|FG000|Overall Study|Progressive disease|0|||
130788100|NCT01603277|470852745|FG000|Overall Study|Adverse Event|1|||
130788101|NCT01603277|470852746|FG001|Overall Study|Adverse Event|2|||
130788102|NCT01603277|470852745|FG000|Overall Study|Physician Decision|0|||
130788103|NCT01603277|470852746|FG001|Overall Study|Physician Decision|1|||
130788104|NCT01603277|470852745|FG000|Overall Study|Protocol Violation|6|||
130788105|NCT01603277|470852746|FG001|Overall Study|Protocol Violation|10|||
130741003|NCT02157935|470673456|FG001|Overall Study|Progressive disease|2|||
130741004|NCT02157935|470673455|FG000|Overall Study|Other|5|||
130741005|NCT02157935|470673456|FG001|Overall Study|Other|12|||
130741006|NCT02157935|470673455|FG000|Overall Study|Lack of Efficacy|0|||
130741007|NCT02157935|470673456|FG001|Overall Study|Lack of Efficacy|1|||
130741008|NCT02157935|470673455|FG000|Overall Study|Death|4|||
130741009|NCT02157935|470673456|FG001|Overall Study|Death|4|||
130741010|NCT02157935|470673455|FG000|Overall Study|Adverse Event|3|||
130741011|NCT02157935|470673456|FG001|Overall Study|Adverse Event|5|||
130741012|NCT02547428|470673457|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
130741013|NCT02547428|470673458|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
130741014|NCT02547428|470673457|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
130741015|NCT02547428|470673458|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
130741016|NCT02547428|470673457|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
130741017|NCT02547428|470673458|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
130741018|NCT02547428|470673457|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
130741019|NCT02547428|470673458|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
130741020|NCT02547428|470673457|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
130741021|NCT02547428|470673458|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
130741022|NCT02547428|470673457|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
130741023|NCT02547428|470673458|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
130741024|NCT02547428|470673457|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
130741025|NCT02547428|470673458|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
130741026|NCT02547428|470673457|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
130741027|NCT02547428|470673458|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
130741028|NCT01103180|470673459|FG000|Overall Study|Withdrawal by Subject|8|||
130741029|NCT01103180|470673460|FG001|Overall Study|Withdrawal by Subject|13|||
130741030|NCT01103180|470673459|FG000|Overall Study|Lost to Follow-up|13|||
130741031|NCT01103180|470673460|FG001|Overall Study|Lost to Follow-up|7|||
130741032|NCT01103180|470673459|FG000|Overall Study|Physician Decision|1|||
130741033|NCT01103180|470673460|FG001|Overall Study|Physician Decision|0|||
130741034|NCT01103180|470673459|FG000|Overall Study|Protocol Violation|0|||
130741035|NCT01103180|470673460|FG001|Overall Study|Protocol Violation|1|||
130741036|NCT01173523|470673461|FG000|Overall Study|Clinical Progression|1|||
130741037|NCT01173523|470673462|FG001|Overall Study|Clinical Progression|1|||
130741038|NCT01173523|470673461|FG000|Overall Study|Progressive Disease|10|||
130741039|NCT01173523|470673462|FG001|Overall Study|Progressive Disease|8|||
130741040|NCT01173523|470673461|FG000|Overall Study|Other|2|||
130741041|NCT01173523|470673462|FG001|Overall Study|Other|3|||
130741042|NCT02717507|470673467|FG000|Overall Study|Lost to Follow-up|5|||
130741043|NCT02717507|470673468|FG001|Overall Study|Lost to Follow-up|8|||
130741044|NCT02717507|470673467|FG000|Overall Study|Pregnancy|1|||
130741045|NCT02717507|470673468|FG001|Overall Study|Pregnancy|1|||
130741046|NCT02717507|470673467|FG000|Overall Study|Protocol Violation|2|||
130741047|NCT02717507|470673468|FG001|Overall Study|Protocol Violation|2|||
130741048|NCT02717507|470673467|FG000|Overall Study|Withdrawal by Subject|20|||
130741049|NCT02717507|470673468|FG001|Overall Study|Withdrawal by Subject|20|||
130741050|NCT02717507|470673467|FG000|Overall Study|Relapse|1|||
130741051|NCT02717507|470673468|FG001|Overall Study|Relapse|1|||
130741052|NCT02717507|470673467|FG000|Overall Study|Cardiac Event|2|||
130741053|NCT02717507|470673468|FG001|Overall Study|Cardiac Event|6|||
130741054|NCT01439802|470673469|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
130741055|NCT01439802|470673469|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
130741056|NCT01866826|470673470|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
130741057|NCT01866826|470673471|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
130741058|NCT01866826|470673470|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
130741059|NCT01866826|470673471|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
130741060|NCT01866826|470673470|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
130741061|NCT01866826|470673471|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
130741062|NCT00709995|470673472|FG000|Overall Study|Adverse Event|4|||
130741063|NCT00709995|470673473|FG001|Overall Study|Adverse Event|2|||
130741064|NCT00709995|470673472|FG000|Overall Study|Withdrawal by Subject|1|||
130741065|NCT00709995|470673473|FG001|Overall Study|Withdrawal by Subject|3|||
130741066|NCT00742209|470673478|FG000|Overall Study|Adverse Event|11|||
130741067|NCT00742209|470673479|FG001|Overall Study|Adverse Event|4|||
130741068|NCT00742209|470673480|FG002|Overall Study|Adverse Event|17|||
130741069|NCT00742209|470673481|FG003|Overall Study|Adverse Event|16|||
130741070|NCT00742209|470673482|FG004|Overall Study|Adverse Event|13|||
130741071|NCT00742209|470673478|FG000|Overall Study|Participant Withdrew Consent|8|||
130741072|NCT00742209|470673479|FG001|Overall Study|Participant Withdrew Consent|4|||
130741073|NCT00742209|470673480|FG002|Overall Study|Participant Withdrew Consent|14|||
130741074|NCT00742209|470673481|FG003|Overall Study|Participant Withdrew Consent|7|||
130741075|NCT00742209|470673482|FG004|Overall Study|Participant Withdrew Consent|4|||
130741076|NCT00742209|470673478|FG000|Overall Study|Protocol Violation|6|||
130741077|NCT00742209|470673479|FG001|Overall Study|Protocol Violation|5|||
130741078|NCT00742209|470673480|FG002|Overall Study|Protocol Violation|4|||
130741079|NCT00742209|470673481|FG003|Overall Study|Protocol Violation|5|||
130741080|NCT00742209|470673482|FG004|Overall Study|Protocol Violation|3|||
130741081|NCT00742209|470673478|FG000|Overall Study|Lost to Follow-up|3|||
130741082|NCT00742209|470673479|FG001|Overall Study|Lost to Follow-up|4|||
130741083|NCT00742209|470673480|FG002|Overall Study|Lost to Follow-up|5|||
130741084|NCT00742209|470673481|FG003|Overall Study|Lost to Follow-up|5|||
130741085|NCT00742209|470673482|FG004|Overall Study|Lost to Follow-up|3|||
130741086|NCT00742209|470673478|FG000|Overall Study|Lack of Efficacy|6|||
130741087|NCT00742209|470673479|FG001|Overall Study|Lack of Efficacy|1|||
130741088|NCT00742209|470673480|FG002|Overall Study|Lack of Efficacy|1|||
130741089|NCT00742209|470673481|FG003|Overall Study|Lack of Efficacy|3|||
130741090|NCT00742209|470673482|FG004|Overall Study|Lack of Efficacy|1|||
130741091|NCT00742209|470673478|FG000|Overall Study|Investigator Discretion|0|||
130741092|NCT00742209|470673479|FG001|Overall Study|Investigator Discretion|0|||
130741093|NCT00742209|470673480|FG002|Overall Study|Investigator Discretion|5|||
130741094|NCT00742209|470673481|FG003|Overall Study|Investigator Discretion|1|||
130741095|NCT00742209|470673482|FG004|Overall Study|Investigator Discretion|1|||
130741096|NCT00595621|470673486|FG000|Open Label Run in|Adverse Event|1|||
130741097|NCT00595621|470673487|FG001|Open Label Run in|Adverse Event|0|||
130741098|NCT00595621|470673486|FG000|Open Label Run in|Physician Decision|1|||
130741099|NCT00595621|470673487|FG001|Open Label Run in|Physician Decision|0|||
130741100|NCT00595621|470673486|FG000|Open Label Run in|Withdrawal by Subject|1|||
130741101|NCT00595621|470673487|FG001|Open Label Run in|Withdrawal by Subject|0|||
130741102|NCT00595621|470673486|FG000|Randomization and Study|Adverse Event|2|||
130741103|NCT00595621|470673487|FG001|Randomization and Study|Adverse Event|0|||
130741104|NCT00595621|470673486|FG000|Randomization and Study|Withdrawal by Subject|0|||
130741105|NCT00595621|470673487|FG001|Randomization and Study|Withdrawal by Subject|1|||
130741106|NCT00324987|470673488|FG000|Overall Study|Adverse Event|2|||
130741107|NCT00324987|470673489|FG001|Overall Study|Adverse Event|1|||
130741108|NCT00324987|470673488|FG000|Overall Study|Withdrawal by Subject|1|||
130741109|NCT00324987|470673489|FG001|Overall Study|Withdrawal by Subject|1|||
130741110|NCT00324987|470673488|FG000|Overall Study|Progression|1|||
130788106|NCT01603277|470852745|FG000|Overall Study|Withdrawal by Subject|5|||
130788107|NCT01603277|470852746|FG001|Overall Study|Withdrawal by Subject|4|||
130788108|NCT01603277|470852745|FG000|Overall Study|Non-Compliance|2|||
130741111|NCT00324987|470673489|FG001|Overall Study|Progression|1|||
130741112|NCT00324987|470673488|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
130741113|NCT00324987|470673489|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
130741114|NCT00942084|470673490|FG000|Overall Study|Death|2|||
130741115|NCT01998919|470673491|FG000|Overall Study|Death|2|||
130741116|NCT01998919|470673492|FG001|Overall Study|Death|2|||
130741117|NCT01998919|470673491|FG000|Overall Study|Adverse Event|0|||
130741118|NCT01998919|470673492|FG001|Overall Study|Adverse Event|5|||
130741119|NCT01998919|470673491|FG000|Overall Study|Disease progression|31|||
130741120|NCT01998919|470673492|FG001|Overall Study|Disease progression|22|||
130741121|NCT01998919|470673491|FG000|Overall Study|Withdrawal by Subject|2|||
130741122|NCT01998919|470673492|FG001|Overall Study|Withdrawal by Subject|4|||
130741123|NCT01998919|470673491|FG000|Overall Study|Lost to Follow-up|2|||
130741124|NCT01998919|470673492|FG001|Overall Study|Lost to Follow-up|0|||
130741125|NCT01998919|470673491|FG000|Overall Study|Other|5|||
130741126|NCT01998919|470673492|FG001|Overall Study|Other|2|||
130741127|NCT00897715|470673496|FG000|Overall Study|Lost to Follow-up|0|||
130741128|NCT00897715|470673497|FG001|Overall Study|Lost to Follow-up|1|||
130741129|NCT00897715|470673496|FG000|Overall Study|Physician Decision|1|||
130741130|NCT00897715|470673497|FG001|Overall Study|Physician Decision|0|||
130741131|NCT00897715|470673496|FG000|Overall Study|increased risk of infection|1|||
130741132|NCT00897715|470673497|FG001|Overall Study|increased risk of infection|0|||
130741133|NCT04341363|470673498|FG000|Overall Study|Adverse Event|1|||
130741134|NCT04341363|470673498|FG000|Overall Study|Withdrawal by Subject|1|||
130741135|NCT00063934|470673499|FG000|Overall Study|Ineligible|1|||
130741136|NCT00840749|470673500|FG000|Overall Study|Death|1|||
130741137|NCT00840749|470673501|FG001|Overall Study|Death|2|||
130741138|NCT00840749|470673500|FG000|Overall Study|not treated on study arm|11|||
130741139|NCT00840749|470673501|FG001|Overall Study|not treated on study arm|11|||
130741140|NCT00840749|470673500|FG000|Overall Study|study closed|19|||
130741141|NCT00840749|470673501|FG001|Overall Study|study closed|14|||
130741142|NCT01960413|470673502|FG000|Overall Study|Withdrawal by Subject|1|||
130741143|NCT01960413|470673503|FG001|Overall Study|Withdrawal by Subject|1|||
130741144|NCT01960413|470673502|FG000|Overall Study|Physician Decision|1|||
130741145|NCT01960413|470673503|FG001|Overall Study|Physician Decision|0|||
130741146|NCT01960413|470673502|FG000|Overall Study|Lost to Follow-up|2|||
130741147|NCT01960413|470673503|FG001|Overall Study|Lost to Follow-up|0|||
130741148|NCT00791778|470673507|FG000|Double-blind Treatment|Adverse Event|49|||
130741149|NCT00791778|470673508|FG001|Double-blind Treatment|Adverse Event|9|||
130741150|NCT00791778|470673507|FG000|Double-blind Treatment|Physician Decision|6|||
130741151|NCT00791778|470673508|FG001|Double-blind Treatment|Physician Decision|26|||
130741152|NCT00791778|470673507|FG000|Double-blind Treatment|Protocol Violation|0|||
130741153|NCT00791778|470673508|FG001|Double-blind Treatment|Protocol Violation|4|||
130741154|NCT00791778|470673507|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
130741155|NCT00791778|470673508|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
130741156|NCT00791778|470673507|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
130741157|NCT00791778|470673508|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
130741158|NCT00791778|470673507|FG000|Follow-up|Withdrawal by Subject|3|||
130788109|NCT01603277|470852746|FG001|Overall Study|Non-Compliance|1|||
130741159|NCT00791778|470673508|FG001|Follow-up|Withdrawal by Subject|0|||
130741160|NCT00791778|470673507|FG000|Follow-up|Lost to Follow-up|2|||
130741161|NCT00791778|470673508|FG001|Follow-up|Lost to Follow-up|1|||
130741162|NCT03335475|470673509|FG000|Overall Study|Did not wear accelerometer|4|||
130741163|NCT03335475|470673510|FG001|Overall Study|Did not wear accelerometer|0|||
130788110|NCT04465422|470852749|FG000|Overall Study|Lost to Follow-up|0|||
130788111|NCT04465422|470852750|FG001|Overall Study|Lost to Follow-up|2|||
130741164|NCT03335475|470673509|FG000|Overall Study|Withdrawal by Subject|0|||
130741165|NCT03335475|470673510|FG001|Overall Study|Withdrawal by Subject|1|||
130741166|NCT05921903|470673513|FG000|Overall Study|Unsolicited non-SAE|0|||
130741167|NCT05921903|470673514|FG001|Overall Study|Unsolicited non-SAE|1|||
130788112|NCT01142336|470852751|FG000|Overall Study|Adverse Event|1|||
130788113|NCT01142336|470852752|FG001|Overall Study|Adverse Event|1|||
130788114|NCT01142336|470852751|FG000|Overall Study|Lost to Follow-up|0|||
130788115|NCT01142336|470852752|FG001|Overall Study|Lost to Follow-up|1|||
130788116|NCT02391337|470852753|FG000|6 Months Follow-up|Death|5|||
130788117|NCT02391337|470852754|FG001|6 Months Follow-up|Death|4|||
130788118|NCT02391337|470852753|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
130788119|NCT02391337|470852754|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
130788120|NCT02391337|470852753|FG000|12 Months Follow-up|Death|2|||
130788121|NCT02391337|470852754|FG001|12 Months Follow-up|Death|0|||
130788122|NCT02391337|470852753|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
130788123|NCT02391337|470852754|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
130788124|NCT02391337|470852753|FG000|12 Months Follow-up|Lost to Follow-up|0|||
130788125|NCT02391337|470852754|FG001|12 Months Follow-up|Lost to Follow-up|2|||
130788126|NCT00746551|470852755|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
130788127|NCT00746551|470852756|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
130788128|NCT00746551|470852755|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
130788129|NCT00746551|470852756|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
130788130|NCT00746551|470852755|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
130788131|NCT00746551|470852756|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
130788132|NCT02029417|470852757|FG000|Overall Study|Death|1|||
130788133|NCT02029417|470852757|FG000|Overall Study|Adverse Event|1|||
130788134|NCT00062166|470852758|FG000|Overall Study|Withdrawal by Subject|6|||
130788135|NCT00833755|470852759|FG000|Overall Study|Physician Decision|4|||
130788136|NCT00833755|470852760|FG001|Overall Study|Physician Decision|4|||
130788137|NCT00833755|470852761|FG002|Overall Study|Physician Decision|2|||
130741168|NCT05921903|470673515|FG002|Overall Study|Unsolicited non-SAE|0|||
130741169|NCT05921903|470673513|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
130741170|NCT05921903|470673514|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
130741171|NCT05921903|470673515|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
130741172|NCT05921903|470673513|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
130741173|NCT05921903|470673514|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
130741174|NCT05921903|470673515|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
130741175|NCT05317312|470673518|FG000|Overall Study|Withdrawal by Subject|0|||
130788138|NCT00833755|470852762|FG003|Overall Study|Physician Decision|6|||
130741176|NCT05317312|470673519|FG001|Overall Study|Withdrawal by Subject|1|||
130741177|NCT05317312|470673520|FG002|Overall Study|Withdrawal by Subject|0|||
130788139|NCT00833755|470852759|FG000|Overall Study|Subject had scheduling issues|0|||
130788140|NCT00833755|470852760|FG001|Overall Study|Subject had scheduling issues|1|||
130788141|NCT00833755|470852761|FG002|Overall Study|Subject had scheduling issues|0|||
130788142|NCT00833755|470852762|FG003|Overall Study|Subject had scheduling issues|0|||
130788143|NCT01776554|470852765|FG000|Overall Study|Adverse Event|1|||
130741178|NCT05317312|470673521|FG003|Overall Study|Withdrawal by Subject|0|||
130741179|NCT05317312|470673518|FG000|Overall Study|Lost to Follow-up|0|||
130741180|NCT05317312|470673519|FG001|Overall Study|Lost to Follow-up|0|||
130741181|NCT05317312|470673520|FG002|Overall Study|Lost to Follow-up|0|||
130741182|NCT05317312|470673521|FG003|Overall Study|Lost to Follow-up|1|||
130741183|NCT05317312|470673518|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
130741184|NCT05317312|470673519|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
130741185|NCT05317312|470673520|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
130741186|NCT05317312|470673521|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
130741187|NCT00235755|470673522|FG000|4-Week Titration Phase|Adverse Event|6|||
130741188|NCT00235755|470673523|FG001|4-Week Titration Phase|Adverse Event|14|||
130741189|NCT00235755|470673524|FG002|4-Week Titration Phase|Adverse Event|20|||
130741190|NCT00235755|470673522|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
130741191|NCT00235755|470673523|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
130741192|NCT00235755|470673524|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
130741193|NCT00235755|470673522|FG000|4-Week Titration Phase|Protocol Violation|2|||
130741194|NCT00235755|470673523|FG001|4-Week Titration Phase|Protocol Violation|2|||
130741195|NCT00235755|470673524|FG002|4-Week Titration Phase|Protocol Violation|1|||
130741196|NCT00235755|470673522|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
130741197|NCT00235755|470673523|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
130741198|NCT00235755|470673524|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
130741199|NCT00235755|470673522|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
130741200|NCT00235755|470673523|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
130741201|NCT00235755|470673524|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
130741202|NCT00235755|470673522|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
130741203|NCT00235755|470673523|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
130741204|NCT00235755|470673524|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
130741205|NCT00235755|470673522|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
130741206|NCT00235755|470673523|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
130741207|NCT00235755|470673524|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
130741208|NCT00235755|470673522|FG000|12-Week Maintenance Phase|Adverse Event|8|||
130741209|NCT00235755|470673523|FG001|12-Week Maintenance Phase|Adverse Event|12|||
130741210|NCT00235755|470673524|FG002|12-Week Maintenance Phase|Adverse Event|26|||
130741211|NCT00235755|470673522|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
130741212|NCT00235755|470673523|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
130741213|NCT00235755|470673524|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
130741214|NCT00235755|470673522|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
130741215|NCT00235755|470673523|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
130741216|NCT00235755|470673524|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
130741217|NCT00235755|470673522|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
130741218|NCT00235755|470673523|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
130741219|NCT00235755|470673524|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
130741220|NCT00235755|470673522|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
130741221|NCT00235755|470673523|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
130741222|NCT00235755|470673524|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
130741223|NCT00235755|470673522|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
130741224|NCT00235755|470673523|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
130788144|NCT01776554|470852766|FG001|Overall Study|Adverse Event|0|||
130741225|NCT00235755|470673524|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
130741226|NCT02314026|470673525|FG000|Overall Study|Protocol Violation|28|||
130741227|NCT01532934|470673526|FG000|Overall Study|Lost to Follow-up|11|||
130788145|NCT01776554|470852765|FG000|Overall Study|Withdrawal by Subject|3|||
130788146|NCT01776554|470852766|FG001|Overall Study|Withdrawal by Subject|8|||
130788147|NCT01776554|470852765|FG000|Overall Study|Lost to Follow-up|6|||
130741228|NCT01532934|470673527|FG001|Overall Study|Lost to Follow-up|11|||
130741229|NCT01532934|470673526|FG000|Overall Study|In controlled environment|3|||
130741230|NCT01532934|470673527|FG001|Overall Study|In controlled environment|2|||
130741231|NCT02291237|470673528|FG000|Overall Study|Study Terminated by Sponsor|72|||
130741232|NCT02291237|470673529|FG001|Overall Study|Study Terminated by Sponsor|67|||
130741233|NCT02291237|470673528|FG000|Overall Study|Adverse Event|1|||
130741234|NCT02291237|470673529|FG001|Overall Study|Adverse Event|3|||
130741235|NCT02291237|470673528|FG000|Overall Study|Investigator's Discretion|0|||
130741236|NCT02291237|470673529|FG001|Overall Study|Investigator's Discretion|3|||
130741237|NCT02291237|470673528|FG000|Overall Study|Withdrew Consent|11|||
130741238|NCT02291237|470673529|FG001|Overall Study|Withdrew Consent|11|||
130741239|NCT02291237|470673528|FG000|Overall Study|Lost to Follow-up|0|||
130741240|NCT02291237|470673529|FG001|Overall Study|Lost to Follow-up|2|||
130741241|NCT02291237|470673528|FG000|Overall Study|Subject Required Prohibited Medication|2|||
130741242|NCT02291237|470673529|FG001|Overall Study|Subject Required Prohibited Medication|0|||
130741243|NCT01149863|470673530|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
130741244|NCT01306305|470673531|FG000|Overall Study|Lost to Follow-up|1|||
130741245|NCT01306305|470673532|FG001|Overall Study|Lost to Follow-up|0|||
130741246|NCT01306305|470673531|FG000|Overall Study|Withdrew consent|1|||
130741247|NCT01306305|470673532|FG001|Overall Study|Withdrew consent|0|||
130741248|NCT03326193|470673533|FG000|Overall Study|Sponsor decision|35|||
130741249|NCT00699998|470673535|FG000|Overall Study|Withdrawal by Subject|194|||
130741250|NCT00699998|470673536|FG001|Overall Study|Withdrawal by Subject|83|||
130788148|NCT01776554|470852766|FG001|Overall Study|Lost to Follow-up|9|||
130741251|NCT00699998|470673537|FG002|Overall Study|Withdrawal by Subject|202|||
130741252|NCT00699998|470673538|FG003|Overall Study|Withdrawal by Subject|80|||
130741253|NCT00699998|470673535|FG000|Overall Study|Physician Decision|3|||
130741254|NCT00699998|470673536|FG001|Overall Study|Physician Decision|2|||
130741255|NCT00699998|470673537|FG002|Overall Study|Physician Decision|1|||
130741256|NCT00699998|470673538|FG003|Overall Study|Physician Decision|1|||
130741257|NCT00699998|470673535|FG000|Overall Study|Lost to Follow-up|2|||
130788149|NCT01776554|470852765|FG000|Overall Study|Administrative Reason|2|||
130741258|NCT00699998|470673536|FG001|Overall Study|Lost to Follow-up|1|||
130741259|NCT00699998|470673537|FG002|Overall Study|Lost to Follow-up|3|||
130788150|NCT01776554|470852766|FG001|Overall Study|Administrative Reason|5|||
130741260|NCT00699998|470673538|FG003|Overall Study|Lost to Follow-up|1|||
130741261|NCT01406574|470673539|FG000|Overall Study|Adverse Event|0|||
130741262|NCT01406574|470673540|FG001|Overall Study|Adverse Event|0|||
130741263|NCT01406574|470673541|FG002|Overall Study|Adverse Event|1|||
130741264|NCT01406574|470673542|FG003|Overall Study|Adverse Event|3|||
130741265|NCT01406574|470673539|FG000|Overall Study|Physician Decision|0|||
130741266|NCT01406574|470673540|FG001|Overall Study|Physician Decision|0|||
130741267|NCT01406574|470673541|FG002|Overall Study|Physician Decision|0|||
130741268|NCT01406574|470673542|FG003|Overall Study|Physician Decision|1|||
130741269|NCT01406574|470673539|FG000|Overall Study|Withdrawal by Subject|0|||
130741270|NCT01406574|470673540|FG001|Overall Study|Withdrawal by Subject|1|||
130741271|NCT01406574|470673541|FG002|Overall Study|Withdrawal by Subject|0|||
130741272|NCT01406574|470673542|FG003|Overall Study|Withdrawal by Subject|0|||
130741273|NCT01406574|470673539|FG000|Overall Study|Definite progression of primary disease|1|||
130741274|NCT01406574|470673540|FG001|Overall Study|Definite progression of primary disease|0|||
130741275|NCT01406574|470673541|FG002|Overall Study|Definite progression of primary disease|0|||
130741276|NCT01406574|470673542|FG003|Overall Study|Definite progression of primary disease|0|||
130741277|NCT03367819|470673547|FG000|Overall Study|Adverse Event|4|||
130741278|NCT03367819|470673548|FG001|Overall Study|Adverse Event|4|||
130741279|NCT03367819|470673547|FG000|Overall Study|Progressive Disease|15|||
130741280|NCT03367819|470673548|FG001|Overall Study|Progressive Disease|13|||
130741281|NCT03367819|470673547|FG000|Overall Study|Withdrawal by Subject|1|||
130741282|NCT03367819|470673548|FG001|Overall Study|Withdrawal by Subject|0|||
130741283|NCT03367819|470673547|FG000|Overall Study|Other|4|||
130741284|NCT03367819|470673548|FG001|Overall Study|Other|2|||
130741285|NCT00584454|470673549|FG000|Overall Study|Adverse Event|1|||
130741286|NCT00584454|470673549|FG000|Overall Study|Relocation|1|||
130741287|NCT00584454|470673549|FG000|Overall Study|Clinical Hold|2|||
130741288|NCT00982657|470673550|FG000|Overall Study|Death|1|||
130741289|NCT00982657|470673551|FG001|Overall Study|Death|0|||
130788151|NCT01776554|470852765|FG000|Overall Study|Protocol Violation|1|||
130788152|NCT01776554|470852766|FG001|Overall Study|Protocol Violation|0|||
130788153|NCT01776554|470852765|FG000|Overall Study|Unclassified|4|||
130788154|NCT01776554|470852766|FG001|Overall Study|Unclassified|1|||
130788155|NCT02475369|470852767|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
130788156|NCT02475369|470852768|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
130741290|NCT00982657|470673552|FG002|Overall Study|Death|1|||
130741291|NCT00982657|470673553|FG003|Overall Study|Death|1|||
130741292|NCT00982657|470673550|FG000|Overall Study|Withdrawal by Subject|0|||
130741293|NCT00982657|470673551|FG001|Overall Study|Withdrawal by Subject|0|||
130741294|NCT00982657|470673552|FG002|Overall Study|Withdrawal by Subject|1|||
130741295|NCT00982657|470673553|FG003|Overall Study|Withdrawal by Subject|3|||
130741296|NCT00982657|470673550|FG000|Overall Study|Other|0|||
130741297|NCT00982657|470673551|FG001|Overall Study|Other|0|||
130741298|NCT00982657|470673552|FG002|Overall Study|Other|0|||
130741299|NCT00982657|470673553|FG003|Overall Study|Other|4|||
130741300|NCT00982657|470673550|FG000|Overall Study|On going at date of cut-off|0|||
130741301|NCT00982657|470673551|FG001|Overall Study|On going at date of cut-off|0|||
130741302|NCT00982657|470673552|FG002|Overall Study|On going at date of cut-off|0|||
130741303|NCT00982657|470673553|FG003|Overall Study|On going at date of cut-off|1|||
130741304|NCT00725920|470673554|FG000|Overall Study|Lack of Efficacy|3|||
130741305|NCT00725920|470673555|FG001|Overall Study|Lack of Efficacy|6|||
130741306|NCT05373108|470673556|FG000|Overall Study|Withdrawal by Subject|2|||
130741307|NCT02546986|470675424|FG000|Treatment Period|Progressive Disease|20|||
130741308|NCT02546986|470675425|FG001|Treatment Period|Progressive Disease|22|||
130741309|NCT02546986|470675424|FG000|Treatment Period|Adverse Event|14|||
130741310|NCT02546986|470675425|FG001|Treatment Period|Adverse Event|6|||
130741311|NCT02546986|470675424|FG000|Treatment Period|Symptomatic Deterioration|4|||
130741312|NCT02546986|470675425|FG001|Treatment Period|Symptomatic Deterioration|3|||
130741313|NCT02546986|470675424|FG000|Treatment Period|Death|3|||
130741314|NCT02546986|470675425|FG001|Treatment Period|Death|4|||
130741315|NCT02546986|470675424|FG000|Treatment Period|Physician Decision|1|||
130741316|NCT02546986|470675425|FG001|Treatment Period|Physician Decision|2|||
130741317|NCT02546986|470675424|FG000|Treatment Period|Protocol Violation|1|||
130741318|NCT02546986|470675425|FG001|Treatment Period|Protocol Violation|0|||
130741319|NCT02546986|470675424|FG000|Treatment Period|Withdrawal by Subject|1|||
130741320|NCT02546986|470675425|FG001|Treatment Period|Withdrawal by Subject|1|||
130741321|NCT02546986|470675424|FG000|Treatment Period|Non-compliance with Study Drug|0|||
130741322|NCT02546986|470675425|FG001|Treatment Period|Non-compliance with Study Drug|1|||
130741323|NCT02546986|470675424|FG000|Treatment Period|Study Terminated by Sponsor|0|||
130741324|NCT02546986|470675425|FG001|Treatment Period|Study Terminated by Sponsor|1|||
130788157|NCT03608826|470852770|FG000|Overall Study|Death|3|||
130788158|NCT03608826|470852770|FG000|Overall Study|Heart Transplant|3|||
130741325|NCT02546986|470675424|FG000|Treatment Period|Miscellaneous|7|||
130741326|NCT02546986|470675425|FG001|Treatment Period|Miscellaneous|9|||
130741327|NCT02546986|470675424|FG000|Survival Follow-Up Phase|Missing Status|3|||
130788159|NCT03608826|470852770|FG000|Overall Study|Physician Decision|4|||
130741328|NCT02546986|470675425|FG001|Survival Follow-Up Phase|Missing Status|5|||
130741329|NCT02546986|470675424|FG000|Survival Follow-Up Phase|Death|18|||
130741330|NCT02546986|470675425|FG001|Survival Follow-Up Phase|Death|12|||
130741331|NCT02546986|470675424|FG000|Survival Follow-Up Phase|Alive|13|||
130741332|NCT02546986|470675425|FG001|Survival Follow-Up Phase|Alive|16|||
130741333|NCT02546986|470675424|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
130741334|NCT02546986|470675425|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
130741335|NCT05016960|470675426|FG000|Overall Study|Withdrawal by Subject|1|||
130741336|NCT05016960|470675427|FG001|Overall Study|Withdrawal by Subject|9|||
130741337|NCT04796961|470675428|FG000|Overall Study|Lost to Follow-up|10|||
130741338|NCT04796961|470675428|FG000|Overall Study|Withdrawal by Subject|3|||
130741339|NCT04796961|470675428|FG000|Overall Study|Left Organization|10|||
130741340|NCT02513160|470675430|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
130741341|NCT02513160|470675431|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
130741342|NCT02513160|470675432|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
130741343|NCT02513160|470675433|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
130741344|NCT02513160|470675430|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
130741345|NCT02513160|470675431|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
130741346|NCT02513160|470675432|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
130741347|NCT02513160|470675433|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
130741348|NCT02513160|470675430|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
130741349|NCT02513160|470675431|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
130741350|NCT02513160|470675432|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
130741351|NCT02513160|470675433|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
130741352|NCT02513160|470675430|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
130741353|NCT02513160|470675431|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
130741354|NCT02513160|470675432|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
130741355|NCT02513160|470675433|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
130741356|NCT02513160|470675430|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
130741357|NCT02513160|470675431|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
130741358|NCT02513160|470675432|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
130741359|NCT02513160|470675433|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
130741360|NCT02513160|470675430|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
130741361|NCT02513160|470675431|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
130741362|NCT02513160|470675432|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
130741363|NCT02513160|470675433|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
130741364|NCT02513160|470675430|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
130741365|NCT02513160|470675431|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
130741366|NCT02513160|470675432|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
130741367|NCT02513160|470675433|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
130741368|NCT02513160|470675430|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
130741369|NCT02513160|470675431|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
130741370|NCT02513160|470675432|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
130741371|NCT02513160|470675433|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
130741372|NCT02513160|470675430|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
130741373|NCT02513160|470675431|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
130741374|NCT02513160|470675432|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
130741375|NCT02513160|470675433|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
130741376|NCT02513160|470675430|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
130741377|NCT02513160|470675431|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
130741378|NCT02513160|470675432|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
130741379|NCT02513160|470675433|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
130741380|NCT02513160|470675430|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
130741381|NCT02513160|470675431|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
130741382|NCT02513160|470675432|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
130741383|NCT02513160|470675433|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
130741384|NCT02513160|470675430|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
130741385|NCT02513160|470675431|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
130741386|NCT02513160|470675432|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
130741387|NCT02513160|470675433|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
130741388|NCT03428958|470675436|FG000|Overall Study|Adverse Event|0|||
130741389|NCT03428958|470675437|FG001|Overall Study|Adverse Event|0|||
130741390|NCT03428958|470675438|FG002|Overall Study|Adverse Event|0|||
130741391|NCT03428958|470675439|FG003|Overall Study|Adverse Event|1|||
130741392|NCT03428958|470675440|FG004|Overall Study|Adverse Event|0|||
130741393|NCT03428958|470675441|FG005|Overall Study|Adverse Event|2|||
130741394|NCT03428958|470675442|FG006|Overall Study|Adverse Event|1|||
130788160|NCT03122171|470852771|FG000|Overall Study|Withdrawal by Subject|1|||
130788161|NCT00617279|470852781|FG000|Overall Study|Study terminated by Sponsor|10|||
130741395|NCT03428958|470675443|FG007|Overall Study|Adverse Event|0|||
130741396|NCT03428958|470675444|FG008|Overall Study|Adverse Event|0|||
130741397|NCT03428958|470675445|FG009|Overall Study|Adverse Event|0|||
130788162|NCT00617279|470852782|FG001|Overall Study|Study terminated by Sponsor|15|||
130741398|NCT03428958|470675446|FG010|Overall Study|Adverse Event|0|||
130741399|NCT03428958|470675447|FG011|Overall Study|Adverse Event|0|||
130741400|NCT03428958|470675448|FG012|Overall Study|Adverse Event|0|||
130741401|NCT03428958|470675449|FG013|Overall Study|Adverse Event|0|||
130741402|NCT03428958|470675450|FG014|Overall Study|Adverse Event|0|||
130741403|NCT03428958|470675451|FG015|Overall Study|Adverse Event|0|||
130741404|NCT03428958|470675452|FG016|Overall Study|Adverse Event|0|||
130788163|NCT00617279|470852781|FG000|Overall Study|Graft abandonment|2|||
130788164|NCT00617279|470852782|FG001|Overall Study|Graft abandonment|0|||
130788165|NCT00617279|470852781|FG000|Overall Study|Lost to Follow-up|1|||
130788166|NCT00617279|470852782|FG001|Overall Study|Lost to Follow-up|0|||
130788167|NCT00617279|470852781|FG000|Overall Study|Death|1|||
130788168|NCT00617279|470852782|FG001|Overall Study|Death|2|||
130788169|NCT00921024|470852787|FG000|Overall Study|Lost to Follow-up|2|||
130788170|NCT00921024|470852788|FG001|Overall Study|Lost to Follow-up|0|||
130788171|NCT00921024|470852787|FG000|Overall Study|Received concomittant therapy|2|||
130788172|NCT00921024|470852788|FG001|Overall Study|Received concomittant therapy|0|||
130788173|NCT00921024|470852787|FG000|Overall Study|Withdrawal by Subject|0|||
130788174|NCT00921024|470852788|FG001|Overall Study|Withdrawal by Subject|3|||
130788175|NCT03415178|470852790|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
130788176|NCT03415178|470852791|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
130788177|NCT03415178|470852790|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
130741405|NCT03428958|470675436|FG000|Overall Study|Clinical Progression|2|||
130788178|NCT03415178|470852791|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
130741406|NCT03428958|470675437|FG001|Overall Study|Clinical Progression|3|||
130741407|NCT03428958|470675438|FG002|Overall Study|Clinical Progression|2|||
130741408|NCT03428958|470675439|FG003|Overall Study|Clinical Progression|1|||
130741409|NCT03428958|470675440|FG004|Overall Study|Clinical Progression|0|||
130788179|NCT00753519|470854488|FG000|Overall Study|Withdrawal by Subject|0|||
130788180|NCT00753519|470854489|FG001|Overall Study|Withdrawal by Subject|2|||
130788181|NCT02807259|470854490|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
130741410|NCT03428958|470675441|FG005|Overall Study|Clinical Progression|2|||
130741411|NCT03428958|470675442|FG006|Overall Study|Clinical Progression|0|||
130741412|NCT03428958|470675443|FG007|Overall Study|Clinical Progression|0|||
130741413|NCT03428958|470675444|FG008|Overall Study|Clinical Progression|0|||
130741414|NCT03428958|470675445|FG009|Overall Study|Clinical Progression|0|||
130741415|NCT03428958|470675446|FG010|Overall Study|Clinical Progression|0|||
130741416|NCT03428958|470675447|FG011|Overall Study|Clinical Progression|0|||
130741417|NCT03428958|470675448|FG012|Overall Study|Clinical Progression|0|||
130741418|NCT03428958|470675449|FG013|Overall Study|Clinical Progression|0|||
130741419|NCT03428958|470675450|FG014|Overall Study|Clinical Progression|0|||
130741420|NCT03428958|470675451|FG015|Overall Study|Clinical Progression|0|||
130741421|NCT03428958|470675452|FG016|Overall Study|Clinical Progression|0|||
130741422|NCT03428958|470675436|FG000|Overall Study|Progression per RECIST|6|||
130741423|NCT03428958|470675437|FG001|Overall Study|Progression per RECIST|6|||
130741424|NCT03428958|470675438|FG002|Overall Study|Progression per RECIST|7|||
130741425|NCT03428958|470675439|FG003|Overall Study|Progression per RECIST|4|||
130741426|NCT03428958|470675440|FG004|Overall Study|Progression per RECIST|0|||
130741427|NCT03428958|470675441|FG005|Overall Study|Progression per RECIST|7|||
130741428|NCT03428958|470675442|FG006|Overall Study|Progression per RECIST|8|||
130741429|NCT03428958|470675443|FG007|Overall Study|Progression per RECIST|0|||
130741430|NCT03428958|470675444|FG008|Overall Study|Progression per RECIST|0|||
130741431|NCT03428958|470675445|FG009|Overall Study|Progression per RECIST|0|||
130741432|NCT03428958|470675446|FG010|Overall Study|Progression per RECIST|0|||
130741433|NCT03428958|470675447|FG011|Overall Study|Progression per RECIST|0|||
130741434|NCT03428958|470675448|FG012|Overall Study|Progression per RECIST|1|||
130741435|NCT03428958|470675449|FG013|Overall Study|Progression per RECIST|0|||
130741436|NCT03428958|470675450|FG014|Overall Study|Progression per RECIST|0|||
130741437|NCT03428958|470675451|FG015|Overall Study|Progression per RECIST|0|||
130741438|NCT03428958|470675452|FG016|Overall Study|Progression per RECIST|0|||
130741439|NCT03428958|470675436|FG000|Overall Study|Death|2|||
130741440|NCT03428958|470675437|FG001|Overall Study|Death|2|||
130741441|NCT03428958|470675438|FG002|Overall Study|Death|0|||
130741442|NCT03428958|470675439|FG003|Overall Study|Death|0|||
130741443|NCT03428958|470675440|FG004|Overall Study|Death|0|||
130741444|NCT03428958|470675441|FG005|Overall Study|Death|7|||
130741445|NCT03428958|470675442|FG006|Overall Study|Death|9|||
130741446|NCT03428958|470675443|FG007|Overall Study|Death|6|||
130741447|NCT03428958|470675444|FG008|Overall Study|Death|0|||
130741448|NCT03428958|470675445|FG009|Overall Study|Death|0|||
130741449|NCT03428958|470675446|FG010|Overall Study|Death|3|||
130741450|NCT03428958|470675447|FG011|Overall Study|Death|0|||
130741451|NCT03428958|470675448|FG012|Overall Study|Death|4|||
130741452|NCT03428958|470675449|FG013|Overall Study|Death|0|||
130741453|NCT03428958|470675450|FG014|Overall Study|Death|0|||
130741454|NCT03428958|470675451|FG015|Overall Study|Death|0|||
130741455|NCT03428958|470675452|FG016|Overall Study|Death|0|||
130741456|NCT03428958|470675436|FG000|Overall Study|Lost to Follow-up|0|||
130741457|NCT03428958|470675437|FG001|Overall Study|Lost to Follow-up|0|||
130741458|NCT03428958|470675438|FG002|Overall Study|Lost to Follow-up|0|||
130741459|NCT03428958|470675439|FG003|Overall Study|Lost to Follow-up|0|||
130741460|NCT03428958|470675440|FG004|Overall Study|Lost to Follow-up|0|||
130741461|NCT03428958|470675441|FG005|Overall Study|Lost to Follow-up|1|||
130741462|NCT03428958|470675442|FG006|Overall Study|Lost to Follow-up|1|||
130741463|NCT03428958|470675443|FG007|Overall Study|Lost to Follow-up|0|||
130741464|NCT03428958|470675444|FG008|Overall Study|Lost to Follow-up|0|||
130741465|NCT03428958|470675445|FG009|Overall Study|Lost to Follow-up|0|||
130741466|NCT03428958|470675446|FG010|Overall Study|Lost to Follow-up|0|||
130741467|NCT03428958|470675447|FG011|Overall Study|Lost to Follow-up|0|||
130741468|NCT03428958|470675448|FG012|Overall Study|Lost to Follow-up|0|||
130741469|NCT03428958|470675449|FG013|Overall Study|Lost to Follow-up|0|||
130741470|NCT03428958|470675450|FG014|Overall Study|Lost to Follow-up|0|||
130741471|NCT03428958|470675451|FG015|Overall Study|Lost to Follow-up|0|||
130741472|NCT03428958|470675452|FG016|Overall Study|Lost to Follow-up|0|||
130741473|NCT03428958|470675436|FG000|Overall Study|Physician/Sponsor Decision|1|||
130741474|NCT03428958|470675437|FG001|Overall Study|Physician/Sponsor Decision|0|||
130741475|NCT03428958|470675438|FG002|Overall Study|Physician/Sponsor Decision|1|||
130741476|NCT03428958|470675439|FG003|Overall Study|Physician/Sponsor Decision|0|||
130741477|NCT03428958|470675440|FG004|Overall Study|Physician/Sponsor Decision|0|||
130741478|NCT03428958|470675441|FG005|Overall Study|Physician/Sponsor Decision|2|||
130741479|NCT03428958|470675442|FG006|Overall Study|Physician/Sponsor Decision|2|||
130741480|NCT03428958|470675443|FG007|Overall Study|Physician/Sponsor Decision|2|||
130741481|NCT03428958|470675444|FG008|Overall Study|Physician/Sponsor Decision|0|||
130741482|NCT03428958|470675445|FG009|Overall Study|Physician/Sponsor Decision|0|||
130741483|NCT03428958|470675446|FG010|Overall Study|Physician/Sponsor Decision|2|||
130741484|NCT03428958|470675447|FG011|Overall Study|Physician/Sponsor Decision|0|||
130741485|NCT03428958|470675448|FG012|Overall Study|Physician/Sponsor Decision|4|||
130741486|NCT03428958|470675449|FG013|Overall Study|Physician/Sponsor Decision|0|||
130741487|NCT03428958|470675450|FG014|Overall Study|Physician/Sponsor Decision|0|||
130741488|NCT03428958|470675451|FG015|Overall Study|Physician/Sponsor Decision|0|||
130741489|NCT03428958|470675452|FG016|Overall Study|Physician/Sponsor Decision|0|||
130741490|NCT03428958|470675436|FG000|Overall Study|Withdrawal by Subject|0|||
130741491|NCT03428958|470675437|FG001|Overall Study|Withdrawal by Subject|0|||
130741492|NCT03428958|470675438|FG002|Overall Study|Withdrawal by Subject|2|||
130741493|NCT03428958|470675439|FG003|Overall Study|Withdrawal by Subject|0|||
130741494|NCT03428958|470675440|FG004|Overall Study|Withdrawal by Subject|0|||
130741495|NCT03428958|470675441|FG005|Overall Study|Withdrawal by Subject|2|||
130741496|NCT03428958|470675442|FG006|Overall Study|Withdrawal by Subject|4|||
130741497|NCT03428958|470675443|FG007|Overall Study|Withdrawal by Subject|1|||
130741498|NCT03428958|470675444|FG008|Overall Study|Withdrawal by Subject|0|||
130741499|NCT03428958|470675445|FG009|Overall Study|Withdrawal by Subject|0|||
130741500|NCT03428958|470675446|FG010|Overall Study|Withdrawal by Subject|0|||
130741501|NCT03428958|470675447|FG011|Overall Study|Withdrawal by Subject|0|||
130741502|NCT03428958|470675448|FG012|Overall Study|Withdrawal by Subject|0|||
130741503|NCT03428958|470675449|FG013|Overall Study|Withdrawal by Subject|0|||
130741504|NCT03428958|470675450|FG014|Overall Study|Withdrawal by Subject|0|||
130741505|NCT03428958|470675451|FG015|Overall Study|Withdrawal by Subject|0|||
130741506|NCT03428958|470675452|FG016|Overall Study|Withdrawal by Subject|0|||
130741507|NCT03874117|470675453|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
130741508|NCT03874117|470675454|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
130741509|NCT03874117|470675453|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
130741510|NCT03874117|470675454|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
130741511|NCT03874117|470675453|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130741512|NCT03874117|470675454|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130741513|NCT03874117|470675453|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
130741514|NCT03874117|470675454|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
130741515|NCT03874117|470675453|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130741516|NCT03874117|470675454|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130741517|NCT05258773|470675455|FG000|Overall Study|Screen Failure|1|||
130741518|NCT05258773|470675456|FG001|Overall Study|Screen Failure|1|||
130741519|NCT05258773|470675455|FG000|Overall Study|Adverse Event|1|||
130741520|NCT05258773|470675456|FG001|Overall Study|Adverse Event|0|||
130741521|NCT05258773|470675455|FG000|Overall Study|Withdrawal by Subject|0|||
130741522|NCT05258773|470675456|FG001|Overall Study|Withdrawal by Subject|1|||
130741523|NCT03018288|470675459|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
130741524|NCT03018288|470675460|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
130741525|NCT03018288|470675461|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
130741526|NCT03018288|470675462|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
130741527|NCT03018288|470675459|FG000|Overall Study|Participant withdrew consent.|0|||
130741528|NCT03018288|470675460|FG001|Overall Study|Participant withdrew consent.|0|||
130741529|NCT03018288|470675461|FG002|Overall Study|Participant withdrew consent.|1|||
130741530|NCT03018288|470675462|FG003|Overall Study|Participant withdrew consent.|0|||
130741531|NCT03018288|470675459|FG000|Overall Study|Switched to alternative treatment.|0|||
130741532|NCT03018288|470675460|FG001|Overall Study|Switched to alternative treatment.|0|||
130741533|NCT03018288|470675461|FG002|Overall Study|Switched to alternative treatment.|1|||
130741534|NCT03018288|470675462|FG003|Overall Study|Switched to alternative treatment.|0|||
130741535|NCT03018288|470675459|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
130741536|NCT03018288|470675460|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
130741537|NCT03018288|470675461|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
130741538|NCT03018288|470675462|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
130741539|NCT03018288|470675459|FG000|Overall Study|Screen failures|0|||
130741540|NCT03018288|470675460|FG001|Overall Study|Screen failures|0|||
130741541|NCT03018288|470675461|FG002|Overall Study|Screen failures|0|||
130741542|NCT03018288|470675462|FG003|Overall Study|Screen failures|51|||
130741543|NCT03018288|470675459|FG000|Overall Study|Chose treatment outside of UNC|0|||
130741544|NCT03018288|470675460|FG001|Overall Study|Chose treatment outside of UNC|0|||
130741545|NCT03018288|470675461|FG002|Overall Study|Chose treatment outside of UNC|0|||
130741546|NCT03018288|470675462|FG003|Overall Study|Chose treatment outside of UNC|1|||
130741547|NCT03018288|470675459|FG000|Overall Study|Unable to comply with protocol requirements|1|||
130741548|NCT03018288|470675460|FG001|Overall Study|Unable to comply with protocol requirements|1|||
130741549|NCT03018288|470675461|FG002|Overall Study|Unable to comply with protocol requirements|0|||
130741550|NCT03018288|470675462|FG003|Overall Study|Unable to comply with protocol requirements|1|||
130741551|NCT03018288|470675459|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
130741552|NCT03018288|470675460|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
130741553|NCT03018288|470675461|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
130741554|NCT03018288|470675462|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
130741555|NCT03018288|470675459|FG000|Overall Study|Physician Decision|0|||
130741556|NCT03018288|470675460|FG001|Overall Study|Physician Decision|0|||
130741557|NCT03018288|470675461|FG002|Overall Study|Physician Decision|0|||
130741558|NCT03018288|470675462|FG003|Overall Study|Physician Decision|1|||
130741559|NCT01127256|470675465|FG000|Overall Study|Adverse Event|13|||
130741560|NCT01127256|470675466|FG001|Overall Study|Adverse Event|13|||
130741561|NCT01127256|470675465|FG000|Overall Study|Lack of Efficacy|4|||
130741562|NCT01127256|470675466|FG001|Overall Study|Lack of Efficacy|0|||
130741563|NCT01127256|470675465|FG000|Overall Study|Lost to Follow-up|16|||
130741564|NCT01127256|470675466|FG001|Overall Study|Lost to Follow-up|17|||
130741565|NCT01127256|470675465|FG000|Overall Study|Withdrawal by Subject|5|||
130741566|NCT01127256|470675466|FG001|Overall Study|Withdrawal by Subject|9|||
130741567|NCT01127256|470675465|FG000|Overall Study|Protocol Violation|1|||
130741568|NCT01127256|470675466|FG001|Overall Study|Protocol Violation|0|||
130741569|NCT00679211|470675467|FG000|Overall Study|Progressive disease|82|||
130741570|NCT00679211|470675467|FG000|Overall Study|Adverse Event|7|||
130741571|NCT00679211|470675467|FG000|Overall Study|Withdrawal by Subject|2|||
130741572|NCT00679211|470675467|FG000|Overall Study|Physician Decision|5|||
130741573|NCT00679211|470675467|FG000|Overall Study|Refused to undergo protocol procedures|1|||
130741574|NCT00679211|470675467|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
130741575|NCT00679211|470675467|FG000|Overall Study|Other|1|||
130741576|NCT01922037|470675468|FG000|Overall Study|Withdrawal by Subject|2|||
130741577|NCT01922037|470675469|FG001|Overall Study|Withdrawal by Subject|44|||
130741578|NCT01922037|470675468|FG000|Overall Study|Adverse Event|1|||
130741579|NCT01922037|470675469|FG001|Overall Study|Adverse Event|7|||
130741580|NCT01922037|470675468|FG000|Overall Study|Death|0|||
130741581|NCT01922037|470675469|FG001|Overall Study|Death|5|||
130741582|NCT01922037|470675468|FG000|Overall Study|Pregnancy|0|||
130741583|NCT01922037|470675469|FG001|Overall Study|Pregnancy|2|||
130741584|NCT01922037|470675468|FG000|Overall Study|Participant non-compliance|4|||
130741585|NCT01922037|470675469|FG001|Overall Study|Participant non-compliance|46|||
130741586|NCT01922037|470675468|FG000|Overall Study|Investigator/Sponsor decision|1|||
130741587|NCT01922037|470675469|FG001|Overall Study|Investigator/Sponsor decision|4|||
130741588|NCT01922037|470675468|FG000|Overall Study|Other unspecified|2|||
130741589|NCT01922037|470675469|FG001|Overall Study|Other unspecified|66|||
130741590|NCT01730053|470675470|FG000|Overall Study|Participant moved|0|||
130741591|NCT01730053|470675471|FG001|Overall Study|Participant moved|0|||
130741592|NCT01730053|470675472|FG002|Overall Study|Participant moved|1|||
130741593|NCT01730053|470675473|FG003|Overall Study|Participant moved|0|||
130741594|NCT01730053|470675474|FG004|Overall Study|Participant moved|0|||
130741595|NCT01730053|470675475|FG005|Overall Study|Participant moved|0|||
130741596|NCT01730053|470675470|FG000|Overall Study|Physician Decision|0|||
130741597|NCT01730053|470675471|FG001|Overall Study|Physician Decision|0|||
130741598|NCT01730053|470675472|FG002|Overall Study|Physician Decision|0|||
130741599|NCT01730053|470675473|FG003|Overall Study|Physician Decision|1|||
130741600|NCT01730053|470675474|FG004|Overall Study|Physician Decision|0|||
130741601|NCT01730053|470675475|FG005|Overall Study|Physician Decision|0|||
130741602|NCT01730053|470675470|FG000|Overall Study|Adverse Event|2|||
130741603|NCT01730053|470675471|FG001|Overall Study|Adverse Event|6|||
130741604|NCT01730053|470675472|FG002|Overall Study|Adverse Event|3|||
130741605|NCT01730053|470675473|FG003|Overall Study|Adverse Event|3|||
130741606|NCT01730053|470675474|FG004|Overall Study|Adverse Event|2|||
130788182|NCT02807259|470854491|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
130741607|NCT01730053|470675475|FG005|Overall Study|Adverse Event|2|||
130741608|NCT01730053|470675470|FG000|Overall Study|Poor compliance to protocol|1|||
130741609|NCT01730053|470675471|FG001|Overall Study|Poor compliance to protocol|2|||
130741610|NCT01730053|470675472|FG002|Overall Study|Poor compliance to protocol|2|||
130741611|NCT01730053|470675473|FG003|Overall Study|Poor compliance to protocol|0|||
130741612|NCT01730053|470675474|FG004|Overall Study|Poor compliance to protocol|0|||
130741613|NCT01730053|470675475|FG005|Overall Study|Poor compliance to protocol|2|||
130788183|NCT02807259|470854490|FG000|Midline (3 Months)|migration, refusal, not available|30|||
130741614|NCT01730053|470675470|FG000|Overall Study|Other than specified|2|||
130741615|NCT01730053|470675471|FG001|Overall Study|Other than specified|6|||
130741616|NCT01730053|470675472|FG002|Overall Study|Other than specified|5|||
130741617|NCT01730053|470675473|FG003|Overall Study|Other than specified|4|||
130741618|NCT01730053|470675474|FG004|Overall Study|Other than specified|7|||
130741619|NCT01730053|470675475|FG005|Overall Study|Other than specified|9|||
130741620|NCT01470248|470675477|FG000|Overall Study|Withdrawal by Subject|1|||
130741621|NCT02243605|470675480|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
130741622|NCT02243605|470675481|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
130741623|NCT02243605|470675480|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
130741624|NCT02243605|470675481|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
130741625|NCT02243605|470675480|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
130741626|NCT02243605|470675481|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
130741627|NCT02243605|470675480|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
130741628|NCT02243605|470675481|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
130741629|NCT02243605|470675480|FG000|Stage 2 - Final Analysis Population|Progression|0|||
130741630|NCT02243605|470675481|FG001|Stage 2 - Final Analysis Population|Progression|1|||
130741631|NCT02019472|470675482|FG000|Overall Study|Adverse Event|14|||
130741632|NCT02019472|470675483|FG001|Overall Study|Adverse Event|23|||
130741633|NCT02019472|470675484|FG002|Overall Study|Adverse Event|17|||
130741634|NCT02019472|470675482|FG000|Overall Study|Death|0|||
130741635|NCT02019472|470675483|FG001|Overall Study|Death|1|||
130741636|NCT02019472|470675484|FG002|Overall Study|Death|1|||
130741637|NCT02019472|470675482|FG000|Overall Study|Lack of Efficacy|7|||
130741638|NCT02019472|470675483|FG001|Overall Study|Lack of Efficacy|4|||
130741639|NCT02019472|470675484|FG002|Overall Study|Lack of Efficacy|4|||
130741640|NCT02019472|470675482|FG000|Overall Study|Lost to Follow-up|0|||
130741641|NCT02019472|470675483|FG001|Overall Study|Lost to Follow-up|2|||
130741642|NCT02019472|470675484|FG002|Overall Study|Lost to Follow-up|1|||
130741643|NCT02019472|470675482|FG000|Overall Study|Physician Decision|1|||
130741644|NCT02019472|470675483|FG001|Overall Study|Physician Decision|2|||
130741645|NCT02019472|470675484|FG002|Overall Study|Physician Decision|0|||
130741646|NCT02019472|470675482|FG000|Overall Study|Pregnancy|1|||
130741647|NCT02019472|470675483|FG001|Overall Study|Pregnancy|2|||
130741648|NCT02019472|470675484|FG002|Overall Study|Pregnancy|2|||
130741649|NCT02019472|470675482|FG000|Overall Study|Withdrawal by Subject|11|||
130741650|NCT02019472|470675483|FG001|Overall Study|Withdrawal by Subject|10|||
130741651|NCT02019472|470675484|FG002|Overall Study|Withdrawal by Subject|11|||
130741652|NCT02019472|470675482|FG000|Overall Study|Other|3|||
130741653|NCT02019472|470675483|FG001|Overall Study|Other|8|||
130741654|NCT02019472|470675484|FG002|Overall Study|Other|6|||
130741655|NCT01479465|470675485|FG000|Overall Study|Disease Progression|9|||
130741656|NCT01479465|470675486|FG001|Overall Study|Disease Progression|61|||
130741657|NCT01479465|470675487|FG002|Overall Study|Disease Progression|65|||
130741658|NCT01479465|470675488|FG003|Overall Study|Disease Progression|70|||
130741659|NCT01479465|470675485|FG000|Overall Study|Study Discontinued by Sponsor|0|||
130741660|NCT01479465|470675486|FG001|Overall Study|Study Discontinued by Sponsor|7|||
130741661|NCT01479465|470675487|FG002|Overall Study|Study Discontinued by Sponsor|5|||
130741662|NCT01479465|470675488|FG003|Overall Study|Study Discontinued by Sponsor|3|||
130741663|NCT01479465|470675485|FG000|Overall Study|Adverse Event|0|||
130741664|NCT01479465|470675486|FG001|Overall Study|Adverse Event|3|||
130741665|NCT01479465|470675487|FG002|Overall Study|Adverse Event|6|||
130741666|NCT01479465|470675488|FG003|Overall Study|Adverse Event|4|||
130741667|NCT01479465|470675485|FG000|Overall Study|Investigator Discretion|1|||
130741668|NCT01479465|470675486|FG001|Overall Study|Investigator Discretion|4|||
130741669|NCT01479465|470675487|FG002|Overall Study|Investigator Discretion|2|||
130741670|NCT01479465|470675488|FG003|Overall Study|Investigator Discretion|4|||
130741671|NCT01479465|470675485|FG000|Overall Study|Subject Request|1|||
130741672|NCT01479465|470675486|FG001|Overall Study|Subject Request|3|||
130741673|NCT01479465|470675487|FG002|Overall Study|Subject Request|4|||
130741674|NCT01479465|470675488|FG003|Overall Study|Subject Request|2|||
130741675|NCT01479465|470675485|FG000|Overall Study|Subject Withdrew Consent|0|||
130788184|NCT02807259|470854491|FG001|Midline (3 Months)|migration, refusal, not available|34|||
130788185|NCT02807259|470854490|FG000|Endline (3 Months)|migration, refusal, not available|35|||
130788186|NCT02807259|470854491|FG001|Endline (3 Months)|migration, refusal, not available|87|||
130788187|NCT03861039|470854492|FG000|Overall Study|Adverse Event|2|||
130788188|NCT03861039|470854493|FG001|Overall Study|Adverse Event|5|||
130788189|NCT03861039|470854494|FG002|Overall Study|Adverse Event|11|||
130741676|NCT01479465|470675486|FG001|Overall Study|Subject Withdrew Consent|5|||
130741677|NCT01479465|470675487|FG002|Overall Study|Subject Withdrew Consent|2|||
130741678|NCT01479465|470675488|FG003|Overall Study|Subject Withdrew Consent|1|||
130741679|NCT01479465|470675485|FG000|Overall Study|Protocol Violation|0|||
130741680|NCT01479465|470675486|FG001|Overall Study|Protocol Violation|1|||
130741681|NCT01479465|470675487|FG002|Overall Study|Protocol Violation|1|||
130741682|NCT01479465|470675488|FG003|Overall Study|Protocol Violation|0|||
130741683|NCT01479465|470675485|FG000|Overall Study|Death|0|||
130741684|NCT01479465|470675486|FG001|Overall Study|Death|0|||
130788190|NCT03861039|470854492|FG000|Overall Study|Withdrawal by Subject|1|||
130741685|NCT01479465|470675487|FG002|Overall Study|Death|0|||
130741686|NCT01479465|470675488|FG003|Overall Study|Death|1|||
130741687|NCT01479465|470675485|FG000|Overall Study|Lost to Follow-up|0|||
130741688|NCT01479465|470675486|FG001|Overall Study|Lost to Follow-up|0|||
130741689|NCT01479465|470675487|FG002|Overall Study|Lost to Follow-up|1|||
130741690|NCT01479465|470675488|FG003|Overall Study|Lost to Follow-up|0|||
130741691|NCT04429503|470675491|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
130741692|NCT04429503|470675492|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
130741693|NCT04429503|470675493|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130741694|NCT04429503|470675494|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130741695|NCT04429503|470675495|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130741696|NCT04429503|470675496|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130741697|NCT04429503|470675491|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
130741698|NCT04429503|470675492|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
130741699|NCT04429503|470675493|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
130741700|NCT04429503|470675494|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
130741701|NCT04429503|470675495|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
130741702|NCT04429503|470675496|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
130741703|NCT04429503|470675491|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
130741704|NCT04429503|470675492|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
130741705|NCT04429503|470675493|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
130741706|NCT04429503|470675494|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
130741707|NCT04429503|470675495|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
130741708|NCT04429503|470675496|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
130741709|NCT04429503|470675491|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
130741710|NCT04429503|470675492|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
130741711|NCT04429503|470675493|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
130741712|NCT04429503|470675494|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
130741713|NCT04429503|470675495|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
130741714|NCT04429503|470675496|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
130741715|NCT04429503|470675491|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
130741716|NCT04429503|470675492|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
130741717|NCT04429503|470675493|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
130741718|NCT04429503|470675494|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
130741719|NCT04429503|470675495|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
130741720|NCT04429503|470675496|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
130741721|NCT04429503|470675491|FG000|Main Study (Up to Wk 96)|Death|9|||
130741722|NCT04429503|470675492|FG001|Main Study (Up to Wk 96)|Death|18|||
130741723|NCT04429503|470675493|FG002|Main Study (Up to Wk 96)|Death|5|||
130741724|NCT04429503|470675494|FG003|Main Study (Up to Wk 96)|Death|0|||
130741725|NCT04429503|470675495|FG004|Main Study (Up to Wk 96)|Death|0|||
130741726|NCT04429503|470675496|FG005|Main Study (Up to Wk 96)|Death|0|||
130741727|NCT04429503|470675491|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130741728|NCT04429503|470675492|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130741729|NCT04429503|470675493|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130741730|NCT04429503|470675494|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
130741731|NCT04429503|470675495|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130741732|NCT04429503|470675496|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130741733|NCT04429503|470675491|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
130741734|NCT04429503|470675492|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
130741735|NCT04429503|470675493|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
130741736|NCT04429503|470675494|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
130741737|NCT04429503|470675495|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
130741738|NCT04429503|470675496|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
130741739|NCT04429503|470675491|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130741740|NCT04429503|470675492|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130741741|NCT04429503|470675493|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130741742|NCT04429503|470675494|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130741743|NCT04429503|470675495|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
130741744|NCT04429503|470675496|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
130741745|NCT04429503|470675491|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
130741746|NCT04429503|470675492|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
130741747|NCT04429503|470675493|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
130741748|NCT04429503|470675494|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
130741749|NCT04429503|470675495|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
130741750|NCT04429503|470675496|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
130741751|NCT04429503|470675491|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
130741752|NCT04429503|470675492|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
130741753|NCT04429503|470675493|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
130741754|NCT04429503|470675494|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
130741755|NCT04429503|470675495|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
130741756|NCT04429503|470675496|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
130741757|NCT04429503|470675491|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
130741758|NCT04429503|470675492|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
130741759|NCT04429503|470675493|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
130741760|NCT04429503|470675494|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
130741761|NCT04429503|470675495|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
130741762|NCT04429503|470675496|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
130741763|NCT05516108|470675497|FG000|Overall Study|Time Commitment|3|||
130741764|NCT05516108|470675498|FG001|Overall Study|Time Commitment|1|||
130741765|NCT05516108|470675497|FG000|Overall Study|Reason Unknown|2|||
130741766|NCT05516108|470675498|FG001|Overall Study|Reason Unknown|4|||
130741767|NCT02003209|470675499|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
130741768|NCT02003209|470675500|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
130741769|NCT00638508|470675501|FG000|Overall Study|Physician Decision|5|||
130741770|NCT00638508|470675502|FG001|Overall Study|Physician Decision|2|||
130741771|NCT00370552|470675503|FG000|Overall Study|Adverse Event|2|||
130741772|NCT00370552|470675504|FG001|Overall Study|Adverse Event|2|||
130741773|NCT00370552|470675505|FG002|Overall Study|Adverse Event|2|||
130741774|NCT00370552|470675503|FG000|Overall Study|Disease progression|23|||
130741775|NCT00370552|470675504|FG001|Overall Study|Disease progression|23|||
130741776|NCT00370552|470675505|FG002|Overall Study|Disease progression|15|||
130741777|NCT00370552|470675503|FG000|Overall Study|Maximum clinical benefit|3|||
130741778|NCT00370552|470675504|FG001|Overall Study|Maximum clinical benefit|5|||
130741779|NCT00370552|470675505|FG002|Overall Study|Maximum clinical benefit|5|||
130741780|NCT00370552|470675503|FG000|Overall Study|Poor or noncompliance|0|||
130741781|NCT00370552|470675504|FG001|Overall Study|Poor or noncompliance|0|||
130741782|NCT00370552|470675505|FG002|Overall Study|Poor or noncompliance|1|||
130741783|NCT00370552|470675503|FG000|Overall Study|Study drug toxicity|11|||
130741784|NCT00370552|470675504|FG001|Overall Study|Study drug toxicity|8|||
130741785|NCT00370552|470675505|FG002|Overall Study|Study drug toxicity|6|||
130741786|NCT00370552|470675503|FG000|Overall Study|Withdrawal by Subject|2|||
130741787|NCT00370552|470675504|FG001|Overall Study|Withdrawal by Subject|0|||
130741788|NCT00370552|470675505|FG002|Overall Study|Withdrawal by Subject|1|||
130741789|NCT00370552|470675503|FG000|Overall Study|Still on treatment|1|||
130741790|NCT00370552|470675504|FG001|Overall Study|Still on treatment|3|||
130741791|NCT00370552|470675505|FG002|Overall Study|Still on treatment|2|||
130741792|NCT00370552|470675503|FG000|Overall Study|Never treated|1|||
130741793|NCT00370552|470675504|FG001|Overall Study|Never treated|0|||
130741794|NCT00370552|470675505|FG002|Overall Study|Never treated|0|||
130741795|NCT00370552|470675503|FG000|Overall Study|Physician Decision|1|||
130741796|NCT00370552|470675504|FG001|Overall Study|Physician Decision|1|||
130741797|NCT00370552|470675505|FG002|Overall Study|Physician Decision|0|||
130741798|NCT00370552|470675503|FG000|Overall Study|Investigator decision|2|||
130741799|NCT00370552|470675504|FG001|Overall Study|Investigator decision|1|||
130741800|NCT00370552|470675505|FG002|Overall Study|Investigator decision|0|||
130741801|NCT00370552|470675503|FG000|Overall Study|High risk of allergic reaction|0|||
130741802|NCT00370552|470675504|FG001|Overall Study|High risk of allergic reaction|1|||
130741803|NCT00370552|470675505|FG002|Overall Study|High risk of allergic reaction|0|||
130741804|NCT00370552|470675503|FG000|Overall Study|Planned radiation for palliation|0|||
130741805|NCT00370552|470675504|FG001|Overall Study|Planned radiation for palliation|1|||
130741806|NCT00370552|470675505|FG002|Overall Study|Planned radiation for palliation|0|||
130741807|NCT03500198|470675506|FG000|Overall Study|Lost to Follow-up|0|||
130741808|NCT03500198|470675507|FG001|Overall Study|Lost to Follow-up|1|||
130741809|NCT03817125|470675519|FG000|Overall Study|Adverse Event|1|||
130741810|NCT03817125|470675520|FG001|Overall Study|Adverse Event|0|||
130741811|NCT03817125|470675519|FG000|Overall Study|Physician Decision|0|||
130741812|NCT03817125|470675520|FG001|Overall Study|Physician Decision|1|||
130741813|NCT03817125|470675519|FG000|Overall Study|Lack of Efficacy|1|||
130741814|NCT03817125|470675520|FG001|Overall Study|Lack of Efficacy|5|||
130741815|NCT01836471|470675521|FG000|Overall Study|Pregnancy|1|||
130741816|NCT01836471|470675522|FG001|Overall Study|Pregnancy|0|||
130741817|NCT01836471|470675523|FG002|Overall Study|Pregnancy|0|||
130741818|NCT01836471|470675524|FG003|Overall Study|Pregnancy|0|||
130741819|NCT01836471|470675525|FG004|Overall Study|Pregnancy|0|||
130741820|NCT01836471|470675521|FG000|Overall Study|Withdrawal by Subject|3|||
130741821|NCT01836471|470675522|FG001|Overall Study|Withdrawal by Subject|4|||
130741822|NCT01836471|470675523|FG002|Overall Study|Withdrawal by Subject|1|||
130741823|NCT01836471|470675524|FG003|Overall Study|Withdrawal by Subject|0|||
130741824|NCT01836471|470675525|FG004|Overall Study|Withdrawal by Subject|2|||
130741825|NCT01836471|470675521|FG000|Overall Study|Physician Decision|0|||
130741826|NCT01836471|470675522|FG001|Overall Study|Physician Decision|1|||
130741827|NCT01836471|470675523|FG002|Overall Study|Physician Decision|0|||
130741828|NCT01836471|470675524|FG003|Overall Study|Physician Decision|0|||
130741829|NCT01836471|470675525|FG004|Overall Study|Physician Decision|0|||
130741830|NCT01836471|470675521|FG000|Overall Study|Lost to Follow-up|0|||
130741831|NCT01836471|470675522|FG001|Overall Study|Lost to Follow-up|0|||
130741832|NCT01836471|470675523|FG002|Overall Study|Lost to Follow-up|0|||
130741833|NCT01836471|470675524|FG003|Overall Study|Lost to Follow-up|1|||
130741834|NCT01836471|470675525|FG004|Overall Study|Lost to Follow-up|1|||
130741835|NCT01836471|470675521|FG000|Overall Study|Adverse Event|6|||
130741836|NCT01836471|470675522|FG001|Overall Study|Adverse Event|3|||
130741837|NCT01836471|470675523|FG002|Overall Study|Adverse Event|1|||
130741838|NCT01836471|470675524|FG003|Overall Study|Adverse Event|1|||
130741839|NCT01836471|470675525|FG004|Overall Study|Adverse Event|2|||
130741840|NCT01836471|470675521|FG000|Overall Study|Non compliance with tx|1|||
130741841|NCT01836471|470675522|FG001|Overall Study|Non compliance with tx|1|||
130741842|NCT01836471|470675523|FG002|Overall Study|Non compliance with tx|0|||
130741843|NCT01836471|470675524|FG003|Overall Study|Non compliance with tx|0|||
130741844|NCT01836471|470675525|FG004|Overall Study|Non compliance with tx|0|||
130741845|NCT02285361|470675528|FG000|Overall Study|Protocol Violation|43|||
130741846|NCT02285361|470675528|FG000|Overall Study|Lost to Follow-up|5|||
130741847|NCT02285361|470675528|FG000|Overall Study|Not taken GIOTRIF|2|||
130741848|NCT02285361|470675528|FG000|Overall Study|Consented prior to the contract date|1|||
130741849|NCT03776357|470675532|FG000|Overall Study|Lost to Follow-up|3|||
130741850|NCT02755103|470675535|FG000|Overall Study|Lost to Follow-up|17|||
130741851|NCT02755103|470675536|FG001|Overall Study|Lost to Follow-up|15|||
130741852|NCT02755103|470675535|FG000|Overall Study|Death|0|||
130741853|NCT02755103|470675536|FG001|Overall Study|Death|1|||
130741854|NCT02755103|470675535|FG000|Overall Study|Physician Decision|0|||
130741855|NCT02755103|470675536|FG001|Overall Study|Physician Decision|1|||
130741856|NCT02755103|470675535|FG000|Overall Study|Pregnancy|0|||
130741857|NCT02755103|470675536|FG001|Overall Study|Pregnancy|1|||
130741858|NCT02755103|470675535|FG000|Overall Study|Withdrawal by Subject|3|||
130741859|NCT02755103|470675536|FG001|Overall Study|Withdrawal by Subject|0|||
130741860|NCT00658723|470675540|FG000|Overall Study|Lost to Follow-up|0|||
130741861|NCT00658723|470675541|FG001|Overall Study|Lost to Follow-up|2|||
130741862|NCT00658723|470675542|FG002|Overall Study|Lost to Follow-up|2|||
130741863|NCT00658723|470675540|FG000|Overall Study|Death|2|||
130741864|NCT00658723|470675541|FG001|Overall Study|Death|1|||
130741865|NCT00658723|470675542|FG002|Overall Study|Death|4|||
130741866|NCT00658723|470675540|FG000|Overall Study|Scheduling Issue|1|||
130741867|NCT00658723|470675541|FG001|Overall Study|Scheduling Issue|1|||
130741868|NCT00658723|470675542|FG002|Overall Study|Scheduling Issue|0|||
130741869|NCT00658723|470675540|FG000|Overall Study|Withdrawal by Subject|1|||
130741870|NCT00658723|470675541|FG001|Overall Study|Withdrawal by Subject|0|||
130741871|NCT00658723|470675542|FG002|Overall Study|Withdrawal by Subject|1|||
130741872|NCT02411656|470675543|FG000|Overall Study|Adverse Event|4|||
130741873|NCT02411656|470675543|FG000|Overall Study|Clinical Progression|33|||
130741874|NCT06481709|470675544|FG000|Overall Study|Withdrawal by Subject|0|||
130741875|NCT06481709|470675545|FG001|Overall Study|Withdrawal by Subject|0|||
130741876|NCT06481709|470675546|FG002|Overall Study|Withdrawal by Subject|2|||
130741877|NCT06481709|470675547|FG003|Overall Study|Withdrawal by Subject|0|||
130741878|NCT03305848|470675548|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
130741879|NCT03305848|470675548|FG000|Overall Study|Physician Decision|2|||
130741880|NCT05366010|470675552|FG000|Overall Study|Withdrawal by Subject|1|||
130741881|NCT05366010|470675552|FG000|Overall Study|Protocol Violation|1|||
130741882|NCT05366010|470675552|FG000|Overall Study|Lost to Follow-up|2|||
130741883|NCT05366010|470675552|FG000|Overall Study|Screen Failure|2|||
130741884|NCT00586703|470675553|FG000|Overall Study|Death|12|||
130741885|NCT01422213|470675554|FG000|Overall Study|Adverse Event|8|||
130741886|NCT01422213|470675555|FG001|Overall Study|Adverse Event|7|||
130741887|NCT01422213|470675556|FG002|Overall Study|Adverse Event|11|||
130741888|NCT01422213|470675554|FG000|Overall Study|Lack of Efficacy|10|||
130741889|NCT01422213|470675555|FG001|Overall Study|Lack of Efficacy|2|||
130741890|NCT01422213|470675556|FG002|Overall Study|Lack of Efficacy|2|||
130741891|NCT01422213|470675554|FG000|Overall Study|Non-compliance with study drug|0|||
130741892|NCT01422213|470675555|FG001|Overall Study|Non-compliance with study drug|1|||
130741893|NCT01422213|470675556|FG002|Overall Study|Non-compliance with study drug|0|||
130741894|NCT01422213|470675554|FG000|Overall Study|Protocol Violation|0|||
130741895|NCT01422213|470675555|FG001|Overall Study|Protocol Violation|2|||
130741896|NCT01422213|470675556|FG002|Overall Study|Protocol Violation|4|||
130741897|NCT01422213|470675554|FG000|Overall Study|Withdrawal of Consent|7|||
130741898|NCT01422213|470675555|FG001|Overall Study|Withdrawal of Consent|3|||
130741899|NCT01422213|470675556|FG002|Overall Study|Withdrawal of Consent|5|||
130741900|NCT01422213|470675554|FG000|Overall Study|Lost to Follow-up|3|||
130741901|NCT01422213|470675555|FG001|Overall Study|Lost to Follow-up|3|||
130741902|NCT01422213|470675556|FG002|Overall Study|Lost to Follow-up|5|||
130741903|NCT01422213|470675554|FG000|Overall Study|Administrative or Other Reason(s)|5|||
130741904|NCT01422213|470675555|FG001|Overall Study|Administrative or Other Reason(s)|4|||
130741905|NCT01422213|470675556|FG002|Overall Study|Administrative or Other Reason(s)|2|||
130741906|NCT05271175|470675557|FG000|One Week Follow up|Lost to Follow-up|10|||
130741907|NCT05271175|470675558|FG001|One Week Follow up|Lost to Follow-up|7|||
130741908|NCT05271175|470675559|FG002|One Week Follow up|Lost to Follow-up|5|||
130741909|NCT05271175|470675557|FG000|One Month Follow up|Lost to Follow-up|12|||
130741910|NCT05271175|470675558|FG001|One Month Follow up|Lost to Follow-up|7|||
130741911|NCT05271175|470675559|FG002|One Month Follow up|Lost to Follow-up|9|||
130741912|NCT05271175|470675557|FG000|Six Months Follow up|Lost to Follow-up|8|||
130741913|NCT05271175|470675558|FG001|Six Months Follow up|Lost to Follow-up|2|||
130741914|NCT05271175|470675559|FG002|Six Months Follow up|Lost to Follow-up|2|||
130741915|NCT00991887|470675560|FG000|Overall Study|Lost to Follow-up|2|||
130741916|NCT00991887|470675561|FG001|Overall Study|Lost to Follow-up|1|||
130741917|NCT01964976|470675562|FG000|Overall Study|Protocol Violation|31|||
130741918|NCT00473590|470675563|FG000|Overall Study|Adverse Event|3|||
130741919|NCT00473590|470675564|FG001|Overall Study|Adverse Event|3|||
130741920|NCT00473590|470675563|FG000|Overall Study|Death|4|||
130741921|NCT00473590|470675564|FG001|Overall Study|Death|2|||
130741922|NCT00473590|470675563|FG000|Overall Study|Progression not resulting in death|24|||
130741923|NCT00473590|470675564|FG001|Overall Study|Progression not resulting in death|20|||
130741924|NCT00473590|470675563|FG000|Overall Study|Non-protocol-specified therapy|7|||
130741925|NCT00473590|470675564|FG001|Overall Study|Non-protocol-specified therapy|5|||
130741926|NCT00473590|470675563|FG000|Overall Study|Physician Decision|2|||
130741927|NCT00473590|470675564|FG001|Overall Study|Physician Decision|4|||
130741928|NCT00473590|470675563|FG000|Overall Study|Withdrawal by Subject|5|||
130741929|NCT00473590|470675564|FG001|Overall Study|Withdrawal by Subject|3|||
130741930|NCT00473590|470675563|FG000|Overall Study|Other|0|||
130741931|NCT00473590|470675564|FG001|Overall Study|Other|1|||
130741932|NCT01891864|470675569|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
130741933|NCT01891864|470675570|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
130741934|NCT01891864|470675571|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130741935|NCT01891864|470675572|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130741936|NCT01891864|470675573|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130741937|NCT01891864|470675574|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130741938|NCT01891864|470675569|FG000|Treatment Period 1|Physician Decision|0|||
130741939|NCT01891864|470675570|FG001|Treatment Period 1|Physician Decision|1|||
130741940|NCT01891864|470675571|FG002|Treatment Period 1|Physician Decision|0|||
130741941|NCT01891864|470675572|FG003|Treatment Period 1|Physician Decision|0|||
130741942|NCT01891864|470675573|FG004|Treatment Period 1|Physician Decision|0|||
130741943|NCT01891864|470675574|FG005|Treatment Period 1|Physician Decision|0|||
130741944|NCT01891864|470675569|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130741945|NCT01891864|470675570|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
130788191|NCT03861039|470854493|FG001|Overall Study|Withdrawal by Subject|3|||
130741946|NCT01891864|470675571|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130741947|NCT01891864|470675572|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130741948|NCT01891864|470675573|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130741949|NCT01891864|470675574|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130741950|NCT01891864|470675569|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
130741951|NCT01891864|470675570|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
130741952|NCT01891864|470675571|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130741953|NCT01891864|470675572|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130741954|NCT01891864|470675573|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130741955|NCT01891864|470675574|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130741956|NCT01891864|470675569|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130741957|NCT01891864|470675570|FG001|Treatment Period 1|Withdrawal by Subject|5|||
130741958|NCT01891864|470675571|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130741959|NCT01891864|470675572|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130741960|NCT01891864|470675573|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130741961|NCT01891864|470675574|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130741962|NCT01891864|470675569|FG000|Treatment Period 1|Lost to Follow-up|1|||
130741963|NCT01891864|470675570|FG001|Treatment Period 1|Lost to Follow-up|0|||
130741964|NCT01891864|470675571|FG002|Treatment Period 1|Lost to Follow-up|0|||
130741965|NCT01891864|470675572|FG003|Treatment Period 1|Lost to Follow-up|0|||
130741966|NCT01891864|470675573|FG004|Treatment Period 1|Lost to Follow-up|0|||
130741967|NCT01891864|470675574|FG005|Treatment Period 1|Lost to Follow-up|0|||
130741968|NCT01891864|470675569|FG000|Treatment Period 2|Protocol Violation|0|||
130741969|NCT01891864|470675570|FG001|Treatment Period 2|Protocol Violation|0|||
130741970|NCT01891864|470675571|FG002|Treatment Period 2|Protocol Violation|0|||
130741971|NCT01891864|470675572|FG003|Treatment Period 2|Protocol Violation|1|||
130741972|NCT01891864|470675573|FG004|Treatment Period 2|Protocol Violation|0|||
130741973|NCT01891864|470675574|FG005|Treatment Period 2|Protocol Violation|0|||
130741974|NCT01891864|470675569|FG000|Treatment Period 2|Physician Decision|0|||
130741975|NCT01891864|470675570|FG001|Treatment Period 2|Physician Decision|0|||
130741976|NCT01891864|470675571|FG002|Treatment Period 2|Physician Decision|1|||
130741977|NCT01891864|470675572|FG003|Treatment Period 2|Physician Decision|0|||
130741978|NCT01891864|470675573|FG004|Treatment Period 2|Physician Decision|0|||
130741979|NCT01891864|470675574|FG005|Treatment Period 2|Physician Decision|0|||
130741980|NCT01891864|470675569|FG000|Treatment Period 2|Site Termination|0|||
130741981|NCT01891864|470675570|FG001|Treatment Period 2|Site Termination|0|||
130741982|NCT01891864|470675571|FG002|Treatment Period 2|Site Termination|1|||
130741983|NCT01891864|470675572|FG003|Treatment Period 2|Site Termination|2|||
130741984|NCT01891864|470675573|FG004|Treatment Period 2|Site Termination|0|||
130741985|NCT01891864|470675574|FG005|Treatment Period 2|Site Termination|0|||
130741986|NCT01891864|470675569|FG000|Treatment Period 2|Lack of Efficacy|0|||
130741987|NCT01891864|470675570|FG001|Treatment Period 2|Lack of Efficacy|0|||
130741988|NCT01891864|470675571|FG002|Treatment Period 2|Lack of Efficacy|1|||
130741989|NCT01891864|470675572|FG003|Treatment Period 2|Lack of Efficacy|0|||
130741990|NCT01891864|470675573|FG004|Treatment Period 2|Lack of Efficacy|1|||
130741991|NCT01891864|470675574|FG005|Treatment Period 2|Lack of Efficacy|0|||
130741992|NCT01891864|470675569|FG000|Treatment Period 2|Adverse Event|0|||
130741993|NCT01891864|470675570|FG001|Treatment Period 2|Adverse Event|0|||
130741994|NCT01891864|470675571|FG002|Treatment Period 2|Adverse Event|1|||
130741995|NCT01891864|470675572|FG003|Treatment Period 2|Adverse Event|2|||
130741996|NCT01891864|470675573|FG004|Treatment Period 2|Adverse Event|0|||
130741997|NCT01891864|470675574|FG005|Treatment Period 2|Adverse Event|4|||
130741998|NCT01891864|470675569|FG000|Treatment Period 2|Termination of Site|0|||
130741999|NCT01891864|470675570|FG001|Treatment Period 2|Termination of Site|0|||
130742000|NCT01891864|470675571|FG002|Treatment Period 2|Termination of Site|0|||
130742001|NCT01891864|470675572|FG003|Treatment Period 2|Termination of Site|0|||
130742002|NCT01891864|470675573|FG004|Treatment Period 2|Termination of Site|2|||
130742003|NCT01891864|470675574|FG005|Treatment Period 2|Termination of Site|0|||
130742004|NCT01891864|470675569|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130742005|NCT01891864|470675570|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130742006|NCT01891864|470675571|FG002|Treatment Period 2|Withdrawal by Subject|3|||
130742007|NCT01891864|470675572|FG003|Treatment Period 2|Withdrawal by Subject|4|||
130788192|NCT03861039|470854494|FG002|Overall Study|Withdrawal by Subject|4|||
130788193|NCT02791269|470854510|FG000|Overall Study|Lost to Follow-up|0|||
130788194|NCT02791269|470854511|FG001|Overall Study|Lost to Follow-up|1|||
130788195|NCT00420745|470854512|FG000|Overall Study|Adverse Event|2|||
130788196|NCT00420745|470854513|FG001|Overall Study|Adverse Event|2|||
130742008|NCT01891864|470675573|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130742009|NCT01891864|470675574|FG005|Treatment Period 2|Withdrawal by Subject|1|||
130742010|NCT01891864|470675569|FG000|Extension Period|Lack of Efficacy|0|||
130742011|NCT01891864|470675570|FG001|Extension Period|Lack of Efficacy|0|||
130742012|NCT01891864|470675571|FG002|Extension Period|Lack of Efficacy|0|||
130742013|NCT01891864|470675572|FG003|Extension Period|Lack of Efficacy|1|||
130742014|NCT01891864|470675573|FG004|Extension Period|Lack of Efficacy|1|||
130742015|NCT01891864|470675574|FG005|Extension Period|Lack of Efficacy|0|||
130788197|NCT00420745|470854512|FG000|Overall Study|Lost to Follow-up|10|||
130742016|NCT01891864|470675569|FG000|Extension Period|Pregnancy|0|||
130742017|NCT01891864|470675570|FG001|Extension Period|Pregnancy|0|||
130742018|NCT01891864|470675571|FG002|Extension Period|Pregnancy|1|||
130742019|NCT01891864|470675572|FG003|Extension Period|Pregnancy|0|||
130742020|NCT01891864|470675573|FG004|Extension Period|Pregnancy|0|||
130742021|NCT01891864|470675574|FG005|Extension Period|Pregnancy|0|||
130742022|NCT01891864|470675569|FG000|Extension Period|Adverse Event|0|||
130742023|NCT01891864|470675570|FG001|Extension Period|Adverse Event|0|||
130742024|NCT01891864|470675571|FG002|Extension Period|Adverse Event|4|||
130742025|NCT01891864|470675572|FG003|Extension Period|Adverse Event|2|||
130742026|NCT01891864|470675573|FG004|Extension Period|Adverse Event|2|||
130742027|NCT01891864|470675574|FG005|Extension Period|Adverse Event|0|||
130742028|NCT01891864|470675569|FG000|Extension Period|Withdrawal by Subject|0|||
130742029|NCT01891864|470675570|FG001|Extension Period|Withdrawal by Subject|0|||
130742030|NCT01891864|470675571|FG002|Extension Period|Withdrawal by Subject|1|||
130742031|NCT01891864|470675572|FG003|Extension Period|Withdrawal by Subject|2|||
130742032|NCT01891864|470675573|FG004|Extension Period|Withdrawal by Subject|4|||
130742033|NCT01891864|470675574|FG005|Extension Period|Withdrawal by Subject|0|||
130742034|NCT01891864|470675569|FG000|Extension Period|Lost to Follow-up|0|||
130742035|NCT01891864|470675570|FG001|Extension Period|Lost to Follow-up|0|||
130742036|NCT01891864|470675571|FG002|Extension Period|Lost to Follow-up|2|||
130742037|NCT01891864|470675572|FG003|Extension Period|Lost to Follow-up|0|||
130742038|NCT01891864|470675573|FG004|Extension Period|Lost to Follow-up|0|||
130742039|NCT01891864|470675574|FG005|Extension Period|Lost to Follow-up|0|||
130742040|NCT02698163|470675575|FG000|Overall Study|Lost to Follow-up|0|||
130742041|NCT02698163|470675576|FG001|Overall Study|Lost to Follow-up|1|||
130742042|NCT02892331|470675577|FG000|Overall Study|Withdrawal by Subject|0|||
130742043|NCT02892331|470675578|FG001|Overall Study|Withdrawal by Subject|1|||
130742044|NCT02892331|470675579|FG002|Overall Study|Withdrawal by Subject|1|||
130742045|NCT02892331|470675577|FG000|Overall Study|Sick family member|0|||
130742046|NCT02892331|470675578|FG001|Overall Study|Sick family member|0|||
130742047|NCT02892331|470675579|FG002|Overall Study|Sick family member|1|||
130742048|NCT02892331|470675577|FG000|Overall Study|Corona virus pandemic|1|||
130742049|NCT02892331|470675578|FG001|Overall Study|Corona virus pandemic|0|||
130742050|NCT02892331|470675579|FG002|Overall Study|Corona virus pandemic|1|||
130742051|NCT02892331|470675577|FG000|Overall Study|Lost to Follow-up|1|||
130742052|NCT02892331|470675578|FG001|Overall Study|Lost to Follow-up|0|||
130742053|NCT02892331|470675579|FG002|Overall Study|Lost to Follow-up|1|||
130742054|NCT02892331|470675577|FG000|Overall Study|Blood pressure was too elevated|0|||
130742055|NCT02892331|470675578|FG001|Overall Study|Blood pressure was too elevated|1|||
130742056|NCT02892331|470675579|FG002|Overall Study|Blood pressure was too elevated|0|||
130742057|NCT02892331|470675577|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
130742058|NCT02892331|470675578|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
130742059|NCT02892331|470675579|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
130742060|NCT00752128|470675583|FG000|Overall Study|Withdrawal by Subject|4|||
130742061|NCT00349973|470675584|FG000|Overall Study|Adverse Event|3|||
130742062|NCT00349973|470675585|FG001|Overall Study|Adverse Event|3|||
130742063|NCT00349973|470675584|FG000|Overall Study|Withdrawal by Subject|1|||
130742064|NCT00349973|470675585|FG001|Overall Study|Withdrawal by Subject|0|||
130742065|NCT02286713|470675589|FG000|One Week Follow-Up|Death|1|||
130742066|NCT02286713|470675590|FG001|One Week Follow-Up|Death|0|||
130742067|NCT02286713|470675589|FG000|One Week Follow-Up|Lost to Follow-up|17|||
130742068|NCT02286713|470675590|FG001|One Week Follow-Up|Lost to Follow-up|21|||
130742069|NCT02286713|470675589|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
130742070|NCT02286713|470675590|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
130742071|NCT02286713|470675589|FG000|Three Month Follow-Up|Death|1|||
130742072|NCT02286713|470675590|FG001|Three Month Follow-Up|Death|1|||
130742073|NCT02286713|470675589|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
130742074|NCT02286713|470675590|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
130742075|NCT02286713|470675589|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
130742076|NCT02286713|470675590|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
130742077|NCT02286713|470675589|FG000|Six Month Follow-Up|Death|2|||
130742078|NCT02286713|470675590|FG001|Six Month Follow-Up|Death|0|||
130742079|NCT02286713|470675589|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
130742080|NCT02286713|470675590|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
130742081|NCT04314037|470675591|FG000|Treatment Period 2|Adverse Event|1|||
130742082|NCT04314037|470675592|FG001|Treatment Period 2|Adverse Event|0|||
130742083|NCT04314037|470675591|FG000|Treatment Period 3|Protocol Violation|1|||
130742084|NCT04314037|470675592|FG001|Treatment Period 3|Protocol Violation|0|||
130742085|NCT04314037|470675591|FG000|Treatment Period 3|Adverse Event|0|||
130742086|NCT04314037|470675592|FG001|Treatment Period 3|Adverse Event|1|||
130742087|NCT03832686|470675595|FG000|Overall Study|Lost to Follow-up|6|||
130742088|NCT03832686|470675596|FG001|Overall Study|Lost to Follow-up|9|||
130742089|NCT03832686|470675595|FG000|Overall Study|Discontinued Intervention|5|||
130742090|NCT03832686|470675596|FG001|Overall Study|Discontinued Intervention|4|||
130742091|NCT02325973|470677896|FG000|Overall Study|Death|5|||
130742092|NCT02325973|470677896|FG000|Overall Study|Withdrawal by subject or investigator|16|||
130742093|NCT01415518|470677897|FG000|Overall Study|Withdrawal by Subject|2|||
130742094|NCT01415518|470677898|FG001|Overall Study|Withdrawal by Subject|12|||
130742095|NCT01415518|470677897|FG000|Overall Study|Protocol Violation|6|||
130742096|NCT01415518|470677898|FG001|Overall Study|Protocol Violation|8|||
130742097|NCT01415518|470677897|FG000|Overall Study|Lost to Follow-up|3|||
130742098|NCT01415518|470677898|FG001|Overall Study|Lost to Follow-up|5|||
130742099|NCT01415518|470677897|FG000|Overall Study|Adverse Event|3|||
130742100|NCT01415518|470677898|FG001|Overall Study|Adverse Event|4|||
130742101|NCT01415518|470677897|FG000|Overall Study|Death|1|||
130742102|NCT01415518|470677898|FG001|Overall Study|Death|1|||
130742103|NCT01415518|470677897|FG000|Overall Study|Condition under Investigation Worsened|1|||
130742104|NCT01415518|470677898|FG001|Overall Study|Condition under Investigation Worsened|1|||
130742105|NCT02068508|470677899|FG000|Overall Study|Case report forms uncollected|27|||
130742106|NCT02068508|470677899|FG000|Overall Study|Patient did not visit the study site|1|||
130742107|NCT02068508|470677899|FG000|Overall Study|Protocol Violation|4|||
130742108|NCT03511105|470677903|FG000|Overall Study|Adverse Event|1|||
130742109|NCT03511105|470677904|FG001|Overall Study|Adverse Event|0|||
130742110|NCT03511105|470677903|FG000|Overall Study|Withdrew consent|1|||
130742111|NCT03511105|470677904|FG001|Overall Study|Withdrew consent|0|||
130742112|NCT02810457|470677905|FG000|Overall Study|Randomised but no treatment received|2|||
130742113|NCT02810457|470677906|FG001|Overall Study|Randomised but no treatment received|1|||
130742114|NCT02810457|470677905|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
130742115|NCT02810457|470677906|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
130742116|NCT02810457|470677905|FG000|Overall Study|Adverse Event|37|||
130742117|NCT02810457|470677906|FG001|Overall Study|Adverse Event|43|||
130742118|NCT02810457|470677905|FG000|Overall Study|Patient decision|31|||
130742119|NCT02810457|470677906|FG001|Overall Study|Patient decision|35|||
130742120|NCT02810457|470677905|FG000|Overall Study|Patient lost to follow-up|2|||
130742121|NCT02810457|470677906|FG001|Overall Study|Patient lost to follow-up|2|||
130742122|NCT02810457|470677905|FG000|Overall Study|Death|39|||
130742123|NCT02810457|470677906|FG001|Overall Study|Death|28|||
130742124|NCT02810457|470677905|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
130742125|NCT02810457|470677906|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
130742126|NCT02810457|470677905|FG000|Overall Study|Clinical progression|15|||
130742127|NCT02810457|470677906|FG001|Overall Study|Clinical progression|16|||
130742128|NCT02810457|470677905|FG000|Overall Study|Investigator decision|3|||
130742129|NCT02810457|470677906|FG001|Overall Study|Investigator decision|2|||
130742130|NCT02810457|470677905|FG000|Overall Study|Patient ineligibility|3|||
130742131|NCT02810457|470677906|FG001|Overall Study|Patient ineligibility|0|||
130742132|NCT02810457|470677905|FG000|Overall Study|Miscalculated PD|1|||
130742133|NCT02810457|470677906|FG001|Overall Study|Miscalculated PD|0|||
130742134|NCT02810457|470677905|FG000|Overall Study|Physician Decision|0|||
130742135|NCT02810457|470677906|FG001|Overall Study|Physician Decision|1|||
130742136|NCT04173507|470677907|FG000|Overall Study|On Treatment|3|||
130742137|NCT04173507|470677907|FG000|Overall Study|Adverse Event|3|||
130742138|NCT04173507|470677907|FG000|Overall Study|Progression/Relapse|34|||
130742139|NCT04173507|470677907|FG000|Overall Study|Death|2|||
130742140|NCT01217112|470677910|FG000|Overall Study|Adverse Event|0|||
130742141|NCT01217112|470677911|FG001|Overall Study|Adverse Event|2|||
130742142|NCT01217112|470677912|FG002|Overall Study|Adverse Event|0|||
130742143|NCT01217112|470677913|FG003|Overall Study|Adverse Event|2|||
130742144|NCT01217112|470677914|FG004|Overall Study|Adverse Event|0|||
130742145|NCT01217112|470677910|FG000|Overall Study|Withdrawal by Subject|0|||
130742146|NCT01217112|470677911|FG001|Overall Study|Withdrawal by Subject|0|||
130742147|NCT01217112|470677912|FG002|Overall Study|Withdrawal by Subject|1|||
130742148|NCT01217112|470677913|FG003|Overall Study|Withdrawal by Subject|0|||
130742149|NCT01217112|470677914|FG004|Overall Study|Withdrawal by Subject|0|||
130742150|NCT01217112|470677910|FG000|Overall Study|Physician Decision|0|||
130742151|NCT01217112|470677911|FG001|Overall Study|Physician Decision|0|||
130742152|NCT01217112|470677912|FG002|Overall Study|Physician Decision|0|||
130742153|NCT01217112|470677913|FG003|Overall Study|Physician Decision|0|||
130742154|NCT01217112|470677914|FG004|Overall Study|Physician Decision|1|||
130742155|NCT03192488|470677915|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
130742156|NCT03192488|470677916|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
130742157|NCT03192488|470677917|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
130742158|NCT03192488|470677918|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
130742159|NCT03192488|470677919|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
130742160|NCT03192488|470677920|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
130742161|NCT03192488|470677915|FG000|Third Intervention (d1)|Adverse Event|0|||
130742162|NCT03192488|470677916|FG001|Third Intervention (d1)|Adverse Event|0|||
130742163|NCT03192488|470677917|FG002|Third Intervention (d1)|Adverse Event|0|||
130742164|NCT03192488|470677918|FG003|Third Intervention (d1)|Adverse Event|0|||
130742165|NCT03192488|470677919|FG004|Third Intervention (d1)|Adverse Event|1|||
130742166|NCT03192488|470677920|FG005|Third Intervention (d1)|Adverse Event|0|||
130742167|NCT01401361|470677921|FG000|Overall Study|Withdrawal by Subject|16|||
130742168|NCT01401361|470677921|FG000|Overall Study|Lack of Efficacy|6|||
130742169|NCT01401361|470677921|FG000|Overall Study|Physician Decision|1|||
130742170|NCT01401361|470677921|FG000|Overall Study|Lost to Follow-up|3|||
130742171|NCT01401361|470677921|FG000|Overall Study|Subject/family decision post procedure|2|||
130742172|NCT02512302|470677923|FG000|Period 1|Adverse Event|0|||
130742173|NCT02512302|470677924|FG001|Period 1|Adverse Event|1|||
130742174|NCT02512302|470677925|FG002|Period 1|Adverse Event|0|||
130742175|NCT02512302|470677926|FG003|Period 1|Adverse Event|0|||
130742176|NCT02512302|470677927|FG004|Period 1|Adverse Event|0|||
130742177|NCT02512302|470677928|FG005|Period 1|Adverse Event|0|||
130742178|NCT02512302|470677929|FG006|Period 1|Adverse Event|0|||
130742179|NCT02512302|470677930|FG007|Period 1|Adverse Event|0|||
130742180|NCT02512302|470677931|FG008|Period 1|Adverse Event|0|||
130742181|NCT02512302|470677932|FG009|Period 1|Adverse Event|0|||
130742182|NCT02512302|470677923|FG000|Period 2|Adverse Event|0|||
130742183|NCT02512302|470677924|FG001|Period 2|Adverse Event|0|||
130742184|NCT02512302|470677925|FG002|Period 2|Adverse Event|0|||
130742185|NCT02512302|470677926|FG003|Period 2|Adverse Event|0|||
130742186|NCT02512302|470677927|FG004|Period 2|Adverse Event|0|||
130742187|NCT02512302|470677928|FG005|Period 2|Adverse Event|0|||
130742188|NCT02512302|470677929|FG006|Period 2|Adverse Event|0|||
130742189|NCT02512302|470677930|FG007|Period 2|Adverse Event|0|||
130742190|NCT02512302|470677931|FG008|Period 2|Adverse Event|0|||
130742191|NCT02512302|470677932|FG009|Period 2|Adverse Event|1|||
130742192|NCT02512302|470677923|FG000|Period 3|Lost to Follow-up|0|||
130742193|NCT02512302|470677924|FG001|Period 3|Lost to Follow-up|0|||
130742194|NCT02512302|470677925|FG002|Period 3|Lost to Follow-up|1|||
130742195|NCT02512302|470677926|FG003|Period 3|Lost to Follow-up|0|||
130742196|NCT02512302|470677927|FG004|Period 3|Lost to Follow-up|0|||
130742197|NCT02512302|470677928|FG005|Period 3|Lost to Follow-up|0|||
130742198|NCT02512302|470677929|FG006|Period 3|Lost to Follow-up|0|||
130742199|NCT02512302|470677930|FG007|Period 3|Lost to Follow-up|0|||
130742200|NCT02512302|470677931|FG008|Period 3|Lost to Follow-up|0|||
130742201|NCT02512302|470677932|FG009|Period 3|Lost to Follow-up|0|||
130742202|NCT02512302|470677923|FG000|Period 4|Adverse Event|0|||
130742203|NCT02512302|470677924|FG001|Period 4|Adverse Event|0|||
130742204|NCT02512302|470677925|FG002|Period 4|Adverse Event|0|||
130742205|NCT02512302|470677926|FG003|Period 4|Adverse Event|0|||
130742206|NCT02512302|470677927|FG004|Period 4|Adverse Event|0|||
130742207|NCT02512302|470677928|FG005|Period 4|Adverse Event|0|||
130742208|NCT02512302|470677929|FG006|Period 4|Adverse Event|1|||
130742209|NCT02512302|470677930|FG007|Period 4|Adverse Event|0|||
130742210|NCT02512302|470677931|FG008|Period 4|Adverse Event|0|||
130742211|NCT02512302|470677932|FG009|Period 4|Adverse Event|0|||
130742212|NCT02764762|470677936|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
130742213|NCT02764762|470677936|FG000|Overall Study|Lost to Follow-up|4|||
130742214|NCT02764762|470677936|FG000|Overall Study|Voluntary Withdrawal|8|||
130742215|NCT02764762|470677936|FG000|Overall Study|Site Termination|1|||
130742216|NCT02764762|470677936|FG000|Overall Study|Lack of Efficacy|16|||
130742217|NCT02764762|470677936|FG000|Overall Study|Reason not Specified|1|||
130742218|NCT01002989|470677937|FG000|Overall Study|exclusion criteria, no consent|5|||
130742219|NCT01892501|470677938|FG000|Overall Study|Protocol Violation|2|||
130742220|NCT01892501|470677938|FG000|Overall Study|Puncture not carried out|9|||
130742221|NCT01892501|470677938|FG000|Overall Study|Radiological monitoring not carried out|5|||
130742222|NCT01892501|470677938|FG000|Overall Study|Non-contributory histological result|12|||
130742223|NCT01068860|470677942|FG000|Overall Study|Withdrawal by Subject|0|||
130742224|NCT01068860|470677943|FG001|Overall Study|Withdrawal by Subject|0|||
130742225|NCT01068860|470677944|FG002|Overall Study|Withdrawal by Subject|0|||
130742226|NCT01068860|470677945|FG003|Overall Study|Withdrawal by Subject|0|||
130742227|NCT01068860|470677946|FG004|Overall Study|Withdrawal by Subject|0|||
130742228|NCT01068860|470677947|FG005|Overall Study|Withdrawal by Subject|2|||
130742229|NCT01068860|470677948|FG006|Overall Study|Withdrawal by Subject|0|||
130742230|NCT01068860|470677949|FG007|Overall Study|Withdrawal by Subject|0|||
130742231|NCT01068860|470677950|FG008|Overall Study|Withdrawal by Subject|0|||
130742232|NCT01068860|470677951|FG009|Overall Study|Withdrawal by Subject|3|||
130742233|NCT01068860|470677942|FG000|Overall Study|Administrative problems; misrandomized|0|||
130742234|NCT01068860|470677943|FG001|Overall Study|Administrative problems; misrandomized|0|||
130742235|NCT01068860|470677944|FG002|Overall Study|Administrative problems; misrandomized|0|||
130742236|NCT01068860|470677945|FG003|Overall Study|Administrative problems; misrandomized|1|||
130742237|NCT01068860|470677946|FG004|Overall Study|Administrative problems; misrandomized|0|||
130742238|NCT01068860|470677947|FG005|Overall Study|Administrative problems; misrandomized|0|||
130742239|NCT01068860|470677948|FG006|Overall Study|Administrative problems; misrandomized|0|||
130742240|NCT01068860|470677949|FG007|Overall Study|Administrative problems; misrandomized|0|||
130742241|NCT01068860|470677950|FG008|Overall Study|Administrative problems; misrandomized|0|||
130742242|NCT01068860|470677951|FG009|Overall Study|Administrative problems; misrandomized|1|||
130742243|NCT01068860|470677942|FG000|Overall Study|Lost to Follow-up|0|||
130742244|NCT01068860|470677943|FG001|Overall Study|Lost to Follow-up|1|||
130742245|NCT01068860|470677944|FG002|Overall Study|Lost to Follow-up|0|||
130742246|NCT01068860|470677945|FG003|Overall Study|Lost to Follow-up|0|||
130742247|NCT01068860|470677946|FG004|Overall Study|Lost to Follow-up|0|||
130742248|NCT01068860|470677947|FG005|Overall Study|Lost to Follow-up|0|||
130742249|NCT01068860|470677948|FG006|Overall Study|Lost to Follow-up|0|||
130742250|NCT01068860|470677949|FG007|Overall Study|Lost to Follow-up|0|||
130742251|NCT01068860|470677950|FG008|Overall Study|Lost to Follow-up|0|||
130742252|NCT01068860|470677951|FG009|Overall Study|Lost to Follow-up|0|||
130742253|NCT01321879|470677952|FG000|Overall Study|Lack of Efficacy|5|||
130742254|NCT01321879|470677952|FG000|Overall Study|Adverse Event|5|||
130742255|NCT01321879|470677952|FG000|Overall Study|Death|3|||
130742256|NCT01321879|470677952|FG000|Overall Study|Withdrawal by Subject|1|||
130742257|NCT00513240|470677954|FG000|Overall Study|Did not have intended surgery|3|||
130742258|NCT00513240|470677955|FG001|Overall Study|Did not have intended surgery|0|||
130742259|NCT00513240|470677954|FG000|Overall Study|Death|3|||
130742260|NCT00513240|470677955|FG001|Overall Study|Death|3|||
130742261|NCT00513240|470677954|FG000|Overall Study|Withdrawal by Subject|7|||
130742262|NCT00513240|470677955|FG001|Overall Study|Withdrawal by Subject|4|||
130742263|NCT05263908|470677956|FG000|Overall Study|No informed consent for publication of study results|397|||
130742264|NCT05263908|470677956|FG000|Overall Study|CRF not collected|1|||
130742265|NCT01641640|470677957|FG000|Overall Study|Enrolled but not treated|1|||
130742266|NCT01641640|470677957|FG000|Overall Study|Efficacy failure|29|||
130742267|NCT01641640|470677957|FG000|Overall Study|Lost to Follow-up|3|||
130742268|NCT01641640|470677957|FG000|Overall Study|Withdrawal by Subject|2|||
130742269|NCT01641640|470677957|FG000|Overall Study|Adverse Event|1|||
130742270|NCT01234350|470677959|FG000|Overall Study|Adverse Event|277|||
130742271|NCT01234350|470677960|FG001|Overall Study|Adverse Event|92|||
130742272|NCT01234350|470677959|FG000|Overall Study|Withdrawal by Subject|61|||
130742273|NCT01234350|470677960|FG001|Overall Study|Withdrawal by Subject|36|||
130742274|NCT01234350|470677959|FG000|Overall Study|Lost to Follow-up|115|||
130742275|NCT01234350|470677960|FG001|Overall Study|Lost to Follow-up|47|||
130742276|NCT01234350|470677959|FG000|Overall Study|Covers a diverse set of reasons|234|||
130742277|NCT01234350|470677960|FG001|Overall Study|Covers a diverse set of reasons|92|||
130742278|NCT01930162|470677963|FG000|Overall Study|Abnormal test procedure result(s)|4|||
130742279|NCT01930162|470677963|FG000|Overall Study|Death|1|||
130742280|NCT01051960|470677964|FG000|Overall Study|Adverse Event|1|||
130742281|NCT02069015|470677974|FG000|Overall Study|Lost to Follow-up|39|||
130742282|NCT02069015|470677975|FG001|Overall Study|Lost to Follow-up|32|||
130742283|NCT02069015|470677974|FG000|Overall Study|Withdrawal by Subject|1|||
130742284|NCT02069015|470677975|FG001|Overall Study|Withdrawal by Subject|1|||
130742285|NCT01082328|470677976|FG000|Overall Study|Adverse Event|1|||
130742286|NCT00031590|470677977|FG000|Overall Study|Adverse Event|1|||
130742287|NCT00031590|470677977|FG000|Overall Study|Withdrawal by parents|2|||
130742288|NCT05506046|470677978|FG000|Overall Study|Lost to Follow-up|89|||
130742289|NCT05506046|470677979|FG001|Overall Study|Lost to Follow-up|101|||
130742290|NCT05506046|470677980|FG002|Overall Study|Lost to Follow-up|102|||
130742291|NCT05506046|470677981|FG003|Overall Study|Lost to Follow-up|99|||
130742292|NCT03051100|470677983|FG000|Overall Study|Withdrawal by Subject|1|||
130742293|NCT03051100|470677984|FG001|Overall Study|Withdrawal by Subject|0|||
130742294|NCT02059135|470677985|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
130742295|NCT02059135|470677986|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
130742296|NCT02059135|470677985|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
130742297|NCT02059135|470677986|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
130742298|NCT02059135|470677985|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
130742299|NCT02059135|470677986|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
130742300|NCT02059135|470677985|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
130742301|NCT02059135|470677986|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
130742302|NCT02059135|470677985|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
130742303|NCT02059135|470677986|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
130742304|NCT02059135|470677985|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
130742305|NCT02059135|470677986|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
130742306|NCT02059135|470677985|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
130742307|NCT02059135|470677986|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
130742308|NCT02059135|470677985|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
130742309|NCT02059135|470677986|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
130742310|NCT00789854|470677989|FG000|Overall Study|Adverse Event|28|||
130742311|NCT00789854|470677990|FG001|Overall Study|Adverse Event|23|||
130742312|NCT00789854|470677991|FG002|Overall Study|Adverse Event|18|||
130742313|NCT00789854|470677989|FG000|Overall Study|Lost to Follow-up|1|||
130742314|NCT00789854|470677990|FG001|Overall Study|Lost to Follow-up|1|||
130742315|NCT00789854|470677991|FG002|Overall Study|Lost to Follow-up|4|||
130742316|NCT00789854|470677989|FG000|Overall Study|Withdrawal by Subject|9|||
130742317|NCT00789854|470677990|FG001|Overall Study|Withdrawal by Subject|6|||
130788198|NCT00420745|470854513|FG001|Overall Study|Lost to Follow-up|2|||
130742318|NCT00789854|470677991|FG002|Overall Study|Withdrawal by Subject|17|||
130742319|NCT00789854|470677989|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130742320|NCT00789854|470677990|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
130742321|NCT00789854|470677991|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130742322|NCT00789854|470677989|FG000|Overall Study|Severe non-compliance to the protocol|3|||
130742323|NCT00789854|470677990|FG001|Overall Study|Severe non-compliance to the protocol|0|||
130742324|NCT00789854|470677991|FG002|Overall Study|Severe non-compliance to the protocol|0|||
130742325|NCT00789854|470677989|FG000|Overall Study|Safety reasons|0|||
130742326|NCT00789854|470677990|FG001|Overall Study|Safety reasons|0|||
130742327|NCT00789854|470677991|FG002|Overall Study|Safety reasons|2|||
130742328|NCT00789854|470677989|FG000|Overall Study|Other|6|||
130742329|NCT00789854|470677990|FG001|Overall Study|Other|0|||
130742330|NCT00789854|470677991|FG002|Overall Study|Other|5|||
130742331|NCT00923013|470677992|FG000|Overall Study|Refused further treatment|0|||
130742332|NCT00923013|470677993|FG001|Overall Study|Refused further treatment|1|||
130742333|NCT00923013|470677994|FG002|Overall Study|Refused further treatment|2|||
130742334|NCT00923013|470677995|FG003|Overall Study|Refused further treatment|0|||
130742335|NCT00923013|470677996|FG004|Overall Study|Refused further treatment|0|||
130742336|NCT00923013|470677997|FG005|Overall Study|Refused further treatment|0|||
130742337|NCT00923013|470677992|FG000|Overall Study|Switched to alternative treatment|0|||
130742338|NCT00923013|470677993|FG001|Overall Study|Switched to alternative treatment|1|||
130742339|NCT00923013|470677994|FG002|Overall Study|Switched to alternative treatment|0|||
130742340|NCT00923013|470677995|FG003|Overall Study|Switched to alternative treatment|0|||
130742341|NCT00923013|470677996|FG004|Overall Study|Switched to alternative treatment|0|||
130742342|NCT00923013|470677997|FG005|Overall Study|Switched to alternative treatment|0|||
130742343|NCT00923013|470677992|FG000|Overall Study|Death on study|2|||
130742344|NCT00923013|470677993|FG001|Overall Study|Death on study|2|||
130742345|NCT00923013|470677994|FG002|Overall Study|Death on study|0|||
130742346|NCT00923013|470677995|FG003|Overall Study|Death on study|1|||
130742347|NCT00923013|470677996|FG004|Overall Study|Death on study|0|||
130742348|NCT00923013|470677997|FG005|Overall Study|Death on study|0|||
130742349|NCT02224157|470677999|FG000|Overall Study|Severe non-compliance to protocol|2|||
130742350|NCT02224157|470678000|FG001|Overall Study|Severe non-compliance to protocol|2|||
130742351|NCT02224157|470677999|FG000|Overall Study|Other|13|||
130742352|NCT02224157|470678000|FG001|Overall Study|Other|10|||
130742353|NCT02224157|470677999|FG000|Overall Study|Subject decision|58|||
130742354|NCT02224157|470678000|FG001|Overall Study|Subject decision|50|||
130742355|NCT02224157|470677999|FG000|Overall Study|Prematurely closed site|4|||
130742356|NCT02224157|470678000|FG001|Overall Study|Prematurely closed site|2|||
130742357|NCT02224157|470677999|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
130742358|NCT02224157|470678000|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
130742359|NCT02224157|470677999|FG000|Overall Study|Lost to Follow-up|27|||
130742360|NCT02224157|470678000|FG001|Overall Study|Lost to Follow-up|35|||
130742361|NCT02224157|470677999|FG000|Overall Study|Death|1|||
130742362|NCT02224157|470678000|FG001|Overall Study|Death|1|||
130742363|NCT02224157|470677999|FG000|Overall Study|Adverse Event|1|||
130742364|NCT02224157|470678000|FG001|Overall Study|Adverse Event|3|||
130742365|NCT05906628|470678003|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
130742366|NCT05906628|470678004|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
130742367|NCT05906628|470678003|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
130742368|NCT05906628|470678004|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
130742369|NCT05906628|470678003|FG000|16-Week DBVC Period|Protocol Violation|4|||
130742370|NCT05906628|470678004|FG001|16-Week DBVC Period|Protocol Violation|2|||
130742371|NCT05906628|470678003|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
130742372|NCT05906628|470678004|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
130742373|NCT05906628|470678003|FG000|16-Week OLE Period|Death|1|||
130742374|NCT05906628|470678004|FG001|16-Week OLE Period|Death|0|||
130742375|NCT05906628|470678003|FG000|16-Week OLE Period|Lost to Follow-up|1|||
130742376|NCT05906628|470678004|FG001|16-Week OLE Period|Lost to Follow-up|1|||
130742377|NCT05906628|470678003|FG000|16-Week OLE Period|Protocol Violation|0|||
130742378|NCT05906628|470678004|FG001|16-Week OLE Period|Protocol Violation|1|||
130742379|NCT05906628|470678003|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
130742380|NCT05906628|470678004|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
130742381|NCT04578535|470678005|FG000|Overall Study|Lost to Follow-up|1|||
130742382|NCT04578535|470678006|FG001|Overall Study|Lost to Follow-up|0|||
130742383|NCT04578535|470678007|FG002|Overall Study|Lost to Follow-up|0|||
130742384|NCT04578535|470678008|FG003|Overall Study|Lost to Follow-up|1|||
130742385|NCT04578535|470678009|FG004|Overall Study|Lost to Follow-up|0|||
130742386|NCT04578535|470678010|FG005|Overall Study|Lost to Follow-up|2|||
130742387|NCT04578535|470678005|FG000|Overall Study|Pregnancy|1|||
130742388|NCT04578535|470678006|FG001|Overall Study|Pregnancy|0|||
130742389|NCT04578535|470678007|FG002|Overall Study|Pregnancy|0|||
130742390|NCT04578535|470678008|FG003|Overall Study|Pregnancy|0|||
130742391|NCT04578535|470678009|FG004|Overall Study|Pregnancy|0|||
130742392|NCT04578535|470678010|FG005|Overall Study|Pregnancy|0|||
130742393|NCT04578535|470678005|FG000|Overall Study|Withdrawal by Subject|0|||
130742394|NCT04578535|470678006|FG001|Overall Study|Withdrawal by Subject|0|||
130742395|NCT04578535|470678007|FG002|Overall Study|Withdrawal by Subject|0|||
130742396|NCT04578535|470678008|FG003|Overall Study|Withdrawal by Subject|1|||
130742397|NCT04578535|470678009|FG004|Overall Study|Withdrawal by Subject|1|||
130742398|NCT04578535|470678010|FG005|Overall Study|Withdrawal by Subject|5|||
130742399|NCT04578535|470678005|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
130742400|NCT04578535|470678006|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
130742401|NCT04578535|470678007|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
130742402|NCT04578535|470678008|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
130742403|NCT04578535|470678009|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
130742404|NCT04578535|470678010|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
130742405|NCT01060072|470678011|FG000|Overall Study|Adverse Event|1|||
130742406|NCT01060072|470678012|FG001|Overall Study|Adverse Event|1|||
130742407|NCT01060072|470678011|FG000|Overall Study|Physician Decision|0|||
130742408|NCT01060072|470678012|FG001|Overall Study|Physician Decision|2|||
130742409|NCT01060072|470678011|FG000|Overall Study|Protocol Violation|0|||
130742410|NCT01060072|470678012|FG001|Overall Study|Protocol Violation|1|||
130742411|NCT01060072|470678011|FG000|Overall Study|Acute cholecystitis|1|||
130742412|NCT01060072|470678012|FG001|Overall Study|Acute cholecystitis|0|||
130742413|NCT01060072|470678011|FG000|Overall Study|Excluded Medications|0|||
130742414|NCT01060072|470678012|FG001|Overall Study|Excluded Medications|1|||
130742415|NCT00837148|470678013|FG000|Overall Study|Adverse Event|1|||
130742416|NCT00837148|470678013|FG000|Overall Study|Death|1|||
130742417|NCT02301169|470678016|FG000|Overall Study|Adverse Event|1|||
130742418|NCT02301169|470678017|FG001|Overall Study|Adverse Event|0|||
130742419|NCT00380874|470678018|FG000|Overall Study|Adverse Event|7|||
130742420|NCT00380874|470678019|FG001|Overall Study|Adverse Event|7|||
130742421|NCT00380874|470678018|FG000|Overall Study|Death|1|||
130742422|NCT00380874|470678019|FG001|Overall Study|Death|0|||
130742423|NCT00380874|470678018|FG000|Overall Study|Withdrawal by Subject|2|||
130742424|NCT00380874|470678019|FG001|Overall Study|Withdrawal by Subject|1|||
130742425|NCT00380874|470678018|FG000|Overall Study|Not related to study drug|3|||
130742426|NCT00380874|470678019|FG001|Overall Study|Not related to study drug|2|||
130742427|NCT03839628|470678020|FG000|Overall Study|Withdrawal by Subject|1|||
130742428|NCT01707290|470678025|FG000|Overall Study|Adverse event (AE)|1|||
130742429|NCT01707290|470678026|FG001|Overall Study|Adverse event (AE)|0|||
130742430|NCT01707290|470678025|FG000|Overall Study|Physician Decision|1|||
130742431|NCT01707290|470678026|FG001|Overall Study|Physician Decision|0|||
130742432|NCT01707290|470678025|FG000|Overall Study|Lost to Follow-up|3|||
130742433|NCT01707290|470678026|FG001|Overall Study|Lost to Follow-up|0|||
130742434|NCT01707290|470678025|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
130742435|NCT01707290|470678026|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
130742436|NCT01707290|470678025|FG000|Overall Study|Commercial drug available|60|||
130742437|NCT01707290|470678026|FG001|Overall Study|Commercial drug available|1|||
130742438|NCT01707290|470678025|FG000|Overall Study|Other unspecified|17|||
130742439|NCT01707290|470678026|FG001|Overall Study|Other unspecified|0|||
130742440|NCT01198470|470678027|FG000|Overall Study|Adverse Event|2|||
130742441|NCT02949973|470678028|FG000|Overall Study|Physician Decision|1|||
130742442|NCT02857816|470678029|FG000|Overall Study|Screen Failure|33|||
130742443|NCT02857816|470678029|FG000|Overall Study|Withdrawal by Subject|4|||
130742444|NCT02857816|470678029|FG000|Overall Study|Lost to Follow-up|1|||
130742445|NCT01147068|470678032|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
130742446|NCT01147068|470678033|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130742447|NCT01147068|470678034|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130742448|NCT01147068|470678035|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130742449|NCT01147068|470678036|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130742450|NCT01147068|470678037|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
130742451|NCT01147068|470678038|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130742452|NCT01147068|470678032|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
130742453|NCT01147068|470678033|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
130742454|NCT01147068|470678034|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
130742455|NCT01147068|470678035|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
130742456|NCT01147068|470678036|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
130742457|NCT01147068|470678037|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
130742458|NCT01147068|470678038|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
130742459|NCT01147068|470678032|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
130742460|NCT01147068|470678033|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
130742461|NCT01147068|470678034|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
130742462|NCT01147068|470678035|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
130742463|NCT01147068|470678036|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
130742464|NCT01147068|470678037|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
130742465|NCT01147068|470678038|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
130742466|NCT01147068|470678032|FG000|Subjects That Received 2nd Dose|Other|0|||
130742467|NCT01147068|470678033|FG001|Subjects That Received 2nd Dose|Other|3|||
130742468|NCT01147068|470678034|FG002|Subjects That Received 2nd Dose|Other|3|||
130742469|NCT01147068|470678035|FG003|Subjects That Received 2nd Dose|Other|0|||
130742470|NCT01147068|470678036|FG004|Subjects That Received 2nd Dose|Other|1|||
130742471|NCT01147068|470678037|FG005|Subjects That Received 2nd Dose|Other|0|||
130742472|NCT01147068|470678038|FG006|Subjects That Received 2nd Dose|Other|0|||
130742473|NCT01147068|470678032|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
130742474|NCT01147068|470678033|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130742475|NCT01147068|470678034|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130742476|NCT01147068|470678035|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130742477|NCT01147068|470678036|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130742478|NCT01147068|470678037|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
130742479|NCT01147068|470678038|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
130742480|NCT01147068|470678032|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130742481|NCT01147068|470678033|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130742482|NCT01147068|470678034|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130742483|NCT01147068|470678035|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
130742484|NCT01147068|470678036|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130742485|NCT01147068|470678037|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130742486|NCT01147068|470678038|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130742487|NCT01147068|470678032|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
130742488|NCT01147068|470678033|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
130742489|NCT01147068|470678034|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
130742490|NCT01147068|470678035|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
130742491|NCT01147068|470678036|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
130742492|NCT01147068|470678037|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
130742493|NCT01147068|470678038|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
130742494|NCT03181633|470678039|FG000|Overall Study|Withdrawal by Subject|1|||
130742495|NCT03181633|470678039|FG000|Overall Study|Missing follow-up visit|1|||
130742496|NCT01597778|470678041|FG000|Overall Study|Death|7|||
130742497|NCT01597778|470678042|FG001|Overall Study|Death|10|||
130742498|NCT01597778|470678041|FG000|Overall Study|Withdrawal by Subject|3|||
130742499|NCT01597778|470678042|FG001|Overall Study|Withdrawal by Subject|4|||
130742500|NCT01597778|470678041|FG000|Overall Study|Adverse Event|1|||
130742501|NCT01597778|470678042|FG001|Overall Study|Adverse Event|1|||
130742502|NCT01597778|470678041|FG000|Overall Study|Protocol Violation|1|||
130742503|NCT01597778|470678042|FG001|Overall Study|Protocol Violation|11|||
130742504|NCT01597778|470678041|FG000|Overall Study|Transplanted off protocol|2|||
130742505|NCT01597778|470678042|FG001|Overall Study|Transplanted off protocol|3|||
130742506|NCT04837196|470678052|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
130742507|NCT04837196|470678053|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
130742508|NCT04837196|470678054|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
130742509|NCT04837196|470678055|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
130742510|NCT04837196|470678056|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
130742511|NCT04837196|470678052|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
130742512|NCT04837196|470678053|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
130742513|NCT04837196|470678054|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
130742514|NCT04837196|470678055|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
130742515|NCT04837196|470678056|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
130742516|NCT04837196|470678052|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130742517|NCT04837196|470678053|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
130742518|NCT04837196|470678054|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130742519|NCT04837196|470678055|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130742520|NCT04837196|470678056|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130742521|NCT04837196|470678052|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130742522|NCT04837196|470678053|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130742523|NCT04837196|470678054|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
130742524|NCT04837196|470678055|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130742525|NCT04837196|470678056|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130742526|NCT04837196|470678052|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130742527|NCT04837196|470678053|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130742528|NCT04837196|470678054|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
130742529|NCT04837196|470678055|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130788199|NCT00420745|470854512|FG000|Overall Study|Protocol Violation|1|||
130742530|NCT04837196|470678056|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130742531|NCT01522456|470678057|FG000|Overall Study|Adverse Event|2|||
130742532|NCT01522456|470678057|FG000|Overall Study|Lost to Follow-up|2|||
130742533|NCT01522456|470678057|FG000|Overall Study|Withdrawal by Subject|2|||
130742534|NCT01522456|470678057|FG000|Overall Study|Pregnancy|1|||
130742535|NCT01522456|470678057|FG000|Overall Study|Tolerability Assessment|1|||
130742536|NCT01565889|470678060|FG000|Part A|Withdrawal by Subject|1|||
130742537|NCT01565889|470678061|FG001|Part A|Withdrawal by Subject|0|||
130742538|NCT01565889|470678062|FG002|Part A|Withdrawal by Subject|0|||
130742539|NCT01565889|470678063|FG003|Part A|Withdrawal by Subject|0|||
130742540|NCT01565889|470678064|FG004|Part A|Withdrawal by Subject|0|||
130742541|NCT01565889|470678065|FG005|Part A|Withdrawal by Subject|0|||
130742542|NCT01565889|470678060|FG000|Part B|Withdrawal by Subject|0|||
130742543|NCT01565889|470678061|FG001|Part B|Withdrawal by Subject|0|||
130742544|NCT01565889|470678062|FG002|Part B|Withdrawal by Subject|0|||
130742545|NCT01565889|470678063|FG003|Part B|Withdrawal by Subject|0|||
130742546|NCT01565889|470678064|FG004|Part B|Withdrawal by Subject|0|||
130742547|NCT01565889|470678065|FG005|Part B|Withdrawal by Subject|1|||
130742548|NCT01565889|470678060|FG000|Part B|Lack of Efficacy|0|||
130742549|NCT01565889|470678061|FG001|Part B|Lack of Efficacy|0|||
130742550|NCT01565889|470678062|FG002|Part B|Lack of Efficacy|0|||
130742551|NCT01565889|470678063|FG003|Part B|Lack of Efficacy|0|||
130742552|NCT01565889|470678064|FG004|Part B|Lack of Efficacy|0|||
130742553|NCT01565889|470678065|FG005|Part B|Lack of Efficacy|2|||
130742554|NCT01565889|470678060|FG000|Part B|Lost to Follow-up|0|||
130742555|NCT01565889|470678061|FG001|Part B|Lost to Follow-up|0|||
130742556|NCT01565889|470678062|FG002|Part B|Lost to Follow-up|0|||
130742557|NCT01565889|470678063|FG003|Part B|Lost to Follow-up|0|||
130742558|NCT01565889|470678064|FG004|Part B|Lost to Follow-up|0|||
130742559|NCT01565889|470678065|FG005|Part B|Lost to Follow-up|1|||
130742560|NCT03918629|470678067|FG000|Overall Study|Adverse Event|19|||
130742561|NCT03918629|470678068|FG001|Overall Study|Adverse Event|20|||
130742562|NCT03918629|470678067|FG000|Overall Study|Death|14|||
130742563|NCT03918629|470678068|FG001|Overall Study|Death|7|||
130742564|NCT03918629|470678067|FG000|Overall Study|Lost to Follow-up|36|||
130742565|NCT03918629|470678068|FG001|Overall Study|Lost to Follow-up|28|||
130742566|NCT03918629|470678067|FG000|Overall Study|Physician Decision|1|||
130742567|NCT03918629|470678068|FG001|Overall Study|Physician Decision|0|||
130742568|NCT03918629|470678067|FG000|Overall Study|Protocol Violation|7|||
130742569|NCT03918629|470678068|FG001|Overall Study|Protocol Violation|4|||
130742570|NCT03918629|470678067|FG000|Overall Study|Withdrawal by Subject|47|||
130742571|NCT03918629|470678068|FG001|Overall Study|Withdrawal by Subject|47|||
130742572|NCT03918629|470678067|FG000|Overall Study|Other|7|||
130742573|NCT03918629|470678068|FG001|Overall Study|Other|11|||
130742574|NCT03918629|470678067|FG000|Overall Study|Randomized but not vaccinated|2|||
130742575|NCT03918629|470678068|FG001|Overall Study|Randomized but not vaccinated|1|||
130742576|NCT01709500|470678072|FG000|Overall Study|Randomized but not treated|0|||
130742577|NCT01709500|470678073|FG001|Overall Study|Randomized but not treated|1|||
130742578|NCT01709500|470678072|FG000|Overall Study|Adverse Event|5|||
130742579|NCT01709500|470678073|FG001|Overall Study|Adverse Event|1|||
130742580|NCT01709500|470678072|FG000|Overall Study|Poor compliance to protocol|2|||
130742581|NCT01709500|470678073|FG001|Overall Study|Poor compliance to protocol|1|||
130742582|NCT01709500|470678072|FG000|Overall Study|Other|3|||
130742583|NCT01709500|470678073|FG001|Overall Study|Other|1|||
130742584|NCT01709500|470678072|FG000|Overall Study|Related to IMP administration|1|||
130742585|NCT01709500|470678073|FG001|Overall Study|Related to IMP administration|0|||
130742586|NCT01709500|470678072|FG000|Overall Study|Treatment ongoing|156|||
130742587|NCT01709500|470678073|FG001|Overall Study|Treatment ongoing|78|||
130742588|NCT00740636|470678074|FG000|Overall Study|Adverse Event|0|||
130742589|NCT00740636|470678075|FG001|Overall Study|Adverse Event|2|||
130742590|NCT00740636|470678074|FG000|Overall Study|Patient Ineligible|0|||
130742591|NCT00740636|470678075|FG001|Overall Study|Patient Ineligible|1|||
130742592|NCT00740636|470678074|FG000|Overall Study|Patient Not Treated|0|||
130742593|NCT00740636|470678075|FG001|Overall Study|Patient Not Treated|1|||
130742594|NCT00740636|470678074|FG000|Overall Study|Progressive Disease|1|||
130742595|NCT00740636|470678075|FG001|Overall Study|Progressive Disease|0|||
130742596|NCT00740636|470678074|FG000|Overall Study|Death|1|||
130742597|NCT00740636|470678075|FG001|Overall Study|Death|0|||
130742598|NCT05479435|470678076|FG000|Overall Study|Withdrawal by Subject|1|||
130742599|NCT05479435|470678077|FG001|Overall Study|Withdrawal by Subject|0|||
130742600|NCT05479435|470678078|FG002|Overall Study|Withdrawal by Subject|0|||
130742601|NCT05479435|470678076|FG000|Overall Study|Covid 19|0|||
130742602|NCT05479435|470678077|FG001|Overall Study|Covid 19|0|||
130742603|NCT05479435|470678078|FG002|Overall Study|Covid 19|2|||
130742604|NCT02844543|470679695|FG000|Overall Study|Withdrawal by Subject|4|||
130742605|NCT02844543|470679695|FG000|Overall Study|Did not meet eligibility criteria|1|||
130742606|NCT04710576|470679701|FG000|Overall Study|Participants still in the study|73|||
130742607|NCT04710576|470679702|FG001|Overall Study|Participants still in the study|70|||
130742608|NCT04710576|470679703|FG002|Overall Study|Participants still in the study|60|||
130742609|NCT04710576|470679701|FG000|Overall Study|Death|2|||
130742610|NCT04710576|470679702|FG001|Overall Study|Death|7|||
130742611|NCT04710576|470679703|FG002|Overall Study|Death|12|||
130742612|NCT04710576|470679701|FG000|Overall Study|Withdrawal by Subject|4|||
130742613|NCT04710576|470679702|FG001|Overall Study|Withdrawal by Subject|3|||
130742614|NCT04710576|470679703|FG002|Overall Study|Withdrawal by Subject|7|||
130742615|NCT04710576|470679701|FG000|Overall Study|Sponsor decision|1|||
130742616|NCT04710576|470679702|FG001|Overall Study|Sponsor decision|0|||
130742617|NCT04710576|470679703|FG002|Overall Study|Sponsor decision|0|||
130742618|NCT04581824|470679704|FG000|Overall Study|Lost to Follow-up|1|||
130742619|NCT04581824|470679705|FG001|Overall Study|Lost to Follow-up|0|||
130742620|NCT04581824|470679704|FG000|Overall Study|Withdrawal by Subject|2|||
130742621|NCT04581824|470679705|FG001|Overall Study|Withdrawal by Subject|7|||
130742622|NCT04581824|470679704|FG000|Overall Study|Study terminated by sponsor|37|||
130742623|NCT04581824|470679705|FG001|Overall Study|Study terminated by sponsor|23|||
130742624|NCT04796909|470679706|FG000|Overall Study|Withdrawal by Subject|1|||
130742625|NCT04796909|470679707|FG001|Overall Study|Withdrawal by Subject|1|||
130742626|NCT03879135|470679708|FG000|Overall Study|Physician Decision|0|||
130742627|NCT03879135|470679709|FG001|Overall Study|Physician Decision|0|||
130742628|NCT03879135|470679710|FG002|Overall Study|Physician Decision|0|||
130742629|NCT03879135|470679711|FG003|Overall Study|Physician Decision|1|||
130742630|NCT03879135|470679712|FG004|Overall Study|Physician Decision|0|||
130742631|NCT03879135|470679713|FG005|Overall Study|Physician Decision|0|||
130742632|NCT03879135|470679708|FG000|Overall Study|Withdrawal by Subject|0|||
130742633|NCT03879135|470679709|FG001|Overall Study|Withdrawal by Subject|0|||
130742634|NCT03879135|470679710|FG002|Overall Study|Withdrawal by Subject|0|||
130742635|NCT03879135|470679711|FG003|Overall Study|Withdrawal by Subject|0|||
130742636|NCT03879135|470679712|FG004|Overall Study|Withdrawal by Subject|0|||
130742637|NCT03879135|470679713|FG005|Overall Study|Withdrawal by Subject|1|||
130742638|NCT03879135|470679708|FG000|Overall Study|Site Closed by Sponsor|0|||
130742639|NCT03879135|470679709|FG001|Overall Study|Site Closed by Sponsor|0|||
130742640|NCT03879135|470679710|FG002|Overall Study|Site Closed by Sponsor|0|||
130742641|NCT03879135|470679711|FG003|Overall Study|Site Closed by Sponsor|1|||
130742642|NCT03879135|470679712|FG004|Overall Study|Site Closed by Sponsor|1|||
130742643|NCT03879135|470679713|FG005|Overall Study|Site Closed by Sponsor|0|||
130742644|NCT04162847|470679714|FG000|Overall Study|Withdrawal by Subject|7|||
130742645|NCT04162847|470679715|FG001|Overall Study|Withdrawal by Subject|1|||
130742646|NCT00813150|470679716|FG000|Treatment Period|Adverse Event|16|||
130742647|NCT00813150|470679717|FG001|Treatment Period|Adverse Event|15|||
130742648|NCT00813150|470679716|FG000|Treatment Period|Death|2|||
130742649|NCT00813150|470679717|FG001|Treatment Period|Death|0|||
130742650|NCT00813150|470679716|FG000|Treatment Period|Progressive disease|1|||
130742651|NCT00813150|470679717|FG001|Treatment Period|Progressive disease|0|||
130742652|NCT00813150|470679716|FG000|Treatment Period|Complete response|0|||
130742653|NCT00813150|470679717|FG001|Treatment Period|Complete response|1|||
130742654|NCT00813150|470679716|FG000|Treatment Period|Stable disease|1|||
130742655|NCT00813150|470679717|FG001|Treatment Period|Stable disease|2|||
130742656|NCT00813150|470679716|FG000|Treatment Period|Protocol Violation|3|||
130742657|NCT00813150|470679717|FG001|Treatment Period|Protocol Violation|4|||
130742658|NCT00813150|470679716|FG000|Treatment Period|Withdrawal by Subject|5|||
130742659|NCT00813150|470679717|FG001|Treatment Period|Withdrawal by Subject|3|||
130742660|NCT00813150|470679716|FG000|Treatment Period|Non compliance|0|||
130742661|NCT00813150|470679717|FG001|Treatment Period|Non compliance|1|||
130742662|NCT00813150|470679716|FG000|Treatment Period|Reason not specified|3|||
130742663|NCT00813150|470679717|FG001|Treatment Period|Reason not specified|4|||
130742664|NCT00813150|470679716|FG000|Treatment Period|Data not available|1|||
130742665|NCT00813150|470679717|FG001|Treatment Period|Data not available|2|||
130742666|NCT00813150|470679716|FG000|Long Term Follow-up|Death|0|||
130742667|NCT00813150|470679717|FG001|Long Term Follow-up|Death|4|||
130742668|NCT00813150|470679716|FG000|Long Term Follow-up|Other|0|||
130742669|NCT00813150|470679717|FG001|Long Term Follow-up|Other|3|||
130742670|NCT00813150|470679716|FG000|Long Term Follow-up|Lost to Follow-up|2|||
130788200|NCT00420745|470854513|FG001|Overall Study|Protocol Violation|0|||
130788201|NCT00420745|470854512|FG000|Overall Study|Physician Decision|1|||
130788202|NCT00420745|470854513|FG001|Overall Study|Physician Decision|1|||
130742671|NCT00813150|470679717|FG001|Long Term Follow-up|Lost to Follow-up|0|||
130742672|NCT00813150|470679716|FG000|Long Term Follow-up|Progression/Relapse|22|||
130742673|NCT00813150|470679717|FG001|Long Term Follow-up|Progression/Relapse|24|||
130742674|NCT05423093|470679718|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
130742675|NCT05423093|470679718|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
130742676|NCT05423093|470679718|FG000|Attended Intervention Session|Lost to Follow-up|3|||
130742677|NCT05423093|470679718|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
130742678|NCT05423093|470679718|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
130742679|NCT02832687|470679719|FG000|Overall Study|Adverse Event|0|||
130742680|NCT02832687|470679720|FG001|Overall Study|Adverse Event|2|||
130742681|NCT00471822|470679721|FG000|Overall Study|Protocol Violation|2|||
130742682|NCT03664232|470679722|FG000|Overall Study|Withdrawal by Subject|0|||
130742683|NCT03664232|470679723|FG001|Overall Study|Withdrawal by Subject|1|||
130742684|NCT03664232|470679724|FG002|Overall Study|Withdrawal by Subject|0|||
130742685|NCT03664232|470679725|FG003|Overall Study|Withdrawal by Subject|1|||
130788203|NCT00420745|470854512|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
130788204|NCT00420745|470854513|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
130742686|NCT03664232|470679722|FG000|Overall Study|Adverse Event|0|||
130742687|NCT03664232|470679723|FG001|Overall Study|Adverse Event|0|||
130742688|NCT03664232|470679724|FG002|Overall Study|Adverse Event|1|||
130742689|NCT03664232|470679725|FG003|Overall Study|Adverse Event|0|||
130742690|NCT03664232|470679722|FG000|Overall Study|Other-Non-compliance with study drug|0|||
130742691|NCT03664232|470679723|FG001|Overall Study|Other-Non-compliance with study drug|1|||
130742692|NCT03664232|470679724|FG002|Overall Study|Other-Non-compliance with study drug|0|||
130742693|NCT03664232|470679725|FG003|Overall Study|Other-Non-compliance with study drug|2|||
130742694|NCT03664232|470679722|FG000|Overall Study|Other-Unspecified|0|||
130742695|NCT03664232|470679723|FG001|Overall Study|Other-Unspecified|3|||
130742696|NCT03664232|470679724|FG002|Overall Study|Other-Unspecified|0|||
130742697|NCT03664232|470679725|FG003|Overall Study|Other-Unspecified|1|||
130742698|NCT03664232|470679722|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
130742699|NCT03664232|470679723|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
130742700|NCT03664232|470679724|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
130742701|NCT03664232|470679725|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
130742702|NCT03334435|470679726|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
130742703|NCT03334435|470679727|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
130742704|NCT03334435|470679728|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
130742705|NCT03334435|470679729|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
130742706|NCT03334435|470679730|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
130742707|NCT03334435|470679731|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130742708|NCT03334435|470679732|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130742709|NCT03334435|470679733|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130742710|NCT03334435|470679734|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130742711|NCT03334435|470679735|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130742712|NCT03334435|470679736|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130742713|NCT03334435|470679737|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130742714|NCT03334435|470679738|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130742715|NCT03334435|470679739|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130742716|NCT03334435|470679740|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130742717|NCT03334435|470679726|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
130742718|NCT03334435|470679727|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
130742719|NCT03334435|470679728|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
130742720|NCT03334435|470679729|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
130742721|NCT03334435|470679730|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
130742722|NCT03334435|470679731|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130742723|NCT03334435|470679732|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130742724|NCT03334435|470679733|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130742725|NCT03334435|470679734|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130742726|NCT03334435|470679735|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130742727|NCT03334435|470679736|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130742728|NCT03334435|470679737|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130742729|NCT03334435|470679738|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130742730|NCT03334435|470679739|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130742731|NCT03334435|470679740|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130742732|NCT03334435|470679726|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
130742733|NCT03334435|470679727|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
130742734|NCT03334435|470679728|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
130742735|NCT03334435|470679729|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
130742736|NCT03334435|470679730|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
130742737|NCT03334435|470679731|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130742738|NCT03334435|470679732|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130788205|NCT00420745|470854512|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
130788206|NCT00420745|470854513|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
130788207|NCT01125930|470854514|FG000|Overall Study|Adverse Event|0|||
130742739|NCT03334435|470679733|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130742740|NCT03334435|470679734|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130742741|NCT03334435|470679735|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130742742|NCT03334435|470679736|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130742743|NCT03334435|470679737|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130742744|NCT03334435|470679738|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130742745|NCT03334435|470679739|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130742746|NCT03334435|470679740|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130742747|NCT03334435|470679726|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
130742748|NCT03334435|470679727|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
130742749|NCT03334435|470679728|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
130742750|NCT03334435|470679729|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
130742751|NCT03334435|470679730|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
130742752|NCT03334435|470679731|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130742753|NCT03334435|470679732|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130742754|NCT03334435|470679733|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130742755|NCT03334435|470679734|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130742756|NCT03334435|470679735|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130742757|NCT03334435|470679736|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130742758|NCT03334435|470679737|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130742759|NCT03334435|470679738|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130742760|NCT03334435|470679739|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130742761|NCT03334435|470679740|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130742762|NCT03334435|470679726|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
130742763|NCT03334435|470679727|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742764|NCT03334435|470679728|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
130742765|NCT03334435|470679729|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
130742766|NCT03334435|470679730|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
130742767|NCT03334435|470679731|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742768|NCT03334435|470679732|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742769|NCT03334435|470679733|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742770|NCT03334435|470679734|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742771|NCT03334435|470679735|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742772|NCT03334435|470679736|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742773|NCT03334435|470679737|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742774|NCT03334435|470679738|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742775|NCT03334435|470679739|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742776|NCT03334435|470679740|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130742777|NCT03334435|470679726|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742778|NCT03334435|470679727|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742779|NCT03334435|470679728|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742780|NCT03334435|470679729|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
130742781|NCT03334435|470679730|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742782|NCT03334435|470679731|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742783|NCT03334435|470679732|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742784|NCT03334435|470679733|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742785|NCT03334435|470679734|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742786|NCT03334435|470679735|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742787|NCT03334435|470679736|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742788|NCT03334435|470679737|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742789|NCT03334435|470679738|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742790|NCT03334435|470679739|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742791|NCT03334435|470679740|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
130742792|NCT03334435|470679726|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
130742793|NCT03334435|470679727|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
130742794|NCT03334435|470679728|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
130742795|NCT03334435|470679729|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
130742796|NCT03334435|470679730|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
130742797|NCT03334435|470679731|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
130742798|NCT03334435|470679732|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
130742799|NCT03334435|470679733|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
130742800|NCT03334435|470679734|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
130742801|NCT03334435|470679735|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
130742802|NCT03334435|470679736|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
130742803|NCT03334435|470679737|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
130788208|NCT01125930|470854515|FG001|Overall Study|Adverse Event|1|||
130742804|NCT03334435|470679738|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
130742805|NCT03334435|470679739|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
130742806|NCT03334435|470679740|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
130742807|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130742808|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130742809|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130742810|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130742811|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130742812|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
130742813|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
130742814|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
130742815|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
130742816|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
130742817|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
130742818|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
130742819|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
130742820|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
130742821|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
130742822|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130742823|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130742824|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130742825|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130742826|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130742827|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
130742828|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
130742829|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
130742830|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
130742831|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
130742832|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
130742833|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
130742834|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
130742835|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
130742836|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
130742837|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130742838|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130742839|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130742840|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130742841|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130742842|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
130742843|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
130742844|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
130742845|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
130742846|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
130742847|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
130742848|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
130742849|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130742850|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
130742851|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
130742852|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130742853|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130742854|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130742855|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130742856|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130742857|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
130742858|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
130742859|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
130742860|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
130742861|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
130742862|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
130742863|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
130742864|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
130742865|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
130742866|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
130742867|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130742868|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130742869|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130742870|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130742871|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130742872|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130742873|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
130742874|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
130742875|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
130742876|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
130742877|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
130742878|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
130742879|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130742880|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
130742881|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
130742882|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742883|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742884|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742885|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742886|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742887|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742888|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742889|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742890|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742891|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742892|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742893|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
130742894|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742895|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
130742896|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130742897|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742898|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742899|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742900|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742901|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742902|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
130742903|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742904|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742905|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742906|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742907|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742908|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742909|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742910|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
130742911|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
130742912|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130742913|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130742914|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130742915|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130742916|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130742917|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130742918|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130742919|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130742920|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130742921|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
130742922|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130742923|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130742924|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130788209|NCT01125930|470854514|FG000|Overall Study|Withdrawal by Subject|1|||
130788210|NCT01125930|470854515|FG001|Overall Study|Withdrawal by Subject|6|||
130788211|NCT01125930|470854514|FG000|Overall Study|Protocol Violation|0|||
130742925|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130742926|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130742927|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130742928|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130742929|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130742930|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130742931|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130742932|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130742933|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130742934|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130742935|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130742936|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130742937|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130742938|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130742939|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130742940|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
130742941|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
130742942|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742943|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742944|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742945|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742946|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742947|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
130742948|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742949|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742950|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742951|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742952|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
130742953|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742954|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742955|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130742956|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
130742957|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130742958|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130742959|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130742960|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130742961|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130742962|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130742963|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130742964|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130742965|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130742966|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130788212|NCT01125930|470854515|FG001|Overall Study|Protocol Violation|1|||
130742967|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130742968|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
130742969|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130742970|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130742971|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130742972|NCT03334435|470679726|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742973|NCT03334435|470679727|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742974|NCT03334435|470679728|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742975|NCT03334435|470679729|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742976|NCT03334435|470679730|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742977|NCT03334435|470679731|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742978|NCT03334435|470679732|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742979|NCT03334435|470679733|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742980|NCT03334435|470679734|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742981|NCT03334435|470679735|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742982|NCT03334435|470679736|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742983|NCT03334435|470679737|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
130742984|NCT03334435|470679738|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130742985|NCT03334435|470679739|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
130742986|NCT03334435|470679740|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
130742987|NCT02342678|470679745|FG000|Overall Study|Lost to Follow-up|0|||
130742988|NCT02342678|470679746|FG001|Overall Study|Lost to Follow-up|1|||
130742989|NCT02342678|470679745|FG000|Overall Study|Too busy to complete study|0|||
130742990|NCT02342678|470679746|FG001|Overall Study|Too busy to complete study|2|||
130742991|NCT02342678|470679745|FG000|Overall Study|Family illness/emergency|0|||
130742992|NCT02342678|470679746|FG001|Overall Study|Family illness/emergency|1|||
130742993|NCT02342678|470679745|FG000|Overall Study|Illness/medical reason|1|||
130742994|NCT02342678|470679746|FG001|Overall Study|Illness/medical reason|1|||
130742995|NCT02383017|470679747|FG000|Overall Study|Injury Sustained Outside Study|1|||
130742996|NCT02383017|470679748|FG001|Overall Study|Injury Sustained Outside Study|0|||
130742997|NCT02383017|470679747|FG000|Overall Study|Compliance|3|||
130742998|NCT02383017|470679748|FG001|Overall Study|Compliance|2|||
130742999|NCT02383017|470679747|FG000|Overall Study|Found to be Hypogonadal|1|||
130743000|NCT02383017|470679748|FG001|Overall Study|Found to be Hypogonadal|0|||
130743001|NCT00460603|470679749|FG000|Phase 1|Death|1|||
130743002|NCT00460603|470679750|FG001|Phase 1|Death|0|||
130743003|NCT00460603|470679751|FG002|Phase 1|Death|0|||
130743004|NCT00460603|470679752|FG003|Phase 1|Death|2|||
130743005|NCT00460603|470679753|FG004|Phase 1|Death|0|||
130743006|NCT00460603|470679754|FG005|Phase 1|Death|0|||
130743007|NCT00460603|470679755|FG006|Phase 1|Death|0|||
130743008|NCT00460603|470679756|FG007|Phase 1|Death|0|||
130743009|NCT00460603|470679757|FG008|Phase 1|Death|1|||
130743010|NCT00460603|470679758|FG009|Phase 1|Death|0|||
130743011|NCT00460603|470679759|FG010|Phase 1|Death|0|||
130743012|NCT00460603|470679760|FG011|Phase 1|Death|0|||
130743013|NCT00460603|470679749|FG000|Phase 1|Adverse Event|3|||
130743014|NCT00460603|470679750|FG001|Phase 1|Adverse Event|1|||
130743015|NCT00460603|470679751|FG002|Phase 1|Adverse Event|1|||
130743016|NCT00460603|470679752|FG003|Phase 1|Adverse Event|2|||
130743017|NCT00460603|470679753|FG004|Phase 1|Adverse Event|0|||
130743018|NCT00460603|470679754|FG005|Phase 1|Adverse Event|0|||
130743019|NCT00460603|470679755|FG006|Phase 1|Adverse Event|3|||
130743020|NCT00460603|470679756|FG007|Phase 1|Adverse Event|0|||
130743021|NCT00460603|470679757|FG008|Phase 1|Adverse Event|4|||
130743022|NCT00460603|470679758|FG009|Phase 1|Adverse Event|0|||
130743023|NCT00460603|470679759|FG010|Phase 1|Adverse Event|0|||
130743024|NCT00460603|470679760|FG011|Phase 1|Adverse Event|0|||
130743025|NCT00460603|470679749|FG000|Phase 1|Lack of Efficacy|1|||
130743026|NCT00460603|470679750|FG001|Phase 1|Lack of Efficacy|0|||
130743027|NCT00460603|470679751|FG002|Phase 1|Lack of Efficacy|1|||
130743028|NCT00460603|470679752|FG003|Phase 1|Lack of Efficacy|2|||
130743029|NCT00460603|470679753|FG004|Phase 1|Lack of Efficacy|2|||
130743030|NCT00460603|470679754|FG005|Phase 1|Lack of Efficacy|2|||
130743031|NCT00460603|470679755|FG006|Phase 1|Lack of Efficacy|2|||
130743032|NCT00460603|470679756|FG007|Phase 1|Lack of Efficacy|2|||
130743033|NCT00460603|470679757|FG008|Phase 1|Lack of Efficacy|11|||
130743034|NCT00460603|470679758|FG009|Phase 1|Lack of Efficacy|0|||
130743035|NCT00460603|470679759|FG010|Phase 1|Lack of Efficacy|0|||
130743036|NCT00460603|470679760|FG011|Phase 1|Lack of Efficacy|0|||
130743037|NCT00460603|470679749|FG000|Phase 1|Withdrawal by Subject|1|||
130743038|NCT00460603|470679750|FG001|Phase 1|Withdrawal by Subject|2|||
130743039|NCT00460603|470679751|FG002|Phase 1|Withdrawal by Subject|1|||
130743040|NCT00460603|470679752|FG003|Phase 1|Withdrawal by Subject|1|||
130743041|NCT00460603|470679753|FG004|Phase 1|Withdrawal by Subject|3|||
130743042|NCT00460603|470679754|FG005|Phase 1|Withdrawal by Subject|0|||
130743043|NCT00460603|470679755|FG006|Phase 1|Withdrawal by Subject|1|||
130743044|NCT00460603|470679756|FG007|Phase 1|Withdrawal by Subject|0|||
130743045|NCT00460603|470679757|FG008|Phase 1|Withdrawal by Subject|2|||
130743046|NCT00460603|470679758|FG009|Phase 1|Withdrawal by Subject|0|||
130743047|NCT00460603|470679759|FG010|Phase 1|Withdrawal by Subject|0|||
130743048|NCT00460603|470679760|FG011|Phase 1|Withdrawal by Subject|0|||
130743049|NCT00460603|470679749|FG000|Phase 1|Other|0|||
130743050|NCT00460603|470679750|FG001|Phase 1|Other|3|||
130743051|NCT00460603|470679751|FG002|Phase 1|Other|1|||
130743052|NCT00460603|470679752|FG003|Phase 1|Other|1|||
130743053|NCT00460603|470679753|FG004|Phase 1|Other|1|||
130743054|NCT00460603|470679754|FG005|Phase 1|Other|2|||
130743055|NCT00460603|470679755|FG006|Phase 1|Other|0|||
130743056|NCT00460603|470679756|FG007|Phase 1|Other|1|||
130743057|NCT00460603|470679757|FG008|Phase 1|Other|0|||
130743058|NCT00460603|470679758|FG009|Phase 1|Other|0|||
130743059|NCT00460603|470679759|FG010|Phase 1|Other|0|||
130743060|NCT00460603|470679760|FG011|Phase 1|Other|0|||
130743061|NCT00460603|470679749|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743062|NCT00460603|470679750|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743063|NCT00460603|470679751|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743064|NCT00460603|470679752|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743065|NCT00460603|470679753|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743066|NCT00460603|470679754|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743067|NCT00460603|470679755|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743068|NCT00460603|470679756|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743069|NCT00460603|470679757|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743070|NCT00460603|470679758|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
130743071|NCT00460603|470679759|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743072|NCT00460603|470679760|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130743073|NCT00460603|470679749|FG000|Phase 2|Adverse Event|0|||
130743074|NCT00460603|470679750|FG001|Phase 2|Adverse Event|0|||
130743075|NCT00460603|470679751|FG002|Phase 2|Adverse Event|0|||
130743076|NCT00460603|470679752|FG003|Phase 2|Adverse Event|0|||
130743077|NCT00460603|470679753|FG004|Phase 2|Adverse Event|0|||
130743078|NCT00460603|470679754|FG005|Phase 2|Adverse Event|0|||
130743079|NCT00460603|470679755|FG006|Phase 2|Adverse Event|0|||
130743080|NCT00460603|470679756|FG007|Phase 2|Adverse Event|0|||
130788213|NCT01125930|470854514|FG000|Overall Study|Lost to Follow-up|0|||
130743081|NCT00460603|470679757|FG008|Phase 2|Adverse Event|0|||
130743082|NCT00460603|470679758|FG009|Phase 2|Adverse Event|12|||
130743083|NCT00460603|470679759|FG010|Phase 2|Adverse Event|9|||
130743084|NCT00460603|470679760|FG011|Phase 2|Adverse Event|10|||
130743085|NCT00460603|470679749|FG000|Phase 2|Death|0|||
130743086|NCT00460603|470679750|FG001|Phase 2|Death|0|||
130743087|NCT00460603|470679751|FG002|Phase 2|Death|0|||
130743088|NCT00460603|470679752|FG003|Phase 2|Death|0|||
130743089|NCT00460603|470679753|FG004|Phase 2|Death|0|||
130743090|NCT00460603|470679754|FG005|Phase 2|Death|0|||
130743091|NCT00460603|470679755|FG006|Phase 2|Death|0|||
130743092|NCT00460603|470679756|FG007|Phase 2|Death|0|||
130743093|NCT00460603|470679757|FG008|Phase 2|Death|0|||
130743094|NCT00460603|470679758|FG009|Phase 2|Death|4|||
130743095|NCT00460603|470679759|FG010|Phase 2|Death|2|||
130743096|NCT00460603|470679760|FG011|Phase 2|Death|2|||
130743097|NCT00460603|470679749|FG000|Phase 2|Protocol Violation|0|||
130743098|NCT00460603|470679750|FG001|Phase 2|Protocol Violation|0|||
130743099|NCT00460603|470679751|FG002|Phase 2|Protocol Violation|0|||
130743100|NCT00460603|470679752|FG003|Phase 2|Protocol Violation|0|||
130743101|NCT00460603|470679753|FG004|Phase 2|Protocol Violation|0|||
130743102|NCT00460603|470679754|FG005|Phase 2|Protocol Violation|0|||
130743103|NCT00460603|470679755|FG006|Phase 2|Protocol Violation|0|||
130743104|NCT00460603|470679756|FG007|Phase 2|Protocol Violation|0|||
130743105|NCT00460603|470679757|FG008|Phase 2|Protocol Violation|0|||
130743106|NCT00460603|470679758|FG009|Phase 2|Protocol Violation|1|||
130743107|NCT00460603|470679759|FG010|Phase 2|Protocol Violation|1|||
130743108|NCT00460603|470679760|FG011|Phase 2|Protocol Violation|0|||
130743109|NCT00460603|470679749|FG000|Phase 2|Lost to Follow-up|0|||
130743110|NCT00460603|470679750|FG001|Phase 2|Lost to Follow-up|0|||
130743111|NCT00460603|470679751|FG002|Phase 2|Lost to Follow-up|0|||
130743112|NCT00460603|470679752|FG003|Phase 2|Lost to Follow-up|0|||
130743113|NCT00460603|470679753|FG004|Phase 2|Lost to Follow-up|0|||
130743114|NCT00460603|470679754|FG005|Phase 2|Lost to Follow-up|0|||
130743115|NCT00460603|470679755|FG006|Phase 2|Lost to Follow-up|0|||
130743116|NCT00460603|470679756|FG007|Phase 2|Lost to Follow-up|0|||
130743117|NCT00460603|470679757|FG008|Phase 2|Lost to Follow-up|0|||
130743118|NCT00460603|470679758|FG009|Phase 2|Lost to Follow-up|1|||
130743119|NCT00460603|470679759|FG010|Phase 2|Lost to Follow-up|0|||
130743120|NCT00460603|470679760|FG011|Phase 2|Lost to Follow-up|0|||
130743121|NCT00460603|470679749|FG000|Phase 2|Other|0|||
130743122|NCT00460603|470679750|FG001|Phase 2|Other|0|||
130743123|NCT00460603|470679751|FG002|Phase 2|Other|0|||
130743124|NCT00460603|470679752|FG003|Phase 2|Other|0|||
130743125|NCT00460603|470679753|FG004|Phase 2|Other|0|||
130743126|NCT00460603|470679754|FG005|Phase 2|Other|0|||
130743127|NCT00460603|470679755|FG006|Phase 2|Other|0|||
130743128|NCT00460603|470679756|FG007|Phase 2|Other|0|||
130743129|NCT00460603|470679757|FG008|Phase 2|Other|0|||
130743130|NCT00460603|470679758|FG009|Phase 2|Other|6|||
130743131|NCT00460603|470679759|FG010|Phase 2|Other|16|||
130743132|NCT00460603|470679760|FG011|Phase 2|Other|7|||
130743133|NCT00460603|470679749|FG000|Phase 2|Objective Progression or Relapse|0|||
130743134|NCT00460603|470679750|FG001|Phase 2|Objective Progression or Relapse|0|||
130743135|NCT00460603|470679751|FG002|Phase 2|Objective Progression or Relapse|0|||
130743136|NCT00460603|470679752|FG003|Phase 2|Objective Progression or Relapse|0|||
130743137|NCT00460603|470679753|FG004|Phase 2|Objective Progression or Relapse|0|||
130743138|NCT00460603|470679754|FG005|Phase 2|Objective Progression or Relapse|0|||
130743139|NCT00460603|470679755|FG006|Phase 2|Objective Progression or Relapse|0|||
130743140|NCT00460603|470679756|FG007|Phase 2|Objective Progression or Relapse|0|||
130743141|NCT00460603|470679757|FG008|Phase 2|Objective Progression or Relapse|0|||
130743142|NCT00460603|470679758|FG009|Phase 2|Objective Progression or Relapse|9|||
130743143|NCT00460603|470679759|FG010|Phase 2|Objective Progression or Relapse|10|||
130743144|NCT00460603|470679760|FG011|Phase 2|Objective Progression or Relapse|17|||
130743145|NCT00460603|470679749|FG000|Phase 2|Global Deterioration of Health Status|0|||
130743146|NCT00460603|470679750|FG001|Phase 2|Global Deterioration of Health Status|0|||
130743147|NCT00460603|470679751|FG002|Phase 2|Global Deterioration of Health Status|0|||
130743148|NCT00460603|470679752|FG003|Phase 2|Global Deterioration of Health Status|0|||
130743149|NCT00460603|470679753|FG004|Phase 2|Global Deterioration of Health Status|0|||
130743150|NCT00460603|470679754|FG005|Phase 2|Global Deterioration of Health Status|0|||
130743151|NCT00460603|470679755|FG006|Phase 2|Global Deterioration of Health Status|0|||
130743152|NCT00460603|470679756|FG007|Phase 2|Global Deterioration of Health Status|0|||
130743153|NCT00460603|470679757|FG008|Phase 2|Global Deterioration of Health Status|0|||
130743154|NCT00460603|470679758|FG009|Phase 2|Global Deterioration of Health Status|0|||
130743155|NCT00460603|470679759|FG010|Phase 2|Global Deterioration of Health Status|1|||
130743156|NCT00460603|470679760|FG011|Phase 2|Global Deterioration of Health Status|0|||
130743157|NCT00460603|470679749|FG000|Phase 2|Withdrawal by Subject|0|||
130743158|NCT00460603|470679750|FG001|Phase 2|Withdrawal by Subject|0|||
130743159|NCT00460603|470679751|FG002|Phase 2|Withdrawal by Subject|0|||
130743160|NCT00460603|470679752|FG003|Phase 2|Withdrawal by Subject|0|||
130743161|NCT00460603|470679753|FG004|Phase 2|Withdrawal by Subject|0|||
130743162|NCT00460603|470679754|FG005|Phase 2|Withdrawal by Subject|0|||
130788214|NCT01125930|470854515|FG001|Overall Study|Lost to Follow-up|2|||
130788215|NCT03098979|470854516|FG000|Overall Study|Adverse Event|1|||
130788216|NCT03098979|470854517|FG001|Overall Study|Adverse Event|0|||
130788217|NCT03098979|470854518|FG002|Overall Study|Adverse Event|1|||
130788218|NCT03098979|470854519|FG003|Overall Study|Adverse Event|4|||
130788219|NCT03098979|470854520|FG004|Overall Study|Adverse Event|6|||
130788220|NCT03098979|470854521|FG005|Overall Study|Adverse Event|1|||
130788221|NCT03098979|470854516|FG000|Overall Study|Withdrawal by Subject|2|||
130788222|NCT03098979|470854517|FG001|Overall Study|Withdrawal by Subject|1|||
130743163|NCT00460603|470679755|FG006|Phase 2|Withdrawal by Subject|0|||
130743164|NCT00460603|470679756|FG007|Phase 2|Withdrawal by Subject|0|||
130743165|NCT00460603|470679757|FG008|Phase 2|Withdrawal by Subject|0|||
130743166|NCT00460603|470679758|FG009|Phase 2|Withdrawal by Subject|5|||
130743167|NCT00460603|470679759|FG010|Phase 2|Withdrawal by Subject|4|||
130743168|NCT00460603|470679760|FG011|Phase 2|Withdrawal by Subject|5|||
130743169|NCT00460603|470679749|FG000|Phase 2|Randomized, but not treated|0|||
130743170|NCT00460603|470679750|FG001|Phase 2|Randomized, but not treated|0|||
130743171|NCT00460603|470679751|FG002|Phase 2|Randomized, but not treated|0|||
130743172|NCT00460603|470679752|FG003|Phase 2|Randomized, but not treated|0|||
130743173|NCT00460603|470679753|FG004|Phase 2|Randomized, but not treated|0|||
130743174|NCT00460603|470679754|FG005|Phase 2|Randomized, but not treated|0|||
130743175|NCT00460603|470679755|FG006|Phase 2|Randomized, but not treated|0|||
130743176|NCT00460603|470679756|FG007|Phase 2|Randomized, but not treated|0|||
130743177|NCT00460603|470679757|FG008|Phase 2|Randomized, but not treated|0|||
130743178|NCT00460603|470679758|FG009|Phase 2|Randomized, but not treated|3|||
130743179|NCT00460603|470679759|FG010|Phase 2|Randomized, but not treated|0|||
130743180|NCT00460603|470679760|FG011|Phase 2|Randomized, but not treated|0|||
130743181|NCT00289848|470679761|FG000|Overall Study|Adverse Event|6|||
130743182|NCT00289848|470679762|FG001|Overall Study|Adverse Event|4|||
130743183|NCT00289848|470679761|FG000|Overall Study|Death|1|||
130743184|NCT00289848|470679762|FG001|Overall Study|Death|0|||
130743185|NCT00289848|470679761|FG000|Overall Study|Lack of Efficacy|20|||
130743186|NCT00289848|470679762|FG001|Overall Study|Lack of Efficacy|24|||
130743187|NCT00289848|470679761|FG000|Overall Study|Lost to Follow-up|3|||
130743188|NCT00289848|470679762|FG001|Overall Study|Lost to Follow-up|1|||
130743189|NCT00289848|470679761|FG000|Overall Study|Protocol Violation|5|||
130743190|NCT00289848|470679762|FG001|Overall Study|Protocol Violation|2|||
130743191|NCT00289848|470679761|FG000|Overall Study|Withdrawal by Subject|5|||
130743192|NCT00289848|470679762|FG001|Overall Study|Withdrawal by Subject|11|||
130743193|NCT00289848|470679761|FG000|Overall Study|Patient Moved|6|||
130743194|NCT00289848|470679762|FG001|Overall Study|Patient Moved|2|||
130743195|NCT00289848|470679761|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
130743196|NCT00289848|470679762|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
130743197|NCT03871543|470679765|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
130743198|NCT03871543|470679765|FG000|Period 1|Investigator Error|1|||
130743199|NCT03871543|470679765|FG000|Period 1|Protocol Violation|2|||
130743200|NCT03871543|470679765|FG000|Period 1|COVID-19 Related|1|||
130743201|NCT03871543|470679765|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
130743202|NCT03871543|470679765|FG000|Period 1|Withdrawal by Subject|10|||
130743203|NCT03871543|470679765|FG000|Period 2|Adverse Event|1|||
130743204|NCT03871543|470679765|FG000|Period 2|Withdrawal by Subject|1|||
130743205|NCT00395629|470679770|FG000|Core Study|Adverse Event|0|||
130743206|NCT00395629|470679771|FG001|Core Study|Adverse Event|3|||
130743207|NCT00395629|470679772|FG002|Core Study|Adverse Event|4|||
130743208|NCT00395629|470679770|FG000|Core Study|Abnormal laboratory value(s)|0|||
130743209|NCT00395629|470679771|FG001|Core Study|Abnormal laboratory value(s)|0|||
130743210|NCT00395629|470679772|FG002|Core Study|Abnormal laboratory value(s)|1|||
130743211|NCT00395629|470679770|FG000|Core Study|Protocol Violation|1|||
130743212|NCT00395629|470679771|FG001|Core Study|Protocol Violation|0|||
130743213|NCT00395629|470679772|FG002|Core Study|Protocol Violation|0|||
130743214|NCT00395629|470679770|FG000|Core Study|Withdrawal by Subject|0|||
130743215|NCT00395629|470679771|FG001|Core Study|Withdrawal by Subject|1|||
130743216|NCT00395629|470679772|FG002|Core Study|Withdrawal by Subject|1|||
130743217|NCT00395629|470679770|FG000|Core Study|Lost to Follow-up|0|||
130743218|NCT00395629|470679771|FG001|Core Study|Lost to Follow-up|0|||
130743219|NCT00395629|470679772|FG002|Core Study|Lost to Follow-up|1|||
130743220|NCT00395629|470679770|FG000|Extension Study|Adverse Event|0|||
130743221|NCT00395629|470679771|FG001|Extension Study|Adverse Event|0|||
130743222|NCT00395629|470679772|FG002|Extension Study|Adverse Event|2|||
130743223|NCT00395629|470679770|FG000|Extension Study|Administrative problems|0|||
130743224|NCT00395629|470679771|FG001|Extension Study|Administrative problems|0|||
130743225|NCT00395629|470679772|FG002|Extension Study|Administrative problems|1|||
130743226|NCT03534687|470679773|FG000|Overall Study|Lost to Follow-up|7|||
130743227|NCT03534687|470679774|FG001|Overall Study|Lost to Follow-up|2|||
130743228|NCT02570308|470679775|FG000|Overall Study|Death|1|||
130743229|NCT02570308|470679776|FG001|Overall Study|Death|5|||
130743230|NCT02570308|470679777|FG002|Overall Study|Death|4|||
130743231|NCT02570308|470679778|FG003|Overall Study|Death|4|||
130743232|NCT02570308|470679779|FG004|Overall Study|Death|69|||
130743233|NCT02570308|470679775|FG000|Overall Study|Lost to Follow-up|0|||
130788223|NCT03098979|470854518|FG002|Overall Study|Withdrawal by Subject|1|||
130743234|NCT02570308|470679776|FG001|Overall Study|Lost to Follow-up|0|||
130743235|NCT02570308|470679777|FG002|Overall Study|Lost to Follow-up|0|||
130743236|NCT02570308|470679778|FG003|Overall Study|Lost to Follow-up|0|||
130743237|NCT02570308|470679779|FG004|Overall Study|Lost to Follow-up|2|||
130743238|NCT02570308|470679775|FG000|Overall Study|Withdrawal by Subject|0|||
130743239|NCT02570308|470679776|FG001|Overall Study|Withdrawal by Subject|0|||
130743240|NCT02570308|470679777|FG002|Overall Study|Withdrawal by Subject|0|||
130743241|NCT02570308|470679778|FG003|Overall Study|Withdrawal by Subject|0|||
130743242|NCT02570308|470679779|FG004|Overall Study|Withdrawal by Subject|1|||
130743243|NCT02570308|470679775|FG000|Overall Study|Other|0|||
130743244|NCT02570308|470679776|FG001|Overall Study|Other|0|||
130743245|NCT02570308|470679777|FG002|Overall Study|Other|0|||
130743246|NCT02570308|470679778|FG003|Overall Study|Other|0|||
130743247|NCT02570308|470679779|FG004|Overall Study|Other|2|||
130743248|NCT04242498|470679780|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
130743249|NCT04242498|470679781|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
130743250|NCT04242498|470679782|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
130743251|NCT04242498|470679783|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130743252|NCT04242498|470679784|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130743253|NCT04242498|470679785|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130743254|NCT04242498|470679786|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130743255|NCT04242498|470679780|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130743256|NCT04242498|470679781|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130743257|NCT04242498|470679782|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
130743258|NCT04242498|470679783|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130743259|NCT04242498|470679784|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130743260|NCT04242498|470679785|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130743261|NCT04242498|470679786|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130743262|NCT04242498|470679780|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
130743263|NCT04242498|470679781|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130743264|NCT04242498|470679782|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
130743265|NCT04242498|470679783|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130743266|NCT04242498|470679784|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130743267|NCT04242498|470679785|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130743268|NCT04242498|470679786|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130743269|NCT04242498|470679780|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
130743270|NCT04242498|470679781|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130743271|NCT04242498|470679782|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
130743272|NCT04242498|470679783|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130743273|NCT04242498|470679784|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130743274|NCT04242498|470679785|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130743275|NCT04242498|470679786|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130743276|NCT04242498|470679780|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
130743277|NCT04242498|470679781|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
130743278|NCT04242498|470679782|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
130743279|NCT04242498|470679783|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130743280|NCT04242498|470679784|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130743281|NCT04242498|470679785|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130743282|NCT04242498|470679786|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130743283|NCT04242498|470679780|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130743284|NCT04242498|470679781|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130743285|NCT04242498|470679782|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
130743286|NCT04242498|470679783|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130743287|NCT04242498|470679784|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130743288|NCT04242498|470679785|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130743289|NCT04242498|470679786|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130743290|NCT04242498|470679780|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130743291|NCT04242498|470679781|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130743292|NCT04242498|470679782|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
130743293|NCT04242498|470679783|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130743294|NCT04242498|470679784|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130743295|NCT04242498|470679785|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130743296|NCT04242498|470679786|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130743297|NCT04242498|470679780|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130743298|NCT04242498|470679781|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
130743299|NCT04242498|470679782|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
130743300|NCT04242498|470679783|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130743301|NCT04242498|470679784|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130743302|NCT04242498|470679785|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130743303|NCT04242498|470679786|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130743304|NCT04242498|470679780|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130743305|NCT04242498|470679781|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130743306|NCT04242498|470679782|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130743307|NCT04242498|470679783|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130743308|NCT04242498|470679784|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
130743309|NCT04242498|470679785|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
130743310|NCT04242498|470679786|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
130743311|NCT04242498|470679780|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130743312|NCT04242498|470679781|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130743313|NCT04242498|470679782|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130743314|NCT04242498|470679783|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130743315|NCT04242498|470679784|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
130743316|NCT04242498|470679785|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
130743317|NCT04242498|470679786|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
130743318|NCT04242498|470679780|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130743319|NCT04242498|470679781|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130743320|NCT04242498|470679782|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130743321|NCT04242498|470679783|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130743322|NCT04242498|470679784|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130743323|NCT04242498|470679785|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
130743324|NCT04242498|470679786|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
130743325|NCT04242498|470679780|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130743326|NCT04242498|470679781|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130743327|NCT04242498|470679782|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130743328|NCT04242498|470679783|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
130743329|NCT04242498|470679784|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
130743330|NCT04242498|470679785|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
130743331|NCT04242498|470679786|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
130743332|NCT04242498|470679780|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130743333|NCT04242498|470679781|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130743334|NCT04242498|470679782|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130743335|NCT04242498|470679783|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
130743336|NCT04242498|470679784|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
130743337|NCT04242498|470679785|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
130743338|NCT04242498|470679786|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
130743339|NCT04242498|470679780|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130743340|NCT04242498|470679781|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130743341|NCT04242498|470679782|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130743342|NCT04242498|470679783|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130743343|NCT04242498|470679784|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
130743344|NCT04242498|470679785|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130743345|NCT04242498|470679786|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130743346|NCT04242498|470679780|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130743347|NCT04242498|470679781|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130743348|NCT04242498|470679782|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130743349|NCT04242498|470679783|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130743350|NCT04242498|470679784|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130743351|NCT04242498|470679785|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
130743352|NCT04242498|470679786|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130743353|NCT04242498|470679780|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130743354|NCT04242498|470679781|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130743355|NCT04242498|470679782|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130743356|NCT04242498|470679783|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130743357|NCT04242498|470679784|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130743358|NCT04242498|470679785|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
130743359|NCT04242498|470679786|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
130743360|NCT00765102|470679787|FG000|Overall Study|Progressive disease|18|||
130743361|NCT00765102|470679787|FG000|Overall Study|Adverse Event|6|||
130743362|NCT00765102|470679787|FG000|Overall Study|Physician Decision|4|||
130743363|NCT00765102|470679787|FG000|Overall Study|Withdrawal by Subject|2|||
130743364|NCT00765102|470679787|FG000|Overall Study|Protocol Violation|1|||
130743365|NCT04129125|470679794|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
130743366|NCT04129125|470679794|FG000|Overall Study|Study device was not used|3|||
130743367|NCT02962648|470679797|FG000|Overall Study|Withdrawal by Subject|3|||
130743368|NCT02962648|470679797|FG000|Overall Study|Lost to Follow-up|3|||
130743369|NCT02962648|470679797|FG000|Overall Study|Physician Decision|1|||
130743370|NCT02962648|470679797|FG000|Overall Study|Subject had problems with transportation|2|||
130743371|NCT04383327|470679798|FG000|Overall Study|Lost to Follow-up|112|||
130743372|NCT04383327|470679799|FG001|Overall Study|Lost to Follow-up|14|||
130743373|NCT04383327|470679800|FG002|Overall Study|Lost to Follow-up|78|||
130743374|NCT04383327|470679801|FG003|Overall Study|Lost to Follow-up|13|||
130743375|NCT04383327|470679802|FG004|Overall Study|Lost to Follow-up|110|||
130743376|NCT04383327|470679803|FG005|Overall Study|Lost to Follow-up|13|||
130743377|NCT04383327|470679804|FG006|Overall Study|Lost to Follow-up|74|||
130743378|NCT04383327|470679805|FG007|Overall Study|Lost to Follow-up|13|||
130743379|NCT04383327|470679806|FG008|Overall Study|Lost to Follow-up|78|||
130788224|NCT03098979|470854519|FG003|Overall Study|Withdrawal by Subject|1|||
130788225|NCT03098979|470854520|FG004|Overall Study|Withdrawal by Subject|2|||
130788226|NCT03098979|470854521|FG005|Overall Study|Withdrawal by Subject|1|||
130788227|NCT03098979|470854516|FG000|Overall Study|Death|1|||
130788228|NCT03098979|470854517|FG001|Overall Study|Death|0|||
130788229|NCT03098979|470854518|FG002|Overall Study|Death|2|||
130788230|NCT03098979|470854519|FG003|Overall Study|Death|0|||
130788231|NCT03098979|470854520|FG004|Overall Study|Death|1|||
130788232|NCT03098979|470854521|FG005|Overall Study|Death|0|||
130788233|NCT03098979|470854516|FG000|Overall Study|Physician Decision|2|||
130788234|NCT03098979|470854517|FG001|Overall Study|Physician Decision|1|||
130788235|NCT03098979|470854518|FG002|Overall Study|Physician Decision|0|||
130788236|NCT03098979|470854519|FG003|Overall Study|Physician Decision|0|||
130788237|NCT03098979|470854520|FG004|Overall Study|Physician Decision|0|||
130788238|NCT03098979|470854521|FG005|Overall Study|Physician Decision|0|||
130788239|NCT03098979|470854516|FG000|Overall Study|Non-compliance|0|||
130788240|NCT03098979|470854517|FG001|Overall Study|Non-compliance|0|||
130788241|NCT03098979|470854518|FG002|Overall Study|Non-compliance|0|||
130788242|NCT03098979|470854519|FG003|Overall Study|Non-compliance|0|||
130788243|NCT03098979|470854520|FG004|Overall Study|Non-compliance|0|||
130788244|NCT03098979|470854521|FG005|Overall Study|Non-compliance|1|||
130788245|NCT03098979|470854516|FG000|Overall Study|Protocol Violation|0|||
130788246|NCT03098979|470854517|FG001|Overall Study|Protocol Violation|0|||
130788247|NCT03098979|470854518|FG002|Overall Study|Protocol Violation|0|||
130788248|NCT03098979|470854519|FG003|Overall Study|Protocol Violation|0|||
130788249|NCT03098979|470854520|FG004|Overall Study|Protocol Violation|0|||
130788250|NCT03098979|470854521|FG005|Overall Study|Protocol Violation|1|||
130788251|NCT02426684|470854522|FG000|Overall Study|Physician Decision|1|||
130788252|NCT02369653|470854523|FG000|Overall Study|Lost to Follow-up|0|||
130788253|NCT02369653|470854524|FG001|Overall Study|Lost to Follow-up|1|||
130788254|NCT02369653|470854523|FG000|Overall Study|Administrative reason by sponsor|0|||
130788255|NCT02369653|470854524|FG001|Overall Study|Administrative reason by sponsor|1|||
130788256|NCT02369653|470854523|FG000|Overall Study|Death|1|||
130788257|NCT02369653|470854524|FG001|Overall Study|Death|2|||
130788258|NCT02369653|470854523|FG000|Overall Study|Participant withdrew consent|13|||
130788259|NCT02369653|470854524|FG001|Overall Study|Participant withdrew consent|3|||
130788260|NCT03587636|470854525|FG000|Overall Study|Lost to Follow-up|2|||
130743380|NCT04383327|470679807|FG009|Overall Study|Lost to Follow-up|10|||
130743381|NCT04383327|470679808|FG010|Overall Study|Lost to Follow-up|160|||
130743382|NCT04383327|470679809|FG011|Overall Study|Lost to Follow-up|13|||
130743383|NCT05303194|470679810|FG000|Overall Study|Lost to Follow-up|1|||
130788261|NCT03587636|470854526|FG001|Overall Study|Lost to Follow-up|5|||
130788262|NCT03248037|470854527|FG000|Overall Study|Withdrawal by Subject|6|||
130788263|NCT03248037|470854528|FG001|Overall Study|Withdrawal by Subject|9|||
130788264|NCT03248037|470854527|FG000|Overall Study|Adverse Event|15|||
130788265|NCT03248037|470854528|FG001|Overall Study|Adverse Event|0|||
130788266|NCT02897349|470854529|FG000|Overall Study|Lost to Follow-up|2|||
130788267|NCT02897349|470854530|FG001|Overall Study|Lost to Follow-up|2|||
130788268|NCT02897349|470854529|FG000|Overall Study|Adverse Event|3|||
130788269|NCT02897349|470854530|FG001|Overall Study|Adverse Event|3|||
130788270|NCT02897349|470854529|FG000|Overall Study|Other than listed above|0|||
130788271|NCT02897349|470854530|FG001|Overall Study|Other than listed above|1|||
130743384|NCT05303194|470679811|FG001|Overall Study|Lost to Follow-up|1|||
130743385|NCT05303194|470679810|FG000|Overall Study|Withdrawal by Subject|0|||
130743386|NCT05303194|470679811|FG001|Overall Study|Withdrawal by Subject|1|||
130743387|NCT01289678|470679812|FG000|Overall Study|Physician Decision|6|||
130743388|NCT04030299|470679813|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
130743389|NCT04030299|470679813|FG000|Overall Study|Withdrawal by Subject|3|||
130743390|NCT02723344|470679817|FG000|Overall Study|Lost to Follow-up|0|||
130743391|NCT02723344|470679818|FG001|Overall Study|Lost to Follow-up|4|||
130743392|NCT01326845|470679820|FG000|Overall Study|Administrative Problems|5|||
130743393|NCT01326845|470679821|FG001|Overall Study|Administrative Problems|2|||
130743394|NCT01326845|470679820|FG000|Overall Study|Adverse Event|1|||
130743395|NCT01326845|470679821|FG001|Overall Study|Adverse Event|0|||
130743396|NCT01326845|470679820|FG000|Overall Study|Misisng|1|||
130743397|NCT01326845|470679821|FG001|Overall Study|Misisng|3|||
130743398|NCT02964247|470679822|FG000|Overall Study|Lost to Follow-up|2|||
130743399|NCT02964247|470679823|FG001|Overall Study|Lost to Follow-up|0|||
130743400|NCT02964247|470679822|FG000|Overall Study|Withdrawal by Subject|1|||
130743401|NCT02964247|470679823|FG001|Overall Study|Withdrawal by Subject|2|||
130743402|NCT01530464|470679826|FG000|Washout (24h)|Withdrawal by Subject|1|||
130743403|NCT01530464|470679827|FG001|Washout (24h)|Withdrawal by Subject|0|||
130743404|NCT01530464|470679826|FG000|Washout (24h)|Withdrawal by Subject|0|||
130743405|NCT01530464|470679827|FG001|Washout (24h)|Withdrawal by Subject|1|||
130743406|NCT00908544|470679828|FG000|Overall Study|Withdrawal by Subject|2|||
130743407|NCT00908544|470679829|FG001|Overall Study|Withdrawal by Subject|4|||
130743408|NCT00908544|470679828|FG000|Overall Study|Lack of Efficacy|0|||
130743409|NCT00908544|470679829|FG001|Overall Study|Lack of Efficacy|1|||
130743410|NCT00908544|470679828|FG000|Overall Study|Pregnancy|1|||
130743411|NCT00908544|470679829|FG001|Overall Study|Pregnancy|0|||
130743412|NCT00908544|470679828|FG000|Overall Study|Relocation abroad|1|||
130743413|NCT00908544|470679829|FG001|Overall Study|Relocation abroad|1|||
130743414|NCT00908544|470679828|FG000|Overall Study|Unable to visit sutdy center|1|||
130743415|NCT00908544|470679829|FG001|Overall Study|Unable to visit sutdy center|0|||
130743416|NCT03539302|470679836|FG000|Overall Study|Spontaneous cardio version|0|||
130743417|NCT03539302|470679837|FG001|Overall Study|Spontaneous cardio version|0|||
130743418|NCT03539302|470679838|FG002|Overall Study|Spontaneous cardio version|0|||
130743419|NCT03539302|470679839|FG003|Overall Study|Spontaneous cardio version|0|||
130743420|NCT03539302|470679840|FG004|Overall Study|Spontaneous cardio version|0|||
130743421|NCT03539302|470679841|FG005|Overall Study|Spontaneous cardio version|1|||
130743422|NCT03539302|470679842|FG006|Overall Study|Spontaneous cardio version|1|||
130743423|NCT01609790|470679848|FG000|Overall Study|Protocol Violation|1|||
130743424|NCT01609790|470679849|FG001|Overall Study|Protocol Violation|7|||
130743425|NCT01609790|470679850|FG002|Overall Study|Protocol Violation|8|||
130743426|NCT05207865|470681476|FG000|Open-Label Treatment Phase|Adverse Event|7|||
130743427|NCT05207865|470681476|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
130743428|NCT05207865|470681476|FG000|Open-Label Treatment Phase|Non-compliance|3|||
130743429|NCT05207865|470681476|FG000|Open-Label Treatment Phase|Other|17|||
130743430|NCT05207865|470681476|FG000|Open-Label Treatment Phase|Physician Decision|2|||
130743431|NCT05207865|470681476|FG000|Open-Label Treatment Phase|Pregnancy|1|||
130788272|NCT01259245|470854537|FG000|Overall Study|Withdrawal by Subject|27|||
130788273|NCT01259245|470854538|FG001|Overall Study|Withdrawal by Subject|24|||
130788274|NCT01259245|470854537|FG000|Overall Study|Death|1|||
130788275|NCT01259245|470854538|FG001|Overall Study|Death|2|||
130788276|NCT00087178|470854539|FG000|Overall Study|No follow up data|5|||
130788277|NCT00087178|470854540|FG001|Overall Study|No follow up data|15|||
130788278|NCT00087178|470854539|FG000|Overall Study|No clinical assessment|1|||
130788279|NCT00087178|470854540|FG001|Overall Study|No clinical assessment|2|||
130743432|NCT05207865|470681476|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
130743433|NCT05207865|470681476|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
130743434|NCT05207865|470681476|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
130743435|NCT05207865|470681476|FG000|Follow-up Phase|Lost to Follow-up|1|||
130743436|NCT05207865|470681476|FG000|Follow-up Phase|Non-compliance|1|||
130743437|NCT05207865|470681476|FG000|Follow-up Phase|Not reported|2|||
130743438|NCT05207865|470681476|FG000|Follow-up Phase|Not collected|11|||
130743439|NCT05364931|470681494|FG000|Overall Study|Adverse Event|0|||
130743440|NCT05364931|470681495|FG001|Overall Study|Adverse Event|2|||
130743441|NCT05364931|470681496|FG002|Overall Study|Adverse Event|1|||
130743442|NCT05364931|470681497|FG003|Overall Study|Adverse Event|0|||
130743443|NCT05364931|470681494|FG000|Overall Study|Lost to Follow-up|1|||
130743444|NCT05364931|470681495|FG001|Overall Study|Lost to Follow-up|0|||
130743445|NCT05364931|470681496|FG002|Overall Study|Lost to Follow-up|0|||
130743446|NCT05364931|470681497|FG003|Overall Study|Lost to Follow-up|0|||
130743447|NCT05364931|470681494|FG000|Overall Study|Withdrawal by Subject|1|||
130743448|NCT05364931|470681495|FG001|Overall Study|Withdrawal by Subject|1|||
130743449|NCT05364931|470681496|FG002|Overall Study|Withdrawal by Subject|3|||
130743450|NCT05364931|470681497|FG003|Overall Study|Withdrawal by Subject|2|||
130743451|NCT05364931|470681494|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
130743452|NCT05364931|470681495|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
130743453|NCT05364931|470681496|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
130743454|NCT05364931|470681497|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
130743455|NCT05364931|470681494|FG000|Overall Study|Discontinued|1|||
130743456|NCT05364931|470681495|FG001|Overall Study|Discontinued|0|||
130743457|NCT05364931|470681496|FG002|Overall Study|Discontinued|0|||
130743458|NCT05364931|470681497|FG003|Overall Study|Discontinued|0|||
130743459|NCT03593525|470681498|FG000|Overall Study|Withdrawal by Subject|1|||
130743460|NCT03593525|470681499|FG001|Overall Study|Withdrawal by Subject|0|||
130743461|NCT03593525|470681498|FG000|Overall Study|Lost to Follow-up|7|||
130743462|NCT03593525|470681499|FG001|Overall Study|Lost to Follow-up|5|||
130743463|NCT03103087|470681507|FG000|Overall Study|Did not receive any study drug|1|||
130743464|NCT03103087|470681508|FG001|Overall Study|Did not receive any study drug|0|||
130743465|NCT03103087|470681509|FG002|Overall Study|Did not receive any study drug|0|||
130743466|NCT03103087|470681507|FG000|Overall Study|Protocol Violation|1|||
130743467|NCT03103087|470681508|FG001|Overall Study|Protocol Violation|2|||
130743468|NCT03103087|470681509|FG002|Overall Study|Protocol Violation|1|||
130743469|NCT03103087|470681507|FG000|Overall Study|Lack of Efficacy|2|||
130743470|NCT03103087|470681508|FG001|Overall Study|Lack of Efficacy|1|||
130743471|NCT03103087|470681509|FG002|Overall Study|Lack of Efficacy|1|||
130743472|NCT03103087|470681507|FG000|Overall Study|Pregnancy|0|||
130743473|NCT03103087|470681508|FG001|Overall Study|Pregnancy|0|||
130743474|NCT03103087|470681509|FG002|Overall Study|Pregnancy|1|||
130743475|NCT03103087|470681507|FG000|Overall Study|Adverse Event|2|||
130743476|NCT03103087|470681508|FG001|Overall Study|Adverse Event|15|||
130743477|NCT03103087|470681509|FG002|Overall Study|Adverse Event|6|||
130743478|NCT03103087|470681507|FG000|Overall Study|Withdrawal by Subject|13|||
130788280|NCT00087178|470854539|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
130788281|NCT00087178|470854540|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
130743479|NCT03103087|470681508|FG001|Overall Study|Withdrawal by Subject|6|||
130743480|NCT03103087|470681509|FG002|Overall Study|Withdrawal by Subject|6|||
130743481|NCT03103087|470681507|FG000|Overall Study|Lost to Follow-up|4|||
130743482|NCT03103087|470681508|FG001|Overall Study|Lost to Follow-up|2|||
130743483|NCT03103087|470681509|FG002|Overall Study|Lost to Follow-up|7|||
130743484|NCT03103087|470681507|FG000|Overall Study|Other reason not reported|1|||
130743485|NCT03103087|470681508|FG001|Overall Study|Other reason not reported|3|||
130743486|NCT03103087|470681509|FG002|Overall Study|Other reason not reported|5|||
130743487|NCT03504397|470681510|FG000|Overall Study|Progressive Disease|151|||
130743488|NCT03504397|470681511|FG001|Overall Study|Progressive Disease|199|||
130743489|NCT03504397|470681510|FG000|Overall Study|Withdrawal by Subject|29|||
130743490|NCT03504397|470681511|FG001|Overall Study|Withdrawal by Subject|17|||
130743491|NCT03504397|470681510|FG000|Overall Study|Lost to Follow-up|1|||
130788282|NCT01692119|470854555|FG000|Overall Study|Protocol Violation|3|||
130788283|NCT01692119|470854556|FG001|Overall Study|Protocol Violation|1|||
130743492|NCT03504397|470681511|FG001|Overall Study|Lost to Follow-up|0|||
130743493|NCT03504397|470681510|FG000|Overall Study|Death|14|||
130743494|NCT03504397|470681511|FG001|Overall Study|Death|16|||
130743495|NCT03504397|470681510|FG000|Overall Study|Adverse Event|40|||
130743496|NCT03504397|470681511|FG001|Overall Study|Adverse Event|14|||
130743497|NCT03504397|470681510|FG000|Overall Study|miscellaneous|17|||
130743498|NCT03504397|470681511|FG001|Overall Study|miscellaneous|15|||
130743499|NCT03504397|470681510|FG000|Overall Study|Protocol deviation|1|||
130743500|NCT03504397|470681511|FG001|Overall Study|Protocol deviation|0|||
130743501|NCT03504397|470681510|FG000|Overall Study|Participants who did not take the study drug|4|||
130743502|NCT03504397|470681511|FG001|Overall Study|Participants who did not take the study drug|4|||
130743503|NCT00413699|470681512|FG000|Initial Period|Death|25|||
130743504|NCT00413699|470681513|FG001|Initial Period|Death|30|||
130743505|NCT00413699|470681514|FG002|Initial Period|Death|0|||
130743506|NCT00413699|470681512|FG000|Initial Period|Lack of Efficacy|59|||
130743507|NCT00413699|470681513|FG001|Initial Period|Lack of Efficacy|115|||
130743508|NCT00413699|470681514|FG002|Initial Period|Lack of Efficacy|0|||
130743509|NCT00413699|470681512|FG000|Initial Period|Lost to Follow-up|31|||
130743510|NCT00413699|470681513|FG001|Initial Period|Lost to Follow-up|101|||
130743511|NCT00413699|470681514|FG002|Initial Period|Lost to Follow-up|0|||
130743512|NCT00413699|470681512|FG000|Initial Period|Protocol Violation|38|||
130743513|NCT00413699|470681513|FG001|Initial Period|Protocol Violation|89|||
130743514|NCT00413699|470681514|FG002|Initial Period|Protocol Violation|0|||
130743515|NCT00413699|470681512|FG000|Initial Period|Pregnancy|10|||
130743516|NCT00413699|470681513|FG001|Initial Period|Pregnancy|8|||
130743517|NCT00413699|470681514|FG002|Initial Period|Pregnancy|0|||
130743518|NCT00413699|470681512|FG000|Initial Period|Did not meet entrance criteria|2|||
130743519|NCT00413699|470681513|FG001|Initial Period|Did not meet entrance criteria|2|||
130743520|NCT00413699|470681514|FG002|Initial Period|Did not meet entrance criteria|0|||
130743521|NCT00413699|470681512|FG000|Initial Period|Medication error without adverse event|0|||
130743522|NCT00413699|470681513|FG001|Initial Period|Medication error without adverse event|1|||
130743523|NCT00413699|470681514|FG002|Initial Period|Medication error without adverse event|0|||
130743524|NCT00413699|470681512|FG000|Initial Period|Study terminated by Sponsor|0|||
130743525|NCT00413699|470681513|FG001|Initial Period|Study terminated by Sponsor|1|||
130743526|NCT00413699|470681514|FG002|Initial Period|Study terminated by Sponsor|0|||
130743527|NCT00413699|470681512|FG000|Initial Period|Other|67|||
130743528|NCT00413699|470681513|FG001|Initial Period|Other|211|||
130743529|NCT00413699|470681514|FG002|Initial Period|Other|0|||
130743530|NCT00413699|470681512|FG000|Initial Period|Adverse event related to study drug|178|||
130743531|NCT00413699|470681513|FG001|Initial Period|Adverse event related to study drug|527|||
130743532|NCT00413699|470681514|FG002|Initial Period|Adverse event related to study drug|0|||
130743533|NCT00413699|470681512|FG000|Initial Period|Adverse event not related to study drug|113|||
130743534|NCT00413699|470681513|FG001|Initial Period|Adverse event not related to study drug|248|||
130743535|NCT00413699|470681514|FG002|Initial Period|Adverse event not related to study drug|0|||
130743536|NCT00413699|470681512|FG000|Initial Period|Missing end of study page|0|||
130743537|NCT00413699|470681513|FG001|Initial Period|Missing end of study page|4|||
130743538|NCT00413699|470681514|FG002|Initial Period|Missing end of study page|0|||
130743539|NCT00413699|470681512|FG000|Initial Period|No longer willing to participate|116|||
130743540|NCT00413699|470681513|FG001|Initial Period|No longer willing to participate|368|||
130743541|NCT00413699|470681514|FG002|Initial Period|No longer willing to participate|0|||
130743542|NCT00413699|470681512|FG000|Extension Period|No Longer Willing to Participate|0|||
130743543|NCT00413699|470681513|FG001|Extension Period|No Longer Willing to Participate|0|||
130743544|NCT00413699|470681514|FG002|Extension Period|No Longer Willing to Participate|2|||
130743545|NCT00413699|470681512|FG000|Extension Period|Protocol Violation|0|||
130743546|NCT00413699|470681513|FG001|Extension Period|Protocol Violation|0|||
130743547|NCT00413699|470681514|FG002|Extension Period|Protocol Violation|1|||
130743548|NCT00413699|470681512|FG000|Extension Period|Adverse Event|0|||
130743549|NCT00413699|470681513|FG001|Extension Period|Adverse Event|0|||
130743550|NCT00413699|470681514|FG002|Extension Period|Adverse Event|2|||
130743551|NCT00075816|470681515|FG000|Overall Study|Did not undergo transplantation|14|||
130743552|NCT00075816|470681516|FG001|Overall Study|Did not undergo transplantation|11|||
130743553|NCT04231825|470681517|FG000|Overall Study|Protocol Violation|3|||
130743554|NCT04231825|470681518|FG001|Overall Study|Protocol Violation|3|||
130743555|NCT04231825|470681517|FG000|Overall Study|Lost to Follow-up|0|||
130743556|NCT04231825|470681518|FG001|Overall Study|Lost to Follow-up|1|||
130743557|NCT02445248|470681519|FG000|Overall Study|Death|45|||
130743558|NCT02445248|470681520|FG001|Overall Study|Death|12|||
130743559|NCT02445248|470681519|FG000|Overall Study|Progressive disease|13|||
130743560|NCT02445248|470681520|FG001|Overall Study|Progressive disease|1|||
130743561|NCT02445248|470681519|FG000|Overall Study|Subject decision|8|||
130743562|NCT02445248|470681520|FG001|Overall Study|Subject decision|0|||
130743563|NCT02445248|470681519|FG000|Overall Study|Physician Decision|5|||
130743564|NCT02445248|470681520|FG001|Overall Study|Physician Decision|0|||
130743565|NCT02445248|470681519|FG000|Overall Study|Adverse Event|1|||
130743566|NCT02445248|470681520|FG001|Overall Study|Adverse Event|0|||
130743567|NCT02445248|470681519|FG000|Overall Study|Lost to Follow-up|1|||
130743568|NCT02445248|470681520|FG001|Overall Study|Lost to Follow-up|0|||
130743569|NCT02596971|470681521|FG000|Overall Study|Death|5|||
130743570|NCT02596971|470681522|FG001|Overall Study|Death|1|||
130743571|NCT02596971|470681523|FG002|Overall Study|Death|5|||
130743572|NCT02596971|470681521|FG000|Overall Study|Withdrawal by Subject|5|||
130743573|NCT02596971|470681522|FG001|Overall Study|Withdrawal by Subject|1|||
130743574|NCT02596971|470681523|FG002|Overall Study|Withdrawal by Subject|4|||
130743575|NCT00595920|470681526|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
130743576|NCT00351468|470681527|FG000|Overall Study|Adverse Event|42|||
130743577|NCT00351468|470681527|FG000|Overall Study|Withdrawal by Subject|39|||
130743578|NCT00351468|470681527|FG000|Overall Study|Various -follow up w clinical team|39|||
130743579|NCT00351468|470681527|FG000|Overall Study|Lack of Efficacy|32|||
130743580|NCT00351468|470681527|FG000|Overall Study|Non-compliance|8|||
130743581|NCT00351468|470681527|FG000|Overall Study|Lost to Follow-up|4|||
130743582|NCT00351468|470681527|FG000|Overall Study|Protocol Violation|3|||
130743583|NCT03588910|470681528|FG000|Overall Study|Withdrawal by Subject|1|||
130743584|NCT03588910|470681529|FG001|Overall Study|Withdrawal by Subject|0|||
130743585|NCT03588910|470681528|FG000|Overall Study|Allergy|2|||
130743586|NCT03588910|470681529|FG001|Overall Study|Allergy|0|||
130743587|NCT03588910|470681528|FG000|Overall Study|Protocol Violation|0|||
130743588|NCT03588910|470681529|FG001|Overall Study|Protocol Violation|3|||
130743589|NCT03588910|470681528|FG000|Overall Study|Did not complete Day 1 Survey|5|||
130743590|NCT03588910|470681529|FG001|Overall Study|Did not complete Day 1 Survey|10|||
130743591|NCT03588910|470681528|FG000|Overall Study|Did not complete Day 7 Survey|5|||
130743592|NCT03588910|470681529|FG001|Overall Study|Did not complete Day 7 Survey|2|||
130743593|NCT00683618|470681530|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
130743594|NCT00683618|470681531|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
130743595|NCT00683618|470681532|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
130743596|NCT00683618|470681530|FG000|Randomised Treatment Period|Protocol Violation|0|||
130743597|NCT00683618|470681531|FG001|Randomised Treatment Period|Protocol Violation|1|||
130743598|NCT00683618|470681532|FG002|Randomised Treatment Period|Protocol Violation|0|||
130743599|NCT00683618|470681530|FG000|Randomised Treatment Period|Adverse Event|2|||
130743600|NCT00683618|470681531|FG001|Randomised Treatment Period|Adverse Event|0|||
130743601|NCT00683618|470681532|FG002|Randomised Treatment Period|Adverse Event|2|||
130743602|NCT00683618|470681530|FG000|Randomised Treatment Period|Reason not provided|0|||
130743603|NCT00683618|470681531|FG001|Randomised Treatment Period|Reason not provided|0|||
130743604|NCT00683618|470681532|FG002|Randomised Treatment Period|Reason not provided|2|||
130743605|NCT00683618|470681530|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
130743606|NCT00683618|470681531|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130743607|NCT00683618|470681532|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
130743608|NCT00683618|470681530|FG000|Extension Treatment Period|Adverse Event|1|||
130743609|NCT00683618|470681531|FG001|Extension Treatment Period|Adverse Event|0|||
130743610|NCT00683618|470681532|FG002|Extension Treatment Period|Adverse Event|0|||
130743611|NCT00683618|470681530|FG000|Extension Treatment Period|Protocol Violation|1|||
130743612|NCT00683618|470681531|FG001|Extension Treatment Period|Protocol Violation|0|||
130743613|NCT00683618|470681532|FG002|Extension Treatment Period|Protocol Violation|0|||
130743614|NCT03922321|470681534|FG000|Overall Study|Participant Moved|1|||
130743615|NCT03922321|470681534|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
130743616|NCT04067050|470681542|FG000|One Month|Lost to Follow-up|4|||
130743617|NCT04067050|470681543|FG001|One Month|Lost to Follow-up|0|||
130743618|NCT04067050|470681542|FG000|Two Month|Lost to Follow-up|1|||
130743619|NCT04067050|470681543|FG001|Two Month|Lost to Follow-up|0|||
130743620|NCT04067050|470681542|FG000|Two Month|Adverse Event|1|||
130743621|NCT04067050|470681543|FG001|Two Month|Adverse Event|0|||
130743622|NCT01062425|470681544|FG000|Overall Study|Protocol Violation|3|||
130743623|NCT01062425|470681545|FG001|Overall Study|Protocol Violation|6|||
130743624|NCT03003962|470681546|FG000|Overall Study|Withdrawal by Subject|5|||
130743625|NCT03003962|470681547|FG001|Overall Study|Withdrawal by Subject|17|||
130743626|NCT03003962|470681546|FG000|Overall Study|Death|274|||
130743627|NCT03003962|470681547|FG001|Overall Study|Death|277|||
130743628|NCT03003962|470681546|FG000|Overall Study|Participants ongoing at DCO|55|||
130743629|NCT03003962|470681547|FG001|Overall Study|Participants ongoing at DCO|40|||
130743630|NCT03802825|470681555|FG000|Overall Study|Lost to follow-up for intervention|12|||
130743631|NCT03802825|470681556|FG001|Overall Study|Lost to follow-up for intervention|3|||
130743632|NCT03802825|470681555|FG000|Overall Study|Received only 1 component of intervention|0|||
130743633|NCT03802825|470681556|FG001|Overall Study|Received only 1 component of intervention|13|||
130743634|NCT03428152|470681558|FG000|Overall Study|Physician Decision|4|||
130743635|NCT03428152|470681559|FG001|Overall Study|Physician Decision|2|||
130743636|NCT03428152|470681558|FG000|Overall Study|Protocol Violation|3|||
130743637|NCT03428152|470681559|FG001|Overall Study|Protocol Violation|5|||
130743638|NCT03428152|470681558|FG000|Overall Study|Lack of Efficacy|0|||
130743639|NCT03428152|470681559|FG001|Overall Study|Lack of Efficacy|4|||
130743640|NCT01293695|470681566|FG000|Overall Study|Withdrawal by Subject|7|||
130743641|NCT01293695|470681567|FG001|Overall Study|Withdrawal by Subject|1|||
130743642|NCT01293695|470681566|FG000|Overall Study|Lost to Follow-up|8|||
130743643|NCT01293695|470681567|FG001|Overall Study|Lost to Follow-up|6|||
130743644|NCT00468819|470681568|FG000|Overall Study|Withdrawal by Subject|4|||
130743645|NCT00468819|470681569|FG001|Overall Study|Withdrawal by Subject|0|||
130743646|NCT00468819|470681570|FG002|Overall Study|Withdrawal by Subject|1|||
130743647|NCT00468819|470681568|FG000|Overall Study|Lost to Follow-up|0|||
130743648|NCT00468819|470681569|FG001|Overall Study|Lost to Follow-up|0|||
130743649|NCT00468819|470681570|FG002|Overall Study|Lost to Follow-up|1|||
130743650|NCT00468819|470681568|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
130743651|NCT00468819|470681569|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
130743652|NCT00468819|470681570|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
130743653|NCT04616612|470681571|FG000|Overall Study|Lost to Follow-up|6|||
130743654|NCT04616612|470681572|FG001|Overall Study|Lost to Follow-up|3|||
130743655|NCT04740918|470681573|FG000|Overall Study|Study Terminated by Sponsor|41|||
130743656|NCT04740918|470681574|FG001|Overall Study|Study Terminated by Sponsor|32|||
130743657|NCT04740918|470681573|FG000|Overall Study|Death|3|||
130743658|NCT04740918|470681574|FG001|Overall Study|Death|6|||
130743659|NCT04740918|470681573|FG000|Overall Study|Withdrawal by Subject|5|||
130743660|NCT04740918|470681574|FG001|Overall Study|Withdrawal by Subject|4|||
130743661|NCT04740918|470681573|FG000|Overall Study|Lost to Follow-up|1|||
130743662|NCT04740918|470681574|FG001|Overall Study|Lost to Follow-up|3|||
130743663|NCT04740918|470681573|FG000|Overall Study|Progressive disease|0|||
130743664|NCT04740918|470681574|FG001|Overall Study|Progressive disease|1|||
130743665|NCT02524847|470681575|FG000|Overall Study|Adverse Event|4|||
130743666|NCT02524847|470681575|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
130743667|NCT02524847|470681575|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
130743668|NCT02524847|470681575|FG000|Overall Study|Death|1|||
130743669|NCT02524847|470681575|FG000|Overall Study|Reason not Specified|1|||
130743670|NCT04352101|470681576|FG000|Overall Study|Physician Decision|2|||
130743671|NCT04352101|470681577|FG001|Overall Study|Physician Decision|1|||
130743672|NCT01288079|470681583|FG000|Overall Study|Withdrawal by Subject|2|||
130743673|NCT01288079|470681584|FG001|Overall Study|Withdrawal by Subject|4|||
130743674|NCT01288079|470681585|FG002|Overall Study|Withdrawal by Subject|1|||
130743675|NCT01288079|470681586|FG003|Overall Study|Withdrawal by Subject|0|||
130743676|NCT01288079|470681583|FG000|Overall Study|Adverse Event|2|||
130743677|NCT01288079|470681584|FG001|Overall Study|Adverse Event|1|||
130743678|NCT01288079|470681585|FG002|Overall Study|Adverse Event|2|||
130743679|NCT01288079|470681586|FG003|Overall Study|Adverse Event|3|||
130743680|NCT01288079|470681583|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
130743681|NCT01288079|470681584|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
130743682|NCT01288079|470681585|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
130743683|NCT01288079|470681586|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
130743684|NCT01288079|470681583|FG000|Overall Study|Condition under Investigation Worsened|0|||
130743685|NCT01288079|470681584|FG001|Overall Study|Condition under Investigation Worsened|0|||
130743686|NCT01288079|470681585|FG002|Overall Study|Condition under Investigation Worsened|0|||
130743687|NCT01288079|470681586|FG003|Overall Study|Condition under Investigation Worsened|1|||
130743688|NCT01288079|470681583|FG000|Overall Study|Lack of Efficacy|2|||
130743689|NCT01288079|470681584|FG001|Overall Study|Lack of Efficacy|2|||
130743690|NCT01288079|470681585|FG002|Overall Study|Lack of Efficacy|0|||
130743691|NCT01288079|470681586|FG003|Overall Study|Lack of Efficacy|2|||
130743692|NCT01288079|470681583|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
130743693|NCT01288079|470681584|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
130743694|NCT01288079|470681585|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
130743695|NCT01288079|470681586|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
130743696|NCT01288079|470681583|FG000|Overall Study|Lost to Follow-up|1|||
130743697|NCT01288079|470681584|FG001|Overall Study|Lost to Follow-up|1|||
130743698|NCT01288079|470681585|FG002|Overall Study|Lost to Follow-up|1|||
130743699|NCT01288079|470681586|FG003|Overall Study|Lost to Follow-up|0|||
130743700|NCT01288079|470681583|FG000|Overall Study|Other or Study Termination|11|||
130743701|NCT01288079|470681584|FG001|Overall Study|Other or Study Termination|15|||
130788284|NCT01692119|470854555|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
130788285|NCT01692119|470854556|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
130788286|NCT00997893|470854557|FG000|Overall Study|Adverse Event|1|||
130788287|NCT00997893|470854558|FG001|Overall Study|Adverse Event|0|||
130788288|NCT00997893|470854559|FG002|Overall Study|Adverse Event|0|||
130788289|NCT00997893|470854557|FG000|Overall Study|Unable to meet study timelines|1|||
130788290|NCT00997893|470854558|FG001|Overall Study|Unable to meet study timelines|0|||
130743702|NCT01288079|470681585|FG002|Overall Study|Other or Study Termination|14|||
130743703|NCT01288079|470681586|FG003|Overall Study|Other or Study Termination|8|||
130743704|NCT03170544|470681587|FG000|Part 1|Lost to Follow-up|1|||
130743705|NCT03170544|470681588|FG001|Part 1|Lost to Follow-up|0|||
130743706|NCT03170544|470681589|FG002|Part 1|Lost to Follow-up|0|||
130743707|NCT03170544|470681590|FG003|Part 1|Lost to Follow-up|0|||
130743708|NCT03170544|470681591|FG004|Part 1|Lost to Follow-up|0|||
130743709|NCT03170544|470681592|FG005|Part 1|Lost to Follow-up|0|||
130743710|NCT03170544|470681593|FG006|Part 1|Lost to Follow-up|0|||
130743711|NCT03170544|470681594|FG007|Part 1|Lost to Follow-up|0|||
130743712|NCT03170544|470681595|FG008|Part 1|Lost to Follow-up|0|||
130743713|NCT03170544|470681596|FG009|Part 1|Lost to Follow-up|0|||
130743714|NCT03170544|470681597|FG010|Part 1|Lost to Follow-up|0|||
130743715|NCT03170544|470681598|FG011|Part 1|Lost to Follow-up|0|||
130743716|NCT03170544|470681587|FG000|Part 1|Not treated|0|||
130743717|NCT03170544|470681588|FG001|Part 1|Not treated|0|||
130743718|NCT03170544|470681589|FG002|Part 1|Not treated|0|||
130743719|NCT03170544|470681590|FG003|Part 1|Not treated|1|||
130743720|NCT03170544|470681591|FG004|Part 1|Not treated|0|||
130743721|NCT03170544|470681592|FG005|Part 1|Not treated|0|||
130743722|NCT03170544|470681593|FG006|Part 1|Not treated|0|||
130743723|NCT03170544|470681594|FG007|Part 1|Not treated|0|||
130743724|NCT03170544|470681595|FG008|Part 1|Not treated|0|||
130743725|NCT03170544|470681596|FG009|Part 1|Not treated|0|||
130743726|NCT03170544|470681597|FG010|Part 1|Not treated|0|||
130743727|NCT03170544|470681598|FG011|Part 1|Not treated|0|||
130743728|NCT02387840|470681599|FG000|Overall Study|Death|0|||
130743729|NCT02387840|470681600|FG001|Overall Study|Death|0|||
130743730|NCT02387840|470681601|FG002|Overall Study|Death|0|||
130743731|NCT02387840|470681602|FG003|Overall Study|Death|0|||
130743732|NCT02387840|470681603|FG004|Overall Study|Death|0|||
130743733|NCT02387840|470681604|FG005|Overall Study|Death|1|||
130743734|NCT02174627|470681607|FG000|Overall Study|Missing|0|||
130743735|NCT02174627|470681608|FG001|Overall Study|Missing|1|||
130743736|NCT02174627|470681607|FG000|Overall Study|Incorrect enrolment before randomization|0|||
130743737|NCT02174627|470681608|FG001|Overall Study|Incorrect enrolment before randomization|1|||
130743738|NCT02174627|470681607|FG000|Overall Study|Participant decision|84|||
130743739|NCT02174627|470681608|FG001|Overall Study|Participant decision|128|||
130743740|NCT04564092|470681609|FG000|Overall Study|Withdrawal by Subject|1|||
130743741|NCT00071110|470681610|FG000|Overall Study|Protocol Violation|0|||
130743742|NCT00071110|470681611|FG001|Overall Study|Protocol Violation|4|||
130743743|NCT02107131|470681615|FG000|Overall Study|Lost to Follow-up|4|||
130743744|NCT02107131|470681616|FG001|Overall Study|Lost to Follow-up|4|||
130743745|NCT02107131|470681615|FG000|Overall Study|Physician Decision|1|||
130743746|NCT02107131|470681616|FG001|Overall Study|Physician Decision|0|||
130743747|NCT02107131|470681615|FG000|Overall Study|Withdrawal by Subject|2|||
130743748|NCT02107131|470681616|FG001|Overall Study|Withdrawal by Subject|0|||
130743749|NCT02107131|470681615|FG000|Overall Study|mental instability|1|||
130743750|NCT02107131|470681616|FG001|Overall Study|mental instability|0|||
130743751|NCT02107131|470681615|FG000|Overall Study|Death|0|||
130743752|NCT02107131|470681616|FG001|Overall Study|Death|1|||
130743753|NCT02107131|470681615|FG000|Overall Study|Protocol Violation|0|||
130743754|NCT02107131|470681616|FG001|Overall Study|Protocol Violation|4|||
130743755|NCT02259010|470681617|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
130743756|NCT03578367|470681618|FG000|Overall Study|Adverse Event|0|||
130743757|NCT03578367|470681619|FG001|Overall Study|Adverse Event|3|||
130743758|NCT03578367|470681620|FG002|Overall Study|Adverse Event|0|||
130743759|NCT03578367|470681621|FG003|Overall Study|Adverse Event|5|||
130743760|NCT03578367|470681618|FG000|Overall Study|Withdrawal by Subject|2|||
130743761|NCT03578367|470681619|FG001|Overall Study|Withdrawal by Subject|2|||
130743762|NCT03578367|470681620|FG002|Overall Study|Withdrawal by Subject|1|||
130743763|NCT03578367|470681621|FG003|Overall Study|Withdrawal by Subject|3|||
130743764|NCT03578367|470681618|FG000|Overall Study|Physician Decision|0|||
130743765|NCT03578367|470681619|FG001|Overall Study|Physician Decision|0|||
130743766|NCT03578367|470681620|FG002|Overall Study|Physician Decision|14|||
130743767|NCT03578367|470681621|FG003|Overall Study|Physician Decision|0|||
130743768|NCT03578367|470681618|FG000|Overall Study|Death|1|||
130743769|NCT03578367|470681619|FG001|Overall Study|Death|0|||
130743770|NCT03578367|470681620|FG002|Overall Study|Death|0|||
130743771|NCT03578367|470681621|FG003|Overall Study|Death|0|||
130743772|NCT03578367|470681618|FG000|Overall Study|Not treated|0|||
130788291|NCT00997893|470854559|FG002|Overall Study|Unable to meet study timelines|0|||
130743773|NCT03578367|470681619|FG001|Overall Study|Not treated|0|||
130743774|NCT03578367|470681620|FG002|Overall Study|Not treated|1|||
130743775|NCT03578367|470681621|FG003|Overall Study|Not treated|0|||
130743776|NCT02729025|470681622|FG000|Overall Study|Sponsor Decision|0|||
130743777|NCT02729025|470681623|FG001|Overall Study|Sponsor Decision|1|||
130743778|NCT04242446|470683447|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
130743779|NCT04242446|470683448|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
130743780|NCT04242446|470683449|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
130743781|NCT04242446|470683450|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130743782|NCT04242446|470683451|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130743783|NCT04242446|470683452|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130743784|NCT04242446|470683453|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130743785|NCT04242446|470683447|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130743786|NCT04242446|470683448|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
130743787|NCT04242446|470683449|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
130743788|NCT04242446|470683450|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130743789|NCT04242446|470683451|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130743790|NCT04242446|470683452|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130743791|NCT04242446|470683453|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130743792|NCT04242446|470683447|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
130743793|NCT04242446|470683448|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
130743794|NCT04242446|470683449|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
130743795|NCT04242446|470683450|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130743796|NCT04242446|470683451|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130743797|NCT04242446|470683452|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130743798|NCT04242446|470683453|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130743799|NCT04242446|470683447|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
130743800|NCT04242446|470683448|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
130743801|NCT04242446|470683449|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
130743802|NCT04242446|470683450|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130743803|NCT04242446|470683451|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130743804|NCT04242446|470683452|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130743805|NCT04242446|470683453|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130743806|NCT04242446|470683447|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
130743807|NCT04242446|470683448|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130743808|NCT04242446|470683449|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130743809|NCT04242446|470683450|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130743810|NCT04242446|470683451|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130743811|NCT04242446|470683452|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130743812|NCT04242446|470683453|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130743813|NCT04242446|470683447|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130743814|NCT04242446|470683448|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130743815|NCT04242446|470683449|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
130743816|NCT04242446|470683450|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130743817|NCT04242446|470683451|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130743818|NCT04242446|470683452|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130743819|NCT04242446|470683453|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130743820|NCT04242446|470683447|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130743821|NCT04242446|470683448|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130743822|NCT04242446|470683449|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
130743823|NCT04242446|470683450|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130743824|NCT04242446|470683451|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130743825|NCT04242446|470683452|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130743826|NCT04242446|470683453|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130743827|NCT04242446|470683447|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130743828|NCT04242446|470683448|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
130743829|NCT04242446|470683449|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
130743830|NCT04242446|470683450|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130743831|NCT04242446|470683451|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130743832|NCT04242446|470683452|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130743833|NCT04242446|470683453|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130743834|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130743835|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130743836|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130743837|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
130743838|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
130743839|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
130743840|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
130743841|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130743842|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130743843|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130743844|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
130743845|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
130743846|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
130743847|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
130743848|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130743849|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130743850|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130743851|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
130743852|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
130743853|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
130743854|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
130743855|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130743856|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130743857|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130743858|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
130743859|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
130743860|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
130743861|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
130743862|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130743863|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130743864|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130743865|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
130743866|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
130743867|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
130743868|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
130743869|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130743870|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130743871|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130743872|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
130743873|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130743874|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130743875|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130743876|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130743877|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130743878|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130743879|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130743880|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
130743881|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130743882|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130743883|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130743884|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130743885|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130743886|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130743887|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
130743888|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130743889|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130743890|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130743891|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130743892|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130743893|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130743894|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
130743895|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130743896|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130743897|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130743898|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130743899|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130743900|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130743901|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
130743902|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130743903|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130743904|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130743905|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130743906|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130743907|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130743908|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
130743909|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130743910|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130743911|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130743912|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130743913|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130743914|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130743915|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130743916|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
130743917|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130743918|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130743919|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130743920|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130743921|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130743922|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130743923|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
130743924|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130743925|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130743926|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130743927|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130743928|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130743929|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130743930|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130743931|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
130743932|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130743933|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130743934|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130743935|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130743936|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130743937|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130743938|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
130743939|NCT04242446|470683447|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130743940|NCT04242446|470683448|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130743941|NCT04242446|470683449|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130743942|NCT04242446|470683450|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130743943|NCT04242446|470683451|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130743944|NCT04242446|470683452|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130743945|NCT04242446|470683453|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
130743946|NCT00739882|470683459|FG000|Double-blind Period|Adverse Event|1|||
130743947|NCT00739882|470683460|FG001|Double-blind Period|Adverse Event|2|||
130743948|NCT00739882|470683459|FG000|Double-blind Period|Protocol Violation|1|||
130743949|NCT00739882|470683460|FG001|Double-blind Period|Protocol Violation|0|||
130743950|NCT00739882|470683459|FG000|Double-blind Period|Lack of Efficacy|1|||
130743951|NCT00739882|470683460|FG001|Double-blind Period|Lack of Efficacy|1|||
130743952|NCT00739882|470683459|FG000|Double-blind Period|Other|16|||
130743953|NCT00739882|470683460|FG001|Double-blind Period|Other|8|||
130743954|NCT00739882|470683459|FG000|Open-label Period|Adverse Event|1|||
130743955|NCT00739882|470683460|FG001|Open-label Period|Adverse Event|0|||
130743956|NCT00739882|470683459|FG000|Open-label Period|Other|9|||
130743957|NCT00739882|470683460|FG001|Open-label Period|Other|5|||
130743958|NCT04021914|470683461|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
130743959|NCT03349060|470683462|FG000|Overall Study|Adverse Event|9|||
130743960|NCT03349060|470683463|FG001|Overall Study|Adverse Event|9|||
130743961|NCT03349060|470683464|FG002|Overall Study|Adverse Event|7|||
130743962|NCT03349060|470683462|FG000|Overall Study|Lack of Efficacy|1|||
130743963|NCT03349060|470683463|FG001|Overall Study|Lack of Efficacy|0|||
130743964|NCT03349060|470683464|FG002|Overall Study|Lack of Efficacy|2|||
130743965|NCT03349060|470683462|FG000|Overall Study|Lost to Follow-up|2|||
130743966|NCT03349060|470683463|FG001|Overall Study|Lost to Follow-up|1|||
130743967|NCT03349060|470683464|FG002|Overall Study|Lost to Follow-up|1|||
130743968|NCT03349060|470683462|FG000|Overall Study|Protocol Violation|2|||
130743969|NCT03349060|470683463|FG001|Overall Study|Protocol Violation|2|||
130743970|NCT03349060|470683464|FG002|Overall Study|Protocol Violation|1|||
130743971|NCT03349060|470683462|FG000|Overall Study|Withdrawal by Subject|5|||
130743972|NCT03349060|470683463|FG001|Overall Study|Withdrawal by Subject|3|||
130743973|NCT03349060|470683464|FG002|Overall Study|Withdrawal by Subject|4|||
130743974|NCT03349060|470683462|FG000|Overall Study|Medication error,no linked adverse event|0|||
130743975|NCT03349060|470683463|FG001|Overall Study|Medication error,no linked adverse event|0|||
130743976|NCT03349060|470683464|FG002|Overall Study|Medication error,no linked adverse event|1|||
130743977|NCT03349060|470683462|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130743978|NCT03349060|470683463|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
130743979|NCT03349060|470683464|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
130743980|NCT03349060|470683462|FG000|Overall Study|Other|2|||
130743981|NCT03349060|470683463|FG001|Overall Study|Other|1|||
130743982|NCT03349060|470683464|FG002|Overall Study|Other|0|||
130743983|NCT02861586|470683465|FG000|Overall Study|Withdrawal by Subject|1|||
130743984|NCT02861586|470683466|FG001|Overall Study|Withdrawal by Subject|2|||
130743985|NCT02861586|470683467|FG002|Overall Study|Withdrawal by Subject|0|||
130743986|NCT02861586|470683468|FG003|Overall Study|Withdrawal by Subject|0|||
130743987|NCT02861586|470683469|FG004|Overall Study|Withdrawal by Subject|0|||
130743988|NCT02861586|470683470|FG005|Overall Study|Withdrawal by Subject|1|||
130743989|NCT02861586|470683471|FG006|Overall Study|Withdrawal by Subject|1|||
130743990|NCT02861586|470683472|FG007|Overall Study|Withdrawal by Subject|0|||
130743991|NCT02861586|470683465|FG000|Overall Study|Lost to Follow-up|3|||
130743992|NCT02861586|470683466|FG001|Overall Study|Lost to Follow-up|1|||
130743993|NCT02861586|470683467|FG002|Overall Study|Lost to Follow-up|1|||
130743994|NCT02861586|470683468|FG003|Overall Study|Lost to Follow-up|0|||
130743995|NCT02861586|470683469|FG004|Overall Study|Lost to Follow-up|0|||
130743996|NCT02861586|470683470|FG005|Overall Study|Lost to Follow-up|3|||
130743997|NCT02861586|470683471|FG006|Overall Study|Lost to Follow-up|0|||
130743998|NCT02861586|470683472|FG007|Overall Study|Lost to Follow-up|0|||
130743999|NCT02861586|470683465|FG000|Overall Study|Adverse Event|0|||
130744000|NCT02861586|470683466|FG001|Overall Study|Adverse Event|0|||
130744001|NCT02861586|470683467|FG002|Overall Study|Adverse Event|0|||
130744002|NCT02861586|470683468|FG003|Overall Study|Adverse Event|0|||
130744003|NCT02861586|470683469|FG004|Overall Study|Adverse Event|0|||
130744004|NCT02861586|470683470|FG005|Overall Study|Adverse Event|1|||
130744005|NCT02861586|470683471|FG006|Overall Study|Adverse Event|0|||
130744006|NCT02861586|470683472|FG007|Overall Study|Adverse Event|0|||
130744007|NCT00485732|470683473|FG000|Overall Study|Protocol Violation|1|||
130744008|NCT00485732|470683474|FG001|Overall Study|Protocol Violation|3|||
130744009|NCT00485732|470683473|FG000|Overall Study|Withdrawal by Subject|5|||
130744010|NCT00485732|470683474|FG001|Overall Study|Withdrawal by Subject|4|||
130744011|NCT00485732|470683473|FG000|Overall Study|Lost to Follow-up|2|||
130744012|NCT00485732|470683474|FG001|Overall Study|Lost to Follow-up|2|||
130744013|NCT01880554|470683475|FG000|Overall Study|Protocol Violation|14|||
130744014|NCT01880554|470683475|FG000|Overall Study|Simon's design requirements|2|||
130744015|NCT03985800|470683476|FG000|Overall Study|Death|1|||
130744016|NCT03985800|470683477|FG001|Overall Study|Death|2|||
130744017|NCT03985800|470683476|FG000|Overall Study|Withdrawal by Subject|3|||
130744018|NCT03985800|470683477|FG001|Overall Study|Withdrawal by Subject|6|||
130744019|NCT03985800|470683476|FG000|Overall Study|Protocol Violation|2|||
130744020|NCT03985800|470683477|FG001|Overall Study|Protocol Violation|0|||
130744025|NCT01662635|470683480|FG000|Overall Study|scarce samples for evaluation|30|||
130744026|NCT00611923|470683483|FG000|Overall Study|Withdrawal by Subject|2|||
130744027|NCT00611923|470683484|FG001|Overall Study|Withdrawal by Subject|2|||
130744028|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
130744029|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
130744030|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
130744031|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
130744032|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
130744033|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
130744034|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
130744035|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
130744036|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
130744037|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
130744038|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
130744039|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
130744040|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130744041|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130744042|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
130744043|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130744044|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
130744045|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
130744046|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
130744047|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
130744048|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
130744049|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
130744050|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
130744051|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
130744052|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
130744053|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
130744054|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
130744055|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
130744056|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
130744057|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
130744058|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
130744059|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
130744060|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
130744061|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
130744062|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
130744063|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
130744064|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
130744065|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
130744066|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
130744067|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
130744068|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
130744069|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
130744070|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
130744071|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
130744072|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
130744073|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
130744074|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
130744075|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
130744076|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
130744077|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
130744078|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
130744079|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
130744080|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Site closed|0|||
130744081|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Site closed|0|||
130744082|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Site closed|1|||
130744083|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Site closed|0|||
130744084|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
130744085|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
130744086|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
130744087|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
130744088|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
130744089|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
130744090|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
130744091|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
130744092|NCT00838903|470683485|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
130744093|NCT00838903|470683486|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
130744094|NCT00838903|470683487|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
130744095|NCT00838903|470683488|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
130744096|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
130744097|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
130744098|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
130744099|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
130744100|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
130744101|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
130744102|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
130744103|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
130744104|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
130744105|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
130744106|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
130744107|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
130744108|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
130744109|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
130744110|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
130744111|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
130744112|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
130744113|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
130744114|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
130744115|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
130744116|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
130744117|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
130744118|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
130744119|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
130744120|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
130744121|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
130744122|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
130744123|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
130744124|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
130744125|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
130744126|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
130744127|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
130744128|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
130744129|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
130744130|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
130744131|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
130744132|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
130744133|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
130744134|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
130744135|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
130744136|NCT00838903|470683485|FG000|Follow-up Period (8 Weeks)|Missing|1|||
130744137|NCT00838903|470683486|FG001|Follow-up Period (8 Weeks)|Missing|2|||
130744138|NCT00838903|470683487|FG002|Follow-up Period (8 Weeks)|Missing|1|||
130744139|NCT00838903|470683488|FG003|Follow-up Period (8 Weeks)|Missing|1|||
130744140|NCT04565145|470683489|FG000|Overall Study|Withdrawal by Subject|1|||
130744141|NCT04565145|470683490|FG001|Overall Study|Withdrawal by Subject|1|||
130744142|NCT03096314|470683491|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
130744143|NCT03096314|470683492|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
130744144|NCT04570670|470683493|FG000|Overall Study|Withdrawal by Subject|1|||
130744145|NCT04570670|470683494|FG001|Overall Study|Withdrawal by Subject|0|||
130744146|NCT02549859|470683495|FG000|Long-term 60 Hz DBS|Study Closed|1|||
130744147|NCT00957801|470683498|FG000|Overall Study|Withdrawal by Subject|0|||
130744148|NCT00957801|470683499|FG001|Overall Study|Withdrawal by Subject|0|||
130744149|NCT00957801|470683500|FG002|Overall Study|Withdrawal by Subject|0|||
130744150|NCT00957801|470683501|FG003|Overall Study|Withdrawal by Subject|1|||
130744151|NCT01778855|470683502|FG000|Overall Study|Death|0|||
130744152|NCT01778855|470683503|FG001|Overall Study|Death|1|||
130744153|NCT00191477|470683504|FG000|Overall Study|Tumor Recurrence|49|||
130744154|NCT00191477|470683505|FG001|Overall Study|Tumor Recurrence|48|||
130744155|NCT00191477|470683504|FG000|Overall Study|Death, Study Disease|1|||
130744156|NCT00191477|470683505|FG001|Overall Study|Death, Study Disease|1|||
130744157|NCT00191477|470683504|FG000|Overall Study|Death, Other Cause|3|||
130744158|NCT00191477|470683505|FG001|Overall Study|Death, Other Cause|6|||
130744159|NCT00191477|470683504|FG000|Overall Study|Lost to Follow-up|23|||
130744160|NCT00191477|470683505|FG001|Overall Study|Lost to Follow-up|21|||
130744161|NCT00191477|470683504|FG000|Overall Study|Protocol Violation|1|||
130744162|NCT00191477|470683505|FG001|Overall Study|Protocol Violation|1|||
130744163|NCT00191477|470683504|FG000|Overall Study|Treatment Change|2|||
130744164|NCT00191477|470683505|FG001|Overall Study|Treatment Change|0|||
130744165|NCT00191477|470683504|FG000|Overall Study|Withdrawal by Subject|2|||
130744166|NCT00191477|470683505|FG001|Overall Study|Withdrawal by Subject|0|||
130744167|NCT00191477|470683504|FG000|Overall Study|Other|2|||
130744168|NCT00191477|470683505|FG001|Overall Study|Other|0|||
130744169|NCT00191477|470683504|FG000|Overall Study|Not Eligible|41|||
130744170|NCT00191477|470683505|FG001|Overall Study|Not Eligible|38|||
130744171|NCT00191477|470683504|FG000|Overall Study|Pathological Specimen Lost|1|||
130744172|NCT00191477|470683505|FG001|Overall Study|Pathological Specimen Lost|0|||
130744173|NCT00191477|470683504|FG000|Overall Study|Discontinued Prior to Instillation|13|||
130744174|NCT00191477|470683505|FG001|Overall Study|Discontinued Prior to Instillation|14|||
130744175|NCT01286467|470683510|FG000|Overall Study|Death|1|||
130744176|NCT01286467|470683511|FG001|Overall Study|Death|1|||
130744177|NCT01286467|470683512|FG002|Overall Study|Death|1|||
130744178|NCT01286467|470683513|FG003|Overall Study|Death|0|||
130744179|NCT01286467|470683510|FG000|Overall Study|Lost to Follow-up|0|||
130744180|NCT01286467|470683511|FG001|Overall Study|Lost to Follow-up|0|||
130744181|NCT01286467|470683512|FG002|Overall Study|Lost to Follow-up|0|||
130744182|NCT01286467|470683513|FG003|Overall Study|Lost to Follow-up|1|||
130744183|NCT01286467|470683510|FG000|Overall Study|Withdrawal by Subject|0|||
130744184|NCT01286467|470683511|FG001|Overall Study|Withdrawal by Subject|0|||
130744185|NCT01286467|470683512|FG002|Overall Study|Withdrawal by Subject|1|||
130744186|NCT01286467|470683513|FG003|Overall Study|Withdrawal by Subject|0|||
130744187|NCT01286467|470683510|FG000|Overall Study|Physician Decision|0|||
130744188|NCT01286467|470683511|FG001|Overall Study|Physician Decision|0|||
130744189|NCT01286467|470683512|FG002|Overall Study|Physician Decision|0|||
130744190|NCT01286467|470683513|FG003|Overall Study|Physician Decision|1|||
130744191|NCT01286467|470683510|FG000|Overall Study|Disease progression|3|||
130744192|NCT01286467|470683511|FG001|Overall Study|Disease progression|2|||
130744193|NCT01286467|470683512|FG002|Overall Study|Disease progression|2|||
130744194|NCT01286467|470683513|FG003|Overall Study|Disease progression|3|||
130744195|NCT01286467|470683510|FG000|Overall Study|Adverse Event|0|||
130744196|NCT01286467|470683511|FG001|Overall Study|Adverse Event|1|||
130744197|NCT01286467|470683512|FG002|Overall Study|Adverse Event|2|||
130744198|NCT01286467|470683513|FG003|Overall Study|Adverse Event|3|||
130744199|NCT01286467|470683510|FG000|Overall Study|Study drug stop longer than 14 days|0|||
130744200|NCT01286467|470683511|FG001|Overall Study|Study drug stop longer than 14 days|0|||
130744201|NCT01286467|470683512|FG002|Overall Study|Study drug stop longer than 14 days|1|||
130744202|NCT01286467|470683513|FG003|Overall Study|Study drug stop longer than 14 days|0|||
130744203|NCT01058642|470683514|FG000|Treatment Period 1|Adverse Event|0|||
130744204|NCT01058642|470683515|FG001|Treatment Period 1|Adverse Event|1|||
130744205|NCT01058642|470683516|FG002|Treatment Period 1|Adverse Event|1|||
130744206|NCT01058642|470683517|FG003|Treatment Period 1|Adverse Event|0|||
130744207|NCT01058642|470683514|FG000|Treatment Period 1|Physician Decision|0|||
130744208|NCT01058642|470683515|FG001|Treatment Period 1|Physician Decision|0|||
130744209|NCT01058642|470683516|FG002|Treatment Period 1|Physician Decision|1|||
130744210|NCT01058642|470683517|FG003|Treatment Period 1|Physician Decision|0|||
130744211|NCT01058642|470683514|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130744212|NCT01058642|470683515|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130744213|NCT01058642|470683516|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130744214|NCT01058642|470683517|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130744215|NCT01058642|470683514|FG000|Treatment Period 1|Lack of Efficacy|0|||
130744216|NCT01058642|470683515|FG001|Treatment Period 1|Lack of Efficacy|0|||
130744217|NCT01058642|470683516|FG002|Treatment Period 1|Lack of Efficacy|0|||
130744218|NCT01058642|470683517|FG003|Treatment Period 1|Lack of Efficacy|1|||
130744219|NCT01058642|470683514|FG000|Treatment Period 1|Protocol Violation|0|||
130744220|NCT01058642|470683515|FG001|Treatment Period 1|Protocol Violation|0|||
130744221|NCT01058642|470683516|FG002|Treatment Period 1|Protocol Violation|0|||
130744222|NCT01058642|470683517|FG003|Treatment Period 1|Protocol Violation|1|||
130744223|NCT01058642|470683514|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
130744224|NCT01058642|470683515|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
130744225|NCT01058642|470683516|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
130744226|NCT01058642|470683517|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
130744227|NCT03876743|470683518|FG000|Overall Study|Lost to Follow-up|6|||
130744228|NCT03876743|470683519|FG001|Overall Study|Lost to Follow-up|4|||
130744229|NCT03876743|470683520|FG002|Overall Study|Lost to Follow-up|4|||
130744230|NCT03876743|470683521|FG003|Overall Study|Lost to Follow-up|7|||
130744231|NCT00092118|470683522|FG000|Overall Study|Adverse Event|35|||
130744232|NCT00092118|470683523|FG001|Overall Study|Adverse Event|32|||
130744233|NCT00092118|470683522|FG000|Overall Study|Lack of Efficacy|12|||
130744234|NCT00092118|470683523|FG001|Overall Study|Lack of Efficacy|14|||
130744235|NCT00092118|470683522|FG000|Overall Study|Lost to Follow-up|4|||
130744236|NCT00092118|470683523|FG001|Overall Study|Lost to Follow-up|3|||
130744237|NCT00092118|470683522|FG000|Overall Study|Protocol Violation|23|||
130744238|NCT00092118|470683523|FG001|Overall Study|Protocol Violation|25|||
130744239|NCT00092118|470683522|FG000|Overall Study|Withdrawal by Subject|4|||
130744240|NCT00092118|470683523|FG001|Overall Study|Withdrawal by Subject|10|||
130744241|NCT00092118|470683522|FG000|Overall Study|Other|6|||
130744242|NCT00092118|470683523|FG001|Overall Study|Other|5|||
130744243|NCT01139125|470683524|FG000|Overall Study|Withdrawal by Subject|1|||
130744244|NCT03751098|470683525|FG000|Overall Study|Withdrawal by Subject|0|||
130744245|NCT03751098|470683526|FG001|Overall Study|Withdrawal by Subject|1|||
130744246|NCT01108718|470683529|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
130744247|NCT01108718|470683530|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
130744248|NCT03380429|470683531|FG000|Overall Study|Physician Decision|0|||
130744249|NCT03380429|470683532|FG001|Overall Study|Physician Decision|1|||
130744250|NCT03380429|470683533|FG002|Overall Study|Physician Decision|0|||
130744251|NCT03380429|470683534|FG003|Overall Study|Physician Decision|1|||
130744252|NCT03380429|470683535|FG004|Overall Study|Physician Decision|1|||
130744253|NCT03380429|470683531|FG000|Overall Study|Withdrawal by Subject|3|||
130744254|NCT03380429|470683532|FG001|Overall Study|Withdrawal by Subject|3|||
130744255|NCT03380429|470683533|FG002|Overall Study|Withdrawal by Subject|5|||
130744256|NCT03380429|470683534|FG003|Overall Study|Withdrawal by Subject|2|||
130744257|NCT03380429|470683535|FG004|Overall Study|Withdrawal by Subject|1|||
130744258|NCT03380429|470683531|FG000|Overall Study|Lost to Follow-up|0|||
130744259|NCT03380429|470683532|FG001|Overall Study|Lost to Follow-up|2|||
130744260|NCT03380429|470683533|FG002|Overall Study|Lost to Follow-up|4|||
130744261|NCT03380429|470683534|FG003|Overall Study|Lost to Follow-up|3|||
130744262|NCT03380429|470683535|FG004|Overall Study|Lost to Follow-up|1|||
130744263|NCT03380429|470683531|FG000|Overall Study|Protocol Violation|1|||
130744264|NCT03380429|470683532|FG001|Overall Study|Protocol Violation|0|||
130744265|NCT03380429|470683533|FG002|Overall Study|Protocol Violation|1|||
130744266|NCT03380429|470683534|FG003|Overall Study|Protocol Violation|0|||
130744267|NCT03380429|470683535|FG004|Overall Study|Protocol Violation|1|||
130744268|NCT03380429|470683531|FG000|Overall Study|Lack of Efficacy|0|||
130744269|NCT03380429|470683532|FG001|Overall Study|Lack of Efficacy|0|||
130744270|NCT03380429|470683533|FG002|Overall Study|Lack of Efficacy|0|||
130744271|NCT03380429|470683534|FG003|Overall Study|Lack of Efficacy|2|||
130744272|NCT03380429|470683535|FG004|Overall Study|Lack of Efficacy|1|||
130744273|NCT03380429|470683531|FG000|Overall Study|Adverse Event|1|||
130744274|NCT03380429|470683532|FG001|Overall Study|Adverse Event|1|||
130744275|NCT03380429|470683533|FG002|Overall Study|Adverse Event|1|||
130744276|NCT03380429|470683534|FG003|Overall Study|Adverse Event|2|||
130744277|NCT03380429|470683535|FG004|Overall Study|Adverse Event|0|||
130744278|NCT04760626|470683538|FG000|Overall Study|Withdrawal by Subject|24|||
130744279|NCT04760626|470683539|FG001|Overall Study|Withdrawal by Subject|20|||
130744280|NCT04760626|470683538|FG000|Overall Study|Lost to Follow-up|14|||
130744281|NCT04760626|470683539|FG001|Overall Study|Lost to Follow-up|19|||
130744282|NCT04760626|470683538|FG000|Overall Study|Physician Decision|3|||
130744283|NCT04760626|470683539|FG001|Overall Study|Physician Decision|5|||
130744284|NCT04760626|470683538|FG000|Overall Study|Death|3|||
130744285|NCT04760626|470683539|FG001|Overall Study|Death|6|||
130744286|NCT04760626|470683538|FG000|Overall Study|Site closure|1|||
130744287|NCT04760626|470683539|FG001|Overall Study|Site closure|0|||
130744288|NCT03762265|470683542|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
130744289|NCT03762265|470683543|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
130744290|NCT03762265|470683542|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
130744291|NCT03762265|470683543|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
130744292|NCT03762265|470683542|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
130744293|NCT03762265|470683543|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
130744294|NCT03762265|470683542|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
130744295|NCT03762265|470683543|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
130744296|NCT03762265|470683542|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
130744297|NCT03762265|470683543|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
130744298|NCT03762265|470683542|FG000|BT Period: Weeks 1 to 37|Other|0|||
130744299|NCT03762265|470683543|FG001|BT Period: Weeks 1 to 37|Other|1|||
130744300|NCT03762265|470683542|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
130744301|NCT03762265|470683543|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
130744302|NCT03762265|470683542|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
130744303|NCT03762265|470683543|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
130744304|NCT03762265|470683542|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
130744305|NCT03762265|470683543|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
130744306|NCT03762265|470683542|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
130744307|NCT03762265|470683543|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
130744308|NCT03762265|470683542|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
130744309|NCT03762265|470683543|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
130744310|NCT03762265|470683542|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
130744311|NCT03762265|470683543|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
130744312|NCT03762265|470683542|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
130744313|NCT03762265|470683543|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
130744314|NCT03762265|470683542|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
130744315|NCT03762265|470683543|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
130744316|NCT03762265|470683542|FG000|LTE Period: Weeks 61 to 109|Other|1|||
130744317|NCT03762265|470683543|FG001|LTE Period: Weeks 61 to 109|Other|0|||
130788292|NCT00997893|470854557|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
130744318|NCT00806403|470683546|FG000|Overall Study|Death|4|||
130744319|NCT00806403|470683547|FG001|Overall Study|Death|3|||
130744320|NCT01882985|470683548|FG000|Overall Study|Lost to Follow-up|1|||
130744321|NCT01882985|470683548|FG000|Overall Study|Withdrawal by Subject|1|||
130744322|NCT01383174|470683549|FG000|3 Month Assessment|Death|0|||
130744323|NCT01383174|470683550|FG001|3 Month Assessment|Death|1|||
130744324|NCT01383174|470683549|FG000|3 Month Assessment|Lost to Follow-up|2|||
130744325|NCT01383174|470683550|FG001|3 Month Assessment|Lost to Follow-up|0|||
130744326|NCT01383174|470683549|FG000|3 Month Assessment|Refused to complete|4|||
130744327|NCT01383174|470683550|FG001|3 Month Assessment|Refused to complete|0|||
130744328|NCT01383174|470683549|FG000|6 Month Assessment|Lost to Follow-up|1|||
130744329|NCT01383174|470683550|FG001|6 Month Assessment|Lost to Follow-up|1|||
130744330|NCT01383174|470683549|FG000|6 Month Assessment|Refused to complete|4|||
130744331|NCT01383174|470683550|FG001|6 Month Assessment|Refused to complete|0|||
130744332|NCT01787292|470683551|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
130744333|NCT01787292|470683552|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
130744334|NCT01787292|470683551|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
130744335|NCT01787292|470683552|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
130744336|NCT01827111|470683553|FG000|Overall Study|Disease Progression|1|||
130744337|NCT02169271|470683554|FG000|Overall Study|Protocol Violation|1|||
130744338|NCT02169271|470683555|FG001|Overall Study|Protocol Violation|2|||
130744339|NCT01924689|470683558|FG000|Overall Study|Death|0|||
130744340|NCT01924689|470683559|FG001|Overall Study|Death|1|||
130744341|NCT01924689|470683560|FG002|Overall Study|Death|0|||
130744342|NCT01924689|470683561|FG003|Overall Study|Death|1|||
130744343|NCT01924689|470683562|FG004|Overall Study|Death|0|||
130744344|NCT01924689|470683563|FG005|Overall Study|Death|0|||
130744345|NCT01924689|470683558|FG000|Overall Study|Disease progression|0|||
130744346|NCT01924689|470683559|FG001|Overall Study|Disease progression|0|||
130744347|NCT01924689|470683560|FG002|Overall Study|Disease progression|2|||
130744348|NCT01924689|470683561|FG003|Overall Study|Disease progression|0|||
130744349|NCT01924689|470683562|FG004|Overall Study|Disease progression|3|||
130744350|NCT01924689|470683563|FG005|Overall Study|Disease progression|2|||
130744351|NCT01924689|470683558|FG000|Overall Study|New therapy or study|3|||
130744352|NCT01924689|470683559|FG001|Overall Study|New therapy or study|2|||
130744353|NCT01924689|470683560|FG002|Overall Study|New therapy or study|1|||
130744354|NCT01924689|470683561|FG003|Overall Study|New therapy or study|4|||
130744355|NCT01924689|470683562|FG004|Overall Study|New therapy or study|2|||
130744356|NCT01924689|470683563|FG005|Overall Study|New therapy or study|0|||
130744357|NCT01924689|470683558|FG000|Overall Study|Withdrawal of consent|0|||
130744358|NCT01924689|470683559|FG001|Overall Study|Withdrawal of consent|0|||
130744359|NCT01924689|470683560|FG002|Overall Study|Withdrawal of consent|1|||
130744360|NCT01924689|470683561|FG003|Overall Study|Withdrawal of consent|1|||
130744361|NCT01924689|470683562|FG004|Overall Study|Withdrawal of consent|0|||
130744362|NCT01924689|470683563|FG005|Overall Study|Withdrawal of consent|0|||
130744363|NCT01924689|470683558|FG000|Overall Study|Other|0|||
130744364|NCT01924689|470683559|FG001|Overall Study|Other|0|||
130744365|NCT01924689|470683560|FG002|Overall Study|Other|0|||
130744366|NCT01924689|470683561|FG003|Overall Study|Other|0|||
130744367|NCT01924689|470683562|FG004|Overall Study|Other|1|||
130744368|NCT01924689|470683563|FG005|Overall Study|Other|0|||
130744369|NCT03267212|470683564|FG000|First Intervention|Lost to Follow-up|0|||
130744370|NCT03267212|470683565|FG001|First Intervention|Lost to Follow-up|2|||
130744371|NCT03267212|470683564|FG000|First Intervention|Withdrawal by Subject|1|||
130744372|NCT03267212|470683565|FG001|First Intervention|Withdrawal by Subject|1|||
130744373|NCT03267212|470683564|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
130744374|NCT03267212|470683565|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
130744375|NCT00226499|470683568|FG000|Overall Study|Adverse Event|10|||
130744376|NCT00226499|470683569|FG001|Overall Study|Adverse Event|6|||
130744377|NCT00226499|470683570|FG002|Overall Study|Adverse Event|3|||
130744378|NCT00226499|470683568|FG000|Overall Study|Others|1064|||
130744379|NCT00226499|470683569|FG001|Overall Study|Others|1066|||
130744380|NCT00226499|470683570|FG002|Overall Study|Others|356|||
130744381|NCT00946920|470683571|FG000|Overall Study|Withdrawal by Subject|28|||
130744382|NCT00946920|470683572|FG001|Overall Study|Withdrawal by Subject|15|||
130744383|NCT00946920|470683571|FG000|Overall Study|Lost to Follow-up|2|||
130744384|NCT00946920|470683572|FG001|Overall Study|Lost to Follow-up|2|||
130744385|NCT00946920|470683571|FG000|Overall Study|Physician Decision|5|||
130744386|NCT00946920|470683572|FG001|Overall Study|Physician Decision|2|||
130744387|NCT00946920|470683571|FG000|Overall Study|Adverse Event|41|||
130744388|NCT00946920|470683572|FG001|Overall Study|Adverse Event|14|||
130744389|NCT00946920|470683571|FG000|Overall Study|Protocol Violation|16|||
130744390|NCT00946920|470683572|FG001|Overall Study|Protocol Violation|8|||
130744391|NCT00946920|470683571|FG000|Overall Study|Miscellaneous reasons|18|||
130744392|NCT00946920|470683572|FG001|Overall Study|Miscellaneous reasons|3|||
130744393|NCT01597973|470683573|FG000|Overall Study|Found ineligible before study medication started|4|||
130744394|NCT01597973|470683574|FG001|Overall Study|Found ineligible before study medication started|2|||
130744395|NCT01597973|470683573|FG000|Overall Study|Eligible pathogen not confirmed|14|||
130744396|NCT01597973|470683574|FG001|Overall Study|Eligible pathogen not confirmed|15|||
130744397|NCT01597973|470683573|FG000|Overall Study|LAR not authorized to consent|0|||
130744398|NCT01597973|470683574|FG001|Overall Study|LAR not authorized to consent|1|||
130744399|NCT01597973|470683573|FG000|Overall Study|Ineligible due to early seizures|1|||
130744400|NCT01597973|470683574|FG001|Overall Study|Ineligible due to early seizures|0|||
130744401|NCT01597973|470683573|FG000|Overall Study|Ineligible due to non-target infection|1|||
130744402|NCT01597973|470683574|FG001|Overall Study|Ineligible due to non-target infection|1|||
130744403|NCT02389829|470683581|FG000|Overall Study|Lost to Follow-up|0|||
130744404|NCT02389829|470683582|FG001|Overall Study|Lost to Follow-up|1|||
130744405|NCT02362360|470683583|FG000|Period 1|Lack of Efficacy|1|||
130744406|NCT02362360|470683584|FG001|Period 1|Lack of Efficacy|0|||
130744407|NCT02362360|470683583|FG000|Period 1|Withdrawal by Subject|2|||
130744408|NCT02362360|470683584|FG001|Period 1|Withdrawal by Subject|1|||
130744409|NCT02208362|470683585|FG000|Overall Study|Participant did not complete treatment|0|||
130744410|NCT02208362|470683586|FG001|Overall Study|Participant did not complete treatment|1|||
130744411|NCT02208362|470683587|FG002|Overall Study|Participant did not complete treatment|0|||
130744412|NCT02208362|470683588|FG003|Overall Study|Participant did not complete treatment|0|||
130744413|NCT02208362|470683589|FG004|Overall Study|Participant did not complete treatment|0|||
130744414|NCT02208362|470683590|FG005|Overall Study|Participant did not complete treatment|0|||
130744415|NCT02208362|470683591|FG006|Overall Study|Participant did not complete treatment|1|||
130744416|NCT02208362|470683592|FG007|Overall Study|Participant did not complete treatment|1|||
130744417|NCT02208362|470683593|FG008|Overall Study|Participant did not complete treatment|2|||
130744418|NCT02208362|470683594|FG009|Overall Study|Participant did not complete treatment|0|||
130744419|NCT02208362|470683595|FG010|Overall Study|Participant did not complete treatment|1|||
130744420|NCT02208362|470683596|FG011|Overall Study|Participant did not complete treatment|0|||
130744421|NCT02208362|470683585|FG000|Overall Study|Participant received disallowed treatment|0|||
130744422|NCT02208362|470683586|FG001|Overall Study|Participant received disallowed treatment|0|||
130744423|NCT02208362|470683587|FG002|Overall Study|Participant received disallowed treatment|0|||
130744424|NCT02208362|470683588|FG003|Overall Study|Participant received disallowed treatment|0|||
130744425|NCT02208362|470683589|FG004|Overall Study|Participant received disallowed treatment|0|||
130744426|NCT02208362|470683590|FG005|Overall Study|Participant received disallowed treatment|0|||
130744427|NCT02208362|470683591|FG006|Overall Study|Participant received disallowed treatment|0|||
130744428|NCT02208362|470683592|FG007|Overall Study|Participant received disallowed treatment|0|||
130744429|NCT02208362|470683593|FG008|Overall Study|Participant received disallowed treatment|1|||
130744430|NCT02208362|470683594|FG009|Overall Study|Participant received disallowed treatment|0|||
130744431|NCT02208362|470683595|FG010|Overall Study|Participant received disallowed treatment|0|||
130744432|NCT02208362|470683596|FG011|Overall Study|Participant received disallowed treatment|0|||
130744433|NCT00955409|470684779|FG000|Overall Study|Lack of Efficacy|1|||
130744434|NCT00955409|470684780|FG001|Overall Study|Lack of Efficacy|0|||
130744435|NCT00955409|470684781|FG002|Overall Study|Lack of Efficacy|0|||
130744436|NCT00955409|470684782|FG003|Overall Study|Lack of Efficacy|0|||
130744437|NCT00955409|470684783|FG004|Overall Study|Lack of Efficacy|0|||
130744438|NCT00955409|470684784|FG005|Overall Study|Lack of Efficacy|0|||
130744439|NCT00955409|470684785|FG006|Overall Study|Lack of Efficacy|0|||
130744440|NCT00955409|470684786|FG007|Overall Study|Lack of Efficacy|0|||
130744441|NCT00955409|470684787|FG008|Overall Study|Lack of Efficacy|0|||
130744442|NCT00955409|470684788|FG009|Overall Study|Lack of Efficacy|0|||
130744443|NCT00955409|470684779|FG000|Overall Study|Withdrawal by Subject|1|||
130744444|NCT00955409|470684780|FG001|Overall Study|Withdrawal by Subject|0|||
130744445|NCT00955409|470684781|FG002|Overall Study|Withdrawal by Subject|5|||
130744446|NCT00955409|470684782|FG003|Overall Study|Withdrawal by Subject|2|||
130744447|NCT00955409|470684783|FG004|Overall Study|Withdrawal by Subject|0|||
130744448|NCT00955409|470684784|FG005|Overall Study|Withdrawal by Subject|0|||
130744449|NCT00955409|470684785|FG006|Overall Study|Withdrawal by Subject|2|||
130744450|NCT00955409|470684786|FG007|Overall Study|Withdrawal by Subject|0|||
130744451|NCT00955409|470684787|FG008|Overall Study|Withdrawal by Subject|1|||
130744452|NCT00955409|470684788|FG009|Overall Study|Withdrawal by Subject|0|||
130744453|NCT00955409|470684779|FG000|Overall Study|Caregiver Request|2|||
130744454|NCT00955409|470684780|FG001|Overall Study|Caregiver Request|0|||
130744455|NCT00955409|470684781|FG002|Overall Study|Caregiver Request|6|||
130744456|NCT00955409|470684782|FG003|Overall Study|Caregiver Request|5|||
130788293|NCT00997893|470854558|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
130788294|NCT00997893|470854559|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
130744457|NCT00955409|470684783|FG004|Overall Study|Caregiver Request|0|||
130744458|NCT00955409|470684784|FG005|Overall Study|Caregiver Request|2|||
130744459|NCT00955409|470684785|FG006|Overall Study|Caregiver Request|3|||
130744460|NCT00955409|470684786|FG007|Overall Study|Caregiver Request|1|||
130744461|NCT00955409|470684787|FG008|Overall Study|Caregiver Request|3|||
130744462|NCT00955409|470684788|FG009|Overall Study|Caregiver Request|0|||
130744463|NCT00955409|470684779|FG000|Overall Study|Investigator Request|0|||
130788295|NCT03451045|470854570|FG000|Overall Study|Lack of Efficacy|3|||
130744464|NCT00955409|470684780|FG001|Overall Study|Investigator Request|0|||
130744465|NCT00955409|470684781|FG002|Overall Study|Investigator Request|1|||
130744466|NCT00955409|470684782|FG003|Overall Study|Investigator Request|0|||
130744467|NCT00955409|470684783|FG004|Overall Study|Investigator Request|0|||
130744468|NCT00955409|470684784|FG005|Overall Study|Investigator Request|0|||
130744469|NCT00955409|470684785|FG006|Overall Study|Investigator Request|0|||
130744470|NCT00955409|470684786|FG007|Overall Study|Investigator Request|0|||
130744471|NCT00955409|470684787|FG008|Overall Study|Investigator Request|0|||
130744472|NCT00955409|470684788|FG009|Overall Study|Investigator Request|0|||
130744473|NCT00955409|470684779|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
130744474|NCT00955409|470684780|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130744475|NCT00955409|470684781|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
130744476|NCT00955409|470684782|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
130744477|NCT00955409|470684783|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
130744478|NCT00955409|470684784|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
130744479|NCT00955409|470684785|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
130744480|NCT00955409|470684786|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
130744481|NCT00955409|470684787|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
130744482|NCT00955409|470684788|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
130744483|NCT00955409|470684779|FG000|Overall Study|Lost to Follow-up|0|||
130744484|NCT00955409|470684780|FG001|Overall Study|Lost to Follow-up|0|||
130744485|NCT00955409|470684781|FG002|Overall Study|Lost to Follow-up|1|||
130744486|NCT00955409|470684782|FG003|Overall Study|Lost to Follow-up|0|||
130744487|NCT00955409|470684783|FG004|Overall Study|Lost to Follow-up|0|||
130744488|NCT00955409|470684784|FG005|Overall Study|Lost to Follow-up|0|||
130744489|NCT00955409|470684785|FG006|Overall Study|Lost to Follow-up|1|||
130744490|NCT00955409|470684786|FG007|Overall Study|Lost to Follow-up|0|||
130744491|NCT00955409|470684787|FG008|Overall Study|Lost to Follow-up|0|||
130744492|NCT00955409|470684788|FG009|Overall Study|Lost to Follow-up|0|||
130744493|NCT00955409|470684779|FG000|Overall Study|Failed to Return|2|||
130744494|NCT00955409|470684780|FG001|Overall Study|Failed to Return|0|||
130744495|NCT00955409|470684781|FG002|Overall Study|Failed to Return|0|||
130744496|NCT00955409|470684782|FG003|Overall Study|Failed to Return|0|||
130744497|NCT00955409|470684783|FG004|Overall Study|Failed to Return|0|||
130744498|NCT00955409|470684784|FG005|Overall Study|Failed to Return|0|||
130744499|NCT00955409|470684785|FG006|Overall Study|Failed to Return|0|||
130744500|NCT00955409|470684786|FG007|Overall Study|Failed to Return|2|||
130744501|NCT00955409|470684787|FG008|Overall Study|Failed to Return|0|||
130744502|NCT00955409|470684788|FG009|Overall Study|Failed to Return|0|||
130744503|NCT00955409|470684779|FG000|Overall Study|Adverse Event (AE)|2|||
130744504|NCT00955409|470684780|FG001|Overall Study|Adverse Event (AE)|0|||
130744505|NCT00955409|470684781|FG002|Overall Study|Adverse Event (AE)|0|||
130744506|NCT00955409|470684782|FG003|Overall Study|Adverse Event (AE)|0|||
130744507|NCT00955409|470684783|FG004|Overall Study|Adverse Event (AE)|0|||
130744508|NCT00955409|470684784|FG005|Overall Study|Adverse Event (AE)|1|||
130744509|NCT00955409|470684785|FG006|Overall Study|Adverse Event (AE)|2|||
130744510|NCT00955409|470684786|FG007|Overall Study|Adverse Event (AE)|0|||
130744511|NCT00955409|470684787|FG008|Overall Study|Adverse Event (AE)|2|||
130744512|NCT00955409|470684788|FG009|Overall Study|Adverse Event (AE)|0|||
130744513|NCT00955409|470684779|FG000|Overall Study|Reason not Specified|2|||
130744514|NCT00955409|470684780|FG001|Overall Study|Reason not Specified|1|||
130744515|NCT00955409|470684781|FG002|Overall Study|Reason not Specified|13|||
130744516|NCT00955409|470684782|FG003|Overall Study|Reason not Specified|1|||
130744517|NCT00955409|470684783|FG004|Overall Study|Reason not Specified|2|||
130744518|NCT00955409|470684784|FG005|Overall Study|Reason not Specified|0|||
130744519|NCT00955409|470684785|FG006|Overall Study|Reason not Specified|16|||
130744520|NCT00955409|470684786|FG007|Overall Study|Reason not Specified|0|||
130744521|NCT00955409|470684787|FG008|Overall Study|Reason not Specified|8|||
130744522|NCT00955409|470684788|FG009|Overall Study|Reason not Specified|1|||
130744523|NCT00803790|470684789|FG000|Period 1|Adverse Event|0|||
130744524|NCT00803790|470684790|FG001|Period 1|Adverse Event|1|||
130744525|NCT00803790|470684791|FG002|Period 1|Adverse Event|0|||
130744526|NCT00803790|470684792|FG003|Period 1|Adverse Event|0|||
130744527|NCT00803790|470684789|FG000|Period 1|Lost to Follow-up|1|||
130744528|NCT00803790|470684790|FG001|Period 1|Lost to Follow-up|2|||
130744529|NCT00803790|470684791|FG002|Period 1|Lost to Follow-up|0|||
130744530|NCT00803790|470684792|FG003|Period 1|Lost to Follow-up|0|||
130744531|NCT00803790|470684789|FG000|Period 1|Withdrawal by Subject|8|||
130744532|NCT00803790|470684790|FG001|Period 1|Withdrawal by Subject|6|||
130744533|NCT00803790|470684791|FG002|Period 1|Withdrawal by Subject|0|||
130744534|NCT00803790|470684792|FG003|Period 1|Withdrawal by Subject|0|||
130744535|NCT00803790|470684789|FG000|Period 1|positive drug screen or personal reasons|0|||
130744536|NCT00803790|470684790|FG001|Period 1|positive drug screen or personal reasons|3|||
130744537|NCT00803790|470684791|FG002|Period 1|positive drug screen or personal reasons|0|||
130744538|NCT00803790|470684792|FG003|Period 1|positive drug screen or personal reasons|4|||
130744539|NCT00803790|470684789|FG000|Period 1|Protocol Violation|0|||
130744540|NCT00803790|470684790|FG001|Period 1|Protocol Violation|0|||
130744541|NCT00803790|470684791|FG002|Period 1|Protocol Violation|1|||
130744542|NCT00803790|470684792|FG003|Period 1|Protocol Violation|0|||
130744543|NCT00803790|470684789|FG000|Period 2|Adverse Event|0|||
130744544|NCT00803790|470684790|FG001|Period 2|Adverse Event|0|||
130744545|NCT00803790|470684791|FG002|Period 2|Adverse Event|1|||
130744546|NCT00803790|470684792|FG003|Period 2|Adverse Event|1|||
130744547|NCT00803790|470684789|FG000|Period 2|Withdrawal by Subject|1|||
130744548|NCT00803790|470684790|FG001|Period 2|Withdrawal by Subject|0|||
130744549|NCT00803790|470684791|FG002|Period 2|Withdrawal by Subject|0|||
130744550|NCT00803790|470684792|FG003|Period 2|Withdrawal by Subject|0|||
130744551|NCT00803790|470684789|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
130744552|NCT00803790|470684790|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
130744553|NCT00803790|470684791|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
130744554|NCT00803790|470684792|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
130744555|NCT05161481|470684793|FG000|Overall Study|Withdrawal of consent|0|||
130744556|NCT05161481|470684794|FG001|Overall Study|Withdrawal of consent|1|||
130744557|NCT05161481|470684795|FG002|Overall Study|Withdrawal of consent|1|||
130744558|NCT05161481|470684793|FG000|Overall Study|Study terminated by sponsor|3|||
130744559|NCT05161481|470684794|FG001|Overall Study|Study terminated by sponsor|3|||
130744560|NCT05161481|470684795|FG002|Overall Study|Study terminated by sponsor|2|||
130744561|NCT05161481|470684793|FG000|Overall Study|Adverse Event|3|||
130744562|NCT05161481|470684794|FG001|Overall Study|Adverse Event|0|||
130744563|NCT05161481|470684795|FG002|Overall Study|Adverse Event|6|||
130744564|NCT05161481|470684793|FG000|Overall Study|Randomised in error and was not treated|1|||
130744565|NCT05161481|470684794|FG001|Overall Study|Randomised in error and was not treated|0|||
130744566|NCT05161481|470684795|FG002|Overall Study|Randomised in error and was not treated|0|||
130744567|NCT05161481|470684793|FG000|Overall Study|Subject decision|0|||
130744568|NCT05161481|470684794|FG001|Overall Study|Subject decision|0|||
130744569|NCT05161481|470684795|FG002|Overall Study|Subject decision|1|||
130744570|NCT00471081|470684796|FG000|Active Phase|Protocol Violation|1|||
130744571|NCT00471081|470684797|FG001|Active Phase|Protocol Violation|1|||
130744572|NCT00471081|470684796|FG000|Active Phase|Withdrawal by Subject|0|||
130744573|NCT00471081|470684797|FG001|Active Phase|Withdrawal by Subject|3|||
130744574|NCT00471081|470684796|FG000|Active Phase|Lost to Follow-up|0|||
130744575|NCT00471081|470684797|FG001|Active Phase|Lost to Follow-up|1|||
130744576|NCT00471081|470684796|FG000|Active Phase|Lost health plan/insurance|1|||
130744577|NCT00471081|470684797|FG001|Active Phase|Lost health plan/insurance|8|||
130744578|NCT00471081|470684796|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
130744579|NCT00471081|470684797|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
130744580|NCT00471081|470684796|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
130744581|NCT00471081|470684797|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
130744582|NCT00471081|470684796|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
130744583|NCT00471081|470684797|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
130744584|NCT04335123|470684799|FG000|Overall Study|Withdrawal by Subject|2|||
130744585|NCT04335123|470684800|FG001|Overall Study|Withdrawal by Subject|0|||
130744586|NCT04335123|470684799|FG000|Overall Study|Physician Decision|2|||
130744587|NCT04335123|470684800|FG001|Overall Study|Physician Decision|0|||
130744588|NCT01283464|470684801|FG000|Overall Study|Lost to Follow-up|0|||
130744589|NCT01283464|470684802|FG001|Overall Study|Lost to Follow-up|1|||
130744590|NCT01283464|470684801|FG000|Overall Study|Withdrawal by Subject|1|||
130744591|NCT01283464|470684802|FG001|Overall Study|Withdrawal by Subject|0|||
130744592|NCT01283464|470684801|FG000|Overall Study|Physician Decision|1|||
130744593|NCT01283464|470684802|FG001|Overall Study|Physician Decision|0|||
130744594|NCT02626026|470684803|FG000|Overall Study|Randomized but Never Treated|0|||
130744595|NCT02626026|470684804|FG001|Overall Study|Randomized but Never Treated|0|||
130744596|NCT02626026|470684805|FG002|Overall Study|Randomized but Never Treated|0|||
130744597|NCT02626026|470684806|FG003|Overall Study|Randomized but Never Treated|0|||
130744598|NCT02626026|470684807|FG004|Overall Study|Randomized but Never Treated|1|||
130744599|NCT02626026|470684808|FG005|Overall Study|Randomized but Never Treated|0|||
130744600|NCT03922308|470684813|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
130744601|NCT03922308|470684814|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
130744602|NCT03922308|470684815|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
130744603|NCT03922308|470684813|FG000|Overall Study|Lost to Follow-up|1|||
130744604|NCT03922308|470684814|FG001|Overall Study|Lost to Follow-up|0|||
130744605|NCT03922308|470684815|FG002|Overall Study|Lost to Follow-up|0|||
130744606|NCT03922308|470684813|FG000|Overall Study|Reason not Specified|0|||
130744607|NCT03922308|470684814|FG001|Overall Study|Reason not Specified|2|||
130744608|NCT03922308|470684815|FG002|Overall Study|Reason not Specified|1|||
130744609|NCT03376789|470684816|FG000|Overall Study|Withdrawal by Subject|3|||
130744610|NCT03376789|470684817|FG001|Overall Study|Withdrawal by Subject|5|||
130744611|NCT03376789|470684816|FG000|Overall Study|Protocol Violation|0|||
130744612|NCT03376789|470684817|FG001|Overall Study|Protocol Violation|1|||
130744613|NCT03376789|470684816|FG000|Overall Study|Adverse Event|0|||
130744614|NCT03376789|470684817|FG001|Overall Study|Adverse Event|1|||
130744615|NCT03376789|470684816|FG000|Overall Study|Lost to Follow-up|1|||
130744616|NCT03376789|470684817|FG001|Overall Study|Lost to Follow-up|1|||
130744617|NCT03376789|470684816|FG000|Overall Study|Per sponsor due to noncompliance|1|||
130744618|NCT03376789|470684817|FG001|Overall Study|Per sponsor due to noncompliance|0|||
130744619|NCT03376789|470684816|FG000|Overall Study|Subject off study medication|0|||
130744620|NCT03376789|470684817|FG001|Overall Study|Subject off study medication|1|||
130744621|NCT04177095|470684820|FG000|Overall Study|Withdrawal by Subject|3|||
130744622|NCT04177095|470684820|FG000|Overall Study|Screen Failure|3|||
130744623|NCT04177095|470684820|FG000|Overall Study|Problems with the Trugraf assay|1|||
130744624|NCT01592786|470684821|FG000|Overall Study|Adverse Event|60|||
130744625|NCT01592786|470684821|FG000|Overall Study|Lack of Efficacy|19|||
130744626|NCT01592786|470684821|FG000|Overall Study|Protocol Violation|14|||
130744627|NCT01592786|470684821|FG000|Overall Study|Withdrawal by Subject|23|||
130744628|NCT01592786|470684821|FG000|Overall Study|Lost to Follow-up|19|||
130744629|NCT01592786|470684821|FG000|Overall Study|Other|3|||
130744630|NCT02172664|470684822|FG000|Overall Study|Lost to Follow-up|4|||
130744631|NCT02172664|470684823|FG001|Overall Study|Lost to Follow-up|4|||
130744632|NCT02172664|470684822|FG000|Overall Study|Death|1|||
130744633|NCT02172664|470684823|FG001|Overall Study|Death|1|||
130744634|NCT02172664|470684822|FG000|Overall Study|Moved out of area|1|||
130744635|NCT02172664|470684823|FG001|Overall Study|Moved out of area|1|||
130744636|NCT04426006|470684824|FG000|Inclusion|Protocol Violation|1|||
130744637|NCT04426006|470684824|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
130744638|NCT04426006|470684824|FG000|Inclusion|Blood sample at inclusion not done|1|||
130744639|NCT04426006|470684824|FG000|3 Months|Lost to Follow-up|17|||
130744640|NCT04426006|470684824|FG000|12 Months|Lost to Follow-up|38|||
130744641|NCT02946463|470684825|FG000|Primary Evaluation Period|Physician Decision|0|||
130744642|NCT02946463|470684826|FG001|Primary Evaluation Period|Physician Decision|1|||
130744643|NCT02946463|470684827|FG002|Primary Evaluation Period|Physician Decision|0|||
130744644|NCT02946463|470684828|FG003|Primary Evaluation Period|Physician Decision|0|||
130744645|NCT02946463|470684825|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
130744646|NCT02946463|470684826|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
130744647|NCT02946463|470684827|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
130744648|NCT02946463|470684828|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
130744649|NCT02946463|470684825|FG000|Extension Period|Death|4|||
130744650|NCT02946463|470684826|FG001|Extension Period|Death|4|||
130744651|NCT02946463|470684827|FG002|Extension Period|Death|0|||
130744652|NCT02946463|470684828|FG003|Extension Period|Death|0|||
130744653|NCT02946463|470684825|FG000|Extension Period|Withdrawal by Subject|4|||
130744654|NCT02946463|470684826|FG001|Extension Period|Withdrawal by Subject|3|||
130744655|NCT02946463|470684827|FG002|Extension Period|Withdrawal by Subject|0|||
130744656|NCT02946463|470684828|FG003|Extension Period|Withdrawal by Subject|0|||
130744657|NCT02946463|470684825|FG000|Extension Period|Other than specified|2|||
130744658|NCT02946463|470684826|FG001|Extension Period|Other than specified|3|||
130744659|NCT02946463|470684827|FG002|Extension Period|Other than specified|2|||
130744660|NCT02946463|470684828|FG003|Extension Period|Other than specified|0|||
130744661|NCT02946463|470684825|FG000|Extension Period|Physician Decision|1|||
130744662|NCT02946463|470684826|FG001|Extension Period|Physician Decision|4|||
130744663|NCT02946463|470684827|FG002|Extension Period|Physician Decision|0|||
130744664|NCT02946463|470684828|FG003|Extension Period|Physician Decision|0|||
130744665|NCT02946463|470684825|FG000|Extension Period|Pregnancy|3|||
130744666|NCT02946463|470684826|FG001|Extension Period|Pregnancy|1|||
130744667|NCT02946463|470684827|FG002|Extension Period|Pregnancy|0|||
130788296|NCT03451045|470854571|FG001|Overall Study|Lack of Efficacy|2|||
130788297|NCT03451045|470854572|FG002|Overall Study|Lack of Efficacy|2|||
130788298|NCT03451045|470854570|FG000|Overall Study|Physician Decision|1|||
130788299|NCT03451045|470854571|FG001|Overall Study|Physician Decision|1|||
130788300|NCT03451045|470854572|FG002|Overall Study|Physician Decision|1|||
130788301|NCT03451045|470854570|FG000|Overall Study|Withdrawal by Subject|4|||
130788302|NCT03451045|470854571|FG001|Overall Study|Withdrawal by Subject|0|||
130744668|NCT02946463|470684828|FG003|Extension Period|Pregnancy|0|||
130744669|NCT02946463|470684825|FG000|Extension Period|Adverse Event|1|||
130744670|NCT02946463|470684826|FG001|Extension Period|Adverse Event|2|||
130744671|NCT02946463|470684827|FG002|Extension Period|Adverse Event|0|||
130744672|NCT02946463|470684828|FG003|Extension Period|Adverse Event|0|||
130744673|NCT02946463|470684825|FG000|Extension Period|Lost to Follow-up|1|||
130744674|NCT02946463|470684826|FG001|Extension Period|Lost to Follow-up|0|||
130744675|NCT02946463|470684827|FG002|Extension Period|Lost to Follow-up|0|||
130744676|NCT02946463|470684828|FG003|Extension Period|Lost to Follow-up|0|||
130744677|NCT05691712|470684831|FG000|Overall Study|Adverse Event|0|||
130744678|NCT05691712|470684832|FG001|Overall Study|Adverse Event|1|||
130744679|NCT05691712|470684833|FG002|Overall Study|Adverse Event|2|||
130744680|NCT05691712|470684834|FG003|Overall Study|Adverse Event|1|||
130788303|NCT03451045|470854572|FG002|Overall Study|Withdrawal by Subject|5|||
130744681|NCT05691712|470684831|FG000|Overall Study|Withdrawal by Subject|2|||
130744682|NCT05691712|470684832|FG001|Overall Study|Withdrawal by Subject|3|||
130744683|NCT05691712|470684833|FG002|Overall Study|Withdrawal by Subject|3|||
130744684|NCT05691712|470684834|FG003|Overall Study|Withdrawal by Subject|1|||
130744685|NCT05691712|470684831|FG000|Overall Study|Death|1|||
130788304|NCT03451045|470854570|FG000|Overall Study|Pregnancy|0|||
130788305|NCT03451045|470854571|FG001|Overall Study|Pregnancy|0|||
130744686|NCT05691712|470684832|FG001|Overall Study|Death|0|||
130744687|NCT05691712|470684833|FG002|Overall Study|Death|0|||
130744688|NCT05691712|470684834|FG003|Overall Study|Death|0|||
130744689|NCT05691712|470684831|FG000|Overall Study|Pregnancy|0|||
130744690|NCT05691712|470684832|FG001|Overall Study|Pregnancy|1|||
130744691|NCT05691712|470684833|FG002|Overall Study|Pregnancy|0|||
130744692|NCT05691712|470684834|FG003|Overall Study|Pregnancy|0|||
130744693|NCT05691712|470684831|FG000|Overall Study|Assigned Treatment by Mistake|1|||
130744694|NCT05691712|470684832|FG001|Overall Study|Assigned Treatment by Mistake|0|||
130744695|NCT05691712|470684833|FG002|Overall Study|Assigned Treatment by Mistake|0|||
130744696|NCT05691712|470684834|FG003|Overall Study|Assigned Treatment by Mistake|1|||
130744697|NCT02166333|470684837|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
130744698|NCT02166333|470684838|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
130744699|NCT02166333|470684839|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
130744700|NCT02166333|470684840|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
130744701|NCT02166333|470684841|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
130744702|NCT02166333|470684842|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
130744703|NCT02166333|470684837|FG000|Stage 1|Death|4|||
130744704|NCT02166333|470684838|FG001|Stage 1|Death|0|||
130744705|NCT02166333|470684839|FG002|Stage 1|Death|2|||
130744706|NCT02166333|470684840|FG003|Stage 1|Death|0|||
130744707|NCT02166333|470684841|FG004|Stage 1|Death|3|||
130744708|NCT02166333|470684842|FG005|Stage 1|Death|2|||
130744709|NCT02166333|470684837|FG000|Stage 1|Lost to Follow-up|12|||
130744710|NCT02166333|470684838|FG001|Stage 1|Lost to Follow-up|0|||
130744711|NCT02166333|470684839|FG002|Stage 1|Lost to Follow-up|6|||
130744712|NCT02166333|470684840|FG003|Stage 1|Lost to Follow-up|0|||
130744713|NCT02166333|470684841|FG004|Stage 1|Lost to Follow-up|3|||
130744714|NCT02166333|470684842|FG005|Stage 1|Lost to Follow-up|3|||
130744715|NCT02166333|470684837|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
130744716|NCT02166333|470684838|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
130744717|NCT02166333|470684839|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
130744718|NCT02166333|470684840|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
130744719|NCT02166333|470684841|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
130744720|NCT02166333|470684842|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
130744721|NCT02166333|470684837|FG000|Stage 2|Death|4|||
130744722|NCT02166333|470684838|FG001|Stage 2|Death|2|||
130744723|NCT02166333|470684839|FG002|Stage 2|Death|1|||
130744724|NCT02166333|470684840|FG003|Stage 2|Death|0|||
130744725|NCT02166333|470684841|FG004|Stage 2|Death|0|||
130744726|NCT02166333|470684842|FG005|Stage 2|Death|1|||
130744727|NCT02166333|470684837|FG000|Stage 2|Lost to Follow-up|23|||
130744728|NCT02166333|470684838|FG001|Stage 2|Lost to Follow-up|4|||
130744729|NCT02166333|470684839|FG002|Stage 2|Lost to Follow-up|11|||
130744730|NCT02166333|470684840|FG003|Stage 2|Lost to Follow-up|9|||
130744731|NCT02166333|470684841|FG004|Stage 2|Lost to Follow-up|3|||
130744732|NCT02166333|470684842|FG005|Stage 2|Lost to Follow-up|6|||
130744733|NCT00682786|470684844|FG000|Overall Study|Withdrawal by Subject|2|||
130744734|NCT00682786|470684845|FG001|Overall Study|Withdrawal by Subject|2|||
130744735|NCT00682786|470684844|FG000|Overall Study|Did not receive irinotecan|0|||
130744736|NCT00682786|470684845|FG001|Overall Study|Did not receive irinotecan|1|||
130744737|NCT00359424|470684846|FG000|Overall Study|Death|99|||
130744738|NCT00359424|470684847|FG001|Overall Study|Death|58|||
130744739|NCT00359424|470684846|FG000|Overall Study|Lost to Follow-up|19|||
130744740|NCT00359424|470684847|FG001|Overall Study|Lost to Follow-up|7|||
130744741|NCT00359424|470684846|FG000|Overall Study|Withdrawal by Subject|10|||
130788306|NCT03451045|470854572|FG002|Overall Study|Pregnancy|2|||
130788307|NCT03451045|470854570|FG000|Overall Study|Adverse Event|7|||
130788308|NCT03451045|470854571|FG001|Overall Study|Adverse Event|1|||
130744742|NCT00359424|470684847|FG001|Overall Study|Withdrawal by Subject|2|||
130744743|NCT00359424|470684846|FG000|Overall Study|follow up not conducted|2|||
130744744|NCT00359424|470684847|FG001|Overall Study|follow up not conducted|0|||
130744745|NCT01831635|470684848|FG000|Overall Study|Withdrawal by Subject|0|||
130744746|NCT01831635|470684849|FG001|Overall Study|Withdrawal by Subject|2|||
130744747|NCT01831635|470684850|FG002|Overall Study|Withdrawal by Subject|0|||
130744748|NCT03830333|470684853|FG000|Overall Study|Death|0|||
130744749|NCT03830333|470684854|FG001|Overall Study|Death|1|||
130744750|NCT03830333|470684853|FG000|Overall Study|Withdrawal by Subject|5|||
130744751|NCT03830333|470684854|FG001|Overall Study|Withdrawal by Subject|1|||
130744752|NCT03830333|470684853|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
130744753|NCT03830333|470684854|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
130744754|NCT03805412|470684855|FG000|Overall Study|Lost to Follow-up|0|||
130744755|NCT03805412|470684856|FG001|Overall Study|Lost to Follow-up|1|||
130788309|NCT03451045|470854572|FG002|Overall Study|Adverse Event|3|||
130744756|NCT03525678|470684871|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
130744757|NCT03525678|470684872|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
130744758|NCT03525678|470684873|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
130744759|NCT03525678|470684874|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
130744760|NCT03525678|470684875|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
130744761|NCT03525678|470684871|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
130744762|NCT03525678|470684872|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
130744763|NCT03525678|470684873|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
130744764|NCT03525678|470684874|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
130744765|NCT03525678|470684875|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
130744766|NCT03525678|470684871|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
130744767|NCT03525678|470684872|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
130744768|NCT03525678|470684873|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
130744769|NCT03525678|470684874|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
130744770|NCT03525678|470684875|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
130744771|NCT03525678|470684871|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
130744772|NCT03525678|470684872|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
130744773|NCT03525678|470684873|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
130744774|NCT03525678|470684874|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
130744775|NCT03525678|470684875|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
130744776|NCT03525678|470684871|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
130744777|NCT03525678|470684872|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
130744778|NCT03525678|470684873|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
130744779|NCT03525678|470684874|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
130744780|NCT03525678|470684875|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
130744781|NCT03525678|470684871|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
130744782|NCT03525678|470684872|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
130744783|NCT03525678|470684873|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
130744784|NCT03525678|470684874|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
130744785|NCT03525678|470684875|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
130744786|NCT02747108|470684876|FG000|Overall Study|Death|2|||
130744787|NCT02747108|470684877|FG001|Overall Study|Death|2|||
130744788|NCT02747108|470684876|FG000|Overall Study|Withdrawal by Subject|1|||
130744789|NCT02747108|470684877|FG001|Overall Study|Withdrawal by Subject|0|||
130744790|NCT02747108|470684876|FG000|Overall Study|Protocol Violation|2|||
130744791|NCT02747108|470684877|FG001|Overall Study|Protocol Violation|0|||
130744792|NCT05966584|470684878|FG000|Overall Study|Lost to Follow-up|1|||
130744793|NCT04563754|470685766|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
130744794|NCT04563754|470685767|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
130744795|NCT04563754|470685768|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
130744796|NCT04563754|470685766|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
130744797|NCT04563754|470685767|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
130744798|NCT04563754|470685768|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
130744799|NCT04563754|470685766|FG000|Follow up|Lost to Follow-up|61|||
130744800|NCT04563754|470685767|FG001|Follow up|Lost to Follow-up|23|||
130744801|NCT04563754|470685768|FG002|Follow up|Lost to Follow-up|5|||
130744802|NCT04563754|470685766|FG000|Follow up|Death|0|||
130744803|NCT04563754|470685767|FG001|Follow up|Death|2|||
130744804|NCT04563754|470685768|FG002|Follow up|Death|0|||
130744805|NCT04563754|470685766|FG000|Follow up|Ongoing|0|||
130744806|NCT04563754|470685767|FG001|Follow up|Ongoing|28|||
130744807|NCT04563754|470685768|FG002|Follow up|Ongoing|0|||
130744808|NCT04023396|470685769|FG000|Overall Study|Adverse Event|16|||
130744809|NCT04023396|470685769|FG000|Overall Study|Death|1|||
130744810|NCT04023396|470685769|FG000|Overall Study|Lost to Follow-up|1|||
130744811|NCT04023396|470685769|FG000|Overall Study|Withdrawal by Subject|14|||
130744812|NCT04023396|470685769|FG000|Overall Study|Pregnancy|4|||
130744813|NCT04023396|470685769|FG000|Overall Study|Lack of Efficacy|3|||
130744814|NCT04023396|470685769|FG000|Overall Study|Physician Decision|4|||
130744815|NCT04023396|470685769|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
130744816|NCT04075825|470685770|FG000|Overall Study|Withdrawal by Subject|6|||
130744817|NCT04075825|470685771|FG001|Overall Study|Withdrawal by Subject|8|||
130744818|NCT04075825|470685770|FG000|Overall Study|Physician Decision|3|||
130744819|NCT04075825|470685771|FG001|Overall Study|Physician Decision|1|||
130744820|NCT04075825|470685770|FG000|Overall Study|Lost to Follow-up|5|||
130744821|NCT04075825|470685771|FG001|Overall Study|Lost to Follow-up|1|||
130744822|NCT04075825|470685770|FG000|Overall Study|Participation in New Clinical Trial|1|||
130744823|NCT04075825|470685771|FG001|Overall Study|Participation in New Clinical Trial|1|||
130744824|NCT04075825|470685770|FG000|Overall Study|Reason Not Specified|2|||
130744825|NCT04075825|470685771|FG001|Overall Study|Reason Not Specified|2|||
130744826|NCT04815083|470685772|FG000|Overall Study|Physician Decision|1|||
130744827|NCT04815083|470685772|FG000|Overall Study|Study pause|2|||
130744828|NCT04815083|470685772|FG000|Overall Study|Screening failure|4|||
130744829|NCT04225715|470685773|FG000|Overall Study|Reason not Specified|1|||
130744830|NCT04225715|470685774|FG001|Overall Study|Reason not Specified|0|||
130744831|NCT04225715|470685775|FG002|Overall Study|Reason not Specified|0|||
130744832|NCT04225715|470685776|FG003|Overall Study|Reason not Specified|0|||
130744833|NCT04225715|470685777|FG004|Overall Study|Reason not Specified|0|||
130744834|NCT04225715|470685778|FG005|Overall Study|Reason not Specified|0|||
130744835|NCT04225715|470685779|FG006|Overall Study|Reason not Specified|0|||
130744836|NCT04225715|470685780|FG007|Overall Study|Reason not Specified|0|||
130744837|NCT04225715|470685781|FG008|Overall Study|Reason not Specified|0|||
130744838|NCT04225715|470685773|FG000|Overall Study|Protocol Violation|1|||
130744839|NCT04225715|470685774|FG001|Overall Study|Protocol Violation|0|||
130744840|NCT04225715|470685775|FG002|Overall Study|Protocol Violation|0|||
130744841|NCT04225715|470685776|FG003|Overall Study|Protocol Violation|0|||
130744842|NCT04225715|470685777|FG004|Overall Study|Protocol Violation|0|||
130744843|NCT04225715|470685778|FG005|Overall Study|Protocol Violation|9|||
130744844|NCT04225715|470685779|FG006|Overall Study|Protocol Violation|0|||
130744845|NCT04225715|470685780|FG007|Overall Study|Protocol Violation|0|||
130744846|NCT04225715|470685781|FG008|Overall Study|Protocol Violation|0|||
130744847|NCT04225715|470685773|FG000|Overall Study|Withdrawal by Subject|4|||
130744848|NCT04225715|470685774|FG001|Overall Study|Withdrawal by Subject|1|||
130744849|NCT04225715|470685775|FG002|Overall Study|Withdrawal by Subject|1|||
130744850|NCT04225715|470685776|FG003|Overall Study|Withdrawal by Subject|0|||
130744851|NCT04225715|470685777|FG004|Overall Study|Withdrawal by Subject|3|||
130744852|NCT04225715|470685778|FG005|Overall Study|Withdrawal by Subject|1|||
130744853|NCT04225715|470685779|FG006|Overall Study|Withdrawal by Subject|1|||
130744854|NCT04225715|470685780|FG007|Overall Study|Withdrawal by Subject|1|||
130744855|NCT04225715|470685781|FG008|Overall Study|Withdrawal by Subject|0|||
130744856|NCT04225715|470685773|FG000|Overall Study|Adverse Event|0|||
130744857|NCT04225715|470685774|FG001|Overall Study|Adverse Event|0|||
130744858|NCT04225715|470685775|FG002|Overall Study|Adverse Event|0|||
130744859|NCT04225715|470685776|FG003|Overall Study|Adverse Event|0|||
130744860|NCT04225715|470685777|FG004|Overall Study|Adverse Event|0|||
130744861|NCT04225715|470685778|FG005|Overall Study|Adverse Event|0|||
130744862|NCT04225715|470685779|FG006|Overall Study|Adverse Event|0|||
130744863|NCT04225715|470685780|FG007|Overall Study|Adverse Event|0|||
130744864|NCT04225715|470685781|FG008|Overall Study|Adverse Event|1|||
130744865|NCT04225715|470685773|FG000|Overall Study|Arm Terminated By Sponsor|0|||
130744866|NCT04225715|470685774|FG001|Overall Study|Arm Terminated By Sponsor|0|||
130744867|NCT04225715|470685775|FG002|Overall Study|Arm Terminated By Sponsor|0|||
130744868|NCT04225715|470685776|FG003|Overall Study|Arm Terminated By Sponsor|0|||
130744869|NCT04225715|470685777|FG004|Overall Study|Arm Terminated By Sponsor|0|||
130744870|NCT04225715|470685778|FG005|Overall Study|Arm Terminated By Sponsor|0|||
130744871|NCT04225715|470685779|FG006|Overall Study|Arm Terminated By Sponsor|0|||
130744872|NCT04225715|470685780|FG007|Overall Study|Arm Terminated By Sponsor|17|||
130744873|NCT04225715|470685781|FG008|Overall Study|Arm Terminated By Sponsor|18|||
130744874|NCT03318861|470685789|FG000|Overall Study|Death|2|||
130744875|NCT03318861|470685790|FG001|Overall Study|Death|3|||
130744876|NCT03318861|470685791|FG002|Overall Study|Death|3|||
130744877|NCT03318861|470685792|FG003|Overall Study|Death|2|||
130744878|NCT03318861|470685793|FG004|Overall Study|Death|2|||
130744879|NCT03318861|470685789|FG000|Overall Study|Enrolled But Never Treated|0|||
130744880|NCT03318861|470685790|FG001|Overall Study|Enrolled But Never Treated|1|||
130744881|NCT03318861|470685791|FG002|Overall Study|Enrolled But Never Treated|0|||
130744882|NCT03318861|470685792|FG003|Overall Study|Enrolled But Never Treated|1|||
130744883|NCT03318861|470685793|FG004|Overall Study|Enrolled But Never Treated|1|||
130744884|NCT03318861|470685789|FG000|Overall Study|Informed Consent Withdraw|0|||
130744885|NCT03318861|470685790|FG001|Overall Study|Informed Consent Withdraw|0|||
130744886|NCT03318861|470685791|FG002|Overall Study|Informed Consent Withdraw|0|||
130744887|NCT03318861|470685792|FG003|Overall Study|Informed Consent Withdraw|1|||
130744888|NCT03318861|470685793|FG004|Overall Study|Informed Consent Withdraw|0|||
130744889|NCT03318861|470685789|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
130788310|NCT03451045|470854570|FG000|Overall Study|Non-compliance with study|2|||
130788311|NCT03451045|470854571|FG001|Overall Study|Non-compliance with study|0|||
130788312|NCT03451045|470854572|FG002|Overall Study|Non-compliance with study|1|||
130744890|NCT03318861|470685790|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130744891|NCT03318861|470685791|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130744892|NCT03318861|470685792|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130744893|NCT03318861|470685793|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130744894|NCT00917852|470685794|FG000|Overall Study|Death|6|||
130744895|NCT02844933|470685795|FG000|Overall Study|Discontinued due to premature termination of study|3|||
130744896|NCT02844933|470685796|FG001|Overall Study|Discontinued due to premature termination of study|2|||
130744897|NCT04537078|470685797|FG000|Overall Study|Protocol Violation|3|||
130744898|NCT04537078|470685798|FG001|Overall Study|Protocol Violation|2|||
130744899|NCT04537078|470685797|FG000|Overall Study|Lost to Follow-up|1|||
130744900|NCT04537078|470685798|FG001|Overall Study|Lost to Follow-up|0|||
130744901|NCT04537078|470685797|FG000|Overall Study|Withdrawal by Subject|0|||
130744902|NCT04537078|470685798|FG001|Overall Study|Withdrawal by Subject|1|||
130744903|NCT01568892|470685800|FG000|Open-label Phase|Adverse Event|2|||
130744904|NCT01568892|470685801|FG001|Open-label Phase|Adverse Event|0|||
130744905|NCT01568892|470685800|FG000|Open-label Phase|Lack of Efficacy|4|||
130744906|NCT01568892|470685801|FG001|Open-label Phase|Lack of Efficacy|2|||
130744907|NCT01568892|470685800|FG000|Open-label Phase|Lost to Follow-up|0|||
130744908|NCT01568892|470685801|FG001|Open-label Phase|Lost to Follow-up|1|||
130744909|NCT01256450|470685804|FG000|Open-label Titration|Adverse Event|39|||
130744910|NCT01256450|470685805|FG001|Open-label Titration|Adverse Event|0|||
130744911|NCT01256450|470685806|FG002|Open-label Titration|Adverse Event|0|||
130744912|NCT01256450|470685804|FG000|Open-label Titration|Lost to Follow-up|7|||
130744913|NCT01256450|470685805|FG001|Open-label Titration|Lost to Follow-up|0|||
130744914|NCT01256450|470685806|FG002|Open-label Titration|Lost to Follow-up|0|||
130744915|NCT01256450|470685804|FG000|Open-label Titration|Lack of analgesic effect|30|||
130744916|NCT01256450|470685805|FG001|Open-label Titration|Lack of analgesic effect|0|||
130744917|NCT01256450|470685806|FG002|Open-label Titration|Lack of analgesic effect|0|||
130744918|NCT01256450|470685804|FG000|Open-label Titration|Non-compliance|9|||
130744919|NCT01256450|470685805|FG001|Open-label Titration|Non-compliance|0|||
130744920|NCT01256450|470685806|FG002|Open-label Titration|Non-compliance|0|||
130744921|NCT01256450|470685804|FG000|Open-label Titration|Screen failure|1|||
130744922|NCT01256450|470685805|FG001|Open-label Titration|Screen failure|0|||
130744923|NCT01256450|470685806|FG002|Open-label Titration|Screen failure|0|||
130744924|NCT01256450|470685804|FG000|Open-label Titration|Other|13|||
130744925|NCT01256450|470685805|FG001|Open-label Titration|Other|0|||
130744926|NCT01256450|470685806|FG002|Open-label Titration|Other|0|||
130744927|NCT01256450|470685804|FG000|Double-blind Treatment|Adverse Event|0|||
130744928|NCT01256450|470685805|FG001|Double-blind Treatment|Adverse Event|8|||
130744929|NCT01256450|470685806|FG002|Double-blind Treatment|Adverse Event|6|||
130744930|NCT01256450|470685804|FG000|Double-blind Treatment|Lost to Follow-up|0|||
130744931|NCT01256450|470685805|FG001|Double-blind Treatment|Lost to Follow-up|1|||
130744932|NCT01256450|470685806|FG002|Double-blind Treatment|Lost to Follow-up|7|||
130744933|NCT01256450|470685804|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
130744934|NCT01256450|470685805|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
130744935|NCT01256450|470685806|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
130744936|NCT01256450|470685804|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
130744937|NCT01256450|470685805|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
130744938|NCT01256450|470685806|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
130744939|NCT01256450|470685804|FG000|Double-blind Treatment|Non-compliance|0|||
130744940|NCT01256450|470685805|FG001|Double-blind Treatment|Non-compliance|5|||
130744941|NCT01256450|470685806|FG002|Double-blind Treatment|Non-compliance|4|||
130744942|NCT01256450|470685804|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
130744943|NCT01256450|470685805|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
130744944|NCT01256450|470685806|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
130744945|NCT01256450|470685804|FG000|Double-blind Treatment|Other|0|||
130744946|NCT01256450|470685805|FG001|Double-blind Treatment|Other|9|||
130744947|NCT01256450|470685806|FG002|Double-blind Treatment|Other|12|||
130744948|NCT00777296|470685812|FG000|Overall Study|Adverse Event|0|||
130744949|NCT00777296|470685813|FG001|Overall Study|Adverse Event|1|||
130744950|NCT00777296|470685814|FG002|Overall Study|Adverse Event|0|||
130744951|NCT00777296|470685815|FG003|Overall Study|Adverse Event|1|||
130744952|NCT00777296|470685812|FG000|Overall Study|Withdrawal by Subject|1|||
130744953|NCT00777296|470685813|FG001|Overall Study|Withdrawal by Subject|0|||
130744954|NCT00777296|470685814|FG002|Overall Study|Withdrawal by Subject|0|||
130744955|NCT00777296|470685815|FG003|Overall Study|Withdrawal by Subject|0|||
130744956|NCT00777296|470685812|FG000|Overall Study|CRF form not completed|0|||
130744957|NCT00777296|470685813|FG001|Overall Study|CRF form not completed|0|||
130744958|NCT00777296|470685814|FG002|Overall Study|CRF form not completed|2|||
130744959|NCT00777296|470685815|FG003|Overall Study|CRF form not completed|0|||
130744960|NCT03889418|470685818|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
130744961|NCT03889418|470685819|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130744962|NCT03889418|470685820|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130744963|NCT03889418|470685821|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130744964|NCT03889418|470685822|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130744965|NCT03889418|470685823|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130744966|NCT03889418|470685824|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130744967|NCT03889418|470685825|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130788313|NCT03451045|470854570|FG000|Overall Study|any other reason|10|||
130788314|NCT03451045|470854571|FG001|Overall Study|any other reason|2|||
130744968|NCT03889418|470685826|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130744969|NCT03889418|470685827|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130744970|NCT03889418|470685818|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130744971|NCT03889418|470685819|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
130788315|NCT03451045|470854572|FG002|Overall Study|any other reason|13|||
130744972|NCT03889418|470685820|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
130744973|NCT03889418|470685821|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130744974|NCT03889418|470685822|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130744975|NCT03889418|470685823|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130744976|NCT03889418|470685824|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130744977|NCT03889418|470685825|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130744978|NCT03889418|470685826|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130744979|NCT03889418|470685827|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130744980|NCT03889418|470685818|FG000|October-December 2019 (Month 7-9)|Death|0|||
130744981|NCT03889418|470685819|FG001|October-December 2019 (Month 7-9)|Death|0|||
130744982|NCT03889418|470685820|FG002|October-December 2019 (Month 7-9)|Death|0|||
130744983|NCT03889418|470685821|FG003|October-December 2019 (Month 7-9)|Death|0|||
130744984|NCT03889418|470685822|FG004|October-December 2019 (Month 7-9)|Death|0|||
130744985|NCT03889418|470685823|FG005|October-December 2019 (Month 7-9)|Death|0|||
130744986|NCT03889418|470685824|FG006|October-December 2019 (Month 7-9)|Death|0|||
130744987|NCT03889418|470685825|FG007|October-December 2019 (Month 7-9)|Death|0|||
130744988|NCT03889418|470685826|FG008|October-December 2019 (Month 7-9)|Death|1|||
130744989|NCT03889418|470685827|FG009|October-December 2019 (Month 7-9)|Death|0|||
130744990|NCT03889418|470685818|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130744991|NCT03889418|470685819|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130744992|NCT03889418|470685820|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130744993|NCT03889418|470685821|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
130744994|NCT03889418|470685822|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130744995|NCT03889418|470685823|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130744996|NCT03889418|470685824|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130744997|NCT03889418|470685825|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
130744998|NCT03889418|470685826|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130744999|NCT03889418|470685827|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130745000|NCT03889418|470685818|FG000|April - June 2020 (Month 13-15)|Death|0|||
130745001|NCT03889418|470685819|FG001|April - June 2020 (Month 13-15)|Death|1|||
130745002|NCT03889418|470685820|FG002|April - June 2020 (Month 13-15)|Death|0|||
130745003|NCT03889418|470685821|FG003|April - June 2020 (Month 13-15)|Death|0|||
130745004|NCT03889418|470685822|FG004|April - June 2020 (Month 13-15)|Death|0|||
130745005|NCT03889418|470685823|FG005|April - June 2020 (Month 13-15)|Death|0|||
130745006|NCT03889418|470685824|FG006|April - June 2020 (Month 13-15)|Death|0|||
130745007|NCT03889418|470685825|FG007|April - June 2020 (Month 13-15)|Death|0|||
130745008|NCT03889418|470685826|FG008|April - June 2020 (Month 13-15)|Death|0|||
130745009|NCT03889418|470685827|FG009|April - June 2020 (Month 13-15)|Death|0|||
130745010|NCT03889418|470685818|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130745011|NCT03889418|470685819|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130745012|NCT03889418|470685820|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130745013|NCT03889418|470685821|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
130745014|NCT03889418|470685822|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130745015|NCT03889418|470685823|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130745016|NCT03889418|470685824|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130745017|NCT03889418|470685825|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130745018|NCT03889418|470685826|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130745019|NCT03889418|470685827|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130745020|NCT03889418|470685818|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
130745021|NCT03889418|470685819|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
130745022|NCT03889418|470685820|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
130745023|NCT03889418|470685821|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
130745024|NCT03889418|470685822|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
130745025|NCT03889418|470685823|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
130745026|NCT03889418|470685824|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
130745027|NCT03889418|470685825|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
130745028|NCT03889418|470685826|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
130745029|NCT03889418|470685827|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
130745030|NCT03889418|470685818|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130745031|NCT03889418|470685819|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
130745032|NCT03889418|470685820|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
130745033|NCT03889418|470685821|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
130745034|NCT03889418|470685822|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130745035|NCT03889418|470685823|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130745036|NCT03889418|470685824|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130745037|NCT03889418|470685825|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
130745038|NCT03889418|470685826|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130745039|NCT03889418|470685827|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
130745040|NCT01909934|470685834|FG000|Overall Study|Withdrawal by Subject|3|||
130745041|NCT01909934|470685834|FG000|Overall Study|Lost to Follow-up|1|||
130745042|NCT01909934|470685834|FG000|Overall Study|Death|25|||
130745043|NCT01909934|470685834|FG000|Overall Study|Withdrawal of Informed Consent|1|||
130745044|NCT01909934|470685834|FG000|Overall Study|Reason Not Specified|1|||
130745045|NCT03810092|470685835|FG000|Overall Study|no ground support|17|||
130745046|NCT03810092|470685835|FG000|Overall Study|ADL not done at J0|16|||
130745047|NCT03810092|470685835|FG000|Overall Study|No hemoglobin measure at J5|27|||
130745048|NCT01139775|470685841|FG000|Overall Study|Adverse Event|0|||
130745049|NCT01139775|470685842|FG001|Overall Study|Adverse Event|6|||
130745050|NCT01139775|470685843|FG002|Overall Study|Adverse Event|2|||
130745051|NCT01139775|470685841|FG000|Overall Study|Protocol Violation|0|||
130745052|NCT01139775|470685842|FG001|Overall Study|Protocol Violation|5|||
130745053|NCT01139775|470685843|FG002|Overall Study|Protocol Violation|0|||
130745054|NCT01139775|470685841|FG000|Overall Study|Withdrawal by Subject|1|||
130745055|NCT01139775|470685842|FG001|Overall Study|Withdrawal by Subject|0|||
130745056|NCT01139775|470685843|FG002|Overall Study|Withdrawal by Subject|2|||
130745057|NCT01139775|470685841|FG000|Overall Study|Physician Decision|0|||
130745058|NCT01139775|470685842|FG001|Overall Study|Physician Decision|2|||
130745059|NCT01139775|470685843|FG002|Overall Study|Physician Decision|2|||
130745060|NCT01753310|470685846|FG000|Overall Study|Entered into open label extension study|25|||
130745061|NCT01753310|470685847|FG001|Overall Study|Entered into open label extension study|22|||
130745062|NCT01753310|470685846|FG000|Overall Study|Adverse Event|1|||
130745063|NCT01753310|470685847|FG001|Overall Study|Adverse Event|0|||
130745064|NCT01753310|470685846|FG000|Overall Study|Lost to Follow-up|2|||
130745065|NCT01753310|470685847|FG001|Overall Study|Lost to Follow-up|0|||
130745066|NCT01753310|470685846|FG000|Overall Study|Subject decision|2|||
130745067|NCT01753310|470685847|FG001|Overall Study|Subject decision|2|||
130745068|NCT01753310|470685846|FG000|Overall Study|Sponsor decision|1|||
130745069|NCT01753310|470685847|FG001|Overall Study|Sponsor decision|0|||
130745070|NCT01753310|470685846|FG000|Overall Study|Withdrawal by Subject|1|||
130745071|NCT01753310|470685847|FG001|Overall Study|Withdrawal by Subject|0|||
130745072|NCT03193853|470685848|FG000|Overall Study|Death|6|||
130745073|NCT02022202|470685849|FG000|Overall Study|Withdrawal by Subject|2|||
130745074|NCT02022202|470685849|FG000|Overall Study|Disease Progression|3|||
130745075|NCT02022202|470685849|FG000|Overall Study|Desire go to immediately to surgery|3|||
130745076|NCT05581641|470685853|FG000|Overall Study|Withdrawal by Subject|0|||
130745077|NCT05581641|470685854|FG001|Overall Study|Withdrawal by Subject|1|||
130745078|NCT05581641|470685855|FG002|Overall Study|Withdrawal by Subject|3|||
130745079|NCT05581641|470685856|FG003|Overall Study|Withdrawal by Subject|1|||
130745080|NCT05581641|470685853|FG000|Overall Study|Lost to Follow-up|0|||
130745081|NCT05581641|470685854|FG001|Overall Study|Lost to Follow-up|1|||
130745082|NCT05581641|470685855|FG002|Overall Study|Lost to Follow-up|0|||
130745083|NCT05581641|470685856|FG003|Overall Study|Lost to Follow-up|1|||
130745084|NCT05581641|470685853|FG000|Overall Study|Protocol Violation|1|||
130745085|NCT05581641|470685854|FG001|Overall Study|Protocol Violation|0|||
130745086|NCT05581641|470685855|FG002|Overall Study|Protocol Violation|0|||
130745087|NCT05581641|470685856|FG003|Overall Study|Protocol Violation|0|||
130745088|NCT05581641|470685853|FG000|Overall Study|Other|1|||
130745089|NCT05581641|470685854|FG001|Overall Study|Other|0|||
130745090|NCT05581641|470685855|FG002|Overall Study|Other|2|||
130745091|NCT05581641|470685856|FG003|Overall Study|Other|1|||
130745092|NCT00503698|470685863|FG000|Overall Study|Protocol Violation|5|||
130745093|NCT00503698|470685864|FG001|Overall Study|Protocol Violation|6|||
130745094|NCT00503698|470685863|FG000|Overall Study|Adverse Event|52|||
130745095|NCT00503698|470685864|FG001|Overall Study|Adverse Event|41|||
130745096|NCT00503698|470685863|FG000|Overall Study|Death|1|||
130745097|NCT00503698|470685864|FG001|Overall Study|Death|0|||
130745098|NCT00503698|470685863|FG000|Overall Study|Lack of Efficacy|3|||
130745099|NCT00503698|470685864|FG001|Overall Study|Lack of Efficacy|4|||
130745100|NCT00503698|470685863|FG000|Overall Study|Trial terminated|216|||
130745101|NCT00503698|470685864|FG001|Overall Study|Trial terminated|253|||
130745102|NCT00503698|470685863|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
130745103|NCT00503698|470685864|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
130745104|NCT00503698|470685863|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
130745105|NCT00503698|470685864|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
130745106|NCT00503698|470685863|FG000|Overall Study|Any condition in exclusion criteria|4|||
130745107|NCT00503698|470685864|FG001|Overall Study|Any condition in exclusion criteria|6|||
130745108|NCT00503698|470685863|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
130745109|NCT00503698|470685864|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
130745110|NCT00503698|470685863|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
130745111|NCT00503698|470685864|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
130745112|NCT00503698|470685863|FG000|Overall Study|Critically ill|2|||
130745113|NCT00503698|470685864|FG001|Overall Study|Critically ill|0|||
130745114|NCT00503698|470685863|FG000|Overall Study|Unclassified|48|||
130745115|NCT00503698|470685864|FG001|Overall Study|Unclassified|32|||
130745116|NCT00503698|470685863|FG000|Overall Study|Not exposed to trial drug|11|||
130745117|NCT00503698|470685864|FG001|Overall Study|Not exposed to trial drug|6|||
130745118|NCT02462603|470685872|FG000|Overall Study|Investigator Decision|1|||
130745119|NCT02462603|470685872|FG000|Overall Study|Non-Compliance|1|||
130745120|NCT02462603|470685872|FG000|Overall Study|Withdrawal by Subject|2|||
130745121|NCT01591096|470685874|FG000|Overall Study|Adverse Event|1|||
130745122|NCT01445730|470685875|FG000|Overall Study|Adverse Event|1|||
130745123|NCT01445730|470685875|FG000|Overall Study|For the advice of a dentist|1|||
130745124|NCT01445730|470685875|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
130745125|NCT00734994|470685876|FG000|Overall Study|Withdrawal by Subject|1|||
130745126|NCT01546025|470685877|FG000|Overall Study|Lost to Follow-up|0|||
130745127|NCT01546025|470685878|FG001|Overall Study|Lost to Follow-up|1|||
130745128|NCT05514873|470685879|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
130745129|NCT05514873|470685879|FG000|Main Treatment Period|Adverse Event|2|||
130745130|NCT05514873|470685879|FG000|Extension Treatment Period|Lost to Follow-up|3|||
130745131|NCT05177484|470687098|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
130745132|NCT05177484|470687099|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
130745133|NCT05177484|470687098|FG000|Overall Study|Inadvertently withdrawn|3|||
130745134|NCT05177484|470687099|FG001|Overall Study|Inadvertently withdrawn|1|||
130745135|NCT05177484|470687098|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
130745136|NCT05177484|470687099|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
130745137|NCT02393950|470687104|FG000|Overall Study|Adverse Event|1|||
130745138|NCT02393950|470687105|FG001|Overall Study|Adverse Event|0|||
130745139|NCT02393950|470687104|FG000|Overall Study|Withdrawal by Subject|0|||
130745140|NCT02393950|470687105|FG001|Overall Study|Withdrawal by Subject|1|||
130745141|NCT05486091|470687106|FG000|Overall Study|Withdrawal by Subject|1|||
130745142|NCT05486091|470687106|FG000|Overall Study|Lost to Follow-up|2|||
130745143|NCT03971071|470687107|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130745144|NCT03971071|470687108|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
130745145|NCT03971071|470687109|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130745146|NCT03971071|470687110|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130745147|NCT03971071|470687111|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130745148|NCT03971071|470687107|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
130745149|NCT03971071|470687108|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
130745150|NCT03971071|470687109|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
130745151|NCT03971071|470687110|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130745152|NCT03971071|470687111|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130745153|NCT03971071|470687107|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
130745154|NCT03971071|470687108|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
130745155|NCT03971071|470687109|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
130745156|NCT03971071|470687110|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
130745157|NCT03971071|470687111|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
130745158|NCT03971071|470687107|FG000|Open-label Treatment Period|Sponsor decision|0|||
130745159|NCT03971071|470687108|FG001|Open-label Treatment Period|Sponsor decision|0|||
130745160|NCT03971071|470687109|FG002|Open-label Treatment Period|Sponsor decision|0|||
130745161|NCT03971071|470687110|FG003|Open-label Treatment Period|Sponsor decision|0|||
130745162|NCT03971071|470687111|FG004|Open-label Treatment Period|Sponsor decision|1|||
130745163|NCT03971071|470687107|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
130745164|NCT03971071|470687108|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130745165|NCT03971071|470687109|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
130745166|NCT03971071|470687110|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
130745167|NCT03971071|470687111|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
130745168|NCT03971071|470687107|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130745169|NCT03971071|470687108|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
130745170|NCT03971071|470687109|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
130745171|NCT03971071|470687110|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
130745172|NCT03971071|470687111|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
130745173|NCT01697748|470687112|FG000|Overall Study|ineligible skin incision|1|||
130745174|NCT01697748|470687113|FG001|Overall Study|ineligible skin incision|2|||
130745175|NCT01697748|470687112|FG000|Overall Study|ineligible uterine incision|4|||
130745176|NCT01697748|470687113|FG001|Overall Study|ineligible uterine incision|1|||
130745177|NCT01697748|470687112|FG000|Overall Study|Lost to Follow-up|53|||
130745178|NCT01697748|470687113|FG001|Overall Study|Lost to Follow-up|65|||
130745179|NCT01704495|470687117|FG000|Subjects Randomized|Other Reason|3|||
130745180|NCT01704495|470687118|FG001|Subjects Randomized|Other Reason|2|||
130745181|NCT01704495|470687119|FG002|Subjects Randomized|Other Reason|3|||
130745182|NCT01704495|470687120|FG003|Subjects Randomized|Other Reason|2|||
130745183|NCT01704495|470687117|FG000|Subjects Randomized|Discontinuation criteria met|4|||
130745184|NCT01704495|470687118|FG001|Subjects Randomized|Discontinuation criteria met|2|||
130745185|NCT01704495|470687119|FG002|Subjects Randomized|Discontinuation criteria met|2|||
130745186|NCT01704495|470687120|FG003|Subjects Randomized|Discontinuation criteria met|0|||
130745187|NCT01704495|470687117|FG000|Subjects Randomized|Adverse Event|8|||
130745188|NCT01704495|470687118|FG001|Subjects Randomized|Adverse Event|2|||
130745189|NCT01704495|470687119|FG002|Subjects Randomized|Adverse Event|0|||
130745190|NCT01704495|470687120|FG003|Subjects Randomized|Adverse Event|7|||
130745191|NCT01704495|470687117|FG000|Subjects Randomized|Withdrawal by Subject|5|||
130745192|NCT01704495|470687118|FG001|Subjects Randomized|Withdrawal by Subject|5|||
130745193|NCT01704495|470687119|FG002|Subjects Randomized|Withdrawal by Subject|5|||
130745194|NCT01704495|470687120|FG003|Subjects Randomized|Withdrawal by Subject|5|||
130745195|NCT01704495|470687117|FG000|Subjects Randomized|Protocol Violation|1|||
130745196|NCT01704495|470687118|FG001|Subjects Randomized|Protocol Violation|1|||
130745197|NCT01704495|470687119|FG002|Subjects Randomized|Protocol Violation|2|||
130745198|NCT01704495|470687120|FG003|Subjects Randomized|Protocol Violation|0|||
130745199|NCT01704495|470687117|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
130745200|NCT01704495|470687118|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
130745201|NCT01704495|470687119|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
130745202|NCT01704495|470687120|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
130745203|NCT01704495|470687117|FG000|Optional Safety Extension|Adverse Event|0|||
130745204|NCT01704495|470687118|FG001|Optional Safety Extension|Adverse Event|4|||
130745205|NCT01704495|470687119|FG002|Optional Safety Extension|Adverse Event|0|||
130745206|NCT01704495|470687120|FG003|Optional Safety Extension|Adverse Event|1|||
130745207|NCT01704495|470687117|FG000|Optional Safety Extension|Other reason|27|||
130745208|NCT01704495|470687118|FG001|Optional Safety Extension|Other reason|29|||
130745209|NCT01704495|470687119|FG002|Optional Safety Extension|Other reason|30|||
130745210|NCT01704495|470687120|FG003|Optional Safety Extension|Other reason|28|||
130745211|NCT01704495|470687117|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
130745212|NCT01704495|470687118|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
130745213|NCT01704495|470687119|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
130745214|NCT01704495|470687120|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
130745215|NCT03866512|470687121|FG000|Overall Study|Lost to Follow-up|1|||
130745216|NCT03866512|470687122|FG001|Overall Study|Lost to Follow-up|2|||
130745217|NCT03866512|470687123|FG002|Overall Study|Lost to Follow-up|1|||
130745218|NCT03866512|470687121|FG000|Overall Study|Cannulation issues|0|||
130745219|NCT03866512|470687122|FG001|Overall Study|Cannulation issues|1|||
130745220|NCT03866512|470687123|FG002|Overall Study|Cannulation issues|2|||
130745221|NCT00997373|470687128|FG000|Overall Study|Withdrawal by Subject|5|||
130745222|NCT00997373|470687129|FG001|Overall Study|Withdrawal by Subject|0|||
130745223|NCT00997373|470687128|FG000|Overall Study|wrong tumor type|4|||
130745224|NCT00997373|470687129|FG001|Overall Study|wrong tumor type|0|||
130745225|NCT00997373|470687128|FG000|Overall Study|could not have hysterectomy|6|||
130745226|NCT00997373|470687129|FG001|Overall Study|could not have hysterectomy|0|||
130745231|NCT01956773|470687136|FG000|Overall Study|Lost to Follow-up|628|||
130745232|NCT01956773|470687137|FG001|Overall Study|Lost to Follow-up|1|||
130745233|NCT00450437|470687138|FG000|Overall Study|Withdrawal by Subject|10|||
130745234|NCT00450437|470687139|FG001|Overall Study|Withdrawal by Subject|2|||
130745235|NCT00450437|470687140|FG002|Overall Study|Withdrawal by Subject|0|||
130745236|NCT00450437|470687141|FG003|Overall Study|Withdrawal by Subject|1|||
130745237|NCT00450437|470687138|FG000|Overall Study|Lost to Follow-up|31|||
130745238|NCT00450437|470687139|FG001|Overall Study|Lost to Follow-up|12|||
130745239|NCT00450437|470687140|FG002|Overall Study|Lost to Follow-up|19|||
130745240|NCT00450437|470687141|FG003|Overall Study|Lost to Follow-up|9|||
130745241|NCT00450437|470687138|FG000|Overall Study|Protocol Violation|0|||
130745242|NCT00450437|470687139|FG001|Overall Study|Protocol Violation|1|||
130745243|NCT00450437|470687140|FG002|Overall Study|Protocol Violation|0|||
130745244|NCT00450437|470687141|FG003|Overall Study|Protocol Violation|1|||
130745245|NCT00450437|470687138|FG000|Overall Study|Inappropriate enrollment|4|||
130745246|NCT00450437|470687139|FG001|Overall Study|Inappropriate enrollment|1|||
130745247|NCT00450437|470687140|FG002|Overall Study|Inappropriate enrollment|3|||
130745248|NCT00450437|470687141|FG003|Overall Study|Inappropriate enrollment|0|||
130745249|NCT00450437|470687138|FG000|Overall Study|Administrative reason|0|||
130745250|NCT00450437|470687139|FG001|Overall Study|Administrative reason|0|||
130745251|NCT00450437|470687140|FG002|Overall Study|Administrative reason|1|||
130745252|NCT00450437|470687141|FG003|Overall Study|Administrative reason|0|||
130745253|NCT00450437|470687138|FG000|Overall Study|Unable to Classify|1|||
130745254|NCT00450437|470687139|FG001|Overall Study|Unable to Classify|0|||
130745255|NCT00450437|470687140|FG002|Overall Study|Unable to Classify|1|||
130788316|NCT00863707|470854573|FG000|Overall Study|Randomized, but drug not received|4|||
130788317|NCT00863707|470854574|FG001|Overall Study|Randomized, but drug not received|3|||
130788318|NCT00289276|470854575|FG000|Second Part of FAST Study (Expansion)|Death|0|||
130788319|NCT00289276|470854576|FG001|Second Part of FAST Study (Expansion)|Death|2|||
130788320|NCT00289276|470854575|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
130788321|NCT00289276|470854576|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
130745256|NCT00450437|470687141|FG003|Overall Study|Unable to Classify|0|||
130745257|NCT02492867|470687142|FG000|Overall Study|Alternate therapy|1|||
130745258|NCT02492867|470687142|FG000|Overall Study|Withdrawal by Subject|2|||
130745259|NCT02492867|470687142|FG000|Overall Study|Disease progression after treatment started|1|||
130745260|NCT02492867|470687142|FG000|Overall Study|Death|1|||
130745261|NCT03296527|470687143|FG000|Overall Study|Adverse Event|15|||
130788322|NCT02783911|470854577|FG000|Overall Study|Lost to Follow-up|3|||
130745262|NCT03296527|470687144|FG001|Overall Study|Adverse Event|33|||
130745263|NCT03296527|470687143|FG000|Overall Study|Protocol Deviation|4|||
130745264|NCT03296527|470687144|FG001|Overall Study|Protocol Deviation|0|||
130745265|NCT03296527|470687143|FG000|Overall Study|Participant withdrew consent|3|||
130745266|NCT03296527|470687144|FG001|Overall Study|Participant withdrew consent|1|||
130745267|NCT03296527|470687143|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
130745268|NCT03296527|470687144|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
130745269|NCT03296527|470687143|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
130745270|NCT03296527|470687144|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
130745271|NCT03296527|470687143|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
130745272|NCT03296527|470687144|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
130745273|NCT03296527|470687143|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
130745274|NCT03296527|470687144|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
130745275|NCT03296527|470687143|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
130745276|NCT03296527|470687144|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
130745277|NCT00122382|470687145|FG000|Double-Blind Study|Adverse Event|9|||
130745278|NCT00122382|470687146|FG001|Double-Blind Study|Adverse Event|11|||
130745279|NCT00122382|470687147|FG002|Double-Blind Study|Adverse Event|0|||
130745280|NCT00122382|470687145|FG000|Double-Blind Study|Death|2|||
130745281|NCT00122382|470687146|FG001|Double-Blind Study|Death|2|||
130745282|NCT00122382|470687147|FG002|Double-Blind Study|Death|0|||
130745283|NCT00122382|470687145|FG000|Double-Blind Study|Lack of Efficacy|0|||
130745284|NCT00122382|470687146|FG001|Double-Blind Study|Lack of Efficacy|8|||
130745285|NCT00122382|470687147|FG002|Double-Blind Study|Lack of Efficacy|0|||
130745286|NCT00122382|470687145|FG000|Double-Blind Study|Lost to Follow-up|2|||
130745287|NCT00122382|470687146|FG001|Double-Blind Study|Lost to Follow-up|1|||
130745288|NCT00122382|470687147|FG002|Double-Blind Study|Lost to Follow-up|0|||
130745289|NCT00122382|470687145|FG000|Double-Blind Study|Pregnancy|2|||
130745290|NCT00122382|470687146|FG001|Double-Blind Study|Pregnancy|0|||
130745291|NCT00122382|470687147|FG002|Double-Blind Study|Pregnancy|0|||
130745292|NCT00122382|470687145|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
130745293|NCT00122382|470687146|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
130745294|NCT00122382|470687147|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
130745295|NCT00122382|470687145|FG000|Double-Blind Study|Withdrawal of Consent|7|||
130745296|NCT00122382|470687146|FG001|Double-Blind Study|Withdrawal of Consent|3|||
130745297|NCT00122382|470687147|FG002|Double-Blind Study|Withdrawal of Consent|0|||
130745298|NCT00122382|470687145|FG000|Double-Blind Study|Protocol Violation|1|||
130745299|NCT00122382|470687146|FG001|Double-Blind Study|Protocol Violation|0|||
130745300|NCT00122382|470687147|FG002|Double-Blind Study|Protocol Violation|0|||
130745301|NCT00122382|470687145|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
130745302|NCT00122382|470687146|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
130745303|NCT00122382|470687147|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
130745304|NCT00122382|470687145|FG000|Double-Blind Study|Randomized but not treated|0|||
130745305|NCT00122382|470687146|FG001|Double-Blind Study|Randomized but not treated|2|||
130745306|NCT00122382|470687147|FG002|Double-Blind Study|Randomized but not treated|0|||
130745307|NCT00122382|470687145|FG000|Open-Label Study|Adverse Event|0|||
130745308|NCT00122382|470687146|FG001|Open-Label Study|Adverse Event|0|||
130745309|NCT00122382|470687147|FG002|Open-Label Study|Adverse Event|11|||
130745310|NCT00122382|470687145|FG000|Open-Label Study|Death|0|||
130745311|NCT00122382|470687146|FG001|Open-Label Study|Death|0|||
130745312|NCT00122382|470687147|FG002|Open-Label Study|Death|2|||
130745313|NCT00122382|470687145|FG000|Open-Label Study|Lack of Efficacy|0|||
130745314|NCT00122382|470687146|FG001|Open-Label Study|Lack of Efficacy|0|||
130745315|NCT00122382|470687147|FG002|Open-Label Study|Lack of Efficacy|3|||
130745316|NCT00122382|470687145|FG000|Open-Label Study|Lost to Follow-up|0|||
130745317|NCT00122382|470687146|FG001|Open-Label Study|Lost to Follow-up|0|||
130745318|NCT00122382|470687147|FG002|Open-Label Study|Lost to Follow-up|3|||
130745319|NCT00122382|470687145|FG000|Open-Label Study|Pregnancy|0|||
130745320|NCT00122382|470687146|FG001|Open-Label Study|Pregnancy|0|||
130745321|NCT00122382|470687147|FG002|Open-Label Study|Pregnancy|2|||
130745322|NCT00122382|470687145|FG000|Open-Label Study|Poor/Non-Compliance|0|||
130745323|NCT00122382|470687146|FG001|Open-Label Study|Poor/Non-Compliance|0|||
130745324|NCT00122382|470687147|FG002|Open-Label Study|Poor/Non-Compliance|1|||
130745325|NCT00122382|470687145|FG000|Open-Label Study|Withdrawal of Consent|0|||
130745326|NCT00122382|470687146|FG001|Open-Label Study|Withdrawal of Consent|0|||
130745327|NCT00122382|470687147|FG002|Open-Label Study|Withdrawal of Consent|4|||
130745328|NCT02040805|470687149|FG000|Overall Study|Lost to Follow-up|14|||
130745329|NCT02040805|470687150|FG001|Overall Study|Lost to Follow-up|9|||
130745330|NCT02040805|470687149|FG000|Overall Study|Withdrawal by Subject|28|||
130745331|NCT02040805|470687150|FG001|Overall Study|Withdrawal by Subject|41|||
130745332|NCT01213966|470687151|FG000|Overall Study|Protocol Violation|1|||
130745333|NCT01213966|470687152|FG001|Overall Study|Protocol Violation|0|||
130745334|NCT01213966|470687153|FG002|Overall Study|Protocol Violation|3|||
130745335|NCT01213966|470687154|FG003|Overall Study|Protocol Violation|1|||
130745336|NCT03591874|470687155|FG000|Overall Study|Adverse Event|4|||
130745337|NCT03591874|470687156|FG001|Overall Study|Adverse Event|0|||
130745338|NCT03591874|470687155|FG000|Overall Study|Withdrawal by Subject|2|||
130745339|NCT03591874|470687156|FG001|Overall Study|Withdrawal by Subject|1|||
130745340|NCT03591874|470687155|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
130745341|NCT03591874|470687156|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
130745342|NCT03591874|470687155|FG000|Overall Study|On Study at Time of Study Termination|12|||
130745343|NCT03591874|470687156|FG001|Overall Study|On Study at Time of Study Termination|6|||
130745344|NCT03644342|470687159|FG000|Overall Study|Adverse Event|2|||
130745345|NCT03644342|470687160|FG001|Overall Study|Adverse Event|0|||
130745346|NCT03644342|470687159|FG000|Overall Study|Protocol Violation|0|||
130745347|NCT03644342|470687160|FG001|Overall Study|Protocol Violation|1|||
130745348|NCT03655405|470687161|FG000|Overall Study|Death after initial data collection|4|||
130745349|NCT03655405|470687162|FG001|Overall Study|Death after initial data collection|2|||
130745350|NCT03655405|470687161|FG000|Overall Study|Died before initial data collection|1|||
130745351|NCT03655405|470687162|FG001|Overall Study|Died before initial data collection|2|||
130745352|NCT03655405|470687161|FG000|Overall Study|Protocol Violation|0|||
130745353|NCT03655405|470687162|FG001|Overall Study|Protocol Violation|1|||
130745354|NCT01991743|470687163|FG000|Overall Study|external cephalic version not performed|0|||
130745355|NCT01991743|470687164|FG001|Overall Study|external cephalic version not performed|0|||
130745356|NCT01991743|470687165|FG002|Overall Study|external cephalic version not performed|1|||
130745357|NCT01991743|470687166|FG003|Overall Study|external cephalic version not performed|0|||
130745358|NCT02859337|470687169|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
130745359|NCT02859337|470687170|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
130745360|NCT02859337|470687171|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
130745361|NCT02859337|470687169|FG000|Overall Study|Withdrawal by Subject|3|||
130745362|NCT02859337|470687170|FG001|Overall Study|Withdrawal by Subject|1|||
130745363|NCT02859337|470687171|FG002|Overall Study|Withdrawal by Subject|0|||
130745364|NCT02859337|470687169|FG000|Overall Study|Lost to Follow-up|1|||
130745365|NCT02859337|470687170|FG001|Overall Study|Lost to Follow-up|0|||
130745366|NCT02859337|470687171|FG002|Overall Study|Lost to Follow-up|0|||
130745367|NCT01167140|470687174|FG000|Overall Study|Withdrawal by Subject|1|||
130745368|NCT04390113|470687175|FG000|Overall Study|Not Treated|0|||
130745369|NCT04390113|470687176|FG001|Overall Study|Not Treated|1|||
130745370|NCT04390113|470687175|FG000|Overall Study|Adverse Event|1|||
130745371|NCT04390113|470687176|FG001|Overall Study|Adverse Event|0|||
130745372|NCT04390113|470687175|FG000|Overall Study|Death|2|||
130745373|NCT04390113|470687176|FG001|Overall Study|Death|1|||
130745374|NCT04390113|470687175|FG000|Overall Study|Physician Decision|1|||
130788323|NCT02783911|470854578|FG001|Overall Study|Lost to Follow-up|32|||
130788324|NCT05219162|470854581|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
130788325|NCT05219162|470854581|FG000|Overall Study|Withdrawal by Subject|23|||
130745375|NCT04390113|470687176|FG001|Overall Study|Physician Decision|3|||
130745376|NCT04390113|470687175|FG000|Overall Study|Study Terminated by Sponsor|5|||
130745377|NCT04390113|470687176|FG001|Overall Study|Study Terminated by Sponsor|3|||
130745378|NCT04390113|470687175|FG000|Overall Study|Withdrawal by Subject|10|||
130745379|NCT04390113|470687176|FG001|Overall Study|Withdrawal by Subject|5|||
130745380|NCT04390113|470687175|FG000|Overall Study|Other|1|||
130745381|NCT04390113|470687176|FG001|Overall Study|Other|0|||
130745382|NCT04390113|470687175|FG000|Overall Study|Missing|0|||
130745383|NCT04390113|470687176|FG001|Overall Study|Missing|1|||
130745384|NCT01611883|470687177|FG000|Overall Study|Adverse Event|1|||
130745385|NCT01611883|470687178|FG001|Overall Study|Adverse Event|1|||
130745386|NCT00030901|470687181|FG000|Initial Registration|Ineligible|167|||
130745387|NCT00030901|470687182|FG001|Initial Registration|Ineligible|0|||
130745388|NCT00030901|470687183|FG002|Initial Registration|Ineligible|0|||
130745389|NCT00030901|470687181|FG000|Randomization|Adverse Event|0|||
130745390|NCT00030901|470687182|FG001|Randomization|Adverse Event|11|||
130745391|NCT00030901|470687183|FG002|Randomization|Adverse Event|7|||
130745392|NCT00030901|470687181|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
130745393|NCT00030901|470687182|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
130745394|NCT00030901|470687183|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
130745395|NCT00030901|470687181|FG000|Randomization|Progression/Relapse|0|||
130745396|NCT00030901|470687182|FG001|Randomization|Progression/Relapse|22|||
130745397|NCT00030901|470687183|FG002|Randomization|Progression/Relapse|21|||
130745398|NCT00030901|470687181|FG000|Randomization|Death|0|||
130745399|NCT00030901|470687182|FG001|Randomization|Death|1|||
130745400|NCT00030901|470687183|FG002|Randomization|Death|3|||
130745401|NCT00030901|470687181|FG000|Randomization|Other|0|||
130745402|NCT00030901|470687182|FG001|Randomization|Other|36|||
130745403|NCT00030901|470687183|FG002|Randomization|Other|33|||
130745404|NCT00030901|470687181|FG000|Randomization|Ineligible|0|||
130745405|NCT00030901|470687182|FG001|Randomization|Ineligible|15|||
130745406|NCT00030901|470687183|FG002|Randomization|Ineligible|14|||
130745407|NCT02576847|470687184|FG000|Overall Study|Adverse Event|27|||
130745408|NCT02576847|470687184|FG000|Overall Study|Lost to Follow-up|22|||
130745409|NCT02576847|470687184|FG000|Overall Study|Physician Decision|1|||
130745410|NCT02576847|470687184|FG000|Overall Study|Pregnancy|1|||
130745411|NCT02576847|470687184|FG000|Overall Study|Protocol Violation|3|||
130745412|NCT02576847|470687184|FG000|Overall Study|Withdrawal by Subject|78|||
130745413|NCT02576847|470687184|FG000|Overall Study|Other|5|||
130745414|NCT01806051|470687185|FG000|Overall Study|Withdrawal by Subject|6|||
130745415|NCT01205776|470687186|FG000|Overall Study|Lost to Follow-up|53|||
130745416|NCT01205776|470687187|FG001|Overall Study|Lost to Follow-up|61|||
130745417|NCT01205776|470687186|FG000|Overall Study|Withdrawal by Subject|11|||
130745418|NCT01205776|470687187|FG001|Overall Study|Withdrawal by Subject|34|||
130745419|NCT05142722|470688359|FG000|Overall Study|Lost to Follow-up|16|||
130745420|NCT05142722|470688360|FG001|Overall Study|Lost to Follow-up|38|||
130745421|NCT05142722|470688359|FG000|Overall Study|Withdrawal by Subject|20|||
130745422|NCT05142722|470688360|FG001|Overall Study|Withdrawal by Subject|27|||
130745423|NCT05142722|470688359|FG000|Overall Study|Death|11|||
130745424|NCT05142722|470688360|FG001|Overall Study|Death|17|||
130745425|NCT05142722|470688359|FG000|Overall Study|Physician Decision|0|||
130745426|NCT05142722|470688360|FG001|Overall Study|Physician Decision|1|||
130745427|NCT05142722|470688359|FG000|Overall Study|Participant Moved Away|0|||
130745428|NCT05142722|470688360|FG001|Overall Study|Participant Moved Away|2|||
130745429|NCT05142722|470688359|FG000|Overall Study|Adverse Event|2|||
130745430|NCT05142722|470688360|FG001|Overall Study|Adverse Event|1|||
130745431|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
130745432|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130745433|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
130745434|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130745435|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
130745436|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130745437|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130745438|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130745439|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130745440|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130745441|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
130745442|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130745443|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130745444|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
130745445|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130745446|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130745447|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130745448|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130745449|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
130745450|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130745451|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130745452|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
130745453|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130745454|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
130745455|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130745456|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130745457|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130745458|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130745459|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130745460|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130745461|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130745462|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130745463|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745464|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745465|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
130745466|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745467|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745468|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745469|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
130745470|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745471|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130745472|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130745473|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
130745474|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130745475|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130745476|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
130745477|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130745478|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
130745479|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
130745480|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
130745481|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130745482|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130745483|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130745484|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130745485|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130745486|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130745487|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130745488|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
130745489|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130745490|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130745491|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130745492|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130745493|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130745494|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130745495|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130745496|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130745497|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130745498|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130745499|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
130745500|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130745501|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130745502|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130745503|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745504|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745505|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130788326|NCT00171249|470854584|FG000|Overall Study|Withdrawal by Subject|2|||
130788327|NCT00171249|470854585|FG001|Overall Study|Withdrawal by Subject|0|||
130788328|NCT00171249|470854586|FG002|Overall Study|Withdrawal by Subject|0|||
130788329|NCT00171249|470854587|FG003|Overall Study|Withdrawal by Subject|6|||
130745506|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745507|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745508|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
130745509|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745510|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130745511|NCT03896503|470688361|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130745512|NCT03896503|470688362|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130745513|NCT03896503|470688363|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130745514|NCT03896503|470688364|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130745515|NCT03896503|470688365|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130745516|NCT03896503|470688366|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
130745517|NCT03896503|470688367|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
130745518|NCT03896503|470688368|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130745519|NCT05734157|470688369|FG000|Overall Study|Death|3|||
130745520|NCT05734157|470688369|FG000|Overall Study|Withdrawal by Subject|2|||
130745521|NCT05734157|470688369|FG000|Overall Study|Lost to Follow-up|1|||
130745522|NCT05734157|470688369|FG000|Overall Study|Telephone call|3|||
130745523|NCT01467713|470688371|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
130745524|NCT01467713|470688372|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
130745525|NCT01467713|470688373|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
130745526|NCT01467713|470688374|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
130745527|NCT01467713|470688371|FG000|Overall Study|Major Protocol Deviation|2|||
130745528|NCT01467713|470688372|FG001|Overall Study|Major Protocol Deviation|4|||
130745529|NCT01467713|470688373|FG002|Overall Study|Major Protocol Deviation|4|||
130745530|NCT01467713|470688374|FG003|Overall Study|Major Protocol Deviation|1|||
130745531|NCT01467713|470688371|FG000|Overall Study|Lost to Follow-up|9|||
130745532|NCT01467713|470688372|FG001|Overall Study|Lost to Follow-up|12|||
130745533|NCT01467713|470688373|FG002|Overall Study|Lost to Follow-up|6|||
130745534|NCT01467713|470688374|FG003|Overall Study|Lost to Follow-up|9|||
130745535|NCT01467713|470688371|FG000|Overall Study|Voluntary Withdrawal|18|||
130745536|NCT01467713|470688372|FG001|Overall Study|Voluntary Withdrawal|14|||
130745537|NCT01467713|470688373|FG002|Overall Study|Voluntary Withdrawal|21|||
130745538|NCT01467713|470688374|FG003|Overall Study|Voluntary Withdrawal|20|||
130745539|NCT01467713|470688371|FG000|Overall Study|Study Termination|23|||
130745540|NCT01467713|470688372|FG001|Overall Study|Study Termination|33|||
130745541|NCT01467713|470688373|FG002|Overall Study|Study Termination|28|||
130745542|NCT01467713|470688374|FG003|Overall Study|Study Termination|29|||
130745543|NCT01467713|470688371|FG000|Overall Study|Pregnancy|0|||
130745544|NCT01467713|470688372|FG001|Overall Study|Pregnancy|1|||
130745545|NCT01467713|470688373|FG002|Overall Study|Pregnancy|1|||
130745546|NCT01467713|470688374|FG003|Overall Study|Pregnancy|3|||
130745547|NCT01467713|470688371|FG000|Overall Study|Relapse|35|||
130745548|NCT01467713|470688372|FG001|Overall Study|Relapse|25|||
130745549|NCT01467713|470688373|FG002|Overall Study|Relapse|28|||
130745550|NCT01467713|470688374|FG003|Overall Study|Relapse|35|||
130745551|NCT01467713|470688371|FG000|Overall Study|Reason not Specified|6|||
130745552|NCT01467713|470688372|FG001|Overall Study|Reason not Specified|11|||
130745553|NCT01467713|470688373|FG002|Overall Study|Reason not Specified|8|||
130745554|NCT01467713|470688374|FG003|Overall Study|Reason not Specified|7|||
130745555|NCT00210210|470688375|FG000|Overall Study|Withdrawal by Subject|3|||
130745556|NCT00210210|470688376|FG001|Overall Study|Withdrawal by Subject|2|||
130745557|NCT00210210|470688375|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
130745558|NCT00210210|470688376|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
130745559|NCT01100086|470688380|FG000|Period 1|Withdrawal by Subject|1|||
130745560|NCT01100086|470688381|FG001|Period 1|Withdrawal by Subject|0|||
130745561|NCT01611935|470688382|FG000|Overall Study|Family Declined Participation|1|||
130745562|NCT01611935|470688383|FG001|Overall Study|Family Declined Participation|0|||
130745563|NCT01735916|470688384|FG000|Overall Study|Subject not eligible to be randomized|11|||
130745564|NCT01735916|470688385|FG001|Overall Study|Subject not eligible to be randomized|0|||
130745565|NCT01735916|470688386|FG002|Overall Study|Subject not eligible to be randomized|0|||
130745566|NCT01735916|470688384|FG000|Overall Study|Early termination of study by sponsor|4|||
130745567|NCT01735916|470688385|FG001|Overall Study|Early termination of study by sponsor|19|||
130745568|NCT01735916|470688386|FG002|Overall Study|Early termination of study by sponsor|7|||
130745569|NCT01735916|470688384|FG000|Overall Study|Withdrawal by Subject|3|||
130745570|NCT01735916|470688385|FG001|Overall Study|Withdrawal by Subject|0|||
130745571|NCT01735916|470688386|FG002|Overall Study|Withdrawal by Subject|0|||
130745572|NCT02275546|470688397|FG000|Treatment Period 2|Withdrawal by Subject|2|||
130745573|NCT02275546|470688398|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130745574|NCT02275546|470688397|FG000|Treatment Period 2|Protocol Violation|0|||
130745575|NCT02275546|470688398|FG001|Treatment Period 2|Protocol Violation|1|||
130745576|NCT02955355|470688399|FG000|Overall Study|Adverse Event|4|||
130745577|NCT02955355|470688399|FG000|Overall Study|Death|1|||
130745578|NCT02955355|470688399|FG000|Overall Study|Physician Decision|21|||
130745579|NCT02955355|470688399|FG000|Overall Study|Site Terminated by Sponsor|35|||
130745580|NCT02955355|470688399|FG000|Overall Study|Withdrawal by Subject|19|||
130745581|NCT02955355|470688399|FG000|Overall Study|Reason Not Specified|5|||
130745582|NCT02612623|470688400|FG000|Overall Study|Withdrawal by Subject|0|||
130745583|NCT02612623|470688401|FG001|Overall Study|Withdrawal by Subject|1|||
130745584|NCT02612623|470688402|FG002|Overall Study|Withdrawal by Subject|0|||
130745585|NCT02612623|470688403|FG003|Overall Study|Withdrawal by Subject|0|||
130745586|NCT02612623|470688400|FG000|Overall Study|Adverse Event|1|||
130745587|NCT02612623|470688401|FG001|Overall Study|Adverse Event|0|||
130745588|NCT02612623|470688402|FG002|Overall Study|Adverse Event|1|||
130745589|NCT02612623|470688403|FG003|Overall Study|Adverse Event|0|||
130745590|NCT05344560|470688410|FG000|Period 1|Subject out of visit window|1|||
130745591|NCT05344560|470688411|FG001|Period 1|Subject out of visit window|1|||
130745592|NCT05344560|470688410|FG000|Period 2|Covid-19 Related|1|||
130745593|NCT05344560|470688411|FG001|Period 2|Covid-19 Related|0|||
130745594|NCT05344560|470688410|FG000|Period 2|Adverse Event|1|||
130745595|NCT05344560|470688411|FG001|Period 2|Adverse Event|0|||
130745596|NCT05344560|470688410|FG000|Period 2|Subject out of visit window|1|||
130745597|NCT05344560|470688411|FG001|Period 2|Subject out of visit window|1|||
130745598|NCT05344560|470688410|FG000|Period 3|Subject out of visit window|1|||
130745599|NCT05344560|470688411|FG001|Period 3|Subject out of visit window|0|||
130745600|NCT00360282|470688412|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
130745601|NCT00360282|470688413|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
130745602|NCT00360282|470688414|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
130745603|NCT00360282|470688415|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
130745604|NCT00360282|470688412|FG000|Second Intervention|Adverse Event|0|||
130745605|NCT00360282|470688413|FG001|Second Intervention|Adverse Event|1|||
130745606|NCT00360282|470688414|FG002|Second Intervention|Adverse Event|0|||
130745607|NCT00360282|470688415|FG003|Second Intervention|Adverse Event|0|||
130745608|NCT03817853|470688416|FG000|Induction Phase|Adverse Event|5|||
130745609|NCT03817853|470688417|FG001|Induction Phase|Adverse Event|0|||
130745610|NCT03817853|470688418|FG002|Induction Phase|Adverse Event|0|||
130745611|NCT03817853|470688416|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
130745612|NCT03817853|470688417|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
130745613|NCT03817853|470688418|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
130745614|NCT03817853|470688416|FG000|Induction Phase|Physician Decision|2|||
130745615|NCT03817853|470688417|FG001|Induction Phase|Physician Decision|0|||
130745616|NCT03817853|470688418|FG002|Induction Phase|Physician Decision|0|||
130745617|NCT03817853|470688416|FG000|Induction Phase|Progressive Disease|6|||
130745618|NCT03817853|470688417|FG001|Induction Phase|Progressive Disease|0|||
130745619|NCT03817853|470688418|FG002|Induction Phase|Progressive Disease|0|||
130745620|NCT03817853|470688416|FG000|Induction Phase|Withdrawal by Subject|4|||
130745621|NCT03817853|470688417|FG001|Induction Phase|Withdrawal by Subject|0|||
130745622|NCT03817853|470688418|FG002|Induction Phase|Withdrawal by Subject|0|||
130745623|NCT03817853|470688416|FG000|Maintenance Phase|Adverse Event|0|||
130745624|NCT03817853|470688417|FG001|Maintenance Phase|Adverse Event|8|||
130745625|NCT03817853|470688418|FG002|Maintenance Phase|Adverse Event|0|||
130745626|NCT03817853|470688416|FG000|Maintenance Phase|Death|0|||
130745627|NCT03817853|470688417|FG001|Maintenance Phase|Death|5|||
130745628|NCT03817853|470688418|FG002|Maintenance Phase|Death|0|||
130745629|NCT03817853|470688416|FG000|Maintenance Phase|Progressive Disease|0|||
130745630|NCT03817853|470688417|FG001|Maintenance Phase|Progressive Disease|7|||
130745631|NCT03817853|470688418|FG002|Maintenance Phase|Progressive Disease|0|||
130745632|NCT03817853|470688416|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130745633|NCT03817853|470688417|FG001|Maintenance Phase|Withdrawal by Subject|2|||
130745634|NCT03817853|470688418|FG002|Maintenance Phase|Withdrawal by Subject|0|||
130745635|NCT03817853|470688416|FG000|Maintenance Phase|Physician Decision|0|||
130745636|NCT03817853|470688417|FG001|Maintenance Phase|Physician Decision|1|||
130745637|NCT03817853|470688418|FG002|Maintenance Phase|Physician Decision|0|||
130745638|NCT03817853|470688416|FG000|Maintenance Phase|Various reasons|0|||
130745639|NCT03817853|470688417|FG001|Maintenance Phase|Various reasons|4|||
130745640|NCT03817853|470688418|FG002|Maintenance Phase|Various reasons|0|||
130745641|NCT03817853|470688416|FG000|Maintenance Phase|Protocol Deviation|0|||
130745642|NCT03817853|470688417|FG001|Maintenance Phase|Protocol Deviation|1|||
130745643|NCT03817853|470688418|FG002|Maintenance Phase|Protocol Deviation|0|||
130745644|NCT03817853|470688416|FG000|Follow-up Phase|Adverse Event|0|||
130745645|NCT03817853|470688417|FG001|Follow-up Phase|Adverse Event|0|||
130745646|NCT03817853|470688418|FG002|Follow-up Phase|Adverse Event|2|||
130745647|NCT03817853|470688416|FG000|Follow-up Phase|Death|0|||
130745648|NCT03817853|470688417|FG001|Follow-up Phase|Death|0|||
130745649|NCT03817853|470688418|FG002|Follow-up Phase|Death|1|||
130745650|NCT03817853|470688416|FG000|Follow-up Phase|Progressive Disease|0|||
130745651|NCT03817853|470688417|FG001|Follow-up Phase|Progressive Disease|0|||
130745652|NCT03817853|470688418|FG002|Follow-up Phase|Progressive Disease|3|||
130745653|NCT03817853|470688416|FG000|Follow-up Phase|Withdrawal by Subject|0|||
130745654|NCT03817853|470688417|FG001|Follow-up Phase|Withdrawal by Subject|0|||
130745655|NCT03817853|470688418|FG002|Follow-up Phase|Withdrawal by Subject|1|||
130745656|NCT00314340|470688419|FG000|Overall Study|lost interest|1|||
130745657|NCT01620138|470688422|FG000|Overall Study|Withdrawal by Subject|3|||
130745658|NCT01620138|470688423|FG001|Overall Study|Withdrawal by Subject|0|||
130745659|NCT01620138|470688422|FG000|Overall Study|Lack of Efficacy|1|||
130745660|NCT01620138|470688423|FG001|Overall Study|Lack of Efficacy|0|||
130745661|NCT01620138|470688422|FG000|Overall Study|Adverse Event|2|||
130745662|NCT01620138|470688423|FG001|Overall Study|Adverse Event|0|||
130745663|NCT00449865|470688426|FG000|Overall Study|Withdrawal by Subject|110|||
130745664|NCT00449865|470688427|FG001|Overall Study|Withdrawal by Subject|110|||
130745665|NCT00449865|470688426|FG000|Overall Study|Lost to Follow-up|36|||
130745666|NCT00449865|470688427|FG001|Overall Study|Lost to Follow-up|37|||
130745667|NCT00449865|470688426|FG000|Overall Study|Physician Decision|13|||
130745668|NCT00449865|470688427|FG001|Overall Study|Physician Decision|12|||
130745669|NCT00449865|470688426|FG000|Overall Study|Death|31|||
130745670|NCT00449865|470688427|FG001|Overall Study|Death|40|||
130745671|NCT00449865|470688426|FG000|Overall Study|Protocol Violation|8|||
130745672|NCT00449865|470688427|FG001|Overall Study|Protocol Violation|7|||
130745673|NCT00449865|470688426|FG000|Overall Study|Study was stopped|324|||
130745674|NCT00449865|470688427|FG001|Overall Study|Study was stopped|328|||
130745675|NCT03252535|470688428|FG000|Overall Study|Withdrawal by Subject|1|||
130745676|NCT03252535|470688429|FG001|Overall Study|Withdrawal by Subject|0|||
130745677|NCT03252535|470688430|FG002|Overall Study|Withdrawal by Subject|0|||
130745678|NCT03252535|470688428|FG000|Overall Study|Physician Decision|0|||
130745679|NCT03252535|470688429|FG001|Overall Study|Physician Decision|1|||
130745680|NCT03252535|470688430|FG002|Overall Study|Physician Decision|0|||
130745681|NCT03252535|470688428|FG000|Overall Study|Met discontinuation criteria|0|||
130745682|NCT03252535|470688429|FG001|Overall Study|Met discontinuation criteria|1|||
130745683|NCT03252535|470688430|FG002|Overall Study|Met discontinuation criteria|0|||
130745684|NCT01346059|470688431|FG000|Overall Study|Withdrawal by Subject|1|||
130745685|NCT01346059|470688432|FG001|Overall Study|Withdrawal by Subject|0|||
130745686|NCT05600283|470688436|FG000|Overall Study|Withdrawal by Subject|3|||
130745687|NCT05600283|470688437|FG001|Overall Study|Withdrawal by Subject|8|||
130745688|NCT05600283|470688436|FG000|Overall Study|invalid individual swab|1|||
130745689|NCT05600283|470688437|FG001|Overall Study|invalid individual swab|0|||
130745690|NCT05600283|470688436|FG000|Overall Study|missing clinician collection|3|||
130745691|NCT05600283|470688437|FG001|Overall Study|missing clinician collection|0|||
130745692|NCT05600283|470688436|FG000|Overall Study|screening failure|0|||
130745693|NCT05600283|470688437|FG001|Overall Study|screening failure|2|||
130745694|NCT02269098|470688442|FG000|Overall Study|Lost to Follow-up|14|||
130745695|NCT02269098|470688443|FG001|Overall Study|Lost to Follow-up|9|||
130745696|NCT03194542|470688446|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
130745697|NCT03194542|470688447|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
130745698|NCT03194542|470688448|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
130745699|NCT03194542|470688449|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
130745700|NCT03194542|470688446|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
130745701|NCT03194542|470688447|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
130745702|NCT03194542|470688448|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
130745703|NCT03194542|470688449|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
130745704|NCT03194542|470688446|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
130745705|NCT03194542|470688447|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
130745706|NCT03194542|470688448|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
130745707|NCT03194542|470688449|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
130745708|NCT03194542|470688446|FG000|Overall Study|Loss of Response|4|||
130745709|NCT03194542|470688447|FG001|Overall Study|Loss of Response|2|||
130745710|NCT03194542|470688448|FG002|Overall Study|Loss of Response|3|||
130745711|NCT03194542|470688449|FG003|Overall Study|Loss of Response|4|||
130745712|NCT03194542|470688446|FG000|Overall Study|Physician Decision|0|||
130745713|NCT03194542|470688447|FG001|Overall Study|Physician Decision|1|||
130745714|NCT03194542|470688448|FG002|Overall Study|Physician Decision|0|||
130745715|NCT03194542|470688449|FG003|Overall Study|Physician Decision|0|||
130745716|NCT03194542|470688446|FG000|Overall Study|Lack of Efficacy|2|||
130745717|NCT03194542|470688447|FG001|Overall Study|Lack of Efficacy|2|||
130745718|NCT03194542|470688448|FG002|Overall Study|Lack of Efficacy|2|||
130745719|NCT03194542|470688449|FG003|Overall Study|Lack of Efficacy|6|||
130745720|NCT03194542|470688446|FG000|Overall Study|Withdrawal by Subject|2|||
130745721|NCT03194542|470688447|FG001|Overall Study|Withdrawal by Subject|1|||
130745722|NCT03194542|470688448|FG002|Overall Study|Withdrawal by Subject|5|||
130745723|NCT03194542|470688449|FG003|Overall Study|Withdrawal by Subject|4|||
130745724|NCT03194542|470688446|FG000|Overall Study|Progressive Disease|1|||
130745725|NCT03194542|470688447|FG001|Overall Study|Progressive Disease|0|||
130745726|NCT03194542|470688448|FG002|Overall Study|Progressive Disease|1|||
130745727|NCT03194542|470688449|FG003|Overall Study|Progressive Disease|1|||
130745728|NCT03194542|470688446|FG000|Overall Study|Adverse Event|1|||
130745729|NCT03194542|470688447|FG001|Overall Study|Adverse Event|2|||
130745730|NCT03194542|470688448|FG002|Overall Study|Adverse Event|0|||
130745731|NCT03194542|470688449|FG003|Overall Study|Adverse Event|5|||
130745732|NCT03194542|470688446|FG000|Overall Study|Death|1|||
130745733|NCT03194542|470688447|FG001|Overall Study|Death|2|||
130745734|NCT03194542|470688448|FG002|Overall Study|Death|0|||
130745735|NCT03194542|470688449|FG003|Overall Study|Death|5|||
130745736|NCT03194542|470688446|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
130745737|NCT03194542|470688447|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
130745738|NCT03194542|470688448|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
130745739|NCT03194542|470688449|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
130745740|NCT04762160|470688450|FG000|Overall Study|Study terminated early due to business reasons|5|||
130745741|NCT00571727|470688457|FG000|Overall Study|Did not enter in this study|1|||
130745742|NCT00571727|470688457|FG000|Overall Study|Non-compliance|4|||
130745743|NCT00571727|470688457|FG000|Overall Study|Lost to Follow-up|30|||
130745744|NCT00571727|470688457|FG000|Overall Study|Poor growth|1|||
130745745|NCT00571727|470688457|FG000|Overall Study|Parent/patient decision|2|||
130745746|NCT00571727|470688457|FG000|Overall Study|Participant transferred to commercial drug|14|||
130745747|NCT00571727|470688457|FG000|Overall Study|Unable to provide study drug|6|||
130745748|NCT00571727|470688457|FG000|Overall Study|On-treatment at end of study|8|||
130745749|NCT03817190|470688458|FG000|Overall Study|Early Termination|13|||
130745750|NCT03817190|470688459|FG001|Overall Study|Early Termination|20|||
130745751|NCT03817190|470688458|FG000|Overall Study|Adverse Event|10|||
130745752|NCT03817190|470688459|FG001|Overall Study|Adverse Event|17|||
130745753|NCT03817190|470688458|FG000|Overall Study|Withdrawal by Subject|12|||
130745754|NCT03817190|470688459|FG001|Overall Study|Withdrawal by Subject|8|||
130745755|NCT03817190|470688458|FG000|Overall Study|Lost to Follow-up|11|||
130745756|NCT03817190|470688459|FG001|Overall Study|Lost to Follow-up|7|||
130745757|NCT03817190|470688458|FG000|Overall Study|Lack of Efficacy|7|||
130745758|NCT03817190|470688459|FG001|Overall Study|Lack of Efficacy|5|||
130745759|NCT03817190|470688458|FG000|Overall Study|Investigator Decision|5|||
130745760|NCT03817190|470688459|FG001|Overall Study|Investigator Decision|1|||
130745761|NCT03817190|470688458|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
130745762|NCT03817190|470688459|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
130745763|NCT03817190|470688458|FG000|Overall Study|Lack of Contact|1|||
130745764|NCT03817190|470688459|FG001|Overall Study|Lack of Contact|0|||
130745765|NCT03817190|470688458|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
130745766|NCT03817190|470688459|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
130745767|NCT04146012|470688460|FG000|Overall Study|Study Terminated|30|||
130745768|NCT04146012|470688461|FG001|Overall Study|Study Terminated|15|||
130745769|NCT01622673|470688462|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130745770|NCT01622673|470688463|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130745771|NCT01622673|470688464|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130745772|NCT01622673|470688465|FG003|Treatment Period 1|Withdrawal by Subject|1|||
130745773|NCT01622673|470688466|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130745774|NCT01622673|470688467|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130745775|NCT01622673|470688462|FG000|Treatment Period 1|Protocol Violation|0|||
130745776|NCT01622673|470688463|FG001|Treatment Period 1|Protocol Violation|1|||
130745777|NCT01622673|470688464|FG002|Treatment Period 1|Protocol Violation|0|||
130745778|NCT01622673|470688465|FG003|Treatment Period 1|Protocol Violation|0|||
130745779|NCT01622673|470688466|FG004|Treatment Period 1|Protocol Violation|0|||
130745780|NCT01622673|470688467|FG005|Treatment Period 1|Protocol Violation|0|||
130745781|NCT01622673|470688462|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130745782|NCT01622673|470688463|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130745783|NCT01622673|470688464|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130745784|NCT01622673|470688465|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130745785|NCT01622673|470688466|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130745786|NCT01622673|470688467|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130745787|NCT01622673|470688462|FG000|Treatment Period 3|Protocol Violation|0|||
130745788|NCT01622673|470688463|FG001|Treatment Period 3|Protocol Violation|1|||
130745789|NCT01622673|470688464|FG002|Treatment Period 3|Protocol Violation|0|||
130745790|NCT01622673|470688465|FG003|Treatment Period 3|Protocol Violation|0|||
130745791|NCT01622673|470688466|FG004|Treatment Period 3|Protocol Violation|0|||
130745792|NCT01622673|470688467|FG005|Treatment Period 3|Protocol Violation|0|||
130745793|NCT05731700|470689464|FG000|Overall Study|Death|1|||
130745794|NCT00437021|470689483|FG000|Overall Study|Adverse Event|0|||
130745795|NCT00437021|470689484|FG001|Overall Study|Adverse Event|0|||
130745796|NCT00437021|470689485|FG002|Overall Study|Adverse Event|0|||
130745797|NCT00437021|470689486|FG003|Overall Study|Adverse Event|0|||
130745798|NCT00437021|470689487|FG004|Overall Study|Adverse Event|0|||
130745799|NCT00437021|470689488|FG005|Overall Study|Adverse Event|0|||
130745800|NCT00437021|470689489|FG006|Overall Study|Adverse Event|1|||
130745801|NCT00437021|470689490|FG007|Overall Study|Adverse Event|0|||
130745802|NCT00437021|470689491|FG008|Overall Study|Adverse Event|0|||
130745803|NCT00437021|470689492|FG009|Overall Study|Adverse Event|0|||
130745804|NCT00437021|470689493|FG010|Overall Study|Adverse Event|0|||
130745805|NCT00437021|470689494|FG011|Overall Study|Adverse Event|0|||
130745806|NCT00437021|470689483|FG000|Overall Study|Lost to Follow-up|0|||
130745807|NCT00437021|470689484|FG001|Overall Study|Lost to Follow-up|3|||
130745808|NCT00437021|470689485|FG002|Overall Study|Lost to Follow-up|0|||
130745809|NCT00437021|470689486|FG003|Overall Study|Lost to Follow-up|0|||
130745810|NCT00437021|470689487|FG004|Overall Study|Lost to Follow-up|0|||
130745811|NCT00437021|470689488|FG005|Overall Study|Lost to Follow-up|2|||
130745812|NCT00437021|470689489|FG006|Overall Study|Lost to Follow-up|0|||
130745813|NCT00437021|470689490|FG007|Overall Study|Lost to Follow-up|1|||
130745814|NCT00437021|470689491|FG008|Overall Study|Lost to Follow-up|0|||
130745815|NCT00437021|470689492|FG009|Overall Study|Lost to Follow-up|0|||
130745816|NCT00437021|470689493|FG010|Overall Study|Lost to Follow-up|0|||
130745817|NCT00437021|470689494|FG011|Overall Study|Lost to Follow-up|0|||
130745818|NCT00437021|470689483|FG000|Overall Study|Withdrawal by Subject|2|||
130745819|NCT00437021|470689484|FG001|Overall Study|Withdrawal by Subject|1|||
130745820|NCT00437021|470689485|FG002|Overall Study|Withdrawal by Subject|0|||
130745821|NCT00437021|470689486|FG003|Overall Study|Withdrawal by Subject|0|||
130745822|NCT00437021|470689487|FG004|Overall Study|Withdrawal by Subject|0|||
130745823|NCT00437021|470689488|FG005|Overall Study|Withdrawal by Subject|0|||
130745824|NCT00437021|470689489|FG006|Overall Study|Withdrawal by Subject|0|||
130745825|NCT00437021|470689490|FG007|Overall Study|Withdrawal by Subject|0|||
130745826|NCT00437021|470689491|FG008|Overall Study|Withdrawal by Subject|0|||
130745827|NCT00437021|470689492|FG009|Overall Study|Withdrawal by Subject|0|||
130745828|NCT00437021|470689493|FG010|Overall Study|Withdrawal by Subject|0|||
130745829|NCT00437021|470689494|FG011|Overall Study|Withdrawal by Subject|0|||
130745830|NCT05468164|470689495|FG000|Treatment Period 4|Adverse Event|0|||
130745831|NCT05468164|470689496|FG001|Treatment Period 4|Adverse Event|0|||
130745832|NCT05468164|470689497|FG002|Treatment Period 4|Adverse Event|0|||
130745833|NCT05468164|470689498|FG003|Treatment Period 4|Adverse Event|1|||
130745834|NCT05573464|470689499|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
130745835|NCT05573464|470689500|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
130745836|NCT05573464|470689499|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
130745837|NCT05573464|470689500|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
130745838|NCT05573464|470689499|FG000|12-week Treatment Period|Protocol Violation|3|||
130745839|NCT05573464|470689500|FG001|12-week Treatment Period|Protocol Violation|1|||
130745840|NCT05573464|470689499|FG000|12-week Treatment Period|Physician Decision|1|||
130745841|NCT05573464|470689500|FG001|12-week Treatment Period|Physician Decision|2|||
130745842|NCT05573464|470689499|FG000|12-week Treatment Period|Lost to Follow-up|2|||
130745843|NCT05573464|470689500|FG001|12-week Treatment Period|Lost to Follow-up|0|||
130745844|NCT05573464|470689499|FG000|12-week Treatment Period|Adverse Event|20|||
130745845|NCT05573464|470689500|FG001|12-week Treatment Period|Adverse Event|9|||
130745846|NCT05573464|470689499|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
130745847|NCT05573464|470689500|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
130745848|NCT05573464|470689499|FG000|12-week Treatment Period|Randomised, not treated|0|||
130745849|NCT05573464|470689500|FG001|12-week Treatment Period|Randomised, not treated|1|||
130745850|NCT05573464|470689499|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
130745851|NCT05573464|470689500|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
130745852|NCT05573464|470689499|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
130745853|NCT05573464|470689500|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
130745854|NCT05573464|470689499|FG000|52-week Treatment Period|Protocol Violation|1|||
130745855|NCT05573464|470689500|FG001|52-week Treatment Period|Protocol Violation|1|||
130745856|NCT05573464|470689499|FG000|52-week Treatment Period|Physician Decision|2|||
130745857|NCT05573464|470689500|FG001|52-week Treatment Period|Physician Decision|2|||
130745858|NCT05573464|470689499|FG000|52-week Treatment Period|Lost to Follow-up|1|||
130745859|NCT05573464|470689500|FG001|52-week Treatment Period|Lost to Follow-up|1|||
130745860|NCT05573464|470689499|FG000|52-week Treatment Period|Adverse Event|11|||
130745861|NCT05573464|470689500|FG001|52-week Treatment Period|Adverse Event|8|||
130745862|NCT05573464|470689499|FG000|52-week Treatment Period|Death|1|||
130745863|NCT05573464|470689500|FG001|52-week Treatment Period|Death|1|||
130745864|NCT04846569|470689501|FG000|Overall Study|Withdrawal by Subject|3|||
130745865|NCT04846569|470689502|FG001|Overall Study|Withdrawal by Subject|1|||
130745866|NCT00536939|470689507|FG000|Overall Study|Withdrawal by Subject|1|||
130745867|NCT00536939|470689508|FG001|Overall Study|Withdrawal by Subject|0|||
130745868|NCT00536939|470689507|FG000|Overall Study|Other Complicating Disease|1|||
130745869|NCT00536939|470689508|FG001|Overall Study|Other Complicating Disease|0|||
130745870|NCT02954601|470689509|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
130745871|NCT02954601|470689510|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
130745872|NCT02954601|470689511|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
130745873|NCT02954601|470689512|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
130745874|NCT00333983|470689516|FG000|Overall Study|Lost to Follow-up|2|||
130745875|NCT00333983|470689517|FG001|Overall Study|Lost to Follow-up|1|||
130745876|NCT00333983|470689518|FG002|Overall Study|Lost to Follow-up|0|||
130745877|NCT00333983|470689516|FG000|Overall Study|Adverse Event|1|||
130745878|NCT00333983|470689517|FG001|Overall Study|Adverse Event|1|||
130745879|NCT00333983|470689518|FG002|Overall Study|Adverse Event|1|||
130745880|NCT00333983|470689516|FG000|Overall Study|Withdrawal by Subject|0|||
130745881|NCT00333983|470689517|FG001|Overall Study|Withdrawal by Subject|3|||
130745882|NCT00333983|470689518|FG002|Overall Study|Withdrawal by Subject|1|||
130745883|NCT04227197|470689519|FG000|Randomization|Protocol Violation|1|||
130745884|NCT04227197|470689520|FG001|Randomization|Protocol Violation|0|||
130745885|NCT04227197|470689519|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
130745886|NCT04227197|470689520|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
130745887|NCT04227197|470689519|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
130745888|NCT04227197|470689520|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
130745889|NCT04227197|470689519|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
130745890|NCT04227197|470689520|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
130745891|NCT04227197|470689519|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
130745892|NCT04227197|470689520|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
130745893|NCT04227197|470689519|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
130745894|NCT04227197|470689520|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
130745895|NCT04227197|470689519|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
130745896|NCT04227197|470689520|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
130745897|NCT00570141|470689521|FG000|Overall Study|Adverse Event|1|||
130745898|NCT00570141|470689521|FG000|Overall Study|Missed visits|1|||
130745899|NCT00570141|470689521|FG000|Overall Study|Lost to Follow-up|1|||
130745900|NCT01209949|470689531|FG000|Overall Study|Lost to Follow-up|3|||
130745901|NCT00729612|470689536|FG000|Overall Study|Non evaluable for response|10|||
130745902|NCT02075203|470689537|FG000|Overall Study|Withdrawal by Subject|1|||
130745903|NCT02075203|470689538|FG001|Overall Study|Withdrawal by Subject|0|||
130745904|NCT02075203|470689539|FG002|Overall Study|Withdrawal by Subject|1|||
130745905|NCT02075203|470689537|FG000|Overall Study|Adverse Event|1|||
130745906|NCT02075203|470689538|FG001|Overall Study|Adverse Event|0|||
130745907|NCT02075203|470689539|FG002|Overall Study|Adverse Event|0|||
130745908|NCT02075203|470689537|FG000|Overall Study|participant refused to use contraception|1|||
130745909|NCT02075203|470689538|FG001|Overall Study|participant refused to use contraception|0|||
130745910|NCT02075203|470689539|FG002|Overall Study|participant refused to use contraception|0|||
130745911|NCT05266053|470689540|FG000|Overall Study|Withdrawal by Subject|8|||
130745912|NCT05266053|470689541|FG001|Overall Study|Withdrawal by Subject|4|||
130745913|NCT02996968|470689542|FG000|Overall Study|Withdrawal by Subject|1|||
130745914|NCT02996968|470689543|FG001|Overall Study|Withdrawal by Subject|0|||
130745915|NCT00444535|470689546|FG000|Overall Study|Withdrawal by Subject|5|||
130745916|NCT00444535|470689546|FG000|Overall Study|Physician Decision|5|||
130745917|NCT00444535|470689546|FG000|Overall Study|progressive disease|1|||
130745918|NCT00444535|470689546|FG000|Overall Study|Adverse Event|2|||
130745919|NCT05005507|470689548|FG000|Overall Study|Premature termination of study|1|||
130745920|NCT02556775|470689552|FG000|Overall Study|Withdrawal by Subject|1|||
130745921|NCT02556775|470689553|FG001|Overall Study|Withdrawal by Subject|0|||
130745922|NCT02556775|470689554|FG002|Overall Study|Withdrawal by Subject|1|||
130745923|NCT02556775|470689555|FG003|Overall Study|Withdrawal by Subject|0|||
130745924|NCT02556775|470689552|FG000|Overall Study|Lost to Follow-up|1|||
130745925|NCT02556775|470689553|FG001|Overall Study|Lost to Follow-up|0|||
130745926|NCT02556775|470689554|FG002|Overall Study|Lost to Follow-up|0|||
130745927|NCT02556775|470689555|FG003|Overall Study|Lost to Follow-up|0|||
130745928|NCT00558467|470689556|FG000|Overall Study|Adverse Event|1|||
130745929|NCT00558467|470689557|FG001|Overall Study|Adverse Event|2|||
130745930|NCT00558467|470689556|FG000|Overall Study|Lack of Efficacy|0|||
130745931|NCT00558467|470689557|FG001|Overall Study|Lack of Efficacy|1|||
130745932|NCT00558467|470689556|FG000|Overall Study|Patient moving out of state|0|||
130745933|NCT00558467|470689557|FG001|Overall Study|Patient moving out of state|1|||
130745934|NCT02025725|470689564|FG000|Overall Study|Adverse Event|5|||
130745935|NCT02025725|470689565|FG001|Overall Study|Adverse Event|0|||
130745936|NCT02025725|470689564|FG000|Overall Study|Lost to Follow-up|2|||
130745937|NCT02025725|470689565|FG001|Overall Study|Lost to Follow-up|0|||
130745938|NCT02025725|470689564|FG000|Overall Study|Protocol Violation|1|||
130745939|NCT02025725|470689565|FG001|Overall Study|Protocol Violation|1|||
130788330|NCT00171249|470854588|FG004|Overall Study|Withdrawal by Subject|0|||
130788331|NCT00171249|470854589|FG005|Overall Study|Withdrawal by Subject|0|||
130788332|NCT00171249|470854590|FG006|Overall Study|Withdrawal by Subject|0|||
130788333|NCT00171249|470854584|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
130788334|NCT00171249|470854585|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130788335|NCT00171249|470854586|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
130788336|NCT00171249|470854587|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
130788337|NCT00171249|470854588|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130788338|NCT00171249|470854589|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
130788339|NCT00171249|470854590|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130788340|NCT00171249|470854584|FG000|Overall Study|Death|7|||
130788341|NCT00171249|470854585|FG001|Overall Study|Death|1|||
130788342|NCT00171249|470854586|FG002|Overall Study|Death|0|||
130788343|NCT00171249|470854587|FG003|Overall Study|Death|4|||
130788344|NCT00171249|470854588|FG004|Overall Study|Death|0|||
130788345|NCT00171249|470854589|FG005|Overall Study|Death|3|||
130745940|NCT02025725|470689564|FG000|Overall Study|Withdrawal by Subject|3|||
130745941|NCT02025725|470689565|FG001|Overall Study|Withdrawal by Subject|2|||
130745942|NCT02025725|470689564|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
130745943|NCT02025725|470689565|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
130745944|NCT05047211|470689567|FG000|Overall Study|Lost to Follow-up|8|||
130745945|NCT05047211|470689568|FG001|Overall Study|Lost to Follow-up|5|||
130745946|NCT02867592|470689569|FG000|Overall Study|Adverse Event|3|||
130745947|NCT02867592|470689570|FG001|Overall Study|Adverse Event|0|||
130745948|NCT02867592|470689571|FG002|Overall Study|Adverse Event|2|||
130745949|NCT02867592|470689572|FG003|Overall Study|Adverse Event|1|||
130745950|NCT02867592|470689573|FG004|Overall Study|Adverse Event|1|||
130745951|NCT02867592|470689574|FG005|Overall Study|Adverse Event|5|||
130745952|NCT02867592|470689569|FG000|Overall Study|Death|0|||
130745953|NCT02867592|470689570|FG001|Overall Study|Death|0|||
130745954|NCT02867592|470689571|FG002|Overall Study|Death|0|||
130745955|NCT02867592|470689572|FG003|Overall Study|Death|1|||
130745956|NCT02867592|470689573|FG004|Overall Study|Death|0|||
130745957|NCT02867592|470689574|FG005|Overall Study|Death|1|||
130745958|NCT02867592|470689569|FG000|Overall Study|Lack of Efficacy|8|||
130745959|NCT02867592|470689570|FG001|Overall Study|Lack of Efficacy|10|||
130745960|NCT02867592|470689571|FG002|Overall Study|Lack of Efficacy|8|||
130745961|NCT02867592|470689572|FG003|Overall Study|Lack of Efficacy|8|||
130745962|NCT02867592|470689573|FG004|Overall Study|Lack of Efficacy|12|||
130745963|NCT02867592|470689574|FG005|Overall Study|Lack of Efficacy|17|||
130745964|NCT02867592|470689569|FG000|Overall Study|Physician Decision|1|||
130745965|NCT02867592|470689570|FG001|Overall Study|Physician Decision|2|||
130745966|NCT02867592|470689571|FG002|Overall Study|Physician Decision|2|||
130745967|NCT02867592|470689572|FG003|Overall Study|Physician Decision|0|||
130745968|NCT02867592|470689573|FG004|Overall Study|Physician Decision|5|||
130745969|NCT02867592|470689574|FG005|Overall Study|Physician Decision|1|||
130745970|NCT02867592|470689569|FG000|Overall Study|Protocol Violation|0|||
130745971|NCT02867592|470689570|FG001|Overall Study|Protocol Violation|0|||
130745972|NCT02867592|470689571|FG002|Overall Study|Protocol Violation|0|||
130745973|NCT02867592|470689572|FG003|Overall Study|Protocol Violation|0|||
130745974|NCT02867592|470689573|FG004|Overall Study|Protocol Violation|1|||
130745975|NCT02867592|470689574|FG005|Overall Study|Protocol Violation|1|||
130745976|NCT02867592|470689569|FG000|Overall Study|Withdrawal by Subject|0|||
130745977|NCT02867592|470689570|FG001|Overall Study|Withdrawal by Subject|1|||
130745978|NCT02867592|470689571|FG002|Overall Study|Withdrawal by Subject|0|||
130745979|NCT02867592|470689572|FG003|Overall Study|Withdrawal by Subject|1|||
130745980|NCT02867592|470689573|FG004|Overall Study|Withdrawal by Subject|3|||
130788346|NCT00171249|470854590|FG006|Overall Study|Death|1|||
130788347|NCT00171249|470854584|FG000|Overall Study|Other|10|||
130788348|NCT00171249|470854585|FG001|Overall Study|Other|0|||
130788349|NCT00171249|470854586|FG002|Overall Study|Other|0|||
130745981|NCT02867592|470689574|FG005|Overall Study|Withdrawal by Subject|3|||
130745982|NCT02867592|470689569|FG000|Overall Study|Ineligible|1|||
130745983|NCT02867592|470689570|FG001|Overall Study|Ineligible|1|||
130745984|NCT02867592|470689571|FG002|Overall Study|Ineligible|0|||
130745985|NCT02867592|470689572|FG003|Overall Study|Ineligible|0|||
130745986|NCT02867592|470689573|FG004|Overall Study|Ineligible|2|||
130788350|NCT00171249|470854587|FG003|Overall Study|Other|43|||
130745987|NCT02867592|470689574|FG005|Overall Study|Ineligible|0|||
130745988|NCT02867592|470689569|FG000|Overall Study|No Treatment|1|||
130745989|NCT02867592|470689570|FG001|Overall Study|No Treatment|0|||
130745990|NCT02867592|470689571|FG002|Overall Study|No Treatment|0|||
130745991|NCT02867592|470689572|FG003|Overall Study|No Treatment|0|||
130745992|NCT02867592|470689573|FG004|Overall Study|No Treatment|0|||
130745993|NCT02867592|470689574|FG005|Overall Study|No Treatment|0|||
130745994|NCT02867592|470689569|FG000|Overall Study|Still on Therapy|0|||
130745995|NCT02867592|470689570|FG001|Overall Study|Still on Therapy|0|||
130788351|NCT00171249|470854588|FG004|Overall Study|Other|0|||
130788352|NCT00171249|470854589|FG005|Overall Study|Other|2|||
130788353|NCT00171249|470854590|FG006|Overall Study|Other|0|||
130788354|NCT00171249|470854584|FG000|Overall Study|No Longer Requires Study Drug|4|||
130745996|NCT02867592|470689571|FG002|Overall Study|Still on Therapy|0|||
130745997|NCT02867592|470689572|FG003|Overall Study|Still on Therapy|0|||
130745998|NCT02867592|470689573|FG004|Overall Study|Still on Therapy|1|||
130745999|NCT02867592|470689574|FG005|Overall Study|Still on Therapy|0|||
130746000|NCT02867592|470689569|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130746001|NCT02867592|470689570|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130746002|NCT02867592|470689571|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130746003|NCT02867592|470689572|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130746004|NCT02867592|470689573|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130746005|NCT02867592|470689574|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
130746006|NCT02867592|470689569|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
130746007|NCT02867592|470689570|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
130746008|NCT02867592|470689571|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
130746009|NCT02867592|470689572|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
130746010|NCT02867592|470689573|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
130746011|NCT02867592|470689574|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
130746012|NCT00594165|470689575|FG000|Overall Study|Major protocol violation|1|||
130746013|NCT00594165|470689575|FG000|Overall Study|Lack of Efficacy|12|||
130746014|NCT00594165|470689575|FG000|Overall Study|Adverse Event|52|||
130746015|NCT00594165|470689575|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
130746016|NCT00594165|470689575|FG000|Overall Study|Subject withdrew consent|27|||
130746017|NCT00594165|470689575|FG000|Overall Study|Study ended per sponsor|102|||
130746018|NCT00594165|470689575|FG000|Overall Study|Lost to Follow-up|4|||
130746019|NCT00594165|470689575|FG000|Overall Study|Other: PI discretion|5|||
130746020|NCT00594165|470689575|FG000|Overall Study|Other: Subject moving|3|||
130746021|NCT00594165|470689575|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
130746022|NCT00594165|470689575|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
130746023|NCT00594165|470689575|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
130746024|NCT00594165|470689575|FG000|Overall Study|Other: Site terminated participation|2|||
130746025|NCT03581292|470689580|FG000|Overall Study|Physician Decision|9|||
130746026|NCT03581292|470689581|FG001|Overall Study|Physician Decision|5|||
130746027|NCT03581292|470689580|FG000|Overall Study|Withdrawal by Subject|3|||
130746028|NCT03581292|470689581|FG001|Overall Study|Withdrawal by Subject|0|||
130746029|NCT03581292|470689580|FG000|Overall Study|Withdrawal before Therapy Start|1|||
130746030|NCT03581292|470689581|FG001|Overall Study|Withdrawal before Therapy Start|0|||
130746031|NCT00824772|470690909|FG000|Overall Study|Withdrawal by Subject|8|||
130746032|NCT03214224|470690918|FG000|Overall Study|Protocol Violation|1|||
130746033|NCT03214224|470690918|FG000|Overall Study|Withdrawal by Subject|2|||
130746034|NCT03214224|470690918|FG000|Overall Study|Practice controls or therapists|6|||
130746035|NCT02712320|470690919|FG000|Overall Study|Lost to Follow-up|1|||
130746036|NCT02712320|470690919|FG000|Overall Study|Withdrawal by Subject|1|||
130746037|NCT02712320|470690919|FG000|Overall Study|Transferred to another facility|1|||
130746038|NCT02712320|470690919|FG000|Overall Study|Treating with the prohibited medications|2|||
130746039|NCT00568451|470690922|FG000|Overall Study|Disease Progression|0|||
130746040|NCT00568451|470690923|FG001|Overall Study|Disease Progression|0|||
130746041|NCT00568451|470690924|FG002|Overall Study|Disease Progression|2|||
130746042|NCT00568451|470690925|FG003|Overall Study|Disease Progression|7|||
130746043|NCT01343043|470690928|FG000|Overall Study|Disease progression before treatment|1|||
130746044|NCT01343043|470690929|FG001|Overall Study|Disease progression before treatment|0|||
130746045|NCT01343043|470690930|FG002|Overall Study|Disease progression before treatment|0|||
130746046|NCT01343043|470690931|FG003|Overall Study|Disease progression before treatment|0|||
130746047|NCT01343043|470690928|FG000|Overall Study|Withdrawal by Subject|1|||
130746048|NCT01343043|470690929|FG001|Overall Study|Withdrawal by Subject|0|||
130746049|NCT01343043|470690930|FG002|Overall Study|Withdrawal by Subject|0|||
130746050|NCT01343043|470690931|FG003|Overall Study|Withdrawal by Subject|0|||
130746051|NCT01343043|470690928|FG000|Overall Study|Death|1|||
130746052|NCT01343043|470690929|FG001|Overall Study|Death|1|||
130746053|NCT01343043|470690930|FG002|Overall Study|Death|0|||
130746054|NCT01343043|470690931|FG003|Overall Study|Death|1|||
130746055|NCT00925704|470690932|FG000|First Intervention|Withdrew consent|0|||
130746056|NCT00925704|470690933|FG001|First Intervention|Withdrew consent|0|||
130746057|NCT00925704|470690934|FG002|First Intervention|Withdrew consent|0|||
130746058|NCT00925704|470690935|FG003|First Intervention|Withdrew consent|1|||
130746059|NCT00925704|470690936|FG004|First Intervention|Withdrew consent|1|||
130746060|NCT00925704|470690937|FG005|First Intervention|Withdrew consent|0|||
130746061|NCT00925704|470690932|FG000|Second Intervention|Withdrawal by Subject|1|||
130746062|NCT00925704|470690933|FG001|Second Intervention|Withdrawal by Subject|0|||
130746063|NCT00925704|470690934|FG002|Second Intervention|Withdrawal by Subject|0|||
130746064|NCT00925704|470690935|FG003|Second Intervention|Withdrawal by Subject|0|||
130788355|NCT00171249|470854585|FG001|Overall Study|No Longer Requires Study Drug|0|||
130788356|NCT00171249|470854586|FG002|Overall Study|No Longer Requires Study Drug|0|||
130788357|NCT00171249|470854587|FG003|Overall Study|No Longer Requires Study Drug|3|||
130788358|NCT00171249|470854588|FG004|Overall Study|No Longer Requires Study Drug|0|||
130788359|NCT00171249|470854589|FG005|Overall Study|No Longer Requires Study Drug|5|||
130788360|NCT00171249|470854590|FG006|Overall Study|No Longer Requires Study Drug|0|||
130788361|NCT00171249|470854584|FG000|Overall Study|Administrative Problems|1|||
130788362|NCT00171249|470854585|FG001|Overall Study|Administrative Problems|0|||
130788363|NCT00171249|470854586|FG002|Overall Study|Administrative Problems|0|||
130788364|NCT00171249|470854587|FG003|Overall Study|Administrative Problems|2|||
130788365|NCT00171249|470854588|FG004|Overall Study|Administrative Problems|0|||
130788366|NCT00171249|470854589|FG005|Overall Study|Administrative Problems|0|||
130788367|NCT00171249|470854590|FG006|Overall Study|Administrative Problems|0|||
130788368|NCT00171249|470854584|FG000|Overall Study|Adverse Event|3|||
130788369|NCT00171249|470854585|FG001|Overall Study|Adverse Event|1|||
130788370|NCT00171249|470854586|FG002|Overall Study|Adverse Event|0|||
130788371|NCT00171249|470854587|FG003|Overall Study|Adverse Event|15|||
130788372|NCT00171249|470854588|FG004|Overall Study|Adverse Event|0|||
130788373|NCT00171249|470854589|FG005|Overall Study|Adverse Event|2|||
130788374|NCT00171249|470854590|FG006|Overall Study|Adverse Event|0|||
130788375|NCT00171249|470854584|FG000|Overall Study|Lost to Follow-up|5|||
130788376|NCT00171249|470854585|FG001|Overall Study|Lost to Follow-up|0|||
130788377|NCT00171249|470854586|FG002|Overall Study|Lost to Follow-up|0|||
130788378|NCT00171249|470854587|FG003|Overall Study|Lost to Follow-up|9|||
130788379|NCT00171249|470854588|FG004|Overall Study|Lost to Follow-up|0|||
130788380|NCT00171249|470854589|FG005|Overall Study|Lost to Follow-up|0|||
130788381|NCT00171249|470854590|FG006|Overall Study|Lost to Follow-up|0|||
130788382|NCT01041859|470854591|FG000|Open-Label Titration|Adverse Event|69|||
130788383|NCT01041859|470854592|FG001|Open-Label Titration|Adverse Event|0|||
130788384|NCT01041859|470854593|FG002|Open-Label Titration|Adverse Event|0|||
130788385|NCT01041859|470854591|FG000|Open-Label Titration|Lack of Efficacy|3|||
130788386|NCT01041859|470854592|FG001|Open-Label Titration|Lack of Efficacy|0|||
130788387|NCT01041859|470854593|FG002|Open-Label Titration|Lack of Efficacy|0|||
130788388|NCT01041859|470854591|FG000|Open-Label Titration|Lost to Follow-up|1|||
130788389|NCT01041859|470854592|FG001|Open-Label Titration|Lost to Follow-up|0|||
130788390|NCT01041859|470854593|FG002|Open-Label Titration|Lost to Follow-up|0|||
130788391|NCT01041859|470854591|FG000|Open-Label Titration|Physician Decision|1|||
130788392|NCT01041859|470854592|FG001|Open-Label Titration|Physician Decision|0|||
130788393|NCT01041859|470854593|FG002|Open-Label Titration|Physician Decision|0|||
130788394|NCT01041859|470854591|FG000|Open-Label Titration|Protocol Violation|1|||
130788395|NCT01041859|470854592|FG001|Open-Label Titration|Protocol Violation|0|||
130788396|NCT01041859|470854593|FG002|Open-Label Titration|Protocol Violation|0|||
130788397|NCT01041859|470854591|FG000|Open-Label Titration|Other|7|||
130788398|NCT01041859|470854592|FG001|Open-Label Titration|Other|0|||
130788399|NCT01041859|470854593|FG002|Open-Label Titration|Other|0|||
130788400|NCT01041859|470854591|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
130788401|NCT01041859|470854592|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
130788402|NCT01041859|470854593|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
130788403|NCT01041859|470854591|FG000|Open-Label Titration|Withdrawal by Subject|11|||
130788404|NCT01041859|470854592|FG001|Open-Label Titration|Withdrawal by Subject|0|||
130788405|NCT01041859|470854593|FG002|Open-Label Titration|Withdrawal by Subject|0|||
130788406|NCT01041859|470854591|FG000|Double-Blind Maintenance|Adverse Event|0|||
130788407|NCT01041859|470854592|FG001|Double-Blind Maintenance|Adverse Event|23|||
130746065|NCT00925704|470690936|FG004|Second Intervention|Withdrawal by Subject|1|||
130746066|NCT00925704|470690937|FG005|Second Intervention|Withdrawal by Subject|0|||
130746067|NCT00925704|470690932|FG000|Third Intervention|Withdrew consent|0|||
130746068|NCT00925704|470690933|FG001|Third Intervention|Withdrew consent|0|||
130746069|NCT00925704|470690934|FG002|Third Intervention|Withdrew consent|0|||
130746070|NCT00925704|470690935|FG003|Third Intervention|Withdrew consent|0|||
130746071|NCT00925704|470690936|FG004|Third Intervention|Withdrew consent|0|||
130746072|NCT00925704|470690937|FG005|Third Intervention|Withdrew consent|1|||
130746073|NCT02044302|470690941|FG000|Overall Study|study terminated|2|||
130746074|NCT02044302|470690942|FG001|Overall Study|study terminated|0|||
130746075|NCT03207815|470690943|FG000|Overall Study|Protocol Violation|3|||
130746076|NCT03207815|470690944|FG001|Overall Study|Protocol Violation|1|||
130746077|NCT03207815|470690943|FG000|Overall Study|Adverse Event|1|||
130746078|NCT03207815|470690944|FG001|Overall Study|Adverse Event|2|||
130746079|NCT03207815|470690943|FG000|Overall Study|Lost to Follow-up|1|||
130746080|NCT03207815|470690944|FG001|Overall Study|Lost to Follow-up|2|||
130746081|NCT03207815|470690943|FG000|Overall Study|Investigator's Discretion|1|||
130746082|NCT03207815|470690944|FG001|Overall Study|Investigator's Discretion|1|||
130746083|NCT03207815|470690943|FG000|Overall Study|Lack of Efficacy|0|||
130746084|NCT03207815|470690944|FG001|Overall Study|Lack of Efficacy|1|||
130746085|NCT03207815|470690943|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
130746086|NCT03207815|470690944|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
130746087|NCT03207815|470690943|FG000|Overall Study|Withdrew Consent|1|||
130746088|NCT03207815|470690944|FG001|Overall Study|Withdrew Consent|0|||
130746089|NCT01671007|470690945|FG000|Overall Study|Other reasons than listed|166|||
130746090|NCT01671007|470690946|FG001|Overall Study|Other reasons than listed|373|||
130746091|NCT01671007|470690947|FG002|Overall Study|Other reasons than listed|197|||
130746092|NCT01671007|470690948|FG003|Overall Study|Other reasons than listed|228|||
130746093|NCT01671007|470690949|FG004|Overall Study|Other reasons than listed|14|||
130746094|NCT01671007|470690950|FG005|Overall Study|Other reasons than listed|71|||
130746095|NCT01671007|470690951|FG006|Overall Study|Other reasons than listed|17|||
130746096|NCT01671007|470690952|FG007|Overall Study|Other reasons than listed|66|||
130746097|NCT01671007|470690953|FG008|Overall Study|Other reasons than listed|0|||
130746098|NCT01671007|470690945|FG000|Overall Study|Withdrawal by Subject|36|||
130746099|NCT01671007|470690946|FG001|Overall Study|Withdrawal by Subject|59|||
130746100|NCT01671007|470690947|FG002|Overall Study|Withdrawal by Subject|53|||
130746101|NCT01671007|470690948|FG003|Overall Study|Withdrawal by Subject|58|||
130746102|NCT01671007|470690949|FG004|Overall Study|Withdrawal by Subject|4|||
130746103|NCT01671007|470690950|FG005|Overall Study|Withdrawal by Subject|15|||
130746104|NCT01671007|470690951|FG006|Overall Study|Withdrawal by Subject|1|||
130746105|NCT01671007|470690952|FG007|Overall Study|Withdrawal by Subject|19|||
130746106|NCT01671007|470690953|FG008|Overall Study|Withdrawal by Subject|0|||
130746107|NCT01671007|470690945|FG000|Overall Study|Lost to Follow-up|93|||
130746108|NCT01671007|470690946|FG001|Overall Study|Lost to Follow-up|142|||
130746109|NCT01671007|470690947|FG002|Overall Study|Lost to Follow-up|91|||
130746110|NCT01671007|470690948|FG003|Overall Study|Lost to Follow-up|63|||
130746111|NCT01671007|470690949|FG004|Overall Study|Lost to Follow-up|7|||
130746112|NCT01671007|470690950|FG005|Overall Study|Lost to Follow-up|20|||
130746113|NCT01671007|470690951|FG006|Overall Study|Lost to Follow-up|2|||
130746114|NCT01671007|470690952|FG007|Overall Study|Lost to Follow-up|28|||
130746115|NCT01671007|470690953|FG008|Overall Study|Lost to Follow-up|0|||
130746116|NCT01671007|470690945|FG000|Overall Study|No end of study case report form|3|||
130746117|NCT01671007|470690946|FG001|Overall Study|No end of study case report form|1|||
130746118|NCT01671007|470690947|FG002|Overall Study|No end of study case report form|0|||
130746119|NCT01671007|470690948|FG003|Overall Study|No end of study case report form|2|||
130746120|NCT01671007|470690949|FG004|Overall Study|No end of study case report form|0|||
130746121|NCT01671007|470690950|FG005|Overall Study|No end of study case report form|0|||
130788408|NCT01041859|470854593|FG002|Double-Blind Maintenance|Adverse Event|13|||
130788409|NCT01041859|470854591|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
130788410|NCT01041859|470854592|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
130788411|NCT01041859|470854593|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
130788412|NCT01041859|470854591|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
130788413|NCT01041859|470854592|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
130788414|NCT01041859|470854593|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
130788415|NCT01041859|470854591|FG000|Double-Blind Maintenance|Physician Decision|0|||
130788416|NCT01041859|470854592|FG001|Double-Blind Maintenance|Physician Decision|2|||
130788417|NCT01041859|470854593|FG002|Double-Blind Maintenance|Physician Decision|1|||
130788418|NCT01041859|470854591|FG000|Double-Blind Maintenance|Protocol Violation|0|||
130788419|NCT01041859|470854592|FG001|Double-Blind Maintenance|Protocol Violation|1|||
130788420|NCT01041859|470854593|FG002|Double-Blind Maintenance|Protocol Violation|3|||
130788421|NCT01041859|470854591|FG000|Double-Blind Maintenance|Other|0|||
130788422|NCT01041859|470854592|FG001|Double-Blind Maintenance|Other|6|||
130788423|NCT01041859|470854593|FG002|Double-Blind Maintenance|Other|2|||
130788424|NCT01041859|470854591|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
130788425|NCT01041859|470854592|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
130788426|NCT01041859|470854593|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
130788427|NCT01041859|470854591|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
130788428|NCT01041859|470854592|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
130746122|NCT01671007|470690951|FG006|Overall Study|No end of study case report form|0|||
130746123|NCT01671007|470690952|FG007|Overall Study|No end of study case report form|0|||
130746124|NCT01671007|470690953|FG008|Overall Study|No end of study case report form|0|||
130746125|NCT01671007|470690945|FG000|Overall Study|Not eligible|23|||
130746126|NCT01671007|470690946|FG001|Overall Study|Not eligible|76|||
130746127|NCT01671007|470690947|FG002|Overall Study|Not eligible|25|||
130746128|NCT01671007|470690948|FG003|Overall Study|Not eligible|17|||
130746129|NCT01671007|470690949|FG004|Overall Study|Not eligible|0|||
130746130|NCT01671007|470690950|FG005|Overall Study|Not eligible|6|||
130746131|NCT01671007|470690951|FG006|Overall Study|Not eligible|1|||
130746132|NCT01671007|470690952|FG007|Overall Study|Not eligible|19|||
130746133|NCT01671007|470690953|FG008|Overall Study|Not eligible|0|||
130746134|NCT00391768|470690954|FG000|Overall Study|Withdrawal by Subject|0|||
130746135|NCT00391768|470690955|FG001|Overall Study|Withdrawal by Subject|0|||
130746136|NCT00391768|470690956|FG002|Overall Study|Withdrawal by Subject|1|||
130746137|NCT00391768|470690957|FG003|Overall Study|Withdrawal by Subject|0|||
130788429|NCT01041859|470854593|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
130788430|NCT02908347|470854599|FG000|Overall Study|Adverse Event|0|||
130788431|NCT02908347|470854600|FG001|Overall Study|Adverse Event|1|||
130788432|NCT02908347|470854599|FG000|Overall Study|Lost to Follow-up|1|||
130788433|NCT02908347|470854600|FG001|Overall Study|Lost to Follow-up|0|||
130788434|NCT01326871|470854601|FG000|Overall Study|Major surgery|0|||
130788435|NCT01326871|470854602|FG001|Overall Study|Major surgery|1|||
130746138|NCT00391768|470690958|FG004|Overall Study|Withdrawal by Subject|0|||
130746139|NCT00391768|470690959|FG005|Overall Study|Withdrawal by Subject|1|||
130746140|NCT00391768|470690960|FG006|Overall Study|Withdrawal by Subject|1|||
130746141|NCT00391768|470690954|FG000|Overall Study|Lost to Follow-up|0|||
130746142|NCT00391768|470690955|FG001|Overall Study|Lost to Follow-up|0|||
130746143|NCT00391768|470690956|FG002|Overall Study|Lost to Follow-up|0|||
130746144|NCT00391768|470690957|FG003|Overall Study|Lost to Follow-up|1|||
130746145|NCT00391768|470690958|FG004|Overall Study|Lost to Follow-up|2|||
130746146|NCT00391768|470690959|FG005|Overall Study|Lost to Follow-up|2|||
130746147|NCT00391768|470690960|FG006|Overall Study|Lost to Follow-up|3|||
130746148|NCT00406367|470690961|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
130746149|NCT00406367|470690962|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
130746150|NCT00406367|470690961|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
130746151|NCT00406367|470690962|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
130746152|NCT00406367|470690961|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
130746153|NCT00406367|470690962|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
130746154|NCT00406367|470690961|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
130746155|NCT00406367|470690962|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
130746156|NCT00406367|470690961|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
130746157|NCT00406367|470690962|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
130746158|NCT00406367|470690961|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
130746159|NCT00406367|470690962|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
130746160|NCT00406367|470690961|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
130746161|NCT00406367|470690962|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
130746162|NCT00406367|470690961|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
130746163|NCT00406367|470690962|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
130746164|NCT00406367|470690961|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
130746165|NCT00406367|470690962|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
130746166|NCT00406367|470690961|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
130746167|NCT00406367|470690962|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
130746168|NCT00406367|470690961|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
130746169|NCT00406367|470690962|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
130788436|NCT01326871|470854603|FG002|Overall Study|Major surgery|0|||
130788437|NCT01326871|470854601|FG000|Overall Study|SAE and death|0|||
130788438|NCT01326871|470854602|FG001|Overall Study|SAE and death|2|||
130788439|NCT01326871|470854603|FG002|Overall Study|SAE and death|0|||
130788440|NCT01326871|470854601|FG000|Overall Study|Physician decision and decreased performance status|0|||
130788441|NCT01326871|470854602|FG001|Overall Study|Physician decision and decreased performance status|1|||
130788442|NCT01326871|470854603|FG002|Overall Study|Physician decision and decreased performance status|0|||
130788443|NCT01326871|470854601|FG000|Overall Study|Disease progression|0|||
130788444|NCT01326871|470854602|FG001|Overall Study|Disease progression|11|||
130788445|NCT01326871|470854603|FG002|Overall Study|Disease progression|5|||
130788446|NCT01326871|470854601|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
130788447|NCT01326871|470854602|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
130788448|NCT01326871|470854603|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
130788449|NCT01326871|470854601|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
130788450|NCT01326871|470854602|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
130788451|NCT01326871|470854603|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
130788452|NCT01326871|470854601|FG000|Overall Study|Withdrawal by Subject|0|||
130788453|NCT01326871|470854602|FG001|Overall Study|Withdrawal by Subject|1|||
130788454|NCT01326871|470854603|FG002|Overall Study|Withdrawal by Subject|0|||
130788455|NCT01326871|470854601|FG000|Overall Study|DLT|0|||
130788456|NCT01326871|470854602|FG001|Overall Study|DLT|2|||
130788457|NCT01326871|470854603|FG002|Overall Study|DLT|0|||
130788458|NCT01326871|470854601|FG000|Overall Study|SAE, disease progression and subject decision|0|||
130788459|NCT01326871|470854602|FG001|Overall Study|SAE, disease progression and subject decision|1|||
130788460|NCT01326871|470854603|FG002|Overall Study|SAE, disease progression and subject decision|0|||
130788461|NCT01326871|470854601|FG000|Overall Study|Death|0|||
130788462|NCT01326871|470854602|FG001|Overall Study|Death|1|||
130788463|NCT01326871|470854603|FG002|Overall Study|Death|0|||
130788464|NCT01326871|470854601|FG000|Overall Study|Other|0|||
130788465|NCT01326871|470854602|FG001|Overall Study|Other|3|||
130788466|NCT01326871|470854603|FG002|Overall Study|Other|0|||
130788467|NCT01326871|470854601|FG000|Overall Study|SAE and disease progression|0|||
130788468|NCT01326871|470854602|FG001|Overall Study|SAE and disease progression|0|||
130788469|NCT01326871|470854603|FG002|Overall Study|SAE and disease progression|1|||
130788470|NCT01326871|470854601|FG000|Overall Study|SAE and physician decision|0|||
130788471|NCT01326871|470854602|FG001|Overall Study|SAE and physician decision|0|||
130746170|NCT00406367|470690961|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
130788472|NCT01326871|470854603|FG002|Overall Study|SAE and physician decision|1|||
130788473|NCT01326871|470854601|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
130746171|NCT00406367|470690962|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
130788474|NCT01326871|470854602|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
130746172|NCT00171210|470690963|FG000|Overall Study|Adverse Event|16|||
130746173|NCT00171210|470690964|FG001|Overall Study|Adverse Event|27|||
130746174|NCT00171210|470690963|FG000|Overall Study|Abnormal laboratory value(s)|6|||
130746175|NCT00171210|470690964|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130746176|NCT00171210|470690963|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130746177|NCT00171210|470690964|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130746178|NCT00171210|470690963|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
130746179|NCT00171210|470690964|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
130746180|NCT00171210|470690963|FG000|Overall Study|Protocol Violation|0|||
130746181|NCT00171210|470690964|FG001|Overall Study|Protocol Violation|2|||
130746182|NCT00171210|470690963|FG000|Overall Study|Withdrawal by Subject|32|||
130746183|NCT00171210|470690964|FG001|Overall Study|Withdrawal by Subject|30|||
130746184|NCT00171210|470690963|FG000|Overall Study|Lost to Follow-up|1|||
130746185|NCT00171210|470690964|FG001|Overall Study|Lost to Follow-up|0|||
130746186|NCT00171210|470690963|FG000|Overall Study|Administrative problems|1|||
130746187|NCT00171210|470690964|FG001|Overall Study|Administrative problems|1|||
130746188|NCT00171210|470690963|FG000|Overall Study|Death|2|||
130746189|NCT00171210|470690964|FG001|Overall Study|Death|3|||
130746190|NCT00171210|470690963|FG000|Overall Study|Stopped at end of core|0|||
130746191|NCT00171210|470690964|FG001|Overall Study|Stopped at end of core|32|||
130746192|NCT00171210|470690963|FG000|Overall Study|Stopped at end of extension 1|0|||
130746193|NCT00171210|470690964|FG001|Overall Study|Stopped at end of extension 1|1|||
130746194|NCT03187301|470690967|FG000|Titration Period|Adverse Event|0|||
130746195|NCT03187301|470690968|FG001|Titration Period|Adverse Event|0|||
130746196|NCT03187301|470690969|FG002|Titration Period|Adverse Event|0|||
130746197|NCT03187301|470690970|FG003|Titration Period|Adverse Event|0|||
130746198|NCT03187301|470690971|FG004|Titration Period|Adverse Event|0|||
130746199|NCT03187301|470690972|FG005|Titration Period|Adverse Event|0|||
130746200|NCT03187301|470690973|FG006|Titration Period|Adverse Event|5|||
130746201|NCT03187301|470690967|FG000|Titration Period|Withdrawal by Subject|0|||
130746202|NCT03187301|470690968|FG001|Titration Period|Withdrawal by Subject|0|||
130746203|NCT03187301|470690969|FG002|Titration Period|Withdrawal by Subject|0|||
130746204|NCT03187301|470690970|FG003|Titration Period|Withdrawal by Subject|0|||
130746205|NCT03187301|470690971|FG004|Titration Period|Withdrawal by Subject|0|||
130746206|NCT03187301|470690972|FG005|Titration Period|Withdrawal by Subject|0|||
130746207|NCT03187301|470690973|FG006|Titration Period|Withdrawal by Subject|1|||
130746208|NCT03187301|470690967|FG000|Titration Period|Exclusion Criteria Met|0|||
130746209|NCT03187301|470690968|FG001|Titration Period|Exclusion Criteria Met|0|||
130746210|NCT03187301|470690969|FG002|Titration Period|Exclusion Criteria Met|0|||
130746211|NCT03187301|470690970|FG003|Titration Period|Exclusion Criteria Met|0|||
130746212|NCT03187301|470690971|FG004|Titration Period|Exclusion Criteria Met|0|||
130746213|NCT03187301|470690972|FG005|Titration Period|Exclusion Criteria Met|0|||
130746214|NCT03187301|470690973|FG006|Titration Period|Exclusion Criteria Met|1|||
130746215|NCT03187301|470690967|FG000|Pre-Intervention|Withdrawal by Subject|1|||
130746216|NCT03187301|470690968|FG001|Pre-Intervention|Withdrawal by Subject|0|||
130746217|NCT03187301|470690969|FG002|Pre-Intervention|Withdrawal by Subject|0|||
130746218|NCT03187301|470690970|FG003|Pre-Intervention|Withdrawal by Subject|0|||
130746219|NCT03187301|470690971|FG004|Pre-Intervention|Withdrawal by Subject|0|||
130746220|NCT03187301|470690972|FG005|Pre-Intervention|Withdrawal by Subject|0|||
130746221|NCT03187301|470690973|FG006|Pre-Intervention|Withdrawal by Subject|0|||
130746222|NCT02182843|470690981|FG000|Overall Study|Withdrawal by Subject|7|||
130746223|NCT02182843|470690981|FG000|Overall Study|Lost to Follow-up|2|||
130746224|NCT02182843|470690981|FG000|Overall Study|Adverse Event|1|||
130746225|NCT02375971|470690982|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
130746226|NCT02375971|470690983|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
130746227|NCT02375971|470690984|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
130746228|NCT02375971|470690982|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
130746229|NCT02375971|470690983|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
130746230|NCT02375971|470690984|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
130746231|NCT02375971|470690982|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
130746232|NCT02375971|470690983|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
130746233|NCT02375971|470690984|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
130746234|NCT02375971|470690982|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
130746235|NCT02375971|470690983|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
130746236|NCT02375971|470690984|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
130746237|NCT02375971|470690982|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
130746238|NCT02375971|470690983|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
130746239|NCT02375971|470690984|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
130746240|NCT02375971|470690982|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
130746241|NCT02375971|470690983|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
130746242|NCT02375971|470690984|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
130746243|NCT02375971|470690982|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
130746244|NCT02375971|470690983|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
130746245|NCT02375971|470690984|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
130746246|NCT02375971|470690982|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
130746247|NCT02375971|470690983|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
130746248|NCT02375971|470690984|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
130746249|NCT00832455|470690986|FG000|Overall Study|Adverse Event|13|||
130746250|NCT00832455|470690986|FG000|Overall Study|Lost to Follow-up|26|||
130746251|NCT00832455|470690986|FG000|Overall Study|Protocol Violation|4|||
130746252|NCT00832455|470690986|FG000|Overall Study|Withdrawal by Subject|17|||
130746253|NCT00832455|470690986|FG000|Overall Study|Screening Failure|2|||
130746254|NCT00832455|470690986|FG000|Overall Study|Stopped Medication|4|||
130746255|NCT00832455|470690986|FG000|Overall Study|Parent misunderstood study|1|||
130746256|NCT00832455|470690986|FG000|Overall Study|Parent dissatisfied|1|||
130746257|NCT00832455|470690986|FG000|Overall Study|No improvement|3|||
130746258|NCT00832455|470690986|FG000|Overall Study|Patient moved|1|||
130746259|NCT00561392|470690989|FG000|Overall Study|Adverse Event|38|||
130746260|NCT00561392|470690989|FG000|Overall Study|Lack of Efficacy|2|||
130746261|NCT00561392|470690989|FG000|Overall Study|Protocol Violation|1|||
130746262|NCT00561392|470690989|FG000|Overall Study|Withdrawal by Subject|8|||
130746263|NCT00561392|470690989|FG000|Overall Study|Administrative problems|4|||
130746264|NCT01741688|470690990|FG000|Overall Study|Lack of insurance coverage|2|||
130746265|NCT01741688|470690990|FG000|Overall Study|Withdrawal by Subject|1|||
130746266|NCT01262872|470690995|FG000|Step 2|Death|0|||
130746267|NCT01262872|470690996|FG001|Step 2|Death|0|||
130746268|NCT01262872|470690997|FG002|Step 2|Death|0|||
130746269|NCT01262872|470690998|FG003|Step 2|Death|1|||
130746270|NCT01262872|470690999|FG004|Step 2|Death|0|||
130746271|NCT01262872|470691000|FG005|Step 2|Death|2|||
130746272|NCT01262872|470691001|FG006|Step 2|Death|2|||
130746273|NCT01262872|470691002|FG007|Step 2|Death|1|||
130746274|NCT01262872|470690995|FG000|Step 2|Protocol Violation|0|||
130746275|NCT01262872|470690996|FG001|Step 2|Protocol Violation|0|||
130746276|NCT01262872|470690997|FG002|Step 2|Protocol Violation|1|||
130746277|NCT01262872|470690998|FG003|Step 2|Protocol Violation|0|||
130746278|NCT01262872|470690999|FG004|Step 2|Protocol Violation|0|||
130746279|NCT01262872|470691000|FG005|Step 2|Protocol Violation|0|||
130746280|NCT01262872|470691001|FG006|Step 2|Protocol Violation|3|||
130746281|NCT01262872|470691002|FG007|Step 2|Protocol Violation|1|||
130746282|NCT01262872|470690995|FG000|Step 2|Withdrawal by Subject|0|||
130746283|NCT01262872|470690996|FG001|Step 2|Withdrawal by Subject|0|||
130746284|NCT01262872|470690997|FG002|Step 2|Withdrawal by Subject|4|||
130746285|NCT01262872|470690998|FG003|Step 2|Withdrawal by Subject|6|||
130746286|NCT01262872|470690999|FG004|Step 2|Withdrawal by Subject|3|||
130746287|NCT01262872|470691000|FG005|Step 2|Withdrawal by Subject|1|||
130746288|NCT01262872|470691001|FG006|Step 2|Withdrawal by Subject|2|||
130746289|NCT01262872|470691002|FG007|Step 2|Withdrawal by Subject|1|||
130746290|NCT01262872|470690995|FG000|Step 2|Migrated/moved from study area|0|||
130746291|NCT01262872|470690996|FG001|Step 2|Migrated/moved from study area|0|||
130746292|NCT01262872|470690997|FG002|Step 2|Migrated/moved from study area|4|||
130746293|NCT01262872|470690998|FG003|Step 2|Migrated/moved from study area|3|||
130746294|NCT01262872|470690999|FG004|Step 2|Migrated/moved from study area|2|||
130746295|NCT01262872|470691000|FG005|Step 2|Migrated/moved from study area|6|||
130746296|NCT01262872|470691001|FG006|Step 2|Migrated/moved from study area|2|||
130746297|NCT01262872|470691002|FG007|Step 2|Migrated/moved from study area|3|||
130746298|NCT00365794|470691005|FG000|Overall Study|Withdrawal by Subject|2|||
130746299|NCT00745901|470691006|FG000|Overall Study|Adverse Event|3|||
130746300|NCT00745901|470691007|FG001|Overall Study|Adverse Event|4|||
130746301|NCT00745901|470691006|FG000|Overall Study|Protocol Violation|0|||
130746302|NCT00745901|470691007|FG001|Overall Study|Protocol Violation|1|||
130746303|NCT00745901|470691006|FG000|Overall Study|Withdrawal by Subject|1|||
130746304|NCT00745901|470691007|FG001|Overall Study|Withdrawal by Subject|0|||
130746305|NCT00745901|470691006|FG000|Overall Study|Lost to Follow-up|7|||
130746306|NCT00745901|470691007|FG001|Overall Study|Lost to Follow-up|4|||
130746307|NCT00745901|470691006|FG000|Overall Study|Pregnancy|2|||
130746308|NCT00745901|470691007|FG001|Overall Study|Pregnancy|4|||
130746309|NCT00745901|470691006|FG000|Overall Study|Lack of compliance|2|||
130746310|NCT00745901|470691007|FG001|Overall Study|Lack of compliance|2|||
130746311|NCT00745901|470691006|FG000|Overall Study|Patient's next menses did not start with|1|||
130746312|NCT00745901|470691007|FG001|Overall Study|Patient's next menses did not start with|0|||
130746313|NCT00745901|470691006|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
130746314|NCT00745901|470691007|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
130746315|NCT00745901|470691006|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
130746316|NCT00745901|470691007|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
130746317|NCT00745901|470691006|FG000|Overall Study|Patient didn't take any study medication|7|||
130746318|NCT00745901|470691007|FG001|Overall Study|Patient didn't take any study medication|3|||
130746319|NCT01804946|470691009|FG000|Overall Study|Protocol Violation|1|||
130746320|NCT01804946|470691010|FG001|Overall Study|Protocol Violation|0|||
130746321|NCT01804946|470691009|FG000|Overall Study|Adverse Event|0|||
130746322|NCT01804946|470691010|FG001|Overall Study|Adverse Event|1|||
130746323|NCT01804946|470691009|FG000|Overall Study|Insufficient data available|0|||
130746324|NCT01804946|470691010|FG001|Overall Study|Insufficient data available|1|||
130746325|NCT01804946|470691009|FG000|Overall Study|Do not meet inclusion criteria|1|||
130746326|NCT01804946|470691010|FG001|Overall Study|Do not meet inclusion criteria|2|||
130746327|NCT00722137|470691012|FG000|Overall Study|Overt Disease Progression|5|||
130746328|NCT00722137|470691013|FG001|Overall Study|Overt Disease Progression|4|||
130746329|NCT00722137|470691012|FG000|Overall Study|Adverse Event|17|||
130746330|NCT00722137|470691013|FG001|Overall Study|Adverse Event|21|||
130746331|NCT00722137|470691012|FG000|Overall Study|Death|12|||
130746332|NCT00722137|470691013|FG001|Overall Study|Death|7|||
130746333|NCT00722137|470691012|FG000|Overall Study|Withdrawal by Subject|6|||
130746334|NCT00722137|470691013|FG001|Overall Study|Withdrawal by Subject|9|||
130746335|NCT00722137|470691012|FG000|Overall Study|Other Reason Unknown|3|||
130746336|NCT00722137|470691013|FG001|Overall Study|Other Reason Unknown|4|||
130746337|NCT00722137|470691012|FG000|Overall Study|Randomized But Not Treated|2|||
130746338|NCT00722137|470691013|FG001|Overall Study|Randomized But Not Treated|3|||
130746339|NCT00848718|470691014|FG000|Overall Study|Adverse Event|2|||
130746340|NCT00848718|470691015|FG001|Overall Study|Adverse Event|2|||
130746341|NCT00848718|470691016|FG002|Overall Study|Adverse Event|1|||
130746342|NCT00848718|470691017|FG003|Overall Study|Adverse Event|1|||
130746343|NCT00848718|470691018|FG004|Overall Study|Adverse Event|1|||
130746344|NCT00848718|470691019|FG005|Overall Study|Adverse Event|0|||
130746345|NCT00848718|470691020|FG006|Overall Study|Adverse Event|0|||
130746346|NCT00848718|470691021|FG007|Overall Study|Adverse Event|1|||
130746347|NCT00848718|470691022|FG008|Overall Study|Adverse Event|1|||
130746348|NCT00848718|470691023|FG009|Overall Study|Adverse Event|0|||
130746349|NCT00848718|470691024|FG010|Overall Study|Adverse Event|0|||
130746350|NCT00848718|470691025|FG011|Overall Study|Adverse Event|0|||
130746351|NCT00848718|470691026|FG012|Overall Study|Adverse Event|2|||
130746352|NCT00848718|470691014|FG000|Overall Study|Lack of Efficacy|0|||
130746353|NCT00848718|470691015|FG001|Overall Study|Lack of Efficacy|0|||
130746354|NCT00848718|470691016|FG002|Overall Study|Lack of Efficacy|1|||
130746355|NCT00848718|470691017|FG003|Overall Study|Lack of Efficacy|0|||
130746356|NCT00848718|470691018|FG004|Overall Study|Lack of Efficacy|0|||
130746357|NCT00848718|470691019|FG005|Overall Study|Lack of Efficacy|0|||
130746358|NCT00848718|470691020|FG006|Overall Study|Lack of Efficacy|1|||
130746359|NCT00848718|470691021|FG007|Overall Study|Lack of Efficacy|0|||
130746360|NCT00848718|470691022|FG008|Overall Study|Lack of Efficacy|0|||
130746361|NCT00848718|470691023|FG009|Overall Study|Lack of Efficacy|0|||
130746362|NCT00848718|470691024|FG010|Overall Study|Lack of Efficacy|0|||
130746363|NCT00848718|470691025|FG011|Overall Study|Lack of Efficacy|0|||
130746364|NCT00848718|470691026|FG012|Overall Study|Lack of Efficacy|0|||
130746365|NCT00848718|470691014|FG000|Overall Study|Physician Decision|0|||
130746366|NCT00848718|470691015|FG001|Overall Study|Physician Decision|1|||
130746367|NCT00848718|470691016|FG002|Overall Study|Physician Decision|0|||
130746368|NCT00848718|470691017|FG003|Overall Study|Physician Decision|0|||
130746369|NCT00848718|470691018|FG004|Overall Study|Physician Decision|1|||
130746370|NCT00848718|470691019|FG005|Overall Study|Physician Decision|1|||
130746371|NCT00848718|470691020|FG006|Overall Study|Physician Decision|0|||
130746372|NCT00848718|470691021|FG007|Overall Study|Physician Decision|0|||
130746373|NCT00848718|470691022|FG008|Overall Study|Physician Decision|1|||
130746374|NCT00848718|470691023|FG009|Overall Study|Physician Decision|2|||
130746375|NCT00848718|470691024|FG010|Overall Study|Physician Decision|0|||
130746376|NCT00848718|470691025|FG011|Overall Study|Physician Decision|0|||
130746377|NCT00848718|470691026|FG012|Overall Study|Physician Decision|1|||
130746378|NCT00848718|470691014|FG000|Overall Study|Progressive disease before treatment|1|||
130746379|NCT00848718|470691015|FG001|Overall Study|Progressive disease before treatment|5|||
130746380|NCT00848718|470691016|FG002|Overall Study|Progressive disease before treatment|1|||
130746381|NCT00848718|470691017|FG003|Overall Study|Progressive disease before treatment|3|||
130746382|NCT00848718|470691018|FG004|Overall Study|Progressive disease before treatment|4|||
130746383|NCT00848718|470691019|FG005|Overall Study|Progressive disease before treatment|4|||
130746384|NCT00848718|470691020|FG006|Overall Study|Progressive disease before treatment|2|||
130746385|NCT00848718|470691021|FG007|Overall Study|Progressive disease before treatment|1|||
130746386|NCT00848718|470691022|FG008|Overall Study|Progressive disease before treatment|2|||
130746387|NCT00848718|470691023|FG009|Overall Study|Progressive disease before treatment|7|||
130746388|NCT00848718|470691024|FG010|Overall Study|Progressive disease before treatment|3|||
130746389|NCT00848718|470691025|FG011|Overall Study|Progressive disease before treatment|6|||
130746390|NCT00848718|470691026|FG012|Overall Study|Progressive disease before treatment|2|||
130746391|NCT00848718|470691014|FG000|Overall Study|Protocol Violation|0|||
130746392|NCT00848718|470691015|FG001|Overall Study|Protocol Violation|1|||
130746393|NCT00848718|470691016|FG002|Overall Study|Protocol Violation|0|||
130746394|NCT00848718|470691017|FG003|Overall Study|Protocol Violation|0|||
130746395|NCT00848718|470691018|FG004|Overall Study|Protocol Violation|0|||
130746396|NCT00848718|470691019|FG005|Overall Study|Protocol Violation|0|||
130746397|NCT00848718|470691020|FG006|Overall Study|Protocol Violation|0|||
130746398|NCT00848718|470691021|FG007|Overall Study|Protocol Violation|1|||
130746399|NCT00848718|470691022|FG008|Overall Study|Protocol Violation|0|||
130746400|NCT00848718|470691023|FG009|Overall Study|Protocol Violation|0|||
130746401|NCT00848718|470691024|FG010|Overall Study|Protocol Violation|0|||
130746402|NCT00848718|470691025|FG011|Overall Study|Protocol Violation|0|||
130746403|NCT00848718|470691026|FG012|Overall Study|Protocol Violation|1|||
130746404|NCT00848718|470691014|FG000|Overall Study|Withdrawal by Subject|1|||
130788475|NCT01326871|470854603|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
130788476|NCT01326871|470854601|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
130788477|NCT01326871|470854602|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
130788478|NCT01326871|470854603|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
130788479|NCT01326871|470854601|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
130788480|NCT01326871|470854602|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
130788481|NCT01326871|470854603|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
130788482|NCT01326871|470854601|FG000|Overall Study|Physician Decision|0|||
130788483|NCT01326871|470854602|FG001|Overall Study|Physician Decision|0|||
130788484|NCT01326871|470854603|FG002|Overall Study|Physician Decision|1|||
130788485|NCT01326871|470854601|FG000|Overall Study|SAE|0|||
130788486|NCT01326871|470854602|FG001|Overall Study|SAE|0|||
130788487|NCT01326871|470854603|FG002|Overall Study|SAE|1|||
130788488|NCT01326871|470854601|FG000|Overall Study|Disease progression and death|0|||
130788489|NCT01326871|470854602|FG001|Overall Study|Disease progression and death|0|||
130788490|NCT01326871|470854603|FG002|Overall Study|Disease progression and death|1|||
130788491|NCT01326871|470854601|FG000|Overall Study|Subject decision|0|||
130788492|NCT01326871|470854602|FG001|Overall Study|Subject decision|0|||
130788493|NCT01326871|470854603|FG002|Overall Study|Subject decision|1|||
130788494|NCT01200329|470854604|FG000|Overall Study|Lack of financial coverage|2|||
130788495|NCT01200329|470854604|FG000|Overall Study|Progressive disease|1|||
130788496|NCT03087058|470854607|FG000|Overall Study|Withdrawal by Subject|2|||
130788497|NCT03087058|470854608|FG001|Overall Study|Withdrawal by Subject|0|||
130788498|NCT03087058|470854609|FG002|Overall Study|Withdrawal by Subject|0|||
130746405|NCT00848718|470691015|FG001|Overall Study|Withdrawal by Subject|0|||
130746406|NCT00848718|470691016|FG002|Overall Study|Withdrawal by Subject|0|||
130746407|NCT00848718|470691017|FG003|Overall Study|Withdrawal by Subject|1|||
130746408|NCT00848718|470691018|FG004|Overall Study|Withdrawal by Subject|0|||
130746409|NCT00848718|470691019|FG005|Overall Study|Withdrawal by Subject|0|||
130746410|NCT00848718|470691020|FG006|Overall Study|Withdrawal by Subject|0|||
130746411|NCT00848718|470691021|FG007|Overall Study|Withdrawal by Subject|0|||
130746412|NCT00848718|470691022|FG008|Overall Study|Withdrawal by Subject|0|||
130746413|NCT00848718|470691023|FG009|Overall Study|Withdrawal by Subject|0|||
130746414|NCT00848718|470691024|FG010|Overall Study|Withdrawal by Subject|1|||
130746415|NCT00848718|470691025|FG011|Overall Study|Withdrawal by Subject|0|||
130746416|NCT00848718|470691026|FG012|Overall Study|Withdrawal by Subject|0|||
130746417|NCT00848718|470691014|FG000|Overall Study|Progressive disease during treatment|3|||
130746418|NCT00848718|470691015|FG001|Overall Study|Progressive disease during treatment|0|||
130746419|NCT00848718|470691016|FG002|Overall Study|Progressive disease during treatment|3|||
130788499|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
130746420|NCT00848718|470691017|FG003|Overall Study|Progressive disease during treatment|0|||
130746421|NCT00848718|470691018|FG004|Overall Study|Progressive disease during treatment|0|||
130746422|NCT00848718|470691019|FG005|Overall Study|Progressive disease during treatment|0|||
130746423|NCT00848718|470691020|FG006|Overall Study|Progressive disease during treatment|0|||
130746424|NCT00848718|470691021|FG007|Overall Study|Progressive disease during treatment|2|||
130746425|NCT00848718|470691022|FG008|Overall Study|Progressive disease during treatment|0|||
130746426|NCT00848718|470691023|FG009|Overall Study|Progressive disease during treatment|0|||
130746427|NCT00848718|470691024|FG010|Overall Study|Progressive disease during treatment|0|||
130746428|NCT00848718|470691025|FG011|Overall Study|Progressive disease during treatment|0|||
130746429|NCT00848718|470691026|FG012|Overall Study|Progressive disease during treatment|2|||
130746430|NCT02431676|470691028|FG000|Overall Study|no lab obtained|0|||
130746431|NCT02431676|470691029|FG001|Overall Study|no lab obtained|1|||
130746432|NCT02431676|470691030|FG002|Overall Study|no lab obtained|2|||
130746433|NCT01120184|470693350|FG000|Overall Study|Adverse Event|0|||
130746434|NCT01120184|470693351|FG001|Overall Study|Adverse Event|1|||
130746435|NCT01120184|470693352|FG002|Overall Study|Adverse Event|0|||
130746436|NCT01120184|470693350|FG000|Overall Study|Lost to Follow-up|13|||
130746437|NCT01120184|470693351|FG001|Overall Study|Lost to Follow-up|13|||
130746438|NCT01120184|470693352|FG002|Overall Study|Lost to Follow-up|11|||
130746439|NCT01120184|470693350|FG000|Overall Study|Physician Decision|9|||
130746440|NCT01120184|470693351|FG001|Overall Study|Physician Decision|1|||
130746441|NCT01120184|470693352|FG002|Overall Study|Physician Decision|3|||
130746442|NCT01120184|470693350|FG000|Overall Study|Reason not Specified|8|||
130746443|NCT01120184|470693351|FG001|Overall Study|Reason not Specified|3|||
130746444|NCT01120184|470693352|FG002|Overall Study|Reason not Specified|12|||
130746445|NCT01120184|470693350|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
130746446|NCT01120184|470693351|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
130746447|NCT01120184|470693352|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
130746448|NCT01120184|470693350|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
130746449|NCT01120184|470693351|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
130746450|NCT01120184|470693352|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
130746451|NCT01120184|470693350|FG000|Overall Study|Death|170|||
130746452|NCT01120184|470693351|FG001|Overall Study|Death|176|||
130746453|NCT01120184|470693352|FG002|Overall Study|Death|169|||
130746454|NCT02525783|470693353|FG000|Overall Study|Lost to Follow-up|10|||
130746455|NCT00866281|470693354|FG000|Overall Study|Adverse Event|1|||
130746456|NCT00866281|470693355|FG001|Overall Study|Adverse Event|0|||
130746457|NCT00866281|470693354|FG000|Overall Study|Withdrawal by participants|3|||
130746458|NCT00866281|470693355|FG001|Overall Study|Withdrawal by participants|0|||
130746459|NCT00866281|470693354|FG000|Overall Study|Disease progression|3|||
130746460|NCT00866281|470693355|FG001|Overall Study|Disease progression|11|||
130746461|NCT00866281|470693354|FG000|Overall Study|New cancer therapy|0|||
130746462|NCT00866281|470693355|FG001|Overall Study|New cancer therapy|4|||
130746463|NCT01894841|470693358|FG000|Overall Study|Withdrawal by Subject|9|||
130746464|NCT01894841|470693359|FG001|Overall Study|Withdrawal by Subject|4|||
130746465|NCT01894841|470693358|FG000|Overall Study|Withdrawn by investigator|2|||
130746466|NCT01894841|470693359|FG001|Overall Study|Withdrawn by investigator|2|||
130746467|NCT01894841|470693358|FG000|Overall Study|Lost to Follow-up|7|||
130746468|NCT01894841|470693359|FG001|Overall Study|Lost to Follow-up|3|||
130746469|NCT00529087|470693365|FG000|Overall Study|Adverse Event|10|||
130746470|NCT00529087|470693366|FG001|Overall Study|Adverse Event|13|||
130746471|NCT00529087|470693367|FG002|Overall Study|Adverse Event|4|||
130746472|NCT00529087|470693365|FG000|Overall Study|Lost to Follow-up|6|||
130746473|NCT00529087|470693366|FG001|Overall Study|Lost to Follow-up|4|||
130746474|NCT00529087|470693367|FG002|Overall Study|Lost to Follow-up|1|||
130746475|NCT00529087|470693365|FG000|Overall Study|Protocol Violation|8|||
130746476|NCT00529087|470693366|FG001|Overall Study|Protocol Violation|7|||
130746477|NCT00529087|470693367|FG002|Overall Study|Protocol Violation|6|||
130746478|NCT00529087|470693365|FG000|Overall Study|Withdrawal by Subject|3|||
130746479|NCT00529087|470693366|FG001|Overall Study|Withdrawal by Subject|3|||
130746480|NCT00529087|470693367|FG002|Overall Study|Withdrawal by Subject|3|||
130746481|NCT00529087|470693365|FG000|Overall Study|Protocol deviation|1|||
130746482|NCT00529087|470693366|FG001|Overall Study|Protocol deviation|1|||
130746483|NCT00529087|470693367|FG002|Overall Study|Protocol deviation|2|||
130746484|NCT00318474|470693368|FG000|Overall Study|Adverse Event|1|||
130746485|NCT00318474|470693369|FG001|Overall Study|Adverse Event|1|||
130746486|NCT00318474|470693368|FG000|Overall Study|Lost to Follow-up|0|||
130746487|NCT00318474|470693369|FG001|Overall Study|Lost to Follow-up|1|||
130746488|NCT00318474|470693368|FG000|Overall Study|Pregnancy|0|||
130746489|NCT00318474|470693369|FG001|Overall Study|Pregnancy|2|||
130746490|NCT00318474|470693368|FG000|Overall Study|Protocol Violation|1|||
130746491|NCT00318474|470693369|FG001|Overall Study|Protocol Violation|0|||
130746492|NCT00318474|470693368|FG000|Overall Study|Withdrawal by Subject|3|||
130746493|NCT00318474|470693369|FG001|Overall Study|Withdrawal by Subject|2|||
130746494|NCT00318474|470693368|FG000|Overall Study|Fall in GFR|3|||
130746495|NCT00318474|470693369|FG001|Overall Study|Fall in GFR|3|||
130746496|NCT00318474|470693368|FG000|Overall Study|Post-therapy hyperflycemia|0|||
130746497|NCT00318474|470693369|FG001|Overall Study|Post-therapy hyperflycemia|1|||
130746498|NCT00318474|470693368|FG000|Overall Study|Trial terminated|10|||
130746499|NCT00318474|470693369|FG001|Overall Study|Trial terminated|7|||
130746500|NCT00833105|470693379|FG000|Overall Study|Withdrawal by Subject|1|||
130746501|NCT00833105|470693379|FG000|Overall Study|Adverse Event|2|||
130746502|NCT03656068|470693384|FG000|Overall Study|Withdrawal by Subject|4|||
130746503|NCT03656068|470693384|FG000|Overall Study|Adverse Event|1|||
130746504|NCT05326529|470693385|FG000|Overall Study|Lack of Efficacy|0|||
130746505|NCT05326529|470693386|FG001|Overall Study|Lack of Efficacy|1|||
130746506|NCT05326529|470693387|FG002|Overall Study|Lack of Efficacy|0|||
130746507|NCT05326529|470693385|FG000|Overall Study|Physician Decision|0|||
130746508|NCT05326529|470693386|FG001|Overall Study|Physician Decision|0|||
130746509|NCT05326529|470693387|FG002|Overall Study|Physician Decision|2|||
130746510|NCT01379768|470693388|FG000|Overall Study|Adverse Event|1|||
130746511|NCT01379768|470693389|FG001|Overall Study|Adverse Event|1|||
130746512|NCT01379768|470693390|FG002|Overall Study|Adverse Event|0|||
130746513|NCT01379768|470693388|FG000|Overall Study|Lost to Follow-up|2|||
130746514|NCT01379768|470693389|FG001|Overall Study|Lost to Follow-up|0|||
130746515|NCT01379768|470693390|FG002|Overall Study|Lost to Follow-up|0|||
130746516|NCT00708552|470693391|FG000|Overall Study|Adverse Event|10|||
130746517|NCT00708552|470693392|FG001|Overall Study|Adverse Event|3|||
130746518|NCT00708552|470693393|FG002|Overall Study|Adverse Event|4|||
130746519|NCT00708552|470693394|FG003|Overall Study|Adverse Event|6|||
130746520|NCT00708552|470693391|FG000|Overall Study|Lack of Efficacy|0|||
130746521|NCT00708552|470693392|FG001|Overall Study|Lack of Efficacy|4|||
130746522|NCT00708552|470693393|FG002|Overall Study|Lack of Efficacy|1|||
130746523|NCT00708552|470693394|FG003|Overall Study|Lack of Efficacy|0|||
130746524|NCT00708552|470693391|FG000|Overall Study|Protocol Violation|0|||
130746525|NCT00708552|470693392|FG001|Overall Study|Protocol Violation|0|||
130746526|NCT00708552|470693393|FG002|Overall Study|Protocol Violation|2|||
130746527|NCT00708552|470693394|FG003|Overall Study|Protocol Violation|4|||
130746528|NCT00708552|470693391|FG000|Overall Study|Lost to Follow-up|4|||
130746529|NCT00708552|470693392|FG001|Overall Study|Lost to Follow-up|2|||
130746530|NCT00708552|470693393|FG002|Overall Study|Lost to Follow-up|0|||
130746531|NCT00708552|470693394|FG003|Overall Study|Lost to Follow-up|1|||
130746532|NCT00708552|470693391|FG000|Overall Study|Physician Decision|1|||
130746533|NCT00708552|470693392|FG001|Overall Study|Physician Decision|2|||
130746534|NCT00708552|470693393|FG002|Overall Study|Physician Decision|0|||
130746535|NCT00708552|470693394|FG003|Overall Study|Physician Decision|0|||
130746536|NCT00708552|470693391|FG000|Overall Study|Withdrawal by Subject|12|||
130746537|NCT00708552|470693392|FG001|Overall Study|Withdrawal by Subject|7|||
130746538|NCT00708552|470693393|FG002|Overall Study|Withdrawal by Subject|8|||
130746539|NCT00708552|470693394|FG003|Overall Study|Withdrawal by Subject|10|||
130746540|NCT00455403|470693396|FG000|Overall Study|Lost to Follow-up|2|||
130746541|NCT00455403|470693397|FG001|Overall Study|Lost to Follow-up|1|||
130746542|NCT00455403|470693396|FG000|Overall Study|Withdrawal by Subject|1|||
130746543|NCT00455403|470693397|FG001|Overall Study|Withdrawal by Subject|3|||
130746544|NCT00455403|470693396|FG000|Overall Study|Protocol Violation|0|||
130746545|NCT00455403|470693397|FG001|Overall Study|Protocol Violation|2|||
130746546|NCT00350207|470693398|FG000|Overall Study|Adverse Event|5|||
130746547|NCT00350207|470693399|FG001|Overall Study|Adverse Event|2|||
130746548|NCT00350207|470693400|FG002|Overall Study|Adverse Event|2|||
130746549|NCT00350207|470693398|FG000|Overall Study|Lack of Efficacy|1|||
130746550|NCT00350207|470693399|FG001|Overall Study|Lack of Efficacy|0|||
130746551|NCT00350207|470693400|FG002|Overall Study|Lack of Efficacy|2|||
130746552|NCT00350207|470693398|FG000|Overall Study|Lost to Follow-up|1|||
130746553|NCT00350207|470693399|FG001|Overall Study|Lost to Follow-up|0|||
130746554|NCT00350207|470693400|FG002|Overall Study|Lost to Follow-up|1|||
130746555|NCT00350207|470693398|FG000|Overall Study|Withdrawal by Subject|0|||
130746556|NCT00350207|470693399|FG001|Overall Study|Withdrawal by Subject|1|||
130746557|NCT00350207|470693400|FG002|Overall Study|Withdrawal by Subject|1|||
130746558|NCT00350207|470693398|FG000|Overall Study|Other|1|||
130746559|NCT00350207|470693399|FG001|Overall Study|Other|3|||
130746560|NCT00350207|470693400|FG002|Overall Study|Other|1|||
130746561|NCT00495391|470693401|FG000|Overall Study|Lack of Efficacy|34|||
130746562|NCT00495391|470693402|FG001|Overall Study|Lack of Efficacy|18|||
130746563|NCT00495391|470693401|FG000|Overall Study|Withdrawal by Subject|2|||
130746564|NCT00495391|470693402|FG001|Overall Study|Withdrawal by Subject|3|||
130746565|NCT04509076|470693411|FG000|Overall Study|Withdrawal by Subject|1|||
130746566|NCT04509076|470693412|FG001|Overall Study|Withdrawal by Subject|2|||
130746567|NCT04509076|470693411|FG000|Overall Study|Lost to Follow-up|1|||
130746568|NCT04509076|470693412|FG001|Overall Study|Lost to Follow-up|2|||
130746569|NCT00502242|470693417|FG000|Overall Study|Lack of Efficacy|1|||
130746570|NCT00502242|470693418|FG001|Overall Study|Lack of Efficacy|11|||
130746571|NCT00502242|470693417|FG000|Overall Study|Adverse Event|31|||
130746572|NCT00502242|470693418|FG001|Overall Study|Adverse Event|20|||
130746573|NCT00502242|470693417|FG000|Overall Study|Physician Decision|2|||
130746574|NCT00502242|470693418|FG001|Overall Study|Physician Decision|3|||
130746575|NCT00502242|470693417|FG000|Overall Study|Other - Unspecified|8|||
130746576|NCT00502242|470693418|FG001|Overall Study|Other - Unspecified|14|||
130746577|NCT00502242|470693417|FG000|Overall Study|Protocol Violation|3|||
130746578|NCT00502242|470693418|FG001|Overall Study|Protocol Violation|1|||
130746579|NCT00502242|470693417|FG000|Overall Study|Withdrawal by Subject|6|||
130746580|NCT00502242|470693418|FG001|Overall Study|Withdrawal by Subject|7|||
130746581|NCT01812109|470693419|FG000|Overall Study|research personnel delay|16|||
130746582|NCT01812109|470693419|FG000|Overall Study|NIRS Unattainable|17|||
130746583|NCT03313180|470693420|FG000|Overall Study|Adverse Event|120|||
130746584|NCT03313180|470693420|FG000|Overall Study|Lost to Follow-up|3|||
130746585|NCT03313180|470693420|FG000|Overall Study|Withdrawal by Subject|39|||
130746586|NCT03313180|470693420|FG000|Overall Study|Other than listed above|15|||
130746587|NCT03313180|470693420|FG000|Overall Study|Covid-19 related|2|||
130746588|NCT01966120|470693421|FG000|Overall Study|Withdrawal by Subject|0|||
130746589|NCT01966120|470693422|FG001|Overall Study|Withdrawal by Subject|5|||
130746590|NCT01966120|470693421|FG000|Overall Study|Lost to Follow-up|1|||
130746591|NCT01966120|470693422|FG001|Overall Study|Lost to Follow-up|1|||
130746592|NCT00461630|470693423|FG000|Overall Study|Death|798|||
130746593|NCT00461630|470693424|FG001|Overall Study|Death|732|||
130746594|NCT00461630|470693423|FG000|Overall Study|Lost to Follow-up|108|||
130746595|NCT00461630|470693424|FG001|Overall Study|Lost to Follow-up|95|||
130746596|NCT04630002|470693425|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
130746597|NCT04630002|470693426|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130746598|NCT04630002|470693427|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130746599|NCT04630002|470693425|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
130746600|NCT04630002|470693426|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130746601|NCT04630002|470693427|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130746602|NCT04630002|470693425|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
130746603|NCT04630002|470693426|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130746604|NCT04630002|470693427|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130746605|NCT04630002|470693425|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130746606|NCT04630002|470693426|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
130746607|NCT04630002|470693427|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130746608|NCT04630002|470693425|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130746609|NCT04630002|470693426|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
130746610|NCT04630002|470693427|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130746611|NCT04630002|470693425|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130746612|NCT04630002|470693426|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
130746613|NCT04630002|470693427|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130788500|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
130788501|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
130788502|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
130746614|NCT04630002|470693425|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
130746615|NCT04630002|470693426|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
130746616|NCT04630002|470693427|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
130746617|NCT04630002|470693425|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
130746618|NCT04630002|470693426|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
130746619|NCT04630002|470693427|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
130746620|NCT00442897|470693428|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
130746621|NCT00442897|470693429|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
130746622|NCT00442897|470693428|FG000|Base Study (12 Week Follow-up)|Death|0|||
130746623|NCT00442897|470693429|FG001|Base Study (12 Week Follow-up)|Death|1|||
130746624|NCT00442897|470693428|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
130746625|NCT00442897|470693429|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
130746626|NCT00442897|470693428|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
130746627|NCT00442897|470693429|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
130746628|NCT00442897|470693428|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
130746629|NCT00442897|470693429|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
130746630|NCT00442897|470693428|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
130746631|NCT00442897|470693429|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
130746632|NCT00442897|470693428|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
130746633|NCT00442897|470693429|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
130746634|NCT00442897|470693428|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
130746635|NCT00442897|470693429|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
130746636|NCT04498182|470693430|FG000|Overall Study|Adverse Event|2|||
130746637|NCT04498182|470693431|FG001|Overall Study|Adverse Event|3|||
130746638|NCT04498182|470693432|FG002|Overall Study|Adverse Event|2|||
130746639|NCT04498182|470693430|FG000|Overall Study|Withdrawal of Consent|3|||
130746640|NCT04498182|470693431|FG001|Overall Study|Withdrawal of Consent|4|||
130746641|NCT04498182|470693432|FG002|Overall Study|Withdrawal of Consent|3|||
130746642|NCT04498182|470693430|FG000|Overall Study|Non-Compliant|1|||
130746643|NCT04498182|470693431|FG001|Overall Study|Non-Compliant|0|||
130746644|NCT04498182|470693432|FG002|Overall Study|Non-Compliant|1|||
130746645|NCT04498182|470693430|FG000|Overall Study|Lost to Follow-up|0|||
130746646|NCT04498182|470693431|FG001|Overall Study|Lost to Follow-up|0|||
130746647|NCT04498182|470693432|FG002|Overall Study|Lost to Follow-up|1|||
130746648|NCT04498182|470693430|FG000|Overall Study|Investigator Decision|0|||
130746649|NCT04498182|470693431|FG001|Overall Study|Investigator Decision|0|||
130746650|NCT04498182|470693432|FG002|Overall Study|Investigator Decision|1|||
130746651|NCT04498182|470693430|FG000|Overall Study|Protocol Violation|1|||
130746652|NCT04498182|470693431|FG001|Overall Study|Protocol Violation|0|||
130746653|NCT04498182|470693432|FG002|Overall Study|Protocol Violation|2|||
130746654|NCT00891020|470693437|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
130746655|NCT00891020|470693438|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
130746656|NCT00891020|470693439|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
130746657|NCT00891020|470693437|FG000|24 Week Treatment Period|Death|0|||
130746658|NCT00891020|470693438|FG001|24 Week Treatment Period|Death|2|||
130746659|NCT00891020|470693439|FG002|24 Week Treatment Period|Death|0|||
130746660|NCT00891020|470693437|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
130746661|NCT00891020|470693438|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
130746662|NCT00891020|470693439|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
130746663|NCT00891020|470693437|FG000|24 Week Treatment Period|Failure to return|4|||
130746664|NCT00891020|470693438|FG001|24 Week Treatment Period|Failure to return|5|||
130746665|NCT00891020|470693439|FG002|24 Week Treatment Period|Failure to return|5|||
130746666|NCT00891020|470693437|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
130746667|NCT00891020|470693438|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
130746668|NCT00891020|470693439|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
130746669|NCT00891020|470693437|FG000|24 Week Treatment Period|Other protocol violation|1|||
130746670|NCT00891020|470693438|FG001|24 Week Treatment Period|Other protocol violation|1|||
130746671|NCT00891020|470693439|FG002|24 Week Treatment Period|Other protocol violation|2|||
130746672|NCT00891020|470693437|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
130746673|NCT00891020|470693438|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
130746674|NCT00891020|470693439|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
130746675|NCT00891020|470693437|FG000|24 Week Treatment Period|Withdrew consent|6|||
130746676|NCT00891020|470693438|FG001|24 Week Treatment Period|Withdrew consent|3|||
130746677|NCT00891020|470693439|FG002|24 Week Treatment Period|Withdrew consent|15|||
130746678|NCT00891020|470693437|FG000|24 Week Treatment Period|Administrative/Other|5|||
130746679|NCT00891020|470693438|FG001|24 Week Treatment Period|Administrative/Other|6|||
130746680|NCT00891020|470693439|FG002|24 Week Treatment Period|Administrative/Other|1|||
130746681|NCT00891020|470693437|FG000|Long-term Extension Period|Adverse Event|1|||
130746682|NCT00891020|470693438|FG001|Long-term Extension Period|Adverse Event|11|||
130746683|NCT00891020|470693439|FG002|Long-term Extension Period|Adverse Event|10|||
130746684|NCT00891020|470693437|FG000|Long-term Extension Period|Death|0|||
130746685|NCT00891020|470693438|FG001|Long-term Extension Period|Death|0|||
130746686|NCT00891020|470693439|FG002|Long-term Extension Period|Death|1|||
130746687|NCT00891020|470693437|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
130746688|NCT00891020|470693438|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
130746689|NCT00891020|470693439|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
130746690|NCT00891020|470693437|FG000|Long-term Extension Period|Protocol Violation|0|||
130746691|NCT00891020|470693438|FG001|Long-term Extension Period|Protocol Violation|1|||
130746692|NCT00891020|470693439|FG002|Long-term Extension Period|Protocol Violation|1|||
130746693|NCT00891020|470693437|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
130746694|NCT00891020|470693438|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
130746695|NCT00891020|470693439|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
130746696|NCT00891020|470693437|FG000|Long-term Extension Period|Failure to return|0|||
130746697|NCT00891020|470693438|FG001|Long-term Extension Period|Failure to return|2|||
130746698|NCT00891020|470693439|FG002|Long-term Extension Period|Failure to return|3|||
130746699|NCT00891020|470693437|FG000|Long-term Extension Period|Administrative|1|||
130746700|NCT00891020|470693438|FG001|Long-term Extension Period|Administrative|2|||
130746701|NCT00891020|470693439|FG002|Long-term Extension Period|Administrative|2|||
130746702|NCT00320710|470693447|FG000|Overall Study|Disease progression|24|||
130746703|NCT00320710|470693448|FG001|Overall Study|Disease progression|19|||
130746704|NCT00320710|470693449|FG002|Overall Study|Disease progression|2|||
130746705|NCT00320710|470693447|FG000|Overall Study|Death|10|||
130746706|NCT00320710|470693448|FG001|Overall Study|Death|7|||
130746707|NCT00320710|470693449|FG002|Overall Study|Death|1|||
130746708|NCT00320710|470693447|FG000|Overall Study|Administrative problems|1|||
130746709|NCT00320710|470693448|FG001|Overall Study|Administrative problems|2|||
130746710|NCT00320710|470693449|FG002|Overall Study|Administrative problems|0|||
130746711|NCT00320710|470693447|FG000|Overall Study|Withdrawal by Subject|20|||
130746712|NCT00320710|470693448|FG001|Overall Study|Withdrawal by Subject|26|||
130746713|NCT00320710|470693449|FG002|Overall Study|Withdrawal by Subject|1|||
130746714|NCT00320710|470693447|FG000|Overall Study|Protocol Violation|6|||
130746715|NCT00320710|470693448|FG001|Overall Study|Protocol Violation|5|||
130746716|NCT00320710|470693449|FG002|Overall Study|Protocol Violation|0|||
130746717|NCT00320710|470693447|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130746718|NCT00320710|470693448|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130746719|NCT00320710|470693449|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130746720|NCT00320710|470693447|FG000|Overall Study|Abnormal laboratory value(s)|12|||
130746721|NCT00320710|470693448|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130746722|NCT00320710|470693449|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130746723|NCT00320710|470693447|FG000|Overall Study|Adverse Event|18|||
130746724|NCT00320710|470693448|FG001|Overall Study|Adverse Event|14|||
130746725|NCT00320710|470693449|FG002|Overall Study|Adverse Event|1|||
130746726|NCT00320710|470693447|FG000|Overall Study|Lost to Follow-up|1|||
130746727|NCT00320710|470693448|FG001|Overall Study|Lost to Follow-up|0|||
130746728|NCT00320710|470693449|FG002|Overall Study|Lost to Follow-up|0|||
130746729|NCT03448419|470693450|FG000|Overall Study|Adverse Event|10|||
130746730|NCT03448419|470693451|FG001|Overall Study|Adverse Event|9|||
130746731|NCT03448419|470693450|FG000|Overall Study|Lost to Follow-up|0|||
130746732|NCT03448419|470693451|FG001|Overall Study|Lost to Follow-up|2|||
130746733|NCT03448419|470693450|FG000|Overall Study|Withdrawal by Subject|3|||
130746734|NCT03448419|470693451|FG001|Overall Study|Withdrawal by Subject|1|||
130746735|NCT03448419|470693450|FG000|Overall Study|Not treated|0|||
130746736|NCT03448419|470693451|FG001|Overall Study|Not treated|1|||
130746737|NCT03448419|470693450|FG000|Overall Study|Patient did not attend all visits|0|||
130746738|NCT03448419|470693451|FG001|Overall Study|Patient did not attend all visits|2|||
130746739|NCT03448419|470693450|FG000|Overall Study|Withdrawn by Sponsor|0|||
130746740|NCT03448419|470693451|FG001|Overall Study|Withdrawn by Sponsor|1|||
130746741|NCT02841995|470693452|FG000|Overall Study|Disease progression|5|||
130746742|NCT02841995|470693453|FG001|Overall Study|Disease progression|11|||
130746743|NCT02841995|470693454|FG002|Overall Study|Disease progression|8|||
130746744|NCT02841995|470693452|FG000|Overall Study|Withdrawal by Subject|2|||
130746745|NCT02841995|470693453|FG001|Overall Study|Withdrawal by Subject|4|||
130746746|NCT02841995|470693454|FG002|Overall Study|Withdrawal by Subject|4|||
130746747|NCT02841995|470693452|FG000|Overall Study|Adverse Event|2|||
130746748|NCT02841995|470693453|FG001|Overall Study|Adverse Event|0|||
130746749|NCT02841995|470693454|FG002|Overall Study|Adverse Event|1|||
130746750|NCT02841995|470693452|FG000|Overall Study|Investigator decision|2|||
130746751|NCT02841995|470693453|FG001|Overall Study|Investigator decision|0|||
130746752|NCT02841995|470693454|FG002|Overall Study|Investigator decision|1|||
130746753|NCT02841995|470693452|FG000|Overall Study|Death|0|||
130746754|NCT02841995|470693453|FG001|Overall Study|Death|0|||
130746755|NCT02841995|470693454|FG002|Overall Study|Death|2|||
130746756|NCT02841995|470693452|FG000|Overall Study|Noncompliance to protocol|1|||
130746757|NCT02841995|470693453|FG001|Overall Study|Noncompliance to protocol|0|||
130746758|NCT02841995|470693454|FG002|Overall Study|Noncompliance to protocol|0|||
130746759|NCT02841995|470693452|FG000|Overall Study|Sponsor decision|1|||
130746760|NCT02841995|470693453|FG001|Overall Study|Sponsor decision|0|||
130746761|NCT02841995|470693454|FG002|Overall Study|Sponsor decision|0|||
130746762|NCT02841995|470693452|FG000|Overall Study|Other|4|||
130746763|NCT02841995|470693453|FG001|Overall Study|Other|1|||
130746764|NCT02841995|470693454|FG002|Overall Study|Other|5|||
130746765|NCT01703260|470693455|FG000|Overall Study|Adverse Event|1|||
130746766|NCT01703260|470693456|FG001|Overall Study|Adverse Event|2|||
130746767|NCT01703260|470693457|FG002|Overall Study|Adverse Event|2|||
130746768|NCT01703260|470693455|FG000|Overall Study|Lost to Follow-up|1|||
130746769|NCT01703260|470693456|FG001|Overall Study|Lost to Follow-up|0|||
130746770|NCT01703260|470693457|FG002|Overall Study|Lost to Follow-up|0|||
130746771|NCT01703260|470693455|FG000|Overall Study|Withdrawal by Subject|0|||
130746772|NCT01703260|470693456|FG001|Overall Study|Withdrawal by Subject|0|||
130746773|NCT01703260|470693457|FG002|Overall Study|Withdrawal by Subject|1|||
130746774|NCT01703260|470693455|FG000|Overall Study|Study Termination|1|||
130746775|NCT01703260|470693456|FG001|Overall Study|Study Termination|2|||
130746776|NCT01703260|470693457|FG002|Overall Study|Study Termination|0|||
130746777|NCT04548193|470693461|FG000|Overall Study|Lost to Follow-up|0|||
130746778|NCT04548193|470693462|FG001|Overall Study|Lost to Follow-up|1|||
130746779|NCT04548193|470693461|FG000|Overall Study|Death|0|||
130746780|NCT04548193|470693462|FG001|Overall Study|Death|1|||
130746781|NCT04548193|470693461|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
130746782|NCT04548193|470693462|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
130746783|NCT04548193|470693461|FG000|Overall Study|Withdrawal by Subject|2|||
130746784|NCT04548193|470693462|FG001|Overall Study|Withdrawal by Subject|2|||
130746785|NCT00630825|470693463|FG000|Overall Study|Adverse Event|4|||
130746786|NCT00630825|470693464|FG001|Overall Study|Adverse Event|4|||
130746787|NCT00630825|470693465|FG002|Overall Study|Adverse Event|3|||
130746788|NCT00630825|470693466|FG003|Overall Study|Adverse Event|1|||
130746789|NCT00630825|470693463|FG000|Overall Study|Entry Criteria Not Met|1|||
130746790|NCT00630825|470693464|FG001|Overall Study|Entry Criteria Not Met|0|||
130746791|NCT00630825|470693465|FG002|Overall Study|Entry Criteria Not Met|2|||
130746792|NCT00630825|470693466|FG003|Overall Study|Entry Criteria Not Met|1|||
130746793|NCT00630825|470693463|FG000|Overall Study|Lost to Follow-up|1|||
130746794|NCT00630825|470693464|FG001|Overall Study|Lost to Follow-up|1|||
130746795|NCT00630825|470693465|FG002|Overall Study|Lost to Follow-up|1|||
130746796|NCT00630825|470693466|FG003|Overall Study|Lost to Follow-up|1|||
130746797|NCT00630825|470693463|FG000|Overall Study|Physician Decision|1|||
130746798|NCT00630825|470693464|FG001|Overall Study|Physician Decision|0|||
130746799|NCT00630825|470693465|FG002|Overall Study|Physician Decision|0|||
130746800|NCT00630825|470693466|FG003|Overall Study|Physician Decision|0|||
130746801|NCT00630825|470693463|FG000|Overall Study|Withdrawal by Subject|2|||
130746802|NCT00630825|470693464|FG001|Overall Study|Withdrawal by Subject|2|||
130746803|NCT00630825|470693465|FG002|Overall Study|Withdrawal by Subject|2|||
130788503|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
130788504|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
130788505|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
130788506|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130788507|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130788508|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130788509|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
130788510|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
130788511|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
130788512|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
130788513|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
130788514|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
130788515|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
130788516|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130788517|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130788518|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130788519|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
130788520|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
130788521|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130788522|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130788523|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130788524|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
130788525|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
130788526|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
130788527|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
130788528|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
130788529|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
130788530|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
130788531|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
130788532|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
130788533|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
130746804|NCT00630825|470693466|FG003|Overall Study|Withdrawal by Subject|3|||
130746805|NCT02275819|470693467|FG000|Overall Study|Adverse Event|0|||
130746806|NCT02275819|470693468|FG001|Overall Study|Adverse Event|1|||
130746807|NCT02211209|470693472|FG000|Overall Study|Investigator judgment|0|||
130746808|NCT02211209|470693473|FG001|Overall Study|Investigator judgment|1|||
130746809|NCT02211209|470693472|FG000|Overall Study|Voluntary withdrawal|1|||
130746810|NCT02211209|470693473|FG001|Overall Study|Voluntary withdrawal|4|||
130746811|NCT02211209|470693472|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130746812|NCT02211209|470693473|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
130746813|NCT02211209|470693472|FG000|Overall Study|Reason Not Specified|1|||
130746814|NCT02211209|470693473|FG001|Overall Study|Reason Not Specified|0|||
130746815|NCT02792062|470693476|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
130746816|NCT02792062|470693477|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130746817|NCT02792062|470693478|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130746818|NCT02792062|470693479|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130746819|NCT02792062|470693480|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130746820|NCT02792062|470693481|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130746821|NCT00931255|470693484|FG000|Overall Study|Follow up biopsy not done|2|||
130746822|NCT00931255|470693485|FG001|Overall Study|Follow up biopsy not done|3|||
130746823|NCT01681212|470693491|FG000|Overall Study|No longer met study criteria|5|||
130746824|NCT01681212|470693491|FG000|Overall Study|Administrative reason by sponsor|1|||
130746825|NCT02220764|470693494|FG000|Overall Study|Lost to Follow-up|3|||
130746826|NCT02220764|470693495|FG001|Overall Study|Lost to Follow-up|1|||
130746827|NCT02220764|470693494|FG000|Overall Study|Death|1|||
130746828|NCT02220764|470693495|FG001|Overall Study|Death|0|||
130746829|NCT02198664|470693496|FG000|Overall Study|Adverse Event|2|||
130746830|NCT02198664|470693497|FG001|Overall Study|Adverse Event|0|||
130746831|NCT02198664|470693496|FG000|Overall Study|Withdrawal by Subject|11|||
130746832|NCT02198664|470693497|FG001|Overall Study|Withdrawal by Subject|8|||
130746833|NCT02198664|470693496|FG000|Overall Study|Failure to tolerate|2|||
130746834|NCT02198664|470693497|FG001|Overall Study|Failure to tolerate|0|||
130746835|NCT02198664|470693496|FG000|Overall Study|Not stated|1|||
130746836|NCT02198664|470693497|FG001|Overall Study|Not stated|0|||
130746837|NCT03859427|470693501|FG000|Overall Study|Withdrawal by Subject|4|||
130746838|NCT03859427|470693502|FG001|Overall Study|Withdrawal by Subject|7|||
130746839|NCT03859427|470693501|FG000|Overall Study|Decision by sponsor|0|||
130746840|NCT03859427|470693502|FG001|Overall Study|Decision by sponsor|3|||
130746841|NCT03859427|470693501|FG000|Overall Study|Lost to Follow-up|3|||
130746842|NCT03859427|470693502|FG001|Overall Study|Lost to Follow-up|2|||
130746843|NCT03859427|470693501|FG000|Overall Study|Death|22|||
130746844|NCT03859427|470693502|FG001|Overall Study|Death|25|||
130746845|NCT02503540|470693503|FG000|Overall Study|Death|2|||
130746846|NCT02503540|470693503|FG000|Overall Study|Withdrawal by Subject|1|||
130746847|NCT01662492|470693504|FG000|Overall Study|Other miscellaneous reasons.|1|||
130746848|NCT01662492|470693505|FG001|Overall Study|Other miscellaneous reasons.|0|||
130746849|NCT01662492|470693506|FG002|Overall Study|Other miscellaneous reasons.|1|||
130746850|NCT01662492|470693504|FG000|Overall Study|Withdrawal by Subject|0|||
130746851|NCT01662492|470693505|FG001|Overall Study|Withdrawal by Subject|0|||
130746852|NCT01662492|470693506|FG002|Overall Study|Withdrawal by Subject|1|||
130746853|NCT01662492|470693504|FG000|Overall Study|Protocol Violation|1|||
130746854|NCT01662492|470693505|FG001|Overall Study|Protocol Violation|0|||
130746855|NCT01662492|470693506|FG002|Overall Study|Protocol Violation|0|||
130746856|NCT01662492|470693504|FG000|Overall Study|Lost to Follow-up|0|||
130746857|NCT01662492|470693505|FG001|Overall Study|Lost to Follow-up|0|||
130746858|NCT01662492|470693506|FG002|Overall Study|Lost to Follow-up|2|||
130746859|NCT01662492|470693504|FG000|Overall Study|Lack of Efficacy|1|||
130746860|NCT01662492|470693505|FG001|Overall Study|Lack of Efficacy|1|||
130746861|NCT01662492|470693506|FG002|Overall Study|Lack of Efficacy|2|||
130746862|NCT02418182|470693511|FG000|Overall Study|Unable to re-consent|18|||
130746863|NCT02418182|470693512|FG001|Overall Study|Unable to re-consent|15|||
130746864|NCT02418182|470693511|FG000|Overall Study|Lost to Follow-up|0|||
130746865|NCT02418182|470693512|FG001|Overall Study|Lost to Follow-up|2|||
130746866|NCT00570687|470695220|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746867|NCT00570687|470695221|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746868|NCT00570687|470695222|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746869|NCT00570687|470695223|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746870|NCT00570687|470695224|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130746871|NCT00570687|470695225|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130746872|NCT00570687|470695226|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
130746873|NCT00570687|470695227|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130746874|NCT00570687|470695228|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
130746875|NCT00570687|470695229|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130746876|NCT00570687|470695220|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746877|NCT00570687|470695221|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746878|NCT00570687|470695222|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746879|NCT00570687|470695223|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746880|NCT00570687|470695224|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746881|NCT00570687|470695225|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746882|NCT00570687|470695226|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746883|NCT00570687|470695227|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746884|NCT00570687|470695228|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
130746885|NCT00570687|470695229|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746886|NCT00570687|470695220|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746887|NCT00570687|470695221|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746888|NCT00570687|470695222|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746889|NCT00570687|470695223|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746890|NCT00570687|470695224|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746891|NCT00570687|470695225|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746892|NCT00570687|470695226|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
130746893|NCT00570687|470695227|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746894|NCT00570687|470695228|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746895|NCT00570687|470695229|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130746896|NCT01102257|470695237|FG000|Overall Study|Adverse Event|1|||
130746897|NCT01102257|470695238|FG001|Overall Study|Adverse Event|0|||
130746898|NCT01102257|470695237|FG000|Overall Study|Adverse Event|1|||
130746899|NCT01102257|470695238|FG001|Overall Study|Adverse Event|0|||
130746900|NCT04003636|470695239|FG000|Overall Study|Death|409|||
130746901|NCT04003636|470695240|FG001|Overall Study|Death|443|||
130746902|NCT04003636|470695239|FG000|Overall Study|Lost to Follow-up|0|||
130746903|NCT04003636|470695240|FG001|Overall Study|Lost to Follow-up|1|||
130746904|NCT04003636|470695239|FG000|Overall Study|Withdrawal by Subject|5|||
130746905|NCT04003636|470695240|FG001|Overall Study|Withdrawal by Subject|2|||
130746906|NCT04003636|470695239|FG000|Overall Study|Participant On-going|119|||
130746907|NCT04003636|470695240|FG001|Overall Study|Participant On-going|90|||
130746908|NCT03048747|470695241|FG000|Overall Study|Adverse Event|2|||
130746909|NCT03048747|470695241|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
130746910|NCT03048747|470695241|FG000|Overall Study|Physician Decision|1|||
130746911|NCT03270657|470695243|FG000|Overall Study|Withdrawal by Subject|1|||
130746912|NCT00162981|470695244|FG000|Overall Study|Adverse Event|2|||
130746913|NCT00162981|470695245|FG001|Overall Study|Adverse Event|5|||
130746914|NCT00162981|470695244|FG000|Overall Study|Withdrawal by Subject|1|||
130746915|NCT00162981|470695245|FG001|Overall Study|Withdrawal by Subject|1|||
130746916|NCT00162981|470695244|FG000|Overall Study|Physician Decision|1|||
130746917|NCT00162981|470695245|FG001|Overall Study|Physician Decision|0|||
130746918|NCT02588612|470695253|FG000|Overall Study|Physician Decision|1|||
130746919|NCT02588612|470695253|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
130746920|NCT02588612|470695253|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
130746921|NCT02588612|470695253|FG000|Overall Study|Death prior to T-cell infusion|1|||
130746922|NCT03809663|470695254|FG000|Overall Study|Decision by sponsor|24|||
130746923|NCT03809663|470695255|FG001|Overall Study|Decision by sponsor|18|||
130746924|NCT03809663|470695256|FG002|Overall Study|Decision by sponsor|20|||
130746925|NCT03809663|470695257|FG003|Overall Study|Decision by sponsor|20|||
130746926|NCT03809663|470695258|FG004|Overall Study|Decision by sponsor|0|||
130746927|NCT03809663|470695259|FG005|Overall Study|Decision by sponsor|0|||
130746928|NCT03809663|470695254|FG000|Overall Study|Withdrawal by Subject|26|||
130746929|NCT03809663|470695255|FG001|Overall Study|Withdrawal by Subject|22|||
130746930|NCT03809663|470695256|FG002|Overall Study|Withdrawal by Subject|27|||
130746931|NCT03809663|470695257|FG003|Overall Study|Withdrawal by Subject|26|||
130746932|NCT03809663|470695258|FG004|Overall Study|Withdrawal by Subject|0|||
130746933|NCT03809663|470695259|FG005|Overall Study|Withdrawal by Subject|0|||
130746934|NCT03809663|470695254|FG000|Overall Study|Lost to Follow-up|1|||
130746935|NCT03809663|470695255|FG001|Overall Study|Lost to Follow-up|4|||
130746936|NCT03809663|470695256|FG002|Overall Study|Lost to Follow-up|1|||
130746937|NCT03809663|470695257|FG003|Overall Study|Lost to Follow-up|1|||
130746938|NCT03809663|470695258|FG004|Overall Study|Lost to Follow-up|0|||
130746939|NCT03809663|470695259|FG005|Overall Study|Lost to Follow-up|0|||
130746940|NCT02042014|470695260|FG000|Overall Study|Adverse Event|1|||
130746941|NCT02042014|470695260|FG000|Overall Study|Physician Decision|7|||
130746942|NCT03309943|470695261|FG000|Overall Study|Withdrawal by Subject|0|||
130746943|NCT03309943|470695262|FG001|Overall Study|Withdrawal by Subject|1|||
130746944|NCT03309943|470695261|FG000|Overall Study|Inappropriate behavior towards staff|0|||
130746945|NCT03309943|470695262|FG001|Overall Study|Inappropriate behavior towards staff|1|||
130746946|NCT01372995|470695263|FG000|Overall Study|Spouse withdrew participant from study|0|||
130746947|NCT01372995|470695264|FG001|Overall Study|Spouse withdrew participant from study|1|||
130746948|NCT01372995|470695265|FG002|Overall Study|Spouse withdrew participant from study|0|||
130746949|NCT01372995|470695263|FG000|Overall Study|Physician Decision|0|||
130746950|NCT01372995|470695264|FG001|Overall Study|Physician Decision|0|||
130746951|NCT01372995|470695265|FG002|Overall Study|Physician Decision|1|||
130746952|NCT03123393|470695269|FG000|Overall Study|Study Terminated by Sponsor|6|||
130746953|NCT03123393|470695270|FG001|Overall Study|Study Terminated by Sponsor|9|||
130746954|NCT03123393|470695269|FG000|Overall Study|Withdrawal by Subject|2|||
130746955|NCT03123393|470695270|FG001|Overall Study|Withdrawal by Subject|1|||
130746956|NCT03123393|470695269|FG000|Overall Study|Reason not Specified|13|||
130746957|NCT03123393|470695270|FG001|Overall Study|Reason not Specified|13|||
130746958|NCT00558701|470695271|FG000|Overall Study|Protocol Deviations|1|||
130746959|NCT00558701|470695272|FG001|Overall Study|Protocol Deviations|4|||
130746960|NCT00427648|470695273|FG000|Overall Study|Protocol Violation|1|||
130746961|NCT00427648|470695274|FG001|Overall Study|Protocol Violation|2|||
130746962|NCT00427648|470695273|FG000|Overall Study|Adverse Event|0|||
130746963|NCT00427648|470695274|FG001|Overall Study|Adverse Event|1|||
130746964|NCT00105079|470695275|FG000|Overall Study|Adverse Event|5|||
130746965|NCT00105079|470695276|FG001|Overall Study|Adverse Event|12|||
130746966|NCT00105079|470695275|FG000|Overall Study|Death|3|||
130746967|NCT00105079|470695276|FG001|Overall Study|Death|1|||
130746968|NCT00105079|470695275|FG000|Overall Study|Lost to Follow-up|12|||
130746969|NCT00105079|470695276|FG001|Overall Study|Lost to Follow-up|12|||
130746970|NCT00105079|470695275|FG000|Overall Study|Lack of Efficacy|9|||
130746971|NCT00105079|470695276|FG001|Overall Study|Lack of Efficacy|3|||
130746972|NCT00105079|470695275|FG000|Overall Study|Refused treatment|6|||
130746973|NCT00105079|470695276|FG001|Overall Study|Refused treatment|4|||
130746974|NCT00105079|470695275|FG000|Overall Study|Violation of selection criteria at entry|0|||
130746975|NCT00105079|470695276|FG001|Overall Study|Violation of selection criteria at entry|2|||
130746976|NCT00105079|470695275|FG000|Overall Study|Protocol Violation|1|||
130746977|NCT00105079|470695276|FG001|Overall Study|Protocol Violation|0|||
130746978|NCT00105079|470695275|FG000|Overall Study|Other|3|||
130746979|NCT00105079|470695276|FG001|Overall Study|Other|1|||
130746980|NCT01609296|470695277|FG000|Overall Study|Death|253|||
130746981|NCT01609296|470695277|FG000|Overall Study|Withdrawal by Subject|151|||
130746982|NCT01609296|470695277|FG000|Overall Study|Lost to Follow-up|21|||
130746983|NCT01609296|470695277|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
130746984|NCT01609296|470695277|FG000|Overall Study|missed visit but known to be alive|28|||
130746985|NCT00386360|470695280|FG000|Overall Study|Adverse Event|4|||
130788534|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
130788535|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
130788536|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
130788537|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
130746986|NCT00386360|470695281|FG001|Overall Study|Adverse Event|2|||
130746987|NCT00386360|470695280|FG000|Overall Study|Physician Decision|2|||
130746988|NCT00386360|470695281|FG001|Overall Study|Physician Decision|2|||
130746989|NCT00386360|470695280|FG000|Overall Study|Lost to Follow-up|0|||
130746990|NCT00386360|470695281|FG001|Overall Study|Lost to Follow-up|2|||
130746991|NCT00386360|470695280|FG000|Overall Study|Protocol Violation|0|||
130746992|NCT00386360|470695281|FG001|Overall Study|Protocol Violation|3|||
130746993|NCT00386360|470695280|FG000|Overall Study|Withdrawal by Subject|3|||
130746994|NCT00386360|470695281|FG001|Overall Study|Withdrawal by Subject|6|||
130746995|NCT00386360|470695280|FG000|Overall Study|Did not take any study medication|0|||
130746996|NCT00386360|470695281|FG001|Overall Study|Did not take any study medication|2|||
130746997|NCT02230904|470695282|FG000|Overall Study|Safety follow up could not take place|0|||
130746998|NCT02230904|470695283|FG001|Overall Study|Safety follow up could not take place|1|||
130746999|NCT01464424|470695284|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
130747000|NCT01464424|470695285|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
130747001|NCT01464333|470695287|FG000|Overall Study|Adverse Event|34|||
130747002|NCT01464333|470695287|FG000|Overall Study|Lack of Efficacy|72|||
130747003|NCT01464333|470695287|FG000|Overall Study|Withdrawal by Subject|11|||
130747004|NCT01464333|470695287|FG000|Overall Study|Other|4|||
130747005|NCT01464333|470695287|FG000|Overall Study|No Hospital Visit|42|||
130747006|NCT02187198|470695290|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
130747007|NCT02187198|470695291|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
130747008|NCT02187198|470695290|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
130747009|NCT02187198|470695291|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
130747010|NCT01532518|470695292|FG000|Overall Study|Withdrawal by Subject|0|||
130747011|NCT01532518|470695293|FG001|Overall Study|Withdrawal by Subject|0|||
130747012|NCT01532518|470695294|FG002|Overall Study|Withdrawal by Subject|1|||
130747013|NCT01575834|470695295|FG000|Overall Study|Withdrawal by Subject|352|||
130747014|NCT01575834|470695296|FG001|Overall Study|Withdrawal by Subject|390|||
130747015|NCT01575834|470695295|FG000|Overall Study|Death|81|||
130747016|NCT01575834|470695296|FG001|Overall Study|Death|74|||
130747017|NCT01575834|470695295|FG000|Overall Study|Other|70|||
130747018|NCT01575834|470695296|FG001|Overall Study|Other|70|||
130747019|NCT01575834|470695295|FG000|Overall Study|Adverse Event|63|||
130747020|NCT01575834|470695296|FG001|Overall Study|Adverse Event|61|||
130747021|NCT01575834|470695295|FG000|Overall Study|Lost to Follow-up|55|||
130747022|NCT01575834|470695296|FG001|Overall Study|Lost to Follow-up|68|||
130747023|NCT01575834|470695295|FG000|Overall Study|Noncompliance|52|||
130747024|NCT01575834|470695296|FG001|Overall Study|Noncompliance|27|||
130747025|NCT01575834|470695295|FG000|Overall Study|Administrative decision|15|||
130747026|NCT01575834|470695296|FG001|Overall Study|Administrative decision|33|||
130747027|NCT01575834|470695295|FG000|Overall Study|Ineligibility Determined|5|||
130747028|NCT01575834|470695296|FG001|Overall Study|Ineligibility Determined|8|||
130747029|NCT01575834|470695295|FG000|Overall Study|Protocol Deviation|4|||
130747030|NCT01575834|470695296|FG001|Overall Study|Protocol Deviation|3|||
130747031|NCT01575834|470695295|FG000|Overall Study|Requirement for Alternative Therapy|2|||
130747032|NCT01575834|470695296|FG001|Overall Study|Requirement for Alternative Therapy|4|||
130747033|NCT02155283|470695297|FG000|Overall Study|Lost to Follow-up|3|||
130747034|NCT02155283|470695297|FG000|Overall Study|Withdrawal by Subject|1|||
130747035|NCT02155283|470695297|FG000|Overall Study|Protocol Violation|3|||
130747036|NCT02282813|470695300|FG000|Overall Study|Withdrawal by Subject|4|||
130747037|NCT02282813|470695301|FG001|Overall Study|Withdrawal by Subject|5|||
130747038|NCT02282813|470695302|FG002|Overall Study|Withdrawal by Subject|0|||
130747039|NCT02282813|470695300|FG000|Overall Study|Adverse Event|3|||
130747040|NCT02282813|470695301|FG001|Overall Study|Adverse Event|10|||
130747041|NCT02282813|470695302|FG002|Overall Study|Adverse Event|1|||
130747042|NCT02282813|470695300|FG000|Overall Study|Subject non-compliance|1|||
130747043|NCT02282813|470695301|FG001|Overall Study|Subject non-compliance|4|||
130747044|NCT02282813|470695302|FG002|Overall Study|Subject non-compliance|0|||
130747045|NCT02282813|470695300|FG000|Overall Study|Physician Decision|0|||
130747046|NCT02282813|470695301|FG001|Overall Study|Physician Decision|3|||
130747047|NCT02282813|470695302|FG002|Overall Study|Physician Decision|1|||
130747048|NCT02282813|470695300|FG000|Overall Study|Lost to Follow-up|2|||
130747049|NCT02282813|470695301|FG001|Overall Study|Lost to Follow-up|0|||
130747050|NCT02282813|470695302|FG002|Overall Study|Lost to Follow-up|1|||
130747051|NCT02282813|470695300|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
130747052|NCT02282813|470695301|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
130747053|NCT02282813|470695302|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
130747054|NCT02282813|470695300|FG000|Overall Study|Lack of Efficacy|1|||
130747055|NCT02282813|470695301|FG001|Overall Study|Lack of Efficacy|0|||
130747056|NCT02282813|470695302|FG002|Overall Study|Lack of Efficacy|0|||
130747057|NCT02282813|470695300|FG000|Overall Study|Administrative reasons|0|||
130747058|NCT02282813|470695301|FG001|Overall Study|Administrative reasons|1|||
130747059|NCT02282813|470695302|FG002|Overall Study|Administrative reasons|0|||
130747060|NCT05000164|470695307|FG000|Overall Study|Adverse Event|1|||
130747061|NCT05000164|470695307|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130747062|NCT05000164|470695307|FG000|Overall Study|Lens Discomfort|3|||
130747063|NCT05000164|470695307|FG000|Overall Study|Withdrew Consent during Study|2|||
130747064|NCT05000164|470695307|FG000|Overall Study|Subject Withdrawn by PI|2|||
130747065|NCT05000164|470695307|FG000|Overall Study|Other Fractured Test Article|1|||
130747066|NCT06509438|470695313|FG000|Overall Study|Adverse Event|1|||
130747067|NCT06509438|470695313|FG000|Overall Study|Lost to Follow-up|3|||
130747068|NCT03331796|470695314|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
130747069|NCT03331796|470695315|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
130747070|NCT03331796|470695316|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
130747071|NCT03331796|470695314|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
130747072|NCT03331796|470695315|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
130747073|NCT03331796|470695316|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
130747074|NCT03331796|470695314|FG000|Extended Follow-up|Adverse Event|1|||
130747075|NCT03331796|470695315|FG001|Extended Follow-up|Adverse Event|0|||
130747076|NCT03331796|470695316|FG002|Extended Follow-up|Adverse Event|1|||
130747077|NCT03331796|470695314|FG000|Extended Follow-up|Lost to Follow-up|0|||
130747078|NCT03331796|470695315|FG001|Extended Follow-up|Lost to Follow-up|0|||
130747079|NCT03331796|470695316|FG002|Extended Follow-up|Lost to Follow-up|1|||
130747080|NCT03331796|470695314|FG000|Extended Follow-up|Withdrawal by Subject|1|||
130747081|NCT03331796|470695315|FG001|Extended Follow-up|Withdrawal by Subject|0|||
130747082|NCT03331796|470695316|FG002|Extended Follow-up|Withdrawal by Subject|0|||
130747083|NCT03331796|470695314|FG000|Extended Follow-up|Termination of Funding|0|||
130747084|NCT03331796|470695315|FG001|Extended Follow-up|Termination of Funding|1|||
130747085|NCT03331796|470695316|FG002|Extended Follow-up|Termination of Funding|0|||
130747086|NCT01753570|470695317|FG000|Overall Study|Adverse Event|1|||
130747087|NCT01753570|470695318|FG001|Overall Study|Adverse Event|0|||
130747088|NCT01753570|470695319|FG002|Overall Study|Adverse Event|1|||
130747089|NCT01753570|470695317|FG000|Overall Study|Physician Decision|0|||
130747090|NCT01753570|470695318|FG001|Overall Study|Physician Decision|1|||
130747091|NCT01753570|470695319|FG002|Overall Study|Physician Decision|0|||
130747092|NCT01753570|470695317|FG000|Overall Study|Withdrawal by Subject|1|||
130747093|NCT01753570|470695318|FG001|Overall Study|Withdrawal by Subject|4|||
130747094|NCT01753570|470695319|FG002|Overall Study|Withdrawal by Subject|0|||
130747095|NCT01000155|470695320|FG000|Overall Study|Withdrawal by Subject|1|||
130747096|NCT01000155|470695320|FG000|Overall Study|Adverse Event|1|||
130747097|NCT00720213|470695323|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
130747098|NCT00720213|470695324|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
130747099|NCT00720213|470695325|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
130747100|NCT01808066|470695329|FG000|Overall Study|Withdrawal by Subject|15|||
130747101|NCT01420068|470695330|FG000|Overall Study|Administrative problems|1|||
130747102|NCT01420068|470695331|FG001|Overall Study|Administrative problems|3|||
130747103|NCT01420068|470695330|FG000|Overall Study|Withdrawal by Subject|1|||
130747104|NCT01420068|470695331|FG001|Overall Study|Withdrawal by Subject|2|||
130747105|NCT01252095|470695332|FG000|Overall Study|Disease progression|1|||
130747106|NCT01252095|470695333|FG001|Overall Study|Disease progression|0|||
130747107|NCT02554682|470695334|FG000|Overall Study|Lost to Follow-up|11|||
130747108|NCT02554682|470695335|FG001|Overall Study|Lost to Follow-up|9|||
130747109|NCT02554682|470695336|FG002|Overall Study|Lost to Follow-up|4|||
130747110|NCT02554682|470695337|FG003|Overall Study|Lost to Follow-up|3|||
130747111|NCT02554682|470695338|FG004|Overall Study|Lost to Follow-up|2|||
130747112|NCT02554682|470695339|FG005|Overall Study|Lost to Follow-up|1|||
130747113|NCT02554682|470695340|FG006|Overall Study|Lost to Follow-up|6|||
130747114|NCT02554682|470695341|FG007|Overall Study|Lost to Follow-up|6|||
130747115|NCT02554682|470695342|FG008|Overall Study|Lost to Follow-up|2|||
130747116|NCT02554682|470695343|FG009|Overall Study|Lost to Follow-up|2|||
130747117|NCT02554682|470695334|FG000|Overall Study|Withdrawal by Subject|2|||
130747118|NCT02554682|470695335|FG001|Overall Study|Withdrawal by Subject|1|||
130747119|NCT02554682|470695336|FG002|Overall Study|Withdrawal by Subject|0|||
130747120|NCT02554682|470695337|FG003|Overall Study|Withdrawal by Subject|0|||
130747121|NCT02554682|470695338|FG004|Overall Study|Withdrawal by Subject|0|||
130747122|NCT02554682|470695339|FG005|Overall Study|Withdrawal by Subject|0|||
130747123|NCT02554682|470695340|FG006|Overall Study|Withdrawal by Subject|0|||
130747124|NCT02554682|470695341|FG007|Overall Study|Withdrawal by Subject|0|||
130747125|NCT02554682|470695342|FG008|Overall Study|Withdrawal by Subject|0|||
130747126|NCT02554682|470695343|FG009|Overall Study|Withdrawal by Subject|0|||
130747127|NCT02554682|470695334|FG000|Overall Study|Physician Decision|2|||
130747128|NCT02554682|470695335|FG001|Overall Study|Physician Decision|2|||
130747129|NCT02554682|470695336|FG002|Overall Study|Physician Decision|0|||
130747130|NCT02554682|470695337|FG003|Overall Study|Physician Decision|0|||
130747131|NCT02554682|470695338|FG004|Overall Study|Physician Decision|0|||
130747132|NCT02554682|470695339|FG005|Overall Study|Physician Decision|0|||
130747133|NCT02554682|470695340|FG006|Overall Study|Physician Decision|0|||
130747134|NCT02554682|470695341|FG007|Overall Study|Physician Decision|0|||
130747135|NCT02554682|470695342|FG008|Overall Study|Physician Decision|0|||
130747136|NCT02554682|470695343|FG009|Overall Study|Physician Decision|0|||
130747137|NCT00884117|470695346|FG000|Overall Study|Adverse Event|2|||
130747138|NCT00884117|470695346|FG000|Overall Study|Withdrawal by Subject|89|||
130747139|NCT00884117|470695346|FG000|Overall Study|Death|3|||
130747140|NCT00884117|470695346|FG000|Overall Study|Lost to Follow-up|143|||
130747141|NCT00884117|470695346|FG000|Overall Study|Other|12|||
130747142|NCT04830969|470695349|FG000|Overall Study|Withdrawal by Subject|6|||
130747143|NCT04830969|470695350|FG001|Overall Study|Withdrawal by Subject|2|||
130747144|NCT04830969|470695349|FG000|Overall Study|Protocol Violation|3|||
130747145|NCT04830969|470695350|FG001|Overall Study|Protocol Violation|9|||
130747146|NCT04830969|470695349|FG000|Overall Study|Lost to Follow-up|4|||
130747147|NCT04830969|470695350|FG001|Overall Study|Lost to Follow-up|4|||
130747148|NCT01153815|470695355|FG000|Overall Study|Adverse Event|3|||
130747149|NCT01153815|470695356|FG001|Overall Study|Adverse Event|1|||
130747150|NCT01153815|470695355|FG000|Overall Study|Withdrawal by Subject|6|||
130747151|NCT01153815|470695356|FG001|Overall Study|Withdrawal by Subject|4|||
130747152|NCT01786993|470695357|FG000|Overall Study|Death|6|||
130747153|NCT01786993|470695358|FG001|Overall Study|Death|7|||
130747154|NCT01786993|470695357|FG000|Overall Study|Withdrawal by Subject|3|||
130747155|NCT01786993|470695358|FG001|Overall Study|Withdrawal by Subject|2|||
130747156|NCT01786993|470695357|FG000|Overall Study|Lost to Follow-up|0|||
130747157|NCT01786993|470695358|FG001|Overall Study|Lost to Follow-up|1|||
130747158|NCT01786993|470695357|FG000|Overall Study|Subject Non-Compliance|1|||
130747159|NCT01786993|470695358|FG001|Overall Study|Subject Non-Compliance|0|||
130747160|NCT01786993|470695357|FG000|Overall Study|System Explant|1|||
130747161|NCT01786993|470695358|FG001|Overall Study|System Explant|0|||
130747162|NCT01786993|470695357|FG000|Overall Study|Hospice Admission|1|||
130747163|NCT01786993|470695358|FG001|Overall Study|Hospice Admission|0|||
130747164|NCT01890122|470695359|FG000|Overall Study|Adverse Event|1|||
130747165|NCT01890122|470695360|FG001|Overall Study|Adverse Event|1|||
130747166|NCT01890122|470695361|FG002|Overall Study|Adverse Event|1|||
130747167|NCT01890122|470695362|FG003|Overall Study|Adverse Event|2|||
130747168|NCT01890122|470695359|FG000|Overall Study|Major Protocol Deviation|3|||
130747169|NCT01890122|470695360|FG001|Overall Study|Major Protocol Deviation|1|||
130747170|NCT01890122|470695361|FG002|Overall Study|Major Protocol Deviation|0|||
130747171|NCT01890122|470695362|FG003|Overall Study|Major Protocol Deviation|1|||
130747172|NCT01890122|470695359|FG000|Overall Study|Lost to Follow-up|0|||
130747173|NCT01890122|470695360|FG001|Overall Study|Lost to Follow-up|1|||
130747174|NCT01890122|470695361|FG002|Overall Study|Lost to Follow-up|2|||
130747175|NCT01890122|470695362|FG003|Overall Study|Lost to Follow-up|2|||
130747176|NCT01890122|470695359|FG000|Overall Study|Voluntary Withdrawal|8|||
130747177|NCT01890122|470695360|FG001|Overall Study|Voluntary Withdrawal|8|||
130747178|NCT01890122|470695361|FG002|Overall Study|Voluntary Withdrawal|2|||
130747179|NCT01890122|470695362|FG003|Overall Study|Voluntary Withdrawal|11|||
130747180|NCT01890122|470695359|FG000|Overall Study|Lack of Efficacy|14|||
130747181|NCT01890122|470695360|FG001|Overall Study|Lack of Efficacy|24|||
130747182|NCT01890122|470695361|FG002|Overall Study|Lack of Efficacy|7|||
130747183|NCT01890122|470695362|FG003|Overall Study|Lack of Efficacy|41|||
130747184|NCT01890122|470695359|FG000|Overall Study|Reason not Specified|0|||
130747185|NCT01890122|470695360|FG001|Overall Study|Reason not Specified|1|||
130747186|NCT01890122|470695361|FG002|Overall Study|Reason not Specified|1|||
130747187|NCT01890122|470695362|FG003|Overall Study|Reason not Specified|2|||
130747188|NCT01890122|470695359|FG000|Overall Study|Randomized but not Treated|1|||
130747189|NCT01890122|470695360|FG001|Overall Study|Randomized but not Treated|1|||
130747190|NCT01890122|470695361|FG002|Overall Study|Randomized but not Treated|0|||
130747191|NCT01890122|470695362|FG003|Overall Study|Randomized but not Treated|0|||
130747192|NCT02505217|470695366|FG000|Overall Study|Withdrawal by Subject|1|||
130747193|NCT02505217|470695367|FG001|Overall Study|Withdrawal by Subject|2|||
130747194|NCT00153179|470695377|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
130747195|NCT00153179|470695378|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
130747196|NCT00153179|470695379|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
130747197|NCT00153179|470695380|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
130747198|NCT04495829|470695381|FG000|Overall Study|Lost to Follow-up|2|||
130747199|NCT04495829|470695381|FG000|Overall Study|Inclusion criterion not met|3|||
130747200|NCT02712554|470695384|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
130747201|NCT02712554|470695385|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
130747202|NCT02712554|470695384|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
130747203|NCT02712554|470695385|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
130747204|NCT02712554|470695384|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
130747205|NCT02712554|470695385|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
130747206|NCT02712554|470695384|FG000|Part B: Qualification Phase|Adverse Event|0|||
130747207|NCT02712554|470695385|FG001|Part B: Qualification Phase|Adverse Event|1|||
130747208|NCT02712554|470695384|FG000|Part B: Treatment Phase|Adverse Event|0|||
130747209|NCT02712554|470695385|FG001|Part B: Treatment Phase|Adverse Event|1|||
130747210|NCT02712554|470695384|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
130747211|NCT02712554|470695385|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
130747212|NCT02712554|470695384|FG000|Part B: Treatment Phase|Other|0|||
130747213|NCT02712554|470695385|FG001|Part B: Treatment Phase|Other|1|||
130747214|NCT00979654|470695386|FG000|Overall Study|Lost to Follow-up|1|||
130747215|NCT00979654|470695386|FG000|Overall Study|Withdrawal by Subject|22|||
130747216|NCT00979654|470695386|FG000|Overall Study|Death|1|||
130747217|NCT00979654|470695386|FG000|Overall Study|Lack of Efficacy|6|||
130747218|NCT00979654|470695386|FG000|Overall Study|Adverse Event|1|||
130747219|NCT00979654|470695386|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
130747220|NCT00979654|470695386|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
130747221|NCT00979654|470695386|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
130747222|NCT00979654|470695386|FG000|Overall Study|Serious Adverse Event|1|||
130747223|NCT00979654|470695386|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
130747224|NCT01129557|470695387|FG000|Overall Study|Adverse Event|1|||
130747225|NCT01129557|470695388|FG001|Overall Study|Adverse Event|2|||
130747226|NCT01129557|470695389|FG002|Overall Study|Adverse Event|2|||
130747227|NCT01129557|470695387|FG000|Overall Study|Novartis terminated study early|3|||
130747228|NCT01129557|470695388|FG001|Overall Study|Novartis terminated study early|3|||
130747229|NCT01129557|470695389|FG002|Overall Study|Novartis terminated study early|2|||
130747230|NCT00669669|470695390|FG000|Overall Study|To late to start treatment|1|||
130747231|NCT01068678|470696907|FG000|Overall Study|Lack of Efficacy|3|||
130747232|NCT01068678|470696908|FG001|Overall Study|Lack of Efficacy|2|||
130747233|NCT01068678|470696907|FG000|Overall Study|Protocol Violation|5|||
130747234|NCT01068678|470696908|FG001|Overall Study|Protocol Violation|1|||
130747235|NCT01068678|470696907|FG000|Overall Study|Withdrawal criteria|12|||
130747236|NCT01068678|470696908|FG001|Overall Study|Withdrawal criteria|6|||
130747237|NCT01068678|470696907|FG000|Overall Study|Unclassified|18|||
130747238|NCT01068678|470696908|FG001|Overall Study|Unclassified|15|||
130747239|NCT03055338|470696911|FG000|Overall Study|Lost to Follow-up|9|||
130747240|NCT03055338|470696912|FG001|Overall Study|Lost to Follow-up|2|||
130747241|NCT03055338|470696913|FG002|Overall Study|Lost to Follow-up|3|||
130747242|NCT03055338|470696911|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
130747243|NCT03055338|470696912|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
130747244|NCT03055338|470696913|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
130747245|NCT03055338|470696911|FG000|Overall Study|Physician Decision|0|||
130747246|NCT03055338|470696912|FG001|Overall Study|Physician Decision|0|||
130747247|NCT03055338|470696913|FG002|Overall Study|Physician Decision|2|||
130747248|NCT03055338|470696911|FG000|Overall Study|Withdrawal by Subject|9|||
130747249|NCT03055338|470696912|FG001|Overall Study|Withdrawal by Subject|8|||
130747250|NCT03055338|470696913|FG002|Overall Study|Withdrawal by Subject|7|||
130747251|NCT00975611|470696914|FG000|Overall Study|Screen Fail|16|||
130747252|NCT00975611|470696914|FG000|Overall Study|Physician Decision|1|||
130747253|NCT03058705|470696915|FG000|Overall Study|Withdrawal by Subject|2|||
130747254|NCT03058705|470696915|FG000|Overall Study|Physician Decision|2|||
130747255|NCT01682226|470696916|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
130747256|NCT01682226|470696916|FG000|Overall Study|Participants did not receive treatment|2|||
130747257|NCT01682226|470696916|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
130747258|NCT02159053|470696917|FG000|Overall Study|Death|2|||
130747259|NCT02159053|470696918|FG001|Overall Study|Death|0|||
130747260|NCT02159053|470696919|FG002|Overall Study|Death|1|||
130747261|NCT02159053|470696917|FG000|Overall Study|Physician Decision|0|||
130747262|NCT02159053|470696918|FG001|Overall Study|Physician Decision|1|||
130747263|NCT02159053|470696919|FG002|Overall Study|Physician Decision|1|||
130747264|NCT02159053|470696917|FG000|Overall Study|Lack of Efficacy|3|||
130747265|NCT02159053|470696918|FG001|Overall Study|Lack of Efficacy|4|||
130747266|NCT02159053|470696919|FG002|Overall Study|Lack of Efficacy|7|||
130747267|NCT02159053|470696917|FG000|Overall Study|Adverse Event|7|||
130747268|NCT02159053|470696918|FG001|Overall Study|Adverse Event|6|||
130747269|NCT02159053|470696919|FG002|Overall Study|Adverse Event|5|||
130747270|NCT02159053|470696917|FG000|Overall Study|Participants/guardian decision|8|||
130747271|NCT02159053|470696918|FG001|Overall Study|Participants/guardian decision|10|||
130747272|NCT02159053|470696919|FG002|Overall Study|Participants/guardian decision|6|||
130747273|NCT00457002|470696924|FG000|Overall Study|Death|40|||
130747274|NCT00457002|470696925|FG001|Overall Study|Death|47|||
130747275|NCT00457002|470696924|FG000|Overall Study|Adverse Event|284|||
130747276|NCT00457002|470696925|FG001|Overall Study|Adverse Event|260|||
130747277|NCT00457002|470696924|FG000|Overall Study|Withdrawal by Subject|299|||
130747278|NCT00457002|470696925|FG001|Overall Study|Withdrawal by Subject|271|||
130788538|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
130788539|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
130747279|NCT00457002|470696924|FG000|Overall Study|Lost to Follow-up|72|||
130747280|NCT00457002|470696925|FG001|Overall Study|Lost to Follow-up|71|||
130747281|NCT00457002|470696924|FG000|Overall Study|Poor/Non-compliance|46|||
130747282|NCT00457002|470696925|FG001|Overall Study|Poor/Non-compliance|33|||
130747283|NCT00457002|470696924|FG000|Overall Study|No longer met criteria|41|||
130747284|NCT00457002|470696925|FG001|Overall Study|No longer met criteria|37|||
130747285|NCT00457002|470696924|FG000|Overall Study|Administrative reason by Sponsor|1|||
130747286|NCT00457002|470696925|FG001|Overall Study|Administrative reason by Sponsor|0|||
130747287|NCT00457002|470696924|FG000|Overall Study|non-specified|29|||
130747288|NCT00457002|470696925|FG001|Overall Study|non-specified|38|||
130747289|NCT00457002|470696924|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
130788540|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130747290|NCT00457002|470696925|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
130747291|NCT02283268|470696926|FG000|Overall Study|Withdrawal by Subject|1|||
130747292|NCT00454246|470696927|FG000|Overall Study|Adverse Event|2|||
130747293|NCT00454246|470696928|FG001|Overall Study|Adverse Event|2|||
130747294|NCT00454246|470696929|FG002|Overall Study|Adverse Event|0|||
130747295|NCT00454246|470696927|FG000|Overall Study|Violation of selection criteria at entry|6|||
130747296|NCT00454246|470696928|FG001|Overall Study|Violation of selection criteria at entry|0|||
130747297|NCT00454246|470696929|FG002|Overall Study|Violation of selection criteria at entry|0|||
130747298|NCT00454246|470696927|FG000|Overall Study|Protocol Violation|1|||
130747299|NCT00454246|470696928|FG001|Overall Study|Protocol Violation|0|||
130788541|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130788542|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130788543|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130747300|NCT00454246|470696929|FG002|Overall Study|Protocol Violation|0|||
130747301|NCT00454246|470696927|FG000|Overall Study|Refused Treatment|1|||
130747302|NCT00454246|470696928|FG001|Overall Study|Refused Treatment|1|||
130747303|NCT00454246|470696929|FG002|Overall Study|Refused Treatment|0|||
130747304|NCT00454246|470696927|FG000|Overall Study|Failure to return|1|||
130747305|NCT00454246|470696928|FG001|Overall Study|Failure to return|0|||
130747306|NCT00454246|470696929|FG002|Overall Study|Failure to return|0|||
130747307|NCT00454246|470696927|FG000|Overall Study|Early termination of study|62|||
130747308|NCT00454246|470696928|FG001|Overall Study|Early termination of study|26|||
130747309|NCT00454246|470696929|FG002|Overall Study|Early termination of study|9|||
130747310|NCT01085630|470696940|FG000|Overall Study|Insufficient data|1|||
130747311|NCT01085630|470696941|FG001|Overall Study|Insufficient data|0|||
130747312|NCT01085630|470696940|FG000|Overall Study|Ineligible|3|||
130747313|NCT01085630|470696941|FG001|Overall Study|Ineligible|0|||
130747314|NCT01017874|470696942|FG000|Overall Study|Withdrawal by Subject|23|||
130747315|NCT01017874|470696943|FG001|Overall Study|Withdrawal by Subject|20|||
130747316|NCT01017874|470696942|FG000|Overall Study|Sponsor decision|3|||
130747317|NCT01017874|470696943|FG001|Overall Study|Sponsor decision|1|||
130747318|NCT01017874|470696942|FG000|Overall Study|Lost to Follow-up|3|||
130747319|NCT01017874|470696943|FG001|Overall Study|Lost to Follow-up|2|||
130747320|NCT01017874|470696942|FG000|Overall Study|Physician Decision|1|||
130747321|NCT01017874|470696943|FG001|Overall Study|Physician Decision|3|||
130747322|NCT01346696|470696944|FG000|Overall Study|Death|1|||
130747323|NCT00506415|470696955|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
130747324|NCT00506415|470696956|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130747325|NCT00506415|470696957|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130747326|NCT00506415|470696958|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130747327|NCT00506415|470696955|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
130747328|NCT00506415|470696956|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
130747329|NCT00506415|470696957|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
130747330|NCT00506415|470696958|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
130747331|NCT00506415|470696955|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
130747332|NCT00506415|470696956|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
130747333|NCT00506415|470696957|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
130747334|NCT00506415|470696958|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
130747335|NCT00506415|470696955|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
130747336|NCT00506415|470696956|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130747337|NCT00506415|470696957|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130747338|NCT00506415|470696958|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130747339|NCT00506415|470696955|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
130747340|NCT00506415|470696956|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130747341|NCT00506415|470696957|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130747342|NCT00506415|470696958|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130747343|NCT00506415|470696955|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
130747344|NCT00506415|470696956|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130747345|NCT00506415|470696957|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130747346|NCT00506415|470696958|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130747347|NCT00506415|470696955|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
130747348|NCT00506415|470696956|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
130747349|NCT00506415|470696957|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
130747350|NCT00506415|470696958|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
130747351|NCT00506415|470696955|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
130747352|NCT00506415|470696956|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
130747353|NCT00506415|470696957|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
130747354|NCT00506415|470696958|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
130747355|NCT00506415|470696955|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
130747356|NCT00506415|470696956|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130747357|NCT00506415|470696957|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130747358|NCT00506415|470696958|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130747359|NCT00506415|470696955|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
130747360|NCT00506415|470696956|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
130747361|NCT00506415|470696957|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
130747362|NCT00506415|470696958|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
130747363|NCT00506415|470696955|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
130747364|NCT00506415|470696956|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
130747365|NCT00506415|470696957|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
130747366|NCT00506415|470696958|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
130747367|NCT00506415|470696955|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
130747368|NCT00506415|470696956|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
130747369|NCT00506415|470696957|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
130747370|NCT00506415|470696958|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
130747371|NCT00506415|470696955|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
130747372|NCT00506415|470696956|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
130747373|NCT00506415|470696957|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
130747374|NCT00506415|470696958|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
130747375|NCT00506415|470696955|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
130747376|NCT00506415|470696956|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
130747377|NCT00506415|470696957|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
130747378|NCT00506415|470696958|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
130747379|NCT00506415|470696955|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
130747380|NCT00506415|470696956|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
130747381|NCT00506415|470696957|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
130747382|NCT00506415|470696958|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
130747383|NCT00506415|470696955|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
130747384|NCT00506415|470696956|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
130747385|NCT00506415|470696957|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
130747386|NCT00506415|470696958|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
130747387|NCT00506415|470696955|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
130747388|NCT00506415|470696956|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
130747389|NCT00506415|470696957|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
130747390|NCT00506415|470696958|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
130747391|NCT00506415|470696955|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
130747392|NCT00506415|470696956|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
130747393|NCT00506415|470696957|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
130747394|NCT00506415|470696958|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
130788544|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
130747395|NCT00506415|470696955|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130747396|NCT00506415|470696956|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130747397|NCT00506415|470696957|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130747398|NCT00506415|470696958|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
130747399|NCT00506415|470696955|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130747400|NCT00506415|470696956|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130747401|NCT00506415|470696957|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130747402|NCT00506415|470696958|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
130747403|NCT00506415|470696955|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130747404|NCT00506415|470696956|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130747405|NCT00506415|470696957|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130747406|NCT00506415|470696958|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
130747407|NCT00506415|470696955|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130747408|NCT00506415|470696956|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130747409|NCT00506415|470696957|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130747410|NCT00506415|470696958|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
130747411|NCT00506415|470696955|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130747412|NCT00506415|470696956|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130747413|NCT00506415|470696957|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130747414|NCT00506415|470696958|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
130747415|NCT00506415|470696955|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
130747416|NCT00506415|470696956|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
130747417|NCT00506415|470696957|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
130747418|NCT00506415|470696958|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
130747419|NCT04578457|470696959|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
130747420|NCT04578457|470696959|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
130747421|NCT04578457|470696959|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
130747422|NCT04578457|470696959|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
130747423|NCT01297517|470696975|FG000|Overall Study|Adverse Event|21|||
130747424|NCT01297517|470696976|FG001|Overall Study|Adverse Event|7|||
130747425|NCT01297517|470696977|FG002|Overall Study|Adverse Event|16|||
130747426|NCT01297517|470696975|FG000|Overall Study|Lost to Follow-up|1|||
130747427|NCT01297517|470696976|FG001|Overall Study|Lost to Follow-up|0|||
130747428|NCT01297517|470696977|FG002|Overall Study|Lost to Follow-up|1|||
130747429|NCT01297517|470696975|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
130747430|NCT01297517|470696976|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
130747431|NCT01297517|470696977|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
130747432|NCT01297517|470696975|FG000|Overall Study|Noncompliance|1|||
130747433|NCT01297517|470696976|FG001|Overall Study|Noncompliance|0|||
130747434|NCT01297517|470696977|FG002|Overall Study|Noncompliance|0|||
130747435|NCT01297517|470696975|FG000|Overall Study|Protocol Violation|1|||
130747436|NCT01297517|470696976|FG001|Overall Study|Protocol Violation|1|||
130747437|NCT01297517|470696977|FG002|Overall Study|Protocol Violation|1|||
130747438|NCT01297517|470696975|FG000|Overall Study|Inadequate Control of IOP|1|||
130747439|NCT01297517|470696976|FG001|Overall Study|Inadequate Control of IOP|1|||
130747440|NCT01297517|470696977|FG002|Overall Study|Inadequate Control of IOP|2|||
130747441|NCT00628212|470696980|FG000|Overall Study|Adverse Event|2|||
130747442|NCT00628212|470696981|FG001|Overall Study|Adverse Event|0|||
130747443|NCT00628212|470696982|FG002|Overall Study|Adverse Event|1|||
130747444|NCT00628212|470696983|FG003|Overall Study|Adverse Event|2|||
130747445|NCT00628212|470696980|FG000|Overall Study|Physician Decision|1|||
130747446|NCT00628212|470696981|FG001|Overall Study|Physician Decision|1|||
130747447|NCT00628212|470696982|FG002|Overall Study|Physician Decision|2|||
130747448|NCT00628212|470696983|FG003|Overall Study|Physician Decision|3|||
130747449|NCT00789373|470696986|FG000|Induction|Adverse Event|64|||
130747450|NCT00789373|470696987|FG001|Induction|Adverse Event|0|||
130747451|NCT00789373|470696988|FG002|Induction|Adverse Event|0|||
130747452|NCT00789373|470696986|FG000|Induction|Death Due to study disease|24|||
130747453|NCT00789373|470696987|FG001|Induction|Death Due to study disease|0|||
130747454|NCT00789373|470696988|FG002|Induction|Death Due to study disease|0|||
130747455|NCT00789373|470696986|FG000|Induction|Death due to adverse event|19|||
130747456|NCT00789373|470696987|FG001|Induction|Death due to adverse event|0|||
130747457|NCT00789373|470696988|FG002|Induction|Death due to adverse event|0|||
130747458|NCT00789373|470696986|FG000|Induction|Death due to toxicity|11|||
130747459|NCT00789373|470696987|FG001|Induction|Death due to toxicity|0|||
130747460|NCT00789373|470696988|FG002|Induction|Death due to toxicity|0|||
130747461|NCT00789373|470696986|FG000|Induction|Death due to procedure|1|||
130747462|NCT00789373|470696987|FG001|Induction|Death due to procedure|0|||
130747463|NCT00789373|470696988|FG002|Induction|Death due to procedure|0|||
130747464|NCT00789373|470696986|FG000|Induction|Investigator decision|7|||
130747465|NCT00789373|470696987|FG001|Induction|Investigator decision|0|||
130747466|NCT00789373|470696988|FG002|Induction|Investigator decision|0|||
130747467|NCT00789373|470696986|FG000|Induction|Protocol entry criteria not met|9|||
130747468|NCT00789373|470696987|FG001|Induction|Protocol entry criteria not met|0|||
130747469|NCT00789373|470696988|FG002|Induction|Protocol entry criteria not met|0|||
130747470|NCT00789373|470696986|FG000|Induction|Lost to Follow-up|6|||
130747471|NCT00789373|470696987|FG001|Induction|Lost to Follow-up|0|||
130747472|NCT00789373|470696988|FG002|Induction|Lost to Follow-up|0|||
130747473|NCT00789373|470696986|FG000|Induction|Protocol Violation|1|||
130747474|NCT00789373|470696987|FG001|Induction|Protocol Violation|0|||
130747475|NCT00789373|470696988|FG002|Induction|Protocol Violation|0|||
130747476|NCT00789373|470696986|FG000|Induction|Progressive Disease|220|||
130747477|NCT00789373|470696987|FG001|Induction|Progressive Disease|0|||
130747478|NCT00789373|470696988|FG002|Induction|Progressive Disease|0|||
130747479|NCT00789373|470696986|FG000|Induction|Withdrawal by Subject|37|||
130747480|NCT00789373|470696987|FG001|Induction|Withdrawal by Subject|0|||
130747481|NCT00789373|470696988|FG002|Induction|Withdrawal by Subject|0|||
130747482|NCT00789373|470696986|FG000|Maintenance|Adverse Event|0|||
130747483|NCT00789373|470696987|FG001|Maintenance|Adverse Event|65|||
130747484|NCT00789373|470696988|FG002|Maintenance|Adverse Event|12|||
130747485|NCT00789373|470696986|FG000|Maintenance|Death due to study disease|0|||
130747486|NCT00789373|470696987|FG001|Maintenance|Death due to study disease|3|||
130747487|NCT00789373|470696988|FG002|Maintenance|Death due to study disease|1|||
130747488|NCT00789373|470696986|FG000|Maintenance|Death due to adverse event|0|||
130747489|NCT00789373|470696987|FG001|Maintenance|Death due to adverse event|4|||
130747490|NCT00789373|470696988|FG002|Maintenance|Death due to adverse event|1|||
130747491|NCT00789373|470696986|FG000|Maintenance|Death due to toxicity|0|||
130747492|NCT00789373|470696987|FG001|Maintenance|Death due to toxicity|1|||
130747493|NCT00789373|470696988|FG002|Maintenance|Death due to toxicity|2|||
130747494|NCT00789373|470696986|FG000|Maintenance|Investigator Decision|0|||
130747495|NCT00789373|470696987|FG001|Maintenance|Investigator Decision|4|||
130747496|NCT00789373|470696988|FG002|Maintenance|Investigator Decision|2|||
130747497|NCT00789373|470696986|FG000|Maintenance|Protocol entry criteria not met|0|||
130747498|NCT00789373|470696987|FG001|Maintenance|Protocol entry criteria not met|2|||
130747499|NCT00789373|470696988|FG002|Maintenance|Protocol entry criteria not met|0|||
130747500|NCT00789373|470696986|FG000|Maintenance|Lost to Follow-up|0|||
130747501|NCT00789373|470696987|FG001|Maintenance|Lost to Follow-up|2|||
130747502|NCT00789373|470696988|FG002|Maintenance|Lost to Follow-up|0|||
130747503|NCT00789373|470696986|FG000|Maintenance|Progressive Disease|0|||
130747504|NCT00789373|470696987|FG001|Maintenance|Progressive Disease|253|||
130747505|NCT00789373|470696988|FG002|Maintenance|Progressive Disease|152|||
130747506|NCT00789373|470696986|FG000|Maintenance|Withdrawal by Subject|0|||
130747507|NCT00789373|470696987|FG001|Maintenance|Withdrawal by Subject|21|||
130747508|NCT00789373|470696988|FG002|Maintenance|Withdrawal by Subject|8|||
130747509|NCT00789373|470696986|FG000|Maintenance|Sponsor Decision|0|||
130747510|NCT00789373|470696987|FG001|Maintenance|Sponsor Decision|0|||
130747511|NCT00789373|470696988|FG002|Maintenance|Sponsor Decision|2|||
130747512|NCT00789373|470696986|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
130747513|NCT00789373|470696987|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
130747514|NCT00789373|470696988|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
130747515|NCT00546377|470696989|FG000|Overall Study|Deemed ineligible|1|||
130747516|NCT00546377|470696989|FG000|Overall Study|Adverse Event|6|||
130747517|NCT03321968|470696990|FG000|Overall Study|Withdrawal by Subject|1|||
130747518|NCT03321968|470696991|FG001|Overall Study|Withdrawal by Subject|2|||
130747519|NCT03321968|470696992|FG002|Overall Study|Withdrawal by Subject|1|||
130747520|NCT03321968|470696990|FG000|Overall Study|Lost to Follow-up|2|||
130747521|NCT03321968|470696991|FG001|Overall Study|Lost to Follow-up|0|||
130747522|NCT03321968|470696992|FG002|Overall Study|Lost to Follow-up|1|||
130747523|NCT03321968|470696990|FG000|Overall Study|Other than specified|0|||
130747524|NCT03321968|470696991|FG001|Overall Study|Other than specified|0|||
130747525|NCT03321968|470696992|FG002|Overall Study|Other than specified|1|||
130747526|NCT00463047|470696998|FG000|Titration Period 1|Adverse Event|10|||
130747527|NCT00463047|470696999|FG001|Titration Period 1|Adverse Event|8|||
130747528|NCT00463047|470696998|FG000|Titration Period 1|Lack of Efficacy|10|||
130747529|NCT00463047|470696999|FG001|Titration Period 1|Lack of Efficacy|4|||
130747530|NCT00463047|470696998|FG000|Titration Period 1|Lost to Follow-up|2|||
130747531|NCT00463047|470696999|FG001|Titration Period 1|Lost to Follow-up|0|||
130747532|NCT00463047|470696998|FG000|Titration Period 1|Non-compliance with study medication|3|||
130747533|NCT00463047|470696999|FG001|Titration Period 1|Non-compliance with study medication|5|||
130747534|NCT00463047|470696998|FG000|Titration Period 1|Protocol Violation|5|||
130747535|NCT00463047|470696999|FG001|Titration Period 1|Protocol Violation|5|||
130747536|NCT00463047|470696998|FG000|Titration Period 1|Withdrawal by Subject|3|||
130747537|NCT00463047|470696999|FG001|Titration Period 1|Withdrawal by Subject|5|||
130747538|NCT00463047|470696998|FG000|Titration Period 1|Non-compliance procedures|4|||
130747539|NCT00463047|470696999|FG001|Titration Period 1|Non-compliance procedures|10|||
130747540|NCT00463047|470696998|FG000|Titration Period 1|Other|0|||
130747541|NCT00463047|470696999|FG001|Titration Period 1|Other|2|||
130747542|NCT00463047|470696998|FG000|Titration Period 2|Adverse Event|9|||
130747543|NCT00463047|470696999|FG001|Titration Period 2|Adverse Event|9|||
130747544|NCT00463047|470696998|FG000|Titration Period 2|Lack of Efficacy|6|||
130747545|NCT00463047|470696999|FG001|Titration Period 2|Lack of Efficacy|4|||
130747546|NCT00463047|470696998|FG000|Titration Period 2|Withdrawal by Subject|1|||
130747547|NCT00463047|470696999|FG001|Titration Period 2|Withdrawal by Subject|0|||
130747548|NCT00463047|470696998|FG000|Titration Period 2|Protocol Violation|2|||
130747549|NCT00463047|470696999|FG001|Titration Period 2|Protocol Violation|3|||
130747550|NCT00463047|470696998|FG000|Titration Period 2|Lost to Follow-up|1|||
130747551|NCT00463047|470696999|FG001|Titration Period 2|Lost to Follow-up|2|||
130788545|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
130747552|NCT00463047|470696998|FG000|Titration Period 2|Non-compliance study medication|4|||
130747553|NCT00463047|470696999|FG001|Titration Period 2|Non-compliance study medication|2|||
130747554|NCT00463047|470696998|FG000|Titration Period 2|Non-compliance procedures|4|||
130747555|NCT00463047|470696999|FG001|Titration Period 2|Non-compliance procedures|1|||
130747556|NCT00463047|470696998|FG000|Titration Period 2|Other|3|||
130747557|NCT00463047|470696999|FG001|Titration Period 2|Other|2|||
130747558|NCT00463047|470696998|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
130747559|NCT00463047|470696999|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
130747560|NCT00463047|470696998|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
130747561|NCT00463047|470696999|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
130747562|NCT00463047|470696998|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
130747563|NCT00463047|470696999|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
130747564|NCT00463047|470696998|FG000|Double-Blind Treatment Period 1|Other|1|||
130747565|NCT00463047|470696999|FG001|Double-Blind Treatment Period 1|Other|0|||
130747566|NCT00463047|470696998|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
130747567|NCT00463047|470696999|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
130747568|NCT00463047|470696998|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
130747569|NCT00463047|470696999|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
130747570|NCT00463047|470696998|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
130747571|NCT00463047|470696999|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
130747572|NCT03020992|470697003|FG000|Overall Study|Adverse Event|5|||
130747573|NCT03020992|470697003|FG000|Overall Study|Withdrawal by Subject|1|||
130747574|NCT02861807|470697004|FG000|Overall Study|Lost to Follow-up|7|||
130747575|NCT02861807|470697005|FG001|Overall Study|Lost to Follow-up|6|||
130747576|NCT02861807|470697004|FG000|Overall Study|Withdrawal by Subject|5|||
130747577|NCT02861807|470697005|FG001|Overall Study|Withdrawal by Subject|8|||
130747578|NCT01006122|470697006|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
130747579|NCT01006122|470697007|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
130747580|NCT01006122|470697006|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
130747581|NCT01006122|470697007|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
130747582|NCT01006122|470697006|FG000|First Double-blind Intervention Period|Pregnancy|0|||
130747583|NCT01006122|470697007|FG001|First Double-blind Intervention Period|Pregnancy|1|||
130747584|NCT01006122|470697006|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
130747585|NCT01006122|470697007|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
130747586|NCT01006122|470697006|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
130747587|NCT01006122|470697007|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
130747588|NCT01006122|470697006|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
130747589|NCT01006122|470697007|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
130747590|NCT01006122|470697006|FG000|First Double-blind Intervention Period|Other|3|||
130747591|NCT01006122|470697007|FG001|First Double-blind Intervention Period|Other|0|||
130747592|NCT01006122|470697006|FG000|First Double-blind Intervention Period|Adverse Event|0|||
130747593|NCT01006122|470697007|FG001|First Double-blind Intervention Period|Adverse Event|4|||
130747594|NCT01006122|470697006|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
130747595|NCT01006122|470697007|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
130747596|NCT01006122|470697006|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
130747597|NCT01006122|470697007|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
130747598|NCT01006122|470697006|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
130747599|NCT01006122|470697007|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
130747600|NCT01006122|470697006|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
130747601|NCT01006122|470697007|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
130747602|NCT01006122|470697006|FG000|Second Double-blind Intervention Period|Death|0|||
130747603|NCT01006122|470697007|FG001|Second Double-blind Intervention Period|Death|1|||
130747604|NCT03493854|470697010|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
130747605|NCT03493854|470697011|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
130747606|NCT03493854|470697010|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
130747607|NCT03493854|470697011|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
130747608|NCT03493854|470697010|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
130747609|NCT03493854|470697011|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
130747610|NCT03493854|470697010|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
130747611|NCT03493854|470697011|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
130747612|NCT03493854|470697010|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
130747613|NCT03493854|470697011|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
130747614|NCT03493854|470697010|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
130747615|NCT03493854|470697011|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
130747616|NCT03493854|470697010|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
130747617|NCT03493854|470697011|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
130747618|NCT03493854|470697010|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
130747619|NCT03493854|470697011|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
130747620|NCT03493854|470697010|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
130747621|NCT03493854|470697011|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
130747622|NCT03493854|470697010|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
130747623|NCT03493854|470697011|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
130747624|NCT03493854|470697010|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
130747625|NCT03493854|470697011|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
130747626|NCT03493854|470697010|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
130747627|NCT03493854|470697011|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
130747628|NCT03493854|470697010|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
130747629|NCT03493854|470697011|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
130747630|NCT03493854|470697010|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
130747631|NCT03493854|470697011|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
130747632|NCT03493854|470697010|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
130747633|NCT03493854|470697011|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
130747634|NCT03493854|470697010|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
130788546|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
130788547|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
130747635|NCT03493854|470697011|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
130747636|NCT03493854|470697010|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
130747637|NCT03493854|470697011|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
130747638|NCT03493854|470697010|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
130747639|NCT03493854|470697011|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
130747640|NCT00739661|470697014|FG000|Overall Study|Adverse Event|2|||
130747641|NCT00739661|470697015|FG001|Overall Study|Adverse Event|0|||
130747642|NCT00739661|470697014|FG000|Overall Study|Physician decision to withdraw patient|1|||
130747643|NCT00739661|470697015|FG001|Overall Study|Physician decision to withdraw patient|0|||
130747644|NCT00739661|470697014|FG000|Overall Study|Patient decision to withdraw|9|||
130747645|NCT00739661|470697015|FG001|Overall Study|Patient decision to withdraw|4|||
130747646|NCT00739661|470697014|FG000|Overall Study|Disease progression, radiographic|33|||
130747647|NCT00739661|470697015|FG001|Overall Study|Disease progression, radiographic|37|||
130747648|NCT00739661|470697014|FG000|Overall Study|Reason for discontinuation not available|1|||
130747649|NCT00739661|470697015|FG001|Overall Study|Reason for discontinuation not available|1|||
130747650|NCT00529308|470697016|FG000|Overall Study|Withdrawal by Subject|1|||
130747651|NCT00529308|470697017|FG001|Overall Study|Withdrawal by Subject|1|||
130747652|NCT05343364|470697024|FG000|Overall Study|Miscellaneous|0|||
130747653|NCT05343364|470697025|FG001|Overall Study|Miscellaneous|1|||
130747654|NCT02105987|470697026|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
130747655|NCT02105987|470697027|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130747656|NCT02105987|470697028|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130747657|NCT02105987|470697029|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130747658|NCT02105987|470697030|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130747659|NCT02105987|470697031|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130747660|NCT02105987|470697026|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
130747661|NCT02105987|470697027|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
130747662|NCT02105987|470697028|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130747663|NCT02105987|470697029|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130747664|NCT02105987|470697030|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130747665|NCT02105987|470697031|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130747666|NCT02105987|470697026|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
130747667|NCT02105987|470697027|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
130747668|NCT02105987|470697028|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130747669|NCT02105987|470697029|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130747670|NCT02105987|470697030|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130747671|NCT02105987|470697031|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130747672|NCT02105987|470697026|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
130747673|NCT02105987|470697027|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
130747674|NCT02105987|470697028|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130747675|NCT02105987|470697029|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130747676|NCT02105987|470697030|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130747677|NCT02105987|470697031|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130747678|NCT02105987|470697026|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
130747679|NCT02105987|470697027|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
130747680|NCT02105987|470697028|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130747681|NCT02105987|470697029|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130747682|NCT02105987|470697030|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130747683|NCT02105987|470697031|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130747684|NCT02105987|470697026|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130747685|NCT02105987|470697027|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
130747686|NCT02105987|470697028|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130747687|NCT02105987|470697029|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130747688|NCT02105987|470697030|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130747689|NCT02105987|470697031|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130747690|NCT02105987|470697026|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130747691|NCT02105987|470697027|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130747692|NCT02105987|470697028|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
130747693|NCT02105987|470697029|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
130747694|NCT02105987|470697030|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130747695|NCT02105987|470697031|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130747696|NCT02105987|470697026|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130747697|NCT02105987|470697027|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130747698|NCT02105987|470697028|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
130747699|NCT02105987|470697029|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
130747700|NCT02105987|470697030|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130747701|NCT02105987|470697031|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130747702|NCT02105987|470697026|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130788548|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
130747703|NCT02105987|470697027|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130747704|NCT02105987|470697028|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
130747705|NCT02105987|470697029|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
130747706|NCT02105987|470697030|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130747707|NCT02105987|470697031|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130747708|NCT02105987|470697026|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130747709|NCT02105987|470697027|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130747710|NCT02105987|470697028|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
130747711|NCT02105987|470697029|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
130747712|NCT02105987|470697030|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130747713|NCT02105987|470697031|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130747714|NCT02105987|470697026|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130747715|NCT02105987|470697027|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130747716|NCT02105987|470697028|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
130747717|NCT02105987|470697029|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130747718|NCT02105987|470697030|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130747719|NCT02105987|470697031|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130747720|NCT02105987|470697026|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130747721|NCT02105987|470697027|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130747722|NCT02105987|470697028|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130747723|NCT02105987|470697029|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
130747724|NCT02105987|470697030|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130747725|NCT02105987|470697031|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130747726|NCT02105987|470697026|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130747727|NCT02105987|470697027|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130747728|NCT02105987|470697028|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
130747729|NCT02105987|470697029|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130747730|NCT02105987|470697030|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130747731|NCT02105987|470697031|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130747732|NCT02105987|470697026|FG000|Continuation Phase|Protocol Violation|0|||
130747733|NCT02105987|470697027|FG001|Continuation Phase|Protocol Violation|0|||
130747734|NCT02105987|470697028|FG002|Continuation Phase|Protocol Violation|0|||
130747735|NCT02105987|470697029|FG003|Continuation Phase|Protocol Violation|0|||
130747736|NCT02105987|470697030|FG004|Continuation Phase|Protocol Violation|1|||
130747737|NCT02105987|470697031|FG005|Continuation Phase|Protocol Violation|0|||
130747738|NCT02268916|470697036|FG000|Overall Study|Lost to Follow-up|1|||
130747739|NCT02268916|470697037|FG001|Overall Study|Lost to Follow-up|1|||
130747740|NCT02268916|470697036|FG000|Overall Study|Withdrawal by Subject|6|||
130747741|NCT02268916|470697037|FG001|Overall Study|Withdrawal by Subject|5|||
130747742|NCT02268916|470697036|FG000|Overall Study|Participant did not have diabetes|1|||
130747743|NCT02268916|470697037|FG001|Overall Study|Participant did not have diabetes|0|||
130747744|NCT02268916|470697036|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
130747745|NCT02268916|470697037|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
130747746|NCT02418949|470697038|FG000|Overall Study|Withdrawal by Subject|1|||
130747747|NCT02418949|470697039|FG001|Overall Study|Withdrawal by Subject|0|||
130747748|NCT02418949|470697040|FG002|Overall Study|Withdrawal by Subject|1|||
130747749|NCT02418949|470697041|FG003|Overall Study|Withdrawal by Subject|1|||
130747750|NCT02418949|470697038|FG000|Overall Study|Lost to Follow-up|1|||
130747751|NCT02418949|470697039|FG001|Overall Study|Lost to Follow-up|0|||
130747752|NCT02418949|470697040|FG002|Overall Study|Lost to Follow-up|1|||
130747753|NCT02418949|470697041|FG003|Overall Study|Lost to Follow-up|0|||
130747754|NCT02418949|470697038|FG000|Overall Study|Physician Decision|1|||
130747755|NCT02418949|470697039|FG001|Overall Study|Physician Decision|1|||
130747756|NCT02418949|470697040|FG002|Overall Study|Physician Decision|1|||
130747757|NCT02418949|470697041|FG003|Overall Study|Physician Decision|0|||
130747758|NCT03926117|470697042|FG000|Overall Study|Unclassified|1|||
130747759|NCT03926117|470697043|FG001|Overall Study|Unclassified|4|||
130747760|NCT03926117|470697044|FG002|Overall Study|Unclassified|1|||
130747761|NCT03926117|470697045|FG003|Overall Study|Unclassified|4|||
130747762|NCT03926117|470697042|FG000|Overall Study|Withdrawal by Subject|3|||
130747763|NCT03926117|470697043|FG001|Overall Study|Withdrawal by Subject|0|||
130747764|NCT03926117|470697044|FG002|Overall Study|Withdrawal by Subject|1|||
130747765|NCT03926117|470697045|FG003|Overall Study|Withdrawal by Subject|1|||
130747766|NCT03926117|470697042|FG000|Overall Study|Lost to Follow-up|0|||
130747767|NCT03926117|470697043|FG001|Overall Study|Lost to Follow-up|2|||
130747768|NCT03926117|470697044|FG002|Overall Study|Lost to Follow-up|1|||
130747769|NCT03926117|470697045|FG003|Overall Study|Lost to Follow-up|0|||
130747770|NCT03926117|470697042|FG000|Overall Study|Adverse Event|1|||
130747771|NCT03926117|470697043|FG001|Overall Study|Adverse Event|2|||
130747772|NCT03926117|470697044|FG002|Overall Study|Adverse Event|3|||
130747773|NCT03926117|470697045|FG003|Overall Study|Adverse Event|1|||
130747774|NCT03926117|470697042|FG000|Overall Study|Randomized but not treated|1|||
130747775|NCT03926117|470697043|FG001|Overall Study|Randomized but not treated|1|||
130747776|NCT03926117|470697044|FG002|Overall Study|Randomized but not treated|0|||
130747777|NCT03926117|470697045|FG003|Overall Study|Randomized but not treated|1|||
130747778|NCT04526288|470697048|FG000|Overall Study|Disease Progression|1|||
130747779|NCT04526288|470697049|FG001|Overall Study|Disease Progression|0|||
130747780|NCT02684097|470697052|FG000|Overall Study|Lack of Efficacy|13|||
130747781|NCT02684097|470697053|FG001|Overall Study|Lack of Efficacy|6|||
130747782|NCT00460811|470697054|FG000|Overall Study|Adverse Event|4|||
130747783|NCT00460811|470697055|FG001|Overall Study|Adverse Event|6|||
130747784|NCT00460811|470697056|FG002|Overall Study|Adverse Event|3|||
130747785|NCT00460811|470697057|FG003|Overall Study|Adverse Event|10|||
130747786|NCT00460811|470697058|FG004|Overall Study|Adverse Event|2|||
130747787|NCT00460811|470697054|FG000|Overall Study|Noncompliance|1|||
130747788|NCT00460811|470697055|FG001|Overall Study|Noncompliance|0|||
130747789|NCT00460811|470697056|FG002|Overall Study|Noncompliance|0|||
130747790|NCT00460811|470697057|FG003|Overall Study|Noncompliance|2|||
130747791|NCT00460811|470697058|FG004|Overall Study|Noncompliance|1|||
130747792|NCT00460811|470697054|FG000|Overall Study|Withdrawal by Subject|7|||
130747793|NCT00460811|470697055|FG001|Overall Study|Withdrawal by Subject|7|||
130747794|NCT00460811|470697056|FG002|Overall Study|Withdrawal by Subject|6|||
130747795|NCT00460811|470697057|FG003|Overall Study|Withdrawal by Subject|3|||
130747796|NCT00460811|470697058|FG004|Overall Study|Withdrawal by Subject|11|||
130747797|NCT00460811|470697054|FG000|Overall Study|Physician Decision|1|||
130747798|NCT00460811|470697055|FG001|Overall Study|Physician Decision|0|||
130747799|NCT00460811|470697056|FG002|Overall Study|Physician Decision|0|||
130747800|NCT00460811|470697057|FG003|Overall Study|Physician Decision|0|||
130747801|NCT00460811|470697058|FG004|Overall Study|Physician Decision|0|||
130747802|NCT00460811|470697054|FG000|Overall Study|Lost to Follow-up|3|||
130747803|NCT00460811|470697055|FG001|Overall Study|Lost to Follow-up|2|||
130747804|NCT00460811|470697056|FG002|Overall Study|Lost to Follow-up|5|||
130747805|NCT00460811|470697057|FG003|Overall Study|Lost to Follow-up|3|||
130747806|NCT00460811|470697058|FG004|Overall Study|Lost to Follow-up|6|||
130747807|NCT02748356|470697059|FG000|Overall Study|Withdrawal by Subject|1|||
130747808|NCT00237458|470697060|FG000|Overall Study|Lack of Efficacy|1|||
130747809|NCT00237458|470697060|FG000|Overall Study|Adverse Event|1|||
130747810|NCT00237458|470697060|FG000|Overall Study|Withdrawal by Subject|1|||
130747811|NCT00952068|470697061|FG000|Overall Study|Adverse Event|3|||
130747812|NCT00952068|470697061|FG000|Overall Study|Withdrawal by Subject|4|||
130747813|NCT05870371|470697062|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
130747814|NCT05870371|470697063|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
130747815|NCT02062450|470697067|FG000|Overall Study|No follow-up visit|124|||
130747816|NCT02907177|470697070|FG000|Overall Study|Death|0|||
130747817|NCT02907177|470697071|FG001|Overall Study|Death|1|||
130747818|NCT02907177|470697070|FG000|Overall Study|Physician Decision|3|||
130747819|NCT02907177|470697071|FG001|Overall Study|Physician Decision|3|||
130747820|NCT02907177|470697070|FG000|Overall Study|Withdrawal by Subject|15|||
130747821|NCT02907177|470697071|FG001|Overall Study|Withdrawal by Subject|7|||
130747822|NCT02907177|470697070|FG000|Overall Study|Sponsor's Decision|50|||
130747823|NCT02907177|470697071|FG001|Overall Study|Sponsor's Decision|57|||
130747824|NCT01537042|470697077|FG000|Overall Study|Adverse Event|0|||
130747825|NCT01537042|470697078|FG001|Overall Study|Adverse Event|2|||
130747826|NCT01537042|470697077|FG000|Overall Study|Lack of Efficacy|0|||
130747827|NCT01537042|470697078|FG001|Overall Study|Lack of Efficacy|1|||
130747828|NCT01537042|470697077|FG000|Overall Study|Protocol Violation|0|||
130747829|NCT01537042|470697078|FG001|Overall Study|Protocol Violation|1|||
130747830|NCT01537042|470697077|FG000|Overall Study|Other|0|||
130747831|NCT01537042|470697078|FG001|Overall Study|Other|1|||
130747832|NCT03379727|470697079|FG000|Overall Study|Lack of Efficacy|73|||
130747833|NCT03379727|470697079|FG000|Overall Study|Adverse Event|32|||
130747834|NCT03379727|470697079|FG000|Overall Study|Death|18|||
130747835|NCT03379727|470697079|FG000|Overall Study|Patient/guardian decision|17|||
130747836|NCT03379727|470697079|FG000|Overall Study|Physician Decision|104|||
130747837|NCT03379727|470697079|FG000|Overall Study|Protocol Violation|4|||
130747838|NCT03379727|470697079|FG000|Overall Study|Lost to Follow-up|1|||
130747839|NCT02151851|470698794|FG000|Overall Study|Lack of Efficacy|67|||
130747840|NCT02151851|470698795|FG001|Overall Study|Lack of Efficacy|94|||
130747841|NCT02151851|470698794|FG000|Overall Study|Protocol Violation|0|||
130747842|NCT02151851|470698795|FG001|Overall Study|Protocol Violation|1|||
130747843|NCT02151851|470698794|FG000|Overall Study|Withdrawal by Subject|2|||
130747844|NCT02151851|470698795|FG001|Overall Study|Withdrawal by Subject|5|||
130747845|NCT02151851|470698794|FG000|Overall Study|Medical impairment|1|||
130747846|NCT02151851|470698795|FG001|Overall Study|Medical impairment|0|||
130747847|NCT02151851|470698794|FG000|Overall Study|Low compliance to study visits|0|||
130747848|NCT02151851|470698795|FG001|Overall Study|Low compliance to study visits|1|||
130747849|NCT02151851|470698794|FG000|Overall Study|Subject entered into study in error|0|||
130747850|NCT02151851|470698795|FG001|Overall Study|Subject entered into study in error|1|||
130747851|NCT02151851|470698794|FG000|Overall Study|Adverse Event|6|||
130747852|NCT02151851|470698795|FG001|Overall Study|Adverse Event|28|||
130747853|NCT01540487|470698796|FG000|Overall Study|Protocol Violation|1|||
130747854|NCT01540487|470698797|FG001|Overall Study|Protocol Violation|0|||
130747855|NCT03503370|470698800|FG000|Overall Study|Death|3|||
130747856|NCT03503370|470698801|FG001|Overall Study|Death|1|||
130747857|NCT00298272|470698806|FG000|Double-blind Phase|Adverse Event|2|||
130747858|NCT00298272|470698807|FG001|Double-blind Phase|Adverse Event|0|||
130747859|NCT00298272|470698806|FG000|Double-blind Phase|Failure to Return|2|||
130747860|NCT00298272|470698807|FG001|Double-blind Phase|Failure to Return|0|||
130747861|NCT00298272|470698806|FG000|Double-blind Phase|Protocol Violation|2|||
130747862|NCT00298272|470698807|FG001|Double-blind Phase|Protocol Violation|0|||
130747863|NCT00298272|470698806|FG000|Double-blind Phase|Withdrawal by Subject|2|||
130747864|NCT00298272|470698807|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130747865|NCT00298272|470698806|FG000|Open Label Retreatment Phase|Adverse Event|1|||
130747866|NCT00298272|470698807|FG001|Open Label Retreatment Phase|Adverse Event|2|||
130747867|NCT00298272|470698806|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
130747868|NCT00298272|470698807|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
130747869|NCT00298272|470698806|FG000|Open Label Retreatment Phase|Failure to Return|1|||
130747870|NCT00298272|470698807|FG001|Open Label Retreatment Phase|Failure to Return|0|||
130747871|NCT00298272|470698806|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
130747872|NCT00298272|470698807|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
130747873|NCT00298272|470698806|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
130747874|NCT00298272|470698807|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
130747875|NCT00298272|470698806|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
130747876|NCT00298272|470698807|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
130747877|NCT00298272|470698806|FG000|Safety Follow-up Phase|Failure to Return|1|||
130747878|NCT00298272|470698807|FG001|Safety Follow-up Phase|Failure to Return|1|||
130747879|NCT00298272|470698806|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
130747880|NCT00298272|470698807|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
130747881|NCT00298272|470698806|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
130747882|NCT00298272|470698807|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
130747883|NCT04168112|470698808|FG000|Overall Study|Lost to Follow-up|1|||
130747884|NCT04168112|470698809|FG001|Overall Study|Lost to Follow-up|0|||
130747885|NCT04168112|470698808|FG000|Overall Study|Withdrawal by Subject|1|||
130747886|NCT04168112|470698809|FG001|Overall Study|Withdrawal by Subject|0|||
130747887|NCT05253573|470698812|FG000|Overall Study|Death|1|||
130747888|NCT05253573|470698813|FG001|Overall Study|Death|0|||
130747889|NCT01436370|470698814|FG000|Overall Study|Lost to Follow-up|0|||
130747890|NCT01436370|470698815|FG001|Overall Study|Lost to Follow-up|0|||
130747891|NCT01436370|470698816|FG002|Overall Study|Lost to Follow-up|0|||
130747892|NCT01436370|470698817|FG003|Overall Study|Lost to Follow-up|0|||
130747893|NCT01436370|470698818|FG004|Overall Study|Lost to Follow-up|1|||
130747894|NCT01436370|470698819|FG005|Overall Study|Lost to Follow-up|0|||
130747895|NCT01436370|470698820|FG006|Overall Study|Lost to Follow-up|0|||
130747896|NCT01436370|470698821|FG007|Overall Study|Lost to Follow-up|0|||
130747897|NCT02395848|470698822|FG000|Overall Study|Lost to Follow-up|2|||
130747898|NCT01754129|470698823|FG000|Overall Study|Death|13|||
130747899|NCT01754129|470698823|FG000|Overall Study|Duodopa discontinuation|9|||
130747900|NCT01754129|470698823|FG000|Overall Study|Lost to Follow-up|7|||
130747901|NCT01754129|470698823|FG000|Overall Study|Withdrew consent|1|||
130747902|NCT01754129|470698823|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
130747903|NCT02276560|470698824|FG000|Overall Study|Adverse Event|1|||
130747904|NCT02276560|470698825|FG001|Overall Study|Adverse Event|0|||
130747905|NCT02276560|470698826|FG002|Overall Study|Adverse Event|0|||
130747906|NCT02126579|470698828|FG000|Overall Study|disease progression|0|||
130747907|NCT02126579|470698829|FG001|Overall Study|disease progression|0|||
130747908|NCT02126579|470698830|FG002|Overall Study|disease progression|0|||
130747909|NCT02126579|470698831|FG003|Overall Study|disease progression|1|||
130747910|NCT02126579|470698832|FG004|Overall Study|disease progression|0|||
130747911|NCT02126579|470698833|FG005|Overall Study|disease progression|0|||
130747912|NCT02126579|470698834|FG006|Overall Study|disease progression|1|||
130747913|NCT01780038|470698838|FG000|Overall Study|Lost to Follow-up|4|||
130747914|NCT01780038|470698839|FG001|Overall Study|Lost to Follow-up|1|||
130747915|NCT02609607|470698845|FG000|Overall Study|Lost to Follow-up|0|||
130747916|NCT02609607|470698846|FG001|Overall Study|Lost to Follow-up|1|||
130747917|NCT03168711|470698849|FG000|Overall Study|Adverse Event|2|||
130747918|NCT03168711|470698850|FG001|Overall Study|Adverse Event|0|||
130747919|NCT03168711|470698849|FG000|Overall Study|Withdrawal by Subject|0|||
130747920|NCT03168711|470698850|FG001|Overall Study|Withdrawal by Subject|1|||
130747921|NCT03168711|470698849|FG000|Overall Study|Death|0|||
130747922|NCT03168711|470698850|FG001|Overall Study|Death|1|||
130747923|NCT02877004|470698857|FG000|Overall Study|Pregnancy|0|||
130747924|NCT02877004|470698858|FG001|Overall Study|Pregnancy|0|||
130747925|NCT02877004|470698859|FG002|Overall Study|Pregnancy|1|||
130747926|NCT02633293|470698860|FG000|Overall Study|Death|56|||
130747927|NCT02633293|470698860|FG000|Overall Study|Progressive Disease|12|||
130747928|NCT02633293|470698860|FG000|Overall Study|Adverse Event|29|||
130747929|NCT02633293|470698860|FG000|Overall Study|Withdrawal by Subject|41|||
130747930|NCT02633293|470698860|FG000|Overall Study|Protocol Violation|1|||
130747931|NCT02633293|470698860|FG000|Overall Study|Lost to Follow-up|1|||
130747932|NCT02633293|470698860|FG000|Overall Study|Study Terminated by Sponsor|24|||
130747933|NCT02633293|470698860|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
130747934|NCT02633293|470698860|FG000|Overall Study|Lung Transplant|5|||
130747935|NCT02633293|470698860|FG000|Overall Study|Lack of Efficacy|2|||
130747936|NCT02633293|470698860|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
130747937|NCT00778817|470698861|FG000|Overall Study|Adverse Event|2|||
130747938|NCT00778817|470698861|FG000|Overall Study|Withdrawal by Subject|2|||
130747939|NCT02356588|470698862|FG000|Overall Study|Lack of Efficacy|4|||
130747940|NCT02356588|470698863|FG001|Overall Study|Lack of Efficacy|10|||
130747941|NCT02356588|470698862|FG000|Overall Study|Adverse Event|0|||
130747942|NCT02356588|470698863|FG001|Overall Study|Adverse Event|2|||
130747943|NCT02356588|470698862|FG000|Overall Study|Withdrawal by Subject|1|||
130747944|NCT02356588|470698863|FG001|Overall Study|Withdrawal by Subject|0|||
130747945|NCT02356588|470698862|FG000|Overall Study|Protocol Violation|0|||
130747946|NCT02356588|470698863|FG001|Overall Study|Protocol Violation|1|||
130747947|NCT01418378|470698864|FG000|Overall Study|Death|1|||
130747948|NCT01418378|470698865|FG001|Overall Study|Death|2|||
130747949|NCT01418378|470698864|FG000|Overall Study|Physician Decision|0|||
130747950|NCT01418378|470698865|FG001|Overall Study|Physician Decision|1|||
130747951|NCT01418378|470698864|FG000|Overall Study|ligament imbalance|0|||
130747952|NCT01418378|470698865|FG001|Overall Study|ligament imbalance|1|||
130747953|NCT01418378|470698864|FG000|Overall Study|developed chronic myopathy|0|||
130747954|NCT01418378|470698865|FG001|Overall Study|developed chronic myopathy|1|||
130747955|NCT01790984|470698866|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
130747956|NCT01790984|470698867|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
130747957|NCT01790984|470698868|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
130747958|NCT01790984|470698869|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
130747959|NCT01051791|470698876|FG000|Overall Study|Failed screening|3|||
130747960|NCT01051791|470698876|FG000|Overall Study|Withdrawal by Subject|1|||
130747961|NCT01081769|470698877|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
130747962|NCT01081769|470698878|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
130747963|NCT01081769|470698877|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
130747964|NCT01081769|470698878|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
130747965|NCT01081769|470698877|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
130747966|NCT01081769|470698878|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
130747967|NCT01081769|470698877|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
130747968|NCT01081769|470698878|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
130747969|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Adverse Event|14|||
130747970|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Adverse Event|11|||
130747971|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Death|1|||
130747972|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Death|1|||
130747973|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
130747974|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
130747975|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
130747976|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
130747977|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Pregnancy|1|||
130747978|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Pregnancy|0|||
130747979|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
130747980|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
130747981|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
130747982|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
130747983|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Other|0|||
130747984|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Other|1|||
130747985|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Ineligibility|3|||
130747986|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Ineligibility|4|||
130747987|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
130747988|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
130747989|NCT01081769|470698877|FG000|CORE Intent-To-Treat|Patient Moved|2|||
130747990|NCT01081769|470698878|FG001|CORE Intent-To-Treat|Patient Moved|2|||
130747991|NCT00507455|470698879|FG000|Overall Study|Adverse Event|3|||
130747992|NCT00507455|470698880|FG001|Overall Study|Adverse Event|3|||
130747993|NCT00507455|470698881|FG002|Overall Study|Adverse Event|6|||
130747994|NCT00507455|470698879|FG000|Overall Study|Withdrawal by Subject|2|||
130747995|NCT00507455|470698880|FG001|Overall Study|Withdrawal by Subject|1|||
130747996|NCT00507455|470698881|FG002|Overall Study|Withdrawal by Subject|2|||
130747997|NCT00507455|470698879|FG000|Overall Study|Protocol Violation|4|||
130747998|NCT00507455|470698880|FG001|Overall Study|Protocol Violation|1|||
130747999|NCT00507455|470698881|FG002|Overall Study|Protocol Violation|1|||
130748000|NCT00507455|470698879|FG000|Overall Study|Lost to Follow-up|2|||
130748001|NCT00507455|470698880|FG001|Overall Study|Lost to Follow-up|0|||
130748002|NCT00507455|470698881|FG002|Overall Study|Lost to Follow-up|2|||
130748003|NCT00507455|470698879|FG000|Overall Study|Lack of Efficacy|0|||
130748004|NCT00507455|470698880|FG001|Overall Study|Lack of Efficacy|1|||
130748005|NCT00507455|470698881|FG002|Overall Study|Lack of Efficacy|0|||
130748006|NCT00507455|470698879|FG000|Overall Study|Other - miscellaneous reason|1|||
130748007|NCT00507455|470698880|FG001|Overall Study|Other - miscellaneous reason|0|||
130748008|NCT00507455|470698881|FG002|Overall Study|Other - miscellaneous reason|1|||
130748009|NCT01737710|470698882|FG000|Overall Study|Lost to Follow-up|0|||
130748010|NCT01737710|470698883|FG001|Overall Study|Lost to Follow-up|2|||
130748011|NCT01737710|470698884|FG002|Overall Study|Lost to Follow-up|2|||
130748012|NCT01737710|470698885|FG003|Overall Study|Lost to Follow-up|0|||
130748013|NCT01737710|470698886|FG004|Overall Study|Lost to Follow-up|0|||
130748014|NCT01737710|470698882|FG000|Overall Study|Withdrawal by Subject|1|||
130748015|NCT01737710|470698883|FG001|Overall Study|Withdrawal by Subject|1|||
130748016|NCT01737710|470698884|FG002|Overall Study|Withdrawal by Subject|1|||
130748017|NCT01737710|470698885|FG003|Overall Study|Withdrawal by Subject|0|||
130748018|NCT01737710|470698886|FG004|Overall Study|Withdrawal by Subject|0|||
130748019|NCT01737710|470698882|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
130748020|NCT01737710|470698883|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
130748021|NCT01737710|470698884|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
130748022|NCT01737710|470698885|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
130748023|NCT01737710|470698886|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
130748024|NCT03363776|470698887|FG000|Overall Study|Progressive disease|2|||
130748025|NCT03363776|470698888|FG001|Overall Study|Progressive disease|3|||
130748026|NCT03363776|470698889|FG002|Overall Study|Progressive disease|1|||
130748027|NCT03363776|470698887|FG000|Overall Study|Study drug toxicity|0|||
130748028|NCT03363776|470698888|FG001|Overall Study|Study drug toxicity|0|||
130748029|NCT03363776|470698889|FG002|Overall Study|Study drug toxicity|1|||
130748030|NCT03363776|470698887|FG000|Overall Study|Death|1|||
130748031|NCT03363776|470698888|FG001|Overall Study|Death|0|||
130748032|NCT03363776|470698889|FG002|Overall Study|Death|0|||
130748033|NCT00410813|470698890|FG000|Overall Study|Adverse Event|6|||
130748034|NCT00410813|470698891|FG001|Overall Study|Adverse Event|11|||
130748035|NCT00410813|470698890|FG000|Overall Study|Progression|32|||
130748036|NCT00410813|470698891|FG001|Overall Study|Progression|21|||
130748037|NCT00410813|470698890|FG000|Overall Study|Not protocol specified|3|||
130748038|NCT00410813|470698891|FG001|Overall Study|Not protocol specified|4|||
130748039|NCT00410813|470698890|FG000|Overall Study|Ineligible|2|||
130748040|NCT00410813|470698891|FG001|Overall Study|Ineligible|4|||
130748041|NCT00410813|470698890|FG000|Overall Study|Death|0|||
130748042|NCT00410813|470698891|FG001|Overall Study|Death|2|||
130748043|NCT00812981|470698892|FG000|Overall Study|Other|0|||
130748044|NCT00812981|470698893|FG001|Overall Study|Other|1|||
130748045|NCT02199795|470698894|FG000|Overall Study|no longer met inclusion criteria|1|||
130748046|NCT02199795|470698895|FG001|Overall Study|no longer met inclusion criteria|0|||
130748047|NCT02199795|470698894|FG000|Overall Study|withdrew due to shoulder pain|1|||
130748048|NCT02199795|470698895|FG001|Overall Study|withdrew due to shoulder pain|0|||
130748049|NCT01791894|470698897|FG000|Overall Study|Adverse Event|1|||
130748050|NCT00996125|470698899|FG000|Overall Study|Adverse Event|0|||
130748051|NCT00996125|470698900|FG001|Overall Study|Adverse Event|2|||
130748052|NCT00996125|470698899|FG000|Overall Study|Lost to Follow-up|1|||
130748053|NCT00996125|470698900|FG001|Overall Study|Lost to Follow-up|6|||
130748054|NCT00996125|470698899|FG000|Overall Study|Withdrawal by Subject|4|||
130748055|NCT00996125|470698900|FG001|Overall Study|Withdrawal by Subject|3|||
130748056|NCT04331067|470698901|FG000|Overall Study|Adverse Event|1|||
130788549|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
130788550|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
130788551|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
130748057|NCT04331067|470698902|FG001|Overall Study|Adverse Event|3|||
130748058|NCT04331067|470698903|FG002|Overall Study|Adverse Event|1|||
130748059|NCT04331067|470698901|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
130748060|NCT04331067|470698902|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
130748061|NCT04331067|470698903|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
130748062|NCT02203721|470698904|FG000|Overall Study|Lost to Follow-up|1|||
130748063|NCT02203721|470698905|FG001|Overall Study|Lost to Follow-up|0|||
130748064|NCT02203721|470698904|FG000|Overall Study|Death|0|||
130748065|NCT02203721|470698905|FG001|Overall Study|Death|2|||
130748066|NCT02203721|470698904|FG000|Overall Study|Illness|0|||
130748067|NCT02203721|470698905|FG001|Overall Study|Illness|1|||
130748068|NCT00708461|470698910|FG000|Overall Study|Lost to Follow-up|18|||
130748069|NCT00708461|470698911|FG001|Overall Study|Lost to Follow-up|11|||
130748070|NCT00708461|470698910|FG000|Overall Study|Withdrawal by Subject|8|||
130748071|NCT00708461|470698911|FG001|Overall Study|Withdrawal by Subject|9|||
130748072|NCT00708461|470698910|FG000|Overall Study|left workforce|115|||
130748073|NCT00708461|470698911|FG001|Overall Study|left workforce|180|||
130748074|NCT01796392|470698912|FG000|Overall Study|Withdrawal by Subject|2|||
130748075|NCT01796392|470698913|FG001|Overall Study|Withdrawal by Subject|0|||
130748076|NCT01796392|470698912|FG000|Overall Study|Death|5|||
130748077|NCT01796392|470698913|FG001|Overall Study|Death|1|||
130748078|NCT01796392|470698912|FG000|Overall Study|Excluded for medical reasons|1|||
130748079|NCT01796392|470698913|FG001|Overall Study|Excluded for medical reasons|2|||
130748080|NCT01796392|470698912|FG000|Overall Study|Lost to Follow-up|1|||
130748081|NCT01796392|470698913|FG001|Overall Study|Lost to Follow-up|0|||
130748082|NCT03517540|470698916|FG000|Overall Study|Protocol Violation|2|||
130748083|NCT03517540|470698917|FG001|Overall Study|Protocol Violation|0|||
130748084|NCT03517540|470698918|FG002|Overall Study|Protocol Violation|0|||
130748085|NCT03517540|470698919|FG003|Overall Study|Protocol Violation|1|||
130748086|NCT03517540|470698916|FG000|Overall Study|Adverse Event|9|||
130748087|NCT03517540|470698917|FG001|Overall Study|Adverse Event|3|||
130748088|NCT03517540|470698918|FG002|Overall Study|Adverse Event|8|||
130748089|NCT03517540|470698919|FG003|Overall Study|Adverse Event|1|||
130748090|NCT03517540|470698916|FG000|Overall Study|Withdrawal by Subject|3|||
130748091|NCT03517540|470698917|FG001|Overall Study|Withdrawal by Subject|4|||
130748092|NCT03517540|470698918|FG002|Overall Study|Withdrawal by Subject|1|||
130748093|NCT03517540|470698919|FG003|Overall Study|Withdrawal by Subject|3|||
130748094|NCT01779440|470698922|FG000|Overall Study|Withdrawal by Subject|3|||
130748095|NCT01779440|470698923|FG001|Overall Study|Withdrawal by Subject|5|||
130748096|NCT01205269|470698924|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130748097|NCT01205269|470698925|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130748098|NCT01205269|470698926|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130748099|NCT01205269|470698927|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
130748100|NCT01205269|470698928|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130748101|NCT01205269|470698929|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130748102|NCT01408303|470698930|FG000|Overall Study|Adverse Event|3|||
130748103|NCT01408303|470698931|FG001|Overall Study|Adverse Event|7|||
130748104|NCT01408303|470698932|FG002|Overall Study|Adverse Event|2|||
130748105|NCT01408303|470698930|FG000|Overall Study|Lost to Follow-up|0|||
130748106|NCT01408303|470698931|FG001|Overall Study|Lost to Follow-up|1|||
130748107|NCT01408303|470698932|FG002|Overall Study|Lost to Follow-up|2|||
130748108|NCT01408303|470698930|FG000|Overall Study|Withdrawal by Subject|2|||
130748109|NCT01408303|470698931|FG001|Overall Study|Withdrawal by Subject|3|||
130748110|NCT01408303|470698932|FG002|Overall Study|Withdrawal by Subject|1|||
130748111|NCT01408303|470698930|FG000|Overall Study|Protocol Violation|0|||
130748112|NCT01408303|470698931|FG001|Overall Study|Protocol Violation|1|||
130748113|NCT01408303|470698932|FG002|Overall Study|Protocol Violation|0|||
130748114|NCT01408303|470698930|FG000|Overall Study|Noncompliance|1|||
130748115|NCT01408303|470698931|FG001|Overall Study|Noncompliance|0|||
130748116|NCT01408303|470698932|FG002|Overall Study|Noncompliance|1|||
130748117|NCT01207687|470698933|FG000|Overall Study|Adverse Event|1|||
130748118|NCT01207687|470698933|FG000|Overall Study|Withdrawal by Subject|1|||
130748119|NCT01486446|470698934|FG000|Overall Study|Adverse Event|1|||
130748120|NCT01486446|470698935|FG001|Overall Study|Adverse Event|0|||
130748121|NCT00523848|470698936|FG000|Overall Study|Adverse Event|11|||
130748122|NCT00523848|470698936|FG000|Overall Study|Withdrawal by Subject|2|||
130748123|NCT00523848|470698936|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
130748124|NCT00523848|470698936|FG000|Overall Study|Disease Progression|5|||
130748125|NCT00523848|470698936|FG000|Overall Study|Other, unspecified|4|||
130748126|NCT01801865|470698937|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
130748127|NCT01801865|470698937|FG000|Overall Study|Physician Decision|7|||
130748128|NCT01367886|470698940|FG000|Overall Study|Lost to Follow-up|4|||
130748129|NCT01367886|470698940|FG000|Overall Study|Lack of Efficacy|2|||
130748130|NCT01367886|470698940|FG000|Overall Study|Death|1|||
130748131|NCT00985504|470698945|FG000|Acute Treatment Period|Adverse Event|3|||
130748132|NCT00985504|470698946|FG001|Acute Treatment Period|Adverse Event|4|||
130748133|NCT00985504|470698945|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
130748134|NCT00985504|470698946|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
130748135|NCT00985504|470698945|FG000|Acute Treatment Period|Protocol Violation|2|||
130748136|NCT00985504|470698946|FG001|Acute Treatment Period|Protocol Violation|0|||
130748137|NCT00985504|470698945|FG000|Acute Treatment Period|Sponsor Decision|0|||
130748138|NCT00985504|470698946|FG001|Acute Treatment Period|Sponsor Decision|1|||
130748139|NCT00985504|470698945|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
130748140|NCT00985504|470698946|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
130748141|NCT00985504|470698945|FG000|Optimization Period|Adverse Event|7|||
130748142|NCT00985504|470698946|FG001|Optimization Period|Adverse Event|9|||
130788552|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
130788553|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
130788554|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
130788555|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130788556|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130788557|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130788558|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130788559|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
130788560|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130788561|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130788562|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130788563|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130788564|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130788565|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
130788566|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130788567|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130748143|NCT00985504|470698945|FG000|Optimization Period|Death|0|||
130748144|NCT00985504|470698946|FG001|Optimization Period|Death|1|||
130748145|NCT00985504|470698945|FG000|Optimization Period|Lack of Efficacy|5|||
130748146|NCT00985504|470698946|FG001|Optimization Period|Lack of Efficacy|3|||
130748147|NCT00985504|470698945|FG000|Optimization Period|Lost to Follow-up|0|||
130748148|NCT00985504|470698946|FG001|Optimization Period|Lost to Follow-up|1|||
130748149|NCT00985504|470698945|FG000|Optimization Period|Physician Decision|1|||
130748150|NCT00985504|470698946|FG001|Optimization Period|Physician Decision|0|||
130748151|NCT00985504|470698945|FG000|Optimization Period|Protocol Violation|3|||
130748152|NCT00985504|470698946|FG001|Optimization Period|Protocol Violation|1|||
130748153|NCT00985504|470698945|FG000|Optimization Period|Withdrawal by Subject|10|||
130748154|NCT00985504|470698946|FG001|Optimization Period|Withdrawal by Subject|8|||
130748155|NCT03711786|470698947|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
130748156|NCT03711786|470698948|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
130748157|NCT03711786|470698947|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
130748158|NCT03711786|470698948|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
130748159|NCT03711786|470698947|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
130748160|NCT03711786|470698948|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
130748161|NCT03711786|470698947|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
130748162|NCT03711786|470698948|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
130748163|NCT03711786|470698947|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
130748164|NCT03711786|470698948|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
130748165|NCT03711786|470698947|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
130748166|NCT03711786|470698948|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
130748167|NCT04031846|470698952|FG000|Overall Study|Lost to Follow-up|4|||
130748168|NCT04031846|470698953|FG001|Overall Study|Lost to Follow-up|4|||
130748169|NCT04031846|470698952|FG000|Overall Study|Physician Decision|0|||
130748170|NCT04031846|470698953|FG001|Overall Study|Physician Decision|1|||
130748171|NCT04031846|470698952|FG000|Overall Study|Protocol Violation|1|||
130748172|NCT04031846|470698953|FG001|Overall Study|Protocol Violation|1|||
130748173|NCT04031846|470698952|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
130748174|NCT04031846|470698953|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
130748175|NCT06868654|470698954|FG000|Overall Study|Death|4|||
130748176|NCT06868654|470698955|FG001|Overall Study|Death|14|||
130748177|NCT06868654|470698954|FG000|Overall Study|Lost to Follow-up|0|||
130748178|NCT06868654|470698955|FG001|Overall Study|Lost to Follow-up|1|||
130748179|NCT06868654|470698954|FG000|Overall Study|Withdrawal by Subject|5|||
130748180|NCT06868654|470698955|FG001|Overall Study|Withdrawal by Subject|3|||
130748181|NCT06868654|470698954|FG000|Overall Study|Physician Decision|0|||
130748182|NCT06868654|470698955|FG001|Overall Study|Physician Decision|1|||
130748183|NCT06868654|470698954|FG000|Overall Study|Ongoing|23|||
130748184|NCT06868654|470698955|FG001|Overall Study|Ongoing|21|||
130748185|NCT01777282|470698962|FG000|Overall Study|Persistent Hyperglycemia|0|||
130748186|NCT01777282|470698963|FG001|Overall Study|Persistent Hyperglycemia|0|||
130748187|NCT01777282|470698964|FG002|Overall Study|Persistent Hyperglycemia|1|||
130748188|NCT01777282|470698965|FG003|Overall Study|Persistent Hyperglycemia|0|||
130748189|NCT01777282|470698966|FG004|Overall Study|Persistent Hyperglycemia|0|||
130748190|NCT01777282|470698962|FG000|Overall Study|New Antidiabetic Medication|0|||
130748191|NCT01777282|470698963|FG001|Overall Study|New Antidiabetic Medication|0|||
130748192|NCT01777282|470698964|FG002|Overall Study|New Antidiabetic Medication|1|||
130748193|NCT01777282|470698965|FG003|Overall Study|New Antidiabetic Medication|0|||
130748194|NCT01777282|470698966|FG004|Overall Study|New Antidiabetic Medication|0|||
130748195|NCT01777282|470698962|FG000|Overall Study|Adverse Event|4|||
130748196|NCT01777282|470698963|FG001|Overall Study|Adverse Event|4|||
130748197|NCT01777282|470698964|FG002|Overall Study|Adverse Event|2|||
130748198|NCT01777282|470698965|FG003|Overall Study|Adverse Event|1|||
130748199|NCT01777282|470698966|FG004|Overall Study|Adverse Event|3|||
130748200|NCT01777282|470698962|FG000|Overall Study|Withdrawal by Subject|4|||
130748201|NCT01777282|470698963|FG001|Overall Study|Withdrawal by Subject|0|||
130748202|NCT01777282|470698964|FG002|Overall Study|Withdrawal by Subject|0|||
130788568|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130748203|NCT01777282|470698965|FG003|Overall Study|Withdrawal by Subject|1|||
130748204|NCT01777282|470698966|FG004|Overall Study|Withdrawal by Subject|2|||
130748205|NCT01777282|470698962|FG000|Overall Study|Protocol Violation|2|||
130748206|NCT01777282|470698963|FG001|Overall Study|Protocol Violation|0|||
130748207|NCT01777282|470698964|FG002|Overall Study|Protocol Violation|1|||
130748208|NCT01777282|470698965|FG003|Overall Study|Protocol Violation|0|||
130748209|NCT01777282|470698966|FG004|Overall Study|Protocol Violation|2|||
130748210|NCT01777282|470698962|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
130748211|NCT01777282|470698963|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
130748212|NCT01777282|470698964|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
130788569|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
130748213|NCT01777282|470698965|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
130748214|NCT01777282|470698966|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
130748215|NCT00764660|470698967|FG000|Overall Study|Adverse Event|6|||
130748216|NCT00764660|470698968|FG001|Overall Study|Adverse Event|3|||
130748217|NCT00764660|470698967|FG000|Overall Study|Lost to Follow-up|3|||
130748218|NCT00764660|470698968|FG001|Overall Study|Lost to Follow-up|4|||
130748219|NCT00764660|470698967|FG000|Overall Study|Withdrawal by Subject|7|||
130748220|NCT00764660|470698968|FG001|Overall Study|Withdrawal by Subject|3|||
130748221|NCT00764660|470698967|FG000|Overall Study|Noncompliance With Protocol|5|||
130748222|NCT00764660|470698968|FG001|Overall Study|Noncompliance With Protocol|1|||
130748223|NCT00764660|470698967|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
130748224|NCT00764660|470698968|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
130748225|NCT01131455|470698969|FG000|Overall Study|Death of PI|6|||
130748226|NCT01131455|470698970|FG001|Overall Study|Death of PI|4|||
130748227|NCT01131455|470698971|FG002|Overall Study|Death of PI|0|||
130748228|NCT03103152|470698972|FG000|Overall Study|Physician Decision|5|||
130748229|NCT03103152|470698973|FG001|Overall Study|Physician Decision|2|||
130748230|NCT03103152|470698974|FG002|Overall Study|Physician Decision|6|||
130748231|NCT03103152|470698975|FG003|Overall Study|Physician Decision|3|||
130748232|NCT03103152|470698976|FG004|Overall Study|Physician Decision|3|||
130748233|NCT03103152|470698977|FG005|Overall Study|Physician Decision|1|||
130748234|NCT03103152|470698972|FG000|Overall Study|Protocol Violation|2|||
130788570|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
130788571|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
130788572|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
130788573|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
130788574|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130788575|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
130788576|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130788577|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130788578|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130788579|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
130788580|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130788581|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130788582|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130788583|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130788584|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130788585|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
130788586|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130788587|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130788588|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130748235|NCT03103152|470698973|FG001|Overall Study|Protocol Violation|2|||
130748236|NCT03103152|470698974|FG002|Overall Study|Protocol Violation|1|||
130748237|NCT03103152|470698975|FG003|Overall Study|Protocol Violation|2|||
130748238|NCT03103152|470698976|FG004|Overall Study|Protocol Violation|1|||
130748239|NCT03103152|470698977|FG005|Overall Study|Protocol Violation|1|||
130748240|NCT03103152|470698972|FG000|Overall Study|Inter-current illness|0|||
130748241|NCT03103152|470698973|FG001|Overall Study|Inter-current illness|0|||
130748242|NCT03103152|470698974|FG002|Overall Study|Inter-current illness|1|||
130748243|NCT03103152|470698975|FG003|Overall Study|Inter-current illness|0|||
130788589|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
130788590|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130788591|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130788592|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130788593|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130788594|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130788595|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
130748244|NCT03103152|470698976|FG004|Overall Study|Inter-current illness|0|||
130748245|NCT03103152|470698977|FG005|Overall Study|Inter-current illness|0|||
130748246|NCT03103152|470698972|FG000|Overall Study|Death|0|||
130748247|NCT03103152|470698973|FG001|Overall Study|Death|1|||
130748248|NCT03103152|470698974|FG002|Overall Study|Death|0|||
130748249|NCT03103152|470698975|FG003|Overall Study|Death|0|||
130788596|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130788597|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130748250|NCT03103152|470698976|FG004|Overall Study|Death|0|||
130748251|NCT03103152|470698977|FG005|Overall Study|Death|0|||
130748252|NCT03103152|470698972|FG000|Overall Study|Adverse Event|0|||
130748253|NCT03103152|470698973|FG001|Overall Study|Adverse Event|0|||
130788598|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130748254|NCT03103152|470698974|FG002|Overall Study|Adverse Event|1|||
130748255|NCT03103152|470698975|FG003|Overall Study|Adverse Event|0|||
130748256|NCT03103152|470698976|FG004|Overall Study|Adverse Event|0|||
130748257|NCT03103152|470698977|FG005|Overall Study|Adverse Event|1|||
130748258|NCT03103152|470698972|FG000|Overall Study|Withdrawal by Subject|1|||
130748259|NCT03103152|470698973|FG001|Overall Study|Withdrawal by Subject|0|||
130748260|NCT03103152|470698974|FG002|Overall Study|Withdrawal by Subject|1|||
130748261|NCT03103152|470698975|FG003|Overall Study|Withdrawal by Subject|1|||
130748262|NCT03103152|470698976|FG004|Overall Study|Withdrawal by Subject|1|||
130748263|NCT03103152|470698977|FG005|Overall Study|Withdrawal by Subject|1|||
130748264|NCT03103152|470698972|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
130748265|NCT03103152|470698973|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
130748266|NCT03103152|470698974|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
130748267|NCT03103152|470698975|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
130748268|NCT03103152|470698976|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
130748269|NCT03103152|470698977|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
130748270|NCT03103152|470698972|FG000|Overall Study|Unacceptable side effects|0|||
130748271|NCT03103152|470698973|FG001|Overall Study|Unacceptable side effects|0|||
130748272|NCT03103152|470698974|FG002|Overall Study|Unacceptable side effects|0|||
130748273|NCT03103152|470698975|FG003|Overall Study|Unacceptable side effects|0|||
130748274|NCT03103152|470698976|FG004|Overall Study|Unacceptable side effects|0|||
130748275|NCT03103152|470698977|FG005|Overall Study|Unacceptable side effects|1|||
130748276|NCT03103152|470698972|FG000|Overall Study|Lost to Follow-up|0|||
130748277|NCT03103152|470698973|FG001|Overall Study|Lost to Follow-up|1|||
130748278|NCT03103152|470698974|FG002|Overall Study|Lost to Follow-up|0|||
130748279|NCT03103152|470698975|FG003|Overall Study|Lost to Follow-up|1|||
130748280|NCT03103152|470698976|FG004|Overall Study|Lost to Follow-up|0|||
130748281|NCT03103152|470698977|FG005|Overall Study|Lost to Follow-up|1|||
130748282|NCT03103152|470698972|FG000|Overall Study|Testicular pain|0|||
130748283|NCT03103152|470698973|FG001|Overall Study|Testicular pain|0|||
130748284|NCT03103152|470698974|FG002|Overall Study|Testicular pain|0|||
130748285|NCT03103152|470698975|FG003|Overall Study|Testicular pain|1|||
130748286|NCT03103152|470698976|FG004|Overall Study|Testicular pain|0|||
130748287|NCT03103152|470698977|FG005|Overall Study|Testicular pain|0|||
130748288|NCT03668119|470700364|FG000|Pre-treatment|Disease Progression|1|||
130748289|NCT03668119|470700365|FG001|Pre-treatment|Disease Progression|0|||
130748290|NCT03668119|470700364|FG000|Treatment|Disease Progression|76|||
130748291|NCT03668119|470700365|FG001|Treatment|Disease Progression|57|||
130748292|NCT03668119|470700364|FG000|Treatment|Study drug toxicity|19|||
130748293|NCT03668119|470700365|FG001|Treatment|Study drug toxicity|1|||
130748294|NCT03668119|470700364|FG000|Treatment|Death|3|||
130748295|NCT03668119|470700365|FG001|Treatment|Death|0|||
130748296|NCT03668119|470700364|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
130748297|NCT03668119|470700365|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
130748298|NCT03668119|470700364|FG000|Treatment|Withdrawal by Subject|1|||
130748299|NCT03668119|470700365|FG001|Treatment|Withdrawal by Subject|1|||
130748300|NCT03668119|470700364|FG000|Treatment|Participant request to discontinue study treatment|3|||
130748301|NCT03668119|470700365|FG001|Treatment|Participant request to discontinue study treatment|1|||
130748302|NCT03668119|470700364|FG000|Treatment|Maximum Clinical Benefit|0|||
130748303|NCT03668119|470700365|FG001|Treatment|Maximum Clinical Benefit|1|||
130748304|NCT03668119|470700364|FG000|Treatment|Participants completed treatment|27|||
130748305|NCT03668119|470700365|FG001|Treatment|Participants completed treatment|11|||
130748306|NCT03668119|470700364|FG000|Treatment|Other reasons|2|||
130748307|NCT03668119|470700365|FG001|Treatment|Other reasons|1|||
130748308|NCT05336227|470700366|FG000|Overall Study|Adverse Event|1|||
130748309|NCT05336227|470700367|FG001|Overall Study|Adverse Event|0|||
130748310|NCT05336227|470700366|FG000|Overall Study|Lost to Follow-up|2|||
130748311|NCT05336227|470700367|FG001|Overall Study|Lost to Follow-up|0|||
130748312|NCT05336227|470700366|FG000|Overall Study|Withdrawal by Subject|1|||
130748313|NCT05336227|470700367|FG001|Overall Study|Withdrawal by Subject|0|||
130748314|NCT00684411|470700370|FG000|Overall Study|New Primary Cancer|1|||
130748315|NCT00684411|470700370|FG000|Overall Study|Disease Progression|10|||
130748316|NCT00684411|470700370|FG000|Overall Study|Adverse Event|1|||
130748317|NCT01344824|470700371|FG000|Overall Study|Adverse Event|15|||
130748318|NCT01344824|470700371|FG000|Overall Study|Withdrawal by Subject|6|||
130748319|NCT01344824|470700371|FG000|Overall Study|Other complicating disease|1|||
130748320|NCT01344824|470700371|FG000|Overall Study|Progression|15|||
130748321|NCT01295671|470700374|FG000|Overall Study|Lost to Follow-up|4|||
130748322|NCT01295671|470700375|FG001|Overall Study|Lost to Follow-up|6|||
130748323|NCT01295671|470700376|FG002|Overall Study|Lost to Follow-up|3|||
130748324|NCT01295671|470700374|FG000|Overall Study|Withdrawal by Subject|3|||
130748325|NCT01295671|470700375|FG001|Overall Study|Withdrawal by Subject|1|||
130748326|NCT01295671|470700376|FG002|Overall Study|Withdrawal by Subject|0|||
130748327|NCT02058537|470700377|FG000|Overall Study|Withdrawal by Subject|1|||
130748328|NCT02366637|470700378|FG000|First Intervention Period|Adverse Event|0|||
130748329|NCT02366637|470700379|FG001|First Intervention Period|Adverse Event|1|||
130748330|NCT02366637|470700378|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
130748331|NCT02366637|470700379|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
130748332|NCT02366637|470700378|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
130748333|NCT02366637|470700379|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
130748334|NCT01609010|470700380|FG000|Overall Study|Stable disease (SD)|22|||
130748335|NCT01609010|470700381|FG001|Overall Study|Stable disease (SD)|16|||
130748336|NCT01609010|470700380|FG000|Overall Study|Progressive disease (PD)|8|||
130748337|NCT01609010|470700381|FG001|Overall Study|Progressive disease (PD)|10|||
130748338|NCT01609010|470700380|FG000|Overall Study|Adverse Event|3|||
130748339|NCT01609010|470700381|FG001|Overall Study|Adverse Event|6|||
130748340|NCT01609010|470700380|FG000|Overall Study|Withdrawal by Subject|2|||
130748341|NCT01609010|470700381|FG001|Overall Study|Withdrawal by Subject|2|||
130748342|NCT01609010|470700380|FG000|Overall Study|Other|2|||
130748343|NCT01609010|470700381|FG001|Overall Study|Other|0|||
130748344|NCT01609010|470700380|FG000|Overall Study|Other malignancy|1|||
130748345|NCT01609010|470700381|FG001|Overall Study|Other malignancy|0|||
130748346|NCT01609010|470700380|FG000|Overall Study|Pathology review|2|||
130748347|NCT01609010|470700381|FG001|Overall Study|Pathology review|1|||
130748348|NCT01609010|470700380|FG000|Overall Study|Protocol Violation|1|||
130748349|NCT01609010|470700381|FG001|Overall Study|Protocol Violation|1|||
130748350|NCT01609010|470700380|FG000|Overall Study|New cancer|1|||
130748351|NCT01609010|470700381|FG001|Overall Study|New cancer|0|||
130748352|NCT01609010|470700380|FG000|Overall Study|Lost to Follow-up|1|||
130748353|NCT01609010|470700381|FG001|Overall Study|Lost to Follow-up|1|||
130748354|NCT00651261|470700382|FG000|Overall Study|Adverse Event|32|||
130748355|NCT00651261|470700383|FG001|Overall Study|Adverse Event|22|||
130748356|NCT00651261|470700382|FG000|Overall Study|Death|18|||
130748357|NCT00651261|470700383|FG001|Overall Study|Death|18|||
130748358|NCT00651261|470700382|FG000|Overall Study|Withdrawal by Subject|22|||
130748359|NCT00651261|470700383|FG001|Overall Study|Withdrawal by Subject|40|||
130748360|NCT00651261|470700382|FG000|Overall Study|Induction failure|24|||
130748361|NCT00651261|470700383|FG001|Overall Study|Induction failure|35|||
130748362|NCT00651261|470700382|FG000|Overall Study|Disease progression|58|||
130748363|NCT00651261|470700383|FG001|Overall Study|Disease progression|58|||
130748364|NCT00651261|470700382|FG000|Overall Study|Alternative therapy|109|||
130748365|NCT00651261|470700383|FG001|Overall Study|Alternative therapy|107|||
130748366|NCT00651261|470700382|FG000|Overall Study|Other disease or participant decisions|23|||
130748367|NCT00651261|470700383|FG001|Overall Study|Other disease or participant decisions|23|||
130748368|NCT00651261|470700382|FG000|Overall Study|Never treated|5|||
130748369|NCT00651261|470700383|FG001|Overall Study|Never treated|3|||
130748370|NCT01134107|470700384|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
130748371|NCT01134107|470700385|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
130748372|NCT01134107|470700384|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
130748373|NCT01134107|470700385|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
130748374|NCT01134107|470700384|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
130748375|NCT01134107|470700385|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
130748376|NCT01134107|470700384|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
130748377|NCT01134107|470700385|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
130748378|NCT01134107|470700384|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
130748379|NCT01134107|470700385|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
130748380|NCT01134107|470700384|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
130748381|NCT01134107|470700385|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
130748382|NCT01134107|470700384|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
130748383|NCT01134107|470700385|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
130748384|NCT00687271|470700386|FG000|Overall Study|Adverse Event|1|||
130748385|NCT00687271|470700387|FG001|Overall Study|Adverse Event|3|||
130748386|NCT00687271|470700388|FG002|Overall Study|Adverse Event|1|||
130748387|NCT00687271|470700389|FG003|Overall Study|Adverse Event|0|||
130748388|NCT00687271|470700386|FG000|Overall Study|Lost to Follow-up|0|||
130748389|NCT00687271|470700387|FG001|Overall Study|Lost to Follow-up|1|||
130748390|NCT00687271|470700388|FG002|Overall Study|Lost to Follow-up|0|||
130748391|NCT00687271|470700389|FG003|Overall Study|Lost to Follow-up|0|||
130748392|NCT00687271|470700386|FG000|Overall Study|Protocol Violation|2|||
130748393|NCT00687271|470700387|FG001|Overall Study|Protocol Violation|1|||
130748394|NCT00687271|470700388|FG002|Overall Study|Protocol Violation|1|||
130748395|NCT00687271|470700389|FG003|Overall Study|Protocol Violation|0|||
130748396|NCT00687271|470700386|FG000|Overall Study|Withdrawal by Subject|0|||
130748397|NCT00687271|470700387|FG001|Overall Study|Withdrawal by Subject|1|||
130748398|NCT00687271|470700388|FG002|Overall Study|Withdrawal by Subject|3|||
130748399|NCT00687271|470700389|FG003|Overall Study|Withdrawal by Subject|0|||
130748400|NCT05483686|470700396|FG000|Overall Study|Lost to Follow-up|5|||
130748401|NCT05483686|470700397|FG001|Overall Study|Lost to Follow-up|7|||
130748402|NCT03351608|470700401|FG000|Overall Study|Lost to Follow-up|0|||
130748403|NCT03351608|470700402|FG001|Overall Study|Lost to Follow-up|1|||
130748404|NCT03351608|470700403|FG002|Overall Study|Lost to Follow-up|1|||
130748405|NCT03351608|470700404|FG003|Overall Study|Lost to Follow-up|1|||
130748406|NCT03351608|470700405|FG004|Overall Study|Lost to Follow-up|1|||
130748407|NCT03351608|470700401|FG000|Overall Study|Physician Decision|1|||
130748408|NCT03351608|470700402|FG001|Overall Study|Physician Decision|0|||
130748409|NCT03351608|470700403|FG002|Overall Study|Physician Decision|0|||
130748410|NCT03351608|470700404|FG003|Overall Study|Physician Decision|2|||
130748411|NCT03351608|470700405|FG004|Overall Study|Physician Decision|1|||
130748412|NCT03351608|470700401|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
130748413|NCT03351608|470700402|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
130748414|NCT03351608|470700403|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
130748415|NCT03351608|470700404|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
130748416|NCT03351608|470700405|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
130748417|NCT03351608|470700401|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130788599|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
130788600|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130748418|NCT03351608|470700402|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130748419|NCT03351608|470700403|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130748420|NCT03351608|470700404|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130748421|NCT03351608|470700405|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130748422|NCT03351608|470700401|FG000|Overall Study|Other|0|||
130748423|NCT03351608|470700402|FG001|Overall Study|Other|1|||
130748424|NCT03351608|470700403|FG002|Overall Study|Other|1|||
130748425|NCT03351608|470700404|FG003|Overall Study|Other|3|||
130748426|NCT03351608|470700405|FG004|Overall Study|Other|0|||
130748427|NCT02727478|470700406|FG000|Overall Study|Withdrawal by Subject|8|||
130748428|NCT02727478|470700407|FG001|Overall Study|Withdrawal by Subject|10|||
130748429|NCT00808210|470700411|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
130748430|NCT00808210|470700412|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
130748431|NCT00808210|470700411|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
130748432|NCT00808210|470700412|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
130748433|NCT00808210|470700411|FG000|Double-Blind TX Period|Adverse Event|0|||
130748434|NCT00808210|470700412|FG001|Double-Blind TX Period|Adverse Event|1|||
130748435|NCT00808210|470700411|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
130748436|NCT00808210|470700412|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
130748437|NCT00808210|470700411|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
130748438|NCT00808210|470700412|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
130748439|NCT00808210|470700411|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
130748440|NCT00808210|470700412|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
130748441|NCT03877068|470700413|FG000|Overall Study|Physician Decision|9|||
130748442|NCT03877068|470700414|FG001|Overall Study|Physician Decision|3|||
130748443|NCT03150719|470700417|FG000|Overall Study|Adverse Event|0|||
130748444|NCT03150719|470700418|FG001|Overall Study|Adverse Event|1|||
130748445|NCT03150719|470700417|FG000|Overall Study|Death|0|||
130748446|NCT03150719|470700418|FG001|Overall Study|Death|1|||
130748447|NCT03150719|470700417|FG000|Overall Study|Other|1|||
130748448|NCT03150719|470700418|FG001|Overall Study|Other|0|||
130748449|NCT00288626|470700423|FG000|Overall Study|Death|3|||
130748450|NCT00288626|470700423|FG000|Overall Study|Withdrawal by Subject|4|||
130748451|NCT02019264|470700425|FG000|Overall Study|Not treated|6|||
130748452|NCT02019264|470700426|FG001|Overall Study|Not treated|4|||
130748453|NCT02019264|470700425|FG000|Overall Study|Lost to Follow-up|50|||
130748454|NCT02019264|470700426|FG001|Overall Study|Lost to Follow-up|47|||
130748455|NCT02019264|470700425|FG000|Overall Study|Withdrawal by Subject|142|||
130748456|NCT02019264|470700426|FG001|Overall Study|Withdrawal by Subject|117|||
130748457|NCT02019264|470700425|FG000|Overall Study|Administrative reason|36|||
130748458|NCT02019264|470700426|FG001|Overall Study|Administrative reason|28|||
130748459|NCT02019264|470700425|FG000|Overall Study|Missing|14|||
130748460|NCT02019264|470700426|FG001|Overall Study|Missing|11|||
130748461|NCT02914613|470700427|FG000|Overall Study|Withdrawal by Subject|1|||
130748462|NCT02914613|470700428|FG001|Overall Study|Withdrawal by Subject|2|||
130748463|NCT02914613|470700427|FG000|Overall Study|Adverse Event|1|||
130748464|NCT02914613|470700428|FG001|Overall Study|Adverse Event|0|||
130748465|NCT01964222|470700432|FG000|Overall Study|Lost to Follow-up|7|||
130748466|NCT01964222|470700433|FG001|Overall Study|Lost to Follow-up|5|||
130748467|NCT01964222|470700432|FG000|Overall Study|Withdrawal by Subject|6|||
130748468|NCT01964222|470700433|FG001|Overall Study|Withdrawal by Subject|6|||
130748469|NCT01964222|470700432|FG000|Overall Study|Screening Failure|2|||
130748470|NCT01964222|470700433|FG001|Overall Study|Screening Failure|0|||
130748471|NCT02677922|470700444|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
130748472|NCT02677922|470700445|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
130748473|NCT02677922|470700446|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
130748474|NCT02677922|470700447|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
130748475|NCT02677922|470700448|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
130748476|NCT02677922|470700449|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
130748477|NCT02677922|470700444|FG000|Treatment Period|Adverse Event|0|||
130748478|NCT02677922|470700445|FG001|Treatment Period|Adverse Event|0|||
130748479|NCT02677922|470700446|FG002|Treatment Period|Adverse Event|1|||
130748480|NCT02677922|470700447|FG003|Treatment Period|Adverse Event|3|||
130748481|NCT02677922|470700448|FG004|Treatment Period|Adverse Event|5|||
130748482|NCT02677922|470700449|FG005|Treatment Period|Adverse Event|2|||
130748483|NCT02677922|470700444|FG000|Treatment Period|Progressive Disease|1|||
130748484|NCT02677922|470700445|FG001|Treatment Period|Progressive Disease|1|||
130748485|NCT02677922|470700446|FG002|Treatment Period|Progressive Disease|0|||
130748486|NCT02677922|470700447|FG003|Treatment Period|Progressive Disease|0|||
130748487|NCT02677922|470700448|FG004|Treatment Period|Progressive Disease|8|||
130748488|NCT02677922|470700449|FG005|Treatment Period|Progressive Disease|7|||
130748489|NCT02677922|470700444|FG000|Treatment Period|Lack of Efficacy|0|||
130748490|NCT02677922|470700445|FG001|Treatment Period|Lack of Efficacy|0|||
130748491|NCT02677922|470700446|FG002|Treatment Period|Lack of Efficacy|0|||
130748492|NCT02677922|470700447|FG003|Treatment Period|Lack of Efficacy|1|||
130748493|NCT02677922|470700448|FG004|Treatment Period|Lack of Efficacy|1|||
130748494|NCT02677922|470700449|FG005|Treatment Period|Lack of Efficacy|6|||
130748495|NCT02677922|470700444|FG000|Treatment Period|Withdrawal by Subject|0|||
130748496|NCT02677922|470700445|FG001|Treatment Period|Withdrawal by Subject|0|||
130748497|NCT02677922|470700446|FG002|Treatment Period|Withdrawal by Subject|1|||
130748498|NCT02677922|470700447|FG003|Treatment Period|Withdrawal by Subject|3|||
130748499|NCT02677922|470700448|FG004|Treatment Period|Withdrawal by Subject|5|||
130748500|NCT02677922|470700449|FG005|Treatment Period|Withdrawal by Subject|5|||
130748501|NCT02677922|470700444|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
130748502|NCT02677922|470700445|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
130748503|NCT02677922|470700446|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
130748504|NCT02677922|470700447|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
130748505|NCT02677922|470700448|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
130748506|NCT02677922|470700449|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
130748507|NCT02677922|470700444|FG000|Treatment Period|Disease Relapse|0|||
130748508|NCT02677922|470700445|FG001|Treatment Period|Disease Relapse|0|||
130748509|NCT02677922|470700446|FG002|Treatment Period|Disease Relapse|0|||
130748510|NCT02677922|470700447|FG003|Treatment Period|Disease Relapse|3|||
130748511|NCT02677922|470700448|FG004|Treatment Period|Disease Relapse|6|||
130748512|NCT02677922|470700449|FG005|Treatment Period|Disease Relapse|1|||
130748513|NCT02677922|470700444|FG000|Treatment Period|Allogeneic HSCT|1|||
130748514|NCT02677922|470700445|FG001|Treatment Period|Allogeneic HSCT|0|||
130748515|NCT02677922|470700446|FG002|Treatment Period|Allogeneic HSCT|0|||
130748516|NCT02677922|470700447|FG003|Treatment Period|Allogeneic HSCT|1|||
130748517|NCT02677922|470700448|FG004|Treatment Period|Allogeneic HSCT|4|||
130748518|NCT02677922|470700449|FG005|Treatment Period|Allogeneic HSCT|1|||
130748519|NCT02677922|470700444|FG000|Treatment Period|Other Reasons|0|||
130748520|NCT02677922|470700445|FG001|Treatment Period|Other Reasons|0|||
130748521|NCT02677922|470700446|FG002|Treatment Period|Other Reasons|0|||
130748522|NCT02677922|470700447|FG003|Treatment Period|Other Reasons|1|||
130748523|NCT02677922|470700448|FG004|Treatment Period|Other Reasons|3|||
130748524|NCT02677922|470700449|FG005|Treatment Period|Other Reasons|5|||
130748525|NCT02677922|470700444|FG000|Treatment Period|Death|0|||
130748526|NCT02677922|470700445|FG001|Treatment Period|Death|0|||
130748527|NCT02677922|470700446|FG002|Treatment Period|Death|0|||
130748528|NCT02677922|470700447|FG003|Treatment Period|Death|0|||
130748529|NCT02677922|470700448|FG004|Treatment Period|Death|12|||
130748530|NCT02677922|470700449|FG005|Treatment Period|Death|1|||
130748531|NCT02677922|470700444|FG000|Treatment Period|Non-compliance with Study Drug|0|||
130748532|NCT02677922|470700445|FG001|Treatment Period|Non-compliance with Study Drug|0|||
130748533|NCT02677922|470700446|FG002|Treatment Period|Non-compliance with Study Drug|0|||
130748534|NCT02677922|470700447|FG003|Treatment Period|Non-compliance with Study Drug|0|||
130748535|NCT02677922|470700448|FG004|Treatment Period|Non-compliance with Study Drug|1|||
130748536|NCT02677922|470700449|FG005|Treatment Period|Non-compliance with Study Drug|0|||
130748537|NCT02677922|470700444|FG000|Treatment Period|Physician Decision|0|||
130748538|NCT02677922|470700445|FG001|Treatment Period|Physician Decision|0|||
130748539|NCT02677922|470700446|FG002|Treatment Period|Physician Decision|0|||
130748540|NCT02677922|470700447|FG003|Treatment Period|Physician Decision|0|||
130748541|NCT02677922|470700448|FG004|Treatment Period|Physician Decision|0|||
130748542|NCT02677922|470700449|FG005|Treatment Period|Physician Decision|1|||
130748543|NCT02677922|470700444|FG000|Treatment Period|Symptomatic Deterioration|0|||
130748544|NCT02677922|470700445|FG001|Treatment Period|Symptomatic Deterioration|0|||
130748545|NCT02677922|470700446|FG002|Treatment Period|Symptomatic Deterioration|0|||
130748546|NCT02677922|470700447|FG003|Treatment Period|Symptomatic Deterioration|0|||
130748547|NCT02677922|470700448|FG004|Treatment Period|Symptomatic Deterioration|1|||
130788601|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130788602|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130748548|NCT02677922|470700449|FG005|Treatment Period|Symptomatic Deterioration|0|||
130748549|NCT05310071|470700450|FG000|Overall Study|Death|0|||
130748550|NCT05310071|470700451|FG001|Overall Study|Death|3|||
130748551|NCT05310071|470700450|FG000|Overall Study|Adverse Event|4|||
130748552|NCT05310071|470700451|FG001|Overall Study|Adverse Event|31|||
130748553|NCT05310071|470700450|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
130748554|NCT05310071|470700451|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
130748555|NCT05310071|470700450|FG000|Overall Study|Protocol Deviation|2|||
130748556|NCT05310071|470700451|FG001|Overall Study|Protocol Deviation|0|||
130748557|NCT05310071|470700450|FG000|Overall Study|Randomized by Mistake|0|||
130748558|NCT05310071|470700451|FG001|Overall Study|Randomized by Mistake|1|||
130748559|NCT05310071|470700450|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
130748560|NCT05310071|470700451|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
130748561|NCT05310071|470700450|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
130748562|NCT05310071|470700451|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
130748563|NCT05310071|470700450|FG000|Overall Study|Site Terminated by Sponsor|0|||
130748564|NCT05310071|470700451|FG001|Overall Study|Site Terminated by Sponsor|2|||
130748565|NCT05310071|470700450|FG000|Overall Study|Study Terminated by Sponsor|282|||
130748566|NCT05310071|470700451|FG001|Overall Study|Study Terminated by Sponsor|559|||
130748567|NCT05310071|470700450|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
130748568|NCT05310071|470700451|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
130748569|NCT05310071|470700450|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
130748570|NCT05310071|470700451|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
130748571|NCT05310071|470700450|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
130748572|NCT05310071|470700451|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
130748573|NCT05310071|470700450|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
130748574|NCT05310071|470700451|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
130748575|NCT05310071|470700450|FG000|Overall Study|Withdrawal by Participant - Other|25|||
130748576|NCT05310071|470700451|FG001|Overall Study|Withdrawal by Participant - Other|30|||
130748577|NCT05310071|470700450|FG000|Overall Study|Lost to Follow-up|2|||
130748578|NCT05310071|470700451|FG001|Overall Study|Lost to Follow-up|4|||
130748579|NCT05310071|470700450|FG000|Overall Study|Reason Not Specified|1|||
130748580|NCT05310071|470700451|FG001|Overall Study|Reason Not Specified|3|||
130748581|NCT03515811|470700456|FG000|Overall Study|Lost to Follow-up|2|||
130748582|NCT03515811|470700457|FG001|Overall Study|Lost to Follow-up|1|||
130748583|NCT03515811|470700456|FG000|Overall Study|Protocol Violation|1|||
130748584|NCT03515811|470700457|FG001|Overall Study|Protocol Violation|1|||
130748585|NCT03515811|470700456|FG000|Overall Study|Death|1|||
130748586|NCT03515811|470700457|FG001|Overall Study|Death|1|||
130748587|NCT03515811|470700456|FG000|Overall Study|Withdrawal by Subject|0|||
130748588|NCT03515811|470700457|FG001|Overall Study|Withdrawal by Subject|2|||
130748589|NCT03515811|470700456|FG000|Overall Study|Technical Problems|1|||
130748590|NCT03515811|470700457|FG001|Overall Study|Technical Problems|0|||
130748591|NCT03515811|470700456|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
130748592|NCT03515811|470700457|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
130748593|NCT03515811|470700456|FG000|Overall Study|COVID-19|0|||
130748594|NCT03515811|470700457|FG001|Overall Study|COVID-19|1|||
130748595|NCT05107492|470700458|FG000|Overall Study|Lost to Follow-up|1|||
130748596|NCT05107492|470700459|FG001|Overall Study|Lost to Follow-up|0|||
130748597|NCT04339062|470700460|FG000|Overall Study|Death|0|||
130748598|NCT04339062|470700461|FG001|Overall Study|Death|1|||
130748599|NCT02589639|470700463|FG000|Overall Study|Lost to Follow-up|1|||
130748600|NCT02589639|470700464|FG001|Overall Study|Lost to Follow-up|0|||
130748601|NCT02589639|470700465|FG002|Overall Study|Lost to Follow-up|0|||
130748602|NCT02589639|470700463|FG000|Overall Study|Protocol Violation|1|||
130748603|NCT02589639|470700464|FG001|Overall Study|Protocol Violation|0|||
130748604|NCT02589639|470700465|FG002|Overall Study|Protocol Violation|0|||
130748605|NCT02589639|470700463|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
130748606|NCT02589639|470700464|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
130748607|NCT02589639|470700465|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
130748608|NCT02589639|470700463|FG000|Overall Study|Adverse Event|4|||
130748609|NCT02589639|470700464|FG001|Overall Study|Adverse Event|5|||
130748610|NCT02589639|470700465|FG002|Overall Study|Adverse Event|3|||
130748611|NCT02589639|470700463|FG000|Overall Study|Other reason than specified above|1|||
130748612|NCT02589639|470700464|FG001|Overall Study|Other reason than specified above|2|||
130748613|NCT02589639|470700465|FG002|Overall Study|Other reason than specified above|1|||
130748614|NCT02589639|470700463|FG000|Overall Study|Not Treated|0|||
130748615|NCT02589639|470700464|FG001|Overall Study|Not Treated|3|||
130748616|NCT02589639|470700465|FG002|Overall Study|Not Treated|0|||
130748617|NCT00703157|470700466|FG000|Overall Study|Lost to Follow-up|0|||
130748618|NCT00703157|470700467|FG001|Overall Study|Lost to Follow-up|1|||
130748619|NCT00703157|470700466|FG000|Overall Study|source data permanently lost/ other|4|||
130748620|NCT00703157|470700467|FG001|Overall Study|source data permanently lost/ other|1|||
130748621|NCT02968173|470700468|FG000|Overall Study|Withdrawal by Subject|1|||
130748622|NCT02670525|470700469|FG000|Overall Study|Death|94|||
130748623|NCT02670525|470700470|FG001|Overall Study|Death|14|||
130748624|NCT02670525|470700469|FG000|Overall Study|Lost to Follow-up|4|||
130748625|NCT02670525|470700470|FG001|Overall Study|Lost to Follow-up|1|||
130748626|NCT02670525|470700469|FG000|Overall Study|Subject withdrew consent|1|||
130748627|NCT02670525|470700470|FG001|Overall Study|Subject withdrew consent|0|||
130748628|NCT02670525|470700469|FG000|Overall Study|Unknown, data entry delayed|123|||
130748629|NCT02670525|470700470|FG001|Overall Study|Unknown, data entry delayed|78|||
130748630|NCT00591565|470700471|FG000|Overall Study|lost follow up, withdrawn|5|||
130748631|NCT03564119|470700475|FG000|Overall Study|Adverse Event|4|||
130748632|NCT03564119|470700476|FG001|Overall Study|Adverse Event|0|||
130748633|NCT03564119|470700475|FG000|Overall Study|Lost to Follow-up|1|||
130748634|NCT03564119|470700476|FG001|Overall Study|Lost to Follow-up|4|||
130748635|NCT03564119|470700475|FG000|Overall Study|Protocol Violation|1|||
130748636|NCT03564119|470700476|FG001|Overall Study|Protocol Violation|0|||
130748637|NCT03564119|470700475|FG000|Overall Study|Withdrawal by Subject|9|||
130748638|NCT03564119|470700476|FG001|Overall Study|Withdrawal by Subject|4|||
130748639|NCT03564119|470700475|FG000|Overall Study|Other Than Specified|0|||
130748640|NCT03564119|470700476|FG001|Overall Study|Other Than Specified|1|||
130748641|NCT00634036|470700477|FG000|Overall Study|Lost to Follow-up|1|||
130748642|NCT00634036|470700478|FG001|Overall Study|Lost to Follow-up|1|||
130748643|NCT00634036|470700477|FG000|Overall Study|Withdrawal by Subject|1|||
130748644|NCT00634036|470700478|FG001|Overall Study|Withdrawal by Subject|1|||
130748645|NCT03896022|470700484|FG000|Overall Study|Withdrawal by Subject|1|||
130748646|NCT03896022|470700485|FG001|Overall Study|Withdrawal by Subject|0|||
130748647|NCT03896022|470700486|FG002|Overall Study|Withdrawal by Subject|0|||
130748648|NCT03896022|470700484|FG000|Overall Study|Did not have procedure|3|||
130748649|NCT03896022|470700485|FG001|Overall Study|Did not have procedure|0|||
130748650|NCT03896022|470700486|FG002|Overall Study|Did not have procedure|0|||
130748651|NCT00564850|470700491|FG000|Overall Study|Protocol Violation|2|||
130748652|NCT00314327|470700492|FG000|Overall Study|Withdrawal by Subject|1|||
130748653|NCT02741076|470700493|FG000|Overall Study|Adverse Event|0|||
130748654|NCT02741076|470700494|FG001|Overall Study|Adverse Event|1|||
130748655|NCT02741076|470700495|FG002|Overall Study|Adverse Event|1|||
130748656|NCT02741076|470700496|FG003|Overall Study|Adverse Event|0|||
130748657|NCT02741076|470700493|FG000|Overall Study|Lack of Efficacy|1|||
130748658|NCT02741076|470700494|FG001|Overall Study|Lack of Efficacy|0|||
130748659|NCT02741076|470700495|FG002|Overall Study|Lack of Efficacy|0|||
130748660|NCT02741076|470700496|FG003|Overall Study|Lack of Efficacy|0|||
130748661|NCT02741076|470700493|FG000|Overall Study|Withdrawal by Subject|0|||
130748662|NCT02741076|470700494|FG001|Overall Study|Withdrawal by Subject|1|||
130748663|NCT02741076|470700495|FG002|Overall Study|Withdrawal by Subject|0|||
130748664|NCT02741076|470700496|FG003|Overall Study|Withdrawal by Subject|0|||
130748665|NCT02741076|470700493|FG000|Overall Study|Sponsor Request|2|||
130748666|NCT02741076|470700494|FG001|Overall Study|Sponsor Request|3|||
130748667|NCT02741076|470700495|FG002|Overall Study|Sponsor Request|0|||
130748668|NCT02741076|470700496|FG003|Overall Study|Sponsor Request|1|||
130748669|NCT02741076|470700493|FG000|Overall Study|No additional information available|0|||
130748670|NCT02741076|470700494|FG001|Overall Study|No additional information available|0|||
130748671|NCT02741076|470700495|FG002|Overall Study|No additional information available|1|||
130748672|NCT02741076|470700496|FG003|Overall Study|No additional information available|1|||
130748673|NCT01500382|470700499|FG000|Washout Period|Study site went out of business|0|||
130748674|NCT01500382|470700500|FG001|Washout Period|Study site went out of business|0|||
130748675|NCT01500382|470700501|FG002|Washout Period|Study site went out of business|1|||
130748676|NCT01500382|470700502|FG003|Washout Period|Study site went out of business|0|||
130748677|NCT02134015|470700503|FG000|Overall Study|Protocol Violation|0|||
130748678|NCT02134015|470700504|FG001|Overall Study|Protocol Violation|1|||
130748679|NCT02134015|470700503|FG000|Overall Study|Death|2|||
130748680|NCT02134015|470700504|FG001|Overall Study|Death|1|||
130748681|NCT02134015|470700503|FG000|Overall Study|Reason not provided|1|||
130748682|NCT02134015|470700504|FG001|Overall Study|Reason not provided|2|||
130748683|NCT02134015|470700503|FG000|Overall Study|Clinical progression|14|||
130748684|NCT02134015|470700504|FG001|Overall Study|Clinical progression|7|||
130748685|NCT02134015|470700503|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
130748686|NCT02134015|470700504|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
130748687|NCT02134015|470700503|FG000|Overall Study|Study terminated by sponsor|2|||
130748688|NCT02134015|470700504|FG001|Overall Study|Study terminated by sponsor|3|||
130748689|NCT02134015|470700503|FG000|Overall Study|Adverse Event|9|||
130748690|NCT02134015|470700504|FG001|Overall Study|Adverse Event|10|||
130748691|NCT02134015|470700503|FG000|Overall Study|Withdrawal by Subject|3|||
130748692|NCT02134015|470700504|FG001|Overall Study|Withdrawal by Subject|7|||
130748693|NCT00347958|470702251|FG000|Overall Study|Adverse Event|1|||
130748694|NCT00347958|470702251|FG000|Overall Study|Protocol Violation|2|||
130748695|NCT00347958|470702251|FG000|Overall Study|Withdrawal by Subject|1|||
130788603|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130788604|NCT02717195|470854610|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
130788605|NCT02717195|470854611|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130788606|NCT02717195|470854612|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130788607|NCT02717195|470854613|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130788608|NCT02717195|470854614|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130788609|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
130788610|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
130788611|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
130748696|NCT00754234|470702252|FG000|Overall Study|Withdrawal by Subject|3|||
130748697|NCT00915018|470702253|FG000|Overall Study|Death|75|||
130748698|NCT00915018|470702254|FG001|Overall Study|Death|70|||
130748699|NCT00915018|470702253|FG000|Overall Study|Lost to Follow-up|10|||
130748700|NCT00915018|470702254|FG001|Overall Study|Lost to Follow-up|5|||
130748701|NCT00915018|470702253|FG000|Overall Study|Withdrawal by Subject|38|||
130748702|NCT00915018|470702254|FG001|Overall Study|Withdrawal by Subject|27|||
130748703|NCT00915018|470702253|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
130748704|NCT00915018|470702254|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
130748705|NCT00326716|470702255|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
130748706|NCT00326716|470702256|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
130748707|NCT00326716|470702257|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
130748708|NCT00326716|470702258|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
130748709|NCT04134767|470702259|FG000|Overall Study|Death|0|||
130748710|NCT04134767|470702260|FG001|Overall Study|Death|1|||
130748711|NCT04134767|470702259|FG000|Overall Study|Removed for harassing staff|0|||
130748712|NCT04134767|470702260|FG001|Overall Study|Removed for harassing staff|1|||
130748713|NCT04134767|470702259|FG000|Overall Study|Lost to Follow-up|44|||
130748714|NCT04134767|470702260|FG001|Overall Study|Lost to Follow-up|40|||
130748715|NCT00300885|470702261|FG000|Treatment|Adverse Event|134|||
130748716|NCT00300885|470702262|FG001|Treatment|Adverse Event|82|||
130748717|NCT00300885|470702261|FG000|Treatment|Death|20|||
130748718|NCT00300885|470702262|FG001|Treatment|Death|7|||
130748719|NCT00300885|470702261|FG000|Treatment|Lack of Efficacy|1|||
130748720|NCT00300885|470702262|FG001|Treatment|Lack of Efficacy|1|||
130748721|NCT00300885|470702261|FG000|Treatment|Lost to Follow-up|3|||
130748722|NCT00300885|470702262|FG001|Treatment|Lost to Follow-up|2|||
130748723|NCT00300885|470702261|FG000|Treatment|Physician Decision|4|||
130748724|NCT00300885|470702262|FG001|Treatment|Physician Decision|5|||
130748725|NCT00300885|470702261|FG000|Treatment|Protocol Violation|11|||
130748726|NCT00300885|470702262|FG001|Treatment|Protocol Violation|11|||
130748727|NCT00300885|470702261|FG000|Treatment|Withdrawal by Subject|26|||
130748728|NCT00300885|470702262|FG001|Treatment|Withdrawal by Subject|23|||
130748729|NCT00300885|470702261|FG000|Treatment|Disease progression|171|||
130748730|NCT00300885|470702262|FG001|Treatment|Disease progression|238|||
130748731|NCT00300885|470702261|FG000|Treatment|Random code broken (subject died)|0|||
130748732|NCT00300885|470702262|FG001|Treatment|Random code broken (subject died)|1|||
130748733|NCT00300885|470702261|FG000|Treatment|Non-compliant with study medication|3|||
130748734|NCT00300885|470702262|FG001|Treatment|Non-compliant with study medication|4|||
130748735|NCT00300885|470702261|FG000|Follow-up|Death|141|||
130748736|NCT00300885|470702262|FG001|Follow-up|Death|163|||
130748737|NCT00300885|470702261|FG000|Follow-up|Lost to Follow-up|11|||
130748738|NCT00300885|470702262|FG001|Follow-up|Lost to Follow-up|7|||
130748739|NCT00300885|470702261|FG000|Follow-up|Withdrawal by Subject|26|||
130748740|NCT00300885|470702262|FG001|Follow-up|Withdrawal by Subject|25|||
130748741|NCT02309411|470702271|FG000|Overall Study|Physician Decision|1|||
130748742|NCT02309411|470702272|FG001|Overall Study|Physician Decision|0|||
130748743|NCT02309411|470702273|FG002|Overall Study|Physician Decision|0|||
130748744|NCT02309411|470702271|FG000|Overall Study|Withdrawal by Subject|1|||
130748745|NCT02309411|470702272|FG001|Overall Study|Withdrawal by Subject|1|||
130748746|NCT02309411|470702273|FG002|Overall Study|Withdrawal by Subject|0|||
130748747|NCT03656692|470702274|FG000|Overall Study|Worsening of disease activity|2|||
130748748|NCT03656692|470702274|FG000|Overall Study|Physician Decision|1|||
130748749|NCT02693106|470702275|FG000|Overall Study|No time|3|||
130748750|NCT00839800|470702276|FG000|Overall Study|Adverse Event|8|||
130748751|NCT00839800|470702277|FG001|Overall Study|Adverse Event|12|||
130748752|NCT00839800|470702276|FG000|Overall Study|Lost to Follow-up|31|||
130748753|NCT00839800|470702277|FG001|Overall Study|Lost to Follow-up|26|||
130748754|NCT00839800|470702276|FG000|Overall Study|Withdrawal by Subject|28|||
130748755|NCT00839800|470702277|FG001|Overall Study|Withdrawal by Subject|34|||
130748756|NCT00839800|470702276|FG000|Overall Study|Incorrect Enrolment|3|||
130748757|NCT00839800|470702277|FG001|Overall Study|Incorrect Enrolment|3|||
130748758|NCT00839800|470702276|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
130748759|NCT00839800|470702277|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
130748760|NCT00839800|470702276|FG000|Overall Study|Safety Reasons|2|||
130748761|NCT00839800|470702277|FG001|Overall Study|Safety Reasons|1|||
130748762|NCT00839800|470702276|FG000|Overall Study|Other|8|||
130748763|NCT00839800|470702277|FG001|Overall Study|Other|14|||
130748764|NCT00839800|470702276|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
130748765|NCT00839800|470702277|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
130748766|NCT02801617|470702281|FG000|Overall Study|Protocol Violation|2|||
130748767|NCT02801617|470702282|FG001|Overall Study|Protocol Violation|6|||
130748768|NCT01372618|470702283|FG000|Overall Study|PI Died. Study Terminated|9|||
130748769|NCT01954056|470702284|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
130748770|NCT01954056|470702285|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
130748771|NCT06110494|470702286|FG000|Overall Study|Protocol Violation|2|||
130748772|NCT06110494|470702287|FG001|Overall Study|Protocol Violation|0|||
130748773|NCT06110494|470702288|FG002|Overall Study|Protocol Violation|1|||
130748774|NCT06110494|470702286|FG000|Overall Study|Dixon's test for outlier analysis|1|||
130788612|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
130788613|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
130788614|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
130788615|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
130788616|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
130788617|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
130788618|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
130788619|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
130788620|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
130788621|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
130788622|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
130788623|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
130748775|NCT06110494|470702287|FG001|Overall Study|Dixon's test for outlier analysis|1|||
130748776|NCT06110494|470702288|FG002|Overall Study|Dixon's test for outlier analysis|0|||
130748777|NCT04938180|470702293|FG000|Overall Study|Adverse Event|1|||
130748778|NCT04747886|470702305|FG000|Overall Study|Withdrawal by Subject|1|||
130748779|NCT04747886|470702306|FG001|Overall Study|Withdrawal by Subject|4|||
130748780|NCT03850496|470702307|FG000|Overall Study|Withdrawal by Subject|1|||
130748781|NCT03850496|470702308|FG001|Overall Study|Withdrawal by Subject|0|||
130748782|NCT03850496|470702309|FG002|Overall Study|Withdrawal by Subject|0|||
130748783|NCT03850496|470702307|FG000|Overall Study|Lost to Follow-up|0|||
130748784|NCT03850496|470702308|FG001|Overall Study|Lost to Follow-up|1|||
130748785|NCT03850496|470702309|FG002|Overall Study|Lost to Follow-up|4|||
130748786|NCT03674112|470702310|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
130748787|NCT03674112|470702311|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
130748788|NCT03674112|470702310|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
130748789|NCT03674112|470702311|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
130748790|NCT03674112|470702310|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
130748791|NCT03674112|470702311|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
130748792|NCT03674112|470702310|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
130748793|NCT03674112|470702311|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
130748794|NCT03674112|470702310|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
130748795|NCT03674112|470702311|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
130748796|NCT03674112|470702310|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
130748797|NCT03674112|470702311|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
130748798|NCT03674112|470702310|FG000|Follow-Up Period (≥3 Years)|Death|2|||
130748799|NCT03674112|470702311|FG001|Follow-Up Period (≥3 Years)|Death|0|||
130748800|NCT03674112|470702310|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
130748801|NCT03674112|470702311|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
130748802|NCT02097238|470702314|FG000|Overall Study|Death|1|||
130748803|NCT02097238|470702314|FG000|Overall Study|Physician Decision|1|||
130748804|NCT02097238|470702314|FG000|Overall Study|Progressive Disease|17|||
130748805|NCT01106911|470702316|FG000|Overall Study|Physician Decision|2|||
130748806|NCT01106911|470702316|FG000|Overall Study|deemed ineligible after screening|3|||
130748807|NCT01814696|470702324|FG000|Overall Study|Withdrawal by Subject|1|||
130788624|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
130788625|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
130748808|NCT01814696|470702325|FG001|Overall Study|Withdrawal by Subject|0|||
130748809|NCT01814696|470702324|FG000|Overall Study|Randomized to wrong group|1|||
130748810|NCT01814696|470702325|FG001|Overall Study|Randomized to wrong group|0|||
130748811|NCT00954941|470702326|FG000|Overall Study|Received treatment at home|1|||
130748812|NCT00954941|470702327|FG001|Overall Study|Received treatment at home|0|||
130748813|NCT00954941|470702326|FG000|Overall Study|Withdrawal by Subject|1|||
130748814|NCT00954941|470702327|FG001|Overall Study|Withdrawal by Subject|0|||
130748815|NCT00954941|470702326|FG000|Overall Study|Insurance Denial|2|||
130748816|NCT00954941|470702327|FG001|Overall Study|Insurance Denial|2|||
130748817|NCT00954941|470702326|FG000|Overall Study|Physician Decision|2|||
130748818|NCT00954941|470702327|FG001|Overall Study|Physician Decision|2|||
130748819|NCT00954941|470702326|FG000|Overall Study|Ineligible|2|||
130748820|NCT00954941|470702327|FG001|Overall Study|Ineligible|2|||
130748821|NCT00954941|470702326|FG000|Overall Study|Adverse Event|0|||
130748822|NCT00954941|470702327|FG001|Overall Study|Adverse Event|1|||
130748823|NCT00984542|470702344|FG000|Overall Study|disease progression|19|||
130748824|NCT00984542|470702344|FG000|Overall Study|toxicity|7|||
130748825|NCT00984542|470702344|FG000|Overall Study|Death|7|||
130748826|NCT00984542|470702344|FG000|Overall Study|complicating disease|3|||
130748827|NCT00984542|470702344|FG000|Overall Study|Withdrawal by Subject|3|||
130748828|NCT00984542|470702344|FG000|Overall Study|clinical deterioration|2|||
130748829|NCT01422889|470702345|FG000|Overall Study|No Data Entered for Study Stent|9|||
130748830|NCT00488644|470702350|FG000|Overall Study|Not Eligible|1|||
130748831|NCT00488644|470702350|FG000|Overall Study|Not Evaluable|1|||
130748832|NCT02977572|470702351|FG000|Overall Study|Exclusion criterion|2|||
130748833|NCT02977572|470702352|FG001|Overall Study|Exclusion criterion|2|||
130748834|NCT01197534|470702354|FG000|Overall Study|Not reported|16|||
130748835|NCT01197534|470702355|FG001|Overall Study|Not reported|10|||
130748836|NCT01197534|470702356|FG002|Overall Study|Not reported|16|||
130748837|NCT01197534|470702354|FG000|Overall Study|Enrolment in long term extension|57|||
130748838|NCT01197534|470702355|FG001|Overall Study|Enrolment in long term extension|66|||
130748839|NCT01197534|470702356|FG002|Overall Study|Enrolment in long term extension|119|||
130748840|NCT01197534|470702354|FG000|Overall Study|Severe non-compliance to protocol|3|||
130748841|NCT01197534|470702355|FG001|Overall Study|Severe non-compliance to protocol|4|||
130748842|NCT01197534|470702356|FG002|Overall Study|Severe non-compliance to protocol|1|||
130748843|NCT01197534|470702354|FG000|Overall Study|Lack of therapeutic response|9|||
130748844|NCT01197534|470702355|FG001|Overall Study|Lack of therapeutic response|4|||
130748845|NCT01197534|470702356|FG002|Overall Study|Lack of therapeutic response|9|||
130748846|NCT01197534|470702354|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
130748847|NCT01197534|470702355|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
130748848|NCT01197534|470702356|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
130748849|NCT01197534|470702354|FG000|Overall Study|Lost to Follow-up|1|||
130748850|NCT01197534|470702355|FG001|Overall Study|Lost to Follow-up|4|||
130748851|NCT01197534|470702356|FG002|Overall Study|Lost to Follow-up|2|||
130748852|NCT01197534|470702354|FG000|Overall Study|Adverse Event|35|||
130748853|NCT01197534|470702355|FG001|Overall Study|Adverse Event|36|||
130748854|NCT01197534|470702356|FG002|Overall Study|Adverse Event|24|||
130748855|NCT02593097|470702369|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
130748856|NCT02593097|470702370|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
130748857|NCT02593097|470702369|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130748858|NCT02593097|470702370|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
130748859|NCT02593097|470702369|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
130748860|NCT02593097|470702370|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
130748861|NCT02593097|470702369|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
130748862|NCT02593097|470702370|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
130788626|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
130788627|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
130788628|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
130748863|NCT02593097|470702369|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
130748864|NCT02593097|470702370|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
130748865|NCT02522884|470702371|FG000|Overall Study|Withdrawal by Subject|6|||
130748866|NCT02522884|470702371|FG000|Overall Study|Death|3|||
130748867|NCT02522884|470702371|FG000|Overall Study|Missed 12-month Follow-up|9|||
130748868|NCT02630251|470702372|FG000|Overall Study|Physician Decision|0|||
130748869|NCT02630251|470702373|FG001|Overall Study|Physician Decision|0|||
130748870|NCT02630251|470702374|FG002|Overall Study|Physician Decision|1|||
130748871|NCT02630251|470702375|FG003|Overall Study|Physician Decision|0|||
130748872|NCT01863667|470702376|FG000|Overall Study|Adverse Event|1|||
130748873|NCT01863667|470702377|FG001|Overall Study|Adverse Event|0|||
130748874|NCT01863667|470702376|FG000|Overall Study|Study terminated by Sponsor|30|||
130748875|NCT01863667|470702377|FG001|Overall Study|Study terminated by Sponsor|30|||
130748876|NCT01863667|470702376|FG000|Overall Study|Withdrawal by Subject|2|||
130748877|NCT01863667|470702377|FG001|Overall Study|Withdrawal by Subject|2|||
130748878|NCT03627546|470702380|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
130748879|NCT03627546|470702381|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
130748880|NCT03627546|470702382|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
130748881|NCT03627546|470702380|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
130748882|NCT03627546|470702381|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
130748883|NCT03627546|470702382|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
130748884|NCT00615550|470702383|FG000|Overall Study|Lost to Follow-up|6|||
130748885|NCT00615550|470702384|FG001|Overall Study|Lost to Follow-up|1|||
130748886|NCT02640664|470702385|FG000|Epoch 1|Withdrawal of informed consent|1|||
130748887|NCT02640664|470702386|FG001|Epoch 1|Withdrawal of informed consent|0|||
130748888|NCT02640664|470702387|FG002|Epoch 1|Withdrawal of informed consent|0|||
130748889|NCT02640664|470702385|FG000|Epoch 1|Death|0|||
130748890|NCT02640664|470702386|FG001|Epoch 1|Death|0|||
130748891|NCT02640664|470702387|FG002|Epoch 1|Death|1|||
130748892|NCT02640664|470702385|FG000|Epoch 2|Withdrawal of informed consent|3|||
130748893|NCT02640664|470702386|FG001|Epoch 2|Withdrawal of informed consent|4|||
130748894|NCT02640664|470702387|FG002|Epoch 2|Withdrawal of informed consent|2|||
130748895|NCT02640664|470702385|FG000|Epoch 2|Subject/guardian decision|0|||
130748896|NCT02640664|470702386|FG001|Epoch 2|Subject/guardian decision|2|||
130748897|NCT02640664|470702387|FG002|Epoch 2|Subject/guardian decision|2|||
130748898|NCT02640664|470702385|FG000|Epoch 2|Lost to Follow-up|3|||
130748899|NCT02640664|470702386|FG001|Epoch 2|Lost to Follow-up|4|||
130748900|NCT02640664|470702387|FG002|Epoch 2|Lost to Follow-up|1|||
130748901|NCT02640664|470702385|FG000|Epoch 2|Death|0|||
130748902|NCT02640664|470702386|FG001|Epoch 2|Death|0|||
130748903|NCT02640664|470702387|FG002|Epoch 2|Death|1|||
130748904|NCT02965573|470702388|FG000|Overall Study|Lack of Efficacy|1|||
130748905|NCT02965573|470702389|FG001|Overall Study|Lack of Efficacy|0|||
130748906|NCT00315458|470702391|FG000|Overall Study|Administrative|0|||
130748907|NCT00315458|470702392|FG001|Overall Study|Administrative|3|||
130748908|NCT00315458|470702393|FG002|Overall Study|Administrative|8|||
130748909|NCT00315458|470702394|FG003|Overall Study|Administrative|21|||
130748910|NCT00315458|470702391|FG000|Overall Study|Adverse Event|2|||
130748911|NCT00315458|470702392|FG001|Overall Study|Adverse Event|4|||
130748912|NCT00315458|470702393|FG002|Overall Study|Adverse Event|23|||
130748913|NCT00315458|470702394|FG003|Overall Study|Adverse Event|3|||
130748914|NCT00315458|470702391|FG000|Overall Study|Lost to Follow-up|1|||
130748915|NCT00315458|470702392|FG001|Overall Study|Lost to Follow-up|2|||
130748916|NCT00315458|470702393|FG002|Overall Study|Lost to Follow-up|0|||
130748917|NCT00315458|470702394|FG003|Overall Study|Lost to Follow-up|2|||
130748918|NCT00315458|470702391|FG000|Overall Study|Withdrawal by Subject|0|||
130748919|NCT00315458|470702392|FG001|Overall Study|Withdrawal by Subject|3|||
130748920|NCT00315458|470702393|FG002|Overall Study|Withdrawal by Subject|0|||
130748921|NCT00315458|470702394|FG003|Overall Study|Withdrawal by Subject|2|||
130748922|NCT00315458|470702391|FG000|Overall Study|Lack of Efficacy|0|||
130748923|NCT00315458|470702392|FG001|Overall Study|Lack of Efficacy|0|||
130748924|NCT00315458|470702393|FG002|Overall Study|Lack of Efficacy|20|||
130748925|NCT00315458|470702394|FG003|Overall Study|Lack of Efficacy|1|||
130748926|NCT00315458|470702391|FG000|Overall Study|Did not qualify|0|||
130748927|NCT00315458|470702392|FG001|Overall Study|Did not qualify|0|||
130748928|NCT00315458|470702393|FG002|Overall Study|Did not qualify|1|||
130748929|NCT00315458|470702394|FG003|Overall Study|Did not qualify|0|||
130748930|NCT00987337|470702395|FG000|Overall Study|Adverse Event|10|||
130748931|NCT00987337|470702396|FG001|Overall Study|Adverse Event|9|||
130748932|NCT00987337|470702397|FG002|Overall Study|Adverse Event|8|||
130748933|NCT00987337|470702395|FG000|Overall Study|Insufficient Virologic Response|10|||
130788629|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130788630|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130748934|NCT00987337|470702396|FG001|Overall Study|Insufficient Virologic Response|7|||
130748935|NCT00987337|470702397|FG002|Overall Study|Insufficient Virologic Response|12|||
130748936|NCT00987337|470702395|FG000|Overall Study|Virologic Breakthrough|2|||
130748937|NCT00987337|470702396|FG001|Overall Study|Virologic Breakthrough|2|||
130748938|NCT00987337|470702397|FG002|Overall Study|Virologic Breakthrough|8|||
130748939|NCT00987337|470702395|FG000|Overall Study|Lost to Follow-up|10|||
130748940|NCT00987337|470702396|FG001|Overall Study|Lost to Follow-up|6|||
130748941|NCT00987337|470702397|FG002|Overall Study|Lost to Follow-up|2|||
130748942|NCT00987337|470702395|FG000|Overall Study|Withdrawal by Subject|6|||
130748943|NCT00987337|470702396|FG001|Overall Study|Withdrawal by Subject|9|||
130748944|NCT00987337|470702397|FG002|Overall Study|Withdrawal by Subject|9|||
130748945|NCT00987337|470702395|FG000|Overall Study|Other|0|||
130748946|NCT00987337|470702396|FG001|Overall Study|Other|2|||
130748947|NCT00987337|470702397|FG002|Overall Study|Other|5|||
130748948|NCT00987337|470702395|FG000|Overall Study|Protocol Violation|1|||
130748949|NCT00987337|470702396|FG001|Overall Study|Protocol Violation|0|||
130748950|NCT00987337|470702397|FG002|Overall Study|Protocol Violation|2|||
130748951|NCT00987337|470702395|FG000|Overall Study|Participant Relapsed|18|||
130748952|NCT00987337|470702396|FG001|Overall Study|Participant Relapsed|20|||
130748953|NCT00987337|470702397|FG002|Overall Study|Participant Relapsed|5|||
130748954|NCT00086619|470702400|FG000|Overall Study|Withdrawal by Subject|6|||
130748955|NCT00086619|470702401|FG001|Overall Study|Withdrawal by Subject|6|||
130748956|NCT00086619|470702400|FG000|Overall Study|Adverse Event|8|||
130748957|NCT00086619|470702401|FG001|Overall Study|Adverse Event|10|||
130748958|NCT00086619|470702400|FG000|Overall Study|Protocol Violation|1|||
130748959|NCT00086619|470702401|FG001|Overall Study|Protocol Violation|1|||
130748960|NCT00489918|470702402|FG000|Overall Study|Withdrawal by Subject|2|||
130748961|NCT00489918|470702403|FG001|Overall Study|Withdrawal by Subject|1|||
130748962|NCT00489918|470702404|FG002|Overall Study|Withdrawal by Subject|1|||
130748963|NCT00489918|470702405|FG003|Overall Study|Withdrawal by Subject|0|||
130748964|NCT00489918|470702406|FG004|Overall Study|Withdrawal by Subject|1|||
130748965|NCT00489918|470702402|FG000|Overall Study|Adverse Event|0|||
130748966|NCT00489918|470702403|FG001|Overall Study|Adverse Event|1|||
130748967|NCT00489918|470702404|FG002|Overall Study|Adverse Event|1|||
130748968|NCT00489918|470702405|FG003|Overall Study|Adverse Event|0|||
130748969|NCT00489918|470702406|FG004|Overall Study|Adverse Event|0|||
130748970|NCT00489918|470702402|FG000|Overall Study|Lost to Follow-up|0|||
130748971|NCT00489918|470702403|FG001|Overall Study|Lost to Follow-up|0|||
130748972|NCT00489918|470702404|FG002|Overall Study|Lost to Follow-up|1|||
130748973|NCT00489918|470702405|FG003|Overall Study|Lost to Follow-up|1|||
130748974|NCT00489918|470702406|FG004|Overall Study|Lost to Follow-up|0|||
130748975|NCT00489918|470702402|FG000|Overall Study|Physician Decision|0|||
130748976|NCT00489918|470702403|FG001|Overall Study|Physician Decision|0|||
130748977|NCT00489918|470702404|FG002|Overall Study|Physician Decision|1|||
130748978|NCT00489918|470702405|FG003|Overall Study|Physician Decision|0|||
130748979|NCT00489918|470702406|FG004|Overall Study|Physician Decision|0|||
130748980|NCT02748213|470702407|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
130748981|NCT02748213|470702408|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
130748982|NCT02748213|470702407|FG000|Overall Study|Abnormal Laboratory Test|1|||
130748983|NCT02748213|470702408|FG001|Overall Study|Abnormal Laboratory Test|0|||
130748984|NCT02748213|470702407|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
130748985|NCT02748213|470702408|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
130748986|NCT02748213|470702407|FG000|Overall Study|Death|5|||
130748987|NCT02748213|470702408|FG001|Overall Study|Death|3|||
130748988|NCT02748213|470702407|FG000|Overall Study|Insufficient Therapeutic Response|56|||
130748989|NCT02748213|470702408|FG001|Overall Study|Insufficient Therapeutic Response|57|||
130748990|NCT02748213|470702407|FG000|Overall Study|Violation of Selection Criteria|2|||
130748991|NCT02748213|470702408|FG001|Overall Study|Violation of Selection Criteria|0|||
130748992|NCT02748213|470702407|FG000|Overall Study|Protocol Violation|6|||
130748993|NCT02748213|470702408|FG001|Overall Study|Protocol Violation|4|||
130748994|NCT02748213|470702407|FG000|Overall Study|Refused Treatment*|6|||
130748995|NCT02748213|470702408|FG001|Overall Study|Refused Treatment*|6|||
130748996|NCT02748213|470702407|FG000|Overall Study|Failure to Return|1|||
130748997|NCT02748213|470702408|FG001|Overall Study|Failure to Return|0|||
130748998|NCT02748213|470702407|FG000|Overall Study|Other|30|||
130748999|NCT02748213|470702408|FG001|Overall Study|Other|29|||
130749000|NCT01209520|470702410|FG000|Overall Study|Withdrawal by Subject|3|||
130749001|NCT00961350|470702411|FG000|Overall Study|Adverse Event|18|||
130749002|NCT00961350|470702412|FG001|Overall Study|Adverse Event|33|||
130749003|NCT00961350|470702411|FG000|Overall Study|Withdrawal by Subject|10|||
130749004|NCT00961350|470702412|FG001|Overall Study|Withdrawal by Subject|10|||
130749005|NCT00961350|470702411|FG000|Overall Study|Lost to Follow-up|3|||
130749006|NCT00961350|470702412|FG001|Overall Study|Lost to Follow-up|3|||
130749007|NCT00961350|470702411|FG000|Overall Study|Misc|16|||
130749008|NCT00961350|470702412|FG001|Overall Study|Misc|21|||
130749009|NCT00550745|470702413|FG000|Overall Study|Death|20|||
130749010|NCT00550745|470702414|FG001|Overall Study|Death|16|||
130749011|NCT00550745|470702413|FG000|Overall Study|Lost to Follow-up|45|||
130749012|NCT00550745|470702414|FG001|Overall Study|Lost to Follow-up|30|||
130749013|NCT00550745|470702413|FG000|Overall Study|Physician Decision|0|||
130749014|NCT00550745|470702414|FG001|Overall Study|Physician Decision|2|||
130749015|NCT00550745|470702413|FG000|Overall Study|Protocol Violation|4|||
130749016|NCT00550745|470702414|FG001|Overall Study|Protocol Violation|2|||
130749017|NCT00550745|470702413|FG000|Overall Study|Withdrawal by Subject|17|||
130749018|NCT00550745|470702414|FG001|Overall Study|Withdrawal by Subject|10|||
130749019|NCT00550745|470702413|FG000|Overall Study|Screen failure|1|||
130749020|NCT00550745|470702414|FG001|Overall Study|Screen failure|0|||
130749021|NCT00617890|470704434|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
130749022|NCT00617890|470704435|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
130749023|NCT00617890|470704436|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
130749024|NCT00617890|470704437|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
130749025|NCT00617890|470704434|FG000|Overall Study|Lack of Efficacy|23|||
130749026|NCT00617890|470704435|FG001|Overall Study|Lack of Efficacy|26|||
130749027|NCT00617890|470704436|FG002|Overall Study|Lack of Efficacy|30|||
130749028|NCT00617890|470704437|FG003|Overall Study|Lack of Efficacy|97|||
130749029|NCT00617890|470704434|FG000|Overall Study|Lost to Follow-up|0|||
130749030|NCT00617890|470704435|FG001|Overall Study|Lost to Follow-up|0|||
130749031|NCT00617890|470704436|FG002|Overall Study|Lost to Follow-up|1|||
130749032|NCT00617890|470704437|FG003|Overall Study|Lost to Follow-up|2|||
130749033|NCT00617890|470704434|FG000|Overall Study|Withdrawal by Subject|4|||
130749034|NCT00617890|470704435|FG001|Overall Study|Withdrawal by Subject|1|||
130749035|NCT00617890|470704436|FG002|Overall Study|Withdrawal by Subject|0|||
130749036|NCT00617890|470704437|FG003|Overall Study|Withdrawal by Subject|2|||
130749037|NCT00617890|470704434|FG000|Overall Study|Protocol Violation|2|||
130749038|NCT00617890|470704435|FG001|Overall Study|Protocol Violation|1|||
130749039|NCT00617890|470704436|FG002|Overall Study|Protocol Violation|0|||
130749040|NCT00617890|470704437|FG003|Overall Study|Protocol Violation|0|||
130749041|NCT00617890|470704434|FG000|Overall Study|Adverse Event|1|||
130749042|NCT00617890|470704435|FG001|Overall Study|Adverse Event|0|||
130749043|NCT00617890|470704436|FG002|Overall Study|Adverse Event|3|||
130749044|NCT00617890|470704437|FG003|Overall Study|Adverse Event|8|||
130749045|NCT00617890|470704434|FG000|Overall Study|Not treated|1|||
130749046|NCT00617890|470704435|FG001|Overall Study|Not treated|0|||
130749047|NCT00617890|470704436|FG002|Overall Study|Not treated|1|||
130749048|NCT00617890|470704437|FG003|Overall Study|Not treated|1|||
130749049|NCT02640950|470704439|FG000|Overall Study|Adverse Event|1|||
130749050|NCT02640950|470704439|FG000|Overall Study|Withdrawal by Subject|1|||
130749051|NCT00154284|470704440|FG000|Overall Study|Adverse Event|6|||
130749052|NCT00154284|470704441|FG001|Overall Study|Adverse Event|9|||
130749053|NCT00154284|470704440|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130749054|NCT00154284|470704441|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130749055|NCT00154284|470704440|FG000|Overall Study|Lack of Efficacy|1|||
130749056|NCT00154284|470704441|FG001|Overall Study|Lack of Efficacy|2|||
130749057|NCT00154284|470704440|FG000|Overall Study|Protocol Violation|0|||
130749058|NCT00154284|470704441|FG001|Overall Study|Protocol Violation|1|||
130749059|NCT00566020|470704442|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
130749060|NCT00566020|470704443|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
130749061|NCT00566020|470704442|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
130749062|NCT00566020|470704443|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
130749063|NCT00566020|470704442|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
130749064|NCT00566020|470704443|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
130749065|NCT00566020|470704442|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
130749066|NCT00566020|470704443|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
130749067|NCT00566020|470704442|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
130749068|NCT00566020|470704443|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
130749069|NCT00566020|470704442|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
130749070|NCT00566020|470704443|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
130749071|NCT02582242|470704444|FG000|Overall Study|Adverse Event|4|||
130749072|NCT02582242|470704445|FG001|Overall Study|Adverse Event|3|||
130749073|NCT02582242|470704444|FG000|Overall Study|Protocol Violation|3|||
130749074|NCT02582242|470704445|FG001|Overall Study|Protocol Violation|1|||
130749075|NCT02582242|470704444|FG000|Overall Study|Lost to Follow-up|0|||
130749076|NCT02582242|470704445|FG001|Overall Study|Lost to Follow-up|1|||
130749077|NCT02582242|470704444|FG000|Overall Study|Withdrawal by Subject|11|||
130749078|NCT02582242|470704445|FG001|Overall Study|Withdrawal by Subject|11|||
130749079|NCT02582242|470704444|FG000|Overall Study|Unclassified|2|||
130749080|NCT02582242|470704445|FG001|Overall Study|Unclassified|1|||
130749081|NCT02101736|470704446|FG000|Overall Study|Protocol Violation|3|||
130749082|NCT02101736|470704447|FG001|Overall Study|Protocol Violation|0|||
130749083|NCT02101736|470704446|FG000|Overall Study|Withdrawal by Subject|1|||
130749084|NCT02101736|470704447|FG001|Overall Study|Withdrawal by Subject|1|||
130749085|NCT00459290|470704448|FG000|Overall Study|Adverse Event|3|||
130749086|NCT00459290|470704448|FG000|Overall Study|Ineligible|2|||
130749087|NCT02176655|470704456|FG000|Overall Study|Subjects did not treat|6|||
130749088|NCT01464593|470704459|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
130749089|NCT02476578|470704466|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
130749090|NCT02476578|470704467|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
130749091|NCT02476578|470704466|FG000|Overall Study|Lost to Follow-up|6|||
130749092|NCT02476578|470704467|FG001|Overall Study|Lost to Follow-up|13|||
130749093|NCT01019694|470704468|FG000|Overall Study|Adverse Event|12|||
130749094|NCT01019694|470704469|FG001|Overall Study|Adverse Event|16|||
130749095|NCT01019694|470704470|FG002|Overall Study|Adverse Event|19|||
130749096|NCT01019694|470704468|FG000|Overall Study|Protocol Violation|2|||
130749097|NCT01019694|470704469|FG001|Overall Study|Protocol Violation|6|||
130749098|NCT01019694|470704470|FG002|Overall Study|Protocol Violation|4|||
130749099|NCT01019694|470704468|FG000|Overall Study|Lost to Follow-up|5|||
130749100|NCT01019694|470704469|FG001|Overall Study|Lost to Follow-up|3|||
130749101|NCT01019694|470704470|FG002|Overall Study|Lost to Follow-up|3|||
130749102|NCT01019694|470704468|FG000|Overall Study|Withdrawal by Subject|4|||
130749103|NCT01019694|470704469|FG001|Overall Study|Withdrawal by Subject|6|||
130749104|NCT01019694|470704470|FG002|Overall Study|Withdrawal by Subject|12|||
130749105|NCT01019694|470704468|FG000|Overall Study|Not treated|0|||
130749106|NCT01019694|470704469|FG001|Overall Study|Not treated|2|||
130749107|NCT01019694|470704470|FG002|Overall Study|Not treated|3|||
130749108|NCT01019694|470704468|FG000|Overall Study|Other reason (not specified)|1|||
130749109|NCT01019694|470704469|FG001|Overall Study|Other reason (not specified)|5|||
130749110|NCT01019694|470704470|FG002|Overall Study|Other reason (not specified)|6|||
130749111|NCT00026494|470704477|FG000|Overall Study|Withdrawal by Subject|1|||
130749112|NCT00026494|470704478|FG001|Overall Study|Withdrawal by Subject|0|||
130749113|NCT00026494|470704479|FG002|Overall Study|Withdrawal by Subject|1|||
130749114|NCT00026494|470704480|FG003|Overall Study|Withdrawal by Subject|0|||
130749115|NCT00026494|470704477|FG000|Overall Study|Patient non-compliance|1|||
130749116|NCT00026494|470704478|FG001|Overall Study|Patient non-compliance|0|||
130749117|NCT00026494|470704479|FG002|Overall Study|Patient non-compliance|0|||
130749118|NCT00026494|470704480|FG003|Overall Study|Patient non-compliance|0|||
130749119|NCT00026494|470704477|FG000|Overall Study|Patient not treated|0|||
130749120|NCT00026494|470704478|FG001|Overall Study|Patient not treated|0|||
130749121|NCT00026494|470704479|FG002|Overall Study|Patient not treated|2|||
130749122|NCT00026494|470704480|FG003|Overall Study|Patient not treated|0|||
130749123|NCT00026494|470704477|FG000|Overall Study|Clinical progression|0|||
130749124|NCT00026494|470704478|FG001|Overall Study|Clinical progression|0|||
130749125|NCT00026494|470704479|FG002|Overall Study|Clinical progression|3|||
130749126|NCT00026494|470704480|FG003|Overall Study|Clinical progression|0|||
130749127|NCT01684423|470704481|FG000|Overall Study|Withdrawal by Subject|0|||
130749128|NCT01684423|470704482|FG001|Overall Study|Withdrawal by Subject|0|||
130749129|NCT01684423|470704483|FG002|Overall Study|Withdrawal by Subject|1|||
130749130|NCT01684423|470704484|FG003|Overall Study|Withdrawal by Subject|0|||
130749131|NCT01684423|470704485|FG004|Overall Study|Withdrawal by Subject|0|||
130749132|NCT00441129|470704486|FG000|Overall Study|Withdrawal by Subject|6|||
130749133|NCT00441129|470704487|FG001|Overall Study|Withdrawal by Subject|14|||
130749134|NCT01455597|470704488|FG000|Overall Study|Adverse Event|7|||
130749135|NCT01455597|470704489|FG001|Overall Study|Adverse Event|0|||
130749136|NCT01455597|470704490|FG002|Overall Study|Adverse Event|5|||
130749137|NCT01455597|470704491|FG003|Overall Study|Adverse Event|1|||
130788631|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
130788632|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
130788633|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
130788634|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
130788635|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
130788636|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
130788637|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
130788638|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
130788639|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130788640|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130788641|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
130788642|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130788643|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130788644|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
130788645|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
130788646|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
130788647|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
130788648|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
130788649|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
130788650|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
130788651|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
130749138|NCT01455597|470704488|FG000|Overall Study|Lack of Efficacy|0|||
130749139|NCT01455597|470704489|FG001|Overall Study|Lack of Efficacy|1|||
130749140|NCT01455597|470704490|FG002|Overall Study|Lack of Efficacy|2|||
130749141|NCT01455597|470704491|FG003|Overall Study|Lack of Efficacy|0|||
130749142|NCT01455597|470704488|FG000|Overall Study|Lost to Follow-up|3|||
130749143|NCT01455597|470704489|FG001|Overall Study|Lost to Follow-up|0|||
130749144|NCT01455597|470704490|FG002|Overall Study|Lost to Follow-up|2|||
130749145|NCT01455597|470704491|FG003|Overall Study|Lost to Follow-up|1|||
130749146|NCT01455597|470704488|FG000|Overall Study|Withdrew Consent|6|||
130749147|NCT01455597|470704489|FG001|Overall Study|Withdrew Consent|5|||
130749148|NCT01455597|470704490|FG002|Overall Study|Withdrew Consent|8|||
130749149|NCT01455597|470704491|FG003|Overall Study|Withdrew Consent|5|||
130749150|NCT01455597|470704488|FG000|Overall Study|Reason not Specified|1|||
130749151|NCT01455597|470704489|FG001|Overall Study|Reason not Specified|2|||
130749152|NCT01455597|470704490|FG002|Overall Study|Reason not Specified|3|||
130749153|NCT01455597|470704491|FG003|Overall Study|Reason not Specified|3|||
130749154|NCT03412734|470704494|FG000|Overall Study|Incorrect labeling of samples|2|||
130749155|NCT03412734|470704495|FG001|Overall Study|Incorrect labeling of samples|0|||
130749156|NCT03412734|470704494|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
130749157|NCT03412734|470704495|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
130749158|NCT03777436|470704500|FG000|Placebo-controlled Phase|Adverse Event|8|||
130749159|NCT03777436|470704501|FG001|Placebo-controlled Phase|Adverse Event|10|||
130749160|NCT03777436|470704502|FG002|Placebo-controlled Phase|Adverse Event|0|||
130749161|NCT03777436|470704500|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
130749162|NCT03777436|470704501|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
130749163|NCT03777436|470704502|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
130749164|NCT03777436|470704500|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
130749165|NCT03777436|470704501|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
130749166|NCT03777436|470704502|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
130749167|NCT03777436|470704500|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
130749168|NCT03777436|470704501|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
130749169|NCT03777436|470704502|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
130749170|NCT03777436|470704500|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
130749171|NCT03777436|470704501|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
130749172|NCT03777436|470704502|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
130749173|NCT03777436|470704500|FG000|Placebo-controlled Phase|Physician Decision|0|||
130749174|NCT03777436|470704501|FG001|Placebo-controlled Phase|Physician Decision|1|||
130788652|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
130788653|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
130788654|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130749175|NCT03777436|470704502|FG002|Placebo-controlled Phase|Physician Decision|0|||
130749176|NCT03777436|470704500|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
130749177|NCT03777436|470704501|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
130749178|NCT03777436|470704502|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
130749179|NCT03777436|470704500|FG000|Apremilast Extension Phase|Adverse Event|0|||
130749180|NCT03777436|470704501|FG001|Apremilast Extension Phase|Adverse Event|0|||
130749181|NCT03777436|470704502|FG002|Apremilast Extension Phase|Adverse Event|6|||
130749182|NCT03777436|470704500|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
130749183|NCT03777436|470704501|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
130749184|NCT03777436|470704502|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
130749185|NCT03777436|470704500|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
130749186|NCT03777436|470704501|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
130749187|NCT03777436|470704502|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
130749188|NCT03777436|470704500|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
130749189|NCT03777436|470704501|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
130749190|NCT03777436|470704502|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
130749191|NCT03777436|470704500|FG000|Apremilast Extension Phase|Miscellaneous|0|||
130749192|NCT03777436|470704501|FG001|Apremilast Extension Phase|Miscellaneous|0|||
130749193|NCT03777436|470704502|FG002|Apremilast Extension Phase|Miscellaneous|1|||
130749194|NCT00869999|470704507|FG000|Overall Study|Withdrawal by Subject|1|||
130749195|NCT00869999|470704507|FG000|Overall Study|removed prior to starting therapy|1|||
130749196|NCT04478695|470704508|FG000|Overall Study|Death|1|||
130749197|NCT04478695|470704509|FG001|Overall Study|Death|0|||
130749198|NCT00644917|470704510|FG000|Overall Study|Withdrawal by Subject|2|||
130749199|NCT01136356|470704511|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
130749200|NCT01136356|470704512|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
130749201|NCT01136356|470704511|FG000|First 18-day Withdrawal|Physician Decision|1|||
130749202|NCT01136356|470704512|FG001|First 18-day Withdrawal|Physician Decision|0|||
130749203|NCT01136356|470704511|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
130749204|NCT01136356|470704512|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
130749205|NCT00758485|470704513|FG000|Overall Study|Lost to Follow-up|0|||
130749206|NCT00758485|470704514|FG001|Overall Study|Lost to Follow-up|1|||
130749207|NCT00758485|470704513|FG000|Overall Study|Not Treated|1|||
130749208|NCT00758485|470704514|FG001|Overall Study|Not Treated|2|||
130749209|NCT00402688|470704515|FG000|Overall Study|Adverse Event|12|||
130749210|NCT00402688|470704516|FG001|Overall Study|Adverse Event|9|||
130749211|NCT00402688|470704517|FG002|Overall Study|Adverse Event|3|||
130749212|NCT00402688|470704515|FG000|Overall Study|Withdrawal by Subject|3|||
130749213|NCT00402688|470704516|FG001|Overall Study|Withdrawal by Subject|1|||
130749214|NCT00402688|470704517|FG002|Overall Study|Withdrawal by Subject|1|||
130749215|NCT00402688|470704515|FG000|Overall Study|Physician Decision|0|||
130749216|NCT00402688|470704516|FG001|Overall Study|Physician Decision|0|||
130749217|NCT00402688|470704517|FG002|Overall Study|Physician Decision|1|||
130749218|NCT00402688|470704515|FG000|Overall Study|Lack of Efficacy|4|||
130749219|NCT00402688|470704516|FG001|Overall Study|Lack of Efficacy|4|||
130749220|NCT00402688|470704517|FG002|Overall Study|Lack of Efficacy|5|||
130749221|NCT00402688|470704515|FG000|Overall Study|Protocol Violation|1|||
130749222|NCT00402688|470704516|FG001|Overall Study|Protocol Violation|1|||
130749223|NCT00402688|470704517|FG002|Overall Study|Protocol Violation|1|||
130749224|NCT00402688|470704515|FG000|Overall Study|Lost to Follow-up|1|||
130749225|NCT00402688|470704516|FG001|Overall Study|Lost to Follow-up|0|||
130749226|NCT00402688|470704517|FG002|Overall Study|Lost to Follow-up|2|||
130749227|NCT00402688|470704515|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
130749228|NCT00402688|470704516|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
130749229|NCT00402688|470704517|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
130749230|NCT00402688|470704515|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
130749231|NCT00402688|470704516|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
130749232|NCT00402688|470704517|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
130749233|NCT00402688|470704515|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
130749234|NCT00402688|470704516|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
130749235|NCT00402688|470704517|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
130749236|NCT02347774|470704518|FG000|Study Participation|Lost to Follow-up|3|||
130749237|NCT02347774|470704519|FG001|Study Participation|Lost to Follow-up|6|||
130749238|NCT02347774|470704520|FG002|Study Participation|Lost to Follow-up|2|||
130749239|NCT02347774|470704518|FG000|Study Participation|Withdrawal by Subject|8|||
130749240|NCT02347774|470704519|FG001|Study Participation|Withdrawal by Subject|9|||
130749241|NCT02347774|470704520|FG002|Study Participation|Withdrawal by Subject|15|||
130749242|NCT02347774|470704518|FG000|Study Participation|Adverse Event|1|||
130749243|NCT02347774|470704519|FG001|Study Participation|Adverse Event|4|||
130749244|NCT02347774|470704520|FG002|Study Participation|Adverse Event|6|||
130749245|NCT02347774|470704518|FG000|Study Participation|withdrew consent|1|||
130749246|NCT02347774|470704519|FG001|Study Participation|withdrew consent|1|||
130749247|NCT02347774|470704520|FG002|Study Participation|withdrew consent|1|||
130749248|NCT02347774|470704518|FG000|Study Participation|Met Prolonged QT criteria|1|||
130749249|NCT02347774|470704519|FG001|Study Participation|Met Prolonged QT criteria|0|||
130749250|NCT02347774|470704520|FG002|Study Participation|Met Prolonged QT criteria|0|||
130749251|NCT02347774|470704518|FG000|Study Participation|non-compliance with study drug|0|||
130749252|NCT02347774|470704519|FG001|Study Participation|non-compliance with study drug|1|||
130749253|NCT02347774|470704520|FG002|Study Participation|non-compliance with study drug|0|||
130749254|NCT02347774|470704518|FG000|Study Participation|incarceration|1|||
130749255|NCT02347774|470704519|FG001|Study Participation|incarceration|0|||
130749256|NCT02347774|470704520|FG002|Study Participation|incarceration|0|||
130749257|NCT02347774|470704518|FG000|Study Participation|randomized in error|0|||
130749258|NCT02347774|470704519|FG001|Study Participation|randomized in error|0|||
130749259|NCT02347774|470704520|FG002|Study Participation|randomized in error|1|||
130749260|NCT02347774|470704518|FG000|On Study Treatment|Adverse Event|9|||
130749261|NCT02347774|470704519|FG001|On Study Treatment|Adverse Event|15|||
130749262|NCT02347774|470704520|FG002|On Study Treatment|Adverse Event|19|||
130749263|NCT02347774|470704518|FG000|On Study Treatment|Lack of Efficacy|3|||
130749264|NCT02347774|470704519|FG001|On Study Treatment|Lack of Efficacy|0|||
130749265|NCT02347774|470704520|FG002|On Study Treatment|Lack of Efficacy|2|||
130749266|NCT02347774|470704518|FG000|On Study Treatment|non-complicance with study medication|0|||
130749267|NCT02347774|470704519|FG001|On Study Treatment|non-complicance with study medication|2|||
130749268|NCT02347774|470704520|FG002|On Study Treatment|non-complicance with study medication|0|||
130749269|NCT02347774|470704518|FG000|On Study Treatment|Protocol Violation|0|||
130749270|NCT02347774|470704519|FG001|On Study Treatment|Protocol Violation|0|||
130749271|NCT02347774|470704520|FG002|On Study Treatment|Protocol Violation|1|||
130749272|NCT02347774|470704518|FG000|On Study Treatment|withdrew consent|9|||
130749273|NCT02347774|470704519|FG001|On Study Treatment|withdrew consent|8|||
130749274|NCT02347774|470704520|FG002|On Study Treatment|withdrew consent|12|||
130749275|NCT02347774|470704518|FG000|On Study Treatment|Lost to Follow-up|2|||
130749276|NCT02347774|470704519|FG001|On Study Treatment|Lost to Follow-up|6|||
130749277|NCT02347774|470704520|FG002|On Study Treatment|Lost to Follow-up|1|||
130749278|NCT02347774|470704518|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
130749279|NCT02347774|470704519|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
130749280|NCT02347774|470704520|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
130749281|NCT02347774|470704518|FG000|On Study Treatment|ranomized in error|0|||
130749282|NCT02347774|470704519|FG001|On Study Treatment|ranomized in error|0|||
130749283|NCT02347774|470704520|FG002|On Study Treatment|ranomized in error|1|||
130749284|NCT00656292|470704521|FG000|Overall Study|Withdrawal by Subject|2|||
130749285|NCT00656292|470704522|FG001|Overall Study|Withdrawal by Subject|3|||
130749286|NCT00656292|470704521|FG000|Overall Study|Screen failure|1|||
130749287|NCT00656292|470704522|FG001|Overall Study|Screen failure|2|||
130749288|NCT00921557|470704523|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
130749289|NCT00921557|470704524|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
130749290|NCT00921557|470704525|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
130749291|NCT00921557|470704523|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
130749292|NCT00921557|470704524|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
130749293|NCT00921557|470704525|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
130749294|NCT00921557|470704523|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
130749295|NCT00921557|470704524|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
130749296|NCT00921557|470704525|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
130749297|NCT00921557|470704523|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
130749298|NCT00921557|470704524|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
130749299|NCT00921557|470704525|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
130749300|NCT00921557|470704523|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
130749301|NCT00921557|470704524|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
130749302|NCT00921557|470704525|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
130749303|NCT03259425|470704526|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
130788655|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130788656|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130749304|NCT04112043|470704527|FG000|Overall Study|Withdrawal by Subject|1|||
130749305|NCT04112043|470704528|FG001|Overall Study|Withdrawal by Subject|1|||
130749306|NCT04112043|470704529|FG002|Overall Study|Withdrawal by Subject|1|||
130749307|NCT04112043|470704527|FG000|Overall Study|Taking NR supplement|1|||
130749308|NCT04112043|470704528|FG001|Overall Study|Taking NR supplement|0|||
130749309|NCT04112043|470704529|FG002|Overall Study|Taking NR supplement|0|||
130749310|NCT04112043|470704527|FG000|Overall Study|Adverse Event|0|||
130749311|NCT04112043|470704528|FG001|Overall Study|Adverse Event|1|||
130749312|NCT04112043|470704529|FG002|Overall Study|Adverse Event|0|||
130749313|NCT04157296|470704530|FG000|Overall Study|Withdrawal by Subject|0|||
130749314|NCT04157296|470704531|FG001|Overall Study|Withdrawal by Subject|1|||
130749315|NCT04157296|470704530|FG000|Overall Study|Did not obtain second fMRI.|0|||
130749316|NCT04157296|470704531|FG001|Overall Study|Did not obtain second fMRI.|1|||
130749317|NCT04157296|470704530|FG000|Overall Study|MRI failed/no second fMRI|0|||
130749318|NCT04157296|470704531|FG001|Overall Study|MRI failed/no second fMRI|1|||
130749319|NCT00356148|470704534|FG000|Overall Study|Reoperation within 30 days|2|||
130749320|NCT00356148|470704535|FG001|Overall Study|Reoperation within 30 days|1|||
130749321|NCT02484456|470704536|FG000|Washout Period|Withdrawal by Subject|0|||
130749322|NCT02484456|470704537|FG001|Washout Period|Withdrawal by Subject|1|||
130749323|NCT02484456|470704536|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
130749324|NCT02484456|470704537|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
130749325|NCT02484456|470704536|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
130749326|NCT02484456|470704537|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
130749327|NCT02484456|470704536|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
130749328|NCT02484456|470704537|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
130749329|NCT01996254|470704540|FG000|Overall Study|Change in Eligibility|0|||
130749330|NCT01996254|470704541|FG001|Overall Study|Change in Eligibility|2|||
130749331|NCT01996254|470704542|FG002|Overall Study|Change in Eligibility|0|||
130749332|NCT01996254|470704540|FG000|Overall Study|Withdrawal by Subject|0|||
130749333|NCT01996254|470704541|FG001|Overall Study|Withdrawal by Subject|3|||
130749334|NCT01996254|470704542|FG002|Overall Study|Withdrawal by Subject|4|||
130749335|NCT01996254|470704540|FG000|Overall Study|Lost to Follow-up|1|||
130749336|NCT01996254|470704541|FG001|Overall Study|Lost to Follow-up|0|||
130749337|NCT01996254|470704542|FG002|Overall Study|Lost to Follow-up|4|||
130749338|NCT03348930|470704543|FG000|Washout (1 Week)|Lost to Follow-up|1|||
130749339|NCT03348930|470704544|FG001|Washout (1 Week)|Lost to Follow-up|1|||
130749340|NCT02091089|470704546|FG000|Overall Study|Lost to Follow-up|2|||
130749341|NCT01580670|470704547|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
130749342|NCT01580670|470704547|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
130749343|NCT02097745|470704548|FG000|Overall Study|Adverse Event|25|||
130749344|NCT02097745|470704548|FG000|Overall Study|Death|16|||
130749345|NCT02097745|470704548|FG000|Overall Study|Failure to Return|14|||
130749346|NCT02097745|470704548|FG000|Overall Study|Administrative/Other|27|||
130749347|NCT02097745|470704548|FG000|Overall Study|Reason Not Specified|96|||
130749348|NCT00425750|470704549|FG000|Overall Study|Death|1|||
130749349|NCT00425750|470704549|FG000|Overall Study|Withdrawal by Subject|3|||
130749350|NCT00425750|470704549|FG000|Overall Study|Adverse Event|3|||
130749351|NCT00425750|470704549|FG000|Overall Study|Progression of disease|18|||
130749352|NCT01757184|470704550|FG000|Double-blind Period|Adverse Event|1|||
130749353|NCT01757184|470704551|FG001|Double-blind Period|Adverse Event|0|||
130749354|NCT01757184|470704552|FG002|Double-blind Period|Adverse Event|0|||
130749355|NCT01757184|470704553|FG003|Double-blind Period|Adverse Event|0|||
130749356|NCT01757184|470704550|FG000|Open-label Period|Lost to Follow-up|0|||
130749357|NCT01757184|470704551|FG001|Open-label Period|Lost to Follow-up|0|||
130749358|NCT01757184|470704552|FG002|Open-label Period|Lost to Follow-up|2|||
130749359|NCT01757184|470704553|FG003|Open-label Period|Lost to Follow-up|0|||
130749360|NCT01757184|470704550|FG000|Open-label Period|Withdrawal by Subject|0|||
130749361|NCT01757184|470704551|FG001|Open-label Period|Withdrawal by Subject|0|||
130749362|NCT01757184|470704552|FG002|Open-label Period|Withdrawal by Subject|1|||
130749363|NCT01757184|470704553|FG003|Open-label Period|Withdrawal by Subject|1|||
130749364|NCT01757184|470704550|FG000|Open-label Period|Discontinued by Sponsor|0|||
130749365|NCT01757184|470704551|FG001|Open-label Period|Discontinued by Sponsor|0|||
130749366|NCT01757184|470704552|FG002|Open-label Period|Discontinued by Sponsor|1|||
130749367|NCT01757184|470704553|FG003|Open-label Period|Discontinued by Sponsor|2|||
130749368|NCT00554515|470704554|FG000|Overall Study|Withdrawal by Subject|3|||
130749369|NCT00554515|470704554|FG000|Overall Study|Disease progression|52|||
130749370|NCT00554515|470704554|FG000|Overall Study|Physician Decision|18|||
130749371|NCT00554515|470704554|FG000|Overall Study|Withdrawal by Subject|11|||
130749372|NCT00554515|470704554|FG000|Overall Study|Adverse Event|9|||
130749373|NCT00554515|470704554|FG000|Overall Study|Death|2|||
130749374|NCT00554515|470704554|FG000|Overall Study|Achieved Stable Disease|7|||
130749375|NCT00554515|470704554|FG000|Overall Study|Other|1|||
130749376|NCT00554515|470704554|FG000|Overall Study|Misc|15|||
130749377|NCT01276756|470704557|FG000|Overall Study|Lost to Follow-up|2|||
130749378|NCT01276756|470704558|FG001|Overall Study|Lost to Follow-up|0|||
130749379|NCT01276756|470704557|FG000|Overall Study|Adverse Event|3|||
130749380|NCT01276756|470704558|FG001|Overall Study|Adverse Event|2|||
130749381|NCT01554527|470704566|FG000|Overall Study|Withdrawal by Subject|1|||
130749382|NCT01554527|470704567|FG001|Overall Study|Withdrawal by Subject|0|||
130749383|NCT01554527|470704568|FG002|Overall Study|Withdrawal by Subject|3|||
130749384|NCT01554527|470704566|FG000|Overall Study|Lost to Follow-up|0|||
130749385|NCT01554527|470704567|FG001|Overall Study|Lost to Follow-up|0|||
130749386|NCT01554527|470704568|FG002|Overall Study|Lost to Follow-up|4|||
130749387|NCT01554527|470704566|FG000|Overall Study|Physician Decision|0|||
130749388|NCT01554527|470704567|FG001|Overall Study|Physician Decision|0|||
130749389|NCT01554527|470704568|FG002|Overall Study|Physician Decision|1|||
130749390|NCT01052480|470704569|FG000|Overall Study|Lost to Follow-up|3|||
130749391|NCT01052480|470704570|FG001|Overall Study|Lost to Follow-up|3|||
130749392|NCT01052480|470704569|FG000|Overall Study|Protocol Violation|1|||
130749393|NCT01052480|470704570|FG001|Overall Study|Protocol Violation|0|||
130749394|NCT01052480|470704569|FG000|Overall Study|Withdrawal by Subject|3|||
130749395|NCT01052480|470704570|FG001|Overall Study|Withdrawal by Subject|7|||
130749396|NCT01052480|470704569|FG000|Overall Study|Physician Decision|0|||
130749397|NCT01052480|470704570|FG001|Overall Study|Physician Decision|2|||
130749398|NCT01052480|470704569|FG000|Overall Study|Death|1|||
130749399|NCT01052480|470704570|FG001|Overall Study|Death|5|||
130749400|NCT00529373|470704577|FG000|Base Study|Adverse Event|525|||
130749401|NCT00529373|470704578|FG001|Base Study|Adverse Event|470|||
130749402|NCT00529373|470704577|FG000|Base Study|Lack of Efficacy|16|||
130749403|NCT00529373|470704578|FG001|Base Study|Lack of Efficacy|75|||
130749404|NCT00529373|470704577|FG000|Base Study|Lost to Follow-up|221|||
130749405|NCT00529373|470704578|FG001|Base Study|Lost to Follow-up|208|||
130749406|NCT00529373|470704577|FG000|Base Study|Other Protocol Specified Criteria|19|||
130749407|NCT00529373|470704578|FG001|Base Study|Other Protocol Specified Criteria|20|||
130749408|NCT00529373|470704577|FG000|Base Study|Physician Decision|60|||
130749409|NCT00529373|470704578|FG001|Base Study|Physician Decision|52|||
130749410|NCT00529373|470704577|FG000|Base Study|Protocol Violation|48|||
130749411|NCT00529373|470704578|FG001|Base Study|Protocol Violation|38|||
130749412|NCT00529373|470704577|FG000|Base Study|Withdrawal by Subject|1062|||
130749413|NCT00529373|470704578|FG001|Base Study|Withdrawal by Subject|967|||
130749414|NCT00529373|470704577|FG000|Base Study|Did not continue into Extension|1795|||
130749415|NCT00529373|470704578|FG001|Base Study|Did not continue into Extension|2238|||
130749416|NCT00529373|470704577|FG000|First Extension Study|Adverse Event|162|||
130749417|NCT00529373|470704578|FG001|First Extension Study|Adverse Event|142|||
130749418|NCT00529373|470704577|FG000|First Extension Study|Lack of Efficacy|65|||
130749419|NCT00529373|470704578|FG001|First Extension Study|Lack of Efficacy|427|||
130749420|NCT00529373|470704577|FG000|First Extension Study|Lost to Follow-up|41|||
130749421|NCT00529373|470704578|FG001|First Extension Study|Lost to Follow-up|37|||
130749422|NCT00529373|470704577|FG000|First Extension Study|Other|27|||
130749423|NCT00529373|470704578|FG001|First Extension Study|Other|47|||
130749424|NCT00529373|470704577|FG000|First Extension Study|Physician Decision|50|||
130749425|NCT00529373|470704578|FG001|First Extension Study|Physician Decision|45|||
130749426|NCT00529373|470704577|FG000|First Extension Study|Protocol Violation|16|||
130749427|NCT00529373|470704578|FG001|First Extension Study|Protocol Violation|13|||
130749428|NCT00529373|470704577|FG000|First Extension Study|Withdrawal by Subject|296|||
130749429|NCT00529373|470704578|FG001|First Extension Study|Withdrawal by Subject|287|||
130749430|NCT00529373|470704577|FG000|First Extension Study|Disposition record non-existing|0|||
130749431|NCT00529373|470704578|FG001|First Extension Study|Disposition record non-existing|1|||
130749432|NCT00529373|470704577|FG000|First Extension Study|Discontinued after 5 years completion|208|||
130749433|NCT00529373|470704578|FG001|First Extension Study|Discontinued after 5 years completion|346|||
130749434|NCT00529373|470704577|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
130749435|NCT00529373|470704578|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
130749436|NCT00529373|470704577|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
130749437|NCT00529373|470704578|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
130749438|NCT00529373|470704577|FG000|Second Extension Study|Adverse Event|101|||
130749439|NCT00529373|470704578|FG001|Second Extension Study|Adverse Event|51|||
130749440|NCT00529373|470704577|FG000|Second Extension Study|Lack of Efficacy|7|||
130749441|NCT00529373|470704578|FG001|Second Extension Study|Lack of Efficacy|15|||
130749442|NCT00529373|470704577|FG000|Second Extension Study|Lost to Follow-up|18|||
130749443|NCT00529373|470704578|FG001|Second Extension Study|Lost to Follow-up|12|||
130749444|NCT00529373|470704577|FG000|Second Extension Study|Other|7|||
130749445|NCT00529373|470704578|FG001|Second Extension Study|Other|12|||
130749446|NCT00529373|470704577|FG000|Second Extension Study|Physician Decision|63|||
130749447|NCT00529373|470704578|FG001|Second Extension Study|Physician Decision|26|||
130749448|NCT00529373|470704577|FG000|Second Extension Study|Protocol Violation|2|||
130749449|NCT00529373|470704578|FG001|Second Extension Study|Protocol Violation|1|||
130749450|NCT00529373|470704577|FG000|Second Extension Study|Withdrawal by Subject|97|||
130749451|NCT00529373|470704578|FG001|Second Extension Study|Withdrawal by Subject|75|||
130749452|NCT00529373|470704577|FG000|Second Extension Study|Status Missing|5|||
130749453|NCT00529373|470704578|FG001|Second Extension Study|Status Missing|5|||
130749454|NCT00757042|470704581|FG000|Overall Study|Lost to Follow-up|0|||
130749455|NCT00757042|470704582|FG001|Overall Study|Lost to Follow-up|0|||
130749456|NCT00757042|470704583|FG002|Overall Study|Lost to Follow-up|0|||
130749457|NCT00757042|470704584|FG003|Overall Study|Lost to Follow-up|0|||
130749458|NCT00757042|470704585|FG004|Overall Study|Lost to Follow-up|0|||
130749459|NCT00757042|470704586|FG005|Overall Study|Lost to Follow-up|0|||
130749460|NCT00757042|470704587|FG006|Overall Study|Lost to Follow-up|0|||
130749461|NCT00757042|470704588|FG007|Overall Study|Lost to Follow-up|0|||
130749462|NCT00757042|470704589|FG008|Overall Study|Lost to Follow-up|1|||
130749463|NCT00757042|470704590|FG009|Overall Study|Lost to Follow-up|0|||
130749464|NCT00757042|470704591|FG010|Overall Study|Lost to Follow-up|0|||
130749465|NCT00757042|470704581|FG000|Overall Study|Ineligibility Determined|0|||
130749466|NCT00757042|470704582|FG001|Overall Study|Ineligibility Determined|0|||
130749467|NCT00757042|470704583|FG002|Overall Study|Ineligibility Determined|0|||
130749468|NCT00757042|470704584|FG003|Overall Study|Ineligibility Determined|0|||
130749469|NCT00757042|470704585|FG004|Overall Study|Ineligibility Determined|0|||
130749470|NCT00757042|470704586|FG005|Overall Study|Ineligibility Determined|0|||
130749471|NCT00757042|470704587|FG006|Overall Study|Ineligibility Determined|0|||
130749472|NCT00757042|470704588|FG007|Overall Study|Ineligibility Determined|0|||
130749473|NCT00757042|470704589|FG008|Overall Study|Ineligibility Determined|0|||
130749474|NCT00757042|470704590|FG009|Overall Study|Ineligibility Determined|0|||
130749475|NCT00757042|470704591|FG010|Overall Study|Ineligibility Determined|1|||
130749476|NCT00757042|470704581|FG000|Overall Study|Withdrawal by Subject|0|||
130749477|NCT00757042|470704582|FG001|Overall Study|Withdrawal by Subject|0|||
130749478|NCT00757042|470704583|FG002|Overall Study|Withdrawal by Subject|0|||
130749479|NCT00757042|470704584|FG003|Overall Study|Withdrawal by Subject|0|||
130749480|NCT00757042|470704585|FG004|Overall Study|Withdrawal by Subject|0|||
130749481|NCT00757042|470704586|FG005|Overall Study|Withdrawal by Subject|0|||
130749482|NCT00757042|470704587|FG006|Overall Study|Withdrawal by Subject|0|||
130749483|NCT00757042|470704588|FG007|Overall Study|Withdrawal by Subject|0|||
130749484|NCT00757042|470704589|FG008|Overall Study|Withdrawal by Subject|0|||
130749485|NCT00757042|470704590|FG009|Overall Study|Withdrawal by Subject|1|||
130749486|NCT00757042|470704591|FG010|Overall Study|Withdrawal by Subject|0|||
130749487|NCT01870973|470704595|FG000|Overall Study|Lost to Follow-up|10|||
130749488|NCT01870973|470704596|FG001|Overall Study|Lost to Follow-up|3|||
130749489|NCT01266291|470704598|FG000|Overall Study|Adverse Event|1|||
130749490|NCT03291431|470704599|FG000|Overall Study|Protocol Violation|2|||
130749491|NCT03291431|470704600|FG001|Overall Study|Protocol Violation|1|||
130749492|NCT03291431|470704599|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
130749493|NCT03291431|470704600|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
130749494|NCT03291431|470704599|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
130749495|NCT03291431|470704600|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
130749496|NCT03850483|470704605|FG000|Treatment for Stage 1|Adverse Event|1|||
130749497|NCT03850483|470704606|FG001|Treatment for Stage 1|Adverse Event|1|||
130749498|NCT03850483|470704607|FG002|Treatment for Stage 1|Adverse Event|3|||
130749499|NCT03850483|470704608|FG003|Treatment for Stage 1|Adverse Event|0|||
130749500|NCT03850483|470704609|FG004|Treatment for Stage 1|Adverse Event|2|||
130749501|NCT03850483|470704610|FG005|Treatment for Stage 1|Adverse Event|0|||
130749502|NCT03850483|470704611|FG006|Treatment for Stage 1|Adverse Event|2|||
130749503|NCT03850483|470704612|FG007|Treatment for Stage 1|Adverse Event|2|||
130749504|NCT03850483|470704613|FG008|Treatment for Stage 1|Adverse Event|0|||
130749505|NCT03850483|470704614|FG009|Treatment for Stage 1|Adverse Event|0|||
130749506|NCT03850483|470704605|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
130749507|NCT03850483|470704606|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
130749508|NCT03850483|470704607|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
130749509|NCT03850483|470704608|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
130749510|NCT03850483|470704609|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
130749511|NCT03850483|470704610|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
130749512|NCT03850483|470704611|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
130749513|NCT03850483|470704612|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
130749514|NCT03850483|470704613|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
130749515|NCT03850483|470704614|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
130749516|NCT03850483|470704605|FG000|Treatment for Stage 1|Protocol Violation|1|||
130749517|NCT03850483|470704606|FG001|Treatment for Stage 1|Protocol Violation|0|||
130749518|NCT03850483|470704607|FG002|Treatment for Stage 1|Protocol Violation|0|||
130749519|NCT03850483|470704608|FG003|Treatment for Stage 1|Protocol Violation|0|||
130749520|NCT03850483|470704609|FG004|Treatment for Stage 1|Protocol Violation|0|||
130749521|NCT03850483|470704610|FG005|Treatment for Stage 1|Protocol Violation|0|||
130749522|NCT03850483|470704611|FG006|Treatment for Stage 1|Protocol Violation|1|||
130749523|NCT03850483|470704612|FG007|Treatment for Stage 1|Protocol Violation|0|||
130749524|NCT03850483|470704613|FG008|Treatment for Stage 1|Protocol Violation|0|||
130749525|NCT03850483|470704614|FG009|Treatment for Stage 1|Protocol Violation|0|||
130749526|NCT03850483|470704605|FG000|Treatment for Stage 1|Physician Decision|0|||
130749527|NCT03850483|470704606|FG001|Treatment for Stage 1|Physician Decision|0|||
130749528|NCT03850483|470704607|FG002|Treatment for Stage 1|Physician Decision|0|||
130749529|NCT03850483|470704608|FG003|Treatment for Stage 1|Physician Decision|0|||
130749530|NCT03850483|470704609|FG004|Treatment for Stage 1|Physician Decision|0|||
130749531|NCT03850483|470704610|FG005|Treatment for Stage 1|Physician Decision|1|||
130749532|NCT03850483|470704611|FG006|Treatment for Stage 1|Physician Decision|0|||
130749533|NCT03850483|470704612|FG007|Treatment for Stage 1|Physician Decision|0|||
130749534|NCT03850483|470704613|FG008|Treatment for Stage 1|Physician Decision|0|||
130749535|NCT03850483|470704614|FG009|Treatment for Stage 1|Physician Decision|0|||
130749536|NCT03850483|470704605|FG000|Treatment for Stage 1|Other|0|||
130749537|NCT03850483|470704606|FG001|Treatment for Stage 1|Other|0|||
130749538|NCT03850483|470704607|FG002|Treatment for Stage 1|Other|0|||
130749539|NCT03850483|470704608|FG003|Treatment for Stage 1|Other|0|||
130749540|NCT03850483|470704609|FG004|Treatment for Stage 1|Other|2|||
130749541|NCT03850483|470704610|FG005|Treatment for Stage 1|Other|1|||
130788657|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130788658|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
130788659|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
130749542|NCT03850483|470704611|FG006|Treatment for Stage 1|Other|0|||
130749543|NCT03850483|470704612|FG007|Treatment for Stage 1|Other|0|||
130749544|NCT03850483|470704613|FG008|Treatment for Stage 1|Other|0|||
130749545|NCT03850483|470704614|FG009|Treatment for Stage 1|Other|0|||
130749546|NCT03850483|470704605|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130749547|NCT03850483|470704606|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130749548|NCT03850483|470704607|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
130749549|NCT03850483|470704608|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130749550|NCT03850483|470704609|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130749551|NCT03850483|470704610|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130749552|NCT03850483|470704611|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130749553|NCT03850483|470704612|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130749554|NCT03850483|470704613|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130749555|NCT03850483|470704614|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130749556|NCT03850483|470704605|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130749557|NCT03850483|470704606|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130749558|NCT03850483|470704607|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130749559|NCT03850483|470704608|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130749560|NCT03850483|470704609|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130749561|NCT03850483|470704610|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
130749562|NCT03850483|470704611|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130749563|NCT03850483|470704612|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130749564|NCT03850483|470704613|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130749565|NCT03850483|470704614|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130749566|NCT03850483|470704605|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
130749567|NCT03850483|470704606|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
130749568|NCT03850483|470704607|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
130749569|NCT03850483|470704608|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
130749570|NCT03850483|470704609|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
130749571|NCT03850483|470704610|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
130749572|NCT03850483|470704611|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
130749573|NCT03850483|470704612|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
130749574|NCT03850483|470704613|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
130749575|NCT03850483|470704614|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
130749576|NCT03850483|470704605|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
130749577|NCT03850483|470704606|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
130749578|NCT03850483|470704607|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
130749579|NCT03850483|470704608|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
130749580|NCT03850483|470704609|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
130749581|NCT03850483|470704610|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
130749582|NCT03850483|470704611|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
130749583|NCT03850483|470704612|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
130749584|NCT03850483|470704613|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
130749585|NCT03850483|470704614|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
130749586|NCT03850483|470704605|FG000|Treatment for Stage 1|Death|0|||
130749587|NCT03850483|470704606|FG001|Treatment for Stage 1|Death|0|||
130749588|NCT03850483|470704607|FG002|Treatment for Stage 1|Death|0|||
130749589|NCT03850483|470704608|FG003|Treatment for Stage 1|Death|0|||
130749590|NCT03850483|470704609|FG004|Treatment for Stage 1|Death|0|||
130749591|NCT03850483|470704610|FG005|Treatment for Stage 1|Death|1|||
130749592|NCT03850483|470704611|FG006|Treatment for Stage 1|Death|0|||
130749593|NCT03850483|470704612|FG007|Treatment for Stage 1|Death|0|||
130749594|NCT03850483|470704613|FG008|Treatment for Stage 1|Death|0|||
130749595|NCT03850483|470704614|FG009|Treatment for Stage 1|Death|0|||
130749596|NCT03850483|470704605|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
130749597|NCT03850483|470704606|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
130749598|NCT03850483|470704607|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
130749599|NCT03850483|470704608|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
130749600|NCT03850483|470704609|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
130749601|NCT03850483|470704610|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
130749602|NCT03850483|470704611|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
130749603|NCT03850483|470704612|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
130749604|NCT03850483|470704613|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
130749605|NCT03850483|470704614|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
130749606|NCT03850483|470704605|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
130749607|NCT03850483|470704606|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
130749608|NCT03850483|470704607|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
130749609|NCT03850483|470704608|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
130749610|NCT03850483|470704609|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
130749611|NCT03850483|470704610|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
130749612|NCT03850483|470704611|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
130749613|NCT03850483|470704612|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
130749614|NCT03850483|470704613|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
130749615|NCT03850483|470704614|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
130749616|NCT03850483|470704605|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
130749617|NCT03850483|470704606|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
130749618|NCT03850483|470704607|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
130749619|NCT03850483|470704608|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
130749620|NCT03850483|470704609|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
130749621|NCT03850483|470704610|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
130749622|NCT03850483|470704611|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
130749623|NCT03850483|470704612|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
130749624|NCT03850483|470704613|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
130749625|NCT03850483|470704614|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
130749626|NCT03850483|470704605|FG000|Follow-up for Stage 1|Physician Decision|0|||
130749627|NCT03850483|470704606|FG001|Follow-up for Stage 1|Physician Decision|0|||
130749628|NCT03850483|470704607|FG002|Follow-up for Stage 1|Physician Decision|0|||
130749629|NCT03850483|470704608|FG003|Follow-up for Stage 1|Physician Decision|0|||
130749630|NCT03850483|470704609|FG004|Follow-up for Stage 1|Physician Decision|1|||
130749631|NCT03850483|470704610|FG005|Follow-up for Stage 1|Physician Decision|0|||
130749632|NCT03850483|470704611|FG006|Follow-up for Stage 1|Physician Decision|1|||
130749633|NCT03850483|470704612|FG007|Follow-up for Stage 1|Physician Decision|0|||
130749634|NCT03850483|470704613|FG008|Follow-up for Stage 1|Physician Decision|0|||
130749635|NCT03850483|470704614|FG009|Follow-up for Stage 1|Physician Decision|0|||
130749636|NCT03850483|470704605|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
130749637|NCT03850483|470704606|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
130749638|NCT03850483|470704607|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
130749639|NCT03850483|470704608|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
130749640|NCT03850483|470704609|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
130749641|NCT03850483|470704610|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
130749642|NCT03850483|470704611|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
130749643|NCT03850483|470704612|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
130749644|NCT03850483|470704613|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
130749645|NCT03850483|470704614|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
130749646|NCT03850483|470704605|FG000|Follow-up for Stage 1|Adverse Event|0|||
130749647|NCT03850483|470704606|FG001|Follow-up for Stage 1|Adverse Event|0|||
130749648|NCT03850483|470704607|FG002|Follow-up for Stage 1|Adverse Event|1|||
130749649|NCT03850483|470704608|FG003|Follow-up for Stage 1|Adverse Event|0|||
130749650|NCT03850483|470704609|FG004|Follow-up for Stage 1|Adverse Event|0|||
130749651|NCT03850483|470704610|FG005|Follow-up for Stage 1|Adverse Event|1|||
130749652|NCT03850483|470704611|FG006|Follow-up for Stage 1|Adverse Event|0|||
130749653|NCT03850483|470704612|FG007|Follow-up for Stage 1|Adverse Event|0|||
130749654|NCT03850483|470704613|FG008|Follow-up for Stage 1|Adverse Event|0|||
130749655|NCT03850483|470704614|FG009|Follow-up for Stage 1|Adverse Event|0|||
130749656|NCT03850483|470704605|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130749657|NCT03850483|470704606|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
130749658|NCT03850483|470704607|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130749659|NCT03850483|470704608|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130749660|NCT03850483|470704609|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
130749661|NCT03850483|470704610|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
130749662|NCT03850483|470704611|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130749663|NCT03850483|470704612|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130749664|NCT03850483|470704613|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130749665|NCT03850483|470704614|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130749666|NCT03850483|470704605|FG000|Follow-up for Stage 1|Other|0|||
130749667|NCT03850483|470704606|FG001|Follow-up for Stage 1|Other|2|||
130749668|NCT03850483|470704607|FG002|Follow-up for Stage 1|Other|0|||
130749669|NCT03850483|470704608|FG003|Follow-up for Stage 1|Other|2|||
130749670|NCT03850483|470704609|FG004|Follow-up for Stage 1|Other|0|||
130749671|NCT03850483|470704610|FG005|Follow-up for Stage 1|Other|1|||
130749672|NCT03850483|470704611|FG006|Follow-up for Stage 1|Other|0|||
130749673|NCT03850483|470704612|FG007|Follow-up for Stage 1|Other|0|||
130749674|NCT03850483|470704613|FG008|Follow-up for Stage 1|Other|0|||
130749675|NCT03850483|470704614|FG009|Follow-up for Stage 1|Other|0|||
130749676|NCT03850483|470704605|FG000|Treatment for Stage 2|Adverse Event|0|||
130749677|NCT03850483|470704606|FG001|Treatment for Stage 2|Adverse Event|0|||
130749678|NCT03850483|470704607|FG002|Treatment for Stage 2|Adverse Event|0|||
130749679|NCT03850483|470704608|FG003|Treatment for Stage 2|Adverse Event|0|||
130749680|NCT03850483|470704609|FG004|Treatment for Stage 2|Adverse Event|0|||
130749681|NCT03850483|470704610|FG005|Treatment for Stage 2|Adverse Event|0|||
130749682|NCT03850483|470704611|FG006|Treatment for Stage 2|Adverse Event|0|||
130749683|NCT03850483|470704612|FG007|Treatment for Stage 2|Adverse Event|0|||
130749684|NCT03850483|470704613|FG008|Treatment for Stage 2|Adverse Event|0|||
130749685|NCT03850483|470704614|FG009|Treatment for Stage 2|Adverse Event|1|||
130749686|NCT03850483|470704605|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
130749687|NCT03850483|470704606|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
130749688|NCT03850483|470704607|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
130749689|NCT03850483|470704608|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
130749690|NCT03850483|470704609|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
130749691|NCT03850483|470704610|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
130749692|NCT03850483|470704611|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
130749693|NCT03850483|470704612|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
130749694|NCT03850483|470704613|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
130749695|NCT03850483|470704614|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
130749696|NCT03850483|470704605|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
130749697|NCT03850483|470704606|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
130749698|NCT03850483|470704607|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
130749699|NCT03850483|470704608|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
130749700|NCT03850483|470704609|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
130749701|NCT03850483|470704610|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
130749702|NCT03850483|470704611|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
130749703|NCT03850483|470704612|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
130749704|NCT03850483|470704613|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
130749705|NCT03850483|470704614|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
130749706|NCT03850483|470704605|FG000|Treatment for Stage 2|Physician Decision|0|||
130749707|NCT03850483|470704606|FG001|Treatment for Stage 2|Physician Decision|0|||
130749708|NCT03850483|470704607|FG002|Treatment for Stage 2|Physician Decision|0|||
130749709|NCT03850483|470704608|FG003|Treatment for Stage 2|Physician Decision|0|||
130749710|NCT03850483|470704609|FG004|Treatment for Stage 2|Physician Decision|0|||
130749711|NCT03850483|470704610|FG005|Treatment for Stage 2|Physician Decision|0|||
130749712|NCT03850483|470704611|FG006|Treatment for Stage 2|Physician Decision|0|||
130749713|NCT03850483|470704612|FG007|Treatment for Stage 2|Physician Decision|0|||
130749714|NCT03850483|470704613|FG008|Treatment for Stage 2|Physician Decision|0|||
130749715|NCT03850483|470704614|FG009|Treatment for Stage 2|Physician Decision|1|||
130749716|NCT03850483|470704605|FG000|Treatment for Stage 2|Protocol Violation|0|||
130749717|NCT03850483|470704606|FG001|Treatment for Stage 2|Protocol Violation|0|||
130749718|NCT03850483|470704607|FG002|Treatment for Stage 2|Protocol Violation|0|||
130749719|NCT03850483|470704608|FG003|Treatment for Stage 2|Protocol Violation|0|||
130749720|NCT03850483|470704609|FG004|Treatment for Stage 2|Protocol Violation|0|||
130749721|NCT03850483|470704610|FG005|Treatment for Stage 2|Protocol Violation|0|||
130749722|NCT03850483|470704611|FG006|Treatment for Stage 2|Protocol Violation|0|||
130749723|NCT03850483|470704612|FG007|Treatment for Stage 2|Protocol Violation|0|||
130749724|NCT03850483|470704613|FG008|Treatment for Stage 2|Protocol Violation|1|||
130749725|NCT03850483|470704614|FG009|Treatment for Stage 2|Protocol Violation|0|||
130749726|NCT03850483|470704605|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
130749727|NCT03850483|470704606|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
130749728|NCT03850483|470704607|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
130749729|NCT03850483|470704608|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
130749730|NCT03850483|470704609|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
130749731|NCT03850483|470704610|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
130749732|NCT03850483|470704611|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
130749733|NCT03850483|470704612|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
130749734|NCT03850483|470704613|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
130749735|NCT03850483|470704614|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
130749736|NCT03850483|470704605|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130749737|NCT03850483|470704606|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130749738|NCT03850483|470704607|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130749739|NCT03850483|470704608|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130749740|NCT03850483|470704609|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130749741|NCT03850483|470704610|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130749742|NCT03850483|470704611|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130749743|NCT03850483|470704612|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130749744|NCT03850483|470704613|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130749745|NCT03850483|470704614|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
130749746|NCT03850483|470704605|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
130749747|NCT03850483|470704606|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
130749748|NCT03850483|470704607|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
130749749|NCT03850483|470704608|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
130749750|NCT03850483|470704609|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
130749751|NCT03850483|470704610|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
130749752|NCT03850483|470704611|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
130749753|NCT03850483|470704612|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
130749754|NCT03850483|470704613|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
130749755|NCT03850483|470704614|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
130749756|NCT03850483|470704605|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
130749757|NCT03850483|470704606|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
130749758|NCT03850483|470704607|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
130749759|NCT03850483|470704608|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
130749760|NCT03850483|470704609|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
130788660|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
130749761|NCT03850483|470704610|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
130749762|NCT03850483|470704611|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
130749763|NCT03850483|470704612|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
130749764|NCT03850483|470704613|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
130749765|NCT03850483|470704614|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
130749766|NCT03850483|470704605|FG000|Follow-up For Stage 2|Other|0|||
130749767|NCT03850483|470704606|FG001|Follow-up For Stage 2|Other|0|||
130749768|NCT03850483|470704607|FG002|Follow-up For Stage 2|Other|0|||
130749769|NCT03850483|470704608|FG003|Follow-up For Stage 2|Other|0|||
130749770|NCT03850483|470704609|FG004|Follow-up For Stage 2|Other|0|||
130749771|NCT03850483|470704610|FG005|Follow-up For Stage 2|Other|0|||
130749772|NCT03850483|470704611|FG006|Follow-up For Stage 2|Other|0|||
130749773|NCT03850483|470704612|FG007|Follow-up For Stage 2|Other|0|||
130749774|NCT03850483|470704613|FG008|Follow-up For Stage 2|Other|0|||
130749775|NCT03850483|470704614|FG009|Follow-up For Stage 2|Other|1|||
130749776|NCT04432831|470706371|FG000|Overall Study|Withdrawal by Subject|24|||
130749777|NCT04432831|470706372|FG001|Overall Study|Withdrawal by Subject|28|||
130749778|NCT04432831|470706373|FG002|Overall Study|Withdrawal by Subject|21|||
130749779|NCT04432831|470706371|FG000|Overall Study|Death|23|||
130749780|NCT04432831|470706372|FG001|Overall Study|Death|23|||
130749781|NCT04432831|470706373|FG002|Overall Study|Death|17|||
130749782|NCT04432831|470706371|FG000|Overall Study|Lost to Follow-up|15|||
130749783|NCT04432831|470706372|FG001|Overall Study|Lost to Follow-up|15|||
130749784|NCT04432831|470706373|FG002|Overall Study|Lost to Follow-up|12|||
130749785|NCT04432831|470706371|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
130749786|NCT04432831|470706372|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
130749787|NCT04432831|470706373|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
130749788|NCT04432831|470706371|FG000|Overall Study|Reason Not Specified|7|||
130749789|NCT04432831|470706372|FG001|Overall Study|Reason Not Specified|11|||
130749790|NCT04432831|470706373|FG002|Overall Study|Reason Not Specified|9|||
130749791|NCT04432831|470706371|FG000|Overall Study|Adverse Event|7|||
130749792|NCT04432831|470706372|FG001|Overall Study|Adverse Event|7|||
130749793|NCT04432831|470706373|FG002|Overall Study|Adverse Event|7|||
130749794|NCT04432831|470706371|FG000|Overall Study|Physician Decision|1|||
130749795|NCT04432831|470706372|FG001|Overall Study|Physician Decision|3|||
130749796|NCT04432831|470706373|FG002|Overall Study|Physician Decision|6|||
130749797|NCT04432831|470706371|FG000|Overall Study|Protocol Violation|1|||
130749798|NCT04432831|470706372|FG001|Overall Study|Protocol Violation|0|||
130749799|NCT04432831|470706373|FG002|Overall Study|Protocol Violation|2|||
130749800|NCT04432831|470706371|FG000|Overall Study|Pregnancy|0|||
130749801|NCT04432831|470706372|FG001|Overall Study|Pregnancy|1|||
130749802|NCT04432831|470706373|FG002|Overall Study|Pregnancy|0|||
130749803|NCT04432831|470706371|FG000|Overall Study|Lack of Efficacy|0|||
130749804|NCT04432831|470706372|FG001|Overall Study|Lack of Efficacy|0|||
130749805|NCT04432831|470706373|FG002|Overall Study|Lack of Efficacy|2|||
130749806|NCT00652626|470706376|FG000|Initial Treatment Phase|Adverse Event|0|||
130749807|NCT00652626|470706377|FG001|Initial Treatment Phase|Adverse Event|0|||
130749808|NCT00652626|470706378|FG002|Initial Treatment Phase|Adverse Event|0|||
130749809|NCT00652626|470706379|FG003|Initial Treatment Phase|Adverse Event|0|||
130749810|NCT00652626|470706380|FG004|Initial Treatment Phase|Adverse Event|1|||
130749811|NCT00652626|470706381|FG005|Initial Treatment Phase|Adverse Event|0|||
130749812|NCT00652626|470706382|FG006|Initial Treatment Phase|Adverse Event|0|||
130749813|NCT00652626|470706376|FG000|Initial Treatment Phase|Protocol Violation|0|||
130749814|NCT00652626|470706377|FG001|Initial Treatment Phase|Protocol Violation|0|||
130749815|NCT00652626|470706378|FG002|Initial Treatment Phase|Protocol Violation|0|||
130749816|NCT00652626|470706379|FG003|Initial Treatment Phase|Protocol Violation|1|||
130749817|NCT00652626|470706380|FG004|Initial Treatment Phase|Protocol Violation|0|||
130749818|NCT00652626|470706381|FG005|Initial Treatment Phase|Protocol Violation|0|||
130749819|NCT00652626|470706382|FG006|Initial Treatment Phase|Protocol Violation|0|||
130749820|NCT00652626|470706376|FG000|Initial Treatment Phase|Physician Decision|0|||
130749821|NCT00652626|470706377|FG001|Initial Treatment Phase|Physician Decision|0|||
130749822|NCT00652626|470706378|FG002|Initial Treatment Phase|Physician Decision|0|||
130749823|NCT00652626|470706379|FG003|Initial Treatment Phase|Physician Decision|0|||
130749824|NCT00652626|470706380|FG004|Initial Treatment Phase|Physician Decision|1|||
130749825|NCT00652626|470706381|FG005|Initial Treatment Phase|Physician Decision|0|||
130749826|NCT00652626|470706382|FG006|Initial Treatment Phase|Physician Decision|0|||
130749827|NCT00652626|470706376|FG000|Initial Treatment Phase|Sponsor Request|0|||
130749828|NCT00652626|470706377|FG001|Initial Treatment Phase|Sponsor Request|0|||
130749829|NCT00652626|470706378|FG002|Initial Treatment Phase|Sponsor Request|1|||
130749830|NCT00652626|470706379|FG003|Initial Treatment Phase|Sponsor Request|0|||
130749831|NCT00652626|470706380|FG004|Initial Treatment Phase|Sponsor Request|0|||
130749832|NCT00652626|470706381|FG005|Initial Treatment Phase|Sponsor Request|0|||
130749833|NCT00652626|470706382|FG006|Initial Treatment Phase|Sponsor Request|0|||
130749834|NCT00652626|470706376|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
130749835|NCT00652626|470706377|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
130749836|NCT00652626|470706378|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
130749837|NCT00652626|470706379|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
130749838|NCT00652626|470706380|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
130749839|NCT00652626|470706381|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
130749840|NCT00652626|470706382|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
130749841|NCT00652626|470706376|FG000|Extension Phase|Withdrawal by Subject|0|||
130749842|NCT00652626|470706377|FG001|Extension Phase|Withdrawal by Subject|0|||
130749843|NCT00652626|470706378|FG002|Extension Phase|Withdrawal by Subject|0|||
130749844|NCT00652626|470706379|FG003|Extension Phase|Withdrawal by Subject|0|||
130749845|NCT00652626|470706380|FG004|Extension Phase|Withdrawal by Subject|0|||
130749846|NCT00652626|470706381|FG005|Extension Phase|Withdrawal by Subject|2|||
130749847|NCT00652626|470706382|FG006|Extension Phase|Withdrawal by Subject|0|||
130749848|NCT00652626|470706376|FG000|Extension Phase|Adverse Event|0|||
130749849|NCT00652626|470706377|FG001|Extension Phase|Adverse Event|0|||
130749850|NCT00652626|470706378|FG002|Extension Phase|Adverse Event|0|||
130749851|NCT00652626|470706379|FG003|Extension Phase|Adverse Event|0|||
130749852|NCT00652626|470706380|FG004|Extension Phase|Adverse Event|0|||
130749853|NCT00652626|470706381|FG005|Extension Phase|Adverse Event|2|||
130749854|NCT00652626|470706382|FG006|Extension Phase|Adverse Event|1|||
130749855|NCT00652626|470706376|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130749856|NCT00652626|470706377|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130749857|NCT00652626|470706378|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130749858|NCT00652626|470706379|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130749859|NCT00652626|470706380|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130749860|NCT00652626|470706381|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
130749861|NCT00652626|470706382|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130749862|NCT00652626|470706376|FG000|Extension Phase|Physician Decision|0|||
130749863|NCT00652626|470706377|FG001|Extension Phase|Physician Decision|0|||
130749864|NCT00652626|470706378|FG002|Extension Phase|Physician Decision|0|||
130749865|NCT00652626|470706379|FG003|Extension Phase|Physician Decision|0|||
130749866|NCT00652626|470706380|FG004|Extension Phase|Physician Decision|0|||
130749867|NCT00652626|470706381|FG005|Extension Phase|Physician Decision|1|||
130749868|NCT00652626|470706382|FG006|Extension Phase|Physician Decision|1|||
130749869|NCT00652626|470706376|FG000|Extension Phase|Death|0|||
130749870|NCT00652626|470706377|FG001|Extension Phase|Death|0|||
130749871|NCT00652626|470706378|FG002|Extension Phase|Death|0|||
130749872|NCT00652626|470706379|FG003|Extension Phase|Death|0|||
130749873|NCT00652626|470706380|FG004|Extension Phase|Death|0|||
130749874|NCT00652626|470706381|FG005|Extension Phase|Death|1|||
130749875|NCT00652626|470706382|FG006|Extension Phase|Death|1|||
130749876|NCT01623310|470706383|FG000|Overall Study|Adverse Event|21|||
130749877|NCT01623310|470706383|FG000|Overall Study|Lost to Follow-up|18|||
130749878|NCT01623310|470706383|FG000|Overall Study|Lack of Efficacy|6|||
130749879|NCT01623310|470706383|FG000|Overall Study|Protocol Violation|6|||
130749880|NCT01623310|470706383|FG000|Overall Study|Withdrawal by Subject|25|||
130749881|NCT01623310|470706383|FG000|Overall Study|Became potentially child-bearing|1|||
130749882|NCT01623310|470706383|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
130749883|NCT01623310|470706383|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
130749884|NCT02898597|470706384|FG000|Overall Study|Protocol Violation|4|||
130749885|NCT02898597|470706385|FG001|Overall Study|Protocol Violation|2|||
130749886|NCT02898597|470706384|FG000|Overall Study|Lost to Follow-up|0|||
130749887|NCT02898597|470706385|FG001|Overall Study|Lost to Follow-up|9|||
130749888|NCT02898597|470706384|FG000|Overall Study|Death|0|||
130749889|NCT02898597|470706385|FG001|Overall Study|Death|1|||
130749890|NCT02530125|470706386|FG000|Completed Treatment|Early termination of study|1|||
130749891|NCT02530125|470706386|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
130749892|NCT01568034|470706387|FG000|Overall Study|Withdrawal by Subject|1|||
130749893|NCT01568034|470706388|FG001|Overall Study|Withdrawal by Subject|0|||
130749894|NCT01568034|470706389|FG002|Overall Study|Withdrawal by Subject|0|||
130749895|NCT01568034|470706390|FG003|Overall Study|Withdrawal by Subject|0|||
130749896|NCT06098339|470706391|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
130749897|NCT06098339|470706392|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
130749898|NCT06098339|470706391|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
130749899|NCT06098339|470706392|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
130749900|NCT02492984|470706393|FG000|Overall Study|Adverse Event|1|||
130749901|NCT02492984|470706394|FG001|Overall Study|Adverse Event|0|||
130749902|NCT02492984|470706393|FG000|Overall Study|Protocol Violation|1|||
130749903|NCT02492984|470706394|FG001|Overall Study|Protocol Violation|0|||
130749904|NCT02492984|470706393|FG000|Overall Study|Withdrawal by Subject|1|||
130749905|NCT02492984|470706394|FG001|Overall Study|Withdrawal by Subject|0|||
130749906|NCT02498444|470706395|FG000|Overall Study|Withdrawal by Subject|3|||
130749907|NCT02498444|470706396|FG001|Overall Study|Withdrawal by Subject|0|||
130749908|NCT02498444|470706395|FG000|Overall Study|Physician Decision|1|||
130749909|NCT02498444|470706396|FG001|Overall Study|Physician Decision|0|||
130749910|NCT02027545|470706397|FG000|Overall Study|Failed to sign HIPAA|0|||
130749911|NCT02027545|470706398|FG001|Overall Study|Failed to sign HIPAA|2|||
130749912|NCT02027545|470706397|FG000|Overall Study|Failed to attend study visit|2|||
130749913|NCT02027545|470706398|FG001|Overall Study|Failed to attend study visit|0|||
130749914|NCT02027545|470706397|FG000|Overall Study|Protocol Violation|1|||
130749915|NCT02027545|470706398|FG001|Overall Study|Protocol Violation|0|||
130749916|NCT02453334|470706399|FG000|Overall Study|Death|15|||
130749917|NCT02453334|470706400|FG001|Overall Study|Death|13|||
130749918|NCT02453334|470706399|FG000|Overall Study|Adverse Event|2|||
130749919|NCT02453334|470706400|FG001|Overall Study|Adverse Event|1|||
130749920|NCT02453334|470706399|FG000|Overall Study|Lost to Follow-up|5|||
130749921|NCT02453334|470706400|FG001|Overall Study|Lost to Follow-up|9|||
130749922|NCT02453334|470706399|FG000|Overall Study|Physician Decision|1|||
130749923|NCT02453334|470706400|FG001|Overall Study|Physician Decision|0|||
130749924|NCT02453334|470706399|FG000|Overall Study|Withdrawal by Subject|17|||
130749925|NCT02453334|470706400|FG001|Overall Study|Withdrawal by Subject|13|||
130749926|NCT02453334|470706399|FG000|Overall Study|Other reason|1|||
130749927|NCT02453334|470706400|FG001|Overall Study|Other reason|4|||
130749928|NCT04090060|470706403|FG000|Overall Study|Lost to Follow-up|76|||
130749929|NCT04090060|470706404|FG001|Overall Study|Lost to Follow-up|77|||
130749930|NCT03337113|470706411|FG000|Overall Study|Adverse Event|1|||
130749931|NCT03337113|470706412|FG001|Overall Study|Adverse Event|1|||
130749932|NCT03337113|470706413|FG002|Overall Study|Adverse Event|0|||
130749933|NCT03337113|470706414|FG003|Overall Study|Adverse Event|1|||
130749934|NCT03337113|470706411|FG000|Overall Study|Physician Decision|0|||
130749935|NCT03337113|470706412|FG001|Overall Study|Physician Decision|2|||
130749936|NCT03337113|470706413|FG002|Overall Study|Physician Decision|0|||
130749937|NCT03337113|470706414|FG003|Overall Study|Physician Decision|1|||
130749938|NCT03337113|470706411|FG000|Overall Study|Withdrawal by Subject|0|||
130749939|NCT03337113|470706412|FG001|Overall Study|Withdrawal by Subject|0|||
130749940|NCT03337113|470706413|FG002|Overall Study|Withdrawal by Subject|1|||
130749941|NCT03337113|470706414|FG003|Overall Study|Withdrawal by Subject|0|||
130749942|NCT01164579|470706415|FG000|Overall Study|Lack of Efficacy|0|||
130749943|NCT01164579|470706416|FG001|Overall Study|Lack of Efficacy|0|||
130749944|NCT01164579|470706417|FG002|Overall Study|Lack of Efficacy|6|||
130749945|NCT01164579|470706415|FG000|Overall Study|Lost to Follow-up|1|||
130749946|NCT01164579|470706416|FG001|Overall Study|Lost to Follow-up|1|||
130749947|NCT01164579|470706417|FG002|Overall Study|Lost to Follow-up|0|||
130749948|NCT01164579|470706415|FG000|Overall Study|Withdrawal by Subject|2|||
130749949|NCT01164579|470706416|FG001|Overall Study|Withdrawal by Subject|5|||
130749950|NCT01164579|470706417|FG002|Overall Study|Withdrawal by Subject|3|||
130749951|NCT01164579|470706415|FG000|Overall Study|Protocol Violation|0|||
130749952|NCT01164579|470706416|FG001|Overall Study|Protocol Violation|1|||
130749953|NCT01164579|470706417|FG002|Overall Study|Protocol Violation|2|||
130749954|NCT01164579|470706415|FG000|Overall Study|Adverse Event|4|||
130749955|NCT01164579|470706416|FG001|Overall Study|Adverse Event|2|||
130749956|NCT01164579|470706417|FG002|Overall Study|Adverse Event|5|||
130749957|NCT01164579|470706415|FG000|Overall Study|Reason not specified|1|||
130749958|NCT01164579|470706416|FG001|Overall Study|Reason not specified|0|||
130749959|NCT01164579|470706417|FG002|Overall Study|Reason not specified|0|||
130749960|NCT00302328|470706418|FG000|Overall Study|Physician Decision|0|||
130749961|NCT00302328|470706419|FG001|Overall Study|Physician Decision|1|||
130749962|NCT00302328|470706420|FG002|Overall Study|Physician Decision|0|||
130749963|NCT03491462|470706425|FG000|Overall Study|Lost to Follow-up|2|||
130749964|NCT03491462|470706426|FG001|Overall Study|Lost to Follow-up|0|||
130749965|NCT03491462|470706425|FG000|Overall Study|Adverse Event|11|||
130749966|NCT03491462|470706426|FG001|Overall Study|Adverse Event|1|||
130749967|NCT03491462|470706425|FG000|Overall Study|Physician Decision|3|||
130749968|NCT03491462|470706426|FG001|Overall Study|Physician Decision|0|||
130749969|NCT03491462|470706425|FG000|Overall Study|Withdrawal by Subject|22|||
130749970|NCT03491462|470706426|FG001|Overall Study|Withdrawal by Subject|15|||
130749971|NCT00423332|470706430|FG000|Overall Study|Adverse Event|6|||
130749972|NCT00423332|470706431|FG001|Overall Study|Adverse Event|2|||
130749973|NCT00423332|470706430|FG000|Overall Study|Withdrawal by Subject|1|||
130749974|NCT00423332|470706431|FG001|Overall Study|Withdrawal by Subject|0|||
130749975|NCT00423332|470706430|FG000|Overall Study|Condition under investigation worsened|1|||
130749976|NCT00423332|470706431|FG001|Overall Study|Condition under investigation worsened|1|||
130749977|NCT00423332|470706430|FG000|Overall Study|Progressive at Week 6|0|||
130749978|NCT00423332|470706431|FG001|Overall Study|Progressive at Week 6|1|||
130749979|NCT00423332|470706430|FG000|Overall Study|Unblinded before 12 weeks|1|||
130749980|NCT00423332|470706431|FG001|Overall Study|Unblinded before 12 weeks|3|||
130749981|NCT00685399|470706442|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130749982|NCT00685399|470706443|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130749983|NCT00685399|470706444|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130749984|NCT00685399|470706445|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130749985|NCT00685399|470706446|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130749986|NCT00685399|470706447|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130749987|NCT00685399|470706448|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130749988|NCT00685399|470706449|FG007|Treatment Period 1|Withdrawal by Subject|0|||
130749989|NCT00685399|470706442|FG000|Treatment Period 1|Protocol Violation|1|||
130749990|NCT00685399|470706443|FG001|Treatment Period 1|Protocol Violation|0|||
130749991|NCT00685399|470706444|FG002|Treatment Period 1|Protocol Violation|0|||
130749992|NCT00685399|470706445|FG003|Treatment Period 1|Protocol Violation|0|||
130749993|NCT00685399|470706446|FG004|Treatment Period 1|Protocol Violation|0|||
130749994|NCT00685399|470706447|FG005|Treatment Period 1|Protocol Violation|0|||
130749995|NCT00685399|470706448|FG006|Treatment Period 1|Protocol Violation|0|||
130749996|NCT00685399|470706449|FG007|Treatment Period 1|Protocol Violation|0|||
130749997|NCT00685399|470706442|FG000|Treatment Period 1|Administrative|2|||
130749998|NCT00685399|470706443|FG001|Treatment Period 1|Administrative|0|||
130749999|NCT00685399|470706444|FG002|Treatment Period 1|Administrative|0|||
130750000|NCT00685399|470706445|FG003|Treatment Period 1|Administrative|0|||
130750001|NCT00685399|470706446|FG004|Treatment Period 1|Administrative|0|||
130750002|NCT00685399|470706447|FG005|Treatment Period 1|Administrative|0|||
130750003|NCT00685399|470706448|FG006|Treatment Period 1|Administrative|0|||
130750004|NCT00685399|470706449|FG007|Treatment Period 1|Administrative|0|||
130750005|NCT00685399|470706442|FG000|Treatment Period 1|Lack of Efficacy|1|||
130750006|NCT00685399|470706443|FG001|Treatment Period 1|Lack of Efficacy|0|||
130750007|NCT00685399|470706444|FG002|Treatment Period 1|Lack of Efficacy|0|||
130750008|NCT00685399|470706445|FG003|Treatment Period 1|Lack of Efficacy|0|||
130750009|NCT00685399|470706446|FG004|Treatment Period 1|Lack of Efficacy|0|||
130750010|NCT00685399|470706447|FG005|Treatment Period 1|Lack of Efficacy|0|||
130750011|NCT00685399|470706448|FG006|Treatment Period 1|Lack of Efficacy|0|||
130750012|NCT00685399|470706449|FG007|Treatment Period 1|Lack of Efficacy|0|||
130750013|NCT00685399|470706442|FG000|Treatment Period 2|Administrative Problems|0|||
130750014|NCT00685399|470706443|FG001|Treatment Period 2|Administrative Problems|2|||
130750015|NCT00685399|470706444|FG002|Treatment Period 2|Administrative Problems|1|||
130750016|NCT00685399|470706445|FG003|Treatment Period 2|Administrative Problems|0|||
130750017|NCT00685399|470706446|FG004|Treatment Period 2|Administrative Problems|0|||
130750018|NCT00685399|470706447|FG005|Treatment Period 2|Administrative Problems|0|||
130750019|NCT00685399|470706448|FG006|Treatment Period 2|Administrative Problems|0|||
130750020|NCT00685399|470706449|FG007|Treatment Period 2|Administrative Problems|0|||
130750021|NCT00685399|470706442|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130750022|NCT00685399|470706443|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130750023|NCT00685399|470706444|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130750024|NCT00685399|470706445|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130750025|NCT00685399|470706446|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130750026|NCT00685399|470706447|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130750027|NCT00685399|470706448|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130750028|NCT00685399|470706449|FG007|Treatment Period 2|Withdrawal by Subject|2|||
130750029|NCT00685399|470706442|FG000|Treatment Period 2|Adverse Event|0|||
130750030|NCT00685399|470706443|FG001|Treatment Period 2|Adverse Event|0|||
130750031|NCT00685399|470706444|FG002|Treatment Period 2|Adverse Event|0|||
130750032|NCT00685399|470706445|FG003|Treatment Period 2|Adverse Event|0|||
130750033|NCT00685399|470706446|FG004|Treatment Period 2|Adverse Event|0|||
130750034|NCT00685399|470706447|FG005|Treatment Period 2|Adverse Event|1|||
130750035|NCT00685399|470706448|FG006|Treatment Period 2|Adverse Event|0|||
130750036|NCT00685399|470706449|FG007|Treatment Period 2|Adverse Event|0|||
130750037|NCT00685399|470706442|FG000|Treatment Period 2|Lack of Efficacy|0|||
130750038|NCT00685399|470706443|FG001|Treatment Period 2|Lack of Efficacy|10|||
130750039|NCT00685399|470706444|FG002|Treatment Period 2|Lack of Efficacy|2|||
130750040|NCT00685399|470706445|FG003|Treatment Period 2|Lack of Efficacy|0|||
130750041|NCT00685399|470706446|FG004|Treatment Period 2|Lack of Efficacy|0|||
130750042|NCT00685399|470706447|FG005|Treatment Period 2|Lack of Efficacy|1|||
130750043|NCT00685399|470706448|FG006|Treatment Period 2|Lack of Efficacy|0|||
130750044|NCT00685399|470706449|FG007|Treatment Period 2|Lack of Efficacy|0|||
130750045|NCT00685399|470706442|FG000|Extension|Administrative Issues|0|||
130750046|NCT00685399|470706443|FG001|Extension|Administrative Issues|0|||
130750047|NCT00685399|470706444|FG002|Extension|Administrative Issues|0|||
130750048|NCT00685399|470706445|FG003|Extension|Administrative Issues|1|||
130750049|NCT00685399|470706446|FG004|Extension|Administrative Issues|0|||
130750050|NCT00685399|470706447|FG005|Extension|Administrative Issues|0|||
130750051|NCT00685399|470706448|FG006|Extension|Administrative Issues|0|||
130750052|NCT00685399|470706449|FG007|Extension|Administrative Issues|0|||
130750053|NCT00685399|470706442|FG000|Extension|Withdrawal by Subject|0|||
130750054|NCT00685399|470706443|FG001|Extension|Withdrawal by Subject|0|||
130750055|NCT00685399|470706444|FG002|Extension|Withdrawal by Subject|0|||
130750056|NCT00685399|470706445|FG003|Extension|Withdrawal by Subject|1|||
130750057|NCT00685399|470706446|FG004|Extension|Withdrawal by Subject|0|||
130750058|NCT00685399|470706447|FG005|Extension|Withdrawal by Subject|0|||
130750059|NCT00685399|470706448|FG006|Extension|Withdrawal by Subject|0|||
130750060|NCT00685399|470706449|FG007|Extension|Withdrawal by Subject|0|||
130750061|NCT00685399|470706442|FG000|Extension|Protocol Violation|0|||
130750062|NCT00685399|470706443|FG001|Extension|Protocol Violation|0|||
130750063|NCT00685399|470706444|FG002|Extension|Protocol Violation|0|||
130750064|NCT00685399|470706445|FG003|Extension|Protocol Violation|1|||
130750065|NCT00685399|470706446|FG004|Extension|Protocol Violation|0|||
130750066|NCT00685399|470706447|FG005|Extension|Protocol Violation|0|||
130750067|NCT00685399|470706448|FG006|Extension|Protocol Violation|0|||
130750068|NCT00685399|470706449|FG007|Extension|Protocol Violation|0|||
130750069|NCT00685399|470706442|FG000|Extension|Lack of Efficacy|0|||
130750070|NCT00685399|470706443|FG001|Extension|Lack of Efficacy|0|||
130750071|NCT00685399|470706444|FG002|Extension|Lack of Efficacy|0|||
130750072|NCT00685399|470706445|FG003|Extension|Lack of Efficacy|2|||
130750073|NCT00685399|470706446|FG004|Extension|Lack of Efficacy|0|||
130750074|NCT00685399|470706447|FG005|Extension|Lack of Efficacy|0|||
130750075|NCT00685399|470706448|FG006|Extension|Lack of Efficacy|0|||
130750076|NCT00685399|470706449|FG007|Extension|Lack of Efficacy|0|||
130750077|NCT00685399|470706442|FG000|Extension|Adverse Event|0|||
130750078|NCT00685399|470706443|FG001|Extension|Adverse Event|0|||
130750079|NCT00685399|470706444|FG002|Extension|Adverse Event|0|||
130750080|NCT00685399|470706445|FG003|Extension|Adverse Event|2|||
130750081|NCT00685399|470706446|FG004|Extension|Adverse Event|0|||
130750082|NCT00685399|470706447|FG005|Extension|Adverse Event|0|||
130750083|NCT00685399|470706448|FG006|Extension|Adverse Event|0|||
130750084|NCT00685399|470706449|FG007|Extension|Adverse Event|0|||
130750085|NCT00927862|470706450|FG000|Overall Study|Missing data needed for endpt analyses|27|||
130750086|NCT00927862|470706451|FG001|Overall Study|Missing data needed for endpt analyses|45|||
130750087|NCT00820248|470706452|FG000|Overall Study|No treated|4|||
130750088|NCT00820248|470706453|FG001|Overall Study|No treated|1|||
130750089|NCT02237196|470706455|FG000|Overall Study|Adverse Event|0|||
130750090|NCT02237196|470706456|FG001|Overall Study|Adverse Event|1|||
130750091|NCT02237196|470706457|FG002|Overall Study|Adverse Event|1|||
130750092|NCT02237196|470706458|FG003|Overall Study|Adverse Event|0|||
130750093|NCT02237196|470706455|FG000|Overall Study|Lost to Follow-up|4|||
130750094|NCT02237196|470706456|FG001|Overall Study|Lost to Follow-up|2|||
130750095|NCT02237196|470706457|FG002|Overall Study|Lost to Follow-up|4|||
130750096|NCT02237196|470706458|FG003|Overall Study|Lost to Follow-up|6|||
130750097|NCT02237196|470706455|FG000|Overall Study|Physician Decision|2|||
130750098|NCT02237196|470706456|FG001|Overall Study|Physician Decision|0|||
130750099|NCT02237196|470706457|FG002|Overall Study|Physician Decision|0|||
130750100|NCT02237196|470706458|FG003|Overall Study|Physician Decision|1|||
130750101|NCT02237196|470706455|FG000|Overall Study|Pregnancy|0|||
130750102|NCT02237196|470706456|FG001|Overall Study|Pregnancy|0|||
130750103|NCT02237196|470706457|FG002|Overall Study|Pregnancy|1|||
130750104|NCT02237196|470706458|FG003|Overall Study|Pregnancy|1|||
130750105|NCT02237196|470706455|FG000|Overall Study|Withdrawal by Subject|1|||
130750106|NCT02237196|470706456|FG001|Overall Study|Withdrawal by Subject|1|||
130750107|NCT02237196|470706457|FG002|Overall Study|Withdrawal by Subject|4|||
130750108|NCT02237196|470706458|FG003|Overall Study|Withdrawal by Subject|1|||
130750109|NCT02237196|470706455|FG000|Overall Study|Site Error|1|||
130750110|NCT02237196|470706456|FG001|Overall Study|Site Error|2|||
130750111|NCT02237196|470706457|FG002|Overall Study|Site Error|0|||
130750112|NCT02237196|470706458|FG003|Overall Study|Site Error|2|||
130750113|NCT01750697|470706461|FG000|Overall Study|Transferred Back to Local Hospital|1|||
130750114|NCT01750697|470706461|FG000|Overall Study|Physician and Family Decision|1|||
130750115|NCT01750697|470706461|FG000|Overall Study|Transferred to Adult Services|5|||
130750116|NCT01750697|470706461|FG000|Overall Study|Physician Decision|1|||
130750117|NCT01750697|470706461|FG000|Overall Study|Withdrawal by Subject|1|||
130750118|NCT01562782|470706471|FG000|Overall Study|Withdrawal by Subject|3|||
130750119|NCT01562782|470706472|FG001|Overall Study|Withdrawal by Subject|3|||
130750120|NCT01562782|470706471|FG000|Overall Study|screen failure|1|||
130750121|NCT01562782|470706472|FG001|Overall Study|screen failure|2|||
130750122|NCT01421225|470706475|FG000|Overall Study|Withdrawal by Subject|0|||
130750123|NCT01421225|470706476|FG001|Overall Study|Withdrawal by Subject|1|||
130750124|NCT02049814|470706479|FG000|Overall Study|Reason not Specified|4|||
130750125|NCT02049814|470706480|FG001|Overall Study|Reason not Specified|3|||
130750126|NCT02049814|470706479|FG000|Overall Study|Pregnancy|1|||
130750127|NCT02049814|470706480|FG001|Overall Study|Pregnancy|0|||
130750128|NCT02049814|470706479|FG000|Overall Study|Lost to Follow-up|2|||
130750129|NCT02049814|470706480|FG001|Overall Study|Lost to Follow-up|3|||
130750130|NCT02049814|470706479|FG000|Overall Study|Serious Protocol Violation|5|||
130750131|NCT02049814|470706480|FG001|Overall Study|Serious Protocol Violation|7|||
130750132|NCT02049814|470706479|FG000|Overall Study|Study Termination|0|||
130750133|NCT02049814|470706480|FG001|Overall Study|Study Termination|1|||
130750134|NCT02049814|470706479|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
130750135|NCT02049814|470706480|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
130750136|NCT02049814|470706479|FG000|Overall Study|Voluntary withdrawal|9|||
130750137|NCT02049814|470706480|FG001|Overall Study|Voluntary withdrawal|8|||
130750138|NCT01282372|470706481|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
130750139|NCT01282372|470706481|FG000|Overall Study|Lost to Follow-up|23|||
130750140|NCT01282372|470706481|FG000|Overall Study|Withdrawal by Subject|11|||
130750141|NCT01282372|470706481|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
130750142|NCT01282372|470706481|FG000|Overall Study|Death|1|||
130750143|NCT01282372|470706481|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
130750144|NCT01282372|470706481|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
130750145|NCT01282372|470706481|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
130750146|NCT01282372|470706481|FG000|Overall Study|Adverse Event|12|||
130750147|NCT02993250|470706483|FG000|Overall Study|Lost to Follow-up|0|||
130750148|NCT02993250|470706484|FG001|Overall Study|Lost to Follow-up|1|||
130750149|NCT00713258|470706485|FG000|Overall Study|Adverse Event|2|||
130750150|NCT00713258|470706486|FG001|Overall Study|Adverse Event|4|||
130750151|NCT00713258|470706485|FG000|Overall Study|Non-Compliance|2|||
130750152|NCT00713258|470706486|FG001|Overall Study|Non-Compliance|1|||
130750153|NCT00713258|470706485|FG000|Overall Study|Other|1|||
130788661|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
130750154|NCT00713258|470706486|FG001|Overall Study|Other|1|||
130750155|NCT02527434|470706487|FG000|Overall Study|Lost to Follow-up|2|||
130750156|NCT02527434|470706488|FG001|Overall Study|Lost to Follow-up|2|||
130750157|NCT02527434|470706489|FG002|Overall Study|Lost to Follow-up|0|||
130750158|NCT02527434|470706487|FG000|Overall Study|Death|19|||
130750159|NCT02527434|470706488|FG001|Overall Study|Death|6|||
130750160|NCT02527434|470706489|FG002|Overall Study|Death|17|||
130750161|NCT02527434|470706487|FG000|Overall Study|Withdrawal by Subject|5|||
130750162|NCT02527434|470706488|FG001|Overall Study|Withdrawal by Subject|3|||
130750163|NCT02527434|470706489|FG002|Overall Study|Withdrawal by Subject|3|||
130750164|NCT02527434|470706487|FG000|Overall Study|Reason Not Specified|1|||
130750165|NCT02527434|470706488|FG001|Overall Study|Reason Not Specified|0|||
130750166|NCT02527434|470706489|FG002|Overall Study|Reason Not Specified|0|||
130750167|NCT02527434|470706487|FG000|Overall Study|Site closure|1|||
130750168|NCT02527434|470706488|FG001|Overall Study|Site closure|0|||
130750169|NCT02527434|470706489|FG002|Overall Study|Site closure|0|||
130750170|NCT01322490|470706490|FG000|Treatment Period|Adverse Event|12|||
130750171|NCT01322490|470706491|FG001|Treatment Period|Adverse Event|18|||
130750172|NCT01322490|470706492|FG002|Treatment Period|Adverse Event|15|||
130750173|NCT01322490|470706490|FG000|Treatment Period|Death|5|||
130750174|NCT01322490|470706491|FG001|Treatment Period|Death|7|||
130750175|NCT01322490|470706492|FG002|Treatment Period|Death|3|||
130750176|NCT01322490|470706490|FG000|Treatment Period|Lack of Efficacy|89|||
130750177|NCT01322490|470706491|FG001|Treatment Period|Lack of Efficacy|100|||
130750178|NCT01322490|470706492|FG002|Treatment Period|Lack of Efficacy|112|||
130750179|NCT01322490|470706490|FG000|Treatment Period|Physician Decision|0|||
130750180|NCT01322490|470706491|FG001|Treatment Period|Physician Decision|2|||
130750181|NCT01322490|470706492|FG002|Treatment Period|Physician Decision|1|||
130750182|NCT01322490|470706490|FG000|Treatment Period|Protocol Violation|7|||
130750183|NCT01322490|470706491|FG001|Treatment Period|Protocol Violation|5|||
130750184|NCT01322490|470706492|FG002|Treatment Period|Protocol Violation|4|||
130750185|NCT01322490|470706490|FG000|Treatment Period|Withdrawal by Subject|14|||
130750186|NCT01322490|470706491|FG001|Treatment Period|Withdrawal by Subject|16|||
130750187|NCT01322490|470706492|FG002|Treatment Period|Withdrawal by Subject|11|||
130750188|NCT01322490|470706490|FG000|Treatment Period|Non-compliance with study drug|0|||
130750189|NCT01322490|470706491|FG001|Treatment Period|Non-compliance with study drug|0|||
130750190|NCT01322490|470706492|FG002|Treatment Period|Non-compliance with study drug|1|||
130750191|NCT01322490|470706490|FG000|Treatment Period|Other per report|2|||
130750192|NCT01322490|470706491|FG001|Treatment Period|Other per report|2|||
130750193|NCT01322490|470706492|FG002|Treatment Period|Other per report|1|||
130750194|NCT01322490|470706490|FG000|Treatment Period|Randomized but Not Treated|3|||
130750195|NCT01322490|470706491|FG001|Treatment Period|Randomized but Not Treated|3|||
130750196|NCT01322490|470706492|FG002|Treatment Period|Randomized but Not Treated|5|||
130750197|NCT01322490|470706490|FG000|Long Term Follow-up Period|Death|235|||
130750198|NCT01322490|470706491|FG001|Long Term Follow-up Period|Death|239|||
130750199|NCT01322490|470706492|FG002|Long Term Follow-up Period|Death|236|||
130750200|NCT01322490|470706490|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
130750201|NCT01322490|470706491|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
130750202|NCT01322490|470706492|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
130750203|NCT01322490|470706490|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
130750204|NCT01322490|470706491|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
130750205|NCT01322490|470706492|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
130750206|NCT01322490|470706490|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
130750207|NCT01322490|470706491|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
130750208|NCT01322490|470706492|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
130750209|NCT01322490|470706490|FG000|Long Term Follow-up Period|Other per report|3|||
130750210|NCT01322490|470706491|FG001|Long Term Follow-up Period|Other per report|2|||
130750211|NCT01322490|470706492|FG002|Long Term Follow-up Period|Other per report|2|||
130750212|NCT01322490|470706490|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
130750213|NCT01322490|470706491|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
130750214|NCT01322490|470706492|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
130750215|NCT01431716|470706493|FG000|Overall Study|Withdrawal of consent|1|||
130750216|NCT00568061|470706494|FG000|Overall Study|Inclusion / exclusion criteria|5|||
130750217|NCT00568061|470706495|FG001|Overall Study|Inclusion / exclusion criteria|1|||
130750218|NCT00568061|470706494|FG000|Overall Study|Adverse Event|0|||
130750219|NCT00568061|470706495|FG001|Overall Study|Adverse Event|1|||
130750220|NCT01896128|470706496|FG000|Overall Study|Withdrawal by Subject|3|||
130750221|NCT01896128|470706497|FG001|Overall Study|Withdrawal by Subject|3|||
130750222|NCT05027451|470706498|FG000|Overall Study|Lost to Follow-up|1|||
130750223|NCT05027451|470706499|FG001|Overall Study|Lost to Follow-up|1|||
130750224|NCT02693002|470706504|FG000|Overall Study|Withdrawal by Subject|1|||
130750225|NCT02693002|470706505|FG001|Overall Study|Withdrawal by Subject|0|||
130750226|NCT00708214|470706506|FG000|Overall Study|Other Adverse Event|3|||
130750227|NCT00708214|470706507|FG001|Overall Study|Other Adverse Event|6|||
130750228|NCT00708214|470706508|FG002|Overall Study|Other Adverse Event|2|||
130750229|NCT00708214|470706506|FG000|Overall Study|Other|0|||
130750230|NCT00708214|470706507|FG001|Overall Study|Other|1|||
130750231|NCT00708214|470706508|FG002|Overall Study|Other|1|||
130750232|NCT00708214|470706506|FG000|Overall Study|Progressive Disease|4|||
130750233|NCT00708214|470706507|FG001|Overall Study|Progressive Disease|6|||
130750234|NCT00708214|470706508|FG002|Overall Study|Progressive Disease|5|||
130750235|NCT02929589|470706543|FG000|Overall Study|Withdrawal by Subject|1|||
130750236|NCT02929589|470706544|FG001|Overall Study|Withdrawal by Subject|0|||
130750237|NCT02929589|470706545|FG002|Overall Study|Withdrawal by Subject|0|||
130750238|NCT02929589|470706546|FG003|Overall Study|Withdrawal by Subject|0|||
130750239|NCT02929589|470706543|FG000|Overall Study|Physician Decision|2|||
130750240|NCT02929589|470706544|FG001|Overall Study|Physician Decision|0|||
130750241|NCT02929589|470706545|FG002|Overall Study|Physician Decision|0|||
130788662|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
130788663|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
130788664|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130788665|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130788666|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130750242|NCT02929589|470706546|FG003|Overall Study|Physician Decision|0|||
130750243|NCT02343939|470706547|FG000|Overall Study|Death|0|||
130750244|NCT02343939|470706548|FG001|Overall Study|Death|15|||
130750245|NCT02343939|470706549|FG002|Overall Study|Death|4|||
130750246|NCT02343939|470706550|FG003|Overall Study|Death|2|||
130750247|NCT02343939|470706551|FG004|Overall Study|Death|5|||
130750248|NCT02343939|470706552|FG005|Overall Study|Death|11|||
130750249|NCT02343939|470706553|FG006|Overall Study|Death|8|||
130750250|NCT02343939|470706554|FG007|Overall Study|Death|22|||
130750251|NCT02343939|470706555|FG008|Overall Study|Death|1|||
130750252|NCT02343939|470706547|FG000|Overall Study|Study terminated by sponsor|0|||
130750253|NCT02343939|470706548|FG001|Overall Study|Study terminated by sponsor|27|||
130750254|NCT02343939|470706549|FG002|Overall Study|Study terminated by sponsor|0|||
130750255|NCT02343939|470706550|FG003|Overall Study|Study terminated by sponsor|1|||
130750256|NCT02343939|470706551|FG004|Overall Study|Study terminated by sponsor|1|||
130750257|NCT02343939|470706552|FG005|Overall Study|Study terminated by sponsor|5|||
130750258|NCT02343939|470706553|FG006|Overall Study|Study terminated by sponsor|3|||
130750259|NCT02343939|470706554|FG007|Overall Study|Study terminated by sponsor|4|||
130750260|NCT02343939|470706555|FG008|Overall Study|Study terminated by sponsor|0|||
130750261|NCT02343939|470706547|FG000|Overall Study|Withdrew consent|3|||
130750262|NCT02343939|470706548|FG001|Overall Study|Withdrew consent|6|||
130750263|NCT02343939|470706549|FG002|Overall Study|Withdrew consent|1|||
130750264|NCT02343939|470706550|FG003|Overall Study|Withdrew consent|2|||
130750265|NCT02343939|470706551|FG004|Overall Study|Withdrew consent|2|||
130788667|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130788668|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
130750266|NCT02343939|470706552|FG005|Overall Study|Withdrew consent|0|||
130750267|NCT02343939|470706553|FG006|Overall Study|Withdrew consent|0|||
130750268|NCT02343939|470706554|FG007|Overall Study|Withdrew consent|8|||
130750269|NCT02343939|470706555|FG008|Overall Study|Withdrew consent|6|||
130750270|NCT02343939|470706547|FG000|Overall Study|Treatment failure|0|||
130750271|NCT02343939|470706548|FG001|Overall Study|Treatment failure|0|||
130750272|NCT02343939|470706549|FG002|Overall Study|Treatment failure|0|||
130750273|NCT02343939|470706550|FG003|Overall Study|Treatment failure|0|||
130750274|NCT02343939|470706551|FG004|Overall Study|Treatment failure|0|||
130750275|NCT02343939|470706552|FG005|Overall Study|Treatment failure|0|||
130750276|NCT02343939|470706553|FG006|Overall Study|Treatment failure|2|||
130750277|NCT02343939|470706554|FG007|Overall Study|Treatment failure|1|||
130750278|NCT02343939|470706555|FG008|Overall Study|Treatment failure|0|||
130750279|NCT02343939|470706547|FG000|Overall Study|Investigator's discretion|0|||
130750280|NCT02343939|470706548|FG001|Overall Study|Investigator's discretion|0|||
130750281|NCT02343939|470706549|FG002|Overall Study|Investigator's discretion|0|||
130750282|NCT02343939|470706550|FG003|Overall Study|Investigator's discretion|1|||
130750283|NCT02343939|470706551|FG004|Overall Study|Investigator's discretion|0|||
130750284|NCT02343939|470706552|FG005|Overall Study|Investigator's discretion|0|||
130750285|NCT02343939|470706553|FG006|Overall Study|Investigator's discretion|1|||
130750286|NCT02343939|470706554|FG007|Overall Study|Investigator's discretion|0|||
130750287|NCT02343939|470706555|FG008|Overall Study|Investigator's discretion|0|||
130750288|NCT02343939|470706547|FG000|Overall Study|Adverse Event|0|||
130750289|NCT02343939|470706548|FG001|Overall Study|Adverse Event|0|||
130750290|NCT02343939|470706549|FG002|Overall Study|Adverse Event|0|||
130750291|NCT02343939|470706550|FG003|Overall Study|Adverse Event|0|||
130750292|NCT02343939|470706551|FG004|Overall Study|Adverse Event|0|||
130750293|NCT02343939|470706552|FG005|Overall Study|Adverse Event|1|||
130750294|NCT02343939|470706553|FG006|Overall Study|Adverse Event|0|||
130750295|NCT02343939|470706554|FG007|Overall Study|Adverse Event|0|||
130750296|NCT02343939|470706555|FG008|Overall Study|Adverse Event|0|||
130750297|NCT02343939|470706547|FG000|Overall Study|Never Treated With ENTO|0|||
130750298|NCT02343939|470706548|FG001|Overall Study|Never Treated With ENTO|0|||
130750299|NCT02343939|470706549|FG002|Overall Study|Never Treated With ENTO|0|||
130750300|NCT02343939|470706550|FG003|Overall Study|Never Treated With ENTO|0|||
130750301|NCT02343939|470706551|FG004|Overall Study|Never Treated With ENTO|0|||
130750302|NCT02343939|470706552|FG005|Overall Study|Never Treated With ENTO|0|||
130750303|NCT02343939|470706553|FG006|Overall Study|Never Treated With ENTO|1|||
130750304|NCT02343939|470706554|FG007|Overall Study|Never Treated With ENTO|2|||
130750305|NCT02343939|470706555|FG008|Overall Study|Never Treated With ENTO|0|||
130750306|NCT01303172|470706562|FG000|Overall Study|Physician Decision|9|||
130750307|NCT01303172|470706563|FG001|Overall Study|Physician Decision|6|||
130750308|NCT01303172|470706562|FG000|Overall Study|Adverse Event|5|||
130750309|NCT01303172|470706563|FG001|Overall Study|Adverse Event|2|||
130750310|NCT01303172|470706562|FG000|Overall Study|Withdrawal by Subject|4|||
130750311|NCT01303172|470706563|FG001|Overall Study|Withdrawal by Subject|2|||
130750312|NCT01303172|470706562|FG000|Overall Study|Death|20|||
130750313|NCT01303172|470706563|FG001|Overall Study|Death|7|||
130750314|NCT01303172|470706562|FG000|Overall Study|Lack of Efficacy|25|||
130750315|NCT01303172|470706563|FG001|Overall Study|Lack of Efficacy|17|||
130750316|NCT00462709|470706566|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
130750317|NCT00462709|470706566|FG000|Overall Study|Lost to Follow-up|10|||
130750318|NCT00462709|470706566|FG000|Overall Study|Withdrawal by Subject|8|||
130750319|NCT00462709|470706566|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
130750320|NCT00462709|470706566|FG000|Overall Study|Death|2|||
130750321|NCT00462709|470706566|FG000|Overall Study|Logistical reasons|2|||
130750322|NCT00462709|470706566|FG000|Overall Study|Physician Decision|1|||
130750323|NCT00462709|470706566|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
130750324|NCT04468347|470706567|FG000|Overall Study|Withdrawal by Subject|0|||
130750325|NCT04468347|470706568|FG001|Overall Study|Withdrawal by Subject|1|||
130750326|NCT04468347|470706569|FG002|Overall Study|Withdrawal by Subject|3|||
130750327|NCT04468347|470706570|FG003|Overall Study|Withdrawal by Subject|3|||
130750328|NCT04468347|470706567|FG000|Overall Study|Lost to Follow-up|0|||
130750329|NCT04468347|470706568|FG001|Overall Study|Lost to Follow-up|0|||
130750330|NCT04468347|470706569|FG002|Overall Study|Lost to Follow-up|1|||
130750331|NCT04468347|470706570|FG003|Overall Study|Lost to Follow-up|1|||
130750332|NCT04468347|470706567|FG000|Overall Study|Physician Decision|1|||
130750333|NCT04468347|470706568|FG001|Overall Study|Physician Decision|0|||
130750334|NCT04468347|470706569|FG002|Overall Study|Physician Decision|2|||
130750335|NCT04468347|470706570|FG003|Overall Study|Physician Decision|0|||
130750336|NCT04468347|470706567|FG000|Overall Study|Protocol Violation|1|||
130750337|NCT04468347|470706568|FG001|Overall Study|Protocol Violation|0|||
130750338|NCT04468347|470706569|FG002|Overall Study|Protocol Violation|0|||
130750339|NCT04468347|470706570|FG003|Overall Study|Protocol Violation|0|||
130750340|NCT00665431|470706571|FG000|Overall Study|Adverse Event|16|||
130750341|NCT00665431|470706572|FG001|Overall Study|Adverse Event|22|||
130750342|NCT00665431|470706573|FG002|Overall Study|Adverse Event|6|||
130750343|NCT00665431|470706571|FG000|Overall Study|Withdrawal by Subject|17|||
130750344|NCT00665431|470706572|FG001|Overall Study|Withdrawal by Subject|25|||
130750345|NCT00665431|470706573|FG002|Overall Study|Withdrawal by Subject|15|||
130750346|NCT00665431|470706571|FG000|Overall Study|Lost to Follow-up|3|||
130750347|NCT00665431|470706572|FG001|Overall Study|Lost to Follow-up|3|||
130750348|NCT00665431|470706573|FG002|Overall Study|Lost to Follow-up|1|||
130750349|NCT00665431|470706571|FG000|Overall Study|Other|4|||
130750350|NCT00665431|470706572|FG001|Overall Study|Other|7|||
130750351|NCT00665431|470706573|FG002|Overall Study|Other|2|||
130750352|NCT03483961|470708581|FG000|Overall Study|Lost to Follow-up|7|||
130750353|NCT03483961|470708582|FG001|Overall Study|Lost to Follow-up|6|||
130750354|NCT03483961|470708583|FG002|Overall Study|Lost to Follow-up|6|||
130750355|NCT03483961|470708584|FG003|Overall Study|Lost to Follow-up|6|||
130750356|NCT03483961|470708585|FG004|Overall Study|Lost to Follow-up|6|||
130750357|NCT03483961|470708586|FG005|Overall Study|Lost to Follow-up|4|||
130750358|NCT03483961|470708587|FG006|Overall Study|Lost to Follow-up|4|||
130750359|NCT03483961|470708588|FG007|Overall Study|Lost to Follow-up|11|||
130750360|NCT03483961|470708589|FG008|Overall Study|Lost to Follow-up|1|||
130750361|NCT03483961|470708590|FG009|Overall Study|Lost to Follow-up|0|||
130750362|NCT03483961|470708581|FG000|Overall Study|Withdrawal by Subject|3|||
130750363|NCT03483961|470708582|FG001|Overall Study|Withdrawal by Subject|4|||
130750364|NCT03483961|470708583|FG002|Overall Study|Withdrawal by Subject|5|||
130750365|NCT03483961|470708584|FG003|Overall Study|Withdrawal by Subject|3|||
130750366|NCT03483961|470708585|FG004|Overall Study|Withdrawal by Subject|4|||
130750367|NCT03483961|470708586|FG005|Overall Study|Withdrawal by Subject|2|||
130750368|NCT03483961|470708587|FG006|Overall Study|Withdrawal by Subject|1|||
130750369|NCT03483961|470708588|FG007|Overall Study|Withdrawal by Subject|2|||
130750370|NCT03483961|470708589|FG008|Overall Study|Withdrawal by Subject|1|||
130750371|NCT03483961|470708590|FG009|Overall Study|Withdrawal by Subject|0|||
130750372|NCT03483961|470708581|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
130750373|NCT03483961|470708582|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130750374|NCT03483961|470708583|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130750375|NCT03483961|470708584|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130750376|NCT03483961|470708585|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130750377|NCT03483961|470708586|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130750378|NCT03483961|470708587|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130750379|NCT03483961|470708588|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130750380|NCT03483961|470708589|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130750381|NCT03483961|470708590|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130750382|NCT03483961|470708581|FG000|Overall Study|Adverse Event|0|||
130750383|NCT03483961|470708582|FG001|Overall Study|Adverse Event|0|||
130750384|NCT03483961|470708583|FG002|Overall Study|Adverse Event|1|||
130750385|NCT03483961|470708584|FG003|Overall Study|Adverse Event|0|||
130750386|NCT03483961|470708585|FG004|Overall Study|Adverse Event|0|||
130750387|NCT03483961|470708586|FG005|Overall Study|Adverse Event|0|||
130750388|NCT03483961|470708587|FG006|Overall Study|Adverse Event|0|||
130750389|NCT03483961|470708588|FG007|Overall Study|Adverse Event|0|||
130750390|NCT03483961|470708589|FG008|Overall Study|Adverse Event|0|||
130750391|NCT03483961|470708590|FG009|Overall Study|Adverse Event|0|||
130750392|NCT00356603|470708591|FG000|Overall Study|Other|6|||
130750393|NCT00356603|470708592|FG001|Overall Study|Other|3|||
130750394|NCT00728468|470708594|FG000|Overall Study|Enrolled but not treated|1|||
130750395|NCT00728468|470708594|FG000|Overall Study|Death|1|||
130750396|NCT00728468|470708594|FG000|Overall Study|Protocol Violation|4|||
130750397|NCT00728468|470708594|FG000|Overall Study|Objective progression or relapse|9|||
130750398|NCT00728468|470708594|FG000|Overall Study|Study terminated by sponsor|1|||
130750399|NCT01262287|470708595|FG000|Overall Study|Lost to Follow-up|2|||
130750400|NCT01262287|470708596|FG001|Overall Study|Lost to Follow-up|1|||
130750401|NCT00932373|470708597|FG000|Overall Study|Progressive disease|3|||
130750402|NCT00932373|470708598|FG001|Overall Study|Progressive disease|1|||
130750403|NCT00932373|470708599|FG002|Overall Study|Progressive disease|0|||
130750404|NCT00932373|470708600|FG003|Overall Study|Progressive disease|0|||
130750405|NCT00932373|470708601|FG004|Overall Study|Progressive disease|10|||
130750406|NCT00932373|470708602|FG005|Overall Study|Progressive disease|1|||
130750407|NCT00932373|470708603|FG006|Overall Study|Progressive disease|0|||
130750408|NCT00932373|470708604|FG007|Overall Study|Progressive disease|2|||
130750409|NCT00932373|470708605|FG008|Overall Study|Progressive disease|1|||
130750410|NCT00932373|470708606|FG009|Overall Study|Progressive disease|9|||
130750411|NCT00932373|470708607|FG010|Overall Study|Progressive disease|2|||
130750412|NCT00932373|470708597|FG000|Overall Study|Adverse Event|0|||
130750413|NCT00932373|470708598|FG001|Overall Study|Adverse Event|0|||
130750414|NCT00932373|470708599|FG002|Overall Study|Adverse Event|0|||
130750415|NCT00932373|470708600|FG003|Overall Study|Adverse Event|0|||
130750416|NCT00932373|470708601|FG004|Overall Study|Adverse Event|2|||
130750417|NCT00932373|470708602|FG005|Overall Study|Adverse Event|1|||
130750418|NCT00932373|470708603|FG006|Overall Study|Adverse Event|0|||
130750419|NCT00932373|470708604|FG007|Overall Study|Adverse Event|1|||
130750420|NCT00932373|470708605|FG008|Overall Study|Adverse Event|0|||
130750421|NCT00932373|470708606|FG009|Overall Study|Adverse Event|2|||
130750422|NCT00932373|470708607|FG010|Overall Study|Adverse Event|1|||
130750423|NCT00932373|470708597|FG000|Overall Study|Physician Decision|0|||
130750424|NCT00932373|470708598|FG001|Overall Study|Physician Decision|0|||
130750425|NCT00932373|470708599|FG002|Overall Study|Physician Decision|1|||
130750426|NCT00932373|470708600|FG003|Overall Study|Physician Decision|0|||
130750427|NCT00932373|470708601|FG004|Overall Study|Physician Decision|2|||
130750428|NCT00932373|470708602|FG005|Overall Study|Physician Decision|0|||
130750429|NCT00932373|470708603|FG006|Overall Study|Physician Decision|0|||
130750430|NCT00932373|470708604|FG007|Overall Study|Physician Decision|0|||
130750431|NCT00932373|470708605|FG008|Overall Study|Physician Decision|0|||
130750432|NCT00932373|470708606|FG009|Overall Study|Physician Decision|1|||
130750433|NCT00932373|470708607|FG010|Overall Study|Physician Decision|0|||
130750434|NCT00932373|470708597|FG000|Overall Study|Dose limiting toxicity|0|||
130750435|NCT00932373|470708598|FG001|Overall Study|Dose limiting toxicity|0|||
130750436|NCT00932373|470708599|FG002|Overall Study|Dose limiting toxicity|0|||
130750437|NCT00932373|470708600|FG003|Overall Study|Dose limiting toxicity|0|||
130750438|NCT00932373|470708601|FG004|Overall Study|Dose limiting toxicity|0|||
130750439|NCT00932373|470708602|FG005|Overall Study|Dose limiting toxicity|1|||
130750440|NCT00932373|470708603|FG006|Overall Study|Dose limiting toxicity|0|||
130750441|NCT00932373|470708604|FG007|Overall Study|Dose limiting toxicity|0|||
130750442|NCT00932373|470708605|FG008|Overall Study|Dose limiting toxicity|0|||
130750443|NCT00932373|470708606|FG009|Overall Study|Dose limiting toxicity|0|||
130750444|NCT00932373|470708607|FG010|Overall Study|Dose limiting toxicity|0|||
130750445|NCT00932373|470708597|FG000|Overall Study|Withdrawal by Subject|0|||
130750446|NCT00932373|470708598|FG001|Overall Study|Withdrawal by Subject|0|||
130750447|NCT00932373|470708599|FG002|Overall Study|Withdrawal by Subject|0|||
130750448|NCT00932373|470708600|FG003|Overall Study|Withdrawal by Subject|0|||
130750449|NCT00932373|470708601|FG004|Overall Study|Withdrawal by Subject|0|||
130750450|NCT00932373|470708602|FG005|Overall Study|Withdrawal by Subject|0|||
130750451|NCT00932373|470708603|FG006|Overall Study|Withdrawal by Subject|0|||
130750452|NCT00932373|470708604|FG007|Overall Study|Withdrawal by Subject|0|||
130750453|NCT00932373|470708605|FG008|Overall Study|Withdrawal by Subject|1|||
130750454|NCT00932373|470708606|FG009|Overall Study|Withdrawal by Subject|0|||
130750455|NCT00932373|470708607|FG010|Overall Study|Withdrawal by Subject|0|||
130750456|NCT00932373|470708597|FG000|Overall Study|Clinical progression|0|||
130750457|NCT00932373|470708598|FG001|Overall Study|Clinical progression|0|||
130750458|NCT00932373|470708599|FG002|Overall Study|Clinical progression|0|||
130750459|NCT00932373|470708600|FG003|Overall Study|Clinical progression|0|||
130750460|NCT00932373|470708601|FG004|Overall Study|Clinical progression|0|||
130750461|NCT00932373|470708602|FG005|Overall Study|Clinical progression|0|||
130750462|NCT00932373|470708603|FG006|Overall Study|Clinical progression|1|||
130750463|NCT00932373|470708604|FG007|Overall Study|Clinical progression|0|||
130750464|NCT00932373|470708605|FG008|Overall Study|Clinical progression|0|||
130750465|NCT00932373|470708606|FG009|Overall Study|Clinical progression|0|||
130750466|NCT00932373|470708607|FG010|Overall Study|Clinical progression|0|||
130750467|NCT00932373|470708597|FG000|Overall Study|Lack of Efficacy|0|||
130750468|NCT00932373|470708598|FG001|Overall Study|Lack of Efficacy|0|||
130750469|NCT00932373|470708599|FG002|Overall Study|Lack of Efficacy|0|||
130750470|NCT00932373|470708600|FG003|Overall Study|Lack of Efficacy|0|||
130750471|NCT00932373|470708601|FG004|Overall Study|Lack of Efficacy|0|||
130750472|NCT00932373|470708602|FG005|Overall Study|Lack of Efficacy|0|||
130750473|NCT00932373|470708603|FG006|Overall Study|Lack of Efficacy|0|||
130750474|NCT00932373|470708604|FG007|Overall Study|Lack of Efficacy|0|||
130750475|NCT00932373|470708605|FG008|Overall Study|Lack of Efficacy|0|||
130750476|NCT00932373|470708606|FG009|Overall Study|Lack of Efficacy|1|||
130750477|NCT00932373|470708607|FG010|Overall Study|Lack of Efficacy|0|||
130750478|NCT01637922|470708608|FG000|Overall Study|Adverse Event|0|||
130750479|NCT01637922|470708609|FG001|Overall Study|Adverse Event|1|||
130750480|NCT01637922|470708608|FG000|Overall Study|Protocol Violation|0|||
130750481|NCT01637922|470708609|FG001|Overall Study|Protocol Violation|1|||
130750482|NCT01637922|470708608|FG000|Overall Study|Withdrawal by Subject|0|||
130750483|NCT01637922|470708609|FG001|Overall Study|Withdrawal by Subject|3|||
130750484|NCT01637922|470708608|FG000|Overall Study|Lost to Follow-up|2|||
130750485|NCT01637922|470708609|FG001|Overall Study|Lost to Follow-up|0|||
130750486|NCT00638404|470708610|FG000|Overall Study|Physician Decision|8|||
130750487|NCT00638404|470708611|FG001|Overall Study|Physician Decision|0|||
130750488|NCT02509507|470708612|FG000|Overall Study|Death|21|||
130750489|NCT02509507|470708613|FG001|Overall Study|Death|3|||
130750490|NCT02509507|470708614|FG002|Overall Study|Death|22|||
130750491|NCT02509507|470708615|FG003|Overall Study|Death|14|||
130750492|NCT02509507|470708616|FG004|Overall Study|Death|8|||
130750493|NCT02509507|470708617|FG005|Overall Study|Death|12|||
130750494|NCT02509507|470708618|FG006|Overall Study|Death|5|||
130750495|NCT02509507|470708619|FG007|Overall Study|Death|4|||
130750496|NCT02509507|470708620|FG008|Overall Study|Death|8|||
130750497|NCT02509507|470708612|FG000|Overall Study|Lost to Follow-up|0|||
130750498|NCT02509507|470708613|FG001|Overall Study|Lost to Follow-up|1|||
130750499|NCT02509507|470708614|FG002|Overall Study|Lost to Follow-up|0|||
130750500|NCT02509507|470708615|FG003|Overall Study|Lost to Follow-up|0|||
130750501|NCT02509507|470708616|FG004|Overall Study|Lost to Follow-up|0|||
130750502|NCT02509507|470708617|FG005|Overall Study|Lost to Follow-up|2|||
130750503|NCT02509507|470708618|FG006|Overall Study|Lost to Follow-up|0|||
130750504|NCT02509507|470708619|FG007|Overall Study|Lost to Follow-up|0|||
130750505|NCT02509507|470708620|FG008|Overall Study|Lost to Follow-up|0|||
130750506|NCT02509507|470708612|FG000|Overall Study|Withdrawal by Subject|2|||
130750507|NCT02509507|470708613|FG001|Overall Study|Withdrawal by Subject|0|||
130750508|NCT02509507|470708614|FG002|Overall Study|Withdrawal by Subject|1|||
130750509|NCT02509507|470708615|FG003|Overall Study|Withdrawal by Subject|4|||
130750510|NCT02509507|470708616|FG004|Overall Study|Withdrawal by Subject|1|||
130750511|NCT02509507|470708617|FG005|Overall Study|Withdrawal by Subject|3|||
130788669|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130750512|NCT02509507|470708618|FG006|Overall Study|Withdrawal by Subject|4|||
130750513|NCT02509507|470708619|FG007|Overall Study|Withdrawal by Subject|0|||
130750514|NCT02509507|470708620|FG008|Overall Study|Withdrawal by Subject|1|||
130750515|NCT02510664|470708624|FG000|Overall Study|Transferred Care|9|||
130750516|NCT02510664|470708625|FG001|Overall Study|Transferred Care|9|||
130750517|NCT02510664|470708626|FG002|Overall Study|Transferred Care|0|||
130750518|NCT02510664|470708624|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
130788670|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130750519|NCT02510664|470708625|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
130750520|NCT02510664|470708626|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
130750521|NCT02510664|470708624|FG000|Overall Study|Time Constraints|1|||
130750522|NCT02510664|470708625|FG001|Overall Study|Time Constraints|1|||
130750523|NCT02510664|470708626|FG002|Overall Study|Time Constraints|0|||
130750524|NCT00912743|470708639|FG000|Overall Study|Adverse Event|3|||
130750525|NCT00912743|470708640|FG001|Overall Study|Adverse Event|1|||
130750526|NCT00912743|470708639|FG000|Overall Study|Lack of Efficacy|9|||
130750527|NCT00912743|470708640|FG001|Overall Study|Lack of Efficacy|18|||
130750528|NCT00912743|470708639|FG000|Overall Study|Toxicity|0|||
130750529|NCT00912743|470708640|FG001|Overall Study|Toxicity|1|||
130750530|NCT00912743|470708639|FG000|Overall Study|End of treatment form was not collected|1|||
130750531|NCT00912743|470708640|FG001|Overall Study|End of treatment form was not collected|0|||
130750532|NCT00862823|470708642|FG000|First Intervention|Withdrawal by Subject|1|||
130750533|NCT00862823|470708643|FG001|First Intervention|Withdrawal by Subject|1|||
130750534|NCT02714595|470708647|FG000|Overall Study|Lost to Follow-up|1|||
130750535|NCT02714595|470708648|FG001|Overall Study|Lost to Follow-up|0|||
130750536|NCT02714595|470708647|FG000|Overall Study|Withdrawal by Subject|1|||
130750537|NCT02714595|470708648|FG001|Overall Study|Withdrawal by Subject|2|||
130750538|NCT02714595|470708647|FG000|Overall Study|Lack of Efficacy|0|||
130750539|NCT02714595|470708648|FG001|Overall Study|Lack of Efficacy|1|||
130750540|NCT02714595|470708647|FG000|Overall Study|Death|30|||
130750541|NCT02714595|470708648|FG001|Overall Study|Death|9|||
130750542|NCT02714595|470708647|FG000|Overall Study|Other-Miscellaneous|0|||
130750543|NCT02714595|470708648|FG001|Overall Study|Other-Miscellaneous|1|||
130750544|NCT02411396|470708649|FG000|Overall Study|Lost to Follow-up|31|||
130750545|NCT02411396|470708649|FG000|Overall Study|Death|10|||
130750546|NCT02423343|470708650|FG000|Overall Study|Withdrawal by Subject|0|||
130750547|NCT02423343|470708651|FG001|Overall Study|Withdrawal by Subject|1|||
130750548|NCT02423343|470708652|FG002|Overall Study|Withdrawal by Subject|0|||
130750549|NCT02423343|470708653|FG003|Overall Study|Withdrawal by Subject|0|||
130750550|NCT02423343|470708654|FG004|Overall Study|Withdrawal by Subject|0|||
130750551|NCT02423343|470708655|FG005|Overall Study|Withdrawal by Subject|0|||
130750552|NCT02423343|470708650|FG000|Overall Study|Progressive Disease|0|||
130750553|NCT02423343|470708651|FG001|Overall Study|Progressive Disease|0|||
130750554|NCT02423343|470708652|FG002|Overall Study|Progressive Disease|0|||
130750555|NCT02423343|470708653|FG003|Overall Study|Progressive Disease|0|||
130750556|NCT02423343|470708654|FG004|Overall Study|Progressive Disease|2|||
130750557|NCT02423343|470708655|FG005|Overall Study|Progressive Disease|0|||
130750558|NCT02423343|470708650|FG000|Overall Study|Adverse Event|0|||
130750559|NCT02423343|470708651|FG001|Overall Study|Adverse Event|0|||
130750560|NCT02423343|470708652|FG002|Overall Study|Adverse Event|0|||
130750561|NCT02423343|470708653|FG003|Overall Study|Adverse Event|0|||
130750562|NCT02423343|470708654|FG004|Overall Study|Adverse Event|2|||
130750563|NCT02423343|470708655|FG005|Overall Study|Adverse Event|0|||
130750564|NCT02423343|470708650|FG000|Overall Study|Death|0|||
130750565|NCT02423343|470708651|FG001|Overall Study|Death|0|||
130750566|NCT02423343|470708652|FG002|Overall Study|Death|0|||
130750567|NCT02423343|470708653|FG003|Overall Study|Death|0|||
130750568|NCT02423343|470708654|FG004|Overall Study|Death|1|||
130750569|NCT02423343|470708655|FG005|Overall Study|Death|0|||
130750570|NCT02865499|470708656|FG000|Baseline|Adverse Event|1|||
130750571|NCT02865499|470708656|FG000|Baseline|Withdrawal by Subject|1|||
130750572|NCT01860040|470708662|FG000|Overall Study|Withdrawal by Subject|1|||
130750573|NCT01860040|470708663|FG001|Overall Study|Withdrawal by Subject|0|||
130750574|NCT01931995|470708664|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
130750575|NCT01931995|470708665|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
130750576|NCT01931995|470708664|FG000|First Intervention (1 Day)|Physician Decision|1|||
130750577|NCT01931995|470708665|FG001|First Intervention (1 Day)|Physician Decision|1|||
130750578|NCT01931995|470708664|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
130750579|NCT01931995|470708665|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
130750580|NCT00014495|470708666|FG000|Overall Study|Death|0|||
130750581|NCT00014495|470708667|FG001|Overall Study|Death|0|||
130750582|NCT00014495|470708668|FG002|Overall Study|Death|1|||
130750583|NCT00014495|470708669|FG003|Overall Study|Death|0|||
130750584|NCT00014495|470708666|FG000|Overall Study|Clinical deterioration|0|||
130750585|NCT00014495|470708667|FG001|Overall Study|Clinical deterioration|0|||
130750586|NCT00014495|470708668|FG002|Overall Study|Clinical deterioration|0|||
130750587|NCT00014495|470708669|FG003|Overall Study|Clinical deterioration|1|||
130750588|NCT00403481|470708671|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
130750589|NCT00403481|470708671|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
130750590|NCT00403481|470708671|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
130750591|NCT00403481|470708671|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
130750592|NCT00403481|470708671|FG000|Olm 40 mg|Adverse Event|2|||
130750593|NCT00403481|470708671|FG000|Olm 40 mg|Protocol Violation|1|||
130750594|NCT00403481|470708671|FG000|Olm 40 mg|Withdrawal by Subject|1|||
130750595|NCT00403481|470708671|FG000|Olm 40 mg|Other|1|||
130750596|NCT00403481|470708671|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
130750597|NCT00403481|470708671|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
130750598|NCT00403481|470708671|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
130750599|NCT00403481|470708671|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
130750600|NCT00403481|470708671|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
130750601|NCT00403481|470708671|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
130750602|NCT02099110|470708679|FG000|Overall Study|Protocol Violation|2|||
130750603|NCT02099110|470708680|FG001|Overall Study|Protocol Violation|1|||
130750604|NCT02099110|470708681|FG002|Overall Study|Protocol Violation|0|||
130750605|NCT02099110|470708682|FG003|Overall Study|Protocol Violation|3|||
130750606|NCT02099110|470708683|FG004|Overall Study|Protocol Violation|1|||
130750607|NCT02099110|470708679|FG000|Overall Study|Participant moved|1|||
130750608|NCT02099110|470708680|FG001|Overall Study|Participant moved|1|||
130750609|NCT02099110|470708681|FG002|Overall Study|Participant moved|1|||
130750610|NCT02099110|470708682|FG003|Overall Study|Participant moved|0|||
130750611|NCT02099110|470708683|FG004|Overall Study|Participant moved|2|||
130750612|NCT02099110|470708679|FG000|Overall Study|Withdrawal by Subject|7|||
130750613|NCT02099110|470708680|FG001|Overall Study|Withdrawal by Subject|11|||
130750614|NCT02099110|470708681|FG002|Overall Study|Withdrawal by Subject|13|||
130750615|NCT02099110|470708682|FG003|Overall Study|Withdrawal by Subject|9|||
130750616|NCT02099110|470708683|FG004|Overall Study|Withdrawal by Subject|13|||
130750617|NCT02099110|470708679|FG000|Overall Study|Adverse Event|3|||
130750618|NCT02099110|470708680|FG001|Overall Study|Adverse Event|5|||
130750619|NCT02099110|470708681|FG002|Overall Study|Adverse Event|2|||
130750620|NCT02099110|470708682|FG003|Overall Study|Adverse Event|3|||
130750621|NCT02099110|470708683|FG004|Overall Study|Adverse Event|2|||
130750622|NCT02099110|470708679|FG000|Overall Study|Lost to Follow-up|6|||
130750623|NCT02099110|470708680|FG001|Overall Study|Lost to Follow-up|12|||
130750624|NCT02099110|470708681|FG002|Overall Study|Lost to Follow-up|11|||
130750625|NCT02099110|470708682|FG003|Overall Study|Lost to Follow-up|5|||
130750626|NCT02099110|470708683|FG004|Overall Study|Lost to Follow-up|6|||
130750627|NCT02099110|470708679|FG000|Overall Study|Death|0|||
130750628|NCT02099110|470708680|FG001|Overall Study|Death|1|||
130750629|NCT02099110|470708681|FG002|Overall Study|Death|0|||
130750630|NCT02099110|470708682|FG003|Overall Study|Death|0|||
130750631|NCT02099110|470708683|FG004|Overall Study|Death|0|||
130750632|NCT02099110|470708679|FG000|Overall Study|Screen failure|0|||
130750633|NCT02099110|470708680|FG001|Overall Study|Screen failure|0|||
130750634|NCT02099110|470708681|FG002|Overall Study|Screen failure|0|||
130750635|NCT02099110|470708682|FG003|Overall Study|Screen failure|0|||
130750636|NCT02099110|470708683|FG004|Overall Study|Screen failure|1|||
130750637|NCT02099110|470708679|FG000|Overall Study|Non-compliance with study drug|2|||
130750638|NCT02099110|470708680|FG001|Overall Study|Non-compliance with study drug|0|||
130750639|NCT02099110|470708681|FG002|Overall Study|Non-compliance with study drug|0|||
130750640|NCT02099110|470708682|FG003|Overall Study|Non-compliance with study drug|0|||
130750641|NCT02099110|470708683|FG004|Overall Study|Non-compliance with study drug|1|||
130750642|NCT02099110|470708679|FG000|Overall Study|Physician Decision|3|||
130750643|NCT02099110|470708680|FG001|Overall Study|Physician Decision|0|||
130750644|NCT02099110|470708681|FG002|Overall Study|Physician Decision|1|||
130750645|NCT02099110|470708682|FG003|Overall Study|Physician Decision|2|||
130750646|NCT02099110|470708683|FG004|Overall Study|Physician Decision|1|||
130750647|NCT02064816|470708684|FG000|Overall Study|Adverse Event|3|||
130750648|NCT02064816|470708685|FG001|Overall Study|Adverse Event|2|||
130750649|NCT02064816|470708684|FG000|Overall Study|Withdrawal by Subject|2|||
130750650|NCT02064816|470708685|FG001|Overall Study|Withdrawal by Subject|1|||
130750651|NCT02064816|470708684|FG000|Overall Study|Lost to Follow-up|2|||
130750652|NCT02064816|470708685|FG001|Overall Study|Lost to Follow-up|1|||
130750653|NCT02064816|470708684|FG000|Overall Study|Therapeutic failure|0|||
130750654|NCT02064816|470708685|FG001|Overall Study|Therapeutic failure|1|||
130750655|NCT02064816|470708684|FG000|Overall Study|Other|1|||
130750656|NCT02064816|470708685|FG001|Overall Study|Other|3|||
130750657|NCT01732458|470708690|FG000|Overall Study|Lost to Follow-up|0|||
130750658|NCT01732458|470708691|FG001|Overall Study|Lost to Follow-up|2|||
130750659|NCT01732458|470708692|FG002|Overall Study|Lost to Follow-up|0|||
130750660|NCT01732458|470708693|FG003|Overall Study|Lost to Follow-up|0|||
130750661|NCT01732458|470708690|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130750662|NCT01732458|470708691|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130750663|NCT01732458|470708692|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130750664|NCT01732458|470708693|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130750665|NCT01732458|470708690|FG000|Overall Study|Physician Decision|1|||
130750666|NCT01732458|470708691|FG001|Overall Study|Physician Decision|2|||
130750667|NCT01732458|470708692|FG002|Overall Study|Physician Decision|2|||
130750668|NCT01732458|470708693|FG003|Overall Study|Physician Decision|0|||
130750669|NCT01732458|470708690|FG000|Overall Study|Protocol Violation|2|||
130750670|NCT01732458|470708691|FG001|Overall Study|Protocol Violation|0|||
130750671|NCT01732458|470708692|FG002|Overall Study|Protocol Violation|0|||
130750672|NCT01732458|470708693|FG003|Overall Study|Protocol Violation|2|||
130750673|NCT01732458|470708690|FG000|Overall Study|Screen Failure|0|||
130750674|NCT01732458|470708691|FG001|Overall Study|Screen Failure|1|||
130750675|NCT01732458|470708692|FG002|Overall Study|Screen Failure|0|||
130750676|NCT01732458|470708693|FG003|Overall Study|Screen Failure|0|||
130750677|NCT00994461|470708694|FG000|Overall Study|Adverse Event|2|||
130750678|NCT00994461|470708695|FG001|Overall Study|Adverse Event|1|||
130750679|NCT00994461|470708696|FG002|Overall Study|Adverse Event|0|||
130750680|NCT02887248|470708702|FG000|Overall Study|Withdrawal by Subject|1|||
130750681|NCT02887248|470708702|FG000|Overall Study|Adverse Event|1|||
130750682|NCT02887248|470708702|FG000|Overall Study|Progressive Disease|1|||
130750683|NCT03759587|470708703|FG000|Overall Study|Adverse Event|5|||
130750684|NCT03759587|470708703|FG000|Overall Study|Progressive Disease|10|||
130750685|NCT03759587|470708703|FG000|Overall Study|Site Terminated by Sponsor|3|||
130750686|NCT03759587|470708703|FG000|Overall Study|Withdrawal by Subject|1|||
130750687|NCT00454363|470708706|FG000|Overall Study|Adverse Event|1|||
130750688|NCT00454363|470708707|FG001|Overall Study|Adverse Event|2|||
130750689|NCT00454363|470708706|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
130750690|NCT00454363|470708707|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
130750691|NCT00570063|470708708|FG000|Overall Study|Adverse Event|4|||
130750692|NCT00570063|470708709|FG001|Overall Study|Adverse Event|1|||
130750693|NCT00570063|470708708|FG000|Overall Study|Lack of Efficacy|0|||
130750694|NCT00570063|470708709|FG001|Overall Study|Lack of Efficacy|1|||
130750695|NCT00570063|470708708|FG000|Overall Study|Withdrawal by Subject|4|||
130750696|NCT00570063|470708709|FG001|Overall Study|Withdrawal by Subject|3|||
130750697|NCT00570063|470708708|FG000|Overall Study|Sponsor's Decision|7|||
130750698|NCT00570063|470708709|FG001|Overall Study|Sponsor's Decision|3|||
130750699|NCT00697463|470708710|FG000|Overall Study|Withdrawal by Subject|1|||
130750700|NCT03307252|470708711|FG000|Part 2, Period 1|Treatment not received|0|||
130750701|NCT03307252|470708712|FG001|Part 2, Period 1|Treatment not received|0|||
130750702|NCT03307252|470708713|FG002|Part 2, Period 1|Treatment not received|0|||
130750703|NCT03307252|470708714|FG003|Part 2, Period 1|Treatment not received|0|||
130750704|NCT03307252|470708715|FG004|Part 2, Period 1|Treatment not received|0|||
130750705|NCT03307252|470708716|FG005|Part 2, Period 1|Treatment not received|1|||
130750706|NCT03307252|470708717|FG006|Part 2, Period 1|Treatment not received|0|||
130750707|NCT03307252|470708718|FG007|Part 2, Period 1|Treatment not received|0|||
130750708|NCT03307252|470708719|FG008|Part 2, Period 1|Treatment not received|0|||
130750709|NCT03307252|470708720|FG009|Part 2, Period 1|Treatment not received|0|||
130750710|NCT03307252|470708721|FG010|Part 2, Period 1|Treatment not received|0|||
130750711|NCT03307252|470708711|FG000|Part 2, Period 3|Other than listed|0|||
130750712|NCT03307252|470708712|FG001|Part 2, Period 3|Other than listed|0|||
130750713|NCT03307252|470708713|FG002|Part 2, Period 3|Other than listed|0|||
130750714|NCT03307252|470708714|FG003|Part 2, Period 3|Other than listed|0|||
130750715|NCT03307252|470708715|FG004|Part 2, Period 3|Other than listed|1|||
130750716|NCT03307252|470708716|FG005|Part 2, Period 3|Other than listed|0|||
130750717|NCT03307252|470708717|FG006|Part 2, Period 3|Other than listed|0|||
130750718|NCT03307252|470708718|FG007|Part 2, Period 3|Other than listed|0|||
130750719|NCT03307252|470708719|FG008|Part 2, Period 3|Other than listed|0|||
130750720|NCT03307252|470708720|FG009|Part 2, Period 3|Other than listed|0|||
130750721|NCT03307252|470708721|FG010|Part 2, Period 3|Other than listed|0|||
130750722|NCT03307252|470708711|FG000|Part 2, Period 4|Other than listed|0|||
130750723|NCT03307252|470708712|FG001|Part 2, Period 4|Other than listed|0|||
130750724|NCT03307252|470708713|FG002|Part 2, Period 4|Other than listed|0|||
130750725|NCT03307252|470708714|FG003|Part 2, Period 4|Other than listed|0|||
130750726|NCT03307252|470708715|FG004|Part 2, Period 4|Other than listed|0|||
130750727|NCT03307252|470708716|FG005|Part 2, Period 4|Other than listed|0|||
130750728|NCT03307252|470708717|FG006|Part 2, Period 4|Other than listed|1|||
130750729|NCT03307252|470708718|FG007|Part 2, Period 4|Other than listed|0|||
130750730|NCT03307252|470708719|FG008|Part 2, Period 4|Other than listed|0|||
130750731|NCT03307252|470708720|FG009|Part 2, Period 4|Other than listed|0|||
130750732|NCT03307252|470708721|FG010|Part 2, Period 4|Other than listed|0|||
130750733|NCT03307252|470708711|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130750734|NCT03307252|470708712|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130750735|NCT03307252|470708713|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130750736|NCT03307252|470708714|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130750737|NCT03307252|470708715|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130750738|NCT03307252|470708716|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130750739|NCT03307252|470708717|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130750740|NCT03307252|470708718|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130750741|NCT03307252|470708719|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130750742|NCT03307252|470708720|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130750743|NCT03307252|470708721|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
130750744|NCT03482453|470708722|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750745|NCT03482453|470708723|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750746|NCT03482453|470708724|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750747|NCT03482453|470708725|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750748|NCT03482453|470708726|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750749|NCT03482453|470708727|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750750|NCT03482453|470708728|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750751|NCT03482453|470708729|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750752|NCT03482453|470708730|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750753|NCT03482453|470708731|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750754|NCT03482453|470708732|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
130750755|NCT03482453|470708733|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130750756|NCT02568189|470708734|FG000|Overall Study|Protocol Violation|0|||
130750757|NCT02568189|470708735|FG001|Overall Study|Protocol Violation|0|||
130750758|NCT02568189|470708736|FG002|Overall Study|Protocol Violation|19|||
130750759|NCT02568189|470708737|FG003|Overall Study|Protocol Violation|18|||
130750760|NCT02157376|470708738|FG000|Overall Study|Death|10|||
130750761|NCT02157376|470708739|FG001|Overall Study|Death|4|||
130750762|NCT02157376|470708738|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130750763|NCT02157376|470708739|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130750764|NCT02157376|470708738|FG000|Overall Study|Withdrawal by Subject|3|||
130750765|NCT02157376|470708739|FG001|Overall Study|Withdrawal by Subject|8|||
130750766|NCT02157376|470708738|FG000|Overall Study|Not treated|8|||
130750767|NCT02157376|470708739|FG001|Overall Study|Not treated|3|||
130750768|NCT02157376|470708738|FG000|Overall Study|Investigator's misjudgement|1|||
130750769|NCT02157376|470708739|FG001|Overall Study|Investigator's misjudgement|2|||
130750770|NCT01074268|470708742|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
130750771|NCT01074268|470708743|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
130750772|NCT01074268|470708742|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
130750773|NCT01074268|470708743|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
130750774|NCT01074268|470708742|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
130750775|NCT01074268|470708743|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
130750776|NCT01074268|470708742|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
130750777|NCT01074268|470708743|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
130750778|NCT01074268|470708742|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
130750779|NCT01074268|470708743|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
130750780|NCT01074268|470708742|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
130750781|NCT01074268|470708743|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
130750782|NCT01074268|470708742|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
130750783|NCT01074268|470708743|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
130750784|NCT01074268|470708742|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
130750785|NCT01074268|470708743|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
130750786|NCT01074268|470708742|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
130750787|NCT01074268|470708743|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
130750788|NCT01578239|470708744|FG000|Treatment Period|Progressive Disease|19|||
130750789|NCT01578239|470708745|FG001|Treatment Period|Progressive Disease|64|||
130750790|NCT01578239|470708744|FG000|Treatment Period|Physician Decision|17|||
130750791|NCT01578239|470708745|FG001|Treatment Period|Physician Decision|17|||
130750792|NCT01578239|470708744|FG000|Treatment Period|Adverse Event|13|||
130750793|NCT01578239|470708745|FG001|Treatment Period|Adverse Event|10|||
130750794|NCT01578239|470708744|FG000|Treatment Period|Non-compliance|2|||
130750795|NCT01578239|470708745|FG001|Treatment Period|Non-compliance|0|||
130750796|NCT01578239|470708744|FG000|Treatment Period|Withdrawal by Subject|10|||
130750797|NCT01578239|470708745|FG001|Treatment Period|Withdrawal by Subject|9|||
130750798|NCT01578239|470708744|FG000|Treatment Period|Other|6|||
130750799|NCT01578239|470708745|FG001|Treatment Period|Other|1|||
130750800|NCT01578239|470708744|FG000|Long-term Follow-Up Period|Death|69|||
130750801|NCT01578239|470708745|FG001|Long-term Follow-Up Period|Death|64|||
130750802|NCT01578239|470708744|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
130750803|NCT01578239|470708745|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
130750804|NCT01578239|470708744|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
130750805|NCT01578239|470708745|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
130750806|NCT01578239|470708744|FG000|Long-term Follow-Up Period|Other|2|||
130750807|NCT01578239|470708745|FG001|Long-term Follow-Up Period|Other|2|||
130750808|NCT02347813|470708749|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
130750809|NCT02347813|470708750|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
130750810|NCT02347813|470708749|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
130750811|NCT02347813|470708750|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
130750812|NCT02837731|470708755|FG000|Allocation|Admitted to General Floor|3|||
130750813|NCT02837731|470708756|FG001|Allocation|Admitted to General Floor|4|||
130750814|NCT02837731|470708755|FG000|Allocation|Immediate surgery/withdrew|2|||
130750815|NCT02837731|470708756|FG001|Allocation|Immediate surgery/withdrew|0|||
130750816|NCT02837731|470708755|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
130750817|NCT02837731|470708756|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
130750818|NCT02837731|470708755|FG000|Allocation|Withdrawal by Subject|2|||
130750819|NCT02837731|470708756|FG001|Allocation|Withdrawal by Subject|0|||
130750820|NCT02837731|470708755|FG000|Allocation|Device not available|1|||
130750821|NCT02837731|470708756|FG001|Allocation|Device not available|0|||
130750822|NCT02837731|470708755|FG000|Allocation|Protocol not implemented|7|||
130750823|NCT02837731|470708756|FG001|Allocation|Protocol not implemented|0|||
130750824|NCT02837731|470708755|FG000|Allocation|Moribund/Do not resuscitate|2|||
130750825|NCT02837731|470708756|FG001|Allocation|Moribund/Do not resuscitate|0|||
130750826|NCT02837731|470708755|FG000|Allocation|Did not meet sepsis criteria|1|||
130750827|NCT02837731|470708756|FG001|Allocation|Did not meet sepsis criteria|2|||
130750828|NCT02837731|470708755|FG000|Allocation|Known aortic abnormalities|0|||
130750829|NCT02837731|470708756|FG001|Allocation|Known aortic abnormalities|1|||
130750830|NCT01119859|470708757|FG000|Overall Study|Adverse Event|9|||
130750831|NCT01119859|470708758|FG001|Overall Study|Adverse Event|10|||
130750832|NCT01119859|470708757|FG000|Overall Study|Death|2|||
130750833|NCT01119859|470708758|FG001|Overall Study|Death|0|||
130750834|NCT01119859|470708757|FG000|Overall Study|Insufficient therapeutic response|7|||
130750835|NCT01119859|470708758|FG001|Overall Study|Insufficient therapeutic response|14|||
130750836|NCT01119859|470708757|FG000|Overall Study|Refused treatment|3|||
130750837|NCT01119859|470708758|FG001|Overall Study|Refused treatment|6|||
130750838|NCT01119859|470708757|FG000|Overall Study|Failure to return|3|||
130750839|NCT01119859|470708758|FG001|Overall Study|Failure to return|0|||
130750840|NCT04200651|470708759|FG000|Overall Study|Moved to another country during follow-up|2|||
130750841|NCT04200651|470708760|FG001|Overall Study|Moved to another country during follow-up|2|||
130750842|NCT04200651|470708759|FG000|Overall Study|Lost to Follow-up|1|||
130750843|NCT04200651|470708760|FG001|Overall Study|Lost to Follow-up|3|||
130750844|NCT03225105|470708761|FG000|Overall Study|Withdrawal by Subject|1|||
130750845|NCT03225105|470708762|FG001|Overall Study|Withdrawal by Subject|0|||
130750846|NCT03225105|470708763|FG002|Overall Study|Withdrawal by Subject|0|||
130750847|NCT03225105|470708764|FG003|Overall Study|Withdrawal by Subject|0|||
130750848|NCT03225105|470708761|FG000|Overall Study|Death|0|||
130750849|NCT03225105|470708762|FG001|Overall Study|Death|4|||
130750850|NCT03225105|470708763|FG002|Overall Study|Death|2|||
130750851|NCT03225105|470708764|FG003|Overall Study|Death|0|||
130750852|NCT03225105|470708761|FG000|Overall Study|Study termination per Sponsor Decision|2|||
130750853|NCT03225105|470708762|FG001|Overall Study|Study termination per Sponsor Decision|0|||
130750854|NCT03225105|470708763|FG002|Overall Study|Study termination per Sponsor Decision|3|||
130750855|NCT03225105|470708764|FG003|Overall Study|Study termination per Sponsor Decision|3|||
130750856|NCT02887183|470708766|FG000|Overall Study|Adverse Event|44|||
130750857|NCT02887183|470708766|FG000|Overall Study|Death|30|||
130750858|NCT02887183|470708766|FG000|Overall Study|Pregnancy|1|||
130750859|NCT02887183|470708766|FG000|Overall Study|Protocol Violation|6|||
130750860|NCT02887183|470708766|FG000|Overall Study|Technical Problems|2|||
130750861|NCT02887183|470708766|FG000|Overall Study|Lost to Follow-up|13|||
130750862|NCT02887183|470708766|FG000|Overall Study|Physician Decision|10|||
130750863|NCT02887183|470708766|FG000|Overall Study|Withdrawal by Subject|35|||
130750864|NCT01031680|470708767|FG000|Overall Study|Adverse Event|8|||
130750865|NCT01031680|470708768|FG001|Overall Study|Adverse Event|3|||
130750866|NCT01031680|470708767|FG000|Overall Study|Lost to Follow-up|2|||
130750867|NCT01031680|470708768|FG001|Overall Study|Lost to Follow-up|10|||
130750868|NCT01031680|470708767|FG000|Overall Study|Withdrawal by Subject|12|||
130750869|NCT01031680|470708768|FG001|Overall Study|Withdrawal by Subject|16|||
130750870|NCT01031680|470708767|FG000|Overall Study|Death|2|||
130750871|NCT01031680|470708768|FG001|Overall Study|Death|1|||
130750872|NCT01031680|470708767|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
130750873|NCT01031680|470708768|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
130750874|NCT01031680|470708767|FG000|Overall Study|Poor/Non-compliance|5|||
130750875|NCT01031680|470708768|FG001|Overall Study|Poor/Non-compliance|6|||
130750876|NCT01031680|470708767|FG000|Overall Study|Safety|1|||
130750877|NCT01031680|470708768|FG001|Overall Study|Safety|0|||
130750878|NCT01031680|470708767|FG000|Overall Study|Incorrect Enrolment|1|||
130750879|NCT01031680|470708768|FG001|Overall Study|Incorrect Enrolment|2|||
130750880|NCT01031680|470708767|FG000|Overall Study|Administrative Reason by Sponsor|0|||
130750881|NCT01031680|470708768|FG001|Overall Study|Administrative Reason by Sponsor|1|||
130750882|NCT01031680|470708767|FG000|Overall Study|Various|0|||
130750883|NCT01031680|470708768|FG001|Overall Study|Various|2|||
130750884|NCT02654977|470708775|FG000|Overall Study|Death|1|||
130750885|NCT02654977|470708775|FG000|Overall Study|Lost to Follow-up|1|||
130750886|NCT02654977|470708775|FG000|Overall Study|Adverse Event|1|||
130750887|NCT02654977|470708775|FG000|Overall Study|Withdrawal by Subject|1|||
130750888|NCT02654977|470708775|FG000|Overall Study|Lack of Efficacy|3|||
130750889|NCT01921101|470708776|FG000|Overall Study|Death|16|||
130750890|NCT01921101|470708777|FG001|Overall Study|Death|6|||
130750891|NCT01483027|470708778|FG000|Overall Study|Administrative Reasons|2|||
130750892|NCT01483027|470708779|FG001|Overall Study|Administrative Reasons|1|||
130750893|NCT01483027|470708778|FG000|Overall Study|Withdrawal by Subject|21|||
130750894|NCT01483027|470708779|FG001|Overall Study|Withdrawal by Subject|32|||
130750895|NCT01483027|470708778|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
130750896|NCT01483027|470708779|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
130750897|NCT01483027|470708778|FG000|Overall Study|Lost to Follow-up|1|||
130750898|NCT01483027|470708779|FG001|Overall Study|Lost to Follow-up|1|||
130750899|NCT01483027|470708778|FG000|Overall Study|Adverse Event|0|||
130750900|NCT01483027|470708779|FG001|Overall Study|Adverse Event|1|||
130750901|NCT01483027|470708778|FG000|Overall Study|Withdrawal by Subject|0|||
130750902|NCT01483027|470708779|FG001|Overall Study|Withdrawal by Subject|1|||
130750903|NCT03691207|470710004|FG000|Overall Study|Death|41|||
130750904|NCT03691207|470710005|FG001|Overall Study|Death|26|||
130750905|NCT03691207|470710004|FG000|Overall Study|Lost to Follow-up|1|||
130750906|NCT03691207|470710005|FG001|Overall Study|Lost to Follow-up|1|||
130750907|NCT03691207|470710004|FG000|Overall Study|Withdrawal by Subject|2|||
130750908|NCT03691207|470710005|FG001|Overall Study|Withdrawal by Subject|8|||
130750909|NCT03691207|470710004|FG000|Overall Study|Sponsor decision|1|||
130750910|NCT03691207|470710005|FG001|Overall Study|Sponsor decision|7|||
130750911|NCT01288937|470710008|FG000|Overall Study|Adverse Event|1|||
130750912|NCT01288937|470710009|FG001|Overall Study|Adverse Event|0|||
130750913|NCT02490371|470710010|FG000|Overall Study|Lost to Follow-up|1|||
130750914|NCT02490371|470710011|FG001|Overall Study|Lost to Follow-up|1|||
130750915|NCT00610155|470710012|FG000|Period 1|Withdrawal by Subject|0|||
130750916|NCT00610155|470710013|FG001|Period 1|Withdrawal by Subject|0|||
130750917|NCT00610155|470710014|FG002|Period 1|Withdrawal by Subject|1|||
130750918|NCT00610155|470710015|FG003|Period 1|Withdrawal by Subject|0|||
130750919|NCT00610155|470710016|FG004|Period 1|Withdrawal by Subject|0|||
130750920|NCT00610155|470710017|FG005|Period 1|Withdrawal by Subject|0|||
130750921|NCT00610155|470710012|FG000|Period 3|Adverse Event|1|||
130750922|NCT00610155|470710013|FG001|Period 3|Adverse Event|0|||
130750923|NCT00610155|470710014|FG002|Period 3|Adverse Event|0|||
130750924|NCT00610155|470710015|FG003|Period 3|Adverse Event|0|||
130750925|NCT00610155|470710016|FG004|Period 3|Adverse Event|0|||
130750926|NCT00610155|470710017|FG005|Period 3|Adverse Event|0|||
130750927|NCT01718535|470710018|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
130750928|NCT01718535|470710019|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
130750929|NCT01718535|470710020|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
130750930|NCT01718535|470710021|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
130750931|NCT01718535|470710022|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
130750932|NCT01718535|470710023|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
130750933|NCT01718535|470710024|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
130750934|NCT01718535|470710025|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
130750935|NCT01718535|470710026|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
130750936|NCT01718535|470710027|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
130750937|NCT03018080|470710033|FG000|Overall Study|Death|12|||
130750938|NCT03018080|470710034|FG001|Overall Study|Death|19|||
130750939|NCT00740792|470710035|FG000|Overall Study|Adverse Event|3|||
130750940|NCT00740792|470710036|FG001|Overall Study|Adverse Event|1|||
130750941|NCT00740792|470710037|FG002|Overall Study|Adverse Event|1|||
130750942|NCT00740792|470710038|FG003|Overall Study|Adverse Event|3|||
130750943|NCT00740792|470710035|FG000|Overall Study|Lack of Efficacy|1|||
130750944|NCT00740792|470710036|FG001|Overall Study|Lack of Efficacy|1|||
130750945|NCT00740792|470710037|FG002|Overall Study|Lack of Efficacy|0|||
130750946|NCT00740792|470710038|FG003|Overall Study|Lack of Efficacy|3|||
130750947|NCT00740792|470710035|FG000|Overall Study|Lost to Follow-up|2|||
130750948|NCT00740792|470710036|FG001|Overall Study|Lost to Follow-up|1|||
130750949|NCT00740792|470710037|FG002|Overall Study|Lost to Follow-up|0|||
130750950|NCT00740792|470710038|FG003|Overall Study|Lost to Follow-up|0|||
130750951|NCT00740792|470710035|FG000|Overall Study|Protocol Violation|0|||
130750952|NCT00740792|470710036|FG001|Overall Study|Protocol Violation|1|||
130750953|NCT00740792|470710037|FG002|Overall Study|Protocol Violation|0|||
130750954|NCT00740792|470710038|FG003|Overall Study|Protocol Violation|2|||
130750955|NCT00740792|470710035|FG000|Overall Study|Withdrawal by Subject|1|||
130750956|NCT00740792|470710036|FG001|Overall Study|Withdrawal by Subject|1|||
130750957|NCT00740792|470710037|FG002|Overall Study|Withdrawal by Subject|0|||
130750958|NCT00740792|470710038|FG003|Overall Study|Withdrawal by Subject|0|||
130750959|NCT00740792|470710035|FG000|Overall Study|administrative|3|||
130750960|NCT00740792|470710036|FG001|Overall Study|administrative|3|||
130750961|NCT00740792|470710037|FG002|Overall Study|administrative|8|||
130750962|NCT00740792|470710038|FG003|Overall Study|administrative|2|||
130750963|NCT00179660|470710041|FG000|Overall Study|Adverse Event|7|||
130750964|NCT00179660|470710041|FG000|Overall Study|Lack of therapeutic effect|28|||
130750965|NCT00179660|470710041|FG000|Overall Study|Withdrawal by Subject|2|||
130750966|NCT00179660|470710041|FG000|Overall Study|Lost to Follow-up|1|||
130750967|NCT00179660|470710041|FG000|Overall Study|Death|3|||
130750968|NCT00179660|470710041|FG000|Overall Study|Other - Unspecified|9|||
130750969|NCT02035202|470710044|FG000|Overall Study|Lost to Follow-up|8|||
130750970|NCT02035202|470710045|FG001|Overall Study|Lost to Follow-up|16|||
130750971|NCT02035202|470710046|FG002|Overall Study|Lost to Follow-up|2|||
130750972|NCT00178685|470710047|FG000|Overall Study|Death|3|||
130750973|NCT00178685|470710048|FG001|Overall Study|Death|3|||
130750974|NCT00178685|470710049|FG002|Overall Study|Death|6|||
130750975|NCT00178685|470710047|FG000|Overall Study|Lost to Follow-up|100|||
130750976|NCT00178685|470710048|FG001|Overall Study|Lost to Follow-up|187|||
130750977|NCT00178685|470710049|FG002|Overall Study|Lost to Follow-up|183|||
130750978|NCT00178685|470710047|FG000|Overall Study|Withdrawal by Subject|8|||
130750979|NCT00178685|470710048|FG001|Overall Study|Withdrawal by Subject|14|||
130750980|NCT00178685|470710049|FG002|Overall Study|Withdrawal by Subject|7|||
130750981|NCT00267969|470710061|FG000|Controlled Period|Adverse Event|6|||
130750982|NCT00267969|470710062|FG001|Controlled Period|Adverse Event|0|||
130750983|NCT00267969|470710063|FG002|Controlled Period|Adverse Event|2|||
130750984|NCT00267969|470710064|FG003|Controlled Period|Adverse Event|0|||
130750985|NCT00267969|470710065|FG004|Controlled Period|Adverse Event|0|||
130750986|NCT00267969|470710066|FG005|Controlled Period|Adverse Event|0|||
130750987|NCT00267969|470710067|FG006|Controlled Period|Adverse Event|0|||
130750988|NCT00267969|470710061|FG000|Controlled Period|Lack of Efficacy|3|||
130750989|NCT00267969|470710062|FG001|Controlled Period|Lack of Efficacy|0|||
130750990|NCT00267969|470710063|FG002|Controlled Period|Lack of Efficacy|1|||
130750991|NCT00267969|470710064|FG003|Controlled Period|Lack of Efficacy|0|||
130750992|NCT00267969|470710065|FG004|Controlled Period|Lack of Efficacy|0|||
130750993|NCT00267969|470710066|FG005|Controlled Period|Lack of Efficacy|0|||
130750994|NCT00267969|470710067|FG006|Controlled Period|Lack of Efficacy|0|||
130750995|NCT00267969|470710061|FG000|Controlled Period|Lost to Follow-up|1|||
130750996|NCT00267969|470710062|FG001|Controlled Period|Lost to Follow-up|0|||
130750997|NCT00267969|470710063|FG002|Controlled Period|Lost to Follow-up|1|||
130750998|NCT00267969|470710064|FG003|Controlled Period|Lost to Follow-up|0|||
130750999|NCT00267969|470710065|FG004|Controlled Period|Lost to Follow-up|0|||
130751000|NCT00267969|470710066|FG005|Controlled Period|Lost to Follow-up|0|||
130751001|NCT00267969|470710067|FG006|Controlled Period|Lost to Follow-up|0|||
130751002|NCT00267969|470710061|FG000|Controlled Period|Randomized but not treated|0|||
130751003|NCT00267969|470710062|FG001|Controlled Period|Randomized but not treated|0|||
130751004|NCT00267969|470710063|FG002|Controlled Period|Randomized but not treated|1|||
130751005|NCT00267969|470710064|FG003|Controlled Period|Randomized but not treated|0|||
130751006|NCT00267969|470710065|FG004|Controlled Period|Randomized but not treated|0|||
130751007|NCT00267969|470710066|FG005|Controlled Period|Randomized but not treated|0|||
130751008|NCT00267969|470710067|FG006|Controlled Period|Randomized but not treated|0|||
130751009|NCT00267969|470710061|FG000|Controlled Period|Other|2|||
130751010|NCT00267969|470710062|FG001|Controlled Period|Other|1|||
130751011|NCT00267969|470710063|FG002|Controlled Period|Other|6|||
130751012|NCT00267969|470710064|FG003|Controlled Period|Other|0|||
130751013|NCT00267969|470710065|FG004|Controlled Period|Other|0|||
130751014|NCT00267969|470710066|FG005|Controlled Period|Other|0|||
130751015|NCT00267969|470710067|FG006|Controlled Period|Other|0|||
130751016|NCT00267969|470710061|FG000|After Controlled Period|Adverse Event|0|||
130751017|NCT00267969|470710062|FG001|After Controlled Period|Adverse Event|0|||
130751018|NCT00267969|470710063|FG002|After Controlled Period|Adverse Event|0|||
130751019|NCT00267969|470710064|FG003|After Controlled Period|Adverse Event|7|||
130751020|NCT00267969|470710065|FG004|After Controlled Period|Adverse Event|8|||
130751021|NCT00267969|470710066|FG005|After Controlled Period|Adverse Event|23|||
130751022|NCT00267969|470710067|FG006|After Controlled Period|Adverse Event|21|||
130751023|NCT00267969|470710061|FG000|After Controlled Period|Death|0|||
130751024|NCT00267969|470710062|FG001|After Controlled Period|Death|0|||
130751025|NCT00267969|470710063|FG002|After Controlled Period|Death|0|||
130751026|NCT00267969|470710064|FG003|After Controlled Period|Death|1|||
130751027|NCT00267969|470710065|FG004|After Controlled Period|Death|2|||
130751028|NCT00267969|470710066|FG005|After Controlled Period|Death|0|||
130751029|NCT00267969|470710067|FG006|After Controlled Period|Death|1|||
130751030|NCT00267969|470710061|FG000|After Controlled Period|Lack of Efficacy|0|||
130751031|NCT00267969|470710062|FG001|After Controlled Period|Lack of Efficacy|0|||
130751032|NCT00267969|470710063|FG002|After Controlled Period|Lack of Efficacy|0|||
130751033|NCT00267969|470710064|FG003|After Controlled Period|Lack of Efficacy|10|||
130751034|NCT00267969|470710065|FG004|After Controlled Period|Lack of Efficacy|6|||
130751035|NCT00267969|470710066|FG005|After Controlled Period|Lack of Efficacy|28|||
130751036|NCT00267969|470710067|FG006|After Controlled Period|Lack of Efficacy|15|||
130751037|NCT00267969|470710061|FG000|After Controlled Period|Lost to Follow-up|0|||
130751038|NCT00267969|470710062|FG001|After Controlled Period|Lost to Follow-up|0|||
130751039|NCT00267969|470710063|FG002|After Controlled Period|Lost to Follow-up|0|||
130751040|NCT00267969|470710064|FG003|After Controlled Period|Lost to Follow-up|5|||
130751041|NCT00267969|470710065|FG004|After Controlled Period|Lost to Follow-up|8|||
130751042|NCT00267969|470710066|FG005|After Controlled Period|Lost to Follow-up|9|||
130751043|NCT00267969|470710067|FG006|After Controlled Period|Lost to Follow-up|10|||
130751044|NCT00267969|470710061|FG000|After Controlled Period|Other|0|||
130751045|NCT00267969|470710062|FG001|After Controlled Period|Other|0|||
130751046|NCT00267969|470710063|FG002|After Controlled Period|Other|0|||
130751047|NCT00267969|470710064|FG003|After Controlled Period|Other|13|||
130751048|NCT00267969|470710065|FG004|After Controlled Period|Other|11|||
130751049|NCT00267969|470710066|FG005|After Controlled Period|Other|22|||
130751050|NCT00267969|470710067|FG006|After Controlled Period|Other|25|||
130751051|NCT01053663|470710071|FG000|Overall Study|Death|2|||
130751052|NCT01053663|470710071|FG000|Overall Study|Lost to Follow-up|1|||
130751053|NCT01053663|470710071|FG000|Overall Study|Poor IV Access|1|||
130751054|NCT01053663|470710071|FG000|Overall Study|Transferred to Another Hospital|1|||
130751055|NCT01053663|470710071|FG000|Overall Study|Negative Influenza Diagnosis|1|||
130751056|NCT03533114|470710072|FG000|Overall|Adverse Event|16|||
130751057|NCT03533114|470710073|FG001|Overall|Adverse Event|11|||
130751058|NCT03533114|470710072|FG000|Overall|Consent Withdrawal by Participant|7|||
130751059|NCT03533114|470710073|FG001|Overall|Consent Withdrawal by Participant|6|||
130751060|NCT03533114|470710072|FG000|Overall|Lack of Efficacy|5|||
130751061|NCT03533114|470710073|FG001|Overall|Lack of Efficacy|3|||
130751062|NCT03533114|470710072|FG000|Overall|Lost to Follow-up|1|||
130751063|NCT03533114|470710073|FG001|Overall|Lost to Follow-up|1|||
130751064|NCT03533114|470710072|FG000|Overall|Physician Decision|0|||
130751065|NCT03533114|470710073|FG001|Overall|Physician Decision|2|||
130751066|NCT03533114|470710072|FG000|Overall|Protocol deviation|1|||
130751067|NCT03533114|470710073|FG001|Overall|Protocol deviation|1|||
130751068|NCT03533114|470710072|FG000|Overall|Failure to meet randomization criteria|1|||
130751069|NCT03533114|470710073|FG001|Overall|Failure to meet randomization criteria|2|||
130751070|NCT03533114|470710072|FG000|Overall|Non-Compliance with study drug|0|||
130751071|NCT03533114|470710073|FG001|Overall|Non-Compliance with study drug|1|||
130751072|NCT03533114|470710072|FG000|Overall|Other|0|||
130751073|NCT03533114|470710073|FG001|Overall|Other|1|||
130751074|NCT03533114|470710072|FG000|Open Label Titration and Optimization|Adverse Event|11|||
130751075|NCT03533114|470710073|FG001|Open Label Titration and Optimization|Adverse Event|8|||
130751076|NCT03533114|470710072|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
130751077|NCT03533114|470710073|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
130751078|NCT03533114|470710072|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
130751079|NCT03533114|470710073|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
130751080|NCT03533114|470710072|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
130751081|NCT03533114|470710073|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
130751082|NCT03533114|470710072|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
130751083|NCT03533114|470710073|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
130751084|NCT03533114|470710072|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
130751085|NCT03533114|470710073|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
130751086|NCT03533114|470710072|FG000|Stable Dose|Adverse Event|0|||
130751087|NCT03533114|470710073|FG001|Stable Dose|Adverse Event|2|||
130751088|NCT03533114|470710072|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
130751089|NCT03533114|470710073|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
130751090|NCT03533114|470710072|FG000|Stable Dose|Lack of Efficacy|1|||
130751091|NCT03533114|470710073|FG001|Stable Dose|Lack of Efficacy|0|||
130751092|NCT03533114|470710072|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
130751093|NCT03533114|470710073|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
130751094|NCT03533114|470710072|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
130751095|NCT03533114|470710073|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
130751096|NCT03533114|470710072|FG000|Open-Label Safety Extension|Adverse Event|3|||
130751097|NCT03533114|470710073|FG001|Open-Label Safety Extension|Adverse Event|0|||
130751098|NCT03533114|470710072|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
130751099|NCT03533114|470710073|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
130751100|NCT03533114|470710072|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
130751101|NCT03533114|470710073|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
130751102|NCT03533114|470710072|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
130751103|NCT03533114|470710073|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
130751104|NCT03533114|470710072|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
130751105|NCT03533114|470710073|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
130751106|NCT01862250|470710074|FG000|Overall Study|Adverse Event|4|||
130751107|NCT02016105|470710075|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
130751108|NCT02016105|470710076|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
130751109|NCT02016105|470710077|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
130751110|NCT02016105|470710078|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
130751111|NCT02016105|470710079|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
130751112|NCT02016105|470710080|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
130751113|NCT02016105|470710075|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
130751114|NCT02016105|470710076|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
130751115|NCT02016105|470710077|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
130751116|NCT02016105|470710078|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
130751117|NCT02016105|470710079|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
130751118|NCT02016105|470710080|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
130751119|NCT02016105|470710075|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
130751120|NCT02016105|470710076|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
130751121|NCT02016105|470710077|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130751122|NCT02016105|470710078|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130751123|NCT02016105|470710079|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130751124|NCT02016105|470710080|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130751125|NCT02016105|470710075|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
130751126|NCT02016105|470710076|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
130751127|NCT02016105|470710077|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
130751128|NCT02016105|470710078|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
130751129|NCT02016105|470710079|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
130751130|NCT02016105|470710080|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
130751131|NCT02016105|470710075|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
130751132|NCT02016105|470710076|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
130751133|NCT02016105|470710077|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
130751134|NCT02016105|470710078|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
130751135|NCT02016105|470710079|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
130751136|NCT02016105|470710080|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
130751137|NCT02016105|470710075|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
130751138|NCT02016105|470710076|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
130751139|NCT02016105|470710077|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130751140|NCT02016105|470710078|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130751141|NCT02016105|470710079|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130751142|NCT02016105|470710080|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130751143|NCT02016105|470710075|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
130751144|NCT02016105|470710076|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
130751145|NCT02016105|470710077|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130751146|NCT02016105|470710078|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130751147|NCT02016105|470710079|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130751148|NCT02016105|470710080|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130751149|NCT02016105|470710075|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
130751150|NCT02016105|470710076|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
130751151|NCT02016105|470710077|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
130751152|NCT02016105|470710078|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
130751153|NCT02016105|470710079|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
130751154|NCT02016105|470710080|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
130751155|NCT02016105|470710075|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
130751156|NCT02016105|470710076|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
130751157|NCT02016105|470710077|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
130751158|NCT02016105|470710078|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
130751159|NCT02016105|470710079|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
130751160|NCT02016105|470710080|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
130751161|NCT02016105|470710075|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
130751162|NCT02016105|470710076|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
130751163|NCT02016105|470710077|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
130751164|NCT02016105|470710078|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
130751165|NCT02016105|470710079|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
130751166|NCT02016105|470710080|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
130751167|NCT02016105|470710075|FG000|TREATMENT PERIOD 2|Death|0|||
130751168|NCT02016105|470710076|FG001|TREATMENT PERIOD 2|Death|0|||
130751169|NCT02016105|470710077|FG002|TREATMENT PERIOD 2|Death|0|||
130751170|NCT02016105|470710078|FG003|TREATMENT PERIOD 2|Death|0|||
130751171|NCT02016105|470710079|FG004|TREATMENT PERIOD 2|Death|0|||
130751172|NCT02016105|470710080|FG005|TREATMENT PERIOD 2|Death|1|||
130751173|NCT02016105|470710075|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
130751174|NCT02016105|470710076|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
130751175|NCT02016105|470710077|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
130751176|NCT02016105|470710078|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
130751177|NCT02016105|470710079|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
130751178|NCT02016105|470710080|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
130751179|NCT02016105|470710075|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
130751180|NCT02016105|470710076|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
130751181|NCT02016105|470710077|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
130751182|NCT02016105|470710078|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
130751183|NCT02016105|470710079|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
130751184|NCT02016105|470710080|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
130751185|NCT02016105|470710075|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130751186|NCT02016105|470710076|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130751187|NCT02016105|470710077|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
130751188|NCT02016105|470710078|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130751189|NCT02016105|470710079|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130751190|NCT02016105|470710080|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
130751191|NCT02016105|470710075|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
130751192|NCT02016105|470710076|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
130751193|NCT02016105|470710077|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
130751194|NCT02016105|470710078|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
130751195|NCT02016105|470710079|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
130751196|NCT02016105|470710080|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
130751197|NCT02016105|470710075|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
130751198|NCT02016105|470710076|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
130751199|NCT02016105|470710077|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
130751200|NCT02016105|470710078|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
130751201|NCT02016105|470710079|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
130751202|NCT02016105|470710080|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
130751203|NCT02016105|470710075|FG000|EXTENSION PERIOD|Adverse Event|0|||
130751204|NCT02016105|470710076|FG001|EXTENSION PERIOD|Adverse Event|0|||
130751205|NCT02016105|470710077|FG002|EXTENSION PERIOD|Adverse Event|2|||
130751206|NCT02016105|470710078|FG003|EXTENSION PERIOD|Adverse Event|0|||
130751207|NCT02016105|470710079|FG004|EXTENSION PERIOD|Adverse Event|1|||
130751208|NCT02016105|470710080|FG005|EXTENSION PERIOD|Adverse Event|0|||
130751209|NCT02016105|470710075|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
130751210|NCT02016105|470710076|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
130751211|NCT02016105|470710077|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
130751212|NCT02016105|470710078|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
130751213|NCT02016105|470710079|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
130751214|NCT02016105|470710080|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
130751215|NCT02016105|470710075|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
130751216|NCT02016105|470710076|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
130751217|NCT02016105|470710077|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
130751218|NCT02016105|470710078|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
130788671|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
130788672|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130751219|NCT02016105|470710079|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
130751220|NCT02016105|470710080|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
130751221|NCT02016105|470710075|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
130751222|NCT02016105|470710076|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
130788673|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130788674|NCT02717195|470854610|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
130751223|NCT02016105|470710077|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
130751224|NCT02016105|470710078|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
130751225|NCT02016105|470710079|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
130751226|NCT02016105|470710080|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
130822745|NCT00812955|470980590|FG001|Overall Study|Withdrawal by Subject|0|||
130751227|NCT00900159|470710085|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
130751228|NCT00900159|470710086|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
130751229|NCT01377922|470710093|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
130751230|NCT01377922|470710094|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
130751231|NCT04615403|470710095|FG000|Overall Study|Death|1|||
130751232|NCT03170362|470710096|FG000|Overall Study|Death|2|||
130751233|NCT03170362|470710097|FG001|Overall Study|Death|2|||
130751234|NCT03170362|470710096|FG000|Overall Study|Withdrawal by Subject|23|||
130751235|NCT03170362|470710097|FG001|Overall Study|Withdrawal by Subject|22|||
130751236|NCT03170362|470710096|FG000|Overall Study|Lost to Follow-up|187|||
130751237|NCT03170362|470710097|FG001|Overall Study|Lost to Follow-up|167|||
130751238|NCT03340454|470710098|FG000|Overall Study|Lost to Follow-up|0|||
130751239|NCT03340454|470710099|FG001|Overall Study|Lost to Follow-up|4|||
130751240|NCT03682848|470710100|FG000|Overall Study|Withdrawal by Subject|2|||
130751241|NCT03682848|470710100|FG000|Overall Study|Site closed|5|||
130751242|NCT03682848|470710100|FG000|Overall Study|Protocol Deviation|1|||
130751243|NCT03682848|470710100|FG000|Overall Study|Adverse Event|1|||
130751244|NCT01464164|470710101|FG000|Overall Study|Screen failure|0|||
130751245|NCT01464164|470710102|FG001|Overall Study|Screen failure|1|||
130751246|NCT01464164|470710103|FG002|Overall Study|Screen failure|2|||
130751247|NCT01464164|470710104|FG003|Overall Study|Screen failure|0|||
130751248|NCT01464164|470710105|FG004|Overall Study|Screen failure|0|||
130751249|NCT01464164|470710106|FG005|Overall Study|Screen failure|0|||
130751250|NCT01464164|470710107|FG006|Overall Study|Screen failure|0|||
130751251|NCT01464164|470710101|FG000|Overall Study|Physician Decision|0|||
130751252|NCT01464164|470710102|FG001|Overall Study|Physician Decision|1|||
130751253|NCT01464164|470710103|FG002|Overall Study|Physician Decision|0|||
130751254|NCT01464164|470710104|FG003|Overall Study|Physician Decision|0|||
130751255|NCT01464164|470710105|FG004|Overall Study|Physician Decision|0|||
130751256|NCT01464164|470710106|FG005|Overall Study|Physician Decision|0|||
130751257|NCT01464164|470710107|FG006|Overall Study|Physician Decision|2|||
130751258|NCT00603473|470710108|FG000|Overall Study|Adverse Event|4|||
130751259|NCT00603473|470710108|FG000|Overall Study|Lack of Efficacy|4|||
130751260|NCT00603473|470710108|FG000|Overall Study|Protocol Violation|1|||
130788675|NCT02717195|470854611|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
130788676|NCT02717195|470854612|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
130788677|NCT02717195|470854613|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
130788678|NCT02717195|470854614|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
130788679|NCT02577029|470854615|FG000|Overall Study|Adverse Event|1|||
130788680|NCT02577029|470854616|FG001|Overall Study|Adverse Event|0|||
130788681|NCT02577029|470854617|FG002|Overall Study|Adverse Event|2|||
130788682|NCT02577029|470854618|FG003|Overall Study|Adverse Event|0|||
130788683|NCT02577029|470854619|FG004|Overall Study|Adverse Event|1|||
130788684|NCT02577029|470854620|FG005|Overall Study|Adverse Event|0|||
130788685|NCT02577029|470854621|FG006|Overall Study|Adverse Event|0|||
130788686|NCT02577029|470854622|FG007|Overall Study|Adverse Event|0|||
130751261|NCT02644668|470710109|FG000|Overall Study|Adverse Event|2|||
130788687|NCT02577029|470854615|FG000|Overall Study|Withdrawal by Subject|0|||
130788688|NCT02577029|470854616|FG001|Overall Study|Withdrawal by Subject|0|||
130751262|NCT02644668|470710110|FG001|Overall Study|Adverse Event|0|||
130751263|NCT02644668|470710111|FG002|Overall Study|Adverse Event|1|||
130788689|NCT02577029|470854617|FG002|Overall Study|Withdrawal by Subject|0|||
130751264|NCT02644668|470710109|FG000|Overall Study|Protocol Violation|0|||
130751265|NCT02644668|470710110|FG001|Overall Study|Protocol Violation|0|||
130751266|NCT02644668|470710111|FG002|Overall Study|Protocol Violation|1|||
130751267|NCT02644668|470710109|FG000|Overall Study|Withdrawal by Subject|0|||
130751268|NCT02644668|470710110|FG001|Overall Study|Withdrawal by Subject|0|||
130751269|NCT02644668|470710111|FG002|Overall Study|Withdrawal by Subject|1|||
130751270|NCT01134939|470710115|FG000|Overall Study|Adverse Event|9|||
130751271|NCT01134939|470710116|FG001|Overall Study|Adverse Event|3|||
130751272|NCT01134939|470710117|FG002|Overall Study|Adverse Event|4|||
130751273|NCT01134939|470710118|FG003|Overall Study|Adverse Event|5|||
130751274|NCT01134939|470710119|FG004|Overall Study|Adverse Event|5|||
130751275|NCT01134939|470710120|FG005|Overall Study|Adverse Event|5|||
130751276|NCT01134939|470710121|FG006|Overall Study|Adverse Event|1|||
130751277|NCT01134939|470710122|FG007|Overall Study|Adverse Event|0|||
130751278|NCT01134939|470710115|FG000|Overall Study|Lack of Efficacy|2|||
130751279|NCT01134939|470710116|FG001|Overall Study|Lack of Efficacy|5|||
130751280|NCT01134939|470710117|FG002|Overall Study|Lack of Efficacy|1|||
130751281|NCT01134939|470710118|FG003|Overall Study|Lack of Efficacy|0|||
130751282|NCT01134939|470710119|FG004|Overall Study|Lack of Efficacy|3|||
130751283|NCT01134939|470710120|FG005|Overall Study|Lack of Efficacy|0|||
130751284|NCT01134939|470710121|FG006|Overall Study|Lack of Efficacy|1|||
130751285|NCT01134939|470710122|FG007|Overall Study|Lack of Efficacy|0|||
130751286|NCT01134939|470710115|FG000|Overall Study|Lost to Follow-up|2|||
130751287|NCT01134939|470710116|FG001|Overall Study|Lost to Follow-up|3|||
130751288|NCT01134939|470710117|FG002|Overall Study|Lost to Follow-up|0|||
130751289|NCT01134939|470710118|FG003|Overall Study|Lost to Follow-up|1|||
130751290|NCT01134939|470710119|FG004|Overall Study|Lost to Follow-up|2|||
130751291|NCT01134939|470710120|FG005|Overall Study|Lost to Follow-up|1|||
130751292|NCT01134939|470710121|FG006|Overall Study|Lost to Follow-up|0|||
130751293|NCT01134939|470710122|FG007|Overall Study|Lost to Follow-up|0|||
130751294|NCT01134939|470710115|FG000|Overall Study|Death|0|||
130751295|NCT01134939|470710116|FG001|Overall Study|Death|1|||
130751296|NCT01134939|470710117|FG002|Overall Study|Death|0|||
130751297|NCT01134939|470710118|FG003|Overall Study|Death|0|||
130751298|NCT01134939|470710119|FG004|Overall Study|Death|0|||
130751299|NCT01134939|470710120|FG005|Overall Study|Death|0|||
130751300|NCT01134939|470710121|FG006|Overall Study|Death|0|||
130751301|NCT01134939|470710122|FG007|Overall Study|Death|0|||
130751302|NCT01134939|470710115|FG000|Overall Study|Termination page not available|4|||
130751303|NCT01134939|470710116|FG001|Overall Study|Termination page not available|6|||
130751304|NCT01134939|470710117|FG002|Overall Study|Termination page not available|5|||
130751305|NCT01134939|470710118|FG003|Overall Study|Termination page not available|8|||
130751306|NCT01134939|470710119|FG004|Overall Study|Termination page not available|0|||
130751307|NCT01134939|470710120|FG005|Overall Study|Termination page not available|3|||
130751308|NCT01134939|470710121|FG006|Overall Study|Termination page not available|7|||
130751309|NCT01134939|470710122|FG007|Overall Study|Termination page not available|0|||
130751310|NCT00733421|470710123|FG000|Overall Study|Withdrawal by Subject|1|||
130751311|NCT00733421|470710124|FG001|Overall Study|Withdrawal by Subject|1|||
130751312|NCT02547220|470710132|FG000|Overall Study|Withdrawal by Subject|1|||
130751313|NCT02547220|470710133|FG001|Overall Study|Withdrawal by Subject|0|||
130751314|NCT02547220|470710132|FG000|Overall Study|Study terminated by sponsor|18|||
130751315|NCT02547220|470710133|FG001|Overall Study|Study terminated by sponsor|20|||
130751316|NCT00550043|470710134|FG000|Overall Study|Adverse Event|0|||
130751317|NCT00550043|470710135|FG001|Overall Study|Adverse Event|0|||
130751318|NCT00550043|470710136|FG002|Overall Study|Adverse Event|0|||
130751319|NCT00550043|470710137|FG003|Overall Study|Adverse Event|1|||
130751320|NCT00550043|470710138|FG004|Overall Study|Adverse Event|1|||
130751321|NCT00550043|470710134|FG000|Overall Study|Subject Withdrew Consent|0|||
130751322|NCT00550043|470710135|FG001|Overall Study|Subject Withdrew Consent|2|||
130751323|NCT00550043|470710136|FG002|Overall Study|Subject Withdrew Consent|1|||
130751324|NCT00550043|470710137|FG003|Overall Study|Subject Withdrew Consent|0|||
130751325|NCT00550043|470710138|FG004|Overall Study|Subject Withdrew Consent|0|||
130751326|NCT00550043|470710134|FG000|Overall Study|Other Reasons- Unspecified|0|||
130751327|NCT00550043|470710135|FG001|Overall Study|Other Reasons- Unspecified|1|||
130751328|NCT00550043|470710136|FG002|Overall Study|Other Reasons- Unspecified|0|||
130751329|NCT00550043|470710137|FG003|Overall Study|Other Reasons- Unspecified|1|||
130751330|NCT00550043|470710138|FG004|Overall Study|Other Reasons- Unspecified|0|||
130751331|NCT04185220|470710139|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
130788690|NCT02577029|470854618|FG003|Overall Study|Withdrawal by Subject|0|||
130751332|NCT04185220|470710140|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
130751333|NCT04185220|470710139|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
130751334|NCT04185220|470710140|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
130751335|NCT03478644|470710142|FG000|Phase 2|Withdrawal by Subject|2|||
130751336|NCT03478644|470710143|FG001|Phase 2|Withdrawal by Subject|1|||
130751337|NCT03478644|470710142|FG000|Phase 2|Lost to Follow-up|1|||
130751338|NCT03478644|470710143|FG001|Phase 2|Lost to Follow-up|0|||
130751339|NCT01029782|470710144|FG000|Overall Study|Lost to Follow-up|2|||
130751340|NCT01029782|470710145|FG001|Overall Study|Lost to Follow-up|2|||
130751341|NCT01029782|470710144|FG000|Overall Study|Diagnosis changed|1|||
130751342|NCT01029782|470710145|FG001|Overall Study|Diagnosis changed|1|||
130751343|NCT01029782|470710144|FG000|Overall Study|Adverse Event|0|||
130751344|NCT01029782|470710145|FG001|Overall Study|Adverse Event|1|||
130751345|NCT01029782|470710144|FG000|Overall Study|Physician Decision|0|||
130751346|NCT01029782|470710145|FG001|Overall Study|Physician Decision|1|||
130751347|NCT01029782|470710144|FG000|Overall Study|Protocol Violation|0|||
130751348|NCT01029782|470710145|FG001|Overall Study|Protocol Violation|2|||
130751349|NCT01029782|470710144|FG000|Overall Study|Withdrawal by Subject|0|||
130751350|NCT01029782|470710145|FG001|Overall Study|Withdrawal by Subject|1|||
130751351|NCT02195869|470710147|FG000|Overall Study|cGVHD Progression|5|||
130751352|NCT02195869|470710147|FG000|Overall Study|Malignancy Progression/relapse|2|||
130751353|NCT02195869|470710147|FG000|Overall Study|Adverse Event|15|||
130751354|NCT02195869|470710147|FG000|Overall Study|Withdrawal by Subject|7|||
130751355|NCT02195869|470710147|FG000|Overall Study|Physician Decision|4|||
130751356|NCT02195869|470710147|FG000|Overall Study|Study Terminated by Sponsor|7|||
130751357|NCT02195869|470710147|FG000|Overall Study|Noncompliance with study drug|2|||
130751358|NCT00789698|470710148|FG000|Overall Study|Lack of Efficacy|10|||
130751359|NCT00789698|470710149|FG001|Overall Study|Lack of Efficacy|4|||
130751360|NCT00789698|470710150|FG002|Overall Study|Lack of Efficacy|5|||
130751361|NCT00789698|470710151|FG003|Overall Study|Lack of Efficacy|18|||
130751362|NCT00789698|470710148|FG000|Overall Study|Adverse Event|5|||
130751363|NCT00789698|470710149|FG001|Overall Study|Adverse Event|5|||
130751364|NCT00789698|470710150|FG002|Overall Study|Adverse Event|3|||
130751365|NCT00789698|470710151|FG003|Overall Study|Adverse Event|4|||
130751366|NCT00789698|470710148|FG000|Overall Study|Lost to Follow-up|5|||
130751367|NCT00789698|470710149|FG001|Overall Study|Lost to Follow-up|5|||
130751368|NCT00789698|470710150|FG002|Overall Study|Lost to Follow-up|2|||
130751369|NCT00789698|470710151|FG003|Overall Study|Lost to Follow-up|9|||
130751370|NCT00789698|470710148|FG000|Overall Study|Protocol Violation|6|||
130751371|NCT00789698|470710149|FG001|Overall Study|Protocol Violation|1|||
130751372|NCT00789698|470710150|FG002|Overall Study|Protocol Violation|2|||
130751373|NCT00789698|470710151|FG003|Overall Study|Protocol Violation|1|||
130751374|NCT00789698|470710148|FG000|Overall Study|Withdrawal by Subject|14|||
130751375|NCT00789698|470710149|FG001|Overall Study|Withdrawal by Subject|15|||
130751376|NCT00789698|470710150|FG002|Overall Study|Withdrawal by Subject|12|||
130751377|NCT00789698|470710151|FG003|Overall Study|Withdrawal by Subject|19|||
130751378|NCT00789698|470710148|FG000|Overall Study|Administrative|0|||
130751379|NCT00789698|470710149|FG001|Overall Study|Administrative|3|||
130751380|NCT00789698|470710150|FG002|Overall Study|Administrative|3|||
130751381|NCT00789698|470710151|FG003|Overall Study|Administrative|1|||
130751382|NCT03300505|470712027|FG000|Overall Study|Death|0|||
130751383|NCT03300505|470712028|FG001|Overall Study|Death|1|||
130751384|NCT03300505|470712029|FG002|Overall Study|Death|0|||
130751385|NCT03300505|470712027|FG000|Overall Study|Withdrawal by Subject|0|||
130751386|NCT03300505|470712028|FG001|Overall Study|Withdrawal by Subject|1|||
130751387|NCT03300505|470712029|FG002|Overall Study|Withdrawal by Subject|1|||
130751388|NCT03300505|470712027|FG000|Overall Study|Sponsor Termination|0|||
130751389|NCT03300505|470712028|FG001|Overall Study|Sponsor Termination|1|||
130751390|NCT03300505|470712029|FG002|Overall Study|Sponsor Termination|0|||
130751391|NCT03300505|470712027|FG000|Overall Study|Adverse Event|0|||
130751392|NCT03300505|470712028|FG001|Overall Study|Adverse Event|0|||
130751393|NCT03300505|470712029|FG002|Overall Study|Adverse Event|2|||
130751394|NCT05119595|470712030|FG000|Overall Study|Death|1|||
130751395|NCT05119595|470712030|FG000|Overall Study|Lost to Follow-up|7|||
130751396|NCT03056638|470712033|FG000|Overall Study|Death|1|||
130751397|NCT03056638|470712034|FG001|Overall Study|Death|0|||
130751398|NCT00468481|470712035|FG000|Overall Study|Adverse Event|13|||
130751399|NCT00468481|470712036|FG001|Overall Study|Adverse Event|3|||
130751400|NCT00468481|470712035|FG000|Overall Study|Lost to Follow-up|25|||
130751401|NCT00468481|470712036|FG001|Overall Study|Lost to Follow-up|8|||
130751402|NCT00468481|470712035|FG000|Overall Study|Pregnancy|2|||
130751403|NCT00468481|470712036|FG001|Overall Study|Pregnancy|0|||
130751404|NCT00468481|470712035|FG000|Overall Study|Protocol Violation|18|||
130751405|NCT00468481|470712036|FG001|Overall Study|Protocol Violation|8|||
130751406|NCT00468481|470712035|FG000|Overall Study|Withdrawal by Subject|12|||
130751407|NCT00468481|470712036|FG001|Overall Study|Withdrawal by Subject|3|||
130751408|NCT00468481|470712035|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
130751409|NCT00468481|470712036|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
130751410|NCT00468481|470712035|FG000|Overall Study|Prohibited Medication|1|||
130751411|NCT00468481|470712036|FG001|Overall Study|Prohibited Medication|1|||
130751412|NCT00468481|470712035|FG000|Overall Study|Egg Donor|1|||
130751413|NCT00468481|470712036|FG001|Overall Study|Egg Donor|0|||
130751414|NCT00468481|470712035|FG000|Overall Study|Moved out of area|4|||
130751415|NCT00468481|470712036|FG001|Overall Study|Moved out of area|1|||
130751416|NCT00468481|470712035|FG000|Overall Study|Non-Compliance|5|||
130751417|NCT00468481|470712036|FG001|Overall Study|Non-Compliance|0|||
130751418|NCT00468481|470712035|FG000|Overall Study|Other|6|||
130751419|NCT00468481|470712036|FG001|Overall Study|Other|0|||
130751420|NCT00734162|470712037|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
130751421|NCT00734162|470712038|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
130751422|NCT00734162|470712039|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
130751423|NCT00734162|470712040|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
130751424|NCT00734162|470712037|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
130751425|NCT00734162|470712038|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
130751426|NCT00734162|470712039|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
130751427|NCT00734162|470712040|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
130751428|NCT00734162|470712037|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
130751429|NCT00734162|470712038|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
130751430|NCT00734162|470712039|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
130751431|NCT00734162|470712040|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
130751432|NCT00734162|470712037|FG000|Open-Label Phase|Withdrew Consent|1|||
130751433|NCT00734162|470712038|FG001|Open-Label Phase|Withdrew Consent|0|||
130751434|NCT00734162|470712039|FG002|Open-Label Phase|Withdrew Consent|1|||
130751435|NCT00734162|470712040|FG003|Open-Label Phase|Withdrew Consent|1|||
130751436|NCT00734162|470712037|FG000|Open-Label Phase|Lost to Follow-up|1|||
130751437|NCT00734162|470712038|FG001|Open-Label Phase|Lost to Follow-up|2|||
130751438|NCT00734162|470712039|FG002|Open-Label Phase|Lost to Follow-up|0|||
130751439|NCT00734162|470712040|FG003|Open-Label Phase|Lost to Follow-up|1|||
130751440|NCT00734162|470712037|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130751441|NCT00734162|470712038|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130751442|NCT00734162|470712039|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130751443|NCT00734162|470712040|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
130751444|NCT03831113|470712041|FG000|Overall Study|Withdrawal by Subject|0|||
130751445|NCT03831113|470712042|FG001|Overall Study|Withdrawal by Subject|2|||
130751446|NCT03831113|470712041|FG000|Overall Study|Protocol Violation|0|||
130751447|NCT03831113|470712042|FG001|Overall Study|Protocol Violation|9|||
130751448|NCT03508726|470712043|FG000|Overall Study|Withdrawal by Subject|0|||
130751449|NCT03508726|470712044|FG001|Overall Study|Withdrawal by Subject|1|||
130751450|NCT01515865|470712046|FG000|Part A (Open-label)|Other|3|||
130751451|NCT01515865|470712047|FG001|Part A (Open-label)|Other|0|||
130751452|NCT01515865|470712048|FG002|Part A (Open-label)|Other|0|||
130751453|NCT01515865|470712046|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
130751454|NCT01515865|470712047|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
130751455|NCT01515865|470712048|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
130751456|NCT01515865|470712046|FG000|Part B (Open-label)|Other|1|||
130751457|NCT01515865|470712047|FG001|Part B (Open-label)|Other|0|||
130751458|NCT01515865|470712048|FG002|Part B (Open-label)|Other|0|||
130751459|NCT01073605|470712049|FG000|Overall Study|Ongoing at Cutoff Date|1|||
130751460|NCT01073605|470712050|FG001|Overall Study|Ongoing at Cutoff Date|1|||
130751461|NCT01073605|470712051|FG002|Overall Study|Ongoing at Cutoff Date|0|||
130751462|NCT01073605|470712049|FG000|Overall Study|Adverse Event|2|||
130751463|NCT01073605|470712050|FG001|Overall Study|Adverse Event|1|||
130751464|NCT01073605|470712051|FG002|Overall Study|Adverse Event|0|||
130751465|NCT01073605|470712049|FG000|Overall Study|Lost to Follow-up|3|||
130751466|NCT01073605|470712050|FG001|Overall Study|Lost to Follow-up|4|||
130751467|NCT01073605|470712051|FG002|Overall Study|Lost to Follow-up|9|||
130751468|NCT01073605|470712049|FG000|Overall Study|Other|25|||
130751469|NCT01073605|470712050|FG001|Overall Study|Other|21|||
130751470|NCT01073605|470712051|FG002|Overall Study|Other|29|||
130751471|NCT01073605|470712049|FG000|Overall Study|Withdrawal by Subject|31|||
130751472|NCT01073605|470712050|FG001|Overall Study|Withdrawal by Subject|39|||
130751473|NCT01073605|470712051|FG002|Overall Study|Withdrawal by Subject|22|||
130751474|NCT01073605|470712049|FG000|Overall Study|Randomized But Not Treated|0|||
130751475|NCT01073605|470712050|FG001|Overall Study|Randomized But Not Treated|1|||
130751476|NCT01073605|470712051|FG002|Overall Study|Randomized But Not Treated|1|||
130751477|NCT02875613|470712052|FG000|Overall Study|Withdrawal by Subject|1|||
130751478|NCT02875613|470712052|FG000|Overall Study|Screen Failure|1|||
130751479|NCT02308540|470712054|FG000|Overall Study|Lost to Follow-up|0|||
130751480|NCT02308540|470712055|FG001|Overall Study|Lost to Follow-up|0|||
130751481|NCT02308540|470712056|FG002|Overall Study|Lost to Follow-up|0|||
130751482|NCT02308540|470712057|FG003|Overall Study|Lost to Follow-up|0|||
130751483|NCT02308540|470712058|FG004|Overall Study|Lost to Follow-up|0|||
130751484|NCT02308540|470712059|FG005|Overall Study|Lost to Follow-up|1|||
130751485|NCT02285166|470712060|FG000|Overall Study|Case Report Forms Uncollected|564|||
130751486|NCT02285166|470712060|FG000|Overall Study|Protocol Deviation|402|||
130751487|NCT00443079|470712061|FG000|Overall Study|Lost to Follow-up|0|||
130751488|NCT00443079|470712062|FG001|Overall Study|Lost to Follow-up|1|||
130751489|NCT02649439|470712063|FG000|Overall Study|Switched to alternative treatment|6|||
130751490|NCT02649439|470712064|FG001|Overall Study|Switched to alternative treatment|4|||
130751491|NCT02649439|470712063|FG000|Overall Study|Patient decision|1|||
130751492|NCT02649439|470712064|FG001|Overall Study|Patient decision|0|||
130751493|NCT02649439|470712063|FG000|Overall Study|Patient going out of country|1|||
130751494|NCT02649439|470712064|FG001|Overall Study|Patient going out of country|0|||
130751495|NCT02649439|470712063|FG000|Overall Study|To start finasteride|1|||
130751496|NCT02649439|470712064|FG001|Overall Study|To start finasteride|0|||
130751497|NCT02649439|470712063|FG000|Overall Study|Physician Decision|1|||
130751498|NCT02649439|470712064|FG001|Overall Study|Physician Decision|0|||
130751499|NCT02649439|470712063|FG000|Overall Study|Disease progression on study|12|||
130751500|NCT02649439|470712064|FG001|Overall Study|Disease progression on study|13|||
130751501|NCT02649439|470712063|FG000|Overall Study|Refused further treatment|1|||
130751502|NCT02649439|470712064|FG001|Overall Study|Refused further treatment|0|||
130751503|NCT02649439|470712063|FG000|Overall Study|Refused further follow up|2|||
130751504|NCT02649439|470712064|FG001|Overall Study|Refused further follow up|7|||
130788691|NCT02577029|470854619|FG004|Overall Study|Withdrawal by Subject|0|||
130751505|NCT02649439|470712063|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
130751506|NCT02649439|470712064|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
130751507|NCT02649439|470712063|FG000|Overall Study|No treatment, per protocol|1|||
130751508|NCT02649439|470712064|FG001|Overall Study|No treatment, per protocol|0|||
130751509|NCT02649439|470712063|FG000|Overall Study|PSA DT makes ineligible|0|||
130751510|NCT02649439|470712064|FG001|Overall Study|PSA DT makes ineligible|1|||
130751511|NCT02649439|470712063|FG000|Overall Study|Rising PSA No Mets|0|||
130751512|NCT02649439|470712064|FG001|Overall Study|Rising PSA No Mets|1|||
130751513|NCT02649439|470712063|FG000|Overall Study|Rising PSA|0|||
130751514|NCT02649439|470712064|FG001|Overall Study|Rising PSA|1|||
130751515|NCT02649439|470712063|FG000|Overall Study|Signed follow up protocol|0|||
130751516|NCT02649439|470712064|FG001|Overall Study|Signed follow up protocol|1|||
130751517|NCT03852264|470712067|FG000|Third Research Visit|Lost to Follow-up|1|||
130751518|NCT03852264|470712068|FG001|Third Research Visit|Lost to Follow-up|0|||
130751519|NCT00090493|470712069|FG000|Overall Study|Physician Decision|2|||
130751520|NCT02071706|470712070|FG000|Overall Study|Adverse Event|1|||
130751521|NCT02071706|470712070|FG000|Overall Study|Withdrawal by Subject|2|||
130751522|NCT01908829|470712076|FG000|Overall Study|Adverse Event|13|||
130751523|NCT01908829|470712077|FG001|Overall Study|Adverse Event|11|||
130751524|NCT01908829|470712078|FG002|Overall Study|Adverse Event|13|||
130751525|NCT01908829|470712076|FG000|Overall Study|Lost to Follow-up|4|||
130751526|NCT01908829|470712077|FG001|Overall Study|Lost to Follow-up|2|||
130751527|NCT01908829|470712078|FG002|Overall Study|Lost to Follow-up|1|||
130751528|NCT01908829|470712076|FG000|Overall Study|Randomized no double-blind drug received|1|||
130751529|NCT01908829|470712077|FG001|Overall Study|Randomized no double-blind drug received|0|||
130751530|NCT01908829|470712078|FG002|Overall Study|Randomized no double-blind drug received|1|||
130751531|NCT01908829|470712076|FG000|Overall Study|Discontinued (no EoT page)|2|||
130751532|NCT01908829|470712077|FG001|Overall Study|Discontinued (no EoT page)|0|||
130751533|NCT01908829|470712078|FG002|Overall Study|Discontinued (no EoT page)|0|||
130751534|NCT01908829|470712076|FG000|Overall Study|Miscellaneous|0|||
130751535|NCT01908829|470712077|FG001|Overall Study|Miscellaneous|2|||
130751536|NCT01908829|470712078|FG002|Overall Study|Miscellaneous|0|||
130751537|NCT01908829|470712076|FG000|Overall Study|Protocol Violation|2|||
130751538|NCT01908829|470712077|FG001|Overall Study|Protocol Violation|2|||
130751539|NCT01908829|470712078|FG002|Overall Study|Protocol Violation|0|||
130751540|NCT01908829|470712076|FG000|Overall Study|Lack of Efficacy|1|||
130751541|NCT01908829|470712077|FG001|Overall Study|Lack of Efficacy|3|||
130751542|NCT01908829|470712078|FG002|Overall Study|Lack of Efficacy|2|||
130751543|NCT01908829|470712076|FG000|Overall Study|Withdrawal by Subject|26|||
130751544|NCT01908829|470712077|FG001|Overall Study|Withdrawal by Subject|29|||
130751545|NCT01908829|470712078|FG002|Overall Study|Withdrawal by Subject|22|||
130751546|NCT02792192|470712079|FG000|Overall Study|Death|1|||
130751547|NCT02792192|470712080|FG001|Overall Study|Death|0|||
130751548|NCT02792192|470712081|FG002|Overall Study|Death|0|||
130751549|NCT02792192|470712082|FG003|Overall Study|Death|0|||
130751550|NCT02792192|470712079|FG000|Overall Study|Informed Consent Withdrawn|4|||
130751551|NCT02792192|470712080|FG001|Overall Study|Informed Consent Withdrawn|0|||
130751552|NCT02792192|470712081|FG002|Overall Study|Informed Consent Withdrawn|0|||
130751553|NCT02792192|470712082|FG003|Overall Study|Informed Consent Withdrawn|0|||
130751554|NCT02792192|470712079|FG000|Overall Study|Physician Decision|1|||
130751555|NCT02792192|470712080|FG001|Overall Study|Physician Decision|0|||
130751556|NCT02792192|470712081|FG002|Overall Study|Physician Decision|0|||
130751557|NCT02792192|470712082|FG003|Overall Study|Physician Decision|0|||
130751558|NCT02792192|470712079|FG000|Overall Study|Progressive Disease|0|||
130751559|NCT02792192|470712080|FG001|Overall Study|Progressive Disease|1|||
130751560|NCT02792192|470712081|FG002|Overall Study|Progressive Disease|0|||
130751561|NCT02792192|470712082|FG003|Overall Study|Progressive Disease|0|||
130751562|NCT02792192|470712079|FG000|Overall Study|Study Terminated By Sponsor|6|||
130751563|NCT02792192|470712080|FG001|Overall Study|Study Terminated By Sponsor|10|||
130751564|NCT02792192|470712081|FG002|Overall Study|Study Terminated By Sponsor|0|||
130751565|NCT02792192|470712082|FG003|Overall Study|Study Terminated By Sponsor|0|||
130751566|NCT02247440|470712083|FG000|Overall Study|Withdrawal by Subject|1|||
130751567|NCT02247440|470712083|FG000|Overall Study|Lack of Efficacy|3|||
130751568|NCT02320058|470712084|FG000|Overall Study|Death|25|||
130751569|NCT02320058|470712085|FG001|Overall Study|Death|10|||
130751570|NCT02320058|470712084|FG000|Overall Study|Lost to Follow-up|4|||
130751571|NCT02320058|470712085|FG001|Overall Study|Lost to Follow-up|0|||
130751572|NCT02320058|470712084|FG000|Overall Study|Other reasons|4|||
130751573|NCT02320058|470712085|FG001|Overall Study|Other reasons|1|||
130751574|NCT02320058|470712084|FG000|Overall Study|Withdrawal by Subject|8|||
130751575|NCT02320058|470712085|FG001|Overall Study|Withdrawal by Subject|2|||
130751576|NCT02320058|470712084|FG000|Overall Study|Not reported|1|||
130788692|NCT02577029|470854620|FG005|Overall Study|Withdrawal by Subject|1|||
130751577|NCT02320058|470712085|FG001|Overall Study|Not reported|0|||
130751578|NCT01339923|470712086|FG000|Overall Study|Adverse Event|1|||
130751579|NCT01339923|470712087|FG001|Overall Study|Adverse Event|1|||
130751580|NCT01339923|470712088|FG002|Overall Study|Adverse Event|1|||
130751581|NCT01339923|470712089|FG003|Overall Study|Adverse Event|0|||
130751582|NCT01339923|470712090|FG004|Overall Study|Adverse Event|0|||
130751583|NCT01339923|470712091|FG005|Overall Study|Adverse Event|0|||
130751584|NCT01339923|470712092|FG006|Overall Study|Adverse Event|1|||
130751585|NCT01339923|470712086|FG000|Overall Study|Inappropriate Enrollment|1|||
130751586|NCT01339923|470712087|FG001|Overall Study|Inappropriate Enrollment|0|||
130751587|NCT01339923|470712088|FG002|Overall Study|Inappropriate Enrollment|0|||
130751588|NCT01339923|470712089|FG003|Overall Study|Inappropriate Enrollment|0|||
130751589|NCT01339923|470712090|FG004|Overall Study|Inappropriate Enrollment|0|||
130751590|NCT01339923|470712091|FG005|Overall Study|Inappropriate Enrollment|1|||
130751591|NCT01339923|470712092|FG006|Overall Study|Inappropriate Enrollment|0|||
130751592|NCT01339923|470712086|FG000|Overall Study|Lost to Follow-up|4|||
130751593|NCT01339923|470712087|FG001|Overall Study|Lost to Follow-up|4|||
130751594|NCT01339923|470712088|FG002|Overall Study|Lost to Follow-up|0|||
130751595|NCT01339923|470712089|FG003|Overall Study|Lost to Follow-up|3|||
130751596|NCT01339923|470712090|FG004|Overall Study|Lost to Follow-up|1|||
130751597|NCT01339923|470712091|FG005|Overall Study|Lost to Follow-up|1|||
130751598|NCT01339923|470712092|FG006|Overall Study|Lost to Follow-up|5|||
130751599|NCT01339923|470712086|FG000|Overall Study|Protocol Violation|0|||
130751600|NCT01339923|470712087|FG001|Overall Study|Protocol Violation|0|||
130751601|NCT01339923|470712088|FG002|Overall Study|Protocol Violation|0|||
130751602|NCT01339923|470712089|FG003|Overall Study|Protocol Violation|0|||
130751603|NCT01339923|470712090|FG004|Overall Study|Protocol Violation|0|||
130751604|NCT01339923|470712091|FG005|Overall Study|Protocol Violation|3|||
130751605|NCT01339923|470712092|FG006|Overall Study|Protocol Violation|1|||
130751606|NCT01339923|470712086|FG000|Overall Study|Unable to Classify|1|||
130751607|NCT01339923|470712087|FG001|Overall Study|Unable to Classify|0|||
130751608|NCT01339923|470712088|FG002|Overall Study|Unable to Classify|1|||
130751609|NCT01339923|470712089|FG003|Overall Study|Unable to Classify|0|||
130751610|NCT01339923|470712090|FG004|Overall Study|Unable to Classify|0|||
130751611|NCT01339923|470712091|FG005|Overall Study|Unable to Classify|1|||
130751612|NCT01339923|470712092|FG006|Overall Study|Unable to Classify|5|||
130751613|NCT01339923|470712086|FG000|Overall Study|Withdrawal by Subject|7|||
130751614|NCT01339923|470712087|FG001|Overall Study|Withdrawal by Subject|11|||
130751615|NCT01339923|470712088|FG002|Overall Study|Withdrawal by Subject|6|||
130751616|NCT01339923|470712089|FG003|Overall Study|Withdrawal by Subject|1|||
130751617|NCT01339923|470712090|FG004|Overall Study|Withdrawal by Subject|4|||
130751618|NCT01339923|470712091|FG005|Overall Study|Withdrawal by Subject|3|||
130751619|NCT01339923|470712092|FG006|Overall Study|Withdrawal by Subject|2|||
130751620|NCT00729157|470712093|FG000|Overall Study|Withdrawal by Subject|1|||
130751621|NCT01430403|470712099|FG000|Overall Study|Lost to Follow-up|5|||
130751622|NCT01430403|470712100|FG001|Overall Study|Lost to Follow-up|5|||
130751623|NCT01430403|470712101|FG002|Overall Study|Lost to Follow-up|3|||
130751624|NCT01430403|470712099|FG000|Overall Study|Physician Decision|1|||
130751625|NCT01430403|470712100|FG001|Overall Study|Physician Decision|0|||
130751626|NCT01430403|470712101|FG002|Overall Study|Physician Decision|0|||
130751627|NCT01430403|470712099|FG000|Overall Study|Protocol Violation|2|||
130751628|NCT01430403|470712100|FG001|Overall Study|Protocol Violation|3|||
130751629|NCT01430403|470712101|FG002|Overall Study|Protocol Violation|2|||
130751630|NCT01430403|470712099|FG000|Overall Study|Withdrawal by Subject|9|||
130751631|NCT01430403|470712100|FG001|Overall Study|Withdrawal by Subject|1|||
130751632|NCT01430403|470712101|FG002|Overall Study|Withdrawal by Subject|3|||
130751633|NCT04481789|470712102|FG000|Period 1|Withdrawal by Subject|1|||
130751634|NCT04481789|470712103|FG001|Period 1|Withdrawal by Subject|0|||
130751635|NCT04481789|470712104|FG002|Period 1|Withdrawal by Subject|0|||
130751636|NCT04481789|470712105|FG003|Period 1|Withdrawal by Subject|0|||
130751637|NCT04481789|470712106|FG004|Period 1|Withdrawal by Subject|0|||
130751638|NCT04481789|470712107|FG005|Period 1|Withdrawal by Subject|0|||
130751639|NCT03124407|470712114|FG000|Overall Study|Lost to Follow-up|1|||
130751640|NCT03124407|470712115|FG001|Overall Study|Lost to Follow-up|0|||
130751641|NCT03124407|470712116|FG002|Overall Study|Lost to Follow-up|0|||
130751642|NCT03124407|470712117|FG003|Overall Study|Lost to Follow-up|0|||
130751643|NCT03124407|470712114|FG000|Overall Study|Adverse Event|0|||
130751644|NCT03124407|470712115|FG001|Overall Study|Adverse Event|0|||
130751645|NCT03124407|470712116|FG002|Overall Study|Adverse Event|1|||
130751646|NCT03124407|470712117|FG003|Overall Study|Adverse Event|0|||
130751647|NCT00396656|470712118|FG000|First Treatment Period|Withdrawal by Subject|0|||
130751648|NCT00396656|470712119|FG001|First Treatment Period|Withdrawal by Subject|2|||
130751649|NCT00396656|470712118|FG000|Second Treatment Period|Adverse Event|0|||
130751650|NCT00396656|470712119|FG001|Second Treatment Period|Adverse Event|1|||
130751651|NCT02821754|470712120|FG000|Overall Study|Procedure not required prior to amendment change|13|||
130751652|NCT02821754|470712121|FG001|Overall Study|Procedure not required prior to amendment change|11|||
130751653|NCT02821754|470712122|FG002|Overall Study|Procedure not required prior to amendment change|0|||
130751654|NCT02821754|470712120|FG000|Overall Study|Participant's Clinical status|2|||
130751655|NCT02821754|470712121|FG001|Overall Study|Participant's Clinical status|0|||
130751656|NCT02821754|470712122|FG002|Overall Study|Participant's Clinical status|0|||
130751657|NCT02821754|470712120|FG000|Overall Study|Participant removed for noncompliance|1|||
130751658|NCT02821754|470712121|FG001|Overall Study|Participant removed for noncompliance|0|||
130751659|NCT02821754|470712122|FG002|Overall Study|Participant removed for noncompliance|0|||
130751660|NCT02821754|470712120|FG000|Overall Study|Drug not available.|0|||
130751661|NCT02821754|470712121|FG001|Overall Study|Drug not available.|0|||
130751662|NCT02821754|470712122|FG002|Overall Study|Drug not available.|1|||
130751663|NCT02821754|470712120|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
130751664|NCT02821754|470712121|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
130751665|NCT02821754|470712122|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
130751666|NCT02477332|470712132|FG000|Overall Study|Adverse Event|0|||
130751667|NCT02477332|470712133|FG001|Overall Study|Adverse Event|1|||
130751668|NCT02477332|470712134|FG002|Overall Study|Adverse Event|1|||
130751669|NCT02477332|470712135|FG003|Overall Study|Adverse Event|2|||
130751670|NCT02477332|470712136|FG004|Overall Study|Adverse Event|1|||
130751671|NCT02477332|470712137|FG005|Overall Study|Adverse Event|2|||
130751672|NCT02477332|470712132|FG000|Overall Study|Lack of Efficacy|1|||
130751673|NCT02477332|470712133|FG001|Overall Study|Lack of Efficacy|2|||
130751674|NCT02477332|470712134|FG002|Overall Study|Lack of Efficacy|1|||
130751675|NCT02477332|470712135|FG003|Overall Study|Lack of Efficacy|2|||
130751676|NCT02477332|470712136|FG004|Overall Study|Lack of Efficacy|1|||
130751677|NCT02477332|470712137|FG005|Overall Study|Lack of Efficacy|1|||
130751678|NCT02477332|470712132|FG000|Overall Study|Non-compliance with study treatment|0|||
130751679|NCT02477332|470712133|FG001|Overall Study|Non-compliance with study treatment|1|||
130751680|NCT02477332|470712134|FG002|Overall Study|Non-compliance with study treatment|2|||
130751681|NCT02477332|470712135|FG003|Overall Study|Non-compliance with study treatment|0|||
130751682|NCT02477332|470712136|FG004|Overall Study|Non-compliance with study treatment|0|||
130751683|NCT02477332|470712137|FG005|Overall Study|Non-compliance with study treatment|0|||
130751684|NCT02477332|470712132|FG000|Overall Study|Pregnancy|0|||
130751685|NCT02477332|470712133|FG001|Overall Study|Pregnancy|0|||
130751686|NCT02477332|470712134|FG002|Overall Study|Pregnancy|0|||
130751687|NCT02477332|470712135|FG003|Overall Study|Pregnancy|1|||
130751688|NCT02477332|470712136|FG004|Overall Study|Pregnancy|0|||
130751689|NCT02477332|470712137|FG005|Overall Study|Pregnancy|0|||
130751690|NCT02477332|470712132|FG000|Overall Study|Protocol Violation|2|||
130751691|NCT02477332|470712133|FG001|Overall Study|Protocol Violation|0|||
130751692|NCT02477332|470712134|FG002|Overall Study|Protocol Violation|3|||
130751693|NCT02477332|470712135|FG003|Overall Study|Protocol Violation|3|||
130751694|NCT02477332|470712136|FG004|Overall Study|Protocol Violation|1|||
130751695|NCT02477332|470712137|FG005|Overall Study|Protocol Violation|1|||
130751696|NCT02477332|470712132|FG000|Overall Study|Technical problems|0|||
130751697|NCT02477332|470712133|FG001|Overall Study|Technical problems|0|||
130751698|NCT02477332|470712134|FG002|Overall Study|Technical problems|1|||
130751699|NCT02477332|470712135|FG003|Overall Study|Technical problems|0|||
130751700|NCT02477332|470712136|FG004|Overall Study|Technical problems|0|||
130751701|NCT02477332|470712137|FG005|Overall Study|Technical problems|0|||
130751702|NCT02477332|470712132|FG000|Overall Study|Lost to Follow-up|0|||
130751703|NCT02477332|470712133|FG001|Overall Study|Lost to Follow-up|0|||
130751704|NCT02477332|470712134|FG002|Overall Study|Lost to Follow-up|2|||
130751705|NCT02477332|470712135|FG003|Overall Study|Lost to Follow-up|0|||
130751706|NCT02477332|470712136|FG004|Overall Study|Lost to Follow-up|0|||
130751707|NCT02477332|470712137|FG005|Overall Study|Lost to Follow-up|0|||
130751708|NCT02477332|470712132|FG000|Overall Study|Physician Decision|0|||
130751709|NCT02477332|470712133|FG001|Overall Study|Physician Decision|0|||
130751710|NCT02477332|470712134|FG002|Overall Study|Physician Decision|1|||
130751711|NCT02477332|470712135|FG003|Overall Study|Physician Decision|3|||
130751712|NCT02477332|470712136|FG004|Overall Study|Physician Decision|0|||
130751713|NCT02477332|470712137|FG005|Overall Study|Physician Decision|1|||
130751714|NCT02477332|470712132|FG000|Overall Study|Withdrawal by Subject|0|||
130788693|NCT02577029|470854621|FG006|Overall Study|Withdrawal by Subject|0|||
130788694|NCT02577029|470854622|FG007|Overall Study|Withdrawal by Subject|0|||
130788695|NCT02577029|470854615|FG000|Overall Study|Sponsor Termination of the Study|9|||
130751715|NCT02477332|470712133|FG001|Overall Study|Withdrawal by Subject|3|||
130751716|NCT02477332|470712134|FG002|Overall Study|Withdrawal by Subject|1|||
130751717|NCT02477332|470712135|FG003|Overall Study|Withdrawal by Subject|2|||
130751718|NCT02477332|470712136|FG004|Overall Study|Withdrawal by Subject|1|||
130788696|NCT02577029|470854616|FG001|Overall Study|Sponsor Termination of the Study|2|||
130788697|NCT02577029|470854617|FG002|Overall Study|Sponsor Termination of the Study|5|||
130751719|NCT02477332|470712137|FG005|Overall Study|Withdrawal by Subject|0|||
130751720|NCT02549287|470712138|FG000|Overall Study|Lost to Follow-up|65|||
130751721|NCT02549287|470712139|FG001|Overall Study|Lost to Follow-up|26|||
130751722|NCT02549287|470712138|FG000|Overall Study|Withdrawal by Subject|15|||
130751723|NCT02549287|470712139|FG001|Overall Study|Withdrawal by Subject|6|||
130751724|NCT03793842|470712140|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
130751725|NCT03793842|470712141|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
130751726|NCT03793842|470712140|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
130751727|NCT03793842|470712141|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
130751728|NCT00427921|470712142|FG000|Overall Study|Adverse Event|26|||
130751729|NCT00427921|470712142|FG000|Overall Study|Withdrawal by Subject|4|||
130751730|NCT00427921|470712142|FG000|Overall Study|Lost to Follow-up|2|||
130751731|NCT00427921|470712142|FG000|Overall Study|Other reason not specified|10|||
130751732|NCT00427921|470712142|FG000|Overall Study|Adverse Event + Hospitalization|1|||
130751733|NCT00427921|470712142|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
130751734|NCT00427921|470712142|FG000|Overall Study|Adverse Event + No Response|1|||
130751735|NCT00427921|470712142|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
130751736|NCT00427921|470712142|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
130751737|NCT00427921|470712142|FG000|Overall Study|Adverse Event + Lost Response|1|||
130751738|NCT00427921|470712142|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
130751739|NCT00427921|470712142|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
130751740|NCT01166438|470712143|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
130751741|NCT01166438|470712144|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
130751742|NCT01166438|470712143|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
130751743|NCT01166438|470712144|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
130751744|NCT01166438|470712143|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
130751745|NCT01166438|470712144|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
130751746|NCT01166438|470712143|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
130751747|NCT01166438|470712144|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
130751748|NCT01166438|470712143|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
130751749|NCT01166438|470712144|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
130751750|NCT01166438|470712143|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
130751751|NCT01166438|470712144|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
130751752|NCT00347009|470712145|FG000|Overall Study|Death|1|||
130751753|NCT00347009|470712145|FG000|Overall Study|Adverse Event|6|||
130751754|NCT00347009|470712145|FG000|Overall Study|Withdrawal by Subject|3|||
130751755|NCT00347009|470712145|FG000|Overall Study|Physician Decision|5|||
130751756|NCT00347009|470712145|FG000|Overall Study|Lost to Follow-up|4|||
130751757|NCT00347009|470712145|FG000|Overall Study|Protocol Violation|2|||
130751758|NCT00347009|470712145|FG000|Overall Study|Adverse Laboratory Experience|1|||
130751759|NCT00347009|470712145|FG000|Overall Study|Insufficient Viral Suppression|3|||
130751760|NCT00347009|470712145|FG000|Overall Study|Increased ALT/HBV DNA|1|||
130751761|NCT00347009|470712145|FG000|Overall Study|Serious Adverse Event|1|||
130751762|NCT01972438|470712147|FG000|Baseline-Month 3 Crossover Period|Death|1|||
130751763|NCT01972438|470712148|FG001|Baseline-Month 3 Crossover Period|Death|0|||
130751764|NCT01972438|470712147|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
130751765|NCT01972438|470712148|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
130751766|NCT01972438|470712147|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
130751767|NCT01972438|470712148|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
130751768|NCT01972438|470712147|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
130751769|NCT01972438|470712148|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
130751770|NCT01972438|470712147|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
130751771|NCT01972438|470712148|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
130751772|NCT01972438|470712147|FG000|Months 6-12 Study Period|Death|1|||
130751773|NCT01972438|470712148|FG001|Months 6-12 Study Period|Death|0|||
130751774|NCT01972438|470712147|FG000|Months 6-12 Study Period|Early Study Closure|2|||
130751775|NCT01972438|470712148|FG001|Months 6-12 Study Period|Early Study Closure|2|||
130751776|NCT01972438|470712147|FG000|Post Month 12 Study Period|Early Study Closure|3|||
130751777|NCT01972438|470712148|FG001|Post Month 12 Study Period|Early Study Closure|4|||
130751778|NCT01186692|470712151|FG000|Overall Study|Not Catheterized|11|||
130751779|NCT01186692|470712151|FG000|Overall Study|Futher testing contraindicated implant|19|||
130751780|NCT01186692|470712151|FG000|Overall Study|Adverse Event|2|||
130751781|NCT00596817|470712152|FG000|Open-label Period|Adverse Event|0|||
130751782|NCT00596817|470712153|FG001|Open-label Period|Adverse Event|49|||
130751783|NCT00596817|470712152|FG000|Open-label Period|Lack of Efficacy|0|||
130751784|NCT00596817|470712153|FG001|Open-label Period|Lack of Efficacy|33|||
130751785|NCT00596817|470712152|FG000|Open-label Period|Other Reasons|0|||
130751786|NCT00596817|470712153|FG001|Open-label Period|Other Reasons|65|||
130751787|NCT00596817|470712152|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
130751788|NCT00596817|470712153|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
130751789|NCT00596817|470712152|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
130751790|NCT00596817|470712153|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
130751791|NCT00596817|470712152|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
130751792|NCT00596817|470712153|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
130751793|NCT00596817|470712152|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
130751794|NCT00596817|470712153|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
130751795|NCT00596817|470712152|FG000|Double-blind Period|Adverse Event|5|||
130751796|NCT00596817|470712153|FG001|Double-blind Period|Adverse Event|16|||
130751797|NCT00596817|470712152|FG000|Double-blind Period|Lack of Efficacy|52|||
130751798|NCT00596817|470712153|FG001|Double-blind Period|Lack of Efficacy|28|||
130751799|NCT00596817|470712152|FG000|Double-blind Period|Non-compliance With Study Product|3|||
130751800|NCT00596817|470712153|FG001|Double-blind Period|Non-compliance With Study Product|4|||
130751801|NCT00596817|470712152|FG000|Double-blind Period|Protocol Violation|11|||
130751802|NCT00596817|470712153|FG001|Double-blind Period|Protocol Violation|8|||
130751803|NCT00596817|470712152|FG000|Double-blind Period|Withdrawal of Consent|7|||
130751804|NCT00596817|470712153|FG001|Double-blind Period|Withdrawal of Consent|3|||
130751805|NCT00596817|470712152|FG000|Double-blind Period|Lost to Follow-up|0|||
130751806|NCT00596817|470712153|FG001|Double-blind Period|Lost to Follow-up|2|||
130751807|NCT00596817|470712152|FG000|Double-blind Period|Other Reasons|10|||
130751808|NCT00596817|470712153|FG001|Double-blind Period|Other Reasons|18|||
130751809|NCT00679029|470713360|FG000|Overall Study|Adverse Event|3|||
130751810|NCT00679029|470713360|FG000|Overall Study|Withdrawal by Subject|1|||
130751811|NCT00679029|470713360|FG000|Overall Study|Lost to Follow-up|1|||
130751812|NCT01108341|470713361|FG000|Overall Study|Death|2|||
130751813|NCT01108341|470713361|FG000|Overall Study|Withdrawal by Subject|1|||
130751814|NCT01108341|470713361|FG000|Overall Study|Lost to Follow-up|1|||
130751815|NCT01108341|470713361|FG000|Overall Study|Other|1|||
130751816|NCT04402138|470713362|FG000|Overall Study|Progressive Disease|2|||
130751817|NCT04402138|470713362|FG000|Overall Study|Adverse Event|1|||
130751818|NCT00596687|470713365|FG000|Overall Study|< 24 hours of insulin treatment|8|||
130751819|NCT00596687|470713366|FG001|Overall Study|< 24 hours of insulin treatment|6|||
130751820|NCT00596687|470713365|FG000|Overall Study|continuous insulin infusion during TPN|2|||
130751821|NCT00596687|470713366|FG001|Overall Study|continuous insulin infusion during TPN|1|||
130751822|NCT00596687|470713365|FG000|Overall Study|Withdrawal by Subject|3|||
130751823|NCT00596687|470713366|FG001|Overall Study|Withdrawal by Subject|1|||
130751824|NCT00596687|470713365|FG000|Overall Study|cancelled surgery|1|||
130751825|NCT00596687|470713366|FG001|Overall Study|cancelled surgery|1|||
130751826|NCT01284348|470713369|FG000|Overall Study|Death|1|||
130751827|NCT01284348|470713370|FG001|Overall Study|Death|1|||
130751828|NCT01284348|470713369|FG000|Overall Study|Withdrew consent|0|||
130751829|NCT01284348|470713370|FG001|Overall Study|Withdrew consent|1|||
130751830|NCT01284348|470713369|FG000|Overall Study|Status not recorded|9|||
130751831|NCT01284348|470713370|FG001|Overall Study|Status not recorded|10|||
130751832|NCT03645395|470713377|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
130751833|NCT03645395|470713378|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
130751834|NCT03645395|470713379|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
130751835|NCT03645395|470713380|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
130751836|NCT03645395|470713377|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
130751837|NCT03645395|470713378|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
130751838|NCT03645395|470713379|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
130751839|NCT03645395|470713380|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
130751840|NCT03645395|470713377|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
130751841|NCT03645395|470713378|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
130751842|NCT03645395|470713379|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
130751843|NCT03645395|470713380|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
130751844|NCT03645395|470713377|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
130751845|NCT03645395|470713378|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
130751846|NCT03645395|470713379|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
130751847|NCT03645395|470713380|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
130751848|NCT01057810|470713381|FG000|Overall Study|Disease progression|156|||
130751849|NCT01057810|470713382|FG001|Overall Study|Disease progression|197|||
130751850|NCT01057810|470713381|FG000|Overall Study|Study drug toxicity|5|||
130751851|NCT01057810|470713382|FG001|Overall Study|Study drug toxicity|114|||
130751852|NCT01057810|470713381|FG000|Overall Study|Adverse event unrelated to study drug|13|||
130751853|NCT01057810|470713382|FG001|Overall Study|Adverse event unrelated to study drug|29|||
130751854|NCT01057810|470713381|FG000|Overall Study|Withdrawal by Subject|10|||
130751855|NCT01057810|470713382|FG001|Overall Study|Withdrawal by Subject|25|||
130751856|NCT01057810|470713381|FG000|Overall Study|Death|2|||
130751857|NCT01057810|470713382|FG001|Overall Study|Death|12|||
130751858|NCT01057810|470713381|FG000|Overall Study|Maximum clinical benefit|5|||
130751859|NCT01057810|470713382|FG001|Overall Study|Maximum clinical benefit|5|||
130751860|NCT01057810|470713381|FG000|Overall Study|Poor/non-compliance|0|||
130751861|NCT01057810|470713382|FG001|Overall Study|Poor/non-compliance|1|||
130751862|NCT01057810|470713381|FG000|Overall Study|No longer met study criteria|0|||
130751863|NCT01057810|470713382|FG001|Overall Study|No longer met study criteria|1|||
130751864|NCT01057810|470713381|FG000|Overall Study|Other|7|||
130751865|NCT01057810|470713382|FG001|Overall Study|Other|14|||
130751866|NCT02088905|470713383|FG000|Overall Study|Withdrawal by Subject|5|||
130751867|NCT02088905|470713384|FG001|Overall Study|Withdrawal by Subject|1|||
130751868|NCT01091662|470713385|FG000|Overall Study|Adverse Event|1|||
130751869|NCT01091662|470713386|FG001|Overall Study|Adverse Event|9|||
130751870|NCT01091662|470713385|FG000|Overall Study|Physician Decision|1|||
130751871|NCT01091662|470713386|FG001|Overall Study|Physician Decision|1|||
130751872|NCT01091662|470713385|FG000|Overall Study|Withdrawal by Subject|7|||
130751873|NCT01091662|470713386|FG001|Overall Study|Withdrawal by Subject|6|||
130751874|NCT01091662|470713385|FG000|Overall Study|met exit criteria|7|||
130751875|NCT01091662|470713386|FG001|Overall Study|met exit criteria|13|||
130751876|NCT01091662|470713385|FG000|Overall Study|met exclusion criteria|1|||
130751877|NCT01091662|470713386|FG001|Overall Study|met exclusion criteria|0|||
130751878|NCT01091662|470713385|FG000|Overall Study|Lost to Follow-up|0|||
130751879|NCT01091662|470713386|FG001|Overall Study|Lost to Follow-up|1|||
130751880|NCT01091662|470713385|FG000|Overall Study|Pregnancy|0|||
130751881|NCT01091662|470713386|FG001|Overall Study|Pregnancy|1|||
130751882|NCT01091662|470713385|FG000|Overall Study|Protocol Violation|0|||
130751883|NCT01091662|470713386|FG001|Overall Study|Protocol Violation|2|||
130751884|NCT01091662|470713385|FG000|Overall Study|unable to swallow capsule|0|||
130751885|NCT01091662|470713386|FG001|Overall Study|unable to swallow capsule|1|||
130751886|NCT01222520|470713387|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
130751887|NCT01222520|470713388|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
130751888|NCT01222520|470713387|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
130751889|NCT01222520|470713388|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
130751890|NCT01222520|470713387|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
130751891|NCT01222520|470713388|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
130751892|NCT01222520|470713387|FG000|Double-blind Period|Adverse Event|0|||
130751893|NCT01222520|470713388|FG001|Double-blind Period|Adverse Event|1|||
130751894|NCT01222520|470713387|FG000|Double-blind Period|Lack of Efficacy|0|||
130751895|NCT01222520|470713388|FG001|Double-blind Period|Lack of Efficacy|1|||
130751896|NCT01222520|470713387|FG000|Double-blind Period|Study medication stolen|1|||
130751897|NCT01222520|470713388|FG001|Double-blind Period|Study medication stolen|0|||
130751898|NCT04109391|470713389|FG000|Overall Study|Adverse Event|2|||
130751899|NCT04109391|470713390|FG001|Overall Study|Adverse Event|2|||
130751900|NCT04109391|470713391|FG002|Overall Study|Adverse Event|0|||
130751901|NCT04109391|470713389|FG000|Overall Study|Withdrawal by Subject|2|||
130751902|NCT04109391|470713390|FG001|Overall Study|Withdrawal by Subject|0|||
130751903|NCT04109391|470713391|FG002|Overall Study|Withdrawal by Subject|0|||
130751904|NCT04109391|470713389|FG000|Overall Study|Pregnancy|1|||
130751905|NCT04109391|470713390|FG001|Overall Study|Pregnancy|0|||
130751906|NCT04109391|470713391|FG002|Overall Study|Pregnancy|0|||
130751907|NCT04109391|470713389|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
130751908|NCT04109391|470713390|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
130751909|NCT04109391|470713391|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
130751910|NCT04109391|470713389|FG000|Overall Study|Lost to Follow-up|0|||
130751911|NCT04109391|470713390|FG001|Overall Study|Lost to Follow-up|0|||
130751912|NCT04109391|470713391|FG002|Overall Study|Lost to Follow-up|1|||
130751913|NCT04109391|470713389|FG000|Overall Study|Lack of Efficacy|2|||
130751914|NCT04109391|470713390|FG001|Overall Study|Lack of Efficacy|2|||
130751915|NCT04109391|470713391|FG002|Overall Study|Lack of Efficacy|3|||
130751916|NCT01089608|470713394|FG000|Overall Study|Adverse Event|0|||
130751917|NCT01089608|470713395|FG001|Overall Study|Adverse Event|4|||
130751918|NCT01089608|470713394|FG000|Overall Study|Lost to Follow-up|0|||
130751919|NCT01089608|470713395|FG001|Overall Study|Lost to Follow-up|2|||
130751920|NCT00384839|470713398|FG000|Overall Study|Adverse Event|4|||
130751921|NCT00384839|470713398|FG000|Overall Study|Investigator Request|1|||
130751922|NCT00384839|470713398|FG000|Overall Study|Patient Request|1|||
130751923|NCT00384839|470713398|FG000|Overall Study|Ineligible|2|||
130751924|NCT00280397|470713399|FG000|Overall Study|Adverse Event|1|||
130751925|NCT02257489|470713400|FG000|Overall Study|Withdrawal by Subject|0|||
130751926|NCT02257489|470713401|FG001|Overall Study|Withdrawal by Subject|0|||
130751927|NCT02257489|470713402|FG002|Overall Study|Withdrawal by Subject|0|||
130751928|NCT02257489|470713403|FG003|Overall Study|Withdrawal by Subject|1|||
130751929|NCT02257489|470713404|FG004|Overall Study|Withdrawal by Subject|0|||
130751930|NCT02257489|470713405|FG005|Overall Study|Withdrawal by Subject|0|||
130751931|NCT02257489|470713406|FG006|Overall Study|Withdrawal by Subject|0|||
130751932|NCT02257489|470713407|FG007|Overall Study|Withdrawal by Subject|0|||
130751933|NCT02257489|470713408|FG008|Overall Study|Withdrawal by Subject|0|||
130751934|NCT04606394|470713409|FG000|Overall Study|Withdrawal by Subject|3|||
130751935|NCT04606394|470713409|FG000|Overall Study|Exclusion criteria screen failure|12|||
130751936|NCT00955955|470713410|FG000|Overall Study|Lost to Follow-up|2|||
130751937|NCT00955955|470713411|FG001|Overall Study|Lost to Follow-up|0|||
130751938|NCT00955955|470713412|FG002|Overall Study|Lost to Follow-up|0|||
130751939|NCT03423173|470713413|FG000|Overall Study|Randomized but not vaccinated|1|||
130751940|NCT03423173|470713414|FG001|Overall Study|Randomized but not vaccinated|0|||
130751941|NCT03423173|470713415|FG002|Overall Study|Randomized but not vaccinated|2|||
130751942|NCT03423173|470713416|FG003|Overall Study|Randomized but not vaccinated|1|||
130751943|NCT03423173|470713413|FG000|Overall Study|Adverse Event|1|||
130751944|NCT03423173|470713414|FG001|Overall Study|Adverse Event|1|||
130751945|NCT03423173|470713415|FG002|Overall Study|Adverse Event|1|||
130751946|NCT03423173|470713416|FG003|Overall Study|Adverse Event|1|||
130751947|NCT03423173|470713413|FG000|Overall Study|Lost to Follow-up|10|||
130751948|NCT03423173|470713414|FG001|Overall Study|Lost to Follow-up|19|||
130751949|NCT03423173|470713415|FG002|Overall Study|Lost to Follow-up|17|||
130751950|NCT03423173|470713416|FG003|Overall Study|Lost to Follow-up|22|||
130751951|NCT03423173|470713413|FG000|Overall Study|Withdrawal of consent|4|||
130751952|NCT03423173|470713414|FG001|Overall Study|Withdrawal of consent|10|||
130751953|NCT03423173|470713415|FG002|Overall Study|Withdrawal of consent|4|||
130751954|NCT03423173|470713416|FG003|Overall Study|Withdrawal of consent|5|||
130751955|NCT03423173|470713413|FG000|Overall Study|Death|1|||
130751956|NCT03423173|470713414|FG001|Overall Study|Death|0|||
130751957|NCT03423173|470713415|FG002|Overall Study|Death|0|||
130751958|NCT03423173|470713416|FG003|Overall Study|Death|0|||
130751959|NCT03423173|470713413|FG000|Overall Study|Reason not Specified|2|||
130751960|NCT03423173|470713414|FG001|Overall Study|Reason not Specified|5|||
130751961|NCT03423173|470713415|FG002|Overall Study|Reason not Specified|3|||
130751962|NCT03423173|470713416|FG003|Overall Study|Reason not Specified|1|||
130751963|NCT02217410|470713422|FG000|Overall Study|Graft Loss|0|||
130751964|NCT02217410|470713423|FG001|Overall Study|Graft Loss|0|||
130751965|NCT02217410|470713424|FG002|Overall Study|Graft Loss|2|||
130751966|NCT02217410|470713422|FG000|Overall Study|Withdrawal by Subject|0|||
130751967|NCT02217410|470713423|FG001|Overall Study|Withdrawal by Subject|0|||
130751968|NCT02217410|470713424|FG002|Overall Study|Withdrawal by Subject|2|||
130751969|NCT02217410|470713422|FG000|Overall Study|Lost to Follow-up|0|||
130751970|NCT02217410|470713423|FG001|Overall Study|Lost to Follow-up|0|||
130751971|NCT02217410|470713424|FG002|Overall Study|Lost to Follow-up|1|||
130751972|NCT02217410|470713422|FG000|Overall Study|Lack of Efficacy|0|||
130751973|NCT02217410|470713423|FG001|Overall Study|Lack of Efficacy|1|||
130751974|NCT02217410|470713424|FG002|Overall Study|Lack of Efficacy|0|||
130751975|NCT02217410|470713422|FG000|Overall Study|Physician Decision|1|||
130751976|NCT02217410|470713423|FG001|Overall Study|Physician Decision|3|||
130751977|NCT02217410|470713424|FG002|Overall Study|Physician Decision|0|||
130751978|NCT00661609|470713426|FG000|Overall Study|Adverse Event|4|||
130751979|NCT00661609|470713426|FG000|Overall Study|Death|20|||
130751980|NCT00661609|470713426|FG000|Overall Study|Withdrawal by Subject|2|||
130751981|NCT00661609|470713426|FG000|Overall Study|PI Decision|1|||
130751982|NCT00661609|470713426|FG000|Overall Study|Survival follow up stage discontinued|11|||
130751983|NCT00661609|470713426|FG000|Overall Study|Disease progression|3|||
130751984|NCT00637000|470713427|FG000|Overall Study|Withdrawal by Subject|4|||
130751985|NCT00637000|470713428|FG001|Overall Study|Withdrawal by Subject|3|||
130751986|NCT02751450|470713431|FG000|Overall Study|Adverse Event|1|||
130751987|NCT02751450|470713432|FG001|Overall Study|Adverse Event|0|||
130751988|NCT01290679|470713433|FG000|Overall Study|Adverse Event|2|||
130751989|NCT01290679|470713434|FG001|Overall Study|Adverse Event|0|||
130751990|NCT01290679|470713433|FG000|Overall Study|Lost to Follow-up|8|||
130751991|NCT01290679|470713434|FG001|Overall Study|Lost to Follow-up|10|||
130751992|NCT01290679|470713433|FG000|Overall Study|Protocol Violation|0|||
130751993|NCT01290679|470713434|FG001|Overall Study|Protocol Violation|1|||
130751994|NCT01290679|470713433|FG000|Overall Study|Withdrawal by Subject|6|||
130751995|NCT01290679|470713434|FG001|Overall Study|Withdrawal by Subject|5|||
130751996|NCT01290679|470713433|FG000|Overall Study|Subject Entered Another Trial|0|||
130751997|NCT01290679|470713434|FG001|Overall Study|Subject Entered Another Trial|5|||
130751998|NCT00562302|470713435|FG000|Overall Study|Lost to Follow-up|3|||
130751999|NCT00562302|470713436|FG001|Overall Study|Lost to Follow-up|3|||
130752000|NCT00562302|470713435|FG000|Overall Study|Adverse Event|0|||
130752001|NCT00562302|470713436|FG001|Overall Study|Adverse Event|6|||
130752002|NCT00562302|470713435|FG000|Overall Study|Non-compliance|1|||
130752003|NCT00562302|470713436|FG001|Overall Study|Non-compliance|2|||
130752004|NCT00562302|470713435|FG000|Overall Study|Withdrawal by Subject|7|||
130752005|NCT00562302|470713436|FG001|Overall Study|Withdrawal by Subject|8|||
130752006|NCT00562302|470713435|FG000|Overall Study|Death|1|||
130752007|NCT00562302|470713436|FG001|Overall Study|Death|2|||
130752008|NCT00562302|470713435|FG000|Overall Study|Lung resection prior to study completion|7|||
130752009|NCT00562302|470713436|FG001|Overall Study|Lung resection prior to study completion|7|||
130752010|NCT00562302|470713435|FG000|Overall Study|Not stated|1|||
130752011|NCT00562302|470713436|FG001|Overall Study|Not stated|4|||
130752012|NCT01855243|470713437|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
130752013|NCT01855243|470713438|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
130752014|NCT01855243|470713439|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
130752015|NCT03315286|470713440|FG000|Overall Study|Lost to Follow-up|0|||
130752016|NCT03315286|470713441|FG001|Overall Study|Lost to Follow-up|3|||
130752017|NCT03315286|470713440|FG000|Overall Study|Withdrawal by Subject|1|||
130752018|NCT03315286|470713441|FG001|Overall Study|Withdrawal by Subject|0|||
130752019|NCT03315286|470713440|FG000|Overall Study|Protocol Violation|0|||
130752020|NCT03315286|470713441|FG001|Overall Study|Protocol Violation|1|||
130752021|NCT03075891|470713442|FG000|Overall Study|Withdrawal by Subject|3|||
130752022|NCT03075891|470713443|FG001|Overall Study|Withdrawal by Subject|6|||
130752023|NCT03075891|470713442|FG000|Overall Study|Lost to Follow-up|1|||
130752024|NCT03075891|470713443|FG001|Overall Study|Lost to Follow-up|0|||
130752025|NCT03075891|470713442|FG000|Overall Study|Pregnancy|3|||
130752026|NCT03075891|470713443|FG001|Overall Study|Pregnancy|1|||
130752027|NCT03075891|470713442|FG000|Overall Study|visits not performed (no time)|1|||
130752028|NCT03075891|470713443|FG001|Overall Study|visits not performed (no time)|0|||
130752029|NCT03075891|470713442|FG000|Overall Study|Drug abuse relapse issue|0|||
130752030|NCT03075891|470713443|FG001|Overall Study|Drug abuse relapse issue|1|||
130752031|NCT03075891|470713442|FG000|Overall Study|Participant requiring study withdrawal|0|||
130752032|NCT03075891|470713443|FG001|Overall Study|Participant requiring study withdrawal|1|||
130752033|NCT03075891|470713442|FG000|Overall Study|Adverse event, non-fatal|1|||
130752034|NCT03075891|470713443|FG001|Overall Study|Adverse event, non-fatal|4|||
130752035|NCT00828568|470713446|FG000|Randomized|Withdrawal by Subject|1|||
130752036|NCT00828568|470713447|FG001|Randomized|Withdrawal by Subject|0|||
130752037|NCT00828568|470713448|FG002|Randomized|Withdrawal by Subject|2|||
130752038|NCT00828568|470713446|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
130752039|NCT00828568|470713447|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
130752040|NCT00828568|470713448|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
130752041|NCT00828568|470713446|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
130752042|NCT00828568|470713447|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
130752043|NCT00828568|470713448|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
130752044|NCT00828568|470713446|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
130752045|NCT00828568|470713447|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
130752046|NCT00828568|470713448|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
130752047|NCT00828568|470713446|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
130752048|NCT00828568|470713447|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
130752049|NCT00828568|470713448|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
130752050|NCT03474731|470713449|FG000|Overall Study|Withdrawal by Subject|36|||
130752051|NCT03474731|470713450|FG001|Overall Study|Withdrawal by Subject|29|||
130752052|NCT03474731|470713451|FG002|Overall Study|Withdrawal by Subject|11|||
130752053|NCT03474731|470713452|FG003|Overall Study|Withdrawal by Subject|27|||
130752054|NCT03474731|470713449|FG000|Overall Study|COVID|0|||
130752055|NCT03474731|470713450|FG001|Overall Study|COVID|23|||
130752056|NCT03474731|470713451|FG002|Overall Study|COVID|0|||
130752057|NCT03474731|470713452|FG003|Overall Study|COVID|0|||
130752058|NCT03474731|470713449|FG000|Overall Study|Participant moved from area|1|||
130752059|NCT03474731|470713450|FG001|Overall Study|Participant moved from area|0|||
130752060|NCT03474731|470713451|FG002|Overall Study|Participant moved from area|0|||
130752061|NCT03474731|470713452|FG003|Overall Study|Participant moved from area|0|||
130752062|NCT03474731|470713449|FG000|Overall Study|Lost to Follow-up|11|||
130752063|NCT03474731|470713450|FG001|Overall Study|Lost to Follow-up|3|||
130752064|NCT03474731|470713451|FG002|Overall Study|Lost to Follow-up|18|||
130752065|NCT03474731|470713452|FG003|Overall Study|Lost to Follow-up|17|||
130752066|NCT03474731|470713449|FG000|Overall Study|Death|0|||
130752067|NCT03474731|470713450|FG001|Overall Study|Death|1|||
130752068|NCT03474731|470713451|FG002|Overall Study|Death|0|||
130752069|NCT03474731|470713452|FG003|Overall Study|Death|0|||
130752070|NCT03474731|470713449|FG000|Overall Study|Participant Removed|0|||
130752071|NCT03474731|470713450|FG001|Overall Study|Participant Removed|0|||
130752072|NCT03474731|470713451|FG002|Overall Study|Participant Removed|0|||
130752073|NCT03474731|470713452|FG003|Overall Study|Participant Removed|1|||
130752074|NCT00766636|470713453|FG000|Overall Study|Withdrawal by Subject|1|||
130752075|NCT00766636|470713454|FG001|Overall Study|Withdrawal by Subject|1|||
130752076|NCT00766636|470713453|FG000|Overall Study|Incomplete Treatment|0|||
130752077|NCT00766636|470713454|FG001|Overall Study|Incomplete Treatment|1|||
130752078|NCT00766636|470713453|FG000|Overall Study|Adverse Event|1|||
130752079|NCT00766636|470713454|FG001|Overall Study|Adverse Event|0|||
130752080|NCT00766636|470713453|FG000|Overall Study|Disease Progression|1|||
130752081|NCT00766636|470713454|FG001|Overall Study|Disease Progression|0|||
130752082|NCT04657198|470713455|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
130752083|NCT04657198|470713456|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
130752084|NCT04657198|470713457|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
130752085|NCT01075256|470713460|FG000|Overall Study|Withdrawal by Subject|1|||
130752086|NCT01075256|470713461|FG001|Overall Study|Withdrawal by Subject|0|||
130752087|NCT01075256|470713462|FG002|Overall Study|Withdrawal by Subject|0|||
130752088|NCT00765336|470713463|FG000|Overall Study|Protocol Violation|4|||
130752089|NCT00765336|470713464|FG001|Overall Study|Protocol Violation|2|||
130752090|NCT00765336|470713463|FG000|Overall Study|Withdrawal by Subject|6|||
130752091|NCT00765336|470713464|FG001|Overall Study|Withdrawal by Subject|4|||
130752092|NCT00765336|470713463|FG000|Overall Study|Lost to Follow-up|7|||
130752093|NCT00765336|470713464|FG001|Overall Study|Lost to Follow-up|9|||
130752094|NCT00765336|470713463|FG000|Overall Study|Adverse Event|2|||
130752095|NCT00765336|470713464|FG001|Overall Study|Adverse Event|1|||
130752096|NCT02858583|470713465|FG000|Overall Study|Declined consent|1|||
130752097|NCT02858583|470713466|FG001|Overall Study|Declined consent|1|||
130752098|NCT01218087|470713467|FG000|Overall Study|Death|2|||
130752099|NCT01218087|470713468|FG001|Overall Study|Death|1|||
130752100|NCT01218087|470713467|FG000|Overall Study|Withdrawal by Subject|5|||
130752101|NCT01218087|470713468|FG001|Overall Study|Withdrawal by Subject|0|||
130752102|NCT01218087|470713467|FG000|Overall Study|Transferred|8|||
130752103|NCT01218087|470713468|FG001|Overall Study|Transferred|5|||
130752104|NCT01314872|470713474|FG000|Treatment Period 1|Protocol Violation|2|||
130752105|NCT01314872|470713475|FG001|Treatment Period 1|Protocol Violation|1|||
130752106|NCT01314872|470713476|FG002|Treatment Period 1|Protocol Violation|1|||
130752107|NCT01314872|470713477|FG003|Treatment Period 1|Protocol Violation|0|||
130752108|NCT01314872|470713478|FG004|Treatment Period 1|Protocol Violation|1|||
130752109|NCT01314872|470713479|FG005|Treatment Period 1|Protocol Violation|0|||
130752110|NCT01314872|470713480|FG006|Treatment Period 1|Protocol Violation|0|||
130752111|NCT01314872|470713481|FG007|Treatment Period 1|Protocol Violation|0|||
130752112|NCT01314872|470713482|FG008|Treatment Period 1|Protocol Violation|0|||
130752113|NCT01314872|470713483|FG009|Treatment Period 1|Protocol Violation|1|||
130752114|NCT01314872|470713484|FG010|Treatment Period 1|Protocol Violation|1|||
130752115|NCT01314872|470713485|FG011|Treatment Period 1|Protocol Violation|0|||
130752116|NCT01314872|470713486|FG012|Treatment Period 1|Protocol Violation|0|||
130752117|NCT01314872|470713487|FG013|Treatment Period 1|Protocol Violation|0|||
130752118|NCT01314872|470713488|FG014|Treatment Period 1|Protocol Violation|0|||
130752119|NCT01314872|470713474|FG000|Treatment Period 1|Physician Decision|0|||
130752120|NCT01314872|470713475|FG001|Treatment Period 1|Physician Decision|1|||
130752121|NCT01314872|470713476|FG002|Treatment Period 1|Physician Decision|0|||
130752122|NCT01314872|470713477|FG003|Treatment Period 1|Physician Decision|1|||
130752123|NCT01314872|470713478|FG004|Treatment Period 1|Physician Decision|0|||
130752124|NCT01314872|470713479|FG005|Treatment Period 1|Physician Decision|0|||
130752125|NCT01314872|470713480|FG006|Treatment Period 1|Physician Decision|0|||
130752126|NCT01314872|470713481|FG007|Treatment Period 1|Physician Decision|0|||
130752127|NCT01314872|470713482|FG008|Treatment Period 1|Physician Decision|0|||
130752128|NCT01314872|470713483|FG009|Treatment Period 1|Physician Decision|1|||
130752129|NCT01314872|470713484|FG010|Treatment Period 1|Physician Decision|0|||
130752130|NCT01314872|470713485|FG011|Treatment Period 1|Physician Decision|0|||
130752131|NCT01314872|470713486|FG012|Treatment Period 1|Physician Decision|0|||
130752132|NCT01314872|470713487|FG013|Treatment Period 1|Physician Decision|0|||
130752133|NCT01314872|470713488|FG014|Treatment Period 1|Physician Decision|0|||
130752134|NCT01314872|470713474|FG000|Treatment Period 1|Lack of Efficacy|1|||
130752135|NCT01314872|470713475|FG001|Treatment Period 1|Lack of Efficacy|0|||
130752136|NCT01314872|470713476|FG002|Treatment Period 1|Lack of Efficacy|0|||
130752137|NCT01314872|470713477|FG003|Treatment Period 1|Lack of Efficacy|0|||
130752138|NCT01314872|470713478|FG004|Treatment Period 1|Lack of Efficacy|0|||
130752139|NCT01314872|470713479|FG005|Treatment Period 1|Lack of Efficacy|1|||
130752140|NCT01314872|470713480|FG006|Treatment Period 1|Lack of Efficacy|0|||
130752141|NCT01314872|470713481|FG007|Treatment Period 1|Lack of Efficacy|2|||
130752142|NCT01314872|470713482|FG008|Treatment Period 1|Lack of Efficacy|0|||
130752143|NCT01314872|470713483|FG009|Treatment Period 1|Lack of Efficacy|0|||
130752144|NCT01314872|470713484|FG010|Treatment Period 1|Lack of Efficacy|0|||
130752145|NCT01314872|470713485|FG011|Treatment Period 1|Lack of Efficacy|0|||
130752146|NCT01314872|470713486|FG012|Treatment Period 1|Lack of Efficacy|0|||
130752147|NCT01314872|470713487|FG013|Treatment Period 1|Lack of Efficacy|0|||
130752148|NCT01314872|470713488|FG014|Treatment Period 1|Lack of Efficacy|0|||
130752149|NCT01314872|470713474|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
130752150|NCT01314872|470713475|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
130752151|NCT01314872|470713476|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
130752152|NCT01314872|470713477|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
130752153|NCT01314872|470713478|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
130752154|NCT01314872|470713479|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
130752155|NCT01314872|470713480|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
130752156|NCT01314872|470713481|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
130752157|NCT01314872|470713482|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
130752158|NCT01314872|470713483|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
130752159|NCT01314872|470713484|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
130752160|NCT01314872|470713485|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
130752161|NCT01314872|470713486|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
130752162|NCT01314872|470713487|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
130752163|NCT01314872|470713488|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
130752164|NCT01314872|470713474|FG000|Treatment Period 1|Withdrawal by Subject|3|||
130752165|NCT01314872|470713475|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130752166|NCT01314872|470713476|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130752167|NCT01314872|470713477|FG003|Treatment Period 1|Withdrawal by Subject|2|||
130752168|NCT01314872|470713478|FG004|Treatment Period 1|Withdrawal by Subject|3|||
130752169|NCT01314872|470713479|FG005|Treatment Period 1|Withdrawal by Subject|1|||
130752170|NCT01314872|470713480|FG006|Treatment Period 1|Withdrawal by Subject|3|||
130752171|NCT01314872|470713481|FG007|Treatment Period 1|Withdrawal by Subject|2|||
130752172|NCT01314872|470713482|FG008|Treatment Period 1|Withdrawal by Subject|2|||
130752173|NCT01314872|470713483|FG009|Treatment Period 1|Withdrawal by Subject|2|||
130752174|NCT01314872|470713484|FG010|Treatment Period 1|Withdrawal by Subject|1|||
130752175|NCT01314872|470713485|FG011|Treatment Period 1|Withdrawal by Subject|0|||
130752176|NCT01314872|470713486|FG012|Treatment Period 1|Withdrawal by Subject|0|||
130752177|NCT01314872|470713487|FG013|Treatment Period 1|Withdrawal by Subject|0|||
130752178|NCT01314872|470713488|FG014|Treatment Period 1|Withdrawal by Subject|0|||
130752179|NCT01314872|470713474|FG000|Treatment Period 1|Lost to Follow-up|0|||
130752180|NCT01314872|470713475|FG001|Treatment Period 1|Lost to Follow-up|1|||
130752181|NCT01314872|470713476|FG002|Treatment Period 1|Lost to Follow-up|2|||
130752182|NCT01314872|470713477|FG003|Treatment Period 1|Lost to Follow-up|2|||
130752183|NCT01314872|470713478|FG004|Treatment Period 1|Lost to Follow-up|1|||
130752184|NCT01314872|470713479|FG005|Treatment Period 1|Lost to Follow-up|1|||
130752185|NCT01314872|470713480|FG006|Treatment Period 1|Lost to Follow-up|1|||
130752186|NCT01314872|470713481|FG007|Treatment Period 1|Lost to Follow-up|1|||
130752187|NCT01314872|470713482|FG008|Treatment Period 1|Lost to Follow-up|1|||
130752188|NCT01314872|470713483|FG009|Treatment Period 1|Lost to Follow-up|0|||
130752189|NCT01314872|470713484|FG010|Treatment Period 1|Lost to Follow-up|0|||
130752190|NCT01314872|470713485|FG011|Treatment Period 1|Lost to Follow-up|0|||
130752191|NCT01314872|470713486|FG012|Treatment Period 1|Lost to Follow-up|0|||
130752192|NCT01314872|470713487|FG013|Treatment Period 1|Lost to Follow-up|0|||
130752193|NCT01314872|470713488|FG014|Treatment Period 1|Lost to Follow-up|0|||
130752194|NCT01314872|470713474|FG000|Period 2|Protocol Violation|0|||
130752195|NCT01314872|470713475|FG001|Period 2|Protocol Violation|0|||
130752196|NCT01314872|470713476|FG002|Period 2|Protocol Violation|0|||
130752197|NCT01314872|470713477|FG003|Period 2|Protocol Violation|0|||
130788698|NCT02577029|470854618|FG003|Overall Study|Sponsor Termination of the Study|12|||
130788699|NCT02577029|470854619|FG004|Overall Study|Sponsor Termination of the Study|10|||
130788700|NCT02577029|470854620|FG005|Overall Study|Sponsor Termination of the Study|12|||
130788701|NCT02577029|470854621|FG006|Overall Study|Sponsor Termination of the Study|12|||
130752198|NCT01314872|470713478|FG004|Period 2|Protocol Violation|0|||
130752199|NCT01314872|470713479|FG005|Period 2|Protocol Violation|0|||
130752200|NCT01314872|470713480|FG006|Period 2|Protocol Violation|0|||
130752201|NCT01314872|470713481|FG007|Period 2|Protocol Violation|0|||
130752202|NCT01314872|470713482|FG008|Period 2|Protocol Violation|0|||
130752203|NCT01314872|470713483|FG009|Period 2|Protocol Violation|0|||
130752204|NCT01314872|470713484|FG010|Period 2|Protocol Violation|0|||
130752205|NCT01314872|470713485|FG011|Period 2|Protocol Violation|3|||
130752206|NCT01314872|470713486|FG012|Period 2|Protocol Violation|3|||
130752207|NCT01314872|470713487|FG013|Period 2|Protocol Violation|2|||
130752208|NCT01314872|470713488|FG014|Period 2|Protocol Violation|0|||
130752209|NCT01314872|470713474|FG000|Period 2|Non-compliance with study drug|0|||
130752210|NCT01314872|470713475|FG001|Period 2|Non-compliance with study drug|0|||
130752211|NCT01314872|470713476|FG002|Period 2|Non-compliance with study drug|0|||
130752212|NCT01314872|470713477|FG003|Period 2|Non-compliance with study drug|0|||
130752213|NCT01314872|470713478|FG004|Period 2|Non-compliance with study drug|0|||
130752214|NCT01314872|470713479|FG005|Period 2|Non-compliance with study drug|0|||
130752215|NCT01314872|470713480|FG006|Period 2|Non-compliance with study drug|0|||
130752216|NCT01314872|470713481|FG007|Period 2|Non-compliance with study drug|0|||
130752217|NCT01314872|470713482|FG008|Period 2|Non-compliance with study drug|0|||
130752218|NCT01314872|470713483|FG009|Period 2|Non-compliance with study drug|0|||
130752219|NCT01314872|470713484|FG010|Period 2|Non-compliance with study drug|0|||
130752220|NCT01314872|470713485|FG011|Period 2|Non-compliance with study drug|3|||
130752221|NCT01314872|470713486|FG012|Period 2|Non-compliance with study drug|3|||
130752222|NCT01314872|470713487|FG013|Period 2|Non-compliance with study drug|1|||
130752223|NCT01314872|470713488|FG014|Period 2|Non-compliance with study drug|2|||
130752224|NCT01314872|470713474|FG000|Period 2|Lack of Efficacy|0|||
130752225|NCT01314872|470713475|FG001|Period 2|Lack of Efficacy|0|||
130752226|NCT01314872|470713476|FG002|Period 2|Lack of Efficacy|0|||
130752227|NCT01314872|470713477|FG003|Period 2|Lack of Efficacy|0|||
130752228|NCT01314872|470713478|FG004|Period 2|Lack of Efficacy|0|||
130752229|NCT01314872|470713479|FG005|Period 2|Lack of Efficacy|0|||
130752230|NCT01314872|470713480|FG006|Period 2|Lack of Efficacy|0|||
130752231|NCT01314872|470713481|FG007|Period 2|Lack of Efficacy|0|||
130752232|NCT01314872|470713482|FG008|Period 2|Lack of Efficacy|0|||
130752233|NCT01314872|470713483|FG009|Period 2|Lack of Efficacy|0|||
130752234|NCT01314872|470713484|FG010|Period 2|Lack of Efficacy|0|||
130752235|NCT01314872|470713485|FG011|Period 2|Lack of Efficacy|7|||
130752236|NCT01314872|470713486|FG012|Period 2|Lack of Efficacy|12|||
130752237|NCT01314872|470713487|FG013|Period 2|Lack of Efficacy|9|||
130752238|NCT01314872|470713488|FG014|Period 2|Lack of Efficacy|2|||
130752239|NCT01314872|470713474|FG000|Period 2|Pregnancy|0|||
130752240|NCT01314872|470713475|FG001|Period 2|Pregnancy|0|||
130752241|NCT01314872|470713476|FG002|Period 2|Pregnancy|0|||
130752242|NCT01314872|470713477|FG003|Period 2|Pregnancy|0|||
130752243|NCT01314872|470713478|FG004|Period 2|Pregnancy|0|||
130752244|NCT01314872|470713479|FG005|Period 2|Pregnancy|0|||
130752245|NCT01314872|470713480|FG006|Period 2|Pregnancy|0|||
130752246|NCT01314872|470713481|FG007|Period 2|Pregnancy|0|||
130752247|NCT01314872|470713482|FG008|Period 2|Pregnancy|0|||
130752248|NCT01314872|470713483|FG009|Period 2|Pregnancy|0|||
130752249|NCT01314872|470713484|FG010|Period 2|Pregnancy|0|||
130752250|NCT01314872|470713485|FG011|Period 2|Pregnancy|0|||
130752251|NCT01314872|470713486|FG012|Period 2|Pregnancy|0|||
130752252|NCT01314872|470713487|FG013|Period 2|Pregnancy|0|||
130752253|NCT01314872|470713488|FG014|Period 2|Pregnancy|1|||
130752254|NCT01314872|470713474|FG000|Period 2|Study terminated by Sponsor|0|||
130752255|NCT01314872|470713475|FG001|Period 2|Study terminated by Sponsor|0|||
130752256|NCT01314872|470713476|FG002|Period 2|Study terminated by Sponsor|0|||
130752257|NCT01314872|470713477|FG003|Period 2|Study terminated by Sponsor|0|||
130752258|NCT01314872|470713478|FG004|Period 2|Study terminated by Sponsor|0|||
130752259|NCT01314872|470713479|FG005|Period 2|Study terminated by Sponsor|0|||
130752260|NCT01314872|470713480|FG006|Period 2|Study terminated by Sponsor|0|||
130752261|NCT01314872|470713481|FG007|Period 2|Study terminated by Sponsor|0|||
130752262|NCT01314872|470713482|FG008|Period 2|Study terminated by Sponsor|0|||
130752263|NCT01314872|470713483|FG009|Period 2|Study terminated by Sponsor|0|||
130752264|NCT01314872|470713484|FG010|Period 2|Study terminated by Sponsor|0|||
130752265|NCT01314872|470713485|FG011|Period 2|Study terminated by Sponsor|2|||
130752266|NCT01314872|470713486|FG012|Period 2|Study terminated by Sponsor|2|||
130752267|NCT01314872|470713487|FG013|Period 2|Study terminated by Sponsor|3|||
130752268|NCT01314872|470713488|FG014|Period 2|Study terminated by Sponsor|0|||
130752269|NCT01314872|470713474|FG000|Period 2|Adverse event, non-fatal|0|||
130788702|NCT02577029|470854622|FG007|Overall Study|Sponsor Termination of the Study|12|||
130788703|NCT02078817|470854623|FG000|Overall Study|Withdrawal by Subject|1|||
130788704|NCT01420536|470854624|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
130788705|NCT01420536|470854625|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
130788706|NCT01265498|470854630|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
130788707|NCT01265498|470854631|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
130788708|NCT01652690|470854633|FG000|Overall Study|Withdrawal by Subject|16|||
130752270|NCT01314872|470713475|FG001|Period 2|Adverse event, non-fatal|0|||
130752271|NCT01314872|470713476|FG002|Period 2|Adverse event, non-fatal|0|||
130752272|NCT01314872|470713477|FG003|Period 2|Adverse event, non-fatal|0|||
130752273|NCT01314872|470713478|FG004|Period 2|Adverse event, non-fatal|0|||
130752274|NCT01314872|470713479|FG005|Period 2|Adverse event, non-fatal|0|||
130752275|NCT01314872|470713480|FG006|Period 2|Adverse event, non-fatal|0|||
130752276|NCT01314872|470713481|FG007|Period 2|Adverse event, non-fatal|0|||
130752277|NCT01314872|470713482|FG008|Period 2|Adverse event, non-fatal|0|||
130752278|NCT01314872|470713483|FG009|Period 2|Adverse event, non-fatal|0|||
130752279|NCT01314872|470713484|FG010|Period 2|Adverse event, non-fatal|0|||
130752280|NCT01314872|470713485|FG011|Period 2|Adverse event, non-fatal|13|||
130752281|NCT01314872|470713486|FG012|Period 2|Adverse event, non-fatal|16|||
130752282|NCT01314872|470713487|FG013|Period 2|Adverse event, non-fatal|24|||
130752283|NCT01314872|470713488|FG014|Period 2|Adverse event, non-fatal|9|||
130752284|NCT01314872|470713474|FG000|Period 2|Withdrawal by Subject|0|||
130752285|NCT01314872|470713475|FG001|Period 2|Withdrawal by Subject|0|||
130752286|NCT01314872|470713476|FG002|Period 2|Withdrawal by Subject|0|||
130752287|NCT01314872|470713477|FG003|Period 2|Withdrawal by Subject|0|||
130752288|NCT01314872|470713478|FG004|Period 2|Withdrawal by Subject|0|||
130752289|NCT01314872|470713479|FG005|Period 2|Withdrawal by Subject|0|||
130752290|NCT01314872|470713480|FG006|Period 2|Withdrawal by Subject|0|||
130752291|NCT01314872|470713481|FG007|Period 2|Withdrawal by Subject|0|||
130752292|NCT01314872|470713482|FG008|Period 2|Withdrawal by Subject|0|||
130752293|NCT01314872|470713483|FG009|Period 2|Withdrawal by Subject|0|||
130752294|NCT01314872|470713484|FG010|Period 2|Withdrawal by Subject|0|||
130752295|NCT01314872|470713485|FG011|Period 2|Withdrawal by Subject|14|||
130752296|NCT01314872|470713486|FG012|Period 2|Withdrawal by Subject|17|||
130752297|NCT01314872|470713487|FG013|Period 2|Withdrawal by Subject|12|||
130752298|NCT01314872|470713488|FG014|Period 2|Withdrawal by Subject|4|||
130752299|NCT01314872|470713474|FG000|Period 2|Lost to Follow-up|0|||
130752300|NCT01314872|470713475|FG001|Period 2|Lost to Follow-up|0|||
130752301|NCT01314872|470713476|FG002|Period 2|Lost to Follow-up|0|||
130752302|NCT01314872|470713477|FG003|Period 2|Lost to Follow-up|0|||
130752303|NCT01314872|470713478|FG004|Period 2|Lost to Follow-up|0|||
130752304|NCT01314872|470713479|FG005|Period 2|Lost to Follow-up|0|||
130752305|NCT01314872|470713480|FG006|Period 2|Lost to Follow-up|0|||
130752306|NCT01314872|470713481|FG007|Period 2|Lost to Follow-up|0|||
130752307|NCT01314872|470713482|FG008|Period 2|Lost to Follow-up|0|||
130752308|NCT01314872|470713483|FG009|Period 2|Lost to Follow-up|0|||
130752309|NCT01314872|470713484|FG010|Period 2|Lost to Follow-up|0|||
130752310|NCT01314872|470713485|FG011|Period 2|Lost to Follow-up|6|||
130752311|NCT01314872|470713486|FG012|Period 2|Lost to Follow-up|7|||
130752312|NCT01314872|470713487|FG013|Period 2|Lost to Follow-up|2|||
130752313|NCT01314872|470713488|FG014|Period 2|Lost to Follow-up|6|||
130752314|NCT03232931|470715001|FG000|Overall Study|Physician Decision|1|||
130752315|NCT03232931|470715002|FG001|Overall Study|Physician Decision|1|||
130752316|NCT03232931|470715001|FG000|Overall Study|Withdrawal by Subject|6|||
130752317|NCT03232931|470715002|FG001|Overall Study|Withdrawal by Subject|0|||
130752318|NCT03232931|470715001|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
130752319|NCT03232931|470715002|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
130752320|NCT03232931|470715001|FG000|Overall Study|Parent did not record voice|1|||
130752321|NCT03232931|470715002|FG001|Overall Study|Parent did not record voice|2|||
130752322|NCT03232931|470715001|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
130752323|NCT03232931|470715002|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
130752324|NCT04925557|470715003|FG000|Overall Study|Study closed|5|||
130752325|NCT04925557|470715004|FG001|Overall Study|Study closed|3|||
130752326|NCT05488470|470715005|FG000|Overall Study|Physician Decision|2|||
130752327|NCT05488470|470715005|FG000|Overall Study|Withdrawal by Subject|1|||
130752328|NCT05488470|470715005|FG000|Overall Study|Death|1|||
130752329|NCT04390503|470715012|FG000|Overall Study|Physician Decision|2|||
130752330|NCT04390503|470715013|FG001|Overall Study|Physician Decision|1|||
130752331|NCT04390503|470715012|FG000|Overall Study|Adverse Event|1|||
130752332|NCT04390503|470715013|FG001|Overall Study|Adverse Event|0|||
130752333|NCT01068730|470715015|FG000|Period 3|Personal reason|1|||
130752334|NCT01068730|470715016|FG001|Period 3|Personal reason|0|||
130752335|NCT01068730|470715017|FG002|Period 3|Personal reason|0|||
130752336|NCT01068730|470715018|FG003|Period 3|Personal reason|0|||
130752337|NCT01068730|470715015|FG000|Period 4|Family emergency|0|||
130752338|NCT01068730|470715016|FG001|Period 4|Family emergency|1|||
130752339|NCT01068730|470715017|FG002|Period 4|Family emergency|0|||
130752340|NCT01068730|470715018|FG003|Period 4|Family emergency|0|||
130752341|NCT00594100|470715022|FG000|Procedure|Technical Failure|9|||
130752342|NCT00594100|470715022|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
130752343|NCT00594100|470715022|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
130752344|NCT00594100|470715022|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
130752345|NCT02448537|470715023|FG000|Overall Study|Withdrawal by Subject|1|||
130752346|NCT02448537|470715024|FG001|Overall Study|Withdrawal by Subject|1|||
130752347|NCT02448537|470715025|FG002|Overall Study|Withdrawal by Subject|1|||
130752348|NCT01270464|470715026|FG000|Overall Study|Protocol Violation|4|||
130752349|NCT01270464|470715027|FG001|Overall Study|Protocol Violation|3|||
130752350|NCT01270464|470715028|FG002|Overall Study|Protocol Violation|2|||
130752351|NCT01270464|470715026|FG000|Overall Study|Lack of Efficacy|2|||
130752352|NCT01270464|470715027|FG001|Overall Study|Lack of Efficacy|3|||
130752353|NCT01270464|470715028|FG002|Overall Study|Lack of Efficacy|1|||
130752354|NCT01270464|470715026|FG000|Overall Study|Adverse Event|9|||
130752355|NCT01270464|470715027|FG001|Overall Study|Adverse Event|1|||
130752356|NCT01270464|470715028|FG002|Overall Study|Adverse Event|7|||
130752357|NCT01270464|470715026|FG000|Overall Study|Withdrawal by Subject|2|||
130752358|NCT01270464|470715027|FG001|Overall Study|Withdrawal by Subject|1|||
130752359|NCT01270464|470715028|FG002|Overall Study|Withdrawal by Subject|4|||
130752360|NCT01270464|470715026|FG000|Overall Study|Lost to Follow-up|2|||
130752361|NCT01270464|470715027|FG001|Overall Study|Lost to Follow-up|3|||
130752362|NCT01270464|470715028|FG002|Overall Study|Lost to Follow-up|1|||
130752363|NCT01270464|470715026|FG000|Overall Study|Other|1|||
130752364|NCT01270464|470715027|FG001|Overall Study|Other|1|||
130752365|NCT01270464|470715028|FG002|Overall Study|Other|3|||
130752366|NCT03981900|470715029|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
130752367|NCT03981900|470715029|FG000|Overall Study|Adverse Event|5|||
130752368|NCT03981900|470715029|FG000|Overall Study|Protocol Violation|1|||
130752369|NCT03981900|470715029|FG000|Overall Study|Withdrawal by Subject|7|||
130752370|NCT03981900|470715029|FG000|Overall Study|Lost to Follow-up|46|||
130752371|NCT03981900|470715029|FG000|Overall Study|Decision of the researcher|3|||
130752372|NCT03981900|470715029|FG000|Overall Study|Death|3|||
130752373|NCT03981900|470715029|FG000|Overall Study|Other|5|||
130752374|NCT04725812|470715034|FG000|Overall Study|Withdrawal by Subject|1|||
130752375|NCT04696055|470715039|FG000|Overall Study|Adverse Event|10|||
130752376|NCT04696055|470715040|FG001|Overall Study|Adverse Event|2|||
130752377|NCT04696055|470715039|FG000|Overall Study|Death|4|||
130752378|NCT04696055|470715040|FG001|Overall Study|Death|0|||
130752379|NCT04696055|470715039|FG000|Overall Study|Other|7|||
130752380|NCT04696055|470715040|FG001|Overall Study|Other|2|||
130752381|NCT04696055|470715039|FG000|Overall Study|Physician Decision|3|||
130752382|NCT04696055|470715040|FG001|Overall Study|Physician Decision|0|||
130752383|NCT04696055|470715039|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
130752384|NCT04696055|470715040|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
130752385|NCT04696055|470715039|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
130752386|NCT04696055|470715040|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
130752387|NCT04696055|470715039|FG000|Overall Study|Subject Decision|1|||
130752388|NCT04696055|470715040|FG001|Overall Study|Subject Decision|2|||
130752389|NCT03969901|470715041|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130752390|NCT03969901|470715042|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130752391|NCT03969901|470715043|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130752392|NCT03969901|470715044|FG003|Overall Study|Withdrawal by parent/guardian|0|||
130752393|NCT03969901|470715045|FG004|Overall Study|Withdrawal by parent/guardian|1|||
130752394|NCT03969901|470715046|FG005|Overall Study|Withdrawal by parent/guardian|0|||
130752395|NCT03969901|470715047|FG006|Overall Study|Withdrawal by parent/guardian|0|||
130752396|NCT03969901|470715048|FG007|Overall Study|Withdrawal by parent/guardian|1|||
130752397|NCT03969901|470715049|FG008|Overall Study|Withdrawal by parent/guardian|1|||
130752398|NCT03969901|470715050|FG009|Overall Study|Withdrawal by parent/guardian|0|||
130752399|NCT04411810|470715051|FG000|Overall Study|Screen failure|1|||
130752400|NCT04411810|470715051|FG000|Overall Study|Withdrawal by Subject|1|||
130752401|NCT01920958|470715052|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
130752402|NCT01560234|470715053|FG000|Overall Study|Lost to Follow-up|3|||
130752403|NCT01560234|470715054|FG001|Overall Study|Lost to Follow-up|0|||
130752404|NCT01560234|470715055|FG002|Overall Study|Lost to Follow-up|1|||
130752405|NCT01560234|470715056|FG003|Overall Study|Lost to Follow-up|0|||
130752406|NCT01560234|470715057|FG004|Overall Study|Lost to Follow-up|0|||
130752407|NCT01560234|470715058|FG005|Overall Study|Lost to Follow-up|2|||
130752408|NCT01560234|470715059|FG006|Overall Study|Lost to Follow-up|0|||
130752409|NCT01560234|470715060|FG007|Overall Study|Lost to Follow-up|2|||
130752410|NCT01163851|470715061|FG000|Overall Study|Site Closure|0|||
130752411|NCT01163851|470715062|FG001|Overall Study|Site Closure|1|||
130752412|NCT01163851|470715061|FG000|Overall Study|Enrolled but not treated|1|||
130752413|NCT01163851|470715062|FG001|Overall Study|Enrolled but not treated|0|||
130752414|NCT00083759|470715069|FG000|Overall Study|Adverse Event|5|||
130752415|NCT00083759|470715070|FG001|Overall Study|Adverse Event|3|||
130752416|NCT00083759|470715069|FG000|Overall Study|Lost to Follow-up|1|||
130752417|NCT00083759|470715070|FG001|Overall Study|Lost to Follow-up|0|||
130752418|NCT00083759|470715069|FG000|Overall Study|Death|1|||
130752419|NCT00083759|470715070|FG001|Overall Study|Death|1|||
130752420|NCT00083759|470715069|FG000|Overall Study|Inadequate Therapeutic Response|32|||
130752421|NCT00083759|470715070|FG001|Overall Study|Inadequate Therapeutic Response|35|||
130752422|NCT00083759|470715069|FG000|Overall Study|Subject Withdrew Consent|2|||
130752423|NCT00083759|470715070|FG001|Overall Study|Subject Withdrew Consent|2|||
130752424|NCT00083759|470715069|FG000|Overall Study|Non-Compliance|1|||
130752425|NCT00083759|470715070|FG001|Overall Study|Non-Compliance|0|||
130752426|NCT00083759|470715069|FG000|Overall Study|Sponsor's Discretion|28|||
130752427|NCT00083759|470715070|FG001|Overall Study|Sponsor's Discretion|29|||
130752428|NCT00083759|470715069|FG000|Overall Study|Other|14|||
130752429|NCT00083759|470715070|FG001|Overall Study|Other|13|||
130752430|NCT00887315|470715073|FG000|Overall Study|Study termination|7|||
130752431|NCT00887315|470715074|FG001|Overall Study|Study termination|4|||
130752432|NCT00619892|470715075|FG000|Overall Study|Adverse Event|3|||
130752433|NCT00619892|470715076|FG001|Overall Study|Adverse Event|0|||
130752434|NCT00619892|470715075|FG000|Overall Study|Lost to Follow-up|0|||
130752435|NCT00619892|470715076|FG001|Overall Study|Lost to Follow-up|1|||
130752436|NCT00619892|470715075|FG000|Overall Study|Intercurrent illness|0|||
130752437|NCT00619892|470715076|FG001|Overall Study|Intercurrent illness|1|||
130752438|NCT00379080|470715077|FG000|Overall Study|Withdrawal by Subject|0|||
130752439|NCT00379080|470715078|FG001|Overall Study|Withdrawal by Subject|4|||
130752440|NCT00379080|470715079|FG002|Overall Study|Withdrawal by Subject|0|||
130752441|NCT00857896|470715085|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
130752442|NCT02920008|470715090|FG000|Overall Study|Death|117|||
130752443|NCT02920008|470715091|FG001|Overall Study|Death|127|||
130752444|NCT02920008|470715090|FG000|Overall Study|Withdrawal by Subject|3|||
130752445|NCT02920008|470715091|FG001|Overall Study|Withdrawal by Subject|6|||
130752446|NCT02920008|470715090|FG000|Overall Study|Lost to Follow-up|0|||
130752447|NCT02920008|470715091|FG001|Overall Study|Lost to Follow-up|1|||
130752448|NCT02737930|470715092|FG000|Overall Study|Withdrawal by Subject|0|||
130752449|NCT02737930|470715093|FG001|Overall Study|Withdrawal by Subject|1|||
130752450|NCT03169881|470715094|FG000|Overall Study|Incomplete Follow-up|10|||
130752451|NCT03169881|470715095|FG001|Overall Study|Incomplete Follow-up|15|||
130752452|NCT03169881|470715094|FG000|Overall Study|Lost to Follow-up|18|||
130752453|NCT03169881|470715095|FG001|Overall Study|Lost to Follow-up|20|||
130752454|NCT03169881|470715094|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
130752455|NCT03169881|470715095|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
130752456|NCT01028014|470715096|FG000|Overall Study|Lost to Follow-up|1|||
130752457|NCT01028014|470715097|FG001|Overall Study|Lost to Follow-up|2|||
130752458|NCT01028014|470715098|FG002|Overall Study|Lost to Follow-up|0|||
130752459|NCT01028014|470715099|FG003|Overall Study|Lost to Follow-up|1|||
130752460|NCT01028014|470715100|FG004|Overall Study|Lost to Follow-up|1|||
130752461|NCT01028014|470715101|FG005|Overall Study|Lost to Follow-up|2|||
130752462|NCT01127451|470715111|FG000|Overall Study|Other|2|||
130752463|NCT01127451|470715112|FG001|Overall Study|Other|1|||
130752464|NCT01127451|470715111|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
130752465|NCT01127451|470715112|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
130752466|NCT01127451|470715111|FG000|Overall Study|Death|22|||
130752467|NCT01127451|470715112|FG001|Overall Study|Death|17|||
130752468|NCT01127451|470715111|FG000|Overall Study|Lost to Follow-up|3|||
130752469|NCT01127451|470715112|FG001|Overall Study|Lost to Follow-up|0|||
130752470|NCT01127451|470715111|FG000|Overall Study|Administrative Reason by Sponsor|2|||
130752471|NCT01127451|470715112|FG001|Overall Study|Administrative Reason by Sponsor|2|||
130752472|NCT00930774|470715113|FG000|Overall Study|Withdrawal by Subject|1|||
130752473|NCT00930774|470715114|FG001|Overall Study|Withdrawal by Subject|9|||
130752474|NCT00930774|470715115|FG002|Overall Study|Withdrawal by Subject|2|||
130752475|NCT00930774|470715116|FG003|Overall Study|Withdrawal by Subject|0|||
130752476|NCT03200704|470715117|FG000|Overall Study|Withdrawal by Subject|1|||
130752477|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
130752478|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
130752479|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
130752480|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
130752481|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
130752482|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
130752483|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
130752484|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
130752485|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
130752486|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
130752487|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
130752488|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
130752489|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
130752490|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
130752491|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
130752492|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
130752493|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
130752494|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
130752495|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
130752496|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
130752497|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
130752498|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
130752499|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
130752500|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
130752501|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
130752502|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
130752503|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
130752504|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
130752505|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
130752506|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
130752507|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
130752508|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
130752509|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
130752510|NCT00839527|470715119|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
130752511|NCT00839527|470715120|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
130752512|NCT00839527|470715121|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
130752513|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
130752514|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
130752515|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
130752516|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
130752517|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
130752518|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
130752519|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
130752520|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
130752521|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
130752522|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
130752523|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
130752524|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
130752525|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
130752526|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
130752527|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
130752528|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
130752529|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
130752530|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
130752531|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
130752532|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
130752533|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
130752534|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
130752535|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
130752536|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
130752537|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
130752538|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
130752539|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
130752540|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
130752541|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
130752542|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
130752543|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
130752544|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
130752545|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
130752546|NCT00839527|470715119|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
130752547|NCT00839527|470715120|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
130752548|NCT00839527|470715121|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
130752549|NCT01704651|470715124|FG000|Overall Study|Pre-op withdrawal by subject|1|||
130752550|NCT01704651|470715125|FG001|Overall Study|Pre-op withdrawal by subject|1|||
130752551|NCT01704651|470715124|FG000|Overall Study|Pre-op change in treatment plan|1|||
130752552|NCT01704651|470715125|FG001|Overall Study|Pre-op change in treatment plan|4|||
130752553|NCT01704651|470715124|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
130752554|NCT01704651|470715125|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
130752555|NCT01704651|470715124|FG000|Overall Study|Post-op did not have laparotomy|2|||
130752556|NCT01704651|470715125|FG001|Overall Study|Post-op did not have laparotomy|1|||
130752557|NCT00634803|470715127|FG000|Overall Study|Lost to Follow-up|6|||
130752558|NCT00634803|470715128|FG001|Overall Study|Lost to Follow-up|7|||
130752559|NCT00634803|470715129|FG002|Overall Study|Lost to Follow-up|7|||
130752560|NCT00364923|470715131|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
130752561|NCT00364923|470715131|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
130752562|NCT04087720|470715135|FG000|Overall Study|Withdrawal by Subject|2|||
130788709|NCT01652690|470854634|FG001|Overall Study|Withdrawal by Subject|4|||
130752563|NCT04087720|470715135|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
130752564|NCT03706430|470715138|FG000|Overall Study|No A-Line placed|5|||
130752565|NCT03706430|470715138|FG000|Overall Study|Subject had gel nail polish|1|||
130752566|NCT03706430|470715138|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
130752567|NCT03706430|470715138|FG000|Overall Study|Cancelled Case|6|||
130752568|NCT03706430|470715138|FG000|Overall Study|Physician Decision|2|||
130752569|NCT00520533|470715139|FG000|Overall Study|Death|1|||
130752570|NCT00520533|470715139|FG000|Overall Study|Suspension of the study for safety reasons|1|||
130752571|NCT00520533|470715139|FG000|Overall Study|Withdrawal by Subject|1|||
130752572|NCT00520533|470715139|FG000|Overall Study|Physician Decision|1|||
130752573|NCT00478777|470715140|FG000|Overall Study|Adverse Event|29|||
130752574|NCT00478777|470715140|FG000|Overall Study|Lack of Efficacy|23|||
130752575|NCT00478777|470715140|FG000|Overall Study|Withdrawal by Subject|4|||
130752576|NCT00478777|470715140|FG000|Overall Study|Death|3|||
130752577|NCT00478777|470715140|FG000|Overall Study|Protocol Violation|3|||
130752578|NCT00478777|470715140|FG000|Overall Study|Lost to Follow-up|3|||
130752579|NCT00478777|470715140|FG000|Overall Study|Physician Decision|1|||
130752580|NCT00478777|470715140|FG000|Overall Study|Intolerance of therapy|1|||
130752581|NCT00478777|470715140|FG000|Overall Study|Lack of compliance|1|||
130752582|NCT00478777|470715140|FG000|Overall Study|Lymphocytes infusion|1|||
130752583|NCT00478777|470715140|FG000|Overall Study|End of therapy|2|||
130752584|NCT00478777|470715140|FG000|Overall Study|Not treated with lenalidomide|6|||
130752585|NCT00552396|470715141|FG000|Overall Study|protocol withdrawal criteria|3|||
130752586|NCT00552396|470715142|FG001|Overall Study|protocol withdrawal criteria|3|||
130752587|NCT00552396|470715143|FG002|Overall Study|protocol withdrawal criteria|3|||
130752588|NCT00552396|470715144|FG003|Overall Study|protocol withdrawal criteria|6|||
130752589|NCT00552396|470715145|FG004|Overall Study|protocol withdrawal criteria|3|||
130752590|NCT00552396|470715146|FG005|Overall Study|protocol withdrawal criteria|3|||
130752591|NCT00552396|470715147|FG006|Overall Study|protocol withdrawal criteria|9|||
130752592|NCT02553499|470715148|FG000|Overall Study|Adverse Event|0|||
130752593|NCT02553499|470715149|FG001|Overall Study|Adverse Event|0|||
130752594|NCT02553499|470715150|FG002|Overall Study|Adverse Event|0|||
130752595|NCT02553499|470715151|FG003|Overall Study|Adverse Event|0|||
130752596|NCT02553499|470715152|FG004|Overall Study|Adverse Event|0|||
130752597|NCT02553499|470715153|FG005|Overall Study|Adverse Event|0|||
130752598|NCT02553499|470715154|FG006|Overall Study|Adverse Event|1|||
130752599|NCT02553499|470715155|FG007|Overall Study|Adverse Event|1|||
130752600|NCT02553499|470715156|FG008|Overall Study|Adverse Event|0|||
130752601|NCT02553499|470715157|FG009|Overall Study|Adverse Event|0|||
130752602|NCT02553499|470715158|FG010|Overall Study|Adverse Event|0|||
130752603|NCT02553499|470715159|FG011|Overall Study|Adverse Event|0|||
130752604|NCT02553499|470715160|FG012|Overall Study|Adverse Event|0|||
130752605|NCT02553499|470715161|FG013|Overall Study|Adverse Event|1|||
130752606|NCT02553499|470715148|FG000|Overall Study|Death|0|||
130752607|NCT02553499|470715149|FG001|Overall Study|Death|1|||
130752608|NCT02553499|470715150|FG002|Overall Study|Death|1|||
130752609|NCT02553499|470715151|FG003|Overall Study|Death|0|||
130752610|NCT02553499|470715152|FG004|Overall Study|Death|1|||
130752611|NCT02553499|470715153|FG005|Overall Study|Death|2|||
130752612|NCT02553499|470715154|FG006|Overall Study|Death|0|||
130752613|NCT02553499|470715155|FG007|Overall Study|Death|0|||
130752614|NCT02553499|470715156|FG008|Overall Study|Death|0|||
130752615|NCT02553499|470715157|FG009|Overall Study|Death|0|||
130752616|NCT02553499|470715158|FG010|Overall Study|Death|1|||
130752617|NCT02553499|470715159|FG011|Overall Study|Death|0|||
130752618|NCT02553499|470715160|FG012|Overall Study|Death|0|||
130752619|NCT02553499|470715161|FG013|Overall Study|Death|0|||
130752620|NCT02553499|470715148|FG000|Overall Study|Lost to Follow-up|0|||
130752621|NCT02553499|470715149|FG001|Overall Study|Lost to Follow-up|0|||
130752622|NCT02553499|470715150|FG002|Overall Study|Lost to Follow-up|0|||
130752623|NCT02553499|470715151|FG003|Overall Study|Lost to Follow-up|0|||
130752624|NCT02553499|470715152|FG004|Overall Study|Lost to Follow-up|0|||
130752625|NCT02553499|470715153|FG005|Overall Study|Lost to Follow-up|0|||
130752626|NCT02553499|470715154|FG006|Overall Study|Lost to Follow-up|1|||
130752627|NCT02553499|470715155|FG007|Overall Study|Lost to Follow-up|0|||
130752628|NCT02553499|470715156|FG008|Overall Study|Lost to Follow-up|0|||
130752629|NCT02553499|470715157|FG009|Overall Study|Lost to Follow-up|0|||
130752630|NCT02553499|470715158|FG010|Overall Study|Lost to Follow-up|0|||
130752631|NCT02553499|470715159|FG011|Overall Study|Lost to Follow-up|0|||
130752632|NCT02553499|470715160|FG012|Overall Study|Lost to Follow-up|0|||
130752633|NCT02553499|470715161|FG013|Overall Study|Lost to Follow-up|0|||
130752634|NCT02553499|470715148|FG000|Overall Study|Physician Decision|0|||
130752635|NCT02553499|470715149|FG001|Overall Study|Physician Decision|1|||
130752636|NCT02553499|470715150|FG002|Overall Study|Physician Decision|1|||
130752637|NCT02553499|470715151|FG003|Overall Study|Physician Decision|0|||
130752638|NCT02553499|470715152|FG004|Overall Study|Physician Decision|1|||
130752639|NCT02553499|470715153|FG005|Overall Study|Physician Decision|0|||
130752640|NCT02553499|470715154|FG006|Overall Study|Physician Decision|0|||
130752641|NCT02553499|470715155|FG007|Overall Study|Physician Decision|1|||
130752642|NCT02553499|470715156|FG008|Overall Study|Physician Decision|1|||
130752643|NCT02553499|470715157|FG009|Overall Study|Physician Decision|2|||
130752644|NCT02553499|470715158|FG010|Overall Study|Physician Decision|1|||
130752645|NCT02553499|470715159|FG011|Overall Study|Physician Decision|3|||
130752646|NCT02553499|470715160|FG012|Overall Study|Physician Decision|1|||
130752647|NCT02553499|470715161|FG013|Overall Study|Physician Decision|0|||
130752648|NCT02553499|470715148|FG000|Overall Study|Progressive Disease|0|||
130752649|NCT02553499|470715149|FG001|Overall Study|Progressive Disease|0|||
130752650|NCT02553499|470715150|FG002|Overall Study|Progressive Disease|0|||
130752651|NCT02553499|470715151|FG003|Overall Study|Progressive Disease|2|||
130752652|NCT02553499|470715152|FG004|Overall Study|Progressive Disease|1|||
130752653|NCT02553499|470715153|FG005|Overall Study|Progressive Disease|1|||
130752654|NCT02553499|470715154|FG006|Overall Study|Progressive Disease|1|||
130752655|NCT02553499|470715155|FG007|Overall Study|Progressive Disease|0|||
130752656|NCT02553499|470715156|FG008|Overall Study|Progressive Disease|0|||
130752657|NCT02553499|470715157|FG009|Overall Study|Progressive Disease|1|||
130752658|NCT02553499|470715158|FG010|Overall Study|Progressive Disease|0|||
130752659|NCT02553499|470715159|FG011|Overall Study|Progressive Disease|0|||
130752660|NCT02553499|470715160|FG012|Overall Study|Progressive Disease|2|||
130752661|NCT02553499|470715161|FG013|Overall Study|Progressive Disease|1|||
130752662|NCT02553499|470715148|FG000|Overall Study|Study Terminated by Sponsor|0|||
130752663|NCT02553499|470715149|FG001|Overall Study|Study Terminated by Sponsor|0|||
130752664|NCT02553499|470715150|FG002|Overall Study|Study Terminated by Sponsor|0|||
130752665|NCT02553499|470715151|FG003|Overall Study|Study Terminated by Sponsor|0|||
130752666|NCT02553499|470715152|FG004|Overall Study|Study Terminated by Sponsor|0|||
130752667|NCT02553499|470715153|FG005|Overall Study|Study Terminated by Sponsor|0|||
130752668|NCT02553499|470715154|FG006|Overall Study|Study Terminated by Sponsor|0|||
130752669|NCT02553499|470715155|FG007|Overall Study|Study Terminated by Sponsor|0|||
130752670|NCT02553499|470715156|FG008|Overall Study|Study Terminated by Sponsor|1|||
130752671|NCT02553499|470715157|FG009|Overall Study|Study Terminated by Sponsor|0|||
130752672|NCT02553499|470715158|FG010|Overall Study|Study Terminated by Sponsor|0|||
130752673|NCT02553499|470715159|FG011|Overall Study|Study Terminated by Sponsor|0|||
130752674|NCT02553499|470715160|FG012|Overall Study|Study Terminated by Sponsor|0|||
130752675|NCT02553499|470715161|FG013|Overall Study|Study Terminated by Sponsor|0|||
130752676|NCT02553499|470715148|FG000|Overall Study|Withdrawal by Subject|2|||
130752677|NCT02553499|470715149|FG001|Overall Study|Withdrawal by Subject|0|||
130752678|NCT02553499|470715150|FG002|Overall Study|Withdrawal by Subject|0|||
130752679|NCT02553499|470715151|FG003|Overall Study|Withdrawal by Subject|0|||
130752680|NCT02553499|470715152|FG004|Overall Study|Withdrawal by Subject|0|||
130752681|NCT02553499|470715153|FG005|Overall Study|Withdrawal by Subject|0|||
130752682|NCT02553499|470715154|FG006|Overall Study|Withdrawal by Subject|0|||
130752683|NCT02553499|470715155|FG007|Overall Study|Withdrawal by Subject|1|||
130752684|NCT02553499|470715156|FG008|Overall Study|Withdrawal by Subject|1|||
130752685|NCT02553499|470715157|FG009|Overall Study|Withdrawal by Subject|0|||
130752686|NCT02553499|470715158|FG010|Overall Study|Withdrawal by Subject|1|||
130752687|NCT02553499|470715159|FG011|Overall Study|Withdrawal by Subject|0|||
130752688|NCT02553499|470715160|FG012|Overall Study|Withdrawal by Subject|0|||
130752689|NCT02553499|470715161|FG013|Overall Study|Withdrawal by Subject|0|||
130752690|NCT03319732|470715167|FG000|Overall Study|Adverse Event|40|||
130752691|NCT03319732|470715167|FG000|Overall Study|Withdrawal by Subject|50|||
130752692|NCT03319732|470715167|FG000|Overall Study|MS relapse|10|||
130752693|NCT03319732|470715167|FG000|Overall Study|reason not specified|5|||
130752694|NCT00767455|470715168|FG000|Overall Study|Investigator error|19|||
130752695|NCT03386994|470715169|FG000|Overall Study|Lung transplant|1|||
130752696|NCT03386994|470715169|FG000|Overall Study|Adverse Event|14|||
130752697|NCT03386994|470715169|FG000|Overall Study|Lost to Follow-up|4|||
130752698|NCT03386994|470715169|FG000|Overall Study|Withdrawal by Subject|3|||
130752699|NCT03386994|470715169|FG000|Overall Study|Death|16|||
130752700|NCT00068393|470716729|FG000|Overall Study|Adverse Event|2|||
130752701|NCT00068393|470716729|FG000|Overall Study|Death|3|||
130752702|NCT00068393|470716729|FG000|Overall Study|Withdrawal by Subject|3|||
130752703|NCT00068393|470716729|FG000|Overall Study|Alternative treatment|1|||
130752704|NCT00068393|470716729|FG000|Overall Study|Quality of life worsening|1|||
130752705|NCT04981470|470716733|FG000|Overall Study|Device failure in all 4 patients|4|||
130752706|NCT00593684|470716734|FG000|Overall Study|Death|2|||
130752707|NCT00593684|470716735|FG001|Overall Study|Death|1|||
130752708|NCT00078767|470716736|FG000|Overall Study|Withdrawal by Subject|1|||
130752709|NCT00078767|470716737|FG001|Overall Study|Withdrawal by Subject|1|||
130752710|NCT02282631|470716742|FG000|Overall Study|Lost to Follow-up|2|||
130752711|NCT02282631|470716743|FG001|Overall Study|Lost to Follow-up|0|||
130752712|NCT01736397|470716744|FG000|Overall Study|Lack of Efficacy|1|||
130752713|NCT01736397|470716745|FG001|Overall Study|Lack of Efficacy|11|||
130788710|NCT01652690|470854633|FG000|Overall Study|Other|8|||
130752714|NCT01736397|470716744|FG000|Overall Study|Withdrawal by Subject|6|||
130752715|NCT01736397|470716745|FG001|Overall Study|Withdrawal by Subject|5|||
130752716|NCT01736397|470716744|FG000|Overall Study|Lost to Follow-up|0|||
130752717|NCT01736397|470716745|FG001|Overall Study|Lost to Follow-up|1|||
130752718|NCT01736397|470716744|FG000|Overall Study|Adverse Event|6|||
130752719|NCT01736397|470716745|FG001|Overall Study|Adverse Event|3|||
130752720|NCT01736397|470716744|FG000|Overall Study|Not stated|1|||
130752721|NCT01736397|470716745|FG001|Overall Study|Not stated|4|||
130752722|NCT05088603|470716746|FG000|Overall Study|Protocol Violation|6|||
130752723|NCT05088603|470716747|FG001|Overall Study|Protocol Violation|1|||
130752724|NCT01841762|470716749|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
130752725|NCT01841762|470716749|FG000|Treatment Period|Adverse Event|16|||
130752726|NCT01841762|470716749|FG000|Treatment Period|Death|1|||
130752727|NCT01841762|470716749|FG000|Treatment Period|Withdrawal by Subject|7|||
130752728|NCT01841762|470716749|FG000|Treatment Period|Lost to Follow-up|1|||
130752729|NCT01841762|470716749|FG000|Treatment Period|Physician Decision|2|||
130752730|NCT01841762|470716749|FG000|Treatment Period|Other, including non-compliance|5|||
130752731|NCT01841762|470716749|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
130752732|NCT01841762|470716749|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
130752733|NCT01841762|470716749|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
130752734|NCT01841762|470716749|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
130752735|NCT03260244|470716750|FG000|Overall Study|Death|19|||
130752736|NCT03260244|470716750|FG000|Overall Study|Lost to Follow-up|60|||
130752737|NCT03260244|470716750|FG000|Overall Study|Withdrawal by Subject|48|||
130752738|NCT03260244|470716750|FG000|Overall Study|Procedure Not Performed|21|||
130752739|NCT03260244|470716750|FG000|Overall Study|Enrollment Criteria Not Met|31|||
130752740|NCT03260244|470716750|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
130752741|NCT03260244|470716750|FG000|Overall Study|Subject Noncompliance|6|||
130752742|NCT03260244|470716750|FG000|Overall Study|No inducible Arrhythmia|2|||
130752743|NCT03260244|470716750|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
130752744|NCT03260244|470716750|FG000|Overall Study|Screen Failure|2|||
130752745|NCT03260244|470716750|FG000|Overall Study|Treated Off Label|69|||
130752746|NCT03260244|470716750|FG000|Overall Study|No Radiofrequency Ablation|14|||
130752747|NCT03528369|470716755|FG000|Overall Study|Withdrawal by Subject|2|||
130752748|NCT03528369|470716756|FG001|Overall Study|Withdrawal by Subject|0|||
130752749|NCT03528369|470716757|FG002|Overall Study|Withdrawal by Subject|0|||
130752750|NCT03528369|470716755|FG000|Overall Study|Lost to Follow-up|1|||
130752751|NCT03528369|470716756|FG001|Overall Study|Lost to Follow-up|0|||
130752752|NCT03528369|470716757|FG002|Overall Study|Lost to Follow-up|0|||
130752753|NCT03528369|470716755|FG000|Overall Study|Adverse Event|0|||
130752754|NCT03528369|470716756|FG001|Overall Study|Adverse Event|1|||
130752755|NCT03528369|470716757|FG002|Overall Study|Adverse Event|0|||
130752756|NCT02162719|470716758|FG000|Overall Study|Death|41|||
130752757|NCT02162719|470716759|FG001|Overall Study|Death|46|||
130752758|NCT02162719|470716758|FG000|Overall Study|Lost to Follow-up|1|||
130752759|NCT02162719|470716759|FG001|Overall Study|Lost to Follow-up|3|||
130752760|NCT02162719|470716758|FG000|Overall Study|Disease Progression|2|||
130752761|NCT02162719|470716759|FG001|Overall Study|Disease Progression|1|||
130752762|NCT02162719|470716758|FG000|Overall Study|Withdrawal by Subject|8|||
130752763|NCT02162719|470716759|FG001|Overall Study|Withdrawal by Subject|2|||
130752764|NCT02162719|470716758|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
130752765|NCT02162719|470716759|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
130752766|NCT03555565|470716760|FG000|Overall Study|Case Report Forms Uncollected|2|||
130752767|NCT03555565|470716760|FG000|Overall Study|Protocol Deviation|13|||
130752768|NCT03192306|470716766|FG000|Overall Study|Did not treat cold sore during study|149|||
130752769|NCT03192306|470716767|FG001|Overall Study|Did not treat cold sore during study|143|||
130752770|NCT03192306|470716766|FG000|Overall Study|Withdrawal by Subject|1|||
130752771|NCT03192306|470716767|FG001|Overall Study|Withdrawal by Subject|1|||
130752772|NCT03192306|470716766|FG000|Overall Study|Lost to Follow-up|1|||
130752773|NCT03192306|470716767|FG001|Overall Study|Lost to Follow-up|0|||
130752774|NCT03192306|470716766|FG000|Overall Study|Protocol Violation|1|||
130752775|NCT03192306|470716767|FG001|Overall Study|Protocol Violation|1|||
130752776|NCT02589626|470716772|FG000|Overall Study|Other than the reason specified|1|||
130752777|NCT02589626|470716773|FG001|Overall Study|Other than the reason specified|0|||
130752778|NCT02589626|470716772|FG000|Overall Study|Withdrawal by Subject|1|||
130752779|NCT02589626|470716773|FG001|Overall Study|Withdrawal by Subject|1|||
130752780|NCT02589626|470716772|FG000|Overall Study|Adverse Event|1|||
130752781|NCT02589626|470716773|FG001|Overall Study|Adverse Event|1|||
130752782|NCT02564900|470716774|FG000|Dose Escalation|Progressive disease per RECIST|2|||
130752783|NCT02564900|470716775|FG001|Dose Escalation|Progressive disease per RECIST|3|||
130752784|NCT02564900|470716776|FG002|Dose Escalation|Progressive disease per RECIST|3|||
130752785|NCT02564900|470716777|FG003|Dose Escalation|Progressive disease per RECIST|3|||
130752786|NCT02564900|470716778|FG004|Dose Escalation|Progressive disease per RECIST|3|||
130752787|NCT02564900|470716779|FG005|Dose Escalation|Progressive disease per RECIST|1|||
130752788|NCT02564900|470716780|FG006|Dose Escalation|Progressive disease per RECIST|0|||
130752789|NCT02564900|470716781|FG007|Dose Escalation|Progressive disease per RECIST|0|||
130752790|NCT02564900|470716782|FG008|Dose Escalation|Progressive disease per RECIST|0|||
130752791|NCT02564900|470716783|FG009|Dose Escalation|Progressive disease per RECIST|0|||
130752792|NCT02564900|470716784|FG010|Dose Escalation|Progressive disease per RECIST|0|||
130752793|NCT02564900|470716785|FG011|Dose Escalation|Progressive disease per RECIST|0|||
130752794|NCT02564900|470716786|FG012|Dose Escalation|Progressive disease per RECIST|0|||
130752795|NCT02564900|470716787|FG013|Dose Escalation|Progressive disease per RECIST|0|||
130752796|NCT02564900|470716788|FG014|Dose Escalation|Progressive disease per RECIST|0|||
130752797|NCT02564900|470716774|FG000|Dose Escalation|Ongoing|1|||
130752798|NCT02564900|470716775|FG001|Dose Escalation|Ongoing|0|||
130752799|NCT02564900|470716776|FG002|Dose Escalation|Ongoing|0|||
130752800|NCT02564900|470716777|FG003|Dose Escalation|Ongoing|2|||
130752801|NCT02564900|470716778|FG004|Dose Escalation|Ongoing|2|||
130752802|NCT02564900|470716779|FG005|Dose Escalation|Ongoing|2|||
130752803|NCT02564900|470716780|FG006|Dose Escalation|Ongoing|0|||
130752804|NCT02564900|470716781|FG007|Dose Escalation|Ongoing|0|||
130752805|NCT02564900|470716782|FG008|Dose Escalation|Ongoing|0|||
130752806|NCT02564900|470716783|FG009|Dose Escalation|Ongoing|0|||
130752807|NCT02564900|470716784|FG010|Dose Escalation|Ongoing|0|||
130752808|NCT02564900|470716785|FG011|Dose Escalation|Ongoing|0|||
130752809|NCT02564900|470716786|FG012|Dose Escalation|Ongoing|0|||
130752810|NCT02564900|470716787|FG013|Dose Escalation|Ongoing|0|||
130752811|NCT02564900|470716788|FG014|Dose Escalation|Ongoing|0|||
130752812|NCT02564900|470716774|FG000|Dose Escalation|Adverse Event|0|||
130752813|NCT02564900|470716775|FG001|Dose Escalation|Adverse Event|0|||
130752814|NCT02564900|470716776|FG002|Dose Escalation|Adverse Event|0|||
130752815|NCT02564900|470716777|FG003|Dose Escalation|Adverse Event|1|||
130752816|NCT02564900|470716778|FG004|Dose Escalation|Adverse Event|1|||
130752817|NCT02564900|470716779|FG005|Dose Escalation|Adverse Event|3|||
130752818|NCT02564900|470716780|FG006|Dose Escalation|Adverse Event|0|||
130752819|NCT02564900|470716781|FG007|Dose Escalation|Adverse Event|0|||
130752820|NCT02564900|470716782|FG008|Dose Escalation|Adverse Event|0|||
130752821|NCT02564900|470716783|FG009|Dose Escalation|Adverse Event|0|||
130752822|NCT02564900|470716784|FG010|Dose Escalation|Adverse Event|0|||
130752823|NCT02564900|470716785|FG011|Dose Escalation|Adverse Event|0|||
130752824|NCT02564900|470716786|FG012|Dose Escalation|Adverse Event|0|||
130752825|NCT02564900|470716787|FG013|Dose Escalation|Adverse Event|0|||
130752826|NCT02564900|470716788|FG014|Dose Escalation|Adverse Event|0|||
130752827|NCT02564900|470716774|FG000|Dose Expansion|Progressive disease per RECIST|0|||
130752828|NCT02564900|470716775|FG001|Dose Expansion|Progressive disease per RECIST|0|||
130788711|NCT01652690|470854634|FG001|Overall Study|Other|9|||
130752829|NCT02564900|470716776|FG002|Dose Expansion|Progressive disease per RECIST|0|||
130752830|NCT02564900|470716777|FG003|Dose Expansion|Progressive disease per RECIST|0|||
130752831|NCT02564900|470716778|FG004|Dose Expansion|Progressive disease per RECIST|0|||
130752832|NCT02564900|470716779|FG005|Dose Expansion|Progressive disease per RECIST|0|||
130752833|NCT02564900|470716780|FG006|Dose Expansion|Progressive disease per RECIST|19|||
130752834|NCT02564900|470716781|FG007|Dose Expansion|Progressive disease per RECIST|17|||
130752835|NCT02564900|470716782|FG008|Dose Expansion|Progressive disease per RECIST|8|||
130752836|NCT02564900|470716783|FG009|Dose Expansion|Progressive disease per RECIST|16|||
130752837|NCT02564900|470716784|FG010|Dose Expansion|Progressive disease per RECIST|13|||
130752838|NCT02564900|470716785|FG011|Dose Expansion|Progressive disease per RECIST|19|||
130752839|NCT02564900|470716786|FG012|Dose Expansion|Progressive disease per RECIST|10|||
130752840|NCT02564900|470716787|FG013|Dose Expansion|Progressive disease per RECIST|13|||
130752841|NCT02564900|470716788|FG014|Dose Expansion|Progressive disease per RECIST|11|||
130752842|NCT02564900|470716774|FG000|Dose Expansion|Clinical progression|0|||
130752843|NCT02564900|470716775|FG001|Dose Expansion|Clinical progression|0|||
130752844|NCT02564900|470716776|FG002|Dose Expansion|Clinical progression|0|||
130752845|NCT02564900|470716777|FG003|Dose Expansion|Clinical progression|0|||
130752846|NCT02564900|470716778|FG004|Dose Expansion|Clinical progression|0|||
130752847|NCT02564900|470716779|FG005|Dose Expansion|Clinical progression|0|||
130752848|NCT02564900|470716780|FG006|Dose Expansion|Clinical progression|5|||
130752849|NCT02564900|470716781|FG007|Dose Expansion|Clinical progression|12|||
130752850|NCT02564900|470716782|FG008|Dose Expansion|Clinical progression|0|||
130752851|NCT02564900|470716783|FG009|Dose Expansion|Clinical progression|3|||
130752852|NCT02564900|470716784|FG010|Dose Expansion|Clinical progression|2|||
130752853|NCT02564900|470716785|FG011|Dose Expansion|Clinical progression|0|||
130752854|NCT02564900|470716786|FG012|Dose Expansion|Clinical progression|1|||
130752855|NCT02564900|470716787|FG013|Dose Expansion|Clinical progression|3|||
130752856|NCT02564900|470716788|FG014|Dose Expansion|Clinical progression|1|||
130752857|NCT02564900|470716774|FG000|Dose Expansion|Adverse Event|0|||
130752858|NCT02564900|470716775|FG001|Dose Expansion|Adverse Event|0|||
130752859|NCT02564900|470716776|FG002|Dose Expansion|Adverse Event|0|||
130752860|NCT02564900|470716777|FG003|Dose Expansion|Adverse Event|0|||
130752861|NCT02564900|470716778|FG004|Dose Expansion|Adverse Event|0|||
130752862|NCT02564900|470716779|FG005|Dose Expansion|Adverse Event|0|||
130752863|NCT02564900|470716780|FG006|Dose Expansion|Adverse Event|9|||
130752864|NCT02564900|470716781|FG007|Dose Expansion|Adverse Event|22|||
130752865|NCT02564900|470716782|FG008|Dose Expansion|Adverse Event|0|||
130752866|NCT02564900|470716783|FG009|Dose Expansion|Adverse Event|11|||
130752867|NCT02564900|470716784|FG010|Dose Expansion|Adverse Event|0|||
130752868|NCT02564900|470716785|FG011|Dose Expansion|Adverse Event|5|||
130752869|NCT02564900|470716786|FG012|Dose Expansion|Adverse Event|2|||
130752870|NCT02564900|470716787|FG013|Dose Expansion|Adverse Event|2|||
130752871|NCT02564900|470716788|FG014|Dose Expansion|Adverse Event|1|||
130752872|NCT02564900|470716774|FG000|Dose Expansion|Ongoing|0|||
130752873|NCT02564900|470716775|FG001|Dose Expansion|Ongoing|0|||
130752874|NCT02564900|470716776|FG002|Dose Expansion|Ongoing|0|||
130752875|NCT02564900|470716777|FG003|Dose Expansion|Ongoing|0|||
130752876|NCT02564900|470716778|FG004|Dose Expansion|Ongoing|0|||
130752877|NCT02564900|470716779|FG005|Dose Expansion|Ongoing|0|||
130752878|NCT02564900|470716780|FG006|Dose Expansion|Ongoing|9|||
130752879|NCT02564900|470716781|FG007|Dose Expansion|Ongoing|10|||
130752880|NCT02564900|470716782|FG008|Dose Expansion|Ongoing|11|||
130752881|NCT02564900|470716783|FG009|Dose Expansion|Ongoing|3|||
130752882|NCT02564900|470716784|FG010|Dose Expansion|Ongoing|0|||
130752883|NCT02564900|470716785|FG011|Dose Expansion|Ongoing|0|||
130752884|NCT02564900|470716786|FG012|Dose Expansion|Ongoing|4|||
130752885|NCT02564900|470716787|FG013|Dose Expansion|Ongoing|0|||
130752886|NCT02564900|470716788|FG014|Dose Expansion|Ongoing|6|||
130752887|NCT02564900|470716774|FG000|Dose Expansion|Death|0|||
130752888|NCT02564900|470716775|FG001|Dose Expansion|Death|0|||
130752889|NCT02564900|470716776|FG002|Dose Expansion|Death|0|||
130752890|NCT02564900|470716777|FG003|Dose Expansion|Death|0|||
130752891|NCT02564900|470716778|FG004|Dose Expansion|Death|0|||
130752892|NCT02564900|470716779|FG005|Dose Expansion|Death|0|||
130752893|NCT02564900|470716780|FG006|Dose Expansion|Death|1|||
130752894|NCT02564900|470716781|FG007|Dose Expansion|Death|0|||
130752895|NCT02564900|470716782|FG008|Dose Expansion|Death|0|||
130752896|NCT02564900|470716783|FG009|Dose Expansion|Death|0|||
130752897|NCT02564900|470716784|FG010|Dose Expansion|Death|1|||
130752898|NCT02564900|470716785|FG011|Dose Expansion|Death|0|||
130752899|NCT02564900|470716786|FG012|Dose Expansion|Death|1|||
130752900|NCT02564900|470716787|FG013|Dose Expansion|Death|1|||
130752901|NCT02564900|470716788|FG014|Dose Expansion|Death|0|||
130752902|NCT02564900|470716774|FG000|Dose Expansion|Withdrawal by Subject|0|||
130752903|NCT02564900|470716775|FG001|Dose Expansion|Withdrawal by Subject|0|||
130752904|NCT02564900|470716776|FG002|Dose Expansion|Withdrawal by Subject|0|||
130752905|NCT02564900|470716777|FG003|Dose Expansion|Withdrawal by Subject|0|||
130752906|NCT02564900|470716778|FG004|Dose Expansion|Withdrawal by Subject|0|||
130752907|NCT02564900|470716779|FG005|Dose Expansion|Withdrawal by Subject|0|||
130788712|NCT01652690|470854633|FG000|Overall Study|Lost to Follow-up|6|||
130752908|NCT02564900|470716780|FG006|Dose Expansion|Withdrawal by Subject|4|||
130752909|NCT02564900|470716781|FG007|Dose Expansion|Withdrawal by Subject|0|||
130752910|NCT02564900|470716782|FG008|Dose Expansion|Withdrawal by Subject|0|||
130752911|NCT02564900|470716783|FG009|Dose Expansion|Withdrawal by Subject|0|||
130752912|NCT02564900|470716784|FG010|Dose Expansion|Withdrawal by Subject|1|||
130752913|NCT02564900|470716785|FG011|Dose Expansion|Withdrawal by Subject|0|||
130752914|NCT02564900|470716786|FG012|Dose Expansion|Withdrawal by Subject|0|||
130752915|NCT02564900|470716787|FG013|Dose Expansion|Withdrawal by Subject|1|||
130752916|NCT02564900|470716788|FG014|Dose Expansion|Withdrawal by Subject|1|||
130752917|NCT02564900|470716774|FG000|Dose Expansion|Other|0|||
130752918|NCT02564900|470716775|FG001|Dose Expansion|Other|0|||
130752919|NCT02564900|470716776|FG002|Dose Expansion|Other|0|||
130752920|NCT02564900|470716777|FG003|Dose Expansion|Other|0|||
130752921|NCT02564900|470716778|FG004|Dose Expansion|Other|0|||
130752922|NCT02564900|470716779|FG005|Dose Expansion|Other|0|||
130752923|NCT02564900|470716780|FG006|Dose Expansion|Other|1|||
130752924|NCT02564900|470716781|FG007|Dose Expansion|Other|0|||
130752925|NCT02564900|470716782|FG008|Dose Expansion|Other|1|||
130752926|NCT02564900|470716783|FG009|Dose Expansion|Other|0|||
130752927|NCT02564900|470716784|FG010|Dose Expansion|Other|0|||
130752928|NCT02564900|470716785|FG011|Dose Expansion|Other|0|||
130752929|NCT02564900|470716786|FG012|Dose Expansion|Other|0|||
130752930|NCT02564900|470716787|FG013|Dose Expansion|Other|0|||
130752931|NCT02564900|470716788|FG014|Dose Expansion|Other|1|||
130752932|NCT02564900|470716774|FG000|Dose Expansion|Did not receive treatment|0|||
130752933|NCT02564900|470716775|FG001|Dose Expansion|Did not receive treatment|0|||
130752934|NCT02564900|470716776|FG002|Dose Expansion|Did not receive treatment|0|||
130752935|NCT02564900|470716777|FG003|Dose Expansion|Did not receive treatment|0|||
130752936|NCT02564900|470716778|FG004|Dose Expansion|Did not receive treatment|0|||
130752937|NCT02564900|470716779|FG005|Dose Expansion|Did not receive treatment|0|||
130752938|NCT02564900|470716780|FG006|Dose Expansion|Did not receive treatment|1|||
130752939|NCT02564900|470716781|FG007|Dose Expansion|Did not receive treatment|1|||
130752940|NCT02564900|470716782|FG008|Dose Expansion|Did not receive treatment|0|||
130752941|NCT02564900|470716783|FG009|Dose Expansion|Did not receive treatment|0|||
130752942|NCT02564900|470716784|FG010|Dose Expansion|Did not receive treatment|0|||
130752943|NCT02564900|470716785|FG011|Dose Expansion|Did not receive treatment|0|||
130752944|NCT02564900|470716786|FG012|Dose Expansion|Did not receive treatment|0|||
130752945|NCT02564900|470716787|FG013|Dose Expansion|Did not receive treatment|0|||
130752946|NCT02564900|470716788|FG014|Dose Expansion|Did not receive treatment|1|||
130752947|NCT00892151|470716789|FG000|Overall Study|Protocol Violation|1|||
130752948|NCT04075682|470716793|FG000|Overall Study|Lost to Follow-up|5|||
130752949|NCT04075682|470716794|FG001|Overall Study|Lost to Follow-up|5|||
130752950|NCT04075682|470716795|FG002|Overall Study|Lost to Follow-up|2|||
130752951|NCT04075682|470716796|FG003|Overall Study|Lost to Follow-up|2|||
130752952|NCT04075682|470716793|FG000|Overall Study|Withdrawal by Subject|1|||
130752953|NCT04075682|470716794|FG001|Overall Study|Withdrawal by Subject|0|||
130752954|NCT04075682|470716795|FG002|Overall Study|Withdrawal by Subject|1|||
130752955|NCT04075682|470716796|FG003|Overall Study|Withdrawal by Subject|0|||
130752956|NCT04075682|470716793|FG000|Overall Study|Protocol Violation|0|||
130752957|NCT04075682|470716794|FG001|Overall Study|Protocol Violation|1|||
130752958|NCT04075682|470716795|FG002|Overall Study|Protocol Violation|1|||
130752959|NCT04075682|470716796|FG003|Overall Study|Protocol Violation|0|||
130752960|NCT04075682|470716793|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
130752961|NCT04075682|470716794|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
130752962|NCT04075682|470716795|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
130788713|NCT01652690|470854634|FG001|Overall Study|Lost to Follow-up|6|||
130788714|NCT01652690|470854633|FG000|Overall Study|Death|5|||
130752963|NCT04075682|470716796|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
130752964|NCT04075682|470716793|FG000|Overall Study|Lost study phone the first day of study participation|0|||
130752965|NCT04075682|470716794|FG001|Overall Study|Lost study phone the first day of study participation|1|||
130752966|NCT04075682|470716795|FG002|Overall Study|Lost study phone the first day of study participation|0|||
130752967|NCT04075682|470716796|FG003|Overall Study|Lost study phone the first day of study participation|0|||
130752968|NCT01289639|470716800|FG000|Overall Study|Lost to Follow-up|1|||
130752969|NCT01289639|470716801|FG001|Overall Study|Lost to Follow-up|0|||
130752970|NCT01289639|470716802|FG002|Overall Study|Lost to Follow-up|0|||
130752971|NCT02780713|470716803|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130752972|NCT02780713|470716804|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130752973|NCT02780713|470716805|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
130752974|NCT02780713|470716806|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130788715|NCT01652690|470854634|FG001|Overall Study|Death|2|||
130752975|NCT02780713|470716807|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130752976|NCT01931475|470716810|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
130752977|NCT01931475|470716811|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
130752978|NCT01931475|470716810|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
130752979|NCT01931475|470716811|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
130752980|NCT01931475|470716810|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
130752981|NCT01931475|470716811|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
130752982|NCT01931475|470716810|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
130752983|NCT01931475|470716811|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
130752984|NCT01931475|470716810|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
130752985|NCT01931475|470716811|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
130752986|NCT01931475|470716810|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
130752987|NCT01931475|470716811|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
130752988|NCT01931475|470716810|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
130752989|NCT01931475|470716811|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
130752990|NCT01931475|470716810|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
130752991|NCT01931475|470716811|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
130752992|NCT01931475|470716810|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
130752993|NCT01931475|470716811|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
130752994|NCT01931475|470716810|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
130752995|NCT01931475|470716811|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
130752996|NCT01931475|470716810|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
130752997|NCT01931475|470716811|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
130752998|NCT04292912|470716812|FG000|Overall Study|Physician Decision|1|||
130752999|NCT04292912|470716812|FG000|Overall Study|Protocol Violation|6|||
130753000|NCT02475265|470716822|FG000|Overall Study|Physician Decision|1|||
130753001|NCT02475265|470716822|FG000|Overall Study|Withdrawal by Subject|2|||
130753002|NCT01726270|470716826|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
130753003|NCT01726270|470716826|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
130753004|NCT01726270|470716826|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
130753005|NCT01726270|470716826|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
130753006|NCT01726270|470716826|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
130753007|NCT01726270|470716826|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
130753008|NCT01323387|470716827|FG000|Overall Study|Withdrawal by Subject|41|||
130753009|NCT01323387|470716827|FG000|Overall Study|Radiographic Data Unavailable|1|||
130753010|NCT01323387|470716827|FG000|Overall Study|Revision|14|||
130753011|NCT01323387|470716827|FG000|Overall Study|Protocol Violation|12|||
130753012|NCT01323387|470716827|FG000|Overall Study|Randomized but Never Treated|16|||
130753013|NCT00582608|470716828|FG000|Overall Study|Not Treated|7|||
130753014|NCT00582608|470716828|FG000|Overall Study|Patient Ineligible|1|||
130753015|NCT00582608|470716828|FG000|Overall Study|Lack of accrual|4|||
130753016|NCT02073929|470716844|FG000|Overall Study|Lost to Follow-up|2|||
130753017|NCT02073929|470716845|FG001|Overall Study|Lost to Follow-up|1|||
130753018|NCT02073929|470716844|FG000|Overall Study|Adverse Event|2|||
130753019|NCT02073929|470716845|FG001|Overall Study|Adverse Event|1|||
130753020|NCT02073929|470716844|FG000|Overall Study|Withdrawal by Subject|0|||
130753021|NCT02073929|470716845|FG001|Overall Study|Withdrawal by Subject|1|||
130753022|NCT00430573|470716846|FG000|Overall Study|Withdrawal by Subject|5|||
130753023|NCT04463251|470716847|FG000|Overall Study|Death|1|||
130753024|NCT04463251|470716848|FG001|Overall Study|Death|0|||
130753025|NCT04463251|470716849|FG002|Overall Study|Death|1|||
130753026|NCT04463251|470716847|FG000|Overall Study|Adverse Event|0|||
130753027|NCT04463251|470716848|FG001|Overall Study|Adverse Event|1|||
130753028|NCT04463251|470716849|FG002|Overall Study|Adverse Event|0|||
130753029|NCT04463251|470716847|FG000|Overall Study|Lost to Follow-up|0|||
130753030|NCT04463251|470716848|FG001|Overall Study|Lost to Follow-up|1|||
130753031|NCT04463251|470716849|FG002|Overall Study|Lost to Follow-up|0|||
130753032|NCT04463251|470716847|FG000|Overall Study|Withdrawal by Subject|0|||
130753033|NCT04463251|470716848|FG001|Overall Study|Withdrawal by Subject|2|||
130753034|NCT04463251|470716849|FG002|Overall Study|Withdrawal by Subject|2|||
130753035|NCT05020665|470716850|FG000|Overall Study|Study terminated by Sponsor|5|||
130753036|NCT05020665|470716851|FG001|Overall Study|Study terminated by Sponsor|4|||
130753037|NCT05020665|470716850|FG000|Overall Study|Death|2|||
130753038|NCT05020665|470716851|FG001|Overall Study|Death|1|||
130753039|NCT05020665|470716850|FG000|Overall Study|Physician Decision|0|||
130753040|NCT05020665|470716851|FG001|Overall Study|Physician Decision|1|||
130753041|NCT05020665|470716850|FG000|Overall Study|Withdrawal by Subject|0|||
130753042|NCT05020665|470716851|FG001|Overall Study|Withdrawal by Subject|1|||
130753043|NCT05020665|470716850|FG000|Overall Study|Reason not specified|1|||
130753044|NCT05020665|470716851|FG001|Overall Study|Reason not specified|0|||
130753045|NCT01732640|470716852|FG000|Overall Study|Adverse Event|0|||
130753046|NCT01732640|470716853|FG001|Overall Study|Adverse Event|1|||
130753047|NCT01732640|470716852|FG000|Overall Study|Death|0|||
130753048|NCT01732640|470716853|FG001|Overall Study|Death|1|||
130753049|NCT03070002|470716854|FG000|Follow up for 2 Years|Death|1|||
130753050|NCT02147158|470716855|FG000|Treatment Course 1|Adverse Event|1|||
130753051|NCT02147158|470716856|FG001|Treatment Course 1|Adverse Event|4|||
130753052|NCT02147158|470716857|FG002|Treatment Course 1|Adverse Event|3|||
130753053|NCT02147158|470716858|FG003|Treatment Course 1|Adverse Event|4|||
130753054|NCT02147158|470716859|FG004|Treatment Course 1|Adverse Event|1|||
130753055|NCT02147158|470716860|FG005|Treatment Course 1|Adverse Event|2|||
130753056|NCT02147158|470716855|FG000|Treatment Course 1|Lost to Follow-up|2|||
130753057|NCT02147158|470716856|FG001|Treatment Course 1|Lost to Follow-up|4|||
130753058|NCT02147158|470716857|FG002|Treatment Course 1|Lost to Follow-up|3|||
130753059|NCT02147158|470716858|FG003|Treatment Course 1|Lost to Follow-up|3|||
130753060|NCT02147158|470716859|FG004|Treatment Course 1|Lost to Follow-up|2|||
130753061|NCT02147158|470716860|FG005|Treatment Course 1|Lost to Follow-up|4|||
130753062|NCT02147158|470716855|FG000|Treatment Course 1|Protocol Violation|0|||
130753063|NCT02147158|470716856|FG001|Treatment Course 1|Protocol Violation|0|||
130753064|NCT02147158|470716857|FG002|Treatment Course 1|Protocol Violation|1|||
130753065|NCT02147158|470716858|FG003|Treatment Course 1|Protocol Violation|1|||
130753066|NCT02147158|470716859|FG004|Treatment Course 1|Protocol Violation|0|||
130753067|NCT02147158|470716860|FG005|Treatment Course 1|Protocol Violation|0|||
130753068|NCT02147158|470716855|FG000|Treatment Course 1|Withdrawal of Consent|1|||
130753069|NCT02147158|470716856|FG001|Treatment Course 1|Withdrawal of Consent|1|||
130753070|NCT02147158|470716857|FG002|Treatment Course 1|Withdrawal of Consent|1|||
130753071|NCT02147158|470716858|FG003|Treatment Course 1|Withdrawal of Consent|5|||
130753072|NCT02147158|470716859|FG004|Treatment Course 1|Withdrawal of Consent|3|||
130753073|NCT02147158|470716860|FG005|Treatment Course 1|Withdrawal of Consent|2|||
130753074|NCT02147158|470716855|FG000|Off-Treatment Interval 1|Adverse Event|1|||
130753075|NCT02147158|470716856|FG001|Off-Treatment Interval 1|Adverse Event|0|||
130753076|NCT02147158|470716857|FG002|Off-Treatment Interval 1|Adverse Event|0|||
130753077|NCT02147158|470716858|FG003|Off-Treatment Interval 1|Adverse Event|1|||
130753078|NCT02147158|470716859|FG004|Off-Treatment Interval 1|Adverse Event|0|||
130753079|NCT02147158|470716860|FG005|Off-Treatment Interval 1|Adverse Event|0|||
130753080|NCT02147158|470716855|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
130753081|NCT02147158|470716856|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
130753082|NCT02147158|470716857|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
130753083|NCT02147158|470716858|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
130753084|NCT02147158|470716859|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
130753085|NCT02147158|470716860|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
130753086|NCT02147158|470716855|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
130753087|NCT02147158|470716856|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
130753088|NCT02147158|470716857|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
130753089|NCT02147158|470716858|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
130753090|NCT02147158|470716859|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
130753091|NCT02147158|470716860|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
130753092|NCT02147158|470716855|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
130753093|NCT02147158|470716856|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
130753094|NCT02147158|470716857|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
130753095|NCT02147158|470716858|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
130753096|NCT02147158|470716859|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
130753097|NCT02147158|470716860|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
130753098|NCT02147158|470716855|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
130753099|NCT02147158|470716856|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
130753100|NCT02147158|470716857|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
130753101|NCT02147158|470716858|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
130753102|NCT02147158|470716859|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
130753103|NCT02147158|470716860|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
130753104|NCT02147158|470716855|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
130753105|NCT02147158|470716856|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
130753106|NCT02147158|470716857|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
130753107|NCT02147158|470716858|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
130753108|NCT02147158|470716859|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
130753109|NCT02147158|470716860|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
130753110|NCT02147158|470716855|FG000|Treatment Course 2|Adverse Event|0|||
130753111|NCT02147158|470716856|FG001|Treatment Course 2|Adverse Event|4|||
130753112|NCT02147158|470716857|FG002|Treatment Course 2|Adverse Event|2|||
130753113|NCT02147158|470716858|FG003|Treatment Course 2|Adverse Event|1|||
130753114|NCT02147158|470716859|FG004|Treatment Course 2|Adverse Event|0|||
130753115|NCT02147158|470716860|FG005|Treatment Course 2|Adverse Event|1|||
130753116|NCT02147158|470716855|FG000|Treatment Course 2|Withdrawal of Consent|0|||
130753117|NCT02147158|470716856|FG001|Treatment Course 2|Withdrawal of Consent|1|||
130753118|NCT02147158|470716857|FG002|Treatment Course 2|Withdrawal of Consent|2|||
130753119|NCT02147158|470716858|FG003|Treatment Course 2|Withdrawal of Consent|3|||
130753120|NCT02147158|470716859|FG004|Treatment Course 2|Withdrawal of Consent|0|||
130753121|NCT02147158|470716860|FG005|Treatment Course 2|Withdrawal of Consent|0|||
130753122|NCT02147158|470716855|FG000|Treatment Course 2|Lost to Follow-up|1|||
130753123|NCT02147158|470716856|FG001|Treatment Course 2|Lost to Follow-up|0|||
130753124|NCT02147158|470716857|FG002|Treatment Course 2|Lost to Follow-up|1|||
130753125|NCT02147158|470716858|FG003|Treatment Course 2|Lost to Follow-up|1|||
130753126|NCT02147158|470716859|FG004|Treatment Course 2|Lost to Follow-up|0|||
130753127|NCT02147158|470716860|FG005|Treatment Course 2|Lost to Follow-up|1|||
130753128|NCT02147158|470716855|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
130753129|NCT02147158|470716856|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
130753130|NCT02147158|470716857|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
130753131|NCT02147158|470716858|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
130753132|NCT02147158|470716859|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
130753133|NCT02147158|470716860|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
130753134|NCT02147158|470716855|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
130753135|NCT02147158|470716856|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
130753136|NCT02147158|470716857|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
130753137|NCT02147158|470716858|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
130753138|NCT02147158|470716859|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
130753139|NCT02147158|470716860|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
130753140|NCT02147158|470716855|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
130753141|NCT02147158|470716856|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
130753142|NCT02147158|470716857|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
130753143|NCT02147158|470716858|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
130753144|NCT02147158|470716859|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
130753145|NCT02147158|470716860|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
130753146|NCT02147158|470716855|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
130753147|NCT02147158|470716856|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
130753148|NCT02147158|470716857|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
130753149|NCT02147158|470716858|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
130753150|NCT02147158|470716859|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
130753151|NCT02147158|470716860|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
130753152|NCT02147158|470716855|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
130753153|NCT02147158|470716856|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
130753154|NCT02147158|470716857|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
130753155|NCT02147158|470716858|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
130753156|NCT02147158|470716859|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
130753157|NCT02147158|470716860|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
130753158|NCT03425396|470716861|FG000|Overall Study|Lost to Follow-up|2|||
130753159|NCT03425396|470716862|FG001|Overall Study|Lost to Follow-up|5|||
130788716|NCT03225287|470854635|FG000|Overall Study|Adverse Event|0|||
130753160|NCT03425396|470716863|FG002|Overall Study|Lost to Follow-up|2|||
130753161|NCT03425396|470716864|FG003|Overall Study|Lost to Follow-up|0|||
130753162|NCT03425396|470716865|FG004|Overall Study|Lost to Follow-up|0|||
130753163|NCT03425396|470716861|FG000|Overall Study|Withdrawal by Subject|0|||
130753164|NCT03425396|470716862|FG001|Overall Study|Withdrawal by Subject|1|||
130753165|NCT03425396|470716863|FG002|Overall Study|Withdrawal by Subject|0|||
130753166|NCT03425396|470716864|FG003|Overall Study|Withdrawal by Subject|1|||
130753167|NCT03425396|470716865|FG004|Overall Study|Withdrawal by Subject|0|||
130753168|NCT03425396|470716861|FG000|Overall Study|Other|0|||
130753169|NCT03425396|470716862|FG001|Overall Study|Other|1|||
130753170|NCT03425396|470716863|FG002|Overall Study|Other|1|||
130753171|NCT03425396|470716864|FG003|Overall Study|Other|0|||
130753172|NCT03425396|470716865|FG004|Overall Study|Other|1|||
130753173|NCT01441765|470716866|FG000|Overall Study|Death|1|||
130753174|NCT01441765|470716867|FG001|Overall Study|Death|0|||
130753175|NCT04520997|470716869|FG000|Overall Study|Lost to Follow-up|1|||
130753176|NCT04520997|470716870|FG001|Overall Study|Lost to Follow-up|1|||
130753177|NCT04520997|470716869|FG000|Overall Study|Withdrawal by Subject|1|||
130753178|NCT04520997|470716870|FG001|Overall Study|Withdrawal by Subject|0|||
130753179|NCT04520997|470716869|FG000|Overall Study|Not Treated|0|||
130753180|NCT04520997|470716870|FG001|Overall Study|Not Treated|1|||
130753181|NCT02981082|470716873|FG000|Overall Study|Withdrawal by Subject|2|||
130753182|NCT02981082|470716874|FG001|Overall Study|Withdrawal by Subject|0|||
130753183|NCT02981082|470716873|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
130753184|NCT02981082|470716874|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
130753185|NCT02981082|470716873|FG000|Overall Study|Adverse Event|0|||
130753186|NCT02981082|470716874|FG001|Overall Study|Adverse Event|1|||
130753187|NCT03689374|470716875|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
130753188|NCT03689374|470716876|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
130753189|NCT03689374|470716877|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
130753190|NCT03689374|470716875|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
130753191|NCT03689374|470716876|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
130753192|NCT03689374|470716877|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
130753193|NCT03689374|470716875|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
130753194|NCT03689374|470716876|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
130753195|NCT03689374|470716877|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
130753196|NCT03689374|470716875|FG000|Treatment Period (Week 0 to 52)|Death|0|||
130753197|NCT03689374|470716876|FG001|Treatment Period (Week 0 to 52)|Death|11|||
130753198|NCT03689374|470716877|FG002|Treatment Period (Week 0 to 52)|Death|1|||
130753199|NCT05367973|470716878|FG000|Overall Study|Adverse Event|0|||
130753200|NCT05367973|470716879|FG001|Overall Study|Adverse Event|2|||
130753201|NCT02805660|470716880|FG000|Overall Study|Death|5|||
130753202|NCT02805660|470716881|FG001|Overall Study|Death|2|||
130753203|NCT02805660|470716882|FG002|Overall Study|Death|9|||
130753204|NCT02805660|470716883|FG003|Overall Study|Death|5|||
130753205|NCT02805660|470716884|FG004|Overall Study|Death|0|||
130753206|NCT02805660|470716885|FG005|Overall Study|Death|14|||
130753207|NCT02805660|470716886|FG006|Overall Study|Death|12|||
130753208|NCT02805660|470716880|FG000|Overall Study|Lost to Follow-up|0|||
130753209|NCT02805660|470716881|FG001|Overall Study|Lost to Follow-up|1|||
130753210|NCT02805660|470716882|FG002|Overall Study|Lost to Follow-up|1|||
130753211|NCT02805660|470716883|FG003|Overall Study|Lost to Follow-up|2|||
130753212|NCT02805660|470716884|FG004|Overall Study|Lost to Follow-up|0|||
130753213|NCT02805660|470716885|FG005|Overall Study|Lost to Follow-up|0|||
130753214|NCT02805660|470716886|FG006|Overall Study|Lost to Follow-up|0|||
130753215|NCT02805660|470716880|FG000|Overall Study|Withdrawal by Subject|0|||
130753216|NCT02805660|470716881|FG001|Overall Study|Withdrawal by Subject|0|||
130753217|NCT02805660|470716882|FG002|Overall Study|Withdrawal by Subject|0|||
130753218|NCT02805660|470716883|FG003|Overall Study|Withdrawal by Subject|3|||
130753219|NCT02805660|470716884|FG004|Overall Study|Withdrawal by Subject|1|||
130788717|NCT03225287|470854636|FG001|Overall Study|Adverse Event|0|||
130788718|NCT03225287|470854637|FG002|Overall Study|Adverse Event|1|||
130788719|NCT03225287|470854635|FG000|Overall Study|Protocol non-compliance|0|||
130788720|NCT03225287|470854636|FG001|Overall Study|Protocol non-compliance|0|||
130788721|NCT03225287|470854637|FG002|Overall Study|Protocol non-compliance|1|||
130788722|NCT03225287|470854635|FG000|Overall Study|Subject withdraws consent|3|||
130788723|NCT03225287|470854636|FG001|Overall Study|Subject withdraws consent|0|||
130788724|NCT03225287|470854637|FG002|Overall Study|Subject withdraws consent|0|||
130753220|NCT02805660|470716885|FG005|Overall Study|Withdrawal by Subject|0|||
130753221|NCT02805660|470716886|FG006|Overall Study|Withdrawal by Subject|2|||
130753222|NCT02805660|470716880|FG000|Overall Study|Study terminated by Sponsor|0|||
130753223|NCT02805660|470716881|FG001|Overall Study|Study terminated by Sponsor|0|||
130753224|NCT02805660|470716882|FG002|Overall Study|Study terminated by Sponsor|1|||
130753225|NCT02805660|470716883|FG003|Overall Study|Study terminated by Sponsor|4|||
130753226|NCT02805660|470716884|FG004|Overall Study|Study terminated by Sponsor|2|||
130753227|NCT02805660|470716885|FG005|Overall Study|Study terminated by Sponsor|3|||
130753228|NCT02805660|470716886|FG006|Overall Study|Study terminated by Sponsor|1|||
130753229|NCT02805660|470716880|FG000|Overall Study|Miscellaneous|0|||
130753230|NCT02805660|470716881|FG001|Overall Study|Miscellaneous|1|||
130753231|NCT02805660|470716882|FG002|Overall Study|Miscellaneous|0|||
130753232|NCT02805660|470716883|FG003|Overall Study|Miscellaneous|4|||
130753233|NCT02805660|470716884|FG004|Overall Study|Miscellaneous|0|||
130753234|NCT02805660|470716885|FG005|Overall Study|Miscellaneous|6|||
130753235|NCT02805660|470716886|FG006|Overall Study|Miscellaneous|4|||
130753236|NCT00809471|470718074|FG000|Overall Study|Protocol non-compliance|15|||
130753237|NCT00809471|470718075|FG001|Overall Study|Protocol non-compliance|15|||
130753238|NCT00809471|470718076|FG002|Overall Study|Protocol non-compliance|6|||
130753239|NCT00809471|470718074|FG000|Overall Study|Lost to Follow-up|4|||
130753240|NCT00809471|470718075|FG001|Overall Study|Lost to Follow-up|2|||
130753241|NCT00809471|470718076|FG002|Overall Study|Lost to Follow-up|9|||
130753242|NCT00809471|470718074|FG000|Overall Study|Adverse Event|0|||
130753243|NCT00809471|470718075|FG001|Overall Study|Adverse Event|2|||
130753244|NCT00809471|470718076|FG002|Overall Study|Adverse Event|2|||
130753245|NCT00809471|470718074|FG000|Overall Study|Requirement for restricted medication|1|||
130753246|NCT00809471|470718075|FG001|Overall Study|Requirement for restricted medication|1|||
130753247|NCT00809471|470718076|FG002|Overall Study|Requirement for restricted medication|0|||
130753248|NCT00831311|470718077|FG000|Overall Study|Definitive Contraindication|3|||
130788725|NCT03225287|470854635|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
130788726|NCT03225287|470854636|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
130753249|NCT00831311|470718078|FG001|Overall Study|Definitive Contraindication|3|||
130753250|NCT00831311|470718077|FG000|Overall Study|Lost to Follow-up|3|||
130788727|NCT03225287|470854637|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
130788728|NCT03225287|470854635|FG000|Overall Study|Trial drug not effective|0|||
130788729|NCT03225287|470854636|FG001|Overall Study|Trial drug not effective|1|||
130788730|NCT03225287|470854637|FG002|Overall Study|Trial drug not effective|0|||
130788731|NCT03225287|470854635|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
130788732|NCT03225287|470854636|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
130788733|NCT03225287|470854637|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
130788734|NCT03225287|470854635|FG000|Overall Study|Stem cell transplantation|0|||
130788735|NCT03225287|470854636|FG001|Overall Study|Stem cell transplantation|1|||
130788736|NCT03225287|470854637|FG002|Overall Study|Stem cell transplantation|0|||
130753251|NCT00831311|470718078|FG001|Overall Study|Lost to Follow-up|0|||
130753252|NCT00831311|470718077|FG000|Overall Study|Physician Decision|0|||
130753253|NCT00831311|470718078|FG001|Overall Study|Physician Decision|1|||
130753254|NCT00831311|470718077|FG000|Overall Study|Withdrawal by Subject|6|||
130753255|NCT00831311|470718078|FG001|Overall Study|Withdrawal by Subject|4|||
130753256|NCT01868438|470718079|FG000|First Intervention|Withdrawal by Subject|5|||
130753257|NCT01868438|470718080|FG001|First Intervention|Withdrawal by Subject|1|||
130788737|NCT06996301|470854639|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
130753258|NCT01868438|470718079|FG000|First Intervention|Lost to Follow-up|2|||
130788738|NCT06996301|470854640|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
130788739|NCT06996301|470854639|FG000|Overall Study|Patients with discordant diagnostic results|107|||
130753259|NCT01868438|470718080|FG001|First Intervention|Lost to Follow-up|3|||
130753260|NCT01868438|470718079|FG000|First Intervention|Meeting the non-redosing criteria|0|||
130753261|NCT01868438|470718080|FG001|First Intervention|Meeting the non-redosing criteria|1|||
130753262|NCT01868438|470718079|FG000|Second Intervention|Adverse Event|3|||
130753263|NCT01868438|470718080|FG001|Second Intervention|Adverse Event|3|||
130753264|NCT00956592|470718081|FG000|Overall Study|Protocol Violation|1|||
130753265|NCT00956592|470718082|FG001|Overall Study|Protocol Violation|3|||
130753266|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
130753267|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
130753268|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
130753269|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
130753270|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
130753271|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
130753272|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
130753273|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
130753274|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Death|0|||
130753275|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Death|1|||
130753276|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
130753277|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
130788740|NCT06996301|470854640|FG001|Overall Study|Patients with discordant diagnostic results|90|||
130788741|NCT06996301|470854639|FG000|Overall Study|Lost to Follow-up|31|||
130753278|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
130753279|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
130753280|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
130753281|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
130753282|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
130753283|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
130788742|NCT06996301|470854640|FG001|Overall Study|Lost to Follow-up|56|||
130753284|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
130753285|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
130753286|NCT00394836|470718085|FG000|Teatment or Follow-up Phase|Non compliance|0|||
130753287|NCT00394836|470718086|FG001|Teatment or Follow-up Phase|Non compliance|1|||
130753288|NCT00394836|470718085|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
130753289|NCT00394836|470718086|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
130753290|NCT00394836|470718085|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
130753291|NCT00394836|470718086|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
130753292|NCT00394836|470718085|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
130753293|NCT00394836|470718086|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
130753294|NCT00394836|470718085|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
130753295|NCT00394836|470718086|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
130753296|NCT02028767|470718087|FG000|Treatment Period 2|Non compliant with protocol|1|||
130753297|NCT02028767|470718088|FG001|Treatment Period 2|Non compliant with protocol|0|||
130753298|NCT02028767|470718087|FG000|Treatment Period 2|Reason other than those specified above|1|||
130753299|NCT02028767|470718088|FG001|Treatment Period 2|Reason other than those specified above|0|||
130753300|NCT05338502|470718091|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
130753301|NCT05338502|470718092|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
130753302|NCT05338502|470718093|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
130753303|NCT05338502|470718091|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
130753304|NCT05338502|470718092|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
130753305|NCT05338502|470718093|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
130753306|NCT03575793|470718094|FG000|Overall Study|Withdrawal by Subject|0|||
130753307|NCT03575793|470718095|FG001|Overall Study|Withdrawal by Subject|1|||
130753308|NCT03575793|470718094|FG000|Overall Study|Never Treated|0|||
130753309|NCT03575793|470718095|FG001|Overall Study|Never Treated|2|||
130753310|NCT01250873|470718096|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
130753311|NCT01250873|470718096|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
130753312|NCT02278939|470718097|FG000|Overall Study|lack of time|1|||
130753313|NCT02278939|470718098|FG001|Overall Study|lack of time|0|||
130753314|NCT02278939|470718097|FG000|Overall Study|Lost to Follow-up|1|||
130753315|NCT02278939|470718098|FG001|Overall Study|Lost to Follow-up|1|||
130753316|NCT02278939|470718097|FG000|Overall Study|death in family|1|||
130753317|NCT02278939|470718098|FG001|Overall Study|death in family|0|||
130753318|NCT02278939|470718097|FG000|Overall Study|family emergency unable to commit|2|||
130753319|NCT02278939|470718098|FG001|Overall Study|family emergency unable to commit|0|||
130753320|NCT03436693|470718101|FG000|Overall Study|Adverse Event|22|||
130753321|NCT03436693|470718102|FG001|Overall Study|Adverse Event|10|||
130753322|NCT03436693|470718101|FG000|Overall Study|Physician Decision|3|||
130753323|NCT03436693|470718102|FG001|Overall Study|Physician Decision|3|||
130753324|NCT03436693|470718101|FG000|Overall Study|Withdrawal by Subject|4|||
130753325|NCT03436693|470718102|FG001|Overall Study|Withdrawal by Subject|13|||
130753326|NCT03436693|470718101|FG000|Overall Study|Progressive Disease|1|||
130753327|NCT03436693|470718102|FG001|Overall Study|Progressive Disease|1|||
130753328|NCT01680861|470718103|FG000|Early Post-transplant Period|Protocol Violation|1|||
130753329|NCT01680861|470718104|FG001|Early Post-transplant Period|Protocol Violation|1|||
130753330|NCT02111577|470718105|FG000|Overall Study|Protocol Violation|2|||
130753331|NCT02111577|470718106|FG001|Overall Study|Protocol Violation|0|||
130753332|NCT02111577|470718105|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
130753333|NCT02111577|470718106|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
130788743|NCT06996301|470854639|FG000|Overall Study|Withdrawal by Subject|12|||
130788744|NCT06996301|470854640|FG001|Overall Study|Withdrawal by Subject|7|||
130788745|NCT04030598|470854641|FG000|Overall Study|Voluntary Withdrawal|0|||
130788746|NCT04030598|470854642|FG001|Overall Study|Voluntary Withdrawal|1|||
130788747|NCT04030598|470854643|FG002|Overall Study|Voluntary Withdrawal|0|||
130788748|NCT02097823|470854646|FG000|Overall Study|Withdrawal by Subject|1|||
130788749|NCT02097823|470854647|FG001|Overall Study|Withdrawal by Subject|1|||
130788750|NCT00666237|470854652|FG000|Overall Study|Death|5|||
130788751|NCT00666237|470854653|FG001|Overall Study|Death|5|||
130788752|NCT00666237|470854652|FG000|Overall Study|Lost to Follow-up|29|||
130788753|NCT00666237|470854653|FG001|Overall Study|Lost to Follow-up|25|||
130788754|NCT00959751|470856644|FG000|Overall Study|Lost to Follow-up|2|||
130788755|NCT00959751|470856645|FG001|Overall Study|Lost to Follow-up|3|||
130788756|NCT00959751|470856644|FG000|Overall Study|Consent Withdrawn|0|||
130753334|NCT02111577|470718105|FG000|Overall Study|Failure to produce study treatment|6|||
130753335|NCT02111577|470718106|FG001|Overall Study|Failure to produce study treatment|0|||
130753336|NCT02111577|470718105|FG000|Overall Study|Death|518|||
130753337|NCT02111577|470718106|FG001|Overall Study|Death|254|||
130753338|NCT02111577|470718105|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
130753339|NCT02111577|470718106|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
130753340|NCT02111577|470718105|FG000|Overall Study|Adverse Event|1|||
130753341|NCT02111577|470718106|FG001|Overall Study|Adverse Event|1|||
130753342|NCT02111577|470718105|FG000|Overall Study|Withdrawal by Subject|51|||
130753343|NCT02111577|470718106|FG001|Overall Study|Withdrawal by Subject|23|||
130753344|NCT02111577|470718105|FG000|Overall Study|Disease progression|0|||
130753345|NCT02111577|470718106|FG001|Overall Study|Disease progression|1|||
130753346|NCT02111577|470718105|FG000|Overall Study|Lost to Follow-up|19|||
130753347|NCT02111577|470718106|FG001|Overall Study|Lost to Follow-up|10|||
130753348|NCT04967885|470718107|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
130753349|NCT04967885|470718108|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
130753350|NCT04967885|470718107|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
130753351|NCT04967885|470718108|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
130753352|NCT04967885|470718107|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
130753353|NCT04967885|470718108|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
130753354|NCT04967885|470718107|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
130753355|NCT04967885|470718108|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
130753356|NCT04967885|470718107|FG000|EMI-II Intervention|Lost to Follow-up|14|||
130753357|NCT04967885|470718108|FG001|EMI-II Intervention|Lost to Follow-up|10|||
130753358|NCT00654875|470718109|FG000|Overall Study|Adverse Event|5|||
130753359|NCT00654875|470718110|FG001|Overall Study|Adverse Event|5|||
130753360|NCT00654875|470718109|FG000|Overall Study|Withdrawal by Subject|4|||
130753361|NCT00654875|470718110|FG001|Overall Study|Withdrawal by Subject|4|||
130753362|NCT00654875|470718109|FG000|Overall Study|Protocol Violation|3|||
130753363|NCT00654875|470718110|FG001|Overall Study|Protocol Violation|3|||
130753364|NCT00654875|470718109|FG000|Overall Study|Lack of Efficacy|2|||
130753365|NCT00654875|470718110|FG001|Overall Study|Lack of Efficacy|2|||
130788757|NCT00959751|470856645|FG001|Overall Study|Consent Withdrawn|1|||
130788758|NCT00959751|470856644|FG000|Overall Study|Non-compliance to Study Procedures|0|||
130788759|NCT00959751|470856645|FG001|Overall Study|Non-compliance to Study Procedures|1|||
130788760|NCT00959751|470856644|FG000|Overall Study|No migraine headache without aura|7|||
130788761|NCT00959751|470856645|FG001|Overall Study|No migraine headache without aura|7|||
130753366|NCT00654875|470718109|FG000|Overall Study|Lost to Follow-up|1|||
130753367|NCT00654875|470718110|FG001|Overall Study|Lost to Follow-up|3|||
130753368|NCT00654875|470718109|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130753369|NCT00654875|470718110|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130753370|NCT00654875|470718109|FG000|Overall Study|Administrative Problems|1|||
130753371|NCT00654875|470718110|FG001|Overall Study|Administrative Problems|0|||
130753372|NCT02042950|470718113|FG000|Overall Study|Progressive Disease|4|||
130753373|NCT00886743|470718116|FG000|Overall Study|Adverse Event|3|||
130753374|NCT00886743|470718116|FG000|Overall Study|Other|1|||
130753375|NCT01940887|470718117|FG000|Year 1|Protocol Violation|0|||
130753376|NCT01940887|470718118|FG001|Year 1|Protocol Violation|1|||
130753377|NCT01940887|470718117|FG000|Year 1|Physician Decision|7|||
130753378|NCT01940887|470718118|FG001|Year 1|Physician Decision|3|||
130753379|NCT01940887|470718117|FG000|Year 1|Death|5|||
130753380|NCT01940887|470718118|FG001|Year 1|Death|3|||
130753381|NCT01940887|470718117|FG000|Year 1|Adverse Event|7|||
130753382|NCT01940887|470718118|FG001|Year 1|Adverse Event|6|||
130753383|NCT01940887|470718117|FG000|Year 1|Withdrawal by Subject|18|||
130753384|NCT01940887|470718118|FG001|Year 1|Withdrawal by Subject|9|||
130753385|NCT01940887|470718117|FG000|Year 1|Lost to Follow-up|2|||
130753386|NCT01940887|470718118|FG001|Year 1|Lost to Follow-up|1|||
130753387|NCT01940887|470718117|FG000|Year 2|Physician Decision|8|||
130753388|NCT01940887|470718118|FG001|Year 2|Physician Decision|1|||
130753389|NCT01940887|470718117|FG000|Year 2|Death|0|||
130753390|NCT01940887|470718118|FG001|Year 2|Death|2|||
130753391|NCT01940887|470718117|FG000|Year 2|Sponsor Decision, early termination|192|||
130753392|NCT01940887|470718118|FG001|Year 2|Sponsor Decision, early termination|203|||
130753393|NCT01940887|470718117|FG000|Year 2|Adverse Event|8|||
130753394|NCT01940887|470718118|FG001|Year 2|Adverse Event|2|||
130753395|NCT01940887|470718117|FG000|Year 2|Withdrawal by Subject|8|||
130753396|NCT01940887|470718118|FG001|Year 2|Withdrawal by Subject|8|||
130753397|NCT01940887|470718117|FG000|Year 2|Lost to Follow-up|1|||
130753398|NCT01940887|470718118|FG001|Year 2|Lost to Follow-up|6|||
130753399|NCT02429778|470718120|FG000|Overall Study|Lost to Follow-up|2|||
130753400|NCT02429778|470718121|FG001|Overall Study|Lost to Follow-up|0|||
130753401|NCT02429778|470718120|FG000|Overall Study|Withdrawal by Subject|5|||
130753402|NCT02429778|470718121|FG001|Overall Study|Withdrawal by Subject|0|||
130753403|NCT04791319|470718125|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
130753404|NCT04791319|470718126|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
130753405|NCT04791319|470718127|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
130753406|NCT04791319|470718128|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
130753407|NCT04791319|470718129|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130753408|NCT04791319|470718130|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130753409|NCT04791319|470718131|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130753410|NCT04791319|470718132|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130753411|NCT04791319|470718133|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130753412|NCT04791319|470718134|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130753413|NCT04791319|470718135|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130788762|NCT00900562|470856648|FG000|Overall Study|Progressive disease|9|||
130788763|NCT00900562|470856649|FG001|Overall Study|Progressive disease|5|||
130788764|NCT00900562|470856648|FG000|Overall Study|Toxicity|1|||
130788765|NCT00900562|470856649|FG001|Overall Study|Toxicity|0|||
130788766|NCT00900562|470856648|FG000|Overall Study|Death|1|||
130788767|NCT00900562|470856649|FG001|Overall Study|Death|1|||
130788768|NCT00900562|470856648|FG000|Overall Study|Withdrawal by Subject|0|||
130788769|NCT00900562|470856649|FG001|Overall Study|Withdrawal by Subject|1|||
130753414|NCT04791319|470718125|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
130753415|NCT04791319|470718126|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130753416|NCT04791319|470718127|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
130753417|NCT04791319|470718128|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
130753418|NCT04791319|470718129|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130753419|NCT04791319|470718130|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130788770|NCT00900562|470856648|FG000|Overall Study|Unrelated adverse event|1|||
130788771|NCT00900562|470856649|FG001|Overall Study|Unrelated adverse event|0|||
130788772|NCT04459338|470856650|FG000|Overall Study|Loss of IV during study|1|||
130788773|NCT04459338|470856651|FG001|Overall Study|Loss of IV during study|0|||
130788774|NCT01454284|470856652|FG000|Overall Study|Adverse Event|20|||
130788775|NCT01454284|470856653|FG001|Overall Study|Adverse Event|7|||
130788776|NCT01454284|470856652|FG000|Overall Study|Death|0|||
130788777|NCT01454284|470856653|FG001|Overall Study|Death|3|||
130788778|NCT01454284|470856652|FG000|Overall Study|Lost to Follow-up|13|||
130788779|NCT01454284|470856653|FG001|Overall Study|Lost to Follow-up|8|||
130788780|NCT01454284|470856652|FG000|Overall Study|Protocol Violation|9|||
130788781|NCT01454284|470856653|FG001|Overall Study|Protocol Violation|6|||
130788782|NCT01454284|470856652|FG000|Overall Study|Withdrawal by Subject|58|||
130788783|NCT01454284|470856653|FG001|Overall Study|Withdrawal by Subject|36|||
130788784|NCT01454284|470856652|FG000|Overall Study|Physician Decision|16|||
130788785|NCT01454284|470856653|FG001|Overall Study|Physician Decision|11|||
130788786|NCT01454284|470856652|FG000|Overall Study|Sponsor Decision|0|||
130788787|NCT01454284|470856653|FG001|Overall Study|Sponsor Decision|2|||
130788788|NCT02665117|470856654|FG000|Overall Study|Physician Decision|1|||
130788789|NCT02665117|470856655|FG001|Overall Study|Physician Decision|0|||
130788790|NCT01829347|470856663|FG000|VTI-210|Death|5|||
130788791|NCT01829347|470856664|FG001|VTI-210|Death|3|||
130788792|NCT01829347|470856663|FG000|VTI-210|Withdrawal by Subject|1|||
130788793|NCT01829347|470856664|FG001|VTI-210|Withdrawal by Subject|0|||
130788794|NCT01829347|470856663|FG000|VTI-210E|Death|2|||
130788795|NCT01829347|470856664|FG001|VTI-210E|Death|1|||
130788796|NCT01829347|470856663|FG000|VTI-210E|Study terminated prematurely|1|||
130788797|NCT01829347|470856664|FG001|VTI-210E|Study terminated prematurely|5|||
130788798|NCT04018066|470856665|FG000|Overall Study|participants started taking medications during the study period|3|||
130788799|NCT04018066|470856665|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
130788800|NCT03817528|470856666|FG000|Overall Study|Withdrawal by Subject|1|||
130788801|NCT03817528|470856666|FG000|Overall Study|Adverse Event|2|||
130788802|NCT03451071|470856672|FG000|First Vaccine|Withdrawal by Subject|1|||
130788803|NCT03451071|470856672|FG000|Second Vaccine|Lost to Follow-up|19|||
130788804|NCT03451071|470856672|FG000|Third Vaccine|Lost to Follow-up|22|||
130788805|NCT03451071|470856672|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
130788806|NCT02065557|470856673|FG000|Induction Period|Withdrawal by Subject|2|||
130788807|NCT02065557|470856674|FG001|Induction Period|Withdrawal by Subject|1|||
130788808|NCT02065557|470856675|FG002|Induction Period|Withdrawal by Subject|0|||
130788809|NCT02065557|470856676|FG003|Induction Period|Withdrawal by Subject|0|||
130788810|NCT02065557|470856677|FG004|Induction Period|Withdrawal by Subject|0|||
130788811|NCT02065557|470856678|FG005|Induction Period|Withdrawal by Subject|0|||
130788812|NCT02065557|470856673|FG000|Induction Period|Lack of Efficacy|2|||
130788813|NCT02065557|470856674|FG001|Induction Period|Lack of Efficacy|1|||
130788814|NCT02065557|470856675|FG002|Induction Period|Lack of Efficacy|1|||
130788815|NCT02065557|470856676|FG003|Induction Period|Lack of Efficacy|0|||
130788816|NCT02065557|470856677|FG004|Induction Period|Lack of Efficacy|0|||
130788817|NCT02065557|470856678|FG005|Induction Period|Lack of Efficacy|0|||
130788818|NCT02065557|470856673|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
130788819|NCT02065557|470856674|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
130788820|NCT02065557|470856675|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
130788821|NCT02065557|470856676|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
130788822|NCT02065557|470856677|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
130788823|NCT02065557|470856678|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
130788824|NCT02065557|470856673|FG000|Induction Period|Non-Responder at Week 8|4|||
130788825|NCT02065557|470856674|FG001|Induction Period|Non-Responder at Week 8|4|||
130788826|NCT02065557|470856675|FG002|Induction Period|Non-Responder at Week 8|0|||
130788827|NCT02065557|470856676|FG003|Induction Period|Non-Responder at Week 8|0|||
130788828|NCT02065557|470856677|FG004|Induction Period|Non-Responder at Week 8|0|||
130753420|NCT04791319|470718131|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130753421|NCT04791319|470718132|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130753422|NCT04791319|470718133|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130753423|NCT04791319|470718134|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130753424|NCT04791319|470718135|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130753425|NCT04791319|470718125|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
130753426|NCT04791319|470718126|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
130753427|NCT04791319|470718127|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
130753428|NCT04791319|470718128|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
130753429|NCT04791319|470718129|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130753430|NCT04791319|470718130|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130753431|NCT04791319|470718131|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130788829|NCT02065557|470856678|FG005|Induction Period|Non-Responder at Week 8|0|||
130788830|NCT02065557|470856673|FG000|Induction Period|Adverse Event|1|||
130788831|NCT02065557|470856674|FG001|Induction Period|Adverse Event|1|||
130788832|NCT02065557|470856675|FG002|Induction Period|Adverse Event|0|||
130788833|NCT02065557|470856676|FG003|Induction Period|Adverse Event|0|||
130788834|NCT02065557|470856677|FG004|Induction Period|Adverse Event|0|||
130788835|NCT02065557|470856678|FG005|Induction Period|Adverse Event|0|||
130788836|NCT02065557|470856673|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130788837|NCT02065557|470856674|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130788838|NCT02065557|470856675|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130788839|NCT02065557|470856676|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
130788840|NCT02065557|470856677|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
130788841|NCT02065557|470856678|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130788842|NCT02065557|470856673|FG000|Maintenance Period|Withdrawal by Subject|0|||
130788843|NCT02065557|470856674|FG001|Maintenance Period|Withdrawal by Subject|0|||
130788844|NCT02065557|470856675|FG002|Maintenance Period|Withdrawal by Subject|0|||
130788845|NCT02065557|470856676|FG003|Maintenance Period|Withdrawal by Subject|0|||
130788846|NCT02065557|470856677|FG004|Maintenance Period|Withdrawal by Subject|2|||
130788847|NCT02065557|470856678|FG005|Maintenance Period|Withdrawal by Subject|1|||
130788848|NCT02065557|470856673|FG000|Maintenance Period|Lack of Efficacy|0|||
130788849|NCT02065557|470856674|FG001|Maintenance Period|Lack of Efficacy|0|||
130788850|NCT02065557|470856675|FG002|Maintenance Period|Lack of Efficacy|0|||
130788851|NCT02065557|470856676|FG003|Maintenance Period|Lack of Efficacy|0|||
130788852|NCT02065557|470856677|FG004|Maintenance Period|Lack of Efficacy|5|||
130788853|NCT02065557|470856678|FG005|Maintenance Period|Lack of Efficacy|2|||
130788854|NCT02065557|470856673|FG000|Maintenance Period|Subject Non-Compliance|0|||
130788855|NCT02065557|470856674|FG001|Maintenance Period|Subject Non-Compliance|0|||
130788856|NCT02065557|470856675|FG002|Maintenance Period|Subject Non-Compliance|0|||
130788857|NCT02065557|470856676|FG003|Maintenance Period|Subject Non-Compliance|0|||
130788858|NCT02065557|470856677|FG004|Maintenance Period|Subject Non-Compliance|0|||
130788859|NCT02065557|470856678|FG005|Maintenance Period|Subject Non-Compliance|1|||
130788860|NCT00250588|470856679|FG000|Overall Study|Withdrawal by Subject|3|||
130788861|NCT00250588|470856680|FG001|Overall Study|Withdrawal by Subject|6|||
130788862|NCT00250588|470856681|FG002|Overall Study|Withdrawal by Subject|0|||
130788863|NCT00250588|470856679|FG000|Overall Study|Lost to Follow-up|6|||
130788864|NCT00250588|470856680|FG001|Overall Study|Lost to Follow-up|13|||
130788865|NCT00250588|470856681|FG002|Overall Study|Lost to Follow-up|13|||
130788866|NCT03502798|470856682|FG000|Overall Study|equipment failure|0|||
130788867|NCT03502798|470856683|FG001|Overall Study|equipment failure|7|||
130788868|NCT00485303|470856684|FG000|Overall Study|Adverse Event|5|||
130788869|NCT00485303|470856684|FG000|Overall Study|Progressive Disease|44|||
130788870|NCT00485303|470856684|FG000|Overall Study|Other|3|||
130788871|NCT00485303|470856684|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
130788872|NCT00485303|470856684|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
130788873|NCT00296335|470856687|FG000|Overall Study|Recurrence|3|||
130788874|NCT00296335|470856688|FG001|Overall Study|Recurrence|51|||
130788875|NCT00296335|470856687|FG000|Overall Study|Adverse Event|17|||
130788876|NCT00296335|470856688|FG001|Overall Study|Adverse Event|27|||
130788877|NCT00296335|470856687|FG000|Overall Study|Lost to Follow-up|7|||
130788878|NCT00296335|470856688|FG001|Overall Study|Lost to Follow-up|33|||
130788879|NCT00296335|470856687|FG000|Overall Study|Physician Decision|3|||
130788880|NCT00296335|470856688|FG001|Overall Study|Physician Decision|11|||
130788881|NCT01401322|470856689|FG000|Overall Study|Withdrawal by Subject|1|||
130788882|NCT01401322|470856689|FG000|Overall Study|Physician Decision|1|||
130788883|NCT02737722|470856690|FG000|Overall Study|Physician Decision|0|||
130788884|NCT02737722|470856691|FG001|Overall Study|Physician Decision|0|||
130788885|NCT02737722|470856692|FG002|Overall Study|Physician Decision|1|||
130788886|NCT02737722|470856693|FG003|Overall Study|Physician Decision|0|||
130788887|NCT00112957|470856694|FG000|Overall Study|Progressive disease|18|||
130788888|NCT00112957|470856694|FG000|Overall Study|Physician Decision|1|||
130788889|NCT03444584|470856700|FG000|Overall Study|Withdrawal by Subject|0|||
130788890|NCT03444584|470856701|FG001|Overall Study|Withdrawal by Subject|1|||
130788891|NCT03444584|470856700|FG000|Overall Study|Other|0|||
130788892|NCT03444584|470856701|FG001|Overall Study|Other|1|||
130788893|NCT03704064|470856702|FG000|Overall Study|Lost to Follow-up|8|||
130788894|NCT03704064|470856703|FG001|Overall Study|Lost to Follow-up|4|||
130788895|NCT03704064|470856702|FG000|Overall Study|Withdrawal by Subject|1|||
130788896|NCT03704064|470856703|FG001|Overall Study|Withdrawal by Subject|1|||
130788897|NCT03704064|470856702|FG000|Overall Study|No longer available for study visits|0|||
130788898|NCT03704064|470856703|FG001|Overall Study|No longer available for study visits|1|||
130788899|NCT03704064|470856702|FG000|Overall Study|Censoring event|1|||
130788900|NCT03704064|470856703|FG001|Overall Study|Censoring event|0|||
130788901|NCT04142242|470856704|FG000|Stage I|Non-compliance with the protocol|1|||
130788902|NCT04142242|470856705|FG001|Stage I|Non-compliance with the protocol|0|||
130788903|NCT04142242|470856706|FG002|Stage I|Non-compliance with the protocol|0|||
130788904|NCT04142242|470856707|FG003|Stage I|Non-compliance with the protocol|0|||
130788905|NCT04142242|470856708|FG004|Stage I|Non-compliance with the protocol|0|||
130788906|NCT04142242|470856709|FG005|Stage I|Non-compliance with the protocol|1|||
130753432|NCT04791319|470718132|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130753433|NCT04791319|470718133|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130753434|NCT04791319|470718134|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130753435|NCT04791319|470718135|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130753436|NCT04791319|470718125|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
130753437|NCT04791319|470718126|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
130753438|NCT04791319|470718127|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
130753439|NCT04791319|470718128|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
130753440|NCT04791319|470718129|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130753441|NCT04791319|470718130|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130753442|NCT04791319|470718131|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130753443|NCT04791319|470718132|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130753444|NCT04791319|470718133|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130753445|NCT04791319|470718134|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130753446|NCT04791319|470718135|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130753447|NCT04791319|470718125|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130753448|NCT04791319|470718126|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130753449|NCT04791319|470718127|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130753450|NCT04791319|470718128|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
130753451|NCT04791319|470718129|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130753452|NCT04791319|470718130|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130753453|NCT04791319|470718131|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130753454|NCT04791319|470718132|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130753455|NCT04791319|470718133|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130753456|NCT04791319|470718134|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130753457|NCT04791319|470718135|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130753458|NCT04791319|470718125|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130753459|NCT04791319|470718126|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130753460|NCT04791319|470718127|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130753461|NCT04791319|470718128|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130753462|NCT04791319|470718129|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
130788907|NCT04142242|470856704|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130788908|NCT04142242|470856705|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
130788909|NCT04142242|470856706|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130788910|NCT04142242|470856707|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130788911|NCT04142242|470856708|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130788912|NCT04142242|470856709|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130788913|NCT04142242|470856704|FG000|Stage II|Non-compliance with the protocol|0|||
130788914|NCT04142242|470856705|FG001|Stage II|Non-compliance with the protocol|0|||
130788915|NCT04142242|470856706|FG002|Stage II|Non-compliance with the protocol|0|||
130788916|NCT04142242|470856707|FG003|Stage II|Non-compliance with the protocol|2|||
130788917|NCT04142242|470856708|FG004|Stage II|Non-compliance with the protocol|0|||
130788918|NCT04142242|470856709|FG005|Stage II|Non-compliance with the protocol|0|||
130788919|NCT04142242|470856704|FG000|Stage II|Lost to Follow-up|0|||
130788920|NCT04142242|470856705|FG001|Stage II|Lost to Follow-up|0|||
130788921|NCT04142242|470856706|FG002|Stage II|Lost to Follow-up|1|||
130788922|NCT04142242|470856707|FG003|Stage II|Lost to Follow-up|2|||
130788923|NCT04142242|470856708|FG004|Stage II|Lost to Follow-up|0|||
130788924|NCT04142242|470856709|FG005|Stage II|Lost to Follow-up|0|||
130753463|NCT04791319|470718130|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
130753464|NCT04791319|470718131|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
130753465|NCT04791319|470718132|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130753466|NCT04791319|470718133|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130753467|NCT04791319|470718134|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130753468|NCT04791319|470718135|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
130753469|NCT04791319|470718125|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130753470|NCT04791319|470718126|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130753471|NCT04791319|470718127|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130753472|NCT04791319|470718128|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130753473|NCT04791319|470718129|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130753474|NCT04791319|470718130|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130753475|NCT04791319|470718131|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130753476|NCT04791319|470718132|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130753477|NCT04791319|470718133|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130753478|NCT04791319|470718134|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
130753479|NCT04791319|470718135|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130753480|NCT04791319|470718125|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130753481|NCT04791319|470718126|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130753482|NCT04791319|470718127|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130753483|NCT04791319|470718128|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130753484|NCT04791319|470718129|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
130753485|NCT04791319|470718130|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
130753486|NCT04791319|470718131|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
130753487|NCT04791319|470718132|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130753488|NCT04791319|470718133|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
130753489|NCT04791319|470718134|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
130753490|NCT04791319|470718135|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
130753491|NCT04791319|470718125|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130753492|NCT04791319|470718126|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130753493|NCT04791319|470718127|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130753494|NCT04791319|470718128|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130753495|NCT04791319|470718129|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
130753496|NCT04791319|470718130|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
130753497|NCT04791319|470718131|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
130753498|NCT04791319|470718132|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
130753499|NCT04791319|470718133|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
130753500|NCT04791319|470718134|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
130753501|NCT04791319|470718135|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
130753502|NCT00355147|470718140|FG000|Overall Study|Lost to Follow-up|10|||
130753503|NCT00355147|470718141|FG001|Overall Study|Lost to Follow-up|8|||
130753504|NCT00355147|470718140|FG000|Overall Study|Withdrawal by Subject|8|||
130753505|NCT00355147|470718141|FG001|Overall Study|Withdrawal by Subject|12|||
130753506|NCT02828124|470718142|FG000|Overall Study|Disease Progression|1|||
130753507|NCT02828124|470718143|FG001|Overall Study|Disease Progression|2|||
130753508|NCT02828124|470718144|FG002|Overall Study|Disease Progression|1|||
130753509|NCT02828124|470718145|FG003|Overall Study|Disease Progression|4|||
130753510|NCT02828124|470718142|FG000|Overall Study|AE Unrelated to Study Drug|0|||
130788925|NCT04142242|470856704|FG000|Stage II|Withdrawal by Subject|0|||
130788926|NCT04142242|470856705|FG001|Stage II|Withdrawal by Subject|0|||
130788927|NCT04142242|470856706|FG002|Stage II|Withdrawal by Subject|5|||
130788928|NCT04142242|470856707|FG003|Stage II|Withdrawal by Subject|9|||
130753511|NCT02828124|470718143|FG001|Overall Study|AE Unrelated to Study Drug|0|||
130753512|NCT02828124|470718144|FG002|Overall Study|AE Unrelated to Study Drug|0|||
130753513|NCT02828124|470718145|FG003|Overall Study|AE Unrelated to Study Drug|1|||
130753514|NCT02828124|470718142|FG000|Overall Study|Subject Withdrew Consent|0|||
130753515|NCT02828124|470718143|FG001|Overall Study|Subject Withdrew Consent|0|||
130753516|NCT02828124|470718144|FG002|Overall Study|Subject Withdrew Consent|0|||
130753517|NCT02828124|470718145|FG003|Overall Study|Subject Withdrew Consent|1|||
130753518|NCT00072280|470718156|FG000|Treatment|Found ineligible|1|||
130753519|NCT00072280|470718157|FG001|Treatment|Found ineligible|2|||
130753520|NCT00072280|470718156|FG000|Follow-up|Early termination of study|2|||
130753521|NCT00072280|470718157|FG001|Follow-up|Early termination of study|2|||
130753522|NCT00022698|470718161|FG000|Overall Study|Adverse Event|5|||
130753523|NCT00022698|470718162|FG001|Overall Study|Adverse Event|9|||
130753524|NCT00022698|470718161|FG000|Overall Study|Death|0|||
130753525|NCT00022698|470718162|FG001|Overall Study|Death|2|||
130753526|NCT00022698|470718161|FG000|Overall Study|Failure to return|0|||
130788929|NCT04142242|470856708|FG004|Stage II|Withdrawal by Subject|0|||
130788930|NCT04142242|470856709|FG005|Stage II|Withdrawal by Subject|0|||
130788931|NCT03040726|470856712|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
130788932|NCT03040726|470856713|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
130788933|NCT03040726|470856712|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
130788934|NCT03040726|470856713|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
130788935|NCT03040726|470856712|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
130788936|NCT03040726|470856713|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
130788937|NCT03040726|470856712|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
130788938|NCT03040726|470856713|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
130788939|NCT03040726|470856712|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
130788940|NCT03040726|470856713|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
130788941|NCT00071981|470856714|FG000|Overall Study|Lack of Efficacy|37|||
130788942|NCT00071981|470856715|FG001|Overall Study|Lack of Efficacy|29|||
130788943|NCT00071981|470856716|FG002|Overall Study|Lack of Efficacy|30|||
130788944|NCT00071981|470856717|FG003|Overall Study|Lack of Efficacy|43|||
130788945|NCT00071981|470856714|FG000|Overall Study|Adverse Event|4|||
130788946|NCT00071981|470856715|FG001|Overall Study|Adverse Event|4|||
130788947|NCT00071981|470856716|FG002|Overall Study|Adverse Event|3|||
130788948|NCT00071981|470856717|FG003|Overall Study|Adverse Event|1|||
130788949|NCT00071981|470856714|FG000|Overall Study|Death|0|||
130788950|NCT00071981|470856715|FG001|Overall Study|Death|0|||
130788951|NCT00071981|470856716|FG002|Overall Study|Death|1|||
130788952|NCT00071981|470856717|FG003|Overall Study|Death|1|||
130788953|NCT00071981|470856714|FG000|Overall Study|Withdrawal by Subject|3|||
130788954|NCT00071981|470856715|FG001|Overall Study|Withdrawal by Subject|1|||
130788955|NCT00071981|470856716|FG002|Overall Study|Withdrawal by Subject|0|||
130753527|NCT00022698|470718162|FG001|Overall Study|Failure to return|1|||
130753528|NCT00022698|470718161|FG000|Overall Study|Refused treatment|0|||
130753529|NCT00022698|470718162|FG001|Overall Study|Refused treatment|2|||
130753530|NCT00022698|470718161|FG000|Overall Study|Insufficient therapeutic response|2|||
130753531|NCT00022698|470718162|FG001|Overall Study|Insufficient therapeutic response|14|||
130753532|NCT00022698|470718161|FG000|Overall Study|Administrative /other|1|||
130753533|NCT00022698|470718162|FG001|Overall Study|Administrative /other|7|||
130753534|NCT02504827|470718163|FG000|Overall Study|Could not produce sputum|1|||
130753535|NCT00877487|470718172|FG000|Open-label Treatment Phase|Adverse Event|1|||
130753536|NCT00877487|470718173|FG001|Open-label Treatment Phase|Adverse Event|0|||
130753537|NCT00877487|470718172|FG000|Open-label Treatment Phase|Protocol Violation|3|||
130753538|NCT00877487|470718173|FG001|Open-label Treatment Phase|Protocol Violation|0|||
130753539|NCT00877487|470718172|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
130753540|NCT00877487|470718173|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
130753541|NCT00877487|470718172|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
130753542|NCT00877487|470718173|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
130753543|NCT00877487|470718172|FG000|Open-label Treatment Phase|Out of country for business|1|||
130753544|NCT00877487|470718173|FG001|Open-label Treatment Phase|Out of country for business|0|||
130753545|NCT00877487|470718172|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
130753546|NCT00877487|470718173|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
130753547|NCT00877487|470718172|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
130753548|NCT00877487|470718173|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
130753549|NCT00877487|470718172|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
130753550|NCT00877487|470718173|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
130753551|NCT00877487|470718172|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
130753552|NCT00877487|470718173|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
130753553|NCT00712543|470718176|FG000|Day 8-14|Lost to Follow-up|0|||
130753554|NCT00712543|470718177|FG001|Day 8-14|Lost to Follow-up|2|||
130753555|NCT02729051|470718180|FG000|Overall Study|Adverse Event|21|||
130753556|NCT02729051|470718181|FG001|Overall Study|Adverse Event|11|||
130753557|NCT02729051|470718180|FG000|Overall Study|Lack of Efficacy|1|||
130753558|NCT02729051|470718181|FG001|Overall Study|Lack of Efficacy|1|||
130753559|NCT02729051|470718180|FG000|Overall Study|Lost to Follow-up|1|||
130788956|NCT00071981|470856717|FG003|Overall Study|Withdrawal by Subject|0|||
130788957|NCT00071981|470856714|FG000|Overall Study|No protocol therapy|2|||
130788958|NCT00071981|470856715|FG001|Overall Study|No protocol therapy|5|||
130788959|NCT00071981|470856716|FG002|Overall Study|No protocol therapy|1|||
130753560|NCT02729051|470718181|FG001|Overall Study|Lost to Follow-up|2|||
130753561|NCT02729051|470718180|FG000|Overall Study|Physician Decision|1|||
130753562|NCT02729051|470718181|FG001|Overall Study|Physician Decision|1|||
130753563|NCT02729051|470718180|FG000|Overall Study|Withdrawal by Subject|6|||
130788960|NCT00071981|470856717|FG003|Overall Study|No protocol therapy|0|||
130753564|NCT02729051|470718181|FG001|Overall Study|Withdrawal by Subject|17|||
130753565|NCT02702388|470718182|FG000|Overall Study|Disease Progression|18|||
130753566|NCT02702388|470718183|FG001|Overall Study|Disease Progression|25|||
130753567|NCT02702388|470718182|FG000|Overall Study|Withdrawal by Subject|9|||
130753568|NCT02702388|470718183|FG001|Overall Study|Withdrawal by Subject|7|||
130753569|NCT02702388|470718182|FG000|Overall Study|Adverse Event|11|||
130753570|NCT02702388|470718183|FG001|Overall Study|Adverse Event|15|||
130753571|NCT02702388|470718182|FG000|Overall Study|Other|2|||
130753572|NCT02702388|470718183|FG001|Overall Study|Other|4|||
130753573|NCT04740827|470718195|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
130753574|NCT04740827|470718196|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
130753575|NCT04740827|470718195|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
130788961|NCT00071981|470856714|FG000|Overall Study|others (not specified in the study)|0|||
130788962|NCT00071981|470856715|FG001|Overall Study|others (not specified in the study)|2|||
130788963|NCT00071981|470856716|FG002|Overall Study|others (not specified in the study)|2|||
130788964|NCT00071981|470856717|FG003|Overall Study|others (not specified in the study)|0|||
130753576|NCT04740827|470718196|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
130753577|NCT04740827|470718195|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
130753578|NCT04740827|470718196|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
130753579|NCT04740827|470718195|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
130753580|NCT04740827|470718196|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
130753581|NCT04740827|470718195|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
130753582|NCT04740827|470718196|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
130753583|NCT04740827|470718195|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
130753584|NCT04740827|470718196|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
130753585|NCT01190410|470720264|FG000|Overall Study|Adverse Event|0|||
130753586|NCT01190410|470720265|FG001|Overall Study|Adverse Event|3|||
130753587|NCT01190410|470720264|FG000|Overall Study|Lack of Efficacy|0|||
130753588|NCT01190410|470720265|FG001|Overall Study|Lack of Efficacy|2|||
130753589|NCT01190410|470720264|FG000|Overall Study|Withdrawal by Subject|0|||
130753590|NCT01190410|470720265|FG001|Overall Study|Withdrawal by Subject|2|||
130753591|NCT01190410|470720264|FG000|Overall Study|Administrative decision|1|||
130753592|NCT01190410|470720265|FG001|Overall Study|Administrative decision|0|||
130753593|NCT01190410|470720264|FG000|Overall Study|PI discretion|0|||
130753594|NCT01190410|470720265|FG001|Overall Study|PI discretion|2|||
130753595|NCT03652636|470720266|FG000|Overall Study|Withdrawal by Subject|7|||
130753596|NCT00504725|470720273|FG000|Overall Study|Protocol Violation|1|||
130753597|NCT00504725|470720274|FG001|Overall Study|Protocol Violation|0|||
130753598|NCT01435018|470720276|FG000|Overall Study|Death|37|||
130753599|NCT01435018|470720277|FG001|Overall Study|Death|18|||
130753600|NCT01435018|470720278|FG002|Overall Study|Death|25|||
130753601|NCT01435018|470720276|FG000|Overall Study|Site is closing|4|||
130753602|NCT01435018|470720277|FG001|Overall Study|Site is closing|9|||
130753603|NCT01435018|470720278|FG002|Overall Study|Site is closing|7|||
130753604|NCT01435018|470720276|FG000|Overall Study|Withdrew consent|0|||
130753605|NCT01435018|470720277|FG001|Overall Study|Withdrew consent|3|||
130753606|NCT01435018|470720278|FG002|Overall Study|Withdrew consent|1|||
130753607|NCT01435018|470720276|FG000|Overall Study|Not willing to adhere to requirements|0|||
130753608|NCT01435018|470720277|FG001|Overall Study|Not willing to adhere to requirements|2|||
130753609|NCT01435018|470720278|FG002|Overall Study|Not willing to adhere to requirements|3|||
130753610|NCT01435018|470720276|FG000|Overall Study|Not able to get to clinic|2|||
130753611|NCT01435018|470720277|FG001|Overall Study|Not able to get to clinic|0|||
130753612|NCT01435018|470720278|FG002|Overall Study|Not able to get to clinic|2|||
130753613|NCT01435018|470720276|FG000|Overall Study|Severe debilitation, unable to continue|0|||
130753614|NCT01435018|470720277|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130753615|NCT01435018|470720278|FG002|Overall Study|Severe debilitation, unable to continue|1|||
130753616|NCT01435018|470720276|FG000|Overall Study|Unable to contact participant/parent|1|||
130753617|NCT01435018|470720277|FG001|Overall Study|Unable to contact participant/parent|1|||
130753618|NCT01435018|470720278|FG002|Overall Study|Unable to contact participant/parent|1|||
130753619|NCT01435018|470720276|FG000|Overall Study|Enrollment Violation|0|||
130753620|NCT01435018|470720277|FG001|Overall Study|Enrollment Violation|1|||
130753621|NCT01435018|470720278|FG002|Overall Study|Enrollment Violation|0|||
130753622|NCT01435018|470720276|FG000|Overall Study|Never started chemotherapy|3|||
130753623|NCT01435018|470720277|FG001|Overall Study|Never started chemotherapy|0|||
130753624|NCT01435018|470720278|FG002|Overall Study|Never started chemotherapy|1|||
130753625|NCT00769067|470720279|FG000|Overall Study|Death|89|||
130753626|NCT00769067|470720280|FG001|Overall Study|Death|86|||
130753627|NCT00769067|470720279|FG000|Overall Study|Lost to Follow-up|3|||
130753628|NCT00769067|470720280|FG001|Overall Study|Lost to Follow-up|1|||
130753629|NCT00769067|470720279|FG000|Overall Study|Study terminated by sponsor|1|||
130753630|NCT00769067|470720280|FG001|Overall Study|Study terminated by sponsor|3|||
130753631|NCT00769067|470720279|FG000|Overall Study|Other|1|||
130753632|NCT00769067|470720280|FG001|Overall Study|Other|3|||
130753633|NCT00769067|470720279|FG000|Overall Study|Withdrawal by Subject|0|||
130753634|NCT00769067|470720280|FG001|Overall Study|Withdrawal by Subject|1|||
130753635|NCT03806933|470720281|FG000|Main Period|Physician Decision|0|||
130753636|NCT03806933|470720282|FG001|Main Period|Physician Decision|0|||
130753637|NCT03806933|470720283|FG002|Main Period|Physician Decision|0|||
130753638|NCT03806933|470720284|FG003|Main Period|Physician Decision|1|||
130753639|NCT03806933|470720281|FG000|Main Period|Pregnancy|0|||
130753640|NCT03806933|470720282|FG001|Main Period|Pregnancy|0|||
130753641|NCT03806933|470720283|FG002|Main Period|Pregnancy|1|||
130753642|NCT03806933|470720284|FG003|Main Period|Pregnancy|0|||
130753643|NCT03806933|470720281|FG000|Main Period|Withdrawal by Subject|2|||
130753644|NCT03806933|470720282|FG001|Main Period|Withdrawal by Subject|1|||
130753645|NCT03806933|470720283|FG002|Main Period|Withdrawal by Subject|1|||
130753646|NCT03806933|470720284|FG003|Main Period|Withdrawal by Subject|2|||
130753647|NCT03806933|470720281|FG000|Main Period|Lost to Follow-up|2|||
130753648|NCT03806933|470720282|FG001|Main Period|Lost to Follow-up|2|||
130753649|NCT03806933|470720283|FG002|Main Period|Lost to Follow-up|0|||
130753650|NCT03806933|470720284|FG003|Main Period|Lost to Follow-up|0|||
130753651|NCT03806933|470720281|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
130753652|NCT03806933|470720282|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
130753653|NCT03806933|470720283|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
130753654|NCT03806933|470720284|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
130753655|NCT03625466|470720285|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
130753656|NCT03625466|470720286|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
130753657|NCT03625466|470720287|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
130788965|NCT01123655|470856718|FG000|Overall Study|Medication for RA had to be changed|1|||
130788966|NCT01123655|470856719|FG001|Overall Study|Medication for RA had to be changed|0|||
130788967|NCT01123655|470856720|FG002|Overall Study|Medication for RA had to be changed|0|||
130788968|NCT01123655|470856718|FG000|Overall Study|new illness|0|||
130788969|NCT01123655|470856719|FG001|Overall Study|new illness|1|||
130753658|NCT03625466|470720285|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130753659|NCT03625466|470720286|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
130753660|NCT03625466|470720287|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130753661|NCT03625466|470720285|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130753662|NCT03625466|470720286|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130753663|NCT03625466|470720287|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
130753664|NCT00076752|470720293|FG000|Overall Study|Death|2|||
130753665|NCT00076752|470720293|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
130753666|NCT01014988|470720298|FG000|Overall Study|Adverse Event|20|||
130753667|NCT01014988|470720299|FG001|Overall Study|Adverse Event|0|||
130753668|NCT01014988|470720300|FG002|Overall Study|Adverse Event|1|||
130753669|NCT01014988|470720301|FG003|Overall Study|Adverse Event|0|||
130788970|NCT01123655|470856720|FG002|Overall Study|new illness|0|||
130753670|NCT01014988|470720302|FG004|Overall Study|Adverse Event|1|||
130753671|NCT01014988|470720303|FG005|Overall Study|Adverse Event|3|||
130753672|NCT01014988|470720298|FG000|Overall Study|Lost to Follow-up|1|||
130753673|NCT01014988|470720299|FG001|Overall Study|Lost to Follow-up|0|||
130753674|NCT01014988|470720300|FG002|Overall Study|Lost to Follow-up|1|||
130753675|NCT01014988|470720301|FG003|Overall Study|Lost to Follow-up|0|||
130753676|NCT01014988|470720302|FG004|Overall Study|Lost to Follow-up|0|||
130753677|NCT01014988|470720303|FG005|Overall Study|Lost to Follow-up|0|||
130753678|NCT01014988|470720298|FG000|Overall Study|Physician Decision|1|||
130753679|NCT01014988|470720299|FG001|Overall Study|Physician Decision|0|||
130753680|NCT01014988|470720300|FG002|Overall Study|Physician Decision|0|||
130753681|NCT01014988|470720301|FG003|Overall Study|Physician Decision|0|||
130753682|NCT01014988|470720302|FG004|Overall Study|Physician Decision|0|||
130753683|NCT01014988|470720303|FG005|Overall Study|Physician Decision|0|||
130753684|NCT01014988|470720298|FG000|Overall Study|Withdrawal by Subject|1|||
130753685|NCT01014988|470720299|FG001|Overall Study|Withdrawal by Subject|0|||
130753686|NCT01014988|470720300|FG002|Overall Study|Withdrawal by Subject|0|||
130753687|NCT01014988|470720301|FG003|Overall Study|Withdrawal by Subject|0|||
130753688|NCT01014988|470720302|FG004|Overall Study|Withdrawal by Subject|0|||
130753689|NCT01014988|470720303|FG005|Overall Study|Withdrawal by Subject|0|||
130753722|NCT01867710|470720307|FG000|Overall Study|Death|25|||
130753723|NCT01867710|470720308|FG001|Overall Study|Death|15|||
130753724|NCT01867710|470720309|FG002|Overall Study|Death|27|||
130753725|NCT01867710|470720310|FG003|Overall Study|Death|20|||
130753726|NCT01867710|470720307|FG000|Overall Study|Lost to Follow-up|3|||
130753727|NCT01867710|470720308|FG001|Overall Study|Lost to Follow-up|4|||
130753728|NCT01867710|470720309|FG002|Overall Study|Lost to Follow-up|3|||
130753729|NCT01867710|470720310|FG003|Overall Study|Lost to Follow-up|2|||
130753730|NCT01867710|470720307|FG000|Overall Study|Withdrawal of consent|2|||
130753731|NCT01867710|470720308|FG001|Overall Study|Withdrawal of consent|5|||
130753732|NCT01867710|470720309|FG002|Overall Study|Withdrawal of consent|1|||
130753733|NCT01867710|470720310|FG003|Overall Study|Withdrawal of consent|2|||
130753734|NCT01867710|470720307|FG000|Overall Study|Study Terminated by Sponsor|9|||
130753735|NCT01867710|470720308|FG001|Overall Study|Study Terminated by Sponsor|13|||
130753736|NCT01867710|470720309|FG002|Overall Study|Study Terminated by Sponsor|8|||
130753737|NCT01867710|470720310|FG003|Overall Study|Study Terminated by Sponsor|16|||
130753738|NCT01867710|470720307|FG000|Overall Study|Biochemical progression|0|||
130753739|NCT01867710|470720308|FG001|Overall Study|Biochemical progression|1|||
130753740|NCT01867710|470720309|FG002|Overall Study|Biochemical progression|0|||
130753741|NCT01867710|470720310|FG003|Overall Study|Biochemical progression|0|||
130753742|NCT01867710|470720307|FG000|Overall Study|Clinical progression|0|||
130753743|NCT01867710|470720308|FG001|Overall Study|Clinical progression|0|||
130753744|NCT01867710|470720309|FG002|Overall Study|Clinical progression|1|||
130753745|NCT01867710|470720310|FG003|Overall Study|Clinical progression|0|||
130753746|NCT01867710|470720307|FG000|Overall Study|Disease progression|1|||
130753747|NCT01867710|470720308|FG001|Overall Study|Disease progression|0|||
130753748|NCT01867710|470720309|FG002|Overall Study|Disease progression|0|||
130753749|NCT01867710|470720310|FG003|Overall Study|Disease progression|0|||
130753750|NCT01867710|470720307|FG000|Overall Study|Patient decision|0|||
130753751|NCT01867710|470720308|FG001|Overall Study|Patient decision|0|||
130753752|NCT01867710|470720309|FG002|Overall Study|Patient decision|0|||
130753753|NCT01867710|470720310|FG003|Overall Study|Patient decision|1|||
130753754|NCT01867710|470720307|FG000|Overall Study|Patient to follow subsequent treatment|0|||
130753755|NCT01867710|470720308|FG001|Overall Study|Patient to follow subsequent treatment|1|||
130753756|NCT01867710|470720309|FG002|Overall Study|Patient to follow subsequent treatment|0|||
130753757|NCT01867710|470720310|FG003|Overall Study|Patient to follow subsequent treatment|0|||
130753758|NCT01867710|470720307|FG000|Overall Study|Progressive disease|1|||
130753759|NCT01867710|470720308|FG001|Overall Study|Progressive disease|0|||
130753760|NCT01867710|470720309|FG002|Overall Study|Progressive disease|0|||
130753761|NCT01867710|470720310|FG003|Overall Study|Progressive disease|0|||
130753762|NCT01867710|470720307|FG000|Overall Study|Protocol Violation|0|||
130753763|NCT01867710|470720308|FG001|Overall Study|Protocol Violation|0|||
130753764|NCT01867710|470720309|FG002|Overall Study|Protocol Violation|0|||
130753765|NCT01867710|470720310|FG003|Overall Study|Protocol Violation|1|||
130753766|NCT01867710|470720307|FG000|Overall Study|PSA-progression|0|||
130753767|NCT01867710|470720308|FG001|Overall Study|PSA-progression|1|||
130753768|NCT01867710|470720309|FG002|Overall Study|PSA-progression|0|||
130753769|NCT01867710|470720310|FG003|Overall Study|PSA-progression|0|||
130753770|NCT01867710|470720307|FG000|Overall Study|Study medication no longer effective|0|||
130753771|NCT01867710|470720308|FG001|Overall Study|Study medication no longer effective|1|||
130753772|NCT01867710|470720309|FG002|Overall Study|Study medication no longer effective|0|||
130753773|NCT01867710|470720310|FG003|Overall Study|Study medication no longer effective|0|||
130753774|NCT03521115|470720311|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
130753775|NCT03521115|470720312|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
130753776|NCT03521115|470720311|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
130753777|NCT03521115|470720312|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
130753778|NCT01981954|470720317|FG000|Titration Period|Protocol Deviation|1|||
130753779|NCT01981954|470720317|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
130753780|NCT03655470|470720318|FG000|Overall Study|Lost to Follow-up|6|||
130753781|NCT03655470|470720319|FG001|Overall Study|Lost to Follow-up|7|||
130753782|NCT04590586|470720323|FG000|Overall Study|Death|7|||
130753783|NCT04590586|470720324|FG001|Overall Study|Death|1|||
130753784|NCT04590586|470720325|FG002|Overall Study|Death|37|||
130753785|NCT04590586|470720326|FG003|Overall Study|Death|34|||
130753786|NCT04590586|470720327|FG004|Overall Study|Death|19|||
130753787|NCT04590586|470720328|FG005|Overall Study|Death|3|||
130753788|NCT04590586|470720323|FG000|Overall Study|Lost to Follow-up|3|||
130753789|NCT04590586|470720324|FG001|Overall Study|Lost to Follow-up|0|||
130753790|NCT04590586|470720325|FG002|Overall Study|Lost to Follow-up|11|||
130753791|NCT04590586|470720326|FG003|Overall Study|Lost to Follow-up|11|||
130753792|NCT04590586|470720327|FG004|Overall Study|Lost to Follow-up|6|||
130753793|NCT04590586|470720328|FG005|Overall Study|Lost to Follow-up|0|||
130753794|NCT04590586|470720323|FG000|Overall Study|Withdrawal by Subject|0|||
130753795|NCT04590586|470720324|FG001|Overall Study|Withdrawal by Subject|0|||
130753796|NCT04590586|470720325|FG002|Overall Study|Withdrawal by Subject|6|||
130753797|NCT04590586|470720326|FG003|Overall Study|Withdrawal by Subject|0|||
130753798|NCT04590586|470720327|FG004|Overall Study|Withdrawal by Subject|3|||
130753799|NCT04590586|470720328|FG005|Overall Study|Withdrawal by Subject|0|||
130753800|NCT04590586|470720323|FG000|Overall Study|Other|3|||
130753801|NCT04590586|470720324|FG001|Overall Study|Other|0|||
130753802|NCT04590586|470720325|FG002|Overall Study|Other|1|||
130753803|NCT04590586|470720326|FG003|Overall Study|Other|1|||
130753804|NCT04590586|470720327|FG004|Overall Study|Other|2|||
130753805|NCT04590586|470720328|FG005|Overall Study|Other|1|||
130753806|NCT03063086|470720329|FG000|Overall Study|technical problems|1|||
130753807|NCT03063086|470720330|FG001|Overall Study|technical problems|0|||
130753808|NCT03063086|470720331|FG002|Overall Study|technical problems|0|||
130753809|NCT03063086|470720332|FG003|Overall Study|technical problems|0|||
130753810|NCT03063086|470720333|FG004|Overall Study|technical problems|0|||
130753811|NCT03063086|470720334|FG005|Overall Study|technical problems|0|||
130753812|NCT03063086|470720329|FG000|Overall Study|Adverse Event|1|||
130788971|NCT01123655|470856718|FG000|Overall Study|began prohibitive drug|0|||
130788972|NCT01123655|470856719|FG001|Overall Study|began prohibitive drug|0|||
130753813|NCT03063086|470720330|FG001|Overall Study|Adverse Event|1|||
130753814|NCT03063086|470720331|FG002|Overall Study|Adverse Event|1|||
130753815|NCT03063086|470720332|FG003|Overall Study|Adverse Event|1|||
130753816|NCT03063086|470720333|FG004|Overall Study|Adverse Event|0|||
130753817|NCT03063086|470720334|FG005|Overall Study|Adverse Event|0|||
130753818|NCT03063086|470720329|FG000|Overall Study|subject/guardian decision|1|||
130753819|NCT03063086|470720330|FG001|Overall Study|subject/guardian decision|0|||
130753820|NCT03063086|470720331|FG002|Overall Study|subject/guardian decision|0|||
130753821|NCT03063086|470720332|FG003|Overall Study|subject/guardian decision|0|||
130753822|NCT03063086|470720333|FG004|Overall Study|subject/guardian decision|0|||
130753823|NCT03063086|470720334|FG005|Overall Study|subject/guardian decision|0|||
130753824|NCT03063086|470720329|FG000|Overall Study|Non-compliance with study treatment|0|||
130753825|NCT03063086|470720330|FG001|Overall Study|Non-compliance with study treatment|0|||
130753826|NCT03063086|470720331|FG002|Overall Study|Non-compliance with study treatment|0|||
130753827|NCT03063086|470720332|FG003|Overall Study|Non-compliance with study treatment|1|||
130753828|NCT03063086|470720333|FG004|Overall Study|Non-compliance with study treatment|0|||
130753829|NCT03063086|470720334|FG005|Overall Study|Non-compliance with study treatment|1|||
130753830|NCT03063086|470720329|FG000|Overall Study|Physician Decision|0|||
130753831|NCT03063086|470720330|FG001|Overall Study|Physician Decision|0|||
130753832|NCT03063086|470720331|FG002|Overall Study|Physician Decision|0|||
130753833|NCT03063086|470720332|FG003|Overall Study|Physician Decision|1|||
130753834|NCT03063086|470720333|FG004|Overall Study|Physician Decision|0|||
130753835|NCT03063086|470720334|FG005|Overall Study|Physician Decision|0|||
130753836|NCT01893281|470720335|FG000|Overall Study|Adverse Event|1|||
130788973|NCT01123655|470856720|FG002|Overall Study|began prohibitive drug|1|||
130788974|NCT00885118|470856723|FG000|Overall Study|Adverse Event|1|||
130753837|NCT01893281|470720335|FG000|Overall Study|Protocol Violation|1|||
130753838|NCT01893281|470720335|FG000|Overall Study|Withdrawal by Subject|1|||
130753839|NCT02218736|470720336|FG000|Overall Study|Withdrawal by Subject|10|||
130753840|NCT02218736|470720337|FG001|Overall Study|Withdrawal by Subject|9|||
130753841|NCT02218736|470720336|FG000|Overall Study|Protocol Violation|2|||
130788975|NCT00885118|470856724|FG001|Overall Study|Adverse Event|0|||
130753842|NCT02218736|470720337|FG001|Overall Study|Protocol Violation|0|||
130753843|NCT05481125|470720340|FG000|Overall Study|Adverse Event|1|||
130753844|NCT05481125|470720341|FG001|Overall Study|Adverse Event|0|||
130753845|NCT05481125|470720340|FG000|Overall Study|Lost to Follow-up|0|||
130753846|NCT05481125|470720341|FG001|Overall Study|Lost to Follow-up|1|||
130753847|NCT05481125|470720340|FG000|Overall Study|Withdrawal by Subject|0|||
130753848|NCT05481125|470720341|FG001|Overall Study|Withdrawal by Subject|1|||
130753849|NCT02244463|470720342|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
130753850|NCT02244463|470720343|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130753851|NCT02244463|470720344|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130788976|NCT00885118|470856725|FG002|Overall Study|Adverse Event|0|||
130788977|NCT00885118|470856726|FG003|Overall Study|Adverse Event|0|||
130788978|NCT00885118|470856727|FG004|Overall Study|Adverse Event|0|||
130788979|NCT00885118|470856723|FG000|Overall Study|Withdrawal by Subject|0|||
130788980|NCT00885118|470856724|FG001|Overall Study|Withdrawal by Subject|0|||
130788981|NCT00885118|470856725|FG002|Overall Study|Withdrawal by Subject|0|||
130788982|NCT00885118|470856726|FG003|Overall Study|Withdrawal by Subject|0|||
130788983|NCT00885118|470856727|FG004|Overall Study|Withdrawal by Subject|1|||
130788984|NCT00885118|470856723|FG000|Overall Study|Other reason not defined above|0|||
130788985|NCT00885118|470856724|FG001|Overall Study|Other reason not defined above|0|||
130788986|NCT00885118|470856725|FG002|Overall Study|Other reason not defined above|1|||
130788987|NCT00885118|470856726|FG003|Overall Study|Other reason not defined above|0|||
130788988|NCT00885118|470856727|FG004|Overall Study|Other reason not defined above|0|||
130788989|NCT02814526|470856732|FG000|Overall Study|Adverse Event|4|||
130788990|NCT02814526|470856733|FG001|Overall Study|Adverse Event|3|||
130788991|NCT02814526|470856732|FG000|Overall Study|Death|1|||
130788992|NCT02814526|470856733|FG001|Overall Study|Death|1|||
130788993|NCT02814526|470856732|FG000|Overall Study|Lost to Follow-up|3|||
130788994|NCT02814526|470856733|FG001|Overall Study|Lost to Follow-up|4|||
130788995|NCT02814526|470856732|FG000|Overall Study|non site physician decision|1|||
130788996|NCT02814526|470856733|FG001|Overall Study|non site physician decision|0|||
130788997|NCT02814526|470856732|FG000|Overall Study|participant noncompliance|1|||
130788998|NCT02814526|470856733|FG001|Overall Study|participant noncompliance|1|||
130788999|NCT02814526|470856732|FG000|Overall Study|Withdrawal by Subject|20|||
130789000|NCT02814526|470856733|FG001|Overall Study|Withdrawal by Subject|14|||
130789001|NCT02814526|470856732|FG000|Overall Study|safety risk|2|||
130789002|NCT02814526|470856733|FG001|Overall Study|safety risk|1|||
130789003|NCT02814526|470856732|FG000|Overall Study|early termination-study terminated|1|||
130789004|NCT02814526|470856733|FG001|Overall Study|early termination-study terminated|2|||
130789005|NCT02814526|470856732|FG000|Overall Study|Other|0|||
130789006|NCT02814526|470856733|FG001|Overall Study|Other|4|||
130789007|NCT03883386|470856734|FG000|First Assignment|Lost to Follow-up|1|||
130789008|NCT03883386|470856735|FG001|First Assignment|Lost to Follow-up|0|||
130789009|NCT03883386|470856734|FG000|First Assignment|Withdrawal by Subject|1|||
130789010|NCT03883386|470856735|FG001|First Assignment|Withdrawal by Subject|1|||
130789011|NCT00251758|470856736|FG000|Overall Study|Adverse Event|7|||
130789012|NCT00251758|470856737|FG001|Overall Study|Adverse Event|9|||
130789013|NCT00251758|470856738|FG002|Overall Study|Adverse Event|11|||
130789014|NCT00251758|470856736|FG000|Overall Study|Lost to Follow-up|4|||
130789015|NCT00251758|470856737|FG001|Overall Study|Lost to Follow-up|2|||
130789016|NCT00251758|470856738|FG002|Overall Study|Lost to Follow-up|5|||
130789017|NCT00251758|470856736|FG000|Overall Study|Withdrawal by Subject|13|||
130789018|NCT00251758|470856737|FG001|Overall Study|Withdrawal by Subject|7|||
130789019|NCT00251758|470856738|FG002|Overall Study|Withdrawal by Subject|3|||
130789020|NCT00251758|470856736|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130789021|NCT00251758|470856737|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
130789022|NCT00251758|470856738|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
130789023|NCT00251758|470856736|FG000|Overall Study|Lack of Efficacy|3|||
130789024|NCT00251758|470856737|FG001|Overall Study|Lack of Efficacy|0|||
130789025|NCT00251758|470856738|FG002|Overall Study|Lack of Efficacy|0|||
130789026|NCT00251758|470856736|FG000|Overall Study|Noncompliant|0|||
130789027|NCT00251758|470856737|FG001|Overall Study|Noncompliant|2|||
130789028|NCT00251758|470856738|FG002|Overall Study|Noncompliant|2|||
130753852|NCT02244463|470720345|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130753853|NCT02244463|470720346|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130789029|NCT00251758|470856736|FG000|Overall Study|Pregnancy|0|||
130789030|NCT00251758|470856737|FG001|Overall Study|Pregnancy|1|||
130789031|NCT00251758|470856738|FG002|Overall Study|Pregnancy|0|||
130789032|NCT00251758|470856736|FG000|Overall Study|Per Subject Request|0|||
130789033|NCT00251758|470856737|FG001|Overall Study|Per Subject Request|0|||
130789034|NCT00251758|470856738|FG002|Overall Study|Per Subject Request|1|||
130789035|NCT00251758|470856736|FG000|Overall Study|Per Investigator Request|1|||
130789036|NCT00251758|470856737|FG001|Overall Study|Per Investigator Request|0|||
130789037|NCT00251758|470856738|FG002|Overall Study|Per Investigator Request|0|||
130789038|NCT01387269|470856739|FG000|Overall Study|Death|38|||
130789039|NCT01387269|470856740|FG001|Overall Study|Death|20|||
130789040|NCT01387269|470856739|FG000|Overall Study|Other|8|||
130789041|NCT01387269|470856740|FG001|Overall Study|Other|7|||
130753854|NCT02244463|470720347|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130753855|NCT02244463|470720342|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
130753856|NCT02244463|470720343|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
130753857|NCT02244463|470720344|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
130753858|NCT02244463|470720345|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
130753859|NCT02244463|470720346|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
130753860|NCT02244463|470720347|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
130753861|NCT02244463|470720342|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130753862|NCT02244463|470720343|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
130753863|NCT02244463|470720344|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130753864|NCT02244463|470720345|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130753865|NCT02244463|470720346|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130753866|NCT02244463|470720347|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130753867|NCT02244463|470720342|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130753868|NCT02244463|470720343|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130753869|NCT02244463|470720344|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
130753870|NCT02244463|470720345|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130753871|NCT02244463|470720346|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130753872|NCT02244463|470720347|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130753873|NCT02244463|470720342|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130753874|NCT02244463|470720343|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130753875|NCT02244463|470720344|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130753876|NCT02244463|470720345|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
130753877|NCT02244463|470720346|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130753878|NCT02244463|470720347|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130753879|NCT02244463|470720342|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130753880|NCT02244463|470720343|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130753881|NCT02244463|470720344|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130753882|NCT02244463|470720345|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
130753883|NCT02244463|470720346|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130753884|NCT02244463|470720347|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130753885|NCT02244463|470720342|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130753886|NCT02244463|470720343|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130753887|NCT02244463|470720344|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130753888|NCT02244463|470720345|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
130753889|NCT02244463|470720346|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130753890|NCT02244463|470720347|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130753891|NCT02244463|470720342|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130753892|NCT02244463|470720343|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130753893|NCT02244463|470720344|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130753894|NCT02244463|470720345|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
130753895|NCT02244463|470720346|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130753896|NCT02244463|470720347|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130753897|NCT02244463|470720342|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130753898|NCT02244463|470720343|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130753899|NCT02244463|470720344|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130753900|NCT02244463|470720345|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
130753901|NCT02244463|470720346|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130753902|NCT02244463|470720347|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130753903|NCT02244463|470720342|FG000|Period 5: Phase II|Disease Progression|0|||
130753904|NCT02244463|470720343|FG001|Period 5: Phase II|Disease Progression|0|||
130753905|NCT02244463|470720344|FG002|Period 5: Phase II|Disease Progression|0|||
130753906|NCT02244463|470720345|FG003|Period 5: Phase II|Disease Progression|0|||
130753907|NCT02244463|470720346|FG004|Period 5: Phase II|Disease Progression|10|||
130753908|NCT02244463|470720347|FG005|Period 5: Phase II|Disease Progression|11|||
130753909|NCT02244463|470720342|FG000|Period 5: Phase II|Physician Decision|0|||
130753910|NCT02244463|470720343|FG001|Period 5: Phase II|Physician Decision|0|||
130753911|NCT02244463|470720344|FG002|Period 5: Phase II|Physician Decision|0|||
130753912|NCT02244463|470720345|FG003|Period 5: Phase II|Physician Decision|0|||
130753913|NCT02244463|470720346|FG004|Period 5: Phase II|Physician Decision|3|||
130753914|NCT02244463|470720347|FG005|Period 5: Phase II|Physician Decision|2|||
130753915|NCT02244463|470720342|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
130753916|NCT02244463|470720343|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
130753917|NCT02244463|470720344|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
130753918|NCT02244463|470720345|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
130753919|NCT02244463|470720346|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
130753920|NCT02244463|470720347|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
130753921|NCT02244463|470720342|FG000|Period 5: Phase II|Intercurrent Illness|0|||
130753922|NCT02244463|470720343|FG001|Period 5: Phase II|Intercurrent Illness|0|||
130753923|NCT02244463|470720344|FG002|Period 5: Phase II|Intercurrent Illness|0|||
130753924|NCT02244463|470720345|FG003|Period 5: Phase II|Intercurrent Illness|0|||
130753925|NCT02244463|470720346|FG004|Period 5: Phase II|Intercurrent Illness|2|||
130753926|NCT02244463|470720347|FG005|Period 5: Phase II|Intercurrent Illness|0|||
130753927|NCT02244463|470720342|FG000|Period 5: Phase II|Adverse Event|0|||
130753928|NCT02244463|470720343|FG001|Period 5: Phase II|Adverse Event|0|||
130753929|NCT02244463|470720344|FG002|Period 5: Phase II|Adverse Event|0|||
130753930|NCT02244463|470720345|FG003|Period 5: Phase II|Adverse Event|0|||
130753931|NCT02244463|470720346|FG004|Period 5: Phase II|Adverse Event|0|||
130753932|NCT02244463|470720347|FG005|Period 5: Phase II|Adverse Event|2|||
130753933|NCT02244463|470720342|FG000|Period 5: Phase II|Still On treatment|0|||
130753934|NCT02244463|470720343|FG001|Period 5: Phase II|Still On treatment|0|||
130753935|NCT02244463|470720344|FG002|Period 5: Phase II|Still On treatment|0|||
130753936|NCT02244463|470720345|FG003|Period 5: Phase II|Still On treatment|0|||
130753937|NCT02244463|470720346|FG004|Period 5: Phase II|Still On treatment|0|||
130753938|NCT02244463|470720347|FG005|Period 5: Phase II|Still On treatment|3|||
130753939|NCT01769508|470720348|FG000|Overall Study|Death|3|||
130753940|NCT01769508|470720348|FG000|Overall Study|Withdrawal by Subject|1|||
130753941|NCT01769508|470720348|FG000|Overall Study|Adverse Event|1|||
130753942|NCT01769508|470720348|FG000|Overall Study|Lost to Follow-up|1|||
130753943|NCT01598090|470720352|FG000|Treatment Period|Poor/non-compliance|0|||
130753944|NCT01598090|470720353|FG001|Treatment Period|Poor/non-compliance|2|||
130753945|NCT01598090|470720354|FG002|Treatment Period|Poor/non-compliance|0|||
130753946|NCT01598090|470720352|FG000|Treatment Period|No longer meet study criteria|0|||
130753947|NCT01598090|470720353|FG001|Treatment Period|No longer meet study criteria|1|||
130753948|NCT01598090|470720354|FG002|Treatment Period|No longer meet study criteria|0|||
130753949|NCT01598090|470720352|FG000|Treatment Period|Lack of Efficacy|5|||
130753950|NCT01598090|470720353|FG001|Treatment Period|Lack of Efficacy|14|||
130753951|NCT01598090|470720354|FG002|Treatment Period|Lack of Efficacy|6|||
130753952|NCT01598090|470720352|FG000|Treatment Period|Adverse Event|2|||
130753953|NCT01598090|470720353|FG001|Treatment Period|Adverse Event|33|||
130753954|NCT01598090|470720354|FG002|Treatment Period|Adverse Event|17|||
130753955|NCT01598090|470720352|FG000|Treatment Period|Other reasons|0|||
130753956|NCT01598090|470720353|FG001|Treatment Period|Other reasons|4|||
130753957|NCT01598090|470720354|FG002|Treatment Period|Other reasons|1|||
130753958|NCT01598090|470720352|FG000|Treatment Period|Withdrawal by Subject|3|||
130753959|NCT01598090|470720353|FG001|Treatment Period|Withdrawal by Subject|13|||
130753960|NCT01598090|470720354|FG002|Treatment Period|Withdrawal by Subject|10|||
130753961|NCT01598090|470720352|FG000|Treatment Period|Lost to Follow-up|1|||
130753962|NCT01598090|470720353|FG001|Treatment Period|Lost to Follow-up|5|||
130753963|NCT01598090|470720354|FG002|Treatment Period|Lost to Follow-up|1|||
130753964|NCT01598090|470720352|FG000|Follow-up Period|Death|0|||
130753965|NCT01598090|470720353|FG001|Follow-up Period|Death|1|||
130753966|NCT01598090|470720354|FG002|Follow-up Period|Death|0|||
130753967|NCT01598090|470720352|FG000|Follow-up Period|No longer required per protocol|1|||
130753968|NCT01598090|470720353|FG001|Follow-up Period|No longer required per protocol|3|||
130753969|NCT01598090|470720354|FG002|Follow-up Period|No longer required per protocol|2|||
130753970|NCT01598090|470720352|FG000|Follow-up Period|Not reported|0|||
130753971|NCT01598090|470720353|FG001|Follow-up Period|Not reported|10|||
130753972|NCT01598090|470720354|FG002|Follow-up Period|Not reported|4|||
130753973|NCT01598090|470720352|FG000|Follow-up Period|Withdrawal by Subject|0|||
130753974|NCT01598090|470720353|FG001|Follow-up Period|Withdrawal by Subject|3|||
130753975|NCT01598090|470720354|FG002|Follow-up Period|Withdrawal by Subject|2|||
130753976|NCT01598090|470720352|FG000|Follow-up Period|Other reasons|2|||
130753977|NCT01598090|470720353|FG001|Follow-up Period|Other reasons|8|||
130753978|NCT01598090|470720354|FG002|Follow-up Period|Other reasons|8|||
130753979|NCT01598090|470720352|FG000|Follow-up Period|Lost to Follow-up|2|||
130753980|NCT01598090|470720353|FG001|Follow-up Period|Lost to Follow-up|10|||
130753981|NCT01598090|470720354|FG002|Follow-up Period|Lost to Follow-up|12|||
130753982|NCT03615144|470720355|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
130753983|NCT03615144|470720356|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
130753984|NCT02587598|470720359|FG000|Overall Study|Death|4|||
130753985|NCT02587598|470720360|FG001|Overall Study|Death|8|||
130753986|NCT02587598|470720361|FG002|Overall Study|Death|4|||
130753987|NCT02587598|470720362|FG003|Overall Study|Death|16|||
130753988|NCT02587598|470720363|FG004|Overall Study|Death|9|||
130753989|NCT02587598|470720364|FG005|Overall Study|Death|4|||
130753990|NCT02587598|470720365|FG006|Overall Study|Death|6|||
130753991|NCT02587598|470720366|FG007|Overall Study|Death|7|||
130753992|NCT02587598|470720367|FG008|Overall Study|Death|9|||
130753993|NCT02587598|470720368|FG009|Overall Study|Death|1|||
130753994|NCT02587598|470720369|FG010|Overall Study|Death|3|||
130753995|NCT02587598|470720359|FG000|Overall Study|Study Terminated by the Sponsor|0|||
130753996|NCT02587598|470720360|FG001|Overall Study|Study Terminated by the Sponsor|1|||
130753997|NCT02587598|470720361|FG002|Overall Study|Study Terminated by the Sponsor|0|||
130753998|NCT02587598|470720362|FG003|Overall Study|Study Terminated by the Sponsor|3|||
130753999|NCT02587598|470720363|FG004|Overall Study|Study Terminated by the Sponsor|0|||
130754000|NCT02587598|470720364|FG005|Overall Study|Study Terminated by the Sponsor|1|||
130754001|NCT02587598|470720365|FG006|Overall Study|Study Terminated by the Sponsor|0|||
130754002|NCT02587598|470720366|FG007|Overall Study|Study Terminated by the Sponsor|0|||
130754003|NCT02587598|470720367|FG008|Overall Study|Study Terminated by the Sponsor|0|||
130754004|NCT02587598|470720368|FG009|Overall Study|Study Terminated by the Sponsor|1|||
130754005|NCT02587598|470720369|FG010|Overall Study|Study Terminated by the Sponsor|6|||
130754006|NCT02587598|470720359|FG000|Overall Study|Reason for study withdrawal not specified|0|||
130754007|NCT02587598|470720360|FG001|Overall Study|Reason for study withdrawal not specified|1|||
130754008|NCT02587598|470720361|FG002|Overall Study|Reason for study withdrawal not specified|0|||
130754009|NCT02587598|470720362|FG003|Overall Study|Reason for study withdrawal not specified|0|||
130754010|NCT02587598|470720363|FG004|Overall Study|Reason for study withdrawal not specified|0|||
130754011|NCT02587598|470720364|FG005|Overall Study|Reason for study withdrawal not specified|0|||
130754012|NCT02587598|470720365|FG006|Overall Study|Reason for study withdrawal not specified|0|||
130754013|NCT02587598|470720366|FG007|Overall Study|Reason for study withdrawal not specified|0|||
130754014|NCT02587598|470720367|FG008|Overall Study|Reason for study withdrawal not specified|0|||
130754015|NCT02587598|470720368|FG009|Overall Study|Reason for study withdrawal not specified|0|||
130754016|NCT02587598|470720369|FG010|Overall Study|Reason for study withdrawal not specified|0|||
130754017|NCT02587598|470720359|FG000|Overall Study|Withdrawal by Subject|0|||
130754018|NCT02587598|470720360|FG001|Overall Study|Withdrawal by Subject|1|||
130754019|NCT02587598|470720361|FG002|Overall Study|Withdrawal by Subject|0|||
130754020|NCT02587598|470720362|FG003|Overall Study|Withdrawal by Subject|2|||
130754021|NCT02587598|470720363|FG004|Overall Study|Withdrawal by Subject|3|||
130754022|NCT02587598|470720364|FG005|Overall Study|Withdrawal by Subject|1|||
130754023|NCT02587598|470720365|FG006|Overall Study|Withdrawal by Subject|0|||
130754024|NCT02587598|470720366|FG007|Overall Study|Withdrawal by Subject|0|||
130754025|NCT02587598|470720367|FG008|Overall Study|Withdrawal by Subject|0|||
130754026|NCT02587598|470720368|FG009|Overall Study|Withdrawal by Subject|1|||
130754027|NCT02587598|470720369|FG010|Overall Study|Withdrawal by Subject|2|||
130754028|NCT02587598|470720359|FG000|Overall Study|Physician Decision|0|||
130754029|NCT02587598|470720360|FG001|Overall Study|Physician Decision|0|||
130754030|NCT02587598|470720361|FG002|Overall Study|Physician Decision|0|||
130754031|NCT02587598|470720362|FG003|Overall Study|Physician Decision|0|||
130754032|NCT02587598|470720363|FG004|Overall Study|Physician Decision|0|||
130754033|NCT02587598|470720364|FG005|Overall Study|Physician Decision|0|||
130754034|NCT02587598|470720365|FG006|Overall Study|Physician Decision|0|||
130754035|NCT02587598|470720366|FG007|Overall Study|Physician Decision|0|||
130754036|NCT02587598|470720367|FG008|Overall Study|Physician Decision|0|||
130754037|NCT02587598|470720368|FG009|Overall Study|Physician Decision|0|||
130754038|NCT02587598|470720369|FG010|Overall Study|Physician Decision|3|||
130754039|NCT02394340|470720374|FG000|Overall Study|Failed drug screen test|1|||
130754040|NCT02394340|470720374|FG000|Overall Study|Adverse Event|1|||
130754041|NCT00256854|470720375|FG000|Overall Study|Withdrawal by Subject|2|||
130754042|NCT00256854|470720376|FG001|Overall Study|Withdrawal by Subject|3|||
130754043|NCT00256854|470720377|FG002|Overall Study|Withdrawal by Subject|0|||
130754044|NCT00256854|470720378|FG003|Overall Study|Withdrawal by Subject|0|||
130754045|NCT00256854|470720379|FG004|Overall Study|Withdrawal by Subject|0|||
130754046|NCT00256854|470720380|FG005|Overall Study|Withdrawal by Subject|0|||
130754047|NCT00256854|470720375|FG000|Overall Study|Lack of Efficacy|1|||
130754048|NCT00256854|470720376|FG001|Overall Study|Lack of Efficacy|0|||
130754049|NCT00256854|470720377|FG002|Overall Study|Lack of Efficacy|0|||
130754050|NCT00256854|470720378|FG003|Overall Study|Lack of Efficacy|0|||
130754051|NCT00256854|470720379|FG004|Overall Study|Lack of Efficacy|0|||
130754052|NCT00256854|470720380|FG005|Overall Study|Lack of Efficacy|0|||
130754053|NCT00256854|470720375|FG000|Overall Study|Protocol Violation|0|||
130754054|NCT00256854|470720376|FG001|Overall Study|Protocol Violation|1|||
130754055|NCT00256854|470720377|FG002|Overall Study|Protocol Violation|1|||
130754056|NCT00256854|470720378|FG003|Overall Study|Protocol Violation|1|||
130754057|NCT00256854|470720379|FG004|Overall Study|Protocol Violation|0|||
130754058|NCT00256854|470720380|FG005|Overall Study|Protocol Violation|0|||
130789042|NCT01387269|470856739|FG000|Overall Study|Unrelated AE|12|||
130754059|NCT00256854|470720375|FG000|Overall Study|Adverse Event|0|||
130754060|NCT00256854|470720376|FG001|Overall Study|Adverse Event|0|||
130754061|NCT00256854|470720377|FG002|Overall Study|Adverse Event|2|||
130754062|NCT00256854|470720378|FG003|Overall Study|Adverse Event|2|||
130754063|NCT00256854|470720379|FG004|Overall Study|Adverse Event|0|||
130754064|NCT00256854|470720380|FG005|Overall Study|Adverse Event|1|||
130754065|NCT00256854|470720375|FG000|Overall Study|Not compliant with the study drug|0|||
130754066|NCT00256854|470720376|FG001|Overall Study|Not compliant with the study drug|0|||
130754067|NCT00256854|470720377|FG002|Overall Study|Not compliant with the study drug|0|||
130754068|NCT00256854|470720378|FG003|Overall Study|Not compliant with the study drug|0|||
130754069|NCT00256854|470720379|FG004|Overall Study|Not compliant with the study drug|1|||
130754070|NCT00256854|470720380|FG005|Overall Study|Not compliant with the study drug|0|||
130754071|NCT02353442|470720381|FG000|Overall Study|Withdrawal by Subject|3|||
130754072|NCT02353442|470720382|FG001|Overall Study|Withdrawal by Subject|4|||
130754073|NCT03514485|470720383|FG000|Overall Study|Lost to Follow-up|5|||
130754074|NCT03514485|470720384|FG001|Overall Study|Lost to Follow-up|3|||
130754075|NCT03514485|470720385|FG002|Overall Study|Lost to Follow-up|2|||
130754076|NCT03514485|470720386|FG003|Overall Study|Lost to Follow-up|0|||
130754077|NCT03514485|470720387|FG004|Overall Study|Lost to Follow-up|1|||
130754078|NCT03514485|470720388|FG005|Overall Study|Lost to Follow-up|4|||
130754079|NCT03514485|470720383|FG000|Overall Study|Withdrawal by Subject|0|||
130754080|NCT03514485|470720384|FG001|Overall Study|Withdrawal by Subject|1|||
130754081|NCT03514485|470720385|FG002|Overall Study|Withdrawal by Subject|3|||
130754082|NCT03514485|470720386|FG003|Overall Study|Withdrawal by Subject|1|||
130754083|NCT03514485|470720387|FG004|Overall Study|Withdrawal by Subject|2|||
130754084|NCT03514485|470720388|FG005|Overall Study|Withdrawal by Subject|1|||
130754085|NCT00791661|470720389|FG000|7 Day Wash-out|Adverse Event|0|||
130754086|NCT00791661|470720390|FG001|7 Day Wash-out|Adverse Event|0|||
130754087|NCT00791661|470720391|FG002|7 Day Wash-out|Adverse Event|1|||
130754088|NCT00791661|470720389|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
130754089|NCT00791661|470720390|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
130754090|NCT00791661|470720391|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
130754091|NCT01355575|470720394|FG000|Overall Study|Withdrawal by Subject|2|||
130754092|NCT02294396|470720395|FG000|Overall Study|Adverse Event|26|||
130754093|NCT02294396|470720396|FG001|Overall Study|Adverse Event|25|||
130754094|NCT02294396|470720397|FG002|Overall Study|Adverse Event|21|||
130754095|NCT02294396|470720398|FG003|Overall Study|Adverse Event|24|||
130754096|NCT02294396|470720395|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
130754097|NCT02294396|470720396|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
130754098|NCT02294396|470720397|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
130754099|NCT02294396|470720398|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
130754100|NCT02294396|470720395|FG000|Overall Study|Withdrawal by Subject|8|||
130754101|NCT02294396|470720396|FG001|Overall Study|Withdrawal by Subject|6|||
130754102|NCT02294396|470720397|FG002|Overall Study|Withdrawal by Subject|6|||
130754103|NCT02294396|470720398|FG003|Overall Study|Withdrawal by Subject|8|||
130754104|NCT02294396|470720395|FG000|Overall Study|Lost to Follow-up|0|||
130754105|NCT02294396|470720396|FG001|Overall Study|Lost to Follow-up|0|||
130754106|NCT02294396|470720397|FG002|Overall Study|Lost to Follow-up|1|||
130754107|NCT02294396|470720398|FG003|Overall Study|Lost to Follow-up|1|||
130754108|NCT02294396|470720395|FG000|Overall Study|Protocol Deviation|3|||
130754109|NCT02294396|470720396|FG001|Overall Study|Protocol Deviation|2|||
130754110|NCT02294396|470720397|FG002|Overall Study|Protocol Deviation|2|||
130754111|NCT02294396|470720398|FG003|Overall Study|Protocol Deviation|1|||
130754112|NCT02294396|470720395|FG000|Overall Study|Miscellaneous|2|||
130754113|NCT02294396|470720396|FG001|Overall Study|Miscellaneous|0|||
130754114|NCT02294396|470720397|FG002|Overall Study|Miscellaneous|5|||
130754115|NCT02294396|470720398|FG003|Overall Study|Miscellaneous|2|||
130754116|NCT02120833|470720399|FG000|Overall Study|Adverse Event|1|||
130754117|NCT02120833|470720400|FG001|Overall Study|Adverse Event|0|||
130754118|NCT02120833|470720399|FG000|Overall Study|Withdrawal by Subject|2|||
130754119|NCT02120833|470720400|FG001|Overall Study|Withdrawal by Subject|0|||
130754120|NCT02120833|470720399|FG000|Overall Study|Lost to Follow-up|1|||
130754121|NCT02120833|470720400|FG001|Overall Study|Lost to Follow-up|1|||
130754122|NCT02438826|470720401|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
130754123|NCT02438826|470720402|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
130754124|NCT02438826|470720403|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
130754125|NCT02438826|470720404|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130754126|NCT02438826|470720401|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
130754127|NCT02438826|470720402|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130754128|NCT02438826|470720403|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130754129|NCT02438826|470720404|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130754130|NCT02438826|470720401|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
130754131|NCT02438826|470720402|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
130754132|NCT02438826|470720403|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130754133|NCT02438826|470720404|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130754134|NCT02438826|470720401|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
130754135|NCT02438826|470720402|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
130754136|NCT02438826|470720403|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
130754137|NCT02438826|470720404|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
130754138|NCT02438826|470720401|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
130754139|NCT02438826|470720402|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
130754140|NCT02438826|470720403|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
130754141|NCT02438826|470720404|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
130754142|NCT02438826|470720401|FG000|Open-Label Treatment Phase|Adverse Event|11|||
130754143|NCT02438826|470720402|FG001|Open-Label Treatment Phase|Adverse Event|6|||
130754144|NCT02438826|470720403|FG002|Open-Label Treatment Phase|Adverse Event|0|||
130754145|NCT02438826|470720404|FG003|Open-Label Treatment Phase|Adverse Event|0|||
130754146|NCT02438826|470720401|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
130754147|NCT02438826|470720402|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
130754148|NCT02438826|470720403|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
130754149|NCT02438826|470720404|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
130754150|NCT02438826|470720401|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
130754151|NCT02438826|470720402|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
130754152|NCT02438826|470720403|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
130754153|NCT02438826|470720404|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
130754154|NCT02438826|470720401|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
130754155|NCT02438826|470720402|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
130754156|NCT02438826|470720403|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
130754157|NCT02438826|470720404|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
130754158|NCT02438826|470720401|FG000|Post-Treatment Phase|Adverse Event|3|||
130754159|NCT02438826|470720402|FG001|Post-Treatment Phase|Adverse Event|0|||
130754160|NCT02438826|470720403|FG002|Post-Treatment Phase|Adverse Event|0|||
130754161|NCT02438826|470720404|FG003|Post-Treatment Phase|Adverse Event|0|||
130754162|NCT02438826|470720401|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
130754163|NCT02438826|470720402|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
130754164|NCT02438826|470720403|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
130754165|NCT02438826|470720404|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
130754166|NCT02438826|470720401|FG000|Post-Treatment Phase|Physician Decision|1|||
130754167|NCT02438826|470720402|FG001|Post-Treatment Phase|Physician Decision|0|||
130754168|NCT02438826|470720403|FG002|Post-Treatment Phase|Physician Decision|0|||
130754169|NCT02438826|470720404|FG003|Post-Treatment Phase|Physician Decision|0|||
130754170|NCT02438826|470720401|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
130754171|NCT02438826|470720402|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
130754172|NCT02438826|470720403|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
130754173|NCT02438826|470720404|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
130754174|NCT04105218|470720410|FG000|Overall Study|Withdrawal by Subject|3|||
130754175|NCT04105218|470720411|FG001|Overall Study|Withdrawal by Subject|2|||
130754176|NCT04105218|470720410|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
130754177|NCT04105218|470720411|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
130754178|NCT04105218|470720410|FG000|Overall Study|Failed screening tests|2|||
130754179|NCT04105218|470720411|FG001|Overall Study|Failed screening tests|1|||
130754180|NCT01435460|470720412|FG000|Overall Study|Adverse Event|2|||
130754181|NCT01435460|470720413|FG001|Overall Study|Adverse Event|1|||
130754182|NCT01435460|470720412|FG000|Overall Study|Lost to Follow-up|6|||
130754183|NCT01435460|470720413|FG001|Overall Study|Lost to Follow-up|1|||
130754184|NCT01435460|470720412|FG000|Overall Study|Withdrawal by Subject|1|||
130754185|NCT01435460|470720413|FG001|Overall Study|Withdrawal by Subject|3|||
130754186|NCT01435460|470720412|FG000|Overall Study|Protocol Violation|0|||
130754187|NCT01435460|470720413|FG001|Overall Study|Protocol Violation|1|||
130754188|NCT01435460|470720412|FG000|Overall Study|Did not meet eligibility criteria|2|||
130754189|NCT01435460|470720413|FG001|Overall Study|Did not meet eligibility criteria|0|||
130754190|NCT01706939|470720414|FG000|Pre Randomization|Screen Failure|1|||
130754191|NCT01706939|470720415|FG001|Pre Randomization|Screen Failure|0|||
130754192|NCT01706939|470720416|FG002|Pre Randomization|Screen Failure|0|||
130754193|NCT01706939|470720414|FG000|Pre Randomization|Ineligible for Randomization|1|||
130754194|NCT01706939|470720415|FG001|Pre Randomization|Ineligible for Randomization|0|||
130754195|NCT01706939|470720416|FG002|Pre Randomization|Ineligible for Randomization|0|||
130754196|NCT01706939|470720414|FG000|Pre Randomization|Withdrawal by Subject|1|||
130754197|NCT01706939|470720415|FG001|Pre Randomization|Withdrawal by Subject|0|||
130754198|NCT01706939|470720416|FG002|Pre Randomization|Withdrawal by Subject|0|||
130754199|NCT01706939|470720414|FG000|Randomization|Insufficient QoL survey compliance|0|||
130754200|NCT01706939|470720415|FG001|Randomization|Insufficient QoL survey compliance|1|||
130754201|NCT01706939|470720416|FG002|Randomization|Insufficient QoL survey compliance|1|||
130754202|NCT01706939|470720414|FG000|Randomization|Progression of disease|0|||
130754203|NCT01706939|470720415|FG001|Randomization|Progression of disease|2|||
130754204|NCT01706939|470720416|FG002|Randomization|Progression of disease|1|||
130754205|NCT01046903|470720418|FG000|Overall Study|Lost to Follow-up|16|||
130754206|NCT01046903|470720418|FG000|Overall Study|Adverse Event|4|||
130754207|NCT01046903|470720418|FG000|Overall Study|Withdrawal by Subject|3|||
130754208|NCT01046903|470720418|FG000|Overall Study|Other|5|||
130754209|NCT04152837|470720430|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
130754210|NCT04152837|470720430|FG000|Maintenance Period|Adverse Event|1|||
130754211|NCT04152837|470720430|FG000|Maintenance Period|Withdrawal by Subject|1|||
130754212|NCT04152837|470720430|FG000|Maintenance Period|Sponsor Termination of Study|2|||
130754213|NCT00101166|470720433|FG000|Overall Study|progressive disease|10|||
130754214|NCT00686829|470720434|FG000|Overall Study|Adverse Event|5|||
130754215|NCT00686829|470720434|FG000|Overall Study|Lack of Efficacy|6|||
130754216|NCT00686829|470720434|FG000|Overall Study|Lost to Follow-up|4|||
130754217|NCT00686829|470720434|FG000|Overall Study|Withdrawal by Subject|14|||
130754218|NCT00686829|470720434|FG000|Overall Study|Protocol Violation|3|||
130754219|NCT00686829|470720434|FG000|Overall Study|Sponsor discontinued VCV|47|||
130754220|NCT01217476|470720437|FG000|Overall Study|Adverse Event|6|||
130754221|NCT01217476|470720438|FG001|Overall Study|Adverse Event|1|||
130754222|NCT01217476|470720437|FG000|Overall Study|Physician Decision|0|||
130754223|NCT01217476|470720438|FG001|Overall Study|Physician Decision|1|||
130754224|NCT01217476|470720437|FG000|Overall Study|Withdrawal by Subject|3|||
130754225|NCT01217476|470720438|FG001|Overall Study|Withdrawal by Subject|3|||
130754226|NCT01217476|470720437|FG000|Overall Study|Surgery on the Target Limb|0|||
130754227|NCT01217476|470720438|FG001|Overall Study|Surgery on the Target Limb|2|||
130754228|NCT01217476|470720437|FG000|Overall Study|Protocol Deviation|1|||
130754229|NCT01217476|470720438|FG001|Overall Study|Protocol Deviation|0|||
130754230|NCT01217476|470720437|FG000|Overall Study|Other|2|||
130754231|NCT01217476|470720438|FG001|Overall Study|Other|0|||
130754232|NCT03033602|470720439|FG000|Overall Study|Withdrawal by Subject|11|||
130754233|NCT03033602|470720440|FG001|Overall Study|Withdrawal by Subject|21|||
130754234|NCT03033602|470720439|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
130754235|NCT03033602|470720440|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
130754236|NCT04445714|470720441|FG000|Overall Study|Discontinuation of the study|14|||
130754237|NCT04445714|470720441|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
130754238|NCT04445714|470720441|FG000|Overall Study|Withdrawal of Informed Consent|8|||
130754239|NCT01672710|470720442|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
130754240|NCT01672710|470720443|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
130754241|NCT01672710|470720442|FG000|3 Month Follow up|Lost to Follow-up|2|||
130754242|NCT01672710|470720443|FG001|3 Month Follow up|Lost to Follow-up|3|||
130754243|NCT01672710|470720442|FG000|3 Month Follow up|follow up due after termination date|4|||
130754244|NCT01672710|470720443|FG001|3 Month Follow up|follow up due after termination date|1|||
130754245|NCT04999163|470720444|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
130754246|NCT04999163|470720445|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
130754247|NCT04999163|470720444|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
130754248|NCT04999163|470720445|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
130754249|NCT04999163|470720444|FG000|Overall Study|Withdrawal by Subject|1|||
130754250|NCT04999163|470720445|FG001|Overall Study|Withdrawal by Subject|0|||
130754251|NCT01399047|470721966|FG000|Overall Study|Withdrawal by Subject|0|||
130754252|NCT01399047|470721967|FG001|Overall Study|Withdrawal by Subject|1|||
130754253|NCT01283334|470721975|FG000|Overall Study|Withdrawal by Subject|1|||
130754254|NCT01283334|470721975|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
130754255|NCT01283334|470721975|FG000|Overall Study|Adverse Event|4|||
130754256|NCT01283334|470721975|FG000|Overall Study|Physician Decision|1|||
130754257|NCT03467217|470721976|FG000|Overall Study|Trial stopped early|5|||
130754258|NCT03467217|470721977|FG001|Overall Study|Trial stopped early|2|||
130754259|NCT03467217|470721976|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
130754260|NCT03467217|470721977|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
130754261|NCT03467217|470721976|FG000|Overall Study|Lost to Follow-up|0|||
130754262|NCT03467217|470721977|FG001|Overall Study|Lost to Follow-up|2|||
130754263|NCT03233529|470721981|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
130754264|NCT03233529|470721981|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
130754265|NCT01177293|470721982|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
130754266|NCT01177293|470721983|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
130754267|NCT00160706|470721985|FG000|Overall Study|Adverse Event|53|||
130754268|NCT00160706|470721985|FG000|Overall Study|Adverse Event and Other Reason|105|||
130754269|NCT00160706|470721985|FG000|Overall Study|Protocol Violation|3|||
130754270|NCT00160706|470721985|FG000|Overall Study|Withdrawal by Subject|41|||
130754271|NCT00160706|470721985|FG000|Overall Study|Withdrawal by Subject and Other|12|||
130754272|NCT00160706|470721985|FG000|Overall Study|Physician Decision|10|||
130754273|NCT00160706|470721985|FG000|Overall Study|Physician Decision and Other|3|||
130754274|NCT00160706|470721985|FG000|Overall Study|Lost to Follow-up|4|||
130754275|NCT00160706|470721985|FG000|Overall Study|Lost to Follow-up and Other|1|||
130754276|NCT00160706|470721985|FG000|Overall Study|Lack of Efficacy|42|||
130754277|NCT00160706|470721985|FG000|Overall Study|Lack of Efficacy and Other|1|||
130754278|NCT00160706|470721985|FG000|Overall Study|Other Reason|11|||
130754279|NCT03214380|470721986|FG000|Lead-in|Adverse Event|3|||
130754280|NCT03214380|470721987|FG001|Lead-in|Adverse Event|0|||
130754281|NCT03214380|470721988|FG002|Lead-in|Adverse Event|0|||
130754282|NCT03214380|470721989|FG003|Lead-in|Adverse Event|1|||
130754283|NCT03214380|470721990|FG004|Lead-in|Adverse Event|0|||
130754284|NCT03214380|470721991|FG005|Lead-in|Adverse Event|0|||
130754285|NCT03214380|470721986|FG000|Lead-in|Lost to Follow-up|4|||
130754286|NCT03214380|470721987|FG001|Lead-in|Lost to Follow-up|0|||
130754287|NCT03214380|470721988|FG002|Lead-in|Lost to Follow-up|0|||
130754288|NCT03214380|470721989|FG003|Lead-in|Lost to Follow-up|1|||
130754289|NCT03214380|470721990|FG004|Lead-in|Lost to Follow-up|0|||
130754290|NCT03214380|470721991|FG005|Lead-in|Lost to Follow-up|0|||
130754291|NCT03214380|470721986|FG000|Lead-in|Eligibility Criteria|3|||
130754292|NCT03214380|470721987|FG001|Lead-in|Eligibility Criteria|0|||
130754293|NCT03214380|470721988|FG002|Lead-in|Eligibility Criteria|0|||
130754294|NCT03214380|470721989|FG003|Lead-in|Eligibility Criteria|0|||
130754295|NCT03214380|470721990|FG004|Lead-in|Eligibility Criteria|0|||
130754296|NCT03214380|470721991|FG005|Lead-in|Eligibility Criteria|0|||
130754297|NCT03214380|470721986|FG000|Lead-in|Physician Decision|6|||
130754298|NCT03214380|470721987|FG001|Lead-in|Physician Decision|0|||
130754299|NCT03214380|470721988|FG002|Lead-in|Physician Decision|0|||
130754300|NCT03214380|470721989|FG003|Lead-in|Physician Decision|0|||
130754301|NCT03214380|470721990|FG004|Lead-in|Physician Decision|0|||
130754302|NCT03214380|470721991|FG005|Lead-in|Physician Decision|0|||
130754303|NCT03214380|470721986|FG000|Lead-in|Protocol Deviation|7|||
130754304|NCT03214380|470721987|FG001|Lead-in|Protocol Deviation|0|||
130754305|NCT03214380|470721988|FG002|Lead-in|Protocol Deviation|0|||
130754306|NCT03214380|470721989|FG003|Lead-in|Protocol Deviation|3|||
130754307|NCT03214380|470721990|FG004|Lead-in|Protocol Deviation|0|||
130754308|NCT03214380|470721991|FG005|Lead-in|Protocol Deviation|0|||
130754309|NCT03214380|470721986|FG000|Lead-in|Withdrawal by Subject|41|||
130754310|NCT03214380|470721987|FG001|Lead-in|Withdrawal by Subject|0|||
130754311|NCT03214380|470721988|FG002|Lead-in|Withdrawal by Subject|0|||
130754312|NCT03214380|470721989|FG003|Lead-in|Withdrawal by Subject|14|||
130754313|NCT03214380|470721990|FG004|Lead-in|Withdrawal by Subject|0|||
130754314|NCT03214380|470721991|FG005|Lead-in|Withdrawal by Subject|0|||
130754315|NCT03214380|470721986|FG000|Lead-in|Family Emergency|1|||
130754316|NCT03214380|470721987|FG001|Lead-in|Family Emergency|0|||
130754317|NCT03214380|470721988|FG002|Lead-in|Family Emergency|0|||
130754318|NCT03214380|470721989|FG003|Lead-in|Family Emergency|0|||
130754319|NCT03214380|470721990|FG004|Lead-in|Family Emergency|0|||
130754320|NCT03214380|470721991|FG005|Lead-in|Family Emergency|0|||
130754321|NCT03214380|470721986|FG000|Lead-in|Natural Disaster|9|||
130754322|NCT03214380|470721987|FG001|Lead-in|Natural Disaster|0|||
130754323|NCT03214380|470721988|FG002|Lead-in|Natural Disaster|0|||
130754324|NCT03214380|470721989|FG003|Lead-in|Natural Disaster|0|||
130754325|NCT03214380|470721990|FG004|Lead-in|Natural Disaster|0|||
130754326|NCT03214380|470721991|FG005|Lead-in|Natural Disaster|0|||
130754327|NCT03214380|470721986|FG000|Lead-in|Non Compliance|1|||
130754328|NCT03214380|470721987|FG001|Lead-in|Non Compliance|0|||
130754329|NCT03214380|470721988|FG002|Lead-in|Non Compliance|0|||
130754330|NCT03214380|470721989|FG003|Lead-in|Non Compliance|0|||
130754331|NCT03214380|470721990|FG004|Lead-in|Non Compliance|0|||
130754332|NCT03214380|470721991|FG005|Lead-in|Non Compliance|0|||
130754333|NCT03214380|470721986|FG000|Lead-in|Participant Schedule|2|||
130754334|NCT03214380|470721987|FG001|Lead-in|Participant Schedule|0|||
130754335|NCT03214380|470721988|FG002|Lead-in|Participant Schedule|0|||
130754336|NCT03214380|470721989|FG003|Lead-in|Participant Schedule|0|||
130754337|NCT03214380|470721990|FG004|Lead-in|Participant Schedule|0|||
130754338|NCT03214380|470721991|FG005|Lead-in|Participant Schedule|0|||
130754339|NCT03214380|470721986|FG000|Treatment Period|Adverse Event|0|||
130754340|NCT03214380|470721987|FG001|Treatment Period|Adverse Event|1|||
130754341|NCT03214380|470721988|FG002|Treatment Period|Adverse Event|1|||
130754342|NCT03214380|470721989|FG003|Treatment Period|Adverse Event|0|||
130754343|NCT03214380|470721990|FG004|Treatment Period|Adverse Event|1|||
130754344|NCT03214380|470721991|FG005|Treatment Period|Adverse Event|0|||
130754345|NCT03214380|470721986|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
130754346|NCT03214380|470721987|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
130754347|NCT03214380|470721988|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
130754348|NCT03214380|470721989|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
130754349|NCT03214380|470721990|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
130754350|NCT03214380|470721991|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
130754351|NCT03214380|470721986|FG000|Treatment Period|Withdrawal by Subject|0|||
130754352|NCT03214380|470721987|FG001|Treatment Period|Withdrawal by Subject|10|||
130754353|NCT03214380|470721988|FG002|Treatment Period|Withdrawal by Subject|8|||
130754354|NCT03214380|470721989|FG003|Treatment Period|Withdrawal by Subject|0|||
130754355|NCT03214380|470721990|FG004|Treatment Period|Withdrawal by Subject|7|||
130754356|NCT03214380|470721991|FG005|Treatment Period|Withdrawal by Subject|11|||
130754357|NCT03214380|470721986|FG000|Treatment Period|Death|0|||
130754358|NCT03214380|470721987|FG001|Treatment Period|Death|1|||
130754359|NCT03214380|470721988|FG002|Treatment Period|Death|2|||
130754360|NCT03214380|470721989|FG003|Treatment Period|Death|0|||
130754361|NCT03214380|470721990|FG004|Treatment Period|Death|0|||
130754362|NCT03214380|470721991|FG005|Treatment Period|Death|0|||
130754363|NCT03214380|470721986|FG000|Treatment Period|Lost to Follow-up|0|||
130754364|NCT03214380|470721987|FG001|Treatment Period|Lost to Follow-up|6|||
130754365|NCT03214380|470721988|FG002|Treatment Period|Lost to Follow-up|3|||
130754366|NCT03214380|470721989|FG003|Treatment Period|Lost to Follow-up|0|||
130754367|NCT03214380|470721990|FG004|Treatment Period|Lost to Follow-up|0|||
130754368|NCT03214380|470721991|FG005|Treatment Period|Lost to Follow-up|0|||
130754369|NCT03214380|470721986|FG000|Treatment Period|Participant schedule|0|||
130754370|NCT03214380|470721987|FG001|Treatment Period|Participant schedule|0|||
130754371|NCT03214380|470721988|FG002|Treatment Period|Participant schedule|1|||
130754372|NCT03214380|470721989|FG003|Treatment Period|Participant schedule|0|||
130754373|NCT03214380|470721990|FG004|Treatment Period|Participant schedule|0|||
130754374|NCT03214380|470721991|FG005|Treatment Period|Participant schedule|0|||
130754375|NCT03214380|470721986|FG000|Treatment Period|Treatment Interruption|0|||
130754376|NCT03214380|470721987|FG001|Treatment Period|Treatment Interruption|0|||
130754377|NCT03214380|470721988|FG002|Treatment Period|Treatment Interruption|1|||
130754378|NCT03214380|470721989|FG003|Treatment Period|Treatment Interruption|0|||
130754379|NCT03214380|470721990|FG004|Treatment Period|Treatment Interruption|0|||
130754380|NCT03214380|470721991|FG005|Treatment Period|Treatment Interruption|0|||
130754381|NCT01905553|470721998|FG000|Period 2|Adverse Event|1|||
130754382|NCT01905553|470721999|FG001|Period 2|Adverse Event|0|||
130754383|NCT01683266|470722009|FG000|Overall Study|Adverse Event|5|||
130754384|NCT01683266|470722010|FG001|Overall Study|Adverse Event|4|||
130754385|NCT01683266|470722009|FG000|Overall Study|Lack of Efficacy|5|||
130754386|NCT01683266|470722010|FG001|Overall Study|Lack of Efficacy|2|||
130754387|NCT01683266|470722009|FG000|Overall Study|Protocol Violation|13|||
130754388|NCT01683266|470722010|FG001|Overall Study|Protocol Violation|6|||
130754389|NCT01683266|470722009|FG000|Overall Study|Personal Reason|17|||
130754390|NCT01683266|470722010|FG001|Overall Study|Personal Reason|25|||
130754391|NCT01683266|470722009|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
130754392|NCT01683266|470722010|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
130754393|NCT01683266|470722009|FG000|Overall Study|Lost to Follow-up|5|||
130754394|NCT01683266|470722010|FG001|Overall Study|Lost to Follow-up|0|||
130754395|NCT01683266|470722009|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
130754396|NCT01683266|470722010|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
130754397|NCT01683266|470722009|FG000|Overall Study|Nonserious Hypoglycemia|0|||
130754398|NCT01683266|470722010|FG001|Overall Study|Nonserious Hypoglycemia|3|||
130754399|NCT01683266|470722009|FG000|Overall Study|Perceived Lack of Efficacy|1|||
130754400|NCT01683266|470722010|FG001|Overall Study|Perceived Lack of Efficacy|1|||
130754401|NCT01683266|470722009|FG000|Overall Study|Possibly Hypoglycemia|1|||
130754402|NCT01683266|470722010|FG001|Overall Study|Possibly Hypoglycemia|0|||
130754403|NCT01683266|470722009|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
130754404|NCT01683266|470722010|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
130754405|NCT00626821|470722011|FG000|Overall Study|Adverse Event|44|||
130754406|NCT00626821|470722011|FG000|Overall Study|Protocol Violation|33|||
130754407|NCT00626821|470722011|FG000|Overall Study|Withdrawal by Subject|10|||
130754408|NCT00626821|470722011|FG000|Overall Study|Physician Decision|9|||
130754409|NCT00626821|470722011|FG000|Overall Study|Product dysfunction|21|||
130754410|NCT00626821|470722011|FG000|Overall Study|other/unknown reason|104|||
130754411|NCT01062113|470722019|FG000|Overall Study|Adverse Event|1|||
130754412|NCT01062113|470722020|FG001|Overall Study|Adverse Event|0|||
130754413|NCT01062113|470722021|FG002|Overall Study|Adverse Event|0|||
130754414|NCT01062113|470722019|FG000|Overall Study|Lack of Efficacy|38|||
130754415|NCT01062113|470722020|FG001|Overall Study|Lack of Efficacy|22|||
130754416|NCT01062113|470722021|FG002|Overall Study|Lack of Efficacy|31|||
130754417|NCT01062113|470722019|FG000|Overall Study|Withdrawal by Subject|1|||
130754418|NCT01062113|470722020|FG001|Overall Study|Withdrawal by Subject|0|||
130754419|NCT01062113|470722021|FG002|Overall Study|Withdrawal by Subject|0|||
130754420|NCT01471340|470722022|FG000|Overall Study|Death|5|||
130754421|NCT01471340|470722023|FG001|Overall Study|Death|4|||
130754422|NCT01471340|470722022|FG000|Overall Study|Lost to Follow-up|0|||
130754423|NCT01471340|470722023|FG001|Overall Study|Lost to Follow-up|1|||
130754424|NCT01471340|470722022|FG000|Overall Study|Investigational site closure|0|||
130754425|NCT01471340|470722023|FG001|Overall Study|Investigational site closure|1|||
130754426|NCT01471340|470722022|FG000|Overall Study|Invalid informed consent|1|||
130754427|NCT01471340|470722023|FG001|Overall Study|Invalid informed consent|0|||
130754428|NCT00526669|470722026|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
130754429|NCT00526669|470722027|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
130754430|NCT00526669|470722026|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
130754431|NCT00526669|470722027|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
130754432|NCT00526669|470722026|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
130754433|NCT00526669|470722027|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
130754434|NCT00526669|470722026|FG000|Combined Treatment Phase|Death|0|||
130754435|NCT00526669|470722027|FG001|Combined Treatment Phase|Death|2|||
130754436|NCT03499899|470722028|FG000|Overall Study|Adverse Event|2|||
130754437|NCT03499899|470722029|FG001|Overall Study|Adverse Event|3|||
130754438|NCT03499899|470722030|FG002|Overall Study|Adverse Event|3|||
130754439|NCT03499899|470722028|FG000|Overall Study|Death|0|||
130754440|NCT03499899|470722029|FG001|Overall Study|Death|0|||
130754441|NCT03499899|470722030|FG002|Overall Study|Death|1|||
130754442|NCT03499899|470722028|FG000|Overall Study|Physician Decision|3|||
130754443|NCT03499899|470722029|FG001|Overall Study|Physician Decision|6|||
130754444|NCT03499899|470722030|FG002|Overall Study|Physician Decision|6|||
130754445|NCT03499899|470722028|FG000|Overall Study|Progressive disease|15|||
130754446|NCT03499899|470722029|FG001|Overall Study|Progressive disease|23|||
130754447|NCT03499899|470722030|FG002|Overall Study|Progressive disease|23|||
130754448|NCT03499899|470722028|FG000|Overall Study|Patient decision|0|||
130754449|NCT03499899|470722029|FG001|Overall Study|Patient decision|1|||
130754450|NCT03499899|470722030|FG002|Overall Study|Patient decision|1|||
130754451|NCT03499899|470722028|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
130754452|NCT03499899|470722029|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
130754453|NCT03499899|470722030|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
130754454|NCT01082211|470722032|FG000|Overall Study|Protocol Violation|4|||
130754455|NCT01082211|470722032|FG000|Overall Study|No protocol treatment received|3|||
130754456|NCT04016779|470722045|FG000|Overall Study|Adverse Event|9|||
130754457|NCT04016779|470722046|FG001|Overall Study|Adverse Event|17|||
130754458|NCT04016779|470722045|FG000|Overall Study|Lack of Efficacy|4|||
130754459|NCT04016779|470722046|FG001|Overall Study|Lack of Efficacy|1|||
130754460|NCT04016779|470722045|FG000|Overall Study|Lost to Follow-up|5|||
130754461|NCT04016779|470722046|FG001|Overall Study|Lost to Follow-up|14|||
130754462|NCT04016779|470722045|FG000|Overall Study|Physician Decision|1|||
130754463|NCT04016779|470722046|FG001|Overall Study|Physician Decision|3|||
130754464|NCT04016779|470722045|FG000|Overall Study|Withdrawal by Subject|6|||
130754465|NCT04016779|470722046|FG001|Overall Study|Withdrawal by Subject|8|||
130754466|NCT04016779|470722045|FG000|Overall Study|Non-compliance with Study Drug|2|||
130754467|NCT04016779|470722046|FG001|Overall Study|Non-compliance with Study Drug|3|||
130754468|NCT04016779|470722045|FG000|Overall Study|Other, Multiple categories|17|||
130754469|NCT04016779|470722046|FG001|Overall Study|Other, Multiple categories|17|||
130754470|NCT02295020|470722047|FG000|Overall Study|Adverse Event|0|||
130754471|NCT02295020|470722048|FG001|Overall Study|Adverse Event|1|||
130754472|NCT02295020|470722047|FG000|Overall Study|Withdrawal by Subject|3|||
130754473|NCT02295020|470722048|FG001|Overall Study|Withdrawal by Subject|2|||
130754474|NCT06586788|470722050|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
130754475|NCT00679289|470722052|FG000|Overall Study|Progressive disease|4|||
130754476|NCT00679289|470722053|FG001|Overall Study|Progressive disease|5|||
130754477|NCT00679289|470722054|FG002|Overall Study|Progressive disease|18|||
130754478|NCT00679289|470722052|FG000|Overall Study|Withdrawal by Subject|0|||
130754479|NCT00679289|470722053|FG001|Overall Study|Withdrawal by Subject|1|||
130754480|NCT00679289|470722054|FG002|Overall Study|Withdrawal by Subject|1|||
130754481|NCT00679289|470722052|FG000|Overall Study|Adverse Event|0|||
130754482|NCT00679289|470722053|FG001|Overall Study|Adverse Event|0|||
130754483|NCT00679289|470722054|FG002|Overall Study|Adverse Event|3|||
130754484|NCT00679289|470722052|FG000|Overall Study|Physician Decision|1|||
130754485|NCT00679289|470722053|FG001|Overall Study|Physician Decision|0|||
130754486|NCT00679289|470722054|FG002|Overall Study|Physician Decision|1|||
130754487|NCT01053962|470722055|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
130754488|NCT01053962|470722056|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
130754489|NCT01053962|470722057|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
130754490|NCT01053962|470722058|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
130754491|NCT01053962|470722059|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
130754492|NCT01053962|470722055|FG000|Pretreatment Period|Venipuncture Failure|0|||
130754493|NCT01053962|470722056|FG001|Pretreatment Period|Venipuncture Failure|0|||
130754494|NCT01053962|470722057|FG002|Pretreatment Period|Venipuncture Failure|1|||
130754495|NCT01053962|470722058|FG003|Pretreatment Period|Venipuncture Failure|0|||
130754496|NCT01053962|470722059|FG004|Pretreatment Period|Venipuncture Failure|0|||
130754497|NCT01053962|470722055|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130754498|NCT01053962|470722056|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
130754499|NCT01053962|470722057|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130754500|NCT01053962|470722058|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130754501|NCT01053962|470722059|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130754502|NCT01053962|470722055|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130754503|NCT01053962|470722056|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130754504|NCT01053962|470722057|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130754505|NCT01053962|470722058|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
130754506|NCT01053962|470722059|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130754507|NCT01053962|470722055|FG000|Treatment Period|Lack of Efficacy|0|||
130754508|NCT01053962|470722056|FG001|Treatment Period|Lack of Efficacy|0|||
130754509|NCT01053962|470722057|FG002|Treatment Period|Lack of Efficacy|0|||
130754510|NCT01053962|470722058|FG003|Treatment Period|Lack of Efficacy|0|||
130754511|NCT01053962|470722059|FG004|Treatment Period|Lack of Efficacy|1|||
130754512|NCT01053962|470722055|FG000|Treatment Period|Adverse Event|0|||
130754513|NCT01053962|470722056|FG001|Treatment Period|Adverse Event|0|||
130754514|NCT01053962|470722057|FG002|Treatment Period|Adverse Event|0|||
130754515|NCT01053962|470722058|FG003|Treatment Period|Adverse Event|0|||
130754516|NCT01053962|470722059|FG004|Treatment Period|Adverse Event|1|||
130754517|NCT01053962|470722055|FG000|Treatment Period|Withdrawal by Subject|0|||
130754518|NCT01053962|470722056|FG001|Treatment Period|Withdrawal by Subject|0|||
130754519|NCT01053962|470722057|FG002|Treatment Period|Withdrawal by Subject|0|||
130754520|NCT01053962|470722058|FG003|Treatment Period|Withdrawal by Subject|0|||
130754521|NCT01053962|470722059|FG004|Treatment Period|Withdrawal by Subject|1|||
130754522|NCT01053962|470722055|FG000|Treatment Period|Noncompliance with protocol|1|||
130754523|NCT01053962|470722056|FG001|Treatment Period|Noncompliance with protocol|0|||
130754524|NCT01053962|470722057|FG002|Treatment Period|Noncompliance with protocol|0|||
130754525|NCT01053962|470722058|FG003|Treatment Period|Noncompliance with protocol|0|||
130754526|NCT01053962|470722059|FG004|Treatment Period|Noncompliance with protocol|0|||
130754527|NCT00937040|470722060|FG000|Overall Study|Adverse Event|5|||
130754528|NCT00937040|470722061|FG001|Overall Study|Adverse Event|8|||
130754529|NCT00937040|470722060|FG000|Overall Study|Lost to Follow-up|12|||
130754530|NCT00937040|470722061|FG001|Overall Study|Lost to Follow-up|12|||
130754531|NCT00937040|470722060|FG000|Overall Study|Protocol Violation|3|||
130754532|NCT00937040|470722061|FG001|Overall Study|Protocol Violation|0|||
130754533|NCT00937040|470722060|FG000|Overall Study|Withdrawal by Subject|13|||
130754534|NCT00937040|470722061|FG001|Overall Study|Withdrawal by Subject|7|||
130754535|NCT00937040|470722060|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
130754536|NCT00937040|470722061|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
130754537|NCT00937040|470722060|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
130754538|NCT00937040|470722061|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
130754539|NCT00638443|470722062|FG000|First Intervention|Adverse Event|2|||
130754540|NCT00638443|470722063|FG001|First Intervention|Adverse Event|1|||
130754541|NCT00179673|470722065|FG000|Overall Study|Adverse Event|7|||
130754542|NCT00179673|470722065|FG000|Overall Study|Lack of Efficacy|15|||
130754543|NCT00179673|470722065|FG000|Overall Study|Withdrawal by Subject|3|||
130754544|NCT00179673|470722065|FG000|Overall Study|Death|4|||
130754545|NCT00179673|470722065|FG000|Overall Study|Other Observations and options|14|||
130754546|NCT03502070|470722067|FG000|Overall Study|Withdrawal by Subject|1|||
130754547|NCT03502070|470722067|FG000|Overall Study|Screen Failure|1|||
130754548|NCT00595517|470722070|FG000|Overall Study|Adverse Event|6|||
130754549|NCT00595517|470722070|FG000|Overall Study|Withdrawal by Subject|4|||
130754550|NCT00595517|470722070|FG000|Overall Study|Protocol Violation|2|||
130754551|NCT00595517|470722070|FG000|Overall Study|Recurrence of ulcer|5|||
130754552|NCT00595517|470722070|FG000|Overall Study|usage of prohibited treatment|1|||
130754553|NCT00595517|470722070|FG000|Overall Study|No intention to attend regularly|1|||
130754554|NCT01167881|470722073|FG000|Overall Study|Adverse Event|47|||
130754555|NCT01167881|470722074|FG001|Overall Study|Adverse Event|51|||
130754556|NCT01167881|470722073|FG000|Overall Study|Lack of Efficacy|4|||
130754557|NCT01167881|470722074|FG001|Overall Study|Lack of Efficacy|7|||
130754558|NCT01167881|470722073|FG000|Overall Study|Non compliant with protocol|9|||
130754559|NCT01167881|470722074|FG001|Overall Study|Non compliant with protocol|18|||
130754560|NCT01167881|470722073|FG000|Overall Study|Lost to Follow-up|19|||
130754561|NCT01167881|470722074|FG001|Overall Study|Lost to Follow-up|20|||
130754562|NCT01167881|470722073|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
130754563|NCT01167881|470722074|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
130754564|NCT01167881|470722073|FG000|Overall Study|Not treated|4|||
130754565|NCT01167881|470722074|FG001|Overall Study|Not treated|0|||
130754566|NCT01167881|470722073|FG000|Overall Study|Other not defined above|31|||
130754567|NCT01167881|470722074|FG001|Overall Study|Other not defined above|55|||
130754568|NCT01894100|470722075|FG000|Overall Study|Lost to Follow-up|0|||
130754569|NCT01894100|470722076|FG001|Overall Study|Lost to Follow-up|1|||
130754570|NCT01894100|470722075|FG000|Overall Study|Withdrawal by Subject|3|||
130754571|NCT01894100|470722076|FG001|Overall Study|Withdrawal by Subject|0|||
130754572|NCT04013672|470722077|FG000|Overall Study|Withdrawal by Subject|3|||
130754573|NCT04013672|470722078|FG001|Overall Study|Withdrawal by Subject|0|||
130754574|NCT04013672|470722077|FG000|Overall Study|Death|1|||
130754575|NCT04013672|470722078|FG001|Overall Study|Death|0|||
130754576|NCT04013672|470722077|FG000|Overall Study|Physician Decision|5|||
130754577|NCT04013672|470722078|FG001|Overall Study|Physician Decision|0|||
130754578|NCT01827267|470722079|FG000|Overall Study|Did not receive study drug|1|||
130754579|NCT01827267|470722080|FG001|Overall Study|Did not receive study drug|1|||
130754580|NCT01827267|470722079|FG000|Overall Study|Physician Decision|1|||
130754581|NCT01827267|470722080|FG001|Overall Study|Physician Decision|0|||
130754582|NCT01827267|470722079|FG000|Overall Study|Disease Progression|1|||
130754583|NCT01827267|470722080|FG001|Overall Study|Disease Progression|1|||
130754584|NCT01827267|470722079|FG000|Overall Study|Sponsor Discontinued Study|2|||
130754585|NCT01827267|470722080|FG001|Overall Study|Sponsor Discontinued Study|8|||
130754586|NCT01827267|470722079|FG000|Overall Study|Still on study|0|||
130754587|NCT01827267|470722080|FG001|Overall Study|Still on study|2|||
130754588|NCT00986921|470722085|FG000|Overall Study|Physician Decision|1|||
130754589|NCT00986921|470722086|FG001|Overall Study|Physician Decision|0|||
130754590|NCT00813813|470722087|FG000|Overall Study|Withdrawal by Subject|1|||
130754591|NCT00813813|470722088|FG001|Overall Study|Withdrawal by Subject|1|||
130754592|NCT00813813|470722087|FG000|Overall Study|Lost to Follow-up|2|||
130754593|NCT00813813|470722088|FG001|Overall Study|Lost to Follow-up|7|||
130754594|NCT00813813|470722087|FG000|Overall Study|Other|0|||
130754595|NCT00813813|470722088|FG001|Overall Study|Other|1|||
130754596|NCT01684943|470722089|FG000|Overall Study|Inadequate Venous Access|3|||
130754597|NCT01684943|470722090|FG001|Overall Study|Inadequate Venous Access|0|||
130754598|NCT01684943|470722091|FG002|Overall Study|Inadequate Venous Access|0|||
130754599|NCT01684943|470722089|FG000|Overall Study|Principal Investigator Determination|1|||
130754600|NCT01684943|470722090|FG001|Overall Study|Principal Investigator Determination|0|||
130754601|NCT01684943|470722091|FG002|Overall Study|Principal Investigator Determination|0|||
130754602|NCT01684943|470722089|FG000|Overall Study|Excluded from Analysis|1|||
130754603|NCT01684943|470722090|FG001|Overall Study|Excluded from Analysis|1|||
130754604|NCT01684943|470722091|FG002|Overall Study|Excluded from Analysis|1|||
130754605|NCT01684943|470722089|FG000|Overall Study|Lost to Follow-up|3|||
130754606|NCT01684943|470722090|FG001|Overall Study|Lost to Follow-up|0|||
130754607|NCT01684943|470722091|FG002|Overall Study|Lost to Follow-up|0|||
130754608|NCT01684943|470722089|FG000|Overall Study|Planning Pregnancy|1|||
130754609|NCT01684943|470722090|FG001|Overall Study|Planning Pregnancy|0|||
130754610|NCT01684943|470722091|FG002|Overall Study|Planning Pregnancy|0|||
130754611|NCT00972816|470724405|FG000|Overall Study|Adverse Event|0|||
130754612|NCT00972816|470724406|FG001|Overall Study|Adverse Event|0|||
130754613|NCT00972816|470724407|FG002|Overall Study|Adverse Event|1|||
130754614|NCT00972816|470724408|FG003|Overall Study|Adverse Event|0|||
130754615|NCT00972816|470724409|FG004|Overall Study|Adverse Event|0|||
130754616|NCT00972816|470724410|FG005|Overall Study|Adverse Event|0|||
130754617|NCT00972816|470724411|FG006|Overall Study|Adverse Event|0|||
130754618|NCT00972816|470724412|FG007|Overall Study|Adverse Event|0|||
130754619|NCT00972816|470724405|FG000|Overall Study|Withdrawal by Subject|4|||
130754620|NCT00972816|470724406|FG001|Overall Study|Withdrawal by Subject|2|||
130754621|NCT00972816|470724407|FG002|Overall Study|Withdrawal by Subject|1|||
130754622|NCT00972816|470724408|FG003|Overall Study|Withdrawal by Subject|3|||
130754623|NCT00972816|470724409|FG004|Overall Study|Withdrawal by Subject|0|||
130754624|NCT00972816|470724410|FG005|Overall Study|Withdrawal by Subject|1|||
130754625|NCT00972816|470724411|FG006|Overall Study|Withdrawal by Subject|1|||
130754626|NCT00972816|470724412|FG007|Overall Study|Withdrawal by Subject|2|||
130754627|NCT00972816|470724405|FG000|Overall Study|Lost to Follow-up|11|||
130754628|NCT00972816|470724406|FG001|Overall Study|Lost to Follow-up|9|||
130754629|NCT00972816|470724407|FG002|Overall Study|Lost to Follow-up|7|||
130754630|NCT00972816|470724408|FG003|Overall Study|Lost to Follow-up|5|||
130754631|NCT00972816|470724409|FG004|Overall Study|Lost to Follow-up|11|||
130754632|NCT00972816|470724410|FG005|Overall Study|Lost to Follow-up|10|||
130754633|NCT00972816|470724411|FG006|Overall Study|Lost to Follow-up|7|||
130754634|NCT00972816|470724412|FG007|Overall Study|Lost to Follow-up|7|||
130754635|NCT00972816|470724405|FG000|Overall Study|Inappropriate enrolment|0|||
130754636|NCT00972816|470724406|FG001|Overall Study|Inappropriate enrolment|0|||
130789043|NCT01387269|470856740|FG001|Overall Study|Unrelated AE|3|||
130789044|NCT01387269|470856739|FG000|Overall Study|Withdrawal by patient|32|||
130789045|NCT01387269|470856740|FG001|Overall Study|Withdrawal by patient|10|||
130789046|NCT01387269|470856739|FG000|Overall Study|Study drug-related AE|1|||
130754637|NCT00972816|470724407|FG002|Overall Study|Inappropriate enrolment|0|||
130754638|NCT00972816|470724408|FG003|Overall Study|Inappropriate enrolment|0|||
130789047|NCT01387269|470856740|FG001|Overall Study|Study drug-related AE|0|||
130754639|NCT00972816|470724409|FG004|Overall Study|Inappropriate enrolment|0|||
130754640|NCT00972816|470724410|FG005|Overall Study|Inappropriate enrolment|0|||
130754641|NCT00972816|470724411|FG006|Overall Study|Inappropriate enrolment|2|||
130754642|NCT00972816|470724412|FG007|Overall Study|Inappropriate enrolment|0|||
130754643|NCT00972816|470724405|FG000|Overall Study|Unable to classify|2|||
130754644|NCT00972816|470724406|FG001|Overall Study|Unable to classify|0|||
130754645|NCT00972816|470724407|FG002|Overall Study|Unable to classify|0|||
130754646|NCT00972816|470724408|FG003|Overall Study|Unable to classify|0|||
130754647|NCT00972816|470724409|FG004|Overall Study|Unable to classify|1|||
130754648|NCT00972816|470724410|FG005|Overall Study|Unable to classify|0|||
130754649|NCT00972816|470724411|FG006|Overall Study|Unable to classify|0|||
130754650|NCT00972816|470724412|FG007|Overall Study|Unable to classify|0|||
130754651|NCT03854370|470724415|FG000|Overall Study|samples not collected|1|||
130754652|NCT03854370|470724416|FG001|Overall Study|samples not collected|1|||
130754653|NCT03854370|470724417|FG002|Overall Study|samples not collected|1|||
130754654|NCT03854370|470724418|FG003|Overall Study|samples not collected|1|||
130754655|NCT00452673|470724419|FG000|Dose Escalation Period|Disease Progression|6|||
130754656|NCT00452673|470724420|FG001|Dose Escalation Period|Disease Progression|6|||
130754657|NCT00452673|470724421|FG002|Dose Escalation Period|Disease Progression|2|||
130754658|NCT00452673|470724422|FG003|Dose Escalation Period|Disease Progression|6|||
130754659|NCT00452673|470724423|FG004|Dose Escalation Period|Disease Progression|0|||
130754660|NCT00452673|470724419|FG000|Dose Escalation Period|study drug toxicity|1|||
130754661|NCT00452673|470724420|FG001|Dose Escalation Period|study drug toxicity|3|||
130754662|NCT00452673|470724421|FG002|Dose Escalation Period|study drug toxicity|3|||
130754663|NCT00452673|470724422|FG003|Dose Escalation Period|study drug toxicity|1|||
130754664|NCT00452673|470724423|FG004|Dose Escalation Period|study drug toxicity|0|||
130754665|NCT00452673|470724419|FG000|Dose Escalation Period|Other|0|||
130754666|NCT00452673|470724420|FG001|Dose Escalation Period|Other|0|||
130754667|NCT00452673|470724421|FG002|Dose Escalation Period|Other|1|||
130754668|NCT00452673|470724422|FG003|Dose Escalation Period|Other|0|||
130754669|NCT00452673|470724423|FG004|Dose Escalation Period|Other|0|||
130754670|NCT00452673|470724419|FG000|Dose Escalation Period|Adverse Event|0|||
130754671|NCT00452673|470724420|FG001|Dose Escalation Period|Adverse Event|0|||
130754672|NCT00452673|470724421|FG002|Dose Escalation Period|Adverse Event|0|||
130754673|NCT00452673|470724422|FG003|Dose Escalation Period|Adverse Event|1|||
130754674|NCT00452673|470724423|FG004|Dose Escalation Period|Adverse Event|0|||
130754675|NCT00452673|470724419|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
130754676|NCT00452673|470724420|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
130754677|NCT00452673|470724421|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
130754678|NCT00452673|470724422|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
130754679|NCT00452673|470724423|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
130754680|NCT00452673|470724419|FG000|Dose Expansion Period|Disease Progression|0|||
130754681|NCT00452673|470724420|FG001|Dose Expansion Period|Disease Progression|0|||
130754682|NCT00452673|470724421|FG002|Dose Expansion Period|Disease Progression|0|||
130754683|NCT00452673|470724422|FG003|Dose Expansion Period|Disease Progression|0|||
130754684|NCT00452673|470724423|FG004|Dose Expansion Period|Disease Progression|19|||
130754685|NCT00452673|470724419|FG000|Dose Expansion Period|Other|0|||
130754686|NCT00452673|470724420|FG001|Dose Expansion Period|Other|0|||
130754687|NCT00452673|470724421|FG002|Dose Expansion Period|Other|0|||
130754688|NCT00452673|470724422|FG003|Dose Expansion Period|Other|0|||
130754689|NCT00452673|470724423|FG004|Dose Expansion Period|Other|2|||
130754690|NCT02656290|470724424|FG000|Overall Study|Lost to Follow-up|1|||
130754691|NCT02656290|470724424|FG000|Overall Study|Reintervention|3|||
130754692|NCT01608087|470724427|FG000|Overall Study|Lost to Follow-up|0|||
130754693|NCT01608087|470724428|FG001|Overall Study|Lost to Follow-up|1|||
130754694|NCT01608087|470724429|FG002|Overall Study|Lost to Follow-up|0|||
130754695|NCT01608087|470724427|FG000|Overall Study|Other Reason|0|||
130754696|NCT01608087|470724428|FG001|Overall Study|Other Reason|1|||
130754697|NCT01608087|470724429|FG002|Overall Study|Other Reason|0|||
130754698|NCT00348595|470724430|FG000|Overall Study|Adverse Event|5|||
130754699|NCT00348595|470724431|FG001|Overall Study|Adverse Event|8|||
130754700|NCT01942486|470724438|FG000|Overall Study|Lost to Follow-up|27|||
130754701|NCT03728426|470724439|FG000|Overall Study|Death|3|||
130754702|NCT00231114|470724441|FG000|Randomized|Withdrawal by Subject|6|||
130754703|NCT00231114|470724442|FG001|Randomized|Withdrawal by Subject|3|||
130754704|NCT00231114|470724441|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
130754705|NCT00231114|470724442|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
130754706|NCT00231114|470724441|FG000|Post-Treatment Period|Lost to Follow-up|6|||
130754707|NCT00231114|470724442|FG001|Post-Treatment Period|Lost to Follow-up|1|||
130754708|NCT00231114|470724441|FG000|Post-Treatment Period|Physician Decision|1|||
130754709|NCT00231114|470724442|FG001|Post-Treatment Period|Physician Decision|0|||
130754710|NCT00231114|470724441|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
130754711|NCT00231114|470724442|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
130754712|NCT02048826|470724444|FG000|Overall Study|Withdrawal by Subject|1|||
130754713|NCT02048826|470724445|FG001|Overall Study|Withdrawal by Subject|0|||
130754714|NCT04470544|470724446|FG000|Overall Study|Withdrawal by Subject|4|||
130754715|NCT04470544|470724447|FG001|Overall Study|Withdrawal by Subject|6|||
130754716|NCT00712881|470724448|FG000|Overall Study|Adverse Event|3|||
130754717|NCT00712881|470724449|FG001|Overall Study|Adverse Event|3|||
130754718|NCT00712881|470724448|FG000|Overall Study|Withdrawal by Subject|1|||
130754719|NCT00712881|470724449|FG001|Overall Study|Withdrawal by Subject|1|||
130754720|NCT00712881|470724448|FG000|Overall Study|Disease Progression|2|||
130754721|NCT00712881|470724449|FG001|Overall Study|Disease Progression|1|||
130754722|NCT00712881|470724448|FG000|Overall Study|Lost to Follow-up|1|||
130754723|NCT00712881|470724449|FG001|Overall Study|Lost to Follow-up|1|||
130754724|NCT00712881|470724448|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
130754725|NCT00712881|470724449|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
130754726|NCT00712881|470724448|FG000|Overall Study|Protocol Violation|1|||
130754727|NCT00712881|470724449|FG001|Overall Study|Protocol Violation|1|||
130754728|NCT00712881|470724448|FG000|Overall Study|Randomized but not treated|1|||
130754729|NCT00712881|470724449|FG001|Overall Study|Randomized but not treated|0|||
130754730|NCT01194999|470724451|FG000|Overall Study|Lost to Follow-up|17|||
130754731|NCT01011465|470724452|FG000|Overall Study|Withdrawal by Subject|2|||
130754732|NCT01011465|470724453|FG001|Overall Study|Withdrawal by Subject|1|||
130754733|NCT01011465|470724454|FG002|Overall Study|Withdrawal by Subject|0|||
130754734|NCT01011465|470724455|FG003|Overall Study|Withdrawal by Subject|0|||
130754735|NCT01011465|470724456|FG004|Overall Study|Withdrawal by Subject|1|||
130754736|NCT01011465|470724457|FG005|Overall Study|Withdrawal by Subject|0|||
130754737|NCT01011465|470724458|FG006|Overall Study|Withdrawal by Subject|1|||
130754738|NCT01011465|470724459|FG007|Overall Study|Withdrawal by Subject|0|||
130754739|NCT00723008|470724461|FG000|Enrollment|Lost to Follow-up|1|||
130754740|NCT00723008|470724462|FG001|Enrollment|Lost to Follow-up|0|||
130754741|NCT00723008|470724461|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
130754742|NCT00723008|470724462|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
130754743|NCT00723008|470724461|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
130754744|NCT00723008|470724462|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
130754745|NCT00723008|470724461|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
130754746|NCT00723008|470724462|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
130754747|NCT00723008|470724461|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
130754748|NCT00723008|470724462|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
130754749|NCT00723008|470724461|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
130754750|NCT00723008|470724462|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
130754751|NCT05835011|470724464|FG000|Overall Study|Study Terminated by the Sponsor|1|||
130754752|NCT05835011|470724464|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
130754753|NCT03702010|470724477|FG000|Follow-up (30days)|Lack of Efficacy|2|||
130754754|NCT03702010|470724478|FG001|Follow-up (30days)|Lack of Efficacy|2|||
130754755|NCT01137110|470724479|FG000|Overall Study|Protocol Violation|1|||
130754756|NCT01137110|470724480|FG001|Overall Study|Protocol Violation|0|||
130754757|NCT03557931|470724481|FG000|Overall Study|Adverse Event|4|||
130754758|NCT03557931|470724482|FG001|Overall Study|Adverse Event|6|||
130754759|NCT03557931|470724483|FG002|Overall Study|Adverse Event|1|||
130754760|NCT03557931|470724481|FG000|Overall Study|Lost to Follow-up|4|||
130754761|NCT03557931|470724482|FG001|Overall Study|Lost to Follow-up|4|||
130754762|NCT03557931|470724483|FG002|Overall Study|Lost to Follow-up|1|||
130754763|NCT03557931|470724481|FG000|Overall Study|Protocol Violation|1|||
130754764|NCT03557931|470724482|FG001|Overall Study|Protocol Violation|4|||
130754765|NCT03557931|470724483|FG002|Overall Study|Protocol Violation|1|||
130754766|NCT03557931|470724481|FG000|Overall Study|Withdrawal by Subject|14|||
130754767|NCT03557931|470724482|FG001|Overall Study|Withdrawal by Subject|0|||
130754768|NCT03557931|470724483|FG002|Overall Study|Withdrawal by Subject|7|||
130754769|NCT03557931|470724481|FG000|Overall Study|Miscellaneous|8|||
130754770|NCT03557931|470724482|FG001|Overall Study|Miscellaneous|5|||
130754771|NCT03557931|470724483|FG002|Overall Study|Miscellaneous|3|||
130754772|NCT02829723|470724484|FG000|Overall Study|Adverse Event|0|||
130754773|NCT02829723|470724485|FG001|Overall Study|Adverse Event|0|||
130754774|NCT02829723|470724486|FG002|Overall Study|Adverse Event|1|||
130754775|NCT02829723|470724487|FG003|Overall Study|Adverse Event|1|||
130754776|NCT02829723|470724488|FG004|Overall Study|Adverse Event|0|||
130754777|NCT02829723|470724489|FG005|Overall Study|Adverse Event|0|||
130754778|NCT02829723|470724490|FG006|Overall Study|Adverse Event|0|||
130754779|NCT02829723|470724491|FG007|Overall Study|Adverse Event|1|||
130754780|NCT02829723|470724492|FG008|Overall Study|Adverse Event|0|||
130754781|NCT02829723|470724493|FG009|Overall Study|Adverse Event|0|||
130754782|NCT02829723|470724494|FG010|Overall Study|Adverse Event|0|||
130754783|NCT02829723|470724495|FG011|Overall Study|Adverse Event|0|||
130754784|NCT02829723|470724496|FG012|Overall Study|Adverse Event|0|||
130754785|NCT02829723|470724497|FG013|Overall Study|Adverse Event|0|||
130754786|NCT02829723|470724498|FG014|Overall Study|Adverse Event|1|||
130754787|NCT02829723|470724499|FG015|Overall Study|Adverse Event|1|||
130754788|NCT02829723|470724500|FG016|Overall Study|Adverse Event|1|||
130754789|NCT02829723|470724501|FG017|Overall Study|Adverse Event|2|||
130754790|NCT02829723|470724502|FG018|Overall Study|Adverse Event|1|||
130754791|NCT02829723|470724503|FG019|Overall Study|Adverse Event|1|||
130754792|NCT02829723|470724504|FG020|Overall Study|Adverse Event|3|||
130754793|NCT02829723|470724505|FG021|Overall Study|Adverse Event|0|||
130754794|NCT02829723|470724506|FG022|Overall Study|Adverse Event|0|||
130754795|NCT02829723|470724507|FG023|Overall Study|Adverse Event|1|||
130754796|NCT02829723|470724508|FG024|Overall Study|Adverse Event|1|||
130754797|NCT02829723|470724509|FG025|Overall Study|Adverse Event|3|||
130754798|NCT02829723|470724510|FG026|Overall Study|Adverse Event|5|||
130754799|NCT02829723|470724484|FG000|Overall Study|Death|1|||
130754800|NCT02829723|470724485|FG001|Overall Study|Death|0|||
130754801|NCT02829723|470724486|FG002|Overall Study|Death|1|||
130754802|NCT02829723|470724487|FG003|Overall Study|Death|1|||
130754803|NCT02829723|470724488|FG004|Overall Study|Death|0|||
130754804|NCT02829723|470724489|FG005|Overall Study|Death|0|||
130754805|NCT02829723|470724490|FG006|Overall Study|Death|2|||
130754806|NCT02829723|470724491|FG007|Overall Study|Death|0|||
130754807|NCT02829723|470724492|FG008|Overall Study|Death|1|||
130754808|NCT02829723|470724493|FG009|Overall Study|Death|0|||
130754809|NCT02829723|470724494|FG010|Overall Study|Death|0|||
130754810|NCT02829723|470724495|FG011|Overall Study|Death|0|||
130754811|NCT02829723|470724496|FG012|Overall Study|Death|2|||
130754812|NCT02829723|470724497|FG013|Overall Study|Death|1|||
130754813|NCT02829723|470724498|FG014|Overall Study|Death|0|||
130754814|NCT02829723|470724499|FG015|Overall Study|Death|0|||
130754815|NCT02829723|470724500|FG016|Overall Study|Death|0|||
130754816|NCT02829723|470724501|FG017|Overall Study|Death|0|||
130754817|NCT02829723|470724502|FG018|Overall Study|Death|0|||
130754818|NCT02829723|470724503|FG019|Overall Study|Death|0|||
130754819|NCT02829723|470724504|FG020|Overall Study|Death|0|||
130754820|NCT02829723|470724505|FG021|Overall Study|Death|2|||
130754821|NCT02829723|470724506|FG022|Overall Study|Death|0|||
130754822|NCT02829723|470724507|FG023|Overall Study|Death|0|||
130754823|NCT02829723|470724508|FG024|Overall Study|Death|0|||
130754824|NCT02829723|470724509|FG025|Overall Study|Death|1|||
130754825|NCT02829723|470724510|FG026|Overall Study|Death|2|||
130754826|NCT02829723|470724484|FG000|Overall Study|Physician Decision|0|||
130754827|NCT02829723|470724485|FG001|Overall Study|Physician Decision|0|||
130754828|NCT02829723|470724486|FG002|Overall Study|Physician Decision|0|||
130754829|NCT02829723|470724487|FG003|Overall Study|Physician Decision|0|||
130754830|NCT02829723|470724488|FG004|Overall Study|Physician Decision|0|||
130754831|NCT02829723|470724489|FG005|Overall Study|Physician Decision|0|||
130754832|NCT02829723|470724490|FG006|Overall Study|Physician Decision|0|||
130754833|NCT02829723|470724491|FG007|Overall Study|Physician Decision|0|||
130754834|NCT02829723|470724492|FG008|Overall Study|Physician Decision|0|||
130754835|NCT02829723|470724493|FG009|Overall Study|Physician Decision|1|||
130754836|NCT02829723|470724494|FG010|Overall Study|Physician Decision|1|||
130754837|NCT02829723|470724495|FG011|Overall Study|Physician Decision|0|||
130754838|NCT02829723|470724496|FG012|Overall Study|Physician Decision|0|||
130754839|NCT02829723|470724497|FG013|Overall Study|Physician Decision|1|||
130754840|NCT02829723|470724498|FG014|Overall Study|Physician Decision|0|||
130754841|NCT02829723|470724499|FG015|Overall Study|Physician Decision|0|||
130754842|NCT02829723|470724500|FG016|Overall Study|Physician Decision|2|||
130754843|NCT02829723|470724501|FG017|Overall Study|Physician Decision|0|||
130754844|NCT02829723|470724502|FG018|Overall Study|Physician Decision|0|||
130754845|NCT02829723|470724503|FG019|Overall Study|Physician Decision|0|||
130754846|NCT02829723|470724504|FG020|Overall Study|Physician Decision|0|||
130754847|NCT02829723|470724505|FG021|Overall Study|Physician Decision|0|||
130754848|NCT02829723|470724506|FG022|Overall Study|Physician Decision|1|||
130754849|NCT02829723|470724507|FG023|Overall Study|Physician Decision|1|||
130754850|NCT02829723|470724508|FG024|Overall Study|Physician Decision|1|||
130754851|NCT02829723|470724509|FG025|Overall Study|Physician Decision|1|||
130754852|NCT02829723|470724510|FG026|Overall Study|Physician Decision|3|||
130754853|NCT02829723|470724484|FG000|Overall Study|Progressive disease|4|||
130754854|NCT02829723|470724485|FG001|Overall Study|Progressive disease|6|||
130754855|NCT02829723|470724486|FG002|Overall Study|Progressive disease|3|||
130754856|NCT02829723|470724487|FG003|Overall Study|Progressive disease|3|||
130754857|NCT02829723|470724488|FG004|Overall Study|Progressive disease|3|||
130754858|NCT02829723|470724489|FG005|Overall Study|Progressive disease|5|||
130754859|NCT02829723|470724490|FG006|Overall Study|Progressive disease|4|||
130754860|NCT02829723|470724491|FG007|Overall Study|Progressive disease|6|||
130754861|NCT02829723|470724492|FG008|Overall Study|Progressive disease|8|||
130754862|NCT02829723|470724493|FG009|Overall Study|Progressive disease|4|||
130754863|NCT02829723|470724494|FG010|Overall Study|Progressive disease|9|||
130754864|NCT02829723|470724495|FG011|Overall Study|Progressive disease|0|||
130754865|NCT02829723|470724496|FG012|Overall Study|Progressive disease|3|||
130754866|NCT02829723|470724497|FG013|Overall Study|Progressive disease|4|||
130754867|NCT02829723|470724498|FG014|Overall Study|Progressive disease|2|||
130754868|NCT02829723|470724499|FG015|Overall Study|Progressive disease|4|||
130754869|NCT02829723|470724500|FG016|Overall Study|Progressive disease|5|||
130754870|NCT02829723|470724501|FG017|Overall Study|Progressive disease|3|||
130754871|NCT02829723|470724502|FG018|Overall Study|Progressive disease|4|||
130754872|NCT02829723|470724503|FG019|Overall Study|Progressive disease|4|||
130754873|NCT02829723|470724504|FG020|Overall Study|Progressive disease|7|||
130754874|NCT02829723|470724505|FG021|Overall Study|Progressive disease|6|||
130754875|NCT02829723|470724506|FG022|Overall Study|Progressive disease|3|||
130754876|NCT02829723|470724507|FG023|Overall Study|Progressive disease|3|||
130754877|NCT02829723|470724508|FG024|Overall Study|Progressive disease|3|||
130754878|NCT02829723|470724509|FG025|Overall Study|Progressive disease|16|||
130754879|NCT02829723|470724510|FG026|Overall Study|Progressive disease|10|||
130754880|NCT02829723|470724484|FG000|Overall Study|Subject/guardian decision|0|||
130754881|NCT02829723|470724485|FG001|Overall Study|Subject/guardian decision|1|||
130754882|NCT02829723|470724486|FG002|Overall Study|Subject/guardian decision|0|||
130754883|NCT02829723|470724487|FG003|Overall Study|Subject/guardian decision|1|||
130754884|NCT02829723|470724488|FG004|Overall Study|Subject/guardian decision|0|||
130754885|NCT02829723|470724489|FG005|Overall Study|Subject/guardian decision|0|||
130754886|NCT02829723|470724490|FG006|Overall Study|Subject/guardian decision|0|||
130754887|NCT02829723|470724491|FG007|Overall Study|Subject/guardian decision|1|||
130754888|NCT02829723|470724492|FG008|Overall Study|Subject/guardian decision|0|||
130754889|NCT02829723|470724493|FG009|Overall Study|Subject/guardian decision|0|||
130754890|NCT02829723|470724494|FG010|Overall Study|Subject/guardian decision|0|||
130754891|NCT02829723|470724495|FG011|Overall Study|Subject/guardian decision|0|||
130754892|NCT02829723|470724496|FG012|Overall Study|Subject/guardian decision|0|||
130754893|NCT02829723|470724497|FG013|Overall Study|Subject/guardian decision|0|||
130754894|NCT02829723|470724498|FG014|Overall Study|Subject/guardian decision|1|||
130754895|NCT02829723|470724499|FG015|Overall Study|Subject/guardian decision|0|||
130754896|NCT02829723|470724500|FG016|Overall Study|Subject/guardian decision|1|||
130754897|NCT02829723|470724501|FG017|Overall Study|Subject/guardian decision|0|||
130754898|NCT02829723|470724502|FG018|Overall Study|Subject/guardian decision|1|||
130754899|NCT02829723|470724503|FG019|Overall Study|Subject/guardian decision|0|||
130754900|NCT02829723|470724504|FG020|Overall Study|Subject/guardian decision|1|||
130754901|NCT02829723|470724505|FG021|Overall Study|Subject/guardian decision|0|||
130754902|NCT02829723|470724506|FG022|Overall Study|Subject/guardian decision|0|||
130754903|NCT02829723|470724507|FG023|Overall Study|Subject/guardian decision|1|||
130754904|NCT02829723|470724508|FG024|Overall Study|Subject/guardian decision|0|||
130754905|NCT02829723|470724509|FG025|Overall Study|Subject/guardian decision|1|||
130754906|NCT02829723|470724510|FG026|Overall Study|Subject/guardian decision|1|||
130754907|NCT02829723|470724484|FG000|Overall Study|Study terminated by sponsor|0|||
130754908|NCT02829723|470724485|FG001|Overall Study|Study terminated by sponsor|0|||
130754909|NCT02829723|470724486|FG002|Overall Study|Study terminated by sponsor|0|||
130754910|NCT02829723|470724487|FG003|Overall Study|Study terminated by sponsor|0|||
130754911|NCT02829723|470724488|FG004|Overall Study|Study terminated by sponsor|0|||
130754912|NCT02829723|470724489|FG005|Overall Study|Study terminated by sponsor|0|||
130789048|NCT01387269|470856739|FG000|Overall Study|Lost to Follow-up|1|||
130754913|NCT02829723|470724490|FG006|Overall Study|Study terminated by sponsor|0|||
130754914|NCT02829723|470724491|FG007|Overall Study|Study terminated by sponsor|0|||
130754915|NCT02829723|470724492|FG008|Overall Study|Study terminated by sponsor|0|||
130754916|NCT02829723|470724493|FG009|Overall Study|Study terminated by sponsor|0|||
130754917|NCT02829723|470724494|FG010|Overall Study|Study terminated by sponsor|0|||
130754918|NCT02829723|470724495|FG011|Overall Study|Study terminated by sponsor|0|||
130754919|NCT02829723|470724496|FG012|Overall Study|Study terminated by sponsor|0|||
130754920|NCT02829723|470724497|FG013|Overall Study|Study terminated by sponsor|0|||
130754921|NCT02829723|470724498|FG014|Overall Study|Study terminated by sponsor|0|||
130754922|NCT02829723|470724499|FG015|Overall Study|Study terminated by sponsor|0|||
130754923|NCT02829723|470724500|FG016|Overall Study|Study terminated by sponsor|0|||
130754924|NCT02829723|470724501|FG017|Overall Study|Study terminated by sponsor|0|||
130754925|NCT02829723|470724502|FG018|Overall Study|Study terminated by sponsor|0|||
130754926|NCT02829723|470724503|FG019|Overall Study|Study terminated by sponsor|0|||
130754927|NCT02829723|470724504|FG020|Overall Study|Study terminated by sponsor|0|||
130754928|NCT02829723|470724505|FG021|Overall Study|Study terminated by sponsor|1|||
130754929|NCT02829723|470724506|FG022|Overall Study|Study terminated by sponsor|0|||
130754930|NCT02829723|470724507|FG023|Overall Study|Study terminated by sponsor|0|||
130754931|NCT02829723|470724508|FG024|Overall Study|Study terminated by sponsor|0|||
130754932|NCT02829723|470724509|FG025|Overall Study|Study terminated by sponsor|0|||
130754933|NCT02829723|470724510|FG026|Overall Study|Study terminated by sponsor|0|||
130754934|NCT02989649|470724511|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
130754935|NCT02989649|470724511|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
130754936|NCT02989649|470724511|FG000|Overall Study|Lost For Observation During Study|3|||
130754937|NCT02989649|470724511|FG000|Overall Study|Reason Not Specified|13|||
130754938|NCT02004886|470724512|FG000|Overall Study|Adverse Event|0|||
130754939|NCT02004886|470724513|FG001|Overall Study|Adverse Event|1|||
130754940|NCT02004886|470724514|FG002|Overall Study|Adverse Event|0|||
130754941|NCT02004886|470724515|FG003|Overall Study|Adverse Event|0|||
130754942|NCT02004886|470724512|FG000|Overall Study|Unable to attend future visits|1|||
130754943|NCT02004886|470724513|FG001|Overall Study|Unable to attend future visits|0|||
130754944|NCT02004886|470724514|FG002|Overall Study|Unable to attend future visits|0|||
130754945|NCT02004886|470724515|FG003|Overall Study|Unable to attend future visits|0|||
130754946|NCT01876784|470724518|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
130754947|NCT01876784|470724519|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
130754948|NCT01876784|470724518|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
130754949|NCT01876784|470724519|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
130754950|NCT01876784|470724518|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
130754951|NCT01876784|470724519|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
130754952|NCT01876784|470724518|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
130754953|NCT01876784|470724519|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
130754954|NCT01876784|470724518|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
130754955|NCT01876784|470724519|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
130754956|NCT01876784|470724518|FG000|Randomized Treatment Period (40 Months)|Death|1|||
130754957|NCT01876784|470724519|FG001|Randomized Treatment Period (40 Months)|Death|0|||
130754958|NCT01876784|470724518|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
130754959|NCT01876784|470724519|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
130754960|NCT01876784|470724518|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
130754961|NCT01876784|470724519|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
130754962|NCT01876784|470724518|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
130754963|NCT01876784|470724519|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
130754964|NCT01876784|470724518|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
130754965|NCT01876784|470724519|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
130754966|NCT01876784|470724518|FG000|Open-label Period (31 Months)|Adverse Event|2|||
130754967|NCT01876784|470724519|FG001|Open-label Period (31 Months)|Adverse Event|6|||
130754968|NCT01876784|470724518|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
130754969|NCT01876784|470724519|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
130754970|NCT01876784|470724518|FG000|Open-label Period (31 Months)|Progressive disease|4|||
130754971|NCT01876784|470724519|FG001|Open-label Period (31 Months)|Progressive disease|35|||
130754972|NCT01876784|470724518|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
130754973|NCT01876784|470724519|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
130754974|NCT01876784|470724518|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
130754975|NCT01876784|470724519|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
130754976|NCT01876784|470724518|FG000|Open-label Period (31 Months)|Death|0|||
130754977|NCT01876784|470724519|FG001|Open-label Period (31 Months)|Death|1|||
130754978|NCT01876784|470724518|FG000|Open-label Period (31 Months)|Other than specified above|9|||
130754979|NCT01876784|470724519|FG001|Open-label Period (31 Months)|Other than specified above|18|||
130754980|NCT03605862|470724520|FG000|Overall Study|Withdrawal by Subject|12|||
130789049|NCT01387269|470856740|FG001|Overall Study|Lost to Follow-up|0|||
130754981|NCT03605862|470724521|FG001|Overall Study|Withdrawal by Subject|9|||
130754982|NCT03605862|470724520|FG000|Overall Study|Adverse Event|2|||
130754983|NCT03605862|470724521|FG001|Overall Study|Adverse Event|1|||
130754984|NCT03605862|470724520|FG000|Overall Study|Physician Decision|3|||
130754985|NCT03605862|470724521|FG001|Overall Study|Physician Decision|1|||
130754986|NCT03605862|470724520|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
130754987|NCT03605862|470724521|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
130754988|NCT01194531|470724522|FG000|Overall Study|Withdrawal by Subject|1|||
130754989|NCT01194531|470724523|FG001|Overall Study|Withdrawal by Subject|0|||
130754990|NCT01194531|470724522|FG000|Overall Study|Protocol Violation|4|||
130754991|NCT01194531|470724523|FG001|Overall Study|Protocol Violation|1|||
130754992|NCT01194531|470724522|FG000|Overall Study|Physician Decision|0|||
130754993|NCT01194531|470724523|FG001|Overall Study|Physician Decision|2|||
130754994|NCT05239494|470724524|FG000|Overall Study|Lost to Follow-up|1|||
130754995|NCT03891862|470724525|FG000|Open-label Period|Adverse Event|2|||
130754996|NCT03891862|470724526|FG001|Open-label Period|Adverse Event|0|||
130754997|NCT03891862|470724527|FG002|Open-label Period|Adverse Event|0|||
130754998|NCT03891862|470724525|FG000|Open-label Period|Protocol Violation|5|||
130754999|NCT03891862|470724526|FG001|Open-label Period|Protocol Violation|0|||
130755000|NCT03891862|470724527|FG002|Open-label Period|Protocol Violation|0|||
130755001|NCT03891862|470724525|FG000|Open-label Period|Withdrawal by Subject|6|||
130755002|NCT03891862|470724526|FG001|Open-label Period|Withdrawal by Subject|0|||
130755003|NCT03891862|470724527|FG002|Open-label Period|Withdrawal by Subject|0|||
130755004|NCT03891862|470724525|FG000|Open-label Period|Death|1|||
130755005|NCT03891862|470724526|FG001|Open-label Period|Death|0|||
130755006|NCT03891862|470724527|FG002|Open-label Period|Death|0|||
130755007|NCT03891862|470724525|FG000|Open-label Period|Lost to Follow-up|2|||
130755008|NCT03891862|470724526|FG001|Open-label Period|Lost to Follow-up|0|||
130755009|NCT03891862|470724527|FG002|Open-label Period|Lost to Follow-up|0|||
130755010|NCT03891862|470724525|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
130755011|NCT03891862|470724526|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
130755012|NCT03891862|470724527|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
130755013|NCT03891862|470724525|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
130755014|NCT03891862|470724526|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
130755015|NCT03891862|470724527|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
130755016|NCT03891862|470724525|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
130755017|NCT03891862|470724526|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
130755018|NCT03891862|470724527|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
130755019|NCT03891862|470724525|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
130755020|NCT03891862|470724526|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
130755021|NCT03891862|470724527|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
130755022|NCT04603482|470724528|FG000|Overall Study|Lost to Follow-up|15|||
130755023|NCT04603482|470724529|FG001|Overall Study|Lost to Follow-up|15|||
130755024|NCT04603482|470724530|FG002|Overall Study|Lost to Follow-up|15|||
130755025|NCT00977314|470724533|FG000|Overall Study|Withdrawal by Subject|1|||
130755026|NCT00977314|470724534|FG001|Overall Study|Withdrawal by Subject|0|||
130755027|NCT00977314|470724533|FG000|Overall Study|Physician Decision|1|||
130755028|NCT00977314|470724534|FG001|Overall Study|Physician Decision|0|||
130755029|NCT02107859|470724535|FG000|Overall Study|Withdrawal by Subject|14|||
130755030|NCT02107859|470724535|FG000|Overall Study|Adverse Event|3|||
130755031|NCT02107859|470724535|FG000|Overall Study|Study closure|41|||
130755032|NCT02107859|470724535|FG000|Overall Study|Other than specified|3|||
130755033|NCT00135512|470724538|FG000|Overall Study|Adverse Event|56|||
130755034|NCT00135512|470724538|FG000|Overall Study|Lack of Efficacy|25|||
130755035|NCT00135512|470724538|FG000|Overall Study|Other|42|||
130755036|NCT01094301|470724539|FG000|Trial Stage|Withdrawal by Subject|1|||
130755037|NCT01094301|470724539|FG000|Implant Stage|Adverse Event|1|||
130755038|NCT01094301|470724539|FG000|Implant Stage|Protocol Violation|1|||
130755039|NCT01094301|470724539|FG000|Implant Stage|Withdrawal by Subject|2|||
130755040|NCT01094301|470724539|FG000|Implant Stage|No return of pain|4|||
130755041|NCT02235077|470724540|FG000|Overall Study|Death|5|||
130755042|NCT02235077|470724541|FG001|Overall Study|Death|7|||
130755043|NCT02235077|470724540|FG000|Overall Study|Lost to Follow-up|5|||
130755044|NCT02235077|470724541|FG001|Overall Study|Lost to Follow-up|6|||
130755045|NCT02235077|470724540|FG000|Overall Study|Withdrawal by Subject|8|||
130755046|NCT02235077|470724541|FG001|Overall Study|Withdrawal by Subject|5|||
130755047|NCT02235077|470724540|FG000|Overall Study|Physician Decision|0|||
130755048|NCT02235077|470724541|FG001|Overall Study|Physician Decision|1|||
130755049|NCT03852628|470724542|FG000|Overall Study|Lost to Follow-up|7|||
130755050|NCT03852628|470724543|FG001|Overall Study|Lost to Follow-up|6|||
130755051|NCT03852628|470724542|FG000|Overall Study|Lack of Efficacy|6|||
130755052|NCT03852628|470724543|FG001|Overall Study|Lack of Efficacy|6|||
130755053|NCT00586820|470724545|FG000|Overall Study|Unsuccessful PCI|1|||
130755054|NCT00586820|470724546|FG001|Overall Study|Unsuccessful PCI|0|||
130755055|NCT03887442|470724547|FG000|Overall Study|Adverse Event|1|||
130755056|NCT03887442|470724548|FG001|Overall Study|Adverse Event|0|||
130755057|NCT01868022|470724549|FG000|Overall Study|Withdrawal by Subject|0|||
130755058|NCT01868022|470724550|FG001|Overall Study|Withdrawal by Subject|0|||
130755059|NCT01868022|470724551|FG002|Overall Study|Withdrawal by Subject|1|||
130755060|NCT01868022|470724552|FG003|Overall Study|Withdrawal by Subject|1|||
130755061|NCT01868022|470724553|FG004|Overall Study|Withdrawal by Subject|0|||
130755062|NCT01868022|470724554|FG005|Overall Study|Withdrawal by Subject|0|||
130755063|NCT01868022|470724555|FG006|Overall Study|Withdrawal by Subject|0|||
130755064|NCT01868022|470724556|FG007|Overall Study|Withdrawal by Subject|1|||
130755065|NCT01868022|470724557|FG008|Overall Study|Withdrawal by Subject|0|||
130755066|NCT01868022|470724549|FG000|Overall Study|Adverse Event|0|||
130755067|NCT01868022|470724550|FG001|Overall Study|Adverse Event|0|||
130755068|NCT01868022|470724551|FG002|Overall Study|Adverse Event|0|||
130755069|NCT01868022|470724552|FG003|Overall Study|Adverse Event|0|||
130755070|NCT01868022|470724553|FG004|Overall Study|Adverse Event|2|||
130755071|NCT01868022|470724554|FG005|Overall Study|Adverse Event|0|||
130755072|NCT01868022|470724555|FG006|Overall Study|Adverse Event|0|||
130755073|NCT01868022|470724556|FG007|Overall Study|Adverse Event|2|||
130755074|NCT01868022|470724557|FG008|Overall Study|Adverse Event|2|||
130755075|NCT01868022|470724549|FG000|Overall Study|Physician Decision|0|||
130755076|NCT01868022|470724550|FG001|Overall Study|Physician Decision|0|||
130755077|NCT01868022|470724551|FG002|Overall Study|Physician Decision|0|||
130755078|NCT01868022|470724552|FG003|Overall Study|Physician Decision|0|||
130755079|NCT01868022|470724553|FG004|Overall Study|Physician Decision|0|||
130755080|NCT01868022|470724554|FG005|Overall Study|Physician Decision|1|||
130755081|NCT01868022|470724555|FG006|Overall Study|Physician Decision|0|||
130755082|NCT01868022|470724556|FG007|Overall Study|Physician Decision|2|||
130755083|NCT01868022|470724557|FG008|Overall Study|Physician Decision|0|||
130755084|NCT01868022|470724549|FG000|Overall Study|Study closed/terminated|0|||
130755085|NCT01868022|470724550|FG001|Overall Study|Study closed/terminated|0|||
130755086|NCT01868022|470724551|FG002|Overall Study|Study closed/terminated|0|||
130755087|NCT01868022|470724552|FG003|Overall Study|Study closed/terminated|0|||
130755088|NCT01868022|470724553|FG004|Overall Study|Study closed/terminated|0|||
130755089|NCT01868022|470724554|FG005|Overall Study|Study closed/terminated|0|||
130755090|NCT01868022|470724555|FG006|Overall Study|Study closed/terminated|0|||
130755091|NCT01868022|470724556|FG007|Overall Study|Study closed/terminated|1|||
130755092|NCT01868022|470724557|FG008|Overall Study|Study closed/terminated|0|||
130755093|NCT01868022|470724549|FG000|Overall Study|Ongoing|0|||
130755094|NCT01868022|470724550|FG001|Overall Study|Ongoing|0|||
130755095|NCT01868022|470724551|FG002|Overall Study|Ongoing|0|||
130755096|NCT01868022|470724552|FG003|Overall Study|Ongoing|0|||
130755097|NCT01868022|470724553|FG004|Overall Study|Ongoing|0|||
130755098|NCT01868022|470724554|FG005|Overall Study|Ongoing|0|||
130755099|NCT01868022|470724555|FG006|Overall Study|Ongoing|0|||
130755100|NCT01868022|470724556|FG007|Overall Study|Ongoing|3|||
130755101|NCT01868022|470724557|FG008|Overall Study|Ongoing|0|||
130755102|NCT01628198|470724558|FG000|Overall Study|Lost to Follow-up|7|||
130755103|NCT01628198|470724558|FG000|Overall Study|Withdrawal by Subject|10|||
130755104|NCT01628198|470724558|FG000|Overall Study|Screen failure|1|||
130755105|NCT00833482|470724567|FG000|Days 11-20|Adverse Event|0|||
130755106|NCT00833482|470724568|FG001|Days 11-20|Adverse Event|2|||
130755107|NCT00833482|470724569|FG002|Days 11-20|Adverse Event|0|||
130755108|NCT00833482|470724570|FG003|Days 11-20|Adverse Event|0|||
130755109|NCT00833482|470724571|FG004|Days 11-20|Adverse Event|0|||
130755110|NCT00833482|470724572|FG005|Days 11-20|Adverse Event|0|||
130755111|NCT00833482|470724567|FG000|Days 11-20|Withdrawal by Subject|0|||
130755112|NCT00833482|470724568|FG001|Days 11-20|Withdrawal by Subject|1|||
130755113|NCT00833482|470724569|FG002|Days 11-20|Withdrawal by Subject|0|||
130755114|NCT00833482|470724570|FG003|Days 11-20|Withdrawal by Subject|0|||
130755115|NCT00833482|470724571|FG004|Days 11-20|Withdrawal by Subject|0|||
130789050|NCT00769561|470856745|FG000|Overall Study|Withdrawal by Subject|2|||
130755116|NCT00833482|470724572|FG005|Days 11-20|Withdrawal by Subject|0|||
130755117|NCT00833482|470724567|FG000|Days 21-30|Adverse Event|0|||
130755118|NCT00833482|470724568|FG001|Days 21-30|Adverse Event|0|||
130755119|NCT00833482|470724569|FG002|Days 21-30|Adverse Event|1|||
130755120|NCT00833482|470724570|FG003|Days 21-30|Adverse Event|0|||
130755121|NCT00833482|470724571|FG004|Days 21-30|Adverse Event|0|||
130789051|NCT00769561|470856746|FG001|Overall Study|Withdrawal by Subject|2|||
130755122|NCT00833482|470724572|FG005|Days 21-30|Adverse Event|0|||
130755123|NCT00833482|470724567|FG000|Days 21-30|Withdrawal by Subject|0|||
130755124|NCT00833482|470724568|FG001|Days 21-30|Withdrawal by Subject|0|||
130755125|NCT00833482|470724569|FG002|Days 21-30|Withdrawal by Subject|0|||
130755126|NCT00833482|470724570|FG003|Days 21-30|Withdrawal by Subject|0|||
130755127|NCT00833482|470724571|FG004|Days 21-30|Withdrawal by Subject|1|||
130755128|NCT00833482|470724572|FG005|Days 21-30|Withdrawal by Subject|0|||
130755129|NCT02778074|470724573|FG000|Overall Study|Lost to Follow-up|7|||
130755130|NCT02778074|470724574|FG001|Overall Study|Lost to Follow-up|10|||
130755131|NCT03489707|470724575|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
130755132|NCT03489707|470724576|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
130755133|NCT03489707|470724575|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
130755134|NCT03489707|470724576|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
130755135|NCT01817582|470724577|FG000|Overall Study|Withdrawal by Subject|0|||
130755136|NCT01817582|470724578|FG001|Overall Study|Withdrawal by Subject|1|||
130755137|NCT01817582|470724579|FG002|Overall Study|Withdrawal by Subject|0|||
130755138|NCT01817582|470724577|FG000|Overall Study|Participant revealed masked treatment|1|||
130755139|NCT01817582|470724578|FG001|Overall Study|Participant revealed masked treatment|0|||
130755140|NCT01817582|470724579|FG002|Overall Study|Participant revealed masked treatment|0|||
130755141|NCT01817582|470724577|FG000|Overall Study|Randomized but exclusion criteria met|1|||
130755142|NCT01817582|470724578|FG001|Overall Study|Randomized but exclusion criteria met|0|||
130755143|NCT01817582|470724579|FG002|Overall Study|Randomized but exclusion criteria met|0|||
130755144|NCT03617770|470724582|FG000|Overall Study|Lost to Follow-up|1|||
130755145|NCT03617770|470724583|FG001|Overall Study|Lost to Follow-up|0|||
130755146|NCT00356135|470724584|FG000|Overall Study|Protocol Violation|1|||
130755147|NCT00356135|470724585|FG001|Overall Study|Protocol Violation|0|||
130755148|NCT00356135|470724586|FG002|Overall Study|Protocol Violation|0|||
130755149|NCT00356135|470724584|FG000|Overall Study|Adverse Event|1|||
130755150|NCT00356135|470724585|FG001|Overall Study|Adverse Event|0|||
130755151|NCT00356135|470724586|FG002|Overall Study|Adverse Event|0|||
130755152|NCT00356135|470724584|FG000|Overall Study|Lost to Follow-up|0|||
130755153|NCT00356135|470724585|FG001|Overall Study|Lost to Follow-up|0|||
130755154|NCT00356135|470724586|FG002|Overall Study|Lost to Follow-up|1|||
130755155|NCT00356135|470724584|FG000|Overall Study|Physician Decision|1|||
130755156|NCT00356135|470724585|FG001|Overall Study|Physician Decision|1|||
130755157|NCT00356135|470724586|FG002|Overall Study|Physician Decision|1|||
130755158|NCT00356135|470724584|FG000|Overall Study|Subject non-compliance|1|||
130755159|NCT00356135|470724585|FG001|Overall Study|Subject non-compliance|1|||
130755160|NCT00356135|470724586|FG002|Overall Study|Subject non-compliance|3|||
130755161|NCT02122887|470724588|FG000|Overall Study|Withdrawal by Subject|20|||
130755162|NCT02122887|470724589|FG001|Overall Study|Withdrawal by Subject|2|||
130755163|NCT03725761|470724594|FG000|Overall Study|still on study|1|||
130755164|NCT00378508|470726918|FG000|Overall Study|Withdrawal by Subject|1|||
130755165|NCT00378508|470726919|FG001|Overall Study|Withdrawal by Subject|3|||
130755166|NCT00378508|470726918|FG000|Overall Study|Lost to Follow-up|1|||
130755167|NCT00378508|470726919|FG001|Overall Study|Lost to Follow-up|0|||
130755168|NCT03917472|470726923|FG000|Overall Study|Physician Decision|4|||
130755169|NCT03917472|470726924|FG001|Overall Study|Physician Decision|0|||
130755170|NCT03917472|470726923|FG000|Overall Study|Adverse Event|3|||
130755171|NCT03917472|470726924|FG001|Overall Study|Adverse Event|1|||
130755172|NCT03917472|470726923|FG000|Overall Study|Death|7|||
130755173|NCT03917472|470726924|FG001|Overall Study|Death|5|||
130755174|NCT03917472|470726923|FG000|Overall Study|Withdrawal by Subject|11|||
130755175|NCT03917472|470726924|FG001|Overall Study|Withdrawal by Subject|4|||
130755176|NCT03917472|470726923|FG000|Overall Study|Lost to Follow-up|10|||
130755177|NCT03917472|470726924|FG001|Overall Study|Lost to Follow-up|5|||
130755178|NCT01953601|470726928|FG000|Part 1 (Base Study)|Adverse Event|24|||
130755179|NCT01953601|470726929|FG001|Part 1 (Base Study)|Adverse Event|37|||
130755180|NCT01953601|470726930|FG002|Part 1 (Base Study)|Adverse Event|15|||
130755181|NCT01953601|470726928|FG000|Part 1 (Base Study)|Death|2|||
130755182|NCT01953601|470726929|FG001|Part 1 (Base Study)|Death|0|||
130755183|NCT01953601|470726930|FG002|Part 1 (Base Study)|Death|3|||
130755184|NCT01953601|470726928|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
130755185|NCT01953601|470726929|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
130755186|NCT01953601|470726930|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
130755187|NCT01953601|470726928|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
130755188|NCT01953601|470726929|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
130755189|NCT01953601|470726930|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
130755190|NCT01953601|470726928|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
130755191|NCT01953601|470726929|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
130755192|NCT01953601|470726930|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
130755193|NCT01953601|470726928|FG000|Part 1 (Base Study)|Physician Decision|3|||
130755194|NCT01953601|470726929|FG001|Part 1 (Base Study)|Physician Decision|7|||
130755195|NCT01953601|470726930|FG002|Part 1 (Base Study)|Physician Decision|4|||
130755196|NCT01953601|470726928|FG000|Part 1 (Base Study)|Screen failure|1|||
130755197|NCT01953601|470726929|FG001|Part 1 (Base Study)|Screen failure|0|||
130755198|NCT01953601|470726930|FG002|Part 1 (Base Study)|Screen failure|1|||
130755199|NCT01953601|470726928|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
130755200|NCT01953601|470726929|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
130755201|NCT01953601|470726930|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
130755202|NCT01953601|470726928|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
130755203|NCT01953601|470726929|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
130755204|NCT01953601|470726930|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
130755205|NCT01953601|470726928|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
130755206|NCT01953601|470726929|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
130755207|NCT01953601|470726930|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
130755208|NCT01953601|470726928|FG000|Part 1 (Base Study)|Subject moved|2|||
130755209|NCT01953601|470726929|FG001|Part 1 (Base Study)|Subject moved|2|||
130755210|NCT01953601|470726930|FG002|Part 1 (Base Study)|Subject moved|1|||
130755211|NCT01953601|470726928|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
130755212|NCT01953601|470726929|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
130755213|NCT01953601|470726930|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
130755214|NCT01953601|470726928|FG000|Part 2 (Extension Study)|Adverse Event|1|||
130755215|NCT01953601|470726929|FG001|Part 2 (Extension Study)|Adverse Event|1|||
130755216|NCT01953601|470726930|FG002|Part 2 (Extension Study)|Adverse Event|10|||
130755217|NCT01953601|470726928|FG000|Part 2 (Extension Study)|Death|0|||
130755218|NCT01953601|470726929|FG001|Part 2 (Extension Study)|Death|3|||
130755219|NCT01953601|470726930|FG002|Part 2 (Extension Study)|Death|0|||
130755220|NCT01953601|470726928|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
130755221|NCT01953601|470726929|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
130755222|NCT01953601|470726930|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
130755223|NCT01953601|470726928|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
130755224|NCT01953601|470726929|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
130755225|NCT01953601|470726930|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
130755226|NCT01953601|470726928|FG000|Part 2 (Extension Study)|Physician Decision|2|||
130755227|NCT01953601|470726929|FG001|Part 2 (Extension Study)|Physician Decision|0|||
130755228|NCT01953601|470726930|FG002|Part 2 (Extension Study)|Physician Decision|2|||
130755229|NCT01953601|470726928|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
130755230|NCT01953601|470726929|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
130755231|NCT01953601|470726930|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
130755232|NCT01953601|470726928|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
130755233|NCT01953601|470726929|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
130755234|NCT01953601|470726930|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
130755235|NCT01953601|470726928|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
130755236|NCT01953601|470726929|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
130755237|NCT01953601|470726930|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
130755238|NCT01953601|470726928|FG000|Part 2 (Extension Study)|Subject moved|0|||
130755239|NCT01953601|470726929|FG001|Part 2 (Extension Study)|Subject moved|0|||
130755240|NCT01953601|470726930|FG002|Part 2 (Extension Study)|Subject moved|1|||
130755241|NCT01953601|470726928|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
130755242|NCT01953601|470726929|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
130755243|NCT01953601|470726930|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
130755244|NCT01943851|470726935|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755245|NCT01943851|470726936|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755246|NCT01943851|470726937|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755247|NCT01943851|470726938|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130755248|NCT01943851|470726939|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755249|NCT01943851|470726940|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755250|NCT01943851|470726941|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130755251|NCT01943851|470726942|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130755252|NCT01943851|470726943|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130755253|NCT01943851|470726944|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755254|NCT01943851|470726945|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755255|NCT01943851|470726946|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755256|NCT01943851|470726947|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755257|NCT01943851|470726948|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755258|NCT01943851|470726949|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755259|NCT01943851|470726950|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755260|NCT01943851|470726951|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755261|NCT01943851|470726952|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130755262|NCT01943851|470726935|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755263|NCT01943851|470726936|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755264|NCT01943851|470726937|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755265|NCT01943851|470726938|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755266|NCT01943851|470726939|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
130755267|NCT01943851|470726940|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755268|NCT01943851|470726941|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755269|NCT01943851|470726942|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
130755270|NCT01943851|470726943|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755271|NCT01943851|470726944|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755272|NCT01943851|470726945|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755273|NCT01943851|470726946|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755274|NCT01943851|470726947|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755275|NCT01943851|470726948|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755276|NCT01943851|470726949|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755277|NCT01943851|470726950|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755278|NCT01943851|470726951|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755279|NCT01943851|470726952|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130755280|NCT01943851|470726935|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755281|NCT01943851|470726936|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755282|NCT01943851|470726937|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755283|NCT01943851|470726938|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755284|NCT01943851|470726939|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755285|NCT01943851|470726940|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755286|NCT01943851|470726941|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755287|NCT01943851|470726942|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755288|NCT01943851|470726943|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755289|NCT01943851|470726944|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755290|NCT01943851|470726945|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755291|NCT01943851|470726946|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755292|NCT01943851|470726947|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755293|NCT01943851|470726948|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
130755294|NCT01943851|470726949|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755295|NCT01943851|470726950|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755296|NCT01943851|470726951|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755297|NCT01943851|470726952|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130755298|NCT01943851|470726935|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755299|NCT01943851|470726936|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755300|NCT01943851|470726937|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755301|NCT01943851|470726938|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755302|NCT01943851|470726939|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755303|NCT01943851|470726940|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755304|NCT01943851|470726941|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755305|NCT01943851|470726942|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755306|NCT01943851|470726943|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755307|NCT01943851|470726944|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755308|NCT01943851|470726945|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755309|NCT01943851|470726946|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755310|NCT01943851|470726947|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755311|NCT01943851|470726948|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755312|NCT01943851|470726949|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130789052|NCT00769561|470856745|FG000|Overall Study|Lost to Follow-up|1|||
130755313|NCT01943851|470726950|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
130755314|NCT01943851|470726951|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755315|NCT01943851|470726952|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130755316|NCT01943851|470726935|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755317|NCT01943851|470726936|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755318|NCT01943851|470726937|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755319|NCT01943851|470726938|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755320|NCT01943851|470726939|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755321|NCT01943851|470726940|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755322|NCT01943851|470726941|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755323|NCT01943851|470726942|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755324|NCT01943851|470726943|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130789053|NCT00769561|470856746|FG001|Overall Study|Lost to Follow-up|3|||
130755325|NCT01943851|470726944|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755326|NCT01943851|470726945|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755327|NCT01943851|470726946|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755328|NCT01943851|470726947|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755329|NCT01943851|470726948|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755330|NCT01943851|470726949|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130755331|NCT01943851|470726950|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
130755332|NCT01943851|470726951|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
130755333|NCT01943851|470726952|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
130755334|NCT03320850|470726953|FG000|Overall Study|Lost to Follow-up|0|||
130755335|NCT03320850|470726954|FG001|Overall Study|Lost to Follow-up|0|||
130755336|NCT03320850|470726955|FG002|Overall Study|Lost to Follow-up|0|||
130755337|NCT03320850|470726956|FG003|Overall Study|Lost to Follow-up|0|||
130755338|NCT03320850|470726957|FG004|Overall Study|Lost to Follow-up|1|||
130755339|NCT03320850|470726958|FG005|Overall Study|Lost to Follow-up|2|||
130755340|NCT03320850|470726959|FG006|Overall Study|Lost to Follow-up|2|||
130755341|NCT03320850|470726960|FG007|Overall Study|Lost to Follow-up|0|||
130755342|NCT03320850|470726961|FG008|Overall Study|Lost to Follow-up|6|||
130755343|NCT03320850|470726962|FG009|Overall Study|Lost to Follow-up|4|||
130755344|NCT03320850|470726953|FG000|Overall Study|Withdrawal by Subject|0|||
130755345|NCT03320850|470726954|FG001|Overall Study|Withdrawal by Subject|0|||
130755346|NCT03320850|470726955|FG002|Overall Study|Withdrawal by Subject|0|||
130755347|NCT03320850|470726956|FG003|Overall Study|Withdrawal by Subject|0|||
130755348|NCT03320850|470726957|FG004|Overall Study|Withdrawal by Subject|1|||
130755349|NCT03320850|470726958|FG005|Overall Study|Withdrawal by Subject|2|||
130755350|NCT03320850|470726959|FG006|Overall Study|Withdrawal by Subject|4|||
130755351|NCT03320850|470726960|FG007|Overall Study|Withdrawal by Subject|5|||
130755352|NCT03320850|470726961|FG008|Overall Study|Withdrawal by Subject|2|||
130755353|NCT03320850|470726962|FG009|Overall Study|Withdrawal by Subject|1|||
130755354|NCT03320850|470726953|FG000|Overall Study|Lack of Efficacy|0|||
130755355|NCT03320850|470726954|FG001|Overall Study|Lack of Efficacy|0|||
130755356|NCT03320850|470726955|FG002|Overall Study|Lack of Efficacy|0|||
130755357|NCT03320850|470726956|FG003|Overall Study|Lack of Efficacy|1|||
130755358|NCT03320850|470726957|FG004|Overall Study|Lack of Efficacy|0|||
130755359|NCT03320850|470726958|FG005|Overall Study|Lack of Efficacy|1|||
130755360|NCT03320850|470726959|FG006|Overall Study|Lack of Efficacy|0|||
130755361|NCT03320850|470726960|FG007|Overall Study|Lack of Efficacy|2|||
130755362|NCT03320850|470726961|FG008|Overall Study|Lack of Efficacy|0|||
130755363|NCT03320850|470726962|FG009|Overall Study|Lack of Efficacy|3|||
130755364|NCT03320850|470726953|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130755365|NCT03320850|470726954|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
130755366|NCT03320850|470726955|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
130755367|NCT03320850|470726956|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
130755368|NCT03320850|470726957|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
130755369|NCT03320850|470726958|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
130755370|NCT03320850|470726959|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
130755371|NCT03320850|470726960|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
130755372|NCT03320850|470726961|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
130755373|NCT03320850|470726962|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
130755374|NCT03320850|470726953|FG000|Overall Study|Adverse Event|0|||
130755375|NCT03320850|470726954|FG001|Overall Study|Adverse Event|0|||
130755376|NCT03320850|470726955|FG002|Overall Study|Adverse Event|0|||
130755377|NCT03320850|470726956|FG003|Overall Study|Adverse Event|0|||
130755378|NCT03320850|470726957|FG004|Overall Study|Adverse Event|0|||
130755379|NCT03320850|470726958|FG005|Overall Study|Adverse Event|2|||
130755380|NCT03320850|470726959|FG006|Overall Study|Adverse Event|1|||
130755381|NCT03320850|470726960|FG007|Overall Study|Adverse Event|0|||
130755382|NCT03320850|470726961|FG008|Overall Study|Adverse Event|2|||
130755383|NCT03320850|470726962|FG009|Overall Study|Adverse Event|0|||
130755384|NCT03320850|470726953|FG000|Overall Study|Reason Not Specified|0|||
130755385|NCT03320850|470726954|FG001|Overall Study|Reason Not Specified|0|||
130755386|NCT03320850|470726955|FG002|Overall Study|Reason Not Specified|0|||
130755387|NCT03320850|470726956|FG003|Overall Study|Reason Not Specified|0|||
130755388|NCT03320850|470726957|FG004|Overall Study|Reason Not Specified|0|||
130755389|NCT03320850|470726958|FG005|Overall Study|Reason Not Specified|1|||
130755390|NCT03320850|470726959|FG006|Overall Study|Reason Not Specified|0|||
130755391|NCT03320850|470726960|FG007|Overall Study|Reason Not Specified|0|||
130755392|NCT03320850|470726961|FG008|Overall Study|Reason Not Specified|0|||
130755393|NCT03320850|470726962|FG009|Overall Study|Reason Not Specified|1|||
130755394|NCT03991299|470726963|FG000|Overall Study|Study closed, sponsor decision|3|||
130755395|NCT03991299|470726963|FG000|Overall Study|Withdrawal by Subject|1|||
130755396|NCT04429555|470726966|FG000|Overall Study|Death|0|||
130755397|NCT04429555|470726967|FG001|Overall Study|Death|2|||
130755398|NCT04429555|470726966|FG000|Overall Study|Other|2|||
130755399|NCT04429555|470726967|FG001|Overall Study|Other|0|||
130755400|NCT00941863|470726970|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
130755401|NCT00941863|470726971|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
130755402|NCT00941863|470726972|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
130755403|NCT00941863|470726973|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
130755404|NCT00941863|470726974|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
130755405|NCT00941863|470726970|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
130755406|NCT00941863|470726971|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
130755407|NCT00941863|470726972|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
130755408|NCT00941863|470726973|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
130755409|NCT00941863|470726974|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
130755410|NCT00941863|470726970|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
130755411|NCT00941863|470726971|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
130755412|NCT00941863|470726972|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
130755413|NCT00941863|470726973|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
130755414|NCT00941863|470726974|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
130755415|NCT00941863|470726970|FG000|Until Primary Completion Date (PCD)|Death|0|||
130755416|NCT00941863|470726971|FG001|Until Primary Completion Date (PCD)|Death|0|||
130755417|NCT00941863|470726972|FG002|Until Primary Completion Date (PCD)|Death|1|||
130755418|NCT00941863|470726973|FG003|Until Primary Completion Date (PCD)|Death|2|||
130755419|NCT00941863|470726974|FG004|Until Primary Completion Date (PCD)|Death|7|||
130755420|NCT00941863|470726970|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
130755421|NCT00941863|470726971|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
130755422|NCT00941863|470726972|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
130755423|NCT00941863|470726973|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
130755424|NCT00941863|470726974|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
130755425|NCT00941863|470726970|FG000|Continued After PCD|Withdrawal by Subject|0|||
130755426|NCT00941863|470726971|FG001|Continued After PCD|Withdrawal by Subject|0|||
130755427|NCT00941863|470726972|FG002|Continued After PCD|Withdrawal by Subject|0|||
130755428|NCT00941863|470726973|FG003|Continued After PCD|Withdrawal by Subject|0|||
130755429|NCT00941863|470726974|FG004|Continued After PCD|Withdrawal by Subject|1|||
130755430|NCT00941863|470726970|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
130755431|NCT00941863|470726971|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
130755432|NCT00941863|470726972|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
130755433|NCT00941863|470726973|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
130755434|NCT00941863|470726974|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
130755435|NCT04533412|470726975|FG000|Overall Study|Withdrawal by Subject|1|||
130755436|NCT04533412|470726976|FG001|Overall Study|Withdrawal by Subject|1|||
130755437|NCT04533412|470726975|FG000|Overall Study|Lost to Follow-up|1|||
130755438|NCT04533412|470726976|FG001|Overall Study|Lost to Follow-up|4|||
130755439|NCT05113979|470726982|FG000|Overall Study|Death|2|||
130755440|NCT05113979|470726982|FG000|Overall Study|Lost to Follow-up|1|||
130755441|NCT00968981|470726983|FG000|Overall Study|Adverse Event|2|||
130755442|NCT00968981|470726984|FG001|Overall Study|Adverse Event|0|||
130755443|NCT00968981|470726985|FG002|Overall Study|Adverse Event|0|||
130755444|NCT00968981|470726983|FG000|Overall Study|Disease Progression|14|||
130755445|NCT00968981|470726984|FG001|Overall Study|Disease Progression|16|||
130755446|NCT00968981|470726985|FG002|Overall Study|Disease Progression|13|||
130755447|NCT00968981|470726983|FG000|Overall Study|Lost to Follow-up|0|||
130755448|NCT00968981|470726984|FG001|Overall Study|Lost to Follow-up|0|||
130755449|NCT00968981|470726985|FG002|Overall Study|Lost to Follow-up|1|||
130755450|NCT00968981|470726983|FG000|Overall Study|Physician Decision|5|||
130755451|NCT00968981|470726984|FG001|Overall Study|Physician Decision|3|||
130755452|NCT00968981|470726985|FG002|Overall Study|Physician Decision|5|||
130755453|NCT00968981|470726983|FG000|Overall Study|Withdrawal by Subject|1|||
130755454|NCT00968981|470726984|FG001|Overall Study|Withdrawal by Subject|3|||
130755455|NCT00968981|470726985|FG002|Overall Study|Withdrawal by Subject|3|||
130755456|NCT01489254|470726988|FG000|Double-blind Part|Adverse Event|7|||
130755457|NCT01489254|470726989|FG001|Double-blind Part|Adverse Event|2|||
130755458|NCT01489254|470726990|FG002|Double-blind Part|Adverse Event|2|||
130755459|NCT01489254|470726991|FG003|Double-blind Part|Adverse Event|0|||
130755460|NCT01489254|470726988|FG000|Double-blind Part|Pregnancy|1|||
130755461|NCT01489254|470726989|FG001|Double-blind Part|Pregnancy|3|||
130755462|NCT01489254|470726990|FG002|Double-blind Part|Pregnancy|0|||
130755463|NCT01489254|470726991|FG003|Double-blind Part|Pregnancy|0|||
130755464|NCT01489254|470726988|FG000|Double-blind Part|Withdrawal by Subject|12|||
130755465|NCT01489254|470726989|FG001|Double-blind Part|Withdrawal by Subject|20|||
130755466|NCT01489254|470726990|FG002|Double-blind Part|Withdrawal by Subject|1|||
130755467|NCT01489254|470726991|FG003|Double-blind Part|Withdrawal by Subject|0|||
130755468|NCT01489254|470726988|FG000|Double-blind Part|Lost to Follow-up|1|||
130755469|NCT01489254|470726989|FG001|Double-blind Part|Lost to Follow-up|2|||
130755470|NCT01489254|470726990|FG002|Double-blind Part|Lost to Follow-up|0|||
130755471|NCT01489254|470726991|FG003|Double-blind Part|Lost to Follow-up|0|||
130755472|NCT01489254|470726988|FG000|Double-blind Part|Other reasons for not completing study|4|||
130755473|NCT01489254|470726989|FG001|Double-blind Part|Other reasons for not completing study|6|||
130755474|NCT01489254|470726990|FG002|Double-blind Part|Other reasons for not completing study|0|||
130755475|NCT01489254|470726991|FG003|Double-blind Part|Other reasons for not completing study|0|||
130755476|NCT01489254|470726988|FG000|Open-label Extension Part|Adverse Event|0|||
130755477|NCT01489254|470726989|FG001|Open-label Extension Part|Adverse Event|0|||
130755478|NCT01489254|470726990|FG002|Open-label Extension Part|Adverse Event|0|||
130755479|NCT01489254|470726991|FG003|Open-label Extension Part|Adverse Event|10|||
130755480|NCT01489254|470726988|FG000|Open-label Extension Part|Pregnancy|0|||
130755481|NCT01489254|470726989|FG001|Open-label Extension Part|Pregnancy|0|||
130755482|NCT01489254|470726990|FG002|Open-label Extension Part|Pregnancy|0|||
130755483|NCT01489254|470726991|FG003|Open-label Extension Part|Pregnancy|3|||
130755484|NCT01489254|470726988|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
130755485|NCT01489254|470726989|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
130755486|NCT01489254|470726990|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
130755487|NCT01489254|470726991|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
130755488|NCT01489254|470726988|FG000|Open-label Extension Part|Protocol Violation|0|||
130755489|NCT01489254|470726989|FG001|Open-label Extension Part|Protocol Violation|0|||
130755490|NCT01489254|470726990|FG002|Open-label Extension Part|Protocol Violation|0|||
130755491|NCT01489254|470726991|FG003|Open-label Extension Part|Protocol Violation|1|||
130755492|NCT01489254|470726988|FG000|Open-label Extension Part|Lost to Follow-up|0|||
130755493|NCT01489254|470726989|FG001|Open-label Extension Part|Lost to Follow-up|0|||
130755494|NCT01489254|470726990|FG002|Open-label Extension Part|Lost to Follow-up|0|||
130755495|NCT01489254|470726991|FG003|Open-label Extension Part|Lost to Follow-up|9|||
130755496|NCT01489254|470726988|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
130755497|NCT01489254|470726989|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
130755498|NCT01489254|470726990|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
130755499|NCT01489254|470726991|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
130755500|NCT00281632|470726999|FG000|Overall Study|Adverse Event|7|||
130755501|NCT00281632|470726999|FG000|Overall Study|Withdrawal by Subject|2|||
130755502|NCT00281632|470726999|FG000|Overall Study|Disease Progression|22|||
130755503|NCT00281632|470726999|FG000|Overall Study|Death|1|||
130755504|NCT00281632|470726999|FG000|Overall Study|Physician Decision|1|||
130755505|NCT00281632|470726999|FG000|Overall Study|Ongoing|3|||
130755506|NCT03990571|470727000|FG000|Overall Study|Withdrawal by Subject|1|||
130755507|NCT03990571|470727000|FG000|Overall Study|Insurance Issues|3|||
130755508|NCT03990571|470727000|FG000|Overall Study|Covid Restrictions|2|||
130755509|NCT00782184|470727007|FG000|Overall Study|Adverse Event|1|||
130755510|NCT00782184|470727008|FG001|Overall Study|Adverse Event|2|||
130755511|NCT00782184|470727007|FG000|Overall Study|Protocol Violation|0|||
130755512|NCT00782184|470727008|FG001|Overall Study|Protocol Violation|1|||
130755513|NCT00782184|470727007|FG000|Overall Study|Withdrawal by Subject|3|||
130755514|NCT00782184|470727008|FG001|Overall Study|Withdrawal by Subject|2|||
130755515|NCT03614078|470727009|FG000|Overall Study|Withdrawal by Subject|2|||
130755516|NCT03614078|470727010|FG001|Overall Study|Withdrawal by Subject|2|||
130755517|NCT03614078|470727011|FG002|Overall Study|Withdrawal by Subject|3|||
130755518|NCT03614078|470727009|FG000|Overall Study|Participant Did Not Return for Visit|0|||
130755519|NCT03614078|470727010|FG001|Overall Study|Participant Did Not Return for Visit|1|||
130755520|NCT03614078|470727011|FG002|Overall Study|Participant Did Not Return for Visit|0|||
130755521|NCT03614078|470727009|FG000|Overall Study|High Neutrophils|0|||
130755522|NCT03614078|470727010|FG001|Overall Study|High Neutrophils|0|||
130755523|NCT03614078|470727011|FG002|Overall Study|High Neutrophils|2|||
130755524|NCT03614078|470727009|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
130755525|NCT03614078|470727010|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
130755526|NCT03614078|470727011|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
130755527|NCT03614078|470727009|FG000|Overall Study|Exacerbation of Psoriasis|0|||
130755528|NCT03614078|470727010|FG001|Overall Study|Exacerbation of Psoriasis|1|||
130755529|NCT03614078|470727011|FG002|Overall Study|Exacerbation of Psoriasis|0|||
130755530|NCT03614078|470727009|FG000|Overall Study|Adverse Event|0|||
130755531|NCT03614078|470727010|FG001|Overall Study|Adverse Event|2|||
130755532|NCT03614078|470727011|FG002|Overall Study|Adverse Event|0|||
130755533|NCT03614078|470727009|FG000|Overall Study|Dizziness and Rash|0|||
130755534|NCT03614078|470727010|FG001|Overall Study|Dizziness and Rash|1|||
130789054|NCT03824561|470856751|FG000|Overall Study|Protocol Violation|19|||
130789055|NCT01773928|470856752|FG000|Overall Study|Adverse Event|0|||
130755535|NCT03614078|470727011|FG002|Overall Study|Dizziness and Rash|0|||
130755536|NCT04143594|470727014|FG000|Overall Study|Withdrew consent|3|||
130755537|NCT04143594|470727015|FG001|Overall Study|Withdrew consent|10|||
130755538|NCT04143594|470727016|FG002|Overall Study|Withdrew consent|3|||
130755539|NCT04143594|470727017|FG003|Overall Study|Withdrew consent|1|||
130755540|NCT04143594|470727014|FG000|Overall Study|Lost to Follow-up|3|||
130755541|NCT04143594|470727015|FG001|Overall Study|Lost to Follow-up|5|||
130755542|NCT04143594|470727016|FG002|Overall Study|Lost to Follow-up|11|||
130755543|NCT04143594|470727017|FG003|Overall Study|Lost to Follow-up|0|||
130755544|NCT04143594|470727014|FG000|Overall Study|Investigator's discretion|2|||
130755545|NCT04143594|470727015|FG001|Overall Study|Investigator's discretion|2|||
130755546|NCT04143594|470727016|FG002|Overall Study|Investigator's discretion|0|||
130755547|NCT04143594|470727017|FG003|Overall Study|Investigator's discretion|0|||
130789056|NCT01773928|470856753|FG001|Overall Study|Adverse Event|0|||
130755548|NCT04143594|470727014|FG000|Overall Study|Randomized but never treated|0|||
130755549|NCT04143594|470727015|FG001|Overall Study|Randomized but never treated|0|||
130755550|NCT04143594|470727016|FG002|Overall Study|Randomized but never treated|0|||
130755551|NCT04143594|470727017|FG003|Overall Study|Randomized but never treated|1|||
130755552|NCT04143594|470727014|FG000|Overall Study|Death|1|||
130755553|NCT04143594|470727015|FG001|Overall Study|Death|0|||
130755554|NCT04143594|470727016|FG002|Overall Study|Death|1|||
130755555|NCT04143594|470727017|FG003|Overall Study|Death|0|||
130755556|NCT04143594|470727014|FG000|Overall Study|Adverse Event|1|||
130755557|NCT04143594|470727015|FG001|Overall Study|Adverse Event|0|||
130755558|NCT04143594|470727016|FG002|Overall Study|Adverse Event|0|||
130755559|NCT04143594|470727017|FG003|Overall Study|Adverse Event|0|||
130755560|NCT04143594|470727014|FG000|Overall Study|Pregnancy|0|||
130755561|NCT04143594|470727015|FG001|Overall Study|Pregnancy|0|||
130755562|NCT04143594|470727016|FG002|Overall Study|Pregnancy|1|||
130755563|NCT04143594|470727017|FG003|Overall Study|Pregnancy|0|||
130755564|NCT04143594|470727014|FG000|Overall Study|Lack of Efficacy|1|||
130755565|NCT04143594|470727015|FG001|Overall Study|Lack of Efficacy|1|||
130755566|NCT04143594|470727016|FG002|Overall Study|Lack of Efficacy|0|||
130755567|NCT04143594|470727017|FG003|Overall Study|Lack of Efficacy|0|||
130755568|NCT01054196|470727018|FG000|Overall Study|Physician Decision|0|||
130755569|NCT01054196|470727019|FG001|Overall Study|Physician Decision|0|||
130755570|NCT01054196|470727020|FG002|Overall Study|Physician Decision|0|||
130755571|NCT01054196|470727021|FG003|Overall Study|Physician Decision|1|||
130755572|NCT01054196|470727022|FG004|Overall Study|Physician Decision|0|||
130755573|NCT01054196|470727023|FG005|Overall Study|Physician Decision|0|||
130755574|NCT01054196|470727024|FG006|Overall Study|Physician Decision|1|||
130755575|NCT00492648|470727025|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
130755576|NCT00492648|470727026|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
130755577|NCT00282113|470727027|FG000|Overall Study|Removed at parents request|1|||
130755578|NCT00282113|470727028|FG001|Overall Study|Removed at parents request|0|||
130755579|NCT00282113|470727029|FG002|Overall Study|Removed at parents request|0|||
130755580|NCT02949843|470727030|FG000|Overall Study|Withdrawal by Subject|0|||
130755581|NCT02949843|470727031|FG001|Overall Study|Withdrawal by Subject|1|||
130755582|NCT02949843|470727032|FG002|Overall Study|Withdrawal by Subject|1|||
130755583|NCT01500187|470727034|FG000|Overall Study|Lost to Follow-up|6|||
130755584|NCT01500187|470727035|FG001|Overall Study|Lost to Follow-up|0|||
130755585|NCT01343277|470727052|FG000|Overall Study|Other|3|||
130755586|NCT01343277|470727053|FG001|Overall Study|Other|3|||
130755587|NCT01343277|470727052|FG000|Overall Study|Withdrawal by Subject|18|||
130755588|NCT01343277|470727053|FG001|Overall Study|Withdrawal by Subject|13|||
130755589|NCT01343277|470727052|FG000|Overall Study|Physician Decision|1|||
130755590|NCT01343277|470727053|FG001|Overall Study|Physician Decision|2|||
130755591|NCT01343277|470727052|FG000|Overall Study|Death|10|||
130755592|NCT01343277|470727053|FG001|Overall Study|Death|1|||
130755593|NCT01343277|470727052|FG000|Overall Study|Adverse Event|67|||
130755594|NCT01343277|470727053|FG001|Overall Study|Adverse Event|13|||
130755595|NCT01343277|470727052|FG000|Overall Study|Disease progression|270|||
130755596|NCT01343277|470727053|FG001|Overall Study|Disease progression|138|||
130755597|NCT01343277|470727052|FG000|Overall Study|Randomized not treated|6|||
130755598|NCT01343277|470727053|FG001|Overall Study|Randomized not treated|21|||
130755599|NCT01343277|470727052|FG000|Overall Study|Treatment ongoing|8|||
130755600|NCT01343277|470727053|FG001|Overall Study|Treatment ongoing|2|||
130755601|NCT01343277|470727052|FG000|Overall Study|Subsequent anticancer therapy|1|||
130755602|NCT01343277|470727053|FG001|Overall Study|Subsequent anticancer therapy|0|||
130755603|NCT01582178|470727054|FG000|Overall Study|Physician Decision|6|||
130755604|NCT01582178|470727055|FG001|Overall Study|Physician Decision|5|||
130755605|NCT00556933|470727063|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
130755606|NCT00556933|470727064|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
130755607|NCT00556933|470727065|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
130755608|NCT00556933|470727066|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
130755609|NCT00556933|470727063|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
130755610|NCT00556933|470727064|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
130755611|NCT00556933|470727065|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
130755612|NCT00556933|470727066|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
130755613|NCT00556933|470727063|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
130755614|NCT00556933|470727064|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
130755615|NCT00556933|470727065|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
130755616|NCT00556933|470727066|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
130755617|NCT00556933|470727063|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
130755618|NCT00556933|470727064|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
130755619|NCT00556933|470727065|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
130755620|NCT00556933|470727066|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
130755621|NCT00556933|470727063|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
130755622|NCT00556933|470727064|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
130755623|NCT00556933|470727065|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
130755624|NCT00556933|470727066|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
130755625|NCT00556933|470727063|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
130755626|NCT00556933|470727064|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
130755627|NCT00556933|470727065|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
130755628|NCT00556933|470727066|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
130755629|NCT00556933|470727063|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
130755630|NCT00556933|470727064|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
130755631|NCT00556933|470727065|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
130755632|NCT00556933|470727066|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
130755633|NCT00556933|470727063|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
130755634|NCT00556933|470727064|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
130755635|NCT00556933|470727065|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
130755636|NCT00556933|470727066|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
130755637|NCT00556933|470727063|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
130755638|NCT00556933|470727064|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
130755639|NCT00556933|470727065|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
130755640|NCT00556933|470727066|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
130755641|NCT00556933|470727063|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
130755642|NCT00556933|470727064|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
130755643|NCT00556933|470727065|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
130755644|NCT00556933|470727066|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
130755645|NCT00556933|470727063|FG000|CNI Withdrawal vs. Minimization|Death|0|||
130755646|NCT00556933|470727064|FG001|CNI Withdrawal vs. Minimization|Death|0|||
130755647|NCT00556933|470727065|FG002|CNI Withdrawal vs. Minimization|Death|0|||
130755648|NCT00556933|470727066|FG003|CNI Withdrawal vs. Minimization|Death|1|||
130755649|NCT01295827|470727069|FG000|Overall Study|Adverse Event|1|||
130755650|NCT01295827|470727070|FG001|Overall Study|Adverse Event|2|||
130755651|NCT01295827|470727071|FG002|Overall Study|Adverse Event|2|||
130755652|NCT01295827|470727072|FG003|Overall Study|Adverse Event|1|||
130755653|NCT01295827|470727073|FG004|Overall Study|Adverse Event|1|||
130755654|NCT01295827|470727074|FG005|Overall Study|Adverse Event|4|||
130755655|NCT01295827|470727075|FG006|Overall Study|Adverse Event|15|||
130755656|NCT01295827|470727076|FG007|Overall Study|Adverse Event|49|||
130755657|NCT01295827|470727077|FG008|Overall Study|Adverse Event|22|||
130755658|NCT01295827|470727078|FG009|Overall Study|Adverse Event|7|||
130755659|NCT01295827|470727079|FG010|Overall Study|Adverse Event|50|||
130755660|NCT01295827|470727080|FG011|Overall Study|Adverse Event|21|||
130755661|NCT01295827|470727081|FG012|Overall Study|Adverse Event|0|||
130755662|NCT01295827|470727082|FG013|Overall Study|Adverse Event|0|||
130755663|NCT01295827|470727083|FG014|Overall Study|Adverse Event|0|||
130755664|NCT01295827|470727069|FG000|Overall Study|Lost to Follow-up|0|||
130755665|NCT01295827|470727070|FG001|Overall Study|Lost to Follow-up|0|||
130755666|NCT01295827|470727071|FG002|Overall Study|Lost to Follow-up|3|||
130755667|NCT01295827|470727072|FG003|Overall Study|Lost to Follow-up|0|||
130755668|NCT01295827|470727073|FG004|Overall Study|Lost to Follow-up|1|||
130755669|NCT01295827|470727074|FG005|Overall Study|Lost to Follow-up|0|||
130755670|NCT01295827|470727075|FG006|Overall Study|Lost to Follow-up|4|||
130755671|NCT01295827|470727076|FG007|Overall Study|Lost to Follow-up|8|||
130755672|NCT01295827|470727077|FG008|Overall Study|Lost to Follow-up|7|||
130755673|NCT01295827|470727078|FG009|Overall Study|Lost to Follow-up|4|||
130755674|NCT01295827|470727079|FG010|Overall Study|Lost to Follow-up|7|||
130755675|NCT01295827|470727080|FG011|Overall Study|Lost to Follow-up|3|||
130755676|NCT01295827|470727081|FG012|Overall Study|Lost to Follow-up|0|||
130755677|NCT01295827|470727082|FG013|Overall Study|Lost to Follow-up|0|||
130755678|NCT01295827|470727083|FG014|Overall Study|Lost to Follow-up|0|||
130755679|NCT01295827|470727069|FG000|Overall Study|Not Reported|0|||
130755680|NCT01295827|470727070|FG001|Overall Study|Not Reported|0|||
130755681|NCT01295827|470727071|FG002|Overall Study|Not Reported|0|||
130755682|NCT01295827|470727072|FG003|Overall Study|Not Reported|1|||
130755683|NCT01295827|470727073|FG004|Overall Study|Not Reported|0|||
130755684|NCT01295827|470727074|FG005|Overall Study|Not Reported|0|||
130755685|NCT01295827|470727075|FG006|Overall Study|Not Reported|24|||
130755686|NCT01295827|470727076|FG007|Overall Study|Not Reported|58|||
130755687|NCT01295827|470727077|FG008|Overall Study|Not Reported|41|||
130755688|NCT01295827|470727078|FG009|Overall Study|Not Reported|2|||
130755689|NCT01295827|470727079|FG010|Overall Study|Not Reported|23|||
130755690|NCT01295827|470727080|FG011|Overall Study|Not Reported|13|||
130755691|NCT01295827|470727081|FG012|Overall Study|Not Reported|0|||
130755692|NCT01295827|470727082|FG013|Overall Study|Not Reported|0|||
130755693|NCT01295827|470727083|FG014|Overall Study|Not Reported|0|||
130755694|NCT01295827|470727069|FG000|Overall Study|Progressive Disease|2|||
130755695|NCT01295827|470727070|FG001|Overall Study|Progressive Disease|1|||
130755696|NCT01295827|470727071|FG002|Overall Study|Progressive Disease|5|||
130755697|NCT01295827|470727072|FG003|Overall Study|Progressive Disease|2|||
130755698|NCT01295827|470727073|FG004|Overall Study|Progressive Disease|0|||
130755699|NCT01295827|470727074|FG005|Overall Study|Progressive Disease|1|||
130755700|NCT01295827|470727075|FG006|Overall Study|Progressive Disease|87|||
130755701|NCT01295827|470727076|FG007|Overall Study|Progressive Disease|144|||
130755702|NCT01295827|470727077|FG008|Overall Study|Progressive Disease|85|||
130755703|NCT01295827|470727078|FG009|Overall Study|Progressive Disease|40|||
130755704|NCT01295827|470727079|FG010|Overall Study|Progressive Disease|175|||
130755705|NCT01295827|470727080|FG011|Overall Study|Progressive Disease|136|||
130755706|NCT01295827|470727081|FG012|Overall Study|Progressive Disease|0|||
130755707|NCT01295827|470727082|FG013|Overall Study|Progressive Disease|0|||
130755708|NCT01295827|470727083|FG014|Overall Study|Progressive Disease|0|||
130755709|NCT01295827|470727069|FG000|Overall Study|Screen Failure|0|||
130755710|NCT01295827|470727070|FG001|Overall Study|Screen Failure|0|||
130755711|NCT01295827|470727071|FG002|Overall Study|Screen Failure|0|||
130755712|NCT01295827|470727072|FG003|Overall Study|Screen Failure|0|||
130755713|NCT01295827|470727073|FG004|Overall Study|Screen Failure|0|||
130755714|NCT01295827|470727074|FG005|Overall Study|Screen Failure|0|||
130755715|NCT01295827|470727075|FG006|Overall Study|Screen Failure|2|||
130755716|NCT01295827|470727076|FG007|Overall Study|Screen Failure|2|||
130755717|NCT01295827|470727077|FG008|Overall Study|Screen Failure|2|||
130755718|NCT01295827|470727078|FG009|Overall Study|Screen Failure|0|||
130755719|NCT01295827|470727079|FG010|Overall Study|Screen Failure|1|||
130755720|NCT01295827|470727080|FG011|Overall Study|Screen Failure|0|||
130755721|NCT01295827|470727081|FG012|Overall Study|Screen Failure|0|||
130755722|NCT01295827|470727082|FG013|Overall Study|Screen Failure|0|||
130755723|NCT01295827|470727083|FG014|Overall Study|Screen Failure|0|||
130755724|NCT01295827|470727069|FG000|Overall Study|Withdrawal by Subject|1|||
130755725|NCT01295827|470727070|FG001|Overall Study|Withdrawal by Subject|0|||
130755726|NCT01295827|470727071|FG002|Overall Study|Withdrawal by Subject|2|||
130755727|NCT01295827|470727072|FG003|Overall Study|Withdrawal by Subject|0|||
130755728|NCT01295827|470727073|FG004|Overall Study|Withdrawal by Subject|0|||
130755729|NCT01295827|470727074|FG005|Overall Study|Withdrawal by Subject|1|||
130755730|NCT01295827|470727075|FG006|Overall Study|Withdrawal by Subject|13|||
130755731|NCT01295827|470727076|FG007|Overall Study|Withdrawal by Subject|35|||
130755732|NCT01295827|470727077|FG008|Overall Study|Withdrawal by Subject|11|||
130755733|NCT01295827|470727078|FG009|Overall Study|Withdrawal by Subject|2|||
130755734|NCT01295827|470727079|FG010|Overall Study|Withdrawal by Subject|18|||
130755735|NCT01295827|470727080|FG011|Overall Study|Withdrawal by Subject|13|||
130755736|NCT01295827|470727081|FG012|Overall Study|Withdrawal by Subject|0|||
130755737|NCT01295827|470727082|FG013|Overall Study|Withdrawal by Subject|0|||
130755738|NCT01295827|470727083|FG014|Overall Study|Withdrawal by Subject|0|||
130755739|NCT01295827|470727069|FG000|Overall Study|Other|0|||
130755740|NCT01295827|470727070|FG001|Overall Study|Other|0|||
130755741|NCT01295827|470727071|FG002|Overall Study|Other|0|||
130755742|NCT01295827|470727072|FG003|Overall Study|Other|0|||
130755743|NCT01295827|470727073|FG004|Overall Study|Other|0|||
130755744|NCT01295827|470727074|FG005|Overall Study|Other|0|||
130755745|NCT01295827|470727075|FG006|Overall Study|Other|1|||
130755746|NCT01295827|470727076|FG007|Overall Study|Other|1|||
130755747|NCT01295827|470727077|FG008|Overall Study|Other|1|||
130755748|NCT01295827|470727078|FG009|Overall Study|Other|0|||
130755749|NCT01295827|470727079|FG010|Overall Study|Other|2|||
130755750|NCT01295827|470727080|FG011|Overall Study|Other|0|||
130755751|NCT01295827|470727081|FG012|Overall Study|Other|0|||
130755752|NCT01295827|470727082|FG013|Overall Study|Other|0|||
130755753|NCT01295827|470727083|FG014|Overall Study|Other|0|||
130755754|NCT01668173|470727084|FG000|Overall Study|Adverse Event|3|||
130755755|NCT01668173|470727084|FG000|Overall Study|Trial suspension|4|||
130755756|NCT00746564|470727087|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
130755757|NCT02640677|470727091|FG000|Overall Study|Lost to Follow-up|1|||
130755758|NCT02640677|470727091|FG000|Overall Study|Withdrawal by Subject|1|||
130755759|NCT01516008|470727092|FG000|Overall Study|Adverse Event|0|||
130755760|NCT01516008|470727093|FG001|Overall Study|Adverse Event|2|||
130755761|NCT01516008|470727094|FG002|Overall Study|Adverse Event|7|||
130755762|NCT01516008|470727092|FG000|Overall Study|Lack of Efficacy|44|||
130755763|NCT01516008|470727093|FG001|Overall Study|Lack of Efficacy|14|||
130755764|NCT01516008|470727094|FG002|Overall Study|Lack of Efficacy|10|||
130755765|NCT01516008|470727092|FG000|Overall Study|Protocol Violation|1|||
130755766|NCT01516008|470727093|FG001|Overall Study|Protocol Violation|0|||
130755767|NCT01516008|470727094|FG002|Overall Study|Protocol Violation|0|||
130755768|NCT01516008|470727092|FG000|Overall Study|Reason not specified|0|||
130755769|NCT01516008|470727093|FG001|Overall Study|Reason not specified|0|||
130755770|NCT01516008|470727094|FG002|Overall Study|Reason not specified|1|||
130755771|NCT03963232|470727098|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130755772|NCT03963232|470727099|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
130755773|NCT03963232|470727098|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
130755774|NCT03963232|470727099|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
130755775|NCT03963232|470727098|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
130755776|NCT03963232|470727099|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
130755777|NCT03963232|470727098|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
130789057|NCT01773928|470856754|FG002|Overall Study|Adverse Event|0|||
130755778|NCT03963232|470727099|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
130755779|NCT03963232|470727098|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
130755780|NCT03963232|470727099|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
130755781|NCT03963232|470727098|FG000|Open-Label Treatment Phase|Adverse Event|1|||
130755782|NCT03963232|470727099|FG001|Open-Label Treatment Phase|Adverse Event|2|||
130755783|NCT03963232|470727098|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
130755784|NCT03963232|470727099|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
130755785|NCT03963232|470727098|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
130755786|NCT03963232|470727099|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
130755787|NCT03963232|470727098|FG000|Open-Label Treatment Phase|Pregnancy|1|||
130755788|NCT03963232|470727099|FG001|Open-Label Treatment Phase|Pregnancy|0|||
130755789|NCT03963232|470727098|FG000|Follow-up Phase|Withdrawal by Subject|7|||
130755790|NCT03963232|470727099|FG001|Follow-up Phase|Withdrawal by Subject|5|||
130755791|NCT03963232|470727098|FG000|Follow-up Phase|Protocol Violation|0|||
130755792|NCT03963232|470727099|FG001|Follow-up Phase|Protocol Violation|2|||
130755793|NCT03963232|470727098|FG000|Follow-up Phase|Adverse Event|0|||
130755794|NCT03963232|470727099|FG001|Follow-up Phase|Adverse Event|1|||
130755795|NCT03963232|470727098|FG000|Follow-up Phase|Lost to Follow-up|0|||
130755796|NCT03963232|470727099|FG001|Follow-up Phase|Lost to Follow-up|1|||
130755797|NCT03512210|470727100|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
130755798|NCT03512210|470727100|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
130755799|NCT03512210|470727100|FG000|Step 2:Post-MINMON|Death|2|||
130755800|NCT03512210|470727100|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
130755801|NCT03512210|470727100|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
130755802|NCT02836236|470729278|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
130755803|NCT02836236|470729279|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
130755804|NCT02836236|470729280|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
130755805|NCT02836236|470729281|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
130755806|NCT02836236|470729278|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
130755807|NCT02836236|470729279|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
130755808|NCT02836236|470729280|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130755809|NCT02836236|470729281|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130755810|NCT02836236|470729278|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130755811|NCT02836236|470729279|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
130755812|NCT02836236|470729280|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
130755813|NCT02836236|470729281|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130755814|NCT02836236|470729278|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
130755815|NCT02836236|470729279|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130755816|NCT02836236|470729280|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130755817|NCT02836236|470729281|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130755818|NCT02836236|470729278|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130755819|NCT02836236|470729279|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130755820|NCT02836236|470729280|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
130755821|NCT02836236|470729281|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
130755822|NCT02836236|470729278|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130755823|NCT02836236|470729279|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130755824|NCT02836236|470729280|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
130755825|NCT02836236|470729281|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
130755826|NCT02836236|470729278|FG000|Open-Label TAF Treatment Phase|Death|0|||
130755827|NCT02836236|470729279|FG001|Open-Label TAF Treatment Phase|Death|0|||
130755828|NCT02836236|470729280|FG002|Open-Label TAF Treatment Phase|Death|1|||
130755829|NCT02836236|470729281|FG003|Open-Label TAF Treatment Phase|Death|1|||
130755830|NCT02836236|470729278|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
130755831|NCT02836236|470729279|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
130755832|NCT02836236|470729280|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
130755833|NCT02836236|470729281|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
130755834|NCT01806961|470729282|FG000|Overall Study|sponsor decision|16|||
130755835|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
130755836|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
130755837|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
130755838|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
130755839|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Death|0|||
130755840|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Death|0|||
130755841|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Death|1|||
130755842|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Death|0|||
130755843|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
130755844|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
130755845|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
130755846|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
130755847|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
130755848|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
130755849|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
130755850|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
130755851|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
130755852|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
130755853|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
130755854|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
130755855|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
130755856|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
130755857|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
130755858|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
130755859|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
130755860|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
130755861|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
130755862|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
130755863|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
130755864|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
130755865|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
130755866|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
130755867|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130755868|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
130755869|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130755870|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130755871|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
130755872|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
130755873|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
130755874|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
130755875|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
130755876|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
130755877|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
130755878|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
130755879|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Other|8|||
130755880|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Other|14|||
130755881|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Other|8|||
130755882|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Other|23|||
130755883|NCT01106677|470729283|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
130755884|NCT01106677|470729284|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
130755885|NCT01106677|470729285|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
130755886|NCT01106677|470729286|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
130755887|NCT01106677|470729283|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130755888|NCT01106677|470729284|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130755889|NCT01106677|470729285|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
130755890|NCT01106677|470729286|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
130755891|NCT01106677|470729283|FG000|Extension Period: Week 26 to Week 52|Death|0|||
130755892|NCT01106677|470729284|FG001|Extension Period: Week 26 to Week 52|Death|0|||
130755893|NCT01106677|470729285|FG002|Extension Period: Week 26 to Week 52|Death|0|||
130755894|NCT01106677|470729286|FG003|Extension Period: Week 26 to Week 52|Death|1|||
130755895|NCT01106677|470729283|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
130755896|NCT01106677|470729284|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
130755897|NCT01106677|470729285|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
130755898|NCT01106677|470729286|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
130755899|NCT01106677|470729283|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130755900|NCT01106677|470729284|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130755901|NCT01106677|470729285|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130755902|NCT01106677|470729286|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130755903|NCT01106677|470729283|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130755904|NCT01106677|470729284|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
130755905|NCT01106677|470729285|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130755906|NCT01106677|470729286|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
130755907|NCT01106677|470729283|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130755908|NCT01106677|470729284|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130755909|NCT01106677|470729285|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130755910|NCT01106677|470729286|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130755911|NCT01106677|470729283|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130755912|NCT01106677|470729284|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
130755913|NCT01106677|470729285|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
130755914|NCT01106677|470729286|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130755915|NCT01106677|470729283|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
130755916|NCT01106677|470729284|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
130755917|NCT01106677|470729285|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
130755918|NCT01106677|470729286|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
130755919|NCT01106677|470729283|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130755920|NCT01106677|470729284|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130755921|NCT01106677|470729285|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130755922|NCT01106677|470729286|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130755923|NCT01106677|470729283|FG000|Extension Period: Week 26 to Week 52|Other|6|||
130755924|NCT01106677|470729284|FG001|Extension Period: Week 26 to Week 52|Other|5|||
130755925|NCT01106677|470729285|FG002|Extension Period: Week 26 to Week 52|Other|8|||
130755926|NCT01106677|470729286|FG003|Extension Period: Week 26 to Week 52|Other|5|||
130755927|NCT03937908|470729287|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
130755928|NCT03937908|470729288|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
130755929|NCT03875092|470729289|FG000|Overall Study|Adverse Event|2|||
130755930|NCT03875092|470729290|FG001|Overall Study|Adverse Event|5|||
130755931|NCT03875092|470729289|FG000|Overall Study|Death|44|||
130755932|NCT03875092|470729290|FG001|Overall Study|Death|51|||
130755933|NCT03875092|470729289|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
130755934|NCT03875092|470729290|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
130755935|NCT00784238|470729291|FG000|Overall Study|Adverse Event|14|||
130755936|NCT00784238|470729291|FG000|Overall Study|Death|2|||
130755937|NCT00784238|470729291|FG000|Overall Study|Lack of Efficacy|33|||
130755938|NCT00784238|470729291|FG000|Overall Study|Lost to Follow-up|29|||
130755939|NCT00784238|470729291|FG000|Overall Study|Pregnancy|1|||
130755940|NCT00784238|470729291|FG000|Overall Study|Withdrawal by Subject|26|||
130755941|NCT00784238|470729291|FG000|Overall Study|Other|14|||
130755942|NCT03693612|470729292|FG000|Overall Study|Lost to Follow-up|0|||
130755943|NCT03693612|470729293|FG001|Overall Study|Lost to Follow-up|0|||
130755944|NCT03693612|470729294|FG002|Overall Study|Lost to Follow-up|0|||
130755945|NCT03693612|470729295|FG003|Overall Study|Lost to Follow-up|0|||
130755946|NCT03693612|470729296|FG004|Overall Study|Lost to Follow-up|1|||
130755947|NCT03693612|470729297|FG005|Overall Study|Lost to Follow-up|0|||
130755948|NCT03693612|470729298|FG006|Overall Study|Lost to Follow-up|0|||
130755949|NCT03693612|470729292|FG000|Overall Study|Withdrawal by Subject|0|||
130755950|NCT03693612|470729293|FG001|Overall Study|Withdrawal by Subject|0|||
130755951|NCT03693612|470729294|FG002|Overall Study|Withdrawal by Subject|1|||
130755952|NCT03693612|470729295|FG003|Overall Study|Withdrawal by Subject|0|||
130755953|NCT03693612|470729296|FG004|Overall Study|Withdrawal by Subject|2|||
130755954|NCT03693612|470729297|FG005|Overall Study|Withdrawal by Subject|0|||
130755955|NCT03693612|470729298|FG006|Overall Study|Withdrawal by Subject|0|||
130755956|NCT03693612|470729292|FG000|Overall Study|Study Terminated by Sponsor|0|||
130755957|NCT03693612|470729293|FG001|Overall Study|Study Terminated by Sponsor|1|||
130755958|NCT03693612|470729294|FG002|Overall Study|Study Terminated by Sponsor|0|||
130755959|NCT03693612|470729295|FG003|Overall Study|Study Terminated by Sponsor|0|||
130755960|NCT03693612|470729296|FG004|Overall Study|Study Terminated by Sponsor|3|||
130755961|NCT03693612|470729297|FG005|Overall Study|Study Terminated by Sponsor|0|||
130755962|NCT03693612|470729298|FG006|Overall Study|Study Terminated by Sponsor|0|||
130755963|NCT05318092|470729299|FG000|Overall Study|Lost to Follow-up|3|||
130755964|NCT05318092|470729299|FG000|Overall Study|Withdrawal by Subject|1|||
130755965|NCT04434469|470729300|FG000|Overall Study|Death|2|||
130755966|NCT04434469|470729301|FG001|Overall Study|Death|3|||
130755967|NCT04434469|470729302|FG002|Overall Study|Death|2|||
130755968|NCT04434469|470729303|FG003|Overall Study|Death|2|||
130755969|NCT04434469|470729304|FG004|Overall Study|Death|2|||
130755970|NCT04434469|470729305|FG005|Overall Study|Death|0|||
130755971|NCT04434469|470729300|FG000|Overall Study|Lost to Follow-up|0|||
130755972|NCT04434469|470729301|FG001|Overall Study|Lost to Follow-up|0|||
130755973|NCT04434469|470729302|FG002|Overall Study|Lost to Follow-up|0|||
130755974|NCT04434469|470729303|FG003|Overall Study|Lost to Follow-up|1|||
130755975|NCT04434469|470729304|FG004|Overall Study|Lost to Follow-up|1|||
130755976|NCT04434469|470729305|FG005|Overall Study|Lost to Follow-up|0|||
130755977|NCT04434469|470729300|FG000|Overall Study|Study terminated by sponsor|1|||
130755978|NCT04434469|470729301|FG001|Overall Study|Study terminated by sponsor|1|||
130755979|NCT04434469|470729302|FG002|Overall Study|Study terminated by sponsor|1|||
130755980|NCT04434469|470729303|FG003|Overall Study|Study terminated by sponsor|2|||
130755981|NCT04434469|470729304|FG004|Overall Study|Study terminated by sponsor|3|||
130755982|NCT04434469|470729305|FG005|Overall Study|Study terminated by sponsor|3|||
130755983|NCT04434469|470729300|FG000|Overall Study|Withdrawal by Subject|0|||
130755984|NCT04434469|470729301|FG001|Overall Study|Withdrawal by Subject|0|||
130755985|NCT04434469|470729302|FG002|Overall Study|Withdrawal by Subject|1|||
130755986|NCT04434469|470729303|FG003|Overall Study|Withdrawal by Subject|0|||
130755987|NCT04434469|470729304|FG004|Overall Study|Withdrawal by Subject|0|||
130755988|NCT04434469|470729305|FG005|Overall Study|Withdrawal by Subject|0|||
130755989|NCT01154296|470729308|FG000|Randomization and Intervention|Decided to decline|1|||
130789058|NCT01773928|470856755|FG003|Overall Study|Adverse Event|0|||
130755990|NCT01154296|470729309|FG001|Randomization and Intervention|Decided to decline|1|||
130755991|NCT01154296|470729308|FG000|Randomization and Intervention|Declined by staff|1|||
130755992|NCT01154296|470729309|FG001|Randomization and Intervention|Declined by staff|0|||
130755993|NCT01154296|470729308|FG000|Randomization and Intervention|Did not return|1|||
130755994|NCT01154296|470729309|FG001|Randomization and Intervention|Did not return|0|||
130755995|NCT01154296|470729308|FG000|Randomization and Intervention|Left before test|0|||
130755996|NCT01154296|470729309|FG001|Randomization and Intervention|Left before test|1|||
130755997|NCT01154296|470729308|FG000|Randomization and Intervention|Left clinic early|2|||
130755998|NCT01154296|470729309|FG001|Randomization and Intervention|Left clinic early|0|||
130755999|NCT01154296|470729308|FG000|6-month Follow-up|Lost contact|269|||
130756000|NCT01154296|470729309|FG001|6-month Follow-up|Lost contact|275|||
130756001|NCT01154296|470729308|FG000|6-month Follow-up|Incarcerated|37|||
130756002|NCT01154296|470729309|FG001|6-month Follow-up|Incarcerated|32|||
130756003|NCT01154296|470729308|FG000|6-month Follow-up|Withdrew consent|14|||
130756004|NCT01154296|470729309|FG001|6-month Follow-up|Withdrew consent|15|||
130756005|NCT01154296|470729308|FG000|6-month Follow-up|Death|3|||
130756006|NCT01154296|470729309|FG001|6-month Follow-up|Death|2|||
130756007|NCT01154296|470729308|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
130756008|NCT01154296|470729309|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
130756009|NCT02759055|470729310|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
130756010|NCT02759055|470729311|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
130756011|NCT03692325|470729323|FG000|Overall Study|Adverse Event|2|||
130756012|NCT03692325|470729323|FG000|Overall Study|Progression/Recurrence|2|||
130756013|NCT02461524|470729326|FG000|Overall Study|Death|16|||
130756014|NCT02461524|470729326|FG000|Overall Study|Withdrawal by Subject|4|||
130756015|NCT02461524|470729326|FG000|Overall Study|Device Explanted|5|||
130756016|NCT02461524|470729326|FG000|Overall Study|Missed Visit|6|||
130756017|NCT01936181|470729331|FG000|Randomised, Double-blind|Adverse Event|27|||
130756018|NCT01936181|470729332|FG001|Randomised, Double-blind|Adverse Event|21|||
130756019|NCT01936181|470729333|FG002|Randomised, Double-blind|Adverse Event|0|||
130756020|NCT01936181|470729334|FG003|Randomised, Double-blind|Adverse Event|0|||
130756021|NCT01936181|470729331|FG000|Randomised, Double-blind|Protocol Violation|1|||
130756022|NCT01936181|470729332|FG001|Randomised, Double-blind|Protocol Violation|5|||
130756023|NCT01936181|470729333|FG002|Randomised, Double-blind|Protocol Violation|0|||
130756024|NCT01936181|470729334|FG003|Randomised, Double-blind|Protocol Violation|0|||
130756025|NCT01936181|470729331|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
130756026|NCT01936181|470729332|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
130756027|NCT01936181|470729333|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
130756028|NCT01936181|470729334|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
130756029|NCT01936181|470729331|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
130756030|NCT01936181|470729332|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
130756031|NCT01936181|470729333|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
130756032|NCT01936181|470729334|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
130756033|NCT01936181|470729331|FG000|Randomised, Double-blind|Pregnancy|0|||
130756034|NCT01936181|470729332|FG001|Randomised, Double-blind|Pregnancy|1|||
130756035|NCT01936181|470729333|FG002|Randomised, Double-blind|Pregnancy|0|||
130756036|NCT01936181|470729334|FG003|Randomised, Double-blind|Pregnancy|0|||
130756037|NCT01936181|470729331|FG000|Randomised, Double-blind|Physician Decision|4|||
130756038|NCT01936181|470729332|FG001|Randomised, Double-blind|Physician Decision|4|||
130756039|NCT01936181|470729333|FG002|Randomised, Double-blind|Physician Decision|0|||
130756040|NCT01936181|470729334|FG003|Randomised, Double-blind|Physician Decision|0|||
130756041|NCT01936181|470729331|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
130756042|NCT01936181|470729332|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
130756043|NCT01936181|470729333|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
130756044|NCT01936181|470729334|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
130756045|NCT01936181|470729331|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
130756046|NCT01936181|470729332|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
130756047|NCT01936181|470729333|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
130756048|NCT01936181|470729334|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
130789059|NCT01773928|470856756|FG004|Overall Study|Adverse Event|0|||
130789060|NCT01773928|470856757|FG005|Overall Study|Adverse Event|0|||
130789061|NCT01773928|470856758|FG006|Overall Study|Adverse Event|0|||
130789062|NCT01773928|470856759|FG007|Overall Study|Adverse Event|1|||
130789063|NCT01773928|470856760|FG008|Overall Study|Adverse Event|0|||
130789064|NCT01773928|470856752|FG000|Overall Study|Physician Decision|0|||
130789065|NCT01773928|470856753|FG001|Overall Study|Physician Decision|0|||
130756049|NCT01936181|470729331|FG000|Transition-extension|Adverse Event|3|||
130756050|NCT01936181|470729332|FG001|Transition-extension|Adverse Event|0|||
130756051|NCT01936181|470729333|FG002|Transition-extension|Adverse Event|3|||
130756052|NCT01936181|470729334|FG003|Transition-extension|Adverse Event|1|||
130756053|NCT01936181|470729331|FG000|Transition-extension|Lost to Follow-up|3|||
130756054|NCT01936181|470729332|FG001|Transition-extension|Lost to Follow-up|0|||
130789066|NCT01773928|470856754|FG002|Overall Study|Physician Decision|0|||
130756055|NCT01936181|470729333|FG002|Transition-extension|Lost to Follow-up|1|||
130756056|NCT01936181|470729334|FG003|Transition-extension|Lost to Follow-up|2|||
130756057|NCT01936181|470729331|FG000|Transition-extension|Physician Decision|2|||
130756058|NCT01936181|470729332|FG001|Transition-extension|Physician Decision|0|||
130756059|NCT01936181|470729333|FG002|Transition-extension|Physician Decision|0|||
130756060|NCT01936181|470729334|FG003|Transition-extension|Physician Decision|1|||
130756061|NCT01936181|470729331|FG000|Transition-extension|Withdrawal by Subject|7|||
130756062|NCT01936181|470729332|FG001|Transition-extension|Withdrawal by Subject|0|||
130756063|NCT01936181|470729333|FG002|Transition-extension|Withdrawal by Subject|2|||
130756064|NCT01936181|470729334|FG003|Transition-extension|Withdrawal by Subject|1|||
130756065|NCT02817516|470729335|FG000|Overall Study|Other|0|||
130756066|NCT02817516|470729336|FG001|Overall Study|Other|0|||
130756067|NCT02817516|470729337|FG002|Overall Study|Other|1|||
130756068|NCT02817516|470729338|FG003|Overall Study|Other|0|||
130756069|NCT00664859|470729339|FG000|Overall Study|Adverse Event|2|||
130756070|NCT00664859|470729340|FG001|Overall Study|Adverse Event|1|||
130756071|NCT00664859|470729341|FG002|Overall Study|Adverse Event|3|||
130756072|NCT00664859|470729339|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
130756073|NCT00664859|470729340|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
130756074|NCT00664859|470729341|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
130756075|NCT00664859|470729339|FG000|Overall Study|Noncompliance with protocol|1|||
130756076|NCT00664859|470729340|FG001|Overall Study|Noncompliance with protocol|0|||
130756077|NCT00664859|470729341|FG002|Overall Study|Noncompliance with protocol|4|||
130756078|NCT00664859|470729339|FG000|Overall Study|Laboratory abnormality|2|||
130756079|NCT00664859|470729340|FG001|Overall Study|Laboratory abnormality|1|||
130756080|NCT00664859|470729341|FG002|Overall Study|Laboratory abnormality|4|||
130756081|NCT00664859|470729339|FG000|Overall Study|Withdrawal by Subject|4|||
130756082|NCT00664859|470729340|FG001|Overall Study|Withdrawal by Subject|1|||
130756083|NCT00664859|470729341|FG002|Overall Study|Withdrawal by Subject|3|||
130756084|NCT00664859|470729339|FG000|Overall Study|Lost to Follow-up|2|||
130756085|NCT00664859|470729340|FG001|Overall Study|Lost to Follow-up|2|||
130756086|NCT00664859|470729341|FG002|Overall Study|Lost to Follow-up|1|||
130756087|NCT00664859|470729339|FG000|Overall Study|Other|0|||
130756088|NCT00664859|470729340|FG001|Overall Study|Other|1|||
130756089|NCT00664859|470729341|FG002|Overall Study|Other|2|||
130756090|NCT00900757|470729342|FG000|Overall Study|screen failure|19|||
130756091|NCT00748189|470729343|FG000|Overall Study|Death|99|||
130756092|NCT00748189|470729344|FG001|Overall Study|Death|84|||
130756093|NCT00748189|470729343|FG000|Overall Study|Withdrawal by Subject|23|||
130756094|NCT00748189|470729344|FG001|Overall Study|Withdrawal by Subject|29|||
130756095|NCT00748189|470729343|FG000|Overall Study|Physician Decision|16|||
130756096|NCT00748189|470729344|FG001|Overall Study|Physician Decision|5|||
130756097|NCT00748189|470729343|FG000|Overall Study|Lost to Follow-up|8|||
130756098|NCT00748189|470729344|FG001|Overall Study|Lost to Follow-up|15|||
130756099|NCT00748189|470729343|FG000|Overall Study|Study terminated by Sponsor|70|||
130756100|NCT00748189|470729344|FG001|Overall Study|Study terminated by Sponsor|79|||
130756101|NCT04481191|470729345|FG000|Overall Study|Withdrawn by parent/guardian|15|||
130756102|NCT04481191|470729346|FG001|Overall Study|Withdrawn by parent/guardian|10|||
130756103|NCT01424514|470729347|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
130756104|NCT01424514|470729348|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
130756105|NCT01424514|470729347|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
130756106|NCT01424514|470729348|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
130756107|NCT00546117|470729349|FG000|Overall Study|Withdrawal by Subject|3|||
130756108|NCT00546117|470729350|FG001|Overall Study|Withdrawal by Subject|0|||
130756109|NCT00546117|470729349|FG000|Overall Study|Inability to schedule follow-up visit|1|||
130756110|NCT00546117|470729350|FG001|Overall Study|Inability to schedule follow-up visit|0|||
130756111|NCT02487771|470729353|FG000|Overall Study|Lost to Follow-up|2|||
130756112|NCT02487771|470729354|FG001|Overall Study|Lost to Follow-up|3|||
130756113|NCT02487771|470729353|FG000|Overall Study|Moved out of area|5|||
130756114|NCT02487771|470729354|FG001|Overall Study|Moved out of area|6|||
130756115|NCT02487771|470729353|FG000|Overall Study|Withdrawal by Subject|3|||
130756116|NCT02487771|470729354|FG001|Overall Study|Withdrawal by Subject|5|||
130756117|NCT02653170|470729355|FG000|Overall Study|Withdrawal by Subject|3|||
130756118|NCT02653170|470729356|FG001|Overall Study|Withdrawal by Subject|8|||
130756119|NCT02653170|470729357|FG002|Overall Study|Withdrawal by Subject|3|||
130756120|NCT02653170|470729355|FG000|Overall Study|withdrawn by study team|2|||
130756121|NCT02653170|470729356|FG001|Overall Study|withdrawn by study team|4|||
130756122|NCT02653170|470729357|FG002|Overall Study|withdrawn by study team|5|||
130756123|NCT02653170|470729355|FG000|Overall Study|Lost to Follow-up|12|||
130756124|NCT02653170|470729356|FG001|Overall Study|Lost to Follow-up|4|||
130756125|NCT02653170|470729357|FG002|Overall Study|Lost to Follow-up|10|||
130756126|NCT04984278|470729368|FG000|Period 1|Withdrawal by Subject|1|||
130756127|NCT04984278|470729369|FG001|Period 1|Withdrawal by Subject|0|||
130756128|NCT04984278|470729368|FG000|Period 1|Other|0|||
130756129|NCT04984278|470729369|FG001|Period 1|Other|1|||
130789067|NCT01773928|470856755|FG003|Overall Study|Physician Decision|1|||
130756130|NCT04984278|470729368|FG000|Period 2|Adverse Event|1|||
130756131|NCT04984278|470729369|FG001|Period 2|Adverse Event|0|||
130756132|NCT04984278|470729368|FG000|Period 2|Other|0|||
130756133|NCT04984278|470729369|FG001|Period 2|Other|1|||
130756134|NCT04304235|470729370|FG000|Overall Study|incomplete triage data|0|||
130756135|NCT04304235|470729371|FG001|Overall Study|incomplete triage data|69|||
130756136|NCT04304235|470729372|FG002|Overall Study|incomplete triage data|0|||
130756137|NCT04304235|470729373|FG003|Overall Study|incomplete triage data|0|||
130756138|NCT04304235|470729374|FG004|Overall Study|incomplete triage data|289|||
130756139|NCT04304235|470729375|FG005|Overall Study|incomplete triage data|123|||
130756140|NCT04304235|470729376|FG006|Overall Study|incomplete triage data|65|||
130756141|NCT00425061|470729377|FG000|Overall Study|Adverse Event|1|||
130756142|NCT00425061|470729378|FG001|Overall Study|Adverse Event|0|||
130756143|NCT00425061|470729379|FG002|Overall Study|Adverse Event|0|||
130756144|NCT00425061|470729380|FG003|Overall Study|Adverse Event|2|||
130756145|NCT00425061|470729381|FG004|Overall Study|Adverse Event|2|||
130756146|NCT00425061|470729382|FG005|Overall Study|Adverse Event|0|||
130756147|NCT00425061|470729383|FG006|Overall Study|Adverse Event|0|||
130756148|NCT00425061|470729377|FG000|Overall Study|Lost to Follow-up|0|||
130756149|NCT00425061|470729378|FG001|Overall Study|Lost to Follow-up|1|||
130756150|NCT00425061|470729379|FG002|Overall Study|Lost to Follow-up|0|||
130756151|NCT00425061|470729380|FG003|Overall Study|Lost to Follow-up|0|||
130756152|NCT00425061|470729381|FG004|Overall Study|Lost to Follow-up|0|||
130756153|NCT00425061|470729382|FG005|Overall Study|Lost to Follow-up|0|||
130756154|NCT00425061|470729383|FG006|Overall Study|Lost to Follow-up|0|||
130756155|NCT00425061|470729377|FG000|Overall Study|Protocol Violation|1|||
130756156|NCT00425061|470729378|FG001|Overall Study|Protocol Violation|0|||
130756157|NCT00425061|470729379|FG002|Overall Study|Protocol Violation|0|||
130756158|NCT00425061|470729380|FG003|Overall Study|Protocol Violation|0|||
130756159|NCT00425061|470729381|FG004|Overall Study|Protocol Violation|0|||
130756160|NCT00425061|470729382|FG005|Overall Study|Protocol Violation|0|||
130756161|NCT00425061|470729383|FG006|Overall Study|Protocol Violation|0|||
130756162|NCT00425061|470729377|FG000|Overall Study|Withdrawal by Subject|0|||
130756163|NCT00425061|470729378|FG001|Overall Study|Withdrawal by Subject|1|||
130756164|NCT00425061|470729379|FG002|Overall Study|Withdrawal by Subject|0|||
130756165|NCT00425061|470729380|FG003|Overall Study|Withdrawal by Subject|0|||
130756166|NCT00425061|470729381|FG004|Overall Study|Withdrawal by Subject|1|||
130756167|NCT00425061|470729382|FG005|Overall Study|Withdrawal by Subject|0|||
130756168|NCT00425061|470729383|FG006|Overall Study|Withdrawal by Subject|3|||
130756169|NCT00425061|470729377|FG000|Overall Study|Sponsor's request|0|||
130756170|NCT00425061|470729378|FG001|Overall Study|Sponsor's request|0|||
130756171|NCT00425061|470729379|FG002|Overall Study|Sponsor's request|0|||
130756172|NCT00425061|470729380|FG003|Overall Study|Sponsor's request|0|||
130756173|NCT00425061|470729381|FG004|Overall Study|Sponsor's request|19|||
130756174|NCT00425061|470729382|FG005|Overall Study|Sponsor's request|4|||
130756175|NCT00425061|470729383|FG006|Overall Study|Sponsor's request|15|||
130756176|NCT00425061|470729377|FG000|Overall Study|Physician Decision|0|||
130756177|NCT00425061|470729378|FG001|Overall Study|Physician Decision|0|||
130756178|NCT00425061|470729379|FG002|Overall Study|Physician Decision|0|||
130756179|NCT00425061|470729380|FG003|Overall Study|Physician Decision|0|||
130756180|NCT00425061|470729381|FG004|Overall Study|Physician Decision|1|||
130756181|NCT00425061|470729382|FG005|Overall Study|Physician Decision|0|||
130756182|NCT00425061|470729383|FG006|Overall Study|Physician Decision|0|||
130756183|NCT00425061|470729377|FG000|Overall Study|Other|0|||
130756184|NCT00425061|470729378|FG001|Overall Study|Other|0|||
130756185|NCT00425061|470729379|FG002|Overall Study|Other|0|||
130756186|NCT00425061|470729380|FG003|Overall Study|Other|0|||
130756187|NCT00425061|470729381|FG004|Overall Study|Other|3|||
130756188|NCT00425061|470729382|FG005|Overall Study|Other|0|||
130756189|NCT00425061|470729383|FG006|Overall Study|Other|1|||
130756190|NCT04720911|470729386|FG000|Overall Study|Withdrawal by Subject|0|||
130756191|NCT04720911|470729387|FG001|Overall Study|Withdrawal by Subject|1|||
130756192|NCT04720911|470729388|FG002|Overall Study|Withdrawal by Subject|0|||
130756193|NCT00090220|470729389|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
130756194|NCT00090220|470729390|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
130756195|NCT00090220|470729391|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130756196|NCT00090220|470729392|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130756197|NCT00090220|470729393|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130756198|NCT00090220|470729394|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130756199|NCT00090220|470729389|FG000|Base Study Vaccination Period|Adverse Event|6|||
130756200|NCT00090220|470729390|FG001|Base Study Vaccination Period|Adverse Event|1|||
130756201|NCT00090220|470729391|FG002|Base Study Vaccination Period|Adverse Event|0|||
130756202|NCT00090220|470729392|FG003|Base Study Vaccination Period|Adverse Event|0|||
130756203|NCT00090220|470729393|FG004|Base Study Vaccination Period|Adverse Event|0|||
130756204|NCT00090220|470729394|FG005|Base Study Vaccination Period|Adverse Event|0|||
130756205|NCT00090220|470729389|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
130756206|NCT00090220|470729390|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
130756207|NCT00090220|470729391|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
130756208|NCT00090220|470729392|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
130756209|NCT00090220|470729393|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
130756210|NCT00090220|470729394|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
130756211|NCT00090220|470729389|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
130756212|NCT00090220|470729390|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
130756213|NCT00090220|470729391|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
130756214|NCT00090220|470729392|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
130756215|NCT00090220|470729393|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
130756216|NCT00090220|470729394|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
130756217|NCT00090220|470729389|FG000|Base Study Vaccination Period|Patient Moved|6|||
130756218|NCT00090220|470729390|FG001|Base Study Vaccination Period|Patient Moved|2|||
130756219|NCT00090220|470729391|FG002|Base Study Vaccination Period|Patient Moved|0|||
130756220|NCT00090220|470729392|FG003|Base Study Vaccination Period|Patient Moved|0|||
130756221|NCT00090220|470729393|FG004|Base Study Vaccination Period|Patient Moved|0|||
130756222|NCT00090220|470729394|FG005|Base Study Vaccination Period|Patient Moved|0|||
130756223|NCT00090220|470729389|FG000|Base Study Vaccination Period|Other|4|||
130756224|NCT00090220|470729390|FG001|Base Study Vaccination Period|Other|4|||
130756225|NCT00090220|470729391|FG002|Base Study Vaccination Period|Other|0|||
130756226|NCT00090220|470729392|FG003|Base Study Vaccination Period|Other|0|||
130756227|NCT00090220|470729393|FG004|Base Study Vaccination Period|Other|0|||
130756228|NCT00090220|470729394|FG005|Base Study Vaccination Period|Other|0|||
130756229|NCT00090220|470729389|FG000|Base Study Follow-up Period|Adverse Event|6|||
130756230|NCT00090220|470729390|FG001|Base Study Follow-up Period|Adverse Event|1|||
130756231|NCT00090220|470729391|FG002|Base Study Follow-up Period|Adverse Event|0|||
130756232|NCT00090220|470729392|FG003|Base Study Follow-up Period|Adverse Event|0|||
130756233|NCT00090220|470729393|FG004|Base Study Follow-up Period|Adverse Event|0|||
130756234|NCT00090220|470729394|FG005|Base Study Follow-up Period|Adverse Event|0|||
130756235|NCT00090220|470729389|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
130756236|NCT00090220|470729390|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
130756237|NCT00090220|470729391|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
130756238|NCT00090220|470729392|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
130756239|NCT00090220|470729393|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
130756240|NCT00090220|470729394|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
130756241|NCT00090220|470729389|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
130756242|NCT00090220|470729390|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
130756243|NCT00090220|470729391|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
130756244|NCT00090220|470729392|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
130756245|NCT00090220|470729393|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
130756246|NCT00090220|470729394|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
130756247|NCT00090220|470729389|FG000|Base Study Follow-up Period|Patient Moved|20|||
130756248|NCT00090220|470729390|FG001|Base Study Follow-up Period|Patient Moved|28|||
130756249|NCT00090220|470729391|FG002|Base Study Follow-up Period|Patient Moved|0|||
130756250|NCT00090220|470729392|FG003|Base Study Follow-up Period|Patient Moved|0|||
130756251|NCT00090220|470729393|FG004|Base Study Follow-up Period|Patient Moved|0|||
130756252|NCT00090220|470729394|FG005|Base Study Follow-up Period|Patient Moved|0|||
130756253|NCT00090220|470729389|FG000|Base Study Follow-up Period|Other|19|||
130756254|NCT00090220|470729390|FG001|Base Study Follow-up Period|Other|21|||
130756255|NCT00090220|470729391|FG002|Base Study Follow-up Period|Other|0|||
130756256|NCT00090220|470729392|FG003|Base Study Follow-up Period|Other|0|||
130756257|NCT00090220|470729393|FG004|Base Study Follow-up Period|Other|0|||
130756258|NCT00090220|470729394|FG005|Base Study Follow-up Period|Other|0|||
130756259|NCT00090220|470729389|FG000|Extension 1 (EXT1)|Adverse Event|0|||
130756260|NCT00090220|470729390|FG001|Extension 1 (EXT1)|Adverse Event|0|||
130756261|NCT00090220|470729391|FG002|Extension 1 (EXT1)|Adverse Event|4|||
130756262|NCT00090220|470729392|FG003|Extension 1 (EXT1)|Adverse Event|0|||
130789068|NCT01773928|470856756|FG004|Overall Study|Physician Decision|0|||
130756263|NCT00090220|470729393|FG004|Extension 1 (EXT1)|Adverse Event|0|||
130756264|NCT00090220|470729394|FG005|Extension 1 (EXT1)|Adverse Event|0|||
130756265|NCT00090220|470729389|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
130756266|NCT00090220|470729390|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
130756267|NCT00090220|470729391|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
130756268|NCT00090220|470729392|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
130789069|NCT01773928|470856757|FG005|Overall Study|Physician Decision|0|||
130756269|NCT00090220|470729393|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
130756270|NCT00090220|470729394|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
130756271|NCT00090220|470729389|FG000|Extension 1 (EXT1)|Moved|0|||
130756272|NCT00090220|470729390|FG001|Extension 1 (EXT1)|Moved|0|||
130756273|NCT00090220|470729391|FG002|Extension 1 (EXT1)|Moved|2|||
130756274|NCT00090220|470729392|FG003|Extension 1 (EXT1)|Moved|1|||
130789070|NCT01773928|470856758|FG006|Overall Study|Physician Decision|0|||
130789071|NCT01773928|470856759|FG007|Overall Study|Physician Decision|0|||
130756275|NCT00090220|470729393|FG004|Extension 1 (EXT1)|Moved|0|||
130789072|NCT01773928|470856760|FG008|Overall Study|Physician Decision|0|||
130756276|NCT00090220|470729394|FG005|Extension 1 (EXT1)|Moved|0|||
130756277|NCT00090220|470729389|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130756278|NCT00090220|470729390|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130756279|NCT00090220|470729391|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
130756280|NCT00090220|470729392|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130756281|NCT00090220|470729393|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130756282|NCT00090220|470729394|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130756283|NCT00090220|470729389|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
130756284|NCT00090220|470729390|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
130756285|NCT00090220|470729391|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
130756286|NCT00090220|470729392|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
130756287|NCT00090220|470729393|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
130756288|NCT00090220|470729394|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
130756289|NCT00090220|470729389|FG000|Extension 1 (EXT1)|Other reason|0|||
130756290|NCT00090220|470729390|FG001|Extension 1 (EXT1)|Other reason|0|||
130756291|NCT00090220|470729391|FG002|Extension 1 (EXT1)|Other reason|2|||
130756292|NCT00090220|470729392|FG003|Extension 1 (EXT1)|Other reason|0|||
130756293|NCT00090220|470729393|FG004|Extension 1 (EXT1)|Other reason|0|||
130756294|NCT00090220|470729394|FG005|Extension 1 (EXT1)|Other reason|0|||
130756295|NCT00090220|470729389|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130756296|NCT00090220|470729390|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130756297|NCT00090220|470729391|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130756298|NCT00090220|470729392|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130756299|NCT00090220|470729393|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
130756300|NCT00090220|470729394|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
130756301|NCT00090220|470729389|FG000|Long-term Follow-up (EXT2)|Death|0|||
130756302|NCT00090220|470729390|FG001|Long-term Follow-up (EXT2)|Death|0|||
130756303|NCT00090220|470729391|FG002|Long-term Follow-up (EXT2)|Death|0|||
130756304|NCT00090220|470729392|FG003|Long-term Follow-up (EXT2)|Death|0|||
130756305|NCT00090220|470729393|FG004|Long-term Follow-up (EXT2)|Death|1|||
130756306|NCT00090220|470729394|FG005|Long-term Follow-up (EXT2)|Death|1|||
130756307|NCT00090220|470729389|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130756308|NCT00090220|470729390|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130756309|NCT00090220|470729391|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130756310|NCT00090220|470729392|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130756311|NCT00090220|470729393|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
130756312|NCT00090220|470729394|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
130756313|NCT00090220|470729389|FG000|Long-term Follow-up (EXT2)|Other|0|||
130756314|NCT00090220|470729390|FG001|Long-term Follow-up (EXT2)|Other|0|||
130756315|NCT00090220|470729391|FG002|Long-term Follow-up (EXT2)|Other|0|||
130756316|NCT00090220|470729392|FG003|Long-term Follow-up (EXT2)|Other|0|||
130756317|NCT00090220|470729393|FG004|Long-term Follow-up (EXT2)|Other|1|||
130756318|NCT00090220|470729394|FG005|Long-term Follow-up (EXT2)|Other|0|||
130789073|NCT01773928|470856752|FG000|Overall Study|Withdrawal by Subject|5|||
130789074|NCT01773928|470856753|FG001|Overall Study|Withdrawal by Subject|4|||
130756385|NCT00537316|470729398|FG000|Part 1|Adverse Event|7|||
130756386|NCT00537316|470729399|FG001|Part 1|Adverse Event|11|||
130756387|NCT00537316|470729400|FG002|Part 1|Adverse Event|8|||
130756388|NCT00537316|470729401|FG003|Part 1|Adverse Event|0|||
130756389|NCT00537316|470729402|FG004|Part 1|Adverse Event|0|||
130756390|NCT00537316|470729403|FG005|Part 1|Adverse Event|0|||
130756391|NCT00537316|470729404|FG006|Part 1|Adverse Event|0|||
130756392|NCT00537316|470729398|FG000|Part 1|Protocol defined clinical event|1|||
130756393|NCT00537316|470729399|FG001|Part 1|Protocol defined clinical event|0|||
130756394|NCT00537316|470729400|FG002|Part 1|Protocol defined clinical event|0|||
130756395|NCT00537316|470729401|FG003|Part 1|Protocol defined clinical event|0|||
130756396|NCT00537316|470729402|FG004|Part 1|Protocol defined clinical event|0|||
130756397|NCT00537316|470729403|FG005|Part 1|Protocol defined clinical event|0|||
130756398|NCT00537316|470729404|FG006|Part 1|Protocol defined clinical event|0|||
130756399|NCT00537316|470729398|FG000|Part 1|Lost to Follow-up|1|||
130756400|NCT00537316|470729399|FG001|Part 1|Lost to Follow-up|0|||
130756401|NCT00537316|470729400|FG002|Part 1|Lost to Follow-up|0|||
130756402|NCT00537316|470729401|FG003|Part 1|Lost to Follow-up|0|||
130756403|NCT00537316|470729402|FG004|Part 1|Lost to Follow-up|0|||
130756404|NCT00537316|470729403|FG005|Part 1|Lost to Follow-up|0|||
130756405|NCT00537316|470729404|FG006|Part 1|Lost to Follow-up|0|||
130756406|NCT00537316|470729398|FG000|Part 1|Withdrawal by Subject|3|||
130756407|NCT00537316|470729399|FG001|Part 1|Withdrawal by Subject|8|||
130756408|NCT00537316|470729400|FG002|Part 1|Withdrawal by Subject|4|||
130756409|NCT00537316|470729401|FG003|Part 1|Withdrawal by Subject|0|||
130756410|NCT00537316|470729402|FG004|Part 1|Withdrawal by Subject|0|||
130756411|NCT00537316|470729403|FG005|Part 1|Withdrawal by Subject|0|||
130756412|NCT00537316|470729404|FG006|Part 1|Withdrawal by Subject|0|||
130756413|NCT00537316|470729398|FG000|Part 1|Protocol Violation|1|||
130756414|NCT00537316|470729399|FG001|Part 1|Protocol Violation|5|||
130756415|NCT00537316|470729400|FG002|Part 1|Protocol Violation|1|||
130756416|NCT00537316|470729401|FG003|Part 1|Protocol Violation|0|||
130756417|NCT00537316|470729402|FG004|Part 1|Protocol Violation|0|||
130756418|NCT00537316|470729403|FG005|Part 1|Protocol Violation|0|||
130756419|NCT00537316|470729404|FG006|Part 1|Protocol Violation|0|||
130756420|NCT00537316|470729398|FG000|Part 1|Did not meet protocol eligibility|1|||
130756421|NCT00537316|470729399|FG001|Part 1|Did not meet protocol eligibility|3|||
130756422|NCT00537316|470729400|FG002|Part 1|Did not meet protocol eligibility|2|||
130756423|NCT00537316|470729401|FG003|Part 1|Did not meet protocol eligibility|0|||
130756424|NCT00537316|470729402|FG004|Part 1|Did not meet protocol eligibility|0|||
130756425|NCT00537316|470729403|FG005|Part 1|Did not meet protocol eligibility|0|||
130756426|NCT00537316|470729404|FG006|Part 1|Did not meet protocol eligibility|0|||
130756427|NCT00537316|470729398|FG000|Part 1|Administrative|0|||
130756428|NCT00537316|470729399|FG001|Part 1|Administrative|0|||
130756429|NCT00537316|470729400|FG002|Part 1|Administrative|2|||
130756430|NCT00537316|470729401|FG003|Part 1|Administrative|0|||
130756431|NCT00537316|470729402|FG004|Part 1|Administrative|0|||
130756432|NCT00537316|470729403|FG005|Part 1|Administrative|0|||
130756433|NCT00537316|470729404|FG006|Part 1|Administrative|0|||
130756434|NCT00537316|470729398|FG000|Part 2|Never entered follow-up|0|||
130756435|NCT00537316|470729399|FG001|Part 2|Never entered follow-up|0|||
130756436|NCT00537316|470729400|FG002|Part 2|Never entered follow-up|0|||
130756437|NCT00537316|470729401|FG003|Part 2|Never entered follow-up|0|||
130756438|NCT00537316|470729402|FG004|Part 2|Never entered follow-up|0|||
130756439|NCT00537316|470729403|FG005|Part 2|Never entered follow-up|0|||
130756440|NCT00537316|470729404|FG006|Part 2|Never entered follow-up|1|||
130756441|NCT00537316|470729398|FG000|Part 2|Adverse Event|4|||
130756442|NCT00537316|470729399|FG001|Part 2|Adverse Event|0|||
130756443|NCT00537316|470729400|FG002|Part 2|Adverse Event|2|||
130756444|NCT00537316|470729401|FG003|Part 2|Adverse Event|0|||
130756445|NCT00537316|470729402|FG004|Part 2|Adverse Event|0|||
130756446|NCT00537316|470729403|FG005|Part 2|Adverse Event|0|||
130756447|NCT00537316|470729404|FG006|Part 2|Adverse Event|0|||
130756448|NCT00537316|470729398|FG000|Part 2|Lost to Follow-up|1|||
130756449|NCT00537316|470729399|FG001|Part 2|Lost to Follow-up|0|||
130756450|NCT00537316|470729400|FG002|Part 2|Lost to Follow-up|2|||
130756451|NCT00537316|470729401|FG003|Part 2|Lost to Follow-up|0|||
130756452|NCT00537316|470729402|FG004|Part 2|Lost to Follow-up|0|||
130756453|NCT00537316|470729403|FG005|Part 2|Lost to Follow-up|0|||
130756454|NCT00537316|470729404|FG006|Part 2|Lost to Follow-up|0|||
130756455|NCT00537316|470729398|FG000|Part 2|Withdrawal by Subject|5|||
130756456|NCT00537316|470729399|FG001|Part 2|Withdrawal by Subject|1|||
130756457|NCT00537316|470729400|FG002|Part 2|Withdrawal by Subject|4|||
130756458|NCT00537316|470729401|FG003|Part 2|Withdrawal by Subject|0|||
130756459|NCT00537316|470729402|FG004|Part 2|Withdrawal by Subject|0|||
130756460|NCT00537316|470729403|FG005|Part 2|Withdrawal by Subject|0|||
130756461|NCT00537316|470729404|FG006|Part 2|Withdrawal by Subject|0|||
130756462|NCT00537316|470729398|FG000|Part 2|Administrative|16|||
130756463|NCT00537316|470729399|FG001|Part 2|Administrative|8|||
130756464|NCT00537316|470729400|FG002|Part 2|Administrative|24|||
130756465|NCT00537316|470729401|FG003|Part 2|Administrative|3|||
130756466|NCT00537316|470729402|FG004|Part 2|Administrative|1|||
130756467|NCT00537316|470729403|FG005|Part 2|Administrative|4|||
130756468|NCT00537316|470729404|FG006|Part 2|Administrative|1|||
130756469|NCT02651155|470729405|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130756470|NCT02651155|470729406|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
130756471|NCT02651155|470729405|FG000|Overall Study|Voluntary Withdrawal|5|||
130756472|NCT02651155|470729406|FG001|Overall Study|Voluntary Withdrawal|0|||
130756473|NCT01609543|470729409|FG000|Overall Study|Disease Progression|28|||
130756474|NCT01609543|470729409|FG000|Overall Study|Adverse Event|5|||
130756475|NCT01609543|470729409|FG000|Overall Study|Withdrawal by Subject|1|||
130756476|NCT01609543|470729409|FG000|Overall Study|Protocol Violation|1|||
130756477|NCT01609543|470729409|FG000|Overall Study|Death|7|||
130756478|NCT00507819|470729410|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
130756479|NCT00507819|470729411|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
130756480|NCT03452488|470729415|FG000|Overall Study|Adverse Event|4|||
130756481|NCT03452488|470729416|FG001|Overall Study|Adverse Event|6|||
130756482|NCT03452488|470729417|FG002|Overall Study|Adverse Event|1|||
130756483|NCT03452488|470729415|FG000|Overall Study|Death|0|||
130756484|NCT03452488|470729416|FG001|Overall Study|Death|0|||
130756485|NCT03452488|470729417|FG002|Overall Study|Death|1|||
130756486|NCT03452488|470729415|FG000|Overall Study|Lost to Follow-up|1|||
130756487|NCT03452488|470729416|FG001|Overall Study|Lost to Follow-up|2|||
130756488|NCT03452488|470729417|FG002|Overall Study|Lost to Follow-up|0|||
130756489|NCT03452488|470729415|FG000|Overall Study|PI Decision|1|||
130756490|NCT03452488|470729416|FG001|Overall Study|PI Decision|0|||
130756491|NCT03452488|470729417|FG002|Overall Study|PI Decision|0|||
130756492|NCT03452488|470729415|FG000|Overall Study|Withdrew consent|4|||
130756493|NCT03452488|470729416|FG001|Overall Study|Withdrew consent|2|||
130756494|NCT03452488|470729417|FG002|Overall Study|Withdrew consent|2|||
130756495|NCT03452488|470729415|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
130756496|NCT03452488|470729416|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
130756497|NCT03452488|470729417|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
130756498|NCT03452488|470729415|FG000|Overall Study|Other|0|||
130756499|NCT03452488|470729416|FG001|Overall Study|Other|2|||
130756500|NCT03452488|470729417|FG002|Overall Study|Other|2|||
130756501|NCT01254318|470729420|FG000|Overall Study|Lost to Follow-up|5|||
130756502|NCT01254318|470729420|FG000|Overall Study|Death|47|||
130756503|NCT00330343|470729423|FG000|Overall Study|Lost to Follow-up|5|||
130756504|NCT01992653|470729424|FG000|Overall Study|Death|0|||
130756505|NCT01992653|470729425|FG001|Overall Study|Death|0|||
130756506|NCT01992653|470729426|FG002|Overall Study|Death|1|||
130756507|NCT01992653|470729427|FG003|Overall Study|Death|0|||
130756508|NCT01992653|470729428|FG004|Overall Study|Death|1|||
130756509|NCT01992653|470729429|FG005|Overall Study|Death|0|||
130756510|NCT01992653|470729430|FG006|Overall Study|Death|4|||
130756511|NCT01992653|470729431|FG007|Overall Study|Death|2|||
130756512|NCT01992653|470729424|FG000|Overall Study|Lost to Follow-up|0|||
130756513|NCT01992653|470729425|FG001|Overall Study|Lost to Follow-up|0|||
130756514|NCT01992653|470729426|FG002|Overall Study|Lost to Follow-up|0|||
130756515|NCT01992653|470729427|FG003|Overall Study|Lost to Follow-up|0|||
130756516|NCT01992653|470729428|FG004|Overall Study|Lost to Follow-up|0|||
130756517|NCT01992653|470729429|FG005|Overall Study|Lost to Follow-up|0|||
130756518|NCT01992653|470729430|FG006|Overall Study|Lost to Follow-up|0|||
130756519|NCT01992653|470729431|FG007|Overall Study|Lost to Follow-up|1|||
130756520|NCT01992653|470729424|FG000|Overall Study|Study Completed|0|||
130756521|NCT01992653|470729425|FG001|Overall Study|Study Completed|0|||
130756522|NCT01992653|470729426|FG002|Overall Study|Study Completed|0|||
130756523|NCT01992653|470729427|FG003|Overall Study|Study Completed|0|||
130756524|NCT01992653|470729428|FG004|Overall Study|Study Completed|0|||
130756525|NCT01992653|470729429|FG005|Overall Study|Study Completed|0|||
130756526|NCT01992653|470729430|FG006|Overall Study|Study Completed|0|||
130756527|NCT01992653|470729431|FG007|Overall Study|Study Completed|1|||
130756528|NCT01992653|470729424|FG000|Overall Study|Disease Progression|0|||
130756529|NCT01992653|470729425|FG001|Overall Study|Disease Progression|0|||
130756530|NCT01992653|470729426|FG002|Overall Study|Disease Progression|0|||
130756531|NCT01992653|470729427|FG003|Overall Study|Disease Progression|0|||
130756532|NCT01992653|470729428|FG004|Overall Study|Disease Progression|0|||
130756533|NCT01992653|470729429|FG005|Overall Study|Disease Progression|0|||
130756534|NCT01992653|470729430|FG006|Overall Study|Disease Progression|4|||
130756535|NCT01992653|470729431|FG007|Overall Study|Disease Progression|0|||
130756536|NCT02964208|470729434|FG000|Overall Study|Death|103|||
130756537|NCT02964208|470729434|FG000|Overall Study|Withdrawal by Subject|6|||
130756538|NCT02964208|470729434|FG000|Overall Study|Lost to Follow-up|6|||
130756539|NCT02964208|470729434|FG000|Overall Study|Unsuccessful Procedure|5|||
130756540|NCT02964208|470729434|FG000|Overall Study|Device Explant|1|||
130756541|NCT02964208|470729434|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
130756542|NCT01743560|470729435|FG000|Overall Study|Disease progression|26|||
130756543|NCT01743560|470729435|FG000|Overall Study|Adverse Event|8|||
130756544|NCT01743560|470729435|FG000|Overall Study|Death|3|||
130756545|NCT01743560|470729435|FG000|Overall Study|Withdrawal by Subject|2|||
130756546|NCT01743560|470729435|FG000|Overall Study|Protocol Violation|1|||
130756547|NCT01743560|470729435|FG000|Overall Study|>1 dose of study drug|3|||
130756548|NCT03226769|470729436|FG000|Overall Study|Withdrawal by Subject|0|||
130756549|NCT03226769|470729437|FG001|Overall Study|Withdrawal by Subject|1|||
130756550|NCT00940823|470729438|FG000|Overall Study|Death|8|||
130756551|NCT00940823|470729439|FG001|Overall Study|Death|12|||
130756552|NCT00940823|470729438|FG000|Overall Study|Lost to Follow-up|27|||
130756553|NCT00940823|470729439|FG001|Overall Study|Lost to Follow-up|20|||
130756554|NCT01758731|470729440|FG000|Overall Study|Physician Decision|1|||
130756555|NCT05270395|470729453|FG000|Overall Study|Lost to Follow-up|2|||
130756556|NCT05270395|470729454|FG001|Overall Study|Lost to Follow-up|2|||
130756557|NCT05270395|470729453|FG000|Overall Study|Death|1|||
130756558|NCT05270395|470729454|FG001|Overall Study|Death|2|||
130756559|NCT05270395|470729453|FG000|Overall Study|Study Team Withdrew|1|||
130756560|NCT05270395|470729454|FG001|Overall Study|Study Team Withdrew|0|||
130756561|NCT00199797|470731192|FG000|Overall Study|Progressive Disease|1|||
130756562|NCT00199797|470731192|FG000|Overall Study|Adverse Event|1|||
130756563|NCT00199797|470731192|FG000|Overall Study|Physician Decision|1|||
130756564|NCT04250350|470731199|FG000|Overall Study|Withdrawal by Subject|13|||
130756565|NCT04250350|470731199|FG000|Overall Study|Lost to Follow-up|8|||
130756566|NCT04250350|470731199|FG000|Overall Study|Adverse Event|5|||
130756567|NCT04250350|470731199|FG000|Overall Study|Lack of Efficacy|4|||
130756568|NCT04250350|470731199|FG000|Overall Study|Physician Decision|1|||
130756569|NCT04250350|470731199|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
130756570|NCT00784550|470731200|FG000|Overall Study|Adverse Event|12|||
130756571|NCT00784550|470731201|FG001|Overall Study|Adverse Event|10|||
130756572|NCT00784550|470731200|FG000|Overall Study|Lack of Efficacy|0|||
130756573|NCT00784550|470731201|FG001|Overall Study|Lack of Efficacy|1|||
130756574|NCT00784550|470731200|FG000|Overall Study|Protocol Violation|10|||
130756575|NCT00784550|470731201|FG001|Overall Study|Protocol Violation|10|||
130756576|NCT00784550|470731200|FG000|Overall Study|Lost to Follow-up|8|||
130756577|NCT00784550|470731201|FG001|Overall Study|Lost to Follow-up|5|||
130756578|NCT00784550|470731200|FG000|Overall Study|Physician Decision|2|||
130756579|NCT00784550|470731201|FG001|Overall Study|Physician Decision|3|||
130756580|NCT00784550|470731200|FG000|Overall Study|Withdrawal by Subject|4|||
130756581|NCT00784550|470731201|FG001|Overall Study|Withdrawal by Subject|13|||
130756582|NCT00688701|470731202|FG000|Overall Study|Adverse Event|1|||
130756583|NCT00688701|470731203|FG001|Overall Study|Adverse Event|0|||
130756584|NCT00688701|470731204|FG002|Overall Study|Adverse Event|5|||
130756585|NCT00688701|470731205|FG003|Overall Study|Adverse Event|3|||
130756586|NCT00688701|470731202|FG000|Overall Study|Lack of Efficacy|0|||
130756587|NCT00688701|470731203|FG001|Overall Study|Lack of Efficacy|1|||
130756588|NCT00688701|470731204|FG002|Overall Study|Lack of Efficacy|0|||
130756589|NCT00688701|470731205|FG003|Overall Study|Lack of Efficacy|0|||
130756590|NCT00688701|470731202|FG000|Overall Study|Withdrawal by Subject|3|||
130756591|NCT00688701|470731203|FG001|Overall Study|Withdrawal by Subject|3|||
130756592|NCT00688701|470731204|FG002|Overall Study|Withdrawal by Subject|4|||
130756593|NCT00688701|470731205|FG003|Overall Study|Withdrawal by Subject|8|||
130756594|NCT00688701|470731202|FG000|Overall Study|Poor compliance to protocol|0|||
130756595|NCT00688701|470731203|FG001|Overall Study|Poor compliance to protocol|1|||
130756596|NCT00688701|470731204|FG002|Overall Study|Poor compliance to protocol|1|||
130756597|NCT00688701|470731205|FG003|Overall Study|Poor compliance to protocol|0|||
130756598|NCT03205761|470731217|FG000|Overall Study|Withdrawal by Subject|1|||
130756599|NCT03205761|470731217|FG000|Overall Study|Progressive Disease|10|||
130756600|NCT04420585|470731218|FG000|Overall Study|Adverse Event|1|||
130756601|NCT04420585|470731218|FG000|Overall Study|Never initiated medication|2|||
130756602|NCT02163226|470731219|FG000|Overall Study|Death|2|||
130756603|NCT02163226|470731220|FG001|Overall Study|Death|1|||
130756604|NCT02163226|470731219|FG000|Overall Study|Withdrawal by Subject|5|||
130756605|NCT02163226|470731220|FG001|Overall Study|Withdrawal by Subject|2|||
130756606|NCT02163226|470731219|FG000|Overall Study|Returned home, local radiotherapy|3|||
130756607|NCT02163226|470731220|FG001|Overall Study|Returned home, local radiotherapy|0|||
130756608|NCT02163226|470731219|FG000|Overall Study|Repeat imaging showed no disease|2|||
130756609|NCT02163226|470731220|FG001|Overall Study|Repeat imaging showed no disease|0|||
130756610|NCT02163226|470731219|FG000|Overall Study|Incomplete radiotherapy|3|||
130756611|NCT02163226|470731220|FG001|Overall Study|Incomplete radiotherapy|0|||
130756612|NCT02163226|470731219|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
130756613|NCT02163226|470731220|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
130756614|NCT02163226|470731219|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
130756615|NCT02163226|470731220|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
130756616|NCT02163226|470731219|FG000|Overall Study|ineligible|0|||
130756617|NCT02163226|470731220|FG001|Overall Study|ineligible|3|||
130756618|NCT04114357|470731221|FG000|Baseline-Randomization|Adverse Event|2|||
130756619|NCT04114357|470731222|FG001|Baseline-Randomization|Adverse Event|1|||
130756620|NCT04114357|470731221|FG000|Baseline-Randomization|Lost to Follow-up|1|||
130756621|NCT04114357|470731222|FG001|Baseline-Randomization|Lost to Follow-up|1|||
130756622|NCT04114357|470731221|FG000|Cross-over|Adverse Event|0|||
130756623|NCT04114357|470731222|FG001|Cross-over|Adverse Event|1|||
130756624|NCT03558152|470731223|FG000|Overall Study|Adverse Event|0|||
130756625|NCT03558152|470731224|FG001|Overall Study|Adverse Event|0|||
130756626|NCT03558152|470731225|FG002|Overall Study|Adverse Event|1|||
130756627|NCT03558152|470731226|FG003|Overall Study|Adverse Event|1|||
130756628|NCT03558152|470731227|FG004|Overall Study|Adverse Event|2|||
130756629|NCT03558152|470731228|FG005|Overall Study|Adverse Event|1|||
130756630|NCT03558152|470731229|FG006|Overall Study|Adverse Event|1|||
130756631|NCT03558152|470731230|FG007|Overall Study|Adverse Event|0|||
130756632|NCT03558152|470731223|FG000|Overall Study|Death|0|||
130756633|NCT03558152|470731224|FG001|Overall Study|Death|0|||
130756634|NCT03558152|470731225|FG002|Overall Study|Death|0|||
130756635|NCT03558152|470731226|FG003|Overall Study|Death|0|||
130756636|NCT03558152|470731227|FG004|Overall Study|Death|1|||
130756637|NCT03558152|470731228|FG005|Overall Study|Death|0|||
130789075|NCT01773928|470856754|FG002|Overall Study|Withdrawal by Subject|4|||
130789076|NCT01773928|470856755|FG003|Overall Study|Withdrawal by Subject|4|||
130789077|NCT01773928|470856756|FG004|Overall Study|Withdrawal by Subject|7|||
130789078|NCT01773928|470856757|FG005|Overall Study|Withdrawal by Subject|1|||
130789079|NCT01773928|470856758|FG006|Overall Study|Withdrawal by Subject|0|||
130789080|NCT01773928|470856759|FG007|Overall Study|Withdrawal by Subject|0|||
130789081|NCT01773928|470856760|FG008|Overall Study|Withdrawal by Subject|1|||
130789082|NCT01773928|470856752|FG000|Overall Study|Lost to Follow-up|0|||
130789083|NCT01773928|470856753|FG001|Overall Study|Lost to Follow-up|0|||
130789084|NCT01773928|470856754|FG002|Overall Study|Lost to Follow-up|0|||
130789085|NCT01773928|470856755|FG003|Overall Study|Lost to Follow-up|0|||
130789086|NCT01773928|470856756|FG004|Overall Study|Lost to Follow-up|0|||
130789087|NCT01773928|470856757|FG005|Overall Study|Lost to Follow-up|1|||
130789088|NCT01773928|470856758|FG006|Overall Study|Lost to Follow-up|0|||
130789089|NCT01773928|470856759|FG007|Overall Study|Lost to Follow-up|0|||
130789090|NCT01773928|470856760|FG008|Overall Study|Lost to Follow-up|0|||
130789091|NCT01773928|470856752|FG000|Overall Study|Subject misrepresented age|0|||
130789092|NCT01773928|470856753|FG001|Overall Study|Subject misrepresented age|1|||
130789093|NCT01773928|470856754|FG002|Overall Study|Subject misrepresented age|0|||
130789094|NCT01773928|470856755|FG003|Overall Study|Subject misrepresented age|0|||
130789095|NCT01773928|470856756|FG004|Overall Study|Subject misrepresented age|0|||
130789096|NCT01773928|470856757|FG005|Overall Study|Subject misrepresented age|0|||
130789097|NCT01773928|470856758|FG006|Overall Study|Subject misrepresented age|0|||
130789098|NCT01773928|470856759|FG007|Overall Study|Subject misrepresented age|0|||
130789099|NCT01773928|470856760|FG008|Overall Study|Subject misrepresented age|0|||
130789100|NCT01773928|470856752|FG000|Overall Study|Subject met exclusion criteria|0|||
130789101|NCT01773928|470856753|FG001|Overall Study|Subject met exclusion criteria|0|||
130789102|NCT01773928|470856754|FG002|Overall Study|Subject met exclusion criteria|0|||
130789103|NCT01773928|470856755|FG003|Overall Study|Subject met exclusion criteria|0|||
130789104|NCT01773928|470856756|FG004|Overall Study|Subject met exclusion criteria|0|||
130789105|NCT01773928|470856757|FG005|Overall Study|Subject met exclusion criteria|0|||
130789106|NCT01773928|470856758|FG006|Overall Study|Subject met exclusion criteria|0|||
130789107|NCT01773928|470856759|FG007|Overall Study|Subject met exclusion criteria|0|||
130789108|NCT01773928|470856760|FG008|Overall Study|Subject met exclusion criteria|1|||
130789109|NCT01773928|470856752|FG000|Overall Study|Randomized, had to leave, never returned|0|||
130789110|NCT01773928|470856753|FG001|Overall Study|Randomized, had to leave, never returned|0|||
130789111|NCT01773928|470856754|FG002|Overall Study|Randomized, had to leave, never returned|0|||
130789112|NCT01773928|470856755|FG003|Overall Study|Randomized, had to leave, never returned|1|||
130789113|NCT01773928|470856756|FG004|Overall Study|Randomized, had to leave, never returned|0|||
130789114|NCT01773928|470856757|FG005|Overall Study|Randomized, had to leave, never returned|0|||
130789115|NCT01773928|470856758|FG006|Overall Study|Randomized, had to leave, never returned|0|||
130789116|NCT01773928|470856759|FG007|Overall Study|Randomized, had to leave, never returned|0|||
130789117|NCT01773928|470856760|FG008|Overall Study|Randomized, had to leave, never returned|0|||
130789118|NCT01773928|470856752|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
130789119|NCT01773928|470856753|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
130789120|NCT01773928|470856754|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
130789121|NCT01773928|470856755|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
130789122|NCT01773928|470856756|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
130789123|NCT01773928|470856757|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
130789124|NCT01773928|470856758|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
130789125|NCT01773928|470856759|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
130756638|NCT03558152|470731229|FG006|Overall Study|Death|0|||
130756639|NCT03558152|470731230|FG007|Overall Study|Death|0|||
130756640|NCT03558152|470731223|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
130756641|NCT03558152|470731224|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130756642|NCT03558152|470731225|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130756643|NCT03558152|470731226|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130756644|NCT03558152|470731227|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130756645|NCT03558152|470731228|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130756646|NCT03558152|470731229|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130756647|NCT03558152|470731230|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130756648|NCT03558152|470731223|FG000|Overall Study|Miscalculation in mmcs|0|||
130789126|NCT01773928|470856760|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
130789127|NCT03054428|470856761|FG000|Overall Study|Physician Decision|0|||
130756649|NCT03558152|470731224|FG001|Overall Study|Miscalculation in mmcs|0|||
130789128|NCT03054428|470856762|FG001|Overall Study|Physician Decision|1|||
130789129|NCT03054428|470856763|FG002|Overall Study|Physician Decision|1|||
130756650|NCT03558152|470731225|FG002|Overall Study|Miscalculation in mmcs|0|||
130789130|NCT03054428|470856761|FG000|Overall Study|Lack of Efficacy|3|||
130789131|NCT03054428|470856762|FG001|Overall Study|Lack of Efficacy|1|||
130789132|NCT03054428|470856763|FG002|Overall Study|Lack of Efficacy|0|||
130789133|NCT03054428|470856761|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
130756651|NCT03558152|470731226|FG003|Overall Study|Miscalculation in mmcs|0|||
130756652|NCT03558152|470731227|FG004|Overall Study|Miscalculation in mmcs|0|||
130756653|NCT03558152|470731228|FG005|Overall Study|Miscalculation in mmcs|0|||
130756654|NCT03558152|470731229|FG006|Overall Study|Miscalculation in mmcs|1|||
130756655|NCT03558152|470731230|FG007|Overall Study|Miscalculation in mmcs|0|||
130756656|NCT03558152|470731223|FG000|Overall Study|Mistake in calculation|0|||
130756657|NCT03558152|470731224|FG001|Overall Study|Mistake in calculation|0|||
130756658|NCT03558152|470731225|FG002|Overall Study|Mistake in calculation|0|||
130756659|NCT03558152|470731226|FG003|Overall Study|Mistake in calculation|1|||
130756660|NCT03558152|470731227|FG004|Overall Study|Mistake in calculation|0|||
130756661|NCT03558152|470731228|FG005|Overall Study|Mistake in calculation|0|||
130756662|NCT03558152|470731229|FG006|Overall Study|Mistake in calculation|0|||
130756663|NCT03558152|470731230|FG007|Overall Study|Mistake in calculation|0|||
130756664|NCT03558152|470731223|FG000|Overall Study|Mistake in evaluation of disease status|0|||
130756665|NCT03558152|470731224|FG001|Overall Study|Mistake in evaluation of disease status|0|||
130756666|NCT03558152|470731225|FG002|Overall Study|Mistake in evaluation of disease status|0|||
130756667|NCT03558152|470731226|FG003|Overall Study|Mistake in evaluation of disease status|0|||
130756668|NCT03558152|470731227|FG004|Overall Study|Mistake in evaluation of disease status|0|||
130756669|NCT03558152|470731228|FG005|Overall Study|Mistake in evaluation of disease status|0|||
130756670|NCT03558152|470731229|FG006|Overall Study|Mistake in evaluation of disease status|0|||
130756671|NCT03558152|470731230|FG007|Overall Study|Mistake in evaluation of disease status|1|||
130756672|NCT03558152|470731223|FG000|Overall Study|Physician Decision|0|||
130756673|NCT03558152|470731224|FG001|Overall Study|Physician Decision|0|||
130756674|NCT03558152|470731225|FG002|Overall Study|Physician Decision|0|||
130756675|NCT03558152|470731226|FG003|Overall Study|Physician Decision|0|||
130756676|NCT03558152|470731227|FG004|Overall Study|Physician Decision|0|||
130756677|NCT03558152|470731228|FG005|Overall Study|Physician Decision|0|||
130756678|NCT03558152|470731229|FG006|Overall Study|Physician Decision|1|||
130756679|NCT03558152|470731230|FG007|Overall Study|Physician Decision|0|||
130756680|NCT03558152|470731223|FG000|Overall Study|Withdrawal by Subject|2|||
130756681|NCT03558152|470731224|FG001|Overall Study|Withdrawal by Subject|3|||
130756682|NCT03558152|470731225|FG002|Overall Study|Withdrawal by Subject|2|||
130756683|NCT03558152|470731226|FG003|Overall Study|Withdrawal by Subject|1|||
130756684|NCT03558152|470731227|FG004|Overall Study|Withdrawal by Subject|1|||
130756685|NCT03558152|470731228|FG005|Overall Study|Withdrawal by Subject|1|||
130756686|NCT03558152|470731229|FG006|Overall Study|Withdrawal by Subject|3|||
130756687|NCT03558152|470731230|FG007|Overall Study|Withdrawal by Subject|2|||
130756688|NCT03558152|470731223|FG000|Overall Study|Lack of Efficacy|11|||
130756689|NCT03558152|470731224|FG001|Overall Study|Lack of Efficacy|11|||
130756690|NCT03558152|470731225|FG002|Overall Study|Lack of Efficacy|10|||
130756691|NCT03558152|470731226|FG003|Overall Study|Lack of Efficacy|11|||
130756692|NCT03558152|470731227|FG004|Overall Study|Lack of Efficacy|14|||
130756693|NCT03558152|470731228|FG005|Overall Study|Lack of Efficacy|12|||
130756694|NCT03558152|470731229|FG006|Overall Study|Lack of Efficacy|14|||
130756695|NCT03558152|470731230|FG007|Overall Study|Lack of Efficacy|13|||
130756696|NCT03558152|470731223|FG000|Overall Study|Protocol Violation|1|||
130756697|NCT03558152|470731224|FG001|Overall Study|Protocol Violation|1|||
130756698|NCT03558152|470731225|FG002|Overall Study|Protocol Violation|0|||
130756699|NCT03558152|470731226|FG003|Overall Study|Protocol Violation|1|||
130756700|NCT03558152|470731227|FG004|Overall Study|Protocol Violation|1|||
130756701|NCT03558152|470731228|FG005|Overall Study|Protocol Violation|0|||
130756702|NCT03558152|470731229|FG006|Overall Study|Protocol Violation|2|||
130756703|NCT03558152|470731230|FG007|Overall Study|Protocol Violation|0|||
130756704|NCT01669174|470731234|FG000|Overall Study|Subject withdrew consent|2|||
130756705|NCT01669174|470731235|FG001|Overall Study|Subject withdrew consent|2|||
130756706|NCT01669174|470731234|FG000|Overall Study|Lost to Follow-up|1|||
130756707|NCT01669174|470731235|FG001|Overall Study|Lost to Follow-up|0|||
130756708|NCT01669174|470731234|FG000|Overall Study|Adverse Event|2|||
130756709|NCT01669174|470731235|FG001|Overall Study|Adverse Event|2|||
130756710|NCT01669174|470731234|FG000|Overall Study|Administrative problems|1|||
130756711|NCT01669174|470731235|FG001|Overall Study|Administrative problems|2|||
130756712|NCT04310397|470731236|FG000|Overall Study|Lack of Efficacy|3|||
130756713|NCT04310397|470731236|FG000|Overall Study|Withdrawal by Subject|1|||
130756714|NCT01300338|470731239|FG000|Overall Study|Lost to Follow-up|5|||
130756715|NCT01300338|470731240|FG001|Overall Study|Lost to Follow-up|0|||
130756716|NCT00970632|470731241|FG000|Overall Study|Adverse Event|2|||
130756717|NCT00970632|470731242|FG001|Overall Study|Adverse Event|2|||
130789134|NCT03054428|470856762|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
130789135|NCT03054428|470856763|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
130789136|NCT03054428|470856761|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
130756718|NCT00970632|470731243|FG002|Overall Study|Adverse Event|1|||
130756719|NCT00970632|470731241|FG000|Overall Study|Lack of Efficacy|3|||
130756720|NCT00970632|470731242|FG001|Overall Study|Lack of Efficacy|0|||
130756721|NCT00970632|470731243|FG002|Overall Study|Lack of Efficacy|0|||
130756722|NCT00970632|470731241|FG000|Overall Study|Lost to Follow-up|3|||
130756723|NCT00970632|470731242|FG001|Overall Study|Lost to Follow-up|0|||
130756724|NCT00970632|470731243|FG002|Overall Study|Lost to Follow-up|2|||
130756725|NCT00970632|470731241|FG000|Overall Study|Protocol Violation|8|||
130756726|NCT00970632|470731242|FG001|Overall Study|Protocol Violation|5|||
130756727|NCT00970632|470731243|FG002|Overall Study|Protocol Violation|8|||
130756728|NCT00970632|470731241|FG000|Overall Study|Withdrawal by Subject|7|||
130756729|NCT00970632|470731242|FG001|Overall Study|Withdrawal by Subject|6|||
130756730|NCT00970632|470731243|FG002|Overall Study|Withdrawal by Subject|4|||
130756731|NCT00970632|470731241|FG000|Overall Study|Entry criteria not met|0|||
130756732|NCT00970632|470731242|FG001|Overall Study|Entry criteria not met|2|||
130756733|NCT00970632|470731243|FG002|Overall Study|Entry criteria not met|2|||
130756734|NCT00970632|470731241|FG000|Overall Study|Sponsor decision|1|||
130756735|NCT00970632|470731242|FG001|Overall Study|Sponsor decision|0|||
130756736|NCT00970632|470731243|FG002|Overall Study|Sponsor decision|1|||
130756737|NCT02002533|470731250|FG000|Overall Study|Withdrawal by Subject|6|||
130756738|NCT02002533|470731251|FG001|Overall Study|Withdrawal by Subject|13|||
130756739|NCT02002533|470731250|FG000|Overall Study|Protocol Violation|0|||
130756740|NCT02002533|470731251|FG001|Overall Study|Protocol Violation|1|||
130756741|NCT02002533|470731250|FG000|Overall Study|Adverse Event|0|||
130756742|NCT02002533|470731251|FG001|Overall Study|Adverse Event|3|||
130756743|NCT02002533|470731250|FG000|Overall Study|Lost to Follow-up|0|||
130756744|NCT02002533|470731251|FG001|Overall Study|Lost to Follow-up|1|||
130756745|NCT00976820|470731254|FG000|Overall Study|Lost to Follow-up|5|||
130756746|NCT00976820|470731255|FG001|Overall Study|Lost to Follow-up|16|||
130756747|NCT00976820|470731256|FG002|Overall Study|Lost to Follow-up|2|||
130756748|NCT00976820|470731257|FG003|Overall Study|Lost to Follow-up|3|||
130756749|NCT00976820|470731254|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
130756750|NCT00976820|470731255|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
130756751|NCT00976820|470731256|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
130756752|NCT00976820|470731257|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
130756753|NCT00976820|470731254|FG000|Overall Study|Withdrawal by Subject|2|||
130756754|NCT00976820|470731255|FG001|Overall Study|Withdrawal by Subject|4|||
130756755|NCT00976820|470731256|FG002|Overall Study|Withdrawal by Subject|1|||
130756756|NCT00976820|470731257|FG003|Overall Study|Withdrawal by Subject|4|||
130756757|NCT03261674|470731258|FG000|Overall Study|Lost to Follow-up|6|||
130756758|NCT03261674|470731259|FG001|Overall Study|Lost to Follow-up|7|||
130756759|NCT03261674|470731258|FG000|Overall Study|Protocol Violation|1|||
130756760|NCT03261674|470731259|FG001|Overall Study|Protocol Violation|4|||
130756761|NCT03261674|470731258|FG000|Overall Study|Withdrawal by Subject|1|||
130756762|NCT03261674|470731259|FG001|Overall Study|Withdrawal by Subject|4|||
130756763|NCT03261674|470731258|FG000|Overall Study|Physician Decision|1|||
130756764|NCT03261674|470731259|FG001|Overall Study|Physician Decision|0|||
130756765|NCT00623935|470731260|FG000|Overall Study|Death|1|||
130756766|NCT00623935|470731260|FG000|Overall Study|Patient Declined Transplant|1|||
130756767|NCT00747474|470731263|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756768|NCT00747474|470731264|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756769|NCT00747474|470731265|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756770|NCT00747474|470731266|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756771|NCT00747474|470731267|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756772|NCT00747474|470731268|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756773|NCT00747474|470731269|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756774|NCT00747474|470731270|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
130756775|NCT00747474|470731271|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756776|NCT00747474|470731272|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756777|NCT00747474|470731273|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756778|NCT00747474|470731274|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130756779|NCT00890084|470731275|FG000|Overall Study|Adverse Event|16|||
130756780|NCT00890084|470731275|FG000|Overall Study|Lost to Follow-up|126|||
130756781|NCT02691936|470731281|FG000|Overall Study|Withdrawal by Subject|2|||
130756782|NCT02691936|470731282|FG001|Overall Study|Withdrawal by Subject|5|||
130756783|NCT01878084|470731283|FG000|Overall Study|Physician Decision|2|||
130756784|NCT00749684|470731284|FG000|Overall Study|Death|1|||
130756785|NCT00749684|470731284|FG000|Overall Study|Adverse Event|27|||
130756786|NCT00749684|470731284|FG000|Overall Study|Participant's Wish|10|||
130756787|NCT00749684|470731284|FG000|Overall Study|Not Documented|1|||
130756788|NCT00749684|470731284|FG000|Overall Study|Progressive Desease|31|||
130756789|NCT00749684|470731284|FG000|Overall Study|Therapy according to protocol + AE|2|||
130756790|NCT00749684|470731284|FG000|Overall Study|AE+discontinuation on participants wish|1|||
130756791|NCT00749684|470731284|FG000|Overall Study|Missing|9|||
130756792|NCT02892422|470731289|FG000|Overall Study|Enrolled not treated|4|||
130756793|NCT02892422|470731289|FG000|Overall Study|Adverse Event|38|||
130756794|NCT02892422|470731289|FG000|Overall Study|Lack of Efficacy|32|||
130756795|NCT02892422|470731289|FG000|Overall Study|Non-compliance with study drug|11|||
130756796|NCT02892422|470731289|FG000|Overall Study|Protocol Violation|4|||
130756797|NCT02892422|470731289|FG000|Overall Study|Withdrawal by Subject|56|||
130756798|NCT02892422|470731289|FG000|Overall Study|Lost to Follow-up|5|||
130756799|NCT02892422|470731289|FG000|Overall Study|sponsor information 16159A results|21|||
130756800|NCT02892422|470731289|FG000|Overall Study|withdrawal of consent|13|||
130756801|NCT02892422|470731289|FG000|Overall Study|exclusion criteria met|3|||
130756802|NCT02892422|470731289|FG000|Overall Study|moving elsewhere|4|||
130756803|NCT02892422|470731289|FG000|Overall Study|non-compliance|10|||
130756804|NCT02892422|470731289|FG000|Overall Study|patient legally incapable|1|||
130756805|NCT02892422|470731289|FG000|Overall Study|patient decision|7|||
130756806|NCT02892422|470731289|FG000|Overall Study|Investigator decision|1|||
130756807|NCT01023256|470731290|FG000|Overall Study|Protocol Violation|2|||
130756808|NCT01023256|470731291|FG001|Overall Study|Protocol Violation|3|||
130756809|NCT01023256|470731292|FG002|Overall Study|Protocol Violation|0|||
130756810|NCT01023256|470731293|FG003|Overall Study|Protocol Violation|0|||
130756811|NCT01023256|470731290|FG000|Overall Study|Randomized but not treated|1|||
130756812|NCT01023256|470731291|FG001|Overall Study|Randomized but not treated|0|||
130756813|NCT01023256|470731292|FG002|Overall Study|Randomized but not treated|1|||
130756814|NCT01023256|470731293|FG003|Overall Study|Randomized but not treated|0|||
130756815|NCT01023256|470731290|FG000|Overall Study|Other|1|||
130756816|NCT01023256|470731291|FG001|Overall Study|Other|0|||
130756817|NCT01023256|470731292|FG002|Overall Study|Other|0|||
130756818|NCT01023256|470731293|FG003|Overall Study|Other|2|||
130756819|NCT01023256|470731290|FG000|Overall Study|Adverse Event|0|||
130756820|NCT01023256|470731291|FG001|Overall Study|Adverse Event|0|||
130756821|NCT01023256|470731292|FG002|Overall Study|Adverse Event|0|||
130756822|NCT01023256|470731293|FG003|Overall Study|Adverse Event|1|||
130756823|NCT01023256|470731290|FG000|Overall Study|Withdrawal by Subject|0|||
130756824|NCT01023256|470731291|FG001|Overall Study|Withdrawal by Subject|0|||
130756825|NCT01023256|470731292|FG002|Overall Study|Withdrawal by Subject|0|||
130756826|NCT01023256|470731293|FG003|Overall Study|Withdrawal by Subject|2|||
130756827|NCT03155178|470731294|FG000|Overall Study|Did not meet treatment day baseline|7|||
130756828|NCT03155178|470731295|FG001|Overall Study|Did not meet treatment day baseline|7|||
130756829|NCT03155178|470731296|FG002|Overall Study|Did not meet treatment day baseline|7|||
130756830|NCT03155178|470731297|FG003|Overall Study|Did not meet treatment day baseline|7|||
130756831|NCT03089697|470731298|FG000|Overall Study|Adverse Event|1|||
130756832|NCT03089697|470731299|FG001|Overall Study|Adverse Event|2|||
130756833|NCT03089697|470731298|FG000|Overall Study|Withdrawal by Subject|1|||
130756834|NCT03089697|470731299|FG001|Overall Study|Withdrawal by Subject|0|||
130756835|NCT04323306|470731300|FG000|Overall Study|Physician Decision|1|||
130756836|NCT04323306|470731301|FG001|Overall Study|Physician Decision|0|||
130756837|NCT04323306|470731302|FG002|Overall Study|Physician Decision|0|||
130756838|NCT04323306|470731303|FG003|Overall Study|Physician Decision|0|||
130756839|NCT04323306|470731304|FG004|Overall Study|Physician Decision|0|||
130756840|NCT04323306|470731305|FG005|Overall Study|Physician Decision|0|||
130789137|NCT03054428|470856762|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
130789138|NCT03054428|470856763|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
130789139|NCT03054428|470856761|FG000|Overall Study|Transitioned to OLE study|76|||
130789140|NCT03054428|470856762|FG001|Overall Study|Transitioned to OLE study|76|||
130789141|NCT03054428|470856763|FG002|Overall Study|Transitioned to OLE study|73|||
130789142|NCT03054428|470856761|FG000|Overall Study|Withdrawal by Subject|3|||
130789143|NCT03054428|470856762|FG001|Overall Study|Withdrawal by Subject|2|||
130789144|NCT03054428|470856763|FG002|Overall Study|Withdrawal by Subject|3|||
130789145|NCT03054428|470856761|FG000|Overall Study|Lost to Follow-up|0|||
130789146|NCT03054428|470856762|FG001|Overall Study|Lost to Follow-up|0|||
130789147|NCT03054428|470856763|FG002|Overall Study|Lost to Follow-up|1|||
130789148|NCT03092752|470856764|FG000|Overall Study|Aged <40 years|14209|||
130789149|NCT03092752|470856764|FG000|Overall Study|At least one claim with T2DM|61299|||
130789150|NCT03092752|470856764|FG000|Overall Study|Having no claim of study drugs|29282|||
130789151|NCT03092752|470856764|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
130789152|NCT03092752|470856764|FG000|Overall Study|<6 month history|245900|||
130789153|NCT03573297|470856773|FG000|Open Label Treatment Period|Adverse Event|67|||
130789154|NCT03573297|470856774|FG001|Open Label Treatment Period|Adverse Event|0|||
130789155|NCT03573297|470856775|FG002|Open Label Treatment Period|Adverse Event|0|||
130789156|NCT03573297|470856776|FG003|Open Label Treatment Period|Adverse Event|0|||
130789157|NCT03573297|470856773|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
130789158|NCT03573297|470856774|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
130789159|NCT03573297|470856775|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
130756841|NCT04323306|470731306|FG006|Overall Study|Physician Decision|0|||
130756842|NCT04323306|470731307|FG007|Overall Study|Physician Decision|0|||
130756843|NCT04323306|470731308|FG008|Overall Study|Physician Decision|0|||
130756844|NCT04323306|470731300|FG000|Overall Study|Withdrawal by Subject|0|||
130756845|NCT04323306|470731301|FG001|Overall Study|Withdrawal by Subject|0|||
130756846|NCT04323306|470731302|FG002|Overall Study|Withdrawal by Subject|0|||
130756847|NCT04323306|470731303|FG003|Overall Study|Withdrawal by Subject|0|||
130756848|NCT04323306|470731304|FG004|Overall Study|Withdrawal by Subject|0|||
130756849|NCT04323306|470731305|FG005|Overall Study|Withdrawal by Subject|1|||
130756850|NCT04323306|470731306|FG006|Overall Study|Withdrawal by Subject|3|||
130756851|NCT04323306|470731307|FG007|Overall Study|Withdrawal by Subject|0|||
130756852|NCT04323306|470731308|FG008|Overall Study|Withdrawal by Subject|1|||
130756853|NCT00834639|470731309|FG000|Second Intervention|Physician Decision|0|||
130756854|NCT00834639|470731310|FG001|Second Intervention|Physician Decision|2|||
130756855|NCT05129137|470731311|FG000|Second Period|Adverse Event|1|||
130756856|NCT05129137|470731312|FG001|Second Period|Adverse Event|0|||
130756857|NCT05129137|470731313|FG002|Second Period|Adverse Event|0|||
130756858|NCT05129137|470731314|FG003|Second Period|Adverse Event|0|||
130756859|NCT05129137|470731311|FG000|Second Period|Protocol Violation|0|||
130756860|NCT05129137|470731312|FG001|Second Period|Protocol Violation|0|||
130756861|NCT05129137|470731313|FG002|Second Period|Protocol Violation|0|||
130756862|NCT05129137|470731314|FG003|Second Period|Protocol Violation|1|||
130756863|NCT05129137|470731311|FG000|Third Period|Protocol Violation|0|||
130756864|NCT05129137|470731312|FG001|Third Period|Protocol Violation|0|||
130756865|NCT05129137|470731313|FG002|Third Period|Protocol Violation|0|||
130756866|NCT05129137|470731314|FG003|Third Period|Protocol Violation|1|||
130756867|NCT05129137|470731311|FG000|Forth Period|Protocol Violation|0|||
130756868|NCT05129137|470731312|FG001|Forth Period|Protocol Violation|1|||
130756869|NCT05129137|470731313|FG002|Forth Period|Protocol Violation|0|||
130756870|NCT05129137|470731314|FG003|Forth Period|Protocol Violation|0|||
130756871|NCT05129137|470731311|FG000|Forth Period|Withdrawal by Subject|0|||
130756872|NCT05129137|470731312|FG001|Forth Period|Withdrawal by Subject|0|||
130756873|NCT05129137|470731313|FG002|Forth Period|Withdrawal by Subject|1|||
130756874|NCT05129137|470731314|FG003|Forth Period|Withdrawal by Subject|0|||
130756875|NCT03382834|470731327|FG000|Step 1|Lost to Follow-up|0|||
130756876|NCT03382834|470731328|FG001|Step 1|Lost to Follow-up|1|||
130756877|NCT03382834|470731327|FG000|Step 2|Death|1|||
130756878|NCT03382834|470731328|FG001|Step 2|Death|0|||
130756879|NCT03382834|470731327|FG000|Step 2|Lost to Follow-up|2|||
130756880|NCT03382834|470731328|FG001|Step 2|Lost to Follow-up|2|||
130756881|NCT03382834|470731327|FG000|Step 2|Site Terminated by Sponsor|1|||
130756882|NCT03382834|470731328|FG001|Step 2|Site Terminated by Sponsor|0|||
130756883|NCT02387957|470731329|FG000|Overall Study|The study was discontinued|21|||
130756884|NCT02387957|470731330|FG001|Overall Study|The study was discontinued|21|||
130756885|NCT02387957|470731331|FG002|Overall Study|The study was discontinued|20|||
130756886|NCT03613649|470731332|FG000|Second Treatment|Lost to Follow-up|0|||
130756887|NCT03613649|470731333|FG001|Second Treatment|Lost to Follow-up|0|||
130756888|NCT03613649|470731334|FG002|Second Treatment|Lost to Follow-up|1|||
130756889|NCT03613649|470731335|FG003|Second Treatment|Lost to Follow-up|0|||
130756890|NCT03613649|470731336|FG004|Second Treatment|Lost to Follow-up|0|||
130756891|NCT03613649|470731337|FG005|Second Treatment|Lost to Follow-up|0|||
130756892|NCT03613649|470731338|FG006|Second Treatment|Lost to Follow-up|0|||
130756893|NCT03613649|470731339|FG007|Second Treatment|Lost to Follow-up|0|||
130756894|NCT03613649|470731340|FG008|Second Treatment|Lost to Follow-up|0|||
130756895|NCT03613649|470731341|FG009|Second Treatment|Lost to Follow-up|0|||
130756896|NCT03613649|470731342|FG010|Second Treatment|Lost to Follow-up|0|||
130756897|NCT03613649|470731343|FG011|Second Treatment|Lost to Follow-up|0|||
130756898|NCT03613649|470731332|FG000|Second Treatment|Withdrawal by Subject|0|||
130756899|NCT03613649|470731333|FG001|Second Treatment|Withdrawal by Subject|0|||
130756900|NCT03613649|470731334|FG002|Second Treatment|Withdrawal by Subject|0|||
130756901|NCT03613649|470731335|FG003|Second Treatment|Withdrawal by Subject|0|||
130756902|NCT03613649|470731336|FG004|Second Treatment|Withdrawal by Subject|1|||
130756903|NCT03613649|470731337|FG005|Second Treatment|Withdrawal by Subject|0|||
130756904|NCT03613649|470731338|FG006|Second Treatment|Withdrawal by Subject|0|||
130756905|NCT03613649|470731339|FG007|Second Treatment|Withdrawal by Subject|0|||
130756906|NCT03613649|470731340|FG008|Second Treatment|Withdrawal by Subject|0|||
130756907|NCT03613649|470731341|FG009|Second Treatment|Withdrawal by Subject|0|||
130756908|NCT03613649|470731342|FG010|Second Treatment|Withdrawal by Subject|0|||
130789160|NCT03573297|470856776|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
130756909|NCT03613649|470731343|FG011|Second Treatment|Withdrawal by Subject|0|||
130756910|NCT03613649|470731332|FG000|Third Treatment|Lost to Follow-up|0|||
130756911|NCT03613649|470731333|FG001|Third Treatment|Lost to Follow-up|0|||
130756912|NCT03613649|470731334|FG002|Third Treatment|Lost to Follow-up|0|||
130756913|NCT03613649|470731335|FG003|Third Treatment|Lost to Follow-up|0|||
130756914|NCT03613649|470731336|FG004|Third Treatment|Lost to Follow-up|1|||
130756915|NCT03613649|470731337|FG005|Third Treatment|Lost to Follow-up|0|||
130756916|NCT03613649|470731338|FG006|Third Treatment|Lost to Follow-up|0|||
130756917|NCT03613649|470731339|FG007|Third Treatment|Lost to Follow-up|0|||
130756918|NCT03613649|470731340|FG008|Third Treatment|Lost to Follow-up|0|||
130756919|NCT03613649|470731341|FG009|Third Treatment|Lost to Follow-up|0|||
130756920|NCT03613649|470731342|FG010|Third Treatment|Lost to Follow-up|0|||
130756921|NCT03613649|470731343|FG011|Third Treatment|Lost to Follow-up|1|||
130756922|NCT03613649|470731332|FG000|Third Treatment|Protocol Violation|0|||
130756923|NCT03613649|470731333|FG001|Third Treatment|Protocol Violation|0|||
130756924|NCT03613649|470731334|FG002|Third Treatment|Protocol Violation|0|||
130756925|NCT03613649|470731335|FG003|Third Treatment|Protocol Violation|0|||
130756926|NCT03613649|470731336|FG004|Third Treatment|Protocol Violation|0|||
130756927|NCT03613649|470731337|FG005|Third Treatment|Protocol Violation|0|||
130756928|NCT03613649|470731338|FG006|Third Treatment|Protocol Violation|1|||
130756929|NCT03613649|470731339|FG007|Third Treatment|Protocol Violation|0|||
130756930|NCT03613649|470731340|FG008|Third Treatment|Protocol Violation|0|||
130756931|NCT03613649|470731341|FG009|Third Treatment|Protocol Violation|0|||
130756932|NCT03613649|470731342|FG010|Third Treatment|Protocol Violation|0|||
130756933|NCT03613649|470731343|FG011|Third Treatment|Protocol Violation|1|||
130756934|NCT03613649|470731332|FG000|Fourth Treatment|Protocol Violation|1|||
130756935|NCT03613649|470731333|FG001|Fourth Treatment|Protocol Violation|0|||
130756936|NCT03613649|470731334|FG002|Fourth Treatment|Protocol Violation|0|||
130756937|NCT03613649|470731335|FG003|Fourth Treatment|Protocol Violation|0|||
130756938|NCT03613649|470731336|FG004|Fourth Treatment|Protocol Violation|1|||
130756939|NCT03613649|470731337|FG005|Fourth Treatment|Protocol Violation|0|||
130756940|NCT03613649|470731338|FG006|Fourth Treatment|Protocol Violation|0|||
130756941|NCT03613649|470731339|FG007|Fourth Treatment|Protocol Violation|0|||
130756942|NCT03613649|470731340|FG008|Fourth Treatment|Protocol Violation|0|||
130756943|NCT03613649|470731341|FG009|Fourth Treatment|Protocol Violation|0|||
130756944|NCT03613649|470731342|FG010|Fourth Treatment|Protocol Violation|0|||
130756945|NCT03613649|470731343|FG011|Fourth Treatment|Protocol Violation|0|||
130756946|NCT03613649|470731332|FG000|Fourth Treatment|Physician Decision|0|||
130756947|NCT03613649|470731333|FG001|Fourth Treatment|Physician Decision|0|||
130756948|NCT03613649|470731334|FG002|Fourth Treatment|Physician Decision|0|||
130756949|NCT03613649|470731335|FG003|Fourth Treatment|Physician Decision|0|||
130756950|NCT03613649|470731336|FG004|Fourth Treatment|Physician Decision|0|||
130756951|NCT03613649|470731337|FG005|Fourth Treatment|Physician Decision|0|||
130756952|NCT03613649|470731338|FG006|Fourth Treatment|Physician Decision|1|||
130756953|NCT03613649|470731339|FG007|Fourth Treatment|Physician Decision|0|||
130756954|NCT03613649|470731340|FG008|Fourth Treatment|Physician Decision|0|||
130756955|NCT03613649|470731341|FG009|Fourth Treatment|Physician Decision|0|||
130756956|NCT03613649|470731342|FG010|Fourth Treatment|Physician Decision|0|||
130756957|NCT03613649|470731343|FG011|Fourth Treatment|Physician Decision|0|||
130756958|NCT00675428|470731344|FG000|Overall Study|Disease Progression|2|||
130756959|NCT00675428|470731345|FG001|Overall Study|Disease Progression|2|||
130756960|NCT00675428|470731344|FG000|Overall Study|No Disease Response After Cycle 6|0|||
130756961|NCT00675428|470731345|FG001|Overall Study|No Disease Response After Cycle 6|1|||
130756962|NCT00675428|470731344|FG000|Overall Study|Physician Decision|1|||
130756963|NCT00675428|470731345|FG001|Overall Study|Physician Decision|0|||
130756964|NCT00319592|470731346|FG000|Overall Study|Protocol Violation|1|||
130756965|NCT00319592|470731347|FG001|Overall Study|Protocol Violation|0|||
130756966|NCT00319592|470731346|FG000|Overall Study|Physician Decision|0|||
130756967|NCT00319592|470731347|FG001|Overall Study|Physician Decision|1|||
130756968|NCT00750139|470731350|FG000|Overall Study|Adverse Event|1|||
130756969|NCT00750139|470731351|FG001|Overall Study|Adverse Event|2|||
130756970|NCT00750139|470731352|FG002|Overall Study|Adverse Event|0|||
130756971|NCT00750139|470731353|FG003|Overall Study|Adverse Event|1|||
130756972|NCT00750139|470731350|FG000|Overall Study|Lost to Follow-up|17|||
130756973|NCT00750139|470731351|FG001|Overall Study|Lost to Follow-up|12|||
130756974|NCT00750139|470731352|FG002|Overall Study|Lost to Follow-up|15|||
130756975|NCT00750139|470731353|FG003|Overall Study|Lost to Follow-up|6|||
130756976|NCT00750139|470731350|FG000|Overall Study|Withdrawal by Subject|3|||
130756977|NCT00750139|470731351|FG001|Overall Study|Withdrawal by Subject|2|||
130756978|NCT00750139|470731352|FG002|Overall Study|Withdrawal by Subject|6|||
130756979|NCT00750139|470731353|FG003|Overall Study|Withdrawal by Subject|2|||
130756980|NCT00750139|470731350|FG000|Overall Study|Physician Decision|1|||
130756981|NCT00750139|470731351|FG001|Overall Study|Physician Decision|1|||
130756982|NCT00750139|470731352|FG002|Overall Study|Physician Decision|0|||
130756983|NCT00750139|470731353|FG003|Overall Study|Physician Decision|0|||
130756984|NCT00750139|470731350|FG000|Overall Study|Non-compliance|1|||
130756985|NCT00750139|470731351|FG001|Overall Study|Non-compliance|0|||
130756986|NCT00750139|470731352|FG002|Overall Study|Non-compliance|1|||
130756987|NCT00750139|470731353|FG003|Overall Study|Non-compliance|3|||
130756988|NCT00750139|470731350|FG000|Overall Study|Termination by sponsor|4|||
130756989|NCT00750139|470731351|FG001|Overall Study|Termination by sponsor|0|||
130756990|NCT00750139|470731352|FG002|Overall Study|Termination by sponsor|0|||
130756991|NCT00750139|470731353|FG003|Overall Study|Termination by sponsor|1|||
130756992|NCT00750139|470731350|FG000|Overall Study|Non-specific|62|||
130756993|NCT00750139|470731351|FG001|Overall Study|Non-specific|42|||
130756994|NCT00750139|470731352|FG002|Overall Study|Non-specific|79|||
130756995|NCT00750139|470731353|FG003|Overall Study|Non-specific|33|||
130756996|NCT04439214|470731357|FG000|Overall Study|Adverse Event|13|||
130789161|NCT03573297|470856773|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
130789162|NCT03573297|470856774|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
130789163|NCT03573297|470856775|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
130789164|NCT03573297|470856776|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
130789165|NCT03573297|470856773|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
130789166|NCT03573297|470856774|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
130789167|NCT03573297|470856775|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
130789168|NCT03573297|470856776|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
130789169|NCT03573297|470856773|FG000|Open Label Treatment Period|Pregnancy|1|||
130789170|NCT03573297|470856774|FG001|Open Label Treatment Period|Pregnancy|0|||
130789171|NCT03573297|470856775|FG002|Open Label Treatment Period|Pregnancy|0|||
130789172|NCT03573297|470856776|FG003|Open Label Treatment Period|Pregnancy|0|||
130789173|NCT03573297|470856773|FG000|Open Label Treatment Period|Protocol Violation|17|||
130789174|NCT03573297|470856774|FG001|Open Label Treatment Period|Protocol Violation|0|||
130789175|NCT03573297|470856775|FG002|Open Label Treatment Period|Protocol Violation|0|||
130789176|NCT03573297|470856776|FG003|Open Label Treatment Period|Protocol Violation|0|||
130789177|NCT03573297|470856773|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
130789178|NCT03573297|470856774|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
130789179|NCT03573297|470856775|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
130789180|NCT03573297|470856776|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
130789181|NCT03573297|470856773|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
130789182|NCT03573297|470856774|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
130789183|NCT03573297|470856775|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
130789184|NCT03573297|470856776|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
130789185|NCT03573297|470856773|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
130789186|NCT03573297|470856774|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
130789187|NCT03573297|470856775|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
130789188|NCT03573297|470856776|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
130789189|NCT03573297|470856773|FG000|Open Label Treatment Period|Other, Not Specified|7|||
130789190|NCT03573297|470856774|FG001|Open Label Treatment Period|Other, Not Specified|0|||
130789191|NCT03573297|470856775|FG002|Open Label Treatment Period|Other, Not Specified|0|||
130789192|NCT03573297|470856776|FG003|Open Label Treatment Period|Other, Not Specified|0|||
130789193|NCT03573297|470856773|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
130789194|NCT03573297|470856774|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
130789195|NCT03573297|470856775|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
130789196|NCT03573297|470856776|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
130789197|NCT03573297|470856773|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130789198|NCT03573297|470856774|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130789199|NCT03573297|470856775|FG002|Double-Blind Treatment Period|Adverse Event|5|||
130789200|NCT03573297|470856776|FG003|Double-Blind Treatment Period|Adverse Event|1|||
130789201|NCT03573297|470856773|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130789202|NCT03573297|470856774|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
130789203|NCT03573297|470856775|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
130789204|NCT03573297|470856776|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
130789205|NCT03573297|470856773|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130789206|NCT03573297|470856774|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
130789207|NCT03573297|470856775|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
130789208|NCT03573297|470856776|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
130789209|NCT03573297|470856773|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130756997|NCT04439214|470731357|FG000|Overall Study|Disease progression|16|||
130756998|NCT04439214|470731357|FG000|Overall Study|Death|1|||
130756999|NCT04439214|470731357|FG000|Overall Study|Withdrawal by Subject|2|||
130757000|NCT04439214|470731357|FG000|Overall Study|Declining health|1|||
130757001|NCT04439214|470731357|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
130757002|NCT04439214|470731357|FG000|Overall Study|Ineligible|5|||
130757003|NCT04553471|470731358|FG000|Overall Study|Did not start treatment on protocol|3|||
130757004|NCT04553471|470731358|FG000|Overall Study|Death|1|||
130757005|NCT00477750|470732756|FG000|Overall Study|Currently Receiving Treatment|11|||
130757006|NCT00601172|470732757|FG000|Overall Study|Adverse Event|43|||
130757007|NCT00601172|470732758|FG001|Overall Study|Adverse Event|32|||
130757008|NCT00601172|470732757|FG000|Overall Study|Lack of Efficacy|11|||
130757009|NCT00601172|470732758|FG001|Overall Study|Lack of Efficacy|12|||
130757010|NCT00601172|470732757|FG000|Overall Study|Protocol Violation|2|||
130757011|NCT00601172|470732758|FG001|Overall Study|Protocol Violation|5|||
130757012|NCT00601172|470732757|FG000|Overall Study|Lost to Follow-up|4|||
130757013|NCT00601172|470732758|FG001|Overall Study|Lost to Follow-up|3|||
130757014|NCT00601172|470732757|FG000|Overall Study|Physician Decision|27|||
130757015|NCT00601172|470732758|FG001|Overall Study|Physician Decision|28|||
130757016|NCT00601172|470732757|FG000|Overall Study|Withdrawal by Subject|35|||
130757017|NCT00601172|470732758|FG001|Overall Study|Withdrawal by Subject|27|||
130757018|NCT00601172|470732757|FG000|Overall Study|Did not meet continuation criteria|19|||
130757019|NCT00601172|470732758|FG001|Overall Study|Did not meet continuation criteria|20|||
130757020|NCT03030989|470732759|FG000|Overall Study|Fever|2|||
130757021|NCT03030989|470732760|FG001|Overall Study|Fever|2|||
130757022|NCT03030989|470732759|FG000|Overall Study|Rash|2|||
130757023|NCT03030989|470732760|FG001|Overall Study|Rash|1|||
130757024|NCT03030989|470732759|FG000|Overall Study|Fatigue/Overwhelmed|1|||
130757025|NCT03030989|470732760|FG001|Overall Study|Fatigue/Overwhelmed|5|||
130757026|NCT03030989|470732759|FG000|Overall Study|Positive Blood Cultures|2|||
130757027|NCT03030989|470732760|FG001|Overall Study|Positive Blood Cultures|1|||
130757028|NCT03030989|470732759|FG000|Overall Study|Line Removed|0|||
130757029|NCT03030989|470732760|FG001|Overall Study|Line Removed|2|||
130757030|NCT03030989|470732759|FG000|Overall Study|No longer interested|5|||
130757031|NCT03030989|470732760|FG001|Overall Study|No longer interested|3|||
130757032|NCT02706886|470732761|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
130757033|NCT02706886|470732762|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
130757034|NCT02706886|470732763|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
130757035|NCT02706886|470732764|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
130757036|NCT02706886|470732765|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
130757037|NCT02706886|470732766|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
130757038|NCT02706886|470732767|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
130757039|NCT02706886|470732768|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
130757040|NCT02706886|470732769|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
130757041|NCT00723255|470732778|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
130757042|NCT00723255|470732778|FG000|Overall Study|Ineligible: Second primary|1|||
130757043|NCT00723255|470732778|FG000|Overall Study|Ineligible: Wrong Primary|2|||
130757044|NCT00614523|470732779|FG000|Overall Study|Adverse Event|4|||
130757045|NCT00614523|470732780|FG001|Overall Study|Adverse Event|20|||
130757046|NCT00614523|470732779|FG000|Overall Study|Death|5|||
130757047|NCT00614523|470732780|FG001|Overall Study|Death|8|||
130757048|NCT00614523|470732779|FG000|Overall Study|Lack of Efficacy|9|||
130757049|NCT00614523|470732780|FG001|Overall Study|Lack of Efficacy|11|||
130757050|NCT00614523|470732779|FG000|Overall Study|Lost to Follow-up|0|||
130757051|NCT00614523|470732780|FG001|Overall Study|Lost to Follow-up|1|||
130757052|NCT00614523|470732779|FG000|Overall Study|Protocol Violation|3|||
130757053|NCT00614523|470732780|FG001|Overall Study|Protocol Violation|2|||
130757054|NCT00614523|470732779|FG000|Overall Study|Withdrawal by Subject|12|||
130757055|NCT00614523|470732780|FG001|Overall Study|Withdrawal by Subject|22|||
130757056|NCT00614523|470732779|FG000|Overall Study|Other|6|||
130757057|NCT00614523|470732780|FG001|Overall Study|Other|11|||
130757058|NCT00614523|470732779|FG000|Overall Study|Ineligibility Determined|1|||
130757059|NCT00614523|470732780|FG001|Overall Study|Ineligibility Determined|2|||
130757060|NCT00614523|470732779|FG000|Overall Study|Disease Progression|0|||
130757061|NCT00614523|470732780|FG001|Overall Study|Disease Progression|8|||
130757062|NCT00614523|470732779|FG000|Overall Study|Administrative Decision|23|||
130757063|NCT00614523|470732780|FG001|Overall Study|Administrative Decision|46|||
130757064|NCT04598451|470732786|FG000|Overall Study|Adverse Event|3|||
130757065|NCT04598451|470732787|FG001|Overall Study|Adverse Event|2|||
130757066|NCT04598451|470732786|FG000|Overall Study|Withdrawal by Subject|3|||
130757067|NCT04598451|470732787|FG001|Overall Study|Withdrawal by Subject|7|||
130757068|NCT04598451|470732786|FG000|Overall Study|Lost to Follow-up|2|||
130757069|NCT04598451|470732787|FG001|Overall Study|Lost to Follow-up|0|||
130757070|NCT04598451|470732786|FG000|Overall Study|Physician Decision|4|||
130757071|NCT04598451|470732787|FG001|Overall Study|Physician Decision|1|||
130757072|NCT04598451|470732786|FG000|Overall Study|Requires Prohibited Medication|1|||
130757073|NCT04598451|470732787|FG001|Overall Study|Requires Prohibited Medication|0|||
130757074|NCT04598451|470732786|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
130757075|NCT04598451|470732787|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
130757076|NCT01482065|470732792|FG000|Overall Study|Withdrawal by Subject|0|||
130757077|NCT01482065|470732793|FG001|Overall Study|Withdrawal by Subject|1|||
130757078|NCT02005692|470732798|FG000|Overall Study|Protocol Violation|1|||
130757079|NCT02005692|470732798|FG000|Overall Study|Withdrawal by Subject|1|||
130757080|NCT02005692|470732798|FG000|Overall Study|Discharged earlier than anticipated|5|||
130757081|NCT01895270|470732799|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
130757082|NCT01895270|470732800|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
130757083|NCT01895270|470732799|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
130757084|NCT01895270|470732800|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
130757085|NCT01895270|470732799|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
130757086|NCT01895270|470732800|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
130757087|NCT01895270|470732799|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
130757088|NCT01895270|470732800|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
130757089|NCT01895270|470732799|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
130757090|NCT01895270|470732800|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
130757091|NCT01895270|470732799|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
130757092|NCT01895270|470732800|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
130757093|NCT01895270|470732799|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
130757094|NCT01895270|470732800|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
130757095|NCT02091375|470732802|FG000|Overall Study|Adverse Event|8|||
130757096|NCT02091375|470732803|FG001|Overall Study|Adverse Event|1|||
130757097|NCT02091375|470732802|FG000|Overall Study|Lost to Follow-up|0|||
130757098|NCT02091375|470732803|FG001|Overall Study|Lost to Follow-up|1|||
130757099|NCT02091375|470732802|FG000|Overall Study|Withdrawal by Subject|0|||
130757100|NCT02091375|470732803|FG001|Overall Study|Withdrawal by Subject|1|||
130757101|NCT02091375|470732802|FG000|Overall Study|Withdrawn by the investigator|1|||
130757102|NCT02091375|470732803|FG001|Overall Study|Withdrawn by the investigator|0|||
130757103|NCT01741792|470732804|FG000|Overall Study|Death|6|||
130757104|NCT01741792|470732805|FG001|Overall Study|Death|1|||
130757105|NCT01741792|470732806|FG002|Overall Study|Death|12|||
130757106|NCT04507256|470732811|FG000|Overall Study|Withdrawal by Subject|1|||
130757107|NCT04507256|470732812|FG001|Overall Study|Withdrawal by Subject|0|||
130757108|NCT04507256|470732813|FG002|Overall Study|Withdrawal by Subject|0|||
130757109|NCT04507256|470732814|FG003|Overall Study|Withdrawal by Subject|1|||
130757110|NCT04507256|470732815|FG004|Overall Study|Withdrawal by Subject|0|||
130757111|NCT04507256|470732816|FG005|Overall Study|Withdrawal by Subject|0|||
130757112|NCT00631410|470732817|FG000|Overall Study|Adverse Event|1|||
130757113|NCT00631410|470732818|FG001|Overall Study|Adverse Event|3|||
130757114|NCT00631410|470732817|FG000|Overall Study|Objective Progression or Relapse|4|||
130757115|NCT00631410|470732818|FG001|Overall Study|Objective Progression or Relapse|3|||
130757116|NCT00631410|470732817|FG000|Overall Study|Surgery|1|||
130757117|NCT00631410|470732818|FG001|Overall Study|Surgery|0|||
130757118|NCT02980341|470732823|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
130757119|NCT02980341|470732824|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
130757120|NCT02980341|470732825|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
130757121|NCT02980341|470732826|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
130757122|NCT02980341|470732827|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
130757123|NCT02980341|470732828|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130757124|NCT02980341|470732829|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130757125|NCT02980341|470732830|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130757126|NCT02980341|470732831|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130757127|NCT02980341|470732832|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130757128|NCT02980341|470732833|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130757129|NCT02980341|470732823|FG000|Dose Escalation|Clinical progression|0|||
130757130|NCT02980341|470732824|FG001|Dose Escalation|Clinical progression|0|||
130757131|NCT02980341|470732825|FG002|Dose Escalation|Clinical progression|2|||
130757132|NCT02980341|470732826|FG003|Dose Escalation|Clinical progression|1|||
130757133|NCT02980341|470732827|FG004|Dose Escalation|Clinical progression|0|||
130757134|NCT02980341|470732828|FG005|Dose Escalation|Clinical progression|0|||
130757135|NCT02980341|470732829|FG006|Dose Escalation|Clinical progression|0|||
130757136|NCT02980341|470732830|FG007|Dose Escalation|Clinical progression|0|||
130757137|NCT02980341|470732831|FG008|Dose Escalation|Clinical progression|0|||
130757138|NCT02980341|470732832|FG009|Dose Escalation|Clinical progression|0|||
130757139|NCT02980341|470732833|FG010|Dose Escalation|Clinical progression|0|||
130757140|NCT02980341|470732823|FG000|Dose Escalation|Adverse Event|0|||
130757141|NCT02980341|470732824|FG001|Dose Escalation|Adverse Event|0|||
130757142|NCT02980341|470732825|FG002|Dose Escalation|Adverse Event|1|||
130757143|NCT02980341|470732826|FG003|Dose Escalation|Adverse Event|2|||
130757144|NCT02980341|470732827|FG004|Dose Escalation|Adverse Event|2|||
130757145|NCT02980341|470732828|FG005|Dose Escalation|Adverse Event|0|||
130757146|NCT02980341|470732829|FG006|Dose Escalation|Adverse Event|0|||
130757147|NCT02980341|470732830|FG007|Dose Escalation|Adverse Event|0|||
130757148|NCT02980341|470732831|FG008|Dose Escalation|Adverse Event|0|||
130757149|NCT02980341|470732832|FG009|Dose Escalation|Adverse Event|0|||
130757150|NCT02980341|470732833|FG010|Dose Escalation|Adverse Event|0|||
130757151|NCT02980341|470732823|FG000|Dose Escalation|Withdrawal by Subject|0|||
130757152|NCT02980341|470732824|FG001|Dose Escalation|Withdrawal by Subject|0|||
130757153|NCT02980341|470732825|FG002|Dose Escalation|Withdrawal by Subject|1|||
130757154|NCT02980341|470732826|FG003|Dose Escalation|Withdrawal by Subject|0|||
130757155|NCT02980341|470732827|FG004|Dose Escalation|Withdrawal by Subject|0|||
130757156|NCT02980341|470732828|FG005|Dose Escalation|Withdrawal by Subject|0|||
130757157|NCT02980341|470732829|FG006|Dose Escalation|Withdrawal by Subject|0|||
130757158|NCT02980341|470732830|FG007|Dose Escalation|Withdrawal by Subject|0|||
130757159|NCT02980341|470732831|FG008|Dose Escalation|Withdrawal by Subject|0|||
130757160|NCT02980341|470732832|FG009|Dose Escalation|Withdrawal by Subject|0|||
130757161|NCT02980341|470732833|FG010|Dose Escalation|Withdrawal by Subject|0|||
130757162|NCT02980341|470732823|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
130757163|NCT02980341|470732824|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
130757164|NCT02980341|470732825|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
130757165|NCT02980341|470732826|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
130757166|NCT02980341|470732827|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
130757167|NCT02980341|470732828|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
130757168|NCT02980341|470732829|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
130757169|NCT02980341|470732830|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
130757170|NCT02980341|470732831|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
130757171|NCT02980341|470732832|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
130757172|NCT02980341|470732833|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
130757173|NCT02980341|470732823|FG000|Dose Escalation|Due to investigator's decision|0|||
130757174|NCT02980341|470732824|FG001|Dose Escalation|Due to investigator's decision|0|||
130757175|NCT02980341|470732825|FG002|Dose Escalation|Due to investigator's decision|0|||
130757176|NCT02980341|470732826|FG003|Dose Escalation|Due to investigator's decision|0|||
130757177|NCT02980341|470732827|FG004|Dose Escalation|Due to investigator's decision|1|||
130757178|NCT02980341|470732828|FG005|Dose Escalation|Due to investigator's decision|0|||
130757179|NCT02980341|470732829|FG006|Dose Escalation|Due to investigator's decision|0|||
130757180|NCT02980341|470732830|FG007|Dose Escalation|Due to investigator's decision|0|||
130757181|NCT02980341|470732831|FG008|Dose Escalation|Due to investigator's decision|0|||
130757182|NCT02980341|470732832|FG009|Dose Escalation|Due to investigator's decision|0|||
130757183|NCT02980341|470732833|FG010|Dose Escalation|Due to investigator's decision|0|||
130757184|NCT02980341|470732823|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
130757185|NCT02980341|470732824|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
130757186|NCT02980341|470732825|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
130757187|NCT02980341|470732826|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
130757188|NCT02980341|470732827|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
130757189|NCT02980341|470732828|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
130757190|NCT02980341|470732829|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
130757191|NCT02980341|470732830|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
130757192|NCT02980341|470732831|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
130757193|NCT02980341|470732832|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
130757194|NCT02980341|470732833|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
130757195|NCT02980341|470732823|FG000|Dose Finding|Adverse Event|0|||
130757196|NCT02980341|470732824|FG001|Dose Finding|Adverse Event|0|||
130757197|NCT02980341|470732825|FG002|Dose Finding|Adverse Event|0|||
130757198|NCT02980341|470732826|FG003|Dose Finding|Adverse Event|0|||
130757199|NCT02980341|470732827|FG004|Dose Finding|Adverse Event|0|||
130757200|NCT02980341|470732828|FG005|Dose Finding|Adverse Event|3|||
130757201|NCT02980341|470732829|FG006|Dose Finding|Adverse Event|0|||
130757202|NCT02980341|470732830|FG007|Dose Finding|Adverse Event|0|||
130757203|NCT02980341|470732831|FG008|Dose Finding|Adverse Event|0|||
130757204|NCT02980341|470732832|FG009|Dose Finding|Adverse Event|0|||
130757205|NCT02980341|470732833|FG010|Dose Finding|Adverse Event|0|||
130757206|NCT02980341|470732823|FG000|Dose Finding|Withdrawal by Subject|0|||
130757207|NCT02980341|470732824|FG001|Dose Finding|Withdrawal by Subject|0|||
130757208|NCT02980341|470732825|FG002|Dose Finding|Withdrawal by Subject|0|||
130757209|NCT02980341|470732826|FG003|Dose Finding|Withdrawal by Subject|0|||
130757210|NCT02980341|470732827|FG004|Dose Finding|Withdrawal by Subject|0|||
130757211|NCT02980341|470732828|FG005|Dose Finding|Withdrawal by Subject|1|||
130757212|NCT02980341|470732829|FG006|Dose Finding|Withdrawal by Subject|1|||
130757213|NCT02980341|470732830|FG007|Dose Finding|Withdrawal by Subject|0|||
130757214|NCT02980341|470732831|FG008|Dose Finding|Withdrawal by Subject|0|||
130757215|NCT02980341|470732832|FG009|Dose Finding|Withdrawal by Subject|0|||
130757216|NCT02980341|470732833|FG010|Dose Finding|Withdrawal by Subject|0|||
130757217|NCT02980341|470732823|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130757218|NCT02980341|470732824|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130757219|NCT02980341|470732825|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130757220|NCT02980341|470732826|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130789210|NCT03573297|470856774|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
130789211|NCT03573297|470856775|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
130789212|NCT03573297|470856776|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
130789213|NCT03573297|470856773|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130789214|NCT03573297|470856774|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
130789215|NCT03573297|470856775|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
130789216|NCT03573297|470856776|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
130789217|NCT03573297|470856773|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
130789218|NCT03573297|470856774|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
130789219|NCT03573297|470856775|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
130789220|NCT03573297|470856776|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
130789221|NCT03573297|470856773|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
130789222|NCT03573297|470856774|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
130789223|NCT03573297|470856775|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
130789224|NCT03573297|470856776|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
130789225|NCT01499810|470856777|FG000|Overall Study|Lost to Follow-up|10|||
130789226|NCT01499810|470856777|FG000|Overall Study|Protocol Violation|1|||
130789227|NCT01499810|470856777|FG000|Overall Study|Withdrawal by Subject|1|||
130789228|NCT01884597|470856780|FG000|Overall Study|Adverse Event|0|||
130789229|NCT01884597|470856781|FG001|Overall Study|Adverse Event|0|||
130789230|NCT01884597|470856782|FG002|Overall Study|Adverse Event|1|||
130789231|NCT01884597|470856780|FG000|Overall Study|Lack of Efficacy|1|||
130789232|NCT01884597|470856781|FG001|Overall Study|Lack of Efficacy|0|||
130789233|NCT01884597|470856782|FG002|Overall Study|Lack of Efficacy|0|||
130789234|NCT01884597|470856780|FG000|Overall Study|Death|0|||
130789235|NCT01884597|470856781|FG001|Overall Study|Death|1|||
130789236|NCT01884597|470856782|FG002|Overall Study|Death|0|||
130789237|NCT02273167|470856783|FG000|Overall Study|Adverse Event|1|||
130789238|NCT02273167|470856784|FG001|Overall Study|Adverse Event|0|||
130789239|NCT02273167|470856785|FG002|Overall Study|Adverse Event|0|||
130789240|NCT02273167|470856783|FG000|Overall Study|Protocol Violation|3|||
130789241|NCT02273167|470856784|FG001|Overall Study|Protocol Violation|1|||
130789242|NCT02273167|470856785|FG002|Overall Study|Protocol Violation|1|||
130789243|NCT02273167|470856783|FG000|Overall Study|Lost to Follow-up|0|||
130789244|NCT02273167|470856784|FG001|Overall Study|Lost to Follow-up|1|||
130789245|NCT02273167|470856785|FG002|Overall Study|Lost to Follow-up|1|||
130789246|NCT02273167|470856783|FG000|Overall Study|Withdrawal by Subject|10|||
130789247|NCT02273167|470856784|FG001|Overall Study|Withdrawal by Subject|12|||
130789248|NCT02273167|470856785|FG002|Overall Study|Withdrawal by Subject|11|||
130789249|NCT02273167|470856783|FG000|Overall Study|Various|10|||
130789250|NCT02273167|470856784|FG001|Overall Study|Various|9|||
130789251|NCT02273167|470856785|FG002|Overall Study|Various|8|||
130789252|NCT01093846|470856786|FG000|Overall Study|Adverse Event|0|||
130789253|NCT01093846|470856787|FG001|Overall Study|Adverse Event|0|||
130789254|NCT01093846|470856788|FG002|Overall Study|Adverse Event|1|||
130789255|NCT01093846|470856786|FG000|Overall Study|Lack of Efficacy|0|||
130789256|NCT01093846|470856787|FG001|Overall Study|Lack of Efficacy|0|||
130789257|NCT01093846|470856788|FG002|Overall Study|Lack of Efficacy|4|||
130789258|NCT01093846|470856786|FG000|Overall Study|Condition no longer required study drug|1|||
130789259|NCT01093846|470856787|FG001|Overall Study|Condition no longer required study drug|1|||
130789260|NCT01093846|470856788|FG002|Overall Study|Condition no longer required study drug|1|||
130789261|NCT01093846|470856786|FG000|Overall Study|Administrative Problems|18|||
130789262|NCT01093846|470856787|FG001|Overall Study|Administrative Problems|17|||
130789263|NCT01093846|470856788|FG002|Overall Study|Administrative Problems|15|||
130789264|NCT03082729|470856789|FG000|Overall Study|Lost to Follow-up|7|||
130789265|NCT03082729|470856789|FG000|Overall Study|Physician Decision|2|||
130789266|NCT03082729|470856789|FG000|Overall Study|Withdrawal by Subject|1|||
130789267|NCT03082729|470856789|FG000|Overall Study|Lack of Efficacy|9|||
130789268|NCT03082729|470856789|FG000|Overall Study|Adverse Event|4|||
130789269|NCT03082729|470856789|FG000|Overall Study|Protocol Violation|6|||
130789270|NCT03082729|470856789|FG000|Overall Study|Fear of study procedure|1|||
130789271|NCT03082729|470856789|FG000|Overall Study|Scheduling conflict|1|||
130789272|NCT03321721|470856790|FG000|Overall Study|Lost to Follow-up|4|||
130789273|NCT03321721|470856791|FG001|Overall Study|Lost to Follow-up|8|||
130789274|NCT03321721|470856792|FG002|Overall Study|Lost to Follow-up|11|||
130789275|NCT01416571|470856793|FG000|Overall Study|Lost to Follow-up|2|||
130757221|NCT02980341|470732827|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130757222|NCT02980341|470732828|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130757223|NCT02980341|470732829|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130757224|NCT02980341|470732830|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
130757225|NCT02980341|470732831|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
130757226|NCT02980341|470732832|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
130757227|NCT02980341|470732833|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
130757228|NCT02980341|470732823|FG000|Dose Expansion|Clinical progression|0|||
130757229|NCT02980341|470732824|FG001|Dose Expansion|Clinical progression|0|||
130757230|NCT02980341|470732825|FG002|Dose Expansion|Clinical progression|0|||
130757231|NCT02980341|470732826|FG003|Dose Expansion|Clinical progression|0|||
130757232|NCT02980341|470732827|FG004|Dose Expansion|Clinical progression|0|||
130757233|NCT02980341|470732828|FG005|Dose Expansion|Clinical progression|0|||
130757234|NCT02980341|470732829|FG006|Dose Expansion|Clinical progression|0|||
130757235|NCT02980341|470732830|FG007|Dose Expansion|Clinical progression|4|||
130757236|NCT02980341|470732831|FG008|Dose Expansion|Clinical progression|3|||
130757237|NCT02980341|470732832|FG009|Dose Expansion|Clinical progression|1|||
130757238|NCT02980341|470732833|FG010|Dose Expansion|Clinical progression|4|||
130757239|NCT02980341|470732823|FG000|Dose Expansion|Adverse Event|0|||
130757240|NCT02980341|470732824|FG001|Dose Expansion|Adverse Event|0|||
130757241|NCT02980341|470732825|FG002|Dose Expansion|Adverse Event|0|||
130757242|NCT02980341|470732826|FG003|Dose Expansion|Adverse Event|0|||
130757243|NCT02980341|470732827|FG004|Dose Expansion|Adverse Event|0|||
130757244|NCT02980341|470732828|FG005|Dose Expansion|Adverse Event|0|||
130757245|NCT02980341|470732829|FG006|Dose Expansion|Adverse Event|0|||
130757246|NCT02980341|470732830|FG007|Dose Expansion|Adverse Event|3|||
130757247|NCT02980341|470732831|FG008|Dose Expansion|Adverse Event|0|||
130757248|NCT02980341|470732832|FG009|Dose Expansion|Adverse Event|1|||
130757249|NCT02980341|470732833|FG010|Dose Expansion|Adverse Event|3|||
130757250|NCT02980341|470732823|FG000|Dose Expansion|Death|0|||
130757251|NCT02980341|470732824|FG001|Dose Expansion|Death|0|||
130757252|NCT02980341|470732825|FG002|Dose Expansion|Death|0|||
130757253|NCT02980341|470732826|FG003|Dose Expansion|Death|0|||
130757254|NCT02980341|470732827|FG004|Dose Expansion|Death|0|||
130757255|NCT02980341|470732828|FG005|Dose Expansion|Death|0|||
130757256|NCT02980341|470732829|FG006|Dose Expansion|Death|0|||
130757257|NCT02980341|470732830|FG007|Dose Expansion|Death|0|||
130757258|NCT02980341|470732831|FG008|Dose Expansion|Death|2|||
130757259|NCT02980341|470732832|FG009|Dose Expansion|Death|1|||
130757260|NCT02980341|470732833|FG010|Dose Expansion|Death|0|||
130757261|NCT02980341|470732823|FG000|Dose Expansion|Withdrawal by Subject|0|||
130757262|NCT02980341|470732824|FG001|Dose Expansion|Withdrawal by Subject|0|||
130757263|NCT02980341|470732825|FG002|Dose Expansion|Withdrawal by Subject|0|||
130757264|NCT02980341|470732826|FG003|Dose Expansion|Withdrawal by Subject|0|||
130757265|NCT02980341|470732827|FG004|Dose Expansion|Withdrawal by Subject|0|||
130757266|NCT02980341|470732828|FG005|Dose Expansion|Withdrawal by Subject|0|||
130757267|NCT02980341|470732829|FG006|Dose Expansion|Withdrawal by Subject|0|||
130757268|NCT02980341|470732830|FG007|Dose Expansion|Withdrawal by Subject|2|||
130757269|NCT02980341|470732831|FG008|Dose Expansion|Withdrawal by Subject|0|||
130757270|NCT02980341|470732832|FG009|Dose Expansion|Withdrawal by Subject|1|||
130757271|NCT02980341|470732833|FG010|Dose Expansion|Withdrawal by Subject|0|||
130757272|NCT02980341|470732823|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130757273|NCT02980341|470732824|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130757274|NCT02980341|470732825|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130757275|NCT02980341|470732826|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130757276|NCT02980341|470732827|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130757277|NCT02980341|470732828|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130757278|NCT02980341|470732829|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130757279|NCT02980341|470732830|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
130757280|NCT02980341|470732831|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130757281|NCT02980341|470732832|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130757282|NCT02980341|470732833|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130757283|NCT02980341|470732823|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130757284|NCT02980341|470732824|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130757285|NCT02980341|470732825|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130757286|NCT02980341|470732826|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130757287|NCT02980341|470732827|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130757288|NCT02980341|470732828|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130757289|NCT02980341|470732829|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130757290|NCT02980341|470732830|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130757291|NCT02980341|470732831|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
130757292|NCT02980341|470732832|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130757293|NCT02980341|470732833|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130757294|NCT02980341|470732823|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130757295|NCT02980341|470732824|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130757296|NCT02980341|470732825|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130757297|NCT02980341|470732826|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130757298|NCT02980341|470732827|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130757299|NCT02980341|470732828|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130757300|NCT02980341|470732829|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130757301|NCT02980341|470732830|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130757302|NCT02980341|470732831|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
130757303|NCT02980341|470732832|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130757304|NCT02980341|470732833|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130757305|NCT02980341|470732823|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130757306|NCT02980341|470732824|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130757307|NCT02980341|470732825|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130757308|NCT02980341|470732826|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130757309|NCT02980341|470732827|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130757310|NCT02980341|470732828|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130757311|NCT02980341|470732829|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130757312|NCT02980341|470732830|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130757313|NCT02980341|470732831|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130757314|NCT02980341|470732832|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130757315|NCT02980341|470732833|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
130757316|NCT01647516|470732834|FG000|Induction Period (IP)|Physician Decision|2|||
130757317|NCT01647516|470732835|FG001|Induction Period (IP)|Physician Decision|0|||
130757318|NCT01647516|470732836|FG002|Induction Period (IP)|Physician Decision|0|||
130757319|NCT01647516|470732837|FG003|Induction Period (IP)|Physician Decision|0|||
130757320|NCT01647516|470732838|FG004|Induction Period (IP)|Physician Decision|0|||
130757321|NCT01647516|470732839|FG005|Induction Period (IP)|Physician Decision|0|||
130757322|NCT01647516|470732834|FG000|Induction Period (IP)|Adverse Event|1|||
130757323|NCT01647516|470732835|FG001|Induction Period (IP)|Adverse Event|2|||
130757324|NCT01647516|470732836|FG002|Induction Period (IP)|Adverse Event|0|||
130757325|NCT01647516|470732837|FG003|Induction Period (IP)|Adverse Event|0|||
130757326|NCT01647516|470732838|FG004|Induction Period (IP)|Adverse Event|0|||
130757327|NCT01647516|470732839|FG005|Induction Period (IP)|Adverse Event|0|||
130757328|NCT01647516|470732834|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
130757329|NCT01647516|470732835|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
130757330|NCT01647516|470732836|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
130757331|NCT01647516|470732837|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
130757332|NCT01647516|470732838|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
130757333|NCT01647516|470732839|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
130757334|NCT01647516|470732834|FG000|Induction Period (IP)|Participant Choice|0|||
130757335|NCT01647516|470732835|FG001|Induction Period (IP)|Participant Choice|0|||
130757336|NCT01647516|470732836|FG002|Induction Period (IP)|Participant Choice|1|||
130757337|NCT01647516|470732837|FG003|Induction Period (IP)|Participant Choice|0|||
130757338|NCT01647516|470732838|FG004|Induction Period (IP)|Participant Choice|0|||
130757339|NCT01647516|470732839|FG005|Induction Period (IP)|Participant Choice|0|||
130757340|NCT01647516|470732834|FG000|Induction Period (IP)|Lack of Efficacy|1|||
130757341|NCT01647516|470732835|FG001|Induction Period (IP)|Lack of Efficacy|0|||
130757342|NCT01647516|470732836|FG002|Induction Period (IP)|Lack of Efficacy|0|||
130757343|NCT01647516|470732837|FG003|Induction Period (IP)|Lack of Efficacy|0|||
130757344|NCT01647516|470732838|FG004|Induction Period (IP)|Lack of Efficacy|0|||
130757345|NCT01647516|470732839|FG005|Induction Period (IP)|Lack of Efficacy|0|||
130757346|NCT01647516|470732834|FG000|Induction Period (IP)|No study drug received|1|||
130757347|NCT01647516|470732835|FG001|Induction Period (IP)|No study drug received|1|||
130757348|NCT01647516|470732836|FG002|Induction Period (IP)|No study drug received|0|||
130757349|NCT01647516|470732837|FG003|Induction Period (IP)|No study drug received|0|||
130757350|NCT01647516|470732838|FG004|Induction Period (IP)|No study drug received|0|||
130789276|NCT03353220|470856794|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
130789277|NCT03353220|470856795|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
130789278|NCT00661388|470856802|FG000|Overall Study|Adverse Event|14|||
130757351|NCT01647516|470732839|FG005|Induction Period (IP)|No study drug received|0|||
130757352|NCT01647516|470732834|FG000|Maintenance Period (MP)|Adverse Event|2|||
130757353|NCT01647516|470732835|FG001|Maintenance Period (MP)|Adverse Event|1|||
130757354|NCT01647516|470732836|FG002|Maintenance Period (MP)|Adverse Event|0|||
130757355|NCT01647516|470732837|FG003|Maintenance Period (MP)|Adverse Event|0|||
130757356|NCT01647516|470732838|FG004|Maintenance Period (MP)|Adverse Event|0|||
130757357|NCT01647516|470732839|FG005|Maintenance Period (MP)|Adverse Event|0|||
130757358|NCT01647516|470732834|FG000|Maintenance Period (MP)|Non-compliance|1|||
130757359|NCT01647516|470732835|FG001|Maintenance Period (MP)|Non-compliance|0|||
130757360|NCT01647516|470732836|FG002|Maintenance Period (MP)|Non-compliance|0|||
130757361|NCT01647516|470732837|FG003|Maintenance Period (MP)|Non-compliance|0|||
130757362|NCT01647516|470732838|FG004|Maintenance Period (MP)|Non-compliance|0|||
130757363|NCT01647516|470732839|FG005|Maintenance Period (MP)|Non-compliance|0|||
130757364|NCT01647516|470732834|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
130757365|NCT01647516|470732835|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
130757366|NCT01647516|470732836|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
130757367|NCT01647516|470732837|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
130757368|NCT01647516|470732838|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
130757369|NCT01647516|470732839|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
130757370|NCT01647516|470732834|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
130757371|NCT01647516|470732835|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
130757372|NCT01647516|470732836|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
130757373|NCT01647516|470732837|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
130757374|NCT01647516|470732838|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
130757375|NCT01647516|470732839|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
130757376|NCT01647516|470732834|FG000|Open-Label Period|Adverse Event|0|||
130757377|NCT01647516|470732835|FG001|Open-Label Period|Adverse Event|0|||
130757378|NCT01647516|470732836|FG002|Open-Label Period|Adverse Event|0|||
130757379|NCT01647516|470732837|FG003|Open-Label Period|Adverse Event|5|||
130757380|NCT01647516|470732838|FG004|Open-Label Period|Adverse Event|6|||
130757381|NCT01647516|470732839|FG005|Open-Label Period|Adverse Event|3|||
130757382|NCT01647516|470732834|FG000|Open-Label Period|Pregnancy|0|||
130757383|NCT01647516|470732835|FG001|Open-Label Period|Pregnancy|0|||
130757384|NCT01647516|470732836|FG002|Open-Label Period|Pregnancy|0|||
130757385|NCT01647516|470732837|FG003|Open-Label Period|Pregnancy|0|||
130757386|NCT01647516|470732838|FG004|Open-Label Period|Pregnancy|0|||
130757387|NCT01647516|470732839|FG005|Open-Label Period|Pregnancy|1|||
130757388|NCT01647516|470732834|FG000|Open-Label Period|Non-compliance|0|||
130757389|NCT01647516|470732835|FG001|Open-Label Period|Non-compliance|0|||
130757390|NCT01647516|470732836|FG002|Open-Label Period|Non-compliance|0|||
130757391|NCT01647516|470732837|FG003|Open-Label Period|Non-compliance|1|||
130757392|NCT01647516|470732838|FG004|Open-Label Period|Non-compliance|0|||
130757393|NCT01647516|470732839|FG005|Open-Label Period|Non-compliance|1|||
130757394|NCT01647516|470732834|FG000|Open-Label Period|Physician Decision|0|||
130757395|NCT01647516|470732835|FG001|Open-Label Period|Physician Decision|0|||
130757396|NCT01647516|470732836|FG002|Open-Label Period|Physician Decision|0|||
130757397|NCT01647516|470732837|FG003|Open-Label Period|Physician Decision|1|||
130757398|NCT01647516|470732838|FG004|Open-Label Period|Physician Decision|1|||
130757399|NCT01647516|470732839|FG005|Open-Label Period|Physician Decision|0|||
130757400|NCT01647516|470732834|FG000|Open-Label Period|Withdrawal by Subject|0|||
130757401|NCT01647516|470732835|FG001|Open-Label Period|Withdrawal by Subject|0|||
130757402|NCT01647516|470732836|FG002|Open-Label Period|Withdrawal by Subject|0|||
130757403|NCT01647516|470732837|FG003|Open-Label Period|Withdrawal by Subject|9|||
130757404|NCT01647516|470732838|FG004|Open-Label Period|Withdrawal by Subject|11|||
130757405|NCT01647516|470732839|FG005|Open-Label Period|Withdrawal by Subject|6|||
130757406|NCT01647516|470732834|FG000|Open-Label Period|Lost to Follow-up|0|||
130757407|NCT01647516|470732835|FG001|Open-Label Period|Lost to Follow-up|0|||
130757408|NCT01647516|470732836|FG002|Open-Label Period|Lost to Follow-up|0|||
130757409|NCT01647516|470732837|FG003|Open-Label Period|Lost to Follow-up|1|||
130789279|NCT00661388|470856802|FG000|Overall Study|Protocol Violation|7|||
130789280|NCT00661388|470856802|FG000|Overall Study|Renal transplantation|1|||
130789281|NCT00661388|470856802|FG000|Overall Study|Dialysis initiation|1|||
130789282|NCT00661388|470856802|FG000|Overall Study|Administrative reasons|1|||
130789283|NCT01673386|470858690|FG000|Overall Study|Study terminated by sponsor|16|||
130789284|NCT01673386|470858691|FG001|Overall Study|Study terminated by sponsor|22|||
130757410|NCT01647516|470732838|FG004|Open-Label Period|Lost to Follow-up|0|||
130757411|NCT01647516|470732839|FG005|Open-Label Period|Lost to Follow-up|1|||
130757412|NCT01647516|470732834|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
130757413|NCT01647516|470732835|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
130757414|NCT01647516|470732836|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
130757415|NCT01647516|470732837|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
130757416|NCT01647516|470732838|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
130789285|NCT01673386|470858690|FG000|Overall Study|Adverse Event|5|||
130789286|NCT01673386|470858691|FG001|Overall Study|Adverse Event|2|||
130757417|NCT01647516|470732839|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
130757418|NCT01647516|470732834|FG000|Open-Label Period|Lack of Efficacy|0|||
130757419|NCT01647516|470732835|FG001|Open-Label Period|Lack of Efficacy|0|||
130757420|NCT01647516|470732836|FG002|Open-Label Period|Lack of Efficacy|0|||
130757421|NCT01647516|470732837|FG003|Open-Label Period|Lack of Efficacy|7|||
130757422|NCT01647516|470732838|FG004|Open-Label Period|Lack of Efficacy|9|||
130757423|NCT01647516|470732839|FG005|Open-Label Period|Lack of Efficacy|10|||
130757424|NCT01647516|470732834|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
130757425|NCT01647516|470732835|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
130757426|NCT01647516|470732836|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
130757427|NCT01647516|470732837|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
130757428|NCT01647516|470732838|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
130757429|NCT01647516|470732839|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
130757430|NCT01647516|470732834|FG000|Open-Label Period|No completion / discontinuation visit|0|||
130757431|NCT01647516|470732835|FG001|Open-Label Period|No completion / discontinuation visit|0|||
130757432|NCT01647516|470732836|FG002|Open-Label Period|No completion / discontinuation visit|0|||
130757433|NCT01647516|470732837|FG003|Open-Label Period|No completion / discontinuation visit|0|||
130757434|NCT01647516|470732838|FG004|Open-Label Period|No completion / discontinuation visit|2|||
130757435|NCT01647516|470732839|FG005|Open-Label Period|No completion / discontinuation visit|1|||
130757436|NCT03193801|470732840|FG000|Overall Study|Physician Decision|2|||
130757437|NCT03193801|470732840|FG000|Overall Study|Withdrawal by Subject|1|||
130757438|NCT04964544|470732843|FG000|Overall Study|Screen failure or other uncategorised|10|||
130757439|NCT04964544|470732843|FG000|Overall Study|Physician Decision|4|||
130757440|NCT04964544|470732843|FG000|Overall Study|Lost to Follow-up|9|||
130757441|NCT04964544|470732843|FG000|Overall Study|Withdrawal by Subject|18|||
130757442|NCT04964544|470732843|FG000|Overall Study|Death|1|||
130757443|NCT01613222|470732844|FG000|Overall Study|Physician Decision|1|||
130757444|NCT01613222|470732844|FG000|Overall Study|Unable to place arterial line|1|||
130757445|NCT01613222|470732844|FG000|Overall Study|Reused disposable sensors|10|||
130757446|NCT03696108|470732845|FG000|Overall Study|Physician Decision|1|||
130757447|NCT03696108|470732846|FG001|Overall Study|Physician Decision|0|||
130757448|NCT03696108|470732845|FG000|Overall Study|Withdrawal by Subject|3|||
130757449|NCT03696108|470732846|FG001|Overall Study|Withdrawal by Subject|6|||
130757450|NCT03505593|470732847|FG000|Overall Study|Withdrawal by Subject|1|||
130757451|NCT03505593|470732847|FG000|Overall Study|Died before procedure|1|||
130757452|NCT03505593|470732847|FG000|Overall Study|Anatomical abnormality|1|||
130757453|NCT03505593|470732847|FG000|Overall Study|Unable to pass through esophagus|1|||
130757454|NCT03505593|470732847|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
130757455|NCT01899742|470732848|FG000|Overall Study|Adverse Event|5|||
130757456|NCT01899742|470732849|FG001|Overall Study|Adverse Event|4|||
130757457|NCT01899742|470732848|FG000|Overall Study|Lack of Efficacy|1|||
130757458|NCT01899742|470732849|FG001|Overall Study|Lack of Efficacy|5|||
130757459|NCT01899742|470732848|FG000|Overall Study|Protocol Violation|2|||
130757460|NCT01899742|470732849|FG001|Overall Study|Protocol Violation|2|||
130757461|NCT01899742|470732848|FG000|Overall Study|Withdrawal by Subject|9|||
130757462|NCT01899742|470732849|FG001|Overall Study|Withdrawal by Subject|5|||
130757463|NCT00089778|470732850|FG000|Overall Study|Protocol Violation|0|||
130757464|NCT00089778|470732851|FG001|Overall Study|Protocol Violation|0|||
130757465|NCT00089778|470732852|FG002|Overall Study|Protocol Violation|1|||
130757466|NCT01154088|470732855|FG000|Overall Study|Lost to Follow-up|4|||
130757467|NCT01154088|470732856|FG001|Overall Study|Lost to Follow-up|6|||
130757468|NCT01154088|470732857|FG002|Overall Study|Lost to Follow-up|7|||
130757469|NCT01104246|470732858|FG000|Overall Study|Withdrawal by Subject|1|||
130757470|NCT01104246|470732858|FG000|Overall Study|did not meet inclusion criteria|4|||
130757471|NCT01475851|470732859|FG000|Overall Study|Protocol defined stopping criteria|1|||
130757472|NCT01475851|470732860|FG001|Overall Study|Protocol defined stopping criteria|0|||
130757473|NCT01867294|470732863|FG000|Overall Study|Withdrawal by Subject|1|||
130757474|NCT01867294|470732864|FG001|Overall Study|Withdrawal by Subject|1|||
130757475|NCT01867294|470732865|FG002|Overall Study|Withdrawal by Subject|0|||
130757476|NCT01867294|470732866|FG003|Overall Study|Withdrawal by Subject|0|||
130757477|NCT02447497|470732867|FG000|Overall Study|Did not meet treatment day baseline.|6|||
130757478|NCT02447497|470732868|FG001|Overall Study|Did not meet treatment day baseline.|5|||
130757479|NCT02447497|470732869|FG002|Overall Study|Did not meet treatment day baseline.|2|||
130757480|NCT02447497|470732870|FG003|Overall Study|Did not meet treatment day baseline.|2|||
130757481|NCT02447497|470732867|FG000|Overall Study|Dressing was compromised|0|||
130757482|NCT02447497|470732868|FG001|Overall Study|Dressing was compromised|1|||
130757483|NCT02447497|470732869|FG002|Overall Study|Dressing was compromised|0|||
130757484|NCT02447497|470732870|FG003|Overall Study|Dressing was compromised|0|||
130757485|NCT02017912|470732871|FG000|Overall Study|Withdrawal by Subject|2|||
130757486|NCT02017912|470732872|FG001|Overall Study|Withdrawal by Subject|1|||
130757487|NCT02017912|470732871|FG000|Overall Study|miscellaneous|1|||
130757488|NCT02017912|470732872|FG001|Overall Study|miscellaneous|1|||
130757489|NCT01322035|470732873|FG000|Overall Study|Lost to Follow-up|8|||
130757490|NCT01322035|470732874|FG001|Overall Study|Lost to Follow-up|3|||
130757491|NCT02496091|470732878|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130757492|NCT02272842|470732879|FG000|Overall Study|Lost to Follow-up|8|||
130757493|NCT02272842|470732880|FG001|Overall Study|Lost to Follow-up|8|||
130757494|NCT02272842|470732879|FG000|Overall Study|Withdrawal by Subject|8|||
130757495|NCT02272842|470732880|FG001|Overall Study|Withdrawal by Subject|2|||
130757496|NCT02396420|470732883|FG000|Overall Study|Death|1|||
130757497|NCT05033262|470732884|FG000|Overall Study|Lost to Follow-up|1|||
130757498|NCT05033262|470732885|FG001|Overall Study|Lost to Follow-up|0|||
130757499|NCT05033262|470732886|FG002|Overall Study|Lost to Follow-up|0|||
130757500|NCT05033262|470732887|FG003|Overall Study|Lost to Follow-up|1|||
130757501|NCT01273623|470732890|FG000|Overall Study|did not meet IVUS criteria|29|||
130757502|NCT01493284|470732891|FG000|Overall Study|Death|29|||
130757503|NCT01493284|470732891|FG000|Overall Study|Withdrawal by Subject|32|||
130757504|NCT00325156|470732894|FG000|Overall Study|Protocol Violation|8|||
130757505|NCT00325156|470732894|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
130757506|NCT00325156|470732894|FG000|Overall Study|Migrated/moved from study area|12|||
130757507|NCT00325156|470732894|FG000|Overall Study|Adverse event, non-fatal|3|||
130757508|NCT00325156|470732894|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
130757509|NCT00325156|470732894|FG000|Overall Study|Other|1|||
130757510|NCT00325156|470732894|FG000|Overall Study|Withdrawal by Subject|31|||
130757511|NCT00519428|470732895|FG000|Overall Study|Adverse Event|5|||
130757512|NCT00519428|470732896|FG001|Overall Study|Adverse Event|2|||
130757513|NCT00519428|470732897|FG002|Overall Study|Adverse Event|10|||
130757514|NCT00519428|470732895|FG000|Overall Study|Lost to Follow-up|7|||
130757515|NCT00519428|470732896|FG001|Overall Study|Lost to Follow-up|7|||
130757516|NCT00519428|470732897|FG002|Overall Study|Lost to Follow-up|6|||
130757517|NCT00519428|470732895|FG000|Overall Study|Withdrawal by Subject|8|||
130757518|NCT00519428|470732896|FG001|Overall Study|Withdrawal by Subject|3|||
130757519|NCT00519428|470732897|FG002|Overall Study|Withdrawal by Subject|7|||
130757520|NCT00519428|470732895|FG000|Overall Study|unstated|1|||
130757521|NCT00519428|470732896|FG001|Overall Study|unstated|3|||
130757522|NCT00519428|470732897|FG002|Overall Study|unstated|2|||
130757523|NCT04064411|470732898|FG000|Overall Study|Adverse Event|29|||
130757524|NCT04064411|470732899|FG001|Overall Study|Adverse Event|19|||
130757525|NCT04064411|470732898|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
130757526|NCT04064411|470732899|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
130757527|NCT04064411|470732898|FG000|Overall Study|Protocol Deviation|0|||
130757528|NCT04064411|470732899|FG001|Overall Study|Protocol Deviation|2|||
130757529|NCT04064411|470732898|FG000|Overall Study|Withdrawal by Subject|25|||
130757530|NCT04064411|470732899|FG001|Overall Study|Withdrawal by Subject|29|||
130757531|NCT04064411|470732898|FG000|Overall Study|Lost to Follow-up|5|||
130757532|NCT04064411|470732899|FG001|Overall Study|Lost to Follow-up|2|||
130757533|NCT04064411|470732898|FG000|Overall Study|Other than Specified|4|||
130757534|NCT04064411|470732899|FG001|Overall Study|Other than Specified|1|||
130757535|NCT04064411|470732898|FG000|Overall Study|Death|1|||
130757536|NCT04064411|470732899|FG001|Overall Study|Death|0|||
130757537|NCT03395184|470732900|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
130757538|NCT03395184|470732901|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
130757539|NCT03395184|470732902|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
130757540|NCT03395184|470732903|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130757541|NCT03395184|470732904|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130757542|NCT03395184|470732905|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130757543|NCT03395184|470732906|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130789287|NCT01673386|470858690|FG000|Overall Study|Progressive disease|4|||
130757544|NCT03395184|470732900|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130757545|NCT03395184|470732901|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
130757546|NCT03395184|470732902|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
130757547|NCT03395184|470732903|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130789288|NCT01673386|470858691|FG001|Overall Study|Progressive disease|1|||
130757548|NCT03395184|470732904|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130757549|NCT03395184|470732905|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130757550|NCT03395184|470732906|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130757551|NCT03395184|470732900|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
130757552|NCT03395184|470732901|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
130757553|NCT03395184|470732902|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130757554|NCT03395184|470732903|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130757555|NCT03395184|470732904|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130757556|NCT03395184|470732905|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130757557|NCT03395184|470732906|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130757558|NCT03395184|470732900|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130757559|NCT03395184|470732901|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
130757560|NCT03395184|470732902|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130757561|NCT03395184|470732903|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130757562|NCT03395184|470732904|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130757563|NCT03395184|470732905|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130757564|NCT03395184|470732906|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130757565|NCT03395184|470732900|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
130757566|NCT03395184|470732901|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130757567|NCT03395184|470732902|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
130757568|NCT03395184|470732903|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130757569|NCT03395184|470732904|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130757570|NCT03395184|470732905|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130757571|NCT03395184|470732906|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130757572|NCT03395184|470732900|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
130757573|NCT03395184|470732901|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
130757574|NCT03395184|470732902|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
130757575|NCT03395184|470732903|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
130757576|NCT03395184|470732904|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
130757577|NCT03395184|470732905|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
130757578|NCT03395184|470732906|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
130757579|NCT03395184|470732900|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
130757580|NCT03395184|470732901|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
130757581|NCT03395184|470732902|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
130757582|NCT03395184|470732903|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
130757583|NCT03395184|470732904|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
130757584|NCT03395184|470732905|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
130757585|NCT03395184|470732906|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
130757586|NCT03395184|470732900|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
130757587|NCT03395184|470732901|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
130757588|NCT03395184|470732902|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
130757589|NCT03395184|470732903|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
130757590|NCT03395184|470732904|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
130757591|NCT03395184|470732905|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
130757592|NCT03395184|470732906|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
130757593|NCT03395184|470732900|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130757594|NCT03395184|470732901|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130757595|NCT03395184|470732902|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130757596|NCT03395184|470732903|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130757597|NCT03395184|470732904|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
130757598|NCT03395184|470732905|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130757599|NCT03395184|470732906|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130757600|NCT03395184|470732900|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
130757601|NCT03395184|470732901|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
130757602|NCT03395184|470732902|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
130757603|NCT03395184|470732903|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
130757604|NCT03395184|470732904|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
130757605|NCT03395184|470732905|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
130789289|NCT01673386|470858690|FG000|Overall Study|Withdrawal by Subject|0|||
130789290|NCT01673386|470858691|FG001|Overall Study|Withdrawal by Subject|2|||
130789291|NCT02934178|470858692|FG000|Received Vaccination 2|Death|0|||
130789292|NCT02934178|470858693|FG001|Received Vaccination 2|Death|1|||
130789293|NCT02934178|470858692|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
130757606|NCT03395184|470732906|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
130757607|NCT03395184|470732900|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130757608|NCT03395184|470732901|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130789294|NCT02934178|470858693|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
130789295|NCT01898078|470858697|FG000|Overall Study|Progressive Disease|1|||
130789296|NCT01898078|470858698|FG001|Overall Study|Progressive Disease|5|||
130789297|NCT01898078|470858697|FG000|Overall Study|Adverse Event|2|||
130789298|NCT01898078|470858698|FG001|Overall Study|Adverse Event|1|||
130789299|NCT01898078|470858697|FG000|Overall Study|Withdrawal by Subject|1|||
130789300|NCT01898078|470858698|FG001|Overall Study|Withdrawal by Subject|1|||
130789301|NCT01898078|470858697|FG000|Overall Study|Symptomatic Deterioration|2|||
130789302|NCT01898078|470858698|FG001|Overall Study|Symptomatic Deterioration|0|||
130789303|NCT01898078|470858697|FG000|Overall Study|Reason not Specified|0|||
130789304|NCT01898078|470858698|FG001|Overall Study|Reason not Specified|1|||
130789305|NCT01075048|470858699|FG000|Overall Study|Death|4|||
130789306|NCT01075048|470858700|FG001|Overall Study|Death|17|||
130789307|NCT01075048|470858701|FG002|Overall Study|Death|12|||
130789308|NCT01075048|470858699|FG000|Overall Study|Start of other or new therapy|4|||
130789309|NCT01075048|470858700|FG001|Overall Study|Start of other or new therapy|36|||
130789310|NCT01075048|470858701|FG002|Overall Study|Start of other or new therapy|46|||
130789311|NCT01075048|470858699|FG000|Overall Study|Withdrawal by Subject|1|||
130789312|NCT01075048|470858700|FG001|Overall Study|Withdrawal by Subject|6|||
130789313|NCT01075048|470858701|FG002|Overall Study|Withdrawal by Subject|3|||
130789314|NCT01075048|470858699|FG000|Overall Study|Lost to Follow-up|0|||
130789315|NCT01075048|470858700|FG001|Overall Study|Lost to Follow-up|1|||
130789316|NCT01075048|470858701|FG002|Overall Study|Lost to Follow-up|1|||
130789317|NCT01287936|470858705|FG000|Overall Study|Lost to Follow-up|0|||
130789318|NCT01287936|470858706|FG001|Overall Study|Lost to Follow-up|1|||
130789319|NCT01287936|470858707|FG002|Overall Study|Lost to Follow-up|1|||
130789320|NCT01140906|470858708|FG000|Overall Study|Adverse Event|7|||
130789321|NCT01140906|470858709|FG001|Overall Study|Adverse Event|10|||
130789322|NCT01140906|470858710|FG002|Overall Study|Adverse Event|17|||
130789323|NCT01140906|470858711|FG003|Overall Study|Adverse Event|7|||
130789324|NCT01140906|470858708|FG000|Overall Study|Lack of Efficacy|6|||
130789325|NCT01140906|470858709|FG001|Overall Study|Lack of Efficacy|8|||
130789326|NCT01140906|470858710|FG002|Overall Study|Lack of Efficacy|2|||
130789327|NCT01140906|470858711|FG003|Overall Study|Lack of Efficacy|1|||
130789328|NCT01140906|470858708|FG000|Overall Study|Non-compliance|0|||
130789329|NCT01140906|470858709|FG001|Overall Study|Non-compliance|1|||
130789330|NCT01140906|470858710|FG002|Overall Study|Non-compliance|0|||
130789331|NCT01140906|470858711|FG003|Overall Study|Non-compliance|1|||
130789332|NCT01140906|470858708|FG000|Overall Study|Protocol Violation|5|||
130789333|NCT01140906|470858709|FG001|Overall Study|Protocol Violation|3|||
130789334|NCT01140906|470858710|FG002|Overall Study|Protocol Violation|2|||
130789335|NCT01140906|470858711|FG003|Overall Study|Protocol Violation|1|||
130789336|NCT01140906|470858708|FG000|Overall Study|Withdrawal of consent|6|||
130789337|NCT01140906|470858709|FG001|Overall Study|Withdrawal of consent|6|||
130789338|NCT01140906|470858710|FG002|Overall Study|Withdrawal of consent|2|||
130789339|NCT01140906|470858711|FG003|Overall Study|Withdrawal of consent|2|||
130789340|NCT01140906|470858708|FG000|Overall Study|Lost to Follow-up|1|||
130789341|NCT01140906|470858709|FG001|Overall Study|Lost to Follow-up|1|||
130789342|NCT01140906|470858710|FG002|Overall Study|Lost to Follow-up|0|||
130789343|NCT01140906|470858711|FG003|Overall Study|Lost to Follow-up|2|||
130789344|NCT01140906|470858708|FG000|Overall Study|Administrative or other reason|0|||
130789345|NCT01140906|470858709|FG001|Overall Study|Administrative or other reason|5|||
130789346|NCT01140906|470858710|FG002|Overall Study|Administrative or other reason|3|||
130789347|NCT01140906|470858711|FG003|Overall Study|Administrative or other reason|2|||
130789348|NCT00703534|470858712|FG000|Overall Study|Adverse Event|14|||
130789349|NCT00703534|470858713|FG001|Overall Study|Adverse Event|3|||
130789350|NCT00703534|470858712|FG000|Overall Study|Withdrawal by Subject|8|||
130789351|NCT00703534|470858713|FG001|Overall Study|Withdrawal by Subject|7|||
130789352|NCT00703534|470858712|FG000|Overall Study|Incorrect Enrollment|6|||
130789353|NCT00703534|470858713|FG001|Overall Study|Incorrect Enrollment|6|||
130789354|NCT00703534|470858712|FG000|Overall Study|Lost to Follow-up|1|||
130789355|NCT00703534|470858713|FG001|Overall Study|Lost to Follow-up|4|||
130789356|NCT00703534|470858712|FG000|Overall Study|Severe Non Compliance|1|||
130789357|NCT00703534|470858713|FG001|Overall Study|Severe Non Compliance|5|||
130789358|NCT00336544|470858714|FG000|Overall Study|Lack of Efficacy|8|||
130789359|NCT00336544|470858715|FG001|Overall Study|Lack of Efficacy|5|||
130789360|NCT00336544|470858714|FG000|Overall Study|Adverse Event|4|||
130789361|NCT00336544|470858715|FG001|Overall Study|Adverse Event|9|||
130789362|NCT00336544|470858714|FG000|Overall Study|Withdrawal by Subject|4|||
130789363|NCT00336544|470858715|FG001|Overall Study|Withdrawal by Subject|3|||
130789364|NCT00336544|470858714|FG000|Overall Study|Other|3|||
130789365|NCT00336544|470858715|FG001|Overall Study|Other|5|||
130789366|NCT01649765|470858716|FG000|Overall Study|Adverse Event|5|||
130789367|NCT01649765|470858717|FG001|Overall Study|Adverse Event|3|||
130789368|NCT01649765|470858716|FG000|Overall Study|Lack of Efficacy|1|||
130789369|NCT01649765|470858717|FG001|Overall Study|Lack of Efficacy|1|||
130789370|NCT01649765|470858716|FG000|Overall Study|Physician Decision|0|||
130789371|NCT01649765|470858717|FG001|Overall Study|Physician Decision|3|||
130789372|NCT01649765|470858716|FG000|Overall Study|Protocol Violation|1|||
130789373|NCT01649765|470858717|FG001|Overall Study|Protocol Violation|0|||
130789374|NCT01649765|470858716|FG000|Overall Study|Withdrawal by Subject|2|||
130789375|NCT01649765|470858717|FG001|Overall Study|Withdrawal by Subject|1|||
130789376|NCT00715208|470858718|FG000|Overall Study|Withdrawal by Subject|1|||
130757609|NCT03395184|470732902|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130757610|NCT03395184|470732903|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
130757611|NCT03395184|470732904|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130757612|NCT03395184|470732905|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
130757613|NCT03395184|470732906|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130757614|NCT03395184|470732900|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
130757615|NCT03395184|470732901|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
130757616|NCT03395184|470732902|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
130757617|NCT03395184|470732903|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
130757618|NCT03395184|470732904|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
130757619|NCT03395184|470732905|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
130757620|NCT03395184|470732906|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
130757621|NCT03053063|470732912|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
130757622|NCT03053063|470732913|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
130757623|NCT03053063|470732914|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
130757624|NCT03053063|470732915|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
130757625|NCT03053063|470732912|FG000|Randomized Phase|Withdrew consent|8|||
130757626|NCT03053063|470732913|FG001|Randomized Phase|Withdrew consent|11|||
130757627|NCT03053063|470732914|FG002|Randomized Phase|Withdrew consent|5|||
130757628|NCT03053063|470732915|FG003|Randomized Phase|Withdrew consent|0|||
130757629|NCT03053063|470732912|FG000|Randomized Phase|Investigator's Discretion|8|||
130757630|NCT03053063|470732913|FG001|Randomized Phase|Investigator's Discretion|6|||
130757631|NCT03053063|470732914|FG002|Randomized Phase|Investigator's Discretion|2|||
130757632|NCT03053063|470732915|FG003|Randomized Phase|Investigator's Discretion|0|||
130757633|NCT03053063|470732912|FG000|Randomized Phase|Lost to Follow-up|3|||
130757634|NCT03053063|470732913|FG001|Randomized Phase|Lost to Follow-up|5|||
130757635|NCT03053063|470732914|FG002|Randomized Phase|Lost to Follow-up|1|||
130757636|NCT03053063|470732915|FG003|Randomized Phase|Lost to Follow-up|0|||
130757637|NCT03053063|470732912|FG000|Randomized Phase|Adverse Event|0|||
130757638|NCT03053063|470732913|FG001|Randomized Phase|Adverse Event|1|||
130757639|NCT03053063|470732914|FG002|Randomized Phase|Adverse Event|0|||
130757640|NCT03053063|470732915|FG003|Randomized Phase|Adverse Event|0|||
130757641|NCT03053063|470732912|FG000|Randomized Phase|Randomized but Never Treated|1|||
130757642|NCT03053063|470732913|FG001|Randomized Phase|Randomized but Never Treated|3|||
130757643|NCT03053063|470732914|FG002|Randomized Phase|Randomized but Never Treated|2|||
130757644|NCT03053063|470732915|FG003|Randomized Phase|Randomized but Never Treated|0|||
130757645|NCT03053063|470732912|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
130757646|NCT03053063|470732913|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
130757647|NCT03053063|470732914|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
130757648|NCT03053063|470732915|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
130757649|NCT03053063|470732912|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
130757650|NCT03053063|470732913|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
130757651|NCT03053063|470732914|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
130757652|NCT03053063|470732915|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
130757653|NCT03053063|470732912|FG000|Open-Label Phase|Death|0|||
130757654|NCT03053063|470732913|FG001|Open-Label Phase|Death|0|||
130757655|NCT03053063|470732914|FG002|Open-Label Phase|Death|0|||
130757656|NCT03053063|470732915|FG003|Open-Label Phase|Death|2|||
130757657|NCT03053063|470732912|FG000|Open-Label Phase|Investigator's discretion|0|||
130757658|NCT03053063|470732913|FG001|Open-Label Phase|Investigator's discretion|0|||
130757659|NCT03053063|470732914|FG002|Open-Label Phase|Investigator's discretion|0|||
130757660|NCT03053063|470732915|FG003|Open-Label Phase|Investigator's discretion|2|||
130757661|NCT01970475|470732917|FG000|Overall Study|Withdrawal by Subject|11|||
130757662|NCT01970475|470732918|FG001|Overall Study|Withdrawal by Subject|6|||
130757663|NCT01970475|470732917|FG000|Overall Study|Adverse Event|7|||
130757664|NCT01970475|470732918|FG001|Overall Study|Adverse Event|3|||
130757665|NCT01970475|470732917|FG000|Overall Study|Lost to Follow-up|2|||
130757666|NCT01970475|470732918|FG001|Overall Study|Lost to Follow-up|2|||
130757667|NCT01970475|470732917|FG000|Overall Study|Protocol Violation|1|||
130757668|NCT01970475|470732918|FG001|Overall Study|Protocol Violation|0|||
130757669|NCT01397786|470735905|FG000|Phase A|Lost to Follow-up|0|||
130757670|NCT01397786|470735906|FG001|Phase A|Lost to Follow-up|0|||
130757671|NCT01397786|470735907|FG002|Phase A|Lost to Follow-up|6|||
130789377|NCT00715208|470858719|FG001|Overall Study|Withdrawal by Subject|1|||
130757672|NCT01397786|470735905|FG000|Phase A|Adverse Event|0|||
130757673|NCT01397786|470735906|FG001|Phase A|Adverse Event|0|||
130757674|NCT01397786|470735907|FG002|Phase A|Adverse Event|8|||
130757675|NCT01397786|470735905|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
130757676|NCT01397786|470735906|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
130757677|NCT01397786|470735907|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
130757678|NCT01397786|470735905|FG000|Phase A|Physician Decision|0|||
130757679|NCT01397786|470735906|FG001|Phase A|Physician Decision|0|||
130757680|NCT01397786|470735907|FG002|Phase A|Physician Decision|1|||
130757681|NCT01397786|470735905|FG000|Phase A|Withdrawal by Subject|0|||
130757682|NCT01397786|470735906|FG001|Phase A|Withdrawal by Subject|0|||
130757683|NCT01397786|470735907|FG002|Phase A|Withdrawal by Subject|5|||
130757684|NCT01397786|470735905|FG000|Phase A|Lack of Efficacy|0|||
130757685|NCT01397786|470735906|FG001|Phase A|Lack of Efficacy|0|||
130757686|NCT01397786|470735907|FG002|Phase A|Lack of Efficacy|1|||
130757687|NCT01397786|470735905|FG000|Phase B|Lost to Follow-up|22|||
130757688|NCT01397786|470735906|FG001|Phase B|Lost to Follow-up|12|||
130757689|NCT01397786|470735907|FG002|Phase B|Lost to Follow-up|22|||
130757690|NCT01397786|470735905|FG000|Phase B|Adverse Event|109|||
130757691|NCT01397786|470735906|FG001|Phase B|Adverse Event|23|||
130757692|NCT01397786|470735907|FG002|Phase B|Adverse Event|27|||
130757693|NCT01397786|470735905|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
130757694|NCT01397786|470735906|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
130757695|NCT01397786|470735907|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
130757696|NCT01397786|470735905|FG000|Phase B|Physician Decision|9|||
130757697|NCT01397786|470735906|FG001|Phase B|Physician Decision|1|||
130757698|NCT01397786|470735907|FG002|Phase B|Physician Decision|3|||
130757699|NCT01397786|470735905|FG000|Phase B|Withdrawal by Subject|102|||
130757700|NCT01397786|470735906|FG001|Phase B|Withdrawal by Subject|45|||
130757701|NCT01397786|470735907|FG002|Phase B|Withdrawal by Subject|30|||
130757702|NCT01397786|470735905|FG000|Phase B|Protocol Deviation|1|||
130757703|NCT01397786|470735906|FG001|Phase B|Protocol Deviation|2|||
130757704|NCT01397786|470735907|FG002|Phase B|Protocol Deviation|4|||
130757705|NCT01397786|470735905|FG000|Phase B|Lack of Efficacy|22|||
130757706|NCT01397786|470735906|FG001|Phase B|Lack of Efficacy|7|||
130757707|NCT01397786|470735907|FG002|Phase B|Lack of Efficacy|14|||
130757708|NCT03339726|470735910|FG000|Overall Study|Withdrawal by Subject|1|||
130757709|NCT03339726|470735911|FG001|Overall Study|Withdrawal by Subject|0|||
130757710|NCT03339726|470735912|FG002|Overall Study|Withdrawal by Subject|0|||
130757711|NCT03339726|470735910|FG000|Overall Study|Lost to Follow-up|0|||
130757712|NCT03339726|470735911|FG001|Overall Study|Lost to Follow-up|1|||
130757713|NCT03339726|470735912|FG002|Overall Study|Lost to Follow-up|0|||
130757714|NCT01275755|470735913|FG000|Double-blind Treatment Period|Adverse Event|0|||
130757715|NCT01275755|470735914|FG001|Double-blind Treatment Period|Adverse Event|2|||
130757716|NCT01275755|470735913|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130757717|NCT01275755|470735914|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
130757718|NCT01275755|470735913|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130757719|NCT01275755|470735914|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130757720|NCT01275755|470735913|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
130757721|NCT01275755|470735914|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
130757722|NCT00636194|470735921|FG000|Overall Study|Study related symptoms and complaints|1|||
130757723|NCT00636194|470735922|FG001|Overall Study|Study related symptoms and complaints|0|||
130757724|NCT00636194|470735921|FG000|Overall Study|Protocol Violation|2|||
130757725|NCT00636194|470735922|FG001|Overall Study|Protocol Violation|0|||
130757726|NCT03962790|470735926|FG000|Period 1|Adverse Event|0|||
130757727|NCT03962790|470735927|FG001|Period 1|Adverse Event|1|||
130757728|NCT03962790|470735926|FG000|Period 1|Failed to meet all eligibility criteria|1|||
130757729|NCT03962790|470735927|FG001|Period 1|Failed to meet all eligibility criteria|1|||
130757730|NCT03962790|470735926|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
130757731|NCT03962790|470735927|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
130757732|NCT03962790|470735926|FG000|Period 1|Withdrawal by Subject|1|||
130757733|NCT03962790|470735927|FG001|Period 1|Withdrawal by Subject|0|||
130757734|NCT00381238|470735930|FG000|Overall Study|Adverse Event|3|||
130757735|NCT00381238|470735930|FG000|Overall Study|Protocol Violation|1|||
130757736|NCT00381238|470735930|FG000|Overall Study|Withdrawal by Subject|4|||
130757737|NCT00381238|470735930|FG000|Overall Study|Lack of Efficacy|2|||
130757738|NCT00381238|470735930|FG000|Overall Study|Withdrew by physician|1|||
130757739|NCT00381238|470735930|FG000|Overall Study|Disease progression|1|||
130757740|NCT02086448|470735933|FG000|Overall Study|Withdrawal by Subject|1|||
130757741|NCT02086448|470735934|FG001|Overall Study|Withdrawal by Subject|0|||
130757742|NCT02086448|470735935|FG002|Overall Study|Withdrawal by Subject|0|||
130757743|NCT02086448|470735936|FG003|Overall Study|Withdrawal by Subject|2|||
130757744|NCT03535194|470735937|FG000|Induction Period|Adverse Event|2|||
130757745|NCT03535194|470735938|FG001|Induction Period|Adverse Event|2|||
130757746|NCT03535194|470735939|FG002|Induction Period|Adverse Event|1|||
130757747|NCT03535194|470735940|FG003|Induction Period|Adverse Event|3|||
130757748|NCT03535194|470735941|FG004|Induction Period|Adverse Event|0|||
130757749|NCT03535194|470735937|FG000|Induction Period|Death|0|||
130757750|NCT03535194|470735938|FG001|Induction Period|Death|1|||
130757751|NCT03535194|470735939|FG002|Induction Period|Death|0|||
130757752|NCT03535194|470735940|FG003|Induction Period|Death|0|||
130757753|NCT03535194|470735941|FG004|Induction Period|Death|0|||
130757754|NCT03535194|470735937|FG000|Induction Period|Lack of Efficacy|1|||
130757755|NCT03535194|470735938|FG001|Induction Period|Lack of Efficacy|3|||
130757756|NCT03535194|470735939|FG002|Induction Period|Lack of Efficacy|2|||
130757757|NCT03535194|470735940|FG003|Induction Period|Lack of Efficacy|2|||
130757758|NCT03535194|470735941|FG004|Induction Period|Lack of Efficacy|0|||
130757759|NCT03535194|470735937|FG000|Induction Period|Lost to Follow-up|3|||
130757760|NCT03535194|470735938|FG001|Induction Period|Lost to Follow-up|5|||
130757761|NCT03535194|470735939|FG002|Induction Period|Lost to Follow-up|2|||
130757762|NCT03535194|470735940|FG003|Induction Period|Lost to Follow-up|3|||
130757763|NCT03535194|470735941|FG004|Induction Period|Lost to Follow-up|0|||
130757764|NCT03535194|470735937|FG000|Induction Period|Physician Decision|1|||
130757765|NCT03535194|470735938|FG001|Induction Period|Physician Decision|1|||
130757766|NCT03535194|470735939|FG002|Induction Period|Physician Decision|0|||
130757767|NCT03535194|470735940|FG003|Induction Period|Physician Decision|0|||
130757768|NCT03535194|470735941|FG004|Induction Period|Physician Decision|0|||
130757769|NCT03535194|470735937|FG000|Induction Period|Protocol Violation|1|||
130757770|NCT03535194|470735938|FG001|Induction Period|Protocol Violation|0|||
130757771|NCT03535194|470735939|FG002|Induction Period|Protocol Violation|0|||
130757772|NCT03535194|470735940|FG003|Induction Period|Protocol Violation|1|||
130757773|NCT03535194|470735941|FG004|Induction Period|Protocol Violation|0|||
130757774|NCT03535194|470735937|FG000|Induction Period|Screen Failure|0|||
130757775|NCT03535194|470735938|FG001|Induction Period|Screen Failure|1|||
130757776|NCT03535194|470735939|FG002|Induction Period|Screen Failure|0|||
130757777|NCT03535194|470735940|FG003|Induction Period|Screen Failure|0|||
130757778|NCT03535194|470735941|FG004|Induction Period|Screen Failure|0|||
130757779|NCT03535194|470735937|FG000|Induction Period|Withdrawal by Subject|3|||
130757780|NCT03535194|470735938|FG001|Induction Period|Withdrawal by Subject|4|||
130757781|NCT03535194|470735939|FG002|Induction Period|Withdrawal by Subject|3|||
130757782|NCT03535194|470735940|FG003|Induction Period|Withdrawal by Subject|2|||
130757783|NCT03535194|470735941|FG004|Induction Period|Withdrawal by Subject|0|||
130757784|NCT03535194|470735937|FG000|Maintenance Period|Adverse Event|6|||
130757785|NCT03535194|470735938|FG001|Maintenance Period|Adverse Event|5|||
130757786|NCT03535194|470735939|FG002|Maintenance Period|Adverse Event|1|||
130757787|NCT03535194|470735940|FG003|Maintenance Period|Adverse Event|11|||
130757788|NCT03535194|470735941|FG004|Maintenance Period|Adverse Event|4|||
130757789|NCT03535194|470735937|FG000|Maintenance Period|Lack of Efficacy|3|||
130757790|NCT03535194|470735938|FG001|Maintenance Period|Lack of Efficacy|2|||
130757791|NCT03535194|470735939|FG002|Maintenance Period|Lack of Efficacy|5|||
130757792|NCT03535194|470735940|FG003|Maintenance Period|Lack of Efficacy|9|||
130757793|NCT03535194|470735941|FG004|Maintenance Period|Lack of Efficacy|0|||
130757794|NCT03535194|470735937|FG000|Maintenance Period|Lost to Follow-up|4|||
130757795|NCT03535194|470735938|FG001|Maintenance Period|Lost to Follow-up|2|||
130757796|NCT03535194|470735939|FG002|Maintenance Period|Lost to Follow-up|1|||
130757797|NCT03535194|470735940|FG003|Maintenance Period|Lost to Follow-up|5|||
130757798|NCT03535194|470735941|FG004|Maintenance Period|Lost to Follow-up|2|||
130757799|NCT03535194|470735937|FG000|Maintenance Period|Other|1|||
130757800|NCT03535194|470735938|FG001|Maintenance Period|Other|2|||
130757801|NCT03535194|470735939|FG002|Maintenance Period|Other|0|||
130757802|NCT03535194|470735940|FG003|Maintenance Period|Other|0|||
130757803|NCT03535194|470735941|FG004|Maintenance Period|Other|0|||
130757804|NCT03535194|470735937|FG000|Maintenance Period|Physician Decision|1|||
130757805|NCT03535194|470735938|FG001|Maintenance Period|Physician Decision|2|||
130757806|NCT03535194|470735939|FG002|Maintenance Period|Physician Decision|0|||
130757807|NCT03535194|470735940|FG003|Maintenance Period|Physician Decision|2|||
130757808|NCT03535194|470735941|FG004|Maintenance Period|Physician Decision|0|||
130757809|NCT03535194|470735937|FG000|Maintenance Period|Pregnancy|0|||
130757810|NCT03535194|470735938|FG001|Maintenance Period|Pregnancy|0|||
130757811|NCT03535194|470735939|FG002|Maintenance Period|Pregnancy|0|||
130757812|NCT03535194|470735940|FG003|Maintenance Period|Pregnancy|2|||
130757813|NCT03535194|470735941|FG004|Maintenance Period|Pregnancy|0|||
130757814|NCT03535194|470735937|FG000|Maintenance Period|Protocol Violation|0|||
130757815|NCT03535194|470735938|FG001|Maintenance Period|Protocol Violation|1|||
130757816|NCT03535194|470735939|FG002|Maintenance Period|Protocol Violation|0|||
130757817|NCT03535194|470735940|FG003|Maintenance Period|Protocol Violation|0|||
130757818|NCT03535194|470735941|FG004|Maintenance Period|Protocol Violation|0|||
130757819|NCT03535194|470735937|FG000|Maintenance Period|Withdrawal by Subject|7|||
130757820|NCT03535194|470735938|FG001|Maintenance Period|Withdrawal by Subject|2|||
130757821|NCT03535194|470735939|FG002|Maintenance Period|Withdrawal by Subject|1|||
130757822|NCT03535194|470735940|FG003|Maintenance Period|Withdrawal by Subject|8|||
130757823|NCT03535194|470735941|FG004|Maintenance Period|Withdrawal by Subject|0|||
130757824|NCT03535194|470735937|FG000|Post-Treatment Followup Period|Adverse Event|4|||
130757825|NCT03535194|470735938|FG001|Post-Treatment Followup Period|Adverse Event|5|||
130757826|NCT03535194|470735939|FG002|Post-Treatment Followup Period|Adverse Event|1|||
130757827|NCT03535194|470735940|FG003|Post-Treatment Followup Period|Adverse Event|8|||
130757828|NCT03535194|470735941|FG004|Post-Treatment Followup Period|Adverse Event|0|||
130757829|NCT03535194|470735937|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
130757830|NCT03535194|470735938|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
130757831|NCT03535194|470735939|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
130757832|NCT03535194|470735940|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
130757833|NCT03535194|470735941|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
130757834|NCT03535194|470735937|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
130757835|NCT03535194|470735938|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
130757836|NCT03535194|470735939|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
130789378|NCT00715208|470858718|FG000|Overall Study|Adverse Event|0|||
130789379|NCT00715208|470858719|FG001|Overall Study|Adverse Event|6|||
130789380|NCT00715208|470858718|FG000|Overall Study|Lack of Efficacy|0|||
130789381|NCT00715208|470858719|FG001|Overall Study|Lack of Efficacy|2|||
130757837|NCT03535194|470735940|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
130757838|NCT03535194|470735941|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
130757839|NCT03535194|470735937|FG000|Post-Treatment Followup Period|Other|1|||
130757840|NCT03535194|470735938|FG001|Post-Treatment Followup Period|Other|0|||
130757841|NCT03535194|470735939|FG002|Post-Treatment Followup Period|Other|0|||
130757842|NCT03535194|470735940|FG003|Post-Treatment Followup Period|Other|5|||
130757843|NCT03535194|470735941|FG004|Post-Treatment Followup Period|Other|0|||
130757844|NCT03535194|470735937|FG000|Post-Treatment Followup Period|Physician Decision|0|||
130757845|NCT03535194|470735938|FG001|Post-Treatment Followup Period|Physician Decision|2|||
130757846|NCT03535194|470735939|FG002|Post-Treatment Followup Period|Physician Decision|1|||
130757847|NCT03535194|470735940|FG003|Post-Treatment Followup Period|Physician Decision|1|||
130757848|NCT03535194|470735941|FG004|Post-Treatment Followup Period|Physician Decision|0|||
130757849|NCT03535194|470735937|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
130757850|NCT03535194|470735938|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
130757851|NCT03535194|470735939|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
130757852|NCT03535194|470735940|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
130757853|NCT03535194|470735941|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130757854|NCT02682823|470735944|FG000|Overall Study|Withdrawal by Subject|0|||
130757855|NCT02682823|470735945|FG001|Overall Study|Withdrawal by Subject|0|||
130757856|NCT02682823|470735946|FG002|Overall Study|Withdrawal by Subject|1|||
130757857|NCT02682823|470735947|FG003|Overall Study|Withdrawal by Subject|0|||
130757858|NCT02682823|470735948|FG004|Overall Study|Withdrawal by Subject|1|||
130757859|NCT02682823|470735944|FG000|Overall Study|Protocol Deviation|0|||
130757860|NCT02682823|470735945|FG001|Overall Study|Protocol Deviation|1|||
130757861|NCT02682823|470735946|FG002|Overall Study|Protocol Deviation|0|||
130757862|NCT02682823|470735947|FG003|Overall Study|Protocol Deviation|0|||
130757863|NCT02682823|470735948|FG004|Overall Study|Protocol Deviation|0|||
130757864|NCT02682823|470735944|FG000|Overall Study|Adverse Event|0|||
130757865|NCT02682823|470735945|FG001|Overall Study|Adverse Event|0|||
130757866|NCT02682823|470735946|FG002|Overall Study|Adverse Event|0|||
130757867|NCT02682823|470735947|FG003|Overall Study|Adverse Event|1|||
130757868|NCT02682823|470735948|FG004|Overall Study|Adverse Event|0|||
130757869|NCT01938430|470735949|FG000|Overall Study|Randomized but Not Treated|0|||
130757870|NCT01938430|470735950|FG001|Overall Study|Randomized but Not Treated|0|||
130757871|NCT01938430|470735951|FG002|Overall Study|Randomized but Not Treated|0|||
130757872|NCT01938430|470735952|FG003|Overall Study|Randomized but Not Treated|0|||
130757873|NCT01938430|470735953|FG004|Overall Study|Randomized but Not Treated|0|||
130757874|NCT01938430|470735954|FG005|Overall Study|Randomized but Not Treated|0|||
130757875|NCT01938430|470735955|FG006|Overall Study|Randomized but Not Treated|0|||
130757876|NCT01938430|470735956|FG007|Overall Study|Randomized but Not Treated|0|||
130757877|NCT01938430|470735957|FG008|Overall Study|Randomized but Not Treated|0|||
130757878|NCT01938430|470735958|FG009|Overall Study|Randomized but Not Treated|0|||
130757879|NCT01938430|470735959|FG010|Overall Study|Randomized but Not Treated|1|||
130757880|NCT01938430|470735960|FG011|Overall Study|Randomized but Not Treated|0|||
130757881|NCT01938430|470735961|FG012|Overall Study|Randomized but Not Treated|0|||
130757882|NCT01938430|470735962|FG013|Overall Study|Randomized but Not Treated|1|||
130757883|NCT01938430|470735949|FG000|Overall Study|Adverse Event|0|||
130757884|NCT01938430|470735950|FG001|Overall Study|Adverse Event|0|||
130757885|NCT01938430|470735951|FG002|Overall Study|Adverse Event|0|||
130757886|NCT01938430|470735952|FG003|Overall Study|Adverse Event|0|||
130757887|NCT01938430|470735953|FG004|Overall Study|Adverse Event|0|||
130757888|NCT01938430|470735954|FG005|Overall Study|Adverse Event|0|||
130757889|NCT01938430|470735955|FG006|Overall Study|Adverse Event|1|||
130757890|NCT01938430|470735956|FG007|Overall Study|Adverse Event|0|||
130757891|NCT01938430|470735957|FG008|Overall Study|Adverse Event|0|||
130789382|NCT01648764|470858720|FG000|Overall Study|Progressive Disease|0|||
130789383|NCT01648764|470858721|FG001|Overall Study|Progressive Disease|1|||
130757892|NCT01938430|470735958|FG009|Overall Study|Adverse Event|0|||
130757893|NCT01938430|470735959|FG010|Overall Study|Adverse Event|0|||
130757894|NCT01938430|470735960|FG011|Overall Study|Adverse Event|0|||
130757895|NCT01938430|470735961|FG012|Overall Study|Adverse Event|0|||
130757896|NCT01938430|470735962|FG013|Overall Study|Adverse Event|0|||
130757897|NCT01938430|470735949|FG000|Overall Study|Death|1|||
130757898|NCT01938430|470735950|FG001|Overall Study|Death|2|||
130757899|NCT01938430|470735951|FG002|Overall Study|Death|2|||
130757900|NCT01938430|470735952|FG003|Overall Study|Death|1|||
130757901|NCT01938430|470735953|FG004|Overall Study|Death|0|||
130757902|NCT01938430|470735954|FG005|Overall Study|Death|0|||
130789384|NCT01648764|470858722|FG002|Overall Study|Progressive Disease|0|||
130757903|NCT01938430|470735955|FG006|Overall Study|Death|1|||
130757904|NCT01938430|470735956|FG007|Overall Study|Death|1|||
130757905|NCT01938430|470735957|FG008|Overall Study|Death|2|||
130757906|NCT01938430|470735958|FG009|Overall Study|Death|3|||
130757907|NCT01938430|470735959|FG010|Overall Study|Death|0|||
130757908|NCT01938430|470735960|FG011|Overall Study|Death|0|||
130757909|NCT01938430|470735961|FG012|Overall Study|Death|0|||
130757910|NCT01938430|470735962|FG013|Overall Study|Death|0|||
130757911|NCT01938430|470735949|FG000|Overall Study|Investigator's Discretion|0|||
130757912|NCT01938430|470735950|FG001|Overall Study|Investigator's Discretion|0|||
130757913|NCT01938430|470735951|FG002|Overall Study|Investigator's Discretion|1|||
130757914|NCT01938430|470735952|FG003|Overall Study|Investigator's Discretion|0|||
130757915|NCT01938430|470735953|FG004|Overall Study|Investigator's Discretion|0|||
130757916|NCT01938430|470735954|FG005|Overall Study|Investigator's Discretion|0|||
130757917|NCT01938430|470735955|FG006|Overall Study|Investigator's Discretion|0|||
130757918|NCT01938430|470735956|FG007|Overall Study|Investigator's Discretion|0|||
130757919|NCT01938430|470735957|FG008|Overall Study|Investigator's Discretion|0|||
130757920|NCT01938430|470735958|FG009|Overall Study|Investigator's Discretion|0|||
130757921|NCT01938430|470735959|FG010|Overall Study|Investigator's Discretion|0|||
130757922|NCT01938430|470735960|FG011|Overall Study|Investigator's Discretion|0|||
130757923|NCT01938430|470735961|FG012|Overall Study|Investigator's Discretion|0|||
130757924|NCT01938430|470735962|FG013|Overall Study|Investigator's Discretion|0|||
130757925|NCT01938430|470735949|FG000|Overall Study|Lack of Efficacy|3|||
130757926|NCT01938430|470735950|FG001|Overall Study|Lack of Efficacy|1|||
130757927|NCT01938430|470735951|FG002|Overall Study|Lack of Efficacy|1|||
130757928|NCT01938430|470735952|FG003|Overall Study|Lack of Efficacy|1|||
130757929|NCT01938430|470735953|FG004|Overall Study|Lack of Efficacy|0|||
130757930|NCT01938430|470735954|FG005|Overall Study|Lack of Efficacy|0|||
130757931|NCT01938430|470735955|FG006|Overall Study|Lack of Efficacy|0|||
130757932|NCT01938430|470735956|FG007|Overall Study|Lack of Efficacy|0|||
130757933|NCT01938430|470735957|FG008|Overall Study|Lack of Efficacy|1|||
130757934|NCT01938430|470735958|FG009|Overall Study|Lack of Efficacy|0|||
130757935|NCT01938430|470735959|FG010|Overall Study|Lack of Efficacy|2|||
130757936|NCT01938430|470735960|FG011|Overall Study|Lack of Efficacy|1|||
130757937|NCT01938430|470735961|FG012|Overall Study|Lack of Efficacy|0|||
130757938|NCT01938430|470735962|FG013|Overall Study|Lack of Efficacy|0|||
130757939|NCT01938430|470735949|FG000|Overall Study|Lost to Follow-up|0|||
130757940|NCT01938430|470735950|FG001|Overall Study|Lost to Follow-up|0|||
130757941|NCT01938430|470735951|FG002|Overall Study|Lost to Follow-up|1|||
130757942|NCT01938430|470735952|FG003|Overall Study|Lost to Follow-up|0|||
130757943|NCT01938430|470735953|FG004|Overall Study|Lost to Follow-up|0|||
130757944|NCT01938430|470735954|FG005|Overall Study|Lost to Follow-up|1|||
130757945|NCT01938430|470735955|FG006|Overall Study|Lost to Follow-up|0|||
130757946|NCT01938430|470735956|FG007|Overall Study|Lost to Follow-up|0|||
130757947|NCT01938430|470735957|FG008|Overall Study|Lost to Follow-up|0|||
130757948|NCT01938430|470735958|FG009|Overall Study|Lost to Follow-up|0|||
130757949|NCT01938430|470735959|FG010|Overall Study|Lost to Follow-up|0|||
130757950|NCT01938430|470735960|FG011|Overall Study|Lost to Follow-up|0|||
130757951|NCT01938430|470735961|FG012|Overall Study|Lost to Follow-up|0|||
130757952|NCT01938430|470735962|FG013|Overall Study|Lost to Follow-up|0|||
130757953|NCT01938430|470735949|FG000|Overall Study|Withdrew Consent|0|||
130757954|NCT01938430|470735950|FG001|Overall Study|Withdrew Consent|0|||
130757955|NCT01938430|470735951|FG002|Overall Study|Withdrew Consent|0|||
130757956|NCT01938430|470735952|FG003|Overall Study|Withdrew Consent|0|||
130757957|NCT01938430|470735953|FG004|Overall Study|Withdrew Consent|0|||
130757958|NCT01938430|470735954|FG005|Overall Study|Withdrew Consent|0|||
130757959|NCT01938430|470735955|FG006|Overall Study|Withdrew Consent|0|||
130757960|NCT01938430|470735956|FG007|Overall Study|Withdrew Consent|0|||
130757961|NCT01938430|470735957|FG008|Overall Study|Withdrew Consent|1|||
130757962|NCT01938430|470735958|FG009|Overall Study|Withdrew Consent|0|||
130757963|NCT01938430|470735959|FG010|Overall Study|Withdrew Consent|0|||
130757964|NCT01938430|470735960|FG011|Overall Study|Withdrew Consent|0|||
130757965|NCT01938430|470735961|FG012|Overall Study|Withdrew Consent|0|||
130757966|NCT01938430|470735962|FG013|Overall Study|Withdrew Consent|0|||
130757967|NCT02662764|470735970|FG000|Overall Study|Adverse Event|6|||
130757968|NCT02662764|470735970|FG000|Overall Study|Lack of Efficacy|8|||
130757969|NCT02662764|470735970|FG000|Overall Study|Protocol Violation|1|||
130757970|NCT02662764|470735970|FG000|Overall Study|Withdrawal by Subject|5|||
130757971|NCT02662764|470735970|FG000|Overall Study|Device failure|4|||
130757972|NCT02662764|470735970|FG000|Overall Study|Patient changed treatment|1|||
130757973|NCT02662764|470735970|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
130757974|NCT05178641|470735971|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
130757975|NCT05178641|470735972|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
130757976|NCT05178641|470735971|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
130757977|NCT05178641|470735972|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
130757978|NCT01869699|470735973|FG000|Overall Study|Withdrawal by Subject|1|||
130757979|NCT01869699|470735974|FG001|Overall Study|Withdrawal by Subject|0|||
130757980|NCT00732758|470735975|FG000|Overall Study|Lost to Follow-up|8|||
130757981|NCT00732758|470735976|FG001|Overall Study|Lost to Follow-up|16|||
130757982|NCT04240457|470735979|FG000|Overall Study|Lost to Follow-up|5|||
130757983|NCT04240457|470735980|FG001|Overall Study|Lost to Follow-up|1|||
130757984|NCT01508130|470735984|FG000|Overall Study|Adverse Event|81|||
130757985|NCT01508130|470735985|FG001|Overall Study|Adverse Event|28|||
130757986|NCT01508130|470735984|FG000|Overall Study|Death|3|||
130757987|NCT01508130|470735985|FG001|Overall Study|Death|1|||
130757988|NCT01508130|470735984|FG000|Overall Study|Protocol Violation|2|||
130757989|NCT01508130|470735985|FG001|Overall Study|Protocol Violation|0|||
130757990|NCT01508130|470735984|FG000|Overall Study|Lost to Follow-up|25|||
130757991|NCT01508130|470735985|FG001|Overall Study|Lost to Follow-up|2|||
130757992|NCT01508130|470735984|FG000|Overall Study|Withdrawal by Subject|3|||
130757993|NCT01508130|470735985|FG001|Overall Study|Withdrawal by Subject|3|||
130757994|NCT01508130|470735984|FG000|Overall Study|Subject's substantial non-compliance|25|||
130757995|NCT01508130|470735985|FG001|Overall Study|Subject's substantial non-compliance|9|||
130757996|NCT01508130|470735984|FG000|Overall Study|Insufficient therapeutic response|74|||
130757997|NCT01508130|470735985|FG001|Overall Study|Insufficient therapeutic response|23|||
130757998|NCT01508130|470735984|FG000|Overall Study|Administrative|14|||
130757999|NCT01508130|470735985|FG001|Overall Study|Administrative|3|||
130758000|NCT01680159|470735986|FG000|Screening Period|Not meet criteria for dose-up period|7|||
130758001|NCT01680159|470735986|FG000|Increased Dose Period|Adverse Event|6|||
130758002|NCT01680159|470735986|FG000|Increased Dose Period|Withdrawal by Subject|2|||
130758003|NCT01252563|470735992|FG000|Overall Study|Contract Deviation|41|||
130758004|NCT01252563|470735992|FG000|Overall Study|Centralized Registration Deviation|30|||
130758005|NCT01252563|470735992|FG000|Overall Study|Lost to Follow-up|161|||
130758006|NCT01252563|470735992|FG000|Overall Study|No visit after first day of treatment|194|||
130758007|NCT01252563|470735992|FG000|Overall Study|No drug administration|6|||
130758008|NCT03429244|470735993|FG000|Overall Study|Withdrawal by Subject|2|||
130758009|NCT03429244|470735994|FG001|Overall Study|Withdrawal by Subject|1|||
130758010|NCT03429244|470735995|FG002|Overall Study|Withdrawal by Subject|1|||
130758011|NCT03843632|470736003|FG000|Overall Study|Withdrawal by Subject|1|||
130758012|NCT03843632|470736004|FG001|Overall Study|Withdrawal by Subject|0|||
130758013|NCT03843632|470736005|FG002|Overall Study|Withdrawal by Subject|0|||
130758014|NCT03843632|470736006|FG003|Overall Study|Withdrawal by Subject|0|||
130758015|NCT03403751|470736007|FG000|Overall Study|Death|5|||
130758016|NCT03403751|470736008|FG001|Overall Study|Death|6|||
130758017|NCT03403751|470736007|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
130758018|NCT03403751|470736008|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
130758019|NCT01820572|470736009|FG000|Randomization|Not Treated|2|||
130758020|NCT01820572|470736010|FG001|Randomization|Not Treated|1|||
130758021|NCT01820572|470736009|FG000|Treatment Period|Adverse Event|12|||
130758022|NCT01820572|470736010|FG001|Treatment Period|Adverse Event|7|||
130758023|NCT01820572|470736009|FG000|Treatment Period|Death|3|||
130758024|NCT01820572|470736010|FG001|Treatment Period|Death|3|||
130758025|NCT01820572|470736009|FG000|Treatment Period|Lack of Efficacy|1|||
130758026|NCT01820572|470736010|FG001|Treatment Period|Lack of Efficacy|0|||
130758027|NCT01820572|470736009|FG000|Treatment Period|poor/non compliance|0|||
130758028|NCT01820572|470736010|FG001|Treatment Period|poor/non compliance|3|||
130758029|NCT01820572|470736009|FG000|Treatment Period|request to discontinue|6|||
130758030|NCT01820572|470736010|FG001|Treatment Period|request to discontinue|11|||
130758031|NCT01820572|470736009|FG000|Treatment Period|No longer meets study criteria|3|||
130758032|NCT01820572|470736010|FG001|Treatment Period|No longer meets study criteria|10|||
130758033|NCT01820572|470736009|FG000|Treatment Period|withdrew consent|1|||
130758034|NCT01820572|470736010|FG001|Treatment Period|withdrew consent|2|||
130758035|NCT05036668|470736011|FG000|Overall Study|lost to follow Up|0|||
130758036|NCT05036668|470736012|FG001|Overall Study|lost to follow Up|0|||
130758037|NCT05036668|470736013|FG002|Overall Study|lost to follow Up|1|||
130758038|NCT00658775|470736016|FG000|Overall Study|Adverse Event|4|||
130758039|NCT00658775|470736017|FG001|Overall Study|Adverse Event|6|||
130758040|NCT00658775|470736016|FG000|Overall Study|Lost to Follow-up|17|||
130758041|NCT00658775|470736017|FG001|Overall Study|Lost to Follow-up|18|||
130758042|NCT00658775|470736016|FG000|Overall Study|Withdrawal by Subject|6|||
130758043|NCT00658775|470736017|FG001|Overall Study|Withdrawal by Subject|4|||
130758044|NCT00658775|470736016|FG000|Overall Study|Withdrawal of consent|8|||
130758045|NCT00658775|470736017|FG001|Overall Study|Withdrawal of consent|7|||
130758046|NCT00658775|470736016|FG000|Overall Study|Other|7|||
130758047|NCT00658775|470736017|FG001|Overall Study|Other|8|||
130758048|NCT00387010|470736018|FG000|Dose Titration Period|Adverse Event|12|||
130758049|NCT00387010|470736018|FG000|Dose Titration Period|Lack of Efficacy|5|||
130758050|NCT00387010|470736018|FG000|Dose Titration Period|Withdrawal by Subject|3|||
130758051|NCT00387010|470736018|FG000|Dose Titration Period|Protocol Violation|1|||
130758052|NCT00387010|470736018|FG000|Dose Titration Period|Lost to Follow-up|2|||
130758053|NCT00387010|470736018|FG000|Dose Titration Period|Noncompliance with study medication|8|||
130758054|NCT00387010|470736018|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
130758055|NCT00387010|470736018|FG000|Treatment Period|Adverse Event|4|||
130758056|NCT00387010|470736018|FG000|Treatment Period|Withdrawal by Subject|1|||
130758057|NCT00387010|470736018|FG000|Treatment Period|Noncompliance with study medication|2|||
130758058|NCT00387010|470736018|FG000|Treatment Period|Noncompliance with study procedures|3|||
130758059|NCT00387010|470736018|FG000|Treatment Period|Participant reported study drug stolen|1|||
130758060|NCT01931956|470736023|FG000|Overall Study|Death|42|||
130758061|NCT01931956|470736024|FG001|Overall Study|Death|7|||
130758062|NCT01931956|470736025|FG002|Overall Study|Death|379|||
130758063|NCT01931956|470736026|FG003|Overall Study|Death|96|||
130758064|NCT01931956|470736023|FG000|Overall Study|Withdrawal by Subject|5|||
130758065|NCT01931956|470736024|FG001|Overall Study|Withdrawal by Subject|0|||
130758066|NCT01931956|470736025|FG002|Overall Study|Withdrawal by Subject|70|||
130758067|NCT01931956|470736026|FG003|Overall Study|Withdrawal by Subject|30|||
130758068|NCT01931956|470736023|FG000|Overall Study|Lost to Follow-up|2|||
130758069|NCT01931956|470736024|FG001|Overall Study|Lost to Follow-up|0|||
130758070|NCT01931956|470736025|FG002|Overall Study|Lost to Follow-up|11|||
130758071|NCT01931956|470736026|FG003|Overall Study|Lost to Follow-up|7|||
130758072|NCT01931956|470736023|FG000|Overall Study|Expected|2|||
130758073|NCT01931956|470736024|FG001|Overall Study|Expected|0|||
130758074|NCT01931956|470736025|FG002|Overall Study|Expected|6|||
130758075|NCT01931956|470736026|FG003|Overall Study|Expected|0|||
130758076|NCT01931956|470736023|FG000|Overall Study|Not due|0|||
130758077|NCT01931956|470736024|FG001|Overall Study|Not due|0|||
130758078|NCT01931956|470736025|FG002|Overall Study|Not due|21|||
130758079|NCT01931956|470736026|FG003|Overall Study|Not due|0|||
130758080|NCT02847494|470736031|FG000|Overall Study|Lost to Follow-up|8|||
130758081|NCT02847494|470736032|FG001|Overall Study|Lost to Follow-up|5|||
130758082|NCT01901653|470736033|FG000|Overall Study|Death|2|||
130758083|NCT01901653|470736034|FG001|Overall Study|Death|1|||
130758084|NCT01901653|470736035|FG002|Overall Study|Death|8|||
130758085|NCT01901653|470736036|FG003|Overall Study|Death|3|||
130758086|NCT01901653|470736037|FG004|Overall Study|Death|2|||
130758087|NCT01901653|470736038|FG005|Overall Study|Death|2|||
130758088|NCT01901653|470736039|FG006|Overall Study|Death|6|||
130758089|NCT01901653|470736040|FG007|Overall Study|Death|9|||
130758090|NCT01901653|470736041|FG008|Overall Study|Death|1|||
130758091|NCT01901653|470736042|FG009|Overall Study|Death|16|||
130758092|NCT01901653|470736043|FG010|Overall Study|Death|2|||
130758093|NCT01901653|470736044|FG011|Overall Study|Death|15|||
130758094|NCT01901653|470736045|FG012|Overall Study|Death|4|||
130758095|NCT01901653|470736033|FG000|Overall Study|Lost to Follow-up|1|||
130758096|NCT01901653|470736034|FG001|Overall Study|Lost to Follow-up|0|||
130758097|NCT01901653|470736035|FG002|Overall Study|Lost to Follow-up|2|||
130758098|NCT01901653|470736036|FG003|Overall Study|Lost to Follow-up|0|||
130758099|NCT01901653|470736037|FG004|Overall Study|Lost to Follow-up|0|||
130758100|NCT01901653|470736038|FG005|Overall Study|Lost to Follow-up|1|||
130758101|NCT01901653|470736039|FG006|Overall Study|Lost to Follow-up|0|||
130758102|NCT01901653|470736040|FG007|Overall Study|Lost to Follow-up|1|||
130758103|NCT01901653|470736041|FG008|Overall Study|Lost to Follow-up|0|||
130758104|NCT01901653|470736042|FG009|Overall Study|Lost to Follow-up|0|||
130758105|NCT01901653|470736043|FG010|Overall Study|Lost to Follow-up|0|||
130758106|NCT01901653|470736044|FG011|Overall Study|Lost to Follow-up|0|||
130758107|NCT01901653|470736045|FG012|Overall Study|Lost to Follow-up|0|||
130758108|NCT01901653|470736033|FG000|Overall Study|Withdrawal by Subject|0|||
130758109|NCT01901653|470736034|FG001|Overall Study|Withdrawal by Subject|0|||
130758110|NCT01901653|470736035|FG002|Overall Study|Withdrawal by Subject|0|||
130758111|NCT01901653|470736036|FG003|Overall Study|Withdrawal by Subject|0|||
130758112|NCT01901653|470736037|FG004|Overall Study|Withdrawal by Subject|0|||
130758113|NCT01901653|470736038|FG005|Overall Study|Withdrawal by Subject|0|||
130758114|NCT01901653|470736039|FG006|Overall Study|Withdrawal by Subject|1|||
130758115|NCT01901653|470736040|FG007|Overall Study|Withdrawal by Subject|0|||
130758116|NCT01901653|470736041|FG008|Overall Study|Withdrawal by Subject|0|||
130758117|NCT01901653|470736042|FG009|Overall Study|Withdrawal by Subject|0|||
130758118|NCT01901653|470736043|FG010|Overall Study|Withdrawal by Subject|0|||
130758119|NCT01901653|470736044|FG011|Overall Study|Withdrawal by Subject|0|||
130758120|NCT01901653|470736045|FG012|Overall Study|Withdrawal by Subject|0|||
130758121|NCT01901653|470736033|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
130758122|NCT01901653|470736034|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
130758123|NCT01901653|470736035|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
130758124|NCT01901653|470736036|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
130758125|NCT01901653|470736037|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
130758126|NCT01901653|470736038|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
130758127|NCT01901653|470736039|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
130758128|NCT01901653|470736040|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
130758129|NCT01901653|470736041|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
130758130|NCT01901653|470736042|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
130758131|NCT01901653|470736043|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
130758132|NCT01901653|470736044|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
130758133|NCT01901653|470736045|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
130758134|NCT02841280|470736048|FG000|Overall Study|Adverse Event|2|||
130758135|NCT02841280|470736049|FG001|Overall Study|Adverse Event|1|||
130758136|NCT02841280|470736048|FG000|Overall Study|Death|1|||
130758137|NCT02841280|470736049|FG001|Overall Study|Death|0|||
130758138|NCT02841280|470736048|FG000|Overall Study|Lost to Follow-up|2|||
130789385|NCT01648764|470858723|FG003|Overall Study|Progressive Disease|0|||
130789386|NCT01648764|470858724|FG004|Overall Study|Progressive Disease|0|||
130789387|NCT01648764|470858725|FG005|Overall Study|Progressive Disease|1|||
130789388|NCT01648764|470858726|FG006|Overall Study|Progressive Disease|1|||
130789389|NCT01648764|470858727|FG007|Overall Study|Progressive Disease|0|||
130789390|NCT01648764|470858728|FG008|Overall Study|Progressive Disease|0|||
130789391|NCT01648764|470858729|FG009|Overall Study|Progressive Disease|2|||
130789392|NCT01648764|470858730|FG010|Overall Study|Progressive Disease|0|||
130789393|NCT01648764|470858731|FG011|Overall Study|Progressive Disease|1|||
130789394|NCT01648764|470858732|FG012|Overall Study|Progressive Disease|2|||
130789395|NCT01648764|470858733|FG013|Overall Study|Progressive Disease|1|||
130789396|NCT01648764|470858720|FG000|Overall Study|Adverse Event|0|||
130789397|NCT01648764|470858721|FG001|Overall Study|Adverse Event|0|||
130789398|NCT01648764|470858722|FG002|Overall Study|Adverse Event|0|||
130789399|NCT01648764|470858723|FG003|Overall Study|Adverse Event|0|||
130789400|NCT01648764|470858724|FG004|Overall Study|Adverse Event|0|||
130789401|NCT01648764|470858725|FG005|Overall Study|Adverse Event|1|||
130789402|NCT01648764|470858726|FG006|Overall Study|Adverse Event|0|||
130789403|NCT01648764|470858727|FG007|Overall Study|Adverse Event|0|||
130789404|NCT01648764|470858728|FG008|Overall Study|Adverse Event|0|||
130789405|NCT01648764|470858729|FG009|Overall Study|Adverse Event|1|||
130789406|NCT01648764|470858730|FG010|Overall Study|Adverse Event|0|||
130789407|NCT01648764|470858731|FG011|Overall Study|Adverse Event|3|||
130789408|NCT01648764|470858732|FG012|Overall Study|Adverse Event|1|||
130789409|NCT01648764|470858733|FG013|Overall Study|Adverse Event|1|||
130789410|NCT01648764|470858720|FG000|Overall Study|Death|0|||
130789411|NCT01648764|470858721|FG001|Overall Study|Death|0|||
130789412|NCT01648764|470858722|FG002|Overall Study|Death|0|||
130789413|NCT01648764|470858723|FG003|Overall Study|Death|0|||
130789414|NCT01648764|470858724|FG004|Overall Study|Death|0|||
130789415|NCT01648764|470858725|FG005|Overall Study|Death|0|||
130789416|NCT01648764|470858726|FG006|Overall Study|Death|1|||
130789417|NCT01648764|470858727|FG007|Overall Study|Death|0|||
130789418|NCT01648764|470858728|FG008|Overall Study|Death|0|||
130758139|NCT02841280|470736049|FG001|Overall Study|Lost to Follow-up|2|||
130758140|NCT02841280|470736048|FG000|Overall Study|Withdrawal by Subject|7|||
130758141|NCT02841280|470736049|FG001|Overall Study|Withdrawal by Subject|3|||
130758142|NCT02841280|470736048|FG000|Overall Study|Stop Point: BP above threshold|2|||
130758143|NCT02841280|470736049|FG001|Overall Study|Stop Point: BP above threshold|0|||
130758144|NCT02727777|470736050|FG000|Overall Study|Screen Failure|2|||
130758145|NCT02727777|470736051|FG001|Overall Study|Screen Failure|0|||
130758146|NCT02727777|470736052|FG002|Overall Study|Screen Failure|0|||
130758147|NCT02727777|470736050|FG000|Overall Study|Progressive disease|2|||
130758148|NCT02727777|470736051|FG001|Overall Study|Progressive disease|0|||
130758149|NCT02727777|470736052|FG002|Overall Study|Progressive disease|0|||
130758150|NCT00957268|470736053|FG000|Overall Study|Voluntary Withdrawal|0|||
130758151|NCT00957268|470736054|FG001|Overall Study|Voluntary Withdrawal|0|||
130758152|NCT00957268|470736055|FG002|Overall Study|Voluntary Withdrawal|1|||
130758153|NCT00957268|470736056|FG003|Overall Study|Voluntary Withdrawal|0|||
130758154|NCT00957268|470736057|FG004|Overall Study|Voluntary Withdrawal|0|||
130758155|NCT01738503|470736059|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
130758156|NCT01738503|470736060|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
130758157|NCT01738503|470736061|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
130758158|NCT01738503|470736062|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
130758159|NCT01738503|470736063|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
130758160|NCT01738503|470736064|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
130758161|NCT01738503|470736065|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
130758162|NCT01738503|470736059|FG000|Treatment Period|Adverse Event|0|||
130758163|NCT01738503|470736060|FG001|Treatment Period|Adverse Event|1|||
130758164|NCT01738503|470736061|FG002|Treatment Period|Adverse Event|0|||
130758165|NCT01738503|470736062|FG003|Treatment Period|Adverse Event|1|||
130758166|NCT01738503|470736063|FG004|Treatment Period|Adverse Event|2|||
130758167|NCT01738503|470736064|FG005|Treatment Period|Adverse Event|2|||
130758168|NCT01738503|470736065|FG006|Treatment Period|Adverse Event|2|||
130758169|NCT01738503|470736059|FG000|Treatment Period|Lost to Follow-up|0|||
130758170|NCT01738503|470736060|FG001|Treatment Period|Lost to Follow-up|0|||
130758171|NCT01738503|470736061|FG002|Treatment Period|Lost to Follow-up|3|||
130758172|NCT01738503|470736062|FG003|Treatment Period|Lost to Follow-up|4|||
130758173|NCT01738503|470736063|FG004|Treatment Period|Lost to Follow-up|1|||
130758174|NCT01738503|470736064|FG005|Treatment Period|Lost to Follow-up|1|||
130758175|NCT01738503|470736065|FG006|Treatment Period|Lost to Follow-up|5|||
130789419|NCT01648764|470858729|FG009|Overall Study|Death|0|||
130789420|NCT01648764|470858730|FG010|Overall Study|Death|0|||
130789421|NCT01648764|470858731|FG011|Overall Study|Death|0|||
130789422|NCT01648764|470858732|FG012|Overall Study|Death|0|||
130789423|NCT01648764|470858733|FG013|Overall Study|Death|1|||
130789424|NCT01648764|470858720|FG000|Overall Study|Withdrawal by Subject|0|||
130789425|NCT01648764|470858721|FG001|Overall Study|Withdrawal by Subject|0|||
130789426|NCT01648764|470858722|FG002|Overall Study|Withdrawal by Subject|0|||
130758176|NCT01738503|470736059|FG000|Treatment Period|Withdrawal by Subject|0|||
130758177|NCT01738503|470736060|FG001|Treatment Period|Withdrawal by Subject|1|||
130758178|NCT01738503|470736061|FG002|Treatment Period|Withdrawal by Subject|0|||
130758179|NCT01738503|470736062|FG003|Treatment Period|Withdrawal by Subject|1|||
130758180|NCT01738503|470736063|FG004|Treatment Period|Withdrawal by Subject|1|||
130758181|NCT01738503|470736064|FG005|Treatment Period|Withdrawal by Subject|1|||
130758182|NCT01738503|470736065|FG006|Treatment Period|Withdrawal by Subject|1|||
130758183|NCT01738503|470736059|FG000|Treatment Period|Protocol Violation|0|||
130758184|NCT01738503|470736060|FG001|Treatment Period|Protocol Violation|3|||
130758185|NCT01738503|470736061|FG002|Treatment Period|Protocol Violation|1|||
130758186|NCT01738503|470736062|FG003|Treatment Period|Protocol Violation|0|||
130758187|NCT01738503|470736063|FG004|Treatment Period|Protocol Violation|4|||
130758188|NCT01738503|470736064|FG005|Treatment Period|Protocol Violation|2|||
130758189|NCT01738503|470736065|FG006|Treatment Period|Protocol Violation|0|||
130758190|NCT01738503|470736059|FG000|Treatment Period|Other|0|||
130758191|NCT01738503|470736060|FG001|Treatment Period|Other|0|||
130758192|NCT01738503|470736061|FG002|Treatment Period|Other|1|||
130758193|NCT01738503|470736062|FG003|Treatment Period|Other|0|||
130758194|NCT01738503|470736063|FG004|Treatment Period|Other|0|||
130758195|NCT01738503|470736064|FG005|Treatment Period|Other|0|||
130758196|NCT01738503|470736065|FG006|Treatment Period|Other|0|||
130758197|NCT01738503|470736059|FG000|PET Imaging Sub-study|Adverse Event|0|||
130758198|NCT01738503|470736060|FG001|PET Imaging Sub-study|Adverse Event|0|||
130758199|NCT01738503|470736061|FG002|PET Imaging Sub-study|Adverse Event|0|||
130758200|NCT01738503|470736062|FG003|PET Imaging Sub-study|Adverse Event|0|||
130758201|NCT01738503|470736063|FG004|PET Imaging Sub-study|Adverse Event|0|||
130758202|NCT01738503|470736064|FG005|PET Imaging Sub-study|Adverse Event|1|||
130758203|NCT01738503|470736065|FG006|PET Imaging Sub-study|Adverse Event|0|||
130758204|NCT01738503|470736059|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130758205|NCT01738503|470736060|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130758206|NCT01738503|470736061|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130758207|NCT01738503|470736062|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130758208|NCT01738503|470736063|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130758209|NCT01738503|470736064|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
130758210|NCT01738503|470736065|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
130758211|NCT01340027|470736066|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
130758212|NCT01340027|470736067|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
130758213|NCT01340027|470736068|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
130758214|NCT01340027|470736069|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
130758215|NCT01340027|470736070|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
130758216|NCT01340027|470736071|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
130758217|NCT01340027|470736072|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
130758218|NCT01340027|470736073|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
130758219|NCT01340027|470736074|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
130758220|NCT01340027|470736075|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
130758221|NCT01340027|470736076|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
130758222|NCT01340027|470736077|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
130758223|NCT01340027|470736066|FG000|Overall Study|Adverse Event|0|||
130758224|NCT01340027|470736067|FG001|Overall Study|Adverse Event|1|||
130758225|NCT01340027|470736068|FG002|Overall Study|Adverse Event|2|||
130758226|NCT01340027|470736069|FG003|Overall Study|Adverse Event|0|||
130758227|NCT01340027|470736070|FG004|Overall Study|Adverse Event|1|||
130758228|NCT01340027|470736071|FG005|Overall Study|Adverse Event|2|||
130758229|NCT01340027|470736072|FG006|Overall Study|Adverse Event|2|||
130758230|NCT01340027|470736073|FG007|Overall Study|Adverse Event|1|||
130758231|NCT01340027|470736074|FG008|Overall Study|Adverse Event|4|||
130758232|NCT01340027|470736075|FG009|Overall Study|Adverse Event|1|||
130758233|NCT01340027|470736076|FG010|Overall Study|Adverse Event|1|||
130758234|NCT01340027|470736077|FG011|Overall Study|Adverse Event|3|||
130758235|NCT01340027|470736066|FG000|Overall Study|Lack of Efficacy|0|||
130758236|NCT01340027|470736067|FG001|Overall Study|Lack of Efficacy|0|||
130758237|NCT01340027|470736068|FG002|Overall Study|Lack of Efficacy|0|||
130758238|NCT01340027|470736069|FG003|Overall Study|Lack of Efficacy|0|||
130758239|NCT01340027|470736070|FG004|Overall Study|Lack of Efficacy|0|||
130758240|NCT01340027|470736071|FG005|Overall Study|Lack of Efficacy|0|||
130758241|NCT01340027|470736072|FG006|Overall Study|Lack of Efficacy|1|||
130758242|NCT01340027|470736073|FG007|Overall Study|Lack of Efficacy|1|||
130758243|NCT01340027|470736074|FG008|Overall Study|Lack of Efficacy|1|||
130758244|NCT01340027|470736075|FG009|Overall Study|Lack of Efficacy|0|||
130758245|NCT01340027|470736076|FG010|Overall Study|Lack of Efficacy|0|||
130758246|NCT01340027|470736077|FG011|Overall Study|Lack of Efficacy|0|||
130758247|NCT01340027|470736066|FG000|Overall Study|Lost to Follow-up|0|||
130758248|NCT01340027|470736067|FG001|Overall Study|Lost to Follow-up|1|||
130758249|NCT01340027|470736068|FG002|Overall Study|Lost to Follow-up|0|||
130789427|NCT01648764|470858723|FG003|Overall Study|Withdrawal by Subject|0|||
130789428|NCT01648764|470858724|FG004|Overall Study|Withdrawal by Subject|0|||
130789429|NCT01648764|470858725|FG005|Overall Study|Withdrawal by Subject|0|||
130789430|NCT01648764|470858726|FG006|Overall Study|Withdrawal by Subject|2|||
130789431|NCT01648764|470858727|FG007|Overall Study|Withdrawal by Subject|0|||
130789432|NCT01648764|470858728|FG008|Overall Study|Withdrawal by Subject|0|||
130789433|NCT01648764|470858729|FG009|Overall Study|Withdrawal by Subject|0|||
130789434|NCT01648764|470858730|FG010|Overall Study|Withdrawal by Subject|0|||
130789435|NCT01648764|470858731|FG011|Overall Study|Withdrawal by Subject|0|||
130789436|NCT01648764|470858732|FG012|Overall Study|Withdrawal by Subject|1|||
130789437|NCT01648764|470858733|FG013|Overall Study|Withdrawal by Subject|0|||
130789438|NCT01648764|470858720|FG000|Overall Study|Investigator Decision|0|||
130789439|NCT01648764|470858721|FG001|Overall Study|Investigator Decision|0|||
130789440|NCT01648764|470858722|FG002|Overall Study|Investigator Decision|0|||
130789441|NCT01648764|470858723|FG003|Overall Study|Investigator Decision|0|||
130789442|NCT01648764|470858724|FG004|Overall Study|Investigator Decision|0|||
130789443|NCT01648764|470858725|FG005|Overall Study|Investigator Decision|0|||
130789444|NCT01648764|470858726|FG006|Overall Study|Investigator Decision|1|||
130789445|NCT01648764|470858727|FG007|Overall Study|Investigator Decision|0|||
130789446|NCT01648764|470858728|FG008|Overall Study|Investigator Decision|0|||
130789447|NCT01648764|470858729|FG009|Overall Study|Investigator Decision|0|||
130789448|NCT01648764|470858730|FG010|Overall Study|Investigator Decision|0|||
130789449|NCT01648764|470858731|FG011|Overall Study|Investigator Decision|1|||
130789450|NCT01648764|470858732|FG012|Overall Study|Investigator Decision|0|||
130789451|NCT01648764|470858733|FG013|Overall Study|Investigator Decision|0|||
130789452|NCT00076570|470858734|FG000|Overall Study|Drug intolerance|8|||
130789453|NCT00076570|470858735|FG001|Overall Study|Drug intolerance|8|||
130789454|NCT03427411|470858736|FG000|Overall Study|Screen failure - platelets too low|0|||
130789455|NCT03427411|470858737|FG001|Overall Study|Screen failure - platelets too low|1|||
130789456|NCT01715831|470858738|FG000|Overall Study|Adverse Event|1|||
130789457|NCT00316004|470858739|FG000|Overall Study|Subject was not given study fluid.|14|||
130789458|NCT00316004|470858740|FG001|Overall Study|Subject was not given study fluid.|14|||
130789459|NCT00316004|470858741|FG002|Overall Study|Subject was not given study fluid.|21|||
130789460|NCT01118299|470858744|FG000|Overall Study|Death|7|||
130789461|NCT01118299|470858745|FG001|Overall Study|Death|5|||
130789462|NCT01118299|470858744|FG000|Overall Study|Withdrawal by Subject|8|||
130789463|NCT01118299|470858745|FG001|Overall Study|Withdrawal by Subject|8|||
130789464|NCT01118299|470858744|FG000|Overall Study|Lost to Follow-up|2|||
130789465|NCT01118299|470858745|FG001|Overall Study|Lost to Follow-up|1|||
130789466|NCT01118299|470858744|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
130789467|NCT01118299|470858745|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
130789468|NCT00784875|470858746|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
130789469|NCT00784875|470858747|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
130789470|NCT00784875|470858748|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
130789471|NCT00784875|470858749|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
130789472|NCT00784875|470858746|FG000|Period A - Baseline|Adverse Event|0|||
130758250|NCT01340027|470736069|FG003|Overall Study|Lost to Follow-up|0|||
130758251|NCT01340027|470736070|FG004|Overall Study|Lost to Follow-up|0|||
130758252|NCT01340027|470736071|FG005|Overall Study|Lost to Follow-up|0|||
130758253|NCT01340027|470736072|FG006|Overall Study|Lost to Follow-up|1|||
130758254|NCT01340027|470736073|FG007|Overall Study|Lost to Follow-up|0|||
130758255|NCT01340027|470736074|FG008|Overall Study|Lost to Follow-up|0|||
130758256|NCT01340027|470736075|FG009|Overall Study|Lost to Follow-up|1|||
130758257|NCT01340027|470736076|FG010|Overall Study|Lost to Follow-up|0|||
130758258|NCT01340027|470736077|FG011|Overall Study|Lost to Follow-up|0|||
130758259|NCT01340027|470736066|FG000|Overall Study|Protocol Violation|1|||
130758260|NCT01340027|470736067|FG001|Overall Study|Protocol Violation|2|||
130758261|NCT01340027|470736068|FG002|Overall Study|Protocol Violation|0|||
130758262|NCT01340027|470736069|FG003|Overall Study|Protocol Violation|0|||
130758263|NCT01340027|470736070|FG004|Overall Study|Protocol Violation|6|||
130789473|NCT00784875|470858747|FG001|Period A - Baseline|Adverse Event|0|||
130789474|NCT00784875|470858748|FG002|Period A - Baseline|Adverse Event|0|||
130789475|NCT00784875|470858749|FG003|Period A - Baseline|Adverse Event|8|||
130789476|NCT00784875|470858746|FG000|Period A - Baseline|Protocol Violation|0|||
130758264|NCT01340027|470736071|FG005|Overall Study|Protocol Violation|0|||
130758265|NCT01340027|470736072|FG006|Overall Study|Protocol Violation|0|||
130758266|NCT01340027|470736073|FG007|Overall Study|Protocol Violation|1|||
130758267|NCT01340027|470736074|FG008|Overall Study|Protocol Violation|2|||
130758268|NCT01340027|470736075|FG009|Overall Study|Protocol Violation|2|||
130789477|NCT00784875|470858747|FG001|Period A - Baseline|Protocol Violation|0|||
130789478|NCT00784875|470858748|FG002|Period A - Baseline|Protocol Violation|0|||
130789479|NCT00784875|470858749|FG003|Period A - Baseline|Protocol Violation|25|||
130789480|NCT00784875|470858746|FG000|Period A - Baseline|Withdrawal by Subject|0|||
130789481|NCT00784875|470858747|FG001|Period A - Baseline|Withdrawal by Subject|0|||
130789482|NCT00784875|470858748|FG002|Period A - Baseline|Withdrawal by Subject|0|||
130758269|NCT01340027|470736076|FG010|Overall Study|Protocol Violation|0|||
130789483|NCT00784875|470858749|FG003|Period A - Baseline|Withdrawal by Subject|27|||
130758270|NCT01340027|470736077|FG011|Overall Study|Protocol Violation|0|||
130758271|NCT01340027|470736066|FG000|Overall Study|Withdrawal by Subject|4|||
130758272|NCT01340027|470736067|FG001|Overall Study|Withdrawal by Subject|3|||
130758273|NCT01340027|470736068|FG002|Overall Study|Withdrawal by Subject|1|||
130758274|NCT01340027|470736069|FG003|Overall Study|Withdrawal by Subject|3|||
130758275|NCT01340027|470736070|FG004|Overall Study|Withdrawal by Subject|3|||
130758276|NCT01340027|470736071|FG005|Overall Study|Withdrawal by Subject|2|||
130758277|NCT01340027|470736072|FG006|Overall Study|Withdrawal by Subject|3|||
130758278|NCT01340027|470736073|FG007|Overall Study|Withdrawal by Subject|4|||
130758279|NCT01340027|470736074|FG008|Overall Study|Withdrawal by Subject|1|||
130758280|NCT01340027|470736075|FG009|Overall Study|Withdrawal by Subject|2|||
130758281|NCT01340027|470736076|FG010|Overall Study|Withdrawal by Subject|0|||
130758282|NCT01340027|470736077|FG011|Overall Study|Withdrawal by Subject|1|||
130758283|NCT01340027|470736066|FG000|Overall Study|Miscellaneous|0|||
130758284|NCT01340027|470736067|FG001|Overall Study|Miscellaneous|0|||
130758285|NCT01340027|470736068|FG002|Overall Study|Miscellaneous|0|||
130758286|NCT01340027|470736069|FG003|Overall Study|Miscellaneous|1|||
130758287|NCT01340027|470736070|FG004|Overall Study|Miscellaneous|0|||
130758288|NCT01340027|470736071|FG005|Overall Study|Miscellaneous|0|||
130758289|NCT01340027|470736072|FG006|Overall Study|Miscellaneous|0|||
130758290|NCT01340027|470736073|FG007|Overall Study|Miscellaneous|0|||
130758291|NCT01340027|470736074|FG008|Overall Study|Miscellaneous|0|||
130758292|NCT01340027|470736075|FG009|Overall Study|Miscellaneous|0|||
130758293|NCT01340027|470736076|FG010|Overall Study|Miscellaneous|1|||
130758294|NCT01340027|470736077|FG011|Overall Study|Miscellaneous|0|||
130758295|NCT03005327|470736078|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
130758296|NCT03005327|470736079|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
130758297|NCT03005327|470736080|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
130758298|NCT03005327|470736081|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
130758299|NCT03005327|470736078|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130758300|NCT03005327|470736079|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130758301|NCT03005327|470736080|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130758302|NCT03005327|470736081|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130758303|NCT04687072|470736082|FG000|Overall Study|Adverse Event|2|||
130758304|NCT04687072|470736083|FG001|Overall Study|Adverse Event|0|||
130758305|NCT04687072|470736082|FG000|Overall Study|Death|1|||
130758306|NCT04687072|470736083|FG001|Overall Study|Death|0|||
130758307|NCT04687072|470736082|FG000|Overall Study|Lack of Efficacy|2|||
130758308|NCT04687072|470736083|FG001|Overall Study|Lack of Efficacy|1|||
130758309|NCT04687072|470736082|FG000|Overall Study|Physician Decision|1|||
130758310|NCT04687072|470736083|FG001|Overall Study|Physician Decision|0|||
130758311|NCT04687072|470736082|FG000|Overall Study|Pregnancy|1|||
130758312|NCT04687072|470736083|FG001|Overall Study|Pregnancy|0|||
130758313|NCT04687072|470736082|FG000|Overall Study|Requires Prohibited Medication|2|||
130758314|NCT04687072|470736083|FG001|Overall Study|Requires Prohibited Medication|0|||
130758315|NCT04687072|470736082|FG000|Overall Study|Withdrawal of Consent|11|||
130758316|NCT04687072|470736083|FG001|Overall Study|Withdrawal of Consent|6|||
130758317|NCT04687072|470736082|FG000|Overall Study|Miscellaneous|4|||
130758318|NCT04687072|470736083|FG001|Overall Study|Miscellaneous|1|||
130758319|NCT00915876|470736084|FG000|Overall Study|Adverse Event|0|||
130758320|NCT00915876|470736085|FG001|Overall Study|Adverse Event|1|||
130758321|NCT02572076|470736089|FG000|Overall Study|Protocol Violation|1|||
130758322|NCT00533702|470736092|FG000|Overall Study|Withdrawal by Subject|3|||
130758323|NCT00533702|470736093|FG001|Overall Study|Withdrawal by Subject|1|||
130758324|NCT00533702|470736092|FG000|Overall Study|Found ineligible after randomization|2|||
130758325|NCT00533702|470736093|FG001|Overall Study|Found ineligible after randomization|1|||
130758326|NCT04413552|470736099|FG000|Overall Study|Adverse Event|0|||
130758327|NCT04413552|470736100|FG001|Overall Study|Adverse Event|0|||
130758328|NCT04413552|470736101|FG002|Overall Study|Adverse Event|0|||
130758329|NCT04413552|470736102|FG003|Overall Study|Adverse Event|0|||
130758330|NCT04413552|470736103|FG004|Overall Study|Adverse Event|0|||
130758331|NCT04413552|470736104|FG005|Overall Study|Adverse Event|0|||
130758332|NCT04413552|470736105|FG006|Overall Study|Adverse Event|1|||
130758333|NCT04413552|470736106|FG007|Overall Study|Adverse Event|0|||
130758334|NCT04413552|470736107|FG008|Overall Study|Adverse Event|0|||
130758335|NCT04413552|470736108|FG009|Overall Study|Adverse Event|0|||
130758336|NCT06366087|470737632|FG000|Overall Study|Withdrawal by Subject|0|||
130758337|NCT06366087|470737633|FG001|Overall Study|Withdrawal by Subject|1|||
130758338|NCT00860249|470737635|FG000|Overall Study|trial was terminated prior to completion|21|||
130758339|NCT00860249|470737636|FG001|Overall Study|trial was terminated prior to completion|18|||
130758340|NCT00860249|470737637|FG002|Overall Study|trial was terminated prior to completion|21|||
130758341|NCT00174967|470737638|FG000|Overall Study|Adverse Event|1|||
130758342|NCT00174967|470737639|FG001|Overall Study|Adverse Event|2|||
130789484|NCT00784875|470858746|FG000|Period A - Baseline|Physician Decision|0|||
130789485|NCT00784875|470858747|FG001|Period A - Baseline|Physician Decision|0|||
130758343|NCT00174967|470737640|FG002|Overall Study|Adverse Event|2|||
130758344|NCT00174967|470737641|FG003|Overall Study|Adverse Event|1|||
130758345|NCT00174967|470737638|FG000|Overall Study|Gout Flare|0|||
130758346|NCT00174967|470737639|FG001|Overall Study|Gout Flare|0|||
130758347|NCT00174967|470737640|FG002|Overall Study|Gout Flare|0|||
130758348|NCT00174967|470737641|FG003|Overall Study|Gout Flare|1|||
130758349|NCT00174967|470737638|FG000|Overall Study|Other|0|||
130758350|NCT00174967|470737639|FG001|Overall Study|Other|1|||
130758351|NCT00174967|470737640|FG002|Overall Study|Other|0|||
130758352|NCT00174967|470737641|FG003|Overall Study|Other|0|||
130758353|NCT04934189|470737642|FG000|Overall Study|Lost to Follow-up|4|||
130758354|NCT04934189|470737642|FG000|Overall Study|Withdrawal by Subject|17|||
130758355|NCT01286168|470737651|FG000|Overall Study|Withdrawal by Subject|1|||
130758356|NCT01286168|470737651|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
130758357|NCT00843037|470737656|FG000|Overall Study|Lost to Follow-up|1|||
130758358|NCT02091960|470737659|FG000|Overall Study|Death|7|||
130758359|NCT02091960|470737659|FG000|Overall Study|Withdrawal by Subject|1|||
130758360|NCT02091960|470737659|FG000|Overall Study|Miscellaneous Reasons|37|||
130758361|NCT02738879|470737670|FG000|Overall Study|Adverse Event|1|||
130758362|NCT02738879|470737671|FG001|Overall Study|Adverse Event|1|||
130758363|NCT02738879|470737670|FG000|Overall Study|Death|0|||
130758364|NCT02738879|470737671|FG001|Overall Study|Death|2|||
130758365|NCT02738879|470737670|FG000|Overall Study|Lost to Follow-up|1|||
130758366|NCT02738879|470737671|FG001|Overall Study|Lost to Follow-up|5|||
130758367|NCT02738879|470737670|FG000|Overall Study|Protocol Violation|1|||
130758368|NCT02738879|470737671|FG001|Overall Study|Protocol Violation|3|||
130758369|NCT02738879|470737670|FG000|Overall Study|Physician Decision|3|||
130758370|NCT02738879|470737671|FG001|Overall Study|Physician Decision|4|||
130758371|NCT02738879|470737670|FG000|Overall Study|Pregnancy|0|||
130758372|NCT02738879|470737671|FG001|Overall Study|Pregnancy|1|||
130758373|NCT02738879|470737670|FG000|Overall Study|Screen Failure|1|||
130758374|NCT02738879|470737671|FG001|Overall Study|Screen Failure|2|||
130758375|NCT02738879|470737670|FG000|Overall Study|Site Discontinued Study Participation|1|||
130758376|NCT02738879|470737671|FG001|Overall Study|Site Discontinued Study Participation|0|||
130758377|NCT02738879|470737670|FG000|Overall Study|Withdrawal by Subject|5|||
130758378|NCT02738879|470737671|FG001|Overall Study|Withdrawal by Subject|7|||
130758379|NCT01438294|470737672|FG000|Overall Study|Lost to Follow-up|3|||
130758380|NCT01438294|470737673|FG001|Overall Study|Lost to Follow-up|7|||
130758381|NCT01346189|470737676|FG000|Overall Study|Withdrawal by Subject|7|||
130758382|NCT01346189|470737677|FG001|Overall Study|Withdrawal by Subject|5|||
130758383|NCT01346189|470737678|FG002|Overall Study|Withdrawal by Subject|3|||
130758384|NCT01346189|470737679|FG003|Overall Study|Withdrawal by Subject|5|||
130758385|NCT01346189|470737676|FG000|Overall Study|Physician Decision|4|||
130758386|NCT01346189|470737677|FG001|Overall Study|Physician Decision|0|||
130758387|NCT01346189|470737678|FG002|Overall Study|Physician Decision|0|||
130758388|NCT01346189|470737679|FG003|Overall Study|Physician Decision|0|||
130758389|NCT01346189|470737676|FG000|Overall Study|Moved|3|||
130758390|NCT01346189|470737677|FG001|Overall Study|Moved|0|||
130758391|NCT01346189|470737678|FG002|Overall Study|Moved|4|||
130758392|NCT01346189|470737679|FG003|Overall Study|Moved|0|||
130758393|NCT01346189|470737676|FG000|Overall Study|Other|2|||
130758394|NCT01346189|470737677|FG001|Overall Study|Other|4|||
130758395|NCT01346189|470737678|FG002|Overall Study|Other|7|||
130758396|NCT01346189|470737679|FG003|Overall Study|Other|3|||
130758397|NCT01346189|470737676|FG000|Overall Study|Death|0|||
130758398|NCT01346189|470737677|FG001|Overall Study|Death|3|||
130758399|NCT01346189|470737678|FG002|Overall Study|Death|0|||
130758400|NCT01346189|470737679|FG003|Overall Study|Death|0|||
130758401|NCT01346189|470737676|FG000|Overall Study|Non-health system primary care physician|0|||
130758402|NCT01346189|470737677|FG001|Overall Study|Non-health system primary care physician|5|||
130758403|NCT01346189|470737678|FG002|Overall Study|Non-health system primary care physician|0|||
130758404|NCT01346189|470737679|FG003|Overall Study|Non-health system primary care physician|0|||
130758405|NCT01346189|470737676|FG000|Overall Study|Travel|0|||
130758406|NCT01346189|470737677|FG001|Overall Study|Travel|0|||
130758407|NCT01346189|470737678|FG002|Overall Study|Travel|0|||
130758408|NCT01346189|470737679|FG003|Overall Study|Travel|3|||
130758409|NCT01730534|470737680|FG000|Overall Study|Withdrawal by Subject|97|||
130758410|NCT01730534|470737681|FG001|Overall Study|Withdrawal by Subject|127|||
130758411|NCT01730534|470737680|FG000|Overall Study|Lost to Follow-up|12|||
130758412|NCT01730534|470737681|FG001|Overall Study|Lost to Follow-up|18|||
130758413|NCT01895608|470737682|FG000|Overall Study|change in health status|0|||
130758414|NCT01895608|470737683|FG001|Overall Study|change in health status|1|||
130758415|NCT01895608|470737684|FG002|Overall Study|change in health status|1|||
130758416|NCT01895608|470737685|FG003|Overall Study|change in health status|0|||
130758417|NCT01895608|470737682|FG000|Overall Study|Withdrawal by Subject|0|||
130758418|NCT01895608|470737683|FG001|Overall Study|Withdrawal by Subject|0|||
130758419|NCT01895608|470737684|FG002|Overall Study|Withdrawal by Subject|2|||
130758420|NCT01895608|470737685|FG003|Overall Study|Withdrawal by Subject|0|||
130758421|NCT02855359|470737688|FG000|Overall Study|Death|2|||
130758422|NCT02855359|470737689|FG001|Overall Study|Death|2|||
130758423|NCT02855359|470737690|FG002|Overall Study|Death|0|||
130758424|NCT02855359|470737691|FG003|Overall Study|Death|0|||
130758425|NCT02855359|470737688|FG000|Overall Study|Study Termination by Sponsor|9|||
130758426|NCT02855359|470737689|FG001|Overall Study|Study Termination by Sponsor|11|||
130758427|NCT02855359|470737690|FG002|Overall Study|Study Termination by Sponsor|0|||
130758428|NCT02855359|470737691|FG003|Overall Study|Study Termination by Sponsor|0|||
130758429|NCT02833844|470737692|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130758430|NCT02833844|470737693|FG001|Double-Blind Period|Withdrawal by Subject|3|||
130758431|NCT02833844|470737692|FG000|Double-Blind Period|Protocol Violation|0|||
130758432|NCT02833844|470737693|FG001|Double-Blind Period|Protocol Violation|4|||
130789486|NCT00784875|470858748|FG002|Period A - Baseline|Physician Decision|0|||
130758433|NCT02833844|470737692|FG000|Open-Label Period|Death|0|||
130758434|NCT02833844|470737693|FG001|Open-Label Period|Death|2|||
130758435|NCT02833844|470737692|FG000|Open-Label Period|Lost to Follow-up|1|||
130758436|NCT02833844|470737693|FG001|Open-Label Period|Lost to Follow-up|0|||
130758437|NCT02833844|470737692|FG000|Open-Label Period|Withdrawal by Subject|1|||
130758438|NCT02833844|470737693|FG001|Open-Label Period|Withdrawal by Subject|0|||
130758439|NCT02541669|470737696|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
130758440|NCT02541669|470737697|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
130758441|NCT02541669|470737698|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
130758442|NCT02541669|470737699|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
130758443|NCT02541669|470737700|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
130758444|NCT01084668|470737702|FG000|Overall Study|Lack of Efficacy|5|||
130758445|NCT01084668|470737702|FG000|Overall Study|Withdrawal by Subject|2|||
130758446|NCT01084668|470737702|FG000|Overall Study|Pregnancy|1|||
130758447|NCT01084668|470737702|FG000|Overall Study|Non-compliance|1|||
130758448|NCT00655733|470737709|FG000|Overall Study|Lost to Follow-up|2|||
130758449|NCT00655733|470737710|FG001|Overall Study|Lost to Follow-up|2|||
130758450|NCT00655733|470737709|FG000|Overall Study|Adverse Event|2|||
130758451|NCT00655733|470737710|FG001|Overall Study|Adverse Event|2|||
130758452|NCT00655733|470737709|FG000|Overall Study|Withdrawal by Subject|3|||
130758453|NCT00655733|470737710|FG001|Overall Study|Withdrawal by Subject|3|||
130758454|NCT00655733|470737709|FG000|Overall Study|Physician Decision|0|||
130758455|NCT00655733|470737710|FG001|Overall Study|Physician Decision|1|||
130758456|NCT02122770|470737711|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
130758457|NCT02122770|470737712|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
130758458|NCT02122770|470737713|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
130758459|NCT02122770|470737714|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
130758460|NCT02122770|470737715|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
130758461|NCT02122770|470737716|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
130758462|NCT02122770|470737711|FG000|Part A: Drug-drug Interaction 2|Other|0|||
130758463|NCT02122770|470737712|FG001|Part A: Drug-drug Interaction 2|Other|0|||
130758464|NCT02122770|470737713|FG002|Part A: Drug-drug Interaction 2|Other|1|||
130758465|NCT02122770|470737714|FG003|Part A: Drug-drug Interaction 2|Other|0|||
130758466|NCT02122770|470737715|FG004|Part A: Drug-drug Interaction 2|Other|0|||
130758467|NCT02122770|470737716|FG005|Part A: Drug-drug Interaction 2|Other|0|||
130758468|NCT02122770|470737711|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130758469|NCT02122770|470737712|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
130758470|NCT02122770|470737713|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130758471|NCT02122770|470737714|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130758472|NCT02122770|470737715|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130758473|NCT02122770|470737716|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130758474|NCT02122770|470737711|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
130758475|NCT02122770|470737712|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
130758476|NCT02122770|470737713|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
130758477|NCT02122770|470737714|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
130758478|NCT02122770|470737715|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
130758479|NCT02122770|470737716|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
130758480|NCT02122770|470737711|FG000|Part B: Standard of Care|Adverse Event|0|||
130758481|NCT02122770|470737712|FG001|Part B: Standard of Care|Adverse Event|0|||
130758482|NCT02122770|470737713|FG002|Part B: Standard of Care|Adverse Event|0|||
130758483|NCT02122770|470737714|FG003|Part B: Standard of Care|Adverse Event|0|||
130758484|NCT02122770|470737715|FG004|Part B: Standard of Care|Adverse Event|4|||
130758485|NCT02122770|470737716|FG005|Part B: Standard of Care|Adverse Event|1|||
130758486|NCT02122770|470737711|FG000|Part B: Standard of Care|Other|0|||
130758487|NCT02122770|470737712|FG001|Part B: Standard of Care|Other|0|||
130758488|NCT02122770|470737713|FG002|Part B: Standard of Care|Other|0|||
130758489|NCT02122770|470737714|FG003|Part B: Standard of Care|Other|0|||
130758490|NCT02122770|470737715|FG004|Part B: Standard of Care|Other|0|||
130758491|NCT02122770|470737716|FG005|Part B: Standard of Care|Other|2|||
130758492|NCT02122770|470737711|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
130758493|NCT02122770|470737712|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
130758494|NCT02122770|470737713|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
130758495|NCT02122770|470737714|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
130758496|NCT02122770|470737715|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
130758497|NCT02122770|470737716|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
130758498|NCT02122770|470737711|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
130758499|NCT02122770|470737712|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
130758500|NCT02122770|470737713|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
130758501|NCT02122770|470737714|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
130758502|NCT02122770|470737715|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
130758503|NCT02122770|470737716|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
130758504|NCT02122770|470737711|FG000|Part B: Standard of Care|Progressive Disease|0|||
130758505|NCT02122770|470737712|FG001|Part B: Standard of Care|Progressive Disease|0|||
130758506|NCT02122770|470737713|FG002|Part B: Standard of Care|Progressive Disease|0|||
130758507|NCT02122770|470737714|FG003|Part B: Standard of Care|Progressive Disease|0|||
130758508|NCT02122770|470737715|FG004|Part B: Standard of Care|Progressive Disease|10|||
130758509|NCT02122770|470737716|FG005|Part B: Standard of Care|Progressive Disease|8|||
130758510|NCT01740128|470737717|FG000|Overall Study|Pregnancy|0|||
130758511|NCT01740128|470737718|FG001|Overall Study|Pregnancy|1|||
130758512|NCT01740128|470737717|FG000|Overall Study|Protocol Violation|1|||
130758513|NCT01740128|470737718|FG001|Overall Study|Protocol Violation|2|||
130758514|NCT01740128|470737717|FG000|Overall Study|Lost to Follow-up|2|||
130758515|NCT01740128|470737718|FG001|Overall Study|Lost to Follow-up|2|||
130758516|NCT01740128|470737717|FG000|Overall Study|Withdrawal by Subject|1|||
130758517|NCT01740128|470737718|FG001|Overall Study|Withdrawal by Subject|0|||
130758518|NCT01740128|470737717|FG000|Overall Study|Insufficient protocol compliance|2|||
130758519|NCT01740128|470737718|FG001|Overall Study|Insufficient protocol compliance|2|||
130758520|NCT02474589|470737719|FG000|Overall Study|Adverse Event|6|||
130758521|NCT02474589|470737720|FG001|Overall Study|Adverse Event|2|||
130758522|NCT02474589|470737719|FG000|Overall Study|Lost to Follow-up|6|||
130758523|NCT02474589|470737720|FG001|Overall Study|Lost to Follow-up|1|||
130758524|NCT02474589|470737719|FG000|Overall Study|Protocol Violation|4|||
130758525|NCT02474589|470737720|FG001|Overall Study|Protocol Violation|1|||
130758526|NCT02474589|470737719|FG000|Overall Study|Withdrawal by Subject|4|||
130758527|NCT02474589|470737720|FG001|Overall Study|Withdrawal by Subject|0|||
130758528|NCT02474589|470737719|FG000|Overall Study|Inability to complete study procedures|5|||
130758529|NCT02474589|470737720|FG001|Overall Study|Inability to complete study procedures|1|||
130758530|NCT02658734|470737723|FG000|Overall Study|Adverse Event|2|||
130758531|NCT02658734|470737723|FG000|Overall Study|Death|4|||
130758532|NCT02658734|470737723|FG000|Overall Study|Lost to Follow-up|7|||
130758533|NCT02658734|470737723|FG000|Overall Study|Withdrawal of Consent|16|||
130758534|NCT02658734|470737723|FG000|Overall Study|Disease Progression|28|||
130758535|NCT00459706|470737725|FG000|Overall Study|Adverse Event|19|||
130758536|NCT00459706|470737726|FG001|Overall Study|Adverse Event|13|||
130758537|NCT00459706|470737725|FG000|Overall Study|Withdrawal by Subject|1|||
130758538|NCT00459706|470737726|FG001|Overall Study|Withdrawal by Subject|6|||
130758539|NCT00459706|470737725|FG000|Overall Study|Physician Decision|2|||
130758540|NCT00459706|470737726|FG001|Overall Study|Physician Decision|0|||
130758541|NCT00459706|470737725|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130758542|NCT00459706|470737726|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130758543|NCT00459706|470737725|FG000|Overall Study|Protocol Violation|2|||
130758544|NCT00459706|470737726|FG001|Overall Study|Protocol Violation|1|||
130758545|NCT00459706|470737725|FG000|Overall Study|Failed to Return|1|||
130758546|NCT00459706|470737726|FG001|Overall Study|Failed to Return|0|||
130758547|NCT00459706|470737725|FG000|Overall Study|Other|0|||
130758548|NCT00459706|470737726|FG001|Overall Study|Other|1|||
130758549|NCT00189306|470737727|FG000|Treatment Period|Withdrawal by Subject|2|||
130758550|NCT00189306|470737727|FG000|Treatment Period|Adverse Event|2|||
130758551|NCT00189306|470737727|FG000|Treatment Period|Protocol Violation|1|||
130758552|NCT00189306|470737727|FG000|Posttreatment Period|Death|1|||
130758553|NCT00189306|470737727|FG000|Posttreatment Period|Withdrawal by Subject|2|||
130758554|NCT00189306|470737727|FG000|Posttreatment Period|Noncompliance|1|||
130758555|NCT00189306|470737727|FG000|Posttreatment Period|Target lesion excised|1|||
130758556|NCT00189306|470737727|FG000|Posttreatment Period|Protocol Violation|1|||
130758557|NCT00189306|470737727|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
130758558|NCT00189306|470737727|FG000|Posttreatment Period|Local skin reaction/sign|1|||
130758559|NCT00189306|470737727|FG000|Long-Term Follow-up|Adverse Event|2|||
130758560|NCT00189306|470737727|FG000|Long-Term Follow-up|Death|4|||
130758561|NCT00189306|470737727|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
130758562|NCT00189306|470737727|FG000|Long-Term Follow-up|Intercurrent disease|2|||
130758563|NCT00189306|470737727|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
130758564|NCT00189306|470737727|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
130758565|NCT03640481|470737728|FG000|Overall Study|Death|14|||
130758566|NCT03640481|470737729|FG001|Overall Study|Death|14|||
130758567|NCT03640481|470737730|FG002|Overall Study|Death|0|||
130758568|NCT03640481|470737731|FG003|Overall Study|Death|0|||
130758569|NCT03640481|470737728|FG000|Overall Study|Lost to Follow-up|2|||
130758570|NCT03640481|470737729|FG001|Overall Study|Lost to Follow-up|0|||
130758571|NCT03640481|470737730|FG002|Overall Study|Lost to Follow-up|0|||
130758572|NCT03640481|470737731|FG003|Overall Study|Lost to Follow-up|0|||
130758573|NCT03640481|470737728|FG000|Overall Study|Site terminated by sponsor|1|||
130758574|NCT03640481|470737729|FG001|Overall Study|Site terminated by sponsor|3|||
130758575|NCT03640481|470737730|FG002|Overall Study|Site terminated by sponsor|0|||
130758576|NCT03640481|470737731|FG003|Overall Study|Site terminated by sponsor|0|||
130758577|NCT03640481|470737728|FG000|Overall Study|Study terminated by sponsor|29|||
130758578|NCT03640481|470737729|FG001|Overall Study|Study terminated by sponsor|42|||
130758579|NCT03640481|470737730|FG002|Overall Study|Study terminated by sponsor|1|||
130758580|NCT03640481|470737731|FG003|Overall Study|Study terminated by sponsor|0|||
130758581|NCT03640481|470737728|FG000|Overall Study|Withdrawal by Subject|5|||
130758582|NCT03640481|470737729|FG001|Overall Study|Withdrawal by Subject|4|||
130758583|NCT03640481|470737730|FG002|Overall Study|Withdrawal by Subject|0|||
130758584|NCT03640481|470737731|FG003|Overall Study|Withdrawal by Subject|1|||
130758585|NCT03640481|470737728|FG000|Overall Study|Other|26|||
130758586|NCT03640481|470737729|FG001|Overall Study|Other|12|||
130758587|NCT03640481|470737730|FG002|Overall Study|Other|1|||
130758588|NCT03640481|470737731|FG003|Overall Study|Other|0|||
130758589|NCT03640481|470737728|FG000|Overall Study|Randomized, but not treated|1|||
130758590|NCT03640481|470737729|FG001|Overall Study|Randomized, but not treated|3|||
130758591|NCT03640481|470737730|FG002|Overall Study|Randomized, but not treated|0|||
130758592|NCT03640481|470737731|FG003|Overall Study|Randomized, but not treated|0|||
130758593|NCT00727844|470737732|FG000|Initial Randomization|Physician Decision|2|||
130758594|NCT00727844|470737733|FG001|Initial Randomization|Physician Decision|0|||
130758595|NCT00727844|470737734|FG002|Initial Randomization|Physician Decision|0|||
130758596|NCT00727844|470737735|FG003|Initial Randomization|Physician Decision|0|||
130758597|NCT00373958|470737736|FG000|Infant Series|Withdrawal by Subject|13|||
130758598|NCT00373958|470737737|FG001|Infant Series|Withdrawal by Subject|15|||
130758599|NCT00373958|470737736|FG000|Infant Series|Failed to return|8|||
130758600|NCT00373958|470737737|FG001|Infant Series|Failed to return|13|||
130758601|NCT00373958|470737736|FG000|Infant Series|Lost to Follow-up|6|||
130758602|NCT00373958|470737737|FG001|Infant Series|Lost to Follow-up|5|||
130758603|NCT00373958|470737736|FG000|Infant Series|Protocol Violation|3|||
130758604|NCT00373958|470737737|FG001|Infant Series|Protocol Violation|7|||
130758605|NCT00373958|470737736|FG000|Infant Series|Lost Kaiser coverage|4|||
130758606|NCT00373958|470737737|FG001|Infant Series|Lost Kaiser coverage|0|||
130758607|NCT00373958|470737736|FG000|Infant Series|Child relocated|1|||
130758608|NCT00373958|470737737|FG001|Infant Series|Child relocated|0|||
130758609|NCT00373958|470737736|FG000|Infant Series|Consent was not received|1|||
130758610|NCT00373958|470737737|FG001|Infant Series|Consent was not received|0|||
130758611|NCT00373958|470737736|FG000|Infant Series|Adverse Event|3|||
130758612|NCT00373958|470737737|FG001|Infant Series|Adverse Event|1|||
130758613|NCT00373958|470737736|FG000|Infant Series|Physician Decision|1|||
130758614|NCT00373958|470737737|FG001|Infant Series|Physician Decision|1|||
130758615|NCT00373958|470737736|FG000|Toddler Dose|Lost to Follow-up|5|||
130758616|NCT00373958|470737737|FG001|Toddler Dose|Lost to Follow-up|8|||
130758617|NCT00373958|470737736|FG000|Toddler Dose|Withdrawal by Subject|2|||
130758618|NCT00373958|470737737|FG001|Toddler Dose|Withdrawal by Subject|2|||
130758619|NCT00373958|470737736|FG000|Toddler Dose|Failed to return|1|||
130789487|NCT00784875|470858749|FG003|Period A - Baseline|Physician Decision|2|||
130789488|NCT00784875|470858746|FG000|Period A - Baseline|Sponsor Decision|0|||
130758620|NCT00373958|470737737|FG001|Toddler Dose|Failed to return|2|||
130758621|NCT00373958|470737736|FG000|Toddler Dose|Protocol Violation|0|||
130758622|NCT00373958|470737737|FG001|Toddler Dose|Protocol Violation|1|||
130758623|NCT00373958|470737736|FG000|Toddler Dose|Withdrawn after infant series|22|||
130758624|NCT00373958|470737737|FG001|Toddler Dose|Withdrawn after infant series|25|||
130758625|NCT01552915|470737738|FG000|Overall Study|Adverse Event|3|||
130758626|NCT01552915|470737739|FG001|Overall Study|Adverse Event|14|||
130758627|NCT01552915|470737740|FG002|Overall Study|Adverse Event|3|||
130758628|NCT01552915|470737738|FG000|Overall Study|Lost to Follow-up|4|||
130789489|NCT00784875|470858747|FG001|Period A - Baseline|Sponsor Decision|0|||
130789490|NCT00784875|470858748|FG002|Period A - Baseline|Sponsor Decision|0|||
130758629|NCT01552915|470737739|FG001|Overall Study|Lost to Follow-up|6|||
130758630|NCT01552915|470737740|FG002|Overall Study|Lost to Follow-up|5|||
130758631|NCT01552915|470737738|FG000|Overall Study|Withdrawal by Subject|6|||
130758632|NCT01552915|470737739|FG001|Overall Study|Withdrawal by Subject|4|||
130758633|NCT01552915|470737740|FG002|Overall Study|Withdrawal by Subject|5|||
130758634|NCT01552915|470737738|FG000|Overall Study|Protocol Violation|0|||
130758635|NCT01552915|470737739|FG001|Overall Study|Protocol Violation|4|||
130758636|NCT01552915|470737740|FG002|Overall Study|Protocol Violation|4|||
130758637|NCT01552915|470737738|FG000|Overall Study|Lack of Efficacy|8|||
130758638|NCT01552915|470737739|FG001|Overall Study|Lack of Efficacy|1|||
130758639|NCT01552915|470737740|FG002|Overall Study|Lack of Efficacy|4|||
130758640|NCT01552915|470737738|FG000|Overall Study|Other|2|||
130758641|NCT01552915|470737739|FG001|Overall Study|Other|0|||
130758642|NCT01552915|470737740|FG002|Overall Study|Other|6|||
130758643|NCT01880086|470737743|FG000|Overall Study|Lost to Follow-up|1|||
130758644|NCT01880086|470737744|FG001|Overall Study|Lost to Follow-up|1|||
130758645|NCT00520481|470737751|FG000|Overall Study|Adverse Event|4|||
130758646|NCT00520481|470737752|FG001|Overall Study|Adverse Event|1|||
130758647|NCT00520481|470737751|FG000|Overall Study|Withdrawal by Subject|3|||
130758648|NCT00520481|470737752|FG001|Overall Study|Withdrawal by Subject|0|||
130758649|NCT02091986|470737753|FG000|Overall Study|7 rand in error 1 patient decision|2|||
130758650|NCT02091986|470737754|FG001|Overall Study|7 rand in error 1 patient decision|3|||
130758651|NCT02091986|470737755|FG002|Overall Study|7 rand in error 1 patient decision|3|||
130758652|NCT02091986|470737753|FG000|Overall Study|Lost to Follow-up|1|||
130758653|NCT02091986|470737754|FG001|Overall Study|Lost to Follow-up|0|||
130758654|NCT02091986|470737755|FG002|Overall Study|Lost to Follow-up|0|||
130758655|NCT02091986|470737753|FG000|Overall Study|Withdrawal by Subject|4|||
130758656|NCT02091986|470737754|FG001|Overall Study|Withdrawal by Subject|8|||
130758657|NCT02091986|470737755|FG002|Overall Study|Withdrawal by Subject|3|||
130758658|NCT02091986|470737753|FG000|Overall Study|Adverse Event|0|||
130758659|NCT02091986|470737754|FG001|Overall Study|Adverse Event|0|||
130758660|NCT02091986|470737755|FG002|Overall Study|Adverse Event|2|||
130758661|NCT02537431|470737759|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
130758662|NCT00794040|470737760|FG000|Overall Study|Withdrawal by Subject|3|||
130758663|NCT00794040|470737761|FG001|Overall Study|Withdrawal by Subject|4|||
130758664|NCT00794040|470737760|FG000|Overall Study|Physician Decision|0|||
130758665|NCT00794040|470737761|FG001|Overall Study|Physician Decision|1|||
130758666|NCT03626363|470737762|FG000|Overall Study|Protocol Violation|4|||
130758667|NCT03626363|470737763|FG001|Overall Study|Protocol Violation|0|||
130758668|NCT03626363|470737762|FG000|Overall Study|Lost to Follow-up|5|||
130758669|NCT03626363|470737763|FG001|Overall Study|Lost to Follow-up|7|||
130758670|NCT02600845|470737764|FG000|Overall Study|Reason Not Specified|3|||
130758671|NCT02600845|470737764|FG000|Overall Study|Non-compliance with Study Procedures|10|||
130758672|NCT02600845|470737764|FG000|Overall Study|Consent Withdrawal|5|||
130758673|NCT04852679|470737765|FG000|Main Intervention Period|Withdrawal by Subject|3|||
130758674|NCT04852679|470737765|FG000|Main Intervention Period|Adverse Event|1|||
130758675|NCT04852679|470737765|FG000|Main Intervention Period|Progressive Disease|16|||
130758676|NCT04852679|470737765|FG000|Main Intervention Period|Refused study visit|1|||
130758677|NCT04852679|470737765|FG000|Independent Injection Period|Missed study visit|1|||
130758678|NCT01294696|470737766|FG000|Overall Study|Screening failures|7|||
130758679|NCT01294696|470737766|FG000|Overall Study|Protocol Violation|8|||
130758680|NCT01294696|470737766|FG000|Overall Study|Missing BPI Response|7|||
130758681|NCT01294696|470737766|FG000|Overall Study|Site closure|52|||
130758682|NCT01871402|470739441|FG000|Overall Study|Lost to Follow-up|1|||
130758683|NCT01871402|470739442|FG001|Overall Study|Lost to Follow-up|0|||
130789491|NCT00784875|470858749|FG003|Period A - Baseline|Sponsor Decision|113|||
130789492|NCT00784875|470858746|FG000|Period A - Baseline|Lost to Follow-up|0|||
130789493|NCT00784875|470858747|FG001|Period A - Baseline|Lost to Follow-up|0|||
130789494|NCT00784875|470858748|FG002|Period A - Baseline|Lost to Follow-up|0|||
130789495|NCT00784875|470858749|FG003|Period A - Baseline|Lost to Follow-up|2|||
130789496|NCT00784875|470858746|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
130758684|NCT01871402|470739441|FG000|Overall Study|Withdrawal by Subject|0|||
130758685|NCT01871402|470739442|FG001|Overall Study|Withdrawal by Subject|2|||
130758686|NCT01871402|470739441|FG000|Overall Study|Non-compliance|0|||
130789497|NCT00784875|470858747|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
130789498|NCT00784875|470858748|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
130789499|NCT00784875|470858749|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
130789500|NCT00784875|470858746|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
130758687|NCT01871402|470739442|FG001|Overall Study|Non-compliance|1|||
130758688|NCT04594941|470739443|FG000|Overall Study|Other|0|||
130758689|NCT04594941|470739444|FG001|Overall Study|Other|3|||
130758690|NCT04594941|470739445|FG002|Overall Study|Other|1|||
130758691|NCT04594941|470739446|FG003|Overall Study|Other|0|||
130758692|NCT02424630|470739447|FG000|Overall Study|No rotator cuff tear|1|||
130758693|NCT02424630|470739448|FG001|Overall Study|No rotator cuff tear|2|||
130758694|NCT02424630|470739447|FG000|Overall Study|Open procedure|0|||
130758695|NCT02424630|470739448|FG001|Overall Study|Open procedure|1|||
130758696|NCT02703272|470739449|FG000|Overall Study|Death|4|||
130758697|NCT02703272|470739450|FG001|Overall Study|Death|9|||
130758698|NCT02703272|470739451|FG002|Overall Study|Death|19|||
130758699|NCT02703272|470739452|FG003|Overall Study|Death|10|||
130758700|NCT02703272|470739449|FG000|Overall Study|Withdrawal by Subject|0|||
130758701|NCT02703272|470739450|FG001|Overall Study|Withdrawal by Subject|0|||
130758702|NCT02703272|470739451|FG002|Overall Study|Withdrawal by Subject|4|||
130758703|NCT02703272|470739452|FG003|Overall Study|Withdrawal by Subject|2|||
130758704|NCT02703272|470739449|FG000|Overall Study|Study Terminated by Sponsor|6|||
130758705|NCT02703272|470739450|FG001|Overall Study|Study Terminated by Sponsor|1|||
130758706|NCT02703272|470739451|FG002|Overall Study|Study Terminated by Sponsor|12|||
130758707|NCT02703272|470739452|FG003|Overall Study|Study Terminated by Sponsor|4|||
130758708|NCT02703272|470739449|FG000|Overall Study|Other|1|||
130758709|NCT02703272|470739450|FG001|Overall Study|Other|0|||
130758710|NCT02703272|470739451|FG002|Overall Study|Other|0|||
130758711|NCT02703272|470739452|FG003|Overall Study|Other|0|||
130758712|NCT02637895|470739453|FG000|Overall Study|Lost to Follow-up|4|||
130758713|NCT02637895|470739454|FG001|Overall Study|Lost to Follow-up|0|||
130758714|NCT02637895|470739453|FG000|Overall Study|Protocol Violation|0|||
130758715|NCT02637895|470739454|FG001|Overall Study|Protocol Violation|1|||
130758716|NCT02637895|470739453|FG000|Overall Study|Lack of Efficacy|1|||
130758717|NCT02637895|470739454|FG001|Overall Study|Lack of Efficacy|0|||
130758718|NCT02637895|470739453|FG000|Overall Study|Withdrawal by Subject|1|||
130758719|NCT02637895|470739454|FG001|Overall Study|Withdrawal by Subject|1|||
130758720|NCT02637895|470739453|FG000|Overall Study|Abnormal baseline lab|0|||
130758721|NCT02637895|470739454|FG001|Overall Study|Abnormal baseline lab|1|||
130758722|NCT02031640|470739455|FG000|Screening Period|Adverse Event|1|||
130758723|NCT02031640|470739456|FG001|Screening Period|Adverse Event|0|||
130758724|NCT02031640|470739457|FG002|Screening Period|Adverse Event|0|||
130758725|NCT02031640|470739458|FG003|Screening Period|Adverse Event|0|||
130758726|NCT02031640|470739459|FG004|Screening Period|Adverse Event|0|||
130758727|NCT02031640|470739460|FG005|Screening Period|Adverse Event|0|||
130758728|NCT02031640|470739455|FG000|Screening Period|Withdrawal by Subject|29|||
130758729|NCT02031640|470739456|FG001|Screening Period|Withdrawal by Subject|0|||
130758730|NCT02031640|470739457|FG002|Screening Period|Withdrawal by Subject|0|||
130758731|NCT02031640|470739458|FG003|Screening Period|Withdrawal by Subject|0|||
130758732|NCT02031640|470739459|FG004|Screening Period|Withdrawal by Subject|0|||
130758733|NCT02031640|470739460|FG005|Screening Period|Withdrawal by Subject|0|||
130758734|NCT02031640|470739455|FG000|Screening Period|Inclusion criteria not met|312|||
130758735|NCT02031640|470739456|FG001|Screening Period|Inclusion criteria not met|0|||
130758736|NCT02031640|470739457|FG002|Screening Period|Inclusion criteria not met|0|||
130758737|NCT02031640|470739458|FG003|Screening Period|Inclusion criteria not met|0|||
130758738|NCT02031640|470739459|FG004|Screening Period|Inclusion criteria not met|0|||
130758739|NCT02031640|470739460|FG005|Screening Period|Inclusion criteria not met|0|||
130758740|NCT02031640|470739455|FG000|Screening Period|Exclusion criteria met|30|||
130758741|NCT02031640|470739456|FG001|Screening Period|Exclusion criteria met|0|||
130758742|NCT02031640|470739457|FG002|Screening Period|Exclusion criteria met|0|||
130758743|NCT02031640|470739458|FG003|Screening Period|Exclusion criteria met|0|||
130758744|NCT02031640|470739459|FG004|Screening Period|Exclusion criteria met|0|||
130758745|NCT02031640|470739460|FG005|Screening Period|Exclusion criteria met|0|||
130758746|NCT02031640|470739455|FG000|Screening Period|Lost to Follow-up|14|||
130758747|NCT02031640|470739456|FG001|Screening Period|Lost to Follow-up|0|||
130758748|NCT02031640|470739457|FG002|Screening Period|Lost to Follow-up|0|||
130758749|NCT02031640|470739458|FG003|Screening Period|Lost to Follow-up|0|||
130758750|NCT02031640|470739459|FG004|Screening Period|Lost to Follow-up|0|||
130758751|NCT02031640|470739460|FG005|Screening Period|Lost to Follow-up|0|||
130758752|NCT02031640|470739455|FG000|Screening Period|Enrollment closed|26|||
130758753|NCT02031640|470739456|FG001|Screening Period|Enrollment closed|0|||
130758754|NCT02031640|470739457|FG002|Screening Period|Enrollment closed|0|||
130758755|NCT02031640|470739458|FG003|Screening Period|Enrollment closed|0|||
130758756|NCT02031640|470739459|FG004|Screening Period|Enrollment closed|0|||
130758757|NCT02031640|470739460|FG005|Screening Period|Enrollment closed|0|||
130758758|NCT02031640|470739455|FG000|Run-In Period|Adverse Event|4|||
130758759|NCT02031640|470739456|FG001|Run-In Period|Adverse Event|0|||
130758760|NCT02031640|470739457|FG002|Run-In Period|Adverse Event|0|||
130758761|NCT02031640|470739458|FG003|Run-In Period|Adverse Event|0|||
130758762|NCT02031640|470739459|FG004|Run-In Period|Adverse Event|0|||
130758763|NCT02031640|470739460|FG005|Run-In Period|Adverse Event|0|||
130758764|NCT02031640|470739455|FG000|Run-In Period|Withdrawal by Subject|17|||
130758765|NCT02031640|470739456|FG001|Run-In Period|Withdrawal by Subject|0|||
130758766|NCT02031640|470739457|FG002|Run-In Period|Withdrawal by Subject|0|||
130758767|NCT02031640|470739458|FG003|Run-In Period|Withdrawal by Subject|0|||
130758768|NCT02031640|470739459|FG004|Run-In Period|Withdrawal by Subject|0|||
130758769|NCT02031640|470739460|FG005|Run-In Period|Withdrawal by Subject|0|||
130758770|NCT02031640|470739455|FG000|Run-In Period|Inclusion criteria not met|38|||
130758771|NCT02031640|470739456|FG001|Run-In Period|Inclusion criteria not met|0|||
130758772|NCT02031640|470739457|FG002|Run-In Period|Inclusion criteria not met|0|||
130758773|NCT02031640|470739458|FG003|Run-In Period|Inclusion criteria not met|0|||
130789501|NCT00784875|470858747|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
130758774|NCT02031640|470739459|FG004|Run-In Period|Inclusion criteria not met|0|||
130758775|NCT02031640|470739460|FG005|Run-In Period|Inclusion criteria not met|0|||
130758776|NCT02031640|470739455|FG000|Run-In Period|Exclusion criteria met|8|||
130758777|NCT02031640|470739456|FG001|Run-In Period|Exclusion criteria met|0|||
130758778|NCT02031640|470739457|FG002|Run-In Period|Exclusion criteria met|0|||
130758779|NCT02031640|470739458|FG003|Run-In Period|Exclusion criteria met|0|||
130758780|NCT02031640|470739459|FG004|Run-In Period|Exclusion criteria met|0|||
130758781|NCT02031640|470739460|FG005|Run-In Period|Exclusion criteria met|0|||
130758782|NCT02031640|470739455|FG000|Run-In Period|Randomization criteria not met|85|||
130758783|NCT02031640|470739456|FG001|Run-In Period|Randomization criteria not met|0|||
130758784|NCT02031640|470739457|FG002|Run-In Period|Randomization criteria not met|0|||
130758785|NCT02031640|470739458|FG003|Run-In Period|Randomization criteria not met|0|||
130758786|NCT02031640|470739459|FG004|Run-In Period|Randomization criteria not met|0|||
130758787|NCT02031640|470739460|FG005|Run-In Period|Randomization criteria not met|0|||
130758788|NCT02031640|470739455|FG000|Run-In Period|Various administrative reasons|17|||
130758789|NCT02031640|470739456|FG001|Run-In Period|Various administrative reasons|0|||
130758790|NCT02031640|470739457|FG002|Run-In Period|Various administrative reasons|0|||
130758791|NCT02031640|470739458|FG003|Run-In Period|Various administrative reasons|0|||
130758792|NCT02031640|470739459|FG004|Run-In Period|Various administrative reasons|0|||
130758793|NCT02031640|470739460|FG005|Run-In Period|Various administrative reasons|0|||
130758794|NCT02031640|470739455|FG000|Double-blind Treatment Period|Protocol deviation|0|||
130758795|NCT02031640|470739456|FG001|Double-blind Treatment Period|Protocol deviation|2|||
130758796|NCT02031640|470739457|FG002|Double-blind Treatment Period|Protocol deviation|0|||
130758797|NCT02031640|470739458|FG003|Double-blind Treatment Period|Protocol deviation|1|||
130758798|NCT02031640|470739459|FG004|Double-blind Treatment Period|Protocol deviation|3|||
130758799|NCT02031640|470739460|FG005|Double-blind Treatment Period|Protocol deviation|1|||
130758800|NCT02031640|470739455|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130758801|NCT02031640|470739456|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
130758802|NCT02031640|470739457|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
130758803|NCT02031640|470739458|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
130758804|NCT02031640|470739459|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
130758805|NCT02031640|470739460|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
130758806|NCT02031640|470739455|FG000|Double-blind Treatment Period|Non-compliance|0|||
130758807|NCT02031640|470739456|FG001|Double-blind Treatment Period|Non-compliance|1|||
130758808|NCT02031640|470739457|FG002|Double-blind Treatment Period|Non-compliance|0|||
130758809|NCT02031640|470739458|FG003|Double-blind Treatment Period|Non-compliance|1|||
130758810|NCT02031640|470739459|FG004|Double-blind Treatment Period|Non-compliance|1|||
130758811|NCT02031640|470739460|FG005|Double-blind Treatment Period|Non-compliance|0|||
130758812|NCT02031640|470739455|FG000|Double-blind Treatment Period|Adverse Event|0|||
130758813|NCT02031640|470739456|FG001|Double-blind Treatment Period|Adverse Event|0|||
130758814|NCT02031640|470739457|FG002|Double-blind Treatment Period|Adverse Event|0|||
130758815|NCT02031640|470739458|FG003|Double-blind Treatment Period|Adverse Event|2|||
130758816|NCT02031640|470739459|FG004|Double-blind Treatment Period|Adverse Event|0|||
130758817|NCT02031640|470739460|FG005|Double-blind Treatment Period|Adverse Event|0|||
130758818|NCT02031640|470739455|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
130758819|NCT02031640|470739456|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130758820|NCT02031640|470739457|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
130758821|NCT02031640|470739458|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
130758822|NCT02031640|470739459|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
130758823|NCT02031640|470739460|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
130758824|NCT02031640|470739455|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130758825|NCT02031640|470739456|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
130758826|NCT02031640|470739457|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130758827|NCT02031640|470739458|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
130758828|NCT02031640|470739459|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
130758829|NCT02031640|470739460|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
130758830|NCT05896527|470739465|FG000|Overall Study|Withdrawal by Subject|11|||
130758831|NCT05896527|470739466|FG001|Overall Study|Withdrawal by Subject|10|||
130758832|NCT05896527|470739467|FG002|Overall Study|Withdrawal by Subject|4|||
130758833|NCT05896527|470739468|FG003|Overall Study|Withdrawal by Subject|3|||
130758834|NCT05896527|470739469|FG004|Overall Study|Withdrawal by Subject|2|||
130758835|NCT05896527|470739465|FG000|Overall Study|Lost to Follow-up|0|||
130758836|NCT05896527|470739466|FG001|Overall Study|Lost to Follow-up|2|||
130758837|NCT05896527|470739467|FG002|Overall Study|Lost to Follow-up|2|||
130758838|NCT05896527|470739468|FG003|Overall Study|Lost to Follow-up|2|||
130758839|NCT05896527|470739469|FG004|Overall Study|Lost to Follow-up|1|||
130758840|NCT05896527|470739465|FG000|Overall Study|Significant protocol noncompliance|0|||
130758841|NCT05896527|470739466|FG001|Overall Study|Significant protocol noncompliance|1|||
130758842|NCT05896527|470739467|FG002|Overall Study|Significant protocol noncompliance|0|||
130758843|NCT05896527|470739468|FG003|Overall Study|Significant protocol noncompliance|0|||
130758844|NCT05896527|470739469|FG004|Overall Study|Significant protocol noncompliance|0|||
130758845|NCT05896527|470739465|FG000|Overall Study|Eligibility criteria not met|1|||
130758846|NCT05896527|470739466|FG001|Overall Study|Eligibility criteria not met|0|||
130758847|NCT05896527|470739467|FG002|Overall Study|Eligibility criteria not met|0|||
130758848|NCT05896527|470739468|FG003|Overall Study|Eligibility criteria not met|0|||
130758849|NCT05896527|470739469|FG004|Overall Study|Eligibility criteria not met|0|||
130758850|NCT05896527|470739465|FG000|Overall Study|Sponsor's decision|0|||
130758851|NCT05896527|470739466|FG001|Overall Study|Sponsor's decision|0|||
130758852|NCT05896527|470739467|FG002|Overall Study|Sponsor's decision|0|||
130758853|NCT05896527|470739468|FG003|Overall Study|Sponsor's decision|1|||
130758854|NCT05896527|470739469|FG004|Overall Study|Sponsor's decision|0|||
130758855|NCT05896527|470739465|FG000|Overall Study|Investigator's decision|0|||
130758856|NCT05896527|470739466|FG001|Overall Study|Investigator's decision|1|||
130758857|NCT05896527|470739467|FG002|Overall Study|Investigator's decision|0|||
130758858|NCT05896527|470739468|FG003|Overall Study|Investigator's decision|0|||
130758859|NCT05896527|470739469|FG004|Overall Study|Investigator's decision|0|||
130758860|NCT05896527|470739465|FG000|Overall Study|Pregnancy of his partner|0|||
130758861|NCT05896527|470739466|FG001|Overall Study|Pregnancy of his partner|0|||
130758862|NCT05896527|470739467|FG002|Overall Study|Pregnancy of his partner|0|||
130758863|NCT05896527|470739468|FG003|Overall Study|Pregnancy of his partner|1|||
130758864|NCT05896527|470739469|FG004|Overall Study|Pregnancy of his partner|0|||
130758865|NCT03085238|470739470|FG000|Overall Study|Adverse Event|2|||
130758866|NCT03085238|470739470|FG000|Overall Study|Death|2|||
130758867|NCT01279070|470739471|FG000|Overall Study|Withdrawal by Subject|2|||
130758868|NCT01279070|470739472|FG001|Overall Study|Withdrawal by Subject|3|||
130758869|NCT01279070|470739471|FG000|Overall Study|Acute exacerbation|3|||
130758870|NCT01279070|470739472|FG001|Overall Study|Acute exacerbation|1|||
130758871|NCT03781583|470739473|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
130758872|NCT03781583|470739474|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
130758873|NCT03781583|470739475|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
130758874|NCT03781583|470739476|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
130758875|NCT03781583|470739473|FG000|Overall Study|Technology did not work for that person in that environment|1|||
130758876|NCT03781583|470739474|FG001|Overall Study|Technology did not work for that person in that environment|0|||
130758877|NCT03781583|470739475|FG002|Overall Study|Technology did not work for that person in that environment|0|||
130758878|NCT03781583|470739476|FG003|Overall Study|Technology did not work for that person in that environment|0|||
130758879|NCT03781583|470739473|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
130758880|NCT03781583|470739474|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
130758881|NCT03781583|470739475|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
130758882|NCT03781583|470739476|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
130758883|NCT03781583|470739473|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
130758884|NCT03781583|470739474|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
130758885|NCT03781583|470739475|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
130758886|NCT03781583|470739476|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
130758887|NCT05139303|470739477|FG000|Overall Study|Lost to Follow-up|3|||
130758888|NCT05139303|470739478|FG001|Overall Study|Lost to Follow-up|0|||
130758889|NCT05139303|470739477|FG000|Overall Study|Adverse Event|1|||
130758890|NCT05139303|470739478|FG001|Overall Study|Adverse Event|0|||
130758891|NCT02222545|470739479|FG000|Overall Study|Adverse Event|1|||
130758892|NCT02222545|470739480|FG001|Overall Study|Adverse Event|0|||
130758893|NCT02222545|470739481|FG002|Overall Study|Adverse Event|2|||
130758894|NCT02222545|470739479|FG000|Overall Study|Death|0|||
130758895|NCT02222545|470739480|FG001|Overall Study|Death|0|||
130758896|NCT02222545|470739481|FG002|Overall Study|Death|9|||
130758897|NCT02222545|470739479|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
130758898|NCT02222545|470739480|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
130758899|NCT02222545|470739481|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
130758900|NCT02222545|470739479|FG000|Overall Study|Withdrawal by Subject|0|||
130758901|NCT02222545|470739480|FG001|Overall Study|Withdrawal by Subject|0|||
130758902|NCT02222545|470739481|FG002|Overall Study|Withdrawal by Subject|3|||
130758903|NCT02222545|470739479|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
130758904|NCT02222545|470739480|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
130758905|NCT02222545|470739481|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
130758906|NCT00761280|470739482|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
130758907|NCT00761280|470739483|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
130758908|NCT00761280|470739482|FG000|Randomization to First Dose|Sponsor decision|1|||
130758909|NCT00761280|470739483|FG001|Randomization to First Dose|Sponsor decision|0|||
130758910|NCT00761280|470739482|FG000|Randomization to First Dose|Other|1|||
130758911|NCT00761280|470739483|FG001|Randomization to First Dose|Other|0|||
130758912|NCT00761280|470739482|FG000|First Dose to End of Study|End of trial|5|||
130758913|NCT00761280|470739483|FG001|First Dose to End of Study|End of trial|5|||
130758914|NCT00761280|470739482|FG000|First Dose to End of Study|Progressive disease|5|||
130758915|NCT00761280|470739483|FG001|First Dose to End of Study|Progressive disease|3|||
130758916|NCT00761280|470739482|FG000|First Dose to End of Study|Sponsor decision|1|||
130758917|NCT00761280|470739483|FG001|First Dose to End of Study|Sponsor decision|2|||
130758918|NCT00761280|470739482|FG000|First Dose to End of Study|Death|1|||
130758919|NCT00761280|470739483|FG001|First Dose to End of Study|Death|0|||
130758920|NCT00761280|470739482|FG000|First Dose to End of Study|Lost to Follow-up|0|||
130758921|NCT00761280|470739483|FG001|First Dose to End of Study|Lost to Follow-up|1|||
130758922|NCT03875482|470739484|FG000|Overall Study|Adverse Event|0|||
130758923|NCT03875482|470739485|FG001|Overall Study|Adverse Event|1|||
130758924|NCT03875482|470739484|FG000|Overall Study|Withdrew consent|5|||
130758925|NCT03875482|470739485|FG001|Overall Study|Withdrew consent|6|||
130758926|NCT03875482|470739484|FG000|Overall Study|Lost to Follow-up|8|||
130758927|NCT03875482|470739485|FG001|Overall Study|Lost to Follow-up|2|||
130758928|NCT03875482|470739484|FG000|Overall Study|Lack of Efficacy|0|||
130758929|NCT03875482|470739485|FG001|Overall Study|Lack of Efficacy|11|||
130758930|NCT02045862|470739487|FG000|Overall Study|Death|0|||
130758931|NCT02045862|470739488|FG001|Overall Study|Death|0|||
130758932|NCT02045862|470739489|FG002|Overall Study|Death|1|||
130758933|NCT02045862|470739487|FG000|Overall Study|Miscellaneous|5|||
130758934|NCT02045862|470739488|FG001|Overall Study|Miscellaneous|0|||
130758935|NCT02045862|470739489|FG002|Overall Study|Miscellaneous|8|||
130758936|NCT02045862|470739487|FG000|Overall Study|Withdrawal by Patient|18|||
130758937|NCT02045862|470739488|FG001|Overall Study|Withdrawal by Patient|27|||
130758938|NCT02045862|470739489|FG002|Overall Study|Withdrawal by Patient|57|||
130758939|NCT02045862|470739487|FG000|Overall Study|Protocol Violation|0|||
130758940|NCT02045862|470739488|FG001|Overall Study|Protocol Violation|0|||
130758941|NCT02045862|470739489|FG002|Overall Study|Protocol Violation|6|||
130758942|NCT02045862|470739487|FG000|Overall Study|Lack of Efficacy|8|||
130758943|NCT02045862|470739488|FG001|Overall Study|Lack of Efficacy|4|||
130758944|NCT02045862|470739489|FG002|Overall Study|Lack of Efficacy|13|||
130758945|NCT02045862|470739487|FG000|Overall Study|Randomized but not Received Study Drug|0|||
130758946|NCT02045862|470739488|FG001|Overall Study|Randomized but not Received Study Drug|2|||
130758947|NCT02045862|470739489|FG002|Overall Study|Randomized but not Received Study Drug|8|||
130758948|NCT02045862|470739487|FG000|Overall Study|Adverse Event|7|||
130758949|NCT02045862|470739488|FG001|Overall Study|Adverse Event|5|||
130758950|NCT02045862|470739489|FG002|Overall Study|Adverse Event|27|||
130758951|NCT02045862|470739487|FG000|Overall Study|Lost to Follow-up|1|||
130758952|NCT02045862|470739488|FG001|Overall Study|Lost to Follow-up|2|||
130758953|NCT02045862|470739489|FG002|Overall Study|Lost to Follow-up|6|||
130789502|NCT00784875|470858748|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
130789503|NCT00784875|470858749|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
130789504|NCT00784875|470858746|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
130789505|NCT00784875|470858747|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
130789506|NCT00784875|470858748|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
130789507|NCT00784875|470858749|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
130789508|NCT00784875|470858746|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
130758954|NCT02691013|470739490|FG000|Overall Study|Withdrawal by Subject|3|||
130758955|NCT02691013|470739491|FG001|Overall Study|Withdrawal by Subject|0|||
130758956|NCT02111785|470739495|FG000|Overall Study|Death|0|||
130758957|NCT02111785|470739496|FG001|Overall Study|Death|1|||
130758958|NCT02111785|470739497|FG002|Overall Study|Death|0|||
130758959|NCT02111785|470739498|FG003|Overall Study|Death|0|||
130758960|NCT01075646|470739501|FG000|Overall Study|Lost to Follow-up|4|||
130758961|NCT01075646|470739502|FG001|Overall Study|Lost to Follow-up|3|||
130758962|NCT01075646|470739503|FG002|Overall Study|Lost to Follow-up|1|||
130789509|NCT00784875|470858747|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
130789510|NCT00784875|470858748|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
130789511|NCT00784875|470858749|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
130758963|NCT01075646|470739504|FG003|Overall Study|Lost to Follow-up|2|||
130758964|NCT01676896|470739508|FG000|Overall Study|Withdrawal by Subject|12|||
130758965|NCT01676896|470739509|FG001|Overall Study|Withdrawal by Subject|7|||
130758966|NCT01676896|470739510|FG002|Overall Study|Withdrawal by Subject|19|||
130758967|NCT02256982|470739511|FG000|Overall Study|Disease Progression|0|||
130758968|NCT02256982|470739512|FG001|Overall Study|Disease Progression|1|||
130758969|NCT02822573|470739513|FG000|Overall Study|Lost to Follow-up|5|||
130789512|NCT00784875|470858746|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
130758970|NCT02822573|470739514|FG001|Overall Study|Lost to Follow-up|3|||
130758971|NCT02822573|470739513|FG000|Overall Study|Physician Decision|1|||
130758972|NCT02822573|470739514|FG001|Overall Study|Physician Decision|1|||
130758973|NCT02822573|470739513|FG000|Overall Study|Withdrawal by Subject|9|||
130758974|NCT02822573|470739514|FG001|Overall Study|Withdrawal by Subject|5|||
130758975|NCT02822573|470739513|FG000|Overall Study|Protocol Violation|6|||
130758976|NCT02822573|470739514|FG001|Overall Study|Protocol Violation|4|||
130758977|NCT02822573|470739513|FG000|Overall Study|Too sick or ill|2|||
130758978|NCT02822573|470739514|FG001|Overall Study|Too sick or ill|1|||
130758979|NCT02822573|470739513|FG000|Overall Study|Disease Progression|1|||
130758980|NCT02822573|470739514|FG001|Overall Study|Disease Progression|1|||
130758981|NCT02822573|470739513|FG000|Overall Study|No reason given|6|||
130758982|NCT02822573|470739514|FG001|Overall Study|No reason given|4|||
130758983|NCT01044290|470739515|FG000|Follow-up 1|Death|3|||
130758984|NCT01044290|470739516|FG001|Follow-up 1|Death|3|||
130758985|NCT01044290|470739517|FG002|Follow-up 1|Death|1|||
130758986|NCT01044290|470739515|FG000|Follow-up 1|Withdrawal by Subject|2|||
130758987|NCT01044290|470739516|FG001|Follow-up 1|Withdrawal by Subject|2|||
130758988|NCT01044290|470739517|FG002|Follow-up 1|Withdrawal by Subject|0|||
130758989|NCT01044290|470739515|FG000|Follow-Up 2|Death|0|||
130758990|NCT01044290|470739516|FG001|Follow-Up 2|Death|1|||
130758991|NCT01044290|470739517|FG002|Follow-Up 2|Death|1|||
130758992|NCT01044290|470739515|FG000|Follow-Up 2|Withdrawal by Subject|0|||
130758993|NCT01044290|470739516|FG001|Follow-Up 2|Withdrawal by Subject|1|||
130758994|NCT01044290|470739517|FG002|Follow-Up 2|Withdrawal by Subject|1|||
130758995|NCT00759785|470739523|FG000|Overall Study|Participant sample not evaluable|11|||
130758996|NCT00759785|470739524|FG001|Overall Study|Participant sample not evaluable|2|||
130758997|NCT00759785|470739523|FG000|Overall Study|Participant sample lost|0|||
130758998|NCT00759785|470739524|FG001|Overall Study|Participant sample lost|1|||
130758999|NCT00759785|470739523|FG000|Overall Study|Protocol Violation|1|||
130759000|NCT00759785|470739524|FG001|Overall Study|Protocol Violation|0|||
130759001|NCT00759785|470739523|FG000|Overall Study|Physician Decision|0|||
130759002|NCT00759785|470739524|FG001|Overall Study|Physician Decision|1|||
130759003|NCT00759785|470739523|FG000|Overall Study|Withdrawal by Subject|0|||
130759004|NCT00759785|470739524|FG001|Overall Study|Withdrawal by Subject|1|||
130759005|NCT01646021|470739525|FG000|Overall Study|Death|77|||
130759006|NCT01646021|470739526|FG001|Overall Study|Death|83|||
130759007|NCT01646021|470739525|FG000|Overall Study|Study Terminated by Sponsor|50|||
130759008|NCT01646021|470739526|FG001|Overall Study|Study Terminated by Sponsor|41|||
130759009|NCT01646021|470739525|FG000|Overall Study|Lost to Follow-up|2|||
130759010|NCT01646021|470739526|FG001|Overall Study|Lost to Follow-up|2|||
130759011|NCT01646021|470739525|FG000|Overall Study|Withdrawal by Subject|10|||
130759012|NCT01646021|470739526|FG001|Overall Study|Withdrawal by Subject|15|||
130759013|NCT02777970|470739534|FG000|Overall Study|Lost to Follow-up|0|||
130759014|NCT02777970|470739535|FG001|Overall Study|Lost to Follow-up|1|||
130759015|NCT02777970|470739536|FG002|Overall Study|Lost to Follow-up|0|||
130759016|NCT02777970|470739534|FG000|Overall Study|Protocol Violation|1|||
130759017|NCT02777970|470739535|FG001|Overall Study|Protocol Violation|0|||
130759018|NCT02777970|470739536|FG002|Overall Study|Protocol Violation|0|||
130759019|NCT01967706|470739537|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
130759020|NCT01967706|470739538|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
130759021|NCT01967706|470739539|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
130759022|NCT01967706|470739540|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
130759023|NCT02347891|470739544|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
130759024|NCT02347891|470739545|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
130759025|NCT02347891|470739544|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
130759026|NCT02347891|470739545|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
130759027|NCT01083186|470739548|FG000|Overall Study|Lost to Follow-up|48|||
130759028|NCT01083186|470739548|FG000|Overall Study|Consent Withdrawal|7|||
130759029|NCT01083186|470739548|FG000|Overall Study|Death|3|||
130759030|NCT01083186|470739548|FG000|Overall Study|Adverse Event|3|||
130759031|NCT01083186|470739548|FG000|Overall Study|Lack of Efficacy|2|||
130759032|NCT01083186|470739548|FG000|Overall Study|Hemodialysis Initiation|28|||
130759033|NCT01083186|470739548|FG000|Overall Study|Administrative Reasons|2|||
130759034|NCT01083186|470739548|FG000|Overall Study|Non-compliance to Study Treatment|1|||
130759035|NCT03419598|470739555|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
130759036|NCT04569968|470739556|FG000|Overall Study|Lost to Follow-up|2|||
130759037|NCT04569968|470739557|FG001|Overall Study|Lost to Follow-up|5|||
130759038|NCT04569968|470739556|FG000|Overall Study|Story of head and/or neck surgery|2|||
130759039|NCT04569968|470739557|FG001|Overall Study|Story of head and/or neck surgery|2|||
130759040|NCT04569968|470739556|FG000|Overall Study|Time of stroke onset|8|||
130759041|NCT04569968|470739557|FG001|Overall Study|Time of stroke onset|7|||
130789513|NCT00784875|470858747|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
130759042|NCT04569968|470739556|FG000|Overall Study|Type of strokr|12|||
130759043|NCT04569968|470739557|FG001|Overall Study|Type of strokr|8|||
130759044|NCT04569968|470739556|FG000|Overall Study|Cooperation|8|||
130759045|NCT04569968|470739557|FG001|Overall Study|Cooperation|8|||
130759046|NCT04569968|470739556|FG000|Overall Study|Age interval|17|||
130759047|NCT04569968|470739557|FG001|Overall Study|Age interval|6|||
130759048|NCT04569968|470739556|FG000|Overall Study|Denial of participation to the study|0|||
130759049|NCT04569968|470739557|FG001|Overall Study|Denial of participation to the study|3|||
130759050|NCT04569968|470739556|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
130759051|NCT04569968|470739557|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
130759052|NCT04569968|470739556|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
130759053|NCT04569968|470739557|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
130759054|NCT04569968|470739556|FG000|Overall Study|Quarantine|1|||
130759055|NCT04569968|470739557|FG001|Overall Study|Quarantine|0|||
130789514|NCT00784875|470858748|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
130759056|NCT04569968|470739556|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
130759057|NCT04569968|470739557|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
130759058|NCT04569968|470739556|FG000|Overall Study|Repetitive stroke|8|||
130759059|NCT04569968|470739557|FG001|Overall Study|Repetitive stroke|0|||
130759060|NCT04569968|470739556|FG000|Overall Study|Insufficient mastication|1|||
130759061|NCT04569968|470739557|FG001|Overall Study|Insufficient mastication|0|||
130759062|NCT04569968|470739556|FG000|Overall Study|Infection|1|||
130759063|NCT04569968|470739557|FG001|Overall Study|Infection|0|||
130759064|NCT02370667|470739558|FG000|Overall Study|Lost to Follow-up|0|||
130759065|NCT02370667|470739559|FG001|Overall Study|Lost to Follow-up|1|||
130759066|NCT02370667|470739560|FG002|Overall Study|Lost to Follow-up|0|||
130759067|NCT00976209|470739563|FG000|Treatment Period 1|Protocol Violation|1|||
130759068|NCT00976209|470739564|FG001|Treatment Period 1|Protocol Violation|0|||
130759069|NCT00976209|470739563|FG000|Treatment Period 1|Lost to Follow-up|2|||
130759070|NCT00976209|470739564|FG001|Treatment Period 1|Lost to Follow-up|0|||
130759071|NCT00976209|470739563|FG000|Treatment Period 1|Other|0|||
130759072|NCT00976209|470739564|FG001|Treatment Period 1|Other|1|||
130759073|NCT00976209|470739563|FG000|Wash-out Period|Adverse Event|1|||
130759074|NCT00976209|470739564|FG001|Wash-out Period|Adverse Event|2|||
130759075|NCT00976209|470739563|FG000|Wash-out Period|Lost to Follow-up|1|||
130759076|NCT00976209|470739564|FG001|Wash-out Period|Lost to Follow-up|0|||
130759077|NCT00976209|470739563|FG000|Wash-out Period|Protocol Violation|1|||
130759078|NCT00976209|470739564|FG001|Wash-out Period|Protocol Violation|0|||
130759079|NCT00976209|470739563|FG000|Wash-out Period|Other|1|||
130759080|NCT00976209|470739564|FG001|Wash-out Period|Other|0|||
130759081|NCT00976209|470739563|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130759082|NCT00976209|470739564|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130759083|NCT00976209|470739563|FG000|Treatment Period 2|Lost to Follow-up|0|||
130759084|NCT00976209|470739564|FG001|Treatment Period 2|Lost to Follow-up|1|||
130759085|NCT03197870|470739568|FG000|Overall Study|Adverse Event|9|||
130759086|NCT03197870|470739569|FG001|Overall Study|Adverse Event|4|||
130759087|NCT03197870|470739570|FG002|Overall Study|Adverse Event|6|||
130759088|NCT03197870|470739568|FG000|Overall Study|Withdrawal by Subject|2|||
130759089|NCT03197870|470739569|FG001|Overall Study|Withdrawal by Subject|3|||
130759090|NCT03197870|470739570|FG002|Overall Study|Withdrawal by Subject|0|||
130759091|NCT03197870|470739568|FG000|Overall Study|Lost to Follow-up|2|||
130759092|NCT03197870|470739569|FG001|Overall Study|Lost to Follow-up|2|||
130759093|NCT03197870|470739570|FG002|Overall Study|Lost to Follow-up|0|||
130759094|NCT03197870|470739568|FG000|Overall Study|data not available|1|||
130759095|NCT03197870|470739569|FG001|Overall Study|data not available|1|||
130759096|NCT03197870|470739570|FG002|Overall Study|data not available|0|||
130759097|NCT00176644|470739571|FG000|Overall Study|Withdrawal by Subject|1|||
130759098|NCT02693171|470739572|FG000|Overall Study|Adverse Event|1|||
130759099|NCT02693171|470739572|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
130759100|NCT00978250|470739574|FG000|Overall Study|Late determination of ineligibility|0|||
130759101|NCT00978250|470739575|FG001|Overall Study|Late determination of ineligibility|1|||
130759102|NCT00978250|470739576|FG002|Overall Study|Late determination of ineligibility|0|||
130759103|NCT00978250|470739577|FG003|Overall Study|Late determination of ineligibility|1|||
130759104|NCT03973918|470739578|FG000|Overall Study|Adverse Event|0|||
130759105|NCT03973918|470739579|FG001|Overall Study|Adverse Event|0|||
130759106|NCT03973918|470739580|FG002|Overall Study|Adverse Event|0|||
130759107|NCT03973918|470739581|FG003|Overall Study|Adverse Event|1|||
130759108|NCT03973918|470739578|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
130759109|NCT03973918|470739579|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
130759110|NCT03973918|470739580|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
130759111|NCT03973918|470739581|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
130759112|NCT02951533|470739589|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
130759113|NCT02951533|470739590|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
130759114|NCT02951533|470739591|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
130759115|NCT02951533|470739589|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
130759116|NCT02951533|470739590|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
130759117|NCT02951533|470739591|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
130759118|NCT02951533|470739589|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
130759119|NCT02951533|470739590|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
130759120|NCT02951533|470739591|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
130759121|NCT02951533|470739589|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
130759122|NCT02951533|470739590|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
130759123|NCT02951533|470739591|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
130759124|NCT02951533|470739589|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
130759125|NCT02951533|470739590|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
130759126|NCT02951533|470739591|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
130759127|NCT02951533|470739589|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
130759128|NCT02951533|470739590|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
130759129|NCT02951533|470739591|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
130759130|NCT02951533|470739589|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
130759131|NCT02951533|470739590|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
130759132|NCT02951533|470739591|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
130759133|NCT02951533|470739589|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
130759134|NCT02951533|470739590|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
130759135|NCT02951533|470739591|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
130759136|NCT02951533|470739589|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
130759137|NCT02951533|470739590|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
130759138|NCT02951533|470739591|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
130759139|NCT02951533|470739589|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
130759140|NCT02951533|470739590|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
130759141|NCT02951533|470739591|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
130759142|NCT02951533|470739589|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
130759143|NCT02951533|470739590|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
130759144|NCT02951533|470739591|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
130759145|NCT05174949|470739592|FG000|Overall Study|Physician Decision|1|||
130759146|NCT05174949|470739593|FG001|Overall Study|Physician Decision|2|||
130759147|NCT05174949|470739594|FG002|Overall Study|Physician Decision|0|||
130759148|NCT05174949|470739595|FG003|Overall Study|Physician Decision|1|||
130759149|NCT05174949|470739596|FG004|Overall Study|Physician Decision|0|||
130759150|NCT05174949|470739597|FG005|Overall Study|Physician Decision|0|||
130759151|NCT05174949|470739592|FG000|Overall Study|Withdrawal by Subject|0|||
130759152|NCT05174949|470739593|FG001|Overall Study|Withdrawal by Subject|1|||
130759153|NCT05174949|470739594|FG002|Overall Study|Withdrawal by Subject|0|||
130759154|NCT05174949|470739595|FG003|Overall Study|Withdrawal by Subject|0|||
130759155|NCT05174949|470739596|FG004|Overall Study|Withdrawal by Subject|0|||
130759156|NCT05174949|470739597|FG005|Overall Study|Withdrawal by Subject|0|||
130759157|NCT05174949|470739592|FG000|Overall Study|Lost to Follow-up|0|||
130759158|NCT05174949|470739593|FG001|Overall Study|Lost to Follow-up|0|||
130759159|NCT05174949|470739594|FG002|Overall Study|Lost to Follow-up|0|||
130759160|NCT05174949|470739595|FG003|Overall Study|Lost to Follow-up|1|||
130759161|NCT05174949|470739596|FG004|Overall Study|Lost to Follow-up|0|||
130759162|NCT05174949|470739597|FG005|Overall Study|Lost to Follow-up|0|||
130759163|NCT02029989|470739598|FG000|Overall Study|Withdrawal by Subject|1|||
130759164|NCT02029989|470739599|FG001|Overall Study|Withdrawal by Subject|0|||
130759165|NCT02029989|470739598|FG000|Overall Study|Withdrawal: Fear of needles|1|||
130759166|NCT02029989|470739599|FG001|Overall Study|Withdrawal: Fear of needles|0|||
130759167|NCT02029989|470739598|FG000|Overall Study|Change of location|2|||
130759168|NCT02029989|470739599|FG001|Overall Study|Change of location|3|||
130759169|NCT02029989|470739598|FG000|Overall Study|Physician Decision|2|||
130759170|NCT02029989|470739599|FG001|Overall Study|Physician Decision|0|||
130759171|NCT02029989|470739598|FG000|Overall Study|Lost to Follow-up|9|||
130759172|NCT02029989|470739599|FG001|Overall Study|Lost to Follow-up|7|||
130759173|NCT02029989|470739598|FG000|Overall Study|Death|0|||
130759174|NCT02029989|470739599|FG001|Overall Study|Death|1|||
130759175|NCT02029989|470739598|FG000|Overall Study|Protocol Violation|1|||
130759176|NCT02029989|470739599|FG001|Overall Study|Protocol Violation|0|||
130759177|NCT04351373|470739600|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
130759178|NCT00742508|470739611|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
130759179|NCT00742508|470739612|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
130759180|NCT00742508|470739611|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
130759181|NCT00742508|470739612|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
130759182|NCT00742508|470739611|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
130759183|NCT00742508|470739612|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
130759184|NCT00742508|470739611|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
130759185|NCT00742508|470739612|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
130759186|NCT00742508|470739611|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
130759187|NCT00742508|470739612|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
130759188|NCT04696354|470739615|FG000|Overall Study|Study termination|6|||
130759189|NCT04696354|470739616|FG001|Overall Study|Study termination|6|||
130759190|NCT02730377|470741997|FG000|Overall Study|Other|5|||
130759191|NCT02730377|470741998|FG001|Overall Study|Other|4|||
130759192|NCT02730377|470741997|FG000|Overall Study|Death|1|||
130759193|NCT02730377|470741998|FG001|Overall Study|Death|8|||
130759194|NCT02730377|470741997|FG000|Overall Study|Inadequate glycaemic control|368|||
130759195|NCT02730377|470741998|FG001|Overall Study|Inadequate glycaemic control|473|||
130759196|NCT02730377|470741997|FG000|Overall Study|Adverse Event|79|||
130759197|NCT02730377|470741998|FG001|Overall Study|Adverse Event|41|||
130759198|NCT02730377|470741997|FG000|Overall Study|Protocol Violation|23|||
130759199|NCT02730377|470741998|FG001|Overall Study|Protocol Violation|30|||
130759200|NCT02730377|470741997|FG000|Overall Study|Lack of Efficacy|4|||
130759201|NCT02730377|470741998|FG001|Overall Study|Lack of Efficacy|13|||
130759202|NCT02730377|470741997|FG000|Overall Study|Pregnancy|0|||
130759203|NCT02730377|470741998|FG001|Overall Study|Pregnancy|1|||
130759204|NCT02730377|470741997|FG000|Overall Study|Withdrawal by Subject|45|||
130759205|NCT02730377|470741998|FG001|Overall Study|Withdrawal by Subject|42|||
130759206|NCT02730377|470741997|FG000|Overall Study|Lost to Follow-up|25|||
130759207|NCT02730377|470741998|FG001|Overall Study|Lost to Follow-up|21|||
130759208|NCT04045132|470742001|FG000|Overall Study|Lost to Follow-up|3|||
130759209|NCT04045132|470742002|FG001|Overall Study|Lost to Follow-up|6|||
130759210|NCT02143791|470742005|FG000|Enrolled|Withdrawal by Subject|4|||
130759211|NCT02143791|470742005|FG000|Trial Stimulation|Lack of Efficacy|21|||
130759212|NCT02143791|470742005|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
130759213|NCT02143791|470742005|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
130759214|NCT02143791|470742005|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
130759215|NCT02143791|470742005|FG000|Any Programming (3-6 Months)|Missing Data|1|||
130759216|NCT02143791|470742005|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
130759217|NCT00401544|470742006|FG000|Overall Study|Adverse Event|5|||
130759218|NCT00401544|470742007|FG001|Overall Study|Adverse Event|1|||
130759219|NCT00401544|470742008|FG002|Overall Study|Adverse Event|1|||
130759220|NCT00401544|470742009|FG003|Overall Study|Adverse Event|1|||
130759221|NCT00401544|470742006|FG000|Overall Study|Death|3|||
130759222|NCT00401544|470742007|FG001|Overall Study|Death|6|||
130759223|NCT00401544|470742008|FG002|Overall Study|Death|2|||
130759224|NCT00401544|470742009|FG003|Overall Study|Death|5|||
130759225|NCT00401544|470742006|FG000|Overall Study|Lost to Follow-up|2|||
130759226|NCT00401544|470742007|FG001|Overall Study|Lost to Follow-up|0|||
130759227|NCT00401544|470742008|FG002|Overall Study|Lost to Follow-up|1|||
130759228|NCT00401544|470742009|FG003|Overall Study|Lost to Follow-up|1|||
130759229|NCT00401544|470742006|FG000|Overall Study|Withdrawal by Subject|7|||
130759230|NCT00401544|470742007|FG001|Overall Study|Withdrawal by Subject|6|||
130759231|NCT00401544|470742008|FG002|Overall Study|Withdrawal by Subject|6|||
130759232|NCT00401544|470742009|FG003|Overall Study|Withdrawal by Subject|5|||
130759233|NCT00401544|470742006|FG000|Overall Study|Physician Decision|1|||
130759234|NCT00401544|470742007|FG001|Overall Study|Physician Decision|3|||
130759235|NCT00401544|470742008|FG002|Overall Study|Physician Decision|0|||
130759236|NCT00401544|470742009|FG003|Overall Study|Physician Decision|0|||
130759237|NCT00401544|470742006|FG000|Overall Study|Ineligibility determined|0|||
130759238|NCT00401544|470742007|FG001|Overall Study|Ineligibility determined|1|||
130759239|NCT00401544|470742008|FG002|Overall Study|Ineligibility determined|0|||
130759240|NCT00401544|470742009|FG003|Overall Study|Ineligibility determined|2|||
130759241|NCT00401544|470742006|FG000|Overall Study|Disease progression|0|||
130759242|NCT00401544|470742007|FG001|Overall Study|Disease progression|1|||
130759243|NCT00401544|470742008|FG002|Overall Study|Disease progression|0|||
130759244|NCT00401544|470742009|FG003|Overall Study|Disease progression|0|||
130759245|NCT00401544|470742006|FG000|Overall Study|Other|0|||
130759246|NCT00401544|470742007|FG001|Overall Study|Other|0|||
130759247|NCT00401544|470742008|FG002|Overall Study|Other|2|||
130759248|NCT00401544|470742009|FG003|Overall Study|Other|2|||
130759249|NCT02275780|470742023|FG000|Base Study: 96 Weeks|Adverse Event|6|||
130759250|NCT02275780|470742024|FG001|Base Study: 96 Weeks|Adverse Event|14|||
130759251|NCT02275780|470742023|FG000|Base Study: 96 Weeks|Death|3|||
130759252|NCT02275780|470742024|FG001|Base Study: 96 Weeks|Death|1|||
130759253|NCT02275780|470742023|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
130759254|NCT02275780|470742024|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
130759255|NCT02275780|470742023|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
130759256|NCT02275780|470742024|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
130759257|NCT02275780|470742023|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
130759258|NCT02275780|470742024|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
130759259|NCT02275780|470742023|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
130759260|NCT02275780|470742024|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
130759261|NCT02275780|470742023|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
130759262|NCT02275780|470742024|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
130759263|NCT02275780|470742023|FG000|Base Study: 96 Weeks|Physician Decision|2|||
130759264|NCT02275780|470742024|FG001|Base Study: 96 Weeks|Physician Decision|4|||
130759265|NCT02275780|470742023|FG000|Base Study: 96 Weeks|Pregnancy|2|||
130759266|NCT02275780|470742024|FG001|Base Study: 96 Weeks|Pregnancy|1|||
130759267|NCT02275780|470742023|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
130759268|NCT02275780|470742024|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
130759269|NCT02275780|470742023|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
130759270|NCT02275780|470742024|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
130759271|NCT02275780|470742023|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
130759272|NCT02275780|470742024|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
130759273|NCT02275780|470742023|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
130759274|NCT02275780|470742024|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
130759275|NCT02275780|470742023|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
130759276|NCT02275780|470742024|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
130759277|NCT02275780|470742023|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
130759278|NCT02275780|470742024|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
130759279|NCT02275780|470742023|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
130759280|NCT02275780|470742024|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
130759281|NCT02275780|470742023|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
130759282|NCT02275780|470742024|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
130759283|NCT02275780|470742023|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
130759284|NCT02275780|470742024|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
130759285|NCT02275780|470742023|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
130759286|NCT02275780|470742024|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
130759287|NCT02275780|470742023|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
130759288|NCT02275780|470742024|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
130759289|NCT02275780|470742023|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
130759290|NCT02275780|470742024|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
130759291|NCT02275780|470742023|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
130759292|NCT02275780|470742024|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
130759293|NCT02275780|470742023|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
130759294|NCT02275780|470742024|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
130759295|NCT02275780|470742023|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
130759296|NCT02275780|470742024|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
130759297|NCT02275780|470742023|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
130759298|NCT02275780|470742024|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
130759299|NCT02275780|470742023|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
130759300|NCT02275780|470742024|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
130759301|NCT02275780|470742023|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
130759302|NCT02275780|470742024|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
130759303|NCT02275780|470742023|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
130759304|NCT02275780|470742024|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
130759305|NCT02275780|470742023|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
130759306|NCT02275780|470742024|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
130759307|NCT02275780|470742023|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
130759308|NCT02275780|470742024|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
130759309|NCT02275780|470742023|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
130759310|NCT02275780|470742024|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
130759311|NCT00738881|470742027|FG000|Overall Study|Withdrawal by Subject|0|||
130759312|NCT00738881|470742028|FG001|Overall Study|Withdrawal by Subject|2|||
130759313|NCT00348790|470742029|FG000|Completed Treatment|Withdrawal by Subject|4|||
130759314|NCT00348790|470742029|FG000|Completed Treatment|Disease progression|14|||
130759315|NCT00348790|470742029|FG000|Completed Treatment|Adverse Event|4|||
130759316|NCT00348790|470742029|FG000|Completed Treatment|Required surgery|2|||
130759317|NCT00348790|470742029|FG000|Completed Treatment|Unable to travel to study site|1|||
130759318|NCT04712019|470742031|FG000|Overall Study|Withdrawal by Subject|2|||
130759319|NCT04712019|470742032|FG001|Overall Study|Withdrawal by Subject|2|||
130759320|NCT04712019|470742031|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
130759321|NCT04712019|470742032|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
130759322|NCT01282164|470742038|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
130759323|NCT01282164|470742039|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
130759324|NCT04521621|470742040|FG000|Overall Study|Death|17|||
130759325|NCT04521621|470742041|FG001|Overall Study|Death|8|||
130759326|NCT04521621|470742042|FG002|Overall Study|Death|8|||
130759327|NCT04521621|470742043|FG003|Overall Study|Death|5|||
130759328|NCT04521621|470742044|FG004|Overall Study|Death|2|||
130759329|NCT04521621|470742045|FG005|Overall Study|Death|7|||
130759330|NCT04521621|470742046|FG006|Overall Study|Death|0|||
130759331|NCT04521621|470742047|FG007|Overall Study|Death|0|||
130759332|NCT04521621|470742040|FG000|Overall Study|Study Terminated by Sponsor|4|||
130759333|NCT04521621|470742041|FG001|Overall Study|Study Terminated by Sponsor|6|||
130759334|NCT04521621|470742042|FG002|Overall Study|Study Terminated by Sponsor|8|||
130759335|NCT04521621|470742043|FG003|Overall Study|Study Terminated by Sponsor|0|||
130759336|NCT04521621|470742044|FG004|Overall Study|Study Terminated by Sponsor|1|||
130759337|NCT04521621|470742045|FG005|Overall Study|Study Terminated by Sponsor|7|||
130759338|NCT04521621|470742046|FG006|Overall Study|Study Terminated by Sponsor|0|||
130759339|NCT04521621|470742047|FG007|Overall Study|Study Terminated by Sponsor|0|||
130759340|NCT04521621|470742040|FG000|Overall Study|Withdrawal by Subject|0|||
130759341|NCT04521621|470742041|FG001|Overall Study|Withdrawal by Subject|0|||
130759342|NCT04521621|470742042|FG002|Overall Study|Withdrawal by Subject|1|||
130759343|NCT04521621|470742043|FG003|Overall Study|Withdrawal by Subject|1|||
130789515|NCT00784875|470858749|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
130759344|NCT04521621|470742044|FG004|Overall Study|Withdrawal by Subject|0|||
130759345|NCT04521621|470742045|FG005|Overall Study|Withdrawal by Subject|0|||
130759346|NCT04521621|470742046|FG006|Overall Study|Withdrawal by Subject|0|||
130759347|NCT04521621|470742047|FG007|Overall Study|Withdrawal by Subject|0|||
130759348|NCT04521621|470742040|FG000|Overall Study|Allocated in error without study intervention|1|||
130759349|NCT04521621|470742041|FG001|Overall Study|Allocated in error without study intervention|0|||
130759350|NCT04521621|470742042|FG002|Overall Study|Allocated in error without study intervention|0|||
130759351|NCT04521621|470742043|FG003|Overall Study|Allocated in error without study intervention|0|||
130759352|NCT04521621|470742044|FG004|Overall Study|Allocated in error without study intervention|0|||
130759353|NCT04521621|470742045|FG005|Overall Study|Allocated in error without study intervention|0|||
130759354|NCT04521621|470742046|FG006|Overall Study|Allocated in error without study intervention|0|||
130759355|NCT04521621|470742047|FG007|Overall Study|Allocated in error without study intervention|0|||
130759356|NCT05845567|470742050|FG000|Overall Study|Withdrawal by Subject|1|||
130759357|NCT00725608|470742051|FG000|Overall Study|Lost to Follow-up|60|||
130759358|NCT00725608|470742051|FG000|Overall Study|Adverse Event|14|||
130759359|NCT00725608|470742051|FG000|Overall Study|Individual reasons|86|||
130759360|NCT00725608|470742051|FG000|Overall Study|Other|7|||
130759361|NCT03409107|470742052|FG000|Overall Study|Withdrawal by Subject|4|||
130759362|NCT03409107|470742053|FG001|Overall Study|Withdrawal by Subject|2|||
130759363|NCT03409107|470742052|FG000|Overall Study|Physician Decision|1|||
130759364|NCT03409107|470742053|FG001|Overall Study|Physician Decision|0|||
130759365|NCT03409107|470742052|FG000|Overall Study|Lost to Follow-up|7|||
130759366|NCT03409107|470742053|FG001|Overall Study|Lost to Follow-up|2|||
130759367|NCT03409107|470742052|FG000|Overall Study|Adverse Event|5|||
130759368|NCT03409107|470742053|FG001|Overall Study|Adverse Event|3|||
130759369|NCT00535847|470742055|FG000|Overall Study|Adverse Event|5|||
130759370|NCT00535847|470742056|FG001|Overall Study|Adverse Event|3|||
130759371|NCT00535847|470742057|FG002|Overall Study|Adverse Event|2|||
130759372|NCT00535847|470742055|FG000|Overall Study|Non compliance|1|||
130759373|NCT00535847|470742056|FG001|Overall Study|Non compliance|1|||
130759374|NCT00535847|470742057|FG002|Overall Study|Non compliance|0|||
130759375|NCT00535847|470742055|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
130759376|NCT00535847|470742056|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
130759377|NCT00535847|470742057|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
130759378|NCT00423189|470742058|FG000|Overall Study|Death|0|||
130759379|NCT00423189|470742059|FG001|Overall Study|Death|1|||
130759380|NCT00423189|470742060|FG002|Overall Study|Death|0|||
130759381|NCT01459718|470742063|FG000|Overall Study|Physician Decision|1|||
130759382|NCT01459718|470742063|FG000|Overall Study|Lost to Follow-up|1|||
130759383|NCT01459718|470742063|FG000|Overall Study|Adverse Event|1|||
130759384|NCT01258075|470742069|FG000|Overall Study|Adverse Event|8|||
130759385|NCT01258075|470742070|FG001|Overall Study|Adverse Event|3|||
130759386|NCT01258075|470742069|FG000|Overall Study|Lost to Follow-up|11|||
130759387|NCT01258075|470742070|FG001|Overall Study|Lost to Follow-up|6|||
130759388|NCT01258075|470742069|FG000|Overall Study|Withdrawal by Subject|10|||
130759389|NCT01258075|470742070|FG001|Overall Study|Withdrawal by Subject|7|||
130759390|NCT01258075|470742069|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
130759391|NCT01258075|470742070|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
130759392|NCT01258075|470742069|FG000|Overall Study|Other|12|||
130759393|NCT01258075|470742070|FG001|Overall Study|Other|5|||
130759394|NCT01618019|470742072|FG000|Overall Study|Withdrawal by Subject|14|||
130759395|NCT01618019|470742073|FG001|Overall Study|Withdrawal by Subject|14|||
130759396|NCT01542034|470742074|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
130759397|NCT01542034|470742075|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
130759398|NCT01542034|470742074|FG000|Overall Study|Administrative decision|0|||
130759399|NCT01542034|470742075|FG001|Overall Study|Administrative decision|3|||
130759400|NCT01542034|470742074|FG000|Overall Study|Subject Noncompliance|1|||
130759401|NCT01542034|470742075|FG001|Overall Study|Subject Noncompliance|0|||
130759402|NCT01542034|470742074|FG000|Overall Study|Adverse Event|2|||
130759403|NCT01542034|470742075|FG001|Overall Study|Adverse Event|2|||
130759404|NCT01542034|470742074|FG000|Overall Study|Lost to Follow-up|7|||
130759405|NCT01542034|470742075|FG001|Overall Study|Lost to Follow-up|6|||
130759406|NCT02612610|470742076|FG000|Overall Study|Withdrawal by Subject|1|||
130759407|NCT02612610|470742077|FG001|Overall Study|Withdrawal by Subject|1|||
130759408|NCT02612610|470742078|FG002|Overall Study|Withdrawal by Subject|0|||
130759409|NCT02612610|470742079|FG003|Overall Study|Withdrawal by Subject|2|||
130759410|NCT02612610|470742076|FG000|Overall Study|Adverse Event|2|||
130759411|NCT02612610|470742077|FG001|Overall Study|Adverse Event|2|||
130759412|NCT02612610|470742078|FG002|Overall Study|Adverse Event|3|||
130759413|NCT02612610|470742079|FG003|Overall Study|Adverse Event|10|||
130759414|NCT02612610|470742076|FG000|Overall Study|Lost to Follow-up|0|||
130759415|NCT02612610|470742077|FG001|Overall Study|Lost to Follow-up|1|||
130759416|NCT02612610|470742078|FG002|Overall Study|Lost to Follow-up|0|||
130759417|NCT02612610|470742079|FG003|Overall Study|Lost to Follow-up|0|||
130759418|NCT02612610|470742076|FG000|Overall Study|Protocol Violation|0|||
130759419|NCT02612610|470742077|FG001|Overall Study|Protocol Violation|1|||
130759420|NCT02612610|470742078|FG002|Overall Study|Protocol Violation|1|||
130759421|NCT02612610|470742079|FG003|Overall Study|Protocol Violation|0|||
130759422|NCT02612610|470742076|FG000|Overall Study|Lack of Efficacy|1|||
130759423|NCT02612610|470742077|FG001|Overall Study|Lack of Efficacy|2|||
130759424|NCT02612610|470742078|FG002|Overall Study|Lack of Efficacy|0|||
130759425|NCT02612610|470742079|FG003|Overall Study|Lack of Efficacy|1|||
130759426|NCT02612610|470742076|FG000|Overall Study|Physician Decision|0|||
130759427|NCT02612610|470742077|FG001|Overall Study|Physician Decision|1|||
130759428|NCT02612610|470742078|FG002|Overall Study|Physician Decision|0|||
130759429|NCT02612610|470742079|FG003|Overall Study|Physician Decision|0|||
130759430|NCT02612610|470742076|FG000|Overall Study|Noncompliance|1|||
130759431|NCT02612610|470742077|FG001|Overall Study|Noncompliance|0|||
130759432|NCT02612610|470742078|FG002|Overall Study|Noncompliance|0|||
130759433|NCT02612610|470742079|FG003|Overall Study|Noncompliance|0|||
130759434|NCT02612610|470742076|FG000|Overall Study|Cough Improvement|0|||
130759435|NCT02612610|470742077|FG001|Overall Study|Cough Improvement|0|||
130759436|NCT02612610|470742078|FG002|Overall Study|Cough Improvement|1|||
130759437|NCT02612610|470742079|FG003|Overall Study|Cough Improvement|0|||
130759438|NCT01801280|470742080|FG000|Period 1|Withdrawal by Subject|0|||
130759439|NCT01801280|470742081|FG001|Period 1|Withdrawal by Subject|1|||
130759440|NCT01801280|470742082|FG002|Period 1|Withdrawal by Subject|0|||
130759441|NCT01801280|470742083|FG003|Period 1|Withdrawal by Subject|0|||
130759442|NCT01801280|470742080|FG000|Period 2|Withdrawal by Subject|1|||
130759443|NCT01801280|470742081|FG001|Period 2|Withdrawal by Subject|0|||
130759444|NCT01801280|470742082|FG002|Period 2|Withdrawal by Subject|0|||
130759445|NCT01801280|470742083|FG003|Period 2|Withdrawal by Subject|0|||
130759446|NCT01801280|470742080|FG000|Period 4|Protocol Violation|0|||
130759447|NCT01801280|470742081|FG001|Period 4|Protocol Violation|0|||
130759448|NCT01801280|470742082|FG002|Period 4|Protocol Violation|1|||
130759449|NCT01801280|470742083|FG003|Period 4|Protocol Violation|0|||
130759450|NCT02783729|470742084|FG000|Overall Study|Lack of Efficacy|1|||
130759451|NCT02783729|470742085|FG001|Overall Study|Lack of Efficacy|0|||
130759452|NCT02783729|470742086|FG002|Overall Study|Lack of Efficacy|0|||
130759453|NCT02783729|470742087|FG003|Overall Study|Lack of Efficacy|0|||
130759454|NCT02783729|470742084|FG000|Overall Study|Adverse Event|2|||
130759455|NCT02783729|470742085|FG001|Overall Study|Adverse Event|6|||
130759456|NCT02783729|470742086|FG002|Overall Study|Adverse Event|2|||
130759457|NCT02783729|470742087|FG003|Overall Study|Adverse Event|3|||
130759458|NCT02783729|470742084|FG000|Overall Study|Other|1|||
130759459|NCT02783729|470742085|FG001|Overall Study|Other|6|||
130759460|NCT02783729|470742086|FG002|Overall Study|Other|2|||
130759461|NCT02783729|470742087|FG003|Overall Study|Other|3|||
130759462|NCT02783729|470742084|FG000|Overall Study|Withdrawal by Subject|2|||
130759463|NCT02783729|470742085|FG001|Overall Study|Withdrawal by Subject|3|||
130759464|NCT02783729|470742086|FG002|Overall Study|Withdrawal by Subject|1|||
130759465|NCT02783729|470742087|FG003|Overall Study|Withdrawal by Subject|2|||
130759466|NCT02783729|470742084|FG000|Overall Study|Participant's choice|2|||
130759467|NCT02783729|470742085|FG001|Overall Study|Participant's choice|1|||
130759468|NCT02783729|470742086|FG002|Overall Study|Participant's choice|2|||
130759469|NCT02783729|470742087|FG003|Overall Study|Participant's choice|1|||
130759470|NCT02783729|470742084|FG000|Overall Study|Lost to Follow-up|2|||
130759471|NCT02783729|470742085|FG001|Overall Study|Lost to Follow-up|1|||
130759472|NCT02783729|470742086|FG002|Overall Study|Lost to Follow-up|1|||
130759473|NCT02783729|470742087|FG003|Overall Study|Lost to Follow-up|0|||
130759474|NCT01866657|470742090|FG000|Overall Study|Surgery canceled|2|||
130759475|NCT01866657|470742091|FG001|Overall Study|Surgery canceled|0|||
130759476|NCT04021121|470742103|FG000|Overall Study|Death|3|||
130759477|NCT04021121|470742104|FG001|Overall Study|Death|3|||
130759478|NCT04021121|470742105|FG002|Overall Study|Death|5|||
130759479|NCT04021121|470742106|FG003|Overall Study|Death|4|||
130759480|NCT02288091|470742108|FG000|Overall Study|Lost to Follow-up|1|||
130759481|NCT02288091|470742108|FG000|Overall Study|Screen fail|7|||
130759482|NCT03099694|470742116|FG000|Overall Study|Withdrawal by Subject|11|||
130759483|NCT03099694|470742117|FG001|Overall Study|Withdrawal by Subject|13|||
130759484|NCT03099694|470742116|FG000|Overall Study|Lost to Follow-up|9|||
130759485|NCT03099694|470742117|FG001|Overall Study|Lost to Follow-up|5|||
130759486|NCT00471718|470742123|FG000|Overall Study|Adverse Event|3|||
130759487|NCT00471718|470742123|FG000|Overall Study|other complicating disease|1|||
130759488|NCT00471718|470742123|FG000|Overall Study|disease progression|22|||
130759489|NCT00471718|470742123|FG000|Overall Study|Withdrawal by Subject|1|||
130759490|NCT02880865|470742124|FG000|Overall Study|Adverse Event|1|||
130759491|NCT02880865|470742125|FG001|Overall Study|Adverse Event|0|||
130759492|NCT02880865|470742124|FG000|Overall Study|Withdrawal by Subject|0|||
130789516|NCT00784875|470858746|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
130789517|NCT00784875|470858747|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
130759493|NCT02880865|470742125|FG001|Overall Study|Withdrawal by Subject|2|||
130759494|NCT02880865|470742124|FG000|Overall Study|Physician Decision|0|||
130759495|NCT02880865|470742125|FG001|Overall Study|Physician Decision|1|||
130759496|NCT01446237|470742127|FG000|Overall Study|Adverse Event|1|||
130759497|NCT01446237|470742127|FG000|Overall Study|Lost to Follow-up|2|||
130759498|NCT01446237|470742127|FG000|Overall Study|Withdrawal by Subject|7|||
130759499|NCT01190267|470742130|FG000|Overall Study|Adverse Event|10|||
130759500|NCT01190267|470742131|FG001|Overall Study|Adverse Event|0|||
130759501|NCT01190267|470742130|FG000|Overall Study|Treatment Failure|8|||
130759502|NCT01190267|470742131|FG001|Overall Study|Treatment Failure|2|||
130759503|NCT01190267|470742130|FG000|Overall Study|Lost to Follow-up|2|||
130759504|NCT01190267|470742131|FG001|Overall Study|Lost to Follow-up|0|||
130789518|NCT00784875|470858748|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
130759505|NCT01190267|470742130|FG000|Overall Study|Withdrawal by Subject|13|||
130789519|NCT00784875|470858749|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
130789520|NCT00784875|470858746|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
130789521|NCT00784875|470858747|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
130789522|NCT00784875|470858748|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
130789523|NCT00784875|470858749|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
130789524|NCT00784875|470858746|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
130789525|NCT00784875|470858747|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
130789526|NCT00784875|470858748|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
130789527|NCT00784875|470858749|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
130789528|NCT00784875|470858746|FG000|Period C|Adverse Event|1|||
130789529|NCT00784875|470858747|FG001|Period C|Adverse Event|0|||
130789530|NCT00784875|470858748|FG002|Period C|Adverse Event|4|||
130789531|NCT00784875|470858749|FG003|Period C|Adverse Event|2|||
130789532|NCT00784875|470858746|FG000|Period C|Protocol Violation|0|||
130789533|NCT00784875|470858747|FG001|Period C|Protocol Violation|0|||
130789534|NCT00784875|470858748|FG002|Period C|Protocol Violation|1|||
130789535|NCT00784875|470858749|FG003|Period C|Protocol Violation|2|||
130789536|NCT00784875|470858746|FG000|Period C|Lack of Efficacy|0|||
130789537|NCT00784875|470858747|FG001|Period C|Lack of Efficacy|0|||
130789538|NCT00784875|470858748|FG002|Period C|Lack of Efficacy|1|||
130789539|NCT00784875|470858749|FG003|Period C|Lack of Efficacy|0|||
130789540|NCT00784875|470858746|FG000|Period C|Withdrawal by Subject|1|||
130789541|NCT00784875|470858747|FG001|Period C|Withdrawal by Subject|1|||
130789542|NCT00784875|470858748|FG002|Period C|Withdrawal by Subject|2|||
130789543|NCT00784875|470858749|FG003|Period C|Withdrawal by Subject|0|||
130789544|NCT00784875|470858746|FG000|Period C|Physician Decision|0|||
130789545|NCT00784875|470858747|FG001|Period C|Physician Decision|0|||
130789546|NCT00784875|470858748|FG002|Period C|Physician Decision|1|||
130789547|NCT00784875|470858749|FG003|Period C|Physician Decision|1|||
130789548|NCT00784875|470858746|FG000|Period C|Sponsor Decision|5|||
130789549|NCT00784875|470858747|FG001|Period C|Sponsor Decision|5|||
130789550|NCT00784875|470858748|FG002|Period C|Sponsor Decision|4|||
130789551|NCT00784875|470858749|FG003|Period C|Sponsor Decision|2|||
130789552|NCT00784875|470858746|FG000|Period D|Adverse Event|0|||
130789553|NCT00784875|470858747|FG001|Period D|Adverse Event|2|||
130789554|NCT00784875|470858748|FG002|Period D|Adverse Event|2|||
130789555|NCT00784875|470858749|FG003|Period D|Adverse Event|0|||
130789556|NCT00784875|470858746|FG000|Period D|Protocol Violation|1|||
130789557|NCT00784875|470858747|FG001|Period D|Protocol Violation|0|||
130789558|NCT00784875|470858748|FG002|Period D|Protocol Violation|0|||
130789559|NCT00784875|470858749|FG003|Period D|Protocol Violation|0|||
130789560|NCT00784875|470858746|FG000|Period D|Withdrawal by Subject|2|||
130789561|NCT00784875|470858747|FG001|Period D|Withdrawal by Subject|0|||
130789562|NCT00784875|470858748|FG002|Period D|Withdrawal by Subject|2|||
130789563|NCT00784875|470858749|FG003|Period D|Withdrawal by Subject|0|||
130759506|NCT01190267|470742131|FG001|Overall Study|Withdrawal by Subject|1|||
130759507|NCT01190267|470742130|FG000|Overall Study|Protocol Violation|8|||
130759508|NCT01190267|470742131|FG001|Overall Study|Protocol Violation|1|||
130759509|NCT04017832|470742134|FG000|Overall Study|Withdrawal by Subject|13|||
130759510|NCT04017832|470742135|FG001|Overall Study|Withdrawal by Subject|12|||
130759511|NCT04017832|470742136|FG002|Overall Study|Withdrawal by Subject|21|||
130759512|NCT04017832|470742137|FG003|Overall Study|Withdrawal by Subject|7|||
130759513|NCT04017832|470742134|FG000|Overall Study|Lost to Follow-up|0|||
130759514|NCT04017832|470742135|FG001|Overall Study|Lost to Follow-up|3|||
130759515|NCT04017832|470742136|FG002|Overall Study|Lost to Follow-up|3|||
130759516|NCT04017832|470742137|FG003|Overall Study|Lost to Follow-up|1|||
130759517|NCT04017832|470742134|FG000|Overall Study|Physician Decision|1|||
130759518|NCT04017832|470742135|FG001|Overall Study|Physician Decision|1|||
130759519|NCT04017832|470742136|FG002|Overall Study|Physician Decision|1|||
130759520|NCT04017832|470742137|FG003|Overall Study|Physician Decision|1|||
130759521|NCT04017832|470742134|FG000|Overall Study|Death|2|||
130759522|NCT04017832|470742135|FG001|Overall Study|Death|2|||
130759523|NCT04017832|470742136|FG002|Overall Study|Death|1|||
130759524|NCT04017832|470742137|FG003|Overall Study|Death|0|||
130759525|NCT02294175|470742139|FG000|Overall Study|Withdrawal by Subject|1|||
130759526|NCT02294175|470742140|FG001|Overall Study|Withdrawal by Subject|2|||
130759527|NCT02294175|470742139|FG000|Overall Study|pt taking excluded medication|3|||
130759528|NCT02294175|470742140|FG001|Overall Study|pt taking excluded medication|1|||
130759529|NCT02294175|470742139|FG000|Overall Study|Protocol Violation|1|||
130759530|NCT02294175|470742140|FG001|Overall Study|Protocol Violation|0|||
130759531|NCT02294175|470742139|FG000|Overall Study|Lost to Follow-up|0|||
130759532|NCT02294175|470742140|FG001|Overall Study|Lost to Follow-up|1|||
130759533|NCT02294175|470742139|FG000|Overall Study|wound healed|0|||
130759534|NCT02294175|470742140|FG001|Overall Study|wound healed|2|||
130759535|NCT05238025|470742144|FG000|Overall Study|Adverse Event|2|||
130759536|NCT05238025|470742145|FG001|Overall Study|Adverse Event|2|||
130759537|NCT05238025|470742144|FG000|Overall Study|Lost to Follow-up|334|||
130759538|NCT05238025|470742145|FG001|Overall Study|Lost to Follow-up|339|||
130759539|NCT05238025|470742144|FG000|Overall Study|Withdrawal by Subject|203|||
130759540|NCT05238025|470742145|FG001|Overall Study|Withdrawal by Subject|222|||
130759541|NCT05238025|470742144|FG000|Overall Study|Physician Decision|20|||
130759542|NCT05238025|470742145|FG001|Overall Study|Physician Decision|8|||
130759543|NCT05238025|470742144|FG000|Overall Study|Protocol Violation|6|||
130759544|NCT05238025|470742145|FG001|Overall Study|Protocol Violation|2|||
130759545|NCT05238025|470742144|FG000|Overall Study|Death|38|||
130759546|NCT05238025|470742145|FG001|Overall Study|Death|32|||
130759547|NCT05238025|470742144|FG000|Overall Study|Study terminated by Sponsor|6358|||
130759548|NCT05238025|470742145|FG001|Overall Study|Study terminated by Sponsor|6358|||
130759549|NCT05238025|470742144|FG000|Overall Study|Other Reason|669|||
130759550|NCT05238025|470742145|FG001|Overall Study|Other Reason|690|||
130759551|NCT01263782|470742147|FG000|Overall Study|Death|0|||
130759552|NCT01263782|470742148|FG001|Overall Study|Death|0|||
130759553|NCT01263782|470742149|FG002|Overall Study|Death|1|||
130759554|NCT01263782|470742150|FG003|Overall Study|Death|0|||
130759555|NCT01263782|470742147|FG000|Overall Study|Progressive disease|0|||
130759556|NCT01263782|470742148|FG001|Overall Study|Progressive disease|0|||
130759557|NCT01263782|470742149|FG002|Overall Study|Progressive disease|0|||
130759558|NCT01263782|470742150|FG003|Overall Study|Progressive disease|1|||
130759559|NCT01263782|470742147|FG000|Overall Study|Too early|0|||
130759560|NCT01263782|470742148|FG001|Overall Study|Too early|0|||
130759561|NCT01263782|470742149|FG002|Overall Study|Too early|1|||
130759562|NCT01263782|470742150|FG003|Overall Study|Too early|0|||
130759563|NCT01263782|470742147|FG000|Overall Study|Inevaluable|0|||
130759564|NCT01263782|470742148|FG001|Overall Study|Inevaluable|0|||
130759565|NCT01263782|470742149|FG002|Overall Study|Inevaluable|1|||
130759566|NCT01263782|470742150|FG003|Overall Study|Inevaluable|0|||
130759567|NCT00965341|470742156|FG000|Overall Study|Withdrew consent|1|||
130759568|NCT00965341|470742157|FG001|Overall Study|Withdrew consent|5|||
130759569|NCT00965341|470742156|FG000|Overall Study|Lost to Follow-up|1|||
130759570|NCT00965341|470742157|FG001|Overall Study|Lost to Follow-up|0|||
130759571|NCT00965341|470742156|FG000|Overall Study|Transportation issues|4|||
130759572|NCT00965341|470742157|FG001|Overall Study|Transportation issues|3|||
130759573|NCT01077739|470742158|FG000|Overall Study|Premature withdrawal|1|||
130759574|NCT01077739|470742159|FG001|Overall Study|Premature withdrawal|3|||
130759575|NCT01077739|470742158|FG000|Overall Study|Withdrawal by Subject|1|||
130759576|NCT01077739|470742159|FG001|Overall Study|Withdrawal by Subject|0|||
130759577|NCT01077739|470742158|FG000|Overall Study|Death|0|||
130759578|NCT01077739|470742159|FG001|Overall Study|Death|3|||
130759579|NCT01077739|470742158|FG000|Overall Study|Unacceptable toxicity|1|||
130759580|NCT01077739|470742159|FG001|Overall Study|Unacceptable toxicity|2|||
130759581|NCT01077739|470742158|FG000|Overall Study|Other|2|||
130759582|NCT01077739|470742159|FG001|Overall Study|Other|2|||
130759583|NCT00960986|470742160|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
130759584|NCT00960986|470742161|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
130759585|NCT00960986|470742162|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
130759586|NCT00960986|470742163|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
130759587|NCT00960986|470742160|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
130759588|NCT00960986|470742161|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
130759589|NCT00960986|470742162|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
130759590|NCT00960986|470742163|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
130759591|NCT00960986|470742160|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
130759592|NCT00960986|470742161|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
130759593|NCT00960986|470742162|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
130759594|NCT00960986|470742163|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
130759595|NCT00960986|470742160|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
130759596|NCT00960986|470742161|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
130759597|NCT00960986|470742162|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
130759598|NCT00960986|470742163|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
130759599|NCT00960986|470742160|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
130759600|NCT00960986|470742161|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
130759601|NCT00960986|470742162|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
130759602|NCT00960986|470742163|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
130759603|NCT00960986|470742160|FG000|Period 3 (7-week Therapy Period)|Death|0|||
130759604|NCT00960986|470742161|FG001|Period 3 (7-week Therapy Period)|Death|0|||
130759605|NCT00960986|470742162|FG002|Period 3 (7-week Therapy Period)|Death|1|||
130759606|NCT00960986|470742163|FG003|Period 3 (7-week Therapy Period)|Death|0|||
130759607|NCT00960986|470742160|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
130759608|NCT00960986|470742161|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
130759609|NCT00960986|470742162|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
130759610|NCT00960986|470742163|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
130759611|NCT00960986|470742160|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
130759612|NCT00960986|470742161|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
130759613|NCT00960986|470742162|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
130759614|NCT00960986|470742163|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
130759615|NCT00960986|470742160|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
130759616|NCT00960986|470742161|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
130759617|NCT00960986|470742162|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
130759618|NCT00960986|470742163|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
130759619|NCT00960986|470742160|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
130759620|NCT00960986|470742161|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
130759621|NCT00960986|470742162|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
130759622|NCT00960986|470742163|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
130759623|NCT04464720|470742164|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
130759624|NCT00954512|470742171|FG000|Overall Study|Withdrawal by Subject|0|||
130759625|NCT00954512|470742172|FG001|Overall Study|Withdrawal by Subject|0|||
130759626|NCT00954512|470742173|FG002|Overall Study|Withdrawal by Subject|0|||
130759627|NCT00954512|470742174|FG003|Overall Study|Withdrawal by Subject|0|||
130759628|NCT00954512|470742175|FG004|Overall Study|Withdrawal by Subject|0|||
130759629|NCT00954512|470742176|FG005|Overall Study|Withdrawal by Subject|1|||
130759630|NCT00954512|470742171|FG000|Overall Study|Adverse Event|0|||
130759631|NCT00954512|470742172|FG001|Overall Study|Adverse Event|0|||
130759632|NCT00954512|470742173|FG002|Overall Study|Adverse Event|0|||
130759633|NCT00954512|470742174|FG003|Overall Study|Adverse Event|0|||
130759634|NCT00954512|470742175|FG004|Overall Study|Adverse Event|1|||
130759635|NCT00954512|470742176|FG005|Overall Study|Adverse Event|2|||
130759636|NCT00954512|470742171|FG000|Overall Study|Physician Decision|0|||
130759637|NCT00954512|470742172|FG001|Overall Study|Physician Decision|1|||
130759638|NCT00954512|470742173|FG002|Overall Study|Physician Decision|0|||
130759639|NCT00954512|470742174|FG003|Overall Study|Physician Decision|1|||
130759640|NCT00954512|470742175|FG004|Overall Study|Physician Decision|0|||
130759641|NCT00954512|470742176|FG005|Overall Study|Physician Decision|0|||
130759642|NCT00954512|470742171|FG000|Overall Study|Symptomatic Deterioration|0|||
130759643|NCT00954512|470742172|FG001|Overall Study|Symptomatic Deterioration|1|||
130759644|NCT00954512|470742173|FG002|Overall Study|Symptomatic Deterioration|0|||
130759645|NCT00954512|470742174|FG003|Overall Study|Symptomatic Deterioration|0|||
130759646|NCT00954512|470742175|FG004|Overall Study|Symptomatic Deterioration|2|||
130759647|NCT00954512|470742176|FG005|Overall Study|Symptomatic Deterioration|0|||
130759648|NCT00954512|470742171|FG000|Overall Study|Progression of Disease|2|||
130759649|NCT00954512|470742172|FG001|Overall Study|Progression of Disease|1|||
130759650|NCT00954512|470742173|FG002|Overall Study|Progression of Disease|0|||
130759651|NCT00954512|470742174|FG003|Overall Study|Progression of Disease|1|||
130759652|NCT00954512|470742175|FG004|Overall Study|Progression of Disease|1|||
130759653|NCT00954512|470742176|FG005|Overall Study|Progression of Disease|1|||
130789564|NCT00784875|470858746|FG000|Period D|Physician Decision|0|||
130789565|NCT00784875|470858747|FG001|Period D|Physician Decision|1|||
130789566|NCT00784875|470858748|FG002|Period D|Physician Decision|0|||
130789567|NCT00784875|470858749|FG003|Period D|Physician Decision|0|||
130789568|NCT00784875|470858746|FG000|Period D|Sponsor Decision|1|||
130789569|NCT00784875|470858747|FG001|Period D|Sponsor Decision|1|||
130789570|NCT00784875|470858748|FG002|Period D|Sponsor Decision|1|||
130789571|NCT00784875|470858749|FG003|Period D|Sponsor Decision|0|||
130789572|NCT00784875|470858746|FG000|Period D|Lost to Follow-up|1|||
130789573|NCT00784875|470858747|FG001|Period D|Lost to Follow-up|0|||
130789574|NCT00784875|470858748|FG002|Period D|Lost to Follow-up|1|||
130789575|NCT00784875|470858749|FG003|Period D|Lost to Follow-up|1|||
130789576|NCT01027949|470858750|FG000|Overall Study|Death|174|||
130789577|NCT01027949|470858750|FG000|Overall Study|Progressive Disease|163|||
130789578|NCT01027949|470858750|FG000|Overall Study|Adverse Event|172|||
130789579|NCT01027949|470858750|FG000|Overall Study|Withdrawal by Subject|113|||
130789580|NCT01027949|470858750|FG000|Overall Study|Lost to Follow-up|17|||
130789581|NCT01027949|470858750|FG000|Overall Study|Protocol Violation|13|||
130789582|NCT01027949|470858750|FG000|Overall Study|PI Decision|8|||
130789583|NCT01027949|470858750|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
130789584|NCT01027949|470858750|FG000|Overall Study|Non-compliance with Study Procedures|7|||
130789585|NCT01027949|470858750|FG000|Overall Study|Lung Transplant|5|||
130789586|NCT01027949|470858750|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
130789587|NCT01027949|470858750|FG000|Overall Study|Use of Excluded Medication|2|||
130789588|NCT01027949|470858750|FG000|Overall Study|Patient Self-discontinuation|1|||
130789589|NCT01027949|470858750|FG000|Overall Study|Pregnancy|1|||
130789590|NCT01027949|470858750|FG000|Overall Study|Surgery|1|||
130789591|NCT02152007|470858762|FG000|Overall Study|Withdrawal by Subject|1|||
130789592|NCT00706797|470858765|FG000|Overall Study|Lack of Efficacy|3|||
130789593|NCT00706797|470858766|FG001|Overall Study|Lack of Efficacy|0|||
130789594|NCT00706797|470858765|FG000|Overall Study|Adverse Event|0|||
130789595|NCT00706797|470858766|FG001|Overall Study|Adverse Event|3|||
130789596|NCT00706797|470858765|FG000|Overall Study|Withdrawal by Subject|8|||
130789597|NCT00706797|470858766|FG001|Overall Study|Withdrawal by Subject|1|||
130789598|NCT00706797|470858765|FG000|Overall Study|Death|1|||
130789599|NCT00706797|470858766|FG001|Overall Study|Death|0|||
130789600|NCT00706797|470858765|FG000|Overall Study|Discontinuation of study by sponsor|52|||
130789601|NCT00706797|470858766|FG001|Overall Study|Discontinuation of study by sponsor|63|||
130789602|NCT00706797|470858765|FG000|Overall Study|Protocol Violation|3|||
130789603|NCT00706797|470858766|FG001|Overall Study|Protocol Violation|2|||
130789604|NCT00706797|470858765|FG000|Overall Study|Lost to Follow-up|1|||
130789605|NCT00706797|470858766|FG001|Overall Study|Lost to Follow-up|2|||
130789606|NCT00706797|470858765|FG000|Overall Study|Other|1|||
130789607|NCT00706797|470858766|FG001|Overall Study|Other|0|||
130789608|NCT02309359|470858769|FG000|Overall Study|Adverse Event|4|||
130789609|NCT02309359|470858770|FG001|Overall Study|Adverse Event|5|||
130789610|NCT02309359|470858771|FG002|Overall Study|Adverse Event|5|||
130789611|NCT02309359|470858772|FG003|Overall Study|Adverse Event|4|||
130789612|NCT02309359|470858773|FG004|Overall Study|Adverse Event|4|||
130789613|NCT02309359|470858769|FG000|Overall Study|Death|1|||
130789614|NCT02309359|470858770|FG001|Overall Study|Death|0|||
130789615|NCT02309359|470858771|FG002|Overall Study|Death|0|||
130789616|NCT02309359|470858772|FG003|Overall Study|Death|0|||
130789617|NCT02309359|470858773|FG004|Overall Study|Death|0|||
130789618|NCT02309359|470858769|FG000|Overall Study|Withdrawal by Subject|2|||
130789619|NCT02309359|470858770|FG001|Overall Study|Withdrawal by Subject|2|||
130789620|NCT02309359|470858771|FG002|Overall Study|Withdrawal by Subject|4|||
130789621|NCT02309359|470858772|FG003|Overall Study|Withdrawal by Subject|4|||
130789622|NCT02309359|470858773|FG004|Overall Study|Withdrawal by Subject|0|||
130789623|NCT02309359|470858769|FG000|Overall Study|Lack of Efficacy|3|||
130789624|NCT02309359|470858770|FG001|Overall Study|Lack of Efficacy|1|||
130789625|NCT02309359|470858771|FG002|Overall Study|Lack of Efficacy|0|||
130789626|NCT02309359|470858772|FG003|Overall Study|Lack of Efficacy|0|||
130789627|NCT02309359|470858773|FG004|Overall Study|Lack of Efficacy|3|||
130789628|NCT02309359|470858769|FG000|Overall Study|Lost to Follow-up|0|||
130789629|NCT02309359|470858770|FG001|Overall Study|Lost to Follow-up|0|||
130789630|NCT02309359|470858771|FG002|Overall Study|Lost to Follow-up|0|||
130789631|NCT02309359|470858772|FG003|Overall Study|Lost to Follow-up|1|||
130789632|NCT02309359|470858773|FG004|Overall Study|Lost to Follow-up|0|||
130789633|NCT02309359|470858769|FG000|Overall Study|Other|2|||
130789634|NCT02309359|470858770|FG001|Overall Study|Other|0|||
130789635|NCT02309359|470858771|FG002|Overall Study|Other|2|||
130789636|NCT02309359|470858772|FG003|Overall Study|Other|3|||
130789637|NCT02309359|470858773|FG004|Overall Study|Other|2|||
130789638|NCT00701363|470858775|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
130789639|NCT00701363|470858776|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
130789640|NCT00701363|470858777|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
130789641|NCT00701363|470858778|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
130789642|NCT00701363|470858775|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
130759654|NCT01794793|470742177|FG000|Treatment Period|Withdrawal by Subject|24|||
130759655|NCT01794793|470742177|FG000|Treatment Period|Lack of Efficacy|22|||
130759656|NCT01794793|470742177|FG000|Treatment Period|Adverse Event|17|||
130759657|NCT01794793|470742177|FG000|Treatment Period|Physician Decision|14|||
130759658|NCT01794793|470742177|FG000|Treatment Period|Lost to Follow-up|7|||
130759659|NCT01794793|470742177|FG000|Treatment Period|Death|6|||
130759660|NCT01794793|470742177|FG000|Treatment Period|Protocol Violation|5|||
130759661|NCT01794793|470742177|FG000|Treatment Period|administrative problem|3|||
130759662|NCT01794793|470742177|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
130759663|NCT01794793|470742177|FG000|Post-treatment Follow-up|Adverse Event|8|||
130759664|NCT01794793|470742177|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
130759665|NCT01794793|470742177|FG000|Post-treatment Follow-up|administrative problem|5|||
130759666|NCT01794793|470742177|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
130759667|NCT01794793|470742177|FG000|Post-treatment Follow-up|Protocol Violation|3|||
130759668|NCT03495154|470742178|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
130759669|NCT03495154|470742178|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
130759670|NCT03495154|470742178|FG000|Overall Study|Screen Failures During Surgery|6|||
130759671|NCT03495154|470742178|FG000|Overall Study|Death|2|||
130759672|NCT03495154|470742178|FG000|Overall Study|Lost to Follow-up|16|||
130759673|NCT03495154|470742178|FG000|Overall Study|Withdrawal by Subject|2|||
130759674|NCT03495154|470742178|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
130759675|NCT05685732|470742179|FG000|Overall Study|Withdrawal by Subject|2|||
130759676|NCT05685732|470742180|FG001|Overall Study|Withdrawal by Subject|0|||
130759677|NCT05685732|470742181|FG002|Overall Study|Withdrawal by Subject|2|||
130759678|NCT05685732|470742182|FG003|Overall Study|Withdrawal by Subject|3|||
130759679|NCT05685732|470742179|FG000|Overall Study|Protocol Violation|1|||
130759680|NCT05685732|470742180|FG001|Overall Study|Protocol Violation|2|||
130759681|NCT05685732|470742181|FG002|Overall Study|Protocol Violation|4|||
130759682|NCT05685732|470742182|FG003|Overall Study|Protocol Violation|1|||
130759683|NCT05685732|470742179|FG000|Overall Study|Lost to Follow-up|5|||
130759684|NCT05685732|470742180|FG001|Overall Study|Lost to Follow-up|1|||
130759685|NCT05685732|470742181|FG002|Overall Study|Lost to Follow-up|3|||
130759686|NCT05685732|470742182|FG003|Overall Study|Lost to Follow-up|1|||
130759687|NCT05685732|470742179|FG000|Overall Study|Adverse Event|2|||
130759688|NCT05685732|470742180|FG001|Overall Study|Adverse Event|1|||
130759689|NCT05685732|470742181|FG002|Overall Study|Adverse Event|0|||
130759690|NCT05685732|470742182|FG003|Overall Study|Adverse Event|0|||
130759691|NCT05685732|470742179|FG000|Overall Study|Physician Decision|1|||
130759692|NCT05685732|470742180|FG001|Overall Study|Physician Decision|0|||
130759693|NCT05685732|470742181|FG002|Overall Study|Physician Decision|0|||
130759694|NCT05685732|470742182|FG003|Overall Study|Physician Decision|0|||
130759695|NCT02640404|470742183|FG000|Overall Study|Protocol Violation|1|||
130759696|NCT02640404|470742184|FG001|Overall Study|Protocol Violation|0|||
130759697|NCT02640404|470742183|FG000|Overall Study|Withdrawal by Subject|1|||
130759698|NCT02640404|470742184|FG001|Overall Study|Withdrawal by Subject|0|||
130759699|NCT05397171|470742186|FG000|Overall Study|Death|2|||
130759700|NCT05397171|470742187|FG001|Overall Study|Death|3|||
130759701|NCT05397171|470742188|FG002|Overall Study|Death|3|||
130759702|NCT05397171|470742186|FG000|Overall Study|Study Terminated By Sponsor|1|||
130759703|NCT05397171|470742187|FG001|Overall Study|Study Terminated By Sponsor|2|||
130759704|NCT05397171|470742188|FG002|Overall Study|Study Terminated By Sponsor|3|||
130759705|NCT05397171|470742186|FG000|Overall Study|Withdrawal by Subject|0|||
130759706|NCT05397171|470742187|FG001|Overall Study|Withdrawal by Subject|1|||
130759707|NCT05397171|470742188|FG002|Overall Study|Withdrawal by Subject|1|||
130789643|NCT00701363|470858776|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
130789644|NCT00701363|470858777|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
130789645|NCT00701363|470858778|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
130789646|NCT00701363|470858775|FG000|Treatment Phase 1|Adverse Event|7|||
130759708|NCT02100670|470742189|FG000|Overall Study|Adverse Event|10|||
130759709|NCT02100670|470742190|FG001|Overall Study|Adverse Event|3|||
130759710|NCT02100670|470742191|FG002|Overall Study|Adverse Event|3|||
130759711|NCT02100670|470742192|FG003|Overall Study|Adverse Event|0|||
130759712|NCT02100670|470742189|FG000|Overall Study|Lost to Follow-up|1|||
130759713|NCT02100670|470742190|FG001|Overall Study|Lost to Follow-up|0|||
130759714|NCT02100670|470742191|FG002|Overall Study|Lost to Follow-up|0|||
130759715|NCT02100670|470742192|FG003|Overall Study|Lost to Follow-up|0|||
130759716|NCT02100670|470742189|FG000|Overall Study|Protocol Violation|0|||
130789647|NCT00701363|470858776|FG001|Treatment Phase 1|Adverse Event|0|||
130759717|NCT02100670|470742190|FG001|Overall Study|Protocol Violation|1|||
130759718|NCT02100670|470742191|FG002|Overall Study|Protocol Violation|0|||
130759719|NCT02100670|470742192|FG003|Overall Study|Protocol Violation|1|||
130759720|NCT02100670|470742189|FG000|Overall Study|Withdrawal of Consent|0|||
130759721|NCT02100670|470742190|FG001|Overall Study|Withdrawal of Consent|1|||
130759722|NCT02100670|470742191|FG002|Overall Study|Withdrawal of Consent|1|||
130759723|NCT02100670|470742192|FG003|Overall Study|Withdrawal of Consent|0|||
130759724|NCT02100670|470742189|FG000|Overall Study|No swelling no pain|1|||
130759725|NCT02100670|470742190|FG001|Overall Study|No swelling no pain|0|||
130759726|NCT02100670|470742191|FG002|Overall Study|No swelling no pain|0|||
130789648|NCT00701363|470858777|FG002|Treatment Phase 1|Adverse Event|0|||
130759727|NCT02100670|470742192|FG003|Overall Study|No swelling no pain|0|||
130759728|NCT02100670|470742189|FG000|Overall Study|Poor Efficacy|0|||
130759729|NCT02100670|470742190|FG001|Overall Study|Poor Efficacy|1|||
130759730|NCT02100670|470742191|FG002|Overall Study|Poor Efficacy|0|||
130759731|NCT02100670|470742192|FG003|Overall Study|Poor Efficacy|0|||
130759732|NCT02100670|470742189|FG000|Overall Study|Physician Decision|0|||
130759733|NCT02100670|470742190|FG001|Overall Study|Physician Decision|1|||
130759734|NCT02100670|470742191|FG002|Overall Study|Physician Decision|0|||
130759735|NCT02100670|470742192|FG003|Overall Study|Physician Decision|0|||
130759736|NCT02100670|470742189|FG000|Overall Study|Withdrawal by Subject|1|||
130759737|NCT02100670|470742190|FG001|Overall Study|Withdrawal by Subject|0|||
130759738|NCT02100670|470742191|FG002|Overall Study|Withdrawal by Subject|0|||
130759739|NCT02100670|470742192|FG003|Overall Study|Withdrawal by Subject|0|||
130759740|NCT02234596|470742193|FG000|Overall Study|Participant not treated|2|||
130759741|NCT03634033|470743851|FG000|Overall Study|Did not have a post-assessment|384|||
130759742|NCT03634033|470743852|FG001|Overall Study|Did not have a post-assessment|291|||
130759743|NCT03634033|470743853|FG002|Overall Study|Did not have a post-assessment|114|||
130759744|NCT03634033|470743854|FG003|Overall Study|Did not have a post-assessment|161|||
130759745|NCT03634033|470743855|FG004|Overall Study|Did not have a post-assessment|5|||
130759746|NCT03634033|470743856|FG005|Overall Study|Did not have a post-assessment|0|||
130759747|NCT03634033|470743857|FG006|Overall Study|Did not have a post-assessment|0|||
130759748|NCT03634033|470743851|FG000|Overall Study|Death|0|||
130759749|NCT03634033|470743852|FG001|Overall Study|Death|0|||
130759750|NCT03634033|470743853|FG002|Overall Study|Death|0|||
130759751|NCT03634033|470743854|FG003|Overall Study|Death|0|||
130759752|NCT03634033|470743855|FG004|Overall Study|Death|0|||
130759753|NCT03634033|470743856|FG005|Overall Study|Death|7|||
130759754|NCT03634033|470743857|FG006|Overall Study|Death|7|||
130759755|NCT03634033|470743851|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130759756|NCT03634033|470743852|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130759757|NCT03634033|470743853|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130759758|NCT03634033|470743854|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130759759|NCT03634033|470743855|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130759760|NCT03634033|470743856|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
130759761|NCT03634033|470743857|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
130759762|NCT03634033|470743851|FG000|Overall Study|Lost to Follow-up|0|||
130759763|NCT03634033|470743852|FG001|Overall Study|Lost to Follow-up|0|||
130759764|NCT03634033|470743853|FG002|Overall Study|Lost to Follow-up|0|||
130759765|NCT03634033|470743854|FG003|Overall Study|Lost to Follow-up|0|||
130759766|NCT03634033|470743855|FG004|Overall Study|Lost to Follow-up|0|||
130759767|NCT03634033|470743856|FG005|Overall Study|Lost to Follow-up|1|||
130759768|NCT03634033|470743857|FG006|Overall Study|Lost to Follow-up|2|||
130759769|NCT03634033|470743851|FG000|Overall Study|Withdrawal by Subject|0|||
130759770|NCT03634033|470743852|FG001|Overall Study|Withdrawal by Subject|0|||
130759771|NCT03634033|470743853|FG002|Overall Study|Withdrawal by Subject|0|||
130759772|NCT03634033|470743854|FG003|Overall Study|Withdrawal by Subject|0|||
130759773|NCT03634033|470743855|FG004|Overall Study|Withdrawal by Subject|0|||
130759774|NCT03634033|470743856|FG005|Overall Study|Withdrawal by Subject|0|||
130759775|NCT03634033|470743857|FG006|Overall Study|Withdrawal by Subject|1|||
130759776|NCT01944670|470743860|FG000|Overall Study|Lost to Follow-up|2|||
130759777|NCT00743288|470743861|FG000|Overall Study|Adverse Event|1|||
130759778|NCT00743288|470743862|FG001|Overall Study|Adverse Event|1|||
130759779|NCT00743288|470743863|FG002|Overall Study|Adverse Event|2|||
130759780|NCT00743288|470743864|FG003|Overall Study|Adverse Event|2|||
130759781|NCT00743288|470743865|FG004|Overall Study|Adverse Event|1|||
130759782|NCT00743288|470743866|FG005|Overall Study|Adverse Event|1|||
130759783|NCT00743288|470743867|FG006|Overall Study|Adverse Event|2|||
130759784|NCT00743288|470743861|FG000|Overall Study|Withdrawal by Subject|0|||
130759785|NCT00743288|470743862|FG001|Overall Study|Withdrawal by Subject|0|||
130759786|NCT00743288|470743863|FG002|Overall Study|Withdrawal by Subject|1|||
130759787|NCT00743288|470743864|FG003|Overall Study|Withdrawal by Subject|0|||
130759788|NCT00743288|470743865|FG004|Overall Study|Withdrawal by Subject|0|||
130759789|NCT00743288|470743866|FG005|Overall Study|Withdrawal by Subject|1|||
130759790|NCT00743288|470743867|FG006|Overall Study|Withdrawal by Subject|1|||
130759791|NCT00743288|470743861|FG000|Overall Study|Progressive disease (PD)|2|||
130759792|NCT00743288|470743862|FG001|Overall Study|Progressive disease (PD)|0|||
130759793|NCT00743288|470743863|FG002|Overall Study|Progressive disease (PD)|1|||
130759794|NCT00743288|470743864|FG003|Overall Study|Progressive disease (PD)|4|||
130759795|NCT00743288|470743865|FG004|Overall Study|Progressive disease (PD)|5|||
130759796|NCT00743288|470743866|FG005|Overall Study|Progressive disease (PD)|3|||
130759797|NCT00743288|470743867|FG006|Overall Study|Progressive disease (PD)|6|||
130759798|NCT00743288|470743861|FG000|Overall Study|Worsening of condition (Not PD)|0|||
130759799|NCT00743288|470743862|FG001|Overall Study|Worsening of condition (Not PD)|2|||
130759800|NCT00743288|470743863|FG002|Overall Study|Worsening of condition (Not PD)|1|||
130759801|NCT00743288|470743864|FG003|Overall Study|Worsening of condition (Not PD)|1|||
130759802|NCT00743288|470743865|FG004|Overall Study|Worsening of condition (Not PD)|0|||
130759803|NCT00743288|470743866|FG005|Overall Study|Worsening of condition (Not PD)|0|||
130759804|NCT00743288|470743867|FG006|Overall Study|Worsening of condition (Not PD)|0|||
130759805|NCT05903924|470743868|FG000|Overall Study|Lost to Follow-up|1|||
130759806|NCT05903924|470743869|FG001|Overall Study|Lost to Follow-up|0|||
130759807|NCT05903924|470743870|FG002|Overall Study|Lost to Follow-up|0|||
130759808|NCT04338269|470743871|FG000|Overall Study|Death|86|||
130759809|NCT04338269|470743872|FG001|Overall Study|Death|89|||
130759810|NCT04338269|470743871|FG000|Overall Study|Lost to Follow-up|1|||
130759811|NCT04338269|470743872|FG001|Overall Study|Lost to Follow-up|2|||
130759812|NCT04338269|470743871|FG000|Overall Study|Physician Decision|1|||
130759813|NCT04338269|470743872|FG001|Overall Study|Physician Decision|0|||
130759814|NCT04338269|470743871|FG000|Overall Study|Withdrawal by Subject|14|||
130759815|NCT04338269|470743872|FG001|Overall Study|Withdrawal by Subject|11|||
130759816|NCT02203851|470743876|FG000|Overall Study|Lost to Follow-up|4|||
130759817|NCT02203851|470743876|FG000|Overall Study|Withdrawal by Subject|6|||
130759818|NCT02203851|470743876|FG000|Overall Study|Other|1|||
130759819|NCT01632150|470743877|FG000|Overall Study|Disease progression|27|||
130759820|NCT01632150|470743877|FG000|Overall Study|Study drug toxicity|1|||
130759821|NCT01632150|470743877|FG000|Overall Study|Unrelated adverse event|7|||
130759822|NCT01632150|470743877|FG000|Overall Study|Withdrawal by Subject|2|||
130759823|NCT01632150|470743877|FG000|Overall Study|Patient underwent autologous transplant|1|||
130759824|NCT01632150|470743877|FG000|Overall Study|Moved to compassionate program|2|||
130759825|NCT03391232|470743880|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
130759826|NCT03391232|470743881|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
130759827|NCT03391232|470743880|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
130759828|NCT03391232|470743881|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
130759829|NCT01054300|470743885|FG000|Period 1|Adverse Event|1|||
130759830|NCT01054300|470743886|FG001|Period 1|Adverse Event|0|||
130759831|NCT01054300|470743887|FG002|Period 1|Adverse Event|0|||
130759832|NCT01054300|470743888|FG003|Period 1|Adverse Event|0|||
130759833|NCT01054300|470743885|FG000|Period 2|Withdrawal by Subject|0|||
130759834|NCT01054300|470743886|FG001|Period 2|Withdrawal by Subject|0|||
130759835|NCT01054300|470743887|FG002|Period 2|Withdrawal by Subject|1|||
130759836|NCT01054300|470743888|FG003|Period 2|Withdrawal by Subject|0|||
130759837|NCT00308087|470743891|FG000|Overall Study|Progressive Disease|19|||
130759838|NCT00308087|470743892|FG001|Overall Study|Progressive Disease|21|||
130759839|NCT00308087|470743891|FG000|Overall Study|Study Closure|11|||
130759840|NCT00308087|470743892|FG001|Overall Study|Study Closure|12|||
130759841|NCT00308087|470743891|FG000|Overall Study|Withdrawal by Subject|2|||
130759842|NCT00308087|470743892|FG001|Overall Study|Withdrawal by Subject|1|||
130759843|NCT00308087|470743891|FG000|Overall Study|Other|4|||
130759844|NCT00308087|470743892|FG001|Overall Study|Other|3|||
130759845|NCT00177307|470743895|FG000|Overall Study|Withdrawal by Subject|1|||
130759846|NCT02677038|470743899|FG000|Overall Study|Physician Decision|1|||
130759847|NCT02677038|470743899|FG000|Overall Study|Withdrawal by Subject|1|||
130759848|NCT03671564|470743900|FG000|Overall Study|Progressive Disease|3|||
130759849|NCT03671564|470743901|FG001|Overall Study|Progressive Disease|5|||
130759850|NCT03671564|470743902|FG002|Overall Study|Progressive Disease|3|||
130759851|NCT03671564|470743900|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
130759852|NCT03671564|470743901|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
130759853|NCT03671564|470743902|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
130759854|NCT03671564|470743900|FG000|Overall Study|Withdrawal by Subject|1|||
130759855|NCT03671564|470743901|FG001|Overall Study|Withdrawal by Subject|1|||
130759856|NCT03671564|470743902|FG002|Overall Study|Withdrawal by Subject|0|||
130759857|NCT00380081|470743903|FG000|Overall Study|Withdrawal by Subject|0|||
130759858|NCT00380081|470743904|FG001|Overall Study|Withdrawal by Subject|0|||
130759859|NCT00380081|470743905|FG002|Overall Study|Withdrawal by Subject|0|||
130759860|NCT00380081|470743906|FG003|Overall Study|Withdrawal by Subject|0|||
130759861|NCT00380081|470743907|FG004|Overall Study|Withdrawal by Subject|1|||
130759862|NCT00380081|470743908|FG005|Overall Study|Withdrawal by Subject|0|||
130759863|NCT00380081|470743903|FG000|Overall Study|Family Emergency|0|||
130759864|NCT00380081|470743904|FG001|Overall Study|Family Emergency|0|||
130759865|NCT00380081|470743905|FG002|Overall Study|Family Emergency|0|||
130759866|NCT00380081|470743906|FG003|Overall Study|Family Emergency|0|||
130759867|NCT00380081|470743907|FG004|Overall Study|Family Emergency|0|||
130759868|NCT00380081|470743908|FG005|Overall Study|Family Emergency|1|||
130759869|NCT05007041|470743909|FG000|Overall Study|Missing Diary Entries|0|||
130759870|NCT05007041|470743910|FG001|Overall Study|Missing Diary Entries|1|||
130759871|NCT01546168|470743913|FG000|Overall Study|Lost to Follow-up|1|||
130759872|NCT01546168|470743914|FG001|Overall Study|Lost to Follow-up|0|||
130759873|NCT01546168|470743913|FG000|Overall Study|Withdrawal by Subject|1|||
130759874|NCT01546168|470743914|FG001|Overall Study|Withdrawal by Subject|0|||
130759875|NCT01546168|470743913|FG000|Overall Study|ineligible after signing consent|2|||
130759876|NCT01546168|470743914|FG001|Overall Study|ineligible after signing consent|0|||
130759877|NCT02850016|470743915|FG000|Overall Study|Withdrawal by Subject|1|||
130759878|NCT02850016|470743916|FG001|Overall Study|Withdrawal by Subject|2|||
130759879|NCT02954653|470743917|FG000|Overall Study|Death|3|||
130759880|NCT02954653|470743918|FG001|Overall Study|Death|1|||
130759881|NCT02954653|470743919|FG002|Overall Study|Death|0|||
130759882|NCT02954653|470743920|FG003|Overall Study|Death|0|||
130759883|NCT02954653|470743921|FG004|Overall Study|Death|0|||
130759884|NCT02954653|470743922|FG005|Overall Study|Death|0|||
130759885|NCT02954653|470743923|FG006|Overall Study|Death|0|||
130759886|NCT02954653|470743924|FG007|Overall Study|Death|0|||
130759887|NCT02954653|470743925|FG008|Overall Study|Death|0|||
130759888|NCT02954653|470743917|FG000|Overall Study|Randomized but did not receive treatment|1|||
130759889|NCT02954653|470743918|FG001|Overall Study|Randomized but did not receive treatment|0|||
130759890|NCT02954653|470743919|FG002|Overall Study|Randomized but did not receive treatment|0|||
130759891|NCT02954653|470743920|FG003|Overall Study|Randomized but did not receive treatment|0|||
130759892|NCT02954653|470743921|FG004|Overall Study|Randomized but did not receive treatment|0|||
130759893|NCT02954653|470743922|FG005|Overall Study|Randomized but did not receive treatment|0|||
130759894|NCT02954653|470743923|FG006|Overall Study|Randomized but did not receive treatment|0|||
130759895|NCT02954653|470743924|FG007|Overall Study|Randomized but did not receive treatment|0|||
130759896|NCT02954653|470743925|FG008|Overall Study|Randomized but did not receive treatment|0|||
130759897|NCT02954653|470743917|FG000|Overall Study|Started another anti-cancer therapy|0|||
130759898|NCT02954653|470743918|FG001|Overall Study|Started another anti-cancer therapy|1|||
130759899|NCT02954653|470743919|FG002|Overall Study|Started another anti-cancer therapy|0|||
130759900|NCT02954653|470743920|FG003|Overall Study|Started another anti-cancer therapy|0|||
130759901|NCT02954653|470743921|FG004|Overall Study|Started another anti-cancer therapy|0|||
130759902|NCT02954653|470743922|FG005|Overall Study|Started another anti-cancer therapy|0|||
130759903|NCT02954653|470743923|FG006|Overall Study|Started another anti-cancer therapy|0|||
130759904|NCT02954653|470743924|FG007|Overall Study|Started another anti-cancer therapy|0|||
130759905|NCT02954653|470743925|FG008|Overall Study|Started another anti-cancer therapy|0|||
130759906|NCT02954653|470743917|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
130759907|NCT02954653|470743918|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
130759908|NCT02954653|470743919|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
130759909|NCT02954653|470743920|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
130759910|NCT02954653|470743921|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
130759911|NCT02954653|470743922|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
130759912|NCT02954653|470743923|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
130759913|NCT02954653|470743924|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
130759914|NCT02954653|470743925|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
130759915|NCT00070018|470743929|FG000|Overall Study|Adverse Event|2|||
130759916|NCT00070018|470743929|FG000|Overall Study|Lack of Efficacy|1|||
130759917|NCT00070018|470743929|FG000|Overall Study|Withdrawal by Subject|1|||
130759918|NCT02939716|470743931|FG000|Overall Study|scanner failure|0|||
130759919|NCT02939716|470743932|FG001|Overall Study|scanner failure|0|||
130759920|NCT02939716|470743933|FG002|Overall Study|scanner failure|0|||
130759921|NCT02939716|470743934|FG003|Overall Study|scanner failure|1|||
130759922|NCT02939716|470743935|FG004|Overall Study|scanner failure|1|||
130759923|NCT02939716|470743936|FG005|Overall Study|scanner failure|1|||
130759924|NCT02543892|470743940|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
130759925|NCT02543892|470743941|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
130759926|NCT02543892|470743942|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
130759927|NCT02543892|470743943|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
130759928|NCT02543892|470743944|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
130759929|NCT02543892|470743945|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
130759930|NCT02543892|470743946|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
130759931|NCT02543892|470743947|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
130759932|NCT02543892|470743940|FG000|Received Vaccination 2|Physician Decision|0|||
130759933|NCT02543892|470743941|FG001|Received Vaccination 2|Physician Decision|0|||
130759934|NCT02543892|470743942|FG002|Received Vaccination 2|Physician Decision|0|||
130759935|NCT02543892|470743943|FG003|Received Vaccination 2|Physician Decision|0|||
130759936|NCT02543892|470743944|FG004|Received Vaccination 2|Physician Decision|0|||
130759937|NCT02543892|470743945|FG005|Received Vaccination 2|Physician Decision|1|||
130759938|NCT02543892|470743946|FG006|Received Vaccination 2|Physician Decision|0|||
130759939|NCT02543892|470743947|FG007|Received Vaccination 2|Physician Decision|0|||
130759940|NCT02543892|470743940|FG000|Received Vaccination 2|Adverse Event|0|||
130759941|NCT02543892|470743941|FG001|Received Vaccination 2|Adverse Event|1|||
130759942|NCT02543892|470743942|FG002|Received Vaccination 2|Adverse Event|0|||
130759943|NCT02543892|470743943|FG003|Received Vaccination 2|Adverse Event|0|||
130759944|NCT02543892|470743944|FG004|Received Vaccination 2|Adverse Event|0|||
130759945|NCT02543892|470743945|FG005|Received Vaccination 2|Adverse Event|0|||
130759946|NCT02543892|470743946|FG006|Received Vaccination 2|Adverse Event|0|||
130759947|NCT02543892|470743947|FG007|Received Vaccination 2|Adverse Event|0|||
130759948|NCT02543892|470743940|FG000|Had Immunology Data|Withdrawal by Subject|0|||
130759949|NCT02543892|470743941|FG001|Had Immunology Data|Withdrawal by Subject|0|||
130759950|NCT02543892|470743942|FG002|Had Immunology Data|Withdrawal by Subject|0|||
130759951|NCT02543892|470743943|FG003|Had Immunology Data|Withdrawal by Subject|0|||
130759952|NCT02543892|470743944|FG004|Had Immunology Data|Withdrawal by Subject|0|||
130759953|NCT02543892|470743945|FG005|Had Immunology Data|Withdrawal by Subject|0|||
130759954|NCT02543892|470743946|FG006|Had Immunology Data|Withdrawal by Subject|1|||
130759955|NCT02543892|470743947|FG007|Had Immunology Data|Withdrawal by Subject|0|||
130759956|NCT00785213|470743950|FG000|Quinine Sulfate Alone|Adverse Event|4|||
130759957|NCT00785213|470743950|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
130759958|NCT01500213|470743951|FG000|Overall Study|Adverse Event|35|||
130759959|NCT01500213|470743952|FG001|Overall Study|Adverse Event|35|||
130759960|NCT01500213|470743951|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
130759961|NCT01500213|470743952|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
130759962|NCT01500213|470743951|FG000|Overall Study|Withdrawal by Subject|28|||
130759963|NCT01500213|470743952|FG001|Overall Study|Withdrawal by Subject|37|||
130759964|NCT01500213|470743951|FG000|Overall Study|Death|7|||
130759965|NCT01500213|470743952|FG001|Overall Study|Death|3|||
130759966|NCT01500213|470743951|FG000|Overall Study|Disease Progression|13|||
130759967|NCT01500213|470743952|FG001|Overall Study|Disease Progression|21|||
130759968|NCT01500213|470743951|FG000|Overall Study|Protocol Violation|19|||
130759969|NCT01500213|470743952|FG001|Overall Study|Protocol Violation|19|||
130759970|NCT01500213|470743951|FG000|Overall Study|Physician Decision|12|||
130759971|NCT01500213|470743952|FG001|Overall Study|Physician Decision|10|||
130759972|NCT01500213|470743951|FG000|Overall Study|Lack of Efficacy|9|||
130759973|NCT01500213|470743952|FG001|Overall Study|Lack of Efficacy|7|||
130759974|NCT01500213|470743951|FG000|Overall Study|Lost to Follow-up|3|||
130759975|NCT01500213|470743952|FG001|Overall Study|Lost to Follow-up|6|||
130759976|NCT01500213|470743951|FG000|Overall Study|Other Reasons|7|||
130759977|NCT01500213|470743952|FG001|Overall Study|Other Reasons|5|||
130759978|NCT00525902|470743953|FG000|Overall Study|Lack of Efficacy|1|||
130759979|NCT00985959|470743954|FG000|Overall Study|Adverse Event|0|||
130759980|NCT00985959|470743955|FG001|Overall Study|Adverse Event|0|||
130759981|NCT00985959|470743956|FG002|Overall Study|Adverse Event|19|||
130759982|NCT00985959|470743954|FG000|Overall Study|Withdrawal by Subject|0|||
130759983|NCT00985959|470743955|FG001|Overall Study|Withdrawal by Subject|0|||
130759984|NCT00985959|470743956|FG002|Overall Study|Withdrawal by Subject|8|||
130759985|NCT00985959|470743954|FG000|Overall Study|Progressive disease|1|||
130759986|NCT00985959|470743955|FG001|Overall Study|Progressive disease|2|||
130759987|NCT00985959|470743956|FG002|Overall Study|Progressive disease|8|||
130759988|NCT00985959|470743954|FG000|Overall Study|Unrecovered toxicity|0|||
130759989|NCT00985959|470743955|FG001|Overall Study|Unrecovered toxicity|0|||
130759990|NCT00985959|470743956|FG002|Overall Study|Unrecovered toxicity|7|||
130759991|NCT00985959|470743954|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
130759992|NCT00985959|470743955|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
130759993|NCT00985959|470743956|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
130759994|NCT00985959|470743954|FG000|Overall Study|Complete response observed over 2 cycles|0|||
130759995|NCT00985959|470743955|FG001|Overall Study|Complete response observed over 2 cycles|1|||
130759996|NCT00985959|470743956|FG002|Overall Study|Complete response observed over 2 cycles|4|||
130759997|NCT00985959|470743954|FG000|Overall Study|Other|0|||
130759998|NCT00985959|470743955|FG001|Overall Study|Other|0|||
130759999|NCT00985959|470743956|FG002|Overall Study|Other|11|||
130760000|NCT02858180|470743963|FG000|Overall Study|Lost to Follow-up|0|||
130760001|NCT02858180|470743964|FG001|Overall Study|Lost to Follow-up|2|||
130760002|NCT00844480|470743965|FG000|Overall Study|Withdrawal by Subject|2|||
130760003|NCT00844480|470743966|FG001|Overall Study|Withdrawal by Subject|3|||
130760004|NCT00979420|470743967|FG000|Overall Study|Adverse Event|1|||
130760005|NCT00979420|470743968|FG001|Overall Study|Adverse Event|0|||
130760006|NCT00979420|470743969|FG002|Overall Study|Adverse Event|0|||
130760007|NCT00979420|470743970|FG003|Overall Study|Adverse Event|0|||
130760008|NCT00979420|470743967|FG000|Overall Study|Lack of Efficacy|3|||
130760009|NCT00979420|470743968|FG001|Overall Study|Lack of Efficacy|0|||
130760010|NCT00979420|470743969|FG002|Overall Study|Lack of Efficacy|1|||
130760011|NCT00979420|470743970|FG003|Overall Study|Lack of Efficacy|1|||
130760012|NCT00979420|470743967|FG000|Overall Study|Other reasons not related to Viramune|3|||
130760013|NCT00979420|470743968|FG001|Overall Study|Other reasons not related to Viramune|0|||
130760014|NCT00979420|470743969|FG002|Overall Study|Other reasons not related to Viramune|0|||
130760015|NCT00979420|470743970|FG003|Overall Study|Other reasons not related to Viramune|1|||
130760016|NCT00526331|470743971|FG000|Overall Study|Sponsor Termination|55|||
130760017|NCT00574249|470743972|FG000|Overall Study|Adverse Event|6|||
130760018|NCT00574249|470743973|FG001|Overall Study|Adverse Event|18|||
130760019|NCT00574249|470743972|FG000|Overall Study|Lack of Efficacy|5|||
130760020|NCT00574249|470743973|FG001|Overall Study|Lack of Efficacy|3|||
130760021|NCT00574249|470743972|FG000|Overall Study|Lost to Follow-up|4|||
130760022|NCT00574249|470743973|FG001|Overall Study|Lost to Follow-up|3|||
130760023|NCT00574249|470743972|FG000|Overall Study|Protocol Violation|5|||
130760024|NCT00574249|470743973|FG001|Overall Study|Protocol Violation|2|||
130760025|NCT00574249|470743972|FG000|Overall Study|History of carcinoma|1|||
130760026|NCT00574249|470743973|FG001|Overall Study|History of carcinoma|0|||
130760027|NCT00574249|470743972|FG000|Overall Study|Withdrawal by Subject|3|||
130760028|NCT00574249|470743973|FG001|Overall Study|Withdrawal by Subject|0|||
130760029|NCT00574249|470743972|FG000|Overall Study|Physician Decision|1|||
130760030|NCT00574249|470743973|FG001|Overall Study|Physician Decision|0|||
130760031|NCT00574249|470743972|FG000|Overall Study|Pregnancy|1|||
130760032|NCT00574249|470743973|FG001|Overall Study|Pregnancy|0|||
130760033|NCT00574249|470743972|FG000|Overall Study|Excluded by company|0|||
130760034|NCT00574249|470743973|FG001|Overall Study|Excluded by company|1|||
130760035|NCT00574249|470743972|FG000|Overall Study|PPD test taken twice|0|||
130760036|NCT00574249|470743973|FG001|Overall Study|PPD test taken twice|1|||
130760037|NCT00347919|470743976|FG000|Overall Study|Lost to Follow-up|11|||
130760038|NCT00347919|470743977|FG001|Overall Study|Lost to Follow-up|13|||
130760039|NCT00347919|470743978|FG002|Overall Study|Lost to Follow-up|0|||
130760040|NCT00347919|470743976|FG000|Overall Study|Withdrawal by Subject|6|||
130760041|NCT00347919|470743977|FG001|Overall Study|Withdrawal by Subject|8|||
130760042|NCT00347919|470743978|FG002|Overall Study|Withdrawal by Subject|0|||
130760043|NCT00347919|470743976|FG000|Overall Study|Physician Decision|1|||
130760044|NCT00347919|470743977|FG001|Overall Study|Physician Decision|1|||
130760045|NCT00347919|470743978|FG002|Overall Study|Physician Decision|0|||
130760046|NCT00347919|470743976|FG000|Overall Study|Sponsor terminated study|15|||
130760047|NCT00347919|470743977|FG001|Overall Study|Sponsor terminated study|10|||
130760048|NCT00347919|470743978|FG002|Overall Study|Sponsor terminated study|16|||
130760049|NCT00347919|470743976|FG000|Overall Study|Death|35|||
130760050|NCT00347919|470743977|FG001|Overall Study|Death|42|||
130760051|NCT00347919|470743978|FG002|Overall Study|Death|19|||
130760052|NCT00347919|470743976|FG000|Overall Study|Par. Started Other Treatment|1|||
130760053|NCT00347919|470743977|FG001|Overall Study|Par. Started Other Treatment|1|||
130760054|NCT00347919|470743978|FG002|Overall Study|Par. Started Other Treatment|1|||
130760055|NCT00347919|470743976|FG000|Overall Study|Missing|2|||
130760056|NCT00347919|470743977|FG001|Overall Study|Missing|1|||
130760057|NCT00347919|470743978|FG002|Overall Study|Missing|2|||
130760058|NCT01382225|470743988|FG000|Overall Study|Adverse Event|3|||
130760059|NCT01382225|470743989|FG001|Overall Study|Adverse Event|2|||
130760060|NCT01382225|470743988|FG000|Overall Study|Protocol Violation|2|||
130760061|NCT01382225|470743989|FG001|Overall Study|Protocol Violation|1|||
130760062|NCT01382225|470743988|FG000|Overall Study|Subject Withdrew Consent|5|||
130760063|NCT01382225|470743989|FG001|Overall Study|Subject Withdrew Consent|2|||
130760064|NCT01382225|470743988|FG000|Overall Study|Other|4|||
130760065|NCT01382225|470743989|FG001|Overall Study|Other|2|||
130760066|NCT02548351|470744004|FG000|Overall Study|Withdrawal by Subject|149|||
130760067|NCT02548351|470744005|FG001|Overall Study|Withdrawal by Subject|154|||
130760068|NCT02548351|470744006|FG002|Overall Study|Withdrawal by Subject|152|||
130760069|NCT02548351|470744004|FG000|Overall Study|Death|11|||
130760070|NCT02548351|470744005|FG001|Overall Study|Death|15|||
130760071|NCT02548351|470744006|FG002|Overall Study|Death|12|||
130760072|NCT02548351|470744004|FG000|Overall Study|Adverse Event|22|||
130760073|NCT02548351|470744005|FG001|Overall Study|Adverse Event|56|||
130760074|NCT02548351|470744006|FG002|Overall Study|Adverse Event|36|||
130760075|NCT02548351|470744004|FG000|Overall Study|Study Terminated by Sponsor|549|||
130760076|NCT02548351|470744005|FG001|Overall Study|Study Terminated by Sponsor|509|||
130760077|NCT02548351|470744006|FG002|Overall Study|Study Terminated by Sponsor|528|||
130760078|NCT02548351|470744004|FG000|Overall Study|Site Closure|14|||
130760079|NCT02548351|470744005|FG001|Overall Study|Site Closure|5|||
130760080|NCT02548351|470744006|FG002|Overall Study|Site Closure|7|||
130760081|NCT02548351|470744004|FG000|Overall Study|Non-compliance with Study Drug|4|||
130760082|NCT02548351|470744005|FG001|Overall Study|Non-compliance with Study Drug|2|||
130760083|NCT02548351|470744006|FG002|Overall Study|Non-compliance with Study Drug|0|||
130760084|NCT02548351|470744004|FG000|Overall Study|Protocol Violation|2|||
130760085|NCT02548351|470744005|FG001|Overall Study|Protocol Violation|1|||
130760086|NCT02548351|470744006|FG002|Overall Study|Protocol Violation|2|||
130760087|NCT02548351|470744004|FG000|Overall Study|Physician Decision|11|||
130760088|NCT02548351|470744005|FG001|Overall Study|Physician Decision|18|||
130760089|NCT02548351|470744006|FG002|Overall Study|Physician Decision|11|||
130760090|NCT02548351|470744004|FG000|Overall Study|Lost to Follow-up|43|||
130760091|NCT02548351|470744005|FG001|Overall Study|Lost to Follow-up|50|||
130760092|NCT02548351|470744006|FG002|Overall Study|Lost to Follow-up|57|||
130760093|NCT02548351|470744004|FG000|Overall Study|Other|19|||
130760094|NCT02548351|470744005|FG001|Overall Study|Other|16|||
130760095|NCT02548351|470744006|FG002|Overall Study|Other|20|||
130760096|NCT02548351|470744004|FG000|Overall Study|Missing|1|||
130760097|NCT02548351|470744005|FG001|Overall Study|Missing|1|||
130760098|NCT02548351|470744006|FG002|Overall Study|Missing|0|||
130760099|NCT00125242|470744007|FG000|Overall Study|did not qualify|7|||
130760100|NCT00125242|470744008|FG001|Overall Study|did not qualify|2|||
130760101|NCT01664949|470744011|FG000|Overall Study|Adverse Event|11|||
130760102|NCT01664949|470744012|FG001|Overall Study|Adverse Event|12|||
130760103|NCT01664949|470744011|FG000|Overall Study|Lack of Efficacy|1|||
130760104|NCT01664949|470744012|FG001|Overall Study|Lack of Efficacy|1|||
130760105|NCT01664949|470744011|FG000|Overall Study|Lost to Follow-up|1|||
130760106|NCT01664949|470744012|FG001|Overall Study|Lost to Follow-up|2|||
130760107|NCT01664949|470744011|FG000|Overall Study|Personal Reasons|3|||
130760108|NCT01664949|470744012|FG001|Overall Study|Personal Reasons|4|||
130760109|NCT01664949|470744011|FG000|Overall Study|Protocol Violation|5|||
130760110|NCT01664949|470744012|FG001|Overall Study|Protocol Violation|5|||
130760111|NCT01664949|470744011|FG000|Overall Study|Other Miscellaneous Reasons|3|||
130760112|NCT01664949|470744012|FG001|Overall Study|Other Miscellaneous Reasons|1|||
130760113|NCT03003494|470744014|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
130760114|NCT04545567|470744017|FG000|Overall Study|tested positive for SARS-co-V2|1|||
130760115|NCT04545567|470744018|FG001|Overall Study|tested positive for SARS-co-V2|1|||
130760116|NCT04545567|470744017|FG000|Overall Study|Withdrawal by Subject|0|||
130760117|NCT04545567|470744018|FG001|Overall Study|Withdrawal by Subject|1|||
130760118|NCT03814720|470744021|FG000|Overall Study|Lost to Follow-up|0|||
130760119|NCT03814720|470744022|FG001|Overall Study|Lost to Follow-up|1|||
130760120|NCT03814720|470744023|FG002|Overall Study|Lost to Follow-up|0|||
130760121|NCT03814720|470744024|FG003|Overall Study|Lost to Follow-up|0|||
130760122|NCT03814720|470744025|FG004|Overall Study|Lost to Follow-up|0|||
130760123|NCT02135107|470744026|FG000|Treatment Period|Withdrawal by Subject|11|||
130760124|NCT02135107|470744027|FG001|Treatment Period|Withdrawal by Subject|0|||
130760125|NCT02135107|470744028|FG002|Treatment Period|Withdrawal by Subject|0|||
130760126|NCT02135107|470744029|FG003|Treatment Period|Withdrawal by Subject|0|||
130760127|NCT02135107|470744026|FG000|Treatment Period|Adverse Event|5|||
130760128|NCT02135107|470744027|FG001|Treatment Period|Adverse Event|2|||
130760129|NCT02135107|470744028|FG002|Treatment Period|Adverse Event|0|||
130760130|NCT02135107|470744029|FG003|Treatment Period|Adverse Event|0|||
130760131|NCT02135107|470744026|FG000|Treatment Period|Pregnancy|1|||
130760132|NCT02135107|470744027|FG001|Treatment Period|Pregnancy|0|||
130760133|NCT02135107|470744028|FG002|Treatment Period|Pregnancy|0|||
130760134|NCT02135107|470744029|FG003|Treatment Period|Pregnancy|0|||
130760135|NCT02135107|470744026|FG000|Treatment Period|Other|115|||
130760136|NCT02135107|470744027|FG001|Treatment Period|Other|24|||
130760137|NCT02135107|470744028|FG002|Treatment Period|Other|0|||
130760138|NCT02135107|470744029|FG003|Treatment Period|Other|0|||
130760139|NCT02135107|470744026|FG000|Maintenance Therapy Period|Adverse Event|0|||
130760140|NCT02135107|470744027|FG001|Maintenance Therapy Period|Adverse Event|0|||
130760141|NCT02135107|470744028|FG002|Maintenance Therapy Period|Adverse Event|3|||
130760142|NCT02135107|470744029|FG003|Maintenance Therapy Period|Adverse Event|7|||
130760143|NCT02135107|470744026|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
130760144|NCT02135107|470744027|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
130760145|NCT02135107|470744028|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
130760146|NCT02135107|470744029|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
130760147|NCT02135107|470744026|FG000|Maintenance Therapy Period|Pregnancy|0|||
130760148|NCT02135107|470744027|FG001|Maintenance Therapy Period|Pregnancy|0|||
130760149|NCT02135107|470744028|FG002|Maintenance Therapy Period|Pregnancy|0|||
130760150|NCT02135107|470744029|FG003|Maintenance Therapy Period|Pregnancy|1|||
130760151|NCT02135107|470744026|FG000|Maintenance Therapy Period|Other|0|||
130760152|NCT02135107|470744027|FG001|Maintenance Therapy Period|Other|0|||
130760153|NCT02135107|470744028|FG002|Maintenance Therapy Period|Other|7|||
130760154|NCT02135107|470744029|FG003|Maintenance Therapy Period|Other|8|||
130760155|NCT03197324|470744030|FG000|Overall Study|Adverse Event|0|||
130760156|NCT03197324|470744031|FG001|Overall Study|Adverse Event|1|||
130760157|NCT00877071|470744032|FG000|Overall Study|disease progression|2|||
130760158|NCT01984892|470744033|FG000|Overall Study|Progressive disease|7|||
130760159|NCT05723328|470744035|FG000|Overall Study|Investigator's Decision|5|||
130760160|NCT05723328|470744036|FG001|Overall Study|Investigator's Decision|2|||
130760161|NCT03055494|470745506|FG000|Overall Study|Lost to Follow-up|6|||
130760162|NCT03055494|470745507|FG001|Overall Study|Lost to Follow-up|0|||
130760163|NCT03055494|470745506|FG000|Overall Study|Physician Decision|2|||
130760164|NCT03055494|470745507|FG001|Overall Study|Physician Decision|0|||
130760165|NCT03055494|470745506|FG000|Overall Study|Withdrawal by Subject|1|||
130760166|NCT03055494|470745507|FG001|Overall Study|Withdrawal by Subject|0|||
130760167|NCT03055494|470745506|FG000|Overall Study|Adverse Event|0|||
130760168|NCT03055494|470745507|FG001|Overall Study|Adverse Event|1|||
130760169|NCT03055494|470745506|FG000|Overall Study|Non-compliance with study treatment|1|||
130760170|NCT03055494|470745507|FG001|Overall Study|Non-compliance with study treatment|0|||
130760171|NCT04488419|470745512|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
130760172|NCT04488419|470745513|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
130760173|NCT04488419|470745514|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
130760174|NCT04488419|470745512|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
130760175|NCT04488419|470745513|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
130760176|NCT04488419|470745514|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
130760177|NCT04488419|470745512|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
130760178|NCT04488419|470745513|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
130760179|NCT04488419|470745514|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
130760180|NCT04488419|470745512|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
130760181|NCT04488419|470745513|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
130760182|NCT04488419|470745514|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
130760183|NCT04488419|470745512|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
130760184|NCT04488419|470745513|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
130760185|NCT04488419|470745514|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
130760186|NCT04488419|470745512|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
130760187|NCT04488419|470745513|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
130760188|NCT04488419|470745514|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
130760189|NCT04488419|470745512|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
130760190|NCT04488419|470745513|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
130760191|NCT04488419|470745514|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
130760192|NCT04488419|470745512|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
130760193|NCT04488419|470745513|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
130760194|NCT04488419|470745514|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
130760195|NCT04488419|470745512|FG000|Primary Analysis Population|Adverse Event|6|||
130760196|NCT04488419|470745513|FG001|Primary Analysis Population|Adverse Event|9|||
130760197|NCT04488419|470745514|FG002|Primary Analysis Population|Adverse Event|0|||
130760198|NCT04488419|470745512|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
130760199|NCT04488419|470745513|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
130760200|NCT04488419|470745514|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
130760201|NCT04488419|470745512|FG000|Primary Analysis Population|Protocol Violation|1|||
130760202|NCT04488419|470745513|FG001|Primary Analysis Population|Protocol Violation|1|||
130760203|NCT04488419|470745514|FG002|Primary Analysis Population|Protocol Violation|0|||
130760204|NCT04488419|470745512|FG000|Primary Analysis Population|Undetermined|7|||
130760205|NCT04488419|470745513|FG001|Primary Analysis Population|Undetermined|3|||
130760206|NCT04488419|470745514|FG002|Primary Analysis Population|Undetermined|0|||
130760207|NCT04488419|470745512|FG000|Primary Analysis Population|>1 Reason|2|||
130760208|NCT04488419|470745513|FG001|Primary Analysis Population|>1 Reason|4|||
130760209|NCT04488419|470745514|FG002|Primary Analysis Population|>1 Reason|0|||
130760210|NCT04166591|470745515|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
130760211|NCT04166591|470745516|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
130760212|NCT04166591|470745517|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130760213|NCT04166591|470745518|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130760214|NCT04166591|470745515|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
130760215|NCT04166591|470745516|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
130760216|NCT04166591|470745517|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130760217|NCT04166591|470745518|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130760218|NCT04161079|470745521|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
130760219|NCT02515994|470745522|FG000|Overall Study|Protocol Violation|3|||
130760220|NCT02515994|470745523|FG001|Overall Study|Protocol Violation|5|||
130760221|NCT02515994|470745522|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
130760222|NCT02515994|470745523|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
130760223|NCT02515994|470745522|FG000|Overall Study|Adverse Event|3|||
130760224|NCT02515994|470745523|FG001|Overall Study|Adverse Event|1|||
130760225|NCT02515994|470745522|FG000|Overall Study|Withdrawal by Subject|2|||
130760226|NCT02515994|470745523|FG001|Overall Study|Withdrawal by Subject|0|||
130760227|NCT04186806|470745532|FG000|Period 1: 7 Days|Adverse Event|1|||
130760228|NCT04186806|470745533|FG001|Period 1: 7 Days|Adverse Event|0|||
130760229|NCT04739722|470745541|FG000|Overall Study|Lost to Follow-up|5301|||
130760230|NCT04739722|470745541|FG000|Overall Study|Withdrawal by Subject|42|||
130760231|NCT04739722|470745541|FG000|Overall Study|Non Average-risk|1157|||
130760232|NCT03047720|470745545|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
130760233|NCT03047720|470745546|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
130760234|NCT00614120|470745547|FG000|Overall Study|Adverse Event|9|||
130760235|NCT00614120|470745548|FG001|Overall Study|Adverse Event|22|||
130760236|NCT00614120|470745549|FG002|Overall Study|Adverse Event|30|||
130760237|NCT00614120|470745550|FG003|Overall Study|Adverse Event|3|||
130760238|NCT00614120|470745547|FG000|Overall Study|Lack of Efficacy|3|||
130760239|NCT00614120|470745548|FG001|Overall Study|Lack of Efficacy|3|||
130760240|NCT00614120|470745549|FG002|Overall Study|Lack of Efficacy|2|||
130760241|NCT00614120|470745550|FG003|Overall Study|Lack of Efficacy|2|||
130760242|NCT00614120|470745547|FG000|Overall Study|Protocol Violation|2|||
130760243|NCT00614120|470745548|FG001|Overall Study|Protocol Violation|5|||
130760244|NCT00614120|470745549|FG002|Overall Study|Protocol Violation|3|||
130760245|NCT00614120|470745550|FG003|Overall Study|Protocol Violation|1|||
130760246|NCT00614120|470745547|FG000|Overall Study|Withdrawal criteria|1|||
130760247|NCT00614120|470745548|FG001|Overall Study|Withdrawal criteria|0|||
130760248|NCT00614120|470745549|FG002|Overall Study|Withdrawal criteria|0|||
130760249|NCT00614120|470745550|FG003|Overall Study|Withdrawal criteria|0|||
130760250|NCT00614120|470745547|FG000|Overall Study|Withdrawal by Subject|9|||
130760251|NCT00614120|470745548|FG001|Overall Study|Withdrawal by Subject|10|||
130760252|NCT00614120|470745549|FG002|Overall Study|Withdrawal by Subject|16|||
130760253|NCT00614120|470745550|FG003|Overall Study|Withdrawal by Subject|3|||
130760254|NCT00614120|470745547|FG000|Overall Study|Did not meet trial criteria|0|||
130760255|NCT00614120|470745548|FG001|Overall Study|Did not meet trial criteria|1|||
130760256|NCT00614120|470745549|FG002|Overall Study|Did not meet trial criteria|1|||
130760257|NCT00614120|470745550|FG003|Overall Study|Did not meet trial criteria|1|||
130760258|NCT00614120|470745547|FG000|Overall Study|hCG positive (not pregnant)|0|||
130760259|NCT00614120|470745548|FG001|Overall Study|hCG positive (not pregnant)|0|||
130760260|NCT00614120|470745549|FG002|Overall Study|hCG positive (not pregnant)|1|||
130760261|NCT00614120|470745550|FG003|Overall Study|hCG positive (not pregnant)|0|||
130760262|NCT00614120|470745547|FG000|Overall Study|Hypoglycaemia|0|||
130760263|NCT00614120|470745548|FG001|Overall Study|Hypoglycaemia|0|||
130760264|NCT00614120|470745549|FG002|Overall Study|Hypoglycaemia|0|||
130760265|NCT00614120|470745550|FG003|Overall Study|Hypoglycaemia|1|||
130760266|NCT00614120|470745547|FG000|Overall Study|Lack of trial product|3|||
130760267|NCT00614120|470745548|FG001|Overall Study|Lack of trial product|3|||
130760268|NCT00614120|470745549|FG002|Overall Study|Lack of trial product|2|||
130760269|NCT00614120|470745550|FG003|Overall Study|Lack of trial product|0|||
130760270|NCT00614120|470745547|FG000|Overall Study|Late syphilis, latent|1|||
130760271|NCT00614120|470745548|FG001|Overall Study|Late syphilis, latent|0|||
130760272|NCT00614120|470745549|FG002|Overall Study|Late syphilis, latent|0|||
130760273|NCT00614120|470745550|FG003|Overall Study|Late syphilis, latent|0|||
130760274|NCT00614120|470745547|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
130760275|NCT00614120|470745548|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
130760276|NCT00614120|470745549|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
130760277|NCT00614120|470745550|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
130760278|NCT00614120|470745547|FG000|Overall Study|Lost to Follow-up|1|||
130760279|NCT00614120|470745548|FG001|Overall Study|Lost to Follow-up|2|||
130760280|NCT00614120|470745549|FG002|Overall Study|Lost to Follow-up|3|||
130760281|NCT00614120|470745550|FG003|Overall Study|Lost to Follow-up|4|||
130760282|NCT01185509|470745551|FG000|Overall Study|Progression/Relapse|9|||
130760283|NCT01185509|470745552|FG001|Overall Study|Progression/Relapse|15|||
130760284|NCT01185509|470745551|FG000|Overall Study|Physician Decision|2|||
130760285|NCT01185509|470745552|FG001|Overall Study|Physician Decision|2|||
130760286|NCT01185509|470745551|FG000|Overall Study|Withdrawal by Subject|0|||
130760287|NCT01185509|470745552|FG001|Overall Study|Withdrawal by Subject|1|||
130760288|NCT01185509|470745551|FG000|Overall Study|Death|0|||
130760289|NCT01185509|470745552|FG001|Overall Study|Death|1|||
130760290|NCT01185509|470745551|FG000|Overall Study|Intercurrent Illness|0|||
130760291|NCT01185509|470745552|FG001|Overall Study|Intercurrent Illness|1|||
130760292|NCT03687372|470745553|FG000|Overall Study|Lost to Follow-up|12|||
130760293|NCT03687372|470745554|FG001|Overall Study|Lost to Follow-up|21|||
130760294|NCT03687372|470745553|FG000|Overall Study|Withdrawal by Subject|4|||
130760295|NCT03687372|470745554|FG001|Overall Study|Withdrawal by Subject|17|||
130760296|NCT03687372|470745553|FG000|Overall Study|Investigator Decision|1|||
130760297|NCT03687372|470745554|FG001|Overall Study|Investigator Decision|1|||
130760298|NCT00108485|470745555|FG000|Overall Study|Withdrawal by Subject|3|||
130760299|NCT00108485|470745556|FG001|Overall Study|Withdrawal by Subject|0|||
130760300|NCT00108485|470745555|FG000|Overall Study|Lost to Follow-up|0|||
130760301|NCT00108485|470745556|FG001|Overall Study|Lost to Follow-up|2|||
130760302|NCT00878969|470745561|FG000|Overall Study|Physician Decision|5|||
130760303|NCT00878969|470745562|FG001|Overall Study|Physician Decision|3|||
130760304|NCT00878969|470745563|FG002|Overall Study|Physician Decision|2|||
130760305|NCT00878969|470745561|FG000|Overall Study|Withdrawal by Subject|1|||
130760306|NCT00878969|470745562|FG001|Overall Study|Withdrawal by Subject|6|||
130760307|NCT00878969|470745563|FG002|Overall Study|Withdrawal by Subject|3|||
130760308|NCT00878969|470745561|FG000|Overall Study|kidney transplant|2|||
130789649|NCT00701363|470858778|FG003|Treatment Phase 1|Adverse Event|0|||
130789650|NCT00701363|470858775|FG000|Treatment Phase 1|Protocol Violation|1|||
130789651|NCT00701363|470858776|FG001|Treatment Phase 1|Protocol Violation|0|||
130760309|NCT00878969|470745562|FG001|Overall Study|kidney transplant|3|||
130760310|NCT00878969|470745563|FG002|Overall Study|kidney transplant|2|||
130760311|NCT00878969|470745561|FG000|Overall Study|Adverse Event|3|||
130760312|NCT00878969|470745562|FG001|Overall Study|Adverse Event|1|||
130760313|NCT00878969|470745563|FG002|Overall Study|Adverse Event|2|||
130760314|NCT00878969|470745561|FG000|Overall Study|Lost to Follow-up|2|||
130760315|NCT00878969|470745562|FG001|Overall Study|Lost to Follow-up|1|||
130760316|NCT00878969|470745563|FG002|Overall Study|Lost to Follow-up|0|||
130760317|NCT00878969|470745561|FG000|Overall Study|Protocol Violation|2|||
130789652|NCT00701363|470858777|FG002|Treatment Phase 1|Protocol Violation|0|||
130789653|NCT00701363|470858778|FG003|Treatment Phase 1|Protocol Violation|0|||
130760318|NCT00878969|470745562|FG001|Overall Study|Protocol Violation|0|||
130760319|NCT00878969|470745563|FG002|Overall Study|Protocol Violation|0|||
130760320|NCT00878969|470745561|FG000|Overall Study|Death|0|||
130760321|NCT00878969|470745562|FG001|Overall Study|Death|0|||
130760322|NCT00878969|470745563|FG002|Overall Study|Death|2|||
130760323|NCT00878969|470745561|FG000|Overall Study|Pregnancy|0|||
130760324|NCT00878969|470745562|FG001|Overall Study|Pregnancy|1|||
130760325|NCT00878969|470745563|FG002|Overall Study|Pregnancy|0|||
130760326|NCT03729570|470745564|FG000|Overall Study|Lost to Follow-up|16|||
130760327|NCT03729570|470745565|FG001|Overall Study|Lost to Follow-up|20|||
130760328|NCT03729570|470745564|FG000|Overall Study|Seroconversion|5|||
130760329|NCT03729570|470745565|FG001|Overall Study|Seroconversion|0|||
130760330|NCT03729570|470745564|FG000|Overall Study|Moved out of the city|1|||
130760331|NCT03729570|470745565|FG001|Overall Study|Moved out of the city|0|||
130760332|NCT03729570|470745564|FG000|Overall Study|Time Conflict|1|||
130760333|NCT03729570|470745565|FG001|Overall Study|Time Conflict|0|||
130760334|NCT03729570|470745564|FG000|Overall Study|Time Commitment|2|||
130760335|NCT03729570|470745565|FG001|Overall Study|Time Commitment|0|||
130760336|NCT03729570|470745564|FG000|Overall Study|Bad Experience|0|||
130760337|NCT03729570|470745565|FG001|Overall Study|Bad Experience|1|||
130760338|NCT03729570|470745564|FG000|Overall Study|No reason provided|2|||
130760339|NCT03729570|470745565|FG001|Overall Study|No reason provided|1|||
130760340|NCT03729570|470745564|FG000|Overall Study|Family Conflict|0|||
130760341|NCT03729570|470745565|FG001|Overall Study|Family Conflict|1|||
130760342|NCT03729570|470745564|FG000|Overall Study|Did not want to continue taking medications|0|||
130760343|NCT03729570|470745565|FG001|Overall Study|Did not want to continue taking medications|1|||
130760344|NCT03729570|470745564|FG000|Overall Study|Found another PrEP provider|1|||
130760345|NCT03729570|470745565|FG001|Overall Study|Found another PrEP provider|0|||
130760346|NCT03729570|470745564|FG000|Overall Study|Did not enjoy being in the control group|0|||
130760347|NCT03729570|470745565|FG001|Overall Study|Did not enjoy being in the control group|1|||
130760348|NCT01701193|470745568|FG000|Overall Study|Withdrawal by Subject|2|||
130760349|NCT01701193|470745569|FG001|Overall Study|Withdrawal by Subject|2|||
130760350|NCT01701193|470745570|FG002|Overall Study|Withdrawal by Subject|1|||
130760351|NCT01701193|470745571|FG003|Overall Study|Withdrawal by Subject|2|||
130760352|NCT01701193|470745568|FG000|Overall Study|Adverse Event|1|||
130760353|NCT01701193|470745569|FG001|Overall Study|Adverse Event|0|||
130760354|NCT01701193|470745570|FG002|Overall Study|Adverse Event|0|||
130760355|NCT01701193|470745571|FG003|Overall Study|Adverse Event|0|||
130760356|NCT00278148|470745572|FG000|Phase II - Expansion Phase|Disease progression|0|||
130760357|NCT00278148|470745573|FG001|Phase II - Expansion Phase|Disease progression|0|||
130760358|NCT00278148|470745574|FG002|Phase II - Expansion Phase|Disease progression|4|||
130760359|NCT00278148|470745572|FG000|Phase II - Expansion Phase|Adverse Event|0|||
130760360|NCT00278148|470745573|FG001|Phase II - Expansion Phase|Adverse Event|0|||
130760361|NCT00278148|470745574|FG002|Phase II - Expansion Phase|Adverse Event|2|||
130760362|NCT02407457|470745575|FG000|1 Month|Death|3|||
130760363|NCT02407457|470745576|FG001|1 Month|Death|0|||
130760364|NCT02407457|470745575|FG000|1 Month|Lost to Follow-up|1|||
130760365|NCT02407457|470745576|FG001|1 Month|Lost to Follow-up|1|||
130760366|NCT02407457|470745575|FG000|1 Month|missed visit|2|||
130760367|NCT02407457|470745576|FG001|1 Month|missed visit|5|||
130760368|NCT02407457|470745575|FG000|6-Month|Death|2|||
130760369|NCT02407457|470745576|FG001|6-Month|Death|8|||
130760370|NCT02407457|470745575|FG000|6-Month|Lost to Follow-up|2|||
130760371|NCT02407457|470745576|FG001|6-Month|Lost to Follow-up|2|||
130760372|NCT02407457|470745575|FG000|6-Month|missed visit|16|||
130760373|NCT02407457|470745576|FG001|6-Month|missed visit|14|||
130760374|NCT02407457|470745575|FG000|6-Month|Open Repair|0|||
130760375|NCT02407457|470745576|FG001|6-Month|Open Repair|1|||
130760376|NCT02407457|470745575|FG000|1 Year|Death|6|||
130760377|NCT02407457|470745576|FG001|1 Year|Death|11|||
130760378|NCT02407457|470745575|FG000|1 Year|Lost to Follow-up|3|||
130760379|NCT02407457|470745576|FG001|1 Year|Lost to Follow-up|2|||
130760380|NCT02407457|470745575|FG000|1 Year|Missed Visit|24|||
130760381|NCT02407457|470745576|FG001|1 Year|Missed Visit|14|||
130760382|NCT02407457|470745575|FG000|1 Year|Open Repair|0|||
130760383|NCT02407457|470745576|FG001|1 Year|Open Repair|1|||
130760384|NCT02407457|470745575|FG000|2-year|Death|14|||
130760385|NCT02407457|470745576|FG001|2-year|Death|8|||
130760386|NCT02407457|470745575|FG000|2-year|Lost to Follow-up|7|||
130760387|NCT02407457|470745576|FG001|2-year|Lost to Follow-up|10|||
130760388|NCT02407457|470745575|FG000|2-year|Missed Visit|13|||
130760389|NCT02407457|470745576|FG001|2-year|Missed Visit|15|||
130760390|NCT02407457|470745575|FG000|2-year|Open Repair|0|||
130760391|NCT02407457|470745576|FG001|2-year|Open Repair|2|||
130760392|NCT02407457|470745575|FG000|3-year|Death|11|||
130760393|NCT02407457|470745576|FG001|3-year|Death|10|||
130760394|NCT02407457|470745575|FG000|3-year|Lost to Follow-up|9|||
130760395|NCT02407457|470745576|FG001|3-year|Lost to Follow-up|10|||
130760396|NCT02407457|470745575|FG000|3-year|Missed Visit|19|||
130760397|NCT02407457|470745576|FG001|3-year|Missed Visit|16|||
130760398|NCT02407457|470745575|FG000|4-year|Death|18|||
130760399|NCT02407457|470745576|FG001|4-year|Death|10|||
130760400|NCT02407457|470745575|FG000|4-year|Lost to Follow-up|10|||
130760401|NCT02407457|470745576|FG001|4-year|Lost to Follow-up|12|||
130760402|NCT02407457|470745575|FG000|4-year|Missed Visit|18|||
130760403|NCT02407457|470745576|FG001|4-year|Missed Visit|16|||
130760404|NCT02407457|470745575|FG000|5-year|Death|10|||
130760405|NCT02407457|470745576|FG001|5-year|Death|3|||
130760406|NCT02407457|470745575|FG000|5-year|Lost to Follow-up|22|||
130760407|NCT02407457|470745576|FG001|5-year|Lost to Follow-up|13|||
130760408|NCT02407457|470745575|FG000|5-year|Missed Visit|9|||
130760409|NCT02407457|470745576|FG001|5-year|Missed Visit|1|||
130760410|NCT02083185|470745577|FG000|Overall Study|Lost to Follow-up|0|||
130760411|NCT02083185|470745578|FG001|Overall Study|Lost to Follow-up|3|||
130760412|NCT02083185|470745579|FG002|Overall Study|Lost to Follow-up|0|||
130760413|NCT02083185|470745577|FG000|Overall Study|Withdrawal by Subject|9|||
130760414|NCT02083185|470745578|FG001|Overall Study|Withdrawal by Subject|15|||
130760415|NCT02083185|470745579|FG002|Overall Study|Withdrawal by Subject|1|||
130760416|NCT02083185|470745577|FG000|Overall Study|Death|2|||
130760417|NCT02083185|470745578|FG001|Overall Study|Death|2|||
130760418|NCT02083185|470745579|FG002|Overall Study|Death|1|||
130760419|NCT02083185|470745577|FG000|Overall Study|Reason not Specified|9|||
130760420|NCT02083185|470745578|FG001|Overall Study|Reason not Specified|6|||
130760421|NCT02083185|470745579|FG002|Overall Study|Reason not Specified|5|||
130760422|NCT02083185|470745577|FG000|Overall Study|Study Terminated by Sponsor|0|||
130760423|NCT02083185|470745578|FG001|Overall Study|Study Terminated by Sponsor|1|||
130760424|NCT02083185|470745579|FG002|Overall Study|Study Terminated by Sponsor|0|||
130760425|NCT02083185|470745577|FG000|Overall Study|Did not Receive Study Drug|0|||
130760426|NCT02083185|470745578|FG001|Overall Study|Did not Receive Study Drug|2|||
130760427|NCT02083185|470745579|FG002|Overall Study|Did not Receive Study Drug|0|||
130760428|NCT01041976|470745580|FG000|Overall Study|Withdrawal by Subject|3|||
130760429|NCT01041976|470745581|FG001|Overall Study|Withdrawal by Subject|0|||
130760430|NCT01041976|470745580|FG000|Overall Study|Incarceration|2|||
130760431|NCT01041976|470745581|FG001|Overall Study|Incarceration|0|||
130789654|NCT00701363|470858775|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
130789655|NCT00701363|470858776|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
130789656|NCT00701363|470858777|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
130789657|NCT00701363|470858778|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
130789658|NCT00701363|470858775|FG000|Treatment Phase 1|Lack of Efficacy|1|||
130789659|NCT00701363|470858776|FG001|Treatment Phase 1|Lack of Efficacy|0|||
130789660|NCT00701363|470858777|FG002|Treatment Phase 1|Lack of Efficacy|0|||
130789661|NCT00701363|470858778|FG003|Treatment Phase 1|Lack of Efficacy|0|||
130789662|NCT00701363|470858775|FG000|Treatment Phase 2|Adverse Event|0|||
130789663|NCT00701363|470858776|FG001|Treatment Phase 2|Adverse Event|0|||
130789664|NCT00701363|470858777|FG002|Treatment Phase 2|Adverse Event|1|||
130789665|NCT00701363|470858778|FG003|Treatment Phase 2|Adverse Event|0|||
130789666|NCT00701363|470858775|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
130789667|NCT00701363|470858776|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
130789668|NCT00701363|470858777|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
130789669|NCT00701363|470858778|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
130789670|NCT05144945|470858779|FG000|Overall Study|Withdrawal by Subject|1|||
130789671|NCT05144945|470858780|FG001|Overall Study|Withdrawal by Subject|0|||
130789672|NCT00284856|470858781|FG000|Overall Study|Adverse Event|3|||
130789673|NCT00284856|470858782|FG001|Overall Study|Adverse Event|3|||
130789674|NCT00284856|470858783|FG002|Overall Study|Adverse Event|3|||
130789675|NCT00284856|470858781|FG000|Overall Study|Lack of Efficacy|2|||
130760432|NCT01041976|470745580|FG000|Overall Study|Death|0|||
130760433|NCT01041976|470745581|FG001|Overall Study|Death|4|||
130760434|NCT03054064|470745582|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
130760435|NCT03054064|470745582|FG000|Overall Study|Investigator Decision|2|||
130760436|NCT03054064|470745582|FG000|Overall Study|Bladder Issue|1|||
130760437|NCT03054064|470745582|FG000|Overall Study|High Blood Pressure|1|||
130760438|NCT03054064|470745582|FG000|Overall Study|Change in Status|1|||
130760439|NCT03787303|470745583|FG000|Overall Study|Death|1|||
130760440|NCT03787303|470745583|FG000|Overall Study|Premature Termination of Study|1|||
130760441|NCT01210495|470745584|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
130789676|NCT00284856|470858782|FG001|Overall Study|Lack of Efficacy|1|||
130789677|NCT00284856|470858783|FG002|Overall Study|Lack of Efficacy|8|||
130760442|NCT01210495|470745585|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
130760443|NCT01210495|470745586|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
130760444|NCT01210495|470745587|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
130760445|NCT01210495|470745584|FG000|Overall Study|Death|14|||
130760446|NCT01210495|470745585|FG001|Overall Study|Death|7|||
130760447|NCT01210495|470745586|FG002|Overall Study|Death|112|||
130760448|NCT01210495|470745587|FG003|Overall Study|Death|54|||
130789678|NCT00284856|470858781|FG000|Overall Study|Lost to Follow-up|25|||
130760449|NCT01210495|470745584|FG000|Overall Study|Study Terminated by Sponsor|0|||
130760450|NCT01210495|470745585|FG001|Overall Study|Study Terminated by Sponsor|0|||
130760451|NCT01210495|470745586|FG002|Overall Study|Study Terminated by Sponsor|4|||
130760452|NCT01210495|470745587|FG003|Overall Study|Study Terminated by Sponsor|11|||
130760453|NCT01210495|470745584|FG000|Overall Study|Lost to Follow-up|0|||
130760454|NCT01210495|470745585|FG001|Overall Study|Lost to Follow-up|0|||
130760455|NCT01210495|470745586|FG002|Overall Study|Lost to Follow-up|1|||
130760456|NCT01210495|470745587|FG003|Overall Study|Lost to Follow-up|1|||
130760457|NCT01210495|470745584|FG000|Overall Study|Other unspecified|0|||
130760458|NCT01210495|470745585|FG001|Overall Study|Other unspecified|0|||
130760459|NCT01210495|470745586|FG002|Overall Study|Other unspecified|6|||
130760460|NCT01210495|470745587|FG003|Overall Study|Other unspecified|0|||
130760461|NCT01384019|470745590|FG000|Overall Study|Withdrawal by Subject|3|||
130760462|NCT01384019|470745591|FG001|Overall Study|Withdrawal by Subject|0|||
130760463|NCT01384019|470745590|FG000|Overall Study|Death|1|||
130760464|NCT01384019|470745591|FG001|Overall Study|Death|0|||
130760465|NCT01384019|470745590|FG000|Overall Study|MRI refusal|6|||
130760466|NCT01384019|470745591|FG001|Overall Study|MRI refusal|6|||
130760467|NCT00767039|470745594|FG000|Overall Study|Death|5|||
130760468|NCT00767039|470745595|FG001|Overall Study|Death|2|||
130760469|NCT01826370|470745596|FG000|Overall Study|Protocol Violation|6|||
130760470|NCT01826370|470745596|FG000|Overall Study|Lost to Follow-up|12|||
130760471|NCT01826370|470745596|FG000|Overall Study|Other reason not defined above|2|||
130760472|NCT04416737|470745598|FG000|Week 1 (First Injection)|Physician Decision|0|||
130760473|NCT04416737|470745599|FG001|Week 1 (First Injection)|Physician Decision|1|||
130760474|NCT03332628|470745600|FG000|Overall Study|Physician Decision|2|||
130760475|NCT01472757|470745601|FG000|Overall Study|Withdrawal by Subject|1|||
130760476|NCT01472757|470745602|FG001|Overall Study|Withdrawal by Subject|2|||
130760477|NCT01472757|470745603|FG002|Overall Study|Withdrawal by Subject|2|||
130760478|NCT01472757|470745604|FG003|Overall Study|Withdrawal by Subject|0|||
130760479|NCT01472757|470745601|FG000|Overall Study|Asthma exacerbation|4|||
130760480|NCT01472757|470745602|FG001|Overall Study|Asthma exacerbation|1|||
130760481|NCT01472757|470745603|FG002|Overall Study|Asthma exacerbation|2|||
130760482|NCT01472757|470745604|FG003|Overall Study|Asthma exacerbation|1|||
130760483|NCT01472757|470745601|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
130760484|NCT01472757|470745602|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
130760485|NCT01472757|470745603|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
130760486|NCT01472757|470745604|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
130760487|NCT01472757|470745601|FG000|Overall Study|Protocol Violation|3|||
130760488|NCT01472757|470745602|FG001|Overall Study|Protocol Violation|2|||
130760489|NCT01472757|470745603|FG002|Overall Study|Protocol Violation|4|||
130760490|NCT01472757|470745604|FG003|Overall Study|Protocol Violation|4|||
130760491|NCT01472757|470745601|FG000|Overall Study|Other reasons|1|||
130760492|NCT01472757|470745602|FG001|Overall Study|Other reasons|0|||
130760493|NCT01472757|470745603|FG002|Overall Study|Other reasons|2|||
130760494|NCT01472757|470745604|FG003|Overall Study|Other reasons|2|||
130760495|NCT04489381|470745609|FG000|Overall Study|Lost to Follow-up|2|||
130760496|NCT04489381|470745610|FG001|Overall Study|Lost to Follow-up|3|||
130760497|NCT04489381|470745609|FG000|Overall Study|Withdrawal by Subject|1|||
130760498|NCT04489381|470745610|FG001|Overall Study|Withdrawal by Subject|0|||
130760499|NCT01259375|470745615|FG000|Overall Study|Adverse Event|1|||
130760500|NCT00478699|470745618|FG000|Overall Study|Inclusion Error|1|||
130760501|NCT00478699|470745619|FG001|Overall Study|Inclusion Error|7|||
130760502|NCT00478699|470745618|FG000|Overall Study|Not receive study treatment|6|||
130760503|NCT00478699|470745619|FG001|Overall Study|Not receive study treatment|30|||
130760504|NCT01043705|470745624|FG000|Overall Study|Death|28|||
130760505|NCT01043705|470745625|FG001|Overall Study|Death|60|||
130760506|NCT01043705|470745626|FG002|Overall Study|Death|26|||
130760507|NCT01043705|470745624|FG000|Overall Study|Lost to Follow-up|27|||
130789679|NCT00284856|470858782|FG001|Overall Study|Lost to Follow-up|21|||
130760508|NCT01043705|470745625|FG001|Overall Study|Lost to Follow-up|12|||
130760509|NCT01043705|470745626|FG002|Overall Study|Lost to Follow-up|0|||
130760510|NCT01043705|470745624|FG000|Overall Study|Multiple Reasons|4|||
130760511|NCT01043705|470745625|FG001|Overall Study|Multiple Reasons|7|||
130760512|NCT01043705|470745626|FG002|Overall Study|Multiple Reasons|0|||
130760513|NCT01043705|470745624|FG000|Overall Study|Protocol Violation|2|||
130760514|NCT01043705|470745625|FG001|Overall Study|Protocol Violation|1|||
130760515|NCT01043705|470745626|FG002|Overall Study|Protocol Violation|0|||
130760516|NCT01043705|470745624|FG000|Overall Study|Withdrawal by Subject|8|||
130760517|NCT01043705|470745625|FG001|Overall Study|Withdrawal by Subject|6|||
130760518|NCT01043705|470745626|FG002|Overall Study|Withdrawal by Subject|0|||
130760519|NCT01043705|470745624|FG000|Overall Study|Site Closure|8|||
130760520|NCT01043705|470745625|FG001|Overall Study|Site Closure|0|||
130760521|NCT01043705|470745626|FG002|Overall Study|Site Closure|0|||
130760522|NCT01043705|470745624|FG000|Overall Study|Subsequent Procedure|9|||
130760523|NCT01043705|470745625|FG001|Overall Study|Subsequent Procedure|24|||
130760524|NCT01043705|470745626|FG002|Overall Study|Subsequent Procedure|29|||
130760525|NCT01043705|470745624|FG000|Overall Study|Adverse Event|0|||
130760526|NCT01043705|470745625|FG001|Overall Study|Adverse Event|2|||
130760527|NCT01043705|470745626|FG002|Overall Study|Adverse Event|0|||
130760528|NCT01043705|470745624|FG000|Overall Study|Screen Fail|21|||
130760529|NCT01043705|470745625|FG001|Overall Study|Screen Fail|0|||
130760530|NCT01043705|470745626|FG002|Overall Study|Screen Fail|0|||
130760531|NCT01043705|470745624|FG000|Overall Study|Other|0|||
130760532|NCT01043705|470745625|FG001|Overall Study|Other|19|||
130760533|NCT01043705|470745626|FG002|Overall Study|Other|25|||
130760534|NCT01123941|470745629|FG000|Overall Study|Lost to Follow-up|2|||
130760535|NCT01123941|470745630|FG001|Overall Study|Lost to Follow-up|1|||
130760536|NCT04601103|470745631|FG000|Overall Study|Needed crown & cleaning|0|||
130760537|NCT04601103|470745632|FG001|Overall Study|Needed crown & cleaning|0|||
130760538|NCT04601103|470745633|FG002|Overall Study|Needed crown & cleaning|1|||
130760539|NCT04601103|470745631|FG000|Overall Study|study was terminated|18|||
130760540|NCT04601103|470745632|FG001|Overall Study|study was terminated|18|||
130760541|NCT04601103|470745633|FG002|Overall Study|study was terminated|16|||
130760542|NCT06011161|470745634|FG000|Overall Study|Withdrawal by Subject|2|||
130760543|NCT06011161|470745634|FG000|Overall Study|Lost to Follow-up|5|||
130760544|NCT00381043|470745635|FG000|Overall Study|Lost to Follow-up|8|||
130760545|NCT00381043|470745636|FG001|Overall Study|Lost to Follow-up|6|||
130760546|NCT00381043|470745635|FG000|Overall Study|Withdrawal by Subject|3|||
130760547|NCT00381043|470745636|FG001|Overall Study|Withdrawal by Subject|1|||
130760548|NCT00381043|470745635|FG000|Overall Study|wanted more care|0|||
130760549|NCT00381043|470745636|FG001|Overall Study|wanted more care|1|||
130760550|NCT00381043|470745635|FG000|Overall Study|incarcerated|1|||
130760551|NCT00381043|470745636|FG001|Overall Study|incarcerated|0|||
130760552|NCT03045276|470745639|FG000|Intervention Phase|Withdrawal by Subject|7|||
130760553|NCT03045276|470745640|FG001|Intervention Phase|Withdrawal by Subject|2|||
130760554|NCT03045276|470745641|FG002|Intervention Phase|Withdrawal by Subject|3|||
130760555|NCT03045276|470745642|FG003|Intervention Phase|Withdrawal by Subject|7|||
130760556|NCT03045276|470745639|FG000|Intervention Phase|Developed exclusionary criteria|3|||
130760557|NCT03045276|470745640|FG001|Intervention Phase|Developed exclusionary criteria|3|||
130760558|NCT03045276|470745641|FG002|Intervention Phase|Developed exclusionary criteria|0|||
130760559|NCT03045276|470745642|FG003|Intervention Phase|Developed exclusionary criteria|0|||
130760560|NCT03045276|470745639|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
130760561|NCT03045276|470745640|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
130760562|NCT03045276|470745641|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
130760563|NCT03045276|470745642|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
130760564|NCT03045276|470745639|FG000|Follow-Up Phase|Lost to Follow-up|0|||
130760565|NCT03045276|470745640|FG001|Follow-Up Phase|Lost to Follow-up|1|||
130760566|NCT03045276|470745641|FG002|Follow-Up Phase|Lost to Follow-up|0|||
130760567|NCT03045276|470745642|FG003|Follow-Up Phase|Lost to Follow-up|1|||
130760568|NCT03045276|470745639|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
130760569|NCT03045276|470745640|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
130760570|NCT03045276|470745641|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
130760571|NCT03045276|470745642|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
130760572|NCT03379753|470745643|FG000|Overall Study|Withdrawal by Subject|2|||
130760573|NCT03379753|470745644|FG001|Overall Study|Withdrawal by Subject|1|||
130760574|NCT03379753|470745643|FG000|Overall Study|not having correct procedure|1|||
130760575|NCT03379753|470745644|FG001|Overall Study|not having correct procedure|2|||
130760576|NCT03379753|470745643|FG000|Overall Study|No primary outcome|12|||
130760577|NCT03379753|470745644|FG001|Overall Study|No primary outcome|22|||
130760578|NCT01597375|470745645|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
130760579|NCT01597375|470745646|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
130760580|NCT01597375|470745645|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
130760581|NCT01597375|470745646|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
130760582|NCT01597375|470745645|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
130760583|NCT01597375|470745646|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
130760584|NCT01597375|470745645|FG000|Washout (2 Weeks)|Adverse Event|1|||
130760585|NCT01597375|470745646|FG001|Washout (2 Weeks)|Adverse Event|0|||
130760586|NCT01597375|470745645|FG000|Second Intervention|Failed to react at both Aspirin|1|||
130760587|NCT01597375|470745646|FG001|Second Intervention|Failed to react at both Aspirin|1|||
130760588|NCT02225366|470745651|FG000|Overall Study|Lack of Efficacy|1|||
130760589|NCT02225366|470745652|FG001|Overall Study|Lack of Efficacy|0|||
130760590|NCT04713592|470745655|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
130760591|NCT04713592|470745656|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
130760592|NCT04713592|470745657|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
130760593|NCT04713592|470745658|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
130760594|NCT04713592|470745655|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
130760595|NCT04713592|470745656|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
130760596|NCT04713592|470745657|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
130760597|NCT04713592|470745658|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
130760598|NCT04713592|470745655|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
130760599|NCT04713592|470745656|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
130760600|NCT04713592|470745657|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
130760601|NCT04713592|470745658|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
130760602|NCT04713592|470745655|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130760603|NCT04713592|470745656|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130760604|NCT04713592|470745657|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
130760605|NCT04713592|470745658|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
130760606|NCT04713592|470745655|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
130760607|NCT04713592|470745656|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
130760608|NCT04713592|470745657|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
130760609|NCT04713592|470745658|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
130760610|NCT04713592|470745655|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130760611|NCT04713592|470745656|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130760612|NCT04713592|470745657|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130760613|NCT04713592|470745658|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130760614|NCT04713592|470745655|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
130760615|NCT04713592|470745656|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
130760616|NCT04713592|470745657|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
130760617|NCT04713592|470745658|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
130760618|NCT03782298|470745659|FG000|Overall Study|Protocol Deviation|4|||
130760619|NCT01797081|470745662|FG000|Overall Study|Adverse Event|1|||
130760620|NCT01797081|470745663|FG001|Overall Study|Adverse Event|0|||
130760621|NCT01797081|470745664|FG002|Overall Study|Adverse Event|1|||
130760622|NCT01797081|470745665|FG003|Overall Study|Adverse Event|0|||
130760623|NCT01797081|470745662|FG000|Overall Study|Pregnancy|1|||
130760624|NCT01797081|470745663|FG001|Overall Study|Pregnancy|0|||
130760625|NCT01797081|470745664|FG002|Overall Study|Pregnancy|0|||
130760626|NCT01797081|470745665|FG003|Overall Study|Pregnancy|0|||
130760627|NCT01797081|470745662|FG000|Overall Study|Personal Reasons|12|||
130760628|NCT01797081|470745663|FG001|Overall Study|Personal Reasons|4|||
130760629|NCT01797081|470745664|FG002|Overall Study|Personal Reasons|4|||
130760630|NCT01797081|470745665|FG003|Overall Study|Personal Reasons|8|||
130760631|NCT01797081|470745662|FG000|Overall Study|Protocol Violation|0|||
130760632|NCT01797081|470745663|FG001|Overall Study|Protocol Violation|0|||
130760633|NCT01797081|470745664|FG002|Overall Study|Protocol Violation|0|||
130760634|NCT01797081|470745665|FG003|Overall Study|Protocol Violation|1|||
130760635|NCT02484651|470745670|FG000|Overall Study|Patients' data files were corrupted.|1|||
130760636|NCT02484651|470745671|FG001|Overall Study|Patients' data files were corrupted.|1|||
130760637|NCT02484651|470745670|FG000|Overall Study|BIS monitoring failed.|1|||
130760638|NCT02484651|470745671|FG001|Overall Study|BIS monitoring failed.|1|||
130760639|NCT02484651|470745670|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
130760640|NCT02484651|470745671|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
130760641|NCT02375555|470745672|FG000|Induction Period|Adverse Event|7|||
130760642|NCT02375555|470745672|FG000|Induction Period|Withdrawal by Subject|2|||
130760643|NCT02375555|470745672|FG000|Induction Period|Other|1|||
130760644|NCT02375555|470745672|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
130760645|NCT02375555|470745672|FG000|Maintenance Period|Adverse Event|2|||
130760646|NCT02375555|470745672|FG000|Maintenance Period|Withdrawal by Subject|4|||
130760647|NCT02375555|470745672|FG000|Maintenance Period|Death|1|||
130789680|NCT00284856|470858783|FG002|Overall Study|Lost to Follow-up|22|||
130789681|NCT00284856|470858781|FG000|Overall Study|Protocol Violation|5|||
130789682|NCT00284856|470858782|FG001|Overall Study|Protocol Violation|4|||
130760648|NCT02375555|470745672|FG000|Maintenance Period|Disease Progression|5|||
130760649|NCT02375555|470745672|FG000|Maintenance Period|Patient Non-compliance|1|||
130760650|NCT02375555|470745672|FG000|Maintenance Period|Still on maintenance|16|||
130760651|NCT01744184|470745681|FG000|Overall Study|Adverse Event|1|||
130760652|NCT01744184|470745682|FG001|Overall Study|Adverse Event|0|||
130760653|NCT01744184|470745681|FG000|Overall Study|Withdrawal by Subject|0|||
130789683|NCT00284856|470858783|FG002|Overall Study|Protocol Violation|5|||
130789684|NCT00284856|470858781|FG000|Overall Study|Withdrawal by Subject|12|||
130789685|NCT00284856|470858782|FG001|Overall Study|Withdrawal by Subject|16|||
130789686|NCT00284856|470858783|FG002|Overall Study|Withdrawal by Subject|18|||
130789687|NCT00284856|470858781|FG000|Overall Study|Other|4|||
130789688|NCT00284856|470858782|FG001|Overall Study|Other|5|||
130789689|NCT00284856|470858783|FG002|Overall Study|Other|4|||
130789690|NCT01192815|470858784|FG000|Overall Study|Withdrawal by Subject|1|||
130789691|NCT01192815|470858784|FG000|Overall Study|Lack of Efficacy|1|||
130789692|NCT03426878|470858785|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
130789693|NCT03426878|470858785|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
130789694|NCT03426878|470858785|FG000|Overall Study|Declined to receive results|3|||
130789695|NCT03426878|470858785|FG000|Overall Study|Received negative results by mailed letter|65|||
130789696|NCT03426878|470858785|FG000|Overall Study|Lost to Follow-up|177|||
130789697|NCT01286129|470858786|FG000|Overall Study|Withdrawal by Subject|4|||
130789698|NCT01286129|470858787|FG001|Overall Study|Withdrawal by Subject|1|||
130789699|NCT01286129|470858786|FG000|Overall Study|Could not comply with study requirements|4|||
130789700|NCT01286129|470858787|FG001|Overall Study|Could not comply with study requirements|4|||
130789701|NCT01394276|470858792|FG000|Overall Study|Related Adverse event (AEs)|15|||
130789702|NCT01394276|470858792|FG000|Overall Study|Not related AEs|9|||
130789703|NCT01394276|470858792|FG000|Overall Study|Remission of disease|2|||
130789704|NCT01394276|470858792|FG000|Overall Study|Insufficient therapeutic effect|17|||
130789705|NCT01394276|470858792|FG000|Overall Study|Insufficient compliance|9|||
130789706|NCT01394276|470858792|FG000|Overall Study|Lost to Follow-up|5|||
130789707|NCT01394276|470858792|FG000|Overall Study|Participant moved to another site|1|||
130789708|NCT01394276|470858792|FG000|Overall Study|Pregnancy|1|||
130789709|NCT01394276|470858792|FG000|Overall Study|unavailability of drug at the Hospital|2|||
130789710|NCT01394276|470858792|FG000|Overall Study|Symptoms of concurrent diseases|1|||
130789711|NCT00465179|470858793|FG000|Overall Study|Adverse Event|4|||
130789712|NCT00465179|470858793|FG000|Overall Study|Withdrawal by Subject|2|||
130789713|NCT00465179|470858793|FG000|Overall Study|Progression of Disease|47|||
130789714|NCT00262925|470858796|FG000|Overall Study|Lack of Efficacy|3|||
130789715|NCT00262925|470858796|FG000|Overall Study|Adverse Event|4|||
130789716|NCT00262925|470858796|FG000|Overall Study|Death|2|||
130789717|NCT00262925|470858796|FG000|Overall Study|alternative therapy|1|||
130789718|NCT00262925|470858796|FG000|Overall Study|Other|1|||
130789719|NCT04682301|470858797|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
130789720|NCT04682301|470858797|FG000|Overall Study|Death|2|||
130789721|NCT00560404|470858798|FG000|Overall Study|Adverse Event|2|||
130789722|NCT00560404|470858799|FG001|Overall Study|Adverse Event|3|||
130789723|NCT00560404|470858798|FG000|Overall Study|Death|3|||
130789724|NCT00560404|470858799|FG001|Overall Study|Death|3|||
130789725|NCT00560404|470858798|FG000|Overall Study|Protocol Violation|12|||
130789726|NCT00560404|470858799|FG001|Overall Study|Protocol Violation|7|||
130789727|NCT00560404|470858798|FG000|Overall Study|Administrative Reasons|1|||
130789728|NCT00560404|470858799|FG001|Overall Study|Administrative Reasons|1|||
130789729|NCT00560404|470858798|FG000|Overall Study|Withdrew Consent|4|||
130789730|NCT00560404|470858799|FG001|Overall Study|Withdrew Consent|0|||
130789731|NCT00560404|470858798|FG000|Overall Study|Failure to return|1|||
130789732|NCT00560404|470858799|FG001|Overall Study|Failure to return|2|||
130789733|NCT00560404|470858798|FG000|Overall Study|Other withdrawal reason|13|||
130789734|NCT00560404|470858799|FG001|Overall Study|Other withdrawal reason|5|||
130789735|NCT02187783|470858800|FG000|Overall Study|Adverse Event|8|||
130789736|NCT02187783|470858800|FG000|Overall Study|Death|3|||
130789737|NCT02187783|470858800|FG000|Overall Study|Progressive disease|80|||
130789738|NCT02187783|470858800|FG000|Overall Study|Protocol Violation|3|||
130789739|NCT02187783|470858800|FG000|Overall Study|Physician Decision|2|||
130789740|NCT02187783|470858800|FG000|Overall Study|Withdrawal by Subject|9|||
130789741|NCT02187783|470858800|FG000|Overall Study|Study terminated by sponsor|1|||
130789742|NCT00471497|470858801|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
130789743|NCT00471497|470858802|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
130789744|NCT00471497|470858803|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
130789745|NCT00471497|470858801|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
130789746|NCT00471497|470858802|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
130789747|NCT00471497|470858803|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
130789748|NCT00471497|470858801|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
130789749|NCT00471497|470858802|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
130789750|NCT00471497|470858803|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
130789751|NCT00471497|470858801|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
130789752|NCT00471497|470858802|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
130789753|NCT00471497|470858803|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
130789754|NCT00471497|470858801|FG000|Core Treatment Phase|Lost to Follow-up|6|||
130789755|NCT00471497|470858802|FG001|Core Treatment Phase|Lost to Follow-up|6|||
130789756|NCT00471497|470858803|FG002|Core Treatment Phase|Lost to Follow-up|3|||
130789757|NCT00471497|470858801|FG000|Core Treatment Phase|Death|3|||
130789758|NCT00471497|470858802|FG001|Core Treatment Phase|Death|9|||
130789759|NCT00471497|470858803|FG002|Core Treatment Phase|Death|3|||
130789760|NCT00471497|470858801|FG000|Core Treatment Phase|Disease Progression|10|||
130789761|NCT00471497|470858802|FG001|Core Treatment Phase|Disease Progression|2|||
130789762|NCT00471497|470858803|FG002|Core Treatment Phase|Disease Progression|4|||
130789763|NCT00471497|470858801|FG000|Core Treatment Phase|Protocol Violation|6|||
130789764|NCT00471497|470858802|FG001|Core Treatment Phase|Protocol Violation|15|||
130789765|NCT00471497|470858803|FG002|Core Treatment Phase|Protocol Violation|11|||
130789766|NCT00471497|470858801|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
130789767|NCT00471497|470858802|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
130789768|NCT00471497|470858803|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
130789769|NCT00471497|470858801|FG000|Core Treatment Phase|Administrative problems|14|||
130789770|NCT00471497|470858802|FG001|Core Treatment Phase|Administrative problems|14|||
130789771|NCT00471497|470858803|FG002|Core Treatment Phase|Administrative problems|12|||
130789772|NCT00471497|470858801|FG000|Core Treatment Phase|Adverse Event|43|||
130789773|NCT00471497|470858802|FG001|Core Treatment Phase|Adverse Event|53|||
130789774|NCT00471497|470858803|FG002|Core Treatment Phase|Adverse Event|89|||
130789775|NCT00471497|470858801|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
130789776|NCT00471497|470858802|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
130789777|NCT00471497|470858803|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
130789778|NCT00471497|470858801|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
130789779|NCT00471497|470858802|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
130789780|NCT00471497|470858803|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
130789781|NCT00471497|470858801|FG000|Extension Phase|Adverse Event|9|||
130760654|NCT01744184|470745682|FG001|Overall Study|Withdrawal by Subject|1|||
130760655|NCT01095978|470745686|FG000|Overall Study|Did not take Klacid SR|2|||
130760656|NCT01095978|470745686|FG000|Overall Study|Adverse Event|1|||
130760657|NCT00808639|470745690|FG000|Overall Study|Disease progression before surgery.|1|||
130760658|NCT01790828|470745692|FG000|Overall Study|Other|34|||
130760659|NCT00197002|470747417|FG000|Overall Study|Adverse Event|0|||
130760660|NCT00197002|470747418|FG001|Overall Study|Adverse Event|1|||
130760661|NCT00197002|470747419|FG002|Overall Study|Adverse Event|0|||
130760662|NCT00197002|470747417|FG000|Overall Study|Protocol Violation|1|||
130760663|NCT00197002|470747418|FG001|Overall Study|Protocol Violation|0|||
130760664|NCT00197002|470747419|FG002|Overall Study|Protocol Violation|2|||
130760665|NCT00197002|470747417|FG000|Overall Study|Withdrawal by Subject|9|||
130760666|NCT00197002|470747418|FG001|Overall Study|Withdrawal by Subject|5|||
130760667|NCT00197002|470747419|FG002|Overall Study|Withdrawal by Subject|7|||
130760668|NCT00197002|470747417|FG000|Overall Study|Migrated/moved from study area|3|||
130760669|NCT00197002|470747418|FG001|Overall Study|Migrated/moved from study area|5|||
130760670|NCT00197002|470747419|FG002|Overall Study|Migrated/moved from study area|1|||
130760671|NCT00197002|470747417|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
130760672|NCT00197002|470747418|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
130760673|NCT00197002|470747419|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
130760674|NCT00197002|470747417|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
130760675|NCT00197002|470747418|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
130760676|NCT00197002|470747419|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
130760677|NCT00197002|470747417|FG000|Overall Study|Others|3|||
130760678|NCT00197002|470747418|FG001|Overall Study|Others|1|||
130760679|NCT00197002|470747419|FG002|Overall Study|Others|1|||
130760680|NCT02017717|470747420|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130760681|NCT02017717|470747421|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130760682|NCT02017717|470747422|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130760683|NCT02017717|470747423|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130760684|NCT02017717|470747424|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130760685|NCT02017717|470747425|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130760686|NCT02017717|470747426|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130760687|NCT02017717|470747427|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
130789782|NCT00471497|470858802|FG001|Extension Phase|Adverse Event|5|||
130789783|NCT00471497|470858803|FG002|Extension Phase|Adverse Event|1|||
130789784|NCT00471497|470858801|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
130789785|NCT00471497|470858802|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
130789786|NCT00471497|470858803|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
130789787|NCT00471497|470858801|FG000|Extension Phase|Withdrawal by Subject|3|||
130789788|NCT00471497|470858802|FG001|Extension Phase|Withdrawal by Subject|1|||
130789789|NCT00471497|470858803|FG002|Extension Phase|Withdrawal by Subject|0|||
130789790|NCT00471497|470858801|FG000|Extension Phase|Lost to Follow-up|2|||
130789791|NCT00471497|470858802|FG001|Extension Phase|Lost to Follow-up|0|||
130760688|NCT02017717|470747428|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130760689|NCT02017717|470747420|FG000|Before Treatment Period|Participant request to stop therapy|0|||
130760690|NCT02017717|470747421|FG001|Before Treatment Period|Participant request to stop therapy|0|||
130789792|NCT00471497|470858803|FG002|Extension Phase|Lost to Follow-up|0|||
130760691|NCT02017717|470747422|FG002|Before Treatment Period|Participant request to stop therapy|0|||
130760692|NCT02017717|470747423|FG003|Before Treatment Period|Participant request to stop therapy|0|||
130760693|NCT02017717|470747424|FG004|Before Treatment Period|Participant request to stop therapy|0|||
130760694|NCT02017717|470747425|FG005|Before Treatment Period|Participant request to stop therapy|0|||
130760695|NCT02017717|470747426|FG006|Before Treatment Period|Participant request to stop therapy|0|||
130760696|NCT02017717|470747427|FG007|Before Treatment Period|Participant request to stop therapy|0|||
130760697|NCT02017717|470747428|FG008|Before Treatment Period|Participant request to stop therapy|5|||
130760698|NCT02017717|470747420|FG000|Before Treatment Period|Participant withdrew consent|0|||
130760699|NCT02017717|470747421|FG001|Before Treatment Period|Participant withdrew consent|0|||
130760700|NCT02017717|470747422|FG002|Before Treatment Period|Participant withdrew consent|0|||
130760701|NCT02017717|470747423|FG003|Before Treatment Period|Participant withdrew consent|0|||
130760702|NCT02017717|470747424|FG004|Before Treatment Period|Participant withdrew consent|0|||
130760703|NCT02017717|470747425|FG005|Before Treatment Period|Participant withdrew consent|0|||
130760704|NCT02017717|470747426|FG006|Before Treatment Period|Participant withdrew consent|2|||
130760705|NCT02017717|470747427|FG007|Before Treatment Period|Participant withdrew consent|0|||
130760706|NCT02017717|470747428|FG008|Before Treatment Period|Participant withdrew consent|11|||
130760707|NCT02017717|470747420|FG000|Before Treatment Period|Lost to Follow-up|0|||
130760708|NCT02017717|470747421|FG001|Before Treatment Period|Lost to Follow-up|0|||
130760709|NCT02017717|470747422|FG002|Before Treatment Period|Lost to Follow-up|0|||
130760710|NCT02017717|470747423|FG003|Before Treatment Period|Lost to Follow-up|0|||
130760711|NCT02017717|470747424|FG004|Before Treatment Period|Lost to Follow-up|0|||
130760712|NCT02017717|470747425|FG005|Before Treatment Period|Lost to Follow-up|0|||
130760713|NCT02017717|470747426|FG006|Before Treatment Period|Lost to Follow-up|0|||
130760714|NCT02017717|470747427|FG007|Before Treatment Period|Lost to Follow-up|0|||
130760715|NCT02017717|470747428|FG008|Before Treatment Period|Lost to Follow-up|1|||
130760716|NCT02017717|470747420|FG000|Before Treatment Period|Participant no longer met criteria|0|||
130760717|NCT02017717|470747421|FG001|Before Treatment Period|Participant no longer met criteria|0|||
130760718|NCT02017717|470747422|FG002|Before Treatment Period|Participant no longer met criteria|0|||
130760719|NCT02017717|470747423|FG003|Before Treatment Period|Participant no longer met criteria|0|||
130760720|NCT02017717|470747424|FG004|Before Treatment Period|Participant no longer met criteria|0|||
130760721|NCT02017717|470747425|FG005|Before Treatment Period|Participant no longer met criteria|1|||
130760722|NCT02017717|470747426|FG006|Before Treatment Period|Participant no longer met criteria|0|||
130760723|NCT02017717|470747427|FG007|Before Treatment Period|Participant no longer met criteria|1|||
130760724|NCT02017717|470747428|FG008|Before Treatment Period|Participant no longer met criteria|2|||
130760725|NCT02017717|470747420|FG000|Before Treatment Period|other reason|0|||
130760726|NCT02017717|470747421|FG001|Before Treatment Period|other reason|0|||
130760727|NCT02017717|470747422|FG002|Before Treatment Period|other reason|0|||
130760728|NCT02017717|470747423|FG003|Before Treatment Period|other reason|0|||
130760729|NCT02017717|470747424|FG004|Before Treatment Period|other reason|0|||
130760730|NCT02017717|470747425|FG005|Before Treatment Period|other reason|0|||
130760731|NCT02017717|470747426|FG006|Before Treatment Period|other reason|0|||
130760732|NCT02017717|470747427|FG007|Before Treatment Period|other reason|0|||
130760733|NCT02017717|470747428|FG008|Before Treatment Period|other reason|1|||
130760734|NCT02017717|470747420|FG000|Treatment Period|Disease progression|7|||
130760735|NCT02017717|470747421|FG001|Treatment Period|Disease progression|9|||
130760736|NCT02017717|470747422|FG002|Treatment Period|Disease progression|12|||
130760737|NCT02017717|470747423|FG003|Treatment Period|Disease progression|20|||
130760738|NCT02017717|470747424|FG004|Treatment Period|Disease progression|26|||
130760739|NCT02017717|470747425|FG005|Treatment Period|Disease progression|16|||
130760740|NCT02017717|470747426|FG006|Treatment Period|Disease progression|22|||
130760741|NCT02017717|470747427|FG007|Treatment Period|Disease progression|165|||
130760742|NCT02017717|470747428|FG008|Treatment Period|Disease progression|135|||
130760743|NCT02017717|470747420|FG000|Treatment Period|Study drug toxicity|3|||
130760744|NCT02017717|470747421|FG001|Treatment Period|Study drug toxicity|0|||
130760745|NCT02017717|470747422|FG002|Treatment Period|Study drug toxicity|1|||
130760746|NCT02017717|470747423|FG003|Treatment Period|Study drug toxicity|4|||
130760747|NCT02017717|470747424|FG004|Treatment Period|Study drug toxicity|4|||
130760748|NCT02017717|470747425|FG005|Treatment Period|Study drug toxicity|5|||
130760749|NCT02017717|470747426|FG006|Treatment Period|Study drug toxicity|3|||
130760750|NCT02017717|470747427|FG007|Treatment Period|Study drug toxicity|7|||
130760751|NCT02017717|470747428|FG008|Treatment Period|Study drug toxicity|11|||
130760752|NCT02017717|470747420|FG000|Treatment Period|Death|0|||
130760753|NCT02017717|470747421|FG001|Treatment Period|Death|0|||
130760754|NCT02017717|470747422|FG002|Treatment Period|Death|1|||
130760755|NCT02017717|470747423|FG003|Treatment Period|Death|0|||
130760756|NCT02017717|470747424|FG004|Treatment Period|Death|0|||
130760757|NCT02017717|470747425|FG005|Treatment Period|Death|2|||
130760758|NCT02017717|470747426|FG006|Treatment Period|Death|0|||
130760759|NCT02017717|470747427|FG007|Treatment Period|Death|0|||
130760760|NCT02017717|470747428|FG008|Treatment Period|Death|0|||
130760761|NCT02017717|470747420|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
130760762|NCT02017717|470747421|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
130760763|NCT02017717|470747422|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
130760764|NCT02017717|470747423|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
130760765|NCT02017717|470747424|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
130760766|NCT02017717|470747425|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
130760767|NCT02017717|470747426|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
130760768|NCT02017717|470747427|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
130760769|NCT02017717|470747428|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
130760770|NCT02017717|470747420|FG000|Treatment Period|Participant request to stop therapy|0|||
130760771|NCT02017717|470747421|FG001|Treatment Period|Participant request to stop therapy|0|||
130760772|NCT02017717|470747422|FG002|Treatment Period|Participant request to stop therapy|3|||
130760773|NCT02017717|470747423|FG003|Treatment Period|Participant request to stop therapy|6|||
130760774|NCT02017717|470747424|FG004|Treatment Period|Participant request to stop therapy|0|||
130760775|NCT02017717|470747425|FG005|Treatment Period|Participant request to stop therapy|2|||
130760776|NCT02017717|470747426|FG006|Treatment Period|Participant request to stop therapy|1|||
130760777|NCT02017717|470747427|FG007|Treatment Period|Participant request to stop therapy|4|||
130760778|NCT02017717|470747428|FG008|Treatment Period|Participant request to stop therapy|7|||
130760779|NCT02017717|470747420|FG000|Treatment Period|Participant withdrew consent|0|||
130760780|NCT02017717|470747421|FG001|Treatment Period|Participant withdrew consent|0|||
130760781|NCT02017717|470747422|FG002|Treatment Period|Participant withdrew consent|1|||
130760782|NCT02017717|470747423|FG003|Treatment Period|Participant withdrew consent|0|||
130760783|NCT02017717|470747424|FG004|Treatment Period|Participant withdrew consent|0|||
130760784|NCT02017717|470747425|FG005|Treatment Period|Participant withdrew consent|2|||
130760785|NCT02017717|470747426|FG006|Treatment Period|Participant withdrew consent|0|||
130760786|NCT02017717|470747427|FG007|Treatment Period|Participant withdrew consent|1|||
130760787|NCT02017717|470747428|FG008|Treatment Period|Participant withdrew consent|4|||
130760788|NCT02017717|470747420|FG000|Treatment Period|Participant no longer met criteria|0|||
130760789|NCT02017717|470747421|FG001|Treatment Period|Participant no longer met criteria|0|||
130760790|NCT02017717|470747422|FG002|Treatment Period|Participant no longer met criteria|0|||
130760791|NCT02017717|470747423|FG003|Treatment Period|Participant no longer met criteria|0|||
130760792|NCT02017717|470747424|FG004|Treatment Period|Participant no longer met criteria|0|||
130760793|NCT02017717|470747425|FG005|Treatment Period|Participant no longer met criteria|0|||
130760794|NCT02017717|470747426|FG006|Treatment Period|Participant no longer met criteria|0|||
130760795|NCT02017717|470747427|FG007|Treatment Period|Participant no longer met criteria|0|||
130760796|NCT02017717|470747428|FG008|Treatment Period|Participant no longer met criteria|1|||
130760797|NCT02017717|470747420|FG000|Treatment Period|Other reasons|0|||
130760798|NCT02017717|470747421|FG001|Treatment Period|Other reasons|0|||
130760799|NCT02017717|470747422|FG002|Treatment Period|Other reasons|0|||
130760800|NCT02017717|470747423|FG003|Treatment Period|Other reasons|1|||
130760801|NCT02017717|470747424|FG004|Treatment Period|Other reasons|0|||
130760802|NCT02017717|470747425|FG005|Treatment Period|Other reasons|1|||
130760803|NCT02017717|470747426|FG006|Treatment Period|Other reasons|1|||
130760804|NCT02017717|470747427|FG007|Treatment Period|Other reasons|1|||
130760805|NCT02017717|470747428|FG008|Treatment Period|Other reasons|1|||
130760806|NCT02017717|470747420|FG000|Treatment Period|Maximum clinical benefit|0|||
130760807|NCT02017717|470747421|FG001|Treatment Period|Maximum clinical benefit|0|||
130760808|NCT02017717|470747422|FG002|Treatment Period|Maximum clinical benefit|0|||
130760809|NCT02017717|470747423|FG003|Treatment Period|Maximum clinical benefit|0|||
130760810|NCT02017717|470747424|FG004|Treatment Period|Maximum clinical benefit|0|||
130760811|NCT02017717|470747425|FG005|Treatment Period|Maximum clinical benefit|0|||
130760812|NCT02017717|470747426|FG006|Treatment Period|Maximum clinical benefit|0|||
130760813|NCT02017717|470747427|FG007|Treatment Period|Maximum clinical benefit|0|||
130789793|NCT00471497|470858801|FG000|Extension Phase|Death|1|||
130760814|NCT02017717|470747428|FG008|Treatment Period|Maximum clinical benefit|1|||
130760815|NCT02017717|470747420|FG000|Treatment Period|Not reported|0|||
130760816|NCT02017717|470747421|FG001|Treatment Period|Not reported|1|||
130760817|NCT02017717|470747422|FG002|Treatment Period|Not reported|0|||
130760818|NCT02017717|470747423|FG003|Treatment Period|Not reported|0|||
130760819|NCT02017717|470747424|FG004|Treatment Period|Not reported|0|||
130760820|NCT02017717|470747425|FG005|Treatment Period|Not reported|0|||
130760821|NCT02017717|470747426|FG006|Treatment Period|Not reported|0|||
130760822|NCT02017717|470747427|FG007|Treatment Period|Not reported|0|||
130760823|NCT02017717|470747428|FG008|Treatment Period|Not reported|0|||
130760824|NCT00623597|470747429|FG000|Overall Study|Failed to return|1|||
130760825|NCT00623597|470747430|FG001|Overall Study|Failed to return|0|||
130760826|NCT02339155|470747434|FG000|Overall Study|Adverse Event|0|||
130760827|NCT02339155|470747435|FG001|Overall Study|Adverse Event|6|||
130760828|NCT02339155|470747434|FG000|Overall Study|Death|1|||
130760829|NCT02339155|470747435|FG001|Overall Study|Death|1|||
130760830|NCT02339155|470747434|FG000|Overall Study|Lost to Follow-up|8|||
130760831|NCT02339155|470747435|FG001|Overall Study|Lost to Follow-up|9|||
130760832|NCT02339155|470747434|FG000|Overall Study|Physician Decision|2|||
130760833|NCT02339155|470747435|FG001|Overall Study|Physician Decision|1|||
130760834|NCT02339155|470747434|FG000|Overall Study|Withdrawal by Subject|4|||
130760835|NCT02339155|470747435|FG001|Overall Study|Withdrawal by Subject|4|||
130760836|NCT01214252|470747438|FG000|Overall Study|Not eligible per protocol|82|||
130760837|NCT04327661|470747442|FG000|Overall Study|Withdrawal by Subject|1|||
130760838|NCT04327661|470747443|FG001|Overall Study|Withdrawal by Subject|0|||
130760839|NCT04327661|470747444|FG002|Overall Study|Withdrawal by Subject|0|||
130760840|NCT03427268|470747445|FG000|Overall Study|Progressive disease|25|||
130760841|NCT03427268|470747445|FG000|Overall Study|Never treated|2|||
130760842|NCT03427268|470747445|FG000|Overall Study|Compassionate use|1|||
130760843|NCT03427268|470747445|FG000|Overall Study|Withdrawal by Subject|1|||
130760844|NCT03427268|470747445|FG000|Overall Study|Adverse Event|3|||
130760845|NCT00345878|470747447|FG000|Overall Study|Adverse Event|1|||
130760846|NCT00345878|470747448|FG001|Overall Study|Adverse Event|0|||
130760847|NCT00345878|470747447|FG000|Overall Study|Lost to Follow-up|2|||
130760848|NCT00345878|470747448|FG001|Overall Study|Lost to Follow-up|1|||
130760849|NCT00345878|470747447|FG000|Overall Study|Other|1|||
130760850|NCT00345878|470747448|FG001|Overall Study|Other|0|||
130760851|NCT01995175|470747450|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
130760852|NCT01995175|470747450|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
130760853|NCT01995175|470747450|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
130760854|NCT01995175|470747450|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
130760855|NCT01995175|470747450|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
130760856|NCT01995175|470747450|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
130760857|NCT01995175|470747450|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
130760858|NCT01995175|470747450|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
130760859|NCT01995175|470747450|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
130760860|NCT01877551|470747451|FG000|Overall Study|Physician Decision|0|||
130760861|NCT01877551|470747452|FG001|Overall Study|Physician Decision|1|||
130760862|NCT00984061|470747453|FG000|Clarithromycin Alone|Protocol Violation|1|||
130760863|NCT02659514|470747456|FG000|Overall Study|Adverse Event|3|||
130760864|NCT02659514|470747457|FG001|Overall Study|Adverse Event|12|||
130760865|NCT02659514|470747456|FG000|Overall Study|Disease Progression|23|||
130760866|NCT02659514|470747457|FG001|Overall Study|Disease Progression|13|||
130760867|NCT02659514|470747456|FG000|Overall Study|Withdrawal by Subject|0|||
130789794|NCT00471497|470858802|FG001|Extension Phase|Death|0|||
130789795|NCT00471497|470858803|FG002|Extension Phase|Death|0|||
130789796|NCT00471497|470858801|FG000|Extension Phase|Disease progression|2|||
130789797|NCT00471497|470858802|FG001|Extension Phase|Disease progression|0|||
130760868|NCT02659514|470747457|FG001|Overall Study|Withdrawal by Subject|4|||
130760869|NCT02659514|470747456|FG000|Overall Study|Lost to Follow-up|0|||
130760870|NCT02659514|470747457|FG001|Overall Study|Lost to Follow-up|1|||
130760871|NCT02659514|470747456|FG000|Overall Study|Death|6|||
130760872|NCT02659514|470747457|FG001|Overall Study|Death|1|||
130760873|NCT02659514|470747456|FG000|Overall Study|Reason Unspecified|0|||
130760874|NCT02659514|470747457|FG001|Overall Study|Reason Unspecified|3|||
130760875|NCT01968707|470747463|FG000|Overall Study|Did not meet treatment day baseline|49|||
130760876|NCT01968707|470747464|FG001|Overall Study|Did not meet treatment day baseline|12|||
130760877|NCT01968707|470747465|FG002|Overall Study|Did not meet treatment day baseline|41|||
130789798|NCT00471497|470858803|FG002|Extension Phase|Disease progression|0|||
130760878|NCT01968707|470747466|FG003|Overall Study|Did not meet treatment day baseline|44|||
130760879|NCT01968707|470747467|FG004|Overall Study|Did not meet treatment day baseline|36|||
130760880|NCT01968707|470747468|FG005|Overall Study|Did not meet treatment day baseline|11|||
130760881|NCT01968707|470747469|FG006|Overall Study|Did not meet treatment day baseline|34|||
130760882|NCT01968707|470747470|FG007|Overall Study|Did not meet treatment day baseline|35|||
130760883|NCT00916344|470747471|FG000|Overall Study|Death|2|||
130760884|NCT00916344|470747471|FG000|Overall Study|ICD upgrade|1|||
130789799|NCT00471497|470858801|FG000|Extension Phase|Protocol Violation|2|||
130760885|NCT00916344|470747471|FG000|Overall Study|Drop-out|5|||
130760886|NCT01097421|470747488|FG000|Overall Study|Adverse Event|8|||
130760887|NCT01097421|470747488|FG000|Overall Study|Protocol Violation|2|||
130760888|NCT01097421|470747488|FG000|Overall Study|Lost to Follow-up|1|||
130760889|NCT01097421|470747488|FG000|Overall Study|Withdrawal by Subject|3|||
130760890|NCT02062944|470747496|FG000|Overall Study|Lost to Follow-up|1|||
130760891|NCT02062944|470747496|FG000|Overall Study|New hemotological disorder identified|1|||
130760892|NCT02062944|470747496|FG000|Overall Study|Uncontrolled Hypertension|1|||
130760893|NCT02062944|470747496|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
130760894|NCT01088243|470747498|FG000|Overall Study|Adverse Event|1|||
130760895|NCT01088243|470747499|FG001|Overall Study|Adverse Event|0|||
130760896|NCT02231879|470747500|FG000|Overall Study|Adverse Event|2|||
130760897|NCT02231879|470747501|FG001|Overall Study|Adverse Event|1|||
130760898|NCT02231879|470747500|FG000|Overall Study|Lack of Efficacy|0|||
130760899|NCT02231879|470747501|FG001|Overall Study|Lack of Efficacy|1|||
130760900|NCT00723190|470747505|FG000|Overall Study|Withdrawal by Subject|45|||
130760901|NCT00723190|470747505|FG000|Overall Study|Lost to Follow-up|37|||
130760902|NCT00723190|470747505|FG000|Overall Study|Adverse Event|18|||
130760903|NCT00723190|470747505|FG000|Overall Study|Lack of Efficacy|16|||
130760904|NCT00723190|470747505|FG000|Overall Study|Protocol Violation|15|||
130760905|NCT00723190|470747505|FG000|Overall Study|Other-Premature Discontinuation|9|||
130760906|NCT00723190|470747505|FG000|Overall Study|Other-Not included in safety population|2|||
130760907|NCT00454818|470747506|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
130760908|NCT00454818|470747507|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130760909|NCT00454818|470747508|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130760910|NCT00454818|470747509|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130760911|NCT00454818|470747510|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130760912|NCT00454818|470747506|FG000|Phase I: Open-label Dose-escalation|Death|0|||
130760913|NCT00454818|470747507|FG001|Phase I: Open-label Dose-escalation|Death|1|||
130760914|NCT00454818|470747508|FG002|Phase I: Open-label Dose-escalation|Death|0|||
130760915|NCT00454818|470747509|FG003|Phase I: Open-label Dose-escalation|Death|0|||
130760916|NCT00454818|470747510|FG004|Phase I: Open-label Dose-escalation|Death|0|||
130760917|NCT00454818|470747506|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
130760918|NCT00454818|470747507|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
130760919|NCT00454818|470747508|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
130760920|NCT00454818|470747509|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
130760921|NCT00454818|470747510|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
130760922|NCT00454818|470747506|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
130760923|NCT00454818|470747507|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
130760924|NCT00454818|470747508|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
130760925|NCT00454818|470747509|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
130760926|NCT00454818|470747510|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
130760927|NCT00454818|470747506|FG000|Phase 2: Randomized Double-blind|Death|0|||
130760928|NCT00454818|470747507|FG001|Phase 2: Randomized Double-blind|Death|1|||
130760929|NCT00454818|470747508|FG002|Phase 2: Randomized Double-blind|Death|0|||
130760930|NCT00454818|470747509|FG003|Phase 2: Randomized Double-blind|Death|0|||
130760931|NCT00454818|470747510|FG004|Phase 2: Randomized Double-blind|Death|1|||
130789800|NCT00471497|470858802|FG001|Extension Phase|Protocol Violation|2|||
130789801|NCT00471497|470858803|FG002|Extension Phase|Protocol Violation|0|||
130789802|NCT00392223|470858804|FG000|Overall Study|Adverse Event|5|||
130789803|NCT00392223|470858805|FG001|Overall Study|Adverse Event|4|||
130789804|NCT00392223|470858804|FG000|Overall Study|Lost to Follow-up|1|||
130789805|NCT00392223|470858805|FG001|Overall Study|Lost to Follow-up|4|||
130789806|NCT00392223|470858804|FG000|Overall Study|Protocol Violation|0|||
130789807|NCT00392223|470858805|FG001|Overall Study|Protocol Violation|3|||
130789808|NCT00392223|470858804|FG000|Overall Study|Withdrawal by Subject|3|||
130789809|NCT00392223|470858805|FG001|Overall Study|Withdrawal by Subject|2|||
130789810|NCT00402831|470858808|FG000|Overall Study|Lost to Follow-up|1|||
130789811|NCT00402831|470858809|FG001|Overall Study|Lost to Follow-up|2|||
130789812|NCT00402831|470858808|FG000|Overall Study|Non-compliance with protocol|0|||
130789813|NCT00402831|470858809|FG001|Overall Study|Non-compliance with protocol|1|||
130789814|NCT01114724|470858812|FG000|Overall Study|Death|8|||
130789815|NCT01114724|470858812|FG000|Overall Study|Lost to Follow-up|1|||
130789816|NCT01114724|470858812|FG000|Overall Study|Withdrawal by Subject|1|||
130789817|NCT01981616|470858821|FG000|Overall Study|Adverse Event|0|||
130789818|NCT01981616|470858822|FG001|Overall Study|Adverse Event|1|||
130760932|NCT00454818|470747506|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
130760933|NCT00454818|470747507|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
130760934|NCT00454818|470747508|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
130760935|NCT00454818|470747509|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
130760936|NCT00454818|470747510|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
130760937|NCT00454818|470747506|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
130760938|NCT00454818|470747507|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
130760939|NCT00454818|470747508|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
130760940|NCT00454818|470747509|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
130760941|NCT00454818|470747510|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
130760942|NCT02505334|470747516|FG000|Main Treatment Period|Adverse Event|3|||
130789819|NCT01981616|470858821|FG000|Overall Study|Protocol Violation|1|||
130789820|NCT01981616|470858822|FG001|Overall Study|Protocol Violation|0|||
130789821|NCT01020123|470858823|FG000|Main Period|Withdrawal by Subject|6|||
130789822|NCT01020123|470858824|FG001|Main Period|Withdrawal by Subject|5|||
130760943|NCT02505334|470747517|FG001|Main Treatment Period|Adverse Event|3|||
130760944|NCT02505334|470747516|FG000|Main Treatment Period|Lack of Efficacy|7|||
130760945|NCT02505334|470747517|FG001|Main Treatment Period|Lack of Efficacy|17|||
130760946|NCT02505334|470747516|FG000|Main Treatment Period|Protocol Violation|0|||
130760947|NCT02505334|470747517|FG001|Main Treatment Period|Protocol Violation|1|||
130789823|NCT01020123|470858825|FG002|Main Period|Withdrawal by Subject|3|||
130760948|NCT02505334|470747516|FG000|Main Treatment Period|Withdrawal by Subject|1|||
130760949|NCT02505334|470747517|FG001|Main Treatment Period|Withdrawal by Subject|8|||
130789824|NCT01020123|470858826|FG003|Main Period|Withdrawal by Subject|1|||
130789825|NCT01020123|470858827|FG004|Main Period|Withdrawal by Subject|6|||
130789826|NCT01020123|470858828|FG005|Main Period|Withdrawal by Subject|3|||
130789827|NCT01020123|470858829|FG006|Main Period|Withdrawal by Subject|2|||
130760950|NCT02505334|470747516|FG000|Main Treatment Period|Unclassified|4|||
130760951|NCT02505334|470747517|FG001|Main Treatment Period|Unclassified|10|||
130760952|NCT02505334|470747516|FG000|Extension Treatment Period|Adverse Event|5|||
130760953|NCT02505334|470747517|FG001|Extension Treatment Period|Adverse Event|0|||
130760954|NCT02505334|470747516|FG000|Extension Treatment Period|Lack of Efficacy|4|||
130760955|NCT02505334|470747517|FG001|Extension Treatment Period|Lack of Efficacy|0|||
130760956|NCT02505334|470747516|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
130760957|NCT02505334|470747517|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130760958|NCT02505334|470747516|FG000|Extension Treatment Period|Unclassified|3|||
130760959|NCT02505334|470747517|FG001|Extension Treatment Period|Unclassified|0|||
130760960|NCT00581542|470747520|FG000|Overall Study|they met an exclusion criteria|2|||
130760961|NCT00581542|470747521|FG001|Overall Study|they met an exclusion criteria|2|||
130760962|NCT00581542|470747520|FG000|Overall Study|Lost to Follow-up|9|||
130760963|NCT00581542|470747521|FG001|Overall Study|Lost to Follow-up|21|||
130760964|NCT00656851|470747522|FG000|Overall Study|Withdrawal by Subject|0|||
130760965|NCT00656851|470747523|FG001|Overall Study|Withdrawal by Subject|4|||
130760966|NCT02291601|470747524|FG000|Abdomen|Did not qualify|333|||
130760967|NCT02291601|470747525|FG001|Abdomen|Did not qualify|54|||
130760968|NCT02291601|470747526|FG002|Abdomen|Did not qualify|339|||
130760969|NCT02291601|470747524|FG000|Groin|Did not qualify|183|||
130760970|NCT02291601|470747525|FG001|Groin|Did not qualify|30|||
130760971|NCT02291601|470747526|FG002|Groin|Did not qualify|177|||
130760972|NCT01032239|470747527|FG000|Overall Study|Lost to Follow-up|3|||
130760973|NCT01032239|470747528|FG001|Overall Study|Lost to Follow-up|2|||
130760974|NCT01032239|470747527|FG000|Overall Study|Withdrawal by Subject|2|||
130760975|NCT01032239|470747528|FG001|Overall Study|Withdrawal by Subject|3|||
130760976|NCT01032239|470747527|FG000|Overall Study|Death|1|||
130760977|NCT01032239|470747528|FG001|Overall Study|Death|0|||
130760978|NCT01032239|470747527|FG000|Overall Study|Protocol Violation|1|||
130760979|NCT01032239|470747528|FG001|Overall Study|Protocol Violation|0|||
130760980|NCT01940900|470747531|FG000|Overall Study|Physician Decision|4|||
130760981|NCT01940900|470747532|FG001|Overall Study|Physician Decision|0|||
130760982|NCT01940900|470747531|FG000|Overall Study|Adverse Event|10|||
130760983|NCT01940900|470747532|FG001|Overall Study|Adverse Event|15|||
130760984|NCT01940900|470747531|FG000|Overall Study|Withdrawal by Subject|11|||
130760985|NCT01940900|470747532|FG001|Overall Study|Withdrawal by Subject|15|||
130760986|NCT01940900|470747531|FG000|Overall Study|Lost to Follow-up|1|||
130760987|NCT01940900|470747532|FG001|Overall Study|Lost to Follow-up|0|||
130760988|NCT01940900|470747531|FG000|Overall Study|Sponsor Decision|1|||
130760989|NCT01940900|470747532|FG001|Overall Study|Sponsor Decision|0|||
130760990|NCT01940900|470747531|FG000|Overall Study|subject non-compliance|1|||
130760991|NCT01940900|470747532|FG001|Overall Study|subject non-compliance|1|||
130760992|NCT01940900|470747531|FG000|Overall Study|other|1|||
130760993|NCT01940900|470747532|FG001|Overall Study|other|0|||
130760994|NCT04972968|470747535|FG000|Overall Study|Adverse Event|3|||
130760995|NCT04972968|470747536|FG001|Overall Study|Adverse Event|1|||
130760996|NCT04972968|470747537|FG002|Overall Study|Adverse Event|1|||
130760997|NCT04972968|470747538|FG003|Overall Study|Adverse Event|7|||
130760998|NCT04972968|470747535|FG000|Overall Study|Lack of Efficacy|2|||
130760999|NCT04972968|470747536|FG001|Overall Study|Lack of Efficacy|1|||
130761000|NCT04972968|470747537|FG002|Overall Study|Lack of Efficacy|0|||
130761001|NCT04972968|470747538|FG003|Overall Study|Lack of Efficacy|0|||
130761002|NCT04972968|470747535|FG000|Overall Study|Withdrawal by Subject|7|||
130761003|NCT04972968|470747536|FG001|Overall Study|Withdrawal by Subject|4|||
130761004|NCT04972968|470747537|FG002|Overall Study|Withdrawal by Subject|3|||
130761005|NCT04972968|470747538|FG003|Overall Study|Withdrawal by Subject|2|||
130761006|NCT04972968|470747535|FG000|Overall Study|Study Terminated by Sponsor|25|||
130761007|NCT04972968|470747536|FG001|Overall Study|Study Terminated by Sponsor|28|||
130761008|NCT04972968|470747537|FG002|Overall Study|Study Terminated by Sponsor|32|||
130761009|NCT04972968|470747538|FG003|Overall Study|Study Terminated by Sponsor|27|||
130761010|NCT04972968|470747535|FG000|Overall Study|Other|1|||
130761011|NCT04972968|470747536|FG001|Overall Study|Other|0|||
130761012|NCT04972968|470747537|FG002|Overall Study|Other|1|||
130761013|NCT04972968|470747538|FG003|Overall Study|Other|1|||
130761014|NCT01698879|470747539|FG000|Overall Study|Withdrawal by Subject|1|||
130761015|NCT01698879|470747540|FG001|Overall Study|Withdrawal by Subject|0|||
130761016|NCT01698879|470747541|FG002|Overall Study|Withdrawal by Subject|0|||
130761017|NCT02419612|470747547|FG000|Short-term Treatment Period|Adverse Event|1|||
130761018|NCT02419612|470747548|FG001|Short-term Treatment Period|Adverse Event|1|||
130761019|NCT02419612|470747547|FG000|Short-term Treatment Period|Death|0|||
130761020|NCT02419612|470747548|FG001|Short-term Treatment Period|Death|2|||
130761021|NCT02419612|470747547|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
130761022|NCT02419612|470747548|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
130761023|NCT02419612|470747547|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
130761024|NCT02419612|470747548|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
130761025|NCT02419612|470747547|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
130761026|NCT02419612|470747548|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
130761027|NCT02419612|470747547|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
130761028|NCT02419612|470747548|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
130761029|NCT02419612|470747547|FG000|Short-term Treatment Period|Worsening of liver function|0|||
130761030|NCT02419612|470747548|FG001|Short-term Treatment Period|Worsening of liver function|1|||
130761031|NCT02419612|470747547|FG000|Short-term Treatment Period|Subject moved out of state|0|||
130761032|NCT02419612|470747548|FG001|Short-term Treatment Period|Subject moved out of state|1|||
130761033|NCT02419612|470747547|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
130761034|NCT02419612|470747548|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
130761035|NCT02419612|470747547|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
130761036|NCT02419612|470747548|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
130761037|NCT02419612|470747547|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
130761038|NCT02419612|470747548|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
130761039|NCT02419612|470747547|FG000|Long-term Treatment Period|Death|0|||
130761040|NCT02419612|470747548|FG001|Long-term Treatment Period|Death|1|||
130761041|NCT02419612|470747547|FG000|Long-term Treatment Period|Adverse Event|0|||
130761042|NCT02419612|470747548|FG001|Long-term Treatment Period|Adverse Event|5|||
130761043|NCT02419612|470747547|FG000|Long-term Treatment Period|Other|4|||
130761044|NCT02419612|470747548|FG001|Long-term Treatment Period|Other|4|||
130789828|NCT01020123|470858823|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
130789829|NCT01020123|470858824|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
130789830|NCT01020123|470858825|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
130789831|NCT01020123|470858826|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
130789832|NCT01020123|470858827|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
130789833|NCT01020123|470858828|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
130789834|NCT01020123|470858829|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
130789835|NCT01020123|470858823|FG000|Main Period|Adverse Event|5|||
130789836|NCT01020123|470858824|FG001|Main Period|Adverse Event|2|||
130789837|NCT01020123|470858825|FG002|Main Period|Adverse Event|2|||
130789838|NCT01020123|470858826|FG003|Main Period|Adverse Event|1|||
130789839|NCT01020123|470858827|FG004|Main Period|Adverse Event|1|||
130789840|NCT01020123|470858828|FG005|Main Period|Adverse Event|2|||
130789841|NCT01020123|470858829|FG006|Main Period|Adverse Event|1|||
130789842|NCT01020123|470858823|FG000|Main Period|Protocol Violation|4|||
130789843|NCT01020123|470858824|FG001|Main Period|Protocol Violation|4|||
130789844|NCT01020123|470858825|FG002|Main Period|Protocol Violation|2|||
130789845|NCT01020123|470858826|FG003|Main Period|Protocol Violation|5|||
130789846|NCT01020123|470858827|FG004|Main Period|Protocol Violation|2|||
130789847|NCT01020123|470858828|FG005|Main Period|Protocol Violation|3|||
130789848|NCT01020123|470858829|FG006|Main Period|Protocol Violation|2|||
130789849|NCT01020123|470858823|FG000|Main Period|Lost to Follow-up|0|||
130789850|NCT01020123|470858824|FG001|Main Period|Lost to Follow-up|2|||
130789851|NCT01020123|470858825|FG002|Main Period|Lost to Follow-up|0|||
130789852|NCT01020123|470858826|FG003|Main Period|Lost to Follow-up|0|||
130789853|NCT01020123|470858827|FG004|Main Period|Lost to Follow-up|0|||
130789854|NCT01020123|470858828|FG005|Main Period|Lost to Follow-up|0|||
130789855|NCT01020123|470858829|FG006|Main Period|Lost to Follow-up|0|||
130789856|NCT01020123|470858823|FG000|Main Period|Unclasified|2|||
130789857|NCT01020123|470858824|FG001|Main Period|Unclasified|0|||
130789858|NCT01020123|470858825|FG002|Main Period|Unclasified|1|||
130789859|NCT01020123|470858826|FG003|Main Period|Unclasified|0|||
130789860|NCT01020123|470858827|FG004|Main Period|Unclasified|1|||
130789861|NCT01020123|470858828|FG005|Main Period|Unclasified|3|||
130789862|NCT01020123|470858829|FG006|Main Period|Unclasified|6|||
130789863|NCT01020123|470858823|FG000|Extention Period|Withdrawal by Subject|2|||
130789864|NCT01020123|470858824|FG001|Extention Period|Withdrawal by Subject|1|||
130789865|NCT01020123|470858825|FG002|Extention Period|Withdrawal by Subject|1|||
130789866|NCT01020123|470858826|FG003|Extention Period|Withdrawal by Subject|0|||
130789867|NCT01020123|470858827|FG004|Extention Period|Withdrawal by Subject|0|||
130789868|NCT01020123|470858828|FG005|Extention Period|Withdrawal by Subject|0|||
130789869|NCT01020123|470858829|FG006|Extention Period|Withdrawal by Subject|0|||
130789870|NCT01020123|470858823|FG000|Extention Period|Adverse Event|0|||
130789871|NCT01020123|470858824|FG001|Extention Period|Adverse Event|0|||
130789872|NCT01020123|470858825|FG002|Extention Period|Adverse Event|0|||
130789873|NCT01020123|470858826|FG003|Extention Period|Adverse Event|1|||
130789874|NCT01020123|470858827|FG004|Extention Period|Adverse Event|0|||
130789875|NCT01020123|470858828|FG005|Extention Period|Adverse Event|0|||
130789876|NCT01020123|470858829|FG006|Extention Period|Adverse Event|0|||
130789877|NCT01020123|470858823|FG000|Extention Period|Protocol Violation|1|||
130789878|NCT01020123|470858824|FG001|Extention Period|Protocol Violation|1|||
130789879|NCT01020123|470858825|FG002|Extention Period|Protocol Violation|1|||
130789880|NCT01020123|470858826|FG003|Extention Period|Protocol Violation|0|||
130789881|NCT01020123|470858827|FG004|Extention Period|Protocol Violation|0|||
130789882|NCT01020123|470858828|FG005|Extention Period|Protocol Violation|0|||
130789883|NCT01020123|470858829|FG006|Extention Period|Protocol Violation|1|||
130789884|NCT01020123|470858823|FG000|Extention Period|Lost to Follow-up|0|||
130789885|NCT01020123|470858824|FG001|Extention Period|Lost to Follow-up|0|||
130789886|NCT01020123|470858825|FG002|Extention Period|Lost to Follow-up|0|||
130789887|NCT01020123|470858826|FG003|Extention Period|Lost to Follow-up|0|||
130789888|NCT01020123|470858827|FG004|Extention Period|Lost to Follow-up|0|||
130789889|NCT01020123|470858828|FG005|Extention Period|Lost to Follow-up|2|||
130789890|NCT01020123|470858829|FG006|Extention Period|Lost to Follow-up|0|||
130789891|NCT00094445|470858830|FG000|Overall Study|Withdrawal by Subject|3|||
130789892|NCT00094445|470858830|FG000|Overall Study|Lost to Follow-up|1|||
130789893|NCT00094445|470858830|FG000|Overall Study|Progressive Disease|2|||
130789894|NCT04711005|470858833|FG000|Overall Study|Withdrawal by Subject|0|||
130789895|NCT04711005|470858834|FG001|Overall Study|Withdrawal by Subject|0|||
130789896|NCT04711005|470858835|FG002|Overall Study|Withdrawal by Subject|0|||
130789897|NCT04711005|470858836|FG003|Overall Study|Withdrawal by Subject|0|||
130789898|NCT04711005|470858837|FG004|Overall Study|Withdrawal by Subject|0|||
130789899|NCT04711005|470858838|FG005|Overall Study|Withdrawal by Subject|0|||
130789900|NCT04711005|470858839|FG006|Overall Study|Withdrawal by Subject|0|||
130789901|NCT04711005|470858840|FG007|Overall Study|Withdrawal by Subject|1|||
130789902|NCT04711005|470858841|FG008|Overall Study|Withdrawal by Subject|0|||
130789903|NCT04711005|470858842|FG009|Overall Study|Withdrawal by Subject|0|||
130789904|NCT04711005|470858833|FG000|Overall Study|Physician Decision|0|||
130789905|NCT04711005|470858834|FG001|Overall Study|Physician Decision|0|||
130789906|NCT04711005|470858835|FG002|Overall Study|Physician Decision|0|||
130789907|NCT04711005|470858836|FG003|Overall Study|Physician Decision|0|||
130789908|NCT04711005|470858837|FG004|Overall Study|Physician Decision|0|||
130789909|NCT04711005|470858838|FG005|Overall Study|Physician Decision|0|||
130789910|NCT04711005|470858839|FG006|Overall Study|Physician Decision|0|||
130789911|NCT04711005|470858840|FG007|Overall Study|Physician Decision|2|||
130789912|NCT04711005|470858841|FG008|Overall Study|Physician Decision|1|||
130761045|NCT02419612|470747547|FG000|Long-term Treatment Period|Subject Decision|2|||
130761046|NCT02419612|470747548|FG001|Long-term Treatment Period|Subject Decision|4|||
130761047|NCT02419612|470747547|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
130761048|NCT02419612|470747548|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
130761049|NCT00474045|470747549|FG000|Overall Study|Adverse Event|18|||
130761050|NCT00474045|470747550|FG001|Overall Study|Adverse Event|8|||
130761051|NCT00474045|470747549|FG000|Overall Study|Unclassified|1|||
130761052|NCT00474045|470747550|FG001|Overall Study|Unclassified|3|||
130761053|NCT00474045|470747549|FG000|Overall Study|Lack of Efficacy|0|||
130761054|NCT00474045|470747550|FG001|Overall Study|Lack of Efficacy|9|||
130761055|NCT00474045|470747549|FG000|Overall Study|Lost to Follow-up|1|||
130761056|NCT00474045|470747550|FG001|Overall Study|Lost to Follow-up|1|||
130761057|NCT00474045|470747549|FG000|Overall Study|Protocol Violation|10|||
130761058|NCT00474045|470747550|FG001|Overall Study|Protocol Violation|12|||
130761059|NCT00474045|470747549|FG000|Overall Study|Withdrawal by Subject|16|||
130761060|NCT00474045|470747550|FG001|Overall Study|Withdrawal by Subject|18|||
130761061|NCT00474045|470747549|FG000|Overall Study|Withdrawal criteria|60|||
130761062|NCT00474045|470747550|FG001|Overall Study|Withdrawal criteria|50|||
130761063|NCT02009397|470747559|FG000|Overall Study|Protocol Violation|6|||
130761064|NCT02009397|470747559|FG000|Overall Study|Death|8|||
130761065|NCT02009397|470747559|FG000|Overall Study|Lost to Follow-up|6|||
130761066|NCT02278120|470747560|FG000|Treatment Period|Progressive disease|234|||
130761067|NCT02278120|470747561|FG001|Treatment Period|Progressive disease|260|||
130761068|NCT02278120|470747560|FG000|Treatment Period|Subject/guardian decision|23|||
130761069|NCT02278120|470747561|FG001|Treatment Period|Subject/guardian decision|20|||
130761070|NCT02278120|470747560|FG000|Treatment Period|Adverse Event|16|||
130761071|NCT02278120|470747561|FG001|Treatment Period|Adverse Event|14|||
130761072|NCT02278120|470747560|FG000|Treatment Period|Physician Decision|14|||
130789913|NCT04711005|470858842|FG009|Overall Study|Physician Decision|0|||
130789914|NCT02781324|470858846|FG000|Overall Study|Withdrawal by Subject|1|||
130761073|NCT02278120|470747561|FG001|Treatment Period|Physician Decision|27|||
130761074|NCT02278120|470747560|FG000|Treatment Period|Death|3|||
130761075|NCT02278120|470747561|FG001|Treatment Period|Death|3|||
130761076|NCT02278120|470747560|FG000|Treatment Period|Lost to Follow-up|2|||
130761077|NCT02278120|470747561|FG001|Treatment Period|Lost to Follow-up|0|||
130761078|NCT02278120|470747560|FG000|Treatment Period|Protocol deviation|0|||
130761079|NCT02278120|470747561|FG001|Treatment Period|Protocol deviation|2|||
130761080|NCT02278120|470747560|FG000|Treatment Period|Study terminated as per protocol|43|||
130761081|NCT02278120|470747561|FG001|Treatment Period|Study terminated as per protocol|11|||
130761082|NCT02278120|470747560|FG000|Post-treatment Efficacy Follow-up|Death|0|||
130761083|NCT02278120|470747561|FG001|Post-treatment Efficacy Follow-up|Death|1|||
130761084|NCT02278120|470747560|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
130761085|NCT02278120|470747561|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130761086|NCT02278120|470747560|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
130761087|NCT02278120|470747561|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
130761088|NCT02278120|470747560|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
130761089|NCT02278120|470747561|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
130789915|NCT02781324|470858847|FG001|Overall Study|Withdrawal by Subject|0|||
130761090|NCT02278120|470747560|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130789916|NCT02781324|470858846|FG000|Overall Study|Physician Decision|1|||
130789917|NCT02781324|470858847|FG001|Overall Study|Physician Decision|2|||
130789918|NCT03370172|470861042|FG000|Overall Study|Withdrawal by Subject|0|||
130789919|NCT03370172|470861043|FG001|Overall Study|Withdrawal by Subject|1|||
130789920|NCT03729362|470861044|FG000|Overall Study|Withdrawal by Subject|2|||
130789921|NCT03729362|470861045|FG001|Overall Study|Withdrawal by Subject|0|||
130789922|NCT03729362|470861044|FG000|Overall Study|Physician Decision|1|||
130789923|NCT03729362|470861045|FG001|Overall Study|Physician Decision|0|||
130789924|NCT03729362|470861044|FG000|Overall Study|COVID-19 Pandemic|1|||
130789925|NCT03729362|470861045|FG001|Overall Study|COVID-19 Pandemic|0|||
130789926|NCT03729362|470861044|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
130789927|NCT03729362|470861045|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
130789928|NCT03729362|470861044|FG000|Overall Study|Adverse Event|0|||
130789929|NCT03729362|470861045|FG001|Overall Study|Adverse Event|1|||
130789930|NCT03729362|470861044|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
130789931|NCT03729362|470861045|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
130789932|NCT01171534|470861052|FG000|Overall Study|Lost to Follow-up|0|||
130789933|NCT01171534|470861053|FG001|Overall Study|Lost to Follow-up|2|||
130789934|NCT01171534|470861052|FG000|Overall Study|screen failure|0|||
130789935|NCT01171534|470861053|FG001|Overall Study|screen failure|1|||
130789936|NCT00849056|470861054|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
130789937|NCT00849056|470861055|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
130789938|NCT00849056|470861054|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
130789939|NCT00849056|470861055|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
130789940|NCT00849056|470861054|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
130789941|NCT00849056|470861055|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
130789942|NCT00849056|470861054|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
130789943|NCT00849056|470861055|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
130761091|NCT02278120|470747561|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130761092|NCT01966068|470747566|FG000|Overall Study|Withdrawal by Subject|57|||
130761093|NCT01966068|470747566|FG000|Overall Study|Lost to Follow-up|81|||
130761094|NCT00191282|470747571|FG000|Overall Study|Adverse Event|5|||
130761095|NCT00191282|470747572|FG001|Overall Study|Adverse Event|6|||
130761096|NCT00191282|470747571|FG000|Overall Study|Death|51|||
130761097|NCT00191282|470747572|FG001|Overall Study|Death|51|||
130761098|NCT00191282|470747571|FG000|Overall Study|Lack of Efficacy|11|||
130761099|NCT00191282|470747572|FG001|Overall Study|Lack of Efficacy|6|||
130789944|NCT00849056|470861054|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
130789945|NCT00849056|470861055|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
130789946|NCT00849056|470861054|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
130789947|NCT00849056|470861055|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
130789948|NCT00849056|470861054|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
130789949|NCT00849056|470861055|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
130789950|NCT00849056|470861054|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
130789951|NCT00849056|470861055|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
130789952|NCT00849056|470861054|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
130789953|NCT00849056|470861055|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
130789954|NCT00849056|470861054|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
130789955|NCT00849056|470861055|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
130789956|NCT00849056|470861054|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
130789957|NCT00849056|470861055|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
130789958|NCT00849056|470861054|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
130789959|NCT00849056|470861055|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
130789960|NCT00849056|470861054|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
130789961|NCT00849056|470861055|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
130789962|NCT00849056|470861054|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
130789963|NCT00849056|470861055|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
130789964|NCT00849056|470861054|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
130789965|NCT00849056|470861055|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
130789966|NCT00849056|470861054|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
130789967|NCT00849056|470861055|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
130789968|NCT01113749|470861056|FG000|Overall Study|Lost to Follow-up|1|||
130789969|NCT01113749|470861057|FG001|Overall Study|Lost to Follow-up|2|||
130789970|NCT03427892|470861058|FG000|Overall Study|Lost to Follow-up|2|||
130789971|NCT00548327|470861059|FG000|Overall Study|Adverse Event|0|||
130789972|NCT00548327|470861060|FG001|Overall Study|Adverse Event|1|||
130789973|NCT00274456|470861064|FG000|Overall Study|Still on treatment|2|||
130789974|NCT00274456|470861065|FG001|Overall Study|Still on treatment|3|||
130789975|NCT00274456|470861066|FG002|Overall Study|Still on treatment|5|||
130789976|NCT00274456|470861067|FG003|Overall Study|Still on treatment|1|||
130789977|NCT00274456|470861064|FG000|Overall Study|Unacceptable toxicity|10|||
130789978|NCT00274456|470861065|FG001|Overall Study|Unacceptable toxicity|5|||
130789979|NCT00274456|470861066|FG002|Overall Study|Unacceptable toxicity|12|||
130789980|NCT00274456|470861067|FG003|Overall Study|Unacceptable toxicity|16|||
130789981|NCT00274456|470861064|FG000|Overall Study|Adverse Event|0|||
130789982|NCT00274456|470861065|FG001|Overall Study|Adverse Event|1|||
130789983|NCT00274456|470861066|FG002|Overall Study|Adverse Event|2|||
130789984|NCT00274456|470861067|FG003|Overall Study|Adverse Event|2|||
130789985|NCT00274456|470861064|FG000|Overall Study|Physician Decision|7|||
130789986|NCT00274456|470861065|FG001|Overall Study|Physician Decision|5|||
130789987|NCT00274456|470861066|FG002|Overall Study|Physician Decision|6|||
130789988|NCT00274456|470861067|FG003|Overall Study|Physician Decision|13|||
130789989|NCT00274456|470861064|FG000|Overall Study|Lost to Follow-up|0|||
130789990|NCT00274456|470861065|FG001|Overall Study|Lost to Follow-up|0|||
130789991|NCT00274456|470861066|FG002|Overall Study|Lost to Follow-up|1|||
130789992|NCT00274456|470861067|FG003|Overall Study|Lost to Follow-up|0|||
130789993|NCT00274456|470861064|FG000|Overall Study|Withdrawal by Subject|18|||
130789994|NCT00274456|470861065|FG001|Overall Study|Withdrawal by Subject|13|||
130789995|NCT00274456|470861066|FG002|Overall Study|Withdrawal by Subject|9|||
130789996|NCT00274456|470861067|FG003|Overall Study|Withdrawal by Subject|13|||
130789997|NCT03255187|470861068|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
130789998|NCT03255187|470861069|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
130789999|NCT03255187|470861068|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
130790000|NCT03255187|470861069|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
130790001|NCT00375752|470861070|FG000|Overall Study|Lack of Efficacy|4|||
130790002|NCT00375752|470861071|FG001|Overall Study|Lack of Efficacy|4|||
130790003|NCT00375752|470861070|FG000|Overall Study|Adverse Event|1|||
130790004|NCT00375752|470861071|FG001|Overall Study|Adverse Event|6|||
130790005|NCT00375752|470861070|FG000|Overall Study|Withdrawal by Subject|6|||
130790006|NCT00375752|470861071|FG001|Overall Study|Withdrawal by Subject|1|||
130790007|NCT00375752|470861070|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
130790008|NCT00375752|470861071|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
130790009|NCT00375752|470861070|FG000|Overall Study|Protocol Violation|0|||
130790010|NCT00375752|470861071|FG001|Overall Study|Protocol Violation|2|||
130790011|NCT00375752|470861070|FG000|Overall Study|Administrative Problems|0|||
130790012|NCT00375752|470861071|FG001|Overall Study|Administrative Problems|1|||
130790013|NCT02034006|470861072|FG000|Overall Study|Withdrawal by Subject|7|||
130790014|NCT02034006|470861072|FG000|Overall Study|Lost to Follow-up|5|||
130790015|NCT02034006|470861072|FG000|Overall Study|Death|1|||
130790016|NCT02034006|470861072|FG000|Overall Study|Pregnancy|1|||
130761100|NCT00191282|470747571|FG000|Overall Study|Noncompliance|14|||
130790017|NCT00109343|470861076|FG000|Overall Study|Adverse Event|1|||
130790018|NCT00109343|470861077|FG001|Overall Study|Adverse Event|0|||
130790019|NCT00109343|470861078|FG002|Overall Study|Adverse Event|2|||
130790020|NCT00109343|470861076|FG000|Overall Study|Lack of Efficacy|1|||
130790021|NCT00109343|470861077|FG001|Overall Study|Lack of Efficacy|0|||
130790022|NCT00109343|470861078|FG002|Overall Study|Lack of Efficacy|0|||
130790023|NCT00109343|470861076|FG000|Overall Study|Lost to Follow-up|35|||
130790024|NCT00109343|470861077|FG001|Overall Study|Lost to Follow-up|20|||
130790025|NCT00109343|470861078|FG002|Overall Study|Lost to Follow-up|14|||
130790026|NCT00109343|470861076|FG000|Overall Study|Protocol Violation|1|||
130790027|NCT00109343|470861077|FG001|Overall Study|Protocol Violation|2|||
130790028|NCT00109343|470861078|FG002|Overall Study|Protocol Violation|2|||
130790029|NCT00109343|470861076|FG000|Overall Study|Withdrawal by Subject|15|||
130790030|NCT00109343|470861077|FG001|Overall Study|Withdrawal by Subject|11|||
130790031|NCT00109343|470861078|FG002|Overall Study|Withdrawal by Subject|10|||
130790032|NCT00109343|470861076|FG000|Overall Study|Subject Moved|6|||
130790033|NCT00109343|470861077|FG001|Overall Study|Subject Moved|2|||
130790034|NCT00109343|470861078|FG002|Overall Study|Subject Moved|1|||
130790035|NCT00109343|470861076|FG000|Overall Study|Other|5|||
130790036|NCT00109343|470861077|FG001|Overall Study|Other|2|||
130790037|NCT00109343|470861078|FG002|Overall Study|Other|1|||
130790038|NCT00750269|470861079|FG000|Overall Study|Protocol Violation|0|||
130790039|NCT00750269|470861080|FG001|Overall Study|Protocol Violation|1|||
130790040|NCT00750269|470861081|FG002|Overall Study|Protocol Violation|1|||
130790041|NCT00750269|470861082|FG003|Overall Study|Protocol Violation|2|||
130790042|NCT00750269|470861083|FG004|Overall Study|Protocol Violation|4|||
130790043|NCT00750269|470861079|FG000|Overall Study|Withdrawal by Subject|0|||
130790044|NCT00750269|470861080|FG001|Overall Study|Withdrawal by Subject|0|||
130790045|NCT00750269|470861081|FG002|Overall Study|Withdrawal by Subject|2|||
130790046|NCT00750269|470861082|FG003|Overall Study|Withdrawal by Subject|2|||
130790047|NCT00750269|470861083|FG004|Overall Study|Withdrawal by Subject|2|||
130790048|NCT00750269|470861079|FG000|Overall Study|Physician Decision|0|||
130790049|NCT00750269|470861080|FG001|Overall Study|Physician Decision|0|||
130790050|NCT00750269|470861081|FG002|Overall Study|Physician Decision|0|||
130790051|NCT00750269|470861082|FG003|Overall Study|Physician Decision|0|||
130790052|NCT00750269|470861083|FG004|Overall Study|Physician Decision|2|||
130790053|NCT00750269|470861079|FG000|Overall Study|Patient too large for positioning|0|||
130790054|NCT00750269|470861080|FG001|Overall Study|Patient too large for positioning|0|||
130790055|NCT00750269|470861081|FG002|Overall Study|Patient too large for positioning|1|||
130790056|NCT00750269|470861082|FG003|Overall Study|Patient too large for positioning|0|||
130790057|NCT00750269|470861083|FG004|Overall Study|Patient too large for positioning|0|||
130790058|NCT00750269|470861079|FG000|Overall Study|Site error|0|||
130790059|NCT00750269|470861080|FG001|Overall Study|Site error|0|||
130790060|NCT00750269|470861081|FG002|Overall Study|Site error|0|||
130790061|NCT00750269|470861082|FG003|Overall Study|Site error|1|||
130790062|NCT00750269|470861083|FG004|Overall Study|Site error|0|||
130790063|NCT00750269|470861079|FG000|Overall Study|SBRT plan could not be drawn|0|||
130790064|NCT00750269|470861080|FG001|Overall Study|SBRT plan could not be drawn|0|||
130790065|NCT00750269|470861081|FG002|Overall Study|SBRT plan could not be drawn|0|||
130790066|NCT00750269|470861082|FG003|Overall Study|SBRT plan could not be drawn|0|||
130790067|NCT00750269|470861083|FG004|Overall Study|SBRT plan could not be drawn|1|||
130790068|NCT00750269|470861079|FG000|Overall Study|Fiducials could not be placed|0|||
130761101|NCT00191282|470747572|FG001|Overall Study|Noncompliance|17|||
130761102|NCT00191282|470747571|FG000|Overall Study|Patient moved|11|||
130761103|NCT00191282|470747572|FG001|Overall Study|Patient moved|14|||
130790069|NCT00750269|470861080|FG001|Overall Study|Fiducials could not be placed|0|||
130790070|NCT00750269|470861081|FG002|Overall Study|Fiducials could not be placed|0|||
130761104|NCT00191282|470747571|FG000|Overall Study|Withdrawal by Subject|59|||
130761105|NCT00191282|470747572|FG001|Overall Study|Withdrawal by Subject|44|||
130761106|NCT00191282|470747571|FG000|Overall Study|Physician Decision|18|||
130761107|NCT00191282|470747572|FG001|Overall Study|Physician Decision|15|||
130761108|NCT00191282|470747571|FG000|Overall Study|Protocol entry criteria not met|14|||
130761109|NCT00191282|470747572|FG001|Overall Study|Protocol entry criteria not met|9|||
130790071|NCT00750269|470861082|FG003|Overall Study|Fiducials could not be placed|0|||
130790072|NCT00750269|470861083|FG004|Overall Study|Fiducials could not be placed|1|||
130790073|NCT02100631|470861084|FG000|Overall Study|Withdrawal by Subject|1|||
130790074|NCT02100631|470861085|FG001|Overall Study|Withdrawal by Subject|0|||
130790075|NCT02100631|470861086|FG002|Overall Study|Withdrawal by Subject|0|||
130790076|NCT02100631|470861084|FG000|Overall Study|Lost to Follow-up|3|||
130790077|NCT02100631|470861085|FG001|Overall Study|Lost to Follow-up|4|||
130790078|NCT02100631|470861086|FG002|Overall Study|Lost to Follow-up|0|||
130790079|NCT02100631|470861084|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
130790080|NCT02100631|470861085|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
130790081|NCT02100631|470861086|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
130790082|NCT01316614|470861087|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
130790083|NCT01316614|470861087|FG000|Overall Study|Cytology slides not available for review|4|||
130790084|NCT01316614|470861087|FG000|Overall Study|Cystic lesion|5|||
130790085|NCT01316614|470861087|FG000|Overall Study|Inadequate number of passes|2|||
130790086|NCT01316614|470861087|FG000|Overall Study|Medically unstable|1|||
130790087|NCT04889040|470861088|FG000|Overall Study|Withdrawal by Subject|3|||
130790088|NCT04889040|470861089|FG001|Overall Study|Withdrawal by Subject|3|||
130790089|NCT04889040|470861088|FG000|Overall Study|Lost to Follow-up|0|||
130790090|NCT04889040|470861089|FG001|Overall Study|Lost to Follow-up|1|||
130790091|NCT04889040|470861088|FG000|Overall Study|Adverse Event|2|||
130790092|NCT04889040|470861089|FG001|Overall Study|Adverse Event|1|||
130790093|NCT02058095|470861090|FG000|Overall Study|Adverse Event|1|||
130790094|NCT02058095|470861091|FG001|Overall Study|Adverse Event|0|||
130790095|NCT00998946|470861092|FG000|Overall Study|Lost to Follow-up|1|||
130790096|NCT00998946|470861092|FG000|Overall Study|Withdrawal by Subject|1|||
130790097|NCT00998946|470861092|FG000|Overall Study|Death|2|||
130790098|NCT00998946|470861092|FG000|Overall Study|Reason Unspecified|3|||
130790099|NCT00998946|470861092|FG000|Overall Study|Enrolled but not Dosed|2|||
130790100|NCT00977197|470861095|FG000|Overall Study|Withdrawal by Subject|3|||
130790101|NCT00977197|470861096|FG001|Overall Study|Withdrawal by Subject|4|||
130790102|NCT00977197|470861095|FG000|Overall Study|Adverse Event|3|||
130790103|NCT00977197|470861096|FG001|Overall Study|Adverse Event|1|||
130790104|NCT00977197|470861095|FG000|Overall Study|Lack of Efficacy|1|||
130761110|NCT00191282|470747571|FG000|Overall Study|Protocol Violation|9|||
130761111|NCT00191282|470747572|FG001|Overall Study|Protocol Violation|12|||
130761112|NCT00191282|470747571|FG000|Overall Study|Severity of outcome|2|||
130761113|NCT00191282|470747572|FG001|Overall Study|Severity of outcome|5|||
130761114|NCT00191282|470747571|FG000|Overall Study|Sponsor's decision|2|||
130790105|NCT00977197|470861096|FG001|Overall Study|Lack of Efficacy|0|||
130790106|NCT00977197|470861095|FG000|Overall Study|Lost to Follow-up|1|||
130790107|NCT00977197|470861096|FG001|Overall Study|Lost to Follow-up|3|||
130790108|NCT00977197|470861095|FG000|Overall Study|Nonadherence|1|||
130790109|NCT00977197|470861096|FG001|Overall Study|Nonadherence|1|||
130790110|NCT01432951|470861097|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
130790111|NCT00853385|470861098|FG000|Overall Study|Death|0|||
130790112|NCT00853385|470861099|FG001|Overall Study|Death|0|||
130790113|NCT00853385|470861100|FG002|Overall Study|Death|0|||
130790114|NCT00853385|470861101|FG003|Overall Study|Death|0|||
130790115|NCT00853385|470861102|FG004|Overall Study|Death|1|||
130790116|NCT00853385|470861098|FG000|Overall Study|Adverse Event|24|||
130790117|NCT00853385|470861099|FG001|Overall Study|Adverse Event|24|||
130790118|NCT00853385|470861100|FG002|Overall Study|Adverse Event|2|||
130790119|NCT00853385|470861101|FG003|Overall Study|Adverse Event|5|||
130790120|NCT00853385|470861102|FG004|Overall Study|Adverse Event|22|||
130790121|NCT00853385|470861098|FG000|Overall Study|Lack of Efficacy|6|||
130790122|NCT00853385|470861099|FG001|Overall Study|Lack of Efficacy|7|||
130790123|NCT00853385|470861100|FG002|Overall Study|Lack of Efficacy|3|||
130790124|NCT00853385|470861101|FG003|Overall Study|Lack of Efficacy|3|||
130790125|NCT00853385|470861102|FG004|Overall Study|Lack of Efficacy|6|||
130790126|NCT00853385|470861098|FG000|Overall Study|Lost to Follow-up|2|||
130790127|NCT00853385|470861099|FG001|Overall Study|Lost to Follow-up|1|||
130790128|NCT00853385|470861100|FG002|Overall Study|Lost to Follow-up|0|||
130790129|NCT00853385|470861101|FG003|Overall Study|Lost to Follow-up|0|||
130790130|NCT00853385|470861102|FG004|Overall Study|Lost to Follow-up|0|||
130790131|NCT00853385|470861098|FG000|Overall Study|Withdrawal by Subject|4|||
130790132|NCT00853385|470861099|FG001|Overall Study|Withdrawal by Subject|2|||
130790133|NCT00853385|470861100|FG002|Overall Study|Withdrawal by Subject|0|||
130790134|NCT00853385|470861101|FG003|Overall Study|Withdrawal by Subject|1|||
130790135|NCT00853385|470861102|FG004|Overall Study|Withdrawal by Subject|1|||
130790136|NCT00853385|470861098|FG000|Overall Study|Other|18|||
130790137|NCT00853385|470861099|FG001|Overall Study|Other|9|||
130790138|NCT00853385|470861100|FG002|Overall Study|Other|4|||
130790139|NCT00853385|470861101|FG003|Overall Study|Other|4|||
130790140|NCT00853385|470861102|FG004|Overall Study|Other|12|||
130790141|NCT02842866|470861105|FG000|Overall Study|Serious Adverse Event|0|||
130790142|NCT02842866|470861106|FG001|Overall Study|Serious Adverse Event|1|||
130790143|NCT02842866|470861105|FG000|Overall Study|Protocol Violation|4|||
130790144|NCT02842866|470861106|FG001|Overall Study|Protocol Violation|2|||
130790145|NCT02842866|470861105|FG000|Overall Study|Lost to Follow-up|2|||
130790146|NCT02842866|470861106|FG001|Overall Study|Lost to Follow-up|0|||
130790147|NCT02842866|470861105|FG000|Overall Study|Withdrawal by Subject|1|||
130790148|NCT02842866|470861106|FG001|Overall Study|Withdrawal by Subject|0|||
130790149|NCT00577408|470861107|FG000|Overall Study|Stopped attending study visits|9|||
130790150|NCT00577408|470861108|FG001|Overall Study|Stopped attending study visits|11|||
130790151|NCT00577408|470861107|FG000|Overall Study|Continued opioid use|3|||
130790152|NCT00577408|470861108|FG001|Overall Study|Continued opioid use|2|||
130790153|NCT00577408|470861107|FG000|Overall Study|Non-compliance with study meds|0|||
130790154|NCT00577408|470861108|FG001|Overall Study|Non-compliance with study meds|3|||
130790155|NCT00577408|470861107|FG000|Overall Study|Refused Oral Naltrexone|0|||
130790156|NCT00577408|470861108|FG001|Overall Study|Refused Oral Naltrexone|1|||
130790157|NCT00577408|470861107|FG000|Overall Study|Moved out of state|0|||
130790158|NCT00577408|470861108|FG001|Overall Study|Moved out of state|1|||
130790159|NCT00577408|470861107|FG000|Overall Study|Scheduling Issues|0|||
130790160|NCT00577408|470861108|FG001|Overall Study|Scheduling Issues|3|||
130790161|NCT00577408|470861107|FG000|Overall Study|Death|0|||
130790162|NCT00577408|470861108|FG001|Overall Study|Death|1|||
130790163|NCT00577408|470861107|FG000|Overall Study|Psychiatric hospitalization|0|||
130790164|NCT00577408|470861108|FG001|Overall Study|Psychiatric hospitalization|1|||
130790165|NCT00656617|470861109|FG000|Overall Study|Adverse Event|1|||
130790166|NCT00656617|470861109|FG000|Overall Study|Death|2|||
130790167|NCT00656617|470861109|FG000|Overall Study|Insurance Issues|2|||
130790168|NCT00656617|470861109|FG000|Overall Study|Move to different clinical trial|2|||
130790169|NCT02349386|470861119|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
130790170|NCT02349386|470861120|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
130790171|NCT02349386|470861121|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
130790172|NCT02349386|470861122|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
130790173|NCT02349386|470861119|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
130790174|NCT02349386|470861120|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
130790175|NCT02349386|470861121|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
130790176|NCT02349386|470861122|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
130790177|NCT02349386|470861119|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
130790178|NCT02349386|470861120|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
130790179|NCT02349386|470861121|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
130790180|NCT02349386|470861122|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
130790181|NCT02349386|470861119|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
130790182|NCT02349386|470861120|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
130790183|NCT02349386|470861121|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
130761115|NCT00191282|470747572|FG001|Overall Study|Sponsor's decision|2|||
130761116|NCT00191282|470747571|FG000|Overall Study|Lost to Follow-up|24|||
130761117|NCT00191282|470747572|FG001|Overall Study|Lost to Follow-up|31|||
130761118|NCT00102531|470747573|FG000|Overall Study|Adverse Event|0|||
130761119|NCT00102531|470747574|FG001|Overall Study|Adverse Event|1|||
130761120|NCT00102531|470747573|FG000|Overall Study|Disease Progression|5|||
130761121|NCT00102531|470747574|FG001|Overall Study|Disease Progression|9|||
130761122|NCT00102531|470747573|FG000|Overall Study|Physician Decision|0|||
130761123|NCT00102531|470747574|FG001|Overall Study|Physician Decision|1|||
130761124|NCT04756154|470747575|FG000|Overall Study|Did not meet treatment day baseline|30|||
130761125|NCT04756154|470747576|FG001|Overall Study|Did not meet treatment day baseline|28|||
130761126|NCT04756154|470747577|FG002|Overall Study|Did not meet treatment day baseline|7|||
130761127|NCT04756154|470747575|FG000|Overall Study|Did not return for final sample collection|1|||
130761128|NCT04756154|470747576|FG001|Overall Study|Did not return for final sample collection|1|||
130761129|NCT04756154|470747577|FG002|Overall Study|Did not return for final sample collection|0|||
130761130|NCT03589976|470747579|FG000|Overall Study|Death|5|||
130761131|NCT03589976|470747580|FG001|Overall Study|Death|1|||
130761132|NCT03589976|470747579|FG000|Overall Study|Adverse Event|5|||
130761133|NCT03589976|470747580|FG001|Overall Study|Adverse Event|1|||
130761134|NCT03589976|470747579|FG000|Overall Study|Withdrawal by Subject|4|||
130761135|NCT03589976|470747580|FG001|Overall Study|Withdrawal by Subject|1|||
130761136|NCT03589976|470747579|FG000|Overall Study|Lost to Follow-up|1|||
130761137|NCT03589976|470747580|FG001|Overall Study|Lost to Follow-up|0|||
130761138|NCT03589976|470747579|FG000|Overall Study|Other|4|||
130761139|NCT03589976|470747580|FG001|Overall Study|Other|3|||
130761140|NCT03721835|470747581|FG000|Overall Study|Participant not able to return|1|||
130761141|NCT03721835|470747581|FG000|Overall Study|Lost to Follow-up|1|||
130761142|NCT03721835|470747581|FG000|Overall Study|Revision of the components of the study device|2|||
130761143|NCT03721835|470747581|FG000|Overall Study|Sponsor terminated study|6|||
130761144|NCT03721835|470747581|FG000|Overall Study|Death|1|||
130761145|NCT03721835|470747581|FG000|Overall Study|Sponsor decision|1|||
130761146|NCT01390428|470748980|FG000|Overall Study|Elective Surgery|0|||
130761147|NCT01390428|470748981|FG001|Overall Study|Elective Surgery|0|||
130761148|NCT01390428|470748982|FG002|Overall Study|Elective Surgery|0|||
130761149|NCT01390428|470748983|FG003|Overall Study|Elective Surgery|0|||
130761150|NCT01390428|470748984|FG004|Overall Study|Elective Surgery|1|||
130761151|NCT01390428|470748985|FG005|Overall Study|Elective Surgery|0|||
130761152|NCT01390428|470748980|FG000|Overall Study|Withdrawal by Subject|0|||
130761153|NCT01390428|470748981|FG001|Overall Study|Withdrawal by Subject|0|||
130761154|NCT01390428|470748982|FG002|Overall Study|Withdrawal by Subject|1|||
130761155|NCT01390428|470748983|FG003|Overall Study|Withdrawal by Subject|0|||
130761156|NCT01390428|470748984|FG004|Overall Study|Withdrawal by Subject|0|||
130761157|NCT01390428|470748985|FG005|Overall Study|Withdrawal by Subject|0|||
130761158|NCT05079750|470748986|FG000|Overall Study|Lost to Follow-up|0|||
130761159|NCT05079750|470748987|FG001|Overall Study|Lost to Follow-up|0|||
130761160|NCT05079750|470748988|FG002|Overall Study|Lost to Follow-up|1|||
130761161|NCT05897827|470748989|FG000|Overall Study|Lost to Follow-up|33|||
130761162|NCT05897827|470748990|FG001|Overall Study|Lost to Follow-up|14|||
130761163|NCT05897827|470748989|FG000|Overall Study|Withdrawal by Subject|1|||
130761164|NCT05897827|470748990|FG001|Overall Study|Withdrawal by Subject|1|||
130761165|NCT02276053|470748993|FG000|Overall Study|Death|2|||
130761166|NCT02276053|470748993|FG000|Overall Study|Adverse Event|5|||
130761167|NCT02276053|470748993|FG000|Overall Study|Lack of Efficacy|2|||
130761168|NCT02276053|470748993|FG000|Overall Study|Withdrawal by Subject|1|||
130761169|NCT02276053|470748993|FG000|Overall Study|Patient does not meet selection criteria|3|||
130761170|NCT02276053|470748993|FG000|Overall Study|Patient needs to increase baseline AED|1|||
130761171|NCT04542499|470748996|FG000|Overall Study|Adverse Event|23|||
130761172|NCT04542499|470748997|FG001|Overall Study|Adverse Event|43|||
130761173|NCT04542499|470748996|FG000|Overall Study|Lack of Efficacy|5|||
130761174|NCT04542499|470748997|FG001|Overall Study|Lack of Efficacy|2|||
130761175|NCT04542499|470748996|FG000|Overall Study|Lost to Follow-up|3|||
130761176|NCT04542499|470748997|FG001|Overall Study|Lost to Follow-up|4|||
130761177|NCT04542499|470748996|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
130761178|NCT04542499|470748997|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
130761179|NCT04542499|470748996|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
130761180|NCT04542499|470748997|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
130761181|NCT04542499|470748996|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130761182|NCT04542499|470748997|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130761183|NCT04542499|470748996|FG000|Overall Study|Physician Decision|0|||
130761184|NCT04542499|470748997|FG001|Overall Study|Physician Decision|1|||
130761185|NCT04542499|470748996|FG000|Overall Study|Site Terminated by Sponsor|3|||
130761186|NCT04542499|470748997|FG001|Overall Study|Site Terminated by Sponsor|5|||
130761187|NCT04542499|470748996|FG000|Overall Study|Withdrawal by Subject|12|||
130790184|NCT02349386|470861122|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
130790185|NCT02349386|470861119|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
130790186|NCT02349386|470861120|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
130790187|NCT02349386|470861121|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
130790188|NCT02349386|470861122|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
130790189|NCT02349386|470861119|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
130790190|NCT02349386|470861120|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
130790191|NCT02349386|470861121|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
130790192|NCT02349386|470861122|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
130790193|NCT00676143|470861123|FG000|Overall Study|Adverse Event|34|||
130790194|NCT00676143|470861124|FG001|Overall Study|Adverse Event|60|||
130790195|NCT00676143|470861123|FG000|Overall Study|Death|4|||
130790196|NCT00676143|470861124|FG001|Overall Study|Death|4|||
130790197|NCT00676143|470861123|FG000|Overall Study|Lack of Efficacy|0|||
130790198|NCT00676143|470861124|FG001|Overall Study|Lack of Efficacy|6|||
130790199|NCT00676143|470861123|FG000|Overall Study|Lost to Follow-up|0|||
130790200|NCT00676143|470861124|FG001|Overall Study|Lost to Follow-up|13|||
130790201|NCT00676143|470861123|FG000|Overall Study|Physician Decision|5|||
130790202|NCT00676143|470861124|FG001|Overall Study|Physician Decision|8|||
130790203|NCT00676143|470861123|FG000|Overall Study|Protocol Violation|4|||
130790204|NCT00676143|470861124|FG001|Overall Study|Protocol Violation|8|||
130790205|NCT00676143|470861123|FG000|Overall Study|Withdrawal by Subject|24|||
130790206|NCT00676143|470861124|FG001|Overall Study|Withdrawal by Subject|42|||
130790207|NCT00676143|470861123|FG000|Overall Study|Discontinuation of study by sponsor|65|||
130790208|NCT00676143|470861124|FG001|Overall Study|Discontinuation of study by sponsor|88|||
130790209|NCT00676143|470861123|FG000|Overall Study|Failed to return|2|||
130790210|NCT00676143|470861124|FG001|Overall Study|Failed to return|1|||
130790211|NCT00676143|470861123|FG000|Overall Study|Loss of caregiver|5|||
130790212|NCT00676143|470861124|FG001|Overall Study|Loss of caregiver|3|||
130790213|NCT00676143|470861123|FG000|Overall Study|Other|11|||
130790214|NCT00676143|470861124|FG001|Overall Study|Other|20|||
130790215|NCT00676143|470861123|FG000|Overall Study|Participant participation unknown|1|||
130790216|NCT00676143|470861124|FG001|Overall Study|Participant participation unknown|4|||
130790217|NCT00676143|470861123|FG000|Overall Study|Vasogenic edema recurrence|1|||
130790218|NCT00676143|470861124|FG001|Overall Study|Vasogenic edema recurrence|3|||
130790219|NCT01901185|470861125|FG000|Overall Study|Withdrawal by Subject|2|||
130790220|NCT04759131|470861128|FG000|Overall Study|Investigator's discretion|1|||
130790221|NCT04759131|470861129|FG001|Overall Study|Investigator's discretion|0|||
130790222|NCT04759131|470861128|FG000|Overall Study|Subject withdrawal|1|||
130790223|NCT04759131|470861129|FG001|Overall Study|Subject withdrawal|0|||
130790224|NCT03692949|470861130|FG000|Overall Study|Lost to Follow-up|0|||
130790225|NCT03692949|470861131|FG001|Overall Study|Lost to Follow-up|0|||
130790226|NCT03692949|470861132|FG002|Overall Study|Lost to Follow-up|0|||
130790227|NCT03692949|470861133|FG003|Overall Study|Lost to Follow-up|0|||
130790228|NCT03692949|470861134|FG004|Overall Study|Lost to Follow-up|0|||
130790229|NCT03692949|470861135|FG005|Overall Study|Lost to Follow-up|0|||
130790230|NCT03692949|470861136|FG006|Overall Study|Lost to Follow-up|0|||
130790231|NCT03692949|470861137|FG007|Overall Study|Lost to Follow-up|1|||
130790232|NCT02592824|470861145|FG000|Overall Study|Protocol Violation|5|||
130790233|NCT02592824|470861146|FG001|Overall Study|Protocol Violation|3|||
130790234|NCT02592824|470861145|FG000|Overall Study|Lost to Follow-up|2|||
130790235|NCT02592824|470861146|FG001|Overall Study|Lost to Follow-up|1|||
130790236|NCT05233761|470861147|FG000|Treatment Period A|Withdrawal by Subject|12|||
130790237|NCT05233761|470861148|FG001|Treatment Period A|Withdrawal by Subject|10|||
130790238|NCT05233761|470861147|FG000|Treatment Period A|Lost to Follow-up|6|||
130790239|NCT05233761|470861148|FG001|Treatment Period A|Lost to Follow-up|12|||
130790240|NCT05233761|470861147|FG000|Treatment Period A|Protocol Violation|8|||
130790241|NCT05233761|470861148|FG001|Treatment Period A|Protocol Violation|15|||
130790242|NCT01604785|470861149|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
130790243|NCT01604785|470861150|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
130790244|NCT00869960|470861151|FG000|Overall Study|Lost to Follow-up|2|||
130790245|NCT01654276|470861161|FG000|Overall Study|Lack of Efficacy|1|||
130790246|NCT01654276|470861161|FG000|Overall Study|Lost to Follow-up|4|||
130790247|NCT01654276|470861161|FG000|Overall Study|Withdrawal by Subject|1|||
130790248|NCT01991795|470861162|FG000|Overall Study|Lost to Follow-up|6|||
130790249|NCT01991795|470861163|FG001|Overall Study|Lost to Follow-up|4|||
130790250|NCT01991795|470861162|FG000|Overall Study|Withdrawal by Subject|117|||
130790251|NCT01991795|470861163|FG001|Overall Study|Withdrawal by Subject|94|||
130790252|NCT01991795|470861162|FG000|Overall Study|Site prematurely closed by sponsor|26|||
130790253|NCT01991795|470861163|FG001|Overall Study|Site prematurely closed by sponsor|25|||
130790254|NCT03344757|470861164|FG000|Overall Study|Withdrawal by Subject|18|||
130790255|NCT03344757|470861165|FG001|Overall Study|Withdrawal by Subject|16|||
130790256|NCT03344757|470861164|FG000|Overall Study|Lost to Follow-up|0|||
130790257|NCT03344757|470861165|FG001|Overall Study|Lost to Follow-up|2|||
130790258|NCT04798027|470861171|FG000|Overall Study|Protocol Violation|0|||
130790259|NCT04798027|470861172|FG001|Overall Study|Protocol Violation|0|||
130790260|NCT04798027|470861173|FG002|Overall Study|Protocol Violation|0|||
130790261|NCT04798027|470861174|FG003|Overall Study|Protocol Violation|0|||
130790262|NCT04798027|470861175|FG004|Overall Study|Protocol Violation|1|||
130790263|NCT04798027|470861176|FG005|Overall Study|Protocol Violation|0|||
130790264|NCT04798027|470861177|FG006|Overall Study|Protocol Violation|0|||
130790265|NCT04798027|470861178|FG007|Overall Study|Protocol Violation|1|||
130790266|NCT04798027|470861179|FG008|Overall Study|Protocol Violation|0|||
130790267|NCT04798027|470861171|FG000|Overall Study|Withdrawal by Subject|1|||
130790268|NCT04798027|470861172|FG001|Overall Study|Withdrawal by Subject|0|||
130790269|NCT04798027|470861173|FG002|Overall Study|Withdrawal by Subject|1|||
130790270|NCT04798027|470861174|FG003|Overall Study|Withdrawal by Subject|1|||
130790271|NCT04798027|470861175|FG004|Overall Study|Withdrawal by Subject|1|||
130790272|NCT04798027|470861176|FG005|Overall Study|Withdrawal by Subject|1|||
130790273|NCT04798027|470861177|FG006|Overall Study|Withdrawal by Subject|3|||
130790274|NCT04798027|470861178|FG007|Overall Study|Withdrawal by Subject|2|||
130790275|NCT04798027|470861179|FG008|Overall Study|Withdrawal by Subject|2|||
130790276|NCT04798027|470861171|FG000|Overall Study|Lost to Follow-up|1|||
130790277|NCT04798027|470861172|FG001|Overall Study|Lost to Follow-up|3|||
130790278|NCT04798027|470861173|FG002|Overall Study|Lost to Follow-up|0|||
130790279|NCT04798027|470861174|FG003|Overall Study|Lost to Follow-up|0|||
130790280|NCT04798027|470861175|FG004|Overall Study|Lost to Follow-up|0|||
130790281|NCT04798027|470861176|FG005|Overall Study|Lost to Follow-up|1|||
130790282|NCT04798027|470861177|FG006|Overall Study|Lost to Follow-up|0|||
130790283|NCT04798027|470861178|FG007|Overall Study|Lost to Follow-up|0|||
130790284|NCT04798027|470861179|FG008|Overall Study|Lost to Follow-up|1|||
130790285|NCT04798027|470861171|FG000|Overall Study|Withdrawal by Sponsor|8|||
130790286|NCT04798027|470861172|FG001|Overall Study|Withdrawal by Sponsor|22|||
130790287|NCT04798027|470861173|FG002|Overall Study|Withdrawal by Sponsor|9|||
130790288|NCT04798027|470861174|FG003|Overall Study|Withdrawal by Sponsor|26|||
130790289|NCT04798027|470861175|FG004|Overall Study|Withdrawal by Sponsor|24|||
130790290|NCT04798027|470861176|FG005|Overall Study|Withdrawal by Sponsor|11|||
130790291|NCT04798027|470861177|FG006|Overall Study|Withdrawal by Sponsor|25|||
130790292|NCT04798027|470861178|FG007|Overall Study|Withdrawal by Sponsor|26|||
130790293|NCT04798027|470861179|FG008|Overall Study|Withdrawal by Sponsor|11|||
130790294|NCT03104374|470861180|FG000|Period 1|Adverse Event|7|||
130790295|NCT03104374|470861181|FG001|Period 1|Adverse Event|7|||
130790296|NCT03104374|470861182|FG002|Period 1|Adverse Event|12|||
130790297|NCT03104374|470861183|FG003|Period 1|Adverse Event|14|||
130790298|NCT03104374|470861180|FG000|Period 1|Withdrawal by Subject|18|||
130790299|NCT03104374|470861181|FG001|Period 1|Withdrawal by Subject|9|||
130790300|NCT03104374|470861182|FG002|Period 1|Withdrawal by Subject|10|||
130790301|NCT03104374|470861183|FG003|Period 1|Withdrawal by Subject|17|||
130790302|NCT03104374|470861180|FG000|Period 1|Lost to Follow-up|4|||
130790303|NCT03104374|470861181|FG001|Period 1|Lost to Follow-up|4|||
130790304|NCT03104374|470861182|FG002|Period 1|Lost to Follow-up|6|||
130790305|NCT03104374|470861183|FG003|Period 1|Lost to Follow-up|8|||
130790306|NCT03104374|470861180|FG000|Period 1|Lack of Efficacy|6|||
130790307|NCT03104374|470861181|FG001|Period 1|Lack of Efficacy|7|||
130790308|NCT03104374|470861182|FG002|Period 1|Lack of Efficacy|12|||
130790309|NCT03104374|470861183|FG003|Period 1|Lack of Efficacy|6|||
130790310|NCT03104374|470861180|FG000|Period 1|Other|2|||
130790311|NCT03104374|470861181|FG001|Period 1|Other|2|||
130790312|NCT03104374|470861182|FG002|Period 1|Other|4|||
130790313|NCT03104374|470861183|FG003|Period 1|Other|7|||
130790314|NCT03104374|470861180|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
130790315|NCT03104374|470861181|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
130790316|NCT03104374|470861182|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
130790317|NCT03104374|470861183|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
130790318|NCT03104374|470861180|FG000|Period 2|Adverse Event|4|||
130790319|NCT03104374|470861181|FG001|Period 2|Adverse Event|7|||
130790320|NCT03104374|470861182|FG002|Period 2|Adverse Event|10|||
130790321|NCT03104374|470861183|FG003|Period 2|Adverse Event|10|||
130790322|NCT03104374|470861180|FG000|Period 2|Withdrawal by Subject|3|||
130790323|NCT03104374|470861181|FG001|Period 2|Withdrawal by Subject|7|||
130790324|NCT03104374|470861182|FG002|Period 2|Withdrawal by Subject|13|||
130790325|NCT03104374|470861183|FG003|Period 2|Withdrawal by Subject|16|||
130790326|NCT03104374|470861180|FG000|Period 2|Lost to Follow-up|2|||
130790327|NCT03104374|470861181|FG001|Period 2|Lost to Follow-up|2|||
130790328|NCT03104374|470861182|FG002|Period 2|Lost to Follow-up|3|||
130790329|NCT03104374|470861183|FG003|Period 2|Lost to Follow-up|5|||
130790330|NCT03104374|470861180|FG000|Period 2|Lack of Efficacy|2|||
130790331|NCT03104374|470861181|FG001|Period 2|Lack of Efficacy|4|||
130790332|NCT03104374|470861182|FG002|Period 2|Lack of Efficacy|7|||
130790333|NCT03104374|470861183|FG003|Period 2|Lack of Efficacy|4|||
130790334|NCT03104374|470861180|FG000|Period 2|COVID-19 Infection|0|||
130790335|NCT03104374|470861181|FG001|Period 2|COVID-19 Infection|0|||
130790336|NCT03104374|470861182|FG002|Period 2|COVID-19 Infection|1|||
130790337|NCT03104374|470861183|FG003|Period 2|COVID-19 Infection|0|||
130790338|NCT03104374|470861180|FG000|Period 2|Other|3|||
130790339|NCT03104374|470861181|FG001|Period 2|Other|2|||
130790340|NCT03104374|470861182|FG002|Period 2|Other|2|||
130790341|NCT03104374|470861183|FG003|Period 2|Other|4|||
130790342|NCT02121210|470861186|FG000|Overall Study|Adverse Event|5|||
130790343|NCT02121210|470861187|FG001|Overall Study|Adverse Event|7|||
130790344|NCT02121210|470861186|FG000|Overall Study|Lack of Efficacy|2|||
130790345|NCT02121210|470861187|FG001|Overall Study|Lack of Efficacy|0|||
130790346|NCT02121210|470861186|FG000|Overall Study|Other than specified above|0|||
130761188|NCT04542499|470748997|FG001|Overall Study|Withdrawal by Subject|33|||
130790347|NCT02121210|470861187|FG001|Overall Study|Other than specified above|2|||
130790348|NCT04609514|470861188|FG000|Overall Study|Lost to Follow-up|5|||
130790349|NCT04609514|470861189|FG001|Overall Study|Lost to Follow-up|4|||
130790350|NCT04609514|470861188|FG000|Overall Study|Withdrawal by PI|0|||
130790351|NCT04609514|470861189|FG001|Overall Study|Withdrawal by PI|2|||
130790352|NCT00909870|470861190|FG000|Overall Study|Adverse Event|13|||
130790353|NCT00909870|470861191|FG001|Overall Study|Adverse Event|7|||
130790354|NCT00909870|470861190|FG000|Overall Study|Protocol Violation|1|||
130790355|NCT00909870|470861191|FG001|Overall Study|Protocol Violation|2|||
130790356|NCT00909870|470861190|FG000|Overall Study|Withdrawal by Subject|5|||
130790357|NCT00909870|470861191|FG001|Overall Study|Withdrawal by Subject|8|||
130790358|NCT00909870|470861190|FG000|Overall Study|Lost to Follow-up|3|||
130790359|NCT00909870|470861191|FG001|Overall Study|Lost to Follow-up|3|||
130790360|NCT00909870|470861190|FG000|Overall Study|Physician Decision|0|||
130790361|NCT00909870|470861191|FG001|Overall Study|Physician Decision|2|||
130790362|NCT00909870|470861190|FG000|Overall Study|Other|1|||
130790363|NCT00909870|470861191|FG001|Overall Study|Other|5|||
130790364|NCT01316575|470861192|FG000|Overall Study|Withdrawal by Subject|2|||
130790365|NCT01316575|470861193|FG001|Overall Study|Withdrawal by Subject|0|||
130790366|NCT01316575|470861192|FG000|Overall Study|Required alternate treatment|0|||
130790367|NCT01316575|470861193|FG001|Overall Study|Required alternate treatment|1|||
130790368|NCT01232283|470861194|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
130790369|NCT01232283|470861195|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
130790370|NCT01232283|470861196|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130790371|NCT01232283|470861197|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130790372|NCT01232283|470861198|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130790373|NCT01232283|470861199|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130790374|NCT01232283|470861200|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130790375|NCT01232283|470861201|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130790376|NCT01232283|470861202|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130790377|NCT01232283|470861203|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130790378|NCT01232283|470861194|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
130790379|NCT01232283|470861195|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
130790380|NCT01232283|470861196|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130790381|NCT01232283|470861197|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130790382|NCT01232283|470861198|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130790383|NCT01232283|470861199|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130790384|NCT01232283|470861200|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130761189|NCT04542499|470748996|FG000|Overall Study|Other|2|||
130761190|NCT04542499|470748997|FG001|Overall Study|Other|2|||
130761191|NCT04322539|470749004|FG000|Overall Study|Adverse Event|2|||
130790385|NCT01232283|470861201|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130790386|NCT01232283|470861202|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130790387|NCT01232283|470861203|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130790388|NCT01232283|470861194|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
130790389|NCT01232283|470861195|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130790390|NCT01232283|470861196|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130790391|NCT01232283|470861197|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130790392|NCT01232283|470861198|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130790393|NCT01232283|470861199|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130790394|NCT01232283|470861200|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130790395|NCT01232283|470861201|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130790396|NCT01232283|470861202|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130790397|NCT01232283|470861203|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130790398|NCT01232283|470861194|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
130790399|NCT01232283|470861195|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
130790400|NCT01232283|470861196|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130790401|NCT01232283|470861197|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130790402|NCT01232283|470861198|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130790403|NCT01232283|470861199|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130790404|NCT01232283|470861200|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130790405|NCT01232283|470861201|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130790406|NCT01232283|470861202|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130790407|NCT01232283|470861203|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130790408|NCT01232283|470861194|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
130790409|NCT01232283|470861195|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
130790410|NCT01232283|470861196|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130790411|NCT01232283|470861197|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130790412|NCT01232283|470861198|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130790413|NCT01232283|470861199|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130761192|NCT04322539|470749005|FG001|Overall Study|Adverse Event|0|||
130761193|NCT04322539|470749004|FG000|Overall Study|Death|411|||
130761194|NCT04322539|470749005|FG001|Overall Study|Death|203|||
130761195|NCT04322539|470749004|FG000|Overall Study|Lost to Follow-up|3|||
130761196|NCT04322539|470749005|FG001|Overall Study|Lost to Follow-up|1|||
130761197|NCT04322539|470749004|FG000|Overall Study|Withdrawal of consent|14|||
130761198|NCT04322539|470749005|FG001|Overall Study|Withdrawal of consent|8|||
130790414|NCT01232283|470861200|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130790415|NCT01232283|470861201|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130790416|NCT01232283|470861202|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130790417|NCT01232283|470861203|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130790418|NCT01232283|470861194|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
130790419|NCT01232283|470861195|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
130761199|NCT04322539|470749004|FG000|Overall Study|Radiological Disease Progression|6|||
130761200|NCT04322539|470749005|FG001|Overall Study|Radiological Disease Progression|0|||
130761201|NCT04322539|470749004|FG000|Overall Study|Sponsor Decision|19|||
130761202|NCT04322539|470749005|FG001|Overall Study|Sponsor Decision|14|||
130761203|NCT04322539|470749004|FG000|Overall Study|Other|6|||
130761204|NCT04322539|470749005|FG001|Overall Study|Other|4|||
130761205|NCT03617861|470749008|FG000|Second Intervention (1 Day)|Adverse Event|0|||
130761206|NCT03617861|470749009|FG001|Second Intervention (1 Day)|Adverse Event|0|||
130790420|NCT01232283|470861196|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130761207|NCT03617861|470749010|FG002|Second Intervention (1 Day)|Adverse Event|1|||
130761208|NCT03617861|470749011|FG003|Second Intervention (1 Day)|Adverse Event|0|||
130761209|NCT01702532|470749012|FG000|Overall Study|Adverse Event|0|||
130761210|NCT01702532|470749013|FG001|Overall Study|Adverse Event|1|||
130761211|NCT01846221|470749023|FG000|Overall Study|Catheter Failure|2|||
130761212|NCT01846221|470749024|FG001|Overall Study|Catheter Failure|0|||
130761213|NCT01846221|470749023|FG000|Overall Study|Age Exclusion|1|||
130761214|NCT01846221|470749024|FG001|Overall Study|Age Exclusion|0|||
130761215|NCT01668966|470749025|FG000|Overall Study|Withdrawal by Subject|1|||
130761216|NCT01668966|470749025|FG000|Overall Study|Death|1|||
130761217|NCT01668966|470749025|FG000|Overall Study|Not treated|2|||
130761218|NCT02879994|470749026|FG000|Overall Study|off treatment early|7|||
130761219|NCT02879994|470749026|FG000|Overall Study|Adverse Event|2|||
130761220|NCT02879994|470749026|FG000|Overall Study|Death|2|||
130761221|NCT00552032|470749027|FG000|Overall Study|Withdrawal by Subject|2|||
130761222|NCT00552032|470749028|FG001|Overall Study|Withdrawal by Subject|2|||
130761223|NCT00552032|470749027|FG000|Overall Study|Protocol Violation|7|||
130761224|NCT00552032|470749028|FG001|Overall Study|Protocol Violation|12|||
130761225|NCT00552032|470749027|FG000|Overall Study|Lost to Follow-up|8|||
130761226|NCT00552032|470749028|FG001|Overall Study|Lost to Follow-up|5|||
130761227|NCT01643798|470749029|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
130761228|NCT01643798|470749030|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
130761229|NCT03602391|470749035|FG000|Overall Study|COVID-19|7|||
130761230|NCT03602391|470749036|FG001|Overall Study|COVID-19|6|||
130761231|NCT02035748|470749037|FG000|Overall Study|Adverse Event|5|||
130761232|NCT02035748|470749037|FG000|Overall Study|Death|3|||
130761233|NCT02035748|470749037|FG000|Overall Study|Lost to Follow-up|2|||
130761234|NCT02035748|470749037|FG000|Overall Study|Physician Decision|3|||
130761235|NCT02035748|470749037|FG000|Overall Study|Withdrawal by Subject|6|||
130761236|NCT02035748|470749037|FG000|Overall Study|Progressive Disease|1|||
130761237|NCT04495816|470749038|FG000|Overall Study|Lost to Follow-up|10|||
130761238|NCT04495816|470749039|FG001|Overall Study|Lost to Follow-up|4|||
130761239|NCT04495816|470749038|FG000|Overall Study|Withdrawal by Subject|3|||
130761240|NCT04495816|470749039|FG001|Overall Study|Withdrawal by Subject|5|||
130761241|NCT02052596|470749040|FG000|Active Phase|Adverse Event|3|||
130761242|NCT02052596|470749041|FG001|Active Phase|Adverse Event|2|||
130761243|NCT02052596|470749040|FG000|Active Phase|Lost to Follow-up|8|||
130761244|NCT02052596|470749041|FG001|Active Phase|Lost to Follow-up|11|||
130761245|NCT02052596|470749040|FG000|Active Phase|Protocol Violation|1|||
130761246|NCT02052596|470749041|FG001|Active Phase|Protocol Violation|2|||
130761247|NCT02052596|470749040|FG000|Active Phase|Withdrawal by Subject|3|||
130761248|NCT02052596|470749041|FG001|Active Phase|Withdrawal by Subject|4|||
130761249|NCT02052596|470749040|FG000|Active Phase|Enrolled in error|1|||
130761250|NCT02052596|470749041|FG001|Active Phase|Enrolled in error|0|||
130761251|NCT02052596|470749040|FG000|Active Phase|Lost due to Crohn's disease|0|||
130761252|NCT02052596|470749041|FG001|Active Phase|Lost due to Crohn's disease|1|||
130761253|NCT02052596|470749040|FG000|Safety Phase|Adverse Event|6|||
130761254|NCT02052596|470749041|FG001|Safety Phase|Adverse Event|3|||
130761255|NCT02052596|470749040|FG000|Safety Phase|Lost to Follow-up|11|||
130761256|NCT02052596|470749041|FG001|Safety Phase|Lost to Follow-up|18|||
130761257|NCT02052596|470749040|FG000|Safety Phase|Protocol Violation|1|||
130761258|NCT02052596|470749041|FG001|Safety Phase|Protocol Violation|2|||
130761259|NCT02052596|470749040|FG000|Safety Phase|Withdrawal by Subject|8|||
130761260|NCT02052596|470749041|FG001|Safety Phase|Withdrawal by Subject|11|||
130761261|NCT02052596|470749040|FG000|Safety Phase|Enrolled in error|1|||
130761262|NCT02052596|470749041|FG001|Safety Phase|Enrolled in error|0|||
130761263|NCT02052596|470749040|FG000|Safety Phase|Lost due to Crohn's disease|0|||
130761264|NCT02052596|470749041|FG001|Safety Phase|Lost due to Crohn's disease|1|||
130761265|NCT00558896|470749042|FG000|Overall Study|Adverse Event|1|||
130761266|NCT00558896|470749043|FG001|Overall Study|Adverse Event|1|||
130761267|NCT00558896|470749044|FG002|Overall Study|Adverse Event|1|||
130761268|NCT00558896|470749045|FG003|Overall Study|Adverse Event|3|||
130761269|NCT00558896|470749046|FG004|Overall Study|Adverse Event|4|||
130761270|NCT00558896|470749047|FG005|Overall Study|Adverse Event|10|||
130761271|NCT00558896|470749048|FG006|Overall Study|Adverse Event|3|||
130761272|NCT00558896|470749042|FG000|Overall Study|Death|3|||
130761273|NCT00558896|470749043|FG001|Overall Study|Death|0|||
130761274|NCT00558896|470749044|FG002|Overall Study|Death|2|||
130761275|NCT00558896|470749045|FG003|Overall Study|Death|3|||
130761276|NCT00558896|470749046|FG004|Overall Study|Death|2|||
130761277|NCT00558896|470749047|FG005|Overall Study|Death|2|||
130761278|NCT00558896|470749048|FG006|Overall Study|Death|6|||
130761279|NCT00558896|470749042|FG000|Overall Study|Withdrawal by Subject|2|||
130761280|NCT00558896|470749043|FG001|Overall Study|Withdrawal by Subject|1|||
130761281|NCT00558896|470749044|FG002|Overall Study|Withdrawal by Subject|1|||
130761282|NCT00558896|470749045|FG003|Overall Study|Withdrawal by Subject|1|||
130761283|NCT00558896|470749046|FG004|Overall Study|Withdrawal by Subject|1|||
130761284|NCT00558896|470749047|FG005|Overall Study|Withdrawal by Subject|5|||
130761285|NCT00558896|470749048|FG006|Overall Study|Withdrawal by Subject|5|||
130761286|NCT00558896|470749042|FG000|Overall Study|Alternative Treatment|2|||
130761287|NCT00558896|470749043|FG001|Overall Study|Alternative Treatment|2|||
130761288|NCT00558896|470749044|FG002|Overall Study|Alternative Treatment|0|||
130761289|NCT00558896|470749045|FG003|Overall Study|Alternative Treatment|2|||
130761290|NCT00558896|470749046|FG004|Overall Study|Alternative Treatment|6|||
130761291|NCT00558896|470749047|FG005|Overall Study|Alternative Treatment|7|||
130761292|NCT00558896|470749048|FG006|Overall Study|Alternative Treatment|1|||
130761293|NCT00558896|470749042|FG000|Overall Study|Physician discretion|3|||
130761294|NCT00558896|470749043|FG001|Overall Study|Physician discretion|2|||
130761295|NCT00558896|470749044|FG002|Overall Study|Physician discretion|1|||
130761296|NCT00558896|470749045|FG003|Overall Study|Physician discretion|2|||
130761297|NCT00558896|470749046|FG004|Overall Study|Physician discretion|1|||
130761298|NCT00558896|470749047|FG005|Overall Study|Physician discretion|3|||
130761299|NCT00558896|470749048|FG006|Overall Study|Physician discretion|3|||
130761300|NCT00558896|470749042|FG000|Overall Study|Continues on treatment|10|||
130761301|NCT00558896|470749043|FG001|Overall Study|Continues on treatment|1|||
130761302|NCT00558896|470749044|FG002|Overall Study|Continues on treatment|0|||
130761303|NCT00558896|470749045|FG003|Overall Study|Continues on treatment|1|||
130761304|NCT00558896|470749046|FG004|Overall Study|Continues on treatment|9|||
130761305|NCT00558896|470749047|FG005|Overall Study|Continues on treatment|25|||
130761306|NCT00558896|470749048|FG006|Overall Study|Continues on treatment|6|||
130761307|NCT00705718|470749049|FG000|Overall Study|Death|6|||
130761308|NCT00705718|470749050|FG001|Overall Study|Death|6|||
130761309|NCT00705718|470749049|FG000|Overall Study|Not due for Visit|0|||
130761310|NCT00705718|470749050|FG001|Overall Study|Not due for Visit|12|||
130761311|NCT00705718|470749049|FG000|Overall Study|Follow up not done|1|||
130761312|NCT00705718|470749050|FG001|Overall Study|Follow up not done|4|||
130761313|NCT06137703|470749051|FG000|Overall Study|Other|0|||
130761314|NCT06137703|470749052|FG001|Overall Study|Other|1|||
130761315|NCT06137703|470749053|FG002|Overall Study|Other|0|||
130761316|NCT06137703|470749054|FG003|Overall Study|Other|0|||
130761317|NCT06137703|470749051|FG000|Overall Study|Adverse Event|0|||
130761318|NCT06137703|470749052|FG001|Overall Study|Adverse Event|0|||
130761319|NCT06137703|470749053|FG002|Overall Study|Adverse Event|1|||
130761320|NCT06137703|470749054|FG003|Overall Study|Adverse Event|0|||
130761321|NCT04329091|470749057|FG000|Overall Study|Physician Decision|5|||
130761322|NCT00741091|470749060|FG000|Overall Study|Death|13|||
130761323|NCT00741091|470749060|FG000|Overall Study|Lost to Follow-up|16|||
130761324|NCT00741091|470749060|FG000|Overall Study|Withdrawal by Subject|6|||
130761325|NCT00741091|470749060|FG000|Overall Study|Missed Visit|22|||
130761326|NCT01527487|470749061|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
130761327|NCT01527487|470749062|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
130761328|NCT01527487|470749061|FG000|Overall Study|Disease Progression|4|||
130761329|NCT01527487|470749062|FG001|Overall Study|Disease Progression|1|||
130761330|NCT01527487|470749061|FG000|Overall Study|Adverse Event|1|||
130761331|NCT01527487|470749062|FG001|Overall Study|Adverse Event|1|||
130761332|NCT01527487|470749061|FG000|Overall Study|Death|0|||
130761333|NCT01527487|470749062|FG001|Overall Study|Death|1|||
130761334|NCT03181503|470749063|FG000|Overall Study|Adverse Event|2|||
130761335|NCT03181503|470749064|FG001|Overall Study|Adverse Event|2|||
130761336|NCT03181503|470749063|FG000|Overall Study|Protocol Violation|1|||
130761337|NCT03181503|470749064|FG001|Overall Study|Protocol Violation|0|||
130761338|NCT03181503|470749063|FG000|Overall Study|Withdrawal by Subject|3|||
130761339|NCT03181503|470749064|FG001|Overall Study|Withdrawal by Subject|0|||
130761340|NCT03181503|470749063|FG000|Overall Study|Lost to Follow-up|1|||
130761341|NCT03181503|470749064|FG001|Overall Study|Lost to Follow-up|1|||
130761342|NCT00597506|470749065|FG000|Overall Study|Subject is being followed for survival|1|||
130761343|NCT03199612|470749066|FG000|Overall Study|Adverse Event|1|||
130761344|NCT03199612|470749067|FG001|Overall Study|Adverse Event|0|||
130761345|NCT00081731|470749072|FG000|Overall Study|scientific integrity issue|8|||
130761346|NCT00081731|470749073|FG001|Overall Study|scientific integrity issue|8|||
130761347|NCT02386345|470749074|FG000|Overall Study|Not treated|14|||
130761348|NCT02386345|470749074|FG000|Overall Study|Lost to Follow-up|1|||
130761349|NCT02386345|470749074|FG000|Overall Study|Adverse Event|5|||
130761350|NCT02386345|470749074|FG000|Overall Study|Repeat Procedure|10|||
130761351|NCT02386345|470749074|FG000|Overall Study|Did not complete 12-month follow-up|72|||
130761352|NCT02258542|470749075|FG000|Overall Study|eg. not made to the visit|7|||
130761353|NCT02258542|470749076|FG001|Overall Study|eg. not made to the visit|4|||
130761354|NCT02258542|470749077|FG002|Overall Study|eg. not made to the visit|0|||
130761355|NCT02258542|470749078|FG003|Overall Study|eg. not made to the visit|1|||
130761356|NCT02258542|470749075|FG000|Overall Study|study specific discount. criteria|1|||
130761357|NCT02258542|470749076|FG001|Overall Study|study specific discount. criteria|1|||
130761358|NCT02258542|470749077|FG002|Overall Study|study specific discount. criteria|0|||
130761359|NCT02258542|470749078|FG003|Overall Study|study specific discount. criteria|0|||
130761360|NCT02258542|470749075|FG000|Overall Study|Withdrawal by Subject|20|||
130761361|NCT02258542|470749076|FG001|Overall Study|Withdrawal by Subject|20|||
130761362|NCT02258542|470749077|FG002|Overall Study|Withdrawal by Subject|7|||
130761363|NCT02258542|470749078|FG003|Overall Study|Withdrawal by Subject|1|||
130761364|NCT02258542|470749075|FG000|Overall Study|Lost to Follow-up|5|||
130761365|NCT02258542|470749076|FG001|Overall Study|Lost to Follow-up|12|||
130761366|NCT02258542|470749077|FG002|Overall Study|Lost to Follow-up|1|||
130761367|NCT02258542|470749078|FG003|Overall Study|Lost to Follow-up|2|||
130761368|NCT02258542|470749075|FG000|Overall Study|Death|5|||
130761369|NCT02258542|470749076|FG001|Overall Study|Death|4|||
130761370|NCT02258542|470749077|FG002|Overall Study|Death|0|||
130761371|NCT02258542|470749078|FG003|Overall Study|Death|1|||
130761372|NCT02258542|470749075|FG000|Overall Study|Adverse Event|3|||
130761373|NCT02258542|470749076|FG001|Overall Study|Adverse Event|4|||
130761374|NCT02258542|470749077|FG002|Overall Study|Adverse Event|0|||
130761375|NCT02258542|470749078|FG003|Overall Study|Adverse Event|0|||
130761376|NCT02258542|470749075|FG000|Overall Study|Protocol Violation|1|||
130761377|NCT02258542|470749076|FG001|Overall Study|Protocol Violation|2|||
130761378|NCT02258542|470749077|FG002|Overall Study|Protocol Violation|0|||
130761379|NCT02258542|470749078|FG003|Overall Study|Protocol Violation|0|||
130761380|NCT02258542|470749075|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130761381|NCT02258542|470749076|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
130761382|NCT02258542|470749077|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130761383|NCT02258542|470749078|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
130761384|NCT00514904|470749093|FG000|Overall Study|Withdrawal by Subject|3|||
130761385|NCT00514904|470749094|FG001|Overall Study|Withdrawal by Subject|2|||
130761386|NCT00514904|470749093|FG000|Overall Study|Lost to Follow-up|21|||
130761387|NCT00514904|470749094|FG001|Overall Study|Lost to Follow-up|3|||
130761388|NCT03430895|470749095|FG000|Overall Study|Not Treated|2|||
130761389|NCT01645891|470749101|FG000|Overall Study|Adverse Event|6|||
130761390|NCT01645891|470749102|FG001|Overall Study|Adverse Event|10|||
130761391|NCT01645891|470749101|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
130761392|NCT01645891|470749102|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
130761393|NCT01645891|470749101|FG000|Overall Study|Withdrawal by Subject|3|||
130761394|NCT01645891|470749102|FG001|Overall Study|Withdrawal by Subject|3|||
130761395|NCT01645891|470749101|FG000|Overall Study|Protocol Violation|4|||
130761396|NCT01645891|470749102|FG001|Overall Study|Protocol Violation|0|||
130761397|NCT01645891|470749101|FG000|Overall Study|Lost to Follow-up|4|||
130761398|NCT01645891|470749102|FG001|Overall Study|Lost to Follow-up|1|||
130761399|NCT01645891|470749101|FG000|Overall Study|Death|0|||
130761400|NCT01645891|470749102|FG001|Overall Study|Death|2|||
130761401|NCT00138073|470749103|FG000|Overall Study|lack of resources|55|||
130761402|NCT03026530|470749104|FG000|Overall Study|Lost to Follow-up|19|||
130761403|NCT03026530|470749105|FG001|Overall Study|Lost to Follow-up|24|||
130761404|NCT03026530|470749104|FG000|Overall Study|Protocol Violation|2|||
130761405|NCT03026530|470749105|FG001|Overall Study|Protocol Violation|5|||
130761406|NCT02417961|470750206|FG000|Overall Study|Adverse Event|1|||
130761407|NCT02417961|470750206|FG000|Overall Study|Lost to Follow-up|1|||
130761408|NCT02417961|470750206|FG000|Overall Study|Withdrawal by Subject|2|||
130761409|NCT03197467|470750209|FG000|Overall Study|Withdrawal by Subject|1|||
130761410|NCT03666533|470750211|FG000|Overall Study|Lost to Follow-up|2|||
130790421|NCT01232283|470861197|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130790422|NCT01232283|470861198|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130790423|NCT01232283|470861199|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130790424|NCT01232283|470861200|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130790425|NCT01232283|470861201|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130790426|NCT01232283|470861202|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130790427|NCT01232283|470861203|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130790428|NCT01232283|470861194|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
130790429|NCT01232283|470861195|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
130790430|NCT01232283|470861196|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130790431|NCT01232283|470861197|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130790432|NCT01232283|470861198|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130790433|NCT01232283|470861199|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130790434|NCT01232283|470861200|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130790435|NCT01232283|470861201|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130790436|NCT01232283|470861202|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130790437|NCT01232283|470861203|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130790438|NCT01232283|470861194|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130790439|NCT01232283|470861195|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130790440|NCT01232283|470861196|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
130790441|NCT01232283|470861197|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
130790442|NCT01232283|470861198|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130790443|NCT01232283|470861199|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130790444|NCT01232283|470861200|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130790445|NCT01232283|470861201|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130790446|NCT01232283|470861202|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130761411|NCT03666533|470750212|FG001|Overall Study|Lost to Follow-up|2|||
130761412|NCT01632904|470750217|FG000|Overall Study|Adverse Event|4|||
130790447|NCT01232283|470861203|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130790448|NCT01232283|470861194|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130790449|NCT01232283|470861195|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130790450|NCT01232283|470861196|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
130790451|NCT01232283|470861197|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
130790452|NCT01232283|470861198|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130790453|NCT01232283|470861199|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130761413|NCT01632904|470750218|FG001|Overall Study|Adverse Event|1|||
130761414|NCT01632904|470750217|FG000|Overall Study|Physician Decision|0|||
130761415|NCT01632904|470750218|FG001|Overall Study|Physician Decision|1|||
130761416|NCT01632904|470750217|FG000|Overall Study|Subject decision|3|||
130761417|NCT01632904|470750218|FG001|Overall Study|Subject decision|2|||
130761418|NCT01632904|470750217|FG000|Overall Study|Disease Progression|0|||
130761419|NCT01632904|470750218|FG001|Overall Study|Disease Progression|1|||
130761420|NCT01632904|470750217|FG000|Overall Study|Reason for discontinuation not available|0|||
130761421|NCT01632904|470750218|FG001|Overall Study|Reason for discontinuation not available|1|||
130761422|NCT04743804|470750219|FG000|Overall Study|Other|1|||
130761423|NCT04743804|470750220|FG001|Overall Study|Other|0|||
130761424|NCT04743804|470750219|FG000|Overall Study|Withdrawal by Subject|0|||
130761425|NCT04743804|470750220|FG001|Overall Study|Withdrawal by Subject|1|||
130761426|NCT04743804|470750219|FG000|Overall Study|Study Terminated by Sponsor|1|||
130761427|NCT04743804|470750220|FG001|Overall Study|Study Terminated by Sponsor|4|||
130761428|NCT04743804|470750219|FG000|Overall Study|Physician Decision|0|||
130761429|NCT04743804|470750220|FG001|Overall Study|Physician Decision|1|||
130761430|NCT04743804|470750219|FG000|Overall Study|Death|3|||
130761431|NCT04743804|470750220|FG001|Overall Study|Death|0|||
130761432|NCT02059434|470750224|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
130761433|NCT02059434|470750225|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
130761434|NCT02059434|470750226|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
130761435|NCT02059434|470750227|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
130761436|NCT02059434|470750228|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
130761437|NCT02059434|470750229|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
130761438|NCT02059434|470750230|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
130761439|NCT02059434|470750231|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
130761440|NCT02059434|470750232|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
130761441|NCT02059434|470750224|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
130761442|NCT02059434|470750225|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
130761443|NCT02059434|470750226|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
130761444|NCT02059434|470750227|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
130761445|NCT02059434|470750228|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
130761446|NCT02059434|470750229|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
130761447|NCT02059434|470750230|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
130761448|NCT02059434|470750231|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
130761449|NCT02059434|470750232|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
130761450|NCT02059434|470750224|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
130761451|NCT02059434|470750225|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
130761452|NCT02059434|470750226|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
130761453|NCT02059434|470750227|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
130761454|NCT02059434|470750228|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
130761455|NCT02059434|470750229|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
130761456|NCT02059434|470750230|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
130761457|NCT02059434|470750231|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
130761458|NCT02059434|470750232|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
130761459|NCT02059434|470750224|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
130761460|NCT02059434|470750225|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
130761461|NCT02059434|470750226|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
130761462|NCT02059434|470750227|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
130761463|NCT02059434|470750228|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
130761464|NCT02059434|470750229|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
130761465|NCT02059434|470750230|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
130761466|NCT02059434|470750231|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
130761467|NCT02059434|470750232|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
130761468|NCT02059434|470750224|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130761469|NCT02059434|470750225|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130761470|NCT02059434|470750226|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130761471|NCT02059434|470750227|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130761472|NCT02059434|470750228|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130761473|NCT02059434|470750229|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130761474|NCT02059434|470750230|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130761475|NCT02059434|470750231|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130761476|NCT02059434|470750232|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
130761477|NCT04392167|470750250|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
130761478|NCT04063657|470750251|FG000|Overall Study|Lost to Follow-up|1|||
130761479|NCT04063657|470750252|FG001|Overall Study|Lost to Follow-up|0|||
130761480|NCT03408444|470750253|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
130761481|NCT03408444|470750254|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130790454|NCT01232283|470861200|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130790455|NCT01232283|470861201|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130790456|NCT01232283|470861202|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130790457|NCT01232283|470861203|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130790458|NCT01232283|470861194|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130790459|NCT01232283|470861195|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130790460|NCT01232283|470861196|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
130790461|NCT01232283|470861197|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130790462|NCT01232283|470861198|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130790463|NCT01232283|470861199|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130790464|NCT01232283|470861200|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130790465|NCT01232283|470861201|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130790466|NCT01232283|470861202|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130790467|NCT01232283|470861203|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130790468|NCT01232283|470861194|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130790469|NCT01232283|470861195|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130790470|NCT01232283|470861196|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
130790471|NCT01232283|470861197|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
130790472|NCT01232283|470861198|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130790473|NCT01232283|470861199|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130790474|NCT01232283|470861200|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130790475|NCT01232283|470861201|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130790476|NCT01232283|470861202|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130790477|NCT01232283|470861203|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130790478|NCT01232283|470861194|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130790479|NCT01232283|470861195|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130790480|NCT01232283|470861196|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
130790481|NCT01232283|470861197|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
130790482|NCT01232283|470861198|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130790483|NCT01232283|470861199|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130790484|NCT01232283|470861200|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130790485|NCT01232283|470861201|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130790486|NCT01232283|470861202|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130790487|NCT01232283|470861203|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130790488|NCT01232283|470861194|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
130790489|NCT01232283|470861195|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
130790490|NCT01232283|470861196|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
130790491|NCT01232283|470861197|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
130790492|NCT01232283|470861198|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
130790493|NCT01232283|470861199|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
130790494|NCT01232283|470861200|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
130790495|NCT01232283|470861201|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
130761482|NCT03408444|470750255|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130790496|NCT01232283|470861202|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
130790497|NCT01232283|470861203|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
130790498|NCT01232283|470861194|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130761483|NCT03408444|470750256|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130761484|NCT03408444|470750253|FG000|Overall Study|Lens Discomfort|0|||
130761485|NCT03408444|470750254|FG001|Overall Study|Lens Discomfort|1|||
130761486|NCT03408444|470750255|FG002|Overall Study|Lens Discomfort|0|||
130761487|NCT03408444|470750256|FG003|Overall Study|Lens Discomfort|0|||
130761488|NCT03408444|470750253|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
130761489|NCT03408444|470750254|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
130761490|NCT03408444|470750255|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130761491|NCT03408444|470750256|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
130761492|NCT03408444|470750253|FG000|Overall Study|Withdrawal by Subject|0|||
130761493|NCT03408444|470750254|FG001|Overall Study|Withdrawal by Subject|2|||
130761494|NCT03408444|470750255|FG002|Overall Study|Withdrawal by Subject|3|||
130761495|NCT03408444|470750256|FG003|Overall Study|Withdrawal by Subject|0|||
130761496|NCT03408444|470750253|FG000|Overall Study|Lost to Follow-up|0|||
130761497|NCT03408444|470750254|FG001|Overall Study|Lost to Follow-up|0|||
130761498|NCT03408444|470750255|FG002|Overall Study|Lost to Follow-up|1|||
130761499|NCT03408444|470750256|FG003|Overall Study|Lost to Follow-up|0|||
130761500|NCT03408444|470750253|FG000|Overall Study|Adverse Event|0|||
130761501|NCT03408444|470750254|FG001|Overall Study|Adverse Event|0|||
130761502|NCT03408444|470750255|FG002|Overall Study|Adverse Event|0|||
130761503|NCT03408444|470750256|FG003|Overall Study|Adverse Event|1|||
130761504|NCT03408444|470750253|FG000|Overall Study|Lens Handling Difficulties|0|||
130761505|NCT03408444|470750254|FG001|Overall Study|Lens Handling Difficulties|0|||
130761506|NCT03408444|470750255|FG002|Overall Study|Lens Handling Difficulties|1|||
130761507|NCT03408444|470750256|FG003|Overall Study|Lens Handling Difficulties|0|||
130761508|NCT03408444|470750253|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
130761509|NCT03408444|470750254|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
130761510|NCT03408444|470750255|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
130761511|NCT03408444|470750256|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
130761512|NCT04984681|470750257|FG000|Overall Study|Lost to Follow-up|3|||
130761513|NCT04984681|470750258|FG001|Overall Study|Lost to Follow-up|1|||
130761514|NCT01473394|470750261|FG000|Overall Study|Adverse Event|13|||
130761515|NCT01473394|470750262|FG001|Overall Study|Adverse Event|16|||
130761516|NCT01473394|470750261|FG000|Overall Study|Insufficient Therapeutic Response|4|||
130761517|NCT01473394|470750262|FG001|Overall Study|Insufficient Therapeutic Response|1|||
130761518|NCT01473394|470750261|FG000|Overall Study|Protocol Violation|7|||
130761519|NCT01473394|470750262|FG001|Overall Study|Protocol Violation|5|||
130761520|NCT01473394|470750261|FG000|Overall Study|Withdrew Consent|12|||
130761521|NCT01473394|470750262|FG001|Overall Study|Withdrew Consent|10|||
130761522|NCT01473394|470750261|FG000|Overall Study|Lost to Follow-up|9|||
130761523|NCT01473394|470750262|FG001|Overall Study|Lost to Follow-up|11|||
130761524|NCT01482962|470750265|FG000|Overall Study|Progressive Disease|65|||
130761525|NCT01482962|470750266|FG001|Overall Study|Progressive Disease|53|||
130761526|NCT01482962|470750265|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
130761527|NCT01482962|470750266|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
130761528|NCT01482962|470750265|FG000|Overall Study|Adverse Event|18|||
130761529|NCT01482962|470750266|FG001|Overall Study|Adverse Event|22|||
130761530|NCT01482962|470750265|FG000|Overall Study|Withdrawal by Participant|8|||
130761531|NCT01482962|470750266|FG001|Overall Study|Withdrawal by Participant|13|||
130761532|NCT01482962|470750265|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
130761533|NCT01482962|470750266|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
130761534|NCT01482962|470750265|FG000|Overall Study|Other Reason|1|||
130761535|NCT01482962|470750266|FG001|Overall Study|Other Reason|5|||
130761536|NCT01482962|470750265|FG000|Overall Study|Study Terminated by Sponsor|5|||
130761537|NCT01482962|470750266|FG001|Overall Study|Study Terminated by Sponsor|2|||
130761538|NCT01482962|470750265|FG000|Overall Study|Did not Receive Study Drug|1|||
130761539|NCT01482962|470750266|FG001|Overall Study|Did not Receive Study Drug|6|||
130761540|NCT00250458|470750270|FG000|Overall Study|Lost to Follow-up|4|||
130761541|NCT00250458|470750271|FG001|Overall Study|Lost to Follow-up|2|||
130761542|NCT00250458|470750270|FG000|Overall Study|Protocol Violation|0|||
130761543|NCT00250458|470750271|FG001|Overall Study|Protocol Violation|1|||
130761544|NCT00250458|470750270|FG000|Overall Study|Withdrawal by Subject|4|||
130761545|NCT00250458|470750271|FG001|Overall Study|Withdrawal by Subject|2|||
130761546|NCT00250458|470750270|FG000|Overall Study|Lack of Migraine Attack|20|||
130761547|NCT00250458|470750271|FG001|Overall Study|Lack of Migraine Attack|9|||
130761548|NCT00250458|470750270|FG000|Overall Study|Qualifying migraine but did not treat|3|||
130761549|NCT00250458|470750271|FG001|Overall Study|Qualifying migraine but did not treat|3|||
130761550|NCT00250458|470750270|FG000|Overall Study|Other|1|||
130761551|NCT00250458|470750271|FG001|Overall Study|Other|0|||
130761552|NCT01801358|470750272|FG000|Overall Study|Adverse Event|0|||
130761553|NCT01801358|470750273|FG001|Overall Study|Adverse Event|2|||
130761554|NCT01801358|470750274|FG002|Overall Study|Adverse Event|1|||
130761555|NCT01801358|470750275|FG003|Overall Study|Adverse Event|0|||
130761556|NCT01801358|470750276|FG004|Overall Study|Adverse Event|0|||
130761557|NCT01801358|470750277|FG005|Overall Study|Adverse Event|1|||
130761558|NCT01801358|470750272|FG000|Overall Study|Physician Decision|0|||
130761559|NCT01801358|470750273|FG001|Overall Study|Physician Decision|0|||
130761560|NCT01801358|470750274|FG002|Overall Study|Physician Decision|1|||
130761561|NCT01801358|470750275|FG003|Overall Study|Physician Decision|0|||
130761562|NCT01801358|470750276|FG004|Overall Study|Physician Decision|0|||
130761563|NCT01801358|470750277|FG005|Overall Study|Physician Decision|0|||
130761564|NCT01801358|470750272|FG000|Overall Study|Progressive Disease|6|||
130761565|NCT01801358|470750273|FG001|Overall Study|Progressive Disease|4|||
130761566|NCT01801358|470750274|FG002|Overall Study|Progressive Disease|4|||
130761567|NCT01801358|470750275|FG003|Overall Study|Progressive Disease|5|||
130761568|NCT01801358|470750276|FG004|Overall Study|Progressive Disease|6|||
130761569|NCT01801358|470750277|FG005|Overall Study|Progressive Disease|5|||
130761570|NCT01801358|470750272|FG000|Overall Study|Withdrawal by Subject|0|||
130761571|NCT01801358|470750273|FG001|Overall Study|Withdrawal by Subject|0|||
130761572|NCT01801358|470750274|FG002|Overall Study|Withdrawal by Subject|0|||
130761573|NCT01801358|470750275|FG003|Overall Study|Withdrawal by Subject|1|||
130761574|NCT01801358|470750276|FG004|Overall Study|Withdrawal by Subject|0|||
130761575|NCT01801358|470750277|FG005|Overall Study|Withdrawal by Subject|2|||
130761576|NCT01549041|470750285|FG000|Overall Study|Lack of Efficacy|2|||
130761577|NCT01549041|470750286|FG001|Overall Study|Lack of Efficacy|4|||
130761578|NCT01549041|470750285|FG000|Overall Study|Adverse Event|0|||
130761579|NCT01549041|470750286|FG001|Overall Study|Adverse Event|4|||
130761580|NCT01537068|470750291|FG000|Overall Study|Lost to Follow-up|2|||
130761581|NCT01537068|470750292|FG001|Overall Study|Lost to Follow-up|1|||
130761582|NCT01537068|470750291|FG000|Overall Study|Adverse Event|0|||
130761583|NCT01537068|470750292|FG001|Overall Study|Adverse Event|1|||
130761584|NCT01537068|470750291|FG000|Overall Study|Withdrawal by Subject|1|||
130761585|NCT01537068|470750292|FG001|Overall Study|Withdrawal by Subject|1|||
130761586|NCT01537068|470750291|FG000|Overall Study|Lack of Efficacy|1|||
130761587|NCT01537068|470750292|FG001|Overall Study|Lack of Efficacy|0|||
130761588|NCT00483704|470750293|FG000|Randomization|Withdrawal by Subject|19|||
130761589|NCT00483704|470750294|FG001|Randomization|Withdrawal by Subject|28|||
130761590|NCT00483704|470750295|FG002|Randomization|Withdrawal by Subject|18|||
130761591|NCT00483704|470750293|FG000|Randomization|Protocol Violation|14|||
130761592|NCT00483704|470750294|FG001|Randomization|Protocol Violation|25|||
130761593|NCT00483704|470750295|FG002|Randomization|Protocol Violation|22|||
130761594|NCT00483704|470750293|FG000|Randomization|Lost to Follow-up|14|||
130761595|NCT00483704|470750294|FG001|Randomization|Lost to Follow-up|14|||
130761596|NCT00483704|470750295|FG002|Randomization|Lost to Follow-up|19|||
130761597|NCT00483704|470750293|FG000|Randomization|Pregnancy|1|||
130761598|NCT00483704|470750294|FG001|Randomization|Pregnancy|0|||
130761599|NCT00483704|470750295|FG002|Randomization|Pregnancy|0|||
130761600|NCT00483704|470750293|FG000|Randomization|Physician Decision|2|||
130761601|NCT00483704|470750294|FG001|Randomization|Physician Decision|4|||
130761602|NCT00483704|470750295|FG002|Randomization|Physician Decision|0|||
130761603|NCT00483704|470750293|FG000|Randomization|Progressive disease|0|||
130761604|NCT00483704|470750294|FG001|Randomization|Progressive disease|0|||
130761605|NCT00483704|470750295|FG002|Randomization|Progressive disease|1|||
130761606|NCT00483704|470750293|FG000|Randomization|Lack of qualifying migraines|21|||
130790499|NCT01232283|470861195|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130790500|NCT01232283|470861196|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130790501|NCT01232283|470861197|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130790502|NCT01232283|470861198|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
130790503|NCT01232283|470861199|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
130790504|NCT01232283|470861200|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130790505|NCT01232283|470861201|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
130790506|NCT01232283|470861202|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130790507|NCT01232283|470861203|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130790508|NCT01232283|470861194|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130790509|NCT01232283|470861195|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130761607|NCT00483704|470750294|FG001|Randomization|Lack of qualifying migraines|25|||
130790510|NCT01232283|470861196|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130790511|NCT01232283|470861197|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130790512|NCT01232283|470861198|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
130790513|NCT01232283|470861199|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130790514|NCT01232283|470861200|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
130790515|NCT01232283|470861201|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
130790516|NCT01232283|470861202|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130790517|NCT01232283|470861203|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130790518|NCT01232283|470861194|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130790519|NCT01232283|470861195|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130790520|NCT01232283|470861196|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130790521|NCT01232283|470861197|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130790522|NCT01232283|470861198|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
130790523|NCT01232283|470861199|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
130790524|NCT01232283|470861200|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
130790525|NCT01232283|470861201|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
130790526|NCT01232283|470861202|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130790527|NCT01232283|470861203|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130790528|NCT01232283|470861194|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130790529|NCT01232283|470861195|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130790530|NCT01232283|470861196|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130790531|NCT01232283|470861197|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130790532|NCT01232283|470861198|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
130790533|NCT01232283|470861199|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130790534|NCT01232283|470861200|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130790535|NCT01232283|470861201|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130790536|NCT01232283|470861202|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130790537|NCT01232283|470861203|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130790538|NCT01232283|470861194|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130790539|NCT01232283|470861195|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130790540|NCT01232283|470861196|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130790541|NCT01232283|470861197|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130790542|NCT01232283|470861198|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
130790543|NCT01232283|470861199|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130790544|NCT01232283|470861200|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
130790545|NCT01232283|470861201|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
130790546|NCT01232283|470861202|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130790547|NCT01232283|470861203|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130790548|NCT01232283|470861194|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130761608|NCT00483704|470750295|FG002|Randomization|Lack of qualifying migraines|31|||
130761609|NCT00483704|470750293|FG000|Treatment|Lack of qualifying migraines|101|||
130761610|NCT00483704|470750294|FG001|Treatment|Lack of qualifying migraines|99|||
130761611|NCT00483704|470750295|FG002|Treatment|Lack of qualifying migraines|116|||
130761612|NCT00483704|470750293|FG000|Treatment|Adverse Event|3|||
130761613|NCT00483704|470750294|FG001|Treatment|Adverse Event|5|||
130761614|NCT00483704|470750295|FG002|Treatment|Adverse Event|4|||
130761615|NCT00483704|470750293|FG000|Treatment|Withdrawal by Subject|16|||
130761616|NCT00483704|470750294|FG001|Treatment|Withdrawal by Subject|12|||
130761617|NCT00483704|470750295|FG002|Treatment|Withdrawal by Subject|21|||
130761618|NCT00483704|470750293|FG000|Treatment|Protocol Violation|6|||
130761619|NCT00483704|470750294|FG001|Treatment|Protocol Violation|3|||
130761620|NCT00483704|470750295|FG002|Treatment|Protocol Violation|5|||
130761621|NCT00483704|470750293|FG000|Treatment|Lost to Follow-up|2|||
130761622|NCT00483704|470750294|FG001|Treatment|Lost to Follow-up|7|||
130761623|NCT00483704|470750295|FG002|Treatment|Lost to Follow-up|5|||
130761624|NCT00483704|470750293|FG000|Treatment|Lack of Efficacy|1|||
130761625|NCT00483704|470750294|FG001|Treatment|Lack of Efficacy|1|||
130761626|NCT00483704|470750295|FG002|Treatment|Lack of Efficacy|1|||
130761627|NCT00483704|470750293|FG000|Treatment|Pregnancy|0|||
130761628|NCT00483704|470750294|FG001|Treatment|Pregnancy|1|||
130761629|NCT00483704|470750295|FG002|Treatment|Pregnancy|0|||
130761630|NCT00483704|470750293|FG000|Treatment|Physician Decision|0|||
130761631|NCT00483704|470750294|FG001|Treatment|Physician Decision|1|||
130761632|NCT00483704|470750295|FG002|Treatment|Physician Decision|4|||
130761633|NCT04442269|470750296|FG000|Overall Study|Adverse Event|1|||
130761634|NCT04442269|470750297|FG001|Overall Study|Adverse Event|0|||
130761635|NCT04442269|470750296|FG000|Overall Study|Death|0|||
130761636|NCT04442269|470750297|FG001|Overall Study|Death|1|||
130761637|NCT04442269|470750296|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
130761638|NCT04442269|470750297|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
130761639|NCT04442269|470750296|FG000|Overall Study|Lost to Follow-up|1|||
130761640|NCT04442269|470750297|FG001|Overall Study|Lost to Follow-up|0|||
130761641|NCT04442269|470750296|FG000|Overall Study|Withdrawal by Subject|3|||
130761642|NCT04442269|470750297|FG001|Overall Study|Withdrawal by Subject|2|||
130761643|NCT04442269|470750296|FG000|Overall Study|Protocol Deviation|0|||
130761644|NCT04442269|470750297|FG001|Overall Study|Protocol Deviation|1|||
130761645|NCT04442269|470750296|FG000|Overall Study|Travel Limitations|1|||
130761646|NCT04442269|470750297|FG001|Overall Study|Travel Limitations|1|||
130761647|NCT01793688|470750298|FG000|Overall Study|Protocol Violation|2|||
130761648|NCT04450407|470750301|FG000|Overall Study|Withdrawal by Subject|10|||
130761649|NCT04450407|470750302|FG001|Overall Study|Withdrawal by Subject|1|||
130761650|NCT04450407|470750303|FG002|Overall Study|Withdrawal by Subject|4|||
130761651|NCT04450407|470750301|FG000|Overall Study|Adverse Event|0|||
130761652|NCT04450407|470750302|FG001|Overall Study|Adverse Event|0|||
130761653|NCT04450407|470750303|FG002|Overall Study|Adverse Event|1|||
130761654|NCT04450407|470750301|FG000|Overall Study|Lost to Follow-up|1|||
130761655|NCT04450407|470750302|FG001|Overall Study|Lost to Follow-up|0|||
130761656|NCT04450407|470750303|FG002|Overall Study|Lost to Follow-up|0|||
130761657|NCT04450407|470750301|FG000|Overall Study|Physician Decision|0|||
130761658|NCT04450407|470750302|FG001|Overall Study|Physician Decision|0|||
130761659|NCT04450407|470750303|FG002|Overall Study|Physician Decision|1|||
130761660|NCT04450407|470750301|FG000|Overall Study|Pregnancy|1|||
130761661|NCT04450407|470750302|FG001|Overall Study|Pregnancy|0|||
130761662|NCT04450407|470750303|FG002|Overall Study|Pregnancy|0|||
130761663|NCT04450407|470750301|FG000|Overall Study|Protocol Violation|2|||
130761664|NCT04450407|470750302|FG001|Overall Study|Protocol Violation|0|||
130761665|NCT04450407|470750303|FG002|Overall Study|Protocol Violation|0|||
130761666|NCT04450407|470750301|FG000|Overall Study|Investigational site terminated by sponsor|3|||
130761667|NCT04450407|470750302|FG001|Overall Study|Investigational site terminated by sponsor|0|||
130761668|NCT04450407|470750303|FG002|Overall Study|Investigational site terminated by sponsor|2|||
130761669|NCT01317797|470750307|FG000|Overall Study|Other|0|||
130761670|NCT01317797|470750308|FG001|Overall Study|Other|1|||
130761671|NCT01317797|470750309|FG002|Overall Study|Other|0|||
130761672|NCT01317797|470750307|FG000|Overall Study|Withdrawal of Patient|0|||
130761673|NCT01317797|470750308|FG001|Overall Study|Withdrawal of Patient|0|||
130761674|NCT01317797|470750309|FG002|Overall Study|Withdrawal of Patient|1|||
130790549|NCT01232283|470861195|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130790550|NCT01232283|470861196|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130790551|NCT01232283|470861197|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130790552|NCT01232283|470861198|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130790553|NCT01232283|470861199|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130790554|NCT01232283|470861200|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130790555|NCT01232283|470861201|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
130790556|NCT01232283|470861202|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130790557|NCT01232283|470861203|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130790558|NCT01232283|470861194|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130790559|NCT01232283|470861195|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130790560|NCT01232283|470861196|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130790561|NCT01232283|470861197|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130790562|NCT01232283|470861198|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130790563|NCT01232283|470861199|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
130790564|NCT01232283|470861200|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130790565|NCT01232283|470861201|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130790566|NCT01232283|470861202|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130790567|NCT01232283|470861203|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130790568|NCT01232283|470861194|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130790569|NCT01232283|470861195|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130790570|NCT01232283|470861196|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130790571|NCT01232283|470861197|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130790572|NCT01232283|470861198|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130790573|NCT01232283|470861199|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130790574|NCT01232283|470861200|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130790575|NCT01232283|470861201|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130790576|NCT01232283|470861202|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
130790577|NCT01232283|470861203|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
130790578|NCT01232283|470861194|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130790579|NCT01232283|470861195|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130790580|NCT01232283|470861196|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130790581|NCT01232283|470861197|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130790582|NCT01232283|470861198|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130790583|NCT01232283|470861199|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130790584|NCT01232283|470861200|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130790585|NCT01232283|470861201|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130790586|NCT01232283|470861202|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
130790587|NCT01232283|470861203|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
130790588|NCT01232283|470861194|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130790589|NCT01232283|470861195|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130790590|NCT01232283|470861196|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130790591|NCT01232283|470861197|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130790592|NCT01232283|470861198|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130790593|NCT01232283|470861199|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130790594|NCT01232283|470861200|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130790595|NCT01232283|470861201|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130790596|NCT01232283|470861202|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
130790597|NCT01232283|470861203|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
130790598|NCT01232283|470861194|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130790599|NCT01232283|470861195|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130790600|NCT01232283|470861196|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130790601|NCT01232283|470861197|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130790602|NCT01232283|470861198|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130790603|NCT01232283|470861199|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130790604|NCT01232283|470861200|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130790605|NCT01232283|470861201|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130790606|NCT01232283|470861202|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
130790607|NCT01232283|470861203|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
130790608|NCT01232283|470861194|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130790609|NCT01232283|470861195|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130790610|NCT01232283|470861196|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130790611|NCT01232283|470861197|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130790612|NCT01232283|470861198|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130790613|NCT01232283|470861199|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130790614|NCT01232283|470861200|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130790615|NCT01232283|470861201|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130790616|NCT01232283|470861202|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
130790617|NCT01232283|470861203|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
130790618|NCT01232283|470861194|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130790619|NCT01232283|470861195|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130790620|NCT01232283|470861196|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130790621|NCT01232283|470861197|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130790622|NCT01232283|470861198|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130790623|NCT01232283|470861199|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130790624|NCT01232283|470861200|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130790625|NCT01232283|470861201|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130790626|NCT01232283|470861202|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
130790627|NCT01232283|470861203|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130790628|NCT01232283|470861194|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130790629|NCT01232283|470861195|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130790630|NCT01232283|470861196|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130790631|NCT01232283|470861197|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130790632|NCT01232283|470861198|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130790633|NCT01232283|470861199|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130790634|NCT01232283|470861200|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130790635|NCT01232283|470861201|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130790636|NCT01232283|470861202|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
130790637|NCT01232283|470861203|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130790638|NCT01232283|470861194|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130790639|NCT01232283|470861195|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130790640|NCT01232283|470861196|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130790641|NCT01232283|470861197|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130790642|NCT01232283|470861198|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130790643|NCT01232283|470861199|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130790644|NCT01232283|470861200|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130790645|NCT01232283|470861201|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130790646|NCT01232283|470861202|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
130790647|NCT01232283|470861203|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
130790648|NCT02792504|470861206|FG000|Overall Study|Lost to Follow-up|24|||
130790649|NCT02792504|470861206|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
130790650|NCT00848497|470861213|FG000|Overall Study|Screen failure|2|||
130790651|NCT00848497|470861214|FG001|Overall Study|Screen failure|0|||
130790652|NCT00848497|470861213|FG000|Overall Study|Withdrawal by Subject|0|||
130790653|NCT00848497|470861214|FG001|Overall Study|Withdrawal by Subject|1|||
130790654|NCT02966834|470861215|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130790655|NCT02966834|470861216|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130790656|NCT02966834|470861217|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130790657|NCT02966834|470861218|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130790658|NCT02966834|470861219|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
130790659|NCT02966834|470861220|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130790660|NCT02966834|470861215|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
130790661|NCT02966834|470861216|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130790662|NCT02966834|470861217|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130790663|NCT02966834|470861218|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130790664|NCT02966834|470861219|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130790665|NCT02966834|470861220|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130790666|NCT02966834|470861215|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
130790667|NCT02966834|470861216|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
130790668|NCT02966834|470861217|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
130790669|NCT02966834|470861218|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
130790670|NCT02966834|470861219|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
130790671|NCT02966834|470861220|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
130790672|NCT02966834|470861215|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
130790673|NCT02966834|470861216|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
130790674|NCT02966834|470861217|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
130790675|NCT02966834|470861218|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
130790676|NCT02966834|470861219|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
130790677|NCT02966834|470861220|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
130790678|NCT02966834|470861215|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130790679|NCT02966834|470861216|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130790680|NCT02966834|470861217|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130790681|NCT02966834|470861218|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
130790682|NCT02966834|470861219|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130790683|NCT02966834|470861220|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130790684|NCT02966834|470861215|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130790685|NCT02966834|470861216|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130790686|NCT02966834|470861217|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130790687|NCT02966834|470861218|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
130790688|NCT02966834|470861219|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130790689|NCT02966834|470861220|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130790690|NCT02711137|470862722|FG000|Overall Study|Death|1|||
130790691|NCT02711137|470862723|FG001|Overall Study|Death|4|||
130790692|NCT02711137|470862724|FG002|Overall Study|Death|5|||
130790693|NCT02711137|470862725|FG003|Overall Study|Death|5|||
130790694|NCT02711137|470862726|FG004|Overall Study|Death|3|||
130790695|NCT02711137|470862727|FG005|Overall Study|Death|1|||
130790696|NCT02711137|470862728|FG006|Overall Study|Death|61|||
130790697|NCT02711137|470862729|FG007|Overall Study|Death|3|||
130790698|NCT02711137|470862730|FG008|Overall Study|Death|0|||
130790699|NCT02711137|470862731|FG009|Overall Study|Death|1|||
130790700|NCT02711137|470862732|FG010|Overall Study|Death|1|||
130790701|NCT02711137|470862733|FG011|Overall Study|Death|1|||
130790702|NCT02711137|470862734|FG012|Overall Study|Death|0|||
130790703|NCT02711137|470862735|FG013|Overall Study|Death|0|||
130790704|NCT02711137|470862736|FG014|Overall Study|Death|0|||
130790705|NCT02711137|470862722|FG000|Overall Study|Study Terminated by Sponsor|0|||
130790706|NCT02711137|470862723|FG001|Overall Study|Study Terminated by Sponsor|0|||
130790707|NCT02711137|470862724|FG002|Overall Study|Study Terminated by Sponsor|1|||
130790708|NCT02711137|470862725|FG003|Overall Study|Study Terminated by Sponsor|0|||
130790709|NCT02711137|470862726|FG004|Overall Study|Study Terminated by Sponsor|0|||
130790710|NCT02711137|470862727|FG005|Overall Study|Study Terminated by Sponsor|0|||
130790711|NCT02711137|470862728|FG006|Overall Study|Study Terminated by Sponsor|1|||
130790712|NCT02711137|470862729|FG007|Overall Study|Study Terminated by Sponsor|0|||
130790713|NCT02711137|470862730|FG008|Overall Study|Study Terminated by Sponsor|0|||
130790714|NCT02711137|470862731|FG009|Overall Study|Study Terminated by Sponsor|0|||
130790715|NCT02711137|470862732|FG010|Overall Study|Study Terminated by Sponsor|0|||
130790716|NCT02711137|470862733|FG011|Overall Study|Study Terminated by Sponsor|0|||
130790717|NCT02711137|470862734|FG012|Overall Study|Study Terminated by Sponsor|0|||
130790718|NCT02711137|470862735|FG013|Overall Study|Study Terminated by Sponsor|0|||
130790719|NCT02711137|470862736|FG014|Overall Study|Study Terminated by Sponsor|0|||
130790720|NCT02711137|470862722|FG000|Overall Study|Physician Decision|1|||
130790721|NCT02711137|470862723|FG001|Overall Study|Physician Decision|0|||
130790722|NCT02711137|470862724|FG002|Overall Study|Physician Decision|2|||
130790723|NCT02711137|470862725|FG003|Overall Study|Physician Decision|1|||
130790724|NCT02711137|470862726|FG004|Overall Study|Physician Decision|1|||
130790725|NCT02711137|470862727|FG005|Overall Study|Physician Decision|0|||
130790726|NCT02711137|470862728|FG006|Overall Study|Physician Decision|12|||
130790727|NCT02711137|470862729|FG007|Overall Study|Physician Decision|2|||
130790728|NCT02711137|470862730|FG008|Overall Study|Physician Decision|1|||
130790729|NCT02711137|470862731|FG009|Overall Study|Physician Decision|1|||
130790730|NCT02711137|470862732|FG010|Overall Study|Physician Decision|3|||
130790731|NCT02711137|470862733|FG011|Overall Study|Physician Decision|2|||
130790732|NCT02711137|470862734|FG012|Overall Study|Physician Decision|1|||
130790733|NCT02711137|470862735|FG013|Overall Study|Physician Decision|1|||
130790734|NCT02711137|470862736|FG014|Overall Study|Physician Decision|2|||
130790735|NCT02711137|470862722|FG000|Overall Study|Other|0|||
130790736|NCT02711137|470862723|FG001|Overall Study|Other|1|||
130790737|NCT02711137|470862724|FG002|Overall Study|Other|0|||
130790738|NCT02711137|470862725|FG003|Overall Study|Other|0|||
130790739|NCT02711137|470862726|FG004|Overall Study|Other|0|||
130790740|NCT02711137|470862727|FG005|Overall Study|Other|0|||
130790741|NCT02711137|470862728|FG006|Overall Study|Other|3|||
130790742|NCT02711137|470862729|FG007|Overall Study|Other|0|||
130790743|NCT02711137|470862730|FG008|Overall Study|Other|0|||
130790744|NCT02711137|470862731|FG009|Overall Study|Other|0|||
130790745|NCT02711137|470862732|FG010|Overall Study|Other|0|||
130790746|NCT02711137|470862733|FG011|Overall Study|Other|0|||
130790747|NCT02711137|470862734|FG012|Overall Study|Other|0|||
130790748|NCT02711137|470862735|FG013|Overall Study|Other|0|||
130790749|NCT02711137|470862736|FG014|Overall Study|Other|1|||
130790750|NCT02711137|470862722|FG000|Overall Study|Withdrawal by Subject|1|||
130790751|NCT02711137|470862723|FG001|Overall Study|Withdrawal by Subject|0|||
130790752|NCT02711137|470862724|FG002|Overall Study|Withdrawal by Subject|0|||
130790753|NCT02711137|470862725|FG003|Overall Study|Withdrawal by Subject|1|||
130790754|NCT02711137|470862726|FG004|Overall Study|Withdrawal by Subject|1|||
130790755|NCT02711137|470862727|FG005|Overall Study|Withdrawal by Subject|0|||
130790756|NCT02711137|470862728|FG006|Overall Study|Withdrawal by Subject|7|||
130790757|NCT02711137|470862729|FG007|Overall Study|Withdrawal by Subject|0|||
130790758|NCT02711137|470862730|FG008|Overall Study|Withdrawal by Subject|0|||
130790759|NCT02711137|470862731|FG009|Overall Study|Withdrawal by Subject|0|||
130790760|NCT02711137|470862732|FG010|Overall Study|Withdrawal by Subject|0|||
130790761|NCT02711137|470862733|FG011|Overall Study|Withdrawal by Subject|0|||
130790762|NCT02711137|470862734|FG012|Overall Study|Withdrawal by Subject|0|||
130790763|NCT02711137|470862735|FG013|Overall Study|Withdrawal by Subject|1|||
130790764|NCT02711137|470862736|FG014|Overall Study|Withdrawal by Subject|0|||
130790765|NCT02711137|470862722|FG000|Overall Study|Lost to Follow-up|1|||
130790766|NCT02711137|470862723|FG001|Overall Study|Lost to Follow-up|0|||
130790767|NCT02711137|470862724|FG002|Overall Study|Lost to Follow-up|0|||
130790768|NCT02711137|470862725|FG003|Overall Study|Lost to Follow-up|0|||
130790769|NCT02711137|470862726|FG004|Overall Study|Lost to Follow-up|0|||
130790770|NCT02711137|470862727|FG005|Overall Study|Lost to Follow-up|0|||
130790771|NCT02711137|470862728|FG006|Overall Study|Lost to Follow-up|2|||
130790772|NCT02711137|470862729|FG007|Overall Study|Lost to Follow-up|0|||
130790773|NCT02711137|470862730|FG008|Overall Study|Lost to Follow-up|0|||
130790774|NCT02711137|470862731|FG009|Overall Study|Lost to Follow-up|0|||
130790775|NCT02711137|470862732|FG010|Overall Study|Lost to Follow-up|0|||
130790776|NCT02711137|470862733|FG011|Overall Study|Lost to Follow-up|0|||
130790777|NCT02711137|470862734|FG012|Overall Study|Lost to Follow-up|0|||
130790778|NCT02711137|470862735|FG013|Overall Study|Lost to Follow-up|0|||
130790779|NCT02711137|470862736|FG014|Overall Study|Lost to Follow-up|0|||
130790780|NCT03944616|470862741|FG000|Overall Study|Lost to Follow-up|0|||
130790781|NCT03944616|470862742|FG001|Overall Study|Lost to Follow-up|2|||
130790782|NCT01721798|470862743|FG000|Overall Study|Death|0|||
130790783|NCT01721798|470862744|FG001|Overall Study|Death|0|||
130790784|NCT01721798|470862745|FG002|Overall Study|Death|1|||
130790785|NCT01721798|470862746|FG003|Overall Study|Death|1|||
130790786|NCT01721798|470862743|FG000|Overall Study|Lost to Follow-up|2|||
130790787|NCT01721798|470862744|FG001|Overall Study|Lost to Follow-up|2|||
130790788|NCT01721798|470862745|FG002|Overall Study|Lost to Follow-up|9|||
130790789|NCT01721798|470862746|FG003|Overall Study|Lost to Follow-up|9|||
130790790|NCT01721798|470862743|FG000|Overall Study|Pregnancy|0|||
130790791|NCT01721798|470862744|FG001|Overall Study|Pregnancy|0|||
130790792|NCT01721798|470862745|FG002|Overall Study|Pregnancy|1|||
130790793|NCT01721798|470862746|FG003|Overall Study|Pregnancy|1|||
130790794|NCT01721798|470862743|FG000|Overall Study|Withdrawal by Subject|1|||
130790795|NCT01721798|470862744|FG001|Overall Study|Withdrawal by Subject|0|||
130790796|NCT01721798|470862745|FG002|Overall Study|Withdrawal by Subject|2|||
130790797|NCT01721798|470862746|FG003|Overall Study|Withdrawal by Subject|1|||
130790798|NCT01721798|470862743|FG000|Overall Study|Not eligible for 24 month visit|1|||
130790799|NCT01721798|470862744|FG001|Overall Study|Not eligible for 24 month visit|0|||
130790800|NCT01721798|470862745|FG002|Overall Study|Not eligible for 24 month visit|8|||
130790801|NCT01721798|470862746|FG003|Overall Study|Not eligible for 24 month visit|7|||
130790802|NCT00961064|470862747|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
130790803|NCT00961064|470862747|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
130790804|NCT00961064|470862747|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
130790805|NCT00961064|470862747|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
130790806|NCT00961064|470862747|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
130790807|NCT00961064|470862747|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
130790808|NCT00961064|470862747|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
130790809|NCT00961064|470862747|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
130790810|NCT01294046|470862748|FG000|Overall Study|Infection and surgical explant|1|||
130790811|NCT01294046|470862748|FG000|Overall Study|Eligibility criteria expanded|1|||
130790812|NCT01294046|470862748|FG000|Overall Study|Stimulation response inadqequate|1|||
130790813|NCT00761319|470862749|FG000|Overall Study|Protocol Violation|21|||
130790814|NCT00761319|470862750|FG001|Overall Study|Protocol Violation|14|||
130790815|NCT00761319|470862749|FG000|Overall Study|Adverse Event|11|||
130790816|NCT00761319|470862750|FG001|Overall Study|Adverse Event|7|||
130790817|NCT00761319|470862749|FG000|Overall Study|Withdrawal by Subject|8|||
130790818|NCT00761319|470862750|FG001|Overall Study|Withdrawal by Subject|7|||
130790819|NCT00761319|470862749|FG000|Overall Study|Noncompliance|4|||
130790820|NCT00761319|470862750|FG001|Overall Study|Noncompliance|3|||
130790821|NCT00761319|470862749|FG000|Overall Study|Lost to Follow-up|1|||
130790822|NCT00761319|470862750|FG001|Overall Study|Lost to Follow-up|1|||
130790823|NCT00761319|470862749|FG000|Overall Study|Nonspecified|2|||
130790824|NCT00761319|470862750|FG001|Overall Study|Nonspecified|2|||
130790825|NCT00761319|470862749|FG000|Overall Study|Missing|1|||
130790826|NCT00761319|470862750|FG001|Overall Study|Missing|0|||
130790827|NCT03261401|470862751|FG000|Overall Study|Withdrawal by Subject|0|||
130790828|NCT03261401|470862752|FG001|Overall Study|Withdrawal by Subject|0|||
130790829|NCT03261401|470862753|FG002|Overall Study|Withdrawal by Subject|0|||
130790830|NCT03261401|470862754|FG003|Overall Study|Withdrawal by Subject|0|||
130790831|NCT03261401|470862755|FG004|Overall Study|Withdrawal by Subject|0|||
130790832|NCT03261401|470862756|FG005|Overall Study|Withdrawal by Subject|1|||
130790833|NCT03261401|470862757|FG006|Overall Study|Withdrawal by Subject|0|||
130790834|NCT03261401|470862758|FG007|Overall Study|Withdrawal by Subject|0|||
130790835|NCT03261401|470862759|FG008|Overall Study|Withdrawal by Subject|0|||
130790836|NCT03261401|470862760|FG009|Overall Study|Withdrawal by Subject|0|||
130790837|NCT03261401|470862761|FG010|Overall Study|Withdrawal by Subject|0|||
130790838|NCT03261401|470862762|FG011|Overall Study|Withdrawal by Subject|0|||
130790839|NCT03261401|470862763|FG012|Overall Study|Withdrawal by Subject|0|||
130790840|NCT03261401|470862751|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
130790841|NCT03261401|470862752|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
130790842|NCT03261401|470862753|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
130790843|NCT03261401|470862754|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
130790844|NCT03261401|470862755|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
130790845|NCT03261401|470862756|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
130790846|NCT03261401|470862757|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
130790847|NCT03261401|470862758|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
130790848|NCT03261401|470862759|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
130790849|NCT03261401|470862760|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
130790850|NCT03261401|470862761|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
130790851|NCT03261401|470862762|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
130790852|NCT03261401|470862763|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
130790853|NCT01715298|470862764|FG000|Overall Study|Lost to Follow-up|0|||
130790854|NCT01715298|470862765|FG001|Overall Study|Lost to Follow-up|2|||
130790855|NCT01715298|470862764|FG000|Overall Study|Patient/guardian decision|7|||
130790856|NCT01715298|470862765|FG001|Overall Study|Patient/guardian decision|9|||
130790857|NCT01499511|470862770|FG000|Overall Study|Death|1|||
130790858|NCT01499511|470862771|FG001|Overall Study|Death|0|||
130790859|NCT00726453|470862773|FG000|Primary Enrollment Group|Death|18|||
130790860|NCT00726453|470862774|FG001|Primary Enrollment Group|Death|0|||
130790861|NCT00726453|470862773|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
130790862|NCT00726453|470862774|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
130790863|NCT00726453|470862773|FG000|38 mm Length Group|Death|0|||
130790864|NCT00726453|470862774|FG001|38 mm Length Group|Death|3|||
130790865|NCT00915525|470862776|FG000|Overall Study|Protocol Violation|9|||
130790866|NCT00915525|470862777|FG001|Overall Study|Protocol Violation|4|||
130790867|NCT00915525|470862776|FG000|Overall Study|Withdrawal by Subject|59|||
130790868|NCT00915525|470862777|FG001|Overall Study|Withdrawal by Subject|21|||
130790869|NCT00915525|470862776|FG000|Overall Study|Lost to Follow-up|27|||
130790870|NCT00915525|470862777|FG001|Overall Study|Lost to Follow-up|16|||
130790871|NCT00915525|470862776|FG000|Overall Study|Pregnancy|2|||
130790872|NCT00915525|470862777|FG001|Overall Study|Pregnancy|0|||
130790873|NCT00915525|470862776|FG000|Overall Study|Lack of Efficacy|15|||
130790874|NCT00915525|470862777|FG001|Overall Study|Lack of Efficacy|32|||
130790875|NCT00915525|470862776|FG000|Overall Study|Adverse Event|29|||
130790876|NCT00915525|470862777|FG001|Overall Study|Adverse Event|13|||
130790877|NCT00915525|470862776|FG000|Overall Study|Missing|12|||
130790878|NCT00915525|470862777|FG001|Overall Study|Missing|1|||
130790879|NCT00915525|470862776|FG000|Overall Study|Other Reason|35|||
130790880|NCT00915525|470862777|FG001|Overall Study|Other Reason|12|||
130790881|NCT00915525|470862776|FG000|Overall Study|Site Closed|27|||
130790882|NCT00915525|470862777|FG001|Overall Study|Site Closed|9|||
130790883|NCT00915525|470862776|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
130790884|NCT00915525|470862777|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
130790885|NCT00915525|470862776|FG000|Overall Study|Study Burden|28|||
130790886|NCT00915525|470862777|FG001|Overall Study|Study Burden|12|||
130790887|NCT00915525|470862776|FG000|Overall Study|Non-Compliance|3|||
130790888|NCT00915525|470862777|FG001|Overall Study|Non-Compliance|1|||
130790889|NCT00915525|470862776|FG000|Overall Study|Patient Moved|15|||
130790890|NCT00915525|470862777|FG001|Overall Study|Patient Moved|9|||
130790891|NCT00941928|470862778|FG000|Overall Study|Withdrawal by Subject|1|||
130790892|NCT00941928|470862778|FG000|Overall Study|Disease Progression|1|||
130790893|NCT02765035|470862786|FG000|First Intervention (90 Days)|Adverse Event|1|||
130790894|NCT02765035|470862787|FG001|First Intervention (90 Days)|Adverse Event|1|||
130790895|NCT02765035|470862786|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
130790896|NCT02765035|470862787|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
130790897|NCT01712178|470862788|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
130790898|NCT01712178|470862789|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
130790899|NCT01712178|470862788|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
130790900|NCT01712178|470862789|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
130790901|NCT01712178|470862788|FG000|Overall Study|Lost to Follow-up|0|||
130790902|NCT01712178|470862789|FG001|Overall Study|Lost to Follow-up|1|||
130790903|NCT00091819|470862790|FG000|Overall Study|Adverse Event|1|||
130790904|NCT00091819|470862791|FG001|Overall Study|Adverse Event|1|||
130790905|NCT00091819|470862790|FG000|Overall Study|Death|4|||
130790906|NCT00091819|470862791|FG001|Overall Study|Death|5|||
130790907|NCT00091819|470862790|FG000|Overall Study|Lost to Follow-up|26|||
130790908|NCT00091819|470862791|FG001|Overall Study|Lost to Follow-up|23|||
130790909|NCT00091819|470862790|FG000|Overall Study|Withdrawal by Subject|5|||
130790910|NCT00091819|470862791|FG001|Overall Study|Withdrawal by Subject|8|||
130790911|NCT00091819|470862790|FG000|Overall Study|Protocol Violation|1|||
130790912|NCT00091819|470862791|FG001|Overall Study|Protocol Violation|2|||
130790913|NCT00091819|470862790|FG000|Overall Study|Other|2|||
130790914|NCT00091819|470862791|FG001|Overall Study|Other|3|||
130790915|NCT00091819|470862790|FG000|Overall Study|Never received study treatment|3|||
130790916|NCT00091819|470862791|FG001|Overall Study|Never received study treatment|4|||
130790917|NCT00984867|470862792|FG000|Overall Study|Adverse Event|3|||
130790918|NCT00984867|470862793|FG001|Overall Study|Adverse Event|7|||
130790919|NCT00984867|470862792|FG000|Overall Study|Death|1|||
130790920|NCT00984867|470862793|FG001|Overall Study|Death|0|||
130790921|NCT00984867|470862792|FG000|Overall Study|Withdrawal by Subject|13|||
130790922|NCT00984867|470862793|FG001|Overall Study|Withdrawal by Subject|4|||
130790923|NCT00984867|470862792|FG000|Overall Study|Lost to Follow-up|3|||
130790924|NCT00984867|470862793|FG001|Overall Study|Lost to Follow-up|4|||
130790925|NCT00984867|470862792|FG000|Overall Study|Poor/non-compliance|0|||
130790926|NCT00984867|470862793|FG001|Overall Study|Poor/non-compliance|1|||
130790927|NCT00984867|470862792|FG000|Overall Study|Subject no longer meets study criteria|1|||
130790928|NCT00984867|470862793|FG001|Overall Study|Subject no longer meets study criteria|1|||
130790929|NCT00984867|470862792|FG000|Overall Study|site closing|1|||
130790930|NCT00984867|470862793|FG001|Overall Study|site closing|0|||
130790931|NCT00984867|470862792|FG000|Overall Study|lack of efficacy and subject compliance|1|||
130790932|NCT00984867|470862793|FG001|Overall Study|lack of efficacy and subject compliance|0|||
130790933|NCT00634504|470862798|FG000|Overall Study|Protocol Violation|1|||
130790934|NCT00634504|470862799|FG001|Overall Study|Protocol Violation|0|||
130790935|NCT05001620|470862802|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
130790936|NCT05001620|470862803|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
130790937|NCT00481676|470862804|FG000|Overall Study|Adverse Event|0|||
130790938|NCT00481676|470862805|FG001|Overall Study|Adverse Event|1|||
130790939|NCT00481676|470862804|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130790940|NCT00481676|470862805|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130790941|NCT00481676|470862804|FG000|Overall Study|Administrative problem|1|||
130790942|NCT00481676|470862805|FG001|Overall Study|Administrative problem|0|||
130790943|NCT03937778|470862806|FG000|Overall Study|Withdrawal by Subject|1|||
130790944|NCT03937778|470862806|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
130790945|NCT00819039|470862807|FG000|Overall Study|Physician Decision|1|||
130790946|NCT00819039|470862808|FG001|Overall Study|Physician Decision|0|||
130790947|NCT00819039|470862809|FG002|Overall Study|Physician Decision|1|||
130790948|NCT00819039|470862807|FG000|Overall Study|Protocol Violation|1|||
130790949|NCT00819039|470862808|FG001|Overall Study|Protocol Violation|0|||
130790950|NCT00819039|470862809|FG002|Overall Study|Protocol Violation|0|||
130790951|NCT01513590|470862810|FG000|Overall Study|Adverse Event|2|||
130790952|NCT01513590|470862811|FG001|Overall Study|Adverse Event|3|||
130790953|NCT01513590|470862810|FG000|Overall Study|Withdrawal Criteria|3|||
130790954|NCT01513590|470862811|FG001|Overall Study|Withdrawal Criteria|0|||
130790955|NCT01513590|470862810|FG000|Overall Study|Unclassified|5|||
130790956|NCT01513590|470862811|FG001|Overall Study|Unclassified|10|||
130790957|NCT01240694|470862812|FG000|Overall Study|Adverse Event|9|||
130790958|NCT01240694|470862812|FG000|Overall Study|Lack of Efficacy|6|||
130790959|NCT01240694|470862812|FG000|Overall Study|Withdrawal by Subject|6|||
130790960|NCT01240694|470862812|FG000|Overall Study|Protocol Violation|2|||
130790961|NCT01240694|470862812|FG000|Overall Study|Lost to Follow-up|2|||
130790962|NCT01240694|470862812|FG000|Overall Study|Other than specified|3|||
130790963|NCT01240694|470862812|FG000|Overall Study|Withdrawn due to early study termination|107|||
130790964|NCT01056276|470862813|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
130790965|NCT01056276|470862814|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
130790966|NCT01056276|470862813|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
130790967|NCT01056276|470862814|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
130790968|NCT01056276|470862813|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
130790969|NCT01056276|470862814|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
130790970|NCT01056276|470862813|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
130790971|NCT01056276|470862814|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
130790972|NCT01056276|470862813|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
130790973|NCT01056276|470862814|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
130790974|NCT01056276|470862813|FG000|Treatment Period-Cycles 1-8|Death|3|||
130790975|NCT01056276|470862814|FG001|Treatment Period-Cycles 1-8|Death|1|||
130790976|NCT01056276|470862813|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
130790977|NCT01056276|470862814|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
130790978|NCT01056276|470862813|FG000|Maintenance Therapy|Toxicity|0|||
130790979|NCT01056276|470862814|FG001|Maintenance Therapy|Toxicity|2|||
130790980|NCT01056276|470862813|FG000|Maintenance Therapy|Progressive Disease|0|||
130790981|NCT01056276|470862814|FG001|Maintenance Therapy|Progressive Disease|9|||
130790982|NCT01056276|470862813|FG000|Maintenance Therapy|Physician Decision|0|||
130790983|NCT01056276|470862814|FG001|Maintenance Therapy|Physician Decision|1|||
130790984|NCT01056276|470862813|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
130790985|NCT01056276|470862814|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
130790986|NCT01056276|470862813|FG000|Maintenance Therapy|Intercurrent Illness|0|||
130790987|NCT01056276|470862814|FG001|Maintenance Therapy|Intercurrent Illness|1|||
130790988|NCT01056276|470862813|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
130790989|NCT01056276|470862814|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
130790990|NCT01881425|470862815|FG000|Overall Study|Death|5|||
130790991|NCT01881425|470862816|FG001|Overall Study|Death|1|||
130790992|NCT01881425|470862815|FG000|Overall Study|Withdrawal by Subject|8|||
130790993|NCT01881425|470862816|FG001|Overall Study|Withdrawal by Subject|3|||
130790994|NCT01881425|470862815|FG000|Overall Study|Physician Decision|2|||
130790995|NCT01881425|470862816|FG001|Overall Study|Physician Decision|1|||
130790996|NCT01881425|470862815|FG000|Overall Study|Adverse Event|3|||
130790997|NCT01881425|470862816|FG001|Overall Study|Adverse Event|0|||
130790998|NCT01881425|470862815|FG000|Overall Study|General Anesthesia panic attack|0|||
130790999|NCT01881425|470862816|FG001|Overall Study|General Anesthesia panic attack|1|||
130791000|NCT01881425|470862815|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
130791001|NCT01881425|470862816|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
130791002|NCT01881425|470862815|FG000|Overall Study|Lost to Follow-up|7|||
130791003|NCT01881425|470862816|FG001|Overall Study|Lost to Follow-up|2|||
130791004|NCT01200355|470862817|FG000|Overall Study|Death|7|||
130791005|NCT01200355|470862818|FG001|Overall Study|Death|2|||
130791006|NCT04424901|470862819|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
130791007|NCT04424901|470862820|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
130791008|NCT01206764|470862821|FG000|Overall Study|Adverse Event|20|||
130791009|NCT01206764|470862821|FG000|Overall Study|Abnormal laboratory value|2|||
130791010|NCT01206764|470862821|FG000|Overall Study|Abnormal test procedure result|1|||
130791011|NCT01206764|470862821|FG000|Overall Study|Patient withdrew consent|5|||
130791012|NCT01206764|470862821|FG000|Overall Study|Lost to Follow-up|6|||
130791013|NCT01206764|470862821|FG000|Overall Study|Death|11|||
130791014|NCT01206764|470862821|FG000|Overall Study|New cancer therapy|2|||
130791015|NCT01206764|470862821|FG000|Overall Study|Disease progression|88|||
130791016|NCT01206764|470862821|FG000|Overall Study|Protocol deviation|3|||
130791017|NCT00410163|470862823|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
130791018|NCT00410163|470862824|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
130791019|NCT00410163|470862823|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
130791020|NCT00410163|470862824|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
130791021|NCT00410163|470862823|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
130791022|NCT00410163|470862824|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
130791023|NCT00410163|470862823|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
130791024|NCT00410163|470862824|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
130761675|NCT00962091|470750312|FG000|Overall Study|Withdrawal by Subject|1|||
130761676|NCT00962091|470750313|FG001|Overall Study|Withdrawal by Subject|2|||
130761677|NCT00962091|470750314|FG002|Overall Study|Withdrawal by Subject|1|||
130761678|NCT00962091|470750315|FG003|Overall Study|Withdrawal by Subject|1|||
130761679|NCT00962091|470750316|FG004|Overall Study|Withdrawal by Subject|0|||
130761680|NCT00962091|470750317|FG005|Overall Study|Withdrawal by Subject|1|||
130761681|NCT00962091|470750318|FG006|Overall Study|Withdrawal by Subject|0|||
130761682|NCT00962091|470750312|FG000|Overall Study|Adverse Event|0|||
130761683|NCT00962091|470750313|FG001|Overall Study|Adverse Event|0|||
130761684|NCT00962091|470750314|FG002|Overall Study|Adverse Event|0|||
130761685|NCT00962091|470750315|FG003|Overall Study|Adverse Event|0|||
130761686|NCT00962091|470750316|FG004|Overall Study|Adverse Event|0|||
130761687|NCT00962091|470750317|FG005|Overall Study|Adverse Event|0|||
130761688|NCT00962091|470750318|FG006|Overall Study|Adverse Event|1|||
130761689|NCT02326298|470750319|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761690|NCT02326298|470750320|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761691|NCT02326298|470750321|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
130761692|NCT02326298|470750322|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761693|NCT02326298|470750323|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761694|NCT02326298|470750324|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761695|NCT02326298|470750325|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761696|NCT02326298|470750326|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761697|NCT02326298|470750327|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761698|NCT02326298|470750328|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761699|NCT02326298|470750329|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761700|NCT02326298|470750330|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761701|NCT02326298|470750331|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761702|NCT02326298|470750332|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130761703|NCT02326298|470750319|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
130761704|NCT02326298|470750320|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761705|NCT02326298|470750321|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761706|NCT02326298|470750322|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761707|NCT02326298|470750323|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761708|NCT02326298|470750324|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761709|NCT02326298|470750325|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761710|NCT02326298|470750326|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761711|NCT02326298|470750327|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761712|NCT02326298|470750328|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761713|NCT02326298|470750329|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761714|NCT02326298|470750330|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761715|NCT02326298|470750331|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761716|NCT02326298|470750332|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130761717|NCT02326298|470750319|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
130761718|NCT02326298|470750320|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
130761719|NCT02326298|470750321|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761720|NCT02326298|470750322|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761721|NCT02326298|470750323|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761722|NCT02326298|470750324|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761723|NCT02326298|470750325|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761724|NCT02326298|470750326|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761725|NCT02326298|470750327|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761726|NCT02326298|470750328|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761727|NCT02326298|470750329|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761728|NCT02326298|470750330|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761729|NCT02326298|470750331|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761730|NCT02326298|470750332|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130761731|NCT02326298|470750319|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
130761732|NCT02326298|470750320|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
130761733|NCT02326298|470750321|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761734|NCT02326298|470750322|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761735|NCT02326298|470750323|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761736|NCT02326298|470750324|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761737|NCT02326298|470750325|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761738|NCT02326298|470750326|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761739|NCT02326298|470750327|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761740|NCT02326298|470750328|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761741|NCT02326298|470750329|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761742|NCT02326298|470750330|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130791025|NCT00410163|470862823|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
130791026|NCT00410163|470862824|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
130791027|NCT00410163|470862823|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
130791028|NCT00410163|470862824|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
130791029|NCT00410163|470862823|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
130791030|NCT00410163|470862824|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
130791031|NCT00410163|470862823|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
130791032|NCT00410163|470862824|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
130791033|NCT00410163|470862823|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
130791034|NCT00410163|470862824|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
130791035|NCT00410163|470862823|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
130791036|NCT00410163|470862824|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
130791037|NCT00410163|470862823|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
130791038|NCT00410163|470862824|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
130791039|NCT00410163|470862823|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
130791040|NCT00410163|470862824|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
130791041|NCT00410163|470862823|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
130791042|NCT00410163|470862824|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
130791043|NCT00410163|470862823|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
130791044|NCT00410163|470862824|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
130791045|NCT00797563|470862826|FG000|Overall Study|Adverse Event|1|||
130791046|NCT00688597|470862827|FG000|Overall Study|Adverse Event|2|||
130791047|NCT00688597|470862828|FG001|Overall Study|Adverse Event|0|||
130791048|NCT00688597|470862829|FG002|Overall Study|Adverse Event|0|||
130791049|NCT00688597|470862827|FG000|Overall Study|Physician Decision|1|||
130791050|NCT00688597|470862828|FG001|Overall Study|Physician Decision|0|||
130791051|NCT00688597|470862829|FG002|Overall Study|Physician Decision|0|||
130791052|NCT05853120|470862830|FG000|Overall Study|Lost to Follow-up|4|||
130791053|NCT05853120|470862831|FG001|Overall Study|Lost to Follow-up|4|||
130791054|NCT05853120|470862830|FG000|Overall Study|Physician Decision|3|||
130791055|NCT05853120|470862831|FG001|Overall Study|Physician Decision|0|||
130791056|NCT05853120|470862830|FG000|Overall Study|Withdrawal by Subject|5|||
130791057|NCT05853120|470862831|FG001|Overall Study|Withdrawal by Subject|2|||
130791058|NCT02855268|470862832|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
130791059|NCT02855268|470862833|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
130791060|NCT02855268|470862832|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
130791061|NCT02855268|470862833|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
130791062|NCT02855268|470862832|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
130791063|NCT02855268|470862833|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
130791064|NCT02855268|470862832|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
130791065|NCT02855268|470862833|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
130791066|NCT02855268|470862832|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
130791067|NCT02855268|470862833|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
130791068|NCT02855268|470862832|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
130791069|NCT02855268|470862833|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
130791070|NCT00465517|470862834|FG000|Overall Study|Adverse Event|7|||
130791071|NCT00465517|470862835|FG001|Overall Study|Adverse Event|3|||
130791072|NCT00465517|470862834|FG000|Overall Study|Lost to Follow-up|1|||
130791073|NCT00465517|470862835|FG001|Overall Study|Lost to Follow-up|0|||
130791074|NCT00465517|470862834|FG000|Overall Study|Withdrawal by Subject|4|||
130791075|NCT00465517|470862835|FG001|Overall Study|Withdrawal by Subject|1|||
130791076|NCT00834041|470862843|FG000|Overall Study|Withdrawal by Subject|1|||
130791077|NCT00834041|470862844|FG001|Overall Study|Withdrawal by Subject|0|||
130791078|NCT00834041|470862843|FG000|Overall Study|Lost to Follow-up|0|||
130791079|NCT00834041|470862844|FG001|Overall Study|Lost to Follow-up|1|||
130791080|NCT01799889|470864120|FG000|Overall Study|Adverse Event|4|||
130791081|NCT01799889|470864121|FG001|Overall Study|Adverse Event|4|||
130791082|NCT01799889|470864122|FG002|Overall Study|Adverse Event|5|||
130791083|NCT01799889|470864123|FG003|Overall Study|Adverse Event|1|||
130791084|NCT01799889|470864124|FG004|Overall Study|Adverse Event|11|||
130791085|NCT01799889|470864125|FG005|Overall Study|Adverse Event|1|||
130791086|NCT01799889|470864126|FG006|Overall Study|Adverse Event|5|||
130791087|NCT01799889|470864127|FG007|Overall Study|Adverse Event|2|||
130791088|NCT01799889|470864128|FG008|Overall Study|Adverse Event|3|||
130791089|NCT01799889|470864129|FG009|Overall Study|Adverse Event|1|||
130791090|NCT01799889|470864130|FG010|Overall Study|Adverse Event|1|||
130791091|NCT01799889|470864131|FG011|Overall Study|Adverse Event|0|||
130791092|NCT01799889|470864120|FG000|Overall Study|Death|1|||
130791093|NCT01799889|470864121|FG001|Overall Study|Death|0|||
130791094|NCT01799889|470864122|FG002|Overall Study|Death|5|||
130791095|NCT01799889|470864123|FG003|Overall Study|Death|3|||
130791096|NCT01799889|470864124|FG004|Overall Study|Death|1|||
130791097|NCT01799889|470864125|FG005|Overall Study|Death|0|||
130791098|NCT01799889|470864126|FG006|Overall Study|Death|0|||
130791099|NCT01799889|470864127|FG007|Overall Study|Death|0|||
130791100|NCT01799889|470864128|FG008|Overall Study|Death|1|||
130791101|NCT01799889|470864129|FG009|Overall Study|Death|0|||
130791102|NCT01799889|470864130|FG010|Overall Study|Death|1|||
130791103|NCT01799889|470864131|FG011|Overall Study|Death|0|||
130791104|NCT01799889|470864120|FG000|Overall Study|Lack of Efficacy|1|||
130791105|NCT01799889|470864121|FG001|Overall Study|Lack of Efficacy|1|||
130791106|NCT01799889|470864122|FG002|Overall Study|Lack of Efficacy|0|||
130791107|NCT01799889|470864123|FG003|Overall Study|Lack of Efficacy|1|||
130791108|NCT01799889|470864124|FG004|Overall Study|Lack of Efficacy|2|||
130791109|NCT01799889|470864125|FG005|Overall Study|Lack of Efficacy|2|||
130791110|NCT01799889|470864126|FG006|Overall Study|Lack of Efficacy|0|||
130791111|NCT01799889|470864127|FG007|Overall Study|Lack of Efficacy|0|||
130791112|NCT01799889|470864128|FG008|Overall Study|Lack of Efficacy|2|||
130791113|NCT01799889|470864129|FG009|Overall Study|Lack of Efficacy|0|||
130791114|NCT01799889|470864130|FG010|Overall Study|Lack of Efficacy|1|||
130791115|NCT01799889|470864131|FG011|Overall Study|Lack of Efficacy|0|||
130791116|NCT01799889|470864120|FG000|Overall Study|Lost to Follow-up|0|||
130791117|NCT01799889|470864121|FG001|Overall Study|Lost to Follow-up|1|||
130791118|NCT01799889|470864122|FG002|Overall Study|Lost to Follow-up|0|||
130791119|NCT01799889|470864123|FG003|Overall Study|Lost to Follow-up|0|||
130791120|NCT01799889|470864124|FG004|Overall Study|Lost to Follow-up|0|||
130791121|NCT01799889|470864125|FG005|Overall Study|Lost to Follow-up|0|||
130791122|NCT01799889|470864126|FG006|Overall Study|Lost to Follow-up|0|||
130791123|NCT01799889|470864127|FG007|Overall Study|Lost to Follow-up|0|||
130791124|NCT01799889|470864128|FG008|Overall Study|Lost to Follow-up|0|||
130791125|NCT01799889|470864129|FG009|Overall Study|Lost to Follow-up|0|||
130791126|NCT01799889|470864130|FG010|Overall Study|Lost to Follow-up|0|||
130791127|NCT01799889|470864131|FG011|Overall Study|Lost to Follow-up|0|||
130791128|NCT01799889|470864120|FG000|Overall Study|Physician Decision|3|||
130791129|NCT01799889|470864121|FG001|Overall Study|Physician Decision|2|||
130791130|NCT01799889|470864122|FG002|Overall Study|Physician Decision|4|||
130791131|NCT01799889|470864123|FG003|Overall Study|Physician Decision|4|||
130791132|NCT01799889|470864124|FG004|Overall Study|Physician Decision|5|||
130791133|NCT01799889|470864125|FG005|Overall Study|Physician Decision|5|||
130791134|NCT01799889|470864126|FG006|Overall Study|Physician Decision|5|||
130791135|NCT01799889|470864127|FG007|Overall Study|Physician Decision|2|||
130791136|NCT01799889|470864128|FG008|Overall Study|Physician Decision|6|||
130791137|NCT01799889|470864129|FG009|Overall Study|Physician Decision|0|||
130791138|NCT01799889|470864130|FG010|Overall Study|Physician Decision|0|||
130791139|NCT01799889|470864131|FG011|Overall Study|Physician Decision|1|||
130791140|NCT01799889|470864120|FG000|Overall Study|Progressive Disease|30|||
130791141|NCT01799889|470864121|FG001|Overall Study|Progressive Disease|26|||
130791142|NCT01799889|470864122|FG002|Overall Study|Progressive Disease|25|||
130791143|NCT01799889|470864123|FG003|Overall Study|Progressive Disease|30|||
130791144|NCT01799889|470864124|FG004|Overall Study|Progressive Disease|23|||
130791145|NCT01799889|470864125|FG005|Overall Study|Progressive Disease|9|||
130791146|NCT01799889|470864126|FG006|Overall Study|Progressive Disease|8|||
130791147|NCT01799889|470864127|FG007|Overall Study|Progressive Disease|13|||
130791148|NCT01799889|470864128|FG008|Overall Study|Progressive Disease|18|||
130791149|NCT01799889|470864129|FG009|Overall Study|Progressive Disease|5|||
130791150|NCT01799889|470864130|FG010|Overall Study|Progressive Disease|3|||
130791151|NCT01799889|470864131|FG011|Overall Study|Progressive Disease|1|||
130791152|NCT01799889|470864120|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
130791153|NCT01799889|470864121|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
130791154|NCT01799889|470864122|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
130791155|NCT01799889|470864123|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
130791156|NCT01799889|470864124|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
130791157|NCT01799889|470864125|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
130791158|NCT01799889|470864126|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
130791159|NCT01799889|470864127|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
130791160|NCT01799889|470864128|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
130791161|NCT01799889|470864129|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
130791162|NCT01799889|470864130|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
130791163|NCT01799889|470864131|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
130791164|NCT01799889|470864120|FG000|Overall Study|Study Terminated By Sponsor|1|||
130791165|NCT01799889|470864121|FG001|Overall Study|Study Terminated By Sponsor|0|||
130791166|NCT01799889|470864122|FG002|Overall Study|Study Terminated By Sponsor|0|||
130791167|NCT01799889|470864123|FG003|Overall Study|Study Terminated By Sponsor|0|||
130791168|NCT01799889|470864124|FG004|Overall Study|Study Terminated By Sponsor|2|||
130791169|NCT01799889|470864125|FG005|Overall Study|Study Terminated By Sponsor|1|||
130791170|NCT01799889|470864126|FG006|Overall Study|Study Terminated By Sponsor|0|||
130791171|NCT01799889|470864127|FG007|Overall Study|Study Terminated By Sponsor|2|||
130791172|NCT01799889|470864128|FG008|Overall Study|Study Terminated By Sponsor|1|||
130791173|NCT01799889|470864129|FG009|Overall Study|Study Terminated By Sponsor|1|||
130791174|NCT01799889|470864130|FG010|Overall Study|Study Terminated By Sponsor|0|||
130791175|NCT01799889|470864131|FG011|Overall Study|Study Terminated By Sponsor|0|||
130791176|NCT01799889|470864120|FG000|Overall Study|Withdrawal by Subject|1|||
130791177|NCT01799889|470864121|FG001|Overall Study|Withdrawal by Subject|6|||
130791178|NCT01799889|470864122|FG002|Overall Study|Withdrawal by Subject|4|||
130791179|NCT01799889|470864123|FG003|Overall Study|Withdrawal by Subject|0|||
130791180|NCT01799889|470864124|FG004|Overall Study|Withdrawal by Subject|5|||
130791181|NCT01799889|470864125|FG005|Overall Study|Withdrawal by Subject|1|||
130791182|NCT01799889|470864126|FG006|Overall Study|Withdrawal by Subject|3|||
130791183|NCT01799889|470864127|FG007|Overall Study|Withdrawal by Subject|1|||
130791184|NCT01799889|470864128|FG008|Overall Study|Withdrawal by Subject|2|||
130791185|NCT01799889|470864129|FG009|Overall Study|Withdrawal by Subject|1|||
130791186|NCT01799889|470864130|FG010|Overall Study|Withdrawal by Subject|1|||
130791187|NCT01799889|470864131|FG011|Overall Study|Withdrawal by Subject|1|||
130791188|NCT01799889|470864120|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130791189|NCT01799889|470864121|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130791190|NCT01799889|470864122|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130791191|NCT01799889|470864123|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130791192|NCT01799889|470864124|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130791193|NCT01799889|470864125|FG005|Overall Study|Non-Compliance With Study Drug|1|||
130791194|NCT01799889|470864126|FG006|Overall Study|Non-Compliance With Study Drug|0|||
130791195|NCT01799889|470864127|FG007|Overall Study|Non-Compliance With Study Drug|0|||
130791196|NCT01799889|470864128|FG008|Overall Study|Non-Compliance With Study Drug|0|||
130791197|NCT01799889|470864129|FG009|Overall Study|Non-Compliance With Study Drug|0|||
130791198|NCT01799889|470864130|FG010|Overall Study|Non-Compliance With Study Drug|0|||
130791199|NCT01799889|470864131|FG011|Overall Study|Non-Compliance With Study Drug|0|||
130791200|NCT02194465|470864134|FG000|Overall Study|Adverse Event|6|||
130791201|NCT02194465|470864135|FG001|Overall Study|Adverse Event|1|||
130791202|NCT02194465|470864136|FG002|Overall Study|Adverse Event|4|||
130791203|NCT02194465|470864137|FG003|Overall Study|Adverse Event|4|||
130791204|NCT02194465|470864138|FG004|Overall Study|Adverse Event|4|||
130791205|NCT02194465|470864139|FG005|Overall Study|Adverse Event|2|||
130791206|NCT02194465|470864140|FG006|Overall Study|Adverse Event|0|||
130791207|NCT02194465|470864134|FG000|Overall Study|Lost to Follow-up|0|||
130791208|NCT02194465|470864135|FG001|Overall Study|Lost to Follow-up|0|||
130791209|NCT02194465|470864136|FG002|Overall Study|Lost to Follow-up|0|||
130791210|NCT02194465|470864137|FG003|Overall Study|Lost to Follow-up|1|||
130791211|NCT02194465|470864138|FG004|Overall Study|Lost to Follow-up|0|||
130791212|NCT02194465|470864139|FG005|Overall Study|Lost to Follow-up|1|||
130791213|NCT02194465|470864140|FG006|Overall Study|Lost to Follow-up|0|||
130791214|NCT02194465|470864134|FG000|Overall Study|Physician Decision|1|||
130791215|NCT02194465|470864135|FG001|Overall Study|Physician Decision|0|||
130791216|NCT02194465|470864136|FG002|Overall Study|Physician Decision|0|||
130791217|NCT02194465|470864137|FG003|Overall Study|Physician Decision|0|||
130791218|NCT02194465|470864138|FG004|Overall Study|Physician Decision|0|||
130791219|NCT02194465|470864139|FG005|Overall Study|Physician Decision|0|||
130791220|NCT02194465|470864140|FG006|Overall Study|Physician Decision|0|||
130791221|NCT02194465|470864134|FG000|Overall Study|Protocol Violation|1|||
130791222|NCT02194465|470864135|FG001|Overall Study|Protocol Violation|1|||
130791223|NCT02194465|470864136|FG002|Overall Study|Protocol Violation|2|||
130791224|NCT02194465|470864137|FG003|Overall Study|Protocol Violation|1|||
130791225|NCT02194465|470864138|FG004|Overall Study|Protocol Violation|1|||
130791226|NCT02194465|470864139|FG005|Overall Study|Protocol Violation|0|||
130791227|NCT02194465|470864140|FG006|Overall Study|Protocol Violation|0|||
130791228|NCT02194465|470864134|FG000|Overall Study|Withdrawal by Subject|1|||
130791229|NCT02194465|470864135|FG001|Overall Study|Withdrawal by Subject|3|||
130791230|NCT02194465|470864136|FG002|Overall Study|Withdrawal by Subject|1|||
130791231|NCT02194465|470864137|FG003|Overall Study|Withdrawal by Subject|2|||
130791232|NCT02194465|470864138|FG004|Overall Study|Withdrawal by Subject|2|||
130791233|NCT02194465|470864139|FG005|Overall Study|Withdrawal by Subject|1|||
130791234|NCT02194465|470864140|FG006|Overall Study|Withdrawal by Subject|2|||
130791235|NCT02194465|470864134|FG000|Overall Study|Discontinued follow-up period|0|||
130791236|NCT02194465|470864135|FG001|Overall Study|Discontinued follow-up period|2|||
130791237|NCT02194465|470864136|FG002|Overall Study|Discontinued follow-up period|1|||
130791238|NCT02194465|470864137|FG003|Overall Study|Discontinued follow-up period|0|||
130791239|NCT02194465|470864138|FG004|Overall Study|Discontinued follow-up period|2|||
130791240|NCT02194465|470864139|FG005|Overall Study|Discontinued follow-up period|0|||
130791241|NCT02194465|470864140|FG006|Overall Study|Discontinued follow-up period|0|||
130791242|NCT01408641|470864141|FG000|Overall Study|Physician Decision|1|||
130791243|NCT01408641|470864142|FG001|Overall Study|Physician Decision|0|||
130791244|NCT00576758|470864143|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
130791245|NCT00576758|470864144|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
130791246|NCT00576758|470864143|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
130791247|NCT00576758|470864144|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
130791248|NCT00576758|470864143|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
130791249|NCT00576758|470864144|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
130791250|NCT00576758|470864143|FG000|Induction Treatment Period|Death|1|||
130791251|NCT00576758|470864144|FG001|Induction Treatment Period|Death|0|||
130791252|NCT00576758|470864143|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
130791253|NCT00576758|470864144|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
130791254|NCT00576758|470864143|FG000|Induction Treatment Period|Withdrew consent|1|||
130791255|NCT00576758|470864144|FG001|Induction Treatment Period|Withdrew consent|0|||
130791256|NCT00576758|470864143|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
130791257|NCT00576758|470864144|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
130791258|NCT00576758|470864143|FG000|Extension Treatment Period|Death|1|||
130791259|NCT00576758|470864144|FG001|Extension Treatment Period|Death|1|||
130791260|NCT00576758|470864143|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
130791261|NCT00576758|470864144|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
130791262|NCT00576758|470864143|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
130791263|NCT00576758|470864144|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
130791264|NCT00576758|470864143|FG000|Extension Treatment Period|Administrative/Other|3|||
130791265|NCT00576758|470864144|FG001|Extension Treatment Period|Administrative/Other|1|||
130791266|NCT00576758|470864143|FG000|Follow-up Period|Administrative/Other|6|||
130791267|NCT00576758|470864144|FG001|Follow-up Period|Administrative/Other|8|||
130791268|NCT00576758|470864143|FG000|Follow-up Period|Death|3|||
130791269|NCT00576758|470864144|FG001|Follow-up Period|Death|3|||
130791270|NCT00576758|470864143|FG000|Follow-up Period|Insufficient therapeutic response|16|||
130791271|NCT00576758|470864144|FG001|Follow-up Period|Insufficient therapeutic response|5|||
130791272|NCT00576758|470864143|FG000|Follow-up Period|Withdrew consent|2|||
130791273|NCT00576758|470864144|FG001|Follow-up Period|Withdrew consent|1|||
130791274|NCT00089648|470864145|FG000|Overall Study|Adverse Event|7|||
130791275|NCT00089648|470864145|FG000|Overall Study|Withdrawal by Subject|1|||
130791276|NCT00089648|470864145|FG000|Overall Study|Lack of Efficacy|33|||
130791277|NCT00423605|470864146|FG000|Overall Study|Adverse Event|129|||
130791278|NCT00423605|470864146|FG000|Overall Study|Withdrawal by Subject|36|||
130791279|NCT00423605|470864146|FG000|Overall Study|Lost to Follow-up|15|||
130791280|NCT00423605|470864146|FG000|Overall Study|Lack of Efficacy|38|||
130791281|NCT00423605|470864146|FG000|Overall Study|Sponsor Decision|3|||
130791282|NCT00423605|470864146|FG000|Overall Study|Physician Decision|8|||
130791283|NCT00423605|470864146|FG000|Overall Study|Protocol Violation|7|||
130791284|NCT00423605|470864146|FG000|Overall Study|Not one of the pre-specified options|5|||
130791285|NCT03183908|470864149|FG000|Overall Study|Missing Symptom Diary Data|0|||
130791286|NCT03183908|470864150|FG001|Overall Study|Missing Symptom Diary Data|2|||
130791287|NCT03738696|470864151|FG000|Overall Study|Withdrawal by Subject|0|||
130791288|NCT03738696|470864152|FG001|Overall Study|Withdrawal by Subject|1|||
130791289|NCT03738696|470864151|FG000|Overall Study|Lost to Follow-up|8|||
130791290|NCT03738696|470864152|FG001|Overall Study|Lost to Follow-up|14|||
130791291|NCT02566005|470864155|FG000|Overall Study|vaginal bleeding|0|||
130791292|NCT02566005|470864156|FG001|Overall Study|vaginal bleeding|1|||
130791293|NCT02566005|470864155|FG000|Overall Study|received foley|8|||
130791294|NCT02566005|470864156|FG001|Overall Study|received foley|0|||
130791295|NCT02566005|470864155|FG000|Overall Study|did not receive foley|0|||
130791296|NCT02566005|470864156|FG001|Overall Study|did not receive foley|1|||
130791297|NCT02566005|470864155|FG000|Overall Study|labor after randomization|0|||
130791298|NCT02566005|470864156|FG001|Overall Study|labor after randomization|4|||
130791299|NCT03617588|470864157|FG000|Overall Study|Withdrawal by Subject|1|||
130791300|NCT03617588|470864158|FG001|Overall Study|Withdrawal by Subject|0|||
130791301|NCT01294514|470864159|FG000|Overall Study|Excluded due to Arrhythmia|1|||
130791302|NCT03482024|470864166|FG000|Overall Study|Physician Decision|1|||
130791303|NCT03482024|470864167|FG001|Overall Study|Physician Decision|0|||
130791304|NCT03482024|470864168|FG002|Overall Study|Physician Decision|0|||
130791305|NCT03482024|470864169|FG003|Overall Study|Physician Decision|0|||
130791306|NCT03482024|470864170|FG004|Overall Study|Physician Decision|0|||
130791307|NCT04796415|470864171|FG000|Overall Study|not interested|12|||
130791308|NCT04796415|470864171|FG000|Overall Study|health issue|8|||
130791309|NCT04796415|470864171|FG000|Overall Study|Other|4|||
130791310|NCT04796415|470864171|FG000|Overall Study|discharged from home health service|3|||
130791311|NCT04796415|470864171|FG000|Overall Study|re-hospitalization|2|||
130791312|NCT04796415|470864171|FG000|Overall Study|moving to nursing home|1|||
130791313|NCT04796415|470864171|FG000|Overall Study|lost contact|1|||
130791314|NCT00147238|470864178|FG000|Overall Study|Inevaluable|8|||
130791315|NCT00297167|470864179|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
130791316|NCT00297167|470864180|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
130791317|NCT00297167|470864181|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
130791318|NCT00297167|470864179|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
130791319|NCT00297167|470864180|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
130791320|NCT00297167|470864181|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
130791321|NCT03185208|470864184|FG000|Overall Study|Did not start study medication|0|||
130791322|NCT03185208|470864185|FG001|Overall Study|Did not start study medication|3|||
130791323|NCT03834350|470864186|FG000|Overall Study|Withdrawal by Subject|1|||
130791324|NCT02410629|470864187|FG000|Overall Study|Family cannot commit to the study|2|||
130791325|NCT02410629|470864188|FG001|Overall Study|Family cannot commit to the study|1|||
130791326|NCT02410629|470864187|FG000|Overall Study|Subject returned to work|1|||
130791327|NCT02410629|470864188|FG001|Overall Study|Subject returned to work|0|||
130791328|NCT02410629|470864187|FG000|Overall Study|Subject moved back to home country|0|||
130791329|NCT02410629|470864188|FG001|Overall Study|Subject moved back to home country|1|||
130791330|NCT02410629|470864187|FG000|Overall Study|Subject underwent heart surgery|0|||
130791331|NCT02410629|470864188|FG001|Overall Study|Subject underwent heart surgery|1|||
130791332|NCT02765165|470864189|FG000|Treatment Period|Progressive disease|3|||
130791333|NCT02765165|470864190|FG001|Treatment Period|Progressive disease|2|||
130791334|NCT02765165|470864191|FG002|Treatment Period|Progressive disease|3|||
130791335|NCT02765165|470864192|FG003|Treatment Period|Progressive disease|3|||
130791336|NCT02765165|470864193|FG004|Treatment Period|Progressive disease|4|||
130791337|NCT02765165|470864194|FG005|Treatment Period|Progressive disease|2|||
130791338|NCT02765165|470864195|FG006|Treatment Period|Progressive disease|2|||
130791339|NCT02765165|470864189|FG000|Treatment Period|Physician Decision|0|||
130791340|NCT02765165|470864190|FG001|Treatment Period|Physician Decision|1|||
130791341|NCT02765165|470864191|FG002|Treatment Period|Physician Decision|0|||
130791342|NCT02765165|470864192|FG003|Treatment Period|Physician Decision|0|||
130791343|NCT02765165|470864193|FG004|Treatment Period|Physician Decision|0|||
130791344|NCT02765165|470864194|FG005|Treatment Period|Physician Decision|0|||
130791345|NCT02765165|470864195|FG006|Treatment Period|Physician Decision|0|||
130791346|NCT02765165|470864189|FG000|Treatment Period|Adverse Event|0|||
130791347|NCT02765165|470864190|FG001|Treatment Period|Adverse Event|1|||
130791348|NCT02765165|470864191|FG002|Treatment Period|Adverse Event|0|||
130791349|NCT02765165|470864192|FG003|Treatment Period|Adverse Event|0|||
130791350|NCT02765165|470864193|FG004|Treatment Period|Adverse Event|0|||
130791351|NCT02765165|470864194|FG005|Treatment Period|Adverse Event|0|||
130791352|NCT02765165|470864195|FG006|Treatment Period|Adverse Event|0|||
130791353|NCT02765165|470864189|FG000|Treatment Period|Withdrawal by Subject|0|||
130791354|NCT02765165|470864190|FG001|Treatment Period|Withdrawal by Subject|0|||
130791355|NCT02765165|470864191|FG002|Treatment Period|Withdrawal by Subject|0|||
130791356|NCT02765165|470864192|FG003|Treatment Period|Withdrawal by Subject|0|||
130791357|NCT02765165|470864193|FG004|Treatment Period|Withdrawal by Subject|2|||
130791358|NCT02765165|470864194|FG005|Treatment Period|Withdrawal by Subject|0|||
130791359|NCT02765165|470864195|FG006|Treatment Period|Withdrawal by Subject|0|||
130791360|NCT02765165|470864189|FG000|Treatment Period|Study terminated|0|||
130791361|NCT02765165|470864190|FG001|Treatment Period|Study terminated|0|||
130791362|NCT02765165|470864191|FG002|Treatment Period|Study terminated|0|||
130791363|NCT02765165|470864192|FG003|Treatment Period|Study terminated|0|||
130791364|NCT02765165|470864193|FG004|Treatment Period|Study terminated|0|||
130791365|NCT02765165|470864194|FG005|Treatment Period|Study terminated|1|||
130791366|NCT02765165|470864195|FG006|Treatment Period|Study terminated|2|||
130791367|NCT02765165|470864189|FG000|Post-treatment Follow-up|Death|1|||
130791368|NCT02765165|470864190|FG001|Post-treatment Follow-up|Death|2|||
130791369|NCT02765165|470864191|FG002|Post-treatment Follow-up|Death|1|||
130791370|NCT02765165|470864192|FG003|Post-treatment Follow-up|Death|1|||
130791371|NCT02765165|470864193|FG004|Post-treatment Follow-up|Death|1|||
130791372|NCT02765165|470864194|FG005|Post-treatment Follow-up|Death|1|||
130791373|NCT02765165|470864195|FG006|Post-treatment Follow-up|Death|0|||
130791374|NCT02765165|470864189|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
130791375|NCT02765165|470864190|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
130791376|NCT02765165|470864191|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
130791377|NCT02765165|470864192|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
130791378|NCT02765165|470864193|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
130791379|NCT02765165|470864194|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
130791380|NCT02765165|470864195|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
130791381|NCT02765165|470864189|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
130791382|NCT02765165|470864190|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
130791383|NCT02765165|470864191|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
130791384|NCT02765165|470864192|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
130791385|NCT02765165|470864193|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
130791386|NCT02765165|470864194|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
130791387|NCT02765165|470864195|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
130791388|NCT02765165|470864189|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130791389|NCT02765165|470864190|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130791390|NCT02765165|470864191|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
130791391|NCT02765165|470864192|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
130791392|NCT02765165|470864193|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130791393|NCT02765165|470864194|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130791394|NCT02765165|470864195|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130791395|NCT02765165|470864189|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
130791396|NCT02765165|470864190|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
130791397|NCT02765165|470864191|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
130791398|NCT02765165|470864192|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
130791399|NCT02765165|470864193|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
130791400|NCT02765165|470864194|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
130791401|NCT02765165|470864195|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
130791402|NCT02765165|470864189|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130791403|NCT02765165|470864190|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130791404|NCT02765165|470864191|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130791405|NCT02765165|470864192|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130791406|NCT02765165|470864193|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
130791407|NCT02765165|470864194|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
130791408|NCT02765165|470864195|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
130791409|NCT01186770|470864196|FG000|Overall Study|Ineligibility|0|||
130791410|NCT01186770|470864197|FG001|Overall Study|Ineligibility|0|||
130791411|NCT01186770|470864198|FG002|Overall Study|Ineligibility|2|||
130791412|NCT01186770|470864199|FG003|Overall Study|Ineligibility|0|||
130791413|NCT01186770|470864196|FG000|Overall Study|Protocol Violation|7|||
130791414|NCT01186770|470864197|FG001|Overall Study|Protocol Violation|9|||
130791415|NCT01186770|470864198|FG002|Overall Study|Protocol Violation|12|||
130791416|NCT01186770|470864199|FG003|Overall Study|Protocol Violation|14|||
130791417|NCT01186770|470864196|FG000|Overall Study|Adverse Event|2|||
130791418|NCT01186770|470864197|FG001|Overall Study|Adverse Event|9|||
130791419|NCT01186770|470864198|FG002|Overall Study|Adverse Event|7|||
130791420|NCT01186770|470864199|FG003|Overall Study|Adverse Event|9|||
130791421|NCT01186770|470864196|FG000|Overall Study|Withdrawal by Subject|15|||
130791422|NCT01186770|470864197|FG001|Overall Study|Withdrawal by Subject|13|||
130791423|NCT01186770|470864198|FG002|Overall Study|Withdrawal by Subject|11|||
130791424|NCT01186770|470864199|FG003|Overall Study|Withdrawal by Subject|17|||
130791425|NCT01186770|470864196|FG000|Overall Study|Lost to Follow-up|10|||
130791426|NCT01186770|470864197|FG001|Overall Study|Lost to Follow-up|6|||
130791427|NCT01186770|470864198|FG002|Overall Study|Lost to Follow-up|14|||
130791428|NCT01186770|470864199|FG003|Overall Study|Lost to Follow-up|9|||
130791429|NCT01186770|470864196|FG000|Overall Study|Insufficient response to treatment|7|||
130791430|NCT01186770|470864197|FG001|Overall Study|Insufficient response to treatment|8|||
130791431|NCT01186770|470864198|FG002|Overall Study|Insufficient response to treatment|5|||
130791432|NCT01186770|470864199|FG003|Overall Study|Insufficient response to treatment|7|||
130791433|NCT01186770|470864196|FG000|Overall Study|Other than specified|0|||
130791434|NCT01186770|470864197|FG001|Overall Study|Other than specified|1|||
130791435|NCT01186770|470864198|FG002|Overall Study|Other than specified|1|||
130791436|NCT01186770|470864199|FG003|Overall Study|Other than specified|2|||
130791437|NCT02567188|470864200|FG000|Overall Study|Death|10|||
130791438|NCT02567188|470864200|FG000|Overall Study|Terminated Mircera Treatment|9|||
130791439|NCT02567188|470864200|FG000|Overall Study|Lost to Follow-up|5|||
130791440|NCT02567188|470864200|FG000|Overall Study|Adverse Event|1|||
130791441|NCT02567188|470864200|FG000|Overall Study|Withdrawal by Subject|1|||
130791442|NCT02567188|470864200|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
130791443|NCT02567188|470864200|FG000|Overall Study|Moved and Changed Clinic|1|||
130791444|NCT02567188|470864200|FG000|Overall Study|Started Hemodialysis|2|||
130791445|NCT02567188|470864200|FG000|Overall Study|Protocol Violation|5|||
130761743|NCT02326298|470750331|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761744|NCT02326298|470750332|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130761745|NCT02326298|470750319|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761746|NCT02326298|470750320|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761747|NCT02326298|470750321|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
130761748|NCT02326298|470750322|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761749|NCT02326298|470750323|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761750|NCT02326298|470750324|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761751|NCT02326298|470750325|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761752|NCT02326298|470750326|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761753|NCT02326298|470750327|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761754|NCT02326298|470750328|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761755|NCT02326298|470750329|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130791446|NCT00321763|470864203|FG000|Overall Study|Adverse Event|1|||
130791447|NCT00321763|470864204|FG001|Overall Study|Adverse Event|1|||
130791448|NCT00321763|470864205|FG002|Overall Study|Adverse Event|0|||
130791449|NCT00321763|470864206|FG003|Overall Study|Adverse Event|1|||
130791450|NCT00321763|470864203|FG000|Overall Study|Withdrawal by Subject|2|||
130791451|NCT00321763|470864204|FG001|Overall Study|Withdrawal by Subject|0|||
130791452|NCT00321763|470864205|FG002|Overall Study|Withdrawal by Subject|1|||
130791453|NCT00321763|470864206|FG003|Overall Study|Withdrawal by Subject|0|||
130791454|NCT00321763|470864203|FG000|Overall Study|Lost to Follow-up|3|||
130791455|NCT00321763|470864204|FG001|Overall Study|Lost to Follow-up|1|||
130791456|NCT00321763|470864205|FG002|Overall Study|Lost to Follow-up|5|||
130791457|NCT00321763|470864206|FG003|Overall Study|Lost to Follow-up|4|||
130791458|NCT01572792|470864207|FG000|Lead-in Study|Lost to Follow-up|5|||
130791459|NCT01572792|470864208|FG001|Lead-in Study|Lost to Follow-up|9|||
130791460|NCT01572792|470864209|FG002|Lead-in Study|Lost to Follow-up|4|||
130791461|NCT01572792|470864210|FG003|Lead-in Study|Lost to Follow-up|2|||
130791462|NCT01572792|470864211|FG004|Lead-in Study|Lost to Follow-up|4|||
130791463|NCT01572792|470864207|FG000|Lead-in Study|Withdrawal by Subject|22|||
130791464|NCT01572792|470864208|FG001|Lead-in Study|Withdrawal by Subject|11|||
130791465|NCT01572792|470864209|FG002|Lead-in Study|Withdrawal by Subject|12|||
130791466|NCT01572792|470864210|FG003|Lead-in Study|Withdrawal by Subject|24|||
130791467|NCT01572792|470864211|FG004|Lead-in Study|Withdrawal by Subject|11|||
130791468|NCT01572792|470864207|FG000|Lead-in Study|Protocol Violation|19|||
130791469|NCT01572792|470864208|FG001|Lead-in Study|Protocol Violation|10|||
130791470|NCT01572792|470864209|FG002|Lead-in Study|Protocol Violation|12|||
130791471|NCT01572792|470864210|FG003|Lead-in Study|Protocol Violation|13|||
130791472|NCT01572792|470864211|FG004|Lead-in Study|Protocol Violation|21|||
130791473|NCT01572792|470864207|FG000|Lead-in Study|Lack of Efficacy|20|||
130791474|NCT01572792|470864208|FG001|Lead-in Study|Lack of Efficacy|5|||
130791475|NCT01572792|470864209|FG002|Lead-in Study|Lack of Efficacy|4|||
130791476|NCT01572792|470864210|FG003|Lead-in Study|Lack of Efficacy|8|||
130791477|NCT01572792|470864211|FG004|Lead-in Study|Lack of Efficacy|10|||
130791478|NCT01572792|470864207|FG000|Lead-in Study|Adverse Event|21|||
130791479|NCT01572792|470864208|FG001|Lead-in Study|Adverse Event|21|||
130791480|NCT01572792|470864209|FG002|Lead-in Study|Adverse Event|22|||
130791481|NCT01572792|470864210|FG003|Lead-in Study|Adverse Event|16|||
130791482|NCT01572792|470864211|FG004|Lead-in Study|Adverse Event|14|||
130791483|NCT01572792|470864207|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
130791484|NCT01572792|470864208|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
130791485|NCT01572792|470864209|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
130791486|NCT01572792|470864210|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
130791487|NCT01572792|470864211|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
130791488|NCT01572792|470864207|FG000|Extension Study|Lost to Follow-up|6|||
130791489|NCT01572792|470864208|FG001|Extension Study|Lost to Follow-up|2|||
130791490|NCT01572792|470864209|FG002|Extension Study|Lost to Follow-up|0|||
130791491|NCT01572792|470864210|FG003|Extension Study|Lost to Follow-up|3|||
130791492|NCT01572792|470864211|FG004|Extension Study|Lost to Follow-up|3|||
130791493|NCT01572792|470864207|FG000|Extension Study|Withdrawal by Subject|7|||
130791494|NCT01572792|470864208|FG001|Extension Study|Withdrawal by Subject|6|||
130791495|NCT01572792|470864209|FG002|Extension Study|Withdrawal by Subject|11|||
130791496|NCT01572792|470864210|FG003|Extension Study|Withdrawal by Subject|8|||
130791497|NCT01572792|470864211|FG004|Extension Study|Withdrawal by Subject|14|||
130791498|NCT01572792|470864207|FG000|Extension Study|Protocol Violation|0|||
130791499|NCT01572792|470864208|FG001|Extension Study|Protocol Violation|4|||
130791500|NCT01572792|470864209|FG002|Extension Study|Protocol Violation|3|||
130791501|NCT01572792|470864210|FG003|Extension Study|Protocol Violation|4|||
130791502|NCT01572792|470864211|FG004|Extension Study|Protocol Violation|3|||
130791503|NCT01572792|470864207|FG000|Extension Study|Lack of Efficacy|2|||
130791504|NCT01572792|470864208|FG001|Extension Study|Lack of Efficacy|3|||
130791505|NCT01572792|470864209|FG002|Extension Study|Lack of Efficacy|3|||
130791506|NCT01572792|470864210|FG003|Extension Study|Lack of Efficacy|2|||
130791507|NCT01572792|470864211|FG004|Extension Study|Lack of Efficacy|2|||
130791508|NCT01572792|470864207|FG000|Extension Study|Adverse Event|7|||
130791509|NCT01572792|470864208|FG001|Extension Study|Adverse Event|6|||
130791510|NCT01572792|470864209|FG002|Extension Study|Adverse Event|5|||
130791511|NCT01572792|470864210|FG003|Extension Study|Adverse Event|6|||
130791512|NCT01572792|470864211|FG004|Extension Study|Adverse Event|4|||
130791513|NCT01572792|470864207|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
130791514|NCT01572792|470864208|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
130791515|NCT01572792|470864209|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
130791516|NCT01572792|470864210|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
130791517|NCT01572792|470864211|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
130791518|NCT01129128|470864212|FG000|Overall Study|Lost to Follow-up|2|||
130791519|NCT01129128|470864213|FG001|Overall Study|Lost to Follow-up|2|||
130791520|NCT01129128|470864214|FG002|Overall Study|Lost to Follow-up|1|||
130791521|NCT01129128|470864212|FG000|Overall Study|Protocol Violation|0|||
130791522|NCT01129128|470864213|FG001|Overall Study|Protocol Violation|1|||
130791523|NCT01129128|470864214|FG002|Overall Study|Protocol Violation|0|||
130791524|NCT01129128|470864212|FG000|Overall Study|Withdrawal by Subject|0|||
130791525|NCT01129128|470864213|FG001|Overall Study|Withdrawal by Subject|1|||
130791526|NCT01129128|470864214|FG002|Overall Study|Withdrawal by Subject|3|||
130791527|NCT01129128|470864212|FG000|Overall Study|Physician Decision|1|||
130791528|NCT01129128|470864213|FG001|Overall Study|Physician Decision|0|||
130791529|NCT01129128|470864214|FG002|Overall Study|Physician Decision|0|||
130791530|NCT00961415|470864215|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
130791531|NCT00961415|470864216|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
130791532|NCT00961415|470864217|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
130791533|NCT00961415|470864215|FG000|Induction Treatment Phase|Death|77|||
130791534|NCT00961415|470864216|FG001|Induction Treatment Phase|Death|0|||
130791535|NCT00961415|470864217|FG002|Induction Treatment Phase|Death|0|||
130791536|NCT00961415|470864215|FG000|Induction Treatment Phase|Protocol Violation|1|||
130791537|NCT00961415|470864216|FG001|Induction Treatment Phase|Protocol Violation|0|||
130791538|NCT00961415|470864217|FG002|Induction Treatment Phase|Protocol Violation|0|||
130791539|NCT00961415|470864215|FG000|Induction Treatment Phase|Physician Decision|2|||
130791540|NCT00961415|470864216|FG001|Induction Treatment Phase|Physician Decision|0|||
130791541|NCT00961415|470864217|FG002|Induction Treatment Phase|Physician Decision|0|||
130791542|NCT00961415|470864215|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
130791543|NCT00961415|470864216|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
130791544|NCT00961415|470864217|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
130791545|NCT00961415|470864215|FG000|Induction Treatment Phase|Other Reason|5|||
130791546|NCT00961415|470864216|FG001|Induction Treatment Phase|Other Reason|0|||
130791547|NCT00961415|470864217|FG002|Induction Treatment Phase|Other Reason|0|||
130791548|NCT00961415|470864215|FG000|Maintenance Treatment Phase|Death|0|||
130791549|NCT00961415|470864216|FG001|Maintenance Treatment Phase|Death|42|||
130791550|NCT00961415|470864217|FG002|Maintenance Treatment Phase|Death|34|||
130791551|NCT00961415|470864215|FG000|Maintenance Treatment Phase|Investigators decision|0|||
130791552|NCT00961415|470864216|FG001|Maintenance Treatment Phase|Investigators decision|2|||
130791553|NCT00961415|470864217|FG002|Maintenance Treatment Phase|Investigators decision|0|||
130791554|NCT00961415|470864215|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130791555|NCT00961415|470864216|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
130791556|NCT00961415|470864217|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
130791557|NCT00961415|470864215|FG000|Maintenance Treatment Phase|Other reason|0|||
130791558|NCT00961415|470864216|FG001|Maintenance Treatment Phase|Other reason|1|||
130791559|NCT00961415|470864217|FG002|Maintenance Treatment Phase|Other reason|3|||
130791560|NCT00639509|470864230|FG000|Overall Study|Death|1|||
130791561|NCT01933594|470864231|FG000|Overall Study|Lost to Follow-up|1|||
130791562|NCT01933594|470864232|FG001|Overall Study|Lost to Follow-up|0|||
130791563|NCT01933594|470864233|FG002|Overall Study|Lost to Follow-up|0|||
130791564|NCT01933594|470864234|FG003|Overall Study|Lost to Follow-up|0|||
130791565|NCT01933594|470864235|FG004|Overall Study|Lost to Follow-up|1|||
130791566|NCT01933594|470864236|FG005|Overall Study|Lost to Follow-up|0|||
130791567|NCT01933594|470864231|FG000|Overall Study|Ineligible for subsequent study step|0|||
130791568|NCT01933594|470864232|FG001|Overall Study|Ineligible for subsequent study step|0|||
130791569|NCT01933594|470864233|FG002|Overall Study|Ineligible for subsequent study step|0|||
130791570|NCT01933594|470864234|FG003|Overall Study|Ineligible for subsequent study step|0|||
130791571|NCT01933594|470864235|FG004|Overall Study|Ineligible for subsequent study step|1|||
130791572|NCT01933594|470864236|FG005|Overall Study|Ineligible for subsequent study step|0|||
130791573|NCT05049122|470864237|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
130791574|NCT05049122|470864237|FG000|Overall Study|Participant moved|1|||
130791575|NCT05049122|470864237|FG000|Overall Study|At the direction of the doctor|1|||
130791576|NCT05722015|470864238|FG000|Overall Study|Death|57|||
130791577|NCT05722015|470864239|FG001|Overall Study|Death|37|||
130791578|NCT05722015|470864238|FG000|Overall Study|Lost to Follow-up|1|||
130791579|NCT05722015|470864239|FG001|Overall Study|Lost to Follow-up|0|||
130791580|NCT05722015|470864238|FG000|Overall Study|Withdrawal by Subject|5|||
130791581|NCT05722015|470864239|FG001|Overall Study|Withdrawal by Subject|1|||
130791582|NCT05722015|470864238|FG000|Overall Study|Participants Ongoing|188|||
130791583|NCT05722015|470864239|FG001|Overall Study|Participants Ongoing|88|||
130791584|NCT04513366|470864240|FG000|Treatment Phase|Withdrawal by Subject|6|||
130791585|NCT04513366|470864241|FG001|Treatment Phase|Withdrawal by Subject|8|||
130791586|NCT04513366|470864242|FG002|Treatment Phase|Withdrawal by Subject|3|||
130791587|NCT04513366|470864240|FG000|Treatment Phase|Lost to Follow-up|1|||
130791588|NCT04513366|470864241|FG001|Treatment Phase|Lost to Follow-up|2|||
130791589|NCT04513366|470864242|FG002|Treatment Phase|Lost to Follow-up|5|||
130791590|NCT04513366|470864240|FG000|Treatment Phase|Other than Specified|1|||
130791591|NCT04513366|470864241|FG001|Treatment Phase|Other than Specified|0|||
130791592|NCT04513366|470864242|FG002|Treatment Phase|Other than Specified|2|||
130791593|NCT04513366|470864240|FG000|Treatment Phase|Physician Decision|2|||
130791594|NCT04513366|470864241|FG001|Treatment Phase|Physician Decision|0|||
130791595|NCT04513366|470864242|FG002|Treatment Phase|Physician Decision|0|||
130791596|NCT04513366|470864240|FG000|Treatment Phase|Adverse Event|0|||
130791597|NCT04513366|470864241|FG001|Treatment Phase|Adverse Event|1|||
130791598|NCT04513366|470864242|FG002|Treatment Phase|Adverse Event|1|||
130791599|NCT04513366|470864240|FG000|Extension Phase|Withdrawal by Subject|3|||
130791600|NCT04513366|470864241|FG001|Extension Phase|Withdrawal by Subject|1|||
130791601|NCT04513366|470864242|FG002|Extension Phase|Withdrawal by Subject|1|||
130791602|NCT04513366|470864240|FG000|Extension Phase|Other than Specified|4|||
130791603|NCT04513366|470864241|FG001|Extension Phase|Other than Specified|0|||
130791604|NCT04513366|470864242|FG002|Extension Phase|Other than Specified|1|||
130791605|NCT04513366|470864240|FG000|Extension Phase|Lost to Follow-up|1|||
130791606|NCT04513366|470864241|FG001|Extension Phase|Lost to Follow-up|1|||
130791607|NCT04513366|470864242|FG002|Extension Phase|Lost to Follow-up|1|||
130791608|NCT04513366|470864240|FG000|Extension Phase|Sponsor Decision|0|||
130791609|NCT04513366|470864241|FG001|Extension Phase|Sponsor Decision|1|||
130791610|NCT04513366|470864242|FG002|Extension Phase|Sponsor Decision|0|||
130791611|NCT04513366|470864240|FG000|Extension Phase|Death|0|||
130791612|NCT04513366|470864241|FG001|Extension Phase|Death|1|||
130791613|NCT04513366|470864242|FG002|Extension Phase|Death|0|||
130791614|NCT04513366|470864240|FG000|Extension Phase|Adverse Event|0|||
130791615|NCT04513366|470864241|FG001|Extension Phase|Adverse Event|0|||
130791616|NCT04513366|470864242|FG002|Extension Phase|Adverse Event|1|||
130791617|NCT02657551|470864245|FG000|Overall Study|Adverse Event|2|||
130791618|NCT02657551|470864245|FG000|Overall Study|Withdrawal by Subject|1|||
130791619|NCT02657551|470864245|FG000|Overall Study|Non-Compliance|1|||
130791620|NCT02657551|470864245|FG000|Overall Study|Progression / Relapse|4|||
130791621|NCT04478266|470864247|FG000|Overall Study|Adverse Event|20|||
130791622|NCT04478266|470864248|FG001|Overall Study|Adverse Event|21|||
130791623|NCT04478266|470864247|FG000|Overall Study|Progressive disease|146|||
130791624|NCT04478266|470864248|FG001|Overall Study|Progressive disease|168|||
130791625|NCT04478266|470864247|FG000|Overall Study|Poor compliance to protocol|1|||
130791626|NCT04478266|470864248|FG001|Overall Study|Poor compliance to protocol|0|||
130791627|NCT04478266|470864247|FG000|Overall Study|Withdrawal by Subject|19|||
130791628|NCT04478266|470864248|FG001|Overall Study|Withdrawal by Subject|16|||
130791629|NCT04478266|470864247|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
130791630|NCT04478266|470864248|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
130791631|NCT04478266|470864247|FG000|Overall Study|Study terminated by sponsor|33|||
130791632|NCT04478266|470864248|FG001|Overall Study|Study terminated by sponsor|35|||
130791633|NCT04478266|470864247|FG000|Overall Study|Other: unspecified|5|||
130791634|NCT04478266|470864248|FG001|Overall Study|Other: unspecified|7|||
130791635|NCT04478266|470864247|FG000|Overall Study|Randomized but not treated|1|||
130791636|NCT04478266|470864248|FG001|Overall Study|Randomized but not treated|1|||
130791637|NCT04058717|470864249|FG000|Randomization Period|Lost to Follow-up|2|||
130791638|NCT04058717|470864250|FG001|Randomization Period|Lost to Follow-up|3|||
130791639|NCT04058717|470864251|FG002|Randomization Period|Lost to Follow-up|4|||
130791640|NCT04058717|470864252|FG003|Randomization Period|Lost to Follow-up|4|||
130791641|NCT04058717|470864249|FG000|Randomization Period|Withdrawal by Subject|1|||
130791642|NCT04058717|470864250|FG001|Randomization Period|Withdrawal by Subject|3|||
130791643|NCT04058717|470864251|FG002|Randomization Period|Withdrawal by Subject|3|||
130791644|NCT04058717|470864252|FG003|Randomization Period|Withdrawal by Subject|3|||
130791645|NCT04058717|470864249|FG000|Randomization Period|PI decision|0|||
130791646|NCT04058717|470864250|FG001|Randomization Period|PI decision|1|||
130791647|NCT04058717|470864251|FG002|Randomization Period|PI decision|0|||
130791648|NCT04058717|470864252|FG003|Randomization Period|PI decision|0|||
130791649|NCT00671788|470864253|FG000|Overall Study|Adverse Event|8|||
130791650|NCT00671788|470864253|FG000|Overall Study|Refused further treatment|3|||
130791651|NCT00671788|470864253|FG000|Overall Study|Ineligible|1|||
130791652|NCT00671788|470864253|FG000|Overall Study|MD Decision|1|||
130791653|NCT00671788|470864253|FG000|Overall Study|Other|1|||
130791654|NCT01035138|470864254|FG000|Overall Study|Adverse Event|4|||
130791655|NCT01035138|470864255|FG001|Overall Study|Adverse Event|0|||
130791656|NCT01035138|470864256|FG002|Overall Study|Adverse Event|2|||
130791657|NCT01035138|470864254|FG000|Overall Study|Caregiver Decision|2|||
130791658|NCT01035138|470864255|FG001|Overall Study|Caregiver Decision|0|||
130791659|NCT01035138|470864256|FG002|Overall Study|Caregiver Decision|1|||
130791660|NCT01035138|470864254|FG000|Overall Study|Withdrawal by Subject|1|||
130791661|NCT01035138|470864255|FG001|Overall Study|Withdrawal by Subject|0|||
130791662|NCT01035138|470864256|FG002|Overall Study|Withdrawal by Subject|0|||
130791663|NCT01035138|470864254|FG000|Overall Study|Physician Decision|0|||
130791664|NCT01035138|470864255|FG001|Overall Study|Physician Decision|0|||
130791665|NCT01035138|470864256|FG002|Overall Study|Physician Decision|1|||
130791666|NCT01035138|470864254|FG000|Overall Study|Sponsor Decision|66|||
130791667|NCT01035138|470864255|FG001|Overall Study|Sponsor Decision|60|||
130791668|NCT01035138|470864256|FG002|Overall Study|Sponsor Decision|42|||
130791669|NCT01035138|470864254|FG000|Overall Study|Lost to Follow-up|0|||
130791670|NCT01035138|470864255|FG001|Overall Study|Lost to Follow-up|0|||
130791671|NCT01035138|470864256|FG002|Overall Study|Lost to Follow-up|1|||
130791672|NCT01832766|470864257|FG000|Washout|Lost to Follow-up|0|||
130791673|NCT01832766|470864258|FG001|Washout|Lost to Follow-up|1|||
130791674|NCT02916927|470864259|FG000|Overall Study|Discharged prior to study drug receipt|0|||
130791675|NCT02916927|470864260|FG001|Overall Study|Discharged prior to study drug receipt|2|||
130791676|NCT02916927|470864259|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
130791677|NCT02916927|470864260|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
130791678|NCT02916927|470864259|FG000|Overall Study|Withdrawal before first time point|1|||
130791679|NCT02916927|470864260|FG001|Overall Study|Withdrawal before first time point|0|||
130791680|NCT00655889|470864261|FG000|Overall Study|Inadequate cell growth|1|||
130791681|NCT00655889|470864261|FG000|Overall Study|Protocol Violation|1|||
130791682|NCT03074500|470864266|FG000|Overall Study|Lost to Follow-up|1|||
130791683|NCT03074500|470864267|FG001|Overall Study|Lost to Follow-up|0|||
130791684|NCT03074500|470864268|FG002|Overall Study|Lost to Follow-up|0|||
130791685|NCT03074500|470864266|FG000|Overall Study|Lack of Efficacy|0|||
130791686|NCT03074500|470864267|FG001|Overall Study|Lack of Efficacy|1|||
130791687|NCT03074500|470864268|FG002|Overall Study|Lack of Efficacy|0|||
130791688|NCT03074500|470864266|FG000|Overall Study|Adverse Event|0|||
130791689|NCT03074500|470864267|FG001|Overall Study|Adverse Event|0|||
130791690|NCT03074500|470864268|FG002|Overall Study|Adverse Event|1|||
130791691|NCT05399680|470865542|FG000|Overall Study|Lost to Follow-up|1|||
130791692|NCT05399680|470865543|FG001|Overall Study|Lost to Follow-up|0|||
130791693|NCT05399680|470865542|FG000|Overall Study|Death|0|||
130791694|NCT05399680|470865543|FG001|Overall Study|Death|1|||
130791695|NCT02659865|470865548|FG000|Period 1|Withdrawal by Subject|1|||
130791696|NCT02659865|470865549|FG001|Period 1|Withdrawal by Subject|0|||
130791697|NCT02659865|470865550|FG002|Period 1|Withdrawal by Subject|0|||
130791698|NCT02659865|470865551|FG003|Period 1|Withdrawal by Subject|0|||
130791699|NCT02659865|470865552|FG004|Period 1|Withdrawal by Subject|0|||
130791700|NCT02659865|470865548|FG000|Period 1|Adverse Event|0|||
130791701|NCT02659865|470865549|FG001|Period 1|Adverse Event|0|||
130791702|NCT02659865|470865550|FG002|Period 1|Adverse Event|0|||
130791703|NCT02659865|470865551|FG003|Period 1|Adverse Event|0|||
130791704|NCT02659865|470865552|FG004|Period 1|Adverse Event|1|||
130791705|NCT01288430|470865554|FG000|Part 1|Progressive disease|2|||
130791706|NCT01288430|470865555|FG001|Part 1|Progressive disease|1|||
130791707|NCT01288430|470865556|FG002|Part 1|Progressive disease|1|||
130791708|NCT01288430|470865557|FG003|Part 1|Progressive disease|6|||
130791709|NCT01288430|470865558|FG004|Part 1|Progressive disease|2|||
130791710|NCT01288430|470865559|FG005|Part 1|Progressive disease|4|||
130791711|NCT01288430|470865560|FG006|Part 1|Progressive disease|2|||
130791712|NCT01288430|470865561|FG007|Part 1|Progressive disease|0|||
130791713|NCT01288430|470865562|FG008|Part 1|Progressive disease|0|||
130791714|NCT01288430|470865563|FG009|Part 1|Progressive disease|0|||
130791715|NCT01288430|470865554|FG000|Part 1|Clinical disease progression|0|||
130791716|NCT01288430|470865555|FG001|Part 1|Clinical disease progression|0|||
130791717|NCT01288430|470865556|FG002|Part 1|Clinical disease progression|1|||
130791718|NCT01288430|470865557|FG003|Part 1|Clinical disease progression|0|||
130791719|NCT01288430|470865558|FG004|Part 1|Clinical disease progression|0|||
130791720|NCT01288430|470865559|FG005|Part 1|Clinical disease progression|2|||
130791721|NCT01288430|470865560|FG006|Part 1|Clinical disease progression|2|||
130791722|NCT01288430|470865561|FG007|Part 1|Clinical disease progression|0|||
130791723|NCT01288430|470865562|FG008|Part 1|Clinical disease progression|0|||
130791724|NCT01288430|470865563|FG009|Part 1|Clinical disease progression|0|||
130791725|NCT01288430|470865554|FG000|Part 1|Death due to disease progression|0|||
130791726|NCT01288430|470865555|FG001|Part 1|Death due to disease progression|0|||
130791727|NCT01288430|470865556|FG002|Part 1|Death due to disease progression|0|||
130791728|NCT01288430|470865557|FG003|Part 1|Death due to disease progression|0|||
130791729|NCT01288430|470865558|FG004|Part 1|Death due to disease progression|1|||
130791730|NCT01288430|470865559|FG005|Part 1|Death due to disease progression|0|||
130791731|NCT01288430|470865560|FG006|Part 1|Death due to disease progression|0|||
130791732|NCT01288430|470865561|FG007|Part 1|Death due to disease progression|0|||
130791733|NCT01288430|470865562|FG008|Part 1|Death due to disease progression|0|||
130791734|NCT01288430|470865563|FG009|Part 1|Death due to disease progression|0|||
130791735|NCT01288430|470865554|FG000|Part 1|Adverse Event|0|||
130791736|NCT01288430|470865555|FG001|Part 1|Adverse Event|0|||
130791737|NCT01288430|470865556|FG002|Part 1|Adverse Event|3|||
130791738|NCT01288430|470865557|FG003|Part 1|Adverse Event|1|||
130791739|NCT01288430|470865558|FG004|Part 1|Adverse Event|0|||
130791740|NCT01288430|470865559|FG005|Part 1|Adverse Event|0|||
130791741|NCT01288430|470865560|FG006|Part 1|Adverse Event|2|||
130791742|NCT01288430|470865561|FG007|Part 1|Adverse Event|0|||
130791743|NCT01288430|470865562|FG008|Part 1|Adverse Event|0|||
130791744|NCT01288430|470865563|FG009|Part 1|Adverse Event|0|||
130791745|NCT01288430|470865554|FG000|Part 1|Other|0|||
130791746|NCT01288430|470865555|FG001|Part 1|Other|2|||
130791747|NCT01288430|470865556|FG002|Part 1|Other|0|||
130791748|NCT01288430|470865557|FG003|Part 1|Other|0|||
130791749|NCT01288430|470865558|FG004|Part 1|Other|0|||
130791750|NCT01288430|470865559|FG005|Part 1|Other|0|||
130791751|NCT01288430|470865560|FG006|Part 1|Other|1|||
130791752|NCT01288430|470865561|FG007|Part 1|Other|0|||
130791753|NCT01288430|470865562|FG008|Part 1|Other|0|||
130791754|NCT01288430|470865563|FG009|Part 1|Other|0|||
130791755|NCT01288430|470865554|FG000|Part 2|Progressive disease|0|||
130791756|NCT01288430|470865555|FG001|Part 2|Progressive disease|0|||
130791757|NCT01288430|470865556|FG002|Part 2|Progressive disease|0|||
130791758|NCT01288430|470865557|FG003|Part 2|Progressive disease|0|||
130791759|NCT01288430|470865558|FG004|Part 2|Progressive disease|0|||
130791760|NCT01288430|470865559|FG005|Part 2|Progressive disease|0|||
130791761|NCT01288430|470865560|FG006|Part 2|Progressive disease|0|||
130791762|NCT01288430|470865561|FG007|Part 2|Progressive disease|8|||
130791763|NCT01288430|470865562|FG008|Part 2|Progressive disease|7|||
130791764|NCT01288430|470865563|FG009|Part 2|Progressive disease|2|||
130791765|NCT01288430|470865554|FG000|Part 2|Clinical disease progression|0|||
130791766|NCT01288430|470865555|FG001|Part 2|Clinical disease progression|0|||
130791767|NCT01288430|470865556|FG002|Part 2|Clinical disease progression|0|||
130791768|NCT01288430|470865557|FG003|Part 2|Clinical disease progression|0|||
130791769|NCT01288430|470865558|FG004|Part 2|Clinical disease progression|0|||
130791770|NCT01288430|470865559|FG005|Part 2|Clinical disease progression|0|||
130791771|NCT01288430|470865560|FG006|Part 2|Clinical disease progression|0|||
130791772|NCT01288430|470865561|FG007|Part 2|Clinical disease progression|2|||
130791773|NCT01288430|470865562|FG008|Part 2|Clinical disease progression|0|||
130791774|NCT01288430|470865563|FG009|Part 2|Clinical disease progression|0|||
130791775|NCT01288430|470865554|FG000|Part 2|Withdrawal by Subject|0|||
130791776|NCT01288430|470865555|FG001|Part 2|Withdrawal by Subject|0|||
130791777|NCT01288430|470865556|FG002|Part 2|Withdrawal by Subject|0|||
130791778|NCT01288430|470865557|FG003|Part 2|Withdrawal by Subject|0|||
130791779|NCT01288430|470865558|FG004|Part 2|Withdrawal by Subject|0|||
130791780|NCT01288430|470865559|FG005|Part 2|Withdrawal by Subject|0|||
130791781|NCT01288430|470865560|FG006|Part 2|Withdrawal by Subject|0|||
130791782|NCT01288430|470865561|FG007|Part 2|Withdrawal by Subject|1|||
130791783|NCT01288430|470865562|FG008|Part 2|Withdrawal by Subject|4|||
130791784|NCT01288430|470865563|FG009|Part 2|Withdrawal by Subject|0|||
130791785|NCT01288430|470865554|FG000|Part 2|Adverse Event|0|||
130791786|NCT01288430|470865555|FG001|Part 2|Adverse Event|0|||
130791787|NCT01288430|470865556|FG002|Part 2|Adverse Event|0|||
130791788|NCT01288430|470865557|FG003|Part 2|Adverse Event|0|||
130791789|NCT01288430|470865558|FG004|Part 2|Adverse Event|0|||
130791790|NCT01288430|470865559|FG005|Part 2|Adverse Event|0|||
130791791|NCT01288430|470865560|FG006|Part 2|Adverse Event|0|||
130791792|NCT01288430|470865561|FG007|Part 2|Adverse Event|1|||
130791793|NCT01288430|470865562|FG008|Part 2|Adverse Event|1|||
130791794|NCT01288430|470865563|FG009|Part 2|Adverse Event|0|||
130791795|NCT01288430|470865554|FG000|Part 2|Other|0|||
130791796|NCT01288430|470865555|FG001|Part 2|Other|0|||
130791797|NCT01288430|470865556|FG002|Part 2|Other|0|||
130791798|NCT01288430|470865557|FG003|Part 2|Other|0|||
130791799|NCT01288430|470865558|FG004|Part 2|Other|0|||
130791800|NCT01288430|470865559|FG005|Part 2|Other|0|||
130791801|NCT01288430|470865560|FG006|Part 2|Other|0|||
130791802|NCT01288430|470865561|FG007|Part 2|Other|0|||
130791803|NCT01288430|470865562|FG008|Part 2|Other|0|||
130791804|NCT01288430|470865563|FG009|Part 2|Other|1|||
130791805|NCT00362232|470865564|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
130791806|NCT00362232|470865565|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
130791807|NCT00362232|470865564|FG000|Treatment (12 +/- 2 Days)|Death|1|||
130791808|NCT00362232|470865565|FG001|Treatment (12 +/- 2 Days)|Death|3|||
130791809|NCT00362232|470865564|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
130791810|NCT00362232|470865565|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
130791811|NCT00362232|470865564|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
130791812|NCT00362232|470865565|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
130791813|NCT00362232|470865564|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
130791814|NCT00362232|470865565|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
130791815|NCT00362232|470865564|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
130791816|NCT00362232|470865565|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
130791817|NCT00362232|470865564|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
130791818|NCT00362232|470865565|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
130791819|NCT00362232|470865564|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
130791820|NCT00362232|470865565|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
130791821|NCT00362232|470865564|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
130791822|NCT00362232|470865565|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
130791823|NCT00362232|470865564|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
130791824|NCT00362232|470865565|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
130791825|NCT00362232|470865564|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
130791826|NCT00362232|470865565|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
130791827|NCT00362232|470865564|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
130791828|NCT00362232|470865565|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
130791829|NCT00362232|470865564|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
130791830|NCT00362232|470865565|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
130791831|NCT02233413|470865568|FG000|Overall Study|Lost to Follow-up|7|||
130791832|NCT02233413|470865569|FG001|Overall Study|Lost to Follow-up|9|||
130791833|NCT02233413|470865568|FG000|Overall Study|Withdrawal by Subject|4|||
130791834|NCT02233413|470865569|FG001|Overall Study|Withdrawal by Subject|5|||
130791835|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
130791836|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
130791837|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
130791838|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
130791839|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
130791840|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
130791841|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
130791842|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
130791843|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
130791844|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
130791845|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
130791846|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
130791847|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
130791848|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
130791849|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
130791850|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
130791851|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
130791852|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
130791853|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
130791854|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
130791855|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
130791856|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
130791857|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
130791858|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
130791859|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
130791860|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
130791861|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
130791862|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
130791863|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
130791864|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
130791865|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
130791866|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
130791867|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
130791868|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
130791869|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
130791870|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
130791871|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
130791872|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
130791873|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
130791874|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
130791875|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
130791876|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
130791877|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
130791878|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
130791879|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
130791880|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
130791881|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
130791882|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
130791883|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
130791884|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
130791885|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
130791886|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
130791887|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
130791888|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
130791889|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
130791890|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
130791891|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
130791892|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
130791893|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
130791894|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
130791895|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
130791896|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
130791897|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
130791898|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
130791899|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
130791900|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
130791901|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
130791902|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
130791903|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
130791904|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
130791905|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
130791906|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
130791907|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
130791908|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
130791909|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
130791910|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
130791911|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
130791912|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
130791913|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
130791914|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
130791915|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
130791916|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
130791917|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
130791918|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
130791919|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
130791920|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
130791921|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
130791922|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
130791923|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
130791924|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
130791925|NCT00090103|470865570|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
130791926|NCT00090103|470865571|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
130791927|NCT00090103|470865572|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
130791928|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
130791929|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
130791930|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
130791931|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
130791932|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
130791933|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
130791934|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
130791935|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
130791936|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
130791937|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
130791938|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
130791939|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
130791940|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
130791941|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
130791942|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
130791943|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
130791944|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
130791945|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
130791946|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
130791947|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
130791948|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
130791949|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
130791950|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
130791951|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
130791952|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
130791953|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
130791954|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
130791955|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
130791956|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
130791957|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
130791958|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
130791959|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
130791960|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
130791961|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
130791962|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
130791963|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
130791964|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
130791965|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
130791966|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
130791967|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
130791968|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
130791969|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
130791970|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
130791971|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
130791972|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
130791973|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
130791974|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
130791975|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
130791976|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Death|1|||
130791977|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Death|0|||
130791978|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Death|1|||
130791979|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
130791980|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
130791981|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
130791982|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
130791983|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
130791984|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
130791985|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
130791986|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
130791987|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
130791988|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
130791989|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
130791990|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
130791991|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
130791992|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
130791993|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
130791994|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
130791995|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
130791996|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
130791997|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
130791998|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
130791999|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
130792000|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Depression|0|||
130792001|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Depression|1|||
130792002|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Depression|0|||
130792003|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
130792004|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
130792005|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
130792006|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Jailed|0|||
130792007|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Jailed|1|||
130792008|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Jailed|0|||
130792009|NCT00090103|470865570|FG000|16-Week Safety Follow-up Period|Other|0|||
130792010|NCT00090103|470865571|FG001|16-Week Safety Follow-up Period|Other|1|||
130792011|NCT00090103|470865572|FG002|16-Week Safety Follow-up Period|Other|0|||
130792012|NCT03979313|470865573|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
130792013|NCT03979313|470865574|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
130792014|NCT03979313|470865573|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
130792015|NCT03979313|470865574|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
130792016|NCT03979313|470865573|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
130792017|NCT03979313|470865574|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
130792018|NCT03979313|470865573|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
130792019|NCT03979313|470865574|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
130792020|NCT03979313|470865573|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
130792021|NCT03979313|470865574|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
130792022|NCT03979313|470865573|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
130792023|NCT03979313|470865574|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
130792024|NCT03979313|470865573|FG000|All Subjects|Any Other Reason|16|||
130792025|NCT03979313|470865574|FG001|All Subjects|Any Other Reason|23|||
130792026|NCT03979313|470865573|FG000|All Subjects|Covid-19|1|||
130792027|NCT03979313|470865574|FG001|All Subjects|Covid-19|3|||
130792028|NCT03979313|470865573|FG000|All Subjects|Withdrawal by Subject|35|||
130792029|NCT03979313|470865574|FG001|All Subjects|Withdrawal by Subject|44|||
130792030|NCT03979313|470865573|FG000|All Subjects|Death|0|||
130792031|NCT03979313|470865574|FG001|All Subjects|Death|5|||
130792032|NCT03979313|470865573|FG000|All Subjects|Lost to Follow-up|28|||
130792033|NCT03979313|470865574|FG001|All Subjects|Lost to Follow-up|61|||
130792034|NCT00300053|470865575|FG000|Overall Study|Patient/Caregiver Preference|2|||
130792035|NCT00300053|470865576|FG001|Overall Study|Patient/Caregiver Preference|2|||
130792036|NCT00300053|470865577|FG002|Overall Study|Patient/Caregiver Preference|3|||
130792037|NCT00300053|470865575|FG000|Overall Study|Death|0|||
130792038|NCT00300053|470865576|FG001|Overall Study|Death|0|||
130792039|NCT00300053|470865577|FG002|Overall Study|Death|3|||
130792040|NCT00300053|470865575|FG000|Overall Study|Lost to Follow-up|0|||
130792041|NCT00300053|470865576|FG001|Overall Study|Lost to Follow-up|1|||
130792042|NCT00300053|470865577|FG002|Overall Study|Lost to Follow-up|0|||
130792043|NCT02472405|470865581|FG000|Overall Study|Lost to Follow-up|9|||
130792044|NCT02472405|470865581|FG000|Overall Study|Adverse Event|1|||
130792045|NCT02471183|470865582|FG000|Main Treatment Period|Adverse Event|1|||
130792046|NCT02471183|470865582|FG000|Main Treatment Period|Withdrawal by Subject|1|||
130792047|NCT02471183|470865582|FG000|Extended Treatment Period|Lack of Efficacy|1|||
130792048|NCT02690727|470865583|FG000|Overall Study|Adverse Event|2|||
130792049|NCT02690727|470865584|FG001|Overall Study|Adverse Event|2|||
130792050|NCT02736617|470865590|FG000|Treatment|Adverse Event|1|||
130792051|NCT02736617|470865590|FG000|Treatment|Lack of Efficacy|1|||
130792052|NCT02736617|470865590|FG000|Treatment|Withdrawal by Subject|1|||
130792053|NCT02736617|470865590|FG000|Maintenance|Lack of Efficacy|4|||
130792054|NCT02736617|470865590|FG000|Maintenance|Physician Decision|1|||
130792055|NCT02911116|470865595|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130792056|NCT02911116|470865596|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130792057|NCT02911116|470865595|FG000|Overall Study|Lost to Follow-up|0|||
130792058|NCT02911116|470865596|FG001|Overall Study|Lost to Follow-up|1|||
130792059|NCT02469857|470865597|FG000|Overall Study|Death|24|||
130792060|NCT02469857|470865598|FG001|Overall Study|Death|29|||
130792061|NCT02469857|470865597|FG000|Overall Study|Discontinuation|1|||
130792062|NCT02469857|470865598|FG001|Overall Study|Discontinuation|3|||
130792063|NCT02110693|470865599|FG000|Overall Study|Withdrawal by Subject|6|||
130792064|NCT02110693|470865600|FG001|Overall Study|Withdrawal by Subject|7|||
130792065|NCT02110693|470865599|FG000|Overall Study|skipped assessment|15|||
130792066|NCT02110693|470865600|FG001|Overall Study|skipped assessment|18|||
130792067|NCT02110693|470865599|FG000|Overall Study|technical difficulties|6|||
130792068|NCT02110693|470865600|FG001|Overall Study|technical difficulties|4|||
130792069|NCT02110693|470865599|FG000|Overall Study|Other|1|||
130792070|NCT02110693|470865600|FG001|Overall Study|Other|0|||
130792071|NCT04810962|470865601|FG000|Overall Study|Adverse Event|0|||
130792072|NCT04810962|470865602|FG001|Overall Study|Adverse Event|1|||
130792073|NCT04810962|470865601|FG000|Overall Study|Lost to Follow-up|2|||
130792074|NCT04810962|470865602|FG001|Overall Study|Lost to Follow-up|1|||
130792075|NCT04810962|470865601|FG000|Overall Study|Physician Decision|1|||
130792076|NCT04810962|470865602|FG001|Overall Study|Physician Decision|0|||
130792077|NCT04810962|470865601|FG000|Overall Study|Withdrawal by Subject|1|||
130792078|NCT04810962|470865602|FG001|Overall Study|Withdrawal by Subject|3|||
130792079|NCT04810962|470865601|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
130792080|NCT04810962|470865602|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
130792081|NCT00805532|470865603|FG000|Overall Study|invalid data|0|||
130792082|NCT00805532|470865604|FG001|Overall Study|invalid data|1|||
130792083|NCT01859741|470865605|FG000|Overall Study|Death|3|||
130792084|NCT01859741|470865606|FG001|Overall Study|Death|2|||
130792085|NCT01859741|470865607|FG002|Overall Study|Death|4|||
130792086|NCT01859741|470865608|FG003|Overall Study|Death|3|||
130792087|NCT01859741|470865609|FG004|Overall Study|Death|5|||
130792088|NCT01859741|470865610|FG005|Overall Study|Death|4|||
130792089|NCT01859741|470865611|FG006|Overall Study|Death|51|||
130792090|NCT01859741|470865612|FG007|Overall Study|Death|51|||
130792091|NCT01859741|470865605|FG000|Overall Study|Lost to Follow-up|0|||
130792092|NCT01859741|470865606|FG001|Overall Study|Lost to Follow-up|0|||
130792093|NCT01859741|470865607|FG002|Overall Study|Lost to Follow-up|0|||
130792094|NCT01859741|470865608|FG003|Overall Study|Lost to Follow-up|0|||
130792095|NCT01859741|470865609|FG004|Overall Study|Lost to Follow-up|0|||
130792096|NCT01859741|470865610|FG005|Overall Study|Lost to Follow-up|1|||
130792097|NCT01859741|470865611|FG006|Overall Study|Lost to Follow-up|0|||
130792098|NCT01859741|470865612|FG007|Overall Study|Lost to Follow-up|4|||
130792099|NCT01859741|470865605|FG000|Overall Study|Withdrawal by Subject|0|||
130792100|NCT01859741|470865606|FG001|Overall Study|Withdrawal by Subject|1|||
130792101|NCT01859741|470865607|FG002|Overall Study|Withdrawal by Subject|2|||
130792102|NCT01859741|470865608|FG003|Overall Study|Withdrawal by Subject|0|||
130792103|NCT01859741|470865609|FG004|Overall Study|Withdrawal by Subject|0|||
130792104|NCT01859741|470865610|FG005|Overall Study|Withdrawal by Subject|1|||
130792105|NCT01859741|470865611|FG006|Overall Study|Withdrawal by Subject|1|||
130792106|NCT01859741|470865612|FG007|Overall Study|Withdrawal by Subject|1|||
130792107|NCT01859741|470865605|FG000|Overall Study|Study Terminated by Sponsor|0|||
130792108|NCT01859741|470865606|FG001|Overall Study|Study Terminated by Sponsor|0|||
130792109|NCT01859741|470865607|FG002|Overall Study|Study Terminated by Sponsor|0|||
130792110|NCT01859741|470865608|FG003|Overall Study|Study Terminated by Sponsor|0|||
130792111|NCT01859741|470865609|FG004|Overall Study|Study Terminated by Sponsor|1|||
130792112|NCT01859741|470865610|FG005|Overall Study|Study Terminated by Sponsor|0|||
130792113|NCT01859741|470865611|FG006|Overall Study|Study Terminated by Sponsor|16|||
130792114|NCT01859741|470865612|FG007|Overall Study|Study Terminated by Sponsor|14|||
130792115|NCT01859741|470865605|FG000|Overall Study|Other|0|||
130792116|NCT01859741|470865606|FG001|Overall Study|Other|0|||
130792117|NCT01859741|470865607|FG002|Overall Study|Other|0|||
130792118|NCT01859741|470865608|FG003|Overall Study|Other|0|||
130792119|NCT01859741|470865609|FG004|Overall Study|Other|0|||
130792120|NCT01859741|470865610|FG005|Overall Study|Other|0|||
130792121|NCT01859741|470865611|FG006|Overall Study|Other|2|||
130792122|NCT01859741|470865612|FG007|Overall Study|Other|0|||
130792123|NCT02412657|470865616|FG000|Overall Study|Lost to Follow-up|1|||
130792124|NCT02412657|470865617|FG001|Overall Study|Lost to Follow-up|0|||
130792125|NCT02412657|470865618|FG002|Overall Study|Lost to Follow-up|0|||
130792126|NCT02412657|470865616|FG000|Overall Study|Protocol Violation|0|||
130792127|NCT02412657|470865617|FG001|Overall Study|Protocol Violation|2|||
130792128|NCT02412657|470865618|FG002|Overall Study|Protocol Violation|3|||
130792129|NCT02701634|470865623|FG000|Overall Study|Adverse Event|2|||
130792130|NCT02701634|470865624|FG001|Overall Study|Adverse Event|3|||
130792131|NCT02701634|470865623|FG000|Overall Study|Death|1|||
130792132|NCT02701634|470865624|FG001|Overall Study|Death|0|||
130792133|NCT02701634|470865623|FG000|Overall Study|Investigator's Discretion|7|||
130792134|NCT02701634|470865624|FG001|Overall Study|Investigator's Discretion|4|||
130792135|NCT02701634|470865623|FG000|Overall Study|Study terminated by Sponsor|15|||
130792136|NCT02701634|470865624|FG001|Overall Study|Study terminated by Sponsor|17|||
130792137|NCT02701634|470865623|FG000|Overall Study|Withdrew Consent|6|||
130792138|NCT02701634|470865624|FG001|Overall Study|Withdrew Consent|7|||
130792139|NCT02701634|470865623|FG000|Overall Study|Randomized but not treated|1|||
130792140|NCT02701634|470865624|FG001|Overall Study|Randomized but not treated|0|||
130792141|NCT01033136|470865625|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
130792142|NCT01033136|470865626|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
130792143|NCT00630292|470865627|FG000|Overall Study|Withdrawal by Subject|1|||
130792144|NCT00142415|470865630|FG000|Overall Study|Physician Decision|0|||
130792145|NCT00142415|470865631|FG001|Overall Study|Physician Decision|0|||
130792146|NCT00142415|470865632|FG002|Overall Study|Physician Decision|0|||
130792147|NCT00142415|470865633|FG003|Overall Study|Physician Decision|0|||
130792148|NCT00142415|470865634|FG004|Overall Study|Physician Decision|1|||
130792149|NCT00142415|470865635|FG005|Overall Study|Physician Decision|2|||
130792150|NCT01189266|470865638|FG000|Overall Study|Adverse Event|1|||
130792151|NCT01189266|470865639|FG001|Overall Study|Adverse Event|0|||
130792152|NCT01189266|470865640|FG002|Overall Study|Adverse Event|5|||
130792153|NCT01189266|470865638|FG000|Overall Study|Death|0|||
130792154|NCT01189266|470865639|FG001|Overall Study|Death|0|||
130792155|NCT01189266|470865640|FG002|Overall Study|Death|5|||
130792156|NCT01189266|470865638|FG000|Overall Study|Lack of Efficacy|4|||
130792157|NCT01189266|470865639|FG001|Overall Study|Lack of Efficacy|5|||
130792158|NCT01189266|470865640|FG002|Overall Study|Lack of Efficacy|44|||
130792159|NCT01189266|470865638|FG000|Overall Study|Physician Decision|0|||
130792160|NCT01189266|470865639|FG001|Overall Study|Physician Decision|0|||
130792161|NCT01189266|470865640|FG002|Overall Study|Physician Decision|1|||
130792162|NCT01189266|470865638|FG000|Overall Study|Protocol Violation|0|||
130792163|NCT01189266|470865639|FG001|Overall Study|Protocol Violation|1|||
130792164|NCT01189266|470865640|FG002|Overall Study|Protocol Violation|1|||
130792165|NCT01189266|470865638|FG000|Overall Study|Withdrawal by Subject|0|||
130792166|NCT01189266|470865639|FG001|Overall Study|Withdrawal by Subject|0|||
130792167|NCT01189266|470865640|FG002|Overall Study|Withdrawal by Subject|1|||
130792168|NCT01189266|470865638|FG000|Overall Study|Patient refuses further therapy|1|||
130792169|NCT01189266|470865639|FG001|Overall Study|Patient refuses further therapy|0|||
130792170|NCT01189266|470865640|FG002|Overall Study|Patient refuses further therapy|7|||
130792171|NCT01189266|470865638|FG000|Overall Study|No treatment|0|||
130792172|NCT01189266|470865639|FG001|Overall Study|No treatment|0|||
130792173|NCT01189266|470865640|FG002|Overall Study|No treatment|1|||
130792174|NCT04009837|470865641|FG000|Overall Study|Withdrawal by Subject|5|||
130792175|NCT04009837|470865642|FG001|Overall Study|Withdrawal by Subject|4|||
130792176|NCT04009837|470865641|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
130792177|NCT04009837|470865642|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
130792178|NCT03530696|470865645|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
130792179|NCT03530696|470865646|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
130792180|NCT02472353|470865647|FG000|Overall Study|Lost to Follow-up|1|||
130792181|NCT02472353|470865648|FG001|Overall Study|Lost to Follow-up|1|||
130792182|NCT02472353|470865647|FG000|Overall Study|Withdrawal by Subject|2|||
130792183|NCT02472353|470865648|FG001|Overall Study|Withdrawal by Subject|1|||
130792184|NCT02472353|470865647|FG000|Overall Study|Study Termination|1|||
130792185|NCT02472353|470865648|FG001|Overall Study|Study Termination|4|||
130792186|NCT03416179|470865649|FG000|Overall Study|Death|90|||
130792187|NCT03416179|470865650|FG001|Overall Study|Death|87|||
130792188|NCT03416179|470865651|FG002|Overall Study|Death|117|||
130792189|NCT03416179|470865652|FG003|Overall Study|Death|113|||
130792190|NCT03416179|470865649|FG000|Overall Study|Withdrawal by Subject|15|||
130792191|NCT03416179|470865650|FG001|Overall Study|Withdrawal by Subject|20|||
130792192|NCT03416179|470865651|FG002|Overall Study|Withdrawal by Subject|6|||
130792193|NCT03416179|470865652|FG003|Overall Study|Withdrawal by Subject|9|||
130792194|NCT03416179|470865649|FG000|Overall Study|Lost to Follow-up|1|||
130792195|NCT03416179|470865650|FG001|Overall Study|Lost to Follow-up|1|||
130792196|NCT03416179|470865651|FG002|Overall Study|Lost to Follow-up|0|||
130792197|NCT03416179|470865652|FG003|Overall Study|Lost to Follow-up|3|||
130792198|NCT03416179|470865649|FG000|Overall Study|Study participation terminated by Sponsor|93|||
130792199|NCT03416179|470865650|FG001|Overall Study|Study participation terminated by Sponsor|91|||
130792200|NCT03416179|470865651|FG002|Overall Study|Study participation terminated by Sponsor|26|||
130792201|NCT03416179|470865652|FG003|Overall Study|Study participation terminated by Sponsor|31|||
130792202|NCT03416179|470865649|FG000|Overall Study|Other|2|||
130792203|NCT03416179|470865650|FG001|Overall Study|Other|3|||
130792204|NCT03416179|470865651|FG002|Overall Study|Other|1|||
130792205|NCT03416179|470865652|FG003|Overall Study|Other|0|||
130792206|NCT04585893|470865672|FG000|Overall Study|Death|1|||
130792207|NCT04585893|470865673|FG001|Overall Study|Death|0|||
130792208|NCT01366092|470865674|FG000|Overall Study|Progressive cGVHD|2|||
130792209|NCT01366092|470865674|FG000|Overall Study|Physician Decision|1|||
130792210|NCT01366092|470865674|FG000|Overall Study|Withdrawal by Subject|1|||
130792211|NCT03608163|470865675|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
130792212|NCT03608163|470865676|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
130792213|NCT04530630|470867172|FG000|Overall Study|Physician Decision|1|||
130792214|NCT03675308|470867175|FG000|Overall Study|Adverse Event|3|||
130792215|NCT03675308|470867176|FG001|Overall Study|Adverse Event|2|||
130792216|NCT03675308|470867175|FG000|Overall Study|Withdrawal by Subject|6|||
130792217|NCT03675308|470867176|FG001|Overall Study|Withdrawal by Subject|4|||
130792218|NCT03675308|470867175|FG000|Overall Study|Lost to Follow-up|3|||
130792219|NCT03675308|470867176|FG001|Overall Study|Lost to Follow-up|0|||
130792220|NCT03675308|470867175|FG000|Overall Study|Lack of Efficacy|1|||
130792221|NCT03675308|470867176|FG001|Overall Study|Lack of Efficacy|1|||
130792222|NCT03675308|470867175|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
130792223|NCT03675308|470867176|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
130792224|NCT03675308|470867175|FG000|Overall Study|Other|0|||
130792225|NCT03675308|470867176|FG001|Overall Study|Other|1|||
130792226|NCT03836053|470867185|FG000|Overall Study|Protocol-specified criteria|0|||
130792227|NCT03836053|470867186|FG001|Overall Study|Protocol-specified criteria|2|||
130792228|NCT03836053|470867187|FG002|Overall Study|Protocol-specified criteria|1|||
130792229|NCT03836053|470867185|FG000|Overall Study|Death|1|||
130792230|NCT03836053|470867186|FG001|Overall Study|Death|6|||
130792231|NCT03836053|470867187|FG002|Overall Study|Death|4|||
130792232|NCT03836053|470867185|FG000|Overall Study|Withdrawal of consent from study|0|||
130792233|NCT03836053|470867186|FG001|Overall Study|Withdrawal of consent from study|0|||
130792234|NCT03836053|470867187|FG002|Overall Study|Withdrawal of consent from study|1|||
130792235|NCT03836053|470867185|FG000|Overall Study|Decision by sponsor|0|||
130792236|NCT03836053|470867186|FG001|Overall Study|Decision by sponsor|2|||
130792237|NCT03836053|470867187|FG002|Overall Study|Decision by sponsor|4|||
130792238|NCT00788671|470867188|FG000|Overall Study|Death|2|||
130792239|NCT00788671|470867188|FG000|Overall Study|Unable to biopsy|1|||
130792240|NCT00788671|470867188|FG000|Overall Study|Withdrawal by Subject|4|||
130792241|NCT00788671|470867188|FG000|Overall Study|IUD expulsed|1|||
130792242|NCT00788671|470867188|FG000|Overall Study|Lost to follow up|2|||
130792243|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
130792244|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
130792245|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
130792246|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|Death|1|||
130792247|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|Death|1|||
130792248|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|Death|0|||
130792249|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
130792250|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
130792251|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
130792252|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
130792253|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
130792254|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
130792255|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
130792256|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
130792257|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
130792258|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
130792259|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
130792260|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
130792261|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
130792262|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
130792263|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
130792264|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
130792265|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
130792266|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
130792267|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
130792268|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
130792269|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
130792270|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
130792271|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
130792272|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
130792273|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|Other|10|||
130792274|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|Other|4|||
130792275|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|Other|0|||
130792276|NCT04006457|470867189|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
130792277|NCT04006457|470867190|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
130792278|NCT04006457|470867191|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
130792279|NCT04006457|470867189|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
130792280|NCT04006457|470867190|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
130792281|NCT04006457|470867191|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
130792282|NCT04006457|470867189|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
130792283|NCT04006457|470867190|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
130792284|NCT04006457|470867191|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
130792285|NCT04006457|470867189|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
130792286|NCT04006457|470867190|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
130792287|NCT04006457|470867191|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
130792288|NCT04006457|470867189|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
130792289|NCT04006457|470867190|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
130792290|NCT04006457|470867191|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
130792291|NCT04006457|470867189|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
130792292|NCT04006457|470867190|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
130792293|NCT04006457|470867191|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
130792294|NCT04006457|470867189|FG000|Main Study: Treatment Period 2|Other|2|||
130792295|NCT04006457|470867190|FG001|Main Study: Treatment Period 2|Other|3|||
130792296|NCT04006457|470867191|FG002|Main Study: Treatment Period 2|Other|0|||
130792297|NCT04006457|470867189|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
130792298|NCT04006457|470867190|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
130792299|NCT04006457|470867191|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
130792300|NCT04006457|470867189|FG000|Main Study: Treatment Period 2|Ongoing|86|||
130792301|NCT04006457|470867190|FG001|Main Study: Treatment Period 2|Ongoing|96|||
130792302|NCT04006457|470867191|FG002|Main Study: Treatment Period 2|Ongoing|0|||
130792303|NCT04006457|470867189|FG000|Main Study Observation Period|Adverse Event|1|||
130792304|NCT04006457|470867190|FG001|Main Study Observation Period|Adverse Event|1|||
130792305|NCT04006457|470867191|FG002|Main Study Observation Period|Adverse Event|0|||
130792306|NCT04006457|470867189|FG000|Main Study Observation Period|Lost to Follow-up|0|||
130792307|NCT04006457|470867190|FG001|Main Study Observation Period|Lost to Follow-up|1|||
130792308|NCT04006457|470867191|FG002|Main Study Observation Period|Lost to Follow-up|0|||
130792309|NCT04006457|470867189|FG000|Main Study Observation Period|Pregnancy|1|||
130792310|NCT04006457|470867190|FG001|Main Study Observation Period|Pregnancy|0|||
130792311|NCT04006457|470867191|FG002|Main Study Observation Period|Pregnancy|0|||
130792312|NCT04006457|470867189|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
130792313|NCT04006457|470867190|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
130792314|NCT04006457|470867191|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
130792315|NCT04006457|470867189|FG000|Main Study Observation Period|Other|8|||
130792316|NCT04006457|470867190|FG001|Main Study Observation Period|Other|16|||
130792317|NCT04006457|470867191|FG002|Main Study Observation Period|Other|0|||
130792318|NCT04006457|470867189|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
130792319|NCT04006457|470867190|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
130792320|NCT04006457|470867191|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
130792321|NCT04006457|470867189|FG000|Main Study Observation Period|Ongoing|2|||
130792322|NCT04006457|470867190|FG001|Main Study Observation Period|Ongoing|1|||
130792323|NCT04006457|470867191|FG002|Main Study Observation Period|Ongoing|0|||
130792324|NCT04006457|470867189|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
130792325|NCT04006457|470867190|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
130792326|NCT04006457|470867191|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
130792327|NCT04486716|470867192|FG000|Core Phase|Subject decision|6|||
130792328|NCT04486716|470867192|FG000|Core Phase|Adverse Event|5|||
130792329|NCT04486716|470867192|FG000|Core Phase|Lost to Follow-up|1|||
130792330|NCT04486716|470867192|FG000|Core Phase|Physician Decision|1|||
130792331|NCT04486716|470867192|FG000|Core Phase|Enrolled subjects not treated|9|||
130792332|NCT05172609|470867193|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
130792333|NCT05172609|470867194|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
130792334|NCT05172609|470867193|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
130792335|NCT05172609|470867194|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
130792336|NCT05172609|470867193|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
130792337|NCT05172609|470867194|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
130792338|NCT02332707|470867195|FG000|Overall Study|Adverse Event|0|||
130792339|NCT02332707|470867196|FG001|Overall Study|Adverse Event|0|||
130792340|NCT02332707|470867197|FG002|Overall Study|Adverse Event|0|||
130792341|NCT02332707|470867198|FG003|Overall Study|Adverse Event|0|||
130792342|NCT02332707|470867199|FG004|Overall Study|Adverse Event|0|||
130792343|NCT02332707|470867200|FG005|Overall Study|Adverse Event|0|||
130792344|NCT02332707|470867201|FG006|Overall Study|Adverse Event|0|||
130792345|NCT02332707|470867202|FG007|Overall Study|Adverse Event|0|||
130792346|NCT02332707|470867203|FG008|Overall Study|Adverse Event|0|||
130792347|NCT02332707|470867204|FG009|Overall Study|Adverse Event|0|||
130792348|NCT02332707|470867205|FG010|Overall Study|Adverse Event|0|||
130792349|NCT02332707|470867206|FG011|Overall Study|Adverse Event|0|||
130792350|NCT02332707|470867207|FG012|Overall Study|Adverse Event|1|||
130792351|NCT02332707|470867208|FG013|Overall Study|Adverse Event|0|||
130792352|NCT02332707|470867209|FG014|Overall Study|Adverse Event|0|||
130792353|NCT02332707|470867210|FG015|Overall Study|Adverse Event|0|||
130792354|NCT02332707|470867211|FG016|Overall Study|Adverse Event|0|||
130792355|NCT02332707|470867212|FG017|Overall Study|Adverse Event|0|||
130792356|NCT02332707|470867195|FG000|Overall Study|Lost to Follow-up|0|||
130792357|NCT02332707|470867196|FG001|Overall Study|Lost to Follow-up|0|||
130792358|NCT02332707|470867197|FG002|Overall Study|Lost to Follow-up|0|||
130792359|NCT02332707|470867198|FG003|Overall Study|Lost to Follow-up|0|||
130792360|NCT02332707|470867199|FG004|Overall Study|Lost to Follow-up|0|||
130792361|NCT02332707|470867200|FG005|Overall Study|Lost to Follow-up|1|||
130792362|NCT02332707|470867201|FG006|Overall Study|Lost to Follow-up|0|||
130792363|NCT02332707|470867202|FG007|Overall Study|Lost to Follow-up|0|||
130792364|NCT02332707|470867203|FG008|Overall Study|Lost to Follow-up|0|||
130792365|NCT02332707|470867204|FG009|Overall Study|Lost to Follow-up|0|||
130792366|NCT02332707|470867205|FG010|Overall Study|Lost to Follow-up|2|||
130792367|NCT02332707|470867206|FG011|Overall Study|Lost to Follow-up|0|||
130792368|NCT02332707|470867207|FG012|Overall Study|Lost to Follow-up|3|||
130792369|NCT02332707|470867208|FG013|Overall Study|Lost to Follow-up|0|||
130792370|NCT02332707|470867209|FG014|Overall Study|Lost to Follow-up|0|||
130792371|NCT02332707|470867210|FG015|Overall Study|Lost to Follow-up|0|||
130792372|NCT02332707|470867211|FG016|Overall Study|Lost to Follow-up|0|||
130792373|NCT02332707|470867212|FG017|Overall Study|Lost to Follow-up|0|||
130792374|NCT02332707|470867195|FG000|Overall Study|Physician Decision|0|||
130792375|NCT02332707|470867196|FG001|Overall Study|Physician Decision|0|||
130792376|NCT02332707|470867197|FG002|Overall Study|Physician Decision|0|||
130792377|NCT02332707|470867198|FG003|Overall Study|Physician Decision|1|||
130792378|NCT02332707|470867199|FG004|Overall Study|Physician Decision|0|||
130792379|NCT02332707|470867200|FG005|Overall Study|Physician Decision|0|||
130792380|NCT02332707|470867201|FG006|Overall Study|Physician Decision|0|||
130792381|NCT02332707|470867202|FG007|Overall Study|Physician Decision|0|||
130792382|NCT02332707|470867203|FG008|Overall Study|Physician Decision|0|||
130792383|NCT02332707|470867204|FG009|Overall Study|Physician Decision|0|||
130792384|NCT02332707|470867205|FG010|Overall Study|Physician Decision|0|||
130792385|NCT02332707|470867206|FG011|Overall Study|Physician Decision|0|||
130792386|NCT02332707|470867207|FG012|Overall Study|Physician Decision|1|||
130792387|NCT02332707|470867208|FG013|Overall Study|Physician Decision|0|||
130792388|NCT02332707|470867209|FG014|Overall Study|Physician Decision|0|||
130792389|NCT02332707|470867210|FG015|Overall Study|Physician Decision|0|||
130792390|NCT02332707|470867211|FG016|Overall Study|Physician Decision|0|||
130792391|NCT02332707|470867212|FG017|Overall Study|Physician Decision|0|||
130792392|NCT02332707|470867195|FG000|Overall Study|Withdrawal by Subject|0|||
130792393|NCT02332707|470867196|FG001|Overall Study|Withdrawal by Subject|0|||
130792394|NCT02332707|470867197|FG002|Overall Study|Withdrawal by Subject|1|||
130792395|NCT02332707|470867198|FG003|Overall Study|Withdrawal by Subject|0|||
130792396|NCT02332707|470867199|FG004|Overall Study|Withdrawal by Subject|0|||
130792397|NCT02332707|470867200|FG005|Overall Study|Withdrawal by Subject|0|||
130792398|NCT02332707|470867201|FG006|Overall Study|Withdrawal by Subject|0|||
130792399|NCT02332707|470867202|FG007|Overall Study|Withdrawal by Subject|0|||
130792400|NCT02332707|470867203|FG008|Overall Study|Withdrawal by Subject|0|||
130792401|NCT02332707|470867204|FG009|Overall Study|Withdrawal by Subject|3|||
130792402|NCT02332707|470867205|FG010|Overall Study|Withdrawal by Subject|0|||
130792403|NCT02332707|470867206|FG011|Overall Study|Withdrawal by Subject|0|||
130792404|NCT02332707|470867207|FG012|Overall Study|Withdrawal by Subject|0|||
130792405|NCT02332707|470867208|FG013|Overall Study|Withdrawal by Subject|0|||
130792406|NCT02332707|470867209|FG014|Overall Study|Withdrawal by Subject|0|||
130792407|NCT02332707|470867210|FG015|Overall Study|Withdrawal by Subject|0|||
130792408|NCT02332707|470867211|FG016|Overall Study|Withdrawal by Subject|0|||
130792409|NCT02332707|470867212|FG017|Overall Study|Withdrawal by Subject|0|||
130792410|NCT04761822|470867213|FG000|Overall Study|Adverse Event|3|||
130792411|NCT04761822|470867214|FG001|Overall Study|Adverse Event|1|||
130792412|NCT04761822|470867215|FG002|Overall Study|Adverse Event|1|||
130792413|NCT04761822|470867216|FG003|Overall Study|Adverse Event|3|||
130792414|NCT04761822|470867213|FG000|Overall Study|Lost to Follow-up|1|||
130792415|NCT04761822|470867214|FG001|Overall Study|Lost to Follow-up|0|||
130792416|NCT04761822|470867215|FG002|Overall Study|Lost to Follow-up|2|||
130792417|NCT04761822|470867216|FG003|Overall Study|Lost to Follow-up|3|||
130792418|NCT04761822|470867213|FG000|Overall Study|Physician Decision|0|||
130792419|NCT04761822|470867214|FG001|Overall Study|Physician Decision|1|||
130792420|NCT04761822|470867215|FG002|Overall Study|Physician Decision|0|||
130792421|NCT04761822|470867216|FG003|Overall Study|Physician Decision|0|||
130792422|NCT04761822|470867213|FG000|Overall Study|Withdrawal by Subject|3|||
130792423|NCT04761822|470867214|FG001|Overall Study|Withdrawal by Subject|8|||
130792424|NCT04761822|470867215|FG002|Overall Study|Withdrawal by Subject|1|||
130761756|NCT02326298|470750330|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761757|NCT02326298|470750331|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761758|NCT02326298|470750332|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130761759|NCT02326298|470750319|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130761760|NCT02326298|470750320|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130761761|NCT02326298|470750321|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130761762|NCT02326298|470750322|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130761763|NCT02326298|470750323|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130761764|NCT02326298|470750324|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130761765|NCT02326298|470750325|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
130761766|NCT02326298|470750326|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130761767|NCT02326298|470750327|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130761768|NCT02326298|470750328|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130761769|NCT02326298|470750329|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130761770|NCT02326298|470750330|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130761771|NCT02326298|470750331|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130761772|NCT02326298|470750332|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130761773|NCT02326298|470750319|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761774|NCT02326298|470750320|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761775|NCT02326298|470750321|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761776|NCT02326298|470750322|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761777|NCT02326298|470750323|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761778|NCT02326298|470750324|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
130761779|NCT02326298|470750325|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
130761780|NCT02326298|470750326|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761781|NCT02326298|470750327|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
130761782|NCT02326298|470750328|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761783|NCT02326298|470750329|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761784|NCT02326298|470750330|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761785|NCT02326298|470750331|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761786|NCT02326298|470750332|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130761787|NCT02326298|470750319|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761788|NCT02326298|470750320|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130792425|NCT04761822|470867216|FG003|Overall Study|Withdrawal by Subject|11|||
130792426|NCT04761822|470867213|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
130792427|NCT04761822|470867214|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
130792428|NCT04761822|470867215|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
130761789|NCT02326298|470750321|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761790|NCT02326298|470750322|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761791|NCT02326298|470750323|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761792|NCT02326298|470750324|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
130761793|NCT02326298|470750325|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761794|NCT02326298|470750326|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761795|NCT02326298|470750327|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761796|NCT02326298|470750328|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761797|NCT02326298|470750329|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761798|NCT02326298|470750330|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761799|NCT02326298|470750331|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761800|NCT02326298|470750332|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130761801|NCT02326298|470750319|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761802|NCT02326298|470750320|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761803|NCT02326298|470750321|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761804|NCT02326298|470750322|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761805|NCT02326298|470750323|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761806|NCT02326298|470750324|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761807|NCT02326298|470750325|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
130761808|NCT02326298|470750326|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761809|NCT02326298|470750327|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761810|NCT02326298|470750328|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761811|NCT02326298|470750329|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761812|NCT02326298|470750330|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761813|NCT02326298|470750331|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761814|NCT02326298|470750332|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130761815|NCT02326298|470750319|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761816|NCT02326298|470750320|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761817|NCT02326298|470750321|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761818|NCT02326298|470750322|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761819|NCT02326298|470750323|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761820|NCT02326298|470750324|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761821|NCT02326298|470750325|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761822|NCT02326298|470750326|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
130761823|NCT02326298|470750327|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761824|NCT02326298|470750328|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761825|NCT02326298|470750329|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761826|NCT02326298|470750330|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761827|NCT02326298|470750331|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761828|NCT02326298|470750332|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130761829|NCT02326298|470750319|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761830|NCT02326298|470750320|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761831|NCT02326298|470750321|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761832|NCT02326298|470750322|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761833|NCT02326298|470750323|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761834|NCT02326298|470750324|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761835|NCT02326298|470750325|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
130761836|NCT02326298|470750326|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
130761837|NCT02326298|470750327|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761838|NCT02326298|470750328|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761839|NCT02326298|470750329|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761840|NCT02326298|470750330|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761841|NCT02326298|470750331|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761842|NCT02326298|470750332|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130761843|NCT02326298|470750319|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761844|NCT02326298|470750320|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761845|NCT02326298|470750321|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761846|NCT02326298|470750322|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761847|NCT02326298|470750323|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761848|NCT02326298|470750324|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761849|NCT02326298|470750325|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761850|NCT02326298|470750326|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130761851|NCT02326298|470750327|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130792429|NCT04761822|470867216|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
130792430|NCT04761822|470867213|FG000|Overall Study|Participant requested unblinding|0|||
130792431|NCT04761822|470867214|FG001|Overall Study|Participant requested unblinding|0|||
130792432|NCT04761822|470867215|FG002|Overall Study|Participant requested unblinding|0|||
130792433|NCT04761822|470867216|FG003|Overall Study|Participant requested unblinding|1|||
130792434|NCT00947544|470867223|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
130792435|NCT00947544|470867224|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
130792436|NCT01240746|470867225|FG000|Overall Study|Adverse Event|2|||
130792437|NCT01240746|470867226|FG001|Overall Study|Adverse Event|0|||
130792438|NCT01240746|470867227|FG002|Overall Study|Adverse Event|10|||
130792439|NCT01240746|470867225|FG000|Overall Study|Lost to Follow-up|23|||
130792440|NCT01240746|470867226|FG001|Overall Study|Lost to Follow-up|20|||
130792441|NCT01240746|470867227|FG002|Overall Study|Lost to Follow-up|102|||
130792442|NCT01240746|470867225|FG000|Overall Study|Protocol Violation|24|||
130792443|NCT01240746|470867226|FG001|Overall Study|Protocol Violation|15|||
130792444|NCT01240746|470867227|FG002|Overall Study|Protocol Violation|72|||
130792445|NCT01240746|470867225|FG000|Overall Study|Withdrawal by Subject|10|||
130792446|NCT01240746|470867226|FG001|Overall Study|Withdrawal by Subject|13|||
130792447|NCT01240746|470867227|FG002|Overall Study|Withdrawal by Subject|59|||
130792448|NCT03801252|470867232|FG000|Overall Study|Protocol Violation|1|||
130792449|NCT03801252|470867233|FG001|Overall Study|Protocol Violation|2|||
130792450|NCT01134042|470867234|FG000|Overall Study|Adverse Event|3|||
130792451|NCT01134042|470867235|FG001|Overall Study|Adverse Event|7|||
130792452|NCT01134042|470867236|FG002|Overall Study|Adverse Event|2|||
130792453|NCT01134042|470867234|FG000|Overall Study|Lack of Efficacy|21|||
130792454|NCT01134042|470867235|FG001|Overall Study|Lack of Efficacy|6|||
130792455|NCT01134042|470867236|FG002|Overall Study|Lack of Efficacy|18|||
130792456|NCT01134042|470867234|FG000|Overall Study|Protocol Violation|5|||
130792457|NCT01134042|470867235|FG001|Overall Study|Protocol Violation|3|||
130792458|NCT01134042|470867236|FG002|Overall Study|Protocol Violation|5|||
130792459|NCT01134042|470867234|FG000|Overall Study|Lost to Follow-up|2|||
130792460|NCT01134042|470867235|FG001|Overall Study|Lost to Follow-up|0|||
130792461|NCT01134042|470867236|FG002|Overall Study|Lost to Follow-up|1|||
130792462|NCT01134042|470867234|FG000|Overall Study|Physician Decision|4|||
130792463|NCT01134042|470867235|FG001|Overall Study|Physician Decision|8|||
130792464|NCT01134042|470867236|FG002|Overall Study|Physician Decision|1|||
130792465|NCT01134042|470867234|FG000|Overall Study|Withdrawal by Subject|13|||
130792466|NCT01134042|470867235|FG001|Overall Study|Withdrawal by Subject|4|||
130792467|NCT01134042|470867236|FG002|Overall Study|Withdrawal by Subject|7|||
130792468|NCT01461551|470867241|FG000|Overall Study|Physician Decision|2|||
130792469|NCT01461551|470867242|FG001|Overall Study|Physician Decision|1|||
130792470|NCT01461551|470867243|FG002|Overall Study|Physician Decision|2|||
130792471|NCT00827567|470867244|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
130792472|NCT01155141|470867245|FG000|Overall Study|Withdrawal by Subject|1|||
130792473|NCT01155141|470867245|FG000|Overall Study|Screen Failure|1|||
130792474|NCT03473197|470867246|FG000|Overall Study|Adverse Event|4|||
130792475|NCT03473197|470867246|FG000|Overall Study|Lost to Follow-up|1|||
130792476|NCT03473197|470867246|FG000|Overall Study|Withdrawal by Subject|5|||
130792477|NCT00785629|470867249|FG000|Overall Study|Adverse Event|2|||
130792478|NCT00785629|470867250|FG001|Overall Study|Adverse Event|1|||
130792479|NCT00785629|470867251|FG002|Overall Study|Adverse Event|1|||
130792480|NCT00785629|470867252|FG003|Overall Study|Adverse Event|5|||
130792481|NCT00785629|470867249|FG000|Overall Study|Protocol Violation|1|||
130792482|NCT00785629|470867250|FG001|Overall Study|Protocol Violation|2|||
130792483|NCT00785629|470867251|FG002|Overall Study|Protocol Violation|4|||
130792484|NCT00785629|470867252|FG003|Overall Study|Protocol Violation|5|||
130792485|NCT00785629|470867249|FG000|Overall Study|administrative decision|5|||
130792486|NCT00785629|470867250|FG001|Overall Study|administrative decision|1|||
130792487|NCT00785629|470867251|FG002|Overall Study|administrative decision|3|||
130792488|NCT00785629|470867252|FG003|Overall Study|administrative decision|4|||
130792489|NCT00785629|470867249|FG000|Overall Study|Withdrawal by Subject|0|||
130792490|NCT00785629|470867250|FG001|Overall Study|Withdrawal by Subject|1|||
130792491|NCT00785629|470867251|FG002|Overall Study|Withdrawal by Subject|2|||
130792492|NCT00785629|470867252|FG003|Overall Study|Withdrawal by Subject|2|||
130792493|NCT00851591|470867253|FG000|Overall Study|Withdrawal by Subject|2|||
130792494|NCT00851591|470867254|FG001|Overall Study|Withdrawal by Subject|0|||
130792495|NCT02326883|470867256|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
130792496|NCT02326883|470867257|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
130792497|NCT02326883|470867258|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
130792498|NCT04154956|470867259|FG000|Overall Study|Death|109|||
130792499|NCT04154956|470867260|FG001|Overall Study|Death|110|||
130792500|NCT04154956|470867259|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
130792501|NCT04154956|470867260|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
130792502|NCT04154956|470867259|FG000|Overall Study|Withdrawal by Subject|1|||
130792503|NCT04154956|470867260|FG001|Overall Study|Withdrawal by Subject|7|||
130792504|NCT04154956|470867259|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
130792505|NCT04154956|470867260|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
130792506|NCT03620162|470867261|FG000|Overall Study|Physician Decision|4|||
130792507|NCT03620162|470867262|FG001|Overall Study|Physician Decision|0|||
130792508|NCT03620162|470867263|FG002|Overall Study|Physician Decision|1|||
130792509|NCT03620162|470867264|FG003|Overall Study|Physician Decision|0|||
130792510|NCT03620162|470867265|FG004|Overall Study|Physician Decision|2|||
130792511|NCT03620162|470867261|FG000|Overall Study|Lost to Follow-up|2|||
130792512|NCT03620162|470867262|FG001|Overall Study|Lost to Follow-up|6|||
130792513|NCT03620162|470867263|FG002|Overall Study|Lost to Follow-up|7|||
130792514|NCT03620162|470867264|FG003|Overall Study|Lost to Follow-up|3|||
130792515|NCT03620162|470867265|FG004|Overall Study|Lost to Follow-up|2|||
130792516|NCT03620162|470867261|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
130792517|NCT03620162|470867262|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
130792518|NCT03620162|470867263|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
130792519|NCT03620162|470867264|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
130792520|NCT03620162|470867265|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
130792521|NCT01682031|470867268|FG000|Overall Study|Withdrawal by Subject|0|||
130792522|NCT01682031|470867269|FG001|Overall Study|Withdrawal by Subject|1|||
130792523|NCT01682031|470867268|FG000|Overall Study|Adverse Event|0|||
130792524|NCT01682031|470867269|FG001|Overall Study|Adverse Event|2|||
130792525|NCT01682031|470867268|FG000|Overall Study|MRI results indicate increased nodul|0|||
130792526|NCT01682031|470867269|FG001|Overall Study|MRI results indicate increased nodul|1|||
130792527|NCT01682031|470867268|FG000|Overall Study|Patient could not swallow tablets|1|||
130792528|NCT01682031|470867269|FG001|Overall Study|Patient could not swallow tablets|0|||
130792529|NCT01682031|470867268|FG000|Overall Study|Patient stopped selenium on his own|0|||
130792530|NCT01682031|470867269|FG001|Overall Study|Patient stopped selenium on his own|1|||
130792531|NCT01311661|470867271|FG000|Overall Study|Adverse Event|2|||
130792532|NCT01311661|470867271|FG000|Overall Study|Protocol Violation|3|||
130792533|NCT01311661|470867271|FG000|Overall Study|Withdrawal by Subject|2|||
130792534|NCT01056536|470867272|FG000|Overall Study|Lost to Follow-up|202|||
130792535|NCT01056536|470867273|FG001|Overall Study|Lost to Follow-up|116|||
130792536|NCT01056536|470867274|FG002|Overall Study|Lost to Follow-up|248|||
130792537|NCT02763566|470867275|FG000|Overall Study|Lost to Follow-up|1|||
130792538|NCT02763566|470867276|FG001|Overall Study|Lost to Follow-up|4|||
130792539|NCT02763566|470867277|FG002|Overall Study|Lost to Follow-up|0|||
130792540|NCT02763566|470867278|FG003|Overall Study|Lost to Follow-up|1|||
130792541|NCT02763566|470867275|FG000|Overall Study|On study treatment at study conclusion|114|||
130792542|NCT02763566|470867276|FG001|Overall Study|On study treatment at study conclusion|34|||
130792543|NCT02763566|470867277|FG002|Overall Study|On study treatment at study conclusion|54|||
130792544|NCT02763566|470867278|FG003|Overall Study|On study treatment at study conclusion|13|||
130792545|NCT02763566|470867275|FG000|Overall Study|Withdrawal by Subject|3|||
130792546|NCT02763566|470867276|FG001|Overall Study|Withdrawal by Subject|1|||
130792547|NCT02763566|470867277|FG002|Overall Study|Withdrawal by Subject|0|||
130792548|NCT02763566|470867278|FG003|Overall Study|Withdrawal by Subject|0|||
130792549|NCT00315445|470867279|FG000|Overall Study|Adverse Event|7|||
130792550|NCT00315445|470867280|FG001|Overall Study|Adverse Event|12|||
130792551|NCT00315445|470867281|FG002|Overall Study|Adverse Event|15|||
130792552|NCT00315445|470867279|FG000|Overall Study|Lack of Efficacy|16|||
130792553|NCT00315445|470867280|FG001|Overall Study|Lack of Efficacy|1|||
130792554|NCT00315445|470867281|FG002|Overall Study|Lack of Efficacy|7|||
130792555|NCT00315445|470867279|FG000|Overall Study|Lost to Follow-up|1|||
130792556|NCT00315445|470867280|FG001|Overall Study|Lost to Follow-up|0|||
130792557|NCT00315445|470867281|FG002|Overall Study|Lost to Follow-up|1|||
130792558|NCT00315445|470867279|FG000|Overall Study|Protocol Violation|2|||
130792559|NCT00315445|470867280|FG001|Overall Study|Protocol Violation|0|||
130792560|NCT00315445|470867281|FG002|Overall Study|Protocol Violation|1|||
130792561|NCT00315445|470867279|FG000|Overall Study|Other|1|||
130792562|NCT00315445|470867280|FG001|Overall Study|Other|3|||
130792563|NCT00315445|470867281|FG002|Overall Study|Other|0|||
130792564|NCT01101178|470867284|FG000|Period 1|Withdrawal by Subject|1|||
130792565|NCT01101178|470867285|FG001|Period 1|Withdrawal by Subject|2|||
130792566|NCT01101178|470867284|FG000|Period 1|Positive drug screen|1|||
130792567|NCT01101178|470867285|FG001|Period 1|Positive drug screen|1|||
130792568|NCT01101178|470867284|FG000|Period 1|Adverse Event|2|||
130792569|NCT01101178|470867285|FG001|Period 1|Adverse Event|1|||
130792570|NCT01101178|470867284|FG000|Period 2|Withdrawal by Subject|0|||
130792571|NCT01101178|470867285|FG001|Period 2|Withdrawal by Subject|1|||
130792572|NCT01850641|470867286|FG000|Overall Study|Physician Decision|1|||
130792573|NCT01850641|470867286|FG000|Overall Study|Decrease in serum phosphorus|1|||
130792574|NCT01850641|470867286|FG000|Overall Study|Decrease in serum calcium|2|||
130792575|NCT01850641|470867286|FG000|Overall Study|Increase in serum ferritin|1|||
130792576|NCT00141817|470867287|FG000|Overall Study|Protocol Violation|0|||
130792577|NCT00141817|470867288|FG001|Overall Study|Protocol Violation|0|||
130792578|NCT00141817|470867289|FG002|Overall Study|Protocol Violation|1|||
130792579|NCT00141817|470867290|FG003|Overall Study|Protocol Violation|0|||
130792580|NCT00141817|470867287|FG000|Overall Study|Parent request|1|||
130792581|NCT00141817|470867288|FG001|Overall Study|Parent request|0|||
130792582|NCT00141817|470867289|FG002|Overall Study|Parent request|0|||
130792583|NCT00141817|470867290|FG003|Overall Study|Parent request|0|||
130792584|NCT00846365|470867297|FG000|Overall Study|Adverse Event|20|||
130792585|NCT00846365|470867298|FG001|Overall Study|Adverse Event|30|||
130792586|NCT00846365|470867299|FG002|Overall Study|Adverse Event|11|||
130792587|NCT00846365|470867297|FG000|Overall Study|Protocol Violation|5|||
130792588|NCT00846365|470867298|FG001|Overall Study|Protocol Violation|4|||
130792589|NCT00846365|470867299|FG002|Overall Study|Protocol Violation|0|||
130792590|NCT00846365|470867297|FG000|Overall Study|Lost to Follow-up|8|||
130792591|NCT00846365|470867298|FG001|Overall Study|Lost to Follow-up|2|||
130792592|NCT00846365|470867299|FG002|Overall Study|Lost to Follow-up|5|||
130792593|NCT00846365|470867297|FG000|Overall Study|Withdrawal by Subject|11|||
130792594|NCT00846365|470867298|FG001|Overall Study|Withdrawal by Subject|11|||
130792595|NCT00846365|470867299|FG002|Overall Study|Withdrawal by Subject|9|||
130792596|NCT00846365|470867297|FG000|Overall Study|Pregnancy|1|||
130792597|NCT00846365|470867298|FG001|Overall Study|Pregnancy|0|||
130792598|NCT00846365|470867299|FG002|Overall Study|Pregnancy|0|||
130792599|NCT00846365|470867297|FG000|Overall Study|Lack of Efficacy|1|||
130792600|NCT00846365|470867298|FG001|Overall Study|Lack of Efficacy|1|||
130792601|NCT00846365|470867299|FG002|Overall Study|Lack of Efficacy|2|||
130792602|NCT00846365|470867297|FG000|Overall Study|Other|9|||
130792603|NCT00846365|470867298|FG001|Overall Study|Other|1|||
130792604|NCT00846365|470867299|FG002|Overall Study|Other|6|||
130792605|NCT03479905|470867300|FG000|Overall Study|Other airway method used|4|||
130792606|NCT03479905|470867301|FG001|Overall Study|Other airway method used|5|||
130792607|NCT03479905|470867302|FG002|Overall Study|Other airway method used|5|||
130792608|NCT00862992|470867303|FG000|Overall Study|Adverse Event|2|||
130792609|NCT00862992|470867304|FG001|Overall Study|Adverse Event|1|||
130792610|NCT00862992|470867305|FG002|Overall Study|Adverse Event|1|||
130792611|NCT00862992|470867303|FG000|Overall Study|Physician Decision|1|||
130792612|NCT00862992|470867304|FG001|Overall Study|Physician Decision|0|||
130792613|NCT00862992|470867305|FG002|Overall Study|Physician Decision|0|||
130792614|NCT00862992|470867303|FG000|Overall Study|Withdrawal by Subject|0|||
130792615|NCT00862992|470867304|FG001|Overall Study|Withdrawal by Subject|0|||
130792616|NCT00862992|470867305|FG002|Overall Study|Withdrawal by Subject|2|||
130792617|NCT00720759|470867306|FG000|Overall Study|Lost to Follow-up|0|||
130792618|NCT00720759|470867307|FG001|Overall Study|Lost to Follow-up|1|||
130792619|NCT00720759|470867308|FG002|Overall Study|Lost to Follow-up|1|||
130792620|NCT00720759|470867309|FG003|Overall Study|Lost to Follow-up|0|||
130792621|NCT01047319|470867310|FG000|Overall Study|Teva requested participant withdrawal|3|||
130792622|NCT01047319|470867311|FG001|Overall Study|Teva requested participant withdrawal|0|||
130792623|NCT01047319|470867312|FG002|Overall Study|Teva requested participant withdrawal|1|||
130792624|NCT01047319|470867310|FG000|Overall Study|Protocol Violation|3|||
130792625|NCT01047319|470867311|FG001|Overall Study|Protocol Violation|2|||
130792626|NCT01047319|470867312|FG002|Overall Study|Protocol Violation|4|||
130792627|NCT01047319|470867310|FG000|Overall Study|Lack of Efficacy|4|||
130792628|NCT01047319|470867311|FG001|Overall Study|Lack of Efficacy|3|||
130792629|NCT01047319|470867312|FG002|Overall Study|Lack of Efficacy|3|||
130792630|NCT01047319|470867310|FG000|Overall Study|Death|5|||
130792631|NCT01047319|470867311|FG001|Overall Study|Death|1|||
130792632|NCT01047319|470867312|FG002|Overall Study|Death|5|||
130792633|NCT01047319|470867310|FG000|Overall Study|Pregnancy|13|||
130792634|NCT01047319|470867311|FG001|Overall Study|Pregnancy|8|||
130792635|NCT01047319|470867312|FG002|Overall Study|Pregnancy|8|||
130792636|NCT01047319|470867310|FG000|Overall Study|Physician Decision|12|||
130792637|NCT01047319|470867311|FG001|Overall Study|Physician Decision|9|||
130792638|NCT01047319|470867312|FG002|Overall Study|Physician Decision|10|||
130792639|NCT01047319|470867310|FG000|Overall Study|Lost to Follow-up|14|||
130792640|NCT01047319|470867311|FG001|Overall Study|Lost to Follow-up|10|||
130792641|NCT01047319|470867312|FG002|Overall Study|Lost to Follow-up|10|||
130792642|NCT01047319|470867310|FG000|Overall Study|Adverse Event|16|||
130792643|NCT01047319|470867311|FG001|Overall Study|Adverse Event|27|||
130792644|NCT01047319|470867312|FG002|Overall Study|Adverse Event|21|||
130792645|NCT01047319|470867310|FG000|Overall Study|Withdrawal by Subject|77|||
130792646|NCT01047319|470867311|FG001|Overall Study|Withdrawal by Subject|75|||
130792647|NCT01047319|470867312|FG002|Overall Study|Withdrawal by Subject|87|||
130792648|NCT01047319|470867310|FG000|Overall Study|Study terminated by Sponsor|198|||
130792649|NCT01047319|470867311|FG001|Overall Study|Study terminated by Sponsor|215|||
130792650|NCT01047319|470867312|FG002|Overall Study|Study terminated by Sponsor|203|||
130792651|NCT02318940|470867313|FG000|Overall Study|lost the record|1|||
130792652|NCT02318940|470867314|FG001|Overall Study|lost the record|0|||
130792653|NCT01277861|470867317|FG000|Overall Study|Physician Decision|2|||
130792654|NCT01277861|470867318|FG001|Overall Study|Physician Decision|2|||
130792655|NCT02696798|470867319|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
130792656|NCT02696798|470867320|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
130792657|NCT02696798|470867321|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
130792658|NCT02696798|470867319|FG000|Blinded Treatment Dosing Period|Death|0|||
130792659|NCT02696798|470867320|FG001|Blinded Treatment Dosing Period|Death|0|||
130792660|NCT02696798|470867321|FG002|Blinded Treatment Dosing Period|Death|1|||
130792661|NCT02696798|470867319|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
130792662|NCT02696798|470867320|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
130792663|NCT02696798|470867321|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
130792664|NCT02696798|470867319|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
130792665|NCT02696798|470867320|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
130792666|NCT02696798|470867321|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
130792667|NCT02696798|470867319|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
130792668|NCT02696798|470867320|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
130792669|NCT02696798|470867321|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
130792670|NCT02696798|470867319|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
130792671|NCT02696798|470867320|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
130792672|NCT02696798|470867321|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
130792673|NCT02696798|470867319|FG000|Extended Treatment Period|Adverse Event|1|||
130792674|NCT02696798|470867320|FG001|Extended Treatment Period|Adverse Event|4|||
130792675|NCT02696798|470867321|FG002|Extended Treatment Period|Adverse Event|5|||
130792676|NCT02696798|470867319|FG000|Extended Treatment Period|Lack of Efficacy|7|||
130792677|NCT02696798|470867320|FG001|Extended Treatment Period|Lack of Efficacy|2|||
130792678|NCT02696798|470867321|FG002|Extended Treatment Period|Lack of Efficacy|2|||
130792679|NCT02696798|470867319|FG000|Extended Treatment Period|Lost to Follow-up|1|||
130792680|NCT02696798|470867320|FG001|Extended Treatment Period|Lost to Follow-up|0|||
130792681|NCT02696798|470867321|FG002|Extended Treatment Period|Lost to Follow-up|0|||
130792682|NCT02696798|470867319|FG000|Extended Treatment Period|Physician Decision|0|||
130792683|NCT02696798|470867320|FG001|Extended Treatment Period|Physician Decision|1|||
130792684|NCT02696798|470867321|FG002|Extended Treatment Period|Physician Decision|0|||
130792685|NCT02696798|470867319|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
130792686|NCT02696798|470867320|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
130792687|NCT02696798|470867321|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
130792688|NCT02696798|470867319|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
130792689|NCT02696798|470867320|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
130792690|NCT02696798|470867321|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
130792691|NCT02696798|470867319|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
130792692|NCT02696798|470867320|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
130792693|NCT02696798|470867321|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
130792694|NCT02696798|470867319|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
130792695|NCT02696798|470867320|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
130792696|NCT02696798|470867321|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
130792697|NCT02696798|470867319|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
130792698|NCT02696798|470867320|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
130792699|NCT02696798|470867321|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
130792700|NCT02696798|470867319|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
130792701|NCT02696798|470867320|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
130792702|NCT02696798|470867321|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
130792703|NCT02696798|470867319|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
130792704|NCT02696798|470867320|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
130792705|NCT02696798|470867321|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
130792706|NCT00857389|470867322|FG000|Overall Study|Did not proceed to transplant|2|||
130792707|NCT01157845|470867323|FG000|Overall Study|Lost to Follow-up|5|||
130792708|NCT01157845|470867323|FG000|Overall Study|Withdrawal by Subject|12|||
130792709|NCT01157845|470867323|FG000|Overall Study|Physician Decision|3|||
130792710|NCT01157845|470867323|FG000|Overall Study|Protocol Violation|13|||
130792711|NCT01157845|470867323|FG000|Overall Study|Study was ended|1|||
130792712|NCT01157845|470867323|FG000|Overall Study|Device malfunction|1|||
130792713|NCT03311555|470867324|FG000|Overall Study|Adverse Event|1|||
130792714|NCT03737994|470869086|FG000|Overall Study|Withdrawal by Subject|0|||
130792715|NCT03737994|470869087|FG001|Overall Study|Withdrawal by Subject|0|||
130792716|NCT03737994|470869088|FG002|Overall Study|Withdrawal by Subject|0|||
130792717|NCT03737994|470869089|FG003|Overall Study|Withdrawal by Subject|0|||
130792718|NCT03737994|470869090|FG004|Overall Study|Withdrawal by Subject|0|||
130792719|NCT03737994|470869091|FG005|Overall Study|Withdrawal by Subject|0|||
130792720|NCT03737994|470869092|FG006|Overall Study|Withdrawal by Subject|1|||
130792721|NCT03846479|470869093|FG000|Overall Study|Death|8|||
130792722|NCT03846479|470869093|FG000|Overall Study|Lost to Follow-up|1|||
130792723|NCT01473134|470869094|FG000|Overall Study|Lost to Follow-up|21|||
130792724|NCT01473134|470869095|FG001|Overall Study|Lost to Follow-up|13|||
130792725|NCT01473134|470869094|FG000|Overall Study|Protocol Violation|32|||
130792726|NCT01473134|470869095|FG001|Overall Study|Protocol Violation|19|||
130792727|NCT01473134|470869094|FG000|Overall Study|Withdrawal by Subject|1|||
130792728|NCT01473134|470869095|FG001|Overall Study|Withdrawal by Subject|2|||
130792729|NCT01473134|470869094|FG000|Overall Study|Death|0|||
130792730|NCT01473134|470869095|FG001|Overall Study|Death|1|||
130822746|NCT00812955|470980591|FG002|Overall Study|Withdrawal by Subject|1|||
130792731|NCT01473134|470869094|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
130792732|NCT01473134|470869095|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
130792733|NCT05020015|470869098|FG000|Overall Study|Ongoing on study|1|||
130792734|NCT05020015|470869099|FG001|Overall Study|Ongoing on study|3|||
130792735|NCT05020015|470869100|FG002|Overall Study|Ongoing on study|4|||
130792736|NCT05020015|470869101|FG003|Overall Study|Ongoing on study|7|||
130792737|NCT05020015|470869098|FG000|Overall Study|Death|2|||
130792738|NCT05020015|470869099|FG001|Overall Study|Death|3|||
130792739|NCT05020015|470869100|FG002|Overall Study|Death|4|||
130792740|NCT05020015|470869101|FG003|Overall Study|Death|0|||
130792741|NCT05020015|470869098|FG000|Overall Study|Withdrawal by Subject|0|||
130792742|NCT05020015|470869099|FG001|Overall Study|Withdrawal by Subject|0|||
130792743|NCT05020015|470869100|FG002|Overall Study|Withdrawal by Subject|1|||
130792744|NCT05020015|470869101|FG003|Overall Study|Withdrawal by Subject|0|||
130792745|NCT05020015|470869098|FG000|Overall Study|Reason Not Specified|0|||
130792746|NCT05020015|470869099|FG001|Overall Study|Reason Not Specified|0|||
130792747|NCT05020015|470869100|FG002|Overall Study|Reason Not Specified|2|||
130792748|NCT05020015|470869101|FG003|Overall Study|Reason Not Specified|0|||
130792749|NCT04476043|470869104|FG000|Overall Study|Withdrawal by Subject|1|||
130792750|NCT04476043|470869105|FG001|Overall Study|Withdrawal by Subject|3|||
130792751|NCT04476043|470869106|FG002|Overall Study|Withdrawal by Subject|4|||
130792752|NCT04476043|470869107|FG003|Overall Study|Withdrawal by Subject|1|||
130792753|NCT04476043|470869104|FG000|Overall Study|Lost to Follow-up|1|||
130792754|NCT04476043|470869105|FG001|Overall Study|Lost to Follow-up|1|||
130792755|NCT04476043|470869106|FG002|Overall Study|Lost to Follow-up|2|||
130792756|NCT04476043|470869107|FG003|Overall Study|Lost to Follow-up|1|||
130792757|NCT04476043|470869104|FG000|Overall Study|Adverse Event|2|||
130792758|NCT04476043|470869105|FG001|Overall Study|Adverse Event|0|||
130792759|NCT04476043|470869106|FG002|Overall Study|Adverse Event|1|||
130792760|NCT04476043|470869107|FG003|Overall Study|Adverse Event|0|||
130792761|NCT04476043|470869104|FG000|Overall Study|Protocol Violation|0|||
130792762|NCT04476043|470869105|FG001|Overall Study|Protocol Violation|1|||
130792763|NCT04476043|470869106|FG002|Overall Study|Protocol Violation|0|||
130792764|NCT04476043|470869107|FG003|Overall Study|Protocol Violation|0|||
130792765|NCT06217380|470869108|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
130792766|NCT06217380|470869108|FG000|Overall Study|Physician Decision|1|||
130792767|NCT06217380|470869108|FG000|Overall Study|Withdrawal by Subject|2|||
130792768|NCT06633965|470869109|FG000|Overall Study|Withdrawal by Subject|0|||
130792769|NCT06633965|470869110|FG001|Overall Study|Withdrawal by Subject|1|||
130792770|NCT01963611|470869117|FG000|Overall Study|Adverse Event|1|||
130792771|NCT01963611|470869118|FG001|Overall Study|Adverse Event|1|||
130792772|NCT01963611|470869119|FG002|Overall Study|Adverse Event|3|||
130792773|NCT01963611|470869120|FG003|Overall Study|Adverse Event|4|||
130792774|NCT01963611|470869121|FG004|Overall Study|Adverse Event|3|||
130792775|NCT01963611|470869117|FG000|Overall Study|Protocol Violation|0|||
130792776|NCT01963611|470869118|FG001|Overall Study|Protocol Violation|0|||
130792777|NCT01963611|470869119|FG002|Overall Study|Protocol Violation|0|||
130792778|NCT01963611|470869120|FG003|Overall Study|Protocol Violation|1|||
130792779|NCT01963611|470869121|FG004|Overall Study|Protocol Violation|0|||
130792780|NCT01963611|470869117|FG000|Overall Study|Lack of Efficacy|0|||
130792781|NCT01963611|470869118|FG001|Overall Study|Lack of Efficacy|0|||
130792782|NCT01963611|470869119|FG002|Overall Study|Lack of Efficacy|0|||
130792783|NCT01963611|470869120|FG003|Overall Study|Lack of Efficacy|1|||
130792784|NCT01963611|470869121|FG004|Overall Study|Lack of Efficacy|0|||
130792785|NCT01963611|470869117|FG000|Overall Study|Withdrawal by Subject|3|||
130792786|NCT01963611|470869118|FG001|Overall Study|Withdrawal by Subject|2|||
130792787|NCT01963611|470869119|FG002|Overall Study|Withdrawal by Subject|1|||
130792788|NCT01963611|470869120|FG003|Overall Study|Withdrawal by Subject|1|||
130792789|NCT01963611|470869121|FG004|Overall Study|Withdrawal by Subject|3|||
130792790|NCT01963611|470869117|FG000|Overall Study|Other|47|||
130792791|NCT01963611|470869118|FG001|Overall Study|Other|46|||
130792792|NCT01963611|470869119|FG002|Overall Study|Other|48|||
130792793|NCT01963611|470869120|FG003|Overall Study|Other|45|||
130792794|NCT01963611|470869121|FG004|Overall Study|Other|45|||
130792795|NCT01126424|470869122|FG000|Overall Study|Adverse Event|0|||
130792796|NCT01126424|470869123|FG001|Overall Study|Adverse Event|0|||
130792797|NCT01126424|470869124|FG002|Overall Study|Adverse Event|0|||
130792798|NCT01126424|470869125|FG003|Overall Study|Adverse Event|0|||
130792799|NCT01126424|470869126|FG004|Overall Study|Adverse Event|1|||
130792800|NCT01126424|470869127|FG005|Overall Study|Adverse Event|0|||
130792801|NCT01126424|470869122|FG000|Overall Study|Withdrawal by Subject|0|||
130792802|NCT01126424|470869123|FG001|Overall Study|Withdrawal by Subject|0|||
130792803|NCT01126424|470869124|FG002|Overall Study|Withdrawal by Subject|1|||
130792804|NCT01126424|470869125|FG003|Overall Study|Withdrawal by Subject|3|||
130792805|NCT01126424|470869126|FG004|Overall Study|Withdrawal by Subject|1|||
130792806|NCT01126424|470869127|FG005|Overall Study|Withdrawal by Subject|0|||
130792807|NCT02328105|470869128|FG000|Overall Study|Death|6|||
130792808|NCT02328105|470869128|FG000|Overall Study|Withdrawal by Subject|1|||
130792809|NCT02328105|470869128|FG000|Overall Study|Still On Study in Follow-Up|4|||
130792810|NCT01588509|470869132|FG000|Overall Study|Lost to Follow-up|1|||
130792811|NCT01588509|470869133|FG001|Overall Study|Lost to Follow-up|0|||
130792812|NCT01983930|470869134|FG000|Overall Study|Withdrawal by Subject|9|||
130792813|NCT01983930|470869135|FG001|Overall Study|Withdrawal by Subject|8|||
130792814|NCT01983930|470869134|FG000|Overall Study|Adverse Event|0|||
130792815|NCT01983930|470869135|FG001|Overall Study|Adverse Event|1|||
130792816|NCT00393367|470869136|FG000|Overall Study|Protocol Violation|2|||
130792817|NCT00393367|470869137|FG001|Overall Study|Protocol Violation|5|||
130792818|NCT00393367|470869136|FG000|Overall Study|Withdrawal by Subject|0|||
130792819|NCT00393367|470869137|FG001|Overall Study|Withdrawal by Subject|2|||
130792820|NCT03286504|470869138|FG000|Overall Study|Lost to Follow-up|19|||
130792821|NCT03286504|470869139|FG001|Overall Study|Lost to Follow-up|16|||
130792822|NCT01432327|470869140|FG000|Posttest 3 Months|depression|3|||
130792823|NCT01432327|470869141|FG001|Posttest 3 Months|depression|0|||
130792824|NCT01432327|470869142|FG002|Posttest 3 Months|depression|0|||
130792825|NCT01432327|470869143|FG003|Posttest 3 Months|depression|0|||
130792826|NCT01432327|470869140|FG000|Posttest 3 Months|Lost to Follow-up|1|||
130792827|NCT01432327|470869141|FG001|Posttest 3 Months|Lost to Follow-up|0|||
130792828|NCT01432327|470869142|FG002|Posttest 3 Months|Lost to Follow-up|2|||
130792829|NCT01432327|470869143|FG003|Posttest 3 Months|Lost to Follow-up|1|||
130792830|NCT01432327|470869140|FG000|Posttest 3 Months|Allergic reaction|0|||
130792831|NCT01432327|470869141|FG001|Posttest 3 Months|Allergic reaction|2|||
130792832|NCT01432327|470869142|FG002|Posttest 3 Months|Allergic reaction|0|||
130792833|NCT01432327|470869143|FG003|Posttest 3 Months|Allergic reaction|0|||
130792834|NCT01432327|470869140|FG000|Posttest 6 Months|Lost to Follow-up|0|||
130792835|NCT01432327|470869141|FG001|Posttest 6 Months|Lost to Follow-up|0|||
130792836|NCT01432327|470869142|FG002|Posttest 6 Months|Lost to Follow-up|3|||
130792837|NCT01432327|470869143|FG003|Posttest 6 Months|Lost to Follow-up|2|||
130792838|NCT01432327|470869140|FG000|Posttest 6 Months|Allergic reaction|0|||
130792839|NCT01432327|470869141|FG001|Posttest 6 Months|Allergic reaction|0|||
130792840|NCT01432327|470869142|FG002|Posttest 6 Months|Allergic reaction|1|||
130792841|NCT01432327|470869143|FG003|Posttest 6 Months|Allergic reaction|0|||
130792842|NCT01432327|470869140|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
130792843|NCT01432327|470869141|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
130792844|NCT01432327|470869142|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
130792845|NCT01432327|470869143|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
130792846|NCT01432327|470869140|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
130792847|NCT01432327|470869141|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
130792848|NCT01432327|470869142|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
130792849|NCT01432327|470869143|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
130792850|NCT01432327|470869140|FG000|Posttest 1 Year|Lost to Follow-up|0|||
130792851|NCT01432327|470869141|FG001|Posttest 1 Year|Lost to Follow-up|0|||
130792852|NCT01432327|470869142|FG002|Posttest 1 Year|Lost to Follow-up|4|||
130792853|NCT01432327|470869143|FG003|Posttest 1 Year|Lost to Follow-up|2|||
130792854|NCT01432327|470869140|FG000|Posttest 1 Year|Allergic reaction|0|||
130792855|NCT01432327|470869141|FG001|Posttest 1 Year|Allergic reaction|0|||
130792856|NCT01432327|470869142|FG002|Posttest 1 Year|Allergic reaction|1|||
130792857|NCT01432327|470869143|FG003|Posttest 1 Year|Allergic reaction|1|||
130792858|NCT00141921|470869146|FG000|Overall Study|Remain on Study|28|||
130792859|NCT00141921|470869146|FG000|Overall Study|Withdrawal by Subject|42|||
130792860|NCT00141921|470869146|FG000|Overall Study|Lost to Follow-up|19|||
130792861|NCT00141921|470869146|FG000|Overall Study|Noncompliance|17|||
130792862|NCT00141921|470869146|FG000|Overall Study|Disease Progression|7|||
130792863|NCT00141921|470869146|FG000|Overall Study|Protocol Deviation|7|||
130792864|NCT00141921|470869146|FG000|Overall Study|Adverse Event|5|||
130792865|NCT00141921|470869146|FG000|Overall Study|Administrative Decision|2|||
130792866|NCT00141921|470869146|FG000|Overall Study|Pregnancy|4|||
130792867|NCT00141921|470869146|FG000|Overall Study|Ineligibility Determined|2|||
130792868|NCT00141921|470869146|FG000|Overall Study|Other|8|||
130792869|NCT02030600|470869149|FG000|Treatment Period 1|Adverse Event|5|||
130792870|NCT02030600|470869150|FG001|Treatment Period 1|Adverse Event|7|||
130792871|NCT02030600|470869149|FG000|Treatment Period 1|Lack of Efficacy|0|||
130792872|NCT02030600|470869150|FG001|Treatment Period 1|Lack of Efficacy|1|||
130792873|NCT02030600|470869149|FG000|Treatment Period 1|Lost to Follow-up|11|||
130792874|NCT02030600|470869150|FG001|Treatment Period 1|Lost to Follow-up|3|||
130792875|NCT02030600|470869149|FG000|Treatment Period 1|Protocol Violation|22|||
130792876|NCT02030600|470869150|FG001|Treatment Period 1|Protocol Violation|17|||
130792877|NCT02030600|470869149|FG000|Treatment Period 1|Withdrawal by Subject|13|||
130792878|NCT02030600|470869150|FG001|Treatment Period 1|Withdrawal by Subject|17|||
130792879|NCT02030600|470869149|FG000|Treatment Period 1|Casebook Unsigned|1|||
130792880|NCT02030600|470869150|FG001|Treatment Period 1|Casebook Unsigned|0|||
130792881|NCT02030600|470869149|FG000|Treatment Period 1|Unclassified|1|||
130792882|NCT02030600|470869150|FG001|Treatment Period 1|Unclassified|0|||
130792883|NCT02030600|470869149|FG000|Treatment Period 2|Adverse Event|4|||
130792884|NCT02030600|470869150|FG001|Treatment Period 2|Adverse Event|4|||
130792885|NCT02030600|470869149|FG000|Treatment Period 2|Lack of Efficacy|2|||
130792886|NCT02030600|470869150|FG001|Treatment Period 2|Lack of Efficacy|1|||
130792887|NCT02030600|470869149|FG000|Treatment Period 2|Lost to Follow-up|4|||
130792888|NCT02030600|470869150|FG001|Treatment Period 2|Lost to Follow-up|2|||
130792889|NCT02030600|470869149|FG000|Treatment Period 2|Protocol Violation|1|||
130792890|NCT02030600|470869150|FG001|Treatment Period 2|Protocol Violation|2|||
130792891|NCT02030600|470869149|FG000|Treatment Period 2|Withdrawal by Subject|13|||
130792892|NCT02030600|470869150|FG001|Treatment Period 2|Withdrawal by Subject|9|||
130792893|NCT02030600|470869149|FG000|Treatment Period 2|Unclassified|1|||
130792894|NCT02030600|470869150|FG001|Treatment Period 2|Unclassified|0|||
130792895|NCT01155323|470869151|FG000|First Intervention|exclusion criteria|1|||
130792896|NCT01155323|470869152|FG001|First Intervention|exclusion criteria|1|||
130792897|NCT01155323|470869151|FG000|Second Intervention|Lost to Follow-up|1|||
130792898|NCT01155323|470869152|FG001|Second Intervention|Lost to Follow-up|1|||
130792899|NCT02471339|470869154|FG000|Overall Study|Did not provide follow-up data|2|||
130792900|NCT02471339|470869155|FG001|Overall Study|Did not provide follow-up data|0|||
130792901|NCT00626639|470869163|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
130792902|NCT00626639|470869164|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
130792903|NCT00303186|470869166|FG000|Overall Study|Other|52|||
130792904|NCT00937950|470869167|FG000|Overall Study|Withdrawal by Subject|23|||
130792905|NCT00937950|470869167|FG000|Overall Study|Migrated/moved from study area|27|||
130792906|NCT00937950|470869167|FG000|Overall Study|Lost to Follow-up|144|||
130792907|NCT00937950|470869167|FG000|Overall Study|Missing confirmed|4|||
130792908|NCT00937950|470869167|FG000|Overall Study|Other|18|||
130792909|NCT01137786|470869168|FG000|Overall Study|Lost to Follow-up|0|||
130792910|NCT01137786|470869169|FG001|Overall Study|Lost to Follow-up|2|||
130792911|NCT01137786|470869168|FG000|Overall Study|Withdrawal by Subject|1|||
130792912|NCT01137786|470869169|FG001|Overall Study|Withdrawal by Subject|1|||
130792913|NCT00460798|470869171|FG000|Overall Study|Death|59|||
130792914|NCT00460798|470869171|FG000|Overall Study|Adverse Event|27|||
130792915|NCT00460798|470869171|FG000|Overall Study|Lost to Follow-up|19|||
130792916|NCT00460798|470869171|FG000|Overall Study|Progressive Disease|99|||
130792917|NCT00460798|470869171|FG000|Overall Study|Other|27|||
130792918|NCT00460798|470869171|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
130792919|NCT00460798|470869171|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
130792920|NCT01898130|470869172|FG000|Treatment|Withdrawal by Subject|2|||
130792921|NCT01898130|470869172|FG000|Treatment|Progressive Disease|4|||
130792922|NCT01898130|470869172|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
130792923|NCT01281306|470869176|FG000|Overall Study|Lack of Efficacy|0|||
130792924|NCT01281306|470869177|FG001|Overall Study|Lack of Efficacy|1|||
130792925|NCT01281306|470869178|FG002|Overall Study|Lack of Efficacy|3|||
130792926|NCT01281306|470869179|FG003|Overall Study|Lack of Efficacy|0|||
130792927|NCT01281306|470869180|FG004|Overall Study|Lack of Efficacy|2|||
130792928|NCT01281306|470869181|FG005|Overall Study|Lack of Efficacy|0|||
130792929|NCT01281306|470869182|FG006|Overall Study|Lack of Efficacy|1|||
130792930|NCT01281306|470869176|FG000|Overall Study|Withdrawal by Subject|1|||
130792931|NCT01281306|470869177|FG001|Overall Study|Withdrawal by Subject|0|||
130792932|NCT01281306|470869178|FG002|Overall Study|Withdrawal by Subject|2|||
130792933|NCT01281306|470869179|FG003|Overall Study|Withdrawal by Subject|4|||
130792934|NCT01281306|470869180|FG004|Overall Study|Withdrawal by Subject|1|||
130792935|NCT01281306|470869181|FG005|Overall Study|Withdrawal by Subject|3|||
130792936|NCT01281306|470869182|FG006|Overall Study|Withdrawal by Subject|1|||
130792937|NCT01281306|470869176|FG000|Overall Study|Protocol deviation|0|||
130792938|NCT01281306|470869177|FG001|Overall Study|Protocol deviation|1|||
130792939|NCT01281306|470869178|FG002|Overall Study|Protocol deviation|1|||
130792940|NCT01281306|470869179|FG003|Overall Study|Protocol deviation|1|||
130792941|NCT01281306|470869180|FG004|Overall Study|Protocol deviation|1|||
130792942|NCT01281306|470869181|FG005|Overall Study|Protocol deviation|0|||
130792943|NCT01281306|470869182|FG006|Overall Study|Protocol deviation|0|||
130792944|NCT01281306|470869176|FG000|Overall Study|Condition no longer requires study drug|1|||
130792945|NCT01281306|470869177|FG001|Overall Study|Condition no longer requires study drug|0|||
130792946|NCT01281306|470869178|FG002|Overall Study|Condition no longer requires study drug|0|||
130792947|NCT01281306|470869179|FG003|Overall Study|Condition no longer requires study drug|0|||
130792948|NCT01281306|470869180|FG004|Overall Study|Condition no longer requires study drug|0|||
130792949|NCT01281306|470869181|FG005|Overall Study|Condition no longer requires study drug|1|||
130792950|NCT01281306|470869182|FG006|Overall Study|Condition no longer requires study drug|1|||
130792951|NCT01281306|470869176|FG000|Overall Study|Lost to Follow-up|1|||
130792952|NCT01281306|470869177|FG001|Overall Study|Lost to Follow-up|0|||
130792953|NCT01281306|470869178|FG002|Overall Study|Lost to Follow-up|0|||
130792954|NCT01281306|470869179|FG003|Overall Study|Lost to Follow-up|2|||
130792955|NCT01281306|470869180|FG004|Overall Study|Lost to Follow-up|0|||
130792956|NCT01281306|470869181|FG005|Overall Study|Lost to Follow-up|0|||
130792957|NCT01281306|470869182|FG006|Overall Study|Lost to Follow-up|1|||
130792958|NCT01281306|470869176|FG000|Overall Study|Death|1|||
130792959|NCT01281306|470869177|FG001|Overall Study|Death|0|||
130792960|NCT01281306|470869178|FG002|Overall Study|Death|0|||
130792961|NCT01281306|470869179|FG003|Overall Study|Death|0|||
130792962|NCT01281306|470869180|FG004|Overall Study|Death|0|||
130792963|NCT01281306|470869181|FG005|Overall Study|Death|0|||
130792964|NCT01281306|470869182|FG006|Overall Study|Death|0|||
130792965|NCT01281306|470869176|FG000|Overall Study|Adverse Event|3|||
130792966|NCT01281306|470869177|FG001|Overall Study|Adverse Event|2|||
130792967|NCT01281306|470869178|FG002|Overall Study|Adverse Event|2|||
130792968|NCT01281306|470869179|FG003|Overall Study|Adverse Event|3|||
130792969|NCT01281306|470869180|FG004|Overall Study|Adverse Event|5|||
130792970|NCT01281306|470869181|FG005|Overall Study|Adverse Event|3|||
130792971|NCT01281306|470869182|FG006|Overall Study|Adverse Event|3|||
130792972|NCT01281306|470869176|FG000|Overall Study|Randomized in error|1|||
130792973|NCT01281306|470869177|FG001|Overall Study|Randomized in error|0|||
130792974|NCT01281306|470869178|FG002|Overall Study|Randomized in error|0|||
130792975|NCT01281306|470869179|FG003|Overall Study|Randomized in error|1|||
130792976|NCT01281306|470869180|FG004|Overall Study|Randomized in error|0|||
130792977|NCT01281306|470869181|FG005|Overall Study|Randomized in error|0|||
130792978|NCT01281306|470869182|FG006|Overall Study|Randomized in error|0|||
130792979|NCT02320396|470869183|FG000|Overall Study|Adverse Event|2|||
130792980|NCT02320396|470869184|FG001|Overall Study|Adverse Event|2|||
130792981|NCT02320396|470869183|FG000|Overall Study|Pregnancy|0|||
130792982|NCT02320396|470869184|FG001|Overall Study|Pregnancy|1|||
130792983|NCT02320396|470869183|FG000|Overall Study|Protocol Violation|0|||
130792984|NCT02320396|470869184|FG001|Overall Study|Protocol Violation|1|||
130792985|NCT02320396|470869183|FG000|Overall Study|Withdrawal by Subject|2|||
130792986|NCT02320396|470869184|FG001|Overall Study|Withdrawal by Subject|0|||
130792987|NCT02606253|470869185|FG000|Overall Study|Adverse Event|2|||
130792988|NCT02606253|470869186|FG001|Overall Study|Adverse Event|0|||
130792989|NCT02606253|470869187|FG002|Overall Study|Adverse Event|0|||
130792990|NCT02606253|470869185|FG000|Overall Study|Protocol Violation|2|||
130792991|NCT02606253|470869186|FG001|Overall Study|Protocol Violation|1|||
130792992|NCT02606253|470869187|FG002|Overall Study|Protocol Violation|0|||
130792993|NCT02606253|470869185|FG000|Overall Study|Physician Decision|1|||
130792994|NCT02606253|470869186|FG001|Overall Study|Physician Decision|1|||
130792995|NCT02606253|470869187|FG002|Overall Study|Physician Decision|0|||
130792996|NCT03331562|470869190|FG000|Overall Study|Adverse Event|2|||
130792997|NCT03331562|470869191|FG001|Overall Study|Adverse Event|0|||
130792998|NCT03331562|470869190|FG000|Overall Study|Death|1|||
130792999|NCT03331562|470869191|FG001|Overall Study|Death|0|||
130793000|NCT03718000|470869192|FG000|Overall Study|Relocation|2|||
130793001|NCT03718000|470869193|FG001|Overall Study|Relocation|4|||
130793002|NCT03718000|470869192|FG000|Overall Study|Pregnancy|0|||
130793003|NCT03718000|470869193|FG001|Overall Study|Pregnancy|1|||
130793004|NCT02475213|470869194|FG000|Overall Study|Adverse Event|2|||
130793005|NCT02475213|470869195|FG001|Overall Study|Adverse Event|0|||
130793006|NCT02475213|470869196|FG002|Overall Study|Adverse Event|0|||
130793007|NCT02475213|470869197|FG003|Overall Study|Adverse Event|1|||
130793008|NCT02475213|470869198|FG004|Overall Study|Adverse Event|1|||
130793009|NCT02475213|470869199|FG005|Overall Study|Adverse Event|4|||
130793010|NCT02475213|470869200|FG006|Overall Study|Adverse Event|6|||
130793011|NCT02475213|470869201|FG007|Overall Study|Adverse Event|2|||
130793012|NCT02475213|470869194|FG000|Overall Study|Physician Decision|1|||
130793013|NCT02475213|470869195|FG001|Overall Study|Physician Decision|1|||
130793014|NCT02475213|470869196|FG002|Overall Study|Physician Decision|1|||
130793015|NCT02475213|470869197|FG003|Overall Study|Physician Decision|0|||
130793016|NCT02475213|470869198|FG004|Overall Study|Physician Decision|0|||
130793017|NCT02475213|470869199|FG005|Overall Study|Physician Decision|1|||
130793018|NCT02475213|470869200|FG006|Overall Study|Physician Decision|4|||
130793019|NCT02475213|470869201|FG007|Overall Study|Physician Decision|0|||
130793020|NCT02475213|470869194|FG000|Overall Study|Progressive Disease|3|||
130793021|NCT02475213|470869195|FG001|Overall Study|Progressive Disease|2|||
130793022|NCT02475213|470869196|FG002|Overall Study|Progressive Disease|2|||
130793023|NCT02475213|470869197|FG003|Overall Study|Progressive Disease|13|||
130793024|NCT02475213|470869198|FG004|Overall Study|Progressive Disease|15|||
130793025|NCT02475213|470869199|FG005|Overall Study|Progressive Disease|25|||
130793026|NCT02475213|470869200|FG006|Overall Study|Progressive Disease|30|||
130793027|NCT02475213|470869201|FG007|Overall Study|Progressive Disease|10|||
130793028|NCT02475213|470869194|FG000|Overall Study|Death|0|||
130793029|NCT02475213|470869195|FG001|Overall Study|Death|0|||
130793030|NCT02475213|470869196|FG002|Overall Study|Death|0|||
130793031|NCT02475213|470869197|FG003|Overall Study|Death|0|||
130793032|NCT02475213|470869198|FG004|Overall Study|Death|0|||
130793033|NCT02475213|470869199|FG005|Overall Study|Death|4|||
130793034|NCT02475213|470869200|FG006|Overall Study|Death|1|||
130793035|NCT02475213|470869201|FG007|Overall Study|Death|0|||
130793036|NCT02475213|470869194|FG000|Overall Study|Protocol Violation|0|||
130793037|NCT02475213|470869195|FG001|Overall Study|Protocol Violation|0|||
130793038|NCT02475213|470869196|FG002|Overall Study|Protocol Violation|0|||
130793039|NCT02475213|470869197|FG003|Overall Study|Protocol Violation|0|||
130793040|NCT02475213|470869198|FG004|Overall Study|Protocol Violation|1|||
130793041|NCT02475213|470869199|FG005|Overall Study|Protocol Violation|0|||
130793042|NCT02475213|470869200|FG006|Overall Study|Protocol Violation|0|||
130793043|NCT02475213|470869201|FG007|Overall Study|Protocol Violation|0|||
130793044|NCT02475213|470869194|FG000|Overall Study|Withdrawal by Subject|0|||
130793045|NCT02475213|470869195|FG001|Overall Study|Withdrawal by Subject|0|||
130793046|NCT02475213|470869196|FG002|Overall Study|Withdrawal by Subject|0|||
130793047|NCT02475213|470869197|FG003|Overall Study|Withdrawal by Subject|1|||
130793048|NCT02475213|470869198|FG004|Overall Study|Withdrawal by Subject|0|||
130793049|NCT02475213|470869199|FG005|Overall Study|Withdrawal by Subject|2|||
130793050|NCT02475213|470869200|FG006|Overall Study|Withdrawal by Subject|2|||
130793051|NCT02475213|470869201|FG007|Overall Study|Withdrawal by Subject|0|||
130793052|NCT02475213|470869194|FG000|Overall Study|Other|0|||
130793053|NCT02475213|470869195|FG001|Overall Study|Other|0|||
130793054|NCT02475213|470869196|FG002|Overall Study|Other|0|||
130793055|NCT02475213|470869197|FG003|Overall Study|Other|1|||
130793056|NCT02475213|470869198|FG004|Overall Study|Other|3|||
130793057|NCT02475213|470869199|FG005|Overall Study|Other|1|||
130793058|NCT02475213|470869200|FG006|Overall Study|Other|0|||
130793059|NCT02475213|470869201|FG007|Overall Study|Other|0|||
130793060|NCT04666298|470869206|FG000|Overall Study|Subject decision|1|||
130793061|NCT04666298|470869207|FG001|Overall Study|Subject decision|0|||
130793062|NCT04666298|470869208|FG002|Overall Study|Subject decision|0|||
130793063|NCT04666298|470869209|FG003|Overall Study|Subject decision|2|||
130793064|NCT04666298|470869206|FG000|Overall Study|Death|1|||
130793065|NCT04666298|470869207|FG001|Overall Study|Death|0|||
130793066|NCT04666298|470869208|FG002|Overall Study|Death|0|||
130793067|NCT04666298|470869209|FG003|Overall Study|Death|0|||
130793068|NCT04666298|470869206|FG000|Overall Study|Lost to Follow-up|0|||
130793069|NCT04666298|470869207|FG001|Overall Study|Lost to Follow-up|0|||
130793070|NCT04666298|470869208|FG002|Overall Study|Lost to Follow-up|0|||
130793071|NCT04666298|470869209|FG003|Overall Study|Lost to Follow-up|1|||
130793072|NCT04666298|470869206|FG000|Overall Study|Physician Decision|0|||
130793073|NCT04666298|470869207|FG001|Overall Study|Physician Decision|0|||
130793074|NCT04666298|470869208|FG002|Overall Study|Physician Decision|0|||
130793075|NCT04666298|470869209|FG003|Overall Study|Physician Decision|1|||
130793076|NCT04666298|470869206|FG000|Overall Study|Protocol deviation|0|||
130793077|NCT04666298|470869207|FG001|Overall Study|Protocol deviation|0|||
130793078|NCT04666298|470869208|FG002|Overall Study|Protocol deviation|1|||
130793079|NCT04666298|470869209|FG003|Overall Study|Protocol deviation|0|||
130793080|NCT00844519|470869210|FG000|Overall Study|Withdrawal by Subject|1|||
130793081|NCT00844519|470869211|FG001|Overall Study|Withdrawal by Subject|1|||
130793082|NCT00844519|470869210|FG000|Overall Study|Adverse Event|1|||
130793083|NCT00844519|470869211|FG001|Overall Study|Adverse Event|0|||
130793084|NCT00226655|470869212|FG000|Overall Study|Death|13|||
130793085|NCT00226655|470869212|FG000|Overall Study|Withdrawal by Subject|15|||
130793086|NCT00226655|470869212|FG000|Overall Study|Adverse Event|35|||
130793087|NCT00226655|470869212|FG000|Overall Study|Physician Decision|6|||
130793088|NCT00226655|470869212|FG000|Overall Study|Clinical deterioration|10|||
130793089|NCT06438601|470869213|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
130793090|NCT06438601|470869214|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
130793091|NCT06438601|470869213|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
130793092|NCT06438601|470869214|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
130793093|NCT03188822|470869217|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
130793094|NCT03188822|470869217|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
130793095|NCT01285518|470869218|FG000|Overall Study|Lost to Follow-up|0|||
130793096|NCT01285518|470869219|FG001|Overall Study|Lost to Follow-up|0|||
130793097|NCT01285518|470869220|FG002|Overall Study|Lost to Follow-up|0|||
130793098|NCT01285518|470869221|FG003|Overall Study|Lost to Follow-up|0|||
130793099|NCT01285518|470869222|FG004|Overall Study|Lost to Follow-up|0|||
130793100|NCT01285518|470869223|FG005|Overall Study|Lost to Follow-up|1|||
130793101|NCT01285518|470869224|FG006|Overall Study|Lost to Follow-up|0|||
130793102|NCT01285518|470869225|FG007|Overall Study|Lost to Follow-up|0|||
130793103|NCT03805841|470869226|FG000|Overall Study|Clinical Progression|2|||
130793104|NCT03805841|470869227|FG001|Overall Study|Clinical Progression|0|||
130793105|NCT03805841|470869228|FG002|Overall Study|Clinical Progression|0|||
130793106|NCT03805841|470869226|FG000|Overall Study|Death|0|||
130793107|NCT03805841|470869227|FG001|Overall Study|Death|3|||
130793108|NCT03805841|470869228|FG002|Overall Study|Death|1|||
130793109|NCT03805841|470869226|FG000|Overall Study|Lost to Follow-up|0|||
130793110|NCT03805841|470869227|FG001|Overall Study|Lost to Follow-up|0|||
130793111|NCT03805841|470869228|FG002|Overall Study|Lost to Follow-up|1|||
130793112|NCT03805841|470869226|FG000|Overall Study|Withdrawal by Subject|2|||
130793113|NCT03805841|470869227|FG001|Overall Study|Withdrawal by Subject|3|||
130793114|NCT03805841|470869228|FG002|Overall Study|Withdrawal by Subject|0|||
130793115|NCT03805841|470869226|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
130793116|NCT03805841|470869227|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
130793117|NCT03805841|470869228|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
130793118|NCT01977846|470869236|FG000|Total Study - Prospective|Death|0|||
130793119|NCT01977846|470869237|FG001|Total Study - Prospective|Death|1|||
130793120|NCT01977846|470869236|FG000|Total Study - Prospective|Lost to Follow-up|0|||
130793121|NCT01977846|470869237|FG001|Total Study - Prospective|Lost to Follow-up|8|||
130793122|NCT01977846|470869236|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
130793123|NCT01977846|470869237|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
130793124|NCT01977846|470869236|FG000|Total Study - Prospective|Not available at time of visit|0|||
130793125|NCT01977846|470869237|FG001|Total Study - Prospective|Not available at time of visit|5|||
130793126|NCT01977846|470869236|FG000|Total Study - Prospective|No show|0|||
130793127|NCT01977846|470869237|FG001|Total Study - Prospective|No show|1|||
130793128|NCT01977846|470869236|FG000|Total Study - Prospective|Protocol Violation|0|||
130761852|NCT02326298|470750328|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761853|NCT02326298|470750329|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761854|NCT02326298|470750330|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761855|NCT02326298|470750331|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761856|NCT02326298|470750332|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130761857|NCT02326298|470750319|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761858|NCT02326298|470750320|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761859|NCT02326298|470750321|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761860|NCT02326298|470750322|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761861|NCT02326298|470750323|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761862|NCT02326298|470750324|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
130761863|NCT02326298|470750325|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761864|NCT02326298|470750326|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761865|NCT02326298|470750327|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761866|NCT02326298|470750328|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761867|NCT02326298|470750329|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761868|NCT02326298|470750330|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761869|NCT02326298|470750331|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761870|NCT02326298|470750332|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130761871|NCT02326298|470750319|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
130761872|NCT02326298|470750320|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
130761873|NCT02326298|470750321|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
130761874|NCT02326298|470750322|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
130761875|NCT02326298|470750323|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
130761876|NCT02326298|470750324|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
130761877|NCT02326298|470750325|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
130761878|NCT02326298|470750326|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
130761879|NCT02326298|470750327|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
130761880|NCT02326298|470750328|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
130761881|NCT02326298|470750329|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
130761882|NCT02326298|470750330|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
130761883|NCT02326298|470750331|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
130761884|NCT02326298|470750332|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
130761885|NCT02326298|470750319|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761886|NCT02326298|470750320|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761887|NCT02326298|470750321|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761888|NCT02326298|470750322|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761889|NCT02326298|470750323|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761890|NCT02326298|470750324|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761891|NCT02326298|470750325|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761892|NCT02326298|470750326|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761893|NCT02326298|470750327|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761894|NCT02326298|470750328|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761895|NCT02326298|470750329|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761896|NCT02326298|470750330|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
130761897|NCT02326298|470750331|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
130761898|NCT02326298|470750332|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130761899|NCT02326298|470750319|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761900|NCT02326298|470750320|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761901|NCT02326298|470750321|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130793129|NCT01977846|470869237|FG001|Total Study - Prospective|Protocol Violation|1|||
130793130|NCT02460289|470869238|FG000|Overall Study|Adverse Event|1|||
130793131|NCT02460289|470869238|FG000|Overall Study|Withdrawal by Subject|8|||
130793132|NCT02460289|470869238|FG000|Overall Study|Lost to Follow-up|1|||
130793133|NCT02164916|470869239|FG000|Overall Study|Adverse Event|3|||
130793134|NCT02164916|470869240|FG001|Overall Study|Adverse Event|8|||
130793135|NCT02164916|470869239|FG000|Overall Study|Death|1|||
130793136|NCT02164916|470869240|FG001|Overall Study|Death|1|||
130793137|NCT02164916|470869239|FG000|Overall Study|Refusal unrelated to adverse event|3|||
130793138|NCT02164916|470869240|FG001|Overall Study|Refusal unrelated to adverse event|7|||
130793139|NCT02164916|470869239|FG000|Overall Study|Progression|37|||
130793140|NCT02164916|470869240|FG001|Overall Study|Progression|26|||
130793141|NCT02164916|470869239|FG000|Overall Study|Not protocol specified|5|||
130793142|NCT02164916|470869240|FG001|Overall Study|Not protocol specified|1|||
130793143|NCT02164916|470869239|FG000|Overall Study|Reason under review|1|||
130793144|NCT02164916|470869240|FG001|Overall Study|Reason under review|6|||
130793145|NCT02164916|470869239|FG000|Overall Study|Not eligible|2|||
130793146|NCT02164916|470869240|FG001|Overall Study|Not eligible|5|||
130793147|NCT00596635|470869245|FG000|Overall Study|Lost to Follow-up|0|||
130793148|NCT00596635|470869246|FG001|Overall Study|Lost to Follow-up|2|||
130793149|NCT00596635|470869247|FG002|Overall Study|Lost to Follow-up|0|||
130793150|NCT00596635|470869245|FG000|Overall Study|Treatment for symptomatic UTI|4|||
130793151|NCT00596635|470869246|FG001|Overall Study|Treatment for symptomatic UTI|6|||
130793152|NCT00596635|470869247|FG002|Overall Study|Treatment for symptomatic UTI|3|||
130793153|NCT00596635|470869245|FG000|Overall Study|Hip fracture|2|||
130793154|NCT00596635|470869246|FG001|Overall Study|Hip fracture|3|||
130793155|NCT00596635|470869247|FG002|Overall Study|Hip fracture|3|||
130793156|NCT00596635|470869245|FG000|Overall Study|Could not provide urine specimen|1|||
130793157|NCT00596635|470869246|FG001|Overall Study|Could not provide urine specimen|2|||
130793158|NCT00596635|470869247|FG002|Overall Study|Could not provide urine specimen|2|||
130793159|NCT00127803|470869249|FG000|Overall Study|Adverse Event|2|||
130793160|NCT00127803|470869250|FG001|Overall Study|Adverse Event|0|||
130793161|NCT00127803|470869251|FG002|Overall Study|Adverse Event|0|||
130793162|NCT00127803|470869252|FG003|Overall Study|Adverse Event|0|||
130793163|NCT00127803|470869249|FG000|Overall Study|Withdrawal by Subject|1|||
130793164|NCT00127803|470869250|FG001|Overall Study|Withdrawal by Subject|0|||
130793165|NCT00127803|470869251|FG002|Overall Study|Withdrawal by Subject|0|||
130793166|NCT00127803|470869252|FG003|Overall Study|Withdrawal by Subject|0|||
130793167|NCT00127803|470869249|FG000|Overall Study|Lost to Follow-up|0|||
130793168|NCT00127803|470869250|FG001|Overall Study|Lost to Follow-up|0|||
130793169|NCT00127803|470869251|FG002|Overall Study|Lost to Follow-up|0|||
130793170|NCT00127803|470869252|FG003|Overall Study|Lost to Follow-up|1|||
130793171|NCT01925417|470869257|FG000|Overall Study|Withdrawal by Subject|2|||
130793172|NCT01925417|470869257|FG000|Overall Study|Death|1|||
130822747|NCT00812955|470980592|FG003|Overall Study|Withdrawal by Subject|2|||
130822748|NCT00812955|470980589|FG000|Overall Study|randomized in error|0|||
130822749|NCT00812955|470980590|FG001|Overall Study|randomized in error|0|||
130822750|NCT00812955|470980591|FG002|Overall Study|randomized in error|1|||
130822751|NCT00812955|470980592|FG003|Overall Study|randomized in error|0|||
130822752|NCT01772550|470980594|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
130822753|NCT01772550|470980595|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
130822754|NCT01772550|470980596|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
130822755|NCT01772550|470980594|FG000|Overall Study|Adverse Event|0|||
130822756|NCT01772550|470980595|FG001|Overall Study|Adverse Event|0|||
130822757|NCT01772550|470980596|FG002|Overall Study|Adverse Event|1|||
130822758|NCT01815424|470980597|FG000|Week 0 to 16|Adverse Event|1|||
130822759|NCT01815424|470980598|FG001|Week 0 to 16|Adverse Event|3|||
130822760|NCT01815424|470980599|FG002|Week 0 to 16|Adverse Event|3|||
130822761|NCT01815424|470980600|FG003|Week 0 to 16|Adverse Event|0|||
130822762|NCT01815424|470980601|FG004|Week 0 to 16|Adverse Event|0|||
130822763|NCT01815424|470980597|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
130822764|NCT01815424|470980598|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130822765|NCT01815424|470980599|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130822766|NCT01815424|470980600|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130822767|NCT01815424|470980601|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130822768|NCT01815424|470980597|FG000|Week 0 to 16|Lost to Follow-up|0|||
130822769|NCT01815424|470980598|FG001|Week 0 to 16|Lost to Follow-up|1|||
130822770|NCT01815424|470980599|FG002|Week 0 to 16|Lost to Follow-up|0|||
130822771|NCT01815424|470980600|FG003|Week 0 to 16|Lost to Follow-up|0|||
130822772|NCT01815424|470980601|FG004|Week 0 to 16|Lost to Follow-up|0|||
130822773|NCT01815424|470980597|FG000|Week 0 to 16|Withdrawal by Subject|0|||
130822774|NCT01815424|470980598|FG001|Week 0 to 16|Withdrawal by Subject|0|||
130822775|NCT01815424|470980599|FG002|Week 0 to 16|Withdrawal by Subject|1|||
130822776|NCT01815424|470980600|FG003|Week 0 to 16|Withdrawal by Subject|0|||
130822777|NCT01815424|470980601|FG004|Week 0 to 16|Withdrawal by Subject|0|||
130822778|NCT01815424|470980597|FG000|Week 0 to 16|Other|1|||
130822779|NCT01815424|470980598|FG001|Week 0 to 16|Other|0|||
130822780|NCT01815424|470980599|FG002|Week 0 to 16|Other|3|||
130822781|NCT01815424|470980600|FG003|Week 0 to 16|Other|0|||
130822782|NCT01815424|470980601|FG004|Week 0 to 16|Other|0|||
130793173|NCT03454555|470871003|FG000|Overall Study|Death|6|||
130793174|NCT03454555|470871004|FG001|Overall Study|Death|6|||
130793175|NCT03454555|470871003|FG000|Overall Study|Lost to Follow-up|31|||
130793176|NCT03454555|470871004|FG001|Overall Study|Lost to Follow-up|12|||
130793177|NCT03454555|470871003|FG000|Overall Study|Physician Decision|2|||
130793178|NCT03454555|470871004|FG001|Overall Study|Physician Decision|6|||
130793179|NCT03454555|470871003|FG000|Overall Study|Withdrawal by Subject|34|||
130793180|NCT03454555|470871004|FG001|Overall Study|Withdrawal by Subject|5|||
130793181|NCT03454555|470871003|FG000|Overall Study|Ineligible|1|||
130793182|NCT03454555|470871004|FG001|Overall Study|Ineligible|5|||
130793183|NCT01386385|470871005|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
130793184|NCT01386385|470871006|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130793185|NCT01386385|470871007|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130793186|NCT01386385|470871008|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130793187|NCT01386385|470871009|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130793188|NCT01386385|470871010|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130793189|NCT01386385|470871011|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130793190|NCT01386385|470871012|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130793191|NCT01386385|470871005|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
130793192|NCT01386385|470871006|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130793193|NCT01386385|470871007|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130793194|NCT01386385|470871008|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130793195|NCT01386385|470871009|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130793196|NCT01386385|470871010|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130793197|NCT01386385|470871011|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130793198|NCT01386385|470871012|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130793199|NCT01386385|470871005|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130793200|NCT01386385|470871006|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130793201|NCT01386385|470871007|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
130793202|NCT01386385|470871008|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130793203|NCT01386385|470871009|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130793204|NCT01386385|470871010|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130793205|NCT01386385|470871011|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130793206|NCT01386385|470871012|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130793207|NCT01386385|470871005|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130793208|NCT01386385|470871006|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130793209|NCT01386385|470871007|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130793210|NCT01386385|470871008|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130793211|NCT01386385|470871009|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
130793212|NCT01386385|470871010|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130793213|NCT01386385|470871011|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130793214|NCT01386385|470871012|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130793215|NCT01386385|470871005|FG000|Phase II Concurrent CRT|Adverse Event|0|||
130793216|NCT01386385|470871006|FG001|Phase II Concurrent CRT|Adverse Event|0|||
130793217|NCT01386385|470871007|FG002|Phase II Concurrent CRT|Adverse Event|0|||
130793218|NCT01386385|470871008|FG003|Phase II Concurrent CRT|Adverse Event|0|||
130793219|NCT01386385|470871009|FG004|Phase II Concurrent CRT|Adverse Event|0|||
130793220|NCT01386385|470871010|FG005|Phase II Concurrent CRT|Adverse Event|0|||
130793221|NCT01386385|470871011|FG006|Phase II Concurrent CRT|Adverse Event|3|||
130793222|NCT01386385|470871012|FG007|Phase II Concurrent CRT|Adverse Event|3|||
130793223|NCT01386385|470871005|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130793224|NCT01386385|470871006|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130793225|NCT01386385|470871007|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130793226|NCT01386385|470871008|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130793227|NCT01386385|470871009|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130793228|NCT01386385|470871010|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130793229|NCT01386385|470871011|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
130793230|NCT01386385|470871012|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130793231|NCT01386385|470871005|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
130793232|NCT01386385|470871006|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
130793233|NCT01386385|470871007|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
130793234|NCT01386385|470871008|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
130793235|NCT01386385|470871009|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
130793236|NCT01386385|470871010|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
130793237|NCT01386385|470871011|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
130793238|NCT01386385|470871012|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
130793239|NCT01386385|470871005|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130793240|NCT01386385|470871006|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130793241|NCT01386385|470871007|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130793242|NCT01386385|470871008|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130761902|NCT02326298|470750322|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761903|NCT02326298|470750323|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761904|NCT02326298|470750324|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761905|NCT02326298|470750325|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761906|NCT02326298|470750326|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761907|NCT02326298|470750327|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761908|NCT02326298|470750328|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761909|NCT02326298|470750329|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761910|NCT02326298|470750330|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130761911|NCT02326298|470750331|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130761912|NCT02326298|470750332|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130761913|NCT02326298|470750319|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761914|NCT02326298|470750320|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761915|NCT02326298|470750321|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761916|NCT02326298|470750322|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761917|NCT02326298|470750323|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761918|NCT02326298|470750324|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761919|NCT02326298|470750325|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761920|NCT02326298|470750326|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761921|NCT02326298|470750327|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761922|NCT02326298|470750328|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761923|NCT02326298|470750329|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761924|NCT02326298|470750330|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761925|NCT02326298|470750331|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130761926|NCT02326298|470750332|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
130761927|NCT02326298|470750319|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761928|NCT02326298|470750320|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761929|NCT02326298|470750321|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761930|NCT02326298|470750322|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761931|NCT02326298|470750323|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761932|NCT02326298|470750324|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761933|NCT02326298|470750325|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761934|NCT02326298|470750326|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761935|NCT02326298|470750327|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761936|NCT02326298|470750328|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761937|NCT02326298|470750329|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130761938|NCT02326298|470750330|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
130761939|NCT02326298|470750331|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
130761940|NCT02326298|470750332|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
130761941|NCT02326298|470750319|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761942|NCT02326298|470750320|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761943|NCT02326298|470750321|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761944|NCT02326298|470750322|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761945|NCT02326298|470750323|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761946|NCT02326298|470750324|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761947|NCT02326298|470750325|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761948|NCT02326298|470750326|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761949|NCT02326298|470750327|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761950|NCT02326298|470750328|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761951|NCT02326298|470750329|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130761952|NCT02326298|470750330|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
130761953|NCT02326298|470750331|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
130761954|NCT02326298|470750332|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
130761955|NCT02326298|470750319|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130761956|NCT02326298|470750320|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130761957|NCT02326298|470750321|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130761958|NCT02326298|470750322|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130761959|NCT02326298|470750323|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130761960|NCT02326298|470750324|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130761961|NCT02326298|470750325|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130761962|NCT02326298|470750326|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130822783|NCT01815424|470980597|FG000|Week 0 to 16|Protocol Violation|1|||
130793243|NCT01386385|470871009|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130793244|NCT01386385|470871010|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130793245|NCT01386385|470871011|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
130793246|NCT01386385|470871012|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130793247|NCT01386385|470871005|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
130793248|NCT01386385|470871006|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
130793249|NCT01386385|470871007|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
130793250|NCT01386385|470871008|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
130793251|NCT01386385|470871009|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
130793252|NCT01386385|470871010|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
130793253|NCT01386385|470871011|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
130793254|NCT01386385|470871012|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
130793255|NCT05399485|470871013|FG000|DBT Phase|Other|6|||
130793256|NCT05399485|470871014|FG001|DBT Phase|Other|5|||
130793257|NCT05399485|470871013|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
130793258|NCT05399485|470871014|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
130793259|NCT05399485|470871013|FG000|DBT Phase|Withdrawal by Subject|3|||
130793260|NCT05399485|470871014|FG001|DBT Phase|Withdrawal by Subject|2|||
130793261|NCT05399485|470871013|FG000|DBT Phase|Protocol Violation|2|||
130793262|NCT05399485|470871014|FG001|DBT Phase|Protocol Violation|1|||
130793263|NCT05399485|470871013|FG000|DBT Phase|Physician Decision|0|||
130793264|NCT05399485|470871014|FG001|DBT Phase|Physician Decision|1|||
130793265|NCT05399485|470871013|FG000|DBT Phase|Adverse Event|2|||
130793266|NCT05399485|470871014|FG001|DBT Phase|Adverse Event|1|||
130793267|NCT05399485|470871013|FG000|OLE Phase|Not reported|0|||
130793268|NCT05399485|470871014|FG001|OLE Phase|Not reported|1|||
130793269|NCT05399485|470871013|FG000|OLE Phase|Other|3|||
130793270|NCT05399485|470871014|FG001|OLE Phase|Other|3|||
130793271|NCT05399485|470871013|FG000|OLE Phase|Withdrawal by Subject|8|||
130793272|NCT05399485|470871014|FG001|OLE Phase|Withdrawal by Subject|5|||
130793273|NCT05399485|470871013|FG000|OLE Phase|Pregnancy|0|||
130793274|NCT05399485|470871014|FG001|OLE Phase|Pregnancy|1|||
130793275|NCT05399485|470871013|FG000|OLE Phase|Physician Decision|2|||
130793276|NCT05399485|470871014|FG001|OLE Phase|Physician Decision|0|||
130793277|NCT05399485|470871013|FG000|OLE Phase|Adverse Event|0|||
130793278|NCT05399485|470871014|FG001|OLE Phase|Adverse Event|1|||
130793279|NCT05399485|470871013|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
130793280|NCT05399485|470871014|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
130793281|NCT03405870|470871017|FG000|Overall Study|Withdrawal|1|||
130793282|NCT03405870|470871018|FG001|Overall Study|Withdrawal|0|||
130793283|NCT03405870|470871019|FG002|Overall Study|Withdrawal|1|||
130793284|NCT03405870|470871020|FG003|Overall Study|Withdrawal|0|||
130793285|NCT03405870|470871021|FG004|Overall Study|Withdrawal|0|||
130793286|NCT03405870|470871022|FG005|Overall Study|Withdrawal|0|||
130793287|NCT03405870|470871023|FG006|Overall Study|Withdrawal|1|||
130793288|NCT03405870|470871024|FG007|Overall Study|Withdrawal|0|||
130793289|NCT00614393|470871035|FG000|Overall Study|Adverse Event|20|||
130793290|NCT00614393|470871036|FG001|Overall Study|Adverse Event|2|||
130793291|NCT00614393|470871037|FG002|Overall Study|Adverse Event|3|||
130793292|NCT00614393|470871038|FG003|Overall Study|Adverse Event|13|||
130793293|NCT00614393|470871039|FG004|Overall Study|Adverse Event|21|||
130793294|NCT00614393|470871035|FG000|Overall Study|Lost to Follow-up|0|||
130793295|NCT00614393|470871036|FG001|Overall Study|Lost to Follow-up|0|||
130793296|NCT00614393|470871037|FG002|Overall Study|Lost to Follow-up|0|||
130793297|NCT00614393|470871038|FG003|Overall Study|Lost to Follow-up|1|||
130793298|NCT00614393|470871039|FG004|Overall Study|Lost to Follow-up|2|||
130793299|NCT00614393|470871035|FG000|Overall Study|Physician Decision|17|||
130793300|NCT00614393|470871036|FG001|Overall Study|Physician Decision|0|||
130793301|NCT00614393|470871037|FG002|Overall Study|Physician Decision|1|||
130793302|NCT00614393|470871038|FG003|Overall Study|Physician Decision|8|||
130793303|NCT00614393|470871039|FG004|Overall Study|Physician Decision|9|||
130793304|NCT00614393|470871035|FG000|Overall Study|Progressive Disease|118|||
130793305|NCT00614393|470871036|FG001|Overall Study|Progressive Disease|5|||
130793306|NCT00614393|470871037|FG002|Overall Study|Progressive Disease|5|||
130793307|NCT00614393|470871038|FG003|Overall Study|Progressive Disease|138|||
130793308|NCT00614393|470871039|FG004|Overall Study|Progressive Disease|130|||
130793309|NCT00614393|470871035|FG000|Overall Study|Protocol Violation|1|||
130793310|NCT00614393|470871036|FG001|Overall Study|Protocol Violation|0|||
130793311|NCT00614393|470871037|FG002|Overall Study|Protocol Violation|0|||
130793312|NCT00614393|470871038|FG003|Overall Study|Protocol Violation|0|||
130793313|NCT00614393|470871039|FG004|Overall Study|Protocol Violation|0|||
130793314|NCT00614393|470871035|FG000|Overall Study|Terminated by Sponsor|0|||
130793315|NCT00614393|470871036|FG001|Overall Study|Terminated by Sponsor|0|||
130793316|NCT00614393|470871037|FG002|Overall Study|Terminated by Sponsor|0|||
130793317|NCT00614393|470871038|FG003|Overall Study|Terminated by Sponsor|0|||
130793318|NCT00614393|470871039|FG004|Overall Study|Terminated by Sponsor|1|||
130793319|NCT00614393|470871035|FG000|Overall Study|Withdrawal by Subject|20|||
130793320|NCT00614393|470871036|FG001|Overall Study|Withdrawal by Subject|1|||
130793321|NCT00614393|470871037|FG002|Overall Study|Withdrawal by Subject|1|||
130793322|NCT00614393|470871038|FG003|Overall Study|Withdrawal by Subject|16|||
130793323|NCT00614393|470871039|FG004|Overall Study|Withdrawal by Subject|13|||
130793324|NCT00614393|470871035|FG000|Overall Study|Other|4|||
130793325|NCT00614393|470871036|FG001|Overall Study|Other|0|||
130793326|NCT00614393|470871037|FG002|Overall Study|Other|0|||
130793327|NCT00614393|470871038|FG003|Overall Study|Other|4|||
130793328|NCT00614393|470871039|FG004|Overall Study|Other|2|||
130793329|NCT00614393|470871035|FG000|Overall Study|Not Treated|0|||
130793330|NCT00614393|470871036|FG001|Overall Study|Not Treated|0|||
130793331|NCT00614393|470871037|FG002|Overall Study|Not Treated|0|||
130793332|NCT00614393|470871038|FG003|Overall Study|Not Treated|0|||
130793333|NCT00614393|470871039|FG004|Overall Study|Not Treated|2|||
130793334|NCT00855582|470871040|FG000|Overall Study|Adverse Event|2|||
130793335|NCT00855582|470871041|FG001|Overall Study|Adverse Event|6|||
130793336|NCT00855582|470871042|FG002|Overall Study|Adverse Event|3|||
130793337|NCT00855582|470871040|FG000|Overall Study|Death|1|||
130793338|NCT00855582|470871041|FG001|Overall Study|Death|0|||
130793339|NCT00855582|470871042|FG002|Overall Study|Death|0|||
130793340|NCT00855582|470871040|FG000|Overall Study|Lack of Efficacy|1|||
130793341|NCT00855582|470871041|FG001|Overall Study|Lack of Efficacy|3|||
130793342|NCT00855582|470871042|FG002|Overall Study|Lack of Efficacy|8|||
130793343|NCT00855582|470871040|FG000|Overall Study|Lost to Follow-up|1|||
130793344|NCT00855582|470871041|FG001|Overall Study|Lost to Follow-up|3|||
130793345|NCT00855582|470871042|FG002|Overall Study|Lost to Follow-up|1|||
130793346|NCT00855582|470871040|FG000|Overall Study|Physician Decision|0|||
130793347|NCT00855582|470871041|FG001|Overall Study|Physician Decision|0|||
130793348|NCT00855582|470871042|FG002|Overall Study|Physician Decision|1|||
130793349|NCT00855582|470871040|FG000|Overall Study|Protocol Violation|6|||
130793350|NCT00855582|470871041|FG001|Overall Study|Protocol Violation|2|||
130793351|NCT00855582|470871042|FG002|Overall Study|Protocol Violation|6|||
130793352|NCT00855582|470871040|FG000|Overall Study|Entry Criteria Not Met|8|||
130793353|NCT00855582|470871041|FG001|Overall Study|Entry Criteria Not Met|6|||
130793354|NCT00855582|470871042|FG002|Overall Study|Entry Criteria Not Met|3|||
130793355|NCT00855582|470871040|FG000|Overall Study|Withdrawal by Subject|7|||
130793356|NCT00855582|470871041|FG001|Overall Study|Withdrawal by Subject|4|||
130793357|NCT00855582|470871042|FG002|Overall Study|Withdrawal by Subject|8|||
130793358|NCT03345004|470871043|FG000|Overall Study|Physician Decision|1|||
130793359|NCT03345004|470871044|FG001|Overall Study|Physician Decision|0|||
130793360|NCT03345004|470871043|FG000|Overall Study|Withdrawal by Subject|0|||
130793361|NCT03345004|470871044|FG001|Overall Study|Withdrawal by Subject|1|||
130793362|NCT01013753|470871045|FG000|Overall Study|Adverse Event|8|||
130793363|NCT01013753|470871045|FG000|Overall Study|Protocol Violation|3|||
130793364|NCT01013753|470871045|FG000|Overall Study|Lost to Follow-up|1|||
130793365|NCT01013753|470871045|FG000|Overall Study|Withdrawal by Subject|2|||
130793366|NCT01013753|470871045|FG000|Overall Study|Other|2|||
130793367|NCT03320369|470871048|FG000|Overall Study|Adverse Event|1|||
130793368|NCT03320369|470871048|FG000|Overall Study|Withdrawal by Subject|2|||
130793369|NCT01732692|470871049|FG000|Overall Study|Adverse Event|0|||
130793370|NCT01732692|470871050|FG001|Overall Study|Adverse Event|1|||
130793371|NCT00435942|470871053|FG000|Overall Study|Death|17|||
130793372|NCT00435942|470871054|FG001|Overall Study|Death|10|||
130793373|NCT00435942|470871053|FG000|Overall Study|Withdrawal by Subject|2|||
130793374|NCT00435942|470871054|FG001|Overall Study|Withdrawal by Subject|0|||
130793375|NCT00435942|470871053|FG000|Overall Study|Lost to Follow-up|0|||
130793376|NCT00435942|470871054|FG001|Overall Study|Lost to Follow-up|16|||
130793377|NCT00435942|470871053|FG000|Overall Study|Conversion to Open Repair|1|||
130793378|NCT00435942|470871054|FG001|Overall Study|Conversion to Open Repair|0|||
130793379|NCT00435942|470871053|FG000|Overall Study|Technical Failure|3|||
130793380|NCT00435942|470871054|FG001|Overall Study|Technical Failure|0|||
130793381|NCT00435942|470871053|FG000|Overall Study|Other|0|||
130793382|NCT00435942|470871054|FG001|Overall Study|Other|1|||
130793383|NCT04491994|470871055|FG000|Overall Study|Withdrawal by Subject|10|||
130793384|NCT04491994|470871056|FG001|Overall Study|Withdrawal by Subject|5|||
130793385|NCT04491994|470871055|FG000|Overall Study|developed fever > 3 days|4|||
130793386|NCT04491994|470871056|FG001|Overall Study|developed fever > 3 days|1|||
130793387|NCT04491994|470871055|FG000|Overall Study|Protocol Violation|11|||
130793388|NCT04491994|470871056|FG001|Overall Study|Protocol Violation|2|||
130793389|NCT04491994|470871055|FG000|Overall Study|Lost to Follow-up|4|||
130793390|NCT04491994|470871056|FG001|Overall Study|Lost to Follow-up|3|||
130793391|NCT05522751|470871062|FG000|Overall Study|Adverse Event|1|||
130793392|NCT00505921|470871063|FG000|Overall Study|Ineligible|1|||
130793393|NCT00505921|470871063|FG000|Overall Study|Failed to Mobilize|8|||
130793394|NCT02441283|470871064|FG000|Overall Study|Withdrew consent|15|||
130793395|NCT02441283|470871064|FG000|Overall Study|Lost to Follow-up|42|||
130793396|NCT02441283|470871064|FG000|Overall Study|Death|1|||
130793397|NCT02441283|470871064|FG000|Overall Study|Other, not specified|32|||
130793398|NCT02382939|470871070|FG000|Overall Study|Adverse Event|1|||
130793399|NCT02382939|470871071|FG001|Overall Study|Adverse Event|1|||
130793400|NCT02382939|470871070|FG000|Overall Study|Withdrawal by Subject|2|||
130793401|NCT02382939|470871071|FG001|Overall Study|Withdrawal by Subject|2|||
130793402|NCT00537277|470871074|FG000|Overall Study|Adverse Event|1|||
130793403|NCT00537277|470871074|FG000|Overall Study|Lack of Efficacy|2|||
130793404|NCT00537277|470871074|FG000|Overall Study|Lost to Follow-up|12|||
130793405|NCT00537277|470871074|FG000|Overall Study|Protocol Violation|11|||
130793406|NCT00537277|470871074|FG000|Overall Study|Unclassified|4|||
130793407|NCT00537277|470871074|FG000|Overall Study|Inability to tolerate trial medication|4|||
130793408|NCT00537277|470871074|FG000|Overall Study|Non-compliance with trial procedures|15|||
130793409|NCT05383209|470871075|FG000|Overall Study|Adverse Event: Non-ocular|0|||
130793410|NCT05383209|470871076|FG001|Overall Study|Adverse Event: Non-ocular|1|||
130793411|NCT05383209|470871077|FG002|Overall Study|Adverse Event: Non-ocular|0|||
130793412|NCT05383209|470871075|FG000|Overall Study|Lost to Follow-up|2|||
130793413|NCT05383209|470871076|FG001|Overall Study|Lost to Follow-up|1|||
130793414|NCT05383209|470871077|FG002|Overall Study|Lost to Follow-up|4|||
130793415|NCT05383209|470871075|FG000|Overall Study|Withdrawal by Subject|2|||
130793416|NCT05383209|470871076|FG001|Overall Study|Withdrawal by Subject|0|||
130793417|NCT05383209|470871077|FG002|Overall Study|Withdrawal by Subject|1|||
130793418|NCT05383209|470871075|FG000|Overall Study|Death|1|||
130793419|NCT05383209|470871076|FG001|Overall Study|Death|0|||
130793420|NCT05383209|470871077|FG002|Overall Study|Death|0|||
130793421|NCT05383209|470871075|FG000|Overall Study|Other|0|||
130793422|NCT05383209|470871076|FG001|Overall Study|Other|1|||
130793423|NCT05383209|470871077|FG002|Overall Study|Other|0|||
130793424|NCT00717886|470871078|FG000|Overall Study|Withdrawal by Subject|3|||
130793425|NCT00717886|470871078|FG000|Overall Study|Treatment Failure|1|||
130793426|NCT00716417|470871079|FG000|Overall Study|Adverse Event|0|||
130793427|NCT00716417|470871080|FG001|Overall Study|Adverse Event|0|||
130793428|NCT00716417|470871081|FG002|Overall Study|Adverse Event|2|||
130793429|NCT00716417|470871082|FG003|Overall Study|Adverse Event|1|||
130793430|NCT00716417|470871083|FG004|Overall Study|Adverse Event|0|||
130793431|NCT00716417|470871084|FG005|Overall Study|Adverse Event|0|||
130793432|NCT00716417|470871085|FG006|Overall Study|Adverse Event|3|||
130793433|NCT00716417|470871086|FG007|Overall Study|Adverse Event|1|||
130793434|NCT00716417|470871087|FG008|Overall Study|Adverse Event|0|||
130793435|NCT00716417|470871088|FG009|Overall Study|Adverse Event|3|||
130793436|NCT00716417|470871079|FG000|Overall Study|Withdrawal by Subject|0|||
130793437|NCT00716417|470871080|FG001|Overall Study|Withdrawal by Subject|1|||
130793438|NCT00716417|470871081|FG002|Overall Study|Withdrawal by Subject|0|||
130793439|NCT00716417|470871082|FG003|Overall Study|Withdrawal by Subject|2|||
130793440|NCT00716417|470871083|FG004|Overall Study|Withdrawal by Subject|0|||
130793441|NCT00716417|470871084|FG005|Overall Study|Withdrawal by Subject|0|||
130793442|NCT00716417|470871085|FG006|Overall Study|Withdrawal by Subject|1|||
130793443|NCT00716417|470871086|FG007|Overall Study|Withdrawal by Subject|0|||
130793444|NCT00716417|470871087|FG008|Overall Study|Withdrawal by Subject|0|||
130793445|NCT00716417|470871088|FG009|Overall Study|Withdrawal by Subject|0|||
130793446|NCT00716417|470871079|FG000|Overall Study|Progressive disease|3|||
130793447|NCT00716417|470871080|FG001|Overall Study|Progressive disease|5|||
130793448|NCT00716417|470871081|FG002|Overall Study|Progressive disease|3|||
130793449|NCT00716417|470871082|FG003|Overall Study|Progressive disease|8|||
130793450|NCT00716417|470871083|FG004|Overall Study|Progressive disease|0|||
130793451|NCT00716417|470871084|FG005|Overall Study|Progressive disease|3|||
130793452|NCT00716417|470871085|FG006|Overall Study|Progressive disease|3|||
130793453|NCT00716417|470871086|FG007|Overall Study|Progressive disease|1|||
130793454|NCT00716417|470871087|FG008|Overall Study|Progressive disease|5|||
130793455|NCT00716417|470871088|FG009|Overall Study|Progressive disease|0|||
130793456|NCT00716417|470871079|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
130793457|NCT00716417|470871080|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
130793458|NCT00716417|470871081|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
130793459|NCT00716417|470871082|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
130793460|NCT00716417|470871083|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
130793461|NCT00716417|470871084|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
130793462|NCT00716417|470871085|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
130793463|NCT00716417|470871086|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
130793464|NCT00716417|470871087|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
130793465|NCT00716417|470871088|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
130793466|NCT00716417|470871079|FG000|Overall Study|On patient request due to toxicities|0|||
130793467|NCT00716417|470871080|FG001|Overall Study|On patient request due to toxicities|0|||
130793468|NCT00716417|470871081|FG002|Overall Study|On patient request due to toxicities|0|||
130793469|NCT00716417|470871082|FG003|Overall Study|On patient request due to toxicities|0|||
130793470|NCT00716417|470871083|FG004|Overall Study|On patient request due to toxicities|0|||
130793471|NCT00716417|470871084|FG005|Overall Study|On patient request due to toxicities|0|||
130793472|NCT00716417|470871085|FG006|Overall Study|On patient request due to toxicities|0|||
130793473|NCT00716417|470871086|FG007|Overall Study|On patient request due to toxicities|1|||
130793474|NCT00716417|470871087|FG008|Overall Study|On patient request due to toxicities|0|||
130793475|NCT00716417|470871088|FG009|Overall Study|On patient request due to toxicities|0|||
130793476|NCT01553851|470871089|FG000|Overall Study|Adverse Event|2|||
130793477|NCT01553851|470871089|FG000|Overall Study|constipation|1|||
130793478|NCT01369433|470871090|FG000|Overall Study|Adverse Event|31|||
130793479|NCT01369433|470871091|FG001|Overall Study|Adverse Event|1|||
130793480|NCT01369433|470871090|FG000|Overall Study|Required significant surgical procedure|1|||
130793481|NCT01369433|470871091|FG001|Overall Study|Required significant surgical procedure|0|||
130793482|NCT01369433|470871090|FG000|Overall Study|Non-compliance|1|||
130793483|NCT01369433|470871091|FG001|Overall Study|Non-compliance|0|||
130793484|NCT01369433|470871090|FG000|Overall Study|Withdrawal by Subject|5|||
130793485|NCT01369433|470871091|FG001|Overall Study|Withdrawal by Subject|2|||
130793486|NCT01369433|470871090|FG000|Overall Study|Study terminated by Sponsor|67|||
130793487|NCT01369433|470871091|FG001|Overall Study|Study terminated by Sponsor|0|||
130793488|NCT01369433|470871090|FG000|Overall Study|Lost to Follow-up|1|||
130793489|NCT01369433|470871091|FG001|Overall Study|Lost to Follow-up|0|||
130793490|NCT01369433|470871090|FG000|Overall Study|Death|5|||
130793491|NCT01369433|470871091|FG001|Overall Study|Death|0|||
130793492|NCT01369433|470871090|FG000|Overall Study|Investigator discretion|6|||
130793493|NCT01369433|470871091|FG001|Overall Study|Investigator discretion|1|||
130793494|NCT01369433|470871090|FG000|Overall Study|Progressive Disease|92|||
130793495|NCT01369433|470871091|FG001|Overall Study|Progressive Disease|12|||
130793496|NCT01838876|470871093|FG000|Overall Study|Adverse Event|49|||
130793497|NCT01838876|470871093|FG000|Overall Study|Insufficient Therapeutic Response|10|||
130793498|NCT01838876|470871093|FG000|Overall Study|Protocol Violation|34|||
130793499|NCT01838876|470871093|FG000|Overall Study|Withdrawal of Consent|33|||
130793500|NCT01838876|470871093|FG000|Overall Study|Lost to Follow-up|21|||
130793501|NCT01838876|470871093|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
130793502|NCT01838876|470871093|FG000|Overall Study|Reason not Specified|7|||
130793503|NCT01838876|470871093|FG000|Overall Study|Did not meet eligibility criteria|78|||
130793504|NCT02101294|470871094|FG000|Overall Study|Withdrawal by Subject|5|||
130793505|NCT02101294|470871094|FG000|Overall Study|Lost to Follow-up|6|||
130793506|NCT02755090|470871100|FG000|Overall Study|equipment malfunction|1|||
130793507|NCT02755090|470871101|FG001|Overall Study|equipment malfunction|0|||
130793508|NCT00207740|470871105|FG000|Overall Study|Adverse Event|4|||
130793509|NCT00207740|470871106|FG001|Overall Study|Adverse Event|14|||
130793510|NCT00207740|470871107|FG002|Overall Study|Adverse Event|14|||
130793511|NCT00207740|470871108|FG003|Overall Study|Adverse Event|11|||
130793512|NCT00207740|470871105|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130793513|NCT00207740|470871106|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130793514|NCT00207740|470871107|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130793515|NCT00207740|470871108|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
130793516|NCT00207740|470871105|FG000|Overall Study|Lost to Follow-up|0|||
130793517|NCT00207740|470871106|FG001|Overall Study|Lost to Follow-up|2|||
130793518|NCT00207740|470871107|FG002|Overall Study|Lost to Follow-up|1|||
130793519|NCT00207740|470871108|FG003|Overall Study|Lost to Follow-up|1|||
130793520|NCT00207740|470871105|FG000|Overall Study|Death|0|||
130793521|NCT00207740|470871106|FG001|Overall Study|Death|0|||
130793522|NCT00207740|470871107|FG002|Overall Study|Death|0|||
130793523|NCT00207740|470871108|FG003|Overall Study|Death|1|||
130793524|NCT00207740|470871105|FG000|Overall Study|Sponsor Directive|22|||
130793525|NCT00207740|470871106|FG001|Overall Study|Sponsor Directive|15|||
130793526|NCT00207740|470871107|FG002|Overall Study|Sponsor Directive|16|||
130793527|NCT00207740|470871108|FG003|Overall Study|Sponsor Directive|21|||
130793528|NCT00207740|470871105|FG000|Overall Study|Other|2|||
130793529|NCT00207740|470871106|FG001|Overall Study|Other|10|||
130793530|NCT00207740|470871107|FG002|Overall Study|Other|7|||
130793531|NCT00207740|470871108|FG003|Overall Study|Other|5|||
130793532|NCT00390013|470871109|FG000|Phase 1|tired|0|||
130793533|NCT00390013|470871110|FG001|Phase 1|tired|0|||
130793534|NCT00390013|470871111|FG002|Phase 1|tired|0|||
130793535|NCT00390013|470871112|FG003|Phase 1|tired|1|||
130793536|NCT00390013|470871109|FG000|Phase 2 First Treatment|tired|1|||
130793537|NCT00390013|470871110|FG001|Phase 2 First Treatment|tired|0|||
130793538|NCT00390013|470871111|FG002|Phase 2 First Treatment|tired|0|||
130793539|NCT00390013|470871112|FG003|Phase 2 First Treatment|tired|0|||
130793540|NCT00390013|470871109|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
130793541|NCT00390013|470871110|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
130793542|NCT00390013|470871111|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
130793543|NCT00390013|470871112|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
130793544|NCT00924898|470871118|FG000|Overall Study|Withdrawal by Subject|2|||
130793545|NCT00294658|470871119|FG000|Overall Study|Death|0|||
130793546|NCT00294658|470871120|FG001|Overall Study|Death|1|||
130793547|NCT00294658|470871119|FG000|Overall Study|Lost to Follow-up|4|||
130793548|NCT00294658|470871120|FG001|Overall Study|Lost to Follow-up|0|||
130793549|NCT00294658|470871119|FG000|Overall Study|Physician Decision|1|||
130793550|NCT00294658|470871120|FG001|Overall Study|Physician Decision|2|||
130793551|NCT00294658|470871119|FG000|Overall Study|Pregnancy|0|||
130793552|NCT00294658|470871120|FG001|Overall Study|Pregnancy|1|||
130793553|NCT00294658|470871119|FG000|Overall Study|Withdrawal by Subject|0|||
130793554|NCT00294658|470871120|FG001|Overall Study|Withdrawal by Subject|4|||
130793555|NCT00294658|470871119|FG000|Overall Study|Found to have invasive thymoma|1|||
130793556|NCT00294658|470871120|FG001|Overall Study|Found to have invasive thymoma|0|||
130793557|NCT00294658|470871119|FG000|Overall Study|Patient and family were not satisfied|0|||
130793558|NCT00294658|470871120|FG001|Overall Study|Patient and family were not satisfied|1|||
130793559|NCT01910441|470871121|FG000|Overall Study|Sponsor decision|0|||
130793560|NCT01910441|470871122|FG001|Overall Study|Sponsor decision|2|||
130793561|NCT01910441|470871121|FG000|Overall Study|Lost to Follow-up|6|||
130793562|NCT01910441|470871122|FG001|Overall Study|Lost to Follow-up|5|||
130793563|NCT01910441|470871121|FG000|Overall Study|Withdrawal by Subject|0|||
130793564|NCT01910441|470871122|FG001|Overall Study|Withdrawal by Subject|1|||
130793565|NCT01910441|470871121|FG000|Overall Study|Non-compliance|0|||
130793566|NCT01910441|470871122|FG001|Overall Study|Non-compliance|1|||
130793567|NCT01910441|470871121|FG000|Overall Study|Adverse Event|1|||
130793568|NCT01910441|470871122|FG001|Overall Study|Adverse Event|0|||
130793569|NCT01910441|470871121|FG000|Overall Study|Physician Decision|0|||
130793570|NCT01910441|470871122|FG001|Overall Study|Physician Decision|1|||
130793571|NCT01811238|470871123|FG000|Overall Study|Withdrawal by Subject|42|||
130793572|NCT01811238|470871123|FG000|Overall Study|Adverse Event|25|||
130793573|NCT01811238|470871123|FG000|Overall Study|Protocol Violation|4|||
130793574|NCT01811238|470871123|FG000|Overall Study|Lack of Efficacy|4|||
130793575|NCT01811238|470871123|FG000|Overall Study|subject refused study medication|6|||
130793576|NCT02340949|470871124|FG000|Overall Study|Adverse Event|4|||
130793577|NCT02340949|470871125|FG001|Overall Study|Adverse Event|2|||
130793578|NCT02340949|470871124|FG000|Overall Study|Withdrawal by Subject|2|||
130793579|NCT02340949|470871125|FG001|Overall Study|Withdrawal by Subject|0|||
130793580|NCT02340949|470871124|FG000|Overall Study|Progression disease|6|||
130793581|NCT02340949|470871125|FG001|Overall Study|Progression disease|2|||
130793582|NCT02340949|470871124|FG000|Overall Study|Death|3|||
130793583|NCT02340949|470871125|FG001|Overall Study|Death|0|||
130793584|NCT02340949|470871124|FG000|Overall Study|Physician Decision|1|||
130793585|NCT02340949|470871125|FG001|Overall Study|Physician Decision|0|||
130793586|NCT01192178|470871126|FG000|Overall Study|Withdrawal by Subject|6|||
130793587|NCT01192178|470871127|FG001|Overall Study|Withdrawal by Subject|10|||
130793588|NCT01192178|470871126|FG000|Overall Study|Protocol Violation|10|||
130793589|NCT01192178|470871127|FG001|Overall Study|Protocol Violation|3|||
130793590|NCT01192178|470871126|FG000|Overall Study|Physician Decision|2|||
130793591|NCT01192178|470871127|FG001|Overall Study|Physician Decision|4|||
130793592|NCT01192178|470871126|FG000|Overall Study|Lost to Follow-up|3|||
130793593|NCT01192178|470871127|FG001|Overall Study|Lost to Follow-up|3|||
130793594|NCT01192178|470871126|FG000|Overall Study|Adverse Event|2|||
130793595|NCT01192178|470871127|FG001|Overall Study|Adverse Event|1|||
130793596|NCT01192178|470871126|FG000|Overall Study|Lack of Efficacy|1|||
130793597|NCT01192178|470871127|FG001|Overall Study|Lack of Efficacy|2|||
130793598|NCT01155570|470871128|FG000|Overall Study|Adverse Event|39|||
130793599|NCT01155570|470871128|FG000|Overall Study|Lack of Efficacy|46|||
130793600|NCT01155570|470871128|FG000|Overall Study|Participant's Economic Reasons|17|||
130793601|NCT01155570|470871128|FG000|Overall Study|No Hospital Visits|7|||
130793602|NCT01155570|470871128|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
130793603|NCT01155570|470871128|FG000|Overall Study|Adverse Event + Other Reasons|7|||
130793604|NCT01155570|470871128|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
130793605|NCT01155570|470871128|FG000|Overall Study|Other Reasons|23|||
130793606|NCT00296517|470871129|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
130793607|NCT00296517|470871130|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
130793608|NCT00296517|470871129|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
130793609|NCT00296517|470871130|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
130793610|NCT00296517|470871129|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
130793611|NCT00296517|470871130|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
130793612|NCT00296517|470871129|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
130793613|NCT00296517|470871130|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
130793614|NCT00296517|470871129|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
130793615|NCT00296517|470871130|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
130793616|NCT00296517|470871129|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
130793617|NCT00296517|470871130|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
130793618|NCT00296517|470871129|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
130793619|NCT00296517|470871130|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
130793620|NCT00296517|470871129|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
130793621|NCT00296517|470871130|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
130793622|NCT00296517|470871129|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
130793623|NCT00296517|470871130|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
130793624|NCT02774889|470871137|FG000|Overall Study|Lost to Follow-up|2|||
130793625|NCT02774889|470871138|FG001|Overall Study|Lost to Follow-up|1|||
130793626|NCT01349595|470871139|FG000|Overall Study|Lack of funding|2|||
130793627|NCT01349595|470871140|FG001|Overall Study|Lack of funding|2|||
130793628|NCT04584788|470871160|FG000|Overall Study|Physician Decision|8|||
130793629|NCT04584788|470871160|FG000|Overall Study|Withdrawal by Subject|1|||
130793630|NCT04584788|470871160|FG000|Overall Study|Adverse Event|3|||
130793631|NCT03095287|470873021|FG000|Overall Study|Treatment Failure|1|||
130793632|NCT03095287|470873021|FG000|Overall Study|Adverse Event|1|||
130793633|NCT02394275|470873022|FG000|Overall Study|Adverse Event|22|||
130793634|NCT02394275|470873022|FG000|Overall Study|Lost to Follow-up|7|||
130793635|NCT04757636|470873028|FG000|Overall Study|Adverse Event|25|||
130793636|NCT04757636|470873029|FG001|Overall Study|Adverse Event|8|||
130793637|NCT04757636|470873030|FG002|Overall Study|Adverse Event|11|||
130793638|NCT04757636|470873028|FG000|Overall Study|Death|9|||
130793639|NCT04757636|470873029|FG001|Overall Study|Death|12|||
130793640|NCT04757636|470873030|FG002|Overall Study|Death|6|||
130793641|NCT04757636|470873028|FG000|Overall Study|Lack of Efficacy|2|||
130793642|NCT04757636|470873029|FG001|Overall Study|Lack of Efficacy|0|||
130793643|NCT04757636|470873030|FG002|Overall Study|Lack of Efficacy|0|||
130793644|NCT04757636|470873028|FG000|Overall Study|Lost to Follow-up|1|||
130793645|NCT04757636|470873029|FG001|Overall Study|Lost to Follow-up|6|||
130793646|NCT04757636|470873030|FG002|Overall Study|Lost to Follow-up|7|||
130793647|NCT04757636|470873028|FG000|Overall Study|Physician Decision|1|||
130793648|NCT04757636|470873029|FG001|Overall Study|Physician Decision|3|||
130793649|NCT04757636|470873030|FG002|Overall Study|Physician Decision|4|||
130793650|NCT04757636|470873028|FG000|Overall Study|Withdrawal by Subject|20|||
130793651|NCT04757636|470873029|FG001|Overall Study|Withdrawal by Subject|23|||
130793652|NCT04757636|470873030|FG002|Overall Study|Withdrawal by Subject|18|||
130793653|NCT04757636|470873028|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
130793654|NCT04757636|470873029|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
130793655|NCT04757636|470873030|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
130793656|NCT04757636|470873028|FG000|Overall Study|Study Terminated by Sponsor|103|||
130793657|NCT04757636|470873029|FG001|Overall Study|Study Terminated by Sponsor|104|||
130793658|NCT04757636|470873030|FG002|Overall Study|Study Terminated by Sponsor|114|||
130793659|NCT04757636|470873028|FG000|Overall Study|Sponsor Decision|0|||
130793660|NCT04757636|470873029|FG001|Overall Study|Sponsor Decision|0|||
130793661|NCT04757636|470873030|FG002|Overall Study|Sponsor Decision|1|||
130793662|NCT04757636|470873028|FG000|Overall Study|Randomized in Error|0|||
130793663|NCT04757636|470873029|FG001|Overall Study|Randomized in Error|0|||
130793664|NCT04757636|470873030|FG002|Overall Study|Randomized in Error|2|||
130793665|NCT05350423|470873032|FG000|Overall Study|Lost to Follow-up|3|||
130793666|NCT05350423|470873033|FG001|Overall Study|Lost to Follow-up|3|||
130793667|NCT05350423|470873032|FG000|Overall Study|screen failure|5|||
130793668|NCT05350423|470873033|FG001|Overall Study|screen failure|6|||
130793669|NCT02097277|470873038|FG000|Overall Study|Subject no longer meets study criteria|0|||
130822784|NCT01815424|470980598|FG001|Week 0 to 16|Protocol Violation|0|||
130793670|NCT02097277|470873039|FG001|Overall Study|Subject no longer meets study criteria|1|||
130793671|NCT02097277|470873040|FG002|Overall Study|Subject no longer meets study criteria|0|||
130793672|NCT02097277|470873041|FG003|Overall Study|Subject no longer meets study criteria|1|||
130793673|NCT02097277|470873042|FG004|Overall Study|Subject no longer meets study criteria|0|||
130793674|NCT02097277|470873038|FG000|Overall Study|Subject request to discontinue treatment|0|||
130793675|NCT02097277|470873039|FG001|Overall Study|Subject request to discontinue treatment|0|||
130793676|NCT02097277|470873040|FG002|Overall Study|Subject request to discontinue treatment|0|||
130793677|NCT02097277|470873041|FG003|Overall Study|Subject request to discontinue treatment|0|||
130793678|NCT02097277|470873042|FG004|Overall Study|Subject request to discontinue treatment|1|||
130793679|NCT02097277|470873038|FG000|Overall Study|Lost to Follow-up|0|||
130793680|NCT02097277|470873039|FG001|Overall Study|Lost to Follow-up|1|||
130793681|NCT02097277|470873040|FG002|Overall Study|Lost to Follow-up|1|||
130793682|NCT02097277|470873041|FG003|Overall Study|Lost to Follow-up|0|||
130793683|NCT02097277|470873042|FG004|Overall Study|Lost to Follow-up|0|||
130793684|NCT02097277|470873038|FG000|Overall Study|Withdrawal by Subject|2|||
130793685|NCT02097277|470873039|FG001|Overall Study|Withdrawal by Subject|1|||
130793686|NCT02097277|470873040|FG002|Overall Study|Withdrawal by Subject|0|||
130793687|NCT02097277|470873041|FG003|Overall Study|Withdrawal by Subject|1|||
130793688|NCT02097277|470873042|FG004|Overall Study|Withdrawal by Subject|0|||
130793689|NCT02097277|470873038|FG000|Overall Study|Adverse Event|0|||
130793690|NCT02097277|470873039|FG001|Overall Study|Adverse Event|0|||
130793691|NCT02097277|470873040|FG002|Overall Study|Adverse Event|1|||
130793692|NCT02097277|470873041|FG003|Overall Study|Adverse Event|2|||
130793693|NCT02097277|470873042|FG004|Overall Study|Adverse Event|0|||
130793694|NCT01091259|470873045|FG000|Overall Study|Adverse Event|3|||
130793695|NCT01091259|470873045|FG000|Overall Study|Lack of Efficacy|2|||
130793696|NCT00671060|470873048|FG000|Overall Study|Protocol Violation|1|||
130793697|NCT00671060|470873049|FG001|Overall Study|Protocol Violation|0|||
130793698|NCT00671060|470873048|FG000|Overall Study|Physician Decision|0|||
130793699|NCT00671060|470873049|FG001|Overall Study|Physician Decision|1|||
130793700|NCT06057064|470873050|FG000|Overall Study|Death|2|||
130793701|NCT06057064|470873051|FG001|Overall Study|Death|0|||
130793702|NCT06057064|470873050|FG000|Overall Study|Physician Decision|1|||
130793703|NCT06057064|470873051|FG001|Overall Study|Physician Decision|0|||
130793704|NCT06057064|470873050|FG000|Overall Study|Withdrawal by Subject|1|||
130793705|NCT06057064|470873051|FG001|Overall Study|Withdrawal by Subject|1|||
130793706|NCT01541748|470873052|FG000|Overall Study|Lost to Follow-up|17|||
130793707|NCT01541748|470873052|FG000|Overall Study|Moved out of state|1|||
130793708|NCT01541748|470873052|FG000|Overall Study|Withdrawal by Subject|7|||
130793709|NCT01541748|470873052|FG000|Overall Study|Screen failure|5|||
130793710|NCT01541748|470873052|FG000|Overall Study|Did not receive study device|1|||
130793711|NCT02832037|470873053|FG000|Overall Study|Administrative reasons|0|||
130793712|NCT02832037|470873054|FG001|Overall Study|Administrative reasons|0|||
130793713|NCT02832037|470873055|FG002|Overall Study|Administrative reasons|1|||
130793714|NCT02832037|470873056|FG003|Overall Study|Administrative reasons|0|||
130793715|NCT02832037|470873057|FG004|Overall Study|Administrative reasons|0|||
130793716|NCT02832037|470873053|FG000|Overall Study|Protocol Violation|3|||
130793717|NCT02832037|470873054|FG001|Overall Study|Protocol Violation|0|||
130793718|NCT02832037|470873055|FG002|Overall Study|Protocol Violation|4|||
130793719|NCT02832037|470873056|FG003|Overall Study|Protocol Violation|1|||
130793720|NCT02832037|470873057|FG004|Overall Study|Protocol Violation|2|||
130793721|NCT02832037|470873053|FG000|Overall Study|Lost to Follow-up|2|||
130793722|NCT02832037|470873054|FG001|Overall Study|Lost to Follow-up|0|||
130793723|NCT02832037|470873055|FG002|Overall Study|Lost to Follow-up|3|||
130793724|NCT02832037|470873056|FG003|Overall Study|Lost to Follow-up|0|||
130793725|NCT02832037|470873057|FG004|Overall Study|Lost to Follow-up|5|||
130793726|NCT02832037|470873053|FG000|Overall Study|Withdrawal by Subject|9|||
130793727|NCT02832037|470873054|FG001|Overall Study|Withdrawal by Subject|8|||
130793728|NCT02832037|470873055|FG002|Overall Study|Withdrawal by Subject|0|||
130793729|NCT02832037|470873056|FG003|Overall Study|Withdrawal by Subject|4|||
130793730|NCT02832037|470873057|FG004|Overall Study|Withdrawal by Subject|8|||
130793731|NCT02832037|470873053|FG000|Overall Study|Adverse Event|5|||
130793732|NCT02832037|470873054|FG001|Overall Study|Adverse Event|4|||
130793733|NCT02832037|470873055|FG002|Overall Study|Adverse Event|0|||
130793734|NCT02832037|470873056|FG003|Overall Study|Adverse Event|2|||
130793735|NCT02832037|470873057|FG004|Overall Study|Adverse Event|4|||
130793736|NCT03329989|470873058|FG000|Overall Study|Withdrawal by Subject|9|||
130793737|NCT03329989|470873058|FG000|Overall Study|Lost to Follow-up|8|||
130793738|NCT03329989|470873058|FG000|Overall Study|Adverse Event|5|||
130793739|NCT03329989|470873058|FG000|Overall Study|Protocol Violation|1|||
130793740|NCT04167462|470873063|FG000|Overall Study|Other reasons|3|||
130793741|NCT04167462|470873064|FG001|Overall Study|Other reasons|2|||
130793742|NCT04167462|470873063|FG000|Overall Study|Withdrawal by Subject|6|||
130793743|NCT04167462|470873064|FG001|Overall Study|Withdrawal by Subject|7|||
130793744|NCT04167462|470873063|FG000|Overall Study|Adverse Event|4|||
130793745|NCT04167462|470873064|FG001|Overall Study|Adverse Event|0|||
130793746|NCT04167462|470873063|FG000|Overall Study|Pregnancy|1|||
130793747|NCT04167462|470873064|FG001|Overall Study|Pregnancy|0|||
130793748|NCT04167462|470873063|FG000|Overall Study|Lack of Efficacy|0|||
130793749|NCT04167462|470873064|FG001|Overall Study|Lack of Efficacy|1|||
130793750|NCT03881371|470873069|FG000|Overall Study|Adverse Event|8|||
130793751|NCT03881371|470873070|FG001|Overall Study|Adverse Event|9|||
130793752|NCT03881371|470873069|FG000|Overall Study|Death|1|||
130793753|NCT03881371|470873070|FG001|Overall Study|Death|0|||
130793754|NCT03881371|470873069|FG000|Overall Study|Lost to Follow-up|1|||
130793755|NCT03881371|470873070|FG001|Overall Study|Lost to Follow-up|0|||
130793756|NCT03881371|470873069|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130793757|NCT03881371|470873070|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130793758|NCT03881371|470873069|FG000|Overall Study|Physician Decision|3|||
130793759|NCT03881371|470873070|FG001|Overall Study|Physician Decision|3|||
130793760|NCT03881371|470873069|FG000|Overall Study|Withdrawal by Subject|2|||
130793761|NCT03881371|470873070|FG001|Overall Study|Withdrawal by Subject|10|||
130793762|NCT03881371|470873069|FG000|Overall Study|Discontinuation from Study|1|||
130793763|NCT03881371|470873070|FG001|Overall Study|Discontinuation from Study|0|||
130793764|NCT00933933|470873074|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
130793765|NCT00933933|470873075|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
130793766|NCT00933933|470873076|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
130793767|NCT00933933|470873074|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
130793768|NCT00933933|470873075|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
130793769|NCT00933933|470873076|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
130793770|NCT01138046|470873077|FG000|Overall Study|Withdrawal due to death|6|||
130793771|NCT02178956|470873078|FG000|Overall Study|Lost to Follow-up|4|||
130793772|NCT02178956|470873079|FG001|Overall Study|Lost to Follow-up|4|||
130793773|NCT02178956|470873078|FG000|Overall Study|Sponsor terminated study|49|||
130793774|NCT02178956|470873079|FG001|Overall Study|Sponsor terminated study|58|||
130793775|NCT02178956|470873078|FG000|Overall Study|Withdrawal by Subject|15|||
130793776|NCT02178956|470873079|FG001|Overall Study|Withdrawal by Subject|11|||
130793777|NCT02178956|470873078|FG000|Overall Study|Various Reasons|3|||
130793778|NCT02178956|470873079|FG001|Overall Study|Various Reasons|5|||
130793779|NCT01900314|470873080|FG000|Overall Study|Lost to Follow-up|1|||
130793780|NCT01900314|470873081|FG001|Overall Study|Lost to Follow-up|0|||
130793781|NCT01900314|470873080|FG000|Overall Study|Protocol Violation|0|||
130793782|NCT01900314|470873081|FG001|Overall Study|Protocol Violation|1|||
130793783|NCT01900314|470873080|FG000|Overall Study|Withdrawal by Subject|3|||
130793784|NCT01900314|470873081|FG001|Overall Study|Withdrawal by Subject|3|||
130793785|NCT04225832|470873083|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
130793786|NCT04225832|470873084|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
130793787|NCT04225832|470873083|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
130793788|NCT04225832|470873084|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
130793789|NCT03282097|470873085|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
130793790|NCT03282097|470873086|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
130793791|NCT03282097|470873085|FG000|Intervention Visit Complete|Patient Death|13|||
130793792|NCT03282097|470873086|FG001|Intervention Visit Complete|Patient Death|15|||
130793793|NCT03282097|470873085|FG000|Intervention Visit Complete|Caregiver Death|0|||
130793794|NCT03282097|470873086|FG001|Intervention Visit Complete|Caregiver Death|3|||
130793795|NCT03282097|470873085|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
130793796|NCT03282097|470873086|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
130793797|NCT03282097|470873085|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
130793798|NCT03282097|470873086|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
130793799|NCT03282097|470873085|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
130793800|NCT03282097|470873086|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
130793801|NCT03282097|470873085|FG000|Primary Outcome Data Collection Complete|Missing|2|||
130793802|NCT03282097|470873086|FG001|Primary Outcome Data Collection Complete|Missing|3|||
130793803|NCT03282097|470873085|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
130793804|NCT03282097|470873086|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
130793805|NCT03282097|470873085|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
130793806|NCT03282097|470873086|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
130793807|NCT03282097|470873085|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
130793808|NCT03282097|470873086|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
130793809|NCT06001021|470873090|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
130793810|NCT06001021|470873091|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
130793811|NCT06001021|470873092|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
130793812|NCT06001021|470873093|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
130793813|NCT06001021|470873094|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
130793814|NCT06001021|470873095|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
130793815|NCT06001021|470873096|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
130793816|NCT06001021|470873090|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
130793817|NCT06001021|470873091|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130761963|NCT02326298|470750327|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130761964|NCT02326298|470750328|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130761965|NCT02326298|470750329|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130761966|NCT02326298|470750330|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
130761967|NCT02326298|470750331|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
130761968|NCT02326298|470750332|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
130761969|NCT05072964|470750337|FG000|Overall Study|Withdrawal by Subject|4|||
130761970|NCT05072964|470750337|FG000|Overall Study|Death|1|||
130761971|NCT04240886|470751945|FG000|Treatment Phase|Death|4|||
130761972|NCT04240886|470751945|FG000|Treatment Phase|Discontinuation by Subject|1|||
130761973|NCT04240886|470751945|FG000|Treatment Phase|Adverse Event|5|||
130761974|NCT04240886|470751945|FG000|Follow-up Phase|Withdrawal by Subject|1|||
130761975|NCT04240886|470751945|FG000|Follow-up Phase|Discontinuation by Subject|1|||
130761976|NCT04240886|470751945|FG000|Follow-up Phase|Death|2|||
130761977|NCT01004406|470751946|FG000|Overall Study|Withdrawal by Subject|2|||
130761978|NCT01004406|470751947|FG001|Overall Study|Withdrawal by Subject|0|||
130761979|NCT01004406|470751946|FG000|Overall Study|Lost to Follow-up|1|||
130761980|NCT01004406|470751947|FG001|Overall Study|Lost to Follow-up|0|||
130761981|NCT02928770|470751948|FG000|Overall Study|Withdrawal by Subject|2|||
130761982|NCT03201874|470751951|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
130761983|NCT03201874|470751952|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
130761984|NCT03201874|470751951|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
130761985|NCT03201874|470751952|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
130761986|NCT02907593|470751953|FG000|Overall Study|Withdrawal by Subject|0|||
130761987|NCT02907593|470751954|FG001|Overall Study|Withdrawal by Subject|0|||
130761988|NCT02907593|470751955|FG002|Overall Study|Withdrawal by Subject|1|||
130761989|NCT02907593|470751956|FG003|Overall Study|Withdrawal by Subject|0|||
130761990|NCT03226678|470751957|FG000|Part A (Core Study Phase)|Adverse Event|0|||
130761991|NCT03226678|470751958|FG001|Part A (Core Study Phase)|Adverse Event|1|||
130761992|NCT03226678|470751959|FG002|Part A (Core Study Phase)|Adverse Event|0|||
130761993|NCT03226678|470751960|FG003|Part A (Core Study Phase)|Adverse Event|0|||
130761994|NCT03226678|470751961|FG004|Part A (Core Study Phase)|Adverse Event|0|||
130761995|NCT03226678|470751962|FG005|Part A (Core Study Phase)|Adverse Event|0|||
130761996|NCT03226678|470751957|FG000|Part A (Core Study Phase)|Death|0|||
130761997|NCT03226678|470751958|FG001|Part A (Core Study Phase)|Death|0|||
130761998|NCT03226678|470751959|FG002|Part A (Core Study Phase)|Death|1|||
130761999|NCT03226678|470751960|FG003|Part A (Core Study Phase)|Death|0|||
130762000|NCT03226678|470751961|FG004|Part A (Core Study Phase)|Death|0|||
130762001|NCT03226678|470751962|FG005|Part A (Core Study Phase)|Death|0|||
130762002|NCT03226678|470751957|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
130762003|NCT03226678|470751958|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
130762004|NCT03226678|470751959|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
130762005|NCT03226678|470751960|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
130762006|NCT03226678|470751961|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
130762007|NCT03226678|470751962|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
130762008|NCT03226678|470751957|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130762009|NCT03226678|470751958|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130762010|NCT03226678|470751959|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
130762011|NCT03226678|470751960|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130762012|NCT03226678|470751961|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130762013|NCT03226678|470751962|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130762014|NCT03226678|470751957|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130762015|NCT03226678|470751958|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130762016|NCT03226678|470751959|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130762017|NCT03226678|470751960|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
130762018|NCT03226678|470751961|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130762019|NCT03226678|470751962|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130762020|NCT03226678|470751957|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
130762021|NCT03226678|470751958|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
130762022|NCT03226678|470751959|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130762023|NCT03226678|470751960|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130762024|NCT03226678|470751961|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130762025|NCT03226678|470751962|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130762026|NCT03226678|470751957|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130762027|NCT03226678|470751958|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130762028|NCT03226678|470751959|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130762029|NCT03226678|470751960|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130762030|NCT03226678|470751961|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
130762031|NCT03226678|470751962|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
130762032|NCT03226678|470751957|FG000|Part B (Long-Term Extension Phase)|Death|0|||
130793818|NCT06001021|470873092|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130793819|NCT06001021|470873093|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
130793820|NCT06001021|470873094|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
130793821|NCT06001021|470873095|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130793822|NCT06001021|470873096|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130793823|NCT04797169|470873097|FG000|Overall Study|Lost to Follow-up|84|||
130793824|NCT04797169|470873098|FG001|Overall Study|Lost to Follow-up|67|||
130793825|NCT04797169|470873097|FG000|Overall Study|Pregnancy|1|||
130793826|NCT04797169|470873098|FG001|Overall Study|Pregnancy|3|||
130793827|NCT04797169|470873097|FG000|Overall Study|Withdrawal by Subject|27|||
130793828|NCT04797169|470873098|FG001|Overall Study|Withdrawal by Subject|35|||
130793829|NCT03839641|470873107|FG000|Overall Study|Withdrawal by Subject|1|||
130793830|NCT03839641|470873108|FG001|Overall Study|Withdrawal by Subject|1|||
130793831|NCT03034967|470873109|FG000|Overall Study|Withdrawal by Subject|9|||
130793832|NCT03034967|470873110|FG001|Overall Study|Withdrawal by Subject|2|||
130793833|NCT03034967|470873111|FG002|Overall Study|Withdrawal by Subject|6|||
130793834|NCT03034967|470873112|FG003|Overall Study|Withdrawal by Subject|6|||
130793835|NCT03034967|470873113|FG004|Overall Study|Withdrawal by Subject|9|||
130793836|NCT03034967|470873114|FG005|Overall Study|Withdrawal by Subject|2|||
130793837|NCT03034967|470873109|FG000|Overall Study|Physician Decision|1|||
130793838|NCT03034967|470873110|FG001|Overall Study|Physician Decision|0|||
130793839|NCT03034967|470873111|FG002|Overall Study|Physician Decision|1|||
130793840|NCT03034967|470873112|FG003|Overall Study|Physician Decision|1|||
130793841|NCT03034967|470873113|FG004|Overall Study|Physician Decision|1|||
130793842|NCT03034967|470873114|FG005|Overall Study|Physician Decision|0|||
130793843|NCT03034967|470873109|FG000|Overall Study|Lost to Follow-up|0|||
130793844|NCT03034967|470873110|FG001|Overall Study|Lost to Follow-up|0|||
130793845|NCT03034967|470873111|FG002|Overall Study|Lost to Follow-up|0|||
130793846|NCT03034967|470873112|FG003|Overall Study|Lost to Follow-up|1|||
130793847|NCT03034967|470873113|FG004|Overall Study|Lost to Follow-up|0|||
130793848|NCT03034967|470873114|FG005|Overall Study|Lost to Follow-up|2|||
130793849|NCT03034967|470873109|FG000|Overall Study|Liver function test abnormality|0|||
130793850|NCT03034967|470873110|FG001|Overall Study|Liver function test abnormality|0|||
130793851|NCT03034967|470873111|FG002|Overall Study|Liver function test abnormality|1|||
130793852|NCT03034967|470873112|FG003|Overall Study|Liver function test abnormality|0|||
130793853|NCT03034967|470873113|FG004|Overall Study|Liver function test abnormality|0|||
130793854|NCT03034967|470873114|FG005|Overall Study|Liver function test abnormality|0|||
130793855|NCT03034967|470873109|FG000|Overall Study|Protocol Violation|1|||
130793856|NCT03034967|470873110|FG001|Overall Study|Protocol Violation|0|||
130793857|NCT03034967|470873111|FG002|Overall Study|Protocol Violation|0|||
130793858|NCT03034967|470873112|FG003|Overall Study|Protocol Violation|0|||
130793859|NCT03034967|470873113|FG004|Overall Study|Protocol Violation|0|||
130793860|NCT03034967|470873114|FG005|Overall Study|Protocol Violation|2|||
130793861|NCT03034967|470873109|FG000|Overall Study|Lack of Efficacy|0|||
130793862|NCT03034967|470873110|FG001|Overall Study|Lack of Efficacy|1|||
130793863|NCT03034967|470873111|FG002|Overall Study|Lack of Efficacy|2|||
130793864|NCT03034967|470873112|FG003|Overall Study|Lack of Efficacy|1|||
130793865|NCT03034967|470873113|FG004|Overall Study|Lack of Efficacy|1|||
130793866|NCT03034967|470873114|FG005|Overall Study|Lack of Efficacy|0|||
130793867|NCT03034967|470873109|FG000|Overall Study|Adverse Event, non-fatal|3|||
130793868|NCT03034967|470873110|FG001|Overall Study|Adverse Event, non-fatal|1|||
130793869|NCT03034967|470873111|FG002|Overall Study|Adverse Event, non-fatal|2|||
130793870|NCT03034967|470873112|FG003|Overall Study|Adverse Event, non-fatal|0|||
130793871|NCT03034967|470873113|FG004|Overall Study|Adverse Event, non-fatal|2|||
130793872|NCT03034967|470873114|FG005|Overall Study|Adverse Event, non-fatal|8|||
130793873|NCT03034967|470873109|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
130793874|NCT03034967|470873110|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
130793875|NCT03034967|470873111|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
130793876|NCT03034967|470873112|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
130793877|NCT03034967|470873113|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
130793878|NCT03034967|470873114|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
130793879|NCT02550795|470873128|FG000|Overall Study|Physician Decision|0|||
130793880|NCT02550795|470873129|FG001|Overall Study|Physician Decision|1|||
130793881|NCT02550795|470873130|FG002|Overall Study|Physician Decision|0|||
130793882|NCT02802228|470873131|FG000|Overall Study|Withdrawal by Subject|2|||
130793883|NCT02802228|470873132|FG001|Overall Study|Withdrawal by Subject|0|||
130793884|NCT02802228|470873131|FG000|Overall Study|Lost to Follow-up|1|||
130793885|NCT02802228|470873132|FG001|Overall Study|Lost to Follow-up|0|||
130793886|NCT02802228|470873131|FG000|Overall Study|Adverse Event|1|||
130793887|NCT02802228|470873132|FG001|Overall Study|Adverse Event|0|||
130793888|NCT02802228|470873131|FG000|Overall Study|Physician Decision|1|||
130793889|NCT02802228|470873132|FG001|Overall Study|Physician Decision|0|||
130793890|NCT02225587|470873133|FG000|Overall Study|Adverse Event|5|||
130793891|NCT02225587|470873134|FG001|Overall Study|Adverse Event|5|||
130793892|NCT02225587|470873133|FG000|Overall Study|Lost to Follow-up|5|||
130793893|NCT02225587|470873134|FG001|Overall Study|Lost to Follow-up|5|||
130793894|NCT02225587|470873133|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130793895|NCT02225587|470873134|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130793896|NCT02225587|470873133|FG000|Overall Study|Physician Decision|2|||
130793897|NCT02225587|470873134|FG001|Overall Study|Physician Decision|0|||
130793898|NCT02225587|470873133|FG000|Overall Study|Protocol Violation|1|||
130793899|NCT02225587|470873134|FG001|Overall Study|Protocol Violation|0|||
130793900|NCT02225587|470873133|FG000|Overall Study|Participant Moved|1|||
130793901|NCT02225587|470873134|FG001|Overall Study|Participant Moved|0|||
130793902|NCT02225587|470873133|FG000|Overall Study|Withdrawal by Subject|13|||
130793903|NCT02225587|470873134|FG001|Overall Study|Withdrawal by Subject|28|||
130793904|NCT02879695|470873137|FG000|Overall Study|Did not start study treatment|2|||
130793905|NCT02879695|470873138|FG001|Overall Study|Did not start study treatment|0|||
130793906|NCT02879695|470873139|FG002|Overall Study|Did not start study treatment|3|||
130793907|NCT02879695|470873140|FG003|Overall Study|Did not start study treatment|0|||
130793908|NCT00879658|470873141|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130793909|NCT00879658|470873142|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130793910|NCT00879658|470873143|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130793911|NCT00879658|470873144|FG003|Overall Study|Abnormal laboratory value(s)|1|||
130793912|NCT00879658|470873145|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130793913|NCT00879658|470873146|FG005|Overall Study|Abnormal laboratory value(s)|0|||
130793914|NCT00879658|470873147|FG006|Overall Study|Abnormal laboratory value(s)|0|||
130793915|NCT00879658|470873141|FG000|Overall Study|Administrative problems|2|||
130793916|NCT00879658|470873142|FG001|Overall Study|Administrative problems|1|||
130793917|NCT00879658|470873143|FG002|Overall Study|Administrative problems|0|||
130793918|NCT00879658|470873144|FG003|Overall Study|Administrative problems|1|||
130793919|NCT00879658|470873145|FG004|Overall Study|Administrative problems|0|||
130793920|NCT00879658|470873146|FG005|Overall Study|Administrative problems|0|||
130793921|NCT00879658|470873147|FG006|Overall Study|Administrative problems|0|||
130793922|NCT00879658|470873141|FG000|Overall Study|Adverse Event|6|||
130793923|NCT00879658|470873142|FG001|Overall Study|Adverse Event|4|||
130793924|NCT00879658|470873143|FG002|Overall Study|Adverse Event|3|||
130793925|NCT00879658|470873144|FG003|Overall Study|Adverse Event|1|||
130793926|NCT00879658|470873145|FG004|Overall Study|Adverse Event|2|||
130793927|NCT00879658|470873146|FG005|Overall Study|Adverse Event|0|||
130793928|NCT00879658|470873147|FG006|Overall Study|Adverse Event|0|||
130793929|NCT00879658|470873141|FG000|Overall Study|Protocol Violation|1|||
130793930|NCT00879658|470873142|FG001|Overall Study|Protocol Violation|0|||
130793931|NCT00879658|470873143|FG002|Overall Study|Protocol Violation|0|||
130793932|NCT00879658|470873144|FG003|Overall Study|Protocol Violation|0|||
130793933|NCT00879658|470873145|FG004|Overall Study|Protocol Violation|0|||
130793934|NCT00879658|470873146|FG005|Overall Study|Protocol Violation|0|||
130793935|NCT00879658|470873147|FG006|Overall Study|Protocol Violation|0|||
130793936|NCT00879658|470873141|FG000|Overall Study|Withdrawal by Subject|3|||
130793937|NCT00879658|470873142|FG001|Overall Study|Withdrawal by Subject|0|||
130793938|NCT00879658|470873143|FG002|Overall Study|Withdrawal by Subject|2|||
130793939|NCT00879658|470873144|FG003|Overall Study|Withdrawal by Subject|0|||
130793940|NCT00879658|470873145|FG004|Overall Study|Withdrawal by Subject|0|||
130793941|NCT00879658|470873146|FG005|Overall Study|Withdrawal by Subject|1|||
130793942|NCT00879658|470873147|FG006|Overall Study|Withdrawal by Subject|0|||
130793943|NCT00879658|470873141|FG000|Overall Study|Lack of Efficacy|0|||
130793944|NCT00879658|470873142|FG001|Overall Study|Lack of Efficacy|0|||
130793945|NCT00879658|470873143|FG002|Overall Study|Lack of Efficacy|2|||
130793946|NCT00879658|470873144|FG003|Overall Study|Lack of Efficacy|0|||
130793947|NCT00879658|470873145|FG004|Overall Study|Lack of Efficacy|0|||
130793948|NCT00879658|470873146|FG005|Overall Study|Lack of Efficacy|0|||
130793949|NCT00879658|470873147|FG006|Overall Study|Lack of Efficacy|0|||
130793950|NCT00879658|470873141|FG000|Overall Study|misrandomized (never received study med)|0|||
130793951|NCT00879658|470873142|FG001|Overall Study|misrandomized (never received study med)|0|||
130793952|NCT00879658|470873143|FG002|Overall Study|misrandomized (never received study med)|0|||
130793953|NCT00879658|470873144|FG003|Overall Study|misrandomized (never received study med)|1|||
130793954|NCT00879658|470873145|FG004|Overall Study|misrandomized (never received study med)|0|||
130793955|NCT00879658|470873146|FG005|Overall Study|misrandomized (never received study med)|0|||
130793956|NCT00879658|470873147|FG006|Overall Study|misrandomized (never received study med)|0|||
130793957|NCT00580840|470873148|FG000|Run-in|Adverse Event|17|||
130793958|NCT00580840|470873149|FG001|Run-in|Adverse Event|0|||
130793959|NCT00580840|470873150|FG002|Run-in|Adverse Event|0|||
130793960|NCT00580840|470873151|FG003|Run-in|Adverse Event|0|||
130793961|NCT00580840|470873148|FG000|Run-in|Lack of Efficacy|93|||
130793962|NCT00580840|470873149|FG001|Run-in|Lack of Efficacy|0|||
130793963|NCT00580840|470873150|FG002|Run-in|Lack of Efficacy|0|||
130793964|NCT00580840|470873151|FG003|Run-in|Lack of Efficacy|0|||
130793965|NCT00580840|470873148|FG000|Run-in|Loss of Efficacy|1|||
130793966|NCT00580840|470873149|FG001|Run-in|Loss of Efficacy|0|||
130793967|NCT00580840|470873150|FG002|Run-in|Loss of Efficacy|0|||
130793968|NCT00580840|470873151|FG003|Run-in|Loss of Efficacy|0|||
130793969|NCT00580840|470873148|FG000|Run-in|Lost to Follow-up|4|||
130793970|NCT00580840|470873149|FG001|Run-in|Lost to Follow-up|0|||
130793971|NCT00580840|470873150|FG002|Run-in|Lost to Follow-up|0|||
130793972|NCT00580840|470873151|FG003|Run-in|Lost to Follow-up|0|||
130762033|NCT03226678|470751958|FG001|Part B (Long-Term Extension Phase)|Death|0|||
130762034|NCT03226678|470751959|FG002|Part B (Long-Term Extension Phase)|Death|0|||
130762035|NCT03226678|470751960|FG003|Part B (Long-Term Extension Phase)|Death|0|||
130762036|NCT03226678|470751961|FG004|Part B (Long-Term Extension Phase)|Death|0|||
130762037|NCT03226678|470751962|FG005|Part B (Long-Term Extension Phase)|Death|1|||
130762038|NCT03226678|470751957|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130762039|NCT03226678|470751958|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130762040|NCT03226678|470751959|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130762041|NCT03226678|470751960|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130762042|NCT03226678|470751961|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130762043|NCT03226678|470751962|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
130762044|NCT03226678|470751957|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130762045|NCT03226678|470751958|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130762046|NCT03226678|470751959|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130762047|NCT03226678|470751960|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130762048|NCT03226678|470751961|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
130762049|NCT03226678|470751962|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
130762050|NCT03226678|470751957|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130762051|NCT03226678|470751958|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130762052|NCT03226678|470751959|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130762053|NCT03226678|470751960|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130762054|NCT03226678|470751961|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130762055|NCT03226678|470751962|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
130762056|NCT03385304|470751963|FG000|Overall Study|Death|19|||
130762057|NCT03385304|470751964|FG001|Overall Study|Death|7|||
130762058|NCT03385304|470751963|FG000|Overall Study|Lost to Follow-up|17|||
130762059|NCT03385304|470751964|FG001|Overall Study|Lost to Follow-up|14|||
130762060|NCT03385304|470751963|FG000|Overall Study|Withdrawal by Subject|3|||
130762061|NCT03385304|470751964|FG001|Overall Study|Withdrawal by Subject|2|||
130762062|NCT03385304|470751963|FG000|Overall Study|Incarceration|2|||
130762063|NCT03385304|470751964|FG001|Overall Study|Incarceration|3|||
130762064|NCT01120249|470751965|FG000|Overall Study|No protocol treatment received|21|||
130762065|NCT01120249|470751966|FG001|Overall Study|No protocol treatment received|15|||
130762066|NCT01120249|470751965|FG000|Overall Study|Disease recurrence|107|||
130762067|NCT01120249|470751966|FG001|Overall Study|Disease recurrence|57|||
130762068|NCT01120249|470751965|FG000|Overall Study|Death|1|||
130762069|NCT01120249|470751966|FG001|Overall Study|Death|0|||
130762070|NCT01120249|470751965|FG000|Overall Study|Adverse Event|40|||
130762071|NCT01120249|470751966|FG001|Overall Study|Adverse Event|276|||
130762072|NCT01120249|470751965|FG000|Overall Study|Participant refusal|34|||
130762073|NCT01120249|470751966|FG001|Overall Study|Participant refusal|42|||
130762074|NCT01120249|470751965|FG000|Overall Study|Other reasons, not protocol specified|29|||
130762075|NCT01120249|470751966|FG001|Overall Study|Other reasons, not protocol specified|22|||
130762076|NCT01447446|470751967|FG000|Overall Study|Death|6|||
130762077|NCT01447446|470751968|FG001|Overall Study|Death|3|||
130762078|NCT01447446|470751969|FG002|Overall Study|Death|2|||
130762079|NCT01447446|470751970|FG003|Overall Study|Death|1|||
130762080|NCT01447446|470751971|FG004|Overall Study|Death|7|||
130762081|NCT01447446|470751972|FG005|Overall Study|Death|0|||
130762082|NCT01447446|470751967|FG000|Overall Study|Adverse Event|3|||
130762083|NCT01447446|470751968|FG001|Overall Study|Adverse Event|0|||
130762084|NCT01447446|470751969|FG002|Overall Study|Adverse Event|1|||
130762085|NCT01447446|470751970|FG003|Overall Study|Adverse Event|0|||
130762086|NCT01447446|470751971|FG004|Overall Study|Adverse Event|2|||
130762087|NCT01447446|470751972|FG005|Overall Study|Adverse Event|0|||
130762088|NCT01447446|470751967|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
130762089|NCT01447446|470751968|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
130762090|NCT01447446|470751969|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
130762091|NCT01447446|470751970|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
130762092|NCT01447446|470751971|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
130762093|NCT01447446|470751972|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
130762094|NCT01447446|470751967|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
130762095|NCT01447446|470751968|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
130762096|NCT01447446|470751969|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
130762097|NCT01447446|470751970|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
130762098|NCT01447446|470751971|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
130762099|NCT01447446|470751972|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
130762100|NCT01447446|470751967|FG000|Overall Study|Administrative/Other|34|||
130762101|NCT01447446|470751968|FG001|Overall Study|Administrative/Other|9|||
130762102|NCT01447446|470751969|FG002|Overall Study|Administrative/Other|10|||
130762103|NCT01447446|470751970|FG003|Overall Study|Administrative/Other|2|||
130762104|NCT01447446|470751971|FG004|Overall Study|Administrative/Other|33|||
130793973|NCT00580840|470873148|FG000|Run-in|Withdrawal by Subject|5|||
130793974|NCT00580840|470873149|FG001|Run-in|Withdrawal by Subject|0|||
130793975|NCT00580840|470873150|FG002|Run-in|Withdrawal by Subject|0|||
130793976|NCT00580840|470873151|FG003|Run-in|Withdrawal by Subject|0|||
130793977|NCT00580840|470873148|FG000|Run-in|Other: Per Sponsor Request|2|||
130793978|NCT00580840|470873149|FG001|Run-in|Other: Per Sponsor Request|0|||
130793979|NCT00580840|470873150|FG002|Run-in|Other: Per Sponsor Request|0|||
130793980|NCT00580840|470873151|FG003|Run-in|Other: Per Sponsor Request|0|||
130793981|NCT00580840|470873148|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
130793982|NCT00580840|470873149|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
130793983|NCT00580840|470873150|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
130793984|NCT00580840|470873151|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
130793985|NCT00580840|470873148|FG000|Run-in|Other: Exclusionary Lab Value|1|||
130793986|NCT00580840|470873149|FG001|Run-in|Other: Exclusionary Lab Value|0|||
130793987|NCT00580840|470873150|FG002|Run-in|Other: Exclusionary Lab Value|0|||
130793988|NCT00580840|470873151|FG003|Run-in|Other: Exclusionary Lab Value|0|||
130793989|NCT00580840|470873148|FG000|Double-Blind|Adverse Event|0|||
130793990|NCT00580840|470873149|FG001|Double-Blind|Adverse Event|3|||
130793991|NCT00580840|470873150|FG002|Double-Blind|Adverse Event|4|||
130793992|NCT00580840|470873151|FG003|Double-Blind|Adverse Event|1|||
130793993|NCT00580840|470873148|FG000|Double-Blind|Loss of Efficacy|0|||
130793994|NCT00580840|470873149|FG001|Double-Blind|Loss of Efficacy|1|||
130793995|NCT00580840|470873150|FG002|Double-Blind|Loss of Efficacy|2|||
130793996|NCT00580840|470873151|FG003|Double-Blind|Loss of Efficacy|10|||
130793997|NCT00580840|470873148|FG000|Double-Blind|Lost to Follow-up|0|||
130793998|NCT00580840|470873149|FG001|Double-Blind|Lost to Follow-up|1|||
130793999|NCT00580840|470873150|FG002|Double-Blind|Lost to Follow-up|0|||
130794000|NCT00580840|470873151|FG003|Double-Blind|Lost to Follow-up|2|||
130794001|NCT00580840|470873148|FG000|Double-Blind|Withdrawal by Subject|0|||
130794002|NCT00580840|470873149|FG001|Double-Blind|Withdrawal by Subject|1|||
130794003|NCT00580840|470873150|FG002|Double-Blind|Withdrawal by Subject|2|||
130794004|NCT00580840|470873151|FG003|Double-Blind|Withdrawal by Subject|2|||
130794005|NCT00580840|470873148|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
130794006|NCT00580840|470873149|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
130794007|NCT00580840|470873150|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
130794008|NCT00580840|470873151|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
130794009|NCT00580840|470873148|FG000|Double-Blind|Other: Forbidden Medication|0|||
130794010|NCT00580840|470873149|FG001|Double-Blind|Other: Forbidden Medication|0|||
130794011|NCT00580840|470873150|FG002|Double-Blind|Other: Forbidden Medication|1|||
130794012|NCT00580840|470873151|FG003|Double-Blind|Other: Forbidden Medication|0|||
130794013|NCT01551173|470873152|FG000|Overall Study|Withdrawal by Subject|11|||
130794014|NCT01551173|470873153|FG001|Overall Study|Withdrawal by Subject|16|||
130794015|NCT01551173|470873152|FG000|Overall Study|Adverse Event|7|||
130794016|NCT01551173|470873153|FG001|Overall Study|Adverse Event|6|||
130794017|NCT01551173|470873152|FG000|Overall Study|Lost to Follow-up|5|||
130794018|NCT01551173|470873153|FG001|Overall Study|Lost to Follow-up|7|||
130794019|NCT01551173|470873152|FG000|Overall Study|Other|5|||
130794020|NCT01551173|470873153|FG001|Overall Study|Other|3|||
130794021|NCT04530344|470873154|FG000|Overall Study|Lost to Follow-up|3|||
130794022|NCT04530344|470873155|FG001|Overall Study|Lost to Follow-up|3|||
130794023|NCT04530344|470873156|FG002|Overall Study|Lost to Follow-up|3|||
130794024|NCT04530344|470873157|FG003|Overall Study|Lost to Follow-up|10|||
130794025|NCT04530344|470873154|FG000|Overall Study|Withdrawal by Subject|14|||
130794026|NCT04530344|470873155|FG001|Overall Study|Withdrawal by Subject|5|||
130794027|NCT04530344|470873156|FG002|Overall Study|Withdrawal by Subject|18|||
130794028|NCT04530344|470873157|FG003|Overall Study|Withdrawal by Subject|33|||
130794029|NCT04530344|470873154|FG000|Overall Study|Adverse Event|0|||
130794030|NCT04530344|470873155|FG001|Overall Study|Adverse Event|0|||
130794031|NCT04530344|470873156|FG002|Overall Study|Adverse Event|0|||
130794032|NCT04530344|470873157|FG003|Overall Study|Adverse Event|1|||
130794033|NCT04530344|470873154|FG000|Overall Study|Lack of Efficacy|0|||
130794034|NCT04530344|470873155|FG001|Overall Study|Lack of Efficacy|0|||
130794035|NCT04530344|470873156|FG002|Overall Study|Lack of Efficacy|0|||
130794036|NCT04530344|470873157|FG003|Overall Study|Lack of Efficacy|1|||
130794037|NCT04530344|470873154|FG000|Overall Study|Physician Decision|0|||
130794038|NCT04530344|470873155|FG001|Overall Study|Physician Decision|0|||
130794039|NCT04530344|470873156|FG002|Overall Study|Physician Decision|1|||
130794040|NCT04530344|470873157|FG003|Overall Study|Physician Decision|1|||
130794041|NCT04530344|470873154|FG000|Overall Study|Pregnancy|0|||
130794042|NCT04530344|470873155|FG001|Overall Study|Pregnancy|0|||
130794043|NCT04530344|470873156|FG002|Overall Study|Pregnancy|2|||
130794044|NCT04530344|470873157|FG003|Overall Study|Pregnancy|1|||
130794045|NCT04530344|470873154|FG000|Overall Study|Protocol Violation|0|||
130794046|NCT04530344|470873155|FG001|Overall Study|Protocol Violation|0|||
130794047|NCT04530344|470873156|FG002|Overall Study|Protocol Violation|0|||
130794048|NCT04530344|470873157|FG003|Overall Study|Protocol Violation|1|||
130794049|NCT04530344|470873154|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
130794050|NCT04530344|470873155|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
130822785|NCT01815424|470980599|FG002|Week 0 to 16|Protocol Violation|0|||
130794051|NCT04530344|470873156|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
130794052|NCT04530344|470873157|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
130794053|NCT04530344|470873154|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
130794054|NCT04530344|470873155|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
130794055|NCT04530344|470873156|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
130794056|NCT04530344|470873157|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
130794057|NCT04530344|470873154|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
130794058|NCT04530344|470873155|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
130762105|NCT01447446|470751972|FG005|Overall Study|Administrative/Other|4|||
130762106|NCT01447446|470751967|FG000|Overall Study|SVR12 Assessment|13|||
130762107|NCT01447446|470751968|FG001|Overall Study|SVR12 Assessment|1|||
130762108|NCT01447446|470751969|FG002|Overall Study|SVR12 Assessment|2|||
130762109|NCT01447446|470751970|FG003|Overall Study|SVR12 Assessment|1|||
130762110|NCT01447446|470751971|FG004|Overall Study|SVR12 Assessment|5|||
130762111|NCT01447446|470751972|FG005|Overall Study|SVR12 Assessment|5|||
130762112|NCT01447446|470751967|FG000|Overall Study|New Treatment Started|8|||
130762113|NCT01447446|470751968|FG001|Overall Study|New Treatment Started|2|||
130762114|NCT01447446|470751969|FG002|Overall Study|New Treatment Started|1|||
130762115|NCT01447446|470751970|FG003|Overall Study|New Treatment Started|0|||
130762116|NCT01447446|470751971|FG004|Overall Study|New Treatment Started|2|||
130762117|NCT01447446|470751972|FG005|Overall Study|New Treatment Started|0|||
130762118|NCT01447446|470751967|FG000|Overall Study|Reason not Specified|1|||
130762119|NCT01447446|470751968|FG001|Overall Study|Reason not Specified|1|||
130762120|NCT01447446|470751969|FG002|Overall Study|Reason not Specified|1|||
130762121|NCT01447446|470751970|FG003|Overall Study|Reason not Specified|1|||
130762122|NCT01447446|470751971|FG004|Overall Study|Reason not Specified|1|||
130762123|NCT01447446|470751972|FG005|Overall Study|Reason not Specified|0|||
130762124|NCT01892085|470751982|FG000|Overall Study|Death|4|||
130762125|NCT01892085|470751983|FG001|Overall Study|Death|1|||
130762126|NCT01892085|470751984|FG002|Overall Study|Death|3|||
130762127|NCT01892085|470751982|FG000|Overall Study|Withdrawal by Subject|2|||
130762128|NCT01892085|470751983|FG001|Overall Study|Withdrawal by Subject|0|||
130762129|NCT01892085|470751984|FG002|Overall Study|Withdrawal by Subject|2|||
130762130|NCT01629823|470751985|FG000|Trial Period|Missed visit|11|||
130762131|NCT01629823|470751986|FG001|Trial Period|Missed visit|9|||
130762132|NCT01629823|470751987|FG002|Trial Period|Missed visit|8|||
130762133|NCT01629823|470751985|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
130762134|NCT01629823|470751986|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
130762135|NCT01629823|470751987|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
130762136|NCT01629823|470751985|FG000|Trial Period|Pregnancy|1|||
130762137|NCT01629823|470751986|FG001|Trial Period|Pregnancy|0|||
130762138|NCT01629823|470751987|FG002|Trial Period|Pregnancy|0|||
130762139|NCT01629823|470751985|FG000|Trial Period|Adverse Event|0|||
130762140|NCT01629823|470751986|FG001|Trial Period|Adverse Event|1|||
130762141|NCT01629823|470751987|FG002|Trial Period|Adverse Event|0|||
130762142|NCT01629823|470751985|FG000|Trial Period|Out-of-window visit|0|||
130762143|NCT01629823|470751986|FG001|Trial Period|Out-of-window visit|2|||
130762144|NCT01629823|470751987|FG002|Trial Period|Out-of-window visit|0|||
130762145|NCT01629823|470751985|FG000|Trial Period|Failed to hold medication|0|||
130762146|NCT01629823|470751986|FG001|Trial Period|Failed to hold medication|0|||
130762147|NCT01629823|470751987|FG002|Trial Period|Failed to hold medication|1|||
130762148|NCT01629823|470751985|FG000|Washout Period|Safety|2|||
130762149|NCT01629823|470751986|FG001|Washout Period|Safety|5|||
130762150|NCT01629823|470751987|FG002|Washout Period|Safety|0|||
130762151|NCT01629823|470751985|FG000|Washout Period|Pregnancy|1|||
130762152|NCT01629823|470751986|FG001|Washout Period|Pregnancy|0|||
130762153|NCT01629823|470751987|FG002|Washout Period|Pregnancy|0|||
130762154|NCT01629823|470751985|FG000|Washout Period|Protocol Violation|0|||
130762155|NCT01629823|470751986|FG001|Washout Period|Protocol Violation|1|||
130762156|NCT01629823|470751987|FG002|Washout Period|Protocol Violation|0|||
130762157|NCT02609724|470751988|FG000|Overall Study|Death|2|||
130762158|NCT02609724|470751989|FG001|Overall Study|Death|0|||
130762159|NCT02609724|470751990|FG002|Overall Study|Death|1|||
130762160|NCT02609724|470751988|FG000|Overall Study|Withdrawal by Subject|1|||
130762161|NCT02609724|470751989|FG001|Overall Study|Withdrawal by Subject|2|||
130762162|NCT02609724|470751990|FG002|Overall Study|Withdrawal by Subject|3|||
130762163|NCT02609724|470751988|FG000|Overall Study|Illness|2|||
130762164|NCT02609724|470751989|FG001|Overall Study|Illness|1|||
130762165|NCT02609724|470751990|FG002|Overall Study|Illness|0|||
130762166|NCT03077659|470751991|FG000|Overall Study|Withdrawal by Subject|0|||
130762167|NCT03077659|470751992|FG001|Overall Study|Withdrawal by Subject|0|||
130762168|NCT03077659|470751993|FG002|Overall Study|Withdrawal by Subject|1|||
130762169|NCT02844907|470751994|FG000|With Dexamethasone|No IV access|1|||
130762170|NCT00550862|470751995|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
130762171|NCT00550862|470751996|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
130762172|NCT00550862|470751997|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
130762173|NCT00550862|470751998|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
130762174|NCT00550862|470751999|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
130794059|NCT04530344|470873156|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
130794060|NCT04530344|470873157|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
130794061|NCT04530344|470873154|FG000|Overall Study|Personal Reasons|0|||
130794062|NCT04530344|470873155|FG001|Overall Study|Personal Reasons|0|||
130794063|NCT04530344|470873156|FG002|Overall Study|Personal Reasons|0|||
130794064|NCT04530344|470873157|FG003|Overall Study|Personal Reasons|1|||
130794065|NCT04530344|470873154|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
130794066|NCT04530344|470873155|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
130794067|NCT04530344|470873156|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
130794068|NCT04530344|470873157|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
130794069|NCT01402700|470873158|FG000|Overall Study|Death|3|||
130794070|NCT01402700|470873158|FG000|Overall Study|Withdrawal by Subject|3|||
130794071|NCT01402700|470873158|FG000|Overall Study|Missed Visit|1|||
130794072|NCT02401230|470873162|FG000|Overall Study|Adverse Event|3|||
130794073|NCT02401230|470873163|FG001|Overall Study|Adverse Event|2|||
130794074|NCT02401230|470873164|FG002|Overall Study|Adverse Event|0|||
130794075|NCT02401230|470873162|FG000|Overall Study|Withdrawal by Subject|2|||
130794076|NCT02401230|470873163|FG001|Overall Study|Withdrawal by Subject|1|||
130794077|NCT02401230|470873164|FG002|Overall Study|Withdrawal by Subject|1|||
130794078|NCT02401230|470873162|FG000|Overall Study|Lost to Follow-up|1|||
130794079|NCT02401230|470873163|FG001|Overall Study|Lost to Follow-up|3|||
130794080|NCT02401230|470873164|FG002|Overall Study|Lost to Follow-up|3|||
130794081|NCT00830765|470873165|FG000|Overall Study|Protocol Violation|3|||
130794082|NCT00830765|470873166|FG001|Overall Study|Protocol Violation|2|||
130794083|NCT01299909|470873167|FG000|Overall Study|Lost to Follow-up|22|||
130794084|NCT01299909|470873168|FG001|Overall Study|Lost to Follow-up|18|||
130794085|NCT01299909|470873169|FG002|Overall Study|Lost to Follow-up|17|||
130794086|NCT00964782|470873170|FG000|Overall Study|Lost to Follow-up|1|||
130794087|NCT00964782|470873171|FG001|Overall Study|Lost to Follow-up|0|||
130794088|NCT01143324|470873174|FG000|Overall Study|Lost to Follow-up|11|||
130794089|NCT01143324|470873174|FG000|Overall Study|Withdrawal by Subject|4|||
130794090|NCT01143324|470873174|FG000|Overall Study|Explant of the device|4|||
130794091|NCT00858988|470873184|FG000|Analysis|Lactulose unable to be detected in urine|2|||
130794092|NCT00858988|470873185|FG001|Analysis|Lactulose unable to be detected in urine|1|||
130794093|NCT00549055|470874901|FG000|Overall Study|Adverse Event|4|||
130794094|NCT00549055|470874901|FG000|Overall Study|Lack of Efficacy|18|||
130794095|NCT00549055|470874901|FG000|Overall Study|Stabilization|5|||
130794096|NCT00549055|470874901|FG000|Overall Study|Progression to fibrosis|2|||
130794097|NCT00549055|470874901|FG000|Overall Study|Decrease of size|1|||
130794098|NCT00549055|470874901|FG000|Overall Study|Active choroidal neovascula increased|1|||
130794099|NCT00549055|470874901|FG000|Overall Study|Vitreous hemorrhage|1|||
130794100|NCT00549055|470874901|FG000|Overall Study|Growth choroidal neovascularisation|1|||
130794101|NCT00549055|470874901|FG000|Overall Study|Choroidal neovascularization|1|||
130794102|NCT00549055|470874901|FG000|Overall Study|Very low visual acuity (VA)|1|||
130794103|NCT00770809|470874906|FG000|Overall Study|Adverse Event|9|||
130794104|NCT00770809|470874907|FG001|Overall Study|Adverse Event|1|||
130794105|NCT00770809|470874908|FG002|Overall Study|Adverse Event|12|||
130794106|NCT00770809|470874906|FG000|Overall Study|Death|1|||
130794107|NCT00770809|470874907|FG001|Overall Study|Death|0|||
130794108|NCT00770809|470874908|FG002|Overall Study|Death|0|||
130794109|NCT00770809|470874906|FG000|Overall Study|Withdrawal by Subject|3|||
130794110|NCT00770809|470874907|FG001|Overall Study|Withdrawal by Subject|3|||
130794111|NCT00770809|470874908|FG002|Overall Study|Withdrawal by Subject|7|||
130794112|NCT00770809|470874906|FG000|Overall Study|Progression|2|||
130794113|NCT00770809|470874907|FG001|Overall Study|Progression|2|||
130794114|NCT00770809|470874908|FG002|Overall Study|Progression|0|||
130794115|NCT00770809|470874906|FG000|Overall Study|Complicating illness|0|||
130794116|NCT00770809|470874907|FG001|Overall Study|Complicating illness|0|||
130794117|NCT00770809|470874908|FG002|Overall Study|Complicating illness|1|||
130794118|NCT00770809|470874906|FG000|Overall Study|Other Medical Reasons|2|||
130794119|NCT00770809|470874907|FG001|Overall Study|Other Medical Reasons|4|||
130794120|NCT00770809|470874908|FG002|Overall Study|Other Medical Reasons|3|||
130794121|NCT02469233|470874909|FG000|Overall Study|Death|1|||
130794122|NCT02469233|470874910|FG001|Overall Study|Death|1|||
130794123|NCT02469233|470874909|FG000|Overall Study|Lost to post or 6 month follow up|7|||
130794124|NCT02469233|470874910|FG001|Overall Study|Lost to post or 6 month follow up|2|||
130794125|NCT03474107|470874911|FG000|Overall Study|Adverse Event|42|||
130794126|NCT03474107|470874912|FG001|Overall Study|Adverse Event|46|||
130794127|NCT03474107|470874911|FG000|Overall Study|Death|2|||
130794128|NCT03474107|470874912|FG001|Overall Study|Death|2|||
130794129|NCT03474107|470874911|FG000|Overall Study|Lost to Follow-up|0|||
130794130|NCT03474107|470874912|FG001|Overall Study|Lost to Follow-up|1|||
130794131|NCT03474107|470874911|FG000|Overall Study|Progressive Disease|177|||
130794132|NCT03474107|470874912|FG001|Overall Study|Progressive Disease|180|||
130794133|NCT03474107|470874911|FG000|Overall Study|Protocol Violation|1|||
130762175|NCT00550862|470751995|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
130762176|NCT00550862|470751996|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
130762177|NCT00550862|470751997|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
130762178|NCT00550862|470751998|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
130762179|NCT00550862|470751999|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
130762180|NCT00550862|470751995|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130762181|NCT00550862|470751996|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130762182|NCT00550862|470751997|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
130762183|NCT00550862|470751998|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130762184|NCT00550862|470751999|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130762185|NCT00550862|470751995|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130762186|NCT00550862|470751996|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130762187|NCT00550862|470751997|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
130762188|NCT00550862|470751998|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130762189|NCT00550862|470751999|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130762190|NCT00550862|470751995|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130762191|NCT00550862|470751996|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
130762192|NCT00550862|470751997|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130762193|NCT00550862|470751998|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130762194|NCT00550862|470751999|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130762195|NCT00550862|470751995|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130762196|NCT00550862|470751996|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130762197|NCT00550862|470751997|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130762198|NCT00550862|470751998|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130762199|NCT00550862|470751999|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
130762200|NCT00550862|470751995|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130762201|NCT00550862|470751996|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130762202|NCT00550862|470751997|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130762203|NCT00550862|470751998|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130762204|NCT00550862|470751999|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
130762205|NCT00550862|470751995|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130762206|NCT00550862|470751996|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130762207|NCT00550862|470751997|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130762208|NCT00550862|470751998|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130762209|NCT00550862|470751999|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
130762210|NCT00550862|470751995|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
130762211|NCT00550862|470751996|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
130762212|NCT00550862|470751997|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
130762213|NCT00550862|470751998|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
130762214|NCT00550862|470751999|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
130762215|NCT00550862|470751995|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130762216|NCT00550862|470751996|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130762217|NCT00550862|470751997|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130762218|NCT00550862|470751998|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130762219|NCT00550862|470751999|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
130762220|NCT03488225|470752002|FG000|Overall Study|Off Protocol Therapy|2|||
130762221|NCT03488225|470752002|FG000|Overall Study|Stem Cell Transplant|2|||
130762222|NCT00986986|470752003|FG000|Overall Study|Lost to Follow-up|0|||
130762223|NCT00986986|470752004|FG001|Overall Study|Lost to Follow-up|1|||
130762224|NCT02003963|470752007|FG000|Overall Study|Lost to Follow-up|2|||
130762225|NCT02003963|470752008|FG001|Overall Study|Lost to Follow-up|1|||
130762226|NCT05020366|470752010|FG000|Overall Study|Lost to Follow-up|2|||
130762227|NCT05020366|470752011|FG001|Overall Study|Lost to Follow-up|0|||
130762228|NCT05020366|470752010|FG000|Overall Study|Withdrawal by Subject|2|||
130762229|NCT05020366|470752011|FG001|Overall Study|Withdrawal by Subject|0|||
130794134|NCT03474107|470874912|FG001|Overall Study|Protocol Violation|1|||
130794135|NCT03474107|470874911|FG000|Overall Study|Withdrawal by Subject|15|||
130794136|NCT03474107|470874912|FG001|Overall Study|Withdrawal by Subject|27|||
130794137|NCT03474107|470874911|FG000|Overall Study|Physician Decision|7|||
130762230|NCT04050124|470752013|FG000|Overall Study|Death|1|||
130762231|NCT04050124|470752014|FG001|Overall Study|Death|0|||
130762232|NCT00430352|470752016|FG000|Overall Study|Disease progression|58|||
130794138|NCT03474107|470874912|FG001|Overall Study|Physician Decision|22|||
130794139|NCT03474107|470874911|FG000|Overall Study|Miscellaneous|1|||
130794140|NCT03474107|470874912|FG001|Overall Study|Miscellaneous|6|||
130794141|NCT02127671|470874913|FG000|Overall Study|Death|2|||
130794142|NCT02127671|470874914|FG001|Overall Study|Death|2|||
130762233|NCT00430352|470752016|FG000|Overall Study|Withdrawal by Subject|11|||
130762234|NCT00430352|470752016|FG000|Overall Study|Adverse Event|16|||
130762235|NCT00430352|470752016|FG000|Overall Study|Death|5|||
130762236|NCT00430352|470752016|FG000|Overall Study|Other|48|||
130762237|NCT00819780|470752019|FG000|Overall Study|Did not receive study drug|3|||
130762238|NCT00819780|470752020|FG001|Overall Study|Did not receive study drug|4|||
130794143|NCT02127671|470874913|FG000|Overall Study|Lost to Follow-up|4|||
130762239|NCT00819780|470752019|FG000|Overall Study|Still in treatment|25|||
130762240|NCT00819780|470752020|FG001|Overall Study|Still in treatment|17|||
130762241|NCT00150800|470752021|FG000|Overall Study|Adverse Event|89|||
130762242|NCT00150800|470752021|FG000|Overall Study|Death|18|||
130762243|NCT00150800|470752021|FG000|Overall Study|Lack of Efficacy|166|||
130762244|NCT00150800|470752021|FG000|Overall Study|Lost to Follow-up|58|||
130762245|NCT00150800|470752021|FG000|Overall Study|Subject's choice|90|||
130762246|NCT00150800|470752021|FG000|Overall Study|No compliance|18|||
130762247|NCT00150800|470752021|FG000|Overall Study|IP misshandling|1|||
130762248|NCT00150800|470752021|FG000|Overall Study|Site closure|24|||
130762249|NCT00150800|470752021|FG000|Overall Study|Protocol non-adherence|2|||
130762250|NCT00150800|470752021|FG000|Overall Study|Nobody to accompany patient|1|||
130762251|NCT00150800|470752021|FG000|Overall Study|Distance too long for patient|1|||
130762252|NCT00150800|470752021|FG000|Overall Study|Neurosurgery|2|||
130762253|NCT00150800|470752021|FG000|Overall Study|BRV monotherapy|1|||
130762254|NCT00150800|470752021|FG000|Overall Study|Visit refusal|3|||
130762255|NCT00150800|470752021|FG000|Overall Study|Sponsor's request|2|||
130762256|NCT00150800|470752021|FG000|Overall Study|Generalized Epilepsy|1|||
130762257|NCT00150800|470752021|FG000|Overall Study|Moved from area/country|8|||
130762258|NCT00150800|470752021|FG000|Overall Study|PI retiring|2|||
130762259|NCT00150800|470752021|FG000|Overall Study|PI leaving site|2|||
130762260|NCT00150800|470752021|FG000|Overall Study|Patient insurance|1|||
130762261|NCT00150800|470752021|FG000|Overall Study|Surgical intervention|4|||
130762262|NCT00150800|470752021|FG000|Overall Study|Pregnancy planned|1|||
130762263|NCT00150800|470752021|FG000|Overall Study|PI discontinuation request|1|||
130762264|NCT02089334|470752022|FG000|Overall Study|Withdrawal by Subject|0|||
130762265|NCT02089334|470752023|FG001|Overall Study|Withdrawal by Subject|0|||
130762266|NCT02089334|470752024|FG002|Overall Study|Withdrawal by Subject|0|||
130794144|NCT02127671|470874914|FG001|Overall Study|Lost to Follow-up|2|||
130794145|NCT02127671|470874913|FG000|Overall Study|Physician Decision|1|||
130794146|NCT02127671|470874914|FG001|Overall Study|Physician Decision|0|||
130794147|NCT02127671|470874913|FG000|Overall Study|incarceration|0|||
130794148|NCT02127671|470874914|FG001|Overall Study|incarceration|1|||
130794149|NCT02127671|470874913|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
130794150|NCT02127671|470874914|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
130762267|NCT02089334|470752025|FG003|Overall Study|Withdrawal by Subject|2|||
130762268|NCT02089334|470752022|FG000|Overall Study|Adverse Event|0|||
130762269|NCT02089334|470752023|FG001|Overall Study|Adverse Event|0|||
130762270|NCT02089334|470752024|FG002|Overall Study|Adverse Event|0|||
130762271|NCT02089334|470752025|FG003|Overall Study|Adverse Event|2|||
130762272|NCT02089334|470752022|FG000|Overall Study|Progressive disease|0|||
130762273|NCT02089334|470752023|FG001|Overall Study|Progressive disease|0|||
130762274|NCT02089334|470752024|FG002|Overall Study|Progressive disease|0|||
130762275|NCT02089334|470752025|FG003|Overall Study|Progressive disease|2|||
130762276|NCT02089334|470752022|FG000|Overall Study|Physician Decision|0|||
130762277|NCT02089334|470752023|FG001|Overall Study|Physician Decision|0|||
130762278|NCT02089334|470752024|FG002|Overall Study|Physician Decision|1|||
130794151|NCT00764517|470874915|FG000|Overall Study|Adverse Event|9|||
130794152|NCT00764517|470874916|FG001|Overall Study|Adverse Event|3|||
130794153|NCT00764517|470874915|FG000|Overall Study|Death|3|||
130794154|NCT00764517|470874916|FG001|Overall Study|Death|11|||
130794155|NCT00764517|470874915|FG000|Overall Study|Physician Decision|3|||
130794156|NCT00764517|470874916|FG001|Overall Study|Physician Decision|0|||
130794157|NCT03813654|470874921|FG000|Overall Study|Protocol Violation|0|||
130794158|NCT03813654|470874922|FG001|Overall Study|Protocol Violation|1|||
130794159|NCT03813654|470874923|FG002|Overall Study|Protocol Violation|2|||
130794160|NCT03813654|470874921|FG000|Overall Study|Withdrawal by Subject|1|||
130794161|NCT03813654|470874922|FG001|Overall Study|Withdrawal by Subject|0|||
130794162|NCT03813654|470874923|FG002|Overall Study|Withdrawal by Subject|0|||
130794163|NCT01208051|470874924|FG000|Total Enrollment|Withdrawal by Subject|0|||
130794164|NCT01208051|470874925|FG001|Total Enrollment|Withdrawal by Subject|1|||
130794165|NCT01208051|470874926|FG002|Total Enrollment|Withdrawal by Subject|0|||
130794166|NCT01208051|470874927|FG003|Total Enrollment|Withdrawal by Subject|0|||
130794167|NCT01208051|470874928|FG004|Total Enrollment|Withdrawal by Subject|2|||
130794168|NCT01208051|470874924|FG000|Total Enrollment|Brain metastases|0|||
130794169|NCT01208051|470874925|FG001|Total Enrollment|Brain metastases|0|||
130794170|NCT01208051|470874926|FG002|Total Enrollment|Brain metastases|1|||
130794171|NCT01208051|470874927|FG003|Total Enrollment|Brain metastases|0|||
130794172|NCT01208051|470874928|FG004|Total Enrollment|Brain metastases|0|||
130794173|NCT02107898|470874931|FG000|Overall Study|Adverse Event|4|||
130794174|NCT02107898|470874932|FG001|Overall Study|Adverse Event|7|||
130794175|NCT02107898|470874931|FG000|Overall Study|Poor compliance to protocol|0|||
130794176|NCT02107898|470874932|FG001|Overall Study|Poor compliance to protocol|1|||
130794177|NCT02107898|470874931|FG000|Overall Study|Participant moved|0|||
130794178|NCT02107898|470874932|FG001|Overall Study|Participant moved|2|||
130794179|NCT02107898|470874931|FG000|Overall Study|Consent withdrawn by participant|2|||
130794180|NCT02107898|470874932|FG001|Overall Study|Consent withdrawn by participant|1|||
130794181|NCT02107898|470874931|FG000|Overall Study|Randomized but not treated|0|||
130794182|NCT02107898|470874932|FG001|Overall Study|Randomized but not treated|1|||
130794183|NCT01283386|470874933|FG000|Overall Study|Death|2|||
130794184|NCT01283386|470874934|FG001|Overall Study|Death|0|||
130794185|NCT01283386|470874933|FG000|Overall Study|Withdrawal by Subject|2|||
130794186|NCT01283386|470874934|FG001|Overall Study|Withdrawal by Subject|1|||
130794187|NCT01283386|470874933|FG000|Overall Study|Relapse of underlying disease|1|||
130794188|NCT01283386|470874934|FG001|Overall Study|Relapse of underlying disease|3|||
130794189|NCT01283386|470874933|FG000|Overall Study|Progression of underlying disease|2|||
130794190|NCT01283386|470874934|FG001|Overall Study|Progression of underlying disease|7|||
130794191|NCT01283386|470874933|FG000|Overall Study|Reason not specified|1|||
130794192|NCT01283386|470874934|FG001|Overall Study|Reason not specified|0|||
130794193|NCT01283386|470874933|FG000|Overall Study|Protocol Violation|0|||
130794194|NCT01283386|470874934|FG001|Overall Study|Protocol Violation|1|||
130794195|NCT01531153|470874935|FG000|Overall Study|Withdrawal by Subject|10|||
130794196|NCT01531153|470874936|FG001|Overall Study|Withdrawal by Subject|9|||
130794197|NCT01531153|470874937|FG002|Overall Study|Withdrawal by Subject|15|||
130794198|NCT00770367|470874938|FG000|First Intervention|Withdrawal by Subject|0|||
130794199|NCT00770367|470874939|FG001|First Intervention|Withdrawal by Subject|2|||
130794200|NCT00770367|470874938|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
130794201|NCT00770367|470874939|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
130794202|NCT00770367|470874938|FG000|Second Intervention|Lost to Follow-up|2|||
130794203|NCT00770367|470874939|FG001|Second Intervention|Lost to Follow-up|0|||
130794204|NCT00920816|470874941|FG000|Overall Study|Death|116|||
130794205|NCT00920816|470874942|FG001|Overall Study|Death|63|||
130794206|NCT00920816|470874943|FG002|Overall Study|Death|8|||
130794207|NCT00920816|470874944|FG003|Overall Study|Death|3|||
130794208|NCT00920816|470874941|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
130794209|NCT00920816|470874942|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
130794210|NCT00920816|470874943|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
130794211|NCT00920816|470874944|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
130794212|NCT00920816|470874941|FG000|Overall Study|Global deterioration of health status|2|||
130794213|NCT00920816|470874942|FG001|Overall Study|Global deterioration of health status|0|||
130762279|NCT02089334|470752025|FG003|Overall Study|Physician Decision|1|||
130762280|NCT02832375|470752026|FG000|Overall Study|Lost to Follow-up|1|||
130762281|NCT02832375|470752027|FG001|Overall Study|Lost to Follow-up|0|||
130762282|NCT02832375|470752026|FG000|Overall Study|Withdrawal of Consent|1|||
130762283|NCT02832375|470752027|FG001|Overall Study|Withdrawal of Consent|0|||
130762284|NCT00084318|470752030|FG000|Overall Study|Withdrawal by Subject|5|||
130762285|NCT00084318|470752031|FG001|Overall Study|Withdrawal by Subject|2|||
130762286|NCT00084318|470752030|FG000|Overall Study|Protocol Violation|15|||
130762287|NCT00084318|470752031|FG001|Overall Study|Protocol Violation|11|||
130762288|NCT00084318|470752030|FG000|Overall Study|No protocol treatment|2|||
130762289|NCT00084318|470752031|FG001|Overall Study|No protocol treatment|0|||
130762290|NCT03301740|470752033|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
130762291|NCT03301740|470752034|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
130762292|NCT03301740|470752033|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
130762293|NCT03301740|470752034|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
130762294|NCT01037127|470752035|FG000|Overall Study|Lost to Follow-up|2|||
130762295|NCT01037127|470752036|FG001|Overall Study|Lost to Follow-up|4|||
130762296|NCT01037127|470752035|FG000|Overall Study|Physician Decision|1|||
130762297|NCT01037127|470752036|FG001|Overall Study|Physician Decision|0|||
130762298|NCT01037127|470752035|FG000|Overall Study|Study Closed Terminated|2|||
130762299|NCT01037127|470752036|FG001|Overall Study|Study Closed Terminated|17|||
130762300|NCT02637713|470752043|FG000|Overall Study|Screen Failure|2|||
130762301|NCT02847182|470752044|FG000|Overall Study|Withdrawal by Subject|0|||
130762302|NCT02847182|470752045|FG001|Overall Study|Withdrawal by Subject|1|||
130762303|NCT02345889|470752046|FG000|Overall Study|Inadequate Bowel Prep|17|||
130762304|NCT02345889|470752047|FG001|Overall Study|Inadequate Bowel Prep|16|||
130762305|NCT02345889|470752048|FG002|Overall Study|Inadequate Bowel Prep|18|||
130762306|NCT02345889|470752049|FG003|Overall Study|Inadequate Bowel Prep|14|||
130762307|NCT02345889|470752046|FG000|Overall Study|Polyposis identified during procedure|1|||
130762308|NCT02345889|470752047|FG001|Overall Study|Polyposis identified during procedure|1|||
130762309|NCT02345889|470752048|FG002|Overall Study|Polyposis identified during procedure|0|||
130762310|NCT02345889|470752049|FG003|Overall Study|Polyposis identified during procedure|1|||
130762311|NCT02345889|470752046|FG000|Overall Study|Recognized ineligible post-randomization|1|||
130762312|NCT02345889|470752047|FG001|Overall Study|Recognized ineligible post-randomization|0|||
130762313|NCT02345889|470752048|FG002|Overall Study|Recognized ineligible post-randomization|2|||
130762314|NCT02345889|470752049|FG003|Overall Study|Recognized ineligible post-randomization|1|||
130762315|NCT02345889|470752046|FG000|Overall Study|Ulcerative Colitis identified|1|||
130762316|NCT02345889|470752047|FG001|Overall Study|Ulcerative Colitis identified|0|||
130762317|NCT02345889|470752048|FG002|Overall Study|Ulcerative Colitis identified|0|||
130762318|NCT02345889|470752049|FG003|Overall Study|Ulcerative Colitis identified|0|||
130762319|NCT02345889|470752046|FG000|Overall Study|Cecum not intubated|1|||
130762320|NCT02345889|470752047|FG001|Overall Study|Cecum not intubated|0|||
130762321|NCT02345889|470752048|FG002|Overall Study|Cecum not intubated|0|||
130794214|NCT00920816|470874943|FG002|Overall Study|Global deterioration of health status|0|||
130762322|NCT02345889|470752049|FG003|Overall Study|Cecum not intubated|0|||
130762323|NCT01173055|470752051|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
130762324|NCT01173055|470752052|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
130762325|NCT01173055|470752051|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
130762326|NCT01173055|470752052|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
130794215|NCT00920816|470874944|FG003|Overall Study|Global deterioration of health status|0|||
130794216|NCT00920816|470874941|FG000|Overall Study|Objective progression or relapse|6|||
130794217|NCT00920816|470874942|FG001|Overall Study|Objective progression or relapse|2|||
130794218|NCT00920816|470874943|FG002|Overall Study|Objective progression or relapse|0|||
130794219|NCT00920816|470874944|FG003|Overall Study|Objective progression or relapse|0|||
130794220|NCT00920816|470874941|FG000|Overall Study|Other|26|||
130762327|NCT04325698|470752053|FG000|Overall Study|Study Terminated By Sponsor|1|||
130762328|NCT04325698|470752054|FG001|Overall Study|Study Terminated By Sponsor|1|||
130762329|NCT04325698|470752053|FG000|Overall Study|Withdrawal by Subject|0|||
130762330|NCT04325698|470752054|FG001|Overall Study|Withdrawal by Subject|2|||
130762331|NCT04253782|470752055|FG000|Overall Study|Death|2|||
130762332|NCT04253782|470752056|FG001|Overall Study|Death|0|||
130762333|NCT04216589|470752057|FG000|Overall Study|Withdrawal by Subject|2|||
130794221|NCT00920816|470874942|FG001|Overall Study|Other|15|||
130794222|NCT00920816|470874943|FG002|Overall Study|Other|1|||
130794223|NCT00920816|470874944|FG003|Overall Study|Other|2|||
130794224|NCT00920816|470874941|FG000|Overall Study|Lost to Follow-up|11|||
130794225|NCT00920816|470874942|FG001|Overall Study|Lost to Follow-up|2|||
130794226|NCT00920816|470874943|FG002|Overall Study|Lost to Follow-up|0|||
130794227|NCT00920816|470874944|FG003|Overall Study|Lost to Follow-up|0|||
130794228|NCT00920816|470874941|FG000|Overall Study|Adverse Event|1|||
130794229|NCT00920816|470874942|FG001|Overall Study|Adverse Event|1|||
130794230|NCT00920816|470874943|FG002|Overall Study|Adverse Event|1|||
130794231|NCT00920816|470874944|FG003|Overall Study|Adverse Event|0|||
130794232|NCT00920816|470874941|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
130762334|NCT04216589|470752057|FG000|Overall Study|Protocol Violation|1|||
130762335|NCT04216589|470752057|FG000|Overall Study|Incarceration|1|||
130794233|NCT00920816|470874942|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
130794234|NCT00920816|470874943|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
130794235|NCT00920816|470874944|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
130794236|NCT00920816|470874941|FG000|Overall Study|Randomized but not treated|3|||
130794237|NCT00920816|470874942|FG001|Overall Study|Randomized but not treated|0|||
130794238|NCT00920816|470874943|FG002|Overall Study|Randomized but not treated|0|||
130794239|NCT00920816|470874944|FG003|Overall Study|Randomized but not treated|0|||
130794240|NCT01180777|470874945|FG000|Overall Study|Protocol Violation|6|||
130794241|NCT01180777|470874945|FG000|Overall Study|Poor lens fit|4|||
130794242|NCT01180777|470874945|FG000|Overall Study|Lost to Follow-up|1|||
130794243|NCT01180777|470874945|FG000|Overall Study|Adverse Event|1|||
130794244|NCT03517137|470874948|FG000|Overall Study|Lack of Efficacy|1|||
130794245|NCT03517137|470874948|FG000|Overall Study|Adverse Event|2|||
130794246|NCT03517137|470874948|FG000|Overall Study|Withdrawal by Subject|2|||
130794247|NCT03517137|470874948|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
130794248|NCT01582451|470874949|FG000|Overall Study|Adverse Event|1|||
130794249|NCT01582451|470874950|FG001|Overall Study|Adverse Event|3|||
130794250|NCT01582451|470874949|FG000|Overall Study|Death|3|||
130794251|NCT01582451|470874950|FG001|Overall Study|Death|3|||
130794252|NCT01582451|470874949|FG000|Overall Study|Lost to Follow-up|0|||
130794253|NCT01582451|470874950|FG001|Overall Study|Lost to Follow-up|2|||
130794254|NCT01582451|470874949|FG000|Overall Study|Protocol Violation|11|||
130794255|NCT01582451|470874950|FG001|Overall Study|Protocol Violation|3|||
130794256|NCT01582451|470874949|FG000|Overall Study|Withdrawal by Subject|13|||
130794257|NCT01582451|470874950|FG001|Overall Study|Withdrawal by Subject|9|||
130794258|NCT01582451|470874949|FG000|Overall Study|Physician Decision|3|||
130794259|NCT01582451|470874950|FG001|Overall Study|Physician Decision|0|||
130794260|NCT01582451|470874949|FG000|Overall Study|Sponsor Decision|1|||
130794261|NCT01582451|470874950|FG001|Overall Study|Sponsor Decision|0|||
130794262|NCT00487188|470874954|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
130794263|NCT00487188|470874955|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
130794264|NCT00487188|470874956|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
130794265|NCT00487188|470874954|FG000|Induction Phase|Adverse Event|5|||
130794266|NCT00487188|470874955|FG001|Induction Phase|Adverse Event|0|||
130794267|NCT00487188|470874956|FG002|Induction Phase|Adverse Event|0|||
130794268|NCT00487188|470874954|FG000|Induction Phase|Lack of Efficacy|0|||
130794269|NCT00487188|470874955|FG001|Induction Phase|Lack of Efficacy|1|||
130794270|NCT00487188|470874956|FG002|Induction Phase|Lack of Efficacy|0|||
130794271|NCT00487188|470874954|FG000|Induction Phase|Protocol Violation|1|||
130794272|NCT00487188|470874955|FG001|Induction Phase|Protocol Violation|0|||
130794273|NCT00487188|470874956|FG002|Induction Phase|Protocol Violation|0|||
130794274|NCT00487188|470874954|FG000|Induction Phase|Refused Treatment|1|||
130794275|NCT00487188|470874955|FG001|Induction Phase|Refused Treatment|2|||
130794276|NCT00487188|470874956|FG002|Induction Phase|Refused Treatment|0|||
130794277|NCT00487188|470874954|FG000|Induction Phase|Lost to Follow-up|2|||
130794278|NCT00487188|470874955|FG001|Induction Phase|Lost to Follow-up|2|||
130794279|NCT00487188|470874956|FG002|Induction Phase|Lost to Follow-up|0|||
130794280|NCT00487188|470874954|FG000|Induction Phase|Administrative|0|||
130794281|NCT00487188|470874955|FG001|Induction Phase|Administrative|1|||
130794282|NCT00487188|470874956|FG002|Induction Phase|Administrative|0|||
130794283|NCT00487188|470874954|FG000|Maintenance Phase|Adverse Event|1|||
130794284|NCT00487188|470874955|FG001|Maintenance Phase|Adverse Event|0|||
130794285|NCT00487188|470874956|FG002|Maintenance Phase|Adverse Event|0|||
130794286|NCT00487188|470874954|FG000|Maintenance Phase|Death|1|||
130794287|NCT00487188|470874955|FG001|Maintenance Phase|Death|0|||
130794288|NCT00487188|470874956|FG002|Maintenance Phase|Death|0|||
130794289|NCT00487188|470874954|FG000|Maintenance Phase|Lost to Follow-up|1|||
130794290|NCT00487188|470874955|FG001|Maintenance Phase|Lost to Follow-up|0|||
130794291|NCT00487188|470874956|FG002|Maintenance Phase|Lost to Follow-up|0|||
130794292|NCT00487188|470874954|FG000|Maintenance Phase|Administrative|0|||
130794293|NCT00487188|470874955|FG001|Maintenance Phase|Administrative|0|||
130794294|NCT00487188|470874956|FG002|Maintenance Phase|Administrative|1|||
130794295|NCT03822416|470874959|FG000|Overall Study|Lost to Follow-up|1|||
130794296|NCT03822416|470874960|FG001|Overall Study|Lost to Follow-up|0|||
130794297|NCT03822416|470874959|FG000|Overall Study|Withdrawal by Subject|0|||
130794298|NCT03822416|470874960|FG001|Overall Study|Withdrawal by Subject|1|||
130794299|NCT01995201|470874963|FG000|From Baseline Until Week 24|Adverse Event|4|||
130794300|NCT01995201|470874964|FG001|From Baseline Until Week 24|Adverse Event|15|||
130794301|NCT01995201|470874965|FG002|From Baseline Until Week 24|Adverse Event|0|||
130794302|NCT01995201|470874966|FG003|From Baseline Until Week 24|Adverse Event|0|||
130794303|NCT01995201|470874967|FG004|From Baseline Until Week 24|Adverse Event|0|||
130794304|NCT01995201|470874968|FG005|From Baseline Until Week 24|Adverse Event|0|||
130794305|NCT01995201|470874969|FG006|From Baseline Until Week 24|Adverse Event|0|||
130794306|NCT01995201|470874963|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130794307|NCT01995201|470874964|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
130794308|NCT01995201|470874965|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130794309|NCT01995201|470874966|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130794310|NCT01995201|470874967|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130794311|NCT01995201|470874968|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130794312|NCT01995201|470874969|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130794313|NCT01995201|470874963|FG000|From Baseline Until Week 24|Death|0|||
130794314|NCT01995201|470874964|FG001|From Baseline Until Week 24|Death|1|||
130794315|NCT01995201|470874965|FG002|From Baseline Until Week 24|Death|0|||
130794316|NCT01995201|470874966|FG003|From Baseline Until Week 24|Death|0|||
130794317|NCT01995201|470874967|FG004|From Baseline Until Week 24|Death|0|||
130794318|NCT01995201|470874968|FG005|From Baseline Until Week 24|Death|0|||
130794319|NCT01995201|470874969|FG006|From Baseline Until Week 24|Death|0|||
130794320|NCT01995201|470874963|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
130794321|NCT01995201|470874964|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
130794322|NCT01995201|470874965|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
130794323|NCT01995201|470874966|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
130794324|NCT01995201|470874967|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
130794325|NCT01995201|470874968|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
130794326|NCT01995201|470874969|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
130794327|NCT01995201|470874963|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
130794328|NCT01995201|470874964|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
130794329|NCT01995201|470874965|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
130794330|NCT01995201|470874966|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
130794331|NCT01995201|470874967|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
130794332|NCT01995201|470874968|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
130794333|NCT01995201|470874969|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
130794334|NCT01995201|470874963|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
130794335|NCT01995201|470874964|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
130794336|NCT01995201|470874965|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
130794337|NCT01995201|470874966|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
130794338|NCT01995201|470874967|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
130794339|NCT01995201|470874968|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
130794340|NCT01995201|470874969|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
130794341|NCT01995201|470874963|FG000|From Baseline Until Week 24|Physician Decision|0|||
130794342|NCT01995201|470874964|FG001|From Baseline Until Week 24|Physician Decision|2|||
130794343|NCT01995201|470874965|FG002|From Baseline Until Week 24|Physician Decision|0|||
130794344|NCT01995201|470874966|FG003|From Baseline Until Week 24|Physician Decision|0|||
130794345|NCT01995201|470874967|FG004|From Baseline Until Week 24|Physician Decision|0|||
130794346|NCT01995201|470874968|FG005|From Baseline Until Week 24|Physician Decision|0|||
130794347|NCT01995201|470874969|FG006|From Baseline Until Week 24|Physician Decision|0|||
130794348|NCT01995201|470874963|FG000|From Baseline Until Week 24|Protocol Violation|0|||
130794349|NCT01995201|470874964|FG001|From Baseline Until Week 24|Protocol Violation|9|||
130794350|NCT01995201|470874965|FG002|From Baseline Until Week 24|Protocol Violation|0|||
130794351|NCT01995201|470874966|FG003|From Baseline Until Week 24|Protocol Violation|0|||
130794352|NCT01995201|470874967|FG004|From Baseline Until Week 24|Protocol Violation|0|||
130794353|NCT01995201|470874968|FG005|From Baseline Until Week 24|Protocol Violation|0|||
130794354|NCT01995201|470874969|FG006|From Baseline Until Week 24|Protocol Violation|0|||
130794355|NCT01995201|470874963|FG000|From Week 24 Until Week 48|Adverse Event|0|||
130794356|NCT01995201|470874964|FG001|From Week 24 Until Week 48|Adverse Event|0|||
130794357|NCT01995201|470874965|FG002|From Week 24 Until Week 48|Adverse Event|2|||
130794358|NCT01995201|470874966|FG003|From Week 24 Until Week 48|Adverse Event|1|||
130794359|NCT01995201|470874967|FG004|From Week 24 Until Week 48|Adverse Event|1|||
130794360|NCT01995201|470874968|FG005|From Week 24 Until Week 48|Adverse Event|3|||
130794361|NCT01995201|470874969|FG006|From Week 24 Until Week 48|Adverse Event|1|||
130794362|NCT01995201|470874963|FG000|From Week 24 Until Week 48|Death|0|||
130794363|NCT01995201|470874964|FG001|From Week 24 Until Week 48|Death|0|||
130794364|NCT01995201|470874965|FG002|From Week 24 Until Week 48|Death|0|||
130794365|NCT01995201|470874966|FG003|From Week 24 Until Week 48|Death|0|||
130794366|NCT01995201|470874967|FG004|From Week 24 Until Week 48|Death|0|||
130794367|NCT01995201|470874968|FG005|From Week 24 Until Week 48|Death|2|||
130794368|NCT01995201|470874969|FG006|From Week 24 Until Week 48|Death|0|||
130794369|NCT01995201|470874963|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
130794370|NCT01995201|470874964|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
130794371|NCT01995201|470874965|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
130794372|NCT01995201|470874966|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
130794373|NCT01995201|470874967|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
130794374|NCT01995201|470874968|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
130794375|NCT01995201|470874969|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
130794376|NCT01995201|470874963|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
130794377|NCT01995201|470874964|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
130794378|NCT01995201|470874965|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
130794379|NCT01995201|470874966|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
130794380|NCT01995201|470874967|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
130794381|NCT01995201|470874968|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
130794382|NCT01995201|470874969|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
130794383|NCT01995201|470874963|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130794384|NCT01995201|470874964|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130794385|NCT01995201|470874965|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
130794386|NCT01995201|470874966|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130794387|NCT01995201|470874967|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
130794388|NCT01995201|470874968|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130794389|NCT01995201|470874969|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130794390|NCT01995201|470874963|FG000|From Week 24 Until Week 48|Physician Decision|0|||
130794391|NCT01995201|470874964|FG001|From Week 24 Until Week 48|Physician Decision|0|||
130794392|NCT01995201|470874965|FG002|From Week 24 Until Week 48|Physician Decision|0|||
130794393|NCT01995201|470874966|FG003|From Week 24 Until Week 48|Physician Decision|0|||
130794394|NCT01995201|470874967|FG004|From Week 24 Until Week 48|Physician Decision|1|||
130794395|NCT01995201|470874968|FG005|From Week 24 Until Week 48|Physician Decision|0|||
130794396|NCT01995201|470874969|FG006|From Week 24 Until Week 48|Physician Decision|0|||
130794397|NCT01995201|470874963|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
130794398|NCT01995201|470874964|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
130794399|NCT01995201|470874965|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
130794400|NCT01995201|470874966|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
130794401|NCT01995201|470874967|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
130794402|NCT01995201|470874968|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
130794403|NCT01995201|470874969|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
130794404|NCT03329001|470874970|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130794405|NCT03329001|470874971|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130794406|NCT03329001|470874972|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
130794407|NCT03329001|470874973|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
130794408|NCT03329001|470874974|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130794409|NCT03329001|470874975|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130794410|NCT03329001|470874976|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130794411|NCT03329001|470874977|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130794412|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130794413|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130794414|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130794415|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
130794416|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130794417|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130794418|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130794419|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130794420|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130794421|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130794422|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130794423|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
130794424|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130794425|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130794426|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130794427|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130794428|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130794429|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130794430|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130794431|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
130794432|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130794433|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130794434|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130794435|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130794436|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130794437|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130794438|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
130794439|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130794440|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130794441|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130794442|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130794443|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130794444|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130794445|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130794446|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
130794447|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130794448|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130794449|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130794450|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130794451|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130794452|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130794453|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130794454|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
130794455|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130794456|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130794457|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130794458|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130794459|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130794460|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130762336|NCT03191864|470752064|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
130762337|NCT03191864|470752065|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
130762338|NCT03191864|470752066|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
130762339|NCT03191864|470752067|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
130762340|NCT03191864|470752068|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
130762341|NCT03191864|470752069|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
130762342|NCT03191864|470752064|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130762343|NCT03191864|470752065|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130762344|NCT03191864|470752066|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130762345|NCT03191864|470752067|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130762346|NCT03191864|470752068|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130762347|NCT03191864|470752069|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
130762348|NCT03191864|470752064|FG000|Baseline Symptom Assessment|Adverse Event|0|||
130762349|NCT03191864|470752065|FG001|Baseline Symptom Assessment|Adverse Event|0|||
130762350|NCT03191864|470752066|FG002|Baseline Symptom Assessment|Adverse Event|0|||
130762351|NCT03191864|470752067|FG003|Baseline Symptom Assessment|Adverse Event|0|||
130762352|NCT03191864|470752068|FG004|Baseline Symptom Assessment|Adverse Event|0|||
130762353|NCT03191864|470752069|FG005|Baseline Symptom Assessment|Adverse Event|2|||
130762354|NCT03191864|470752064|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130762355|NCT03191864|470752065|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130762356|NCT03191864|470752066|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130762357|NCT03191864|470752067|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130762358|NCT03191864|470752068|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130762359|NCT03191864|470752069|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
130762360|NCT03191864|470752064|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130762361|NCT03191864|470752065|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130762362|NCT03191864|470752066|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130762363|NCT03191864|470752067|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130762364|NCT03191864|470752068|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130762365|NCT03191864|470752069|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
130762366|NCT03191864|470752064|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130762367|NCT03191864|470752065|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130762368|NCT03191864|470752066|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
130762369|NCT03191864|470752067|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130762370|NCT03191864|470752068|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130762371|NCT03191864|470752069|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
130762372|NCT03191864|470752064|FG000|Part 1 - Induction|Adverse Event|0|||
130762373|NCT03191864|470752065|FG001|Part 1 - Induction|Adverse Event|2|||
130762374|NCT03191864|470752066|FG002|Part 1 - Induction|Adverse Event|0|||
130762375|NCT03191864|470752067|FG003|Part 1 - Induction|Adverse Event|1|||
130762376|NCT03191864|470752068|FG004|Part 1 - Induction|Adverse Event|0|||
130762377|NCT03191864|470752069|FG005|Part 1 - Induction|Adverse Event|2|||
130762378|NCT03191864|470752064|FG000|Part 1 - Induction|Randomized but never dosed|0|||
130762379|NCT03191864|470752065|FG001|Part 1 - Induction|Randomized but never dosed|0|||
130762380|NCT03191864|470752066|FG002|Part 1 - Induction|Randomized but never dosed|1|||
130762381|NCT03191864|470752067|FG003|Part 1 - Induction|Randomized but never dosed|0|||
130762382|NCT03191864|470752068|FG004|Part 1 - Induction|Randomized but never dosed|0|||
130762383|NCT03191864|470752069|FG005|Part 1 - Induction|Randomized but never dosed|0|||
130762384|NCT03191864|470752064|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
130762385|NCT03191864|470752065|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
130762386|NCT03191864|470752066|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
130762387|NCT03191864|470752067|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
130762388|NCT03191864|470752068|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
130762389|NCT03191864|470752069|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
130762390|NCT03191864|470752064|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130762391|NCT03191864|470752065|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130762392|NCT03191864|470752066|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
130762393|NCT03191864|470752067|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130762394|NCT03191864|470752068|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130762395|NCT03191864|470752069|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130762396|NCT03191864|470752064|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
130762397|NCT03191864|470752065|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130762398|NCT03191864|470752066|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130762399|NCT03191864|470752067|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130762400|NCT03191864|470752068|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130762401|NCT03191864|470752069|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130762402|NCT03191864|470752064|FG000|Part 2 - Maintenance|Physician Decision|1|||
130794461|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130794462|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
130794463|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130794464|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130794465|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130794466|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130794467|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130794468|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130794469|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130794470|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
130794471|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
130794472|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130794473|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130794474|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130794475|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130794476|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130794477|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130794478|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
130794479|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130794480|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130794481|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130794482|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130794483|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130794484|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130794485|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130794486|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
130794487|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
130794488|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130794489|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130794490|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130794491|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130794492|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130794493|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130794494|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
130794495|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
130794496|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130794497|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130794498|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130794499|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130794500|NCT03329001|470874970|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130794501|NCT03329001|470874971|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130794502|NCT03329001|470874972|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
130794503|NCT03329001|470874973|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
130794504|NCT03329001|470874974|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130794505|NCT03329001|470874975|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130794506|NCT03329001|470874976|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130794507|NCT03329001|470874977|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130794508|NCT03329001|470874970|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130794509|NCT03329001|470874971|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130794510|NCT03329001|470874972|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130794511|NCT03329001|470874973|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
130794512|NCT03329001|470874974|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130794513|NCT03329001|470874975|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130794514|NCT03329001|470874976|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130794515|NCT03329001|470874977|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130794516|NCT03329001|470874970|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130794517|NCT03329001|470874971|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130794518|NCT03329001|470874972|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130794519|NCT03329001|470874973|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
130794520|NCT03329001|470874974|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130794521|NCT03329001|470874975|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130794522|NCT03329001|470874976|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130794523|NCT03329001|470874977|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130794524|NCT03329001|470874970|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130794525|NCT03329001|470874971|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130794526|NCT03329001|470874972|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
130794527|NCT03329001|470874973|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130794528|NCT03329001|470874974|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130794529|NCT03329001|470874975|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130794530|NCT03329001|470874976|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130794531|NCT03329001|470874977|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130794532|NCT03329001|470874970|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130794533|NCT03329001|470874971|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130794534|NCT03329001|470874972|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
130794535|NCT03329001|470874973|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
130794536|NCT03329001|470874974|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130794537|NCT03329001|470874975|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130794538|NCT03329001|470874976|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130794539|NCT03329001|470874977|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130794540|NCT03329001|470874970|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130794541|NCT03329001|470874971|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130794542|NCT03329001|470874972|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
130794543|NCT03329001|470874973|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130794544|NCT03329001|470874974|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130794545|NCT03329001|470874975|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130794546|NCT03329001|470874976|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130794547|NCT03329001|470874977|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130794548|NCT03329001|470874970|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130794549|NCT03329001|470874971|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130794550|NCT03329001|470874972|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
130794551|NCT03329001|470874973|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130794552|NCT03329001|470874974|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130794553|NCT03329001|470874975|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130794554|NCT03329001|470874976|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130794555|NCT03329001|470874977|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130794556|NCT03329001|470874970|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130794557|NCT03329001|470874971|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130794558|NCT03329001|470874972|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130794559|NCT03329001|470874973|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
130794560|NCT03329001|470874974|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130794561|NCT03329001|470874975|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130794562|NCT03329001|470874976|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130794563|NCT03329001|470874977|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130794564|NCT03329001|470874970|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130794565|NCT03329001|470874971|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130794566|NCT03329001|470874972|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130794567|NCT03329001|470874973|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130794568|NCT03329001|470874974|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130794569|NCT03329001|470874975|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
130794570|NCT03329001|470874976|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130794571|NCT03329001|470874977|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130794572|NCT03329001|470874970|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130794573|NCT03329001|470874971|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130794574|NCT03329001|470874972|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130794575|NCT03329001|470874973|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130794576|NCT03329001|470874974|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
130794577|NCT03329001|470874975|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130794578|NCT03329001|470874976|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130794579|NCT03329001|470874977|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130794580|NCT03329001|470874970|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130794581|NCT03329001|470874971|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130794582|NCT03329001|470874972|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130794583|NCT03329001|470874973|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130794584|NCT03329001|470874974|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
130794585|NCT03329001|470874975|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
130762403|NCT03191864|470752065|FG001|Part 2 - Maintenance|Physician Decision|0|||
130762404|NCT03191864|470752066|FG002|Part 2 - Maintenance|Physician Decision|0|||
130762405|NCT03191864|470752067|FG003|Part 2 - Maintenance|Physician Decision|0|||
130762406|NCT03191864|470752068|FG004|Part 2 - Maintenance|Physician Decision|0|||
130762407|NCT03191864|470752069|FG005|Part 2 - Maintenance|Physician Decision|0|||
130762408|NCT03191864|470752064|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
130762409|NCT03191864|470752065|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
130762410|NCT03191864|470752066|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
130762411|NCT03191864|470752067|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
130762412|NCT03191864|470752068|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
130762413|NCT03191864|470752069|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
130762414|NCT03191864|470752064|FG000|Part 2 - Maintenance|Adverse Event|0|||
130762415|NCT03191864|470752065|FG001|Part 2 - Maintenance|Adverse Event|0|||
130762416|NCT03191864|470752066|FG002|Part 2 - Maintenance|Adverse Event|0|||
130762417|NCT03191864|470752067|FG003|Part 2 - Maintenance|Adverse Event|0|||
130762418|NCT03191864|470752068|FG004|Part 2 - Maintenance|Adverse Event|1|||
130762419|NCT03191864|470752069|FG005|Part 2 - Maintenance|Adverse Event|0|||
130762420|NCT03191864|470752064|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
130762421|NCT03191864|470752065|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
130762422|NCT03191864|470752066|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
130762423|NCT03191864|470752067|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
130762424|NCT03191864|470752068|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
130762425|NCT03191864|470752069|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
130762426|NCT03191864|470752064|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130762427|NCT03191864|470752065|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130762428|NCT03191864|470752066|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130762429|NCT03191864|470752067|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130762430|NCT03191864|470752068|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
130762431|NCT03191864|470752069|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130762432|NCT02342548|470752070|FG000|Overall Study|Adverse Event|12|||
130762433|NCT02342548|470752071|FG001|Overall Study|Adverse Event|17|||
130762434|NCT02342548|470752072|FG002|Overall Study|Adverse Event|13|||
130762435|NCT02342548|470752070|FG000|Overall Study|Lost to Follow-up|0|||
130762436|NCT02342548|470752071|FG001|Overall Study|Lost to Follow-up|1|||
130762437|NCT02342548|470752072|FG002|Overall Study|Lost to Follow-up|0|||
130762438|NCT02342548|470752070|FG000|Overall Study|Study terminated by sponsor|20|||
130762439|NCT02342548|470752071|FG001|Overall Study|Study terminated by sponsor|39|||
130762440|NCT02342548|470752072|FG002|Overall Study|Study terminated by sponsor|25|||
130762441|NCT02342548|470752070|FG000|Overall Study|Protocol Violation|0|||
130762442|NCT02342548|470752071|FG001|Overall Study|Protocol Violation|1|||
130762443|NCT02342548|470752072|FG002|Overall Study|Protocol Violation|0|||
130762444|NCT02342548|470752070|FG000|Overall Study|Withdrawal by Subject|1|||
130762445|NCT02342548|470752071|FG001|Overall Study|Withdrawal by Subject|3|||
130762446|NCT02342548|470752072|FG002|Overall Study|Withdrawal by Subject|4|||
130762447|NCT02342548|470752070|FG000|Overall Study|Other|1|||
130762448|NCT02342548|470752071|FG001|Overall Study|Other|1|||
130762449|NCT02342548|470752072|FG002|Overall Study|Other|1|||
130762450|NCT01047332|470752073|FG000|Overall Study|SEMS Obstruction|11|||
130762451|NCT01047332|470752074|FG001|Overall Study|SEMS Obstruction|20|||
130762452|NCT01047332|470752073|FG000|Overall Study|Died Unobstructed|38|||
130762453|NCT01047332|470752074|FG001|Overall Study|Died Unobstructed|41|||
130762454|NCT01047332|470752073|FG000|Overall Study|Lost to Follow-up|8|||
130762455|NCT01047332|470752074|FG001|Overall Study|Lost to Follow-up|3|||
130762456|NCT03521817|470752079|FG000|Overall Study|Protocol Violation|0|||
130762457|NCT03521817|470752080|FG001|Overall Study|Protocol Violation|1|||
130762458|NCT04618471|470753316|FG000|Overall Study|Screen Failure|62|||
130762459|NCT04618471|470753316|FG000|Overall Study|Withdrawal by Subject|6|||
130762460|NCT04618471|470753316|FG000|Overall Study|Physician Decision|2|||
130762461|NCT04618471|470753316|FG000|Overall Study|Lost to Follow-up|1|||
130762462|NCT04618471|470753316|FG000|Overall Study|Various other reasons|2|||
130762463|NCT04618471|470753316|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
130762464|NCT01752634|470753317|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
130762465|NCT01752634|470753318|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
130762466|NCT01752634|470753319|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
130762467|NCT01752634|470753320|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
130762468|NCT01752634|470753321|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
130822786|NCT01815424|470980600|FG003|Week 0 to 16|Protocol Violation|0|||
130794586|NCT03329001|470874976|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130794587|NCT03329001|470874977|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130794588|NCT03329001|470874970|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130794589|NCT03329001|470874971|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130794590|NCT03329001|470874972|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130794591|NCT03329001|470874973|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130794592|NCT03329001|470874974|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
130794593|NCT03329001|470874975|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130794594|NCT03329001|470874976|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130794595|NCT03329001|470874977|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130794596|NCT03329001|470874970|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130794597|NCT03329001|470874971|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130794598|NCT03329001|470874972|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130794599|NCT03329001|470874973|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130794600|NCT03329001|470874974|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
130794601|NCT03329001|470874975|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
130794602|NCT03329001|470874976|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130794603|NCT03329001|470874977|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130794604|NCT03329001|470874970|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130794605|NCT03329001|470874971|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130794606|NCT03329001|470874972|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130794607|NCT03329001|470874973|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130794608|NCT03329001|470874974|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130794609|NCT03329001|470874975|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130794610|NCT03329001|470874976|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
130794611|NCT03329001|470874977|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
130794612|NCT03329001|470874970|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130794613|NCT03329001|470874971|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130794614|NCT03329001|470874972|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130794615|NCT03329001|470874973|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130794616|NCT03329001|470874974|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130794617|NCT03329001|470874975|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130794618|NCT03329001|470874976|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
130794619|NCT03329001|470874977|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130794620|NCT03329001|470874970|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130794621|NCT03329001|470874971|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130794622|NCT03329001|470874972|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130794623|NCT03329001|470874973|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130794624|NCT03329001|470874974|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130794625|NCT03329001|470874975|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130794626|NCT03329001|470874976|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
130794627|NCT03329001|470874977|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
130794628|NCT03329001|470874970|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130794629|NCT03329001|470874971|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130794630|NCT03329001|470874972|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130794631|NCT03329001|470874973|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130794632|NCT03329001|470874974|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130794633|NCT03329001|470874975|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130794634|NCT03329001|470874976|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
130794635|NCT03329001|470874977|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
130794636|NCT02709369|470874981|FG000|Overall Study|Lost to Follow-up|15|||
130794637|NCT02709369|470874981|FG000|Overall Study|Withdrawal by Subject|10|||
130794638|NCT02709369|470874981|FG000|Overall Study|Did not received intervention|2|||
130794639|NCT00963235|470874982|FG000|Overall Study|Withdrawal by Subject|22|||
130794640|NCT00963235|470874982|FG000|Overall Study|Lost to Follow-up|14|||
130794641|NCT00963235|470874982|FG000|Overall Study|Failed to return|9|||
130794642|NCT00963235|470874982|FG000|Overall Study|Protocol Violation|7|||
130794643|NCT00963235|470874982|FG000|Overall Study|Adverse Event|5|||
130794644|NCT00963235|470874982|FG000|Overall Study|Physician Decision|2|||
130794645|NCT00963235|470874982|FG000|Overall Study|Other|1|||
130794646|NCT01104766|470874983|FG000|Overall Study|Did not meet inc/exc criteria|1|||
130794647|NCT01104766|470874984|FG001|Overall Study|Did not meet inc/exc criteria|0|||
130794648|NCT01104766|470874985|FG002|Overall Study|Did not meet inc/exc criteria|0|||
130794649|NCT01104766|470874986|FG003|Overall Study|Did not meet inc/exc criteria|0|||
130794650|NCT01104766|470874983|FG000|Overall Study|Adverse Event|17|||
130794651|NCT01104766|470874984|FG001|Overall Study|Adverse Event|15|||
130794652|NCT01104766|470874985|FG002|Overall Study|Adverse Event|20|||
130794653|NCT01104766|470874986|FG003|Overall Study|Adverse Event|14|||
130794654|NCT01104766|470874983|FG000|Overall Study|Lack of Efficacy|20|||
130794655|NCT01104766|470874984|FG001|Overall Study|Lack of Efficacy|15|||
130794656|NCT01104766|470874985|FG002|Overall Study|Lack of Efficacy|14|||
130794657|NCT01104766|470874986|FG003|Overall Study|Lack of Efficacy|8|||
130794658|NCT01104766|470874983|FG000|Overall Study|Protocol Violation|2|||
130794659|NCT01104766|470874984|FG001|Overall Study|Protocol Violation|0|||
130794660|NCT01104766|470874985|FG002|Overall Study|Protocol Violation|0|||
130794661|NCT01104766|470874986|FG003|Overall Study|Protocol Violation|0|||
130794662|NCT01104766|470874983|FG000|Overall Study|Withdrawal by Subject|17|||
130794663|NCT01104766|470874984|FG001|Overall Study|Withdrawal by Subject|19|||
130794664|NCT01104766|470874985|FG002|Overall Study|Withdrawal by Subject|25|||
130794665|NCT01104766|470874986|FG003|Overall Study|Withdrawal by Subject|15|||
130794666|NCT01104766|470874983|FG000|Overall Study|Lost to Follow-up|1|||
130794667|NCT01104766|470874984|FG001|Overall Study|Lost to Follow-up|2|||
130794668|NCT01104766|470874985|FG002|Overall Study|Lost to Follow-up|1|||
130794669|NCT01104766|470874986|FG003|Overall Study|Lost to Follow-up|1|||
130794670|NCT01341470|470874988|FG000|Overall Study|Sponsor decision|0|||
130794671|NCT01341470|470874989|FG001|Overall Study|Sponsor decision|0|||
130794672|NCT01341470|470874990|FG002|Overall Study|Sponsor decision|1|||
130794673|NCT01341470|470874991|FG003|Overall Study|Sponsor decision|1|||
130794674|NCT01341470|470874992|FG004|Overall Study|Sponsor decision|0|||
130794675|NCT01341470|470874993|FG005|Overall Study|Sponsor decision|1|||
130794676|NCT01136915|470874995|FG000|Overall Study|Lost to Follow-up|2|||
130794677|NCT01136915|470874996|FG001|Overall Study|Lost to Follow-up|0|||
130794678|NCT01136915|470874995|FG000|Overall Study|Exclusion criterion met|0|||
130794679|NCT01136915|470874996|FG001|Overall Study|Exclusion criterion met|1|||
130794680|NCT01756235|470874997|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
130794681|NCT05376358|470874998|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
130794682|NCT05376358|470874999|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
130794683|NCT05376358|470874998|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
130794684|NCT05376358|470874999|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
130794685|NCT05376358|470874998|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
130794686|NCT05376358|470874999|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
130794687|NCT05376358|470874998|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
130794688|NCT05376358|470874999|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
130794689|NCT05376358|470874998|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
130794690|NCT05376358|470874999|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
130794691|NCT05376358|470874998|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
130794692|NCT05376358|470874999|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
130794693|NCT03965923|470875002|FG000|Overall Study|Withdrawal by Subject|1|||
130794694|NCT03965923|470875003|FG001|Overall Study|Withdrawal by Subject|2|||
130794695|NCT03965923|470875004|FG002|Overall Study|Withdrawal by Subject|3|||
130794696|NCT03965923|470875005|FG003|Overall Study|Withdrawal by Subject|1|||
130794697|NCT03965923|470875006|FG004|Overall Study|Withdrawal by Subject|2|||
130794698|NCT03965923|470875007|FG005|Overall Study|Withdrawal by Subject|0|||
130794699|NCT03965923|470875008|FG006|Overall Study|Withdrawal by Subject|4|||
130794700|NCT03965923|470875009|FG007|Overall Study|Withdrawal by Subject|3|||
130794701|NCT03965923|470875010|FG008|Overall Study|Withdrawal by Subject|4|||
130794702|NCT03965923|470875011|FG009|Overall Study|Withdrawal by Subject|0|||
130794703|NCT03965923|470875012|FG010|Overall Study|Withdrawal by Subject|2|||
130794704|NCT03965923|470875013|FG011|Overall Study|Withdrawal by Subject|0|||
130794705|NCT03965923|470875002|FG000|Overall Study|Lost to Follow-up|2|||
130794706|NCT03965923|470875003|FG001|Overall Study|Lost to Follow-up|1|||
130794707|NCT03965923|470875004|FG002|Overall Study|Lost to Follow-up|1|||
130794708|NCT03965923|470875005|FG003|Overall Study|Lost to Follow-up|0|||
130794709|NCT03965923|470875006|FG004|Overall Study|Lost to Follow-up|2|||
130794710|NCT03965923|470875007|FG005|Overall Study|Lost to Follow-up|1|||
130794711|NCT03965923|470875008|FG006|Overall Study|Lost to Follow-up|2|||
130794712|NCT03965923|470875009|FG007|Overall Study|Lost to Follow-up|1|||
130794713|NCT03965923|470875010|FG008|Overall Study|Lost to Follow-up|0|||
130794714|NCT03965923|470875011|FG009|Overall Study|Lost to Follow-up|2|||
130794715|NCT03965923|470875012|FG010|Overall Study|Lost to Follow-up|0|||
130794716|NCT03965923|470875013|FG011|Overall Study|Lost to Follow-up|0|||
130794717|NCT03965923|470875002|FG000|Overall Study|Death|0|||
130794718|NCT03965923|470875003|FG001|Overall Study|Death|0|||
130794719|NCT03965923|470875004|FG002|Overall Study|Death|0|||
130794720|NCT03965923|470875005|FG003|Overall Study|Death|0|||
130794721|NCT03965923|470875006|FG004|Overall Study|Death|0|||
130794722|NCT03965923|470875007|FG005|Overall Study|Death|0|||
130794723|NCT03965923|470875008|FG006|Overall Study|Death|0|||
130794724|NCT03965923|470875009|FG007|Overall Study|Death|1|||
130794725|NCT03965923|470875010|FG008|Overall Study|Death|4|||
130794726|NCT03965923|470875011|FG009|Overall Study|Death|0|||
130794727|NCT03965923|470875012|FG010|Overall Study|Death|4|||
130794728|NCT03965923|470875013|FG011|Overall Study|Death|0|||
130794729|NCT03965923|470875002|FG000|Overall Study|Other reason|0|||
130794730|NCT03965923|470875003|FG001|Overall Study|Other reason|0|||
130794731|NCT03965923|470875004|FG002|Overall Study|Other reason|0|||
130794732|NCT03965923|470875005|FG003|Overall Study|Other reason|1|||
130794733|NCT03965923|470875006|FG004|Overall Study|Other reason|0|||
130794734|NCT03965923|470875007|FG005|Overall Study|Other reason|0|||
130794735|NCT03965923|470875008|FG006|Overall Study|Other reason|0|||
130794736|NCT03965923|470875009|FG007|Overall Study|Other reason|0|||
130794737|NCT03965923|470875010|FG008|Overall Study|Other reason|0|||
130794738|NCT03965923|470875011|FG009|Overall Study|Other reason|0|||
130794739|NCT03965923|470875012|FG010|Overall Study|Other reason|2|||
130794740|NCT03965923|470875013|FG011|Overall Study|Other reason|0|||
130794741|NCT05513950|470875016|FG000|Overall Study|Not treated due to technical reasons|0|||
130794742|NCT05513950|470875017|FG001|Overall Study|Not treated due to technical reasons|0|||
130794743|NCT05513950|470875018|FG002|Overall Study|Not treated due to technical reasons|1|||
130794744|NCT05513950|470875019|FG003|Overall Study|Not treated due to technical reasons|0|||
130794745|NCT02337829|470875021|FG000|Overall Study|Death|0|||
130794746|NCT02337829|470875022|FG001|Overall Study|Death|1|||
130794747|NCT02337829|470875023|FG002|Overall Study|Death|0|||
130794748|NCT02337829|470875024|FG003|Overall Study|Death|0|||
130794749|NCT02337829|470875021|FG000|Overall Study|Study terminated by sponsor|12|||
130794750|NCT02337829|470875022|FG001|Overall Study|Study terminated by sponsor|10|||
130794751|NCT02337829|470875023|FG002|Overall Study|Study terminated by sponsor|5|||
130794752|NCT02337829|470875024|FG003|Overall Study|Study terminated by sponsor|6|||
130794753|NCT02337829|470875021|FG000|Overall Study|discontinued for other reasons|6|||
130794754|NCT02337829|470875022|FG001|Overall Study|discontinued for other reasons|3|||
130794755|NCT02337829|470875023|FG002|Overall Study|discontinued for other reasons|1|||
130794756|NCT02337829|470875024|FG003|Overall Study|discontinued for other reasons|4|||
130794757|NCT03330197|470875025|FG000|Overall Study|Adverse Event|0|||
130794758|NCT03330197|470875026|FG001|Overall Study|Adverse Event|1|||
130794759|NCT03330197|470875025|FG000|Overall Study|Withdrawal by Subject|0|||
130794760|NCT03330197|470875026|FG001|Overall Study|Withdrawal by Subject|1|||
130794761|NCT04221490|470875027|FG000|At 30 Days Follow-up|Death|7|||
130794762|NCT04221490|470875027|FG000|At 30 Days Follow-up|Missed Visit|4|||
130794763|NCT04221490|470875027|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
130794764|NCT04221490|470875027|FG000|At 6 Months Follow-up|Death|9|||
130794765|NCT04221490|470875027|FG000|At 6 Months Follow-up|Physician Decision|1|||
130794766|NCT04221490|470875027|FG000|At 6 Months Follow-up|Missed Visit|8|||
130794767|NCT04221490|470875027|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
130794768|NCT04225039|470875034|FG000|Overall Study|Withdrawal by Subject|1|||
130794769|NCT04225039|470875035|FG001|Overall Study|Withdrawal by Subject|0|||
130794770|NCT04225039|470875036|FG002|Overall Study|Withdrawal by Subject|0|||
130794771|NCT04225039|470875037|FG003|Overall Study|Withdrawal by Subject|1|||
130794772|NCT04225039|470875034|FG000|Overall Study|Currently active on study treatment|0|||
130794773|NCT04225039|470875035|FG001|Overall Study|Currently active on study treatment|1|||
130794774|NCT04225039|470875036|FG002|Overall Study|Currently active on study treatment|0|||
130794775|NCT04225039|470875037|FG003|Overall Study|Currently active on study treatment|0|||
130794776|NCT04225039|470875034|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
130794777|NCT04225039|470875035|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
130794778|NCT04225039|470875036|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
130794779|NCT04225039|470875037|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
130794780|NCT04225039|470875034|FG000|Overall Study|Ineligible for treatment|0|||
130794781|NCT04225039|470875035|FG001|Overall Study|Ineligible for treatment|0|||
130794782|NCT04225039|470875036|FG002|Overall Study|Ineligible for treatment|0|||
130794783|NCT04225039|470875037|FG003|Overall Study|Ineligible for treatment|4|||
130794784|NCT03197129|470875041|FG000|Overall Study|did not answer the VPT: shyness|4|||
130794785|NCT03197129|470875042|FG001|Overall Study|did not answer the VPT: shyness|5|||
130794786|NCT01564407|470875043|FG000|Overall Study|Lost to Follow-up|0|||
130794787|NCT01564407|470875044|FG001|Overall Study|Lost to Follow-up|1|||
130794788|NCT01564407|470875045|FG002|Overall Study|Lost to Follow-up|0|||
130794789|NCT01564407|470875046|FG003|Overall Study|Lost to Follow-up|0|||
130794790|NCT01564407|470875047|FG004|Overall Study|Lost to Follow-up|0|||
130794791|NCT01564407|470875043|FG000|Overall Study|Withdrawal by Subject|0|||
130794792|NCT01564407|470875044|FG001|Overall Study|Withdrawal by Subject|1|||
130794793|NCT01564407|470875045|FG002|Overall Study|Withdrawal by Subject|0|||
130794794|NCT01564407|470875046|FG003|Overall Study|Withdrawal by Subject|0|||
130794795|NCT01564407|470875047|FG004|Overall Study|Withdrawal by Subject|0|||
130794796|NCT01564407|470875043|FG000|Overall Study|funding lost, study ended|0|||
130762469|NCT01752634|470753322|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
130762470|NCT01752634|470753317|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130762471|NCT01752634|470753318|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
130762472|NCT01752634|470753319|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130762473|NCT01752634|470753320|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130762474|NCT01752634|470753321|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130762475|NCT01752634|470753322|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130762476|NCT01752634|470753317|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
130762477|NCT01752634|470753318|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
130762478|NCT01752634|470753319|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
130762479|NCT01752634|470753320|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
130762480|NCT01752634|470753321|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
130762481|NCT01752634|470753322|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
130762482|NCT01752634|470753317|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
130762483|NCT01752634|470753318|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
130762484|NCT01752634|470753319|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
130762485|NCT01752634|470753320|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
130762486|NCT01752634|470753321|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
130762487|NCT01752634|470753322|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
130762488|NCT01752634|470753317|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
130762489|NCT01752634|470753318|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
130762490|NCT01752634|470753319|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
130762491|NCT01752634|470753320|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
130762492|NCT01752634|470753321|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
130762493|NCT01752634|470753322|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
130762494|NCT01752634|470753317|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
130762495|NCT01752634|470753318|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
130762496|NCT01752634|470753319|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
130762497|NCT01752634|470753320|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
130762498|NCT01752634|470753321|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
130762499|NCT01752634|470753322|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
130762500|NCT01752634|470753317|FG000|Week 24 to Week 260|Physician Decision|1|||
130762501|NCT01752634|470753318|FG001|Week 24 to Week 260|Physician Decision|2|||
130762502|NCT01752634|470753319|FG002|Week 24 to Week 260|Physician Decision|4|||
130762503|NCT01752634|470753320|FG003|Week 24 to Week 260|Physician Decision|2|||
130762504|NCT01752634|470753321|FG004|Week 24 to Week 260|Physician Decision|1|||
130762505|NCT01752634|470753322|FG005|Week 24 to Week 260|Physician Decision|0|||
130762506|NCT01752634|470753317|FG000|Week 24 to Week 260|Death|0|||
130762507|NCT01752634|470753318|FG001|Week 24 to Week 260|Death|1|||
130762508|NCT01752634|470753319|FG002|Week 24 to Week 260|Death|0|||
130762509|NCT01752634|470753320|FG003|Week 24 to Week 260|Death|0|||
130762510|NCT01752634|470753321|FG004|Week 24 to Week 260|Death|0|||
130762511|NCT01752634|470753322|FG005|Week 24 to Week 260|Death|0|||
130762512|NCT01752634|470753317|FG000|Week 24 to Week 260|Pregnancy|0|||
130762513|NCT01752634|470753318|FG001|Week 24 to Week 260|Pregnancy|0|||
130762514|NCT01752634|470753319|FG002|Week 24 to Week 260|Pregnancy|1|||
130762515|NCT01752634|470753320|FG003|Week 24 to Week 260|Pregnancy|0|||
130762516|NCT01752634|470753321|FG004|Week 24 to Week 260|Pregnancy|0|||
130762517|NCT01752634|470753322|FG005|Week 24 to Week 260|Pregnancy|0|||
130762518|NCT01752634|470753317|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
130762519|NCT01752634|470753318|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
130762520|NCT01752634|470753319|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
130762521|NCT01752634|470753320|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
130762522|NCT01752634|470753321|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
130762523|NCT01752634|470753322|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
130762524|NCT01752634|470753317|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
130762525|NCT01752634|470753318|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
130762526|NCT01752634|470753319|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
130762527|NCT01752634|470753320|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
130762528|NCT01752634|470753321|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
130762529|NCT01752634|470753322|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
130762530|NCT01752634|470753317|FG000|Week 24 to Week 260|Adverse Event|4|||
130762531|NCT01752634|470753318|FG001|Week 24 to Week 260|Adverse Event|8|||
130762532|NCT01752634|470753319|FG002|Week 24 to Week 260|Adverse Event|8|||
130762533|NCT01752634|470753320|FG003|Week 24 to Week 260|Adverse Event|4|||
130762534|NCT01752634|470753321|FG004|Week 24 to Week 260|Adverse Event|2|||
130762535|NCT01752634|470753322|FG005|Week 24 to Week 260|Adverse Event|0|||
130762536|NCT01250171|470753323|FG000|Overall Study|Administrative reasons|1|||
130762537|NCT01250171|470753324|FG001|Overall Study|Administrative reasons|0|||
130762538|NCT01250171|470753325|FG002|Overall Study|Administrative reasons|0|||
130762539|NCT04250714|470753335|FG000|Overall Study|Treatment - withdrawal by subject|14|||
130762540|NCT04250714|470753335|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
130762541|NCT04250714|470753335|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
130794797|NCT01564407|470875044|FG001|Overall Study|funding lost, study ended|0|||
130794798|NCT01564407|470875045|FG002|Overall Study|funding lost, study ended|0|||
130794799|NCT01564407|470875046|FG003|Overall Study|funding lost, study ended|1|||
130794800|NCT01564407|470875047|FG004|Overall Study|funding lost, study ended|0|||
130794801|NCT00157755|470875050|FG000|Overall Study|Death|2|||
130794802|NCT00157755|470875051|FG001|Overall Study|Death|3|||
130794803|NCT00157755|470875052|FG002|Overall Study|Death|3|||
130794804|NCT00157755|470875053|FG003|Overall Study|Death|2|||
130794805|NCT00157755|470875054|FG004|Overall Study|Death|0|||
130794806|NCT00157755|470875055|FG005|Overall Study|Death|0|||
130794807|NCT00157755|470875050|FG000|Overall Study|Lost to Follow-up|0|||
130794808|NCT00157755|470875051|FG001|Overall Study|Lost to Follow-up|0|||
130794809|NCT00157755|470875052|FG002|Overall Study|Lost to Follow-up|1|||
130794810|NCT00157755|470875053|FG003|Overall Study|Lost to Follow-up|0|||
130794811|NCT00157755|470875054|FG004|Overall Study|Lost to Follow-up|0|||
130794812|NCT00157755|470875055|FG005|Overall Study|Lost to Follow-up|0|||
130794813|NCT00157755|470875050|FG000|Overall Study|Withdrawal by Subject|0|||
130794814|NCT00157755|470875051|FG001|Overall Study|Withdrawal by Subject|0|||
130794815|NCT00157755|470875052|FG002|Overall Study|Withdrawal by Subject|1|||
130794816|NCT00157755|470875053|FG003|Overall Study|Withdrawal by Subject|1|||
130794817|NCT00157755|470875054|FG004|Overall Study|Withdrawal by Subject|1|||
130794818|NCT00157755|470875055|FG005|Overall Study|Withdrawal by Subject|2|||
130794819|NCT00157755|470875050|FG000|Overall Study|Explant due to infection|0|||
130794820|NCT00157755|470875051|FG001|Overall Study|Explant due to infection|0|||
130794821|NCT00157755|470875052|FG002|Overall Study|Explant due to infection|1|||
130794822|NCT00157755|470875053|FG003|Overall Study|Explant due to infection|0|||
130794823|NCT00157755|470875054|FG004|Overall Study|Explant due to infection|0|||
130794824|NCT00157755|470875055|FG005|Overall Study|Explant due to infection|0|||
130794825|NCT00157755|470875050|FG000|Overall Study|Medical reason|0|||
130794826|NCT00157755|470875051|FG001|Overall Study|Medical reason|0|||
130794827|NCT00157755|470875052|FG002|Overall Study|Medical reason|1|||
130794828|NCT00157755|470875053|FG003|Overall Study|Medical reason|1|||
130794829|NCT00157755|470875054|FG004|Overall Study|Medical reason|0|||
130794830|NCT00157755|470875055|FG005|Overall Study|Medical reason|0|||
130794831|NCT00157755|470875050|FG000|Overall Study|Study site closure|0|||
130794832|NCT00157755|470875051|FG001|Overall Study|Study site closure|1|||
130794833|NCT00157755|470875052|FG002|Overall Study|Study site closure|0|||
130794834|NCT00157755|470875053|FG003|Overall Study|Study site closure|0|||
130794835|NCT00157755|470875054|FG004|Overall Study|Study site closure|0|||
130794836|NCT00157755|470875055|FG005|Overall Study|Study site closure|0|||
130794837|NCT00157755|470875050|FG000|Overall Study|Subject non-compliance|0|||
130794838|NCT00157755|470875051|FG001|Overall Study|Subject non-compliance|0|||
130794839|NCT00157755|470875052|FG002|Overall Study|Subject non-compliance|0|||
130794840|NCT00157755|470875053|FG003|Overall Study|Subject non-compliance|0|||
130794841|NCT00157755|470875054|FG004|Overall Study|Subject non-compliance|0|||
130794842|NCT00157755|470875055|FG005|Overall Study|Subject non-compliance|1|||
130794843|NCT00157755|470875050|FG000|Overall Study|Study completion|0|||
130794844|NCT00157755|470875051|FG001|Overall Study|Study completion|0|||
130794845|NCT00157755|470875052|FG002|Overall Study|Study completion|0|||
130794846|NCT00157755|470875053|FG003|Overall Study|Study completion|0|||
130794847|NCT00157755|470875054|FG004|Overall Study|Study completion|1|||
130794848|NCT00157755|470875055|FG005|Overall Study|Study completion|2|||
130794849|NCT05523297|470875060|FG000|Overall Study|Death|7|||
130794850|NCT05523297|470875061|FG001|Overall Study|Death|8|||
130794851|NCT05523297|470875060|FG000|Overall Study|Lost to Follow-up|2|||
130794852|NCT05523297|470875061|FG001|Overall Study|Lost to Follow-up|1|||
130794853|NCT03462680|470875062|FG000|Overall Study|Withdrawal by Subject|3|||
130794854|NCT03462680|470875063|FG001|Overall Study|Withdrawal by Subject|5|||
130794855|NCT02246777|470875064|FG000|Overall Study|Adverse Event|2|||
130794856|NCT02246777|470875064|FG000|Overall Study|Change of residence|1|||
130794857|NCT04133909|470875065|FG000|Overall Study|Death|11|||
130794858|NCT04133909|470875066|FG001|Overall Study|Death|11|||
130794859|NCT04133909|470875065|FG000|Overall Study|Adverse Event|4|||
130794860|NCT04133909|470875066|FG001|Overall Study|Adverse Event|5|||
130794861|NCT04133909|470875065|FG000|Overall Study|Lost to Follow-up|3|||
130794862|NCT04133909|470875066|FG001|Overall Study|Lost to Follow-up|5|||
130794863|NCT04133909|470875065|FG000|Overall Study|Physician Decision|4|||
130794864|NCT04133909|470875066|FG001|Overall Study|Physician Decision|7|||
130794865|NCT04133909|470875065|FG000|Overall Study|Withdrawal by Subject|40|||
130794866|NCT04133909|470875066|FG001|Overall Study|Withdrawal by Subject|35|||
130794867|NCT04133909|470875065|FG000|Overall Study|Lack of Efficacy|2|||
130794868|NCT04133909|470875066|FG001|Overall Study|Lack of Efficacy|7|||
130794869|NCT04133909|470875065|FG000|Overall Study|Randomized in error|1|||
130794870|NCT04133909|470875066|FG001|Overall Study|Randomized in error|1|||
130794871|NCT04817410|470877347|FG000|Overall Study|Withdrawal by Subject|5|||
130794872|NCT04817410|470877347|FG000|Overall Study|Physician Decision|3|||
130794873|NCT03595748|470877348|FG000|Overall Study|Death|11|||
130794874|NCT03595748|470877349|FG001|Overall Study|Death|12|||
130794875|NCT03595748|470877348|FG000|Overall Study|Withdrawal by Subject|28|||
130794876|NCT03595748|470877349|FG001|Overall Study|Withdrawal by Subject|29|||
130794877|NCT03595748|470877348|FG000|Overall Study|Protocol Violation|0|||
130794878|NCT03595748|470877349|FG001|Overall Study|Protocol Violation|1|||
130794879|NCT04809974|470877351|FG000|Lead-in Phase|Withdrawal by Subject|3|||
130794880|NCT04809974|470877352|FG001|Lead-in Phase|Withdrawal by Subject|0|||
130794881|NCT04809974|470877353|FG002|Lead-in Phase|Withdrawal by Subject|0|||
130794882|NCT04809974|470877351|FG000|Lead-in Phase|No longer eligible|11|||
130794883|NCT04809974|470877352|FG001|Lead-in Phase|No longer eligible|0|||
130794884|NCT04809974|470877353|FG002|Lead-in Phase|No longer eligible|0|||
130794885|NCT04809974|470877351|FG000|Randomized Phase|Lost to Follow-up|0|||
130794886|NCT04809974|470877352|FG001|Randomized Phase|Lost to Follow-up|1|||
130794887|NCT04809974|470877353|FG002|Randomized Phase|Lost to Follow-up|5|||
130794888|NCT04809974|470877351|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
130794889|NCT04809974|470877352|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
130794890|NCT04809974|470877353|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
130794891|NCT04809974|470877351|FG000|Randomized Phase|Adverse Event|0|||
130794892|NCT04809974|470877352|FG001|Randomized Phase|Adverse Event|1|||
130794893|NCT04809974|470877353|FG002|Randomized Phase|Adverse Event|4|||
130794894|NCT04809974|470877351|FG000|Randomized Phase|Withdrawal by Subject|0|||
130794895|NCT04809974|470877352|FG001|Randomized Phase|Withdrawal by Subject|0|||
130794896|NCT04809974|470877353|FG002|Randomized Phase|Withdrawal by Subject|5|||
130794897|NCT05493111|470877354|FG000|Overall Study|Adverse Event|3|||
130794898|NCT05493111|470877355|FG001|Overall Study|Adverse Event|4|||
130794899|NCT05493111|470877354|FG000|Overall Study|Withdrawal of Consent|19|||
130794900|NCT05493111|470877355|FG001|Overall Study|Withdrawal of Consent|10|||
130794901|NCT05493111|470877354|FG000|Overall Study|Non-compliance|1|||
130794902|NCT05493111|470877355|FG001|Overall Study|Non-compliance|1|||
130794903|NCT05493111|470877354|FG000|Overall Study|Lost to Follow-up|8|||
130794904|NCT05493111|470877355|FG001|Overall Study|Lost to Follow-up|1|||
130794905|NCT05493111|470877354|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
130794906|NCT05493111|470877355|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
130794907|NCT05493111|470877354|FG000|Overall Study|Withdrawal by Subject|1|||
130794908|NCT05493111|470877355|FG001|Overall Study|Withdrawal by Subject|1|||
130794909|NCT06125964|470877356|FG000|Overall Study|Lost to Follow-up|0|||
130794910|NCT06125964|470877357|FG001|Overall Study|Lost to Follow-up|1|||
130794911|NCT06125964|470877358|FG002|Overall Study|Lost to Follow-up|0|||
130794912|NCT06125964|470877359|FG003|Overall Study|Lost to Follow-up|0|||
130794913|NCT01787838|470877360|FG000|Overall Study|refused|1413|||
130794914|NCT01431976|470877361|FG000|Overall Study|Adverse Event|6|||
130794915|NCT01431976|470877361|FG000|Overall Study|Lack of Efficacy|2|||
130794916|NCT01431976|470877361|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
130794917|NCT01431976|470877361|FG000|Overall Study|Physician Decision|1|||
130794918|NCT01431976|470877361|FG000|Overall Study|Withdrawal by Subject|1|||
130794919|NCT01136954|470877367|FG000|Overall Study|Adverse Event|3|||
130794920|NCT01136954|470877368|FG001|Overall Study|Adverse Event|2|||
130794921|NCT01136954|470877367|FG000|Overall Study|Withdrawal by Subject|6|||
130794922|NCT01136954|470877368|FG001|Overall Study|Withdrawal by Subject|2|||
130794923|NCT01136954|470877367|FG000|Overall Study|Lack of Efficacy|14|||
130794924|NCT01136954|470877368|FG001|Overall Study|Lack of Efficacy|13|||
130794925|NCT01136954|470877367|FG000|Overall Study|Physician Decision|0|||
130794926|NCT01136954|470877368|FG001|Overall Study|Physician Decision|1|||
130794927|NCT01136954|470877367|FG000|Overall Study|Other|1|||
130794928|NCT01136954|470877368|FG001|Overall Study|Other|3|||
130794929|NCT00782067|470877369|FG000|Overall Study|Adverse Event|35|||
130794930|NCT00782067|470877369|FG000|Overall Study|Subject withdrew consent|11|||
130794931|NCT00782067|470877369|FG000|Overall Study|Lost to Follow-up|2|||
130794932|NCT00782067|470877369|FG000|Overall Study|Administrative problems|14|||
130794933|NCT00782067|470877369|FG000|Overall Study|Death|9|||
130794934|NCT00782067|470877369|FG000|Overall Study|Disease progression|43|||
130794935|NCT00782067|470877369|FG000|Overall Study|Protocol deviation|2|||
130794936|NCT00973973|470877377|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
130794937|NCT00973973|470877378|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
130794938|NCT00973973|470877377|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
130794939|NCT00973973|470877378|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
130794940|NCT00973973|470877377|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
130794941|NCT00973973|470877378|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
130794942|NCT00973973|470877377|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
130794943|NCT00973973|470877378|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
130794944|NCT00973973|470877377|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
130794945|NCT00973973|470877378|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
130794946|NCT00973973|470877377|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
130794947|NCT00973973|470877378|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
130794948|NCT00973973|470877377|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
130794949|NCT00973973|470877378|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
130794950|NCT00973973|470877377|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
130794951|NCT00973973|470877378|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
130794952|NCT00973973|470877377|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
130794953|NCT00973973|470877378|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
130794954|NCT00973973|470877377|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
130794955|NCT00973973|470877378|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
130794956|NCT00973973|470877377|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
130794957|NCT00973973|470877378|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
130794958|NCT00973973|470877377|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
130794959|NCT00973973|470877378|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
130794960|NCT02020941|470877379|FG000|Overall Study|Adverse Event|1|||
130794961|NCT02020941|470877379|FG000|Overall Study|Physician Decision|2|||
130794962|NCT02020941|470877379|FG000|Overall Study|Withdrawal by Subject|1|||
130794963|NCT02020941|470877379|FG000|Overall Study|Disease Progression|4|||
130794964|NCT00620542|470877381|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
130794965|NCT00620542|470877382|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
130794966|NCT00620542|470877383|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
130794967|NCT00620542|470877384|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
130794968|NCT00620542|470877381|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
130794969|NCT00620542|470877382|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
130794970|NCT00620542|470877383|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130794971|NCT00620542|470877384|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130794972|NCT00620542|470877381|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
130794973|NCT00620542|470877382|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
130794974|NCT00620542|470877383|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
130794975|NCT00620542|470877384|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
130794976|NCT00620542|470877381|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
130794977|NCT00620542|470877382|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
130794978|NCT00620542|470877383|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
130794979|NCT00620542|470877384|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
130794980|NCT00620542|470877381|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130794981|NCT00620542|470877382|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
130794982|NCT00620542|470877383|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130794983|NCT00620542|470877384|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130794984|NCT00620542|470877381|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
130794985|NCT00620542|470877382|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
130794986|NCT00620542|470877383|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
130794987|NCT00620542|470877384|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
130794988|NCT00620542|470877381|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
130794989|NCT00620542|470877382|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
130794990|NCT00620542|470877383|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
130794991|NCT00620542|470877384|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
130794992|NCT00620542|470877381|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
130794993|NCT00620542|470877382|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
130794994|NCT00620542|470877383|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
130794995|NCT00620542|470877384|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
130794996|NCT00620542|470877381|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
130822787|NCT01815424|470980601|FG004|Week 0 to 16|Protocol Violation|0|||
130794997|NCT00620542|470877382|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
130794998|NCT00620542|470877383|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
130794999|NCT00620542|470877384|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
130795000|NCT00620542|470877381|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
130795001|NCT00620542|470877382|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
130795002|NCT00620542|470877383|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
130795003|NCT00620542|470877384|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
130795004|NCT00620542|470877381|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
130795005|NCT00620542|470877382|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
130795006|NCT00620542|470877383|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
130795007|NCT00620542|470877384|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
130795008|NCT00620542|470877381|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
130795009|NCT00620542|470877382|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
130795010|NCT00620542|470877383|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
130795011|NCT00620542|470877384|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
130795012|NCT00620542|470877381|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
130795013|NCT00620542|470877382|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
130795014|NCT00620542|470877383|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
130795015|NCT00620542|470877384|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
130795016|NCT00620542|470877381|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
130795017|NCT00620542|470877382|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
130795018|NCT00620542|470877383|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
130795019|NCT00620542|470877384|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
130795020|NCT00620542|470877381|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
130795021|NCT00620542|470877382|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
130795022|NCT00620542|470877383|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
130795023|NCT00620542|470877384|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
130795024|NCT01970371|470877391|FG000|Overall Study|Death|8|||
130795025|NCT01970371|470877392|FG001|Overall Study|Death|13|||
130795026|NCT01970371|470877393|FG002|Overall Study|Death|12|||
130795027|NCT01970371|470877391|FG000|Overall Study|Lost to Follow-up|0|||
130795028|NCT01970371|470877392|FG001|Overall Study|Lost to Follow-up|0|||
130795029|NCT01970371|470877393|FG002|Overall Study|Lost to Follow-up|1|||
130795030|NCT03483103|470877394|FG000|Pre-Treatment Phase|Other reasons|1|||
130795031|NCT03483103|470877394|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
130795032|NCT03483103|470877394|FG000|Pre-Treatment Phase|Disease-related complications|1|||
130795033|NCT03483103|470877394|FG000|Pre-Treatment Phase|Death|5|||
130795034|NCT03483103|470877394|FG000|Treatment Phase|Withdrawal by Subject|7|||
130795035|NCT03483103|470877394|FG000|Treatment Phase|Other reasons|1|||
130795036|NCT03483103|470877394|FG000|Treatment Phase|Death|23|||
130795037|NCT03483103|470877394|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
130795038|NCT03483103|470877394|FG000|Treatment Phase|Received nonconforming product|1|||
130795039|NCT02239328|470877395|FG000|Overall Study|Benign disease noted at time of surgery|6|||
130795040|NCT02239328|470877395|FG000|Overall Study|Equipment or website malfunction|2|||
130795041|NCT01348269|470877396|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
130795042|NCT01348269|470877397|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
130795043|NCT01348269|470877396|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
130795044|NCT01348269|470877397|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
130795045|NCT01348269|470877396|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
130795046|NCT01348269|470877397|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
130795047|NCT04727749|470877398|FG000|Overall Study|Lost to Follow-up|10|||
130795048|NCT04727749|470877399|FG001|Overall Study|Lost to Follow-up|3|||
130795049|NCT01481779|470877400|FG000|Overall Study|Adverse Event|23|||
130795050|NCT01481779|470877401|FG001|Overall Study|Adverse Event|5|||
130795051|NCT01481779|470877400|FG000|Overall Study|Lost to Follow-up|3|||
130795052|NCT01481779|470877401|FG001|Overall Study|Lost to Follow-up|2|||
130795053|NCT01481779|470877400|FG000|Overall Study|Protocol Violation|2|||
130795054|NCT01481779|470877401|FG001|Overall Study|Protocol Violation|3|||
130795055|NCT01481779|470877400|FG000|Overall Study|Withdrawal by Subject|26|||
130795056|NCT01481779|470877401|FG001|Overall Study|Withdrawal by Subject|13|||
130795057|NCT01481779|470877400|FG000|Overall Study|Physician Decision|13|||
130795058|NCT01481779|470877401|FG001|Overall Study|Physician Decision|4|||
130795059|NCT01481779|470877400|FG000|Overall Study|Sponsor Decision|3|||
130795060|NCT01481779|470877401|FG001|Overall Study|Sponsor Decision|1|||
130795061|NCT02378181|470877402|FG000|Overall Study|Lost to Follow-up|2|||
130795062|NCT02378181|470877403|FG001|Overall Study|Lost to Follow-up|5|||
130795063|NCT02378181|470877402|FG000|Overall Study|Withdrawal by Subject|1|||
130795064|NCT02378181|470877403|FG001|Overall Study|Withdrawal by Subject|1|||
130795065|NCT02378181|470877402|FG000|Overall Study|Incarcerated|0|||
130795066|NCT02378181|470877403|FG001|Overall Study|Incarcerated|1|||
130795067|NCT04115059|470877407|FG000|Overall Study|Withdrawal by Subject|1|||
130795068|NCT04115059|470877407|FG000|Overall Study|Lack of Efficacy|2|||
130795069|NCT03575364|470877415|FG000|Overall Study|Death|45|||
130795070|NCT03575364|470877415|FG000|Overall Study|Lost to Follow-up|114|||
130795071|NCT03575364|470877415|FG000|Overall Study|Withdrawal by Subject|21|||
130795072|NCT03575364|470877415|FG000|Overall Study|Physician Decision|11|||
130795073|NCT03575364|470877415|FG000|Overall Study|Subject Refused Follow-up|13|||
130795074|NCT03575364|470877415|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
130795075|NCT03575364|470877415|FG000|Overall Study|Patient moved out of the state|1|||
130795076|NCT03575364|470877415|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
130795077|NCT03575364|470877415|FG000|Overall Study|Patient is lost to follow up|1|||
130795078|NCT03575364|470877415|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
130795079|NCT06420232|470877417|FG000|Overall Study|Withdrawal by Subject|3|||
130795080|NCT02313155|470877418|FG000|Overall Study|Lost to Follow-up|0|||
130795081|NCT02313155|470877419|FG001|Overall Study|Lost to Follow-up|1|||
130795082|NCT00689936|470877420|FG000|Active Treatment Phase|Adverse Event|68|||
130795083|NCT00689936|470877421|FG001|Active Treatment Phase|Adverse Event|71|||
130795084|NCT00689936|470877422|FG002|Active Treatment Phase|Adverse Event|76|||
130795085|NCT00689936|470877420|FG000|Active Treatment Phase|Disease Progression|273|||
130795086|NCT00689936|470877421|FG001|Active Treatment Phase|Disease Progression|362|||
130795087|NCT00689936|470877422|FG002|Active Treatment Phase|Disease Progression|339|||
130795088|NCT00689936|470877420|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
130795089|NCT00689936|470877421|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
130795090|NCT00689936|470877422|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
130795091|NCT00689936|470877420|FG000|Active Treatment Phase|Death|60|||
130795092|NCT00689936|470877421|FG001|Active Treatment Phase|Death|28|||
130795093|NCT00689936|470877422|FG002|Active Treatment Phase|Death|37|||
130795094|NCT00689936|470877420|FG000|Active Treatment Phase|Lost to Follow-up|0|||
130795095|NCT00689936|470877421|FG001|Active Treatment Phase|Lost to Follow-up|2|||
130795096|NCT00689936|470877422|FG002|Active Treatment Phase|Lost to Follow-up|2|||
130795097|NCT00689936|470877420|FG000|Active Treatment Phase|Protocol Violation|2|||
130795098|NCT00689936|470877421|FG001|Active Treatment Phase|Protocol Violation|2|||
130795099|NCT00689936|470877422|FG002|Active Treatment Phase|Protocol Violation|4|||
130795100|NCT00689936|470877420|FG000|Active Treatment Phase|Study Close Out|64|||
130795101|NCT00689936|470877421|FG001|Active Treatment Phase|Study Close Out|26|||
130795102|NCT00689936|470877422|FG002|Active Treatment Phase|Study Close Out|21|||
130795103|NCT00689936|470877420|FG000|Active Treatment Phase|Miscellaneous|52|||
130795104|NCT00689936|470877421|FG001|Active Treatment Phase|Miscellaneous|34|||
130795105|NCT00689936|470877422|FG002|Active Treatment Phase|Miscellaneous|47|||
130795106|NCT00689936|470877420|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
130795107|NCT00689936|470877421|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
130795108|NCT00689936|470877422|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
130795109|NCT01303419|470877423|FG000|Overall Study|Discontinuation of study|60|||
130795110|NCT01303419|470877423|FG000|Overall Study|Did not complete both imaging methods|5|||
130795111|NCT01303419|470877423|FG000|Overall Study|Did not meet all I/E after screening|31|||
130795112|NCT00311168|470877426|FG000|First Intervention|Withdrawal by Subject|2|||
130795113|NCT00311168|470877427|FG001|First Intervention|Withdrawal by Subject|2|||
130795114|NCT00311168|470877426|FG000|First Intervention|Lost to Follow-up|1|||
130795115|NCT00311168|470877427|FG001|First Intervention|Lost to Follow-up|1|||
130795116|NCT00311168|470877426|FG000|First Intervention|Protocol Violation|1|||
130795117|NCT00311168|470877427|FG001|First Intervention|Protocol Violation|1|||
130795118|NCT00311168|470877426|FG000|First Intervention|Adverse Event|1|||
130795119|NCT00311168|470877427|FG001|First Intervention|Adverse Event|0|||
130795120|NCT00311168|470877426|FG000|First Intervention|Other|2|||
130795121|NCT00311168|470877427|FG001|First Intervention|Other|2|||
130795122|NCT00311168|470877426|FG000|Second Intervention|Lost to Follow-up|9|||
130795123|NCT00311168|470877427|FG001|Second Intervention|Lost to Follow-up|2|||
130795124|NCT00311168|470877426|FG000|Second Intervention|Withdrawal by Subject|0|||
130795125|NCT00311168|470877427|FG001|Second Intervention|Withdrawal by Subject|1|||
130795126|NCT00311168|470877426|FG000|Second Intervention|Other|1|||
130795127|NCT00311168|470877427|FG001|Second Intervention|Other|1|||
130795128|NCT02213926|470877430|FG000|Overall Study|Death|59|||
130795129|NCT02213926|470877430|FG000|Overall Study|Withdrawal by Subject|10|||
130795130|NCT02213926|470877430|FG000|Overall Study|study terminated by sponsor|51|||
130795131|NCT02213926|470877430|FG000|Overall Study|Lost to Follow-up|3|||
130795132|NCT02213926|470877430|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
130795133|NCT01697579|470877431|FG000|Base Study-Cycle 1|Adverse Event|1|||
130795134|NCT01697579|470877432|FG001|Base Study-Cycle 1|Adverse Event|0|||
130795135|NCT01697579|470877433|FG002|Base Study-Cycle 1|Adverse Event|0|||
130795136|NCT01697579|470877434|FG003|Base Study-Cycle 1|Adverse Event|0|||
130795137|NCT01697579|470877435|FG004|Base Study-Cycle 1|Adverse Event|0|||
130795138|NCT01697579|470877436|FG005|Base Study-Cycle 1|Adverse Event|0|||
130795139|NCT01697579|470877437|FG006|Base Study-Cycle 1|Adverse Event|0|||
130795140|NCT01697579|470877431|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
130795141|NCT01697579|470877432|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130795142|NCT01697579|470877433|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130795143|NCT01697579|470877434|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130795144|NCT01697579|470877435|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130795145|NCT01697579|470877436|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130795146|NCT01697579|470877437|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130795147|NCT01697579|470877431|FG000|Base Study-Cycle 1|Protocol Violation|0|||
130795148|NCT01697579|470877432|FG001|Base Study-Cycle 1|Protocol Violation|0|||
130795149|NCT01697579|470877433|FG002|Base Study-Cycle 1|Protocol Violation|0|||
130795150|NCT01697579|470877434|FG003|Base Study-Cycle 1|Protocol Violation|0|||
130795151|NCT01697579|470877435|FG004|Base Study-Cycle 1|Protocol Violation|3|||
130795152|NCT01697579|470877436|FG005|Base Study-Cycle 1|Protocol Violation|0|||
130795153|NCT01697579|470877437|FG006|Base Study-Cycle 1|Protocol Violation|0|||
130795154|NCT01697579|470877431|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130795155|NCT01697579|470877432|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
130795156|NCT01697579|470877433|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130795157|NCT01697579|470877434|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130795158|NCT01697579|470877435|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130795159|NCT01697579|470877436|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130795160|NCT01697579|470877437|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130795161|NCT01697579|470877431|FG000|Base Study-Cycle 1|Technical Problems|0|||
130795162|NCT01697579|470877432|FG001|Base Study-Cycle 1|Technical Problems|0|||
130795163|NCT01697579|470877433|FG002|Base Study-Cycle 1|Technical Problems|1|||
130795164|NCT01697579|470877434|FG003|Base Study-Cycle 1|Technical Problems|1|||
130795165|NCT01697579|470877435|FG004|Base Study-Cycle 1|Technical Problems|0|||
130795166|NCT01697579|470877436|FG005|Base Study-Cycle 1|Technical Problems|0|||
130795167|NCT01697579|470877437|FG006|Base Study-Cycle 1|Technical Problems|0|||
130795168|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Death|0|||
130795169|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Death|0|||
130795170|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Death|0|||
130795171|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Death|0|||
130795172|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Death|0|||
130795173|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Death|0|||
130795174|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Death|2|||
130795175|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130795176|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130795177|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130795178|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130795179|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130795180|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
130795181|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
130795182|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
130795183|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
130795184|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
130795185|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
130795186|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
130795187|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
130795188|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
130795189|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130795190|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130795191|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130795192|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130795193|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130762542|NCT04250714|470753335|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
130795194|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130795195|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
130795196|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130795197|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130795198|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130795199|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130795200|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130795201|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
130795202|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
130795203|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130795204|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130795205|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130795206|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130795207|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130795208|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
130795209|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130795210|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130795211|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130795212|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130795213|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130795214|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130795215|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
130795216|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
130795217|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130795218|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130795219|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130795220|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130795221|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130795222|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
130795223|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
130795224|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130795225|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130795226|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130795227|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130795228|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130795229|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130795230|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
130795231|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
130795232|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
130795233|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
130795234|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
130795235|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
130795236|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
130795237|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
130795238|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
130795239|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
130795240|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
130795241|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
130795242|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
130795243|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
130795244|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
130795245|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130795246|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130795247|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130795248|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130795249|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130795250|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
130795251|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
130795252|NCT01697579|470877431|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130795253|NCT01697579|470877432|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130795254|NCT01697579|470877433|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130795255|NCT01697579|470877434|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130795256|NCT01697579|470877435|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130795257|NCT01697579|470877436|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130795258|NCT01697579|470877437|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
130795259|NCT02452190|470877438|FG000|Overall Study|Withdrawal by Sponsor|1|||
130795260|NCT02452190|470877439|FG001|Overall Study|Withdrawal by Sponsor|3|||
130795261|NCT02452190|470877438|FG000|Overall Study|Pregnancy|1|||
130795262|NCT02452190|470877439|FG001|Overall Study|Pregnancy|0|||
130795263|NCT02452190|470877438|FG000|Overall Study|Investigator's Decision|2|||
130795264|NCT02452190|470877439|FG001|Overall Study|Investigator's Decision|0|||
130795265|NCT02452190|470877438|FG000|Overall Study|Lack of Efficacy|3|||
130795266|NCT02452190|470877439|FG001|Overall Study|Lack of Efficacy|1|||
130795267|NCT02452190|470877438|FG000|Overall Study|Lost to Follow-up|4|||
130795268|NCT02452190|470877439|FG001|Overall Study|Lost to Follow-up|3|||
130795269|NCT02452190|470877438|FG000|Overall Study|Adverse Event|2|||
130795270|NCT02452190|470877439|FG001|Overall Study|Adverse Event|5|||
130795271|NCT02452190|470877438|FG000|Overall Study|Withdrawal by Subject|20|||
130795272|NCT02452190|470877439|FG001|Overall Study|Withdrawal by Subject|11|||
130795273|NCT02452190|470877438|FG000|Overall Study|Noncompliance with study drug|1|||
130795274|NCT02452190|470877439|FG001|Overall Study|Noncompliance with study drug|0|||
130795275|NCT02452190|470877438|FG000|Overall Study|Participant traveled abroad|1|||
130795276|NCT02452190|470877439|FG001|Overall Study|Participant traveled abroad|0|||
130795277|NCT02452190|470877438|FG000|Overall Study|Death|0|||
130795278|NCT02452190|470877439|FG001|Overall Study|Death|1|||
130795279|NCT01044498|470877440|FG000|Overall Study|Withdrew consent|1|||
130795280|NCT01044498|470877441|FG001|Overall Study|Withdrew consent|1|||
130795281|NCT01044498|470877440|FG000|Overall Study|Adverse Event|1|||
130795282|NCT01044498|470877441|FG001|Overall Study|Adverse Event|1|||
130795283|NCT01044498|470877440|FG000|Overall Study|Other|1|||
130795284|NCT01044498|470877441|FG001|Overall Study|Other|0|||
130795285|NCT02327078|470877446|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
130795286|NCT02327078|470877447|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
130795287|NCT02327078|470877448|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
130795288|NCT02327078|470877449|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
130795289|NCT02327078|470877450|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
130795290|NCT02327078|470877451|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
130795291|NCT02327078|470877452|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
130795292|NCT02327078|470877453|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
130795293|NCT02327078|470877454|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
130795294|NCT02327078|470877446|FG000|Overall Study|Death|2|||
130795295|NCT02327078|470877447|FG001|Overall Study|Death|4|||
130795296|NCT02327078|470877448|FG002|Overall Study|Death|10|||
130795297|NCT02327078|470877449|FG003|Overall Study|Death|6|||
130795298|NCT02327078|470877450|FG004|Overall Study|Death|4|||
130795299|NCT02327078|470877451|FG005|Overall Study|Death|3|||
130795300|NCT02327078|470877452|FG006|Overall Study|Death|2|||
130795301|NCT02327078|470877453|FG007|Overall Study|Death|51|||
130795302|NCT02327078|470877454|FG008|Overall Study|Death|97|||
130795303|NCT02327078|470877446|FG000|Overall Study|Lost to Follow-up|0|||
130795304|NCT02327078|470877447|FG001|Overall Study|Lost to Follow-up|1|||
130795305|NCT02327078|470877448|FG002|Overall Study|Lost to Follow-up|1|||
130795306|NCT02327078|470877449|FG003|Overall Study|Lost to Follow-up|0|||
130795307|NCT02327078|470877450|FG004|Overall Study|Lost to Follow-up|0|||
130795308|NCT02327078|470877451|FG005|Overall Study|Lost to Follow-up|0|||
130795309|NCT02327078|470877452|FG006|Overall Study|Lost to Follow-up|0|||
130795310|NCT02327078|470877453|FG007|Overall Study|Lost to Follow-up|2|||
130795311|NCT02327078|470877454|FG008|Overall Study|Lost to Follow-up|5|||
130795312|NCT02327078|470877446|FG000|Overall Study|Site Terminated by Sponsor|1|||
130795313|NCT02327078|470877447|FG001|Overall Study|Site Terminated by Sponsor|0|||
130795314|NCT02327078|470877448|FG002|Overall Study|Site Terminated by Sponsor|1|||
130795315|NCT02327078|470877449|FG003|Overall Study|Site Terminated by Sponsor|4|||
130795316|NCT02327078|470877450|FG004|Overall Study|Site Terminated by Sponsor|0|||
130795317|NCT02327078|470877451|FG005|Overall Study|Site Terminated by Sponsor|0|||
130795318|NCT02327078|470877452|FG006|Overall Study|Site Terminated by Sponsor|0|||
130795319|NCT02327078|470877453|FG007|Overall Study|Site Terminated by Sponsor|11|||
130795320|NCT02327078|470877454|FG008|Overall Study|Site Terminated by Sponsor|25|||
130795321|NCT02327078|470877446|FG000|Overall Study|Physician Decision|0|||
130795322|NCT02327078|470877447|FG001|Overall Study|Physician Decision|0|||
130795323|NCT02327078|470877448|FG002|Overall Study|Physician Decision|0|||
130795324|NCT02327078|470877449|FG003|Overall Study|Physician Decision|1|||
130795325|NCT02327078|470877450|FG004|Overall Study|Physician Decision|0|||
130795326|NCT02327078|470877451|FG005|Overall Study|Physician Decision|0|||
130795327|NCT02327078|470877452|FG006|Overall Study|Physician Decision|0|||
130795328|NCT02327078|470877453|FG007|Overall Study|Physician Decision|0|||
130795329|NCT02327078|470877454|FG008|Overall Study|Physician Decision|1|||
130795330|NCT02327078|470877446|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130795331|NCT02327078|470877447|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130795332|NCT02327078|470877448|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130795333|NCT02327078|470877449|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
130795334|NCT02327078|470877450|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
130795335|NCT02327078|470877451|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130795336|NCT02327078|470877452|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
130795337|NCT02327078|470877453|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
130795338|NCT02327078|470877454|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
130795339|NCT02327078|470877446|FG000|Overall Study|Reason not Specified|0|||
130795340|NCT02327078|470877447|FG001|Overall Study|Reason not Specified|0|||
130795341|NCT02327078|470877448|FG002|Overall Study|Reason not Specified|0|||
130795342|NCT02327078|470877449|FG003|Overall Study|Reason not Specified|0|||
130795343|NCT02327078|470877450|FG004|Overall Study|Reason not Specified|0|||
130795344|NCT02327078|470877451|FG005|Overall Study|Reason not Specified|0|||
130795345|NCT02327078|470877452|FG006|Overall Study|Reason not Specified|0|||
130795346|NCT02327078|470877453|FG007|Overall Study|Reason not Specified|5|||
130795347|NCT02327078|470877454|FG008|Overall Study|Reason not Specified|12|||
130795348|NCT06001866|470877455|FG000|Overall Study|Withdrawal by Subject|0|||
130795349|NCT06001866|470877456|FG001|Overall Study|Withdrawal by Subject|2|||
130795350|NCT06001866|470877455|FG000|Overall Study|Protocol Violation|0|||
130795351|NCT06001866|470877456|FG001|Overall Study|Protocol Violation|2|||
130795352|NCT02903914|470877457|FG000|Overall Study|Adverse Event|0|||
130795353|NCT02903914|470877458|FG001|Overall Study|Adverse Event|0|||
130795354|NCT02903914|470877459|FG002|Overall Study|Adverse Event|1|||
130795355|NCT02903914|470877460|FG003|Overall Study|Adverse Event|0|||
130795356|NCT02903914|470877461|FG004|Overall Study|Adverse Event|0|||
130795357|NCT02903914|470877462|FG005|Overall Study|Adverse Event|0|||
130795358|NCT02903914|470877463|FG006|Overall Study|Adverse Event|2|||
130795359|NCT02903914|470877464|FG007|Overall Study|Adverse Event|0|||
130795360|NCT02903914|470877457|FG000|Overall Study|Withdrawal by Subject|3|||
130795361|NCT02903914|470877458|FG001|Overall Study|Withdrawal by Subject|1|||
130795362|NCT02903914|470877459|FG002|Overall Study|Withdrawal by Subject|28|||
130795363|NCT02903914|470877460|FG003|Overall Study|Withdrawal by Subject|0|||
130795364|NCT02903914|470877461|FG004|Overall Study|Withdrawal by Subject|1|||
130795365|NCT02903914|470877462|FG005|Overall Study|Withdrawal by Subject|2|||
130795366|NCT02903914|470877463|FG006|Overall Study|Withdrawal by Subject|12|||
130795367|NCT02903914|470877464|FG007|Overall Study|Withdrawal by Subject|0|||
130795368|NCT02903914|470877457|FG000|Overall Study|Progressive Disease|1|||
130795369|NCT02903914|470877458|FG001|Overall Study|Progressive Disease|0|||
130795370|NCT02903914|470877459|FG002|Overall Study|Progressive Disease|4|||
130795371|NCT02903914|470877460|FG003|Overall Study|Progressive Disease|0|||
130795372|NCT02903914|470877461|FG004|Overall Study|Progressive Disease|0|||
130795373|NCT02903914|470877462|FG005|Overall Study|Progressive Disease|0|||
130795374|NCT02903914|470877463|FG006|Overall Study|Progressive Disease|2|||
130795375|NCT02903914|470877464|FG007|Overall Study|Progressive Disease|0|||
130795376|NCT02903914|470877457|FG000|Overall Study|Death|0|||
130795377|NCT02903914|470877458|FG001|Overall Study|Death|0|||
130795378|NCT02903914|470877459|FG002|Overall Study|Death|9|||
130795379|NCT02903914|470877460|FG003|Overall Study|Death|0|||
130795380|NCT02903914|470877461|FG004|Overall Study|Death|1|||
130795381|NCT02903914|470877462|FG005|Overall Study|Death|3|||
130795382|NCT02903914|470877463|FG006|Overall Study|Death|24|||
130795383|NCT02903914|470877464|FG007|Overall Study|Death|2|||
130795384|NCT02903914|470877457|FG000|Overall Study|Lost to Follow-up|0|||
130795385|NCT02903914|470877458|FG001|Overall Study|Lost to Follow-up|1|||
130795386|NCT02903914|470877459|FG002|Overall Study|Lost to Follow-up|0|||
130795387|NCT02903914|470877460|FG003|Overall Study|Lost to Follow-up|0|||
130795388|NCT02903914|470877461|FG004|Overall Study|Lost to Follow-up|2|||
130795389|NCT02903914|470877462|FG005|Overall Study|Lost to Follow-up|0|||
130795390|NCT02903914|470877463|FG006|Overall Study|Lost to Follow-up|1|||
130795391|NCT02903914|470877464|FG007|Overall Study|Lost to Follow-up|0|||
130795392|NCT02903914|470877457|FG000|Overall Study|Physician Decision|0|||
130795393|NCT02903914|470877458|FG001|Overall Study|Physician Decision|0|||
130795394|NCT02903914|470877459|FG002|Overall Study|Physician Decision|1|||
130795395|NCT02903914|470877460|FG003|Overall Study|Physician Decision|0|||
130795396|NCT02903914|470877461|FG004|Overall Study|Physician Decision|0|||
130795397|NCT02903914|470877462|FG005|Overall Study|Physician Decision|0|||
130795398|NCT02903914|470877463|FG006|Overall Study|Physician Decision|1|||
130795399|NCT02903914|470877464|FG007|Overall Study|Physician Decision|0|||
130795400|NCT02903914|470877457|FG000|Overall Study|Symptomatic Deterioration|0|||
130795401|NCT02903914|470877458|FG001|Overall Study|Symptomatic Deterioration|0|||
130795402|NCT02903914|470877459|FG002|Overall Study|Symptomatic Deterioration|1|||
130795403|NCT02903914|470877460|FG003|Overall Study|Symptomatic Deterioration|0|||
130795404|NCT02903914|470877461|FG004|Overall Study|Symptomatic Deterioration|0|||
130795405|NCT02903914|470877462|FG005|Overall Study|Symptomatic Deterioration|0|||
130795406|NCT02903914|470877463|FG006|Overall Study|Symptomatic Deterioration|0|||
130795407|NCT02903914|470877464|FG007|Overall Study|Symptomatic Deterioration|0|||
130795408|NCT02903914|470877457|FG000|Overall Study|New Cancer Therapy|2|||
130795409|NCT02903914|470877458|FG001|Overall Study|New Cancer Therapy|2|||
130795410|NCT02903914|470877459|FG002|Overall Study|New Cancer Therapy|21|||
130795411|NCT02903914|470877460|FG003|Overall Study|New Cancer Therapy|4|||
130795412|NCT02903914|470877461|FG004|Overall Study|New Cancer Therapy|3|||
130795413|NCT02903914|470877462|FG005|Overall Study|New Cancer Therapy|6|||
130795414|NCT02903914|470877463|FG006|Overall Study|New Cancer Therapy|56|||
130795415|NCT02903914|470877464|FG007|Overall Study|New Cancer Therapy|3|||
130795416|NCT02903914|470877457|FG000|Overall Study|Didn't Return to Site|1|||
130795417|NCT02903914|470877458|FG001|Overall Study|Didn't Return to Site|0|||
130795418|NCT02903914|470877459|FG002|Overall Study|Didn't Return to Site|1|||
130795419|NCT02903914|470877460|FG003|Overall Study|Didn't Return to Site|1|||
130795420|NCT02903914|470877461|FG004|Overall Study|Didn't Return to Site|0|||
130795421|NCT02903914|470877462|FG005|Overall Study|Didn't Return to Site|0|||
130795422|NCT02903914|470877463|FG006|Overall Study|Didn't Return to Site|2|||
130795423|NCT02903914|470877464|FG007|Overall Study|Didn't Return to Site|0|||
130795424|NCT02903914|470877457|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
130795425|NCT02903914|470877458|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
130795426|NCT02903914|470877459|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
130795427|NCT02903914|470877460|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
130795428|NCT02903914|470877461|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
130795429|NCT02903914|470877462|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
130795430|NCT02903914|470877463|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
130795431|NCT02903914|470877464|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
130795432|NCT02903914|470877457|FG000|Overall Study|Follow-up Did Not Occur|0|||
130795433|NCT02903914|470877458|FG001|Overall Study|Follow-up Did Not Occur|1|||
130795434|NCT02903914|470877459|FG002|Overall Study|Follow-up Did Not Occur|1|||
130795435|NCT02903914|470877460|FG003|Overall Study|Follow-up Did Not Occur|0|||
130795436|NCT02903914|470877461|FG004|Overall Study|Follow-up Did Not Occur|2|||
130795437|NCT02903914|470877462|FG005|Overall Study|Follow-up Did Not Occur|0|||
130795438|NCT02903914|470877463|FG006|Overall Study|Follow-up Did Not Occur|8|||
130795439|NCT02903914|470877464|FG007|Overall Study|Follow-up Did Not Occur|0|||
130795440|NCT02903914|470877457|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
130795441|NCT02903914|470877458|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
130795442|NCT02903914|470877459|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
130795443|NCT02903914|470877460|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
130795444|NCT02903914|470877461|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
130795445|NCT02903914|470877462|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
130795446|NCT02903914|470877463|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
130795447|NCT02903914|470877464|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
130762543|NCT04250714|470753335|FG000|Overall Study|Treatment - Death|1|||
130762544|NCT04250714|470753335|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
130762545|NCT04250714|470753335|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
130762546|NCT04250714|470753335|FG000|Overall Study|Attempt|2|||
130762547|NCT04250714|470753335|FG000|Overall Study|Intent|7|||
130762548|NCT01451164|470753338|FG000|Overall Study|Adverse Event|19|||
130762549|NCT01451164|470753339|FG001|Overall Study|Adverse Event|12|||
130762550|NCT01451164|470753340|FG002|Overall Study|Adverse Event|18|||
130762551|NCT01451164|470753341|FG003|Overall Study|Adverse Event|21|||
130762552|NCT01451164|470753338|FG000|Overall Study|Withdrawal Criteria|1|||
130762553|NCT01451164|470753339|FG001|Overall Study|Withdrawal Criteria|1|||
130762554|NCT01451164|470753340|FG002|Overall Study|Withdrawal Criteria|1|||
130762555|NCT01451164|470753341|FG003|Overall Study|Withdrawal Criteria|1|||
130762556|NCT01451164|470753338|FG000|Overall Study|Physician Decision|2|||
130762557|NCT01451164|470753339|FG001|Overall Study|Physician Decision|0|||
130762558|NCT01451164|470753340|FG002|Overall Study|Physician Decision|1|||
130762559|NCT01451164|470753341|FG003|Overall Study|Physician Decision|0|||
130762560|NCT01451164|470753338|FG000|Overall Study|Withdrawal by Subject|14|||
130762561|NCT01451164|470753339|FG001|Overall Study|Withdrawal by Subject|11|||
130762562|NCT01451164|470753340|FG002|Overall Study|Withdrawal by Subject|16|||
130762563|NCT01451164|470753341|FG003|Overall Study|Withdrawal by Subject|17|||
130762564|NCT01451164|470753338|FG000|Overall Study|Protocol Violation|0|||
130762565|NCT01451164|470753339|FG001|Overall Study|Protocol Violation|1|||
130762566|NCT01451164|470753340|FG002|Overall Study|Protocol Violation|0|||
130762567|NCT01451164|470753341|FG003|Overall Study|Protocol Violation|0|||
130762568|NCT01451164|470753338|FG000|Overall Study|Lack of Efficacy|7|||
130762569|NCT01451164|470753339|FG001|Overall Study|Lack of Efficacy|9|||
130762570|NCT01451164|470753340|FG002|Overall Study|Lack of Efficacy|9|||
130762571|NCT01451164|470753341|FG003|Overall Study|Lack of Efficacy|7|||
130762572|NCT04599933|470753342|FG000|Overall Study|Adverse Event|4|||
130762573|NCT04599933|470753343|FG001|Overall Study|Adverse Event|1|||
130762574|NCT04599933|470753342|FG000|Overall Study|Withdrawal by Subject|4|||
130762575|NCT04599933|470753343|FG001|Overall Study|Withdrawal by Subject|2|||
130762576|NCT04599933|470753342|FG000|Overall Study|Lost to Follow-up|0|||
130762577|NCT04599933|470753343|FG001|Overall Study|Lost to Follow-up|1|||
130762578|NCT04599933|470753342|FG000|Overall Study|Physician Decision|0|||
130762579|NCT04599933|470753343|FG001|Overall Study|Physician Decision|1|||
130762580|NCT04599933|470753342|FG000|Overall Study|Screen Failure|1|||
130762581|NCT04599933|470753343|FG001|Overall Study|Screen Failure|2|||
130762582|NCT03117881|470753346|FG000|Baseline|Withdrawal by Subject|21|||
130762583|NCT03117881|470753347|FG001|Baseline|Withdrawal by Subject|10|||
130795448|NCT02903914|470877457|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
130795449|NCT02903914|470877458|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
130795450|NCT02903914|470877459|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
130795451|NCT02903914|470877460|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
130795452|NCT02903914|470877461|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
130795453|NCT02903914|470877462|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
130795454|NCT02903914|470877463|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
130795455|NCT02903914|470877464|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
130795456|NCT02903914|470877457|FG000|Overall Study|Clinical Disease Progression|0|||
130795457|NCT02903914|470877458|FG001|Overall Study|Clinical Disease Progression|0|||
130795458|NCT02903914|470877459|FG002|Overall Study|Clinical Disease Progression|2|||
130795459|NCT02903914|470877460|FG003|Overall Study|Clinical Disease Progression|0|||
130795460|NCT02903914|470877461|FG004|Overall Study|Clinical Disease Progression|0|||
130795461|NCT02903914|470877462|FG005|Overall Study|Clinical Disease Progression|0|||
130795462|NCT02903914|470877463|FG006|Overall Study|Clinical Disease Progression|0|||
130795463|NCT02903914|470877464|FG007|Overall Study|Clinical Disease Progression|0|||
130795464|NCT02903914|470877457|FG000|Overall Study|Completed Follow-up Period|0|||
130795465|NCT02903914|470877458|FG001|Overall Study|Completed Follow-up Period|0|||
130795466|NCT02903914|470877459|FG002|Overall Study|Completed Follow-up Period|6|||
130795467|NCT02903914|470877460|FG003|Overall Study|Completed Follow-up Period|2|||
130795468|NCT02903914|470877461|FG004|Overall Study|Completed Follow-up Period|1|||
130795469|NCT02903914|470877462|FG005|Overall Study|Completed Follow-up Period|0|||
130795470|NCT02903914|470877463|FG006|Overall Study|Completed Follow-up Period|9|||
130795471|NCT02903914|470877464|FG007|Overall Study|Completed Follow-up Period|1|||
130795472|NCT02903914|470877457|FG000|Overall Study|Taken off Treatment per Protocol|0|||
130795473|NCT02903914|470877458|FG001|Overall Study|Taken off Treatment per Protocol|0|||
130795474|NCT02903914|470877459|FG002|Overall Study|Taken off Treatment per Protocol|0|||
130795475|NCT02903914|470877460|FG003|Overall Study|Taken off Treatment per Protocol|0|||
130795476|NCT02903914|470877461|FG004|Overall Study|Taken off Treatment per Protocol|0|||
130795477|NCT02903914|470877462|FG005|Overall Study|Taken off Treatment per Protocol|1|||
130795478|NCT02903914|470877463|FG006|Overall Study|Taken off Treatment per Protocol|0|||
130795479|NCT02903914|470877464|FG007|Overall Study|Taken off Treatment per Protocol|0|||
130795480|NCT02903914|470877457|FG000|Overall Study|Refused Further Treatment/Contact|0|||
130762584|NCT03117881|470753348|FG002|Baseline|Withdrawal by Subject|0|||
130762585|NCT03117881|470753346|FG000|Baseline|Lost to Follow-up|22|||
130762586|NCT03117881|470753347|FG001|Baseline|Lost to Follow-up|25|||
130762587|NCT03117881|470753348|FG002|Baseline|Lost to Follow-up|0|||
130762588|NCT03117881|470753346|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
130762589|NCT03117881|470753347|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
130762590|NCT03117881|470753348|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
130762591|NCT03117881|470753346|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
130762592|NCT03117881|470753347|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
130762593|NCT03117881|470753348|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
130762594|NCT03117881|470753346|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
130762595|NCT03117881|470753347|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
130762596|NCT03117881|470753348|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
130762597|NCT03117881|470753346|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
130762598|NCT03117881|470753347|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
130762599|NCT03117881|470753348|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
130762600|NCT03117881|470753346|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
130762601|NCT03117881|470753347|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
130762602|NCT03117881|470753348|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
130762603|NCT03117881|470753346|FG000|6-Month Follow-Up|Did not complete test|53|||
130762604|NCT03117881|470753347|FG001|6-Month Follow-Up|Did not complete test|25|||
130762605|NCT03117881|470753348|FG002|6-Month Follow-Up|Did not complete test|7|||
130762606|NCT03117881|470753346|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
130762607|NCT03117881|470753347|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
130762608|NCT03117881|470753348|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
130762609|NCT03117881|470753346|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
130762610|NCT03117881|470753347|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
130762611|NCT03117881|470753348|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
130762612|NCT03117881|470753346|FG000|12-Month Follow-Up|Did not complete test|40|||
130762613|NCT03117881|470753347|FG001|12-Month Follow-Up|Did not complete test|0|||
130762614|NCT03117881|470753348|FG002|12-Month Follow-Up|Did not complete test|0|||
130762615|NCT01027897|470753349|FG000|Overall Study|Protocol Violation|1|||
130762616|NCT01027897|470753349|FG000|Overall Study|Withdrawal by Subject|1|||
130762617|NCT02045732|470753352|FG000|Overall Study|At the discretion of the investigator|1|||
130762618|NCT02045732|470753353|FG001|Overall Study|At the discretion of the investigator|1|||
130762619|NCT00473824|470753354|FG000|Overall Study|Virologic Breakthrough|1|||
130762620|NCT00473824|470753355|FG001|Overall Study|Virologic Breakthrough|0|||
130762621|NCT00473824|470753354|FG000|Overall Study|Adverse Event|1|||
130762622|NCT00473824|470753355|FG001|Overall Study|Adverse Event|0|||
130762623|NCT00473824|470753354|FG000|Overall Study|Death|1|||
130762624|NCT00473824|470753355|FG001|Overall Study|Death|0|||
130762625|NCT00473824|470753354|FG000|Overall Study|Lost to Follow-up|1|||
130762626|NCT00473824|470753355|FG001|Overall Study|Lost to Follow-up|0|||
130762627|NCT00473824|470753354|FG000|Overall Study|Withdrawal by physician|1|||
130762628|NCT00473824|470753355|FG001|Overall Study|Withdrawal by physician|0|||
130762629|NCT02560623|470753356|FG000|Overall Study|Unable to swallow sponge|0|||
130762630|NCT02560623|470753357|FG001|Overall Study|Unable to swallow sponge|1|||
130762631|NCT02560623|470753358|FG002|Overall Study|Unable to swallow sponge|0|||
130762632|NCT02560623|470753359|FG003|Overall Study|Unable to swallow sponge|0|||
130762633|NCT02560623|470753356|FG000|Overall Study|Intervention prior to sponge administration|0|||
130762634|NCT02560623|470753357|FG001|Overall Study|Intervention prior to sponge administration|1|||
130762635|NCT02560623|470753358|FG002|Overall Study|Intervention prior to sponge administration|0|||
130762636|NCT02560623|470753359|FG003|Overall Study|Intervention prior to sponge administration|0|||
130762637|NCT05014815|470753360|FG000|Overall Study|Death|63|||
130762638|NCT05014815|470753361|FG001|Overall Study|Death|70|||
130762639|NCT05014815|470753360|FG000|Overall Study|Withdrawal by Subject|10|||
130762640|NCT05014815|470753361|FG001|Overall Study|Withdrawal by Subject|10|||
130762641|NCT05014815|470753360|FG000|Overall Study|Lost to Follow-up|4|||
130762642|NCT05014815|470753361|FG001|Overall Study|Lost to Follow-up|2|||
130762643|NCT05014815|470753360|FG000|Overall Study|Physician Decision|2|||
130762644|NCT05014815|470753361|FG001|Overall Study|Physician Decision|4|||
130762645|NCT04247880|470753362|FG000|Overall Study|Lost to Follow-up|24|||
130762646|NCT04247880|470753363|FG001|Overall Study|Lost to Follow-up|17|||
130762647|NCT04247880|470753362|FG000|Overall Study|Withdrawal by Subject|3|||
130762648|NCT04247880|470753363|FG001|Overall Study|Withdrawal by Subject|0|||
130762649|NCT06303167|470753364|FG000|Overall Study|Ineligible|1|||
130762650|NCT06303167|470753364|FG000|Overall Study|Never start protocol therapy|2|||
130762651|NCT06303167|470753364|FG000|Overall Study|Disease progression|16|||
130762652|NCT02453282|470753365|FG000|Overall Study|Death|275|||
130762653|NCT02453282|470753366|FG001|Overall Study|Death|277|||
130762654|NCT02453282|470753367|FG002|Overall Study|Death|296|||
130795481|NCT02903914|470877458|FG001|Overall Study|Refused Further Treatment/Contact|0|||
130795482|NCT02903914|470877459|FG002|Overall Study|Refused Further Treatment/Contact|0|||
130795483|NCT02903914|470877460|FG003|Overall Study|Refused Further Treatment/Contact|0|||
130795484|NCT02903914|470877461|FG004|Overall Study|Refused Further Treatment/Contact|0|||
130795485|NCT02903914|470877462|FG005|Overall Study|Refused Further Treatment/Contact|0|||
130795486|NCT02903914|470877463|FG006|Overall Study|Refused Further Treatment/Contact|1|||
130795487|NCT02903914|470877464|FG007|Overall Study|Refused Further Treatment/Contact|0|||
130795488|NCT02903914|470877457|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130795489|NCT02903914|470877458|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130795490|NCT02903914|470877459|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130795491|NCT02903914|470877460|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130795492|NCT02903914|470877461|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130795493|NCT02903914|470877462|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130795494|NCT02903914|470877463|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
130795495|NCT02903914|470877464|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130795496|NCT03112603|470877467|FG000|End of Randomization Period|Lost to Follow-up|3|||
130795497|NCT03112603|470877468|FG001|End of Randomization Period|Lost to Follow-up|0|||
130762655|NCT02453282|470753365|FG000|Overall Study|Lost to Follow-up|1|||
130762656|NCT02453282|470753366|FG001|Overall Study|Lost to Follow-up|0|||
130762657|NCT02453282|470753367|FG002|Overall Study|Lost to Follow-up|2|||
130762658|NCT02453282|470753365|FG000|Overall Study|Withdrawal by Subject|12|||
130762659|NCT02453282|470753366|FG001|Overall Study|Withdrawal by Subject|10|||
130762660|NCT02453282|470753367|FG002|Overall Study|Withdrawal by Subject|11|||
130762661|NCT02453282|470753365|FG000|Overall Study|Participants ongoing at data cut-off|85|||
130762662|NCT02453282|470753366|FG001|Overall Study|Participants ongoing at data cut-off|84|||
130762663|NCT02453282|470753367|FG002|Overall Study|Participants ongoing at data cut-off|62|||
130762664|NCT02453282|470753365|FG000|Overall Study|Other|1|||
130762665|NCT02453282|470753366|FG001|Overall Study|Other|1|||
130762666|NCT02453282|470753367|FG002|Overall Study|Other|1|||
130762667|NCT01661933|470753369|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
130762668|NCT01661933|470753369|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
130762669|NCT03536949|470753378|FG000|Overall Study|Adverse Event|4|||
130762670|NCT03536949|470753379|FG001|Overall Study|Adverse Event|0|||
130762671|NCT03536949|470753378|FG000|Overall Study|Lost to Follow-up|2|||
130762672|NCT03536949|470753379|FG001|Overall Study|Lost to Follow-up|1|||
130762673|NCT03536949|470753378|FG000|Overall Study|Withdrawal by Subject|6|||
130762674|NCT03536949|470753379|FG001|Overall Study|Withdrawal by Subject|0|||
130762675|NCT03536949|470753378|FG000|Overall Study|Non-compliance|2|||
130762676|NCT03536949|470753379|FG001|Overall Study|Non-compliance|1|||
130762677|NCT00435487|470753399|FG000|Overall Study|Death|3|||
130762678|NCT00435487|470753400|FG001|Overall Study|Death|4|||
130762679|NCT00435487|470753399|FG000|Overall Study|Adverse Event|0|||
130762680|NCT00435487|470753400|FG001|Overall Study|Adverse Event|3|||
130762681|NCT00435487|470753399|FG000|Overall Study|Lost to Follow-up|2|||
130762682|NCT00435487|470753400|FG001|Overall Study|Lost to Follow-up|2|||
130762683|NCT00435487|470753399|FG000|Overall Study|Other|5|||
130762684|NCT00435487|470753400|FG001|Overall Study|Other|2|||
130762685|NCT00435487|470753399|FG000|Overall Study|Withdrawal by Subject|2|||
130762686|NCT00435487|470753400|FG001|Overall Study|Withdrawal by Subject|1|||
130762687|NCT00435487|470753399|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
130762688|NCT00435487|470753400|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
130762689|NCT00435487|470753399|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
130762690|NCT00435487|470753400|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
130762691|NCT03301844|470753401|FG000|Overall Study|suspected colon cancer|1|||
130762692|NCT03301844|470753402|FG001|Overall Study|suspected colon cancer|1|||
130762693|NCT05087966|470753403|FG000|Overall Study|Lost to Follow-up|1|||
130762694|NCT05087966|470753403|FG000|Overall Study|Withdrawal by Subject|5|||
130762695|NCT01267201|470753404|FG000|First Intervention Period|Withdrawal by Subject|1|||
130762696|NCT01267201|470753405|FG001|First Intervention Period|Withdrawal by Subject|0|||
130795498|NCT03112603|470877469|FG002|End of Randomization Period|Lost to Follow-up|0|||
130795499|NCT03112603|470877467|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
130795500|NCT03112603|470877468|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
130795501|NCT03112603|470877469|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
130795502|NCT03112603|470877467|FG000|End of Randomization Period|Physician Decision|43|||
130795503|NCT03112603|470877468|FG001|End of Randomization Period|Physician Decision|18|||
130795504|NCT03112603|470877469|FG002|End of Randomization Period|Physician Decision|0|||
130795505|NCT03112603|470877467|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
130795506|NCT03112603|470877468|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
130795507|NCT03112603|470877469|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
130795508|NCT03112603|470877467|FG000|End of Randomization Period|Death|10|||
130795509|NCT03112603|470877468|FG001|End of Randomization Period|Death|7|||
130795510|NCT03112603|470877469|FG002|End of Randomization Period|Death|0|||
130795511|NCT03112603|470877467|FG000|End of Randomization Period|Disease Relapse|12|||
130795512|NCT03112603|470877468|FG001|End of Randomization Period|Disease Relapse|7|||
130795513|NCT03112603|470877469|FG002|End of Randomization Period|Disease Relapse|0|||
130795514|NCT03112603|470877467|FG000|End of Randomization Period|Lack of Efficacy|25|||
130795515|NCT03112603|470877468|FG001|End of Randomization Period|Lack of Efficacy|77|||
130795516|NCT03112603|470877469|FG002|End of Randomization Period|Lack of Efficacy|0|||
130795517|NCT03112603|470877467|FG000|End of Randomization Period|Adverse Event|32|||
130795518|NCT03112603|470877468|FG001|End of Randomization Period|Adverse Event|12|||
130795519|NCT03112603|470877469|FG002|End of Randomization Period|Adverse Event|0|||
130795520|NCT03112603|470877467|FG000|End of Cross Over Period|Death|0|||
130795521|NCT03112603|470877468|FG001|End of Cross Over Period|Death|0|||
130795522|NCT03112603|470877469|FG002|End of Cross Over Period|Death|2|||
130795523|NCT03112603|470877467|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
130795524|NCT03112603|470877468|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
130795525|NCT03112603|470877469|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
130795526|NCT03112603|470877467|FG000|End of Cross Over Period|Physician Decision|0|||
130795527|NCT03112603|470877468|FG001|End of Cross Over Period|Physician Decision|0|||
130795528|NCT03112603|470877469|FG002|End of Cross Over Period|Physician Decision|29|||
130795529|NCT03112603|470877467|FG000|End of Cross Over Period|Lack of Efficacy|0|||
130795530|NCT03112603|470877468|FG001|End of Cross Over Period|Lack of Efficacy|0|||
130795531|NCT03112603|470877469|FG002|End of Cross Over Period|Lack of Efficacy|8|||
130795532|NCT03112603|470877467|FG000|End of Cross Over Period|Adverse Event|0|||
130795533|NCT03112603|470877468|FG001|End of Cross Over Period|Adverse Event|0|||
130795534|NCT03112603|470877469|FG002|End of Cross Over Period|Adverse Event|6|||
130795535|NCT03112603|470877467|FG000|End of Cross Over Period|Disease Relapse|0|||
130795536|NCT03112603|470877468|FG001|End of Cross Over Period|Disease Relapse|0|||
130795537|NCT03112603|470877469|FG002|End of Cross Over Period|Disease Relapse|2|||
130795538|NCT04725188|470877470|FG000|Overall Study|Death|72|||
130795539|NCT04725188|470877471|FG001|Overall Study|Death|69|||
130795540|NCT04725188|470877472|FG002|Overall Study|Death|76|||
130795541|NCT04725188|470877470|FG000|Overall Study|Lost to Follow-up|1|||
130795542|NCT04725188|470877471|FG001|Overall Study|Lost to Follow-up|0|||
130795543|NCT04725188|470877472|FG002|Overall Study|Lost to Follow-up|1|||
130795544|NCT04725188|470877470|FG000|Overall Study|Withdrawal by Subject|2|||
130795545|NCT04725188|470877471|FG001|Overall Study|Withdrawal by Subject|2|||
130795546|NCT04725188|470877472|FG002|Overall Study|Withdrawal by Subject|1|||
130795547|NCT04725188|470877470|FG000|Overall Study|Sponsor Decision|12|||
130795548|NCT04725188|470877471|FG001|Overall Study|Sponsor Decision|12|||
130795549|NCT04725188|470877472|FG002|Overall Study|Sponsor Decision|7|||
130795550|NCT00695019|470877476|FG000|Overall Study|Withdrawal by Subject|8|||
130795551|NCT00695019|470877477|FG001|Overall Study|Withdrawal by Subject|6|||
130795552|NCT00695019|470877478|FG002|Overall Study|Withdrawal by Subject|4|||
130795553|NCT00695019|470877476|FG000|Overall Study|Protocol Violation|1|||
130795554|NCT00695019|470877477|FG001|Overall Study|Protocol Violation|3|||
130795555|NCT00695019|470877478|FG002|Overall Study|Protocol Violation|1|||
130795556|NCT00695019|470877476|FG000|Overall Study|Lack of Efficacy|0|||
130795557|NCT00695019|470877477|FG001|Overall Study|Lack of Efficacy|0|||
130795558|NCT00695019|470877478|FG002|Overall Study|Lack of Efficacy|1|||
130795559|NCT00695019|470877476|FG000|Overall Study|Various|4|||
130795560|NCT00695019|470877477|FG001|Overall Study|Various|5|||
130795561|NCT00695019|470877478|FG002|Overall Study|Various|4|||
130795562|NCT02442349|470877479|FG000|Overall Study|Death|95|||
130795563|NCT02442349|470877479|FG000|Overall Study|Withdrawal by Subject|27|||
130795564|NCT02442349|470877479|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
130795565|NCT02442349|470877479|FG000|Overall Study|Lost to Follow-up|1|||
130795566|NCT00314145|470877480|FG000|Overall Study|Withdrawal by Subject|8|||
130795567|NCT00314145|470877481|FG001|Overall Study|Withdrawal by Subject|10|||
130795568|NCT00314145|470877480|FG000|Overall Study|Lost to Follow-up|5|||
130795569|NCT00314145|470877481|FG001|Overall Study|Lost to Follow-up|12|||
130795570|NCT00314145|470877480|FG000|Overall Study|Physician Decision|3|||
130795571|NCT00314145|470877481|FG001|Overall Study|Physician Decision|4|||
130795572|NCT00314145|470877480|FG000|Overall Study|Adverse Event|0|||
130795573|NCT00314145|470877481|FG001|Overall Study|Adverse Event|3|||
130795574|NCT00314145|470877480|FG000|Overall Study|Protocol Violation|3|||
130795575|NCT00314145|470877481|FG001|Overall Study|Protocol Violation|0|||
130795576|NCT00314145|470877480|FG000|Overall Study|Sponsor Decision|2|||
130795577|NCT00314145|470877481|FG001|Overall Study|Sponsor Decision|0|||
130795578|NCT03507790|470877484|FG000|Overall Study|Adverse Event|0|||
130795579|NCT03507790|470877485|FG001|Overall Study|Adverse Event|11|||
130795580|NCT03507790|470877486|FG002|Overall Study|Adverse Event|3|||
130795581|NCT03507790|470877484|FG000|Overall Study|Withdrawal by Subject|2|||
130795582|NCT03507790|470877485|FG001|Overall Study|Withdrawal by Subject|0|||
130795583|NCT03507790|470877486|FG002|Overall Study|Withdrawal by Subject|0|||
130795584|NCT03507790|470877484|FG000|Overall Study|Subject moved to another location|1|||
130795585|NCT03507790|470877485|FG001|Overall Study|Subject moved to another location|2|||
130795586|NCT03507790|470877486|FG002|Overall Study|Subject moved to another location|0|||
130795587|NCT03507790|470877484|FG000|Overall Study|Non-compliance with study drug|0|||
130795588|NCT03507790|470877485|FG001|Overall Study|Non-compliance with study drug|0|||
130795589|NCT03507790|470877486|FG002|Overall Study|Non-compliance with study drug|1|||
130795590|NCT03507790|470877484|FG000|Overall Study|COVID 19 Pandemic|0|||
130795591|NCT03507790|470877485|FG001|Overall Study|COVID 19 Pandemic|1|||
130795592|NCT03507790|470877486|FG002|Overall Study|COVID 19 Pandemic|0|||
130795593|NCT03507790|470877484|FG000|Overall Study|Lost to Follow-up|0|||
130795594|NCT03507790|470877485|FG001|Overall Study|Lost to Follow-up|1|||
130795595|NCT03507790|470877486|FG002|Overall Study|Lost to Follow-up|0|||
130795596|NCT03507790|470877484|FG000|Overall Study|Discontinuation of the trial at the site|1|||
130795597|NCT03507790|470877485|FG001|Overall Study|Discontinuation of the trial at the site|1|||
130795598|NCT03507790|470877486|FG002|Overall Study|Discontinuation of the trial at the site|0|||
130795599|NCT03507790|470877484|FG000|Overall Study|Randomized in error|0|||
130795600|NCT03507790|470877485|FG001|Overall Study|Randomized in error|0|||
130795601|NCT03507790|470877486|FG002|Overall Study|Randomized in error|1|||
130795602|NCT02296125|470877489|FG000|Overall Study|Withdrawal by Subject|18|||
130795603|NCT02296125|470877490|FG001|Overall Study|Withdrawal by Subject|8|||
130795604|NCT02296125|470877491|FG002|Overall Study|Withdrawal by Subject|6|||
130795605|NCT02296125|470877492|FG003|Overall Study|Withdrawal by Subject|2|||
130795606|NCT02296125|470877489|FG000|Overall Study|Adverse Event|41|||
130795607|NCT02296125|470877490|FG001|Overall Study|Adverse Event|52|||
130795608|NCT02296125|470877491|FG002|Overall Study|Adverse Event|9|||
130795609|NCT02296125|470877492|FG003|Overall Study|Adverse Event|4|||
130795610|NCT02296125|470877489|FG000|Overall Study|Severe non-compliance to protocol|0|||
130795611|NCT02296125|470877490|FG001|Overall Study|Severe non-compliance to protocol|1|||
130795612|NCT02296125|470877491|FG002|Overall Study|Severe non-compliance to protocol|0|||
130795613|NCT02296125|470877492|FG003|Overall Study|Severe non-compliance to protocol|0|||
130795614|NCT02296125|470877489|FG000|Overall Study|Condition under investigation worsened|153|||
130795615|NCT02296125|470877490|FG001|Overall Study|Condition under investigation worsened|199|||
130795616|NCT02296125|470877491|FG002|Overall Study|Condition under investigation worsened|39|||
130795617|NCT02296125|470877492|FG003|Overall Study|Condition under investigation worsened|56|||
130795618|NCT02296125|470877489|FG000|Overall Study|Any reason not specifically recorded|6|||
130795619|NCT02296125|470877490|FG001|Overall Study|Any reason not specifically recorded|4|||
130795620|NCT02296125|470877491|FG002|Overall Study|Any reason not specifically recorded|2|||
130795621|NCT02296125|470877492|FG003|Overall Study|Any reason not specifically recorded|0|||
130795622|NCT01160614|470877493|FG000|Overall Study|Withdrawal by Subject|0|||
130795623|NCT01160614|470877494|FG001|Overall Study|Withdrawal by Subject|2|||
130795624|NCT03314935|470877495|FG000|Phase 1|Death|4|||
130795625|NCT03314935|470877496|FG001|Phase 1|Death|2|||
130795626|NCT03314935|470877497|FG002|Phase 1|Death|5|||
130795627|NCT03314935|470877498|FG003|Phase 1|Death|4|||
130795628|NCT03314935|470877499|FG004|Phase 1|Death|3|||
130795629|NCT03314935|470877500|FG005|Phase 1|Death|4|||
130795630|NCT03314935|470877501|FG006|Phase 1|Death|5|||
130795631|NCT03314935|470877502|FG007|Phase 1|Death|4|||
130795632|NCT03314935|470877503|FG008|Phase 1|Death|3|||
130795633|NCT03314935|470877504|FG009|Phase 1|Death|0|||
130795634|NCT03314935|470877505|FG010|Phase 1|Death|0|||
130795635|NCT03314935|470877506|FG011|Phase 1|Death|0|||
130795636|NCT03314935|470877507|FG012|Phase 1|Death|0|||
130795637|NCT03314935|470877508|FG013|Phase 1|Death|0|||
130795638|NCT03314935|470877509|FG014|Phase 1|Death|0|||
130795639|NCT03314935|470877495|FG000|Phase 1|Withdrawal by Subject|2|||
130795640|NCT03314935|470877496|FG001|Phase 1|Withdrawal by Subject|1|||
130795641|NCT03314935|470877497|FG002|Phase 1|Withdrawal by Subject|1|||
130795642|NCT03314935|470877498|FG003|Phase 1|Withdrawal by Subject|2|||
130795643|NCT03314935|470877499|FG004|Phase 1|Withdrawal by Subject|1|||
130795644|NCT03314935|470877500|FG005|Phase 1|Withdrawal by Subject|0|||
130795645|NCT03314935|470877501|FG006|Phase 1|Withdrawal by Subject|1|||
130795646|NCT03314935|470877502|FG007|Phase 1|Withdrawal by Subject|0|||
130795647|NCT03314935|470877503|FG008|Phase 1|Withdrawal by Subject|1|||
130795648|NCT03314935|470877504|FG009|Phase 1|Withdrawal by Subject|0|||
130795649|NCT03314935|470877505|FG010|Phase 1|Withdrawal by Subject|0|||
130795650|NCT03314935|470877506|FG011|Phase 1|Withdrawal by Subject|0|||
130795651|NCT03314935|470877507|FG012|Phase 1|Withdrawal by Subject|0|||
130795652|NCT03314935|470877508|FG013|Phase 1|Withdrawal by Subject|0|||
130795653|NCT03314935|470877509|FG014|Phase 1|Withdrawal by Subject|0|||
130795654|NCT03314935|470877495|FG000|Phase 1|Progressive Disease|2|||
130795655|NCT03314935|470877496|FG001|Phase 1|Progressive Disease|0|||
130795656|NCT03314935|470877497|FG002|Phase 1|Progressive Disease|0|||
130795657|NCT03314935|470877498|FG003|Phase 1|Progressive Disease|1|||
130795658|NCT03314935|470877499|FG004|Phase 1|Progressive Disease|0|||
130795659|NCT03314935|470877500|FG005|Phase 1|Progressive Disease|0|||
130795660|NCT03314935|470877501|FG006|Phase 1|Progressive Disease|0|||
130795661|NCT03314935|470877502|FG007|Phase 1|Progressive Disease|0|||
130795662|NCT03314935|470877503|FG008|Phase 1|Progressive Disease|0|||
130795663|NCT03314935|470877504|FG009|Phase 1|Progressive Disease|0|||
130795664|NCT03314935|470877505|FG010|Phase 1|Progressive Disease|0|||
130795665|NCT03314935|470877506|FG011|Phase 1|Progressive Disease|0|||
130795666|NCT03314935|470877507|FG012|Phase 1|Progressive Disease|0|||
130795667|NCT03314935|470877508|FG013|Phase 1|Progressive Disease|0|||
130795668|NCT03314935|470877509|FG014|Phase 1|Progressive Disease|0|||
130795669|NCT03314935|470877495|FG000|Phase 1|Study Terminated by Sponsor|0|||
130795670|NCT03314935|470877496|FG001|Phase 1|Study Terminated by Sponsor|1|||
130795671|NCT03314935|470877497|FG002|Phase 1|Study Terminated by Sponsor|0|||
130795672|NCT03314935|470877498|FG003|Phase 1|Study Terminated by Sponsor|0|||
130795673|NCT03314935|470877499|FG004|Phase 1|Study Terminated by Sponsor|0|||
130795674|NCT03314935|470877500|FG005|Phase 1|Study Terminated by Sponsor|0|||
130795675|NCT03314935|470877501|FG006|Phase 1|Study Terminated by Sponsor|0|||
130795676|NCT03314935|470877502|FG007|Phase 1|Study Terminated by Sponsor|0|||
130795677|NCT03314935|470877503|FG008|Phase 1|Study Terminated by Sponsor|1|||
130795678|NCT03314935|470877504|FG009|Phase 1|Study Terminated by Sponsor|0|||
130795679|NCT03314935|470877505|FG010|Phase 1|Study Terminated by Sponsor|0|||
130795680|NCT03314935|470877506|FG011|Phase 1|Study Terminated by Sponsor|0|||
130795681|NCT03314935|470877507|FG012|Phase 1|Study Terminated by Sponsor|0|||
130795682|NCT03314935|470877508|FG013|Phase 1|Study Terminated by Sponsor|0|||
130795683|NCT03314935|470877509|FG014|Phase 1|Study Terminated by Sponsor|0|||
130795684|NCT03314935|470877495|FG000|Phase 1|"Captured as Other in Database"|0|||
130795685|NCT03314935|470877496|FG001|Phase 1|"Captured as Other in Database"|2|||
130795686|NCT03314935|470877497|FG002|Phase 1|"Captured as Other in Database"|0|||
130795687|NCT03314935|470877498|FG003|Phase 1|"Captured as Other in Database"|0|||
130795688|NCT03314935|470877499|FG004|Phase 1|"Captured as Other in Database"|0|||
130795689|NCT03314935|470877500|FG005|Phase 1|"Captured as Other in Database"|0|||
130795690|NCT03314935|470877501|FG006|Phase 1|"Captured as Other in Database"|1|||
130795691|NCT03314935|470877502|FG007|Phase 1|"Captured as Other in Database"|1|||
130795692|NCT03314935|470877503|FG008|Phase 1|"Captured as Other in Database"|1|||
130795693|NCT03314935|470877504|FG009|Phase 1|"Captured as Other in Database"|0|||
130795694|NCT03314935|470877505|FG010|Phase 1|"Captured as Other in Database"|0|||
130795695|NCT03314935|470877506|FG011|Phase 1|"Captured as Other in Database"|0|||
130795696|NCT03314935|470877507|FG012|Phase 1|"Captured as Other in Database"|0|||
130795697|NCT03314935|470877508|FG013|Phase 1|"Captured as Other in Database"|0|||
130795698|NCT03314935|470877509|FG014|Phase 1|"Captured as Other in Database"|0|||
130795699|NCT03314935|470877495|FG000|Phase 1|Lost to Follow-up|0|||
130795700|NCT03314935|470877496|FG001|Phase 1|Lost to Follow-up|0|||
130795701|NCT03314935|470877497|FG002|Phase 1|Lost to Follow-up|0|||
130795702|NCT03314935|470877498|FG003|Phase 1|Lost to Follow-up|0|||
130795703|NCT03314935|470877499|FG004|Phase 1|Lost to Follow-up|0|||
130795704|NCT03314935|470877500|FG005|Phase 1|Lost to Follow-up|0|||
130795705|NCT03314935|470877501|FG006|Phase 1|Lost to Follow-up|0|||
130795706|NCT03314935|470877502|FG007|Phase 1|Lost to Follow-up|0|||
130795707|NCT03314935|470877503|FG008|Phase 1|Lost to Follow-up|1|||
130795708|NCT03314935|470877504|FG009|Phase 1|Lost to Follow-up|0|||
130795709|NCT03314935|470877505|FG010|Phase 1|Lost to Follow-up|0|||
130795710|NCT03314935|470877506|FG011|Phase 1|Lost to Follow-up|0|||
130795711|NCT03314935|470877507|FG012|Phase 1|Lost to Follow-up|0|||
130795712|NCT03314935|470877508|FG013|Phase 1|Lost to Follow-up|0|||
130795713|NCT03314935|470877509|FG014|Phase 1|Lost to Follow-up|0|||
130795714|NCT03314935|470877495|FG000|Phase 2|Death|0|||
130795715|NCT03314935|470877496|FG001|Phase 2|Death|0|||
130795716|NCT03314935|470877497|FG002|Phase 2|Death|0|||
130795717|NCT03314935|470877498|FG003|Phase 2|Death|0|||
130795718|NCT03314935|470877499|FG004|Phase 2|Death|0|||
130795719|NCT03314935|470877500|FG005|Phase 2|Death|0|||
130795720|NCT03314935|470877501|FG006|Phase 2|Death|0|||
130795721|NCT03314935|470877502|FG007|Phase 2|Death|0|||
130795722|NCT03314935|470877503|FG008|Phase 2|Death|0|||
130795723|NCT03314935|470877504|FG009|Phase 2|Death|5|||
130795724|NCT03314935|470877505|FG010|Phase 2|Death|20|||
130795725|NCT03314935|470877506|FG011|Phase 2|Death|6|||
130795726|NCT03314935|470877507|FG012|Phase 2|Death|7|||
130795727|NCT03314935|470877508|FG013|Phase 2|Death|6|||
130795728|NCT03314935|470877509|FG014|Phase 2|Death|17|||
130795729|NCT03314935|470877495|FG000|Phase 2|Withdrawal by Subject|0|||
130795730|NCT03314935|470877496|FG001|Phase 2|Withdrawal by Subject|0|||
130795731|NCT03314935|470877497|FG002|Phase 2|Withdrawal by Subject|0|||
130795732|NCT03314935|470877498|FG003|Phase 2|Withdrawal by Subject|0|||
130795733|NCT03314935|470877499|FG004|Phase 2|Withdrawal by Subject|0|||
130795734|NCT03314935|470877500|FG005|Phase 2|Withdrawal by Subject|0|||
130795735|NCT03314935|470877501|FG006|Phase 2|Withdrawal by Subject|0|||
130795736|NCT03314935|470877502|FG007|Phase 2|Withdrawal by Subject|0|||
130795737|NCT03314935|470877503|FG008|Phase 2|Withdrawal by Subject|0|||
130795738|NCT03314935|470877504|FG009|Phase 2|Withdrawal by Subject|1|||
130795739|NCT03314935|470877505|FG010|Phase 2|Withdrawal by Subject|4|||
130795740|NCT03314935|470877506|FG011|Phase 2|Withdrawal by Subject|0|||
130795741|NCT03314935|470877507|FG012|Phase 2|Withdrawal by Subject|1|||
130795742|NCT03314935|470877508|FG013|Phase 2|Withdrawal by Subject|0|||
130795743|NCT03314935|470877509|FG014|Phase 2|Withdrawal by Subject|1|||
130795744|NCT03314935|470877495|FG000|Phase 2|Progressive Disease|0|||
130795745|NCT03314935|470877496|FG001|Phase 2|Progressive Disease|0|||
130795746|NCT03314935|470877497|FG002|Phase 2|Progressive Disease|0|||
130795747|NCT03314935|470877498|FG003|Phase 2|Progressive Disease|0|||
130795748|NCT03314935|470877499|FG004|Phase 2|Progressive Disease|0|||
130795749|NCT03314935|470877500|FG005|Phase 2|Progressive Disease|0|||
130795750|NCT03314935|470877501|FG006|Phase 2|Progressive Disease|0|||
130795751|NCT03314935|470877502|FG007|Phase 2|Progressive Disease|0|||
130795752|NCT03314935|470877503|FG008|Phase 2|Progressive Disease|0|||
130795753|NCT03314935|470877504|FG009|Phase 2|Progressive Disease|1|||
130795754|NCT03314935|470877505|FG010|Phase 2|Progressive Disease|1|||
130795755|NCT03314935|470877506|FG011|Phase 2|Progressive Disease|1|||
130795756|NCT03314935|470877507|FG012|Phase 2|Progressive Disease|2|||
130795757|NCT03314935|470877508|FG013|Phase 2|Progressive Disease|0|||
130795758|NCT03314935|470877509|FG014|Phase 2|Progressive Disease|1|||
130795759|NCT03314935|470877495|FG000|Phase 2|Study Terminated by Sponsor|0|||
130795760|NCT03314935|470877496|FG001|Phase 2|Study Terminated by Sponsor|0|||
130795761|NCT03314935|470877497|FG002|Phase 2|Study Terminated by Sponsor|0|||
130795762|NCT03314935|470877498|FG003|Phase 2|Study Terminated by Sponsor|0|||
130795763|NCT03314935|470877499|FG004|Phase 2|Study Terminated by Sponsor|0|||
130795764|NCT03314935|470877500|FG005|Phase 2|Study Terminated by Sponsor|0|||
130795765|NCT03314935|470877501|FG006|Phase 2|Study Terminated by Sponsor|0|||
130795766|NCT03314935|470877502|FG007|Phase 2|Study Terminated by Sponsor|0|||
130795767|NCT03314935|470877503|FG008|Phase 2|Study Terminated by Sponsor|0|||
130795768|NCT03314935|470877504|FG009|Phase 2|Study Terminated by Sponsor|0|||
130795769|NCT03314935|470877505|FG010|Phase 2|Study Terminated by Sponsor|7|||
130795770|NCT03314935|470877506|FG011|Phase 2|Study Terminated by Sponsor|2|||
130795771|NCT03314935|470877507|FG012|Phase 2|Study Terminated by Sponsor|1|||
130795772|NCT03314935|470877508|FG013|Phase 2|Study Terminated by Sponsor|4|||
130795773|NCT03314935|470877509|FG014|Phase 2|Study Terminated by Sponsor|4|||
130795774|NCT03314935|470877495|FG000|Phase 2|Lost to Follow-up|0|||
130795775|NCT03314935|470877496|FG001|Phase 2|Lost to Follow-up|0|||
130795776|NCT03314935|470877497|FG002|Phase 2|Lost to Follow-up|0|||
130795777|NCT03314935|470877498|FG003|Phase 2|Lost to Follow-up|0|||
130795778|NCT03314935|470877499|FG004|Phase 2|Lost to Follow-up|0|||
130795779|NCT03314935|470877500|FG005|Phase 2|Lost to Follow-up|0|||
130795780|NCT03314935|470877501|FG006|Phase 2|Lost to Follow-up|0|||
130795781|NCT03314935|470877502|FG007|Phase 2|Lost to Follow-up|0|||
130795782|NCT03314935|470877503|FG008|Phase 2|Lost to Follow-up|0|||
130795783|NCT03314935|470877504|FG009|Phase 2|Lost to Follow-up|1|||
130795784|NCT03314935|470877505|FG010|Phase 2|Lost to Follow-up|0|||
130795785|NCT03314935|470877506|FG011|Phase 2|Lost to Follow-up|0|||
130795786|NCT03314935|470877507|FG012|Phase 2|Lost to Follow-up|0|||
130795787|NCT03314935|470877508|FG013|Phase 2|Lost to Follow-up|0|||
130795788|NCT03314935|470877509|FG014|Phase 2|Lost to Follow-up|1|||
130795789|NCT03314935|470877495|FG000|Phase 2|Physician Decision|0|||
130795790|NCT03314935|470877496|FG001|Phase 2|Physician Decision|0|||
130795791|NCT03314935|470877497|FG002|Phase 2|Physician Decision|0|||
130795792|NCT03314935|470877498|FG003|Phase 2|Physician Decision|0|||
130795793|NCT03314935|470877499|FG004|Phase 2|Physician Decision|0|||
130795794|NCT03314935|470877500|FG005|Phase 2|Physician Decision|0|||
130795795|NCT03314935|470877501|FG006|Phase 2|Physician Decision|0|||
130795796|NCT03314935|470877502|FG007|Phase 2|Physician Decision|0|||
130795797|NCT03314935|470877503|FG008|Phase 2|Physician Decision|0|||
130795798|NCT03314935|470877504|FG009|Phase 2|Physician Decision|0|||
130795799|NCT03314935|470877505|FG010|Phase 2|Physician Decision|1|||
130795800|NCT03314935|470877506|FG011|Phase 2|Physician Decision|0|||
130795801|NCT03314935|470877507|FG012|Phase 2|Physician Decision|0|||
130795802|NCT03314935|470877508|FG013|Phase 2|Physician Decision|0|||
130795803|NCT03314935|470877509|FG014|Phase 2|Physician Decision|0|||
130795804|NCT05845619|470877510|FG000|Overall Study|duplicate enrollment|2|||
130795805|NCT05845619|470877511|FG001|Overall Study|duplicate enrollment|2|||
130795806|NCT05845619|470877512|FG002|Overall Study|duplicate enrollment|1|||
130795807|NCT03636477|470877516|FG000|Overall Study|Adverse Event|0|||
130795808|NCT03636477|470877517|FG001|Overall Study|Adverse Event|0|||
130795809|NCT03636477|470877518|FG002|Overall Study|Adverse Event|1|||
130795810|NCT03621592|470877519|FG000|Overall Study|Lost to Follow-up|1|||
130795811|NCT03621592|470877520|FG001|Overall Study|Lost to Follow-up|0|||
130795812|NCT03621592|470877519|FG000|Overall Study|Lack of Improvement|1|||
130795813|NCT03621592|470877520|FG001|Overall Study|Lack of Improvement|0|||
130795814|NCT03621592|470877519|FG000|Overall Study|Preference to receive wound care closer to home|1|||
130795815|NCT03621592|470877520|FG001|Overall Study|Preference to receive wound care closer to home|0|||
130795816|NCT03621592|470877519|FG000|Overall Study|Lack of healing|0|||
130795817|NCT03621592|470877520|FG001|Overall Study|Lack of healing|2|||
130795818|NCT02382380|470877522|FG000|Overall Study|Withdrawal by Subject|2|||
130795819|NCT02382380|470877523|FG001|Overall Study|Withdrawal by Subject|2|||
130795820|NCT02382380|470877522|FG000|Overall Study|Lost to Follow-up|0|||
130795821|NCT02382380|470877523|FG001|Overall Study|Lost to Follow-up|1|||
130795822|NCT05168800|470877524|FG000|Time 1 Survey|Did not start T1 survey|182|||
130795823|NCT05168800|470877525|FG001|Time 1 Survey|Did not start T1 survey|150|||
130795824|NCT05168800|470877526|FG002|Time 1 Survey|Did not start T1 survey|140|||
130795825|NCT05168800|470877524|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
130795826|NCT05168800|470877525|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
130795827|NCT05168800|470877526|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
130795828|NCT05168800|470877524|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
130795829|NCT05168800|470877525|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
130795830|NCT05168800|470877526|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
130795831|NCT05168800|470877524|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
130795832|NCT05168800|470877525|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
130795833|NCT05168800|470877526|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
130795834|NCT05168800|470877524|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
130795835|NCT05168800|470877525|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
130795836|NCT05168800|470877526|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
130795837|NCT05168800|470877524|FG000|Time 1 Survey|Withdrawal by Subject|6|||
130795838|NCT05168800|470877525|FG001|Time 1 Survey|Withdrawal by Subject|3|||
130795839|NCT05168800|470877526|FG002|Time 1 Survey|Withdrawal by Subject|2|||
130795840|NCT05168800|470877524|FG000|Time 2 Survey|Already excluded at Time 1|228|||
130795841|NCT05168800|470877525|FG001|Time 2 Survey|Already excluded at Time 1|202|||
130795842|NCT05168800|470877526|FG002|Time 2 Survey|Already excluded at Time 1|173|||
130795843|NCT05168800|470877524|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
130795844|NCT05168800|470877525|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
130795845|NCT05168800|470877526|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
130795846|NCT05168800|470877524|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
130795847|NCT05168800|470877525|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
130795848|NCT05168800|470877526|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
130795849|NCT05168800|470877524|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
130795850|NCT05168800|470877525|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
130795851|NCT05168800|470877526|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
130795852|NCT05168800|470877524|FG000|Time 2 Survey|Withdrawal by Subject|1|||
130795853|NCT05168800|470877525|FG001|Time 2 Survey|Withdrawal by Subject|0|||
130795854|NCT05168800|470877526|FG002|Time 2 Survey|Withdrawal by Subject|1|||
130795855|NCT05168800|470877524|FG000|Time 3 Survey|Already excluded at Time 1|228|||
130795856|NCT05168800|470877525|FG001|Time 3 Survey|Already excluded at Time 1|200|||
130795857|NCT05168800|470877526|FG002|Time 3 Survey|Already excluded at Time 1|173|||
130795858|NCT05168800|470877524|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
130795859|NCT05168800|470877525|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
130795860|NCT05168800|470877526|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
130795861|NCT05168800|470877524|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
130795862|NCT05168800|470877525|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
130795863|NCT05168800|470877526|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
130795864|NCT05168800|470877524|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
130795865|NCT05168800|470877525|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
130795866|NCT05168800|470877526|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
130795867|NCT04556097|470877527|FG000|Overall Study|Death|0|||
130795868|NCT04556097|470877528|FG001|Overall Study|Death|5|||
130795869|NCT04556097|470877529|FG002|Overall Study|Death|0|||
130795870|NCT04556097|470877530|FG003|Overall Study|Death|0|||
130795871|NCT04556097|470877527|FG000|Overall Study|No caregiver|43|||
130795872|NCT04556097|470877528|FG001|Overall Study|No caregiver|53|||
130795873|NCT04556097|470877529|FG002|Overall Study|No caregiver|0|||
130795874|NCT04556097|470877530|FG003|Overall Study|No caregiver|0|||
130795875|NCT04556097|470877527|FG000|Overall Study|Ineligible, SNF|2|||
130795876|NCT04556097|470877528|FG001|Overall Study|Ineligible, SNF|2|||
130795877|NCT04556097|470877529|FG002|Overall Study|Ineligible, SNF|0|||
130795878|NCT04556097|470877530|FG003|Overall Study|Ineligible, SNF|0|||
130795879|NCT04556097|470877527|FG000|Overall Study|Ineligible, health|3|||
130795880|NCT04556097|470877528|FG001|Overall Study|Ineligible, health|4|||
130795881|NCT04556097|470877529|FG002|Overall Study|Ineligible, health|0|||
130795882|NCT04556097|470877530|FG003|Overall Study|Ineligible, health|0|||
130795883|NCT04556097|470877527|FG000|Overall Study|Ineligible, language|0|||
130795884|NCT04556097|470877528|FG001|Overall Study|Ineligible, language|1|||
130795885|NCT04556097|470877529|FG002|Overall Study|Ineligible, language|0|||
130795886|NCT04556097|470877530|FG003|Overall Study|Ineligible, language|0|||
130795887|NCT04556097|470877527|FG000|Overall Study|Ineligible, no longer in care management|0|||
130795888|NCT04556097|470877528|FG001|Overall Study|Ineligible, no longer in care management|2|||
130795889|NCT04556097|470877529|FG002|Overall Study|Ineligible, no longer in care management|1|||
130795890|NCT04556097|470877530|FG003|Overall Study|Ineligible, no longer in care management|0|||
130795891|NCT04556097|470877527|FG000|Overall Study|No dementia|13|||
130795892|NCT04556097|470877528|FG001|Overall Study|No dementia|3|||
130795893|NCT04556097|470877529|FG002|Overall Study|No dementia|0|||
130795894|NCT04556097|470877530|FG003|Overall Study|No dementia|0|||
130795895|NCT04556097|470877527|FG000|Overall Study|Missing identifier|2|||
130795896|NCT04556097|470877528|FG001|Overall Study|Missing identifier|4|||
130795897|NCT04556097|470877529|FG002|Overall Study|Missing identifier|0|||
130795898|NCT04556097|470877530|FG003|Overall Study|Missing identifier|0|||
130795899|NCT04556097|470877527|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
130795900|NCT04556097|470877528|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
130795901|NCT04556097|470877529|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
130795902|NCT04556097|470877530|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
130795903|NCT03916926|470879307|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
130795904|NCT03916926|470879308|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
130795905|NCT03916926|470879307|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
130795906|NCT03916926|470879308|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
130795907|NCT03916926|470879307|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
130795908|NCT03916926|470879308|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
130795909|NCT03916926|470879307|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
130795910|NCT03916926|470879308|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
130795911|NCT01081951|470879309|FG000|Overall Study|Death|54|||
130795912|NCT01081951|470879310|FG001|Overall Study|Death|47|||
130795913|NCT01081951|470879309|FG000|Overall Study|Withdrawal by Subject|2|||
130795914|NCT01081951|470879310|FG001|Overall Study|Withdrawal by Subject|6|||
130795915|NCT01081951|470879309|FG000|Overall Study|Allocated treatment but did not take it|0|||
130795916|NCT01081951|470879310|FG001|Overall Study|Allocated treatment but did not take it|1|||
130795917|NCT01081951|470879309|FG000|Overall Study|Lost to Follow-up|0|||
130795918|NCT01081951|470879310|FG001|Overall Study|Lost to Follow-up|1|||
130795919|NCT03765073|470879312|FG000|Stage 1|Lost to Follow-up|1|||
130795920|NCT03765073|470879313|FG001|Stage 1|Lost to Follow-up|0|||
130795921|NCT03765073|470879314|FG002|Stage 1|Lost to Follow-up|0|||
130795922|NCT03765073|470879315|FG003|Stage 1|Lost to Follow-up|0|||
130795923|NCT03765073|470879316|FG004|Stage 1|Lost to Follow-up|0|||
130795924|NCT03765073|470879317|FG005|Stage 1|Lost to Follow-up|0|||
130795925|NCT03765073|470879318|FG006|Stage 1|Lost to Follow-up|0|||
130795926|NCT03765073|470879319|FG007|Stage 1|Lost to Follow-up|0|||
130795927|NCT03765073|470879320|FG008|Stage 1|Lost to Follow-up|0|||
130795928|NCT03765073|470879321|FG009|Stage 1|Lost to Follow-up|0|||
130795929|NCT03765073|470879322|FG010|Stage 1|Lost to Follow-up|0|||
130795930|NCT03765073|470879323|FG011|Stage 1|Lost to Follow-up|0|||
130795931|NCT03765073|470879324|FG012|Stage 1|Lost to Follow-up|0|||
130795932|NCT03765073|470879325|FG013|Stage 1|Lost to Follow-up|0|||
130795933|NCT03765073|470879326|FG014|Stage 1|Lost to Follow-up|0|||
130795934|NCT03765073|470879327|FG015|Stage 1|Lost to Follow-up|0|||
130795935|NCT03765073|470879328|FG016|Stage 1|Lost to Follow-up|0|||
130795936|NCT03765073|470879329|FG017|Stage 1|Lost to Follow-up|0|||
130795937|NCT03765073|470879330|FG018|Stage 1|Lost to Follow-up|0|||
130795938|NCT03765073|470879331|FG019|Stage 1|Lost to Follow-up|0|||
130795939|NCT03765073|470879332|FG020|Stage 1|Lost to Follow-up|0|||
130795940|NCT03765073|470879312|FG000|Stage 1|Withdrawal by participant|0|||
130795941|NCT03765073|470879313|FG001|Stage 1|Withdrawal by participant|1|||
130795942|NCT03765073|470879314|FG002|Stage 1|Withdrawal by participant|0|||
130795943|NCT03765073|470879315|FG003|Stage 1|Withdrawal by participant|0|||
130795944|NCT03765073|470879316|FG004|Stage 1|Withdrawal by participant|0|||
130795945|NCT03765073|470879317|FG005|Stage 1|Withdrawal by participant|0|||
130795946|NCT03765073|470879318|FG006|Stage 1|Withdrawal by participant|0|||
130795947|NCT03765073|470879319|FG007|Stage 1|Withdrawal by participant|0|||
130795948|NCT03765073|470879320|FG008|Stage 1|Withdrawal by participant|0|||
130795949|NCT03765073|470879321|FG009|Stage 1|Withdrawal by participant|0|||
130795950|NCT03765073|470879322|FG010|Stage 1|Withdrawal by participant|0|||
130795951|NCT03765073|470879323|FG011|Stage 1|Withdrawal by participant|0|||
130795952|NCT03765073|470879324|FG012|Stage 1|Withdrawal by participant|0|||
130795953|NCT03765073|470879325|FG013|Stage 1|Withdrawal by participant|0|||
130795954|NCT03765073|470879326|FG014|Stage 1|Withdrawal by participant|0|||
130795955|NCT03765073|470879327|FG015|Stage 1|Withdrawal by participant|0|||
130795956|NCT03765073|470879328|FG016|Stage 1|Withdrawal by participant|0|||
130795957|NCT03765073|470879329|FG017|Stage 1|Withdrawal by participant|0|||
130795958|NCT03765073|470879330|FG018|Stage 1|Withdrawal by participant|0|||
130795959|NCT03765073|470879331|FG019|Stage 1|Withdrawal by participant|0|||
130795960|NCT03765073|470879332|FG020|Stage 1|Withdrawal by participant|0|||
130795961|NCT03765073|470879312|FG000|Stage 2|Death|0|||
130795962|NCT03765073|470879313|FG001|Stage 2|Death|0|||
130795963|NCT03765073|470879314|FG002|Stage 2|Death|0|||
130795964|NCT03765073|470879315|FG003|Stage 2|Death|0|||
130795965|NCT03765073|470879316|FG004|Stage 2|Death|0|||
130795966|NCT03765073|470879317|FG005|Stage 2|Death|0|||
130795967|NCT03765073|470879318|FG006|Stage 2|Death|0|||
130795968|NCT03765073|470879319|FG007|Stage 2|Death|0|||
130795969|NCT03765073|470879320|FG008|Stage 2|Death|0|||
130795970|NCT03765073|470879321|FG009|Stage 2|Death|1|||
130795971|NCT03765073|470879322|FG010|Stage 2|Death|0|||
130795972|NCT03765073|470879323|FG011|Stage 2|Death|1|||
130795973|NCT03765073|470879324|FG012|Stage 2|Death|0|||
130795974|NCT03765073|470879325|FG013|Stage 2|Death|0|||
130795975|NCT03765073|470879326|FG014|Stage 2|Death|0|||
130795976|NCT03765073|470879327|FG015|Stage 2|Death|0|||
130795977|NCT03765073|470879328|FG016|Stage 2|Death|2|||
130795978|NCT03765073|470879329|FG017|Stage 2|Death|0|||
130795979|NCT03765073|470879330|FG018|Stage 2|Death|0|||
130795980|NCT03765073|470879331|FG019|Stage 2|Death|0|||
130795981|NCT03765073|470879332|FG020|Stage 2|Death|0|||
130795982|NCT03765073|470879312|FG000|Stage 2|Lost to Follow-up|0|||
130795983|NCT03765073|470879313|FG001|Stage 2|Lost to Follow-up|0|||
130795984|NCT03765073|470879314|FG002|Stage 2|Lost to Follow-up|0|||
130795985|NCT03765073|470879315|FG003|Stage 2|Lost to Follow-up|5|||
130795986|NCT03765073|470879316|FG004|Stage 2|Lost to Follow-up|1|||
130795987|NCT03765073|470879317|FG005|Stage 2|Lost to Follow-up|0|||
130795988|NCT03765073|470879318|FG006|Stage 2|Lost to Follow-up|3|||
130795989|NCT03765073|470879319|FG007|Stage 2|Lost to Follow-up|3|||
130795990|NCT03765073|470879320|FG008|Stage 2|Lost to Follow-up|1|||
130795991|NCT03765073|470879321|FG009|Stage 2|Lost to Follow-up|6|||
130795992|NCT03765073|470879322|FG010|Stage 2|Lost to Follow-up|5|||
130795993|NCT03765073|470879323|FG011|Stage 2|Lost to Follow-up|1|||
130795994|NCT03765073|470879324|FG012|Stage 2|Lost to Follow-up|1|||
130795995|NCT03765073|470879325|FG013|Stage 2|Lost to Follow-up|3|||
130795996|NCT03765073|470879326|FG014|Stage 2|Lost to Follow-up|3|||
130795997|NCT03765073|470879327|FG015|Stage 2|Lost to Follow-up|1|||
130795998|NCT03765073|470879328|FG016|Stage 2|Lost to Follow-up|6|||
130795999|NCT03765073|470879329|FG017|Stage 2|Lost to Follow-up|0|||
130796000|NCT03765073|470879330|FG018|Stage 2|Lost to Follow-up|0|||
130796001|NCT03765073|470879331|FG019|Stage 2|Lost to Follow-up|0|||
130796002|NCT03765073|470879332|FG020|Stage 2|Lost to Follow-up|0|||
130796003|NCT03765073|470879312|FG000|Stage 2|Other|0|||
130796004|NCT03765073|470879313|FG001|Stage 2|Other|0|||
130796005|NCT03765073|470879314|FG002|Stage 2|Other|0|||
130796006|NCT03765073|470879315|FG003|Stage 2|Other|0|||
130796007|NCT03765073|470879316|FG004|Stage 2|Other|0|||
130762697|NCT01267201|470753406|FG002|First Intervention Period|Withdrawal by Subject|0|||
130762698|NCT01267201|470753407|FG003|First Intervention Period|Withdrawal by Subject|0|||
130762699|NCT01267201|470753408|FG004|First Intervention Period|Withdrawal by Subject|0|||
130762700|NCT01267201|470753409|FG005|First Intervention Period|Withdrawal by Subject|0|||
130762701|NCT01267201|470753404|FG000|Second Intervention Period|Withdrawal by Subject|0|||
130762702|NCT01267201|470753405|FG001|Second Intervention Period|Withdrawal by Subject|1|||
130762703|NCT01267201|470753406|FG002|Second Intervention Period|Withdrawal by Subject|0|||
130762704|NCT01267201|470753407|FG003|Second Intervention Period|Withdrawal by Subject|0|||
130762705|NCT01267201|470753408|FG004|Second Intervention Period|Withdrawal by Subject|0|||
130762706|NCT01267201|470753409|FG005|Second Intervention Period|Withdrawal by Subject|0|||
130762707|NCT00501059|470753410|FG000|Overall Study|Protocol Violation|80|||
130762708|NCT00501059|470753411|FG001|Overall Study|Protocol Violation|69|||
130762709|NCT00501059|470753410|FG000|Overall Study|Death|140|||
130762710|NCT00501059|470753411|FG001|Overall Study|Death|137|||
130762711|NCT00501059|470753410|FG000|Overall Study|Other|236|||
130762712|NCT00501059|470753411|FG001|Overall Study|Other|239|||
130762713|NCT00501059|470753410|FG000|Overall Study|Missing end-of-study page|91|||
130762714|NCT00501059|470753411|FG001|Overall Study|Missing end-of-study page|92|||
130762715|NCT00501059|470753410|FG000|Overall Study|Clinical endpoint reached|110|||
130762716|NCT00501059|470753411|FG001|Overall Study|Clinical endpoint reached|123|||
130762717|NCT00501059|470753410|FG000|Overall Study|Insufficient therapeutic effect|4|||
130762718|NCT00501059|470753411|FG001|Overall Study|Insufficient therapeutic effect|5|||
130796008|NCT03765073|470879317|FG005|Stage 2|Other|0|||
130796009|NCT03765073|470879318|FG006|Stage 2|Other|0|||
130796010|NCT03765073|470879319|FG007|Stage 2|Other|1|||
130796011|NCT03765073|470879320|FG008|Stage 2|Other|1|||
130796012|NCT03765073|470879321|FG009|Stage 2|Other|3|||
130796013|NCT03765073|470879322|FG010|Stage 2|Other|0|||
130796014|NCT03765073|470879323|FG011|Stage 2|Other|0|||
130796015|NCT03765073|470879324|FG012|Stage 2|Other|0|||
130796016|NCT03765073|470879325|FG013|Stage 2|Other|0|||
130796017|NCT03765073|470879326|FG014|Stage 2|Other|0|||
130796018|NCT03765073|470879327|FG015|Stage 2|Other|1|||
130796019|NCT03765073|470879328|FG016|Stage 2|Other|2|||
130796020|NCT03765073|470879329|FG017|Stage 2|Other|0|||
130796021|NCT03765073|470879330|FG018|Stage 2|Other|0|||
130796022|NCT03765073|470879331|FG019|Stage 2|Other|0|||
130796023|NCT03765073|470879332|FG020|Stage 2|Other|0|||
130796024|NCT03765073|470879312|FG000|Stage 2|Withdrawal by parent/guardian|0|||
130796025|NCT03765073|470879313|FG001|Stage 2|Withdrawal by parent/guardian|0|||
130796026|NCT03765073|470879314|FG002|Stage 2|Withdrawal by parent/guardian|0|||
130796027|NCT03765073|470879315|FG003|Stage 2|Withdrawal by parent/guardian|0|||
130796028|NCT03765073|470879316|FG004|Stage 2|Withdrawal by parent/guardian|0|||
130796029|NCT03765073|470879317|FG005|Stage 2|Withdrawal by parent/guardian|0|||
130796030|NCT03765073|470879318|FG006|Stage 2|Withdrawal by parent/guardian|0|||
130796031|NCT03765073|470879319|FG007|Stage 2|Withdrawal by parent/guardian|0|||
130796032|NCT03765073|470879320|FG008|Stage 2|Withdrawal by parent/guardian|0|||
130796033|NCT03765073|470879321|FG009|Stage 2|Withdrawal by parent/guardian|0|||
130796034|NCT03765073|470879322|FG010|Stage 2|Withdrawal by parent/guardian|3|||
130796035|NCT03765073|470879323|FG011|Stage 2|Withdrawal by parent/guardian|3|||
130796036|NCT03765073|470879324|FG012|Stage 2|Withdrawal by parent/guardian|3|||
130796037|NCT03765073|470879325|FG013|Stage 2|Withdrawal by parent/guardian|1|||
130796038|NCT03765073|470879326|FG014|Stage 2|Withdrawal by parent/guardian|1|||
130796039|NCT03765073|470879327|FG015|Stage 2|Withdrawal by parent/guardian|0|||
130796040|NCT03765073|470879328|FG016|Stage 2|Withdrawal by parent/guardian|3|||
130796041|NCT03765073|470879329|FG017|Stage 2|Withdrawal by parent/guardian|0|||
130796042|NCT03765073|470879330|FG018|Stage 2|Withdrawal by parent/guardian|0|||
130796043|NCT03765073|470879331|FG019|Stage 2|Withdrawal by parent/guardian|0|||
130796044|NCT03765073|470879332|FG020|Stage 2|Withdrawal by parent/guardian|0|||
130796045|NCT03765073|470879312|FG000|Stage 2|Withdrawal by Subject|0|||
130796046|NCT03765073|470879313|FG001|Stage 2|Withdrawal by Subject|0|||
130796047|NCT03765073|470879314|FG002|Stage 2|Withdrawal by Subject|0|||
130796048|NCT03765073|470879315|FG003|Stage 2|Withdrawal by Subject|3|||
130796049|NCT03765073|470879316|FG004|Stage 2|Withdrawal by Subject|3|||
130796050|NCT03765073|470879317|FG005|Stage 2|Withdrawal by Subject|3|||
130796051|NCT03765073|470879318|FG006|Stage 2|Withdrawal by Subject|0|||
130796052|NCT03765073|470879319|FG007|Stage 2|Withdrawal by Subject|1|||
130796053|NCT03765073|470879320|FG008|Stage 2|Withdrawal by Subject|0|||
130796054|NCT03765073|470879321|FG009|Stage 2|Withdrawal by Subject|5|||
130796055|NCT03765073|470879322|FG010|Stage 2|Withdrawal by Subject|0|||
130796056|NCT03765073|470879323|FG011|Stage 2|Withdrawal by Subject|0|||
130796057|NCT03765073|470879324|FG012|Stage 2|Withdrawal by Subject|0|||
130796058|NCT03765073|470879325|FG013|Stage 2|Withdrawal by Subject|0|||
130796059|NCT03765073|470879326|FG014|Stage 2|Withdrawal by Subject|0|||
130796060|NCT03765073|470879327|FG015|Stage 2|Withdrawal by Subject|0|||
130796061|NCT03765073|470879328|FG016|Stage 2|Withdrawal by Subject|0|||
130796062|NCT03765073|470879329|FG017|Stage 2|Withdrawal by Subject|0|||
130796063|NCT03765073|470879330|FG018|Stage 2|Withdrawal by Subject|0|||
130796064|NCT03765073|470879331|FG019|Stage 2|Withdrawal by Subject|0|||
130796065|NCT03765073|470879332|FG020|Stage 2|Withdrawal by Subject|0|||
130796066|NCT03765073|470879312|FG000|Stage 3|Adverse Event|0|||
130796067|NCT03765073|470879313|FG001|Stage 3|Adverse Event|0|||
130796068|NCT03765073|470879314|FG002|Stage 3|Adverse Event|0|||
130796069|NCT03765073|470879315|FG003|Stage 3|Adverse Event|0|||
130796070|NCT03765073|470879316|FG004|Stage 3|Adverse Event|0|||
130796071|NCT03765073|470879317|FG005|Stage 3|Adverse Event|0|||
130796072|NCT03765073|470879318|FG006|Stage 3|Adverse Event|0|||
130796073|NCT03765073|470879319|FG007|Stage 3|Adverse Event|0|||
130796074|NCT03765073|470879320|FG008|Stage 3|Adverse Event|0|||
130796075|NCT03765073|470879321|FG009|Stage 3|Adverse Event|0|||
130796076|NCT03765073|470879322|FG010|Stage 3|Adverse Event|0|||
130796077|NCT03765073|470879323|FG011|Stage 3|Adverse Event|0|||
130796078|NCT03765073|470879324|FG012|Stage 3|Adverse Event|0|||
130796079|NCT03765073|470879325|FG013|Stage 3|Adverse Event|0|||
130796080|NCT03765073|470879326|FG014|Stage 3|Adverse Event|0|||
130796081|NCT03765073|470879327|FG015|Stage 3|Adverse Event|0|||
130796082|NCT03765073|470879328|FG016|Stage 3|Adverse Event|0|||
130796083|NCT03765073|470879329|FG017|Stage 3|Adverse Event|0|||
130796084|NCT03765073|470879330|FG018|Stage 3|Adverse Event|1|||
130796085|NCT03765073|470879331|FG019|Stage 3|Adverse Event|0|||
130796086|NCT03765073|470879332|FG020|Stage 3|Adverse Event|0|||
130796087|NCT03765073|470879312|FG000|Stage 3|Death|0|||
130796088|NCT03765073|470879313|FG001|Stage 3|Death|0|||
130796089|NCT03765073|470879314|FG002|Stage 3|Death|0|||
130796090|NCT03765073|470879315|FG003|Stage 3|Death|0|||
130796091|NCT03765073|470879316|FG004|Stage 3|Death|0|||
130796092|NCT03765073|470879317|FG005|Stage 3|Death|0|||
130796093|NCT03765073|470879318|FG006|Stage 3|Death|0|||
130796094|NCT03765073|470879319|FG007|Stage 3|Death|0|||
130796095|NCT03765073|470879320|FG008|Stage 3|Death|0|||
130796096|NCT03765073|470879321|FG009|Stage 3|Death|0|||
130796097|NCT03765073|470879322|FG010|Stage 3|Death|0|||
130796098|NCT03765073|470879323|FG011|Stage 3|Death|0|||
130796099|NCT03765073|470879324|FG012|Stage 3|Death|0|||
130796100|NCT03765073|470879325|FG013|Stage 3|Death|0|||
130796101|NCT03765073|470879326|FG014|Stage 3|Death|0|||
130796102|NCT03765073|470879327|FG015|Stage 3|Death|0|||
130796103|NCT03765073|470879328|FG016|Stage 3|Death|0|||
130796104|NCT03765073|470879329|FG017|Stage 3|Death|0|||
130796105|NCT03765073|470879330|FG018|Stage 3|Death|0|||
130796106|NCT03765073|470879331|FG019|Stage 3|Death|3|||
130796107|NCT03765073|470879332|FG020|Stage 3|Death|2|||
130796108|NCT03765073|470879312|FG000|Stage 3|Lost to Follow-up|0|||
130796109|NCT03765073|470879313|FG001|Stage 3|Lost to Follow-up|0|||
130796110|NCT03765073|470879314|FG002|Stage 3|Lost to Follow-up|0|||
130796111|NCT03765073|470879315|FG003|Stage 3|Lost to Follow-up|0|||
130796112|NCT03765073|470879316|FG004|Stage 3|Lost to Follow-up|0|||
130796113|NCT03765073|470879317|FG005|Stage 3|Lost to Follow-up|0|||
130796114|NCT03765073|470879318|FG006|Stage 3|Lost to Follow-up|0|||
130796115|NCT03765073|470879319|FG007|Stage 3|Lost to Follow-up|0|||
130796116|NCT03765073|470879320|FG008|Stage 3|Lost to Follow-up|0|||
130796117|NCT03765073|470879321|FG009|Stage 3|Lost to Follow-up|0|||
130796118|NCT03765073|470879322|FG010|Stage 3|Lost to Follow-up|0|||
130796119|NCT03765073|470879323|FG011|Stage 3|Lost to Follow-up|0|||
130796120|NCT03765073|470879324|FG012|Stage 3|Lost to Follow-up|0|||
130796121|NCT03765073|470879325|FG013|Stage 3|Lost to Follow-up|0|||
130796122|NCT03765073|470879326|FG014|Stage 3|Lost to Follow-up|0|||
130796123|NCT03765073|470879327|FG015|Stage 3|Lost to Follow-up|0|||
130796124|NCT03765073|470879328|FG016|Stage 3|Lost to Follow-up|0|||
130796125|NCT03765073|470879329|FG017|Stage 3|Lost to Follow-up|8|||
130796126|NCT03765073|470879330|FG018|Stage 3|Lost to Follow-up|5|||
130796127|NCT03765073|470879331|FG019|Stage 3|Lost to Follow-up|7|||
130796128|NCT03765073|470879332|FG020|Stage 3|Lost to Follow-up|4|||
130796129|NCT03765073|470879312|FG000|Stage 3|No longer meets eligibility criteria|0|||
130796130|NCT03765073|470879313|FG001|Stage 3|No longer meets eligibility criteria|0|||
130796131|NCT03765073|470879314|FG002|Stage 3|No longer meets eligibility criteria|0|||
130796132|NCT03765073|470879315|FG003|Stage 3|No longer meets eligibility criteria|0|||
130796133|NCT03765073|470879316|FG004|Stage 3|No longer meets eligibility criteria|0|||
130796134|NCT03765073|470879317|FG005|Stage 3|No longer meets eligibility criteria|0|||
130796135|NCT03765073|470879318|FG006|Stage 3|No longer meets eligibility criteria|0|||
130796136|NCT03765073|470879319|FG007|Stage 3|No longer meets eligibility criteria|0|||
130796137|NCT03765073|470879320|FG008|Stage 3|No longer meets eligibility criteria|0|||
130796138|NCT03765073|470879321|FG009|Stage 3|No longer meets eligibility criteria|0|||
130796139|NCT03765073|470879322|FG010|Stage 3|No longer meets eligibility criteria|0|||
130796140|NCT03765073|470879323|FG011|Stage 3|No longer meets eligibility criteria|0|||
130796141|NCT03765073|470879324|FG012|Stage 3|No longer meets eligibility criteria|0|||
130796142|NCT03765073|470879325|FG013|Stage 3|No longer meets eligibility criteria|0|||
130796143|NCT03765073|470879326|FG014|Stage 3|No longer meets eligibility criteria|0|||
130796144|NCT03765073|470879327|FG015|Stage 3|No longer meets eligibility criteria|0|||
130796145|NCT03765073|470879328|FG016|Stage 3|No longer meets eligibility criteria|0|||
130796146|NCT03765073|470879329|FG017|Stage 3|No longer meets eligibility criteria|0|||
130796147|NCT03765073|470879330|FG018|Stage 3|No longer meets eligibility criteria|1|||
130796148|NCT03765073|470879331|FG019|Stage 3|No longer meets eligibility criteria|0|||
130796149|NCT03765073|470879332|FG020|Stage 3|No longer meets eligibility criteria|1|||
130796150|NCT03765073|470879312|FG000|Stage 3|Other|0|||
130796151|NCT03765073|470879313|FG001|Stage 3|Other|0|||
130796152|NCT03765073|470879314|FG002|Stage 3|Other|0|||
130796153|NCT03765073|470879315|FG003|Stage 3|Other|0|||
130796154|NCT03765073|470879316|FG004|Stage 3|Other|0|||
130796155|NCT03765073|470879317|FG005|Stage 3|Other|0|||
130796156|NCT03765073|470879318|FG006|Stage 3|Other|0|||
130796157|NCT03765073|470879319|FG007|Stage 3|Other|0|||
130796158|NCT03765073|470879320|FG008|Stage 3|Other|0|||
130796159|NCT03765073|470879321|FG009|Stage 3|Other|0|||
130796160|NCT03765073|470879322|FG010|Stage 3|Other|0|||
130796161|NCT03765073|470879323|FG011|Stage 3|Other|0|||
130796162|NCT03765073|470879324|FG012|Stage 3|Other|0|||
130796163|NCT03765073|470879325|FG013|Stage 3|Other|0|||
130796164|NCT03765073|470879326|FG014|Stage 3|Other|0|||
130796165|NCT03765073|470879327|FG015|Stage 3|Other|0|||
130796166|NCT03765073|470879328|FG016|Stage 3|Other|0|||
130796167|NCT03765073|470879329|FG017|Stage 3|Other|1|||
130796168|NCT03765073|470879330|FG018|Stage 3|Other|2|||
130796169|NCT03765073|470879331|FG019|Stage 3|Other|2|||
130796170|NCT03765073|470879332|FG020|Stage 3|Other|2|||
130796171|NCT03765073|470879312|FG000|Stage 3|Withdrawal by parent/guardian|0|||
130796172|NCT03765073|470879313|FG001|Stage 3|Withdrawal by parent/guardian|0|||
130796173|NCT03765073|470879314|FG002|Stage 3|Withdrawal by parent/guardian|0|||
130796174|NCT03765073|470879315|FG003|Stage 3|Withdrawal by parent/guardian|0|||
130796175|NCT03765073|470879316|FG004|Stage 3|Withdrawal by parent/guardian|0|||
130796176|NCT03765073|470879317|FG005|Stage 3|Withdrawal by parent/guardian|0|||
130796177|NCT03765073|470879318|FG006|Stage 3|Withdrawal by parent/guardian|0|||
130796178|NCT03765073|470879319|FG007|Stage 3|Withdrawal by parent/guardian|0|||
130796179|NCT03765073|470879320|FG008|Stage 3|Withdrawal by parent/guardian|0|||
130796180|NCT03765073|470879321|FG009|Stage 3|Withdrawal by parent/guardian|0|||
130796181|NCT03765073|470879322|FG010|Stage 3|Withdrawal by parent/guardian|0|||
130796182|NCT03765073|470879323|FG011|Stage 3|Withdrawal by parent/guardian|0|||
130796183|NCT03765073|470879324|FG012|Stage 3|Withdrawal by parent/guardian|0|||
130796184|NCT03765073|470879325|FG013|Stage 3|Withdrawal by parent/guardian|0|||
130796185|NCT03765073|470879326|FG014|Stage 3|Withdrawal by parent/guardian|0|||
130796186|NCT03765073|470879327|FG015|Stage 3|Withdrawal by parent/guardian|0|||
130796187|NCT03765073|470879328|FG016|Stage 3|Withdrawal by parent/guardian|0|||
130796188|NCT03765073|470879329|FG017|Stage 3|Withdrawal by parent/guardian|0|||
130796189|NCT03765073|470879330|FG018|Stage 3|Withdrawal by parent/guardian|0|||
130796190|NCT03765073|470879331|FG019|Stage 3|Withdrawal by parent/guardian|6|||
130796191|NCT03765073|470879332|FG020|Stage 3|Withdrawal by parent/guardian|9|||
130796192|NCT03765073|470879312|FG000|Stage 3|Withdrawal by Subject|0|||
130796193|NCT03765073|470879313|FG001|Stage 3|Withdrawal by Subject|0|||
130796194|NCT03765073|470879314|FG002|Stage 3|Withdrawal by Subject|0|||
130796195|NCT03765073|470879315|FG003|Stage 3|Withdrawal by Subject|0|||
130796196|NCT03765073|470879316|FG004|Stage 3|Withdrawal by Subject|0|||
130796197|NCT03765073|470879317|FG005|Stage 3|Withdrawal by Subject|0|||
130796198|NCT03765073|470879318|FG006|Stage 3|Withdrawal by Subject|0|||
130796199|NCT03765073|470879319|FG007|Stage 3|Withdrawal by Subject|0|||
130796200|NCT03765073|470879320|FG008|Stage 3|Withdrawal by Subject|0|||
130796201|NCT03765073|470879321|FG009|Stage 3|Withdrawal by Subject|0|||
130796202|NCT03765073|470879322|FG010|Stage 3|Withdrawal by Subject|0|||
130796203|NCT03765073|470879323|FG011|Stage 3|Withdrawal by Subject|0|||
130796204|NCT03765073|470879324|FG012|Stage 3|Withdrawal by Subject|0|||
130796205|NCT03765073|470879325|FG013|Stage 3|Withdrawal by Subject|0|||
130796206|NCT03765073|470879326|FG014|Stage 3|Withdrawal by Subject|0|||
130796207|NCT03765073|470879327|FG015|Stage 3|Withdrawal by Subject|0|||
130796208|NCT03765073|470879328|FG016|Stage 3|Withdrawal by Subject|0|||
130796209|NCT03765073|470879329|FG017|Stage 3|Withdrawal by Subject|8|||
130796210|NCT03765073|470879330|FG018|Stage 3|Withdrawal by Subject|11|||
130796211|NCT03765073|470879331|FG019|Stage 3|Withdrawal by Subject|0|||
130796212|NCT03765073|470879332|FG020|Stage 3|Withdrawal by Subject|0|||
130796213|NCT04537299|470879333|FG000|Overall Study|Withdrawal by Subject|2|||
130796214|NCT04537299|470879334|FG001|Overall Study|Withdrawal by Subject|0|||
130796215|NCT04537299|470879333|FG000|Overall Study|Protocol Violation|1|||
130796216|NCT04537299|470879334|FG001|Overall Study|Protocol Violation|1|||
130796217|NCT03806296|470879337|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
130796218|NCT03806296|470879338|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
130796219|NCT03806296|470879339|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
130796220|NCT03806296|470879337|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
130796221|NCT03806296|470879338|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
130796222|NCT03806296|470879339|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
130796223|NCT03806296|470879337|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
130796224|NCT03806296|470879338|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
130822788|NCT01815424|470980597|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
130762719|NCT00501059|470753410|FG000|Overall Study|Consent withdrawn by subject|817|||
130762720|NCT00501059|470753411|FG001|Overall Study|Consent withdrawn by subject|873|||
130762721|NCT00501059|470753410|FG000|Overall Study|Non-compliant with study treatment|23|||
130762722|NCT00501059|470753411|FG001|Overall Study|Non-compliant with study treatment|16|||
130762723|NCT00501059|470753410|FG000|Overall Study|Reason not given|3|||
130762724|NCT00501059|470753411|FG001|Overall Study|Reason not given|1|||
130762725|NCT00501059|470753410|FG000|Overall Study|Adverse Event|129|||
130762726|NCT00501059|470753411|FG001|Overall Study|Adverse Event|122|||
130762727|NCT00501059|470753410|FG000|Overall Study|Lost to Follow-up|210|||
130762728|NCT00501059|470753411|FG001|Overall Study|Lost to Follow-up|198|||
130762729|NCT00501059|470753410|FG000|Overall Study|Not treated|25|||
130762730|NCT00501059|470753411|FG001|Overall Study|Not treated|17|||
130762731|NCT00955968|470753415|FG000|Overall Study|Death|2|||
130762732|NCT00955968|470753416|FG001|Overall Study|Death|4|||
130762733|NCT00955968|470753415|FG000|Overall Study|Withdrawal by Subject|35|||
130762734|NCT00955968|470753416|FG001|Overall Study|Withdrawal by Subject|31|||
130762735|NCT00955968|470753415|FG000|Overall Study|Lost to Follow-up|45|||
130762736|NCT00955968|470753416|FG001|Overall Study|Lost to Follow-up|39|||
130762737|NCT00955968|470753415|FG000|Overall Study|Site closed|55|||
130762738|NCT00955968|470753416|FG001|Overall Study|Site closed|52|||
130762739|NCT04326439|470753421|FG000|Overall Study|Withdrawal by Subject|1|||
130762740|NCT04326439|470753422|FG001|Overall Study|Withdrawal by Subject|0|||
130762741|NCT04326439|470753421|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
130762742|NCT04326439|470753422|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
130762743|NCT04326439|470753421|FG000|Overall Study|Relapse after Induction 2|0|||
130762744|NCT04326439|470753422|FG001|Overall Study|Relapse after Induction 2|1|||
130762745|NCT04326439|470753421|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
130762746|NCT04326439|470753422|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
130762747|NCT00204477|470753425|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
130762748|NCT00204477|470753426|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
130762749|NCT00204477|470753425|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
130762750|NCT00204477|470753426|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
130762751|NCT04272606|470753429|FG000|Overall Study|Protocol Violation|1|||
130762752|NCT04272606|470753430|FG001|Overall Study|Protocol Violation|1|||
130762753|NCT04272606|470753429|FG000|Overall Study|Physician Decision|0|||
130762754|NCT04272606|470753430|FG001|Overall Study|Physician Decision|1|||
130762755|NCT00710684|470753431|FG000|Overall Study|Adverse Event|11|||
130762756|NCT00710684|470753432|FG001|Overall Study|Adverse Event|19|||
130762757|NCT00710684|470753433|FG002|Overall Study|Adverse Event|16|||
130762758|NCT00710684|470753431|FG000|Overall Study|Lack of Efficacy|4|||
130762759|NCT00710684|470753432|FG001|Overall Study|Lack of Efficacy|3|||
130762760|NCT00710684|470753433|FG002|Overall Study|Lack of Efficacy|5|||
130762761|NCT00710684|470753431|FG000|Overall Study|Protocol Violation|5|||
130762762|NCT00710684|470753432|FG001|Overall Study|Protocol Violation|5|||
130762763|NCT00710684|470753433|FG002|Overall Study|Protocol Violation|5|||
130762764|NCT00710684|470753431|FG000|Overall Study|Lost to Follow-up|4|||
130762765|NCT00710684|470753432|FG001|Overall Study|Lost to Follow-up|6|||
130762766|NCT00710684|470753433|FG002|Overall Study|Lost to Follow-up|7|||
130762767|NCT00710684|470753431|FG000|Overall Study|Physician Decision|0|||
130762768|NCT00710684|470753432|FG001|Overall Study|Physician Decision|2|||
130762769|NCT00710684|470753433|FG002|Overall Study|Physician Decision|4|||
130762770|NCT00710684|470753431|FG000|Overall Study|Withdrawal by Subject|24|||
130762771|NCT00710684|470753432|FG001|Overall Study|Withdrawal by Subject|18|||
130762772|NCT00710684|470753433|FG002|Overall Study|Withdrawal by Subject|11|||
130762773|NCT00710684|470753431|FG000|Overall Study|Missing|1|||
130762774|NCT00710684|470753432|FG001|Overall Study|Missing|0|||
130762775|NCT00710684|470753433|FG002|Overall Study|Missing|0|||
130762776|NCT00710684|470753431|FG000|Overall Study|Did not continue after week 24|25|||
130762777|NCT00710684|470753432|FG001|Overall Study|Did not continue after week 24|21|||
130762778|NCT00710684|470753433|FG002|Overall Study|Did not continue after week 24|16|||
130762779|NCT04778059|470753434|FG000|Overall Study|Death|2|||
130762780|NCT04778059|470753435|FG001|Overall Study|Death|2|||
130762781|NCT04778059|470753436|FG002|Overall Study|Death|1|||
130762782|NCT04778059|470753437|FG003|Overall Study|Death|1|||
130762783|NCT04778059|470753438|FG004|Overall Study|Death|1|||
130762784|NCT04778059|470753434|FG000|Overall Study|Lost to Follow-up|0|||
130762785|NCT04778059|470753435|FG001|Overall Study|Lost to Follow-up|0|||
130762786|NCT04778059|470753436|FG002|Overall Study|Lost to Follow-up|0|||
130762787|NCT04778059|470753437|FG003|Overall Study|Lost to Follow-up|0|||
130762788|NCT04778059|470753438|FG004|Overall Study|Lost to Follow-up|1|||
130762789|NCT04778059|470753434|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
130762790|NCT04778059|470753435|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
130762791|NCT04778059|470753436|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
130762792|NCT04778059|470753437|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
130796225|NCT03806296|470879339|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
130796226|NCT00876343|470879346|FG000|Overall Study|Adverse Event|7|||
130796227|NCT00876343|470879347|FG001|Overall Study|Adverse Event|8|||
130796228|NCT00876343|470879348|FG002|Overall Study|Adverse Event|2|||
130796229|NCT00876343|470879346|FG000|Overall Study|Withdrawal by Subject|4|||
130796230|NCT00876343|470879347|FG001|Overall Study|Withdrawal by Subject|4|||
130796231|NCT00876343|470879348|FG002|Overall Study|Withdrawal by Subject|3|||
130796232|NCT00876343|470879346|FG000|Overall Study|Lack of Efficacy|0|||
130796233|NCT00876343|470879347|FG001|Overall Study|Lack of Efficacy|0|||
130796234|NCT00876343|470879348|FG002|Overall Study|Lack of Efficacy|1|||
130796235|NCT00876343|470879346|FG000|Overall Study|Protocol Violation|4|||
130796236|NCT00876343|470879347|FG001|Overall Study|Protocol Violation|1|||
130796237|NCT00876343|470879348|FG002|Overall Study|Protocol Violation|1|||
130796238|NCT00876343|470879346|FG000|Overall Study|Physician Decision|0|||
130796239|NCT00876343|470879347|FG001|Overall Study|Physician Decision|1|||
130796240|NCT00876343|470879348|FG002|Overall Study|Physician Decision|1|||
130796241|NCT00876343|470879346|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
130796242|NCT00876343|470879347|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
130796243|NCT00876343|470879348|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
130796244|NCT00876343|470879346|FG000|Overall Study|Change of residence or other commitments|2|||
130796245|NCT00876343|470879347|FG001|Overall Study|Change of residence or other commitments|2|||
130796246|NCT00876343|470879348|FG002|Overall Study|Change of residence or other commitments|3|||
130796247|NCT01933932|470879351|FG000|Overall Study|Death|173|||
130796248|NCT01933932|470879352|FG001|Overall Study|Death|163|||
130796249|NCT01933932|470879351|FG000|Overall Study|Withdrawal by Subject|11|||
130796250|NCT01933932|470879352|FG001|Overall Study|Withdrawal by Subject|14|||
130796251|NCT01933932|470879351|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130796252|NCT01933932|470879352|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130796253|NCT01925794|470879360|FG000|180 Days|Death|2|||
130796254|NCT01925794|470879360|FG000|180 Days|Withdrawal by Subject|2|||
130796255|NCT01925794|470879360|FG000|270 Days|Death|2|||
130796256|NCT01925794|470879360|FG000|270 Days|Protocol Violation|3|||
130796257|NCT00790036|470879361|FG000|Overall Study|Abnormal lab values|3|||
130796258|NCT00790036|470879362|FG001|Overall Study|Abnormal lab values|2|||
130796259|NCT00790036|470879361|FG000|Overall Study|Administrative problems|5|||
130796260|NCT00790036|470879362|FG001|Overall Study|Administrative problems|9|||
130796261|NCT00790036|470879361|FG000|Overall Study|Adverse Event|113|||
130796262|NCT00790036|470879362|FG001|Overall Study|Adverse Event|44|||
130796263|NCT00790036|470879361|FG000|Overall Study|Death|1|||
130796264|NCT00790036|470879362|FG001|Overall Study|Death|0|||
130796265|NCT00790036|470879361|FG000|Overall Study|Disease progression|24|||
130796266|NCT00790036|470879362|FG001|Overall Study|Disease progression|48|||
130796267|NCT00790036|470879361|FG000|Overall Study|Lost to Follow-up|1|||
130796268|NCT00790036|470879362|FG001|Overall Study|Lost to Follow-up|2|||
130796269|NCT00790036|470879361|FG000|Overall Study|Protocol Violation|10|||
130796270|NCT00790036|470879362|FG001|Overall Study|Protocol Violation|2|||
130796271|NCT00790036|470879361|FG000|Overall Study|Withdrawal by Subject|18|||
130796272|NCT00790036|470879362|FG001|Overall Study|Withdrawal by Subject|7|||
130796273|NCT00790036|470879361|FG000|Overall Study|Subject/guardian decision|20|||
130796274|NCT00790036|470879362|FG001|Overall Study|Subject/guardian decision|7|||
130796275|NCT03126110|470879371|FG000|Phase 1|Death|2|||
130796276|NCT03126110|470879372|FG001|Phase 1|Death|2|||
130796277|NCT03126110|470879373|FG002|Phase 1|Death|4|||
130796278|NCT03126110|470879374|FG003|Phase 1|Death|3|||
130796279|NCT03126110|470879375|FG004|Phase 1|Death|4|||
130796280|NCT03126110|470879376|FG005|Phase 1|Death|4|||
130796281|NCT03126110|470879377|FG006|Phase 1|Death|3|||
130796282|NCT03126110|470879378|FG007|Phase 1|Death|4|||
130796283|NCT03126110|470879379|FG008|Phase 1|Death|5|||
130796284|NCT03126110|470879380|FG009|Phase 1|Death|2|||
130796285|NCT03126110|470879381|FG010|Phase 1|Death|6|||
130796286|NCT03126110|470879382|FG011|Phase 1|Death|0|||
130796287|NCT03126110|470879383|FG012|Phase 1|Death|0|||
130796288|NCT03126110|470879384|FG013|Phase 1|Death|0|||
130796289|NCT03126110|470879385|FG014|Phase 1|Death|0|||
130796290|NCT03126110|470879386|FG015|Phase 1|Death|0|||
130796291|NCT03126110|470879387|FG016|Phase 1|Death|0|||
130796292|NCT03126110|470879371|FG000|Phase 1|Lost to Follow-up|0|||
130796293|NCT03126110|470879372|FG001|Phase 1|Lost to Follow-up|1|||
130796294|NCT03126110|470879373|FG002|Phase 1|Lost to Follow-up|0|||
130796295|NCT03126110|470879374|FG003|Phase 1|Lost to Follow-up|0|||
130796296|NCT03126110|470879375|FG004|Phase 1|Lost to Follow-up|0|||
130796297|NCT03126110|470879376|FG005|Phase 1|Lost to Follow-up|0|||
130796298|NCT03126110|470879377|FG006|Phase 1|Lost to Follow-up|0|||
130796299|NCT03126110|470879378|FG007|Phase 1|Lost to Follow-up|0|||
130796300|NCT03126110|470879379|FG008|Phase 1|Lost to Follow-up|1|||
130796301|NCT03126110|470879380|FG009|Phase 1|Lost to Follow-up|0|||
130796302|NCT03126110|470879381|FG010|Phase 1|Lost to Follow-up|0|||
130796303|NCT03126110|470879382|FG011|Phase 1|Lost to Follow-up|0|||
130796304|NCT03126110|470879383|FG012|Phase 1|Lost to Follow-up|0|||
130796305|NCT03126110|470879384|FG013|Phase 1|Lost to Follow-up|0|||
130796306|NCT03126110|470879385|FG014|Phase 1|Lost to Follow-up|0|||
130796307|NCT03126110|470879386|FG015|Phase 1|Lost to Follow-up|0|||
130796308|NCT03126110|470879387|FG016|Phase 1|Lost to Follow-up|0|||
130796309|NCT03126110|470879371|FG000|Phase 1|Withdrawal by Subject|1|||
130796310|NCT03126110|470879372|FG001|Phase 1|Withdrawal by Subject|0|||
130796311|NCT03126110|470879373|FG002|Phase 1|Withdrawal by Subject|0|||
130796312|NCT03126110|470879374|FG003|Phase 1|Withdrawal by Subject|1|||
130796313|NCT03126110|470879375|FG004|Phase 1|Withdrawal by Subject|1|||
130796314|NCT03126110|470879376|FG005|Phase 1|Withdrawal by Subject|0|||
130796315|NCT03126110|470879377|FG006|Phase 1|Withdrawal by Subject|0|||
130796316|NCT03126110|470879378|FG007|Phase 1|Withdrawal by Subject|0|||
130796317|NCT03126110|470879379|FG008|Phase 1|Withdrawal by Subject|2|||
130796318|NCT03126110|470879380|FG009|Phase 1|Withdrawal by Subject|1|||
130796319|NCT03126110|470879381|FG010|Phase 1|Withdrawal by Subject|0|||
130796320|NCT03126110|470879382|FG011|Phase 1|Withdrawal by Subject|0|||
130796321|NCT03126110|470879383|FG012|Phase 1|Withdrawal by Subject|0|||
130796322|NCT03126110|470879384|FG013|Phase 1|Withdrawal by Subject|0|||
130796323|NCT03126110|470879385|FG014|Phase 1|Withdrawal by Subject|0|||
130796324|NCT03126110|470879386|FG015|Phase 1|Withdrawal by Subject|0|||
130796325|NCT03126110|470879387|FG016|Phase 1|Withdrawal by Subject|0|||
130796326|NCT03126110|470879371|FG000|Phase 1|Safety follow-up no longer necessary|1|||
130796327|NCT03126110|470879372|FG001|Phase 1|Safety follow-up no longer necessary|0|||
130796328|NCT03126110|470879373|FG002|Phase 1|Safety follow-up no longer necessary|0|||
130796329|NCT03126110|470879374|FG003|Phase 1|Safety follow-up no longer necessary|0|||
130796330|NCT03126110|470879375|FG004|Phase 1|Safety follow-up no longer necessary|0|||
130796331|NCT03126110|470879376|FG005|Phase 1|Safety follow-up no longer necessary|0|||
130796332|NCT03126110|470879377|FG006|Phase 1|Safety follow-up no longer necessary|0|||
130796333|NCT03126110|470879378|FG007|Phase 1|Safety follow-up no longer necessary|0|||
130796334|NCT03126110|470879379|FG008|Phase 1|Safety follow-up no longer necessary|0|||
130796335|NCT03126110|470879380|FG009|Phase 1|Safety follow-up no longer necessary|0|||
130796336|NCT03126110|470879381|FG010|Phase 1|Safety follow-up no longer necessary|0|||
130796337|NCT03126110|470879382|FG011|Phase 1|Safety follow-up no longer necessary|0|||
130796338|NCT03126110|470879383|FG012|Phase 1|Safety follow-up no longer necessary|0|||
130796339|NCT03126110|470879384|FG013|Phase 1|Safety follow-up no longer necessary|0|||
130796340|NCT03126110|470879385|FG014|Phase 1|Safety follow-up no longer necessary|0|||
130796341|NCT03126110|470879386|FG015|Phase 1|Safety follow-up no longer necessary|0|||
130796342|NCT03126110|470879387|FG016|Phase 1|Safety follow-up no longer necessary|0|||
130796343|NCT03126110|470879371|FG000|Phase 1|Survival follow-up no longer necessary|0|||
130796344|NCT03126110|470879372|FG001|Phase 1|Survival follow-up no longer necessary|0|||
130796345|NCT03126110|470879373|FG002|Phase 1|Survival follow-up no longer necessary|1|||
130796346|NCT03126110|470879374|FG003|Phase 1|Survival follow-up no longer necessary|0|||
130796347|NCT03126110|470879375|FG004|Phase 1|Survival follow-up no longer necessary|0|||
130796348|NCT03126110|470879376|FG005|Phase 1|Survival follow-up no longer necessary|0|||
130796349|NCT03126110|470879377|FG006|Phase 1|Survival follow-up no longer necessary|0|||
130796350|NCT03126110|470879378|FG007|Phase 1|Survival follow-up no longer necessary|0|||
130796351|NCT03126110|470879379|FG008|Phase 1|Survival follow-up no longer necessary|0|||
130796352|NCT03126110|470879380|FG009|Phase 1|Survival follow-up no longer necessary|0|||
130796353|NCT03126110|470879381|FG010|Phase 1|Survival follow-up no longer necessary|0|||
130796354|NCT03126110|470879382|FG011|Phase 1|Survival follow-up no longer necessary|0|||
130796355|NCT03126110|470879383|FG012|Phase 1|Survival follow-up no longer necessary|0|||
130796356|NCT03126110|470879384|FG013|Phase 1|Survival follow-up no longer necessary|0|||
130796357|NCT03126110|470879385|FG014|Phase 1|Survival follow-up no longer necessary|0|||
130796358|NCT03126110|470879386|FG015|Phase 1|Survival follow-up no longer necessary|0|||
130796359|NCT03126110|470879387|FG016|Phase 1|Survival follow-up no longer necessary|0|||
130796360|NCT03126110|470879371|FG000|Phase 2|Study terminated by the sponsor|0|||
130796361|NCT03126110|470879372|FG001|Phase 2|Study terminated by the sponsor|0|||
130796362|NCT03126110|470879373|FG002|Phase 2|Study terminated by the sponsor|0|||
130796363|NCT03126110|470879374|FG003|Phase 2|Study terminated by the sponsor|0|||
130796364|NCT03126110|470879375|FG004|Phase 2|Study terminated by the sponsor|0|||
130796365|NCT03126110|470879376|FG005|Phase 2|Study terminated by the sponsor|0|||
130796366|NCT03126110|470879377|FG006|Phase 2|Study terminated by the sponsor|0|||
130796367|NCT03126110|470879378|FG007|Phase 2|Study terminated by the sponsor|0|||
130796368|NCT03126110|470879379|FG008|Phase 2|Study terminated by the sponsor|0|||
130796369|NCT03126110|470879380|FG009|Phase 2|Study terminated by the sponsor|0|||
130796370|NCT03126110|470879381|FG010|Phase 2|Study terminated by the sponsor|0|||
130796371|NCT03126110|470879382|FG011|Phase 2|Study terminated by the sponsor|0|||
130796372|NCT03126110|470879383|FG012|Phase 2|Study terminated by the sponsor|0|||
130796373|NCT03126110|470879384|FG013|Phase 2|Study terminated by the sponsor|4|||
130796374|NCT03126110|470879385|FG014|Phase 2|Study terminated by the sponsor|0|||
130796375|NCT03126110|470879386|FG015|Phase 2|Study terminated by the sponsor|0|||
130796376|NCT03126110|470879387|FG016|Phase 2|Study terminated by the sponsor|0|||
130796377|NCT03126110|470879371|FG000|Phase 2|Withdrawal by Subject|0|||
130796378|NCT03126110|470879372|FG001|Phase 2|Withdrawal by Subject|0|||
130796379|NCT03126110|470879373|FG002|Phase 2|Withdrawal by Subject|0|||
130796380|NCT03126110|470879374|FG003|Phase 2|Withdrawal by Subject|0|||
130796381|NCT03126110|470879375|FG004|Phase 2|Withdrawal by Subject|0|||
130796382|NCT03126110|470879376|FG005|Phase 2|Withdrawal by Subject|0|||
130796383|NCT03126110|470879377|FG006|Phase 2|Withdrawal by Subject|0|||
130796384|NCT03126110|470879378|FG007|Phase 2|Withdrawal by Subject|0|||
130796385|NCT03126110|470879379|FG008|Phase 2|Withdrawal by Subject|0|||
130796386|NCT03126110|470879380|FG009|Phase 2|Withdrawal by Subject|0|||
130796387|NCT03126110|470879381|FG010|Phase 2|Withdrawal by Subject|0|||
130796388|NCT03126110|470879382|FG011|Phase 2|Withdrawal by Subject|1|||
130796389|NCT03126110|470879383|FG012|Phase 2|Withdrawal by Subject|3|||
130796390|NCT03126110|470879384|FG013|Phase 2|Withdrawal by Subject|3|||
130796391|NCT03126110|470879385|FG014|Phase 2|Withdrawal by Subject|2|||
130796392|NCT03126110|470879386|FG015|Phase 2|Withdrawal by Subject|1|||
130796393|NCT03126110|470879387|FG016|Phase 2|Withdrawal by Subject|0|||
130796394|NCT03126110|470879371|FG000|Phase 2|Lost to Follow-up|0|||
130796395|NCT03126110|470879372|FG001|Phase 2|Lost to Follow-up|0|||
130796396|NCT03126110|470879373|FG002|Phase 2|Lost to Follow-up|0|||
130796397|NCT03126110|470879374|FG003|Phase 2|Lost to Follow-up|0|||
130796398|NCT03126110|470879375|FG004|Phase 2|Lost to Follow-up|0|||
130796399|NCT03126110|470879376|FG005|Phase 2|Lost to Follow-up|0|||
130796400|NCT03126110|470879377|FG006|Phase 2|Lost to Follow-up|0|||
130796401|NCT03126110|470879378|FG007|Phase 2|Lost to Follow-up|0|||
130796402|NCT03126110|470879379|FG008|Phase 2|Lost to Follow-up|0|||
130796403|NCT03126110|470879380|FG009|Phase 2|Lost to Follow-up|0|||
130796404|NCT03126110|470879381|FG010|Phase 2|Lost to Follow-up|0|||
130796405|NCT03126110|470879382|FG011|Phase 2|Lost to Follow-up|1|||
130796406|NCT03126110|470879383|FG012|Phase 2|Lost to Follow-up|1|||
130796407|NCT03126110|470879384|FG013|Phase 2|Lost to Follow-up|1|||
130796408|NCT03126110|470879385|FG014|Phase 2|Lost to Follow-up|2|||
130796409|NCT03126110|470879386|FG015|Phase 2|Lost to Follow-up|0|||
130796410|NCT03126110|470879387|FG016|Phase 2|Lost to Follow-up|0|||
130796411|NCT03126110|470879371|FG000|Phase 2|Death|0|||
130796412|NCT03126110|470879372|FG001|Phase 2|Death|0|||
130796413|NCT03126110|470879373|FG002|Phase 2|Death|0|||
130796414|NCT03126110|470879374|FG003|Phase 2|Death|0|||
130796415|NCT03126110|470879375|FG004|Phase 2|Death|0|||
130796416|NCT03126110|470879376|FG005|Phase 2|Death|0|||
130796417|NCT03126110|470879377|FG006|Phase 2|Death|0|||
130796418|NCT03126110|470879378|FG007|Phase 2|Death|0|||
130796419|NCT03126110|470879379|FG008|Phase 2|Death|0|||
130796420|NCT03126110|470879380|FG009|Phase 2|Death|0|||
130796421|NCT03126110|470879381|FG010|Phase 2|Death|0|||
130796422|NCT03126110|470879382|FG011|Phase 2|Death|6|||
130796423|NCT03126110|470879383|FG012|Phase 2|Death|12|||
130796424|NCT03126110|470879384|FG013|Phase 2|Death|25|||
130796425|NCT03126110|470879385|FG014|Phase 2|Death|11|||
130796426|NCT03126110|470879386|FG015|Phase 2|Death|3|||
130796427|NCT03126110|470879387|FG016|Phase 2|Death|2|||
130796428|NCT03126110|470879371|FG000|Phase 2|Progressive Disease|0|||
130796429|NCT03126110|470879372|FG001|Phase 2|Progressive Disease|0|||
130796430|NCT03126110|470879373|FG002|Phase 2|Progressive Disease|0|||
130796431|NCT03126110|470879374|FG003|Phase 2|Progressive Disease|0|||
130796432|NCT03126110|470879375|FG004|Phase 2|Progressive Disease|0|||
130796433|NCT03126110|470879376|FG005|Phase 2|Progressive Disease|0|||
130796434|NCT03126110|470879377|FG006|Phase 2|Progressive Disease|0|||
130796435|NCT03126110|470879378|FG007|Phase 2|Progressive Disease|0|||
130796436|NCT03126110|470879379|FG008|Phase 2|Progressive Disease|0|||
130796437|NCT03126110|470879380|FG009|Phase 2|Progressive Disease|0|||
130796438|NCT03126110|470879381|FG010|Phase 2|Progressive Disease|0|||
130796439|NCT03126110|470879382|FG011|Phase 2|Progressive Disease|0|||
130796440|NCT03126110|470879383|FG012|Phase 2|Progressive Disease|0|||
130796441|NCT03126110|470879384|FG013|Phase 2|Progressive Disease|1|||
130796442|NCT03126110|470879385|FG014|Phase 2|Progressive Disease|0|||
130796443|NCT03126110|470879386|FG015|Phase 2|Progressive Disease|0|||
130796444|NCT03126110|470879387|FG016|Phase 2|Progressive Disease|0|||
130796445|NCT03126110|470879371|FG000|Phase 2|Started new treatment|0|||
130796446|NCT03126110|470879372|FG001|Phase 2|Started new treatment|0|||
130796447|NCT03126110|470879373|FG002|Phase 2|Started new treatment|0|||
130796448|NCT03126110|470879374|FG003|Phase 2|Started new treatment|0|||
130796449|NCT03126110|470879375|FG004|Phase 2|Started new treatment|0|||
130796450|NCT03126110|470879376|FG005|Phase 2|Started new treatment|0|||
130796451|NCT03126110|470879377|FG006|Phase 2|Started new treatment|0|||
130796452|NCT03126110|470879378|FG007|Phase 2|Started new treatment|0|||
130796453|NCT03126110|470879379|FG008|Phase 2|Started new treatment|0|||
130796454|NCT03126110|470879380|FG009|Phase 2|Started new treatment|0|||
130796455|NCT03126110|470879381|FG010|Phase 2|Started new treatment|0|||
130796456|NCT03126110|470879382|FG011|Phase 2|Started new treatment|0|||
130796457|NCT03126110|470879383|FG012|Phase 2|Started new treatment|0|||
130796458|NCT03126110|470879384|FG013|Phase 2|Started new treatment|0|||
130796459|NCT03126110|470879385|FG014|Phase 2|Started new treatment|1|||
130796460|NCT03126110|470879386|FG015|Phase 2|Started new treatment|0|||
130796461|NCT03126110|470879387|FG016|Phase 2|Started new treatment|0|||
130796462|NCT04235374|470879388|FG000|Overall Study|Death|91|||
130796463|NCT04235374|470879389|FG001|Overall Study|Death|91|||
130796464|NCT04235374|470879388|FG000|Overall Study|Refused|2|||
130796465|NCT04235374|470879389|FG001|Overall Study|Refused|2|||
130796466|NCT04235374|470879388|FG000|Overall Study|Unavailable|12|||
130796467|NCT04235374|470879389|FG001|Overall Study|Unavailable|3|||
130796468|NCT04235374|470879388|FG000|Overall Study|Withdrawal by Subject|0|||
130796469|NCT04235374|470879389|FG001|Overall Study|Withdrawal by Subject|1|||
130796470|NCT04235374|470879388|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
130796471|NCT04235374|470879389|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
130796472|NCT00088153|470879390|FG000|Overall Study|Physician Decision|3|||
130796473|NCT00088153|470879391|FG001|Overall Study|Physician Decision|3|||
130796474|NCT00088153|470879390|FG000|Overall Study|Withdrawal by Subject|10|||
130796475|NCT00088153|470879391|FG001|Overall Study|Withdrawal by Subject|10|||
130796476|NCT00088153|470879390|FG000|Overall Study|Lost to Follow-up|11|||
130796477|NCT00088153|470879391|FG001|Overall Study|Lost to Follow-up|12|||
130796478|NCT02864992|470879400|FG000|Overall Study|still on treatment|15|||
130796479|NCT02864992|470879401|FG001|Overall Study|still on treatment|1|||
130796480|NCT02864992|470879402|FG002|Overall Study|still on treatment|33|||
130796481|NCT04967222|470879403|FG000|Randomized|Lost to Follow-up|0|||
130796482|NCT04967222|470879404|FG001|Randomized|Lost to Follow-up|1|||
130796483|NCT04967222|470879405|FG002|Randomized|Lost to Follow-up|1|||
130796484|NCT04967222|470879403|FG000|Randomized|Physician Decision|0|||
130796485|NCT04967222|470879404|FG001|Randomized|Physician Decision|0|||
130796486|NCT04967222|470879405|FG002|Randomized|Physician Decision|1|||
130796487|NCT04967222|470879403|FG000|Randomized|Withdrawal by Subject|0|||
130796488|NCT04967222|470879404|FG001|Randomized|Withdrawal by Subject|0|||
130796489|NCT04967222|470879405|FG002|Randomized|Withdrawal by Subject|2|||
130796490|NCT04967222|470879403|FG000|Randomized|abnormal finding in MRI|0|||
130796491|NCT04967222|470879404|FG001|Randomized|abnormal finding in MRI|2|||
130796492|NCT04967222|470879405|FG002|Randomized|abnormal finding in MRI|0|||
130796493|NCT01295944|470879406|FG000|Overall Study|Switched to alternative treatment|1|||
130796494|NCT01295944|470879406|FG000|Overall Study|Ineligible|9|||
130796495|NCT01295944|470879406|FG000|Overall Study|Withdrawal by Subject|1|||
130796496|NCT01295944|470879406|FG000|Overall Study|Participant chose to be treated in Peru|1|||
130796497|NCT01295944|470879406|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
130796498|NCT01295944|470879406|FG000|Overall Study|Physician Decision|1|||
130796499|NCT01295944|470879406|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
130796500|NCT01295944|470879406|FG000|Overall Study|Disease progression|4|||
130796501|NCT01295944|470879406|FG000|Overall Study|Transferred care before starting new treatment|1|||
130796502|NCT02783274|470879416|FG000|Overall Study|Withdrawal by Subject|16|||
130796503|NCT02783274|470879416|FG000|Overall Study|Physician Decision|6|||
130796504|NCT02783274|470879416|FG000|Overall Study|Death|9|||
130796505|NCT02783274|470879416|FG000|Overall Study|Lost to Follow-up|22|||
130796506|NCT02783274|470879416|FG000|Overall Study|Other|22|||
130796507|NCT04717557|470879417|FG000|Overall Study|Withdrawal by Subject|2|||
130796508|NCT04717557|470879418|FG001|Overall Study|Withdrawal by Subject|0|||
130796509|NCT04717557|470879417|FG000|Overall Study|Death|1|||
130796510|NCT04717557|470879418|FG001|Overall Study|Death|0|||
130796511|NCT00927472|470879424|FG000|Overall Study|Withdrawal by Subject|10|||
130796512|NCT00927472|470879425|FG001|Overall Study|Withdrawal by Subject|11|||
130796513|NCT00927472|470879424|FG000|Overall Study|Lost to Follow-up|1|||
130796514|NCT00927472|470879425|FG001|Overall Study|Lost to Follow-up|6|||
130796515|NCT00927472|470879424|FG000|Overall Study|Protocol Violation|0|||
130796516|NCT00927472|470879425|FG001|Overall Study|Protocol Violation|1|||
130796517|NCT00927472|470879424|FG000|Overall Study|Post treatment Assessment out of window|0|||
130796518|NCT00927472|470879425|FG001|Overall Study|Post treatment Assessment out of window|4|||
130796519|NCT02516241|470879426|FG000|Overall Study|Death|255|||
130796520|NCT02516241|470879427|FG001|Overall Study|Death|262|||
130796521|NCT02516241|470879428|FG002|Overall Study|Death|270|||
130796522|NCT02516241|470879426|FG000|Overall Study|Lost to Follow-up|1|||
130796523|NCT02516241|470879427|FG001|Overall Study|Lost to Follow-up|1|||
130796524|NCT02516241|470879428|FG002|Overall Study|Lost to Follow-up|3|||
130796525|NCT02516241|470879426|FG000|Overall Study|Withdrawal by Subject|2|||
130796526|NCT02516241|470879427|FG001|Overall Study|Withdrawal by Subject|7|||
130796527|NCT02516241|470879428|FG002|Overall Study|Withdrawal by Subject|12|||
130796528|NCT02516241|470879426|FG000|Overall Study|participants ongoing at data cut-off|84|||
130796529|NCT02516241|470879427|FG001|Overall Study|participants ongoing at data cut-off|76|||
130796530|NCT02516241|470879428|FG002|Overall Study|participants ongoing at data cut-off|59|||
130796531|NCT00724945|470879429|FG000|Period 1|non-compliance|1|||
130796532|NCT00724945|470879430|FG001|Period 1|non-compliance|0|||
130796533|NCT00724945|470879429|FG000|Period 1|Adverse Event|1|||
130796534|NCT00724945|470879430|FG001|Period 1|Adverse Event|1|||
130796535|NCT00724945|470879429|FG000|Period 1|Lost to Follow-up|1|||
130796536|NCT00724945|470879430|FG001|Period 1|Lost to Follow-up|0|||
130796537|NCT00724945|470879429|FG000|Period 2|lens comfort issue|3|||
130796538|NCT00724945|470879430|FG001|Period 2|lens comfort issue|0|||
130796539|NCT00724945|470879429|FG000|Period 2|lens physiology issue|1|||
130796540|NCT00724945|470879430|FG001|Period 2|lens physiology issue|0|||
130796541|NCT04835441|470879432|FG000|Overall Study|Physician Decision|4|||
130796542|NCT04835441|470879433|FG001|Overall Study|Physician Decision|4|||
130796543|NCT04835441|470879432|FG000|Overall Study|Other|1|||
130796544|NCT04835441|470879433|FG001|Overall Study|Other|1|||
130796545|NCT04835441|470879432|FG000|Overall Study|Lost to Follow-up|0|||
130796546|NCT04835441|470879433|FG001|Overall Study|Lost to Follow-up|1|||
130796547|NCT05260008|470879434|FG000|Overall Study|Physician Decision|0|||
130796548|NCT05260008|470879435|FG001|Overall Study|Physician Decision|1|||
130796549|NCT05260008|470879436|FG002|Overall Study|Physician Decision|0|||
130796550|NCT05260008|470879437|FG003|Overall Study|Physician Decision|0|||
130796551|NCT03069989|470879441|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
130796552|NCT03069989|470879442|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
130796553|NCT05977868|470880691|FG000|Overall Study|Withdrawal by Subject|1|||
130796554|NCT05977868|470880692|FG001|Overall Study|Withdrawal by Subject|2|||
130796555|NCT05977868|470880691|FG000|Overall Study|Transitioned to comfort care|1|||
130796556|NCT05977868|470880692|FG001|Overall Study|Transitioned to comfort care|0|||
130796557|NCT01901562|470880693|FG000|Overall Study|Protocol Violation|5|||
130796558|NCT01901562|470880693|FG000|Overall Study|Excluded intraoperatively|4|||
130796559|NCT00976027|470880694|FG000|Overall Study|Serious Adverse Event|36|||
130796560|NCT00976027|470880695|FG001|Overall Study|Serious Adverse Event|17|||
130796561|NCT00976027|470880694|FG000|Overall Study|Adverse Event|0|||
130796562|NCT00976027|470880695|FG001|Overall Study|Adverse Event|2|||
130796563|NCT00976027|470880694|FG000|Overall Study|Protocol Violation|60|||
130796564|NCT00976027|470880695|FG001|Overall Study|Protocol Violation|27|||
130796565|NCT00976027|470880694|FG000|Overall Study|Lost to Follow-up|208|||
130796566|NCT00976027|470880695|FG001|Overall Study|Lost to Follow-up|103|||
130796567|NCT00976027|470880694|FG000|Overall Study|Withdrawal by Subject|107|||
130796568|NCT00976027|470880695|FG001|Overall Study|Withdrawal by Subject|66|||
130796569|NCT04435626|470880700|FG000|Overall Study|Lost to Follow-up|1|||
130796570|NCT04435626|470880701|FG001|Overall Study|Lost to Follow-up|5|||
130796571|NCT04435626|470880700|FG000|Overall Study|Withdrawal by Subject|6|||
130796572|NCT04435626|470880701|FG001|Overall Study|Withdrawal by Subject|7|||
130796573|NCT04435626|470880700|FG000|Overall Study|major GCP violations|8|||
130796574|NCT04435626|470880701|FG001|Overall Study|major GCP violations|7|||
130796575|NCT01771107|470880707|FG000|Overall Study|Adverse Event|1|||
130796576|NCT01771107|470880708|FG001|Overall Study|Adverse Event|3|||
130796577|NCT01771107|470880707|FG000|Overall Study|Withdrawal by Subject|0|||
130796578|NCT01771107|470880708|FG001|Overall Study|Withdrawal by Subject|2|||
130796579|NCT01771107|470880707|FG000|Overall Study|Lost to Follow-up|0|||
130796580|NCT01771107|470880708|FG001|Overall Study|Lost to Follow-up|1|||
130796581|NCT01771107|470880707|FG000|Overall Study|participant moved|0|||
130796582|NCT01771107|470880708|FG001|Overall Study|participant moved|1|||
130796583|NCT01771107|470880707|FG000|Overall Study|Other|0|||
130796584|NCT01771107|470880708|FG001|Overall Study|Other|1|||
130796585|NCT05248386|470880710|FG000|Overall Study|Technical problems|0|||
130796586|NCT05248386|470880711|FG001|Overall Study|Technical problems|1|||
130796587|NCT05248386|470880710|FG000|Overall Study|Withdrawal by Subject|15|||
130796588|NCT05248386|470880711|FG001|Overall Study|Withdrawal by Subject|10|||
130796589|NCT05248386|470880710|FG000|Overall Study|Physician Decision|0|||
130796590|NCT05248386|470880711|FG001|Overall Study|Physician Decision|1|||
130796591|NCT05248386|470880710|FG000|Overall Study|Adverse Event|2|||
130796592|NCT05248386|470880711|FG001|Overall Study|Adverse Event|4|||
130796593|NCT05248386|470880710|FG000|Overall Study|Other|1|||
130796594|NCT05248386|470880711|FG001|Overall Study|Other|0|||
130796595|NCT05248386|470880710|FG000|Overall Study|Lack of Efficacy|14|||
130796596|NCT05248386|470880711|FG001|Overall Study|Lack of Efficacy|12|||
130796597|NCT03785366|470880712|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
130796598|NCT03785366|470880713|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
130796599|NCT03785366|470880712|FG000|Overall Study|Lost to Follow-up|1|||
130796600|NCT03785366|470880713|FG001|Overall Study|Lost to Follow-up|0|||
130796601|NCT03785366|470880712|FG000|Overall Study|Partial IUD Expulsion|0|||
130796602|NCT03785366|470880713|FG001|Overall Study|Partial IUD Expulsion|2|||
130796603|NCT03785366|470880712|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
130796604|NCT03785366|470880713|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
130796605|NCT03240874|470880714|FG000|Overall Study|Lost to Follow-up|0|||
130796606|NCT03240874|470880715|FG001|Overall Study|Lost to Follow-up|2|||
130796607|NCT03240874|470880716|FG002|Overall Study|Lost to Follow-up|4|||
130796608|NCT03240874|470880717|FG003|Overall Study|Lost to Follow-up|1|||
130796609|NCT05252702|470880718|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
130796610|NCT05252702|470880718|FG000|Overall Study|Death|16|||
130796611|NCT05252702|470880718|FG000|Overall Study|System explant|5|||
130796612|NCT05252702|470880718|FG000|Overall Study|Lost to Follow-up|1|||
130796613|NCT05252702|470880718|FG000|Overall Study|Withdrawn by investigator|1|||
130796614|NCT05252702|470880718|FG000|Overall Study|Visit not due|306|||
130796615|NCT05252702|470880718|FG000|Overall Study|Visit within window but not completed|92|||
130796616|NCT05252702|470880718|FG000|Overall Study|Unsuccessful implant|1|||
130796617|NCT04153864|470880719|FG000|Overall Study|Withdrawal by Subject|21|||
130796618|NCT04153864|470880720|FG001|Overall Study|Withdrawal by Subject|7|||
130796619|NCT04153864|470880721|FG002|Overall Study|Withdrawal by Subject|23|||
130796620|NCT04153864|470880722|FG003|Overall Study|Withdrawal by Subject|2|||
130796621|NCT04153864|470880719|FG000|Overall Study|Lost to Follow-up|4|||
130796622|NCT04153864|470880720|FG001|Overall Study|Lost to Follow-up|0|||
130796623|NCT04153864|470880721|FG002|Overall Study|Lost to Follow-up|3|||
130796624|NCT04153864|470880722|FG003|Overall Study|Lost to Follow-up|0|||
130796625|NCT04153864|470880719|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
130796626|NCT04153864|470880720|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
130796627|NCT04153864|470880721|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
130796628|NCT04153864|470880722|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
130796629|NCT04958707|470880723|FG000|Post Intervention|Withdrawal by Subject|1|||
130796630|NCT04958707|470880724|FG001|Post Intervention|Withdrawal by Subject|0|||
130796631|NCT04958707|470880725|FG002|Post Intervention|Withdrawal by Subject|0|||
130796632|NCT04958707|470880723|FG000|3 Months Follow- up|Lost to Follow-up|0|||
130796633|NCT04958707|470880724|FG001|3 Months Follow- up|Lost to Follow-up|3|||
130796634|NCT04958707|470880725|FG002|3 Months Follow- up|Lost to Follow-up|0|||
130796635|NCT04958707|470880723|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
130796636|NCT04958707|470880724|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
130796637|NCT04958707|470880725|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
130796638|NCT04279522|470880726|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
130796639|NCT04279522|470880727|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
130796640|NCT04279522|470880726|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
130796641|NCT04279522|470880727|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
130796642|NCT04279522|470880726|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
130796643|NCT04279522|470880727|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
130796644|NCT04279522|470880726|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
130796645|NCT04279522|470880727|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
130796646|NCT04279522|470880726|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
130796647|NCT04279522|470880727|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
130796648|NCT04279522|470880726|FG000|Period 2: Open Label Phase|Physician Decision|0|||
130796649|NCT04279522|470880727|FG001|Period 2: Open Label Phase|Physician Decision|3|||
130796650|NCT04279522|470880726|FG000|Period 2: Open Label Phase|Adverse Event|0|||
130796651|NCT04279522|470880727|FG001|Period 2: Open Label Phase|Adverse Event|1|||
130796652|NCT04279522|470880726|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
130796653|NCT04279522|470880727|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
130796654|NCT02629159|470880728|FG000|Overall Study|Adverse Event|17|||
130796655|NCT02629159|470880729|FG001|Overall Study|Adverse Event|20|||
130796656|NCT02629159|470880730|FG002|Overall Study|Adverse Event|22|||
130796657|NCT02629159|470880728|FG000|Overall Study|Withdrawal by Subject|22|||
130796658|NCT02629159|470880729|FG001|Overall Study|Withdrawal by Subject|11|||
130796659|NCT02629159|470880730|FG002|Overall Study|Withdrawal by Subject|15|||
130796660|NCT02629159|470880728|FG000|Overall Study|Lost to Follow-up|7|||
130796661|NCT02629159|470880729|FG001|Overall Study|Lost to Follow-up|4|||
130796662|NCT02629159|470880730|FG002|Overall Study|Lost to Follow-up|5|||
130796663|NCT02629159|470880728|FG000|Overall Study|Lack of Efficacy|4|||
130796664|NCT02629159|470880729|FG001|Overall Study|Lack of Efficacy|0|||
130796665|NCT02629159|470880730|FG002|Overall Study|Lack of Efficacy|1|||
130796666|NCT02629159|470880728|FG000|Overall Study|Other|6|||
130796667|NCT02629159|470880729|FG001|Overall Study|Other|4|||
130796668|NCT02629159|470880730|FG002|Overall Study|Other|8|||
130796669|NCT05352399|470880743|FG000|Overall Study|Discontinued intervention|6|||
130796670|NCT01802281|470880744|FG000|Overall Study|Death|1|||
130796671|NCT01802281|470880745|FG001|Overall Study|Death|2|||
130796672|NCT01802281|470880744|FG000|Overall Study|Withdrawal by Subject|2|||
130796673|NCT01802281|470880745|FG001|Overall Study|Withdrawal by Subject|1|||
130796674|NCT01802281|470880744|FG000|Overall Study|Ineligible|5|||
130796675|NCT01802281|470880745|FG001|Overall Study|Ineligible|3|||
130796676|NCT02685735|470880746|FG000|Overall Study|Surgery Cancelled|4|||
130796677|NCT02685735|470880747|FG001|Overall Study|Surgery Cancelled|9|||
130796678|NCT02685735|470880746|FG000|Overall Study|Adverse Event|10|||
130796679|NCT02685735|470880747|FG001|Overall Study|Adverse Event|3|||
130796680|NCT02685735|470880746|FG000|Overall Study|Preop testing found to be incomplete|2|||
130796681|NCT02685735|470880747|FG001|Overall Study|Preop testing found to be incomplete|2|||
130796682|NCT02685735|470880746|FG000|Overall Study|Withdrawal by Subject|1|||
130796683|NCT02685735|470880747|FG001|Overall Study|Withdrawal by Subject|2|||
130796684|NCT02685735|470880746|FG000|Overall Study|Death|1|||
130796685|NCT02685735|470880747|FG001|Overall Study|Death|0|||
130796686|NCT05436613|470880762|FG000|Overall Study|Lost to Follow-up|9|||
130796687|NCT05436613|470880762|FG000|Overall Study|Withdrawal by Subject|3|||
130796688|NCT04635423|470880763|FG000|Overall Study|Ongoing|493|||
130796689|NCT04635423|470880764|FG001|Overall Study|Ongoing|501|||
130796690|NCT04635423|470880763|FG000|Overall Study|Withdrawal by Subject|36|||
130796691|NCT04635423|470880764|FG001|Overall Study|Withdrawal by Subject|29|||
130796692|NCT05119569|470880781|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
130796693|NCT05119569|470880782|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
130796694|NCT05119569|470880783|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130796695|NCT05119569|470880784|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130796696|NCT05119569|470880781|FG000|Double Blind Treatment Phase|Adverse Event|6|||
130796697|NCT05119569|470880782|FG001|Double Blind Treatment Phase|Adverse Event|0|||
130796698|NCT05119569|470880783|FG002|Double Blind Treatment Phase|Adverse Event|0|||
130796699|NCT05119569|470880784|FG003|Double Blind Treatment Phase|Adverse Event|0|||
130796700|NCT05119569|470880781|FG000|Open Label Extension Phase|Ongoing in the study|0|||
130796701|NCT05119569|470880782|FG001|Open Label Extension Phase|Ongoing in the study|0|||
130796702|NCT05119569|470880783|FG002|Open Label Extension Phase|Ongoing in the study|65|||
130796703|NCT05119569|470880784|FG003|Open Label Extension Phase|Ongoing in the study|34|||
130796704|NCT03488524|470880785|FG000|Overall Study|Withdrawal by Subject|51|||
130796705|NCT03488524|470880785|FG000|Overall Study|Death|19|||
130796706|NCT03488524|470880785|FG000|Overall Study|Study Sponsor|11|||
130796707|NCT03488524|470880785|FG000|Overall Study|Physician Decision|4|||
130796708|NCT03488524|470880785|FG000|Overall Study|Lost to Follow-up|3|||
130796709|NCT03980223|470880786|FG000|Overall Study|Lost to Follow-up|3|||
130796710|NCT03980223|470880787|FG001|Overall Study|Lost to Follow-up|7|||
130796711|NCT03980223|470880788|FG002|Overall Study|Lost to Follow-up|10|||
130796712|NCT03980223|470880789|FG003|Overall Study|Lost to Follow-up|8|||
130796713|NCT03980223|470880786|FG000|Overall Study|Withdrawal by Subject|0|||
130796714|NCT03980223|470880787|FG001|Overall Study|Withdrawal by Subject|0|||
130796715|NCT03980223|470880788|FG002|Overall Study|Withdrawal by Subject|1|||
130796716|NCT03980223|470880789|FG003|Overall Study|Withdrawal by Subject|2|||
130796717|NCT03980223|470880786|FG000|Overall Study|Physician Decision|0|||
130796718|NCT03980223|470880787|FG001|Overall Study|Physician Decision|0|||
130796719|NCT03980223|470880788|FG002|Overall Study|Physician Decision|1|||
130796720|NCT03980223|470880789|FG003|Overall Study|Physician Decision|0|||
130796721|NCT03980223|470880786|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
130796722|NCT03980223|470880787|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
130796723|NCT03980223|470880788|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
130796724|NCT03980223|470880789|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
130796725|NCT06239610|470880790|FG000|Overall Study|no usable migration data for minimum of one day|11|||
130796726|NCT01922934|470880794|FG000|Eligible Patients|Death|0|||
130796727|NCT01922934|470880795|FG001|Eligible Patients|Death|7|||
130796728|NCT01922934|470880794|FG000|Eligible Patients|Physician Decision|17|||
130796729|NCT01922934|470880795|FG001|Eligible Patients|Physician Decision|0|||
130796730|NCT01922934|470880794|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
130796731|NCT01922934|470880795|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
130796732|NCT01922934|470880794|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
130796733|NCT01922934|470880795|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
130796734|NCT01922934|470880794|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
130796735|NCT01922934|470880795|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
130796736|NCT01922934|470880794|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
130796737|NCT01922934|470880795|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
130796738|NCT01069939|470880800|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
130796739|NCT01069939|470880801|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
130796740|NCT01069939|470880800|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
130796741|NCT01069939|470880801|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
130796742|NCT01069939|470880800|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
130796743|NCT01069939|470880801|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
130796744|NCT01069939|470880800|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
130796745|NCT01069939|470880801|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
130796746|NCT01069939|470880800|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
130796747|NCT01069939|470880801|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
130796748|NCT01069939|470880800|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
130796749|NCT01069939|470880801|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
130796750|NCT01069939|470880800|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
130796751|NCT01069939|470880801|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
130796752|NCT01069939|470880800|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
130796753|NCT01069939|470880801|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
130796754|NCT01069939|470880800|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
130796755|NCT01069939|470880801|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
130796756|NCT01069939|470880800|FG000|Randomised and Included in the Analyses|Removal|1|||
130796757|NCT01069939|470880801|FG001|Randomised and Included in the Analyses|Removal|0|||
130796758|NCT05166876|470880802|FG000|Overall Study|Withdrawal by Subject|1|||
130796759|NCT05166876|470880803|FG001|Overall Study|Withdrawal by Subject|0|||
130796760|NCT05166876|470880804|FG002|Overall Study|Withdrawal by Subject|0|||
130796761|NCT00658528|470880805|FG000|Overall Study|Adverse Event|5|||
130796762|NCT00658528|470880806|FG001|Overall Study|Adverse Event|7|||
130796763|NCT00658528|470880805|FG000|Overall Study|Lost to Follow-up|14|||
130796764|NCT00658528|470880806|FG001|Overall Study|Lost to Follow-up|22|||
130796765|NCT00658528|470880805|FG000|Overall Study|Withdrawal by Subject|8|||
130796766|NCT00658528|470880806|FG001|Overall Study|Withdrawal by Subject|6|||
130796767|NCT00658528|470880805|FG000|Overall Study|Withdrawal of consent|5|||
130796768|NCT00658528|470880806|FG001|Overall Study|Withdrawal of consent|6|||
130796769|NCT00658528|470880805|FG000|Overall Study|Other|8|||
130796770|NCT00658528|470880806|FG001|Overall Study|Other|4|||
130796771|NCT01706328|470880813|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
130796772|NCT01706328|470880814|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130796773|NCT01706328|470880815|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130796774|NCT01706328|470880813|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
130796775|NCT01706328|470880814|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130796776|NCT01706328|470880815|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130796777|NCT01706328|470880813|FG000|2-week Run-in Period|Physician Decision|4|||
130796778|NCT01706328|470880814|FG001|2-week Run-in Period|Physician Decision|0|||
130796779|NCT01706328|470880815|FG002|2-week Run-in Period|Physician Decision|0|||
130796780|NCT01706328|470880813|FG000|2-week Run-in Period|Adverse Event|4|||
130796781|NCT01706328|470880814|FG001|2-week Run-in Period|Adverse Event|0|||
130796782|NCT01706328|470880815|FG002|2-week Run-in Period|Adverse Event|0|||
130796783|NCT01706328|470880813|FG000|2-week Run-in Period|Lost to Follow-up|2|||
130796784|NCT01706328|470880814|FG001|2-week Run-in Period|Lost to Follow-up|0|||
130796785|NCT01706328|470880815|FG002|2-week Run-in Period|Lost to Follow-up|0|||
130796786|NCT01706328|470880813|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
130796787|NCT01706328|470880814|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
130796788|NCT01706328|470880815|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
130796789|NCT01706328|470880813|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
130796790|NCT01706328|470880814|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
130796791|NCT01706328|470880815|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
130796792|NCT01706328|470880813|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
130796793|NCT01706328|470880814|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
130796794|NCT01706328|470880815|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
130796795|NCT01706328|470880813|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
130796796|NCT01706328|470880814|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
130796797|NCT01706328|470880815|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
130796798|NCT01706328|470880813|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
130796799|NCT01706328|470880814|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
130796800|NCT01706328|470880815|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
130796801|NCT01706328|470880813|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
130796802|NCT01706328|470880814|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
130796803|NCT01706328|470880815|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
130796804|NCT01706328|470880813|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130796805|NCT01706328|470880814|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
130796806|NCT01706328|470880815|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
130796807|NCT03018938|470880818|FG000|Overall Study|Death|0|||
130796808|NCT03018938|470880819|FG001|Overall Study|Death|1|||
130796809|NCT03018938|470880818|FG000|Overall Study|Lost to Follow-up|21|||
130796810|NCT03018938|470880819|FG001|Overall Study|Lost to Follow-up|32|||
130796811|NCT03018938|470880818|FG000|Overall Study|Withdrawal by Subject|38|||
130796812|NCT03018938|470880819|FG001|Overall Study|Withdrawal by Subject|45|||
130796813|NCT03018938|470880818|FG000|Overall Study|Physician Decision|3|||
130796814|NCT03018938|470880819|FG001|Overall Study|Physician Decision|2|||
130796815|NCT03018938|470880818|FG000|Overall Study|Sponsor Decision|0|||
130796816|NCT03018938|470880819|FG001|Overall Study|Sponsor Decision|1|||
130796817|NCT03018938|470880818|FG000|Overall Study|Screen failure-After randomization|4|||
130796818|NCT03018938|470880819|FG001|Overall Study|Screen failure-After randomization|2|||
130796819|NCT03018938|470880818|FG000|Overall Study|Not recorded|0|||
130796820|NCT03018938|470880819|FG001|Overall Study|Not recorded|2|||
130796821|NCT00191100|470880822|FG000|Overall Study|Adverse Event|18|||
130796822|NCT00191100|470880823|FG001|Overall Study|Adverse Event|1|||
130796823|NCT00191100|470880822|FG000|Overall Study|Lost to Follow-up|2|||
130796824|NCT00191100|470880823|FG001|Overall Study|Lost to Follow-up|0|||
130796825|NCT00191100|470880822|FG000|Overall Study|Patient Moved|0|||
130796826|NCT00191100|470880823|FG001|Overall Study|Patient Moved|1|||
130796827|NCT00191100|470880822|FG000|Overall Study|Withdrawal by Subject|9|||
130796828|NCT00191100|470880823|FG001|Overall Study|Withdrawal by Subject|3|||
130762793|NCT04778059|470753438|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
130762794|NCT00157248|470753443|FG000|Overall Study|Adverse Event|36|||
130762795|NCT00157248|470753444|FG001|Overall Study|Adverse Event|25|||
130762796|NCT00157248|470753445|FG002|Overall Study|Adverse Event|13|||
130762797|NCT00157248|470753446|FG003|Overall Study|Adverse Event|33|||
130762798|NCT00157248|470753443|FG000|Overall Study|Protocol Violation|4|||
130762799|NCT00157248|470753444|FG001|Overall Study|Protocol Violation|0|||
130762800|NCT00157248|470753445|FG002|Overall Study|Protocol Violation|2|||
130762801|NCT00157248|470753446|FG003|Overall Study|Protocol Violation|2|||
130762802|NCT00157248|470753443|FG000|Overall Study|Lost to Follow-up|0|||
130762803|NCT00157248|470753444|FG001|Overall Study|Lost to Follow-up|1|||
130762804|NCT00157248|470753445|FG002|Overall Study|Lost to Follow-up|0|||
130762805|NCT00157248|470753446|FG003|Overall Study|Lost to Follow-up|0|||
130762806|NCT00157248|470753443|FG000|Overall Study|Withdrawal by Subject|1|||
130762807|NCT00157248|470753444|FG001|Overall Study|Withdrawal by Subject|4|||
130762808|NCT00157248|470753445|FG002|Overall Study|Withdrawal by Subject|3|||
130762809|NCT00157248|470753446|FG003|Overall Study|Withdrawal by Subject|3|||
130762810|NCT00157248|470753443|FG000|Overall Study|site closures, subject moving|7|||
130762811|NCT00157248|470753444|FG001|Overall Study|site closures, subject moving|7|||
130762812|NCT00157248|470753445|FG002|Overall Study|site closures, subject moving|3|||
130762813|NCT00157248|470753446|FG003|Overall Study|site closures, subject moving|9|||
130762814|NCT01306045|470753449|FG000|Met General Eligibility Criteria|Screen failures|193|||
130762815|NCT01306045|470753450|FG001|Met General Eligibility Criteria|Screen failures|11|||
130762816|NCT01306045|470753451|FG002|Met General Eligibility Criteria|Screen failures|8|||
130762817|NCT00787917|470753453|FG000|Blinded Treatment|Adverse Event|1|||
130762818|NCT00787917|470753454|FG001|Blinded Treatment|Adverse Event|0|||
130762819|NCT00787917|470753453|FG000|Blinded Treatment|Lack of Efficacy|1|||
130762820|NCT00787917|470753454|FG001|Blinded Treatment|Lack of Efficacy|0|||
130762821|NCT00787917|470753453|FG000|Blinded Treatment|Administrative problems|3|||
130762822|NCT00787917|470753454|FG001|Blinded Treatment|Administrative problems|2|||
130762823|NCT00787917|470753453|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
130762824|NCT00787917|470753454|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
130762825|NCT00787917|470753453|FG000|Open Label|Administrative problems|3|||
130762826|NCT00787917|470753454|FG001|Open Label|Administrative problems|0|||
130762827|NCT00778102|470753455|FG000|Overall Study|Adverse Event|8|||
130762828|NCT00778102|470753456|FG001|Overall Study|Adverse Event|5|||
130762829|NCT00778102|470753455|FG000|Overall Study|Death|1|||
130762830|NCT00778102|470753456|FG001|Overall Study|Death|1|||
130762831|NCT00778102|470753455|FG000|Overall Study|Lost to Follow-up|1|||
130762832|NCT00778102|470753456|FG001|Overall Study|Lost to Follow-up|0|||
130762833|NCT00778102|470753455|FG000|Overall Study|Violation of Selection Criteria|1|||
130762834|NCT00778102|470753456|FG001|Overall Study|Violation of Selection Criteria|1|||
130762835|NCT00778102|470753455|FG000|Overall Study|Protocol Violation|0|||
130762836|NCT00778102|470753456|FG001|Overall Study|Protocol Violation|1|||
130762837|NCT00778102|470753455|FG000|Overall Study|Refused Treatment|2|||
130762838|NCT00778102|470753456|FG001|Overall Study|Refused Treatment|3|||
130762839|NCT00778102|470753455|FG000|Overall Study|Withdrawal by Subject|1|||
130762840|NCT00778102|470753456|FG001|Overall Study|Withdrawal by Subject|1|||
130762841|NCT00778102|470753455|FG000|Overall Study|Administrative Reason|7|||
130762842|NCT00778102|470753456|FG001|Overall Study|Administrative Reason|10|||
130762843|NCT01328548|470753457|FG000|Overall Study|Death|3|||
130762844|NCT01328548|470753458|FG001|Overall Study|Death|0|||
130762845|NCT01328548|470753457|FG000|Overall Study|Protocol Violation|1|||
130762846|NCT01328548|470753458|FG001|Overall Study|Protocol Violation|0|||
130762847|NCT05128773|470755771|FG000|Overall Study|Sponsor decision to terminate study|3|||
130762848|NCT04676412|470755772|FG000|Overall Study|Death|28|||
130762849|NCT04676412|470755773|FG001|Overall Study|Death|31|||
130762850|NCT04676412|470755772|FG000|Overall Study|Lost to Follow-up|1|||
130762851|NCT04676412|470755773|FG001|Overall Study|Lost to Follow-up|2|||
130762852|NCT04676412|470755772|FG000|Overall Study|Sponsor Decision|20|||
130762853|NCT04676412|470755773|FG001|Overall Study|Sponsor Decision|23|||
130762854|NCT04676412|470755772|FG000|Overall Study|Withdrawal by Subject|0|||
130762855|NCT04676412|470755773|FG001|Overall Study|Withdrawal by Subject|2|||
130762856|NCT04697056|470755774|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
130762857|NCT04697056|470755775|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
130762858|NCT04550832|470755776|FG000|Overall Study|Adverse Event|0|||
130762859|NCT04550832|470755777|FG001|Overall Study|Adverse Event|0|||
130762860|NCT04550832|470755778|FG002|Overall Study|Adverse Event|2|||
130762861|NCT04550832|470755779|FG003|Overall Study|Adverse Event|0|||
130762862|NCT04550832|470755780|FG004|Overall Study|Adverse Event|1|||
130796829|NCT00191100|470880822|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
130796830|NCT00191100|470880823|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
130796831|NCT00191100|470880822|FG000|Overall Study|Clinical Relapse|2|||
130796832|NCT00191100|470880823|FG001|Overall Study|Clinical Relapse|1|||
130796833|NCT00191100|470880822|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
130796834|NCT00191100|470880823|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
130796835|NCT00191100|470880822|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
130796836|NCT00191100|470880823|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
130796837|NCT00191100|470880822|FG000|Overall Study|Physician Decision|3|||
130796838|NCT00191100|470880823|FG001|Overall Study|Physician Decision|1|||
130796839|NCT00191100|470880822|FG000|Overall Study|Death from Study Drug Toxicity|2|||
130796840|NCT00191100|470880823|FG001|Overall Study|Death from Study Drug Toxicity|0|||
130796841|NCT00191100|470880822|FG000|Overall Study|Protocol Violation|1|||
130796842|NCT00191100|470880823|FG001|Overall Study|Protocol Violation|1|||
130796843|NCT00191100|470880822|FG000|Overall Study|Death from Other Cause|1|||
130796844|NCT00191100|470880823|FG001|Overall Study|Death from Other Cause|0|||
130796845|NCT00191100|470880822|FG000|Overall Study|Reason Not Specified|0|||
130796846|NCT00191100|470880823|FG001|Overall Study|Reason Not Specified|1|||
130796847|NCT01525589|470880827|FG000|Overall Study|Non-treatment-related AE|1|||
130796848|NCT01525589|470880828|FG001|Overall Study|Non-treatment-related AE|0|||
130796849|NCT01525589|470880829|FG002|Overall Study|Non-treatment-related AE|0|||
130796850|NCT01525589|470880827|FG000|Overall Study|Progressive disease|48|||
130796851|NCT01525589|470880828|FG001|Overall Study|Progressive disease|15|||
130796852|NCT01525589|470880829|FG002|Overall Study|Progressive disease|29|||
130796853|NCT01525589|470880827|FG000|Overall Study|Never treated|2|||
130796854|NCT01525589|470880828|FG001|Overall Study|Never treated|0|||
130796855|NCT01525589|470880829|FG002|Overall Study|Never treated|0|||
130796856|NCT01525589|470880827|FG000|Overall Study|Physician Decision|4|||
130796857|NCT01525589|470880828|FG001|Overall Study|Physician Decision|2|||
130796858|NCT01525589|470880829|FG002|Overall Study|Physician Decision|2|||
130796859|NCT01525589|470880827|FG000|Overall Study|Death|0|||
130796860|NCT01525589|470880828|FG001|Overall Study|Death|0|||
130796861|NCT01525589|470880829|FG002|Overall Study|Death|2|||
130796862|NCT01525589|470880827|FG000|Overall Study|Treatment-related AE|1|||
130796863|NCT01525589|470880828|FG001|Overall Study|Treatment-related AE|1|||
130796864|NCT01525589|470880829|FG002|Overall Study|Treatment-related AE|2|||
130796865|NCT01525589|470880827|FG000|Overall Study|Other reasons|0|||
130796866|NCT01525589|470880828|FG001|Overall Study|Other reasons|1|||
130796867|NCT01525589|470880829|FG002|Overall Study|Other reasons|0|||
130796868|NCT01525589|470880827|FG000|Overall Study|Withdrawal by Subject|0|||
130796869|NCT01525589|470880828|FG001|Overall Study|Withdrawal by Subject|1|||
130796870|NCT01525589|470880829|FG002|Overall Study|Withdrawal by Subject|0|||
130796871|NCT04409002|470880830|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
130796872|NCT06481579|470880831|FG000|Overall Study|Death|1|||
130796873|NCT06481579|470880832|FG001|Overall Study|Death|0|||
130796874|NCT06481579|470880831|FG000|Overall Study|Withdrawal by Subject|3|||
130796875|NCT06481579|470880832|FG001|Overall Study|Withdrawal by Subject|0|||
130796876|NCT06481579|470880831|FG000|Overall Study|Other|1|||
130796877|NCT06481579|470880832|FG001|Overall Study|Other|1|||
130796878|NCT05032196|470880833|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130796879|NCT05032196|470880834|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
130796880|NCT05032196|470880835|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130796881|NCT05032196|470880836|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130796882|NCT05032196|470880837|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130796883|NCT05032196|470880838|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130796884|NCT05032196|470880833|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130796885|NCT05032196|470880834|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130796886|NCT05032196|470880835|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130796887|NCT05032196|470880836|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
130796888|NCT05032196|470880837|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130796889|NCT05032196|470880838|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130796890|NCT05032196|470880833|FG000|Period 2 (Multidose)|Physician Decision|0|||
130796891|NCT05032196|470880834|FG001|Period 2 (Multidose)|Physician Decision|0|||
130796892|NCT05032196|470880835|FG002|Period 2 (Multidose)|Physician Decision|0|||
130796893|NCT05032196|470880836|FG003|Period 2 (Multidose)|Physician Decision|0|||
130796894|NCT05032196|470880837|FG004|Period 2 (Multidose)|Physician Decision|1|||
130796895|NCT05032196|470880838|FG005|Period 2 (Multidose)|Physician Decision|0|||
130796896|NCT05696847|470881829|FG000|Overall Study|Withdrawal by Subject|1|||
130796897|NCT05696847|470881830|FG001|Overall Study|Withdrawal by Subject|0|||
130796898|NCT05696847|470881831|FG002|Overall Study|Withdrawal by Subject|0|||
130796899|NCT05696847|470881832|FG003|Overall Study|Withdrawal by Subject|0|||
130796900|NCT05696847|470881833|FG004|Overall Study|Withdrawal by Subject|0|||
130796901|NCT05696847|470881834|FG005|Overall Study|Withdrawal by Subject|0|||
130796902|NCT05696847|470881829|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130796903|NCT05696847|470881830|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130796904|NCT05696847|470881831|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130796905|NCT05696847|470881832|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130796906|NCT05696847|470881833|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130796907|NCT05696847|470881834|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130796908|NCT05696847|470881829|FG000|Overall Study|Adverse Event|0|||
130796909|NCT05696847|470881830|FG001|Overall Study|Adverse Event|0|||
130796910|NCT05696847|470881831|FG002|Overall Study|Adverse Event|0|||
130796911|NCT05696847|470881832|FG003|Overall Study|Adverse Event|0|||
130796912|NCT05696847|470881833|FG004|Overall Study|Adverse Event|0|||
130796913|NCT05696847|470881834|FG005|Overall Study|Adverse Event|1|||
130796914|NCT05696847|470881829|FG000|Overall Study|Sponsor Decision|0|||
130796915|NCT05696847|470881830|FG001|Overall Study|Sponsor Decision|0|||
130796916|NCT05696847|470881831|FG002|Overall Study|Sponsor Decision|0|||
130796917|NCT05696847|470881832|FG003|Overall Study|Sponsor Decision|1|||
130796918|NCT05696847|470881833|FG004|Overall Study|Sponsor Decision|0|||
130796919|NCT05696847|470881834|FG005|Overall Study|Sponsor Decision|0|||
130796920|NCT03323502|470881835|FG000|Overall Study|Resident could not be linked to CMS data|594|||
130796921|NCT03323502|470881836|FG001|Overall Study|Resident could not be linked to CMS data|435|||
130796922|NCT03323502|470881835|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
130796923|NCT03323502|470881836|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
130796924|NCT03323502|470881835|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
130796925|NCT03323502|470881836|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
130796926|NCT03323502|470881835|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
130796927|NCT03323502|470881836|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
130796928|NCT03323502|470881835|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
130796929|NCT03323502|470881836|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
130796930|NCT04092777|470881837|FG000|Overall Study|Lost to Follow-up|28|||
130796931|NCT04092777|470881838|FG001|Overall Study|Lost to Follow-up|46|||
130796932|NCT04092777|470881837|FG000|Overall Study|Withdrawal by Subject|8|||
130796933|NCT04092777|470881838|FG001|Overall Study|Withdrawal by Subject|5|||
130796934|NCT00975923|470881843|FG000|Overall Study|Withdrawal by Subject|0|||
130796935|NCT00975923|470881844|FG001|Overall Study|Withdrawal by Subject|1|||
130796936|NCT04896385|470881845|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
130796937|NCT04896385|470881846|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
130796938|NCT04896385|470881847|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
130796939|NCT04896385|470881848|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
130796940|NCT04896385|470881845|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
130796941|NCT04896385|470881846|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
130796942|NCT04896385|470881847|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
130796943|NCT04896385|470881848|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
130796944|NCT04896385|470881845|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
130796945|NCT04896385|470881846|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
130796946|NCT04896385|470881847|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
130796947|NCT04896385|470881848|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
130796948|NCT04896385|470881845|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
130796949|NCT04896385|470881846|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
130796950|NCT04896385|470881847|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
130796951|NCT04896385|470881848|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
130796952|NCT04896385|470881845|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
130796953|NCT04896385|470881846|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
130796954|NCT04896385|470881847|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
130796955|NCT04896385|470881848|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
130796956|NCT04896385|470881845|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
130796957|NCT04896385|470881846|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
130796958|NCT04896385|470881847|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
130796959|NCT04896385|470881848|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
130796960|NCT05291689|470881851|FG000|Overall Study|Adverse Event|3|||
130796961|NCT05291689|470881851|FG000|Overall Study|Lack of Efficacy|10|||
130796962|NCT05291689|470881851|FG000|Overall Study|Withdrawal by Subject|4|||
130796963|NCT01931098|470881852|FG000|Overall Study|Withdrawal by Subject|0|||
130796964|NCT01931098|470881853|FG001|Overall Study|Withdrawal by Subject|1|||
130796965|NCT01931098|470881852|FG000|Overall Study|Enrolled in different protocol|0|||
130796966|NCT01931098|470881853|FG001|Overall Study|Enrolled in different protocol|1|||
130796967|NCT01931098|470881852|FG000|Overall Study|Unable to begin trmt:active infection|0|||
130796968|NCT01931098|470881853|FG001|Overall Study|Unable to begin trmt:active infection|1|||
130796969|NCT01931098|470881852|FG000|Overall Study|Refused further treatment|0|||
130796970|NCT01931098|470881853|FG001|Overall Study|Refused further treatment|1|||
130796971|NCT02278354|470881854|FG000|Overall Study|Lost to Follow-up|2|||
130796972|NCT02278354|470881855|FG001|Overall Study|Lost to Follow-up|2|||
130796973|NCT02278354|470881854|FG000|Overall Study|Withdrawal by Subject|0|||
130796974|NCT02278354|470881855|FG001|Overall Study|Withdrawal by Subject|1|||
130796975|NCT02278354|470881854|FG000|Overall Study|<10 professional fights|2|||
130796976|NCT02278354|470881855|FG001|Overall Study|<10 professional fights|0|||
130796977|NCT02612155|470881857|FG000|Overall Study|Death|1|||
130796978|NCT02612155|470881858|FG001|Overall Study|Death|1|||
130796979|NCT02612155|470881857|FG000|Overall Study|Lost to Follow-up|2|||
130796980|NCT02612155|470881858|FG001|Overall Study|Lost to Follow-up|2|||
130796981|NCT02572167|470881861|FG000|Overall Study|Withdrawal by Subject|0|||
130796982|NCT02572167|470881862|FG001|Overall Study|Withdrawal by Subject|3|||
130796983|NCT02572167|470881863|FG002|Overall Study|Withdrawal by Subject|0|||
130796984|NCT02572167|470881861|FG000|Overall Study|Lost to Follow-up|2|||
130796985|NCT02572167|470881862|FG001|Overall Study|Lost to Follow-up|5|||
130796986|NCT02572167|470881863|FG002|Overall Study|Lost to Follow-up|3|||
130796987|NCT02572167|470881861|FG000|Overall Study|Death|0|||
130796988|NCT02572167|470881862|FG001|Overall Study|Death|8|||
130796989|NCT02572167|470881863|FG002|Overall Study|Death|3|||
130762863|NCT04823130|470755781|FG000|Overall Study|Withdrawal by Subject|2|||
130762864|NCT04823130|470755782|FG001|Overall Study|Withdrawal by Subject|3|||
130762865|NCT04823130|470755781|FG000|Overall Study|Failure to meet inclusion criteria|6|||
130762866|NCT04823130|470755782|FG001|Overall Study|Failure to meet inclusion criteria|4|||
130762867|NCT04823130|470755781|FG000|Overall Study|Other-unspecified|1|||
130762868|NCT04823130|470755782|FG001|Overall Study|Other-unspecified|0|||
130762869|NCT03315455|470755784|FG000|Overall Study|Ongoing in the Study|13|||
130762870|NCT03315455|470755785|FG001|Overall Study|Ongoing in the Study|24|||
130762871|NCT03315455|470755786|FG002|Overall Study|Ongoing in the Study|17|||
130762872|NCT03315455|470755787|FG003|Overall Study|Ongoing in the Study|15|||
130762873|NCT03315455|470755784|FG000|Overall Study|Withdrawal by Subject|0|||
130762874|NCT03315455|470755785|FG001|Overall Study|Withdrawal by Subject|1|||
130762875|NCT03315455|470755786|FG002|Overall Study|Withdrawal by Subject|0|||
130762876|NCT03315455|470755787|FG003|Overall Study|Withdrawal by Subject|0|||
130762877|NCT04439357|470755791|FG000|Overall Study|Disease Progression|4|||
130762878|NCT05906836|470755794|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
130762879|NCT05906836|470755794|FG000|Overall Study|Lost to Follow-up|1|||
130762880|NCT03030118|470755795|FG000|Overall Study|Achieved SLE Diagnosis|11|||
130762881|NCT03030118|470755796|FG001|Overall Study|Achieved SLE Diagnosis|10|||
130762882|NCT03030118|470755795|FG000|Overall Study|Adverse Event|1|||
130762883|NCT03030118|470755796|FG001|Overall Study|Adverse Event|1|||
130762884|NCT03030118|470755795|FG000|Overall Study|Pregnancy|2|||
130762885|NCT03030118|470755796|FG001|Overall Study|Pregnancy|2|||
130762886|NCT03030118|470755795|FG000|Overall Study|Lost to Follow-up|5|||
130762887|NCT03030118|470755796|FG001|Overall Study|Lost to Follow-up|6|||
130762888|NCT03030118|470755795|FG000|Overall Study|Concomitant Medications|1|||
130762889|NCT03030118|470755796|FG001|Overall Study|Concomitant Medications|1|||
130762890|NCT03030118|470755795|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
130762891|NCT03030118|470755796|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
130762892|NCT03030118|470755795|FG000|Overall Study|Other|2|||
130762893|NCT03030118|470755796|FG001|Overall Study|Other|0|||
130762894|NCT03030118|470755795|FG000|Overall Study|Withdrawal by Subject|26|||
130762895|NCT03030118|470755796|FG001|Overall Study|Withdrawal by Subject|21|||
130762896|NCT03030118|470755795|FG000|Overall Study|Protocol Violation|1|||
130762897|NCT03030118|470755796|FG001|Overall Study|Protocol Violation|6|||
130762898|NCT04529850|470755797|FG000|Overall Study|Death|2|||
130762899|NCT04529850|470755797|FG000|Overall Study|Physician Decision|1|||
130762900|NCT04529850|470755797|FG000|Overall Study|Withdrawal by Subject|2|||
130762901|NCT01911780|470755798|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
130762902|NCT01911780|470755799|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
130762903|NCT01911780|470755798|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
130762904|NCT01911780|470755799|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
130762905|NCT01911780|470755798|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
130762906|NCT01911780|470755799|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
130762907|NCT01911780|470755798|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
130762908|NCT01911780|470755799|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
130762909|NCT01911780|470755798|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
130762910|NCT01911780|470755799|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
130762911|NCT01911780|470755798|FG000|Extension Period (52 Weeks)|Personal reason|1|||
130762912|NCT01911780|470755799|FG001|Extension Period (52 Weeks)|Personal reason|1|||
130762913|NCT02720744|470755803|FG000|Overall Study|Protocol Violation|0|||
130762914|NCT02720744|470755804|FG001|Overall Study|Protocol Violation|2|||
130796990|NCT02572167|470881861|FG000|Overall Study|Did not meet inclusion criteria|0|||
130796991|NCT02572167|470881862|FG001|Overall Study|Did not meet inclusion criteria|0|||
130796992|NCT02572167|470881863|FG002|Overall Study|Did not meet inclusion criteria|1|||
130796993|NCT02572167|470881861|FG000|Overall Study|Study closure by Sponsor|4|||
130796994|NCT02572167|470881862|FG001|Overall Study|Study closure by Sponsor|40|||
130796995|NCT02572167|470881863|FG002|Overall Study|Study closure by Sponsor|24|||
130796996|NCT00569127|470881864|FG000|Overall Study|Adverse Event|57|||
130796997|NCT00569127|470881865|FG001|Overall Study|Adverse Event|47|||
130796998|NCT00569127|470881864|FG000|Overall Study|Withdrawal by Subject|13|||
130796999|NCT00569127|470881865|FG001|Overall Study|Withdrawal by Subject|27|||
130797000|NCT00569127|470881864|FG000|Overall Study|Progression|99|||
130797001|NCT00569127|470881865|FG001|Overall Study|Progression|100|||
130797002|NCT00569127|470881864|FG000|Overall Study|Death|4|||
130797003|NCT00569127|470881865|FG001|Overall Study|Death|3|||
130797004|NCT00569127|470881864|FG000|Overall Study|Other|20|||
130797005|NCT00569127|470881865|FG001|Overall Study|Other|19|||
130797006|NCT00569127|470881864|FG000|Overall Study|Lost to Follow-up|0|||
130797007|NCT00569127|470881865|FG001|Overall Study|Lost to Follow-up|3|||
130797008|NCT00569127|470881864|FG000|Overall Study|Not Eligible|14|||
130797009|NCT00569127|470881865|FG001|Overall Study|Not Eligible|11|||
130797010|NCT00569127|470881864|FG000|Overall Study|Still on Treatment|7|||
130797011|NCT00569127|470881865|FG001|Overall Study|Still on Treatment|3|||
130797012|NCT03036254|470881868|FG000|Overall Study|Adverse Event|6|||
130797013|NCT03036254|470881869|FG001|Overall Study|Adverse Event|4|||
130797014|NCT03036254|470881868|FG000|Overall Study|Death|3|||
130797015|NCT03036254|470881869|FG001|Overall Study|Death|1|||
130797016|NCT03036254|470881868|FG000|Overall Study|Lack of Efficacy|5|||
130797017|NCT03036254|470881869|FG001|Overall Study|Lack of Efficacy|1|||
130797018|NCT03036254|470881868|FG000|Overall Study|Withdrawal by Subject|3|||
130797019|NCT03036254|470881869|FG001|Overall Study|Withdrawal by Subject|5|||
130797020|NCT06354257|470881870|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130797021|NCT06354257|470881870|FG000|Treatment Period 2|Adverse Event|1|||
130797022|NCT03168672|470881871|FG000|Overall Study|Withdrawal by Subject|13|||
130797023|NCT03168672|470881871|FG000|Overall Study|Death|3|||
130797024|NCT03168672|470881871|FG000|Overall Study|Investigator's Decision|137|||
130797025|NCT03168672|470881871|FG000|Overall Study|Adverse Event|1|||
130797026|NCT03168672|470881871|FG000|Overall Study|Other|2|||
130797027|NCT03168672|470881871|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
130797028|NCT00433537|470881872|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
130797029|NCT00433537|470881873|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
130797030|NCT00433537|470881874|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
130797031|NCT00433537|470881872|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
130797032|NCT00433537|470881873|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
130797033|NCT00433537|470881874|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
130797034|NCT00433537|470881872|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
130797035|NCT00433537|470881873|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
130797036|NCT00433537|470881874|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
130797037|NCT00433537|470881872|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
130797038|NCT00433537|470881873|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
130797039|NCT00433537|470881874|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
130797040|NCT00433537|470881872|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
130797041|NCT00433537|470881873|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
130797042|NCT00433537|470881874|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
130797043|NCT00433537|470881872|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
130797044|NCT00433537|470881873|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
130797045|NCT00433537|470881874|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
130797046|NCT00433537|470881872|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
130797047|NCT00433537|470881873|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
130797048|NCT00433537|470881874|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
130797049|NCT00433537|470881872|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
130797050|NCT00433537|470881873|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
130797051|NCT00433537|470881874|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
130797052|NCT00433537|470881872|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
130797053|NCT00433537|470881873|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
130797054|NCT00433537|470881874|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
130797055|NCT01757847|470881875|FG000|Overall Study|Withdrawal by Subject|3|||
130797056|NCT01757847|470881876|FG001|Overall Study|Withdrawal by Subject|4|||
130797057|NCT00831844|470881877|FG000|Overall Study|Adverse Event|2|||
130797058|NCT00831844|470881878|FG001|Overall Study|Adverse Event|0|||
130797059|NCT00831844|470881879|FG002|Overall Study|Adverse Event|0|||
130797060|NCT00831844|470881880|FG003|Overall Study|Adverse Event|0|||
130797061|NCT00831844|470881881|FG004|Overall Study|Adverse Event|1|||
130797062|NCT00831844|470881882|FG005|Overall Study|Adverse Event|1|||
130797063|NCT00831844|470881883|FG006|Overall Study|Adverse Event|2|||
130797064|NCT00831844|470881884|FG007|Overall Study|Adverse Event|0|||
130797065|NCT00831844|470881885|FG008|Overall Study|Adverse Event|0|||
130797066|NCT00831844|470881886|FG009|Overall Study|Adverse Event|0|||
130797067|NCT00831844|470881877|FG000|Overall Study|Death|0|||
130797068|NCT00831844|470881878|FG001|Overall Study|Death|0|||
130797069|NCT00831844|470881879|FG002|Overall Study|Death|0|||
130797070|NCT00831844|470881880|FG003|Overall Study|Death|1|||
130797071|NCT00831844|470881881|FG004|Overall Study|Death|0|||
130797072|NCT00831844|470881882|FG005|Overall Study|Death|0|||
130797073|NCT00831844|470881883|FG006|Overall Study|Death|0|||
130797074|NCT00831844|470881884|FG007|Overall Study|Death|0|||
130797075|NCT00831844|470881885|FG008|Overall Study|Death|0|||
130797076|NCT00831844|470881886|FG009|Overall Study|Death|0|||
130797077|NCT00831844|470881877|FG000|Overall Study|Lack of Efficacy|8|||
130797078|NCT00831844|470881878|FG001|Overall Study|Lack of Efficacy|10|||
130797079|NCT00831844|470881879|FG002|Overall Study|Lack of Efficacy|15|||
130797080|NCT00831844|470881880|FG003|Overall Study|Lack of Efficacy|8|||
130797081|NCT00831844|470881881|FG004|Overall Study|Lack of Efficacy|11|||
130797082|NCT00831844|470881882|FG005|Overall Study|Lack of Efficacy|17|||
130797083|NCT00831844|470881883|FG006|Overall Study|Lack of Efficacy|8|||
130797084|NCT00831844|470881884|FG007|Overall Study|Lack of Efficacy|9|||
130797085|NCT00831844|470881885|FG008|Overall Study|Lack of Efficacy|7|||
130797086|NCT00831844|470881886|FG009|Overall Study|Lack of Efficacy|0|||
130797087|NCT00831844|470881877|FG000|Overall Study|Physician Decision|0|||
130797088|NCT00831844|470881878|FG001|Overall Study|Physician Decision|1|||
130797089|NCT00831844|470881879|FG002|Overall Study|Physician Decision|3|||
130797090|NCT00831844|470881880|FG003|Overall Study|Physician Decision|1|||
130797091|NCT00831844|470881881|FG004|Overall Study|Physician Decision|1|||
130797092|NCT00831844|470881882|FG005|Overall Study|Physician Decision|1|||
130797093|NCT00831844|470881883|FG006|Overall Study|Physician Decision|0|||
130797094|NCT00831844|470881884|FG007|Overall Study|Physician Decision|0|||
130797095|NCT00831844|470881885|FG008|Overall Study|Physician Decision|1|||
130797096|NCT00831844|470881886|FG009|Overall Study|Physician Decision|0|||
130797097|NCT00831844|470881877|FG000|Overall Study|Withdrawal by Subject|0|||
130797098|NCT00831844|470881878|FG001|Overall Study|Withdrawal by Subject|0|||
130797099|NCT00831844|470881879|FG002|Overall Study|Withdrawal by Subject|1|||
130797100|NCT00831844|470881880|FG003|Overall Study|Withdrawal by Subject|0|||
130797101|NCT00831844|470881881|FG004|Overall Study|Withdrawal by Subject|0|||
130797102|NCT00831844|470881882|FG005|Overall Study|Withdrawal by Subject|0|||
130797103|NCT00831844|470881883|FG006|Overall Study|Withdrawal by Subject|0|||
130797104|NCT00831844|470881884|FG007|Overall Study|Withdrawal by Subject|1|||
130797105|NCT00831844|470881885|FG008|Overall Study|Withdrawal by Subject|1|||
130797106|NCT00831844|470881886|FG009|Overall Study|Withdrawal by Subject|0|||
130797107|NCT00831844|470881877|FG000|Overall Study|Ineligible|0|||
130797108|NCT00831844|470881878|FG001|Overall Study|Ineligible|1|||
130797109|NCT00831844|470881879|FG002|Overall Study|Ineligible|1|||
130797110|NCT00831844|470881880|FG003|Overall Study|Ineligible|0|||
130797111|NCT00831844|470881881|FG004|Overall Study|Ineligible|1|||
130797112|NCT00831844|470881882|FG005|Overall Study|Ineligible|0|||
130797113|NCT00831844|470881883|FG006|Overall Study|Ineligible|0|||
130797114|NCT00831844|470881884|FG007|Overall Study|Ineligible|0|||
130797115|NCT00831844|470881885|FG008|Overall Study|Ineligible|0|||
130797116|NCT00831844|470881886|FG009|Overall Study|Ineligible|0|||
130797171|NCT05317546|470881892|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
130797172|NCT05317546|470881893|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
130797173|NCT03331250|470881894|FG000|Overall Study|Withdrawal by Subject|1|||
130797174|NCT04590963|470881895|FG000|Overall Study|Death|118|||
130797175|NCT04590963|470881896|FG001|Overall Study|Death|59|||
130797176|NCT04590963|470881895|FG000|Overall Study|Lost to Follow-up|1|||
130797177|NCT04590963|470881896|FG001|Overall Study|Lost to Follow-up|1|||
130797178|NCT04590963|470881895|FG000|Overall Study|Progressive disease|0|||
130797179|NCT04590963|470881896|FG001|Overall Study|Progressive disease|1|||
130797180|NCT04590963|470881895|FG000|Overall Study|Study terminated by sponsor|103|||
130797181|NCT04590963|470881896|FG001|Overall Study|Study terminated by sponsor|50|||
130797182|NCT04590963|470881895|FG000|Overall Study|Withdrawal by Subject|15|||
130797183|NCT04590963|470881896|FG001|Overall Study|Withdrawal by Subject|8|||
130797184|NCT04590963|470881895|FG000|Overall Study|Ongoing at data cut-off|9|||
130797185|NCT04590963|470881896|FG001|Overall Study|Ongoing at data cut-off|4|||
130797186|NCT04590963|470881895|FG000|Overall Study|Screen failure|1|||
130797187|NCT04590963|470881896|FG001|Overall Study|Screen failure|0|||
130797188|NCT04057365|470881897|FG000|Overall Study|Withdrawal by Subject|2|||
130797189|NCT04057365|470881898|FG001|Overall Study|Withdrawal by Subject|0|||
130797190|NCT04738487|470881899|FG000|Overall Study|Participant Ongoing in Study|298|||
130797191|NCT04738487|470881900|FG001|Overall Study|Participant Ongoing in Study|297|||
130797192|NCT04738487|470881899|FG000|Overall Study|Withdrawal by Subject|7|||
130797193|NCT04738487|470881900|FG001|Overall Study|Withdrawal by Subject|9|||
130797194|NCT04738487|470881899|FG000|Overall Study|Lost to Follow-up|2|||
130797195|NCT04738487|470881900|FG001|Overall Study|Lost to Follow-up|0|||
130797196|NCT04738487|470881899|FG000|Overall Study|Death|287|||
130797197|NCT04738487|470881900|FG001|Overall Study|Death|306|||
130797198|NCT05350202|470881901|FG000|Visit 1 - Baseline|Not-treated|18|||
130797199|NCT05350202|470881902|FG001|Visit 1 - Baseline|Not-treated|0|||
130797200|NCT05350202|470881901|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
130797201|NCT05350202|470881902|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
130797202|NCT05350202|470881901|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
130797203|NCT05350202|470881902|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
130797204|NCT05350202|470881901|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
130797205|NCT05350202|470881902|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
130797206|NCT05350202|470881901|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
130797207|NCT05350202|470881902|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
130797208|NCT05350202|470881901|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
130797209|NCT05350202|470881902|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
130797210|NCT05350202|470881901|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
130797211|NCT05350202|470881902|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
130797212|NCT01063114|470881903|FG000|Overall Study|Lost to Follow-up|1|||
130797227|NCT02390284|470881909|FG000|Overall Study|Physician Decision|0|||
130797228|NCT02390284|470881910|FG001|Overall Study|Physician Decision|0|||
130797229|NCT02390284|470881911|FG002|Overall Study|Physician Decision|9|||
130797230|NCT01937299|470881912|FG000|Overall Study|Adverse Event|13|||
130797231|NCT01937299|470881913|FG001|Overall Study|Adverse Event|0|||
130797232|NCT01937299|470881912|FG000|Overall Study|Lack of Efficacy|0|||
130797233|NCT01937299|470881913|FG001|Overall Study|Lack of Efficacy|4|||
130797234|NCT01937299|470881912|FG000|Overall Study|Withdrawal by Subject|1|||
130797235|NCT01937299|470881913|FG001|Overall Study|Withdrawal by Subject|0|||
130797236|NCT00385840|470881914|FG000|Overall Study|Adverse Event|1|||
130797237|NCT00385840|470881915|FG001|Overall Study|Adverse Event|1|||
130797238|NCT00385840|470881914|FG000|Overall Study|Lost to Follow-up|3|||
130797239|NCT00385840|470881915|FG001|Overall Study|Lost to Follow-up|13|||
130797240|NCT02916771|470881926|FG000|Overall Study|Withdrawal by Subject|9|||
130797241|NCT02916771|470881926|FG000|Overall Study|Physician Decision|1|||
130797242|NCT02916771|470881926|FG000|Overall Study|Began treatment for another active malignancy|1|||
130797243|NCT05759338|470881927|FG000|Overall Study|Withdrawal by Subject|3|||
130797244|NCT02924376|470881928|FG000|Overall Study|Progressive Disease|4|||
130797245|NCT02924376|470881929|FG001|Overall Study|Progressive Disease|0|||
130797246|NCT02924376|470881930|FG002|Overall Study|Progressive Disease|1|||
130797247|NCT02924376|470881931|FG003|Overall Study|Progressive Disease|0|||
130797248|NCT02924376|470881928|FG000|Overall Study|Death|73|||
130797249|NCT02924376|470881929|FG001|Overall Study|Death|18|||
130797250|NCT02924376|470881930|FG002|Overall Study|Death|15|||
130797251|NCT02924376|470881931|FG003|Overall Study|Death|2|||
130797252|NCT02924376|470881928|FG000|Overall Study|Lost to Follow-up|3|||
130797253|NCT02924376|470881929|FG001|Overall Study|Lost to Follow-up|0|||
130797254|NCT02924376|470881930|FG002|Overall Study|Lost to Follow-up|0|||
130797255|NCT02924376|470881931|FG003|Overall Study|Lost to Follow-up|0|||
130797256|NCT02924376|470881928|FG000|Overall Study|Study Terminated by Sponsor|19|||
130797257|NCT02924376|470881929|FG001|Overall Study|Study Terminated by Sponsor|0|||
130797258|NCT02924376|470881930|FG002|Overall Study|Study Terminated by Sponsor|0|||
130797259|NCT02924376|470881931|FG003|Overall Study|Study Terminated by Sponsor|0|||
130797260|NCT02924376|470881928|FG000|Overall Study|Physician Decision|1|||
130797261|NCT02924376|470881929|FG001|Overall Study|Physician Decision|0|||
130797262|NCT02924376|470881930|FG002|Overall Study|Physician Decision|0|||
130797263|NCT02924376|470881931|FG003|Overall Study|Physician Decision|0|||
130797264|NCT02924376|470881928|FG000|Overall Study|Withdrawal by Subject|7|||
130797265|NCT02924376|470881929|FG001|Overall Study|Withdrawal by Subject|2|||
130797266|NCT02924376|470881930|FG002|Overall Study|Withdrawal by Subject|1|||
130797267|NCT02924376|470881931|FG003|Overall Study|Withdrawal by Subject|0|||
130797268|NCT02924376|470881928|FG000|Overall Study|Rolled Over to Another Study|1|||
130797269|NCT02924376|470881929|FG001|Overall Study|Rolled Over to Another Study|0|||
130797270|NCT02924376|470881930|FG002|Overall Study|Rolled Over to Another Study|0|||
130797271|NCT02924376|470881931|FG003|Overall Study|Rolled Over to Another Study|0|||
130797272|NCT03459846|470881937|FG000|Overall Study|Death|52|||
130797273|NCT03459846|470881938|FG001|Overall Study|Death|46|||
130797274|NCT03459846|470881937|FG000|Overall Study|Study terminated by sponsor|24|||
130797275|NCT03459846|470881938|FG001|Overall Study|Study terminated by sponsor|28|||
130797276|NCT03459846|470881937|FG000|Overall Study|Withdrawal by Subject|2|||
130797277|NCT03459846|470881938|FG001|Overall Study|Withdrawal by Subject|2|||
130797278|NCT06455111|470881941|FG000|Overall Study|Withdrawal by Subject|11|||
130797279|NCT06455111|470881942|FG001|Overall Study|Withdrawal by Subject|4|||
130797280|NCT05578872|470881948|FG000|Overall Study|Withdrawal by Subject|2|||
130797281|NCT05578872|470881949|FG001|Overall Study|Withdrawal by Subject|1|||
130797282|NCT05578872|470881948|FG000|Overall Study|Adverse Event|1|||
130797283|NCT05578872|470881949|FG001|Overall Study|Adverse Event|1|||
130797284|NCT05578872|470881948|FG000|Overall Study|Physician Decision|1|||
130797285|NCT05578872|470881949|FG001|Overall Study|Physician Decision|2|||
130797286|NCT05578872|470881948|FG000|Overall Study|Progressive disease|10|||
130797287|NCT05578872|470881949|FG001|Overall Study|Progressive disease|9|||
130797288|NCT05578872|470881948|FG000|Overall Study|Sponsor decision|0|||
130797289|NCT05578872|470881949|FG001|Overall Study|Sponsor decision|1|||
130797290|NCT05578872|470881948|FG000|Overall Study|Toxicity and Patient's decision|0|||
130762915|NCT02720744|470755803|FG000|Overall Study|Pregnancy|2|||
130762916|NCT02720744|470755804|FG001|Overall Study|Pregnancy|0|||
130762917|NCT02720744|470755803|FG000|Overall Study|Lack of Efficacy|2|||
130762918|NCT02720744|470755804|FG001|Overall Study|Lack of Efficacy|8|||
130762919|NCT02720744|470755803|FG000|Overall Study|Adverse Event|21|||
130762920|NCT02720744|470755804|FG001|Overall Study|Adverse Event|3|||
130762921|NCT02720744|470755803|FG000|Overall Study|Withdrawal by Subject|11|||
130762922|NCT02720744|470755804|FG001|Overall Study|Withdrawal by Subject|11|||
130762923|NCT02720744|470755803|FG000|Overall Study|Lost to follow up|2|||
130762924|NCT02720744|470755804|FG001|Overall Study|Lost to follow up|0|||
130762925|NCT02720744|470755803|FG000|Overall Study|Non Compliance with Investigational Product|0|||
130762926|NCT02720744|470755804|FG001|Overall Study|Non Compliance with Investigational Product|1|||
130762927|NCT02720744|470755803|FG000|Overall Study|Excluded Concomitant Medication|0|||
130762928|NCT02720744|470755804|FG001|Overall Study|Excluded Concomitant Medication|1|||
130762929|NCT01199822|470755806|FG000|Overall Study|Investigator discontinued therapy|0|||
130762930|NCT01199822|470755807|FG001|Overall Study|Investigator discontinued therapy|1|||
130762931|NCT01199822|470755808|FG002|Overall Study|Investigator discontinued therapy|0|||
130762932|NCT00480493|470755809|FG000|Overall Study|moved|2|||
130762933|NCT00480493|470755810|FG001|Overall Study|moved|7|||
130762934|NCT04027075|470755811|FG000|Overall Study|Lost to Follow-up|41|||
130762935|NCT04027075|470755812|FG001|Overall Study|Lost to Follow-up|22|||
130762936|NCT03769675|470755813|FG000|Overall Study|Lost to Follow-up|1|||
130762937|NCT01032070|470755814|FG000|Overall Study|Disease progression|13|||
130762938|NCT01032070|470755815|FG001|Overall Study|Disease progression|8|||
130762939|NCT01032070|470755814|FG000|Overall Study|Medical or ethical reasons|0|||
130762940|NCT01032070|470755815|FG001|Overall Study|Medical or ethical reasons|2|||
130762941|NCT01032070|470755814|FG000|Overall Study|Withdrawal by Subject|0|||
130762942|NCT01032070|470755815|FG001|Overall Study|Withdrawal by Subject|2|||
130762943|NCT00426660|470755816|FG000|Overall Study|Death|14|||
130762944|NCT00426660|470755816|FG000|Overall Study|Adverse Event|23|||
130762945|NCT00426660|470755816|FG000|Overall Study|Insufficient Clinical Response|22|||
130762946|NCT00426660|470755816|FG000|Overall Study|Lost to Follow-up|15|||
130762947|NCT00426660|470755816|FG000|Overall Study|Other|23|||
130762948|NCT00426660|470755816|FG000|Overall Study|Withdrawal by Subject|18|||
130762949|NCT00426660|470755816|FG000|Overall Study|Protocol Violation|1|||
130762950|NCT00426660|470755816|FG000|Overall Study|Enrolled Not Treated|15|||
130762951|NCT00738062|470755817|FG000|Open Label Treatment|Lack of Efficacy|5|||
130762952|NCT00738062|470755818|FG001|Open Label Treatment|Lack of Efficacy|0|||
130762953|NCT00738062|470755819|FG002|Open Label Treatment|Lack of Efficacy|0|||
130762954|NCT00738062|470755817|FG000|Open Label Treatment|Adverse Event|11|||
130762955|NCT00738062|470755818|FG001|Open Label Treatment|Adverse Event|0|||
130762956|NCT00738062|470755819|FG002|Open Label Treatment|Adverse Event|0|||
130762957|NCT00738062|470755817|FG000|Open Label Treatment|Protocol Violation|2|||
130762958|NCT00738062|470755818|FG001|Open Label Treatment|Protocol Violation|0|||
130762959|NCT00738062|470755819|FG002|Open Label Treatment|Protocol Violation|0|||
130762960|NCT00738062|470755817|FG000|Open Label Treatment|Withdrawal by Subject|9|||
130762961|NCT00738062|470755818|FG001|Open Label Treatment|Withdrawal by Subject|0|||
130762962|NCT00738062|470755819|FG002|Open Label Treatment|Withdrawal by Subject|0|||
130762963|NCT00738062|470755817|FG000|Open Label Treatment|Investigator Decision|1|||
130762964|NCT00738062|470755818|FG001|Open Label Treatment|Investigator Decision|0|||
130762965|NCT00738062|470755819|FG002|Open Label Treatment|Investigator Decision|0|||
130762966|NCT00738062|470755817|FG000|Open-Label Extension|Adverse Event|5|||
130762967|NCT00738062|470755818|FG001|Open-Label Extension|Adverse Event|0|||
130762968|NCT00738062|470755819|FG002|Open-Label Extension|Adverse Event|0|||
130762969|NCT00738062|470755817|FG000|Open-Label Extension|Physician Decision|1|||
130762970|NCT00738062|470755818|FG001|Open-Label Extension|Physician Decision|0|||
130762971|NCT00738062|470755819|FG002|Open-Label Extension|Physician Decision|0|||
130762972|NCT00738062|470755817|FG000|Open-Label Extension|Lack of Efficacy|2|||
130762973|NCT00738062|470755818|FG001|Open-Label Extension|Lack of Efficacy|0|||
130762974|NCT00738062|470755819|FG002|Open-Label Extension|Lack of Efficacy|0|||
130762975|NCT00738062|470755817|FG000|Open-Label Extension|Withdrawal by Subject|6|||
130762976|NCT00738062|470755818|FG001|Open-Label Extension|Withdrawal by Subject|0|||
130762977|NCT00738062|470755819|FG002|Open-Label Extension|Withdrawal by Subject|0|||
130762978|NCT00738062|470755817|FG000|Open-Label Extension|Protocol Violation|1|||
130762979|NCT00738062|470755818|FG001|Open-Label Extension|Protocol Violation|0|||
130797291|NCT05578872|470881949|FG001|Overall Study|Toxicity and Patient's decision|1|||
130797292|NCT00005047|470883063|FG000|Overall Study|Withdrawal by Subject|12|||
130797293|NCT00005047|470883064|FG001|Overall Study|Withdrawal by Subject|0|||
130797294|NCT00005047|470883065|FG002|Overall Study|Withdrawal by Subject|0|||
130797295|NCT00005047|470883066|FG003|Overall Study|Withdrawal by Subject|0|||
130797296|NCT00005047|470883063|FG000|Overall Study|Adverse Event|5|||
130797297|NCT00005047|470883064|FG001|Overall Study|Adverse Event|0|||
130797298|NCT00005047|470883065|FG002|Overall Study|Adverse Event|0|||
130797299|NCT00005047|470883066|FG003|Overall Study|Adverse Event|0|||
130797300|NCT00005047|470883063|FG000|Overall Study|Lost to Follow-up|1|||
130797301|NCT00005047|470883064|FG001|Overall Study|Lost to Follow-up|0|||
130797302|NCT00005047|470883065|FG002|Overall Study|Lost to Follow-up|0|||
130797303|NCT00005047|470883066|FG003|Overall Study|Lost to Follow-up|0|||
130797304|NCT00005047|470883063|FG000|Overall Study|Lack of Efficacy|1|||
130797305|NCT00005047|470883064|FG001|Overall Study|Lack of Efficacy|0|||
130797306|NCT00005047|470883065|FG002|Overall Study|Lack of Efficacy|0|||
130797307|NCT00005047|470883066|FG003|Overall Study|Lack of Efficacy|0|||
130797308|NCT00098475|470883074|FG000|Step 1|Progressive disease|33|||
130797309|NCT00098475|470883075|FG001|Step 1|Progressive disease|35|||
130797310|NCT00098475|470883076|FG002|Step 1|Progressive disease|2|||
130797311|NCT00098475|470883077|FG003|Step 1|Progressive disease|1|||
130797312|NCT00098475|470883074|FG000|Step 1|Adverse Event|56|||
130797313|NCT00098475|470883075|FG001|Step 1|Adverse Event|37|||
130797314|NCT00098475|470883076|FG002|Step 1|Adverse Event|0|||
130797315|NCT00098475|470883077|FG003|Step 1|Adverse Event|1|||
130797316|NCT00098475|470883074|FG000|Step 1|Death|8|||
130797317|NCT00098475|470883075|FG001|Step 1|Death|5|||
130797318|NCT00098475|470883076|FG002|Step 1|Death|0|||
130797319|NCT00098475|470883077|FG003|Step 1|Death|1|||
130797320|NCT00098475|470883074|FG000|Step 1|Withdrawal by Subject|14|||
130797321|NCT00098475|470883075|FG001|Step 1|Withdrawal by Subject|11|||
130797322|NCT00098475|470883076|FG002|Step 1|Withdrawal by Subject|0|||
130797323|NCT00098475|470883077|FG003|Step 1|Withdrawal by Subject|0|||
130797324|NCT00098475|470883074|FG000|Step 1|Physician Decision|5|||
130797325|NCT00098475|470883075|FG001|Step 1|Physician Decision|2|||
130797326|NCT00098475|470883076|FG002|Step 1|Physician Decision|0|||
130797327|NCT00098475|470883077|FG003|Step 1|Physician Decision|0|||
130797328|NCT00098475|470883074|FG000|Step 1|Alternative therapy|31|||
130797329|NCT00098475|470883075|FG001|Step 1|Alternative therapy|43|||
130797330|NCT00098475|470883076|FG002|Step 1|Alternative therapy|1|||
130797331|NCT00098475|470883077|FG003|Step 1|Alternative therapy|0|||
130797332|NCT00098475|470883074|FG000|Step 1|Other disease|2|||
130797333|NCT00098475|470883075|FG001|Step 1|Other disease|1|||
130797334|NCT00098475|470883076|FG002|Step 1|Other disease|1|||
130797335|NCT00098475|470883077|FG003|Step 1|Other disease|0|||
130797336|NCT00098475|470883074|FG000|Step 1|Never started treatment|0|||
130797337|NCT00098475|470883075|FG001|Step 1|Never started treatment|2|||
130797338|NCT00098475|470883076|FG002|Step 1|Never started treatment|0|||
130797339|NCT00098475|470883077|FG003|Step 1|Never started treatment|0|||
130797340|NCT00098475|470883074|FG000|Step 1|Still on treatment as of this analysis|14|||
130797341|NCT00098475|470883075|FG001|Step 1|Still on treatment as of this analysis|27|||
130797342|NCT00098475|470883076|FG002|Step 1|Still on treatment as of this analysis|0|||
130797343|NCT00098475|470883077|FG003|Step 1|Still on treatment as of this analysis|0|||
130797344|NCT00098475|470883074|FG000|Step 1|Knee surgery|1|||
130797345|NCT00098475|470883075|FG001|Step 1|Knee surgery|0|||
130797346|NCT00098475|470883076|FG002|Step 1|Knee surgery|0|||
130797347|NCT00098475|470883077|FG003|Step 1|Knee surgery|0|||
130797348|NCT00098475|470883074|FG000|Step 1|Complications|1|||
130797349|NCT00098475|470883075|FG001|Step 1|Complications|0|||
130797350|NCT00098475|470883076|FG002|Step 1|Complications|0|||
130797351|NCT00098475|470883077|FG003|Step 1|Complications|0|||
130797352|NCT00098475|470883074|FG000|Step 1|Cannot comply due to other tx|0|||
130797353|NCT00098475|470883075|FG001|Step 1|Cannot comply due to other tx|1|||
130797354|NCT00098475|470883076|FG002|Step 1|Cannot comply due to other tx|0|||
130797355|NCT00098475|470883077|FG003|Step 1|Cannot comply due to other tx|0|||
130797356|NCT00098475|470883074|FG000|Step 1|Both patient and physician's decision|2|||
130797357|NCT00098475|470883075|FG001|Step 1|Both patient and physician's decision|1|||
130797358|NCT00098475|470883076|FG002|Step 1|Both patient and physician's decision|0|||
130797359|NCT00098475|470883077|FG003|Step 1|Both patient and physician's decision|0|||
130797360|NCT00098475|470883074|FG000|Step 1|Incorrect disease assessment|2|||
130797361|NCT00098475|470883075|FG001|Step 1|Incorrect disease assessment|0|||
130797362|NCT00098475|470883076|FG002|Step 1|Incorrect disease assessment|0|||
130797363|NCT00098475|470883077|FG003|Step 1|Incorrect disease assessment|0|||
130797364|NCT00098475|470883074|FG000|Step 1|Off treatment for > specified timeframe|1|||
130797365|NCT00098475|470883075|FG001|Step 1|Off treatment for > specified timeframe|1|||
130797366|NCT00098475|470883076|FG002|Step 1|Off treatment for > specified timeframe|0|||
130797367|NCT00098475|470883077|FG003|Step 1|Off treatment for > specified timeframe|0|||
130797368|NCT00098475|470883074|FG000|Step 1|Declining performance status|0|||
130797369|NCT00098475|470883075|FG001|Step 1|Declining performance status|1|||
130797370|NCT00098475|470883076|FG002|Step 1|Declining performance status|0|||
130797371|NCT00098475|470883077|FG003|Step 1|Declining performance status|0|||
130797372|NCT00098475|470883074|FG000|Step 1|Insurance issue|0|||
130797373|NCT00098475|470883075|FG001|Step 1|Insurance issue|1|||
130797374|NCT00098475|470883076|FG002|Step 1|Insurance issue|0|||
130797375|NCT00098475|470883077|FG003|Step 1|Insurance issue|0|||
130797376|NCT00098475|470883074|FG000|Step 1|Rising paraprotein|0|||
130797377|NCT00098475|470883075|FG001|Step 1|Rising paraprotein|1|||
130797378|NCT00098475|470883076|FG002|Step 1|Rising paraprotein|0|||
130797379|NCT00098475|470883077|FG003|Step 1|Rising paraprotein|0|||
130797380|NCT00098475|470883074|FG000|Step 1|Referred to other physicians|0|||
130797381|NCT00098475|470883075|FG001|Step 1|Referred to other physicians|1|||
130797382|NCT00098475|470883076|FG002|Step 1|Referred to other physicians|0|||
130797383|NCT00098475|470883077|FG003|Step 1|Referred to other physicians|0|||
130797384|NCT00098475|470883074|FG000|Step 1|Criteria to continue treatment not met|0|||
130797385|NCT00098475|470883075|FG001|Step 1|Criteria to continue treatment not met|1|||
130797386|NCT00098475|470883076|FG002|Step 1|Criteria to continue treatment not met|0|||
130797387|NCT00098475|470883077|FG003|Step 1|Criteria to continue treatment not met|0|||
130797388|NCT00098475|470883074|FG000|Step 1|Misinterpretation of lab data|0|||
130797389|NCT00098475|470883075|FG001|Step 1|Misinterpretation of lab data|1|||
130797390|NCT00098475|470883076|FG002|Step 1|Misinterpretation of lab data|0|||
130797391|NCT00098475|470883077|FG003|Step 1|Misinterpretation of lab data|0|||
130797392|NCT00098475|470883074|FG000|Step 1|Patient fell with fracture|1|||
130797393|NCT00098475|470883075|FG001|Step 1|Patient fell with fracture|0|||
130797394|NCT00098475|470883076|FG002|Step 1|Patient fell with fracture|0|||
130797395|NCT00098475|470883077|FG003|Step 1|Patient fell with fracture|0|||
130797396|NCT00098475|470883074|FG000|Step 1|Not documented|0|||
130797397|NCT00098475|470883075|FG001|Step 1|Not documented|1|||
130797398|NCT00098475|470883076|FG002|Step 1|Not documented|0|||
130797399|NCT00098475|470883077|FG003|Step 1|Not documented|0|||
130797400|NCT00098475|470883074|FG000|Step 2|Disease progression|1|||
130797401|NCT00098475|470883075|FG001|Step 2|Disease progression|4|||
130797402|NCT00098475|470883076|FG002|Step 2|Disease progression|0|||
130797403|NCT00098475|470883077|FG003|Step 2|Disease progression|0|||
130797404|NCT00098475|470883074|FG000|Step 2|Adverse Event|2|||
130797405|NCT00098475|470883075|FG001|Step 2|Adverse Event|0|||
130797406|NCT00098475|470883076|FG002|Step 2|Adverse Event|0|||
130797407|NCT00098475|470883077|FG003|Step 2|Adverse Event|0|||
130797408|NCT00098475|470883074|FG000|Step 2|Withdrawal by Subject|0|||
130797409|NCT00098475|470883075|FG001|Step 2|Withdrawal by Subject|2|||
130797410|NCT00098475|470883076|FG002|Step 2|Withdrawal by Subject|0|||
130797411|NCT00098475|470883077|FG003|Step 2|Withdrawal by Subject|0|||
130797412|NCT00098475|470883074|FG000|Step 2|Physician Decision|0|||
130797413|NCT00098475|470883075|FG001|Step 2|Physician Decision|1|||
130797414|NCT00098475|470883076|FG002|Step 2|Physician Decision|0|||
130797415|NCT00098475|470883077|FG003|Step 2|Physician Decision|0|||
130797416|NCT00098475|470883074|FG000|Step 2|Alternative therapy|1|||
130797417|NCT00098475|470883075|FG001|Step 2|Alternative therapy|2|||
130797418|NCT00098475|470883076|FG002|Step 2|Alternative therapy|0|||
130797419|NCT00098475|470883077|FG003|Step 2|Alternative therapy|0|||
130797420|NCT00098475|470883074|FG000|Step 2|Never started treatment|1|||
130797421|NCT00098475|470883075|FG001|Step 2|Never started treatment|1|||
130797422|NCT00098475|470883076|FG002|Step 2|Never started treatment|0|||
130797423|NCT00098475|470883077|FG003|Step 2|Never started treatment|0|||
130797424|NCT04132050|470883078|FG000|Period I (Double-blind Period)|Adverse Event|3|||
130797425|NCT04132050|470883079|FG001|Period I (Double-blind Period)|Adverse Event|0|||
130797426|NCT04132050|470883078|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
130797427|NCT04132050|470883079|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
130797428|NCT04132050|470883078|FG000|R788 Treatment Period|Adverse Event|5|||
130797429|NCT04132050|470883079|FG001|R788 Treatment Period|Adverse Event|0|||
130797430|NCT04132050|470883078|FG000|R788 Treatment Period|Lack of Efficacy|5|||
130762980|NCT00738062|470755819|FG002|Open-Label Extension|Protocol Violation|0|||
130762981|NCT00738062|470755817|FG000|Open-Label Extension|Study Terminated|2|||
130762982|NCT00738062|470755818|FG001|Open-Label Extension|Study Terminated|0|||
130762983|NCT00738062|470755819|FG002|Open-Label Extension|Study Terminated|0|||
130762984|NCT02772276|470755820|FG000|Overall Study|Lost to Follow-up|0|||
130762985|NCT02772276|470755821|FG001|Overall Study|Lost to Follow-up|0|||
130762986|NCT02772276|470755822|FG002|Overall Study|Lost to Follow-up|0|||
130762987|NCT02772276|470755823|FG003|Overall Study|Lost to Follow-up|0|||
130762988|NCT02772276|470755824|FG004|Overall Study|Lost to Follow-up|0|||
130762989|NCT02772276|470755825|FG005|Overall Study|Lost to Follow-up|0|||
130762990|NCT02772276|470755826|FG006|Overall Study|Lost to Follow-up|1|||
130762991|NCT02772276|470755827|FG007|Overall Study|Lost to Follow-up|0|||
130762992|NCT02772276|470755828|FG008|Overall Study|Lost to Follow-up|0|||
130762993|NCT02772276|470755829|FG009|Overall Study|Lost to Follow-up|0|||
130762994|NCT02772276|470755830|FG010|Overall Study|Lost to Follow-up|0|||
130762995|NCT02772276|470755831|FG011|Overall Study|Lost to Follow-up|0|||
130762996|NCT02772276|470755832|FG012|Overall Study|Lost to Follow-up|0|||
130762997|NCT02772276|470755820|FG000|Overall Study|Withdrew consent|0|||
130762998|NCT02772276|470755821|FG001|Overall Study|Withdrew consent|0|||
130762999|NCT02772276|470755822|FG002|Overall Study|Withdrew consent|0|||
130763000|NCT02772276|470755823|FG003|Overall Study|Withdrew consent|0|||
130763001|NCT02772276|470755824|FG004|Overall Study|Withdrew consent|0|||
130763002|NCT02772276|470755825|FG005|Overall Study|Withdrew consent|0|||
130763003|NCT02772276|470755826|FG006|Overall Study|Withdrew consent|0|||
130763004|NCT02772276|470755827|FG007|Overall Study|Withdrew consent|1|||
130763005|NCT02772276|470755828|FG008|Overall Study|Withdrew consent|0|||
130763006|NCT02772276|470755829|FG009|Overall Study|Withdrew consent|0|||
130763007|NCT02772276|470755830|FG010|Overall Study|Withdrew consent|0|||
130763008|NCT02772276|470755831|FG011|Overall Study|Withdrew consent|0|||
130763009|NCT02772276|470755832|FG012|Overall Study|Withdrew consent|0|||
130763010|NCT00980174|470755833|FG000|Overall Study|Withdrawal by Subject|1|||
130763011|NCT00980174|470755834|FG001|Overall Study|Withdrawal by Subject|4|||
130763012|NCT00980174|470755833|FG000|Overall Study|Adverse Event|0|||
130763013|NCT00980174|470755834|FG001|Overall Study|Adverse Event|3|||
130763014|NCT00980174|470755833|FG000|Overall Study|Ineligibility determined|2|||
130763015|NCT00980174|470755834|FG001|Overall Study|Ineligibility determined|1|||
130763016|NCT00980174|470755833|FG000|Overall Study|Death|1|||
130763017|NCT00980174|470755834|FG001|Overall Study|Death|1|||
130763018|NCT00980174|470755833|FG000|Overall Study|Other|0|||
130763019|NCT00980174|470755834|FG001|Overall Study|Other|1|||
130763020|NCT00455520|470755836|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
130763021|NCT00455520|470755837|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
130763022|NCT00455520|470755836|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
130763023|NCT00455520|470755837|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
130763024|NCT00455520|470755836|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
130763025|NCT00455520|470755837|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
130763026|NCT00455520|470755836|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
130763027|NCT00455520|470755837|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
130763028|NCT00455520|470755836|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
130763029|NCT00455520|470755837|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
130763030|NCT00455520|470755836|FG000|Open Label Tapentadol Extended Release|All other|33|||
130763031|NCT00455520|470755837|FG001|Open Label Tapentadol Extended Release|All other|0|||
130763032|NCT00455520|470755836|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
130763033|NCT00455520|470755837|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
130763034|NCT00455520|470755836|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
130763035|NCT00455520|470755837|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
130763036|NCT00455520|470755836|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
130763037|NCT00455520|470755837|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
130763038|NCT00455520|470755836|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
130763039|NCT00455520|470755837|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
130763040|NCT00455520|470755836|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
130763041|NCT00455520|470755837|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
130763042|NCT00455520|470755836|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
130763043|NCT00455520|470755837|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
130763044|NCT00628095|470755840|FG000|Overall Study|Adverse Event|5|||
130763045|NCT00628095|470755841|FG001|Overall Study|Adverse Event|3|||
130763046|NCT00628095|470755840|FG000|Overall Study|Lack of Efficacy|0|||
130763047|NCT00628095|470755841|FG001|Overall Study|Lack of Efficacy|3|||
130763048|NCT00628095|470755840|FG000|Overall Study|Withdrawal by Subject|2|||
130763049|NCT00628095|470755841|FG001|Overall Study|Withdrawal by Subject|0|||
130763050|NCT00628095|470755840|FG000|Overall Study|Other|0|||
130763051|NCT00628095|470755841|FG001|Overall Study|Other|1|||
130763052|NCT03235115|470755843|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130763053|NCT03235115|470755844|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130797431|NCT04132050|470883079|FG001|R788 Treatment Period|Lack of Efficacy|0|||
130797432|NCT04132050|470883078|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
130797433|NCT04132050|470883079|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
130797434|NCT03976375|470883080|FG000|Overall Study|Death|158|||
130797435|NCT03976375|470883081|FG001|Overall Study|Death|160|||
130797436|NCT03976375|470883082|FG002|Overall Study|Death|42|||
130797437|NCT03976375|470883080|FG000|Overall Study|Lost to Follow-up|2|||
130797438|NCT03976375|470883081|FG001|Overall Study|Lost to Follow-up|1|||
130797439|NCT03976375|470883082|FG002|Overall Study|Lost to Follow-up|1|||
130797440|NCT03976375|470883080|FG000|Overall Study|Withdrawal by Subject|5|||
130797441|NCT03976375|470883081|FG001|Overall Study|Withdrawal by Subject|9|||
130797442|NCT03976375|470883082|FG002|Overall Study|Withdrawal by Subject|4|||
130797443|NCT03976375|470883080|FG000|Overall Study|Sponsor decision|20|||
130797444|NCT03976375|470883081|FG001|Overall Study|Sponsor decision|19|||
130797445|NCT03976375|470883082|FG002|Overall Study|Sponsor decision|1|||
130797446|NCT05556057|470883095|FG000|Overall Study|Lost to Follow-up|5|||
130797447|NCT05556057|470883096|FG001|Overall Study|Lost to Follow-up|4|||
130797448|NCT05556057|470883095|FG000|Overall Study|Withdrawal by Subject|0|||
130797449|NCT05556057|470883096|FG001|Overall Study|Withdrawal by Subject|2|||
130797450|NCT02466971|470883097|FG000|Overall Study|eligible and never treated|14|||
130797451|NCT02466971|470883098|FG001|Overall Study|eligible and never treated|20|||
130797452|NCT02466971|470883097|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
130797453|NCT02466971|470883098|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
130797454|NCT02466971|470883097|FG000|Overall Study|ineligible and treated|1|||
130797455|NCT02466971|470883098|FG001|Overall Study|ineligible and treated|0|||
130797456|NCT02466971|470883097|FG000|Overall Study|ineligible and never treated|0|||
130797457|NCT02466971|470883098|FG001|Overall Study|ineligible and never treated|1|||
130797458|NCT04818112|470883103|FG000|Overall Study|Withdrawal by Subject|54|||
130797459|NCT04818112|470883104|FG001|Overall Study|Withdrawal by Subject|12|||
130797460|NCT04818112|470883103|FG000|Overall Study|Lost to Follow-up|38|||
130797461|NCT04818112|470883104|FG001|Overall Study|Lost to Follow-up|10|||
130797462|NCT06187909|470883105|FG000|Overall Study|Withdrawal by Subject|2|||
130797463|NCT06187909|470883106|FG001|Overall Study|Withdrawal by Subject|2|||
130797464|NCT05020743|470883107|FG000|Overall Study|Enrollment in Interventional Study|2|||
130797465|NCT05020743|470883108|FG001|Overall Study|Enrollment in Interventional Study|9|||
130797466|NCT05020743|470883109|FG002|Overall Study|Enrollment in Interventional Study|0|||
130797467|NCT05020743|470883107|FG000|Overall Study|Withdrawal by Subject|0|||
130797468|NCT05020743|470883108|FG001|Overall Study|Withdrawal by Subject|3|||
130797469|NCT05020743|470883109|FG002|Overall Study|Withdrawal by Subject|1|||
130797470|NCT05020743|470883107|FG000|Overall Study|Lost to Follow-up|1|||
130797471|NCT05020743|470883108|FG001|Overall Study|Lost to Follow-up|0|||
130797472|NCT05020743|470883109|FG002|Overall Study|Lost to Follow-up|0|||
130797473|NCT05020743|470883107|FG000|Overall Study|Study Termination by Sponsor|10|||
130797474|NCT05020743|470883108|FG001|Overall Study|Study Termination by Sponsor|11|||
130797475|NCT05020743|470883109|FG002|Overall Study|Study Termination by Sponsor|10|||
130797476|NCT01913353|470883112|FG000|Overall Study|Adverse Event|2|||
130797477|NCT01913353|470883113|FG001|Overall Study|Adverse Event|0|||
130797478|NCT01913353|470883112|FG000|Overall Study|Physician Decision|0|||
130797479|NCT01913353|470883113|FG001|Overall Study|Physician Decision|2|||
130797480|NCT01913353|470883112|FG000|Overall Study|Withdrawal by Subject|20|||
130797481|NCT01913353|470883113|FG001|Overall Study|Withdrawal by Subject|6|||
130797482|NCT01913353|470883112|FG000|Overall Study|multiple reasons|10|||
130797483|NCT01913353|470883113|FG001|Overall Study|multiple reasons|7|||
130797484|NCT04017962|470883114|FG000|Overall Study|Death|2|||
130797485|NCT04017962|470883115|FG001|Overall Study|Death|0|||
130797486|NCT04017962|470883114|FG000|Overall Study|Lost to Follow-up|2|||
130797487|NCT04017962|470883115|FG001|Overall Study|Lost to Follow-up|0|||
130797488|NCT04017962|470883114|FG000|Overall Study|Physician Decision|1|||
130797489|NCT04017962|470883115|FG001|Overall Study|Physician Decision|0|||
130797490|NCT04017962|470883114|FG000|Overall Study|Discontinued LTV|5|||
130797491|NCT04017962|470883115|FG001|Overall Study|Discontinued LTV|0|||
130797492|NCT01260948|470883117|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
130797493|NCT01260948|470883118|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
130797494|NCT01260948|470883117|FG000|Second Intervention|Emesis|0|||
130797495|NCT01260948|470883118|FG001|Second Intervention|Emesis|1|||
130797496|NCT00462462|470883119|FG000|Overall Study|Physician Decision|0|||
130797497|NCT00462462|470883120|FG001|Overall Study|Physician Decision|1|||
130797498|NCT01163617|470883121|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130797499|NCT01163617|470883122|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
130797500|NCT01163617|470883123|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130797501|NCT01163617|470883124|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130797502|NCT01163617|470883125|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130797503|NCT01163617|470883126|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130797504|NCT01163617|470883127|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130797505|NCT01163617|470883128|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130797506|NCT01163617|470883121|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130797507|NCT01163617|470883122|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
130797508|NCT01163617|470883123|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130797509|NCT01163617|470883124|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130797510|NCT01163617|470883125|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130797511|NCT01163617|470883126|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130797512|NCT01163617|470883127|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130797513|NCT01163617|470883128|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130797514|NCT01163617|470883121|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130797515|NCT01163617|470883122|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130797516|NCT01163617|470883123|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
130797517|NCT01163617|470883124|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130797518|NCT01163617|470883125|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130797519|NCT01163617|470883126|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130797520|NCT01163617|470883127|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130797521|NCT01163617|470883128|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130797522|NCT02394756|470883129|FG000|Period 1|Lens Discomfort|0|||
130797523|NCT02394756|470883130|FG001|Period 1|Lens Discomfort|0|||
130797524|NCT02394756|470883131|FG002|Period 1|Lens Discomfort|0|||
130797525|NCT02394756|470883132|FG003|Period 1|Lens Discomfort|0|||
130797526|NCT02394756|470883133|FG004|Period 1|Lens Discomfort|0|||
130797527|NCT02394756|470883134|FG005|Period 1|Lens Discomfort|1|||
130797528|NCT02394756|470883129|FG000|Period 1|Withdrawal by Subject|0|||
130797529|NCT02394756|470883130|FG001|Period 1|Withdrawal by Subject|1|||
130797530|NCT02394756|470883131|FG002|Period 1|Withdrawal by Subject|1|||
130797531|NCT02394756|470883132|FG003|Period 1|Withdrawal by Subject|1|||
130797532|NCT02394756|470883133|FG004|Period 1|Withdrawal by Subject|0|||
130797533|NCT02394756|470883134|FG005|Period 1|Withdrawal by Subject|0|||
130797534|NCT02394756|470883129|FG000|Period 2|Unsatisfactory Visual Response|0|||
130797535|NCT02394756|470883130|FG001|Period 2|Unsatisfactory Visual Response|0|||
130797536|NCT02394756|470883131|FG002|Period 2|Unsatisfactory Visual Response|0|||
130797537|NCT02394756|470883132|FG003|Period 2|Unsatisfactory Visual Response|0|||
130797538|NCT02394756|470883133|FG004|Period 2|Unsatisfactory Visual Response|1|||
130797539|NCT02394756|470883134|FG005|Period 2|Unsatisfactory Visual Response|0|||
130797540|NCT02335944|470883135|FG000|Treatment Phase|Progressive Disease|2|||
130797541|NCT02335944|470883136|FG001|Treatment Phase|Progressive Disease|5|||
130797542|NCT02335944|470883137|FG002|Treatment Phase|Progressive Disease|2|||
130797543|NCT02335944|470883138|FG003|Treatment Phase|Progressive Disease|11|||
130797544|NCT02335944|470883139|FG004|Treatment Phase|Progressive Disease|4|||
130797545|NCT02335944|470883140|FG005|Treatment Phase|Progressive Disease|25|||
130797546|NCT02335944|470883141|FG006|Treatment Phase|Progressive Disease|2|||
130797547|NCT02335944|470883142|FG007|Treatment Phase|Progressive Disease|30|||
130797548|NCT02335944|470883143|FG008|Treatment Phase|Progressive Disease|27|||
130797549|NCT02335944|470883144|FG009|Treatment Phase|Progressive Disease|0|||
130797550|NCT02335944|470883135|FG000|Treatment Phase|Adverse Event|2|||
130797551|NCT02335944|470883136|FG001|Treatment Phase|Adverse Event|0|||
130797552|NCT02335944|470883137|FG002|Treatment Phase|Adverse Event|0|||
130797553|NCT02335944|470883138|FG003|Treatment Phase|Adverse Event|2|||
130797554|NCT02335944|470883139|FG004|Treatment Phase|Adverse Event|1|||
130797555|NCT02335944|470883140|FG005|Treatment Phase|Adverse Event|15|||
130797556|NCT02335944|470883141|FG006|Treatment Phase|Adverse Event|0|||
130797557|NCT02335944|470883142|FG007|Treatment Phase|Adverse Event|5|||
130797558|NCT02335944|470883143|FG008|Treatment Phase|Adverse Event|7|||
130797559|NCT02335944|470883144|FG009|Treatment Phase|Adverse Event|0|||
130797560|NCT02335944|470883135|FG000|Treatment Phase|Physician Decision|0|||
130797561|NCT02335944|470883136|FG001|Treatment Phase|Physician Decision|0|||
130797562|NCT02335944|470883137|FG002|Treatment Phase|Physician Decision|0|||
130797563|NCT02335944|470883138|FG003|Treatment Phase|Physician Decision|1|||
130797564|NCT02335944|470883139|FG004|Treatment Phase|Physician Decision|0|||
130797565|NCT02335944|470883140|FG005|Treatment Phase|Physician Decision|6|||
130797566|NCT02335944|470883141|FG006|Treatment Phase|Physician Decision|1|||
130797567|NCT02335944|470883142|FG007|Treatment Phase|Physician Decision|2|||
130797568|NCT02335944|470883143|FG008|Treatment Phase|Physician Decision|1|||
130797569|NCT02335944|470883144|FG009|Treatment Phase|Physician Decision|0|||
130797570|NCT02335944|470883135|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
130797571|NCT02335944|470883136|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
130797572|NCT02335944|470883137|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
130797573|NCT02335944|470883138|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
130797574|NCT02335944|470883139|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
130797575|NCT02335944|470883140|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
130797576|NCT02335944|470883141|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
130763054|NCT03235115|470755845|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130763055|NCT03235115|470755846|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130763056|NCT03235115|470755847|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130763057|NCT03235115|470755848|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
130763058|NCT00006305|470755851|FG000|Overall Study|Withdrawal by Subject|17|||
130763059|NCT00006305|470755852|FG001|Overall Study|Withdrawal by Subject|10|||
130763060|NCT00006305|470755853|FG002|Overall Study|Withdrawal by Subject|15|||
130763061|NCT00006305|470755854|FG003|Overall Study|Withdrawal by Subject|14|||
130763062|NCT00783224|470755855|FG000|Overall Study|Adverse Event|0|||
130763063|NCT00783224|470755856|FG001|Overall Study|Adverse Event|0|||
130763064|NCT00783224|470755857|FG002|Overall Study|Adverse Event|1|||
130763065|NCT00783224|470755858|FG003|Overall Study|Adverse Event|0|||
130763066|NCT00783224|470755855|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
130763067|NCT00783224|470755856|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
130763068|NCT00783224|470755857|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
130763069|NCT00783224|470755858|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
130763070|NCT00783224|470755855|FG000|Overall Study|Inappropriate as a study subject|0|||
130763071|NCT00783224|470755856|FG001|Overall Study|Inappropriate as a study subject|0|||
130763072|NCT00783224|470755857|FG002|Overall Study|Inappropriate as a study subject|0|||
130763073|NCT00783224|470755858|FG003|Overall Study|Inappropriate as a study subject|1|||
130763074|NCT04631107|470755861|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
130763075|NCT04631107|470755861|FG000|Second Intervention (1 Night)|Adverse Event|1|||
130763076|NCT04631107|470755861|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
130763077|NCT04631107|470755861|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
130763078|NCT05385224|470755865|FG000|Overall Study|Unable to swallow capsule|2|||
130763079|NCT05385224|470755865|FG000|Overall Study|Withdrawal by Subject|2|||
130763080|NCT05385224|470755865|FG000|Overall Study|Did not meet study criteria|1|||
130763081|NCT00551161|470755866|FG000|Overall Study|Withdrawal by Subject|1|||
130763082|NCT01935700|470755867|FG000|Overall Study|Withdrawal by Subject|1|||
130763083|NCT01935700|470755868|FG001|Overall Study|Withdrawal by Subject|0|||
130763084|NCT01935700|470755867|FG000|Overall Study|Physician Decision|4|||
130763085|NCT01935700|470755868|FG001|Overall Study|Physician Decision|0|||
130763086|NCT00096993|470755869|FG000|Overall Study|Death|1|||
130763087|NCT00096993|470755870|FG001|Overall Study|Death|0|||
130763088|NCT00096993|470755869|FG000|Overall Study|Disease progression|56|||
130763089|NCT00096993|470755870|FG001|Overall Study|Disease progression|53|||
130763090|NCT00096993|470755869|FG000|Overall Study|Adverse Event|2|||
130763091|NCT00096993|470755870|FG001|Overall Study|Adverse Event|8|||
130763092|NCT00096993|470755869|FG000|Overall Study|Subject's decision|3|||
130763093|NCT00096993|470755870|FG001|Overall Study|Subject's decision|1|||
130763094|NCT00096993|470755869|FG000|Overall Study|Physician Decision|2|||
130763095|NCT00096993|470755870|FG001|Overall Study|Physician Decision|1|||
130763096|NCT00096993|470755869|FG000|Overall Study|Non-compliance|0|||
130763097|NCT00096993|470755870|FG001|Overall Study|Non-compliance|1|||
130763098|NCT00096993|470755869|FG000|Overall Study|Other unspecified|1|||
130763099|NCT00096993|470755870|FG001|Overall Study|Other unspecified|1|||
130763100|NCT01935128|470755871|FG000|Overall Study|Death|1|||
130763101|NCT01935128|470755871|FG000|Overall Study|Adverse Event|6|||
130763102|NCT00772005|470755872|FG000|Overall Study|Adverse Event|9|||
130763103|NCT00772005|470755873|FG001|Overall Study|Adverse Event|14|||
130763104|NCT00772005|470755874|FG002|Overall Study|Adverse Event|10|||
130763105|NCT00772005|470755875|FG003|Overall Study|Adverse Event|13|||
130763106|NCT00772005|470755872|FG000|Overall Study|Lack of Efficacy|0|||
130763107|NCT00772005|470755873|FG001|Overall Study|Lack of Efficacy|1|||
130763108|NCT00772005|470755874|FG002|Overall Study|Lack of Efficacy|0|||
130763109|NCT00772005|470755875|FG003|Overall Study|Lack of Efficacy|0|||
130763110|NCT00772005|470755872|FG000|Overall Study|Withdrawal by Subject|3|||
130763111|NCT00772005|470755873|FG001|Overall Study|Withdrawal by Subject|7|||
130763112|NCT00772005|470755874|FG002|Overall Study|Withdrawal by Subject|10|||
130763113|NCT00772005|470755875|FG003|Overall Study|Withdrawal by Subject|2|||
130763114|NCT00772005|470755872|FG000|Overall Study|Protocol Violation|2|||
130763115|NCT00772005|470755873|FG001|Overall Study|Protocol Violation|4|||
130763116|NCT00772005|470755874|FG002|Overall Study|Protocol Violation|1|||
130763117|NCT00772005|470755875|FG003|Overall Study|Protocol Violation|6|||
130763118|NCT00772005|470755872|FG000|Overall Study|Lost to Follow-up|7|||
130763119|NCT00772005|470755873|FG001|Overall Study|Lost to Follow-up|3|||
130763120|NCT00772005|470755874|FG002|Overall Study|Lost to Follow-up|6|||
130763121|NCT00772005|470755875|FG003|Overall Study|Lost to Follow-up|3|||
130763122|NCT00772005|470755872|FG000|Overall Study|Non-compliance with study procedures|1|||
130763123|NCT00772005|470755873|FG001|Overall Study|Non-compliance with study procedures|1|||
130763124|NCT00772005|470755874|FG002|Overall Study|Non-compliance with study procedures|0|||
130797577|NCT02335944|470883142|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
130797578|NCT02335944|470883143|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
130797579|NCT02335944|470883144|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
130797580|NCT02335944|470883135|FG000|Treatment Phase|Subject/Guardian Decision|0|||
130797581|NCT02335944|470883136|FG001|Treatment Phase|Subject/Guardian Decision|0|||
130797582|NCT02335944|470883137|FG002|Treatment Phase|Subject/Guardian Decision|1|||
130797583|NCT02335944|470883138|FG003|Treatment Phase|Subject/Guardian Decision|0|||
130797584|NCT02335944|470883139|FG004|Treatment Phase|Subject/Guardian Decision|0|||
130797585|NCT02335944|470883140|FG005|Treatment Phase|Subject/Guardian Decision|1|||
130797586|NCT02335944|470883141|FG006|Treatment Phase|Subject/Guardian Decision|0|||
130797587|NCT02335944|470883142|FG007|Treatment Phase|Subject/Guardian Decision|4|||
130797588|NCT02335944|470883143|FG008|Treatment Phase|Subject/Guardian Decision|0|||
130797589|NCT02335944|470883144|FG009|Treatment Phase|Subject/Guardian Decision|0|||
130797590|NCT02335944|470883135|FG000|Post-treatment Follow-up|Progressive Disease|0|||
130797591|NCT02335944|470883136|FG001|Post-treatment Follow-up|Progressive Disease|0|||
130797592|NCT02335944|470883137|FG002|Post-treatment Follow-up|Progressive Disease|0|||
130797593|NCT02335944|470883138|FG003|Post-treatment Follow-up|Progressive Disease|1|||
130797594|NCT02335944|470883139|FG004|Post-treatment Follow-up|Progressive Disease|0|||
130797595|NCT02335944|470883140|FG005|Post-treatment Follow-up|Progressive Disease|9|||
130797596|NCT02335944|470883141|FG006|Post-treatment Follow-up|Progressive Disease|0|||
130797597|NCT02335944|470883142|FG007|Post-treatment Follow-up|Progressive Disease|2|||
130797598|NCT02335944|470883143|FG008|Post-treatment Follow-up|Progressive Disease|3|||
130797599|NCT02335944|470883144|FG009|Post-treatment Follow-up|Progressive Disease|0|||
130797600|NCT02335944|470883135|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130797601|NCT02335944|470883136|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130797602|NCT02335944|470883137|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130797603|NCT02335944|470883138|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130797604|NCT02335944|470883139|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130797605|NCT02335944|470883140|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
130797606|NCT02335944|470883141|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130797607|NCT02335944|470883142|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130797608|NCT02335944|470883143|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130797609|NCT02335944|470883144|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130797610|NCT02335944|470883135|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
130797611|NCT02335944|470883136|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
130797612|NCT02335944|470883137|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
130797613|NCT02335944|470883138|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
130797614|NCT02335944|470883139|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
130797615|NCT02335944|470883140|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
130797616|NCT02335944|470883141|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
130797617|NCT02335944|470883142|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
130797618|NCT02335944|470883143|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
130797619|NCT02335944|470883144|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
130797620|NCT02335944|470883135|FG000|Post-treatment Follow-up|Adverse Event|0|||
130797621|NCT02335944|470883136|FG001|Post-treatment Follow-up|Adverse Event|0|||
130797622|NCT02335944|470883137|FG002|Post-treatment Follow-up|Adverse Event|0|||
130797623|NCT02335944|470883138|FG003|Post-treatment Follow-up|Adverse Event|0|||
130797624|NCT02335944|470883139|FG004|Post-treatment Follow-up|Adverse Event|0|||
130797625|NCT02335944|470883140|FG005|Post-treatment Follow-up|Adverse Event|1|||
130797626|NCT02335944|470883141|FG006|Post-treatment Follow-up|Adverse Event|0|||
130797627|NCT02335944|470883142|FG007|Post-treatment Follow-up|Adverse Event|0|||
130797628|NCT02335944|470883143|FG008|Post-treatment Follow-up|Adverse Event|0|||
130797629|NCT02335944|470883144|FG009|Post-treatment Follow-up|Adverse Event|0|||
130797630|NCT02335944|470883135|FG000|Post-treatment Follow-up|Death|0|||
130797631|NCT02335944|470883136|FG001|Post-treatment Follow-up|Death|0|||
130797632|NCT02335944|470883137|FG002|Post-treatment Follow-up|Death|0|||
130797633|NCT02335944|470883138|FG003|Post-treatment Follow-up|Death|1|||
130797634|NCT02335944|470883139|FG004|Post-treatment Follow-up|Death|0|||
130797635|NCT02335944|470883140|FG005|Post-treatment Follow-up|Death|1|||
130797636|NCT02335944|470883141|FG006|Post-treatment Follow-up|Death|0|||
130797637|NCT02335944|470883142|FG007|Post-treatment Follow-up|Death|0|||
130797638|NCT02335944|470883143|FG008|Post-treatment Follow-up|Death|0|||
130797639|NCT02335944|470883144|FG009|Post-treatment Follow-up|Death|0|||
130797640|NCT02335944|470883135|FG000|Post-treatment Follow-up|Physician Decision|1|||
130797641|NCT02335944|470883136|FG001|Post-treatment Follow-up|Physician Decision|0|||
130797642|NCT02335944|470883137|FG002|Post-treatment Follow-up|Physician Decision|0|||
130797643|NCT02335944|470883138|FG003|Post-treatment Follow-up|Physician Decision|0|||
130797644|NCT02335944|470883139|FG004|Post-treatment Follow-up|Physician Decision|0|||
130797645|NCT02335944|470883140|FG005|Post-treatment Follow-up|Physician Decision|0|||
130797646|NCT02335944|470883141|FG006|Post-treatment Follow-up|Physician Decision|0|||
130797647|NCT02335944|470883142|FG007|Post-treatment Follow-up|Physician Decision|1|||
130797648|NCT02335944|470883143|FG008|Post-treatment Follow-up|Physician Decision|0|||
130797649|NCT02335944|470883144|FG009|Post-treatment Follow-up|Physician Decision|0|||
130797650|NCT00832975|470883145|FG000|Overall Study|Lost to Follow-up|7|||
130797651|NCT00832975|470883145|FG000|Overall Study|Protocol Violation|6|||
130797652|NCT00832975|470883145|FG000|Overall Study|Death|5|||
130797653|NCT00832975|470883145|FG000|Overall Study|Physician Decision|4|||
130797654|NCT00832975|470883145|FG000|Overall Study|Withdrawal by Subject|3|||
130797655|NCT00832975|470883145|FG000|Overall Study|Other reasons|14|||
130797656|NCT02811159|470883146|FG000|Treatment Course 1|Lost to Follow-up|1|||
130797657|NCT04603066|470883147|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
130797658|NCT04603066|470883148|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
130797659|NCT02406612|470883149|FG000|Overall Study|Screening Failure|3|||
130797660|NCT02406612|470883150|FG001|Overall Study|Screening Failure|0|||
130797661|NCT02406612|470883149|FG000|Overall Study|Intra-procedural Exclusion|1|||
130797662|NCT02406612|470883150|FG001|Overall Study|Intra-procedural Exclusion|3|||
130797663|NCT02406612|470883149|FG000|Overall Study|Guidewire Failure|0|||
130797664|NCT02406612|470883150|FG001|Overall Study|Guidewire Failure|1|||
130797665|NCT01371981|470883151|FG000|Overall Study|Adverse Event|12|||
130797666|NCT01371981|470883152|FG001|Overall Study|Adverse Event|17|||
130797667|NCT01371981|470883153|FG002|Overall Study|Adverse Event|0|||
130797668|NCT01371981|470883154|FG003|Overall Study|Adverse Event|4|||
130797669|NCT01371981|470883155|FG004|Overall Study|Adverse Event|1|||
130797670|NCT01371981|470883156|FG005|Overall Study|Adverse Event|0|||
130797671|NCT01371981|470883151|FG000|Overall Study|Death|22|||
130797672|NCT01371981|470883152|FG001|Overall Study|Death|16|||
130797673|NCT01371981|470883153|FG002|Overall Study|Death|0|||
130797674|NCT01371981|470883154|FG003|Overall Study|Death|0|||
130797675|NCT01371981|470883155|FG004|Overall Study|Death|2|||
130797676|NCT01371981|470883156|FG005|Overall Study|Death|2|||
130797677|NCT01371981|470883151|FG000|Overall Study|Lack of Efficacy|69|||
130797678|NCT01371981|470883152|FG001|Overall Study|Lack of Efficacy|61|||
130797679|NCT01371981|470883153|FG002|Overall Study|Lack of Efficacy|4|||
130797680|NCT01371981|470883154|FG003|Overall Study|Lack of Efficacy|8|||
130797681|NCT01371981|470883155|FG004|Overall Study|Lack of Efficacy|5|||
130797682|NCT01371981|470883156|FG005|Overall Study|Lack of Efficacy|0|||
130797683|NCT01371981|470883151|FG000|Overall Study|Physician Decision|48|||
130797684|NCT01371981|470883152|FG001|Overall Study|Physician Decision|63|||
130797685|NCT01371981|470883153|FG002|Overall Study|Physician Decision|1|||
130797686|NCT01371981|470883154|FG003|Overall Study|Physician Decision|7|||
130797687|NCT01371981|470883155|FG004|Overall Study|Physician Decision|14|||
130797688|NCT01371981|470883156|FG005|Overall Study|Physician Decision|3|||
130797689|NCT01371981|470883151|FG000|Overall Study|Withdrawal by Subject|12|||
130797690|NCT01371981|470883152|FG001|Overall Study|Withdrawal by Subject|19|||
130797691|NCT01371981|470883153|FG002|Overall Study|Withdrawal by Subject|1|||
130797692|NCT01371981|470883154|FG003|Overall Study|Withdrawal by Subject|2|||
130797693|NCT01371981|470883155|FG004|Overall Study|Withdrawal by Subject|10|||
130797694|NCT01371981|470883156|FG005|Overall Study|Withdrawal by Subject|3|||
130797695|NCT01371981|470883151|FG000|Overall Study|Ineligible|19|||
130797696|NCT01371981|470883152|FG001|Overall Study|Ineligible|13|||
130797697|NCT01371981|470883153|FG002|Overall Study|Ineligible|0|||
130797698|NCT01371981|470883154|FG003|Overall Study|Ineligible|0|||
130797699|NCT01371981|470883155|FG004|Overall Study|Ineligible|0|||
130797700|NCT01371981|470883156|FG005|Overall Study|Ineligible|4|||
130797701|NCT01371981|470883151|FG000|Overall Study|Did not start treatment|2|||
130797702|NCT01371981|470883152|FG001|Overall Study|Did not start treatment|3|||
130797703|NCT01371981|470883153|FG002|Overall Study|Did not start treatment|0|||
130797704|NCT01371981|470883154|FG003|Overall Study|Did not start treatment|0|||
130797705|NCT01371981|470883155|FG004|Overall Study|Did not start treatment|0|||
130797706|NCT01371981|470883156|FG005|Overall Study|Did not start treatment|2|||
130797707|NCT05253807|470883157|FG000|Overall Study|Death|1|||
130797708|NCT05253807|470883158|FG001|Overall Study|Death|4|||
130797709|NCT05253807|470883157|FG000|Overall Study|Withdrawal by Subject|1|||
130797710|NCT05253807|470883158|FG001|Overall Study|Withdrawal by Subject|0|||
130797711|NCT05253807|470883157|FG000|Overall Study|Study Terminated by Sponsor|1|||
130797712|NCT05253807|470883158|FG001|Overall Study|Study Terminated by Sponsor|1|||
130797713|NCT04611126|470883159|FG000|Overall Study|TIL expansion unsuccessful|1|||
130797714|NCT04611126|470883160|FG001|Overall Study|TIL expansion unsuccessful|0|||
130797715|NCT00632359|470883161|FG000|Overall Study|Withdrawal by Subject|2|||
130797716|NCT06717399|470883162|FG000|Overall Study|Death|1|||
130797726|NCT03506477|470883446|FG000|Overall Study|Withdrawal by Subject|1|||
130797727|NCT03506477|470883447|FG001|Overall Study|Withdrawal by Subject|0|||
130797728|NCT02875080|470883449|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
130797729|NCT02875080|470883450|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
130797730|NCT02875080|470883451|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
130797731|NCT00768053|470883452|FG000|Overall Study|Adverse Event|10|||
130797732|NCT00768053|470883452|FG000|Overall Study|Lost to Follow-up|1|||
130797733|NCT01164475|470883453|FG000|Overall Study|Lack of Efficacy|1|||
130797734|NCT01164475|470883454|FG001|Overall Study|Lack of Efficacy|0|||
130797735|NCT01164475|470883453|FG000|Overall Study|Other|0|||
130797736|NCT01164475|470883454|FG001|Overall Study|Other|1|||
130797737|NCT01164475|470883453|FG000|Overall Study|Progressive disease|0|||
130797738|NCT01164475|470883454|FG001|Overall Study|Progressive disease|1|||
130797739|NCT01164475|470883453|FG000|Overall Study|Protocol Violation|1|||
130797740|NCT01164475|470883454|FG001|Overall Study|Protocol Violation|0|||
130797747|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
130797748|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
130797749|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
130797750|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
130797751|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
130797752|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
130797753|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
130797754|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
130797755|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
130797756|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
130797757|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
130797758|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
130797759|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
130797760|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
130797761|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
130797762|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
130797763|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
130797764|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
130797765|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
130797766|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
130797767|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
130797768|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
130797769|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
130797770|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
130797771|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
130797772|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
130797773|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
130797774|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
130797775|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
130797776|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
130797777|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
130797778|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
130797779|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
130797780|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
130797781|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
130797782|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
130797783|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
130797784|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
130797785|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
130797786|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
130797787|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
130797788|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
130797789|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
130797790|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
130797791|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
130797792|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
130797793|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
130797794|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
130797795|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
130797796|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
130797797|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
130797798|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
130797799|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
130797800|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
130797801|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
130797802|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
130797803|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
130797804|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
130797805|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
130797806|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
130797807|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
130797808|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
130797809|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
130797810|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
130797811|NCT00217737|470883463|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
130797812|NCT00217737|470883464|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
130797813|NCT00217737|470883465|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
130797814|NCT00217737|470883466|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
130797815|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
130797816|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
130797817|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
130797818|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
130797819|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
130797820|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
130797821|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
130797822|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
130797823|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Study suspension|0|||
130797824|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Study suspension|45|||
130797825|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Study suspension|0|||
130797826|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Study suspension|0|||
130797827|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
130797828|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
130797829|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
130797830|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
130797831|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Death|2|||
130797832|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Death|3|||
130797833|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Death|0|||
130797834|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Death|0|||
130797835|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
130797836|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
130797837|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
130797838|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
130797839|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
130797840|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
130797841|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
130797842|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
130763125|NCT00772005|470755875|FG003|Overall Study|Non-compliance with study procedures|1|||
130763126|NCT00772005|470755872|FG000|Overall Study|Non-compliance with drug administration|3|||
130763127|NCT00772005|470755873|FG001|Overall Study|Non-compliance with drug administration|0|||
130763128|NCT00772005|470755874|FG002|Overall Study|Non-compliance with drug administration|1|||
130763129|NCT00772005|470755875|FG003|Overall Study|Non-compliance with drug administration|1|||
130763130|NCT01440569|470755879|FG000|Main Study|Enrolled but not treated|1|||
130763131|NCT01440569|470755880|FG001|Main Study|Enrolled but not treated|0|||
130763132|NCT01440569|470755879|FG000|Main Study|Adverse Event|9|||
130763133|NCT01440569|470755880|FG001|Main Study|Adverse Event|0|||
130763134|NCT01440569|470755879|FG000|Main Study|Pregnancy|1|||
130763135|NCT01440569|470755880|FG001|Main Study|Pregnancy|0|||
130763136|NCT01440569|470755879|FG000|Main Study|Investigator's Discretion|1|||
130763137|NCT01440569|470755880|FG001|Main Study|Investigator's Discretion|1|||
130763138|NCT01440569|470755879|FG000|Main Study|Withdrew Consent|7|||
130763139|NCT01440569|470755880|FG001|Main Study|Withdrew Consent|1|||
130763140|NCT01440569|470755879|FG000|Main Study|Lost to Follow-up|13|||
130763141|NCT01440569|470755880|FG001|Main Study|Lost to Follow-up|2|||
130763142|NCT01440569|470755879|FG000|Main Study|Subject Non-Compliance|3|||
130763143|NCT01440569|470755880|FG001|Main Study|Subject Non-Compliance|0|||
130763144|NCT01440569|470755879|FG000|Main Study|Protocol Violation|1|||
130763145|NCT01440569|470755880|FG001|Main Study|Protocol Violation|0|||
130763146|NCT01440569|470755879|FG000|Open-Label Rollover Phase|Adverse Event|3|||
130763147|NCT01440569|470755880|FG001|Open-Label Rollover Phase|Adverse Event|0|||
130763148|NCT01440569|470755879|FG000|Open-Label Rollover Phase|Pregnancy|1|||
130763149|NCT01440569|470755880|FG001|Open-Label Rollover Phase|Pregnancy|0|||
130763150|NCT01440569|470755879|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
130763151|NCT01440569|470755880|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
130763152|NCT01440569|470755879|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
130763153|NCT01440569|470755880|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
130763154|NCT01440569|470755879|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
130763155|NCT01440569|470755880|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
130763156|NCT01440569|470755879|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
130763157|NCT01440569|470755880|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
130763158|NCT01440569|470755879|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
130763159|NCT01440569|470755880|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
130763160|NCT02431806|470755881|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
130763161|NCT02431806|470755882|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
130763162|NCT02431806|470755883|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
130763163|NCT02431806|470755884|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
130763164|NCT02431806|470755881|FG000|Double-blind Treatment Period|Adverse Event|4|||
130763165|NCT02431806|470755882|FG001|Double-blind Treatment Period|Adverse Event|7|||
130763166|NCT02431806|470755883|FG002|Double-blind Treatment Period|Adverse Event|11|||
130763167|NCT02431806|470755884|FG003|Double-blind Treatment Period|Adverse Event|7|||
130763168|NCT02431806|470755881|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
130763169|NCT02431806|470755882|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
130763170|NCT02431806|470755883|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
130763171|NCT02431806|470755884|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
130763172|NCT02431806|470755881|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
130763173|NCT02431806|470755882|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
130763174|NCT02431806|470755883|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
130763175|NCT02431806|470755884|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
130763176|NCT02431806|470755881|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
130763177|NCT02431806|470755882|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
130763178|NCT02431806|470755883|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
130763179|NCT02431806|470755884|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
130763180|NCT02431806|470755881|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
130763181|NCT02431806|470755882|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
130763182|NCT02431806|470755883|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
130763183|NCT02431806|470755884|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
130797843|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
130797844|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
130797845|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
130797846|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
130763184|NCT02431806|470755881|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
130763185|NCT02431806|470755882|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
130763186|NCT02431806|470755883|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
130797847|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
130797848|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
130797849|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
130797850|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
130797851|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
130797852|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
130797853|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
130797854|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
130797855|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
130797856|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
130797857|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
130797858|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
130797859|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
130797860|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
130797861|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
130797862|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
130797863|NCT00217737|470883463|FG000|Step 2 Randomization/Registration|Other|1|||
130797864|NCT00217737|470883464|FG001|Step 2 Randomization/Registration|Other|2|||
130797865|NCT00217737|470883465|FG002|Step 2 Randomization/Registration|Other|0|||
130797866|NCT00217737|470883466|FG003|Step 2 Randomization/Registration|Other|0|||
130797867|NCT02145390|470883467|FG000|Overall Study|Withdrawal by Subject|1|||
130797868|NCT02293499|470884418|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
130797869|NCT02293499|470884419|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
130797870|NCT02293499|470884420|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
130797871|NCT02293499|470884418|FG000|Intervention - Camp|Withdrawal by Subject|3|||
130797872|NCT02293499|470884419|FG001|Intervention - Camp|Withdrawal by Subject|6|||
130797873|NCT02293499|470884420|FG002|Intervention - Camp|Withdrawal by Subject|2|||
130797874|NCT02293499|470884418|FG000|Intervention - Camp|these are those not showing up at camp|24|||
130797875|NCT02293499|470884419|FG001|Intervention - Camp|these are those not showing up at camp|28|||
130797876|NCT02293499|470884420|FG002|Intervention - Camp|these are those not showing up at camp|4|||
130797877|NCT02293499|470884418|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
130797878|NCT02293499|470884419|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
130797879|NCT02293499|470884420|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
130797880|NCT02293499|470884418|FG000|3 Month Follow Up|Lost to Follow-up|14|||
130797881|NCT02293499|470884419|FG001|3 Month Follow Up|Lost to Follow-up|15|||
130797882|NCT02293499|470884420|FG002|3 Month Follow Up|Lost to Follow-up|6|||
130797883|NCT02293499|470884418|FG000|6 Month Follow Up|Lost to Follow-up|17|||
130797884|NCT02293499|470884419|FG001|6 Month Follow Up|Lost to Follow-up|27|||
130797885|NCT02293499|470884420|FG002|6 Month Follow Up|Lost to Follow-up|6|||
130797886|NCT02293499|470884418|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
130797887|NCT02293499|470884419|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
130797888|NCT02293499|470884420|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
130797889|NCT02293499|470884418|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
130797890|NCT02293499|470884419|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
130797891|NCT02293499|470884420|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
130797892|NCT02293499|470884418|FG000|9 Month Follow Up|Lost to Follow-up|24|||
130797893|NCT02293499|470884419|FG001|9 Month Follow Up|Lost to Follow-up|28|||
130797894|NCT02293499|470884420|FG002|9 Month Follow Up|Lost to Follow-up|4|||
130797895|NCT02293499|470884418|FG000|12 Month Follow Up|Lost to Follow-up|26|||
130797896|NCT02293499|470884419|FG001|12 Month Follow Up|Lost to Follow-up|25|||
130797897|NCT02293499|470884420|FG002|12 Month Follow Up|Lost to Follow-up|6|||
130797898|NCT02293499|470884418|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
130797899|NCT02293499|470884419|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
130797900|NCT02293499|470884420|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
130797901|NCT02293499|470884418|FG000|15 Month Follow Up|Lost to Follow-up|22|||
130797902|NCT02293499|470884419|FG001|15 Month Follow Up|Lost to Follow-up|22|||
130797903|NCT02293499|470884420|FG002|15 Month Follow Up|Lost to Follow-up|7|||
130797904|NCT00690898|470884421|FG000|SCREENING|Screen failure|18|||
130797905|NCT00690898|470884421|FG000|TREATMENT|Adverse Event|3|||
130797906|NCT00690898|470884421|FG000|TREATMENT|Lack of Efficacy|18|||
130797907|NCT00690898|470884421|FG000|TREATMENT|Withdrawal by Subject|4|||
130797908|NCT00690898|470884421|FG000|TREATMENT|Other (not otherwise specified)|1|||
130797909|NCT01732783|470884424|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
130797910|NCT01732783|470884425|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
130797911|NCT01732783|470884426|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
130797912|NCT01732783|470884424|FG000|Overall Study|Death|13|||
130797913|NCT01732783|470884425|FG001|Overall Study|Death|4|||
130797914|NCT01732783|470884426|FG002|Overall Study|Death|1|||
130797915|NCT01732783|470884424|FG000|Overall Study|Lost to Follow-up|7|||
130797916|NCT01732783|470884425|FG001|Overall Study|Lost to Follow-up|1|||
130797917|NCT01732783|470884426|FG002|Overall Study|Lost to Follow-up|1|||
130797918|NCT01732783|470884424|FG000|Overall Study|Administrative Decision|8|||
130797919|NCT01732783|470884425|FG001|Overall Study|Administrative Decision|2|||
130797920|NCT01732783|470884426|FG002|Overall Study|Administrative Decision|1|||
130797921|NCT01732783|470884424|FG000|Overall Study|Withdrawal by Subject|1|||
130797922|NCT01732783|470884425|FG001|Overall Study|Withdrawal by Subject|0|||
130797923|NCT01732783|470884426|FG002|Overall Study|Withdrawal by Subject|0|||
130797924|NCT02299167|470884429|FG000|Overall Study|patients were excluded from the study|11|||
130797925|NCT04615507|470884430|FG000|Period 1|Covid-19 exposure|2|||
130797926|NCT04615507|470884431|FG001|Period 1|Covid-19 exposure|1|||
130797927|NCT04615507|470884430|FG000|Period 2|Covid-19 exposure|0|||
130797928|NCT04615507|470884431|FG001|Period 2|Covid-19 exposure|1|||
130797929|NCT04615507|470884430|FG000|Period 2|Protocol Violation|1|||
130797930|NCT04615507|470884431|FG001|Period 2|Protocol Violation|0|||
130797931|NCT04615507|470884430|FG000|Period 2|Withdrawal by Subject|1|||
130797932|NCT04615507|470884431|FG001|Period 2|Withdrawal by Subject|0|||
130797933|NCT04615507|470884430|FG000|Period 2|Adverse Event|0|||
130797934|NCT04615507|470884431|FG001|Period 2|Adverse Event|1|||
130797935|NCT04615507|470884430|FG000|Period 3|Covid-19 exposure|0|||
130797936|NCT04615507|470884431|FG001|Period 3|Covid-19 exposure|1|||
130797937|NCT02717611|470884432|FG000|Overall Study|Death|13|||
130797938|NCT02717611|470884432|FG000|Overall Study|Withdrawal by Subject|6|||
130797939|NCT02717611|470884432|FG000|Overall Study|Active, not recruiting|40|||
130797940|NCT02717611|470884432|FG000|Overall Study|Complicating disease|1|||
130797941|NCT04598828|470884433|FG000|Overall Study|Physician Decision|1|||
130797942|NCT04598828|470884434|FG001|Overall Study|Physician Decision|0|||
130797943|NCT04598828|470884433|FG000|Overall Study|Withdrawal by Subject|0|||
130797944|NCT04598828|470884434|FG001|Overall Study|Withdrawal by Subject|1|||
130797945|NCT04598828|470884433|FG000|Overall Study|Withdrawal by Subject|0|||
130797946|NCT04598828|470884434|FG001|Overall Study|Withdrawal by Subject|1|||
130797947|NCT00325416|470884435|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
130797948|NCT00325416|470884436|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
130797949|NCT00325416|470884435|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
130797950|NCT00325416|470884436|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
130797951|NCT00325416|470884435|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
130797952|NCT00325416|470884436|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
130797953|NCT00325416|470884435|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
130797954|NCT00325416|470884436|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
130797955|NCT00325416|470884435|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
130763187|NCT02431806|470755884|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
130763188|NCT03627416|470755885|FG000|Overall Study|Adverse Event|0|||
130763189|NCT03627416|470755886|FG001|Overall Study|Adverse Event|1|||
130763190|NCT01294371|470755887|FG000|Overall Study|Adverse Event|1|||
130763191|NCT01294371|470755887|FG000|Overall Study|Withdrawal by Subject|12|||
130797956|NCT00325416|470884436|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
130797957|NCT00325416|470884435|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
130797958|NCT00325416|470884436|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
130797959|NCT04589650|470884437|FG000|Overall Study|Subject decision|6|||
130797960|NCT04589650|470884438|FG001|Overall Study|Subject decision|2|||
130797961|NCT04589650|470884439|FG002|Overall Study|Subject decision|2|||
130797962|NCT04589650|470884440|FG003|Overall Study|Subject decision|0|||
130797963|NCT04589650|470884441|FG004|Overall Study|Subject decision|0|||
130797964|NCT04589650|470884442|FG005|Overall Study|Subject decision|0|||
130797965|NCT04589650|470884437|FG000|Overall Study|Adverse Event|3|||
130797966|NCT04589650|470884438|FG001|Overall Study|Adverse Event|1|||
130763192|NCT01294371|470755887|FG000|Overall Study|Lost to Follow-up|6|||
130763193|NCT01294371|470755887|FG000|Overall Study|Administrative Reason|1|||
130763194|NCT01294371|470755887|FG000|Overall Study|Other|14|||
130763195|NCT05619536|470755888|FG000|Overall Study|Withdrawal by Subject|0|||
130763196|NCT05619536|470755889|FG001|Overall Study|Withdrawal by Subject|1|||
130763197|NCT05619536|470755890|FG002|Overall Study|Withdrawal by Subject|0|||
130797967|NCT04589650|470884439|FG002|Overall Study|Adverse Event|1|||
130797968|NCT04589650|470884440|FG003|Overall Study|Adverse Event|1|||
130797969|NCT04589650|470884441|FG004|Overall Study|Adverse Event|0|||
130797970|NCT04589650|470884442|FG005|Overall Study|Adverse Event|1|||
130797971|NCT04589650|470884437|FG000|Overall Study|Physician Decision|1|||
130797972|NCT04589650|470884438|FG001|Overall Study|Physician Decision|1|||
130797973|NCT04589650|470884439|FG002|Overall Study|Physician Decision|0|||
130797974|NCT04589650|470884440|FG003|Overall Study|Physician Decision|0|||
130797975|NCT04589650|470884441|FG004|Overall Study|Physician Decision|0|||
130797976|NCT04589650|470884442|FG005|Overall Study|Physician Decision|0|||
130797977|NCT04589650|470884437|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130797978|NCT04589650|470884438|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130797979|NCT04589650|470884439|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130797980|NCT04589650|470884440|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130797981|NCT04589650|470884441|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
130797982|NCT04589650|470884442|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
130797983|NCT04589650|470884437|FG000|Overall Study|Death|0|||
130797984|NCT04589650|470884438|FG001|Overall Study|Death|0|||
130797985|NCT04589650|470884439|FG002|Overall Study|Death|0|||
130797986|NCT04589650|470884440|FG003|Overall Study|Death|1|||
130797987|NCT04589650|470884441|FG004|Overall Study|Death|0|||
130797988|NCT04589650|470884442|FG005|Overall Study|Death|0|||
130797989|NCT04589650|470884437|FG000|Overall Study|Guardian Decision|0|||
130797990|NCT04589650|470884438|FG001|Overall Study|Guardian Decision|0|||
130797991|NCT04589650|470884439|FG002|Overall Study|Guardian Decision|0|||
130797992|NCT04589650|470884440|FG003|Overall Study|Guardian Decision|1|||
130797993|NCT04589650|470884441|FG004|Overall Study|Guardian Decision|0|||
130797994|NCT04589650|470884442|FG005|Overall Study|Guardian Decision|0|||
130797995|NCT02324153|470884443|FG000|Overall Study|Withdrawal by Subject|4|||
130797996|NCT02324153|470884444|FG001|Overall Study|Withdrawal by Subject|1|||
130797997|NCT02324153|470884443|FG000|Overall Study|Surgery postponed after randomization|3|||
130797998|NCT02324153|470884444|FG001|Overall Study|Surgery postponed after randomization|0|||
130797999|NCT02324153|470884443|FG000|Overall Study|Developed delirium preoperatively|1|||
130798000|NCT02324153|470884444|FG001|Overall Study|Developed delirium preoperatively|0|||
130798001|NCT03122106|470884447|FG000|Overall Study|Not enough tissue|1|||
130798002|NCT03122106|470884447|FG000|Overall Study|Disease progression during screening|2|||
130798003|NCT03122106|470884447|FG000|Overall Study|Poor RNA quality for vaccine|1|||
130798004|NCT01147458|470884449|FG000|First Intervention|Study terminated by sponsor|8|||
130798005|NCT01147458|470884450|FG001|First Intervention|Study terminated by sponsor|8|||
130798006|NCT01147458|470884451|FG002|First Intervention|Study terminated by sponsor|7|||
130798007|NCT01147458|470884452|FG003|First Intervention|Study terminated by sponsor|8|||
130798008|NCT01147458|470884449|FG000|First Intervention|Protocol Violation|2|||
130798009|NCT01147458|470884450|FG001|First Intervention|Protocol Violation|3|||
130798010|NCT01147458|470884451|FG002|First Intervention|Protocol Violation|2|||
130798011|NCT01147458|470884452|FG003|First Intervention|Protocol Violation|3|||
130798012|NCT01147458|470884449|FG000|First Intervention|Withdrawal by Subject|3|||
130798013|NCT01147458|470884450|FG001|First Intervention|Withdrawal by Subject|0|||
130798014|NCT01147458|470884451|FG002|First Intervention|Withdrawal by Subject|1|||
130798015|NCT01147458|470884452|FG003|First Intervention|Withdrawal by Subject|0|||
130798016|NCT01147458|470884449|FG000|First Intervention|Adverse Event|0|||
130798017|NCT01147458|470884450|FG001|First Intervention|Adverse Event|3|||
130798018|NCT01147458|470884451|FG002|First Intervention|Adverse Event|2|||
130798019|NCT01147458|470884452|FG003|First Intervention|Adverse Event|3|||
130798020|NCT01147458|470884449|FG000|First Intervention|Other|1|||
130798021|NCT01147458|470884450|FG001|First Intervention|Other|2|||
130798022|NCT01147458|470884451|FG002|First Intervention|Other|0|||
130798023|NCT01147458|470884452|FG003|First Intervention|Other|0|||
130798024|NCT01147458|470884449|FG000|Second Intervention|Study terminated by sponsor|7|||
130798025|NCT01147458|470884450|FG001|Second Intervention|Study terminated by sponsor|5|||
130798026|NCT01147458|470884451|FG002|Second Intervention|Study terminated by sponsor|5|||
130798027|NCT01147458|470884452|FG003|Second Intervention|Study terminated by sponsor|3|||
130798028|NCT01147458|470884449|FG000|Second Intervention|Protocol Violation|0|||
130798029|NCT01147458|470884450|FG001|Second Intervention|Protocol Violation|1|||
130798030|NCT01147458|470884451|FG002|Second Intervention|Protocol Violation|1|||
130798031|NCT01147458|470884452|FG003|Second Intervention|Protocol Violation|0|||
130798032|NCT01147458|470884449|FG000|Second Intervention|Withdrawal by Subject|0|||
130798033|NCT01147458|470884450|FG001|Second Intervention|Withdrawal by Subject|1|||
130798034|NCT01147458|470884451|FG002|Second Intervention|Withdrawal by Subject|0|||
130798035|NCT01147458|470884452|FG003|Second Intervention|Withdrawal by Subject|0|||
130798036|NCT01147458|470884449|FG000|Second Intervention|Adverse Event|2|||
130798037|NCT01147458|470884450|FG001|Second Intervention|Adverse Event|0|||
130798038|NCT01147458|470884451|FG002|Second Intervention|Adverse Event|1|||
130798039|NCT01147458|470884452|FG003|Second Intervention|Adverse Event|1|||
130798040|NCT01147458|470884449|FG000|Second Intervention|Other|0|||
130798041|NCT01147458|470884450|FG001|Second Intervention|Other|0|||
130798042|NCT01147458|470884451|FG002|Second Intervention|Other|1|||
130798043|NCT01147458|470884452|FG003|Second Intervention|Other|0|||
130798044|NCT03550209|470884453|FG000|Overall Study|Lost to Follow-up|1|||
130798045|NCT03550209|470884454|FG001|Overall Study|Lost to Follow-up|0|||
130798046|NCT03550209|470884455|FG002|Overall Study|Lost to Follow-up|1|||
130798047|NCT03550209|470884456|FG003|Overall Study|Lost to Follow-up|0|||
130798048|NCT03550209|470884453|FG000|Overall Study|Withdrawal by Subject|0|||
130798049|NCT03550209|470884454|FG001|Overall Study|Withdrawal by Subject|3|||
130798050|NCT03550209|470884455|FG002|Overall Study|Withdrawal by Subject|1|||
130798051|NCT03550209|470884456|FG003|Overall Study|Withdrawal by Subject|2|||
130798052|NCT03550209|470884453|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
130798053|NCT03550209|470884454|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
130798054|NCT03550209|470884455|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
130798055|NCT03550209|470884456|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
130798056|NCT02555878|470884457|FG000|Overall Study|Lost to Follow-up|2|||
130798057|NCT02555878|470884458|FG001|Overall Study|Lost to Follow-up|3|||
130798058|NCT02555878|470884457|FG000|Overall Study|Withdrawal by Subject|48|||
130798059|NCT02555878|470884458|FG001|Overall Study|Withdrawal by Subject|48|||
130798060|NCT02555878|470884457|FG000|Overall Study|Adverse Event|12|||
130798061|NCT02555878|470884458|FG001|Overall Study|Adverse Event|8|||
130798062|NCT02555878|470884457|FG000|Overall Study|Death|74|||
130798063|NCT02555878|470884458|FG001|Overall Study|Death|59|||
130798064|NCT02555878|470884457|FG000|Overall Study|Protocol Violation|1|||
130798065|NCT02555878|470884458|FG001|Overall Study|Protocol Violation|2|||
130798066|NCT02555878|470884457|FG000|Overall Study|Physician Decision|12|||
130798067|NCT02555878|470884458|FG001|Overall Study|Physician Decision|13|||
130798068|NCT02555878|470884457|FG000|Overall Study|Other|17|||
130798069|NCT02555878|470884458|FG001|Overall Study|Other|17|||
130798070|NCT00765076|470884459|FG000|Overall Study|Adverse Event|1|||
130798071|NCT00765076|470884460|FG001|Overall Study|Adverse Event|0|||
130798072|NCT00765076|470884461|FG002|Overall Study|Adverse Event|0|||
130798073|NCT00765076|470884459|FG000|Overall Study|Withdrawal by Subject|0|||
130798074|NCT00765076|470884460|FG001|Overall Study|Withdrawal by Subject|0|||
130798075|NCT00765076|470884461|FG002|Overall Study|Withdrawal by Subject|1|||
130798076|NCT03244189|470884462|FG000|Overall Study|Death|0|||
130798077|NCT03244189|470884463|FG001|Overall Study|Death|2|||
130798078|NCT03244189|470884462|FG000|Overall Study|Lost to Follow-up|92|||
130798079|NCT03244189|470884463|FG001|Overall Study|Lost to Follow-up|107|||
130798080|NCT03244189|470884462|FG000|Overall Study|Physician Decision|4|||
130798081|NCT03244189|470884463|FG001|Overall Study|Physician Decision|2|||
130798082|NCT03244189|470884462|FG000|Overall Study|Pregnancy|7|||
130798083|NCT03244189|470884463|FG001|Overall Study|Pregnancy|5|||
130798084|NCT03244189|470884462|FG000|Overall Study|Protocol Violation|0|||
130798085|NCT03244189|470884463|FG001|Overall Study|Protocol Violation|2|||
130798086|NCT03244189|470884462|FG000|Overall Study|Withdrawal by Subject|45|||
130798087|NCT03244189|470884463|FG001|Overall Study|Withdrawal by Subject|23|||
130798088|NCT03244189|470884462|FG000|Overall Study|Technical Problems|2|||
130798089|NCT03244189|470884463|FG001|Overall Study|Technical Problems|0|||
130798090|NCT06170827|470884464|FG000|Overall Study|Withdrawal by Subject|1|||
130798091|NCT06170827|470884465|FG001|Overall Study|Withdrawal by Subject|1|||
130798092|NCT02180867|470884474|FG000|Overall Study|Adverse Event|3|||
130798093|NCT02180867|470884475|FG001|Overall Study|Adverse Event|4|||
130798094|NCT02180867|470884476|FG002|Overall Study|Adverse Event|1|||
130798095|NCT02180867|470884477|FG003|Overall Study|Adverse Event|5|||
130798096|NCT02180867|470884478|FG004|Overall Study|Adverse Event|0|||
130798097|NCT02180867|470884479|FG005|Overall Study|Adverse Event|0|||
130798098|NCT02180867|470884480|FG006|Overall Study|Adverse Event|0|||
130798099|NCT02180867|470884474|FG000|Overall Study|Death|0|||
130798100|NCT02180867|470884475|FG001|Overall Study|Death|0|||
130798101|NCT02180867|470884476|FG002|Overall Study|Death|0|||
130798102|NCT02180867|470884477|FG003|Overall Study|Death|0|||
130798103|NCT02180867|470884478|FG004|Overall Study|Death|1|||
130798104|NCT02180867|470884479|FG005|Overall Study|Death|0|||
130798105|NCT02180867|470884480|FG006|Overall Study|Death|0|||
130798106|NCT02180867|470884474|FG000|Overall Study|Lack of Efficacy|0|||
130798107|NCT02180867|470884475|FG001|Overall Study|Lack of Efficacy|2|||
130798108|NCT02180867|470884476|FG002|Overall Study|Lack of Efficacy|0|||
130798109|NCT02180867|470884477|FG003|Overall Study|Lack of Efficacy|1|||
130798110|NCT02180867|470884478|FG004|Overall Study|Lack of Efficacy|6|||
130798111|NCT02180867|470884479|FG005|Overall Study|Lack of Efficacy|0|||
130798112|NCT02180867|470884480|FG006|Overall Study|Lack of Efficacy|1|||
130798113|NCT02180867|470884474|FG000|Overall Study|Physician Decision|1|||
130798114|NCT02180867|470884475|FG001|Overall Study|Physician Decision|3|||
130798115|NCT02180867|470884476|FG002|Overall Study|Physician Decision|1|||
130798116|NCT02180867|470884477|FG003|Overall Study|Physician Decision|10|||
130798117|NCT02180867|470884478|FG004|Overall Study|Physician Decision|9|||
130798118|NCT02180867|470884479|FG005|Overall Study|Physician Decision|3|||
130798119|NCT02180867|470884480|FG006|Overall Study|Physician Decision|4|||
130798120|NCT02180867|470884474|FG000|Overall Study|Withdrawal by Subject|0|||
130798121|NCT02180867|470884475|FG001|Overall Study|Withdrawal by Subject|0|||
130798122|NCT02180867|470884476|FG002|Overall Study|Withdrawal by Subject|0|||
130798123|NCT02180867|470884477|FG003|Overall Study|Withdrawal by Subject|1|||
130798124|NCT02180867|470884478|FG004|Overall Study|Withdrawal by Subject|1|||
130798125|NCT02180867|470884479|FG005|Overall Study|Withdrawal by Subject|0|||
130798126|NCT02180867|470884480|FG006|Overall Study|Withdrawal by Subject|0|||
130798127|NCT02180867|470884474|FG000|Overall Study|Ineligible|1|||
130798128|NCT02180867|470884475|FG001|Overall Study|Ineligible|2|||
130798129|NCT02180867|470884476|FG002|Overall Study|Ineligible|0|||
130798130|NCT02180867|470884477|FG003|Overall Study|Ineligible|3|||
130798131|NCT02180867|470884478|FG004|Overall Study|Ineligible|5|||
130798132|NCT02180867|470884479|FG005|Overall Study|Ineligible|0|||
130798133|NCT02180867|470884480|FG006|Overall Study|Ineligible|0|||
130798134|NCT02180867|470884474|FG000|Overall Study|Repeat Eligibility Studies|0|||
130798135|NCT02180867|470884475|FG001|Overall Study|Repeat Eligibility Studies|0|||
130798136|NCT02180867|470884476|FG002|Overall Study|Repeat Eligibility Studies|0|||
130798137|NCT02180867|470884477|FG003|Overall Study|Repeat Eligibility Studies|0|||
130798138|NCT02180867|470884478|FG004|Overall Study|Repeat Eligibility Studies|1|||
130798139|NCT02180867|470884479|FG005|Overall Study|Repeat Eligibility Studies|0|||
130798140|NCT02180867|470884480|FG006|Overall Study|Repeat Eligibility Studies|0|||
130798141|NCT02180867|470884474|FG000|Overall Study|Refusal of further protocol therapy|1|||
130798142|NCT02180867|470884475|FG001|Overall Study|Refusal of further protocol therapy|0|||
130798143|NCT02180867|470884476|FG002|Overall Study|Refusal of further protocol therapy|2|||
130798144|NCT02180867|470884477|FG003|Overall Study|Refusal of further protocol therapy|6|||
130798145|NCT02180867|470884478|FG004|Overall Study|Refusal of further protocol therapy|4|||
130798146|NCT02180867|470884479|FG005|Overall Study|Refusal of further protocol therapy|0|||
130798147|NCT02180867|470884480|FG006|Overall Study|Refusal of further protocol therapy|0|||
130798148|NCT02337686|470884481|FG000|Overall Study|Adverse Event|1|||
130798149|NCT00177671|470885474|FG000|Overall Study|Withdrawal by Subject|5|||
130798150|NCT00177671|470885475|FG001|Overall Study|Withdrawal by Subject|6|||
130798151|NCT00177671|470885474|FG000|Overall Study|medical complications|2|||
130798152|NCT00177671|470885475|FG001|Overall Study|medical complications|0|||
130798153|NCT00177671|470885474|FG000|Overall Study|Adverse Event|6|||
130798154|NCT00177671|470885475|FG001|Overall Study|Adverse Event|0|||
130798155|NCT00177671|470885474|FG000|Overall Study|Physician Decision|12|||
130798156|NCT00177671|470885475|FG001|Overall Study|Physician Decision|8|||
130798157|NCT01847209|470885476|FG000|Overall Study|Withdrawal by Subject|1|||
130798158|NCT01847209|470885476|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
130798159|NCT02008370|470885497|FG000|Overall Study|Lost to Follow-up|7|||
130798160|NCT03317496|470885501|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
130798161|NCT03317496|470885502|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
130798162|NCT03317496|470885503|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
130798163|NCT03317496|470885504|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
130798164|NCT03317496|470885505|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
130798165|NCT03317496|470885501|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130798166|NCT03317496|470885502|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
130798167|NCT03317496|470885503|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130798168|NCT03317496|470885504|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130798169|NCT03317496|470885505|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130798170|NCT03317496|470885501|FG000|Phase 1b Lead-in: Treatment|Death|0|||
130798171|NCT03317496|470885502|FG001|Phase 1b Lead-in: Treatment|Death|0|||
130798172|NCT03317496|470885503|FG002|Phase 1b Lead-in: Treatment|Death|1|||
130798173|NCT03317496|470885504|FG003|Phase 1b Lead-in: Treatment|Death|0|||
130798174|NCT03317496|470885505|FG004|Phase 1b Lead-in: Treatment|Death|0|||
130798175|NCT03317496|470885501|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
130798176|NCT03317496|470885502|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
130798177|NCT03317496|470885503|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
130798178|NCT03317496|470885504|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
130798179|NCT03317496|470885505|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
130798180|NCT03317496|470885501|FG000|Phase 1b Lead-in: Treatment|Other|2|||
130798181|NCT03317496|470885502|FG001|Phase 1b Lead-in: Treatment|Other|1|||
130798182|NCT03317496|470885503|FG002|Phase 1b Lead-in: Treatment|Other|0|||
130798183|NCT03317496|470885504|FG003|Phase 1b Lead-in: Treatment|Other|0|||
130798184|NCT03317496|470885505|FG004|Phase 1b Lead-in: Treatment|Other|0|||
130798185|NCT03317496|470885501|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130798186|NCT03317496|470885502|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130798187|NCT03317496|470885503|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
130798188|NCT03317496|470885504|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130798189|NCT03317496|470885505|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130798190|NCT03317496|470885501|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
130798191|NCT03317496|470885502|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
130798192|NCT03317496|470885503|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
130798193|NCT03317496|470885504|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
130798194|NCT03317496|470885505|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
130798195|NCT03317496|470885501|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
130798196|NCT03317496|470885502|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
130798197|NCT03317496|470885503|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
130798198|NCT03317496|470885504|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
130798199|NCT03317496|470885505|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
130798200|NCT03317496|470885501|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
130798201|NCT03317496|470885502|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130798202|NCT03317496|470885503|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130798203|NCT03317496|470885504|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130798204|NCT03317496|470885505|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130798205|NCT03317496|470885501|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130798206|NCT03317496|470885502|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130763198|NCT05619536|470755891|FG003|Overall Study|Withdrawal by Subject|1|||
130763199|NCT05619536|470755888|FG000|Overall Study|Lost to Follow-up|0|||
130763200|NCT05619536|470755889|FG001|Overall Study|Lost to Follow-up|1|||
130763201|NCT05619536|470755890|FG002|Overall Study|Lost to Follow-up|1|||
130763202|NCT05619536|470755891|FG003|Overall Study|Lost to Follow-up|0|||
130763203|NCT03619902|470755892|FG000|Overall Study|Termination of Study by Investigator|1|||
130763204|NCT03619902|470755892|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
130763205|NCT02923245|470755893|FG000|Overall Study|ultrasound order was cancelled|2|||
130763206|NCT02923245|470755894|FG001|Overall Study|ultrasound order was cancelled|1|||
130763207|NCT02520427|470755895|FG000|Overall Study|Decision by sponsor|0|||
130763208|NCT02520427|470755896|FG001|Overall Study|Decision by sponsor|0|||
130763209|NCT02520427|470755897|FG002|Overall Study|Decision by sponsor|0|||
130763210|NCT02520427|470755898|FG003|Overall Study|Decision by sponsor|0|||
130763211|NCT02520427|470755899|FG004|Overall Study|Decision by sponsor|0|||
130763212|NCT02520427|470755900|FG005|Overall Study|Decision by sponsor|0|||
130763213|NCT02520427|470755901|FG006|Overall Study|Decision by sponsor|0|||
130763214|NCT02520427|470755902|FG007|Overall Study|Decision by sponsor|0|||
130763215|NCT02520427|470755903|FG008|Overall Study|Decision by sponsor|1|||
130763216|NCT02520427|470755904|FG009|Overall Study|Decision by sponsor|1|||
130763217|NCT02520427|470755905|FG010|Overall Study|Decision by sponsor|0|||
130763218|NCT02520427|470755906|FG011|Overall Study|Decision by sponsor|0|||
130763219|NCT02520427|470755907|FG012|Overall Study|Decision by sponsor|0|||
130763220|NCT02520427|470755908|FG013|Overall Study|Decision by sponsor|0|||
130763221|NCT02520427|470755909|FG014|Overall Study|Decision by sponsor|0|||
130763222|NCT02520427|470755910|FG015|Overall Study|Decision by sponsor|0|||
130763223|NCT02520427|470755911|FG016|Overall Study|Decision by sponsor|0|||
130763224|NCT02520427|470755912|FG017|Overall Study|Decision by sponsor|0|||
130763225|NCT02520427|470755913|FG018|Overall Study|Decision by sponsor|0|||
130763226|NCT02520427|470755914|FG019|Overall Study|Decision by sponsor|0|||
130763227|NCT02520427|470755915|FG020|Overall Study|Decision by sponsor|0|||
130763228|NCT02520427|470755916|FG021|Overall Study|Decision by sponsor|0|||
130763229|NCT02520427|470755917|FG022|Overall Study|Decision by sponsor|0|||
130763230|NCT02520427|470755918|FG023|Overall Study|Decision by sponsor|0|||
130763231|NCT02520427|470755919|FG024|Overall Study|Decision by sponsor|0|||
130763232|NCT02520427|470755920|FG025|Overall Study|Decision by sponsor|0|||
130763233|NCT02520427|470755895|FG000|Overall Study|Withdrawal by Subject|0|||
130763234|NCT02520427|470755896|FG001|Overall Study|Withdrawal by Subject|0|||
130763235|NCT02520427|470755897|FG002|Overall Study|Withdrawal by Subject|1|||
130763236|NCT02520427|470755898|FG003|Overall Study|Withdrawal by Subject|0|||
130763237|NCT02520427|470755899|FG004|Overall Study|Withdrawal by Subject|0|||
130763238|NCT02520427|470755900|FG005|Overall Study|Withdrawal by Subject|0|||
130763239|NCT02520427|470755901|FG006|Overall Study|Withdrawal by Subject|0|||
130763240|NCT02520427|470755902|FG007|Overall Study|Withdrawal by Subject|0|||
130763241|NCT02520427|470755903|FG008|Overall Study|Withdrawal by Subject|0|||
130763242|NCT02520427|470755904|FG009|Overall Study|Withdrawal by Subject|0|||
130798207|NCT03317496|470885503|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
130798208|NCT03317496|470885504|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130798209|NCT03317496|470885505|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130798210|NCT03317496|470885501|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
130798211|NCT03317496|470885502|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
130798212|NCT03317496|470885503|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
130798213|NCT03317496|470885504|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
130798214|NCT03317496|470885505|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
130798215|NCT03317496|470885501|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
130798216|NCT03317496|470885502|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
130798217|NCT03317496|470885503|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
130798218|NCT03317496|470885504|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
130798219|NCT03317496|470885505|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
130798220|NCT03317496|470885501|FG000|Phase 2: Treatment|Adverse Event|0|||
130798221|NCT03317496|470885502|FG001|Phase 2: Treatment|Adverse Event|0|||
130798222|NCT03317496|470885503|FG002|Phase 2: Treatment|Adverse Event|0|||
130798223|NCT03317496|470885504|FG003|Phase 2: Treatment|Adverse Event|0|||
130798224|NCT03317496|470885505|FG004|Phase 2: Treatment|Adverse Event|6|||
130798225|NCT03317496|470885501|FG000|Phase 2: Treatment|Progressive disease|0|||
130798226|NCT03317496|470885502|FG001|Phase 2: Treatment|Progressive disease|0|||
130798227|NCT03317496|470885503|FG002|Phase 2: Treatment|Progressive disease|0|||
130798228|NCT03317496|470885504|FG003|Phase 2: Treatment|Progressive disease|0|||
130798229|NCT03317496|470885505|FG004|Phase 2: Treatment|Progressive disease|22|||
130798230|NCT03317496|470885501|FG000|Phase 2: Treatment|Other|0|||
130798231|NCT03317496|470885502|FG001|Phase 2: Treatment|Other|0|||
130798232|NCT03317496|470885503|FG002|Phase 2: Treatment|Other|0|||
130798233|NCT03317496|470885504|FG003|Phase 2: Treatment|Other|0|||
130798234|NCT03317496|470885505|FG004|Phase 2: Treatment|Other|4|||
130798235|NCT03317496|470885501|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
130798236|NCT03317496|470885502|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
130798237|NCT03317496|470885503|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
130798238|NCT03317496|470885504|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
130798239|NCT03317496|470885505|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
130798240|NCT03317496|470885501|FG000|Phase 2: Treatment|Physician Decision|0|||
130798241|NCT03317496|470885502|FG001|Phase 2: Treatment|Physician Decision|0|||
130798242|NCT03317496|470885503|FG002|Phase 2: Treatment|Physician Decision|0|||
130798243|NCT03317496|470885504|FG003|Phase 2: Treatment|Physician Decision|0|||
130798244|NCT03317496|470885505|FG004|Phase 2: Treatment|Physician Decision|1|||
130798245|NCT03317496|470885501|FG000|Phase 2: Treatment|Death|0|||
130798246|NCT03317496|470885502|FG001|Phase 2: Treatment|Death|0|||
130798247|NCT03317496|470885503|FG002|Phase 2: Treatment|Death|0|||
130798248|NCT03317496|470885504|FG003|Phase 2: Treatment|Death|0|||
130798249|NCT03317496|470885505|FG004|Phase 2: Treatment|Death|1|||
130798250|NCT03317496|470885501|FG000|Phase 2: Follow-up|Death|0|||
130798251|NCT03317496|470885502|FG001|Phase 2: Follow-up|Death|0|||
130798252|NCT03317496|470885503|FG002|Phase 2: Follow-up|Death|0|||
130798253|NCT03317496|470885504|FG003|Phase 2: Follow-up|Death|0|||
130798254|NCT03317496|470885505|FG004|Phase 2: Follow-up|Death|24|||
130798255|NCT03317496|470885501|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
130798256|NCT03317496|470885502|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
130798257|NCT03317496|470885503|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
130798258|NCT03317496|470885504|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
130798259|NCT03317496|470885505|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
130798260|NCT03317496|470885501|FG000|Phase 2: Follow-up|Other|0|||
130798261|NCT03317496|470885502|FG001|Phase 2: Follow-up|Other|0|||
130798262|NCT03317496|470885503|FG002|Phase 2: Follow-up|Other|0|||
130798263|NCT03317496|470885504|FG003|Phase 2: Follow-up|Other|0|||
130798264|NCT03317496|470885505|FG004|Phase 2: Follow-up|Other|1|||
130798265|NCT03317496|470885501|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
130798266|NCT03317496|470885502|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
130798267|NCT03317496|470885503|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
130798268|NCT03317496|470885504|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
130798269|NCT03317496|470885505|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
130798270|NCT02737618|470885506|FG000|Overall Study|Withdrawal by Subject|9|||
130798271|NCT00898807|470885509|FG000|Overall Study|Withdrawal by Subject|5|||
130798272|NCT00898807|470885510|FG001|Overall Study|Withdrawal by Subject|3|||
130798273|NCT00898807|470885509|FG000|Overall Study|Family pressure to discontinue|2|||
130798274|NCT00898807|470885510|FG001|Overall Study|Family pressure to discontinue|2|||
130798275|NCT00898807|470885509|FG000|Overall Study|Lost to Follow-up|1|||
130798276|NCT00898807|470885510|FG001|Overall Study|Lost to Follow-up|3|||
130798277|NCT00898807|470885509|FG000|Overall Study|Death|0|||
130798278|NCT00898807|470885510|FG001|Overall Study|Death|1|||
130798279|NCT00817063|470885511|FG000|Overall Study|Adverse Event|32|||
130798280|NCT00817063|470885512|FG001|Overall Study|Adverse Event|13|||
130798281|NCT00817063|470885511|FG000|Overall Study|Death|1|||
130798282|NCT00817063|470885512|FG001|Overall Study|Death|1|||
130798283|NCT00817063|470885511|FG000|Overall Study|Lack of Efficacy|33|||
130798284|NCT00817063|470885512|FG001|Overall Study|Lack of Efficacy|86|||
130798285|NCT00817063|470885511|FG000|Overall Study|Failure to Return|13|||
130798286|NCT00817063|470885512|FG001|Overall Study|Failure to Return|12|||
130798287|NCT00817063|470885511|FG000|Overall Study|Violation of Selection at Entry|7|||
130798288|NCT00817063|470885512|FG001|Overall Study|Violation of Selection at Entry|4|||
130798289|NCT00817063|470885511|FG000|Overall Study|Protocol Violation|3|||
130798290|NCT00817063|470885512|FG001|Overall Study|Protocol Violation|8|||
130798291|NCT00817063|470885511|FG000|Overall Study|Withdrawal by Subject|17|||
130798292|NCT00817063|470885512|FG001|Overall Study|Withdrawal by Subject|37|||
130798293|NCT00817063|470885511|FG000|Overall Study|Early Improvement|19|||
130798294|NCT00817063|470885512|FG001|Overall Study|Early Improvement|4|||
130798295|NCT00817063|470885511|FG000|Overall Study|Administrative|10|||
130798296|NCT00817063|470885512|FG001|Overall Study|Administrative|4|||
130798297|NCT00817063|470885511|FG000|Overall Study|Abnormality of Laboratory Test|2|||
130798298|NCT00817063|470885512|FG001|Overall Study|Abnormality of Laboratory Test|1|||
130798299|NCT01496456|470885513|FG000|Overall Study|Protocol Violation|1|||
130798300|NCT01496456|470885513|FG000|Overall Study|Lost to Follow-up|7|||
130798301|NCT04919161|470885514|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
130798302|NCT04919161|470885515|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
130798303|NCT04919161|470885514|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
130798304|NCT04919161|470885515|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
130798305|NCT04919161|470885514|FG000|Overall Study|Acute ankle sprain after session 1|0|||
130798306|NCT04919161|470885515|FG001|Overall Study|Acute ankle sprain after session 1|1|||
130798307|NCT02489773|470885516|FG000|Overall Study|Lost to Follow-up|4|||
130798308|NCT02489773|470885517|FG001|Overall Study|Lost to Follow-up|1|||
130798309|NCT02489773|470885516|FG000|Overall Study|Physician Decision|1|||
130798310|NCT02489773|470885517|FG001|Overall Study|Physician Decision|0|||
130798311|NCT02489773|470885516|FG000|Overall Study|Withdrawal by Subject|1|||
130798312|NCT02489773|470885517|FG001|Overall Study|Withdrawal by Subject|0|||
130798313|NCT02489773|470885516|FG000|Overall Study|Leave the country or the state|1|||
130798314|NCT02489773|470885517|FG001|Overall Study|Leave the country or the state|1|||
130798315|NCT00712920|470885518|FG000|Overall Study|Adverse Event|3|||
130798316|NCT00712920|470885519|FG001|Overall Study|Adverse Event|4|||
130798317|NCT00712920|470885520|FG002|Overall Study|Adverse Event|7|||
130798318|NCT00712920|470885518|FG000|Overall Study|Withdrawal by Subject|4|||
130798319|NCT00712920|470885519|FG001|Overall Study|Withdrawal by Subject|2|||
130798320|NCT00712920|470885520|FG002|Overall Study|Withdrawal by Subject|1|||
130798321|NCT00712920|470885518|FG000|Overall Study|Lost to Follow-up|1|||
130798322|NCT00712920|470885519|FG001|Overall Study|Lost to Follow-up|4|||
130798323|NCT00712920|470885520|FG002|Overall Study|Lost to Follow-up|0|||
130798324|NCT00712920|470885518|FG000|Overall Study|Lack of Efficacy|1|||
130798325|NCT00712920|470885519|FG001|Overall Study|Lack of Efficacy|0|||
130798326|NCT00712920|470885520|FG002|Overall Study|Lack of Efficacy|1|||
130798327|NCT00712920|470885518|FG000|Overall Study|Other|5|||
130798328|NCT00712920|470885519|FG001|Overall Study|Other|7|||
130798329|NCT00712920|470885520|FG002|Overall Study|Other|3|||
130798330|NCT00712920|470885518|FG000|Overall Study|Non-compliance|3|||
130798331|NCT00712920|470885519|FG001|Overall Study|Non-compliance|0|||
130798332|NCT00712920|470885520|FG002|Overall Study|Non-compliance|0|||
130798333|NCT01879852|470885524|FG000|Overall Study|Withdrawal by Subject|2|||
130798334|NCT01879852|470885525|FG001|Overall Study|Withdrawal by Subject|0|||
130763243|NCT02520427|470755905|FG010|Overall Study|Withdrawal by Subject|0|||
130763244|NCT02520427|470755906|FG011|Overall Study|Withdrawal by Subject|0|||
130763245|NCT02520427|470755907|FG012|Overall Study|Withdrawal by Subject|1|||
130763246|NCT02520427|470755908|FG013|Overall Study|Withdrawal by Subject|1|||
130763247|NCT02520427|470755909|FG014|Overall Study|Withdrawal by Subject|1|||
130763248|NCT02520427|470755910|FG015|Overall Study|Withdrawal by Subject|0|||
130763249|NCT02520427|470755911|FG016|Overall Study|Withdrawal by Subject|1|||
130763250|NCT02520427|470755912|FG017|Overall Study|Withdrawal by Subject|0|||
130763251|NCT02520427|470755913|FG018|Overall Study|Withdrawal by Subject|0|||
130763252|NCT02520427|470755914|FG019|Overall Study|Withdrawal by Subject|3|||
130763253|NCT02520427|470755915|FG020|Overall Study|Withdrawal by Subject|2|||
130763254|NCT02520427|470755916|FG021|Overall Study|Withdrawal by Subject|0|||
130798335|NCT02696616|470885526|FG000|Overall Study|Adverse Event|0|||
130798336|NCT02696616|470885527|FG001|Overall Study|Adverse Event|1|||
130798337|NCT02696616|470885528|FG002|Overall Study|Adverse Event|0|||
130798338|NCT02696616|470885529|FG003|Overall Study|Adverse Event|0|||
130798339|NCT02696616|470885530|FG004|Overall Study|Adverse Event|0|||
130798340|NCT02696616|470885531|FG005|Overall Study|Adverse Event|0|||
130798341|NCT02696616|470885532|FG006|Overall Study|Adverse Event|0|||
130798342|NCT01500083|470885535|FG000|Overall Study|Adverse Event|4|||
130798343|NCT01500083|470885536|FG001|Overall Study|Adverse Event|17|||
130798344|NCT01500083|470885535|FG000|Overall Study|Death|0|||
130798345|NCT01500083|470885536|FG001|Overall Study|Death|2|||
130798346|NCT01500083|470885535|FG000|Overall Study|Lost to Follow-up|1|||
130798347|NCT01500083|470885536|FG001|Overall Study|Lost to Follow-up|0|||
130798348|NCT01500083|470885535|FG000|Overall Study|Withdrawal of Consent|0|||
130798349|NCT01500083|470885536|FG001|Overall Study|Withdrawal of Consent|1|||
130798350|NCT01500083|470885535|FG000|Overall Study|Disease Progression|2|||
130798351|NCT01500083|470885536|FG001|Overall Study|Disease Progression|10|||
130798352|NCT01500083|470885535|FG000|Overall Study|Investigator Discretion|3|||
130798353|NCT01500083|470885536|FG001|Overall Study|Investigator Discretion|8|||
130798354|NCT01500083|470885535|FG000|Overall Study|Other Reasons|2|||
130798355|NCT01500083|470885536|FG001|Overall Study|Other Reasons|5|||
130798356|NCT01555931|470885537|FG000|Overall Study|Lost to Follow-up|2|||
130798357|NCT01555931|470885538|FG001|Overall Study|Lost to Follow-up|5|||
130798358|NCT03600428|470885539|FG000|Overall Study|Not eligible|0|||
130798359|NCT03600428|470885540|FG001|Overall Study|Not eligible|1|||
130798360|NCT03600428|470885539|FG000|Overall Study|Lost to Follow-up|5|||
130798361|NCT03600428|470885540|FG001|Overall Study|Lost to Follow-up|4|||
130798362|NCT02676973|470885541|FG000|Overall Study|Withdrawal by Subject|9|||
130798363|NCT02676973|470885542|FG001|Overall Study|Withdrawal by Subject|8|||
130798364|NCT02676973|470885543|FG002|Overall Study|Withdrawal by Subject|11|||
130798365|NCT02676973|470885541|FG000|Overall Study|Lost to Follow-up|8|||
130798366|NCT02676973|470885542|FG001|Overall Study|Lost to Follow-up|12|||
130798367|NCT02676973|470885543|FG002|Overall Study|Lost to Follow-up|8|||
130798368|NCT02676973|470885541|FG000|Overall Study|Death|2|||
130798369|NCT02676973|470885542|FG001|Overall Study|Death|1|||
130798370|NCT02676973|470885543|FG002|Overall Study|Death|5|||
130798371|NCT01078662|470885545|FG000|Overall Study|Death|41|||
130798372|NCT01078662|470885546|FG001|Overall Study|Death|103|||
130798373|NCT01078662|470885547|FG002|Overall Study|Death|18|||
130798374|NCT01078662|470885548|FG003|Overall Study|Death|5|||
130798375|NCT01078662|470885549|FG004|Overall Study|Death|8|||
130798376|NCT01078662|470885545|FG000|Overall Study|Patients reached data cut-off|12|||
130798377|NCT01078662|470885546|FG001|Overall Study|Patients reached data cut-off|53|||
130798378|NCT01078662|470885547|FG002|Overall Study|Patients reached data cut-off|2|||
130798379|NCT01078662|470885548|FG003|Overall Study|Patients reached data cut-off|2|||
130798380|NCT01078662|470885549|FG004|Overall Study|Patients reached data cut-off|3|||
130798381|NCT01078662|470885545|FG000|Overall Study|Withdrawal by Subject|4|||
130798382|NCT01078662|470885546|FG001|Overall Study|Withdrawal by Subject|11|||
130798383|NCT01078662|470885547|FG002|Overall Study|Withdrawal by Subject|1|||
130798384|NCT01078662|470885548|FG003|Overall Study|Withdrawal by Subject|0|||
130798385|NCT01078662|470885549|FG004|Overall Study|Withdrawal by Subject|0|||
130798386|NCT01078662|470885545|FG000|Overall Study|Protocol Violation|0|||
130798387|NCT01078662|470885546|FG001|Overall Study|Protocol Violation|1|||
130798388|NCT01078662|470885547|FG002|Overall Study|Protocol Violation|0|||
130798389|NCT01078662|470885548|FG003|Overall Study|Protocol Violation|0|||
130763255|NCT02520427|470755917|FG022|Overall Study|Withdrawal by Subject|0|||
130798390|NCT01078662|470885549|FG004|Overall Study|Protocol Violation|0|||
130798391|NCT01078662|470885545|FG000|Overall Study|Lost to Follow-up|1|||
130798392|NCT01078662|470885546|FG001|Overall Study|Lost to Follow-up|0|||
130798393|NCT01078662|470885547|FG002|Overall Study|Lost to Follow-up|0|||
130798394|NCT01078662|470885548|FG003|Overall Study|Lost to Follow-up|0|||
130798395|NCT01078662|470885549|FG004|Overall Study|Lost to Follow-up|0|||
130798396|NCT00700635|470885551|FG000|Overall Study|Adverse Event|1|||
130763256|NCT02520427|470755918|FG023|Overall Study|Withdrawal by Subject|0|||
130763257|NCT02520427|470755919|FG024|Overall Study|Withdrawal by Subject|0|||
130763258|NCT02520427|470755920|FG025|Overall Study|Withdrawal by Subject|0|||
130763259|NCT02520427|470755895|FG000|Overall Study|Death|1|||
130763260|NCT02520427|470755896|FG001|Overall Study|Death|0|||
130763261|NCT02520427|470755897|FG002|Overall Study|Death|0|||
130763262|NCT02520427|470755898|FG003|Overall Study|Death|0|||
130763263|NCT02520427|470755899|FG004|Overall Study|Death|0|||
130763264|NCT02520427|470755900|FG005|Overall Study|Death|0|||
130763265|NCT02520427|470755901|FG006|Overall Study|Death|0|||
130763266|NCT02520427|470755902|FG007|Overall Study|Death|0|||
130763267|NCT02520427|470755903|FG008|Overall Study|Death|0|||
130763268|NCT02520427|470755904|FG009|Overall Study|Death|0|||
130763269|NCT02520427|470755905|FG010|Overall Study|Death|0|||
130763270|NCT02520427|470755906|FG011|Overall Study|Death|0|||
130763271|NCT02520427|470755907|FG012|Overall Study|Death|0|||
130763272|NCT02520427|470755908|FG013|Overall Study|Death|0|||
130763273|NCT02520427|470755909|FG014|Overall Study|Death|0|||
130763274|NCT02520427|470755910|FG015|Overall Study|Death|0|||
130763275|NCT02520427|470755911|FG016|Overall Study|Death|2|||
130763276|NCT02520427|470755912|FG017|Overall Study|Death|1|||
130763277|NCT02520427|470755913|FG018|Overall Study|Death|3|||
130763278|NCT02520427|470755914|FG019|Overall Study|Death|2|||
130763279|NCT02520427|470755915|FG020|Overall Study|Death|0|||
130763280|NCT02520427|470755916|FG021|Overall Study|Death|0|||
130763281|NCT02520427|470755917|FG022|Overall Study|Death|1|||
130763282|NCT02520427|470755918|FG023|Overall Study|Death|0|||
130763283|NCT02520427|470755919|FG024|Overall Study|Death|1|||
130763284|NCT02520427|470755920|FG025|Overall Study|Death|0|||
130763285|NCT02987972|470755923|FG000|Overall Study|Adverse Event|1|||
130763286|NCT02987972|470755924|FG001|Overall Study|Adverse Event|1|||
130763287|NCT02987972|470755925|FG002|Overall Study|Adverse Event|0|||
130798397|NCT00700635|470885552|FG001|Overall Study|Adverse Event|0|||
130798398|NCT00700635|470885553|FG002|Overall Study|Adverse Event|0|||
130798399|NCT00700635|470885551|FG000|Overall Study|Lost to Follow-up|1|||
130798400|NCT00700635|470885552|FG001|Overall Study|Lost to Follow-up|3|||
130798401|NCT00700635|470885553|FG002|Overall Study|Lost to Follow-up|0|||
130798402|NCT00700635|470885551|FG000|Overall Study|Protocol Violation|2|||
130798403|NCT00700635|470885552|FG001|Overall Study|Protocol Violation|2|||
130798404|NCT00700635|470885553|FG002|Overall Study|Protocol Violation|0|||
130798405|NCT00700635|470885551|FG000|Overall Study|Withdrawal by Subject|7|||
130798406|NCT00700635|470885552|FG001|Overall Study|Withdrawal by Subject|3|||
130798407|NCT00700635|470885553|FG002|Overall Study|Withdrawal by Subject|1|||
130798408|NCT05172570|470885554|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
130798409|NCT05172570|470885555|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
130798410|NCT05172570|470885556|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
130798411|NCT05172570|470885554|FG000|Overall Study|PI Decision due to equipment shortages|0|||
130798412|NCT05172570|470885555|FG001|Overall Study|PI Decision due to equipment shortages|0|||
130798413|NCT05172570|470885556|FG002|Overall Study|PI Decision due to equipment shortages|1|||
130798414|NCT04937387|470885559|FG000|Overall Study|Adverse Event|1|||
130798415|NCT04937387|470885560|FG001|Overall Study|Adverse Event|0|||
130798416|NCT04937387|470885561|FG002|Overall Study|Adverse Event|2|||
130798417|NCT04937387|470885562|FG003|Overall Study|Adverse Event|0|||
130798418|NCT04937387|470885559|FG000|Overall Study|Lack of Efficacy|1|||
130798419|NCT04937387|470885560|FG001|Overall Study|Lack of Efficacy|0|||
130798420|NCT04937387|470885561|FG002|Overall Study|Lack of Efficacy|0|||
130798421|NCT04937387|470885562|FG003|Overall Study|Lack of Efficacy|1|||
130798422|NCT04937387|470885559|FG000|Overall Study|Withdrawal by Subject|1|||
130798423|NCT04937387|470885560|FG001|Overall Study|Withdrawal by Subject|0|||
130798424|NCT04937387|470885561|FG002|Overall Study|Withdrawal by Subject|1|||
130798425|NCT04937387|470885562|FG003|Overall Study|Withdrawal by Subject|1|||
130798426|NCT04937387|470885559|FG000|Overall Study|Randomized in error|0|||
130798427|NCT04937387|470885560|FG001|Overall Study|Randomized in error|0|||
130798428|NCT04937387|470885561|FG002|Overall Study|Randomized in error|0|||
130798429|NCT04937387|470885562|FG003|Overall Study|Randomized in error|1|||
130798430|NCT02872714|470885569|FG000|Overall Study|Progressive Disease|1|||
130798431|NCT02872714|470885570|FG001|Overall Study|Progressive Disease|2|||
130798432|NCT02872714|470885571|FG002|Overall Study|Progressive Disease|0|||
130798433|NCT02872714|470885572|FG003|Overall Study|Progressive Disease|0|||
130798434|NCT02872714|470885573|FG004|Overall Study|Progressive Disease|0|||
130798435|NCT02872714|470885569|FG000|Overall Study|Death|87|||
130798436|NCT02872714|470885570|FG001|Overall Study|Death|36|||
130798437|NCT02872714|470885571|FG002|Overall Study|Death|8|||
130798438|NCT02872714|470885572|FG003|Overall Study|Death|81|||
130798439|NCT02872714|470885573|FG004|Overall Study|Death|2|||
130798440|NCT02872714|470885569|FG000|Overall Study|Lost to Follow-up|2|||
130798441|NCT02872714|470885570|FG001|Overall Study|Lost to Follow-up|1|||
130798442|NCT02872714|470885571|FG002|Overall Study|Lost to Follow-up|0|||
130798443|NCT02872714|470885572|FG003|Overall Study|Lost to Follow-up|3|||
130798444|NCT02872714|470885573|FG004|Overall Study|Lost to Follow-up|0|||
130798445|NCT02872714|470885569|FG000|Overall Study|Physician Decision|0|||
130798446|NCT02872714|470885570|FG001|Overall Study|Physician Decision|0|||
130798447|NCT02872714|470885571|FG002|Overall Study|Physician Decision|0|||
130798448|NCT02872714|470885572|FG003|Overall Study|Physician Decision|1|||
130798449|NCT02872714|470885573|FG004|Overall Study|Physician Decision|0|||
130798450|NCT02872714|470885569|FG000|Overall Study|Withdrawal by Subject|1|||
130798451|NCT02872714|470885570|FG001|Overall Study|Withdrawal by Subject|3|||
130798452|NCT02872714|470885571|FG002|Overall Study|Withdrawal by Subject|0|||
130798453|NCT02872714|470885572|FG003|Overall Study|Withdrawal by Subject|2|||
130798454|NCT02872714|470885573|FG004|Overall Study|Withdrawal by Subject|0|||
130798455|NCT02872714|470885569|FG000|Overall Study|Captured as Other|2|||
130798456|NCT02872714|470885570|FG001|Overall Study|Captured as Other|0|||
130798457|NCT02872714|470885571|FG002|Overall Study|Captured as Other|0|||
130798458|NCT02872714|470885572|FG003|Overall Study|Captured as Other|1|||
130798459|NCT02872714|470885573|FG004|Overall Study|Captured as Other|0|||
130798460|NCT00970944|470886836|FG000|Overall Study|Death|1|||
130798461|NCT00970944|470886837|FG001|Overall Study|Death|0|||
130798462|NCT00970944|470886836|FG000|Overall Study|Physician Decision|0|||
130798463|NCT00970944|470886837|FG001|Overall Study|Physician Decision|2|||
130798464|NCT00662259|470886838|FG000|Overall Study|Adverse Event|2|||
130798465|NCT00662259|470886839|FG001|Overall Study|Adverse Event|0|||
130798466|NCT01033942|470886840|FG000|Overall Study|Withdrawal by Subject|1|||
130798467|NCT01033942|470886841|FG001|Overall Study|Withdrawal by Subject|1|||
130798468|NCT01033942|470886842|FG002|Overall Study|Withdrawal by Subject|1|||
130798469|NCT01033942|470886840|FG000|Overall Study|Lost to Follow-up|1|||
130798470|NCT01033942|470886841|FG001|Overall Study|Lost to Follow-up|0|||
130798471|NCT01033942|470886842|FG002|Overall Study|Lost to Follow-up|0|||
130798472|NCT01033942|470886840|FG000|Overall Study|Enrolled in Extension Study|0|||
130798473|NCT01033942|470886841|FG001|Overall Study|Enrolled in Extension Study|3|||
130798474|NCT01033942|470886842|FG002|Overall Study|Enrolled in Extension Study|0|||
130798475|NCT02693418|470886843|FG000|Overall Study|Lost to Follow-up|1|||
130798476|NCT02693418|470886844|FG001|Overall Study|Lost to Follow-up|2|||
130798477|NCT02693418|470886845|FG002|Overall Study|Lost to Follow-up|0|||
130798478|NCT02693418|470886846|FG003|Overall Study|Lost to Follow-up|0|||
130798479|NCT02693418|470886847|FG004|Overall Study|Lost to Follow-up|0|||
130798480|NCT02693418|470886843|FG000|Overall Study|Menses during study period|0|||
130798481|NCT02693418|470886844|FG001|Overall Study|Menses during study period|0|||
130798482|NCT02693418|470886845|FG002|Overall Study|Menses during study period|2|||
130798483|NCT02693418|470886846|FG003|Overall Study|Menses during study period|0|||
130798484|NCT02693418|470886847|FG004|Overall Study|Menses during study period|0|||
130798485|NCT01750346|470886851|FG000|Overall Study|Adverse Event|1|||
130798486|NCT01750346|470886852|FG001|Overall Study|Adverse Event|0|||
130798487|NCT01750346|470886853|FG002|Overall Study|Adverse Event|0|||
130798488|NCT01001104|470886856|FG000|Overall Study|Adverse Event|2|||
130798489|NCT01001104|470886857|FG001|Overall Study|Adverse Event|1|||
130798490|NCT01001104|470886858|FG002|Overall Study|Adverse Event|0|||
130798491|NCT01001104|470886859|FG003|Overall Study|Adverse Event|0|||
130798492|NCT01001104|470886856|FG000|Overall Study|Lost to Follow-up|0|||
130798493|NCT01001104|470886857|FG001|Overall Study|Lost to Follow-up|0|||
130798494|NCT01001104|470886858|FG002|Overall Study|Lost to Follow-up|1|||
130798495|NCT01001104|470886859|FG003|Overall Study|Lost to Follow-up|0|||
130798496|NCT01001104|470886856|FG000|Overall Study|Entry Criteria Not Met|0|||
130798497|NCT01001104|470886857|FG001|Overall Study|Entry Criteria Not Met|0|||
130798498|NCT01001104|470886858|FG002|Overall Study|Entry Criteria Not Met|0|||
130798499|NCT01001104|470886859|FG003|Overall Study|Entry Criteria Not Met|1|||
130798500|NCT01001104|470886856|FG000|Overall Study|Withdrawal by Subject|0|||
130798501|NCT01001104|470886857|FG001|Overall Study|Withdrawal by Subject|0|||
130798502|NCT01001104|470886858|FG002|Overall Study|Withdrawal by Subject|0|||
130798503|NCT01001104|470886859|FG003|Overall Study|Withdrawal by Subject|2|||
130798504|NCT02397837|470886860|FG000|Overall Study|Withdrawal by Subject|6|||
130798505|NCT02397837|470886861|FG001|Overall Study|Withdrawal by Subject|5|||
130798506|NCT02397837|470886860|FG000|Overall Study|Physician Decision|1|||
130798507|NCT02397837|470886861|FG001|Overall Study|Physician Decision|1|||
130798508|NCT00599313|470886863|FG000|Overall Study|Adverse Event|19|||
130798509|NCT00599313|470886863|FG000|Overall Study|Disease Progression|12|||
130798510|NCT00599313|470886863|FG000|Overall Study|Patient Request|4|||
130798511|NCT00599313|470886863|FG000|Overall Study|Ineligible|1|||
130798512|NCT02536794|470886864|FG000|Reached 1st Response Assessment|Adverse Event|2|||
130798513|NCT02536794|470886864|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
130798514|NCT02536794|470886864|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
130798515|NCT02536794|470886864|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
130798516|NCT02536794|470886864|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
130798517|NCT02536794|470886864|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
130798518|NCT02362451|470886877|FG000|Overall Study|Withdrawal by Subject|0|||
130798519|NCT02362451|470886878|FG001|Overall Study|Withdrawal by Subject|1|||
130798520|NCT02362451|470886877|FG000|Overall Study|Lack of Efficacy|2|||
130798521|NCT02362451|470886878|FG001|Overall Study|Lack of Efficacy|0|||
130798522|NCT02362451|470886877|FG000|Overall Study|Progression|1|||
130798523|NCT02362451|470886878|FG001|Overall Study|Progression|0|||
130798524|NCT02362451|470886877|FG000|Overall Study|Participant chose other therapy.|1|||
130798525|NCT02362451|470886878|FG001|Overall Study|Participant chose other therapy.|0|||
130798526|NCT02115386|470886879|FG000|Overall Study|Protocol Violation|1|||
130798527|NCT02115386|470886879|FG000|Overall Study|Administrative - trial was terminated|6|||
130798528|NCT02493855|470886880|FG000|Overall Study|Non-compliance|1|||
130798529|NCT02493855|470886881|FG001|Overall Study|Non-compliance|0|||
130798530|NCT02493855|470886882|FG002|Overall Study|Non-compliance|0|||
130798531|NCT02493855|470886880|FG000|Overall Study|Adverse Event|0|||
130798532|NCT02493855|470886881|FG001|Overall Study|Adverse Event|1|||
130798533|NCT02493855|470886882|FG002|Overall Study|Adverse Event|0|||
130798534|NCT02493855|470886880|FG000|Overall Study|Withdrawal by Subject|1|||
130798535|NCT02493855|470886881|FG001|Overall Study|Withdrawal by Subject|0|||
130798536|NCT02493855|470886882|FG002|Overall Study|Withdrawal by Subject|0|||
130798537|NCT02453048|470886883|FG000|Overall Study|Only part of initial 6 mo. study|0|||
130798538|NCT02453048|470886884|FG001|Overall Study|Only part of initial 6 mo. study|0|||
130798539|NCT02453048|470886885|FG002|Overall Study|Only part of initial 6 mo. study|0|||
130798540|NCT02453048|470886886|FG003|Overall Study|Only part of initial 6 mo. study|0|||
130798541|NCT02453048|470886887|FG004|Overall Study|Only part of initial 6 mo. study|6|||
130798542|NCT02453048|470886883|FG000|Overall Study|Lost to Follow-up|0|||
130798543|NCT02453048|470886884|FG001|Overall Study|Lost to Follow-up|1|||
130798544|NCT02453048|470886885|FG002|Overall Study|Lost to Follow-up|2|||
130798545|NCT02453048|470886886|FG003|Overall Study|Lost to Follow-up|0|||
130798546|NCT02453048|470886887|FG004|Overall Study|Lost to Follow-up|0|||
130798547|NCT03086343|470886889|FG000|Period 1|Adverse Event|7|||
130798548|NCT03086343|470886890|FG001|Period 1|Adverse Event|7|||
130798549|NCT03086343|470886891|FG002|Period 1|Adverse Event|0|||
130798550|NCT03086343|470886892|FG003|Period 1|Adverse Event|1|||
130798551|NCT03086343|470886889|FG000|Period 1|Withdrawal by Subject|6|||
130798552|NCT03086343|470886890|FG001|Period 1|Withdrawal by Subject|10|||
130798553|NCT03086343|470886891|FG002|Period 1|Withdrawal by Subject|0|||
130798554|NCT03086343|470886892|FG003|Period 1|Withdrawal by Subject|0|||
130798555|NCT03086343|470886889|FG000|Period 1|Lost to Follow-up|1|||
130798556|NCT03086343|470886890|FG001|Period 1|Lost to Follow-up|3|||
130798557|NCT03086343|470886891|FG002|Period 1|Lost to Follow-up|1|||
130798558|NCT03086343|470886892|FG003|Period 1|Lost to Follow-up|0|||
130798559|NCT03086343|470886889|FG000|Period 1|Other, Not Specified|10|||
130798560|NCT03086343|470886890|FG001|Period 1|Other, Not Specified|12|||
130798561|NCT03086343|470886891|FG002|Period 1|Other, Not Specified|2|||
130798562|NCT03086343|470886892|FG003|Period 1|Other, Not Specified|1|||
130798563|NCT03086343|470886889|FG000|Period 1|Missing|1|||
130798564|NCT03086343|470886890|FG001|Period 1|Missing|0|||
130798565|NCT03086343|470886891|FG002|Period 1|Missing|0|||
130798566|NCT03086343|470886892|FG003|Period 1|Missing|0|||
130798567|NCT03086343|470886889|FG000|Period 2|Adverse Event|20|||
130798568|NCT03086343|470886890|FG001|Period 2|Adverse Event|11|||
130798569|NCT03086343|470886891|FG002|Period 2|Adverse Event|1|||
130798570|NCT03086343|470886892|FG003|Period 2|Adverse Event|2|||
130798571|NCT03086343|470886889|FG000|Period 2|Withdrawal by Subject|15|||
130798572|NCT03086343|470886890|FG001|Period 2|Withdrawal by Subject|25|||
130798573|NCT03086343|470886891|FG002|Period 2|Withdrawal by Subject|2|||
130798574|NCT03086343|470886892|FG003|Period 2|Withdrawal by Subject|2|||
130798575|NCT03086343|470886889|FG000|Period 2|Lost to Follow-up|6|||
130798576|NCT03086343|470886890|FG001|Period 2|Lost to Follow-up|11|||
130798577|NCT03086343|470886891|FG002|Period 2|Lost to Follow-up|1|||
130798578|NCT03086343|470886892|FG003|Period 2|Lost to Follow-up|0|||
130798579|NCT03086343|470886889|FG000|Period 2|COVID-19 Infection|5|||
130798580|NCT03086343|470886890|FG001|Period 2|COVID-19 Infection|0|||
130798581|NCT03086343|470886891|FG002|Period 2|COVID-19 Infection|0|||
130798582|NCT03086343|470886892|FG003|Period 2|COVID-19 Infection|0|||
130798583|NCT03086343|470886889|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
130798584|NCT03086343|470886890|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
130798585|NCT03086343|470886891|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
130798586|NCT03086343|470886892|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
130798587|NCT03086343|470886889|FG000|Period 2|Other, Not Specified|23|||
130798588|NCT03086343|470886890|FG001|Period 2|Other, Not Specified|22|||
130798589|NCT03086343|470886891|FG002|Period 2|Other, Not Specified|2|||
130798590|NCT03086343|470886892|FG003|Period 2|Other, Not Specified|4|||
130798591|NCT00800540|470886893|FG000|Period One: 6 Weeks|Noncompliance|1|||
130798592|NCT00800540|470886894|FG001|Period One: 6 Weeks|Noncompliance|0|||
130798593|NCT00800540|470886893|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
130798594|NCT00800540|470886894|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
130798595|NCT00800540|470886893|FG000|Period 2: 6 Weeks|Adverse Event|0|||
130798596|NCT00800540|470886894|FG001|Period 2: 6 Weeks|Adverse Event|1|||
130798597|NCT04398134|470886897|FG000|Overall Study|Adverse Event|0|||
130798598|NCT04398134|470886898|FG001|Overall Study|Adverse Event|0|||
130798599|NCT04398134|470886899|FG002|Overall Study|Adverse Event|1|||
130798600|NCT04398134|470886900|FG003|Overall Study|Adverse Event|0|||
130798601|NCT04398134|470886897|FG000|Overall Study|Withdrawal by Subject|2|||
130798602|NCT04398134|470886898|FG001|Overall Study|Withdrawal by Subject|0|||
130798603|NCT04398134|470886899|FG002|Overall Study|Withdrawal by Subject|0|||
130798604|NCT04398134|470886900|FG003|Overall Study|Withdrawal by Subject|1|||
130798605|NCT04398134|470886897|FG000|Overall Study|Study Terminated by Sponsor|30|||
130798606|NCT04398134|470886898|FG001|Overall Study|Study Terminated by Sponsor|11|||
130798607|NCT04398134|470886899|FG002|Overall Study|Study Terminated by Sponsor|32|||
130798608|NCT04398134|470886900|FG003|Overall Study|Study Terminated by Sponsor|11|||
130798609|NCT00153920|470886902|FG000|Overall Study|Adverse Event|9|||
130798610|NCT00153920|470886902|FG000|Overall Study|Progressive Disease|9|||
130798611|NCT00153920|470886902|FG000|Overall Study|Physician Decision|3|||
130798612|NCT00153920|470886902|FG000|Overall Study|Lack of Response|3|||
130798613|NCT00153920|470886902|FG000|Overall Study|Death|2|||
130798614|NCT00153920|470886902|FG000|Overall Study|Withdrawal by Subject|1|||
130798615|NCT00153920|470886902|FG000|Overall Study|Non-Protocol Therapy|1|||
130798616|NCT00153920|470886902|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
130798617|NCT00153920|470886902|FG000|Overall Study|Progressive Disease before Trt|1|||
130798618|NCT02202616|470886906|FG000|Overall Study|Screen failed|24|||
130798619|NCT02202616|470886906|FG000|Overall Study|Adverse Event|32|||
130798620|NCT02202616|470886906|FG000|Overall Study|Protocol deviation|18|||
130798621|NCT02202616|470886906|FG000|Overall Study|Patient withdrew consent|12|||
130798622|NCT02202616|470886906|FG000|Overall Study|Lost to Follow-up|6|||
130798623|NCT02202616|470886906|FG000|Overall Study|Administrative problems|6|||
130798624|NCT02202616|470886906|FG000|Overall Study|Abnormal test procedure result|1|||
130798625|NCT02202616|470886906|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130798626|NCT01334515|470886909|FG000|Overall Study|Adverse Event|1|||
130798627|NCT01334515|470886910|FG001|Overall Study|Adverse Event|6|||
130798628|NCT01334515|470886909|FG000|Overall Study|Death|1|||
130798629|NCT01334515|470886910|FG001|Overall Study|Death|0|||
130798630|NCT01334515|470886909|FG000|Overall Study|Lack of Efficacy|8|||
130798631|NCT01334515|470886910|FG001|Overall Study|Lack of Efficacy|21|||
130798632|NCT01334515|470886909|FG000|Overall Study|Physician Decision|1|||
130798633|NCT01334515|470886910|FG001|Overall Study|Physician Decision|1|||
130798634|NCT01334515|470886909|FG000|Overall Study|Withdrawal by Subject|1|||
130798635|NCT01334515|470886910|FG001|Overall Study|Withdrawal by Subject|1|||
130798636|NCT04327271|470886911|FG000|Overall Study|Death|1|||
130798637|NCT04327271|470886912|FG001|Overall Study|Death|0|||
130798638|NCT04327271|470886911|FG000|Overall Study|Withdrawal by Subject|1|||
130798639|NCT04327271|470886912|FG001|Overall Study|Withdrawal by Subject|0|||
130798640|NCT04327271|470886911|FG000|Overall Study|randomization error (data capture)|4|||
130798641|NCT04327271|470886912|FG001|Overall Study|randomization error (data capture)|3|||
130798642|NCT01695746|470886913|FG000|Overall Study|Adverse Event|1|||
130798643|NCT01695746|470886913|FG000|Overall Study|Non-compliance by the participant|3|||
130798644|NCT01695746|470886913|FG000|Overall Study|Protocol Violation|5|||
130798645|NCT01695746|470886913|FG000|Overall Study|Participant not willing to participate|3|||
130798646|NCT01202591|470886914|FG000|Overall Study|Adverse Event|2|||
130798647|NCT01202591|470886915|FG001|Overall Study|Adverse Event|1|||
130798648|NCT01202591|470886916|FG002|Overall Study|Adverse Event|4|||
130798649|NCT01202591|470886917|FG003|Overall Study|Adverse Event|4|||
130798650|NCT01202591|470886918|FG004|Overall Study|Adverse Event|0|||
130798651|NCT01202591|470886919|FG005|Overall Study|Adverse Event|0|||
130798652|NCT01202591|470886914|FG000|Overall Study|Other reason as per investigator|3|||
130798653|NCT01202591|470886915|FG001|Overall Study|Other reason as per investigator|4|||
130798654|NCT01202591|470886916|FG002|Overall Study|Other reason as per investigator|7|||
130798655|NCT01202591|470886917|FG003|Overall Study|Other reason as per investigator|3|||
130798656|NCT01202591|470886918|FG004|Overall Study|Other reason as per investigator|1|||
130798657|NCT01202591|470886919|FG005|Overall Study|Other reason as per investigator|3|||
130798658|NCT01202591|470886914|FG000|Overall Study|Withdrawal by Subject|0|||
130798659|NCT01202591|470886915|FG001|Overall Study|Withdrawal by Subject|0|||
130798660|NCT01202591|470886916|FG002|Overall Study|Withdrawal by Subject|0|||
130798661|NCT01202591|470886917|FG003|Overall Study|Withdrawal by Subject|0|||
130798662|NCT01202591|470886918|FG004|Overall Study|Withdrawal by Subject|2|||
130798663|NCT01202591|470886919|FG005|Overall Study|Withdrawal by Subject|1|||
130798664|NCT01202591|470886914|FG000|Overall Study|Objective Disease Progression|0|||
130798665|NCT01202591|470886915|FG001|Overall Study|Objective Disease Progression|0|||
130798666|NCT01202591|470886916|FG002|Overall Study|Objective Disease Progression|0|||
130798667|NCT01202591|470886917|FG003|Overall Study|Objective Disease Progression|0|||
130798668|NCT01202591|470886918|FG004|Overall Study|Objective Disease Progression|2|||
130798669|NCT01202591|470886919|FG005|Overall Study|Objective Disease Progression|0|||
130798670|NCT02830087|470886922|FG000|Overall Study|No study staff to follow-up patients|4|||
130798671|NCT02830087|470886923|FG001|Overall Study|No study staff to follow-up patients|4|||
130798672|NCT02830087|470886924|FG002|Overall Study|No study staff to follow-up patients|4|||
130798673|NCT02830087|470886925|FG003|Overall Study|No study staff to follow-up patients|3|||
130798674|NCT02830087|470886926|FG004|Overall Study|No study staff to follow-up patients|3|||
130798675|NCT02830087|470886927|FG005|Overall Study|No study staff to follow-up patients|3|||
130798676|NCT02583269|470886928|FG000|Overall Study|Patient hospitalized prior to start|1|||
130798677|NCT02583269|470886929|FG001|Overall Study|Patient hospitalized prior to start|0|||
130798678|NCT02583269|470886930|FG002|Overall Study|Patient hospitalized prior to start|0|||
130798679|NCT02583269|470886931|FG003|Overall Study|Patient hospitalized prior to start|0|||
130798680|NCT02583269|470886932|FG004|Overall Study|Patient hospitalized prior to start|0|||
130798681|NCT03611946|470886933|FG000|Overall Study|Withdrawal by Subject|0|||
130798682|NCT03611946|470886934|FG001|Overall Study|Withdrawal by Subject|0|||
130798683|NCT03611946|470886935|FG002|Overall Study|Withdrawal by Subject|1|||
130798684|NCT03611946|470886936|FG003|Overall Study|Withdrawal by Subject|0|||
130798685|NCT02207608|470886937|FG000|Overall Study|Adverse Event|1|||
130798686|NCT02207608|470886938|FG001|Overall Study|Adverse Event|0|||
130798687|NCT00980460|470886939|FG000|Overall Study|Death|0|||
130798688|NCT00980460|470886940|FG001|Overall Study|Death|0|||
130798689|NCT00980460|470886941|FG002|Overall Study|Death|1|||
130798690|NCT00980460|470886942|FG003|Overall Study|Death|2|||
130798691|NCT00980460|470886943|FG004|Overall Study|Death|1|||
130798692|NCT00980460|470886939|FG000|Overall Study|Lack of Efficacy|0|||
130798693|NCT00980460|470886940|FG001|Overall Study|Lack of Efficacy|0|||
130798694|NCT00980460|470886941|FG002|Overall Study|Lack of Efficacy|10|||
130798695|NCT00980460|470886942|FG003|Overall Study|Lack of Efficacy|6|||
130798696|NCT00980460|470886943|FG004|Overall Study|Lack of Efficacy|8|||
130798697|NCT00980460|470886939|FG000|Overall Study|Lost to Follow-up|0|||
130798698|NCT00980460|470886940|FG001|Overall Study|Lost to Follow-up|0|||
130798699|NCT00980460|470886941|FG002|Overall Study|Lost to Follow-up|0|||
130798700|NCT00980460|470886942|FG003|Overall Study|Lost to Follow-up|1|||
130798701|NCT00980460|470886943|FG004|Overall Study|Lost to Follow-up|0|||
130798702|NCT00980460|470886939|FG000|Overall Study|Physician Decision|0|||
130798703|NCT00980460|470886940|FG001|Overall Study|Physician Decision|0|||
130798704|NCT00980460|470886941|FG002|Overall Study|Physician Decision|11|||
130798705|NCT00980460|470886942|FG003|Overall Study|Physician Decision|5|||
130798706|NCT00980460|470886943|FG004|Overall Study|Physician Decision|3|||
130798707|NCT00980460|470886939|FG000|Overall Study|Withdrawal by Subject|0|||
130798708|NCT00980460|470886940|FG001|Overall Study|Withdrawal by Subject|0|||
130798709|NCT00980460|470886941|FG002|Overall Study|Withdrawal by Subject|1|||
130798710|NCT00980460|470886942|FG003|Overall Study|Withdrawal by Subject|0|||
130798711|NCT00980460|470886943|FG004|Overall Study|Withdrawal by Subject|0|||
130798712|NCT00980460|470886939|FG000|Overall Study|Ineligible|0|||
130798713|NCT00980460|470886940|FG001|Overall Study|Ineligible|2|||
130798714|NCT00980460|470886941|FG002|Overall Study|Ineligible|3|||
130798715|NCT00980460|470886942|FG003|Overall Study|Ineligible|1|||
130798716|NCT00980460|470886943|FG004|Overall Study|Ineligible|4|||
130798717|NCT00980460|470886939|FG000|Overall Study|Refusal of further therapy|0|||
130798718|NCT00980460|470886940|FG001|Overall Study|Refusal of further therapy|2|||
130798719|NCT00980460|470886941|FG002|Overall Study|Refusal of further therapy|3|||
130798720|NCT00980460|470886942|FG003|Overall Study|Refusal of further therapy|2|||
130798721|NCT00980460|470886943|FG004|Overall Study|Refusal of further therapy|0|||
130798722|NCT00980460|470886939|FG000|Overall Study|No therapy within 42 days of resection|0|||
130798723|NCT00980460|470886940|FG001|Overall Study|No therapy within 42 days of resection|0|||
130798724|NCT00980460|470886941|FG002|Overall Study|No therapy within 42 days of resection|3|||
130798725|NCT00980460|470886942|FG003|Overall Study|No therapy within 42 days of resection|1|||
130798726|NCT00980460|470886943|FG004|Overall Study|No therapy within 42 days of resection|0|||
130798727|NCT00980460|470886939|FG000|Overall Study|No transplant by protocol timepoints|0|||
130798728|NCT00980460|470886940|FG001|Overall Study|No transplant by protocol timepoints|0|||
130798729|NCT00980460|470886941|FG002|Overall Study|No transplant by protocol timepoints|3|||
130798730|NCT00980460|470886942|FG003|Overall Study|No transplant by protocol timepoints|0|||
130798731|NCT00980460|470886943|FG004|Overall Study|No transplant by protocol timepoints|0|||
130798732|NCT03599713|470886944|FG000|Overall Study|Death|38|||
130798733|NCT03599713|470886945|FG001|Overall Study|Death|3|||
130798734|NCT03599713|470886944|FG000|Overall Study|Withdrawal by Subject|17|||
130798735|NCT03599713|470886945|FG001|Overall Study|Withdrawal by Subject|0|||
130798736|NCT03599713|470886944|FG000|Overall Study|Lost to Follow-up|4|||
130798737|NCT03599713|470886945|FG001|Overall Study|Lost to Follow-up|0|||
130798738|NCT03599713|470886944|FG000|Overall Study|Discontinued Due to End of Study|42|||
130798739|NCT03599713|470886945|FG001|Overall Study|Discontinued Due to End of Study|3|||
130798740|NCT05800145|470886946|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
130798741|NCT05800145|470886947|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130798742|NCT05800145|470886948|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130798743|NCT05800145|470886949|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
130798744|NCT05800145|470886950|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130798745|NCT05800145|470886951|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130798746|NCT05800145|470886946|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
130798747|NCT05800145|470886947|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130798748|NCT05800145|470886948|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130798749|NCT05800145|470886949|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
130798750|NCT05800145|470886950|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130798751|NCT05800145|470886951|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130798752|NCT05800145|470886946|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
130798753|NCT05800145|470886947|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
130798754|NCT05800145|470886948|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
130798755|NCT05800145|470886949|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
130798756|NCT05800145|470886950|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
130798757|NCT05800145|470886951|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
130798758|NCT02850406|470886952|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
130798759|NCT02850406|470886953|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
130798760|NCT02850406|470886954|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
130798761|NCT02850406|470886955|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
130798762|NCT02850406|470886956|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
130798763|NCT02850406|470886957|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
130798764|NCT02850406|470886958|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
130798765|NCT02850406|470886959|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
130798766|NCT02850406|470886952|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130798767|NCT02850406|470886953|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130798768|NCT02850406|470886954|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
130798769|NCT02850406|470886955|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
130798770|NCT02850406|470886956|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130798771|NCT02850406|470886957|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130798772|NCT02850406|470886958|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130798773|NCT02850406|470886959|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130798774|NCT02850406|470886952|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130798775|NCT02850406|470886953|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130798776|NCT02850406|470886954|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
130798777|NCT02850406|470886955|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130798778|NCT02850406|470886956|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130798779|NCT02850406|470886957|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130798780|NCT02850406|470886958|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130798781|NCT02850406|470886959|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130798782|NCT02850406|470886952|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
130798783|NCT02850406|470886953|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
130798784|NCT02850406|470886954|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
130798785|NCT02850406|470886955|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
130798786|NCT02850406|470886956|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
130798787|NCT02850406|470886957|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
130798788|NCT02850406|470886958|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
130798789|NCT02850406|470886959|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
130798790|NCT02850406|470886952|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
130798791|NCT02850406|470886953|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
130798792|NCT02850406|470886954|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
130798793|NCT02850406|470886955|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
130798794|NCT02850406|470886956|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
130798795|NCT02850406|470886957|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
130798796|NCT02850406|470886958|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
130798797|NCT02850406|470886959|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
130798798|NCT02850406|470886952|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798799|NCT02850406|470886953|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798800|NCT02850406|470886954|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798801|NCT02850406|470886955|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798802|NCT02850406|470886956|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
130798803|NCT02850406|470886957|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
130798804|NCT02850406|470886958|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798805|NCT02850406|470886959|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798806|NCT02850406|470886952|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
130798807|NCT02850406|470886953|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
130798808|NCT02850406|470886954|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
130798809|NCT02850406|470886955|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
130798810|NCT02850406|470886956|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
130798811|NCT02850406|470886957|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
130798812|NCT02850406|470886958|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
130798813|NCT02850406|470886959|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
130798814|NCT02850406|470886952|FG000|Part C (Up to 52 Weeks)|Other|0|||
130798815|NCT02850406|470886953|FG001|Part C (Up to 52 Weeks)|Other|0|||
130798816|NCT02850406|470886954|FG002|Part C (Up to 52 Weeks)|Other|0|||
130798817|NCT02850406|470886955|FG003|Part C (Up to 52 Weeks)|Other|0|||
130798818|NCT02850406|470886956|FG004|Part C (Up to 52 Weeks)|Other|1|||
130798819|NCT02850406|470886957|FG005|Part C (Up to 52 Weeks)|Other|3|||
130798820|NCT02850406|470886958|FG006|Part C (Up to 52 Weeks)|Other|0|||
130798821|NCT02850406|470886959|FG007|Part C (Up to 52 Weeks)|Other|0|||
130798822|NCT02850406|470886952|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
130798823|NCT02850406|470886953|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
130798824|NCT02850406|470886954|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
130798825|NCT02850406|470886955|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
130798826|NCT02850406|470886956|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
130798827|NCT02850406|470886957|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
130798828|NCT02850406|470886958|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
130798829|NCT02850406|470886959|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
130798830|NCT02850406|470886952|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130763288|NCT02987972|470755923|FG000|Overall Study|Death|1|||
130763289|NCT02987972|470755924|FG001|Overall Study|Death|0|||
130763290|NCT02987972|470755925|FG002|Overall Study|Death|0|||
130763291|NCT02987972|470755923|FG000|Overall Study|Lack of Efficacy|9|||
130763292|NCT02987972|470755924|FG001|Overall Study|Lack of Efficacy|12|||
130763293|NCT02987972|470755925|FG002|Overall Study|Lack of Efficacy|12|||
130763294|NCT02987972|470755923|FG000|Overall Study|Lost to Follow-up|7|||
130763295|NCT02987972|470755924|FG001|Overall Study|Lost to Follow-up|8|||
130763296|NCT02987972|470755925|FG002|Overall Study|Lost to Follow-up|4|||
130763297|NCT02987972|470755923|FG000|Overall Study|Physician Decision|1|||
130763298|NCT02987972|470755924|FG001|Overall Study|Physician Decision|6|||
130763299|NCT02987972|470755925|FG002|Overall Study|Physician Decision|0|||
130763300|NCT02987972|470755923|FG000|Overall Study|Protocol Violation|2|||
130763301|NCT02987972|470755924|FG001|Overall Study|Protocol Violation|1|||
130763302|NCT02987972|470755925|FG002|Overall Study|Protocol Violation|5|||
130763303|NCT02987972|470755923|FG000|Overall Study|Withdrawal by Subject|22|||
130763304|NCT02987972|470755924|FG001|Overall Study|Withdrawal by Subject|17|||
130763305|NCT02987972|470755925|FG002|Overall Study|Withdrawal by Subject|21|||
130763306|NCT00073983|470755928|FG000|Overall Study|not evaluable|1|||
130763307|NCT03800836|470755929|FG000|Overall Study|Other|2|||
130763308|NCT03800836|470755930|FG001|Overall Study|Other|1|||
130763309|NCT03800836|470755931|FG002|Overall Study|Other|0|||
130763310|NCT03800836|470755932|FG003|Overall Study|Other|2|||
130763311|NCT03800836|470755933|FG004|Overall Study|Other|0|||
130763312|NCT03800836|470755934|FG005|Overall Study|Other|1|||
130763313|NCT03800836|470755929|FG000|Overall Study|Lost to Follow-up|2|||
130763314|NCT03800836|470755930|FG001|Overall Study|Lost to Follow-up|0|||
130763315|NCT03800836|470755931|FG002|Overall Study|Lost to Follow-up|1|||
130763316|NCT03800836|470755932|FG003|Overall Study|Lost to Follow-up|1|||
130763317|NCT03800836|470755933|FG004|Overall Study|Lost to Follow-up|3|||
130763318|NCT03800836|470755934|FG005|Overall Study|Lost to Follow-up|0|||
130763319|NCT03800836|470755929|FG000|Overall Study|Withdrawal by Subject|1|||
130763320|NCT03800836|470755930|FG001|Overall Study|Withdrawal by Subject|0|||
130763321|NCT03800836|470755931|FG002|Overall Study|Withdrawal by Subject|0|||
130763322|NCT03800836|470755932|FG003|Overall Study|Withdrawal by Subject|0|||
130763323|NCT03800836|470755933|FG004|Overall Study|Withdrawal by Subject|0|||
130763324|NCT03800836|470755934|FG005|Overall Study|Withdrawal by Subject|0|||
130763325|NCT03800836|470755929|FG000|Overall Study|Physician Decision|31|||
130763326|NCT03800836|470755930|FG001|Overall Study|Physician Decision|3|||
130763327|NCT03800836|470755931|FG002|Overall Study|Physician Decision|6|||
130763328|NCT03800836|470755932|FG003|Overall Study|Physician Decision|4|||
130763329|NCT03800836|470755933|FG004|Overall Study|Physician Decision|4|||
130763330|NCT03800836|470755934|FG005|Overall Study|Physician Decision|5|||
130763331|NCT03800836|470755929|FG000|Overall Study|Death|34|||
130763332|NCT03800836|470755930|FG001|Overall Study|Death|16|||
130763333|NCT03800836|470755931|FG002|Overall Study|Death|5|||
130763334|NCT03800836|470755932|FG003|Overall Study|Death|5|||
130763335|NCT03800836|470755933|FG004|Overall Study|Death|10|||
130763336|NCT03800836|470755934|FG005|Overall Study|Death|0|||
130798831|NCT02850406|470886953|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798832|NCT02850406|470886954|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798833|NCT02850406|470886955|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798834|NCT02850406|470886956|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798835|NCT02850406|470886957|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798836|NCT02850406|470886958|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130798837|NCT02850406|470886959|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
130798838|NCT02850406|470886952|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
130798839|NCT02850406|470886953|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
130798840|NCT02850406|470886954|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
130798841|NCT02850406|470886955|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
130798842|NCT02850406|470886956|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
130798843|NCT02850406|470886957|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
130798844|NCT02850406|470886958|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
130798845|NCT02850406|470886959|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
130798846|NCT02850406|470886952|FG000|Part D (Up to 52 Weeks)|Other|0|||
130798847|NCT02850406|470886953|FG001|Part D (Up to 52 Weeks)|Other|0|||
130798848|NCT02850406|470886954|FG002|Part D (Up to 52 Weeks)|Other|0|||
130798849|NCT02850406|470886955|FG003|Part D (Up to 52 Weeks)|Other|0|||
130798850|NCT02850406|470886956|FG004|Part D (Up to 52 Weeks)|Other|0|||
130798851|NCT02850406|470886957|FG005|Part D (Up to 52 Weeks)|Other|0|||
130798852|NCT02850406|470886958|FG006|Part D (Up to 52 Weeks)|Other|0|||
130798853|NCT02850406|470886959|FG007|Part D (Up to 52 Weeks)|Other|1|||
130798854|NCT01373229|470888150|FG000|Overall Study|Death|3|||
130798855|NCT01373229|470888150|FG000|Overall Study|Physician Decision|3|||
130798856|NCT00143507|470888152|FG000|Overall Study|Death|572|||
130798857|NCT00143507|470888153|FG001|Overall Study|Death|547|||
130798858|NCT00143507|470888152|FG000|Overall Study|Withdrawal by Subject|114|||
130798859|NCT00143507|470888153|FG001|Overall Study|Withdrawal by Subject|102|||
130798860|NCT00143507|470888152|FG000|Overall Study|Lost to Follow-up|1|||
130798861|NCT00143507|470888153|FG001|Overall Study|Lost to Follow-up|0|||
130798862|NCT00143507|470888152|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
130798863|NCT00143507|470888153|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
130798864|NCT00587457|470888154|FG000|Overall Study|Adverse Event|1|||
130798865|NCT00587457|470888155|FG001|Overall Study|Adverse Event|2|||
130798866|NCT00587457|470888156|FG002|Overall Study|Adverse Event|1|||
130798867|NCT00587457|470888154|FG000|Overall Study|Disease progression|2|||
130798868|NCT00587457|470888155|FG001|Overall Study|Disease progression|0|||
130798869|NCT00587457|470888156|FG002|Overall Study|Disease progression|2|||
130798870|NCT00587457|470888154|FG000|Overall Study|Initiation of alternative therapy|0|||
130798871|NCT00587457|470888155|FG001|Overall Study|Initiation of alternative therapy|1|||
130798872|NCT00587457|470888156|FG002|Overall Study|Initiation of alternative therapy|0|||
130798873|NCT00587457|470888154|FG000|Overall Study|Undefined|0|||
130798874|NCT00587457|470888155|FG001|Overall Study|Undefined|0|||
130798875|NCT00587457|470888156|FG002|Overall Study|Undefined|1|||
130798876|NCT00587457|470888154|FG000|Overall Study|Development of neutralizing Abs|0|||
130798877|NCT00587457|470888155|FG001|Overall Study|Development of neutralizing Abs|0|||
130798878|NCT00587457|470888156|FG002|Overall Study|Development of neutralizing Abs|1|||
130798879|NCT03234881|470888157|FG000|Overall Study|Lost to Follow-up|9|||
130798880|NCT03234881|470888158|FG001|Overall Study|Lost to Follow-up|3|||
130798881|NCT00876395|470888159|FG000|Overall Study|Untreated|8|||
130798882|NCT00876395|470888160|FG001|Overall Study|Untreated|1|||
130798883|NCT00876395|470888159|FG000|Overall Study|Adverse Event|63|||
130798884|NCT00876395|470888160|FG001|Overall Study|Adverse Event|11|||
130798885|NCT00876395|470888159|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130798886|NCT00876395|470888160|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130798887|NCT00876395|470888159|FG000|Overall Study|Disease progression|259|||
130798888|NCT00876395|470888160|FG001|Overall Study|Disease progression|162|||
130798889|NCT00876395|470888159|FG000|Overall Study|New cancer therapy|25|||
130798890|NCT00876395|470888160|FG001|Overall Study|New cancer therapy|7|||
130798891|NCT00876395|470888159|FG000|Overall Study|Protocol Violation|5|||
130798892|NCT00876395|470888160|FG001|Overall Study|Protocol Violation|2|||
130798893|NCT00876395|470888159|FG000|Overall Study|Withdrawal by Subject|66|||
130798894|NCT00876395|470888160|FG001|Overall Study|Withdrawal by Subject|33|||
130798895|NCT00876395|470888159|FG000|Overall Study|Lost to Follow-up|2|||
130798896|NCT00876395|470888160|FG001|Overall Study|Lost to Follow-up|0|||
130798897|NCT00876395|470888159|FG000|Overall Study|Administrative problems|39|||
130798898|NCT00876395|470888160|FG001|Overall Study|Administrative problems|23|||
130798899|NCT00876395|470888159|FG000|Overall Study|Death|12|||
130798900|NCT00876395|470888160|FG001|Overall Study|Death|0|||
130798901|NCT03807843|470888161|FG000|Overall Study|Lost to Follow-up|1|||
130798902|NCT03807843|470888162|FG001|Overall Study|Lost to Follow-up|0|||
130798903|NCT01312129|470888163|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
130798904|NCT01312129|470888164|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
130798905|NCT00924651|470888167|FG000|Overall Study|Chemo started too soon|2|||
130798906|NCT00924651|470888168|FG001|Overall Study|Chemo started too soon|3|||
130798907|NCT00924651|470888167|FG000|Overall Study|No Reason|3|||
130798908|NCT00924651|470888168|FG001|Overall Study|No Reason|7|||
130798909|NCT00924651|470888167|FG000|Overall Study|Overwhelmed|6|||
130798910|NCT00924651|470888168|FG001|Overall Study|Overwhelmed|6|||
130798911|NCT00924651|470888167|FG000|Overall Study|Noncompliant|1|||
130798912|NCT00924651|470888168|FG001|Overall Study|Noncompliant|4|||
130798913|NCT00924651|470888167|FG000|Overall Study|Medical|1|||
130798914|NCT00924651|470888168|FG001|Overall Study|Medical|3|||
130798915|NCT00924651|470888167|FG000|Overall Study|Changed Mind|10|||
130798916|NCT00924651|470888168|FG001|Overall Study|Changed Mind|1|||
130798917|NCT00924651|470888167|FG000|Overall Study|Incomplete Form|2|||
130798918|NCT00924651|470888168|FG001|Overall Study|Incomplete Form|1|||
130798919|NCT00729586|470888169|FG000|Overall Study|Ineligible|0|||
130798920|NCT00729586|470888170|FG001|Overall Study|Ineligible|1|||
130798921|NCT00729586|470888169|FG000|Overall Study|never treated|1|||
130798922|NCT00729586|470888170|FG001|Overall Study|never treated|0|||
130798923|NCT01991314|470888171|FG000|Overall Study|Adverse Event|5|||
130798924|NCT01991314|470888172|FG001|Overall Study|Adverse Event|1|||
130798925|NCT01991314|470888171|FG000|Overall Study|Lost to Follow-up|6|||
130798926|NCT01991314|470888172|FG001|Overall Study|Lost to Follow-up|10|||
130798927|NCT00972738|470888174|FG000|Overall Study|Adverse Event|7|||
130798928|NCT00972738|470888175|FG001|Overall Study|Adverse Event|1|||
130798929|NCT00972738|470888176|FG002|Overall Study|Adverse Event|8|||
130798930|NCT00972738|470888174|FG000|Overall Study|Protocol Violation|2|||
130798931|NCT00972738|470888175|FG001|Overall Study|Protocol Violation|1|||
130798932|NCT00972738|470888176|FG002|Overall Study|Protocol Violation|3|||
130798933|NCT00972738|470888174|FG000|Overall Study|Lost to Follow-up|1|||
130798934|NCT00972738|470888175|FG001|Overall Study|Lost to Follow-up|0|||
130798935|NCT00972738|470888176|FG002|Overall Study|Lost to Follow-up|1|||
130798936|NCT00972738|470888174|FG000|Overall Study|Lack of Efficacy|5|||
130798937|NCT00972738|470888175|FG001|Overall Study|Lack of Efficacy|1|||
130798938|NCT00972738|470888176|FG002|Overall Study|Lack of Efficacy|11|||
130798939|NCT00972738|470888174|FG000|Overall Study|Withdrawal by Subject|5|||
130798940|NCT00972738|470888175|FG001|Overall Study|Withdrawal by Subject|1|||
130798941|NCT00972738|470888176|FG002|Overall Study|Withdrawal by Subject|4|||
130798942|NCT00972738|470888174|FG000|Overall Study|Moved|0|||
130798943|NCT00972738|470888175|FG001|Overall Study|Moved|0|||
130798944|NCT00972738|470888176|FG002|Overall Study|Moved|1|||
130798945|NCT00972738|470888174|FG000|Overall Study|Other|1|||
130798946|NCT00972738|470888175|FG001|Overall Study|Other|2|||
130798947|NCT00972738|470888176|FG002|Overall Study|Other|1|||
130798948|NCT03915067|470888177|FG000|Overall Study|Adverse Event|0|||
130798949|NCT03915067|470888178|FG001|Overall Study|Adverse Event|0|||
130798950|NCT03915067|470888179|FG002|Overall Study|Adverse Event|1|||
130798951|NCT03915067|470888177|FG000|Overall Study|Withdrawal by Subject|4|||
130798952|NCT03915067|470888178|FG001|Overall Study|Withdrawal by Subject|3|||
130798953|NCT03915067|470888179|FG002|Overall Study|Withdrawal by Subject|0|||
130798954|NCT03915067|470888177|FG000|Overall Study|Lost to Follow-up|3|||
130798955|NCT03915067|470888178|FG001|Overall Study|Lost to Follow-up|2|||
130798956|NCT03915067|470888179|FG002|Overall Study|Lost to Follow-up|0|||
130798957|NCT03915067|470888177|FG000|Overall Study|Protocol Deviation|0|||
130798958|NCT03915067|470888178|FG001|Overall Study|Protocol Deviation|0|||
130798959|NCT03915067|470888179|FG002|Overall Study|Protocol Deviation|1|||
130798960|NCT03915067|470888177|FG000|Overall Study|Covid-19 Related Issues|2|||
130798961|NCT03915067|470888178|FG001|Overall Study|Covid-19 Related Issues|4|||
130798962|NCT03915067|470888179|FG002|Overall Study|Covid-19 Related Issues|4|||
130798963|NCT03915067|470888177|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
130798964|NCT03915067|470888178|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
130798965|NCT03915067|470888179|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
130798966|NCT02260986|470888187|FG000|Overall Study|Adverse Event|24|||
130798967|NCT02260986|470888188|FG001|Overall Study|Adverse Event|0|||
130798968|NCT02260986|470888189|FG002|Overall Study|Adverse Event|11|||
130798969|NCT02260986|470888187|FG000|Overall Study|Lack of Efficacy|27|||
130798970|NCT02260986|470888188|FG001|Overall Study|Lack of Efficacy|3|||
130798971|NCT02260986|470888189|FG002|Overall Study|Lack of Efficacy|0|||
130798972|NCT02260986|470888187|FG000|Overall Study|Protocol Violation|14|||
130798973|NCT02260986|470888188|FG001|Overall Study|Protocol Violation|5|||
130798974|NCT02260986|470888189|FG002|Overall Study|Protocol Violation|16|||
130798975|NCT02260986|470888187|FG000|Overall Study|Car accident|0|||
130798976|NCT02260986|470888188|FG001|Overall Study|Car accident|0|||
130798977|NCT02260986|470888189|FG002|Overall Study|Car accident|1|||
130798978|NCT02260986|470888187|FG000|Overall Study|Withdrawal by Subject|17|||
130798979|NCT02260986|470888188|FG001|Overall Study|Withdrawal by Subject|4|||
130798980|NCT02260986|470888189|FG002|Overall Study|Withdrawal by Subject|9|||
130798981|NCT02260986|470888187|FG000|Overall Study|Incorrect randomization|0|||
130798982|NCT02260986|470888188|FG001|Overall Study|Incorrect randomization|1|||
130798983|NCT02260986|470888189|FG002|Overall Study|Incorrect randomization|0|||
130798984|NCT02260986|470888187|FG000|Overall Study|Lack of investigation product supply|2|||
130798985|NCT02260986|470888188|FG001|Overall Study|Lack of investigation product supply|0|||
130798986|NCT02260986|470888189|FG002|Overall Study|Lack of investigation product supply|1|||
130798987|NCT02260986|470888187|FG000|Overall Study|Lost to Follow-up|4|||
130798988|NCT02260986|470888188|FG001|Overall Study|Lost to Follow-up|0|||
130798989|NCT02260986|470888189|FG002|Overall Study|Lost to Follow-up|3|||
130798990|NCT02260986|470888187|FG000|Overall Study|Pregnancy|2|||
130798991|NCT02260986|470888188|FG001|Overall Study|Pregnancy|0|||
130798992|NCT02260986|470888189|FG002|Overall Study|Pregnancy|0|||
130798993|NCT02034591|470888192|FG000|Overall Study|Withdrawal by Subject|0|||
130798994|NCT02034591|470888193|FG001|Overall Study|Withdrawal by Subject|0|||
130798995|NCT02034591|470888194|FG002|Overall Study|Withdrawal by Subject|0|||
130798996|NCT02034591|470888195|FG003|Overall Study|Withdrawal by Subject|0|||
130798997|NCT02034591|470888196|FG004|Overall Study|Withdrawal by Subject|1|||
130798998|NCT02034591|470888197|FG005|Overall Study|Withdrawal by Subject|0|||
130798999|NCT01793935|470888200|FG000|Overall Study|Pregnancy|1|||
130799000|NCT01793935|470888201|FG001|Overall Study|Pregnancy|0|||
130799001|NCT01793935|470888200|FG000|Overall Study|Protocol Violation|2|||
130799002|NCT01793935|470888201|FG001|Overall Study|Protocol Violation|1|||
130799003|NCT01793935|470888200|FG000|Overall Study|Adverse Event|2|||
130799004|NCT01793935|470888201|FG001|Overall Study|Adverse Event|0|||
130799005|NCT01793935|470888200|FG000|Overall Study|Patient did not take study medication|1|||
130799006|NCT01793935|470888201|FG001|Overall Study|Patient did not take study medication|1|||
130799007|NCT01793935|470888200|FG000|Overall Study|Lost to Follow-up|0|||
130799008|NCT01793935|470888201|FG001|Overall Study|Lost to Follow-up|1|||
130799009|NCT01121926|470888202|FG000|First Intervention Period|Adverse Event|1|||
130799010|NCT01121926|470888203|FG001|First Intervention Period|Adverse Event|0|||
130799011|NCT01121926|470888202|FG000|Washout Period|Adverse Event|0|||
130799012|NCT01121926|470888203|FG001|Washout Period|Adverse Event|1|||
130799013|NCT01121926|470888202|FG000|Washout Period|Positive pregnancy test|0|||
130799014|NCT01121926|470888203|FG001|Washout Period|Positive pregnancy test|1|||
130799015|NCT00416949|470888205|FG000|Overall Study|Patients refused to participate|5|||
130799016|NCT02782468|470888206|FG000|Overall Study|Progressive Disease|2|||
130799017|NCT02782468|470888207|FG001|Overall Study|Progressive Disease|5|||
130799018|NCT02782468|470888208|FG002|Overall Study|Progressive Disease|0|||
130799019|NCT02782468|470888209|FG003|Overall Study|Progressive Disease|4|||
130799020|NCT02782468|470888206|FG000|Overall Study|Adverse Event|0|||
130799021|NCT02782468|470888207|FG001|Overall Study|Adverse Event|2|||
130799022|NCT02782468|470888208|FG002|Overall Study|Adverse Event|2|||
130799023|NCT02782468|470888209|FG003|Overall Study|Adverse Event|3|||
130799024|NCT02782468|470888206|FG000|Overall Study|Other|0|||
130799025|NCT02782468|470888207|FG001|Overall Study|Other|0|||
130799026|NCT02782468|470888208|FG002|Overall Study|Other|1|||
130799027|NCT02782468|470888209|FG003|Overall Study|Other|1|||
130799028|NCT02782468|470888206|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
130799029|NCT02782468|470888207|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
130799030|NCT02782468|470888208|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
130799031|NCT02782468|470888209|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
130799032|NCT02782468|470888206|FG000|Overall Study|Symptomatic Deterioration|0|||
130799033|NCT02782468|470888207|FG001|Overall Study|Symptomatic Deterioration|0|||
130799034|NCT02782468|470888208|FG002|Overall Study|Symptomatic Deterioration|0|||
130799035|NCT02782468|470888209|FG003|Overall Study|Symptomatic Deterioration|1|||
130799036|NCT02782468|470888206|FG000|Overall Study|Withdrawal by Subject|1|||
130799037|NCT02782468|470888207|FG001|Overall Study|Withdrawal by Subject|0|||
130799038|NCT02782468|470888208|FG002|Overall Study|Withdrawal by Subject|0|||
130799039|NCT02782468|470888209|FG003|Overall Study|Withdrawal by Subject|0|||
130799040|NCT00313170|470888210|FG000|Overall Study|Death|2|||
130799041|NCT00313170|470888211|FG001|Overall Study|Death|4|||
130799042|NCT00313170|470888212|FG002|Overall Study|Death|2|||
130799043|NCT00313170|470888210|FG000|Overall Study|Adverse Event|1|||
130799044|NCT00313170|470888211|FG001|Overall Study|Adverse Event|2|||
130799045|NCT00313170|470888212|FG002|Overall Study|Adverse Event|0|||
130799046|NCT00313170|470888210|FG000|Overall Study|Disease progression|31|||
130799047|NCT00313170|470888211|FG001|Overall Study|Disease progression|26|||
130799048|NCT00313170|470888212|FG002|Overall Study|Disease progression|27|||
130799049|NCT00313170|470888210|FG000|Overall Study|Withdrawal by Subject|1|||
130799050|NCT00313170|470888211|FG001|Overall Study|Withdrawal by Subject|0|||
130799051|NCT00313170|470888212|FG002|Overall Study|Withdrawal by Subject|1|||
130799052|NCT00313170|470888210|FG000|Overall Study|Incorrect enrollment|0|||
130799053|NCT00313170|470888211|FG001|Overall Study|Incorrect enrollment|2|||
130799054|NCT00313170|470888212|FG002|Overall Study|Incorrect enrollment|1|||
130799055|NCT00313170|470888210|FG000|Overall Study|Lost to Follow-up|0|||
130799056|NCT00313170|470888211|FG001|Overall Study|Lost to Follow-up|0|||
130799057|NCT00313170|470888212|FG002|Overall Study|Lost to Follow-up|1|||
130799058|NCT00313170|470888210|FG000|Overall Study|Progression (investigators opinion)|1|||
130799059|NCT00313170|470888211|FG001|Overall Study|Progression (investigators opinion)|0|||
130799060|NCT00313170|470888212|FG002|Overall Study|Progression (investigators opinion)|0|||
130799061|NCT00356590|470888214|FG000|Overall Study|Adverse Event|54|||
130799062|NCT00356590|470888214|FG000|Overall Study|Death|10|||
130799063|NCT00356590|470888214|FG000|Overall Study|Lost to Follow-up|35|||
130799064|NCT00356590|470888214|FG000|Overall Study|Physician Decision|46|||
130799065|NCT00356590|470888214|FG000|Overall Study|Withdrawal by Subject|41|||
130799066|NCT00356590|470888214|FG000|Overall Study|Completed month 12 only|2|||
130799067|NCT00356590|470888214|FG000|Overall Study|Protocol issues|6|||
130799068|NCT00356590|470888214|FG000|Overall Study|Response status|28|||
130799069|NCT00356590|470888214|FG000|Overall Study|Other|52|||
130799070|NCT01482221|470888219|FG000|Overall Study|Lack of Efficacy|1|||
130799071|NCT01482221|470888220|FG001|Overall Study|Lack of Efficacy|0|||
130799072|NCT01482221|470888221|FG002|Overall Study|Lack of Efficacy|1|||
130799073|NCT01482221|470888219|FG000|Overall Study|Lost to Follow-up|3|||
130799074|NCT01482221|470888220|FG001|Overall Study|Lost to Follow-up|2|||
130799075|NCT01482221|470888221|FG002|Overall Study|Lost to Follow-up|1|||
130799076|NCT01482221|470888219|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
130799077|NCT01482221|470888220|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
130799078|NCT01482221|470888221|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
130799079|NCT01482221|470888219|FG000|Overall Study|Condition under Investigation Worsened|3|||
130799080|NCT01482221|470888220|FG001|Overall Study|Condition under Investigation Worsened|2|||
130799081|NCT01482221|470888221|FG002|Overall Study|Condition under Investigation Worsened|4|||
130799082|NCT01482221|470888219|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
130799083|NCT01482221|470888220|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
130799084|NCT01482221|470888221|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
130799085|NCT01482221|470888219|FG000|Overall Study|Adverse Event|1|||
130799086|NCT01482221|470888220|FG001|Overall Study|Adverse Event|7|||
130799087|NCT01482221|470888221|FG002|Overall Study|Adverse Event|3|||
130799088|NCT01482221|470888219|FG000|Overall Study|Withdrawal by Subject|10|||
130799089|NCT01482221|470888220|FG001|Overall Study|Withdrawal by Subject|7|||
130799090|NCT01482221|470888221|FG002|Overall Study|Withdrawal by Subject|12|||
130799091|NCT01482221|470888219|FG000|Overall Study|Incorrect randomization|0|||
130799092|NCT01482221|470888220|FG001|Overall Study|Incorrect randomization|1|||
130799093|NCT01482221|470888221|FG002|Overall Study|Incorrect randomization|0|||
130799094|NCT01482221|470888219|FG000|Overall Study|Physician Decision|0|||
130799095|NCT01482221|470888220|FG001|Overall Study|Physician Decision|1|||
130799096|NCT01482221|470888221|FG002|Overall Study|Physician Decision|0|||
130799097|NCT05607043|470888223|FG000|Overall Study|Lost to Follow-up|2|||
130799098|NCT00741611|470888224|FG000|Overall Study|Death|0|||
130799099|NCT00741611|470888225|FG001|Overall Study|Death|0|||
130799100|NCT00741611|470888226|FG002|Overall Study|Death|1|||
130799101|NCT00741611|470888224|FG000|Overall Study|Withdrawal by Subject|0|||
130799102|NCT00741611|470888225|FG001|Overall Study|Withdrawal by Subject|2|||
130799103|NCT00741611|470888226|FG002|Overall Study|Withdrawal by Subject|2|||
130799104|NCT01922011|470888232|FG000|Overall Study|Protocol Violation|0|||
130799105|NCT01922011|470888233|FG001|Overall Study|Protocol Violation|1|||
130799106|NCT01922011|470888232|FG000|Overall Study|Physician Decision|0|||
130799107|NCT01922011|470888233|FG001|Overall Study|Physician Decision|1|||
130799108|NCT01922011|470888232|FG000|Overall Study|Parent/Guardian Decision|3|||
130799109|NCT01922011|470888233|FG001|Overall Study|Parent/Guardian Decision|0|||
130799110|NCT01922011|470888232|FG000|Overall Study|Lost to Follow-up|0|||
130799111|NCT01922011|470888233|FG001|Overall Study|Lost to Follow-up|1|||
130799112|NCT01922011|470888232|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
130799113|NCT01922011|470888233|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
130799114|NCT01922011|470888232|FG000|Overall Study|Not Treated|1|||
130799115|NCT01922011|470888233|FG001|Overall Study|Not Treated|0|||
130799116|NCT01922011|470888232|FG000|Overall Study|Lack of willing home health agency|1|||
130799117|NCT01922011|470888233|FG001|Overall Study|Lack of willing home health agency|0|||
130799118|NCT01922011|470888232|FG000|Overall Study|Randomized in error|1|||
130799119|NCT01922011|470888233|FG001|Overall Study|Randomized in error|0|||
130799120|NCT01479530|470888235|FG000|Overall Study|Adverse Event|5|||
130799121|NCT01479530|470888236|FG001|Overall Study|Adverse Event|6|||
130799122|NCT01479530|470888235|FG000|Overall Study|Lack of Efficacy|0|||
130799123|NCT01479530|470888236|FG001|Overall Study|Lack of Efficacy|1|||
130799124|NCT01479530|470888235|FG000|Overall Study|Protocol Violation|2|||
130799125|NCT01479530|470888236|FG001|Overall Study|Protocol Violation|3|||
130799126|NCT01479530|470888235|FG000|Overall Study|Withdrawal of Consent|3|||
130799127|NCT01479530|470888236|FG001|Overall Study|Withdrawal of Consent|2|||
130799128|NCT00303628|470888237|FG000|Overall Study|Disease progression|0|||
130799129|NCT00303628|470888238|FG001|Overall Study|Disease progression|1|||
130799130|NCT00303628|470888237|FG000|Overall Study|Adverse Event|26|||
130799131|NCT00303628|470888238|FG001|Overall Study|Adverse Event|36|||
130799132|NCT00303628|470888237|FG000|Overall Study|Death|0|||
130799133|NCT00303628|470888238|FG001|Overall Study|Death|1|||
130799134|NCT00303628|470888237|FG000|Overall Study|Withdrawal by Subject|11|||
130799135|NCT00303628|470888238|FG001|Overall Study|Withdrawal by Subject|20|||
130799136|NCT00303628|470888237|FG000|Overall Study|Alternative therapy|2|||
130799137|NCT00303628|470888238|FG001|Overall Study|Alternative therapy|0|||
130799138|NCT00303628|470888237|FG000|Overall Study|Other complicating disease|0|||
130799139|NCT00303628|470888238|FG001|Overall Study|Other complicating disease|1|||
130799140|NCT00303628|470888237|FG000|Overall Study|Not start protocol therapy|3|||
130799141|NCT00303628|470888238|FG001|Overall Study|Not start protocol therapy|5|||
130799142|NCT00303628|470888237|FG000|Overall Study|Other|8|||
130799143|NCT00303628|470888238|FG001|Overall Study|Other|9|||
130799144|NCT01666652|470888239|FG000|Overall Study|Serious Adverse Event|0|||
130799145|NCT01666652|470888240|FG001|Overall Study|Serious Adverse Event|0|||
130799146|NCT01666652|470888241|FG002|Overall Study|Serious Adverse Event|0|||
130799147|NCT01666652|470888242|FG003|Overall Study|Serious Adverse Event|1|||
130799148|NCT01666652|470888243|FG004|Overall Study|Serious Adverse Event|0|||
130799149|NCT01666652|470888239|FG000|Overall Study|Withdrawal by Subject|0|||
130799150|NCT01666652|470888240|FG001|Overall Study|Withdrawal by Subject|0|||
130799151|NCT01666652|470888241|FG002|Overall Study|Withdrawal by Subject|0|||
130799152|NCT01666652|470888242|FG003|Overall Study|Withdrawal by Subject|0|||
130799153|NCT01666652|470888243|FG004|Overall Study|Withdrawal by Subject|1|||
130799154|NCT01666652|470888239|FG000|Overall Study|Moved from study area|1|||
130799155|NCT01666652|470888240|FG001|Overall Study|Moved from study area|0|||
130799156|NCT01666652|470888241|FG002|Overall Study|Moved from study area|0|||
130799157|NCT01666652|470888242|FG003|Overall Study|Moved from study area|2|||
130799158|NCT01666652|470888243|FG004|Overall Study|Moved from study area|0|||
130799159|NCT01666652|470888239|FG000|Overall Study|Lost to Follow-up|1|||
130799160|NCT01666652|470888240|FG001|Overall Study|Lost to Follow-up|1|||
130799161|NCT01666652|470888241|FG002|Overall Study|Lost to Follow-up|1|||
130799162|NCT01666652|470888242|FG003|Overall Study|Lost to Follow-up|1|||
130799163|NCT01666652|470888243|FG004|Overall Study|Lost to Follow-up|0|||
130799164|NCT01018979|470888244|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
130799165|NCT01018979|470888245|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
130799166|NCT01018979|470888244|FG000|Overall Study|Not received at least one dose|0|||
130799167|NCT01018979|470888245|FG001|Overall Study|Not received at least one dose|1|||
130799168|NCT03010501|470888248|FG000|Study Week 1|Withdrawal by Subject|2|||
130799169|NCT03010501|470888249|FG001|Study Week 1|Withdrawal by Subject|1|||
130799170|NCT03010501|470888250|FG002|Study Week 1|Withdrawal by Subject|0|||
130799171|NCT03010501|470888251|FG003|Study Week 1|Withdrawal by Subject|2|||
130799172|NCT03010501|470888252|FG004|Study Week 1|Withdrawal by Subject|0|||
130799173|NCT03010501|470888253|FG005|Study Week 1|Withdrawal by Subject|0|||
130799174|NCT03010501|470888248|FG000|Study Week 3|Withdrawal by Subject|0|||
130799175|NCT03010501|470888249|FG001|Study Week 3|Withdrawal by Subject|0|||
130799176|NCT03010501|470888250|FG002|Study Week 3|Withdrawal by Subject|0|||
130799177|NCT03010501|470888251|FG003|Study Week 3|Withdrawal by Subject|1|||
130799178|NCT03010501|470888252|FG004|Study Week 3|Withdrawal by Subject|0|||
130799179|NCT03010501|470888253|FG005|Study Week 3|Withdrawal by Subject|0|||
130799180|NCT00640289|470888254|FG000|Overall Study|Death|3|||
130799181|NCT00640289|470888254|FG000|Overall Study|Withdrawal by Subject|1|||
130799182|NCT00640289|470888254|FG000|Overall Study|Lost to Follow-up|1|||
130799183|NCT00640289|470888254|FG000|Overall Study|Data collected under different amendment|2|||
130799184|NCT00640289|470888254|FG000|Overall Study|Transferred to another center|1|||
130799185|NCT00640289|470888254|FG000|Overall Study|Missing status|5|||
130799186|NCT00544882|470888257|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
130799187|NCT00544882|470888258|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
130799188|NCT00544882|470888259|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
130799189|NCT00544882|470888257|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
130799190|NCT00544882|470888258|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
130799191|NCT00544882|470888259|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
130799192|NCT00544882|470888257|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
130799193|NCT00544882|470888258|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
130799194|NCT00544882|470888259|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
130799195|NCT00544882|470888257|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
130799196|NCT00544882|470888258|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
130799197|NCT00544882|470888259|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
130799198|NCT00544882|470888257|FG000|Cycle 3: Follow-up|Noncompliance|0|||
130799199|NCT00544882|470888258|FG001|Cycle 3: Follow-up|Noncompliance|1|||
130799200|NCT00544882|470888259|FG002|Cycle 3: Follow-up|Noncompliance|0|||
130799201|NCT00544882|470888257|FG000|Cycle 3: Follow-up|Pregnancy|0|||
130799202|NCT00544882|470888258|FG001|Cycle 3: Follow-up|Pregnancy|1|||
130799203|NCT00544882|470888259|FG002|Cycle 3: Follow-up|Pregnancy|0|||
130799204|NCT03043573|470888260|FG000|Overall Study|Lost to Follow-up|3|||
130799205|NCT03043573|470888261|FG001|Overall Study|Lost to Follow-up|3|||
130799206|NCT03043573|470888260|FG000|Overall Study|Physician Decision|0|||
130799207|NCT03043573|470888261|FG001|Overall Study|Physician Decision|5|||
130799208|NCT03043573|470888260|FG000|Overall Study|Withdrawal by Subject|0|||
130799209|NCT03043573|470888261|FG001|Overall Study|Withdrawal by Subject|4|||
130799210|NCT05643794|470889430|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
130799211|NCT05643794|470889431|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
130799212|NCT05643794|470889432|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130799213|NCT05643794|470889430|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130799214|NCT05643794|470889431|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130799215|NCT05643794|470889432|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130799216|NCT05643794|470889430|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130799217|NCT05643794|470889431|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
130799218|NCT05643794|470889432|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130799219|NCT05643794|470889430|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130799220|NCT05643794|470889431|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130799221|NCT05643794|470889432|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130799222|NCT05643794|470889430|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
130799223|NCT05643794|470889431|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130799224|NCT05643794|470889432|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130799225|NCT05643794|470889430|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
130799226|NCT05643794|470889431|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
130799227|NCT05643794|470889432|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
130799228|NCT01127061|470889433|FG000|Overall Study|Lost to Follow-up|7|||
130799229|NCT01127061|470889434|FG001|Overall Study|Lost to Follow-up|10|||
130799230|NCT01127061|470889433|FG000|Overall Study|Physician Decision|3|||
130799231|NCT01127061|470889434|FG001|Overall Study|Physician Decision|3|||
130799232|NCT04827446|470889435|FG000|Overall Study|Lost to Follow-up|1|||
130799233|NCT04827446|470889436|FG001|Overall Study|Lost to Follow-up|1|||
130799234|NCT04827446|470889435|FG000|Overall Study|Death|2|||
130799235|NCT04827446|470889436|FG001|Overall Study|Death|0|||
130799236|NCT04827446|470889435|FG000|Overall Study|Withdrawal by Subject|2|||
130799237|NCT04827446|470889436|FG001|Overall Study|Withdrawal by Subject|2|||
130799238|NCT00003456|470889439|FG000|Overall Study|Not evaluable|8|||
130799239|NCT00479232|470889440|FG000|Overall Study|Adverse Event|0|||
130799240|NCT00479232|470889441|FG001|Overall Study|Adverse Event|0|||
130799241|NCT00479232|470889442|FG002|Overall Study|Adverse Event|5|||
130799242|NCT00479232|470889443|FG003|Overall Study|Adverse Event|0|||
130799243|NCT00479232|470889444|FG004|Overall Study|Adverse Event|0|||
130799244|NCT00479232|470889445|FG005|Overall Study|Adverse Event|10|||
130799245|NCT00479232|470889440|FG000|Overall Study|Deviation from Protocol|0|||
130799246|NCT00479232|470889441|FG001|Overall Study|Deviation from Protocol|0|||
130799247|NCT00479232|470889442|FG002|Overall Study|Deviation from Protocol|1|||
130799248|NCT00479232|470889443|FG003|Overall Study|Deviation from Protocol|0|||
130799249|NCT00479232|470889444|FG004|Overall Study|Deviation from Protocol|0|||
130799250|NCT00479232|470889445|FG005|Overall Study|Deviation from Protocol|0|||
130799251|NCT00479232|470889440|FG000|Overall Study|Lack of Efficacy|0|||
130799252|NCT00479232|470889441|FG001|Overall Study|Lack of Efficacy|0|||
130799253|NCT00479232|470889442|FG002|Overall Study|Lack of Efficacy|2|||
130799254|NCT00479232|470889443|FG003|Overall Study|Lack of Efficacy|0|||
130799255|NCT00479232|470889444|FG004|Overall Study|Lack of Efficacy|0|||
130799256|NCT00479232|470889445|FG005|Overall Study|Lack of Efficacy|4|||
130799257|NCT00479232|470889440|FG000|Overall Study|Physician Decision|0|||
130799258|NCT00479232|470889441|FG001|Overall Study|Physician Decision|0|||
130799259|NCT00479232|470889442|FG002|Overall Study|Physician Decision|2|||
130799260|NCT00479232|470889443|FG003|Overall Study|Physician Decision|0|||
130799261|NCT00479232|470889444|FG004|Overall Study|Physician Decision|0|||
130799262|NCT00479232|470889445|FG005|Overall Study|Physician Decision|1|||
130799263|NCT00479232|470889440|FG000|Overall Study|Progressive Disease|3|||
130799264|NCT00479232|470889441|FG001|Overall Study|Progressive Disease|1|||
130799265|NCT00479232|470889442|FG002|Overall Study|Progressive Disease|12|||
130799266|NCT00479232|470889443|FG003|Overall Study|Progressive Disease|3|||
130799267|NCT00479232|470889444|FG004|Overall Study|Progressive Disease|3|||
130799268|NCT00479232|470889445|FG005|Overall Study|Progressive Disease|12|||
130799269|NCT00479232|470889440|FG000|Overall Study|Withdrew Consent|0|||
130799270|NCT00479232|470889441|FG001|Overall Study|Withdrew Consent|2|||
130799271|NCT00479232|470889442|FG002|Overall Study|Withdrew Consent|6|||
130799272|NCT00479232|470889443|FG003|Overall Study|Withdrew Consent|0|||
130799273|NCT00479232|470889444|FG004|Overall Study|Withdrew Consent|1|||
130799274|NCT00479232|470889445|FG005|Overall Study|Withdrew Consent|3|||
130799275|NCT03720847|470889446|FG000|Washout|Physician Decision|1|||
130799276|NCT03720847|470889447|FG001|Washout|Physician Decision|2|||
130799277|NCT03033901|470889448|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
130799278|NCT03033901|470889448|FG000|Overall Study|Refused PSG|23|||
130799279|NCT03033901|470889448|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
130799280|NCT03033901|470889448|FG000|Overall Study|Missing Oximetry Data|3|||
130799281|NCT02513199|470889451|FG000|Treatment|Death|1|||
130799282|NCT02513199|470889451|FG000|Treatment|Lost to Follow-up|1|||
130799283|NCT02513199|470889451|FG000|Follow-Up|Death|11|||
130799284|NCT01410604|470889455|FG000|Overall Study|Adverse Event|2|||
130799285|NCT01410604|470889456|FG001|Overall Study|Adverse Event|1|||
130799286|NCT01410604|470889455|FG000|Overall Study|Lost to Follow-up|1|||
130799287|NCT01410604|470889456|FG001|Overall Study|Lost to Follow-up|0|||
130799288|NCT01410604|470889455|FG000|Overall Study|Physician Decision|0|||
130799289|NCT01410604|470889456|FG001|Overall Study|Physician Decision|1|||
130799290|NCT00529035|470889458|FG000|Overall Study|Withdrawal by Subject|1|||
130799291|NCT03439514|470889459|FG000|Double-Blind Treatment Period|Other|4|||
130799292|NCT03439514|470889460|FG001|Double-Blind Treatment Period|Other|1|||
130799293|NCT03439514|470889459|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
130799294|NCT03439514|470889460|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130799295|NCT03439514|470889459|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
130799296|NCT03439514|470889460|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
130799297|NCT03439514|470889459|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
130799298|NCT03439514|470889460|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
130799299|NCT03439514|470889459|FG000|Double-Blind Treatment Period|Death|1|||
130799300|NCT03439514|470889460|FG001|Double-Blind Treatment Period|Death|2|||
130799301|NCT01521364|470889461|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
130799302|NCT01521364|470889461|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
130799303|NCT02175758|470889462|FG000|Treatment Phase|Lost to Follow-up|0|||
130799304|NCT02175758|470889463|FG001|Treatment Phase|Lost to Follow-up|1|||
130799305|NCT02175758|470889464|FG002|Treatment Phase|Lost to Follow-up|0|||
130799306|NCT02175758|470889465|FG003|Treatment Phase|Lost to Follow-up|0|||
130799307|NCT02175758|470889466|FG004|Treatment Phase|Lost to Follow-up|0|||
130799308|NCT02175758|470889467|FG005|Treatment Phase|Lost to Follow-up|0|||
130799309|NCT02175758|470889462|FG000|Treatment Phase|Adverse Event|0|||
130799310|NCT02175758|470889463|FG001|Treatment Phase|Adverse Event|0|||
130799311|NCT02175758|470889464|FG002|Treatment Phase|Adverse Event|0|||
130799312|NCT02175758|470889465|FG003|Treatment Phase|Adverse Event|0|||
130799313|NCT02175758|470889466|FG004|Treatment Phase|Adverse Event|1|||
130799314|NCT02175758|470889467|FG005|Treatment Phase|Adverse Event|0|||
130799315|NCT04900272|470889468|FG000|Overall Study|Lost to Follow-up|2|||
130799316|NCT04900272|470889468|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
130799317|NCT04900272|470889468|FG000|Overall Study|Withdrawal by Subject|1|||
130799318|NCT05059080|470889469|FG000|Overall Study|Withdrawal by Subject|3|||
130799319|NCT05059080|470889469|FG000|Overall Study|Study Terminated by Sponsor|64|||
130799320|NCT01047501|470889470|FG000|Overall Study|Adverse Event|7|||
130799321|NCT01047501|470889471|FG001|Overall Study|Adverse Event|8|||
130799322|NCT01047501|470889472|FG002|Overall Study|Adverse Event|5|||
130799323|NCT01047501|470889470|FG000|Overall Study|Withdrew Consent|6|||
130799324|NCT01047501|470889471|FG001|Overall Study|Withdrew Consent|2|||
130799325|NCT01047501|470889472|FG002|Overall Study|Withdrew Consent|4|||
130799326|NCT01047501|470889470|FG000|Overall Study|Lost to Follow-up|0|||
130799327|NCT01047501|470889471|FG001|Overall Study|Lost to Follow-up|1|||
130799328|NCT01047501|470889472|FG002|Overall Study|Lost to Follow-up|1|||
130799329|NCT01047501|470889470|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
130799330|NCT01047501|470889471|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
130799331|NCT01047501|470889472|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
130799332|NCT01047501|470889470|FG000|Overall Study|Death|1|||
130799333|NCT01047501|470889471|FG001|Overall Study|Death|0|||
130799334|NCT01047501|470889472|FG002|Overall Study|Death|0|||
130799335|NCT01047501|470889470|FG000|Overall Study|Other discontinuation|1|||
130799336|NCT01047501|470889471|FG001|Overall Study|Other discontinuation|0|||
130799337|NCT01047501|470889472|FG002|Overall Study|Other discontinuation|1|||
130799338|NCT01047501|470889470|FG000|Overall Study|Investigator judgement|0|||
130799339|NCT01047501|470889471|FG001|Overall Study|Investigator judgement|0|||
130799340|NCT01047501|470889472|FG002|Overall Study|Investigator judgement|1|||
130799341|NCT00429299|470889475|FG000|Overall Study|Disease Progression|1|||
130799342|NCT00429299|470889476|FG001|Overall Study|Disease Progression|1|||
130799343|NCT00429299|470889477|FG002|Overall Study|Disease Progression|0|||
130799344|NCT00429299|470889475|FG000|Overall Study|Adverse Event|2|||
130799345|NCT00429299|470889476|FG001|Overall Study|Adverse Event|5|||
130799346|NCT00429299|470889477|FG002|Overall Study|Adverse Event|1|||
130799347|NCT00429299|470889475|FG000|Overall Study|Protocol Violation|1|||
130799348|NCT00429299|470889476|FG001|Overall Study|Protocol Violation|0|||
130799349|NCT00429299|470889477|FG002|Overall Study|Protocol Violation|0|||
130799350|NCT00429299|470889475|FG000|Overall Study|Withdrawal by Subject|0|||
130799351|NCT00429299|470889476|FG001|Overall Study|Withdrawal by Subject|1|||
130799352|NCT00429299|470889477|FG002|Overall Study|Withdrawal by Subject|3|||
130799353|NCT01510756|470889478|FG000|Overall Study|Death|1|||
130799354|NCT01510756|470889478|FG000|Overall Study|Lack of Efficacy|2|||
130799355|NCT01510756|470889478|FG000|Overall Study|Physician Decision|1|||
130799356|NCT03927157|470889479|FG000|Overall Study|Adverse Event|1|||
130799357|NCT03927157|470889480|FG001|Overall Study|Adverse Event|3|||
130799358|NCT03927157|470889479|FG000|Overall Study|Protocol Violation|1|||
130799359|NCT03927157|470889480|FG001|Overall Study|Protocol Violation|2|||
130799360|NCT03927157|470889479|FG000|Overall Study|Withdrawal by Subject|8|||
130799361|NCT03927157|470889480|FG001|Overall Study|Withdrawal by Subject|21|||
130799362|NCT03927157|470889479|FG000|Overall Study|Due to COVID-19 pandemic|5|||
130799363|NCT03927157|470889480|FG001|Overall Study|Due to COVID-19 pandemic|2|||
130799364|NCT03927157|470889479|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
130799365|NCT03927157|470889480|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
130799366|NCT03927157|470889479|FG000|Overall Study|Other than above|0|||
130799367|NCT03927157|470889480|FG001|Overall Study|Other than above|1|||
130799368|NCT04871113|470889481|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130799369|NCT04871113|470889482|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130799370|NCT04871113|470889483|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130799371|NCT04871113|470889484|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130799372|NCT04871113|470889485|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130799373|NCT04871113|470889486|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
130799374|NCT04871113|470889487|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130799375|NCT04871113|470889488|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130799376|NCT04871113|470889489|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130799377|NCT04871113|470889490|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130799378|NCT04871113|470889481|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130799379|NCT04871113|470889482|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130799380|NCT04871113|470889483|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130799381|NCT04871113|470889484|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130799382|NCT04871113|470889485|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130799383|NCT04871113|470889486|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130799384|NCT04871113|470889487|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
130799385|NCT04871113|470889488|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
130799386|NCT04871113|470889489|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130799387|NCT04871113|470889490|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130799388|NCT02447029|470889491|FG000|Overall Study|Withdrawal by Subject|3|||
130799389|NCT02447029|470889492|FG001|Overall Study|Withdrawal by Subject|2|||
130799390|NCT00726557|470889493|FG000|Overall Study|Screening failure|4|||
130799391|NCT00726557|470889493|FG000|Overall Study|No end of treatment documentation|37|||
130799392|NCT00726557|470889493|FG000|Overall Study|No follow-up documentation available|55|||
130799393|NCT00726557|470889493|FG000|Overall Study|Treatment less than 3 months|17|||
130799394|NCT00726557|470889493|FG000|Overall Study|Inclusion criteria not met|15|||
130799395|NCT01239745|470889494|FG000|Overall Study|Study terminated by sponsor|45|||
130799396|NCT01239745|470889494|FG000|Overall Study|Adverse Event|1|||
130799397|NCT01257542|470889497|FG000|Overall Study|Protocol Violation|3|||
130799398|NCT01257542|470889498|FG001|Overall Study|Protocol Violation|5|||
130799399|NCT01257542|470889497|FG000|Overall Study|Withdrawal by Subject|0|||
130799400|NCT01257542|470889498|FG001|Overall Study|Withdrawal by Subject|2|||
130799401|NCT00081458|470889500|FG000|Overall Study|Adverse Event|1|||
130799402|NCT00081458|470889501|FG001|Overall Study|Adverse Event|5|||
130799403|NCT00081458|470889502|FG002|Overall Study|Adverse Event|2|||
130799404|NCT00081458|470889500|FG000|Overall Study|Withdrawal by Subject|0|||
130799405|NCT00081458|470889501|FG001|Overall Study|Withdrawal by Subject|3|||
130799406|NCT00081458|470889502|FG002|Overall Study|Withdrawal by Subject|1|||
130799407|NCT00081458|470889500|FG000|Overall Study|Randomized but not dosed|0|||
130799408|NCT00081458|470889501|FG001|Overall Study|Randomized but not dosed|0|||
130799409|NCT00081458|470889502|FG002|Overall Study|Randomized but not dosed|1|||
130799410|NCT00549328|470889507|FG000|Overall Study|Adverse Event|2|||
130799411|NCT00549328|470889507|FG000|Overall Study|Disease Progression|10|||
130799412|NCT00549328|470889507|FG000|Overall Study|Death|1|||
130799413|NCT00549328|470889507|FG000|Overall Study|Use of Prohibited Medication|1|||
130799414|NCT03097315|470889512|FG000|Overall Study|Withdrawal by Subject|1|||
130799415|NCT01946802|470889513|FG000|Overall Study|Death|1|||
130799416|NCT01946802|470889513|FG000|Overall Study|Withdrawal by Subject|2|||
130799417|NCT01946802|470889513|FG000|Overall Study|Combined septic shock|1|||
130799418|NCT01946802|470889513|FG000|Overall Study|Protocol Violation|1|||
130799419|NCT00376506|470889514|FG000|Overall Study|Death|0|||
130799420|NCT00376506|470889515|FG001|Overall Study|Death|2|||
130799421|NCT00776997|470889516|FG000|Overall Study|Adverse Event|2|||
130799422|NCT02948400|470889517|FG000|Overall Study|Withdrawal by Subject|17|||
130799423|NCT02948400|470889518|FG001|Overall Study|Withdrawal by Subject|10|||
130799424|NCT02948400|470889517|FG000|Overall Study|failed to attend appointments|47|||
130799425|NCT02948400|470889518|FG001|Overall Study|failed to attend appointments|34|||
130799426|NCT02948400|470889517|FG000|Overall Study|COVID-related closure|6|||
130799427|NCT02948400|470889518|FG001|Overall Study|COVID-related closure|2|||
130799428|NCT02948400|470889517|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
130799429|NCT02948400|470889518|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
130799430|NCT02948400|470889517|FG000|Overall Study|motion sickness in virtual reality|2|||
130799431|NCT02948400|470889518|FG001|Overall Study|motion sickness in virtual reality|0|||
130799432|NCT02403271|470889519|FG000|Period 1|Other varied reasons|1|||
130799433|NCT02403271|470889520|FG001|Period 1|Other varied reasons|0|||
130799434|NCT02403271|470889519|FG000|Period 2|Withdrawal by Subject|0|||
130799435|NCT02403271|470889520|FG001|Period 2|Withdrawal by Subject|14|||
130799436|NCT02403271|470889519|FG000|Period 2|Death|0|||
130799437|NCT02403271|470889520|FG001|Period 2|Death|84|||
130799438|NCT02403271|470889519|FG000|Period 2|Lost to Follow-up|0|||
130799439|NCT02403271|470889520|FG001|Period 2|Lost to Follow-up|2|||
130799440|NCT02403271|470889519|FG000|Period 2|Study Terminated by Sponsor|0|||
130799441|NCT02403271|470889520|FG001|Period 2|Study Terminated by Sponsor|14|||
130799442|NCT02403271|470889519|FG000|Period 2|Other varied reasons|0|||
130799443|NCT02403271|470889520|FG001|Period 2|Other varied reasons|10|||
130799444|NCT03487445|470889525|FG000|Randomization|Not treated for administrative reasons|1|||
130799445|NCT03487445|470889526|FG001|Randomization|Not treated for administrative reasons|0|||
130799446|NCT00221104|470889527|FG000|Overall Study|Adverse Event|1|||
130799447|NCT00221104|470889528|FG001|Overall Study|Adverse Event|0|||
130799448|NCT00221104|470889527|FG000|Overall Study|Physician Decision|1|||
130799449|NCT00221104|470889528|FG001|Overall Study|Physician Decision|0|||
130799450|NCT00221104|470889527|FG000|Overall Study|Protocol Violation|2|||
130799451|NCT00221104|470889528|FG001|Overall Study|Protocol Violation|0|||
130799452|NCT00221104|470889527|FG000|Overall Study|Withdrawal by Subject|42|||
130799453|NCT00221104|470889528|FG001|Overall Study|Withdrawal by Subject|29|||
130799454|NCT00221104|470889527|FG000|Overall Study|Others|37|||
130799455|NCT00221104|470889528|FG001|Overall Study|Others|47|||
130799456|NCT02989389|470889529|FG000|Period 1|Lost to Follow-up|0|||
130799457|NCT02989389|470889530|FG001|Period 1|Lost to Follow-up|1|||
130799458|NCT02989389|470889531|FG002|Period 1|Lost to Follow-up|0|||
130799459|NCT02989389|470889532|FG003|Period 1|Lost to Follow-up|0|||
130799460|NCT02989389|470889533|FG004|Period 1|Lost to Follow-up|0|||
130799461|NCT02989389|470889534|FG005|Period 1|Lost to Follow-up|0|||
130799462|NCT02989389|470889535|FG006|Period 1|Lost to Follow-up|0|||
130799463|NCT02989389|470889536|FG007|Period 1|Lost to Follow-up|0|||
130799464|NCT02989389|470889537|FG008|Period 1|Lost to Follow-up|0|||
130799465|NCT02989389|470889538|FG009|Period 1|Lost to Follow-up|0|||
130799466|NCT02989389|470889529|FG000|Period 1|Physician Decision|0|||
130799467|NCT02989389|470889530|FG001|Period 1|Physician Decision|0|||
130799468|NCT02989389|470889531|FG002|Period 1|Physician Decision|0|||
130799469|NCT02989389|470889532|FG003|Period 1|Physician Decision|0|||
130799470|NCT02989389|470889533|FG004|Period 1|Physician Decision|0|||
130799471|NCT02989389|470889534|FG005|Period 1|Physician Decision|0|||
130799472|NCT02989389|470889535|FG006|Period 1|Physician Decision|0|||
130799473|NCT02989389|470889536|FG007|Period 1|Physician Decision|0|||
130799474|NCT02989389|470889537|FG008|Period 1|Physician Decision|1|||
130799475|NCT02989389|470889538|FG009|Period 1|Physician Decision|0|||
130799476|NCT04470427|470889539|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
130799477|NCT04470427|470889540|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
130799478|NCT04470427|470889541|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
130799479|NCT04470427|470889542|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
130799480|NCT04470427|470889543|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
130799481|NCT04470427|470889544|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
130799482|NCT04470427|470889539|FG000|Part B :Open-label|Other than specified|0|||
130799483|NCT04470427|470889540|FG001|Part B :Open-label|Other than specified|0|||
130799484|NCT04470427|470889541|FG002|Part B :Open-label|Other than specified|788|||
130799485|NCT04470427|470889542|FG003|Part B :Open-label|Other than specified|0|||
130799486|NCT04470427|470889543|FG004|Part B :Open-label|Other than specified|523|||
130799487|NCT04470427|470889544|FG005|Part B :Open-label|Other than specified|0|||
130799488|NCT04470427|470889539|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
130799489|NCT04470427|470889540|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
130799490|NCT04470427|470889541|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
130799491|NCT04470427|470889542|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
130799492|NCT04470427|470889543|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
130799493|NCT04470427|470889544|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
130799494|NCT04470427|470889539|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
130799495|NCT04470427|470889540|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
130799496|NCT04470427|470889541|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
130799497|NCT04470427|470889542|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
130799498|NCT04470427|470889543|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
130799499|NCT04470427|470889544|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
130799500|NCT03301714|470889545|FG000|Overall Study|Lost to Follow-up|10|||
130799501|NCT03301714|470889546|FG001|Overall Study|Lost to Follow-up|4|||
130799502|NCT03301714|470889547|FG002|Overall Study|Lost to Follow-up|4|||
130799503|NCT03301714|470889545|FG000|Overall Study|Did not receive allocated intervention|0|||
130799504|NCT03301714|470889546|FG001|Overall Study|Did not receive allocated intervention|2|||
130799505|NCT03301714|470889547|FG002|Overall Study|Did not receive allocated intervention|3|||
130799506|NCT01251861|470889550|FG000|Overall Study|Disease progression|6|||
130799507|NCT01251861|470889551|FG001|Overall Study|Disease progression|6|||
130799508|NCT01251861|470889550|FG000|Overall Study|Adverse Event|2|||
130799509|NCT01251861|470889551|FG001|Overall Study|Adverse Event|17|||
130799510|NCT01251861|470889550|FG000|Overall Study|Withdrawal by Subject|2|||
130799511|NCT01251861|470889551|FG001|Overall Study|Withdrawal by Subject|2|||
130799512|NCT01251861|470889550|FG000|Overall Study|Alternative therapy|1|||
130799513|NCT01251861|470889551|FG001|Overall Study|Alternative therapy|0|||
130799514|NCT01251861|470889550|FG000|Overall Study|Other complicating disease|0|||
130799515|NCT01251861|470889551|FG001|Overall Study|Other complicating disease|1|||
130799516|NCT01251861|470889550|FG000|Overall Study|Physician Decision|1|||
130799517|NCT01251861|470889551|FG001|Overall Study|Physician Decision|0|||
130799518|NCT01251861|470889550|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
130799519|NCT01251861|470889551|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
130799520|NCT01251861|470889550|FG000|Overall Study|Other|1|||
130799521|NCT01251861|470889551|FG001|Overall Study|Other|0|||
130799522|NCT01251861|470889550|FG000|Overall Study|Never started therapy|4|||
130799523|NCT01251861|470889551|FG001|Overall Study|Never started therapy|1|||
130799524|NCT01251861|470889550|FG000|Overall Study|Potential interaction of drugs|0|||
130799525|NCT01251861|470889551|FG001|Overall Study|Potential interaction of drugs|1|||
130799526|NCT03580928|470889554|FG000|Overall Study|Death|0|||
130799527|NCT03580928|470889555|FG001|Overall Study|Death|3|||
130799528|NCT03580928|470889554|FG000|Overall Study|Withdrawal by Subject|2|||
130799529|NCT03580928|470889555|FG001|Overall Study|Withdrawal by Subject|1|||
130799530|NCT03580928|470889554|FG000|Overall Study|Lost to Follow-up|2|||
130799531|NCT03580928|470889555|FG001|Overall Study|Lost to Follow-up|0|||
130799532|NCT03580928|470889554|FG000|Overall Study|Progressive Disease|0|||
130799533|NCT03580928|470889555|FG001|Overall Study|Progressive Disease|1|||
130799534|NCT04167670|470890221|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
130799535|NCT04167670|470890222|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
130799536|NCT04167670|470890223|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
130799537|NCT04167670|470890221|FG000|Overall Study|Significant protocol deviation|3|||
130799538|NCT04167670|470890222|FG001|Overall Study|Significant protocol deviation|1|||
130799539|NCT04167670|470890223|FG002|Overall Study|Significant protocol deviation|0|||
130799540|NCT04167670|470890221|FG000|Overall Study|Lost to Follow-up|0|||
130799541|NCT04167670|470890222|FG001|Overall Study|Lost to Follow-up|3|||
130799542|NCT04167670|470890223|FG002|Overall Study|Lost to Follow-up|3|||
130799543|NCT04167670|470890221|FG000|Overall Study|Voluntary Withdrawal|0|||
130799544|NCT04167670|470890222|FG001|Overall Study|Voluntary Withdrawal|1|||
130799545|NCT04167670|470890223|FG002|Overall Study|Voluntary Withdrawal|1|||
130799546|NCT04167670|470890221|FG000|Overall Study|Withdrawal of Consent|4|||
130799547|NCT04167670|470890222|FG001|Overall Study|Withdrawal of Consent|1|||
130799548|NCT04167670|470890223|FG002|Overall Study|Withdrawal of Consent|3|||
130799549|NCT04167670|470890221|FG000|Overall Study|Miscellaneous|7|||
130799550|NCT04167670|470890222|FG001|Overall Study|Miscellaneous|5|||
130799551|NCT04167670|470890223|FG002|Overall Study|Miscellaneous|3|||
130799552|NCT05399771|470890226|FG000|Overall Study|Physician Decision|3|||
130799553|NCT05399771|470890226|FG000|Overall Study|Adverse Event|1|||
130799554|NCT00484159|470890227|FG000|Overall Study|Lost to Follow-up|1|||
130799555|NCT00484159|470890228|FG001|Overall Study|Lost to Follow-up|1|||
130799556|NCT00484159|470890229|FG002|Overall Study|Lost to Follow-up|0|||
130799557|NCT01239680|470890230|FG000|Overall Study|Withdrawal by Subject|2|||
130799558|NCT01239680|470890231|FG001|Overall Study|Withdrawal by Subject|0|||
130799559|NCT04307394|470890234|FG000|Overall Study|Lost to Follow-up|3|||
130799560|NCT04307394|470890234|FG000|Overall Study|Withdrawal by Subject|2|||
130799561|NCT00770484|470890243|FG000|Overall Study|Withdrawal by Subject|1|||
130799562|NCT00770484|470890244|FG001|Overall Study|Withdrawal by Subject|0|||
130799563|NCT03384966|470890245|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
130799564|NCT03384966|470890246|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
130799565|NCT03384966|470890247|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
130799566|NCT03384966|470890245|FG000|Follow-up Period|Adverse Event|1|||
130799567|NCT03384966|470890246|FG001|Follow-up Period|Adverse Event|0|||
130799568|NCT03384966|470890247|FG002|Follow-up Period|Adverse Event|0|||
130799569|NCT03637374|470890248|FG000|Overall Study|Death|2|||
130799570|NCT03637374|470890249|FG001|Overall Study|Death|0|||
130799571|NCT02836769|470890251|FG000|Overall Study|Lost to Follow-up|10|||
130799572|NCT02836769|470890251|FG000|Overall Study|Medical withdrawal|2|||
130799573|NCT02836769|470890251|FG000|Overall Study|Withdrawal by Subject|3|||
130799574|NCT03412890|470890268|FG000|Overall Study|Adverse Event|5|||
130799575|NCT03412890|470890269|FG001|Overall Study|Adverse Event|5|||
130799576|NCT03412890|470890270|FG002|Overall Study|Adverse Event|9|||
130799577|NCT03412890|470890268|FG000|Overall Study|Protocol deviation|2|||
130799578|NCT03412890|470890269|FG001|Overall Study|Protocol deviation|1|||
130799579|NCT03412890|470890270|FG002|Overall Study|Protocol deviation|2|||
130799580|NCT03412890|470890268|FG000|Overall Study|Lost to Follow-up|7|||
130799581|NCT03412890|470890269|FG001|Overall Study|Lost to Follow-up|10|||
130799582|NCT03412890|470890270|FG002|Overall Study|Lost to Follow-up|10|||
130799583|NCT03412890|470890268|FG000|Overall Study|Withdrawal by Subject|9|||
130799584|NCT03412890|470890269|FG001|Overall Study|Withdrawal by Subject|12|||
130799585|NCT03412890|470890270|FG002|Overall Study|Withdrawal by Subject|11|||
130799586|NCT03412890|470890268|FG000|Overall Study|Lack of Efficacy|2|||
130799587|NCT03412890|470890269|FG001|Overall Study|Lack of Efficacy|7|||
130799588|NCT03412890|470890270|FG002|Overall Study|Lack of Efficacy|5|||
130799589|NCT03412890|470890268|FG000|Overall Study|Other|5|||
130799590|NCT03412890|470890269|FG001|Overall Study|Other|6|||
130799591|NCT03412890|470890270|FG002|Overall Study|Other|5|||
130799592|NCT03412890|470890268|FG000|Overall Study|Participants who did not receive any study drug|0|||
130799593|NCT03412890|470890269|FG001|Overall Study|Participants who did not receive any study drug|1|||
130799594|NCT03412890|470890270|FG002|Overall Study|Participants who did not receive any study drug|0|||
130799595|NCT00021255|470890271|FG000|Overall Study|Death|1|||
130799596|NCT00021255|470890272|FG001|Overall Study|Death|0|||
130799597|NCT00021255|470890273|FG002|Overall Study|Death|2|||
130799598|NCT00021255|470890271|FG000|Overall Study|Breast cancer relapse|5|||
130799599|NCT00021255|470890272|FG001|Overall Study|Breast cancer relapse|18|||
130799600|NCT00021255|470890273|FG002|Overall Study|Breast cancer relapse|11|||
130799601|NCT00021255|470890271|FG000|Overall Study|Second primary malignancy|0|||
130799602|NCT00021255|470890272|FG001|Overall Study|Second primary malignancy|4|||
130799603|NCT00021255|470890273|FG002|Overall Study|Second primary malignancy|1|||
130799604|NCT00021255|470890271|FG000|Overall Study|Withdrawal by Subject|41|||
130799605|NCT00021255|470890272|FG001|Overall Study|Withdrawal by Subject|64|||
130799606|NCT00021255|470890273|FG002|Overall Study|Withdrawal by Subject|26|||
130799607|NCT00021255|470890271|FG000|Overall Study|Lost to Follow-up|0|||
130799608|NCT00021255|470890272|FG001|Overall Study|Lost to Follow-up|2|||
130799609|NCT00021255|470890273|FG002|Overall Study|Lost to Follow-up|3|||
130799610|NCT00021255|470890271|FG000|Overall Study|Cardiac toxicity|0|||
130799611|NCT00021255|470890272|FG001|Overall Study|Cardiac toxicity|61|||
130799612|NCT00021255|470890273|FG002|Overall Study|Cardiac toxicity|32|||
130799613|NCT00021255|470890271|FG000|Overall Study|Herceptin toxicity|0|||
130799614|NCT00021255|470890272|FG001|Overall Study|Herceptin toxicity|22|||
130799615|NCT00021255|470890273|FG002|Overall Study|Herceptin toxicity|6|||
130799616|NCT00021255|470890271|FG000|Overall Study|Adverse Event|46|||
130799617|NCT00021255|470890272|FG001|Overall Study|Adverse Event|30|||
130799618|NCT00021255|470890273|FG002|Overall Study|Adverse Event|18|||
130799619|NCT00021255|470890271|FG000|Overall Study|Protocol Violation|0|||
130799620|NCT00021255|470890272|FG001|Overall Study|Protocol Violation|2|||
130799621|NCT00021255|470890273|FG002|Overall Study|Protocol Violation|0|||
130799622|NCT00021255|470890271|FG000|Overall Study|Other than specified above|0|||
130799623|NCT00021255|470890272|FG001|Overall Study|Other than specified above|38|||
130799624|NCT00021255|470890273|FG002|Overall Study|Other than specified above|19|||
130799625|NCT00021255|470890271|FG000|Overall Study|Missing|0|||
130799626|NCT00021255|470890272|FG001|Overall Study|Missing|27|||
130799627|NCT00021255|470890273|FG002|Overall Study|Missing|13|||
130799628|NCT00021255|470890271|FG000|Overall Study|Randomized but not treated|28|||
130799629|NCT00021255|470890272|FG001|Overall Study|Randomized but not treated|2|||
130799630|NCT00021255|470890273|FG002|Overall Study|Randomized but not treated|18|||
130799631|NCT01132755|470890276|FG000|Overall Study|Procedure not done due to medical reason|23|||
130799632|NCT01132755|470890276|FG000|Overall Study|Protocol Violation|15|||
130799633|NCT01132755|470890276|FG000|Overall Study|Withdrawal by Subject|4|||
130799634|NCT02232698|470890277|FG000|Overall Study|Pregnancy|1|||
130799635|NCT02232698|470890278|FG001|Overall Study|Pregnancy|1|||
130799636|NCT02232698|470890277|FG000|Overall Study|Met exclusion criteria|1|||
130799637|NCT02232698|470890278|FG001|Overall Study|Met exclusion criteria|1|||
130799638|NCT02232698|470890277|FG000|Overall Study|Had device-associated symptoms|7|||
130799639|NCT02232698|470890278|FG001|Overall Study|Had device-associated symptoms|0|||
130799640|NCT02232698|470890277|FG000|Overall Study|Non-compliance with study device|1|||
130799641|NCT02232698|470890278|FG001|Overall Study|Non-compliance with study device|4|||
130799642|NCT02232698|470890277|FG000|Overall Study|Allocated to control group|0|||
130799643|NCT02232698|470890278|FG001|Overall Study|Allocated to control group|3|||
130799644|NCT02232698|470890277|FG000|Overall Study|Withdrawal by Subject|0|||
130799645|NCT02232698|470890278|FG001|Overall Study|Withdrawal by Subject|11|||
130799646|NCT02393755|470890279|FG000|Overall Study|Withdrawal by Subject|0|||
130799647|NCT02393755|470890280|FG001|Overall Study|Withdrawal by Subject|3|||
130799648|NCT02393755|470890279|FG000|Overall Study|Adverse Event|0|||
130799649|NCT02393755|470890280|FG001|Overall Study|Adverse Event|2|||
130799650|NCT02393755|470890279|FG000|Overall Study|Physician Decision|0|||
130799651|NCT02393755|470890280|FG001|Overall Study|Physician Decision|2|||
130799652|NCT02337946|470890281|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
130799653|NCT02337946|470890282|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
130799654|NCT02337946|470890283|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
130799655|NCT02337946|470890281|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
130799656|NCT02337946|470890282|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
130799657|NCT02337946|470890283|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
130799658|NCT02337946|470890281|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
130799659|NCT02337946|470890282|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
130799660|NCT02337946|470890283|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
130799661|NCT02337946|470890281|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
130799662|NCT02337946|470890282|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
130799663|NCT02337946|470890283|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
130799664|NCT02337946|470890281|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
130799665|NCT02337946|470890282|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
130799666|NCT02337946|470890283|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
130799667|NCT02337946|470890281|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
130799668|NCT02337946|470890282|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
130799669|NCT02337946|470890283|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
130799670|NCT02337946|470890281|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
130799671|NCT02337946|470890282|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
130799672|NCT02337946|470890283|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
130799673|NCT02337946|470890281|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
130799674|NCT02337946|470890282|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
130799675|NCT02337946|470890283|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
130799676|NCT02337946|470890281|FG000|In-between Period|Without Informed Consent|1|||
130799677|NCT02337946|470890282|FG001|In-between Period|Without Informed Consent|0|||
130799678|NCT02337946|470890283|FG002|In-between Period|Without Informed Consent|0|||
130799679|NCT02337946|470890281|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
130799680|NCT02337946|470890282|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
130799681|NCT02337946|470890283|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
130799682|NCT02337946|470890281|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
130799683|NCT02337946|470890282|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
130799684|NCT02337946|470890283|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
130799685|NCT02337946|470890281|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
130799686|NCT02337946|470890282|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
130799687|NCT02337946|470890283|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
130799688|NCT02337946|470890281|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
130799689|NCT02337946|470890282|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
130799690|NCT02337946|470890283|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
130799691|NCT02337946|470890281|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
130799692|NCT02337946|470890282|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
130799693|NCT02337946|470890283|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
130799694|NCT02337946|470890281|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
130799695|NCT02337946|470890282|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
130799696|NCT02337946|470890283|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
130799697|NCT05324371|470890285|FG000|Overall Study|Withdrawal by Subject|1|||
130799698|NCT05324371|470890285|FG000|Overall Study|Death|1|||
130799699|NCT02949934|470890287|FG000|Natural Drinking Period|Adverse Event|1|||
130799700|NCT02949934|470890288|FG001|Natural Drinking Period|Adverse Event|0|||
130799701|NCT02949934|470890289|FG002|Natural Drinking Period|Adverse Event|0|||
130799702|NCT02949934|470890290|FG003|Natural Drinking Period|Adverse Event|1|||
130799703|NCT02949934|470890291|FG004|Natural Drinking Period|Adverse Event|0|||
130799704|NCT02949934|470890292|FG005|Natural Drinking Period|Adverse Event|0|||
130799705|NCT02949934|470890287|FG000|Natural Drinking Period|Lost to Follow-up|0|||
130799706|NCT02949934|470890288|FG001|Natural Drinking Period|Lost to Follow-up|0|||
130799707|NCT02949934|470890289|FG002|Natural Drinking Period|Lost to Follow-up|0|||
130799708|NCT02949934|470890290|FG003|Natural Drinking Period|Lost to Follow-up|0|||
130799709|NCT02949934|470890291|FG004|Natural Drinking Period|Lost to Follow-up|1|||
130799710|NCT02949934|470890292|FG005|Natural Drinking Period|Lost to Follow-up|0|||
130799711|NCT02949934|470890287|FG000|Neuroimaging|Protocol Violation|2|||
130799712|NCT02949934|470890288|FG001|Neuroimaging|Protocol Violation|0|||
130799713|NCT02949934|470890289|FG002|Neuroimaging|Protocol Violation|0|||
130799714|NCT02949934|470890290|FG003|Neuroimaging|Protocol Violation|0|||
130799715|NCT02949934|470890291|FG004|Neuroimaging|Protocol Violation|1|||
130799716|NCT02949934|470890292|FG005|Neuroimaging|Protocol Violation|0|||
130799717|NCT02949934|470890287|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
130799718|NCT02949934|470890288|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
130799719|NCT02949934|470890289|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
130799720|NCT02949934|470890290|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
130799721|NCT02949934|470890291|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
130799722|NCT02949934|470890292|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
130799723|NCT02949934|470890287|FG000|Neuroimaging|Not scanned|0|||
130799724|NCT02949934|470890288|FG001|Neuroimaging|Not scanned|0|||
130799725|NCT02949934|470890289|FG002|Neuroimaging|Not scanned|1|||
130799726|NCT02949934|470890290|FG003|Neuroimaging|Not scanned|0|||
130799727|NCT02949934|470890291|FG004|Neuroimaging|Not scanned|0|||
130799728|NCT02949934|470890292|FG005|Neuroimaging|Not scanned|2|||
130799729|NCT02949934|470890287|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
130799730|NCT02949934|470890288|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
130799731|NCT02949934|470890289|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
130799732|NCT02949934|470890290|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
130799733|NCT02949934|470890291|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
130799734|NCT02949934|470890292|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
130799735|NCT02949934|470890287|FG000|Bar Laboratory|Adverse Event|1|||
130799736|NCT02949934|470890288|FG001|Bar Laboratory|Adverse Event|0|||
130799737|NCT02949934|470890289|FG002|Bar Laboratory|Adverse Event|2|||
130799738|NCT02949934|470890290|FG003|Bar Laboratory|Adverse Event|0|||
130799739|NCT02949934|470890291|FG004|Bar Laboratory|Adverse Event|1|||
130799740|NCT02949934|470890292|FG005|Bar Laboratory|Adverse Event|0|||
130799741|NCT02949934|470890287|FG000|Bar Laboratory|Protocol Violation|0|||
130799742|NCT02949934|470890288|FG001|Bar Laboratory|Protocol Violation|0|||
130799743|NCT02949934|470890289|FG002|Bar Laboratory|Protocol Violation|0|||
130799744|NCT02949934|470890290|FG003|Bar Laboratory|Protocol Violation|1|||
130799745|NCT02949934|470890291|FG004|Bar Laboratory|Protocol Violation|0|||
130799746|NCT02949934|470890292|FG005|Bar Laboratory|Protocol Violation|0|||
130799747|NCT04822194|470890293|FG000|Overall Study|Withdrawal by Subject|5|||
130799748|NCT04822194|470890294|FG001|Overall Study|Withdrawal by Subject|4|||
130799749|NCT04822194|470890293|FG000|Overall Study|Technical issues with MR scanner|1|||
130799750|NCT04822194|470890294|FG001|Overall Study|Technical issues with MR scanner|0|||
130799751|NCT04822194|470890293|FG000|Overall Study|Lost to Follow-up|5|||
130799752|NCT04822194|470890294|FG001|Overall Study|Lost to Follow-up|7|||
130799753|NCT03442569|470890298|FG000|Overall Study|Subject was ineligible after enrollment|1|||
130799754|NCT03770455|470890302|FG000|Overall Study|Screen failures|3|||
130799755|NCT01363076|470891196|FG000|Overall Study|Withdrawal by Subject|0|||
130799756|NCT01363076|470891197|FG001|Overall Study|Withdrawal by Subject|1|||
130799757|NCT04706403|470891198|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
130799758|NCT04706403|470891199|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
130799759|NCT04706403|470891200|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
130799760|NCT04706403|470891201|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
130799761|NCT04706403|470891202|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
130799762|NCT00182637|470891203|FG000|Overall Study|Adverse Event|2|||
130799763|NCT00182637|470891203|FG000|Overall Study|Disease Progression|1|||
130799764|NCT04766333|470891206|FG000|Overall Study|Lost to Follow-up|40|||
130799765|NCT04766333|470891207|FG001|Overall Study|Lost to Follow-up|826|||
130799766|NCT00639379|470891208|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
130799767|NCT00639379|470891209|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
130799768|NCT00639379|470891208|FG000|Period 1 - 2 Weeks|lens issue|3|||
130799769|NCT00639379|470891209|FG001|Period 1 - 2 Weeks|lens issue|0|||
130799770|NCT01771913|470891217|FG000|Overall Study|Withdrawal by Subject|1|||
130799771|NCT01771913|470891218|FG001|Overall Study|Withdrawal by Subject|0|||
130799772|NCT00407511|470891219|FG000|Overall Study|Adverse Event|9|||
130799773|NCT00407511|470891219|FG000|Overall Study|Lost to Follow-up|4|||
130799774|NCT00407511|470891219|FG000|Overall Study|Other|5|||
130799775|NCT00407511|470891219|FG000|Overall Study|Withdrawal by Subject|4|||
130799776|NCT02636283|470891220|FG000|Overall Study|Adverse Event|2|||
130799777|NCT02636283|470891221|FG001|Overall Study|Adverse Event|0|||
130799778|NCT02636283|470891220|FG000|Overall Study|Trial Terminated Prematurely|0|||
130799779|NCT02636283|470891221|FG001|Overall Study|Trial Terminated Prematurely|3|||
130799780|NCT01913470|470891226|FG000|Overall Study|Lost to Follow-up|0|||
130799781|NCT01913470|470891227|FG001|Overall Study|Lost to Follow-up|1|||
130799782|NCT01913470|470891226|FG000|Overall Study|Physician Decision|0|||
130799783|NCT01913470|470891227|FG001|Overall Study|Physician Decision|1|||
130799784|NCT01913470|470891226|FG000|Overall Study|Withdrawal by Subject|0|||
130799785|NCT01913470|470891227|FG001|Overall Study|Withdrawal by Subject|1|||
130799786|NCT02573467|470891228|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
130799787|NCT02573467|470891229|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
130799788|NCT02573467|470891230|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
130799789|NCT02573467|470891231|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
130799790|NCT02573467|470891228|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
130799791|NCT02573467|470891229|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
130799792|NCT02573467|470891230|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
130799793|NCT02573467|470891231|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
130799794|NCT02573467|470891228|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
130799795|NCT02573467|470891229|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
130799796|NCT02573467|470891230|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
130799797|NCT02573467|470891231|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
130799798|NCT02573467|470891228|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
130799799|NCT02573467|470891229|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
130799800|NCT02573467|470891230|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
130799801|NCT02573467|470891231|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
130799802|NCT02573467|470891228|FG000|Post-treatment Follow up Epoch|Death|1|||
130799803|NCT02573467|470891229|FG001|Post-treatment Follow up Epoch|Death|1|||
130799804|NCT02573467|470891230|FG002|Post-treatment Follow up Epoch|Death|0|||
130799805|NCT02573467|470891231|FG003|Post-treatment Follow up Epoch|Death|1|||
130799806|NCT02573467|470891228|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
130799807|NCT02573467|470891229|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
130799808|NCT02573467|470891230|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
130799809|NCT02573467|470891231|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
130799810|NCT02573467|470891228|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
130799811|NCT02573467|470891229|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
130799812|NCT02573467|470891230|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
130799813|NCT02573467|470891231|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
130799814|NCT00923702|470891233|FG000|Overall Study|Ongoing enrollment|0|||
130799815|NCT00923702|470891234|FG001|Overall Study|Ongoing enrollment|0|||
130799816|NCT00923702|470891235|FG002|Overall Study|Ongoing enrollment|0|||
130799817|NCT00923702|470891236|FG003|Overall Study|Ongoing enrollment|0|||
130799818|NCT00923702|470891237|FG004|Overall Study|Ongoing enrollment|354|||
130799819|NCT00195429|470891238|FG000|Overall Study|Adverse Event|2|||
130799820|NCT00195429|470891239|FG001|Overall Study|Adverse Event|4|||
130799821|NCT00195429|470891238|FG000|Overall Study|Lack of Efficacy|2|||
130799822|NCT00195429|470891239|FG001|Overall Study|Lack of Efficacy|1|||
130799823|NCT00195429|470891238|FG000|Overall Study|Lost to Follow-up|1|||
130799824|NCT00195429|470891239|FG001|Overall Study|Lost to Follow-up|0|||
130799825|NCT02541903|470891240|FG000|Overall Study|Death|1|||
130799826|NCT00367458|470891241|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
130799827|NCT00367458|470891242|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
130799828|NCT04795323|470891250|FG000|Overall Study|Did not interact with TARA|1|||
130799829|NCT04795323|470891251|FG001|Overall Study|Did not interact with TARA|0|||
130799830|NCT04339972|470891252|FG000|Overall Study|Scheduling Issues|3|||
130799831|NCT04339972|470891253|FG001|Overall Study|Scheduling Issues|3|||
130799832|NCT04339972|470891252|FG000|Overall Study|dropout|1|||
130799833|NCT04339972|470891253|FG001|Overall Study|dropout|1|||
130799834|NCT04339972|470891252|FG000|Overall Study|Technical issues|1|||
130799835|NCT04339972|470891253|FG001|Overall Study|Technical issues|0|||
130799836|NCT04339972|470891252|FG000|Overall Study|Claustraphobia|0|||
130799837|NCT04339972|470891253|FG001|Overall Study|Claustraphobia|1|||
130799838|NCT02691663|470891255|FG000|Overall Study|Screen failure after baseline|2|||
130799839|NCT02691663|470891256|FG001|Overall Study|Screen failure after baseline|2|||
130799840|NCT02691663|470891255|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
130799841|NCT02691663|470891256|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
130799842|NCT02691663|470891255|FG000|Overall Study|Withdrawn after Follow up 2|1|||
130799843|NCT02691663|470891256|FG001|Overall Study|Withdrawn after Follow up 2|1|||
130799844|NCT02691663|470891255|FG000|Overall Study|Lost to Follow-up|3|||
130799845|NCT02691663|470891256|FG001|Overall Study|Lost to Follow-up|2|||
130799846|NCT03142750|470891257|FG000|Overall Study|Lost to Follow-up|4|||
130799847|NCT03142750|470891258|FG001|Overall Study|Lost to Follow-up|1|||
130799848|NCT04925934|470891261|FG000|Overall Study|Adverse Event|1|||
130799849|NCT04925934|470891262|FG001|Overall Study|Adverse Event|0|||
130799850|NCT04925934|470891263|FG002|Overall Study|Adverse Event|0|||
130799851|NCT04925934|470891261|FG000|Overall Study|Lost to Follow-up|2|||
130799852|NCT04925934|470891262|FG001|Overall Study|Lost to Follow-up|0|||
130799853|NCT04925934|470891263|FG002|Overall Study|Lost to Follow-up|1|||
130799854|NCT04925934|470891261|FG000|Overall Study|Death|0|||
130799855|NCT04925934|470891262|FG001|Overall Study|Death|1|||
130799856|NCT04925934|470891263|FG002|Overall Study|Death|0|||
130799857|NCT04925934|470891261|FG000|Overall Study|Withdrawal by Subject|8|||
130799858|NCT04925934|470891262|FG001|Overall Study|Withdrawal by Subject|5|||
130799859|NCT04925934|470891263|FG002|Overall Study|Withdrawal by Subject|9|||
130799860|NCT04925934|470891261|FG000|Overall Study|Other|2|||
130799861|NCT04925934|470891262|FG001|Overall Study|Other|2|||
130799862|NCT04925934|470891263|FG002|Overall Study|Other|2|||
130799863|NCT04925934|470891261|FG000|Overall Study|Eastern European Conflict|7|||
130799864|NCT04925934|470891262|FG001|Overall Study|Eastern European Conflict|3|||
130799865|NCT04925934|470891263|FG002|Overall Study|Eastern European Conflict|2|||
130799866|NCT03158688|470891264|FG000|Overall Study|Withdrawal by Subject|14|||
130799867|NCT03158688|470891265|FG001|Overall Study|Withdrawal by Subject|28|||
130799868|NCT03158688|470891264|FG000|Overall Study|Decision by sponsor|13|||
130799869|NCT03158688|470891265|FG001|Overall Study|Decision by sponsor|37|||
130799870|NCT03158688|470891264|FG000|Overall Study|Lost to Follow-up|4|||
130799871|NCT03158688|470891265|FG001|Overall Study|Lost to Follow-up|3|||
130799872|NCT03158688|470891264|FG000|Overall Study|Death|74|||
130799873|NCT03158688|470891265|FG001|Overall Study|Death|142|||
130799874|NCT02942407|470891266|FG000|Overall Study|Lost to Follow-up|3|||
130799875|NCT02942407|470891267|FG001|Overall Study|Lost to Follow-up|2|||
130799876|NCT02942407|470891266|FG000|Overall Study|Withdrawal by Subject|7|||
130799877|NCT02942407|470891267|FG001|Overall Study|Withdrawal by Subject|9|||
130799878|NCT02942407|470891266|FG000|Overall Study|Death|16|||
130799879|NCT02942407|470891267|FG001|Overall Study|Death|13|||
130799880|NCT01716156|470891272|FG000|Overall Study|Protocol Violation|1|||
130799881|NCT01716156|470891273|FG001|Overall Study|Protocol Violation|0|||
130799882|NCT01716156|470891274|FG002|Overall Study|Protocol Violation|0|||
130799883|NCT01716156|470891272|FG000|Overall Study|Withdrawal by Subject|0|||
130799884|NCT01716156|470891273|FG001|Overall Study|Withdrawal by Subject|1|||
130799885|NCT01716156|470891274|FG002|Overall Study|Withdrawal by Subject|2|||
130799886|NCT01716156|470891272|FG000|Overall Study|Lost to Follow-up|1|||
130799887|NCT01716156|470891273|FG001|Overall Study|Lost to Follow-up|0|||
130799888|NCT01716156|470891274|FG002|Overall Study|Lost to Follow-up|0|||
130799889|NCT03925220|470891275|FG000|Overall Study|Withdrawal by Subject|4|||
130799890|NCT03925220|470891276|FG001|Overall Study|Withdrawal by Subject|4|||
130799891|NCT03925220|470891277|FG002|Overall Study|Withdrawal by Subject|4|||
130799892|NCT03925220|470891278|FG003|Overall Study|Withdrawal by Subject|4|||
130799893|NCT03925220|470891275|FG000|Overall Study|Lost to Follow-up|40|||
130799894|NCT03925220|470891276|FG001|Overall Study|Lost to Follow-up|46|||
130799895|NCT03925220|470891277|FG002|Overall Study|Lost to Follow-up|37|||
130799896|NCT03925220|470891278|FG003|Overall Study|Lost to Follow-up|38|||
130799897|NCT05561140|470891279|FG000|Randomized Treatment Period|Adverse Event|1|||
130799898|NCT05561140|470891280|FG001|Randomized Treatment Period|Adverse Event|0|||
130799899|NCT05561140|470891279|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
130799900|NCT05561140|470891280|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
130799901|NCT05561140|470891279|FG000|Open Label Treatment Period|Adverse Event|6|||
130799902|NCT05561140|470891280|FG001|Open Label Treatment Period|Adverse Event|4|||
130799903|NCT05561140|470891279|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
130799904|NCT05561140|470891280|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
130799905|NCT05561140|470891279|FG000|Open Label Treatment Period|Physician Decision|0|||
130799906|NCT05561140|470891280|FG001|Open Label Treatment Period|Physician Decision|1|||
130799907|NCT05561140|470891279|FG000|Open Label Treatment Period|Pregnancy|1|||
130799908|NCT05561140|470891280|FG001|Open Label Treatment Period|Pregnancy|0|||
130799909|NCT05561140|470891279|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
130799910|NCT05561140|470891280|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
130799911|NCT05561140|470891279|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
130799912|NCT05561140|470891280|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
130799913|NCT05561140|470891279|FG000|Open Label Treatment Period|Other|1|||
130799914|NCT05561140|470891280|FG001|Open Label Treatment Period|Other|0|||
130799915|NCT01944774|470891281|FG000|Overall Study|Withdrawal by Subject|2|||
130799916|NCT01944774|470891282|FG001|Overall Study|Withdrawal by Subject|3|||
130799917|NCT01944774|470891283|FG002|Overall Study|Withdrawal by Subject|3|||
130799918|NCT01944774|470891281|FG000|Overall Study|Adverse Event|3|||
130799919|NCT01944774|470891282|FG001|Overall Study|Adverse Event|2|||
130799920|NCT01944774|470891283|FG002|Overall Study|Adverse Event|3|||
130799921|NCT01944774|470891281|FG000|Overall Study|Lack of Efficacy|1|||
130799922|NCT01944774|470891282|FG001|Overall Study|Lack of Efficacy|2|||
130799923|NCT01944774|470891283|FG002|Overall Study|Lack of Efficacy|2|||
130799924|NCT01944774|470891281|FG000|Overall Study|Lost to Follow-up|0|||
130799925|NCT01944774|470891282|FG001|Overall Study|Lost to Follow-up|1|||
130799926|NCT01944774|470891283|FG002|Overall Study|Lost to Follow-up|0|||
130799927|NCT00374868|470891289|FG000|Overall Study|Adverse Event|12|||
130799928|NCT00374868|470891289|FG000|Overall Study|Progressive Disease|7|||
130799929|NCT00374868|470891289|FG000|Overall Study|Physician Decision|13|||
130799930|NCT00374868|470891289|FG000|Overall Study|Lost to Follow-up|1|||
130799931|NCT00374868|470891289|FG000|Overall Study|Death|2|||
130799932|NCT00374868|470891289|FG000|Overall Study|Other - Not Specified|1|||
130799933|NCT03188185|470891290|FG000|Stage 1|Adverse Event|4|||
130799934|NCT03188185|470891291|FG001|Stage 1|Adverse Event|12|||
130799935|NCT03188185|470891292|FG002|Stage 1|Adverse Event|0|||
130799936|NCT03188185|470891293|FG003|Stage 1|Adverse Event|0|||
130799937|NCT03188185|470891290|FG000|Stage 1|Lack of Efficacy|0|||
130799938|NCT03188185|470891291|FG001|Stage 1|Lack of Efficacy|2|||
130799939|NCT03188185|470891292|FG002|Stage 1|Lack of Efficacy|0|||
130799940|NCT03188185|470891293|FG003|Stage 1|Lack of Efficacy|0|||
130799941|NCT03188185|470891290|FG000|Stage 1|Lost to Follow-up|6|||
130799942|NCT03188185|470891291|FG001|Stage 1|Lost to Follow-up|1|||
130799943|NCT03188185|470891292|FG002|Stage 1|Lost to Follow-up|0|||
130799944|NCT03188185|470891293|FG003|Stage 1|Lost to Follow-up|0|||
130799945|NCT03188185|470891290|FG000|Stage 1|Withdrawal by Subject|9|||
130799946|NCT03188185|470891291|FG001|Stage 1|Withdrawal by Subject|0|||
130799947|NCT03188185|470891292|FG002|Stage 1|Withdrawal by Subject|0|||
130799948|NCT03188185|470891293|FG003|Stage 1|Withdrawal by Subject|0|||
130799949|NCT03188185|470891290|FG000|Stage 1|Identified as a professional patient|0|||
130799950|NCT03188185|470891291|FG001|Stage 1|Identified as a professional patient|1|||
130799951|NCT03188185|470891292|FG002|Stage 1|Identified as a professional patient|0|||
130799952|NCT03188185|470891293|FG003|Stage 1|Identified as a professional patient|0|||
130799953|NCT03188185|470891290|FG000|Stage 2|Adverse Event|0|||
130799954|NCT03188185|470891291|FG001|Stage 2|Adverse Event|0|||
130799955|NCT03188185|470891292|FG002|Stage 2|Adverse Event|2|||
130799956|NCT03188185|470891293|FG003|Stage 2|Adverse Event|4|||
130799957|NCT03188185|470891290|FG000|Stage 2|Lack of Efficacy|0|||
130799958|NCT03188185|470891291|FG001|Stage 2|Lack of Efficacy|0|||
130799959|NCT03188185|470891292|FG002|Stage 2|Lack of Efficacy|3|||
130799960|NCT03188185|470891293|FG003|Stage 2|Lack of Efficacy|0|||
130799961|NCT03188185|470891290|FG000|Stage 2|Lost to Follow-up|0|||
130799962|NCT03188185|470891291|FG001|Stage 2|Lost to Follow-up|0|||
130799963|NCT03188185|470891292|FG002|Stage 2|Lost to Follow-up|1|||
130799964|NCT03188185|470891293|FG003|Stage 2|Lost to Follow-up|0|||
130799965|NCT03188185|470891290|FG000|Stage 2|Physician Decision|0|||
130799966|NCT03188185|470891291|FG001|Stage 2|Physician Decision|0|||
130799967|NCT03188185|470891292|FG002|Stage 2|Physician Decision|0|||
130799968|NCT03188185|470891293|FG003|Stage 2|Physician Decision|1|||
130799969|NCT03188185|470891290|FG000|Stage 2|Withdrawal by Subject|0|||
130799970|NCT03188185|470891291|FG001|Stage 2|Withdrawal by Subject|0|||
130799971|NCT03188185|470891292|FG002|Stage 2|Withdrawal by Subject|3|||
130799972|NCT03188185|470891293|FG003|Stage 2|Withdrawal by Subject|1|||
130799973|NCT02315625|470891297|FG000|First Intervention|Disease Progression|1|||
130799974|NCT02315625|470891298|FG001|First Intervention|Disease Progression|0|||
130799975|NCT02315625|470891297|FG000|Second Intervention|Physician Decision|2|||
130799976|NCT02315625|470891298|FG001|Second Intervention|Physician Decision|1|||
130799977|NCT02315625|470891297|FG000|Second Intervention|Study closure|1|||
130799978|NCT02315625|470891298|FG001|Second Intervention|Study closure|0|||
130799979|NCT02315625|470891297|FG000|Second Intervention|Disease Progression|1|||
130799980|NCT02315625|470891298|FG001|Second Intervention|Disease Progression|0|||
130799981|NCT01947933|470891301|FG000|Overall Study|Withdrawal by Subject|0|||
130799982|NCT01947933|470891302|FG001|Overall Study|Withdrawal by Subject|0|||
130799983|NCT01947933|470891303|FG002|Overall Study|Withdrawal by Subject|1|||
130799984|NCT01947933|470891304|FG003|Overall Study|Withdrawal by Subject|0|||
130799985|NCT01947933|470891305|FG004|Overall Study|Withdrawal by Subject|0|||
130799986|NCT01947933|470891306|FG005|Overall Study|Withdrawal by Subject|0|||
130799987|NCT01947933|470891307|FG006|Overall Study|Withdrawal by Subject|0|||
130799988|NCT01947933|470891308|FG007|Overall Study|Withdrawal by Subject|0|||
130799989|NCT01947933|470891309|FG008|Overall Study|Withdrawal by Subject|0|||
130799990|NCT01947933|470891301|FG000|Overall Study|Lost to Follow-up|0|||
130799991|NCT01947933|470891302|FG001|Overall Study|Lost to Follow-up|0|||
130799992|NCT01947933|470891303|FG002|Overall Study|Lost to Follow-up|0|||
130799993|NCT01947933|470891304|FG003|Overall Study|Lost to Follow-up|0|||
130799994|NCT01947933|470891305|FG004|Overall Study|Lost to Follow-up|0|||
130799995|NCT01947933|470891306|FG005|Overall Study|Lost to Follow-up|0|||
130799996|NCT01947933|470891307|FG006|Overall Study|Lost to Follow-up|0|||
130799997|NCT01947933|470891308|FG007|Overall Study|Lost to Follow-up|0|||
130799998|NCT01947933|470891309|FG008|Overall Study|Lost to Follow-up|1|||
130799999|NCT02965833|470891310|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
130800000|NCT02965833|470891311|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
130800001|NCT02965833|470891310|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
130800002|NCT02965833|470891311|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
130800003|NCT02965833|470891310|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
130800004|NCT02965833|470891311|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
130800005|NCT02965833|470891310|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
130800006|NCT02965833|470891311|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
130800007|NCT02965833|470891310|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
130800008|NCT02965833|470891311|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
130800009|NCT02582632|470893085|FG000|Overall Study|Other|1|||
130800010|NCT03298061|470893086|FG000|Overall Study|Adverse Event|3|||
130800011|NCT03298061|470893086|FG000|Overall Study|Lack of Efficacy|6|||
130800012|NCT03298061|470893086|FG000|Overall Study|Protocol Violation|1|||
130800013|NCT03298061|470893086|FG000|Overall Study|Physician Decision|7|||
130800014|NCT03298061|470893086|FG000|Overall Study|Withdrawal by Subject|10|||
130800015|NCT00992836|470893092|FG000|Overall Study|Lost to Follow-up|1|||
130800016|NCT00992836|470893092|FG000|Overall Study|Withdrawal by Subject|2|||
130800017|NCT00992836|470893092|FG000|Overall Study|Protocol Violation|2|||
130800018|NCT01617967|470893093|FG000|Overall Study|Protocol Violation|0|||
130800019|NCT01617967|470893094|FG001|Overall Study|Protocol Violation|0|||
130800020|NCT01617967|470893095|FG002|Overall Study|Protocol Violation|0|||
130800021|NCT01617967|470893096|FG003|Overall Study|Protocol Violation|1|||
130800022|NCT01617967|470893097|FG004|Overall Study|Protocol Violation|0|||
130800023|NCT01617967|470893098|FG005|Overall Study|Protocol Violation|0|||
130800024|NCT01617967|470893093|FG000|Overall Study|Withdrawal by Subject|0|||
130800025|NCT01617967|470893094|FG001|Overall Study|Withdrawal by Subject|0|||
130800026|NCT01617967|470893095|FG002|Overall Study|Withdrawal by Subject|0|||
130800027|NCT01617967|470893096|FG003|Overall Study|Withdrawal by Subject|0|||
130800028|NCT01617967|470893097|FG004|Overall Study|Withdrawal by Subject|0|||
130800029|NCT01617967|470893098|FG005|Overall Study|Withdrawal by Subject|1|||
130800030|NCT01617967|470893093|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
130800031|NCT01617967|470893094|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
130800032|NCT01617967|470893095|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
130800033|NCT01617967|470893096|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
130800034|NCT01617967|470893097|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
130800035|NCT01617967|470893098|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
130800036|NCT05276804|470893105|FG000|Overall Study|screen failure|23|||
130800037|NCT05276804|470893106|FG001|Overall Study|screen failure|0|||
130800038|NCT02827708|470893107|FG000|Overall Study|Lost to Follow-up|3|||
130800039|NCT02827708|470893108|FG001|Overall Study|Lost to Follow-up|1|||
130800040|NCT02827708|470893107|FG000|Overall Study|Withdrawal by Subject|1|||
130800041|NCT02827708|470893108|FG001|Overall Study|Withdrawal by Subject|2|||
130800042|NCT02827708|470893107|FG000|Overall Study|Death|1|||
130800043|NCT02827708|470893108|FG001|Overall Study|Death|2|||
130800044|NCT01137812|470893109|FG000|Overall Study|Adverse Event|21|||
130800045|NCT01137812|470893110|FG001|Overall Study|Adverse Event|14|||
130800046|NCT01137812|470893109|FG000|Overall Study|Lost to Follow-up|6|||
130800047|NCT01137812|470893110|FG001|Overall Study|Lost to Follow-up|8|||
130800048|NCT01137812|470893109|FG000|Overall Study|Physician Decision|25|||
130800049|NCT01137812|470893110|FG001|Overall Study|Physician Decision|17|||
130800050|NCT01137812|470893109|FG000|Overall Study|Protocol Violation|5|||
130800051|NCT01137812|470893110|FG001|Overall Study|Protocol Violation|4|||
130800052|NCT01137812|470893109|FG000|Overall Study|Withdrawal by Subject|5|||
130800053|NCT01137812|470893110|FG001|Overall Study|Withdrawal by Subject|13|||
130800054|NCT01137812|470893109|FG000|Overall Study|Death|2|||
130800055|NCT01137812|470893110|FG001|Overall Study|Death|0|||
130800056|NCT01137812|470893109|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
130800057|NCT01137812|470893110|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
130800058|NCT01137812|470893109|FG000|Overall Study|Other|19|||
130800059|NCT01137812|470893110|FG001|Overall Study|Other|27|||
130800060|NCT02383173|470893114|FG000|Overall Study|Palliative Care Team withdrew|0|||
130800061|NCT02383173|470893115|FG001|Overall Study|Palliative Care Team withdrew|2|||
130800062|NCT04621760|470893116|FG000|Overall Study|Lost to Follow-up|2|||
130800063|NCT04621760|470893117|FG001|Overall Study|Lost to Follow-up|4|||
130800064|NCT04621760|470893116|FG000|Overall Study|Withdrawal by Subject|1|||
130800065|NCT04621760|470893117|FG001|Overall Study|Withdrawal by Subject|0|||
130800066|NCT01297244|470893118|FG000|Overall Study|Progressive disease|22|||
130800067|NCT01297244|470893119|FG001|Overall Study|Progressive disease|3|||
130800068|NCT01297244|470893118|FG000|Overall Study|Adverse Event|9|||
130800069|NCT01297244|470893119|FG001|Overall Study|Adverse Event|1|||
130800070|NCT01297244|470893118|FG000|Overall Study|Death|1|||
130800071|NCT01297244|470893119|FG001|Overall Study|Death|1|||
130800072|NCT01297244|470893118|FG000|Overall Study|Clinical progression|1|||
130800073|NCT01297244|470893119|FG001|Overall Study|Clinical progression|1|||
130800074|NCT01297244|470893118|FG000|Overall Study|Withdrawal by Subject|2|||
130800075|NCT01297244|470893119|FG001|Overall Study|Withdrawal by Subject|0|||
130800076|NCT03677401|470893120|FG000|Overall Study|Adverse Event|4|||
130800077|NCT03677401|470893121|FG001|Overall Study|Adverse Event|14|||
130800078|NCT03677401|470893120|FG000|Overall Study|Lack of Efficacy|3|||
130800079|NCT03677401|470893121|FG001|Overall Study|Lack of Efficacy|1|||
130800080|NCT03677401|470893120|FG000|Overall Study|Withdrawal by Subject|2|||
130800081|NCT03677401|470893121|FG001|Overall Study|Withdrawal by Subject|2|||
130800082|NCT03677401|470893120|FG000|Overall Study|Sponsor decision|0|||
130800083|NCT03677401|470893121|FG001|Overall Study|Sponsor decision|1|||
130800084|NCT03677401|470893120|FG000|Overall Study|Reason Unspecified|1|||
130800085|NCT03677401|470893121|FG001|Overall Study|Reason Unspecified|0|||
130800086|NCT04602000|470893124|FG000|Overall Study|Withdrawal by Subject|3|||
130800087|NCT04602000|470893125|FG001|Overall Study|Withdrawal by Subject|6|||
130800088|NCT04602000|470893126|FG002|Overall Study|Withdrawal by Subject|3|||
130800089|NCT04602000|470893127|FG003|Overall Study|Withdrawal by Subject|27|||
130800090|NCT04602000|470893128|FG004|Overall Study|Withdrawal by Subject|39|||
130800091|NCT04602000|470893124|FG000|Overall Study|Physician Decision|1|||
130800092|NCT04602000|470893125|FG001|Overall Study|Physician Decision|0|||
130800093|NCT04602000|470893126|FG002|Overall Study|Physician Decision|0|||
130800094|NCT04602000|470893127|FG003|Overall Study|Physician Decision|2|||
130800095|NCT04602000|470893128|FG004|Overall Study|Physician Decision|2|||
130800096|NCT04602000|470893124|FG000|Overall Study|Death|0|||
130800097|NCT04602000|470893125|FG001|Overall Study|Death|1|||
130800098|NCT04602000|470893126|FG002|Overall Study|Death|0|||
130800099|NCT04602000|470893127|FG003|Overall Study|Death|1|||
130800100|NCT04602000|470893128|FG004|Overall Study|Death|2|||
130800101|NCT04602000|470893124|FG000|Overall Study|Lost to Follow-up|0|||
130800102|NCT04602000|470893125|FG001|Overall Study|Lost to Follow-up|0|||
130800103|NCT04602000|470893126|FG002|Overall Study|Lost to Follow-up|0|||
130800104|NCT04602000|470893127|FG003|Overall Study|Lost to Follow-up|3|||
130800105|NCT04602000|470893128|FG004|Overall Study|Lost to Follow-up|4|||
130800106|NCT04602000|470893124|FG000|Overall Study|Other|4|||
130800107|NCT04602000|470893125|FG001|Overall Study|Other|1|||
130800108|NCT04602000|470893126|FG002|Overall Study|Other|2|||
130800109|NCT04602000|470893127|FG003|Overall Study|Other|5|||
130800110|NCT04602000|470893128|FG004|Overall Study|Other|4|||
130800111|NCT04602000|470893124|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130800112|NCT04602000|470893125|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130800113|NCT04602000|470893126|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
130800114|NCT04602000|470893127|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130800115|NCT04602000|470893128|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130800116|NCT01177410|470893129|FG000|Overall Study|Adverse Event|0|||
130800117|NCT01177410|470893130|FG001|Overall Study|Adverse Event|2|||
130800118|NCT01177410|470893131|FG002|Overall Study|Adverse Event|2|||
130800119|NCT01177410|470893129|FG000|Overall Study|Withdrawal by Subject|1|||
130800120|NCT01177410|470893130|FG001|Overall Study|Withdrawal by Subject|4|||
130800121|NCT01177410|470893131|FG002|Overall Study|Withdrawal by Subject|3|||
130800122|NCT01177410|470893129|FG000|Overall Study|Lost to Follow-up|0|||
130800123|NCT01177410|470893130|FG001|Overall Study|Lost to Follow-up|1|||
130800124|NCT01177410|470893131|FG002|Overall Study|Lost to Follow-up|0|||
130800125|NCT00471354|470893132|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
130800126|NCT00471354|470893132|FG000|Overall Study|Adverse Event|13|||
130800127|NCT00471354|470893132|FG000|Overall Study|Protocol Violation|12|||
130800128|NCT00471354|470893132|FG000|Overall Study|Withdrawal by Subject|1|||
130800129|NCT00471354|470893132|FG000|Overall Study|Physician Decision|4|||
130800130|NCT00471354|470893132|FG000|Overall Study|Sponsor Decision|1|||
130800131|NCT00471354|470893132|FG000|Overall Study|Lost to Follow-up|3|||
130800132|NCT00471354|470893132|FG000|Overall Study|Lack of Efficacy|5|||
130800133|NCT00471354|470893132|FG000|Overall Study|Patient/Caregiver Decision|12|||
130800134|NCT00875667|470893134|FG000|Overall Study|Adverse Event|29|||
130800135|NCT00875667|470893135|FG001|Overall Study|Adverse Event|10|||
130800136|NCT00875667|470893134|FG000|Overall Study|Withdrawal by Subject|17|||
130800137|NCT00875667|470893135|FG001|Overall Study|Withdrawal by Subject|5|||
130800138|NCT00875667|470893134|FG000|Overall Study|Death|7|||
130800139|NCT00875667|470893135|FG001|Overall Study|Death|2|||
130800140|NCT00875667|470893134|FG000|Overall Study|Protocol Violation|2|||
130800141|NCT00875667|470893135|FG001|Overall Study|Protocol Violation|0|||
130800142|NCT00875667|470893134|FG000|Overall Study|Disease Progression|100|||
130800143|NCT00875667|470893135|FG001|Overall Study|Disease Progression|49|||
130800144|NCT00875667|470893134|FG000|Overall Study|Miscellaneous|12|||
130800145|NCT00875667|470893135|FG001|Overall Study|Miscellaneous|6|||
130800146|NCT00875667|470893134|FG000|Overall Study|Randomized but no Study Drug Given|3|||
130800147|NCT00875667|470893135|FG001|Overall Study|Randomized but no Study Drug Given|1|||
130800148|NCT00894647|470893136|FG000|Overall Study|Adverse Event|5|||
130800149|NCT00894647|470893137|FG001|Overall Study|Adverse Event|4|||
130800150|NCT00894647|470893136|FG000|Overall Study|Withdrawal by Subject|4|||
130800151|NCT00894647|470893137|FG001|Overall Study|Withdrawal by Subject|4|||
130800152|NCT00894647|470893136|FG000|Overall Study|Lost to Follow-up|0|||
130800153|NCT00894647|470893137|FG001|Overall Study|Lost to Follow-up|2|||
130800154|NCT00894647|470893136|FG000|Overall Study|Non-compliance with study procedures|0|||
130800155|NCT00894647|470893137|FG001|Overall Study|Non-compliance with study procedures|2|||
130800156|NCT00894647|470893136|FG000|Overall Study|Other, not due to AE|1|||
130800157|NCT00894647|470893137|FG001|Overall Study|Other, not due to AE|2|||
130800158|NCT02153827|470893145|FG000|Overall Study|Lost to Follow-up|3|||
130800159|NCT02153827|470893146|FG001|Overall Study|Lost to Follow-up|9|||
130800160|NCT01158404|470893147|FG000|Overall Study|Withdrawal by Subject|0|||
130800161|NCT01158404|470893148|FG001|Overall Study|Withdrawal by Subject|1|||
130800162|NCT01158404|470893149|FG002|Overall Study|Withdrawal by Subject|0|||
130800163|NCT01158404|470893150|FG003|Overall Study|Withdrawal by Subject|0|||
130800164|NCT01158404|470893151|FG004|Overall Study|Withdrawal by Subject|3|||
130800165|NCT01158404|470893152|FG005|Overall Study|Withdrawal by Subject|1|||
130800166|NCT01158404|470893153|FG006|Overall Study|Withdrawal by Subject|0|||
130800167|NCT01158404|470893154|FG007|Overall Study|Withdrawal by Subject|1|||
130800168|NCT01158404|470893147|FG000|Overall Study|Physician Decision|0|||
130800169|NCT01158404|470893148|FG001|Overall Study|Physician Decision|0|||
130800170|NCT01158404|470893149|FG002|Overall Study|Physician Decision|0|||
130800171|NCT01158404|470893150|FG003|Overall Study|Physician Decision|0|||
130800172|NCT01158404|470893151|FG004|Overall Study|Physician Decision|0|||
130800173|NCT01158404|470893152|FG005|Overall Study|Physician Decision|0|||
130800174|NCT01158404|470893153|FG006|Overall Study|Physician Decision|0|||
130800175|NCT01158404|470893154|FG007|Overall Study|Physician Decision|1|||
130800176|NCT01158404|470893147|FG000|Overall Study|Progressive Disease|0|||
130800177|NCT01158404|470893148|FG001|Overall Study|Progressive Disease|0|||
130800178|NCT01158404|470893149|FG002|Overall Study|Progressive Disease|0|||
130800179|NCT01158404|470893150|FG003|Overall Study|Progressive Disease|0|||
130800180|NCT01158404|470893151|FG004|Overall Study|Progressive Disease|0|||
130800181|NCT01158404|470893152|FG005|Overall Study|Progressive Disease|0|||
130800182|NCT01158404|470893153|FG006|Overall Study|Progressive Disease|1|||
130800183|NCT01158404|470893154|FG007|Overall Study|Progressive Disease|0|||
130800184|NCT02143778|470893156|FG000|Overall Study|Withdrawal by Subject|2|||
130800185|NCT02143778|470893156|FG000|Overall Study|Device malfunction|1|||
130800186|NCT00625378|470893158|FG000|Overall Study|Adverse Event|22|||
130800187|NCT00625378|470893159|FG001|Overall Study|Adverse Event|0|||
130800188|NCT00625378|470893158|FG000|Overall Study|Withdrawal by Subject|16|||
130800189|NCT00625378|470893159|FG001|Overall Study|Withdrawal by Subject|0|||
130800190|NCT00625378|470893158|FG000|Overall Study|Death|38|||
130800191|NCT00625378|470893159|FG001|Overall Study|Death|0|||
130800192|NCT00625378|470893158|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
130800193|NCT00625378|470893159|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
130800194|NCT00625378|470893158|FG000|Overall Study|Lost to Follow-up|17|||
130800195|NCT00625378|470893159|FG001|Overall Study|Lost to Follow-up|0|||
130800196|NCT00625378|470893158|FG000|Overall Study|Non-compliant with study medication|3|||
130800197|NCT00625378|470893159|FG001|Overall Study|Non-compliant with study medication|0|||
130800198|NCT00625378|470893158|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
130800199|NCT00625378|470893159|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
130800200|NCT00625378|470893158|FG000|Overall Study|Medical decision|1|||
130800201|NCT00625378|470893159|FG001|Overall Study|Medical decision|0|||
130800202|NCT00625378|470893158|FG000|Overall Study|Multiple toxicities|1|||
130800203|NCT00625378|470893159|FG001|Overall Study|Multiple toxicities|0|||
130800204|NCT00625378|470893158|FG000|Overall Study|New cancer|1|||
130800205|NCT00625378|470893159|FG001|Overall Study|New cancer|0|||
130800206|NCT00625378|470893158|FG000|Overall Study|PTA program|2|||
130800207|NCT00625378|470893159|FG001|Overall Study|PTA program|0|||
130800208|NCT00625378|470893158|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
130800209|NCT00625378|470893159|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
130800210|NCT00625378|470893158|FG000|Overall Study|Sponsor decision|1|||
130800211|NCT00625378|470893159|FG001|Overall Study|Sponsor decision|0|||
130800212|NCT00625378|470893158|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
130800213|NCT00625378|470893159|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
130800214|NCT00625378|470893158|FG000|Overall Study|Switch to commercial drug|6|||
130800215|NCT00625378|470893159|FG001|Overall Study|Switch to commercial drug|1|||
130800216|NCT00625378|470893158|FG000|Overall Study|Missing|2|||
130800217|NCT00625378|470893159|FG001|Overall Study|Missing|0|||
130800218|NCT00625378|470893158|FG000|Overall Study|End of treatment not available|2|||
130800219|NCT00625378|470893159|FG001|Overall Study|End of treatment not available|0|||
130800220|NCT00625378|470893158|FG000|Overall Study|Never treated|2|||
130800221|NCT00625378|470893159|FG001|Overall Study|Never treated|0|||
130800222|NCT02639559|470893161|FG000|Overall Study|Mobilization failure|0|||
130800223|NCT02639559|470893162|FG001|Overall Study|Mobilization failure|3|||
130800224|NCT02639559|470893161|FG000|Overall Study|Issues with vascular acess|1|||
130800225|NCT02639559|470893162|FG001|Overall Study|Issues with vascular acess|0|||
130800226|NCT03880565|470893167|FG000|Overall Study|Withdrawal by Subject|1|||
130800227|NCT03880565|470893168|FG001|Overall Study|Withdrawal by Subject|0|||
130800228|NCT02969018|470893169|FG000|Overall Study|Adverse Event|2|||
130800229|NCT02969018|470893170|FG001|Overall Study|Adverse Event|4|||
130800230|NCT02969018|470893171|FG002|Overall Study|Adverse Event|1|||
130800231|NCT02969018|470893172|FG003|Overall Study|Adverse Event|2|||
130800232|NCT02969018|470893173|FG004|Overall Study|Adverse Event|0|||
130800233|NCT02969018|470893174|FG005|Overall Study|Adverse Event|1|||
130800234|NCT02969018|470893175|FG006|Overall Study|Adverse Event|2|||
130800235|NCT02969018|470893176|FG007|Overall Study|Adverse Event|0|||
130800236|NCT02969018|470893169|FG000|Overall Study|Lack of Efficacy|0|||
130800237|NCT02969018|470893170|FG001|Overall Study|Lack of Efficacy|1|||
130800238|NCT02969018|470893171|FG002|Overall Study|Lack of Efficacy|0|||
130800239|NCT02969018|470893172|FG003|Overall Study|Lack of Efficacy|0|||
130800240|NCT02969018|470893173|FG004|Overall Study|Lack of Efficacy|1|||
130800241|NCT02969018|470893174|FG005|Overall Study|Lack of Efficacy|1|||
130800242|NCT02969018|470893175|FG006|Overall Study|Lack of Efficacy|1|||
130800243|NCT02969018|470893176|FG007|Overall Study|Lack of Efficacy|1|||
130800244|NCT02969018|470893169|FG000|Overall Study|Lost to Follow-up|1|||
130800245|NCT02969018|470893170|FG001|Overall Study|Lost to Follow-up|2|||
130800246|NCT02969018|470893171|FG002|Overall Study|Lost to Follow-up|2|||
130800247|NCT02969018|470893172|FG003|Overall Study|Lost to Follow-up|0|||
130800248|NCT02969018|470893173|FG004|Overall Study|Lost to Follow-up|1|||
130800249|NCT02969018|470893174|FG005|Overall Study|Lost to Follow-up|1|||
130800250|NCT02969018|470893175|FG006|Overall Study|Lost to Follow-up|0|||
130800251|NCT02969018|470893176|FG007|Overall Study|Lost to Follow-up|1|||
130800252|NCT02969018|470893169|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130800253|NCT02969018|470893170|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130800254|NCT02969018|470893171|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130800255|NCT02969018|470893172|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130800256|NCT02969018|470893173|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
130800257|NCT02969018|470893174|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130800258|NCT02969018|470893175|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
130800259|NCT02969018|470893176|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130800260|NCT02969018|470893169|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130800261|NCT02969018|470893170|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130800262|NCT02969018|470893171|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130800263|NCT02969018|470893172|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130800264|NCT02969018|470893173|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130800265|NCT02969018|470893174|FG005|Overall Study|Non-Compliance With Study Drug|0|||
130800266|NCT02969018|470893175|FG006|Overall Study|Non-Compliance With Study Drug|0|||
130800267|NCT02969018|470893176|FG007|Overall Study|Non-Compliance With Study Drug|0|||
130800268|NCT02969018|470893169|FG000|Overall Study|Other|0|||
130800269|NCT02969018|470893170|FG001|Overall Study|Other|0|||
130800270|NCT02969018|470893171|FG002|Overall Study|Other|0|||
130800271|NCT02969018|470893172|FG003|Overall Study|Other|1|||
130800272|NCT02969018|470893173|FG004|Overall Study|Other|0|||
130800273|NCT02969018|470893174|FG005|Overall Study|Other|0|||
130800274|NCT02969018|470893175|FG006|Overall Study|Other|0|||
130800275|NCT02969018|470893176|FG007|Overall Study|Other|2|||
130800276|NCT02969018|470893169|FG000|Overall Study|Pregnancy|0|||
130800277|NCT02969018|470893170|FG001|Overall Study|Pregnancy|0|||
130800278|NCT02969018|470893171|FG002|Overall Study|Pregnancy|0|||
130800279|NCT02969018|470893172|FG003|Overall Study|Pregnancy|0|||
130800280|NCT02969018|470893173|FG004|Overall Study|Pregnancy|0|||
130800281|NCT02969018|470893174|FG005|Overall Study|Pregnancy|1|||
130800282|NCT02969018|470893175|FG006|Overall Study|Pregnancy|0|||
130800283|NCT02969018|470893176|FG007|Overall Study|Pregnancy|0|||
130800284|NCT02969018|470893169|FG000|Overall Study|Protocol Violation|0|||
130800285|NCT02969018|470893170|FG001|Overall Study|Protocol Violation|0|||
130800286|NCT02969018|470893171|FG002|Overall Study|Protocol Violation|1|||
130800287|NCT02969018|470893172|FG003|Overall Study|Protocol Violation|1|||
130800288|NCT02969018|470893173|FG004|Overall Study|Protocol Violation|0|||
130800289|NCT02969018|470893174|FG005|Overall Study|Protocol Violation|0|||
130800290|NCT02969018|470893175|FG006|Overall Study|Protocol Violation|0|||
130800291|NCT02969018|470893176|FG007|Overall Study|Protocol Violation|0|||
130800292|NCT02969018|470893169|FG000|Overall Study|Withdrawal by Subject|0|||
130800293|NCT02969018|470893170|FG001|Overall Study|Withdrawal by Subject|1|||
130800294|NCT02969018|470893171|FG002|Overall Study|Withdrawal by Subject|2|||
130800295|NCT02969018|470893172|FG003|Overall Study|Withdrawal by Subject|1|||
130800296|NCT02969018|470893173|FG004|Overall Study|Withdrawal by Subject|0|||
130800297|NCT02969018|470893174|FG005|Overall Study|Withdrawal by Subject|4|||
130800298|NCT02969018|470893175|FG006|Overall Study|Withdrawal by Subject|4|||
130800299|NCT02969018|470893176|FG007|Overall Study|Withdrawal by Subject|3|||
130800300|NCT04790201|470893180|FG000|Overall Study|Lost to Follow-up|0|||
130800301|NCT04790201|470893181|FG001|Overall Study|Lost to Follow-up|0|||
130800302|NCT04790201|470893182|FG002|Overall Study|Lost to Follow-up|2|||
130800303|NCT04790201|470893180|FG000|Overall Study|Death|0|||
130800304|NCT04790201|470893181|FG001|Overall Study|Death|1|||
130800305|NCT04790201|470893182|FG002|Overall Study|Death|0|||
130800306|NCT04790201|470893180|FG000|Overall Study|Protocol Violation|1|||
130800307|NCT04790201|470893181|FG001|Overall Study|Protocol Violation|0|||
130800308|NCT04790201|470893182|FG002|Overall Study|Protocol Violation|1|||
130800309|NCT05762679|470893185|FG000|Overall Study|Withdrawal by Subject|1|||
130800310|NCT05762679|470893185|FG000|Overall Study|No analyzable imaging data|1|||
130800311|NCT05221866|470893187|FG000|Overall Study|Withdrawal by Subject|5|||
130800312|NCT05221866|470893188|FG001|Overall Study|Withdrawal by Subject|7|||
130800313|NCT05221866|470893189|FG002|Overall Study|Withdrawal by Subject|6|||
130800314|NCT05221866|470893190|FG003|Overall Study|Withdrawal by Subject|4|||
130800315|NCT05221866|470893187|FG000|Overall Study|Physician Decision|3|||
130800316|NCT05221866|470893188|FG001|Overall Study|Physician Decision|2|||
130800317|NCT05221866|470893189|FG002|Overall Study|Physician Decision|1|||
130800318|NCT05221866|470893190|FG003|Overall Study|Physician Decision|4|||
130800319|NCT05221866|470893187|FG000|Overall Study|Lost to Follow-up|12|||
130800320|NCT05221866|470893188|FG001|Overall Study|Lost to Follow-up|17|||
130800321|NCT05221866|470893189|FG002|Overall Study|Lost to Follow-up|14|||
130800322|NCT05221866|470893190|FG003|Overall Study|Lost to Follow-up|14|||
130800323|NCT05221866|470893187|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
130800324|NCT05221866|470893188|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
130800325|NCT05221866|470893189|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
130800326|NCT05221866|470893190|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
130800327|NCT03325439|470893191|FG000|Overall Study|Ineligibility|3|||
130800328|NCT00774748|470893192|FG000|Overall Study|Lost to Follow-up|3|||
130800329|NCT00866320|470893193|FG000|Overall Study|Withdrawal by Subject|4|||
130800330|NCT00866320|470893193|FG000|Overall Study|Death|2|||
130800331|NCT03349515|470893194|FG000|Overall Study|Lack of Efficacy|2|||
130800332|NCT03349515|470893195|FG001|Overall Study|Lack of Efficacy|0|||
130800333|NCT03349515|470893194|FG000|Overall Study|Physician Decision|3|||
130800334|NCT03349515|470893195|FG001|Overall Study|Physician Decision|1|||
130800335|NCT02503865|470893196|FG000|Overall Study|Moved out of area|1|||
130800336|NCT02503865|470893197|FG001|Overall Study|Moved out of area|8|||
130800337|NCT02503865|470893198|FG002|Overall Study|Moved out of area|0|||
130800338|NCT02503865|470893196|FG000|Overall Study|Refused treatment|4|||
130800339|NCT02503865|470893197|FG001|Overall Study|Refused treatment|39|||
130800340|NCT02503865|470893198|FG002|Overall Study|Refused treatment|2|||
130800341|NCT05073315|470893199|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
130800342|NCT05073315|470893200|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
130800343|NCT05073315|470893201|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
130800344|NCT05073315|470893199|FG000|Period 1 (Lead-in Period)|Death|1|||
130800345|NCT05073315|470893200|FG001|Period 1 (Lead-in Period)|Death|0|||
130800346|NCT05073315|470893201|FG002|Period 1 (Lead-in Period)|Death|0|||
130800347|NCT05073315|470893199|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
130800348|NCT05073315|470893200|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
130800349|NCT05073315|470893201|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
130800350|NCT05073315|470893199|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
130800351|NCT05073315|470893200|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
130800352|NCT05073315|470893201|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
130800353|NCT05073315|470893199|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
130800354|NCT05073315|470893200|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
130800355|NCT05073315|470893201|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
130800356|NCT05073315|470893199|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
130800357|NCT05073315|470893200|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
130800358|NCT05073315|470893201|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
130800359|NCT05073315|470893199|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
130800360|NCT05073315|470893200|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
130800361|NCT05073315|470893201|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
130800362|NCT05073315|470893199|FG000|Period 2|Adverse Event|0|||
130800363|NCT05073315|470893200|FG001|Period 2|Adverse Event|3|||
130800364|NCT05073315|470893201|FG002|Period 2|Adverse Event|6|||
130800365|NCT05073315|470893199|FG000|Period 2|Lost to Follow-up|0|||
130800366|NCT05073315|470893200|FG001|Period 2|Lost to Follow-up|5|||
130800367|NCT05073315|470893201|FG002|Period 2|Lost to Follow-up|5|||
130800368|NCT05073315|470893199|FG000|Period 2|Withdrawal by Subject|0|||
130800369|NCT05073315|470893200|FG001|Period 2|Withdrawal by Subject|4|||
130800370|NCT05073315|470893201|FG002|Period 2|Withdrawal by Subject|9|||
130800371|NCT05073315|470893199|FG000|Period 2|Protocol Violation|0|||
130800372|NCT05073315|470893200|FG001|Period 2|Protocol Violation|0|||
130800373|NCT05073315|470893201|FG002|Period 2|Protocol Violation|1|||
130800374|NCT01529268|470893202|FG000|Overall Study|Lost to Follow-up|9|||
130800375|NCT01529268|470893203|FG001|Overall Study|Lost to Follow-up|3|||
130800376|NCT01529268|470893202|FG000|Overall Study|Moved|3|||
130800377|NCT01529268|470893203|FG001|Overall Study|Moved|0|||
130800378|NCT04069520|470893209|FG000|Overall Study|Lost to Follow-up|0|||
130800379|NCT04069520|470893210|FG001|Overall Study|Lost to Follow-up|2|||
130800380|NCT04069520|470893209|FG000|Overall Study|Withdrawal by Subject|0|||
130800381|NCT04069520|470893210|FG001|Overall Study|Withdrawal by Subject|1|||
130800382|NCT04069520|470893209|FG000|Overall Study|Prior Injury|1|||
130800383|NCT04069520|470893210|FG001|Overall Study|Prior Injury|0|||
130800384|NCT04069520|470893209|FG000|Overall Study|Orthodontia|1|||
130800385|NCT04069520|470893210|FG001|Overall Study|Orthodontia|0|||
130800386|NCT04069520|470893209|FG000|Overall Study|Cut from team|0|||
130800387|NCT04069520|470893210|FG001|Overall Study|Cut from team|2|||
130800388|NCT01068912|470893211|FG000|Overall Study|Adverse Event|2|||
130800389|NCT01068912|470893212|FG001|Overall Study|Adverse Event|3|||
130800390|NCT01068912|470893213|FG002|Overall Study|Adverse Event|2|||
130800391|NCT01068912|470893211|FG000|Overall Study|Withdrawal by Subject|5|||
130800392|NCT01068912|470893212|FG001|Overall Study|Withdrawal by Subject|6|||
130800393|NCT01068912|470893213|FG002|Overall Study|Withdrawal by Subject|6|||
130800394|NCT01068912|470893211|FG000|Overall Study|Lost to Follow-up|3|||
130800395|NCT01068912|470893212|FG001|Overall Study|Lost to Follow-up|7|||
130800396|NCT01068912|470893213|FG002|Overall Study|Lost to Follow-up|3|||
130800397|NCT01068912|470893211|FG000|Overall Study|Protocol Violation|0|||
130800398|NCT01068912|470893212|FG001|Overall Study|Protocol Violation|2|||
130800399|NCT01068912|470893213|FG002|Overall Study|Protocol Violation|0|||
130800400|NCT01068912|470893211|FG000|Overall Study|aggravation influenza|1|||
130800401|NCT01068912|470893212|FG001|Overall Study|aggravation influenza|1|||
130800402|NCT01068912|470893213|FG002|Overall Study|aggravation influenza|1|||
130800403|NCT01068912|470893211|FG000|Overall Study|other underlying illness|0|||
130800404|NCT01068912|470893212|FG001|Overall Study|other underlying illness|3|||
130800405|NCT01068912|470893213|FG002|Overall Study|other underlying illness|3|||
130800406|NCT00294398|470893214|FG000|Overall Study|Lost to Follow-up|21|||
130800407|NCT00294398|470893215|FG001|Overall Study|Lost to Follow-up|26|||
130800408|NCT00118287|470893219|FG000|Overall Study|Intracranial haemorrhage|1|||
130800409|NCT00118287|470893219|FG000|Overall Study|Muscle pain|1|||
130800410|NCT03407482|470893220|FG000|Overall Study|Adverse Event|12|||
130800411|NCT03407482|470893220|FG000|Overall Study|Disease Relapse|1|||
130800412|NCT03407482|470893220|FG000|Overall Study|Lost to Follow-up|1|||
130800413|NCT03407482|470893220|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130800414|NCT03407482|470893220|FG000|Overall Study|Pregnancy|2|||
130800415|NCT03407482|470893220|FG000|Overall Study|Protocol Violation|1|||
130800416|NCT03407482|470893220|FG000|Overall Study|Study Terminated By Sponsor|106|||
130800417|NCT03407482|470893220|FG000|Overall Study|Withdrawal by Subject|6|||
130800418|NCT03407482|470893220|FG000|Overall Study|Data Entry Error|1|||
130800419|NCT05089357|470893223|FG000|Overall Study|Withdrawal by Subject|23|||
130800420|NCT05089357|470893223|FG000|Overall Study|Lost to Follow-up|6|||
130800421|NCT05089357|470893223|FG000|Overall Study|Medical reason|1|||
130800422|NCT05089357|470893223|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
130800423|NCT05089357|470893223|FG000|Overall Study|Pregnancy|2|||
130800424|NCT05537571|470893224|FG000|Overall Study|Withdrawal by Subject|1|||
130800425|NCT05537571|470893225|FG001|Overall Study|Withdrawal by Subject|1|||
130800426|NCT05537571|470893226|FG002|Overall Study|Withdrawal by Subject|0|||
130800427|NCT05537571|470893227|FG003|Overall Study|Withdrawal by Subject|0|||
130800428|NCT05537571|470893228|FG004|Overall Study|Withdrawal by Subject|0|||
130800429|NCT05537571|470893224|FG000|Overall Study|Adverse Event|2|||
130800430|NCT05537571|470893225|FG001|Overall Study|Adverse Event|0|||
130800431|NCT05537571|470893226|FG002|Overall Study|Adverse Event|0|||
130800432|NCT05537571|470893227|FG003|Overall Study|Adverse Event|0|||
130800433|NCT05537571|470893228|FG004|Overall Study|Adverse Event|0|||
130800434|NCT05537571|470893224|FG000|Overall Study|Hepatitis A screening result|2|||
130800435|NCT05537571|470893225|FG001|Overall Study|Hepatitis A screening result|0|||
130800436|NCT05537571|470893226|FG002|Overall Study|Hepatitis A screening result|0|||
130800437|NCT05537571|470893227|FG003|Overall Study|Hepatitis A screening result|0|||
130800438|NCT05537571|470893228|FG004|Overall Study|Hepatitis A screening result|0|||
130800439|NCT05537571|470893224|FG000|Overall Study|Lost to Follow-up|0|||
130800440|NCT05537571|470893225|FG001|Overall Study|Lost to Follow-up|0|||
130800441|NCT05537571|470893226|FG002|Overall Study|Lost to Follow-up|1|||
130800442|NCT05537571|470893227|FG003|Overall Study|Lost to Follow-up|0|||
130800443|NCT05537571|470893228|FG004|Overall Study|Lost to Follow-up|1|||
130800444|NCT05752487|470893233|FG000|Overall Study|Enrolled, not treated|9|||
130800445|NCT05752487|470893233|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
130800446|NCT05752487|470893233|FG000|Overall Study|Withdrawal by Subject|2|||
130800447|NCT03091439|470893234|FG000|Overall Study|Study Terminated by the Sponsor|1|||
130800448|NCT03091439|470893235|FG001|Overall Study|Study Terminated by the Sponsor|0|||
130800449|NCT01860989|470893236|FG000|Overall Study|Unsatisfactory therapeutic|5|||
130800450|NCT01685437|470893239|FG000|Overall Study|Withdrawal by Subject|22|||
130800451|NCT01685437|470893239|FG000|Overall Study|Lost to Follow-up|3|||
130800452|NCT01685437|470893239|FG000|Overall Study|Adverse Event|1|||
130800453|NCT01685437|470893239|FG000|Overall Study|Protocol Violation|4|||
130800454|NCT01685437|470893239|FG000|Overall Study|Unable to make visits due to work|1|||
130800455|NCT01214720|470893242|FG000|Overall Study|Alive and still on treatment|34|||
130800456|NCT01214720|470893243|FG001|Overall Study|Alive and still on treatment|18|||
130800457|NCT01214720|470893242|FG000|Overall Study|Alive and in follow-up|45|||
130800458|NCT01214720|470893243|FG001|Overall Study|Alive and in follow-up|48|||
130800459|NCT01214720|470893242|FG000|Overall Study|Lost to Follow-up|6|||
130800460|NCT01214720|470893243|FG001|Overall Study|Lost to Follow-up|2|||
130800461|NCT02347787|470893244|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
130800462|NCT02347787|470893245|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
130800463|NCT02347787|470893244|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
130800464|NCT02347787|470893245|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
130800465|NCT02347787|470893244|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
130800466|NCT02347787|470893245|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
130800467|NCT02347787|470893244|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
130800468|NCT02347787|470893245|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
130800469|NCT01039675|470893254|FG000|Overall Study|Adverse Event|0|||
130800470|NCT01039675|470893255|FG001|Overall Study|Adverse Event|2|||
130800471|NCT01039675|470893254|FG000|Overall Study|Lack of Efficacy|0|||
130800472|NCT01039675|470893255|FG001|Overall Study|Lack of Efficacy|2|||
130800473|NCT01039675|470893254|FG000|Overall Study|Withdrawal by Subject|0|||
130800474|NCT01039675|470893255|FG001|Overall Study|Withdrawal by Subject|1|||
130800475|NCT01039675|470893254|FG000|Overall Study|Lost to Follow-up|0|||
130800476|NCT01039675|470893255|FG001|Overall Study|Lost to Follow-up|1|||
130800477|NCT01039675|470893254|FG000|Overall Study|Physician Decision|0|||
130800478|NCT01039675|470893255|FG001|Overall Study|Physician Decision|1|||
130800479|NCT03921541|470894866|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
130800480|NCT03921541|470894867|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
130800481|NCT02642679|470894868|FG000|Overall Study|Withdrawal by Subject|1|||
130800482|NCT02642679|470894868|FG000|Overall Study|Physician Decision|1|||
130800483|NCT02642679|470894868|FG000|Overall Study|Physician Decision|1|||
130800484|NCT01653262|470894869|FG000|Overall Study|Lack of Efficacy|1|||
130800485|NCT01653262|470894869|FG000|Overall Study|SAE, non-fatal|1|||
130800486|NCT01653262|470894869|FG000|Overall Study|AE, non-serious non-fatal|1|||
130800487|NCT01112267|470894871|FG000|Overall Study|Adverse Event|24|||
130800488|NCT01112267|470894872|FG001|Overall Study|Adverse Event|6|||
130800489|NCT01112267|470894871|FG000|Overall Study|Withdrawal by Subject|3|||
130800490|NCT01112267|470894872|FG001|Overall Study|Withdrawal by Subject|5|||
130800491|NCT01112267|470894871|FG000|Overall Study|Protocol Violation|5|||
130800492|NCT01112267|470894872|FG001|Overall Study|Protocol Violation|3|||
130800493|NCT01112267|470894871|FG000|Overall Study|Participants not compliant|1|||
130800494|NCT01112267|470894872|FG001|Overall Study|Participants not compliant|2|||
130800495|NCT01112267|470894871|FG000|Overall Study|Participants not receive any study drug|1|||
130800496|NCT01112267|470894872|FG001|Overall Study|Participants not receive any study drug|2|||
130800497|NCT00420407|470894874|FG000|Overall Study|Lost to Follow-up|0|||
130800498|NCT00420407|470894875|FG001|Overall Study|Lost to Follow-up|3|||
130800499|NCT00420407|470894874|FG000|Overall Study|Physician Decision|2|||
130800500|NCT00420407|470894875|FG001|Overall Study|Physician Decision|1|||
130800501|NCT00420407|470894874|FG000|Overall Study|subject identified as detainee|1|||
130800502|NCT00420407|470894875|FG001|Overall Study|subject identified as detainee|0|||
130800503|NCT00420407|470894874|FG000|Overall Study|subject identified as Jehovah's witness|1|||
130800504|NCT00420407|470894875|FG001|Overall Study|subject identified as Jehovah's witness|0|||
130800505|NCT00420407|470894874|FG000|Overall Study|Withdrawal by Subject|0|||
130800506|NCT00420407|470894875|FG001|Overall Study|Withdrawal by Subject|2|||
130800507|NCT05638737|470894878|FG000|Overall Study|Withdrawal by Subject|4|||
130800508|NCT05638737|470894879|FG001|Overall Study|Withdrawal by Subject|7|||
130800509|NCT04633447|470894882|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
130800510|NCT04633447|470894883|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
130800511|NCT04633447|470894882|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
130800512|NCT04633447|470894883|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
130800513|NCT04633447|470894882|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
130800514|NCT04633447|470894883|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
130800515|NCT04633447|470894882|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
130800516|NCT04633447|470894883|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
130800517|NCT04633447|470894882|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
130800518|NCT04633447|470894883|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
130800519|NCT04633447|470894882|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
130800520|NCT04633447|470894883|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
130800521|NCT03641924|470894884|FG000|Overall Study|Withdrawal by Subject|26|||
130800522|NCT03641924|470894884|FG000|Overall Study|Lost to Follow-up|16|||
130800523|NCT03641924|470894884|FG000|Overall Study|Protocol Violation|10|||
130800524|NCT04333498|470894885|FG000|Overall Study|Lost to Follow-up|1|||
130800525|NCT04333498|470894886|FG001|Overall Study|Lost to Follow-up|0|||
130800526|NCT04333498|470894885|FG000|Overall Study|Lost to Follow-up|0|||
130800527|NCT04333498|470894886|FG001|Overall Study|Lost to Follow-up|1|||
130800528|NCT01565694|470894887|FG000|Dose-Titration Period|Adverse Event|4|||
130800529|NCT01565694|470894887|FG000|Dose-Titration Period|Protocol Violation|10|||
130800530|NCT01565694|470894887|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
130800531|NCT00541229|470894894|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
130800532|NCT00541229|470894895|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
130800533|NCT00541229|470894896|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
130800534|NCT00541229|470894897|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
130800535|NCT00541229|470894898|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
130800536|NCT00541229|470894899|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
130800537|NCT00541229|470894894|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130800538|NCT00541229|470894895|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130800539|NCT00541229|470894896|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130800540|NCT00541229|470894897|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130800541|NCT00541229|470894898|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130800542|NCT00541229|470894899|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
130800543|NCT00541229|470894894|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130800544|NCT00541229|470894895|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130800545|NCT00541229|470894896|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130800546|NCT00541229|470894897|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130800547|NCT00541229|470894898|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130800548|NCT00541229|470894899|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
130800549|NCT00541229|470894894|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
130800550|NCT00541229|470894895|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
130800551|NCT00541229|470894896|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
130800552|NCT00541229|470894897|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
130800553|NCT00541229|470894898|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
130800554|NCT00541229|470894899|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
130800555|NCT00541229|470894894|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
130800556|NCT00541229|470894895|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
130800557|NCT00541229|470894896|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
130800558|NCT00541229|470894897|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
130800559|NCT00541229|470894898|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
130800560|NCT00541229|470894899|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
130800561|NCT00541229|470894894|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
130800562|NCT00541229|470894895|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
130800563|NCT00541229|470894896|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
130800564|NCT00541229|470894897|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
130800565|NCT00541229|470894898|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
130800566|NCT00541229|470894899|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
130800567|NCT00541229|470894894|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
130800568|NCT00541229|470894895|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
130800569|NCT00541229|470894896|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
130800570|NCT00541229|470894897|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
130800571|NCT00541229|470894898|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
130800572|NCT00541229|470894899|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
130800573|NCT00541229|470894894|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
130800574|NCT00541229|470894895|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
130800575|NCT00541229|470894896|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
130800576|NCT00541229|470894897|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
130800577|NCT00541229|470894898|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
130800578|NCT00541229|470894899|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
130800579|NCT00541229|470894894|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
130800580|NCT00541229|470894895|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
130800581|NCT00541229|470894896|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
130800582|NCT00541229|470894897|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
130800583|NCT00541229|470894898|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
130800584|NCT00541229|470894899|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
130800585|NCT00541229|470894894|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
130800586|NCT00541229|470894895|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130800587|NCT00541229|470894896|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130800588|NCT00541229|470894897|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130800589|NCT00541229|470894898|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130800590|NCT00541229|470894899|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
130800591|NCT00541229|470894894|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
130800592|NCT00541229|470894895|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
130800593|NCT00541229|470894896|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
130800594|NCT00541229|470894897|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
130800595|NCT00541229|470894898|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
130800596|NCT00541229|470894899|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
130800597|NCT00541229|470894894|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130800598|NCT00541229|470894895|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130800599|NCT00541229|470894896|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130800600|NCT00541229|470894897|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130800601|NCT00541229|470894898|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
130800602|NCT00541229|470894899|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130800603|NCT00541229|470894894|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
130800604|NCT00541229|470894895|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
130800605|NCT00541229|470894896|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
130800606|NCT00541229|470894897|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
130800607|NCT00541229|470894898|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
130800608|NCT00541229|470894899|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
130800609|NCT00541229|470894894|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
130800610|NCT00541229|470894895|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
130800611|NCT00541229|470894896|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
130800612|NCT00541229|470894897|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
130800613|NCT00541229|470894898|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
130800614|NCT00541229|470894899|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
130800615|NCT00541229|470894894|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130800616|NCT00541229|470894895|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130800617|NCT00541229|470894896|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130800618|NCT00541229|470894897|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130800619|NCT00541229|470894898|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130800620|NCT00541229|470894899|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
130800621|NCT00541229|470894894|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130800622|NCT00541229|470894895|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130800623|NCT00541229|470894896|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
130800624|NCT00541229|470894897|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130800625|NCT00541229|470894898|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130800626|NCT00541229|470894899|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130800627|NCT00134719|470894900|FG000|Primary Vaccination Phase|Adverse Event|4|||
130800628|NCT00134719|470894901|FG001|Primary Vaccination Phase|Adverse Event|0|||
130800629|NCT00134719|470894902|FG002|Primary Vaccination Phase|Adverse Event|0|||
130800630|NCT00134719|470894900|FG000|Primary Vaccination Phase|Protocol Violation|1|||
130800631|NCT00134719|470894901|FG001|Primary Vaccination Phase|Protocol Violation|0|||
130800632|NCT00134719|470894902|FG002|Primary Vaccination Phase|Protocol Violation|0|||
130800633|NCT00134719|470894900|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
130800634|NCT00134719|470894901|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
130800635|NCT00134719|470894902|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
130800636|NCT00134719|470894900|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
130800637|NCT00134719|470894901|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
130800638|NCT00134719|470894902|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
130800639|NCT00134719|470894900|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
130800640|NCT00134719|470894901|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
130800641|NCT00134719|470894902|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
130800642|NCT00134719|470894900|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
130800643|NCT00134719|470894901|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
130800644|NCT00134719|470894902|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
130800645|NCT03439839|470894903|FG000|Overall Study|Death|3|||
130800646|NCT03439839|470894904|FG001|Overall Study|Death|0|||
130800647|NCT01807520|470894907|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130800648|NCT01807520|470894908|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
130800649|NCT01807520|470894909|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
130800650|NCT01807520|470894910|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130800651|NCT01807520|470894911|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130800652|NCT01807520|470894912|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130800653|NCT01807520|470894913|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130800654|NCT01807520|470894907|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
130800655|NCT01807520|470894908|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130800656|NCT01807520|470894909|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
130800657|NCT01807520|470894910|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130800658|NCT01807520|470894911|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130800659|NCT01807520|470894912|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130800660|NCT01807520|470894913|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130800661|NCT01807520|470894907|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130800662|NCT01807520|470894908|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130800663|NCT01807520|470894909|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
130800664|NCT01807520|470894910|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130800665|NCT01807520|470894911|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130800666|NCT01807520|470894912|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130800667|NCT01807520|470894913|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130800668|NCT01807520|470894907|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
130800669|NCT01807520|470894908|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130800670|NCT01807520|470894909|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130800671|NCT01807520|470894910|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130800672|NCT01807520|470894911|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130800673|NCT01807520|470894912|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130800674|NCT01807520|470894913|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130800675|NCT01807520|470894907|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130800676|NCT01807520|470894908|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130800677|NCT01807520|470894909|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
130800678|NCT01807520|470894910|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130800679|NCT01807520|470894911|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130800680|NCT01807520|470894912|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130800681|NCT01807520|470894913|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130800682|NCT01807520|470894907|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
130800683|NCT01807520|470894908|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130800684|NCT01807520|470894909|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130800685|NCT01807520|470894910|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130800686|NCT01807520|470894911|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130800687|NCT01807520|470894912|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130800688|NCT01807520|470894913|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130800689|NCT01807520|470894907|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
130800690|NCT01807520|470894908|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
130800691|NCT01807520|470894909|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130800692|NCT01807520|470894910|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130800693|NCT01807520|470894911|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
130800694|NCT01807520|470894912|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130800695|NCT01807520|470894913|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130800696|NCT01807520|470894907|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130800697|NCT01807520|470894908|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130800698|NCT01807520|470894909|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130800699|NCT01807520|470894910|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
130800700|NCT01807520|470894911|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130800701|NCT01807520|470894912|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130800702|NCT01807520|470894913|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130800703|NCT01807520|470894907|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
130800704|NCT01807520|470894908|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130800705|NCT01807520|470894909|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130800706|NCT01807520|470894910|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130800707|NCT01807520|470894911|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130763337|NCT03800836|470755929|FG000|Overall Study|Symptomatic Deterioration|1|||
130763338|NCT03800836|470755930|FG001|Overall Study|Symptomatic Deterioration|0|||
130763339|NCT03800836|470755931|FG002|Overall Study|Symptomatic Deterioration|1|||
130763340|NCT03800836|470755932|FG003|Overall Study|Symptomatic Deterioration|0|||
130763341|NCT03800836|470755933|FG004|Overall Study|Symptomatic Deterioration|0|||
130763342|NCT03800836|470755934|FG005|Overall Study|Symptomatic Deterioration|0|||
130763343|NCT05072106|470757273|FG000|Overall Study|Progressive disease|3|||
130763344|NCT05072106|470757274|FG001|Overall Study|Progressive disease|3|||
130763345|NCT05072106|470757273|FG000|Overall Study|Compassionate use|3|||
130763346|NCT05072106|470757274|FG001|Overall Study|Compassionate use|1|||
130763347|NCT05072106|470757273|FG000|Overall Study|Withdrawal by Subject|1|||
130763348|NCT05072106|470757274|FG001|Overall Study|Withdrawal by Subject|0|||
130763349|NCT03839459|470757275|FG000|Overall Study|Withdrawal by Subject|2|||
130763350|NCT03839459|470757275|FG000|Overall Study|progression of disease|3|||
130763351|NCT02542293|470757280|FG000|Overall Study|Death|367|||
130763352|NCT02542293|470757281|FG001|Overall Study|Death|377|||
130763353|NCT02542293|470757280|FG000|Overall Study|Withdrawal by Subject|8|||
130763354|NCT02542293|470757281|FG001|Overall Study|Withdrawal by Subject|19|||
130763355|NCT01458951|470757284|FG000|Overall Study|Other|1|||
130763356|NCT01458951|470757285|FG001|Overall Study|Other|0|||
130763357|NCT01458951|470757286|FG002|Overall Study|Other|0|||
130763358|NCT01458951|470757284|FG000|Overall Study|Protocol Violation|5|||
130763359|NCT01458951|470757285|FG001|Overall Study|Protocol Violation|1|||
130763360|NCT01458951|470757286|FG002|Overall Study|Protocol Violation|0|||
130763361|NCT01458951|470757284|FG000|Overall Study|Withdrawal by Subject|2|||
130763362|NCT01458951|470757285|FG001|Overall Study|Withdrawal by Subject|0|||
130763363|NCT01458951|470757286|FG002|Overall Study|Withdrawal by Subject|2|||
130763364|NCT01458951|470757284|FG000|Overall Study|Adverse Event|7|||
130763365|NCT01458951|470757285|FG001|Overall Study|Adverse Event|0|||
130763366|NCT01458951|470757286|FG002|Overall Study|Adverse Event|2|||
130763367|NCT01458951|470757284|FG000|Overall Study|Insufficient Clinical Response|17|||
130763368|NCT01458951|470757285|FG001|Overall Study|Insufficient Clinical Response|0|||
130763369|NCT01458951|470757286|FG002|Overall Study|Insufficient Clinical Response|11|||
130763370|NCT02963558|470757289|FG000|Overall Study|Withdrawn by investigator|1|||
130763371|NCT02963558|470757290|FG001|Overall Study|Withdrawn by investigator|0|||
130763372|NCT02963558|470757289|FG000|Overall Study|Withdrawal by Subject|0|||
130763373|NCT02963558|470757290|FG001|Overall Study|Withdrawal by Subject|1|||
130763374|NCT01573767|470757291|FG000|Overall Study|Adverse Event|0|||
130763375|NCT01573767|470757292|FG001|Overall Study|Adverse Event|1|||
130763376|NCT01573767|470757293|FG002|Overall Study|Adverse Event|0|||
130763377|NCT01573767|470757294|FG003|Overall Study|Adverse Event|1|||
130763378|NCT01573767|470757291|FG000|Overall Study|Lack of Efficacy|18|||
130763379|NCT01573767|470757292|FG001|Overall Study|Lack of Efficacy|15|||
130763380|NCT01573767|470757293|FG002|Overall Study|Lack of Efficacy|12|||
130763381|NCT01573767|470757294|FG003|Overall Study|Lack of Efficacy|17|||
130763382|NCT01573767|470757291|FG000|Overall Study|Protocol Violation|3|||
130763383|NCT01573767|470757292|FG001|Overall Study|Protocol Violation|1|||
130763384|NCT01573767|470757293|FG002|Overall Study|Protocol Violation|1|||
130763385|NCT01573767|470757294|FG003|Overall Study|Protocol Violation|3|||
130763386|NCT01573767|470757291|FG000|Overall Study|Lost to Follow-up|0|||
130763387|NCT01573767|470757292|FG001|Overall Study|Lost to Follow-up|1|||
130763388|NCT01573767|470757293|FG002|Overall Study|Lost to Follow-up|1|||
130763389|NCT01573767|470757294|FG003|Overall Study|Lost to Follow-up|1|||
130763390|NCT01573767|470757291|FG000|Overall Study|Physician Decision|1|||
130763391|NCT01573767|470757292|FG001|Overall Study|Physician Decision|2|||
130763392|NCT01573767|470757293|FG002|Overall Study|Physician Decision|0|||
130763393|NCT01573767|470757294|FG003|Overall Study|Physician Decision|2|||
130763394|NCT01573767|470757291|FG000|Overall Study|Withdrawal by Subject|0|||
130763395|NCT01573767|470757292|FG001|Overall Study|Withdrawal by Subject|1|||
130763396|NCT01573767|470757293|FG002|Overall Study|Withdrawal by Subject|0|||
130763397|NCT01573767|470757294|FG003|Overall Study|Withdrawal by Subject|0|||
130763398|NCT01371877|470757297|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
130763399|NCT01371877|470757298|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
130763400|NCT00869557|470757299|FG000|Randomized Phase|Lost to Follow-up|2|||
130763401|NCT00869557|470757300|FG001|Randomized Phase|Lost to Follow-up|1|||
130763402|NCT00869557|470757299|FG000|Randomized Phase|Investigator's Discretion|1|||
130763403|NCT00869557|470757300|FG001|Randomized Phase|Investigator's Discretion|0|||
130763404|NCT00869557|470757299|FG000|Randomized Phase|Withdrew Consent|0|||
130763405|NCT00869557|470757300|FG001|Randomized Phase|Withdrew Consent|1|||
130763406|NCT00869557|470757299|FG000|Extension Phase|Adverse Event|2|||
130763407|NCT00869557|470757300|FG001|Extension Phase|Adverse Event|2|||
130763408|NCT00869557|470757299|FG000|Extension Phase|Lack of Efficacy|1|||
130763409|NCT00869557|470757300|FG001|Extension Phase|Lack of Efficacy|0|||
130763410|NCT00869557|470757299|FG000|Extension Phase|Lost to Follow-up|3|||
130763411|NCT00869557|470757300|FG001|Extension Phase|Lost to Follow-up|1|||
130763412|NCT00869557|470757299|FG000|Extension Phase|Investigator's Discretion|2|||
130763413|NCT00869557|470757300|FG001|Extension Phase|Investigator's Discretion|0|||
130763414|NCT00869557|470757299|FG000|Extension Phase|Withdrew Consent|2|||
130800708|NCT01807520|470894912|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130800709|NCT01807520|470894913|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130800710|NCT01807520|470894907|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130800711|NCT01807520|470894908|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
130800712|NCT01807520|470894909|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130800713|NCT01807520|470894910|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130800714|NCT01807520|470894911|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130800715|NCT01807520|470894912|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130800716|NCT01807520|470894913|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130800717|NCT01807520|470894907|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
130800718|NCT01807520|470894908|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130800719|NCT01807520|470894909|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130800720|NCT01807520|470894910|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
130800721|NCT01807520|470894911|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130800722|NCT01807520|470894912|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130800723|NCT01807520|470894913|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130800724|NCT01807520|470894907|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
130800725|NCT01807520|470894908|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
130800726|NCT01807520|470894909|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130800727|NCT01807520|470894910|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130800728|NCT01807520|470894911|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
130800729|NCT01807520|470894912|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130800730|NCT01807520|470894913|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130800731|NCT01807520|470894907|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
130800732|NCT01807520|470894908|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
130800733|NCT01807520|470894909|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130800734|NCT01807520|470894910|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
130800735|NCT01807520|470894911|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130800736|NCT01807520|470894912|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130800737|NCT01807520|470894913|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130800738|NCT01807520|470894907|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
130800739|NCT01807520|470894908|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
130800740|NCT01807520|470894909|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
130800741|NCT01807520|470894910|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
130800742|NCT01807520|470894911|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
130800743|NCT01807520|470894912|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
130800744|NCT01807520|470894913|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
130800745|NCT01807520|470894907|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130800746|NCT01807520|470894908|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130800747|NCT01807520|470894909|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130800748|NCT01807520|470894910|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130800749|NCT01807520|470894911|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130800750|NCT01807520|470894912|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
130800751|NCT01807520|470894913|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130800752|NCT01807520|470894907|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130800753|NCT01807520|470894908|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130800754|NCT01807520|470894909|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130800755|NCT01807520|470894910|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130800756|NCT01807520|470894911|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130800757|NCT01807520|470894912|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
130800758|NCT01807520|470894913|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130800759|NCT01807520|470894907|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130800760|NCT01807520|470894908|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130800761|NCT01807520|470894909|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130800762|NCT01807520|470894910|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130800763|NCT01807520|470894911|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130800764|NCT01807520|470894912|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
130800765|NCT01807520|470894913|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
130800766|NCT01797185|470894917|FG000|Overall Study|Adverse Event|5|||
130800767|NCT01797185|470894918|FG001|Overall Study|Adverse Event|15|||
130800768|NCT01797185|470894919|FG002|Overall Study|Adverse Event|6|||
130800769|NCT01797185|470894917|FG000|Overall Study|Withdrawal by Subject|6|||
130800770|NCT01797185|470894918|FG001|Overall Study|Withdrawal by Subject|9|||
130800771|NCT01797185|470894919|FG002|Overall Study|Withdrawal by Subject|5|||
130800772|NCT01797185|470894917|FG000|Overall Study|Site terminated|8|||
130800773|NCT01797185|470894918|FG001|Overall Study|Site terminated|4|||
130800774|NCT01797185|470894919|FG002|Overall Study|Site terminated|0|||
130800775|NCT01797185|470894917|FG000|Overall Study|Lost to Follow-up|2|||
130800776|NCT01797185|470894918|FG001|Overall Study|Lost to Follow-up|6|||
130800777|NCT01797185|470894919|FG002|Overall Study|Lost to Follow-up|1|||
130800778|NCT01797185|470894917|FG000|Overall Study|Withdrawn per sponsor|5|||
130800779|NCT01797185|470894918|FG001|Overall Study|Withdrawn per sponsor|0|||
130800780|NCT01797185|470894919|FG002|Overall Study|Withdrawn per sponsor|0|||
130800781|NCT01797185|470894917|FG000|Overall Study|Physician Decision|1|||
130800782|NCT01797185|470894918|FG001|Overall Study|Physician Decision|3|||
130800783|NCT01797185|470894919|FG002|Overall Study|Physician Decision|0|||
130800784|NCT01797185|470894917|FG000|Overall Study|Protocol Violation|1|||
130800785|NCT01797185|470894918|FG001|Overall Study|Protocol Violation|1|||
130800786|NCT01797185|470894919|FG002|Overall Study|Protocol Violation|0|||
130800787|NCT00723944|470894920|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
130800788|NCT00723944|470894921|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
130800789|NCT00723944|470894920|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
130800790|NCT00723944|470894921|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
130800791|NCT00723944|470894920|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
130800792|NCT00723944|470894921|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
130800793|NCT05177094|470894922|FG000|Overall Study|Adverse Event|5|||
130800794|NCT05177094|470894923|FG001|Overall Study|Adverse Event|5|||
130800795|NCT05177094|470894922|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
130800796|NCT05177094|470894923|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
130800797|NCT05177094|470894922|FG000|Overall Study|Protocol Deviation|3|||
130800798|NCT05177094|470894923|FG001|Overall Study|Protocol Deviation|0|||
130800799|NCT05177094|470894922|FG000|Overall Study|Withdrawal by Subject|6|||
130800800|NCT05177094|470894923|FG001|Overall Study|Withdrawal by Subject|3|||
130800801|NCT05177094|470894922|FG000|Overall Study|Participant could not tolerate long study visits|1|||
130800802|NCT05177094|470894923|FG001|Overall Study|Participant could not tolerate long study visits|0|||
130800803|NCT03670628|470894924|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
130800804|NCT03670628|470894925|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
130800805|NCT03670628|470894924|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
130800806|NCT03670628|470894925|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
130800807|NCT06377488|470894926|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
130800808|NCT06377488|470894926|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
130800809|NCT06377488|470894926|FG000|Overall Study|Protocol Violation|1|||
130800810|NCT06377488|470894926|FG000|Overall Study|Lost to Follow-up|1|||
130800811|NCT06377488|470894926|FG000|Overall Study|Incorrect Lens Dispensed|2|||
130800812|NCT01179516|470894927|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
130800813|NCT01179516|470894928|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
130800814|NCT01179516|470894929|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
130800815|NCT01179516|470894927|FG000|Overall Study|Lack of Efficacy|4|||
130800816|NCT01179516|470894928|FG001|Overall Study|Lack of Efficacy|2|||
130800817|NCT01179516|470894929|FG002|Overall Study|Lack of Efficacy|0|||
130800818|NCT01179516|470894927|FG000|Overall Study|Noncompliance with Study Drug|2|||
130800819|NCT01179516|470894928|FG001|Overall Study|Noncompliance with Study Drug|0|||
130800820|NCT01179516|470894929|FG002|Overall Study|Noncompliance with Study Drug|1|||
130800821|NCT01179516|470894927|FG000|Overall Study|Protocol Deviations|4|||
130800822|NCT01179516|470894928|FG001|Overall Study|Protocol Deviations|3|||
130800823|NCT01179516|470894929|FG002|Overall Study|Protocol Deviations|3|||
130800824|NCT01179516|470894927|FG000|Overall Study|Withdrawal of Consent|2|||
130800825|NCT01179516|470894928|FG001|Overall Study|Withdrawal of Consent|6|||
130800826|NCT01179516|470894929|FG002|Overall Study|Withdrawal of Consent|10|||
130800827|NCT01179516|470894927|FG000|Overall Study|Lost to Follow-up|7|||
130800828|NCT01179516|470894928|FG001|Overall Study|Lost to Follow-up|7|||
130800829|NCT01179516|470894929|FG002|Overall Study|Lost to Follow-up|3|||
130800830|NCT01179516|470894927|FG000|Overall Study|Other|2|||
130800831|NCT01179516|470894928|FG001|Overall Study|Other|0|||
130800832|NCT01179516|470894929|FG002|Overall Study|Other|2|||
130800833|NCT02112552|470894932|FG000|Overall Study|Withdrawal by Subject|1|||
130800834|NCT02112552|470894932|FG000|Overall Study|Adverse Event|1|||
130800835|NCT02965456|470894933|FG000|Overall Study|Lost to Follow-up|40|||
130800836|NCT02965456|470894934|FG001|Overall Study|Lost to Follow-up|18|||
130800837|NCT02965456|470894933|FG000|Overall Study|Subject Request|22|||
130800838|NCT02965456|470894934|FG001|Overall Study|Subject Request|13|||
130800839|NCT02965456|470894933|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
130800840|NCT02965456|470894934|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
130800841|NCT02965456|470894933|FG000|Overall Study|Adverse Event|3|||
130800842|NCT02965456|470894934|FG001|Overall Study|Adverse Event|0|||
130800843|NCT02965456|470894933|FG000|Overall Study|Noncompliance with Study Drug|1|||
130800844|NCT02965456|470894934|FG001|Overall Study|Noncompliance with Study Drug|1|||
130800845|NCT02965456|470894933|FG000|Overall Study|Worsening Condition|0|||
130800846|NCT02965456|470894934|FG001|Overall Study|Worsening Condition|2|||
130800847|NCT02965456|470894933|FG000|Overall Study|Lack of Efficacy|1|||
130763415|NCT00869557|470757300|FG001|Extension Phase|Withdrew Consent|0|||
130763416|NCT00328094|470757303|FG000|Overall Study|Physician Decision|3|||
130763417|NCT00328094|470757304|FG001|Overall Study|Physician Decision|3|||
130763418|NCT02368210|470757305|FG000|Overall Study|Withdrawal by Subject|1|||
130763419|NCT02368210|470757306|FG001|Overall Study|Withdrawal by Subject|0|||
130763420|NCT02368210|470757305|FG000|Overall Study|Adverse Event|0|||
130763421|NCT02368210|470757306|FG001|Overall Study|Adverse Event|1|||
130763422|NCT00078949|470757307|FG000|Overall Study|No treated|4|||
130763423|NCT00078949|470757308|FG001|Overall Study|No treated|5|||
130763424|NCT00078949|470757309|FG002|Overall Study|No treated|3|||
130763425|NCT00078949|470757310|FG003|Overall Study|No treated|3|||
130763426|NCT02309723|470757311|FG000|Overall Study|Withdrawal by Subject|24|||
130763427|NCT02309723|470757312|FG001|Overall Study|Withdrawal by Subject|23|||
130763428|NCT02309723|470757313|FG002|Overall Study|Withdrawal by Subject|24|||
130763429|NCT01143064|470757314|FG000|Overall Study|Death|109|||
130763430|NCT01143064|470757315|FG001|Overall Study|Death|91|||
130763431|NCT01143064|470757314|FG000|Overall Study|Adverse Event|0|||
130763432|NCT01143064|470757315|FG001|Overall Study|Adverse Event|1|||
130763433|NCT01143064|470757314|FG000|Overall Study|Withdrawal by Subject|7|||
130763434|NCT01143064|470757315|FG001|Overall Study|Withdrawal by Subject|5|||
130763435|NCT01143064|470757314|FG000|Overall Study|Lost to Follow-up|17|||
130763436|NCT01143064|470757315|FG001|Overall Study|Lost to Follow-up|14|||
130763437|NCT01143064|470757314|FG000|Overall Study|Physician Decision|0|||
130763438|NCT01143064|470757315|FG001|Overall Study|Physician Decision|4|||
130763439|NCT01565668|470757318|FG000|Overall Study|Death|2|||
130763440|NCT01565668|470757319|FG001|Overall Study|Death|1|||
130763441|NCT01565668|470757318|FG000|Overall Study|Lack of Efficacy|4|||
130763442|NCT01565668|470757319|FG001|Overall Study|Lack of Efficacy|2|||
130763443|NCT01565668|470757318|FG000|Overall Study|Participant went on Hospice Care|1|||
130763444|NCT01565668|470757319|FG001|Overall Study|Participant went on Hospice Care|0|||
130763445|NCT01565668|470757318|FG000|Overall Study|Adverse Event|6|||
130763446|NCT01565668|470757319|FG001|Overall Study|Adverse Event|1|||
130763447|NCT01565668|470757318|FG000|Overall Study|Randomized, but never received drug|0|||
130763448|NCT01565668|470757319|FG001|Overall Study|Randomized, but never received drug|2|||
130763449|NCT01565668|470757318|FG000|Overall Study|Progressive disease|13|||
130763450|NCT01565668|470757319|FG001|Overall Study|Progressive disease|14|||
130763451|NCT01565668|470757318|FG000|Overall Study|Withdrawal by Subject|1|||
130763452|NCT01565668|470757319|FG001|Overall Study|Withdrawal by Subject|3|||
130763453|NCT01565668|470757318|FG000|Overall Study|HSCT Transplant|11|||
130763454|NCT01565668|470757319|FG001|Overall Study|HSCT Transplant|15|||
130763455|NCT02255552|470757320|FG000|Overall Study|Participants enrolled into another study|0|||
130763456|NCT02255552|470757321|FG001|Overall Study|Participants enrolled into another study|11|||
130763457|NCT02255552|470757320|FG000|Overall Study|Withdrawal by Subject|1|||
130763458|NCT02255552|470757321|FG001|Overall Study|Withdrawal by Subject|4|||
130763459|NCT03747302|470757324|FG000|Overall Study|Withdrawal by Subject|1|||
130763460|NCT03747302|470757325|FG001|Overall Study|Withdrawal by Subject|2|||
130763461|NCT03448939|470757328|FG000|Overall Study|Adverse Event|5|||
130763462|NCT03448939|470757329|FG001|Overall Study|Adverse Event|1|||
130763463|NCT03448939|470757328|FG000|Overall Study|Lost to Follow-up|6|||
130763464|NCT03448939|470757329|FG001|Overall Study|Lost to Follow-up|6|||
130763465|NCT03448939|470757328|FG000|Overall Study|Pregnancy|1|||
130763466|NCT03448939|470757329|FG001|Overall Study|Pregnancy|1|||
130763467|NCT03448939|470757328|FG000|Overall Study|Withdrawal by Subject|9|||
130763468|NCT03448939|470757329|FG001|Overall Study|Withdrawal by Subject|3|||
130763469|NCT00894790|470757330|FG000|Overall Study|Protocol Violation|0|||
130763470|NCT00894790|470757331|FG001|Overall Study|Protocol Violation|1|||
130763471|NCT00894790|470757330|FG000|Overall Study|Lost to Follow-up|0|||
130763472|NCT00894790|470757331|FG001|Overall Study|Lost to Follow-up|1|||
130763473|NCT00894790|470757330|FG000|Overall Study|Did not meet entrance criteria|1|||
130763474|NCT00894790|470757331|FG001|Overall Study|Did not meet entrance criteria|0|||
130763475|NCT01472965|470757332|FG000|Overall Study|Withdrawal by Subject|1|||
130763476|NCT01472965|470757333|FG001|Overall Study|Withdrawal by Subject|0|||
130763477|NCT00662558|470757337|FG000|Overall Study|Adverse Event|21|||
130763478|NCT00662558|470757338|FG001|Overall Study|Adverse Event|59|||
130763479|NCT00662558|470757337|FG000|Overall Study|Lack of Efficacy|4|||
130763480|NCT00662558|470757338|FG001|Overall Study|Lack of Efficacy|7|||
130763481|NCT00662558|470757337|FG000|Overall Study|Lost to Follow-up|13|||
130763482|NCT00662558|470757338|FG001|Overall Study|Lost to Follow-up|10|||
130763483|NCT00662558|470757337|FG000|Overall Study|Other|9|||
130763484|NCT00662558|470757338|FG001|Overall Study|Other|14|||
130763485|NCT00662558|470757337|FG000|Overall Study|Withdrawal by Subject|7|||
130763486|NCT00662558|470757338|FG001|Overall Study|Withdrawal by Subject|12|||
130763487|NCT00662558|470757337|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
130763488|NCT00662558|470757338|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
130763489|NCT01711619|470757339|FG000|Overall Study|Early study termination|10|||
130763490|NCT01711619|470757340|FG001|Overall Study|Early study termination|14|||
130763491|NCT01711619|470757339|FG000|Overall Study|Withdrawal by Subject|3|||
130763492|NCT01711619|470757340|FG001|Overall Study|Withdrawal by Subject|7|||
130800848|NCT02965456|470894934|FG001|Overall Study|Lack of Efficacy|0|||
130800849|NCT02965456|470894933|FG000|Overall Study|Physician Decision|0|||
130800850|NCT02965456|470894934|FG001|Overall Study|Physician Decision|1|||
130800851|NCT02965456|470894933|FG000|Overall Study|Pregnancy|1|||
130800852|NCT02965456|470894934|FG001|Overall Study|Pregnancy|0|||
130800853|NCT02965456|470894933|FG000|Overall Study|Protocol Violation|0|||
130800854|NCT02965456|470894934|FG001|Overall Study|Protocol Violation|1|||
130800855|NCT02965456|470894933|FG000|Overall Study|Participant ran out of study drug|0|||
130800856|NCT02965456|470894934|FG001|Overall Study|Participant ran out of study drug|1|||
130800857|NCT00303953|470894935|FG000|Overall Study|Ineligible|1|||
130800858|NCT00303953|470894935|FG000|Overall Study|Death|1|||
130800859|NCT00303953|470894935|FG000|Overall Study|Adverse Event|4|||
130800860|NCT00303953|470894935|FG000|Overall Study|Lack of Efficacy|12|||
130800861|NCT00303953|470894935|FG000|Overall Study|Physician Decision|1|||
130800862|NCT04465955|470894936|FG000|Overall Study|Withdrew consent|6|||
130800863|NCT04465955|470894937|FG001|Overall Study|Withdrew consent|10|||
130800864|NCT04465955|470894938|FG002|Overall Study|Withdrew consent|7|||
130800865|NCT04465955|470894936|FG000|Overall Study|Adverse Event|6|||
130800866|NCT04465955|470894937|FG001|Overall Study|Adverse Event|5|||
130800867|NCT04465955|470894938|FG002|Overall Study|Adverse Event|1|||
130800868|NCT04465955|470894936|FG000|Overall Study|Lost to Follow-up|2|||
130800869|NCT04465955|470894937|FG001|Overall Study|Lost to Follow-up|0|||
130800870|NCT04465955|470894938|FG002|Overall Study|Lost to Follow-up|3|||
130800871|NCT04465955|470894936|FG000|Overall Study|Other|1|||
130800872|NCT04465955|470894937|FG001|Overall Study|Other|1|||
130800873|NCT04465955|470894938|FG002|Overall Study|Other|3|||
130800874|NCT00387127|470894941|FG000|Overall Study|Lost to Follow-up|0|||
130800875|NCT00387127|470894942|FG001|Overall Study|Lost to Follow-up|4|||
130800876|NCT00387127|470894941|FG000|Overall Study|Death|16|||
130800877|NCT00387127|470894942|FG001|Overall Study|Death|16|||
130800878|NCT00387127|470894941|FG000|Overall Study|Physician Decision|0|||
130800879|NCT00387127|470894942|FG001|Overall Study|Physician Decision|1|||
130800880|NCT00387127|470894941|FG000|Overall Study|Withdrawal by Subject|3|||
130800881|NCT00387127|470894942|FG001|Overall Study|Withdrawal by Subject|2|||
130800882|NCT00387127|470894941|FG000|Overall Study|Required by Protocol Amendment #4|12|||
130800883|NCT00387127|470894942|FG001|Overall Study|Required by Protocol Amendment #4|10|||
130800884|NCT00387127|470894941|FG000|Overall Study|Serious Adverse Event|1|||
130800885|NCT00387127|470894942|FG001|Overall Study|Serious Adverse Event|1|||
130800886|NCT00387127|470894941|FG000|Overall Study|Sponsor Unblinded|1|||
130800887|NCT00387127|470894942|FG001|Overall Study|Sponsor Unblinded|0|||
130800888|NCT00812097|470894943|FG000|Overall Study|Death|3|||
130800889|NCT00812097|470894944|FG001|Overall Study|Death|10|||
130800890|NCT00812097|470894945|FG002|Overall Study|Death|3|||
130800891|NCT00812097|470894946|FG003|Overall Study|Death|3|||
130800892|NCT00812097|470894943|FG000|Overall Study|Withdrawal by Subject|14|||
130800893|NCT00812097|470894944|FG001|Overall Study|Withdrawal by Subject|12|||
130800894|NCT00812097|470894945|FG002|Overall Study|Withdrawal by Subject|8|||
130800895|NCT00812097|470894946|FG003|Overall Study|Withdrawal by Subject|2|||
130800896|NCT00812097|470894943|FG000|Overall Study|Lost to Follow-up|90|||
130800897|NCT00812097|470894944|FG001|Overall Study|Lost to Follow-up|14|||
130800898|NCT00812097|470894945|FG002|Overall Study|Lost to Follow-up|17|||
130800899|NCT00812097|470894946|FG003|Overall Study|Lost to Follow-up|5|||
130800900|NCT00812097|470894943|FG000|Overall Study|Explantation of study device(s)|27|||
130800901|NCT00812097|470894944|FG001|Overall Study|Explantation of study device(s)|29|||
130800902|NCT00812097|470894945|FG002|Overall Study|Explantation of study device(s)|14|||
130800903|NCT00812097|470894946|FG003|Overall Study|Explantation of study device(s)|20|||
130800904|NCT00812097|470894943|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
130800905|NCT00812097|470894944|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
130800906|NCT00812097|470894945|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
130800907|NCT00812097|470894946|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
130800908|NCT01786109|470894947|FG000|Overall Study|fail manometry barostat tube placement|1|||
130800909|NCT01786109|470894948|FG001|Overall Study|fail manometry barostat tube placement|0|||
130800910|NCT01786109|470894949|FG002|Overall Study|fail manometry barostat tube placement|0|||
130800911|NCT01786109|470894947|FG000|Overall Study|unrelated illness|0|||
130800912|NCT01786109|470894948|FG001|Overall Study|unrelated illness|0|||
130800913|NCT01786109|470894949|FG002|Overall Study|unrelated illness|1|||
130800914|NCT01786109|470894947|FG000|Overall Study|adverse effects colon preparation|0|||
130800915|NCT01786109|470894948|FG001|Overall Study|adverse effects colon preparation|0|||
130800916|NCT01786109|470894949|FG002|Overall Study|adverse effects colon preparation|1|||
130800917|NCT00317369|470894950|FG000|Overall Study|Adverse Event|2|||
130800918|NCT00317369|470894951|FG001|Overall Study|Adverse Event|1|||
130800919|NCT00317369|470894952|FG002|Overall Study|Adverse Event|0|||
130800920|NCT00317369|470894950|FG000|Overall Study|Lack of Efficacy|0|||
130800921|NCT00317369|470894951|FG001|Overall Study|Lack of Efficacy|1|||
130800922|NCT00317369|470894952|FG002|Overall Study|Lack of Efficacy|1|||
130800923|NCT00317369|470894950|FG000|Overall Study|Withdrawal by Subject|0|||
130800924|NCT00317369|470894951|FG001|Overall Study|Withdrawal by Subject|0|||
130800925|NCT00317369|470894952|FG002|Overall Study|Withdrawal by Subject|1|||
130800926|NCT00825175|470894955|FG000|Overall Study|Withdrawal by Subject|0|||
130800927|NCT00825175|470894956|FG001|Overall Study|Withdrawal by Subject|5|||
130800928|NCT02762604|470894957|FG000|Overall Study|Lost to Follow-up|2|||
130800929|NCT02762604|470894958|FG001|Overall Study|Lost to Follow-up|7|||
130800930|NCT02762604|470894957|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
130800931|NCT02762604|470894958|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
130800932|NCT02691572|470894964|FG000|Overall Study|Withdrawal by Subject|1|||
130800933|NCT02691572|470894965|FG001|Overall Study|Withdrawal by Subject|0|||
130800934|NCT02691572|470894964|FG000|Overall Study|Protocol Violation|0|||
130800935|NCT02691572|470894965|FG001|Overall Study|Protocol Violation|1|||
130800936|NCT00699751|470894966|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
130800937|NCT00699751|470894967|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
130800938|NCT00699751|470894966|FG000|Period 1: Without/Before Drug Switch|Death|28|||
130800939|NCT00699751|470894967|FG001|Period 1: Without/Before Drug Switch|Death|29|||
130800940|NCT00699751|470894966|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
130800941|NCT00699751|470894967|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
130800942|NCT00699751|470894966|FG000|Period 1: Without/Before Drug Switch|Other|30|||
130800943|NCT00699751|470894967|FG001|Period 1: Without/Before Drug Switch|Other|20|||
130800944|NCT00699751|470894966|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
130800945|NCT00699751|470894967|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
130800946|NCT00699751|470894966|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
130800947|NCT00699751|470894967|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
130800948|NCT00699751|470894966|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
130800949|NCT00699751|470894967|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
130800950|NCT00699751|470894966|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
130800951|NCT00699751|470894967|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
130800952|NCT03370302|470894970|FG000|Dose Escalation Phase|Other|0|||
130800953|NCT03370302|470894971|FG001|Dose Escalation Phase|Other|1|||
130800954|NCT03370302|470894972|FG002|Dose Escalation Phase|Other|1|||
130800955|NCT03370302|470894973|FG003|Dose Escalation Phase|Other|0|||
130800956|NCT03370302|470894974|FG004|Dose Escalation Phase|Other|0|||
130800957|NCT03370302|470894975|FG005|Dose Escalation Phase|Other|0|||
130800958|NCT03370302|470894970|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130800959|NCT03370302|470894971|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
130800960|NCT03370302|470894972|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
130800961|NCT03370302|470894973|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130800962|NCT03370302|470894974|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
130800963|NCT03370302|470894975|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
130800964|NCT03370302|470894970|FG000|Dose Escalation Phase|Adverse Event|1|||
130800965|NCT03370302|470894971|FG001|Dose Escalation Phase|Adverse Event|0|||
130800966|NCT03370302|470894972|FG002|Dose Escalation Phase|Adverse Event|2|||
130800967|NCT03370302|470894973|FG003|Dose Escalation Phase|Adverse Event|0|||
130800968|NCT03370302|470894974|FG004|Dose Escalation Phase|Adverse Event|0|||
130800969|NCT03370302|470894975|FG005|Dose Escalation Phase|Adverse Event|0|||
130800970|NCT03370302|470894970|FG000|Dose Escalation Phase|Progressive Disease|2|||
130800971|NCT03370302|470894971|FG001|Dose Escalation Phase|Progressive Disease|4|||
130800972|NCT03370302|470894972|FG002|Dose Escalation Phase|Progressive Disease|2|||
130800973|NCT03370302|470894973|FG003|Dose Escalation Phase|Progressive Disease|0|||
130800974|NCT03370302|470894974|FG004|Dose Escalation Phase|Progressive Disease|3|||
130800975|NCT03370302|470894975|FG005|Dose Escalation Phase|Progressive Disease|1|||
130800976|NCT03370302|470894970|FG000|Dose Expansion Phase|Progressive Disease|0|||
130800977|NCT03370302|470894971|FG001|Dose Expansion Phase|Progressive Disease|0|||
130800978|NCT03370302|470894972|FG002|Dose Expansion Phase|Progressive Disease|0|||
130800979|NCT03370302|470894973|FG003|Dose Expansion Phase|Progressive Disease|6|||
130800980|NCT03370302|470894974|FG004|Dose Expansion Phase|Progressive Disease|0|||
130800981|NCT03370302|470894975|FG005|Dose Expansion Phase|Progressive Disease|0|||
130800982|NCT01428128|470894976|FG000|Overall Study|Withdrawal by Subject|4|||
130800983|NCT01428128|470894976|FG000|Overall Study|Screen failure by p53|10|||
130800984|NCT01428128|470894976|FG000|Overall Study|Received Neulasta in one cycle|2|||
130800985|NCT01428128|470894976|FG000|Overall Study|Adverse Event|1|||
130800986|NCT00985790|470894979|FG000|Overall Study|Withdrawal by Subject|1|||
130800987|NCT00985790|470894980|FG001|Overall Study|Withdrawal by Subject|1|||
130800988|NCT00985790|470894979|FG000|Overall Study|Lost to Follow-up|6|||
130800989|NCT00985790|470894980|FG001|Overall Study|Lost to Follow-up|7|||
130800990|NCT04124965|470894984|FG000|Overall Study|Adverse event, non-fatal|3|||
130800991|NCT04124965|470894985|FG001|Overall Study|Adverse event, non-fatal|1|||
130800992|NCT04124965|470894984|FG000|Overall Study|Withdrawal by Subject|1|||
130800993|NCT04124965|470894985|FG001|Overall Study|Withdrawal by Subject|1|||
130800994|NCT04124965|470894984|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
130800995|NCT04124965|470894985|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
130800996|NCT04124965|470894984|FG000|Overall Study|Pregnancy|1|||
130800997|NCT04124965|470894985|FG001|Overall Study|Pregnancy|0|||
130800998|NCT04124965|470894984|FG000|Overall Study|Sponsor and participant decision|0|||
130800999|NCT04124965|470894985|FG001|Overall Study|Sponsor and participant decision|1|||
130801000|NCT04124965|470894984|FG000|Overall Study|Personal surgery|0|||
130801001|NCT04124965|470894985|FG001|Overall Study|Personal surgery|1|||
130801002|NCT04124965|470894984|FG000|Overall Study|Physician Decision|0|||
130801003|NCT04124965|470894985|FG001|Overall Study|Physician Decision|1|||
130801004|NCT02184156|470894986|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
130801005|NCT02184156|470894987|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
130801006|NCT02184156|470894986|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
130801007|NCT02184156|470894987|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
130801008|NCT00002874|470894988|FG000|Overall Study|Withdrawal by Subject|1|||
130801009|NCT00002874|470894989|FG001|Overall Study|Withdrawal by Subject|1|||
130801010|NCT00002874|470894988|FG000|Overall Study|Protocol Violation|44|||
130801011|NCT00002874|470894989|FG001|Overall Study|Protocol Violation|34|||
130801012|NCT01397747|470894992|FG000|Overall Study|Multitarget DNA test excluded|689|||
130801013|NCT01397747|470894992|FG000|Overall Study|Colonoscopy excluded|304|||
130801014|NCT01397747|470894992|FG000|Overall Study|FIT excluded|34|||
130801015|NCT03828383|470894993|FG000|Overall Study|Lost to Follow-up|3|||
130801016|NCT03828383|470894994|FG001|Overall Study|Lost to Follow-up|2|||
130801017|NCT03828383|470894993|FG000|Overall Study|Withdrawal by Subject|4|||
130801018|NCT03828383|470894994|FG001|Overall Study|Withdrawal by Subject|5|||
130801019|NCT00308685|470894996|FG000|Overall Study|Lost to Follow-up|1|||
130801020|NCT00308685|470894997|FG001|Overall Study|Lost to Follow-up|0|||
130801021|NCT00308685|470894996|FG000|Overall Study|Need to administer prohibited medication|1|||
130801022|NCT00308685|470894997|FG001|Overall Study|Need to administer prohibited medication|2|||
130801023|NCT00308685|470894996|FG000|Overall Study|Other than specified|1|||
130801024|NCT00308685|470894997|FG001|Overall Study|Other than specified|3|||
130801025|NCT03158311|470895000|FG000|Overall Study|Subject/Guardian Decision|10|||
130801026|NCT03158311|470895001|FG001|Overall Study|Subject/Guardian Decision|6|||
130801027|NCT03158311|470895002|FG002|Overall Study|Subject/Guardian Decision|11|||
130801028|NCT03158311|470895000|FG000|Overall Study|Adverse Event|5|||
130801029|NCT03158311|470895001|FG001|Overall Study|Adverse Event|3|||
130801030|NCT03158311|470895002|FG002|Overall Study|Adverse Event|3|||
130801031|NCT03158311|470895000|FG000|Overall Study|Techinical Problems|3|||
130801032|NCT03158311|470895001|FG001|Overall Study|Techinical Problems|1|||
130801033|NCT03158311|470895002|FG002|Overall Study|Techinical Problems|5|||
130801034|NCT03158311|470895000|FG000|Overall Study|Physician Decision|2|||
130801035|NCT03158311|470895001|FG001|Overall Study|Physician Decision|3|||
130801036|NCT03158311|470895002|FG002|Overall Study|Physician Decision|7|||
130801037|NCT03158311|470895000|FG000|Overall Study|Lost to Follow-up|1|||
130801038|NCT03158311|470895001|FG001|Overall Study|Lost to Follow-up|1|||
130801039|NCT03158311|470895002|FG002|Overall Study|Lost to Follow-up|1|||
130801040|NCT03158311|470895000|FG000|Overall Study|Sponsor decision|1|||
130801041|NCT03158311|470895001|FG001|Overall Study|Sponsor decision|0|||
130801042|NCT03158311|470895002|FG002|Overall Study|Sponsor decision|0|||
130801043|NCT03158311|470895000|FG000|Overall Study|Pregnancy|0|||
130801044|NCT03158311|470895001|FG001|Overall Study|Pregnancy|2|||
130801045|NCT03158311|470895002|FG002|Overall Study|Pregnancy|0|||
130801046|NCT03158311|470895000|FG000|Overall Study|Randomized in error|0|||
130801047|NCT03158311|470895001|FG001|Overall Study|Randomized in error|0|||
130801048|NCT03158311|470895002|FG002|Overall Study|Randomized in error|1|||
130801049|NCT01018953|470895003|FG000|Overall Study|Adverse Event|2|||
130801050|NCT01018953|470895003|FG000|Overall Study|Withdrawal by Subject|1|||
130801051|NCT01018953|470895003|FG000|Overall Study|Study termination by sponsor|5|||
130801052|NCT02665455|470895004|FG000|Overall Study|Withdrawal by Subject|6|||
130801053|NCT02665455|470895004|FG000|Overall Study|Lost to Follow-up|1|||
130801054|NCT02665455|470895004|FG000|Overall Study|Adverse Event|1|||
130801055|NCT02665455|470895004|FG000|Overall Study|Protocol Violation|1|||
130801056|NCT01928771|470895006|FG000|Overall Study|Adverse Event|6|||
130801057|NCT01928771|470895007|FG001|Overall Study|Adverse Event|5|||
130801058|NCT01928771|470895008|FG002|Overall Study|Adverse Event|1|||
130801059|NCT01928771|470895006|FG000|Overall Study|Death|2|||
130801060|NCT01928771|470895007|FG001|Overall Study|Death|2|||
130801061|NCT01928771|470895008|FG002|Overall Study|Death|2|||
130801062|NCT01928771|470895006|FG000|Overall Study|Lost to Follow-up|5|||
130801063|NCT01928771|470895007|FG001|Overall Study|Lost to Follow-up|6|||
130801064|NCT01928771|470895008|FG002|Overall Study|Lost to Follow-up|3|||
130801065|NCT01928771|470895006|FG000|Overall Study|Withdrawal by Subject|20|||
130801066|NCT01928771|470895007|FG001|Overall Study|Withdrawal by Subject|15|||
130801067|NCT01928771|470895008|FG002|Overall Study|Withdrawal by Subject|17|||
130801068|NCT01928771|470895006|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
130801069|NCT01928771|470895007|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
130801070|NCT01928771|470895008|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
130801071|NCT01928771|470895006|FG000|Overall Study|Other Reasons|9|||
130801072|NCT01928771|470895007|FG001|Overall Study|Other Reasons|9|||
130801073|NCT01928771|470895008|FG002|Overall Study|Other Reasons|14|||
130801074|NCT01928771|470895006|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
130801075|NCT01928771|470895007|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
130801076|NCT01928771|470895008|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
130801077|NCT02400736|470896872|FG000|Overall Study|Lost to Follow-up|6|||
130801078|NCT02400736|470896873|FG001|Overall Study|Lost to Follow-up|6|||
130801079|NCT02400736|470896872|FG000|Overall Study|Withdrawal by Subject|2|||
130801080|NCT02400736|470896873|FG001|Overall Study|Withdrawal by Subject|1|||
130801081|NCT02400736|470896872|FG000|Overall Study|Moved from the area|3|||
130801082|NCT02400736|470896873|FG001|Overall Study|Moved from the area|1|||
130801083|NCT03520569|470896874|FG000|Overall Study|Withdrawal by Subject|1|||
130801084|NCT03418675|470896875|FG000|Overall Study|Lost to Follow-up|13|||
130801085|NCT03418675|470896876|FG001|Overall Study|Lost to Follow-up|10|||
130801086|NCT03418675|470896875|FG000|Overall Study|Adverse Event|2|||
130801087|NCT03418675|470896876|FG001|Overall Study|Adverse Event|0|||
130801088|NCT01178411|470896877|FG000|Overall Study|Adverse Event|5|||
130801089|NCT01178411|470896877|FG000|Overall Study|Withdrawal by Subject|4|||
130801090|NCT01178411|470896877|FG000|Overall Study|Protocol Violation|1|||
130801091|NCT01178411|470896877|FG000|Overall Study|Progressive disease per RECIST|32|||
130801092|NCT01178411|470896877|FG000|Overall Study|Progressive disease per clinician|9|||
130801093|NCT01178411|470896877|FG000|Overall Study|Physician Decision|6|||
130801094|NCT01178411|470896877|FG000|Overall Study|Death|1|||
130801095|NCT01178411|470896877|FG000|Overall Study|No reason provided|1|||
130801096|NCT01178411|470896877|FG000|Overall Study|Drug manufacturing ended|1|||
130801097|NCT00845182|470896878|FG000|Overall Study|Lost to Follow-up|3|||
130801098|NCT00845182|470896879|FG001|Overall Study|Lost to Follow-up|3|||
130801099|NCT00845182|470896880|FG002|Overall Study|Lost to Follow-up|4|||
130801100|NCT00845182|470896878|FG000|Overall Study|Adverse Event|0|||
130801101|NCT00845182|470896879|FG001|Overall Study|Adverse Event|1|||
130801102|NCT00845182|470896880|FG002|Overall Study|Adverse Event|1|||
130801103|NCT00845182|470896878|FG000|Overall Study|Physician Decision|0|||
130801104|NCT00845182|470896879|FG001|Overall Study|Physician Decision|0|||
130801105|NCT00845182|470896880|FG002|Overall Study|Physician Decision|1|||
130801106|NCT01625182|470896881|FG000|Overall Study|Administrative problems|1|||
130801107|NCT01625182|470896882|FG001|Overall Study|Administrative problems|0|||
130801108|NCT01625182|470896881|FG000|Overall Study|Protocol deviation|0|||
130801109|NCT01625182|470896882|FG001|Overall Study|Protocol deviation|2|||
130801110|NCT01625182|470896881|FG000|Overall Study|Adverse Event|2|||
130801111|NCT01625182|470896882|FG001|Overall Study|Adverse Event|0|||
130801112|NCT01625182|470896881|FG000|Overall Study|Withdrawal by Subject|5|||
130801113|NCT01625182|470896882|FG001|Overall Study|Withdrawal by Subject|1|||
130801114|NCT01625182|470896881|FG000|Overall Study|Lack of Efficacy|12|||
130801115|NCT01625182|470896882|FG001|Overall Study|Lack of Efficacy|8|||
130801116|NCT00447278|470896885|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
130801117|NCT00447278|470896886|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
130801118|NCT00447278|470896885|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
130801119|NCT00447278|470896886|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
130801120|NCT00447278|470896885|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
130801121|NCT00447278|470896886|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
130801122|NCT00447278|470896885|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
130801123|NCT00447278|470896886|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
130801124|NCT00447278|470896885|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
130801125|NCT00447278|470896886|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
130801126|NCT00447278|470896885|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
130801127|NCT00447278|470896886|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
130801128|NCT00447278|470896885|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
130801129|NCT00447278|470896886|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
130801130|NCT00447278|470896885|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
130801131|NCT00447278|470896886|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
130801132|NCT00447278|470896885|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
130801133|NCT00447278|470896886|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
130801134|NCT00447278|470896885|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
130801135|NCT00447278|470896886|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
130801136|NCT00447278|470896885|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
130801137|NCT00447278|470896886|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
130801138|NCT00447278|470896885|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
130801139|NCT00447278|470896886|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
130801140|NCT00447278|470896885|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
130801141|NCT00447278|470896886|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
130801142|NCT00447278|470896885|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
130801143|NCT00447278|470896886|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
130801144|NCT01348698|470896887|FG000|Overall Study|Does not meet lesion size criteria|1|||
130801145|NCT01348698|470896887|FG000|Overall Study|Death|3|||
130801146|NCT01348698|470896887|FG000|Overall Study|PI decision to close study|68|||
130801147|NCT02595749|470896888|FG000|Overall Study|Withdrawal by Subject|12|||
130801148|NCT02595749|470896889|FG001|Overall Study|Withdrawal by Subject|7|||
130801149|NCT00263562|470896890|FG000|Overall Study|Protocol Violation|3|||
130801150|NCT00263562|470896891|FG001|Overall Study|Protocol Violation|0|||
130801151|NCT05427916|470896897|FG000|Overall Study|Adverse Event|3|||
130801152|NCT05427916|470896898|FG001|Overall Study|Adverse Event|0|||
130801153|NCT05427916|470896897|FG000|Overall Study|Lack of Efficacy|6|||
130801154|NCT05427916|470896898|FG001|Overall Study|Lack of Efficacy|0|||
130801155|NCT05427916|470896897|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
130801156|NCT05427916|470896898|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
130801157|NCT01875237|470896899|FG000|Overall Study|GVDH before DLI|1|||
130801158|NCT01875237|470896900|FG001|Overall Study|GVDH before DLI|0|||
130801159|NCT01875237|470896899|FG000|Overall Study|DLI cells could not be produced|1|||
130801160|NCT01875237|470896900|FG001|Overall Study|DLI cells could not be produced|0|||
130801161|NCT03558672|470896901|FG000|Overall Study|Study Early Termination|10|||
130801162|NCT00421733|470896903|FG000|Overall Study|Adverse Event|4|||
130801163|NCT00421733|470896904|FG001|Overall Study|Adverse Event|9|||
130801164|NCT00421733|470896905|FG002|Overall Study|Adverse Event|2|||
130801165|NCT00421733|470896903|FG000|Overall Study|Lost to Follow-up|1|||
130801166|NCT00421733|470896904|FG001|Overall Study|Lost to Follow-up|2|||
130801167|NCT00421733|470896905|FG002|Overall Study|Lost to Follow-up|4|||
130801168|NCT00421733|470896903|FG000|Overall Study|Withdrawal by Subject|1|||
130801169|NCT00421733|470896904|FG001|Overall Study|Withdrawal by Subject|2|||
130801170|NCT00421733|470896905|FG002|Overall Study|Withdrawal by Subject|7|||
130801171|NCT00421733|470896903|FG000|Overall Study|Death|0|||
130801172|NCT00421733|470896904|FG001|Overall Study|Death|3|||
130801173|NCT00421733|470896905|FG002|Overall Study|Death|0|||
130801174|NCT00421733|470896903|FG000|Overall Study|Required dialysis|1|||
130801175|NCT00421733|470896904|FG001|Overall Study|Required dialysis|0|||
130801176|NCT00421733|470896905|FG002|Overall Study|Required dialysis|0|||
130801177|NCT00421733|470896903|FG000|Overall Study|Administrative|2|||
130801178|NCT00421733|470896904|FG001|Overall Study|Administrative|0|||
130801179|NCT00421733|470896905|FG002|Overall Study|Administrative|0|||
130801180|NCT00421733|470896903|FG000|Overall Study|Did not satisfy entry criteria|1|||
130801181|NCT00421733|470896904|FG001|Overall Study|Did not satisfy entry criteria|3|||
130801182|NCT00421733|470896905|FG002|Overall Study|Did not satisfy entry criteria|2|||
130801183|NCT00421733|470896903|FG000|Overall Study|Sponsor request|1|||
130801184|NCT00421733|470896904|FG001|Overall Study|Sponsor request|0|||
130801185|NCT00421733|470896905|FG002|Overall Study|Sponsor request|3|||
130801186|NCT00421733|470896903|FG000|Overall Study|Protocol deviation|4|||
130801187|NCT00421733|470896904|FG001|Overall Study|Protocol deviation|7|||
130801188|NCT00421733|470896905|FG002|Overall Study|Protocol deviation|2|||
130801189|NCT05558410|470896906|FG000|Overall Study|Adverse Event|1|||
130801190|NCT05558410|470896907|FG001|Overall Study|Adverse Event|2|||
130801191|NCT05558410|470896908|FG002|Overall Study|Adverse Event|0|||
130801192|NCT05558410|470896906|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
130801193|NCT05558410|470896907|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
130801194|NCT05558410|470896908|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
130801195|NCT05558410|470896906|FG000|Overall Study|Lost to Follow-up|10|||
130801196|NCT05558410|470896907|FG001|Overall Study|Lost to Follow-up|17|||
130801197|NCT05558410|470896908|FG002|Overall Study|Lost to Follow-up|19|||
130801198|NCT05558410|470896906|FG000|Overall Study|Death|1|||
130801199|NCT05558410|470896907|FG001|Overall Study|Death|0|||
130801200|NCT05558410|470896908|FG002|Overall Study|Death|0|||
130801201|NCT05558410|470896906|FG000|Overall Study|Other non-compliance|0|||
130801202|NCT05558410|470896907|FG001|Overall Study|Other non-compliance|1|||
130801203|NCT05558410|470896908|FG002|Overall Study|Other non-compliance|2|||
130801204|NCT05558410|470896906|FG000|Overall Study|Sponsor Decision|1|||
130801205|NCT05558410|470896907|FG001|Overall Study|Sponsor Decision|0|||
130801206|NCT05558410|470896908|FG002|Overall Study|Sponsor Decision|0|||
130801207|NCT05558410|470896906|FG000|Overall Study|Other|1|||
130801208|NCT05558410|470896907|FG001|Overall Study|Other|0|||
130801209|NCT05558410|470896908|FG002|Overall Study|Other|1|||
130801210|NCT02265744|470896913|FG000|Overall Study|Poor/Non-compliance|1|||
130801211|NCT02265744|470896914|FG001|Overall Study|Poor/Non-compliance|1|||
130801212|NCT02265744|470896915|FG002|Overall Study|Poor/Non-compliance|0|||
130801213|NCT02265744|470896916|FG003|Overall Study|Poor/Non-compliance|0|||
130801214|NCT02265744|470896917|FG004|Overall Study|Poor/Non-compliance|2|||
130801215|NCT02265744|470896913|FG000|Overall Study|Lost to Follow-up|0|||
130801216|NCT02265744|470896914|FG001|Overall Study|Lost to Follow-up|0|||
130801217|NCT02265744|470896915|FG002|Overall Study|Lost to Follow-up|0|||
130801218|NCT02265744|470896916|FG003|Overall Study|Lost to Follow-up|1|||
130801219|NCT02265744|470896917|FG004|Overall Study|Lost to Follow-up|0|||
130801220|NCT02265744|470896913|FG000|Overall Study|Death|0|||
130801221|NCT02265744|470896914|FG001|Overall Study|Death|0|||
130801222|NCT02265744|470896915|FG002|Overall Study|Death|0|||
130801223|NCT02265744|470896916|FG003|Overall Study|Death|2|||
130801224|NCT02265744|470896917|FG004|Overall Study|Death|0|||
130801225|NCT02265744|470896913|FG000|Overall Study|Withdrawal by Subject|2|||
130801226|NCT02265744|470896914|FG001|Overall Study|Withdrawal by Subject|0|||
130801227|NCT02265744|470896915|FG002|Overall Study|Withdrawal by Subject|0|||
130801228|NCT02265744|470896916|FG003|Overall Study|Withdrawal by Subject|2|||
130763493|NCT01711619|470757339|FG000|Overall Study|Protocol Violation|2|||
130763494|NCT01711619|470757340|FG001|Overall Study|Protocol Violation|3|||
130763495|NCT01711619|470757339|FG000|Overall Study|Adverse Event|2|||
130763496|NCT01711619|470757340|FG001|Overall Study|Adverse Event|0|||
130763497|NCT01711619|470757339|FG000|Overall Study|Lost to Follow-up|1|||
130763498|NCT01711619|470757340|FG001|Overall Study|Lost to Follow-up|0|||
130763499|NCT00503997|470757341|FG000|Overall Study|disease progression|1|||
130763500|NCT00503997|470757341|FG000|Overall Study|Adverse Event|5|||
130763501|NCT00503997|470757341|FG000|Overall Study|Death|1|||
130763502|NCT00503997|470757341|FG000|Overall Study|Withdrawal by Subject|1|||
130763503|NCT01195844|470757342|FG000|Overall Study|Fecal sample not collected|40|||
130763504|NCT01432275|470757346|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
130763505|NCT01432275|470757347|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
130763506|NCT01432275|470757346|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
130763507|NCT01432275|470757347|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
130763508|NCT01432275|470757346|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
130763509|NCT01432275|470757347|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
130763510|NCT01432275|470757346|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
130763511|NCT01432275|470757347|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
130763512|NCT01432275|470757346|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
130763513|NCT01432275|470757347|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
130763514|NCT01432275|470757346|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
130763515|NCT01432275|470757347|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
130763516|NCT01432275|470757346|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
130763517|NCT01432275|470757347|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
130763518|NCT01432275|470757346|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
130763519|NCT01432275|470757347|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
130763520|NCT01432275|470757346|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
130763521|NCT01432275|470757347|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
130763522|NCT02565706|470757348|FG000|Overall Study|Withdrawal by Subject|5|||
130763523|NCT02565706|470757349|FG001|Overall Study|Withdrawal by Subject|7|||
130763524|NCT02565706|470757350|FG002|Overall Study|Withdrawal by Subject|7|||
130763525|NCT02565706|470757351|FG003|Overall Study|Withdrawal by Subject|11|||
130763526|NCT02565706|470757348|FG000|Overall Study|Lost to Follow-up|72|||
130763527|NCT02565706|470757349|FG001|Overall Study|Lost to Follow-up|75|||
130763528|NCT02565706|470757350|FG002|Overall Study|Lost to Follow-up|82|||
130763529|NCT02565706|470757351|FG003|Overall Study|Lost to Follow-up|74|||
130763530|NCT00835679|470757357|FG000|Overall Study|Withdrawal by Subject|1|||
130763531|NCT00835679|470757358|FG001|Overall Study|Withdrawal by Subject|0|||
130763532|NCT00835679|470757359|FG002|Overall Study|Withdrawal by Subject|0|||
130763533|NCT00835679|470757360|FG003|Overall Study|Withdrawal by Subject|0|||
130763534|NCT03802565|470757363|FG000|Overall Study|Adverse Event|0|||
130763535|NCT03802565|470757364|FG001|Overall Study|Adverse Event|1|||
130763536|NCT03802565|470757365|FG002|Overall Study|Adverse Event|2|||
130763537|NCT03802565|470757366|FG003|Overall Study|Adverse Event|1|||
130763538|NCT03802565|470757367|FG004|Overall Study|Adverse Event|1|||
130763539|NCT03802565|470757363|FG000|Overall Study|Withdrawal by Subject|2|||
130763540|NCT03802565|470757364|FG001|Overall Study|Withdrawal by Subject|2|||
130763541|NCT03802565|470757365|FG002|Overall Study|Withdrawal by Subject|2|||
130763542|NCT03802565|470757366|FG003|Overall Study|Withdrawal by Subject|0|||
130763543|NCT03802565|470757367|FG004|Overall Study|Withdrawal by Subject|1|||
130763544|NCT03802565|470757363|FG000|Overall Study|Protocol Violation|2|||
130763545|NCT03802565|470757364|FG001|Overall Study|Protocol Violation|1|||
130763546|NCT03802565|470757365|FG002|Overall Study|Protocol Violation|4|||
130763547|NCT03802565|470757366|FG003|Overall Study|Protocol Violation|5|||
130763548|NCT03802565|470757367|FG004|Overall Study|Protocol Violation|1|||
130763549|NCT03802565|470757363|FG000|Overall Study|Lost to Follow-up|0|||
130763550|NCT03802565|470757364|FG001|Overall Study|Lost to Follow-up|0|||
130763551|NCT03802565|470757365|FG002|Overall Study|Lost to Follow-up|1|||
130763552|NCT03802565|470757366|FG003|Overall Study|Lost to Follow-up|0|||
130763553|NCT03802565|470757367|FG004|Overall Study|Lost to Follow-up|0|||
130763554|NCT03802565|470757363|FG000|Overall Study|Subjects Related to Each Other|1|||
130763555|NCT03802565|470757364|FG001|Overall Study|Subjects Related to Each Other|0|||
130763556|NCT03802565|470757365|FG002|Overall Study|Subjects Related to Each Other|0|||
130763557|NCT03802565|470757366|FG003|Overall Study|Subjects Related to Each Other|2|||
130763558|NCT03802565|470757367|FG004|Overall Study|Subjects Related to Each Other|1|||
130763559|NCT03802565|470757363|FG000|Overall Study|Elevated Enzymes|0|||
130763560|NCT03802565|470757364|FG001|Overall Study|Elevated Enzymes|0|||
130763561|NCT03802565|470757365|FG002|Overall Study|Elevated Enzymes|0|||
130763562|NCT03802565|470757366|FG003|Overall Study|Elevated Enzymes|0|||
130801229|NCT02265744|470896917|FG004|Overall Study|Withdrawal by Subject|0|||
130801230|NCT02265744|470896913|FG000|Overall Study|Participant request to discontinue|2|||
130801231|NCT02265744|470896914|FG001|Overall Study|Participant request to discontinue|2|||
130801232|NCT02265744|470896915|FG002|Overall Study|Participant request to discontinue|2|||
130801233|NCT02265744|470896916|FG003|Overall Study|Participant request to discontinue|0|||
130801234|NCT02265744|470896917|FG004|Overall Study|Participant request to discontinue|0|||
130801235|NCT02265744|470896913|FG000|Overall Study|Adverse Event|8|||
130801236|NCT02265744|470896914|FG001|Overall Study|Adverse Event|4|||
130801237|NCT02265744|470896915|FG002|Overall Study|Adverse Event|9|||
130801238|NCT02265744|470896916|FG003|Overall Study|Adverse Event|8|||
130801239|NCT02265744|470896917|FG004|Overall Study|Adverse Event|2|||
130801240|NCT02265744|470896913|FG000|Overall Study|Lack of Efficacy|2|||
130801241|NCT02265744|470896914|FG001|Overall Study|Lack of Efficacy|4|||
130801242|NCT02265744|470896915|FG002|Overall Study|Lack of Efficacy|3|||
130801243|NCT02265744|470896916|FG003|Overall Study|Lack of Efficacy|4|||
130801244|NCT02265744|470896917|FG004|Overall Study|Lack of Efficacy|5|||
130801245|NCT02265744|470896913|FG000|Overall Study|Reason not provided by Investigator|1|||
130801246|NCT02265744|470896914|FG001|Overall Study|Reason not provided by Investigator|0|||
130801247|NCT02265744|470896915|FG002|Overall Study|Reason not provided by Investigator|0|||
130801248|NCT02265744|470896916|FG003|Overall Study|Reason not provided by Investigator|2|||
130801249|NCT02265744|470896917|FG004|Overall Study|Reason not provided by Investigator|0|||
130801250|NCT02265744|470896913|FG000|Overall Study|Administrative reason by sponsor|3|||
130801251|NCT02265744|470896914|FG001|Overall Study|Administrative reason by sponsor|2|||
130801252|NCT02265744|470896915|FG002|Overall Study|Administrative reason by sponsor|2|||
130801253|NCT02265744|470896916|FG003|Overall Study|Administrative reason by sponsor|3|||
130801254|NCT02265744|470896917|FG004|Overall Study|Administrative reason by sponsor|3|||
130801255|NCT02265744|470896913|FG000|Overall Study|Subject no longer meets study criteria|0|||
130801256|NCT02265744|470896914|FG001|Overall Study|Subject no longer meets study criteria|0|||
130801257|NCT02265744|470896915|FG002|Overall Study|Subject no longer meets study criteria|0|||
130801258|NCT02265744|470896916|FG003|Overall Study|Subject no longer meets study criteria|0|||
130801259|NCT02265744|470896917|FG004|Overall Study|Subject no longer meets study criteria|1|||
130801260|NCT02265744|470896913|FG000|Overall Study|Pregnancy|1|||
130801261|NCT02265744|470896914|FG001|Overall Study|Pregnancy|2|||
130801262|NCT02265744|470896915|FG002|Overall Study|Pregnancy|1|||
130801263|NCT02265744|470896916|FG003|Overall Study|Pregnancy|1|||
130801264|NCT02265744|470896917|FG004|Overall Study|Pregnancy|0|||
130801265|NCT05161936|470896922|FG000|Overall Study|Study terminated by Sponsor|1|||
130801266|NCT05161936|470896923|FG001|Overall Study|Study terminated by Sponsor|0|||
130801267|NCT05161936|470896924|FG002|Overall Study|Study terminated by Sponsor|0|||
130801268|NCT05161936|470896922|FG000|Overall Study|Withdrawal by Subject|0|||
130801269|NCT05161936|470896923|FG001|Overall Study|Withdrawal by Subject|0|||
130801270|NCT05161936|470896924|FG002|Overall Study|Withdrawal by Subject|1|||
130801271|NCT02384460|470896929|FG000|Overall Study|Protocol Violation|0|||
130801272|NCT02384460|470896930|FG001|Overall Study|Protocol Violation|1|||
130801273|NCT02384460|470896929|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
130801274|NCT02384460|470896930|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
130801275|NCT02384460|470896929|FG000|Overall Study|Adverse Event|5|||
130801276|NCT02384460|470896930|FG001|Overall Study|Adverse Event|2|||
130801277|NCT02384460|470896929|FG000|Overall Study|Withdrawal by Subject|0|||
130801278|NCT02384460|470896930|FG001|Overall Study|Withdrawal by Subject|3|||
130801279|NCT02384460|470896929|FG000|Overall Study|Elective medical treatment|1|||
130801280|NCT02384460|470896930|FG001|Overall Study|Elective medical treatment|0|||
130801281|NCT02384460|470896929|FG000|Overall Study|Non-compliance|1|||
130801282|NCT02384460|470896930|FG001|Overall Study|Non-compliance|0|||
130801283|NCT01060111|470896931|FG000|Overall Study|Adverse Event|9|||
130801284|NCT01060111|470896932|FG001|Overall Study|Adverse Event|5|||
130801285|NCT01060111|470896933|FG002|Overall Study|Adverse Event|18|||
130801286|NCT01060111|470896931|FG000|Overall Study|Lack of Efficacy|2|||
130801287|NCT01060111|470896932|FG001|Overall Study|Lack of Efficacy|1|||
130801288|NCT01060111|470896933|FG002|Overall Study|Lack of Efficacy|0|||
130801289|NCT01060111|470896931|FG000|Overall Study|Inappropriate participant|5|||
130801290|NCT01060111|470896932|FG001|Overall Study|Inappropriate participant|4|||
130801291|NCT01060111|470896933|FG002|Overall Study|Inappropriate participant|5|||
130801292|NCT01060111|470896931|FG000|Overall Study|Participants' evasion for hospital visit|0|||
130801293|NCT01060111|470896932|FG001|Overall Study|Participants' evasion for hospital visit|3|||
130801294|NCT01060111|470896933|FG002|Overall Study|Participants' evasion for hospital visit|2|||
130801295|NCT01060111|470896931|FG000|Overall Study|Participants' non-cooperation|8|||
130801296|NCT01060111|470896932|FG001|Overall Study|Participants' non-cooperation|6|||
130801297|NCT01060111|470896933|FG002|Overall Study|Participants' non-cooperation|6|||
130801298|NCT01060111|470896931|FG000|Overall Study|Adverse event and insufficient effect|0|||
130801299|NCT01060111|470896932|FG001|Overall Study|Adverse event and insufficient effect|1|||
130801300|NCT01060111|470896933|FG002|Overall Study|Adverse event and insufficient effect|0|||
130801301|NCT01060111|470896931|FG000|Overall Study|Participants' non-cooperation|1|||
130801302|NCT01060111|470896932|FG001|Overall Study|Participants' non-cooperation|0|||
130801303|NCT01060111|470896933|FG002|Overall Study|Participants' non-cooperation|0|||
130801304|NCT01060111|470896931|FG000|Overall Study|Other|2|||
130801305|NCT01060111|470896932|FG001|Overall Study|Other|3|||
130801306|NCT01060111|470896933|FG002|Overall Study|Other|4|||
130801307|NCT04999020|470896936|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
130801308|NCT04999020|470896937|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
130801309|NCT04999020|470896938|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
130801310|NCT04999020|470896939|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
130801311|NCT04999020|470896936|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
130801312|NCT04999020|470896937|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
130801313|NCT04999020|470896938|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
130801314|NCT04999020|470896939|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
130801315|NCT04999020|470896936|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
130801316|NCT04999020|470896937|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
130801317|NCT04999020|470896938|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
130801318|NCT04999020|470896939|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
130801319|NCT04999020|470896936|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130801320|NCT04999020|470896937|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130801321|NCT04999020|470896938|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
130801322|NCT04999020|470896939|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
130801323|NCT04999020|470896936|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
130801324|NCT04999020|470896937|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
130801325|NCT04999020|470896938|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
130801326|NCT04999020|470896939|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
130801327|NCT04999020|470896936|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
130801328|NCT04999020|470896937|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
130801329|NCT04999020|470896938|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
130801330|NCT04999020|470896939|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
130801331|NCT04999020|470896936|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
130801332|NCT04999020|470896937|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
130801333|NCT04999020|470896938|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
130801334|NCT04999020|470896939|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
130801335|NCT04999020|470896936|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
130801336|NCT04999020|470896937|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
130801337|NCT04999020|470896938|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
130801338|NCT04999020|470896939|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
130801339|NCT02448043|470896940|FG000|Overall Study|Withdrawal by Subject|2|||
130801340|NCT02448043|470896941|FG001|Overall Study|Withdrawal by Subject|2|||
130801341|NCT02448043|470896940|FG000|Overall Study|Protocol Violation|1|||
130801342|NCT02448043|470896941|FG001|Overall Study|Protocol Violation|2|||
130801343|NCT00997126|470896942|FG000|Overall Study|Physician Decision|7|||
130801344|NCT00997126|470896943|FG001|Overall Study|Physician Decision|11|||
130801345|NCT02583477|470896948|FG000|Overall Study|Adverse Event|0|||
130801346|NCT02583477|470896949|FG001|Overall Study|Adverse Event|2|||
130801347|NCT02583477|470896948|FG000|Overall Study|Death|1|||
130801348|NCT02583477|470896949|FG001|Overall Study|Death|16|||
130801349|NCT02583477|470896948|FG000|Overall Study|Study terminated|2|||
130801350|NCT02583477|470896949|FG001|Overall Study|Study terminated|2|||
130801351|NCT01327703|470896952|FG000|Second Treatment Period|Adverse Event|1|||
130801352|NCT01327703|470896953|FG001|Second Treatment Period|Adverse Event|1|||
130801353|NCT01327703|470896952|FG000|Second Treatment Period|Protocol Violation|0|||
130801354|NCT01327703|470896953|FG001|Second Treatment Period|Protocol Violation|1|||
130801355|NCT01131585|470896954|FG000|Overall Study|Adverse Event|0|||
130801356|NCT01131585|470896955|FG001|Overall Study|Adverse Event|2|||
130801357|NCT01131585|470896954|FG000|Overall Study|Abnormal laboratory value|1|||
130801358|NCT01131585|470896955|FG001|Overall Study|Abnormal laboratory value|0|||
130801359|NCT01131585|470896954|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130801360|NCT01131585|470896955|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130801361|NCT01131585|470896954|FG000|Overall Study|Protocol Violation|2|||
130801362|NCT01131585|470896955|FG001|Overall Study|Protocol Violation|1|||
130801363|NCT01131585|470896954|FG000|Overall Study|Withdrawal by Subject|3|||
130801364|NCT01131585|470896955|FG001|Overall Study|Withdrawal by Subject|3|||
130801365|NCT01131585|470896954|FG000|Overall Study|Lost to Follow-up|0|||
130801366|NCT01131585|470896955|FG001|Overall Study|Lost to Follow-up|1|||
130801367|NCT01131585|470896954|FG000|Overall Study|Administrative problems|1|||
130801368|NCT01131585|470896955|FG001|Overall Study|Administrative problems|1|||
130801369|NCT01131585|470896954|FG000|Overall Study|Study termination|78|||
130801370|NCT01131585|470896955|FG001|Overall Study|Study termination|32|||
130801371|NCT00927082|470896956|FG000|Overall Study|Lost to Follow-up|9|||
130801372|NCT00927082|470896957|FG001|Overall Study|Lost to Follow-up|8|||
130801373|NCT00927082|470896958|FG002|Overall Study|Lost to Follow-up|12|||
130801374|NCT00927082|470896959|FG003|Overall Study|Lost to Follow-up|16|||
130801375|NCT00927082|470896956|FG000|Overall Study|Withdrawal by Subject|3|||
130801376|NCT00927082|470896957|FG001|Overall Study|Withdrawal by Subject|2|||
130801377|NCT00927082|470896958|FG002|Overall Study|Withdrawal by Subject|7|||
130801378|NCT00927082|470896959|FG003|Overall Study|Withdrawal by Subject|2|||
130801379|NCT00927082|470896956|FG000|Overall Study|Death|0|||
130801380|NCT00927082|470896957|FG001|Overall Study|Death|0|||
130801381|NCT00927082|470896958|FG002|Overall Study|Death|1|||
130801382|NCT00927082|470896959|FG003|Overall Study|Death|0|||
130801383|NCT00927082|470896956|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
130801384|NCT00927082|470896957|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
130801385|NCT00927082|470896958|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
130801386|NCT00927082|470896959|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
130801387|NCT01860404|470896961|FG000|Overall Study|Lost to Follow-up|3|||
130801388|NCT01860404|470896962|FG001|Overall Study|Lost to Follow-up|4|||
130801389|NCT01860404|470896963|FG002|Overall Study|Lost to Follow-up|1|||
130801390|NCT01860404|470896964|FG003|Overall Study|Lost to Follow-up|6|||
130801391|NCT01860404|470896965|FG004|Overall Study|Lost to Follow-up|4|||
130801392|NCT01860404|470896961|FG000|Overall Study|Withdrawal by Subject|0|||
130801393|NCT01860404|470896962|FG001|Overall Study|Withdrawal by Subject|0|||
130801394|NCT01860404|470896963|FG002|Overall Study|Withdrawal by Subject|4|||
130801395|NCT01860404|470896964|FG003|Overall Study|Withdrawal by Subject|0|||
130801396|NCT01860404|470896965|FG004|Overall Study|Withdrawal by Subject|0|||
130801397|NCT00849472|470896966|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
130801398|NCT00849472|470896966|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
130801399|NCT00849472|470896966|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
130801400|NCT00849472|470896966|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
130801401|NCT00849472|470896966|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
130801402|NCT00849472|470896966|FG000|Weekly Paclitaxel|Disease Progression|1|||
130801403|NCT00849472|470896966|FG000|Weekly Paclitaxel|Adverse Event|11|||
130801404|NCT00849472|470896966|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
130801405|NCT00849472|470896966|FG000|Weekly Paclitaxel|Physician Decision|3|||
130801406|NCT00849472|470896966|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
130801407|NCT00849472|470896966|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
130801408|NCT00849472|470896966|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
130801409|NCT00849472|470896966|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
130801410|NCT00849472|470896966|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
130801411|NCT00849472|470896966|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
130801412|NCT00849472|470896966|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
130801413|NCT00849472|470896966|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
130801414|NCT06038643|470896967|FG000|Overall Study|Withdrawal by Subject|9|||
130801415|NCT06038643|470896968|FG001|Overall Study|Withdrawal by Subject|4|||
130801416|NCT06038643|470896967|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
130801417|NCT06038643|470896968|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
130801418|NCT05259033|470896978|FG000|Overall Study|Withdrawal by Subject|10|||
130801419|NCT05259033|470896979|FG001|Overall Study|Withdrawal by Subject|5|||
130801420|NCT05259033|470896978|FG000|Overall Study|Lost to Follow-up|1|||
130801421|NCT05259033|470896979|FG001|Overall Study|Lost to Follow-up|0|||
130801422|NCT05259033|470896978|FG000|Overall Study|Death|2|||
130801423|NCT05259033|470896979|FG001|Overall Study|Death|0|||
130801424|NCT04180696|470896980|FG000|Overall Study|Death|5|||
130801425|NCT04180696|470896981|FG001|Overall Study|Death|6|||
130801426|NCT04180696|470896980|FG000|Overall Study|Lost to Follow-up|1|||
130801427|NCT04180696|470896981|FG001|Overall Study|Lost to Follow-up|0|||
130801428|NCT04180696|470896980|FG000|Overall Study|Withdrawal by Subject|0|||
130801429|NCT04180696|470896981|FG001|Overall Study|Withdrawal by Subject|1|||
130801430|NCT04210375|470896982|FG000|Overall Study|Death|0|||
130801431|NCT04210375|470896983|FG001|Overall Study|Death|1|||
130801432|NCT04210375|470896984|FG002|Overall Study|Death|0|||
130801433|NCT04210375|470896985|FG003|Overall Study|Death|0|||
130801434|NCT00424008|470896986|FG000|Overall Study|Adverse Event|8|||
130801435|NCT00424008|470896987|FG001|Overall Study|Adverse Event|6|||
130801436|NCT00424008|470896986|FG000|Overall Study|Lack of Efficacy|40|||
130801437|NCT00424008|470896987|FG001|Overall Study|Lack of Efficacy|34|||
130801438|NCT00424008|470896986|FG000|Overall Study|Lost to Follow-up|1|||
130801439|NCT00424008|470896987|FG001|Overall Study|Lost to Follow-up|2|||
130801440|NCT00424008|470896986|FG000|Overall Study|Withdrawal by Subject|5|||
130801441|NCT00424008|470896987|FG001|Overall Study|Withdrawal by Subject|8|||
130801442|NCT00424008|470896986|FG000|Overall Study|Noncompliance with protocol|13|||
130801443|NCT00424008|470896987|FG001|Overall Study|Noncompliance with protocol|7|||
130801444|NCT00424008|470896986|FG000|Overall Study|Did not meet protocol eligibility|16|||
130801445|NCT00424008|470896987|FG001|Overall Study|Did not meet protocol eligibility|21|||
130801446|NCT00424008|470896986|FG000|Overall Study|Administrative|266|||
130801447|NCT00424008|470896987|FG001|Overall Study|Administrative|257|||
130801448|NCT02593864|470896992|FG000|Overall Study|Withdrawal by Subject|3|||
130801449|NCT02593864|470896992|FG000|Overall Study|Lost to Follow-up|3|||
130801450|NCT01405911|470896993|FG000|Overall Study|Pre-treatment lab AE|0|||
130801451|NCT01405911|470896994|FG001|Overall Study|Pre-treatment lab AE|1|||
130801452|NCT01405911|470896995|FG002|Overall Study|Pre-treatment lab AE|0|||
130801453|NCT01405911|470896993|FG000|Overall Study|Lost to Follow-up|0|||
130801454|NCT01405911|470896994|FG001|Overall Study|Lost to Follow-up|1|||
130801455|NCT01405911|470896995|FG002|Overall Study|Lost to Follow-up|0|||
130801456|NCT01405911|470896993|FG000|Overall Study|Protocol Violation|1|||
130801457|NCT01405911|470896994|FG001|Overall Study|Protocol Violation|0|||
130801458|NCT01405911|470896995|FG002|Overall Study|Protocol Violation|0|||
130801459|NCT01405911|470896993|FG000|Overall Study|Withdrawal by Subject|3|||
130801460|NCT01405911|470896994|FG001|Overall Study|Withdrawal by Subject|1|||
130801461|NCT01405911|470896995|FG002|Overall Study|Withdrawal by Subject|1|||
130801462|NCT04739709|470896996|FG000|Overall Study|Physician Decision|1|||
130801463|NCT04739709|470896997|FG001|Overall Study|Physician Decision|0|||
130801464|NCT02530242|470897010|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
130801465|NCT02530242|470897011|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
130801466|NCT00283959|470897012|FG000|Extension Period|Low Compliance|1|||
130801467|NCT05591755|470897013|FG000|Overall Study|Screen Failure|1|||
130801468|NCT05591755|470897014|FG001|Overall Study|Screen Failure|0|||
130801469|NCT05591755|470897015|FG002|Overall Study|Screen Failure|0|||
130801470|NCT05591755|470897016|FG003|Overall Study|Screen Failure|0|||
130801471|NCT05591755|470897013|FG000|Overall Study|Protocol Violation|0|||
130801472|NCT05591755|470897014|FG001|Overall Study|Protocol Violation|0|||
130801473|NCT05591755|470897015|FG002|Overall Study|Protocol Violation|2|||
130801474|NCT05591755|470897016|FG003|Overall Study|Protocol Violation|0|||
130801475|NCT05591755|470897013|FG000|Overall Study|Withdrawal by Subject|0|||
130801476|NCT05591755|470897014|FG001|Overall Study|Withdrawal by Subject|1|||
130801477|NCT05591755|470897015|FG002|Overall Study|Withdrawal by Subject|0|||
130801478|NCT05591755|470897016|FG003|Overall Study|Withdrawal by Subject|0|||
130801479|NCT00433290|470897017|FG000|Overall Study|Adverse Event|24|||
130801480|NCT00433290|470897018|FG001|Overall Study|Adverse Event|7|||
130801481|NCT00433290|470897017|FG000|Overall Study|Lack of Efficacy|1|||
130801482|NCT00433290|470897018|FG001|Overall Study|Lack of Efficacy|5|||
130801483|NCT00433290|470897017|FG000|Overall Study|Withdrawal by Subject|4|||
130801484|NCT00433290|470897018|FG001|Overall Study|Withdrawal by Subject|2|||
130801485|NCT00433290|470897017|FG000|Overall Study|Protocol Violation|3|||
130801486|NCT00433290|470897018|FG001|Overall Study|Protocol Violation|2|||
130801487|NCT00433290|470897017|FG000|Overall Study|Physician Decision|2|||
130801488|NCT00433290|470897018|FG001|Overall Study|Physician Decision|0|||
130801489|NCT00433290|470897017|FG000|Overall Study|Entry Criteria Not Met|0|||
130801490|NCT00433290|470897018|FG001|Overall Study|Entry Criteria Not Met|1|||
130801491|NCT00433290|470897017|FG000|Overall Study|Lost to Follow-up|1|||
130801492|NCT00433290|470897018|FG001|Overall Study|Lost to Follow-up|0|||
130801493|NCT00504309|470897028|FG000|Overall Study|Death|0|||
130801494|NCT00504309|470897029|FG001|Overall Study|Death|0|||
130801495|NCT00504309|470897030|FG002|Overall Study|Death|0|||
130801496|NCT00504309|470897031|FG003|Overall Study|Death|0|||
130801497|NCT00504309|470897032|FG004|Overall Study|Death|1|||
130801498|NCT00504309|470897033|FG005|Overall Study|Death|0|||
130801499|NCT00504309|470897028|FG000|Overall Study|Withdrawal by Subject|0|||
130801500|NCT00504309|470897029|FG001|Overall Study|Withdrawal by Subject|0|||
130801501|NCT00504309|470897030|FG002|Overall Study|Withdrawal by Subject|1|||
130801502|NCT00504309|470897031|FG003|Overall Study|Withdrawal by Subject|0|||
130801503|NCT00504309|470897032|FG004|Overall Study|Withdrawal by Subject|0|||
130801504|NCT00504309|470897033|FG005|Overall Study|Withdrawal by Subject|0|||
130801505|NCT03345095|470897034|FG000|Overall Study|Lack of Efficacy|184|||
130801506|NCT03345095|470897035|FG001|Overall Study|Lack of Efficacy|156|||
130801507|NCT03345095|470897034|FG000|Overall Study|Adverse Event|36|||
130801508|NCT03345095|470897035|FG001|Overall Study|Adverse Event|118|||
130801509|NCT03345095|470897034|FG000|Overall Study|Withdrawal by Subject|22|||
130801510|NCT03345095|470897035|FG001|Overall Study|Withdrawal by Subject|59|||
130801511|NCT03345095|470897034|FG000|Overall Study|Physician Decision|3|||
130801512|NCT03345095|470897035|FG001|Overall Study|Physician Decision|18|||
130801513|NCT03345095|470897034|FG000|Overall Study|Death|2|||
130801514|NCT03345095|470897035|FG001|Overall Study|Death|4|||
130801515|NCT03345095|470897034|FG000|Overall Study|Other reasons|2|||
130801516|NCT03345095|470897035|FG001|Overall Study|Other reasons|11|||
130801517|NCT03345095|470897034|FG000|Overall Study|Protocol Violation|0|||
130801518|NCT03345095|470897035|FG001|Overall Study|Protocol Violation|1|||
130801519|NCT01121575|470897036|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
130801520|NCT01121575|470897037|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
130801521|NCT01121575|470897038|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
130801522|NCT01121575|470897039|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
130801523|NCT01121575|470897040|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
130801524|NCT01121575|470897041|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
130801525|NCT01121575|470897036|FG000|Overall Study|Unspecified Reasons|8|||
130801526|NCT01121575|470897037|FG001|Overall Study|Unspecified Reasons|6|||
130801527|NCT01121575|470897038|FG002|Overall Study|Unspecified Reasons|7|||
130801528|NCT01121575|470897039|FG003|Overall Study|Unspecified Reasons|5|||
130801529|NCT01121575|470897040|FG004|Overall Study|Unspecified Reasons|13|||
130801530|NCT01121575|470897041|FG005|Overall Study|Unspecified Reasons|10|||
130801531|NCT01121575|470897036|FG000|Overall Study|Death|6|||
130801532|NCT01121575|470897037|FG001|Overall Study|Death|0|||
130801533|NCT01121575|470897038|FG002|Overall Study|Death|0|||
130801534|NCT01121575|470897039|FG003|Overall Study|Death|1|||
130801535|NCT01121575|470897040|FG004|Overall Study|Death|7|||
130801536|NCT01121575|470897041|FG005|Overall Study|Death|1|||
130801537|NCT03932331|470897042|FG000|Overall Study|Death|0|||
130801538|NCT03932331|470897043|FG001|Overall Study|Death|7|||
130801539|NCT03932331|470897044|FG002|Overall Study|Death|2|||
130801540|NCT03932331|470897042|FG000|Overall Study|Withdrawal by Subject|0|||
130801541|NCT03932331|470897043|FG001|Overall Study|Withdrawal by Subject|3|||
130801542|NCT03932331|470897044|FG002|Overall Study|Withdrawal by Subject|0|||
130801543|NCT03932331|470897042|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
130801544|NCT03932331|470897043|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
130801545|NCT03932331|470897044|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
130801546|NCT03932331|470897042|FG000|Overall Study|Progressive disease|3|||
130801547|NCT03932331|470897043|FG001|Overall Study|Progressive disease|0|||
130801548|NCT03932331|470897044|FG002|Overall Study|Progressive disease|0|||
130801549|NCT03932331|470897042|FG000|Overall Study|Lung infection|1|||
130801550|NCT03932331|470897043|FG001|Overall Study|Lung infection|0|||
130801551|NCT03932331|470897044|FG002|Overall Study|Lung infection|0|||
130801552|NCT03932331|470897042|FG000|Overall Study|Other|0|||
130801553|NCT03932331|470897043|FG001|Overall Study|Other|0|||
130801554|NCT03932331|470897044|FG002|Overall Study|Other|58|||
130801555|NCT01937117|470897045|FG000|Overall Study|Disease Progression|7|||
130801556|NCT01937117|470897045|FG000|Overall Study|Physician Decision|4|||
130801557|NCT01937117|470897045|FG000|Overall Study|Adverse Event|2|||
130801558|NCT01407367|470897048|FG000|Overall Study|Death|24|||
130801559|NCT01407367|470897049|FG001|Overall Study|Death|32|||
130801560|NCT01407367|470897048|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
130801561|NCT01407367|470897049|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
130801562|NCT01407367|470897048|FG000|Overall Study|Withdrawal by Subject|4|||
130801563|NCT01407367|470897049|FG001|Overall Study|Withdrawal by Subject|15|||
130801564|NCT01407367|470897048|FG000|Overall Study|Lost to Follow-up|0|||
130801565|NCT01407367|470897049|FG001|Overall Study|Lost to Follow-up|2|||
130801566|NCT01452347|470897052|FG000|Overall Study|Adverse Event|2|||
130801567|NCT01452347|470897053|FG001|Overall Study|Adverse Event|1|||
130801568|NCT01452347|470897052|FG000|Overall Study|Non compliance protocol|2|||
130801569|NCT01452347|470897053|FG001|Overall Study|Non compliance protocol|0|||
130801570|NCT01452347|470897052|FG000|Overall Study|Lost to Follow-up|2|||
130801571|NCT01452347|470897053|FG001|Overall Study|Lost to Follow-up|0|||
130801572|NCT01452347|470897052|FG000|Overall Study|Withdrawal by Subject|3|||
130801573|NCT01452347|470897053|FG001|Overall Study|Withdrawal by Subject|3|||
130801574|NCT01452347|470897052|FG000|Overall Study|Not treated|6|||
130801575|NCT01452347|470897053|FG001|Overall Study|Not treated|3|||
130801576|NCT01452347|470897052|FG000|Overall Study|Other reason not defined above|2|||
130801577|NCT01452347|470897053|FG001|Overall Study|Other reason not defined above|0|||
130801578|NCT05417113|470898540|FG000|Overall Study|Lost to Follow-up|2|||
130801579|NCT05417113|470898541|FG001|Overall Study|Lost to Follow-up|2|||
130801580|NCT01022580|470898542|FG000|Overall Study|Death|18|||
130801581|NCT01022580|470898543|FG001|Overall Study|Death|22|||
130801582|NCT01500096|470898546|FG000|Overall Study|Lost to Follow-up|1|||
130801583|NCT01500096|470898547|FG001|Overall Study|Lost to Follow-up|0|||
130801584|NCT01500096|470898548|FG002|Overall Study|Lost to Follow-up|0|||
130801585|NCT01500096|470898549|FG003|Overall Study|Lost to Follow-up|2|||
130801586|NCT01734928|470898550|FG000|Randomization|Physician Decision|0|||
130801587|NCT01734928|470898551|FG001|Randomization|Physician Decision|1|||
130801588|NCT01734928|470898550|FG000|Randomization|clinical progression|0|||
130801589|NCT01734928|470898551|FG001|Randomization|clinical progression|1|||
130801590|NCT01734928|470898550|FG000|Randomization|progressive disease|0|||
130801591|NCT01734928|470898551|FG001|Randomization|progressive disease|2|||
130801592|NCT01734928|470898550|FG000|Randomization|Withdrew informed consent|0|||
130801593|NCT01734928|470898551|FG001|Randomization|Withdrew informed consent|4|||
130801594|NCT01734928|470898550|FG000|Randomization|Death|1|||
130801595|NCT01734928|470898551|FG001|Randomization|Death|0|||
130801596|NCT01734928|470898550|FG000|Randomization|Randomization error|1|||
130801597|NCT01734928|470898551|FG001|Randomization|Randomization error|0|||
130801598|NCT01734928|470898550|FG000|Randomization|Lost to Follow-up|1|||
130801599|NCT01734928|470898551|FG001|Randomization|Lost to Follow-up|0|||
130801600|NCT01734928|470898550|FG000|Treatment Period|Lost to Follow-up|0|||
130801601|NCT01734928|470898551|FG001|Treatment Period|Lost to Follow-up|2|||
130801602|NCT01734928|470898550|FG000|Treatment Period|Progressive Disease|167|||
130801603|NCT01734928|470898551|FG001|Treatment Period|Progressive Disease|165|||
130801604|NCT01734928|470898550|FG000|Treatment Period|Adverse Event|39|||
130763563|NCT03802565|470757367|FG004|Overall Study|Elevated Enzymes|2|||
130763564|NCT05020899|470757368|FG000|8 Week Follow-up|Lost to Follow-up|3|||
130763565|NCT05020899|470757369|FG001|8 Week Follow-up|Lost to Follow-up|6|||
130763566|NCT05020899|470757368|FG000|12 Week Follow-up|Lost to Follow-up|1|||
130763567|NCT05020899|470757369|FG001|12 Week Follow-up|Lost to Follow-up|0|||
130763568|NCT05020899|470757368|FG000|12 Week Follow-up|Death|0|||
130763569|NCT05020899|470757369|FG001|12 Week Follow-up|Death|1|||
130763570|NCT02124759|470757370|FG000|Overall Study|Withdrawal by Subject|3|||
130763571|NCT02124759|470757371|FG001|Overall Study|Withdrawal by Subject|1|||
130763572|NCT02124759|470757372|FG002|Overall Study|Withdrawal by Subject|1|||
130763573|NCT02124759|470757370|FG000|Overall Study|Screen Fail|2|||
130763574|NCT02124759|470757371|FG001|Overall Study|Screen Fail|2|||
130763575|NCT02124759|470757372|FG002|Overall Study|Screen Fail|3|||
130763576|NCT01068626|470757373|FG000|Overall Study|Adverse Event|3|||
130763577|NCT01068626|470757374|FG001|Overall Study|Adverse Event|0|||
130763578|NCT01068626|470757373|FG000|Overall Study|Withdrawal by Subject|0|||
130763579|NCT01068626|470757374|FG001|Overall Study|Withdrawal by Subject|2|||
130763580|NCT01785849|470757377|FG000|Overall Study|Death|7|||
130763581|NCT01785849|470757378|FG001|Overall Study|Death|9|||
130763582|NCT01785849|470757377|FG000|Overall Study|Protocol Specified Criteria|29|||
130763583|NCT01785849|470757378|FG001|Overall Study|Protocol Specified Criteria|1|||
130763584|NCT01785849|470757377|FG000|Overall Study|Withdrawal by Subject|15|||
130763585|NCT01785849|470757378|FG001|Overall Study|Withdrawal by Subject|12|||
130763586|NCT01785849|470757377|FG000|Overall Study|Sponsor Decision|0|||
130763587|NCT01785849|470757378|FG001|Overall Study|Sponsor Decision|1|||
130763588|NCT01785849|470757377|FG000|Overall Study|Lost to Follow-up|10|||
130763589|NCT01785849|470757378|FG001|Overall Study|Lost to Follow-up|11|||
130763594|NCT04249622|470757381|FG000|Overall Study|Withdrawal by Subject|1|||
130763595|NCT04249622|470757382|FG001|Overall Study|Withdrawal by Subject|1|||
130763596|NCT04249622|470757381|FG000|Overall Study|Alternative therapy|1|||
130763597|NCT04249622|470757382|FG001|Overall Study|Alternative therapy|0|||
130763598|NCT04249622|470757381|FG000|Overall Study|Discontinuation of pertuzumab|1|||
130763599|NCT04249622|470757382|FG001|Overall Study|Discontinuation of pertuzumab|0|||
130763600|NCT01634659|470757386|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
130763601|NCT01634659|470757387|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
130763602|NCT01634659|470757386|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
130763603|NCT01634659|470757387|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
130763604|NCT00875433|470757388|FG000|Overall Study|Progressive disease|41|||
130763605|NCT00875433|470757388|FG000|Overall Study|Other Adverse Event|14|||
130763606|NCT00875433|470757388|FG000|Overall Study|Withdrawal by Subject|2|||
130763607|NCT00875433|470757388|FG000|Overall Study|Other|3|||
130763608|NCT00793624|470757389|FG000|Overall Study|Adverse Event|18|||
130763609|NCT00793624|470757390|FG001|Overall Study|Adverse Event|16|||
130763610|NCT00793624|470757391|FG002|Overall Study|Adverse Event|15|||
130763611|NCT00793624|470757392|FG003|Overall Study|Adverse Event|20|||
130763612|NCT00793624|470757389|FG000|Overall Study|Lost to Follow-up|2|||
130763613|NCT00793624|470757390|FG001|Overall Study|Lost to Follow-up|2|||
130763614|NCT00793624|470757391|FG002|Overall Study|Lost to Follow-up|4|||
130763615|NCT00793624|470757392|FG003|Overall Study|Lost to Follow-up|0|||
130763616|NCT00793624|470757389|FG000|Overall Study|Withdrawal by Subject|20|||
130763617|NCT00793624|470757390|FG001|Overall Study|Withdrawal by Subject|9|||
130763618|NCT00793624|470757391|FG002|Overall Study|Withdrawal by Subject|11|||
130763619|NCT00793624|470757392|FG003|Overall Study|Withdrawal by Subject|14|||
130763620|NCT00793624|470757389|FG000|Overall Study|Lack of Efficacy|9|||
130763621|NCT00793624|470757390|FG001|Overall Study|Lack of Efficacy|2|||
130763622|NCT00793624|470757391|FG002|Overall Study|Lack of Efficacy|1|||
130763623|NCT00793624|470757392|FG003|Overall Study|Lack of Efficacy|3|||
130763624|NCT00793624|470757389|FG000|Overall Study|Non compliance with protocol|2|||
130763625|NCT00793624|470757390|FG001|Overall Study|Non compliance with protocol|3|||
130763626|NCT00793624|470757391|FG002|Overall Study|Non compliance with protocol|2|||
130763627|NCT00793624|470757392|FG003|Overall Study|Non compliance with protocol|3|||
130763628|NCT00793624|470757389|FG000|Overall Study|Other reason not described above|6|||
130763629|NCT00793624|470757390|FG001|Overall Study|Other reason not described above|4|||
130763630|NCT00793624|470757391|FG002|Overall Study|Other reason not described above|6|||
130763631|NCT00793624|470757392|FG003|Overall Study|Other reason not described above|3|||
130801605|NCT01734928|470898551|FG001|Treatment Period|Adverse Event|52|||
130801606|NCT01734928|470898550|FG000|Treatment Period|Withdrawal of Consent|25|||
130801607|NCT01734928|470898551|FG001|Treatment Period|Withdrawal of Consent|22|||
130801608|NCT01734928|470898550|FG000|Treatment Period|Death|20|||
130801609|NCT01734928|470898551|FG001|Treatment Period|Death|9|||
130801610|NCT01734928|470898550|FG000|Treatment Period|Other Reasons|27|||
130801611|NCT01734928|470898551|FG001|Treatment Period|Other Reasons|19|||
130801612|NCT01734928|470898550|FG000|Treatment Period|Pregnancy|0|||
130801613|NCT01734928|470898551|FG001|Treatment Period|Pregnancy|1|||
130801614|NCT01778985|470898552|FG000|Overall Study|Lost to Follow-up|1|||
130801615|NCT01778985|470898553|FG001|Overall Study|Lost to Follow-up|0|||
130801616|NCT01778985|470898552|FG000|Overall Study|Physician Decision|2|||
130801617|NCT01778985|470898553|FG001|Overall Study|Physician Decision|2|||
130801618|NCT01778985|470898552|FG000|Overall Study|Protocol Violation|4|||
130801619|NCT01778985|470898553|FG001|Overall Study|Protocol Violation|1|||
130801620|NCT00504231|470898554|FG000|Overall Study|Discrepant chart documentation re route|0|||
130801621|NCT00504231|470898555|FG001|Overall Study|Discrepant chart documentation re route|0|||
130801622|NCT00504231|470898556|FG002|Overall Study|Discrepant chart documentation re route|1|||
130801623|NCT00504231|470898557|FG003|Overall Study|Discrepant chart documentation re route|0|||
130801624|NCT00088881|470898559|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
130801625|NCT00088881|470898559|FG000|Step 1 - R-CHOP|Adverse Event|1|||
130801626|NCT00088881|470898559|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
130801627|NCT00088881|470898559|FG000|Step 1 - R-CHOP|Physician Decision|1|||
130801628|NCT00088881|470898559|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
130801629|NCT00088881|470898559|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
130801630|NCT00088881|470898559|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
130801631|NCT01631188|470898565|FG000|Overall Study|Physician Decision|75|||
130801632|NCT03600350|470898566|FG000|Overall Study|Death|1|||
130801633|NCT03600350|470898566|FG000|Overall Study|On Follow Up|18|||
130801634|NCT00835978|470898567|FG000|Overall Study|Death|33|||
130801635|NCT00835978|470898568|FG001|Overall Study|Death|40|||
130801636|NCT00835978|470898569|FG002|Overall Study|Death|49|||
130801637|NCT00835978|470898570|FG003|Overall Study|Death|4|||
130801638|NCT00835978|470898567|FG000|Overall Study|Lost to Follow-up|3|||
130801639|NCT00835978|470898568|FG001|Overall Study|Lost to Follow-up|4|||
130801640|NCT00835978|470898569|FG002|Overall Study|Lost to Follow-up|2|||
130801641|NCT00835978|470898570|FG003|Overall Study|Lost to Follow-up|1|||
130801642|NCT00835978|470898567|FG000|Overall Study|Other|5|||
130801643|NCT00835978|470898568|FG001|Overall Study|Other|1|||
130801644|NCT00835978|470898569|FG002|Overall Study|Other|8|||
130801645|NCT00835978|470898570|FG003|Overall Study|Other|0|||
130801646|NCT00835978|470898567|FG000|Overall Study|Objective progression or relapse|2|||
130801647|NCT00835978|470898568|FG001|Overall Study|Objective progression or relapse|0|||
130801648|NCT00835978|470898569|FG002|Overall Study|Objective progression or relapse|1|||
130801649|NCT00835978|470898570|FG003|Overall Study|Objective progression or relapse|0|||
130801650|NCT00835978|470898567|FG000|Overall Study|Adverse Event|1|||
130801651|NCT00835978|470898568|FG001|Overall Study|Adverse Event|0|||
130801652|NCT00835978|470898569|FG002|Overall Study|Adverse Event|1|||
130801653|NCT00835978|470898570|FG003|Overall Study|Adverse Event|0|||
130801654|NCT00835978|470898567|FG000|Overall Study|Withdrawal by Subject|0|||
130801655|NCT00835978|470898568|FG001|Overall Study|Withdrawal by Subject|3|||
130801656|NCT00835978|470898569|FG002|Overall Study|Withdrawal by Subject|0|||
130801657|NCT00835978|470898570|FG003|Overall Study|Withdrawal by Subject|5|||
130801658|NCT00835978|470898567|FG000|Overall Study|Study terminated by sponsor|12|||
130801659|NCT00835978|470898568|FG001|Overall Study|Study terminated by sponsor|8|||
130801660|NCT00835978|470898569|FG002|Overall Study|Study terminated by sponsor|30|||
130801661|NCT00835978|470898570|FG003|Overall Study|Study terminated by sponsor|0|||
130801662|NCT03684057|470898571|FG000|Overall Study|Withdrawal by Subject|4|||
130801663|NCT03684057|470898572|FG001|Overall Study|Withdrawal by Subject|5|||
130801664|NCT01105130|470898573|FG000|Overall Study|Withdrawal by Subject|4|||
130801665|NCT01105130|470898574|FG001|Overall Study|Withdrawal by Subject|6|||
130801666|NCT01105130|470898575|FG002|Overall Study|Withdrawal by Subject|2|||
130801667|NCT01105130|470898573|FG000|Overall Study|Never Started|2|||
130801668|NCT01105130|470898574|FG001|Overall Study|Never Started|2|||
130801669|NCT01105130|470898575|FG002|Overall Study|Never Started|4|||
130801670|NCT01105130|470898573|FG000|Overall Study|Toxicity|1|||
130801671|NCT01105130|470898574|FG001|Overall Study|Toxicity|3|||
130801672|NCT01105130|470898575|FG002|Overall Study|Toxicity|2|||
130801673|NCT01105130|470898573|FG000|Overall Study|Multiple Reasons|3|||
130801674|NCT01105130|470898574|FG001|Overall Study|Multiple Reasons|0|||
130801675|NCT01105130|470898575|FG002|Overall Study|Multiple Reasons|2|||
130801676|NCT02927145|470898577|FG000|Initial Recruitment|Withdrawal by Subject|0|||
130801677|NCT02927145|470898578|FG001|Initial Recruitment|Withdrawal by Subject|1|||
130801678|NCT02927145|470898579|FG002|Initial Recruitment|Withdrawal by Subject|1|||
130801679|NCT02927145|470898580|FG003|Initial Recruitment|Withdrawal by Subject|4|||
130801680|NCT02927145|470898581|FG004|Initial Recruitment|Withdrawal by Subject|1|||
130801681|NCT02927145|470898582|FG005|Initial Recruitment|Withdrawal by Subject|1|||
130801682|NCT02927145|470898583|FG006|Initial Recruitment|Withdrawal by Subject|0|||
130801683|NCT02927145|470898584|FG007|Initial Recruitment|Withdrawal by Subject|0|||
130801684|NCT02927145|470898585|FG008|Initial Recruitment|Withdrawal by Subject|2|||
130801685|NCT02927145|470898577|FG000|Initial Recruitment|Adverse Event|0|||
130801686|NCT02927145|470898578|FG001|Initial Recruitment|Adverse Event|0|||
130801687|NCT02927145|470898579|FG002|Initial Recruitment|Adverse Event|0|||
130801688|NCT02927145|470898580|FG003|Initial Recruitment|Adverse Event|0|||
130801689|NCT02927145|470898581|FG004|Initial Recruitment|Adverse Event|2|||
130801690|NCT02927145|470898582|FG005|Initial Recruitment|Adverse Event|0|||
130801691|NCT02927145|470898583|FG006|Initial Recruitment|Adverse Event|0|||
130801692|NCT02927145|470898584|FG007|Initial Recruitment|Adverse Event|0|||
130801693|NCT02927145|470898585|FG008|Initial Recruitment|Adverse Event|0|||
130801694|NCT02927145|470898577|FG000|Invitation for Additional Challenge|Pregnancy|0|||
130801695|NCT02927145|470898578|FG001|Invitation for Additional Challenge|Pregnancy|0|||
130801696|NCT02927145|470898579|FG002|Invitation for Additional Challenge|Pregnancy|0|||
130801697|NCT02927145|470898580|FG003|Invitation for Additional Challenge|Pregnancy|0|||
130801698|NCT02927145|470898581|FG004|Invitation for Additional Challenge|Pregnancy|0|||
130801699|NCT02927145|470898582|FG005|Invitation for Additional Challenge|Pregnancy|0|||
130801700|NCT02927145|470898583|FG006|Invitation for Additional Challenge|Pregnancy|1|||
130801701|NCT02927145|470898584|FG007|Invitation for Additional Challenge|Pregnancy|0|||
130801702|NCT02927145|470898585|FG008|Invitation for Additional Challenge|Pregnancy|0|||
130801703|NCT01363440|470898587|FG000|Overall Study|Adverse Event|5|||
130801704|NCT01363440|470898588|FG001|Overall Study|Adverse Event|4|||
130801705|NCT01363440|470898589|FG002|Overall Study|Adverse Event|4|||
130801706|NCT01363440|470898587|FG000|Overall Study|Death|3|||
130801707|NCT01363440|470898588|FG001|Overall Study|Death|7|||
130801708|NCT01363440|470898589|FG002|Overall Study|Death|5|||
130801709|NCT01363440|470898587|FG000|Overall Study|Withdrawal by Subject|9|||
130801710|NCT01363440|470898588|FG001|Overall Study|Withdrawal by Subject|11|||
130801711|NCT01363440|470898589|FG002|Overall Study|Withdrawal by Subject|11|||
130801712|NCT01363440|470898587|FG000|Overall Study|Lost to Follow-up|2|||
130801713|NCT01363440|470898588|FG001|Overall Study|Lost to Follow-up|4|||
130801714|NCT01363440|470898589|FG002|Overall Study|Lost to Follow-up|5|||
130801715|NCT01363440|470898587|FG000|Overall Study|Other|4|||
130801716|NCT01363440|470898588|FG001|Overall Study|Other|5|||
130801717|NCT01363440|470898589|FG002|Overall Study|Other|2|||
130801718|NCT00266812|470898591|FG000|Overall Study|Disease Progression|9|||
130801719|NCT00266812|470898592|FG001|Overall Study|Disease Progression|3|||
130801720|NCT00266812|470898591|FG000|Overall Study|Death|5|||
130801721|NCT00266812|470898592|FG001|Overall Study|Death|4|||
130801722|NCT00266812|470898591|FG000|Overall Study|Adverse Event|3|||
130801723|NCT00266812|470898592|FG001|Overall Study|Adverse Event|1|||
130801724|NCT00266812|470898591|FG000|Overall Study|Protocol Violation|0|||
130801725|NCT00266812|470898592|FG001|Overall Study|Protocol Violation|1|||
130801726|NCT00266812|470898591|FG000|Overall Study|Withdrawal by Subject|0|||
130801727|NCT00266812|470898592|FG001|Overall Study|Withdrawal by Subject|2|||
130801728|NCT00266812|470898591|FG000|Overall Study|Discontinued before starting study drug|4|||
130801729|NCT00266812|470898592|FG001|Overall Study|Discontinued before starting study drug|0|||
130801730|NCT02323334|470898594|FG000|Period 3|Lost to Follow-up|0|||
130801731|NCT02323334|470898595|FG001|Period 3|Lost to Follow-up|0|||
130801732|NCT02323334|470898596|FG002|Period 3|Lost to Follow-up|1|||
130801733|NCT02323334|470898597|FG003|Period 3|Lost to Follow-up|0|||
130801734|NCT02323334|470898598|FG004|Period 3|Lost to Follow-up|0|||
130801735|NCT02323334|470898599|FG005|Period 3|Lost to Follow-up|0|||
130801736|NCT02323334|470898600|FG006|Period 3|Lost to Follow-up|0|||
130801737|NCT02323334|470898601|FG007|Period 3|Lost to Follow-up|0|||
130801738|NCT02323334|470898602|FG008|Period 3|Lost to Follow-up|0|||
130801739|NCT02323334|470898603|FG009|Period 3|Lost to Follow-up|0|||
130801740|NCT02323334|470898604|FG010|Period 3|Lost to Follow-up|0|||
130801741|NCT02323334|470898605|FG011|Period 3|Lost to Follow-up|0|||
130801742|NCT02323334|470898606|FG012|Period 3|Lost to Follow-up|0|||
130801743|NCT02323334|470898607|FG013|Period 3|Lost to Follow-up|0|||
130801744|NCT02323334|470898608|FG014|Period 3|Lost to Follow-up|0|||
130801745|NCT02323334|470898609|FG015|Period 3|Lost to Follow-up|0|||
130801746|NCT02323334|470898610|FG016|Period 3|Lost to Follow-up|0|||
130801747|NCT02323334|470898594|FG000|Period 3|Withdrawal by Subject|1|||
130801748|NCT02323334|470898595|FG001|Period 3|Withdrawal by Subject|0|||
130801749|NCT02323334|470898596|FG002|Period 3|Withdrawal by Subject|0|||
130801750|NCT02323334|470898597|FG003|Period 3|Withdrawal by Subject|0|||
130801751|NCT02323334|470898598|FG004|Period 3|Withdrawal by Subject|0|||
130801752|NCT02323334|470898599|FG005|Period 3|Withdrawal by Subject|0|||
130801753|NCT02323334|470898600|FG006|Period 3|Withdrawal by Subject|0|||
130801754|NCT02323334|470898601|FG007|Period 3|Withdrawal by Subject|0|||
130801755|NCT02323334|470898602|FG008|Period 3|Withdrawal by Subject|0|||
130801756|NCT02323334|470898603|FG009|Period 3|Withdrawal by Subject|0|||
130801757|NCT02323334|470898604|FG010|Period 3|Withdrawal by Subject|0|||
130801758|NCT02323334|470898605|FG011|Period 3|Withdrawal by Subject|0|||
130801759|NCT02323334|470898606|FG012|Period 3|Withdrawal by Subject|0|||
130801760|NCT02323334|470898607|FG013|Period 3|Withdrawal by Subject|0|||
130801761|NCT02323334|470898608|FG014|Period 3|Withdrawal by Subject|0|||
130801762|NCT02323334|470898609|FG015|Period 3|Withdrawal by Subject|0|||
130801763|NCT02323334|470898610|FG016|Period 3|Withdrawal by Subject|0|||
130801764|NCT03695094|470898611|FG000|Overall Study|Adverse Event|1|||
130801765|NCT03695094|470898612|FG001|Overall Study|Adverse Event|1|||
130801766|NCT03695094|470898611|FG000|Overall Study|Withdrawal by Subject|1|||
130801767|NCT03695094|470898612|FG001|Overall Study|Withdrawal by Subject|0|||
130801768|NCT00456612|470898613|FG000|Overall Study|Withdrawal by Subject|3|||
130801769|NCT02506036|470898614|FG000|First Intervention (4-6 Weeks)|Death|1|||
130801770|NCT02506036|470898615|FG001|First Intervention (4-6 Weeks)|Death|0|||
130801771|NCT02506036|470898614|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
130801772|NCT02506036|470898615|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
130801773|NCT02506036|470898614|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
130801774|NCT02506036|470898615|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
130801775|NCT00530075|470898618|FG000|Overall Study|Adverse Event|1|||
130801776|NCT00530075|470898618|FG000|Overall Study|Death|1|||
130801777|NCT00530075|470898618|FG000|Overall Study|Lack of Efficacy|3|||
130801778|NCT00530075|470898618|FG000|Overall Study|Protocol Violation|1|||
130801779|NCT00530075|470898618|FG000|Overall Study|Withdrawal by Subject|1|||
130801780|NCT02316613|470898619|FG000|Overall Study|Death|63|||
130801781|NCT02316613|470898619|FG000|Overall Study|Lost to Follow-up|9|||
130801782|NCT02316613|470898619|FG000|Overall Study|Lymphoma transformation|2|||
130801783|NCT02316613|470898619|FG000|Overall Study|Participant moved/changed medical team|11|||
130801784|NCT02316613|470898619|FG000|Overall Study|No data and duplicate cases|5|||
130801785|NCT02316613|470898619|FG000|Overall Study|Did not met selection criteria|14|||
130801786|NCT00758043|470898623|FG000|Overall Study|Adverse Event|1|||
130801787|NCT00758043|470898624|FG001|Overall Study|Adverse Event|20|||
130801788|NCT00758043|470898625|FG002|Overall Study|Adverse Event|12|||
130801789|NCT00758043|470898626|FG003|Overall Study|Adverse Event|62|||
130801790|NCT00758043|470898623|FG000|Overall Study|Lack of Efficacy|0|||
130801791|NCT00758043|470898624|FG001|Overall Study|Lack of Efficacy|6|||
130801792|NCT00758043|470898625|FG002|Overall Study|Lack of Efficacy|18|||
130801793|NCT00758043|470898626|FG003|Overall Study|Lack of Efficacy|12|||
130801794|NCT00758043|470898623|FG000|Overall Study|Refused Further Treatment|0|||
130801795|NCT00758043|470898624|FG001|Overall Study|Refused Further Treatment|11|||
130801796|NCT00758043|470898625|FG002|Overall Study|Refused Further Treatment|5|||
130801797|NCT00758043|470898626|FG003|Overall Study|Refused Further Treatment|8|||
130801798|NCT00758043|470898623|FG000|Overall Study|Lost to Follow-up|0|||
130801799|NCT00758043|470898624|FG001|Overall Study|Lost to Follow-up|2|||
130801800|NCT00758043|470898625|FG002|Overall Study|Lost to Follow-up|2|||
130801801|NCT00758043|470898626|FG003|Overall Study|Lost to Follow-up|5|||
130801802|NCT00758043|470898623|FG000|Overall Study|Withdrawal by Subject|0|||
130801803|NCT00758043|470898624|FG001|Overall Study|Withdrawal by Subject|1|||
130801804|NCT00758043|470898625|FG002|Overall Study|Withdrawal by Subject|1|||
130801805|NCT00758043|470898626|FG003|Overall Study|Withdrawal by Subject|4|||
130801806|NCT00758043|470898623|FG000|Overall Study|Required Prohibited Medication|0|||
130801807|NCT00758043|470898624|FG001|Overall Study|Required Prohibited Medication|0|||
130801808|NCT00758043|470898625|FG002|Overall Study|Required Prohibited Medication|1|||
130801809|NCT00758043|470898626|FG003|Overall Study|Required Prohibited Medication|3|||
130763632|NCT02921750|470758609|FG000|Overall Study|Adverse Event|1|||
130763633|NCT02921750|470758610|FG001|Overall Study|Adverse Event|2|||
130763634|NCT02921750|470758609|FG000|Overall Study|Withdrawal by Subject|1|||
130763635|NCT02921750|470758610|FG001|Overall Study|Withdrawal by Subject|1|||
130763636|NCT02921750|470758609|FG000|Overall Study|Lost to Follow-up|3|||
130763637|NCT02921750|470758610|FG001|Overall Study|Lost to Follow-up|3|||
130763638|NCT02921750|470758609|FG000|Overall Study|Wound healed|3|||
130763639|NCT02921750|470758610|FG001|Overall Study|Wound healed|3|||
130763640|NCT02921750|470758609|FG000|Overall Study|Serious Adverse Event|1|||
130763641|NCT02921750|470758610|FG001|Overall Study|Serious Adverse Event|2|||
130763642|NCT03309696|470758611|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
130763643|NCT03309696|470758612|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
130763644|NCT03309696|470758613|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
130763645|NCT03309696|470758614|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
130763646|NCT05940077|470758616|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
130763647|NCT03570554|470758617|FG000|Overall Study|Non-compliance with study drug|0|||
130763648|NCT03570554|470758618|FG001|Overall Study|Non-compliance with study drug|0|||
130763649|NCT03570554|470758619|FG002|Overall Study|Non-compliance with study drug|1|||
130763650|NCT03570554|470758620|FG003|Overall Study|Non-compliance with study drug|0|||
130801810|NCT00758043|470898623|FG000|Overall Study|Non-Compliant With study Drug|0|||
130801811|NCT00758043|470898624|FG001|Overall Study|Non-Compliant With study Drug|0|||
130801812|NCT00758043|470898625|FG002|Overall Study|Non-Compliant With study Drug|0|||
130801813|NCT00758043|470898626|FG003|Overall Study|Non-Compliant With study Drug|1|||
130801814|NCT00758043|470898623|FG000|Overall Study|Other Reasons|0|||
130801815|NCT00758043|470898624|FG001|Overall Study|Other Reasons|1|||
130801816|NCT00758043|470898625|FG002|Overall Study|Other Reasons|0|||
130801817|NCT00758043|470898626|FG003|Overall Study|Other Reasons|5|||
130801818|NCT00552058|470898629|FG000|Overall Study|Adverse Event|8|||
130801819|NCT00552058|470898630|FG001|Overall Study|Adverse Event|7|||
130801820|NCT00552058|470898629|FG000|Overall Study|Lack of Efficacy|1|||
130801821|NCT00552058|470898630|FG001|Overall Study|Lack of Efficacy|5|||
130801822|NCT00552058|470898629|FG000|Overall Study|Lost to Follow-up|1|||
130801823|NCT00552058|470898630|FG001|Overall Study|Lost to Follow-up|0|||
130801824|NCT00552058|470898629|FG000|Overall Study|Withdrawal by Subject|4|||
130801825|NCT00552058|470898630|FG001|Overall Study|Withdrawal by Subject|4|||
130801826|NCT00552058|470898629|FG000|Overall Study|Other: Protocol Violation|0|||
130801827|NCT00552058|470898630|FG001|Overall Study|Other: Protocol Violation|1|||
130801828|NCT00552058|470898629|FG000|Overall Study|Other: Non Compliance|1|||
130801829|NCT00552058|470898630|FG001|Overall Study|Other: Non Compliance|2|||
130801830|NCT00552058|470898629|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
130801831|NCT00552058|470898630|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
130801832|NCT00552058|470898629|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
130801833|NCT00552058|470898630|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
130801834|NCT00552058|470898629|FG000|Overall Study|Other: Positive Stool Result|0|||
130801835|NCT00552058|470898630|FG001|Overall Study|Other: Positive Stool Result|1|||
130801836|NCT00552058|470898629|FG000|Overall Study|Other: Randomized in error|0|||
130801837|NCT00552058|470898630|FG001|Overall Study|Other: Randomized in error|1|||
130801838|NCT00552058|470898629|FG000|Overall Study|Other: Sponsors Decision|0|||
130801839|NCT00552058|470898630|FG001|Overall Study|Other: Sponsors Decision|1|||
130801840|NCT00552058|470898629|FG000|Overall Study|Other: Early Roll Over|1|||
130801841|NCT00552058|470898630|FG001|Overall Study|Other: Early Roll Over|0|||
130801842|NCT03422718|470898633|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
130801843|NCT03422718|470898634|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
130801844|NCT03422718|470898635|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
130801845|NCT03422718|470898636|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
130801846|NCT03422718|470898637|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
130801847|NCT03422718|470898638|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
130801848|NCT03422718|470898639|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
130801849|NCT03422718|470898640|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
130801850|NCT03422718|470898633|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
130801851|NCT03422718|470898634|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
130801852|NCT03422718|470898635|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
130801853|NCT03422718|470898636|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
130801854|NCT03422718|470898637|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
130801855|NCT03422718|470898638|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
130801856|NCT03422718|470898639|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
130801857|NCT03422718|470898640|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
130801858|NCT03422718|470898633|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
130801859|NCT03422718|470898634|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
130801860|NCT03422718|470898635|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
130801861|NCT03422718|470898636|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
130801862|NCT03422718|470898637|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
130801863|NCT03422718|470898638|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
130801864|NCT03422718|470898639|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
130801865|NCT03422718|470898640|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
130801866|NCT03422718|470898633|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130801867|NCT03422718|470898634|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
130801868|NCT03422718|470898635|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130801869|NCT03422718|470898636|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130801870|NCT03422718|470898637|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
130801871|NCT03422718|470898638|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
130801872|NCT03422718|470898639|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130801873|NCT03422718|470898640|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130801874|NCT03422718|470898633|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
130801875|NCT03422718|470898634|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
130801876|NCT03422718|470898635|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
130801877|NCT03422718|470898636|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
130801878|NCT03422718|470898637|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
130801879|NCT03422718|470898638|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
130801880|NCT03422718|470898639|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
130801881|NCT03422718|470898640|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
130801882|NCT03422718|470898633|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
130801883|NCT03422718|470898634|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
130801884|NCT03422718|470898635|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
130801885|NCT03422718|470898636|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
130801886|NCT03422718|470898637|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
130801887|NCT03422718|470898638|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
130801888|NCT03422718|470898639|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
130801889|NCT03422718|470898640|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
130801890|NCT01129284|470898641|FG000|Overall Study|Adverse Event|2|||
130801891|NCT01129284|470898642|FG001|Overall Study|Adverse Event|0|||
130801892|NCT01129284|470898643|FG002|Overall Study|Adverse Event|1|||
130801893|NCT02400580|470898651|FG000|Overall Study|Withdrawal by Subject|1|||
130801894|NCT02400580|470898652|FG001|Overall Study|Withdrawal by Subject|1|||
130801895|NCT02400580|470898651|FG000|Overall Study|Adverse Event|1|||
130801896|NCT02400580|470898652|FG001|Overall Study|Adverse Event|0|||
130801897|NCT00965094|470898655|FG000|Overall Study|Adverse Event|5|||
130801898|NCT00965094|470898656|FG001|Overall Study|Adverse Event|0|||
130801899|NCT00965094|470898655|FG000|Overall Study|Lost to Follow-up|0|||
130801900|NCT00965094|470898656|FG001|Overall Study|Lost to Follow-up|1|||
130801901|NCT01336972|470898660|FG000|Overall Study|Adverse Event|1|||
130801902|NCT01336972|470898661|FG001|Overall Study|Adverse Event|1|||
130801903|NCT01336972|470898662|FG002|Overall Study|Adverse Event|0|||
130801904|NCT02441114|470898663|FG000|Washout2|Withdrawal by Subject|4|||
130801905|NCT03446573|470898665|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
130801906|NCT03446573|470898666|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
130801907|NCT03446573|470898665|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
130801908|NCT03446573|470898666|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
130801909|NCT03446573|470898665|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
130801910|NCT03446573|470898666|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
130801911|NCT03446573|470898665|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
130801912|NCT03446573|470898666|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
130801913|NCT03446573|470898665|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
130801914|NCT03446573|470898666|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
130801915|NCT03446573|470898665|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
130801916|NCT03446573|470898666|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
130801917|NCT03446573|470898665|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
130801918|NCT03446573|470898666|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
130801919|NCT03446573|470898665|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
130801920|NCT03446573|470898666|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
130801921|NCT03446573|470898665|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
130801922|NCT03446573|470898666|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
130801923|NCT03446573|470898665|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
130801924|NCT03446573|470898666|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
130801925|NCT03446573|470898665|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
130801926|NCT03446573|470898666|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
130801927|NCT03446573|470898665|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
130801928|NCT03446573|470898666|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
130801929|NCT03446573|470898665|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
130801930|NCT03446573|470898666|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
130801931|NCT01371565|470898671|FG000|Overall Study|Withdrawal by Subject|1|||
130801932|NCT01371565|470898671|FG000|Overall Study|Death|1|||
130801933|NCT01371565|470898671|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
130801934|NCT04270760|470898672|FG000|Overall Study|Withdrawal by Subject|0|||
130801935|NCT04270760|470898673|FG001|Overall Study|Withdrawal by Subject|1|||
130801936|NCT04270760|470898674|FG002|Overall Study|Withdrawal by Subject|3|||
130801937|NCT04270760|470898675|FG003|Overall Study|Withdrawal by Subject|0|||
130801938|NCT04270760|470898676|FG004|Overall Study|Withdrawal by Subject|0|||
130801939|NCT04270760|470898672|FG000|Overall Study|Lost to Follow-up|1|||
130801940|NCT04270760|470898673|FG001|Overall Study|Lost to Follow-up|2|||
130801941|NCT04270760|470898674|FG002|Overall Study|Lost to Follow-up|1|||
130801942|NCT04270760|470898675|FG003|Overall Study|Lost to Follow-up|0|||
130801943|NCT04270760|470898676|FG004|Overall Study|Lost to Follow-up|0|||
130801944|NCT04270760|470898672|FG000|Overall Study|Death|0|||
130801945|NCT04270760|470898673|FG001|Overall Study|Death|0|||
130801946|NCT04270760|470898674|FG002|Overall Study|Death|0|||
130801947|NCT04270760|470898675|FG003|Overall Study|Death|0|||
130801948|NCT04270760|470898676|FG004|Overall Study|Death|1|||
130801949|NCT02070991|470898677|FG000|Overall Study|Death|2|||
130801950|NCT02070991|470898678|FG001|Overall Study|Death|0|||
130801951|NCT02070991|470898677|FG000|Overall Study|Withdrawal by Subject|1|||
130801952|NCT02070991|470898678|FG001|Overall Study|Withdrawal by Subject|0|||
130801953|NCT00933166|470898679|FG000|Overall Study|Lost to Follow-up|4|||
130801954|NCT00933166|470898679|FG000|Overall Study|Lack of Efficacy|9|||
130801955|NCT00933166|470898679|FG000|Overall Study|Unavailable|4|||
130801956|NCT00933166|470898679|FG000|Overall Study|Withdrawal by Subject|1|||
130801957|NCT03501277|470898683|FG000|Intervention Period 1 (4 Days)|Other|0|||
130801958|NCT03501277|470898684|FG001|Intervention Period 1 (4 Days)|Other|0|||
130801959|NCT03501277|470898685|FG002|Intervention Period 1 (4 Days)|Other|1|||
130801960|NCT03501277|470898686|FG003|Intervention Period 1 (4 Days)|Other|0|||
130801961|NCT03501277|470898683|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
130801962|NCT03501277|470898684|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
130801963|NCT03501277|470898685|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
130801964|NCT03501277|470898686|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
130801965|NCT03501277|470898683|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
130801966|NCT03501277|470898684|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
130801967|NCT03501277|470898685|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
130801968|NCT03501277|470898686|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
130801969|NCT03501277|470898683|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
130801970|NCT03501277|470898684|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
130801971|NCT03501277|470898685|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
130801972|NCT03501277|470898686|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
130801973|NCT01483651|470898690|FG000|Overall Study|Withdrawal by Subject|0|||
130801974|NCT01483651|470898691|FG001|Overall Study|Withdrawal by Subject|1|||
130801975|NCT01483651|470898692|FG002|Overall Study|Withdrawal by Subject|1|||
130801976|NCT01483651|470898693|FG003|Overall Study|Withdrawal by Subject|0|||
130801977|NCT01483651|470898694|FG004|Overall Study|Withdrawal by Subject|0|||
130801978|NCT01483651|470898695|FG005|Overall Study|Withdrawal by Subject|1|||
130801979|NCT00724503|470898697|FG000|Overall Study|Lost to Follow-up|4|||
130801980|NCT00724503|470898698|FG001|Overall Study|Lost to Follow-up|8|||
130801981|NCT00724503|470898697|FG000|Overall Study|Withdrawal by Subject|11|||
130801982|NCT00724503|470898698|FG001|Overall Study|Withdrawal by Subject|23|||
130801983|NCT00724503|470898697|FG000|Overall Study|Death|190|||
130801984|NCT00724503|470898698|FG001|Overall Study|Death|182|||
130801985|NCT00724503|470898697|FG000|Overall Study|Adverse Event|1|||
130801986|NCT00724503|470898698|FG001|Overall Study|Adverse Event|0|||
130801987|NCT00724503|470898697|FG000|Overall Study|Not otherwise specified|4|||
130801988|NCT00724503|470898698|FG001|Overall Study|Not otherwise specified|7|||
130801989|NCT01186419|470898701|FG000|Overall Study|Withdrawal by Subject|5|||
130801990|NCT01186419|470898702|FG001|Overall Study|Withdrawal by Subject|3|||
130801991|NCT01186419|470898701|FG000|Overall Study|Adverse Event|1|||
130801992|NCT01186419|470898702|FG001|Overall Study|Adverse Event|2|||
130801993|NCT01186419|470898701|FG000|Overall Study|Physician Decision|0|||
130801994|NCT01186419|470898702|FG001|Overall Study|Physician Decision|3|||
130801995|NCT01186419|470898701|FG000|Overall Study|Other|1|||
130801996|NCT01186419|470898702|FG001|Overall Study|Other|1|||
130801997|NCT01560416|470898706|FG000|Randomized Phase|Crossover Participants|7|||
130801998|NCT01560416|470898707|FG001|Randomized Phase|Crossover Participants|0|||
130801999|NCT00853047|470898708|FG000|Core Phase|Participant Request|0|||
130802000|NCT00853047|470898709|FG001|Core Phase|Participant Request|0|||
130802001|NCT00853047|470898710|FG002|Core Phase|Participant Request|0|||
130802002|NCT00853047|470898711|FG003|Core Phase|Participant Request|1|||
130802003|NCT00853047|470898712|FG004|Core Phase|Participant Request|0|||
130802004|NCT00853047|470898713|FG005|Core Phase|Participant Request|0|||
130802005|NCT00853047|470898708|FG000|Open-Label Extension Phase|Participant Request|0|||
130802006|NCT00853047|470898709|FG001|Open-Label Extension Phase|Participant Request|0|||
130802007|NCT00853047|470898710|FG002|Open-Label Extension Phase|Participant Request|0|||
130802008|NCT00853047|470898711|FG003|Open-Label Extension Phase|Participant Request|0|||
130802009|NCT00853047|470898712|FG004|Open-Label Extension Phase|Participant Request|0|||
130802010|NCT00853047|470898713|FG005|Open-Label Extension Phase|Participant Request|7|||
130802011|NCT00853047|470898708|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130802012|NCT00853047|470898709|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130802013|NCT00853047|470898710|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130802014|NCT00853047|470898711|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
130802015|NCT00853047|470898712|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
130802016|NCT00853047|470898713|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
130802017|NCT00853047|470898708|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130802018|NCT00853047|470898709|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130802019|NCT00853047|470898710|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130802020|NCT00853047|470898711|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130802021|NCT00853047|470898712|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130802022|NCT00853047|470898713|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
130802023|NCT00853047|470898708|FG000|Open-Label Extension Phase|Investigator Decision|0|||
130802024|NCT00853047|470898709|FG001|Open-Label Extension Phase|Investigator Decision|0|||
130802025|NCT00853047|470898710|FG002|Open-Label Extension Phase|Investigator Decision|0|||
130802026|NCT00853047|470898711|FG003|Open-Label Extension Phase|Investigator Decision|0|||
130802027|NCT00853047|470898712|FG004|Open-Label Extension Phase|Investigator Decision|0|||
130802028|NCT00853047|470898713|FG005|Open-Label Extension Phase|Investigator Decision|1|||
130802029|NCT00853047|470898708|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
130802030|NCT00853047|470898709|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
130802031|NCT00853047|470898710|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
130802032|NCT00853047|470898711|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
130802033|NCT00853047|470898712|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
130802034|NCT00853047|470898713|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
130802035|NCT00004859|470898714|FG000|Overall Study|Lack of Efficacy|43|||
130802036|NCT00004859|470898715|FG001|Overall Study|Lack of Efficacy|113|||
130802037|NCT00004859|470898714|FG000|Overall Study|Adverse Event|31|||
130802038|NCT00004859|470898715|FG001|Overall Study|Adverse Event|93|||
130802039|NCT00004859|470898714|FG000|Overall Study|Death|5|||
130802040|NCT00004859|470898715|FG001|Overall Study|Death|5|||
130802041|NCT00004859|470898714|FG000|Overall Study|Withdrawal by Subject|7|||
130802042|NCT00004859|470898715|FG001|Overall Study|Withdrawal by Subject|33|||
130802043|NCT00004859|470898714|FG000|Overall Study|Protocol Violation|2|||
130802044|NCT00004859|470898715|FG001|Overall Study|Protocol Violation|2|||
130802045|NCT00004859|470898714|FG000|Overall Study|other disease|0|||
130802046|NCT00004859|470898715|FG001|Overall Study|other disease|3|||
130802047|NCT00004859|470898714|FG000|Overall Study|error|3|||
130802048|NCT00004859|470898715|FG001|Overall Study|error|1|||
130802049|NCT00004859|470898714|FG000|Overall Study|missing data|14|||
130802050|NCT00004859|470898715|FG001|Overall Study|missing data|11|||
130802051|NCT00004859|470898714|FG000|Overall Study|Other|13|||
130802052|NCT00004859|470898715|FG001|Overall Study|Other|21|||
130802053|NCT03022630|470900242|FG000|Overall Study|Death|9|||
130802054|NCT03022630|470900243|FG001|Overall Study|Death|7|||
130802055|NCT03022630|470900242|FG000|Overall Study|Withdrawal by Subject|0|||
130802056|NCT03022630|470900243|FG001|Overall Study|Withdrawal by Subject|5|||
130802057|NCT00884949|470900244|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
130802058|NCT00884949|470900244|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
130802059|NCT04575324|470900245|FG000|Overall Study|Lost to Follow-up|29|||
130802060|NCT04575324|470900246|FG001|Overall Study|Lost to Follow-up|25|||
130802061|NCT04575324|470900245|FG000|Overall Study|Death|1|||
130802062|NCT04575324|470900246|FG001|Overall Study|Death|2|||
130802063|NCT04575324|470900245|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
130802064|NCT04575324|470900246|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
130802065|NCT01002105|470900249|FG000|Overall Study|Lost to Follow-up|10|||
130802066|NCT01002105|470900250|FG001|Overall Study|Lost to Follow-up|16|||
130802067|NCT01002105|470900249|FG000|Overall Study|non compliance|5|||
130802068|NCT01002105|470900250|FG001|Overall Study|non compliance|3|||
130802069|NCT01002105|470900249|FG000|Overall Study|condition worsened|4|||
130802070|NCT01002105|470900250|FG001|Overall Study|condition worsened|2|||
130802071|NCT01166945|470900251|FG000|Randomized|diagnosed with Group A strep|4|||
130802072|NCT01166945|470900252|FG001|Randomized|diagnosed with Group A strep|4|||
130802073|NCT01166945|470900251|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
130802074|NCT01166945|470900252|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
130802075|NCT01166945|470900251|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
130802076|NCT01166945|470900252|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
130802077|NCT01166945|470900251|FG000|Day 30|Lost to Follow-up|4|||
130802078|NCT01166945|470900252|FG001|Day 30|Lost to Follow-up|3|||
130802079|NCT00784927|470900256|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
130802080|NCT00784927|470900256|FG000|Overall Study|Protocol Violation|1|||
130802081|NCT00784927|470900256|FG000|Overall Study|Ineligible|1|||
130802082|NCT00422461|470900263|FG000|Overall Study|Adverse Event|1|||
130802083|NCT00422461|470900264|FG001|Overall Study|Adverse Event|2|||
130802084|NCT00422461|470900265|FG002|Overall Study|Adverse Event|1|||
130802085|NCT00422461|470900266|FG003|Overall Study|Adverse Event|1|||
130802086|NCT00422461|470900263|FG000|Overall Study|Other|0|||
130802087|NCT00422461|470900264|FG001|Overall Study|Other|0|||
130802088|NCT00422461|470900265|FG002|Overall Study|Other|0|||
130802089|NCT00422461|470900266|FG003|Overall Study|Other|2|||
130802090|NCT00422461|470900263|FG000|Overall Study|Participants no longer willing to participate in study|1|||
130802091|NCT00422461|470900264|FG001|Overall Study|Participants no longer willing to participate in study|0|||
130802092|NCT00422461|470900265|FG002|Overall Study|Participants no longer willing to participate in study|0|||
130802093|NCT00422461|470900266|FG003|Overall Study|Participants no longer willing to participate in study|0|||
130802094|NCT00422461|470900263|FG000|Overall Study|Randomized but not treated|1|||
130802095|NCT00422461|470900264|FG001|Overall Study|Randomized but not treated|1|||
130802096|NCT00422461|470900265|FG002|Overall Study|Randomized but not treated|0|||
130802097|NCT00422461|470900266|FG003|Overall Study|Randomized but not treated|0|||
130802098|NCT01471574|470900267|FG000|Treatment Period|Lack of Efficacy|12|||
130802099|NCT01471574|470900268|FG001|Treatment Period|Lack of Efficacy|4|||
130802100|NCT01471574|470900269|FG002|Treatment Period|Lack of Efficacy|14|||
130802101|NCT01471574|470900270|FG003|Treatment Period|Lack of Efficacy|1|||
130802102|NCT01471574|470900267|FG000|Treatment Period|Adverse Event|7|||
130802103|NCT01471574|470900268|FG001|Treatment Period|Adverse Event|3|||
130802104|NCT01471574|470900269|FG002|Treatment Period|Adverse Event|6|||
130802105|NCT01471574|470900270|FG003|Treatment Period|Adverse Event|1|||
130802106|NCT01471574|470900267|FG000|Treatment Period|Withdrawal by Subject|5|||
130802107|NCT01471574|470900268|FG001|Treatment Period|Withdrawal by Subject|1|||
130802108|NCT01471574|470900269|FG002|Treatment Period|Withdrawal by Subject|1|||
130802109|NCT01471574|470900270|FG003|Treatment Period|Withdrawal by Subject|0|||
130802110|NCT01471574|470900267|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
130802111|NCT01471574|470900268|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
130802112|NCT01471574|470900269|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
130802113|NCT01471574|470900270|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
130802114|NCT01471574|470900267|FG000|Treatment Period|Lost to Follow-up|1|||
130802115|NCT01471574|470900268|FG001|Treatment Period|Lost to Follow-up|2|||
130802116|NCT01471574|470900269|FG002|Treatment Period|Lost to Follow-up|2|||
130802117|NCT01471574|470900270|FG003|Treatment Period|Lost to Follow-up|0|||
130802118|NCT01471574|470900267|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
130802119|NCT01471574|470900268|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
130802120|NCT01471574|470900269|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
130802121|NCT01471574|470900270|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
130802122|NCT01471574|470900267|FG000|Treatment Period|Other|1|||
130802123|NCT01471574|470900268|FG001|Treatment Period|Other|0|||
130802124|NCT01471574|470900269|FG002|Treatment Period|Other|0|||
130802125|NCT01471574|470900270|FG003|Treatment Period|Other|0|||
130802126|NCT01471574|470900267|FG000|Follow-up Period|Withdrawal by Subject|3|||
130802127|NCT01471574|470900268|FG001|Follow-up Period|Withdrawal by Subject|0|||
130802128|NCT01471574|470900269|FG002|Follow-up Period|Withdrawal by Subject|3|||
130802129|NCT01471574|470900270|FG003|Follow-up Period|Withdrawal by Subject|1|||
130802130|NCT01471574|470900267|FG000|Follow-up Period|Lost to Follow-up|4|||
130802131|NCT01471574|470900268|FG001|Follow-up Period|Lost to Follow-up|1|||
130802132|NCT01471574|470900269|FG002|Follow-up Period|Lost to Follow-up|3|||
130802133|NCT01471574|470900270|FG003|Follow-up Period|Lost to Follow-up|2|||
130802134|NCT01471574|470900267|FG000|Follow-up Period|Death|0|||
130802135|NCT01471574|470900268|FG001|Follow-up Period|Death|0|||
130802136|NCT01471574|470900269|FG002|Follow-up Period|Death|1|||
130802137|NCT01471574|470900270|FG003|Follow-up Period|Death|0|||
130802138|NCT01471574|470900267|FG000|Follow-up Period|Follow-up no longer required|0|||
130802139|NCT01471574|470900268|FG001|Follow-up Period|Follow-up no longer required|1|||
130802140|NCT01471574|470900269|FG002|Follow-up Period|Follow-up no longer required|0|||
130802141|NCT01471574|470900270|FG003|Follow-up Period|Follow-up no longer required|0|||
130802142|NCT01795937|470900271|FG000|Overall Study|Withdrawal by Subject|1|||
130802143|NCT01795937|470900272|FG001|Overall Study|Withdrawal by Subject|0|||
130802144|NCT01795937|470900273|FG002|Overall Study|Withdrawal by Subject|0|||
130802145|NCT01795937|470900271|FG000|Overall Study|Physician Decision|0|||
130802146|NCT01795937|470900272|FG001|Overall Study|Physician Decision|1|||
130802147|NCT01795937|470900273|FG002|Overall Study|Physician Decision|0|||
130802148|NCT01028053|470900274|FG000|Overall Study|Screen Failure|113|||
130802149|NCT01028053|470900274|FG000|Overall Study|Patient Request|11|||
130802150|NCT01028053|470900274|FG000|Overall Study|Protocol Violation|1|||
130802151|NCT01028053|470900274|FG000|Overall Study|Physician Decision|2|||
130802152|NCT01028053|470900274|FG000|Overall Study|Technical Problem|1|||
130802153|NCT01028053|470900274|FG000|Overall Study|Terminated by Sponsor|1|||
130802154|NCT01028053|470900274|FG000|Overall Study|Various reasons|4|||
130802155|NCT04027946|470900275|FG000|Overall Study|Screen failures|3|||
130802156|NCT00827242|470900281|FG000|Overall Study|Withdrawal by Subject|2|||
130802157|NCT00827242|470900282|FG001|Overall Study|Withdrawal by Subject|4|||
130802158|NCT00827242|470900281|FG000|Overall Study|Protocol Violation|1|||
130802159|NCT00827242|470900282|FG001|Overall Study|Protocol Violation|3|||
130802160|NCT00827242|470900281|FG000|Overall Study|Lost to Follow-up|0|||
130802161|NCT00827242|470900282|FG001|Overall Study|Lost to Follow-up|3|||
130802162|NCT00827242|470900281|FG000|Overall Study|Adverse Event Excluding Death|2|||
130802163|NCT00827242|470900282|FG001|Overall Study|Adverse Event Excluding Death|1|||
130802164|NCT00827242|470900281|FG000|Overall Study|Entry Criteria Not Met|4|||
130802165|NCT00827242|470900282|FG001|Overall Study|Entry Criteria Not Met|1|||
130802166|NCT00827242|470900281|FG000|Overall Study|Physician Decision|2|||
130802167|NCT00827242|470900282|FG001|Overall Study|Physician Decision|0|||
130802168|NCT00827242|470900281|FG000|Overall Study|Death|1|||
130802169|NCT00827242|470900282|FG001|Overall Study|Death|0|||
130802170|NCT00827242|470900281|FG000|Overall Study|Lack of Efficacy|1|||
130802171|NCT00827242|470900282|FG001|Overall Study|Lack of Efficacy|0|||
130802172|NCT02609633|470900287|FG000|Overall Study|Consent Withdrawn|0|||
130802173|NCT02609633|470900288|FG001|Overall Study|Consent Withdrawn|1|||
130802174|NCT02609633|470900287|FG000|Overall Study|Protocol Deviation|1|||
130802175|NCT02609633|470900288|FG001|Overall Study|Protocol Deviation|0|||
130802176|NCT02609633|470900287|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
130802177|NCT02609633|470900288|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
130802178|NCT02609633|470900287|FG000|Overall Study|Reason not Specified|2|||
130802179|NCT02609633|470900288|FG001|Overall Study|Reason not Specified|1|||
130802180|NCT05987540|470900289|FG000|Overall Study|Withdrawal by Subject|2|||
130802181|NCT05987540|470900289|FG000|Overall Study|Death|1|||
130802182|NCT05987540|470900289|FG000|Overall Study|Study Termination|1|||
130802183|NCT05987540|470900289|FG000|Overall Study|Adverse Event|2|||
130802184|NCT00471107|470900290|FG000|Overall Study|Technical problems/data loss|3|||
130802185|NCT00471107|470900291|FG001|Overall Study|Technical problems/data loss|1|||
130802186|NCT00471107|470900292|FG002|Overall Study|Technical problems/data loss|3|||
130802187|NCT01769443|470900293|FG000|Overall Study|Study closure|1|||
130802188|NCT01769443|470900294|FG001|Overall Study|Study closure|0|||
130802189|NCT04996264|470900295|FG000|Overall Study|Lost to Follow-up|0|||
130802190|NCT04996264|470900296|FG001|Overall Study|Lost to Follow-up|1|||
130802191|NCT04996264|470900295|FG000|Overall Study|Withdrawal by Subject|4|||
130802192|NCT04996264|470900296|FG001|Overall Study|Withdrawal by Subject|3|||
130802193|NCT04996264|470900295|FG000|Overall Study|1 left AMA|0|||
130802194|NCT04996264|470900296|FG001|Overall Study|1 left AMA|1|||
130802195|NCT04996264|470900295|FG000|Overall Study|Subject changed hospitals|0|||
130802196|NCT04996264|470900296|FG001|Overall Study|Subject changed hospitals|1|||
130802197|NCT04996264|470900295|FG000|Overall Study|unable to complete due to work|0|||
130802198|NCT04996264|470900296|FG001|Overall Study|unable to complete due to work|1|||
130802199|NCT04433975|470900297|FG000|1-month Follow Up|Withdrawal by Subject|1|||
130802200|NCT04433975|470900298|FG001|1-month Follow Up|Withdrawal by Subject|1|||
130802201|NCT04433975|470900297|FG000|1-month Follow Up|Lost to Follow-up|21|||
130802202|NCT04433975|470900298|FG001|1-month Follow Up|Lost to Follow-up|25|||
130763651|NCT03570554|470758617|FG000|Overall Study|Adverse Event|0|||
130763652|NCT03570554|470758618|FG001|Overall Study|Adverse Event|0|||
130763653|NCT03570554|470758619|FG002|Overall Study|Adverse Event|0|||
130763654|NCT03570554|470758620|FG003|Overall Study|Adverse Event|1|||
130763655|NCT02604550|470758623|FG000|Overall Study|Lost to Follow-up|7|||
130763656|NCT02604550|470758624|FG001|Overall Study|Lost to Follow-up|6|||
130763657|NCT02604550|470758623|FG000|Overall Study|Withdrawal by Subject|0|||
130763658|NCT02604550|470758624|FG001|Overall Study|Withdrawal by Subject|1|||
130763659|NCT02604550|470758623|FG000|Overall Study|Incomplete data using paper journal|18|||
130763660|NCT02604550|470758624|FG001|Overall Study|Incomplete data using paper journal|19|||
130763661|NCT00033657|470758628|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
130763662|NCT00033657|470758629|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
130763663|NCT00033657|470758628|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
130763664|NCT00033657|470758629|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
130763665|NCT00033657|470758628|FG000|Neoadjuvant Chemotherapy|Death|1|||
130763666|NCT00033657|470758629|FG001|Neoadjuvant Chemotherapy|Death|1|||
130763667|NCT00033657|470758628|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
130763668|NCT00033657|470758629|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
130763669|NCT00033657|470758628|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
130763670|NCT00033657|470758629|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
130763671|NCT00033657|470758628|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
130763672|NCT00033657|470758629|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
130763673|NCT00033657|470758628|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
130763674|NCT00033657|470758629|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
130763675|NCT00033657|470758628|FG000|Surgical Resection|not complete resection|0|||
130763676|NCT00033657|470758629|FG001|Surgical Resection|not complete resection|3|||
130763677|NCT00033657|470758628|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
130763678|NCT00033657|470758629|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
130763679|NCT00033657|470758628|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
130763680|NCT00033657|470758629|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
130763681|NCT00033657|470758628|FG000|Adjuvant Chemotherapy|Death|2|||
130763682|NCT00033657|470758629|FG001|Adjuvant Chemotherapy|Death|1|||
130763683|NCT00033657|470758628|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
130763684|NCT00033657|470758629|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
130763685|NCT00033657|470758628|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
130763686|NCT00033657|470758629|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
130763687|NCT00033657|470758628|FG000|Adjuvant Chemotherapy|Other|0|||
130763688|NCT00033657|470758629|FG001|Adjuvant Chemotherapy|Other|2|||
130763689|NCT04093492|470758630|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
130763690|NCT04093492|470758631|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
130763691|NCT04093492|470758632|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
130763692|NCT04093492|470758633|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
130763693|NCT04093492|470758630|FG000|25 Weeks Gestational Age (GA)|No response|5|||
130763694|NCT04093492|470758631|FG001|25 Weeks Gestational Age (GA)|No response|5|||
130763695|NCT04093492|470758632|FG002|25 Weeks Gestational Age (GA)|No response|5|||
130763696|NCT04093492|470758633|FG003|25 Weeks Gestational Age (GA)|No response|2|||
130763697|NCT04093492|470758630|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
130763698|NCT04093492|470758631|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
130763699|NCT04093492|470758632|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
130763700|NCT04093492|470758633|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
130763701|NCT04093492|470758630|FG000|30 Weeks GA|Delivered before assessment|1|||
130763702|NCT04093492|470758631|FG001|30 Weeks GA|Delivered before assessment|2|||
130763703|NCT04093492|470758632|FG002|30 Weeks GA|Delivered before assessment|0|||
130763704|NCT04093492|470758633|FG003|30 Weeks GA|Delivered before assessment|0|||
130763705|NCT04093492|470758630|FG000|30 Weeks GA|No response|7|||
130763706|NCT04093492|470758631|FG001|30 Weeks GA|No response|5|||
130763707|NCT04093492|470758632|FG002|30 Weeks GA|No response|5|||
130763708|NCT04093492|470758633|FG003|30 Weeks GA|No response|2|||
130763709|NCT04093492|470758630|FG000|30 Weeks GA|Lost to Follow-up|0|||
130763710|NCT04093492|470758631|FG001|30 Weeks GA|Lost to Follow-up|1|||
130763711|NCT04093492|470758632|FG002|30 Weeks GA|Lost to Follow-up|0|||
130802203|NCT04433975|470900297|FG000|3-month Follow Up|Lost to Follow-up|20|||
130802204|NCT04433975|470900298|FG001|3-month Follow Up|Lost to Follow-up|24|||
130802205|NCT04433975|470900297|FG000|3-month Follow Up|Death|1|||
130802206|NCT04433975|470900298|FG001|3-month Follow Up|Death|0|||
130802207|NCT04433975|470900297|FG000|3-month Follow Up|Withdrawal by Subject|2|||
130802208|NCT04433975|470900298|FG001|3-month Follow Up|Withdrawal by Subject|0|||
130802209|NCT04433975|470900297|FG000|6-month Follow Up|Lost to Follow-up|23|||
130802210|NCT04433975|470900298|FG001|6-month Follow Up|Lost to Follow-up|28|||
130802211|NCT04433975|470900297|FG000|6-month Follow Up|Withdrawal by Subject|1|||
130802212|NCT04433975|470900298|FG001|6-month Follow Up|Withdrawal by Subject|1|||
130802213|NCT04433975|470900297|FG000|9-month Follow Up|Lost to Follow-up|27|||
130802214|NCT04433975|470900298|FG001|9-month Follow Up|Lost to Follow-up|36|||
130802215|NCT04433975|470900297|FG000|9-month Follow Up|Death|0|||
130802216|NCT04433975|470900298|FG001|9-month Follow Up|Death|1|||
130802217|NCT04433975|470900297|FG000|12-month Follow Up|Lost to Follow-up|27|||
130802218|NCT04433975|470900298|FG001|12-month Follow Up|Lost to Follow-up|31|||
130802219|NCT04606771|470900299|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
130802220|NCT04606771|470900300|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
130802221|NCT04606771|470900299|FG000|Overall Study|Death|5|||
130802222|NCT04606771|470900300|FG001|Overall Study|Death|6|||
130802223|NCT04606771|470900299|FG000|Overall Study|Wrong randomisation|0|||
130802224|NCT04606771|470900300|FG001|Overall Study|Wrong randomisation|1|||
130802225|NCT04392635|470900301|FG000|Overall Study|Lost to Follow-up|0|||
130802226|NCT04392635|470900302|FG001|Overall Study|Lost to Follow-up|1|||
130802227|NCT02030418|470900303|FG000|Overall Study|Death|78|||
130802228|NCT02030418|470900303|FG000|Overall Study|Missed 12-Month Visit|9|||
130802229|NCT02030418|470900303|FG000|Overall Study|Withdrawn|57|||
130802230|NCT01149538|470900306|FG000|Overall Study|Lost to Follow-up|0|||
130802231|NCT01149538|470900307|FG001|Overall Study|Lost to Follow-up|1|||
130802232|NCT01149538|470900306|FG000|Overall Study|Withdrawal by Subject|5|||
130802233|NCT01149538|470900307|FG001|Overall Study|Withdrawal by Subject|3|||
130802234|NCT00250718|470900308|FG000|Overall Study|Death|1|||
130802235|NCT00250718|470900308|FG000|Overall Study|Adverse Event|1|||
130802236|NCT00250718|470900308|FG000|Overall Study|Withdrawal by Subject|1|||
130802237|NCT06100250|470900309|FG000|Overall Study|Lost to Follow-up|5|||
130802238|NCT02021318|470900310|FG000|Overall Study|Adverse Event|2|||
130802239|NCT02021318|470900311|FG001|Overall Study|Adverse Event|1|||
130802240|NCT02021318|470900310|FG000|Overall Study|Death|33|||
130802241|NCT02021318|470900311|FG001|Overall Study|Death|34|||
130802242|NCT02021318|470900310|FG000|Overall Study|Lost to Follow-up|3|||
130802243|NCT02021318|470900311|FG001|Overall Study|Lost to Follow-up|3|||
130802244|NCT02021318|470900310|FG000|Overall Study|Progressive Disease|0|||
130802245|NCT02021318|470900311|FG001|Overall Study|Progressive Disease|1|||
130802246|NCT02021318|470900310|FG000|Overall Study|Withdrawal by Subject|30|||
130802247|NCT02021318|470900311|FG001|Overall Study|Withdrawal by Subject|18|||
130802248|NCT02021318|470900310|FG000|Overall Study|Physician Decision|3|||
130802249|NCT02021318|470900311|FG001|Overall Study|Physician Decision|3|||
130802250|NCT02021318|470900310|FG000|Overall Study|Miscellaneous|2|||
130802251|NCT02021318|470900311|FG001|Overall Study|Miscellaneous|3|||
130802252|NCT00421993|470900315|FG000|Overall Study|Withdrawal by Subject|22|||
130802253|NCT00421993|470900316|FG001|Overall Study|Withdrawal by Subject|23|||
130802254|NCT00421993|470900317|FG002|Overall Study|Withdrawal by Subject|23|||
130802255|NCT00421993|470900318|FG003|Overall Study|Withdrawal by Subject|24|||
130802256|NCT00421993|470900315|FG000|Overall Study|Lost to Follow-up|18|||
130802257|NCT00421993|470900316|FG001|Overall Study|Lost to Follow-up|19|||
130802258|NCT00421993|470900317|FG002|Overall Study|Lost to Follow-up|22|||
130802259|NCT00421993|470900318|FG003|Overall Study|Lost to Follow-up|20|||
130802260|NCT00421993|470900315|FG000|Overall Study|Adverse Event|11|||
130802261|NCT00421993|470900316|FG001|Overall Study|Adverse Event|1|||
130802262|NCT00421993|470900317|FG002|Overall Study|Adverse Event|6|||
130802263|NCT00421993|470900318|FG003|Overall Study|Adverse Event|4|||
130802264|NCT00421993|470900315|FG000|Overall Study|Protocol Violation|2|||
130802265|NCT00421993|470900316|FG001|Overall Study|Protocol Violation|2|||
130802266|NCT00421993|470900317|FG002|Overall Study|Protocol Violation|0|||
130802267|NCT00421993|470900318|FG003|Overall Study|Protocol Violation|1|||
130802268|NCT00421993|470900315|FG000|Overall Study|Lack of Efficacy|0|||
130802269|NCT00421993|470900316|FG001|Overall Study|Lack of Efficacy|3|||
130802270|NCT00421993|470900317|FG002|Overall Study|Lack of Efficacy|0|||
130802271|NCT00421993|470900318|FG003|Overall Study|Lack of Efficacy|5|||
130802272|NCT00421993|470900315|FG000|Overall Study|Pregnancy|0|||
130802273|NCT00421993|470900316|FG001|Overall Study|Pregnancy|1|||
130802274|NCT00421993|470900317|FG002|Overall Study|Pregnancy|1|||
130802275|NCT00421993|470900318|FG003|Overall Study|Pregnancy|2|||
130802276|NCT00421993|470900315|FG000|Overall Study|Subject transportation issues|0|||
130802277|NCT00421993|470900316|FG001|Overall Study|Subject transportation issues|0|||
130802278|NCT00421993|470900317|FG002|Overall Study|Subject transportation issues|0|||
130802279|NCT00421993|470900318|FG003|Overall Study|Subject transportation issues|1|||
130763712|NCT04093492|470758633|FG003|30 Weeks GA|Lost to Follow-up|0|||
130763713|NCT04093492|470758630|FG000|34 Weeks GA|Delivered before assessment|6|||
130763714|NCT04093492|470758631|FG001|34 Weeks GA|Delivered before assessment|3|||
130763715|NCT04093492|470758632|FG002|34 Weeks GA|Delivered before assessment|0|||
130763716|NCT04093492|470758633|FG003|34 Weeks GA|Delivered before assessment|0|||
130763717|NCT04093492|470758630|FG000|34 Weeks GA|No response|0|||
130763718|NCT04093492|470758631|FG001|34 Weeks GA|No response|7|||
130763719|NCT04093492|470758632|FG002|34 Weeks GA|No response|5|||
130763720|NCT04093492|470758633|FG003|34 Weeks GA|No response|3|||
130763721|NCT04093492|470758630|FG000|34 Weeks GA|Lost to Follow-up|0|||
130763722|NCT04093492|470758631|FG001|34 Weeks GA|Lost to Follow-up|1|||
130763723|NCT04093492|470758632|FG002|34 Weeks GA|Lost to Follow-up|0|||
130763724|NCT04093492|470758633|FG003|34 Weeks GA|Lost to Follow-up|0|||
130763725|NCT00329641|470758634|FG000|Overall Study|Did not start treatment|1|||
130763726|NCT00329641|470758634|FG000|Overall Study|Not eligible|1|||
130763727|NCT00329641|470758634|FG000|Overall Study|Adverse Event|3|||
130763728|NCT00329641|470758634|FG000|Overall Study|Other reason, not protocol specified|1|||
130763729|NCT02945254|470758637|FG000|Overall Study|Lost to Follow-up|1|||
130763730|NCT02945254|470758638|FG001|Overall Study|Lost to Follow-up|0|||
130763731|NCT02945254|470758637|FG000|Overall Study|Withdrawal by Subject|1|||
130763732|NCT02945254|470758638|FG001|Overall Study|Withdrawal by Subject|0|||
130763733|NCT03422159|470758643|FG000|Overall Study|Exclusion due to terminal disease|2|||
130763734|NCT03422159|470758644|FG001|Overall Study|Exclusion due to terminal disease|1|||
130763735|NCT02631070|470758645|FG000|Overall Study|Withdrawal by Subject|35|||
130763736|NCT02631070|470758646|FG001|Overall Study|Withdrawal by Subject|13|||
130763737|NCT02631070|470758645|FG000|Overall Study|Death|45|||
130763738|NCT02631070|470758646|FG001|Overall Study|Death|24|||
130763739|NCT02631070|470758645|FG000|Overall Study|Lost to Follow-up|5|||
130763740|NCT02631070|470758646|FG001|Overall Study|Lost to Follow-up|1|||
130802280|NCT01980888|470900319|FG000|Overall Study|Study Terminated by Sponsor|116|||
130802281|NCT01980888|470900320|FG001|Overall Study|Study Terminated by Sponsor|122|||
130802282|NCT01980888|470900319|FG000|Overall Study|Withdrew Consent|17|||
130802283|NCT01980888|470900320|FG001|Overall Study|Withdrew Consent|6|||
130802284|NCT01980888|470900319|FG000|Overall Study|Investigator's Discretion|8|||
130802285|NCT01980888|470900320|FG001|Overall Study|Investigator's Discretion|3|||
130802286|NCT01980888|470900319|FG000|Overall Study|Non-Compliance with Study Drug|3|||
130802287|NCT01980888|470900320|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130802288|NCT05762744|470900326|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
130802289|NCT05762744|470900327|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
130802290|NCT05762744|470900326|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
130802291|NCT05762744|470900327|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
130802292|NCT01671059|470900328|FG000|Overall Study|Adverse Event|4|||
130802293|NCT01671059|470900328|FG000|Overall Study|Lack of Efficacy|1|||
130802294|NCT01030900|470900335|FG000|Overall Study|Not treated due to congestive heart failure|1|||
130802295|NCT01030900|470900335|FG000|Overall Study|Not treated due to rapid disease|1|||
130802296|NCT01179399|470900338|FG000|Overall Study|Adverse Event|1|||
130802297|NCT01179399|470900338|FG000|Overall Study|Lack of Efficacy|30|||
130802298|NCT01179399|470900338|FG000|Overall Study|Withdrawal by Subject|1|||
130802299|NCT00441896|470900339|FG000|Overall Study|Withdrawal by Subject|0|||
130802300|NCT00441896|470900340|FG001|Overall Study|Withdrawal by Subject|0|||
130802301|NCT00441896|470900341|FG002|Overall Study|Withdrawal by Subject|0|||
130802302|NCT00441896|470900342|FG003|Overall Study|Withdrawal by Subject|1|||
130802303|NCT00441896|470900343|FG004|Overall Study|Withdrawal by Subject|0|||
130802304|NCT00441896|470900344|FG005|Overall Study|Withdrawal by Subject|0|||
130802305|NCT00441896|470900345|FG006|Overall Study|Withdrawal by Subject|0|||
130802306|NCT00441896|470900346|FG007|Overall Study|Withdrawal by Subject|0|||
130802307|NCT00441896|470900347|FG008|Overall Study|Withdrawal by Subject|0|||
130802308|NCT00441896|470900348|FG009|Overall Study|Withdrawal by Subject|0|||
130802309|NCT00441896|470900339|FG000|Overall Study|Other|0|||
130802310|NCT00441896|470900340|FG001|Overall Study|Other|0|||
130802311|NCT00441896|470900341|FG002|Overall Study|Other|0|||
130802312|NCT00441896|470900342|FG003|Overall Study|Other|0|||
130802313|NCT00441896|470900343|FG004|Overall Study|Other|1|||
130802314|NCT00441896|470900344|FG005|Overall Study|Other|0|||
130802315|NCT00441896|470900345|FG006|Overall Study|Other|0|||
130802316|NCT00441896|470900346|FG007|Overall Study|Other|0|||
130802317|NCT00441896|470900347|FG008|Overall Study|Other|0|||
130802318|NCT00441896|470900348|FG009|Overall Study|Other|0|||
130802319|NCT01301092|470900349|FG000|Overall Study|Lost to Follow-up|0|||
130802320|NCT01301092|470900350|FG001|Overall Study|Lost to Follow-up|0|||
130802321|NCT01301092|470900351|FG002|Overall Study|Lost to Follow-up|1|||
130802322|NCT03334175|470900352|FG000|Overall Study|Lost to Follow-up|0|||
130802323|NCT03334175|470900353|FG001|Overall Study|Lost to Follow-up|1|||
130802324|NCT01350973|470900354|FG000|Overall Study|Adverse Event|4|||
130802325|NCT01350973|470900355|FG001|Overall Study|Adverse Event|7|||
130802326|NCT01350973|470900356|FG002|Overall Study|Adverse Event|7|||
130802327|NCT01350973|470900354|FG000|Overall Study|Voluntary Withdrawal|2|||
130802328|NCT01350973|470900355|FG001|Overall Study|Voluntary Withdrawal|1|||
130802329|NCT01350973|470900356|FG002|Overall Study|Voluntary Withdrawal|1|||
130802330|NCT03738215|470900360|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
130802331|NCT03738215|470900361|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
130802332|NCT03738215|470900362|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
130802333|NCT03738215|470900360|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
130802334|NCT03738215|470900361|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
130802335|NCT03738215|470900362|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130802336|NCT03738215|470900360|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
130802337|NCT03738215|470900361|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
130802338|NCT03738215|470900362|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
130802339|NCT03738215|470900360|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
130802340|NCT03738215|470900361|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
130802341|NCT03738215|470900362|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
130802342|NCT03738215|470900360|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
130802343|NCT03738215|470900361|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130802344|NCT03738215|470900362|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130802345|NCT03738215|470900360|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
130802346|NCT03738215|470900361|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
130802347|NCT03738215|470900362|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
130802348|NCT03738215|470900360|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
130802349|NCT03738215|470900361|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
130802350|NCT03738215|470900362|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
130802351|NCT03738215|470900360|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
130802352|NCT03738215|470900361|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
130802353|NCT03738215|470900362|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
130802354|NCT03738215|470900360|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
130802355|NCT03738215|470900361|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
130802356|NCT03738215|470900362|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
130802357|NCT03738215|470900360|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
130802358|NCT03738215|470900361|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
130802359|NCT03738215|470900362|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
130802360|NCT02638493|470900363|FG000|Overall Study|Inability to provide semen samples|2|||
130802361|NCT02638493|470900364|FG001|Overall Study|Inability to provide semen samples|0|||
130802362|NCT02638493|470900365|FG002|Overall Study|Inability to provide semen samples|0|||
130802363|NCT01033071|470900366|FG000|Overall Study|Adverse Event|28|||
130802364|NCT01033071|470900367|FG001|Overall Study|Adverse Event|51|||
130802365|NCT01033071|470900368|FG002|Overall Study|Adverse Event|26|||
130802366|NCT01033071|470900366|FG000|Overall Study|Protocol Violation|0|||
130802367|NCT01033071|470900367|FG001|Overall Study|Protocol Violation|2|||
130802368|NCT01033071|470900368|FG002|Overall Study|Protocol Violation|1|||
130802369|NCT01033071|470900366|FG000|Overall Study|Lost to Follow-up|4|||
130802370|NCT01033071|470900367|FG001|Overall Study|Lost to Follow-up|5|||
130802371|NCT01033071|470900368|FG002|Overall Study|Lost to Follow-up|5|||
130802372|NCT01033071|470900366|FG000|Overall Study|Withdrawal by Subject|17|||
130802373|NCT01033071|470900367|FG001|Overall Study|Withdrawal by Subject|14|||
130802374|NCT01033071|470900368|FG002|Overall Study|Withdrawal by Subject|11|||
130802375|NCT01033071|470900366|FG000|Overall Study|Lack of Efficacy|0|||
130802376|NCT01033071|470900367|FG001|Overall Study|Lack of Efficacy|1|||
130802377|NCT01033071|470900368|FG002|Overall Study|Lack of Efficacy|1|||
130802378|NCT01033071|470900366|FG000|Overall Study|Other|6|||
130802379|NCT01033071|470900367|FG001|Overall Study|Other|4|||
130802380|NCT01033071|470900368|FG002|Overall Study|Other|3|||
130802381|NCT01695772|470900372|FG000|Overall Study|Withdrawal by Subject|18|||
130802382|NCT01695772|470900372|FG000|Overall Study|Progressive Disease|8|||
130802383|NCT01695772|470900372|FG000|Overall Study|Investigator Decision|5|||
130802384|NCT01695772|470900372|FG000|Overall Study|Lost to Follow-up|4|||
130802385|NCT01695772|470900372|FG000|Overall Study|Protocol Violation|2|||
130802386|NCT01695772|470900372|FG000|Overall Study|Unspecified Reason|1|||
130802387|NCT04073407|470900378|FG000|Part 1|Withdrawal by Subject|1|||
130802388|NCT04073407|470900379|FG001|Part 1|Withdrawal by Subject|0|||
130802389|NCT04073407|470900378|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
130802390|NCT04073407|470900379|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
130802391|NCT04073407|470900378|FG000|Part 2|Withdrawal by Subject|0|||
130802392|NCT04073407|470900379|FG001|Part 2|Withdrawal by Subject|1|||
130802393|NCT04941898|470903097|FG000|Overall Study|Protocol Violation|1|||
130802394|NCT02724644|470903098|FG000|Overall Study|Adverse Event|7|||
130802395|NCT02724644|470903099|FG001|Overall Study|Adverse Event|1|||
130802396|NCT02724644|470903098|FG000|Overall Study|Lost to Follow-up|6|||
130802397|NCT02724644|470903099|FG001|Overall Study|Lost to Follow-up|2|||
130802398|NCT02724644|470903098|FG000|Overall Study|Withdrawal by Subject|7|||
130802399|NCT02724644|470903099|FG001|Overall Study|Withdrawal by Subject|1|||
130802400|NCT02724644|470903098|FG000|Overall Study|Administrative|1|||
130802401|NCT02724644|470903099|FG001|Overall Study|Administrative|0|||
130802402|NCT01567085|470903102|FG000|Overall Study|Death|6|||
130802403|NCT01567085|470903102|FG000|Overall Study|Adverse Event|6|||
130802404|NCT01567085|470903102|FG000|Overall Study|Lost to Follow-up|3|||
130802405|NCT01567085|470903102|FG000|Overall Study|Graft loss|2|||
130802406|NCT01567085|470903102|FG000|Overall Study|Renal transplantectomy|1|||
130802407|NCT01567085|470903102|FG000|Overall Study|Returned to chronic dialysis|1|||
130802408|NCT01567085|470903102|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
130802409|NCT03928704|470903106|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130802410|NCT03928704|470903107|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
130802411|NCT03928704|470903108|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130802412|NCT03928704|470903109|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130802413|NCT03928704|470903110|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130802414|NCT03928704|470903111|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130802415|NCT03928704|470903106|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
130802416|NCT03928704|470903107|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130802417|NCT03928704|470903108|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130802418|NCT03928704|470903109|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130802419|NCT03928704|470903110|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130802420|NCT03928704|470903111|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130802421|NCT03928704|470903106|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
130802422|NCT03928704|470903107|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130802423|NCT03928704|470903108|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130802424|NCT03928704|470903109|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130802425|NCT03928704|470903110|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130802426|NCT03928704|470903111|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130802427|NCT03928704|470903106|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
130802428|NCT03928704|470903107|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
130802429|NCT03928704|470903108|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130802430|NCT03928704|470903109|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130802431|NCT03928704|470903110|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130802432|NCT03928704|470903111|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130802433|NCT03928704|470903106|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130802434|NCT03928704|470903107|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130802435|NCT03928704|470903108|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
130802436|NCT03928704|470903109|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130802437|NCT03928704|470903110|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130802438|NCT03928704|470903111|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130802439|NCT03928704|470903106|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130802440|NCT03928704|470903107|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130802441|NCT03928704|470903108|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
130802442|NCT03928704|470903109|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130802443|NCT03928704|470903110|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130802444|NCT03928704|470903111|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130802445|NCT03928704|470903106|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
130802446|NCT03928704|470903107|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
130802447|NCT03928704|470903108|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
130802448|NCT03928704|470903109|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
130802449|NCT03928704|470903110|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
130802450|NCT03928704|470903111|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
130802451|NCT03928704|470903106|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130802452|NCT03928704|470903107|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130802453|NCT03928704|470903108|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
130802454|NCT03928704|470903109|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130802455|NCT03928704|470903110|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130802456|NCT03928704|470903111|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130802457|NCT03928704|470903106|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130802458|NCT03928704|470903107|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130802459|NCT03928704|470903108|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130802460|NCT03928704|470903109|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130802461|NCT03928704|470903110|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130802462|NCT03928704|470903111|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
130802463|NCT03928704|470903106|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
130802464|NCT03928704|470903107|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
130802465|NCT03928704|470903108|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
130802466|NCT03928704|470903109|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
130802467|NCT03928704|470903110|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
130802468|NCT03928704|470903111|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
130802469|NCT00327171|470903117|FG000|Overall Study|Did not receive study medication|3|||
130802470|NCT00327171|470903118|FG001|Overall Study|Did not receive study medication|0|||
130802471|NCT00327171|470903117|FG000|Overall Study|Adverse Event|23|||
130802472|NCT00327171|470903118|FG001|Overall Study|Adverse Event|23|||
130802473|NCT00327171|470903117|FG000|Overall Study|Disease progression/lack of efficacy|68|||
130802474|NCT00327171|470903118|FG001|Overall Study|Disease progression/lack of efficacy|69|||
130802475|NCT00327171|470903117|FG000|Overall Study|Investigator/participant request|1|||
130802476|NCT00327171|470903118|FG001|Overall Study|Investigator/participant request|8|||
130802477|NCT00327171|470903117|FG000|Overall Study|Clinical progression|12|||
130802478|NCT00327171|470903118|FG001|Overall Study|Clinical progression|8|||
130802479|NCT00327171|470903117|FG000|Overall Study|Undisclosed history of ischemia|0|||
130802480|NCT00327171|470903118|FG001|Overall Study|Undisclosed history of ischemia|1|||
130802481|NCT00327171|470903117|FG000|Overall Study|Other|1|||
130802482|NCT00327171|470903118|FG001|Overall Study|Other|0|||
130802483|NCT00284934|470903119|FG000|Overall Study|Adverse Event|1|||
130802484|NCT00284934|470903120|FG001|Overall Study|Adverse Event|2|||
130802485|NCT00284934|470903119|FG000|Overall Study|Other reasons|3|||
130802486|NCT00284934|470903120|FG001|Overall Study|Other reasons|1|||
130802487|NCT03309605|470903123|FG000|Overall Study|Adverse Event|0|||
130802488|NCT03309605|470903124|FG001|Overall Study|Adverse Event|0|||
130802489|NCT03309605|470903125|FG002|Overall Study|Adverse Event|0|||
130802490|NCT03309605|470903126|FG003|Overall Study|Adverse Event|1|||
130802491|NCT03309605|470903127|FG004|Overall Study|Adverse Event|0|||
130802492|NCT03309605|470903128|FG005|Overall Study|Adverse Event|0|||
130802493|NCT03309605|470903129|FG006|Overall Study|Adverse Event|2|||
130802494|NCT03309605|470903130|FG007|Overall Study|Adverse Event|1|||
130802495|NCT03309605|470903123|FG000|Overall Study|Withdrawal by Subject|0|||
130802496|NCT03309605|470903124|FG001|Overall Study|Withdrawal by Subject|0|||
130802497|NCT03309605|470903125|FG002|Overall Study|Withdrawal by Subject|0|||
130802498|NCT03309605|470903126|FG003|Overall Study|Withdrawal by Subject|0|||
130802499|NCT03309605|470903127|FG004|Overall Study|Withdrawal by Subject|1|||
130802500|NCT03309605|470903128|FG005|Overall Study|Withdrawal by Subject|0|||
130802501|NCT03309605|470903129|FG006|Overall Study|Withdrawal by Subject|1|||
130802502|NCT03309605|470903130|FG007|Overall Study|Withdrawal by Subject|1|||
130802503|NCT03197935|470903131|FG000|Overall Study|Death due to any cause|26|||
130802504|NCT03197935|470903132|FG001|Overall Study|Death due to any cause|15|||
130802505|NCT03197935|470903131|FG000|Overall Study|Lost to Follow-up|3|||
130802506|NCT03197935|470903132|FG001|Overall Study|Lost to Follow-up|5|||
130802507|NCT03197935|470903131|FG000|Overall Study|Physician Decision|2|||
130802508|NCT03197935|470903132|FG001|Overall Study|Physician Decision|1|||
130802509|NCT03197935|470903131|FG000|Overall Study|Withdrawal by Subject|16|||
130802510|NCT03197935|470903132|FG001|Overall Study|Withdrawal by Subject|8|||
130802511|NCT02082483|470903133|FG000|Overall Study|Lost to Follow-up|1|||
130802512|NCT02082483|470903134|FG001|Overall Study|Lost to Follow-up|1|||
130802513|NCT02082483|470903133|FG000|Overall Study|Withdrawal by Subject|2|||
130802514|NCT02082483|470903134|FG001|Overall Study|Withdrawal by Subject|1|||
130802515|NCT02082483|470903133|FG000|Overall Study|Physician Decision|1|||
130802516|NCT02082483|470903134|FG001|Overall Study|Physician Decision|1|||
130802517|NCT02082483|470903133|FG000|Overall Study|Death|2|||
130802518|NCT02082483|470903134|FG001|Overall Study|Death|3|||
130802519|NCT00864513|470903136|FG000|Overall Study|Withdrawal by Subject|3|||
130802520|NCT03073109|470903137|FG000|Overall Study|Adverse Event|0|||
130802521|NCT03073109|470903138|FG001|Overall Study|Adverse Event|1|||
130802522|NCT03073109|470903137|FG000|Overall Study|Other|2|||
130802523|NCT03073109|470903138|FG001|Overall Study|Other|0|||
130802524|NCT03073109|470903137|FG000|Overall Study|Lost to Follow-up|8|||
130802525|NCT03073109|470903138|FG001|Overall Study|Lost to Follow-up|1|||
130802526|NCT05938010|470903139|FG000|Overall Study|Lost to Follow-up|2|||
130802527|NCT01562444|470903144|FG000|Overall Study|Did not meet entry criteria|2|||
130802528|NCT01562444|470903145|FG001|Overall Study|Did not meet entry criteria|0|||
130802529|NCT01562444|470903146|FG002|Overall Study|Did not meet entry criteria|3|||
130802530|NCT01562444|470903144|FG000|Overall Study|Did not comply with blood draw schedule|1|||
130802531|NCT01562444|470903145|FG001|Overall Study|Did not comply with blood draw schedule|0|||
130802532|NCT01562444|470903146|FG002|Overall Study|Did not comply with blood draw schedule|1|||
130802533|NCT01562444|470903144|FG000|Overall Study|Unavailable serological results|0|||
130802534|NCT01562444|470903145|FG001|Overall Study|Unavailable serological results|2|||
130802535|NCT01562444|470903146|FG002|Overall Study|Unavailable serological results|2|||
130802536|NCT01562444|470903144|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
130802537|NCT01562444|470903145|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
130802538|NCT01562444|470903146|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
130802539|NCT01562444|470903144|FG000|Overall Study|Protocol forbidden medication|1|||
130802540|NCT01562444|470903145|FG001|Overall Study|Protocol forbidden medication|0|||
130802541|NCT01562444|470903146|FG002|Overall Study|Protocol forbidden medication|0|||
130802542|NCT00983957|470903154|FG000|Overall Study|Adverse Event|1|||
130802543|NCT00983957|470903154|FG000|Overall Study|Personal Reasons|1|||
130802544|NCT00986232|470903155|FG000|Overall Study|Adverse Event|1|||
130802545|NCT00986232|470903156|FG001|Overall Study|Adverse Event|2|||
130802546|NCT00986232|470903157|FG002|Overall Study|Adverse Event|3|||
130802547|NCT00986232|470903158|FG003|Overall Study|Adverse Event|0|||
130802548|NCT00986232|470903155|FG000|Overall Study|Lost to Follow-up|19|||
130802549|NCT00986232|470903156|FG001|Overall Study|Lost to Follow-up|12|||
130802550|NCT00986232|470903157|FG002|Overall Study|Lost to Follow-up|12|||
130802551|NCT00986232|470903158|FG003|Overall Study|Lost to Follow-up|7|||
130802552|NCT00986232|470903155|FG000|Overall Study|Protocol Violation|2|||
130802553|NCT00986232|470903156|FG001|Overall Study|Protocol Violation|3|||
130802554|NCT00986232|470903157|FG002|Overall Study|Protocol Violation|0|||
130802555|NCT00986232|470903158|FG003|Overall Study|Protocol Violation|1|||
130802556|NCT00986232|470903155|FG000|Overall Study|Withdrawal by Subject|13|||
130802557|NCT00986232|470903156|FG001|Overall Study|Withdrawal by Subject|16|||
130802558|NCT00986232|470903157|FG002|Overall Study|Withdrawal by Subject|12|||
130802559|NCT00986232|470903158|FG003|Overall Study|Withdrawal by Subject|3|||
130802560|NCT00986232|470903155|FG000|Overall Study|Missed one or more bleeds|13|||
130802561|NCT00986232|470903156|FG001|Overall Study|Missed one or more bleeds|10|||
130802562|NCT00986232|470903157|FG002|Overall Study|Missed one or more bleeds|6|||
130802563|NCT00986232|470903158|FG003|Overall Study|Missed one or more bleeds|7|||
130802564|NCT00986232|470903155|FG000|Overall Study|Incomplete safety follow-up|3|||
130802565|NCT00986232|470903156|FG001|Overall Study|Incomplete safety follow-up|7|||
130802566|NCT00986232|470903157|FG002|Overall Study|Incomplete safety follow-up|2|||
130802567|NCT00986232|470903158|FG003|Overall Study|Incomplete safety follow-up|2|||
130802568|NCT00790933|470903159|FG000|Overall Study|Adverse Event|94|||
130802569|NCT00790933|470903160|FG001|Overall Study|Adverse Event|119|||
130802570|NCT00790933|470903161|FG002|Overall Study|Adverse Event|65|||
130802571|NCT00790933|470903162|FG003|Overall Study|Adverse Event|5|||
130802572|NCT00790933|470903163|FG004|Overall Study|Adverse Event|69|||
130802573|NCT00790933|470903159|FG000|Overall Study|Protocol Violation(s)|8|||
130802574|NCT00790933|470903160|FG001|Overall Study|Protocol Violation(s)|18|||
130802575|NCT00790933|470903161|FG002|Overall Study|Protocol Violation(s)|7|||
130802576|NCT00790933|470903162|FG003|Overall Study|Protocol Violation(s)|0|||
130802577|NCT00790933|470903163|FG004|Overall Study|Protocol Violation(s)|12|||
130802578|NCT00790933|470903159|FG000|Overall Study|Lack of Efficacy|192|||
130802579|NCT00790933|470903160|FG001|Overall Study|Lack of Efficacy|176|||
130802580|NCT00790933|470903161|FG002|Overall Study|Lack of Efficacy|130|||
130802581|NCT00790933|470903162|FG003|Overall Study|Lack of Efficacy|1|||
130802582|NCT00790933|470903163|FG004|Overall Study|Lack of Efficacy|121|||
130802583|NCT00790933|470903159|FG000|Overall Study|Study Terminated by Sponsor|0|||
130802584|NCT00790933|470903160|FG001|Overall Study|Study Terminated by Sponsor|0|||
130802585|NCT00790933|470903161|FG002|Overall Study|Study Terminated by Sponsor|1|||
130802586|NCT00790933|470903162|FG003|Overall Study|Study Terminated by Sponsor|0|||
130802587|NCT00790933|470903163|FG004|Overall Study|Study Terminated by Sponsor|0|||
130802588|NCT00790933|470903159|FG000|Overall Study|Withdrawal by Subject|123|||
130802589|NCT00790933|470903160|FG001|Overall Study|Withdrawal by Subject|120|||
130802590|NCT00790933|470903161|FG002|Overall Study|Withdrawal by Subject|52|||
130802591|NCT00790933|470903162|FG003|Overall Study|Withdrawal by Subject|6|||
130802592|NCT00790933|470903163|FG004|Overall Study|Withdrawal by Subject|50|||
130802593|NCT00790933|470903159|FG000|Overall Study|Lost to Follow-up|13|||
130802594|NCT00790933|470903160|FG001|Overall Study|Lost to Follow-up|31|||
130802595|NCT00790933|470903161|FG002|Overall Study|Lost to Follow-up|10|||
130802596|NCT00790933|470903162|FG003|Overall Study|Lost to Follow-up|1|||
130802597|NCT00790933|470903163|FG004|Overall Study|Lost to Follow-up|15|||
130802598|NCT00790933|470903159|FG000|Overall Study|Reason Not Specified|8|||
130802599|NCT00790933|470903160|FG001|Overall Study|Reason Not Specified|16|||
130802600|NCT00790933|470903161|FG002|Overall Study|Reason Not Specified|4|||
130802601|NCT00790933|470903162|FG003|Overall Study|Reason Not Specified|1|||
130802602|NCT00790933|470903163|FG004|Overall Study|Reason Not Specified|9|||
130802603|NCT00245570|470903166|FG000|Washout Between Periods III and IV|Adverse Event|0|||
130802604|NCT00245570|470903167|FG001|Washout Between Periods III and IV|Adverse Event|1|||
130802605|NCT00245570|470903168|FG002|Washout Between Periods III and IV|Adverse Event|0|||
130802606|NCT00245570|470903169|FG003|Washout Between Periods III and IV|Adverse Event|0|||
130802607|NCT00245570|470903170|FG004|Washout Between Periods III and IV|Adverse Event|0|||
130802608|NCT00245570|470903171|FG005|Washout Between Periods III and IV|Adverse Event|0|||
130802609|NCT01829165|470903172|FG000|Overall Study|Did not complete intervention|2|||
130802610|NCT01829165|470903173|FG001|Overall Study|Did not complete intervention|0|||
130802611|NCT00574951|470903174|FG000|Overall Study|Ineligible - improper prior treatment|1|||
130802612|NCT01160744|470903199|FG000|Overall Study|Withdrawal by Subject|11|||
130802613|NCT01160744|470903200|FG001|Overall Study|Withdrawal by Subject|5|||
130802614|NCT01160744|470903201|FG002|Overall Study|Withdrawal by Subject|6|||
130802615|NCT01160744|470903202|FG003|Overall Study|Withdrawal by Subject|4|||
130802616|NCT01160744|470903199|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
130802617|NCT01160744|470903200|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
130802618|NCT01160744|470903201|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
130802619|NCT01160744|470903202|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
130802620|NCT02301429|470903203|FG000|Overall Study|not acceptable vascular anatomy|3|||
130802621|NCT04233580|470903204|FG000|Overall Study|Adverse Event|3|||
130802622|NCT04233580|470903205|FG001|Overall Study|Adverse Event|3|||
130802623|NCT04233580|470903204|FG000|Overall Study|Withdrawal by Subject|2|||
130802624|NCT04233580|470903205|FG001|Overall Study|Withdrawal by Subject|1|||
130802625|NCT03954938|470903206|FG000|Overall Study|Withdrawal by Subject|2|||
130802626|NCT03954938|470903206|FG000|Overall Study|Adverse Event|1|||
130802627|NCT02421510|470903207|FG000|Overall Study|Other|4|||
130802628|NCT02421510|470903208|FG001|Overall Study|Other|2|||
130802629|NCT02421510|470903209|FG002|Overall Study|Other|3|||
130802630|NCT02421510|470903207|FG000|Overall Study|Protocol Violation|1|||
130802631|NCT02421510|470903208|FG001|Overall Study|Protocol Violation|2|||
130802632|NCT02421510|470903209|FG002|Overall Study|Protocol Violation|0|||
130802633|NCT02421510|470903207|FG000|Overall Study|Death|1|||
130802634|NCT02421510|470903208|FG001|Overall Study|Death|0|||
130802635|NCT02421510|470903209|FG002|Overall Study|Death|0|||
130802636|NCT02421510|470903207|FG000|Overall Study|Noncompliance with study drug|1|||
130802637|NCT02421510|470903208|FG001|Overall Study|Noncompliance with study drug|0|||
130802638|NCT02421510|470903209|FG002|Overall Study|Noncompliance with study drug|0|||
130802639|NCT02421510|470903207|FG000|Overall Study|Physician Decision|1|||
130802640|NCT02421510|470903208|FG001|Overall Study|Physician Decision|1|||
130802641|NCT02421510|470903209|FG002|Overall Study|Physician Decision|3|||
130802642|NCT02421510|470903207|FG000|Overall Study|Adverse Event|9|||
130802643|NCT02421510|470903208|FG001|Overall Study|Adverse Event|10|||
130802644|NCT02421510|470903209|FG002|Overall Study|Adverse Event|18|||
130802645|NCT02421510|470903207|FG000|Overall Study|Pregnancy|1|||
130802646|NCT02421510|470903208|FG001|Overall Study|Pregnancy|1|||
130802647|NCT02421510|470903209|FG002|Overall Study|Pregnancy|0|||
130802648|NCT02421510|470903207|FG000|Overall Study|Withdrawal by Subject|14|||
130802649|NCT02421510|470903208|FG001|Overall Study|Withdrawal by Subject|18|||
130802650|NCT02421510|470903209|FG002|Overall Study|Withdrawal by Subject|12|||
130802651|NCT02421510|470903207|FG000|Overall Study|Lost to Follow-up|1|||
130802652|NCT02421510|470903208|FG001|Overall Study|Lost to Follow-up|1|||
130802653|NCT02421510|470903209|FG002|Overall Study|Lost to Follow-up|0|||
130802654|NCT01755637|470903210|FG000|Period 1|Adverse Event|0|||
130802655|NCT01755637|470903211|FG001|Period 1|Adverse Event|1|||
130802656|NCT01814332|470903213|FG000|Overall Study|Adverse Event|8|||
130802657|NCT01814332|470903214|FG001|Overall Study|Adverse Event|3|||
130802658|NCT01814332|470903213|FG000|Overall Study|Withdrawal by Subject|3|||
130802659|NCT01814332|470903214|FG001|Overall Study|Withdrawal by Subject|8|||
130802660|NCT01814332|470903213|FG000|Overall Study|Protocol Violation|0|||
130802661|NCT01814332|470903214|FG001|Overall Study|Protocol Violation|4|||
130802662|NCT01814332|470903213|FG000|Overall Study|Lost to Follow-up|5|||
130802663|NCT01814332|470903214|FG001|Overall Study|Lost to Follow-up|1|||
130802664|NCT00899847|470903215|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
130802665|NCT00724893|470903218|FG000|Overall Study|Adverse Event|76|||
130802666|NCT00724893|470903219|FG001|Overall Study|Adverse Event|142|||
130802667|NCT00724893|470903218|FG000|Overall Study|Withdrawal by Subject|0|||
130802668|NCT00724893|470903219|FG001|Overall Study|Withdrawal by Subject|1|||
130802669|NCT00724893|470903218|FG000|Overall Study|Lack of virologic response|94|||
130802670|NCT00724893|470903219|FG001|Overall Study|Lack of virologic response|202|||
130802671|NCT00724893|470903218|FG000|Overall Study|Reason not specified|193|||
130802672|NCT00724893|470903219|FG001|Overall Study|Reason not specified|7|||
130802673|NCT00724893|470903218|FG000|Overall Study|Patient choice|0|||
130802674|NCT00724893|470903219|FG001|Overall Study|Patient choice|26|||
130802675|NCT00724893|470903218|FG000|Overall Study|Geographic reasons|0|||
130802676|NCT00724893|470903219|FG001|Overall Study|Geographic reasons|11|||
130802677|NCT00724893|470903218|FG000|Overall Study|Incarceration|0|||
130802678|NCT00724893|470903219|FG001|Overall Study|Incarceration|9|||
130802679|NCT00724893|470903218|FG000|Overall Study|Substance abuse|0|||
130802680|NCT00724893|470903219|FG001|Overall Study|Substance abuse|3|||
130802681|NCT00724893|470903218|FG000|Overall Study|Financial reasons|0|||
130802682|NCT00724893|470903219|FG001|Overall Study|Financial reasons|2|||
130802683|NCT00724893|470903218|FG000|Overall Study|Assigned shorter treatment|0|||
130802684|NCT00724893|470903219|FG001|Overall Study|Assigned shorter treatment|2|||
130802685|NCT00724893|470903218|FG000|Overall Study|Lost to Follow-up|0|||
130802686|NCT00724893|470903219|FG001|Overall Study|Lost to Follow-up|52|||
130763741|NCT02631070|470758645|FG000|Overall Study|Transition to rollover protocol|52|||
130763742|NCT02631070|470758646|FG001|Overall Study|Transition to rollover protocol|21|||
130763743|NCT02631070|470758645|FG000|Overall Study|Other reasons|12|||
130763744|NCT02631070|470758646|FG001|Overall Study|Other reasons|5|||
130763745|NCT00980018|470758652|FG000|Overall Study|Adverse Event|8|||
130763746|NCT00980018|470758652|FG000|Overall Study|Patient withdrew consent|3|||
130763747|NCT00980018|470758652|FG000|Overall Study|Lost to Follow-up|1|||
130763748|NCT00087126|470758653|FG000|Overall Study|Ineligible - second primary|1|||
130763749|NCT00087126|470758653|FG000|Overall Study|Never treated|1|||
130763750|NCT01832818|470758654|FG000|Overall Study|Lost to Follow-up|6|||
130763751|NCT00934856|470758657|FG000|Feasibility Part|Progressive disease|4|||
130763752|NCT00934856|470758658|FG001|Feasibility Part|Progressive disease|4|||
130763753|NCT00934856|470758659|FG002|Feasibility Part|Progressive disease|2|||
130763754|NCT00934856|470758660|FG003|Feasibility Part|Progressive disease|3|||
130763755|NCT00934856|470758661|FG004|Feasibility Part|Progressive disease|0|||
130763756|NCT00934856|470758662|FG005|Feasibility Part|Progressive disease|0|||
130763757|NCT00934856|470758657|FG000|Feasibility Part|Physician Decision|0|||
130763758|NCT00934856|470758658|FG001|Feasibility Part|Physician Decision|0|||
130763759|NCT00934856|470758659|FG002|Feasibility Part|Physician Decision|1|||
130763760|NCT00934856|470758660|FG003|Feasibility Part|Physician Decision|0|||
130763761|NCT00934856|470758661|FG004|Feasibility Part|Physician Decision|0|||
130763762|NCT00934856|470758662|FG005|Feasibility Part|Physician Decision|0|||
130763763|NCT00934856|470758657|FG000|Feasibility Part|Adverse Event|1|||
130763764|NCT00934856|470758658|FG001|Feasibility Part|Adverse Event|1|||
130763765|NCT00934856|470758659|FG002|Feasibility Part|Adverse Event|0|||
130763766|NCT00934856|470758660|FG003|Feasibility Part|Adverse Event|1|||
130763767|NCT00934856|470758661|FG004|Feasibility Part|Adverse Event|0|||
130763768|NCT00934856|470758662|FG005|Feasibility Part|Adverse Event|2|||
130763769|NCT00934856|470758657|FG000|Feasibility Part|Withdrawal by Subject|0|||
130763770|NCT00934856|470758658|FG001|Feasibility Part|Withdrawal by Subject|0|||
130763771|NCT00934856|470758659|FG002|Feasibility Part|Withdrawal by Subject|0|||
130763772|NCT00934856|470758660|FG003|Feasibility Part|Withdrawal by Subject|1|||
130763773|NCT00934856|470758661|FG004|Feasibility Part|Withdrawal by Subject|0|||
130763774|NCT00934856|470758662|FG005|Feasibility Part|Withdrawal by Subject|1|||
130763775|NCT00934856|470758657|FG000|Extension Part|Adverse Event|0|||
130763776|NCT00934856|470758658|FG001|Extension Part|Adverse Event|0|||
130763777|NCT00934856|470758659|FG002|Extension Part|Adverse Event|0|||
130763778|NCT00934856|470758660|FG003|Extension Part|Adverse Event|1|||
130763779|NCT00934856|470758661|FG004|Extension Part|Adverse Event|4|||
130763780|NCT00934856|470758662|FG005|Extension Part|Adverse Event|4|||
130763781|NCT00934856|470758657|FG000|Extension Part|Progressive disease|0|||
130763782|NCT00934856|470758658|FG001|Extension Part|Progressive disease|0|||
130763783|NCT00934856|470758659|FG002|Extension Part|Progressive disease|0|||
130763784|NCT00934856|470758660|FG003|Extension Part|Progressive disease|1|||
130763785|NCT00934856|470758661|FG004|Extension Part|Progressive disease|0|||
130763786|NCT00934856|470758662|FG005|Extension Part|Progressive disease|0|||
130763787|NCT00934856|470758657|FG000|Extension Part|Non-compliance with drug|0|||
130763788|NCT00934856|470758658|FG001|Extension Part|Non-compliance with drug|0|||
130763789|NCT00934856|470758659|FG002|Extension Part|Non-compliance with drug|0|||
130763790|NCT00934856|470758660|FG003|Extension Part|Non-compliance with drug|0|||
130763791|NCT00934856|470758661|FG004|Extension Part|Non-compliance with drug|0|||
130763792|NCT00934856|470758662|FG005|Extension Part|Non-compliance with drug|1|||
130763793|NCT01256385|470758663|FG000|Overall Study|Physician Decision|1|||
130763794|NCT01256385|470758664|FG001|Overall Study|Physician Decision|1|||
130763795|NCT01256385|470758663|FG000|Overall Study|Withdrawal by Subject|2|||
130763796|NCT01256385|470758664|FG001|Overall Study|Withdrawal by Subject|2|||
130763797|NCT00401960|470758667|FG000|Overall Study|Lost to Follow-up|3|||
130763798|NCT00401960|470758668|FG001|Overall Study|Lost to Follow-up|0|||
130763799|NCT00401960|470758667|FG000|Overall Study|Death|2|||
130802687|NCT00724893|470903218|FG000|Overall Study|Unknown, missing data|1|||
130802688|NCT00724893|470903219|FG001|Overall Study|Unknown, missing data|1|||
130802689|NCT01279200|470903222|FG000|Overall Study|Withdrawal by Subject|1|||
130802690|NCT01279200|470903223|FG001|Overall Study|Withdrawal by Subject|3|||
130802691|NCT01279200|470903222|FG000|Overall Study|Patient withdrawal due to high cost|0|||
130802692|NCT01279200|470903223|FG001|Overall Study|Patient withdrawal due to high cost|1|||
130802693|NCT01279200|470903222|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
130802694|NCT01279200|470903223|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
130802695|NCT01279200|470903222|FG000|Overall Study|ultrasound screening failure|0|||
130802696|NCT01279200|470903223|FG001|Overall Study|ultrasound screening failure|1|||
130802697|NCT01279200|470903222|FG000|Overall Study|Lost to Follow-up|0|||
130802698|NCT01279200|470903223|FG001|Overall Study|Lost to Follow-up|1|||
130802699|NCT01279200|470903222|FG000|Overall Study|Adverse Event|1|||
130802700|NCT01279200|470903223|FG001|Overall Study|Adverse Event|0|||
130802701|NCT00888849|470903226|FG000|Overall Study|Death|4|||
130802702|NCT00888849|470903227|FG001|Overall Study|Death|7|||
130802703|NCT00888849|470903226|FG000|Overall Study|Lost to Follow-up|1|||
130802704|NCT00888849|470903227|FG001|Overall Study|Lost to Follow-up|2|||
130802705|NCT00896233|470903232|FG000|Overall Study|Claustrophobia during MRI|1|||
130802706|NCT04280562|470903233|FG000|Study|Adverse Event|2|||
130802707|NCT04280562|470903234|FG001|Study|Adverse Event|0|||
130802708|NCT04280562|470903233|FG000|Study|Lost to Follow-up|3|||
130802709|NCT04280562|470903234|FG001|Study|Lost to Follow-up|3|||
130802710|NCT05507450|470903238|FG000|Overall Study|Death|0|||
130802711|NCT05507450|470903239|FG001|Overall Study|Death|0|||
130802712|NCT05507450|470903240|FG002|Overall Study|Death|1|||
130802713|NCT05507450|470903241|FG003|Overall Study|Death|0|||
130802714|NCT05507450|470903238|FG000|Overall Study|Lost to Follow-up|22|||
130802715|NCT05507450|470903239|FG001|Overall Study|Lost to Follow-up|20|||
130802716|NCT05507450|470903240|FG002|Overall Study|Lost to Follow-up|20|||
130802717|NCT05507450|470903241|FG003|Overall Study|Lost to Follow-up|7|||
130802718|NCT05507450|470903238|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130802719|NCT05507450|470903239|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
130802720|NCT05507450|470903240|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130802721|NCT05507450|470903241|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130802722|NCT05507450|470903238|FG000|Overall Study|Withdrawal by Subject|4|||
130802723|NCT05507450|470903239|FG001|Overall Study|Withdrawal by Subject|11|||
130802724|NCT05507450|470903240|FG002|Overall Study|Withdrawal by Subject|7|||
130802725|NCT05507450|470903241|FG003|Overall Study|Withdrawal by Subject|3|||
130802726|NCT05507450|470903238|FG000|Overall Study|Participant left the country|0|||
130802727|NCT05507450|470903239|FG001|Overall Study|Participant left the country|0|||
130802728|NCT05507450|470903240|FG002|Overall Study|Participant left the country|1|||
130802729|NCT05507450|470903241|FG003|Overall Study|Participant left the country|0|||
130802730|NCT00514917|470903245|FG000|Overall Study|Death|4|||
130802731|NCT00514917|470903246|FG001|Overall Study|Death|10|||
130802732|NCT00514917|470903245|FG000|Overall Study|Protocol Violation|1|||
130802733|NCT00514917|470903246|FG001|Overall Study|Protocol Violation|0|||
130802734|NCT00514917|470903245|FG000|Overall Study|Lost to Follow-up|4|||
130802735|NCT00514917|470903246|FG001|Overall Study|Lost to Follow-up|3|||
130802736|NCT00514917|470903245|FG000|Overall Study|Withdrawal by Subject|18|||
130802737|NCT00514917|470903246|FG001|Overall Study|Withdrawal by Subject|16|||
130802738|NCT00514917|470903245|FG000|Overall Study|Discontinued due to study closure|88|||
130802739|NCT00514917|470903246|FG001|Overall Study|Discontinued due to study closure|81|||
130802740|NCT00514917|470903245|FG000|Overall Study|Undefined|11|||
130802741|NCT00514917|470903246|FG001|Overall Study|Undefined|5|||
130802742|NCT02697422|470903247|FG000|Overall Study|Declined exit survey|9|||
130802743|NCT02697422|470903248|FG001|Overall Study|Declined exit survey|2|||
130802744|NCT02697422|470903247|FG000|Overall Study|Lost to Follow-up|13|||
130802745|NCT02697422|470903248|FG001|Overall Study|Lost to Follow-up|8|||
130802746|NCT02697422|470903247|FG000|Overall Study|Death|2|||
130802747|NCT02697422|470903248|FG001|Overall Study|Death|1|||
130802748|NCT02697422|470903247|FG000|Overall Study|Withdrawal by Subject|0|||
130802749|NCT02697422|470903248|FG001|Overall Study|Withdrawal by Subject|1|||
130802750|NCT02697422|470903247|FG000|Overall Study|Physician Decision|1|||
130802751|NCT02697422|470903248|FG001|Overall Study|Physician Decision|1|||
130802752|NCT02697422|470903247|FG000|Overall Study|Exit survey data lost|1|||
130802753|NCT02697422|470903248|FG001|Overall Study|Exit survey data lost|0|||
130802754|NCT01873833|470903252|FG000|Overall Study|Withdrawal by Subject|1|||
130802755|NCT03983109|470903255|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
130802756|NCT03983109|470903256|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
130802757|NCT04149353|470903262|FG000|Overall Study|Study terminated|1|||
130802758|NCT02068599|470903263|FG000|Overall Study|Adverse Event|4|||
130802759|NCT02068599|470903264|FG001|Overall Study|Adverse Event|1|||
130802760|NCT02068599|470903265|FG002|Overall Study|Adverse Event|1|||
130802761|NCT02068599|470903263|FG000|Overall Study|Withdrawal by Subject|2|||
130802762|NCT02068599|470903264|FG001|Overall Study|Withdrawal by Subject|7|||
130802763|NCT02068599|470903265|FG002|Overall Study|Withdrawal by Subject|5|||
130802764|NCT02068599|470903263|FG000|Overall Study|Protocol Violation|4|||
130802765|NCT02068599|470903264|FG001|Overall Study|Protocol Violation|2|||
130802766|NCT02068599|470903265|FG002|Overall Study|Protocol Violation|3|||
130802767|NCT02068599|470903263|FG000|Overall Study|Lost to Follow-up|1|||
130802768|NCT02068599|470903264|FG001|Overall Study|Lost to Follow-up|0|||
130802769|NCT02068599|470903265|FG002|Overall Study|Lost to Follow-up|0|||
130802770|NCT02068599|470903263|FG000|Overall Study|Lack of Efficacy|0|||
130802771|NCT02068599|470903264|FG001|Overall Study|Lack of Efficacy|0|||
130802772|NCT02068599|470903265|FG002|Overall Study|Lack of Efficacy|3|||
130802773|NCT02068599|470903263|FG000|Overall Study|Noncompliance|0|||
130802774|NCT02068599|470903264|FG001|Overall Study|Noncompliance|0|||
130802775|NCT02068599|470903265|FG002|Overall Study|Noncompliance|1|||
130802776|NCT01263028|470903268|FG000|Overall Study|Withdrawal by Subject|1|||
130802777|NCT01263028|470903268|FG000|Overall Study|Adverse Event|1|||
130802778|NCT01263028|470903268|FG000|Overall Study|Study terminated due to low enrollment.|4|||
130802779|NCT00309244|470903269|FG000|Overall Study|Adverse Event|29|||
130802780|NCT00309244|470903270|FG001|Overall Study|Adverse Event|12|||
130802781|NCT00309244|470903269|FG000|Overall Study|Lost to Follow-up|6|||
130802782|NCT00309244|470903270|FG001|Overall Study|Lost to Follow-up|22|||
130802783|NCT00309244|470903269|FG000|Overall Study|Physician Decision|5|||
130802784|NCT00309244|470903270|FG001|Overall Study|Physician Decision|8|||
130802785|NCT00309244|470903269|FG000|Overall Study|Protocol Violation|6|||
130802786|NCT00309244|470903270|FG001|Overall Study|Protocol Violation|3|||
130802787|NCT00309244|470903269|FG000|Overall Study|Withdrawal by Subject|50|||
130802788|NCT00309244|470903270|FG001|Overall Study|Withdrawal by Subject|32|||
130802789|NCT00309244|470903269|FG000|Overall Study|Various|7|||
130802790|NCT00309244|470903270|FG001|Overall Study|Various|7|||
130802791|NCT00309244|470903269|FG000|Overall Study|Randomized but not dosed|11|||
130802792|NCT00309244|470903270|FG001|Overall Study|Randomized but not dosed|12|||
130802793|NCT00309244|470903269|FG000|Overall Study|Death|4|||
130802794|NCT00309244|470903270|FG001|Overall Study|Death|1|||
130802795|NCT03019588|470903271|FG000|Overall Study|Death|44|||
130802796|NCT03019588|470903272|FG001|Overall Study|Death|46|||
130802797|NCT03019588|470903271|FG000|Overall Study|Study terminated by Sponsor|3|||
130802798|NCT03019588|470903272|FG001|Overall Study|Study terminated by Sponsor|1|||
130802799|NCT00887588|470903273|FG000|Core Period|Death|1|||
130802800|NCT00887588|470903274|FG001|Core Period|Death|1|||
130802801|NCT00887588|470903273|FG000|Core Period|Lost to Follow-up|3|||
130802802|NCT00887588|470903274|FG001|Core Period|Lost to Follow-up|1|||
130802803|NCT00887588|470903273|FG000|Core Period|Withdrawal by Subject|6|||
130802804|NCT00887588|470903274|FG001|Core Period|Withdrawal by Subject|8|||
130802805|NCT00887588|470903273|FG000|Core Period|Adverse Event|9|||
130802806|NCT00887588|470903274|FG001|Core Period|Adverse Event|11|||
130802807|NCT00887588|470903273|FG000|Extension Period|Adverse Event|4|||
130802808|NCT00887588|470903274|FG001|Extension Period|Adverse Event|4|||
130802809|NCT00887588|470903273|FG000|Extension Period|Death|0|||
130802810|NCT00887588|470903274|FG001|Extension Period|Death|1|||
130802811|NCT00887588|470903273|FG000|Extension Period|Protocol deviation|1|||
130802812|NCT00887588|470903274|FG001|Extension Period|Protocol deviation|0|||
130802813|NCT00887588|470903273|FG000|Extension Period|Lost to Follow-up|1|||
130802814|NCT00887588|470903274|FG001|Extension Period|Lost to Follow-up|0|||
130802815|NCT00366535|470903275|FG000|First Phase: 12 Weeks|Adverse Event|1|||
130802816|NCT00366535|470903276|FG001|First Phase: 12 Weeks|Adverse Event|3|||
130802817|NCT00366535|470903275|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
130802818|NCT00366535|470903276|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
130802819|NCT00366535|470903275|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
130802820|NCT00366535|470903276|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
130802821|NCT00366535|470903275|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
130802822|NCT00366535|470903276|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
130802823|NCT03753542|470903281|FG000|Overall Study|Lost to Follow-up|9|||
130802824|NCT03753542|470903282|FG001|Overall Study|Lost to Follow-up|14|||
130802825|NCT03554473|470904975|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
130802826|NCT03554473|470904976|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
130802827|NCT03554473|470904977|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
130802828|NCT03554473|470904975|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
130802829|NCT03554473|470904976|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
130802830|NCT03554473|470904977|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
130802831|NCT03554473|470904975|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
130802832|NCT03554473|470904976|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
130802833|NCT03554473|470904977|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
130802834|NCT04971837|470904981|FG000|Overall Study|Long Term Illness|1|||
130802835|NCT04971837|470904981|FG000|Overall Study|BMI too low|9|||
130802836|NCT04971837|470904981|FG000|Overall Study|geographic location|1|||
130802837|NCT04971837|470904981|FG000|Overall Study|Discontinued scheduling conflict|1|||
130802838|NCT00160615|470904982|FG000|Overall Study|Adverse Event|5|||
130802839|NCT00160615|470904983|FG001|Overall Study|Adverse Event|12|||
130802840|NCT00160615|470904982|FG000|Overall Study|Withdrawal by Subject|0|||
130802841|NCT00160615|470904983|FG001|Overall Study|Withdrawal by Subject|2|||
130802842|NCT00160615|470904982|FG000|Overall Study|Lack of Efficacy|11|||
130802843|NCT00160615|470904983|FG001|Overall Study|Lack of Efficacy|23|||
130802844|NCT00160615|470904982|FG000|Overall Study|Patient decision|1|||
130802845|NCT00160615|470904983|FG001|Overall Study|Patient decision|2|||
130802846|NCT00160615|470904982|FG000|Overall Study|Investigator decision|1|||
130802847|NCT00160615|470904983|FG001|Overall Study|Investigator decision|1|||
130802848|NCT00160615|470904982|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
130802849|NCT00160615|470904983|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
130802850|NCT00160615|470904982|FG000|Overall Study|Switch to surgical treatment|0|||
130802851|NCT00160615|470904983|FG001|Overall Study|Switch to surgical treatment|2|||
130802852|NCT00160615|470904982|FG000|Overall Study|Non-compliance was suspected|0|||
130802853|NCT00160615|470904983|FG001|Overall Study|Non-compliance was suspected|1|||
130802854|NCT00160615|470904982|FG000|Overall Study|Poor compliance|0|||
130802855|NCT00160615|470904983|FG001|Overall Study|Poor compliance|1|||
130802856|NCT03166631|470904984|FG000|Overall Study|Progressive disease|2|||
130802857|NCT03166631|470904985|FG001|Overall Study|Progressive disease|1|||
130802858|NCT03166631|470904986|FG002|Overall Study|Progressive disease|3|||
130802859|NCT03166631|470904987|FG003|Overall Study|Progressive disease|4|||
130802860|NCT03166631|470904988|FG004|Overall Study|Progressive disease|2|||
130802861|NCT03166631|470904989|FG005|Overall Study|Progressive disease|2|||
130802862|NCT03166631|470904990|FG006|Overall Study|Progressive disease|5|||
130802863|NCT03166631|470904991|FG007|Overall Study|Progressive disease|6|||
130802864|NCT03166631|470904992|FG008|Overall Study|Progressive disease|11|||
130802865|NCT03166631|470904993|FG009|Overall Study|Progressive disease|5|||
130802866|NCT03166631|470904994|FG010|Overall Study|Progressive disease|7|||
130802867|NCT03166631|470904984|FG000|Overall Study|Physician Decision|0|||
130802868|NCT03166631|470904985|FG001|Overall Study|Physician Decision|0|||
130802869|NCT03166631|470904986|FG002|Overall Study|Physician Decision|0|||
130802870|NCT03166631|470904987|FG003|Overall Study|Physician Decision|0|||
130802871|NCT03166631|470904988|FG004|Overall Study|Physician Decision|0|||
130802872|NCT03166631|470904989|FG005|Overall Study|Physician Decision|0|||
130802873|NCT03166631|470904990|FG006|Overall Study|Physician Decision|1|||
130802874|NCT03166631|470904991|FG007|Overall Study|Physician Decision|0|||
130802875|NCT03166631|470904992|FG008|Overall Study|Physician Decision|1|||
130802876|NCT03166631|470904993|FG009|Overall Study|Physician Decision|0|||
130802877|NCT03166631|470904994|FG010|Overall Study|Physician Decision|1|||
130802878|NCT03166631|470904984|FG000|Overall Study|Death|0|||
130802879|NCT03166631|470904985|FG001|Overall Study|Death|0|||
130802880|NCT03166631|470904986|FG002|Overall Study|Death|0|||
130802881|NCT03166631|470904987|FG003|Overall Study|Death|0|||
130802882|NCT03166631|470904988|FG004|Overall Study|Death|1|||
130802883|NCT03166631|470904989|FG005|Overall Study|Death|0|||
130802884|NCT03166631|470904990|FG006|Overall Study|Death|1|||
130802885|NCT03166631|470904991|FG007|Overall Study|Death|0|||
130802886|NCT03166631|470904992|FG008|Overall Study|Death|0|||
130802887|NCT03166631|470904993|FG009|Overall Study|Death|0|||
130802888|NCT03166631|470904994|FG010|Overall Study|Death|0|||
130802889|NCT03166631|470904984|FG000|Overall Study|Adverse Event|1|||
130802890|NCT03166631|470904985|FG001|Overall Study|Adverse Event|0|||
130802891|NCT03166631|470904986|FG002|Overall Study|Adverse Event|0|||
130802892|NCT03166631|470904987|FG003|Overall Study|Adverse Event|0|||
130802893|NCT03166631|470904988|FG004|Overall Study|Adverse Event|0|||
130802894|NCT03166631|470904989|FG005|Overall Study|Adverse Event|1|||
130802895|NCT03166631|470904990|FG006|Overall Study|Adverse Event|1|||
130802896|NCT03166631|470904991|FG007|Overall Study|Adverse Event|0|||
130802897|NCT03166631|470904992|FG008|Overall Study|Adverse Event|1|||
130802898|NCT03166631|470904993|FG009|Overall Study|Adverse Event|2|||
130802899|NCT03166631|470904994|FG010|Overall Study|Adverse Event|1|||
130802900|NCT03166631|470904984|FG000|Overall Study|Withdrawal by Subject|0|||
130802901|NCT03166631|470904985|FG001|Overall Study|Withdrawal by Subject|0|||
130802902|NCT03166631|470904986|FG002|Overall Study|Withdrawal by Subject|0|||
130802903|NCT03166631|470904987|FG003|Overall Study|Withdrawal by Subject|0|||
130802904|NCT03166631|470904988|FG004|Overall Study|Withdrawal by Subject|0|||
130802905|NCT03166631|470904989|FG005|Overall Study|Withdrawal by Subject|0|||
130802906|NCT03166631|470904990|FG006|Overall Study|Withdrawal by Subject|0|||
130802907|NCT03166631|470904991|FG007|Overall Study|Withdrawal by Subject|0|||
130802908|NCT03166631|470904992|FG008|Overall Study|Withdrawal by Subject|1|||
130802909|NCT03166631|470904993|FG009|Overall Study|Withdrawal by Subject|1|||
130802910|NCT03166631|470904994|FG010|Overall Study|Withdrawal by Subject|0|||
130802911|NCT00567580|470904997|FG000|Overall Study|Protocol Violation|28|||
130802912|NCT00567580|470904998|FG001|Overall Study|Protocol Violation|24|||
130802913|NCT00567580|470904999|FG002|Overall Study|Protocol Violation|24|||
130802914|NCT00382070|470905000|FG000|Overall Study|No follow up data mapped to Other|17|||
130802915|NCT00382070|470905001|FG001|Overall Study|No follow up data mapped to Other|19|||
130802916|NCT00382070|470905000|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
130802917|NCT00382070|470905001|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
130802918|NCT00382070|470905000|FG000|Overall Study|No clinical assessment|9|||
130802919|NCT00382070|470905001|FG001|Overall Study|No clinical assessment|11|||
130802920|NCT05788328|470905010|FG000|Treatment Period 4 (5 Days)|Other|1|||
130802921|NCT05788328|470905010|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
130802922|NCT00145327|470905011|FG000|Overall Study|Withdrawal by Subject|77|||
130802923|NCT00145327|470905012|FG001|Overall Study|Withdrawal by Subject|72|||
130802924|NCT00145327|470905013|FG002|Overall Study|Withdrawal by Subject|164|||
130802925|NCT00145327|470905011|FG000|Overall Study|Death|26|||
130802926|NCT00145327|470905012|FG001|Overall Study|Death|18|||
130802927|NCT00145327|470905013|FG002|Overall Study|Death|30|||
130802928|NCT00145327|470905011|FG000|Overall Study|Adverse Event|14|||
130802929|NCT00145327|470905012|FG001|Overall Study|Adverse Event|11|||
130802930|NCT00145327|470905013|FG002|Overall Study|Adverse Event|22|||
130802931|NCT00145327|470905011|FG000|Overall Study|Lost to Follow-up|9|||
130802932|NCT00145327|470905012|FG001|Overall Study|Lost to Follow-up|14|||
130802933|NCT00145327|470905013|FG002|Overall Study|Lost to Follow-up|14|||
130802934|NCT00145327|470905011|FG000|Overall Study|Administrative problems|12|||
130802935|NCT00145327|470905012|FG001|Overall Study|Administrative problems|9|||
130802936|NCT00145327|470905013|FG002|Overall Study|Administrative problems|13|||
130802937|NCT00145327|470905011|FG000|Overall Study|Protocol Violation|2|||
130802938|NCT00145327|470905012|FG001|Overall Study|Protocol Violation|0|||
130802939|NCT00145327|470905013|FG002|Overall Study|Protocol Violation|2|||
130802940|NCT00145327|470905011|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130802941|NCT00145327|470905012|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130802942|NCT00145327|470905013|FG002|Overall Study|Abnormal laboratory value(s)|2|||
130802943|NCT00145327|470905011|FG000|Overall Study|Missing - not stated|1|||
130802944|NCT00145327|470905012|FG001|Overall Study|Missing - not stated|0|||
130802945|NCT00145327|470905013|FG002|Overall Study|Missing - not stated|1|||
130802946|NCT03315689|470905014|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
130802947|NCT03315689|470905015|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
130802948|NCT03315689|470905014|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
130802949|NCT03315689|470905015|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
130802950|NCT03315689|470905014|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
130802951|NCT03315689|470905015|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
130802952|NCT00762788|470905016|FG000|Overall Study|Lost to Follow-up|26|||
130802953|NCT00762788|470905017|FG001|Overall Study|Lost to Follow-up|37|||
130802954|NCT00762788|470905018|FG002|Overall Study|Lost to Follow-up|21|||
130802955|NCT00762788|470905019|FG003|Overall Study|Lost to Follow-up|26|||
130802956|NCT00762788|470905020|FG004|Overall Study|Lost to Follow-up|13|||
130802957|NCT00762788|470905021|FG005|Overall Study|Lost to Follow-up|21|||
130802958|NCT00669331|470905023|FG000|Randomisation to First Dose|Adverse Event|1|||
130802959|NCT00669331|470905024|FG001|Randomisation to First Dose|Adverse Event|0|||
130802960|NCT00669331|470905023|FG000|Randomisation to First Dose|Protocol Violation|1|||
130802961|NCT00669331|470905024|FG001|Randomisation to First Dose|Protocol Violation|0|||
130802962|NCT00669331|470905023|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
130802963|NCT00669331|470905024|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
130802964|NCT00669331|470905023|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
130802965|NCT00669331|470905024|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
130802966|NCT00669331|470905023|FG000|Randomisation to First Dose|Death|1|||
130802967|NCT00669331|470905024|FG001|Randomisation to First Dose|Death|0|||
130802968|NCT00669331|470905023|FG000|Randomisation to First Dose|Sponsor decision|0|||
130802969|NCT00669331|470905024|FG001|Randomisation to First Dose|Sponsor decision|1|||
130802970|NCT00669331|470905023|FG000|Randomisation to First Dose|Randomised in error|3|||
130802971|NCT00669331|470905024|FG001|Randomisation to First Dose|Randomised in error|10|||
130802972|NCT00669331|470905023|FG000|Blinded Treatment Period|Adverse Event|16|||
130802973|NCT00669331|470905024|FG001|Blinded Treatment Period|Adverse Event|10|||
130802974|NCT00669331|470905023|FG000|Blinded Treatment Period|Protocol Violation|1|||
130802975|NCT00669331|470905024|FG001|Blinded Treatment Period|Protocol Violation|1|||
130802976|NCT00669331|470905023|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
130802977|NCT00669331|470905024|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
130802978|NCT00669331|470905023|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
130802979|NCT00669331|470905024|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
130802980|NCT00669331|470905023|FG000|Blinded Treatment Period|Death|0|||
130802981|NCT00669331|470905024|FG001|Blinded Treatment Period|Death|2|||
130802982|NCT00669331|470905023|FG000|Blinded Treatment Period|Physician Decision|3|||
130802983|NCT00669331|470905024|FG001|Blinded Treatment Period|Physician Decision|3|||
130802984|NCT00669331|470905023|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
130802985|NCT00669331|470905024|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
130802986|NCT01454063|470905025|FG000|Randomized|Adverse Event|1|||
130802987|NCT01454063|470905026|FG001|Randomized|Adverse Event|1|||
130802988|NCT01454063|470905025|FG000|Randomized|Protocol Violation|0|||
130802989|NCT01454063|470905026|FG001|Randomized|Protocol Violation|1|||
130802990|NCT03055195|470905027|FG000|Overall Study|Lack of Efficacy|1|||
130802991|NCT03055195|470905028|FG001|Overall Study|Lack of Efficacy|0|||
130802992|NCT03055195|470905027|FG000|Overall Study|Withdrawal by Subject|6|||
130802993|NCT03055195|470905028|FG001|Overall Study|Withdrawal by Subject|7|||
130802994|NCT03055195|470905027|FG000|Overall Study|Study Terminated by Sponsor|2|||
130802995|NCT03055195|470905028|FG001|Overall Study|Study Terminated by Sponsor|6|||
130802996|NCT03055195|470905027|FG000|Overall Study|Protocol Violation|2|||
130802997|NCT03055195|470905028|FG001|Overall Study|Protocol Violation|1|||
130802998|NCT03055195|470905027|FG000|Overall Study|Physician Decision|1|||
130802999|NCT03055195|470905028|FG001|Overall Study|Physician Decision|0|||
130803000|NCT02568423|470905031|FG000|Overall Study|Lost to Follow-up|0|||
130803001|NCT02568423|470905032|FG001|Overall Study|Lost to Follow-up|2|||
130803002|NCT02568423|470905033|FG002|Overall Study|Lost to Follow-up|0|||
130803003|NCT02568423|470905034|FG003|Overall Study|Lost to Follow-up|0|||
130803004|NCT02568423|470905035|FG004|Overall Study|Lost to Follow-up|0|||
130803005|NCT02568423|470905036|FG005|Overall Study|Lost to Follow-up|0|||
130803006|NCT02568423|470905037|FG006|Overall Study|Lost to Follow-up|0|||
130803007|NCT02568423|470905038|FG007|Overall Study|Lost to Follow-up|0|||
130803008|NCT02568423|470905031|FG000|Overall Study|Physician Decision|0|||
130803009|NCT02568423|470905032|FG001|Overall Study|Physician Decision|0|||
130803010|NCT02568423|470905033|FG002|Overall Study|Physician Decision|0|||
130803011|NCT02568423|470905034|FG003|Overall Study|Physician Decision|0|||
130803012|NCT02568423|470905035|FG004|Overall Study|Physician Decision|0|||
130803013|NCT02568423|470905036|FG005|Overall Study|Physician Decision|1|||
130803014|NCT02568423|470905037|FG006|Overall Study|Physician Decision|0|||
130803015|NCT02568423|470905038|FG007|Overall Study|Physician Decision|0|||
130803016|NCT01027416|470905041|FG000|Overall Study|Withdrawal by Subject|0|||
130803017|NCT01027416|470905042|FG001|Overall Study|Withdrawal by Subject|1|||
130803018|NCT01027416|470905041|FG000|Overall Study|Physician Decision|1|||
130803019|NCT01027416|470905042|FG001|Overall Study|Physician Decision|4|||
130803020|NCT00397930|470905049|FG000|Overall Study|Personal reasons|14|||
130803021|NCT00397930|470905050|FG001|Overall Study|Personal reasons|8|||
130803022|NCT00397930|470905049|FG000|Overall Study|Other medical|9|||
130803023|NCT00397930|470905050|FG001|Overall Study|Other medical|4|||
130803024|NCT00397930|470905049|FG000|Overall Study|Unknown reasons|9|||
130803025|NCT00397930|470905050|FG001|Overall Study|Unknown reasons|14|||
130803026|NCT00397930|470905049|FG000|Overall Study|Noncompliant|3|||
130803027|NCT00397930|470905050|FG001|Overall Study|Noncompliant|2|||
130803028|NCT00397930|470905049|FG000|Overall Study|Too time-consuming|2|||
130803029|NCT00397930|470905050|FG001|Overall Study|Too time-consuming|9|||
130803030|NCT00397930|470905049|FG000|Overall Study|Started own yoga program|1|||
130803031|NCT00397930|470905050|FG001|Overall Study|Started own yoga program|1|||
130803032|NCT00397930|470905049|FG000|Overall Study|Did not want to be in control group|0|||
130803033|NCT00397930|470905050|FG001|Overall Study|Did not want to be in control group|1|||
130803034|NCT00397930|470905049|FG000|Overall Study|Withdrawal by Subject|0|||
130803035|NCT00397930|470905050|FG001|Overall Study|Withdrawal by Subject|8|||
130803036|NCT00397930|470905049|FG000|Overall Study|Missing data|0|||
130803037|NCT00397930|470905050|FG001|Overall Study|Missing data|4|||
130803038|NCT01960842|470905051|FG000|Overall Study|Adverse Event|1|||
130803039|NCT01960842|470905051|FG000|Overall Study|Withdrawal by Subject|2|||
130803040|NCT02391584|470905052|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
130803041|NCT02391584|470905053|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
130803042|NCT02391584|470905052|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
130803043|NCT02391584|470905053|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
130803044|NCT02391584|470905052|FG000|3 Month|Lost to Follow-up|1|||
130803045|NCT02391584|470905053|FG001|3 Month|Lost to Follow-up|0|||
130803046|NCT02391584|470905052|FG000|6 Month|Withdrawal by Subject|1|||
130803047|NCT02391584|470905053|FG001|6 Month|Withdrawal by Subject|0|||
130803048|NCT02391584|470905052|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
130803049|NCT02391584|470905053|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
130803050|NCT02056288|470905056|FG000|In-Hospital Data|Surgery cancelled|1|||
130803051|NCT02056288|470905057|FG001|In-Hospital Data|Surgery cancelled|0|||
130803052|NCT02056288|470905056|FG000|In-Hospital Data|Protocol Violation|3|||
130803053|NCT02056288|470905057|FG001|In-Hospital Data|Protocol Violation|0|||
130803054|NCT02056288|470905056|FG000|In-Hospital Data|Physician Decision|1|||
130803055|NCT02056288|470905057|FG001|In-Hospital Data|Physician Decision|0|||
130803056|NCT02056288|470905056|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
130803057|NCT02056288|470905057|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
130803058|NCT02217982|470905064|FG000|Overall Study|Trial discontinued|1|||
130803059|NCT02217982|470905065|FG001|Overall Study|Trial discontinued|0|||
130803060|NCT02217982|470905064|FG000|Overall Study|Adverse Event|0|||
130803061|NCT02217982|470905065|FG001|Overall Study|Adverse Event|1|||
130803062|NCT01096186|470905070|FG000|Overall Study|Adverse Event|16|||
130803063|NCT01096186|470905070|FG000|Overall Study|Death|4|||
130803064|NCT01096186|470905070|FG000|Overall Study|Lack of Efficacy|4|||
130803065|NCT01096186|470905070|FG000|Overall Study|Lost to Follow-up|2|||
130803066|NCT01096186|470905070|FG000|Overall Study|Withdrawal by Subject|22|||
130803067|NCT01096186|470905070|FG000|Overall Study|Physician Decision|1|||
130803068|NCT01096186|470905070|FG000|Overall Study|Noncompliance with study drug|1|||
130803069|NCT00122187|470905075|FG000|Overall Study|Withdrew because of resource limitations|2|||
130803070|NCT00122187|470905076|FG001|Overall Study|Withdrew because of resource limitations|2|||
130803071|NCT02061592|470905077|FG000|Period 1|Withdrawal by Subject|1|||
130803072|NCT02061592|470905078|FG001|Period 1|Withdrawal by Subject|0|||
130803073|NCT02061592|470905077|FG000|Period 1|Protocol Violation|1|||
130803074|NCT02061592|470905078|FG001|Period 1|Protocol Violation|0|||
130803075|NCT02061592|470905077|FG000|Period 2|Lost to Follow-up|0|||
130803076|NCT02061592|470905078|FG001|Period 2|Lost to Follow-up|1|||
130803077|NCT03338023|470905079|FG000|Overall Study|Withdrawal by Subject|3|||
130803078|NCT03338023|470905080|FG001|Overall Study|Withdrawal by Subject|4|||
130803079|NCT03338023|470905079|FG000|Overall Study|Protocol Violation|3|||
130803080|NCT03338023|470905080|FG001|Overall Study|Protocol Violation|3|||
130803081|NCT03338023|470905079|FG000|Overall Study|Lost to Follow-up|2|||
130803082|NCT03338023|470905080|FG001|Overall Study|Lost to Follow-up|1|||
130803083|NCT03338023|470905079|FG000|Overall Study|Physician Decision|1|||
130803084|NCT03338023|470905080|FG001|Overall Study|Physician Decision|2|||
130803085|NCT00685698|470905081|FG000|Overall Study|Withdrawal by Subject|1|||
130803086|NCT00685698|470905081|FG000|Overall Study|Protocol Violation|6|||
130803087|NCT00685698|470905081|FG000|Overall Study|Adverse Event|3|||
130803088|NCT00685698|470905081|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
130803089|NCT00685698|470905081|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
130803090|NCT00685698|470905081|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
130803091|NCT05061706|470905083|FG000|Overall Study|Adverse Event|29|||
130803092|NCT05061706|470905084|FG001|Overall Study|Adverse Event|1|||
130803093|NCT05061706|470905083|FG000|Overall Study|Lack of Efficacy|0|||
130803094|NCT05061706|470905084|FG001|Overall Study|Lack of Efficacy|1|||
130803095|NCT05061706|470905083|FG000|Overall Study|Lost to Follow-up|2|||
130803096|NCT05061706|470905084|FG001|Overall Study|Lost to Follow-up|2|||
130803097|NCT05061706|470905083|FG000|Overall Study|Protocol Violation|3|||
130803098|NCT05061706|470905084|FG001|Overall Study|Protocol Violation|1|||
130803099|NCT05061706|470905083|FG000|Overall Study|Withdrawal by Subject|3|||
130803100|NCT05061706|470905084|FG001|Overall Study|Withdrawal by Subject|9|||
130803101|NCT01871727|470905085|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
130803102|NCT01871727|470905086|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
130803103|NCT01871727|470905087|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
130803104|NCT01871727|470905088|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
130803105|NCT01871727|470905089|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
130803106|NCT01871727|470905085|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
130803107|NCT01871727|470905086|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
130803108|NCT01871727|470905087|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
130803109|NCT01871727|470905088|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
130803110|NCT01871727|470905089|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
130803111|NCT01871727|470905085|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130803112|NCT01871727|470905086|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130803113|NCT01871727|470905087|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130803114|NCT01871727|470905088|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130803115|NCT01871727|470905089|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
130803116|NCT01871727|470905085|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130803117|NCT01871727|470905086|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130803118|NCT01871727|470905087|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130803119|NCT01871727|470905088|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130803120|NCT01871727|470905089|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
130803121|NCT01871727|470905085|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130803122|NCT01871727|470905086|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130803123|NCT01871727|470905087|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130803124|NCT01871727|470905088|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130803125|NCT01871727|470905089|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
130803126|NCT01871727|470905085|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130803127|NCT01871727|470905086|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130803128|NCT01871727|470905087|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130803129|NCT01871727|470905088|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130803130|NCT01871727|470905089|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
130803131|NCT01871727|470905085|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
130803132|NCT01871727|470905086|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
130803133|NCT01871727|470905087|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
130803134|NCT01871727|470905088|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
130803135|NCT01871727|470905089|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
130803136|NCT00356421|470905091|FG000|Overall Study|Lack of Efficacy|3|||
130803137|NCT00356421|470905092|FG001|Overall Study|Lack of Efficacy|0|||
130803138|NCT00356421|470905091|FG000|Overall Study|Withdrawal by Subject|9|||
130803139|NCT00356421|470905092|FG001|Overall Study|Withdrawal by Subject|2|||
130803140|NCT00356421|470905091|FG000|Overall Study|Related to study drug|15|||
130803141|NCT00356421|470905092|FG001|Overall Study|Related to study drug|12|||
130803142|NCT00356421|470905091|FG000|Overall Study|Not related to study drug|5|||
130803143|NCT00356421|470905092|FG001|Overall Study|Not related to study drug|3|||
130803144|NCT00501085|470905093|FG000|Overall Study|Lost to Follow-up|195|||
130803145|NCT00501085|470905093|FG000|Overall Study|Withdrawal by Subject|34|||
130803146|NCT00501085|470905093|FG000|Overall Study|Subject Decision|1|||
130803147|NCT00501085|470905093|FG000|Overall Study|Revision Surgery|7|||
130803148|NCT00501085|470905093|FG000|Overall Study|Explantation Surgery|26|||
130803149|NCT00501085|470905093|FG000|Overall Study|Adverse Event|4|||
130803150|NCT00501085|470905093|FG000|Overall Study|Non-Compliance|24|||
130803151|NCT00501085|470905093|FG000|Overall Study|Study closed by sponsor|109|||
130803152|NCT00501085|470905093|FG000|Overall Study|Other loss to follow-up|32|||
130803153|NCT02958527|470905094|FG000|Overall Study|Not collected CRFs|12|||
130803154|NCT02945046|470905095|FG000|Overall Study|Adverse Event|1|||
130803155|NCT02945046|470905096|FG001|Overall Study|Adverse Event|0|||
130803156|NCT02945046|470905097|FG002|Overall Study|Adverse Event|2|||
130803157|NCT02945046|470905095|FG000|Overall Study|Withdrawal by Subject|3|||
130803158|NCT02945046|470905096|FG001|Overall Study|Withdrawal by Subject|3|||
130803159|NCT02945046|470905097|FG002|Overall Study|Withdrawal by Subject|3|||
130803160|NCT02945046|470905095|FG000|Overall Study|Protocol Violation|2|||
130803161|NCT02945046|470905096|FG001|Overall Study|Protocol Violation|3|||
130803162|NCT02945046|470905097|FG002|Overall Study|Protocol Violation|2|||
130803163|NCT02945046|470905095|FG000|Overall Study|Lost to Follow-up|1|||
130803164|NCT02945046|470905096|FG001|Overall Study|Lost to Follow-up|1|||
130803165|NCT02945046|470905097|FG002|Overall Study|Lost to Follow-up|0|||
130803166|NCT02945046|470905095|FG000|Overall Study|Lack of Efficacy|1|||
130803167|NCT02945046|470905096|FG001|Overall Study|Lack of Efficacy|2|||
130803168|NCT02945046|470905097|FG002|Overall Study|Lack of Efficacy|1|||
130803169|NCT02945046|470905095|FG000|Overall Study|Other than specified|5|||
130803170|NCT02945046|470905096|FG001|Overall Study|Other than specified|4|||
130803171|NCT02945046|470905097|FG002|Overall Study|Other than specified|7|||
130803172|NCT03113136|470905098|FG000|Overall Study|Lost to Follow-up|22|||
130803173|NCT03113136|470905099|FG001|Overall Study|Lost to Follow-up|47|||
130803174|NCT03113136|470905100|FG002|Overall Study|Lost to Follow-up|54|||
130803175|NCT03113136|470905098|FG000|Overall Study|Withdrawal by Subject|4|||
130803176|NCT03113136|470905099|FG001|Overall Study|Withdrawal by Subject|13|||
130803177|NCT03113136|470905100|FG002|Overall Study|Withdrawal by Subject|14|||
130803178|NCT03113136|470905098|FG000|Overall Study|Ineligible|0|||
130803179|NCT03113136|470905099|FG001|Overall Study|Ineligible|2|||
130803180|NCT03113136|470905100|FG002|Overall Study|Ineligible|1|||
130803181|NCT03113136|470905098|FG000|Overall Study|Study Team Decision|1|||
130803182|NCT03113136|470905099|FG001|Overall Study|Study Team Decision|4|||
130803183|NCT03113136|470905100|FG002|Overall Study|Study Team Decision|0|||
130803184|NCT01666314|470905104|FG000|Overall Study|Adverse Event|3|||
130803185|NCT01666314|470905105|FG001|Overall Study|Adverse Event|13|||
130803186|NCT01666314|470905106|FG002|Overall Study|Adverse Event|7|||
130803187|NCT01666314|470905107|FG003|Overall Study|Adverse Event|7|||
130803188|NCT01666314|470905104|FG000|Overall Study|Progressive Disease|11|||
130803189|NCT01666314|470905105|FG001|Overall Study|Progressive Disease|9|||
130803190|NCT01666314|470905106|FG002|Overall Study|Progressive Disease|19|||
130803191|NCT01666314|470905107|FG003|Overall Study|Progressive Disease|20|||
130803192|NCT01666314|470905104|FG000|Overall Study|Symptomatic Deterioration|1|||
130803193|NCT01666314|470905105|FG001|Overall Study|Symptomatic Deterioration|0|||
130803194|NCT01666314|470905106|FG002|Overall Study|Symptomatic Deterioration|2|||
130803195|NCT01666314|470905107|FG003|Overall Study|Symptomatic Deterioration|0|||
130803196|NCT01666314|470905104|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
130803197|NCT01666314|470905105|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
130803198|NCT01666314|470905106|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
130803199|NCT01666314|470905107|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
130803200|NCT01666314|470905104|FG000|Overall Study|Withdrawal by Subject|1|||
130803201|NCT01666314|470905105|FG001|Overall Study|Withdrawal by Subject|1|||
130803202|NCT01666314|470905106|FG002|Overall Study|Withdrawal by Subject|2|||
130803203|NCT01666314|470905107|FG003|Overall Study|Withdrawal by Subject|3|||
130803204|NCT01666314|470905104|FG000|Overall Study|Reason not Specified|10|||
130803205|NCT01666314|470905105|FG001|Overall Study|Reason not Specified|7|||
130803206|NCT01666314|470905106|FG002|Overall Study|Reason not Specified|5|||
130803207|NCT01666314|470905107|FG003|Overall Study|Reason not Specified|5|||
130803208|NCT02114684|470905110|FG000|Overall Study|Death|6|||
130803209|NCT02114684|470905111|FG001|Overall Study|Death|4|||
130803210|NCT02114684|470905110|FG000|Overall Study|Lost to Follow-up|1|||
130803211|NCT02114684|470905111|FG001|Overall Study|Lost to Follow-up|2|||
130803212|NCT02114684|470905110|FG000|Overall Study|Withdrawal by Subject|1|||
130803213|NCT02114684|470905111|FG001|Overall Study|Withdrawal by Subject|2|||
130803214|NCT02114684|470905110|FG000|Overall Study|Relocation|3|||
130803215|NCT02114684|470905111|FG001|Overall Study|Relocation|1|||
130803216|NCT02114684|470905110|FG000|Overall Study|Rifampicin resistant on culture|0|||
130803217|NCT02114684|470905111|FG001|Overall Study|Rifampicin resistant on culture|1|||
130803218|NCT02114684|470905110|FG000|Overall Study|Patient Incarcerated|1|||
130803219|NCT02114684|470905111|FG001|Overall Study|Patient Incarcerated|0|||
130803220|NCT04625972|470905114|FG000|Overall Study|Death|3|||
130803221|NCT04625972|470905115|FG001|Overall Study|Death|2|||
130803222|NCT04625972|470905114|FG000|Overall Study|Lost to Follow-up|82|||
130803223|NCT04625972|470905115|FG001|Overall Study|Lost to Follow-up|38|||
130803224|NCT04625972|470905114|FG000|Overall Study|Physician Decision|2|||
130803225|NCT04625972|470905115|FG001|Overall Study|Physician Decision|0|||
130803226|NCT04625972|470905114|FG000|Overall Study|Protocol Violation|0|||
130803227|NCT04625972|470905115|FG001|Overall Study|Protocol Violation|1|||
130803228|NCT04625972|470905114|FG000|Overall Study|Withdrawal by Subject|37|||
130803229|NCT04625972|470905115|FG001|Overall Study|Withdrawal by Subject|24|||
130803230|NCT04625972|470905114|FG000|Overall Study|Not specified elsewhere|8|||
130803231|NCT04625972|470905115|FG001|Overall Study|Not specified elsewhere|6|||
130803232|NCT00694122|470905116|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
130803233|NCT00694122|470905117|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
130803234|NCT00694122|470905116|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
130803235|NCT00694122|470905117|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
130803236|NCT00694122|470905116|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
130803237|NCT00694122|470905117|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
130803238|NCT03020888|470905122|FG000|Overall Study|Physician Decision|4|||
130803239|NCT03020888|470905122|FG000|Overall Study|Withdrawal by Subject|6|||
130803240|NCT03020888|470905122|FG000|Overall Study|Insurance coverage|2|||
130803241|NCT03020888|470905122|FG000|Overall Study|Lost to Follow-up|1|||
130803242|NCT01198548|470905129|FG000|Overall Study|Disease Progression|9|||
130803243|NCT01198548|470905129|FG000|Overall Study|Administrative Decision|1|||
130803244|NCT01245062|470905131|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
130803245|NCT01245062|470905132|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
130803246|NCT01245062|470905133|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
130803247|NCT01245062|470905131|FG000|Randomization and Crossover Phase|Physician Decision|2|||
130803248|NCT01245062|470905132|FG001|Randomization and Crossover Phase|Physician Decision|4|||
130803249|NCT01245062|470905133|FG002|Randomization and Crossover Phase|Physician Decision|0|||
130803250|NCT01245062|470905131|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
130803251|NCT01245062|470905132|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
130803252|NCT01245062|470905133|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
130803253|NCT01245062|470905131|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
130803254|NCT01245062|470905132|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
130803255|NCT01245062|470905133|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
130803256|NCT01245062|470905131|FG000|Cross-over Phase|Lost to Follow-up|0|||
130803257|NCT01245062|470905132|FG001|Cross-over Phase|Lost to Follow-up|0|||
130803258|NCT01245062|470905133|FG002|Cross-over Phase|Lost to Follow-up|1|||
130803259|NCT01245062|470905131|FG000|Cross-over Phase|Physician Decision|0|||
130803260|NCT01245062|470905132|FG001|Cross-over Phase|Physician Decision|0|||
130803261|NCT01245062|470905133|FG002|Cross-over Phase|Physician Decision|1|||
130803262|NCT01245062|470905131|FG000|Cross-over Phase|Withdrew Consent|0|||
130803263|NCT01245062|470905132|FG001|Cross-over Phase|Withdrew Consent|0|||
130803264|NCT01245062|470905133|FG002|Cross-over Phase|Withdrew Consent|4|||
130803265|NCT01245062|470905131|FG000|Cross-over Phase|Study closed/ terminated|0|||
130803266|NCT01245062|470905132|FG001|Cross-over Phase|Study closed/ terminated|0|||
130803267|NCT01245062|470905133|FG002|Cross-over Phase|Study closed/ terminated|11|||
130803268|NCT02015104|470905134|FG000|Overall Study|Withdrew consent after first dose drug|1|||
130803269|NCT02015104|470905135|FG001|Overall Study|Withdrew consent after first dose drug|0|||
130803270|NCT02015104|470905134|FG000|Overall Study|Withdrew consent prior to treatment|0|||
130803271|NCT02015104|470905135|FG001|Overall Study|Withdrew consent prior to treatment|1|||
130803272|NCT00710554|470906705|FG000|Overall Study|Adverse Event|24|||
130803273|NCT00710554|470906706|FG001|Overall Study|Adverse Event|7|||
130803274|NCT00710554|470906705|FG000|Overall Study|Withdrawal by Subject|7|||
130803275|NCT00710554|470906706|FG001|Overall Study|Withdrawal by Subject|3|||
130803276|NCT00710554|470906705|FG000|Overall Study|Lost to Follow-up|7|||
130803277|NCT00710554|470906706|FG001|Overall Study|Lost to Follow-up|1|||
130803278|NCT00710554|470906705|FG000|Overall Study|Lack of Efficacy|11|||
130803279|NCT00710554|470906706|FG001|Overall Study|Lack of Efficacy|12|||
130803280|NCT00710554|470906705|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
130803281|NCT00710554|470906706|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
130803282|NCT01301001|470906711|FG000|First Intervention|Lost to Follow-up|4|||
130803283|NCT01301001|470906712|FG001|First Intervention|Lost to Follow-up|4|||
130803284|NCT01301001|470906711|FG000|First Intervention|Withdrawal by Subject|1|||
130803285|NCT01301001|470906712|FG001|First Intervention|Withdrawal by Subject|4|||
130803286|NCT01301001|470906711|FG000|First Intervention|Adverse Event|5|||
130803287|NCT01301001|470906712|FG001|First Intervention|Adverse Event|0|||
130803288|NCT01301001|470906711|FG000|First Intervention|Protocol Violation|0|||
130803289|NCT01301001|470906712|FG001|First Intervention|Protocol Violation|1|||
130803290|NCT01301001|470906711|FG000|Second Intervention|Adverse Event|2|||
130803291|NCT01301001|470906712|FG001|Second Intervention|Adverse Event|0|||
130803292|NCT01301001|470906711|FG000|Second Intervention|Withdrawal by Subject|2|||
130763800|NCT00401960|470758668|FG001|Overall Study|Death|0|||
130763801|NCT02649426|470758669|FG000|Overall Study|Follow-up on going|1|||
130763802|NCT02649426|470758670|FG001|Overall Study|Follow-up on going|26|||
130763803|NCT02649426|470758671|FG002|Overall Study|Follow-up on going|28|||
130763804|NCT02649426|470758672|FG003|Overall Study|Follow-up on going|31|||
130763805|NCT01606202|470758673|FG000|Overall Study|Adverse Event|5|||
130763806|NCT01606202|470758674|FG001|Overall Study|Adverse Event|0|||
130763807|NCT01606202|470758673|FG000|Overall Study|Withdrawal by Subject|2|||
130763808|NCT01606202|470758674|FG001|Overall Study|Withdrawal by Subject|1|||
130763809|NCT01606202|470758673|FG000|Overall Study|Personal problems|0|||
130763810|NCT01606202|470758674|FG001|Overall Study|Personal problems|1|||
130763811|NCT01606202|470758673|FG000|Overall Study|Problems with administration|0|||
130763812|NCT01606202|470758674|FG001|Overall Study|Problems with administration|1|||
130763813|NCT02584959|470758675|FG000|Period 1|Withdrawn from study|3|||
130763814|NCT02584959|470758676|FG001|Period 1|Withdrawn from study|4|||
130763815|NCT02584959|470758677|FG002|Period 1|Withdrawn from study|0|||
130763816|NCT02584959|470758675|FG000|Period 2|Withdrawn from study|6|||
130763817|NCT02584959|470758676|FG001|Period 2|Withdrawn from study|1|||
130763818|NCT02584959|470758677|FG002|Period 2|Withdrawn from study|2|||
130763819|NCT00195494|470758682|FG000|Year 1|Adverse Event|0|||
130763820|NCT00195494|470758683|FG001|Year 1|Adverse Event|0|||
130763821|NCT00195494|470758684|FG002|Year 1|Adverse Event|0|||
130763822|NCT00195494|470758685|FG003|Year 1|Adverse Event|0|||
130763823|NCT00195494|470758686|FG004|Year 1|Adverse Event|34|||
130763824|NCT00195494|470758687|FG005|Year 1|Adverse Event|27|||
130763825|NCT00195494|470758682|FG000|Year 1|System Toxicity|0|||
130763826|NCT00195494|470758683|FG001|Year 1|System Toxicity|0|||
130763827|NCT00195494|470758684|FG002|Year 1|System Toxicity|0|||
130763828|NCT00195494|470758685|FG003|Year 1|System Toxicity|0|||
130763829|NCT00195494|470758686|FG004|Year 1|System Toxicity|0|||
130763830|NCT00195494|470758687|FG005|Year 1|System Toxicity|1|||
130763831|NCT00195494|470758682|FG000|Year 1|Lack of Efficacy|0|||
130763832|NCT00195494|470758683|FG001|Year 1|Lack of Efficacy|0|||
130763833|NCT00195494|470758684|FG002|Year 1|Lack of Efficacy|0|||
130763834|NCT00195494|470758685|FG003|Year 1|Lack of Efficacy|0|||
130763835|NCT00195494|470758686|FG004|Year 1|Lack of Efficacy|24|||
130763836|NCT00195494|470758687|FG005|Year 1|Lack of Efficacy|9|||
130763837|NCT00195494|470758682|FG000|Year 1|Compliance|0|||
130763838|NCT00195494|470758683|FG001|Year 1|Compliance|0|||
130763839|NCT00195494|470758684|FG002|Year 1|Compliance|0|||
130763840|NCT00195494|470758685|FG003|Year 1|Compliance|0|||
130763841|NCT00195494|470758686|FG004|Year 1|Compliance|5|||
130763842|NCT00195494|470758687|FG005|Year 1|Compliance|1|||
130763843|NCT00195494|470758682|FG000|Year 1|Lost to Follow-up|0|||
130763844|NCT00195494|470758683|FG001|Year 1|Lost to Follow-up|0|||
130763845|NCT00195494|470758684|FG002|Year 1|Lost to Follow-up|0|||
130763846|NCT00195494|470758685|FG003|Year 1|Lost to Follow-up|0|||
130763847|NCT00195494|470758686|FG004|Year 1|Lost to Follow-up|1|||
130763848|NCT00195494|470758687|FG005|Year 1|Lost to Follow-up|0|||
130763849|NCT00195494|470758682|FG000|Year 1|Missed >4 consecutive doses|0|||
130763850|NCT00195494|470758683|FG001|Year 1|Missed >4 consecutive doses|0|||
130763851|NCT00195494|470758684|FG002|Year 1|Missed >4 consecutive doses|0|||
130803293|NCT01301001|470906712|FG001|Second Intervention|Withdrawal by Subject|0|||
130803294|NCT01441414|470906715|FG000|Overall Study|Participant died|9|||
130803295|NCT01441414|470906715|FG000|Overall Study|Other reasons|3|||
130803296|NCT01441414|470906715|FG000|Overall Study|Study terminated by sponsor|2|||
130803297|NCT01441414|470906715|FG000|Overall Study|Subject refused further follow-up|1|||
130803298|NCT01433978|470906716|FG000|Core Study|Adverse Event, Non-Fatal|0|||
130803299|NCT01433978|470906717|FG001|Core Study|Adverse Event, Non-Fatal|1|||
130803300|NCT01433978|470906718|FG002|Core Study|Adverse Event, Non-Fatal|0|||
130803301|NCT01433978|470906716|FG000|Core Study|Lack of Efficacy|5|||
130803302|NCT01433978|470906717|FG001|Core Study|Lack of Efficacy|1|||
130803303|NCT01433978|470906718|FG002|Core Study|Lack of Efficacy|0|||
130803304|NCT01433978|470906716|FG000|Core Study|Study Terminated by Sponsor|6|||
130803305|NCT01433978|470906717|FG001|Core Study|Study Terminated by Sponsor|9|||
130803306|NCT01433978|470906718|FG002|Core Study|Study Terminated by Sponsor|0|||
130803307|NCT01433978|470906716|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
130803308|NCT01433978|470906717|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
130803309|NCT01433978|470906718|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
130803310|NCT01433978|470906716|FG000|Extension Phase|Lack of Efficacy|0|||
130803311|NCT01433978|470906717|FG001|Extension Phase|Lack of Efficacy|0|||
130803312|NCT01433978|470906718|FG002|Extension Phase|Lack of Efficacy|1|||
130803313|NCT01433978|470906716|FG000|Extension Phase|Study Terminated by Sponsor|0|||
130803314|NCT01433978|470906717|FG001|Extension Phase|Study Terminated by Sponsor|0|||
130803315|NCT01433978|470906718|FG002|Extension Phase|Study Terminated by Sponsor|4|||
130803316|NCT01773889|470906719|FG000|Overall Study|lack of funding|2|||
130803317|NCT00500110|470906720|FG000|Overall Study|Withdrawal by Subject|3|||
130803318|NCT01502072|470906721|FG000|Overall Study|Withdrawal by Subject|1|||
130803319|NCT01502072|470906722|FG001|Overall Study|Withdrawal by Subject|0|||
130803320|NCT01502072|470906723|FG002|Overall Study|Withdrawal by Subject|0|||
130803321|NCT01502072|470906721|FG000|Overall Study|Death|0|||
130803322|NCT01502072|470906722|FG001|Overall Study|Death|1|||
130803323|NCT01502072|470906723|FG002|Overall Study|Death|0|||
130803324|NCT02565186|470906729|FG000|Overall Study|Adverse Event|113|||
130803325|NCT02565186|470906730|FG001|Overall Study|Adverse Event|148|||
130803326|NCT02565186|470906729|FG000|Overall Study|Lost to Follow-up|102|||
130803327|NCT02565186|470906730|FG001|Overall Study|Lost to Follow-up|93|||
130803328|NCT02565186|470906729|FG000|Overall Study|Non-Compliance|57|||
130803329|NCT02565186|470906730|FG001|Overall Study|Non-Compliance|55|||
130803330|NCT02565186|470906729|FG000|Overall Study|Withdrawal by Subject|229|||
130803331|NCT02565186|470906730|FG001|Overall Study|Withdrawal by Subject|214|||
130803332|NCT02565186|470906729|FG000|Overall Study|Physician Decision|18|||
130803333|NCT02565186|470906730|FG001|Overall Study|Physician Decision|16|||
130803334|NCT02565186|470906729|FG000|Overall Study|Sponsor Request|5|||
130803335|NCT02565186|470906730|FG001|Overall Study|Sponsor Request|9|||
130803336|NCT02565186|470906729|FG000|Overall Study|Missing|1|||
130803337|NCT02565186|470906730|FG001|Overall Study|Missing|0|||
130803338|NCT02565186|470906729|FG000|Overall Study|Did Not Receive Study Drug|55|||
130803339|NCT02565186|470906730|FG001|Overall Study|Did Not Receive Study Drug|86|||
130803340|NCT00976391|470906731|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
130803341|NCT00976391|470906732|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
130803342|NCT00976391|470906731|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
130803343|NCT00976391|470906732|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
130803344|NCT00976391|470906731|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
130803345|NCT00976391|470906732|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
130803346|NCT00976391|470906731|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
130803347|NCT00976391|470906732|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
130803348|NCT00976391|470906731|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
130803349|NCT00976391|470906732|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
130803350|NCT00976391|470906731|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
130803351|NCT00976391|470906732|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
130803352|NCT00976391|470906731|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
130803353|NCT00976391|470906732|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
130803354|NCT00976391|470906731|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
130803355|NCT00976391|470906732|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
130803356|NCT00976391|470906731|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
130803357|NCT00976391|470906732|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
130803358|NCT00976391|470906731|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
130803359|NCT00976391|470906732|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
130803360|NCT00976391|470906731|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
130803361|NCT00976391|470906732|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
130803362|NCT00976391|470906731|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
130803363|NCT00976391|470906732|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
130803364|NCT00976391|470906731|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
130803365|NCT00976391|470906732|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
130803366|NCT00976391|470906731|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
130803367|NCT00976391|470906732|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
130803368|NCT00617903|470906733|FG000|Overall Study|Withdrawal by Subject|2|||
130803369|NCT00617903|470906734|FG001|Overall Study|Withdrawal by Subject|3|||
130803370|NCT00617903|470906733|FG000|Overall Study|Lost to Follow-up|1|||
130803371|NCT00617903|470906734|FG001|Overall Study|Lost to Follow-up|1|||
130803372|NCT00617903|470906733|FG000|Overall Study|Lack of Efficacy|0|||
130803373|NCT00617903|470906734|FG001|Overall Study|Lack of Efficacy|1|||
130803374|NCT00617903|470906733|FG000|Overall Study|Adverse Event|0|||
130803375|NCT00617903|470906734|FG001|Overall Study|Adverse Event|1|||
130803376|NCT00617903|470906733|FG000|Overall Study|noncompliance|0|||
130803377|NCT00617903|470906734|FG001|Overall Study|noncompliance|1|||
130803378|NCT04676646|470906735|FG000|Open-label Run-in Phase|Adverse Event|3|||
130803379|NCT04676646|470906736|FG001|Open-label Run-in Phase|Adverse Event|0|||
130803380|NCT04676646|470906737|FG002|Open-label Run-in Phase|Adverse Event|0|||
130803381|NCT04676646|470906735|FG000|Open-label Run-in Phase|Death|3|||
130803382|NCT04676646|470906736|FG001|Open-label Run-in Phase|Death|0|||
130803383|NCT04676646|470906737|FG002|Open-label Run-in Phase|Death|0|||
130803384|NCT04676646|470906735|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
130803385|NCT04676646|470906736|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
130803386|NCT04676646|470906737|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
130803387|NCT04676646|470906735|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
130803388|NCT04676646|470906736|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
130803389|NCT04676646|470906737|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
130803390|NCT04676646|470906735|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
130803391|NCT04676646|470906736|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
130803392|NCT04676646|470906737|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
130803393|NCT04676646|470906735|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
130803394|NCT04676646|470906736|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
130803395|NCT04676646|470906737|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
130803396|NCT04676646|470906735|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
130803397|NCT04676646|470906736|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
130803398|NCT04676646|470906737|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
130803399|NCT04676646|470906735|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
130803400|NCT04676646|470906736|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
130803401|NCT04676646|470906737|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
130803402|NCT04676646|470906735|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
130803403|NCT04676646|470906736|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
130803404|NCT04676646|470906737|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
130803405|NCT04676646|470906735|FG000|Randomised-withdrawal Phase|Death|0|||
130803406|NCT04676646|470906736|FG001|Randomised-withdrawal Phase|Death|1|||
130803407|NCT04676646|470906737|FG002|Randomised-withdrawal Phase|Death|2|||
130803408|NCT04676646|470906735|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
130803409|NCT04676646|470906736|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
130803410|NCT04676646|470906737|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
130803411|NCT04676646|470906735|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
130803412|NCT04676646|470906736|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
130803413|NCT04676646|470906737|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
130803414|NCT04676646|470906735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
130803415|NCT04676646|470906736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
130803416|NCT04676646|470906737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
130803417|NCT04676646|470906735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
130803418|NCT04676646|470906736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
130803419|NCT04676646|470906737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
130803420|NCT04676646|470906735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
130803421|NCT04676646|470906736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
130803422|NCT04676646|470906737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
130803423|NCT04676646|470906735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
130803424|NCT04676646|470906736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
130803425|NCT04676646|470906737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
130803426|NCT04676646|470906735|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
130803427|NCT04676646|470906736|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
130803428|NCT04676646|470906737|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
130803429|NCT05156125|470906738|FG000|Overall Study|Lack of Efficacy|1|||
130803430|NCT05156125|470906739|FG001|Overall Study|Lack of Efficacy|1|||
130803431|NCT05156125|470906740|FG002|Overall Study|Lack of Efficacy|1|||
130803432|NCT05156125|470906738|FG000|Overall Study|Physician Decision|0|||
130803433|NCT05156125|470906739|FG001|Overall Study|Physician Decision|0|||
130803434|NCT05156125|470906740|FG002|Overall Study|Physician Decision|1|||
130803435|NCT05156125|470906738|FG000|Overall Study|Non-compliance|0|||
130803436|NCT05156125|470906739|FG001|Overall Study|Non-compliance|1|||
130803437|NCT05156125|470906740|FG002|Overall Study|Non-compliance|1|||
130803438|NCT05156125|470906738|FG000|Overall Study|Withdrawal by Subject|0|||
130803439|NCT05156125|470906739|FG001|Overall Study|Withdrawal by Subject|0|||
130803440|NCT05156125|470906740|FG002|Overall Study|Withdrawal by Subject|1|||
130803441|NCT05156125|470906738|FG000|Overall Study|Adverse Event|2|||
130803442|NCT05156125|470906739|FG001|Overall Study|Adverse Event|1|||
130803443|NCT05156125|470906740|FG002|Overall Study|Adverse Event|0|||
130803444|NCT03123588|470906748|FG000|Overall Study|Study Terminated by Sponsor|2|||
130803445|NCT03123588|470906749|FG001|Overall Study|Study Terminated by Sponsor|5|||
130803446|NCT03123588|470906748|FG000|Overall Study|Withdrawal by Subject|1|||
130803447|NCT03123588|470906749|FG001|Overall Study|Withdrawal by Subject|0|||
130803448|NCT03123588|470906748|FG000|Overall Study|Adverse Event|1|||
130803449|NCT03123588|470906749|FG001|Overall Study|Adverse Event|0|||
130803450|NCT03123588|470906748|FG000|Overall Study|Physician Decision|2|||
130803451|NCT03123588|470906749|FG001|Overall Study|Physician Decision|1|||
130803452|NCT01058005|470906750|FG000|Overall Study|Adverse Event|0|||
130803453|NCT01058005|470906751|FG001|Overall Study|Adverse Event|2|||
130803454|NCT01058005|470906752|FG002|Overall Study|Adverse Event|1|||
130803455|NCT01058005|470906750|FG000|Overall Study|Physician Decision|2|||
130803456|NCT01058005|470906751|FG001|Overall Study|Physician Decision|2|||
130803457|NCT01058005|470906752|FG002|Overall Study|Physician Decision|0|||
130803458|NCT01058005|470906750|FG000|Overall Study|Withdrawal by Subject|4|||
130803459|NCT01058005|470906751|FG001|Overall Study|Withdrawal by Subject|5|||
130803460|NCT01058005|470906752|FG002|Overall Study|Withdrawal by Subject|11|||
130803461|NCT01058005|470906750|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
130803462|NCT01058005|470906751|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
130803463|NCT01058005|470906752|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
130803464|NCT01058005|470906750|FG000|Overall Study|Reason Missing|5|||
130803465|NCT01058005|470906751|FG001|Overall Study|Reason Missing|3|||
130803466|NCT01058005|470906752|FG002|Overall Study|Reason Missing|1|||
130803467|NCT02287025|470906753|FG000|Overall Study|Not treated|2|||
130803468|NCT02287025|470906754|FG001|Overall Study|Not treated|0|||
130803469|NCT02287025|470906753|FG000|Overall Study|Progression of disease|3|||
130803470|NCT02287025|470906754|FG001|Overall Study|Progression of disease|2|||
130803471|NCT02287025|470906753|FG000|Overall Study|Adverse Event|2|||
130803472|NCT02287025|470906754|FG001|Overall Study|Adverse Event|4|||
130803473|NCT02287025|470906753|FG000|Overall Study|Withdrawal by Subject|2|||
130803474|NCT02287025|470906754|FG001|Overall Study|Withdrawal by Subject|2|||
130803475|NCT02287025|470906753|FG000|Overall Study|Screening failed|1|||
130803476|NCT02287025|470906754|FG001|Overall Study|Screening failed|1|||
130803477|NCT04053452|470906755|FG000|Overall Study|Withdrawal by Subject|1|||
130803478|NCT04053452|470906756|FG001|Overall Study|Withdrawal by Subject|0|||
130803479|NCT04053452|470906755|FG000|Overall Study|Time restraint due to inpatient needs|1|||
130803480|NCT04053452|470906756|FG001|Overall Study|Time restraint due to inpatient needs|2|||
130803481|NCT01421134|470906757|FG000|Overall Study|Adverse Event|3|||
130803482|NCT01421134|470906758|FG001|Overall Study|Adverse Event|5|||
130803483|NCT01421134|470906757|FG000|Overall Study|Lack of Efficacy|2|||
130803484|NCT01421134|470906758|FG001|Overall Study|Lack of Efficacy|4|||
130803485|NCT01421134|470906757|FG000|Overall Study|Protocol Violation|0|||
130803486|NCT01421134|470906758|FG001|Overall Study|Protocol Violation|3|||
130803487|NCT01421134|470906757|FG000|Overall Study|Withdrawal by Subject|1|||
130803488|NCT01421134|470906758|FG001|Overall Study|Withdrawal by Subject|1|||
130803489|NCT01421134|470906757|FG000|Overall Study|Administrative|0|||
130803490|NCT01421134|470906758|FG001|Overall Study|Administrative|1|||
130803491|NCT01421134|470906757|FG000|Overall Study|Lost to Follow-up|1|||
130803492|NCT01421134|470906758|FG001|Overall Study|Lost to Follow-up|1|||
130803493|NCT02959892|470906759|FG000|Overall Study|PET tracer synthesis failure|1|||
130803494|NCT02959892|470906760|FG001|Overall Study|PET tracer synthesis failure|0|||
130803495|NCT02959892|470906759|FG000|Overall Study|Study termination|0|||
130803496|NCT02959892|470906760|FG001|Overall Study|Study termination|1|||
130803497|NCT00799864|470906764|FG000|Overall Study|Participant reached a virologic endpoint|9|||
130803498|NCT00799864|470906765|FG001|Overall Study|Participant reached a virologic endpoint|2|||
130803499|NCT00799864|470906766|FG002|Overall Study|Participant reached a virologic endpoint|2|||
130803500|NCT00799864|470906767|FG003|Overall Study|Participant reached a virologic endpoint|0|||
130803501|NCT00799864|470906768|FG004|Overall Study|Participant reached a virologic endpoint|0|||
130803502|NCT00799864|470906764|FG000|Overall Study|Other|2|||
130803503|NCT00799864|470906765|FG001|Overall Study|Other|1|||
130803504|NCT00799864|470906766|FG002|Overall Study|Other|0|||
130803505|NCT00799864|470906767|FG003|Overall Study|Other|0|||
130803506|NCT00799864|470906768|FG004|Overall Study|Other|0|||
130803507|NCT02346370|470906771|FG000|Overall Study|Not treated|1|||
130803508|NCT02346370|470906772|FG001|Overall Study|Not treated|0|||
130803509|NCT02346370|470906773|FG002|Overall Study|Not treated|0|||
130803510|NCT02346370|470906771|FG000|Overall Study|Withdrawal of consent|1|||
130803511|NCT02346370|470906772|FG001|Overall Study|Withdrawal of consent|0|||
130803512|NCT02346370|470906773|FG002|Overall Study|Withdrawal of consent|0|||
130803513|NCT02346370|470906771|FG000|Overall Study|Death|1|||
130803514|NCT02346370|470906772|FG001|Overall Study|Death|3|||
130803515|NCT02346370|470906773|FG002|Overall Study|Death|1|||
130803516|NCT02346370|470906771|FG000|Overall Study|Sponsor discontinued study|5|||
130803517|NCT02346370|470906772|FG001|Overall Study|Sponsor discontinued study|0|||
130803518|NCT02346370|470906773|FG002|Overall Study|Sponsor discontinued study|2|||
130803519|NCT02346370|470906771|FG000|Overall Study|Radiologic progression|0|||
130803520|NCT02346370|470906772|FG001|Overall Study|Radiologic progression|0|||
130803521|NCT02346370|470906773|FG002|Overall Study|Radiologic progression|1|||
130803522|NCT02346370|470906771|FG000|Overall Study|Physician Decision|0|||
130803523|NCT02346370|470906772|FG001|Overall Study|Physician Decision|1|||
130803524|NCT02346370|470906773|FG002|Overall Study|Physician Decision|0|||
130803525|NCT03528577|470906774|FG000|Sequence 1|Failed Spirometry|1|||
130803526|NCT03528577|470906774|FG000|Sequence 1|Restricted medication|1|||
130803527|NCT03528577|470906774|FG000|Sequence 2|Adverse Event|1|||
130803528|NCT03528577|470906774|FG000|Sequence 2|Withdrawal by Subject|1|||
130803529|NCT03528577|470906774|FG000|Sequence 2|Failed Spirometry|1|||
130803530|NCT03528577|470906774|FG000|Sequence 3|Failed Spirometry|1|||
130803531|NCT03528577|470906774|FG000|Sequence 4|Failed Spirometry|2|||
130803532|NCT03528577|470906774|FG000|Sequence 4|Adverse Event|1|||
130803533|NCT04882215|470906775|FG000|Overall Study|Withdrawal by Subject|5|||
130803534|NCT04882215|470906776|FG001|Overall Study|Withdrawal by Subject|0|||
130803535|NCT04263532|470906777|FG000|Overall Study|Withdrawal by Subject|2|||
130803536|NCT04263532|470906778|FG001|Overall Study|Withdrawal by Subject|0|||
130803537|NCT04098302|470906781|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
130803538|NCT04098302|470906782|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
130803539|NCT04098302|470906783|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
130803540|NCT04098302|470906784|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
130803541|NCT04098302|470906781|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
130803542|NCT04098302|470906782|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
130803543|NCT04098302|470906783|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
130803544|NCT04098302|470906784|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
130803545|NCT04098302|470906781|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
130803546|NCT04098302|470906782|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
130803547|NCT04098302|470906783|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
130803548|NCT04098302|470906784|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
130803549|NCT04098302|470906781|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
130803550|NCT04098302|470906782|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
130803551|NCT04098302|470906783|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
130803552|NCT04098302|470906784|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
130803553|NCT04098302|470906781|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
130803554|NCT04098302|470906782|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
130803555|NCT04098302|470906783|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
130803556|NCT04098302|470906784|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
130803557|NCT04098302|470906781|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
130803558|NCT04098302|470906782|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
130803559|NCT04098302|470906783|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
130803560|NCT04098302|470906784|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
130803561|NCT04098302|470906781|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
130803562|NCT04098302|470906782|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
130803563|NCT04098302|470906783|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
130803564|NCT04098302|470906784|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
130803565|NCT04098302|470906781|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
130803566|NCT04098302|470906782|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
130803567|NCT04098302|470906783|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
130803568|NCT04098302|470906784|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
130803569|NCT01290731|470906787|FG000|Overall Study|Withdrawal by Subject|1|||
130803570|NCT01399099|470906788|FG000|Overall Study|Lost to Follow-up|14|||
130803571|NCT01399099|470906788|FG000|Overall Study|Physician Decision|1|||
130803572|NCT01399099|470906788|FG000|Overall Study|Protocol Violation|1|||
130803573|NCT01399099|470906788|FG000|Overall Study|Skin Irritation|13|||
130803574|NCT01399099|470906788|FG000|Overall Study|Infection|1|||
130803575|NCT01399099|470906788|FG000|Overall Study|Miscellaneous|4|||
130803576|NCT01668537|470906789|FG000|Overall Study|Request to Discontinue Prematurely|1|||
130803577|NCT01668537|470906790|FG001|Overall Study|Request to Discontinue Prematurely|1|||
130803578|NCT01668537|470906789|FG000|Overall Study|Subject unwilling/unable to comply|5|||
130803579|NCT01668537|470906790|FG001|Overall Study|Subject unwilling/unable to comply|0|||
130803580|NCT01668537|470906789|FG000|Overall Study|Reason Precludes Participation|1|||
130803581|NCT01668537|470906790|FG001|Overall Study|Reason Precludes Participation|0|||
130803582|NCT01668537|470906789|FG000|Overall Study|Lost to Follow-up|13|||
130803583|NCT01668537|470906790|FG001|Overall Study|Lost to Follow-up|6|||
130803584|NCT01668537|470906789|FG000|Overall Study|Other|2|||
130803585|NCT01668537|470906790|FG001|Overall Study|Other|3|||
130803586|NCT05064800|470906791|FG000|Period 3|Withdrawal by Subject|0|||
130803587|NCT05064800|470906792|FG001|Period 3|Withdrawal by Subject|0|||
130803588|NCT05064800|470906793|FG002|Period 3|Withdrawal by Subject|0|||
130803589|NCT05064800|470906794|FG003|Period 3|Withdrawal by Subject|0|||
130803590|NCT05064800|470906795|FG004|Period 3|Withdrawal by Subject|1|||
130803591|NCT05064800|470906796|FG005|Period 3|Withdrawal by Subject|0|||
130803592|NCT04477486|470906797|FG000|Overall Study|Death|2|||
130803593|NCT04477486|470906797|FG000|Overall Study|Ongoing at Time of Analysis|11|||
130803594|NCT03364686|470906798|FG000|Overall Study|Physician Decision|2|||
130803595|NCT01936974|470906801|FG000|Overall Study|Physician Decision|2|||
130803596|NCT01936974|470906802|FG001|Overall Study|Physician Decision|5|||
130803597|NCT04584554|470906803|FG000|Overall Study|Withdrawal by Subject|2|||
130803598|NCT04584554|470906804|FG001|Overall Study|Withdrawal by Subject|2|||
130803599|NCT01078545|470906807|FG000|Overall Study|Lost to Follow-up|13|||
130803600|NCT01078545|470906807|FG000|Overall Study|Physician Decision|6|||
130803601|NCT01078545|470906807|FG000|Overall Study|Withdrawal by Subject|3|||
130803602|NCT01078545|470906807|FG000|Overall Study|Death|3|||
130803603|NCT01078545|470906807|FG000|Overall Study|Participant moved to another physician|1|||
130803604|NCT02497755|470906808|FG000|Overall Study|Protocol Violation|1|||
130803605|NCT02497755|470906809|FG001|Overall Study|Protocol Violation|0|||
130803606|NCT01774370|470906812|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
130803607|NCT01774370|470906812|FG000|Overall Study|Administered prior to the contract date|4|||
130803608|NCT01774370|470906812|FG000|Overall Study|Subjects of contraindications|34|||
130803609|NCT01774370|470906812|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
130803610|NCT01774370|470906812|FG000|Overall Study|Follow-up failure|34|||
130803611|NCT05436288|470906813|FG000|Overall Study|Lost to Follow-up|1|||
130803612|NCT05436288|470906813|FG000|Overall Study|Adverse Event|1|||
130803613|NCT01436500|470906817|FG000|Overall Study|Death|1|||
130803614|NCT01436500|470906818|FG001|Overall Study|Death|0|||
130803615|NCT01436500|470906819|FG002|Overall Study|Death|0|||
130803616|NCT01436500|470906820|FG003|Overall Study|Death|0|||
130803617|NCT01436500|470906821|FG004|Overall Study|Death|0|||
130803618|NCT01436500|470906817|FG000|Overall Study|Adverse Event|0|||
130803619|NCT01436500|470906818|FG001|Overall Study|Adverse Event|2|||
130803620|NCT01436500|470906819|FG002|Overall Study|Adverse Event|2|||
130803621|NCT01436500|470906820|FG003|Overall Study|Adverse Event|0|||
130803622|NCT01436500|470906821|FG004|Overall Study|Adverse Event|1|||
130803623|NCT01436500|470906817|FG000|Overall Study|Withdrawal by Subject|0|||
130803624|NCT01436500|470906818|FG001|Overall Study|Withdrawal by Subject|0|||
130803625|NCT01436500|470906819|FG002|Overall Study|Withdrawal by Subject|2|||
130803626|NCT01436500|470906820|FG003|Overall Study|Withdrawal by Subject|0|||
130803627|NCT01436500|470906821|FG004|Overall Study|Withdrawal by Subject|2|||
130803628|NCT01436500|470906817|FG000|Overall Study|Physician Decision|0|||
130803629|NCT01436500|470906818|FG001|Overall Study|Physician Decision|0|||
130803630|NCT01436500|470906819|FG002|Overall Study|Physician Decision|1|||
130803631|NCT01436500|470906820|FG003|Overall Study|Physician Decision|0|||
130803632|NCT01436500|470906821|FG004|Overall Study|Physician Decision|0|||
130803633|NCT01436500|470906817|FG000|Overall Study|liver transplant|1|||
130803634|NCT01436500|470906818|FG001|Overall Study|liver transplant|0|||
130803635|NCT01436500|470906819|FG002|Overall Study|liver transplant|0|||
130803636|NCT01436500|470906820|FG003|Overall Study|liver transplant|0|||
130803637|NCT01436500|470906821|FG004|Overall Study|liver transplant|0|||
130803638|NCT01436500|470906817|FG000|Overall Study|initiation of dialysis|0|||
130803639|NCT01436500|470906818|FG001|Overall Study|initiation of dialysis|0|||
130803640|NCT01436500|470906819|FG002|Overall Study|initiation of dialysis|0|||
130803641|NCT01436500|470906820|FG003|Overall Study|initiation of dialysis|0|||
130803642|NCT01436500|470906821|FG004|Overall Study|initiation of dialysis|1|||
130803643|NCT01436500|470906817|FG000|Overall Study|discontinued study drug|1|||
130803644|NCT01436500|470906818|FG001|Overall Study|discontinued study drug|0|||
130803645|NCT01436500|470906819|FG002|Overall Study|discontinued study drug|0|||
130803646|NCT01436500|470906820|FG003|Overall Study|discontinued study drug|0|||
130803647|NCT01436500|470906821|FG004|Overall Study|discontinued study drug|0|||
130803648|NCT01436500|470906817|FG000|Overall Study|Other|0|||
130803649|NCT01436500|470906818|FG001|Overall Study|Other|1|||
130803650|NCT01436500|470906819|FG002|Overall Study|Other|0|||
130803651|NCT01436500|470906820|FG003|Overall Study|Other|1|||
130803652|NCT01436500|470906821|FG004|Overall Study|Other|0|||
130803653|NCT01487161|470906823|FG000|Overall Study|Adverse Event|1|||
130803654|NCT01487161|470906824|FG001|Overall Study|Adverse Event|0|||
130803655|NCT01487161|470906825|FG002|Overall Study|Adverse Event|0|||
130803656|NCT01487161|470906826|FG003|Overall Study|Adverse Event|0|||
130803657|NCT01487161|470906823|FG000|Overall Study|Withdrawal by Subject|1|||
130803658|NCT01487161|470906824|FG001|Overall Study|Withdrawal by Subject|1|||
130803659|NCT01487161|470906825|FG002|Overall Study|Withdrawal by Subject|1|||
130803660|NCT01487161|470906826|FG003|Overall Study|Withdrawal by Subject|2|||
130803661|NCT01487161|470906823|FG000|Overall Study|missing data|0|||
130803662|NCT01487161|470906824|FG001|Overall Study|missing data|1|||
130803663|NCT01487161|470906825|FG002|Overall Study|missing data|0|||
130803664|NCT01487161|470906826|FG003|Overall Study|missing data|0|||
130803665|NCT02675452|470906830|FG000|Overall Study|Sponsor decision|0|||
130803666|NCT02675452|470906831|FG001|Overall Study|Sponsor decision|0|||
130803667|NCT02675452|470906832|FG002|Overall Study|Sponsor decision|0|||
130803668|NCT02675452|470906833|FG003|Overall Study|Sponsor decision|0|||
130803669|NCT02675452|470906834|FG004|Overall Study|Sponsor decision|0|||
130803670|NCT02675452|470906835|FG005|Overall Study|Sponsor decision|0|||
130803671|NCT02675452|470906836|FG006|Overall Study|Sponsor decision|0|||
130803672|NCT02675452|470906837|FG007|Overall Study|Sponsor decision|0|||
130803673|NCT02675452|470906838|FG008|Overall Study|Sponsor decision|0|||
130803674|NCT02675452|470906839|FG009|Overall Study|Sponsor decision|1|||
130803675|NCT02675452|470906840|FG010|Overall Study|Sponsor decision|0|||
130803676|NCT02675452|470906841|FG011|Overall Study|Sponsor decision|0|||
130803677|NCT02675452|470906842|FG012|Overall Study|Sponsor decision|0|||
130803678|NCT02675452|470906843|FG013|Overall Study|Sponsor decision|2|||
130803679|NCT02675452|470906844|FG014|Overall Study|Sponsor decision|1|||
130803680|NCT02675452|470906845|FG015|Overall Study|Sponsor decision|0|||
130803681|NCT02675452|470906846|FG016|Overall Study|Sponsor decision|1|||
130803682|NCT02675452|470906847|FG017|Overall Study|Sponsor decision|0|||
130803683|NCT02675452|470906848|FG018|Overall Study|Sponsor decision|0|||
130803684|NCT02675452|470906849|FG019|Overall Study|Sponsor decision|0|||
130803685|NCT02675452|470906850|FG020|Overall Study|Sponsor decision|0|||
130803686|NCT02675452|470906851|FG021|Overall Study|Sponsor decision|0|||
130803687|NCT02675452|470906852|FG022|Overall Study|Sponsor decision|0|||
130803688|NCT02675452|470906853|FG023|Overall Study|Sponsor decision|0|||
130803689|NCT02675452|470906854|FG024|Overall Study|Sponsor decision|0|||
130803690|NCT02675452|470906855|FG025|Overall Study|Sponsor decision|0|||
130803691|NCT02675452|470906856|FG026|Overall Study|Sponsor decision|2|||
130803692|NCT02675452|470906857|FG027|Overall Study|Sponsor decision|0|||
130803693|NCT02675452|470906858|FG028|Overall Study|Sponsor decision|0|||
130803694|NCT02675452|470906830|FG000|Overall Study|Withdrawal by Subject|0|||
130803695|NCT02675452|470906831|FG001|Overall Study|Withdrawal by Subject|0|||
130803696|NCT02675452|470906832|FG002|Overall Study|Withdrawal by Subject|0|||
130803697|NCT02675452|470906833|FG003|Overall Study|Withdrawal by Subject|0|||
130803698|NCT02675452|470906834|FG004|Overall Study|Withdrawal by Subject|0|||
130803699|NCT02675452|470906835|FG005|Overall Study|Withdrawal by Subject|0|||
130803700|NCT02675452|470906836|FG006|Overall Study|Withdrawal by Subject|0|||
130803701|NCT02675452|470906837|FG007|Overall Study|Withdrawal by Subject|0|||
130803702|NCT02675452|470906838|FG008|Overall Study|Withdrawal by Subject|0|||
130803703|NCT02675452|470906839|FG009|Overall Study|Withdrawal by Subject|1|||
130803704|NCT02675452|470906840|FG010|Overall Study|Withdrawal by Subject|0|||
130803705|NCT02675452|470906841|FG011|Overall Study|Withdrawal by Subject|1|||
130803706|NCT02675452|470906842|FG012|Overall Study|Withdrawal by Subject|0|||
130803707|NCT02675452|470906843|FG013|Overall Study|Withdrawal by Subject|1|||
130803708|NCT02675452|470906844|FG014|Overall Study|Withdrawal by Subject|1|||
130803709|NCT02675452|470906845|FG015|Overall Study|Withdrawal by Subject|0|||
130803710|NCT02675452|470906846|FG016|Overall Study|Withdrawal by Subject|2|||
130803711|NCT02675452|470906847|FG017|Overall Study|Withdrawal by Subject|0|||
130803712|NCT02675452|470906848|FG018|Overall Study|Withdrawal by Subject|0|||
130803713|NCT02675452|470906849|FG019|Overall Study|Withdrawal by Subject|0|||
130803714|NCT02675452|470906850|FG020|Overall Study|Withdrawal by Subject|0|||
130803715|NCT02675452|470906851|FG021|Overall Study|Withdrawal by Subject|0|||
130803716|NCT02675452|470906852|FG022|Overall Study|Withdrawal by Subject|3|||
130803717|NCT02675452|470906853|FG023|Overall Study|Withdrawal by Subject|0|||
130803718|NCT02675452|470906854|FG024|Overall Study|Withdrawal by Subject|1|||
130803719|NCT02675452|470906855|FG025|Overall Study|Withdrawal by Subject|0|||
130803720|NCT02675452|470906856|FG026|Overall Study|Withdrawal by Subject|1|||
130803721|NCT02675452|470906857|FG027|Overall Study|Withdrawal by Subject|3|||
130803722|NCT02675452|470906858|FG028|Overall Study|Withdrawal by Subject|4|||
130803723|NCT02675452|470906830|FG000|Overall Study|Death|0|||
130803724|NCT02675452|470906831|FG001|Overall Study|Death|0|||
130803725|NCT02675452|470906832|FG002|Overall Study|Death|1|||
130803726|NCT02675452|470906833|FG003|Overall Study|Death|0|||
130803727|NCT02675452|470906834|FG004|Overall Study|Death|0|||
130803728|NCT02675452|470906835|FG005|Overall Study|Death|1|||
130803729|NCT02675452|470906836|FG006|Overall Study|Death|0|||
130803730|NCT02675452|470906837|FG007|Overall Study|Death|0|||
130803731|NCT02675452|470906838|FG008|Overall Study|Death|1|||
130803732|NCT02675452|470906839|FG009|Overall Study|Death|0|||
130803733|NCT02675452|470906840|FG010|Overall Study|Death|0|||
130803734|NCT02675452|470906841|FG011|Overall Study|Death|0|||
130803735|NCT02675452|470906842|FG012|Overall Study|Death|1|||
130803736|NCT02675452|470906843|FG013|Overall Study|Death|0|||
130803737|NCT02675452|470906844|FG014|Overall Study|Death|0|||
130803738|NCT02675452|470906845|FG015|Overall Study|Death|2|||
130803739|NCT02675452|470906846|FG016|Overall Study|Death|0|||
130803740|NCT02675452|470906847|FG017|Overall Study|Death|0|||
130803741|NCT02675452|470906848|FG018|Overall Study|Death|4|||
130803742|NCT02675452|470906849|FG019|Overall Study|Death|3|||
130803743|NCT02675452|470906850|FG020|Overall Study|Death|3|||
130803744|NCT02675452|470906851|FG021|Overall Study|Death|3|||
130803745|NCT02675452|470906852|FG022|Overall Study|Death|7|||
130803746|NCT02675452|470906853|FG023|Overall Study|Death|5|||
130803747|NCT02675452|470906854|FG024|Overall Study|Death|3|||
130803748|NCT02675452|470906855|FG025|Overall Study|Death|4|||
130803749|NCT02675452|470906856|FG026|Overall Study|Death|7|||
130803750|NCT02675452|470906857|FG027|Overall Study|Death|6|||
130803751|NCT02675452|470906858|FG028|Overall Study|Death|9|||
130803752|NCT02675452|470906830|FG000|Overall Study|Lost to Follow-up|0|||
130803753|NCT02675452|470906831|FG001|Overall Study|Lost to Follow-up|1|||
130803754|NCT02675452|470906832|FG002|Overall Study|Lost to Follow-up|0|||
130803755|NCT02675452|470906833|FG003|Overall Study|Lost to Follow-up|0|||
130803756|NCT02675452|470906834|FG004|Overall Study|Lost to Follow-up|0|||
130803757|NCT02675452|470906835|FG005|Overall Study|Lost to Follow-up|0|||
130803758|NCT02675452|470906836|FG006|Overall Study|Lost to Follow-up|0|||
130803759|NCT02675452|470906837|FG007|Overall Study|Lost to Follow-up|0|||
130803760|NCT02675452|470906838|FG008|Overall Study|Lost to Follow-up|0|||
130803761|NCT02675452|470906839|FG009|Overall Study|Lost to Follow-up|0|||
130803762|NCT02675452|470906840|FG010|Overall Study|Lost to Follow-up|0|||
130803763|NCT02675452|470906841|FG011|Overall Study|Lost to Follow-up|0|||
130803764|NCT02675452|470906842|FG012|Overall Study|Lost to Follow-up|1|||
130803765|NCT02675452|470906843|FG013|Overall Study|Lost to Follow-up|0|||
130803766|NCT02675452|470906844|FG014|Overall Study|Lost to Follow-up|0|||
130803767|NCT02675452|470906845|FG015|Overall Study|Lost to Follow-up|0|||
130803768|NCT02675452|470906846|FG016|Overall Study|Lost to Follow-up|0|||
130803769|NCT02675452|470906847|FG017|Overall Study|Lost to Follow-up|0|||
130803770|NCT02675452|470906848|FG018|Overall Study|Lost to Follow-up|0|||
130803771|NCT02675452|470906849|FG019|Overall Study|Lost to Follow-up|0|||
130803772|NCT02675452|470906850|FG020|Overall Study|Lost to Follow-up|0|||
130803773|NCT02675452|470906851|FG021|Overall Study|Lost to Follow-up|0|||
130803774|NCT02675452|470906852|FG022|Overall Study|Lost to Follow-up|0|||
130803775|NCT02675452|470906853|FG023|Overall Study|Lost to Follow-up|0|||
130803776|NCT02675452|470906854|FG024|Overall Study|Lost to Follow-up|0|||
130803777|NCT02675452|470906855|FG025|Overall Study|Lost to Follow-up|0|||
130803778|NCT02675452|470906856|FG026|Overall Study|Lost to Follow-up|1|||
130803779|NCT02675452|470906857|FG027|Overall Study|Lost to Follow-up|0|||
130803780|NCT02675452|470906858|FG028|Overall Study|Lost to Follow-up|0|||
130803781|NCT02675452|470906830|FG000|Overall Study|Other|0|||
130803782|NCT02675452|470906831|FG001|Overall Study|Other|0|||
130803783|NCT02675452|470906832|FG002|Overall Study|Other|0|||
130803784|NCT02675452|470906833|FG003|Overall Study|Other|0|||
130803785|NCT02675452|470906834|FG004|Overall Study|Other|0|||
130803786|NCT02675452|470906835|FG005|Overall Study|Other|0|||
130803787|NCT02675452|470906836|FG006|Overall Study|Other|0|||
130803788|NCT02675452|470906837|FG007|Overall Study|Other|0|||
130803789|NCT02675452|470906838|FG008|Overall Study|Other|0|||
130803790|NCT02675452|470906839|FG009|Overall Study|Other|0|||
130803791|NCT02675452|470906840|FG010|Overall Study|Other|0|||
130803792|NCT02675452|470906841|FG011|Overall Study|Other|0|||
130803793|NCT02675452|470906842|FG012|Overall Study|Other|0|||
130803794|NCT02675452|470906843|FG013|Overall Study|Other|0|||
130803795|NCT02675452|470906844|FG014|Overall Study|Other|0|||
130803796|NCT02675452|470906845|FG015|Overall Study|Other|0|||
130803797|NCT02675452|470906846|FG016|Overall Study|Other|0|||
130803798|NCT02675452|470906847|FG017|Overall Study|Other|0|||
130803799|NCT02675452|470906848|FG018|Overall Study|Other|0|||
130803800|NCT02675452|470906849|FG019|Overall Study|Other|0|||
130803801|NCT02675452|470906850|FG020|Overall Study|Other|0|||
130803802|NCT02675452|470906851|FG021|Overall Study|Other|0|||
130803803|NCT02675452|470906852|FG022|Overall Study|Other|0|||
130803804|NCT02675452|470906853|FG023|Overall Study|Other|0|||
130803805|NCT02675452|470906854|FG024|Overall Study|Other|0|||
130803806|NCT02675452|470906855|FG025|Overall Study|Other|0|||
130803807|NCT02675452|470906856|FG026|Overall Study|Other|1|||
130803808|NCT02675452|470906857|FG027|Overall Study|Other|0|||
130803809|NCT02675452|470906858|FG028|Overall Study|Other|0|||
130803810|NCT00541775|470906859|FG000|Overall Study|Adverse Event|3|||
130803811|NCT00541775|470906860|FG001|Overall Study|Adverse Event|2|||
130803812|NCT00541775|470906861|FG002|Overall Study|Adverse Event|1|||
130803813|NCT00541775|470906859|FG000|Overall Study|Lack of Efficacy|0|||
130803814|NCT00541775|470906860|FG001|Overall Study|Lack of Efficacy|0|||
130803815|NCT00541775|470906861|FG002|Overall Study|Lack of Efficacy|3|||
130803816|NCT00541775|470906859|FG000|Overall Study|Lost to Follow-up|0|||
130803817|NCT00541775|470906860|FG001|Overall Study|Lost to Follow-up|0|||
130803818|NCT00541775|470906861|FG002|Overall Study|Lost to Follow-up|2|||
130803819|NCT00541775|470906859|FG000|Overall Study|Protocol Violation|1|||
130803820|NCT00541775|470906860|FG001|Overall Study|Protocol Violation|0|||
130803821|NCT00541775|470906861|FG002|Overall Study|Protocol Violation|0|||
130803822|NCT00541775|470906859|FG000|Overall Study|Withdrawal by Subject and Other|5|||
130803823|NCT00541775|470906860|FG001|Overall Study|Withdrawal by Subject and Other|0|||
130803824|NCT00541775|470906861|FG002|Overall Study|Withdrawal by Subject and Other|2|||
130803825|NCT02939781|470906862|FG000|Overall Study|Protocol Violation|8|||
130803826|NCT02939781|470906862|FG000|Overall Study|Withdrawal by Subject|1|||
130803827|NCT00032487|470906863|FG000|Overall Study|Withdrawal by Subject|67|||
130803828|NCT00032487|470906864|FG001|Overall Study|Withdrawal by Subject|43|||
130803829|NCT00032487|470906863|FG000|Overall Study|Adverse Event|3|||
130803830|NCT00032487|470906864|FG001|Overall Study|Adverse Event|7|||
130803831|NCT00032487|470906863|FG000|Overall Study|Lost to Follow-up|57|||
130803832|NCT00032487|470906864|FG001|Overall Study|Lost to Follow-up|58|||
130803833|NCT00032487|470906863|FG000|Overall Study|Had other reason|12|||
130803834|NCT00032487|470906864|FG001|Overall Study|Had other reason|12|||
130803835|NCT00689052|470906866|FG000|Overall Study|Adverse Event|4|||
130803836|NCT00689052|470906867|FG001|Overall Study|Adverse Event|6|||
130803837|NCT00689052|470906866|FG000|Overall Study|Protocol Violation|1|||
130803838|NCT00689052|470906867|FG001|Overall Study|Protocol Violation|0|||
130803839|NCT00689052|470906866|FG000|Overall Study|Lost to Follow-up|2|||
130803840|NCT00689052|470906867|FG001|Overall Study|Lost to Follow-up|0|||
130803841|NCT00689052|470906866|FG000|Overall Study|Withdrawal by Subject|2|||
130803842|NCT00689052|470906867|FG001|Overall Study|Withdrawal by Subject|0|||
130803843|NCT00689052|470906866|FG000|Overall Study|Early termination of the trial|22|||
130803844|NCT00689052|470906867|FG001|Overall Study|Early termination of the trial|24|||
130803845|NCT02569242|470906868|FG000|Overall Study|Death|1|||
130803846|NCT02569242|470906869|FG001|Overall Study|Death|0|||
130803847|NCT02569242|470906868|FG000|Overall Study|Withdrawal by Subject|0|||
130803848|NCT02569242|470906869|FG001|Overall Study|Withdrawal by Subject|1|||
130803849|NCT03003468|470906870|FG000|Overall Study|Withdrawal by Subject|0|||
130803850|NCT03003468|470906871|FG001|Overall Study|Withdrawal by Subject|0|||
130803851|NCT03003468|470906872|FG002|Overall Study|Withdrawal by Subject|1|||
130803852|NCT03003468|470906870|FG000|Overall Study|No measurable lesions|0|||
130803853|NCT03003468|470906871|FG001|Overall Study|No measurable lesions|0|||
130803854|NCT03003468|470906872|FG002|Overall Study|No measurable lesions|1|||
130803855|NCT03259308|470906880|FG000|Overall Study|Adverse Event|5|||
130803856|NCT03259308|470906881|FG001|Overall Study|Adverse Event|4|||
130803857|NCT03259308|470906882|FG002|Overall Study|Adverse Event|1|||
130803858|NCT03259308|470906880|FG000|Overall Study|Withdrawal by Subject|2|||
130803859|NCT03259308|470906881|FG001|Overall Study|Withdrawal by Subject|1|||
130803860|NCT03259308|470906882|FG002|Overall Study|Withdrawal by Subject|3|||
130803861|NCT03259308|470906880|FG000|Overall Study|Lost to Follow-up|0|||
130803862|NCT03259308|470906881|FG001|Overall Study|Lost to Follow-up|0|||
130803863|NCT03259308|470906882|FG002|Overall Study|Lost to Follow-up|1|||
130803864|NCT03259308|470906880|FG000|Overall Study|Pregnancy|0|||
130803865|NCT03259308|470906881|FG001|Overall Study|Pregnancy|0|||
130803866|NCT03259308|470906882|FG002|Overall Study|Pregnancy|1|||
130803867|NCT03259308|470906880|FG000|Overall Study|Protocol Deviation|0|||
130803868|NCT03259308|470906881|FG001|Overall Study|Protocol Deviation|3|||
130803869|NCT03259308|470906882|FG002|Overall Study|Protocol Deviation|0|||
130803870|NCT03259308|470906880|FG000|Overall Study|Lack of Efficacy|0|||
130803871|NCT03259308|470906881|FG001|Overall Study|Lack of Efficacy|0|||
130803872|NCT03259308|470906882|FG002|Overall Study|Lack of Efficacy|1|||
130803873|NCT01727154|470906883|FG000|Overall Study|Death|17|||
130803874|NCT01727154|470906883|FG000|Overall Study|Withdrawal by Subject|14|||
130803875|NCT01727154|470906883|FG000|Overall Study|Subject Withdrew Consent|18|||
130803876|NCT01727154|470906883|FG000|Overall Study|Study Terminated|6|||
130803877|NCT01727154|470906883|FG000|Overall Study|No Discontinuation Documentation|4|||
130803878|NCT00003474|470906884|FG000|Overall Study|Not Evaluable|14|||
130803879|NCT06025695|470906885|FG000|Overall Study|Adverse Event|5|||
130803880|NCT06025695|470906886|FG001|Overall Study|Adverse Event|6|||
130803881|NCT06025695|470906885|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
130803882|NCT06025695|470906886|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
130803883|NCT06025695|470906885|FG000|Overall Study|Other|23|||
130803884|NCT06025695|470906886|FG001|Overall Study|Other|19|||
130803885|NCT06025695|470906885|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
130803886|NCT06025695|470906886|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
130803887|NCT03834883|470906887|FG000|Second Treatment|Withdrawal by Subject|1|||
130803888|NCT03834883|470906888|FG001|Second Treatment|Withdrawal by Subject|0|||
130803889|NCT03834883|470906889|FG002|Second Treatment|Withdrawal by Subject|0|||
130803890|NCT03834883|470906890|FG003|Second Treatment|Withdrawal by Subject|0|||
130803891|NCT03834883|470906887|FG000|Second Treatment|COVID-19 pandemic|1|||
130803892|NCT03834883|470906888|FG001|Second Treatment|COVID-19 pandemic|0|||
130803893|NCT03834883|470906889|FG002|Second Treatment|COVID-19 pandemic|1|||
130803894|NCT03834883|470906890|FG003|Second Treatment|COVID-19 pandemic|1|||
130803895|NCT05206604|470908626|FG000|Overall Study|Non-compliance with study drug|0|||
130803896|NCT05206604|470908627|FG001|Overall Study|Non-compliance with study drug|0|||
130803897|NCT05206604|470908628|FG002|Overall Study|Non-compliance with study drug|0|||
130803898|NCT05206604|470908629|FG003|Overall Study|Non-compliance with study drug|0|||
130803899|NCT05206604|470908630|FG004|Overall Study|Non-compliance with study drug|0|||
130803900|NCT05206604|470908631|FG005|Overall Study|Non-compliance with study drug|1|||
130803901|NCT05206604|470908632|FG006|Overall Study|Non-compliance with study drug|0|||
130803902|NCT05206604|470908633|FG007|Overall Study|Non-compliance with study drug|0|||
130803903|NCT03735498|470908634|FG000|Overall Study|Withdrawal by Subject|3|||
130803904|NCT03735498|470908634|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
130803905|NCT02014103|470908636|FG000|Overall Study|Protocol Violation|7|||
130803906|NCT02014103|470908637|FG001|Overall Study|Protocol Violation|7|||
130803907|NCT02014103|470908636|FG000|Overall Study|Adverse Event|1|||
130803908|NCT02014103|470908637|FG001|Overall Study|Adverse Event|0|||
130803909|NCT02014103|470908636|FG000|Overall Study|Lost venous access|1|||
130803910|NCT02014103|470908637|FG001|Overall Study|Lost venous access|0|||
130803911|NCT02014103|470908636|FG000|Overall Study|Withdrawal by Subject|0|||
130803912|NCT02014103|470908637|FG001|Overall Study|Withdrawal by Subject|2|||
130803913|NCT04289298|470908639|FG000|Overall Study|Lost to Follow-up|5|||
130803914|NCT04289298|470908640|FG001|Overall Study|Lost to Follow-up|0|||
130803915|NCT04289298|470908639|FG000|Overall Study|Withdrawal by Subject|2|||
130803916|NCT04289298|470908640|FG001|Overall Study|Withdrawal by Subject|0|||
130803917|NCT00620035|470908641|FG000|Overall Study|Adverse Event|106|||
130803918|NCT00620035|470908641|FG000|Overall Study|Withdrawal of Informed Consent|1|||
130803919|NCT00620035|470908641|FG000|Overall Study|Other Reason|38|||
130803920|NCT01629563|470908643|FG000|Overall Study|Adverse Event|16|||
130803921|NCT01629563|470908644|FG001|Overall Study|Adverse Event|16|||
130803922|NCT01629563|470908643|FG000|Overall Study|Death|2|||
130803923|NCT01629563|470908644|FG001|Overall Study|Death|0|||
130803924|NCT01629563|470908643|FG000|Overall Study|Lack of Efficacy|2|||
130803925|NCT01629563|470908644|FG001|Overall Study|Lack of Efficacy|3|||
130803926|NCT01629563|470908643|FG000|Overall Study|Lost to Follow-up|1|||
130803927|NCT01629563|470908644|FG001|Overall Study|Lost to Follow-up|0|||
130803928|NCT01629563|470908643|FG000|Overall Study|Pregnancy|1|||
130803929|NCT01629563|470908644|FG001|Overall Study|Pregnancy|2|||
130803930|NCT01629563|470908643|FG000|Overall Study|Protocol Violation|0|||
130803931|NCT01629563|470908644|FG001|Overall Study|Protocol Violation|1|||
130803932|NCT01629563|470908643|FG000|Overall Study|Withdrawal by Subject|27|||
130803933|NCT01629563|470908644|FG001|Overall Study|Withdrawal by Subject|20|||
130803934|NCT01629563|470908643|FG000|Overall Study|surgery|0|||
130803935|NCT01629563|470908644|FG001|Overall Study|surgery|3|||
130803936|NCT01629563|470908643|FG000|Overall Study|Lack of return of menses|12|||
130803937|NCT01629563|470908644|FG001|Overall Study|Lack of return of menses|7|||
130803938|NCT01629563|470908643|FG000|Overall Study|Protocol Violation|0|||
130803939|NCT01629563|470908644|FG001|Overall Study|Protocol Violation|1|||
130803940|NCT01108796|470908646|FG000|Overall Study|Adverse Event|0|||
130803941|NCT01108796|470908647|FG001|Overall Study|Adverse Event|1|||
130803942|NCT01108796|470908646|FG000|Overall Study|Lost to Follow-up|7|||
130803943|NCT01108796|470908647|FG001|Overall Study|Lost to Follow-up|6|||
130803944|NCT00454142|470908648|FG000|Overall Study|Withdrawal by Subject|1|||
130803945|NCT02545127|470908652|FG000|Overall Study|Lost to Follow-up|1|||
130803946|NCT02545127|470908653|FG001|Overall Study|Lost to Follow-up|0|||
130803947|NCT01245751|470908654|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
130803948|NCT01245751|470908655|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
130803949|NCT01245751|470908656|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
130803950|NCT01245751|470908657|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
130803951|NCT01245751|470908654|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
130803952|NCT01245751|470908655|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
130803953|NCT01245751|470908656|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
130803954|NCT01245751|470908657|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
130803955|NCT01245751|470908654|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
130803956|NCT01245751|470908655|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
130803957|NCT01245751|470908656|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
130803958|NCT01245751|470908657|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
130803959|NCT02802865|470908658|FG000|Overall Study|Pregnancy|1|||
130803960|NCT02802865|470908659|FG001|Overall Study|Pregnancy|1|||
130803961|NCT02802865|470908658|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
130803962|NCT02802865|470908659|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
130803963|NCT01783015|470908660|FG000|Blinded Treatment|Adverse Event|0|||
130803964|NCT01783015|470908661|FG001|Blinded Treatment|Adverse Event|1|||
130803965|NCT01783015|470908662|FG002|Blinded Treatment|Adverse Event|0|||
130803966|NCT01783015|470908660|FG000|Blinded Treatment|Protocol Violation|0|||
130803967|NCT01783015|470908661|FG001|Blinded Treatment|Protocol Violation|1|||
130803968|NCT01783015|470908662|FG002|Blinded Treatment|Protocol Violation|0|||
130803969|NCT01783015|470908660|FG000|Blinded Treatment|Withdrawal by Subject|0|||
130803970|NCT01783015|470908661|FG001|Blinded Treatment|Withdrawal by Subject|1|||
130803971|NCT01783015|470908662|FG002|Blinded Treatment|Withdrawal by Subject|0|||
130803972|NCT01783015|470908660|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
130803973|NCT01783015|470908661|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
130803974|NCT01783015|470908662|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
130803975|NCT01783015|470908660|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
130803976|NCT01783015|470908661|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
130803977|NCT01783015|470908662|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
130803978|NCT00509600|470908663|FG000|Overall Study|Adverse Event|1|||
130803979|NCT02930941|470908665|FG000|Overall Study|Lost to Follow-up|1|||
130803980|NCT02930941|470908666|FG001|Overall Study|Lost to Follow-up|2|||
130803981|NCT00289978|470908667|FG000|Overall Study|Withdrawal by Subject|31|||
130803982|NCT00289978|470908668|FG001|Overall Study|Withdrawal by Subject|17|||
130803983|NCT00289978|470908669|FG002|Overall Study|Withdrawal by Subject|28|||
130803984|NCT00289978|470908667|FG000|Overall Study|Adverse Event|22|||
130803985|NCT00289978|470908668|FG001|Overall Study|Adverse Event|13|||
130803986|NCT00289978|470908669|FG002|Overall Study|Adverse Event|18|||
130803987|NCT00289978|470908667|FG000|Overall Study|Lack of Efficacy|13|||
130803988|NCT00289978|470908668|FG001|Overall Study|Lack of Efficacy|6|||
130803989|NCT00289978|470908669|FG002|Overall Study|Lack of Efficacy|25|||
130803990|NCT00289978|470908667|FG000|Overall Study|Abnormal laboratory value(s)|20|||
130803991|NCT00289978|470908668|FG001|Overall Study|Abnormal laboratory value(s)|9|||
130803992|NCT00289978|470908669|FG002|Overall Study|Abnormal laboratory value(s)|1|||
130803993|NCT00289978|470908667|FG000|Overall Study|Lost to Follow-up|3|||
130803994|NCT00289978|470908668|FG001|Overall Study|Lost to Follow-up|5|||
130803995|NCT00289978|470908669|FG002|Overall Study|Lost to Follow-up|7|||
130803996|NCT00289978|470908667|FG000|Overall Study|Protocol Violation|5|||
130803997|NCT00289978|470908668|FG001|Overall Study|Protocol Violation|5|||
130803998|NCT00289978|470908669|FG002|Overall Study|Protocol Violation|4|||
130803999|NCT00289978|470908667|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130804000|NCT00289978|470908668|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130804001|NCT00289978|470908669|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130804002|NCT00289978|470908667|FG000|Overall Study|Death|1|||
130804003|NCT00289978|470908668|FG001|Overall Study|Death|0|||
130804004|NCT00289978|470908669|FG002|Overall Study|Death|2|||
130804005|NCT00720083|470908672|FG000|Overall Study|Ineligible|1|||
130804006|NCT00720083|470908673|FG001|Overall Study|Ineligible|2|||
130804007|NCT01967277|470908674|FG000|Overall Study|Lost to Follow-up|1|||
130804008|NCT01967277|470908675|FG001|Overall Study|Lost to Follow-up|2|||
130804009|NCT01967277|470908674|FG000|Overall Study|Unrelated illness|0|||
130804010|NCT01967277|470908675|FG001|Overall Study|Unrelated illness|1|||
130804011|NCT00103506|470908679|FG000|Overall Study|Study closed by sponsor|34|||
130804012|NCT00103506|470908680|FG001|Overall Study|Study closed by sponsor|37|||
130804013|NCT00103506|470908679|FG000|Overall Study|Death|257|||
130804014|NCT00103506|470908680|FG001|Overall Study|Death|253|||
130804015|NCT00103506|470908679|FG000|Overall Study|Lost to Follow-up|13|||
130804016|NCT00103506|470908680|FG001|Overall Study|Lost to Follow-up|13|||
130804017|NCT00103506|470908679|FG000|Overall Study|Withdrawal by Subject|18|||
130804018|NCT00103506|470908680|FG001|Overall Study|Withdrawal by Subject|21|||
130804019|NCT00585585|470908681|FG000|Overall Study|Adverse Event|1|||
130804020|NCT00585169|470908682|FG000|Overall Study|Withdrawal by Subject|1|||
130804021|NCT00710970|470908685|FG000|Overall Study|Never took drug|3|||
130804022|NCT01028560|470908686|FG000|Overall Study|Lack of Efficacy|3|||
130804023|NCT01028560|470908687|FG001|Overall Study|Lack of Efficacy|6|||
130804024|NCT01028560|470908686|FG000|Overall Study|Withdrawal by Subject|7|||
130804025|NCT01028560|470908687|FG001|Overall Study|Withdrawal by Subject|12|||
130804026|NCT03055221|470908688|FG000|Overall Study|Adverse Event|2|||
130804027|NCT03055221|470908688|FG000|Overall Study|Withdrawal by Subject|4|||
130804028|NCT03055221|470908688|FG000|Overall Study|Death|6|||
130804029|NCT03055221|470908688|FG000|Overall Study|Physician Decision|1|||
130804030|NCT03055221|470908688|FG000|Overall Study|Study terminated by Sponsor|3|||
130804031|NCT03055221|470908688|FG000|Overall Study|Lost to Follow-up|4|||
130804032|NCT01243424|470908689|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
130804033|NCT01243424|470908690|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
130804034|NCT01243424|470908689|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
130804035|NCT01243424|470908690|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
130804036|NCT01243424|470908689|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
130804037|NCT01243424|470908690|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
130804038|NCT01243424|470908689|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
130804039|NCT01243424|470908690|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
130804040|NCT01243424|470908689|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
130804041|NCT01243424|470908690|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
130804042|NCT01243424|470908689|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
130804043|NCT01243424|470908690|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
130804044|NCT01243424|470908689|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
130804045|NCT01243424|470908690|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
130804046|NCT01243424|470908689|FG000|Discontinuation From Treatment|Not treated|5|||
130804047|NCT01243424|470908690|FG001|Discontinuation From Treatment|Not treated|4|||
130804048|NCT01243424|470908689|FG000|Discontinuation From Treatment|Adverse Event|457|||
130804049|NCT01243424|470908690|FG001|Discontinuation From Treatment|Adverse Event|523|||
130804050|NCT01243424|470908689|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
130804051|NCT01243424|470908690|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
130804052|NCT01243424|470908689|FG000|Discontinuation From Treatment|Protocol Violation|46|||
130804053|NCT01243424|470908690|FG001|Discontinuation From Treatment|Protocol Violation|47|||
130804054|NCT01243424|470908689|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
130804055|NCT01243424|470908690|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
130804056|NCT01243424|470908689|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
130804057|NCT01243424|470908690|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
130804058|NCT01243424|470908689|FG000|Discontinuation From Treatment|Other than listed above|230|||
130804059|NCT01243424|470908690|FG001|Discontinuation From Treatment|Other than listed above|211|||
130804060|NCT00378560|470908695|FG000|Overall Study|Adverse Event|1|||
130804061|NCT00378560|470908696|FG001|Overall Study|Adverse Event|0|||
130804062|NCT00378560|470908695|FG000|Overall Study|Lost to Follow-up|24|||
130804063|NCT00378560|470908696|FG001|Overall Study|Lost to Follow-up|29|||
130804064|NCT00378560|470908695|FG000|Overall Study|Protocol Violation|2|||
130804065|NCT00378560|470908696|FG001|Overall Study|Protocol Violation|0|||
130804066|NCT00378560|470908695|FG000|Overall Study|Withdrawal by Subject|17|||
130804067|NCT00378560|470908696|FG001|Overall Study|Withdrawal by Subject|21|||
130804068|NCT00378560|470908695|FG000|Overall Study|Moved|4|||
130804069|NCT00378560|470908696|FG001|Overall Study|Moved|3|||
130804070|NCT00378560|470908695|FG000|Overall Study|Pregnancy|7|||
130804071|NCT00378560|470908696|FG001|Overall Study|Pregnancy|5|||
130804072|NCT00378560|470908695|FG000|Overall Study|Laboratory test values abnormal|1|||
130804073|NCT00378560|470908696|FG001|Overall Study|Laboratory test values abnormal|0|||
130804074|NCT02852434|470908697|FG000|Overall Study|Withdrawal by Subject|0|||
130804075|NCT02852434|470908698|FG001|Overall Study|Withdrawal by Subject|1|||
130804076|NCT02852434|470908697|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
130804077|NCT02852434|470908698|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
130804078|NCT02018887|470908701|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
130804079|NCT02018887|470908702|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130804080|NCT02018887|470908703|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130804081|NCT02018887|470908704|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130804082|NCT02018887|470908705|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130804083|NCT02018887|470908706|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130804084|NCT02018887|470908707|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130804085|NCT02018887|470908708|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130804086|NCT02018887|470908709|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130804087|NCT02018887|470908710|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130804088|NCT02018887|470908711|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130804089|NCT02018887|470908701|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130804090|NCT02018887|470908702|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130804091|NCT02018887|470908703|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130804092|NCT02018887|470908704|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130804093|NCT02018887|470908705|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
130804094|NCT02018887|470908706|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130804095|NCT02018887|470908707|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
130804096|NCT02018887|470908708|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
130804097|NCT02018887|470908709|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130804098|NCT02018887|470908710|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130804099|NCT02018887|470908711|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130804100|NCT02018887|470908701|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
130804101|NCT02018887|470908702|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
130804102|NCT02018887|470908703|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
130804103|NCT02018887|470908704|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
130804104|NCT02018887|470908705|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
130804105|NCT02018887|470908706|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
130804106|NCT02018887|470908707|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
130804107|NCT02018887|470908708|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
130804108|NCT02018887|470908709|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
130804109|NCT02018887|470908710|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
130804110|NCT02018887|470908711|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
130804111|NCT02018887|470908701|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
130804112|NCT02018887|470908702|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
130804113|NCT02018887|470908703|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
130804114|NCT02018887|470908704|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
130804115|NCT02018887|470908705|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
130804116|NCT02018887|470908706|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
130804117|NCT02018887|470908707|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
130804118|NCT02018887|470908708|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
130804119|NCT02018887|470908709|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
130804120|NCT02018887|470908710|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
130804121|NCT02018887|470908711|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
130804122|NCT00927186|470908712|FG000|12 Months Primary Study|Adverse Event|5|||
130804123|NCT00927186|470908713|FG001|12 Months Primary Study|Adverse Event|2|||
130804124|NCT00927186|470908712|FG000|12 Months Primary Study|Lost to Follow-up|1|||
130804125|NCT00927186|470908713|FG001|12 Months Primary Study|Lost to Follow-up|0|||
130804126|NCT00927186|470908712|FG000|12 Months Primary Study|Protocol Violation|0|||
130804127|NCT00927186|470908713|FG001|12 Months Primary Study|Protocol Violation|1|||
130804128|NCT00927186|470908712|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
130804129|NCT00927186|470908713|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
130804130|NCT01145222|470908714|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
130804131|NCT01145222|470908715|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
130804132|NCT01145222|470908716|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
130804133|NCT01145222|470908717|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
130804134|NCT01145222|470908714|FG000|Overall Study|Poor bowel preparation|0|||
130804135|NCT01145222|470908715|FG001|Overall Study|Poor bowel preparation|0|||
130804136|NCT01145222|470908716|FG002|Overall Study|Poor bowel preparation|0|||
130804137|NCT01145222|470908717|FG003|Overall Study|Poor bowel preparation|1|||
130804138|NCT01698008|470908718|FG000|Overall Study|Withdrawal by Subject|1|||
130804139|NCT01698008|470908719|FG001|Overall Study|Withdrawal by Subject|2|||
130804140|NCT01011283|470908721|FG000|Overall Study|Adverse Event|4|||
130804141|NCT01011283|470908722|FG001|Overall Study|Adverse Event|2|||
130804142|NCT01011283|470908721|FG000|Overall Study|Progressive Disease|0|||
130804143|NCT01011283|470908722|FG001|Overall Study|Progressive Disease|2|||
130804144|NCT01011283|470908721|FG000|Overall Study|Terminated by Sponsor|5|||
130804145|NCT01011283|470908722|FG001|Overall Study|Terminated by Sponsor|5|||
130804146|NCT01011283|470908721|FG000|Overall Study|Other|2|||
130804147|NCT01011283|470908722|FG001|Overall Study|Other|2|||
130804148|NCT01210443|470908728|FG000|Overall Study|Study terminated by sponsor|2|||
130804149|NCT02807181|470908731|FG000|Overall Study|Death|28|||
130804150|NCT02807181|470908732|FG001|Overall Study|Death|24|||
130804151|NCT02807181|470908731|FG000|Overall Study|Withdrawal by Subject|1|||
130804152|NCT02807181|470908732|FG001|Overall Study|Withdrawal by Subject|1|||
130804153|NCT02807181|470908731|FG000|Overall Study|Lost to Follow-up|0|||
130804154|NCT02807181|470908732|FG001|Overall Study|Lost to Follow-up|2|||
130804155|NCT02807181|470908731|FG000|Overall Study|Subject decision|1|||
130804156|NCT02807181|470908732|FG001|Overall Study|Subject decision|0|||
130804157|NCT02807181|470908731|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
130804158|NCT02807181|470908732|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
130804159|NCT02807181|470908731|FG000|Overall Study|In Study|3|||
130804160|NCT02807181|470908732|FG001|Overall Study|In Study|3|||
130804161|NCT02807181|470908731|FG000|Overall Study|Post Progression|3|||
130804162|NCT02807181|470908732|FG001|Overall Study|Post Progression|2|||
130804163|NCT00063999|470908733|FG000|Overall Study|Withdrawal by Subject|1|||
130804164|NCT00063999|470908734|FG001|Overall Study|Withdrawal by Subject|0|||
130804165|NCT00063999|470908733|FG000|Overall Study|Ineligible|44|||
130804166|NCT00063999|470908734|FG001|Overall Study|Ineligible|24|||
130804167|NCT03767894|470908735|FG000|Overall Study|Withdrawal by Subject|1|||
130804168|NCT04243837|470908739|FG000|Overall Study|Adverse Event|2|||
130804169|NCT04243837|470908740|FG001|Overall Study|Adverse Event|1|||
130804170|NCT04243837|470908739|FG000|Overall Study|Withdrawal by Subject|4|||
130804171|NCT04243837|470908740|FG001|Overall Study|Withdrawal by Subject|2|||
130804172|NCT04243837|470908739|FG000|Overall Study|Covid-19 lock down|1|||
130804173|NCT04243837|470908740|FG001|Overall Study|Covid-19 lock down|0|||
130804174|NCT04243837|470908739|FG000|Overall Study|Study Terminated by Sponsor|11|||
130804175|NCT04243837|470908740|FG001|Overall Study|Study Terminated by Sponsor|12|||
130804176|NCT02280499|470908744|FG000|Overall Study|Death|14|||
130804177|NCT02280499|470908744|FG000|Overall Study|Lost to Follow-up|42|||
130804178|NCT02280499|470908744|FG000|Overall Study|Adverse Event|5|||
130804179|NCT00977561|470908745|FG000|Overall Study|Death|3|||
130804180|NCT00977561|470908746|FG001|Overall Study|Death|2|||
130804181|NCT00977561|470908745|FG000|Overall Study|Study terminated|0|||
130804182|NCT00977561|470908746|FG001|Overall Study|Study terminated|2|||
130804183|NCT00977561|470908745|FG000|Overall Study|Other|2|||
130804184|NCT00977561|470908746|FG001|Overall Study|Other|0|||
130804185|NCT04689009|470908756|FG000|Overall Study|Adverse Event|1|||
130804186|NCT04689009|470908757|FG001|Overall Study|Adverse Event|0|||
130804187|NCT04689009|470908756|FG000|Overall Study|Lost to Follow-up|1|||
130804188|NCT04689009|470908757|FG001|Overall Study|Lost to Follow-up|2|||
130804189|NCT04689009|470908756|FG000|Overall Study|Withdrawal by Subject|4|||
130804190|NCT04689009|470908757|FG001|Overall Study|Withdrawal by Subject|3|||
130804191|NCT04689009|470908756|FG000|Overall Study|Protocol Violation|1|||
130804192|NCT04689009|470908757|FG001|Overall Study|Protocol Violation|0|||
130804193|NCT02187055|470908758|FG000|Overall Study|Lack of Efficacy|10|||
130804194|NCT02187055|470908759|FG001|Overall Study|Lack of Efficacy|3|||
130804195|NCT02187055|470908760|FG002|Overall Study|Lack of Efficacy|7|||
130804196|NCT02187055|470908758|FG000|Overall Study|Lost to Follow-up|2|||
130804197|NCT02187055|470908759|FG001|Overall Study|Lost to Follow-up|7|||
130804198|NCT02187055|470908760|FG002|Overall Study|Lost to Follow-up|3|||
130804199|NCT02187055|470908758|FG000|Overall Study|No longer meets eligibility criteria|0|||
130804200|NCT02187055|470908759|FG001|Overall Study|No longer meets eligibility criteria|2|||
130804201|NCT02187055|470908760|FG002|Overall Study|No longer meets eligibility criteria|0|||
130804202|NCT02187055|470908758|FG000|Overall Study|No longer willing to participate|6|||
130804203|NCT02187055|470908759|FG001|Overall Study|No longer willing to participate|8|||
130804204|NCT02187055|470908760|FG002|Overall Study|No longer willing to participate|10|||
130804205|NCT02187055|470908758|FG000|Overall Study|Other|5|||
130804206|NCT02187055|470908759|FG001|Overall Study|Other|6|||
130804207|NCT02187055|470908760|FG002|Overall Study|Other|3|||
130804208|NCT02187055|470908758|FG000|Overall Study|Protocol Violation|9|||
130804209|NCT02187055|470908759|FG001|Overall Study|Protocol Violation|9|||
130804210|NCT02187055|470908760|FG002|Overall Study|Protocol Violation|4|||
130804211|NCT02187055|470908758|FG000|Overall Study|Pregnancy|3|||
130804212|NCT02187055|470908759|FG001|Overall Study|Pregnancy|1|||
130804213|NCT02187055|470908760|FG002|Overall Study|Pregnancy|0|||
130804214|NCT02187055|470908758|FG000|Overall Study|Withdrawal by Subject|11|||
130804215|NCT02187055|470908759|FG001|Overall Study|Withdrawal by Subject|11|||
130804216|NCT02187055|470908760|FG002|Overall Study|Withdrawal by Subject|11|||
130804217|NCT02187055|470908758|FG000|Overall Study|Adverse Event|21|||
130804218|NCT02187055|470908759|FG001|Overall Study|Adverse Event|26|||
130804219|NCT02187055|470908760|FG002|Overall Study|Adverse Event|36|||
130804220|NCT02187055|470908758|FG000|Overall Study|Death|2|||
130804221|NCT02187055|470908759|FG001|Overall Study|Death|0|||
130804222|NCT02187055|470908760|FG002|Overall Study|Death|0|||
130804223|NCT05737745|470908761|FG000|Overall Study|Withdrawal by Subject|0|||
130804224|NCT05737745|470908762|FG001|Overall Study|Withdrawal by Subject|6|||
130804225|NCT05737745|470908763|FG002|Overall Study|Withdrawal by Subject|1|||
130804226|NCT00165698|470908764|FG000|Overall Study|Adverse Event|2|||
130804227|NCT00165698|470908765|FG001|Overall Study|Adverse Event|10|||
130804228|NCT00165698|470908764|FG000|Overall Study|Lost to Follow-up|2|||
130804229|NCT00165698|470908765|FG001|Overall Study|Lost to Follow-up|2|||
130804230|NCT00165698|470908764|FG000|Overall Study|Withdrawal by Subject|2|||
130804231|NCT00165698|470908765|FG001|Overall Study|Withdrawal by Subject|1|||
130804232|NCT00165698|470908764|FG000|Overall Study|Protocol Violation|1|||
130804233|NCT00165698|470908765|FG001|Overall Study|Protocol Violation|0|||
130804234|NCT00165698|470908764|FG000|Overall Study|Not Taken/Lost the medicine|1|||
130804235|NCT00165698|470908765|FG001|Overall Study|Not Taken/Lost the medicine|2|||
130804236|NCT03679884|470908766|FG000|Overall Study|Other|12|||
130804237|NCT03679884|470908767|FG001|Overall Study|Other|12|||
130804238|NCT03679884|470908768|FG002|Overall Study|Other|12|||
130804239|NCT03679884|470908769|FG003|Overall Study|Other|7|||
130804240|NCT03679884|470908770|FG004|Overall Study|Other|8|||
130804241|NCT03679884|470908766|FG000|Overall Study|Lack of Efficacy|15|||
130804242|NCT03679884|470908767|FG001|Overall Study|Lack of Efficacy|29|||
130804243|NCT03679884|470908768|FG002|Overall Study|Lack of Efficacy|13|||
130804244|NCT03679884|470908769|FG003|Overall Study|Lack of Efficacy|29|||
130804245|NCT03679884|470908770|FG004|Overall Study|Lack of Efficacy|10|||
130804246|NCT03679884|470908766|FG000|Overall Study|Death|1|||
130804247|NCT03679884|470908767|FG001|Overall Study|Death|0|||
130804248|NCT03679884|470908768|FG002|Overall Study|Death|0|||
130804249|NCT03679884|470908769|FG003|Overall Study|Death|0|||
130804250|NCT03679884|470908770|FG004|Overall Study|Death|0|||
130804251|NCT03679884|470908766|FG000|Overall Study|Adverse Event|2|||
130804252|NCT03679884|470908767|FG001|Overall Study|Adverse Event|10|||
130804253|NCT03679884|470908768|FG002|Overall Study|Adverse Event|9|||
130804254|NCT03679884|470908769|FG003|Overall Study|Adverse Event|6|||
130804255|NCT03679884|470908770|FG004|Overall Study|Adverse Event|6|||
130804256|NCT03679884|470908766|FG000|Overall Study|Withdrawal by Subject|12|||
130804257|NCT03679884|470908767|FG001|Overall Study|Withdrawal by Subject|23|||
130804258|NCT03679884|470908768|FG002|Overall Study|Withdrawal by Subject|8|||
130804259|NCT03679884|470908769|FG003|Overall Study|Withdrawal by Subject|8|||
130804260|NCT03679884|470908770|FG004|Overall Study|Withdrawal by Subject|9|||
130804261|NCT03679884|470908766|FG000|Overall Study|Lost to Follow-up|1|||
130804262|NCT03679884|470908767|FG001|Overall Study|Lost to Follow-up|4|||
130804263|NCT03679884|470908768|FG002|Overall Study|Lost to Follow-up|2|||
130804264|NCT03679884|470908769|FG003|Overall Study|Lost to Follow-up|0|||
130804265|NCT03679884|470908770|FG004|Overall Study|Lost to Follow-up|3|||
130804266|NCT01107457|470908771|FG000|Part A|Adverse Event|1|||
130804267|NCT01107457|470908772|FG001|Part A|Adverse Event|2|||
130804268|NCT01107457|470908773|FG002|Part A|Adverse Event|1|||
130804269|NCT01107457|470908774|FG003|Part A|Adverse Event|0|||
130804270|NCT01107457|470908775|FG004|Part A|Adverse Event|0|||
130804271|NCT01107457|470908776|FG005|Part A|Adverse Event|0|||
130804272|NCT01107457|470908771|FG000|Part A|Withdrawal by Subject|3|||
130804273|NCT01107457|470908772|FG001|Part A|Withdrawal by Subject|3|||
130804274|NCT01107457|470908773|FG002|Part A|Withdrawal by Subject|0|||
130804275|NCT01107457|470908774|FG003|Part A|Withdrawal by Subject|3|||
130804276|NCT01107457|470908775|FG004|Part A|Withdrawal by Subject|1|||
130804277|NCT01107457|470908776|FG005|Part A|Withdrawal by Subject|0|||
130804278|NCT01107457|470908771|FG000|Part A|Lost to Follow-up|0|||
130804279|NCT01107457|470908772|FG001|Part A|Lost to Follow-up|1|||
130804280|NCT01107457|470908773|FG002|Part A|Lost to Follow-up|0|||
130804281|NCT01107457|470908774|FG003|Part A|Lost to Follow-up|0|||
130804282|NCT01107457|470908775|FG004|Part A|Lost to Follow-up|0|||
130804283|NCT01107457|470908776|FG005|Part A|Lost to Follow-up|0|||
130804284|NCT01107457|470908771|FG000|Part A|Lack of Efficacy|1|||
130804285|NCT01107457|470908772|FG001|Part A|Lack of Efficacy|0|||
130804286|NCT01107457|470908773|FG002|Part A|Lack of Efficacy|0|||
130804287|NCT01107457|470908774|FG003|Part A|Lack of Efficacy|0|||
130804288|NCT01107457|470908775|FG004|Part A|Lack of Efficacy|0|||
130804289|NCT01107457|470908776|FG005|Part A|Lack of Efficacy|0|||
130804290|NCT01107457|470908771|FG000|Part A|Protocol Violation|0|||
130804291|NCT01107457|470908772|FG001|Part A|Protocol Violation|1|||
130804292|NCT01107457|470908773|FG002|Part A|Protocol Violation|0|||
130804293|NCT01107457|470908774|FG003|Part A|Protocol Violation|0|||
130804294|NCT01107457|470908775|FG004|Part A|Protocol Violation|0|||
130804295|NCT01107457|470908776|FG005|Part A|Protocol Violation|0|||
130804296|NCT01107457|470908771|FG000|Part B and C|Adverse Event|0|||
130804297|NCT01107457|470908772|FG001|Part B and C|Adverse Event|0|||
130804298|NCT01107457|470908773|FG002|Part B and C|Adverse Event|0|||
130804299|NCT01107457|470908774|FG003|Part B and C|Adverse Event|0|||
130804300|NCT01107457|470908775|FG004|Part B and C|Adverse Event|0|||
130804301|NCT01107457|470908776|FG005|Part B and C|Adverse Event|12|||
130804302|NCT01107457|470908771|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130804303|NCT01107457|470908772|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130804304|NCT01107457|470908773|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130804305|NCT01107457|470908774|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130804306|NCT01107457|470908775|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130804307|NCT01107457|470908776|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
130804308|NCT01107457|470908771|FG000|Part B and C|Physician Decision|0|||
130804309|NCT01107457|470908772|FG001|Part B and C|Physician Decision|0|||
130804310|NCT01107457|470908773|FG002|Part B and C|Physician Decision|0|||
130804311|NCT01107457|470908774|FG003|Part B and C|Physician Decision|0|||
130804312|NCT01107457|470908775|FG004|Part B and C|Physician Decision|0|||
130804313|NCT01107457|470908776|FG005|Part B and C|Physician Decision|3|||
130804314|NCT01107457|470908771|FG000|Part B and C|Lack of Efficacy|0|||
130804315|NCT01107457|470908772|FG001|Part B and C|Lack of Efficacy|0|||
130804316|NCT01107457|470908773|FG002|Part B and C|Lack of Efficacy|0|||
130804317|NCT01107457|470908774|FG003|Part B and C|Lack of Efficacy|0|||
130804318|NCT01107457|470908775|FG004|Part B and C|Lack of Efficacy|0|||
130804319|NCT01107457|470908776|FG005|Part B and C|Lack of Efficacy|7|||
130804320|NCT01107457|470908771|FG000|Part B and C|Lost to Follow-up|0|||
130804321|NCT01107457|470908772|FG001|Part B and C|Lost to Follow-up|0|||
130804322|NCT01107457|470908773|FG002|Part B and C|Lost to Follow-up|0|||
130804323|NCT01107457|470908774|FG003|Part B and C|Lost to Follow-up|0|||
130804324|NCT01107457|470908775|FG004|Part B and C|Lost to Follow-up|0|||
130804325|NCT01107457|470908776|FG005|Part B and C|Lost to Follow-up|10|||
130804326|NCT01107457|470908771|FG000|Part B and C|Protocol Violation|0|||
130804327|NCT01107457|470908772|FG001|Part B and C|Protocol Violation|0|||
130804328|NCT01107457|470908773|FG002|Part B and C|Protocol Violation|0|||
130804329|NCT01107457|470908774|FG003|Part B and C|Protocol Violation|0|||
130804330|NCT01107457|470908775|FG004|Part B and C|Protocol Violation|0|||
130804331|NCT01107457|470908776|FG005|Part B and C|Protocol Violation|1|||
130804332|NCT01107457|470908771|FG000|Part B and C|Sponsor Decision|0|||
130804333|NCT01107457|470908772|FG001|Part B and C|Sponsor Decision|0|||
130804334|NCT01107457|470908773|FG002|Part B and C|Sponsor Decision|0|||
130804335|NCT01107457|470908774|FG003|Part B and C|Sponsor Decision|0|||
130804336|NCT01107457|470908775|FG004|Part B and C|Sponsor Decision|0|||
130804337|NCT01107457|470908776|FG005|Part B and C|Sponsor Decision|66|||
130804338|NCT01107457|470908771|FG000|Part B and C|Withdrawal by Subject|0|||
130804339|NCT01107457|470908772|FG001|Part B and C|Withdrawal by Subject|0|||
130804340|NCT01107457|470908773|FG002|Part B and C|Withdrawal by Subject|0|||
130804341|NCT01107457|470908774|FG003|Part B and C|Withdrawal by Subject|0|||
130804342|NCT01107457|470908775|FG004|Part B and C|Withdrawal by Subject|0|||
130804343|NCT01107457|470908776|FG005|Part B and C|Withdrawal by Subject|16|||
130804344|NCT01107457|470908771|FG000|Part B and C|Clinical Relapse|0|||
130804345|NCT01107457|470908772|FG001|Part B and C|Clinical Relapse|0|||
130804346|NCT01107457|470908773|FG002|Part B and C|Clinical Relapse|0|||
130804347|NCT01107457|470908774|FG003|Part B and C|Clinical Relapse|0|||
130804348|NCT01107457|470908775|FG004|Part B and C|Clinical Relapse|0|||
130804349|NCT01107457|470908776|FG005|Part B and C|Clinical Relapse|4|||
130804350|NCT02547935|470908777|FG000|Overall Study|Other|0|||
130804351|NCT02547935|470908778|FG001|Overall Study|Other|1|||
130804352|NCT02547935|470908779|FG002|Overall Study|Other|0|||
130804353|NCT02547935|470908777|FG000|Overall Study|Withdrawal by Subject|2|||
130804354|NCT02547935|470908778|FG001|Overall Study|Withdrawal by Subject|3|||
130804355|NCT02547935|470908779|FG002|Overall Study|Withdrawal by Subject|4|||
130804356|NCT02547935|470908777|FG000|Overall Study|Screen Failure|2|||
130804357|NCT02547935|470908778|FG001|Overall Study|Screen Failure|0|||
130804358|NCT02547935|470908779|FG002|Overall Study|Screen Failure|0|||
130804359|NCT02547935|470908777|FG000|Overall Study|Physician Decision|0|||
130804360|NCT02547935|470908778|FG001|Overall Study|Physician Decision|1|||
130804361|NCT02547935|470908779|FG002|Overall Study|Physician Decision|0|||
130804362|NCT02547935|470908777|FG000|Overall Study|Lost to Follow-up|0|||
130804363|NCT02547935|470908778|FG001|Overall Study|Lost to Follow-up|2|||
130804364|NCT02547935|470908779|FG002|Overall Study|Lost to Follow-up|1|||
130804365|NCT02547935|470908777|FG000|Overall Study|Death|1|||
130804366|NCT02547935|470908778|FG001|Overall Study|Death|1|||
130804367|NCT02547935|470908779|FG002|Overall Study|Death|0|||
130804368|NCT00086307|470908780|FG000|Overall Study|Lack of Efficacy|1|||
130804369|NCT00086307|470908781|FG001|Overall Study|Lack of Efficacy|1|||
130804370|NCT00086307|470908782|FG002|Overall Study|Lack of Efficacy|2|||
130804371|NCT00086307|470908780|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
130804372|NCT00086307|470908781|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
130804373|NCT00086307|470908782|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
130804374|NCT00086307|470908780|FG000|Overall Study|Nausea and headaches|0|||
130804375|NCT00086307|470908781|FG001|Overall Study|Nausea and headaches|0|||
130804376|NCT00086307|470908782|FG002|Overall Study|Nausea and headaches|1|||
130804377|NCT00086307|470908780|FG000|Overall Study|Constipation and sleepiness|0|||
130804378|NCT00086307|470908781|FG001|Overall Study|Constipation and sleepiness|0|||
130804379|NCT00086307|470908782|FG002|Overall Study|Constipation and sleepiness|1|||
130804380|NCT00086307|470908780|FG000|Overall Study|Suicidal ideation|0|||
130804381|NCT00086307|470908781|FG001|Overall Study|Suicidal ideation|0|||
130804382|NCT00086307|470908782|FG002|Overall Study|Suicidal ideation|1|||
130804383|NCT00086307|470908780|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
130804384|NCT00086307|470908781|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
130804385|NCT00086307|470908782|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
130804386|NCT00086307|470908780|FG000|Overall Study|Withdrawal by Subject|0|||
130804387|NCT00086307|470908781|FG001|Overall Study|Withdrawal by Subject|0|||
130804388|NCT00086307|470908782|FG002|Overall Study|Withdrawal by Subject|2|||
130804389|NCT00362609|470908783|FG000|Overall Study|Withdrawal by Subject|0|||
130804390|NCT00362609|470908784|FG001|Overall Study|Withdrawal by Subject|1|||
130804391|NCT00362609|470908783|FG000|Overall Study|Protocol Violation|0|||
130804392|NCT00362609|470908784|FG001|Overall Study|Protocol Violation|1|||
130804393|NCT02487199|470908787|FG000|Overall Study|Withdrew Consent|0|||
130804394|NCT02487199|470908788|FG001|Overall Study|Withdrew Consent|1|||
130804395|NCT03787212|470911034|FG000|Period 1|Study Termination|2|||
130804396|NCT03787212|470911035|FG001|Period 1|Study Termination|2|||
130804397|NCT04193176|470911036|FG000|Overall Study|Withdrawal by Subject|6|||
130804398|NCT04193176|470911037|FG001|Overall Study|Withdrawal by Subject|10|||
130804399|NCT02370394|470911038|FG000|Overall Study|Lost to Follow-up|2|||
130804400|NCT02370394|470911039|FG001|Overall Study|Lost to Follow-up|1|||
130804401|NCT02370394|470911038|FG000|Overall Study|Withdrawal by Subject|0|||
130804402|NCT02370394|470911039|FG001|Overall Study|Withdrawal by Subject|1|||
130804403|NCT00520572|470911041|FG000|Overall Study|Adverse Event|9|||
130804404|NCT00520572|470911042|FG001|Overall Study|Adverse Event|3|||
130804405|NCT00520572|470911043|FG002|Overall Study|Adverse Event|6|||
130804406|NCT00520572|470911044|FG003|Overall Study|Adverse Event|9|||
130804407|NCT00520572|470911045|FG004|Overall Study|Adverse Event|7|||
130804408|NCT00520572|470911046|FG005|Overall Study|Adverse Event|2|||
130804409|NCT00520572|470911041|FG000|Overall Study|Withdrawal by Subject|0|||
130804410|NCT00520572|470911042|FG001|Overall Study|Withdrawal by Subject|9|||
130804411|NCT00520572|470911043|FG002|Overall Study|Withdrawal by Subject|5|||
130804412|NCT00520572|470911044|FG003|Overall Study|Withdrawal by Subject|2|||
130804413|NCT00520572|470911045|FG004|Overall Study|Withdrawal by Subject|2|||
130804414|NCT00520572|470911046|FG005|Overall Study|Withdrawal by Subject|0|||
130804415|NCT00520572|470911041|FG000|Overall Study|Protocol Violation|0|||
130804416|NCT00520572|470911042|FG001|Overall Study|Protocol Violation|0|||
130804417|NCT00520572|470911043|FG002|Overall Study|Protocol Violation|1|||
130804418|NCT00520572|470911044|FG003|Overall Study|Protocol Violation|0|||
130804419|NCT00520572|470911045|FG004|Overall Study|Protocol Violation|0|||
130804420|NCT00520572|470911046|FG005|Overall Study|Protocol Violation|0|||
130804421|NCT00520572|470911041|FG000|Overall Study|Lack of Efficacy|1|||
130804422|NCT00520572|470911042|FG001|Overall Study|Lack of Efficacy|1|||
130804423|NCT00520572|470911043|FG002|Overall Study|Lack of Efficacy|1|||
130804424|NCT00520572|470911044|FG003|Overall Study|Lack of Efficacy|2|||
130804425|NCT00520572|470911045|FG004|Overall Study|Lack of Efficacy|1|||
130804426|NCT00520572|470911046|FG005|Overall Study|Lack of Efficacy|0|||
130804427|NCT00520572|470911041|FG000|Overall Study|Lost to Follow-up|0|||
130804428|NCT00520572|470911042|FG001|Overall Study|Lost to Follow-up|0|||
130804429|NCT00520572|470911043|FG002|Overall Study|Lost to Follow-up|0|||
130804430|NCT00520572|470911044|FG003|Overall Study|Lost to Follow-up|0|||
130804431|NCT00520572|470911045|FG004|Overall Study|Lost to Follow-up|1|||
130804432|NCT00520572|470911046|FG005|Overall Study|Lost to Follow-up|0|||
130804433|NCT00520572|470911041|FG000|Overall Study|Incorrect enrollment|1|||
130804434|NCT00520572|470911042|FG001|Overall Study|Incorrect enrollment|0|||
130804435|NCT00520572|470911043|FG002|Overall Study|Incorrect enrollment|1|||
130804436|NCT00520572|470911044|FG003|Overall Study|Incorrect enrollment|0|||
130804437|NCT00520572|470911045|FG004|Overall Study|Incorrect enrollment|1|||
130804438|NCT00520572|470911046|FG005|Overall Study|Incorrect enrollment|0|||
130804439|NCT00520572|470911041|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
130804440|NCT00520572|470911042|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
130804441|NCT00520572|470911043|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
130804442|NCT00520572|470911044|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
130804443|NCT00520572|470911045|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
130804444|NCT00520572|470911046|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
130804445|NCT00520572|470911041|FG000|Overall Study|Long break in taking Medication|0|||
130804446|NCT00520572|470911042|FG001|Overall Study|Long break in taking Medication|0|||
130804447|NCT00520572|470911043|FG002|Overall Study|Long break in taking Medication|0|||
130804448|NCT00520572|470911044|FG003|Overall Study|Long break in taking Medication|1|||
130804449|NCT00520572|470911045|FG004|Overall Study|Long break in taking Medication|0|||
130804450|NCT00520572|470911046|FG005|Overall Study|Long break in taking Medication|0|||
130804451|NCT00520572|470911041|FG000|Overall Study|Did not receive Treatment|1|||
130804452|NCT00520572|470911042|FG001|Overall Study|Did not receive Treatment|0|||
130804453|NCT00520572|470911043|FG002|Overall Study|Did not receive Treatment|1|||
130804454|NCT00520572|470911044|FG003|Overall Study|Did not receive Treatment|0|||
130804455|NCT00520572|470911045|FG004|Overall Study|Did not receive Treatment|0|||
130804456|NCT00520572|470911046|FG005|Overall Study|Did not receive Treatment|0|||
130804457|NCT02181621|470911047|FG000|Overall Study|Adverse Event|1|||
130804458|NCT02181621|470911048|FG001|Overall Study|Adverse Event|0|||
130804459|NCT02181621|470911047|FG000|Overall Study|Previously Enrolled|0|||
130804460|NCT02181621|470911048|FG001|Overall Study|Previously Enrolled|1|||
130804461|NCT02181621|470911047|FG000|Overall Study|Enrollment Hold|1|||
130804462|NCT02181621|470911048|FG001|Overall Study|Enrollment Hold|1|||
130804463|NCT00960856|470911049|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130804464|NCT00960856|470911050|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
130804465|NCT00960856|470911051|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
130804466|NCT00960856|470911052|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
130804467|NCT00960856|470911049|FG000|Washout Period of 7 Days|Adverse Event|0|||
130804468|NCT00960856|470911050|FG001|Washout Period of 7 Days|Adverse Event|0|||
130804469|NCT00960856|470911051|FG002|Washout Period of 7 Days|Adverse Event|1|||
130804470|NCT00960856|470911052|FG003|Washout Period of 7 Days|Adverse Event|0|||
130804471|NCT00985192|470911054|FG000|Overall Study|Withdrawal by Subject|1|||
130804472|NCT00985192|470911054|FG000|Overall Study|Disease Progression|1|||
130804473|NCT00985192|470911054|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
130804474|NCT03387046|470911057|FG000|Overall Study|Adverse Event|1|||
130804475|NCT03387046|470911058|FG001|Overall Study|Adverse Event|1|||
130804476|NCT03794544|470911060|FG000|Overall Study|Withdrawal by Subject|1|||
130804477|NCT03794544|470911061|FG001|Overall Study|Withdrawal by Subject|1|||
130804478|NCT03794544|470911062|FG002|Overall Study|Withdrawal by Subject|0|||
130804479|NCT03794544|470911063|FG003|Overall Study|Withdrawal by Subject|0|||
130804480|NCT03794544|470911060|FG000|Overall Study|Death|0|||
130804481|NCT03794544|470911061|FG001|Overall Study|Death|0|||
130804482|NCT03794544|470911062|FG002|Overall Study|Death|0|||
130804483|NCT03794544|470911063|FG003|Overall Study|Death|1|||
130804484|NCT03794544|470911060|FG000|Overall Study|Lost to Follow-up|0|||
130804485|NCT03794544|470911061|FG001|Overall Study|Lost to Follow-up|1|||
130804486|NCT03794544|470911062|FG002|Overall Study|Lost to Follow-up|1|||
130804487|NCT03794544|470911063|FG003|Overall Study|Lost to Follow-up|0|||
130804488|NCT03794544|470911060|FG000|Overall Study|Other|0|||
130804489|NCT03794544|470911061|FG001|Overall Study|Other|1|||
130804490|NCT03794544|470911062|FG002|Overall Study|Other|0|||
130804491|NCT03794544|470911063|FG003|Overall Study|Other|0|||
130804492|NCT00676052|470911066|FG000|Overall Study|Adverse Event|0|||
130804493|NCT00676052|470911067|FG001|Overall Study|Adverse Event|1|||
130804494|NCT00676052|470911068|FG002|Overall Study|Adverse Event|1|||
130804495|NCT00676052|470911069|FG003|Overall Study|Adverse Event|2|||
130804496|NCT00676052|470911070|FG004|Overall Study|Adverse Event|2|||
130804497|NCT00676052|470911071|FG005|Overall Study|Adverse Event|2|||
130804498|NCT00676052|470911066|FG000|Overall Study|Lack of Efficacy|2|||
130804499|NCT00676052|470911067|FG001|Overall Study|Lack of Efficacy|2|||
130804500|NCT00676052|470911068|FG002|Overall Study|Lack of Efficacy|1|||
130804501|NCT00676052|470911069|FG003|Overall Study|Lack of Efficacy|1|||
130804502|NCT00676052|470911070|FG004|Overall Study|Lack of Efficacy|2|||
130804503|NCT00676052|470911071|FG005|Overall Study|Lack of Efficacy|1|||
130804504|NCT00676052|470911066|FG000|Overall Study|Protocol Violation|5|||
130804505|NCT00676052|470911067|FG001|Overall Study|Protocol Violation|3|||
130804506|NCT00676052|470911068|FG002|Overall Study|Protocol Violation|2|||
130804507|NCT00676052|470911069|FG003|Overall Study|Protocol Violation|2|||
130804508|NCT00676052|470911070|FG004|Overall Study|Protocol Violation|1|||
130804509|NCT00676052|470911071|FG005|Overall Study|Protocol Violation|2|||
130804510|NCT00676052|470911066|FG000|Overall Study|Lost to Follow-up|0|||
130804511|NCT00676052|470911067|FG001|Overall Study|Lost to Follow-up|0|||
130804512|NCT00676052|470911068|FG002|Overall Study|Lost to Follow-up|0|||
130804513|NCT00676052|470911069|FG003|Overall Study|Lost to Follow-up|0|||
130804514|NCT00676052|470911070|FG004|Overall Study|Lost to Follow-up|1|||
130804515|NCT00676052|470911071|FG005|Overall Study|Lost to Follow-up|0|||
130804516|NCT00676052|470911066|FG000|Overall Study|Physician Decision|1|||
130804517|NCT00676052|470911067|FG001|Overall Study|Physician Decision|1|||
130804518|NCT00676052|470911068|FG002|Overall Study|Physician Decision|1|||
130804519|NCT00676052|470911069|FG003|Overall Study|Physician Decision|0|||
130804520|NCT00676052|470911070|FG004|Overall Study|Physician Decision|0|||
130804521|NCT00676052|470911071|FG005|Overall Study|Physician Decision|1|||
130804522|NCT00676052|470911066|FG000|Overall Study|Withdrawal by Subject|1|||
130804523|NCT00676052|470911067|FG001|Overall Study|Withdrawal by Subject|0|||
130804524|NCT00676052|470911068|FG002|Overall Study|Withdrawal by Subject|1|||
130804525|NCT00676052|470911069|FG003|Overall Study|Withdrawal by Subject|0|||
130804526|NCT00676052|470911070|FG004|Overall Study|Withdrawal by Subject|0|||
130804527|NCT00676052|470911071|FG005|Overall Study|Withdrawal by Subject|0|||
130804528|NCT00120250|470911072|FG000|Overall Study|Lost to Follow-up|1|||
130804529|NCT00120250|470911073|FG001|Overall Study|Lost to Follow-up|1|||
130804530|NCT00120250|470911072|FG000|Overall Study|Protocol Violation|0|||
130804531|NCT00120250|470911073|FG001|Overall Study|Protocol Violation|1|||
130804532|NCT01964560|470911087|FG000|Overall Study|Adverse Event|23|||
130804533|NCT01964560|470911087|FG000|Overall Study|Lack of Efficacy|46|||
130804534|NCT01964560|470911087|FG000|Overall Study|Protocol deviation|2|||
130804535|NCT01964560|470911087|FG000|Overall Study|Lost to Follow-up|4|||
130804536|NCT01964560|470911087|FG000|Overall Study|Withdrawal by Subject|64|||
130804537|NCT01964560|470911087|FG000|Overall Study|Surgery-hemispherotomy|1|||
130804538|NCT01964560|470911087|FG000|Overall Study|Surgery|1|||
130804539|NCT01964560|470911087|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
130804540|NCT01964560|470911087|FG000|Overall Study|Patient and Investigator choice|1|||
130804541|NCT01964560|470911087|FG000|Overall Study|Patient was prescribed CBD|1|||
130804542|NCT01964560|470911087|FG000|Overall Study|Participant moved to another country|1|||
130804543|NCT00337194|470911088|FG000|Overall Study|Adverse Event|5|||
130804544|NCT00337194|470911089|FG001|Overall Study|Adverse Event|1|||
130804545|NCT00337194|470911088|FG000|Overall Study|Death|2|||
130804546|NCT00337194|470911089|FG001|Overall Study|Death|0|||
130804547|NCT00337194|470911088|FG000|Overall Study|Withdrawal by Subject|1|||
130804548|NCT00337194|470911089|FG001|Overall Study|Withdrawal by Subject|0|||
130804549|NCT00337194|470911088|FG000|Overall Study|Disease progression|1|||
130804550|NCT00337194|470911089|FG001|Overall Study|Disease progression|2|||
130804551|NCT00337194|470911088|FG000|Overall Study|Subsequent non-protocol therapy|3|||
130804552|NCT00337194|470911089|FG001|Overall Study|Subsequent non-protocol therapy|1|||
130804553|NCT03188705|470911090|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
130804554|NCT03188705|470911090|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
130804555|NCT01174459|470911091|FG000|Overall Study|case report form (CRF) not collected|5|||
130804556|NCT01717859|470911093|FG000|Overall Study|Adverse Event|5|||
130804557|NCT01717859|470911093|FG000|Overall Study|Moved out of state|1|||
130804558|NCT01717859|470911093|FG000|Overall Study|Patient concerned about mental health|1|||
130804559|NCT01717859|470911093|FG000|Overall Study|Lost to Follow-up|1|||
130804560|NCT01717859|470911093|FG000|Overall Study|Withdrawal by Subject|2|||
130804561|NCT01623752|470911094|FG000|Phase 1 (78 Weeks)|No Data|249|||
130804562|NCT01623752|470911095|FG001|Phase 1 (78 Weeks)|No Data|66|||
130804563|NCT01623752|470911096|FG002|Phase 1 (78 Weeks)|No Data|2|||
130804564|NCT01623752|470911094|FG000|Phase 1 (78 Weeks)|Other|33|||
130804565|NCT01623752|470911095|FG001|Phase 1 (78 Weeks)|Other|20|||
130804566|NCT01623752|470911096|FG002|Phase 1 (78 Weeks)|Other|0|||
130804567|NCT01623752|470911094|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
130804568|NCT01623752|470911095|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
130804569|NCT01623752|470911096|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
130804570|NCT01623752|470911094|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
130804571|NCT01623752|470911095|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
130804572|NCT01623752|470911096|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
130804573|NCT01623752|470911094|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
130804574|NCT01623752|470911095|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
130804575|NCT01623752|470911096|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
130804576|NCT01623752|470911094|FG000|Phase 2 (78 Weeks)|Other|5|||
130804577|NCT01623752|470911095|FG001|Phase 2 (78 Weeks)|Other|1|||
130804578|NCT01623752|470911096|FG002|Phase 2 (78 Weeks)|Other|0|||
130804579|NCT01623752|470911094|FG000|Phase 2 (78 Weeks)|No Data|43|||
130804580|NCT01623752|470911095|FG001|Phase 2 (78 Weeks)|No Data|11|||
130804581|NCT01623752|470911096|FG002|Phase 2 (78 Weeks)|No Data|0|||
130804582|NCT01623752|470911094|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
130804583|NCT01623752|470911095|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
130804584|NCT01623752|470911096|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
130804585|NCT04389671|470911097|FG000|Overall Study|Death|7|||
130804586|NCT04865978|470911099|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
130804587|NCT04865978|470911100|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
130804588|NCT03835117|470911101|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
130804589|NCT03835117|470911102|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
130804590|NCT00183391|470911104|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
130804591|NCT00183391|470911105|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
130804592|NCT00183391|470911104|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
130804593|NCT00183391|470911105|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
130804594|NCT01543503|470911108|FG000|Overall Study|Lost to Follow-up|32|||
130804595|NCT01543503|470911109|FG001|Overall Study|Lost to Follow-up|36|||
130804596|NCT01543503|470911108|FG000|Overall Study|Adverse Event|9|||
130804597|NCT01543503|470911109|FG001|Overall Study|Adverse Event|13|||
130804598|NCT01543503|470911108|FG000|Overall Study|Lack of Efficacy|4|||
130804599|NCT01543503|470911109|FG001|Overall Study|Lack of Efficacy|16|||
130804600|NCT01543503|470911108|FG000|Overall Study|Participant withdrew informed consent|8|||
130804601|NCT01543503|470911109|FG001|Overall Study|Participant withdrew informed consent|10|||
130804602|NCT01543503|470911108|FG000|Overall Study|Change of jobs|0|||
130804603|NCT01543503|470911109|FG001|Overall Study|Change of jobs|1|||
130804604|NCT01543503|470911108|FG000|Overall Study|Intolerance to the biologic treatment|0|||
130804605|NCT01543503|470911109|FG001|Overall Study|Intolerance to the biologic treatment|1|||
130804606|NCT01543503|470911108|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
130804607|NCT01543503|470911109|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
130804608|NCT01543503|470911108|FG000|Overall Study|Participant did not complete last visit|0|||
130804609|NCT01543503|470911109|FG001|Overall Study|Participant did not complete last visit|2|||
130804610|NCT01543503|470911108|FG000|Overall Study|Refused to continue treatment|7|||
130804611|NCT01543503|470911109|FG001|Overall Study|Refused to continue treatment|0|||
130804612|NCT01543503|470911108|FG000|Overall Study|Incorrect medication received|1|||
130804613|NCT01543503|470911109|FG001|Overall Study|Incorrect medication received|0|||
130804614|NCT01543503|470911108|FG000|Overall Study|Participant moved to another city|2|||
130804615|NCT01543503|470911109|FG001|Overall Study|Participant moved to another city|0|||
130804616|NCT01543503|470911108|FG000|Overall Study|Participant will not return for visits|0|||
130804617|NCT01543503|470911109|FG001|Overall Study|Participant will not return for visits|2|||
130804618|NCT01543503|470911108|FG000|Overall Study|Participant transferred to another city|1|||
130804619|NCT01543503|470911109|FG001|Overall Study|Participant transferred to another city|0|||
130804620|NCT01543503|470911108|FG000|Overall Study|Participant moved to Scotland|1|||
130804621|NCT01543503|470911109|FG001|Overall Study|Participant moved to Scotland|0|||
130804622|NCT01543503|470911108|FG000|Overall Study|Participant decision to stop treatment|1|||
130804623|NCT01543503|470911109|FG001|Overall Study|Participant decision to stop treatment|0|||
130804624|NCT01543503|470911108|FG000|Overall Study|Investigator did not wish to participate|1|||
130804625|NCT01543503|470911109|FG001|Overall Study|Investigator did not wish to participate|1|||
130804626|NCT01543503|470911108|FG000|Overall Study|Participant recruited after closing date|0|||
130804627|NCT01543503|470911109|FG001|Overall Study|Participant recruited after closing date|1|||
130804628|NCT01543503|470911108|FG000|Overall Study|Site stopped participation|5|||
130804629|NCT01543503|470911109|FG001|Overall Study|Site stopped participation|1|||
130804630|NCT01543503|470911108|FG000|Overall Study|Participant did not attend a visit|1|||
130804631|NCT01543503|470911109|FG001|Overall Study|Participant did not attend a visit|0|||
130804632|NCT01543503|470911108|FG000|Overall Study|Moved to other rheumatologic site|0|||
130804633|NCT01543503|470911109|FG001|Overall Study|Moved to other rheumatologic site|1|||
130804634|NCT01543503|470911108|FG000|Overall Study|Participant consented to another study|0|||
130804635|NCT01543503|470911109|FG001|Overall Study|Participant consented to another study|2|||
130804636|NCT01543503|470911108|FG000|Overall Study|Participant went to United States|1|||
130804637|NCT01543503|470911109|FG001|Overall Study|Participant went to United States|0|||
130804638|NCT01543503|470911108|FG000|Overall Study|Screen failure|1|||
130804639|NCT01543503|470911109|FG001|Overall Study|Screen failure|0|||
130804640|NCT01986751|470911114|FG000|Overall Study|improperly consented|10|||
130804641|NCT01986751|470911115|FG001|Overall Study|improperly consented|2|||
130804642|NCT01309100|470911121|FG000|Overall Study|Protocol Violation|1|||
130804643|NCT01309100|470911121|FG000|Overall Study|Positive Slit lamp finding|1|||
130804644|NCT01968785|470911124|FG000|Overall Study|Withdrawal by Subject|1|||
130804645|NCT01968785|470911125|FG001|Overall Study|Withdrawal by Subject|0|||
130804646|NCT03511066|470911127|FG000|Overall Study|Withdrawal by Subject|1|||
130804647|NCT03511066|470911128|FG001|Overall Study|Withdrawal by Subject|2|||
130804648|NCT03511066|470911129|FG002|Overall Study|Withdrawal by Subject|3|||
130804649|NCT03511066|470911127|FG000|Overall Study|Lost to Follow-up|2|||
130804650|NCT03511066|470911128|FG001|Overall Study|Lost to Follow-up|3|||
130804651|NCT03511066|470911129|FG002|Overall Study|Lost to Follow-up|0|||
130804652|NCT04560309|470911134|FG000|Overall Study|Meet drop out criteria|1|||
130804653|NCT04560309|470911135|FG001|Overall Study|Meet drop out criteria|1|||
130804654|NCT05085405|470911136|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130804655|NCT05085405|470911137|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130804656|NCT05085405|470911138|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
130804657|NCT05085405|470911139|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
130804658|NCT05085405|470911140|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130804659|NCT05085405|470911141|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130804660|NCT05085405|470911136|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130804661|NCT05085405|470911137|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130804662|NCT05085405|470911138|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130804663|NCT05085405|470911139|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
130804664|NCT05085405|470911140|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130804665|NCT05085405|470911141|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130804666|NCT04146909|470911142|FG000|Overall Study|Withdrawal by Subject|3|||
130804667|NCT04146909|470911142|FG000|Overall Study|Did not qualify after consented|1|||
130804668|NCT04000724|470911150|FG000|Overall Study|Withdrawal by Subject|5|||
130804669|NCT04000724|470911151|FG001|Overall Study|Withdrawal by Subject|3|||
130804670|NCT04000724|470911152|FG002|Overall Study|Withdrawal by Subject|4|||
130804671|NCT04000724|470911150|FG000|Overall Study|Lost to Follow-up|11|||
130804672|NCT04000724|470911151|FG001|Overall Study|Lost to Follow-up|7|||
130804673|NCT04000724|470911152|FG002|Overall Study|Lost to Follow-up|13|||
130804674|NCT00455455|470911153|FG000|Washout|Withdrawal by Subject|0|||
130804675|NCT00455455|470911154|FG001|Washout|Withdrawal by Subject|1|||
130804676|NCT00455455|470911153|FG000|Washout|Withdrawal by Subject|1|||
130804677|NCT00455455|470911154|FG001|Washout|Withdrawal by Subject|0|||
130804678|NCT03808909|470911155|FG000|Overall Study|Lost to Follow-up|3|||
130804679|NCT03808909|470911156|FG001|Overall Study|Lost to Follow-up|0|||
130804680|NCT01827943|470911157|FG000|Overall Study|Protocol Violation|8|||
130804681|NCT01827943|470911157|FG000|Overall Study|Never treated because of an rapid progression|1|||
130804682|NCT01084135|470911158|FG000|20 Week|Physician Decision|0|||
130804683|NCT01084135|470911159|FG001|20 Week|Physician Decision|1|||
130804684|NCT03335566|470911160|FG000|Overall Study|Adverse Event|0|||
130804685|NCT03335566|470911161|FG001|Overall Study|Adverse Event|1|||
130804686|NCT03335566|470911160|FG000|Overall Study|Lost to Follow-up|1|||
130804687|NCT03335566|470911161|FG001|Overall Study|Lost to Follow-up|0|||
130804688|NCT03335566|470911160|FG000|Overall Study|Technical Problems|1|||
130804689|NCT03335566|470911161|FG001|Overall Study|Technical Problems|0|||
130804690|NCT03335566|470911160|FG000|Overall Study|Protocol Violation|1|||
130804691|NCT03335566|470911161|FG001|Overall Study|Protocol Violation|0|||
130804692|NCT03335566|470911160|FG000|Overall Study|Other than specified above|1|||
130804693|NCT03335566|470911161|FG001|Overall Study|Other than specified above|2|||
130804694|NCT00663351|470911162|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
130804695|NCT00663351|470911163|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
130804696|NCT00663351|470911162|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
130804697|NCT00663351|470911163|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
130804698|NCT00663351|470911162|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
130804699|NCT00663351|470911163|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
130804700|NCT00663351|470911162|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
130804701|NCT00663351|470911163|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
130804702|NCT00663351|470911162|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
130804703|NCT00663351|470911163|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
130804704|NCT00663351|470911162|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
130804705|NCT00663351|470911163|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
130804706|NCT00567112|470911164|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
130804707|NCT00567112|470911165|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
130804708|NCT00567112|470911166|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
130804709|NCT00567112|470911164|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
130804710|NCT00567112|470911165|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
130804711|NCT00567112|470911166|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
130804712|NCT00567112|470911164|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
130804713|NCT00567112|470911165|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
130804714|NCT00567112|470911166|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
130804715|NCT00545948|470911169|FG000|Overall Study|Not Treated|1|||
130804716|NCT00545948|470911170|FG001|Overall Study|Not Treated|1|||
130804717|NCT00545948|470911171|FG002|Overall Study|Not Treated|7|||
130804718|NCT03467945|470911172|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130804719|NCT03467945|470911173|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130804720|NCT03467945|470911174|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130804721|NCT03467945|470911175|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130804722|NCT03467945|470911172|FG000|Treatment Period 3|Withdrawal by Subject|1|||
130804723|NCT03467945|470911173|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130804724|NCT03467945|470911174|FG002|Treatment Period 3|Withdrawal by Subject|2|||
130804725|NCT03467945|470911175|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130804726|NCT03520387|470911190|FG000|Pre-Randomization|Withdrawal by Subject|1|||
130804727|NCT03520387|470911191|FG001|Pre-Randomization|Withdrawal by Subject|0|||
130804728|NCT03520387|470911192|FG002|Pre-Randomization|Withdrawal by Subject|0|||
130804729|NCT03520387|470911193|FG003|Pre-Randomization|Withdrawal by Subject|0|||
130804730|NCT03520387|470911194|FG004|Pre-Randomization|Withdrawal by Subject|0|||
130804731|NCT03520387|470911190|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
130804732|NCT03520387|470911191|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130804733|NCT03520387|470911192|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130804734|NCT03520387|470911193|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130804735|NCT03520387|470911194|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130804736|NCT03336866|470911195|FG000|Overall Study|Lost to Follow-up|2|||
130804737|NCT03336866|470911196|FG001|Overall Study|Lost to Follow-up|0|||
130804738|NCT03336866|470911197|FG002|Overall Study|Lost to Follow-up|3|||
130804739|NCT03336866|470911195|FG000|Overall Study|Withdrawal by Subject|1|||
130804740|NCT03336866|470911196|FG001|Overall Study|Withdrawal by Subject|1|||
130804741|NCT03336866|470911197|FG002|Overall Study|Withdrawal by Subject|0|||
130804742|NCT03336866|470911195|FG000|Overall Study|Noncompliance with clinic house rules|0|||
130804743|NCT03336866|470911196|FG001|Overall Study|Noncompliance with clinic house rules|0|||
130804744|NCT03336866|470911197|FG002|Overall Study|Noncompliance with clinic house rules|1|||
130804745|NCT04913675|470911198|FG000|Main Study (Up to Week 36)|Death|0|||
130804746|NCT04913675|470911199|FG001|Main Study (Up to Week 36)|Death|2|||
130804747|NCT04913675|470911200|FG002|Main Study (Up to Week 36)|Death|2|||
130804748|NCT04913675|470911201|FG003|Main Study (Up to Week 36)|Death|0|||
130804749|NCT04913675|470911198|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
130804750|NCT04913675|470911199|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
130804751|NCT04913675|470911200|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
130804752|NCT04913675|470911201|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
130804753|NCT04913675|470911198|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
130804754|NCT04913675|470911199|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
130804755|NCT04913675|470911200|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
130804756|NCT04913675|470911201|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
130804757|NCT04913675|470911198|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
130804758|NCT04913675|470911199|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
130804759|NCT04913675|470911200|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
130804760|NCT04913675|470911201|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
130804761|NCT04913675|470911198|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
130804762|NCT04913675|470911199|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
130804763|NCT04913675|470911200|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
130804764|NCT04913675|470911201|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
130804765|NCT02975700|470911202|FG000|Overall Study|Adverse Event|1|||
130804766|NCT02975700|470911202|FG000|Overall Study|Progressive disease|3|||
130804767|NCT02975700|470911202|FG000|Overall Study|Failed screening criteria|2|||
130804768|NCT05660538|470911204|FG000|Overall Study|Adverse Event|0|||
130804769|NCT05660538|470911205|FG001|Overall Study|Adverse Event|0|||
130804770|NCT05660538|470911206|FG002|Overall Study|Adverse Event|1|||
130804771|NCT05660538|470911207|FG003|Overall Study|Adverse Event|0|||
130804772|NCT05660538|470911204|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130804773|NCT05660538|470911205|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
130804774|NCT05660538|470911206|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
130804775|NCT05660538|470911207|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
130804776|NCT05660538|470911204|FG000|Overall Study|Lost to Follow-up|0|||
130804777|NCT05660538|470911205|FG001|Overall Study|Lost to Follow-up|0|||
130804778|NCT05660538|470911206|FG002|Overall Study|Lost to Follow-up|1|||
130804779|NCT05660538|470911207|FG003|Overall Study|Lost to Follow-up|1|||
130804780|NCT05660538|470911204|FG000|Overall Study|Death|0|||
130804781|NCT05660538|470911205|FG001|Overall Study|Death|0|||
130804782|NCT05660538|470911206|FG002|Overall Study|Death|1|||
130804783|NCT05660538|470911207|FG003|Overall Study|Death|0|||
130804784|NCT05660538|470911204|FG000|Overall Study|Physician Decision|0|||
130804785|NCT05660538|470911205|FG001|Overall Study|Physician Decision|0|||
130804786|NCT05660538|470911206|FG002|Overall Study|Physician Decision|0|||
130804787|NCT05660538|470911207|FG003|Overall Study|Physician Decision|1|||
130804788|NCT05660538|470911204|FG000|Overall Study|Sponsor Decision|1|||
130804789|NCT05660538|470911205|FG001|Overall Study|Sponsor Decision|0|||
130804790|NCT05660538|470911206|FG002|Overall Study|Sponsor Decision|0|||
130804791|NCT05660538|470911207|FG003|Overall Study|Sponsor Decision|0|||
130804792|NCT05660538|470911204|FG000|Overall Study|Other|1|||
130804793|NCT05660538|470911205|FG001|Overall Study|Other|0|||
130804794|NCT05660538|470911206|FG002|Overall Study|Other|0|||
130804795|NCT05660538|470911207|FG003|Overall Study|Other|1|||
130804796|NCT05660538|470911204|FG000|Overall Study|Randomized but did not receive study drug|1|||
130804797|NCT05660538|470911205|FG001|Overall Study|Randomized but did not receive study drug|0|||
130804798|NCT05660538|470911206|FG002|Overall Study|Randomized but did not receive study drug|0|||
130804799|NCT05660538|470911207|FG003|Overall Study|Randomized but did not receive study drug|1|||
130804800|NCT05660538|470911204|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
130804801|NCT05660538|470911205|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
130804802|NCT05660538|470911206|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
130804803|NCT05660538|470911207|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
130804804|NCT04518410|470911211|FG000|Overall Study|Lost to Follow-up|1|||
130804805|NCT04518410|470911212|FG001|Overall Study|Lost to Follow-up|1|||
130804806|NCT04518410|470911213|FG002|Overall Study|Lost to Follow-up|8|||
130804807|NCT04518410|470911214|FG003|Overall Study|Lost to Follow-up|5|||
130804808|NCT04518410|470911215|FG004|Overall Study|Lost to Follow-up|92|||
130804809|NCT04518410|470911216|FG005|Overall Study|Lost to Follow-up|25|||
130804810|NCT04518410|470911217|FG006|Overall Study|Lost to Follow-up|25|||
130804811|NCT04518410|470911218|FG007|Overall Study|Lost to Follow-up|3|||
130804812|NCT04518410|470911219|FG008|Overall Study|Lost to Follow-up|2|||
130804813|NCT04518410|470911220|FG009|Overall Study|Lost to Follow-up|13|||
130804814|NCT04518410|470911221|FG010|Overall Study|Lost to Follow-up|9|||
130804815|NCT04518410|470911222|FG011|Overall Study|Lost to Follow-up|13|||
130804816|NCT04518410|470911223|FG012|Overall Study|Lost to Follow-up|9|||
130804817|NCT04518410|470911224|FG013|Overall Study|Lost to Follow-up|13|||
130804818|NCT04518410|470911225|FG014|Overall Study|Lost to Follow-up|8|||
130804819|NCT04518410|470911226|FG015|Overall Study|Lost to Follow-up|10|||
130804820|NCT04518410|470911227|FG016|Overall Study|Lost to Follow-up|6|||
130804821|NCT04518410|470911228|FG017|Overall Study|Lost to Follow-up|13|||
130804822|NCT04518410|470911229|FG018|Overall Study|Lost to Follow-up|21|||
130804823|NCT04518410|470911230|FG019|Overall Study|Lost to Follow-up|6|||
130804824|NCT04518410|470911231|FG020|Overall Study|Lost to Follow-up|7|||
130804825|NCT04518410|470911232|FG021|Overall Study|Lost to Follow-up|21|||
130804826|NCT04518410|470911233|FG022|Overall Study|Lost to Follow-up|1|||
130804827|NCT04518410|470911234|FG023|Overall Study|Lost to Follow-up|7|||
130804828|NCT04518410|470911235|FG024|Overall Study|Lost to Follow-up|6|||
130804829|NCT04518410|470911211|FG000|Overall Study|Withdrawal by Subject|1|||
130804830|NCT04518410|470911212|FG001|Overall Study|Withdrawal by Subject|2|||
130804831|NCT04518410|470911213|FG002|Overall Study|Withdrawal by Subject|2|||
130804832|NCT04518410|470911214|FG003|Overall Study|Withdrawal by Subject|3|||
130804833|NCT04518410|470911215|FG004|Overall Study|Withdrawal by Subject|20|||
130804834|NCT04518410|470911216|FG005|Overall Study|Withdrawal by Subject|20|||
130804835|NCT04518410|470911217|FG006|Overall Study|Withdrawal by Subject|25|||
130804836|NCT04518410|470911218|FG007|Overall Study|Withdrawal by Subject|6|||
130804837|NCT04518410|470911219|FG008|Overall Study|Withdrawal by Subject|1|||
130804838|NCT04518410|470911220|FG009|Overall Study|Withdrawal by Subject|12|||
130804839|NCT04518410|470911221|FG010|Overall Study|Withdrawal by Subject|5|||
130804840|NCT04518410|470911222|FG011|Overall Study|Withdrawal by Subject|7|||
130804841|NCT04518410|470911223|FG012|Overall Study|Withdrawal by Subject|2|||
130804842|NCT04518410|470911224|FG013|Overall Study|Withdrawal by Subject|13|||
130804843|NCT04518410|470911225|FG014|Overall Study|Withdrawal by Subject|4|||
130804844|NCT04518410|470911226|FG015|Overall Study|Withdrawal by Subject|9|||
130804845|NCT04518410|470911227|FG016|Overall Study|Withdrawal by Subject|0|||
130804846|NCT04518410|470911228|FG017|Overall Study|Withdrawal by Subject|15|||
130804847|NCT04518410|470911229|FG018|Overall Study|Withdrawal by Subject|12|||
130804848|NCT04518410|470911230|FG019|Overall Study|Withdrawal by Subject|9|||
130804849|NCT04518410|470911231|FG020|Overall Study|Withdrawal by Subject|14|||
130804850|NCT04518410|470911232|FG021|Overall Study|Withdrawal by Subject|3|||
130804851|NCT04518410|470911233|FG022|Overall Study|Withdrawal by Subject|2|||
130804852|NCT04518410|470911234|FG023|Overall Study|Withdrawal by Subject|9|||
130804853|NCT04518410|470911235|FG024|Overall Study|Withdrawal by Subject|8|||
130804854|NCT04518410|470911211|FG000|Overall Study|Other|1|||
130804855|NCT04518410|470911212|FG001|Overall Study|Other|0|||
130804856|NCT04518410|470911213|FG002|Overall Study|Other|0|||
130804857|NCT04518410|470911214|FG003|Overall Study|Other|1|||
130804858|NCT04518410|470911215|FG004|Overall Study|Other|6|||
130804859|NCT04518410|470911216|FG005|Overall Study|Other|6|||
130804860|NCT04518410|470911217|FG006|Overall Study|Other|5|||
130804861|NCT04518410|470911218|FG007|Overall Study|Other|2|||
130804862|NCT04518410|470911219|FG008|Overall Study|Other|0|||
130804863|NCT04518410|470911220|FG009|Overall Study|Other|1|||
130804864|NCT04518410|470911221|FG010|Overall Study|Other|0|||
130804865|NCT04518410|470911222|FG011|Overall Study|Other|2|||
130804866|NCT04518410|470911223|FG012|Overall Study|Other|0|||
130804867|NCT04518410|470911224|FG013|Overall Study|Other|0|||
130804868|NCT04518410|470911225|FG014|Overall Study|Other|0|||
130804869|NCT04518410|470911226|FG015|Overall Study|Other|3|||
130804870|NCT04518410|470911227|FG016|Overall Study|Other|1|||
130804871|NCT04518410|470911228|FG017|Overall Study|Other|1|||
130804872|NCT04518410|470911229|FG018|Overall Study|Other|1|||
130804873|NCT04518410|470911230|FG019|Overall Study|Other|0|||
130804874|NCT04518410|470911231|FG020|Overall Study|Other|1|||
130804875|NCT04518410|470911232|FG021|Overall Study|Other|0|||
130804876|NCT04518410|470911233|FG022|Overall Study|Other|1|||
130804877|NCT04518410|470911234|FG023|Overall Study|Other|2|||
130804878|NCT04518410|470911235|FG024|Overall Study|Other|2|||
130804879|NCT04518410|470911211|FG000|Overall Study|Protocol Violation|0|||
130804880|NCT04518410|470911212|FG001|Overall Study|Protocol Violation|0|||
130804881|NCT04518410|470911213|FG002|Overall Study|Protocol Violation|0|||
130804882|NCT04518410|470911214|FG003|Overall Study|Protocol Violation|2|||
130804883|NCT04518410|470911215|FG004|Overall Study|Protocol Violation|17|||
130804884|NCT04518410|470911216|FG005|Overall Study|Protocol Violation|1|||
130804885|NCT04518410|470911217|FG006|Overall Study|Protocol Violation|2|||
130804886|NCT04518410|470911218|FG007|Overall Study|Protocol Violation|1|||
130804887|NCT04518410|470911219|FG008|Overall Study|Protocol Violation|0|||
130804888|NCT04518410|470911220|FG009|Overall Study|Protocol Violation|0|||
130804889|NCT04518410|470911221|FG010|Overall Study|Protocol Violation|0|||
130804890|NCT04518410|470911222|FG011|Overall Study|Protocol Violation|0|||
130804891|NCT04518410|470911223|FG012|Overall Study|Protocol Violation|0|||
130804892|NCT04518410|470911224|FG013|Overall Study|Protocol Violation|0|||
130804893|NCT04518410|470911225|FG014|Overall Study|Protocol Violation|0|||
130804894|NCT04518410|470911226|FG015|Overall Study|Protocol Violation|0|||
130804895|NCT04518410|470911227|FG016|Overall Study|Protocol Violation|1|||
130804896|NCT04518410|470911228|FG017|Overall Study|Protocol Violation|1|||
130804897|NCT04518410|470911229|FG018|Overall Study|Protocol Violation|0|||
130804898|NCT04518410|470911230|FG019|Overall Study|Protocol Violation|0|||
130804899|NCT04518410|470911231|FG020|Overall Study|Protocol Violation|1|||
130804900|NCT04518410|470911232|FG021|Overall Study|Protocol Violation|2|||
130804901|NCT04518410|470911233|FG022|Overall Study|Protocol Violation|0|||
130804902|NCT04518410|470911234|FG023|Overall Study|Protocol Violation|3|||
130804903|NCT04518410|470911235|FG024|Overall Study|Protocol Violation|0|||
130804904|NCT04518410|470911211|FG000|Overall Study|Death|0|||
130804905|NCT04518410|470911212|FG001|Overall Study|Death|0|||
130804906|NCT04518410|470911213|FG002|Overall Study|Death|0|||
130804907|NCT04518410|470911214|FG003|Overall Study|Death|0|||
130804908|NCT04518410|470911215|FG004|Overall Study|Death|12|||
130804909|NCT04518410|470911216|FG005|Overall Study|Death|2|||
130804910|NCT04518410|470911217|FG006|Overall Study|Death|11|||
130804911|NCT04518410|470911218|FG007|Overall Study|Death|0|||
130804912|NCT04518410|470911219|FG008|Overall Study|Death|1|||
130804913|NCT04518410|470911220|FG009|Overall Study|Death|0|||
130804914|NCT04518410|470911221|FG010|Overall Study|Death|0|||
130804915|NCT04518410|470911222|FG011|Overall Study|Death|0|||
130804916|NCT04518410|470911223|FG012|Overall Study|Death|0|||
130804917|NCT04518410|470911224|FG013|Overall Study|Death|1|||
130804918|NCT04518410|470911225|FG014|Overall Study|Death|1|||
130804919|NCT04518410|470911226|FG015|Overall Study|Death|0|||
130804920|NCT04518410|470911227|FG016|Overall Study|Death|0|||
130804921|NCT04518410|470911228|FG017|Overall Study|Death|1|||
130804922|NCT04518410|470911229|FG018|Overall Study|Death|4|||
130804923|NCT04518410|470911230|FG019|Overall Study|Death|4|||
130804924|NCT04518410|470911231|FG020|Overall Study|Death|1|||
130804925|NCT04518410|470911232|FG021|Overall Study|Death|0|||
130804926|NCT04518410|470911233|FG022|Overall Study|Death|0|||
130804927|NCT04518410|470911234|FG023|Overall Study|Death|0|||
130804928|NCT04518410|470911235|FG024|Overall Study|Death|0|||
130804929|NCT04518410|470911211|FG000|Overall Study|Requirement to start alternative therapy|0|||
130804930|NCT04518410|470911212|FG001|Overall Study|Requirement to start alternative therapy|0|||
130804931|NCT04518410|470911213|FG002|Overall Study|Requirement to start alternative therapy|1|||
130804932|NCT04518410|470911214|FG003|Overall Study|Requirement to start alternative therapy|0|||
130804933|NCT04518410|470911215|FG004|Overall Study|Requirement to start alternative therapy|0|||
130804934|NCT04518410|470911216|FG005|Overall Study|Requirement to start alternative therapy|0|||
130804935|NCT04518410|470911217|FG006|Overall Study|Requirement to start alternative therapy|0|||
130804936|NCT04518410|470911218|FG007|Overall Study|Requirement to start alternative therapy|0|||
130804937|NCT04518410|470911219|FG008|Overall Study|Requirement to start alternative therapy|0|||
130804938|NCT04518410|470911220|FG009|Overall Study|Requirement to start alternative therapy|0|||
130804939|NCT04518410|470911221|FG010|Overall Study|Requirement to start alternative therapy|0|||
130804940|NCT04518410|470911222|FG011|Overall Study|Requirement to start alternative therapy|0|||
130804941|NCT04518410|470911223|FG012|Overall Study|Requirement to start alternative therapy|0|||
130804942|NCT04518410|470911224|FG013|Overall Study|Requirement to start alternative therapy|0|||
130804943|NCT04518410|470911225|FG014|Overall Study|Requirement to start alternative therapy|0|||
130804944|NCT04518410|470911226|FG015|Overall Study|Requirement to start alternative therapy|0|||
130804945|NCT04518410|470911227|FG016|Overall Study|Requirement to start alternative therapy|0|||
130804946|NCT04518410|470911228|FG017|Overall Study|Requirement to start alternative therapy|0|||
130804947|NCT04518410|470911229|FG018|Overall Study|Requirement to start alternative therapy|0|||
130804948|NCT04518410|470911230|FG019|Overall Study|Requirement to start alternative therapy|0|||
130804949|NCT04518410|470911231|FG020|Overall Study|Requirement to start alternative therapy|0|||
130804950|NCT04518410|470911232|FG021|Overall Study|Requirement to start alternative therapy|0|||
130804951|NCT04518410|470911233|FG022|Overall Study|Requirement to start alternative therapy|0|||
130804952|NCT04518410|470911234|FG023|Overall Study|Requirement to start alternative therapy|0|||
130804953|NCT04518410|470911235|FG024|Overall Study|Requirement to start alternative therapy|0|||
130804954|NCT04518410|470911211|FG000|Overall Study|Randomized but not treated|0|||
130804955|NCT04518410|470911212|FG001|Overall Study|Randomized but not treated|0|||
130804956|NCT04518410|470911213|FG002|Overall Study|Randomized but not treated|0|||
130804957|NCT04518410|470911214|FG003|Overall Study|Randomized but not treated|2|||
130804958|NCT04518410|470911215|FG004|Overall Study|Randomized but not treated|6|||
130804959|NCT04518410|470911216|FG005|Overall Study|Randomized but not treated|4|||
130804960|NCT04518410|470911217|FG006|Overall Study|Randomized but not treated|3|||
130804961|NCT04518410|470911218|FG007|Overall Study|Randomized but not treated|3|||
130804962|NCT04518410|470911219|FG008|Overall Study|Randomized but not treated|0|||
130804963|NCT04518410|470911220|FG009|Overall Study|Randomized but not treated|4|||
130804964|NCT04518410|470911221|FG010|Overall Study|Randomized but not treated|0|||
130804965|NCT04518410|470911222|FG011|Overall Study|Randomized but not treated|0|||
130804966|NCT04518410|470911223|FG012|Overall Study|Randomized but not treated|1|||
130804967|NCT04518410|470911224|FG013|Overall Study|Randomized but not treated|3|||
130804968|NCT04518410|470911225|FG014|Overall Study|Randomized but not treated|3|||
130804969|NCT04518410|470911226|FG015|Overall Study|Randomized but not treated|3|||
130804970|NCT04518410|470911227|FG016|Overall Study|Randomized but not treated|4|||
130804971|NCT04518410|470911228|FG017|Overall Study|Randomized but not treated|5|||
130804972|NCT04518410|470911229|FG018|Overall Study|Randomized but not treated|4|||
130804973|NCT04518410|470911230|FG019|Overall Study|Randomized but not treated|0|||
130804974|NCT04518410|470911231|FG020|Overall Study|Randomized but not treated|0|||
130804975|NCT04518410|470911232|FG021|Overall Study|Randomized but not treated|5|||
130804976|NCT04518410|470911233|FG022|Overall Study|Randomized but not treated|0|||
130804977|NCT04518410|470911234|FG023|Overall Study|Randomized but not treated|3|||
130804978|NCT04518410|470911235|FG024|Overall Study|Randomized but not treated|1|||
130804979|NCT04518410|470911211|FG000|Overall Study|Screen Fail but Randomized|0|||
130804980|NCT04518410|470911212|FG001|Overall Study|Screen Fail but Randomized|0|||
130804981|NCT04518410|470911213|FG002|Overall Study|Screen Fail but Randomized|0|||
130804982|NCT04518410|470911214|FG003|Overall Study|Screen Fail but Randomized|0|||
130804983|NCT04518410|470911215|FG004|Overall Study|Screen Fail but Randomized|2|||
130804984|NCT04518410|470911216|FG005|Overall Study|Screen Fail but Randomized|0|||
130804985|NCT04518410|470911217|FG006|Overall Study|Screen Fail but Randomized|0|||
130804986|NCT04518410|470911218|FG007|Overall Study|Screen Fail but Randomized|0|||
130804987|NCT04518410|470911219|FG008|Overall Study|Screen Fail but Randomized|0|||
130804988|NCT04518410|470911220|FG009|Overall Study|Screen Fail but Randomized|0|||
130804989|NCT04518410|470911221|FG010|Overall Study|Screen Fail but Randomized|0|||
130804990|NCT04518410|470911222|FG011|Overall Study|Screen Fail but Randomized|0|||
130804991|NCT04518410|470911223|FG012|Overall Study|Screen Fail but Randomized|0|||
130804992|NCT04518410|470911224|FG013|Overall Study|Screen Fail but Randomized|0|||
130804993|NCT04518410|470911225|FG014|Overall Study|Screen Fail but Randomized|0|||
130804994|NCT04518410|470911226|FG015|Overall Study|Screen Fail but Randomized|0|||
130804995|NCT04518410|470911227|FG016|Overall Study|Screen Fail but Randomized|0|||
130804996|NCT04518410|470911228|FG017|Overall Study|Screen Fail but Randomized|0|||
130804997|NCT04518410|470911229|FG018|Overall Study|Screen Fail but Randomized|0|||
130804998|NCT04518410|470911230|FG019|Overall Study|Screen Fail but Randomized|0|||
130804999|NCT04518410|470911231|FG020|Overall Study|Screen Fail but Randomized|0|||
130805000|NCT04518410|470911232|FG021|Overall Study|Screen Fail but Randomized|0|||
130805001|NCT04518410|470911233|FG022|Overall Study|Screen Fail but Randomized|0|||
130805002|NCT04518410|470911234|FG023|Overall Study|Screen Fail but Randomized|0|||
130805003|NCT04518410|470911235|FG024|Overall Study|Screen Fail but Randomized|0|||
130805004|NCT04518410|470911211|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130805005|NCT04518410|470911212|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130805006|NCT04518410|470911213|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130805007|NCT04518410|470911214|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130805008|NCT04518410|470911215|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
130805009|NCT04518410|470911216|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
130805010|NCT04518410|470911217|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
130805011|NCT04518410|470911218|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130805012|NCT04518410|470911219|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
130805013|NCT04518410|470911220|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
130805014|NCT04518410|470911221|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130805015|NCT04518410|470911222|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130805016|NCT04518410|470911223|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130805017|NCT04518410|470911224|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130805018|NCT04518410|470911225|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130805019|NCT04518410|470911226|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
130805020|NCT04518410|470911227|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
130805021|NCT04518410|470911228|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
130805022|NCT04518410|470911229|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
130805023|NCT04518410|470911230|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
130805024|NCT04518410|470911231|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
130805025|NCT04518410|470911232|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
130805026|NCT04518410|470911233|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
130805027|NCT04518410|470911234|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130805028|NCT04518410|470911235|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
130805029|NCT04518410|470911211|FG000|Overall Study|Dual Enrolled Subject|0|||
130805030|NCT04518410|470911212|FG001|Overall Study|Dual Enrolled Subject|0|||
130805031|NCT04518410|470911213|FG002|Overall Study|Dual Enrolled Subject|0|||
130805032|NCT04518410|470911214|FG003|Overall Study|Dual Enrolled Subject|0|||
130805033|NCT04518410|470911215|FG004|Overall Study|Dual Enrolled Subject|0|||
130805034|NCT04518410|470911216|FG005|Overall Study|Dual Enrolled Subject|0|||
130805035|NCT04518410|470911217|FG006|Overall Study|Dual Enrolled Subject|0|||
130805036|NCT04518410|470911218|FG007|Overall Study|Dual Enrolled Subject|0|||
130805037|NCT04518410|470911219|FG008|Overall Study|Dual Enrolled Subject|0|||
130805038|NCT04518410|470911220|FG009|Overall Study|Dual Enrolled Subject|0|||
130805039|NCT04518410|470911221|FG010|Overall Study|Dual Enrolled Subject|0|||
130805040|NCT04518410|470911222|FG011|Overall Study|Dual Enrolled Subject|0|||
130805041|NCT04518410|470911223|FG012|Overall Study|Dual Enrolled Subject|0|||
130805042|NCT04518410|470911224|FG013|Overall Study|Dual Enrolled Subject|0|||
130805043|NCT04518410|470911225|FG014|Overall Study|Dual Enrolled Subject|0|||
130805044|NCT04518410|470911226|FG015|Overall Study|Dual Enrolled Subject|0|||
130805045|NCT04518410|470911227|FG016|Overall Study|Dual Enrolled Subject|0|||
130805046|NCT04518410|470911228|FG017|Overall Study|Dual Enrolled Subject|1|||
130805047|NCT04518410|470911229|FG018|Overall Study|Dual Enrolled Subject|0|||
130805048|NCT04518410|470911230|FG019|Overall Study|Dual Enrolled Subject|0|||
130805049|NCT04518410|470911231|FG020|Overall Study|Dual Enrolled Subject|0|||
130805050|NCT04518410|470911232|FG021|Overall Study|Dual Enrolled Subject|0|||
130805051|NCT04518410|470911233|FG022|Overall Study|Dual Enrolled Subject|0|||
130805052|NCT04518410|470911234|FG023|Overall Study|Dual Enrolled Subject|0|||
130805053|NCT04518410|470911235|FG024|Overall Study|Dual Enrolled Subject|0|||
130805054|NCT03462563|470911236|FG000|Overall Study|Death|1|||
130805055|NCT03462563|470911237|FG001|Overall Study|Death|1|||
130805056|NCT03462563|470911236|FG000|Overall Study|Termination of study|2|||
130805057|NCT03462563|470911237|FG001|Overall Study|Termination of study|1|||
130805058|NCT03462563|470911236|FG000|Overall Study|Adverse Event|1|||
130805059|NCT03462563|470911237|FG001|Overall Study|Adverse Event|3|||
130805060|NCT03462563|470911236|FG000|Overall Study|Unspecified reason|10|||
130805061|NCT03462563|470911237|FG001|Overall Study|Unspecified reason|12|||
130805062|NCT03462563|470911236|FG000|Overall Study|Physician Decision|1|||
130805063|NCT03462563|470911237|FG001|Overall Study|Physician Decision|0|||
130805064|NCT01740427|470911238|FG000|Overall Study|Objective Progression or Relapse|286|||
130805065|NCT01740427|470911239|FG001|Overall Study|Objective Progression or Relapse|172|||
130805066|NCT01740427|470911238|FG000|Overall Study|Adverse Event|32|||
130805067|NCT01740427|470911239|FG001|Overall Study|Adverse Event|9|||
130805068|NCT01740427|470911238|FG000|Overall Study|Global Deterioration of Health Status|28|||
130805069|NCT01740427|470911239|FG001|Overall Study|Global Deterioration of Health Status|12|||
130805070|NCT01740427|470911238|FG000|Overall Study|Participant Refused Continued Treatment|27|||
130805071|NCT01740427|470911239|FG001|Overall Study|Participant Refused Continued Treatment|15|||
130805072|NCT01740427|470911238|FG000|Overall Study|Unspecified reasons|52|||
130805073|NCT01740427|470911239|FG001|Overall Study|Unspecified reasons|8|||
130805074|NCT01740427|470911238|FG000|Overall Study|Death|10|||
130805075|NCT01740427|470911239|FG001|Overall Study|Death|3|||
130805076|NCT01740427|470911238|FG000|Overall Study|Protocol Violation|5|||
130805077|NCT01740427|470911239|FG001|Overall Study|Protocol Violation|3|||
130805078|NCT01740427|470911238|FG000|Overall Study|Lost to Follow-up|3|||
130805079|NCT01740427|470911239|FG001|Overall Study|Lost to Follow-up|0|||
130805080|NCT01740427|470911238|FG000|Overall Study|Site Terminated by Sponsor|1|||
130805081|NCT01740427|470911239|FG001|Overall Study|Site Terminated by Sponsor|0|||
130805082|NCT04796207|470911242|FG000|Overall Study|Lost to Follow-up|7|||
130805083|NCT04796207|470911243|FG001|Overall Study|Lost to Follow-up|2|||
130805084|NCT02405962|470911246|FG000|Overall Study|Lost to Follow-up|1|||
130805085|NCT02405962|470911247|FG001|Overall Study|Lost to Follow-up|4|||
130805086|NCT02405962|470911246|FG000|Overall Study|A participant has moved to another place|0|||
130805087|NCT02405962|470911247|FG001|Overall Study|A participant has moved to another place|1|||
130805088|NCT00105508|470911252|FG000|Overall Study|Prephase Dropout|1|||
130805089|NCT00105508|470911253|FG001|Overall Study|Prephase Dropout|0|||
130805090|NCT00105508|470911252|FG000|Overall Study|Adverse Event|16|||
130805091|NCT00105508|470911253|FG001|Overall Study|Adverse Event|19|||
130805092|NCT00105508|470911252|FG000|Overall Study|Insufficient Efficacy|1|||
130805093|NCT00105508|470911253|FG001|Overall Study|Insufficient Efficacy|0|||
130805094|NCT00105508|470911252|FG000|Overall Study|Withdrawal by Subject|10|||
130805095|NCT00105508|470911253|FG001|Overall Study|Withdrawal by Subject|6|||
130805096|NCT00105508|470911252|FG000|Overall Study|Lost to Follow-up|3|||
130805097|NCT00105508|470911253|FG001|Overall Study|Lost to Follow-up|0|||
130805098|NCT00105508|470911252|FG000|Overall Study|Protocol Violation|1|||
130805099|NCT00105508|470911253|FG001|Overall Study|Protocol Violation|2|||
130805100|NCT00105508|470911252|FG000|Overall Study|Other|8|||
130805101|NCT00105508|470911253|FG001|Overall Study|Other|9|||
130805102|NCT01800058|470911255|FG000|Overall Study|Lost to Follow-up|1|||
130805103|NCT03548415|470912966|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130805104|NCT03548415|470912967|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130805105|NCT03548415|470912968|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
130805106|NCT03548415|470912969|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
130805107|NCT03548415|470912970|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
130805108|NCT01803737|470912971|FG000|Overall Study|Lack of Time|1|||
130805109|NCT01803737|470912972|FG001|Overall Study|Lack of Time|0|||
130805110|NCT01803737|470912971|FG000|Overall Study|Medical Reason|0|||
130805111|NCT01803737|470912972|FG001|Overall Study|Medical Reason|1|||
130805112|NCT01803737|470912971|FG000|Overall Study|Lost to Follow-up|0|||
130805113|NCT01803737|470912972|FG001|Overall Study|Lost to Follow-up|2|||
130805114|NCT03994120|470912975|FG000|Overall Study|Lost to Follow-up|3|||
130805115|NCT03994120|470912976|FG001|Overall Study|Lost to Follow-up|1|||
130805116|NCT01111292|470912977|FG000|Treatment|Physician Decision|1|||
130805117|NCT01111292|470912978|FG001|Treatment|Physician Decision|1|||
130805118|NCT00564070|470912981|FG000|Overall Study|Lost to Follow-up|9|||
130805119|NCT00564070|470912982|FG001|Overall Study|Lost to Follow-up|7|||
130805120|NCT00564070|470912981|FG000|Overall Study|Worsening depression, referred to care|3|||
130805121|NCT00564070|470912982|FG001|Overall Study|Worsening depression, referred to care|0|||
130805122|NCT03142334|470912986|FG000|Overall Study|Death|18|||
130805123|NCT03142334|470912987|FG001|Overall Study|Death|33|||
130805124|NCT03142334|470912986|FG000|Overall Study|Withdrawal by Subject|15|||
130805125|NCT03142334|470912987|FG001|Overall Study|Withdrawal by Subject|11|||
130805126|NCT03142334|470912986|FG000|Overall Study|Ongoing on trial follow up|463|||
130805127|NCT03142334|470912987|FG001|Overall Study|Ongoing on trial follow up|454|||
130805128|NCT01217047|470912988|FG000|Overall Study|Lost to Follow-up|0|||
130805129|NCT01217047|470912989|FG001|Overall Study|Lost to Follow-up|1|||
130805130|NCT01217047|470912990|FG002|Overall Study|Lost to Follow-up|0|||
130805131|NCT05529173|470912991|FG000|Overall Study|Physician Decision|3|||
130805132|NCT05529173|470912992|FG001|Overall Study|Physician Decision|6|||
130805133|NCT05529173|470912991|FG000|Overall Study|Sample shipment delay more than one day|4|||
130805134|NCT05529173|470912992|FG001|Overall Study|Sample shipment delay more than one day|0|||
130805135|NCT00609973|470913001|FG000|Overall Study|Adverse Event|2|||
130805136|NCT00609973|470913002|FG001|Overall Study|Adverse Event|1|||
130805137|NCT00609973|470913001|FG000|Overall Study|Protocol Violation|4|||
130805138|NCT00609973|470913002|FG001|Overall Study|Protocol Violation|3|||
130805139|NCT00609973|470913001|FG000|Overall Study|Lost to Follow-up|2|||
130805140|NCT00609973|470913002|FG001|Overall Study|Lost to Follow-up|1|||
130805141|NCT00609973|470913001|FG000|Overall Study|Withdrawal by Subject|0|||
130805142|NCT00609973|470913002|FG001|Overall Study|Withdrawal by Subject|1|||
130805143|NCT00191152|470913003|FG000|Initial Treatment|Adverse Event|43|||
130805144|NCT00191152|470913004|FG001|Initial Treatment|Adverse Event|67|||
130805145|NCT00191152|470913003|FG000|Initial Treatment|Physician Decision|40|||
130805146|NCT00191152|470913004|FG001|Initial Treatment|Physician Decision|31|||
130805147|NCT00191152|470913003|FG000|Initial Treatment|Withdrawal by Subject|40|||
130805148|NCT00191152|470913004|FG001|Initial Treatment|Withdrawal by Subject|28|||
130805149|NCT00191152|470913003|FG000|Initial Treatment|Lost to Follow-up|0|||
130805150|NCT00191152|470913004|FG001|Initial Treatment|Lost to Follow-up|6|||
130805151|NCT00191152|470913003|FG000|Initial Treatment|Other|18|||
130805152|NCT00191152|470913004|FG001|Initial Treatment|Other|21|||
130805153|NCT00191152|470913003|FG000|Crossover Treatment|Adverse Event|8|||
130805154|NCT00191152|470913004|FG001|Crossover Treatment|Adverse Event|8|||
130805155|NCT00191152|470913003|FG000|Crossover Treatment|Physician Decision|7|||
130805156|NCT00191152|470913004|FG001|Crossover Treatment|Physician Decision|7|||
130805157|NCT00191152|470913003|FG000|Crossover Treatment|Withdrawal by Subject|6|||
130805158|NCT00191152|470913004|FG001|Crossover Treatment|Withdrawal by Subject|9|||
130805159|NCT00191152|470913003|FG000|Crossover Treatment|Lost to Follow-up|2|||
130805160|NCT00191152|470913004|FG001|Crossover Treatment|Lost to Follow-up|1|||
130805161|NCT00191152|470913003|FG000|Crossover Treatment|Other|4|||
130805162|NCT00191152|470913004|FG001|Crossover Treatment|Other|3|||
130805163|NCT00114777|470913005|FG000|Randomization to Month 36|Death|10|||
130805164|NCT00114777|470913006|FG001|Randomization to Month 36|Death|4|||
130805165|NCT00114777|470913007|FG002|Randomization to Month 36|Death|3|||
130805166|NCT00114777|470913005|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
130805167|NCT00114777|470913006|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
130805168|NCT00114777|470913007|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
130805169|NCT00114777|470913005|FG000|Randomization to Month 36|Lack of Efficacy|19|||
130805170|NCT00114777|470913006|FG001|Randomization to Month 36|Lack of Efficacy|15|||
130805171|NCT00114777|470913007|FG002|Randomization to Month 36|Lack of Efficacy|17|||
130805172|NCT00114777|470913005|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
130805173|NCT00114777|470913006|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
130805174|NCT00114777|470913007|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
130805175|NCT00114777|470913005|FG000|Randomization to Month 36|Adverse Event|34|||
130805176|NCT00114777|470913006|FG001|Randomization to Month 36|Adverse Event|35|||
130805177|NCT00114777|470913007|FG002|Randomization to Month 36|Adverse Event|44|||
130805178|NCT00114777|470913005|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
130805179|NCT00114777|470913006|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
130805180|NCT00114777|470913007|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
130805181|NCT00114777|470913005|FG000|Randomization to Month 36|Other|9|||
130805182|NCT00114777|470913006|FG001|Randomization to Month 36|Other|3|||
130805183|NCT00114777|470913007|FG002|Randomization to Month 36|Other|12|||
130805184|NCT00114777|470913005|FG000|Long-Term Extension to Month 84|Death|8|||
130805185|NCT00114777|470913006|FG001|Long-Term Extension to Month 84|Death|13|||
130805186|NCT00114777|470913007|FG002|Long-Term Extension to Month 84|Death|7|||
130805187|NCT00114777|470913005|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
130805188|NCT00114777|470913006|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
130805189|NCT00114777|470913007|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
130805190|NCT00114777|470913005|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
130805191|NCT00114777|470913006|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
130805192|NCT00114777|470913007|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
130805193|NCT00114777|470913005|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
130805194|NCT00114777|470913006|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
130805195|NCT00114777|470913007|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
130805196|NCT00114777|470913005|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
130805197|NCT00114777|470913006|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
130805198|NCT00114777|470913007|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
130805199|NCT00114777|470913005|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
130805200|NCT00114777|470913006|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
130805201|NCT00114777|470913007|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
130805202|NCT00114777|470913005|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
130805203|NCT00114777|470913006|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
130805204|NCT00114777|470913007|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
130805205|NCT00114777|470913005|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
130805206|NCT00114777|470913006|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
130805207|NCT00114777|470913007|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
130805208|NCT00114777|470913005|FG000|Long-Term Extension to Month 84|Other|2|||
130805209|NCT00114777|470913006|FG001|Long-Term Extension to Month 84|Other|0|||
130805210|NCT00114777|470913007|FG002|Long-Term Extension to Month 84|Other|2|||
130805211|NCT00629239|470913012|FG000|Overall Study|Adverse Event|7|||
130805212|NCT00629239|470913013|FG001|Overall Study|Adverse Event|4|||
130805213|NCT00629239|470913012|FG000|Overall Study|Physician Decision|1|||
130805214|NCT00629239|470913013|FG001|Overall Study|Physician Decision|0|||
130805215|NCT01851369|470913014|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805216|NCT01851369|470913015|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805217|NCT01851369|470913016|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805218|NCT01851369|470913017|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805219|NCT01851369|470913018|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805220|NCT01851369|470913019|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
130805221|NCT01851369|470913020|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805222|NCT01851369|470913021|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805223|NCT01851369|470913022|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805224|NCT01851369|470913023|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805225|NCT01851369|470913024|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805226|NCT01851369|470913025|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805227|NCT01851369|470913026|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130805228|NCT02453191|470913029|FG000|Overall Study|Withdrawal by Subject|1|||
130805229|NCT01520714|470913030|FG000|Overall Study|Protocol Violation|0|||
130805230|NCT01520714|470913031|FG001|Overall Study|Protocol Violation|3|||
130805231|NCT01520714|470913030|FG000|Overall Study|Adverse Event|0|||
130805232|NCT01520714|470913031|FG001|Overall Study|Adverse Event|2|||
130805233|NCT01520714|470913030|FG000|Overall Study|Lack of Efficacy|0|||
130805234|NCT01520714|470913031|FG001|Overall Study|Lack of Efficacy|1|||
130805235|NCT02336503|470913032|FG000|Overall Study|Lost to Follow-up|0|||
130805236|NCT02336503|470913033|FG001|Overall Study|Lost to Follow-up|3|||
130805237|NCT02336503|470913034|FG002|Overall Study|Lost to Follow-up|0|||
130805238|NCT02336503|470913035|FG003|Overall Study|Lost to Follow-up|2|||
130763852|NCT00195494|470758685|FG003|Year 1|Missed >4 consecutive doses|0|||
130763853|NCT00195494|470758686|FG004|Year 1|Missed >4 consecutive doses|3|||
130763854|NCT00195494|470758687|FG005|Year 1|Missed >4 consecutive doses|2|||
130763855|NCT00195494|470758682|FG000|Year 1|Protocol deviation|0|||
130763856|NCT00195494|470758683|FG001|Year 1|Protocol deviation|0|||
130763857|NCT00195494|470758684|FG002|Year 1|Protocol deviation|0|||
130763858|NCT00195494|470758685|FG003|Year 1|Protocol deviation|0|||
130763859|NCT00195494|470758686|FG004|Year 1|Protocol deviation|2|||
130763860|NCT00195494|470758687|FG005|Year 1|Protocol deviation|3|||
130763861|NCT00195494|470758682|FG000|Year 1|Physician Decision|0|||
130763862|NCT00195494|470758683|FG001|Year 1|Physician Decision|0|||
130763863|NCT00195494|470758684|FG002|Year 1|Physician Decision|0|||
130763864|NCT00195494|470758685|FG003|Year 1|Physician Decision|0|||
130763865|NCT00195494|470758686|FG004|Year 1|Physician Decision|1|||
130763866|NCT00195494|470758687|FG005|Year 1|Physician Decision|0|||
130763867|NCT00195494|470758682|FG000|Year 1|Withdrawal by Subject|0|||
130763868|NCT00195494|470758683|FG001|Year 1|Withdrawal by Subject|0|||
130805239|NCT02336503|470913032|FG000|Overall Study|Withdrawal by Subject|2|||
130805240|NCT02336503|470913033|FG001|Overall Study|Withdrawal by Subject|0|||
130805241|NCT02336503|470913034|FG002|Overall Study|Withdrawal by Subject|0|||
130805242|NCT02336503|470913035|FG003|Overall Study|Withdrawal by Subject|4|||
130805243|NCT02336503|470913032|FG000|Overall Study|Adverse Event|0|||
130805244|NCT02336503|470913033|FG001|Overall Study|Adverse Event|0|||
130805245|NCT02336503|470913034|FG002|Overall Study|Adverse Event|1|||
130805246|NCT02336503|470913035|FG003|Overall Study|Adverse Event|0|||
130805247|NCT02460380|470913036|FG000|Overall Study|Withdrawal by Subject|10|||
130805248|NCT02460380|470913037|FG001|Overall Study|Withdrawal by Subject|5|||
130805249|NCT00395512|470913038|FG000|Overall Study|Adverse Event|3|||
130805250|NCT00395512|470913039|FG001|Overall Study|Adverse Event|8|||
130805251|NCT00395512|470913040|FG002|Overall Study|Adverse Event|6|||
130805252|NCT00395512|470913041|FG003|Overall Study|Adverse Event|6|||
130805253|NCT00395512|470913038|FG000|Overall Study|Protocol Violation|2|||
130805254|NCT00395512|470913039|FG001|Overall Study|Protocol Violation|3|||
130805255|NCT00395512|470913040|FG002|Overall Study|Protocol Violation|6|||
130805256|NCT00395512|470913041|FG003|Overall Study|Protocol Violation|7|||
130805257|NCT00395512|470913038|FG000|Overall Study|Lost to Follow-up|2|||
130805258|NCT00395512|470913039|FG001|Overall Study|Lost to Follow-up|6|||
130805259|NCT00395512|470913040|FG002|Overall Study|Lost to Follow-up|5|||
130805260|NCT00395512|470913041|FG003|Overall Study|Lost to Follow-up|5|||
130805261|NCT00395512|470913038|FG000|Overall Study|Withdrawal by Subject|6|||
130805262|NCT00395512|470913039|FG001|Overall Study|Withdrawal by Subject|5|||
130805263|NCT00395512|470913040|FG002|Overall Study|Withdrawal by Subject|5|||
130805264|NCT00395512|470913041|FG003|Overall Study|Withdrawal by Subject|12|||
130805265|NCT00395512|470913038|FG000|Overall Study|Physician Decision|6|||
130805266|NCT00395512|470913039|FG001|Overall Study|Physician Decision|4|||
130805267|NCT00395512|470913040|FG002|Overall Study|Physician Decision|2|||
130805268|NCT00395512|470913041|FG003|Overall Study|Physician Decision|2|||
130805269|NCT00395512|470913038|FG000|Overall Study|Other|1|||
130805270|NCT00395512|470913039|FG001|Overall Study|Other|1|||
130805271|NCT00395512|470913040|FG002|Overall Study|Other|0|||
130805272|NCT00395512|470913041|FG003|Overall Study|Other|0|||
130805273|NCT00395512|470913038|FG000|Overall Study|Hyperglycemic Rescue|18|||
130805274|NCT00395512|470913039|FG001|Overall Study|Hyperglycemic Rescue|10|||
130805275|NCT00395512|470913040|FG002|Overall Study|Hyperglycemic Rescue|4|||
130805276|NCT00395512|470913041|FG003|Overall Study|Hyperglycemic Rescue|6|||
130805277|NCT01478087|470913042|FG000|Overall Study|due to sponsor closing study|1|||
130805278|NCT03566550|470913043|FG000|Overall Study|Withdrawal by Subject|0|||
130805279|NCT03566550|470913044|FG001|Overall Study|Withdrawal by Subject|1|||
130805280|NCT04576949|470913046|FG000|Overall Study|Adverse Event|1|||
130763869|NCT00195494|470758684|FG002|Year 1|Withdrawal by Subject|0|||
130805281|NCT04576949|470913047|FG001|Overall Study|Adverse Event|3|||
130805282|NCT04576949|470913048|FG002|Overall Study|Adverse Event|2|||
130805283|NCT04576949|470913046|FG000|Overall Study|Withdrawal by Subject|41|||
130805284|NCT04576949|470913047|FG001|Overall Study|Withdrawal by Subject|26|||
130805285|NCT04576949|470913048|FG002|Overall Study|Withdrawal by Subject|18|||
130805286|NCT04576949|470913046|FG000|Overall Study|Physician Decision|3|||
130805287|NCT04576949|470913047|FG001|Overall Study|Physician Decision|0|||
130805288|NCT04576949|470913048|FG002|Overall Study|Physician Decision|0|||
130805289|NCT04576949|470913046|FG000|Overall Study|Death|0|||
130805290|NCT04576949|470913047|FG001|Overall Study|Death|1|||
130805291|NCT04576949|470913048|FG002|Overall Study|Death|0|||
130805292|NCT04576949|470913046|FG000|Overall Study|Lost to Follow-up|29|||
130805293|NCT04576949|470913047|FG001|Overall Study|Lost to Follow-up|37|||
130805294|NCT04576949|470913048|FG002|Overall Study|Lost to Follow-up|24|||
130805295|NCT04576949|470913046|FG000|Overall Study|Other, Not Specified|2|||
130805296|NCT04576949|470913047|FG001|Overall Study|Other, Not Specified|3|||
130805297|NCT04576949|470913048|FG002|Overall Study|Other, Not Specified|1|||
130805298|NCT04576949|470913046|FG000|Overall Study|Other|1|||
130805299|NCT04576949|470913047|FG001|Overall Study|Other|0|||
130805300|NCT04576949|470913048|FG002|Overall Study|Other|0|||
130805301|NCT00052715|470913049|FG000|Overall Study|wrong histology|1|||
130805302|NCT01063881|470913050|FG000|Overall Study|Adverse Event|12|||
130805303|NCT01063881|470913051|FG001|Overall Study|Adverse Event|2|||
130805304|NCT01063881|470913052|FG002|Overall Study|Adverse Event|0|||
130805305|NCT01063881|470913050|FG000|Overall Study|Lost to Follow-up|13|||
130805306|NCT01063881|470913051|FG001|Overall Study|Lost to Follow-up|7|||
130805307|NCT01063881|470913052|FG002|Overall Study|Lost to Follow-up|1|||
130805308|NCT01063881|470913050|FG000|Overall Study|Withdrawal by Subject|25|||
130805309|NCT01063881|470913051|FG001|Overall Study|Withdrawal by Subject|1|||
130805310|NCT01063881|470913052|FG002|Overall Study|Withdrawal by Subject|0|||
130805311|NCT01063881|470913050|FG000|Overall Study|Reason for not completed not specified|5|||
130805312|NCT01063881|470913051|FG001|Overall Study|Reason for not completed not specified|1|||
130805313|NCT01063881|470913052|FG002|Overall Study|Reason for not completed not specified|0|||
130805314|NCT01489358|470913053|FG000|Overall Study|Lost to Follow-up|0|||
130805315|NCT01489358|470913054|FG001|Overall Study|Lost to Follow-up|0|||
130805316|NCT01489358|470913055|FG002|Overall Study|Lost to Follow-up|2|||
130805317|NCT00736476|470913056|FG000|Overall Study|Adverse Event|1|||
130805318|NCT00736476|470913057|FG001|Overall Study|Adverse Event|0|||
130805319|NCT03518203|470913062|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
130805320|NCT03518203|470913062|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
130805321|NCT00754559|470913063|FG000|Overall Study|Adverse Event|15|||
130763870|NCT00195494|470758685|FG003|Year 1|Withdrawal by Subject|0|||
130763871|NCT00195494|470758686|FG004|Year 1|Withdrawal by Subject|8|||
130763872|NCT00195494|470758687|FG005|Year 1|Withdrawal by Subject|9|||
130763873|NCT00195494|470758682|FG000|Year 1|Protocol Violation|0|||
130763874|NCT00195494|470758683|FG001|Year 1|Protocol Violation|0|||
130763875|NCT00195494|470758684|FG002|Year 1|Protocol Violation|0|||
130763876|NCT00195494|470758685|FG003|Year 1|Protocol Violation|0|||
130763877|NCT00195494|470758686|FG004|Year 1|Protocol Violation|1|||
130763878|NCT00195494|470758687|FG005|Year 1|Protocol Violation|1|||
130763879|NCT00195494|470758682|FG000|Year 2|Adverse Event|3|||
130763880|NCT00195494|470758683|FG001|Year 2|Adverse Event|7|||
130763881|NCT00195494|470758684|FG002|Year 2|Adverse Event|5|||
130763882|NCT00195494|470758685|FG003|Year 2|Adverse Event|9|||
130763883|NCT00195494|470758686|FG004|Year 2|Adverse Event|0|||
130763884|NCT00195494|470758687|FG005|Year 2|Adverse Event|0|||
130763885|NCT00195494|470758682|FG000|Year 2|Lack of Efficacy|0|||
130763886|NCT00195494|470758683|FG001|Year 2|Lack of Efficacy|1|||
130763887|NCT00195494|470758684|FG002|Year 2|Lack of Efficacy|7|||
130763888|NCT00195494|470758685|FG003|Year 2|Lack of Efficacy|7|||
130763889|NCT00195494|470758686|FG004|Year 2|Lack of Efficacy|0|||
130763890|NCT00195494|470758687|FG005|Year 2|Lack of Efficacy|0|||
130763891|NCT00195494|470758682|FG000|Year 2|Compliance|1|||
130763892|NCT00195494|470758683|FG001|Year 2|Compliance|0|||
130763893|NCT00195494|470758684|FG002|Year 2|Compliance|0|||
130763894|NCT00195494|470758685|FG003|Year 2|Compliance|2|||
130763895|NCT00195494|470758686|FG004|Year 2|Compliance|0|||
130763896|NCT00195494|470758687|FG005|Year 2|Compliance|0|||
130763897|NCT00195494|470758682|FG000|Year 2|Lost to Follow-up|0|||
130763898|NCT00195494|470758683|FG001|Year 2|Lost to Follow-up|0|||
130763899|NCT00195494|470758684|FG002|Year 2|Lost to Follow-up|1|||
130763900|NCT00195494|470758685|FG003|Year 2|Lost to Follow-up|1|||
130763901|NCT00195494|470758686|FG004|Year 2|Lost to Follow-up|0|||
130763902|NCT00195494|470758687|FG005|Year 2|Lost to Follow-up|0|||
130763903|NCT00195494|470758682|FG000|Year 2|Missed >4 consecutive doses|1|||
130763904|NCT00195494|470758683|FG001|Year 2|Missed >4 consecutive doses|1|||
130763905|NCT00195494|470758684|FG002|Year 2|Missed >4 consecutive doses|1|||
130763906|NCT00195494|470758685|FG003|Year 2|Missed >4 consecutive doses|0|||
130763907|NCT00195494|470758686|FG004|Year 2|Missed >4 consecutive doses|0|||
130805322|NCT00754559|470913063|FG000|Overall Study|Protocol Violation|11|||
130805323|NCT00754559|470913063|FG000|Overall Study|Lack of Efficacy|10|||
130805324|NCT00754559|470913063|FG000|Overall Study|Lost to Follow-up|2|||
130805325|NCT00754559|470913063|FG000|Overall Study|Administrative reason|1|||
130805326|NCT00754559|470913063|FG000|Overall Study|Other|5|||
130805327|NCT00754559|470913063|FG000|Overall Study|Withdrawal by Subject|3|||
130805328|NCT01663987|470913064|FG000|Overall Study|Adverse Event|7|||
130805329|NCT01663987|470913065|FG001|Overall Study|Adverse Event|2|||
130805330|NCT01663987|470913064|FG000|Overall Study|Lost to Follow-up|1|||
130805331|NCT01663987|470913065|FG001|Overall Study|Lost to Follow-up|1|||
130805332|NCT01663987|470913064|FG000|Overall Study|Withdrawal by Subject|2|||
130805333|NCT01663987|470913065|FG001|Overall Study|Withdrawal by Subject|3|||
130805334|NCT01663987|470913064|FG000|Overall Study|Other reason not defined above|3|||
130805335|NCT01663987|470913065|FG001|Overall Study|Other reason not defined above|0|||
130805336|NCT01370538|470913067|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
130805337|NCT01370538|470913068|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
130805338|NCT01370538|470913067|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130805339|NCT01370538|470913068|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130805340|NCT01370538|470913067|FG000|Overall Study|Adverse Event|1|||
130805341|NCT01370538|470913068|FG001|Overall Study|Adverse Event|0|||
130805342|NCT01370538|470913067|FG000|Overall Study|Protocol Violation|8|||
130805343|NCT01370538|470913068|FG001|Overall Study|Protocol Violation|5|||
130805344|NCT01370538|470913067|FG000|Overall Study|Development of study specific withdrawal|1|||
130805345|NCT01370538|470913068|FG001|Overall Study|Development of study specific withdrawal|1|||
130805346|NCT01370538|470913067|FG000|Overall Study|Lost to follow up|6|||
130805347|NCT01370538|470913068|FG001|Overall Study|Lost to follow up|10|||
130805348|NCT04193527|470913069|FG000|Overall Study|Other|1|||
130805349|NCT04193527|470913070|FG001|Overall Study|Other|1|||
130805350|NCT04193527|470913071|FG002|Overall Study|Other|0|||
130805351|NCT00676689|470913072|FG000|Overall Study|Screen Failure|2|||
130805352|NCT00676689|470913072|FG000|Overall Study|Death|2|||
130805353|NCT00676689|470913072|FG000|Overall Study|Lost to Follow-up|4|||
130805354|NCT00676689|470913072|FG000|Overall Study|Physician Decision|1|||
130805355|NCT00676689|470913072|FG000|Overall Study|Withdrawal by Subject|3|||
130805356|NCT00676689|470913072|FG000|Overall Study|Continuing FU|49|||
130805357|NCT02362412|470913073|FG000|Treatment Period III|Lost to Follow-up|0|||
130805358|NCT02362412|470913074|FG001|Treatment Period III|Lost to Follow-up|1|||
130805359|NCT01541254|470913075|FG000|Overall Study|Withdrawal by Subject|1|||
130805360|NCT01541254|470913075|FG000|Overall Study|excluded - metal allergy|1|||
130805361|NCT01541254|470913075|FG000|Overall Study|enrolled after study closed|1|||
130805362|NCT01541254|470913075|FG000|Overall Study|GI bleed prior to procedure|1|||
130805363|NCT01541254|470913075|FG000|Overall Study|stent not required|1|||
130805364|NCT01541254|470913075|FG000|Overall Study|alternate stent used|1|||
130805365|NCT05103332|470913076|FG000|Overall Study|Lost to Follow-up|0|||
130805366|NCT05103332|470913077|FG001|Overall Study|Lost to Follow-up|2|||
130805367|NCT05103332|470913078|FG002|Overall Study|Lost to Follow-up|1|||
130805368|NCT05103332|470913079|FG003|Overall Study|Lost to Follow-up|0|||
130805369|NCT05103332|470913080|FG004|Overall Study|Lost to Follow-up|0|||
130805370|NCT05103332|470913081|FG005|Overall Study|Lost to Follow-up|2|||
130805371|NCT05103332|470913076|FG000|Overall Study|Physician Decision|0|||
130805372|NCT05103332|470913077|FG001|Overall Study|Physician Decision|1|||
130805373|NCT05103332|470913078|FG002|Overall Study|Physician Decision|0|||
130805374|NCT05103332|470913079|FG003|Overall Study|Physician Decision|1|||
130805375|NCT05103332|470913080|FG004|Overall Study|Physician Decision|0|||
130805376|NCT05103332|470913081|FG005|Overall Study|Physician Decision|0|||
130805377|NCT05103332|470913076|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
130805378|NCT05103332|470913077|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
130805379|NCT05103332|470913078|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
130805380|NCT05103332|470913079|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
130805381|NCT05103332|470913080|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
130805382|NCT05103332|470913081|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
130805383|NCT05103332|470913076|FG000|Overall Study|Unspeccified|0|||
130805384|NCT05103332|470913077|FG001|Overall Study|Unspeccified|0|||
130805385|NCT05103332|470913078|FG002|Overall Study|Unspeccified|0|||
130805386|NCT05103332|470913079|FG003|Overall Study|Unspeccified|1|||
130805387|NCT05103332|470913080|FG004|Overall Study|Unspeccified|0|||
130805388|NCT05103332|470913081|FG005|Overall Study|Unspeccified|0|||
130805389|NCT02218268|470913082|FG000|24 Hour Washout|Physician Decision|11|||
130805390|NCT02218268|470913083|FG001|24 Hour Washout|Physician Decision|9|||
130805391|NCT03651336|470913084|FG000|Overall Study|Withdrawal by Subject|4|||
130805392|NCT01125748|470913085|FG000|Overall Study|Adverse Event|0|||
130805393|NCT01125748|470913086|FG001|Overall Study|Adverse Event|2|||
130805394|NCT01125748|470913085|FG000|Overall Study|Lost to Follow-up|0|||
130805395|NCT01125748|470913086|FG001|Overall Study|Lost to Follow-up|1|||
130805396|NCT01125748|470913085|FG000|Overall Study|Physician Decision|8|||
130805397|NCT01125748|470913086|FG001|Overall Study|Physician Decision|7|||
130805398|NCT01125748|470913085|FG000|Overall Study|Patient Decision to Withdraw|2|||
130805399|NCT01125748|470913086|FG001|Overall Study|Patient Decision to Withdraw|4|||
130805400|NCT01028391|470913087|FG000|Overall Study|Adverse Event|4|||
130805401|NCT01028391|470913088|FG001|Overall Study|Adverse Event|0|||
130805402|NCT01028391|470913087|FG000|Overall Study|Lack of Efficacy|0|||
130805403|NCT01028391|470913088|FG001|Overall Study|Lack of Efficacy|2|||
130805404|NCT01028391|470913087|FG000|Overall Study|Lost to Follow-up|3|||
130805405|NCT01028391|470913088|FG001|Overall Study|Lost to Follow-up|4|||
130805406|NCT01028391|470913087|FG000|Overall Study|Physician Decision|0|||
130805407|NCT01028391|470913088|FG001|Overall Study|Physician Decision|1|||
130805408|NCT01028391|470913087|FG000|Overall Study|Withdrawal by Subject|6|||
130805409|NCT01028391|470913088|FG001|Overall Study|Withdrawal by Subject|3|||
130805410|NCT01028391|470913087|FG000|Overall Study|Needed excluded medication|1|||
130805411|NCT01028391|470913088|FG001|Overall Study|Needed excluded medication|1|||
130805412|NCT01026038|470913089|FG000|Overall Study|Lost to Follow-up|1|||
130805413|NCT01026038|470913090|FG001|Overall Study|Lost to Follow-up|1|||
130805414|NCT01026038|470913091|FG002|Overall Study|Lost to Follow-up|0|||
130805415|NCT03601052|470913092|FG000|Overall Study|Lost to Follow-up|2|||
130805416|NCT01227395|470913093|FG000|Overall Study|Protocol Violation|0|||
130805417|NCT01227395|470913094|FG001|Overall Study|Protocol Violation|1|||
130805418|NCT00683384|470913095|FG000|Overall Study|Death|1|||
130805419|NCT00683384|470913095|FG000|Overall Study|Adverse Event|1|||
130805420|NCT00120874|470913097|FG000|Overall Study|Death|0|||
130805421|NCT00120874|470913098|FG001|Overall Study|Death|1|||
130805422|NCT00290238|470913113|FG000|Overall Study|Study terminated|27|||
130805423|NCT00290238|470913114|FG001|Overall Study|Study terminated|27|||
130805424|NCT00290238|470913113|FG000|Overall Study|Lost to Follow-up|0|||
130763908|NCT00195494|470758687|FG005|Year 2|Missed >4 consecutive doses|0|||
130763909|NCT00195494|470758682|FG000|Year 2|Protocol deviation|0|||
130763910|NCT00195494|470758683|FG001|Year 2|Protocol deviation|1|||
130763911|NCT00195494|470758684|FG002|Year 2|Protocol deviation|0|||
130763912|NCT00195494|470758685|FG003|Year 2|Protocol deviation|0|||
130763913|NCT00195494|470758686|FG004|Year 2|Protocol deviation|0|||
130763914|NCT00195494|470758687|FG005|Year 2|Protocol deviation|0|||
130763915|NCT00195494|470758682|FG000|Year 2|Physician Decision|1|||
130763916|NCT00195494|470758683|FG001|Year 2|Physician Decision|1|||
130763917|NCT00195494|470758684|FG002|Year 2|Physician Decision|0|||
130763918|NCT00195494|470758685|FG003|Year 2|Physician Decision|0|||
130763919|NCT00195494|470758686|FG004|Year 2|Physician Decision|0|||
130763920|NCT00195494|470758687|FG005|Year 2|Physician Decision|0|||
130763921|NCT00195494|470758682|FG000|Year 2|Withdrawal by Subject|1|||
130763922|NCT00195494|470758683|FG001|Year 2|Withdrawal by Subject|5|||
130763923|NCT00195494|470758684|FG002|Year 2|Withdrawal by Subject|4|||
130763924|NCT00195494|470758685|FG003|Year 2|Withdrawal by Subject|3|||
130763925|NCT00195494|470758686|FG004|Year 2|Withdrawal by Subject|0|||
130763926|NCT00195494|470758687|FG005|Year 2|Withdrawal by Subject|0|||
130763927|NCT00195494|470758682|FG000|Year 2|System toxicity|0|||
130763928|NCT00195494|470758683|FG001|Year 2|System toxicity|0|||
130763929|NCT00195494|470758684|FG002|Year 2|System toxicity|0|||
130763930|NCT00195494|470758685|FG003|Year 2|System toxicity|1|||
130763931|NCT00195494|470758686|FG004|Year 2|System toxicity|0|||
130805425|NCT00290238|470913114|FG001|Overall Study|Lost to Follow-up|1|||
130805426|NCT00290238|470913113|FG000|Overall Study|Withdrawal by Subject|15|||
130805427|NCT00290238|470913114|FG001|Overall Study|Withdrawal by Subject|13|||
130805428|NCT02186171|470913115|FG000|Overall Study|Withdrawal by Subject|1|||
130805429|NCT02186171|470913116|FG001|Overall Study|Withdrawal by Subject|9|||
130805430|NCT02186171|470913115|FG000|Overall Study|Lost to Follow-up|2|||
130805431|NCT02186171|470913116|FG001|Overall Study|Lost to Follow-up|2|||
130805432|NCT02186171|470913115|FG000|Overall Study|Death|1|||
130805433|NCT02186171|470913116|FG001|Overall Study|Death|2|||
130805434|NCT02186171|470913115|FG000|Overall Study|Protocol-specified Criteria|0|||
130805435|NCT02186171|470913116|FG001|Overall Study|Protocol-specified Criteria|2|||
130805436|NCT02946996|470913117|FG000|Overall Study|non-evaluable|3|||
130805437|NCT02946996|470913118|FG001|Overall Study|non-evaluable|6|||
130805438|NCT02946996|470913119|FG002|Overall Study|non-evaluable|5|||
130805439|NCT06868667|470913120|FG000|Overall Study|Death|0|||
130805440|NCT06868667|470913121|FG001|Overall Study|Death|4|||
130805441|NCT06868667|470913120|FG000|Overall Study|Lost to Follow-up|0|||
130805442|NCT06868667|470913121|FG001|Overall Study|Lost to Follow-up|1|||
130805443|NCT06868667|470913120|FG000|Overall Study|Withdrawal by Subject|1|||
130805444|NCT06868667|470913121|FG001|Overall Study|Withdrawal by Subject|0|||
130805445|NCT06868667|470913120|FG000|Overall Study|Ongoing|9|||
130805446|NCT06868667|470913121|FG001|Overall Study|Ongoing|9|||
130805447|NCT06097273|470913123|FG000|Overall Study|Death|2|||
130805448|NCT06097273|470913124|FG001|Overall Study|Death|1|||
130805449|NCT06097273|470913125|FG002|Overall Study|Death|2|||
130805450|NCT06097273|470913126|FG003|Overall Study|Death|2|||
130805451|NCT06097273|470913123|FG000|Overall Study|Lost to Follow-up|27|||
130805452|NCT06097273|470913124|FG001|Overall Study|Lost to Follow-up|18|||
130805453|NCT06097273|470913125|FG002|Overall Study|Lost to Follow-up|36|||
130805454|NCT06097273|470913126|FG003|Overall Study|Lost to Follow-up|31|||
130805455|NCT06097273|470913123|FG000|Overall Study|Physician Decision|0|||
130805456|NCT06097273|470913124|FG001|Overall Study|Physician Decision|1|||
130805457|NCT06097273|470913125|FG002|Overall Study|Physician Decision|0|||
130805458|NCT06097273|470913126|FG003|Overall Study|Physician Decision|3|||
130805459|NCT06097273|470913123|FG000|Overall Study|Protocol Violation|1|||
130805460|NCT06097273|470913124|FG001|Overall Study|Protocol Violation|1|||
130805461|NCT06097273|470913125|FG002|Overall Study|Protocol Violation|2|||
130805462|NCT06097273|470913126|FG003|Overall Study|Protocol Violation|1|||
130805463|NCT06097273|470913123|FG000|Overall Study|Withdrawal by Subject|14|||
130805464|NCT06097273|470913124|FG001|Overall Study|Withdrawal by Subject|11|||
130805465|NCT06097273|470913125|FG002|Overall Study|Withdrawal by Subject|14|||
130805466|NCT06097273|470913126|FG003|Overall Study|Withdrawal by Subject|15|||
130805467|NCT06097273|470913123|FG000|Overall Study|Other Than Specified|7|||
130805468|NCT06097273|470913124|FG001|Overall Study|Other Than Specified|3|||
130805469|NCT06097273|470913125|FG002|Overall Study|Other Than Specified|11|||
130805470|NCT06097273|470913126|FG003|Overall Study|Other Than Specified|6|||
130805471|NCT03882801|470914807|FG000|Period 1|Adverse Event|0|||
130805472|NCT03882801|470914808|FG001|Period 1|Adverse Event|1|||
130805473|NCT03882801|470914807|FG000|Period 1|Non-compliance with study drug|1|||
130805474|NCT03882801|470914808|FG001|Period 1|Non-compliance with study drug|1|||
130805475|NCT03882801|470914807|FG000|Period 1|Never treated with study drug|1|||
130805476|NCT03882801|470914808|FG001|Period 1|Never treated with study drug|0|||
130805477|NCT03882801|470914807|FG000|Washout Period|Physician Decision|0|||
130805478|NCT03882801|470914808|FG001|Washout Period|Physician Decision|1|||
130805479|NCT03882801|470914807|FG000|Period 2|Non-compliance with study drug|0|||
130805480|NCT03882801|470914808|FG001|Period 2|Non-compliance with study drug|1|||
130805481|NCT04605588|470914809|FG000|Overall Study|Withdrawal by Subject|1|||
130805482|NCT04605588|470914810|FG001|Overall Study|Withdrawal by Subject|0|||
130805483|NCT01230814|470914811|FG000|Overall Study|Lost to Follow-up|11|||
130805484|NCT01230814|470914812|FG001|Overall Study|Lost to Follow-up|3|||
130805485|NCT01230814|470914811|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
130805486|NCT01230814|470914812|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
130805487|NCT01529112|470914815|FG000|Overall Study|Adverse Event|2|||
130805488|NCT01529112|470914816|FG001|Overall Study|Adverse Event|0|||
130805489|NCT01529112|470914815|FG000|Overall Study|Death|59|||
130805490|NCT01529112|470914816|FG001|Overall Study|Death|38|||
130805491|NCT01529112|470914815|FG000|Overall Study|Protocol Violation|1|||
130805492|NCT01529112|470914816|FG001|Overall Study|Protocol Violation|0|||
130805493|NCT01529112|470914815|FG000|Overall Study|Withdrawal by Subject|7|||
130805494|NCT01529112|470914816|FG001|Overall Study|Withdrawal by Subject|3|||
130805495|NCT03607695|470914817|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
130805496|NCT03607695|470914817|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
130805497|NCT02741193|470914818|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
130805498|NCT02741193|470914818|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
130805499|NCT02502383|470914819|FG000|Overall Study|Lost to Follow-up|130|||
130805500|NCT02502383|470914820|FG001|Overall Study|Lost to Follow-up|131|||
130805501|NCT02502383|470914819|FG000|Overall Study|Withdrawal by Subject|31|||
130805502|NCT02502383|470914820|FG001|Overall Study|Withdrawal by Subject|24|||
130805503|NCT00903344|470914821|FG000|Overall Study|Pregnancy|2|||
130805504|NCT00903344|470914822|FG001|Overall Study|Pregnancy|3|||
130805505|NCT00903344|470914821|FG000|Overall Study|Lost to Follow-up|3|||
130805506|NCT00903344|470914822|FG001|Overall Study|Lost to Follow-up|0|||
130805507|NCT01524705|470914823|FG000|Overall Study|Adverse Event|2|||
130805508|NCT01524705|470914824|FG001|Overall Study|Adverse Event|0|||
130805509|NCT01524705|470914823|FG000|Overall Study|Death|1|||
130805510|NCT01524705|470914824|FG001|Overall Study|Death|0|||
130805511|NCT01524705|470914823|FG000|Overall Study|Lost to Follow-up|0|||
130805512|NCT01524705|470914824|FG001|Overall Study|Lost to Follow-up|1|||
130805513|NCT01524705|470914823|FG000|Overall Study|Withdrawal by Subject|0|||
130805514|NCT01524705|470914824|FG001|Overall Study|Withdrawal by Subject|1|||
130805515|NCT01524705|470914823|FG000|Overall Study|Pancreatic Cancer|0|||
130805516|NCT01524705|470914824|FG001|Overall Study|Pancreatic Cancer|1|||
130805517|NCT01755156|470914825|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
130805518|NCT01755156|470914826|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
130805519|NCT01755156|470914825|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
130805520|NCT01755156|470914826|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
130805521|NCT01755156|470914825|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
130805522|NCT01755156|470914826|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
130805523|NCT01755156|470914825|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
130805524|NCT01755156|470914826|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
130805525|NCT01755156|470914825|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
130805526|NCT01755156|470914826|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
130805527|NCT01755156|470914825|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
130805528|NCT01755156|470914826|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
130805529|NCT01755156|470914825|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
130805530|NCT01755156|470914826|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
130805531|NCT01755156|470914825|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
130805532|NCT01755156|470914826|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
130805533|NCT01755156|470914825|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
130805534|NCT01755156|470914826|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
130805535|NCT01755156|470914825|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
130805536|NCT01755156|470914826|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
130805537|NCT01755156|470914825|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
130805538|NCT01755156|470914826|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
130805539|NCT02533674|470914827|FG000|Dose Level I|Progressive disease|1|||
130805540|NCT02533674|470914828|FG001|Dose Level I|Progressive disease|0|||
130805541|NCT02533674|470914829|FG002|Dose Level I|Progressive disease|0|||
130805542|NCT02533674|470914830|FG003|Dose Level I|Progressive disease|0|||
130805543|NCT02533674|470914831|FG004|Dose Level I|Progressive disease|0|||
130805544|NCT02533674|470914832|FG005|Dose Level I|Progressive disease|0|||
130805545|NCT02533674|470914833|FG006|Dose Level I|Progressive disease|0|||
130805546|NCT02533674|470914834|FG007|Dose Level I|Progressive disease|0|||
130805547|NCT02533674|470914827|FG000|Dose Level I|Withdrawal by Subject|1|||
130805548|NCT02533674|470914828|FG001|Dose Level I|Withdrawal by Subject|0|||
130805549|NCT02533674|470914829|FG002|Dose Level I|Withdrawal by Subject|0|||
130805550|NCT02533674|470914830|FG003|Dose Level I|Withdrawal by Subject|0|||
130805551|NCT02533674|470914831|FG004|Dose Level I|Withdrawal by Subject|0|||
130805552|NCT02533674|470914832|FG005|Dose Level I|Withdrawal by Subject|0|||
130805553|NCT02533674|470914833|FG006|Dose Level I|Withdrawal by Subject|0|||
130805554|NCT02533674|470914834|FG007|Dose Level I|Withdrawal by Subject|0|||
130805555|NCT02533674|470914827|FG000|Dose Level I|Physician Decision|1|||
130805556|NCT02533674|470914828|FG001|Dose Level I|Physician Decision|0|||
130805557|NCT02533674|470914829|FG002|Dose Level I|Physician Decision|0|||
130805558|NCT02533674|470914830|FG003|Dose Level I|Physician Decision|0|||
130805559|NCT02533674|470914831|FG004|Dose Level I|Physician Decision|0|||
130805560|NCT02533674|470914832|FG005|Dose Level I|Physician Decision|0|||
130805561|NCT02533674|470914833|FG006|Dose Level I|Physician Decision|0|||
130805562|NCT02533674|470914834|FG007|Dose Level I|Physician Decision|0|||
130805563|NCT02533674|470914827|FG000|Dose Level I|Death|1|||
130805564|NCT02533674|470914828|FG001|Dose Level I|Death|0|||
130805565|NCT02533674|470914829|FG002|Dose Level I|Death|0|||
130805566|NCT02533674|470914830|FG003|Dose Level I|Death|0|||
130805567|NCT02533674|470914831|FG004|Dose Level I|Death|0|||
130805568|NCT02533674|470914832|FG005|Dose Level I|Death|0|||
130805569|NCT02533674|470914833|FG006|Dose Level I|Death|0|||
130805570|NCT02533674|470914834|FG007|Dose Level I|Death|0|||
130805571|NCT02533674|470914827|FG000|Dose Level I|Never Treated|1|||
130805572|NCT02533674|470914828|FG001|Dose Level I|Never Treated|0|||
130805573|NCT02533674|470914829|FG002|Dose Level I|Never Treated|0|||
130805574|NCT02533674|470914830|FG003|Dose Level I|Never Treated|0|||
130805575|NCT02533674|470914831|FG004|Dose Level I|Never Treated|0|||
130805576|NCT02533674|470914832|FG005|Dose Level I|Never Treated|0|||
130805577|NCT02533674|470914833|FG006|Dose Level I|Never Treated|0|||
130805578|NCT02533674|470914834|FG007|Dose Level I|Never Treated|0|||
130805579|NCT02533674|470914827|FG000|Dose Level II|Progressive disease|0|||
130805580|NCT02533674|470914828|FG001|Dose Level II|Progressive disease|3|||
130805581|NCT02533674|470914829|FG002|Dose Level II|Progressive disease|0|||
130805582|NCT02533674|470914830|FG003|Dose Level II|Progressive disease|0|||
130805583|NCT02533674|470914831|FG004|Dose Level II|Progressive disease|0|||
130805584|NCT02533674|470914832|FG005|Dose Level II|Progressive disease|0|||
130805585|NCT02533674|470914833|FG006|Dose Level II|Progressive disease|0|||
130805586|NCT02533674|470914834|FG007|Dose Level II|Progressive disease|0|||
130805587|NCT02533674|470914827|FG000|Dose Level II|Withdrawal by Subject|0|||
130805588|NCT02533674|470914828|FG001|Dose Level II|Withdrawal by Subject|1|||
130805589|NCT02533674|470914829|FG002|Dose Level II|Withdrawal by Subject|0|||
130805590|NCT02533674|470914830|FG003|Dose Level II|Withdrawal by Subject|0|||
130805591|NCT02533674|470914831|FG004|Dose Level II|Withdrawal by Subject|0|||
130805592|NCT02533674|470914832|FG005|Dose Level II|Withdrawal by Subject|0|||
130805593|NCT02533674|470914833|FG006|Dose Level II|Withdrawal by Subject|0|||
130805594|NCT02533674|470914834|FG007|Dose Level II|Withdrawal by Subject|0|||
130805595|NCT02533674|470914827|FG000|Dose Level II|Treatment-related AE|0|||
130805596|NCT02533674|470914828|FG001|Dose Level II|Treatment-related AE|1|||
130805597|NCT02533674|470914829|FG002|Dose Level II|Treatment-related AE|0|||
130805598|NCT02533674|470914830|FG003|Dose Level II|Treatment-related AE|0|||
130805599|NCT02533674|470914831|FG004|Dose Level II|Treatment-related AE|0|||
130805600|NCT02533674|470914832|FG005|Dose Level II|Treatment-related AE|0|||
130805601|NCT02533674|470914833|FG006|Dose Level II|Treatment-related AE|0|||
130805602|NCT02533674|470914834|FG007|Dose Level II|Treatment-related AE|0|||
130805603|NCT02533674|470914827|FG000|Dose Level II|Physician Decision|0|||
130805604|NCT02533674|470914828|FG001|Dose Level II|Physician Decision|1|||
130805605|NCT02533674|470914829|FG002|Dose Level II|Physician Decision|0|||
130805606|NCT02533674|470914830|FG003|Dose Level II|Physician Decision|0|||
130805607|NCT02533674|470914831|FG004|Dose Level II|Physician Decision|0|||
130805608|NCT02533674|470914832|FG005|Dose Level II|Physician Decision|0|||
130805609|NCT02533674|470914833|FG006|Dose Level II|Physician Decision|0|||
130805610|NCT02533674|470914834|FG007|Dose Level II|Physician Decision|0|||
130805611|NCT02533674|470914827|FG000|Dose Level II|Non-treatment-related AE|0|||
130805612|NCT02533674|470914828|FG001|Dose Level II|Non-treatment-related AE|1|||
130805613|NCT02533674|470914829|FG002|Dose Level II|Non-treatment-related AE|0|||
130805614|NCT02533674|470914830|FG003|Dose Level II|Non-treatment-related AE|0|||
130805615|NCT02533674|470914831|FG004|Dose Level II|Non-treatment-related AE|0|||
130805616|NCT02533674|470914832|FG005|Dose Level II|Non-treatment-related AE|0|||
130805617|NCT02533674|470914833|FG006|Dose Level II|Non-treatment-related AE|0|||
130805618|NCT02533674|470914834|FG007|Dose Level II|Non-treatment-related AE|0|||
130805619|NCT02533674|470914827|FG000|Dose Level III|Progressive disease|0|||
130805620|NCT02533674|470914828|FG001|Dose Level III|Progressive disease|0|||
130805621|NCT02533674|470914829|FG002|Dose Level III|Progressive disease|2|||
130805622|NCT02533674|470914830|FG003|Dose Level III|Progressive disease|0|||
130805623|NCT02533674|470914831|FG004|Dose Level III|Progressive disease|0|||
130805624|NCT02533674|470914832|FG005|Dose Level III|Progressive disease|0|||
130805625|NCT02533674|470914833|FG006|Dose Level III|Progressive disease|0|||
130805626|NCT02533674|470914834|FG007|Dose Level III|Progressive disease|0|||
130805627|NCT02533674|470914827|FG000|Dose Level III|Withdrawal by Subject|0|||
130805628|NCT02533674|470914828|FG001|Dose Level III|Withdrawal by Subject|0|||
130805629|NCT02533674|470914829|FG002|Dose Level III|Withdrawal by Subject|1|||
130805630|NCT02533674|470914830|FG003|Dose Level III|Withdrawal by Subject|0|||
130805631|NCT02533674|470914831|FG004|Dose Level III|Withdrawal by Subject|0|||
130805632|NCT02533674|470914832|FG005|Dose Level III|Withdrawal by Subject|0|||
130805633|NCT02533674|470914833|FG006|Dose Level III|Withdrawal by Subject|0|||
130805634|NCT02533674|470914834|FG007|Dose Level III|Withdrawal by Subject|0|||
130805635|NCT02533674|470914827|FG000|Dose Level III|Treatment-related AE|0|||
130805636|NCT02533674|470914828|FG001|Dose Level III|Treatment-related AE|0|||
130805637|NCT02533674|470914829|FG002|Dose Level III|Treatment-related AE|1|||
130805638|NCT02533674|470914830|FG003|Dose Level III|Treatment-related AE|0|||
130805639|NCT02533674|470914831|FG004|Dose Level III|Treatment-related AE|0|||
130805640|NCT02533674|470914832|FG005|Dose Level III|Treatment-related AE|0|||
130805641|NCT02533674|470914833|FG006|Dose Level III|Treatment-related AE|0|||
130805642|NCT02533674|470914834|FG007|Dose Level III|Treatment-related AE|0|||
130805643|NCT02533674|470914827|FG000|Dose Level IV|Progressive disease|0|||
130805644|NCT02533674|470914828|FG001|Dose Level IV|Progressive disease|0|||
130805645|NCT02533674|470914829|FG002|Dose Level IV|Progressive disease|0|||
130805646|NCT02533674|470914830|FG003|Dose Level IV|Progressive disease|3|||
130805647|NCT02533674|470914831|FG004|Dose Level IV|Progressive disease|0|||
130805648|NCT02533674|470914832|FG005|Dose Level IV|Progressive disease|0|||
130805649|NCT02533674|470914833|FG006|Dose Level IV|Progressive disease|0|||
130805650|NCT02533674|470914834|FG007|Dose Level IV|Progressive disease|0|||
130805651|NCT02533674|470914827|FG000|Dose Level IV|Withdrawal by Subject|0|||
130805652|NCT02533674|470914828|FG001|Dose Level IV|Withdrawal by Subject|0|||
130805653|NCT02533674|470914829|FG002|Dose Level IV|Withdrawal by Subject|0|||
130805654|NCT02533674|470914830|FG003|Dose Level IV|Withdrawal by Subject|1|||
130805655|NCT02533674|470914831|FG004|Dose Level IV|Withdrawal by Subject|0|||
130805656|NCT02533674|470914832|FG005|Dose Level IV|Withdrawal by Subject|0|||
130805657|NCT02533674|470914833|FG006|Dose Level IV|Withdrawal by Subject|0|||
130805658|NCT02533674|470914834|FG007|Dose Level IV|Withdrawal by Subject|0|||
130805659|NCT02533674|470914827|FG000|Dose Level IV|Physician Decision|0|||
130805660|NCT02533674|470914828|FG001|Dose Level IV|Physician Decision|0|||
130805661|NCT02533674|470914829|FG002|Dose Level IV|Physician Decision|0|||
130805662|NCT02533674|470914830|FG003|Dose Level IV|Physician Decision|1|||
130805663|NCT02533674|470914831|FG004|Dose Level IV|Physician Decision|0|||
130805664|NCT02533674|470914832|FG005|Dose Level IV|Physician Decision|0|||
130805665|NCT02533674|470914833|FG006|Dose Level IV|Physician Decision|0|||
130805666|NCT02533674|470914834|FG007|Dose Level IV|Physician Decision|0|||
130805667|NCT02533674|470914827|FG000|Dose Level V|Progressive disease|0|||
130805668|NCT02533674|470914828|FG001|Dose Level V|Progressive disease|0|||
130805669|NCT02533674|470914829|FG002|Dose Level V|Progressive disease|0|||
130805670|NCT02533674|470914830|FG003|Dose Level V|Progressive disease|0|||
130805671|NCT02533674|470914831|FG004|Dose Level V|Progressive disease|3|||
130805672|NCT02533674|470914832|FG005|Dose Level V|Progressive disease|0|||
130805673|NCT02533674|470914833|FG006|Dose Level V|Progressive disease|0|||
130805674|NCT02533674|470914834|FG007|Dose Level V|Progressive disease|0|||
130805675|NCT02533674|470914827|FG000|Dose Level V|Withdrawal by Subject|0|||
130805676|NCT02533674|470914828|FG001|Dose Level V|Withdrawal by Subject|0|||
130805677|NCT02533674|470914829|FG002|Dose Level V|Withdrawal by Subject|0|||
130805678|NCT02533674|470914830|FG003|Dose Level V|Withdrawal by Subject|0|||
130805679|NCT02533674|470914831|FG004|Dose Level V|Withdrawal by Subject|1|||
130805680|NCT02533674|470914832|FG005|Dose Level V|Withdrawal by Subject|0|||
130805681|NCT02533674|470914833|FG006|Dose Level V|Withdrawal by Subject|0|||
130805682|NCT02533674|470914834|FG007|Dose Level V|Withdrawal by Subject|0|||
130805683|NCT02533674|470914827|FG000|Dose Level V|Physician Decision|0|||
130805684|NCT02533674|470914828|FG001|Dose Level V|Physician Decision|0|||
130805685|NCT02533674|470914829|FG002|Dose Level V|Physician Decision|0|||
130805686|NCT02533674|470914830|FG003|Dose Level V|Physician Decision|0|||
130805687|NCT02533674|470914831|FG004|Dose Level V|Physician Decision|1|||
130805688|NCT02533674|470914832|FG005|Dose Level V|Physician Decision|0|||
130805689|NCT02533674|470914833|FG006|Dose Level V|Physician Decision|0|||
130763932|NCT00195494|470758687|FG005|Year 2|System toxicity|0|||
130763933|NCT02020512|470758688|FG000|Overall Study|Adverse Event|1|||
130763934|NCT02020512|470758688|FG000|Overall Study|Lost to Follow-up|3|||
130763935|NCT02020512|470758688|FG000|Overall Study|Protocol Violation|4|||
130763936|NCT00422422|470758692|FG000|Overall Study|Lack of Efficacy|1|||
130763937|NCT00422422|470758692|FG000|Overall Study|Protocol Violation|1|||
130763938|NCT00422422|470758692|FG000|Overall Study|Withdrawal by Subject|2|||
130763939|NCT00422422|470758692|FG000|Overall Study|SAE, non-fatal|1|||
130763940|NCT00422422|470758692|FG000|Overall Study|AE, non-serious non-fatal|5|||
130763941|NCT04769739|470758701|FG000|Overall Study|Colorectal cancer obstruction|2|||
130763942|NCT04769739|470758702|FG001|Overall Study|Colorectal cancer obstruction|0|||
130763943|NCT04769739|470758703|FG002|Overall Study|Colorectal cancer obstruction|0|||
130763944|NCT04769739|470758704|FG003|Overall Study|Colorectal cancer obstruction|0|||
130763945|NCT04769739|470758701|FG000|Overall Study|Failed cecal intubation|1|||
130763946|NCT04769739|470758702|FG001|Overall Study|Failed cecal intubation|0|||
130763947|NCT04769739|470758703|FG002|Overall Study|Failed cecal intubation|0|||
130763948|NCT04769739|470758704|FG003|Overall Study|Failed cecal intubation|1|||
130763949|NCT04769739|470758701|FG000|Overall Study|Poor bowel preparation|0|||
130763950|NCT04769739|470758702|FG001|Overall Study|Poor bowel preparation|0|||
130763951|NCT04769739|470758703|FG002|Overall Study|Poor bowel preparation|0|||
130763952|NCT04769739|470758704|FG003|Overall Study|Poor bowel preparation|1|||
130763953|NCT03689543|470758705|FG000|Overall Study|Adverse Event|0|||
130763954|NCT03689543|470758706|FG001|Overall Study|Adverse Event|0|||
130763955|NCT03689543|470758707|FG002|Overall Study|Adverse Event|1|||
130763956|NCT00932451|470758708|FG000|Overall Study|Withdrawal by Subject|69|||
130763957|NCT00932451|470758708|FG000|Overall Study|Lost to Follow-up|22|||
130763958|NCT00932451|470758708|FG000|Overall Study|Death|726|||
130763959|NCT00932451|470758708|FG000|Overall Study|Other reasons|5|||
130763960|NCT02968433|470758726|FG000|Overall Study|Withdrawal by Subject|1|||
130763961|NCT00637806|470758727|FG000|Double-blind Phase|Study Discontinued|2|||
130763962|NCT00637806|470758728|FG001|Double-blind Phase|Study Discontinued|0|||
130763963|NCT00637806|470758729|FG002|Double-blind Phase|Study Discontinued|1|||
130763964|NCT00637806|470758730|FG003|Double-blind Phase|Study Discontinued|0|||
130763965|NCT00637806|470758727|FG000|Extension Phase|Study Discontinued|0|||
130763966|NCT00637806|470758728|FG001|Extension Phase|Study Discontinued|0|||
130763967|NCT00637806|470758729|FG002|Extension Phase|Study Discontinued|0|||
130763968|NCT00637806|470758730|FG003|Extension Phase|Study Discontinued|1|||
130763969|NCT00622336|470758731|FG000|Treatment Phase|Progression of Disease|181|||
130763970|NCT00622336|470758731|FG000|Treatment Phase|Adverse Event|46|||
130763971|NCT00622336|470758731|FG000|Treatment Phase|Other|40|||
130763972|NCT00622336|470758731|FG000|Treatment Phase|Death|14|||
130763973|NCT00622336|470758731|FG000|Treatment Phase|Lack of therapeutic effect|13|||
130805690|NCT02533674|470914834|FG007|Dose Level V|Physician Decision|0|||
130805691|NCT02533674|470914827|FG000|Dose Level VI|Progressive disease|0|||
130805692|NCT02533674|470914828|FG001|Dose Level VI|Progressive disease|0|||
130805693|NCT02533674|470914829|FG002|Dose Level VI|Progressive disease|0|||
130805694|NCT02533674|470914830|FG003|Dose Level VI|Progressive disease|0|||
130805695|NCT02533674|470914831|FG004|Dose Level VI|Progressive disease|0|||
130805696|NCT02533674|470914832|FG005|Dose Level VI|Progressive disease|7|||
130805697|NCT02533674|470914833|FG006|Dose Level VI|Progressive disease|0|||
130805698|NCT02533674|470914834|FG007|Dose Level VI|Progressive disease|0|||
130805699|NCT02533674|470914827|FG000|Dose Level VI|Withdrawal by Subject|0|||
130805700|NCT02533674|470914828|FG001|Dose Level VI|Withdrawal by Subject|0|||
130805701|NCT02533674|470914829|FG002|Dose Level VI|Withdrawal by Subject|0|||
130805702|NCT02533674|470914830|FG003|Dose Level VI|Withdrawal by Subject|0|||
130805703|NCT02533674|470914831|FG004|Dose Level VI|Withdrawal by Subject|0|||
130805704|NCT02533674|470914832|FG005|Dose Level VI|Withdrawal by Subject|1|||
130805705|NCT02533674|470914833|FG006|Dose Level VI|Withdrawal by Subject|0|||
130805706|NCT02533674|470914834|FG007|Dose Level VI|Withdrawal by Subject|0|||
130805707|NCT02533674|470914827|FG000|Dose Level VI|Treatment-related AE|0|||
130805708|NCT02533674|470914828|FG001|Dose Level VI|Treatment-related AE|0|||
130805709|NCT02533674|470914829|FG002|Dose Level VI|Treatment-related AE|0|||
130805710|NCT02533674|470914830|FG003|Dose Level VI|Treatment-related AE|0|||
130805711|NCT02533674|470914831|FG004|Dose Level VI|Treatment-related AE|0|||
130805712|NCT02533674|470914832|FG005|Dose Level VI|Treatment-related AE|1|||
130805713|NCT02533674|470914833|FG006|Dose Level VI|Treatment-related AE|0|||
130805714|NCT02533674|470914834|FG007|Dose Level VI|Treatment-related AE|0|||
130805715|NCT02533674|470914827|FG000|Dose Level VII|Progressive disease|0|||
130805716|NCT02533674|470914828|FG001|Dose Level VII|Progressive disease|0|||
130805717|NCT02533674|470914829|FG002|Dose Level VII|Progressive disease|0|||
130805718|NCT02533674|470914830|FG003|Dose Level VII|Progressive disease|0|||
130805719|NCT02533674|470914831|FG004|Dose Level VII|Progressive disease|0|||
130805720|NCT02533674|470914832|FG005|Dose Level VII|Progressive disease|0|||
130805721|NCT02533674|470914833|FG006|Dose Level VII|Progressive disease|10|||
130805722|NCT02533674|470914834|FG007|Dose Level VII|Progressive disease|0|||
130805723|NCT02533674|470914827|FG000|Dose Level VII|Withdrawal by Subject|0|||
130805724|NCT02533674|470914828|FG001|Dose Level VII|Withdrawal by Subject|0|||
130805725|NCT02533674|470914829|FG002|Dose Level VII|Withdrawal by Subject|0|||
130805726|NCT02533674|470914830|FG003|Dose Level VII|Withdrawal by Subject|0|||
130805727|NCT02533674|470914831|FG004|Dose Level VII|Withdrawal by Subject|0|||
130805728|NCT02533674|470914832|FG005|Dose Level VII|Withdrawal by Subject|0|||
130805729|NCT02533674|470914833|FG006|Dose Level VII|Withdrawal by Subject|3|||
130805730|NCT02533674|470914834|FG007|Dose Level VII|Withdrawal by Subject|0|||
130805731|NCT02533674|470914827|FG000|Dose Level VII|Treatment-related AE|0|||
130805732|NCT02533674|470914828|FG001|Dose Level VII|Treatment-related AE|0|||
130805733|NCT02533674|470914829|FG002|Dose Level VII|Treatment-related AE|0|||
130805734|NCT02533674|470914830|FG003|Dose Level VII|Treatment-related AE|0|||
130805735|NCT02533674|470914831|FG004|Dose Level VII|Treatment-related AE|0|||
130805736|NCT02533674|470914832|FG005|Dose Level VII|Treatment-related AE|0|||
130805737|NCT02533674|470914833|FG006|Dose Level VII|Treatment-related AE|1|||
130805738|NCT02533674|470914834|FG007|Dose Level VII|Treatment-related AE|0|||
130805739|NCT02533674|470914827|FG000|Dose Level VII|Death|0|||
130805740|NCT02533674|470914828|FG001|Dose Level VII|Death|0|||
130805741|NCT02533674|470914829|FG002|Dose Level VII|Death|0|||
130805742|NCT02533674|470914830|FG003|Dose Level VII|Death|0|||
130805743|NCT02533674|470914831|FG004|Dose Level VII|Death|0|||
130805744|NCT02533674|470914832|FG005|Dose Level VII|Death|0|||
130805745|NCT02533674|470914833|FG006|Dose Level VII|Death|2|||
130805746|NCT02533674|470914834|FG007|Dose Level VII|Death|0|||
130805747|NCT02533674|470914827|FG000|Dose Level VIII|Progressive disease|0|||
130805748|NCT02533674|470914828|FG001|Dose Level VIII|Progressive disease|0|||
130805749|NCT02533674|470914829|FG002|Dose Level VIII|Progressive disease|0|||
130805750|NCT02533674|470914830|FG003|Dose Level VIII|Progressive disease|0|||
130805751|NCT02533674|470914831|FG004|Dose Level VIII|Progressive disease|0|||
130805752|NCT02533674|470914832|FG005|Dose Level VIII|Progressive disease|0|||
130805753|NCT02533674|470914833|FG006|Dose Level VIII|Progressive disease|0|||
130805754|NCT02533674|470914834|FG007|Dose Level VIII|Progressive disease|3|||
130805755|NCT02533674|470914827|FG000|Dose Level VIII|Withdrawal by Subject|0|||
130805756|NCT02533674|470914828|FG001|Dose Level VIII|Withdrawal by Subject|0|||
130805757|NCT02533674|470914829|FG002|Dose Level VIII|Withdrawal by Subject|0|||
130805758|NCT02533674|470914830|FG003|Dose Level VIII|Withdrawal by Subject|0|||
130805759|NCT02533674|470914831|FG004|Dose Level VIII|Withdrawal by Subject|0|||
130805760|NCT02533674|470914832|FG005|Dose Level VIII|Withdrawal by Subject|0|||
130805761|NCT02533674|470914833|FG006|Dose Level VIII|Withdrawal by Subject|0|||
130805762|NCT02533674|470914834|FG007|Dose Level VIII|Withdrawal by Subject|1|||
130805763|NCT02533674|470914827|FG000|Dose Level VIII|Treatment-related AE|0|||
130805764|NCT02533674|470914828|FG001|Dose Level VIII|Treatment-related AE|0|||
130805765|NCT02533674|470914829|FG002|Dose Level VIII|Treatment-related AE|0|||
130805766|NCT02533674|470914830|FG003|Dose Level VIII|Treatment-related AE|0|||
130805767|NCT02533674|470914831|FG004|Dose Level VIII|Treatment-related AE|0|||
130805768|NCT02533674|470914832|FG005|Dose Level VIII|Treatment-related AE|0|||
130805769|NCT02533674|470914833|FG006|Dose Level VIII|Treatment-related AE|0|||
130805770|NCT02533674|470914834|FG007|Dose Level VIII|Treatment-related AE|1|||
130805771|NCT02533674|470914827|FG000|Dose Level VIII|Never treated|0|||
130805772|NCT02533674|470914828|FG001|Dose Level VIII|Never treated|0|||
130805773|NCT02533674|470914829|FG002|Dose Level VIII|Never treated|0|||
130805774|NCT02533674|470914830|FG003|Dose Level VIII|Never treated|0|||
130805775|NCT02533674|470914831|FG004|Dose Level VIII|Never treated|0|||
130805776|NCT02533674|470914832|FG005|Dose Level VIII|Never treated|0|||
130805777|NCT02533674|470914833|FG006|Dose Level VIII|Never treated|0|||
130805778|NCT02533674|470914834|FG007|Dose Level VIII|Never treated|1|||
130805779|NCT00458705|470914837|FG000|Overall Study|Adverse Event|4|||
130805780|NCT00458705|470914837|FG000|Overall Study|Not Treated|1|||
130805781|NCT00604383|470914838|FG000|Overall Study|Withdrawal by Subject|33|||
130805782|NCT00604383|470914839|FG001|Overall Study|Withdrawal by Subject|31|||
130805783|NCT00604383|470914838|FG000|Overall Study|Lost to Follow-up|24|||
130805784|NCT00604383|470914839|FG001|Overall Study|Lost to Follow-up|19|||
130805785|NCT00604383|470914838|FG000|Overall Study|Death|14|||
130805786|NCT00604383|470914839|FG001|Overall Study|Death|22|||
130805787|NCT00604383|470914838|FG000|Overall Study|Adverse Event|16|||
130805788|NCT00604383|470914839|FG001|Overall Study|Adverse Event|9|||
130805789|NCT00604383|470914838|FG000|Overall Study|Physician Decision|0|||
130805790|NCT00604383|470914839|FG001|Overall Study|Physician Decision|3|||
130805791|NCT01122680|470914840|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
130805792|NCT01122680|470914841|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
130805793|NCT01122680|470914842|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
130805794|NCT01122680|470914843|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
130805795|NCT01122680|470914840|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
130805796|NCT01122680|470914841|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
130805797|NCT01122680|470914842|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
130805798|NCT01122680|470914843|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
130805799|NCT01122680|470914840|FG000|Period 1 (4 Weeks)|Other|1|||
130805800|NCT01122680|470914841|FG001|Period 1 (4 Weeks)|Other|1|||
130805801|NCT01122680|470914842|FG002|Period 1 (4 Weeks)|Other|0|||
130805802|NCT01122680|470914843|FG003|Period 1 (4 Weeks)|Other|0|||
130805803|NCT01122680|470914840|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
130805804|NCT01122680|470914841|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
130805805|NCT01122680|470914842|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
130805806|NCT01122680|470914843|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
130805807|NCT01122680|470914840|FG000|Period 2 (4 Weeks)|Other|1|||
130805808|NCT01122680|470914841|FG001|Period 2 (4 Weeks)|Other|0|||
130805809|NCT01122680|470914842|FG002|Period 2 (4 Weeks)|Other|0|||
130805810|NCT01122680|470914843|FG003|Period 2 (4 Weeks)|Other|0|||
130805811|NCT01122680|470914840|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
130805812|NCT01122680|470914841|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
130805813|NCT01122680|470914842|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
130805814|NCT01122680|470914843|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
130805815|NCT01122680|470914840|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130805816|NCT01122680|470914841|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
130805817|NCT01122680|470914842|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130805818|NCT01122680|470914843|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130805819|NCT00576407|470914844|FG000|Overall Study|Death|7|||
130805820|NCT00576407|470914844|FG000|Overall Study|Physician Decision|1|||
130805821|NCT00225758|470914845|FG000|Overall Study|Adverse Event|4|||
130805822|NCT00756444|470914846|FG000|Overall Study|Adverse Event|1|||
130805823|NCT00756444|470914847|FG001|Overall Study|Adverse Event|1|||
130805824|NCT00756444|470914846|FG000|Overall Study|Withdrawal by Subject|6|||
130805825|NCT00756444|470914847|FG001|Overall Study|Withdrawal by Subject|8|||
130805826|NCT00756444|470914846|FG000|Overall Study|Lost to Follow-up|0|||
130805827|NCT00756444|470914847|FG001|Overall Study|Lost to Follow-up|1|||
130805828|NCT00756444|470914846|FG000|Overall Study|Death|5|||
130805829|NCT00756444|470914847|FG001|Overall Study|Death|4|||
130805830|NCT00756444|470914846|FG000|Overall Study|Disease Progression|2|||
130805831|NCT00756444|470914847|FG001|Overall Study|Disease Progression|7|||
130805832|NCT00756444|470914846|FG000|Overall Study|Ineligibility Determined|1|||
130805833|NCT00756444|470914847|FG001|Overall Study|Ineligibility Determined|0|||
130805834|NCT03071965|470914848|FG000|Overall Study|Adverse Event|0|||
130805835|NCT03071965|470914849|FG001|Overall Study|Adverse Event|0|||
130805836|NCT03071965|470914850|FG002|Overall Study|Adverse Event|1|||
130805837|NCT03071965|470914851|FG003|Overall Study|Adverse Event|0|||
130805838|NCT03071965|470914848|FG000|Overall Study|Death|0|||
130805839|NCT03071965|470914849|FG001|Overall Study|Death|0|||
130805840|NCT03071965|470914850|FG002|Overall Study|Death|1|||
130805841|NCT03071965|470914851|FG003|Overall Study|Death|1|||
130805842|NCT03071965|470914848|FG000|Overall Study|COVID-19|0|||
130805843|NCT03071965|470914849|FG001|Overall Study|COVID-19|1|||
130805844|NCT03071965|470914850|FG002|Overall Study|COVID-19|0|||
130805845|NCT03071965|470914851|FG003|Overall Study|COVID-19|1|||
130805846|NCT03071965|470914848|FG000|Overall Study|Other Health Reason|0|||
130805847|NCT03071965|470914849|FG001|Overall Study|Other Health Reason|0|||
130805848|NCT03071965|470914850|FG002|Overall Study|Other Health Reason|0|||
130805849|NCT03071965|470914851|FG003|Overall Study|Other Health Reason|1|||
130805850|NCT05587998|470914852|FG000|Overall Study|Withdrawal by Subject|1|||
130805851|NCT05587998|470914853|FG001|Overall Study|Withdrawal by Subject|1|||
130805852|NCT05587998|470914852|FG000|Overall Study|Not treated|3|||
130805853|NCT05587998|470914853|FG001|Overall Study|Not treated|1|||
130805854|NCT05587998|470914852|FG000|Overall Study|Non-compliance with study procedures|0|||
130805855|NCT05587998|470914853|FG001|Overall Study|Non-compliance with study procedures|1|||
130805856|NCT00601107|470914857|FG000|Overall Study|Adverse Event|0|||
130805857|NCT00601107|470914858|FG001|Overall Study|Adverse Event|1|||
130805858|NCT00601107|470914859|FG002|Overall Study|Adverse Event|3|||
130805859|NCT00601107|470914860|FG003|Overall Study|Adverse Event|0|||
130805860|NCT00601107|470914857|FG000|Overall Study|Withdrawal by Subject|5|||
130805861|NCT00601107|470914858|FG001|Overall Study|Withdrawal by Subject|4|||
130805862|NCT00601107|470914859|FG002|Overall Study|Withdrawal by Subject|7|||
130805863|NCT00601107|470914860|FG003|Overall Study|Withdrawal by Subject|4|||
130805864|NCT00601107|470914857|FG000|Overall Study|Lost to Follow-up|3|||
130805865|NCT00601107|470914858|FG001|Overall Study|Lost to Follow-up|3|||
130805866|NCT00601107|470914859|FG002|Overall Study|Lost to Follow-up|0|||
130805867|NCT00601107|470914860|FG003|Overall Study|Lost to Follow-up|3|||
130805868|NCT00601107|470914857|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
130805869|NCT00601107|470914858|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
130805870|NCT00601107|470914859|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
130805871|NCT00601107|470914860|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
130805872|NCT00601107|470914857|FG000|Overall Study|Worsening of Psoriasis|4|||
130805873|NCT00601107|470914858|FG001|Overall Study|Worsening of Psoriasis|1|||
130805874|NCT00601107|470914859|FG002|Overall Study|Worsening of Psoriasis|1|||
130805875|NCT00601107|470914860|FG003|Overall Study|Worsening of Psoriasis|4|||
130805876|NCT00601107|470914857|FG000|Overall Study|Undefined|1|||
130805877|NCT00601107|470914858|FG001|Overall Study|Undefined|0|||
130805878|NCT00601107|470914859|FG002|Overall Study|Undefined|1|||
130805879|NCT00601107|470914860|FG003|Overall Study|Undefined|0|||
130805880|NCT01530997|470914861|FG000|Overall Study|Physician Decision|1|||
130805881|NCT01530997|470914861|FG000|Overall Study|Withdrawal by Subject|1|||
130805882|NCT03892915|470914862|FG000|Overall Study|Lost to Follow-up|6|||
130805883|NCT03892915|470914863|FG001|Overall Study|Lost to Follow-up|12|||
130805884|NCT03892915|470914862|FG000|Overall Study|Death|0|||
130805885|NCT03892915|470914863|FG001|Overall Study|Death|2|||
130805886|NCT03892915|470914862|FG000|Overall Study|Withdrawal by Subject|1|||
130805887|NCT03892915|470914863|FG001|Overall Study|Withdrawal by Subject|1|||
130805888|NCT03892915|470914862|FG000|Overall Study|unsuccessful delivery|13|||
130805889|NCT03892915|470914863|FG001|Overall Study|unsuccessful delivery|18|||
130805890|NCT02181738|470914866|FG000|Overall Study|Participant Withdrew Consent|2|||
130805891|NCT02181738|470914867|FG001|Overall Study|Participant Withdrew Consent|1|||
130805892|NCT02181738|470914868|FG002|Overall Study|Participant Withdrew Consent|1|||
130805893|NCT02181738|470914869|FG003|Overall Study|Participant Withdrew Consent|1|||
130805894|NCT02181738|470914866|FG000|Overall Study|Lost to Follow-up|1|||
130805895|NCT02181738|470914867|FG001|Overall Study|Lost to Follow-up|2|||
130805896|NCT02181738|470914868|FG002|Overall Study|Lost to Follow-up|1|||
130805897|NCT02181738|470914869|FG003|Overall Study|Lost to Follow-up|1|||
130805898|NCT02181738|470914866|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
130805899|NCT02181738|470914867|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
130805900|NCT02181738|470914868|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
130805901|NCT02181738|470914869|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
130805902|NCT02181738|470914866|FG000|Overall Study|Poor/Non-Compliance|1|||
130805903|NCT02181738|470914867|FG001|Overall Study|Poor/Non-Compliance|0|||
130805904|NCT02181738|470914868|FG002|Overall Study|Poor/Non-Compliance|2|||
130805905|NCT02181738|470914869|FG003|Overall Study|Poor/Non-Compliance|1|||
130805906|NCT02181738|470914866|FG000|Overall Study|Disease Progression|28|||
130805907|NCT02181738|470914867|FG001|Overall Study|Disease Progression|35|||
130805908|NCT02181738|470914868|FG002|Overall Study|Disease Progression|40|||
130805909|NCT02181738|470914869|FG003|Overall Study|Disease Progression|0|||
130805910|NCT02181738|470914866|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
130805911|NCT02181738|470914867|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
130805912|NCT02181738|470914868|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
130805913|NCT02181738|470914869|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
130805914|NCT02181738|470914866|FG000|Overall Study|Study Drug Toxicity|6|||
130805915|NCT02181738|470914867|FG001|Overall Study|Study Drug Toxicity|11|||
130805916|NCT02181738|470914868|FG002|Overall Study|Study Drug Toxicity|8|||
130805917|NCT02181738|470914869|FG003|Overall Study|Study Drug Toxicity|1|||
130805918|NCT02181738|470914866|FG000|Overall Study|Other Reasons|14|||
130805919|NCT02181738|470914867|FG001|Overall Study|Other Reasons|16|||
130805920|NCT02181738|470914868|FG002|Overall Study|Other Reasons|28|||
130805921|NCT02181738|470914869|FG003|Overall Study|Other Reasons|0|||
130805922|NCT02181738|470914866|FG000|Overall Study|Maximum Clinical Benefit|3|||
130805923|NCT02181738|470914867|FG001|Overall Study|Maximum Clinical Benefit|0|||
130805924|NCT02181738|470914868|FG002|Overall Study|Maximum Clinical Benefit|1|||
130805925|NCT02181738|470914869|FG003|Overall Study|Maximum Clinical Benefit|0|||
130805926|NCT02181738|470914866|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130805927|NCT02181738|470914867|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130805928|NCT02181738|470914868|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
130805929|NCT02181738|470914869|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130805930|NCT01362270|470914872|FG000|Overall Study|Withdrawal by Subject|1|||
130805931|NCT01362270|470914873|FG001|Overall Study|Withdrawal by Subject|0|||
130805932|NCT01362270|470914872|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
130805933|NCT01362270|470914873|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
130805934|NCT01362270|470914872|FG000|Overall Study|Met excl. criteria before 1st session|1|||
130805935|NCT01362270|470914873|FG001|Overall Study|Met excl. criteria before 1st session|1|||
130805936|NCT02318277|470914874|FG000|Overall Study|Physician Decision|0|||
130805937|NCT02318277|470914875|FG001|Overall Study|Physician Decision|0|||
130805938|NCT02318277|470914876|FG002|Overall Study|Physician Decision|0|||
130805939|NCT02318277|470914877|FG003|Overall Study|Physician Decision|0|||
130805940|NCT02318277|470914878|FG004|Overall Study|Physician Decision|0|||
130805941|NCT02318277|470914879|FG005|Overall Study|Physician Decision|0|||
130805942|NCT02318277|470914880|FG006|Overall Study|Physician Decision|0|||
130805943|NCT02318277|470914881|FG007|Overall Study|Physician Decision|1|||
130805944|NCT02318277|470914874|FG000|Overall Study|Other|0|||
130805945|NCT02318277|470914875|FG001|Overall Study|Other|0|||
130805946|NCT02318277|470914876|FG002|Overall Study|Other|0|||
130805947|NCT02318277|470914877|FG003|Overall Study|Other|0|||
130805948|NCT02318277|470914878|FG004|Overall Study|Other|0|||
130805949|NCT02318277|470914879|FG005|Overall Study|Other|0|||
130805950|NCT02318277|470914880|FG006|Overall Study|Other|1|||
130805951|NCT02318277|470914881|FG007|Overall Study|Other|0|||
130805952|NCT02318277|470914874|FG000|Overall Study|Withdrawal by Subject|0|||
130805953|NCT02318277|470914875|FG001|Overall Study|Withdrawal by Subject|0|||
130805954|NCT02318277|470914876|FG002|Overall Study|Withdrawal by Subject|1|||
130805955|NCT02318277|470914877|FG003|Overall Study|Withdrawal by Subject|0|||
130805956|NCT02318277|470914878|FG004|Overall Study|Withdrawal by Subject|1|||
130805957|NCT02318277|470914879|FG005|Overall Study|Withdrawal by Subject|1|||
130805958|NCT02318277|470914880|FG006|Overall Study|Withdrawal by Subject|6|||
130805959|NCT02318277|470914881|FG007|Overall Study|Withdrawal by Subject|14|||
130805960|NCT02318277|470914874|FG000|Overall Study|Participant trial terminated by sponsor|0|||
130805961|NCT02318277|470914875|FG001|Overall Study|Participant trial terminated by sponsor|0|||
130805962|NCT02318277|470914876|FG002|Overall Study|Participant trial terminated by sponsor|1|||
130805963|NCT02318277|470914877|FG003|Overall Study|Participant trial terminated by sponsor|0|||
130805964|NCT02318277|470914878|FG004|Overall Study|Participant trial terminated by sponsor|1|||
130805965|NCT02318277|470914879|FG005|Overall Study|Participant trial terminated by sponsor|2|||
130805966|NCT02318277|470914880|FG006|Overall Study|Participant trial terminated by sponsor|5|||
130805967|NCT02318277|470914881|FG007|Overall Study|Participant trial terminated by sponsor|16|||
130805968|NCT02318277|470914874|FG000|Overall Study|Lost to Follow-up|1|||
130805969|NCT02318277|470914875|FG001|Overall Study|Lost to Follow-up|0|||
130805970|NCT02318277|470914876|FG002|Overall Study|Lost to Follow-up|1|||
130805971|NCT02318277|470914877|FG003|Overall Study|Lost to Follow-up|0|||
130805972|NCT02318277|470914878|FG004|Overall Study|Lost to Follow-up|0|||
130805973|NCT02318277|470914879|FG005|Overall Study|Lost to Follow-up|0|||
130805974|NCT02318277|470914880|FG006|Overall Study|Lost to Follow-up|3|||
130805975|NCT02318277|470914881|FG007|Overall Study|Lost to Follow-up|4|||
130805976|NCT02318277|470914874|FG000|Overall Study|Death|5|||
130805977|NCT02318277|470914875|FG001|Overall Study|Death|3|||
130805978|NCT02318277|470914876|FG002|Overall Study|Death|1|||
130805979|NCT02318277|470914877|FG003|Overall Study|Death|4|||
130805980|NCT02318277|470914878|FG004|Overall Study|Death|6|||
130805981|NCT02318277|470914879|FG005|Overall Study|Death|5|||
130805982|NCT02318277|470914880|FG006|Overall Study|Death|34|||
130805983|NCT02318277|470914881|FG007|Overall Study|Death|58|||
130805984|NCT02318277|470914874|FG000|Overall Study|Transitioned to Hospice|0|||
130805985|NCT02318277|470914875|FG001|Overall Study|Transitioned to Hospice|0|||
130805986|NCT02318277|470914876|FG002|Overall Study|Transitioned to Hospice|0|||
130805987|NCT02318277|470914877|FG003|Overall Study|Transitioned to Hospice|0|||
130805988|NCT02318277|470914878|FG004|Overall Study|Transitioned to Hospice|0|||
130805989|NCT02318277|470914879|FG005|Overall Study|Transitioned to Hospice|1|||
130805990|NCT02318277|470914880|FG006|Overall Study|Transitioned to Hospice|0|||
130805991|NCT02318277|470914881|FG007|Overall Study|Transitioned to Hospice|0|||
130805992|NCT01691482|470914882|FG000|Treatment Period 2|Adverse Event|0|||
130805993|NCT01691482|470914883|FG001|Treatment Period 2|Adverse Event|1|||
130805994|NCT01691482|470914882|FG000|Treatment Period 2|Protocol Violation|1|||
130805995|NCT01691482|470914883|FG001|Treatment Period 2|Protocol Violation|1|||
130805996|NCT00407030|470914884|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
130805997|NCT00407030|470914885|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
130805998|NCT00407030|470914886|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
130805999|NCT00407030|470914884|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
130806000|NCT00407030|470914885|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
130806001|NCT00407030|470914886|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
130806002|NCT00407030|470914884|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
130806003|NCT00407030|470914885|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
130806004|NCT00407030|470914886|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
130806005|NCT00407030|470914884|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
130806006|NCT00407030|470914885|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
130806007|NCT00407030|470914886|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
130806008|NCT00407030|470914884|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
130806009|NCT00407030|470914885|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
130806010|NCT00407030|470914886|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
130806011|NCT00407030|470914884|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
130806012|NCT00407030|470914885|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
130806013|NCT00407030|470914886|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
130806014|NCT00407030|470914884|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
130806015|NCT00407030|470914885|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
130806016|NCT00407030|470914886|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
130806017|NCT00407030|470914884|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
130806018|NCT00407030|470914885|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
130806019|NCT00407030|470914886|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
130806020|NCT00407030|470914884|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
130806021|NCT00407030|470914885|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
130806022|NCT00407030|470914886|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
130806023|NCT00407030|470914884|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
130806024|NCT00407030|470914885|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
130806025|NCT00407030|470914886|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
130806026|NCT00407030|470914884|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
130806027|NCT00407030|470914885|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
130806028|NCT00407030|470914886|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
130806029|NCT00407030|470914884|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
130806030|NCT00407030|470914885|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
130806031|NCT00407030|470914886|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
130806032|NCT00407030|470914884|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
130806033|NCT00407030|470914885|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
130806034|NCT00407030|470914886|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
130806035|NCT02829957|470914888|FG000|Overall Study|Lost to Follow-up|2|||
130806036|NCT02829957|470914889|FG001|Overall Study|Lost to Follow-up|1|||
130806037|NCT02366130|470914890|FG000|Overall Study|Withdrawal by Subject|3|||
130806038|NCT02366130|470914890|FG000|Overall Study|Ineligible|6|||
130806039|NCT01945242|470914891|FG000|Overall Study|Physician Decision|3|||
130806040|NCT01945242|470914892|FG001|Overall Study|Physician Decision|3|||
130806041|NCT05661734|470914893|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
130806042|NCT05661734|470914893|FG000|Overall Study|Lost to Follow-up|13|||
130806043|NCT05661734|470914893|FG000|Overall Study|Enrolled but not dosed|2|||
130806044|NCT01341990|470914894|FG000|Overall Study|Adverse Event|0|||
130806045|NCT01341990|470914895|FG001|Overall Study|Adverse Event|1|||
130806046|NCT01341990|470914894|FG000|Overall Study|Torn Study Lens|1|||
130806047|NCT01341990|470914895|FG001|Overall Study|Torn Study Lens|0|||
130806048|NCT01341990|470914894|FG000|Overall Study|Withdrawal by Subject|2|||
130806049|NCT01341990|470914895|FG001|Overall Study|Withdrawal by Subject|0|||
130806050|NCT01751685|470914896|FG000|6-mo Followup|Missed study visit|1|||
130806051|NCT01751685|470914897|FG001|6-mo Followup|Missed study visit|0|||
130806052|NCT01751685|470914896|FG000|6-mo Followup|Withdrawal by Subject|2|||
130806053|NCT01751685|470914897|FG001|6-mo Followup|Withdrawal by Subject|2|||
130806054|NCT01751685|470914896|FG000|6-mo Followup|Lost to Follow-up|0|||
130806055|NCT01751685|470914897|FG001|6-mo Followup|Lost to Follow-up|1|||
130806056|NCT01751685|470914896|FG000|12-mo Followup|Lost to Follow-up|5|||
130806057|NCT01751685|470914897|FG001|12-mo Followup|Lost to Follow-up|0|||
130806058|NCT04401293|470914898|FG000|Overall Study|Withdrawal by Subject|1|||
130806059|NCT04401293|470914899|FG001|Overall Study|Withdrawal by Subject|3|||
130806060|NCT00694161|470914900|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
130806061|NCT00694161|470914900|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
130806062|NCT00694161|470914900|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
130806063|NCT00837330|470914901|FG000|Overall Study|Lost to Follow-up|1|||
130806064|NCT00837330|470914902|FG001|Overall Study|Lost to Follow-up|3|||
130806065|NCT01348490|470914907|FG000|Overall Study|Death|1|||
130806066|NCT01348490|470914907|FG000|Overall Study|Adverse Event|3|||
130806067|NCT01348490|470914907|FG000|Overall Study|Consent withdrawn|7|||
130806068|NCT01348490|470914907|FG000|Overall Study|Disease progression|3|||
130806069|NCT01348490|470914907|FG000|Overall Study|Lost to Follow-up|1|||
130806070|NCT01348490|470914907|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
130806071|NCT01348490|470914907|FG000|Overall Study|Other Unspecified|8|||
130806072|NCT00300495|470914908|FG000|Overall Study|Protocol Violation|4|||
130806073|NCT00300495|470914909|FG001|Overall Study|Protocol Violation|1|||
130806074|NCT01184118|470914910|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
130806075|NCT01184118|470914910|FG000|Overall Study|No physiologic confirmation of asthma|8|||
130806076|NCT01184118|470914910|FG000|Overall Study|FEV1 <60% predicted|2|||
130806077|NCT01184118|470914910|FG000|Overall Study|Exclusionary medical condition|2|||
130806078|NCT01184118|470914910|FG000|Overall Study|Withdrawal by Subject|5|||
130806079|NCT03632720|470914911|FG000|Overall Study|Adverse Event|2|||
130806080|NCT03632720|470914912|FG001|Overall Study|Adverse Event|0|||
130806081|NCT03632720|470914913|FG002|Overall Study|Adverse Event|0|||
130806082|NCT03632720|470914911|FG000|Overall Study|Lost to Follow-up|0|||
130806083|NCT03632720|470914912|FG001|Overall Study|Lost to Follow-up|1|||
130806084|NCT03632720|470914913|FG002|Overall Study|Lost to Follow-up|0|||
130806085|NCT03632720|470914911|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
130806086|NCT03632720|470914912|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
130806087|NCT03632720|470914913|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
130806088|NCT03632720|470914911|FG000|Overall Study|Screen failure|0|||
130806089|NCT03632720|470914912|FG001|Overall Study|Screen failure|1|||
130806090|NCT03632720|470914913|FG002|Overall Study|Screen failure|0|||
130806091|NCT00682435|470914914|FG000|Overall Study|Insufficient data|5|||
130806092|NCT00682435|470914914|FG000|Overall Study|Erroneously enrolled twice|2|||
130806093|NCT01117350|470914915|FG000|Comparative Period|Not Treated|5|||
130806094|NCT01117350|470914916|FG001|Comparative Period|Not Treated|8|||
130806095|NCT01117350|470914915|FG000|Comparative Period|Adverse Event|6|||
130806096|NCT01117350|470914916|FG001|Comparative Period|Adverse Event|33|||
130806097|NCT01117350|470914915|FG000|Comparative Period|Lost to Follow-up|11|||
130806098|NCT01117350|470914916|FG001|Comparative Period|Lost to Follow-up|7|||
130806099|NCT01117350|470914915|FG000|Comparative Period|Withdrawal by Subject|9|||
130806100|NCT01117350|470914916|FG001|Comparative Period|Withdrawal by Subject|13|||
130806101|NCT01117350|470914915|FG000|Comparative Period|Protocol Violation|8|||
130806102|NCT01117350|470914916|FG001|Comparative Period|Protocol Violation|12|||
130806103|NCT01117350|470914915|FG000|Comparative Period|Lack of Efficacy|1|||
130806104|NCT01117350|470914916|FG001|Comparative Period|Lack of Efficacy|0|||
130806105|NCT01117350|470914915|FG000|Comparative Period|Physician Decision|0|||
130806106|NCT01117350|470914916|FG001|Comparative Period|Physician Decision|1|||
130806107|NCT01117350|470914915|FG000|Comparative Period|Move to another city/country|2|||
130806108|NCT01117350|470914916|FG001|Comparative Period|Move to another city/country|1|||
130806109|NCT01117350|470914915|FG000|Extension Period|Not included in extension, not treated|0|||
130806110|NCT01117350|470914916|FG001|Extension Period|Not included in extension, not treated|50|||
130806111|NCT01117350|470914915|FG000|Extension Period|Adverse Event|0|||
130806112|NCT01117350|470914916|FG001|Extension Period|Adverse Event|2|||
130806113|NCT01117350|470914915|FG000|Extension Period|Protocol Violation|0|||
130806114|NCT01117350|470914916|FG001|Extension Period|Protocol Violation|2|||
130806115|NCT01117350|470914915|FG000|Extension Period|Lost to Follow-up|0|||
130806116|NCT01117350|470914916|FG001|Extension Period|Lost to Follow-up|2|||
130806117|NCT01117350|470914915|FG000|Extension Period|Withdrawal by Subject|0|||
130806118|NCT01117350|470914916|FG001|Extension Period|Withdrawal by Subject|3|||
130806119|NCT01117350|470914915|FG000|Extension Period|Lack of Efficacy|0|||
130806120|NCT01117350|470914916|FG001|Extension Period|Lack of Efficacy|2|||
130806121|NCT01117350|470914915|FG000|Extension Period|Inclusion criteria not respected|0|||
130806122|NCT01117350|470914916|FG001|Extension Period|Inclusion criteria not respected|1|||
130806123|NCT01117350|470914915|FG000|Extension Period|Prohibited medication|0|||
130806124|NCT01117350|470914916|FG001|Extension Period|Prohibited medication|1|||
130806125|NCT01049828|470914922|FG000|Overall Study|Claustrophibia and Frustration|2|||
130806126|NCT05330429|470914929|FG000|Overall Study|Study Terminated by Sponsor|4|||
130806127|NCT05330429|470914930|FG001|Overall Study|Study Terminated by Sponsor|33|||
130806128|NCT05330429|470914931|FG002|Overall Study|Study Terminated by Sponsor|12|||
130806129|NCT05330429|470914929|FG000|Overall Study|Death|5|||
130806130|NCT05330429|470914930|FG001|Overall Study|Death|2|||
130806131|NCT05330429|470914931|FG002|Overall Study|Death|4|||
130806132|NCT05330429|470914929|FG000|Overall Study|Withdrew Consent|0|||
130806133|NCT05330429|470914930|FG001|Overall Study|Withdrew Consent|5|||
130806134|NCT05330429|470914931|FG002|Overall Study|Withdrew Consent|4|||
130806135|NCT05330429|470914929|FG000|Overall Study|Investigator's Discretion|0|||
130806136|NCT05330429|470914930|FG001|Overall Study|Investigator's Discretion|1|||
130806137|NCT05330429|470914931|FG002|Overall Study|Investigator's Discretion|3|||
130806138|NCT05330429|470914929|FG000|Overall Study|Subject Decision|1|||
130806139|NCT05330429|470914930|FG001|Overall Study|Subject Decision|2|||
130806140|NCT05330429|470914931|FG002|Overall Study|Subject Decision|0|||
130806141|NCT05330429|470914929|FG000|Overall Study|Lost to Follow-up|0|||
130806142|NCT05330429|470914930|FG001|Overall Study|Lost to Follow-up|1|||
130806143|NCT05330429|470914931|FG002|Overall Study|Lost to Follow-up|0|||
130806144|NCT03572218|470914932|FG000|Overall Study|Lost to Follow-up|3|||
130806145|NCT03572218|470914933|FG001|Overall Study|Lost to Follow-up|2|||
130806146|NCT03572218|470914932|FG000|Overall Study|No longer available for study visits|2|||
130806147|NCT03572218|470914933|FG001|Overall Study|No longer available for study visits|1|||
130806148|NCT03572218|470914932|FG000|Overall Study|No longer interested|1|||
130806149|NCT03572218|470914933|FG001|Overall Study|No longer interested|2|||
130806150|NCT00286455|470914934|FG000|Overall Study|Hyperglycemia rescue|19|||
130806151|NCT00286455|470914935|FG001|Overall Study|Hyperglycemia rescue|13|||
130806152|NCT00286455|470914936|FG002|Overall Study|Hyperglycemia rescue|10|||
130806153|NCT00286455|470914934|FG000|Overall Study|Adverse Event|1|||
130806154|NCT00286455|470914935|FG001|Overall Study|Adverse Event|3|||
130806155|NCT00286455|470914936|FG002|Overall Study|Adverse Event|2|||
130806156|NCT00286455|470914934|FG000|Overall Study|Lost to Follow-up|0|||
130806157|NCT00286455|470914935|FG001|Overall Study|Lost to Follow-up|3|||
130806158|NCT00286455|470914936|FG002|Overall Study|Lost to Follow-up|3|||
130806159|NCT00286455|470914934|FG000|Overall Study|Physician Decision|3|||
130806160|NCT00286455|470914935|FG001|Overall Study|Physician Decision|0|||
130806161|NCT00286455|470914936|FG002|Overall Study|Physician Decision|2|||
130806162|NCT00286455|470914934|FG000|Overall Study|Protocol Violation|1|||
130806163|NCT00286455|470914935|FG001|Overall Study|Protocol Violation|1|||
130806164|NCT00286455|470914936|FG002|Overall Study|Protocol Violation|0|||
130806165|NCT00286455|470914934|FG000|Overall Study|Participant Non-compliance|1|||
130806166|NCT00286455|470914935|FG001|Overall Study|Participant Non-compliance|0|||
130806167|NCT00286455|470914936|FG002|Overall Study|Participant Non-compliance|0|||
130806168|NCT00286455|470914934|FG000|Overall Study|Withdrawal by Subject|0|||
130806169|NCT00286455|470914935|FG001|Overall Study|Withdrawal by Subject|8|||
130806170|NCT00286455|470914936|FG002|Overall Study|Withdrawal by Subject|7|||
130806171|NCT01245049|470914939|FG000|Overall Study|Migrated/moved from study area|0|||
130806172|NCT01245049|470914940|FG001|Overall Study|Migrated/moved from study area|1|||
130806173|NCT01245049|470914939|FG000|Overall Study|Withdrawal by Subject|0|||
130806174|NCT01245049|470914940|FG001|Overall Study|Withdrawal by Subject|1|||
130806175|NCT01245049|470914939|FG000|Overall Study|Lost to Follow-up|1|||
130806176|NCT01245049|470914940|FG001|Overall Study|Lost to Follow-up|2|||
130806177|NCT00450749|470914941|FG000|Overall Study|Withdrawal by Subject|0|||
130806178|NCT00450749|470914942|FG001|Overall Study|Withdrawal by Subject|0|||
130806179|NCT00450749|470914943|FG002|Overall Study|Withdrawal by Subject|2|||
130806180|NCT00450749|470914941|FG000|Overall Study|Noncompliant|0|||
130806181|NCT00450749|470914942|FG001|Overall Study|Noncompliant|1|||
130806182|NCT00450749|470914943|FG002|Overall Study|Noncompliant|0|||
130806183|NCT01027754|470916396|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
130806184|NCT01027754|470916397|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
130806185|NCT01027754|470916396|FG000|Overall Study|Withdrawal by Subject|0|||
130806186|NCT01027754|470916397|FG001|Overall Study|Withdrawal by Subject|5|||
130806187|NCT01213251|470916398|FG000|Overall Study|Death|2|||
130806188|NCT01213251|470916399|FG001|Overall Study|Death|1|||
130806189|NCT01213251|470916400|FG002|Overall Study|Death|2|||
130806190|NCT01213251|470916398|FG000|Overall Study|Exit|3|||
130806191|NCT01213251|470916399|FG001|Overall Study|Exit|2|||
130806192|NCT01213251|470916400|FG002|Overall Study|Exit|8|||
130806193|NCT01213251|470916398|FG000|Overall Study|Protocol Violation|1|||
130806194|NCT01213251|470916399|FG001|Overall Study|Protocol Violation|1|||
130806195|NCT01213251|470916400|FG002|Overall Study|Protocol Violation|0|||
130806196|NCT01213251|470916398|FG000|Overall Study|Missed 18-Month Follow-up|0|||
130806197|NCT01213251|470916399|FG001|Overall Study|Missed 18-Month Follow-up|0|||
130806198|NCT01213251|470916400|FG002|Overall Study|Missed 18-Month Follow-up|1|||
130806199|NCT01557244|470916401|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
130806200|NCT01557244|470916402|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130806201|NCT01557244|470916403|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130806202|NCT01557244|470916404|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130806203|NCT01557244|470916405|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130806204|NCT01557244|470916406|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
130806205|NCT01557244|470916407|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130806206|NCT01557244|470916401|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
130806207|NCT01557244|470916402|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130806208|NCT01557244|470916403|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
130806209|NCT01557244|470916404|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130806210|NCT01557244|470916405|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130806211|NCT01557244|470916406|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130806212|NCT01557244|470916407|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130806213|NCT01557244|470916401|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
130806214|NCT01557244|470916402|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130806215|NCT01557244|470916403|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130806216|NCT01557244|470916404|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130806217|NCT01557244|470916405|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130806218|NCT01557244|470916406|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130806219|NCT01557244|470916407|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130806220|NCT01557244|470916401|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
130806221|NCT01557244|470916402|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130806222|NCT01557244|470916403|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130806223|NCT01557244|470916404|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130806224|NCT01557244|470916405|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130806225|NCT01557244|470916406|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
130806226|NCT01557244|470916407|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130806227|NCT01557244|470916401|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130806228|NCT01557244|470916402|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
130806229|NCT01557244|470916403|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130806230|NCT01557244|470916404|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130806231|NCT01557244|470916405|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130806232|NCT01557244|470916406|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130806233|NCT01557244|470916407|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130806234|NCT01557244|470916401|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130806235|NCT01557244|470916402|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130806236|NCT01557244|470916403|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130806237|NCT01557244|470916404|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130806238|NCT01557244|470916405|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130806239|NCT01557244|470916406|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
130806240|NCT01557244|470916407|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
130806241|NCT01557244|470916401|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130806242|NCT01557244|470916402|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
130806243|NCT01557244|470916403|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
130763974|NCT00622336|470758731|FG000|Treatment Phase|Withdrawal by Subject|13|||
130763975|NCT00622336|470758731|FG000|Treatment Phase|Lost to Follow-up|2|||
130763976|NCT00622336|470758731|FG000|Extension Phase|Adverse Event|2|||
130806244|NCT01557244|470916404|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130806245|NCT01557244|470916405|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130806246|NCT01557244|470916406|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
130806247|NCT01557244|470916407|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130806248|NCT01557244|470916401|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
130806249|NCT01557244|470916402|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130806250|NCT01557244|470916403|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
130806251|NCT01557244|470916404|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130806252|NCT01557244|470916405|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130806253|NCT01557244|470916406|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130806254|NCT01557244|470916407|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130806255|NCT01557244|470916401|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
130806256|NCT01557244|470916402|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
130806257|NCT01557244|470916403|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130806258|NCT01557244|470916404|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130806259|NCT01557244|470916405|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130806260|NCT01557244|470916406|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
130806261|NCT01557244|470916407|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130806262|NCT01557244|470916401|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
130806263|NCT01557244|470916402|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
130806264|NCT01557244|470916403|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130806265|NCT01557244|470916404|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130806266|NCT01557244|470916405|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130806267|NCT01557244|470916406|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130806268|NCT01557244|470916407|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130806269|NCT01557244|470916401|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130806270|NCT01557244|470916402|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130806271|NCT01557244|470916403|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130806272|NCT01557244|470916404|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
130806273|NCT01557244|470916405|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130806274|NCT01557244|470916406|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130806275|NCT01557244|470916407|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130806276|NCT01557244|470916401|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
130806277|NCT01557244|470916402|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
130806278|NCT01557244|470916403|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130806279|NCT01557244|470916404|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130806280|NCT01557244|470916405|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130806281|NCT01557244|470916406|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130806282|NCT01557244|470916407|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130806283|NCT03312114|470916408|FG000|Overall Study|All the five enrolled dropped out of the|5|||
130806284|NCT00394472|470916412|FG000|Overall Study|Protocol Violation|1|||
130806285|NCT00394472|470916413|FG001|Overall Study|Protocol Violation|3|||
130806286|NCT00394472|470916412|FG000|Overall Study|incorrect enrolment|4|||
130806287|NCT00394472|470916413|FG001|Overall Study|incorrect enrolment|2|||
130806288|NCT00394472|470916412|FG000|Overall Study|Adverse Event|4|||
130806289|NCT00394472|470916413|FG001|Overall Study|Adverse Event|2|||
130806290|NCT00394472|470916412|FG000|Overall Study|Withdrawal by Subject|0|||
130806291|NCT00394472|470916413|FG001|Overall Study|Withdrawal by Subject|2|||
130806292|NCT00394472|470916412|FG000|Overall Study|Physician Decision|0|||
130806293|NCT00394472|470916413|FG001|Overall Study|Physician Decision|1|||
130806294|NCT00394472|470916412|FG000|Overall Study|Lost to Follow-up|0|||
130806295|NCT00394472|470916413|FG001|Overall Study|Lost to Follow-up|1|||
130806296|NCT03931785|470916415|FG000|Overall Study|Lost to Follow-up|4|||
130806297|NCT03931785|470916416|FG001|Overall Study|Lost to Follow-up|1|||
130806298|NCT03931785|470916417|FG002|Overall Study|Lost to Follow-up|4|||
130806299|NCT03931785|470916418|FG003|Overall Study|Lost to Follow-up|3|||
130806300|NCT03931785|470916415|FG000|Overall Study|Adverse Event|1|||
130806301|NCT03931785|470916416|FG001|Overall Study|Adverse Event|0|||
130806302|NCT03931785|470916417|FG002|Overall Study|Adverse Event|3|||
130806303|NCT03931785|470916418|FG003|Overall Study|Adverse Event|4|||
130806304|NCT03931785|470916415|FG000|Overall Study|Protocol Violation|0|||
130806305|NCT03931785|470916416|FG001|Overall Study|Protocol Violation|1|||
130806306|NCT03931785|470916417|FG002|Overall Study|Protocol Violation|0|||
130806307|NCT03931785|470916418|FG003|Overall Study|Protocol Violation|0|||
130806308|NCT03931785|470916415|FG000|Overall Study|Noncompliance With Study drug|0|||
130806309|NCT03931785|470916416|FG001|Overall Study|Noncompliance With Study drug|1|||
130806310|NCT03931785|470916417|FG002|Overall Study|Noncompliance With Study drug|0|||
130806311|NCT03931785|470916418|FG003|Overall Study|Noncompliance With Study drug|0|||
130806312|NCT03931785|470916415|FG000|Overall Study|Other Not specified|0|||
130806313|NCT03931785|470916416|FG001|Overall Study|Other Not specified|2|||
130806314|NCT03931785|470916417|FG002|Overall Study|Other Not specified|2|||
130806315|NCT03931785|470916418|FG003|Overall Study|Other Not specified|2|||
130806316|NCT03931785|470916415|FG000|Overall Study|Withdrawal by Subject|0|||
130806317|NCT03931785|470916416|FG001|Overall Study|Withdrawal by Subject|2|||
130806318|NCT03931785|470916417|FG002|Overall Study|Withdrawal by Subject|4|||
130806319|NCT03931785|470916418|FG003|Overall Study|Withdrawal by Subject|1|||
130806320|NCT03931785|470916415|FG000|Overall Study|Pregnancy|0|||
130806321|NCT03931785|470916416|FG001|Overall Study|Pregnancy|0|||
130806322|NCT03931785|470916417|FG002|Overall Study|Pregnancy|0|||
130806323|NCT03931785|470916418|FG003|Overall Study|Pregnancy|1|||
130806324|NCT01748552|470916423|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
130806325|NCT01748552|470916424|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
130806326|NCT01748552|470916425|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
130806327|NCT01748552|470916426|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
130806328|NCT01748552|470916427|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
130806329|NCT01748552|470916428|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
130806330|NCT01748552|470916429|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
130806331|NCT01748552|470916430|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
130806332|NCT01748552|470916431|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
130806333|NCT01748552|470916432|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
130806334|NCT01748552|470916433|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
130806335|NCT01748552|470916434|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
130806336|NCT01748552|470916423|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130806337|NCT01748552|470916424|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130806338|NCT01748552|470916425|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130806339|NCT01748552|470916426|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130806340|NCT01748552|470916427|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130806341|NCT01748552|470916428|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130806342|NCT01748552|470916429|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
130806343|NCT01748552|470916430|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
130806344|NCT01748552|470916431|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
130806345|NCT01748552|470916432|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130806346|NCT01748552|470916433|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130806347|NCT01748552|470916434|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130806348|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
130806349|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
130806350|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
130806351|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
130806352|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
130806353|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
130806354|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
130806355|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
130806356|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
130806357|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
130806358|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
130806359|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
130806360|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
130806361|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
130806362|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
130806363|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
130806364|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
130806365|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
130806366|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
130806367|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
130806368|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
130806369|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
130806370|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
130806371|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
130806372|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
130806373|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
130806374|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
130806375|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
130806376|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
130806377|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
130806378|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
130806379|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
130806380|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
130806381|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
130806382|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
130806383|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
130806384|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
130806385|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
130806386|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
130806387|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
130806388|NCT02596893|470916437|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
130806389|NCT02596893|470916438|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
130806390|NCT02596893|470916439|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
130806391|NCT02596893|470916440|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
130806392|NCT00004228|470916443|FG000|Overall Study|Adverse Event|0|||
130806393|NCT00004228|470916444|FG001|Overall Study|Adverse Event|1|||
130806394|NCT00004228|470916445|FG002|Overall Study|Adverse Event|0|||
130806395|NCT00004228|470916446|FG003|Overall Study|Adverse Event|0|||
130806396|NCT00004228|470916447|FG004|Overall Study|Adverse Event|1|||
130806397|NCT00004228|470916448|FG005|Overall Study|Adverse Event|0|||
130806398|NCT00004228|470916449|FG006|Overall Study|Adverse Event|0|||
130806399|NCT00004228|470916443|FG000|Overall Study|Death|0|||
130806400|NCT00004228|470916444|FG001|Overall Study|Death|1|||
130806401|NCT00004228|470916445|FG002|Overall Study|Death|2|||
130806402|NCT00004228|470916446|FG003|Overall Study|Death|0|||
130806403|NCT00004228|470916447|FG004|Overall Study|Death|1|||
130806404|NCT00004228|470916448|FG005|Overall Study|Death|0|||
130806405|NCT00004228|470916449|FG006|Overall Study|Death|0|||
130806406|NCT00004228|470916443|FG000|Overall Study|Lack of Efficacy|1|||
130806407|NCT00004228|470916444|FG001|Overall Study|Lack of Efficacy|6|||
130806408|NCT00004228|470916445|FG002|Overall Study|Lack of Efficacy|5|||
130806409|NCT00004228|470916446|FG003|Overall Study|Lack of Efficacy|3|||
130806410|NCT00004228|470916447|FG004|Overall Study|Lack of Efficacy|9|||
130806411|NCT00004228|470916448|FG005|Overall Study|Lack of Efficacy|8|||
130806412|NCT00004228|470916449|FG006|Overall Study|Lack of Efficacy|4|||
130806413|NCT00004228|470916443|FG000|Overall Study|Lost to Follow-up|0|||
130806414|NCT00004228|470916444|FG001|Overall Study|Lost to Follow-up|0|||
130806415|NCT00004228|470916445|FG002|Overall Study|Lost to Follow-up|1|||
130806416|NCT00004228|470916446|FG003|Overall Study|Lost to Follow-up|0|||
130806417|NCT00004228|470916447|FG004|Overall Study|Lost to Follow-up|0|||
130806418|NCT00004228|470916448|FG005|Overall Study|Lost to Follow-up|0|||
130806419|NCT00004228|470916449|FG006|Overall Study|Lost to Follow-up|0|||
130806420|NCT00004228|470916443|FG000|Overall Study|Physician Decision|1|||
130806421|NCT00004228|470916444|FG001|Overall Study|Physician Decision|0|||
130806422|NCT00004228|470916445|FG002|Overall Study|Physician Decision|3|||
130806423|NCT00004228|470916446|FG003|Overall Study|Physician Decision|2|||
130806424|NCT00004228|470916447|FG004|Overall Study|Physician Decision|1|||
130806425|NCT00004228|470916448|FG005|Overall Study|Physician Decision|1|||
130806426|NCT00004228|470916449|FG006|Overall Study|Physician Decision|1|||
130806427|NCT00004228|470916443|FG000|Overall Study|Protocol Violation|0|||
130806428|NCT00004228|470916444|FG001|Overall Study|Protocol Violation|5|||
130806429|NCT00004228|470916445|FG002|Overall Study|Protocol Violation|2|||
130806430|NCT00004228|470916446|FG003|Overall Study|Protocol Violation|1|||
130806431|NCT00004228|470916447|FG004|Overall Study|Protocol Violation|1|||
130806432|NCT00004228|470916448|FG005|Overall Study|Protocol Violation|2|||
130806433|NCT00004228|470916449|FG006|Overall Study|Protocol Violation|0|||
130806434|NCT00004228|470916443|FG000|Overall Study|Withdrawal by Subject|3|||
130806435|NCT00004228|470916444|FG001|Overall Study|Withdrawal by Subject|0|||
130806436|NCT00004228|470916445|FG002|Overall Study|Withdrawal by Subject|1|||
130806437|NCT00004228|470916446|FG003|Overall Study|Withdrawal by Subject|0|||
130806438|NCT00004228|470916447|FG004|Overall Study|Withdrawal by Subject|2|||
130806439|NCT00004228|470916448|FG005|Overall Study|Withdrawal by Subject|1|||
130806440|NCT00004228|470916449|FG006|Overall Study|Withdrawal by Subject|2|||
130806441|NCT00004228|470916443|FG000|Overall Study|Other|0|||
130806442|NCT00004228|470916444|FG001|Overall Study|Other|0|||
130806443|NCT00004228|470916445|FG002|Overall Study|Other|1|||
130806444|NCT00004228|470916446|FG003|Overall Study|Other|0|||
130806445|NCT00004228|470916447|FG004|Overall Study|Other|0|||
130806446|NCT00004228|470916448|FG005|Overall Study|Other|0|||
130806447|NCT00004228|470916449|FG006|Overall Study|Other|0|||
130806448|NCT00004228|470916443|FG000|Overall Study|ineligible|4|||
130806449|NCT00004228|470916444|FG001|Overall Study|ineligible|2|||
130806450|NCT00004228|470916445|FG002|Overall Study|ineligible|4|||
130806451|NCT00004228|470916446|FG003|Overall Study|ineligible|1|||
130806452|NCT00004228|470916447|FG004|Overall Study|ineligible|1|||
130806453|NCT00004228|470916448|FG005|Overall Study|ineligible|2|||
130806454|NCT00004228|470916449|FG006|Overall Study|ineligible|5|||
130806455|NCT02255279|470916450|FG000|Overall Study|Lost to Follow-up|2|||
130806456|NCT02255279|470916451|FG001|Overall Study|Lost to Follow-up|2|||
130806457|NCT02255279|470916450|FG000|Overall Study|Protocol Violation|0|||
130806458|NCT02255279|470916451|FG001|Overall Study|Protocol Violation|1|||
130806459|NCT02255279|470916450|FG000|Overall Study|Withdrawal by Subject|3|||
130806460|NCT02255279|470916451|FG001|Overall Study|Withdrawal by Subject|6|||
130806461|NCT00363467|470916452|FG000|Overall Study|Physician Decision|1|||
130806462|NCT01530256|470916455|FG000|Overall Study|Death|2|||
130806463|NCT00527748|470916456|FG000|Overall Study|Other|3|||
130806464|NCT02004275|470916458|FG000|Phase 1|Ineligible|0|||
130806465|NCT02004275|470916459|FG001|Phase 1|Ineligible|0|||
130806466|NCT02004275|470916460|FG002|Phase 1|Ineligible|0|||
130806467|NCT02004275|470916461|FG003|Phase 1|Ineligible|1|||
130806468|NCT02004275|470916462|FG004|Phase 1|Ineligible|1|||
130806469|NCT02004275|470916463|FG005|Phase 1|Ineligible|0|||
130806470|NCT02004275|470916458|FG000|Phase 1|Protocol Violation|0|||
130806471|NCT02004275|470916459|FG001|Phase 1|Protocol Violation|0|||
130806472|NCT02004275|470916460|FG002|Phase 1|Protocol Violation|0|||
130806473|NCT02004275|470916461|FG003|Phase 1|Protocol Violation|1|||
130806474|NCT02004275|470916462|FG004|Phase 1|Protocol Violation|0|||
130806475|NCT02004275|470916463|FG005|Phase 1|Protocol Violation|5|||
130806476|NCT02004275|470916458|FG000|Phase 2 Part 1|Ineligible|6|||
130806477|NCT02004275|470916459|FG001|Phase 2 Part 1|Ineligible|9|||
130806478|NCT02004275|470916460|FG002|Phase 2 Part 1|Ineligible|0|||
130806479|NCT02004275|470916461|FG003|Phase 2 Part 1|Ineligible|0|||
130806480|NCT02004275|470916462|FG004|Phase 2 Part 1|Ineligible|0|||
130806481|NCT02004275|470916463|FG005|Phase 2 Part 1|Ineligible|0|||
130806482|NCT02004275|470916458|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
130806483|NCT02004275|470916459|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
130806484|NCT02004275|470916460|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
130806485|NCT02004275|470916461|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
130806486|NCT02004275|470916462|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
130806487|NCT02004275|470916463|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
130806488|NCT01093885|470916464|FG000|Overall Study|Adverse Event|4|||
130806489|NCT01093885|470916464|FG000|Overall Study|Lost to Follow-up|1|||
130806490|NCT00292370|470916465|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
130806491|NCT00292370|470916466|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
130806492|NCT00292370|470916467|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
130806493|NCT00292370|470916465|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
130806494|NCT00292370|470916466|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
130806495|NCT00292370|470916467|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
130806496|NCT00292370|470916465|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
130806497|NCT00292370|470916466|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
130806498|NCT00292370|470916467|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
130806499|NCT00292370|470916465|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
130806500|NCT00292370|470916466|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
130806501|NCT00292370|470916467|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
130806502|NCT00292370|470916465|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
130806503|NCT00292370|470916466|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
130806504|NCT00292370|470916467|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
130806505|NCT00292370|470916465|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
130806506|NCT00292370|470916466|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
130806507|NCT00292370|470916467|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
130806508|NCT01560988|470916468|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
130806509|NCT01560988|470916469|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
130806510|NCT01560988|470916468|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
130806511|NCT01560988|470916469|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
130806512|NCT01560988|470916468|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
130806513|NCT01560988|470916469|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
130806514|NCT01346709|470916470|FG000|Overall Study|Protocol Violation|35|||
130806515|NCT01346709|470916470|FG000|Overall Study|Lost to Follow-up|31|||
130806516|NCT01346709|470916470|FG000|Overall Study|Missing data in candidate risk factor|285|||
130806517|NCT01292473|470916474|FG000|Overall Study|Adverse Event|1|||
130806518|NCT01292473|470916475|FG001|Overall Study|Adverse Event|0|||
130806519|NCT01292473|470916476|FG002|Overall Study|Adverse Event|1|||
130806520|NCT01292473|470916477|FG003|Overall Study|Adverse Event|1|||
130806521|NCT01292473|470916474|FG000|Overall Study|Lost to Follow-up|1|||
130806522|NCT01292473|470916475|FG001|Overall Study|Lost to Follow-up|1|||
130806523|NCT01292473|470916476|FG002|Overall Study|Lost to Follow-up|2|||
130806524|NCT01292473|470916477|FG003|Overall Study|Lost to Follow-up|2|||
130806525|NCT01292473|470916474|FG000|Overall Study|Withdrawal by Subject|3|||
130806526|NCT01292473|470916475|FG001|Overall Study|Withdrawal by Subject|4|||
130806527|NCT01292473|470916476|FG002|Overall Study|Withdrawal by Subject|3|||
130806528|NCT01292473|470916477|FG003|Overall Study|Withdrawal by Subject|3|||
130806529|NCT01292473|470916474|FG000|Overall Study|Physician Decision|0|||
130806530|NCT01292473|470916475|FG001|Overall Study|Physician Decision|1|||
130806531|NCT01292473|470916476|FG002|Overall Study|Physician Decision|0|||
130806532|NCT01292473|470916477|FG003|Overall Study|Physician Decision|0|||
130806533|NCT01292473|470916474|FG000|Overall Study|Disease Progression|0|||
130806534|NCT01292473|470916475|FG001|Overall Study|Disease Progression|1|||
130806535|NCT01292473|470916476|FG002|Overall Study|Disease Progression|3|||
130806536|NCT01292473|470916477|FG003|Overall Study|Disease Progression|6|||
130806537|NCT02123511|470916483|FG000|Overall Study|Cancelled treatment|1|||
130806538|NCT02123511|470916484|FG001|Overall Study|Cancelled treatment|0|||
130806539|NCT02123511|470916483|FG000|Overall Study|Incomplete data|1|||
130806540|NCT02123511|470916484|FG001|Overall Study|Incomplete data|3|||
130806541|NCT02123511|470916483|FG000|Overall Study|Ineligible|0|||
130806542|NCT02123511|470916484|FG001|Overall Study|Ineligible|1|||
130806543|NCT04821245|470916485|FG000|Overall Study|Withdrawal by Subject|3|||
130806544|NCT04821245|470916485|FG000|Overall Study|Physician Decision|1|||
130806545|NCT04821245|470916485|FG000|Overall Study|Protocol Violation|5|||
130806546|NCT02595437|470916486|FG000|Triferic Via IV|Withdrawal by Subject|1|||
130806547|NCT01975285|470916502|FG000|Overall Study|Failed Block and follow up|2|||
130806548|NCT01975285|470916503|FG001|Overall Study|Failed Block and follow up|2|||
130806549|NCT04914000|470916508|FG000|Overall Study|Lost to Follow-up|8|||
130806550|NCT04914000|470916508|FG000|Overall Study|Withdrawal by Subject|1|||
130806551|NCT01429623|470916509|FG000|Overall Study|Death|1|||
130806552|NCT01429623|470916510|FG001|Overall Study|Death|0|||
130806553|NCT01429623|470916509|FG000|Overall Study|Adverse Event|7|||
130806554|NCT01429623|470916510|FG001|Overall Study|Adverse Event|14|||
130806555|NCT01429623|470916509|FG000|Overall Study|Withdrawal by Subject|19|||
130806556|NCT01429623|470916510|FG001|Overall Study|Withdrawal by Subject|13|||
130806557|NCT01429623|470916509|FG000|Overall Study|Physician Decision|2|||
130806558|NCT01429623|470916510|FG001|Overall Study|Physician Decision|3|||
130806559|NCT01429623|470916509|FG000|Overall Study|Protocol Violation|3|||
130806560|NCT01429623|470916510|FG001|Overall Study|Protocol Violation|2|||
130806561|NCT01429623|470916509|FG000|Overall Study|Assorted|1|||
130806562|NCT01429623|470916510|FG001|Overall Study|Assorted|2|||
130806563|NCT01429623|470916509|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
130806564|NCT01429623|470916510|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
130806565|NCT01429623|470916509|FG000|Overall Study|No post baseline data|4|||
130806566|NCT01429623|470916510|FG001|Overall Study|No post baseline data|4|||
130806567|NCT06399471|470916517|FG000|Overall Study|Withdrawal by Subject|1|||
130806568|NCT06083493|470916518|FG000|Overall Study|Technical issues with the interventional device|2|||
130806569|NCT06083493|470916519|FG001|Overall Study|Technical issues with the interventional device|2|||
130806570|NCT06083493|470916518|FG000|Overall Study|Performed incorrect visual task|1|||
130806571|NCT06083493|470916519|FG001|Overall Study|Performed incorrect visual task|0|||
130806572|NCT06083493|470916518|FG000|Overall Study|Insufficient baseline performance|0|||
130806573|NCT06083493|470916519|FG001|Overall Study|Insufficient baseline performance|1|||
130806574|NCT03225989|470916520|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
130806575|NCT03225989|470916521|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
130806576|NCT03225989|470916522|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
130806577|NCT03225989|470916520|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
130806578|NCT03225989|470916521|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
130806579|NCT03225989|470916522|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
130806580|NCT03225989|470916520|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
130806581|NCT03225989|470916521|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
130806582|NCT03225989|470916522|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
130806583|NCT03225989|470916520|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
130806584|NCT03225989|470916521|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
130806585|NCT03225989|470916522|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
130806586|NCT03225989|470916520|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
130806587|NCT03225989|470916521|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
130806588|NCT03225989|470916522|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
130806589|NCT03225989|470916520|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
130806590|NCT03225989|470916521|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
130806591|NCT03225989|470916522|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
130806592|NCT03225989|470916520|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
130806593|NCT03225989|470916521|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
130806594|NCT03225989|470916522|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
130806595|NCT03225989|470916520|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
130806596|NCT03225989|470916521|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
130806597|NCT03225989|470916522|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
130806598|NCT03225989|470916520|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
130806599|NCT03225989|470916521|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
130806600|NCT03225989|470916522|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
130806601|NCT03225989|470916520|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
130806602|NCT03225989|470916521|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
130806603|NCT03225989|470916522|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
130806604|NCT03225989|470916520|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
130806605|NCT03225989|470916521|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
130806606|NCT03225989|470916522|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
130806607|NCT03225989|470916520|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
130806608|NCT03225989|470916521|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
130806609|NCT03225989|470916522|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
130806610|NCT01181128|470916523|FG000|Overall Study|Withdrawal by Subject|2|||
130806611|NCT01181128|470916524|FG001|Overall Study|Withdrawal by Subject|2|||
130806612|NCT01181128|470916525|FG002|Overall Study|Withdrawal by Subject|0|||
130806613|NCT01181128|470916523|FG000|Overall Study|Death|1|||
130806614|NCT01181128|470916524|FG001|Overall Study|Death|0|||
130806615|NCT01181128|470916525|FG002|Overall Study|Death|0|||
130806616|NCT01181128|470916523|FG000|Overall Study|Physician Decision|2|||
130806617|NCT01181128|470916524|FG001|Overall Study|Physician Decision|0|||
130806618|NCT01181128|470916525|FG002|Overall Study|Physician Decision|0|||
130806619|NCT01181128|470916523|FG000|Overall Study|Adverse Event|0|||
130806620|NCT01181128|470916524|FG001|Overall Study|Adverse Event|2|||
130806621|NCT01181128|470916525|FG002|Overall Study|Adverse Event|0|||
130806622|NCT01181128|470916523|FG000|Overall Study|Other|1|||
130806623|NCT01181128|470916524|FG001|Overall Study|Other|1|||
130806624|NCT01181128|470916525|FG002|Overall Study|Other|1|||
130806625|NCT04595370|470916528|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
130806626|NCT04595370|470916529|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130806627|NCT04595370|470916530|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130806628|NCT04595370|470916531|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130806629|NCT04595370|470916532|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130806630|NCT04595370|470916533|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130806631|NCT04595370|470916528|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130806632|NCT04595370|470916529|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130806633|NCT04595370|470916530|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
130806634|NCT04595370|470916531|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130806635|NCT04595370|470916532|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130806636|NCT04595370|470916533|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130806637|NCT04595370|470916528|FG000|Overall Study|Adverse Event|0|||
130806638|NCT04595370|470916529|FG001|Overall Study|Adverse Event|4|||
130806639|NCT04595370|470916530|FG002|Overall Study|Adverse Event|3|||
130806640|NCT04595370|470916531|FG003|Overall Study|Adverse Event|1|||
130806641|NCT04595370|470916532|FG004|Overall Study|Adverse Event|1|||
130806642|NCT04595370|470916533|FG005|Overall Study|Adverse Event|1|||
130806643|NCT04595370|470916528|FG000|Overall Study|Withdrawal of Consent|1|||
130806644|NCT04595370|470916529|FG001|Overall Study|Withdrawal of Consent|1|||
130806645|NCT04595370|470916530|FG002|Overall Study|Withdrawal of Consent|1|||
130806646|NCT04595370|470916531|FG003|Overall Study|Withdrawal of Consent|0|||
130806647|NCT04595370|470916532|FG004|Overall Study|Withdrawal of Consent|0|||
130806648|NCT04595370|470916533|FG005|Overall Study|Withdrawal of Consent|0|||
130806649|NCT04595370|470916528|FG000|Overall Study|Death|0|||
130806650|NCT04595370|470916529|FG001|Overall Study|Death|1|||
130806651|NCT04595370|470916530|FG002|Overall Study|Death|0|||
130806652|NCT04595370|470916531|FG003|Overall Study|Death|0|||
130806653|NCT04595370|470916532|FG004|Overall Study|Death|1|||
130806654|NCT04595370|470916533|FG005|Overall Study|Death|0|||
130806655|NCT04595370|470916528|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130806656|NCT04595370|470916529|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130806657|NCT04595370|470916530|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130806658|NCT04595370|470916531|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130806659|NCT04595370|470916532|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130806660|NCT04595370|470916533|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130806661|NCT04595370|470916528|FG000|Overall Study|Withdrawal by Subject|0|||
130806662|NCT04595370|470916529|FG001|Overall Study|Withdrawal by Subject|0|||
130806663|NCT04595370|470916530|FG002|Overall Study|Withdrawal by Subject|1|||
130806664|NCT04595370|470916531|FG003|Overall Study|Withdrawal by Subject|0|||
130806665|NCT04595370|470916532|FG004|Overall Study|Withdrawal by Subject|2|||
130806666|NCT04595370|470916533|FG005|Overall Study|Withdrawal by Subject|0|||
130806667|NCT04595370|470916528|FG000|Overall Study|Lost to Follow-up|0|||
130806668|NCT04595370|470916529|FG001|Overall Study|Lost to Follow-up|0|||
130806669|NCT04595370|470916530|FG002|Overall Study|Lost to Follow-up|0|||
130806670|NCT04595370|470916531|FG003|Overall Study|Lost to Follow-up|0|||
130806671|NCT04595370|470916532|FG004|Overall Study|Lost to Follow-up|1|||
130806672|NCT04595370|470916533|FG005|Overall Study|Lost to Follow-up|0|||
130806673|NCT04595370|470916528|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
130806674|NCT04595370|470916529|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
130806675|NCT04595370|470916530|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
130806676|NCT04595370|470916531|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
130806677|NCT04595370|470916532|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
130806678|NCT04595370|470916533|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
130806679|NCT01108055|470916537|FG000|Overall Study|Ineligible|11|||
130806680|NCT01108055|470916537|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
130806681|NCT03339453|470916539|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
130806682|NCT03339453|470916540|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
130806683|NCT01313676|470918313|FG000|Overall Study|Adverse Event|395|||
130806684|NCT01313676|470918314|FG001|Overall Study|Adverse Event|365|||
130806685|NCT01313676|470918315|FG002|Overall Study|Adverse Event|372|||
130806686|NCT01313676|470918316|FG003|Overall Study|Adverse Event|333|||
130806687|NCT01313676|470918313|FG000|Overall Study|Lack of Efficacy|98|||
130806688|NCT01313676|470918314|FG001|Overall Study|Lack of Efficacy|90|||
130806689|NCT01313676|470918315|FG002|Overall Study|Lack of Efficacy|65|||
130806690|NCT01313676|470918316|FG003|Overall Study|Lack of Efficacy|46|||
130806691|NCT01313676|470918313|FG000|Overall Study|Protocol Violation|37|||
130806692|NCT01313676|470918314|FG001|Overall Study|Protocol Violation|44|||
130806693|NCT01313676|470918315|FG002|Overall Study|Protocol Violation|46|||
130806694|NCT01313676|470918316|FG003|Overall Study|Protocol Violation|44|||
130806695|NCT01313676|470918313|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
130806696|NCT01313676|470918314|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
130806697|NCT01313676|470918315|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
130806698|NCT01313676|470918316|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
130806699|NCT01313676|470918313|FG000|Overall Study|Study Closed/terminated|7|||
130806700|NCT01313676|470918314|FG001|Overall Study|Study Closed/terminated|6|||
130806701|NCT01313676|470918315|FG002|Overall Study|Study Closed/terminated|9|||
130806702|NCT01313676|470918316|FG003|Overall Study|Study Closed/terminated|9|||
130806703|NCT01313676|470918313|FG000|Overall Study|Lost to Follow-up|0|||
130806704|NCT01313676|470918314|FG001|Overall Study|Lost to Follow-up|0|||
130806705|NCT01313676|470918315|FG002|Overall Study|Lost to Follow-up|1|||
130806706|NCT01313676|470918316|FG003|Overall Study|Lost to Follow-up|0|||
130806707|NCT01313676|470918313|FG000|Overall Study|Physician Decision|53|||
130806708|NCT01313676|470918314|FG001|Overall Study|Physician Decision|64|||
130806709|NCT01313676|470918315|FG002|Overall Study|Physician Decision|62|||
130806710|NCT01313676|470918316|FG003|Overall Study|Physician Decision|48|||
130806711|NCT01313676|470918313|FG000|Overall Study|Decision by Participant or Proxy|643|||
130806712|NCT01313676|470918314|FG001|Overall Study|Decision by Participant or Proxy|527|||
130806713|NCT01313676|470918315|FG002|Overall Study|Decision by Participant or Proxy|515|||
130806714|NCT01313676|470918316|FG003|Overall Study|Decision by Participant or Proxy|492|||
130806715|NCT01313676|470918313|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
130806716|NCT01313676|470918314|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
130806717|NCT01313676|470918315|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
130806718|NCT01313676|470918316|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
130806719|NCT01313676|470918313|FG000|Overall Study|Investigator Site Closed|12|||
130806720|NCT01313676|470918314|FG001|Overall Study|Investigator Site Closed|11|||
130806721|NCT01313676|470918315|FG002|Overall Study|Investigator Site Closed|15|||
130806722|NCT01313676|470918316|FG003|Overall Study|Investigator Site Closed|10|||
130806723|NCT01313676|470918313|FG000|Overall Study|Missing|1|||
130806724|NCT01313676|470918314|FG001|Overall Study|Missing|1|||
130806725|NCT01313676|470918315|FG002|Overall Study|Missing|1|||
130806726|NCT01313676|470918316|FG003|Overall Study|Missing|0|||
130806727|NCT00944645|470918317|FG000|Period 2|Adverse Event|1|||
130806728|NCT00944645|470918318|FG001|Period 2|Adverse Event|0|||
130806729|NCT00944645|470918317|FG000|Period 2|Lost to Follow-up|0|||
130806730|NCT00944645|470918318|FG001|Period 2|Lost to Follow-up|3|||
130806731|NCT00944645|470918317|FG000|Period 2|Withdrawal by Subject|7|||
130806732|NCT00944645|470918318|FG001|Period 2|Withdrawal by Subject|6|||
130806733|NCT03537729|470918319|FG000|Overall Study|Death|2|||
130806734|NCT03537729|470918320|FG001|Overall Study|Death|2|||
130806735|NCT03537729|470918321|FG002|Overall Study|Death|7|||
130806736|NCT03537729|470918319|FG000|Overall Study|Withdrawal by Subject|3|||
130806737|NCT03537729|470918320|FG001|Overall Study|Withdrawal by Subject|3|||
130806738|NCT03537729|470918321|FG002|Overall Study|Withdrawal by Subject|0|||
130806739|NCT03537729|470918319|FG000|Overall Study|Subject Moved|8|||
130806740|NCT03537729|470918320|FG001|Overall Study|Subject Moved|5|||
130806741|NCT03537729|470918321|FG002|Overall Study|Subject Moved|4|||
130806742|NCT03537729|470918319|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
130806743|NCT03537729|470918320|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
130806744|NCT03537729|470918321|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
130806745|NCT03537729|470918319|FG000|Overall Study|COVID-19 Site Restrictions|11|||
130806746|NCT03537729|470918320|FG001|Overall Study|COVID-19 Site Restrictions|15|||
130806747|NCT03537729|470918321|FG002|Overall Study|COVID-19 Site Restrictions|18|||
130806748|NCT03537729|470918319|FG000|Overall Study|Decline in Health|5|||
130806749|NCT03537729|470918320|FG001|Overall Study|Decline in Health|9|||
130806750|NCT03537729|470918321|FG002|Overall Study|Decline in Health|4|||
130806751|NCT03537729|470918319|FG000|Overall Study|Determined Ineligible|0|||
130806752|NCT03537729|470918320|FG001|Overall Study|Determined Ineligible|0|||
130806753|NCT03537729|470918321|FG002|Overall Study|Determined Ineligible|1|||
130806754|NCT02562040|470918323|FG000|Overall Study|Lost to Follow-up|20|||
130806755|NCT02562040|470918324|FG001|Overall Study|Lost to Follow-up|28|||
130806756|NCT02562040|470918323|FG000|Overall Study|Withdrawal by Subject|8|||
130806757|NCT02562040|470918324|FG001|Overall Study|Withdrawal by Subject|7|||
130806758|NCT02562040|470918323|FG000|Overall Study|Adverse Event|1|||
130806759|NCT02562040|470918324|FG001|Overall Study|Adverse Event|0|||
130806760|NCT01902303|470918325|FG000|Overall Study|Adverse Event|0|||
130806761|NCT01902303|470918326|FG001|Overall Study|Adverse Event|1|||
130806762|NCT01902303|470918325|FG000|Overall Study|Lost to Follow-up|0|||
130806763|NCT01902303|470918326|FG001|Overall Study|Lost to Follow-up|1|||
130806764|NCT01902303|470918325|FG000|Overall Study|Protocol Violation|2|||
130806765|NCT01902303|470918326|FG001|Overall Study|Protocol Violation|2|||
130806766|NCT01902303|470918325|FG000|Overall Study|subject lost investigational product|0|||
130806767|NCT01902303|470918326|FG001|Overall Study|subject lost investigational product|1|||
130806768|NCT01902303|470918325|FG000|Overall Study|Did not develop a cold sore|21|||
130806769|NCT01902303|470918326|FG001|Overall Study|Did not develop a cold sore|19|||
130806770|NCT02821000|470918327|FG000|Overall Study|Death|89|||
130806771|NCT02821000|470918327|FG000|Overall Study|Sponsor Decision|12|||
130806772|NCT02821000|470918327|FG000|Overall Study|Withdrawal by Subject|2|||
130806773|NCT00326495|470918328|FG000|Overall Study|Switched to alternative treatment|1|||
130806774|NCT00326495|470918328|FG000|Overall Study|Disease progression before treatment|1|||
130806775|NCT00326495|470918328|FG000|Overall Study|Refused further treatment|2|||
130806776|NCT00326495|470918328|FG000|Overall Study|Subject off study before assessment|1|||
130806777|NCT04359680|470918329|FG000|Overall Study|Withdrawal by Subject|29|||
130806778|NCT04359680|470918330|FG001|Overall Study|Withdrawal by Subject|24|||
130806779|NCT04359680|470918329|FG000|Overall Study|Adverse Event|6|||
130806780|NCT04359680|470918330|FG001|Overall Study|Adverse Event|2|||
130806781|NCT04359680|470918329|FG000|Overall Study|Lost to Follow-up|56|||
130806782|NCT04359680|470918330|FG001|Overall Study|Lost to Follow-up|59|||
130806783|NCT04359680|470918329|FG000|Overall Study|Protocol Violation|3|||
130806784|NCT04359680|470918330|FG001|Overall Study|Protocol Violation|5|||
130806785|NCT04359680|470918329|FG000|Overall Study|Physician Decision|1|||
130806786|NCT04359680|470918330|FG001|Overall Study|Physician Decision|1|||
130806787|NCT04359680|470918329|FG000|Overall Study|Sponsor Decision|0|||
130806788|NCT04359680|470918330|FG001|Overall Study|Sponsor Decision|1|||
130806789|NCT01654250|470918331|FG000|Overall Study|Lost to Follow-up|1|||
130806790|NCT01654250|470918332|FG001|Overall Study|Lost to Follow-up|0|||
130806791|NCT01862029|470918333|FG000|Overall Study|Physician Decision|1|||
130806792|NCT00504556|470918335|FG000|Overall Study|Adverse Event|11|||
130806793|NCT00504556|470918336|FG001|Overall Study|Adverse Event|11|||
130806794|NCT00504556|470918337|FG002|Overall Study|Adverse Event|14|||
130806795|NCT00504556|470918338|FG003|Overall Study|Adverse Event|13|||
130806796|NCT00504556|470918339|FG004|Overall Study|Adverse Event|5|||
130806797|NCT00504556|470918335|FG000|Overall Study|Death|3|||
130806798|NCT00504556|470918336|FG001|Overall Study|Death|3|||
130806799|NCT00504556|470918337|FG002|Overall Study|Death|1|||
130806800|NCT00504556|470918338|FG003|Overall Study|Death|0|||
130806801|NCT00504556|470918339|FG004|Overall Study|Death|2|||
130806802|NCT00504556|470918335|FG000|Overall Study|Protocol Violation|1|||
130806803|NCT00504556|470918336|FG001|Overall Study|Protocol Violation|3|||
130806804|NCT00504556|470918337|FG002|Overall Study|Protocol Violation|2|||
130806805|NCT00504556|470918338|FG003|Overall Study|Protocol Violation|1|||
130806806|NCT00504556|470918339|FG004|Overall Study|Protocol Violation|2|||
130806807|NCT00504556|470918335|FG000|Overall Study|Lost to Follow-up|0|||
130806808|NCT00504556|470918336|FG001|Overall Study|Lost to Follow-up|0|||
130806809|NCT00504556|470918337|FG002|Overall Study|Lost to Follow-up|1|||
130806810|NCT00504556|470918338|FG003|Overall Study|Lost to Follow-up|1|||
130806811|NCT00504556|470918339|FG004|Overall Study|Lost to Follow-up|1|||
130806812|NCT00504556|470918335|FG000|Overall Study|Withdrawal by Subject|16|||
130806813|NCT00504556|470918336|FG001|Overall Study|Withdrawal by Subject|16|||
130806814|NCT00504556|470918337|FG002|Overall Study|Withdrawal by Subject|7|||
130806815|NCT00504556|470918338|FG003|Overall Study|Withdrawal by Subject|8|||
130806816|NCT00504556|470918339|FG004|Overall Study|Withdrawal by Subject|12|||
130806817|NCT00504556|470918335|FG000|Overall Study|administrative reasons|0|||
130806818|NCT00504556|470918336|FG001|Overall Study|administrative reasons|2|||
130806819|NCT00504556|470918337|FG002|Overall Study|administrative reasons|2|||
130806820|NCT00504556|470918338|FG003|Overall Study|administrative reasons|1|||
130806821|NCT00504556|470918339|FG004|Overall Study|administrative reasons|2|||
130806822|NCT00504556|470918335|FG000|Overall Study|did not meet entry criteria|2|||
130806823|NCT00504556|470918336|FG001|Overall Study|did not meet entry criteria|0|||
130806824|NCT00504556|470918337|FG002|Overall Study|did not meet entry criteria|1|||
130806825|NCT00504556|470918338|FG003|Overall Study|did not meet entry criteria|1|||
130806826|NCT00504556|470918339|FG004|Overall Study|did not meet entry criteria|0|||
130806827|NCT00504556|470918335|FG000|Overall Study|data monitor committee decision|0|||
130806828|NCT00504556|470918336|FG001|Overall Study|data monitor committee decision|0|||
130806829|NCT00504556|470918337|FG002|Overall Study|data monitor committee decision|0|||
130806830|NCT00504556|470918338|FG003|Overall Study|data monitor committee decision|100|||
130806831|NCT00504556|470918339|FG004|Overall Study|data monitor committee decision|0|||
130806832|NCT00504556|470918335|FG000|Overall Study|Other|2|||
130806833|NCT00504556|470918336|FG001|Overall Study|Other|2|||
130806834|NCT00504556|470918337|FG002|Overall Study|Other|2|||
130806835|NCT00504556|470918338|FG003|Overall Study|Other|3|||
130806836|NCT00504556|470918339|FG004|Overall Study|Other|0|||
130806837|NCT00504556|470918335|FG000|Overall Study|not in safety analysis set|0|||
130806838|NCT00504556|470918336|FG001|Overall Study|not in safety analysis set|1|||
130806839|NCT00504556|470918337|FG002|Overall Study|not in safety analysis set|1|||
130806840|NCT00504556|470918338|FG003|Overall Study|not in safety analysis set|0|||
130806841|NCT00504556|470918339|FG004|Overall Study|not in safety analysis set|1|||
130806842|NCT03280615|470918340|FG000|Overall Study|Lost to Follow-up|1|||
130806843|NCT03280615|470918341|FG001|Overall Study|Lost to Follow-up|2|||
130806844|NCT03280615|470918340|FG000|Overall Study|Adverse Event|1|||
130806845|NCT03280615|470918341|FG001|Overall Study|Adverse Event|1|||
130806846|NCT03280615|470918340|FG000|Overall Study|Withdrawal by Subject|2|||
130806847|NCT03280615|470918341|FG001|Overall Study|Withdrawal by Subject|2|||
130806848|NCT01013870|470918344|FG000|Overall Study|Lost to Follow-up|1|||
130806849|NCT01013870|470918345|FG001|Overall Study|Lost to Follow-up|3|||
130806850|NCT01386645|470918346|FG000|Overall Study|Physician Decision|0|||
130806851|NCT01386645|470918347|FG001|Overall Study|Physician Decision|0|||
130806852|NCT01386645|470918348|FG002|Overall Study|Physician Decision|1|||
130806853|NCT01386645|470918346|FG000|Overall Study|Withdrawal by Subject|0|||
130806854|NCT01386645|470918347|FG001|Overall Study|Withdrawal by Subject|1|||
130806855|NCT01386645|470918348|FG002|Overall Study|Withdrawal by Subject|1|||
130806856|NCT02365064|470918351|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
130806857|NCT02365064|470918352|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
130806858|NCT02365064|470918351|FG000|Overall Study|Withdrawal by Subject|6|||
130806859|NCT02365064|470918352|FG001|Overall Study|Withdrawal by Subject|9|||
130806860|NCT02365064|470918351|FG000|Overall Study|Treatment intolerance|2|||
130806861|NCT02365064|470918352|FG001|Overall Study|Treatment intolerance|4|||
130806862|NCT02773537|470918353|FG000|Overall Study|Lost to Follow-up|0|||
130806863|NCT02773537|470918354|FG001|Overall Study|Lost to Follow-up|1|||
130806864|NCT02773537|470918355|FG002|Overall Study|Lost to Follow-up|4|||
130806865|NCT00662038|470918356|FG000|Overall Study|Reason not specified|3|||
130806866|NCT00662038|470918356|FG000|Overall Study|Withdrawn consent|22|||
130806867|NCT00662038|470918356|FG000|Overall Study|Withdrawal by Subject|83|||
130806868|NCT00662038|470918356|FG000|Overall Study|Sponsor decision|1|||
130806869|NCT00662038|470918356|FG000|Overall Study|Physician Decision|19|||
130806870|NCT00662038|470918356|FG000|Overall Study|Lung transplantation|44|||
130806871|NCT00662038|470918356|FG000|Overall Study|Lost to Follow-up|1|||
130806872|NCT00662038|470918356|FG000|Overall Study|Death|95|||
130806873|NCT00662038|470918356|FG000|Overall Study|Adverse Event|358|||
130806874|NCT00662038|470918356|FG000|Overall Study|Continued treatment|5|||
130806875|NCT01840163|470918357|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
130806876|NCT01840163|470918358|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
130806877|NCT01840163|470918357|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
130806878|NCT01840163|470918358|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
130806879|NCT01840163|470918357|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
130806880|NCT01840163|470918358|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
130806881|NCT03636269|470918361|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
130806882|NCT03636269|470918362|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
130806883|NCT03636269|470918363|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
130806884|NCT03636269|470918361|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
130806885|NCT03636269|470918362|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
130806886|NCT03636269|470918363|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
130806887|NCT03636269|470918361|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
130806888|NCT03636269|470918362|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
130806889|NCT03636269|470918363|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
130806890|NCT03636269|470918361|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
130806891|NCT03636269|470918362|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
130806892|NCT03636269|470918363|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
130806893|NCT03636269|470918361|FG000|Period 1: Double-blind Phase|Other|6|||
130806894|NCT03636269|470918362|FG001|Period 1: Double-blind Phase|Other|3|||
130806895|NCT03636269|470918363|FG002|Period 1: Double-blind Phase|Other|0|||
130806896|NCT03636269|470918361|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
130806897|NCT03636269|470918362|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130806898|NCT03636269|470918363|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130806899|NCT03636269|470918361|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
130806900|NCT03636269|470918362|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
130806901|NCT03636269|470918363|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
130806902|NCT03636269|470918361|FG000|Period 2: Open-label Phase|Adverse Event|0|||
130806903|NCT03636269|470918362|FG001|Period 2: Open-label Phase|Adverse Event|0|||
130806904|NCT03636269|470918363|FG002|Period 2: Open-label Phase|Adverse Event|21|||
130806905|NCT03636269|470918361|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
130806906|NCT03636269|470918362|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
130806907|NCT03636269|470918363|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
130806908|NCT03636269|470918361|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
130806909|NCT03636269|470918362|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
130806910|NCT03636269|470918363|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
130806911|NCT03636269|470918361|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
130806912|NCT03636269|470918362|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
130806913|NCT03636269|470918363|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
130806914|NCT03636269|470918361|FG000|Period 2: Open-label Phase|Administrative|0|||
130806915|NCT03636269|470918362|FG001|Period 2: Open-label Phase|Administrative|0|||
130806916|NCT03636269|470918363|FG002|Period 2: Open-label Phase|Administrative|36|||
130806917|NCT03636269|470918361|FG000|Period 2: Open-label Phase|Other|0|||
130806918|NCT03636269|470918362|FG001|Period 2: Open-label Phase|Other|0|||
130806919|NCT03636269|470918363|FG002|Period 2: Open-label Phase|Other|9|||
130806920|NCT03636269|470918361|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
130806921|NCT03636269|470918362|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
130806922|NCT03636269|470918363|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
130806923|NCT00290758|470918373|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
130806924|NCT00290758|470918374|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
130806925|NCT00290758|470918373|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
130806926|NCT00290758|470918374|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
130806927|NCT00290758|470918373|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
130806928|NCT00290758|470918374|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
130806929|NCT00290758|470918373|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
130806930|NCT00290758|470918374|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
130806931|NCT00290758|470918373|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
130806932|NCT00290758|470918374|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
130806933|NCT00290758|470918373|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
130806934|NCT00290758|470918374|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
130806935|NCT00290758|470918373|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
130806936|NCT00290758|470918374|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
130806937|NCT00290758|470918373|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
130806938|NCT00290758|470918374|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
130806939|NCT01750281|470918375|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
130806940|NCT01750281|470918376|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
130806941|NCT01750281|470918377|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
130806942|NCT01750281|470918375|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
130806943|NCT01750281|470918376|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
130806944|NCT01750281|470918377|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
130806945|NCT01750281|470918375|FG000|Overall Study|Did not receive treatment|0|||
130806946|NCT01750281|470918376|FG001|Overall Study|Did not receive treatment|1|||
130806947|NCT01750281|470918377|FG002|Overall Study|Did not receive treatment|0|||
130806948|NCT01896986|470918378|FG000|Overall Study|samples lost|14|||
130806949|NCT01896986|470918379|FG001|Overall Study|samples lost|23|||
130806950|NCT01061710|470918380|FG000|Overall Study|Protocol Violation|14|||
130806951|NCT03757715|470918381|FG000|Overall Study|Lost to Follow-up|4|||
130806952|NCT03757715|470918382|FG001|Overall Study|Lost to Follow-up|9|||
130806953|NCT03757715|470918381|FG000|Overall Study|Withdrawal by Subject|1|||
130806954|NCT03757715|470918382|FG001|Overall Study|Withdrawal by Subject|1|||
130806955|NCT00281580|470918383|FG000|Overall Study|Adverse Event|2|||
130806956|NCT00281580|470918384|FG001|Overall Study|Adverse Event|0|||
130806957|NCT00281580|470918385|FG002|Overall Study|Adverse Event|2|||
130806958|NCT00281580|470918386|FG003|Overall Study|Adverse Event|4|||
130806959|NCT00281580|470918387|FG004|Overall Study|Adverse Event|1|||
130806960|NCT00281580|470918388|FG005|Overall Study|Adverse Event|0|||
130806961|NCT00281580|470918389|FG006|Overall Study|Adverse Event|1|||
130806962|NCT00281580|470918390|FG007|Overall Study|Adverse Event|0|||
130806963|NCT00281580|470918391|FG008|Overall Study|Adverse Event|1|||
130806964|NCT00281580|470918392|FG009|Overall Study|Adverse Event|6|||
130806965|NCT00281580|470918393|FG010|Overall Study|Adverse Event|0|||
130806966|NCT00281580|470918394|FG011|Overall Study|Adverse Event|5|||
130806967|NCT00281580|470918395|FG012|Overall Study|Adverse Event|8|||
130806968|NCT00281580|470918396|FG013|Overall Study|Adverse Event|2|||
130806969|NCT00281580|470918397|FG014|Overall Study|Adverse Event|3|||
130806970|NCT00281580|470918398|FG015|Overall Study|Adverse Event|3|||
130806971|NCT00281580|470918383|FG000|Overall Study|Protocol Violation|0|||
130806972|NCT00281580|470918384|FG001|Overall Study|Protocol Violation|0|||
130806973|NCT00281580|470918385|FG002|Overall Study|Protocol Violation|1|||
130806974|NCT00281580|470918386|FG003|Overall Study|Protocol Violation|1|||
130806975|NCT00281580|470918387|FG004|Overall Study|Protocol Violation|0|||
130806976|NCT00281580|470918388|FG005|Overall Study|Protocol Violation|0|||
130806977|NCT00281580|470918389|FG006|Overall Study|Protocol Violation|1|||
130806978|NCT00281580|470918390|FG007|Overall Study|Protocol Violation|0|||
130806979|NCT00281580|470918391|FG008|Overall Study|Protocol Violation|2|||
130806980|NCT00281580|470918392|FG009|Overall Study|Protocol Violation|0|||
130806981|NCT00281580|470918393|FG010|Overall Study|Protocol Violation|1|||
130806982|NCT00281580|470918394|FG011|Overall Study|Protocol Violation|2|||
130806983|NCT00281580|470918395|FG012|Overall Study|Protocol Violation|0|||
130806984|NCT00281580|470918396|FG013|Overall Study|Protocol Violation|1|||
130806985|NCT00281580|470918397|FG014|Overall Study|Protocol Violation|1|||
130806986|NCT00281580|470918398|FG015|Overall Study|Protocol Violation|3|||
130806987|NCT00281580|470918383|FG000|Overall Study|Withdrawal by Subject|3|||
130806988|NCT00281580|470918384|FG001|Overall Study|Withdrawal by Subject|0|||
130806989|NCT00281580|470918385|FG002|Overall Study|Withdrawal by Subject|1|||
130806990|NCT00281580|470918386|FG003|Overall Study|Withdrawal by Subject|1|||
130806991|NCT00281580|470918387|FG004|Overall Study|Withdrawal by Subject|1|||
130806992|NCT00281580|470918388|FG005|Overall Study|Withdrawal by Subject|2|||
130806993|NCT00281580|470918389|FG006|Overall Study|Withdrawal by Subject|2|||
130806994|NCT00281580|470918390|FG007|Overall Study|Withdrawal by Subject|0|||
130806995|NCT00281580|470918391|FG008|Overall Study|Withdrawal by Subject|1|||
130806996|NCT00281580|470918392|FG009|Overall Study|Withdrawal by Subject|4|||
130806997|NCT00281580|470918393|FG010|Overall Study|Withdrawal by Subject|1|||
130806998|NCT00281580|470918394|FG011|Overall Study|Withdrawal by Subject|1|||
130806999|NCT00281580|470918395|FG012|Overall Study|Withdrawal by Subject|2|||
130807000|NCT00281580|470918396|FG013|Overall Study|Withdrawal by Subject|2|||
130807001|NCT00281580|470918397|FG014|Overall Study|Withdrawal by Subject|1|||
130807002|NCT00281580|470918398|FG015|Overall Study|Withdrawal by Subject|5|||
130807003|NCT00281580|470918383|FG000|Overall Study|Lack of Efficacy|2|||
130807004|NCT00281580|470918384|FG001|Overall Study|Lack of Efficacy|1|||
130807005|NCT00281580|470918385|FG002|Overall Study|Lack of Efficacy|1|||
130807006|NCT00281580|470918386|FG003|Overall Study|Lack of Efficacy|6|||
130807007|NCT00281580|470918387|FG004|Overall Study|Lack of Efficacy|2|||
130807008|NCT00281580|470918388|FG005|Overall Study|Lack of Efficacy|0|||
130807009|NCT00281580|470918389|FG006|Overall Study|Lack of Efficacy|0|||
130807010|NCT00281580|470918390|FG007|Overall Study|Lack of Efficacy|0|||
130807011|NCT00281580|470918391|FG008|Overall Study|Lack of Efficacy|0|||
130807012|NCT00281580|470918392|FG009|Overall Study|Lack of Efficacy|0|||
130807013|NCT00281580|470918393|FG010|Overall Study|Lack of Efficacy|0|||
130807014|NCT00281580|470918394|FG011|Overall Study|Lack of Efficacy|1|||
130807015|NCT00281580|470918395|FG012|Overall Study|Lack of Efficacy|0|||
130807016|NCT00281580|470918396|FG013|Overall Study|Lack of Efficacy|2|||
130807017|NCT00281580|470918397|FG014|Overall Study|Lack of Efficacy|1|||
130807018|NCT00281580|470918398|FG015|Overall Study|Lack of Efficacy|0|||
130807019|NCT00281580|470918383|FG000|Overall Study|Lost to Follow-up|0|||
130807020|NCT00281580|470918384|FG001|Overall Study|Lost to Follow-up|0|||
130807021|NCT00281580|470918385|FG002|Overall Study|Lost to Follow-up|0|||
130807022|NCT00281580|470918386|FG003|Overall Study|Lost to Follow-up|3|||
130807023|NCT00281580|470918387|FG004|Overall Study|Lost to Follow-up|0|||
130807024|NCT00281580|470918388|FG005|Overall Study|Lost to Follow-up|1|||
130807025|NCT00281580|470918389|FG006|Overall Study|Lost to Follow-up|0|||
130807026|NCT00281580|470918390|FG007|Overall Study|Lost to Follow-up|1|||
130807027|NCT00281580|470918391|FG008|Overall Study|Lost to Follow-up|2|||
130807028|NCT00281580|470918392|FG009|Overall Study|Lost to Follow-up|1|||
130807029|NCT00281580|470918393|FG010|Overall Study|Lost to Follow-up|1|||
130807030|NCT00281580|470918394|FG011|Overall Study|Lost to Follow-up|0|||
130807031|NCT00281580|470918395|FG012|Overall Study|Lost to Follow-up|1|||
130807032|NCT00281580|470918396|FG013|Overall Study|Lost to Follow-up|0|||
130807033|NCT00281580|470918397|FG014|Overall Study|Lost to Follow-up|0|||
130807034|NCT00281580|470918398|FG015|Overall Study|Lost to Follow-up|0|||
130807035|NCT00281580|470918383|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
130807036|NCT00281580|470918384|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
130807037|NCT00281580|470918385|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
130807038|NCT00281580|470918386|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
130807039|NCT00281580|470918387|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
130807040|NCT00281580|470918388|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
130807041|NCT00281580|470918389|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
130807042|NCT00281580|470918390|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
130807043|NCT00281580|470918391|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
130807044|NCT00281580|470918392|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
130807045|NCT00281580|470918393|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
130807046|NCT00281580|470918394|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
130807047|NCT00281580|470918395|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
130807048|NCT00281580|470918396|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
130807049|NCT00281580|470918397|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
130807050|NCT00281580|470918398|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
130807051|NCT03302936|470918399|FG000|Overall Study|Protocol Violation|3|||
130807052|NCT03302936|470918400|FG001|Overall Study|Protocol Violation|4|||
130807053|NCT01550965|470918401|FG000|Overall Study|Adverse Event|26|||
130807054|NCT01550965|470918401|FG000|Overall Study|Withdrawal by Subject|10|||
130807055|NCT01550965|470918401|FG000|Overall Study|Lost to Follow-up|2|||
130807056|NCT01550965|470918401|FG000|Overall Study|Lack of Efficacy|59|||
130807057|NCT01550965|470918401|FG000|Overall Study|Other|13|||
130807058|NCT03016403|470918404|FG000|Baseline|Death|5|||
130807059|NCT03016403|470918405|FG001|Baseline|Death|8|||
130807060|NCT03016403|470918406|FG002|Baseline|Death|1|||
130807061|NCT03016403|470918407|FG003|Baseline|Death|0|||
130807062|NCT03016403|470918404|FG000|Baseline|Withdrawal by Subject|2|||
130807063|NCT03016403|470918405|FG001|Baseline|Withdrawal by Subject|8|||
130807064|NCT03016403|470918406|FG002|Baseline|Withdrawal by Subject|4|||
130807065|NCT03016403|470918407|FG003|Baseline|Withdrawal by Subject|10|||
130807066|NCT03016403|470918404|FG000|Baseline|Lost to Follow-up|9|||
130807067|NCT03016403|470918405|FG001|Baseline|Lost to Follow-up|11|||
130807068|NCT03016403|470918406|FG002|Baseline|Lost to Follow-up|6|||
130807069|NCT03016403|470918407|FG003|Baseline|Lost to Follow-up|24|||
130807070|NCT03016403|470918404|FG000|6-week Follow-up|Death|1|||
130807071|NCT03016403|470918405|FG001|6-week Follow-up|Death|4|||
130807072|NCT03016403|470918406|FG002|6-week Follow-up|Death|0|||
130807073|NCT03016403|470918407|FG003|6-week Follow-up|Death|0|||
130807074|NCT03016403|470918404|FG000|6-week Follow-up|Lost to Follow-up|2|||
130807075|NCT03016403|470918405|FG001|6-week Follow-up|Lost to Follow-up|7|||
130807076|NCT03016403|470918406|FG002|6-week Follow-up|Lost to Follow-up|4|||
130807077|NCT03016403|470918407|FG003|6-week Follow-up|Lost to Follow-up|8|||
130807078|NCT03016403|470918404|FG000|6-week Follow-up|Withdrawal by Subject|0|||
130807079|NCT03016403|470918405|FG001|6-week Follow-up|Withdrawal by Subject|2|||
130807080|NCT03016403|470918406|FG002|6-week Follow-up|Withdrawal by Subject|0|||
130807081|NCT03016403|470918407|FG003|6-week Follow-up|Withdrawal by Subject|1|||
130807082|NCT03016403|470918404|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
130807083|NCT03016403|470918405|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
130807084|NCT03016403|470918406|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
130807085|NCT03016403|470918407|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
130807086|NCT03016403|470918404|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
130807087|NCT03016403|470918405|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
130807088|NCT03016403|470918406|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
130807089|NCT03016403|470918407|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
130807090|NCT03016403|470918404|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
130807091|NCT03016403|470918405|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
130807092|NCT03016403|470918406|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
130807093|NCT03016403|470918407|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
130807094|NCT05463705|470918408|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
130807095|NCT05463705|470918409|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
130807096|NCT05463705|470918410|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
130807097|NCT05463705|470918411|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
130807098|NCT05463705|470918412|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
130807099|NCT05463705|470918413|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
130807100|NCT00621322|470918414|FG000|Overall Study|Lost to Follow-up|0|||
130807101|NCT00621322|470918415|FG001|Overall Study|Lost to Follow-up|0|||
130807102|NCT00621322|470918416|FG002|Overall Study|Lost to Follow-up|0|||
130807103|NCT00621322|470918417|FG003|Overall Study|Lost to Follow-up|0|||
130807104|NCT00621322|470918418|FG004|Overall Study|Lost to Follow-up|1|||
130807105|NCT00621322|470918419|FG005|Overall Study|Lost to Follow-up|0|||
130807106|NCT00621322|470918414|FG000|Overall Study|Physician Decision|0|||
130807107|NCT00621322|470918415|FG001|Overall Study|Physician Decision|0|||
130807108|NCT00621322|470918416|FG002|Overall Study|Physician Decision|1|||
130807109|NCT00621322|470918417|FG003|Overall Study|Physician Decision|1|||
130807110|NCT00621322|470918418|FG004|Overall Study|Physician Decision|0|||
130807111|NCT00621322|470918419|FG005|Overall Study|Physician Decision|0|||
130807112|NCT00621322|470918414|FG000|Overall Study|Withdrawal by Subject|0|||
130807113|NCT00621322|470918415|FG001|Overall Study|Withdrawal by Subject|0|||
130807114|NCT00621322|470918416|FG002|Overall Study|Withdrawal by Subject|0|||
130807115|NCT00621322|470918417|FG003|Overall Study|Withdrawal by Subject|1|||
130807116|NCT00621322|470918418|FG004|Overall Study|Withdrawal by Subject|0|||
130807117|NCT00621322|470918419|FG005|Overall Study|Withdrawal by Subject|2|||
130807118|NCT00621322|470918414|FG000|Overall Study|Migrated/moved from study area|1|||
130807119|NCT00621322|470918415|FG001|Overall Study|Migrated/moved from study area|0|||
130807120|NCT00621322|470918416|FG002|Overall Study|Migrated/moved from study area|1|||
130807121|NCT00621322|470918417|FG003|Overall Study|Migrated/moved from study area|1|||
130807122|NCT00621322|470918418|FG004|Overall Study|Migrated/moved from study area|0|||
130807123|NCT00621322|470918419|FG005|Overall Study|Migrated/moved from study area|2|||
130807124|NCT01655069|470918428|FG000|Overall Study|Physician Decision|0|||
130807125|NCT01655069|470918429|FG001|Overall Study|Physician Decision|0|||
130807126|NCT01655069|470918430|FG002|Overall Study|Physician Decision|0|||
130807127|NCT01655069|470918431|FG003|Overall Study|Physician Decision|1|||
130807128|NCT01655069|470918428|FG000|Overall Study|Adverse Event|6|||
130807129|NCT01655069|470918429|FG001|Overall Study|Adverse Event|7|||
130807130|NCT01655069|470918430|FG002|Overall Study|Adverse Event|2|||
130807131|NCT01655069|470918431|FG003|Overall Study|Adverse Event|3|||
130807132|NCT01655069|470918428|FG000|Overall Study|Lack of Efficacy|0|||
130807133|NCT01655069|470918429|FG001|Overall Study|Lack of Efficacy|1|||
130807134|NCT01655069|470918430|FG002|Overall Study|Lack of Efficacy|0|||
130807135|NCT01655069|470918431|FG003|Overall Study|Lack of Efficacy|0|||
130807136|NCT01655069|470918428|FG000|Overall Study|No Treatment Needed|0|||
130807137|NCT01655069|470918429|FG001|Overall Study|No Treatment Needed|1|||
130807138|NCT01655069|470918430|FG002|Overall Study|No Treatment Needed|0|||
130807139|NCT01655069|470918431|FG003|Overall Study|No Treatment Needed|0|||
130807140|NCT01655069|470918428|FG000|Overall Study|Withdrawal by Subject|2|||
130807141|NCT01655069|470918429|FG001|Overall Study|Withdrawal by Subject|3|||
130807142|NCT01655069|470918430|FG002|Overall Study|Withdrawal by Subject|0|||
130807143|NCT01655069|470918431|FG003|Overall Study|Withdrawal by Subject|0|||
130807144|NCT00986102|470918432|FG000|Overall Study|Lost to Follow-up|0|||
130807145|NCT00986102|470918433|FG001|Overall Study|Lost to Follow-up|1|||
130807146|NCT00986102|470918434|FG002|Overall Study|Lost to Follow-up|0|||
130807147|NCT00986102|470918435|FG003|Overall Study|Lost to Follow-up|1|||
130807148|NCT00986102|470918432|FG000|Overall Study|Withdrawal by Subject|1|||
130807149|NCT00986102|470918433|FG001|Overall Study|Withdrawal by Subject|1|||
130807150|NCT00986102|470918434|FG002|Overall Study|Withdrawal by Subject|0|||
130807151|NCT00986102|470918435|FG003|Overall Study|Withdrawal by Subject|0|||
130807152|NCT00147537|470918439|FG000|Phase 1b|Death|0|||
130807153|NCT00147537|470918440|FG001|Phase 1b|Death|1|||
130807154|NCT00147537|470918441|FG002|Phase 1b|Death|2|||
130807155|NCT00147537|470918442|FG003|Phase 1b|Death|1|||
130807156|NCT00147537|470918443|FG004|Phase 1b|Death|2|||
130807157|NCT00147537|470918444|FG005|Phase 1b|Death|2|||
130807158|NCT00147537|470918445|FG006|Phase 1b|Death|1|||
130807159|NCT00147537|470918446|FG007|Phase 1b|Death|3|||
130807160|NCT00147537|470918447|FG008|Phase 1b|Death|9|||
130807161|NCT00147537|470918448|FG009|Phase 1b|Death|0|||
130807162|NCT00147537|470918449|FG010|Phase 1b|Death|0|||
130807163|NCT00147537|470918439|FG000|Phase 1b|Lost to Follow-up|2|||
130807164|NCT00147537|470918440|FG001|Phase 1b|Lost to Follow-up|1|||
130807165|NCT00147537|470918441|FG002|Phase 1b|Lost to Follow-up|0|||
130807166|NCT00147537|470918442|FG003|Phase 1b|Lost to Follow-up|0|||
130807167|NCT00147537|470918443|FG004|Phase 1b|Lost to Follow-up|0|||
130807168|NCT00147537|470918444|FG005|Phase 1b|Lost to Follow-up|0|||
130807169|NCT00147537|470918445|FG006|Phase 1b|Lost to Follow-up|2|||
130807170|NCT00147537|470918446|FG007|Phase 1b|Lost to Follow-up|0|||
130807171|NCT00147537|470918447|FG008|Phase 1b|Lost to Follow-up|1|||
130807172|NCT00147537|470918448|FG009|Phase 1b|Lost to Follow-up|0|||
130807173|NCT00147537|470918449|FG010|Phase 1b|Lost to Follow-up|0|||
130807174|NCT00147537|470918439|FG000|Phase 1b|Other|0|||
130807175|NCT00147537|470918440|FG001|Phase 1b|Other|0|||
130807176|NCT00147537|470918441|FG002|Phase 1b|Other|2|||
130807177|NCT00147537|470918442|FG003|Phase 1b|Other|1|||
130807178|NCT00147537|470918443|FG004|Phase 1b|Other|1|||
130807179|NCT00147537|470918444|FG005|Phase 1b|Other|1|||
130807180|NCT00147537|470918445|FG006|Phase 1b|Other|14|||
130807181|NCT00147537|470918446|FG007|Phase 1b|Other|4|||
130807182|NCT00147537|470918447|FG008|Phase 1b|Other|4|||
130807183|NCT00147537|470918448|FG009|Phase 1b|Other|0|||
130807184|NCT00147537|470918449|FG010|Phase 1b|Other|0|||
130807185|NCT00147537|470918439|FG000|Phase 1b|Withdrawal by Subject|0|||
130807186|NCT00147537|470918440|FG001|Phase 1b|Withdrawal by Subject|0|||
130807187|NCT00147537|470918441|FG002|Phase 1b|Withdrawal by Subject|0|||
130807188|NCT00147537|470918442|FG003|Phase 1b|Withdrawal by Subject|0|||
130807189|NCT00147537|470918443|FG004|Phase 1b|Withdrawal by Subject|0|||
130807190|NCT00147537|470918444|FG005|Phase 1b|Withdrawal by Subject|0|||
130807191|NCT00147537|470918445|FG006|Phase 1b|Withdrawal by Subject|0|||
130807192|NCT00147537|470918446|FG007|Phase 1b|Withdrawal by Subject|0|||
130807193|NCT00147537|470918447|FG008|Phase 1b|Withdrawal by Subject|2|||
130807194|NCT00147537|470918448|FG009|Phase 1b|Withdrawal by Subject|0|||
130807195|NCT00147537|470918449|FG010|Phase 1b|Withdrawal by Subject|0|||
130807196|NCT00147537|470918439|FG000|Phase 1b|Randomized but not treated|0|||
130807197|NCT00147537|470918440|FG001|Phase 1b|Randomized but not treated|0|||
130807198|NCT00147537|470918441|FG002|Phase 1b|Randomized but not treated|0|||
130807199|NCT00147537|470918442|FG003|Phase 1b|Randomized but not treated|0|||
130807200|NCT00147537|470918443|FG004|Phase 1b|Randomized but not treated|0|||
130807201|NCT00147537|470918444|FG005|Phase 1b|Randomized but not treated|0|||
130807202|NCT00147537|470918445|FG006|Phase 1b|Randomized but not treated|1|||
130807203|NCT00147537|470918446|FG007|Phase 1b|Randomized but not treated|0|||
130807204|NCT00147537|470918447|FG008|Phase 1b|Randomized but not treated|1|||
130807205|NCT00147537|470918448|FG009|Phase 1b|Randomized but not treated|0|||
130807206|NCT00147537|470918449|FG010|Phase 1b|Randomized but not treated|0|||
130807207|NCT00147537|470918439|FG000|Phase 2|Death|0|||
130807208|NCT00147537|470918440|FG001|Phase 2|Death|0|||
130807209|NCT00147537|470918441|FG002|Phase 2|Death|0|||
130807210|NCT00147537|470918442|FG003|Phase 2|Death|0|||
130807211|NCT00147537|470918443|FG004|Phase 2|Death|0|||
130807212|NCT00147537|470918444|FG005|Phase 2|Death|0|||
130807213|NCT00147537|470918445|FG006|Phase 2|Death|0|||
130807214|NCT00147537|470918446|FG007|Phase 2|Death|0|||
130807215|NCT00147537|470918447|FG008|Phase 2|Death|0|||
130807216|NCT00147537|470918448|FG009|Phase 2|Death|85|||
130807217|NCT00147537|470918449|FG010|Phase 2|Death|31|||
130807218|NCT00147537|470918439|FG000|Phase 2|Lost to Follow-up|0|||
130807219|NCT00147537|470918440|FG001|Phase 2|Lost to Follow-up|0|||
130807220|NCT00147537|470918441|FG002|Phase 2|Lost to Follow-up|0|||
130807221|NCT00147537|470918442|FG003|Phase 2|Lost to Follow-up|0|||
130807222|NCT00147537|470918443|FG004|Phase 2|Lost to Follow-up|0|||
130807223|NCT00147537|470918444|FG005|Phase 2|Lost to Follow-up|0|||
130807224|NCT00147537|470918445|FG006|Phase 2|Lost to Follow-up|0|||
130807225|NCT00147537|470918446|FG007|Phase 2|Lost to Follow-up|0|||
130807226|NCT00147537|470918447|FG008|Phase 2|Lost to Follow-up|0|||
130807227|NCT00147537|470918448|FG009|Phase 2|Lost to Follow-up|12|||
130807228|NCT00147537|470918449|FG010|Phase 2|Lost to Follow-up|4|||
130807229|NCT00147537|470918439|FG000|Phase 2|Other|0|||
130807230|NCT00147537|470918440|FG001|Phase 2|Other|0|||
130807231|NCT00147537|470918441|FG002|Phase 2|Other|0|||
130807232|NCT00147537|470918442|FG003|Phase 2|Other|0|||
130807233|NCT00147537|470918443|FG004|Phase 2|Other|0|||
130807234|NCT00147537|470918444|FG005|Phase 2|Other|0|||
130807235|NCT00147537|470918445|FG006|Phase 2|Other|0|||
130807236|NCT00147537|470918446|FG007|Phase 2|Other|0|||
130807237|NCT00147537|470918447|FG008|Phase 2|Other|0|||
130807238|NCT00147537|470918448|FG009|Phase 2|Other|47|||
130807239|NCT00147537|470918449|FG010|Phase 2|Other|12|||
130807240|NCT00147537|470918439|FG000|Phase 2|Withdrawal by Subject|0|||
130807241|NCT00147537|470918440|FG001|Phase 2|Withdrawal by Subject|0|||
130807242|NCT00147537|470918441|FG002|Phase 2|Withdrawal by Subject|0|||
130807243|NCT00147537|470918442|FG003|Phase 2|Withdrawal by Subject|0|||
130807244|NCT00147537|470918443|FG004|Phase 2|Withdrawal by Subject|0|||
130807245|NCT00147537|470918444|FG005|Phase 2|Withdrawal by Subject|0|||
130807246|NCT00147537|470918445|FG006|Phase 2|Withdrawal by Subject|0|||
130807247|NCT00147537|470918446|FG007|Phase 2|Withdrawal by Subject|0|||
130807248|NCT00147537|470918447|FG008|Phase 2|Withdrawal by Subject|0|||
130807249|NCT00147537|470918448|FG009|Phase 2|Withdrawal by Subject|16|||
130807250|NCT00147537|470918449|FG010|Phase 2|Withdrawal by Subject|4|||
130807251|NCT00147537|470918439|FG000|Phase 2|Randomized but not treated|0|||
130807252|NCT00147537|470918440|FG001|Phase 2|Randomized but not treated|0|||
130807253|NCT00147537|470918441|FG002|Phase 2|Randomized but not treated|0|||
130807254|NCT00147537|470918442|FG003|Phase 2|Randomized but not treated|0|||
130807255|NCT00147537|470918443|FG004|Phase 2|Randomized but not treated|0|||
130807256|NCT00147537|470918444|FG005|Phase 2|Randomized but not treated|0|||
130807257|NCT00147537|470918445|FG006|Phase 2|Randomized but not treated|0|||
130807258|NCT00147537|470918446|FG007|Phase 2|Randomized but not treated|0|||
130807259|NCT00147537|470918447|FG008|Phase 2|Randomized but not treated|0|||
130807260|NCT00147537|470918448|FG009|Phase 2|Randomized but not treated|1|||
130807261|NCT00147537|470918449|FG010|Phase 2|Randomized but not treated|1|||
130807262|NCT00345592|470918450|FG000|Overall Study|Death|14|||
130807263|NCT00345592|470918451|FG001|Overall Study|Death|16|||
130807264|NCT00345592|470918450|FG000|Overall Study|Withdrawal by Subject|11|||
130807265|NCT00345592|470918451|FG001|Overall Study|Withdrawal by Subject|8|||
130807266|NCT02006654|470918453|FG000|Overall Study|Withdrawal before treatment|4|||
130807267|NCT02006654|470918454|FG001|Overall Study|Withdrawal before treatment|2|||
130807268|NCT02006654|470918453|FG000|Overall Study|Adverse Event|16|||
130807269|NCT02006654|470918454|FG001|Overall Study|Adverse Event|17|||
130807270|NCT02006654|470918453|FG000|Overall Study|Death|1|||
130807271|NCT02006654|470918454|FG001|Overall Study|Death|0|||
130807272|NCT02006654|470918453|FG000|Overall Study|Withdrawal by Subject|14|||
130807273|NCT02006654|470918454|FG001|Overall Study|Withdrawal by Subject|12|||
130807274|NCT02006654|470918453|FG000|Overall Study|Protocol Violation|5|||
130807275|NCT02006654|470918454|FG001|Overall Study|Protocol Violation|8|||
130807276|NCT02006654|470918453|FG000|Overall Study|Lost to Follow-up|1|||
130807277|NCT02006654|470918454|FG001|Overall Study|Lost to Follow-up|0|||
130807278|NCT02006654|470918453|FG000|Overall Study|patient's will|2|||
130807279|NCT02006654|470918454|FG001|Overall Study|patient's will|1|||
130807280|NCT02006654|470918453|FG000|Overall Study|insufficient compliance|1|||
130807281|NCT02006654|470918454|FG001|Overall Study|insufficient compliance|0|||
130807282|NCT02006654|470918453|FG000|Overall Study|worsening cognitive condition|0|||
130807283|NCT02006654|470918454|FG001|Overall Study|worsening cognitive condition|1|||
130807284|NCT02006654|470918453|FG000|Overall Study|faecal incontinence|0|||
130807285|NCT02006654|470918454|FG001|Overall Study|faecal incontinence|1|||
130807286|NCT02006654|470918453|FG000|Overall Study|mood disorder|0|||
130807287|NCT02006654|470918454|FG001|Overall Study|mood disorder|1|||
130807288|NCT02006654|470918453|FG000|Overall Study|disallowed medication|1|||
130807289|NCT02006654|470918454|FG001|Overall Study|disallowed medication|0|||
130807290|NCT02006654|470918453|FG000|Overall Study|moving out of state|0|||
130807291|NCT02006654|470918454|FG001|Overall Study|moving out of state|1|||
130807292|NCT00478140|470918455|FG000|Overall Study|Clinical Disease Progression|1|||
130807293|NCT03438656|470918456|FG000|Overall Study|Lost to Follow-up|2|||
130807294|NCT03721965|470918457|FG000|Overall Study|Death|1|||
130807295|NCT03721965|470918457|FG000|Overall Study|Study Terminated by Sponsor|1|||
130807296|NCT00563316|470918458|FG000|Overall Study|Adverse Event|2|||
130807297|NCT00563316|470918458|FG000|Overall Study|Physician Decision|1|||
130807298|NCT00563316|470918458|FG000|Overall Study|Lost to Follow-up|2|||
130807299|NCT00563316|470918458|FG000|Overall Study|Death|1|||
130807300|NCT00563316|470918458|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
130807301|NCT00563316|470918458|FG000|Overall Study|Other|1|||
130807302|NCT00800384|470918466|FG000|Overall Study|Withdrawal by Subject|24|||
130807303|NCT00800384|470918467|FG001|Overall Study|Withdrawal by Subject|17|||
130807304|NCT00800384|470918466|FG000|Overall Study|Lost to Follow-up|17|||
130807305|NCT00800384|470918467|FG001|Overall Study|Lost to Follow-up|26|||
130807306|NCT02933151|470920069|FG000|Overall Study|Lost to Follow-up|19|||
130807307|NCT02933151|470920070|FG001|Overall Study|Lost to Follow-up|18|||
130807308|NCT02933151|470920069|FG000|Overall Study|Death|1732|||
130807309|NCT02933151|470920070|FG001|Overall Study|Death|1827|||
130807310|NCT02933151|470920069|FG000|Overall Study|Transplant|210|||
130807311|NCT02933151|470920070|FG001|Overall Study|Transplant|278|||
130807312|NCT02933151|470920069|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
130807313|NCT02933151|470920070|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
130807314|NCT02933151|470920069|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
130807315|NCT02933151|470920070|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
130807316|NCT02933151|470920069|FG000|Overall Study|Recovered Kidney Function|47|||
130807317|NCT02933151|470920070|FG001|Overall Study|Recovered Kidney Function|29|||
130807318|NCT00432991|470920071|FG000|Overall Study|Protocol Violation|7|||
130807319|NCT00432991|470920072|FG001|Overall Study|Protocol Violation|12|||
130807320|NCT03142451|470920082|FG000|Overall Study|Adverse Event|5|||
130807321|NCT03142451|470920083|FG001|Overall Study|Adverse Event|2|||
130807322|NCT03142451|470920082|FG000|Overall Study|Lost to Follow-up|25|||
130807323|NCT03142451|470920083|FG001|Overall Study|Lost to Follow-up|8|||
130807324|NCT03142451|470920082|FG000|Overall Study|Participant request|24|||
130807325|NCT03142451|470920083|FG001|Overall Study|Participant request|12|||
130807326|NCT03142451|470920082|FG000|Overall Study|Protocol Violation|3|||
130807327|NCT03142451|470920083|FG001|Overall Study|Protocol Violation|1|||
130807328|NCT03142451|470920082|FG000|Overall Study|Other|1|||
130807329|NCT03142451|470920083|FG001|Overall Study|Other|1|||
130807330|NCT00090402|470920084|FG000|Overall Study|Death|1|||
130807331|NCT00090402|470920085|FG001|Overall Study|Death|1|||
130807332|NCT00090402|470920086|FG002|Overall Study|Death|0|||
130807333|NCT00090402|470920084|FG000|Overall Study|subject moved|0|||
130807334|NCT00090402|470920085|FG001|Overall Study|subject moved|1|||
130807335|NCT00090402|470920086|FG002|Overall Study|subject moved|0|||
130807336|NCT00090402|470920084|FG000|Overall Study|stopped taking study medication|1|||
130807337|NCT00090402|470920085|FG001|Overall Study|stopped taking study medication|0|||
130807338|NCT00090402|470920086|FG002|Overall Study|stopped taking study medication|1|||
130807339|NCT04621786|470920099|FG000|Overall Study|Lost to Follow-up|9|||
130807340|NCT04621786|470920099|FG000|Overall Study|Protocol Violation|3|||
130807341|NCT04432298|470920101|FG000|Overall Study|Other than specified|1|||
130807342|NCT04432298|470920102|FG001|Overall Study|Other than specified|0|||
130807343|NCT04432298|470920101|FG000|Overall Study|Lost to Follow-up|0|||
130807344|NCT04432298|470920102|FG001|Overall Study|Lost to Follow-up|1|||
130807345|NCT04432298|470920101|FG000|Overall Study|Death|3|||
130807346|NCT04432298|470920102|FG001|Overall Study|Death|2|||
130807347|NCT04432298|470920101|FG000|Overall Study|Withdrawal by Subject|2|||
130807348|NCT04432298|470920102|FG001|Overall Study|Withdrawal by Subject|0|||
130807349|NCT02451007|470920105|FG000|Overall Study|Withdrawal by Subject|4|||
130807350|NCT02451007|470920105|FG000|Overall Study|Adverse Event|1|||
130807351|NCT02451007|470920105|FG000|Overall Study|Disease Progression|2|||
130807352|NCT01716559|470920106|FG000|Overall Study|Adverse Event|11|||
130807353|NCT01716559|470920106|FG000|Overall Study|Death|21|||
130807354|NCT01716559|470920106|FG000|Overall Study|Withdrawal by Subject|4|||
130807355|NCT01716559|470920106|FG000|Overall Study|Other withdrawal reason|75|||
130807356|NCT01133977|470920109|FG000|Overall Study|Adverse Event|0|||
130807357|NCT01133977|470920110|FG001|Overall Study|Adverse Event|0|||
130807358|NCT01133977|470920111|FG002|Overall Study|Adverse Event|1|||
130807359|NCT01133977|470920112|FG003|Overall Study|Adverse Event|0|||
130807360|NCT01133977|470920113|FG004|Overall Study|Adverse Event|0|||
130807361|NCT01133977|470920109|FG000|Overall Study|Death|1|||
130807362|NCT01133977|470920110|FG001|Overall Study|Death|1|||
130807363|NCT01133977|470920111|FG002|Overall Study|Death|1|||
130807364|NCT01133977|470920112|FG003|Overall Study|Death|7|||
130807365|NCT01133977|470920113|FG004|Overall Study|Death|3|||
130807366|NCT01133977|470920109|FG000|Overall Study|Started a New Line of Therapy|2|||
130807367|NCT01133977|470920110|FG001|Overall Study|Started a New Line of Therapy|6|||
130807368|NCT01133977|470920111|FG002|Overall Study|Started a New Line of Therapy|4|||
130807369|NCT01133977|470920112|FG003|Overall Study|Started a New Line of Therapy|25|||
130807370|NCT01133977|470920113|FG004|Overall Study|Started a New Line of Therapy|33|||
130807371|NCT01133977|470920109|FG000|Overall Study|Lost to Follow-up|0|||
130807372|NCT01133977|470920110|FG001|Overall Study|Lost to Follow-up|0|||
130807373|NCT01133977|470920111|FG002|Overall Study|Lost to Follow-up|0|||
130807374|NCT01133977|470920112|FG003|Overall Study|Lost to Follow-up|2|||
130807375|NCT01133977|470920113|FG004|Overall Study|Lost to Follow-up|1|||
130807376|NCT01133977|470920109|FG000|Overall Study|Withdrawal by Subject|0|||
130807377|NCT01133977|470920110|FG001|Overall Study|Withdrawal by Subject|0|||
130807378|NCT01133977|470920111|FG002|Overall Study|Withdrawal by Subject|0|||
130807379|NCT01133977|470920112|FG003|Overall Study|Withdrawal by Subject|5|||
130807380|NCT01133977|470920113|FG004|Overall Study|Withdrawal by Subject|1|||
130807381|NCT00397046|470920114|FG000|Overall Study|Disease Progression|3|||
130807382|NCT00397046|470920115|FG001|Overall Study|Disease Progression|3|||
130807383|NCT00397046|470920116|FG002|Overall Study|Disease Progression|10|||
130807384|NCT00397046|470920117|FG003|Overall Study|Disease Progression|5|||
130807385|NCT00493285|470920123|FG000|Overall Study|Lost to Follow-up|0|||
130807386|NCT00493285|470920124|FG001|Overall Study|Lost to Follow-up|0|||
130807387|NCT00493285|470920125|FG002|Overall Study|Lost to Follow-up|0|||
130807388|NCT00493285|470920126|FG003|Overall Study|Lost to Follow-up|0|||
130807389|NCT00493285|470920127|FG004|Overall Study|Lost to Follow-up|1|||
130807390|NCT00493285|470920128|FG005|Overall Study|Lost to Follow-up|0|||
130807391|NCT04535362|470920129|FG000|Overall Study|Lost to Follow-up|3|||
130807392|NCT04535362|470920130|FG001|Overall Study|Lost to Follow-up|1|||
130807393|NCT03791060|470920131|FG000|Overall Study|Withdrawal by Subject|1|||
130807394|NCT03774810|470920132|FG000|Phase 1|Lack of Efficacy|21|||
130807395|NCT03774810|470920133|FG001|Phase 1|Lack of Efficacy|0|||
130807396|NCT03774810|470920134|FG002|Phase 1|Lack of Efficacy|0|||
130807397|NCT03774810|470920135|FG003|Phase 1|Lack of Efficacy|0|||
130807398|NCT03774810|470920136|FG004|Phase 1|Lack of Efficacy|0|||
130807399|NCT03774810|470920132|FG000|Phase 1|Withdrawal by Subject|9|||
130807400|NCT03774810|470920133|FG001|Phase 1|Withdrawal by Subject|0|||
130807401|NCT03774810|470920134|FG002|Phase 1|Withdrawal by Subject|0|||
130807402|NCT03774810|470920135|FG003|Phase 1|Withdrawal by Subject|0|||
130807403|NCT03774810|470920136|FG004|Phase 1|Withdrawal by Subject|0|||
130807404|NCT03774810|470920132|FG000|Phase 1|Lost to Follow-up|2|||
130807405|NCT03774810|470920133|FG001|Phase 1|Lost to Follow-up|0|||
130807406|NCT03774810|470920134|FG002|Phase 1|Lost to Follow-up|0|||
130807407|NCT03774810|470920135|FG003|Phase 1|Lost to Follow-up|0|||
130807408|NCT03774810|470920136|FG004|Phase 1|Lost to Follow-up|0|||
130807409|NCT03774810|470920132|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
130807410|NCT03774810|470920133|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
130807411|NCT03774810|470920134|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
130807412|NCT03774810|470920135|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
130807413|NCT03774810|470920136|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
130807414|NCT03774810|470920132|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
130807415|NCT03774810|470920133|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
130807416|NCT03774810|470920134|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
130807417|NCT03774810|470920135|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
130807418|NCT03774810|470920136|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
130807419|NCT03774810|470920132|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
130807420|NCT03774810|470920133|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
130807421|NCT03774810|470920134|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
130807422|NCT03774810|470920135|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
130807423|NCT03774810|470920136|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
130807424|NCT03774810|470920132|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
130807425|NCT03774810|470920133|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
130807426|NCT03774810|470920134|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
130807427|NCT03774810|470920135|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
130807428|NCT03774810|470920136|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
130807429|NCT03774810|470920132|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
130807430|NCT03774810|470920133|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
130807431|NCT03774810|470920134|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
130807432|NCT03774810|470920135|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
130807433|NCT03774810|470920136|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
130807434|NCT03774810|470920132|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
130807435|NCT03774810|470920133|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
130807436|NCT03774810|470920134|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
130807437|NCT03774810|470920135|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
130807438|NCT03774810|470920136|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
130807439|NCT00474968|470920142|FG000|Overall Study|Withdrawal by Subject|8|||
130807440|NCT00474968|470920143|FG001|Overall Study|Withdrawal by Subject|7|||
130807441|NCT00474968|470920142|FG000|Overall Study|Protocol Violation|9|||
130807442|NCT00474968|470920143|FG001|Overall Study|Protocol Violation|8|||
130807443|NCT00474968|470920142|FG000|Overall Study|Sample not collected|1|||
130807444|NCT00474968|470920143|FG001|Overall Study|Sample not collected|1|||
130807445|NCT00981175|470920144|FG000|Primary Dose Vaccination|Adverse Event|1|||
130807446|NCT00981175|470920145|FG001|Primary Dose Vaccination|Adverse Event|0|||
130807447|NCT00981175|470920144|FG000|Primary Dose Vaccination|Protocol Violation|0|||
130807448|NCT00981175|470920145|FG001|Primary Dose Vaccination|Protocol Violation|1|||
130807449|NCT00981175|470920144|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
130807450|NCT00981175|470920145|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
130807451|NCT00981175|470920144|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
130807452|NCT00981175|470920145|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
130807453|NCT02619812|470920146|FG000|Overall Study|Withdrawal by Subject|0|||
130807454|NCT02619812|470920147|FG001|Overall Study|Withdrawal by Subject|0|||
130807455|NCT02619812|470920148|FG002|Overall Study|Withdrawal by Subject|1|||
130807456|NCT02619812|470920149|FG003|Overall Study|Withdrawal by Subject|2|||
130807457|NCT04189588|470920151|FG000|Overall Study|Death|0|||
130807458|NCT04189588|470920152|FG001|Overall Study|Death|1|||
130807459|NCT04189588|470920151|FG000|Overall Study|Lost to Follow-up|0|||
130807460|NCT04189588|470920152|FG001|Overall Study|Lost to Follow-up|1|||
130807461|NCT01658735|470920153|FG000|Overall Study|Lack of Efficacy|1|||
130807462|NCT01658735|470920154|FG001|Overall Study|Lack of Efficacy|0|||
130807463|NCT01658735|470920155|FG002|Overall Study|Lack of Efficacy|1|||
130807464|NCT01658735|470920153|FG000|Overall Study|Lost to Follow-up|1|||
130807465|NCT01658735|470920154|FG001|Overall Study|Lost to Follow-up|1|||
130807466|NCT01658735|470920155|FG002|Overall Study|Lost to Follow-up|0|||
130807467|NCT01658735|470920153|FG000|Overall Study|Protocol Violation|0|||
130807468|NCT01658735|470920154|FG001|Overall Study|Protocol Violation|1|||
130807469|NCT01658735|470920155|FG002|Overall Study|Protocol Violation|0|||
130807470|NCT01658735|470920153|FG000|Overall Study|Withdrawal by Subject|3|||
130807471|NCT01658735|470920154|FG001|Overall Study|Withdrawal by Subject|5|||
130807472|NCT01658735|470920155|FG002|Overall Study|Withdrawal by Subject|3|||
130807473|NCT03156621|470920156|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
130807474|NCT03156621|470920157|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
130807475|NCT03156621|470920156|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130807476|NCT03156621|470920157|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
130807477|NCT01379937|470920158|FG000|Overall Study|Protocol Violation|0|||
130807478|NCT01379937|470920159|FG001|Overall Study|Protocol Violation|0|||
130807479|NCT01379937|470920160|FG002|Overall Study|Protocol Violation|0|||
130807480|NCT01379937|470920161|FG003|Overall Study|Protocol Violation|1|||
130807481|NCT01379937|470920158|FG000|Overall Study|Consent withdrawal|0|||
130807482|NCT01379937|470920159|FG001|Overall Study|Consent withdrawal|1|||
130807483|NCT01379937|470920160|FG002|Overall Study|Consent withdrawal|0|||
130807484|NCT01379937|470920161|FG003|Overall Study|Consent withdrawal|0|||
130807485|NCT01379937|470920158|FG000|Overall Study|Lost to Follow-up|1|||
130807486|NCT01379937|470920159|FG001|Overall Study|Lost to Follow-up|2|||
130807487|NCT01379937|470920160|FG002|Overall Study|Lost to Follow-up|2|||
130807488|NCT01379937|470920161|FG003|Overall Study|Lost to Follow-up|0|||
130807489|NCT04985682|470920162|FG000|Overall Study|Withdrawal by Subject|1|||
130807490|NCT00079781|470920174|FG000|Pre-implant Period|Withdrawal by Subject|2|||
130807491|NCT00079781|470920175|FG001|Pre-implant Period|Withdrawal by Subject|0|||
130807492|NCT00079781|470920176|FG002|Pre-implant Period|Withdrawal by Subject|0|||
130807493|NCT00079781|470920174|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
130807494|NCT00079781|470920175|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
130807495|NCT00079781|470920176|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
130807496|NCT00079781|470920174|FG000|Follow-up Period|Withdrawal by Subject|3|||
130807497|NCT00079781|470920175|FG001|Follow-up Period|Withdrawal by Subject|0|||
130807498|NCT00079781|470920176|FG002|Follow-up Period|Withdrawal by Subject|1|||
130807499|NCT00079781|470920174|FG000|Follow-up Period|Lost to Follow-up|1|||
130807500|NCT00079781|470920175|FG001|Follow-up Period|Lost to Follow-up|0|||
130807501|NCT00079781|470920176|FG002|Follow-up Period|Lost to Follow-up|0|||
130807502|NCT00079781|470920174|FG000|Follow-up Period|Death|0|||
130807503|NCT00079781|470920175|FG001|Follow-up Period|Death|0|||
130807504|NCT00079781|470920176|FG002|Follow-up Period|Death|1|||
130807505|NCT04641975|470920177|FG000|Overall Study|Protocol Violation|1|||
130807506|NCT04641975|470920178|FG001|Overall Study|Protocol Violation|2|||
130807507|NCT04641975|470920179|FG002|Overall Study|Protocol Violation|0|||
130807508|NCT04641975|470920180|FG003|Overall Study|Protocol Violation|0|||
130807509|NCT04641975|470920177|FG000|Overall Study|Adverse Event|0|||
130807510|NCT04641975|470920178|FG001|Overall Study|Adverse Event|0|||
130807511|NCT04641975|470920179|FG002|Overall Study|Adverse Event|1|||
130807512|NCT04641975|470920180|FG003|Overall Study|Adverse Event|1|||
130807513|NCT04641975|470920177|FG000|Overall Study|Withdrawal by Subject|1|||
130807514|NCT04641975|470920178|FG001|Overall Study|Withdrawal by Subject|0|||
130807515|NCT04641975|470920179|FG002|Overall Study|Withdrawal by Subject|0|||
130807516|NCT04641975|470920180|FG003|Overall Study|Withdrawal by Subject|0|||
130807517|NCT01259024|470920183|FG000|Overall Study|Physician Decision|1|||
130807518|NCT01657500|470920184|FG000|Overall Study|set impropperly matched|3|||
130807519|NCT01657500|470920185|FG001|Overall Study|set impropperly matched|3|||
130807520|NCT01657500|470920184|FG000|Overall Study|Lost to Follow-up|2|||
130807521|NCT01657500|470920185|FG001|Overall Study|Lost to Follow-up|2|||
130807522|NCT02067156|470920187|FG000|Overall Study|Lost to Follow-up|4|||
130807523|NCT03596983|470920188|FG000|Overall Study|Withdrawal by Subject|3|||
130807524|NCT04034056|470920189|FG000|Overall Study|Withdrawal by Subject|2|||
130807525|NCT04034056|470920189|FG000|Overall Study|Reason Not Specified|13|||
130807526|NCT04034056|470920189|FG000|Overall Study|Adverse Event|56|||
130807527|NCT00819832|470920190|FG000|Overall Study|Sponsor Termination of Study|3|||
130807528|NCT00819832|470920191|FG001|Overall Study|Sponsor Termination of Study|0|||
130807529|NCT00819832|470920192|FG002|Overall Study|Sponsor Termination of Study|0|||
130807530|NCT00819832|470920193|FG003|Overall Study|Sponsor Termination of Study|0|||
130807531|NCT00819832|470920194|FG004|Overall Study|Sponsor Termination of Study|0|||
130807532|NCT00819832|470920195|FG005|Overall Study|Sponsor Termination of Study|0|||
130807533|NCT01260311|470920198|FG000|Overall Study|Adverse Event|11|||
130807534|NCT01260311|470920198|FG000|Overall Study|Lack of Efficacy|4|||
130807535|NCT01260311|470920198|FG000|Overall Study|Lost to Follow-up|25|||
130807536|NCT01260311|470920198|FG000|Overall Study|Withdrawal by Subject|6|||
130807537|NCT01260311|470920198|FG000|Overall Study|Financial Constraints|77|||
130807538|NCT01260311|470920198|FG000|Overall Study|Gone to Province|2|||
130807539|NCT01260311|470920198|FG000|Overall Study|Medication Stopped|1|||
130807540|NCT01260311|470920198|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
130807541|NCT01089543|470920207|FG000|Overall Study|Withdrawal by Subject|2|||
130807542|NCT01089543|470920208|FG001|Overall Study|Withdrawal by Subject|3|||
130807543|NCT01089543|470920209|FG002|Overall Study|Withdrawal by Subject|3|||
130807544|NCT01089543|470920210|FG003|Overall Study|Withdrawal by Subject|1|||
130807545|NCT01089543|470920207|FG000|Overall Study|Physician Decision|1|||
130807546|NCT01089543|470920208|FG001|Overall Study|Physician Decision|0|||
130807547|NCT01089543|470920209|FG002|Overall Study|Physician Decision|0|||
130807548|NCT01089543|470920210|FG003|Overall Study|Physician Decision|1|||
130807549|NCT01089543|470920207|FG000|Overall Study|Adverse Event|0|||
130807550|NCT01089543|470920208|FG001|Overall Study|Adverse Event|1|||
130807551|NCT01089543|470920209|FG002|Overall Study|Adverse Event|0|||
130807552|NCT01089543|470920210|FG003|Overall Study|Adverse Event|0|||
130807553|NCT01248468|470920212|FG000|Overall Study|Administrative problem|1|||
130807554|NCT01248468|470920213|FG001|Overall Study|Administrative problem|0|||
130807555|NCT01248468|470920214|FG002|Overall Study|Administrative problem|0|||
130807556|NCT01248468|470920212|FG000|Overall Study|Lost to Follow-up|9|||
130807557|NCT01248468|470920213|FG001|Overall Study|Lost to Follow-up|12|||
130807558|NCT01248468|470920214|FG002|Overall Study|Lost to Follow-up|4|||
130807559|NCT01248468|470920212|FG000|Overall Study|Pregnancy|1|||
130807560|NCT01248468|470920213|FG001|Overall Study|Pregnancy|0|||
130807561|NCT01248468|470920214|FG002|Overall Study|Pregnancy|0|||
130807562|NCT01248468|470920212|FG000|Overall Study|Withdrawal by Subject|4|||
130807563|NCT01248468|470920213|FG001|Overall Study|Withdrawal by Subject|2|||
130807564|NCT01248468|470920214|FG002|Overall Study|Withdrawal by Subject|0|||
130807565|NCT00468546|470920216|FG000|Week 24 Analysis|Lack of Efficacy|83|||
130807566|NCT00468546|470920217|FG001|Week 24 Analysis|Lack of Efficacy|37|||
130807567|NCT00468546|470920216|FG000|Week 24 Analysis|Refused treatment|5|||
130807568|NCT00468546|470920217|FG001|Week 24 Analysis|Refused treatment|5|||
130807569|NCT00468546|470920216|FG000|Week 24 Analysis|Adverse Event|1|||
130807570|NCT00468546|470920217|FG001|Week 24 Analysis|Adverse Event|8|||
130807571|NCT00468546|470920216|FG000|Week 24 Analysis|Failure to return|3|||
130807572|NCT00468546|470920217|FG001|Week 24 Analysis|Failure to return|4|||
130807573|NCT00468546|470920216|FG000|Week 24 Analysis|Rescue therapy|2|||
130807574|NCT00468546|470920217|FG001|Week 24 Analysis|Rescue therapy|0|||
130807575|NCT00468546|470920216|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
130807576|NCT00468546|470920217|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
130807577|NCT00468546|470920216|FG000|Week 24 Analysis|Due to clinical hold|1|||
130807578|NCT00468546|470920217|FG001|Week 24 Analysis|Due to clinical hold|0|||
130807579|NCT00468546|470920216|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
130807580|NCT00468546|470920217|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
130807581|NCT00468546|470920216|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
130807582|NCT00468546|470920217|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
130807583|NCT00468546|470920216|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
130807584|NCT00468546|470920217|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
130807585|NCT00468546|470920216|FG000|Week 24 to Week 104 Analysis|Death|1|||
130807586|NCT00468546|470920217|FG001|Week 24 to Week 104 Analysis|Death|0|||
130807587|NCT00468546|470920216|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
130807588|NCT00468546|470920217|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
130807589|NCT00468546|470920216|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
130807590|NCT00468546|470920217|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
130807591|NCT00468546|470920216|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
130807592|NCT00468546|470920217|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
130807593|NCT00468546|470920216|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
130807594|NCT00468546|470920217|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
130807595|NCT00468546|470920216|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
130807596|NCT00468546|470920217|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
130807597|NCT00468546|470920216|FG000|Week 24 to Week 104 Analysis|Other|17|||
130807598|NCT00468546|470920217|FG001|Week 24 to Week 104 Analysis|Other|14|||
130807599|NCT00472641|470920218|FG000|Overall Study|Lack of Efficacy|3|||
130807600|NCT00472641|470920218|FG000|Overall Study|Adverse Event|3|||
130807601|NCT00472641|470920218|FG000|Overall Study|Lost to Follow-up|1|||
130807602|NCT01189227|470920221|FG000|Overall Study|Study terminated due to low accrual|6|||
130807603|NCT01189227|470920222|FG001|Overall Study|Study terminated due to low accrual|3|||
130807604|NCT03211832|470920223|FG000|Overall Study|No longer with agency|32|||
130807605|NCT03211832|470920224|FG001|Overall Study|No longer with agency|49|||
130807606|NCT03211832|470920225|FG002|Overall Study|No longer with agency|30|||
130807607|NCT03211832|470920223|FG000|Overall Study|Declined survey|3|||
130807608|NCT03211832|470920224|FG001|Overall Study|Declined survey|3|||
130807609|NCT03211832|470920225|FG002|Overall Study|Declined survey|2|||
130807610|NCT03211832|470920223|FG000|Overall Study|Not available during data collection|1|||
130807611|NCT03211832|470920224|FG001|Overall Study|Not available during data collection|0|||
130807612|NCT03211832|470920225|FG002|Overall Study|Not available during data collection|2|||
130807613|NCT06048705|470920230|FG000|Overall Study|Physician Decision|1|||
130807614|NCT06048705|470920231|FG001|Overall Study|Physician Decision|0|||
130807615|NCT06048705|470920232|FG002|Overall Study|Physician Decision|0|||
130807616|NCT06048705|470920230|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
130807617|NCT06048705|470920231|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
130807618|NCT06048705|470920232|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
130807619|NCT06048705|470920230|FG000|Overall Study|Death prior to lymphodepletion|0|||
130807620|NCT06048705|470920231|FG001|Overall Study|Death prior to lymphodepletion|0|||
130807621|NCT06048705|470920232|FG002|Overall Study|Death prior to lymphodepletion|1|||
130807622|NCT01016015|470920233|FG000|Overall Study|Not Treated|3|||
130807623|NCT01016015|470920233|FG000|Overall Study|Withdrawal by Subject|1|||
130807624|NCT01016015|470920233|FG000|Overall Study|Adverse Event|15|||
130807625|NCT04648241|470920234|FG000|Overall Study|Lost to Follow-up|1|||
130807626|NCT04648241|470920235|FG001|Overall Study|Lost to Follow-up|0|||
130807627|NCT02057666|470920236|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
130807628|NCT02057666|470920237|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
130807629|NCT02057666|470920236|FG000|Double Blind Treatment Period|Poor tolerability|7|||
130807630|NCT02057666|470920237|FG001|Double Blind Treatment Period|Poor tolerability|2|||
130807631|NCT02057666|470920236|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
130807632|NCT02057666|470920237|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
130807633|NCT02057666|470920236|FG000|Double Blind Treatment Period|Physician Decision|1|||
130807634|NCT02057666|470920237|FG001|Double Blind Treatment Period|Physician Decision|0|||
130807635|NCT02057666|470920236|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
130807636|NCT02057666|470920237|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
130807637|NCT02057666|470920236|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
130807638|NCT02057666|470920237|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
130807639|NCT02057666|470920236|FG000|Double Blind Treatment Period|Sponsor's request|70|||
130807640|NCT02057666|470920237|FG001|Double Blind Treatment Period|Sponsor's request|34|||
130807641|NCT02057666|470920236|FG000|Open-Label Treatment Period|Poor tolerability|0|||
130807642|NCT02057666|470920237|FG001|Open-Label Treatment Period|Poor tolerability|1|||
130807643|NCT02057666|470920236|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
130807644|NCT02057666|470920237|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
130807645|NCT02057666|470920236|FG000|Open-Label Treatment Period|Sponsor's request|0|||
130807646|NCT02057666|470920237|FG001|Open-Label Treatment Period|Sponsor's request|4|||
130807647|NCT02489045|470920240|FG000|Overall Study|unable to collect usable data|53|||
130807648|NCT02489045|470920240|FG000|Follow-up|Lost to Follow-up|10|||
130807649|NCT03111732|470920243|FG000|Overall Study|Enrolled in different study|1|||
130807650|NCT03111732|470920243|FG000|Overall Study|Progressive disease|3|||
130807651|NCT03111732|470920243|FG000|Overall Study|Withdrawal by Subject|1|||
130807652|NCT02151604|470920246|FG000|Overall Study|Lost to Follow-up|3|||
130807653|NCT02151604|470920246|FG000|Overall Study|Withdrawal by Subject|2|||
130807654|NCT02151604|470920246|FG000|Overall Study|Physician Decision|3|||
130807655|NCT02151604|470920246|FG000|Overall Study|Death|1|||
130807656|NCT04495478|470920247|FG000|Overall Study|Withdrawal by Subject|0|||
130807657|NCT04495478|470920248|FG001|Overall Study|Withdrawal by Subject|0|||
130807658|NCT04495478|470920249|FG002|Overall Study|Withdrawal by Subject|0|||
130807659|NCT04495478|470920250|FG003|Overall Study|Withdrawal by Subject|1|||
130807660|NCT04495478|470920251|FG004|Overall Study|Withdrawal by Subject|0|||
130807661|NCT04495478|470920252|FG005|Overall Study|Withdrawal by Subject|0|||
130807662|NCT04495478|470920253|FG006|Overall Study|Withdrawal by Subject|0|||
130807663|NCT04495478|470920247|FG000|Overall Study|Physician Decision|0|||
130807664|NCT04495478|470920248|FG001|Overall Study|Physician Decision|1|||
130807665|NCT04495478|470920249|FG002|Overall Study|Physician Decision|0|||
130807666|NCT04495478|470920250|FG003|Overall Study|Physician Decision|0|||
130807667|NCT04495478|470920251|FG004|Overall Study|Physician Decision|1|||
130807668|NCT04495478|470920252|FG005|Overall Study|Physician Decision|0|||
130807669|NCT04495478|470920253|FG006|Overall Study|Physician Decision|0|||
130807670|NCT01793129|470922323|FG000|Overall Study|Lost to Follow-up|3|||
130807671|NCT01793129|470922324|FG001|Overall Study|Lost to Follow-up|7|||
130807672|NCT01793129|470922323|FG000|Overall Study|Withdrawal by Subject|0|||
130807673|NCT01793129|470922324|FG001|Overall Study|Withdrawal by Subject|2|||
130807674|NCT03004183|470922327|FG000|Overall Study|Adverse Event|7|||
130807675|NCT03004183|470922327|FG000|Overall Study|Lost to Follow-up|1|||
130807676|NCT03004183|470922327|FG000|Overall Study|Physician Decision|40|||
130807677|NCT03004183|470922327|FG000|Overall Study|Withdrawal by Subject|1|||
130807678|NCT03004183|470922327|FG000|Overall Study|COVID-19|1|||
130807679|NCT02529488|470922328|FG000|Overall Study|Adverse Event|1|||
130807680|NCT02529488|470922328|FG000|Overall Study|Death|3|||
130807681|NCT02698787|470922329|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
130807682|NCT02698787|470922330|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
130807683|NCT01428713|470922339|FG000|Overall Study|Non-compliance|2|||
130807684|NCT01428713|470922340|FG001|Overall Study|Non-compliance|2|||
130807685|NCT01428713|470922339|FG000|Overall Study|Withdrawal by Subject|1|||
130807686|NCT01428713|470922340|FG001|Overall Study|Withdrawal by Subject|1|||
130807687|NCT01428713|470922339|FG000|Overall Study|Adverse Event|0|||
130807688|NCT01428713|470922340|FG001|Overall Study|Adverse Event|2|||
130807689|NCT03048019|470922341|FG000|Overall Study|Adverse Event|1|||
130807690|NCT03048019|470922342|FG001|Overall Study|Adverse Event|0|||
130807691|NCT00862277|470922343|FG000|Overall Study|Protocol Violation|1|||
130807692|NCT00862277|470922344|FG001|Overall Study|Protocol Violation|2|||
130807693|NCT00862277|470922345|FG002|Overall Study|Protocol Violation|5|||
130807694|NCT03400787|470922346|FG000|Overall Study|Lost to Follow-up|1|||
130807695|NCT03400787|470922347|FG001|Overall Study|Lost to Follow-up|0|||
130807696|NCT03400787|470922346|FG000|Overall Study|Death|1|||
130807697|NCT03400787|470922347|FG001|Overall Study|Death|0|||
130807698|NCT03400787|470922346|FG000|Overall Study|Protocol Violation|0|||
130807699|NCT03400787|470922347|FG001|Overall Study|Protocol Violation|2|||
130807700|NCT03400787|470922346|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
130807701|NCT03400787|470922347|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
130807702|NCT00348374|470922350|FG000|Overall Study|Adverse Event|1|||
130807703|NCT00348374|470922351|FG001|Overall Study|Adverse Event|4|||
130807704|NCT00348374|470922350|FG000|Overall Study|Lost to Follow-up|1|||
130807705|NCT00348374|470922351|FG001|Overall Study|Lost to Follow-up|3|||
130807706|NCT00348374|470922350|FG000|Overall Study|Withdrawal by Subject|5|||
130807707|NCT00348374|470922351|FG001|Overall Study|Withdrawal by Subject|5|||
130807708|NCT00348374|470922350|FG000|Overall Study|Other|11|||
130807709|NCT00348374|470922351|FG001|Overall Study|Other|12|||
130807710|NCT00348374|470922350|FG000|Overall Study|ongoing at date of cutoff|1|||
130807711|NCT00348374|470922351|FG001|Overall Study|ongoing at date of cutoff|1|||
130807712|NCT00348374|470922350|FG000|Overall Study|randomized but did not receive treatment|0|||
130807713|NCT00348374|470922351|FG001|Overall Study|randomized but did not receive treatment|7|||
130807714|NCT00605657|470922360|FG000|Overall Study|Adverse Event|1|||
130807715|NCT00605657|470922360|FG000|Overall Study|Protocol Violation|1|||
130807716|NCT02070380|470922363|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
130807717|NCT02070380|470922364|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
130807718|NCT02070380|470922365|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
130807719|NCT02070380|470922366|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
130807720|NCT02070380|470922363|FG000|Second Injection|Image sets missing or technically inadeq|0|||
130807721|NCT02070380|470922364|FG001|Second Injection|Image sets missing or technically inadeq|1|||
130807722|NCT02070380|470922365|FG002|Second Injection|Image sets missing or technically inadeq|0|||
130807723|NCT02070380|470922366|FG003|Second Injection|Image sets missing or technically inadeq|0|||
130807724|NCT02070380|470922363|FG000|Second Injection|Protocol Violation|0|||
130807725|NCT02070380|470922364|FG001|Second Injection|Protocol Violation|1|||
130807726|NCT02070380|470922365|FG002|Second Injection|Protocol Violation|1|||
130807727|NCT02070380|470922366|FG003|Second Injection|Protocol Violation|5|||
130807728|NCT01791205|470922377|FG000|Phase II|Lack of Efficacy|6|||
130807729|NCT01791205|470922378|FG001|Phase II|Lack of Efficacy|0|||
130807730|NCT01791205|470922377|FG000|Phase II|Adverse Event|2|||
130807731|NCT01791205|470922378|FG001|Phase II|Adverse Event|0|||
130807732|NCT01791205|470922377|FG000|Phase II|Safety|1|||
130807733|NCT01791205|470922378|FG001|Phase II|Safety|0|||
130807734|NCT01791205|470922377|FG000|Phase II|Lost to Follow-up|1|||
130807735|NCT01791205|470922378|FG001|Phase II|Lost to Follow-up|0|||
130807736|NCT01791205|470922377|FG000|Phase II|Remission of disease|1|||
130807737|NCT01791205|470922378|FG001|Phase II|Remission of disease|0|||
130807738|NCT01791205|470922377|FG000|Phase II|Physician's decision|1|||
130807739|NCT01791205|470922378|FG001|Phase II|Physician's decision|0|||
130807740|NCT02242903|470922379|FG000|Overall Study|Withdrawal by Subject|1|||
130807741|NCT02242903|470922380|FG001|Overall Study|Withdrawal by Subject|0|||
130807742|NCT02242903|470922381|FG002|Overall Study|Withdrawal by Subject|0|||
130807743|NCT02242903|470922382|FG003|Overall Study|Withdrawal by Subject|0|||
130807744|NCT02242903|470922383|FG004|Overall Study|Withdrawal by Subject|0|||
130807745|NCT02242903|470922384|FG005|Overall Study|Withdrawal by Subject|0|||
130807746|NCT02242903|470922385|FG006|Overall Study|Withdrawal by Subject|0|||
130807747|NCT02105012|470922386|FG000|Overall Study|Withdrawal by Subject|11|||
130807748|NCT02105012|470922386|FG000|Overall Study|Protocol Specified Criteria|9|||
130807749|NCT02105012|470922386|FG000|Overall Study|Lost to Follow-up|4|||
130807750|NCT02105012|470922386|FG000|Overall Study|Protocol Violation|4|||
130807751|NCT02105012|470922386|FG000|Overall Study|Physician Decision|3|||
130807752|NCT02105012|470922386|FG000|Overall Study|Adverse Event|1|||
130807753|NCT02105012|470922386|FG000|Overall Study|Lack of Efficacy|1|||
130807754|NCT03436420|470922387|FG000|Overall Study|Lack of Efficacy|3|||
130807755|NCT01104870|470922390|FG000|Overall Study|Adverse Event|1|||
130807756|NCT01104870|470922391|FG001|Overall Study|Adverse Event|1|||
130807757|NCT01104870|470922392|FG002|Overall Study|Adverse Event|0|||
130807758|NCT01104870|470922390|FG000|Overall Study|Death|0|||
130807759|NCT01104870|470922391|FG001|Overall Study|Death|0|||
130807760|NCT01104870|470922392|FG002|Overall Study|Death|1|||
130807761|NCT01104870|470922390|FG000|Overall Study|Withdrawal by Subject|0|||
130807762|NCT01104870|470922391|FG001|Overall Study|Withdrawal by Subject|0|||
130807763|NCT01104870|470922392|FG002|Overall Study|Withdrawal by Subject|1|||
130807764|NCT03473301|470922393|FG000|Overall Study|Protocol Violation|4|||
130807765|NCT03473301|470922394|FG001|Overall Study|Protocol Violation|0|||
130807766|NCT03473301|470922395|FG002|Overall Study|Protocol Violation|0|||
130807767|NCT03473301|470922393|FG000|Overall Study|Withdrawal by Subject|0|||
130807768|NCT03473301|470922394|FG001|Overall Study|Withdrawal by Subject|1|||
130807769|NCT03473301|470922395|FG002|Overall Study|Withdrawal by Subject|0|||
130807770|NCT03473301|470922393|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
130807771|NCT03473301|470922394|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
130807772|NCT03473301|470922395|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
130807773|NCT04008069|470922396|FG000|Open-Label Period|Adverse Event|1|||
130807774|NCT04008069|470922397|FG001|Open-Label Period|Adverse Event|0|||
130807775|NCT04008069|470922398|FG002|Open-Label Period|Adverse Event|0|||
130807776|NCT04008069|470922396|FG000|Open-Label Period|Lack of Efficacy|4|||
130807777|NCT04008069|470922397|FG001|Open-Label Period|Lack of Efficacy|0|||
130807778|NCT04008069|470922398|FG002|Open-Label Period|Lack of Efficacy|0|||
130807779|NCT04008069|470922396|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
130807780|NCT04008069|470922397|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
130807781|NCT04008069|470922398|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
130807782|NCT04008069|470922396|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
130807783|NCT04008069|470922397|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
130807784|NCT04008069|470922398|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
130807785|NCT02134028|470922400|FG000|Overall Study|Lack of Efficacy|1|||
130807786|NCT02134028|470922401|FG001|Overall Study|Lack of Efficacy|0|||
130807787|NCT02134028|470922402|FG002|Overall Study|Lack of Efficacy|3|||
130807788|NCT02134028|470922403|FG003|Overall Study|Lack of Efficacy|2|||
130807789|NCT02134028|470922404|FG004|Overall Study|Lack of Efficacy|1|||
130807790|NCT02134028|470922405|FG005|Overall Study|Lack of Efficacy|2|||
130807791|NCT02134028|470922406|FG006|Overall Study|Lack of Efficacy|1|||
130807792|NCT02134028|470922407|FG007|Overall Study|Lack of Efficacy|0|||
130807793|NCT02134028|470922400|FG000|Overall Study|Poor compliance to protocol|1|||
130807794|NCT02134028|470922401|FG001|Overall Study|Poor compliance to protocol|1|||
130807795|NCT02134028|470922402|FG002|Overall Study|Poor compliance to protocol|3|||
130807796|NCT02134028|470922403|FG003|Overall Study|Poor compliance to protocol|7|||
130807797|NCT02134028|470922404|FG004|Overall Study|Poor compliance to protocol|1|||
130807798|NCT02134028|470922405|FG005|Overall Study|Poor compliance to protocol|1|||
130807799|NCT02134028|470922406|FG006|Overall Study|Poor compliance to protocol|0|||
130807800|NCT02134028|470922407|FG007|Overall Study|Poor compliance to protocol|0|||
130807801|NCT02134028|470922400|FG000|Overall Study|Other unspecified|4|||
130807802|NCT02134028|470922401|FG001|Overall Study|Other unspecified|22|||
130807803|NCT02134028|470922402|FG002|Overall Study|Other unspecified|33|||
130807804|NCT02134028|470922403|FG003|Overall Study|Other unspecified|64|||
130807805|NCT02134028|470922404|FG004|Overall Study|Other unspecified|8|||
130807806|NCT02134028|470922405|FG005|Overall Study|Other unspecified|6|||
130807807|NCT02134028|470922406|FG006|Overall Study|Other unspecified|2|||
130807808|NCT02134028|470922407|FG007|Overall Study|Other unspecified|1|||
130807809|NCT02134028|470922400|FG000|Overall Study|Adverse Event|3|||
130807810|NCT02134028|470922401|FG001|Overall Study|Adverse Event|19|||
130807811|NCT02134028|470922402|FG002|Overall Study|Adverse Event|13|||
130807812|NCT02134028|470922403|FG003|Overall Study|Adverse Event|32|||
130807813|NCT02134028|470922404|FG004|Overall Study|Adverse Event|4|||
130807814|NCT02134028|470922405|FG005|Overall Study|Adverse Event|5|||
130807815|NCT02134028|470922406|FG006|Overall Study|Adverse Event|1|||
130807816|NCT02134028|470922407|FG007|Overall Study|Adverse Event|2|||
130807817|NCT01452789|470922414|FG000|Overall Study|Withdrawal by Subject|3|||
130807818|NCT01452789|470922415|FG001|Overall Study|Withdrawal by Subject|2|||
130807819|NCT01340170|470922416|FG000|Overall Study|Lost to Follow-up|2|||
130807820|NCT01340170|470922417|FG001|Overall Study|Lost to Follow-up|4|||
130807821|NCT01340170|470922418|FG002|Overall Study|Lost to Follow-up|0|||
130807822|NCT01340170|470922416|FG000|Overall Study|Implant failure|1|||
130807823|NCT01340170|470922417|FG001|Overall Study|Implant failure|3|||
130807824|NCT01340170|470922418|FG002|Overall Study|Implant failure|0|||
130807825|NCT03878602|470922419|FG000|Overall Study|cord blood donation|7|||
130807826|NCT03878602|470922420|FG001|Overall Study|cord blood donation|1|||
130807827|NCT03878602|470922419|FG000|Overall Study|incomplete data collection|2|||
130807828|NCT03878602|470922420|FG001|Overall Study|incomplete data collection|0|||
130807829|NCT00066170|470922421|FG000|Overall Study|Adverse Event|2|||
130807830|NCT00066170|470922422|FG001|Overall Study|Adverse Event|4|||
130807831|NCT00066170|470922423|FG002|Overall Study|Adverse Event|1|||
130807832|NCT00066170|470922424|FG003|Overall Study|Adverse Event|7|||
130807833|NCT00066170|470922421|FG000|Overall Study|Serious Adverse Event|0|||
130807834|NCT00066170|470922422|FG001|Overall Study|Serious Adverse Event|0|||
130807835|NCT00066170|470922423|FG002|Overall Study|Serious Adverse Event|1|||
130807836|NCT00066170|470922424|FG003|Overall Study|Serious Adverse Event|1|||
130807837|NCT00066170|470922421|FG000|Overall Study|Lost to Follow-up|0|||
130807838|NCT00066170|470922422|FG001|Overall Study|Lost to Follow-up|1|||
130807839|NCT00066170|470922423|FG002|Overall Study|Lost to Follow-up|0|||
130807840|NCT00066170|470922424|FG003|Overall Study|Lost to Follow-up|0|||
130807841|NCT00066170|470922421|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
130807842|NCT00066170|470922422|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
130807843|NCT00066170|470922423|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
130807844|NCT00066170|470922424|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
130807845|NCT00066170|470922421|FG000|Overall Study|Protocol Violation|3|||
130807846|NCT00066170|470922422|FG001|Overall Study|Protocol Violation|0|||
130807847|NCT00066170|470922423|FG002|Overall Study|Protocol Violation|0|||
130807848|NCT00066170|470922424|FG003|Overall Study|Protocol Violation|0|||
130807849|NCT00066170|470922421|FG000|Overall Study|Other|1|||
130807850|NCT00066170|470922422|FG001|Overall Study|Other|5|||
130807851|NCT00066170|470922423|FG002|Overall Study|Other|2|||
130807852|NCT00066170|470922424|FG003|Overall Study|Other|0|||
130807853|NCT00098293|470922425|FG000|Double-blind (DB) Phase|Adverse Event|14|||
130807854|NCT00098293|470922426|FG001|Double-blind (DB) Phase|Adverse Event|27|||
130807855|NCT00098293|470922427|FG002|Double-blind (DB) Phase|Adverse Event|60|||
130807856|NCT00098293|470922428|FG003|Double-blind (DB) Phase|Adverse Event|0|||
130807857|NCT00098293|470922429|FG004|Double-blind (DB) Phase|Adverse Event|0|||
130807858|NCT00098293|470922425|FG000|Double-blind (DB) Phase|Pregnancy|0|||
130807859|NCT00098293|470922426|FG001|Double-blind (DB) Phase|Pregnancy|7|||
130807860|NCT00098293|470922427|FG002|Double-blind (DB) Phase|Pregnancy|9|||
130807861|NCT00098293|470922428|FG003|Double-blind (DB) Phase|Pregnancy|0|||
130807862|NCT00098293|470922429|FG004|Double-blind (DB) Phase|Pregnancy|0|||
130807863|NCT00098293|470922425|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
130807864|NCT00098293|470922426|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
130807865|NCT00098293|470922427|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
130807866|NCT00098293|470922428|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
130807867|NCT00098293|470922429|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
130807868|NCT00098293|470922425|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
130807869|NCT00098293|470922426|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
130807870|NCT00098293|470922427|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
130807871|NCT00098293|470922428|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
130807872|NCT00098293|470922429|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
130807873|NCT00098293|470922425|FG000|Double-blind (DB) Phase|Death|1|||
130807874|NCT00098293|470922426|FG001|Double-blind (DB) Phase|Death|2|||
130807875|NCT00098293|470922427|FG002|Double-blind (DB) Phase|Death|2|||
130807876|NCT00098293|470922428|FG003|Double-blind (DB) Phase|Death|0|||
130807877|NCT00098293|470922429|FG004|Double-blind (DB) Phase|Death|0|||
130807878|NCT00098293|470922425|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
130807879|NCT00098293|470922426|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
130807880|NCT00098293|470922427|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
130807881|NCT00098293|470922428|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
130807882|NCT00098293|470922429|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
130807883|NCT00098293|470922425|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
130807884|NCT00098293|470922426|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
130807885|NCT00098293|470922427|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
130807886|NCT00098293|470922428|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
130807887|NCT00098293|470922429|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
130807888|NCT00098293|470922425|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
130807889|NCT00098293|470922426|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
130807890|NCT00098293|470922427|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
130807891|NCT00098293|470922428|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
130807892|NCT00098293|470922429|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
130807893|NCT00098293|470922425|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130807894|NCT00098293|470922426|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130807895|NCT00098293|470922427|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
130807896|NCT00098293|470922428|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130807897|NCT00098293|470922429|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130807898|NCT00098293|470922425|FG000|Open-label (OL) Phase|Adverse Event|0|||
130807899|NCT00098293|470922426|FG001|Open-label (OL) Phase|Adverse Event|3|||
130807900|NCT00098293|470922427|FG002|Open-label (OL) Phase|Adverse Event|7|||
130807901|NCT00098293|470922428|FG003|Open-label (OL) Phase|Adverse Event|6|||
130807902|NCT00098293|470922429|FG004|Open-label (OL) Phase|Adverse Event|0|||
130807903|NCT00098293|470922425|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
130807904|NCT00098293|470922426|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
130807905|NCT00098293|470922427|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
130807906|NCT00098293|470922428|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
130807907|NCT00098293|470922429|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
130807908|NCT00098293|470922425|FG000|Open-label (OL) Phase|Pregnancy|0|||
130807909|NCT00098293|470922426|FG001|Open-label (OL) Phase|Pregnancy|1|||
130807910|NCT00098293|470922427|FG002|Open-label (OL) Phase|Pregnancy|0|||
130807911|NCT00098293|470922428|FG003|Open-label (OL) Phase|Pregnancy|3|||
130807912|NCT00098293|470922429|FG004|Open-label (OL) Phase|Pregnancy|0|||
130807913|NCT00098293|470922425|FG000|Open-label (OL) Phase|Protocol Violation|0|||
130807914|NCT00098293|470922426|FG001|Open-label (OL) Phase|Protocol Violation|6|||
130807915|NCT00098293|470922427|FG002|Open-label (OL) Phase|Protocol Violation|13|||
130807916|NCT00098293|470922428|FG003|Open-label (OL) Phase|Protocol Violation|16|||
130807917|NCT00098293|470922429|FG004|Open-label (OL) Phase|Protocol Violation|0|||
130807918|NCT00098293|470922425|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
130807919|NCT00098293|470922426|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
130807920|NCT00098293|470922427|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
130807921|NCT00098293|470922428|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
130807922|NCT00098293|470922429|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
130807923|NCT00098293|470922425|FG000|Open-label (OL) Phase|Death|0|||
130807924|NCT00098293|470922426|FG001|Open-label (OL) Phase|Death|2|||
130807925|NCT00098293|470922427|FG002|Open-label (OL) Phase|Death|3|||
130807926|NCT00098293|470922428|FG003|Open-label (OL) Phase|Death|0|||
130807927|NCT00098293|470922429|FG004|Open-label (OL) Phase|Death|0|||
130807928|NCT00098293|470922425|FG000|Supplemental Phase (SP)|Death|0|||
130807929|NCT00098293|470922426|FG001|Supplemental Phase (SP)|Death|0|||
130807930|NCT00098293|470922427|FG002|Supplemental Phase (SP)|Death|0|||
130807931|NCT00098293|470922428|FG003|Supplemental Phase (SP)|Death|0|||
130807932|NCT00098293|470922429|FG004|Supplemental Phase (SP)|Death|1|||
130807933|NCT00098293|470922425|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
130807934|NCT00098293|470922426|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
130807935|NCT00098293|470922427|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
130807936|NCT00098293|470922428|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
130807937|NCT00098293|470922429|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
130807938|NCT00098293|470922425|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130807939|NCT00098293|470922426|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130807940|NCT00098293|470922427|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130807941|NCT00098293|470922428|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130807942|NCT00098293|470922429|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
130807943|NCT00098293|470922425|FG000|Supplemental Phase (SP)|Other|0|||
130807944|NCT00098293|470922426|FG001|Supplemental Phase (SP)|Other|0|||
130807945|NCT00098293|470922427|FG002|Supplemental Phase (SP)|Other|0|||
130807946|NCT00098293|470922428|FG003|Supplemental Phase (SP)|Other|0|||
130807947|NCT00098293|470922429|FG004|Supplemental Phase (SP)|Other|22|||
130807948|NCT01370642|470922430|FG000|Overall Study|Adverse Event|2|||
130807949|NCT01370642|470922431|FG001|Overall Study|Adverse Event|1|||
130807950|NCT01370642|470922432|FG002|Overall Study|Adverse Event|1|||
130807951|NCT01370642|470922430|FG000|Overall Study|Detectable HCV RNA|0|||
130807952|NCT01370642|470922431|FG001|Overall Study|Detectable HCV RNA|0|||
130807953|NCT01370642|470922432|FG002|Overall Study|Detectable HCV RNA|22|||
130807954|NCT01370642|470922430|FG000|Overall Study|Lost to Follow-up|0|||
130807955|NCT01370642|470922431|FG001|Overall Study|Lost to Follow-up|0|||
130807956|NCT01370642|470922432|FG002|Overall Study|Lost to Follow-up|1|||
130807957|NCT01370642|470922430|FG000|Overall Study|Physician Decision|4|||
130807958|NCT01370642|470922431|FG001|Overall Study|Physician Decision|1|||
130807959|NCT01370642|470922432|FG002|Overall Study|Physician Decision|2|||
130807960|NCT01370642|470922430|FG000|Overall Study|Withdrawal by Subject|2|||
130807961|NCT01370642|470922431|FG001|Overall Study|Withdrawal by Subject|4|||
130807962|NCT01370642|470922432|FG002|Overall Study|Withdrawal by Subject|3|||
130807963|NCT01796470|470922433|FG000|Overall Study|Adverse Event|4|||
130807964|NCT01796470|470922434|FG001|Overall Study|Adverse Event|2|||
130807965|NCT01796470|470922435|FG002|Overall Study|Adverse Event|2|||
130807966|NCT01796470|470922436|FG003|Overall Study|Adverse Event|1|||
130807967|NCT01796470|470922437|FG004|Overall Study|Adverse Event|3|||
130807968|NCT01796470|470922433|FG000|Overall Study|Death|2|||
130807969|NCT01796470|470922434|FG001|Overall Study|Death|0|||
130807970|NCT01796470|470922435|FG002|Overall Study|Death|0|||
130807971|NCT01796470|470922436|FG003|Overall Study|Death|0|||
130807972|NCT01796470|470922437|FG004|Overall Study|Death|1|||
130807973|NCT01796470|470922433|FG000|Overall Study|Initiated New Therapy|9|||
130807974|NCT01796470|470922434|FG001|Overall Study|Initiated New Therapy|0|||
130807975|NCT01796470|470922435|FG002|Overall Study|Initiated New Therapy|0|||
130807976|NCT01796470|470922436|FG003|Overall Study|Initiated New Therapy|0|||
130807977|NCT01796470|470922437|FG004|Overall Study|Initiated New Therapy|2|||
130807978|NCT01796470|470922433|FG000|Overall Study|Lost to Follow-up|0|||
130807979|NCT01796470|470922434|FG001|Overall Study|Lost to Follow-up|1|||
130807980|NCT01796470|470922435|FG002|Overall Study|Lost to Follow-up|0|||
130807981|NCT01796470|470922436|FG003|Overall Study|Lost to Follow-up|0|||
130807982|NCT01796470|470922437|FG004|Overall Study|Lost to Follow-up|0|||
130807983|NCT01796470|470922433|FG000|Overall Study|Physician Decision|5|||
130807984|NCT01796470|470922434|FG001|Overall Study|Physician Decision|4|||
130807985|NCT01796470|470922435|FG002|Overall Study|Physician Decision|1|||
130807986|NCT01796470|470922436|FG003|Overall Study|Physician Decision|0|||
130807987|NCT01796470|470922437|FG004|Overall Study|Physician Decision|1|||
130807988|NCT01796470|470922433|FG000|Overall Study|Progressive Disease|7|||
130807989|NCT01796470|470922434|FG001|Overall Study|Progressive Disease|7|||
130807990|NCT01796470|470922435|FG002|Overall Study|Progressive Disease|3|||
130807991|NCT01796470|470922436|FG003|Overall Study|Progressive Disease|2|||
130807992|NCT01796470|470922437|FG004|Overall Study|Progressive Disease|0|||
130807993|NCT01796470|470922433|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
130807994|NCT01796470|470922434|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
130807995|NCT01796470|470922435|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
130807996|NCT01796470|470922436|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
130807997|NCT01796470|470922437|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
130807998|NCT01796470|470922433|FG000|Overall Study|Withdrawal by Subject|7|||
130807999|NCT01796470|470922434|FG001|Overall Study|Withdrawal by Subject|0|||
130808000|NCT01796470|470922435|FG002|Overall Study|Withdrawal by Subject|0|||
130808001|NCT01796470|470922436|FG003|Overall Study|Withdrawal by Subject|0|||
130808002|NCT01796470|470922437|FG004|Overall Study|Withdrawal by Subject|1|||
130808003|NCT01927861|470922438|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
130808004|NCT01927861|470922439|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
130808005|NCT01927861|470922438|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
130808006|NCT01927861|470922439|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
130808007|NCT00987935|470922440|FG000|Overall Study|Progressive disease|3|||
130808008|NCT00987935|470922441|FG001|Overall Study|Progressive disease|2|||
130808009|NCT00987935|470922442|FG002|Overall Study|Progressive disease|3|||
130808010|NCT00987935|470922443|FG003|Overall Study|Progressive disease|2|||
130808011|NCT00987935|470922444|FG004|Overall Study|Progressive disease|5|||
130808012|NCT00987935|470922445|FG005|Overall Study|Progressive disease|3|||
130808013|NCT00987935|470922446|FG006|Overall Study|Progressive disease|9|||
130808014|NCT00987935|470922447|FG007|Overall Study|Progressive disease|48|||
130808015|NCT00987935|470922448|FG008|Overall Study|Progressive disease|23|||
130808016|NCT00987935|470922440|FG000|Overall Study|Adverse Event|0|||
130808017|NCT00987935|470922441|FG001|Overall Study|Adverse Event|1|||
130808018|NCT00987935|470922442|FG002|Overall Study|Adverse Event|0|||
130808019|NCT00987935|470922443|FG003|Overall Study|Adverse Event|1|||
130808020|NCT00987935|470922444|FG004|Overall Study|Adverse Event|1|||
130808021|NCT00987935|470922445|FG005|Overall Study|Adverse Event|0|||
130808022|NCT00987935|470922446|FG006|Overall Study|Adverse Event|2|||
130808023|NCT00987935|470922447|FG007|Overall Study|Adverse Event|10|||
130808024|NCT00987935|470922448|FG008|Overall Study|Adverse Event|6|||
130808025|NCT00987935|470922440|FG000|Overall Study|Refused to continue taking trial med.|1|||
130808026|NCT00987935|470922441|FG001|Overall Study|Refused to continue taking trial med.|0|||
130808027|NCT00987935|470922442|FG002|Overall Study|Refused to continue taking trial med.|0|||
130808028|NCT00987935|470922443|FG003|Overall Study|Refused to continue taking trial med.|0|||
130808029|NCT00987935|470922444|FG004|Overall Study|Refused to continue taking trial med.|1|||
130808030|NCT00987935|470922445|FG005|Overall Study|Refused to continue taking trial med.|0|||
130808031|NCT00987935|470922446|FG006|Overall Study|Refused to continue taking trial med.|4|||
130808032|NCT00987935|470922447|FG007|Overall Study|Refused to continue taking trial med.|4|||
130808033|NCT00987935|470922448|FG008|Overall Study|Refused to continue taking trial med.|2|||
130808034|NCT00987935|470922440|FG000|Overall Study|Reason other than those specified above|0|||
130808035|NCT00987935|470922441|FG001|Overall Study|Reason other than those specified above|0|||
130808036|NCT00987935|470922442|FG002|Overall Study|Reason other than those specified above|0|||
130808037|NCT00987935|470922443|FG003|Overall Study|Reason other than those specified above|0|||
130808038|NCT00987935|470922444|FG004|Overall Study|Reason other than those specified above|0|||
130808039|NCT00987935|470922445|FG005|Overall Study|Reason other than those specified above|0|||
130808040|NCT00987935|470922446|FG006|Overall Study|Reason other than those specified above|0|||
130808041|NCT00987935|470922447|FG007|Overall Study|Reason other than those specified above|0|||
130808042|NCT00987935|470922448|FG008|Overall Study|Reason other than those specified above|1|||
130808043|NCT02176525|470922449|FG000|Overall Study|Adverse Event|0|||
130808044|NCT02176525|470922450|FG001|Overall Study|Adverse Event|0|||
130808045|NCT02176525|470922451|FG002|Overall Study|Adverse Event|0|||
130808046|NCT02176525|470922452|FG003|Overall Study|Adverse Event|1|||
130808047|NCT02176525|470922453|FG004|Overall Study|Adverse Event|1|||
130808048|NCT02176525|470922454|FG005|Overall Study|Adverse Event|0|||
130808049|NCT02176525|470922455|FG006|Overall Study|Adverse Event|1|||
130808050|NCT02176525|470922456|FG007|Overall Study|Adverse Event|0|||
130808051|NCT02176525|470922449|FG000|Overall Study|not treated|1|||
130808052|NCT02176525|470922450|FG001|Overall Study|not treated|0|||
130808053|NCT02176525|470922451|FG002|Overall Study|not treated|0|||
130808054|NCT02176525|470922452|FG003|Overall Study|not treated|0|||
130808055|NCT02176525|470922453|FG004|Overall Study|not treated|0|||
130808056|NCT02176525|470922454|FG005|Overall Study|not treated|1|||
130808057|NCT02176525|470922455|FG006|Overall Study|not treated|0|||
130808058|NCT02176525|470922456|FG007|Overall Study|not treated|0|||
130808059|NCT01905267|470922457|FG000|Overall Study|Physician Decision|2|||
130808060|NCT01905267|470922458|FG001|Overall Study|Physician Decision|2|||
130808061|NCT02554474|470922459|FG000|Overall Study|Protocol Violation|1|||
130808062|NCT02554474|470922460|FG001|Overall Study|Protocol Violation|1|||
130808063|NCT02554474|470922459|FG000|Overall Study|Health issue not related to the study|1|||
130808064|NCT02554474|470922460|FG001|Overall Study|Health issue not related to the study|0|||
130808065|NCT02554474|470922459|FG000|Overall Study|Withdrawal by Subject|1|||
130808066|NCT02554474|470922460|FG001|Overall Study|Withdrawal by Subject|1|||
130808067|NCT02991859|470922461|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808068|NCT02991859|470922462|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
130808069|NCT02991859|470922463|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808070|NCT02991859|470922464|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808071|NCT02991859|470922465|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
130808072|NCT02991859|470922466|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808073|NCT02991859|470922467|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808074|NCT02991859|470922468|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808075|NCT02991859|470922469|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808076|NCT02991859|470922470|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808077|NCT02991859|470922471|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808078|NCT02991859|470922472|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808079|NCT02991859|470922473|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808080|NCT02991859|470922474|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808081|NCT02991859|470922475|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808082|NCT02991859|470922476|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808083|NCT02991859|470922477|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130808084|NCT02991859|470922461|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808085|NCT02991859|470922462|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808086|NCT02991859|470922463|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808087|NCT02991859|470922464|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808088|NCT02991859|470922465|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808089|NCT02991859|470922466|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808090|NCT02991859|470922467|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808091|NCT02991859|470922468|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808092|NCT02991859|470922469|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808093|NCT02991859|470922470|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808094|NCT02991859|470922471|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808095|NCT02991859|470922472|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808096|NCT02991859|470922473|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
130808097|NCT02991859|470922474|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
130808098|NCT02991859|470922475|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808099|NCT02991859|470922476|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808100|NCT02991859|470922477|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130808101|NCT02991859|470922461|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808102|NCT02991859|470922462|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808103|NCT02991859|470922463|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808104|NCT02991859|470922464|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808105|NCT02991859|470922465|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808106|NCT02991859|470922466|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
130808107|NCT02991859|470922467|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808108|NCT02991859|470922468|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808109|NCT02991859|470922469|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808110|NCT02991859|470922470|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808111|NCT02991859|470922471|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808112|NCT02991859|470922472|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808113|NCT02991859|470922473|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808114|NCT02991859|470922474|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808115|NCT02991859|470922475|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808116|NCT02991859|470922476|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808117|NCT02991859|470922477|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130808118|NCT02991859|470922461|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808119|NCT02991859|470922462|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808120|NCT02991859|470922463|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808121|NCT02991859|470922464|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808122|NCT02991859|470922465|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808123|NCT02991859|470922466|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808124|NCT02991859|470922467|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808125|NCT02991859|470922468|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808126|NCT02991859|470922469|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808127|NCT02991859|470922470|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
130808128|NCT02991859|470922471|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808129|NCT02991859|470922472|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808130|NCT02991859|470922473|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808131|NCT02991859|470922474|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808132|NCT02991859|470922475|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808133|NCT02991859|470922476|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808134|NCT02991859|470922477|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130808135|NCT02991859|470922461|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808136|NCT02991859|470922462|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808137|NCT02991859|470922463|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808138|NCT02991859|470922464|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808139|NCT02991859|470922465|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808140|NCT02991859|470922466|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808141|NCT02991859|470922467|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808142|NCT02991859|470922468|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808143|NCT02991859|470922469|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
130808144|NCT02991859|470922470|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808145|NCT02991859|470922471|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808146|NCT02991859|470922472|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808147|NCT02991859|470922473|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808148|NCT02991859|470922474|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808149|NCT02991859|470922475|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808150|NCT02991859|470922476|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808151|NCT02991859|470922477|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130808152|NCT04223687|470922483|FG000|Overall Study|Missing primary outcome|1|||
130808153|NCT04223687|470922484|FG001|Overall Study|Missing primary outcome|0|||
130808154|NCT00425854|470922485|FG000|Overall Study|Progressive Disease|19|||
130808155|NCT00425854|470922486|FG001|Overall Study|Progressive Disease|12|||
130808156|NCT00425854|470922485|FG000|Overall Study|Dose reduction toxicity AE|8|||
130808157|NCT00425854|470922486|FG001|Overall Study|Dose reduction toxicity AE|7|||
130808158|NCT00425854|470922485|FG000|Overall Study|Other Adverse Event|2|||
130808159|NCT00425854|470922486|FG001|Overall Study|Other Adverse Event|2|||
130808160|NCT01608308|470922489|FG000|Overall Study|pretreatment medical and billing reasons|0|||
130808161|NCT01608308|470922490|FG001|Overall Study|pretreatment medical and billing reasons|2|||
130808162|NCT05652140|470922494|FG000|Overall Study|Lost to Follow-up|7|||
130808163|NCT05652140|470922495|FG001|Overall Study|Lost to Follow-up|16|||
130808164|NCT05652140|470922496|FG002|Overall Study|Lost to Follow-up|22|||
130808165|NCT05652140|470922497|FG003|Overall Study|Lost to Follow-up|31|||
130808166|NCT03163264|470922500|FG000|Overall Study|Withdrawal by Subject|13|||
130808167|NCT03163264|470922501|FG001|Overall Study|Withdrawal by Subject|3|||
130808168|NCT03163264|470922502|FG002|Overall Study|Withdrawal by Subject|4|||
130808169|NCT03163264|470922503|FG003|Overall Study|Withdrawal by Subject|2|||
130808170|NCT03163264|470922500|FG000|Overall Study|Lost to Follow-up|17|||
130808171|NCT03163264|470922501|FG001|Overall Study|Lost to Follow-up|20|||
130808172|NCT03163264|470922502|FG002|Overall Study|Lost to Follow-up|0|||
130808173|NCT03163264|470922503|FG003|Overall Study|Lost to Follow-up|0|||
130808174|NCT03163264|470922500|FG000|Overall Study|Death|0|||
130808175|NCT03163264|470922501|FG001|Overall Study|Death|2|||
130808176|NCT03163264|470922502|FG002|Overall Study|Death|0|||
130808177|NCT03163264|470922503|FG003|Overall Study|Death|0|||
130808178|NCT02614066|470922504|FG000|Overall Study|Death|6|||
130808179|NCT02614066|470922505|FG001|Overall Study|Death|14|||
130808180|NCT02614066|470922506|FG002|Overall Study|Death|11|||
130808181|NCT02614066|470922507|FG003|Overall Study|Death|29|||
130808182|NCT02614066|470922504|FG000|Overall Study|Full consent withdrawn|0|||
130808183|NCT02614066|470922505|FG001|Overall Study|Full consent withdrawn|1|||
130808184|NCT02614066|470922506|FG002|Overall Study|Full consent withdrawn|0|||
130808185|NCT02614066|470922507|FG003|Overall Study|Full consent withdrawn|8|||
130808186|NCT02614066|470922504|FG000|Overall Study|Lost to Follow-up|0|||
130808187|NCT02614066|470922505|FG001|Overall Study|Lost to Follow-up|2|||
130808188|NCT02614066|470922506|FG002|Overall Study|Lost to Follow-up|2|||
130808189|NCT02614066|470922507|FG003|Overall Study|Lost to Follow-up|2|||
130808190|NCT02614066|470922504|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
130808191|NCT02614066|470922505|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
130808192|NCT02614066|470922506|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
130808193|NCT02614066|470922507|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
130808194|NCT02614066|470922504|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
130808195|NCT02614066|470922505|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
130808196|NCT02614066|470922506|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
130808197|NCT02614066|470922507|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
130808198|NCT02614066|470922504|FG000|Overall Study|Reason not specified|0|||
130808199|NCT02614066|470922505|FG001|Overall Study|Reason not specified|2|||
130808200|NCT02614066|470922506|FG002|Overall Study|Reason not specified|1|||
130808201|NCT02614066|470922507|FG003|Overall Study|Reason not specified|1|||
130808202|NCT00236197|470922512|FG000|Overall Study|Withdrawal by Subject|3|||
130808203|NCT00236197|470922513|FG001|Overall Study|Withdrawal by Subject|2|||
130808204|NCT00236197|470922512|FG000|Overall Study|Lost to Follow-up|1|||
130808205|NCT00236197|470922513|FG001|Overall Study|Lost to Follow-up|5|||
130808206|NCT00236197|470922512|FG000|Overall Study|Protocol Violation|0|||
130808207|NCT00236197|470922513|FG001|Overall Study|Protocol Violation|3|||
130808208|NCT00236197|470922512|FG000|Overall Study|Medication non-compliance|1|||
130808209|NCT00236197|470922513|FG001|Overall Study|Medication non-compliance|2|||
130808210|NCT00236197|470922512|FG000|Overall Study|Other|0|||
130808211|NCT00236197|470922513|FG001|Overall Study|Other|2|||
130808212|NCT01052428|470924597|FG000|Overall Study|Death|1|||
130808213|NCT01052428|470924598|FG001|Overall Study|Death|0|||
130808214|NCT01052428|470924597|FG000|Overall Study|Withdrawal by Subject|0|||
130808215|NCT01052428|470924598|FG001|Overall Study|Withdrawal by Subject|1|||
130808216|NCT00871000|470924599|FG000|Overall Study|Withdrawal by Subject|1|||
130808217|NCT00871000|470924600|FG001|Overall Study|Withdrawal by Subject|0|||
130808218|NCT01034657|470924601|FG000|Core Phase|Withdrawal by Subject|1|||
130808219|NCT01034657|470924602|FG001|Core Phase|Withdrawal by Subject|0|||
130808220|NCT01034657|470924603|FG002|Core Phase|Withdrawal by Subject|0|||
130808221|NCT01034657|470924601|FG000|Core Phase|Lack of Efficacy|2|||
130808222|NCT01034657|470924602|FG001|Core Phase|Lack of Efficacy|0|||
130808223|NCT01034657|470924603|FG002|Core Phase|Lack of Efficacy|0|||
130808224|NCT01034657|470924601|FG000|Core Phase|Abnormal laboratory value|1|||
130808225|NCT01034657|470924602|FG001|Core Phase|Abnormal laboratory value|0|||
130808226|NCT01034657|470924603|FG002|Core Phase|Abnormal laboratory value|0|||
130808227|NCT01034657|470924601|FG000|Core Phase|Adverse Event|8|||
130808228|NCT01034657|470924602|FG001|Core Phase|Adverse Event|0|||
130808229|NCT01034657|470924603|FG002|Core Phase|Adverse Event|0|||
130808230|NCT01034657|470924601|FG000|Core Phase|Protocol Violation|2|||
130808231|NCT01034657|470924602|FG001|Core Phase|Protocol Violation|0|||
130808232|NCT01034657|470924603|FG002|Core Phase|Protocol Violation|0|||
130808233|NCT01034657|470924601|FG000|Randomized Phase|Withdrawal by Subject|0|||
130808234|NCT01034657|470924602|FG001|Randomized Phase|Withdrawal by Subject|2|||
130808235|NCT01034657|470924603|FG002|Randomized Phase|Withdrawal by Subject|0|||
130808236|NCT01034657|470924601|FG000|Randomized Phase|Lack of Efficacy|5|||
130808237|NCT01034657|470924602|FG001|Randomized Phase|Lack of Efficacy|1|||
130808238|NCT01034657|470924603|FG002|Randomized Phase|Lack of Efficacy|0|||
130808239|NCT01034657|470924601|FG000|Randomized Phase|Abnormal laboratory value|0|||
130808240|NCT01034657|470924602|FG001|Randomized Phase|Abnormal laboratory value|1|||
130808241|NCT01034657|470924603|FG002|Randomized Phase|Abnormal laboratory value|0|||
130808242|NCT01034657|470924601|FG000|Randomized Phase|Adverse Event|0|||
130808243|NCT01034657|470924602|FG001|Randomized Phase|Adverse Event|2|||
130808244|NCT01034657|470924603|FG002|Randomized Phase|Adverse Event|1|||
130808245|NCT05287685|470924620|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
130808246|NCT05287685|470924621|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
130808247|NCT05287685|470924620|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
130808248|NCT05287685|470924621|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
130808249|NCT04135352|470924622|FG000|Overall Study|Not treated-randomization error|0|||
130808250|NCT04135352|470924623|FG001|Overall Study|Not treated-randomization error|0|||
130808251|NCT04135352|470924624|FG002|Overall Study|Not treated-randomization error|1|||
130808252|NCT04135352|470924625|FG003|Overall Study|Not treated-randomization error|0|||
130808253|NCT04135352|470924626|FG004|Overall Study|Not treated-randomization error|0|||
130808254|NCT04135352|470924627|FG005|Overall Study|Not treated-randomization error|0|||
130808255|NCT04135352|470924628|FG006|Overall Study|Not treated-randomization error|0|||
130808256|NCT04135352|470924629|FG007|Overall Study|Not treated-randomization error|0|||
130808257|NCT04135352|470924622|FG000|Overall Study|Withdrawal by Subject|0|||
130808258|NCT04135352|470924623|FG001|Overall Study|Withdrawal by Subject|0|||
130808259|NCT04135352|470924624|FG002|Overall Study|Withdrawal by Subject|2|||
130808260|NCT04135352|470924625|FG003|Overall Study|Withdrawal by Subject|0|||
130808261|NCT04135352|470924626|FG004|Overall Study|Withdrawal by Subject|0|||
130808262|NCT04135352|470924627|FG005|Overall Study|Withdrawal by Subject|0|||
130808263|NCT04135352|470924628|FG006|Overall Study|Withdrawal by Subject|0|||
130808264|NCT04135352|470924629|FG007|Overall Study|Withdrawal by Subject|0|||
130808265|NCT04135352|470924622|FG000|Overall Study|Sponsor Decision|0|||
130808266|NCT04135352|470924623|FG001|Overall Study|Sponsor Decision|0|||
130808267|NCT04135352|470924624|FG002|Overall Study|Sponsor Decision|2|||
130808268|NCT04135352|470924625|FG003|Overall Study|Sponsor Decision|5|||
130808269|NCT04135352|470924626|FG004|Overall Study|Sponsor Decision|1|||
130808270|NCT04135352|470924627|FG005|Overall Study|Sponsor Decision|4|||
130808271|NCT04135352|470924628|FG006|Overall Study|Sponsor Decision|0|||
130808272|NCT04135352|470924629|FG007|Overall Study|Sponsor Decision|0|||
130808273|NCT04135352|470924622|FG000|Overall Study|Physician Decision|0|||
130808274|NCT04135352|470924623|FG001|Overall Study|Physician Decision|0|||
130808275|NCT04135352|470924624|FG002|Overall Study|Physician Decision|1|||
130808276|NCT04135352|470924625|FG003|Overall Study|Physician Decision|0|||
130808277|NCT04135352|470924626|FG004|Overall Study|Physician Decision|1|||
130808278|NCT04135352|470924627|FG005|Overall Study|Physician Decision|0|||
130808279|NCT04135352|470924628|FG006|Overall Study|Physician Decision|0|||
130808280|NCT04135352|470924629|FG007|Overall Study|Physician Decision|0|||
130808281|NCT04135352|470924622|FG000|Overall Study|Death|3|||
130808282|NCT04135352|470924623|FG001|Overall Study|Death|4|||
130808283|NCT04135352|470924624|FG002|Overall Study|Death|7|||
130808284|NCT04135352|470924625|FG003|Overall Study|Death|0|||
130808285|NCT04135352|470924626|FG004|Overall Study|Death|3|||
130808286|NCT04135352|470924627|FG005|Overall Study|Death|1|||
130808287|NCT04135352|470924628|FG006|Overall Study|Death|0|||
130808288|NCT04135352|470924629|FG007|Overall Study|Death|0|||
130808289|NCT03093870|470924630|FG000|Overall Study|Withdrawal by Subject|2|||
130808290|NCT03093870|470924631|FG001|Overall Study|Withdrawal by Subject|6|||
130808291|NCT03093870|470924632|FG002|Overall Study|Withdrawal by Subject|5|||
130808292|NCT03093870|470924630|FG000|Overall Study|Death|1|||
130808293|NCT03093870|470924631|FG001|Overall Study|Death|35|||
130808294|NCT03093870|470924632|FG002|Overall Study|Death|35|||
130808295|NCT03093870|470924630|FG000|Overall Study|Radiographic disease progression|10|||
130808296|NCT03093870|470924631|FG001|Overall Study|Radiographic disease progression|0|||
130808297|NCT03093870|470924632|FG002|Overall Study|Radiographic disease progression|0|||
130808298|NCT03093870|470924630|FG000|Overall Study|Clinical disease progression|1|||
130808299|NCT03093870|470924631|FG001|Overall Study|Clinical disease progression|0|||
130808300|NCT03093870|470924632|FG002|Overall Study|Clinical disease progression|0|||
130808301|NCT03093870|470924630|FG000|Overall Study|Physician Decision|2|||
130808302|NCT03093870|470924631|FG001|Overall Study|Physician Decision|0|||
130808303|NCT03093870|470924632|FG002|Overall Study|Physician Decision|0|||
130808304|NCT03093870|470924630|FG000|Overall Study|Adverse Event|7|||
130808305|NCT03093870|470924631|FG001|Overall Study|Adverse Event|0|||
130808306|NCT03093870|470924632|FG002|Overall Study|Adverse Event|0|||
130808307|NCT03093870|470924630|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
130808308|NCT03093870|470924631|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
130808309|NCT03093870|470924632|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
130808310|NCT03093870|470924630|FG000|Overall Study|Lost to Follow-up|0|||
130808311|NCT03093870|470924631|FG001|Overall Study|Lost to Follow-up|0|||
130808312|NCT03093870|470924632|FG002|Overall Study|Lost to Follow-up|1|||
130808313|NCT03722030|470924638|FG000|Overall Study|Withdrawal by Subject|1|||
130808314|NCT03722030|470924639|FG001|Overall Study|Withdrawal by Subject|0|||
130808315|NCT02191397|470924641|FG000|Overall Study|Adverse Event|28|||
130808316|NCT02191397|470924642|FG001|Overall Study|Adverse Event|17|||
130808317|NCT02191397|470924641|FG000|Overall Study|Lack of Efficacy|10|||
130808318|NCT02191397|470924642|FG001|Overall Study|Lack of Efficacy|5|||
130808319|NCT02191397|470924641|FG000|Overall Study|Protocol Violation|0|||
130808320|NCT02191397|470924642|FG001|Overall Study|Protocol Violation|3|||
130808321|NCT02191397|470924641|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
130808322|NCT02191397|470924642|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
130808323|NCT02191397|470924641|FG000|Overall Study|Lost to Follow-up|10|||
130808324|NCT02191397|470924642|FG001|Overall Study|Lost to Follow-up|11|||
130808325|NCT02191397|470924641|FG000|Overall Study|Physician Decision|8|||
130808326|NCT02191397|470924642|FG001|Overall Study|Physician Decision|3|||
130808327|NCT02191397|470924641|FG000|Overall Study|Withdrawal by Subject|22|||
130808328|NCT02191397|470924642|FG001|Overall Study|Withdrawal by Subject|27|||
130808329|NCT03888482|470924643|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
130808330|NCT03888482|470924644|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
130808331|NCT03888482|470924643|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
130808332|NCT03888482|470924644|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
130808333|NCT03721107|470924645|FG000|Overall Study|Adverse Event|1|||
130808334|NCT03721107|470924646|FG001|Overall Study|Adverse Event|1|||
130808335|NCT03721107|470924647|FG002|Overall Study|Adverse Event|6|||
130808336|NCT03721107|470924648|FG003|Overall Study|Adverse Event|5|||
130808337|NCT03721107|470924645|FG000|Overall Study|Lost to Follow-up|2|||
130808338|NCT03721107|470924646|FG001|Overall Study|Lost to Follow-up|0|||
130808339|NCT03721107|470924647|FG002|Overall Study|Lost to Follow-up|3|||
130808340|NCT03721107|470924648|FG003|Overall Study|Lost to Follow-up|0|||
130808341|NCT03721107|470924645|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
130808342|NCT03721107|470924646|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
130808343|NCT03721107|470924647|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
130808344|NCT03721107|470924648|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
130808345|NCT03721107|470924645|FG000|Overall Study|Physician Decision|0|||
130808346|NCT03721107|470924646|FG001|Overall Study|Physician Decision|1|||
130808347|NCT03721107|470924647|FG002|Overall Study|Physician Decision|0|||
130808348|NCT03721107|470924648|FG003|Overall Study|Physician Decision|0|||
130808349|NCT03721107|470924645|FG000|Overall Study|Pregnancy|0|||
130808350|NCT03721107|470924646|FG001|Overall Study|Pregnancy|0|||
130808351|NCT03721107|470924647|FG002|Overall Study|Pregnancy|1|||
130808352|NCT03721107|470924648|FG003|Overall Study|Pregnancy|0|||
130808353|NCT03721107|470924645|FG000|Overall Study|Withdrawal by Subject|1|||
130808354|NCT03721107|470924646|FG001|Overall Study|Withdrawal by Subject|1|||
130808355|NCT03721107|470924647|FG002|Overall Study|Withdrawal by Subject|5|||
130808356|NCT03721107|470924648|FG003|Overall Study|Withdrawal by Subject|5|||
130808357|NCT03721107|470924645|FG000|Overall Study|Other|1|||
130808358|NCT03721107|470924646|FG001|Overall Study|Other|0|||
130808359|NCT03721107|470924647|FG002|Overall Study|Other|0|||
130808360|NCT03721107|470924648|FG003|Overall Study|Other|1|||
130808361|NCT01602666|470924649|FG000|Induction Chemotherapy|Death|2|||
130808362|NCT01602666|470924650|FG001|Induction Chemotherapy|Death|1|||
130808363|NCT01602666|470924649|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
130808364|NCT01602666|470924650|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
130808365|NCT01602666|470924649|FG000|Induction Chemotherapy|Physician Decision|12|||
130808366|NCT01602666|470924650|FG001|Induction Chemotherapy|Physician Decision|5|||
130808367|NCT01602666|470924649|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
130808368|NCT01602666|470924650|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
130808369|NCT01602666|470924649|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
130808370|NCT01602666|470924650|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
130808371|NCT01602666|470924649|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
130808372|NCT01602666|470924650|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
130808373|NCT01602666|470924649|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
130808374|NCT01602666|470924650|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
130808375|NCT01602666|470924649|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
130808376|NCT01602666|470924650|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
130808377|NCT01602666|470924649|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
130808378|NCT01602666|470924650|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
130808379|NCT01602666|470924649|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
130808380|NCT01602666|470924650|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
130808381|NCT01602666|470924649|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
130808382|NCT01602666|470924650|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
130808383|NCT00215657|470924655|FG000|Overall Study|Adverse Event|5|||
130808384|NCT00215657|470924656|FG001|Overall Study|Adverse Event|1|||
130808385|NCT00215657|470924657|FG002|Overall Study|Adverse Event|3|||
130808386|NCT00215657|470924658|FG003|Overall Study|Adverse Event|0|||
130808387|NCT00215657|470924659|FG004|Overall Study|Adverse Event|3|||
130808388|NCT00215657|470924660|FG005|Overall Study|Adverse Event|1|||
130808389|NCT00215657|470924661|FG006|Overall Study|Adverse Event|0|||
130808390|NCT00215657|470924662|FG007|Overall Study|Adverse Event|3|||
130808391|NCT00215657|470924655|FG000|Overall Study|Withdrawal by Subject|6|||
130808392|NCT00215657|470924656|FG001|Overall Study|Withdrawal by Subject|3|||
130808393|NCT00215657|470924657|FG002|Overall Study|Withdrawal by Subject|3|||
130808394|NCT00215657|470924658|FG003|Overall Study|Withdrawal by Subject|1|||
130808395|NCT00215657|470924659|FG004|Overall Study|Withdrawal by Subject|6|||
130808396|NCT00215657|470924660|FG005|Overall Study|Withdrawal by Subject|1|||
130808397|NCT00215657|470924661|FG006|Overall Study|Withdrawal by Subject|10|||
130808398|NCT00215657|470924662|FG007|Overall Study|Withdrawal by Subject|3|||
130808399|NCT00215657|470924655|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
130808400|NCT00215657|470924656|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
130808401|NCT00215657|470924657|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
130808402|NCT00215657|470924658|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
130808403|NCT00215657|470924659|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
130808404|NCT00215657|470924660|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
130808405|NCT00215657|470924661|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
130808406|NCT00215657|470924662|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
130808407|NCT00215657|470924655|FG000|Overall Study|Insufficient testosterone response|5|||
130808408|NCT00215657|470924656|FG001|Overall Study|Insufficient testosterone response|4|||
130808409|NCT00215657|470924657|FG002|Overall Study|Insufficient testosterone response|1|||
130808410|NCT00215657|470924658|FG003|Overall Study|Insufficient testosterone response|12|||
130808411|NCT00215657|470924659|FG004|Overall Study|Insufficient testosterone response|8|||
130808412|NCT00215657|470924660|FG005|Overall Study|Insufficient testosterone response|12|||
130808413|NCT00215657|470924661|FG006|Overall Study|Insufficient testosterone response|4|||
130808414|NCT00215657|470924662|FG007|Overall Study|Insufficient testosterone response|7|||
130808415|NCT00215657|470924655|FG000|Overall Study|Other|3|||
130808416|NCT00215657|470924656|FG001|Overall Study|Other|1|||
130808417|NCT00215657|470924657|FG002|Overall Study|Other|2|||
130808418|NCT00215657|470924658|FG003|Overall Study|Other|3|||
130808419|NCT00215657|470924659|FG004|Overall Study|Other|5|||
130808420|NCT00215657|470924660|FG005|Overall Study|Other|4|||
130808421|NCT00215657|470924661|FG006|Overall Study|Other|6|||
130808422|NCT00215657|470924662|FG007|Overall Study|Other|1|||
130808423|NCT03769467|470924663|FG000|Overall Study|Adverse Event|1|||
130808424|NCT03769467|470924664|FG001|Overall Study|Adverse Event|1|||
130808425|NCT03769467|470924665|FG002|Overall Study|Adverse Event|0|||
130808426|NCT03769467|470924663|FG000|Overall Study|Death|3|||
130808427|NCT03769467|470924664|FG001|Overall Study|Death|3|||
130808428|NCT03769467|470924665|FG002|Overall Study|Death|0|||
130808429|NCT03769467|470924663|FG000|Overall Study|Study Terminated By Sponsor|2|||
130808430|NCT03769467|470924664|FG001|Overall Study|Study Terminated By Sponsor|1|||
130808431|NCT03769467|470924665|FG002|Overall Study|Study Terminated By Sponsor|0|||
130808432|NCT03769467|470924663|FG000|Overall Study|Withdrawal by Subject|0|||
130808433|NCT03769467|470924664|FG001|Overall Study|Withdrawal by Subject|1|||
130808434|NCT03769467|470924665|FG002|Overall Study|Withdrawal by Subject|0|||
130808435|NCT04754399|470924666|FG000|Overall Study|Adverse Event|5|||
130808436|NCT04754399|470924666|FG000|Overall Study|Withdrawal by Subject|6|||
130808437|NCT04565756|470924667|FG000|Overall Study|Withdrawal by Subject|0|||
130808438|NCT04565756|470924668|FG001|Overall Study|Withdrawal by Subject|0|||
130808439|NCT04565756|470924669|FG002|Overall Study|Withdrawal by Subject|0|||
130808440|NCT04565756|470924670|FG003|Overall Study|Withdrawal by Subject|0|||
130808441|NCT04565756|470924671|FG004|Overall Study|Withdrawal by Subject|1|||
130808442|NCT04565756|470924672|FG005|Overall Study|Withdrawal by Subject|0|||
130808443|NCT04565756|470924667|FG000|Overall Study|Protocol Violation|0|||
130808444|NCT04565756|470924668|FG001|Overall Study|Protocol Violation|0|||
130808445|NCT04565756|470924669|FG002|Overall Study|Protocol Violation|0|||
130808446|NCT04565756|470924670|FG003|Overall Study|Protocol Violation|0|||
130808447|NCT04565756|470924671|FG004|Overall Study|Protocol Violation|0|||
130808448|NCT04565756|470924672|FG005|Overall Study|Protocol Violation|1|||
130808449|NCT05259722|470924681|FG000|Overall Study|Adverse Event|2|||
130808450|NCT05259722|470924682|FG001|Overall Study|Adverse Event|24|||
130808451|NCT05259722|470924681|FG000|Overall Study|Lost to Follow-up|5|||
130808452|NCT05259722|470924682|FG001|Overall Study|Lost to Follow-up|1|||
130808453|NCT05259722|470924681|FG000|Overall Study|Lack of Efficacy|8|||
130808454|NCT05259722|470924682|FG001|Overall Study|Lack of Efficacy|26|||
130808455|NCT05259722|470924681|FG000|Overall Study|Withdrawal by Subject|15|||
130808456|NCT05259722|470924682|FG001|Overall Study|Withdrawal by Subject|33|||
130808457|NCT05259722|470924681|FG000|Overall Study|Various reasons|3|||
130808458|NCT05259722|470924682|FG001|Overall Study|Various reasons|9|||
130808459|NCT05259722|470924681|FG000|Overall Study|Not exposed to IMP|1|||
130808460|NCT05259722|470924682|FG001|Overall Study|Not exposed to IMP|12|||
130808461|NCT05259722|470924681|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
130808462|NCT05259722|470924682|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
130808463|NCT00962650|470924683|FG000|Overall Study|Transgastric DP was not completed|2|||
130808464|NCT00231465|470924685|FG000|Overall Study|Completed only one cycle|1|||
130808465|NCT00231465|470924685|FG000|Overall Study|Did not have follow up CT scans|1|||
130808466|NCT00968968|470924686|FG000|Overall Study|Study closed/terminated|10|||
130808467|NCT00968968|470924687|FG001|Overall Study|Study closed/terminated|10|||
130808468|NCT00968968|470924686|FG000|Overall Study|Protocol defined stopping criteria|3|||
130808469|NCT00968968|470924687|FG001|Overall Study|Protocol defined stopping criteria|1|||
130808470|NCT00968968|470924686|FG000|Overall Study|Withdrawal by Subject|2|||
130808471|NCT00968968|470924687|FG001|Overall Study|Withdrawal by Subject|0|||
130808472|NCT00968968|470924686|FG000|Overall Study|Physician Decision|1|||
130808473|NCT00968968|470924687|FG001|Overall Study|Physician Decision|2|||
130808474|NCT00968968|470924686|FG000|Overall Study|Lost to Follow-up|0|||
130808475|NCT00968968|470924687|FG001|Overall Study|Lost to Follow-up|1|||
130808476|NCT03624036|470924688|FG000|Overall Study|Death|2|||
130808477|NCT03624036|470924689|FG001|Overall Study|Death|3|||
130808478|NCT03624036|470924690|FG002|Overall Study|Death|0|||
130808479|NCT03624036|470924691|FG003|Overall Study|Death|1|||
130808480|NCT03624036|470924688|FG000|Overall Study|Withdrawal by Subject|1|||
130808481|NCT03624036|470924689|FG001|Overall Study|Withdrawal by Subject|0|||
130808482|NCT03624036|470924690|FG002|Overall Study|Withdrawal by Subject|1|||
130808483|NCT03624036|470924691|FG003|Overall Study|Withdrawal by Subject|0|||
130808484|NCT03624036|470924688|FG000|Overall Study|Enrolled but Never Treated|1|||
130808485|NCT03624036|470924689|FG001|Overall Study|Enrolled but Never Treated|0|||
130808486|NCT03624036|470924690|FG002|Overall Study|Enrolled but Never Treated|0|||
130808487|NCT03624036|470924691|FG003|Overall Study|Enrolled but Never Treated|0|||
130808488|NCT03624036|470924688|FG000|Overall Study|Reason not Specified|3|||
130808489|NCT03624036|470924689|FG001|Overall Study|Reason not Specified|0|||
130808490|NCT03624036|470924690|FG002|Overall Study|Reason not Specified|2|||
130808491|NCT03624036|470924691|FG003|Overall Study|Reason not Specified|2|||
130808492|NCT01185366|470924692|FG000|First Line Therapy|Insurance Coverage Denied|1|||
130808493|NCT01185366|470924693|FG001|First Line Therapy|Insurance Coverage Denied|1|||
130808494|NCT01185366|470924692|FG000|First Line Therapy|Withdrawal by Subject|1|||
130808495|NCT01185366|470924693|FG001|First Line Therapy|Withdrawal by Subject|0|||
130808496|NCT01185366|470924692|FG000|First Line Therapy|Lack of Metastatic Site|1|||
130808497|NCT01185366|470924693|FG001|First Line Therapy|Lack of Metastatic Site|0|||
130808498|NCT01185366|470924692|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
130808499|NCT01185366|470924693|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
130808500|NCT01185366|470924692|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
130808501|NCT01185366|470924693|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
130808502|NCT01185366|470924692|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
130808503|NCT01185366|470924693|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
130808504|NCT01185366|470924692|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
130808505|NCT01185366|470924693|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
130808506|NCT02774278|470924698|FG000|Overall Study|Lack of Efficacy|199|||
130808507|NCT02774278|470924698|FG000|Overall Study|Death|29|||
130808508|NCT02774278|470924698|FG000|Overall Study|Adverse event/intercurrent illness|16|||
130808509|NCT02774278|470924698|FG000|Overall Study|Refused treatment/did not cooperate|9|||
130808510|NCT02774278|470924698|FG000|Overall Study|Administrative reasons|6|||
130808511|NCT02774278|470924698|FG000|Overall Study|Withdrawal by Subject|3|||
130808512|NCT02774278|470924698|FG000|Overall Study|Protocol Violation|2|||
130808513|NCT00127933|470924701|FG000|Overall Study|Randomized but not dosed|1|||
130808514|NCT00127933|470924702|FG001|Overall Study|Randomized but not dosed|0|||
130808515|NCT01783938|470924708|FG000|Overall Study|Disease Progression|18|||
130808516|NCT01783938|470924709|FG001|Overall Study|Disease Progression|41|||
130808517|NCT01783938|470924708|FG000|Overall Study|Study Drug Toxicity|27|||
130808518|NCT01783938|470924709|FG001|Overall Study|Study Drug Toxicity|14|||
130808519|NCT01783938|470924708|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
130808520|NCT01783938|470924709|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
130808521|NCT01783938|470924708|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
130808522|NCT01783938|470924709|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
130808523|NCT01783938|470924708|FG000|Overall Study|Participant Withdrew Consent|2|||
130808524|NCT01783938|470924709|FG001|Overall Study|Participant Withdrew Consent|0|||
130808525|NCT01783938|470924708|FG000|Overall Study|Maximum Clinical Benefit|1|||
130808526|NCT01783938|470924709|FG001|Overall Study|Maximum Clinical Benefit|0|||
130808527|NCT01783938|470924708|FG000|Overall Study|Other Reasons|3|||
130808528|NCT01783938|470924709|FG001|Overall Study|Other Reasons|1|||
130808529|NCT00498485|470924711|FG000|Overall Study|Adverse Event|1|||
130808530|NCT00498485|470924712|FG001|Overall Study|Adverse Event|5|||
130808531|NCT00930176|470924713|FG000|Overall Study|Death|1|||
130808532|NCT03072875|470924714|FG000|Overall Study|Lost to Follow-up|1|||
130808533|NCT03478787|470924715|FG000|Overall Study|Adverse Event|5|||
130808534|NCT03478787|470924716|FG001|Overall Study|Adverse Event|1|||
130808535|NCT03478787|470924715|FG000|Overall Study|Protocol Violation|3|||
130808536|NCT03478787|470924716|FG001|Overall Study|Protocol Violation|0|||
130808537|NCT03478787|470924715|FG000|Overall Study|Lack of Efficacy|7|||
130808538|NCT03478787|470924716|FG001|Overall Study|Lack of Efficacy|1|||
130808539|NCT03478787|470924715|FG000|Overall Study|Lost to Follow-up|9|||
130808540|NCT03478787|470924716|FG001|Overall Study|Lost to Follow-up|5|||
130808541|NCT03478787|470924715|FG000|Overall Study|Withdrawal by Subject|2|||
130808542|NCT03478787|470924716|FG001|Overall Study|Withdrawal by Subject|6|||
130808543|NCT03478787|470924715|FG000|Overall Study|Other, Not Specified|3|||
130808544|NCT03478787|470924716|FG001|Overall Study|Other, Not Specified|0|||
130808545|NCT01539525|470924718|FG000|Overall Study|Lost to Follow-up|19|||
130808546|NCT01539525|470924719|FG001|Overall Study|Lost to Follow-up|12|||
130808547|NCT01539525|470924720|FG002|Overall Study|Lost to Follow-up|11|||
130808548|NCT01539525|470924718|FG000|Overall Study|Withdrawal by Subject|0|||
130808549|NCT01539525|470924719|FG001|Overall Study|Withdrawal by Subject|3|||
130808550|NCT01539525|470924720|FG002|Overall Study|Withdrawal by Subject|2|||
130808551|NCT01539525|470924718|FG000|Overall Study|Protocol Violation|1|||
130808552|NCT01539525|470924719|FG001|Overall Study|Protocol Violation|1|||
130808553|NCT01539525|470924720|FG002|Overall Study|Protocol Violation|4|||
130808554|NCT01712074|470924721|FG000|Placebo Run-in Period|Adverse Event|2|||
130808555|NCT01712074|470924722|FG001|Placebo Run-in Period|Adverse Event|0|||
130808556|NCT01712074|470924723|FG002|Placebo Run-in Period|Adverse Event|0|||
130808557|NCT01712074|470924721|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
130808558|NCT01712074|470924722|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
130808559|NCT01712074|470924723|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
130808560|NCT01712074|470924721|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
130808561|NCT01712074|470924722|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
130808562|NCT01712074|470924723|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
130808563|NCT01712074|470924721|FG000|Placebo Run-in Period|Other|1|||
130808564|NCT01712074|470924722|FG001|Placebo Run-in Period|Other|0|||
130808565|NCT01712074|470924723|FG002|Placebo Run-in Period|Other|0|||
130808566|NCT01712074|470924721|FG000|Placebo Run-in Period|No longer willing to participate|1|||
130808567|NCT01712074|470924722|FG001|Placebo Run-in Period|No longer willing to participate|0|||
130808568|NCT01712074|470924723|FG002|Placebo Run-in Period|No longer willing to participate|0|||
130808569|NCT01712074|470924721|FG000|Double Blind Period|Adverse Event|0|||
130808570|NCT01712074|470924722|FG001|Double Blind Period|Adverse Event|2|||
130808571|NCT01712074|470924723|FG002|Double Blind Period|Adverse Event|1|||
130808572|NCT01712074|470924721|FG000|Double Blind Period|No longer willing to participate|0|||
130808573|NCT01712074|470924722|FG001|Double Blind Period|No longer willing to participate|2|||
130808574|NCT01712074|470924723|FG002|Double Blind Period|No longer willing to participate|4|||
130808575|NCT01712074|470924721|FG000|Double Blind Period|Death|0|||
130808576|NCT01712074|470924722|FG001|Double Blind Period|Death|1|||
130808577|NCT01712074|470924723|FG002|Double Blind Period|Death|0|||
130808578|NCT01712074|470924721|FG000|Double Blind Period|Lost to Follow-up|0|||
130808579|NCT01712074|470924722|FG001|Double Blind Period|Lost to Follow-up|2|||
130808580|NCT01712074|470924723|FG002|Double Blind Period|Lost to Follow-up|1|||
130808581|NCT01712074|470924721|FG000|Double Blind Period|Other|0|||
130808582|NCT01712074|470924722|FG001|Double Blind Period|Other|4|||
130808583|NCT01712074|470924723|FG002|Double Blind Period|Other|1|||
130808584|NCT01712074|470924721|FG000|Double Blind Period|Protocol Violation|0|||
130808585|NCT01712074|470924722|FG001|Double Blind Period|Protocol Violation|0|||
130808586|NCT01712074|470924723|FG002|Double Blind Period|Protocol Violation|1|||
130808587|NCT01712074|470924721|FG000|Double Blind Period|No longer met eligibility criteria|0|||
130808588|NCT01712074|470924722|FG001|Double Blind Period|No longer met eligibility criteria|3|||
130808589|NCT01712074|470924723|FG002|Double Blind Period|No longer met eligibility criteria|0|||
130808590|NCT02268851|470924724|FG000|Overall Study|Death|0|||
130808591|NCT02268851|470924725|FG001|Overall Study|Death|0|||
130808592|NCT02268851|470924726|FG002|Overall Study|Death|0|||
130808593|NCT02268851|470924727|FG003|Overall Study|Death|1|||
130808594|NCT02268851|470924728|FG004|Overall Study|Death|2|||
130808595|NCT02268851|470924729|FG005|Overall Study|Death|1|||
130808596|NCT02268851|470924724|FG000|Overall Study|Adverse Event|0|||
130808597|NCT02268851|470924725|FG001|Overall Study|Adverse Event|0|||
130808598|NCT02268851|470924726|FG002|Overall Study|Adverse Event|0|||
130808599|NCT02268851|470924727|FG003|Overall Study|Adverse Event|0|||
130808600|NCT02268851|470924728|FG004|Overall Study|Adverse Event|2|||
130808601|NCT02268851|470924729|FG005|Overall Study|Adverse Event|2|||
130808602|NCT02268851|470924724|FG000|Overall Study|Withdrawal by Subject|0|||
130808603|NCT02268851|470924725|FG001|Overall Study|Withdrawal by Subject|0|||
130808604|NCT02268851|470924726|FG002|Overall Study|Withdrawal by Subject|0|||
130808605|NCT02268851|470924727|FG003|Overall Study|Withdrawal by Subject|2|||
130808606|NCT02268851|470924728|FG004|Overall Study|Withdrawal by Subject|0|||
130808607|NCT02268851|470924729|FG005|Overall Study|Withdrawal by Subject|1|||
130808608|NCT02268851|470924724|FG000|Overall Study|Progressive Disease|1|||
130808609|NCT02268851|470924725|FG001|Overall Study|Progressive Disease|3|||
130808610|NCT02268851|470924726|FG002|Overall Study|Progressive Disease|0|||
130808611|NCT02268851|470924727|FG003|Overall Study|Progressive Disease|0|||
130808612|NCT02268851|470924728|FG004|Overall Study|Progressive Disease|1|||
130808613|NCT02268851|470924729|FG005|Overall Study|Progressive Disease|4|||
130808614|NCT02268851|470924724|FG000|Overall Study|Physician Decision|0|||
130808615|NCT02268851|470924725|FG001|Overall Study|Physician Decision|0|||
130808616|NCT02268851|470924726|FG002|Overall Study|Physician Decision|1|||
130808617|NCT02268851|470924727|FG003|Overall Study|Physician Decision|0|||
130808618|NCT02268851|470924728|FG004|Overall Study|Physician Decision|0|||
130808619|NCT02268851|470924729|FG005|Overall Study|Physician Decision|1|||
130808620|NCT02268851|470924724|FG000|Overall Study|Patient Compliance|0|||
130808621|NCT02268851|470924725|FG001|Overall Study|Patient Compliance|0|||
130808622|NCT02268851|470924726|FG002|Overall Study|Patient Compliance|0|||
130808623|NCT02268851|470924727|FG003|Overall Study|Patient Compliance|0|||
130808624|NCT02268851|470924728|FG004|Overall Study|Patient Compliance|1|||
130808625|NCT02268851|470924729|FG005|Overall Study|Patient Compliance|1|||
130808626|NCT02268851|470924724|FG000|Overall Study|Co-Morbid Condition|0|||
130808627|NCT02268851|470924725|FG001|Overall Study|Co-Morbid Condition|0|||
130808628|NCT02268851|470924726|FG002|Overall Study|Co-Morbid Condition|0|||
130808629|NCT02268851|470924727|FG003|Overall Study|Co-Morbid Condition|0|||
130808630|NCT02268851|470924728|FG004|Overall Study|Co-Morbid Condition|1|||
130808631|NCT02268851|470924729|FG005|Overall Study|Co-Morbid Condition|1|||
130808632|NCT02413346|470924732|FG000|Overall Study|Adverse Event|6|||
130808633|NCT02413346|470924733|FG001|Overall Study|Adverse Event|6|||
130808634|NCT02413346|470924732|FG000|Overall Study|Withdrawal by Subject|30|||
130808635|NCT02413346|470924733|FG001|Overall Study|Withdrawal by Subject|40|||
130808636|NCT02413346|470924732|FG000|Overall Study|Lost to Follow-up|17|||
130808637|NCT02413346|470924733|FG001|Overall Study|Lost to Follow-up|21|||
130808638|NCT02413346|470924732|FG000|Overall Study|Protocol Violation|2|||
130808639|NCT02413346|470924733|FG001|Overall Study|Protocol Violation|0|||
130808640|NCT02413346|470924732|FG000|Overall Study|Other Miscellaneous Reasons|4|||
130808641|NCT02413346|470924733|FG001|Overall Study|Other Miscellaneous Reasons|3|||
130808642|NCT01472835|470924734|FG000|Overall Study|Lost to Follow-up|2|||
130808643|NCT01472835|470924735|FG001|Overall Study|Lost to Follow-up|0|||
130808644|NCT02539394|470924736|FG000|Overall Study|Protocol Violation|1|||
130808645|NCT02539394|470924737|FG001|Overall Study|Protocol Violation|3|||
130808646|NCT02539394|470924736|FG000|Overall Study|Lost to Follow-up|1|||
130808647|NCT02539394|470924737|FG001|Overall Study|Lost to Follow-up|2|||
130808648|NCT02539394|470924736|FG000|Overall Study|Incomplete dataset|6|||
130808649|NCT02539394|470924737|FG001|Overall Study|Incomplete dataset|6|||
130808650|NCT02205359|470924755|FG000|Overall Study|Death|293|||
130808651|NCT02205359|470924756|FG001|Overall Study|Death|327|||
130808652|NCT02205359|470924755|FG000|Overall Study|Lost to Follow-up|182|||
130808653|NCT02205359|470924756|FG001|Overall Study|Lost to Follow-up|162|||
130808654|NCT02205359|470924755|FG000|Overall Study|Physician Decision|51|||
130808655|NCT02205359|470924756|FG001|Overall Study|Physician Decision|53|||
130808656|NCT02205359|470924755|FG000|Overall Study|Withdrawal by Subject|167|||
130808657|NCT02205359|470924756|FG001|Overall Study|Withdrawal by Subject|169|||
130808658|NCT02792257|470924765|FG000|Overall Study|Lost to Follow-up|3|||
130808659|NCT02792257|470924766|FG001|Overall Study|Lost to Follow-up|4|||
130808660|NCT02792257|470924765|FG000|Overall Study|Allergy|0|||
130808661|NCT02792257|470924766|FG001|Overall Study|Allergy|1|||
130808662|NCT02792257|470924765|FG000|Overall Study|Protocol Violation|2|||
130808663|NCT02792257|470924766|FG001|Overall Study|Protocol Violation|0|||
130808664|NCT02792257|470924765|FG000|Overall Study|Excessive Agitation|0|||
130808665|NCT02792257|470924766|FG001|Overall Study|Excessive Agitation|1|||
130808666|NCT02792257|470924765|FG000|Overall Study|Not Feeling Well|0|||
130808667|NCT02792257|470924766|FG001|Overall Study|Not Feeling Well|1|||
130808668|NCT00553475|470924767|FG000|Overall Study|Adverse Event|7|||
130808669|NCT00553475|470924768|FG001|Overall Study|Adverse Event|17|||
130808670|NCT00553475|470924769|FG002|Overall Study|Adverse Event|13|||
130808671|NCT00553475|470924767|FG000|Overall Study|Lack of Efficacy|7|||
130808672|NCT00553475|470924768|FG001|Overall Study|Lack of Efficacy|1|||
130808673|NCT00553475|470924769|FG002|Overall Study|Lack of Efficacy|0|||
130808674|NCT00553475|470924767|FG000|Overall Study|Withdrawal by Subject|1|||
130808675|NCT00553475|470924768|FG001|Overall Study|Withdrawal by Subject|1|||
130808676|NCT00553475|470924769|FG002|Overall Study|Withdrawal by Subject|0|||
130808677|NCT00553475|470924767|FG000|Overall Study|Physician Decision|1|||
130808678|NCT00553475|470924768|FG001|Overall Study|Physician Decision|0|||
130808679|NCT00553475|470924769|FG002|Overall Study|Physician Decision|0|||
130808680|NCT00553475|470924767|FG000|Overall Study|Due to moving|0|||
130808681|NCT00553475|470924768|FG001|Overall Study|Due to moving|1|||
130808682|NCT00553475|470924769|FG002|Overall Study|Due to moving|0|||
130808683|NCT00954538|470924770|FG000|Part III|Withdrawal by Subject|0|||
130808684|NCT00954538|470924771|FG001|Part III|Withdrawal by Subject|0|||
130808685|NCT00954538|470924772|FG002|Part III|Withdrawal by Subject|0|||
130808686|NCT00954538|470924773|FG003|Part III|Withdrawal by Subject|0|||
130808687|NCT00954538|470924774|FG004|Part III|Withdrawal by Subject|1|||
130808688|NCT00954538|470924775|FG005|Part III|Withdrawal by Subject|0|||
130808689|NCT01905683|470924778|FG000|Overall Study|Protocol Violation|1|||
130808690|NCT01905683|470924778|FG000|Overall Study|Re-injection criteria not met; others|13|||
130808691|NCT01905683|470924778|FG000|Overall Study|Physician Decision|1|||
130808692|NCT01905683|470924778|FG000|Overall Study|Lack of Efficacy|8|||
130808693|NCT01905683|470924778|FG000|Overall Study|Withdrawal by Subject|20|||
130808694|NCT01905683|470924778|FG000|Overall Study|Adverse Event|4|||
130808695|NCT01905683|470924778|FG000|Overall Study|Lost to Follow-up|4|||
130808696|NCT00992394|470924779|FG000|Overall Study|Lack of Efficacy|6|||
130808697|NCT00992394|470924780|FG001|Overall Study|Lack of Efficacy|3|||
130808698|NCT00992394|470924779|FG000|Overall Study|Adverse Event|4|||
130808699|NCT00992394|470924780|FG001|Overall Study|Adverse Event|5|||
130808700|NCT00992394|470924779|FG000|Overall Study|Withdrawal by Subject|8|||
130808701|NCT00992394|470924780|FG001|Overall Study|Withdrawal by Subject|2|||
130808702|NCT00992394|470924779|FG000|Overall Study|Physician Decision|1|||
130808703|NCT00992394|470924780|FG001|Overall Study|Physician Decision|0|||
130808704|NCT00992394|470924779|FG000|Overall Study|Protocol Violation|2|||
130808705|NCT00992394|470924780|FG001|Overall Study|Protocol Violation|4|||
130808706|NCT00992394|470924779|FG000|Overall Study|Lost to Follow-up|2|||
130808707|NCT00992394|470924780|FG001|Overall Study|Lost to Follow-up|0|||
130808708|NCT00992394|470924779|FG000|Overall Study|Other event|1|||
130808709|NCT00992394|470924780|FG001|Overall Study|Other event|0|||
130808710|NCT00537082|470924783|FG000|Overall Study|Adverse Event|6|||
130808711|NCT00537082|470924784|FG001|Overall Study|Adverse Event|6|||
130808712|NCT00537082|470924785|FG002|Overall Study|Adverse Event|3|||
130808713|NCT00537082|470924783|FG000|Overall Study|Protocol Violation|0|||
130808714|NCT00537082|470924784|FG001|Overall Study|Protocol Violation|2|||
130808715|NCT00537082|470924785|FG002|Overall Study|Protocol Violation|1|||
130808716|NCT00537082|470924783|FG000|Overall Study|Lack of Efficacy|0|||
130808717|NCT00537082|470924784|FG001|Overall Study|Lack of Efficacy|0|||
130808718|NCT00537082|470924785|FG002|Overall Study|Lack of Efficacy|2|||
130808719|NCT00537082|470924783|FG000|Overall Study|Withdrawal by Subject|0|||
130808720|NCT00537082|470924784|FG001|Overall Study|Withdrawal by Subject|1|||
130808721|NCT00537082|470924785|FG002|Overall Study|Withdrawal by Subject|0|||
130808722|NCT00537082|470924783|FG000|Overall Study|Discontinued before initiating treatment|3|||
130808723|NCT00537082|470924784|FG001|Overall Study|Discontinued before initiating treatment|0|||
130808724|NCT00537082|470924785|FG002|Overall Study|Discontinued before initiating treatment|0|||
130808725|NCT02568254|470924787|FG000|Period 2|Adverse Event|0|||
130808726|NCT02568254|470924788|FG001|Period 2|Adverse Event|0|||
130808727|NCT02568254|470924789|FG002|Period 2|Adverse Event|1|||
130808728|NCT02568254|470924790|FG003|Period 2|Adverse Event|0|||
130808729|NCT02568254|470924791|FG004|Period 2|Adverse Event|0|||
130808730|NCT02568254|470924792|FG005|Period 2|Adverse Event|0|||
130808731|NCT02568254|470924787|FG000|Period 3|Unstatisfactory Lens fitting|0|||
130808732|NCT02568254|470924788|FG001|Period 3|Unstatisfactory Lens fitting|0|||
130808733|NCT02568254|470924789|FG002|Period 3|Unstatisfactory Lens fitting|0|||
130808734|NCT02568254|470924790|FG003|Period 3|Unstatisfactory Lens fitting|0|||
130808735|NCT02568254|470924791|FG004|Period 3|Unstatisfactory Lens fitting|1|||
130808736|NCT02568254|470924792|FG005|Period 3|Unstatisfactory Lens fitting|0|||
130808737|NCT00655746|470924793|FG000|Overall Study|Withdrawal by Subject|1|||
130808738|NCT02931539|470924794|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
130808739|NCT02931539|470924795|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
130808740|NCT02931539|470924796|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
130808741|NCT02931539|470924794|FG000|Period 1: Treatment Phase|Adverse Event|5|||
130808742|NCT02931539|470924795|FG001|Period 1: Treatment Phase|Adverse Event|1|||
130808743|NCT02931539|470924796|FG002|Period 1: Treatment Phase|Adverse Event|0|||
130808744|NCT02931539|470924794|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
130808745|NCT02931539|470924795|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
130808746|NCT02931539|470924796|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
130808747|NCT02931539|470924794|FG000|Period 1: Treatment Phase|Death|8|||
130808748|NCT02931539|470924795|FG001|Period 1: Treatment Phase|Death|24|||
130808749|NCT02931539|470924796|FG002|Period 1: Treatment Phase|Death|0|||
130808750|NCT02931539|470924794|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
130808751|NCT02931539|470924795|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
130808752|NCT02931539|470924796|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
130808753|NCT02931539|470924794|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
130808754|NCT02931539|470924795|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
130808755|NCT02931539|470924796|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
130808756|NCT02931539|470924794|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
130808757|NCT02931539|470924795|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
130808758|NCT02931539|470924796|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
130808759|NCT02931539|470924794|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
130808760|NCT02931539|470924795|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
130808761|NCT02931539|470924796|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
130808762|NCT03178942|470924799|FG000|Overall Study|Withdrawal by Subject|2|||
130808763|NCT03178942|470924800|FG001|Overall Study|Withdrawal by Subject|0|||
130808764|NCT03178942|470924799|FG000|Overall Study|Lost to Follow-up|1|||
130808765|NCT03178942|470924800|FG001|Overall Study|Lost to Follow-up|2|||
130808766|NCT03061214|470924805|FG000|Overall Study|Withdrawal by Subject|21|||
130808767|NCT03061214|470924806|FG001|Overall Study|Withdrawal by Subject|26|||
130808768|NCT03061214|470924807|FG002|Overall Study|Withdrawal by Subject|9|||
130808769|NCT03061214|470924805|FG000|Overall Study|Lost to Follow-up|3|||
130808770|NCT03061214|470924806|FG001|Overall Study|Lost to Follow-up|1|||
130808771|NCT03061214|470924807|FG002|Overall Study|Lost to Follow-up|1|||
130808772|NCT03061214|470924805|FG000|Overall Study|Death|1|||
130808773|NCT03061214|470924806|FG001|Overall Study|Death|1|||
130808774|NCT03061214|470924807|FG002|Overall Study|Death|0|||
130808775|NCT01926509|470926521|FG000|Overall Study|vital sign met discontinuation criteria|1|||
130808776|NCT01926509|470926522|FG001|Overall Study|vital sign met discontinuation criteria|0|||
130808777|NCT01926509|470926523|FG002|Overall Study|vital sign met discontinuation criteria|0|||
130808778|NCT01926509|470926524|FG003|Overall Study|vital sign met discontinuation criteria|0|||
130808779|NCT03681093|470926525|FG000|Overall Study|Subject decision|0|||
130808780|NCT03681093|470926526|FG001|Overall Study|Subject decision|2|||
130808781|NCT03681093|470926527|FG002|Overall Study|Subject decision|1|||
130808782|NCT01882829|470926531|FG000|Overall Study|Adverse Event|4|||
130808783|NCT01882829|470926531|FG000|Overall Study|Protocol Violation|1|||
130808784|NCT01882829|470926531|FG000|Overall Study|Withdrawal by Subject|1|||
130808785|NCT02469961|470926533|FG000|Overall Study|Physician Decision|4|||
130808786|NCT02469961|470926534|FG001|Overall Study|Physician Decision|1|||
130808787|NCT05130281|470926538|FG000|Overall Study|Withdrawal by Subject|0|||
130808788|NCT05130281|470926539|FG001|Overall Study|Withdrawal by Subject|0|||
130808789|NCT05130281|470926540|FG002|Overall Study|Withdrawal by Subject|1|||
130808790|NCT06844812|470926541|FG000|Overall Study|Lost to Follow-up|5|||
130808791|NCT06844812|470926541|FG000|Overall Study|stigmatization concerns|2|||
130808792|NCT06844812|470926541|FG000|Overall Study|medication refusal|2|||
130808793|NCT06844812|470926541|FG000|Overall Study|concerns about possible side effects|2|||
130808794|NCT06844812|470926541|FG000|Overall Study|wanting to seek another specialist opinion|2|||
130808795|NCT06844812|470926541|FG000|Overall Study|side effects (dizziness)|1|||
130808796|NCT00368849|470926544|FG000|Overall Study|Withdrawal by Subject|0|||
130808797|NCT00368849|470926545|FG001|Overall Study|Withdrawal by Subject|1|||
130808798|NCT00368849|470926544|FG000|Overall Study|Physician Decision|0|||
130808799|NCT00368849|470926545|FG001|Overall Study|Physician Decision|1|||
130808800|NCT01699685|470926549|FG000|Period 1|Adverse Event|1|||
130808801|NCT01699685|470926550|FG001|Period 1|Adverse Event|1|||
130808802|NCT01699685|470926549|FG000|Period 1|Medical or ethical, noncompliance|2|||
130808803|NCT01699685|470926550|FG001|Period 1|Medical or ethical, noncompliance|0|||
130808804|NCT01699685|470926549|FG000|Period 1|Other|0|||
130808805|NCT01699685|470926550|FG001|Period 1|Other|1|||
130808806|NCT01699685|470926549|FG000|Period 1|Patient request|0|||
130808807|NCT01699685|470926550|FG001|Period 1|Patient request|1|||
130808808|NCT01699685|470926549|FG000|Period 2|Lost to Follow-up|1|||
130808809|NCT01699685|470926550|FG001|Period 2|Lost to Follow-up|0|||
130808810|NCT03635996|470926551|FG000|Overall Study|Study terminated by Sponsor|94|||
130808811|NCT03635996|470926551|FG000|Overall Study|Withdrawal by Subject|20|||
130808812|NCT03635996|470926551|FG000|Overall Study|Ablation|26|||
130808813|NCT03635996|470926551|FG000|Overall Study|Adverse Event|7|||
130808814|NCT03635996|470926551|FG000|Overall Study|Physician Decision|3|||
130808815|NCT03635996|470926551|FG000|Overall Study|Prohibited medication|5|||
130808816|NCT03635996|470926551|FG000|Overall Study|Did not meet eligibility criteria|5|||
130808817|NCT03635996|470926551|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
130808818|NCT03635996|470926551|FG000|Overall Study|Protocol Violation|1|||
130808819|NCT03635996|470926551|FG000|Overall Study|Lost to Follow-up|1|||
130808820|NCT05058456|470926552|FG000|Overall Study|Death|1|||
130808821|NCT05058456|470926552|FG000|Overall Study|End of Study data not yet due for release|34|||
130808822|NCT01832038|470926553|FG000|Overall Study|Death|5|||
130808823|NCT01832038|470926553|FG000|Overall Study|Adverse Event|50|||
130808824|NCT01832038|470926553|FG000|Overall Study|Lack of Efficacy|81|||
130808825|NCT01832038|470926553|FG000|Overall Study|Protocol Violation|7|||
130808826|NCT01832038|470926553|FG000|Overall Study|Lost to Follow-up|10|||
130808827|NCT01832038|470926553|FG000|Overall Study|Withdrawal by Subject|49|||
130808828|NCT01832038|470926553|FG000|Overall Study|Visit non-compliance|2|||
130808829|NCT01832038|470926553|FG000|Overall Study|Subject refused to return visit|2|||
130808830|NCT01832038|470926553|FG000|Overall Study|Not convenient to come back to site|2|||
130808831|NCT01832038|470926553|FG000|Overall Study|Participant was asked to quit|5|||
130808832|NCT01832038|470926553|FG000|Overall Study|Back home|1|||
130808833|NCT01832038|470926553|FG000|Overall Study|Pregnancy|1|||
130808834|NCT01832038|470926553|FG000|Overall Study|Low compliance|3|||
130808835|NCT01832038|470926553|FG000|Overall Study|Prohibit procedure|2|||
130808836|NCT01832038|470926553|FG000|Overall Study|Not possible to visit the hospital|1|||
130808837|NCT01832038|470926553|FG000|Overall Study|Changes of implementation system|3|||
130808838|NCT01832038|470926553|FG000|Overall Study|Plan to pregnancy|7|||
130808839|NCT01832038|470926553|FG000|Overall Study|Bad mood and has suicidal thought|1|||
130808840|NCT01832038|470926553|FG000|Overall Study|Prohibited concomitant medication|1|||
130808841|NCT01832038|470926553|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
130808842|NCT01832038|470926553|FG000|Overall Study|Subject considered the efficacy was poor|1|||
130808843|NCT00107614|470926561|FG000|Overall Study|Physician Decision|10|||
130808844|NCT00107614|470926561|FG000|Overall Study|Death|2|||
130808845|NCT00101400|470926566|FG000|Survival Follow-Up|Alive|7|||
130808846|NCT05333965|470926587|FG000|First Intervention|Adverse Event|0|||
130808847|NCT05333965|470926588|FG001|First Intervention|Adverse Event|1|||
130808848|NCT05333965|470926587|FG000|First Intervention|Withdrawal by Subject|0|||
130808849|NCT05333965|470926588|FG001|First Intervention|Withdrawal by Subject|1|||
130808850|NCT00382863|470926589|FG000|Overall Study|Death|9|||
130808851|NCT00382863|470926590|FG001|Overall Study|Death|9|||
130808852|NCT00382863|470926589|FG000|Overall Study|Lost to Follow-up|1|||
130808853|NCT00382863|470926590|FG001|Overall Study|Lost to Follow-up|2|||
130808854|NCT00382863|470926589|FG000|Overall Study|Withdrawal by Subject|5|||
130808855|NCT00382863|470926590|FG001|Overall Study|Withdrawal by Subject|25|||
130808856|NCT02168439|470926591|FG000|Overall Study|Protocol Violation|0|||
130808857|NCT02168439|470926592|FG001|Overall Study|Protocol Violation|2|||
130808858|NCT02180672|470926595|FG000|Overall Study|Lost to Follow-up|5|||
130808859|NCT02180672|470926596|FG001|Overall Study|Lost to Follow-up|7|||
130808860|NCT02837952|470926597|FG000|Overall Study|Adverse Event|0|||
130808861|NCT02837952|470926598|FG001|Overall Study|Adverse Event|1|||
130808862|NCT02837952|470926597|FG000|Overall Study|Withdrawal by Subject|4|||
130808863|NCT02837952|470926598|FG001|Overall Study|Withdrawal by Subject|5|||
130808864|NCT02837952|470926597|FG000|Overall Study|Medication Error|1|||
130808865|NCT02837952|470926598|FG001|Overall Study|Medication Error|0|||
130808866|NCT01362530|470926599|FG000|Base Study (Cycle 1)|Adverse Event|2|||
130808867|NCT01362530|470926600|FG001|Base Study (Cycle 1)|Adverse Event|0|||
130808868|NCT01362530|470926599|FG000|Base Study (Cycle 1)|Physician Decision|0|||
130808869|NCT01362530|470926600|FG001|Base Study (Cycle 1)|Physician Decision|1|||
130808870|NCT01362530|470926599|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
130808871|NCT01362530|470926600|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
130808872|NCT01362530|470926599|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
130808873|NCT01362530|470926600|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
130808874|NCT01362530|470926599|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
130808875|NCT01362530|470926600|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
130808876|NCT01362530|470926599|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
130808877|NCT01362530|470926600|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
130808878|NCT01362530|470926599|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
130808879|NCT01362530|470926600|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
130808880|NCT01362530|470926599|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
130808881|NCT01362530|470926600|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
130808882|NCT01362530|470926599|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
130808883|NCT01362530|470926600|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
130808884|NCT01362530|470926599|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
130808885|NCT01362530|470926600|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
130808886|NCT01362530|470926599|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
130808887|NCT01362530|470926600|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
130808888|NCT01362530|470926599|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
130808889|NCT01362530|470926600|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
130808890|NCT01362530|470926599|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
130808891|NCT01362530|470926600|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
130808892|NCT03021005|470926602|FG000|Overall Study|Lost to Follow-up|39|||
130808893|NCT03021005|470926603|FG001|Overall Study|Lost to Follow-up|26|||
130808894|NCT00215553|470926610|FG000|Overall Study|Adverse Event|0|||
130808895|NCT00215553|470926611|FG001|Overall Study|Adverse Event|1|||
130808896|NCT00215553|470926612|FG002|Overall Study|Adverse Event|2|||
130808897|NCT00215553|470926613|FG003|Overall Study|Adverse Event|1|||
130808898|NCT00215553|470926614|FG004|Overall Study|Adverse Event|2|||
130808899|NCT00215553|470926615|FG005|Overall Study|Adverse Event|6|||
130808900|NCT00215553|470926616|FG006|Overall Study|Adverse Event|0|||
130808901|NCT00276380|470926620|FG000|Overall Study|Adverse Event|5|||
130808902|NCT00276380|470926621|FG001|Overall Study|Adverse Event|3|||
130808903|NCT00276380|470926620|FG000|Overall Study|Lost to Follow-up|1|||
130808904|NCT00276380|470926621|FG001|Overall Study|Lost to Follow-up|1|||
130808905|NCT00276380|470926620|FG000|Overall Study|Withdrawal by Subject|3|||
130808906|NCT00276380|470926621|FG001|Overall Study|Withdrawal by Subject|6|||
130808907|NCT00276380|470926620|FG000|Overall Study|Death|5|||
130808908|NCT00276380|470926621|FG001|Overall Study|Death|3|||
130808909|NCT00276380|470926620|FG000|Overall Study|Abnormal aPPT Levels|0|||
130808910|NCT00276380|470926621|FG001|Overall Study|Abnormal aPPT Levels|1|||
130808911|NCT02264821|470926622|FG000|Overall Study|Protocol Violation|1|||
130808912|NCT02264821|470926623|FG001|Overall Study|Protocol Violation|3|||
130808913|NCT02264821|470926624|FG002|Overall Study|Protocol Violation|6|||
130808914|NCT00552279|470926625|FG000|Overall Study|Adverse Event|0|||
130808915|NCT00552279|470926626|FG001|Overall Study|Adverse Event|1|||
130808916|NCT00552279|470926625|FG000|Overall Study|Withdrawal by Subject|12|||
130808917|NCT00552279|470926626|FG001|Overall Study|Withdrawal by Subject|1|||
130808918|NCT00552279|470926625|FG000|Overall Study|Lost to Follow-up|1|||
130808919|NCT00552279|470926626|FG001|Overall Study|Lost to Follow-up|0|||
130808920|NCT00552279|470926625|FG000|Overall Study|Other|1|||
130808921|NCT00552279|470926626|FG001|Overall Study|Other|1|||
130808922|NCT04829214|470926628|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
130808923|NCT04829214|470926629|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
130808924|NCT04829214|470926628|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
130808925|NCT04829214|470926629|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
130808926|NCT02739828|470926630|FG000|Overall Study|Adverse Event|1|||
130808927|NCT02739828|470926630|FG000|Overall Study|Lost to Follow-up|4|||
130808928|NCT01392495|470926631|FG000|Overall Study|Death|3|||
130808929|NCT01392495|470926631|FG000|Overall Study|Administrative problems|8|||
130808930|NCT01392495|470926631|FG000|Overall Study|Withdrawal by Subject|2|||
130808931|NCT01392495|470926631|FG000|Overall Study|Adverse Event|3|||
130808932|NCT02571244|470926632|FG000|Overall Study|Lost to Follow-up|0|||
130808933|NCT02571244|470926633|FG001|Overall Study|Lost to Follow-up|1|||
130808934|NCT02571244|470926632|FG000|Overall Study|Unable to reach out post discharge|3|||
130808935|NCT02571244|470926633|FG001|Overall Study|Unable to reach out post discharge|0|||
130808936|NCT01696214|470926634|FG000|Overall Study|Lost to Follow-up|1|||
130808937|NCT01696214|470926635|FG001|Overall Study|Lost to Follow-up|0|||
130808938|NCT01696214|470926636|FG002|Overall Study|Lost to Follow-up|0|||
130808939|NCT01696214|470926637|FG003|Overall Study|Lost to Follow-up|0|||
130808940|NCT01570192|470926638|FG000|Overall Study|no qualifying organism|6|||
130808941|NCT01570192|470926639|FG001|Overall Study|no qualifying organism|12|||
130808942|NCT01570192|470926638|FG000|Overall Study|changed to palliative care|1|||
130808943|NCT01570192|470926639|FG001|Overall Study|changed to palliative care|0|||
130808944|NCT01570192|470926638|FG000|Overall Study|Physician Decision|0|||
130808945|NCT01570192|470926639|FG001|Overall Study|Physician Decision|1|||
130808946|NCT04629521|470926640|FG000|Overall Study|Death|1|||
130808947|NCT04629521|470926640|FG000|Overall Study|Lost to Follow-up|3|||
130808948|NCT04629521|470926640|FG000|Overall Study|Subject withdrew consent|3|||
130808949|NCT04629521|470926640|FG000|Overall Study|Enrolled in error|1|||
130808950|NCT00728182|470926641|FG000|Overall Study|Adverse Event|1|||
130808951|NCT00728182|470926642|FG001|Overall Study|Adverse Event|0|||
130808952|NCT00728182|470926641|FG000|Overall Study|Lost to Follow-up|2|||
130808953|NCT00728182|470926642|FG001|Overall Study|Lost to Follow-up|0|||
130808954|NCT00728182|470926641|FG000|Overall Study|Death|0|||
130808955|NCT00728182|470926642|FG001|Overall Study|Death|2|||
130808956|NCT00728182|470926641|FG000|Overall Study|Protocol Noncompliance|0|||
130808957|NCT00728182|470926642|FG001|Overall Study|Protocol Noncompliance|1|||
130808958|NCT01618708|470926644|FG000|Overall Study|Adverse Event|10|||
130808959|NCT01618708|470926645|FG001|Overall Study|Adverse Event|10|||
130808960|NCT01618708|470926644|FG000|Overall Study|Lost to Follow-up|3|||
130808961|NCT01618708|470926645|FG001|Overall Study|Lost to Follow-up|3|||
130808962|NCT01618708|470926644|FG000|Overall Study|Withdrawal by Subject|17|||
130808963|NCT01618708|470926645|FG001|Overall Study|Withdrawal by Subject|22|||
130808964|NCT01618708|470926644|FG000|Overall Study|Lack of Efficacy|8|||
130808965|NCT01618708|470926645|FG001|Overall Study|Lack of Efficacy|8|||
130808966|NCT01618708|470926644|FG000|Overall Study|Technical problems|2|||
130808967|NCT01618708|470926645|FG001|Overall Study|Technical problems|0|||
130808968|NCT01618708|470926644|FG000|Overall Study|Other than specified above|1|||
130808969|NCT01618708|470926645|FG001|Overall Study|Other than specified above|1|||
130808970|NCT01618708|470926644|FG000|Overall Study|Randomized but not treated|3|||
130808971|NCT01618708|470926645|FG001|Overall Study|Randomized but not treated|2|||
130808972|NCT01065766|470926654|FG000|Overall Study|Assessed before the contracted date|1|||
130808973|NCT01065766|470926654|FG000|Overall Study|Contraindication to administration|6|||
130808974|NCT01065766|470926654|FG000|Overall Study|Violated dosage/administration|25|||
130808975|NCT01630811|470926659|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
130808976|NCT01630811|470926660|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130808977|NCT04818086|470926661|FG000|Overall Study|Physician Decision|1|||
130808978|NCT04818086|470926662|FG001|Overall Study|Physician Decision|0|||
130808979|NCT04818086|470926661|FG000|Overall Study|Withdrawal by Subject|0|||
130808980|NCT04818086|470926662|FG001|Overall Study|Withdrawal by Subject|1|||
130808981|NCT01725308|470926664|FG000|Treatment Period I|Did Not Receive Drug|1|||
130808982|NCT01725308|470926665|FG001|Treatment Period I|Did Not Receive Drug|0|||
130808983|NCT01725308|470926666|FG002|Treatment Period I|Did Not Receive Drug|0|||
130808984|NCT01725308|470926664|FG000|Treatment Period I|Adverse Event|5|||
130808985|NCT01725308|470926665|FG001|Treatment Period I|Adverse Event|4|||
130808986|NCT01725308|470926666|FG002|Treatment Period I|Adverse Event|21|||
130808987|NCT01725308|470926664|FG000|Treatment Period I|Insufficient Response|7|||
130808988|NCT01725308|470926665|FG001|Treatment Period I|Insufficient Response|0|||
130808989|NCT01725308|470926666|FG002|Treatment Period I|Insufficient Response|5|||
130808990|NCT01725308|470926664|FG000|Treatment Period I|Worsening of the Target Disease|8|||
130808991|NCT01725308|470926665|FG001|Treatment Period I|Worsening of the Target Disease|0|||
130808992|NCT01725308|470926666|FG002|Treatment Period I|Worsening of the Target Disease|2|||
130808993|NCT01725308|470926664|FG000|Treatment Period I|Changes in the Episodes|3|||
130808994|NCT01725308|470926665|FG001|Treatment Period I|Changes in the Episodes|0|||
130808995|NCT01725308|470926666|FG002|Treatment Period I|Changes in the Episodes|2|||
130808996|NCT01725308|470926664|FG000|Treatment Period I|Withdrawal of Consent|12|||
130808997|NCT01725308|470926665|FG001|Treatment Period I|Withdrawal of Consent|7|||
130808998|NCT01725308|470926666|FG002|Treatment Period I|Withdrawal of Consent|5|||
130808999|NCT01725308|470926664|FG000|Treatment Period I|Lost to Follow-up|3|||
130809000|NCT01725308|470926665|FG001|Treatment Period I|Lost to Follow-up|2|||
130809001|NCT01725308|470926666|FG002|Treatment Period I|Lost to Follow-up|2|||
130809002|NCT01725308|470926664|FG000|Treatment Period I|Protocol Deviations|3|||
130809003|NCT01725308|470926665|FG001|Treatment Period I|Protocol Deviations|1|||
130809004|NCT01725308|470926666|FG002|Treatment Period I|Protocol Deviations|1|||
130809005|NCT01725308|470926664|FG000|Treatment Period I|Miscellaneous|2|||
130809006|NCT01725308|470926665|FG001|Treatment Period I|Miscellaneous|0|||
130809007|NCT01725308|470926666|FG002|Treatment Period I|Miscellaneous|3|||
130809008|NCT01725308|470926664|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
130809009|NCT01725308|470926665|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
130809010|NCT01725308|470926666|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
130809011|NCT01725308|470926664|FG000|Treatment Period II|Did Not Receive Drug|4|||
130809012|NCT01725308|470926665|FG001|Treatment Period II|Did Not Receive Drug|0|||
130809013|NCT01725308|470926666|FG002|Treatment Period II|Did Not Receive Drug|0|||
130809014|NCT01725308|470926664|FG000|Treatment Period II|Adverse Event|13|||
130809015|NCT01725308|470926665|FG001|Treatment Period II|Adverse Event|8|||
130809016|NCT01725308|470926666|FG002|Treatment Period II|Adverse Event|20|||
130809017|NCT01725308|470926664|FG000|Treatment Period II|Insufficient Response|2|||
130809018|NCT01725308|470926665|FG001|Treatment Period II|Insufficient Response|4|||
130809019|NCT01725308|470926666|FG002|Treatment Period II|Insufficient Response|6|||
130809020|NCT01725308|470926664|FG000|Treatment Period II|Worsening of the Target Disease|1|||
130809021|NCT01725308|470926665|FG001|Treatment Period II|Worsening of the Target Disease|4|||
130809022|NCT01725308|470926666|FG002|Treatment Period II|Worsening of the Target Disease|2|||
130809023|NCT01725308|470926664|FG000|Treatment Period II|Changes in the Episodes|1|||
130809024|NCT01725308|470926665|FG001|Treatment Period II|Changes in the Episodes|0|||
130809025|NCT01725308|470926666|FG002|Treatment Period II|Changes in the Episodes|5|||
130809026|NCT01725308|470926664|FG000|Treatment Period II|Withdrawal of Consent|28|||
130809027|NCT01725308|470926665|FG001|Treatment Period II|Withdrawal of Consent|2|||
130809028|NCT01725308|470926666|FG002|Treatment Period II|Withdrawal of Consent|16|||
130809029|NCT01725308|470926664|FG000|Treatment Period II|Lost to Follow-up|1|||
130809030|NCT01725308|470926665|FG001|Treatment Period II|Lost to Follow-up|5|||
130809031|NCT01725308|470926666|FG002|Treatment Period II|Lost to Follow-up|3|||
130809032|NCT01725308|470926664|FG000|Treatment Period II|Protocol Deviations|0|||
130809033|NCT01725308|470926665|FG001|Treatment Period II|Protocol Deviations|0|||
130809034|NCT01725308|470926666|FG002|Treatment Period II|Protocol Deviations|1|||
130809035|NCT01725308|470926664|FG000|Treatment Period II|Miscellaneous|5|||
130809036|NCT01725308|470926665|FG001|Treatment Period II|Miscellaneous|3|||
130809037|NCT01725308|470926666|FG002|Treatment Period II|Miscellaneous|7|||
130809038|NCT04128228|470926670|FG000|Overall Study|Withdrawal by Subject|3|||
130809039|NCT04128228|470926671|FG001|Overall Study|Withdrawal by Subject|3|||
130809040|NCT04128228|470926672|FG002|Overall Study|Withdrawal by Subject|0|||
130809041|NCT04128228|470926673|FG003|Overall Study|Withdrawal by Subject|0|||
130809042|NCT04128228|470926670|FG000|Overall Study|noncompliance|2|||
130809043|NCT04128228|470926671|FG001|Overall Study|noncompliance|2|||
130809044|NCT04128228|470926672|FG002|Overall Study|noncompliance|0|||
130809045|NCT04128228|470926673|FG003|Overall Study|noncompliance|0|||
130809046|NCT03511209|470926674|FG000|Overall Study|Withdrawal by Subject|2|||
130809047|NCT03511209|470926675|FG001|Overall Study|Withdrawal by Subject|4|||
130809048|NCT03511209|470926674|FG000|Overall Study|Death|1|||
130809049|NCT03511209|470926675|FG001|Overall Study|Death|0|||
130809050|NCT03511209|470926674|FG000|Overall Study|Lost to Follow-up|0|||
130809051|NCT03511209|470926675|FG001|Overall Study|Lost to Follow-up|2|||
130809052|NCT00401830|470926679|FG000|Overall Study|Adverse Event|10|||
130809053|NCT00401830|470926680|FG001|Overall Study|Adverse Event|18|||
130809054|NCT00401830|470926679|FG000|Overall Study|Lack of Efficacy|11|||
130809055|NCT00401830|470926680|FG001|Overall Study|Lack of Efficacy|5|||
130809056|NCT00401830|470926679|FG000|Overall Study|Withdrawal by Subject|4|||
130809057|NCT00401830|470926680|FG001|Overall Study|Withdrawal by Subject|3|||
130809058|NCT00401830|470926679|FG000|Overall Study|Protocol Violation|3|||
130809059|NCT00401830|470926680|FG001|Overall Study|Protocol Violation|3|||
130809060|NCT00401830|470926679|FG000|Overall Study|Non-compliance with drug study|1|||
130809061|NCT00401830|470926680|FG001|Overall Study|Non-compliance with drug study|0|||
130809062|NCT00401830|470926679|FG000|Overall Study|Lost to Follow-up|1|||
130809063|NCT00401830|470926680|FG001|Overall Study|Lost to Follow-up|3|||
130809064|NCT00401830|470926679|FG000|Overall Study|Other: Personal / Family problems|1|||
130809065|NCT00401830|470926680|FG001|Overall Study|Other: Personal / Family problems|0|||
130809066|NCT03378635|470926683|FG000|Overall Study|Adverse Event|1|||
130809067|NCT03378635|470926684|FG001|Overall Study|Adverse Event|0|||
130809068|NCT03378635|470926685|FG002|Overall Study|Adverse Event|0|||
130809069|NCT03378635|470926683|FG000|Overall Study|Withdrawal by Subject|1|||
130809070|NCT03378635|470926684|FG001|Overall Study|Withdrawal by Subject|0|||
130809071|NCT03378635|470926685|FG002|Overall Study|Withdrawal by Subject|0|||
130809072|NCT01316900|470926689|FG000|Overall Study|Adverse Event|10|||
130809073|NCT01316900|470926690|FG001|Overall Study|Adverse Event|10|||
130809074|NCT01316900|470926691|FG002|Overall Study|Adverse Event|15|||
130809075|NCT01316900|470926692|FG003|Overall Study|Adverse Event|9|||
130809076|NCT01316900|470926689|FG000|Overall Study|Lack of Efficacy|17|||
130809077|NCT01316900|470926690|FG001|Overall Study|Lack of Efficacy|9|||
130809078|NCT01316900|470926691|FG002|Overall Study|Lack of Efficacy|5|||
130809079|NCT01316900|470926692|FG003|Overall Study|Lack of Efficacy|7|||
130809080|NCT01316900|470926689|FG000|Overall Study|Protocol Violation|7|||
130809081|NCT01316900|470926690|FG001|Overall Study|Protocol Violation|1|||
130809082|NCT01316900|470926691|FG002|Overall Study|Protocol Violation|4|||
130809083|NCT01316900|470926692|FG003|Overall Study|Protocol Violation|0|||
130809084|NCT01316900|470926689|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
130809085|NCT01316900|470926690|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
130809086|NCT01316900|470926691|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
130809087|NCT01316900|470926692|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
130809088|NCT01316900|470926689|FG000|Overall Study|Lost to Follow-up|1|||
130809089|NCT01316900|470926690|FG001|Overall Study|Lost to Follow-up|0|||
130809090|NCT01316900|470926691|FG002|Overall Study|Lost to Follow-up|1|||
130809091|NCT01316900|470926692|FG003|Overall Study|Lost to Follow-up|1|||
130809092|NCT01316900|470926689|FG000|Overall Study|Withdrawal by Subject|7|||
130809093|NCT01316900|470926690|FG001|Overall Study|Withdrawal by Subject|8|||
130809094|NCT01316900|470926691|FG002|Overall Study|Withdrawal by Subject|6|||
130809095|NCT01316900|470926692|FG003|Overall Study|Withdrawal by Subject|9|||
130809096|NCT01684033|470926693|FG000|Period 1, First 30 Days|Adverse Event|1|||
130809097|NCT01684033|470926694|FG001|Period 1, First 30 Days|Adverse Event|1|||
130809098|NCT01684033|470926693|FG000|Period 1, First 30 Days|Noncompliance|1|||
130809099|NCT01684033|470926694|FG001|Period 1, First 30 Days|Noncompliance|0|||
130809100|NCT01684033|470926693|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
130809101|NCT01684033|470926694|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
130809102|NCT01684033|470926693|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
130809103|NCT01684033|470926694|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
130809104|NCT01684033|470926693|FG000|Period 2, Second 30 Days|Adverse Event|1|||
130809105|NCT01684033|470926694|FG001|Period 2, Second 30 Days|Adverse Event|0|||
130809106|NCT02496156|470926695|FG000|Overall Study|Lost to Follow-up|5|||
130809107|NCT02496156|470926696|FG001|Overall Study|Lost to Follow-up|0|||
130809108|NCT02496156|470926695|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
130809109|NCT02496156|470926696|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
130809110|NCT00089583|470926697|FG000|Overall Study|Adverse Event|0|||
130809111|NCT00089583|470926698|FG001|Overall Study|Adverse Event|3|||
130809112|NCT00089583|470926697|FG000|Overall Study|Insufficient Viral Load Response|5|||
130809113|NCT00089583|470926698|FG001|Overall Study|Insufficient Viral Load Response|5|||
130809114|NCT00089583|470926697|FG000|Overall Study|Withdrawal by Subject|0|||
130809115|NCT00089583|470926698|FG001|Overall Study|Withdrawal by Subject|4|||
130809116|NCT00089583|470926697|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
130809117|NCT00089583|470926698|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
130809118|NCT00089583|470926697|FG000|Overall Study|Participant Refused Study Medication|0|||
130809119|NCT00089583|470926698|FG001|Overall Study|Participant Refused Study Medication|2|||
130809120|NCT00089583|470926697|FG000|Overall Study|Non-Compliance|0|||
130809121|NCT00089583|470926698|FG001|Overall Study|Non-Compliance|4|||
130809122|NCT00089583|470926697|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
130809123|NCT00089583|470926698|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
130809124|NCT00089583|470926697|FG000|Overall Study|Participant Management Criteria Met|0|||
130809125|NCT00089583|470926698|FG001|Overall Study|Participant Management Criteria Met|1|||
130809126|NCT00089583|470926697|FG000|Overall Study|Reason Not Provided|0|||
130809127|NCT00089583|470926698|FG001|Overall Study|Reason Not Provided|1|||
130809128|NCT00089583|470926697|FG000|Overall Study|Protocol Violation|0|||
130809129|NCT00089583|470926698|FG001|Overall Study|Protocol Violation|3|||
130809130|NCT00089583|470926697|FG000|Overall Study|Principal Investigator Decision|0|||
130809131|NCT00089583|470926698|FG001|Overall Study|Principal Investigator Decision|10|||
130809132|NCT00089583|470926697|FG000|Overall Study|Start of Disallowed Medication|0|||
130809133|NCT00089583|470926698|FG001|Overall Study|Start of Disallowed Medication|1|||
130809134|NCT00089583|470926697|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
130809135|NCT00089583|470926698|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
130809136|NCT00089583|470926697|FG000|Overall Study|Participant Incarcerated|0|||
130809137|NCT00089583|470926698|FG001|Overall Study|Participant Incarcerated|1|||
130809138|NCT01569763|470928497|FG000|Overall Study|Lack of Efficacy|2|||
130809139|NCT01569763|470928498|FG001|Overall Study|Lack of Efficacy|7|||
130809140|NCT01569763|470928497|FG000|Overall Study|Adverse Event|1|||
130809141|NCT01569763|470928498|FG001|Overall Study|Adverse Event|0|||
130809142|NCT02730169|470928499|FG000|Overall Study|Protocol Violation|1|||
130809143|NCT02730169|470928500|FG001|Overall Study|Protocol Violation|0|||
130809144|NCT02730169|470928501|FG002|Overall Study|Protocol Violation|0|||
130809145|NCT02730169|470928502|FG003|Overall Study|Protocol Violation|1|||
130809146|NCT02730169|470928499|FG000|Overall Study|Adverse Event|2|||
130809147|NCT02730169|470928500|FG001|Overall Study|Adverse Event|3|||
130809148|NCT02730169|470928501|FG002|Overall Study|Adverse Event|3|||
130809149|NCT02730169|470928502|FG003|Overall Study|Adverse Event|0|||
130809150|NCT02730169|470928499|FG000|Overall Study|Adverse Event of Special Interest|0|||
130809151|NCT02730169|470928500|FG001|Overall Study|Adverse Event of Special Interest|1|||
130809152|NCT02730169|470928501|FG002|Overall Study|Adverse Event of Special Interest|2|||
130809153|NCT02730169|470928502|FG003|Overall Study|Adverse Event of Special Interest|0|||
130809154|NCT02730169|470928499|FG000|Overall Study|Withdrawal by Subject|6|||
130809155|NCT02730169|470928500|FG001|Overall Study|Withdrawal by Subject|11|||
130809156|NCT02730169|470928501|FG002|Overall Study|Withdrawal by Subject|6|||
130809157|NCT02730169|470928502|FG003|Overall Study|Withdrawal by Subject|8|||
130809158|NCT02730169|470928499|FG000|Overall Study|Lost to Follow-up|5|||
130809159|NCT02730169|470928500|FG001|Overall Study|Lost to Follow-up|6|||
130809160|NCT02730169|470928501|FG002|Overall Study|Lost to Follow-up|5|||
130809161|NCT02730169|470928502|FG003|Overall Study|Lost to Follow-up|6|||
130809162|NCT02730169|470928499|FG000|Overall Study|Other|0|||
130809163|NCT02730169|470928500|FG001|Overall Study|Other|0|||
130809164|NCT02730169|470928501|FG002|Overall Study|Other|1|||
130809165|NCT02730169|470928502|FG003|Overall Study|Other|1|||
130809166|NCT03211858|470928510|FG000|Overall Study|Adverse Event|8|||
130809167|NCT03211858|470928511|FG001|Overall Study|Adverse Event|6|||
130809168|NCT03211858|470928510|FG000|Overall Study|Lack of Efficacy|0|||
130809169|NCT03211858|470928511|FG001|Overall Study|Lack of Efficacy|4|||
130809170|NCT03211858|470928510|FG000|Overall Study|Poor compliance to protocol|6|||
130809171|NCT03211858|470928511|FG001|Overall Study|Poor compliance to protocol|2|||
130809172|NCT03211858|470928510|FG000|Overall Study|Non-serious Hypoglycemia|1|||
130809173|NCT03211858|470928511|FG001|Overall Study|Non-serious Hypoglycemia|0|||
130809174|NCT03211858|470928510|FG000|Overall Study|Other than specified above|22|||
130809175|NCT03211858|470928511|FG001|Overall Study|Other than specified above|21|||
130809176|NCT03810365|470928512|FG000|Overall Study|Lost to Follow-up|2|||
130809177|NCT03810365|470928513|FG001|Overall Study|Lost to Follow-up|2|||
130809178|NCT03810365|470928512|FG000|Overall Study|Withdrawal by Subject|4|||
130809179|NCT03810365|470928513|FG001|Overall Study|Withdrawal by Subject|5|||
130809180|NCT03160573|470928518|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
130809181|NCT03160573|470928519|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
130809182|NCT03160573|470928520|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
130809183|NCT03160573|470928521|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
130809184|NCT02144337|470928526|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
130809185|NCT02144337|470928527|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
130809186|NCT02144337|470928526|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
130809187|NCT02144337|470928527|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
130809188|NCT02144337|470928526|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
130809189|NCT02144337|470928527|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
130809190|NCT02144337|470928526|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
130809191|NCT02144337|470928527|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
130809192|NCT02144337|470928526|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
130809193|NCT02144337|470928527|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
130809194|NCT01730729|470928530|FG000|Overall Study|Adverse Event|1|||
130809195|NCT01730729|470928530|FG000|Overall Study|Death|1|||
130809196|NCT01730729|470928530|FG000|Overall Study|Progressive Disease|12|||
130809197|NCT02402907|470928531|FG000|Overall Study|Delivered vaginally|9|||
130809198|NCT02402907|470928532|FG001|Overall Study|Delivered vaginally|3|||
130809199|NCT02402907|470928531|FG000|Overall Study|Delivered outside of Sinai|1|||
130809200|NCT02402907|470928532|FG001|Overall Study|Delivered outside of Sinai|1|||
130809201|NCT02402907|470928531|FG000|Overall Study|Lost to follow up after C-Section|10|||
130809202|NCT02402907|470928532|FG001|Overall Study|Lost to follow up after C-Section|23|||
130809203|NCT00449787|470928533|FG000|Overall Study|Lost to Follow-up|10|||
130809204|NCT00449787|470928534|FG001|Overall Study|Lost to Follow-up|8|||
130809205|NCT00449787|470928533|FG000|Overall Study|Did not require medication|95|||
130809206|NCT00449787|470928534|FG001|Overall Study|Did not require medication|92|||
130809207|NCT03701074|470928535|FG000|Overall Study|Physician Decision|1|||
130809208|NCT03701074|470928536|FG001|Overall Study|Physician Decision|0|||
130809209|NCT01423084|470928540|FG000|Overall Study|Adverse Event|0|||
130809210|NCT01423084|470928541|FG001|Overall Study|Adverse Event|1|||
130809211|NCT01423084|470928540|FG000|Overall Study|Withdrawal by Subject|2|||
130809212|NCT01423084|470928541|FG001|Overall Study|Withdrawal by Subject|3|||
130809213|NCT00661687|470928542|FG000|Overall Study|Study related symptoms and complaints|5|||
130809214|NCT00661687|470928542|FG000|Overall Study|Positive slit lamp findings|4|||
130809215|NCT00661687|470928542|FG000|Overall Study|Inability to maintain wearing schedule|3|||
130809216|NCT00661687|470928542|FG000|Overall Study|Physician Decision|1|||
130809217|NCT00661687|470928542|FG000|Overall Study|Adverse Event|2|||
130809218|NCT03574389|470928543|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
130809219|NCT03574389|470928544|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
130809220|NCT03574389|470928545|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
130809221|NCT03574389|470928546|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
130809222|NCT03574389|470928547|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
130809223|NCT03574389|470928548|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
130809224|NCT03574389|470928549|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
130809225|NCT03574389|470928543|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
130809226|NCT03574389|470928544|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
130809227|NCT03574389|470928545|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
130809228|NCT03574389|470928546|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
130809229|NCT03574389|470928547|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
130809230|NCT03574389|470928548|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
130809231|NCT03574389|470928549|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
130809232|NCT03574389|470928543|FG000|Vaccination Period|Other|6|||
130809233|NCT03574389|470928544|FG001|Vaccination Period|Other|0|||
130809234|NCT03574389|470928545|FG002|Vaccination Period|Other|0|||
130809235|NCT03574389|470928546|FG003|Vaccination Period|Other|0|||
130809236|NCT03574389|470928547|FG004|Vaccination Period|Other|0|||
130809237|NCT03574389|470928548|FG005|Vaccination Period|Other|0|||
130809238|NCT03574389|470928549|FG006|Vaccination Period|Other|0|||
130809239|NCT03574389|470928543|FG000|Vaccination Period|Adverse Event|0|||
130809240|NCT03574389|470928544|FG001|Vaccination Period|Adverse Event|1|||
130809241|NCT03574389|470928545|FG002|Vaccination Period|Adverse Event|0|||
130809242|NCT03574389|470928546|FG003|Vaccination Period|Adverse Event|0|||
130809243|NCT03574389|470928547|FG004|Vaccination Period|Adverse Event|0|||
130809244|NCT03574389|470928548|FG005|Vaccination Period|Adverse Event|0|||
130809245|NCT03574389|470928549|FG006|Vaccination Period|Adverse Event|0|||
130809246|NCT03574389|470928543|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
130809247|NCT03574389|470928544|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
130809248|NCT03574389|470928545|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
130809249|NCT03574389|470928546|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
130809250|NCT03574389|470928547|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
130809251|NCT03574389|470928548|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
130809252|NCT03574389|470928549|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
130809253|NCT02462057|470928550|FG000|Overall Study|Left Vitality|32|||
130809254|NCT02462057|470928551|FG001|Overall Study|Left Vitality|27|||
130809255|NCT02462057|470928552|FG002|Overall Study|Left Vitality|23|||
130809256|NCT02462057|470928553|FG003|Overall Study|Left Vitality|35|||
130809257|NCT02462057|470928554|FG004|Overall Study|Left Vitality|33|||
130809258|NCT02462057|470928550|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
130809259|NCT02462057|470928551|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
130809260|NCT02462057|470928552|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
130809261|NCT02462057|470928553|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
130809262|NCT02462057|470928554|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
130809263|NCT01682603|470928555|FG000|Overall Study|Lost to Follow-up|3|||
130809264|NCT02336555|470928556|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130809265|NCT02336555|470928557|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
130809266|NCT02336555|470928556|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
130809267|NCT02336555|470928557|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
130809268|NCT02336555|470928556|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
130809269|NCT02336555|470928557|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
130809270|NCT00993473|470928558|FG000|Overall Study|Adverse Event|0|||
130809271|NCT00993473|470928559|FG001|Overall Study|Adverse Event|2|||
130809272|NCT00993473|470928558|FG000|Overall Study|Protocol Violation|1|||
130809273|NCT00993473|470928559|FG001|Overall Study|Protocol Violation|2|||
130809274|NCT00993473|470928558|FG000|Overall Study|Lost to Follow-up|1|||
130809275|NCT00993473|470928559|FG001|Overall Study|Lost to Follow-up|0|||
130809276|NCT00993473|470928558|FG000|Overall Study|Withdrawal by Subject|1|||
130809277|NCT00993473|470928559|FG001|Overall Study|Withdrawal by Subject|5|||
130809278|NCT00993473|470928558|FG000|Overall Study|Technical problem with CGM device|0|||
130809279|NCT00993473|470928559|FG001|Overall Study|Technical problem with CGM device|1|||
130809280|NCT00993473|470928558|FG000|Overall Study|Family event|1|||
130809281|NCT00993473|470928559|FG001|Overall Study|Family event|0|||
130809282|NCT01959919|470928560|FG000|Overall Study|Did not meet the eligibility criteria|2|||
130809283|NCT01697501|470928561|FG000|Overall Study|Protocol Violation|2|||
130809284|NCT02094885|470928564|FG000|Overall Study|Death|1|||
130809285|NCT02094885|470928565|FG001|Overall Study|Death|5|||
130809286|NCT02094885|470928564|FG000|Overall Study|Withdrawn due to age|1|||
130809287|NCT02094885|470928565|FG001|Overall Study|Withdrawn due to age|0|||
130809288|NCT03707821|470928568|FG000|Overall Study|Protocol Violation|0|||
130809289|NCT03707821|470928569|FG001|Overall Study|Protocol Violation|1|||
130809290|NCT03707821|470928568|FG000|Overall Study|Unsatisfactory Visual Response|1|||
130809291|NCT03707821|470928569|FG001|Overall Study|Unsatisfactory Visual Response|0|||
130809292|NCT03707821|470928568|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
130809293|NCT03707821|470928569|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
130809294|NCT00128492|470928570|FG000|Overall Study|AE unrelated to study|2|||
130809295|NCT00128492|470928571|FG001|Overall Study|AE unrelated to study|9|||
130809296|NCT00128492|470928570|FG000|Overall Study|Study drug intolerance (AE)|2|||
130809297|NCT00128492|470928571|FG001|Overall Study|Study drug intolerance (AE)|8|||
130809298|NCT00128492|470928570|FG000|Overall Study|AE related to study|1|||
130809299|NCT00128492|470928571|FG001|Overall Study|AE related to study|4|||
130809300|NCT00128492|470928570|FG000|Overall Study|Death|1|||
130809301|NCT00128492|470928571|FG001|Overall Study|Death|0|||
130809302|NCT00128492|470928570|FG000|Overall Study|Lost to Follow-up|1|||
130809303|NCT00128492|470928571|FG001|Overall Study|Lost to Follow-up|5|||
130809304|NCT00128492|470928570|FG000|Overall Study|Noncompliance|0|||
130809305|NCT00128492|470928571|FG001|Overall Study|Noncompliance|5|||
130809306|NCT00128492|470928570|FG000|Overall Study|Personal or administrative|10|||
130809307|NCT00128492|470928571|FG001|Overall Study|Personal or administrative|22|||
130809308|NCT00128492|470928570|FG000|Overall Study|Withdrawal by Subject|3|||
130809309|NCT00128492|470928571|FG001|Overall Study|Withdrawal by Subject|5|||
130809310|NCT00128492|470928570|FG000|Overall Study|Pregnancy|0|||
130809311|NCT00128492|470928571|FG001|Overall Study|Pregnancy|1|||
130809312|NCT00756314|470928573|FG000|Overall Study|Lost to Follow-up|2|||
130809313|NCT00756314|470928574|FG001|Overall Study|Lost to Follow-up|59|||
130809314|NCT02605967|470928575|FG000|Overall Study|subject / guardian decision|1|||
130809315|NCT02605967|470928576|FG001|Overall Study|subject / guardian decision|2|||
130809316|NCT02605967|470928575|FG000|Overall Study|Physician Decision|10|||
130809317|NCT02605967|470928576|FG001|Overall Study|Physician Decision|1|||
130809318|NCT02605967|470928575|FG000|Overall Study|Death|4|||
130809319|NCT02605967|470928576|FG001|Overall Study|Death|2|||
130809320|NCT02605967|470928575|FG000|Overall Study|Adverse Event|1|||
130809321|NCT02605967|470928576|FG001|Overall Study|Adverse Event|0|||
130809322|NCT02605967|470928575|FG000|Overall Study|progressive disease|66|||
130809323|NCT02605967|470928576|FG001|Overall Study|progressive disease|35|||
130809324|NCT00159874|470928581|FG000|Overall Study|Adverse Event|2|||
130809325|NCT00159874|470928582|FG001|Overall Study|Adverse Event|2|||
130809326|NCT00159874|470928583|FG002|Overall Study|Adverse Event|5|||
130809327|NCT00159874|470928584|FG003|Overall Study|Adverse Event|1|||
130809328|NCT00159874|470928585|FG004|Overall Study|Adverse Event|1|||
130809329|NCT00159874|470928586|FG005|Overall Study|Adverse Event|2|||
130809330|NCT00159874|470928587|FG006|Overall Study|Adverse Event|0|||
130809331|NCT00159874|470928581|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
130809332|NCT00159874|470928582|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
130809333|NCT00159874|470928583|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
130809334|NCT00159874|470928584|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
130809335|NCT00159874|470928585|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
130809336|NCT00159874|470928586|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
130809337|NCT00159874|470928587|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
130809338|NCT00159874|470928581|FG000|Overall Study|Lack of Efficacy|2|||
130809339|NCT00159874|470928582|FG001|Overall Study|Lack of Efficacy|0|||
130809340|NCT00159874|470928583|FG002|Overall Study|Lack of Efficacy|1|||
130809341|NCT00159874|470928584|FG003|Overall Study|Lack of Efficacy|1|||
130809342|NCT00159874|470928585|FG004|Overall Study|Lack of Efficacy|0|||
130809343|NCT00159874|470928586|FG005|Overall Study|Lack of Efficacy|3|||
130809344|NCT00159874|470928587|FG006|Overall Study|Lack of Efficacy|0|||
130809345|NCT00159874|470928581|FG000|Overall Study|Lost to Follow-up|1|||
130809346|NCT00159874|470928582|FG001|Overall Study|Lost to Follow-up|0|||
130809347|NCT00159874|470928583|FG002|Overall Study|Lost to Follow-up|3|||
130809348|NCT00159874|470928584|FG003|Overall Study|Lost to Follow-up|0|||
130809349|NCT00159874|470928585|FG004|Overall Study|Lost to Follow-up|1|||
130809350|NCT00159874|470928586|FG005|Overall Study|Lost to Follow-up|2|||
130809351|NCT00159874|470928587|FG006|Overall Study|Lost to Follow-up|1|||
130809352|NCT00159874|470928581|FG000|Overall Study|Other|8|||
130809353|NCT00159874|470928582|FG001|Overall Study|Other|8|||
130809354|NCT00159874|470928583|FG002|Overall Study|Other|8|||
130809355|NCT00159874|470928584|FG003|Overall Study|Other|0|||
130809356|NCT00159874|470928585|FG004|Overall Study|Other|2|||
130809357|NCT00159874|470928586|FG005|Overall Study|Other|1|||
130809358|NCT00159874|470928587|FG006|Overall Study|Other|3|||
130809359|NCT00159874|470928581|FG000|Overall Study|Protocol Violation|0|||
130809360|NCT00159874|470928582|FG001|Overall Study|Protocol Violation|5|||
130809361|NCT00159874|470928583|FG002|Overall Study|Protocol Violation|2|||
130809362|NCT00159874|470928584|FG003|Overall Study|Protocol Violation|0|||
130809363|NCT00159874|470928585|FG004|Overall Study|Protocol Violation|0|||
130809364|NCT00159874|470928586|FG005|Overall Study|Protocol Violation|0|||
130809365|NCT00159874|470928587|FG006|Overall Study|Protocol Violation|0|||
130809366|NCT00159874|470928581|FG000|Overall Study|Death|3|||
130809367|NCT00159874|470928582|FG001|Overall Study|Death|8|||
130809368|NCT00159874|470928583|FG002|Overall Study|Death|15|||
130809369|NCT00159874|470928584|FG003|Overall Study|Death|0|||
130809370|NCT00159874|470928585|FG004|Overall Study|Death|1|||
130809371|NCT00159874|470928586|FG005|Overall Study|Death|2|||
130809372|NCT00159874|470928587|FG006|Overall Study|Death|0|||
130809373|NCT00159874|470928581|FG000|Overall Study|Withdrawal by Subject|2|||
130809374|NCT00159874|470928582|FG001|Overall Study|Withdrawal by Subject|6|||
130809375|NCT00159874|470928583|FG002|Overall Study|Withdrawal by Subject|8|||
130809376|NCT00159874|470928584|FG003|Overall Study|Withdrawal by Subject|4|||
130809377|NCT00159874|470928585|FG004|Overall Study|Withdrawal by Subject|3|||
130809378|NCT00159874|470928586|FG005|Overall Study|Withdrawal by Subject|2|||
130809379|NCT00159874|470928587|FG006|Overall Study|Withdrawal by Subject|1|||
130809380|NCT00159874|470928581|FG000|Overall Study|Pregnancy|1|||
130809381|NCT00159874|470928582|FG001|Overall Study|Pregnancy|1|||
130809382|NCT00159874|470928583|FG002|Overall Study|Pregnancy|0|||
130809383|NCT00159874|470928584|FG003|Overall Study|Pregnancy|0|||
130809384|NCT00159874|470928585|FG004|Overall Study|Pregnancy|0|||
130809385|NCT00159874|470928586|FG005|Overall Study|Pregnancy|0|||
130809386|NCT00159874|470928587|FG006|Overall Study|Pregnancy|0|||
130809387|NCT05122143|470928590|FG000|Overall Study|Adverse Event|1|||
130809388|NCT05122143|470928591|FG001|Overall Study|Adverse Event|0|||
130809389|NCT05122143|470928592|FG002|Overall Study|Adverse Event|0|||
130809390|NCT05122143|470928593|FG003|Overall Study|Adverse Event|0|||
130809391|NCT05122143|470928594|FG004|Overall Study|Adverse Event|1|||
130809392|NCT05122143|470928595|FG005|Overall Study|Adverse Event|0|||
130809393|NCT05122143|470928590|FG000|Overall Study|Protocol non-compliance|0|||
130809394|NCT05122143|470928591|FG001|Overall Study|Protocol non-compliance|0|||
130809395|NCT05122143|470928592|FG002|Overall Study|Protocol non-compliance|1|||
130809396|NCT05122143|470928593|FG003|Overall Study|Protocol non-compliance|0|||
130809397|NCT05122143|470928594|FG004|Overall Study|Protocol non-compliance|0|||
130809398|NCT05122143|470928595|FG005|Overall Study|Protocol non-compliance|0|||
130809399|NCT05122143|470928590|FG000|Overall Study|Covid contact|0|||
130809400|NCT05122143|470928591|FG001|Overall Study|Covid contact|0|||
130809401|NCT05122143|470928592|FG002|Overall Study|Covid contact|0|||
130809402|NCT05122143|470928593|FG003|Overall Study|Covid contact|0|||
130809403|NCT05122143|470928594|FG004|Overall Study|Covid contact|1|||
130809404|NCT05122143|470928595|FG005|Overall Study|Covid contact|0|||
130809405|NCT01475825|470928596|FG000|Overall Study|Adverse Event|41|||
130809406|NCT01475825|470928597|FG001|Overall Study|Adverse Event|15|||
130809407|NCT01475825|470928598|FG002|Overall Study|Adverse Event|27|||
130809408|NCT01475825|470928599|FG003|Overall Study|Adverse Event|11|||
130809409|NCT01475825|470928596|FG000|Overall Study|Death|1|||
130809410|NCT01475825|470928597|FG001|Overall Study|Death|0|||
130809411|NCT01475825|470928598|FG002|Overall Study|Death|1|||
130809412|NCT01475825|470928599|FG003|Overall Study|Death|0|||
130809413|NCT01475825|470928596|FG000|Overall Study|Lack of Efficacy|0|||
130809414|NCT01475825|470928597|FG001|Overall Study|Lack of Efficacy|0|||
130809415|NCT01475825|470928598|FG002|Overall Study|Lack of Efficacy|1|||
130809416|NCT01475825|470928599|FG003|Overall Study|Lack of Efficacy|0|||
130809417|NCT01475825|470928596|FG000|Overall Study|Lost to Follow-up|0|||
130809418|NCT01475825|470928597|FG001|Overall Study|Lost to Follow-up|0|||
130809419|NCT01475825|470928598|FG002|Overall Study|Lost to Follow-up|3|||
130809420|NCT01475825|470928599|FG003|Overall Study|Lost to Follow-up|1|||
130809421|NCT01475825|470928596|FG000|Overall Study|Non-compliance with Study Drug|1|||
130809422|NCT01475825|470928597|FG001|Overall Study|Non-compliance with Study Drug|2|||
130809423|NCT01475825|470928598|FG002|Overall Study|Non-compliance with Study Drug|4|||
130809424|NCT01475825|470928599|FG003|Overall Study|Non-compliance with Study Drug|0|||
130809425|NCT01475825|470928596|FG000|Overall Study|Other: Not available|0|||
130809426|NCT01475825|470928597|FG001|Overall Study|Other: Not available|0|||
130809427|NCT01475825|470928598|FG002|Overall Study|Other: Not available|2|||
130809428|NCT01475825|470928599|FG003|Overall Study|Other: Not available|0|||
130809429|NCT01475825|470928596|FG000|Overall Study|Protocol Violation|1|||
130809430|NCT01475825|470928597|FG001|Overall Study|Protocol Violation|0|||
130809431|NCT01475825|470928598|FG002|Overall Study|Protocol Violation|0|||
130809432|NCT01475825|470928599|FG003|Overall Study|Protocol Violation|0|||
130809433|NCT01475825|470928596|FG000|Overall Study|Physician Decision|0|||
130809434|NCT01475825|470928597|FG001|Overall Study|Physician Decision|1|||
130809435|NCT01475825|470928598|FG002|Overall Study|Physician Decision|0|||
130809436|NCT01475825|470928599|FG003|Overall Study|Physician Decision|0|||
130809437|NCT01475825|470928596|FG000|Overall Study|Withdrawal by Subject|8|||
130809438|NCT01475825|470928597|FG001|Overall Study|Withdrawal by Subject|3|||
130809439|NCT01475825|470928598|FG002|Overall Study|Withdrawal by Subject|11|||
130809440|NCT01475825|470928599|FG003|Overall Study|Withdrawal by Subject|7|||
130809441|NCT01475825|470928596|FG000|Overall Study|Did not enter OLC|15|||
130809442|NCT01475825|470928597|FG001|Overall Study|Did not enter OLC|11|||
130809443|NCT01475825|470928598|FG002|Overall Study|Did not enter OLC|15|||
130809444|NCT01475825|470928599|FG003|Overall Study|Did not enter OLC|11|||
130809445|NCT00309946|470928602|FG000|Overall Study|Withdrawal by Subject|1|||
130809446|NCT02624687|470928606|FG000|Overall Study|Withdrawal by Subject|1|||
130809447|NCT02624687|470928607|FG001|Overall Study|Withdrawal by Subject|1|||
130809448|NCT02624687|470928606|FG000|Overall Study|medical leave from work|0|||
130809449|NCT02624687|470928607|FG001|Overall Study|medical leave from work|1|||
130809450|NCT03111108|470928608|FG000|Overall Study|Death|0|||
130809451|NCT03111108|470928609|FG001|Overall Study|Death|1|||
130809452|NCT03111108|470928608|FG000|Overall Study|Withdrawal by Subject|1|||
130809453|NCT03111108|470928609|FG001|Overall Study|Withdrawal by Subject|0|||
130809454|NCT02771145|470928610|FG000|Overall Study|Adverse Event|3|||
130809455|NCT02771145|470928610|FG000|Overall Study|Lost to Follow-up|1|||
130809456|NCT02662582|470928611|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
130809457|NCT02662582|470928612|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
130809458|NCT02662582|470928611|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
130809459|NCT02662582|470928612|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
130809460|NCT02662582|470928611|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
130809461|NCT02662582|470928612|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
130809462|NCT02662582|470928611|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130809463|NCT02662582|470928612|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130809464|NCT00511199|470928614|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
130809465|NCT00511199|470928615|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
130809466|NCT00511199|470928614|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
130809467|NCT00511199|470928615|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
130809468|NCT00511199|470928614|FG000|Overall Study|Withdrawal of Informed Consent|19|||
130809469|NCT00511199|470928615|FG001|Overall Study|Withdrawal of Informed Consent|4|||
130809470|NCT00511199|470928614|FG000|Overall Study|Pregnancy|6|||
130809471|NCT00511199|470928615|FG001|Overall Study|Pregnancy|3|||
130809472|NCT00511199|470928614|FG000|Overall Study|Pregnancy Wish|16|||
130809473|NCT00511199|470928615|FG001|Overall Study|Pregnancy Wish|8|||
130809474|NCT00511199|470928614|FG000|Overall Study|Lost to Follow-up|40|||
130809475|NCT00511199|470928615|FG001|Overall Study|Lost to Follow-up|17|||
130809476|NCT00511199|470928614|FG000|Overall Study|Other Reason|78|||
130809477|NCT00511199|470928615|FG001|Overall Study|Other Reason|37|||
130809478|NCT01953354|470928621|FG000|Overall Study|Withdrawal by Subject|0|||
130809479|NCT01953354|470928622|FG001|Overall Study|Withdrawal by Subject|1|||
130809480|NCT01953354|470928621|FG000|Overall Study|Decision of Sponsor|0|||
130809481|NCT01953354|470928622|FG001|Overall Study|Decision of Sponsor|1|||
130809482|NCT01953354|470928621|FG000|Overall Study|Disease Exacerbation|1|||
130809483|NCT01953354|470928622|FG001|Overall Study|Disease Exacerbation|0|||
130809484|NCT00806026|470928623|FG000|Overall Study|Death|0|||
130809485|NCT00806026|470928624|FG001|Overall Study|Death|0|||
130809486|NCT00806026|470928625|FG002|Overall Study|Death|0|||
130809487|NCT00806026|470928626|FG003|Overall Study|Death|1|||
130809488|NCT00806026|470928627|FG004|Overall Study|Death|0|||
130809489|NCT00806026|470928628|FG005|Overall Study|Death|0|||
130809490|NCT00806026|470928623|FG000|Overall Study|Did not meet entrance criteria|4|||
130809491|NCT00806026|470928624|FG001|Overall Study|Did not meet entrance criteria|1|||
130809492|NCT00806026|470928625|FG002|Overall Study|Did not meet entrance criteria|2|||
130809493|NCT00806026|470928626|FG003|Overall Study|Did not meet entrance criteria|1|||
130809494|NCT00806026|470928627|FG004|Overall Study|Did not meet entrance criteria|0|||
130809495|NCT00806026|470928628|FG005|Overall Study|Did not meet entrance criteria|0|||
130809496|NCT00806026|470928623|FG000|Overall Study|Lack of Efficacy|5|||
130809497|NCT00806026|470928624|FG001|Overall Study|Lack of Efficacy|18|||
130809498|NCT00806026|470928625|FG002|Overall Study|Lack of Efficacy|13|||
130809499|NCT00806026|470928626|FG003|Overall Study|Lack of Efficacy|4|||
130809500|NCT00806026|470928627|FG004|Overall Study|Lack of Efficacy|8|||
130809501|NCT00806026|470928628|FG005|Overall Study|Lack of Efficacy|7|||
130809502|NCT00806026|470928623|FG000|Overall Study|Lost to Follow-up|8|||
130809503|NCT00806026|470928624|FG001|Overall Study|Lost to Follow-up|15|||
130809504|NCT00806026|470928625|FG002|Overall Study|Lost to Follow-up|8|||
130809505|NCT00806026|470928626|FG003|Overall Study|Lost to Follow-up|2|||
130809506|NCT00806026|470928627|FG004|Overall Study|Lost to Follow-up|6|||
130809507|NCT00806026|470928628|FG005|Overall Study|Lost to Follow-up|6|||
130809508|NCT00806026|470928623|FG000|Overall Study|Withdrawal by Subject|14|||
130809509|NCT00806026|470928624|FG001|Overall Study|Withdrawal by Subject|17|||
130809510|NCT00806026|470928625|FG002|Overall Study|Withdrawal by Subject|9|||
130809511|NCT00806026|470928626|FG003|Overall Study|Withdrawal by Subject|2|||
130809512|NCT00806026|470928627|FG004|Overall Study|Withdrawal by Subject|5|||
130809513|NCT00806026|470928628|FG005|Overall Study|Withdrawal by Subject|3|||
130809514|NCT00806026|470928623|FG000|Overall Study|Other|3|||
130809515|NCT00806026|470928624|FG001|Overall Study|Other|6|||
130809516|NCT00806026|470928625|FG002|Overall Study|Other|8|||
130809517|NCT00806026|470928626|FG003|Overall Study|Other|2|||
130809518|NCT00806026|470928627|FG004|Overall Study|Other|0|||
130809519|NCT00806026|470928628|FG005|Overall Study|Other|4|||
130809520|NCT00806026|470928623|FG000|Overall Study|Protocol Violation|6|||
130809521|NCT00806026|470928624|FG001|Overall Study|Protocol Violation|9|||
130809522|NCT00806026|470928625|FG002|Overall Study|Protocol Violation|9|||
130809523|NCT00806026|470928626|FG003|Overall Study|Protocol Violation|0|||
130809524|NCT00806026|470928627|FG004|Overall Study|Protocol Violation|2|||
130809525|NCT00806026|470928628|FG005|Overall Study|Protocol Violation|3|||
130809526|NCT00806026|470928623|FG000|Overall Study|Adverse Event|52|||
130809527|NCT00806026|470928624|FG001|Overall Study|Adverse Event|35|||
130809528|NCT00806026|470928625|FG002|Overall Study|Adverse Event|44|||
130809529|NCT00806026|470928626|FG003|Overall Study|Adverse Event|17|||
130809530|NCT00806026|470928627|FG004|Overall Study|Adverse Event|9|||
130809531|NCT00806026|470928628|FG005|Overall Study|Adverse Event|9|||
130809532|NCT03180138|470928629|FG000|Overall Study|Mobile-phone could not be verified|2|||
130809533|NCT03180138|470928630|FG001|Overall Study|Mobile-phone could not be verified|13|||
130809534|NCT03180138|470928631|FG002|Overall Study|Mobile-phone could not be verified|15|||
130809535|NCT03180138|470928629|FG000|Overall Study|No prior immunization records|17|||
130809536|NCT03180138|470928630|FG001|Overall Study|No prior immunization records|0|||
130809537|NCT03180138|470928631|FG002|Overall Study|No prior immunization records|6|||
130809538|NCT03180138|470928629|FG000|Overall Study|Found to be >24 mon after randomization|3|||
130809539|NCT03180138|470928630|FG001|Overall Study|Found to be >24 mon after randomization|0|||
130809540|NCT03180138|470928631|FG002|Overall Study|Found to be >24 mon after randomization|3|||
130809541|NCT00452530|470928633|FG000|Overall Study|Death|1|||
130809542|NCT00452530|470928634|FG001|Overall Study|Death|0|||
130809543|NCT00452530|470928633|FG000|Overall Study|Adverse Event|40|||
130809544|NCT00452530|470928634|FG001|Overall Study|Adverse Event|44|||
130809545|NCT00452530|470928633|FG000|Overall Study|Withdrawal by Subject|68|||
130809546|NCT00452530|470928634|FG001|Overall Study|Withdrawal by Subject|57|||
130809547|NCT00452530|470928633|FG000|Overall Study|Lost to Follow-up|1|||
130809548|NCT00452530|470928634|FG001|Overall Study|Lost to Follow-up|0|||
130809549|NCT00452530|470928633|FG000|Overall Study|Poor compliance/noncompliance|1|||
130809550|NCT00452530|470928634|FG001|Overall Study|Poor compliance/noncompliance|2|||
130809551|NCT00452530|470928633|FG000|Overall Study|No longer met study criteria|18|||
130809552|NCT00452530|470928634|FG001|Overall Study|No longer met study criteria|22|||
130809553|NCT00452530|470928633|FG000|Overall Study|Other|7|||
130809554|NCT00452530|470928634|FG001|Overall Study|Other|11|||
130809555|NCT02100644|470928635|FG000|LTG Escalation Phase|Adverse Event|9|||
130809556|NCT02100644|470928636|FG001|LTG Escalation Phase|Adverse Event|0|||
130809557|NCT02100644|470928637|FG002|LTG Escalation Phase|Adverse Event|0|||
130809558|NCT02100644|470928635|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
130809559|NCT02100644|470928636|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
130809560|NCT02100644|470928637|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
130809561|NCT02100644|470928635|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
130809562|NCT02100644|470928636|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
130809563|NCT02100644|470928637|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
130809564|NCT01898091|470928638|FG000|Overall Study|Lost to Follow-up|1|||
130809565|NCT01898091|470928639|FG001|Overall Study|Lost to Follow-up|1|||
130809566|NCT01898091|470928638|FG000|Overall Study|Withdrawal by Subject|1|||
130809567|NCT01898091|470928639|FG001|Overall Study|Withdrawal by Subject|5|||
130809568|NCT00507507|470928640|FG000|Treatment Period|Lost to Follow-up|0|||
130809569|NCT00507507|470928641|FG001|Treatment Period|Lost to Follow-up|2|||
130809570|NCT00507507|470928640|FG000|Treatment Period|Physician Decision|4|||
130809571|NCT00507507|470928641|FG001|Treatment Period|Physician Decision|1|||
130809572|NCT00507507|470928640|FG000|Treatment Period|Protocol Violation|1|||
130809573|NCT00507507|470928641|FG001|Treatment Period|Protocol Violation|2|||
130809574|NCT00507507|470928640|FG000|Treatment Period|Adverse Event|1|||
130809575|NCT00507507|470928641|FG001|Treatment Period|Adverse Event|1|||
130809576|NCT00507507|470928640|FG000|Treatment Period|Withdrawal by Subject|46|||
130809577|NCT00507507|470928641|FG001|Treatment Period|Withdrawal by Subject|47|||
130809578|NCT00507507|470928640|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
130809579|NCT00507507|470928641|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
130809580|NCT00507507|470928640|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
130809581|NCT00507507|470928641|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
130809582|NCT00507507|470928640|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
130809583|NCT00507507|470928641|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
130809584|NCT02916433|470928642|FG000|Overall Study|Withdrawal by Subject|1|||
130809585|NCT02916433|470928643|FG001|Overall Study|Withdrawal by Subject|0|||
130809586|NCT02916433|470928642|FG000|Overall Study|Physician Decision|1|||
130809587|NCT02916433|470928643|FG001|Overall Study|Physician Decision|0|||
130809588|NCT03760666|470928644|FG000|Overall Study|Adverse Event|2|||
130809589|NCT03760666|470928645|FG001|Overall Study|Adverse Event|4|||
130809590|NCT03760666|470928646|FG002|Overall Study|Adverse Event|1|||
130809591|NCT03760666|470928644|FG000|Overall Study|AML Disease Progression|3|||
130809592|NCT03760666|470928645|FG001|Overall Study|AML Disease Progression|3|||
130809593|NCT03760666|470928646|FG002|Overall Study|AML Disease Progression|0|||
130809594|NCT03760666|470928644|FG000|Overall Study|Physician Decision|0|||
130809595|NCT03760666|470928645|FG001|Overall Study|Physician Decision|3|||
130809596|NCT03760666|470928646|FG002|Overall Study|Physician Decision|0|||
130809597|NCT03760666|470928644|FG000|Overall Study|Withdrawal by Subject|0|||
130809598|NCT03760666|470928645|FG001|Overall Study|Withdrawal by Subject|1|||
130809599|NCT03760666|470928646|FG002|Overall Study|Withdrawal by Subject|0|||
130809600|NCT01623154|470928647|FG000|Overall Study|Did not drink Pranactin Citric|4|||
130809601|NCT00890097|470928648|FG000|Overall Study|Adverse Event|21|||
130809602|NCT00890097|470928649|FG001|Overall Study|Adverse Event|32|||
130809603|NCT00890097|470928650|FG002|Overall Study|Adverse Event|28|||
130809604|NCT00890097|470928648|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
130809605|NCT00890097|470928649|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
130809606|NCT00890097|470928650|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
130809607|NCT00890097|470928648|FG000|Overall Study|Withdrew Consent|9|||
130809608|NCT00890097|470928649|FG001|Overall Study|Withdrew Consent|6|||
130809609|NCT00890097|470928650|FG002|Overall Study|Withdrew Consent|9|||
130809610|NCT00890097|470928648|FG000|Overall Study|Lost to Follow-up|5|||
130809611|NCT00890097|470928649|FG001|Overall Study|Lost to Follow-up|5|||
130809612|NCT00890097|470928650|FG002|Overall Study|Lost to Follow-up|5|||
130809613|NCT00890097|470928648|FG000|Overall Study|Noncompliance|0|||
130809614|NCT00890097|470928649|FG001|Overall Study|Noncompliance|4|||
130809615|NCT00890097|470928650|FG002|Overall Study|Noncompliance|4|||
130809616|NCT00890097|470928648|FG000|Overall Study|Sponsor Decision|7|||
130809617|NCT00890097|470928649|FG001|Overall Study|Sponsor Decision|11|||
130809618|NCT00890097|470928650|FG002|Overall Study|Sponsor Decision|7|||
130809619|NCT00890097|470928648|FG000|Overall Study|Did not attend final visit|2|||
130809620|NCT00890097|470928649|FG001|Overall Study|Did not attend final visit|3|||
130809621|NCT00890097|470928650|FG002|Overall Study|Did not attend final visit|0|||
130809622|NCT00890097|470928648|FG000|Overall Study|Subject Decision|3|||
130809623|NCT00890097|470928649|FG001|Overall Study|Subject Decision|2|||
130809624|NCT00890097|470928650|FG002|Overall Study|Subject Decision|6|||
130809625|NCT00890097|470928648|FG000|Overall Study|Randomization Error|2|||
130809626|NCT00890097|470928649|FG001|Overall Study|Randomization Error|0|||
130809627|NCT00890097|470928650|FG002|Overall Study|Randomization Error|0|||
130809628|NCT00890097|470928648|FG000|Overall Study|Failed inclusion criteria|3|||
130809629|NCT00890097|470928649|FG001|Overall Study|Failed inclusion criteria|4|||
130809630|NCT00890097|470928650|FG002|Overall Study|Failed inclusion criteria|0|||
130809631|NCT00890097|470928648|FG000|Overall Study|Transportation|0|||
130809632|NCT00890097|470928649|FG001|Overall Study|Transportation|2|||
130809633|NCT00890097|470928650|FG002|Overall Study|Transportation|0|||
130809634|NCT00890097|470928648|FG000|Overall Study|Subject Moved|0|||
130809635|NCT00890097|470928649|FG001|Overall Study|Subject Moved|4|||
130809636|NCT00890097|470928650|FG002|Overall Study|Subject Moved|0|||
130809637|NCT00890097|470928648|FG000|Overall Study|Protocol Deviation|1|||
130809638|NCT00890097|470928649|FG001|Overall Study|Protocol Deviation|1|||
130809639|NCT00890097|470928650|FG002|Overall Study|Protocol Deviation|1|||
130809640|NCT02656173|470928654|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
130809641|NCT02656173|470928655|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
130809642|NCT02656173|470928654|FG000|Overall Study|Adverse Event|7|||
130809643|NCT02656173|470928655|FG001|Overall Study|Adverse Event|5|||
130809644|NCT02656173|470928654|FG000|Overall Study|Withdrawal by Subject|1|||
130809645|NCT02656173|470928655|FG001|Overall Study|Withdrawal by Subject|3|||
130809646|NCT02656173|470928654|FG000|Overall Study|Protocol Violation|0|||
130809647|NCT02656173|470928655|FG001|Overall Study|Protocol Violation|1|||
130809648|NCT02656173|470928654|FG000|Overall Study|Miscellaneous|2|||
130809649|NCT02656173|470928655|FG001|Overall Study|Miscellaneous|0|||
130809650|NCT01064622|470928656|FG000|Randomized Phase II|Withdrawal by Subject|2|||
130809651|NCT01064622|470928657|FG001|Randomized Phase II|Withdrawal by Subject|2|||
130809652|NCT01064622|470928656|FG000|Randomized Phase II|Protocol Violation|0|||
130809653|NCT01064622|470928657|FG001|Randomized Phase II|Protocol Violation|1|||
130809654|NCT03449147|470928658|FG000|52-week Treatment Period|Death|0|||
130809655|NCT03449147|470928659|FG001|52-week Treatment Period|Death|1|||
130809656|NCT03449147|470928660|FG002|52-week Treatment Period|Death|0|||
130809657|NCT03449147|470928658|FG000|52-week Treatment Period|Lost to Follow-up|6|||
130809658|NCT03449147|470928659|FG001|52-week Treatment Period|Lost to Follow-up|2|||
130809659|NCT03449147|470928660|FG002|52-week Treatment Period|Lost to Follow-up|5|||
130809660|NCT03449147|470928658|FG000|52-week Treatment Period|Other|0|||
130809661|NCT03449147|470928659|FG001|52-week Treatment Period|Other|1|||
130809662|NCT03449147|470928660|FG002|52-week Treatment Period|Other|2|||
130809663|NCT03449147|470928658|FG000|52-week Treatment Period|Physician Decision|1|||
130809664|NCT03449147|470928659|FG001|52-week Treatment Period|Physician Decision|0|||
130809665|NCT03449147|470928660|FG002|52-week Treatment Period|Physician Decision|3|||
130809666|NCT03449147|470928658|FG000|52-week Treatment Period|Screen Failure|1|||
130809667|NCT03449147|470928659|FG001|52-week Treatment Period|Screen Failure|2|||
130809668|NCT03449147|470928660|FG002|52-week Treatment Period|Screen Failure|0|||
130809669|NCT03449147|470928658|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
130809670|NCT03449147|470928659|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
130809671|NCT03449147|470928660|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
130809672|NCT03449147|470928658|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
130809673|NCT03449147|470928659|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
130809674|NCT03449147|470928660|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
130809675|NCT03449147|470928658|FG000|12-Week Off-Treatment Durability Period|Other|0|||
130809676|NCT03449147|470928659|FG001|12-Week Off-Treatment Durability Period|Other|1|||
130809677|NCT03449147|470928660|FG002|12-Week Off-Treatment Durability Period|Other|0|||
130809678|NCT00974233|470928664|FG000|Induction Chemoimmunotherapy|Death|2|||
130809679|NCT00974233|470928664|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
130809680|NCT00974233|470928664|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
130809681|NCT00974233|470928664|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
130809682|NCT00974233|470928664|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
130809683|NCT00974233|470928664|FG000|Maintenance Lenalidomide|Adverse Event|8|||
130809684|NCT01691092|470928665|FG000|Overall Study|Lost to Follow-up|10|||
130809685|NCT01691092|470928665|FG000|Overall Study|Physician Decision|4|||
130809686|NCT01691092|470928665|FG000|Overall Study|Withdrawal by Subject|3|||
130809687|NCT01691092|470928665|FG000|Overall Study|non-compliance|3|||
130809688|NCT01691092|470928665|FG000|Overall Study|used for different study|2|||
130809689|NCT01691092|470928665|FG000|Overall Study|screen fail|19|||
130809690|NCT01657942|470928666|FG000|Overall Study|Alternative Treatment|7|||
130809691|NCT01657942|470928666|FG000|Overall Study|Lost to Follow-up|1|||
130809692|NCT05520333|470930441|FG000|Overall Study|Lost to Follow-up|3|||
130809693|NCT05520333|470930442|FG001|Overall Study|Lost to Follow-up|6|||
130809694|NCT00185614|470930443|FG000|Inter-treatment Period|Physician Decision|1|||
130809695|NCT00185614|470930443|FG000|Inter-treatment Period|Relapse|2|||
130809696|NCT00185614|470930443|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
130809697|NCT02457546|470930444|FG000|Overall Study|Other reasons|4|||
130809698|NCT02457546|470930445|FG001|Overall Study|Other reasons|1|||
130809699|NCT02457546|470930444|FG000|Overall Study|Refused to complete study/procedures|1|||
130809700|NCT02457546|470930445|FG001|Overall Study|Refused to complete study/procedures|1|||
130809701|NCT02457546|470930444|FG000|Overall Study|Lost to Follow-up|4|||
130809702|NCT02457546|470930445|FG001|Overall Study|Lost to Follow-up|1|||
130809703|NCT02457546|470930444|FG000|Overall Study|Adverse Event|0|||
130809704|NCT02457546|470930445|FG001|Overall Study|Adverse Event|1|||
130809705|NCT01661595|470930446|FG000|Phase 1: Week 0-4|Adverse Event|1|||
130809706|NCT01661595|470930447|FG001|Phase 1: Week 0-4|Adverse Event|0|||
130809707|NCT01661595|470930448|FG002|Phase 1: Week 0-4|Adverse Event|0|||
130809708|NCT01661595|470930449|FG003|Phase 1: Week 0-4|Adverse Event|0|||
130809709|NCT01661595|470930446|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
130809710|NCT01661595|470930447|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
130809711|NCT01661595|470930448|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
130809712|NCT01661595|470930449|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
130809713|NCT00912509|470930450|FG000|Overall Study|Lost to Follow-up|1|||
130809714|NCT00912509|470930451|FG001|Overall Study|Lost to Follow-up|0|||
130809715|NCT00912509|470930450|FG000|Overall Study|Lack of Efficacy|4|||
130809716|NCT00912509|470930451|FG001|Overall Study|Lack of Efficacy|3|||
130809717|NCT02715856|470930452|FG000|Overall Study|Software Issues|12|||
130809718|NCT02715856|470930453|FG001|Overall Study|Software Issues|7|||
130809719|NCT02715856|470930452|FG000|Overall Study|Death|6|||
130809720|NCT02715856|470930453|FG001|Overall Study|Death|5|||
130809721|NCT02715856|470930452|FG000|Overall Study|Non- Compliant|0|||
130809722|NCT02715856|470930453|FG001|Overall Study|Non- Compliant|40|||
130809723|NCT01772693|470930454|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
130809724|NCT01772693|470930455|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
130809725|NCT01772693|470930454|FG000|Overall Study|Withdrawal by Subject|2|||
130809726|NCT01772693|470930455|FG001|Overall Study|Withdrawal by Subject|0|||
130809727|NCT01772693|470930454|FG000|Overall Study|Alternative Treatment|2|||
130809728|NCT01772693|470930455|FG001|Overall Study|Alternative Treatment|0|||
130809729|NCT01633112|470930456|FG000|Overall Study|Lack of Efficacy|1|||
130809730|NCT01633112|470930457|FG001|Overall Study|Lack of Efficacy|6|||
130809731|NCT01633112|470930458|FG002|Overall Study|Lack of Efficacy|13|||
130809732|NCT01633112|470930456|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130809733|NCT01633112|470930457|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130809734|NCT01633112|470930458|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130809735|NCT01633112|470930456|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130809736|NCT01633112|470930457|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130809737|NCT01633112|470930458|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130809738|NCT01633112|470930456|FG000|Overall Study|Administrative problems|1|||
130809739|NCT01633112|470930457|FG001|Overall Study|Administrative problems|2|||
130809740|NCT01633112|470930458|FG002|Overall Study|Administrative problems|5|||
130809741|NCT01633112|470930456|FG000|Overall Study|Adverse Event|16|||
130809742|NCT01633112|470930457|FG001|Overall Study|Adverse Event|18|||
130809743|NCT01633112|470930458|FG002|Overall Study|Adverse Event|20|||
130809744|NCT01633112|470930456|FG000|Overall Study|Lost to Follow-up|7|||
130809745|NCT01633112|470930457|FG001|Overall Study|Lost to Follow-up|19|||
130809746|NCT01633112|470930458|FG002|Overall Study|Lost to Follow-up|6|||
130809747|NCT01633112|470930456|FG000|Overall Study|Protocol Violation|4|||
130809748|NCT01633112|470930457|FG001|Overall Study|Protocol Violation|0|||
130809749|NCT01633112|470930458|FG002|Overall Study|Protocol Violation|2|||
130809750|NCT01633112|470930456|FG000|Overall Study|Subject no longer requires study drug|0|||
130809751|NCT01633112|470930457|FG001|Overall Study|Subject no longer requires study drug|0|||
130809752|NCT01633112|470930458|FG002|Overall Study|Subject no longer requires study drug|1|||
130809753|NCT01633112|470930456|FG000|Overall Study|Withdrawal by Subject|20|||
130809754|NCT01633112|470930457|FG001|Overall Study|Withdrawal by Subject|12|||
130809755|NCT01633112|470930458|FG002|Overall Study|Withdrawal by Subject|41|||
130809756|NCT01633112|470930456|FG000|Overall Study|missing Study Completion CRF|1|||
130809757|NCT01633112|470930457|FG001|Overall Study|missing Study Completion CRF|1|||
130809758|NCT01633112|470930458|FG002|Overall Study|missing Study Completion CRF|4|||
130809759|NCT01908699|470930459|FG000|Overall Study|Adverse Event|8|||
130809760|NCT01908699|470930460|FG001|Overall Study|Adverse Event|12|||
130809761|NCT01908699|470930459|FG000|Overall Study|Lack of Efficacy|2|||
130809762|NCT01908699|470930460|FG001|Overall Study|Lack of Efficacy|2|||
130809763|NCT01908699|470930459|FG000|Overall Study|Lost to Follow-up|2|||
130809764|NCT01908699|470930460|FG001|Overall Study|Lost to Follow-up|4|||
130809765|NCT01908699|470930459|FG000|Overall Study|Physician Decision|8|||
130809766|NCT01908699|470930460|FG001|Overall Study|Physician Decision|8|||
130809767|NCT01908699|470930459|FG000|Overall Study|Withdrawal by Subject|15|||
130809768|NCT01908699|470930460|FG001|Overall Study|Withdrawal by Subject|10|||
130809769|NCT01908699|470930459|FG000|Overall Study|Pregnancy|0|||
130809770|NCT01908699|470930460|FG001|Overall Study|Pregnancy|1|||
130809771|NCT01908699|470930459|FG000|Overall Study|Randomized in Error|1|||
130809772|NCT01908699|470930460|FG001|Overall Study|Randomized in Error|0|||
130809773|NCT01908699|470930459|FG000|Overall Study|Death|9|||
130809774|NCT01908699|470930460|FG001|Overall Study|Death|12|||
130809775|NCT01908699|470930459|FG000|Overall Study|Progressive Disease|30|||
130809776|NCT01908699|470930460|FG001|Overall Study|Progressive Disease|29|||
130809777|NCT03439072|470930461|FG000|Overall Study|Withdrawal by Subject|2|||
130809778|NCT03439072|470930462|FG001|Overall Study|Withdrawal by Subject|3|||
130809779|NCT03439072|470930461|FG000|Overall Study|Physician Decision|0|||
130809780|NCT03439072|470930462|FG001|Overall Study|Physician Decision|1|||
130809781|NCT01537432|470930466|FG000|Overall Study|Lost to Follow-up|3|||
130809782|NCT01537432|470930467|FG001|Overall Study|Lost to Follow-up|1|||
130809783|NCT01537432|470930466|FG000|Overall Study|Withdrawal by Subject|0|||
130809784|NCT01537432|470930467|FG001|Overall Study|Withdrawal by Subject|1|||
130809785|NCT01537432|470930466|FG000|Overall Study|Administrative problems|1|||
130809786|NCT01537432|470930467|FG001|Overall Study|Administrative problems|0|||
130809787|NCT01537432|470930466|FG000|Overall Study|Adverse Event|1|||
130809788|NCT01537432|470930467|FG001|Overall Study|Adverse Event|0|||
130809789|NCT01537432|470930466|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130809790|NCT01537432|470930467|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130809791|NCT00889005|470930468|FG000|Overall Study|Lost to Follow-up|4|||
130809792|NCT00889005|470930469|FG001|Overall Study|Lost to Follow-up|2|||
130809793|NCT00889005|470930468|FG000|Overall Study|Withdrawal by Subject|4|||
130809794|NCT00889005|470930469|FG001|Overall Study|Withdrawal by Subject|0|||
130809795|NCT05166902|470930470|FG000|First Intervention|Lost to Follow-up|0|||
130809796|NCT05166902|470930471|FG001|First Intervention|Lost to Follow-up|1|||
130809797|NCT01998477|470930472|FG000|Overall Study|Lost to Follow-up|4|||
130809798|NCT01998477|470930473|FG001|Overall Study|Lost to Follow-up|5|||
130809799|NCT01998477|470930472|FG000|Overall Study|Withdrawal by Subject|6|||
130809800|NCT01998477|470930473|FG001|Overall Study|Withdrawal by Subject|0|||
130809801|NCT00779909|470930474|FG000|Overall Study|Lost to Follow-up|1|||
130809802|NCT00779909|470930475|FG001|Overall Study|Lost to Follow-up|0|||
130809803|NCT00779909|470930476|FG002|Overall Study|Lost to Follow-up|0|||
130809804|NCT00779909|470930477|FG003|Overall Study|Lost to Follow-up|1|||
130809805|NCT00779909|470930474|FG000|Overall Study|Withdrawal by Subject|0|||
130809806|NCT00779909|470930475|FG001|Overall Study|Withdrawal by Subject|1|||
130809807|NCT00779909|470930476|FG002|Overall Study|Withdrawal by Subject|0|||
130809808|NCT00779909|470930477|FG003|Overall Study|Withdrawal by Subject|0|||
130809809|NCT03523585|470930478|FG000|Overall Study|Progressive Disease|174|||
130809810|NCT03523585|470930479|FG001|Overall Study|Progressive Disease|64|||
130809811|NCT03523585|470930480|FG002|Overall Study|Progressive Disease|77|||
130809812|NCT03523585|470930478|FG000|Overall Study|Adverse Event|74|||
130809813|NCT03523585|470930479|FG001|Overall Study|Adverse Event|5|||
130809814|NCT03523585|470930480|FG002|Overall Study|Adverse Event|9|||
130809815|NCT03523585|470930478|FG000|Overall Study|Withdrawal by Subject|30|||
130809816|NCT03523585|470930479|FG001|Overall Study|Withdrawal by Subject|11|||
130809817|NCT03523585|470930480|FG002|Overall Study|Withdrawal by Subject|6|||
130809818|NCT03523585|470930478|FG000|Overall Study|Clinical Progression|23|||
130809819|NCT03523585|470930479|FG001|Overall Study|Clinical Progression|5|||
130809820|NCT03523585|470930480|FG002|Overall Study|Clinical Progression|10|||
130809821|NCT03523585|470930478|FG000|Overall Study|Death|4|||
130809822|NCT03523585|470930479|FG001|Overall Study|Death|0|||
130809823|NCT03523585|470930480|FG002|Overall Study|Death|1|||
130809824|NCT03523585|470930478|FG000|Overall Study|Physician Decision|2|||
130809825|NCT03523585|470930479|FG001|Overall Study|Physician Decision|1|||
130809826|NCT03523585|470930480|FG002|Overall Study|Physician Decision|0|||
130809827|NCT03523585|470930478|FG000|Overall Study|Lost to Follow-up|1|||
130809828|NCT03523585|470930479|FG001|Overall Study|Lost to Follow-up|0|||
130809829|NCT03523585|470930480|FG002|Overall Study|Lost to Follow-up|0|||
130809830|NCT03523585|470930478|FG000|Overall Study|Miscellaneous|1|||
130809831|NCT03523585|470930479|FG001|Overall Study|Miscellaneous|0|||
130809832|NCT03523585|470930480|FG002|Overall Study|Miscellaneous|0|||
130809833|NCT03523585|470930478|FG000|Overall Study|Protocol Deviation|1|||
130809834|NCT03523585|470930479|FG001|Overall Study|Protocol Deviation|0|||
130809835|NCT03523585|470930480|FG002|Overall Study|Protocol Deviation|1|||
130809836|NCT03523585|470930478|FG000|Overall Study|Randomized But Not Treated|2|||
130809837|NCT03523585|470930479|FG001|Overall Study|Randomized But Not Treated|4|||
130809838|NCT03523585|470930480|FG002|Overall Study|Randomized But Not Treated|3|||
130809839|NCT02872142|470930486|FG000|Overall Study|Adverse Event|2|||
130809840|NCT02872142|470930486|FG000|Overall Study|Death|1|||
130809841|NCT02872142|470930486|FG000|Overall Study|Participant Decision|3|||
130809842|NCT01903720|470930487|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
130809843|NCT01903720|470930487|FG000|Overall Study|Adverse Event|1|||
130809844|NCT01903720|470930487|FG000|Overall Study|Rescinding of informed consent|2|||
130809845|NCT01903720|470930487|FG000|Overall Study|Lost to Follow-up|2|||
130809846|NCT01903720|470930487|FG000|Overall Study|Treatment with alternative drug|1|||
130809847|NCT00692237|470930488|FG000|Overall Study|Withdrawal by Subject|1|||
130809848|NCT00692237|470930489|FG001|Overall Study|Withdrawal by Subject|3|||
130809849|NCT00692237|470930488|FG000|Overall Study|Adverse Event|0|||
130809850|NCT00692237|470930489|FG001|Overall Study|Adverse Event|1|||
130809851|NCT02244957|470930490|FG000|Overall Study|Lack of Efficacy|1|||
130809852|NCT02244957|470930491|FG001|Overall Study|Lack of Efficacy|0|||
130809853|NCT01347086|470930492|FG000|Overall Study|failed screening visit|0|||
130809854|NCT01347086|470930493|FG001|Overall Study|failed screening visit|0|||
130809855|NCT01347086|470930494|FG002|Overall Study|failed screening visit|1|||
130809856|NCT01347086|470930495|FG003|Overall Study|failed screening visit|0|||
130809857|NCT01347086|470930496|FG004|Overall Study|failed screening visit|0|||
130809858|NCT01347086|470930497|FG005|Overall Study|failed screening visit|0|||
130809859|NCT01347086|470930498|FG006|Overall Study|failed screening visit|1|||
130809860|NCT01347086|470930499|FG007|Overall Study|failed screening visit|1|||
130809861|NCT01347086|470930500|FG008|Overall Study|failed screening visit|0|||
130809862|NCT01347086|470930501|FG009|Overall Study|failed screening visit|1|||
130809863|NCT00395447|470930502|FG000|Overall Study|Death|37|||
130809864|NCT00395447|470930503|FG001|Overall Study|Death|32|||
130809865|NCT00395447|470930502|FG000|Overall Study|Lost to Follow-up|52|||
130809866|NCT00395447|470930503|FG001|Overall Study|Lost to Follow-up|43|||
130809867|NCT00395447|470930502|FG000|Overall Study|Withdrawal by Subject|24|||
130809868|NCT00395447|470930503|FG001|Overall Study|Withdrawal by Subject|19|||
130809869|NCT00395447|470930502|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
130809870|NCT00395447|470930503|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
130809871|NCT02150863|470930505|FG000|Overall Study|Lost to Follow-up|0|||
130809872|NCT02150863|470930506|FG001|Overall Study|Lost to Follow-up|1|||
130809873|NCT02150863|470930507|FG002|Overall Study|Lost to Follow-up|0|||
130809874|NCT01651208|470930508|FG000|Overall Study|Lost to Follow-up|14|||
130809875|NCT01651208|470930509|FG001|Overall Study|Lost to Follow-up|16|||
130809876|NCT00104884|470930514|FG000|Overall Study|Disease progression|4|||
130809877|NCT05071027|470930518|FG000|Overall Study|Lost to Follow-up|1|||
130809878|NCT05071027|470930519|FG001|Overall Study|Lost to Follow-up|4|||
130809879|NCT02314247|470930524|FG000|Overall Study|Adverse Event|2|||
130809880|NCT02314247|470930525|FG001|Overall Study|Adverse Event|1|||
130809881|NCT02314247|470930526|FG002|Overall Study|Adverse Event|0|||
130809882|NCT02314247|470930524|FG000|Overall Study|Withdrawal by Subject|1|||
130809883|NCT02314247|470930525|FG001|Overall Study|Withdrawal by Subject|3|||
130809884|NCT02314247|470930526|FG002|Overall Study|Withdrawal by Subject|1|||
130809885|NCT02314247|470930524|FG000|Overall Study|Progression of Disease|6|||
130809886|NCT02314247|470930525|FG001|Overall Study|Progression of Disease|2|||
130809887|NCT02314247|470930526|FG002|Overall Study|Progression of Disease|0|||
130809888|NCT02965976|470930527|FG000|Overall Study|Withdrawal by Subject|2|||
130809889|NCT02965976|470930528|FG001|Overall Study|Withdrawal by Subject|0|||
130809890|NCT01687595|470930529|FG000|Overall Study|Withdrawal by Subject|8|||
130809891|NCT01687595|470930530|FG001|Overall Study|Withdrawal by Subject|0|||
130809892|NCT01687595|470930529|FG000|Overall Study|Lost to Follow-up|3|||
130809893|NCT01687595|470930530|FG001|Overall Study|Lost to Follow-up|1|||
130809894|NCT01687595|470930529|FG000|Overall Study|Investigator's decision|1|||
130809895|NCT01687595|470930530|FG001|Overall Study|Investigator's decision|0|||
130809896|NCT01687595|470930529|FG000|Overall Study|Sponsor's decision|1|||
130809897|NCT01687595|470930530|FG001|Overall Study|Sponsor's decision|0|||
130809898|NCT01687595|470930529|FG000|Overall Study|Noncompliance|1|||
130809899|NCT01687595|470930530|FG001|Overall Study|Noncompliance|2|||
130809900|NCT01687595|470930529|FG000|Overall Study|Other than specified|56|||
130809901|NCT01687595|470930530|FG001|Overall Study|Other than specified|7|||
130809902|NCT00489359|470930533|FG000|Overall Study|Death|0|||
130809903|NCT00489359|470930534|FG001|Overall Study|Death|2|||
130809904|NCT00489359|470930533|FG000|Overall Study|Progressive Disease|5|||
130809905|NCT00489359|470930534|FG001|Overall Study|Progressive Disease|6|||
130809906|NCT00489359|470930533|FG000|Overall Study|Lost to Follow-up|1|||
130809907|NCT00489359|470930534|FG001|Overall Study|Lost to Follow-up|0|||
130809908|NCT00489359|470930533|FG000|Overall Study|Withdrawal by Subject|1|||
130809909|NCT00489359|470930534|FG001|Overall Study|Withdrawal by Subject|5|||
130809910|NCT00489359|470930533|FG000|Overall Study|Adverse Event|0|||
130809911|NCT00489359|470930534|FG001|Overall Study|Adverse Event|16|||
130809912|NCT04191733|470930536|FG000|Overall Study|Withdrawn due to study closure|13|||
130809913|NCT04191733|470930537|FG001|Overall Study|Withdrawn due to study closure|14|||
130809914|NCT04191733|470930536|FG000|Overall Study|Withdrawal by Subject|2|||
130809915|NCT04191733|470930537|FG001|Overall Study|Withdrawal by Subject|4|||
130809916|NCT04191733|470930536|FG000|Overall Study|Physician Decision|1|||
130809917|NCT04191733|470930537|FG001|Overall Study|Physician Decision|1|||
130809918|NCT04191733|470930536|FG000|Overall Study|Lost to Follow-up|5|||
130809919|NCT04191733|470930537|FG001|Overall Study|Lost to Follow-up|6|||
130809920|NCT04191733|470930536|FG000|Overall Study|Death|0|||
130809921|NCT04191733|470930537|FG001|Overall Study|Death|1|||
130809922|NCT01903733|470930540|FG000|Overall Study|Death|23|||
130809923|NCT01903733|470930541|FG001|Overall Study|Death|54|||
130809924|NCT01903733|470930542|FG002|Overall Study|Death|30|||
130809925|NCT01903733|470930543|FG003|Overall Study|Death|98|||
130809926|NCT01903733|470930540|FG000|Overall Study|Participant refused further follow-up|35|||
130809927|NCT01903733|470930541|FG001|Overall Study|Participant refused further follow-up|38|||
130809928|NCT01903733|470930542|FG002|Overall Study|Participant refused further follow-up|13|||
130809929|NCT01903733|470930543|FG003|Overall Study|Participant refused further follow-up|9|||
130809930|NCT01903733|470930540|FG000|Overall Study|Lost to Follow-up|18|||
130809931|NCT01903733|470930541|FG001|Overall Study|Lost to Follow-up|19|||
130809932|NCT01903733|470930542|FG002|Overall Study|Lost to Follow-up|6|||
130809933|NCT01903733|470930543|FG003|Overall Study|Lost to Follow-up|9|||
130809934|NCT01903733|470930540|FG000|Overall Study|Other|10|||
130809935|NCT01903733|470930541|FG001|Overall Study|Other|15|||
130809936|NCT01903733|470930542|FG002|Overall Study|Other|12|||
130809937|NCT01903733|470930543|FG003|Overall Study|Other|3|||
130809938|NCT01903733|470930540|FG000|Overall Study|Missing|2|||
130809939|NCT01903733|470930541|FG001|Overall Study|Missing|0|||
130809940|NCT01903733|470930542|FG002|Overall Study|Missing|0|||
130809941|NCT01903733|470930543|FG003|Overall Study|Missing|0|||
130809942|NCT01903733|470930540|FG000|Overall Study|Investigator request|18|||
130809943|NCT01903733|470930541|FG001|Overall Study|Investigator request|0|||
130809944|NCT01903733|470930542|FG002|Overall Study|Investigator request|0|||
130809945|NCT01903733|470930543|FG003|Overall Study|Investigator request|0|||
130809946|NCT01714063|470930544|FG000|Overall Study|Equipment malfunction|2|||
130809947|NCT02294019|470930546|FG000|Overall Study|Adverse Event|2|||
130809948|NCT02294019|470930546|FG000|Overall Study|Protocol Violation|68|||
130809949|NCT02294019|470930546|FG000|Overall Study|Lost to Follow-up|31|||
130809950|NCT02294019|470930546|FG000|Overall Study|Other|1|||
130809951|NCT02294019|470930546|FG000|Overall Study|Withdrawal by Subject|1|||
130809952|NCT02369159|470930547|FG000|Overall Study|Adverse Event|0|||
130809953|NCT02369159|470930548|FG001|Overall Study|Adverse Event|1|||
130809954|NCT02369159|470930547|FG000|Overall Study|Lost to Follow-up|1|||
130809955|NCT02369159|470930548|FG001|Overall Study|Lost to Follow-up|1|||
130809956|NCT02369159|470930547|FG000|Overall Study|Withdrawal by Subject|7|||
130809957|NCT02369159|470930548|FG001|Overall Study|Withdrawal by Subject|0|||
130809958|NCT03769116|470930549|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
130809959|NCT03769116|470930550|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
130809960|NCT03769116|470930549|FG000|Part 3 - Open Label|Physician Decision|1|||
130809961|NCT03769116|470930550|FG001|Part 3 - Open Label|Physician Decision|0|||
130809962|NCT03769116|470930549|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
130809963|NCT03769116|470930550|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
130809964|NCT01887600|470930552|FG000|Overall Study|Death|39|||
130809965|NCT01887600|470930553|FG001|Overall Study|Death|16|||
130809966|NCT01887600|470930552|FG000|Overall Study|Lack of Efficacy|3|||
130809967|NCT01887600|470930553|FG001|Overall Study|Lack of Efficacy|26|||
130809968|NCT01887600|470930552|FG000|Overall Study|Lost to Follow-up|5|||
130809969|NCT01887600|470930553|FG001|Overall Study|Lost to Follow-up|1|||
130809970|NCT01887600|470930552|FG000|Overall Study|Physician Decision|7|||
130809971|NCT01887600|470930553|FG001|Overall Study|Physician Decision|8|||
130809972|NCT01887600|470930552|FG000|Overall Study|Protocol Deviation|3|||
130809973|NCT01887600|470930553|FG001|Overall Study|Protocol Deviation|0|||
130809974|NCT01887600|470930552|FG000|Overall Study|Withdrawal by Subject|58|||
130809975|NCT01887600|470930553|FG001|Overall Study|Withdrawal by Subject|52|||
130809976|NCT01887600|470930552|FG000|Overall Study|Adverse Event|21|||
130809977|NCT01887600|470930553|FG001|Overall Study|Adverse Event|9|||
130809978|NCT01887600|470930552|FG000|Overall Study|Non-compliance with study drug|3|||
130809979|NCT01887600|470930553|FG001|Overall Study|Non-compliance with study drug|0|||
130809980|NCT01887600|470930552|FG000|Overall Study|Miscellaneous|6|||
130809981|NCT01887600|470930553|FG001|Overall Study|Miscellaneous|2|||
130809982|NCT01887600|470930552|FG000|Overall Study|Progressive Disease|1|||
130809983|NCT01887600|470930553|FG001|Overall Study|Progressive Disease|0|||
130809984|NCT03688139|470930554|FG000|Overall Study|Lost to Follow-up|2|||
130809985|NCT03688139|470930555|FG001|Overall Study|Lost to Follow-up|0|||
130809986|NCT03688139|470930554|FG000|Overall Study|Physician Decision|0|||
130809987|NCT03688139|470930555|FG001|Overall Study|Physician Decision|1|||
130809988|NCT03688139|470930554|FG000|Overall Study|Withdrawal by Subject|2|||
130809989|NCT03688139|470930555|FG001|Overall Study|Withdrawal by Subject|3|||
130809990|NCT00420056|470930556|FG000|Overall Study|Objective progression or relapse|17|||
130809991|NCT00025233|470930560|FG000|Overall Study|Ineligible: wrong cell type|1|||
130809992|NCT00025233|470930560|FG000|Overall Study|Ineligible: wrong primary|1|||
130809993|NCT00025233|470930560|FG000|Overall Study|Ineligible: improper prior treatment|1|||
130809994|NCT00025233|470930560|FG000|Overall Study|Never treated|1|||
130809995|NCT03425188|470930561|FG000|Overall Study|Withdrawal by Subject|1|||
130809996|NCT00655356|470930562|FG000|Overall Study|Withdrawal by Subject|3|||
130809997|NCT00655356|470930563|FG001|Overall Study|Withdrawal by Subject|4|||
130809998|NCT00655356|470930562|FG000|Overall Study|Sponsor Request|10|||
130809999|NCT00655356|470930563|FG001|Overall Study|Sponsor Request|4|||
130810000|NCT00655356|470930562|FG000|Overall Study|Adverse Event|1|||
130810001|NCT00655356|470930563|FG001|Overall Study|Adverse Event|1|||
130810002|NCT00655356|470930562|FG000|Overall Study|Protocol Violation|2|||
130810003|NCT00655356|470930563|FG001|Overall Study|Protocol Violation|1|||
130810004|NCT00655356|470930562|FG000|Overall Study|Other Reason|1|||
130810005|NCT00655356|470930563|FG001|Overall Study|Other Reason|0|||
130810006|NCT01412983|470930564|FG000|1st Period|Ineligible|0|||
130810007|NCT01412983|470930565|FG001|1st Period|Ineligible|1|||
130810008|NCT01412983|470930564|FG000|1st Period|Positive slit lamp finding|0|||
130810009|NCT01412983|470930565|FG001|1st Period|Positive slit lamp finding|1|||
130810010|NCT01412983|470930564|FG000|1st Period|Unacceptable lens movement|0|||
130810011|NCT01412983|470930565|FG001|1st Period|Unacceptable lens movement|1|||
130810012|NCT01412983|470930564|FG000|1st Period|Inability to maintain wear|0|||
130810013|NCT01412983|470930565|FG001|1st Period|Inability to maintain wear|1|||
130810014|NCT01694771|470930566|FG000|Overall Study|Adverse Event|18|||
130810015|NCT01694771|470930567|FG001|Overall Study|Adverse Event|16|||
130810016|NCT01694771|470930566|FG000|Overall Study|Lack of Efficacy|1|||
130810017|NCT01694771|470930567|FG001|Overall Study|Lack of Efficacy|0|||
130810018|NCT01694771|470930566|FG000|Overall Study|Non compliance protocol|7|||
130810019|NCT01694771|470930567|FG001|Overall Study|Non compliance protocol|6|||
130810020|NCT01694771|470930566|FG000|Overall Study|Lost to Follow-up|2|||
130810021|NCT01694771|470930567|FG001|Overall Study|Lost to Follow-up|3|||
130810022|NCT01694771|470930566|FG000|Overall Study|Consent withdrawn|7|||
130810023|NCT01694771|470930567|FG001|Overall Study|Consent withdrawn|9|||
130810024|NCT01694771|470930566|FG000|Overall Study|Other reasons|5|||
130810025|NCT01694771|470930567|FG001|Overall Study|Other reasons|6|||
130810026|NCT00289900|470930568|FG000|Overall Study|Adverse Event|28|||
130810027|NCT00289900|470930569|FG001|Overall Study|Adverse Event|40|||
130810028|NCT00289900|470930570|FG002|Overall Study|Adverse Event|13|||
130810029|NCT00289900|470930571|FG003|Overall Study|Adverse Event|19|||
130810030|NCT00289900|470930572|FG004|Overall Study|Adverse Event|20|||
130810031|NCT00289900|470930573|FG005|Overall Study|Adverse Event|33|||
130810032|NCT00289900|470930568|FG000|Overall Study|Lost to Follow-up|7|||
130810033|NCT00289900|470930569|FG001|Overall Study|Lost to Follow-up|7|||
130810034|NCT00289900|470930570|FG002|Overall Study|Lost to Follow-up|8|||
130810035|NCT00289900|470930571|FG003|Overall Study|Lost to Follow-up|8|||
130810036|NCT00289900|470930572|FG004|Overall Study|Lost to Follow-up|4|||
130810037|NCT00289900|470930573|FG005|Overall Study|Lost to Follow-up|8|||
130810038|NCT00289900|470930568|FG000|Overall Study|Participant had flushing|18|||
130810039|NCT00289900|470930569|FG001|Overall Study|Participant had flushing|42|||
130810040|NCT00289900|470930570|FG002|Overall Study|Participant had flushing|1|||
130810041|NCT00289900|470930571|FG003|Overall Study|Participant had flushing|2|||
130810042|NCT00289900|470930572|FG004|Overall Study|Participant had flushing|0|||
130810043|NCT00289900|470930573|FG005|Overall Study|Participant had flushing|4|||
130810044|NCT00289900|470930568|FG000|Overall Study|Other|0|||
130810045|NCT00289900|470930569|FG001|Overall Study|Other|0|||
130810046|NCT00289900|470930570|FG002|Overall Study|Other|0|||
130810047|NCT00289900|470930571|FG003|Overall Study|Other|5|||
130810048|NCT00289900|470930572|FG004|Overall Study|Other|1|||
130810049|NCT00289900|470930573|FG005|Overall Study|Other|0|||
130810050|NCT00289900|470930568|FG000|Overall Study|Participant moved|1|||
130810051|NCT00289900|470930569|FG001|Overall Study|Participant moved|0|||
130810052|NCT00289900|470930570|FG002|Overall Study|Participant moved|0|||
130810053|NCT00289900|470930571|FG003|Overall Study|Participant moved|1|||
130810054|NCT00289900|470930572|FG004|Overall Study|Participant moved|1|||
130810055|NCT00289900|470930573|FG005|Overall Study|Participant moved|1|||
130810056|NCT00289900|470930568|FG000|Overall Study|Withdrawal by Subject|10|||
130810057|NCT00289900|470930569|FG001|Overall Study|Withdrawal by Subject|21|||
130810058|NCT00289900|470930570|FG002|Overall Study|Withdrawal by Subject|8|||
130810059|NCT00289900|470930571|FG003|Overall Study|Withdrawal by Subject|18|||
130810060|NCT00289900|470930572|FG004|Overall Study|Withdrawal by Subject|12|||
130810061|NCT00289900|470930573|FG005|Overall Study|Withdrawal by Subject|11|||
130810062|NCT00289900|470930568|FG000|Overall Study|Protocol Violation|3|||
130810063|NCT00289900|470930569|FG001|Overall Study|Protocol Violation|9|||
130810064|NCT00289900|470930570|FG002|Overall Study|Protocol Violation|2|||
130810065|NCT00289900|470930571|FG003|Overall Study|Protocol Violation|6|||
130810066|NCT00289900|470930572|FG004|Overall Study|Protocol Violation|7|||
130810067|NCT00289900|470930573|FG005|Overall Study|Protocol Violation|4|||
130810068|NCT00289900|470930568|FG000|Overall Study|site terminated|1|||
130810069|NCT00289900|470930569|FG001|Overall Study|site terminated|0|||
130810070|NCT00289900|470930570|FG002|Overall Study|site terminated|1|||
130810071|NCT00289900|470930571|FG003|Overall Study|site terminated|0|||
130810072|NCT00289900|470930572|FG004|Overall Study|site terminated|0|||
130810073|NCT00289900|470930573|FG005|Overall Study|site terminated|0|||
130810074|NCT00289900|470930568|FG000|Overall Study|Not treated|0|||
130810075|NCT00289900|470930569|FG001|Overall Study|Not treated|1|||
130810076|NCT00289900|470930570|FG002|Overall Study|Not treated|0|||
130810077|NCT00289900|470930571|FG003|Overall Study|Not treated|0|||
130810078|NCT00289900|470930572|FG004|Overall Study|Not treated|0|||
130810079|NCT00289900|470930573|FG005|Overall Study|Not treated|0|||
130810080|NCT01152385|470930574|FG000|Overall Study|Withdrawal by Subject|3|||
130810081|NCT01152385|470930575|FG001|Overall Study|Withdrawal by Subject|1|||
130810082|NCT01152385|470930576|FG002|Overall Study|Withdrawal by Subject|1|||
130810083|NCT01152385|470930577|FG003|Overall Study|Withdrawal by Subject|1|||
130810084|NCT01152385|470930574|FG000|Overall Study|Protocol Violation|0|||
130810085|NCT01152385|470930575|FG001|Overall Study|Protocol Violation|0|||
130810086|NCT01152385|470930576|FG002|Overall Study|Protocol Violation|0|||
130810087|NCT01152385|470930577|FG003|Overall Study|Protocol Violation|1|||
130810088|NCT01152385|470930574|FG000|Overall Study|Adverse Event|1|||
130810089|NCT01152385|470930575|FG001|Overall Study|Adverse Event|1|||
130810090|NCT01152385|470930576|FG002|Overall Study|Adverse Event|0|||
130810091|NCT01152385|470930577|FG003|Overall Study|Adverse Event|0|||
130810092|NCT01152385|470930574|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130810093|NCT01152385|470930575|FG001|Overall Study|Study-specific withdrawal criteria|1|||
130810094|NCT01152385|470930576|FG002|Overall Study|Study-specific withdrawal criteria|2|||
130810095|NCT01152385|470930577|FG003|Overall Study|Study-specific withdrawal criteria|0|||
130810096|NCT01152385|470930574|FG000|Overall Study|Other|4|||
130810097|NCT01152385|470930575|FG001|Overall Study|Other|3|||
130810098|NCT01152385|470930576|FG002|Overall Study|Other|2|||
130810099|NCT01152385|470930577|FG003|Overall Study|Other|3|||
130810100|NCT05486065|470930578|FG000|Overall Study|Withdrawal by Subject|1|||
130810101|NCT05486065|470930579|FG001|Overall Study|Withdrawal by Subject|5|||
130810102|NCT05486065|470930580|FG002|Overall Study|Withdrawal by Subject|4|||
130810103|NCT05486065|470930581|FG003|Overall Study|Withdrawal by Subject|3|||
130810104|NCT05486065|470930578|FG000|Overall Study|Lost to Follow-up|4|||
130810105|NCT05486065|470930579|FG001|Overall Study|Lost to Follow-up|2|||
130810106|NCT05486065|470930580|FG002|Overall Study|Lost to Follow-up|2|||
130810107|NCT05486065|470930581|FG003|Overall Study|Lost to Follow-up|2|||
130810108|NCT05486065|470930578|FG000|Overall Study|Physician Decision|0|||
130810109|NCT05486065|470930579|FG001|Overall Study|Physician Decision|1|||
130810110|NCT05486065|470930580|FG002|Overall Study|Physician Decision|1|||
130810111|NCT05486065|470930581|FG003|Overall Study|Physician Decision|0|||
130810112|NCT05486065|470930578|FG000|Overall Study|Failure to meet randomization criteria|0|||
130810113|NCT05486065|470930579|FG001|Overall Study|Failure to meet randomization criteria|0|||
130810114|NCT05486065|470930580|FG002|Overall Study|Failure to meet randomization criteria|0|||
130810115|NCT05486065|470930581|FG003|Overall Study|Failure to meet randomization criteria|1|||
130810116|NCT03810495|470930586|FG000|Overall Study|Lost to Follow-up|2|||
130810117|NCT03810495|470930586|FG000|Overall Study|Withdrawal by Subject|1|||
130810118|NCT03289741|470930587|FG000|Overall Study|Adverse Event|1|||
130810119|NCT03289741|470930588|FG001|Overall Study|Adverse Event|1|||
130810120|NCT03289741|470930587|FG000|Overall Study|Physician Decision|2|||
130810121|NCT03289741|470930588|FG001|Overall Study|Physician Decision|2|||
130810122|NCT03289741|470930587|FG000|Overall Study|Withdrawal by Subject|1|||
130810123|NCT03289741|470930588|FG001|Overall Study|Withdrawal by Subject|0|||
130810124|NCT02536339|470930590|FG000|Overall Study|Death|20|||
130810125|NCT02536339|470930590|FG000|Overall Study|Withdrawal by Subject|3|||
130810126|NCT02536339|470930590|FG000|Overall Study|Lost to Follow-up|2|||
130810127|NCT02536339|470930590|FG000|Overall Study|Treatment discontinued|2|||
130810128|NCT02536339|470930590|FG000|Overall Study|Physician Decision|1|||
130810129|NCT02037984|470930591|FG000|Overall Study|Lack of Efficacy|0|||
130810130|NCT02037984|470930592|FG001|Overall Study|Lack of Efficacy|0|||
130810131|NCT02037984|470930593|FG002|Overall Study|Lack of Efficacy|3|||
130810132|NCT02037984|470930594|FG003|Overall Study|Lack of Efficacy|10|||
130810133|NCT02037984|470930595|FG004|Overall Study|Lack of Efficacy|2|||
130810134|NCT02037984|470930596|FG005|Overall Study|Lack of Efficacy|2|||
130810135|NCT02037984|470930597|FG006|Overall Study|Lack of Efficacy|4|||
130810136|NCT02037984|470930598|FG007|Overall Study|Lack of Efficacy|3|||
130810137|NCT02037984|470930591|FG000|Overall Study|Lost to Follow-up|1|||
130810138|NCT02037984|470930592|FG001|Overall Study|Lost to Follow-up|0|||
130810139|NCT02037984|470930593|FG002|Overall Study|Lost to Follow-up|3|||
130810140|NCT02037984|470930594|FG003|Overall Study|Lost to Follow-up|5|||
130810141|NCT02037984|470930595|FG004|Overall Study|Lost to Follow-up|2|||
130810142|NCT02037984|470930596|FG005|Overall Study|Lost to Follow-up|2|||
130810143|NCT02037984|470930597|FG006|Overall Study|Lost to Follow-up|2|||
130810144|NCT02037984|470930598|FG007|Overall Study|Lost to Follow-up|4|||
130810145|NCT02037984|470930591|FG000|Overall Study|Physician Decision|0|||
130810146|NCT02037984|470930592|FG001|Overall Study|Physician Decision|0|||
130810147|NCT02037984|470930593|FG002|Overall Study|Physician Decision|0|||
130810148|NCT02037984|470930594|FG003|Overall Study|Physician Decision|0|||
130810149|NCT02037984|470930595|FG004|Overall Study|Physician Decision|0|||
130810150|NCT02037984|470930596|FG005|Overall Study|Physician Decision|0|||
130810151|NCT02037984|470930597|FG006|Overall Study|Physician Decision|1|||
130810152|NCT02037984|470930598|FG007|Overall Study|Physician Decision|0|||
130810153|NCT02037984|470930591|FG000|Overall Study|Protocol Violation|0|||
130810154|NCT02037984|470930592|FG001|Overall Study|Protocol Violation|0|||
130810155|NCT02037984|470930593|FG002|Overall Study|Protocol Violation|0|||
130810156|NCT02037984|470930594|FG003|Overall Study|Protocol Violation|0|||
130810157|NCT02037984|470930595|FG004|Overall Study|Protocol Violation|0|||
130810158|NCT02037984|470930596|FG005|Overall Study|Protocol Violation|1|||
130810159|NCT02037984|470930597|FG006|Overall Study|Protocol Violation|2|||
130810160|NCT02037984|470930598|FG007|Overall Study|Protocol Violation|0|||
130810161|NCT02037984|470930591|FG000|Overall Study|Technical Problems|0|||
130810162|NCT02037984|470930592|FG001|Overall Study|Technical Problems|0|||
130810163|NCT02037984|470930593|FG002|Overall Study|Technical Problems|3|||
130810164|NCT02037984|470930594|FG003|Overall Study|Technical Problems|3|||
130810165|NCT02037984|470930595|FG004|Overall Study|Technical Problems|2|||
130810166|NCT02037984|470930596|FG005|Overall Study|Technical Problems|3|||
130810167|NCT02037984|470930597|FG006|Overall Study|Technical Problems|4|||
130810168|NCT02037984|470930598|FG007|Overall Study|Technical Problems|2|||
130810169|NCT02037984|470930591|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130810170|NCT02037984|470930592|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130810171|NCT02037984|470930593|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
130810172|NCT02037984|470930594|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
130810173|NCT02037984|470930595|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
130810174|NCT02037984|470930596|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
130810175|NCT02037984|470930597|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
130810176|NCT02037984|470930598|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
130810177|NCT02037984|470930591|FG000|Overall Study|Withdrawal by Subject|0|||
130810178|NCT02037984|470930592|FG001|Overall Study|Withdrawal by Subject|0|||
130810179|NCT02037984|470930593|FG002|Overall Study|Withdrawal by Subject|0|||
130810180|NCT02037984|470930594|FG003|Overall Study|Withdrawal by Subject|1|||
130810181|NCT02037984|470930595|FG004|Overall Study|Withdrawal by Subject|1|||
130810182|NCT02037984|470930596|FG005|Overall Study|Withdrawal by Subject|3|||
130810183|NCT02037984|470930597|FG006|Overall Study|Withdrawal by Subject|0|||
130810184|NCT02037984|470930598|FG007|Overall Study|Withdrawal by Subject|1|||
130810185|NCT02113878|470932220|FG000|Overall Study|Adverse Event|1|||
130810186|NCT02113878|470932221|FG001|Overall Study|Adverse Event|0|||
130810187|NCT02113878|470932220|FG000|Overall Study|Withdrawal by Subject|1|||
130810188|NCT02113878|470932221|FG001|Overall Study|Withdrawal by Subject|0|||
130810189|NCT02113878|470932220|FG000|Overall Study|patient non-compliance|1|||
130810190|NCT02113878|470932221|FG001|Overall Study|patient non-compliance|0|||
130810191|NCT04744831|470932222|FG000|Overall Study|Progressive Disease|31|||
130810192|NCT04744831|470932223|FG001|Overall Study|Progressive Disease|27|||
130810193|NCT04744831|470932224|FG002|Overall Study|Progressive Disease|25|||
130810194|NCT04744831|470932222|FG000|Overall Study|Adverse Event|3|||
130810195|NCT04744831|470932223|FG001|Overall Study|Adverse Event|3|||
130810196|NCT04744831|470932224|FG002|Overall Study|Adverse Event|3|||
130810197|NCT04744831|470932222|FG000|Overall Study|Clinical Progression|3|||
130810198|NCT04744831|470932223|FG001|Overall Study|Clinical Progression|2|||
130810199|NCT04744831|470932224|FG002|Overall Study|Clinical Progression|5|||
130810200|NCT04744831|470932222|FG000|Overall Study|Other|0|||
130810201|NCT04744831|470932223|FG001|Overall Study|Other|2|||
130810202|NCT04744831|470932224|FG002|Overall Study|Other|1|||
130810203|NCT04744831|470932222|FG000|Overall Study|Death|0|||
130810204|NCT04744831|470932223|FG001|Overall Study|Death|2|||
130810205|NCT04744831|470932224|FG002|Overall Study|Death|1|||
130810206|NCT00530257|470932230|FG000|Overall Study|Lost to Follow-up|1|||
130810207|NCT01897896|470932234|FG000|Overall Study|Death|1|||
130810208|NCT01897896|470932235|FG001|Overall Study|Death|0|||
130810209|NCT01897896|470932234|FG000|Overall Study|Adverse Event|11|||
130810210|NCT01897896|470932235|FG001|Overall Study|Adverse Event|1|||
130810211|NCT01897896|470932234|FG000|Overall Study|Lost to Follow-up|1|||
130810212|NCT01897896|470932235|FG001|Overall Study|Lost to Follow-up|0|||
130810213|NCT01897896|470932234|FG000|Overall Study|Non-compliance with study drug dosing|1|||
130810214|NCT01897896|470932235|FG001|Overall Study|Non-compliance with study drug dosing|1|||
130810215|NCT01897896|470932234|FG000|Overall Study|Withdrawal by Subject|7|||
130810216|NCT01897896|470932235|FG001|Overall Study|Withdrawal by Subject|1|||
130810217|NCT01897896|470932234|FG000|Overall Study|Require drug that interfere with study|1|||
130810218|NCT01897896|470932235|FG001|Overall Study|Require drug that interfere with study|4|||
130810219|NCT01897896|470932234|FG000|Overall Study|Protocol Violation|1|||
130810220|NCT01897896|470932235|FG001|Overall Study|Protocol Violation|1|||
130810221|NCT01897896|470932234|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
130810222|NCT01897896|470932235|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
130810223|NCT01897896|470932234|FG000|Overall Study|Caregiver can no longer participate|0|||
130810224|NCT01897896|470932235|FG001|Overall Study|Caregiver can no longer participate|2|||
130810225|NCT01897896|470932234|FG000|Overall Study|Other than specified|2|||
130810226|NCT01897896|470932235|FG001|Overall Study|Other than specified|1|||
130810227|NCT05069415|470932236|FG000|Overall Study|Withdrawal by Subject|2|||
130810228|NCT05069415|470932237|FG001|Overall Study|Withdrawal by Subject|0|||
130810229|NCT05069415|470932236|FG000|Overall Study|Adverse Event|2|||
130810230|NCT05069415|470932237|FG001|Overall Study|Adverse Event|0|||
130810231|NCT00203242|470932238|FG000|Overall Study|Lost to Follow-up|1|||
130810232|NCT00866775|470932239|FG000|Overall Study|Adverse Event|5|||
130810233|NCT00866775|470932240|FG001|Overall Study|Adverse Event|19|||
130810234|NCT00866775|470932239|FG000|Overall Study|Death|1|||
130810235|NCT00866775|470932240|FG001|Overall Study|Death|0|||
130810236|NCT00866775|470932239|FG000|Overall Study|Lost to Follow-up|0|||
130810237|NCT00866775|470932240|FG001|Overall Study|Lost to Follow-up|4|||
130810238|NCT00866775|470932239|FG000|Overall Study|Physician Decision|0|||
130810239|NCT00866775|470932240|FG001|Overall Study|Physician Decision|3|||
130810240|NCT00866775|470932239|FG000|Overall Study|Protocol Violation|3|||
130810241|NCT00866775|470932240|FG001|Overall Study|Protocol Violation|4|||
130810242|NCT00866775|470932239|FG000|Overall Study|Withdrawal by Subject|4|||
130810243|NCT00866775|470932240|FG001|Overall Study|Withdrawal by Subject|4|||
130810244|NCT00866775|470932239|FG000|Overall Study|met exit criteria|23|||
130810245|NCT00866775|470932240|FG001|Overall Study|met exit criteria|17|||
130810246|NCT00866775|470932239|FG000|Overall Study|discontinued due to communication error|0|||
130810247|NCT00866775|470932240|FG001|Overall Study|discontinued due to communication error|1|||
130810248|NCT01500135|470932241|FG000|Overall Study|Withdrawal of Consent|4|||
130810249|NCT01500135|470932242|FG001|Overall Study|Withdrawal of Consent|0|||
130810250|NCT01500135|470932241|FG000|Overall Study|Lost to Follow-up|6|||
130810251|NCT01500135|470932242|FG001|Overall Study|Lost to Follow-up|4|||
130810252|NCT01500135|470932241|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
130810253|NCT01500135|470932242|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
130810254|NCT01500135|470932241|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
130810255|NCT01500135|470932242|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
130810256|NCT01500135|470932241|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
130810257|NCT01500135|470932242|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
130810258|NCT01500135|470932241|FG000|Overall Study|Participant was a Safety Concern|1|||
130810259|NCT01500135|470932242|FG001|Overall Study|Participant was a Safety Concern|0|||
130810260|NCT01500135|470932241|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
130810261|NCT01500135|470932242|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
130810262|NCT02003898|470932247|FG000|Overall Study|Death|3|||
130810263|NCT02003898|470932247|FG000|Overall Study|Lost to Follow-up|12|||
130810264|NCT02003898|470932247|FG000|Overall Study|Withdrawal by Subject|52|||
130810265|NCT05345405|470932250|FG000|Overall Study|Withdrawal by Subject|2|||
130810266|NCT05345405|470932251|FG001|Overall Study|Withdrawal by Subject|0|||
130810267|NCT05345405|470932252|FG002|Overall Study|Withdrawal by Subject|0|||
130810268|NCT05345405|470932250|FG000|Overall Study|Did not meet eligibility criteria|0|||
130810269|NCT05345405|470932251|FG001|Overall Study|Did not meet eligibility criteria|2|||
130810270|NCT05345405|470932252|FG002|Overall Study|Did not meet eligibility criteria|0|||
130810271|NCT05345405|470932250|FG000|Overall Study|Lost to Follow-up|0|||
130810272|NCT05345405|470932251|FG001|Overall Study|Lost to Follow-up|0|||
130810273|NCT05345405|470932252|FG002|Overall Study|Lost to Follow-up|1|||
130810274|NCT03766906|470932254|FG000|Overall Study|Withdrawal by Subject|6|||
130810275|NCT00836901|470932255|FG000|First Intervention|Withdrawal by Subject|1|||
130810276|NCT00836901|470932256|FG001|First Intervention|Withdrawal by Subject|0|||
130810277|NCT00830336|470932257|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
130810278|NCT00830336|470932258|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
130810279|NCT03760081|470932259|FG000|Overall Study|Miscellaneous|0|||
130810280|NCT03760081|470932260|FG001|Overall Study|Miscellaneous|1|||
130810281|NCT03760081|470932259|FG000|Overall Study|Progressive Disease|5|||
130810282|NCT03760081|470932260|FG001|Overall Study|Progressive Disease|10|||
130810283|NCT03760081|470932259|FG000|Overall Study|Death|1|||
130810284|NCT03760081|470932260|FG001|Overall Study|Death|1|||
130810285|NCT05261490|470932261|FG000|Overall Study|Other|1|||
130810286|NCT05261490|470932262|FG001|Overall Study|Other|0|||
130810287|NCT05261490|470932263|FG002|Overall Study|Other|0|||
130810288|NCT05261490|470932261|FG000|Overall Study|Study Terminated by Sponsor|1|||
130810289|NCT05261490|470932262|FG001|Overall Study|Study Terminated by Sponsor|1|||
130810290|NCT05261490|470932263|FG002|Overall Study|Study Terminated by Sponsor|4|||
130810291|NCT05261490|470932261|FG000|Overall Study|Death|1|||
130810292|NCT05261490|470932262|FG001|Overall Study|Death|2|||
130810293|NCT05261490|470932263|FG002|Overall Study|Death|0|||
130810294|NCT01646216|470932275|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
130810295|NCT01646216|470932276|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
130810296|NCT01646216|470932275|FG000|Overall Study|Did not complete training|0|||
130810297|NCT01646216|470932276|FG001|Overall Study|Did not complete training|2|||
130810298|NCT01646216|470932275|FG000|Overall Study|Investigator decision|1|||
130810299|NCT01646216|470932276|FG001|Overall Study|Investigator decision|1|||
130810300|NCT02395627|470932277|FG000|Overall Study|Withdrawal by Subject|0|||
130810301|NCT02395627|470932278|FG001|Overall Study|Withdrawal by Subject|2|||
130810302|NCT02395627|470932279|FG002|Overall Study|Withdrawal by Subject|0|||
130810303|NCT02395627|470932277|FG000|Overall Study|Did not receive pembrolizumab|3|||
130810304|NCT02395627|470932278|FG001|Overall Study|Did not receive pembrolizumab|1|||
130810305|NCT02395627|470932279|FG002|Overall Study|Did not receive pembrolizumab|0|||
130810306|NCT02633527|470932280|FG000|Overall Study|Failed to meet eligibility|0|||
130810307|NCT02633527|470932281|FG001|Overall Study|Failed to meet eligibility|1|||
130810308|NCT02633527|470932282|FG002|Overall Study|Failed to meet eligibility|1|||
130810309|NCT02633527|470932283|FG003|Overall Study|Failed to meet eligibility|0|||
130810310|NCT02633527|470932284|FG004|Overall Study|Failed to meet eligibility|1|||
130810311|NCT02633527|470932280|FG000|Overall Study|Adverse Event|0|||
130810312|NCT02633527|470932281|FG001|Overall Study|Adverse Event|4|||
130810313|NCT02633527|470932282|FG002|Overall Study|Adverse Event|3|||
130810314|NCT02633527|470932283|FG003|Overall Study|Adverse Event|1|||
130810315|NCT02633527|470932284|FG004|Overall Study|Adverse Event|5|||
130810316|NCT02633527|470932280|FG000|Overall Study|Lost to Follow-up|1|||
130810317|NCT02633527|470932281|FG001|Overall Study|Lost to Follow-up|2|||
130810318|NCT02633527|470932282|FG002|Overall Study|Lost to Follow-up|5|||
130810319|NCT02633527|470932283|FG003|Overall Study|Lost to Follow-up|5|||
130810320|NCT02633527|470932284|FG004|Overall Study|Lost to Follow-up|4|||
130810321|NCT02633527|470932280|FG000|Overall Study|Withdrawal by Subject|0|||
130810322|NCT02633527|470932281|FG001|Overall Study|Withdrawal by Subject|3|||
130810323|NCT02633527|470932282|FG002|Overall Study|Withdrawal by Subject|5|||
130810324|NCT02633527|470932283|FG003|Overall Study|Withdrawal by Subject|4|||
130810325|NCT02633527|470932284|FG004|Overall Study|Withdrawal by Subject|4|||
130810326|NCT02633527|470932280|FG000|Overall Study|Protocol Violation|0|||
130810327|NCT02633527|470932281|FG001|Overall Study|Protocol Violation|1|||
130810328|NCT02633527|470932282|FG002|Overall Study|Protocol Violation|1|||
130810329|NCT02633527|470932283|FG003|Overall Study|Protocol Violation|1|||
130810330|NCT02633527|470932284|FG004|Overall Study|Protocol Violation|1|||
130810331|NCT02633527|470932280|FG000|Overall Study|Physician Decision|0|||
130810332|NCT02633527|470932281|FG001|Overall Study|Physician Decision|0|||
130810333|NCT02633527|470932282|FG002|Overall Study|Physician Decision|0|||
130810334|NCT02633527|470932283|FG003|Overall Study|Physician Decision|0|||
130810335|NCT02633527|470932284|FG004|Overall Study|Physician Decision|1|||
130810336|NCT02633527|470932280|FG000|Overall Study|Administrative reason|1|||
130810337|NCT02633527|470932281|FG001|Overall Study|Administrative reason|0|||
130810338|NCT02633527|470932282|FG002|Overall Study|Administrative reason|0|||
130810339|NCT02633527|470932283|FG003|Overall Study|Administrative reason|1|||
130810340|NCT02633527|470932284|FG004|Overall Study|Administrative reason|0|||
130810341|NCT02633527|470932280|FG000|Overall Study|Multiple reasons|1|||
130810342|NCT02633527|470932281|FG001|Overall Study|Multiple reasons|0|||
130810343|NCT02633527|470932282|FG002|Overall Study|Multiple reasons|2|||
130810344|NCT02633527|470932283|FG003|Overall Study|Multiple reasons|2|||
130810345|NCT02633527|470932284|FG004|Overall Study|Multiple reasons|1|||
130810346|NCT01681849|470932285|FG000|Overall Study|Protocol Violation|2|||
130810347|NCT01681849|470932286|FG001|Overall Study|Protocol Violation|0|||
130810348|NCT01681849|470932287|FG002|Overall Study|Protocol Violation|0|||
130810349|NCT01681849|470932285|FG000|Overall Study|Withdrawal by Subject|3|||
130810350|NCT01681849|470932286|FG001|Overall Study|Withdrawal by Subject|5|||
130810351|NCT01681849|470932287|FG002|Overall Study|Withdrawal by Subject|33|||
130810352|NCT01681849|470932285|FG000|Overall Study|Lost to Follow-up|3|||
130810353|NCT01681849|470932286|FG001|Overall Study|Lost to Follow-up|2|||
130810354|NCT01681849|470932287|FG002|Overall Study|Lost to Follow-up|6|||
130810355|NCT02852005|470932290|FG000|Overall Study|Lost to Follow-up|0|||
130810356|NCT02852005|470932291|FG001|Overall Study|Lost to Follow-up|0|||
130810357|NCT02852005|470932292|FG002|Overall Study|Lost to Follow-up|0|||
130810358|NCT02852005|470932293|FG003|Overall Study|Lost to Follow-up|0|||
130810359|NCT02852005|470932294|FG004|Overall Study|Lost to Follow-up|1|||
130810360|NCT02852005|470932290|FG000|Overall Study|Withdrawal by Subject|1|||
130810361|NCT02852005|470932291|FG001|Overall Study|Withdrawal by Subject|0|||
130810362|NCT02852005|470932292|FG002|Overall Study|Withdrawal by Subject|0|||
130810363|NCT02852005|470932293|FG003|Overall Study|Withdrawal by Subject|0|||
130810364|NCT02852005|470932294|FG004|Overall Study|Withdrawal by Subject|0|||
130810365|NCT02420314|470932297|FG000|Overall Study|Withdrawal by Subject|1|||
130810366|NCT02420314|470932297|FG000|Overall Study|Protocol Violation|1|||
130810367|NCT03760068|470932299|FG000|Overall Study|Withdrawal by Subject|7|||
130810368|NCT03760068|470932300|FG001|Overall Study|Withdrawal by Subject|8|||
130810369|NCT03760068|470932299|FG000|Overall Study|Adverse Event|1|||
130810370|NCT03760068|470932300|FG001|Overall Study|Adverse Event|2|||
130810371|NCT03760068|470932299|FG000|Overall Study|Administrative Decision by Sponsor|0|||
130810372|NCT03760068|470932300|FG001|Overall Study|Administrative Decision by Sponsor|2|||
130810373|NCT03760068|470932299|FG000|Overall Study|Physician Decision|1|||
130810374|NCT03760068|470932300|FG001|Overall Study|Physician Decision|2|||
130810375|NCT03760068|470932299|FG000|Overall Study|Lost to Follow-up|4|||
130810376|NCT03760068|470932300|FG001|Overall Study|Lost to Follow-up|9|||
130810377|NCT03760068|470932299|FG000|Overall Study|Subject Moved Out of State|1|||
130810378|NCT03760068|470932300|FG001|Overall Study|Subject Moved Out of State|0|||
130810379|NCT03460704|470932304|FG000|Overall Study|Withdrawal by Subject|11|||
130810380|NCT03460704|470932305|FG001|Overall Study|Withdrawal by Subject|14|||
130810381|NCT03460704|470932304|FG000|Overall Study|Study terminated by the Sponsor|29|||
130810382|NCT03460704|470932305|FG001|Overall Study|Study terminated by the Sponsor|19|||
130810383|NCT03460704|470932304|FG000|Overall Study|Adverse Event|10|||
130810384|NCT03460704|470932305|FG001|Overall Study|Adverse Event|5|||
130810385|NCT03460704|470932304|FG000|Overall Study|Death|3|||
130810386|NCT03460704|470932305|FG001|Overall Study|Death|2|||
130810387|NCT03460704|470932304|FG000|Overall Study|Non-Compliance with Study Drug|3|||
130810388|NCT03460704|470932305|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130810389|NCT03460704|470932304|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130810390|NCT03460704|470932305|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
130810391|NCT03460704|470932304|FG000|Overall Study|Other|2|||
130810392|NCT03460704|470932305|FG001|Overall Study|Other|1|||
130810393|NCT02913326|470932310|FG000|Overall Study|Reason not listed|0|||
130810394|NCT02913326|470932311|FG001|Overall Study|Reason not listed|1|||
130810395|NCT02913326|470932310|FG000|Overall Study|Lost to Follow-up|0|||
130810396|NCT02913326|470932311|FG001|Overall Study|Lost to Follow-up|1|||
130810397|NCT02913326|470932310|FG000|Overall Study|Adverse Event|1|||
130810398|NCT02913326|470932311|FG001|Overall Study|Adverse Event|0|||
130810399|NCT01767857|470932312|FG000|Overall Study|Adverse Event|27|||
130810400|NCT01767857|470932313|FG001|Overall Study|Adverse Event|7|||
130810401|NCT01767857|470932312|FG000|Overall Study|Death|28|||
130810402|NCT01767857|470932313|FG001|Overall Study|Death|13|||
130810403|NCT01767857|470932312|FG000|Overall Study|Lack of Efficacy|299|||
130810404|NCT01767857|470932313|FG001|Overall Study|Lack of Efficacy|151|||
130810405|NCT01767857|470932312|FG000|Overall Study|Lost to Follow-up|1|||
130810406|NCT01767857|470932313|FG001|Overall Study|Lost to Follow-up|1|||
130810407|NCT01767857|470932312|FG000|Overall Study|Withdrawal by Subject|38|||
130810408|NCT01767857|470932313|FG001|Overall Study|Withdrawal by Subject|18|||
130810409|NCT01767857|470932312|FG000|Overall Study|Physician Decision|17|||
130810410|NCT01767857|470932313|FG001|Overall Study|Physician Decision|10|||
130810411|NCT01767857|470932312|FG000|Overall Study|Protocol Terminated|1|||
130810412|NCT01767857|470932313|FG001|Overall Study|Protocol Terminated|0|||
130810413|NCT01767857|470932312|FG000|Overall Study|Randomized But Never Treated|19|||
130810414|NCT01767857|470932313|FG001|Overall Study|Randomized But Never Treated|13|||
130810415|NCT01390584|470932337|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
130810416|NCT01390584|470932338|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
130810417|NCT01390584|470932339|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
130810418|NCT01720602|470932340|FG000|Overall Study|Adverse Event|3|||
130810419|NCT01720602|470932340|FG000|Overall Study|Progressive disease on therapy|2|||
130810420|NCT01943825|470932341|FG000|Overall Study|Lost to Follow-up|9|||
130810421|NCT01943825|470932342|FG001|Overall Study|Lost to Follow-up|3|||
130810422|NCT01943825|470932343|FG002|Overall Study|Lost to Follow-up|12|||
130810423|NCT01943825|470932344|FG003|Overall Study|Lost to Follow-up|8|||
130810424|NCT01943825|470932341|FG000|Overall Study|Withdrawal by Subject|1|||
130810425|NCT01943825|470932342|FG001|Overall Study|Withdrawal by Subject|0|||
130810426|NCT01943825|470932343|FG002|Overall Study|Withdrawal by Subject|3|||
130810427|NCT01943825|470932344|FG003|Overall Study|Withdrawal by Subject|2|||
130810428|NCT01943825|470932341|FG000|Overall Study|Other than specified above|0|||
130810429|NCT01943825|470932342|FG001|Overall Study|Other than specified above|1|||
130810430|NCT01943825|470932343|FG002|Overall Study|Other than specified above|0|||
130810431|NCT01943825|470932344|FG003|Overall Study|Other than specified above|1|||
130810432|NCT00452400|470932345|FG000|Overall Study|Adverse Event|1|||
130810433|NCT00452400|470932346|FG001|Overall Study|Adverse Event|1|||
130810434|NCT00452400|470932347|FG002|Overall Study|Adverse Event|5|||
130810435|NCT00452400|470932348|FG003|Overall Study|Adverse Event|0|||
130810436|NCT00452400|470932349|FG004|Overall Study|Adverse Event|2|||
130810437|NCT00452400|470932345|FG000|Overall Study|Protocol Violation|0|||
130810438|NCT00452400|470932346|FG001|Overall Study|Protocol Violation|0|||
130810439|NCT00452400|470932347|FG002|Overall Study|Protocol Violation|1|||
130810440|NCT00452400|470932348|FG003|Overall Study|Protocol Violation|0|||
130810441|NCT00452400|470932349|FG004|Overall Study|Protocol Violation|0|||
130810442|NCT00452400|470932345|FG000|Overall Study|Lost to Follow-up|1|||
130810443|NCT00452400|470932346|FG001|Overall Study|Lost to Follow-up|0|||
130810444|NCT00452400|470932347|FG002|Overall Study|Lost to Follow-up|0|||
130810445|NCT00452400|470932348|FG003|Overall Study|Lost to Follow-up|0|||
130810446|NCT00452400|470932349|FG004|Overall Study|Lost to Follow-up|0|||
130810447|NCT00452400|470932345|FG000|Overall Study|Withdrawal by Subject|1|||
130810448|NCT00452400|470932346|FG001|Overall Study|Withdrawal by Subject|0|||
130810449|NCT00452400|470932347|FG002|Overall Study|Withdrawal by Subject|1|||
130810450|NCT00452400|470932348|FG003|Overall Study|Withdrawal by Subject|0|||
130810451|NCT00452400|470932349|FG004|Overall Study|Withdrawal by Subject|0|||
130810452|NCT00452400|470932345|FG000|Overall Study|Lack of Efficacy|2|||
130810453|NCT00452400|470932346|FG001|Overall Study|Lack of Efficacy|0|||
130810454|NCT00452400|470932347|FG002|Overall Study|Lack of Efficacy|0|||
130810455|NCT00452400|470932348|FG003|Overall Study|Lack of Efficacy|0|||
130810456|NCT00452400|470932349|FG004|Overall Study|Lack of Efficacy|0|||
130810457|NCT00452400|470932345|FG000|Overall Study|Other reasons not listed above|0|||
130810458|NCT00452400|470932346|FG001|Overall Study|Other reasons not listed above|0|||
130810459|NCT00452400|470932347|FG002|Overall Study|Other reasons not listed above|0|||
130810460|NCT00452400|470932348|FG003|Overall Study|Other reasons not listed above|1|||
130810461|NCT00452400|470932349|FG004|Overall Study|Other reasons not listed above|1|||
130810462|NCT01835431|470932350|FG000|Overall Study|Adverse Event|1|||
130810463|NCT01835431|470932351|FG001|Overall Study|Adverse Event|0|||
130810464|NCT01835431|470932350|FG000|Overall Study|other|0|||
130810465|NCT01835431|470932351|FG001|Overall Study|other|2|||
130810466|NCT01835431|470932350|FG000|Overall Study|Withdrawal by Subject|6|||
130810467|NCT01835431|470932351|FG001|Overall Study|Withdrawal by Subject|10|||
130810468|NCT01835431|470932350|FG000|Overall Study|Protocol Violation|1|||
130810469|NCT01835431|470932351|FG001|Overall Study|Protocol Violation|0|||
130810470|NCT00562861|470932354|FG000|Overall Study|Adverse Event|1|||
130810471|NCT00562861|470932355|FG001|Overall Study|Adverse Event|1|||
130810472|NCT00562861|470932354|FG000|Overall Study|Lack of Efficacy|5|||
130810473|NCT00562861|470932355|FG001|Overall Study|Lack of Efficacy|5|||
130810474|NCT00562861|470932354|FG000|Overall Study|noncompliance, moved|7|||
130810475|NCT00562861|470932355|FG001|Overall Study|noncompliance, moved|2|||
130810476|NCT00562861|470932354|FG000|Overall Study|Lost to Follow-up|7|||
130810477|NCT00562861|470932355|FG001|Overall Study|Lost to Follow-up|3|||
130810478|NCT04349098|470932356|FG000|Overall Study|Death|16|||
130810479|NCT04349098|470932357|FG001|Overall Study|Death|8|||
130810480|NCT04349098|470932356|FG000|Overall Study|Lost to Follow-up|11|||
130810481|NCT04349098|470932357|FG001|Overall Study|Lost to Follow-up|8|||
130810482|NCT04349098|470932356|FG000|Overall Study|Withdrawal by Subject|8|||
130810483|NCT04349098|470932357|FG001|Overall Study|Withdrawal by Subject|5|||
130810484|NCT04349098|470932356|FG000|Overall Study|Other|3|||
130810485|NCT04349098|470932357|FG001|Overall Study|Other|5|||
130810486|NCT01703221|470932358|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
130810487|NCT01703221|470932359|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
130810488|NCT01703221|470932360|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
130810489|NCT01703221|470932358|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
130810490|NCT01703221|470932359|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
130810491|NCT01703221|470932360|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
130810492|NCT01703221|470932358|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
130810493|NCT01703221|470932359|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130810494|NCT01703221|470932360|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130810495|NCT01703221|470932358|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
130810496|NCT01703221|470932359|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
130810497|NCT01703221|470932360|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
130810498|NCT01703221|470932358|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130810499|NCT01703221|470932359|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130810500|NCT01703221|470932360|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
130810501|NCT01703221|470932358|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
130810502|NCT01703221|470932359|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
130810503|NCT01703221|470932360|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
130810504|NCT01703221|470932358|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
130810505|NCT01703221|470932359|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
130810506|NCT01703221|470932360|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
130810507|NCT01703221|470932358|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
130810508|NCT01703221|470932359|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
130810509|NCT01703221|470932360|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
130810510|NCT03927846|470932362|FG000|Overall Study|Lost to Follow-up|10|||
130810511|NCT03927846|470932363|FG001|Overall Study|Lost to Follow-up|11|||
130810512|NCT03878069|470932364|FG000|Overall Study|Death|0|||
130810513|NCT03878069|470932365|FG001|Overall Study|Death|1|||
130810514|NCT03878069|470932366|FG002|Overall Study|Death|0|||
130810515|NCT00834587|470932367|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130810516|NCT00834587|470932368|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130810517|NCT00581100|470933884|FG000|Overall Study|Death|1|||
130810518|NCT00581100|470933885|FG001|Overall Study|Death|0|||
130810519|NCT00581100|470933884|FG000|Overall Study|Adverse Event|2|||
130810520|NCT00581100|470933885|FG001|Overall Study|Adverse Event|1|||
130810521|NCT00581100|470933884|FG000|Overall Study|Withdrawal by Subject|1|||
130810522|NCT00581100|470933885|FG001|Overall Study|Withdrawal by Subject|4|||
130810523|NCT00581100|470933884|FG000|Overall Study|Other|3|||
130810524|NCT00581100|470933885|FG001|Overall Study|Other|0|||
130810525|NCT03837509|470933886|FG000|Phase 1|Death|5|||
130810526|NCT03837509|470933887|FG001|Phase 1|Death|2|||
130810527|NCT03837509|470933888|FG002|Phase 1|Death|0|||
130810528|NCT03837509|470933889|FG003|Phase 1|Death|0|||
130810529|NCT03837509|470933890|FG004|Phase 1|Death|0|||
130810530|NCT03837509|470933886|FG000|Phase 2|Death|0|||
130810531|NCT03837509|470933887|FG001|Phase 2|Death|0|||
130810532|NCT03837509|470933888|FG002|Phase 2|Death|0|||
130810533|NCT03837509|470933889|FG003|Phase 2|Death|1|||
130810534|NCT03837509|470933890|FG004|Phase 2|Death|1|||
130810535|NCT01853280|470933893|FG000|Overall Study|Lack of Efficacy|2|||
130810536|NCT01853280|470933894|FG001|Overall Study|Lack of Efficacy|2|||
130810537|NCT01853280|470933893|FG000|Overall Study|Lost to Follow-up|0|||
130810538|NCT01853280|470933894|FG001|Overall Study|Lost to Follow-up|1|||
130810539|NCT01853280|470933893|FG000|Overall Study|Physician Decision|0|||
130810540|NCT01853280|470933894|FG001|Overall Study|Physician Decision|1|||
130810541|NCT01853280|470933893|FG000|Overall Study|Withdrawal by Subject|0|||
130810542|NCT01853280|470933894|FG001|Overall Study|Withdrawal by Subject|1|||
130810543|NCT01853280|470933893|FG000|Overall Study|Ineligible|0|||
130810544|NCT01853280|470933894|FG001|Overall Study|Ineligible|1|||
130810545|NCT03032484|470933895|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
130810546|NCT03032484|470933896|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
130810547|NCT03032484|470933895|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
130810548|NCT03032484|470933896|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
130810549|NCT03268499|470933899|FG000|Overall Study|Withdrawal by Subject|2|||
130810550|NCT03268499|470933900|FG001|Overall Study|Withdrawal by Subject|1|||
130810551|NCT03533491|470933901|FG000|Overall Study|Lost to Follow-up|2|||
130810552|NCT01725282|470933906|FG000|Overall Study|Adverse Event|1|||
130810553|NCT01725282|470933907|FG001|Overall Study|Adverse Event|3|||
130810554|NCT01725282|470933908|FG002|Overall Study|Adverse Event|6|||
130810555|NCT01725282|470933909|FG003|Overall Study|Adverse Event|4|||
130810556|NCT01725282|470933906|FG000|Overall Study|Exacerbation of Target Disease|1|||
130810557|NCT01725282|470933907|FG001|Overall Study|Exacerbation of Target Disease|0|||
130810558|NCT01725282|470933908|FG002|Overall Study|Exacerbation of Target Disease|0|||
130810559|NCT01725282|470933909|FG003|Overall Study|Exacerbation of Target Disease|1|||
130810560|NCT01725282|470933906|FG000|Overall Study|Met Exclusion Criteria|0|||
130810561|NCT01725282|470933907|FG001|Overall Study|Met Exclusion Criteria|0|||
130810562|NCT01725282|470933908|FG002|Overall Study|Met Exclusion Criteria|1|||
130810563|NCT01725282|470933909|FG003|Overall Study|Met Exclusion Criteria|0|||
130810564|NCT01725282|470933906|FG000|Overall Study|Study Site Withdrawal|0|||
130810565|NCT01725282|470933907|FG001|Overall Study|Study Site Withdrawal|1|||
130810566|NCT01725282|470933908|FG002|Overall Study|Study Site Withdrawal|0|||
130810567|NCT01725282|470933909|FG003|Overall Study|Study Site Withdrawal|0|||
130810568|NCT01725282|470933906|FG000|Overall Study|Withdrawal by Subject|0|||
130810569|NCT01725282|470933907|FG001|Overall Study|Withdrawal by Subject|0|||
130810570|NCT01725282|470933908|FG002|Overall Study|Withdrawal by Subject|1|||
130810571|NCT01725282|470933909|FG003|Overall Study|Withdrawal by Subject|1|||
130810572|NCT01725282|470933906|FG000|Overall Study|Lack of Efficacy|0|||
130810573|NCT01725282|470933907|FG001|Overall Study|Lack of Efficacy|1|||
130810574|NCT01725282|470933908|FG002|Overall Study|Lack of Efficacy|0|||
130810575|NCT01725282|470933909|FG003|Overall Study|Lack of Efficacy|1|||
130810576|NCT04064567|470933910|FG000|Overall Study|Lost to Follow-up|23|||
130810577|NCT04064567|470933911|FG001|Overall Study|Lost to Follow-up|22|||
130810578|NCT04064567|470933910|FG000|Overall Study|Withdrawal by Subject|0|||
130810579|NCT04064567|470933911|FG001|Overall Study|Withdrawal by Subject|1|||
130810580|NCT04064567|470933910|FG000|Overall Study|Reincarcerated|7|||
130810581|NCT04064567|470933911|FG001|Overall Study|Reincarcerated|10|||
130810582|NCT04064567|470933910|FG000|Overall Study|Moved out of U.S.|0|||
130810583|NCT04064567|470933911|FG001|Overall Study|Moved out of U.S.|1|||
130810584|NCT04576481|470933912|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
130810585|NCT04576481|470933913|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
130810586|NCT04576481|470933914|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
130810587|NCT04576481|470933915|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
130810588|NCT02758626|470933922|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
130810589|NCT02758626|470933923|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
130810590|NCT02758626|470933922|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
130810591|NCT02758626|470933923|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
130810592|NCT02758626|470933922|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
130810593|NCT02758626|470933923|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
130810594|NCT02758626|470933922|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
130810595|NCT02758626|470933923|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
130810596|NCT01682720|470933925|FG000|Overall Study|Randomized but Not Treated|0|||
130810597|NCT01682720|470933926|FG001|Overall Study|Randomized but Not Treated|1|||
130810598|NCT01682720|470933927|FG002|Overall Study|Randomized but Not Treated|1|||
130810599|NCT01682720|470933928|FG003|Overall Study|Randomized but Not Treated|0|||
130810600|NCT01682720|470933925|FG000|Overall Study|Terminated by Sponsor|83|||
130810601|NCT01682720|470933926|FG001|Overall Study|Terminated by Sponsor|0|||
130810602|NCT01682720|470933927|FG002|Overall Study|Terminated by Sponsor|0|||
130810603|NCT01682720|470933928|FG003|Overall Study|Terminated by Sponsor|0|||
130810604|NCT01682720|470933925|FG000|Overall Study|Efficacy Failure|0|||
130810605|NCT01682720|470933926|FG001|Overall Study|Efficacy Failure|3|||
130810606|NCT01682720|470933927|FG002|Overall Study|Efficacy Failure|3|||
130810607|NCT01682720|470933928|FG003|Overall Study|Efficacy Failure|30|||
130810608|NCT01682720|470933925|FG000|Overall Study|Lost to Follow-up|1|||
130810609|NCT01682720|470933926|FG001|Overall Study|Lost to Follow-up|1|||
130810610|NCT01682720|470933927|FG002|Overall Study|Lost to Follow-up|0|||
130810611|NCT01682720|470933928|FG003|Overall Study|Lost to Follow-up|6|||
130810612|NCT01682720|470933925|FG000|Overall Study|Subject Withdrew Consent|0|||
130810613|NCT01682720|470933926|FG001|Overall Study|Subject Withdrew Consent|0|||
130810614|NCT01682720|470933927|FG002|Overall Study|Subject Withdrew Consent|2|||
130810615|NCT01682720|470933928|FG003|Overall Study|Subject Withdrew Consent|2|||
130810616|NCT01682720|470933925|FG000|Overall Study|Adverse Event|1|||
130810617|NCT01682720|470933926|FG001|Overall Study|Adverse Event|0|||
130810618|NCT01682720|470933927|FG002|Overall Study|Adverse Event|1|||
130810619|NCT01682720|470933928|FG003|Overall Study|Adverse Event|1|||
130810620|NCT04204902|470933929|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
130810621|NCT04204902|470933930|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
130810622|NCT00456365|470933933|FG000|Overall Study|Lost to Follow-up|1|||
130810623|NCT00456365|470933934|FG001|Overall Study|Lost to Follow-up|3|||
130810624|NCT00456365|470933933|FG000|Overall Study|Withdrawal by Subject|4|||
130810625|NCT00456365|470933934|FG001|Overall Study|Withdrawal by Subject|7|||
130810626|NCT00456365|470933933|FG000|Overall Study|Pregnancy|1|||
130810627|NCT00456365|470933934|FG001|Overall Study|Pregnancy|1|||
130810628|NCT00456365|470933933|FG000|Overall Study|oncologic diagnosis|1|||
130810629|NCT00456365|470933934|FG001|Overall Study|oncologic diagnosis|1|||
130810630|NCT05451329|470933935|FG000|Overall Study|Adverse Event|1|||
130810631|NCT05451329|470933936|FG001|Overall Study|Adverse Event|1|||
130810632|NCT05451329|470933937|FG002|Overall Study|Adverse Event|0|||
130810633|NCT05451329|470933935|FG000|Overall Study|Withdrawal by Subject|1|||
130810634|NCT05451329|470933936|FG001|Overall Study|Withdrawal by Subject|0|||
130810635|NCT05451329|470933937|FG002|Overall Study|Withdrawal by Subject|0|||
130810636|NCT05451329|470933935|FG000|Overall Study|Investigational Product Lot exchange|1|||
130810637|NCT05451329|470933936|FG001|Overall Study|Investigational Product Lot exchange|1|||
130810638|NCT05451329|470933937|FG002|Overall Study|Investigational Product Lot exchange|0|||
130810639|NCT02202577|470933938|FG000|Overall Study|Lost to Follow-up|6|||
130810640|NCT02202577|470933939|FG001|Overall Study|Lost to Follow-up|16|||
130810641|NCT02202577|470933938|FG000|Overall Study|Protocol Violation|7|||
130810642|NCT02202577|470933939|FG001|Overall Study|Protocol Violation|3|||
130810643|NCT00069953|470933940|FG000|Overall Study|Protocol Violation|2|||
130810644|NCT02034565|470933941|FG000|Overall Study|Adverse Event|1|||
130810645|NCT02034565|470933942|FG001|Overall Study|Adverse Event|0|||
130810646|NCT00113373|470933943|FG000|Overall Study|Ineligible: wrong primary|1|||
130810647|NCT00113373|470933943|FG000|Overall Study|Ineligible: second primary|1|||
130810648|NCT00113373|470933943|FG000|Overall Study|Never Treated|1|||
130810649|NCT00829868|470933944|FG000|Washout|Physician Decision|1|||
130810650|NCT00829868|470933945|FG001|Washout|Physician Decision|0|||
130810651|NCT02799043|470933947|FG000|Overall Study|Adverse Event|0|||
130810652|NCT02799043|470933948|FG001|Overall Study|Adverse Event|1|||
130810653|NCT02799043|470933947|FG000|Overall Study|Death|1|||
130810654|NCT02799043|470933948|FG001|Overall Study|Death|1|||
130810655|NCT02799043|470933947|FG000|Overall Study|Lost to Follow-up|3|||
130810656|NCT02799043|470933948|FG001|Overall Study|Lost to Follow-up|6|||
130810657|NCT02799043|470933947|FG000|Overall Study|Withdrawal by Subject|4|||
130810658|NCT02799043|470933948|FG001|Overall Study|Withdrawal by Subject|4|||
130810659|NCT02799043|470933947|FG000|Overall Study|Moved to different country|0|||
130810660|NCT02799043|470933948|FG001|Overall Study|Moved to different country|1|||
130810661|NCT02799043|470933947|FG000|Overall Study|Trial Screen Failure|1|||
130810662|NCT02799043|470933948|FG001|Overall Study|Trial Screen Failure|0|||
130810663|NCT02799043|470933947|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
130810664|NCT02799043|470933948|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
130810665|NCT04525183|470933959|FG000|Overall Study|Withdrawal by Subject|0|||
130810666|NCT04525183|470933960|FG001|Overall Study|Withdrawal by Subject|0|||
130810667|NCT04525183|470933961|FG002|Overall Study|Withdrawal by Subject|3|||
130810668|NCT04525183|470933959|FG000|Overall Study|Study non-compliance|0|||
130810669|NCT04525183|470933960|FG001|Overall Study|Study non-compliance|0|||
130810670|NCT04525183|470933961|FG002|Overall Study|Study non-compliance|1|||
130810671|NCT04525183|470933959|FG000|Overall Study|Recurrent disease before starting on study|0|||
130810672|NCT04525183|470933960|FG001|Overall Study|Recurrent disease before starting on study|0|||
130810673|NCT04525183|470933961|FG002|Overall Study|Recurrent disease before starting on study|1|||
130810674|NCT00979407|470933962|FG000|Overall Study|Withdrawal by Subject|3|||
130810675|NCT00979407|470933963|FG001|Overall Study|Withdrawal by Subject|4|||
130810676|NCT00979407|470933962|FG000|Overall Study|Lost to Follow-up|3|||
130810677|NCT00979407|470933963|FG001|Overall Study|Lost to Follow-up|3|||
130810678|NCT01166646|470933964|FG000|Overall Study|Protocol Violation|0|||
130810679|NCT01166646|470933965|FG001|Overall Study|Protocol Violation|1|||
130810680|NCT01166646|470933964|FG000|Overall Study|Adverse Event|1|||
130810681|NCT01166646|470933965|FG001|Overall Study|Adverse Event|0|||
130810682|NCT01335685|470933969|FG000|Overall Study|Study Terminated by Sponsor|2|||
130810683|NCT01335685|470933970|FG001|Overall Study|Study Terminated by Sponsor|1|||
130810684|NCT01335685|470933971|FG002|Overall Study|Study Terminated by Sponsor|1|||
130810685|NCT01335685|470933972|FG003|Overall Study|Study Terminated by Sponsor|10|||
130810686|NCT01335685|470933973|FG004|Overall Study|Study Terminated by Sponsor|0|||
130810687|NCT01335685|470933974|FG005|Overall Study|Study Terminated by Sponsor|4|||
130810688|NCT01335685|470933975|FG006|Overall Study|Study Terminated by Sponsor|2|||
130810689|NCT01335685|470933976|FG007|Overall Study|Study Terminated by Sponsor|3|||
130810690|NCT01335685|470933969|FG000|Overall Study|Withdrawal by Subject|1|||
130810691|NCT01335685|470933970|FG001|Overall Study|Withdrawal by Subject|0|||
130810692|NCT01335685|470933971|FG002|Overall Study|Withdrawal by Subject|0|||
130810693|NCT01335685|470933972|FG003|Overall Study|Withdrawal by Subject|1|||
130810694|NCT01335685|470933973|FG004|Overall Study|Withdrawal by Subject|0|||
130810695|NCT01335685|470933974|FG005|Overall Study|Withdrawal by Subject|0|||
130810696|NCT01335685|470933975|FG006|Overall Study|Withdrawal by Subject|0|||
130810697|NCT01335685|470933976|FG007|Overall Study|Withdrawal by Subject|0|||
130810698|NCT01335685|470933969|FG000|Overall Study|Reason not Specified|0|||
130810699|NCT01335685|470933970|FG001|Overall Study|Reason not Specified|0|||
130810700|NCT01335685|470933971|FG002|Overall Study|Reason not Specified|1|||
130810701|NCT01335685|470933972|FG003|Overall Study|Reason not Specified|0|||
130810702|NCT01335685|470933973|FG004|Overall Study|Reason not Specified|0|||
130810703|NCT01335685|470933974|FG005|Overall Study|Reason not Specified|1|||
130810704|NCT01335685|470933975|FG006|Overall Study|Reason not Specified|0|||
130810705|NCT01335685|470933976|FG007|Overall Study|Reason not Specified|0|||
130810706|NCT03777020|470933981|FG000|Overall Study|Withdrawal by Subject|4|||
130810707|NCT03777020|470933982|FG001|Overall Study|Withdrawal by Subject|4|||
130810708|NCT03777020|470933981|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
130810709|NCT03777020|470933982|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
130810710|NCT00489476|470933983|FG000|Overall Study|Lost to Follow-up|0|||
130810711|NCT00489476|470933984|FG001|Overall Study|Lost to Follow-up|1|||
130810712|NCT00489476|470933985|FG002|Overall Study|Lost to Follow-up|0|||
130810713|NCT00489476|470933986|FG003|Overall Study|Lost to Follow-up|0|||
130810714|NCT00803049|470933987|FG000|Overall Study|Adverse Event|21|||
130810715|NCT00803049|470933988|FG001|Overall Study|Adverse Event|33|||
130810716|NCT00803049|470933989|FG002|Overall Study|Adverse Event|13|||
130810717|NCT00803049|470933990|FG003|Overall Study|Adverse Event|27|||
130810718|NCT00803049|470933987|FG000|Overall Study|Lack of Efficacy|10|||
130810719|NCT00803049|470933988|FG001|Overall Study|Lack of Efficacy|19|||
130810720|NCT00803049|470933989|FG002|Overall Study|Lack of Efficacy|6|||
130810721|NCT00803049|470933990|FG003|Overall Study|Lack of Efficacy|13|||
130810722|NCT00803049|470933987|FG000|Overall Study|Lost to Follow-up|0|||
130810723|NCT00803049|470933988|FG001|Overall Study|Lost to Follow-up|2|||
130810724|NCT00803049|470933989|FG002|Overall Study|Lost to Follow-up|0|||
130810725|NCT00803049|470933990|FG003|Overall Study|Lost to Follow-up|3|||
130810726|NCT00803049|470933987|FG000|Overall Study|Death|2|||
130810727|NCT00803049|470933988|FG001|Overall Study|Death|1|||
130810728|NCT00803049|470933989|FG002|Overall Study|Death|0|||
130810729|NCT00803049|470933990|FG003|Overall Study|Death|2|||
130810730|NCT00803049|470933987|FG000|Overall Study|Progressive Disease|6|||
130810731|NCT00803049|470933988|FG001|Overall Study|Progressive Disease|10|||
130810732|NCT00803049|470933989|FG002|Overall Study|Progressive Disease|6|||
130810733|NCT00803049|470933990|FG003|Overall Study|Progressive Disease|6|||
130810734|NCT00803049|470933987|FG000|Overall Study|Withdrawal by Subject|19|||
130810735|NCT00803049|470933988|FG001|Overall Study|Withdrawal by Subject|43|||
130810736|NCT00803049|470933989|FG002|Overall Study|Withdrawal by Subject|16|||
130810737|NCT00803049|470933990|FG003|Overall Study|Withdrawal by Subject|44|||
130810738|NCT00803049|470933987|FG000|Overall Study|Protocol Violation|0|||
130810739|NCT00803049|470933988|FG001|Overall Study|Protocol Violation|1|||
130810740|NCT00803049|470933989|FG002|Overall Study|Protocol Violation|1|||
130810741|NCT00803049|470933990|FG003|Overall Study|Protocol Violation|0|||
130810742|NCT00803049|470933987|FG000|Overall Study|Randomized and Not Treated|0|||
130810743|NCT00803049|470933988|FG001|Overall Study|Randomized and Not Treated|0|||
130810744|NCT00803049|470933989|FG002|Overall Study|Randomized and Not Treated|0|||
130810745|NCT00803049|470933990|FG003|Overall Study|Randomized and Not Treated|2|||
130810746|NCT00803049|470933987|FG000|Overall Study|Other than Specified Above|3|||
130810747|NCT00803049|470933988|FG001|Overall Study|Other than Specified Above|9|||
130810748|NCT00803049|470933989|FG002|Overall Study|Other than Specified Above|2|||
130810749|NCT00803049|470933990|FG003|Overall Study|Other than Specified Above|5|||
130810750|NCT01421459|470933991|FG000|Overall Study|Adverse Event|6|||
130810751|NCT01421459|470933992|FG001|Overall Study|Adverse Event|10|||
130810752|NCT01421459|470933991|FG000|Overall Study|Death|1|||
130810753|NCT01421459|470933992|FG001|Overall Study|Death|1|||
130810754|NCT01421459|470933991|FG000|Overall Study|Lack of Efficacy|1|||
130810755|NCT01421459|470933992|FG001|Overall Study|Lack of Efficacy|2|||
130810756|NCT01421459|470933991|FG000|Overall Study|Lost to Follow-up|8|||
130810757|NCT01421459|470933992|FG001|Overall Study|Lost to Follow-up|9|||
130810758|NCT01421459|470933991|FG000|Overall Study|Physician Decision|9|||
130810759|NCT01421459|470933992|FG001|Overall Study|Physician Decision|9|||
130810760|NCT01421459|470933991|FG000|Overall Study|Protocol Violation|8|||
130810761|NCT01421459|470933992|FG001|Overall Study|Protocol Violation|5|||
130810762|NCT01421459|470933991|FG000|Overall Study|Withdrawal by Subject|12|||
130810763|NCT01421459|470933992|FG001|Overall Study|Withdrawal by Subject|16|||
130810764|NCT01514422|470933993|FG000|Overall Study|Lost to Follow-up|1|||
130810765|NCT04126174|470933994|FG000|Overall Study|Lost to Follow-up|3|||
130810766|NCT04126174|470933995|FG001|Overall Study|Lost to Follow-up|3|||
130810767|NCT04439903|470934008|FG000|Overall Study|Withdrawal by Subject|2|||
130810768|NCT04439903|470934008|FG000|Overall Study|Screen Failure|1|||
130810769|NCT02899754|470934009|FG000|Overall Study|Lost to Follow-up|7|||
130810770|NCT02899754|470934010|FG001|Overall Study|Lost to Follow-up|9|||
130810771|NCT04003142|470934013|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
130810772|NCT04003142|470934014|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
130810773|NCT04003142|470934015|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
130810774|NCT04003142|470934016|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
130810775|NCT04003142|470934017|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
130810776|NCT04003142|470934013|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
130810777|NCT04003142|470934014|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
130810778|NCT04003142|470934015|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
130810779|NCT04003142|470934016|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
130810780|NCT04003142|470934017|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
130810781|NCT04003142|470934013|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
130810782|NCT04003142|470934014|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
130810783|NCT04003142|470934015|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
130810784|NCT04003142|470934016|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
130810785|NCT04003142|470934017|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
130810786|NCT04003142|470934013|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
130810787|NCT04003142|470934014|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
130810788|NCT04003142|470934015|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
130810789|NCT04003142|470934016|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
130810790|NCT04003142|470934017|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
130810791|NCT04003142|470934013|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
130810792|NCT04003142|470934014|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
130810793|NCT04003142|470934015|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
130810794|NCT04003142|470934016|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
130810795|NCT04003142|470934017|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
130810796|NCT04003142|470934013|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
130810797|NCT04003142|470934014|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
130810798|NCT04003142|470934015|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
130810799|NCT04003142|470934016|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
130810800|NCT04003142|470934017|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
130810801|NCT04003142|470934013|FG000|Extension Period (40 Weeks)|Death|0|||
130810802|NCT04003142|470934014|FG001|Extension Period (40 Weeks)|Death|0|||
130810803|NCT04003142|470934015|FG002|Extension Period (40 Weeks)|Death|0|||
130810804|NCT04003142|470934016|FG003|Extension Period (40 Weeks)|Death|0|||
130810805|NCT04003142|470934017|FG004|Extension Period (40 Weeks)|Death|1|||
130810806|NCT04003142|470934013|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
130810807|NCT04003142|470934014|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
130810808|NCT04003142|470934015|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
130810809|NCT04003142|470934016|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
130810810|NCT04003142|470934017|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
130810811|NCT04003142|470934013|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
130810812|NCT04003142|470934014|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
130810813|NCT04003142|470934015|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
130810814|NCT04003142|470934016|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
130810815|NCT04003142|470934017|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
130810816|NCT04003142|470934013|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
130810817|NCT04003142|470934014|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
130810818|NCT04003142|470934015|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
130810819|NCT04003142|470934016|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
130810820|NCT04003142|470934017|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
130810821|NCT04003142|470934013|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
130810822|NCT04003142|470934014|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
130810823|NCT04003142|470934015|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
130810824|NCT04003142|470934016|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
130810825|NCT04003142|470934017|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
130810826|NCT04042311|470934018|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
130810827|NCT04042311|470934018|FG000|Overall Study|Unable to tolerate|4|||
130810828|NCT04042311|470934018|FG000|Overall Study|Concurrent illness|2|||
130810829|NCT04042311|470934018|FG000|Overall Study|Adverse Event|2|||
130810830|NCT04042311|470934018|FG000|Overall Study|No longer meeting inclusion criteria|2|||
130810831|NCT04042311|470934018|FG000|Overall Study|No reason given|1|||
130810832|NCT04042311|470934018|FG000|Overall Study|Withdrawal by Subject|4|||
130810833|NCT03382873|470934019|FG000|Overall Study|Lost to Follow-up|9|||
130810834|NCT03382873|470934020|FG001|Overall Study|Lost to Follow-up|10|||
130810835|NCT03382873|470934019|FG000|Overall Study|Withdrawal by Subject|6|||
130810836|NCT03382873|470934020|FG001|Overall Study|Withdrawal by Subject|11|||
130810837|NCT03382873|470934019|FG000|Overall Study|Visit not completed due to pandemic|16|||
130810838|NCT03382873|470934020|FG001|Overall Study|Visit not completed due to pandemic|41|||
130810839|NCT01044459|470934033|FG000|Overall Study|Withdrawal by Subject|21|||
130810840|NCT01044459|470934034|FG001|Overall Study|Withdrawal by Subject|28|||
130810841|NCT01044459|470934033|FG000|Overall Study|Terminated by Sponsor|22|||
130810842|NCT01044459|470934034|FG001|Overall Study|Terminated by Sponsor|21|||
130810843|NCT01044459|470934033|FG000|Overall Study|Adverse Event|22|||
130810844|NCT01044459|470934034|FG001|Overall Study|Adverse Event|20|||
130810845|NCT01044459|470934033|FG000|Overall Study|Lack of Efficacy|23|||
130810846|NCT01044459|470934034|FG001|Overall Study|Lack of Efficacy|12|||
130810847|NCT01044459|470934033|FG000|Overall Study|Protocol Violation|11|||
130810848|NCT01044459|470934034|FG001|Overall Study|Protocol Violation|16|||
130810849|NCT01044459|470934033|FG000|Overall Study|Other Reason|7|||
130810850|NCT01044459|470934034|FG001|Overall Study|Other Reason|14|||
130810851|NCT01044459|470934033|FG000|Overall Study|COPD exacerbation|9|||
130810852|NCT01044459|470934034|FG001|Overall Study|COPD exacerbation|8|||
130810853|NCT01044459|470934033|FG000|Overall Study|Lost to Follow-up|18|||
130810854|NCT01044459|470934034|FG001|Overall Study|Lost to Follow-up|12|||
130810855|NCT04105725|470934035|FG000|Primary Intervention|Lost to Follow-up|0|||
130810856|NCT04105725|470934036|FG001|Primary Intervention|Lost to Follow-up|2|||
130810857|NCT04105725|470934035|FG000|Primary Intervention|Withdrawal by Subject|0|||
130810858|NCT04105725|470934036|FG001|Primary Intervention|Withdrawal by Subject|1|||
130810859|NCT05346640|470934037|FG000|Overall Study|Lack of Efficacy|2|||
130810860|NCT05346640|470934037|FG000|Overall Study|Lost to Follow-up|14|||
130810861|NCT05346640|470934037|FG000|Overall Study|Protocol Violation|4|||
130810862|NCT05346640|470934037|FG000|Overall Study|Withdrawal by Subject|2|||
130810863|NCT05346640|470934037|FG000|Overall Study|Physiological Complications|3|||
130810864|NCT05346640|470934037|FG000|Overall Study|Other Reason|3|||
130810865|NCT00480025|470934038|FG000|Overall Study|Protocol Violation|12|||
130810866|NCT00480025|470934039|FG001|Overall Study|Protocol Violation|7|||
130810867|NCT00480025|470934038|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
130810868|NCT00480025|470934039|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
130810869|NCT00480025|470934038|FG000|Overall Study|Disease Progression / Recurrence|449|||
130810870|NCT00480025|470934039|FG001|Overall Study|Disease Progression / Recurrence|224|||
130810871|NCT00480025|470934038|FG000|Overall Study|Adverse Event|44|||
130810872|NCT00480025|470934039|FG001|Overall Study|Adverse Event|12|||
130810873|NCT00480025|470934038|FG000|Overall Study|Other|70|||
130810874|NCT00480025|470934039|FG001|Overall Study|Other|29|||
130810875|NCT00480025|470934038|FG000|Overall Study|SAE including intercurrent illness|76|||
130810876|NCT00480025|470934039|FG001|Overall Study|SAE including intercurrent illness|42|||
130810877|NCT04634331|470934043|FG000|Overall Study|Withdrawal by Subject|2|||
130810878|NCT04634331|470934044|FG001|Overall Study|Withdrawal by Subject|2|||
130810879|NCT03726879|470934046|FG000|Overall Study|Death|11|||
130810880|NCT03726879|470934047|FG001|Overall Study|Death|13|||
130810881|NCT03726879|470934046|FG000|Overall Study|Physician Decision|0|||
130810882|NCT03726879|470934047|FG001|Overall Study|Physician Decision|2|||
130810883|NCT03726879|470934046|FG000|Overall Study|Protocol Violation|0|||
130810884|NCT03726879|470934047|FG001|Overall Study|Protocol Violation|1|||
130810885|NCT03726879|470934046|FG000|Overall Study|Withdrawal by Subject|5|||
130810886|NCT03726879|470934047|FG001|Overall Study|Withdrawal by Subject|6|||
130810887|NCT03726879|470934046|FG000|Overall Study|TSH result is unstable|0|||
130810888|NCT03726879|470934047|FG001|Overall Study|TSH result is unstable|1|||
130810889|NCT03726879|470934046|FG000|Overall Study|Disease relapse|1|||
130810890|NCT03726879|470934047|FG001|Overall Study|Disease relapse|0|||
130810891|NCT03726879|470934046|FG000|Overall Study|Lost to Follow-up|3|||
130810892|NCT03726879|470934047|FG001|Overall Study|Lost to Follow-up|0|||
130810893|NCT02766478|470934048|FG000|Overall Study|Withdrawal by Subject|1|||
130810894|NCT02766478|470934049|FG001|Overall Study|Withdrawal by Subject|1|||
130810895|NCT05626686|470934050|FG000|Overall Study|Protocol Violation|3|||
130810896|NCT05626686|470934050|FG000|Overall Study|Withdrawal by Subject|3|||
130810897|NCT01093573|470934051|FG000|Overall Study|Physician Decision|0|||
130810898|NCT01093573|470934052|FG001|Overall Study|Physician Decision|0|||
130810899|NCT01093573|470934053|FG002|Overall Study|Physician Decision|1|||
130810900|NCT01093573|470934051|FG000|Overall Study|Insurance Denied|0|||
130810901|NCT01093573|470934052|FG001|Overall Study|Insurance Denied|0|||
130810902|NCT01093573|470934053|FG002|Overall Study|Insurance Denied|1|||
130810903|NCT01197300|470935579|FG000|Overall Study|Lost to Follow-up|0|||
130810904|NCT01197300|470935580|FG001|Overall Study|Lost to Follow-up|1|||
130810905|NCT01197300|470935579|FG000|Overall Study|Protocol Violation|0|||
130810906|NCT01197300|470935580|FG001|Overall Study|Protocol Violation|1|||
130810907|NCT03058952|470935583|FG000|Overall Study|Adverse Event|1|||
130810908|NCT03058952|470935584|FG001|Overall Study|Adverse Event|0|||
130810909|NCT03058952|470935583|FG000|Overall Study|Lost to Follow-up|15|||
130810910|NCT03058952|470935584|FG001|Overall Study|Lost to Follow-up|15|||
130810911|NCT03058952|470935583|FG000|Overall Study|Withdrawal by Subject|7|||
130810912|NCT03058952|470935584|FG001|Overall Study|Withdrawal by Subject|11|||
130810913|NCT00590317|470935585|FG000|Overall Study|Lack of Efficacy|1|||
130810914|NCT00590317|470935586|FG001|Overall Study|Lack of Efficacy|5|||
130810915|NCT01251965|470935593|FG000|Overall Study|Participant/physician decision|1|||
130810916|NCT01251965|470935594|FG001|Overall Study|Participant/physician decision|2|||
130810917|NCT01251965|470935595|FG002|Overall Study|Participant/physician decision|0|||
130810918|NCT01251965|470935593|FG000|Overall Study|Death|0|||
130810919|NCT01251965|470935594|FG001|Overall Study|Death|0|||
130810920|NCT01251965|470935595|FG002|Overall Study|Death|11|||
130810921|NCT04616196|470935596|FG000|Overall Study|Progressive Disease|3|||
130810922|NCT04616196|470935597|FG001|Overall Study|Progressive Disease|0|||
130810923|NCT04616196|470935598|FG002|Overall Study|Progressive Disease|4|||
130810924|NCT04616196|470935599|FG003|Overall Study|Progressive Disease|1|||
130810925|NCT04616196|470935596|FG000|Overall Study|Death|2|||
130810926|NCT04616196|470935597|FG001|Overall Study|Death|4|||
130810927|NCT04616196|470935598|FG002|Overall Study|Death|1|||
130810928|NCT04616196|470935599|FG003|Overall Study|Death|0|||
130810929|NCT04616196|470935596|FG000|Overall Study|Withdrawal by Subject|0|||
130810930|NCT04616196|470935597|FG001|Overall Study|Withdrawal by Subject|2|||
130810931|NCT04616196|470935598|FG002|Overall Study|Withdrawal by Subject|0|||
130810932|NCT04616196|470935599|FG003|Overall Study|Withdrawal by Subject|0|||
130810933|NCT04616196|470935596|FG000|Overall Study|Lost to Follow-up|1|||
130810934|NCT04616196|470935597|FG001|Overall Study|Lost to Follow-up|0|||
130810935|NCT04616196|470935598|FG002|Overall Study|Lost to Follow-up|0|||
130810936|NCT04616196|470935599|FG003|Overall Study|Lost to Follow-up|0|||
130810937|NCT04616196|470935596|FG000|Overall Study|Sponsor request|2|||
130810938|NCT04616196|470935597|FG001|Overall Study|Sponsor request|1|||
130810939|NCT04616196|470935598|FG002|Overall Study|Sponsor request|1|||
130810940|NCT04616196|470935599|FG003|Overall Study|Sponsor request|2|||
130810941|NCT05401409|470935600|FG000|Overall Study|Lost to Follow-up|1|||
130810942|NCT05401409|470935601|FG001|Overall Study|Lost to Follow-up|0|||
130810943|NCT02371889|470935602|FG000|Overall Study|Adverse medication effect|11|||
130810944|NCT02371889|470935603|FG001|Overall Study|Adverse medication effect|2|||
130810945|NCT02371889|470935602|FG000|Overall Study|Lost to Follow-up|6|||
130810946|NCT02371889|470935603|FG001|Overall Study|Lost to Follow-up|5|||
130810947|NCT02371889|470935602|FG000|Overall Study|Personal time constraints|2|||
130810948|NCT02371889|470935603|FG001|Overall Study|Personal time constraints|4|||
130810949|NCT02371889|470935602|FG000|Overall Study|Lack of Efficacy|0|||
130810950|NCT02371889|470935603|FG001|Overall Study|Lack of Efficacy|2|||
130810951|NCT02371889|470935602|FG000|Overall Study|Relapse|0|||
130810952|NCT02371889|470935603|FG001|Overall Study|Relapse|1|||
130810953|NCT02579759|470935604|FG000|Overall Study|Protocol Violation|2|||
130810954|NCT02579759|470935605|FG001|Overall Study|Protocol Violation|0|||
130810955|NCT02579759|470935606|FG002|Overall Study|Protocol Violation|0|||
130810956|NCT02579759|470935604|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
130810957|NCT02579759|470935605|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
130810958|NCT02579759|470935606|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
130810959|NCT02579759|470935604|FG000|Overall Study|BfArM hold|13|||
130810960|NCT02579759|470935605|FG001|Overall Study|BfArM hold|12|||
130810961|NCT02579759|470935606|FG002|Overall Study|BfArM hold|12|||
130810962|NCT02579759|470935604|FG000|Overall Study|Sponsor stopped Dose 2|0|||
130810963|NCT02579759|470935605|FG001|Overall Study|Sponsor stopped Dose 2|41|||
130810964|NCT02579759|470935606|FG002|Overall Study|Sponsor stopped Dose 2|0|||
130810965|NCT02579759|470935604|FG000|Overall Study|Non compliance|0|||
130810966|NCT02579759|470935605|FG001|Overall Study|Non compliance|1|||
130810967|NCT02579759|470935606|FG002|Overall Study|Non compliance|0|||
130810968|NCT02579759|470935604|FG000|Overall Study|Pregnancy|0|||
130810969|NCT02579759|470935605|FG001|Overall Study|Pregnancy|1|||
130810970|NCT02579759|470935606|FG002|Overall Study|Pregnancy|0|||
130810971|NCT02579759|470935604|FG000|Overall Study|Inclusion/exclusion criteria|0|||
130810972|NCT02579759|470935605|FG001|Overall Study|Inclusion/exclusion criteria|0|||
130810973|NCT02579759|470935606|FG002|Overall Study|Inclusion/exclusion criteria|1|||
130810974|NCT02579759|470935604|FG000|Overall Study|Adverse Event|4|||
130810975|NCT02579759|470935605|FG001|Overall Study|Adverse Event|3|||
130810976|NCT02579759|470935606|FG002|Overall Study|Adverse Event|1|||
130810977|NCT02579759|470935604|FG000|Overall Study|Withdrawal by Subject|3|||
130810978|NCT02579759|470935605|FG001|Overall Study|Withdrawal by Subject|3|||
130810979|NCT02579759|470935606|FG002|Overall Study|Withdrawal by Subject|5|||
130810980|NCT02579759|470935604|FG000|Overall Study|Lost to Follow-up|2|||
130810981|NCT02579759|470935605|FG001|Overall Study|Lost to Follow-up|2|||
130810982|NCT02579759|470935606|FG002|Overall Study|Lost to Follow-up|2|||
130810983|NCT02410200|470935609|FG000|Overall Study|Adverse Event|2|||
130810984|NCT01050218|470935614|FG000|Overall Study|Adverse Event|37|||
130810985|NCT01050218|470935614|FG000|Overall Study|Lack of Efficacy|8|||
130810986|NCT01050218|470935614|FG000|Overall Study|Protocol Violation|3|||
130810987|NCT01050218|470935614|FG000|Overall Study|Withdrawal by Subject|18|||
130810988|NCT01050218|470935614|FG000|Overall Study|Discontinued by sponsor|18|||
130810989|NCT01050218|470935614|FG000|Overall Study|Compliance|2|||
130810990|NCT01050218|470935614|FG000|Overall Study|Failed to return|7|||
130810991|NCT01050218|470935614|FG000|Overall Study|Serious Adverse Event|1|||
130810992|NCT01050218|470935614|FG000|Overall Study|Family emergency|1|||
130810993|NCT01149460|470935615|FG000|Overall Study|Withdrawal by Subject|0|||
130810994|NCT01149460|470935616|FG001|Overall Study|Withdrawal by Subject|2|||
130810995|NCT03682367|470935622|FG000|Overall Study|Protocol Violation|2|||
130810996|NCT03682367|470935623|FG001|Overall Study|Protocol Violation|1|||
130810997|NCT03682367|470935622|FG000|Overall Study|Closed Study Early|0|||
130810998|NCT03682367|470935623|FG001|Overall Study|Closed Study Early|3|||
130810999|NCT00770679|470935624|FG000|Overall Study|Lost to Follow-up|3|||
130811000|NCT00770679|470935624|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
130811001|NCT00129974|470935625|FG000|Overall Study|Other|1|||
130811002|NCT00414609|470935626|FG000|Core Study|Adverse Event|9|||
130811003|NCT00414609|470935627|FG001|Core Study|Adverse Event|11|||
130811004|NCT00414609|470935628|FG002|Core Study|Adverse Event|0|||
130811005|NCT00414609|470935626|FG000|Core Study|Abnormal laboratory values|0|||
130811006|NCT00414609|470935627|FG001|Core Study|Abnormal laboratory values|1|||
130811007|NCT00414609|470935628|FG002|Core Study|Abnormal laboratory values|0|||
130811008|NCT00414609|470935626|FG000|Core Study|Abnormal test procedure results|1|||
130811009|NCT00414609|470935627|FG001|Core Study|Abnormal test procedure results|1|||
130811010|NCT00414609|470935628|FG002|Core Study|Abnormal test procedure results|0|||
130811011|NCT00414609|470935626|FG000|Core Study|Protocol deviation|0|||
130811012|NCT00414609|470935627|FG001|Core Study|Protocol deviation|1|||
130811013|NCT00414609|470935628|FG002|Core Study|Protocol deviation|0|||
130811014|NCT00414609|470935626|FG000|Core Study|Patient withdrew consent|10|||
130811015|NCT00414609|470935627|FG001|Core Study|Patient withdrew consent|11|||
130811016|NCT00414609|470935628|FG002|Core Study|Patient withdrew consent|0|||
130811017|NCT00414609|470935626|FG000|Core Study|Lost to Follow-up|7|||
130811018|NCT00414609|470935627|FG001|Core Study|Lost to Follow-up|4|||
130811019|NCT00414609|470935628|FG002|Core Study|Lost to Follow-up|0|||
130811020|NCT00414609|470935626|FG000|Core Study|Administrative problems|0|||
130811021|NCT00414609|470935627|FG001|Core Study|Administrative problems|2|||
130811022|NCT00414609|470935628|FG002|Core Study|Administrative problems|0|||
130811023|NCT00414609|470935626|FG000|Core Study|Death|7|||
130811024|NCT00414609|470935627|FG001|Core Study|Death|14|||
130811025|NCT00414609|470935628|FG002|Core Study|Death|0|||
130811026|NCT00414609|470935626|FG000|Extension Study|Adverse Event|0|||
130811027|NCT00414609|470935627|FG001|Extension Study|Adverse Event|0|||
130811028|NCT00414609|470935628|FG002|Extension Study|Adverse Event|14|||
130811029|NCT00414609|470935626|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
130811030|NCT00414609|470935627|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
130811031|NCT00414609|470935628|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
130811032|NCT00414609|470935626|FG000|Extension Study|Withdrawal by Subject|0|||
130811033|NCT00414609|470935627|FG001|Extension Study|Withdrawal by Subject|0|||
130811034|NCT00414609|470935628|FG002|Extension Study|Withdrawal by Subject|13|||
130811035|NCT00414609|470935626|FG000|Extension Study|Lost to Follow-up|0|||
130811036|NCT00414609|470935627|FG001|Extension Study|Lost to Follow-up|0|||
130811037|NCT00414609|470935628|FG002|Extension Study|Lost to Follow-up|10|||
130811038|NCT00414609|470935626|FG000|Extension Study|Administrative problems|0|||
130811039|NCT00414609|470935627|FG001|Extension Study|Administrative problems|0|||
130811040|NCT00414609|470935628|FG002|Extension Study|Administrative problems|1|||
130811041|NCT00414609|470935626|FG000|Extension Study|Death|0|||
130811042|NCT00414609|470935627|FG001|Extension Study|Death|0|||
130811043|NCT00414609|470935628|FG002|Extension Study|Death|17|||
130811044|NCT01514357|470935631|FG000|Overall Study|Screen failure|2|||
130811045|NCT01514357|470935632|FG001|Overall Study|Screen failure|0|||
130811046|NCT01514357|470935631|FG000|Overall Study|Withdrawal by Subject|2|||
130811047|NCT01514357|470935632|FG001|Overall Study|Withdrawal by Subject|0|||
130811048|NCT01047540|470935635|FG000|Overall Study|Protocol Violation|1|||
130811049|NCT01047540|470935636|FG001|Overall Study|Protocol Violation|0|||
130811050|NCT01047540|470935637|FG002|Overall Study|Protocol Violation|0|||
130811051|NCT01047540|470935638|FG003|Overall Study|Protocol Violation|0|||
130811052|NCT01047540|470935639|FG004|Overall Study|Protocol Violation|0|||
130811053|NCT01047540|470935635|FG000|Overall Study|Lost to Follow-up|1|||
130811054|NCT01047540|470935636|FG001|Overall Study|Lost to Follow-up|0|||
130811055|NCT01047540|470935637|FG002|Overall Study|Lost to Follow-up|0|||
130811056|NCT01047540|470935638|FG003|Overall Study|Lost to Follow-up|0|||
130811057|NCT01047540|470935639|FG004|Overall Study|Lost to Follow-up|0|||
130811058|NCT01047540|470935635|FG000|Overall Study|Withdrawal by Subject|1|||
130811059|NCT01047540|470935636|FG001|Overall Study|Withdrawal by Subject|0|||
130811060|NCT01047540|470935637|FG002|Overall Study|Withdrawal by Subject|3|||
130811061|NCT01047540|470935638|FG003|Overall Study|Withdrawal by Subject|0|||
130811062|NCT01047540|470935639|FG004|Overall Study|Withdrawal by Subject|1|||
130811063|NCT01047540|470935635|FG000|Overall Study|Pregnancy|1|||
130811064|NCT01047540|470935636|FG001|Overall Study|Pregnancy|0|||
130811065|NCT01047540|470935637|FG002|Overall Study|Pregnancy|0|||
130811066|NCT01047540|470935638|FG003|Overall Study|Pregnancy|0|||
130811067|NCT01047540|470935639|FG004|Overall Study|Pregnancy|0|||
130811068|NCT01047540|470935635|FG000|Overall Study|Adverse Event|1|||
130811069|NCT01047540|470935636|FG001|Overall Study|Adverse Event|0|||
130811070|NCT01047540|470935637|FG002|Overall Study|Adverse Event|0|||
130811071|NCT01047540|470935638|FG003|Overall Study|Adverse Event|0|||
130811072|NCT01047540|470935639|FG004|Overall Study|Adverse Event|0|||
130811073|NCT01229111|470935640|FG000|Overall Study|Death|1|||
130811074|NCT00835549|470935641|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
130811075|NCT00835549|470935642|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130811076|NCT04893811|470935643|FG000|Vaccination Phase|Death|1|||
130811077|NCT04893811|470935644|FG001|Vaccination Phase|Death|0|||
130811078|NCT04893811|470935643|FG000|Vaccination Phase|Lost to Follow-up|1|||
130811079|NCT04893811|470935644|FG001|Vaccination Phase|Lost to Follow-up|1|||
130811080|NCT04893811|470935643|FG000|Vaccination Phase|Protocol Violation|2|||
130811081|NCT04893811|470935644|FG001|Vaccination Phase|Protocol Violation|0|||
130811082|NCT04893811|470935643|FG000|Vaccination Phase|Withdrawal by Subject|2|||
130811083|NCT04893811|470935644|FG001|Vaccination Phase|Withdrawal by Subject|1|||
130811084|NCT04893811|470935643|FG000|Vaccination Phase|Other|0|||
130811085|NCT04893811|470935644|FG001|Vaccination Phase|Other|1|||
130811086|NCT04893811|470935643|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
130811087|NCT04893811|470935644|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
130811088|NCT04893811|470935643|FG000|Follow-up Phase|Lost to Follow-up|0|||
130811089|NCT04893811|470935644|FG001|Follow-up Phase|Lost to Follow-up|1|||
130811090|NCT00835042|470935645|FG000|First Intervention|Withdrawal by Subject|3|||
130811091|NCT00835042|470935646|FG001|First Intervention|Withdrawal by Subject|0|||
130811092|NCT00835042|470935645|FG000|First Intervention|Adverse Event|1|||
130811093|NCT00835042|470935646|FG001|First Intervention|Adverse Event|2|||
130811094|NCT00835042|470935645|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
130811095|NCT00835042|470935646|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
130811096|NCT05463952|470935666|FG000|Treatment|Progressive disease|4|||
130811097|NCT05463952|470935666|FG000|Treatment|Ongoing|2|||
130811098|NCT01946880|470935667|FG000|Overall Study|Lost to Follow-up|1|||
130811099|NCT01946880|470935668|FG001|Overall Study|Lost to Follow-up|0|||
130811100|NCT01946880|470935667|FG000|Overall Study|Physician Decision|1|||
130811101|NCT01946880|470935668|FG001|Overall Study|Physician Decision|1|||
130811102|NCT01946880|470935667|FG000|Overall Study|Withdrawal by Subject|3|||
130811103|NCT01946880|470935668|FG001|Overall Study|Withdrawal by Subject|2|||
130811104|NCT01946880|470935667|FG000|Overall Study|Met Primary Endpoint|1|||
130811105|NCT01946880|470935668|FG001|Overall Study|Met Primary Endpoint|0|||
130811106|NCT01946880|470935667|FG000|Overall Study|Personal and Family Issues|1|||
130811107|NCT01946880|470935668|FG001|Overall Study|Personal and Family Issues|0|||
130811108|NCT06091956|470935671|FG000|Overall Study|Withdrawal by Subject|1|||
130811109|NCT06091956|470935671|FG000|Overall Study|Complicating Disease|1|||
130811110|NCT04818229|470935674|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
130811111|NCT04818229|470935675|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
130811112|NCT04818229|470935676|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
130811113|NCT04818229|470935674|FG000|Overall Study|Adverse Event|3|||
130811114|NCT04818229|470935675|FG001|Overall Study|Adverse Event|1|||
130811115|NCT04818229|470935676|FG002|Overall Study|Adverse Event|1|||
130811116|NCT04818229|470935674|FG000|Overall Study|Withdrawal by Subject|0|||
130811117|NCT04818229|470935675|FG001|Overall Study|Withdrawal by Subject|0|||
130811118|NCT04818229|470935676|FG002|Overall Study|Withdrawal by Subject|2|||
130811119|NCT04818229|470935674|FG000|Overall Study|Lost to Follow-up|0|||
130811120|NCT04818229|470935675|FG001|Overall Study|Lost to Follow-up|0|||
130811121|NCT04818229|470935676|FG002|Overall Study|Lost to Follow-up|1|||
130811122|NCT03186378|470935677|FG000|Overall Study|Lost to Follow-up|1|||
130811123|NCT03186378|470935678|FG001|Overall Study|Lost to Follow-up|0|||
130811124|NCT02514746|470935679|FG000|Overall Study|Chronically Ill|1|||
130811125|NCT02514746|470935680|FG001|Overall Study|Chronically Ill|2|||
130811126|NCT02514746|470935679|FG000|Overall Study|Physician Decision|4|||
130811127|NCT02514746|470935680|FG001|Overall Study|Physician Decision|2|||
130811128|NCT02514746|470935679|FG000|Overall Study|Withdrawal by Subject|12|||
130811129|NCT02514746|470935680|FG001|Overall Study|Withdrawal by Subject|10|||
130811130|NCT02514746|470935679|FG000|Overall Study|Other|5|||
130811131|NCT02514746|470935680|FG001|Overall Study|Other|1|||
130811132|NCT02181413|470935683|FG000|Overall Study|Withdrawal by Subject|45|||
130811133|NCT02181413|470935684|FG001|Overall Study|Withdrawal by Subject|61|||
130811134|NCT02181413|470935683|FG000|Overall Study|Reason Not Specified|2|||
130811135|NCT02181413|470935684|FG001|Overall Study|Reason Not Specified|5|||
130811136|NCT02181413|470935683|FG000|Overall Study|Lost to Follow-up|8|||
130811137|NCT02181413|470935684|FG001|Overall Study|Lost to Follow-up|7|||
130811138|NCT03996395|470935686|FG000|Overall Study|Lost to Follow-up|4|||
130811139|NCT03996395|470935686|FG000|Overall Study|Withdrawal by Subject|1|||
130811140|NCT03996395|470935686|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
130811141|NCT00392288|470935689|FG000|Overall Study|Adverse Event|17|||
130811142|NCT00392288|470935690|FG001|Overall Study|Adverse Event|7|||
130811143|NCT00392288|470935691|FG002|Overall Study|Adverse Event|8|||
130811144|NCT00392288|470935689|FG000|Overall Study|Lack of Efficacy|8|||
130811145|NCT00392288|470935690|FG001|Overall Study|Lack of Efficacy|5|||
130811146|NCT00392288|470935691|FG002|Overall Study|Lack of Efficacy|3|||
130811147|NCT00392288|470935689|FG000|Overall Study|Protocol Violation|1|||
130811148|NCT00392288|470935690|FG001|Overall Study|Protocol Violation|3|||
130811149|NCT00392288|470935691|FG002|Overall Study|Protocol Violation|1|||
130811150|NCT00392288|470935689|FG000|Overall Study|Lost to Follow-up|1|||
130811151|NCT00392288|470935690|FG001|Overall Study|Lost to Follow-up|1|||
130811152|NCT00392288|470935691|FG002|Overall Study|Lost to Follow-up|1|||
130811153|NCT00392288|470935689|FG000|Overall Study|Withdrawal by Subject|1|||
130811154|NCT00392288|470935690|FG001|Overall Study|Withdrawal by Subject|0|||
130811155|NCT00392288|470935691|FG002|Overall Study|Withdrawal by Subject|2|||
130811156|NCT00392288|470935689|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
130811157|NCT00392288|470935690|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
130811158|NCT00392288|470935691|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
130811159|NCT00392288|470935689|FG000|Overall Study|Other|3|||
130811160|NCT00392288|470935690|FG001|Overall Study|Other|4|||
130811161|NCT00392288|470935691|FG002|Overall Study|Other|1|||
130811162|NCT02544763|470935692|FG000|Overall Study|Adverse Event|8|||
130811163|NCT02544763|470935693|FG001|Overall Study|Adverse Event|8|||
130811164|NCT02544763|470935694|FG002|Overall Study|Adverse Event|0|||
130811165|NCT02544763|470935692|FG000|Overall Study|Withdrawn by parent/guardian|1|||
130811166|NCT02544763|470935693|FG001|Overall Study|Withdrawn by parent/guardian|1|||
130811167|NCT02544763|470935694|FG002|Overall Study|Withdrawn by parent/guardian|1|||
130811168|NCT02544763|470935692|FG000|Overall Study|Met withdrawal criteria|0|||
130811169|NCT02544763|470935693|FG001|Overall Study|Met withdrawal criteria|2|||
130811170|NCT02544763|470935694|FG002|Overall Study|Met withdrawal criteria|0|||
130811171|NCT02544763|470935692|FG000|Overall Study|Physician Decision|0|||
130811172|NCT02544763|470935693|FG001|Overall Study|Physician Decision|1|||
130811173|NCT02544763|470935694|FG002|Overall Study|Physician Decision|0|||
130811174|NCT02544763|470935692|FG000|Overall Study|Difficulties taking IMP|1|||
130811175|NCT02544763|470935693|FG001|Overall Study|Difficulties taking IMP|0|||
130811176|NCT02544763|470935694|FG002|Overall Study|Difficulties taking IMP|0|||
130811177|NCT02097225|470935695|FG000|Dose Level 4|Adverse Event|0|||
130811178|NCT02097225|470935696|FG001|Dose Level 4|Adverse Event|0|||
130811179|NCT02097225|470935697|FG002|Dose Level 4|Adverse Event|0|||
130811180|NCT02097225|470935698|FG003|Dose Level 4|Adverse Event|0|||
130811181|NCT02097225|470935699|FG004|Dose Level 4|Adverse Event|1|||
130811182|NCT01027351|470935701|FG000|Overall Study|Withdrawal by Subject|1|||
130811183|NCT01027351|470935702|FG001|Overall Study|Withdrawal by Subject|0|||
130811184|NCT01027351|470935703|FG002|Overall Study|Withdrawal by Subject|1|||
130811185|NCT01027351|470935704|FG003|Overall Study|Withdrawal by Subject|0|||
130811186|NCT01027351|470935705|FG004|Overall Study|Withdrawal by Subject|3|||
130811187|NCT01027351|470935706|FG005|Overall Study|Withdrawal by Subject|5|||
130811188|NCT01027351|470935701|FG000|Overall Study|Lost to Follow-up|1|||
130811189|NCT01027351|470935702|FG001|Overall Study|Lost to Follow-up|1|||
130811190|NCT01027351|470935703|FG002|Overall Study|Lost to Follow-up|0|||
130811191|NCT01027351|470935704|FG003|Overall Study|Lost to Follow-up|1|||
130811192|NCT01027351|470935705|FG004|Overall Study|Lost to Follow-up|6|||
130811193|NCT01027351|470935706|FG005|Overall Study|Lost to Follow-up|0|||
130811194|NCT01027351|470935701|FG000|Overall Study|Inappropriate enrollment|0|||
130811195|NCT01027351|470935702|FG001|Overall Study|Inappropriate enrollment|0|||
130811196|NCT01027351|470935703|FG002|Overall Study|Inappropriate enrollment|0|||
130811197|NCT01027351|470935704|FG003|Overall Study|Inappropriate enrollment|0|||
130811198|NCT01027351|470935705|FG004|Overall Study|Inappropriate enrollment|1|||
130811199|NCT01027351|470935706|FG005|Overall Study|Inappropriate enrollment|0|||
130811200|NCT01027351|470935701|FG000|Overall Study|Protocol Violation|1|||
130811201|NCT01027351|470935702|FG001|Overall Study|Protocol Violation|0|||
130811202|NCT01027351|470935703|FG002|Overall Study|Protocol Violation|0|||
130811203|NCT01027351|470935704|FG003|Overall Study|Protocol Violation|1|||
130811204|NCT01027351|470935705|FG004|Overall Study|Protocol Violation|1|||
130811205|NCT01027351|470935706|FG005|Overall Study|Protocol Violation|0|||
130811206|NCT02971137|470935707|FG000|Overall Study|Lost to Follow-up|44|||
130811207|NCT02971137|470935708|FG001|Overall Study|Lost to Follow-up|56|||
130811208|NCT02757963|470935709|FG000|Overall Study|Adverse Event|3|||
130811209|NCT02757963|470935709|FG000|Overall Study|Reached Stopping Criteria|1054|||
130811210|NCT02757963|470935709|FG000|Overall Study|Lost to Follow-up|5|||
130811211|NCT02757963|470935709|FG000|Overall Study|Physician Decision|1|||
130811212|NCT02757963|470935709|FG000|Overall Study|Withdrawal by Subject|34|||
130811213|NCT04755231|470935710|FG000|Overall Study|Lost to Follow-up|5|||
130811214|NCT04755231|470935710|FG000|Overall Study|Withdrawal by Subject|5|||
130811215|NCT00911157|470935711|FG000|Overall Study|Adverse Event|4|||
130811216|NCT00911157|470935712|FG001|Overall Study|Adverse Event|1|||
130811217|NCT00911157|470935711|FG000|Overall Study|Withdrawal by Subject|1|||
130811218|NCT00911157|470935712|FG001|Overall Study|Withdrawal by Subject|1|||
130811219|NCT00911157|470935711|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
130811220|NCT00911157|470935712|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
130811221|NCT00911157|470935711|FG000|Overall Study|Need to treat for lung cancer|1|||
130811222|NCT00911157|470935712|FG001|Overall Study|Need to treat for lung cancer|0|||
130811223|NCT04650893|470935713|FG000|Overall Study|Lost to Follow-up|11|||
130811224|NCT04650893|470935714|FG001|Overall Study|Lost to Follow-up|10|||
130811225|NCT04650893|470935715|FG002|Overall Study|Lost to Follow-up|11|||
130811226|NCT00176254|470935728|FG000|Overall Study|Lost to Follow-up|1|||
130811227|NCT04129398|470937079|FG000|Overall Study|Physician Decision|2|||
130811228|NCT02363283|470937084|FG000|Overall Study|Withdrawal by Subject|1|||
130811229|NCT02363283|470937084|FG000|Overall Study|Not eligible due to transaminitis|1|||
130811230|NCT00003907|470937094|FG000|Overall Study|Adverse Event|2|||
130811231|NCT00003907|470937095|FG001|Overall Study|Adverse Event|11|||
130811232|NCT00003907|470937094|FG000|Overall Study|Death|2|||
130811233|NCT00003907|470937095|FG001|Overall Study|Death|0|||
130811234|NCT00003907|470937094|FG000|Overall Study|Withdrawal by Subject|1|||
130811235|NCT00003907|470937095|FG001|Overall Study|Withdrawal by Subject|3|||
130811236|NCT00003907|470937094|FG000|Overall Study|Progressive disease|4|||
130811237|NCT00003907|470937095|FG001|Overall Study|Progressive disease|4|||
130811238|NCT00003907|470937094|FG000|Overall Study|Complicating disease|1|||
130811239|NCT00003907|470937095|FG001|Overall Study|Complicating disease|0|||
130811240|NCT00003907|470937094|FG000|Overall Study|Other|1|||
130811241|NCT00003907|470937095|FG001|Overall Study|Other|3|||
130811242|NCT00003907|470937094|FG000|Overall Study|ineligible or not treated|2|||
130811243|NCT00003907|470937095|FG001|Overall Study|ineligible or not treated|2|||
130811244|NCT01517178|470937096|FG000|Period 1|Adverse Event|1|||
130811245|NCT01517178|470937097|FG001|Period 1|Adverse Event|2|||
130811246|NCT01517178|470937096|FG000|Period 1|Lack of Efficacy|0|||
130811247|NCT01517178|470937097|FG001|Period 1|Lack of Efficacy|1|||
130811248|NCT01517178|470937096|FG000|Period 1|E.g. study termination|3|||
130811249|NCT01517178|470937097|FG001|Period 1|E.g. study termination|1|||
130811250|NCT01517178|470937096|FG000|Period 1|Withdrawal by Subject|0|||
130811251|NCT01517178|470937097|FG001|Period 1|Withdrawal by Subject|1|||
130811252|NCT01517178|470937096|FG000|Period 2|Adverse Event|1|||
130811253|NCT01517178|470937097|FG001|Period 2|Adverse Event|0|||
130811254|NCT01517178|470937096|FG000|Period 2|Withdrawal by Subject|3|||
130811255|NCT01517178|470937097|FG001|Period 2|Withdrawal by Subject|0|||
130811256|NCT01517178|470937096|FG000|Period 2|E.g. study termination|2|||
130811257|NCT01517178|470937097|FG001|Period 2|E.g. study termination|2|||
130811258|NCT01557569|470937100|FG000|Overall Study|Adverse Event|2|||
130811259|NCT01557569|470937101|FG001|Overall Study|Adverse Event|0|||
130811260|NCT01557569|470937100|FG000|Overall Study|high blood pressure|0|||
130811261|NCT01557569|470937101|FG001|Overall Study|high blood pressure|1|||
130811262|NCT01557569|470937100|FG000|Overall Study|Withdrawal by Subject|3|||
130811263|NCT01557569|470937101|FG001|Overall Study|Withdrawal by Subject|5|||
130811264|NCT01557569|470937100|FG000|Overall Study|noncompliance with rules of residential|0|||
130811265|NCT01557569|470937101|FG001|Overall Study|noncompliance with rules of residential|1|||
130811266|NCT02801578|470937111|FG000|Overall Study|Adverse Event|2|||
130811267|NCT00668642|470937112|FG000|First Off-cycle|Cancer progression|1|||
130811268|NCT00668642|470937113|FG001|First Off-cycle|Cancer progression|0|||
130811269|NCT00668642|470937112|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
130811270|NCT00668642|470937113|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
130811271|NCT03412591|470937114|FG000|Overall Study|Withdrawal by Subject|1|||
130811272|NCT03412591|470937115|FG001|Overall Study|Withdrawal by Subject|8|||
130811273|NCT03412591|470937114|FG000|Overall Study|Adverse Event|0|||
130811274|NCT03412591|470937115|FG001|Overall Study|Adverse Event|1|||
130811275|NCT02272985|470937116|FG000|Overall Study|Withdrawal by Subject|1|||
130811276|NCT02272985|470937116|FG000|Overall Study|hip fracture|1|||
130811277|NCT02272985|470937116|FG000|Overall Study|kidney transplantation|1|||
130811278|NCT00266032|470937122|FG000|Treatment|Adverse Event|42|||
130811279|NCT00266032|470937123|FG001|Treatment|Adverse Event|26|||
130811280|NCT00266032|470937124|FG002|Treatment|Adverse Event|10|||
130811281|NCT00266032|470937122|FG000|Treatment|Lost to Follow-up|19|||
130811282|NCT00266032|470937123|FG001|Treatment|Lost to Follow-up|4|||
130811283|NCT00266032|470937124|FG002|Treatment|Lost to Follow-up|2|||
130811284|NCT00266032|470937122|FG000|Treatment|Pregnancy|3|||
130811285|NCT00266032|470937123|FG001|Treatment|Pregnancy|2|||
130811286|NCT00266032|470937124|FG002|Treatment|Pregnancy|2|||
130811287|NCT00266032|470937122|FG000|Treatment|Protocol Violation|6|||
130811288|NCT00266032|470937123|FG001|Treatment|Protocol Violation|14|||
130811289|NCT00266032|470937124|FG002|Treatment|Protocol Violation|13|||
130811290|NCT00266032|470937122|FG000|Treatment|Withdrawal by Subject|28|||
130811291|NCT00266032|470937123|FG001|Treatment|Withdrawal by Subject|13|||
130811292|NCT00266032|470937124|FG002|Treatment|Withdrawal by Subject|12|||
130811293|NCT00266032|470937122|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
130811294|NCT00266032|470937123|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
130811295|NCT00266032|470937124|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
130811296|NCT00266032|470937122|FG000|Open-label Safety Extension|Adverse Event|5|||
130811297|NCT00266032|470937123|FG001|Open-label Safety Extension|Adverse Event|0|||
130811298|NCT00266032|470937124|FG002|Open-label Safety Extension|Adverse Event|4|||
130811299|NCT00266032|470937122|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
130811300|NCT00266032|470937123|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
130811301|NCT00266032|470937124|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
130811302|NCT00266032|470937122|FG000|Open-label Safety Extension|Pregnancy|4|||
130811303|NCT00266032|470937123|FG001|Open-label Safety Extension|Pregnancy|1|||
130811304|NCT00266032|470937124|FG002|Open-label Safety Extension|Pregnancy|2|||
130811305|NCT00266032|470937122|FG000|Open-label Safety Extension|Protocol Violation|1|||
130811306|NCT00266032|470937123|FG001|Open-label Safety Extension|Protocol Violation|3|||
130811307|NCT00266032|470937124|FG002|Open-label Safety Extension|Protocol Violation|2|||
130811308|NCT00266032|470937122|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
130811309|NCT00266032|470937123|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
130811310|NCT00266032|470937124|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
130811311|NCT00266032|470937122|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
130811312|NCT00266032|470937123|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
130811313|NCT00266032|470937124|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
130811314|NCT00814983|470937127|FG000|Overall Study|Screen failure|1|||
130811315|NCT00814983|470937128|FG001|Overall Study|Screen failure|0|||
130811316|NCT00814983|470937127|FG000|Overall Study|Withdrawal by Subject|1|||
130811317|NCT00814983|470937128|FG001|Overall Study|Withdrawal by Subject|0|||
130811318|NCT00814983|470937127|FG000|Overall Study|Graft failure|1|||
130811319|NCT00814983|470937128|FG001|Overall Study|Graft failure|0|||
130811320|NCT03627468|470937129|FG000|Overall Study|Adverse Event|5|||
130811321|NCT03627468|470937130|FG001|Overall Study|Adverse Event|33|||
130811322|NCT03627468|470937129|FG000|Overall Study|Withdrawal by Subject|13|||
130811323|NCT03627468|470937130|FG001|Overall Study|Withdrawal by Subject|23|||
130811324|NCT03627468|470937129|FG000|Overall Study|Physician Decision|1|||
130811325|NCT03627468|470937130|FG001|Overall Study|Physician Decision|0|||
130811326|NCT03627468|470937129|FG000|Overall Study|Protocol Violation|0|||
130811327|NCT03627468|470937130|FG001|Overall Study|Protocol Violation|2|||
130811328|NCT03627468|470937129|FG000|Overall Study|Lost to Follow-up|10|||
130811329|NCT03627468|470937130|FG001|Overall Study|Lost to Follow-up|16|||
130811330|NCT03627468|470937129|FG000|Overall Study|Death|1|||
130811331|NCT03627468|470937130|FG001|Overall Study|Death|0|||
130811332|NCT03627468|470937129|FG000|Overall Study|Pregnancy|1|||
130811333|NCT03627468|470937130|FG001|Overall Study|Pregnancy|1|||
130811334|NCT03627468|470937129|FG000|Overall Study|Lack of Efficacy|0|||
130811335|NCT03627468|470937130|FG001|Overall Study|Lack of Efficacy|2|||
130811336|NCT03627468|470937129|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
130811337|NCT03627468|470937130|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
130811338|NCT04157738|470937131|FG000|Overall Study|Moved out of state|0|||
130811339|NCT04157738|470937132|FG001|Overall Study|Moved out of state|2|||
130811340|NCT04157738|470937131|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
130811341|NCT04157738|470937132|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
130811342|NCT00160563|470937133|FG000|Overall Study|Adverse Event|1|||
130811343|NCT00160563|470937134|FG001|Overall Study|Adverse Event|1|||
130811344|NCT00160563|470937135|FG002|Overall Study|Adverse Event|1|||
130811345|NCT00160563|470937133|FG000|Overall Study|Lost to Follow-up|1|||
130811346|NCT00160563|470937134|FG001|Overall Study|Lost to Follow-up|1|||
130811347|NCT00160563|470937135|FG002|Overall Study|Lost to Follow-up|2|||
130811348|NCT00160563|470937133|FG000|Overall Study|Protocol Violation|0|||
130811349|NCT00160563|470937134|FG001|Overall Study|Protocol Violation|0|||
130811350|NCT00160563|470937135|FG002|Overall Study|Protocol Violation|3|||
130811351|NCT00160563|470937133|FG000|Overall Study|Withdrawal by Subject|1|||
130811352|NCT00160563|470937134|FG001|Overall Study|Withdrawal by Subject|2|||
130811353|NCT00160563|470937135|FG002|Overall Study|Withdrawal by Subject|3|||
130811354|NCT00160563|470937133|FG000|Overall Study|Other (listed in the study report)|48|||
130811355|NCT00160563|470937134|FG001|Overall Study|Other (listed in the study report)|40|||
130811356|NCT00160563|470937135|FG002|Overall Study|Other (listed in the study report)|81|||
130811357|NCT00160563|470937133|FG000|Overall Study|Missing reason|0|||
130811358|NCT00160563|470937134|FG001|Overall Study|Missing reason|1|||
130811359|NCT00160563|470937135|FG002|Overall Study|Missing reason|0|||
130811360|NCT00752219|470937139|FG000|Overall Study|Clinical failure|0|||
130811361|NCT00752219|470937140|FG001|Overall Study|Clinical failure|1|||
130811362|NCT00752219|470937139|FG000|Overall Study|Adverse Event|5|||
130811363|NCT00752219|470937140|FG001|Overall Study|Adverse Event|3|||
130811364|NCT00752219|470937139|FG000|Overall Study|Protocol deviation|1|||
130811365|NCT00752219|470937140|FG001|Overall Study|Protocol deviation|0|||
130811366|NCT00752219|470937139|FG000|Overall Study|Lost to Follow-up|1|||
130811367|NCT00752219|470937140|FG001|Overall Study|Lost to Follow-up|2|||
130811368|NCT00752219|470937139|FG000|Overall Study|Randomized but not treated|1|||
130811369|NCT00752219|470937140|FG001|Overall Study|Randomized but not treated|0|||
130811370|NCT00752219|470937139|FG000|Overall Study|Other|3|||
130811371|NCT00752219|470937140|FG001|Overall Study|Other|0|||
130811372|NCT04691115|470937143|FG000|Overall Study|Withdrawal by Subject|0|||
130811373|NCT04691115|470937144|FG001|Overall Study|Withdrawal by Subject|0|||
130811374|NCT04691115|470937145|FG002|Overall Study|Withdrawal by Subject|0|||
130811375|NCT04691115|470937146|FG003|Overall Study|Withdrawal by Subject|0|||
130811376|NCT04691115|470937147|FG004|Overall Study|Withdrawal by Subject|0|||
130811377|NCT04691115|470937148|FG005|Overall Study|Withdrawal by Subject|1|||
130811378|NCT04691115|470937149|FG006|Overall Study|Withdrawal by Subject|0|||
130811379|NCT04691115|470937150|FG007|Overall Study|Withdrawal by Subject|0|||
130811380|NCT04691115|470937151|FG008|Overall Study|Withdrawal by Subject|0|||
130811381|NCT04691115|470937152|FG009|Overall Study|Withdrawal by Subject|0|||
130811382|NCT04691115|470937153|FG010|Overall Study|Withdrawal by Subject|0|||
130811383|NCT04691115|470937154|FG011|Overall Study|Withdrawal by Subject|0|||
130811384|NCT04691115|470937155|FG012|Overall Study|Withdrawal by Subject|0|||
130811385|NCT04691115|470937156|FG013|Overall Study|Withdrawal by Subject|0|||
130811386|NCT01437189|470937167|FG000|Overall Study|Adverse Event|3|||
130811387|NCT01437189|470937167|FG000|Overall Study|Lack of Efficacy|4|||
130811388|NCT01437189|470937167|FG000|Overall Study|Withdrawal by Subject|8|||
130811389|NCT00347269|470937168|FG000|Overall Study|Lost to Follow-up|74|||
130811390|NCT00347269|470937169|FG001|Overall Study|Lost to Follow-up|65|||
130811391|NCT00347269|470937168|FG000|Overall Study|Withdrawal by Subject|18|||
130811392|NCT00347269|470937169|FG001|Overall Study|Withdrawal by Subject|38|||
130811393|NCT00347269|470937168|FG000|Overall Study|Death|2|||
130811394|NCT00347269|470937169|FG001|Overall Study|Death|3|||
130811395|NCT03654326|470937170|FG000|Overall Study|Withdrawal by Subject|5|||
130811396|NCT03654326|470937171|FG001|Overall Study|Withdrawal by Subject|3|||
130811397|NCT03654326|470937170|FG000|Overall Study|Physician Decision|0|||
130811398|NCT03654326|470937171|FG001|Overall Study|Physician Decision|1|||
130811399|NCT03654326|470937170|FG000|Overall Study|Unable to adhere to study schedule|0|||
130811400|NCT03654326|470937171|FG001|Overall Study|Unable to adhere to study schedule|1|||
130811401|NCT03654326|470937170|FG000|Overall Study|Lost to Follow-up|1|||
130811402|NCT03654326|470937171|FG001|Overall Study|Lost to Follow-up|1|||
130811403|NCT04102514|470937172|FG000|Overall Study|Death|3|||
130811404|NCT04102514|470937173|FG001|Overall Study|Death|0|||
130811405|NCT04102514|470937174|FG002|Overall Study|Death|0|||
130811406|NCT04102514|470937175|FG003|Overall Study|Death|0|||
130811407|NCT04102514|470937172|FG000|Overall Study|Lost to Follow-up|0|||
130811408|NCT04102514|470937173|FG001|Overall Study|Lost to Follow-up|0|||
130811409|NCT04102514|470937174|FG002|Overall Study|Lost to Follow-up|3|||
130811410|NCT04102514|470937175|FG003|Overall Study|Lost to Follow-up|0|||
130811411|NCT04102514|470937172|FG000|Overall Study|Physician Decision|0|||
130811412|NCT04102514|470937173|FG001|Overall Study|Physician Decision|0|||
130811413|NCT04102514|470937174|FG002|Overall Study|Physician Decision|1|||
130811414|NCT04102514|470937175|FG003|Overall Study|Physician Decision|0|||
130811415|NCT04102514|470937172|FG000|Overall Study|Withdrawal by Subject|7|||
130811416|NCT04102514|470937173|FG001|Overall Study|Withdrawal by Subject|13|||
130811417|NCT04102514|470937174|FG002|Overall Study|Withdrawal by Subject|7|||
130811418|NCT04102514|470937175|FG003|Overall Study|Withdrawal by Subject|14|||
130811419|NCT04102514|470937172|FG000|Overall Study|Moved to longterm care facility|6|||
130811420|NCT04102514|470937173|FG001|Overall Study|Moved to longterm care facility|0|||
130811421|NCT04102514|470937174|FG002|Overall Study|Moved to longterm care facility|4|||
130811422|NCT04102514|470937175|FG003|Overall Study|Moved to longterm care facility|0|||
130811423|NCT01689649|470937176|FG000|Overall Study|Lack of Efficacy|3|||
130811424|NCT01689649|470937176|FG000|Overall Study|Non-compliance|11|||
130811425|NCT01689649|470937176|FG000|Overall Study|Protocol Violation|3|||
130811426|NCT01689649|470937176|FG000|Overall Study|Lost to Follow-up|5|||
130811427|NCT00619918|470937177|FG000|Overall Study|Withdrawal by Subject|4|||
130811428|NCT00619918|470937178|FG001|Overall Study|Withdrawal by Subject|3|||
130811429|NCT00619918|470937177|FG000|Overall Study|Physician Decision|2|||
130811430|NCT00619918|470937178|FG001|Overall Study|Physician Decision|4|||
130811431|NCT00619918|470937177|FG000|Overall Study|Transfer to outside facility|3|||
130811432|NCT00619918|470937178|FG001|Overall Study|Transfer to outside facility|3|||
130811433|NCT00619918|470937177|FG000|Overall Study|Left before receiving first dose|7|||
130811434|NCT00619918|470937178|FG001|Overall Study|Left before receiving first dose|6|||
130811435|NCT00619918|470937177|FG000|Overall Study|ICU admission|4|||
130811436|NCT00619918|470937178|FG001|Overall Study|ICU admission|6|||
130811437|NCT05524948|470937190|FG000|Overall Study|Withdrawal by Subject|1|||
130811438|NCT05524948|470937191|FG001|Overall Study|Withdrawal by Subject|0|||
130811439|NCT05524948|470937190|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
130811440|NCT05524948|470937191|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
130811441|NCT00595075|470937192|FG000|Overall Study|Withdrawal by Subject|1|||
130811442|NCT00595075|470937193|FG001|Overall Study|Withdrawal by Subject|0|||
130811443|NCT02096354|470937196|FG000|Overall Study|Physician Decision|4|||
130811444|NCT02096354|470937197|FG001|Overall Study|Physician Decision|5|||
130811445|NCT02096354|470937198|FG002|Overall Study|Physician Decision|0|||
130811446|NCT02096354|470937196|FG000|Overall Study|Withdrawal by Subject|3|||
130811447|NCT02096354|470937197|FG001|Overall Study|Withdrawal by Subject|1|||
130811448|NCT02096354|470937198|FG002|Overall Study|Withdrawal by Subject|0|||
130811449|NCT02096354|470937196|FG000|Overall Study|Adverse Event|7|||
130811450|NCT02096354|470937197|FG001|Overall Study|Adverse Event|4|||
130811451|NCT02096354|470937198|FG002|Overall Study|Adverse Event|0|||
130811452|NCT02096354|470937196|FG000|Overall Study|Ineligible|0|||
130811453|NCT02096354|470937197|FG001|Overall Study|Ineligible|0|||
130811454|NCT02096354|470937198|FG002|Overall Study|Ineligible|11|||
130811455|NCT03715829|470937199|FG000|Dose Ranging Period|Adverse Event|2|||
130811456|NCT03715829|470937200|FG001|Dose Ranging Period|Adverse Event|4|||
130811457|NCT03715829|470937201|FG002|Dose Ranging Period|Adverse Event|5|||
130811458|NCT03715829|470937202|FG003|Dose Ranging Period|Adverse Event|2|||
130811459|NCT03715829|470937203|FG004|Dose Ranging Period|Adverse Event|3|||
130811460|NCT03715829|470937204|FG005|Dose Ranging Period|Adverse Event|3|||
130811461|NCT03715829|470937205|FG006|Dose Ranging Period|Adverse Event|0|||
130811462|NCT03715829|470937206|FG007|Dose Ranging Period|Adverse Event|0|||
130811463|NCT03715829|470937207|FG008|Dose Ranging Period|Adverse Event|0|||
130811464|NCT03715829|470937208|FG009|Dose Ranging Period|Adverse Event|0|||
130811465|NCT03715829|470937209|FG010|Dose Ranging Period|Adverse Event|0|||
130811466|NCT03715829|470937199|FG000|Dose Ranging Period|Lack of Efficacy|0|||
130811467|NCT03715829|470937200|FG001|Dose Ranging Period|Lack of Efficacy|1|||
130811468|NCT03715829|470937201|FG002|Dose Ranging Period|Lack of Efficacy|0|||
130811469|NCT03715829|470937202|FG003|Dose Ranging Period|Lack of Efficacy|1|||
130811470|NCT03715829|470937203|FG004|Dose Ranging Period|Lack of Efficacy|0|||
130811471|NCT03715829|470937204|FG005|Dose Ranging Period|Lack of Efficacy|0|||
130811472|NCT03715829|470937205|FG006|Dose Ranging Period|Lack of Efficacy|0|||
130811473|NCT03715829|470937206|FG007|Dose Ranging Period|Lack of Efficacy|0|||
130811474|NCT03715829|470937207|FG008|Dose Ranging Period|Lack of Efficacy|0|||
130811475|NCT03715829|470937208|FG009|Dose Ranging Period|Lack of Efficacy|0|||
130811476|NCT03715829|470937209|FG010|Dose Ranging Period|Lack of Efficacy|0|||
130811477|NCT03715829|470937199|FG000|Dose Ranging Period|Lost to Follow-up|2|||
130811478|NCT03715829|470937200|FG001|Dose Ranging Period|Lost to Follow-up|0|||
130811479|NCT03715829|470937201|FG002|Dose Ranging Period|Lost to Follow-up|1|||
130811480|NCT03715829|470937202|FG003|Dose Ranging Period|Lost to Follow-up|1|||
130811481|NCT03715829|470937203|FG004|Dose Ranging Period|Lost to Follow-up|1|||
130811482|NCT03715829|470937204|FG005|Dose Ranging Period|Lost to Follow-up|2|||
130811483|NCT03715829|470937205|FG006|Dose Ranging Period|Lost to Follow-up|0|||
130811484|NCT03715829|470937206|FG007|Dose Ranging Period|Lost to Follow-up|0|||
130811485|NCT03715829|470937207|FG008|Dose Ranging Period|Lost to Follow-up|0|||
130811486|NCT03715829|470937208|FG009|Dose Ranging Period|Lost to Follow-up|0|||
130811487|NCT03715829|470937209|FG010|Dose Ranging Period|Lost to Follow-up|0|||
130811488|NCT03715829|470937199|FG000|Dose Ranging Period|Protocol Violation|0|||
130811489|NCT03715829|470937200|FG001|Dose Ranging Period|Protocol Violation|0|||
130811490|NCT03715829|470937201|FG002|Dose Ranging Period|Protocol Violation|0|||
130811491|NCT03715829|470937202|FG003|Dose Ranging Period|Protocol Violation|1|||
130811492|NCT03715829|470937203|FG004|Dose Ranging Period|Protocol Violation|0|||
130811493|NCT03715829|470937204|FG005|Dose Ranging Period|Protocol Violation|0|||
130811494|NCT03715829|470937205|FG006|Dose Ranging Period|Protocol Violation|0|||
130811495|NCT03715829|470937206|FG007|Dose Ranging Period|Protocol Violation|0|||
130811496|NCT03715829|470937207|FG008|Dose Ranging Period|Protocol Violation|0|||
130811497|NCT03715829|470937208|FG009|Dose Ranging Period|Protocol Violation|0|||
130811498|NCT03715829|470937209|FG010|Dose Ranging Period|Protocol Violation|0|||
130811499|NCT03715829|470937199|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
130811500|NCT03715829|470937200|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
130811501|NCT03715829|470937201|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
130811502|NCT03715829|470937202|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
130811503|NCT03715829|470937203|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
130811504|NCT03715829|470937204|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
130811505|NCT03715829|470937205|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
130811506|NCT03715829|470937206|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
130811507|NCT03715829|470937207|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
130811508|NCT03715829|470937208|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
130811509|NCT03715829|470937209|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
130811510|NCT03715829|470937199|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130811511|NCT03715829|470937200|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130811512|NCT03715829|470937201|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
130811513|NCT03715829|470937202|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130811514|NCT03715829|470937203|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130811515|NCT03715829|470937204|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130811516|NCT03715829|470937205|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130811517|NCT03715829|470937206|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130811518|NCT03715829|470937207|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130811519|NCT03715829|470937208|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130811520|NCT03715829|470937209|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130811521|NCT03715829|470937199|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130811522|NCT03715829|470937200|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130811523|NCT03715829|470937201|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
130811524|NCT03715829|470937202|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130811525|NCT03715829|470937203|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
130811526|NCT03715829|470937204|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130811527|NCT03715829|470937205|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130811528|NCT03715829|470937206|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130811529|NCT03715829|470937207|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130811530|NCT03715829|470937208|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130811531|NCT03715829|470937209|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130811532|NCT03715829|470937199|FG000|Dose Ranging Period|Other|0|||
130811533|NCT03715829|470937200|FG001|Dose Ranging Period|Other|0|||
130811534|NCT03715829|470937201|FG002|Dose Ranging Period|Other|2|||
130811535|NCT03715829|470937202|FG003|Dose Ranging Period|Other|0|||
130811536|NCT03715829|470937203|FG004|Dose Ranging Period|Other|0|||
130811537|NCT03715829|470937204|FG005|Dose Ranging Period|Other|3|||
130811538|NCT03715829|470937205|FG006|Dose Ranging Period|Other|0|||
130811539|NCT03715829|470937206|FG007|Dose Ranging Period|Other|0|||
130811540|NCT03715829|470937207|FG008|Dose Ranging Period|Other|0|||
130811541|NCT03715829|470937208|FG009|Dose Ranging Period|Other|0|||
130811542|NCT03715829|470937209|FG010|Dose Ranging Period|Other|0|||
130811543|NCT03715829|470937199|FG000|Extension Period|Adverse Event|0|||
130811544|NCT03715829|470937200|FG001|Extension Period|Adverse Event|0|||
130811545|NCT03715829|470937201|FG002|Extension Period|Adverse Event|0|||
130811546|NCT03715829|470937202|FG003|Extension Period|Adverse Event|0|||
130811547|NCT03715829|470937203|FG004|Extension Period|Adverse Event|0|||
130811548|NCT03715829|470937204|FG005|Extension Period|Adverse Event|0|||
130811549|NCT03715829|470937205|FG006|Extension Period|Adverse Event|3|||
130811550|NCT03715829|470937206|FG007|Extension Period|Adverse Event|1|||
130811551|NCT03715829|470937207|FG008|Extension Period|Adverse Event|6|||
130811552|NCT03715829|470937208|FG009|Extension Period|Adverse Event|0|||
130811553|NCT03715829|470937209|FG010|Extension Period|Adverse Event|0|||
130811554|NCT03715829|470937199|FG000|Extension Period|Lack of Efficacy|0|||
130811555|NCT03715829|470937200|FG001|Extension Period|Lack of Efficacy|0|||
130811556|NCT03715829|470937201|FG002|Extension Period|Lack of Efficacy|0|||
130811557|NCT03715829|470937202|FG003|Extension Period|Lack of Efficacy|0|||
130811558|NCT03715829|470937203|FG004|Extension Period|Lack of Efficacy|0|||
130811559|NCT03715829|470937204|FG005|Extension Period|Lack of Efficacy|0|||
130811560|NCT03715829|470937205|FG006|Extension Period|Lack of Efficacy|1|||
130811561|NCT03715829|470937206|FG007|Extension Period|Lack of Efficacy|9|||
130811562|NCT03715829|470937207|FG008|Extension Period|Lack of Efficacy|2|||
130811563|NCT03715829|470937208|FG009|Extension Period|Lack of Efficacy|0|||
130811564|NCT03715829|470937209|FG010|Extension Period|Lack of Efficacy|0|||
130811565|NCT03715829|470937199|FG000|Extension Period|Lost to Follow-up|0|||
130811566|NCT03715829|470937200|FG001|Extension Period|Lost to Follow-up|0|||
130811567|NCT03715829|470937201|FG002|Extension Period|Lost to Follow-up|0|||
130811568|NCT03715829|470937202|FG003|Extension Period|Lost to Follow-up|0|||
130811569|NCT03715829|470937203|FG004|Extension Period|Lost to Follow-up|0|||
130811570|NCT03715829|470937204|FG005|Extension Period|Lost to Follow-up|0|||
130811571|NCT03715829|470937205|FG006|Extension Period|Lost to Follow-up|0|||
130811572|NCT03715829|470937206|FG007|Extension Period|Lost to Follow-up|0|||
130811573|NCT03715829|470937207|FG008|Extension Period|Lost to Follow-up|2|||
130811574|NCT03715829|470937208|FG009|Extension Period|Lost to Follow-up|0|||
130811575|NCT03715829|470937209|FG010|Extension Period|Lost to Follow-up|0|||
130811576|NCT03715829|470937199|FG000|Extension Period|Protocol Violation|0|||
130811577|NCT03715829|470937200|FG001|Extension Period|Protocol Violation|0|||
130811578|NCT03715829|470937201|FG002|Extension Period|Protocol Violation|0|||
130811579|NCT03715829|470937202|FG003|Extension Period|Protocol Violation|0|||
130811580|NCT03715829|470937203|FG004|Extension Period|Protocol Violation|0|||
130811581|NCT03715829|470937204|FG005|Extension Period|Protocol Violation|0|||
130811582|NCT03715829|470937205|FG006|Extension Period|Protocol Violation|0|||
130811583|NCT03715829|470937206|FG007|Extension Period|Protocol Violation|0|||
130811584|NCT03715829|470937207|FG008|Extension Period|Protocol Violation|1|||
130811585|NCT03715829|470937208|FG009|Extension Period|Protocol Violation|0|||
130811586|NCT03715829|470937209|FG010|Extension Period|Protocol Violation|0|||
130811587|NCT03715829|470937199|FG000|Extension Period|Withdrawal by Subject|0|||
130811588|NCT03715829|470937200|FG001|Extension Period|Withdrawal by Subject|0|||
130811589|NCT03715829|470937201|FG002|Extension Period|Withdrawal by Subject|0|||
130811590|NCT03715829|470937202|FG003|Extension Period|Withdrawal by Subject|0|||
130811591|NCT03715829|470937203|FG004|Extension Period|Withdrawal by Subject|0|||
130811592|NCT03715829|470937204|FG005|Extension Period|Withdrawal by Subject|0|||
130811593|NCT03715829|470937205|FG006|Extension Period|Withdrawal by Subject|3|||
130811594|NCT03715829|470937206|FG007|Extension Period|Withdrawal by Subject|3|||
130811595|NCT03715829|470937207|FG008|Extension Period|Withdrawal by Subject|12|||
130811596|NCT03715829|470937208|FG009|Extension Period|Withdrawal by Subject|3|||
130811597|NCT03715829|470937209|FG010|Extension Period|Withdrawal by Subject|0|||
130811598|NCT03715829|470937199|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
130811599|NCT03715829|470937200|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
130811600|NCT03715829|470937201|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
130811601|NCT03715829|470937202|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
130811602|NCT03715829|470937203|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
130811603|NCT03715829|470937204|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
130811604|NCT03715829|470937205|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
130811605|NCT03715829|470937206|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
130811606|NCT03715829|470937207|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
130811607|NCT03715829|470937208|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
130811608|NCT03715829|470937209|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
130811609|NCT03715829|470937199|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
130811610|NCT03715829|470937200|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
130811611|NCT03715829|470937201|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
130811612|NCT03715829|470937202|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
130811613|NCT03715829|470937203|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
130811614|NCT03715829|470937204|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
130811615|NCT03715829|470937205|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
130811616|NCT03715829|470937206|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
130811617|NCT03715829|470937207|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
130811618|NCT03715829|470937208|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
130811619|NCT03715829|470937209|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
130811620|NCT03715829|470937199|FG000|Extension Period|Other|0|||
130811621|NCT03715829|470937200|FG001|Extension Period|Other|0|||
130811622|NCT03715829|470937201|FG002|Extension Period|Other|0|||
130811623|NCT03715829|470937202|FG003|Extension Period|Other|0|||
130811624|NCT03715829|470937203|FG004|Extension Period|Other|0|||
130811625|NCT03715829|470937204|FG005|Extension Period|Other|0|||
130811626|NCT03715829|470937205|FG006|Extension Period|Other|1|||
130811627|NCT03715829|470937206|FG007|Extension Period|Other|2|||
130811628|NCT03715829|470937207|FG008|Extension Period|Other|4|||
130811629|NCT03715829|470937208|FG009|Extension Period|Other|0|||
130811630|NCT03715829|470937209|FG010|Extension Period|Other|0|||
130811631|NCT03579719|470937210|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
130811632|NCT00855166|470937211|FG000|Overall Study|Adverse Event|0|||
130811633|NCT00855166|470937212|FG001|Overall Study|Adverse Event|2|||
130811634|NCT00855166|470937211|FG000|Overall Study|Death|0|||
130811635|NCT00855166|470937212|FG001|Overall Study|Death|1|||
130811636|NCT00855166|470937211|FG000|Overall Study|Withdrawal by Subject|1|||
130811637|NCT00855166|470937212|FG001|Overall Study|Withdrawal by Subject|4|||
130811638|NCT00855166|470937211|FG000|Overall Study|Poor/non-compliance|2|||
130811639|NCT00855166|470937212|FG001|Overall Study|Poor/non-compliance|0|||
130811640|NCT00855166|470937211|FG000|Overall Study|Administrative reasons by sponsor|1|||
130811641|NCT00855166|470937212|FG001|Overall Study|Administrative reasons by sponsor|0|||
130811642|NCT00855166|470937211|FG000|Overall Study|Subject no longer meets study criteria|1|||
130811643|NCT00855166|470937212|FG001|Overall Study|Subject no longer meets study criteria|1|||
130811644|NCT01422382|470937213|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
130811645|NCT04082364|470937214|FG000|Overall Study|Death|23|||
130811646|NCT04082364|470937215|FG001|Overall Study|Death|1|||
130811647|NCT04082364|470937216|FG002|Overall Study|Death|1|||
130811648|NCT04082364|470937217|FG003|Overall Study|Death|2|||
130811649|NCT04082364|470937218|FG004|Overall Study|Death|1|||
130811650|NCT04082364|470937214|FG000|Overall Study|Lost to Follow-up|1|||
130811651|NCT04082364|470937215|FG001|Overall Study|Lost to Follow-up|0|||
130811652|NCT04082364|470937216|FG002|Overall Study|Lost to Follow-up|0|||
130811653|NCT04082364|470937217|FG003|Overall Study|Lost to Follow-up|0|||
130811654|NCT04082364|470937218|FG004|Overall Study|Lost to Follow-up|1|||
130811655|NCT04082364|470937214|FG000|Overall Study|Physician Decision|1|||
130811656|NCT04082364|470937215|FG001|Overall Study|Physician Decision|1|||
130811657|NCT04082364|470937216|FG002|Overall Study|Physician Decision|0|||
130811658|NCT04082364|470937217|FG003|Overall Study|Physician Decision|2|||
130811659|NCT04082364|470937218|FG004|Overall Study|Physician Decision|1|||
130811660|NCT04082364|470937214|FG000|Overall Study|Withdrawal by Subject|1|||
130811661|NCT04082364|470937215|FG001|Overall Study|Withdrawal by Subject|1|||
130811662|NCT04082364|470937216|FG002|Overall Study|Withdrawal by Subject|0|||
130811663|NCT04082364|470937217|FG003|Overall Study|Withdrawal by Subject|0|||
130811664|NCT04082364|470937218|FG004|Overall Study|Withdrawal by Subject|1|||
130811665|NCT04082364|470937214|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
130811666|NCT04082364|470937215|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
130811667|NCT04082364|470937216|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
130811668|NCT04082364|470937217|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
130811669|NCT04082364|470937218|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
130811670|NCT04082364|470937214|FG000|Overall Study|Disease progression|0|||
130811671|NCT04082364|470937215|FG001|Overall Study|Disease progression|0|||
130811672|NCT04082364|470937216|FG002|Overall Study|Disease progression|0|||
130811673|NCT04082364|470937217|FG003|Overall Study|Disease progression|1|||
130811674|NCT04082364|470937218|FG004|Overall Study|Disease progression|0|||
130811675|NCT03973489|470937224|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
130811676|NCT03973489|470937225|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130811677|NCT03973489|470937226|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130811678|NCT03973489|470937227|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130811679|NCT03973489|470937228|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
130811680|NCT03973489|470937229|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130811681|NCT03973489|470937230|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130811682|NCT03973489|470937231|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130811683|NCT03973489|470937224|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130811684|NCT03973489|470937225|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130811685|NCT03973489|470937226|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130811686|NCT03973489|470937227|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
130811687|NCT03973489|470937228|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
130811688|NCT03973489|470937229|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130811689|NCT03973489|470937230|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130811690|NCT03973489|470937231|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130811691|NCT03973489|470937224|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
130811692|NCT03973489|470937225|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
130811693|NCT03973489|470937226|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
130811694|NCT03973489|470937227|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
130811695|NCT03973489|470937228|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
130811696|NCT03973489|470937229|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
130811697|NCT03973489|470937230|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
130811698|NCT03973489|470937231|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
130811699|NCT03973489|470937224|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
130811700|NCT03973489|470937225|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130811701|NCT03973489|470937226|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130811702|NCT03973489|470937227|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
130811703|NCT03973489|470937228|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130811704|NCT03973489|470937229|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130811705|NCT03973489|470937230|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130811706|NCT03973489|470937231|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130811707|NCT03973489|470937224|FG000|Second Intervention (1 Day)|Adverse Event|0|||
130811708|NCT03973489|470937225|FG001|Second Intervention (1 Day)|Adverse Event|0|||
130811709|NCT03973489|470937226|FG002|Second Intervention (1 Day)|Adverse Event|0|||
130811710|NCT03973489|470937227|FG003|Second Intervention (1 Day)|Adverse Event|1|||
130811711|NCT03973489|470937228|FG004|Second Intervention (1 Day)|Adverse Event|0|||
130811712|NCT03973489|470937229|FG005|Second Intervention (1 Day)|Adverse Event|0|||
130811713|NCT03973489|470937230|FG006|Second Intervention (1 Day)|Adverse Event|0|||
130811714|NCT03973489|470937231|FG007|Second Intervention (1 Day)|Adverse Event|0|||
130811715|NCT03301415|470937232|FG000|Overall Study|Lost to Follow-up|2|||
130811716|NCT03301415|470937232|FG000|Overall Study|Unable to comply with visit schedule|2|||
130811717|NCT03247673|470937233|FG000|Overall Study|Withdrawal by Subject|1|||
130811718|NCT03247673|470937234|FG001|Overall Study|Withdrawal by Subject|0|||
130811719|NCT03247673|470937235|FG002|Overall Study|Withdrawal by Subject|3|||
130811720|NCT03247673|470937233|FG000|Overall Study|Lost to Follow-up|0|||
130811721|NCT03247673|470937234|FG001|Overall Study|Lost to Follow-up|0|||
130811722|NCT03247673|470937235|FG002|Overall Study|Lost to Follow-up|1|||
130811723|NCT01111552|470937236|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
130811724|NCT01111552|470937237|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130811725|NCT01111552|470937238|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130811726|NCT01111552|470937239|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130811727|NCT01111552|470937240|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130811728|NCT01111552|470937236|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
130811729|NCT01111552|470937237|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130811730|NCT01111552|470937238|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130811731|NCT01111552|470937239|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130811732|NCT01111552|470937240|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130811733|NCT01111552|470937236|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
130811734|NCT01111552|470937237|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130811735|NCT01111552|470937238|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130811736|NCT01111552|470937239|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130811737|NCT01111552|470937240|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130811738|NCT01111552|470937236|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
130811739|NCT01111552|470937237|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130811740|NCT01111552|470937238|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130811741|NCT01111552|470937239|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130811742|NCT01111552|470937240|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130811743|NCT01111552|470937236|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
130811744|NCT01111552|470937237|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130811745|NCT01111552|470937238|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130811746|NCT01111552|470937239|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130811747|NCT01111552|470937240|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130811748|NCT01111552|470937236|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
130811749|NCT01111552|470937237|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130811750|NCT01111552|470937238|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130811751|NCT01111552|470937239|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130811752|NCT01111552|470937240|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130811753|NCT01111552|470937236|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
130811754|NCT01111552|470937237|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130811755|NCT01111552|470937238|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130811756|NCT01111552|470937239|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130811757|NCT01111552|470937240|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130811758|NCT01111552|470937236|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
130811759|NCT01111552|470937237|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130811760|NCT01111552|470937238|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130811761|NCT01111552|470937239|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130811762|NCT01111552|470937240|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130811763|NCT01111552|470937236|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130811764|NCT01111552|470937237|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130811765|NCT01111552|470937238|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130811766|NCT01111552|470937239|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
130811767|NCT01111552|470937240|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130811768|NCT01111552|470937236|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
130811769|NCT01111552|470937237|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
130811770|NCT01111552|470937238|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
130811771|NCT01111552|470937239|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
130811772|NCT01111552|470937240|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
130811773|NCT01111552|470937236|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130811774|NCT01111552|470937237|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
130811775|NCT01111552|470937238|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130811776|NCT01111552|470937239|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130811777|NCT01111552|470937240|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130811778|NCT01111552|470937236|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130811779|NCT01111552|470937237|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
130811780|NCT01111552|470937238|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130811781|NCT01111552|470937239|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130811782|NCT01111552|470937240|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130811783|NCT01111552|470937236|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130811784|NCT01111552|470937237|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
130811785|NCT01111552|470937238|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130811786|NCT01111552|470937239|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130811787|NCT01111552|470937240|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130811788|NCT01111552|470937236|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130811789|NCT01111552|470937237|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130811790|NCT01111552|470937238|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
130811791|NCT01111552|470937239|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130811792|NCT01111552|470937240|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130811793|NCT01394185|470938947|FG000|Overall Study|Withdrawal by Subject|2|||
130811794|NCT01394185|470938948|FG001|Overall Study|Withdrawal by Subject|0|||
130811795|NCT01394185|470938949|FG002|Overall Study|Withdrawal by Subject|0|||
130811796|NCT01394185|470938950|FG003|Overall Study|Withdrawal by Subject|0|||
130811797|NCT01394185|470938951|FG004|Overall Study|Withdrawal by Subject|1|||
130811798|NCT01394185|470938952|FG005|Overall Study|Withdrawal by Subject|0|||
130811799|NCT01394185|470938947|FG000|Overall Study|Change in protocol|3|||
130811800|NCT01394185|470938948|FG001|Overall Study|Change in protocol|0|||
130811801|NCT01394185|470938949|FG002|Overall Study|Change in protocol|0|||
130811802|NCT01394185|470938950|FG003|Overall Study|Change in protocol|0|||
130811803|NCT01394185|470938951|FG004|Overall Study|Change in protocol|3|||
130811804|NCT01394185|470938952|FG005|Overall Study|Change in protocol|0|||
130811805|NCT01394185|470938947|FG000|Overall Study|Protocol Violation|1|||
130811806|NCT01394185|470938948|FG001|Overall Study|Protocol Violation|0|||
130811807|NCT01394185|470938949|FG002|Overall Study|Protocol Violation|0|||
130811808|NCT01394185|470938950|FG003|Overall Study|Protocol Violation|1|||
130811809|NCT01394185|470938951|FG004|Overall Study|Protocol Violation|0|||
130811810|NCT01394185|470938952|FG005|Overall Study|Protocol Violation|1|||
130811811|NCT00267488|470938956|FG000|Overall Study|Sponsor Terminated Study|9|||
130811812|NCT00267488|470938956|FG000|Overall Study|Protocol Violation|1|||
130811813|NCT00267488|470938956|FG000|Overall Study|Other (Disease Progression)|1|||
130811814|NCT00831389|470938957|FG000|Overall Study|Withdrawal by Subject|0|||
130811815|NCT00831389|470938958|FG001|Overall Study|Withdrawal by Subject|1|||
130811816|NCT00278161|470938959|FG000|Overall Study|Death|11|||
130811817|NCT01592747|470938960|FG000|Overall Study|Loss of Therapeutic Response|107|||
130811818|NCT01592747|470938961|FG001|Overall Study|Loss of Therapeutic Response|108|||
130811819|NCT01592747|470938962|FG002|Overall Study|Loss of Therapeutic Response|100|||
130811820|NCT01592747|470938960|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
130811821|NCT01592747|470938961|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
130811822|NCT01592747|470938962|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
130811823|NCT01592747|470938960|FG000|Overall Study|Adverse Event|1|||
130811824|NCT01592747|470938961|FG001|Overall Study|Adverse Event|0|||
130811825|NCT01592747|470938962|FG002|Overall Study|Adverse Event|0|||
130811826|NCT01592747|470938960|FG000|Overall Study|Protocol Violation|4|||
130811827|NCT01592747|470938961|FG001|Overall Study|Protocol Violation|0|||
130811828|NCT01592747|470938962|FG002|Overall Study|Protocol Violation|4|||
130811829|NCT01592747|470938960|FG000|Overall Study|Lack of Efficacy|0|||
130811830|NCT01592747|470938961|FG001|Overall Study|Lack of Efficacy|1|||
130811831|NCT01592747|470938962|FG002|Overall Study|Lack of Efficacy|0|||
130811832|NCT01592747|470938960|FG000|Overall Study|Withdrawal by Subject|2|||
130811833|NCT01592747|470938961|FG001|Overall Study|Withdrawal by Subject|0|||
130811834|NCT01592747|470938962|FG002|Overall Study|Withdrawal by Subject|2|||
130811835|NCT01592747|470938960|FG000|Overall Study|Lost to Follow-up|1|||
130811836|NCT01592747|470938961|FG001|Overall Study|Lost to Follow-up|0|||
130811837|NCT01592747|470938962|FG002|Overall Study|Lost to Follow-up|1|||
130811838|NCT01592747|470938960|FG000|Overall Study|Other Reasons|1|||
130811839|NCT01592747|470938961|FG001|Overall Study|Other Reasons|1|||
130811840|NCT01592747|470938962|FG002|Overall Study|Other Reasons|0|||
130811841|NCT00124657|470938963|FG000|Overall Study|Toxicity|0|||
130811842|NCT00124657|470938964|FG001|Overall Study|Toxicity|0|||
130811843|NCT00124657|470938965|FG002|Overall Study|Toxicity|1|||
130811844|NCT00124657|470938963|FG000|Overall Study|Non-compliance|1|||
130811845|NCT00124657|470938964|FG001|Overall Study|Non-compliance|0|||
130811846|NCT00124657|470938965|FG002|Overall Study|Non-compliance|4|||
130811847|NCT00124657|470938963|FG000|Overall Study|Progressive disease|14|||
130811848|NCT00124657|470938964|FG001|Overall Study|Progressive disease|5|||
130811849|NCT00124657|470938965|FG002|Overall Study|Progressive disease|27|||
130811850|NCT00124657|470938963|FG000|Overall Study|Intercurrent illness|1|||
130811851|NCT00124657|470938964|FG001|Overall Study|Intercurrent illness|0|||
130811852|NCT00124657|470938965|FG002|Overall Study|Intercurrent illness|0|||
130811853|NCT01935947|470938966|FG000|Overall Study|Adverse Event|0|||
130811854|NCT01935947|470938967|FG001|Overall Study|Adverse Event|2|||
130811855|NCT01935947|470938968|FG002|Overall Study|Adverse Event|0|||
130811856|NCT01935947|470938966|FG000|Overall Study|Diease Progression|2|||
130811857|NCT01935947|470938967|FG001|Overall Study|Diease Progression|2|||
130811858|NCT01935947|470938968|FG002|Overall Study|Diease Progression|2|||
130811859|NCT01935947|470938966|FG000|Overall Study|Death|1|||
130811860|NCT01935947|470938967|FG001|Overall Study|Death|0|||
130811861|NCT01935947|470938968|FG002|Overall Study|Death|0|||
130811862|NCT04661839|470938969|FG000|Overall Study|Not Treated|0|||
130811863|NCT04661839|470938970|FG001|Overall Study|Not Treated|0|||
130811864|NCT04661839|470938971|FG002|Overall Study|Not Treated|1|||
130811865|NCT04661839|470938972|FG003|Overall Study|Not Treated|0|||
130811866|NCT04661839|470938969|FG000|Overall Study|Lost to Follow-up|1|||
130811867|NCT04661839|470938970|FG001|Overall Study|Lost to Follow-up|0|||
130811868|NCT04661839|470938971|FG002|Overall Study|Lost to Follow-up|0|||
130811869|NCT04661839|470938972|FG003|Overall Study|Lost to Follow-up|1|||
130811870|NCT03647137|470938973|FG000|Overall Study|Scan Limitation|2|||
130811871|NCT03647137|470938974|FG001|Overall Study|Scan Limitation|1|||
130811872|NCT03647137|470938975|FG002|Overall Study|Scan Limitation|1|||
130811873|NCT03647137|470938976|FG003|Overall Study|Scan Limitation|2|||
130811874|NCT02655601|470938980|FG000|Overall Study|Adverse Event|0|||
130811875|NCT02655601|470938981|FG001|Overall Study|Adverse Event|0|||
130811876|NCT02655601|470938982|FG002|Overall Study|Adverse Event|0|||
130811877|NCT02655601|470938983|FG003|Overall Study|Adverse Event|1|||
130811878|NCT02655601|470938984|FG004|Overall Study|Adverse Event|1|||
130811879|NCT02655601|470938985|FG005|Overall Study|Adverse Event|0|||
130811880|NCT02655601|470938980|FG000|Overall Study|Physician Decision|0|||
130811881|NCT02655601|470938981|FG001|Overall Study|Physician Decision|0|||
130811882|NCT02655601|470938982|FG002|Overall Study|Physician Decision|0|||
130811883|NCT02655601|470938983|FG003|Overall Study|Physician Decision|0|||
130811884|NCT02655601|470938984|FG004|Overall Study|Physician Decision|1|||
130811885|NCT02655601|470938985|FG005|Overall Study|Physician Decision|1|||
130811886|NCT02655601|470938980|FG000|Overall Study|Withdrawal by Subject|0|||
130811887|NCT02655601|470938981|FG001|Overall Study|Withdrawal by Subject|0|||
130811888|NCT02655601|470938982|FG002|Overall Study|Withdrawal by Subject|0|||
130811889|NCT02655601|470938983|FG003|Overall Study|Withdrawal by Subject|0|||
130811890|NCT02655601|470938984|FG004|Overall Study|Withdrawal by Subject|4|||
130811891|NCT02655601|470938985|FG005|Overall Study|Withdrawal by Subject|8|||
130811892|NCT02655601|470938980|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
130811893|NCT02655601|470938981|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130811894|NCT02655601|470938982|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130811895|NCT02655601|470938983|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130811896|NCT02655601|470938984|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130811897|NCT02655601|470938985|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130811898|NCT03253627|470938986|FG000|Overall Study|Lost to Follow-up|1|||
130811899|NCT03253627|470938987|FG001|Overall Study|Lost to Follow-up|2|||
130811900|NCT03253627|470938986|FG000|Overall Study|Withdrawal by Subject|0|||
130811901|NCT03253627|470938987|FG001|Overall Study|Withdrawal by Subject|2|||
130811902|NCT03253627|470938986|FG000|Overall Study|Inability to complete MRI|1|||
130811903|NCT03253627|470938987|FG001|Overall Study|Inability to complete MRI|0|||
130811904|NCT03829683|470938990|FG000|Overall Study|Lost to Follow-up|1|||
130811905|NCT03829683|470938991|FG001|Overall Study|Lost to Follow-up|0|||
130811906|NCT03829683|470938990|FG000|Overall Study|Physician Decision|3|||
130811907|NCT03829683|470938991|FG001|Overall Study|Physician Decision|1|||
130811908|NCT03829683|470938990|FG000|Overall Study|Withdrawal by Subject|0|||
130811909|NCT03829683|470938991|FG001|Overall Study|Withdrawal by Subject|1|||
130811910|NCT03829683|470938990|FG000|Overall Study|Discharge from hospital|1|||
130811911|NCT03829683|470938991|FG001|Overall Study|Discharge from hospital|0|||
130811912|NCT01922895|470938995|FG000|Overall Study|Death|0|||
130811913|NCT01922895|470938996|FG001|Overall Study|Death|1|||
130811914|NCT01922895|470938995|FG000|Overall Study|Withdrawal by Subject|1|||
130811915|NCT01922895|470938996|FG001|Overall Study|Withdrawal by Subject|2|||
130811916|NCT01922895|470938995|FG000|Overall Study|Lost to Follow-up|5|||
130811917|NCT01922895|470938996|FG001|Overall Study|Lost to Follow-up|11|||
130811918|NCT01916226|470938997|FG000|Overall Study|Adverse Event|1|||
130811919|NCT01916226|470938998|FG001|Overall Study|Adverse Event|0|||
130811920|NCT01916226|470938999|FG002|Overall Study|Adverse Event|1|||
130811921|NCT01916226|470939000|FG003|Overall Study|Adverse Event|1|||
130811922|NCT01916226|470938997|FG000|Overall Study|Lack of Efficacy|0|||
130811923|NCT01916226|470938998|FG001|Overall Study|Lack of Efficacy|0|||
130811924|NCT01916226|470938999|FG002|Overall Study|Lack of Efficacy|2|||
130811925|NCT01916226|470939000|FG003|Overall Study|Lack of Efficacy|1|||
130811926|NCT01916226|470938997|FG000|Overall Study|Protocol Violation|0|||
130811927|NCT01916226|470938998|FG001|Overall Study|Protocol Violation|1|||
130811928|NCT01916226|470938999|FG002|Overall Study|Protocol Violation|0|||
130811929|NCT01916226|470939000|FG003|Overall Study|Protocol Violation|1|||
130811930|NCT01916226|470938997|FG000|Overall Study|Physician Decision|0|||
130811931|NCT01916226|470938998|FG001|Overall Study|Physician Decision|0|||
130811932|NCT01916226|470938999|FG002|Overall Study|Physician Decision|0|||
130811933|NCT01916226|470939000|FG003|Overall Study|Physician Decision|1|||
130811934|NCT03163667|470939001|FG000|Overall Study|Death|15|||
130811935|NCT03163667|470939002|FG001|Overall Study|Death|27|||
130811936|NCT03163667|470939001|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
130811937|NCT03163667|470939002|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
130811938|NCT05430919|470939003|FG000|Overall Study|Protocol Violation|0|||
130811939|NCT05430919|470939004|FG001|Overall Study|Protocol Violation|0|||
130811940|NCT05430919|470939005|FG002|Overall Study|Protocol Violation|1|||
130811941|NCT05430919|470939006|FG003|Overall Study|Protocol Violation|0|||
130811942|NCT05430919|470939003|FG000|Overall Study|Lost to Follow-up|0|||
130811943|NCT05430919|470939004|FG001|Overall Study|Lost to Follow-up|1|||
130811944|NCT05430919|470939005|FG002|Overall Study|Lost to Follow-up|0|||
130811945|NCT05430919|470939006|FG003|Overall Study|Lost to Follow-up|0|||
130811946|NCT05430919|470939003|FG000|Overall Study|Withdrawal by Subject|3|||
130811947|NCT05430919|470939004|FG001|Overall Study|Withdrawal by Subject|0|||
130811948|NCT05430919|470939005|FG002|Overall Study|Withdrawal by Subject|0|||
130811949|NCT05430919|470939006|FG003|Overall Study|Withdrawal by Subject|1|||
130811950|NCT01848457|470939009|FG000|Overall Study|Death|1|||
130811951|NCT01848457|470939010|FG001|Overall Study|Death|0|||
130811952|NCT01848457|470939011|FG002|Overall Study|Death|0|||
130811953|NCT01848457|470939012|FG003|Overall Study|Death|0|||
130811954|NCT02940223|470939015|FG000|Overall Study|Failed Requirement|2|||
130811955|NCT02940223|470939016|FG001|Overall Study|Failed Requirement|0|||
130811956|NCT01813357|470939019|FG000|Overall Study|Lost to Follow-up|5|||
130811957|NCT01813357|470939020|FG001|Overall Study|Lost to Follow-up|6|||
130811958|NCT03773562|470939021|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
130811959|NCT03773562|470939021|FG000|Overall Study|Lost to Follow-up|10|||
130811960|NCT03773562|470939021|FG000|Overall Study|Withdrawal by Subject|1|||
130811961|NCT03131479|470939022|FG000|Overall Study|Adverse Event|0|||
130811962|NCT03131479|470939023|FG001|Overall Study|Adverse Event|0|||
130811963|NCT03131479|470939024|FG002|Overall Study|Adverse Event|1|||
130811964|NCT03131479|470939025|FG003|Overall Study|Adverse Event|1|||
130811965|NCT03131479|470939026|FG004|Overall Study|Adverse Event|0|||
130811966|NCT03131479|470939022|FG000|Overall Study|Subject/Guardian Decision|0|||
130811967|NCT03131479|470939023|FG001|Overall Study|Subject/Guardian Decision|0|||
130811968|NCT03131479|470939024|FG002|Overall Study|Subject/Guardian Decision|0|||
130811969|NCT03131479|470939025|FG003|Overall Study|Subject/Guardian Decision|1|||
130811970|NCT03131479|470939026|FG004|Overall Study|Subject/Guardian Decision|0|||
130811971|NCT01272219|470939027|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
130811972|NCT01272219|470939028|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
130811973|NCT01272219|470939029|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
130811974|NCT01272219|470939030|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
130811975|NCT01272219|470939031|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
130811976|NCT01272219|470939032|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
130811977|NCT01272219|470939027|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
130811978|NCT01272219|470939028|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
130811979|NCT01272219|470939029|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
130811980|NCT01272219|470939030|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
130811981|NCT01272219|470939031|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
130811982|NCT01272219|470939032|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
130811983|NCT01272219|470939027|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
130811984|NCT01272219|470939028|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
130811985|NCT01272219|470939029|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
130811986|NCT01272219|470939030|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
130811987|NCT01272219|470939031|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
130811988|NCT01272219|470939032|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
130811989|NCT01272219|470939027|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
130811990|NCT01272219|470939028|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
130811991|NCT01272219|470939029|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
130811992|NCT01272219|470939030|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
130811993|NCT01272219|470939031|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
130811994|NCT01272219|470939032|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
130811995|NCT01272219|470939027|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
130811996|NCT01272219|470939028|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
130811997|NCT01272219|470939029|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
130811998|NCT01272219|470939030|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
130811999|NCT01272219|470939031|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
130812000|NCT01272219|470939032|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
130812001|NCT01272219|470939027|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
130812002|NCT01272219|470939028|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
130812003|NCT01272219|470939029|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
130812004|NCT01272219|470939030|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
130812005|NCT01272219|470939031|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
130812006|NCT01272219|470939032|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
130812007|NCT01272219|470939027|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130812008|NCT01272219|470939028|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130812009|NCT01272219|470939029|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130812010|NCT01272219|470939030|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
130812011|NCT01272219|470939031|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130812012|NCT01272219|470939032|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130812013|NCT01272219|470939027|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130812014|NCT01272219|470939028|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
130812015|NCT01272219|470939029|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130812016|NCT01272219|470939030|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
130812017|NCT01272219|470939031|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130812018|NCT01272219|470939032|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130812019|NCT01272219|470939027|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
130812020|NCT01272219|470939028|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
130812021|NCT01272219|470939029|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
130812022|NCT01272219|470939030|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
130812023|NCT01272219|470939031|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
130812024|NCT01272219|470939032|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
130812025|NCT01272219|470939027|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
130812026|NCT01272219|470939028|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
130812027|NCT01272219|470939029|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
130812028|NCT01272219|470939030|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
130812029|NCT01272219|470939031|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
130812030|NCT01272219|470939032|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
130812031|NCT01272219|470939027|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
130812032|NCT01272219|470939028|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
130812033|NCT01272219|470939029|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
130812034|NCT01272219|470939030|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
130812035|NCT01272219|470939031|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
130812036|NCT01272219|470939032|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
130812037|NCT01272219|470939027|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130812038|NCT01272219|470939028|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130812039|NCT01272219|470939029|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130812040|NCT01272219|470939030|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130812041|NCT01272219|470939031|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
130812042|NCT01272219|470939032|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
130812043|NCT01272219|470939027|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130812044|NCT01272219|470939028|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130812045|NCT01272219|470939029|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130812046|NCT01272219|470939030|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130812047|NCT01272219|470939031|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
130812048|NCT01272219|470939032|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
130812049|NCT01272219|470939027|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130812050|NCT01272219|470939028|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130812051|NCT01272219|470939029|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130812052|NCT01272219|470939030|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130812053|NCT01272219|470939031|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
130812054|NCT01272219|470939032|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
130812055|NCT01272219|470939027|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
130812056|NCT01272219|470939028|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
130812057|NCT01272219|470939029|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
130812058|NCT01272219|470939030|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
130812059|NCT01272219|470939031|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
130812060|NCT01272219|470939032|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
130812061|NCT01272219|470939027|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
130812062|NCT01272219|470939028|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
130812063|NCT01272219|470939029|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
130812064|NCT01272219|470939030|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
130812065|NCT01272219|470939031|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
130812066|NCT01272219|470939032|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
130812067|NCT00050011|470939034|FG000|Overall Study|Adverse Event|41|||
130812068|NCT00050011|470939035|FG001|Overall Study|Adverse Event|46|||
130812069|NCT00050011|470939034|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130812070|NCT00050011|470939035|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130812071|NCT00050011|470939034|FG000|Overall Study|Abnormal test procedure results|0|||
130812072|NCT00050011|470939035|FG001|Overall Study|Abnormal test procedure results|1|||
130812073|NCT00050011|470939034|FG000|Overall Study|Lack of Efficacy|16|||
130812074|NCT00050011|470939035|FG001|Overall Study|Lack of Efficacy|21|||
130812075|NCT00050011|470939034|FG000|Overall Study|Participant condition no longer required|1|||
130812076|NCT00050011|470939035|FG001|Overall Study|Participant condition no longer required|0|||
130812077|NCT00050011|470939034|FG000|Overall Study|Protocol Violation|4|||
130812078|NCT00050011|470939035|FG001|Overall Study|Protocol Violation|10|||
130812079|NCT00050011|470939034|FG000|Overall Study|Withdrawal by Subject|34|||
130812080|NCT00050011|470939035|FG001|Overall Study|Withdrawal by Subject|26|||
130812081|NCT00050011|470939034|FG000|Overall Study|Lost to Follow-up|7|||
130812082|NCT00050011|470939035|FG001|Overall Study|Lost to Follow-up|9|||
130812083|NCT00050011|470939034|FG000|Overall Study|Administrative problems|10|||
130812084|NCT00050011|470939035|FG001|Overall Study|Administrative problems|6|||
130812085|NCT00050011|470939034|FG000|Overall Study|Death|7|||
130812086|NCT00050011|470939035|FG001|Overall Study|Death|4|||
130812087|NCT00050011|470939034|FG000|Overall Study|Unknown - Reason is missing|0|||
130812088|NCT00050011|470939035|FG001|Overall Study|Unknown - Reason is missing|2|||
130812089|NCT04806373|470939036|FG000|Overall Study|Withdrawal by Subject|1|||
130812090|NCT04806373|470939037|FG001|Overall Study|Withdrawal by Subject|1|||
130812091|NCT05810597|470939038|FG000|Period 1|Adverse Event|2|||
130812092|NCT05810597|470939039|FG001|Period 1|Adverse Event|0|||
130812093|NCT05810597|470939038|FG000|Period 1|Physician Decision|1|||
130812094|NCT05810597|470939039|FG001|Period 1|Physician Decision|0|||
130812095|NCT05021224|470939044|FG000|Overall Study|Did not complete all survey items|4|||
130812096|NCT05021224|470939045|FG001|Overall Study|Did not complete all survey items|1|||
130812097|NCT05021224|470939046|FG002|Overall Study|Did not complete all survey items|0|||
130812098|NCT05021224|470939047|FG003|Overall Study|Did not complete all survey items|2|||
130812099|NCT02061085|470939048|FG000|Overall Study|Adverse Event|8|||
130812100|NCT04903093|470939053|FG000|Overall Study|Withdrawal by Subject|0|||
130812101|NCT04903093|470939054|FG001|Overall Study|Withdrawal by Subject|0|||
130812102|NCT04903093|470939055|FG002|Overall Study|Withdrawal by Subject|0|||
130812103|NCT04903093|470939056|FG003|Overall Study|Withdrawal by Subject|1|||
130812104|NCT04903093|470939057|FG004|Overall Study|Withdrawal by Subject|0|||
130812105|NCT04903093|470939058|FG005|Overall Study|Withdrawal by Subject|0|||
130812106|NCT02412436|470939059|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
130812107|NCT02412436|470939059|FG000|Overall Study|Lost to Follow-up|6|||
130812108|NCT02412436|470939059|FG000|Overall Study|Unable to get to clinic|3|||
130812109|NCT02412436|470939059|FG000|Overall Study|Death|1|||
130812110|NCT02412436|470939059|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
130812111|NCT04090749|470939065|FG000|Open Label Pilot|Lost to Follow-up|1|||
130812112|NCT04090749|470939066|FG001|Open Label Pilot|Lost to Follow-up|0|||
130812113|NCT04090749|470939067|FG002|Open Label Pilot|Lost to Follow-up|0|||
130812114|NCT04090749|470939065|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
130812115|NCT04090749|470939066|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
130812116|NCT04090749|470939067|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
130812117|NCT04090749|470939065|FG000|Pilot Trial|Lost to Follow-up|0|||
130812118|NCT04090749|470939066|FG001|Pilot Trial|Lost to Follow-up|1|||
130812119|NCT04090749|470939067|FG002|Pilot Trial|Lost to Follow-up|1|||
130812120|NCT02528305|470939068|FG000|Overall Study|Withdrawal by Subject|1|||
130812121|NCT02528305|470939068|FG000|Overall Study|Adverse Event|1|||
130812122|NCT02528305|470939068|FG000|Overall Study|Physician Decision|1|||
130812123|NCT02184442|470939069|FG000|Overall Study|Death|61|||
130812124|NCT02184442|470939070|FG001|Overall Study|Death|65|||
130812125|NCT02184442|470939069|FG000|Overall Study|Withdrawal by Subject|3|||
130812126|NCT02184442|470939070|FG001|Overall Study|Withdrawal by Subject|11|||
130812127|NCT01852214|470939071|FG000|Period 1|Adverse Event|1|||
130812128|NCT01852214|470939072|FG001|Period 1|Adverse Event|2|||
130812129|NCT01852214|470939071|FG000|Period 1|Withdrawal by Subject|0|||
130812130|NCT01852214|470939072|FG001|Period 1|Withdrawal by Subject|1|||
130812131|NCT01852214|470939071|FG000|Washout Period|Withdrawal by Subject|0|||
130812132|NCT01852214|470939072|FG001|Washout Period|Withdrawal by Subject|1|||
130812133|NCT00421408|470939073|FG000|Overall Study|Lost to Follow-up|30|||
130812134|NCT00421408|470939074|FG001|Overall Study|Lost to Follow-up|20|||
130812135|NCT00421408|470939073|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
130812136|NCT00421408|470939074|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
130812137|NCT04091438|470939075|FG000|Treatment Period 1 (1 Day)|Other|1|||
130812138|NCT04091438|470939076|FG001|Treatment Period 1 (1 Day)|Other|0|||
130812139|NCT04091438|470939075|FG000|Washout Period (1 Day)|Protocol deviation|0|||
130812140|NCT04091438|470939076|FG001|Washout Period (1 Day)|Protocol deviation|1|||
130812141|NCT04091438|470939075|FG000|Washout Period (1 Day)|Other|0|||
130812142|NCT04091438|470939076|FG001|Washout Period (1 Day)|Other|1|||
130812143|NCT02691494|470939079|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
130812144|NCT02691494|470939080|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
130812145|NCT02691494|470939081|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
130812146|NCT02691494|470939079|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130812147|NCT02691494|470939080|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130812148|NCT02691494|470939081|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
130812149|NCT02691494|470939079|FG000|Post-Treatment Follow-Up Period|Other|2|||
130812150|NCT02691494|470939080|FG001|Post-Treatment Follow-Up Period|Other|1|||
130812151|NCT02691494|470939081|FG002|Post-Treatment Follow-Up Period|Other|1|||
130812152|NCT02691494|470939079|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
130812153|NCT02691494|470939080|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
130812154|NCT02691494|470939081|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
130812155|NCT02691494|470939079|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130812156|NCT02691494|470939080|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
130812157|NCT02691494|470939081|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
130812158|NCT00773461|470939084|FG000|Overall Study|Adverse Event|1|||
130812159|NCT00773461|470939085|FG001|Overall Study|Adverse Event|3|||
130812160|NCT00773461|470939084|FG000|Overall Study|Withdrawal by Subject|4|||
130812161|NCT00773461|470939085|FG001|Overall Study|Withdrawal by Subject|1|||
130812162|NCT00913835|470939086|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
130812163|NCT00913835|470939087|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
130812164|NCT00913835|470939086|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
130812165|NCT00913835|470939087|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
130812166|NCT00913835|470939086|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
130812167|NCT00913835|470939087|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
130812168|NCT00913835|470939086|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
130812169|NCT00913835|470939087|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
130812170|NCT00913835|470939086|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
130812171|NCT00913835|470939087|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
130812172|NCT00637156|470939088|FG000|Overall Study|Withdrawal by Subject|0|||
130812173|NCT00637156|470939089|FG001|Overall Study|Withdrawal by Subject|7|||
130812174|NCT00637156|470939088|FG000|Overall Study|Death|0|||
130812175|NCT00637156|470939089|FG001|Overall Study|Death|1|||
130812176|NCT00637156|470939088|FG000|Overall Study|Lost to Follow-up|10|||
130812177|NCT00637156|470939089|FG001|Overall Study|Lost to Follow-up|16|||
130812178|NCT03249558|470939094|FG000|Overall Study|Lost to Follow-up|2|||
130812179|NCT03249558|470939095|FG001|Overall Study|Lost to Follow-up|1|||
130812180|NCT03249558|470939096|FG002|Overall Study|Lost to Follow-up|4|||
130812181|NCT03249558|470939094|FG000|Overall Study|Physician Decision|1|||
130812182|NCT03249558|470939095|FG001|Overall Study|Physician Decision|0|||
130812183|NCT03249558|470939096|FG002|Overall Study|Physician Decision|0|||
130812184|NCT03249558|470939094|FG000|Overall Study|Withdrawal by Subject|6|||
130812185|NCT03249558|470939095|FG001|Overall Study|Withdrawal by Subject|5|||
130812186|NCT03249558|470939096|FG002|Overall Study|Withdrawal by Subject|7|||
130812187|NCT03249558|470939094|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
130812188|NCT03249558|470939095|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
130812189|NCT03249558|470939096|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
130812190|NCT03249558|470939094|FG000|Overall Study|Protocol Violation|1|||
130812191|NCT03249558|470939095|FG001|Overall Study|Protocol Violation|1|||
130812192|NCT03249558|470939096|FG002|Overall Study|Protocol Violation|2|||
130812193|NCT02613507|470939098|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
130812194|NCT02613507|470939099|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
130812195|NCT02613507|470939098|FG000|Pre-Treamtent|Participant withdrew consent|0|||
130812196|NCT02613507|470939099|FG001|Pre-Treamtent|Participant withdrew consent|4|||
130812197|NCT02613507|470939098|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
130812198|NCT02613507|470939099|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
130812199|NCT02613507|470939098|FG000|Treatment|Not reported|3|||
130812200|NCT02613507|470939099|FG001|Treatment|Not reported|0|||
130812201|NCT02613507|470939098|FG000|Treatment|Other reasons|8|||
130812202|NCT02613507|470939099|FG001|Treatment|Other reasons|0|||
130812203|NCT02613507|470939098|FG000|Treatment|Participant no longer meets criteria|3|||
130812204|NCT02613507|470939099|FG001|Treatment|Participant no longer meets criteria|0|||
130812205|NCT02613507|470939098|FG000|Treatment|Maximum clinical benefit|5|||
130812206|NCT02613507|470939099|FG001|Treatment|Maximum clinical benefit|10|||
130812207|NCT02613507|470939098|FG000|Treatment|Lost to Follow-up|1|||
130812208|NCT02613507|470939099|FG001|Treatment|Lost to Follow-up|0|||
130812209|NCT02613507|470939098|FG000|Treatment|Participant withdrew consent|0|||
130812210|NCT02613507|470939099|FG001|Treatment|Participant withdrew consent|2|||
130812211|NCT02613507|470939098|FG000|Treatment|Participant request to discontinue study treatment|13|||
130812212|NCT02613507|470939099|FG001|Treatment|Participant request to discontinue study treatment|17|||
130812213|NCT02613507|470939098|FG000|Treatment|Adverse event unrelated to study drug|20|||
130812214|NCT02613507|470939099|FG001|Treatment|Adverse event unrelated to study drug|3|||
130812215|NCT02613507|470939098|FG000|Treatment|Death|2|||
130812216|NCT02613507|470939099|FG001|Treatment|Death|0|||
130812217|NCT02613507|470939098|FG000|Treatment|Study drug toxicity|19|||
130812218|NCT02613507|470939099|FG001|Treatment|Study drug toxicity|14|||
130812219|NCT02613507|470939098|FG000|Treatment|Disease progression|263|||
130812220|NCT02613507|470939099|FG001|Treatment|Disease progression|110|||
130812221|NCT03941093|470939100|FG000|Overall Study|Protocol Violation|0|||
130812222|NCT03941093|470939101|FG001|Overall Study|Protocol Violation|1|||
130812223|NCT03941093|470939100|FG000|Overall Study|Withdrawal by Subject|9|||
130812224|NCT03941093|470939101|FG001|Overall Study|Withdrawal by Subject|6|||
130812225|NCT00561821|470939105|FG000|Overall Study|Not treated|0|||
130812226|NCT00561821|470939106|FG001|Overall Study|Not treated|0|||
130812227|NCT00561821|470939107|FG002|Overall Study|Not treated|1|||
130812228|NCT00561821|470939108|FG003|Overall Study|Not treated|0|||
130812229|NCT00561821|470939105|FG000|Overall Study|Withdrawal by Subject|0|||
130812230|NCT00561821|470939106|FG001|Overall Study|Withdrawal by Subject|1|||
130812231|NCT00561821|470939107|FG002|Overall Study|Withdrawal by Subject|0|||
130812232|NCT00561821|470939108|FG003|Overall Study|Withdrawal by Subject|2|||
130812233|NCT00561821|470939105|FG000|Overall Study|Reasons not related to trial|2|||
130812234|NCT00561821|470939106|FG001|Overall Study|Reasons not related to trial|1|||
130812235|NCT00561821|470939107|FG002|Overall Study|Reasons not related to trial|0|||
130812236|NCT00561821|470939108|FG003|Overall Study|Reasons not related to trial|0|||
130812237|NCT00561821|470939105|FG000|Overall Study|Other (reason not specified)|1|||
130812238|NCT00561821|470939106|FG001|Overall Study|Other (reason not specified)|1|||
130812239|NCT00561821|470939107|FG002|Overall Study|Other (reason not specified)|0|||
130812240|NCT00561821|470939108|FG003|Overall Study|Other (reason not specified)|0|||
130812241|NCT00561821|470939105|FG000|Overall Study|Adverse Event|2|||
130812242|NCT00561821|470939106|FG001|Overall Study|Adverse Event|3|||
130812243|NCT00561821|470939107|FG002|Overall Study|Adverse Event|1|||
130812244|NCT00561821|470939108|FG003|Overall Study|Adverse Event|1|||
130812245|NCT02657356|470939960|FG000|Overall Study|Death|1|||
130812246|NCT02657356|470939961|FG001|Overall Study|Death|0|||
130812247|NCT02657356|470939960|FG000|Overall Study|Withdrawal by Subject|5|||
130812248|NCT02657356|470939961|FG001|Overall Study|Withdrawal by Subject|6|||
130812249|NCT02657356|470939960|FG000|Overall Study|Terminated by Sponsor|8|||
130812250|NCT02657356|470939961|FG001|Overall Study|Terminated by Sponsor|5|||
130812251|NCT02657356|470939960|FG000|Overall Study|Rolled over to EAP study|6|||
130812252|NCT02657356|470939961|FG001|Overall Study|Rolled over to EAP study|4|||
130812253|NCT03379870|470939964|FG000|Overall Study|Lost to Follow-up|1|||
130812254|NCT03379870|470939965|FG001|Overall Study|Lost to Follow-up|0|||
130812255|NCT03379870|470939964|FG000|Overall Study|Protocol Violation|1|||
130812256|NCT03379870|470939965|FG001|Overall Study|Protocol Violation|1|||
130812257|NCT03443401|470939970|FG000|Overall Study|Lost to Follow-up|13|||
130812258|NCT03443401|470939970|FG000|Overall Study|Influential outlier|1|||
130812259|NCT00980044|470939971|FG000|Overall Study|Withdrawal by Subject|5|||
130812260|NCT00980044|470939972|FG001|Overall Study|Withdrawal by Subject|7|||
130812261|NCT00980044|470939973|FG002|Overall Study|Withdrawal by Subject|3|||
130812262|NCT00980044|470939971|FG000|Overall Study|Protocol Violation|0|||
130812263|NCT00980044|470939972|FG001|Overall Study|Protocol Violation|0|||
130812264|NCT00980044|470939973|FG002|Overall Study|Protocol Violation|2|||
130812265|NCT02904265|470939974|FG000|Overall Study|Physician Decision|1|||
130812266|NCT02904265|470939975|FG001|Overall Study|Physician Decision|2|||
130812267|NCT00833703|470939977|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
130812268|NCT00833703|470939978|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
130812269|NCT05538728|470939979|FG000|Overall Study|Withdrawal by Subject|1|||
130812270|NCT05538728|470939980|FG001|Overall Study|Withdrawal by Subject|1|||
130812271|NCT02254460|470939981|FG000|Overall Study|Adverse Event|1|||
130812272|NCT02254460|470939982|FG001|Overall Study|Adverse Event|0|||
130812273|NCT01148771|470939986|FG000|Washout Period|Withdrawal by Subject|0|||
130812274|NCT01148771|470939987|FG001|Washout Period|Withdrawal by Subject|1|||
130812275|NCT05418426|470939989|FG000|Overall Study|Adverse Event|0|||
130812276|NCT05418426|470939990|FG001|Overall Study|Adverse Event|1|||
130812277|NCT05418426|470939991|FG002|Overall Study|Adverse Event|0|||
130812278|NCT05418426|470939989|FG000|Overall Study|Withdrawal by Subject|0|||
130812279|NCT05418426|470939990|FG001|Overall Study|Withdrawal by Subject|1|||
130812280|NCT05418426|470939991|FG002|Overall Study|Withdrawal by Subject|0|||
130812281|NCT05418426|470939989|FG000|Overall Study|Protocol Violation|0|||
130812282|NCT05418426|470939990|FG001|Overall Study|Protocol Violation|0|||
130812283|NCT05418426|470939991|FG002|Overall Study|Protocol Violation|1|||
130812284|NCT01674062|470939992|FG000|Overall Study|Insufficient Therapeutic Response|56|||
130812285|NCT01674062|470939993|FG001|Overall Study|Insufficient Therapeutic Response|26|||
130812286|NCT01674062|470939992|FG000|Overall Study|Other|8|||
130812287|NCT01674062|470939993|FG001|Overall Study|Other|1|||
130812288|NCT01674062|470939992|FG000|Overall Study|Adverse Event|1|||
130812289|NCT01674062|470939993|FG001|Overall Study|Adverse Event|1|||
130812290|NCT01674062|470939992|FG000|Overall Study|Death|0|||
130812291|NCT01674062|470939993|FG001|Overall Study|Death|1|||
130812292|NCT01674062|470939992|FG000|Overall Study|Programming Error|1|||
130812293|NCT01674062|470939993|FG001|Overall Study|Programming Error|0|||
130812294|NCT02951819|470939998|FG000|Overall Study|Death|9|||
130812295|NCT02951819|470939999|FG001|Overall Study|Death|7|||
130812296|NCT02951819|470939998|FG000|Overall Study|Withdrawal by Subject|3|||
130812297|NCT02951819|470939999|FG001|Overall Study|Withdrawal by Subject|0|||
130812298|NCT02951819|470939998|FG000|Overall Study|Adverse Event|1|||
130812299|NCT02951819|470939999|FG001|Overall Study|Adverse Event|0|||
130812300|NCT02951819|470939998|FG000|Overall Study|Lack of Efficacy|4|||
130812301|NCT02951819|470939999|FG001|Overall Study|Lack of Efficacy|0|||
130812302|NCT02951819|470939998|FG000|Overall Study|Lost to Follow-up|1|||
130812303|NCT02951819|470939999|FG001|Overall Study|Lost to Follow-up|0|||
130812304|NCT02951819|470939998|FG000|Overall Study|Progressive Disease|1|||
130812305|NCT02951819|470939999|FG001|Overall Study|Progressive Disease|0|||
130812306|NCT02951819|470939998|FG000|Overall Study|Other|9|||
130812307|NCT02951819|470939999|FG001|Overall Study|Other|0|||
130812308|NCT01443026|470940001|FG000|Overall Study|Physician Decision|1|||
130812309|NCT01443026|470940002|FG001|Overall Study|Physician Decision|0|||
130812310|NCT01443026|470940001|FG000|Overall Study|Death|0|||
130812311|NCT01443026|470940002|FG001|Overall Study|Death|1|||
130812312|NCT01443026|470940001|FG000|Overall Study|Withdrawal by Subject|0|||
130812313|NCT01443026|470940002|FG001|Overall Study|Withdrawal by Subject|3|||
130812314|NCT01443026|470940001|FG000|Overall Study|Lost to Follow-up|2|||
130812315|NCT01443026|470940002|FG001|Overall Study|Lost to Follow-up|1|||
130812316|NCT00581919|470940003|FG000|Overall Study|Adverse Event|8|||
130812317|NCT00581919|470940003|FG000|Overall Study|Death|1|||
130812318|NCT00581919|470940003|FG000|Overall Study|Disease Progression|10|||
130812319|NCT00581919|470940003|FG000|Overall Study|Physician Decision|1|||
130812320|NCT00581919|470940003|FG000|Overall Study|Other Complicating Disease|1|||
130812321|NCT00581919|470940003|FG000|Overall Study|Started Non-Protocol Therapy|2|||
130812322|NCT00581919|470940003|FG000|Overall Study|Withdrawal by Subject|1|||
130812323|NCT02971163|470940006|FG000|Overall Study|Lost to Follow-up|4|||
130812324|NCT02971163|470940007|FG001|Overall Study|Lost to Follow-up|2|||
130812325|NCT00787800|470940010|FG000|Overall Study|Withdrawal by Subject|3|||
130812326|NCT00787800|470940011|FG001|Overall Study|Withdrawal by Subject|5|||
130812327|NCT00787800|470940010|FG000|Overall Study|Death|0|||
130812328|NCT00787800|470940011|FG001|Overall Study|Death|2|||
130812329|NCT04309500|470940012|FG000|Overall Study|Lost to Follow-up|1|||
130812330|NCT04309500|470940013|FG001|Overall Study|Lost to Follow-up|0|||
130812331|NCT04309500|470940014|FG002|Overall Study|Lost to Follow-up|0|||
130812332|NCT04309500|470940015|FG003|Overall Study|Lost to Follow-up|0|||
130812333|NCT00461812|470940016|FG000|Overall Study|study terminated|10|||
130812334|NCT01308788|470940017|FG000|2-year Treatment|medication change by treating physician|4|||
130812335|NCT01308788|470940018|FG001|2-year Treatment|medication change by treating physician|11|||
130812336|NCT03193437|470940019|FG000|Overall Study|Adverse Event|4|||
130812337|NCT03193437|470940019|FG000|Overall Study|Withdrawal by Subject|2|||
130812338|NCT03193437|470940019|FG000|Overall Study|Disease Progression|2|||
130812339|NCT05487378|470940020|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
130812340|NCT05487378|470940021|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
130812341|NCT05487378|470940020|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
130812342|NCT05487378|470940021|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
130812343|NCT02414841|470940022|FG000|Overall Study|Withdrawal by Subject|7|||
130812344|NCT02414841|470940023|FG001|Overall Study|Withdrawal by Subject|5|||
130812345|NCT02414841|470940022|FG000|Overall Study|Lost to Follow-up|13|||
130812346|NCT02414841|470940023|FG001|Overall Study|Lost to Follow-up|6|||
130812347|NCT02414841|470940022|FG000|Overall Study|Death|17|||
130812348|NCT02414841|470940023|FG001|Overall Study|Death|14|||
130812349|NCT02414841|470940022|FG000|Overall Study|Received a Kidney Transplant|13|||
130812350|NCT02414841|470940023|FG001|Overall Study|Received a Kidney Transplant|4|||
130812351|NCT02414841|470940022|FG000|Overall Study|Randomized But Not Treated|6|||
130812352|NCT02414841|470940023|FG001|Overall Study|Randomized But Not Treated|4|||
130812353|NCT00964678|470940039|FG000|Overall Study|Physician Decision|4|||
130812354|NCT03359395|470940042|FG000|First Intervention A / B|Withdrawal by Subject|1|||
130812355|NCT03359395|470940043|FG001|First Intervention A / B|Withdrawal by Subject|0|||
130812356|NCT03359395|470940042|FG000|First Intervention A / B|Lost to Follow-up|2|||
130812357|NCT03359395|470940043|FG001|First Intervention A / B|Lost to Follow-up|3|||
130812358|NCT03359395|470940042|FG000|Second Intervention B/A|Exclusion criteria|0|||
130812359|NCT03359395|470940043|FG001|Second Intervention B/A|Exclusion criteria|1|||
130812360|NCT03359395|470940042|FG000|Second Intervention B/A|Lost to Follow-up|3|||
130812361|NCT03359395|470940043|FG001|Second Intervention B/A|Lost to Follow-up|2|||
130812362|NCT03164356|470940044|FG000|Overall Study|Lost to Follow-up|1|||
130812363|NCT03164356|470940045|FG001|Overall Study|Lost to Follow-up|1|||
130812364|NCT03164356|470940046|FG002|Overall Study|Lost to Follow-up|2|||
130812365|NCT03164356|470940047|FG003|Overall Study|Lost to Follow-up|1|||
130812366|NCT03164356|470940044|FG000|Overall Study|Physician Decision|0|||
130812367|NCT03164356|470940045|FG001|Overall Study|Physician Decision|0|||
130812368|NCT03164356|470940046|FG002|Overall Study|Physician Decision|3|||
130812369|NCT03164356|470940047|FG003|Overall Study|Physician Decision|0|||
130812370|NCT03164356|470940044|FG000|Overall Study|Protocol Violation|2|||
130812371|NCT03164356|470940045|FG001|Overall Study|Protocol Violation|1|||
130812372|NCT03164356|470940046|FG002|Overall Study|Protocol Violation|0|||
130812373|NCT03164356|470940047|FG003|Overall Study|Protocol Violation|0|||
130812374|NCT03164356|470940044|FG000|Overall Study|Withdrawal by Subject|1|||
130812375|NCT03164356|470940045|FG001|Overall Study|Withdrawal by Subject|0|||
130812376|NCT03164356|470940046|FG002|Overall Study|Withdrawal by Subject|0|||
130812377|NCT03164356|470940047|FG003|Overall Study|Withdrawal by Subject|0|||
130812378|NCT03164356|470940044|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
130812379|NCT03164356|470940045|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
130812380|NCT03164356|470940046|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
130812381|NCT03164356|470940047|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
130812382|NCT03164356|470940044|FG000|Overall Study|Subject Incarcerated|0|||
130812383|NCT03164356|470940045|FG001|Overall Study|Subject Incarcerated|1|||
130812384|NCT03164356|470940046|FG002|Overall Study|Subject Incarcerated|0|||
130812385|NCT03164356|470940047|FG003|Overall Study|Subject Incarcerated|0|||
130812386|NCT03164356|470940044|FG000|Overall Study|Prosthetist unable to participate|0|||
130812387|NCT03164356|470940045|FG001|Overall Study|Prosthetist unable to participate|2|||
130812388|NCT03164356|470940046|FG002|Overall Study|Prosthetist unable to participate|1|||
130812389|NCT03164356|470940047|FG003|Overall Study|Prosthetist unable to participate|0|||
130812390|NCT05943990|470940051|FG000|Overall Study|Study Terminated by Sponsor|0|||
130812391|NCT05943990|470940052|FG001|Overall Study|Study Terminated by Sponsor|0|||
130812392|NCT05943990|470940053|FG002|Overall Study|Study Terminated by Sponsor|1|||
130812393|NCT04280783|470941480|FG000|Overall Study|Family issues unrelated to the study.|1|||
130812394|NCT04280783|470941481|FG001|Overall Study|Family issues unrelated to the study.|0|||
130812395|NCT04280783|470941480|FG000|Overall Study|Withdrawal by Subject|0|||
130812396|NCT04280783|470941481|FG001|Overall Study|Withdrawal by Subject|1|||
130812397|NCT02254291|470941483|FG000|Overall Study|Withdrawal by Subject|0|||
130812398|NCT02254291|470941484|FG001|Overall Study|Withdrawal by Subject|3|||
130812399|NCT02254291|470941485|FG002|Overall Study|Withdrawal by Subject|1|||
130812400|NCT02254291|470941483|FG000|Overall Study|Missing follow-up information|0|||
130812401|NCT02254291|470941484|FG001|Overall Study|Missing follow-up information|0|||
130812402|NCT02254291|470941485|FG002|Overall Study|Missing follow-up information|1|||
130812403|NCT00488293|470941490|FG000|Overall Study|Lost to Follow-up|28|||
130812404|NCT00488293|470941491|FG001|Overall Study|Lost to Follow-up|25|||
130812405|NCT00488293|470941490|FG000|Overall Study|Withdrawal by Subject|5|||
130812406|NCT00488293|470941491|FG001|Overall Study|Withdrawal by Subject|3|||
130812407|NCT00488293|470941490|FG000|Overall Study|Death|2|||
130812408|NCT00488293|470941491|FG001|Overall Study|Death|1|||
130812409|NCT00488293|470941490|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
130812410|NCT00488293|470941491|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
130812411|NCT00500331|470941492|FG000|Overall Study|Adverse Event|0|||
130812412|NCT00500331|470941493|FG001|Overall Study|Adverse Event|2|||
130812413|NCT00500331|470941494|FG002|Overall Study|Adverse Event|0|||
130812414|NCT00500331|470941495|FG003|Overall Study|Adverse Event|1|||
130812415|NCT00500331|470941496|FG004|Overall Study|Adverse Event|2|||
130812416|NCT00500331|470941497|FG005|Overall Study|Adverse Event|2|||
130812417|NCT00500331|470941498|FG006|Overall Study|Adverse Event|0|||
130812418|NCT00500331|470941492|FG000|Overall Study|Lost to Follow-up|1|||
130812419|NCT00500331|470941493|FG001|Overall Study|Lost to Follow-up|1|||
130812420|NCT00500331|470941494|FG002|Overall Study|Lost to Follow-up|1|||
130812421|NCT00500331|470941495|FG003|Overall Study|Lost to Follow-up|2|||
130812422|NCT00500331|470941496|FG004|Overall Study|Lost to Follow-up|1|||
130812423|NCT00500331|470941497|FG005|Overall Study|Lost to Follow-up|0|||
130812424|NCT00500331|470941498|FG006|Overall Study|Lost to Follow-up|0|||
130812425|NCT00500331|470941492|FG000|Overall Study|Protocol Violation|3|||
130812426|NCT00500331|470941493|FG001|Overall Study|Protocol Violation|1|||
130812427|NCT00500331|470941494|FG002|Overall Study|Protocol Violation|1|||
130812428|NCT00500331|470941495|FG003|Overall Study|Protocol Violation|0|||
130812429|NCT00500331|470941496|FG004|Overall Study|Protocol Violation|1|||
130812430|NCT00500331|470941497|FG005|Overall Study|Protocol Violation|1|||
130812431|NCT00500331|470941498|FG006|Overall Study|Protocol Violation|1|||
130812432|NCT00500331|470941492|FG000|Overall Study|Withdrawal by Subject|4|||
130812433|NCT00500331|470941493|FG001|Overall Study|Withdrawal by Subject|0|||
130812434|NCT00500331|470941494|FG002|Overall Study|Withdrawal by Subject|1|||
130812435|NCT00500331|470941495|FG003|Overall Study|Withdrawal by Subject|5|||
130812436|NCT00500331|470941496|FG004|Overall Study|Withdrawal by Subject|0|||
130812437|NCT00500331|470941497|FG005|Overall Study|Withdrawal by Subject|1|||
130812438|NCT00500331|470941498|FG006|Overall Study|Withdrawal by Subject|1|||
130812439|NCT00500331|470941492|FG000|Overall Study|Lack of Efficacy|3|||
130812440|NCT00500331|470941493|FG001|Overall Study|Lack of Efficacy|1|||
130812441|NCT00500331|470941494|FG002|Overall Study|Lack of Efficacy|0|||
130812442|NCT00500331|470941495|FG003|Overall Study|Lack of Efficacy|0|||
130812443|NCT00500331|470941496|FG004|Overall Study|Lack of Efficacy|0|||
130812444|NCT00500331|470941497|FG005|Overall Study|Lack of Efficacy|0|||
130812445|NCT00500331|470941498|FG006|Overall Study|Lack of Efficacy|0|||
130812446|NCT00500331|470941492|FG000|Overall Study|Liver function test abnormality|0|||
130812447|NCT00500331|470941493|FG001|Overall Study|Liver function test abnormality|0|||
130812448|NCT00500331|470941494|FG002|Overall Study|Liver function test abnormality|1|||
130812449|NCT00500331|470941495|FG003|Overall Study|Liver function test abnormality|0|||
130812450|NCT00500331|470941496|FG004|Overall Study|Liver function test abnormality|0|||
130812451|NCT00500331|470941497|FG005|Overall Study|Liver function test abnormality|0|||
130812452|NCT00500331|470941498|FG006|Overall Study|Liver function test abnormality|0|||
130812453|NCT00500331|470941492|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
130812454|NCT00500331|470941493|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
130812455|NCT00500331|470941494|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
130812456|NCT00500331|470941495|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
130812457|NCT00500331|470941496|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
130812458|NCT00500331|470941497|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
130812459|NCT00500331|470941498|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
130812460|NCT00500331|470941492|FG000|Overall Study|Didn't return for continuation of study|1|||
130812461|NCT00500331|470941493|FG001|Overall Study|Didn't return for continuation of study|0|||
130812462|NCT00500331|470941494|FG002|Overall Study|Didn't return for continuation of study|0|||
130812463|NCT00500331|470941495|FG003|Overall Study|Didn't return for continuation of study|0|||
130812464|NCT00500331|470941496|FG004|Overall Study|Didn't return for continuation of study|0|||
130812465|NCT00500331|470941497|FG005|Overall Study|Didn't return for continuation of study|0|||
130812466|NCT00500331|470941498|FG006|Overall Study|Didn't return for continuation of study|0|||
130812467|NCT00500331|470941492|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
130812468|NCT00500331|470941493|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
130812469|NCT00500331|470941494|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
130812470|NCT00500331|470941495|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
130812471|NCT00500331|470941496|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
130812472|NCT00500331|470941497|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
130812473|NCT00500331|470941498|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
130812474|NCT00500331|470941492|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
130812475|NCT00500331|470941493|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
130812476|NCT00500331|470941494|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
130812477|NCT00500331|470941495|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
130812478|NCT00500331|470941496|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
130812479|NCT00500331|470941497|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
130812480|NCT00500331|470941498|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
130812481|NCT00500331|470941492|FG000|Overall Study|Participant was randomized by mistake|1|||
130812482|NCT00500331|470941493|FG001|Overall Study|Participant was randomized by mistake|0|||
130812483|NCT00500331|470941494|FG002|Overall Study|Participant was randomized by mistake|0|||
130812484|NCT00500331|470941495|FG003|Overall Study|Participant was randomized by mistake|0|||
130812485|NCT00500331|470941496|FG004|Overall Study|Participant was randomized by mistake|0|||
130812486|NCT00500331|470941497|FG005|Overall Study|Participant was randomized by mistake|0|||
130812487|NCT00500331|470941498|FG006|Overall Study|Participant was randomized by mistake|0|||
130812488|NCT00500331|470941492|FG000|Overall Study|Diabetologist nurse in the study|0|||
130812489|NCT00500331|470941493|FG001|Overall Study|Diabetologist nurse in the study|0|||
130812490|NCT00500331|470941494|FG002|Overall Study|Diabetologist nurse in the study|1|||
130812491|NCT00500331|470941495|FG003|Overall Study|Diabetologist nurse in the study|0|||
130812492|NCT00500331|470941496|FG004|Overall Study|Diabetologist nurse in the study|0|||
130812493|NCT00500331|470941497|FG005|Overall Study|Diabetologist nurse in the study|0|||
130812494|NCT00500331|470941498|FG006|Overall Study|Diabetologist nurse in the study|0|||
130812495|NCT00500331|470941492|FG000|Overall Study|State ban of biological samples export|0|||
130812496|NCT00500331|470941493|FG001|Overall Study|State ban of biological samples export|0|||
130812497|NCT00500331|470941494|FG002|Overall Study|State ban of biological samples export|0|||
130812498|NCT00500331|470941495|FG003|Overall Study|State ban of biological samples export|1|||
130812499|NCT00500331|470941496|FG004|Overall Study|State ban of biological samples export|0|||
130812500|NCT00500331|470941497|FG005|Overall Study|State ban of biological samples export|0|||
130812501|NCT00500331|470941498|FG006|Overall Study|State ban of biological samples export|0|||
130812502|NCT00500331|470941492|FG000|Overall Study|Protocol violated|0|||
130812503|NCT00500331|470941493|FG001|Overall Study|Protocol violated|0|||
130812504|NCT00500331|470941494|FG002|Overall Study|Protocol violated|0|||
130812505|NCT00500331|470941495|FG003|Overall Study|Protocol violated|1|||
130812506|NCT00500331|470941496|FG004|Overall Study|Protocol violated|0|||
130812507|NCT00500331|470941497|FG005|Overall Study|Protocol violated|0|||
130812508|NCT00500331|470941498|FG006|Overall Study|Protocol violated|0|||
130812509|NCT03436732|470941499|FG000|Overall Study|Not treated-enrolled in different study|1|||
130812510|NCT03436732|470941500|FG001|Overall Study|Not treated-enrolled in different study|0|||
130812511|NCT03436732|470941499|FG000|Overall Study|Off study after cycle 1|1|||
130812512|NCT03436732|470941500|FG001|Overall Study|Off study after cycle 1|0|||
130812513|NCT03436732|470941499|FG000|Overall Study|Adverse Event|2|||
130812514|NCT03436732|470941500|FG001|Overall Study|Adverse Event|0|||
130812515|NCT03436732|470941499|FG000|Overall Study|Death|0|||
130812516|NCT03436732|470941500|FG001|Overall Study|Death|1|||
130812517|NCT01904279|470941501|FG000|Overall Study|Lack of Efficacy|2|||
130812518|NCT01904279|470941502|FG001|Overall Study|Lack of Efficacy|3|||
130812519|NCT01904279|470941501|FG000|Overall Study|Withdrawal by Subject|1|||
130812520|NCT01904279|470941502|FG001|Overall Study|Withdrawal by Subject|0|||
130812521|NCT01356940|470941505|FG000|First Intervention (28 Days)|Adverse Event|1|||
130812522|NCT01356940|470941506|FG001|First Intervention (28 Days)|Adverse Event|0|||
130812523|NCT01356940|470941505|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
130812524|NCT01356940|470941506|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
130812525|NCT01344356|470941509|FG000|Overall Study|Physician Decision|0|||
130812526|NCT01344356|470941510|FG001|Overall Study|Physician Decision|3|||
130812527|NCT01344356|470941509|FG000|Overall Study|Lost to Follow-up|0|||
130812528|NCT01344356|470941510|FG001|Overall Study|Lost to Follow-up|6|||
130812529|NCT00095576|470941511|FG000|Overall Study|Adverse Event|5|||
130812530|NCT00095576|470941512|FG001|Overall Study|Adverse Event|3|||
130812531|NCT00095576|470941511|FG000|Overall Study|Lost to Follow-up|233|||
130812532|NCT00095576|470941512|FG001|Overall Study|Lost to Follow-up|229|||
130812533|NCT00095576|470941511|FG000|Overall Study|Protocol Violation|1|||
130812534|NCT00095576|470941512|FG001|Overall Study|Protocol Violation|0|||
130812535|NCT00095576|470941511|FG000|Overall Study|Withdrawal by Subject|34|||
130812536|NCT00095576|470941512|FG001|Overall Study|Withdrawal by Subject|47|||
130812537|NCT00095576|470941511|FG000|Overall Study|Option to switch to a rollover study|1097|||
130812538|NCT00095576|470941512|FG001|Overall Study|Option to switch to a rollover study|1099|||
130812539|NCT00095576|470941511|FG000|Overall Study|Site terminated|75|||
130812540|NCT00095576|470941512|FG001|Overall Study|Site terminated|67|||
130812541|NCT00095576|470941511|FG000|Overall Study|Subject moved|30|||
130812542|NCT00095576|470941512|FG001|Overall Study|Subject moved|36|||
130812543|NCT00505687|470941513|FG000|Overall Study|Important protocol violation|2|||
130812544|NCT00505687|470941513|FG000|Overall Study|Lack of Efficacy|15|||
130812545|NCT00505687|470941513|FG000|Overall Study|Adverse Event|48|||
130812546|NCT00505687|470941513|FG000|Overall Study|Subject withdrew consent|15|||
130812547|NCT00505687|470941513|FG000|Overall Study|Lost to Follow-up|1|||
130812548|NCT00505687|470941513|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
130812549|NCT00505687|470941513|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
130812550|NCT00505687|470941513|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
130812551|NCT00505687|470941513|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
130812552|NCT00505687|470941513|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
130812553|NCT00505687|470941513|FG000|Overall Study|Other: Disease Progression|1|||
130812554|NCT00505687|470941513|FG000|Overall Study|Other: As Per Sponsor|8|||
130812555|NCT00480532|470941516|FG000|Overall Study|Withdrawal by Subject|2|||
130812556|NCT00480532|470941517|FG001|Overall Study|Withdrawal by Subject|4|||
130812557|NCT00480532|470941518|FG002|Overall Study|Withdrawal by Subject|3|||
130812558|NCT00480532|470941519|FG003|Overall Study|Withdrawal by Subject|1|||
130812559|NCT00480532|470941516|FG000|Overall Study|Protocol Violation|0|||
130812560|NCT00480532|470941517|FG001|Overall Study|Protocol Violation|0|||
130812561|NCT00480532|470941518|FG002|Overall Study|Protocol Violation|1|||
130812562|NCT00480532|470941519|FG003|Overall Study|Protocol Violation|0|||
130812563|NCT01817777|470941520|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
130812564|NCT01817777|470941521|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
130812565|NCT01817777|470941522|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
130812566|NCT01817777|470941520|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
130812567|NCT01817777|470941521|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
130812568|NCT01817777|470941522|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
130812569|NCT01817777|470941520|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
130812570|NCT01817777|470941521|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
130812571|NCT01817777|470941522|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
130812572|NCT01817777|470941520|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
130812573|NCT01817777|470941521|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
130812574|NCT01817777|470941522|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
130812575|NCT01817777|470941520|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
130812576|NCT01817777|470941521|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
130812577|NCT01817777|470941522|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
130812578|NCT00443456|470941523|FG000|Overall Study|Adverse Event|16|||
130812579|NCT00443456|470941523|FG000|Overall Study|Move|1|||
130812580|NCT00443456|470941523|FG000|Overall Study|Withdrawal by Subject|1|||
130812581|NCT00557440|470941524|FG000|Treatment Period 1|Adverse Event|0|||
130812582|NCT00557440|470941525|FG001|Treatment Period 1|Adverse Event|0|||
130812583|NCT00557440|470941526|FG002|Treatment Period 1|Adverse Event|1|||
130812584|NCT03524157|470941527|FG000|Overall Study|cytology not readable|0|||
130812585|NCT03524157|470941528|FG001|Overall Study|cytology not readable|0|||
130812586|NCT03524157|470941529|FG002|Overall Study|cytology not readable|1|||
130812587|NCT03242434|470941530|FG000|Overall Study|Death|0|||
130812588|NCT03242434|470941531|FG001|Overall Study|Death|2|||
130812589|NCT02157610|470941532|FG000|Overall Study|Death|4|||
130812590|NCT02157610|470941533|FG001|Overall Study|Death|4|||
130812591|NCT01378195|470941534|FG000|Overall Study|Lost to Follow-up|29|||
130812592|NCT01378195|470941535|FG001|Overall Study|Lost to Follow-up|18|||
130812593|NCT03427619|470941536|FG000|Overall Study|Physician Decision|3|||
130812594|NCT03427619|470941536|FG000|Overall Study|Withdrawal by Subject|4|||
130812595|NCT03427619|470941536|FG000|Overall Study|Lost to Follow-up|5|||
130812596|NCT03427619|470941536|FG000|Overall Study|Administrative|4|||
130812597|NCT03427619|470941536|FG000|Overall Study|Other|2|||
130812598|NCT03427619|470941536|FG000|Overall Study|Unknown or Missing Completion Status|48|||
130812599|NCT00425555|470941537|FG000|Overall Study|Withdrawal by Subject|11|||
130812600|NCT00425555|470941538|FG001|Overall Study|Withdrawal by Subject|8|||
130812601|NCT00425555|470941537|FG000|Overall Study|Lost to Follow-up|0|||
130812602|NCT00425555|470941538|FG001|Overall Study|Lost to Follow-up|1|||
130812603|NCT00425555|470941537|FG000|Overall Study|Administrative problems|3|||
130812604|NCT00425555|470941538|FG001|Overall Study|Administrative problems|0|||
130812605|NCT00425555|470941537|FG000|Overall Study|Death|1|||
130812606|NCT00425555|470941538|FG001|Overall Study|Death|2|||
130812607|NCT00425555|470941537|FG000|Overall Study|New cancer therapy|2|||
130812608|NCT00425555|470941538|FG001|Overall Study|New cancer therapy|1|||
130812609|NCT00425555|470941537|FG000|Overall Study|Disease progression|36|||
130812610|NCT00425555|470941538|FG001|Overall Study|Disease progression|33|||
130812611|NCT00425555|470941537|FG000|Overall Study|Adverse Event|25|||
130812612|NCT00425555|470941538|FG001|Overall Study|Adverse Event|15|||
130812613|NCT00425555|470941537|FG000|Overall Study|Protocol Violation|1|||
130812614|NCT00425555|470941538|FG001|Overall Study|Protocol Violation|0|||
130812615|NCT04620668|470941539|FG000|Overall Study|Withdrawal by Subject|2|||
130812616|NCT04620668|470941540|FG001|Overall Study|Withdrawal by Subject|0|||
130812617|NCT04620668|470941539|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
130812618|NCT04620668|470941540|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
130812619|NCT04620668|470941539|FG000|Overall Study|Removed before analysis: missing data|2|||
130812620|NCT04620668|470941540|FG001|Overall Study|Removed before analysis: missing data|0|||
130812621|NCT04620668|470941539|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
130812622|NCT04620668|470941540|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
130812623|NCT04620668|470941539|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
130812624|NCT04620668|470941540|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
130812625|NCT02796651|470941547|FG000|Overall Study|Adverse Event|6|||
130812626|NCT02796651|470941547|FG000|Overall Study|Lost to Follow-up|1|||
130812627|NCT02796651|470941547|FG000|Overall Study|Withdrawal by Subject|4|||
130812628|NCT02796651|470941547|FG000|Overall Study|Protocol Violation|4|||
130812629|NCT02796651|470941547|FG000|Overall Study|Lack of Efficacy|1|||
130812630|NCT02796651|470941547|FG000|Overall Study|Other|10|||
130812631|NCT05014919|470941548|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
130812632|NCT05014919|470941549|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
130812633|NCT05014919|470941550|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
130812634|NCT05014919|470941548|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
130812635|NCT05014919|470941549|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
130812636|NCT05014919|470941550|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
130812637|NCT05014919|470941548|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
130812638|NCT05014919|470941549|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
130812639|NCT05014919|470941550|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
130812640|NCT05014919|470941548|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
130812641|NCT05014919|470941549|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
130812642|NCT05014919|470941550|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
130812643|NCT05014919|470941548|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
130812644|NCT05014919|470941549|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
130812645|NCT05014919|470941550|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
130812646|NCT05014919|470941548|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
130812647|NCT05014919|470941549|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
130812648|NCT05014919|470941550|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
130812649|NCT05014919|470941548|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
130812650|NCT05014919|470941549|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
130812651|NCT05014919|470941550|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
130812652|NCT05014919|470941548|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
130812653|NCT05014919|470941549|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
130812654|NCT05014919|470941550|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
130812655|NCT00680914|470941551|FG000|Overall Study|Consent withdrawal|6|||
130812656|NCT00680914|470941552|FG001|Overall Study|Consent withdrawal|3|||
130812657|NCT00680914|470941551|FG000|Overall Study|Lost to Follow-up|4|||
130812658|NCT00680914|470941552|FG001|Overall Study|Lost to Follow-up|0|||
130812659|NCT00680914|470941551|FG000|Overall Study|serious adverse event (SAE)|0|||
130812660|NCT00680914|470941552|FG001|Overall Study|serious adverse event (SAE)|1|||
130812661|NCT00539500|470941553|FG000|Overall Study|Disease Progression|1|||
130812662|NCT00539500|470941553|FG000|Overall Study|Lost to Follow-up|2|||
130812663|NCT01491919|470941558|FG000|Overall Study|Insufficient PK sampling|1|||
130812664|NCT01491919|470941559|FG001|Overall Study|Insufficient PK sampling|2|||
130812665|NCT01491919|470941560|FG002|Overall Study|Insufficient PK sampling|1|||
130812666|NCT04003389|470941561|FG000|Overall Study|Adverse Event|27|||
130812667|NCT04003389|470941562|FG001|Overall Study|Adverse Event|34|||
130812668|NCT04003389|470941563|FG002|Overall Study|Adverse Event|28|||
130812669|NCT04003389|470941561|FG000|Overall Study|Lost to Follow-up|39|||
130812670|NCT04003389|470941562|FG001|Overall Study|Lost to Follow-up|30|||
130812671|NCT04003389|470941563|FG002|Overall Study|Lost to Follow-up|33|||
130812672|NCT04003389|470941561|FG000|Overall Study|Protocol Violation|1|||
130812673|NCT04003389|470941562|FG001|Overall Study|Protocol Violation|6|||
130812674|NCT04003389|470941563|FG002|Overall Study|Protocol Violation|5|||
130812675|NCT04003389|470941561|FG000|Overall Study|Withdrawal by Subject|119|||
130812676|NCT04003389|470941562|FG001|Overall Study|Withdrawal by Subject|79|||
130812677|NCT04003389|470941563|FG002|Overall Study|Withdrawal by Subject|85|||
130812678|NCT04003389|470941561|FG000|Overall Study|Miscellaneous|14|||
130812679|NCT04003389|470941562|FG001|Overall Study|Miscellaneous|11|||
130812680|NCT04003389|470941563|FG002|Overall Study|Miscellaneous|14|||
130812681|NCT04003389|470941561|FG000|Overall Study|Participant did not receive study drug|1|||
130812682|NCT04003389|470941562|FG001|Overall Study|Participant did not receive study drug|0|||
130812683|NCT04003389|470941563|FG002|Overall Study|Participant did not receive study drug|0|||
130812684|NCT02871219|470941564|FG000|Overall Study|Adverse Event|15|||
130812685|NCT02871219|470941564|FG000|Overall Study|Death|3|||
130812686|NCT02871219|470941564|FG000|Overall Study|Progression|3|||
130812687|NCT02871219|470941564|FG000|Overall Study|Infections|7|||
130812688|NCT02871219|470941564|FG000|Overall Study|Infusion Related|4|||
130812689|NCT05375929|470941572|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
130812690|NCT05375929|470941573|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
130812691|NCT05375929|470941574|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
130812692|NCT05375929|470941575|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
130812693|NCT05375929|470941572|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
130812694|NCT05375929|470941573|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
130812695|NCT05375929|470941574|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130812696|NCT05375929|470941575|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130812697|NCT05375929|470941572|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
130812698|NCT05375929|470941573|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
130812699|NCT05375929|470941574|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
130812700|NCT05375929|470941575|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
130812701|NCT05375929|470941572|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
130812702|NCT05375929|470941573|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
130812703|NCT05375929|470941574|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
130812704|NCT05375929|470941575|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
130812705|NCT05375929|470941572|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
130812706|NCT05375929|470941573|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
130812707|NCT05375929|470941574|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
130812708|NCT05375929|470941575|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
130812709|NCT05375929|470941572|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
130812710|NCT05375929|470941573|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
130812711|NCT05375929|470941574|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
130812712|NCT05375929|470941575|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
130812713|NCT05375929|470941572|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
130812714|NCT05375929|470941573|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
130812715|NCT05375929|470941574|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
130812716|NCT05375929|470941575|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
130812717|NCT05375929|470941572|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
130812718|NCT05375929|470941573|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
130812719|NCT05375929|470941574|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
130812720|NCT05375929|470941575|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
130812721|NCT05375929|470941572|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
130812722|NCT05375929|470941573|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
130812723|NCT05375929|470941574|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
130812724|NCT05375929|470941575|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
130812725|NCT05375929|470941572|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
130812726|NCT05375929|470941573|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
130812727|NCT05375929|470941574|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
130812728|NCT05375929|470941575|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
130812729|NCT00322218|470941582|FG000|Overall Study|Death|3|||
130812730|NCT00322218|470941583|FG001|Overall Study|Death|6|||
130812731|NCT00908141|470941590|FG000|Overall Study|Withdrawal by Subject|0|||
130812732|NCT00908141|470941591|FG001|Overall Study|Withdrawal by Subject|1|||
130812733|NCT02520154|470941592|FG000|Overall Study|Death|1|||
130812734|NCT02520154|470941592|FG000|Overall Study|Withdrawal by Subject|2|||
130812735|NCT02520154|470941592|FG000|Overall Study|Physician Decision|2|||
130812736|NCT03648372|470941593|FG000|Overall Study|Withdrawal by Subject|2|||
130812737|NCT03648372|470941594|FG001|Overall Study|Withdrawal by Subject|0|||
130812738|NCT03648372|470941595|FG002|Overall Study|Withdrawal by Subject|0|||
130812739|NCT03648372|470941596|FG003|Overall Study|Withdrawal by Subject|0|||
130812740|NCT03648372|470941597|FG004|Overall Study|Withdrawal by Subject|0|||
130812741|NCT03648372|470941598|FG005|Overall Study|Withdrawal by Subject|1|||
130812742|NCT03648372|470941599|FG006|Overall Study|Withdrawal by Subject|2|||
130812743|NCT03648372|470941600|FG007|Overall Study|Withdrawal by Subject|0|||
130812744|NCT03648372|470941601|FG008|Overall Study|Withdrawal by Subject|0|||
130812745|NCT03648372|470941602|FG009|Overall Study|Withdrawal by Subject|0|||
130812746|NCT03648372|470941603|FG010|Overall Study|Withdrawal by Subject|2|||
130812747|NCT03648372|470941604|FG011|Overall Study|Withdrawal by Subject|0|||
130812748|NCT03648372|470941605|FG012|Overall Study|Withdrawal by Subject|2|||
130812749|NCT03648372|470941606|FG013|Overall Study|Withdrawal by Subject|0|||
130812750|NCT03648372|470941607|FG014|Overall Study|Withdrawal by Subject|0|||
130812751|NCT03648372|470941608|FG015|Overall Study|Withdrawal by Subject|0|||
130812752|NCT03648372|470941609|FG016|Overall Study|Withdrawal by Subject|1|||
130812753|NCT03648372|470941610|FG017|Overall Study|Withdrawal by Subject|0|||
130812754|NCT03648372|470941611|FG018|Overall Study|Withdrawal by Subject|0|||
130812755|NCT03648372|470941612|FG019|Overall Study|Withdrawal by Subject|0|||
130812756|NCT03648372|470941613|FG020|Overall Study|Withdrawal by Subject|0|||
130812757|NCT03648372|470941593|FG000|Overall Study|Progressive Disease|2|||
130812758|NCT03648372|470941594|FG001|Overall Study|Progressive Disease|3|||
130812759|NCT03648372|470941595|FG002|Overall Study|Progressive Disease|4|||
130812760|NCT03648372|470941596|FG003|Overall Study|Progressive Disease|3|||
130812761|NCT03648372|470941597|FG004|Overall Study|Progressive Disease|2|||
130812762|NCT03648372|470941598|FG005|Overall Study|Progressive Disease|2|||
130812763|NCT03648372|470941599|FG006|Overall Study|Progressive Disease|3|||
130812764|NCT03648372|470941600|FG007|Overall Study|Progressive Disease|3|||
130812765|NCT03648372|470941601|FG008|Overall Study|Progressive Disease|5|||
130812766|NCT03648372|470941602|FG009|Overall Study|Progressive Disease|5|||
130812767|NCT03648372|470941603|FG010|Overall Study|Progressive Disease|2|||
130812768|NCT03648372|470941604|FG011|Overall Study|Progressive Disease|3|||
130812769|NCT03648372|470941605|FG012|Overall Study|Progressive Disease|3|||
130812770|NCT03648372|470941606|FG013|Overall Study|Progressive Disease|3|||
130812771|NCT03648372|470941607|FG014|Overall Study|Progressive Disease|6|||
130812772|NCT03648372|470941608|FG015|Overall Study|Progressive Disease|0|||
130812773|NCT03648372|470941609|FG016|Overall Study|Progressive Disease|0|||
130812774|NCT03648372|470941610|FG017|Overall Study|Progressive Disease|0|||
130812775|NCT03648372|470941611|FG018|Overall Study|Progressive Disease|0|||
130812776|NCT03648372|470941612|FG019|Overall Study|Progressive Disease|0|||
130812777|NCT03648372|470941613|FG020|Overall Study|Progressive Disease|0|||
130812778|NCT03648372|470941593|FG000|Overall Study|Other|0|||
130812779|NCT03648372|470941594|FG001|Overall Study|Other|0|||
130812780|NCT03648372|470941595|FG002|Overall Study|Other|0|||
130812781|NCT03648372|470941596|FG003|Overall Study|Other|0|||
130812782|NCT03648372|470941597|FG004|Overall Study|Other|1|||
130812783|NCT03648372|470941598|FG005|Overall Study|Other|0|||
130812784|NCT03648372|470941599|FG006|Overall Study|Other|0|||
130812785|NCT03648372|470941600|FG007|Overall Study|Other|0|||
130812786|NCT03648372|470941601|FG008|Overall Study|Other|0|||
130812787|NCT03648372|470941602|FG009|Overall Study|Other|0|||
130812788|NCT03648372|470941603|FG010|Overall Study|Other|1|||
130812789|NCT03648372|470941604|FG011|Overall Study|Other|2|||
130812790|NCT03648372|470941605|FG012|Overall Study|Other|1|||
130812791|NCT03648372|470941606|FG013|Overall Study|Other|3|||
130812792|NCT03648372|470941607|FG014|Overall Study|Other|0|||
130812793|NCT03648372|470941608|FG015|Overall Study|Other|5|||
130812794|NCT03648372|470941609|FG016|Overall Study|Other|1|||
130812795|NCT03648372|470941610|FG017|Overall Study|Other|5|||
130812796|NCT03648372|470941611|FG018|Overall Study|Other|0|||
130812797|NCT03648372|470941612|FG019|Overall Study|Other|1|||
130812798|NCT03648372|470941613|FG020|Overall Study|Other|0|||
130812799|NCT03648372|470941593|FG000|Overall Study|Lost to Follow-up|0|||
130812800|NCT03648372|470941594|FG001|Overall Study|Lost to Follow-up|0|||
130812801|NCT03648372|470941595|FG002|Overall Study|Lost to Follow-up|0|||
130812802|NCT03648372|470941596|FG003|Overall Study|Lost to Follow-up|0|||
130812803|NCT03648372|470941597|FG004|Overall Study|Lost to Follow-up|0|||
130812804|NCT03648372|470941598|FG005|Overall Study|Lost to Follow-up|0|||
130812805|NCT03648372|470941599|FG006|Overall Study|Lost to Follow-up|0|||
130812806|NCT03648372|470941600|FG007|Overall Study|Lost to Follow-up|0|||
130812807|NCT03648372|470941601|FG008|Overall Study|Lost to Follow-up|0|||
130812808|NCT03648372|470941602|FG009|Overall Study|Lost to Follow-up|0|||
130812809|NCT03648372|470941603|FG010|Overall Study|Lost to Follow-up|0|||
130812810|NCT03648372|470941604|FG011|Overall Study|Lost to Follow-up|0|||
130812811|NCT03648372|470941605|FG012|Overall Study|Lost to Follow-up|0|||
130812812|NCT03648372|470941606|FG013|Overall Study|Lost to Follow-up|1|||
130812813|NCT03648372|470941607|FG014|Overall Study|Lost to Follow-up|0|||
130812814|NCT03648372|470941608|FG015|Overall Study|Lost to Follow-up|1|||
130812815|NCT03648372|470941609|FG016|Overall Study|Lost to Follow-up|0|||
130812816|NCT03648372|470941610|FG017|Overall Study|Lost to Follow-up|1|||
130812817|NCT03648372|470941611|FG018|Overall Study|Lost to Follow-up|0|||
130812818|NCT03648372|470941612|FG019|Overall Study|Lost to Follow-up|0|||
130812819|NCT03648372|470941613|FG020|Overall Study|Lost to Follow-up|0|||
130812820|NCT03648372|470941593|FG000|Overall Study|Start of a New Systemic Treatment|0|||
130812821|NCT03648372|470941594|FG001|Overall Study|Start of a New Systemic Treatment|0|||
130812822|NCT03648372|470941595|FG002|Overall Study|Start of a New Systemic Treatment|0|||
130812823|NCT03648372|470941596|FG003|Overall Study|Start of a New Systemic Treatment|0|||
130812824|NCT03648372|470941597|FG004|Overall Study|Start of a New Systemic Treatment|0|||
130812825|NCT03648372|470941598|FG005|Overall Study|Start of a New Systemic Treatment|0|||
130812826|NCT03648372|470941599|FG006|Overall Study|Start of a New Systemic Treatment|0|||
130812827|NCT03648372|470941600|FG007|Overall Study|Start of a New Systemic Treatment|2|||
130812828|NCT03648372|470941601|FG008|Overall Study|Start of a New Systemic Treatment|0|||
130812829|NCT03648372|470941602|FG009|Overall Study|Start of a New Systemic Treatment|0|||
130812830|NCT03648372|470941603|FG010|Overall Study|Start of a New Systemic Treatment|1|||
130812831|NCT03648372|470941604|FG011|Overall Study|Start of a New Systemic Treatment|0|||
130812832|NCT03648372|470941605|FG012|Overall Study|Start of a New Systemic Treatment|0|||
130812833|NCT03648372|470941606|FG013|Overall Study|Start of a New Systemic Treatment|0|||
130812834|NCT03648372|470941607|FG014|Overall Study|Start of a New Systemic Treatment|0|||
130812835|NCT03648372|470941608|FG015|Overall Study|Start of a New Systemic Treatment|0|||
130812836|NCT03648372|470941609|FG016|Overall Study|Start of a New Systemic Treatment|0|||
130812837|NCT03648372|470941610|FG017|Overall Study|Start of a New Systemic Treatment|0|||
130812838|NCT03648372|470941611|FG018|Overall Study|Start of a New Systemic Treatment|0|||
130812839|NCT03648372|470941612|FG019|Overall Study|Start of a New Systemic Treatment|0|||
130812840|NCT03648372|470941613|FG020|Overall Study|Start of a New Systemic Treatment|0|||
130812841|NCT03345550|470942816|FG000|Overall Study|Withdrawal by Subject|1|||
130812842|NCT03345550|470942817|FG001|Overall Study|Withdrawal by Subject|0|||
130812843|NCT03345550|470942816|FG000|Overall Study|Lost to Follow-up|4|||
130812844|NCT03345550|470942817|FG001|Overall Study|Lost to Follow-up|5|||
130812845|NCT00959049|470942818|FG000|Overall Study|Adverse Event|1|||
130812846|NCT00959049|470942819|FG001|Overall Study|Adverse Event|0|||
130812847|NCT00959049|470942820|FG002|Overall Study|Adverse Event|0|||
130812848|NCT00959049|470942821|FG003|Overall Study|Adverse Event|0|||
130812849|NCT00959049|470942822|FG004|Overall Study|Adverse Event|0|||
130812850|NCT00959049|470942823|FG005|Overall Study|Adverse Event|0|||
130812851|NCT00959049|470942818|FG000|Overall Study|Lost to Follow-up|17|||
130812852|NCT00959049|470942819|FG001|Overall Study|Lost to Follow-up|5|||
130812853|NCT00959049|470942820|FG002|Overall Study|Lost to Follow-up|1|||
130812854|NCT00959049|470942821|FG003|Overall Study|Lost to Follow-up|10|||
130812855|NCT00959049|470942822|FG004|Overall Study|Lost to Follow-up|9|||
130812856|NCT00959049|470942823|FG005|Overall Study|Lost to Follow-up|1|||
130812857|NCT00959049|470942818|FG000|Overall Study|Contraindicated medication|0|||
130812858|NCT00959049|470942819|FG001|Overall Study|Contraindicated medication|0|||
130812859|NCT00959049|470942820|FG002|Overall Study|Contraindicated medication|0|||
130812860|NCT00959049|470942821|FG003|Overall Study|Contraindicated medication|1|||
130812861|NCT00959049|470942822|FG004|Overall Study|Contraindicated medication|0|||
130812862|NCT00959049|470942823|FG005|Overall Study|Contraindicated medication|0|||
130812863|NCT00959049|470942818|FG000|Overall Study|Withdrawal by Subject|0|||
130812864|NCT00959049|470942819|FG001|Overall Study|Withdrawal by Subject|2|||
130812865|NCT00959049|470942820|FG002|Overall Study|Withdrawal by Subject|0|||
130812866|NCT00959049|470942821|FG003|Overall Study|Withdrawal by Subject|0|||
130812867|NCT00959049|470942822|FG004|Overall Study|Withdrawal by Subject|0|||
130812868|NCT00959049|470942823|FG005|Overall Study|Withdrawal by Subject|0|||
130812869|NCT00137449|470942824|FG000|Overall Study|Disease Progression|8|||
130812870|NCT00137449|470942825|FG001|Overall Study|Disease Progression|13|||
130812871|NCT00137449|470942824|FG000|Overall Study|Death|4|||
130812872|NCT00137449|470942825|FG001|Overall Study|Death|3|||
130812873|NCT00137449|470942824|FG000|Overall Study|Adverse Event|3|||
130812874|NCT00137449|470942825|FG001|Overall Study|Adverse Event|1|||
130812875|NCT00137449|470942824|FG000|Overall Study|Withdrawal by Subject|1|||
130812876|NCT00137449|470942825|FG001|Overall Study|Withdrawal by Subject|1|||
130812877|NCT02489279|470942826|FG000|Overall Study|Lost to Follow-up|12|||
130812878|NCT02489279|470942827|FG001|Overall Study|Lost to Follow-up|10|||
130812879|NCT02263547|470942828|FG000|Overall Study|Adverse Event|1|||
130812880|NCT02263547|470942828|FG000|Overall Study|Lost to Follow-up|2|||
130812881|NCT00586157|470942829|FG000|First Intervention|Worsening behavior|1|||
130812882|NCT00586157|470942830|FG001|First Intervention|Worsening behavior|0|||
130812883|NCT00586157|470942829|FG000|Second Intervention|Withdrawal by Subject|1|||
130812884|NCT00586157|470942830|FG001|Second Intervention|Withdrawal by Subject|0|||
130812885|NCT00586157|470942829|FG000|Second Intervention|Worsening behavior|1|||
130812886|NCT00586157|470942830|FG001|Second Intervention|Worsening behavior|0|||
130812887|NCT00586157|470942829|FG000|Second Intervention|Adverse Event|0|||
130812888|NCT00586157|470942830|FG001|Second Intervention|Adverse Event|1|||
130812889|NCT02378480|470942832|FG000|Overall Study|Physician Decision|1|||
130812890|NCT02378480|470942833|FG001|Overall Study|Physician Decision|1|||
130812891|NCT02378480|470942832|FG000|Overall Study|Death|1|||
130812892|NCT02378480|470942833|FG001|Overall Study|Death|2|||
130812893|NCT02378480|470942832|FG000|Overall Study|Randomized, but Not Treated|6|||
130812894|NCT02378480|470942833|FG001|Overall Study|Randomized, but Not Treated|4|||
130812895|NCT02378480|470942832|FG000|Overall Study|Adverse Event|0|||
130812896|NCT02378480|470942833|FG001|Overall Study|Adverse Event|1|||
130812897|NCT02378480|470942832|FG000|Overall Study|Missed EOT/PTE Visit|1|||
130812898|NCT02378480|470942833|FG001|Overall Study|Missed EOT/PTE Visit|2|||
130812899|NCT02378480|470942832|FG000|Overall Study|Withdrawal by Subject|9|||
130812900|NCT02378480|470942833|FG001|Overall Study|Withdrawal by Subject|4|||
130812901|NCT02378480|470942832|FG000|Overall Study|Lost to Follow-up|10|||
130812902|NCT02378480|470942833|FG001|Overall Study|Lost to Follow-up|18|||
130812903|NCT02014467|470942837|FG000|Overall Study|Adverse Event|4|||
130812904|NCT02014467|470942838|FG001|Overall Study|Adverse Event|0|||
130812905|NCT02014467|470942837|FG000|Overall Study|Protocol Violation|3|||
130812906|NCT02014467|470942838|FG001|Overall Study|Protocol Violation|0|||
130812907|NCT02014467|470942837|FG000|Overall Study|Physician Decision|2|||
130812908|NCT02014467|470942838|FG001|Overall Study|Physician Decision|3|||
130812909|NCT02014467|470942837|FG000|Overall Study|Withdrawal by Subject|16|||
130812910|NCT02014467|470942838|FG001|Overall Study|Withdrawal by Subject|4|||
130812911|NCT01230060|470942839|FG000|Overall Study|Withdrawal by Subject|1|||
130812912|NCT01217892|470942841|FG000|Overall Study|Adverse Event|1|||
130812913|NCT01217892|470942842|FG001|Overall Study|Adverse Event|1|||
130812914|NCT01217892|470942843|FG002|Overall Study|Adverse Event|1|||
130812915|NCT01217892|470942844|FG003|Overall Study|Adverse Event|0|||
130812916|NCT01217892|470942841|FG000|Overall Study|Withdrawal by Subject|0|||
130812917|NCT01217892|470942842|FG001|Overall Study|Withdrawal by Subject|2|||
130812918|NCT01217892|470942843|FG002|Overall Study|Withdrawal by Subject|1|||
130812919|NCT01217892|470942844|FG003|Overall Study|Withdrawal by Subject|0|||
130812920|NCT01217892|470942841|FG000|Overall Study|Lab value|1|||
130812921|NCT01217892|470942842|FG001|Overall Study|Lab value|0|||
130812922|NCT01217892|470942843|FG002|Overall Study|Lab value|1|||
130812923|NCT01217892|470942844|FG003|Overall Study|Lab value|0|||
130812924|NCT01217892|470942841|FG000|Overall Study|Subject no longer meets study criteria|5|||
130812925|NCT01217892|470942842|FG001|Overall Study|Subject no longer meets study criteria|2|||
130812926|NCT01217892|470942843|FG002|Overall Study|Subject no longer meets study criteria|4|||
130812927|NCT01217892|470942844|FG003|Overall Study|Subject no longer meets study criteria|8|||
130812928|NCT01217892|470942841|FG000|Overall Study|Incorrect enrollment|0|||
130812929|NCT01217892|470942842|FG001|Overall Study|Incorrect enrollment|1|||
130812930|NCT01217892|470942843|FG002|Overall Study|Incorrect enrollment|1|||
130812931|NCT01217892|470942844|FG003|Overall Study|Incorrect enrollment|0|||
130812932|NCT01217892|470942841|FG000|Overall Study|Poor/Non-Compliance|0|||
130812933|NCT01217892|470942842|FG001|Overall Study|Poor/Non-Compliance|0|||
130812934|NCT01217892|470942843|FG002|Overall Study|Poor/Non-Compliance|1|||
130812935|NCT01217892|470942844|FG003|Overall Study|Poor/Non-Compliance|0|||
130812936|NCT01052779|470942845|FG000|Overall Study|Adverse Event|1|||
130812937|NCT01052779|470942846|FG001|Overall Study|Adverse Event|4|||
130812938|NCT01052779|470942845|FG000|Overall Study|Withdrawal by Subject|1|||
130812939|NCT01052779|470942846|FG001|Overall Study|Withdrawal by Subject|2|||
130812940|NCT01052779|470942845|FG000|Overall Study|Other-Protocol Violation|1|||
130812941|NCT01052779|470942846|FG001|Overall Study|Other-Protocol Violation|1|||
130812942|NCT01052779|470942845|FG000|Overall Study|Other-Surgery|0|||
130812943|NCT01052779|470942846|FG001|Overall Study|Other-Surgery|2|||
130812944|NCT01052779|470942845|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
130812945|NCT01052779|470942846|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
130812946|NCT03802916|470942847|FG000|Overall Study|Adverse Event|0|||
130812947|NCT03802916|470942848|FG001|Overall Study|Adverse Event|1|||
130812948|NCT03802916|470942847|FG000|Overall Study|Withdrawal by Subject|0|||
130812949|NCT03802916|470942848|FG001|Overall Study|Withdrawal by Subject|1|||
130812950|NCT03663582|470942849|FG000|Overall Study|Physician Decision|1|||
130812951|NCT04507763|470942852|FG000|Overall Study|Participants did not meet entrance criteria|201|||
130812952|NCT05763381|470942853|FG000|Overall Study|Lost to Follow-up|2|||
130812953|NCT05763381|470942854|FG001|Overall Study|Lost to Follow-up|3|||
130812954|NCT05763381|470942853|FG000|Overall Study|Withdrawal by Subject|1|||
130812955|NCT05763381|470942854|FG001|Overall Study|Withdrawal by Subject|2|||
130812956|NCT02853136|470942855|FG000|Wash-out|Adverse Event|0|||
130812957|NCT02853136|470942856|FG001|Wash-out|Adverse Event|0|||
130812958|NCT02853136|470942857|FG002|Wash-out|Adverse Event|0|||
130812959|NCT02853136|470942858|FG003|Wash-out|Adverse Event|1|||
130812960|NCT00841815|470942859|FG000|Washout|Withdrawal by Subject|0|||
130812961|NCT00841815|470942860|FG001|Washout|Withdrawal by Subject|1|||
130812962|NCT00867334|470942862|FG000|Overall Study|Withdrawal by Subject|0|||
130812963|NCT00867334|470942863|FG001|Overall Study|Withdrawal by Subject|1|||
130812964|NCT00867334|470942862|FG000|Overall Study|Withdrawal by Subject|1|||
130812965|NCT00867334|470942863|FG001|Overall Study|Withdrawal by Subject|0|||
130812966|NCT00867334|470942862|FG000|Overall Study|Withdrawal by Subject|1|||
130812967|NCT00867334|470942863|FG001|Overall Study|Withdrawal by Subject|0|||
130812968|NCT03787615|470942864|FG000|Overall Study|Withdrawal by Subject|2|||
130812969|NCT03787615|470942864|FG000|Overall Study|Lost to Follow-up|2|||
130812970|NCT02697448|470942865|FG000|Overall Study|Protocol Violation|2|||
130812971|NCT02697448|470942866|FG001|Overall Study|Protocol Violation|4|||
130812972|NCT02697448|470942865|FG000|Overall Study|Clinical concerns during ablation|1|||
130812973|NCT02697448|470942866|FG001|Overall Study|Clinical concerns during ablation|1|||
130812974|NCT02697448|470942865|FG000|Overall Study|No data collected|2|||
130812975|NCT02697448|470942866|FG001|Overall Study|No data collected|0|||
130812976|NCT03464461|470942867|FG000|Overall Study|exclusionary medication given ,|1|||
130812977|NCT03464461|470942868|FG001|Overall Study|exclusionary medication given ,|2|||
130812978|NCT03464461|470942869|FG002|Overall Study|exclusionary medication given ,|0|||
130812979|NCT03464461|470942867|FG000|Overall Study|Physician Decision|0|||
130812980|NCT03464461|470942868|FG001|Overall Study|Physician Decision|1|||
130812981|NCT03464461|470942869|FG002|Overall Study|Physician Decision|0|||
130812982|NCT03685149|470942871|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
130812983|NCT03685149|470942872|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
130812984|NCT03685149|470942871|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130812985|NCT03685149|470942872|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130812986|NCT03685149|470942871|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
130812987|NCT03685149|470942872|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
130813002|NCT00209131|470942881|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
130813003|NCT00209131|470942882|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
130813004|NCT05360784|470942883|FG000|Overall Study|Discontinued|25|||
130813005|NCT05360784|470942884|FG001|Overall Study|Discontinued|11|||
130813006|NCT05142306|470942888|FG000|Overall Study|Withdrawal by Subject|0|||
130813007|NCT05142306|470942889|FG001|Overall Study|Withdrawal by Subject|0|||
130813008|NCT05142306|470942890|FG002|Overall Study|Withdrawal by Subject|1|||
130813009|NCT02251041|470942891|FG000|Overall Study|Did not receive intervention|15|||
130813010|NCT02251041|470942892|FG001|Overall Study|Did not receive intervention|4|||
130813011|NCT04079920|470942893|FG000|Overall Study|Adverse event, not related to study drug|2|||
130813012|NCT04079920|470942893|FG000|Overall Study|Adverse event related to study drug|10|||
130813013|NCT04079920|470942893|FG000|Overall Study|Death|2|||
130813014|NCT04079920|470942893|FG000|Overall Study|Lost to Follow-up|22|||
130813015|NCT04079920|470942893|FG000|Overall Study|Physician Decision|1|||
130813016|NCT04079920|470942893|FG000|Overall Study|Withdrawal by Subject|11|||
130813017|NCT04918771|470942894|FG000|Overall Study|Withdrawal by Subject|4|||
130813018|NCT04918771|470942895|FG001|Overall Study|Withdrawal by Subject|5|||
130813019|NCT04918771|470942894|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
130813020|NCT04918771|470942895|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
130813021|NCT01299961|470942902|FG000|Overall Study|Adverse Event|3|||
130813022|NCT01299961|470942902|FG000|Overall Study|Lack of Efficacy|2|||
130813023|NCT01299961|470942902|FG000|Overall Study|Lost to Follow-up|1|||
130813024|NCT02904096|470942903|FG000|Overall Study|Adverse Event|1|||
130813025|NCT02904096|470942904|FG001|Overall Study|Adverse Event|0|||
130813026|NCT02904096|470942903|FG000|Overall Study|Withdrawal by Subject|4|||
130813027|NCT02904096|470942904|FG001|Overall Study|Withdrawal by Subject|3|||
130813028|NCT02904096|470942903|FG000|Overall Study|Lost to Follow-up|10|||
130813029|NCT02904096|470942904|FG001|Overall Study|Lost to Follow-up|17|||
130813030|NCT02904096|470942903|FG000|Overall Study|Non-compliant|3|||
130813031|NCT02904096|470942904|FG001|Overall Study|Non-compliant|1|||
130813032|NCT02904096|470942903|FG000|Overall Study|Sponsor instructed|1|||
130813033|NCT02904096|470942904|FG001|Overall Study|Sponsor instructed|0|||
130813034|NCT05305651|470942905|FG000|Overall Study|Death|1|||
130813035|NCT05305651|470942905|FG000|Overall Study|Withdrawal by Subject|4|||
130813036|NCT05305651|470942905|FG000|Overall Study|Lost to Follow-up|4|||
130813037|NCT00526799|470942906|FG000|Overall Study|Withdrawal by Subject|1|||
130813038|NCT00526799|470942907|FG001|Overall Study|Withdrawal by Subject|0|||
130813039|NCT00526799|470942906|FG000|Overall Study|Intercurrent Complicating Disease|0|||
130813040|NCT00526799|470942907|FG001|Overall Study|Intercurrent Complicating Disease|1|||
130813041|NCT00967499|470942908|FG000|Overall Study|Adverse Event|0|||
130813042|NCT00967499|470942909|FG001|Overall Study|Adverse Event|1|||
130813043|NCT00967499|470942908|FG000|Overall Study|Protocol Violation|1|||
130813044|NCT00967499|470942909|FG001|Overall Study|Protocol Violation|0|||
130813045|NCT00967499|470942908|FG000|Overall Study|Sponsor Decision|1|||
130813046|NCT00967499|470942909|FG001|Overall Study|Sponsor Decision|0|||
130813047|NCT00967499|470942908|FG000|Overall Study|Randomized but not treated|63|||
130813048|NCT00967499|470942909|FG001|Overall Study|Randomized but not treated|59|||
130813049|NCT02298946|470942911|FG000|Overall Study|Did not receive treatment|2|||
130813050|NCT02298946|470942912|FG001|Overall Study|Did not receive treatment|0|||
130813051|NCT02298946|470942911|FG000|Overall Study|Unevaluable|2|||
130813052|NCT02298946|470942912|FG001|Overall Study|Unevaluable|1|||
130813053|NCT05535972|470942913|FG000|Overall Study|Withdrawal by Subject|31|||
130813054|NCT05535972|470942913|FG000|Overall Study|Lost to Follow-up|5|||
130813055|NCT05535972|470942913|FG000|Overall Study|Adverse Event|6|||
130813056|NCT05535972|470942913|FG000|Overall Study|Protocol Deviation|2|||
130813057|NCT04629196|470942917|FG000|Overall Study|Subject discontinued study drug|1|||
130813058|NCT04629196|470942918|FG001|Overall Study|Subject discontinued study drug|0|||
130813059|NCT04629196|470942917|FG000|Overall Study|Subject study drug dosing increased|1|||
130813060|NCT04629196|470942918|FG001|Overall Study|Subject study drug dosing increased|1|||
130813061|NCT04629196|470942917|FG000|Overall Study|Withdrawal by Subject|1|||
130813062|NCT04629196|470942918|FG001|Overall Study|Withdrawal by Subject|2|||
130813063|NCT01450631|470942922|FG000|Overall Study|Lost to Follow-up|2|||
130813064|NCT01450631|470942923|FG001|Overall Study|Lost to Follow-up|4|||
130813065|NCT01450631|470942922|FG000|Overall Study|Withdrawal by Subject|1|||
130813066|NCT01450631|470942923|FG001|Overall Study|Withdrawal by Subject|0|||
130813067|NCT00835354|470942924|FG000|First Intervention|Adverse Event|0|||
130813068|NCT00835354|470942925|FG001|First Intervention|Adverse Event|1|||
130813069|NCT03204812|470942926|FG000|Overall Study|Adverse Event|3|||
130813070|NCT01385995|470942927|FG000|Period 1, 2 Months|Physician Decision|1|||
130813071|NCT01385995|470942928|FG001|Period 1, 2 Months|Physician Decision|0|||
130813072|NCT00112385|470942929|FG000|Overall Study|Lost to Follow-up|1|||
130813073|NCT00112385|470942930|FG001|Overall Study|Lost to Follow-up|0|||
130813074|NCT00112385|470942929|FG000|Overall Study|Withdrawal by Subject|0|||
130813075|NCT00112385|470942930|FG001|Overall Study|Withdrawal by Subject|1|||
130813076|NCT03514134|470944420|FG000|Overall Study|Lost to Follow-up|0|||
130813077|NCT03514134|470944421|FG001|Overall Study|Lost to Follow-up|1|||
130813078|NCT02471144|470944422|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
130813079|NCT02471144|470944423|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
130813080|NCT02471144|470944424|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
130813081|NCT02471144|470944425|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
130813082|NCT02471144|470944426|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
130813083|NCT02471144|470944427|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
130813084|NCT02471144|470944428|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
130813085|NCT02471144|470944429|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
130813086|NCT02471144|470944430|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
130813087|NCT02471144|470944431|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
130813088|NCT02471144|470944432|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
130813089|NCT02471144|470944422|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130813090|NCT02471144|470944423|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130813091|NCT02471144|470944424|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130813092|NCT02471144|470944425|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
130813093|NCT02471144|470944426|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130813094|NCT02471144|470944427|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130813095|NCT02471144|470944428|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130813096|NCT02471144|470944429|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130813097|NCT02471144|470944430|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130813098|NCT02471144|470944431|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130813099|NCT02471144|470944432|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130813100|NCT02471144|470944422|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130813101|NCT02471144|470944423|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130813102|NCT02471144|470944424|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
130813103|NCT02471144|470944425|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130813104|NCT02471144|470944426|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130813105|NCT02471144|470944427|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130813106|NCT02471144|470944428|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130813107|NCT02471144|470944429|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130813108|NCT02471144|470944430|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130813109|NCT02471144|470944431|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130813110|NCT02471144|470944432|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130813111|NCT02471144|470944422|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
130813112|NCT02471144|470944423|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
130813113|NCT02471144|470944424|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130813114|NCT02471144|470944425|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130813115|NCT02471144|470944426|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130813116|NCT02471144|470944427|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130813117|NCT02471144|470944428|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130813118|NCT02471144|470944429|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130813119|NCT02471144|470944430|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130813120|NCT02471144|470944431|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130813121|NCT02471144|470944432|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130813122|NCT02471144|470944422|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130813123|NCT02471144|470944423|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130813124|NCT02471144|470944424|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130813125|NCT02471144|470944425|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130813126|NCT02471144|470944426|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
130813127|NCT02471144|470944427|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130813128|NCT02471144|470944428|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
130813129|NCT02471144|470944429|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130813130|NCT02471144|470944430|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
130813131|NCT02471144|470944431|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130813132|NCT02471144|470944432|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130813133|NCT02471144|470944422|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130813134|NCT02471144|470944423|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130813135|NCT02471144|470944424|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130813136|NCT02471144|470944425|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130813137|NCT02471144|470944426|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130813138|NCT02471144|470944427|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
130813139|NCT02471144|470944428|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130813140|NCT02471144|470944429|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130813141|NCT02471144|470944430|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
130813142|NCT02471144|470944431|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130813143|NCT02471144|470944432|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130813144|NCT02471144|470944422|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130813145|NCT02471144|470944423|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130813146|NCT02471144|470944424|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130813147|NCT02471144|470944425|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130813148|NCT02471144|470944426|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130813149|NCT02471144|470944427|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130813150|NCT02471144|470944428|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130813151|NCT02471144|470944429|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130813152|NCT02471144|470944430|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
130813153|NCT02471144|470944431|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130813154|NCT02471144|470944432|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130813155|NCT02471144|470944422|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130813156|NCT02471144|470944423|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130813157|NCT02471144|470944424|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130813158|NCT02471144|470944425|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130813159|NCT02471144|470944426|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130813160|NCT02471144|470944427|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130813161|NCT02471144|470944428|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130813162|NCT02471144|470944429|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
130813163|NCT02471144|470944430|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
130813164|NCT02471144|470944431|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130813165|NCT02471144|470944432|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130813166|NCT02471144|470944422|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130813167|NCT02471144|470944423|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130813168|NCT02471144|470944424|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130813169|NCT02471144|470944425|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130813170|NCT02471144|470944426|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130813171|NCT02471144|470944427|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130813172|NCT02471144|470944428|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130813173|NCT02471144|470944429|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130813174|NCT02471144|470944430|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130813175|NCT02471144|470944431|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
130813176|NCT02471144|470944432|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
130813177|NCT02471144|470944422|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130813178|NCT02471144|470944423|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130813179|NCT02471144|470944424|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130813180|NCT02471144|470944425|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130813181|NCT02471144|470944426|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130813182|NCT02471144|470944427|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130813183|NCT02471144|470944428|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130813184|NCT02471144|470944429|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130813185|NCT02471144|470944430|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130813186|NCT02471144|470944431|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
130813187|NCT02471144|470944432|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130813188|NCT02471144|470944422|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130813189|NCT02471144|470944423|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130813190|NCT02471144|470944424|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130813191|NCT02471144|470944425|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130813192|NCT02471144|470944426|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130813193|NCT02471144|470944427|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130813194|NCT02471144|470944428|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130813195|NCT02471144|470944429|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130813196|NCT02471144|470944430|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130813197|NCT02471144|470944431|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130813198|NCT02471144|470944432|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
130813199|NCT02471144|470944422|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130813200|NCT02471144|470944423|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130813201|NCT02471144|470944424|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130813202|NCT02471144|470944425|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130813203|NCT02471144|470944426|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130813204|NCT02471144|470944427|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130813205|NCT02471144|470944428|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130813206|NCT02471144|470944429|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130813207|NCT02471144|470944430|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130813208|NCT02471144|470944431|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
130813209|NCT02471144|470944432|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
130813210|NCT02471144|470944422|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130813211|NCT02471144|470944423|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130813212|NCT02471144|470944424|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130813213|NCT02471144|470944425|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130813214|NCT02471144|470944426|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130813215|NCT02471144|470944427|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130813216|NCT02471144|470944428|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130813217|NCT02471144|470944429|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130813218|NCT02471144|470944430|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130813219|NCT02471144|470944431|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
130813220|NCT02471144|470944432|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130813221|NCT02471144|470944422|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130813222|NCT02471144|470944423|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130813223|NCT02471144|470944424|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130813224|NCT02471144|470944425|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130813225|NCT02471144|470944426|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130813226|NCT02471144|470944427|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130813227|NCT02471144|470944428|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130813228|NCT02471144|470944429|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130813229|NCT02471144|470944430|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130813230|NCT02471144|470944431|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
130813231|NCT02471144|470944432|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
130813232|NCT00003645|470944433|FG000|Overall Study|Death|4|||
130813233|NCT00003645|470944434|FG001|Overall Study|Death|1|||
130813234|NCT00003645|470944433|FG000|Overall Study|Lost to Follow-up|7|||
130813235|NCT00003645|470944434|FG001|Overall Study|Lost to Follow-up|8|||
130813236|NCT00003645|470944433|FG000|Overall Study|Withdrawal by Subject|1|||
130813237|NCT00003645|470944434|FG001|Overall Study|Withdrawal by Subject|3|||
130813238|NCT03768336|470944437|FG000|Overall Study|Lost to Follow-up|3|||
130813239|NCT03768336|470944438|FG001|Overall Study|Lost to Follow-up|2|||
130813240|NCT03768336|470944437|FG000|Overall Study|Became Ineligible|2|||
130813241|NCT03768336|470944438|FG001|Overall Study|Became Ineligible|0|||
130813242|NCT03768336|470944437|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
130813243|NCT03768336|470944438|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
130813244|NCT03768336|470944437|FG000|Overall Study|Missed final survey (post-treatment|0|||
130813245|NCT03768336|470944438|FG001|Overall Study|Missed final survey (post-treatment|1|||
130813246|NCT05654181|470944439|FG000|Overall Study|Adverse Event|1|||
130813247|NCT05654181|470944440|FG001|Overall Study|Adverse Event|0|||
130813248|NCT05654181|470944441|FG002|Overall Study|Adverse Event|0|||
130813249|NCT05654181|470944442|FG003|Overall Study|Adverse Event|0|||
130813250|NCT05654181|470944443|FG004|Overall Study|Adverse Event|0|||
130813251|NCT05654181|470944444|FG005|Overall Study|Adverse Event|0|||
130813252|NCT05654181|470944445|FG006|Overall Study|Adverse Event|0|||
130813253|NCT05654181|470944446|FG007|Overall Study|Adverse Event|1|||
130813254|NCT05654181|470944447|FG008|Overall Study|Adverse Event|0|||
130813255|NCT05654181|470944448|FG009|Overall Study|Adverse Event|0|||
130813256|NCT05654181|470944439|FG000|Overall Study|Withdrawal by Subject|0|||
130813257|NCT05654181|470944440|FG001|Overall Study|Withdrawal by Subject|0|||
130813258|NCT05654181|470944441|FG002|Overall Study|Withdrawal by Subject|0|||
130813259|NCT05654181|470944442|FG003|Overall Study|Withdrawal by Subject|0|||
130813260|NCT05654181|470944443|FG004|Overall Study|Withdrawal by Subject|0|||
130813261|NCT05654181|470944444|FG005|Overall Study|Withdrawal by Subject|0|||
130813262|NCT05654181|470944445|FG006|Overall Study|Withdrawal by Subject|0|||
130813263|NCT05654181|470944446|FG007|Overall Study|Withdrawal by Subject|1|||
130813264|NCT05654181|470944447|FG008|Overall Study|Withdrawal by Subject|0|||
130813265|NCT05654181|470944448|FG009|Overall Study|Withdrawal by Subject|0|||
130813266|NCT05654181|470944439|FG000|Overall Study|Other|0|||
130813267|NCT05654181|470944440|FG001|Overall Study|Other|0|||
130813268|NCT05654181|470944441|FG002|Overall Study|Other|0|||
130813269|NCT05654181|470944442|FG003|Overall Study|Other|0|||
130813270|NCT05654181|470944443|FG004|Overall Study|Other|1|||
130813271|NCT05654181|470944444|FG005|Overall Study|Other|1|||
130813272|NCT05654181|470944445|FG006|Overall Study|Other|0|||
130813273|NCT05654181|470944446|FG007|Overall Study|Other|0|||
130813274|NCT05654181|470944447|FG008|Overall Study|Other|0|||
130813275|NCT05654181|470944448|FG009|Overall Study|Other|0|||
130813276|NCT04101331|470944449|FG000|Overall Study|Adverse Event|9|||
130813277|NCT04101331|470944449|FG000|Overall Study|Disease progression|82|||
130813278|NCT04101331|470944449|FG000|Overall Study|Withdrawal by Subject|1|||
130813279|NCT04101331|470944449|FG000|Overall Study|Investigator decision|6|||
130813280|NCT04101331|470944449|FG000|Overall Study|Death|6|||
130813281|NCT04101331|470944449|FG000|Overall Study|Allogenic transplant|1|||
130813282|NCT03977155|470944450|FG000|Overall Study|Adverse Event|3|||
130813283|NCT03977155|470944451|FG001|Overall Study|Adverse Event|0|||
130813284|NCT03977155|470944452|FG002|Overall Study|Adverse Event|0|||
130813285|NCT03977155|470944450|FG000|Overall Study|Lost to Follow-up|0|||
130813286|NCT03977155|470944451|FG001|Overall Study|Lost to Follow-up|1|||
130813287|NCT03977155|470944452|FG002|Overall Study|Lost to Follow-up|0|||
130813288|NCT03977155|470944450|FG000|Overall Study|Withdrawal by Subject|1|||
130813289|NCT03977155|470944451|FG001|Overall Study|Withdrawal by Subject|1|||
130813290|NCT03977155|470944452|FG002|Overall Study|Withdrawal by Subject|2|||
130813291|NCT03977155|470944450|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
130813292|NCT03977155|470944451|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
130813293|NCT03977155|470944452|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
130813294|NCT04110145|470944453|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130813295|NCT04110145|470944454|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130813296|NCT04110145|470944455|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130813297|NCT04110145|470944456|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
130813298|NCT04110145|470944457|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130813299|NCT03502681|470944460|FG000|Overall Study|Adverse Event|1|||
130813300|NCT03502681|470944461|FG001|Overall Study|Adverse Event|1|||
130813301|NCT03502681|470944460|FG000|Overall Study|Disease Progression|2|||
130813302|NCT03502681|470944461|FG001|Overall Study|Disease Progression|1|||
130813303|NCT01444781|470944462|FG000|Overall Study|Lost to Follow-up|0|||
130813304|NCT01444781|470944463|FG001|Overall Study|Lost to Follow-up|3|||
130813305|NCT01444781|470944464|FG002|Overall Study|Lost to Follow-up|1|||
130813306|NCT01444781|470944462|FG000|Overall Study|Withdrawal by Subject|3|||
130813307|NCT01444781|470944463|FG001|Overall Study|Withdrawal by Subject|1|||
130813308|NCT01444781|470944464|FG002|Overall Study|Withdrawal by Subject|2|||
130813309|NCT06790303|470944465|FG000|Overall Study|Study Terminated by sponsor|4|||
130813310|NCT06790303|470944465|FG000|Overall Study|Death|4|||
130813311|NCT00321932|470944478|FG000|Overall Study|Death|3|||
130813312|NCT00321932|470944479|FG001|Overall Study|Death|6|||
130813313|NCT00321932|470944478|FG000|Overall Study|Withdrawal by Subject|3|||
130813314|NCT00321932|470944479|FG001|Overall Study|Withdrawal by Subject|6|||
130813315|NCT00321932|470944478|FG000|Overall Study|Early relapse|2|||
130813316|NCT00321932|470944479|FG001|Overall Study|Early relapse|8|||
130813317|NCT00321932|470944478|FG000|Overall Study|Missing data|2|||
130813318|NCT00321932|470944479|FG001|Overall Study|Missing data|1|||
130813319|NCT03360344|470944482|FG000|Overall Study|Withdrawal by Subject|0|||
130813320|NCT03360344|470944483|FG001|Overall Study|Withdrawal by Subject|1|||
130813321|NCT03360344|470944484|FG002|Overall Study|Withdrawal by Subject|1|||
130813322|NCT03257657|470944489|FG000|Overall Study|Lost to Follow-up|0|||
130813323|NCT03257657|470944490|FG001|Overall Study|Lost to Follow-up|3|||
130813324|NCT03257657|470944489|FG000|Overall Study|Withdrawn|0|||
130813325|NCT03257657|470944490|FG001|Overall Study|Withdrawn|1|||
130813326|NCT03257657|470944489|FG000|Overall Study|Noted not eligible right after enrolled|0|||
130813327|NCT03257657|470944490|FG001|Overall Study|Noted not eligible right after enrolled|1|||
130813328|NCT00567502|470944505|FG000|Overall Study|Lost to Follow-up|91|||
130813329|NCT00567502|470944506|FG001|Overall Study|Lost to Follow-up|14|||
130813330|NCT00567502|470944507|FG002|Overall Study|Lost to Follow-up|351|||
130813331|NCT00567502|470944508|FG003|Overall Study|Lost to Follow-up|2|||
130813332|NCT00567502|470944505|FG000|Overall Study|Death|65|||
130813333|NCT00567502|470944506|FG001|Overall Study|Death|16|||
130813334|NCT00567502|470944507|FG002|Overall Study|Death|360|||
130813335|NCT00567502|470944508|FG003|Overall Study|Death|5|||
130813336|NCT00567502|470944505|FG000|Overall Study|Other|64|||
130813337|NCT00567502|470944506|FG001|Overall Study|Other|2|||
130813338|NCT00567502|470944507|FG002|Overall Study|Other|134|||
130813339|NCT00567502|470944508|FG003|Overall Study|Other|6|||
130813340|NCT00567502|470944505|FG000|Overall Study|Participant request|12|||
130813341|NCT00567502|470944506|FG001|Overall Study|Participant request|1|||
130813342|NCT00567502|470944507|FG002|Overall Study|Participant request|33|||
130813343|NCT00567502|470944508|FG003|Overall Study|Participant request|1|||
130813344|NCT00567502|470944505|FG000|Overall Study|Sponsor request|9|||
130813345|NCT00567502|470944506|FG001|Overall Study|Sponsor request|0|||
130813346|NCT00567502|470944507|FG002|Overall Study|Sponsor request|30|||
130813347|NCT00567502|470944508|FG003|Overall Study|Sponsor request|1|||
130813348|NCT00567502|470944505|FG000|Overall Study|Never Initiated Treatment|0|||
130813349|NCT00567502|470944506|FG001|Overall Study|Never Initiated Treatment|0|||
130813350|NCT00567502|470944507|FG002|Overall Study|Never Initiated Treatment|0|||
130813351|NCT00567502|470944508|FG003|Overall Study|Never Initiated Treatment|72|||
130813352|NCT00337168|470944509|FG000|Overall Study|Death|5|||
130813353|NCT00337168|470944509|FG000|Overall Study|Not protocol specified|2|||
130813354|NCT00337168|470944509|FG000|Overall Study|Did not start therapy|1|||
130813355|NCT03283241|470944510|FG000|Overall Study|Adverse Event|4|||
130813356|NCT03283241|470944511|FG001|Overall Study|Adverse Event|1|||
130813357|NCT03283241|470944510|FG000|Overall Study|Withdrawal by Subject|0|||
130813358|NCT03283241|470944511|FG001|Overall Study|Withdrawal by Subject|1|||
130813359|NCT03283241|470944510|FG000|Overall Study|Subject relocated to Finland|0|||
130813360|NCT03283241|470944511|FG001|Overall Study|Subject relocated to Finland|1|||
130813361|NCT00666263|470944514|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
130813362|NCT00666263|470944515|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
130813363|NCT00666263|470944514|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
130813364|NCT00666263|470944515|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
130813365|NCT00666263|470944514|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
130813366|NCT00666263|470944515|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
130813367|NCT01225952|470944516|FG000|Overall Study|Lost to Follow-up|1|||
130813368|NCT01225952|470944517|FG001|Overall Study|Lost to Follow-up|0|||
130813369|NCT01225952|470944518|FG002|Overall Study|Lost to Follow-up|0|||
130813370|NCT01225952|470944516|FG000|Overall Study|Study Eye Explanted|0|||
130813371|NCT01225952|470944517|FG001|Overall Study|Study Eye Explanted|0|||
130813372|NCT01225952|470944518|FG002|Overall Study|Study Eye Explanted|1|||
130813373|NCT01225952|470944516|FG000|Overall Study|Withdrawal by Subject|4|||
130813374|NCT01225952|470944517|FG001|Overall Study|Withdrawal by Subject|4|||
130813375|NCT01225952|470944518|FG002|Overall Study|Withdrawal by Subject|5|||
130813376|NCT01225952|470944516|FG000|Overall Study|Surgical complications|1|||
130813377|NCT01225952|470944517|FG001|Overall Study|Surgical complications|0|||
130813378|NCT01225952|470944518|FG002|Overall Study|Surgical complications|0|||
130813379|NCT01285102|470944520|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
130813380|NCT01905540|470944530|FG000|Period 3|Other|1|||
130813381|NCT01905540|470944531|FG001|Period 3|Other|0|||
130813382|NCT01905540|470944532|FG002|Period 3|Other|1|||
130813383|NCT01905540|470944533|FG003|Period 3|Other|1|||
130813384|NCT02367885|470944534|FG000|Overall Study|Lost to Follow-up|1|||
130813385|NCT02367885|470944535|FG001|Overall Study|Lost to Follow-up|0|||
130813386|NCT02367885|470944536|FG002|Overall Study|Lost to Follow-up|0|||
130813387|NCT02367885|470944534|FG000|Overall Study|Withdrawal by Subject|1|||
130813388|NCT02367885|470944535|FG001|Overall Study|Withdrawal by Subject|0|||
130813389|NCT02367885|470944536|FG002|Overall Study|Withdrawal by Subject|0|||
130813390|NCT03729609|470944543|FG000|Overall Study|Protocol Violation|1|||
130813391|NCT00605189|470944549|FG000|Overall Study|Adverse Event|1|||
130813392|NCT00605189|470944550|FG001|Overall Study|Adverse Event|0|||
130813393|NCT00605189|470944551|FG002|Overall Study|Adverse Event|0|||
130813394|NCT00605189|470944549|FG000|Overall Study|Other|2|||
130813395|NCT00605189|470944550|FG001|Overall Study|Other|2|||
130813396|NCT00605189|470944551|FG002|Overall Study|Other|0|||
130813397|NCT02919618|470944552|FG000|Overall Study|Death|1|||
130813398|NCT02592863|470944553|FG000|Overall Study|Withdrawal by Subject|2|||
130813399|NCT02592863|470944554|FG001|Overall Study|Withdrawal by Subject|2|||
130813400|NCT02592863|470944553|FG000|Overall Study|Lost to Follow-up|1|||
130813401|NCT02592863|470944554|FG001|Overall Study|Lost to Follow-up|1|||
130813402|NCT02743221|470944555|FG000|Overall Study|Progressive disease|29|||
130813403|NCT02743221|470944556|FG001|Overall Study|Progressive disease|38|||
130813404|NCT02743221|470944555|FG000|Overall Study|Adverse Event|17|||
130813405|NCT02743221|470944556|FG001|Overall Study|Adverse Event|14|||
130813406|NCT02743221|470944555|FG000|Overall Study|non medical reason|8|||
130813407|NCT02743221|470944556|FG001|Overall Study|non medical reason|2|||
130813408|NCT02743221|470944555|FG000|Overall Study|Physician Decision|2|||
130813409|NCT02743221|470944556|FG001|Overall Study|Physician Decision|5|||
130813410|NCT02743221|470944555|FG000|Overall Study|Patient not eligible, not treated|0|||
130813411|NCT02743221|470944556|FG001|Overall Study|Patient not eligible, not treated|1|||
130813412|NCT03411044|470944558|FG000|Overall Study|Death|30|||
130813413|NCT03411044|470944558|FG000|Overall Study|Withdrawal by Subject|48|||
130813414|NCT03411044|470944558|FG000|Overall Study|Lost to Follow-up|78|||
130813415|NCT03411044|470944558|FG000|Overall Study|Adverse Event|30|||
130813416|NCT03411044|470944558|FG000|Overall Study|Missing status|4|||
130813417|NCT02609503|470944559|FG000|Overall Study|Adverse Event|1|||
130813418|NCT02609503|470944559|FG000|Overall Study|Death|1|||
130813419|NCT02609503|470944559|FG000|Overall Study|Withdrawal by Subject|1|||
130813420|NCT02609503|470944559|FG000|Overall Study|Disease progression|1|||
130813421|NCT01969409|470944562|FG000|Overall Study|Death|2|||
130813422|NCT01969409|470944563|FG001|Overall Study|Death|2|||
130813423|NCT01969409|470944562|FG000|Overall Study|Transplant|1|||
130813424|NCT01969409|470944563|FG001|Overall Study|Transplant|1|||
130813425|NCT01969409|470944562|FG000|Overall Study|Withdrawal by Subject|0|||
130813426|NCT01969409|470944563|FG001|Overall Study|Withdrawal by Subject|1|||
130813427|NCT02226653|470944567|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
130813428|NCT02226653|470944568|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
130813429|NCT02226653|470944567|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
130813430|NCT02226653|470944568|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
130813431|NCT03078868|470944570|FG000|Overall Study|Physician Decision|3|||
130813432|NCT04191135|470944582|FG000|Induction Treatment|Not Treated|2|||
130813433|NCT04191135|470944583|FG001|Induction Treatment|Not Treated|0|||
130813434|NCT04191135|470944584|FG002|Induction Treatment|Not Treated|0|||
130813435|NCT04191135|470944582|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
130813436|NCT04191135|470944583|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
130813437|NCT04191135|470944584|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
130813438|NCT04191135|470944582|FG000|Induction Treatment|Adverse Event|25|||
130813439|NCT04191135|470944583|FG001|Induction Treatment|Adverse Event|0|||
130813440|NCT04191135|470944584|FG002|Induction Treatment|Adverse Event|0|||
130813441|NCT04191135|470944582|FG000|Induction Treatment|Clinical Progression|8|||
130813442|NCT04191135|470944583|FG001|Induction Treatment|Clinical Progression|0|||
130813443|NCT04191135|470944584|FG002|Induction Treatment|Clinical Progression|0|||
130813444|NCT04191135|470944582|FG000|Induction Treatment|Excluded Medication|1|||
130813445|NCT04191135|470944583|FG001|Induction Treatment|Excluded Medication|0|||
130813446|NCT04191135|470944584|FG002|Induction Treatment|Excluded Medication|0|||
130813447|NCT04191135|470944582|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
130813448|NCT04191135|470944583|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
130813449|NCT04191135|470944584|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
130813450|NCT04191135|470944582|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
130813451|NCT04191135|470944583|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
130813452|NCT04191135|470944584|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
130813453|NCT04191135|470944582|FG000|Induction Treatment|Physician Decision|2|||
130813454|NCT04191135|470944583|FG001|Induction Treatment|Physician Decision|0|||
130813455|NCT04191135|470944584|FG002|Induction Treatment|Physician Decision|0|||
130813456|NCT04191135|470944582|FG000|Induction Treatment|Progressive Disease|135|||
130813457|NCT04191135|470944583|FG001|Induction Treatment|Progressive Disease|0|||
130813458|NCT04191135|470944584|FG002|Induction Treatment|Progressive Disease|0|||
130813459|NCT04191135|470944582|FG000|Induction Treatment|Protocol Violation|10|||
130813460|NCT04191135|470944583|FG001|Induction Treatment|Protocol Violation|0|||
130813461|NCT04191135|470944584|FG002|Induction Treatment|Protocol Violation|0|||
130813462|NCT04191135|470944582|FG000|Induction Treatment|Withdrawal by Subject|4|||
130813463|NCT04191135|470944583|FG001|Induction Treatment|Withdrawal by Subject|0|||
130813464|NCT04191135|470944584|FG002|Induction Treatment|Withdrawal by Subject|0|||
130813465|NCT04191135|470944582|FG000|Randomized Treatment|Death|0|||
130813466|NCT04191135|470944583|FG001|Randomized Treatment|Death|50|||
130813467|NCT04191135|470944584|FG002|Randomized Treatment|Death|54|||
130813468|NCT04191135|470944582|FG000|Randomized Treatment|Lost to Follow-up|0|||
130813469|NCT04191135|470944583|FG001|Randomized Treatment|Lost to Follow-up|0|||
130813470|NCT04191135|470944584|FG002|Randomized Treatment|Lost to Follow-up|1|||
130813471|NCT04191135|470944582|FG000|Randomized Treatment|Withdrawal by Subject|0|||
130813472|NCT04191135|470944583|FG001|Randomized Treatment|Withdrawal by Subject|2|||
130813473|NCT04191135|470944584|FG002|Randomized Treatment|Withdrawal by Subject|0|||
130813474|NCT04191135|470944582|FG000|Randomized Treatment|Ongoing in Trial|0|||
130813475|NCT04191135|470944583|FG001|Randomized Treatment|Ongoing in Trial|83|||
130813476|NCT04191135|470944584|FG002|Randomized Treatment|Ongoing in Trial|81|||
130813477|NCT02374255|470946170|FG000|Overall Study|Withdrawal by Subject|2|||
130813478|NCT02374255|470946171|FG001|Overall Study|Withdrawal by Subject|0|||
130813479|NCT02374255|470946172|FG002|Overall Study|Withdrawal by Subject|0|||
130813480|NCT02374255|470946173|FG003|Overall Study|Withdrawal by Subject|0|||
130813481|NCT02093520|470946174|FG000|Overall Study|Not treated|6|||
130813482|NCT02093520|470946175|FG001|Overall Study|Not treated|22|||
130813483|NCT01432444|470946182|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
130813484|NCT01432444|470946183|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
130813485|NCT01432444|470946184|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
130813486|NCT01432444|470946182|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
130813487|NCT01432444|470946183|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
130813488|NCT01432444|470946184|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
130813489|NCT01432444|470946182|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
130813490|NCT01432444|470946183|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
130813491|NCT01432444|470946184|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
130813492|NCT01432444|470946182|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
130813493|NCT01432444|470946183|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
130813494|NCT01432444|470946184|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
130813495|NCT01432444|470946182|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
130813496|NCT01432444|470946183|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
130813497|NCT01432444|470946184|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
130813498|NCT01432444|470946182|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
130813499|NCT01432444|470946183|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
130813500|NCT01432444|470946184|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
130813501|NCT01432444|470946182|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
130813502|NCT01432444|470946183|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
130813503|NCT01432444|470946184|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
130813504|NCT01432444|470946182|FG000|Treatment Phase|Lost to Follow-up|0|||
130813505|NCT01432444|470946183|FG001|Treatment Phase|Lost to Follow-up|33|||
130813506|NCT01432444|470946184|FG002|Treatment Phase|Lost to Follow-up|0|||
130813507|NCT01432444|470946182|FG000|Treatment Phase|Adverse Event|0|||
130813508|NCT01432444|470946183|FG001|Treatment Phase|Adverse Event|37|||
130813509|NCT01432444|470946184|FG002|Treatment Phase|Adverse Event|0|||
130813510|NCT01432444|470946182|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
130813511|NCT01432444|470946183|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
130813512|NCT01432444|470946184|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
130813513|NCT01432444|470946182|FG000|Treatment Phase|Physician Decision|0|||
130813514|NCT01432444|470946183|FG001|Treatment Phase|Physician Decision|5|||
130813515|NCT01432444|470946184|FG002|Treatment Phase|Physician Decision|0|||
130813516|NCT01432444|470946182|FG000|Treatment Phase|Withdrawal by Subject|0|||
130813517|NCT01432444|470946183|FG001|Treatment Phase|Withdrawal by Subject|41|||
130813518|NCT01432444|470946184|FG002|Treatment Phase|Withdrawal by Subject|0|||
130813519|NCT01432444|470946182|FG000|Treatment Phase|Protocol Deviation|0|||
130813520|NCT01432444|470946183|FG001|Treatment Phase|Protocol Deviation|3|||
130813521|NCT01432444|470946184|FG002|Treatment Phase|Protocol Deviation|0|||
130813522|NCT01432444|470946182|FG000|Treatment Phase|Lack of Efficacy|0|||
130813523|NCT01432444|470946183|FG001|Treatment Phase|Lack of Efficacy|10|||
130813524|NCT01432444|470946184|FG002|Treatment Phase|Lack of Efficacy|0|||
130813525|NCT01432444|470946182|FG000|Extension Phase|Lost to Follow-up|0|||
130813526|NCT01432444|470946183|FG001|Extension Phase|Lost to Follow-up|0|||
130813527|NCT01432444|470946184|FG002|Extension Phase|Lost to Follow-up|17|||
130813528|NCT01432444|470946182|FG000|Extension Phase|Adverse Event|0|||
130813529|NCT01432444|470946183|FG001|Extension Phase|Adverse Event|0|||
130813530|NCT01432444|470946184|FG002|Extension Phase|Adverse Event|10|||
130813531|NCT01432444|470946182|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
130813532|NCT01432444|470946183|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
130813533|NCT01432444|470946184|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
130813534|NCT01432444|470946182|FG000|Extension Phase|Met Withdrawal Criteria|0|||
130813535|NCT01432444|470946183|FG001|Extension Phase|Met Withdrawal Criteria|0|||
130813536|NCT01432444|470946184|FG002|Extension Phase|Met Withdrawal Criteria|144|||
130813537|NCT01432444|470946182|FG000|Extension Phase|Physician Decision|0|||
130813538|NCT01432444|470946183|FG001|Extension Phase|Physician Decision|0|||
130813539|NCT01432444|470946184|FG002|Extension Phase|Physician Decision|1|||
130813540|NCT01432444|470946182|FG000|Extension Phase|Withdrawal by Subject|0|||
130813541|NCT01432444|470946183|FG001|Extension Phase|Withdrawal by Subject|0|||
130813542|NCT01432444|470946184|FG002|Extension Phase|Withdrawal by Subject|13|||
130813543|NCT02301897|470946185|FG000|Treatment Course 1|Non-Compliance|0|||
130813544|NCT02301897|470946186|FG001|Treatment Course 1|Non-Compliance|0|||
130813545|NCT02301897|470946187|FG002|Treatment Course 1|Non-Compliance|1|||
130813546|NCT02301897|470946185|FG000|Treatment Course 1|Adverse Event|1|||
130813547|NCT02301897|470946186|FG001|Treatment Course 1|Adverse Event|1|||
130813548|NCT02301897|470946187|FG002|Treatment Course 1|Adverse Event|0|||
130813549|NCT02301897|470946185|FG000|Treatment Course 1|Lost to Follow-up|1|||
130813550|NCT02301897|470946186|FG001|Treatment Course 1|Lost to Follow-up|2|||
130813551|NCT02301897|470946187|FG002|Treatment Course 1|Lost to Follow-up|1|||
130813552|NCT02301897|470946185|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
130813553|NCT02301897|470946186|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
130813554|NCT02301897|470946187|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
130813555|NCT02301897|470946185|FG000|Treatment Course 1|Withdrawal by Subject|0|||
130813556|NCT02301897|470946186|FG001|Treatment Course 1|Withdrawal by Subject|0|||
130813557|NCT02301897|470946187|FG002|Treatment Course 1|Withdrawal by Subject|2|||
130813558|NCT02301897|470946185|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
130813559|NCT02301897|470946186|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
130813560|NCT02301897|470946187|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
130813561|NCT02301897|470946185|FG000|Treatment Course 2|Lost to Follow-up|0|||
130813562|NCT02301897|470946186|FG001|Treatment Course 2|Lost to Follow-up|2|||
130813563|NCT02301897|470946187|FG002|Treatment Course 2|Lost to Follow-up|0|||
130813564|NCT02301897|470946185|FG000|Treatment Course 2|Pregnancy|0|||
130813565|NCT02301897|470946186|FG001|Treatment Course 2|Pregnancy|1|||
130813566|NCT02301897|470946187|FG002|Treatment Course 2|Pregnancy|1|||
130813567|NCT02301897|470946185|FG000|Treatment Course 2|Withdrawal by Subject|0|||
130813568|NCT02301897|470946186|FG001|Treatment Course 2|Withdrawal by Subject|2|||
130813569|NCT02301897|470946187|FG002|Treatment Course 2|Withdrawal by Subject|0|||
130813570|NCT02301897|470946185|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
130813571|NCT02301897|470946186|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
130813572|NCT02301897|470946187|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
130813573|NCT01602484|470946188|FG000|Overall Study|Airway issues unrelated to study|0|||
130813574|NCT01602484|470946189|FG001|Overall Study|Airway issues unrelated to study|1|||
130813575|NCT02743962|470946192|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
130813576|NCT02743962|470946193|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
130813577|NCT02327169|470946197|FG000|Overall Study|Progressive Disease|1|||
130813578|NCT02327169|470946198|FG001|Overall Study|Progressive Disease|3|||
130813579|NCT02327169|470946199|FG002|Overall Study|Progressive Disease|4|||
130813580|NCT02327169|470946200|FG003|Overall Study|Progressive Disease|3|||
130813581|NCT02327169|470946201|FG004|Overall Study|Progressive Disease|4|||
130813582|NCT02327169|470946202|FG005|Overall Study|Progressive Disease|3|||
130813583|NCT02327169|470946203|FG006|Overall Study|Progressive Disease|3|||
130813584|NCT02327169|470946204|FG007|Overall Study|Progressive Disease|3|||
130813585|NCT02327169|470946205|FG008|Overall Study|Progressive Disease|4|||
130813586|NCT02327169|470946206|FG009|Overall Study|Progressive Disease|4|||
130813587|NCT02327169|470946207|FG010|Overall Study|Progressive Disease|4|||
130813588|NCT02327169|470946208|FG011|Overall Study|Progressive Disease|3|||
130813589|NCT02327169|470946209|FG012|Overall Study|Progressive Disease|1|||
130813590|NCT02327169|470946210|FG013|Overall Study|Progressive Disease|3|||
130813591|NCT02327169|470946211|FG014|Overall Study|Progressive Disease|3|||
130813592|NCT02327169|470946197|FG000|Overall Study|Adverse Event|2|||
130813593|NCT02327169|470946198|FG001|Overall Study|Adverse Event|0|||
130813594|NCT02327169|470946199|FG002|Overall Study|Adverse Event|1|||
130813595|NCT02327169|470946200|FG003|Overall Study|Adverse Event|0|||
130813596|NCT02327169|470946201|FG004|Overall Study|Adverse Event|1|||
130813597|NCT02327169|470946202|FG005|Overall Study|Adverse Event|0|||
130813598|NCT02327169|470946203|FG006|Overall Study|Adverse Event|0|||
130813599|NCT02327169|470946204|FG007|Overall Study|Adverse Event|0|||
130813600|NCT02327169|470946205|FG008|Overall Study|Adverse Event|0|||
130813601|NCT02327169|470946206|FG009|Overall Study|Adverse Event|2|||
130813602|NCT02327169|470946207|FG010|Overall Study|Adverse Event|0|||
130813603|NCT02327169|470946208|FG011|Overall Study|Adverse Event|3|||
130813604|NCT02327169|470946209|FG012|Overall Study|Adverse Event|0|||
130813605|NCT02327169|470946210|FG013|Overall Study|Adverse Event|2|||
130813606|NCT02327169|470946211|FG014|Overall Study|Adverse Event|1|||
130813607|NCT02327169|470946197|FG000|Overall Study|Symptomatic Deterioration|0|||
130813608|NCT02327169|470946198|FG001|Overall Study|Symptomatic Deterioration|0|||
130813609|NCT02327169|470946199|FG002|Overall Study|Symptomatic Deterioration|1|||
130813610|NCT02327169|470946200|FG003|Overall Study|Symptomatic Deterioration|0|||
130813611|NCT02327169|470946201|FG004|Overall Study|Symptomatic Deterioration|1|||
130813612|NCT02327169|470946202|FG005|Overall Study|Symptomatic Deterioration|1|||
130813613|NCT02327169|470946203|FG006|Overall Study|Symptomatic Deterioration|0|||
130813614|NCT02327169|470946204|FG007|Overall Study|Symptomatic Deterioration|0|||
130813615|NCT02327169|470946205|FG008|Overall Study|Symptomatic Deterioration|2|||
130813616|NCT02327169|470946206|FG009|Overall Study|Symptomatic Deterioration|1|||
130813617|NCT02327169|470946207|FG010|Overall Study|Symptomatic Deterioration|0|||
130813618|NCT02327169|470946208|FG011|Overall Study|Symptomatic Deterioration|0|||
130813619|NCT02327169|470946209|FG012|Overall Study|Symptomatic Deterioration|0|||
130813620|NCT02327169|470946210|FG013|Overall Study|Symptomatic Deterioration|2|||
130813621|NCT02327169|470946211|FG014|Overall Study|Symptomatic Deterioration|1|||
130813622|NCT02327169|470946197|FG000|Overall Study|Reason Not Specified|0|||
130813623|NCT02327169|470946198|FG001|Overall Study|Reason Not Specified|0|||
130813624|NCT02327169|470946199|FG002|Overall Study|Reason Not Specified|1|||
130813625|NCT02327169|470946200|FG003|Overall Study|Reason Not Specified|0|||
130813626|NCT02327169|470946201|FG004|Overall Study|Reason Not Specified|0|||
130813627|NCT02327169|470946202|FG005|Overall Study|Reason Not Specified|0|||
130813628|NCT02327169|470946203|FG006|Overall Study|Reason Not Specified|0|||
130813629|NCT02327169|470946204|FG007|Overall Study|Reason Not Specified|0|||
130813630|NCT02327169|470946205|FG008|Overall Study|Reason Not Specified|0|||
130813631|NCT02327169|470946206|FG009|Overall Study|Reason Not Specified|1|||
130813632|NCT02327169|470946207|FG010|Overall Study|Reason Not Specified|2|||
130813633|NCT02327169|470946208|FG011|Overall Study|Reason Not Specified|1|||
130813634|NCT02327169|470946209|FG012|Overall Study|Reason Not Specified|0|||
130813635|NCT02327169|470946210|FG013|Overall Study|Reason Not Specified|0|||
130813636|NCT02327169|470946211|FG014|Overall Study|Reason Not Specified|2|||
130813637|NCT02327169|470946197|FG000|Overall Study|Withdrawal by Subject|1|||
130813638|NCT02327169|470946198|FG001|Overall Study|Withdrawal by Subject|0|||
130813639|NCT02327169|470946199|FG002|Overall Study|Withdrawal by Subject|0|||
130813640|NCT02327169|470946200|FG003|Overall Study|Withdrawal by Subject|0|||
130813641|NCT02327169|470946201|FG004|Overall Study|Withdrawal by Subject|1|||
130813642|NCT02327169|470946202|FG005|Overall Study|Withdrawal by Subject|0|||
130813643|NCT02327169|470946203|FG006|Overall Study|Withdrawal by Subject|0|||
130813644|NCT02327169|470946204|FG007|Overall Study|Withdrawal by Subject|1|||
130813645|NCT02327169|470946205|FG008|Overall Study|Withdrawal by Subject|0|||
130813646|NCT02327169|470946206|FG009|Overall Study|Withdrawal by Subject|0|||
130813647|NCT02327169|470946207|FG010|Overall Study|Withdrawal by Subject|0|||
130813648|NCT02327169|470946208|FG011|Overall Study|Withdrawal by Subject|0|||
130813649|NCT02327169|470946209|FG012|Overall Study|Withdrawal by Subject|0|||
130813650|NCT02327169|470946210|FG013|Overall Study|Withdrawal by Subject|0|||
130813651|NCT02327169|470946211|FG014|Overall Study|Withdrawal by Subject|3|||
130813652|NCT02327169|470946197|FG000|Overall Study|Lost to Follow-up|0|||
130813653|NCT02327169|470946198|FG001|Overall Study|Lost to Follow-up|0|||
130813654|NCT02327169|470946199|FG002|Overall Study|Lost to Follow-up|0|||
130813655|NCT02327169|470946200|FG003|Overall Study|Lost to Follow-up|0|||
130813656|NCT02327169|470946201|FG004|Overall Study|Lost to Follow-up|1|||
130813657|NCT02327169|470946202|FG005|Overall Study|Lost to Follow-up|0|||
130813658|NCT02327169|470946203|FG006|Overall Study|Lost to Follow-up|0|||
130813659|NCT02327169|470946204|FG007|Overall Study|Lost to Follow-up|0|||
130813660|NCT02327169|470946205|FG008|Overall Study|Lost to Follow-up|0|||
130813661|NCT02327169|470946206|FG009|Overall Study|Lost to Follow-up|0|||
130813662|NCT02327169|470946207|FG010|Overall Study|Lost to Follow-up|0|||
130813663|NCT02327169|470946208|FG011|Overall Study|Lost to Follow-up|0|||
130813664|NCT02327169|470946209|FG012|Overall Study|Lost to Follow-up|0|||
130813665|NCT02327169|470946210|FG013|Overall Study|Lost to Follow-up|0|||
130813666|NCT02327169|470946211|FG014|Overall Study|Lost to Follow-up|0|||
130813667|NCT01381679|470946216|FG000|Overall Study|Adverse Event|3|||
130813668|NCT01381679|470946216|FG000|Overall Study|Lost to Follow-up|885|||
130813669|NCT05473715|470946219|FG000|Overall Study|Trial terminate|2|||
130813670|NCT05473715|470946220|FG001|Overall Study|Trial terminate|1|||
130813671|NCT00427700|470946226|FG000|Overall Study|Lost to Follow-up|2|||
130813672|NCT00427700|470946227|FG001|Overall Study|Lost to Follow-up|5|||
130813673|NCT00427700|470946226|FG000|Overall Study|no induction of menses|1|||
130813674|NCT00427700|470946227|FG001|Overall Study|no induction of menses|4|||
130813675|NCT00427700|470946226|FG000|Overall Study|Pregnancy|0|||
130813676|NCT00427700|470946227|FG001|Overall Study|Pregnancy|2|||
130813677|NCT02014376|470946228|FG000|Overall Study|Adverse Event|1|||
130813678|NCT02014376|470946229|FG001|Overall Study|Adverse Event|1|||
130813679|NCT02014376|470946230|FG002|Overall Study|Adverse Event|0|||
130813680|NCT02014376|470946228|FG000|Overall Study|Lost to Follow-up|2|||
130813681|NCT02014376|470946229|FG001|Overall Study|Lost to Follow-up|0|||
130813682|NCT02014376|470946230|FG002|Overall Study|Lost to Follow-up|0|||
130813683|NCT01051661|470946233|FG000|Overall Study|Adverse Event|1|||
130813684|NCT01051661|470946234|FG001|Overall Study|Adverse Event|1|||
130813685|NCT01051661|470946235|FG002|Overall Study|Adverse Event|1|||
130813686|NCT01051661|470946236|FG003|Overall Study|Adverse Event|1|||
130813687|NCT01051661|470946237|FG004|Overall Study|Adverse Event|0|||
130813688|NCT01051661|470946238|FG005|Overall Study|Adverse Event|0|||
130813689|NCT01051661|470946233|FG000|Overall Study|Lost to Follow-up|13|||
130813690|NCT01051661|470946234|FG001|Overall Study|Lost to Follow-up|22|||
130813691|NCT01051661|470946235|FG002|Overall Study|Lost to Follow-up|15|||
130813692|NCT01051661|470946236|FG003|Overall Study|Lost to Follow-up|17|||
130813693|NCT01051661|470946237|FG004|Overall Study|Lost to Follow-up|10|||
130813694|NCT01051661|470946238|FG005|Overall Study|Lost to Follow-up|24|||
130813695|NCT01051661|470946233|FG000|Overall Study|Migrated/moved from study area|1|||
130813696|NCT01051661|470946234|FG001|Overall Study|Migrated/moved from study area|6|||
130813697|NCT01051661|470946235|FG002|Overall Study|Migrated/moved from study area|6|||
130813698|NCT01051661|470946236|FG003|Overall Study|Migrated/moved from study area|8|||
130813699|NCT01051661|470946237|FG004|Overall Study|Migrated/moved from study area|7|||
130813700|NCT01051661|470946238|FG005|Overall Study|Migrated/moved from study area|3|||
130813701|NCT01051661|470946233|FG000|Overall Study|Refused blood sampling|0|||
130813702|NCT01051661|470946234|FG001|Overall Study|Refused blood sampling|0|||
130813703|NCT01051661|470946235|FG002|Overall Study|Refused blood sampling|0|||
130813704|NCT01051661|470946236|FG003|Overall Study|Refused blood sampling|0|||
130813705|NCT01051661|470946237|FG004|Overall Study|Refused blood sampling|0|||
130813706|NCT01051661|470946238|FG005|Overall Study|Refused blood sampling|1|||
130813707|NCT01051661|470946233|FG000|Overall Study|Data not reliable|1|||
130813708|NCT01051661|470946234|FG001|Overall Study|Data not reliable|0|||
130813709|NCT01051661|470946235|FG002|Overall Study|Data not reliable|0|||
130813710|NCT01051661|470946236|FG003|Overall Study|Data not reliable|0|||
130813711|NCT01051661|470946237|FG004|Overall Study|Data not reliable|0|||
130813712|NCT01051661|470946238|FG005|Overall Study|Data not reliable|1|||
130813713|NCT01051661|470946233|FG000|Overall Study|Unable to attend visit(s)|2|||
130813714|NCT01051661|470946234|FG001|Overall Study|Unable to attend visit(s)|4|||
130813715|NCT01051661|470946235|FG002|Overall Study|Unable to attend visit(s)|2|||
130813716|NCT01051661|470946236|FG003|Overall Study|Unable to attend visit(s)|1|||
130813717|NCT01051661|470946237|FG004|Overall Study|Unable to attend visit(s)|3|||
130813718|NCT01051661|470946238|FG005|Overall Study|Unable to attend visit(s)|2|||
130813719|NCT01051661|470946233|FG000|Overall Study|Consent not received from both parents|0|||
130813720|NCT01051661|470946234|FG001|Overall Study|Consent not received from both parents|0|||
130813721|NCT01051661|470946235|FG002|Overall Study|Consent not received from both parents|0|||
130813722|NCT01051661|470946236|FG003|Overall Study|Consent not received from both parents|0|||
130813723|NCT01051661|470946237|FG004|Overall Study|Consent not received from both parents|0|||
130813724|NCT01051661|470946238|FG005|Overall Study|Consent not received from both parents|1|||
130813725|NCT01051661|470946233|FG000|Overall Study|Failure to comply with protocol|0|||
130813726|NCT01051661|470946234|FG001|Overall Study|Failure to comply with protocol|0|||
130813727|NCT01051661|470946235|FG002|Overall Study|Failure to comply with protocol|2|||
130813728|NCT01051661|470946236|FG003|Overall Study|Failure to comply with protocol|0|||
130813729|NCT01051661|470946237|FG004|Overall Study|Failure to comply with protocol|0|||
130813730|NCT01051661|470946238|FG005|Overall Study|Failure to comply with protocol|0|||
130813731|NCT01051661|470946233|FG000|Overall Study|Subject lost legal representation|0|||
130813732|NCT01051661|470946234|FG001|Overall Study|Subject lost legal representation|0|||
130813733|NCT01051661|470946235|FG002|Overall Study|Subject lost legal representation|0|||
130813734|NCT01051661|470946236|FG003|Overall Study|Subject lost legal representation|0|||
130813735|NCT01051661|470946237|FG004|Overall Study|Subject lost legal representation|1|||
130813736|NCT01051661|470946238|FG005|Overall Study|Subject lost legal representation|0|||
130813737|NCT01051661|470946233|FG000|Overall Study|Protocol Violation|0|||
130813738|NCT01051661|470946234|FG001|Overall Study|Protocol Violation|0|||
130813739|NCT01051661|470946235|FG002|Overall Study|Protocol Violation|0|||
130813740|NCT01051661|470946236|FG003|Overall Study|Protocol Violation|1|||
130813741|NCT01051661|470946237|FG004|Overall Study|Protocol Violation|2|||
130813742|NCT01051661|470946238|FG005|Overall Study|Protocol Violation|1|||
130813743|NCT01051661|470946233|FG000|Overall Study|Withdrawal by Subject|16|||
130813744|NCT01051661|470946234|FG001|Overall Study|Withdrawal by Subject|30|||
130813745|NCT01051661|470946235|FG002|Overall Study|Withdrawal by Subject|13|||
130813746|NCT01051661|470946236|FG003|Overall Study|Withdrawal by Subject|28|||
130813747|NCT01051661|470946237|FG004|Overall Study|Withdrawal by Subject|12|||
130813748|NCT01051661|470946238|FG005|Overall Study|Withdrawal by Subject|34|||
130813749|NCT04642079|470946239|FG000|Overall Study|Lost to Follow-up|2|||
130813750|NCT04642079|470946240|FG001|Overall Study|Lost to Follow-up|5|||
130813751|NCT04642079|470946241|FG002|Overall Study|Lost to Follow-up|2|||
130813752|NCT04642079|470946242|FG003|Overall Study|Lost to Follow-up|0|||
130813753|NCT04642079|470946239|FG000|Overall Study|Withdrawal by Subject|0|||
130813754|NCT04642079|470946240|FG001|Overall Study|Withdrawal by Subject|4|||
130813755|NCT04642079|470946241|FG002|Overall Study|Withdrawal by Subject|1|||
130813756|NCT04642079|470946242|FG003|Overall Study|Withdrawal by Subject|2|||
130813757|NCT04642079|470946239|FG000|Overall Study|Other|0|||
130813758|NCT04642079|470946240|FG001|Overall Study|Other|0|||
130813759|NCT04642079|470946241|FG002|Overall Study|Other|0|||
130813760|NCT04642079|470946242|FG003|Overall Study|Other|1|||
130813761|NCT04642079|470946239|FG000|Overall Study|No longer met eligibility criteria|1|||
130813762|NCT04642079|470946240|FG001|Overall Study|No longer met eligibility criteria|0|||
130813763|NCT04642079|470946241|FG002|Overall Study|No longer met eligibility criteria|1|||
130813764|NCT04642079|470946242|FG003|Overall Study|No longer met eligibility criteria|1|||
130813765|NCT00635050|470946247|FG000|Overall Study|Withdrawal by Subject|1|||
130813766|NCT03038620|470946248|FG000|Overall Study|Lost to Follow-up|18|||
130813767|NCT03038620|470946249|FG001|Overall Study|Lost to Follow-up|23|||
130813768|NCT03038620|470946248|FG000|Overall Study|Withdrawal by Subject|0|||
130813769|NCT03038620|470946249|FG001|Overall Study|Withdrawal by Subject|15|||
130813770|NCT03038620|470946248|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
130813771|NCT03038620|470946249|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
130813772|NCT00759395|470946251|FG000|Overall Study|Adverse Event|1|||
130813773|NCT00759395|470946252|FG001|Overall Study|Adverse Event|0|||
130813774|NCT00759395|470946251|FG000|Overall Study|Withdrawal by Subject|1|||
130813775|NCT00759395|470946252|FG001|Overall Study|Withdrawal by Subject|0|||
130813776|NCT00759395|470946251|FG000|Overall Study|Lack of Efficacy|0|||
130813777|NCT00759395|470946252|FG001|Overall Study|Lack of Efficacy|2|||
130813778|NCT01435356|470946257|FG000|Overall Study|Adverse Event|2|||
130813779|NCT01435356|470946258|FG001|Overall Study|Adverse Event|0|||
130813780|NCT01435356|470946257|FG000|Overall Study|Disease progression/recurrence|17|||
130813781|NCT01435356|470946258|FG001|Overall Study|Disease progression/recurrence|10|||
130813782|NCT01435356|470946257|FG000|Overall Study|Protocol Violation|0|||
130813783|NCT01435356|470946258|FG001|Overall Study|Protocol Violation|1|||
130813784|NCT01435356|470946257|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
130813785|NCT01435356|470946258|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
130813786|NCT01435356|470946257|FG000|Overall Study|Withdrawal by Subject|1|||
130813787|NCT01435356|470946258|FG001|Overall Study|Withdrawal by Subject|1|||
130813788|NCT01435356|470946257|FG000|Overall Study|Facial palsy|1|||
130813789|NCT01435356|470946258|FG001|Overall Study|Facial palsy|0|||
130813790|NCT01435356|470946257|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
130813791|NCT01435356|470946258|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
130813792|NCT01435356|470946257|FG000|Overall Study|Physician Decision|1|||
130813793|NCT01435356|470946258|FG001|Overall Study|Physician Decision|0|||
130813794|NCT01435356|470946257|FG000|Overall Study|Patient decision|3|||
130813795|NCT01435356|470946258|FG001|Overall Study|Patient decision|0|||
130813796|NCT01435356|470946257|FG000|Overall Study|Patient moved to another city|1|||
130813797|NCT01435356|470946258|FG001|Overall Study|Patient moved to another city|1|||
130813798|NCT00437073|470946259|FG000|Overall Study|Sponsor Terminated Study|1|||
130813799|NCT00437073|470946260|FG001|Overall Study|Sponsor Terminated Study|0|||
130813800|NCT00437073|470946259|FG000|Overall Study|Physician Decision|0|||
130813801|NCT00437073|470946260|FG001|Overall Study|Physician Decision|1|||
130813802|NCT03485157|470946261|FG000|Double Blind Phase|Lost to Follow-up|4|||
130813803|NCT03485157|470946262|FG001|Double Blind Phase|Lost to Follow-up|4|||
130813804|NCT03485157|470946261|FG000|Double Blind Phase|Adverse Event|2|||
130813805|NCT03485157|470946262|FG001|Double Blind Phase|Adverse Event|1|||
130813806|NCT03485157|470946261|FG000|Double Blind Phase|Withdrawal by Subject|6|||
130813807|NCT03485157|470946262|FG001|Double Blind Phase|Withdrawal by Subject|9|||
130813808|NCT03485157|470946261|FG000|Double Blind Phase|Removal by PI|3|||
130813809|NCT03485157|470946262|FG001|Double Blind Phase|Removal by PI|7|||
130813810|NCT03485157|470946261|FG000|Open Label Phase|Lost to Follow-up|1|||
130813811|NCT03485157|470946262|FG001|Open Label Phase|Lost to Follow-up|2|||
130813812|NCT03485157|470946261|FG000|Open Label Phase|Adverse Event|0|||
130813813|NCT03485157|470946262|FG001|Open Label Phase|Adverse Event|1|||
130813814|NCT03485157|470946261|FG000|Open Label Phase|Withdrawal by Subject|1|||
130813815|NCT03485157|470946262|FG001|Open Label Phase|Withdrawal by Subject|2|||
130813816|NCT03485157|470946261|FG000|Open Label Phase|Removal by PI|2|||
130813817|NCT03485157|470946262|FG001|Open Label Phase|Removal by PI|0|||
130813818|NCT04875533|470946263|FG000|Overall Study|Adverse Event|6|||
130813819|NCT04875533|470946264|FG001|Overall Study|Adverse Event|4|||
130813820|NCT04875533|470946263|FG000|Overall Study|Protocol Violation|4|||
130813821|NCT04875533|470946264|FG001|Overall Study|Protocol Violation|0|||
130813822|NCT04875533|470946263|FG000|Overall Study|Withdrawal by Subject|8|||
130813823|NCT04875533|470946264|FG001|Overall Study|Withdrawal by Subject|5|||
130813824|NCT04875533|470946263|FG000|Overall Study|No longer meets eligibility criteria|1|||
130813825|NCT04875533|470946264|FG001|Overall Study|No longer meets eligibility criteria|0|||
130813826|NCT04875533|470946263|FG000|Overall Study|Other|0|||
130813827|NCT04875533|470946264|FG001|Overall Study|Other|2|||
130813828|NCT02657343|470946267|FG000|Overall Study|Death|0|||
130813829|NCT02657343|470946268|FG001|Overall Study|Death|2|||
130813830|NCT02657343|470946269|FG002|Overall Study|Death|0|||
130813831|NCT02657343|470946270|FG003|Overall Study|Death|0|||
130813832|NCT02657343|470946271|FG004|Overall Study|Death|0|||
130813833|NCT02657343|470946272|FG005|Overall Study|Death|0|||
130813834|NCT02657343|470946267|FG000|Overall Study|Patient went to hospice|1|||
130813835|NCT02657343|470946268|FG001|Overall Study|Patient went to hospice|0|||
130813836|NCT02657343|470946269|FG002|Overall Study|Patient went to hospice|0|||
130813837|NCT02657343|470946270|FG003|Overall Study|Patient went to hospice|0|||
130813838|NCT02657343|470946271|FG004|Overall Study|Patient went to hospice|0|||
130813839|NCT02657343|470946272|FG005|Overall Study|Patient went to hospice|0|||
130813840|NCT02657343|470946267|FG000|Overall Study|Withdrawal by Subject|0|||
130813841|NCT02657343|470946268|FG001|Overall Study|Withdrawal by Subject|0|||
130813842|NCT02657343|470946269|FG002|Overall Study|Withdrawal by Subject|0|||
130813843|NCT02657343|470946270|FG003|Overall Study|Withdrawal by Subject|0|||
130813844|NCT02657343|470946271|FG004|Overall Study|Withdrawal by Subject|1|||
130813845|NCT02657343|470946272|FG005|Overall Study|Withdrawal by Subject|0|||
130813846|NCT02011542|470946274|FG000|Overall Study|Physician Decision|1|||
130813847|NCT00982280|470946278|FG000|Observation Period|Not eligible to be dosed|19|||
130813848|NCT00982280|470946278|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
130813849|NCT00982280|470946278|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
130813850|NCT00982280|470946278|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
130813851|NCT00982280|470946278|FG000|Maintenance Period|Adverse Event|1|||
130813852|NCT01979185|470946279|FG000|Period 2|Other|0|||
130813853|NCT01979185|470946280|FG001|Period 2|Other|1|||
130813854|NCT00980798|470946281|FG000|Overall Study|Adverse Event|7|||
130813855|NCT00980798|470946282|FG001|Overall Study|Adverse Event|36|||
130813856|NCT00980798|470946281|FG000|Overall Study|Lack of Efficacy|16|||
130813857|NCT00980798|470946282|FG001|Overall Study|Lack of Efficacy|5|||
130813858|NCT00980798|470946281|FG000|Overall Study|Lost to Follow-up|0|||
130813859|NCT00980798|470946282|FG001|Overall Study|Lost to Follow-up|1|||
130813860|NCT00980798|470946281|FG000|Overall Study|Physician Decision|2|||
130813861|NCT00980798|470946282|FG001|Overall Study|Physician Decision|1|||
130813862|NCT00980798|470946281|FG000|Overall Study|Withdrawal by Subject|8|||
130813863|NCT00980798|470946282|FG001|Overall Study|Withdrawal by Subject|11|||
130813864|NCT00980798|470946281|FG000|Overall Study|Other|0|||
130813865|NCT00980798|470946282|FG001|Overall Study|Other|1|||
130813866|NCT04221438|470946283|FG000|Overall Study|Adverse Event|1|||
130813867|NCT04221438|470946283|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
130813868|NCT04724837|470946286|FG000|Overall Study|Other|4|||
130813869|NCT04724837|470946287|FG001|Overall Study|Other|16|||
130813870|NCT04724837|470946288|FG002|Overall Study|Other|0|||
130813871|NCT04724837|470946286|FG000|Overall Study|Withdrawal by Subject|2|||
130813872|NCT04724837|470946287|FG001|Overall Study|Withdrawal by Subject|9|||
130813873|NCT04724837|470946288|FG002|Overall Study|Withdrawal by Subject|9|||
130813874|NCT04724837|470946286|FG000|Overall Study|Adverse Event|2|||
130813875|NCT04724837|470946287|FG001|Overall Study|Adverse Event|7|||
130813876|NCT04724837|470946288|FG002|Overall Study|Adverse Event|4|||
130813877|NCT04724837|470946286|FG000|Overall Study|Lost to Follow-up|0|||
130813878|NCT04724837|470946287|FG001|Overall Study|Lost to Follow-up|1|||
130813879|NCT04724837|470946288|FG002|Overall Study|Lost to Follow-up|3|||
130813880|NCT04724837|470946286|FG000|Overall Study|Physician Decision|1|||
130813881|NCT04724837|470946287|FG001|Overall Study|Physician Decision|2|||
130813882|NCT04724837|470946288|FG002|Overall Study|Physician Decision|0|||
130813883|NCT04724837|470946286|FG000|Overall Study|Death|0|||
130813884|NCT04724837|470946287|FG001|Overall Study|Death|0|||
130813885|NCT04724837|470946288|FG002|Overall Study|Death|1|||
130813886|NCT04724837|470946286|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130813887|NCT04724837|470946287|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
130813888|NCT04724837|470946288|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
130813889|NCT04724837|470946286|FG000|Overall Study|Study Terminated by Sponsor|0|||
130813890|NCT04724837|470946287|FG001|Overall Study|Study Terminated by Sponsor|1|||
130813891|NCT04724837|470946288|FG002|Overall Study|Study Terminated by Sponsor|0|||
130813892|NCT00522379|470946289|FG000|Overall Study|Adverse Event|12|||
130813893|NCT00522379|470946290|FG001|Overall Study|Adverse Event|15|||
130813894|NCT00522379|470946291|FG002|Overall Study|Adverse Event|12|||
130813895|NCT00522379|470946292|FG003|Overall Study|Adverse Event|5|||
130813896|NCT00522379|470946293|FG004|Overall Study|Adverse Event|17|||
130813897|NCT00522379|470946289|FG000|Overall Study|Lack of Efficacy|3|||
130813898|NCT00522379|470946290|FG001|Overall Study|Lack of Efficacy|0|||
130813899|NCT00522379|470946291|FG002|Overall Study|Lack of Efficacy|2|||
130813900|NCT00522379|470946292|FG003|Overall Study|Lack of Efficacy|2|||
130813901|NCT00522379|470946293|FG004|Overall Study|Lack of Efficacy|7|||
130813902|NCT00522379|470946289|FG000|Overall Study|Withdrawal by Subject|2|||
130813903|NCT00522379|470946290|FG001|Overall Study|Withdrawal by Subject|3|||
130813904|NCT00522379|470946291|FG002|Overall Study|Withdrawal by Subject|1|||
130813905|NCT00522379|470946292|FG003|Overall Study|Withdrawal by Subject|2|||
130813906|NCT00522379|470946293|FG004|Overall Study|Withdrawal by Subject|0|||
130813907|NCT00522379|470946289|FG000|Overall Study|Protocol Violation|1|||
130813908|NCT00522379|470946290|FG001|Overall Study|Protocol Violation|1|||
130813909|NCT00522379|470946291|FG002|Overall Study|Protocol Violation|2|||
130813910|NCT00522379|470946292|FG003|Overall Study|Protocol Violation|0|||
130813911|NCT00522379|470946293|FG004|Overall Study|Protocol Violation|0|||
130813912|NCT00522379|470946289|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
130813913|NCT00522379|470946290|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
130813914|NCT00522379|470946291|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
130813915|NCT00522379|470946292|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
130813916|NCT00522379|470946293|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
130813917|NCT00522379|470946289|FG000|Overall Study|Lost to Follow-up|1|||
130813918|NCT00522379|470946290|FG001|Overall Study|Lost to Follow-up|0|||
130813919|NCT00522379|470946291|FG002|Overall Study|Lost to Follow-up|4|||
130813920|NCT00522379|470946292|FG003|Overall Study|Lost to Follow-up|2|||
130813921|NCT00522379|470946293|FG004|Overall Study|Lost to Follow-up|2|||
130813922|NCT00522379|470946289|FG000|Overall Study|Randomization error|0|||
130813923|NCT00522379|470946290|FG001|Overall Study|Randomization error|0|||
130813924|NCT00522379|470946291|FG002|Overall Study|Randomization error|0|||
130813925|NCT00522379|470946292|FG003|Overall Study|Randomization error|0|||
130813926|NCT00522379|470946293|FG004|Overall Study|Randomization error|1|||
130813927|NCT00522379|470946289|FG000|Overall Study|Dispensing error|1|||
130813928|NCT00522379|470946290|FG001|Overall Study|Dispensing error|0|||
130813929|NCT00522379|470946291|FG002|Overall Study|Dispensing error|0|||
130813930|NCT00522379|470946292|FG003|Overall Study|Dispensing error|1|||
130813931|NCT00522379|470946293|FG004|Overall Study|Dispensing error|0|||
130813932|NCT00522379|470946289|FG000|Overall Study|Subject Moved|1|||
130813933|NCT00522379|470946290|FG001|Overall Study|Subject Moved|1|||
130813934|NCT00522379|470946291|FG002|Overall Study|Subject Moved|0|||
130813935|NCT00522379|470946292|FG003|Overall Study|Subject Moved|0|||
130813936|NCT00522379|470946293|FG004|Overall Study|Subject Moved|0|||
130813937|NCT00522379|470946289|FG000|Overall Study|Sponsor Request|0|||
130813938|NCT00522379|470946290|FG001|Overall Study|Sponsor Request|1|||
130813939|NCT00522379|470946291|FG002|Overall Study|Sponsor Request|0|||
130813940|NCT00522379|470946292|FG003|Overall Study|Sponsor Request|0|||
130813941|NCT00522379|470946293|FG004|Overall Study|Sponsor Request|0|||
130813942|NCT00522379|470946289|FG000|Overall Study|Family Problem|0|||
130813943|NCT00522379|470946290|FG001|Overall Study|Family Problem|0|||
130813944|NCT00522379|470946291|FG002|Overall Study|Family Problem|1|||
130813945|NCT00522379|470946292|FG003|Overall Study|Family Problem|0|||
130813946|NCT00522379|470946293|FG004|Overall Study|Family Problem|0|||
130813947|NCT00522379|470946289|FG000|Overall Study|Site Closed|0|||
130813948|NCT00522379|470946290|FG001|Overall Study|Site Closed|0|||
130813949|NCT00522379|470946291|FG002|Overall Study|Site Closed|0|||
130813950|NCT00522379|470946292|FG003|Overall Study|Site Closed|1|||
130813951|NCT00522379|470946293|FG004|Overall Study|Site Closed|0|||
130813952|NCT00522379|470946289|FG000|Overall Study|Subject Withdrawal|0|||
130813953|NCT00522379|470946290|FG001|Overall Study|Subject Withdrawal|0|||
130813954|NCT00522379|470946291|FG002|Overall Study|Subject Withdrawal|0|||
130813955|NCT00522379|470946292|FG003|Overall Study|Subject Withdrawal|1|||
130813956|NCT00522379|470946293|FG004|Overall Study|Subject Withdrawal|0|||
130813957|NCT03034044|470946298|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
130813958|NCT02402647|470946301|FG000|Overall Study|Lost to Follow-up|13|||
130813959|NCT02402647|470946302|FG001|Overall Study|Lost to Follow-up|7|||
130813960|NCT02402647|470946301|FG000|Overall Study|Protocol Violation|1|||
130813961|NCT02402647|470946302|FG001|Overall Study|Protocol Violation|1|||
130813962|NCT02402647|470946301|FG000|Overall Study|scheduled and timed out|2|||
130813963|NCT02402647|470946302|FG001|Overall Study|scheduled and timed out|1|||
130813964|NCT02402647|470946301|FG000|Overall Study|medical illness|2|||
130813965|NCT02402647|470946302|FG001|Overall Study|medical illness|4|||
130813966|NCT02402647|470946301|FG000|Overall Study|Moved|2|||
130813967|NCT02402647|470946302|FG001|Overall Study|Moved|0|||
130813968|NCT02402647|470946301|FG000|Overall Study|loved one illness|1|||
130813969|NCT02402647|470946302|FG001|Overall Study|loved one illness|0|||
130813970|NCT02402647|470946301|FG000|Overall Study|deceased preexisting condition|2|||
130813971|NCT02402647|470946302|FG001|Overall Study|deceased preexisting condition|0|||
130813972|NCT02402647|470946301|FG000|Overall Study|Other|2|||
130813973|NCT02402647|470946302|FG001|Overall Study|Other|1|||
130813974|NCT04197583|470946303|FG000|Overall Study|Study Stent Replacement|34|||
130813975|NCT04197583|470946304|FG001|Overall Study|Study Stent Replacement|8|||
130813976|NCT04197583|470946303|FG000|Overall Study|Lost to Follow-up|14|||
130813977|NCT04197583|470946304|FG001|Overall Study|Lost to Follow-up|3|||
130813978|NCT04197583|470946303|FG000|Overall Study|Death|3|||
130813979|NCT04197583|470946304|FG001|Overall Study|Death|0|||
130813980|NCT04197583|470946303|FG000|Overall Study|Physician Decision|1|||
130813981|NCT04197583|470946304|FG001|Overall Study|Physician Decision|0|||
130813982|NCT04197583|470946303|FG000|Overall Study|Withdrawal by Subject|1|||
130813983|NCT04197583|470946304|FG001|Overall Study|Withdrawal by Subject|1|||
130813984|NCT04197583|470946303|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
130813985|NCT04197583|470946304|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
130813986|NCT04197583|470946303|FG000|Overall Study|Screen Failure|0|||
130813987|NCT04197583|470946304|FG001|Overall Study|Screen Failure|20|||
130813988|NCT00323622|470946308|FG000|Overall Study|Other|30|||
130813989|NCT00323622|470946309|FG001|Overall Study|Other|91|||
130813990|NCT00323622|470946310|FG002|Overall Study|Other|4|||
130813991|NCT00323622|470946311|FG003|Overall Study|Other|12|||
130813992|NCT00323622|470946312|FG004|Overall Study|Other|32|||
130813993|NCT00323622|470946313|FG005|Overall Study|Other|74|||
130813994|NCT00323622|470946314|FG006|Overall Study|Other|5|||
130813995|NCT00323622|470946315|FG007|Overall Study|Other|13|||
130813996|NCT00323622|470946308|FG000|Overall Study|Death|1|||
130813997|NCT00323622|470946309|FG001|Overall Study|Death|1|||
130813998|NCT00323622|470946310|FG002|Overall Study|Death|0|||
130813999|NCT00323622|470946311|FG003|Overall Study|Death|0|||
130814000|NCT00323622|470946312|FG004|Overall Study|Death|7|||
130814001|NCT00323622|470946313|FG005|Overall Study|Death|0|||
130814002|NCT00323622|470946314|FG006|Overall Study|Death|0|||
130814003|NCT00323622|470946315|FG007|Overall Study|Death|2|||
130814004|NCT00936936|470948253|FG000|Overall Study|Adverse Event|7|||
130814005|NCT00936936|470948254|FG001|Overall Study|Adverse Event|1|||
130814006|NCT00936936|470948253|FG000|Overall Study|Disease Progression|2|||
130814007|NCT00936936|470948254|FG001|Overall Study|Disease Progression|2|||
130814008|NCT00936936|470948253|FG000|Overall Study|Unrelated|3|||
130814009|NCT00936936|470948254|FG001|Overall Study|Unrelated|1|||
130814010|NCT01373281|470948255|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
130814011|NCT01373281|470948256|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
130814012|NCT01373281|470948255|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
130814013|NCT01373281|470948256|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
130814014|NCT01373281|470948255|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
130814015|NCT01373281|470948256|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
130814016|NCT01373281|470948255|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
130814017|NCT01373281|470948256|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
130814018|NCT01373281|470948255|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
130814019|NCT01373281|470948256|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
130814020|NCT01373281|470948255|FG000|Surveillance Expansion Period|Protocol Violation|9|||
130814021|NCT01373281|470948256|FG001|Surveillance Expansion Period|Protocol Violation|1|||
130814022|NCT01373281|470948255|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
130814023|NCT01373281|470948256|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
130814024|NCT01373281|470948255|FG000|Surveillance Expansion Period|Serious adverse event|3|||
130814025|NCT01373281|470948256|FG001|Surveillance Expansion Period|Serious adverse event|4|||
130814026|NCT03033784|470948260|FG000|Overall Study|Anxiety related to MRI scanner|0|||
130814027|NCT03033784|470948261|FG001|Overall Study|Anxiety related to MRI scanner|1|||
130814028|NCT03033784|470948262|FG002|Overall Study|Anxiety related to MRI scanner|0|||
130814029|NCT03033784|470948263|FG003|Overall Study|Anxiety related to MRI scanner|0|||
130814030|NCT03033784|470948264|FG004|Overall Study|Anxiety related to MRI scanner|0|||
130814031|NCT03033784|470948265|FG005|Overall Study|Anxiety related to MRI scanner|0|||
130814032|NCT03033784|470948266|FG006|Overall Study|Anxiety related to MRI scanner|0|||
130814033|NCT03033784|470948267|FG007|Overall Study|Anxiety related to MRI scanner|0|||
130814034|NCT03033784|470948268|FG008|Overall Study|Anxiety related to MRI scanner|0|||
130814035|NCT03033784|470948269|FG009|Overall Study|Anxiety related to MRI scanner|0|||
130814036|NCT03033784|470948270|FG010|Overall Study|Anxiety related to MRI scanner|0|||
130814037|NCT03033784|470948271|FG011|Overall Study|Anxiety related to MRI scanner|0|||
130814038|NCT03033784|470948272|FG012|Overall Study|Anxiety related to MRI scanner|0|||
130814039|NCT03033784|470948260|FG000|Overall Study|Withdrawal by Subject|0|||
130814040|NCT03033784|470948261|FG001|Overall Study|Withdrawal by Subject|0|||
130814041|NCT03033784|470948262|FG002|Overall Study|Withdrawal by Subject|0|||
130814042|NCT03033784|470948263|FG003|Overall Study|Withdrawal by Subject|0|||
130814043|NCT03033784|470948264|FG004|Overall Study|Withdrawal by Subject|0|||
130814044|NCT03033784|470948265|FG005|Overall Study|Withdrawal by Subject|0|||
130814045|NCT03033784|470948266|FG006|Overall Study|Withdrawal by Subject|0|||
130814046|NCT03033784|470948267|FG007|Overall Study|Withdrawal by Subject|0|||
130814047|NCT03033784|470948268|FG008|Overall Study|Withdrawal by Subject|0|||
130814048|NCT03033784|470948269|FG009|Overall Study|Withdrawal by Subject|0|||
130814049|NCT03033784|470948270|FG010|Overall Study|Withdrawal by Subject|0|||
130814050|NCT03033784|470948271|FG011|Overall Study|Withdrawal by Subject|0|||
130814051|NCT03033784|470948272|FG012|Overall Study|Withdrawal by Subject|2|||
130814052|NCT03332056|470948274|FG000|Overall Study|Incomplete questionnaires|8|||
130814053|NCT03332056|470948275|FG001|Overall Study|Incomplete questionnaires|9|||
130814054|NCT03332056|470948274|FG000|Overall Study|Passed stone prior to surgery date|1|||
130814055|NCT03332056|470948275|FG001|Overall Study|Passed stone prior to surgery date|0|||
130814056|NCT03332056|470948274|FG000|Overall Study|Did not require a ureteral stent|0|||
130814057|NCT03332056|470948275|FG001|Overall Study|Did not require a ureteral stent|1|||
130814058|NCT03014089|470948276|FG000|Overall Study|Withdrawal by Subject|0|||
130814059|NCT03014089|470948277|FG001|Overall Study|Withdrawal by Subject|1|||
130814060|NCT03014089|470948278|FG002|Overall Study|Withdrawal by Subject|1|||
130814061|NCT03014089|470948279|FG003|Overall Study|Withdrawal by Subject|1|||
130814062|NCT03014089|470948276|FG000|Overall Study|Lost to Follow-up|1|||
130814063|NCT03014089|470948277|FG001|Overall Study|Lost to Follow-up|0|||
130814064|NCT03014089|470948278|FG002|Overall Study|Lost to Follow-up|0|||
130814065|NCT03014089|470948279|FG003|Overall Study|Lost to Follow-up|0|||
130814066|NCT03014089|470948276|FG000|Overall Study|Adverse Event|1|||
130814067|NCT03014089|470948277|FG001|Overall Study|Adverse Event|0|||
130814068|NCT03014089|470948278|FG002|Overall Study|Adverse Event|1|||
130814069|NCT03014089|470948279|FG003|Overall Study|Adverse Event|0|||
130814070|NCT00851084|470948280|FG000|Overall Study|Randomized but not treated|1|||
130814071|NCT00851084|470948281|FG001|Overall Study|Randomized but not treated|0|||
130814072|NCT00851084|470948280|FG000|Overall Study|Adverse Event|26|||
130814073|NCT00851084|470948281|FG001|Overall Study|Adverse Event|36|||
130814074|NCT00851084|470948280|FG000|Overall Study|Disease progression|52|||
130814075|NCT00851084|470948281|FG001|Overall Study|Disease progression|47|||
130814076|NCT00851084|470948280|FG000|Overall Study|Poor compliance to protocol|1|||
130814077|NCT00851084|470948281|FG001|Overall Study|Poor compliance to protocol|1|||
130814078|NCT00851084|470948280|FG000|Overall Study|Physician Decision|13|||
130814079|NCT00851084|470948281|FG001|Overall Study|Physician Decision|14|||
130814080|NCT00851084|470948280|FG000|Overall Study|Consent withdrawn|0|||
130814081|NCT00851084|470948281|FG001|Overall Study|Consent withdrawn|2|||
130814082|NCT00851084|470948280|FG000|Overall Study|Withdrawal by Subject|11|||
130814083|NCT00851084|470948281|FG001|Overall Study|Withdrawal by Subject|12|||
130814084|NCT00851084|470948280|FG000|Overall Study|Metastatic surgery|6|||
130814085|NCT00851084|470948281|FG001|Overall Study|Metastatic surgery|6|||
130814086|NCT00851084|470948280|FG000|Overall Study|Other|7|||
130814087|NCT00851084|470948281|FG001|Overall Study|Other|1|||
130814088|NCT00734032|470948282|FG000|Overall Study|Adverse Event|0|||
130814089|NCT00734032|470948283|FG001|Overall Study|Adverse Event|1|||
130814090|NCT00734032|470948284|FG002|Overall Study|Adverse Event|0|||
130814091|NCT00734032|470948285|FG003|Overall Study|Adverse Event|0|||
130814092|NCT00133705|470948288|FG000|Overall Study|Withdrawal by Subject|2|||
130814093|NCT00133705|470948289|FG001|Overall Study|Withdrawal by Subject|3|||
130814094|NCT01992757|470948293|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
130814095|NCT03440411|470948294|FG000|Overall Study|Adverse Event|0|||
130814096|NCT03440411|470948295|FG001|Overall Study|Adverse Event|0|||
130814097|NCT03440411|470948296|FG002|Overall Study|Adverse Event|1|||
130814098|NCT03440411|470948297|FG003|Overall Study|Adverse Event|0|||
130814099|NCT03440411|470948294|FG000|Overall Study|PD|2|||
130814100|NCT03440411|470948295|FG001|Overall Study|PD|1|||
130814101|NCT03440411|470948296|FG002|Overall Study|PD|1|||
130814102|NCT03440411|470948297|FG003|Overall Study|PD|1|||
130814103|NCT03440411|470948294|FG000|Overall Study|Withdrawal by Subject|1|||
130814104|NCT03440411|470948295|FG001|Overall Study|Withdrawal by Subject|0|||
130814105|NCT03440411|470948296|FG002|Overall Study|Withdrawal by Subject|0|||
130814106|NCT03440411|470948297|FG003|Overall Study|Withdrawal by Subject|0|||
130814107|NCT03440411|470948294|FG000|Overall Study|Closed study by sponsor|0|||
130814108|NCT03440411|470948295|FG001|Overall Study|Closed study by sponsor|0|||
130814109|NCT03440411|470948296|FG002|Overall Study|Closed study by sponsor|0|||
130814110|NCT03440411|470948297|FG003|Overall Study|Closed study by sponsor|1|||
130814113|NCT00688740|470948300|FG000|Overall Study|Adverse Event|45|||
130814114|NCT00688740|470948301|FG001|Overall Study|Adverse Event|8|||
130814115|NCT00688740|470948300|FG000|Overall Study|Death|2|||
130814116|NCT00688740|470948301|FG001|Overall Study|Death|2|||
130814117|NCT00688740|470948300|FG000|Overall Study|Lost to Follow-up|0|||
130814118|NCT00688740|470948301|FG001|Overall Study|Lost to Follow-up|1|||
130814119|NCT00688740|470948300|FG000|Overall Study|Consent Withdrawn|17|||
130814120|NCT00688740|470948301|FG001|Overall Study|Consent Withdrawn|17|||
130814121|NCT00688740|470948300|FG000|Overall Study|Breast Cancer Relapse|1|||
130814122|NCT00688740|470948301|FG001|Overall Study|Breast Cancer Relapse|4|||
130814123|NCT00688740|470948300|FG000|Overall Study|Violation of Inclusion Criteria|1|||
130814124|NCT00688740|470948301|FG001|Overall Study|Violation of Inclusion Criteria|3|||
130814125|NCT00856557|470948302|FG000|Overall Study|No patients with contextual flags|12|||
130814126|NCT00856557|470948303|FG001|Overall Study|No patients with contextual flags|16|||
130814127|NCT03673176|470948304|FG000|Overall Study|Death prior to intervention|1|||
130814128|NCT03673176|470948304|FG000|Overall Study|Death following intervention|3|||
130814129|NCT03673176|470948304|FG000|Overall Study|Withdrawal by Subject|1|||
130814130|NCT02439957|470948305|FG000|Overall Study|Study Terminated|3|||
130814131|NCT02439957|470948306|FG001|Overall Study|Study Terminated|3|||
130814132|NCT00863304|470948311|FG000|Overall Study|Adverse Event|10|||
130814133|NCT00863304|470948312|FG001|Overall Study|Adverse Event|4|||
130814134|NCT00863304|470948313|FG002|Overall Study|Adverse Event|14|||
130814135|NCT00863304|470948314|FG003|Overall Study|Adverse Event|16|||
130814136|NCT00863304|470948311|FG000|Overall Study|Lost to Follow-up|1|||
130814137|NCT00863304|470948312|FG001|Overall Study|Lost to Follow-up|5|||
130814138|NCT00863304|470948313|FG002|Overall Study|Lost to Follow-up|4|||
130814139|NCT00863304|470948314|FG003|Overall Study|Lost to Follow-up|2|||
130814140|NCT00863304|470948311|FG000|Overall Study|Lack of Efficacy|57|||
130814141|NCT00863304|470948312|FG001|Overall Study|Lack of Efficacy|26|||
130814142|NCT00863304|470948313|FG002|Overall Study|Lack of Efficacy|30|||
130814143|NCT00863304|470948314|FG003|Overall Study|Lack of Efficacy|28|||
130814144|NCT00863304|470948311|FG000|Overall Study|Withdrawal by Subject|19|||
130814145|NCT00863304|470948312|FG001|Overall Study|Withdrawal by Subject|14|||
130814146|NCT00863304|470948313|FG002|Overall Study|Withdrawal by Subject|20|||
130814147|NCT00863304|470948314|FG003|Overall Study|Withdrawal by Subject|18|||
130814148|NCT00863304|470948311|FG000|Overall Study|Other|1|||
130814149|NCT00863304|470948312|FG001|Overall Study|Other|0|||
130814150|NCT00863304|470948313|FG002|Overall Study|Other|0|||
130814151|NCT00863304|470948314|FG003|Overall Study|Other|1|||
130814152|NCT00863304|470948311|FG000|Overall Study|Protocol Violation|2|||
130814153|NCT00863304|470948312|FG001|Overall Study|Protocol Violation|6|||
130814154|NCT00863304|470948313|FG002|Overall Study|Protocol Violation|2|||
130814155|NCT00863304|470948314|FG003|Overall Study|Protocol Violation|0|||
130814156|NCT00863304|470948311|FG000|Overall Study|Randomized, but not Treated|3|||
130814157|NCT00863304|470948312|FG001|Overall Study|Randomized, but not Treated|1|||
130814158|NCT00863304|470948313|FG002|Overall Study|Randomized, but not Treated|4|||
130814159|NCT00863304|470948314|FG003|Overall Study|Randomized, but not Treated|1|||
130814160|NCT00863304|470948311|FG000|Overall Study|Entered extension study|101|||
130814161|NCT00863304|470948312|FG001|Overall Study|Entered extension study|129|||
130814162|NCT00863304|470948313|FG002|Overall Study|Entered extension study|113|||
130814163|NCT00863304|470948314|FG003|Overall Study|Entered extension study|125|||
130814164|NCT00478257|470948315|FG000|Overall Study|Withdrawal by Subject|8|||
130814165|NCT00478257|470948316|FG001|Overall Study|Withdrawal by Subject|3|||
130814166|NCT03931330|470948317|FG000|Overall Study|Physician Decision|1|||
130814167|NCT03412929|470948318|FG000|Overall Study|Protocol Violation|3|||
130814168|NCT04023487|470948321|FG000|Overall Study|Lost to Follow-up|5|||
130814169|NCT04023487|470948322|FG001|Overall Study|Lost to Follow-up|4|||
130814170|NCT04023487|470948321|FG000|Overall Study|Pregnancy|1|||
130814171|NCT04023487|470948322|FG001|Overall Study|Pregnancy|2|||
130814172|NCT04023487|470948321|FG000|Overall Study|Withdrawal by Subject|4|||
130814173|NCT04023487|470948322|FG001|Overall Study|Withdrawal by Subject|5|||
130814174|NCT04023487|470948321|FG000|Overall Study|Partially completed testing|8|||
130814175|NCT04023487|470948322|FG001|Overall Study|Partially completed testing|4|||
130814176|NCT03528902|470948325|FG000|Overall Study|Adverse Event|1|||
130814177|NCT03528902|470948326|FG001|Overall Study|Adverse Event|0|||
130814178|NCT04770285|470948327|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
130814179|NCT04770285|470948328|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
130814180|NCT04770285|470948327|FG000|Overall Study|Lack of Efficacy|0|||
130814181|NCT04770285|470948328|FG001|Overall Study|Lack of Efficacy|1|||
130814182|NCT04770285|470948327|FG000|Overall Study|Lost to Follow-up|11|||
130814183|NCT04770285|470948328|FG001|Overall Study|Lost to Follow-up|8|||
130814184|NCT04770285|470948327|FG000|Overall Study|Protocol Deviation|6|||
130814185|NCT04770285|470948328|FG001|Overall Study|Protocol Deviation|6|||
130814186|NCT04770285|470948327|FG000|Overall Study|Technical Problem|0|||
130814187|NCT04770285|470948328|FG001|Overall Study|Technical Problem|1|||
130814188|NCT04770285|470948327|FG000|Overall Study|Withdrawal by Subject|9|||
130814189|NCT04770285|470948328|FG001|Overall Study|Withdrawal by Subject|8|||
130814190|NCT04770285|470948327|FG000|Overall Study|Reason Not Specified|0|||
130814191|NCT04770285|470948328|FG001|Overall Study|Reason Not Specified|1|||
130814192|NCT03766399|470948329|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814193|NCT03766399|470948330|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814194|NCT03766399|470948331|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814195|NCT03766399|470948332|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814196|NCT03766399|470948333|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814197|NCT03766399|470948334|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814198|NCT03766399|470948335|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814199|NCT03766399|470948336|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814200|NCT03766399|470948337|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814201|NCT03766399|470948338|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814202|NCT03766399|470948339|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814203|NCT03766399|470948340|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814204|NCT03766399|470948341|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814205|NCT03766399|470948342|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
130814206|NCT03766399|470948343|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814207|NCT03766399|470948344|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814208|NCT03766399|470948345|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814209|NCT03766399|470948346|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130814210|NCT05030766|470948347|FG000|Phase 1 Participants|Lost to Follow-up|12|||
130814211|NCT05030766|470948348|FG001|Phase 1 Participants|Lost to Follow-up|22|||
130814212|NCT05030766|470948349|FG002|Phase 1 Participants|Lost to Follow-up|0|||
130814213|NCT05030766|470948350|FG003|Phase 1 Participants|Lost to Follow-up|0|||
130814214|NCT05030766|470948347|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
130814215|NCT05030766|470948348|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
130814216|NCT05030766|470948349|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
130814217|NCT05030766|470948350|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
130814218|NCT05030766|470948347|FG000|Phase 2 Participants|Lost to Follow-up|0|||
130814219|NCT05030766|470948348|FG001|Phase 2 Participants|Lost to Follow-up|0|||
130814220|NCT05030766|470948349|FG002|Phase 2 Participants|Lost to Follow-up|6|||
130814221|NCT05030766|470948350|FG003|Phase 2 Participants|Lost to Follow-up|2|||
130814222|NCT00645658|470948351|FG000|Overall Study|Withdrawal by Subject|1|||
130814223|NCT00645658|470948352|FG001|Overall Study|Withdrawal by Subject|0|||
130814224|NCT00645658|470948351|FG000|Overall Study|Did not complete all assesments|0|||
130814225|NCT00645658|470948352|FG001|Overall Study|Did not complete all assesments|2|||
130814226|NCT03895372|470948355|FG000|Investigational Treatment Period|Adverse Event|1|||
130814227|NCT03895372|470948356|FG001|Investigational Treatment Period|Adverse Event|0|||
130814228|NCT03895372|470948357|FG002|Investigational Treatment Period|Adverse Event|0|||
130814229|NCT03895372|470948358|FG003|Investigational Treatment Period|Adverse Event|0|||
130814230|NCT03895372|470948359|FG004|Investigational Treatment Period|Adverse Event|0|||
130814231|NCT03895372|470948360|FG005|Investigational Treatment Period|Adverse Event|0|||
130814232|NCT03895372|470948361|FG006|Investigational Treatment Period|Adverse Event|4|||
130814233|NCT03895372|470948362|FG007|Investigational Treatment Period|Adverse Event|3|||
130814234|NCT03895372|470948355|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
130814235|NCT03895372|470948356|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
130814236|NCT03895372|470948357|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
130814237|NCT03895372|470948358|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
130814238|NCT03895372|470948359|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
130814239|NCT03895372|470948360|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
130814240|NCT03895372|470948361|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
130814241|NCT03895372|470948362|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
130814242|NCT03895372|470948355|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
130814243|NCT03895372|470948356|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
130814244|NCT03895372|470948357|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
130814245|NCT03895372|470948358|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
130814246|NCT03895372|470948359|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
130814247|NCT03895372|470948360|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
130814248|NCT03895372|470948361|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
130814249|NCT03895372|470948362|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
130814250|NCT03895372|470948355|FG000|Investigational Treatment Period|Other|0|||
130814251|NCT03895372|470948356|FG001|Investigational Treatment Period|Other|0|||
130814252|NCT03895372|470948357|FG002|Investigational Treatment Period|Other|0|||
130814253|NCT03895372|470948358|FG003|Investigational Treatment Period|Other|0|||
130814254|NCT03895372|470948359|FG004|Investigational Treatment Period|Other|0|||
130814255|NCT03895372|470948360|FG005|Investigational Treatment Period|Other|1|||
130814256|NCT03895372|470948361|FG006|Investigational Treatment Period|Other|0|||
130814257|NCT03895372|470948362|FG007|Investigational Treatment Period|Other|2|||
130814258|NCT03895372|470948355|FG000|Investigational Treatment Period|Protocol Violation|0|||
130814259|NCT03895372|470948356|FG001|Investigational Treatment Period|Protocol Violation|0|||
130814260|NCT03895372|470948357|FG002|Investigational Treatment Period|Protocol Violation|0|||
130814261|NCT03895372|470948358|FG003|Investigational Treatment Period|Protocol Violation|1|||
130814262|NCT03895372|470948359|FG004|Investigational Treatment Period|Protocol Violation|0|||
130814263|NCT03895372|470948360|FG005|Investigational Treatment Period|Protocol Violation|0|||
130814264|NCT03895372|470948361|FG006|Investigational Treatment Period|Protocol Violation|0|||
130814265|NCT03895372|470948362|FG007|Investigational Treatment Period|Protocol Violation|0|||
130814266|NCT03895372|470948355|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
130814267|NCT03895372|470948356|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
130814268|NCT03895372|470948357|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
130814269|NCT03895372|470948358|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
130814270|NCT03895372|470948359|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
130814271|NCT03895372|470948360|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
130814272|NCT03895372|470948361|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
130814273|NCT03895372|470948362|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
130814274|NCT03895372|470948355|FG000|Extension Treatment Period|Adverse Event|0|||
130814275|NCT03895372|470948356|FG001|Extension Treatment Period|Adverse Event|1|||
130814276|NCT03895372|470948357|FG002|Extension Treatment Period|Adverse Event|0|||
130814277|NCT03895372|470948358|FG003|Extension Treatment Period|Adverse Event|1|||
130814278|NCT03895372|470948359|FG004|Extension Treatment Period|Adverse Event|0|||
130814279|NCT03895372|470948360|FG005|Extension Treatment Period|Adverse Event|0|||
130814280|NCT03895372|470948361|FG006|Extension Treatment Period|Adverse Event|3|||
130814281|NCT03895372|470948362|FG007|Extension Treatment Period|Adverse Event|3|||
130814282|NCT03895372|470948355|FG000|Extension Treatment Period|Other|1|||
130814283|NCT03895372|470948356|FG001|Extension Treatment Period|Other|3|||
130814284|NCT03895372|470948357|FG002|Extension Treatment Period|Other|0|||
130814285|NCT03895372|470948358|FG003|Extension Treatment Period|Other|0|||
130814286|NCT03895372|470948359|FG004|Extension Treatment Period|Other|1|||
130814287|NCT03895372|470948360|FG005|Extension Treatment Period|Other|0|||
130814288|NCT03895372|470948361|FG006|Extension Treatment Period|Other|0|||
130814289|NCT03895372|470948362|FG007|Extension Treatment Period|Other|2|||
130814290|NCT03895372|470948355|FG000|Extension Treatment Period|Pregnancy|0|||
130814291|NCT03895372|470948356|FG001|Extension Treatment Period|Pregnancy|0|||
130814292|NCT03895372|470948357|FG002|Extension Treatment Period|Pregnancy|0|||
130814293|NCT03895372|470948358|FG003|Extension Treatment Period|Pregnancy|0|||
130814294|NCT03895372|470948359|FG004|Extension Treatment Period|Pregnancy|1|||
130814295|NCT03895372|470948360|FG005|Extension Treatment Period|Pregnancy|0|||
130814296|NCT03895372|470948361|FG006|Extension Treatment Period|Pregnancy|0|||
130814297|NCT03895372|470948362|FG007|Extension Treatment Period|Pregnancy|0|||
130814298|NCT03895372|470948355|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
130814299|NCT03895372|470948356|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
130814300|NCT03895372|470948357|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
130814301|NCT03895372|470948358|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
130814302|NCT03895372|470948359|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
130814303|NCT03895372|470948360|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
130814304|NCT03895372|470948361|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
130814305|NCT03895372|470948362|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
130814306|NCT00023595|470948367|FG000|5 Year Follow up|Lost to Follow-up|2|||
130814307|NCT00023595|470948368|FG001|5 Year Follow up|Lost to Follow-up|2|||
130814308|NCT00023595|470948369|FG002|5 Year Follow up|Lost to Follow-up|1|||
130814309|NCT00023595|470948370|FG003|5 Year Follow up|Lost to Follow-up|7|||
130814310|NCT00023595|470948371|FG004|5 Year Follow up|Lost to Follow-up|3|||
130814311|NCT00023595|470948367|FG000|10 Year Follow up|Lost to Follow-up|12|||
130814312|NCT00023595|470948368|FG001|10 Year Follow up|Lost to Follow-up|10|||
130814313|NCT00023595|470948369|FG002|10 Year Follow up|Lost to Follow-up|3|||
130814314|NCT00023595|470948370|FG003|10 Year Follow up|Lost to Follow-up|0|||
130814315|NCT00023595|470948371|FG004|10 Year Follow up|Lost to Follow-up|0|||
130814316|NCT01472185|470948372|FG000|Overall Study|Randomized but Not Treated|0|||
130814317|NCT01472185|470948373|FG001|Overall Study|Randomized but Not Treated|1|||
130814318|NCT01472185|470948372|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
130814319|NCT01472185|470948373|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
130814320|NCT01472185|470948372|FG000|Overall Study|Hyperglycemia|5|||
130814321|NCT01472185|470948373|FG001|Overall Study|Hyperglycemia|2|||
130814322|NCT01472185|470948372|FG000|Overall Study|Investigator's Discretion|3|||
130814323|NCT01472185|470948373|FG001|Overall Study|Investigator's Discretion|1|||
130814324|NCT01472185|470948372|FG000|Overall Study|Lost to Follow-up|4|||
130814325|NCT01472185|470948373|FG001|Overall Study|Lost to Follow-up|1|||
130814326|NCT01472185|470948372|FG000|Overall Study|Protocol Violation|5|||
130814327|NCT01472185|470948373|FG001|Overall Study|Protocol Violation|1|||
130814328|NCT01472185|470948372|FG000|Overall Study|Subject Noncompliance|8|||
130814329|NCT01472185|470948373|FG001|Overall Study|Subject Noncompliance|15|||
130814330|NCT01472185|470948372|FG000|Overall Study|Subject Withdrew Consent|6|||
130814331|NCT01472185|470948373|FG001|Overall Study|Subject Withdrew Consent|3|||
130814332|NCT05889468|470948374|FG000|Overall Study|Lost to Follow-up|9|||
130814333|NCT05889468|470948375|FG001|Overall Study|Lost to Follow-up|2|||
130814334|NCT05889468|470948374|FG000|Overall Study|Withdrawal by Subject|2|||
130814335|NCT05889468|470948375|FG001|Overall Study|Withdrawal by Subject|2|||
130814336|NCT01309230|470948376|FG000|Overall Study|Withdrawal by Subject|0|||
130814337|NCT01309230|470948377|FG001|Overall Study|Withdrawal by Subject|2|||
130814338|NCT01309230|470948376|FG000|Overall Study|Observation arm closed|0|||
130814339|NCT01309230|470948377|FG001|Overall Study|Observation arm closed|2|||
130814340|NCT03900650|470948382|FG000|Overall Study|Withdrawal by Subject|1|||
130814341|NCT03900650|470948383|FG001|Overall Study|Withdrawal by Subject|1|||
130814342|NCT03900650|470948384|FG002|Overall Study|Withdrawal by Subject|0|||
130814343|NCT03900650|470948385|FG003|Overall Study|Withdrawal by Subject|0|||
130814344|NCT03900650|470948382|FG000|Overall Study|Withdrawn by staff|1|||
130814345|NCT03900650|470948383|FG001|Overall Study|Withdrawn by staff|0|||
130814346|NCT03900650|470948384|FG002|Overall Study|Withdrawn by staff|0|||
130814347|NCT03900650|470948385|FG003|Overall Study|Withdrawn by staff|0|||
130814348|NCT00086515|470948388|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
130814349|NCT00086515|470948389|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
130814350|NCT00086515|470948388|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
130814351|NCT00086515|470948389|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
130814352|NCT00086515|470948388|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
130814353|NCT00086515|470948389|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
130814354|NCT00086515|470948388|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
130814355|NCT00086515|470948389|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
130814356|NCT00086515|470948388|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
130814357|NCT00086515|470948389|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
130814358|NCT00086515|470948388|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
130814359|NCT00086515|470948389|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
130814360|NCT00086515|470948388|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
130814361|NCT00086515|470948389|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
130814362|NCT00086515|470948388|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
130814363|NCT00086515|470948389|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
130814364|NCT00086515|470948388|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
130814365|NCT00086515|470948389|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
130814366|NCT00086515|470948388|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
130814367|NCT00086515|470948389|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
130814368|NCT00086515|470948388|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
130814369|NCT00086515|470948389|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
130814370|NCT00086515|470948388|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
130814371|NCT00086515|470948389|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
130814372|NCT00086515|470948388|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
130814373|NCT00086515|470948389|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
130814374|NCT00086515|470948388|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
130814375|NCT00086515|470948389|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
130814376|NCT00086515|470948388|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
130814377|NCT00086515|470948389|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
130814378|NCT00086515|470948388|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
130814379|NCT00086515|470948389|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
130814380|NCT00086515|470948388|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
130814381|NCT00086515|470948389|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
130814382|NCT00086515|470948388|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
130814383|NCT00086515|470948389|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
130814384|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
130814385|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
130814386|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
130814387|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
130814388|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
130814389|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
130814390|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
130814391|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
130814392|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
130814393|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
130814394|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
130814395|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
130814396|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
130814397|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
130814398|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
130814399|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
130814400|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
130814401|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
130814402|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
130814403|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
130814404|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
130814405|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
130814406|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
130814407|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
130814408|NCT00086515|470948388|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
130814409|NCT00086515|470948389|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
130814410|NCT02082977|470948390|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
130814411|NCT02082977|470948391|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
130814412|NCT02082977|470948392|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
130814413|NCT02082977|470948393|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
130814414|NCT02082977|470948394|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
130814415|NCT02082977|470948395|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
130814416|NCT02082977|470948396|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
130814417|NCT02082977|470948397|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
130814418|NCT02082977|470948398|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
130814419|NCT02082977|470948399|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
130814420|NCT02082977|470948390|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130814421|NCT02082977|470948391|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130814422|NCT02082977|470948392|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130814423|NCT02082977|470948393|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130814424|NCT02082977|470948394|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130814425|NCT02082977|470948395|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130814426|NCT02082977|470948396|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130814427|NCT02082977|470948397|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
130814428|NCT02082977|470948398|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130814429|NCT02082977|470948399|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130814430|NCT02082977|470948390|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130814431|NCT02082977|470948391|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130814432|NCT02082977|470948392|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130814433|NCT02082977|470948393|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130814434|NCT02082977|470948394|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130814435|NCT02082977|470948395|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
130814436|NCT02082977|470948396|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130814437|NCT02082977|470948397|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130814438|NCT02082977|470948398|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130814439|NCT02082977|470948399|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130814440|NCT02082977|470948390|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130814441|NCT02082977|470948391|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130814442|NCT02082977|470948392|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130814443|NCT02082977|470948393|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130814444|NCT02082977|470948394|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
130814445|NCT02082977|470948395|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
130814446|NCT02082977|470948396|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
130814447|NCT02082977|470948397|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
130814448|NCT02082977|470948398|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
130814449|NCT02082977|470948399|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130814450|NCT02082977|470948390|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130814451|NCT02082977|470948391|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130814452|NCT02082977|470948392|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130814453|NCT02082977|470948393|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130814454|NCT02082977|470948394|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130814455|NCT02082977|470948395|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130814456|NCT02082977|470948396|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130814457|NCT02082977|470948397|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
130814458|NCT02082977|470948398|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130814459|NCT02082977|470948399|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130814460|NCT00049543|470948400|FG000|Overall Study|still on treatment|2|||
130814461|NCT00049543|470948401|FG001|Overall Study|still on treatment|9|||
130814462|NCT04562090|470948402|FG000|Overall Study|Withdrawal by Subject|3|||
130814463|NCT04562090|470948403|FG001|Overall Study|Withdrawal by Subject|4|||
130814464|NCT04562090|470948402|FG000|Overall Study|Protocol Violation|2|||
130814465|NCT04562090|470948403|FG001|Overall Study|Protocol Violation|0|||
130814466|NCT04562090|470948402|FG000|Overall Study|Lack of Efficacy|0|||
130814467|NCT04562090|470948403|FG001|Overall Study|Lack of Efficacy|1|||
130814468|NCT04562090|470948402|FG000|Overall Study|Adverse Event|1|||
130814469|NCT04562090|470948403|FG001|Overall Study|Adverse Event|4|||
130814470|NCT04562090|470948402|FG000|Overall Study|Miscellaneous|0|||
130814471|NCT04562090|470948403|FG001|Overall Study|Miscellaneous|3|||
130814472|NCT03633058|470948404|FG000|Overall Study|Adverse Event|0|||
130814473|NCT03633058|470948405|FG001|Overall Study|Adverse Event|0|||
130814474|NCT03633058|470948406|FG002|Overall Study|Adverse Event|1|||
130814475|NCT03633058|470948407|FG003|Overall Study|Adverse Event|0|||
130814476|NCT03312543|470948408|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
130814477|NCT03312543|470948409|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
130814478|NCT03312543|470948408|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
130814479|NCT03312543|470948409|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
130814480|NCT03312543|470948408|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
130814481|NCT03312543|470948409|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
130814482|NCT03312543|470948408|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
130814483|NCT03312543|470948409|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
130814484|NCT03312543|470948408|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
130814485|NCT03312543|470948409|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
130814486|NCT03312543|470948408|FG000|Regression (Week 12 to Week 24)|Death|0|||
130814487|NCT03312543|470948409|FG001|Regression (Week 12 to Week 24)|Death|1|||
130814488|NCT04134936|470948410|FG000|Overall Study|Adverse Event|3|||
130814489|NCT04134936|470948411|FG001|Overall Study|Adverse Event|2|||
130814490|NCT04134936|470948410|FG000|Overall Study|Withdrawal by Subject|2|||
130814491|NCT04134936|470948411|FG001|Overall Study|Withdrawal by Subject|3|||
130814492|NCT04134936|470948410|FG000|Overall Study|Physician Decision|0|||
130814493|NCT04134936|470948411|FG001|Overall Study|Physician Decision|1|||
130814494|NCT04134936|470948410|FG000|Overall Study|Progressive disease, joined another trial|1|||
130814495|NCT04134936|470948411|FG001|Overall Study|Progressive disease, joined another trial|0|||
130814496|NCT04134936|470948410|FG000|Overall Study|Progressive disease|1|||
130814497|NCT04134936|470948411|FG001|Overall Study|Progressive disease|0|||
130814498|NCT02420717|470948412|FG000|Overall Study|Did not receive all study medication|2|||
130814499|NCT02420717|470948413|FG001|Overall Study|Did not receive all study medication|0|||
130814500|NCT02420717|470948414|FG002|Overall Study|Did not receive all study medication|0|||
130814501|NCT04144517|470948417|FG000|Overall Study|Physician Decision|0|||
130814502|NCT04144517|470948418|FG001|Overall Study|Physician Decision|1|||
130814503|NCT04144517|470948417|FG000|Overall Study|Other|2|||
130814504|NCT04144517|470948418|FG001|Overall Study|Other|2|||
130814505|NCT04144517|470948417|FG000|Overall Study|Death|6|||
130814506|NCT04144517|470948418|FG001|Overall Study|Death|3|||
130814507|NCT00835367|470948424|FG000|Washout|Adverse Event|2|||
130814508|NCT00835367|470948425|FG001|Washout|Adverse Event|0|||
130814509|NCT00835367|470948424|FG000|Washout|Withdrawal by Subject|1|||
130814510|NCT00835367|470948425|FG001|Washout|Withdrawal by Subject|0|||
130814511|NCT00835367|470948424|FG000|Second Intervention|Adverse Event|1|||
130814512|NCT00835367|470948425|FG001|Second Intervention|Adverse Event|1|||
130814513|NCT02106832|470949854|FG000|Overall Study|Adverse Event|1|||
130814514|NCT02106832|470949855|FG001|Overall Study|Adverse Event|2|||
130814515|NCT02106832|470949856|FG002|Overall Study|Adverse Event|3|||
130814516|NCT02106832|470949857|FG003|Overall Study|Adverse Event|0|||
130814517|NCT02106832|470949854|FG000|Overall Study|Death|4|||
130814518|NCT02106832|470949855|FG001|Overall Study|Death|4|||
130814519|NCT02106832|470949856|FG002|Overall Study|Death|1|||
130814520|NCT02106832|470949857|FG003|Overall Study|Death|4|||
130814521|NCT02106832|470949854|FG000|Overall Study|Deterioration of general conditions|0|||
130814522|NCT02106832|470949855|FG001|Overall Study|Deterioration of general conditions|0|||
130814523|NCT02106832|470949856|FG002|Overall Study|Deterioration of general conditions|1|||
130814524|NCT02106832|470949857|FG003|Overall Study|Deterioration of general conditions|0|||
130814525|NCT02106832|470949854|FG000|Overall Study|Lost to Follow-up|0|||
130814526|NCT02106832|470949855|FG001|Overall Study|Lost to Follow-up|1|||
130814527|NCT02106832|470949856|FG002|Overall Study|Lost to Follow-up|1|||
130814528|NCT02106832|470949857|FG003|Overall Study|Lost to Follow-up|3|||
130814529|NCT02106832|470949854|FG000|Overall Study|Physician Decision|1|||
130814530|NCT02106832|470949855|FG001|Overall Study|Physician Decision|0|||
130814531|NCT02106832|470949856|FG002|Overall Study|Physician Decision|0|||
130814532|NCT02106832|470949857|FG003|Overall Study|Physician Decision|0|||
130814533|NCT02106832|470949854|FG000|Overall Study|Protocol Violation|0|||
130814534|NCT02106832|470949855|FG001|Overall Study|Protocol Violation|0|||
130814535|NCT02106832|470949856|FG002|Overall Study|Protocol Violation|0|||
130814536|NCT02106832|470949857|FG003|Overall Study|Protocol Violation|1|||
130814537|NCT02106832|470949854|FG000|Overall Study|Withdrawal by Subject|17|||
130814538|NCT02106832|470949855|FG001|Overall Study|Withdrawal by Subject|17|||
130814539|NCT02106832|470949856|FG002|Overall Study|Withdrawal by Subject|10|||
130814540|NCT02106832|470949857|FG003|Overall Study|Withdrawal by Subject|7|||
130814541|NCT02106832|470949854|FG000|Overall Study|Technical problems|0|||
130814542|NCT02106832|470949855|FG001|Overall Study|Technical problems|1|||
130814543|NCT02106832|470949856|FG002|Overall Study|Technical problems|0|||
130814544|NCT02106832|470949857|FG003|Overall Study|Technical problems|0|||
130814545|NCT00265122|470949874|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
130814546|NCT00265122|470949875|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
130814547|NCT00265122|470949876|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
130814548|NCT00265122|470949877|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
130814549|NCT00265122|470949878|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
130814550|NCT00265122|470949879|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
130814551|NCT00265122|470949874|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
130814552|NCT00265122|470949875|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130814553|NCT00265122|470949876|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130814554|NCT00265122|470949877|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
130814555|NCT00265122|470949878|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130814556|NCT00265122|470949879|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130814557|NCT00265122|470949874|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
130814558|NCT00265122|470949875|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
130814559|NCT00265122|470949876|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
130814560|NCT00265122|470949877|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
130814561|NCT00265122|470949878|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
130814562|NCT00265122|470949879|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
130814563|NCT00265122|470949874|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
130814564|NCT00265122|470949875|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
130814565|NCT00265122|470949876|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
130814566|NCT00265122|470949877|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
130814567|NCT00265122|470949878|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
130814568|NCT00265122|470949879|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
130814569|NCT00265122|470949874|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
130814570|NCT00265122|470949875|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
130814571|NCT00265122|470949876|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
130814572|NCT00265122|470949877|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
130814573|NCT00265122|470949878|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
130814574|NCT00265122|470949879|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
130814575|NCT00265122|470949874|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
130814576|NCT00265122|470949875|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
130814577|NCT00265122|470949876|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
130814578|NCT00265122|470949877|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
130814579|NCT00265122|470949878|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
130814580|NCT00265122|470949879|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
130814581|NCT04716894|470949880|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
130814582|NCT04716894|470949880|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
130814583|NCT05205616|470949887|FG000|Overall Study|Lost to Follow-up|4|||
130814584|NCT05205616|470949888|FG001|Overall Study|Lost to Follow-up|4|||
130814585|NCT00663260|470949897|FG000|Overall Study|Lack of Efficacy|2|||
130814586|NCT00663260|470949898|FG001|Overall Study|Lack of Efficacy|0|||
130814587|NCT00663260|470949899|FG002|Overall Study|Lack of Efficacy|0|||
130814588|NCT00663260|470949897|FG000|Overall Study|Adverse Event|12|||
130814589|NCT00663260|470949898|FG001|Overall Study|Adverse Event|7|||
130814590|NCT00663260|470949899|FG002|Overall Study|Adverse Event|6|||
130814591|NCT00663260|470949897|FG000|Overall Study|Withdrawal by Subject|3|||
130814592|NCT00663260|470949898|FG001|Overall Study|Withdrawal by Subject|1|||
130814593|NCT00663260|470949899|FG002|Overall Study|Withdrawal by Subject|6|||
130814594|NCT00663260|470949897|FG000|Overall Study|Death|1|||
130814595|NCT00663260|470949898|FG001|Overall Study|Death|0|||
130814596|NCT00663260|470949899|FG002|Overall Study|Death|1|||
130814597|NCT00663260|470949897|FG000|Overall Study|Lost to Follow-up|0|||
130814598|NCT00663260|470949898|FG001|Overall Study|Lost to Follow-up|1|||
130814599|NCT00663260|470949899|FG002|Overall Study|Lost to Follow-up|0|||
130814600|NCT00663260|470949897|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
130814601|NCT00663260|470949898|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
130814602|NCT00663260|470949899|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
130814603|NCT02231580|470949908|FG000|Overall Study|Adverse Event|5|||
130814604|NCT02231580|470949909|FG001|Overall Study|Adverse Event|0|||
130814605|NCT03620981|470949910|FG000|Overall Study|Adverse Event|14|||
130814606|NCT03620981|470949911|FG001|Overall Study|Adverse Event|38|||
130814607|NCT03620981|470949912|FG002|Overall Study|Adverse Event|25|||
130814608|NCT03620981|470949910|FG000|Overall Study|Lack of Efficacy|2|||
130814609|NCT03620981|470949911|FG001|Overall Study|Lack of Efficacy|1|||
130814610|NCT03620981|470949912|FG002|Overall Study|Lack of Efficacy|1|||
130814611|NCT03620981|470949910|FG000|Overall Study|Physician Decision|7|||
130814612|NCT03620981|470949911|FG001|Overall Study|Physician Decision|4|||
130814613|NCT03620981|470949912|FG002|Overall Study|Physician Decision|4|||
130814614|NCT03620981|470949910|FG000|Overall Study|Protocol Violation|1|||
130814615|NCT03620981|470949911|FG001|Overall Study|Protocol Violation|2|||
130814616|NCT03620981|470949912|FG002|Overall Study|Protocol Violation|1|||
130814617|NCT03620981|470949910|FG000|Overall Study|Withdrawal by Legal Representative|2|||
130814618|NCT03620981|470949911|FG001|Overall Study|Withdrawal by Legal Representative|1|||
130814619|NCT03620981|470949912|FG002|Overall Study|Withdrawal by Legal Representative|1|||
130814620|NCT03620981|470949910|FG000|Overall Study|Withdrawal by Care Giver|2|||
130814621|NCT03620981|470949911|FG001|Overall Study|Withdrawal by Care Giver|0|||
130814622|NCT03620981|470949912|FG002|Overall Study|Withdrawal by Care Giver|1|||
130814623|NCT03620981|470949910|FG000|Overall Study|Non-compliance with Study Drug|1|||
130814624|NCT03620981|470949911|FG001|Overall Study|Non-compliance with Study Drug|1|||
130814625|NCT03620981|470949912|FG002|Overall Study|Non-compliance with Study Drug|0|||
130814626|NCT02607722|470949915|FG000|Overall Study|No data reliability|1|||
130814627|NCT02607722|470949915|FG000|Overall Study|no patient visit|18|||
130814628|NCT02607722|470949915|FG000|Overall Study|missing info in CRF|13|||
130814629|NCT02607722|470949915|FG000|Overall Study|Withdrawal by Subject|616|||
130814630|NCT02607722|470949915|FG000|Overall Study|Lost to Follow-up|312|||
130814631|NCT02607722|470949915|FG000|Overall Study|Improved|22|||
130814632|NCT02607722|470949915|FG000|Overall Study|Lack of Efficacy|316|||
130814633|NCT02607722|470949915|FG000|Overall Study|Adverse Event|2553|||
130814634|NCT02607722|470949915|FG000|Overall Study|Not treated|1|||
130814635|NCT02607722|470949915|FG000|Overall Study|No CRF collected|138|||
130814636|NCT02607722|470949915|FG000|Overall Study|without CRF|4225|||
130814637|NCT02607722|470949915|FG000|Overall Study|Physician Decision|367|||
130814638|NCT04347538|470949916|FG000|Overall Study|Lost to Follow-up|4|||
130814639|NCT04347538|470949917|FG001|Overall Study|Lost to Follow-up|5|||
130814640|NCT04347538|470949918|FG002|Overall Study|Lost to Follow-up|7|||
130814641|NCT02135133|470949919|FG000|Overall Study|Adverse Event|10|||
130814642|NCT02135133|470949919|FG000|Overall Study|regulatory mandate|5|||
130814643|NCT03238196|470949920|FG000|Overall Study|Adverse Event|3|||
130814644|NCT03238196|470949921|FG001|Overall Study|Adverse Event|0|||
130814645|NCT03238196|470949922|FG002|Overall Study|Adverse Event|2|||
130814646|NCT03238196|470949923|FG003|Overall Study|Adverse Event|2|||
130814647|NCT03238196|470949920|FG000|Overall Study|Withdrawal by Subject|4|||
130814648|NCT03238196|470949921|FG001|Overall Study|Withdrawal by Subject|1|||
130814649|NCT03238196|470949922|FG002|Overall Study|Withdrawal by Subject|1|||
130814650|NCT03238196|470949923|FG003|Overall Study|Withdrawal by Subject|0|||
130814651|NCT03238196|470949920|FG000|Overall Study|Disease progression|14|||
130814652|NCT03238196|470949921|FG001|Overall Study|Disease progression|2|||
130814653|NCT03238196|470949922|FG002|Overall Study|Disease progression|3|||
130814654|NCT03238196|470949923|FG003|Overall Study|Disease progression|2|||
130814655|NCT03238196|470949920|FG000|Overall Study|Still on treatment|1|||
130814656|NCT03238196|470949921|FG001|Overall Study|Still on treatment|0|||
130814657|NCT03238196|470949922|FG002|Overall Study|Still on treatment|0|||
130814658|NCT03238196|470949923|FG003|Overall Study|Still on treatment|0|||
130814659|NCT05081843|470949924|FG000|Overall Study|Lost to Follow-up|135|||
130814660|NCT05081843|470949925|FG001|Overall Study|Lost to Follow-up|145|||
130814661|NCT02303821|470949926|FG000|Overall Study|Withdrawal by Subject|0|||
130814662|NCT02303821|470949927|FG001|Overall Study|Withdrawal by Subject|0|||
130814663|NCT02303821|470949928|FG002|Overall Study|Withdrawal by Subject|0|||
130814664|NCT02303821|470949929|FG003|Overall Study|Withdrawal by Subject|0|||
130814665|NCT02303821|470949930|FG004|Overall Study|Withdrawal by Subject|0|||
130814666|NCT02303821|470949931|FG005|Overall Study|Withdrawal by Subject|0|||
130814667|NCT02303821|470949932|FG006|Overall Study|Withdrawal by Subject|0|||
130814668|NCT02303821|470949933|FG007|Overall Study|Withdrawal by Subject|2|||
130814669|NCT02303821|470949926|FG000|Overall Study|Death|0|||
130814670|NCT02303821|470949927|FG001|Overall Study|Death|2|||
130814671|NCT02303821|470949928|FG002|Overall Study|Death|0|||
130814672|NCT02303821|470949929|FG003|Overall Study|Death|0|||
130814673|NCT02303821|470949930|FG004|Overall Study|Death|0|||
130814674|NCT02303821|470949931|FG005|Overall Study|Death|3|||
130814675|NCT02303821|470949932|FG006|Overall Study|Death|41|||
130814676|NCT02303821|470949933|FG007|Overall Study|Death|29|||
130814677|NCT02303821|470949926|FG000|Overall Study|Lost to Follow-up|0|||
130814678|NCT02303821|470949927|FG001|Overall Study|Lost to Follow-up|0|||
130814679|NCT02303821|470949928|FG002|Overall Study|Lost to Follow-up|0|||
130814680|NCT02303821|470949929|FG003|Overall Study|Lost to Follow-up|0|||
130814681|NCT02303821|470949930|FG004|Overall Study|Lost to Follow-up|0|||
130814682|NCT02303821|470949931|FG005|Overall Study|Lost to Follow-up|0|||
130814683|NCT02303821|470949932|FG006|Overall Study|Lost to Follow-up|1|||
130814684|NCT02303821|470949933|FG007|Overall Study|Lost to Follow-up|0|||
130814685|NCT02303821|470949926|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130814686|NCT02303821|470949927|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130814687|NCT02303821|470949928|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130814688|NCT02303821|470949929|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130814689|NCT02303821|470949930|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130814690|NCT02303821|470949931|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130814691|NCT02303821|470949932|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
130814692|NCT02303821|470949933|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130814693|NCT02303821|470949926|FG000|Overall Study|Decision by sponsor|0|||
130814694|NCT02303821|470949927|FG001|Overall Study|Decision by sponsor|0|||
130814695|NCT02303821|470949928|FG002|Overall Study|Decision by sponsor|0|||
130814696|NCT02303821|470949929|FG003|Overall Study|Decision by sponsor|0|||
130814697|NCT02303821|470949930|FG004|Overall Study|Decision by sponsor|0|||
130814698|NCT02303821|470949931|FG005|Overall Study|Decision by sponsor|1|||
130814699|NCT02303821|470949932|FG006|Overall Study|Decision by sponsor|0|||
130814700|NCT02303821|470949933|FG007|Overall Study|Decision by sponsor|0|||
130814701|NCT02303821|470949926|FG000|Overall Study|Protocol-specified criteria|0|||
130814702|NCT02303821|470949927|FG001|Overall Study|Protocol-specified criteria|1|||
130814703|NCT02303821|470949928|FG002|Overall Study|Protocol-specified criteria|0|||
130814704|NCT02303821|470949929|FG003|Overall Study|Protocol-specified criteria|0|||
130814705|NCT02303821|470949930|FG004|Overall Study|Protocol-specified criteria|0|||
130814706|NCT02303821|470949931|FG005|Overall Study|Protocol-specified criteria|1|||
130814707|NCT02303821|470949932|FG006|Overall Study|Protocol-specified criteria|0|||
130814708|NCT02303821|470949933|FG007|Overall Study|Protocol-specified criteria|0|||
130814709|NCT04938427|470949936|FG000|Overall Study|Adverse Event|5|||
130814710|NCT04938427|470949937|FG001|Overall Study|Adverse Event|19|||
130814711|NCT04938427|470949936|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130814712|NCT04938427|470949937|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130814713|NCT04938427|470949936|FG000|Overall Study|Withdrawal by Subject|1|||
130814714|NCT04938427|470949937|FG001|Overall Study|Withdrawal by Subject|0|||
130814715|NCT04938427|470949936|FG000|Overall Study|Reason Not Specified|2|||
130814716|NCT04938427|470949937|FG001|Overall Study|Reason Not Specified|1|||
130814717|NCT04507269|470949946|FG000|Overall Study|Withdrawal by Subject|1|||
130814718|NCT04507269|470949947|FG001|Overall Study|Withdrawal by Subject|1|||
130814719|NCT04507269|470949948|FG002|Overall Study|Withdrawal by Subject|0|||
130814720|NCT04507269|470949949|FG003|Overall Study|Withdrawal by Subject|0|||
130814721|NCT04507269|470949950|FG004|Overall Study|Withdrawal by Subject|0|||
130814722|NCT04507269|470949951|FG005|Overall Study|Withdrawal by Subject|0|||
130814723|NCT04507269|470949946|FG000|Overall Study|Lost to Follow-up|0|||
130814724|NCT04507269|470949947|FG001|Overall Study|Lost to Follow-up|0|||
130814725|NCT04507269|470949948|FG002|Overall Study|Lost to Follow-up|0|||
130814726|NCT04507269|470949949|FG003|Overall Study|Lost to Follow-up|0|||
130814727|NCT04507269|470949950|FG004|Overall Study|Lost to Follow-up|1|||
130814728|NCT04507269|470949951|FG005|Overall Study|Lost to Follow-up|0|||
130814729|NCT05852340|470949952|FG000|Period 5|Not completing the meal|0|||
130814730|NCT05852340|470949953|FG001|Period 5|Not completing the meal|1|||
130814731|NCT05852340|470949954|FG002|Period 5|Not completing the meal|0|||
130814732|NCT05852340|470949955|FG003|Period 5|Not completing the meal|0|||
130814733|NCT05852340|470949952|FG000|Period 5|Adverse Event|0|||
130814734|NCT05852340|470949953|FG001|Period 5|Adverse Event|0|||
130814735|NCT05852340|470949954|FG002|Period 5|Adverse Event|0|||
130814736|NCT05852340|470949955|FG003|Period 5|Adverse Event|1|||
130814737|NCT00071032|470949958|FG000|Overall Study|Lost to Follow-up|1|||
130814738|NCT00071032|470949959|FG001|Overall Study|Lost to Follow-up|1|||
130814739|NCT00071032|470949958|FG000|Overall Study|Withdrawal by Subject|8|||
130814740|NCT00071032|470949959|FG001|Overall Study|Withdrawal by Subject|6|||
130814741|NCT00071032|470949958|FG000|Overall Study|Missing Primary Outcome|0|||
130814742|NCT00071032|470949959|FG001|Overall Study|Missing Primary Outcome|1|||
130814743|NCT05852470|470949961|FG000|Overall Study|Withdrawal by Subject|0|||
130814744|NCT05852470|470949962|FG001|Overall Study|Withdrawal by Subject|1|||
130814745|NCT06071104|470949963|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
130814746|NCT01903863|470949964|FG000|Overall Study|Physician Decision|2|||
130814747|NCT01903863|470949965|FG001|Overall Study|Physician Decision|0|||
130814748|NCT04727151|470949970|FG000|Overall Study|Death|0|||
130814749|NCT04727151|470949971|FG001|Overall Study|Death|0|||
130814750|NCT04727151|470949972|FG002|Overall Study|Death|0|||
130814751|NCT04727151|470949973|FG003|Overall Study|Death|0|||
130814752|NCT04727151|470949974|FG004|Overall Study|Death|3|||
130814753|NCT04727151|470949970|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130814754|NCT04727151|470949971|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130814755|NCT04727151|470949972|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130814756|NCT04727151|470949973|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130814757|NCT04727151|470949974|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
130814758|NCT01346592|470949976|FG000|Overall Study|Lost to Follow-up|62|||
130814759|NCT01346592|470949977|FG001|Overall Study|Lost to Follow-up|29|||
130814760|NCT01346592|470949978|FG002|Overall Study|Lost to Follow-up|29|||
130814761|NCT01346592|470949976|FG000|Overall Study|Protocol Violation|2|||
130814762|NCT01346592|470949977|FG001|Overall Study|Protocol Violation|1|||
130814763|NCT01346592|470949978|FG002|Overall Study|Protocol Violation|0|||
130814764|NCT01346592|470949976|FG000|Overall Study|Death|1|||
130814765|NCT01346592|470949977|FG001|Overall Study|Death|3|||
130814766|NCT01346592|470949978|FG002|Overall Study|Death|4|||
130814767|NCT01346592|470949976|FG000|Overall Study|Adverse Event|0|||
130814768|NCT01346592|470949977|FG001|Overall Study|Adverse Event|1|||
130814769|NCT01346592|470949978|FG002|Overall Study|Adverse Event|0|||
130814770|NCT01346592|470949976|FG000|Overall Study|Withdrawal by Subject|77|||
130814771|NCT01346592|470949977|FG001|Overall Study|Withdrawal by Subject|51|||
130814772|NCT01346592|470949978|FG002|Overall Study|Withdrawal by Subject|38|||
130814773|NCT01346592|470949976|FG000|Overall Study|Inappropriate enrollment|3|||
130814774|NCT01346592|470949977|FG001|Overall Study|Inappropriate enrollment|1|||
130814775|NCT01346592|470949978|FG002|Overall Study|Inappropriate enrollment|1|||
130814776|NCT01346592|470949976|FG000|Overall Study|Administrative reason|1|||
130814777|NCT01346592|470949977|FG001|Overall Study|Administrative reason|0|||
130814778|NCT01346592|470949978|FG002|Overall Study|Administrative reason|0|||
130814779|NCT01346592|470949976|FG000|Overall Study|Unable to Classify|7|||
130814780|NCT01346592|470949977|FG001|Overall Study|Unable to Classify|3|||
130814781|NCT01346592|470949978|FG002|Overall Study|Unable to Classify|6|||
130814782|NCT02679274|470949979|FG000|Overall Study|Withdrawal by Subject|1|||
130814783|NCT02679274|470949980|FG001|Overall Study|Withdrawal by Subject|0|||
130814784|NCT02038036|470949985|FG000|Core Study|Adverse Event|7|||
130814785|NCT02038036|470949986|FG001|Core Study|Adverse Event|7|||
130814786|NCT02038036|470949985|FG000|Core Study|Death|1|||
130814787|NCT02038036|470949986|FG001|Core Study|Death|1|||
130814788|NCT02038036|470949985|FG000|Core Study|Disease progression|2|||
130814789|NCT02038036|470949986|FG001|Core Study|Disease progression|2|||
130814790|NCT02038036|470949985|FG000|Core Study|Lost to Follow-up|0|||
130814791|NCT02038036|470949986|FG001|Core Study|Lost to Follow-up|1|||
130814792|NCT02038036|470949985|FG000|Core Study|Physician Decision|2|||
130814793|NCT02038036|470949986|FG001|Core Study|Physician Decision|1|||
130814794|NCT02038036|470949985|FG000|Core Study|Subject/guardian decision|0|||
130814795|NCT02038036|470949986|FG001|Core Study|Subject/guardian decision|1|||
130814796|NCT02038036|470949985|FG000|Core Study|Withdrawal by Subject|3|||
130814797|NCT02038036|470949986|FG001|Core Study|Withdrawal by Subject|1|||
130814798|NCT02038036|470949985|FG000|Crossover Period|Withdrawal by Subject|0|||
130814799|NCT02038036|470949986|FG001|Crossover Period|Withdrawal by Subject|3|||
130814800|NCT02038036|470949985|FG000|Crossover Period|Adverse Event|0|||
130814801|NCT02038036|470949986|FG001|Crossover Period|Adverse Event|9|||
130814802|NCT02038036|470949985|FG000|Crossover Period|Death|0|||
130814803|NCT02038036|470949986|FG001|Crossover Period|Death|2|||
130814804|NCT02038036|470949985|FG000|Crossover Period|Disease progression|0|||
130814805|NCT02038036|470949986|FG001|Crossover Period|Disease progression|3|||
130814806|NCT02038036|470949985|FG000|Crossover Period|Lost to Follow-up|0|||
130814807|NCT02038036|470949986|FG001|Crossover Period|Lost to Follow-up|1|||
130814808|NCT02038036|470949985|FG000|Crossover Period|Physician Decision|0|||
130814809|NCT02038036|470949986|FG001|Crossover Period|Physician Decision|2|||
130814810|NCT05318287|470949992|FG000|Overall Study|Lost to Follow-up|8|||
130814811|NCT03537508|470949995|FG000|Overall Study|Adverse Event|2|||
130814812|NCT03537508|470949996|FG001|Overall Study|Adverse Event|1|||
130814813|NCT03537508|470949995|FG000|Overall Study|Protocol Violation|65|||
130814814|NCT03537508|470949996|FG001|Overall Study|Protocol Violation|48|||
130814815|NCT03537508|470949995|FG000|Overall Study|Lost to Follow-up|86|||
130814816|NCT03537508|470949996|FG001|Overall Study|Lost to Follow-up|60|||
130814817|NCT03537508|470949995|FG000|Overall Study|Withdrawal by parent/guardian|263|||
130814818|NCT03537508|470949996|FG001|Overall Study|Withdrawal by parent/guardian|149|||
130814819|NCT01972659|470949997|FG000|Overall Study|Protocol Violation|2|||
130814820|NCT01972659|470949998|FG001|Overall Study|Protocol Violation|2|||
130814821|NCT01972659|470949997|FG000|Overall Study|problems realted to acceleromyograph|2|||
130814822|NCT01972659|470949998|FG001|Overall Study|problems realted to acceleromyograph|1|||
130814823|NCT00835172|470950020|FG000|Washout|Protocol Violation|0|||
130814824|NCT00835172|470950021|FG001|Washout|Protocol Violation|1|||
130814825|NCT02495883|470950022|FG000|Overall Study|Excessive head motion|1|||
130814826|NCT02495883|470950023|FG001|Overall Study|Excessive head motion|0|||
130814827|NCT00791648|470951758|FG000|Overall Study|Physician Decision|0|||
130814828|NCT00791648|470951759|FG001|Overall Study|Physician Decision|1|||
130814829|NCT00791648|470951758|FG000|Overall Study|Withdrawal by Subject|0|||
130814830|NCT00791648|470951759|FG001|Overall Study|Withdrawal by Subject|1|||
130814831|NCT00462826|470951760|FG000|Overall Study|Ineligible - second primary|1|||
130814832|NCT00462826|470951760|FG000|Overall Study|Ineligible - wrong cell type|1|||
130814833|NCT00462826|470951760|FG000|Overall Study|Ineligible - wrong primary|2|||
130814834|NCT00462826|470951760|FG000|Overall Study|Never treated|1|||
130814835|NCT04976777|470951761|FG000|Overall Study|COVID-19 Infection|1|||
130814836|NCT04976777|470951762|FG001|Overall Study|COVID-19 Infection|0|||
130814837|NCT01397253|470951763|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
130814838|NCT01397253|470951764|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
130814839|NCT01892189|470951767|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
130814840|NCT01892189|470951768|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
130814841|NCT01892189|470951769|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
130814842|NCT01892189|470951770|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
130814843|NCT01892189|470951771|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
130814844|NCT01892189|470951772|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
130814845|NCT01892189|470951773|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
130814846|NCT01892189|470951774|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
130814847|NCT01892189|470951775|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
130814848|NCT01892189|470951767|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130814849|NCT01892189|470951768|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130814850|NCT01892189|470951769|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
130814851|NCT01892189|470951770|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130814852|NCT01892189|470951771|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130814853|NCT01892189|470951772|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130814854|NCT01892189|470951773|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130814855|NCT01892189|470951774|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130814856|NCT01892189|470951775|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130814857|NCT01892189|470951767|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130814858|NCT01892189|470951768|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130814859|NCT01892189|470951769|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130814860|NCT01892189|470951770|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130814861|NCT01892189|470951771|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130814862|NCT01892189|470951772|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
130814863|NCT01892189|470951773|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130814864|NCT01892189|470951774|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130814865|NCT01892189|470951775|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130814866|NCT02332928|470951776|FG000|Overall Study|Withdrawal by Subject|0|||
130814867|NCT02332928|470951777|FG001|Overall Study|Withdrawal by Subject|2|||
130814868|NCT02332928|470951776|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
130814869|NCT02332928|470951777|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
130814870|NCT04484857|470951783|FG000|Overall Study|Adverse Event|2|||
130814871|NCT04484857|470951783|FG000|Overall Study|Death|10|||
130814872|NCT04484857|470951783|FG000|Overall Study|Withdrawal by Subject|3|||
130814873|NCT04484857|470951783|FG000|Overall Study|Transferred/Relocation|5|||
130814874|NCT04484857|470951783|FG000|Overall Study|Kidney Transplant|7|||
130814875|NCT04484857|470951783|FG000|Overall Study|Other than specified|4|||
130814876|NCT04484857|470951783|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
130814877|NCT01822925|470951785|FG000|Overall Study|Adverse Event|1|||
130814878|NCT01822925|470951786|FG001|Overall Study|Adverse Event|1|||
130814879|NCT01822925|470951787|FG002|Overall Study|Adverse Event|1|||
130814880|NCT01822925|470951788|FG003|Overall Study|Adverse Event|1|||
130814881|NCT01822925|470951785|FG000|Overall Study|Lost to Follow-up|0|||
130814882|NCT01822925|470951786|FG001|Overall Study|Lost to Follow-up|1|||
130814883|NCT01822925|470951787|FG002|Overall Study|Lost to Follow-up|0|||
130814884|NCT01822925|470951788|FG003|Overall Study|Lost to Follow-up|0|||
130814885|NCT01822925|470951785|FG000|Overall Study|Protocol Violation|1|||
130814886|NCT01822925|470951786|FG001|Overall Study|Protocol Violation|0|||
130814887|NCT01822925|470951787|FG002|Overall Study|Protocol Violation|0|||
130814888|NCT01822925|470951788|FG003|Overall Study|Protocol Violation|1|||
130814889|NCT01822925|470951785|FG000|Overall Study|Withdrawal by Subject|2|||
130814890|NCT01822925|470951786|FG001|Overall Study|Withdrawal by Subject|0|||
130814891|NCT01822925|470951787|FG002|Overall Study|Withdrawal by Subject|2|||
130814892|NCT01822925|470951788|FG003|Overall Study|Withdrawal by Subject|2|||
130814893|NCT01822925|470951785|FG000|Overall Study|Taking prohibited medication|2|||
130814894|NCT01822925|470951786|FG001|Overall Study|Taking prohibited medication|0|||
130814895|NCT01822925|470951787|FG002|Overall Study|Taking prohibited medication|0|||
130814896|NCT01822925|470951788|FG003|Overall Study|Taking prohibited medication|1|||
130814897|NCT03322566|470951793|FG000|Overall Study|Death|34|||
130814898|NCT03322566|470951794|FG001|Overall Study|Death|35|||
130814899|NCT03322566|470951795|FG002|Overall Study|Death|23|||
130814900|NCT03322566|470951793|FG000|Overall Study|Physician Decision|6|||
130814901|NCT03322566|470951794|FG001|Overall Study|Physician Decision|7|||
130814902|NCT03322566|470951795|FG002|Overall Study|Physician Decision|2|||
130814903|NCT03322566|470951793|FG000|Overall Study|Withdrawal by Subject|4|||
130814904|NCT03322566|470951794|FG001|Overall Study|Withdrawal by Subject|3|||
130814905|NCT03322566|470951795|FG002|Overall Study|Withdrawal by Subject|6|||
130814906|NCT03322566|470951793|FG000|Overall Study|Lost to Follow-up|0|||
130814907|NCT03322566|470951794|FG001|Overall Study|Lost to Follow-up|0|||
130814908|NCT03322566|470951795|FG002|Overall Study|Lost to Follow-up|1|||
130814909|NCT03322566|470951793|FG000|Overall Study|Study terminated by sponsor|1|||
130814910|NCT03322566|470951794|FG001|Overall Study|Study terminated by sponsor|0|||
130814911|NCT03322566|470951795|FG002|Overall Study|Study terminated by sponsor|1|||
130814912|NCT03847519|470951797|FG000|Overall Study|Death|5|||
130814913|NCT03847519|470951798|FG001|Overall Study|Death|8|||
130814914|NCT03847519|470951799|FG002|Overall Study|Death|1|||
130814915|NCT03847519|470951797|FG000|Overall Study|Lost to Follow-up|1|||
130814916|NCT03847519|470951798|FG001|Overall Study|Lost to Follow-up|2|||
130814917|NCT03847519|470951799|FG002|Overall Study|Lost to Follow-up|0|||
130814918|NCT03847519|470951797|FG000|Overall Study|Study Terminated by Sponsor|0|||
130814919|NCT03847519|470951798|FG001|Overall Study|Study Terminated by Sponsor|3|||
130814920|NCT03847519|470951799|FG002|Overall Study|Study Terminated by Sponsor|2|||
130814921|NCT02314923|470951802|FG000|Overall Study|Death|0|||
130814922|NCT02314923|470951803|FG001|Overall Study|Death|0|||
130814923|NCT02314923|470951804|FG002|Overall Study|Death|0|||
130814924|NCT02314923|470951805|FG003|Overall Study|Death|1|||
130814925|NCT02314923|470951806|FG004|Overall Study|Death|0|||
130814926|NCT02314923|470951807|FG005|Overall Study|Death|0|||
130814927|NCT02314923|470951808|FG006|Overall Study|Death|0|||
130814928|NCT02314923|470951809|FG007|Overall Study|Death|0|||
130814929|NCT02314923|470951810|FG008|Overall Study|Death|0|||
130814930|NCT02314923|470951811|FG009|Overall Study|Death|0|||
130814931|NCT02314923|470951802|FG000|Overall Study|Lost to Follow-up|2|||
130814932|NCT02314923|470951803|FG001|Overall Study|Lost to Follow-up|3|||
130814933|NCT02314923|470951804|FG002|Overall Study|Lost to Follow-up|1|||
130814934|NCT02314923|470951805|FG003|Overall Study|Lost to Follow-up|0|||
130814935|NCT02314923|470951806|FG004|Overall Study|Lost to Follow-up|0|||
130814936|NCT02314923|470951807|FG005|Overall Study|Lost to Follow-up|0|||
130814937|NCT02314923|470951808|FG006|Overall Study|Lost to Follow-up|3|||
130814938|NCT02314923|470951809|FG007|Overall Study|Lost to Follow-up|4|||
130814939|NCT02314923|470951810|FG008|Overall Study|Lost to Follow-up|2|||
130814940|NCT02314923|470951811|FG009|Overall Study|Lost to Follow-up|0|||
130814941|NCT02314923|470951802|FG000|Overall Study|Withdrawal by Subject|0|||
130814942|NCT02314923|470951803|FG001|Overall Study|Withdrawal by Subject|0|||
130814943|NCT02314923|470951804|FG002|Overall Study|Withdrawal by Subject|1|||
130814944|NCT02314923|470951805|FG003|Overall Study|Withdrawal by Subject|0|||
130814945|NCT02314923|470951806|FG004|Overall Study|Withdrawal by Subject|1|||
130814946|NCT02314923|470951807|FG005|Overall Study|Withdrawal by Subject|0|||
130814947|NCT02314923|470951808|FG006|Overall Study|Withdrawal by Subject|1|||
130814948|NCT02314923|470951809|FG007|Overall Study|Withdrawal by Subject|0|||
130814949|NCT02314923|470951810|FG008|Overall Study|Withdrawal by Subject|0|||
130814950|NCT02314923|470951811|FG009|Overall Study|Withdrawal by Subject|0|||
130814951|NCT02314923|470951802|FG000|Overall Study|Physician Decision|0|||
130814952|NCT02314923|470951803|FG001|Overall Study|Physician Decision|1|||
130814953|NCT02314923|470951804|FG002|Overall Study|Physician Decision|0|||
130814954|NCT02314923|470951805|FG003|Overall Study|Physician Decision|0|||
130814955|NCT02314923|470951806|FG004|Overall Study|Physician Decision|0|||
130814956|NCT02314923|470951807|FG005|Overall Study|Physician Decision|0|||
130814957|NCT02314923|470951808|FG006|Overall Study|Physician Decision|0|||
130814958|NCT02314923|470951809|FG007|Overall Study|Physician Decision|0|||
130814959|NCT02314923|470951810|FG008|Overall Study|Physician Decision|0|||
130814960|NCT02314923|470951811|FG009|Overall Study|Physician Decision|0|||
130814961|NCT02314923|470951802|FG000|Overall Study|Participant unavailable|0|||
130814962|NCT02314923|470951803|FG001|Overall Study|Participant unavailable|0|||
130814963|NCT02314923|470951804|FG002|Overall Study|Participant unavailable|0|||
130814964|NCT02314923|470951805|FG003|Overall Study|Participant unavailable|0|||
130814965|NCT02314923|470951806|FG004|Overall Study|Participant unavailable|0|||
130814966|NCT02314923|470951807|FG005|Overall Study|Participant unavailable|1|||
130814967|NCT02314923|470951808|FG006|Overall Study|Participant unavailable|0|||
130814968|NCT02314923|470951809|FG007|Overall Study|Participant unavailable|0|||
130814969|NCT02314923|470951810|FG008|Overall Study|Participant unavailable|0|||
130814970|NCT02314923|470951811|FG009|Overall Study|Participant unavailable|0|||
130814971|NCT02314923|470951802|FG000|Overall Study|Screen failure|0|||
130814972|NCT02314923|470951803|FG001|Overall Study|Screen failure|0|||
130814973|NCT02314923|470951804|FG002|Overall Study|Screen failure|0|||
130814974|NCT02314923|470951805|FG003|Overall Study|Screen failure|0|||
130814975|NCT02314923|470951806|FG004|Overall Study|Screen failure|0|||
130814976|NCT02314923|470951807|FG005|Overall Study|Screen failure|0|||
130814977|NCT02314923|470951808|FG006|Overall Study|Screen failure|1|||
130814978|NCT02314923|470951809|FG007|Overall Study|Screen failure|0|||
130814979|NCT02314923|470951810|FG008|Overall Study|Screen failure|0|||
130814980|NCT02314923|470951811|FG009|Overall Study|Screen failure|0|||
130814981|NCT02314923|470951802|FG000|Overall Study|Participant relocation|1|||
130814982|NCT02314923|470951803|FG001|Overall Study|Participant relocation|0|||
130814983|NCT02314923|470951804|FG002|Overall Study|Participant relocation|0|||
130814984|NCT02314923|470951805|FG003|Overall Study|Participant relocation|0|||
130814985|NCT02314923|470951806|FG004|Overall Study|Participant relocation|0|||
130814986|NCT02314923|470951807|FG005|Overall Study|Participant relocation|0|||
130814987|NCT02314923|470951808|FG006|Overall Study|Participant relocation|0|||
130814988|NCT02314923|470951809|FG007|Overall Study|Participant relocation|1|||
130814989|NCT02314923|470951810|FG008|Overall Study|Participant relocation|0|||
130814990|NCT02314923|470951811|FG009|Overall Study|Participant relocation|0|||
130814991|NCT00725985|470951812|FG000|ITP- Treatment Disposition|Adverse Event|20|||
130814992|NCT00725985|470951813|FG001|ITP- Treatment Disposition|Adverse Event|10|||
130814993|NCT00725985|470951814|FG002|ITP- Treatment Disposition|Adverse Event|5|||
130814994|NCT00725985|470951815|FG003|ITP- Treatment Disposition|Adverse Event|0|||
130814995|NCT00725985|470951816|FG004|ITP- Treatment Disposition|Adverse Event|0|||
130814996|NCT00725985|470951817|FG005|ITP- Treatment Disposition|Adverse Event|0|||
130814997|NCT00725985|470951818|FG006|ITP- Treatment Disposition|Adverse Event|0|||
130814998|NCT00725985|470951819|FG007|ITP- Treatment Disposition|Adverse Event|0|||
130814999|NCT00725985|470951820|FG008|ITP- Treatment Disposition|Adverse Event|0|||
130815000|NCT00725985|470951821|FG009|ITP- Treatment Disposition|Adverse Event|0|||
130815001|NCT00725985|470951822|FG010|ITP- Treatment Disposition|Adverse Event|0|||
130815002|NCT00725985|470951823|FG011|ITP- Treatment Disposition|Adverse Event|0|||
130815003|NCT00725985|470951812|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815004|NCT00725985|470951813|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815005|NCT00725985|470951814|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
130815006|NCT00725985|470951815|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815007|NCT00725985|470951816|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815008|NCT00725985|470951817|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815009|NCT00725985|470951818|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815010|NCT00725985|470951819|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815011|NCT00725985|470951820|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815012|NCT00725985|470951821|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815013|NCT00725985|470951822|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815014|NCT00725985|470951823|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
130815015|NCT00725985|470951812|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
130815016|NCT00725985|470951813|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
130815017|NCT00725985|470951814|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
130815018|NCT00725985|470951815|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
130815019|NCT00725985|470951816|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
130815020|NCT00725985|470951817|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
130815021|NCT00725985|470951818|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
130815022|NCT00725985|470951819|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
130815023|NCT00725985|470951820|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
130815024|NCT00725985|470951821|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
130815025|NCT00725985|470951822|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
130815026|NCT00725985|470951823|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
130815027|NCT00725985|470951812|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
130815028|NCT00725985|470951813|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
130815029|NCT00725985|470951814|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
130815030|NCT00725985|470951815|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
130815031|NCT00725985|470951816|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
130815032|NCT00725985|470951817|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
130815033|NCT00725985|470951818|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
130815034|NCT00725985|470951819|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
130815035|NCT00725985|470951820|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
130815036|NCT00725985|470951821|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
130815037|NCT00725985|470951822|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
130815038|NCT00725985|470951823|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
130815039|NCT00725985|470951812|FG000|ITP- Treatment Disposition|Other|50|||
130815040|NCT00725985|470951813|FG001|ITP- Treatment Disposition|Other|38|||
130815041|NCT00725985|470951814|FG002|ITP- Treatment Disposition|Other|24|||
130815042|NCT00725985|470951815|FG003|ITP- Treatment Disposition|Other|0|||
130815043|NCT00725985|470951816|FG004|ITP- Treatment Disposition|Other|0|||
130815044|NCT00725985|470951817|FG005|ITP- Treatment Disposition|Other|0|||
130815045|NCT00725985|470951818|FG006|ITP- Treatment Disposition|Other|0|||
130815046|NCT00725985|470951819|FG007|ITP- Treatment Disposition|Other|0|||
130815047|NCT00725985|470951820|FG008|ITP- Treatment Disposition|Other|0|||
130815048|NCT00725985|470951821|FG009|ITP- Treatment Disposition|Other|0|||
130815049|NCT00725985|470951822|FG010|ITP- Treatment Disposition|Other|0|||
130815050|NCT00725985|470951823|FG011|ITP- Treatment Disposition|Other|0|||
130815051|NCT00725985|470951812|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130815052|NCT00725985|470951813|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130815053|NCT00725985|470951814|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130815054|NCT00725985|470951815|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
130815055|NCT00725985|470951816|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
130815056|NCT00725985|470951817|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
130815057|NCT00725985|470951818|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130815058|NCT00725985|470951819|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130815059|NCT00725985|470951820|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130815060|NCT00725985|470951821|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130815061|NCT00725985|470951822|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130815062|NCT00725985|470951823|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130815063|NCT00725985|470951812|FG000|OLMP (Up to 96 Weeks)|Death|0|||
130815064|NCT00725985|470951813|FG001|OLMP (Up to 96 Weeks)|Death|0|||
130815065|NCT00725985|470951814|FG002|OLMP (Up to 96 Weeks)|Death|0|||
130815066|NCT00725985|470951815|FG003|OLMP (Up to 96 Weeks)|Death|0|||
130815067|NCT00725985|470951816|FG004|OLMP (Up to 96 Weeks)|Death|1|||
130815068|NCT00725985|470951817|FG005|OLMP (Up to 96 Weeks)|Death|0|||
130815069|NCT00725985|470951818|FG006|OLMP (Up to 96 Weeks)|Death|0|||
130815070|NCT00725985|470951819|FG007|OLMP (Up to 96 Weeks)|Death|0|||
130815071|NCT00725985|470951820|FG008|OLMP (Up to 96 Weeks)|Death|0|||
130815072|NCT00725985|470951821|FG009|OLMP (Up to 96 Weeks)|Death|0|||
130815073|NCT00725985|470951822|FG010|OLMP (Up to 96 Weeks)|Death|0|||
130815074|NCT00725985|470951823|FG011|OLMP (Up to 96 Weeks)|Death|0|||
130815075|NCT00725985|470951812|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815076|NCT00725985|470951813|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815077|NCT00725985|470951814|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815078|NCT00725985|470951815|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
130815079|NCT00725985|470951816|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815080|NCT00725985|470951817|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815081|NCT00725985|470951818|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815082|NCT00725985|470951819|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815083|NCT00725985|470951820|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815084|NCT00725985|470951821|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815085|NCT00725985|470951822|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815086|NCT00725985|470951823|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130815087|NCT00725985|470951812|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815088|NCT00725985|470951813|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815089|NCT00725985|470951814|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815090|NCT00725985|470951815|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815091|NCT00725985|470951816|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815092|NCT00725985|470951817|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
130815093|NCT00725985|470951818|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815094|NCT00725985|470951819|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815095|NCT00725985|470951820|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815096|NCT00725985|470951821|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815097|NCT00725985|470951822|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815098|NCT00725985|470951823|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
130815099|NCT00725985|470951812|FG000|OLMP (Up to 96 Weeks)|Other|0|||
130815100|NCT00725985|470951813|FG001|OLMP (Up to 96 Weeks)|Other|0|||
130815101|NCT00725985|470951814|FG002|OLMP (Up to 96 Weeks)|Other|0|||
130815102|NCT00725985|470951815|FG003|OLMP (Up to 96 Weeks)|Other|15|||
130815103|NCT00725985|470951816|FG004|OLMP (Up to 96 Weeks)|Other|20|||
130815104|NCT00725985|470951817|FG005|OLMP (Up to 96 Weeks)|Other|44|||
130815105|NCT00725985|470951818|FG006|OLMP (Up to 96 Weeks)|Other|0|||
130815106|NCT00725985|470951819|FG007|OLMP (Up to 96 Weeks)|Other|0|||
130815107|NCT00725985|470951820|FG008|OLMP (Up to 96 Weeks)|Other|0|||
130815108|NCT00725985|470951821|FG009|OLMP (Up to 96 Weeks)|Other|0|||
130815109|NCT00725985|470951822|FG010|OLMP (Up to 96 Weeks)|Other|0|||
130815110|NCT00725985|470951823|FG011|OLMP (Up to 96 Weeks)|Other|0|||
130815111|NCT00725985|470951812|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815112|NCT00725985|470951813|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815113|NCT00725985|470951814|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815114|NCT00725985|470951815|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815115|NCT00725985|470951816|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815116|NCT00725985|470951817|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815117|NCT00725985|470951818|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815118|NCT00725985|470951819|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
130815119|NCT00725985|470951820|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815120|NCT00725985|470951821|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815121|NCT00725985|470951822|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815122|NCT00725985|470951823|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130815123|NCT00725985|470951812|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815124|NCT00725985|470951813|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815125|NCT00725985|470951814|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815126|NCT00725985|470951815|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815127|NCT00725985|470951816|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815128|NCT00725985|470951817|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815129|NCT00725985|470951818|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815130|NCT00725985|470951819|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815131|NCT00725985|470951820|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
130815132|NCT00725985|470951821|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815133|NCT00725985|470951822|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815134|NCT00725985|470951823|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130815135|NCT00725985|470951812|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130815136|NCT00725985|470951813|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130815137|NCT00725985|470951814|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130815138|NCT00725985|470951815|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130815139|NCT00725985|470951816|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130815140|NCT00725985|470951817|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130815141|NCT00725985|470951818|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
130815142|NCT00725985|470951819|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
130815143|NCT00725985|470951820|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
130815144|NCT00725985|470951821|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130815145|NCT00725985|470951822|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130815146|NCT00725985|470951823|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130815147|NCT00725985|470951812|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130815148|NCT00725985|470951813|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130815149|NCT00725985|470951814|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130815150|NCT00725985|470951815|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130815151|NCT00725985|470951816|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130815152|NCT00725985|470951817|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130815153|NCT00725985|470951818|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130815154|NCT00725985|470951819|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130815155|NCT00725985|470951820|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130815156|NCT00725985|470951821|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
130815157|NCT00725985|470951822|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
130815158|NCT00725985|470951823|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
130815159|NCT02546323|470951824|FG000|Overall Study|Withdrawal by Subject|36|||
130815160|NCT02546323|470951825|FG001|Overall Study|Withdrawal by Subject|33|||
130815161|NCT02546323|470951824|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
130815162|NCT02546323|470951825|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
130815163|NCT02546323|470951824|FG000|Overall Study|Adverse Event|17|||
130815164|NCT02546323|470951825|FG001|Overall Study|Adverse Event|11|||
130815165|NCT02546323|470951824|FG000|Overall Study|Patient Specific Reasons|1|||
130815166|NCT02546323|470951825|FG001|Overall Study|Patient Specific Reasons|2|||
130815167|NCT02546323|470951824|FG000|Overall Study|Lost to Follow-up|2|||
130815168|NCT02546323|470951825|FG001|Overall Study|Lost to Follow-up|3|||
130815169|NCT02546323|470951824|FG000|Overall Study|Non-compliance with Study Drug|2|||
130815170|NCT02546323|470951825|FG001|Overall Study|Non-compliance with Study Drug|2|||
130815171|NCT02546323|470951824|FG000|Overall Study|Met Withdrawal Criteria|2|||
130815172|NCT02546323|470951825|FG001|Overall Study|Met Withdrawal Criteria|14|||
130815173|NCT04476784|470951826|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
130815174|NCT04476784|470951827|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
130815175|NCT04617860|470951828|FG000|Overall Study|Adverse Event|0|||
130815176|NCT04617860|470951829|FG001|Overall Study|Adverse Event|2|||
130815177|NCT04617860|470951830|FG002|Overall Study|Adverse Event|2|||
130815178|NCT04617860|470951828|FG000|Overall Study|Withdrawal by Subject|0|||
130815179|NCT04617860|470951829|FG001|Overall Study|Withdrawal by Subject|0|||
130815180|NCT04617860|470951830|FG002|Overall Study|Withdrawal by Subject|2|||
130815181|NCT04617860|470951828|FG000|Overall Study|Physician Decision|0|||
130815182|NCT04617860|470951829|FG001|Overall Study|Physician Decision|1|||
130815183|NCT04617860|470951830|FG002|Overall Study|Physician Decision|0|||
130815184|NCT04617860|470951828|FG000|Overall Study|Sponsor Decision|0|||
130815185|NCT04617860|470951829|FG001|Overall Study|Sponsor Decision|3|||
130815186|NCT04617860|470951830|FG002|Overall Study|Sponsor Decision|1|||
130815187|NCT04617860|470951828|FG000|Overall Study|Termination of Study by Sponsor|8|||
130815188|NCT04617860|470951829|FG001|Overall Study|Termination of Study by Sponsor|4|||
130815189|NCT04617860|470951830|FG002|Overall Study|Termination of Study by Sponsor|13|||
130815190|NCT01055028|470951831|FG000|Screening|Screen Failure|1|||
130815191|NCT01055028|470951832|FG001|Screening|Screen Failure|1|||
130815192|NCT01055028|470951831|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
130815193|NCT01055028|470951832|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
130815194|NCT01055028|470951831|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
130815195|NCT01055028|470951832|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
130815196|NCT01055028|470951831|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
130815197|NCT01055028|470951832|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
130815198|NCT06582732|470951833|FG000|Initial Study Period|Adverse Event|0|||
130815199|NCT06582732|470951834|FG001|Initial Study Period|Adverse Event|0|||
130815200|NCT06582732|470951835|FG002|Initial Study Period|Adverse Event|0|||
130815201|NCT06582732|470951836|FG003|Initial Study Period|Adverse Event|2|||
130815202|NCT06582732|470951837|FG004|Initial Study Period|Adverse Event|0|||
130815203|NCT06582732|470951838|FG005|Initial Study Period|Adverse Event|0|||
130815204|NCT06582732|470951839|FG006|Initial Study Period|Adverse Event|0|||
130815205|NCT06582732|470951833|FG000|Initial Study Period|Death|1|||
130815206|NCT06582732|470951834|FG001|Initial Study Period|Death|0|||
130815207|NCT06582732|470951835|FG002|Initial Study Period|Death|0|||
130815208|NCT06582732|470951836|FG003|Initial Study Period|Death|0|||
130815209|NCT06582732|470951837|FG004|Initial Study Period|Death|1|||
130815210|NCT06582732|470951838|FG005|Initial Study Period|Death|0|||
130815211|NCT06582732|470951839|FG006|Initial Study Period|Death|0|||
130815212|NCT06582732|470951833|FG000|Initial Study Period|Lost to Follow-up|0|||
130815213|NCT06582732|470951834|FG001|Initial Study Period|Lost to Follow-up|0|||
130815214|NCT06582732|470951835|FG002|Initial Study Period|Lost to Follow-up|2|||
130815215|NCT06582732|470951836|FG003|Initial Study Period|Lost to Follow-up|0|||
130815216|NCT06582732|470951837|FG004|Initial Study Period|Lost to Follow-up|0|||
130815217|NCT06582732|470951838|FG005|Initial Study Period|Lost to Follow-up|0|||
130815218|NCT06582732|470951839|FG006|Initial Study Period|Lost to Follow-up|0|||
130815219|NCT06582732|470951833|FG000|Initial Study Period|Withdrawal by Subject|0|||
130815220|NCT06582732|470951834|FG001|Initial Study Period|Withdrawal by Subject|1|||
130815221|NCT06582732|470951835|FG002|Initial Study Period|Withdrawal by Subject|0|||
130815222|NCT06582732|470951836|FG003|Initial Study Period|Withdrawal by Subject|1|||
130815223|NCT06582732|470951837|FG004|Initial Study Period|Withdrawal by Subject|3|||
130815224|NCT06582732|470951838|FG005|Initial Study Period|Withdrawal by Subject|1|||
130815225|NCT06582732|470951839|FG006|Initial Study Period|Withdrawal by Subject|2|||
130815226|NCT06582732|470951833|FG000|Initial Study Period|Moved Away|0|||
130815227|NCT06582732|470951834|FG001|Initial Study Period|Moved Away|0|||
130815228|NCT06582732|470951835|FG002|Initial Study Period|Moved Away|0|||
130815229|NCT06582732|470951836|FG003|Initial Study Period|Moved Away|0|||
130815230|NCT06582732|470951837|FG004|Initial Study Period|Moved Away|1|||
130815231|NCT06582732|470951838|FG005|Initial Study Period|Moved Away|0|||
130815232|NCT06582732|470951839|FG006|Initial Study Period|Moved Away|0|||
130815233|NCT01182350|470951840|FG000|Overall Study|Adverse Event|5|||
130815234|NCT01182350|470951841|FG001|Overall Study|Adverse Event|0|||
130815235|NCT01182350|470951842|FG002|Overall Study|Adverse Event|0|||
130815236|NCT01182350|470951843|FG003|Overall Study|Adverse Event|0|||
130815237|NCT01182350|470951844|FG004|Overall Study|Adverse Event|0|||
130815238|NCT01182350|470951840|FG000|Overall Study|Disease Progression|15|||
130815239|NCT01182350|470951841|FG001|Overall Study|Disease Progression|12|||
130815240|NCT01182350|470951842|FG002|Overall Study|Disease Progression|0|||
130815241|NCT01182350|470951843|FG003|Overall Study|Disease Progression|1|||
130815242|NCT01182350|470951844|FG004|Overall Study|Disease Progression|0|||
130815243|NCT01182350|470951840|FG000|Overall Study|Death|0|||
130815244|NCT01182350|470951841|FG001|Overall Study|Death|1|||
130815245|NCT01182350|470951842|FG002|Overall Study|Death|1|||
130815246|NCT01182350|470951843|FG003|Overall Study|Death|0|||
130815247|NCT01182350|470951844|FG004|Overall Study|Death|0|||
130815248|NCT01182350|470951840|FG000|Overall Study|Withdrawal by Subject|3|||
130815249|NCT01182350|470951841|FG001|Overall Study|Withdrawal by Subject|1|||
130815250|NCT01182350|470951842|FG002|Overall Study|Withdrawal by Subject|0|||
130815251|NCT01182350|470951843|FG003|Overall Study|Withdrawal by Subject|1|||
130815252|NCT01182350|470951844|FG004|Overall Study|Withdrawal by Subject|0|||
130815253|NCT01182350|470951840|FG000|Overall Study|Alternative Therapy|2|||
130815254|NCT01182350|470951841|FG001|Overall Study|Alternative Therapy|0|||
130815255|NCT01182350|470951842|FG002|Overall Study|Alternative Therapy|1|||
130815256|NCT01182350|470951843|FG003|Overall Study|Alternative Therapy|0|||
130815257|NCT01182350|470951844|FG004|Overall Study|Alternative Therapy|0|||
130815258|NCT01182350|470951840|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
130815259|NCT01182350|470951841|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
130815260|NCT01182350|470951842|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
130815261|NCT01182350|470951843|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
130815262|NCT01182350|470951844|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
130815263|NCT01182350|470951840|FG000|Overall Study|Unevaluable for Biopsy|0|||
130815264|NCT01182350|470951841|FG001|Overall Study|Unevaluable for Biopsy|0|||
130815265|NCT01182350|470951842|FG002|Overall Study|Unevaluable for Biopsy|0|||
130815266|NCT01182350|470951843|FG003|Overall Study|Unevaluable for Biopsy|0|||
130815267|NCT01182350|470951844|FG004|Overall Study|Unevaluable for Biopsy|3|||
130815268|NCT03898180|470951845|FG000|Overall Study|Death|178|||
130815269|NCT03898180|470951846|FG001|Overall Study|Death|173|||
130815270|NCT03898180|470951845|FG000|Overall Study|Physician Decision|1|||
130815271|NCT03898180|470951846|FG001|Overall Study|Physician Decision|0|||
130815272|NCT03898180|470951845|FG000|Overall Study|Sponsor Decision|3|||
130815273|NCT03898180|470951846|FG001|Overall Study|Sponsor Decision|0|||
130815274|NCT03898180|470951845|FG000|Overall Study|Lost to Follow-up|1|||
130815275|NCT03898180|470951846|FG001|Overall Study|Lost to Follow-up|0|||
130815276|NCT03898180|470951845|FG000|Overall Study|Withdrawal by Subject|5|||
130815277|NCT03898180|470951846|FG001|Overall Study|Withdrawal by Subject|4|||
130815278|NCT02507934|470951847|FG000|Overall Study|Lost to Follow-up|2|||
130815279|NCT02507934|470951848|FG001|Overall Study|Lost to Follow-up|0|||
130815280|NCT02507934|470951847|FG000|Overall Study|Withdrawal by Subject|2|||
130815281|NCT02507934|470951848|FG001|Overall Study|Withdrawal by Subject|0|||
130815282|NCT03605693|470951855|FG000|Overall Study|Lost to Follow-up|4|||
130815283|NCT03605693|470951856|FG001|Overall Study|Lost to Follow-up|0|||
130815284|NCT03605693|470951855|FG000|Overall Study|Physician Decision|1|||
130815285|NCT03605693|470951856|FG001|Overall Study|Physician Decision|0|||
130815286|NCT03093415|470951857|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
130815287|NCT03093415|470951858|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
130815288|NCT03093415|470951859|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
130815289|NCT03093415|470951857|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
130815290|NCT03093415|470951858|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
130815291|NCT03093415|470951859|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
130763977|NCT00622336|470758731|FG000|Extension Phase|Progressive Disease|6|||
130815292|NCT03093415|470951857|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
130815293|NCT03093415|470951858|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
130815294|NCT03093415|470951859|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
130815295|NCT03093415|470951857|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
130815296|NCT03093415|470951858|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
130815297|NCT03093415|470951859|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
130815298|NCT03093415|470951857|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
130815299|NCT03093415|470951858|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
130815300|NCT03093415|470951859|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
130815301|NCT03093415|470951857|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
130815302|NCT03093415|470951858|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
130815303|NCT03093415|470951859|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
130815304|NCT03093415|470951857|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
130815305|NCT03093415|470951858|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
130815306|NCT03093415|470951859|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
130815307|NCT03093415|470951857|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
130815308|NCT03093415|470951858|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
130815309|NCT03093415|470951859|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
130815310|NCT03093415|470951857|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
130815311|NCT03093415|470951858|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
130815312|NCT03093415|470951859|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
130815313|NCT03093415|470951857|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
130815314|NCT03093415|470951858|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
130815315|NCT03093415|470951859|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
130815316|NCT03093415|470951857|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
130815317|NCT03093415|470951858|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
130815318|NCT03093415|470951859|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
130815319|NCT03559530|470951860|FG000|Overall Study|non-location of medical records|44|||
130815320|NCT03559530|470951861|FG001|Overall Study|non-location of medical records|0|||
130815321|NCT03559530|470951860|FG000|Overall Study|culture results not considered for treat|29|||
130815322|NCT03559530|470951861|FG001|Overall Study|culture results not considered for treat|0|||
130815323|NCT03559530|470951860|FG000|Overall Study|duplicate cases|8|||
130815324|NCT03559530|470951861|FG001|Overall Study|duplicate cases|0|||
130815325|NCT03559530|470951860|FG000|Overall Study|other species of Acinetobacte|7|||
130815326|NCT03559530|470951861|FG001|Overall Study|other species of Acinetobacte|0|||
130815327|NCT03559530|470951860|FG000|Overall Study|contamination / colonization|3|||
130815328|NCT03559530|470951861|FG001|Overall Study|contamination / colonization|0|||
130815329|NCT03331354|470951862|FG000|Overall Study|Withdrawal by Subject|1|||
130815330|NCT03331354|470951863|FG001|Overall Study|Withdrawal by Subject|3|||
130815331|NCT03331354|470951862|FG000|Overall Study|Lost to Follow-up|3|||
130815332|NCT03331354|470951863|FG001|Overall Study|Lost to Follow-up|3|||
130815333|NCT03331354|470951862|FG000|Overall Study|Found employment before initiated active intervention|0|||
130815334|NCT03331354|470951863|FG001|Overall Study|Found employment before initiated active intervention|4|||
130815335|NCT01646827|470951866|FG000|Overall Study|Lost to Follow-up|0|||
130815336|NCT01646827|470951867|FG001|Overall Study|Lost to Follow-up|3|||
130815337|NCT01646827|470951866|FG000|Overall Study|Physician Decision|1|||
130815338|NCT01646827|470951867|FG001|Overall Study|Physician Decision|2|||
130815339|NCT01646827|470951866|FG000|Overall Study|Withdrawal by Subject|1|||
130815340|NCT01646827|470951867|FG001|Overall Study|Withdrawal by Subject|0|||
130815341|NCT00928668|470951870|FG000|Overall Study|Adverse Event|1|||
130815342|NCT00928668|470951871|FG001|Overall Study|Adverse Event|0|||
130815343|NCT00928668|470951872|FG002|Overall Study|Adverse Event|0|||
130815344|NCT00928668|470951873|FG003|Overall Study|Adverse Event|0|||
130815345|NCT00928668|470951874|FG004|Overall Study|Adverse Event|0|||
130815346|NCT00928668|470951870|FG000|Overall Study|Protocol Violation|0|||
130815347|NCT00928668|470951871|FG001|Overall Study|Protocol Violation|0|||
130815348|NCT00928668|470951872|FG002|Overall Study|Protocol Violation|0|||
130815349|NCT00928668|470951873|FG003|Overall Study|Protocol Violation|0|||
130815350|NCT00928668|470951874|FG004|Overall Study|Protocol Violation|1|||
130815351|NCT00928668|470951870|FG000|Overall Study|Withdrawal by Subject|0|||
130815352|NCT00928668|470951871|FG001|Overall Study|Withdrawal by Subject|1|||
130815353|NCT00928668|470951872|FG002|Overall Study|Withdrawal by Subject|1|||
130815354|NCT00928668|470951873|FG003|Overall Study|Withdrawal by Subject|0|||
130815355|NCT00928668|470951874|FG004|Overall Study|Withdrawal by Subject|0|||
130815356|NCT00928668|470951870|FG000|Overall Study|Other reasons not listed above|0|||
130815357|NCT00928668|470951871|FG001|Overall Study|Other reasons not listed above|0|||
130815358|NCT00928668|470951872|FG002|Overall Study|Other reasons not listed above|0|||
130815359|NCT00928668|470951873|FG003|Overall Study|Other reasons not listed above|1|||
130815360|NCT00928668|470951874|FG004|Overall Study|Other reasons not listed above|0|||
130815361|NCT04581395|470951877|FG000|Overall Study|Protocol Violation|4|||
130815362|NCT04581395|470951878|FG001|Overall Study|Protocol Violation|3|||
130815363|NCT04581395|470951879|FG002|Overall Study|Protocol Violation|2|||
130815364|NCT04581395|470951877|FG000|Overall Study|Physician Decision|0|||
130815365|NCT04581395|470951878|FG001|Overall Study|Physician Decision|1|||
130815366|NCT04581395|470951879|FG002|Overall Study|Physician Decision|0|||
130815367|NCT00815633|470951880|FG000|Overall Study|study terminated|1|||
130815368|NCT00721110|470951881|FG000|Overall Study|Ultram use|1|||
130815369|NCT00721110|470951882|FG001|Overall Study|Ultram use|0|||
130815370|NCT00721110|470951883|FG002|Overall Study|Ultram use|0|||
130815371|NCT00721110|470951884|FG003|Overall Study|Ultram use|0|||
130815372|NCT00721110|470951881|FG000|Overall Study|vertical incision|0|||
130815373|NCT00721110|470951882|FG001|Overall Study|vertical incision|0|||
130815374|NCT00721110|470951883|FG002|Overall Study|vertical incision|1|||
130815375|NCT00721110|470951884|FG003|Overall Study|vertical incision|0|||
130815376|NCT01362790|470951885|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
130815377|NCT01362790|470951886|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130815378|NCT01362790|470951887|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130815379|NCT01362790|470951888|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130815380|NCT01362790|470951889|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130815381|NCT01362790|470951890|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130815382|NCT01362790|470951891|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130815383|NCT01362790|470951885|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
130815384|NCT01362790|470951886|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
130815385|NCT01362790|470951887|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
130815386|NCT01362790|470951888|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
130815387|NCT01362790|470951889|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
130815388|NCT01362790|470951890|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
130815389|NCT01362790|470951891|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
130815390|NCT01362790|470951885|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
130815391|NCT01362790|470951886|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
130815392|NCT01362790|470951887|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
130815393|NCT01362790|470951888|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
130815394|NCT01362790|470951889|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
130815395|NCT01362790|470951890|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
130815396|NCT01362790|470951891|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
130815397|NCT01362790|470951885|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
130815398|NCT01362790|470951886|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
130815399|NCT01362790|470951887|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
130815400|NCT01362790|470951888|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
130815401|NCT01362790|470951889|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
130815402|NCT01362790|470951890|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
130815403|NCT01362790|470951891|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
130815404|NCT01362790|470951885|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
130815405|NCT01362790|470951886|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
130815406|NCT01362790|470951887|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
130815407|NCT01362790|470951888|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
130815408|NCT01362790|470951889|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
130815409|NCT01362790|470951890|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
130815410|NCT01362790|470951891|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
130815411|NCT01362790|470951885|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
130815412|NCT01362790|470951886|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
130815413|NCT01362790|470951887|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
130815414|NCT01362790|470951888|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
130815415|NCT01362790|470951889|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
130815416|NCT01362790|470951890|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
130815417|NCT01362790|470951891|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
130815418|NCT01362790|470951885|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
130815419|NCT01362790|470951886|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130815420|NCT01362790|470951887|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130815421|NCT01362790|470951888|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130815422|NCT01362790|470951889|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130815423|NCT01362790|470951890|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130815424|NCT01362790|470951891|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130815425|NCT01362790|470951885|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130815426|NCT01362790|470951886|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
130815427|NCT01362790|470951887|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130815428|NCT01362790|470951888|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130815429|NCT01362790|470951889|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130815430|NCT01362790|470951890|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130815431|NCT01362790|470951891|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130815432|NCT01362790|470951885|FG000|Pilot Phase & Phase 2|Death on study|0|||
130815433|NCT01362790|470951886|FG001|Pilot Phase & Phase 2|Death on study|0|||
130815434|NCT01362790|470951887|FG002|Pilot Phase & Phase 2|Death on study|0|||
130815435|NCT01362790|470951888|FG003|Pilot Phase & Phase 2|Death on study|1|||
130815436|NCT01362790|470951889|FG004|Pilot Phase & Phase 2|Death on study|0|||
130815437|NCT01362790|470951890|FG005|Pilot Phase & Phase 2|Death on study|0|||
130815438|NCT01362790|470951891|FG006|Pilot Phase & Phase 2|Death on study|0|||
130815439|NCT01362790|470951885|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
130815440|NCT01362790|470951886|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
130815441|NCT01362790|470951887|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
130815442|NCT01362790|470951888|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
130815443|NCT01362790|470951889|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
130815444|NCT01362790|470951890|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
130815445|NCT01362790|470951891|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
130815446|NCT01362790|470951885|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130815447|NCT01362790|470951886|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130815448|NCT01362790|470951887|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130815449|NCT01362790|470951888|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130815450|NCT01362790|470951889|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
130815451|NCT01362790|470951890|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130815452|NCT01362790|470951891|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130815453|NCT01362790|470951885|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
130815454|NCT01362790|470951886|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
130815455|NCT01362790|470951887|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
130815456|NCT01362790|470951888|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
130815457|NCT01362790|470951889|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
130815458|NCT01362790|470951890|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
130815459|NCT01362790|470951891|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
130815460|NCT02457065|470951892|FG000|Overall Study|Lost to Follow-up|9|||
130815461|NCT02457065|470951893|FG001|Overall Study|Lost to Follow-up|11|||
130815462|NCT01554904|470951894|FG000|Overall Study|Withdrawal by Subject|3|||
130815463|NCT01554904|470951894|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
130815464|NCT01605097|470951896|FG000|Overall Study|Protocol Violation|1|||
130815465|NCT02038647|470951897|FG000|Overall Study|Progressive Disease|50|||
130815466|NCT02038647|470951898|FG001|Overall Study|Progressive Disease|59|||
130815467|NCT02038647|470951897|FG000|Overall Study|Adverse Event|18|||
130815468|NCT02038647|470951898|FG001|Overall Study|Adverse Event|10|||
130815469|NCT02038647|470951897|FG000|Overall Study|Symptomatic Deterioration|7|||
130815470|NCT02038647|470951898|FG001|Overall Study|Symptomatic Deterioration|7|||
130815471|NCT02038647|470951897|FG000|Overall Study|Withdrawal by Subject|5|||
130815472|NCT02038647|470951898|FG001|Overall Study|Withdrawal by Subject|2|||
130815473|NCT02038647|470951897|FG000|Overall Study|Not Reported|0|||
130815474|NCT02038647|470951898|FG001|Overall Study|Not Reported|1|||
130815475|NCT02038647|470951897|FG000|Overall Study|Ongoing at Datacut|9|||
130815476|NCT02038647|470951898|FG001|Overall Study|Ongoing at Datacut|10|||
130815477|NCT02757430|470951899|FG000|Overall Study|Physician Decision|6|||
130815478|NCT02757430|470951899|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
130815479|NCT02757430|470951899|FG000|Overall Study|No informed consent|1|||
130815480|NCT02757430|470951899|FG000|Overall Study|No procedure performed|2|||
130815481|NCT03518060|470951905|FG000|Overall Study|Death|1|||
130815482|NCT03518060|470951905|FG000|Overall Study|Poor adherence|1|||
130815483|NCT03518060|470951905|FG000|Overall Study|Withdrawal of informed consent|2|||
130815484|NCT03518060|470951905|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
130815485|NCT03518060|470951905|FG000|Overall Study|Physician Decision|7|||
130815486|NCT03518060|470951905|FG000|Overall Study|Adverse drug reactions|23|||
130815487|NCT03518060|470951905|FG000|Overall Study|Withdrawal by Subject|25|||
130815488|NCT03518060|470951905|FG000|Overall Study|Lost to Follow-up|13|||
130815489|NCT01969058|470951911|FG000|Overall Study|Withdrawal by Subject|2|||
130815490|NCT01969058|470951912|FG001|Overall Study|Withdrawal by Subject|0|||
130815491|NCT01969058|470951911|FG000|Overall Study|Adverse Event|1|||
130815492|NCT01969058|470951912|FG001|Overall Study|Adverse Event|0|||
130815493|NCT04976855|470951913|FG000|Part I|Withdrawal by Subject|0|||
130815494|NCT04976855|470951914|FG001|Part I|Withdrawal by Subject|1|||
130815495|NCT04976855|470951915|FG002|Part I|Withdrawal by Subject|0|||
130815496|NCT04976855|470951916|FG003|Part I|Withdrawal by Subject|0|||
130815497|NCT04976855|470951917|FG004|Part I|Withdrawal by Subject|0|||
130815498|NCT04976855|470951918|FG005|Part I|Withdrawal by Subject|0|||
130815499|NCT04976855|470951919|FG006|Part I|Withdrawal by Subject|0|||
130815500|NCT04976855|470951913|FG000|Part II|Adverse Event|0|||
130815501|NCT04976855|470951914|FG001|Part II|Adverse Event|0|||
130815502|NCT04976855|470951915|FG002|Part II|Adverse Event|0|||
130815503|NCT04976855|470951916|FG003|Part II|Adverse Event|1|||
130815504|NCT04976855|470951917|FG004|Part II|Adverse Event|0|||
130815505|NCT04976855|470951918|FG005|Part II|Adverse Event|0|||
130815506|NCT04976855|470951919|FG006|Part II|Adverse Event|0|||
130815507|NCT04976855|470951913|FG000|Part II|Withdrawal by Subject|0|||
130815508|NCT04976855|470951914|FG001|Part II|Withdrawal by Subject|0|||
130815509|NCT04976855|470951915|FG002|Part II|Withdrawal by Subject|0|||
130815510|NCT04976855|470951916|FG003|Part II|Withdrawal by Subject|0|||
130815511|NCT04976855|470951917|FG004|Part II|Withdrawal by Subject|1|||
130815512|NCT04976855|470951918|FG005|Part II|Withdrawal by Subject|0|||
130815513|NCT04976855|470951919|FG006|Part II|Withdrawal by Subject|0|||
130815514|NCT04976855|470951913|FG000|Part II|Lost to Follow-up|0|||
130815515|NCT04976855|470951914|FG001|Part II|Lost to Follow-up|0|||
130815516|NCT04976855|470951915|FG002|Part II|Lost to Follow-up|0|||
130815517|NCT04976855|470951916|FG003|Part II|Lost to Follow-up|0|||
130815518|NCT04976855|470951917|FG004|Part II|Lost to Follow-up|0|||
130815519|NCT04976855|470951918|FG005|Part II|Lost to Follow-up|1|||
130815520|NCT04976855|470951919|FG006|Part II|Lost to Follow-up|0|||
130815521|NCT02776735|470951935|FG000|Overall Study|Adverse Event|0|||
130815522|NCT02776735|470951936|FG001|Overall Study|Adverse Event|0|||
130815523|NCT02776735|470951937|FG002|Overall Study|Adverse Event|0|||
130815524|NCT02776735|470951938|FG003|Overall Study|Adverse Event|1|||
130815525|NCT02776735|470951939|FG004|Overall Study|Adverse Event|0|||
130815526|NCT02776735|470951940|FG005|Overall Study|Adverse Event|1|||
130815527|NCT02776735|470951935|FG000|Overall Study|Lost to Follow-up|0|||
130815528|NCT02776735|470951936|FG001|Overall Study|Lost to Follow-up|0|||
130815529|NCT02776735|470951937|FG002|Overall Study|Lost to Follow-up|0|||
130815530|NCT02776735|470951938|FG003|Overall Study|Lost to Follow-up|1|||
130815531|NCT02776735|470951939|FG004|Overall Study|Lost to Follow-up|0|||
130815532|NCT02776735|470951940|FG005|Overall Study|Lost to Follow-up|0|||
130815533|NCT02776735|470951935|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130815534|NCT02776735|470951936|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130815535|NCT02776735|470951937|FG002|Overall Study|Withdrawal by parent/guardian|2|||
130815536|NCT02776735|470951938|FG003|Overall Study|Withdrawal by parent/guardian|2|||
130815537|NCT02776735|470951939|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130815538|NCT02776735|470951940|FG005|Overall Study|Withdrawal by parent/guardian|0|||
130815539|NCT02776735|470951935|FG000|Overall Study|Withdrawal by Subject|1|||
130815540|NCT02776735|470951936|FG001|Overall Study|Withdrawal by Subject|0|||
130815541|NCT02776735|470951937|FG002|Overall Study|Withdrawal by Subject|0|||
130815542|NCT02776735|470951938|FG003|Overall Study|Withdrawal by Subject|0|||
130815543|NCT02776735|470951939|FG004|Overall Study|Withdrawal by Subject|0|||
130815544|NCT02776735|470951940|FG005|Overall Study|Withdrawal by Subject|1|||
130815545|NCT02776735|470951935|FG000|Overall Study|Other|0|||
130815546|NCT02776735|470951936|FG001|Overall Study|Other|0|||
130815547|NCT02776735|470951937|FG002|Overall Study|Other|3|||
130815548|NCT02776735|470951938|FG003|Overall Study|Other|0|||
130815549|NCT02776735|470951939|FG004|Overall Study|Other|0|||
130815550|NCT02776735|470951940|FG005|Overall Study|Other|0|||
130815551|NCT02278003|470953435|FG000|Overall Study|Withdrawal by Subject|11|||
130815552|NCT02278003|470953436|FG001|Overall Study|Withdrawal by Subject|0|||
130815553|NCT02278003|470953435|FG000|Overall Study|Not Treated|1|||
130815554|NCT02278003|470953436|FG001|Overall Study|Not Treated|0|||
130815555|NCT02278003|470953435|FG000|Overall Study|Recognition task improperly completed|7|||
130815556|NCT02278003|470953436|FG001|Overall Study|Recognition task improperly completed|0|||
130815557|NCT04123704|470953439|FG000|Overall Study|Disease progression|2|||
130815558|NCT00939185|470953440|FG000|Overall Study|Adverse Event|3|||
130815559|NCT00939185|470953440|FG000|Overall Study|Lack of Efficacy|1|||
130815560|NCT00939185|470953440|FG000|Overall Study|Lost to Follow-up|6|||
130815561|NCT00939185|470953440|FG000|Overall Study|Other|3|||
130815562|NCT00939185|470953440|FG000|Overall Study|Withdrawal by Subject|2|||
130815563|NCT00939185|470953440|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
130815564|NCT00363298|470953441|FG000|First Study Week|Lack of Efficacy|6|||
130815565|NCT00363298|470953442|FG001|First Study Week|Lack of Efficacy|5|||
130815566|NCT00363298|470953441|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
130815567|NCT00363298|470953442|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
130815568|NCT03552029|470953446|FG000|Overall Study|Death|3|||
130815569|NCT03552029|470953447|FG001|Overall Study|Death|0|||
130815570|NCT03552029|470953446|FG000|Overall Study|Adverse Event|1|||
130815571|NCT03552029|470953447|FG001|Overall Study|Adverse Event|0|||
130815572|NCT03552029|470953446|FG000|Overall Study|Lack of Efficacy|0|||
130815573|NCT03552029|470953447|FG001|Overall Study|Lack of Efficacy|2|||
130815574|NCT03552029|470953446|FG000|Overall Study|Physician Decision|0|||
130815575|NCT03552029|470953447|FG001|Overall Study|Physician Decision|1|||
130815576|NCT03552029|470953446|FG000|Overall Study|Study terminated by Sponsor|0|||
130815577|NCT03552029|470953447|FG001|Overall Study|Study terminated by Sponsor|1|||
130815578|NCT03552029|470953446|FG000|Overall Study|Other|0|||
130815579|NCT03552029|470953447|FG001|Overall Study|Other|2|||
130815580|NCT03468998|470953450|FG000|Overall Study|Withdrawal by Subject|1|||
130815581|NCT03468998|470953451|FG001|Overall Study|Withdrawal by Subject|1|||
130815582|NCT03468998|470953452|FG002|Overall Study|Withdrawal by Subject|0|||
130815583|NCT03468998|470953453|FG003|Overall Study|Withdrawal by Subject|4|||
130815584|NCT03468998|470953454|FG004|Overall Study|Withdrawal by Subject|1|||
130815585|NCT03468998|470953455|FG005|Overall Study|Withdrawal by Subject|0|||
130815586|NCT00836706|470953458|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
130815587|NCT00836706|470953459|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
130815588|NCT02989857|470953460|FG000|Randomization Phase|Not Treated|3|||
130815589|NCT02989857|470953461|FG001|Randomization Phase|Not Treated|2|||
130815590|NCT02989857|470953462|FG002|Randomization Phase|Not Treated|0|||
130815591|NCT00633126|470953467|FG000|Overall Study|Did not receive full dose|1|||
130815592|NCT02538614|470953480|FG000|Overall Study|Progressive Disease|2|||
130815593|NCT01767987|470953486|FG000|Overall Study|Physician Decision|4|||
130815594|NCT01767987|470953487|FG001|Overall Study|Physician Decision|1|||
130815595|NCT03232567|470953488|FG000|Overall Study|Withdrawal by Subject|0|||
130815596|NCT03232567|470953489|FG001|Overall Study|Withdrawal by Subject|1|||
130815597|NCT03232567|470953490|FG002|Overall Study|Withdrawal by Subject|0|||
130815598|NCT03232567|470953491|FG003|Overall Study|Withdrawal by Subject|0|||
130815599|NCT05837481|470953493|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
130815600|NCT05837481|470953494|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
130815601|NCT03038087|470953507|FG000|Overall Study|lost data|1|||
130815602|NCT00654355|470953508|FG000|Overall Study|Lost to Follow-up|2|||
130815603|NCT00654355|470953509|FG001|Overall Study|Lost to Follow-up|2|||
130815604|NCT05805150|470953516|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
130815605|NCT05805150|470953517|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
130815606|NCT02284893|470953518|FG000|26 Week (Short Term)|Adverse Event|1|||
130815607|NCT02284893|470953519|FG001|26 Week (Short Term)|Adverse Event|9|||
130815608|NCT02284893|470953518|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
130815609|NCT02284893|470953519|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
130815610|NCT02284893|470953518|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
130815611|NCT02284893|470953519|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
130815612|NCT02284893|470953518|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
130815613|NCT02284893|470953519|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
130815614|NCT02284893|470953518|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
130815615|NCT02284893|470953519|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
130815616|NCT02284893|470953518|FG000|26 Week (Short Term)|Other|1|||
130815617|NCT02284893|470953519|FG001|26 Week (Short Term)|Other|1|||
130815618|NCT02284893|470953518|FG000|52 Week (Long Term)|Adverse Event|3|||
130815619|NCT02284893|470953519|FG001|52 Week (Long Term)|Adverse Event|1|||
130815620|NCT02284893|470953518|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
130815621|NCT02284893|470953519|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
130815622|NCT02284893|470953518|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
130815623|NCT02284893|470953519|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
130815624|NCT02284893|470953518|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
130815625|NCT02284893|470953519|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
130815626|NCT02284893|470953518|FG000|52 Week (Long Term)|Non-Compliance|2|||
130815627|NCT02284893|470953519|FG001|52 Week (Long Term)|Non-Compliance|3|||
130815628|NCT00105066|470953526|FG000|Overall Study|Adverse Event|2|||
130815629|NCT00105066|470953527|FG001|Overall Study|Adverse Event|5|||
130815630|NCT01506726|470953546|FG000|Overall Study|Adverse Event|1|||
130815631|NCT01506726|470953547|FG001|Overall Study|Adverse Event|2|||
130815632|NCT02259231|470953548|FG000|Overall Study|Adverse Event|1|||
130815633|NCT02259231|470953549|FG001|Overall Study|Adverse Event|1|||
130815634|NCT02259231|470953550|FG002|Overall Study|Adverse Event|2|||
130815635|NCT02259231|470953551|FG003|Overall Study|Adverse Event|0|||
130815636|NCT02259231|470953552|FG004|Overall Study|Adverse Event|0|||
130815637|NCT02259231|470953553|FG005|Overall Study|Adverse Event|0|||
130815638|NCT02259231|470953554|FG006|Overall Study|Adverse Event|0|||
130815639|NCT02259231|470953548|FG000|Overall Study|Progressive Disease|4|||
130815640|NCT02259231|470953549|FG001|Overall Study|Progressive Disease|5|||
130815641|NCT02259231|470953550|FG002|Overall Study|Progressive Disease|4|||
130815642|NCT02259231|470953551|FG003|Overall Study|Progressive Disease|5|||
130815643|NCT02259231|470953552|FG004|Overall Study|Progressive Disease|4|||
130815644|NCT02259231|470953553|FG005|Overall Study|Progressive Disease|5|||
130815645|NCT02259231|470953554|FG006|Overall Study|Progressive Disease|4|||
130815646|NCT02259231|470953548|FG000|Overall Study|Sponsor termination of study|1|||
130815647|NCT02259231|470953549|FG001|Overall Study|Sponsor termination of study|0|||
130815648|NCT02259231|470953550|FG002|Overall Study|Sponsor termination of study|0|||
130815649|NCT02259231|470953551|FG003|Overall Study|Sponsor termination of study|1|||
130815650|NCT02259231|470953552|FG004|Overall Study|Sponsor termination of study|2|||
130815651|NCT02259231|470953553|FG005|Overall Study|Sponsor termination of study|1|||
130815652|NCT02259231|470953554|FG006|Overall Study|Sponsor termination of study|1|||
130815653|NCT00847730|470953558|FG000|Overall Study|Multiple interruptions in therapy|8|||
130815654|NCT04116489|470953562|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
130815655|NCT04116489|470953562|FG000|Overall Study|Withdrawal by Subject|1|||
130815656|NCT02255656|470953567|FG000|Overall Study|Adverse Event|11|||
130815657|NCT02255656|470953567|FG000|Overall Study|Poor compliance to protocol|3|||
130815658|NCT02255656|470953567|FG000|Overall Study|Lost to Follow-up|30|||
130815659|NCT02255656|470953567|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
130815660|NCT02255656|470953567|FG000|Overall Study|Other|126|||
130815661|NCT03734536|470953568|FG000|Overall Study|Withdrew Consent|1|||
130815662|NCT03734536|470953569|FG001|Overall Study|Withdrew Consent|5|||
130815663|NCT03734536|470953568|FG000|Overall Study|Lost to Follow-up|10|||
130815664|NCT03734536|470953569|FG001|Overall Study|Lost to Follow-up|7|||
130815665|NCT01877278|470953570|FG000|Overall Study|Lost to Follow-up|3|||
130815666|NCT01877278|470953571|FG001|Overall Study|Lost to Follow-up|3|||
130815667|NCT05185453|470953578|FG000|Overall Study|Lost to Follow-up|13|||
130815668|NCT05185453|470953579|FG001|Overall Study|Lost to Follow-up|3|||
130815669|NCT02457793|470953580|FG000|Overall Study|Reason not specified|0|||
130815670|NCT02457793|470953581|FG001|Overall Study|Reason not specified|0|||
130815671|NCT02457793|470953582|FG002|Overall Study|Reason not specified|0|||
130815672|NCT02457793|470953583|FG003|Overall Study|Reason not specified|1|||
130815673|NCT02457793|470953584|FG004|Overall Study|Reason not specified|1|||
130815674|NCT02457793|470953585|FG005|Overall Study|Reason not specified|1|||
130815675|NCT02457793|470953580|FG000|Overall Study|Withdrawal by Subject|0|||
130815676|NCT02457793|470953581|FG001|Overall Study|Withdrawal by Subject|4|||
130815677|NCT02457793|470953582|FG002|Overall Study|Withdrawal by Subject|2|||
130815678|NCT02457793|470953583|FG003|Overall Study|Withdrawal by Subject|2|||
130815679|NCT02457793|470953584|FG004|Overall Study|Withdrawal by Subject|2|||
130815680|NCT02457793|470953585|FG005|Overall Study|Withdrawal by Subject|2|||
130815681|NCT02457793|470953580|FG000|Overall Study|Adverse Event|0|||
130815682|NCT02457793|470953581|FG001|Overall Study|Adverse Event|0|||
130815683|NCT02457793|470953582|FG002|Overall Study|Adverse Event|0|||
130815684|NCT02457793|470953583|FG003|Overall Study|Adverse Event|1|||
130815685|NCT02457793|470953584|FG004|Overall Study|Adverse Event|0|||
130815686|NCT02457793|470953585|FG005|Overall Study|Adverse Event|0|||
130815687|NCT02457793|470953580|FG000|Overall Study|Physician Decision|1|||
130815688|NCT02457793|470953581|FG001|Overall Study|Physician Decision|0|||
130815689|NCT02457793|470953582|FG002|Overall Study|Physician Decision|1|||
130815690|NCT02457793|470953583|FG003|Overall Study|Physician Decision|1|||
130815691|NCT02457793|470953584|FG004|Overall Study|Physician Decision|1|||
130815692|NCT02457793|470953585|FG005|Overall Study|Physician Decision|3|||
130815693|NCT02757768|470953590|FG000|Overall Study|Randomized Never Received Study Drug|3|||
130815694|NCT02757768|470953591|FG001|Overall Study|Randomized Never Received Study Drug|4|||
130815695|NCT02757768|470953590|FG000|Overall Study|Adverse Event|5|||
130815696|NCT02757768|470953591|FG001|Overall Study|Adverse Event|3|||
130815697|NCT02757768|470953590|FG000|Overall Study|Lack of Efficacy|2|||
130815698|NCT02757768|470953591|FG001|Overall Study|Lack of Efficacy|1|||
130815699|NCT02757768|470953590|FG000|Overall Study|Lost to Follow-up|1|||
130815700|NCT02757768|470953591|FG001|Overall Study|Lost to Follow-up|0|||
130815701|NCT02757768|470953590|FG000|Overall Study|Protocol Deviation|2|||
130815702|NCT02757768|470953591|FG001|Overall Study|Protocol Deviation|9|||
130815703|NCT02757768|470953590|FG000|Overall Study|Withdrawal by Subject|16|||
130815704|NCT02757768|470953591|FG001|Overall Study|Withdrawal by Subject|9|||
130815705|NCT02757768|470953590|FG000|Overall Study|Miscellaneous|4|||
130815706|NCT02757768|470953591|FG001|Overall Study|Miscellaneous|2|||
130815707|NCT05929326|470953592|FG000|Overall Study|unqualified sample|2|||
130815708|NCT05929326|470953593|FG001|Overall Study|unqualified sample|3|||
130815709|NCT05929326|470953594|FG002|Overall Study|unqualified sample|7|||
130815710|NCT04890509|470953595|FG000|Overall Study|Death|4|||
130815711|NCT04890509|470953596|FG001|Overall Study|Death|4|||
130815712|NCT01657370|470955417|FG000|Overall Study|Withdrawal by Subject|0|||
130815713|NCT01657370|470955418|FG001|Overall Study|Withdrawal by Subject|0|||
130815714|NCT01657370|470955419|FG002|Overall Study|Withdrawal by Subject|1|||
130815715|NCT01657370|470955420|FG003|Overall Study|Withdrawal by Subject|0|||
130815716|NCT01657370|470955421|FG004|Overall Study|Withdrawal by Subject|0|||
130815717|NCT01657370|470955422|FG005|Overall Study|Withdrawal by Subject|1|||
130815718|NCT01657370|470955417|FG000|Overall Study|Physician Decision|2|||
130815719|NCT01657370|470955418|FG001|Overall Study|Physician Decision|3|||
130815720|NCT01657370|470955419|FG002|Overall Study|Physician Decision|1|||
130815721|NCT01657370|470955420|FG003|Overall Study|Physician Decision|2|||
130815722|NCT01657370|470955421|FG004|Overall Study|Physician Decision|5|||
130815723|NCT01657370|470955422|FG005|Overall Study|Physician Decision|0|||
130815724|NCT01657370|470955417|FG000|Overall Study|Lack of Qualifying Event|1|||
130815725|NCT01657370|470955418|FG001|Overall Study|Lack of Qualifying Event|0|||
130815726|NCT01657370|470955419|FG002|Overall Study|Lack of Qualifying Event|3|||
130815727|NCT01657370|470955420|FG003|Overall Study|Lack of Qualifying Event|2|||
130815728|NCT01657370|470955421|FG004|Overall Study|Lack of Qualifying Event|1|||
130815729|NCT01657370|470955422|FG005|Overall Study|Lack of Qualifying Event|2|||
130815730|NCT01657370|470955417|FG000|Overall Study|Adverse Event|0|||
130815731|NCT01657370|470955418|FG001|Overall Study|Adverse Event|0|||
130815732|NCT01657370|470955419|FG002|Overall Study|Adverse Event|0|||
130815733|NCT01657370|470955420|FG003|Overall Study|Adverse Event|0|||
130815734|NCT01657370|470955421|FG004|Overall Study|Adverse Event|1|||
130815735|NCT01657370|470955422|FG005|Overall Study|Adverse Event|0|||
130815736|NCT01657370|470955417|FG000|Overall Study|Protocol Violation|1|||
130815737|NCT01657370|470955418|FG001|Overall Study|Protocol Violation|1|||
130815738|NCT01657370|470955419|FG002|Overall Study|Protocol Violation|1|||
130815739|NCT01657370|470955420|FG003|Overall Study|Protocol Violation|1|||
130815740|NCT01657370|470955421|FG004|Overall Study|Protocol Violation|0|||
130815741|NCT01657370|470955422|FG005|Overall Study|Protocol Violation|0|||
130815742|NCT01657370|470955417|FG000|Overall Study|Lost to Follow-up|2|||
130815743|NCT01657370|470955418|FG001|Overall Study|Lost to Follow-up|0|||
130815744|NCT01657370|470955419|FG002|Overall Study|Lost to Follow-up|1|||
130815745|NCT01657370|470955420|FG003|Overall Study|Lost to Follow-up|0|||
130815746|NCT01657370|470955421|FG004|Overall Study|Lost to Follow-up|0|||
130815747|NCT01657370|470955422|FG005|Overall Study|Lost to Follow-up|1|||
130815748|NCT03440385|470955433|FG000|Overall Study|Other Reason|4|||
130815749|NCT03440385|470955434|FG001|Overall Study|Other Reason|1|||
130815750|NCT03440385|470955433|FG000|Overall Study|Site Closed|1|||
130815751|NCT03440385|470955434|FG001|Overall Study|Site Closed|0|||
130815752|NCT03440385|470955433|FG000|Overall Study|Lost to Follow-up|2|||
130815753|NCT03440385|470955434|FG001|Overall Study|Lost to Follow-up|0|||
130815754|NCT03440385|470955433|FG000|Overall Study|Withdrawal by Subject|12|||
130815755|NCT03440385|470955434|FG001|Overall Study|Withdrawal by Subject|6|||
130815756|NCT03440385|470955433|FG000|Overall Study|Lack of Efficacy|9|||
130815757|NCT03440385|470955434|FG001|Overall Study|Lack of Efficacy|2|||
130815758|NCT03440385|470955433|FG000|Overall Study|Adverse Event|15|||
130815759|NCT03440385|470955434|FG001|Overall Study|Adverse Event|11|||
130815760|NCT01168596|470955440|FG000|Overall Study|Withdrawal by Subject|3|||
130815761|NCT01168596|470955441|FG001|Overall Study|Withdrawal by Subject|1|||
130815762|NCT00876447|470955444|FG000|Overall Study|Other miscellaneous reasons|3|||
130815763|NCT00876447|470955445|FG001|Overall Study|Other miscellaneous reasons|8|||
130815764|NCT00876447|470955444|FG000|Overall Study|Site closure|19|||
130815765|NCT00876447|470955445|FG001|Overall Study|Site closure|14|||
130815766|NCT00876447|470955444|FG000|Overall Study|Protocol Violation|9|||
130815767|NCT00876447|470955445|FG001|Overall Study|Protocol Violation|3|||
130815768|NCT00876447|470955444|FG000|Overall Study|Personal reasons|30|||
130815769|NCT00876447|470955445|FG001|Overall Study|Personal reasons|28|||
130815770|NCT00876447|470955444|FG000|Overall Study|Lost to Follow-up|6|||
130815771|NCT00876447|470955445|FG001|Overall Study|Lost to Follow-up|15|||
130815772|NCT00876447|470955444|FG000|Overall Study|Pregnancy|4|||
130815773|NCT00876447|470955445|FG001|Overall Study|Pregnancy|2|||
130815774|NCT00876447|470955444|FG000|Overall Study|Lack of Efficacy|5|||
130815775|NCT00876447|470955445|FG001|Overall Study|Lack of Efficacy|3|||
130815776|NCT00876447|470955444|FG000|Overall Study|Adverse Event|4|||
130815777|NCT00876447|470955445|FG001|Overall Study|Adverse Event|8|||
130815778|NCT01425814|470955454|FG000|Period 1|Stability criteria not fulfilled|0|||
130815779|NCT01425814|470955455|FG001|Period 1|Stability criteria not fulfilled|1|||
130815780|NCT01425814|470955456|FG002|Period 1|Stability criteria not fulfilled|0|||
130815781|NCT01425814|470955457|FG003|Period 1|Stability criteria not fulfilled|0|||
130815782|NCT01425814|470955458|FG004|Period 1|Stability criteria not fulfilled|0|||
130815783|NCT01425814|470955459|FG005|Period 1|Stability criteria not fulfilled|0|||
130815784|NCT01425814|470955454|FG000|Period 2|Stability criteria not fulfilled|0|||
130815785|NCT01425814|470955455|FG001|Period 2|Stability criteria not fulfilled|1|||
130815786|NCT01425814|470955456|FG002|Period 2|Stability criteria not fulfilled|0|||
130815787|NCT01425814|470955457|FG003|Period 2|Stability criteria not fulfilled|0|||
130815788|NCT01425814|470955458|FG004|Period 2|Stability criteria not fulfilled|0|||
130815789|NCT01425814|470955459|FG005|Period 2|Stability criteria not fulfilled|0|||
130815790|NCT01425814|470955454|FG000|Period 3|Adverse Event|0|||
130815791|NCT01425814|470955455|FG001|Period 3|Adverse Event|0|||
130815792|NCT01425814|470955456|FG002|Period 3|Adverse Event|0|||
130815793|NCT01425814|470955457|FG003|Period 3|Adverse Event|0|||
130815794|NCT01425814|470955458|FG004|Period 3|Adverse Event|0|||
130815795|NCT01425814|470955459|FG005|Period 3|Adverse Event|1|||
130815796|NCT01425814|470955454|FG000|Period 4|Adverse Event|1|||
130815797|NCT01425814|470955455|FG001|Period 4|Adverse Event|0|||
130815798|NCT01425814|470955456|FG002|Period 4|Adverse Event|1|||
130815799|NCT01425814|470955457|FG003|Period 4|Adverse Event|0|||
130815800|NCT01425814|470955458|FG004|Period 4|Adverse Event|0|||
130815801|NCT01425814|470955459|FG005|Period 4|Adverse Event|0|||
130815802|NCT01425814|470955454|FG000|Period 5|Stability criteria not fulfilled|0|||
130815803|NCT01425814|470955455|FG001|Period 5|Stability criteria not fulfilled|0|||
130815804|NCT01425814|470955456|FG002|Period 5|Stability criteria not fulfilled|1|||
130815805|NCT01425814|470955457|FG003|Period 5|Stability criteria not fulfilled|0|||
130815806|NCT01425814|470955458|FG004|Period 5|Stability criteria not fulfilled|0|||
130815807|NCT01425814|470955459|FG005|Period 5|Stability criteria not fulfilled|1|||
130815808|NCT00565747|470955461|FG000|Overall Study|No embryo transfer|67|||
130815809|NCT00565747|470955462|FG001|Overall Study|No embryo transfer|73|||
130815810|NCT02684461|470955465|FG000|Overall Study|Adverse Event|1|||
130815811|NCT02684461|470955466|FG001|Overall Study|Adverse Event|0|||
130815812|NCT02684461|470955467|FG002|Overall Study|Adverse Event|0|||
130815813|NCT02684461|470955465|FG000|Overall Study|Lack of Efficacy|1|||
130815814|NCT02684461|470955466|FG001|Overall Study|Lack of Efficacy|2|||
130815815|NCT02684461|470955467|FG002|Overall Study|Lack of Efficacy|0|||
130815816|NCT02390076|470955468|FG000|Overall Study|Lost to Follow-up|2|||
130815817|NCT02390076|470955469|FG001|Overall Study|Lost to Follow-up|1|||
130815818|NCT02390076|470955470|FG002|Overall Study|Lost to Follow-up|4|||
130815819|NCT01358734|470955476|FG000|Overall Study|Adverse Event|4|||
130815820|NCT01358734|470955477|FG001|Overall Study|Adverse Event|7|||
130815821|NCT01358734|470955478|FG002|Overall Study|Adverse Event|3|||
130815822|NCT01358734|470955476|FG000|Overall Study|Lack of Efficacy|0|||
130815823|NCT01358734|470955477|FG001|Overall Study|Lack of Efficacy|1|||
130815824|NCT01358734|470955478|FG002|Overall Study|Lack of Efficacy|3|||
130815825|NCT01358734|470955476|FG000|Overall Study|Withdrawal by Subject|1|||
130815826|NCT01358734|470955477|FG001|Overall Study|Withdrawal by Subject|6|||
130815827|NCT01358734|470955478|FG002|Overall Study|Withdrawal by Subject|3|||
130815828|NCT01358734|470955476|FG000|Overall Study|Death|3|||
130815829|NCT01358734|470955477|FG001|Overall Study|Death|7|||
130815830|NCT01358734|470955478|FG002|Overall Study|Death|2|||
130815831|NCT01358734|470955476|FG000|Overall Study|Progressive Disease|5|||
130815832|NCT01358734|470955477|FG001|Overall Study|Progressive Disease|13|||
130815833|NCT01358734|470955478|FG002|Overall Study|Progressive Disease|16|||
130815834|NCT01358734|470955476|FG000|Overall Study|Non-compliance with study drug|0|||
130815835|NCT01358734|470955477|FG001|Overall Study|Non-compliance with study drug|0|||
130815836|NCT01358734|470955478|FG002|Overall Study|Non-compliance with study drug|1|||
130815837|NCT01358734|470955476|FG000|Overall Study|Other|2|||
130815838|NCT01358734|470955477|FG001|Overall Study|Other|5|||
130815839|NCT01358734|470955478|FG002|Overall Study|Other|4|||
130815840|NCT01358734|470955476|FG000|Overall Study|Protocol Violation|0|||
130815841|NCT01358734|470955477|FG001|Overall Study|Protocol Violation|0|||
130815842|NCT01358734|470955478|FG002|Overall Study|Protocol Violation|2|||
130815843|NCT03243084|470955482|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
130815844|NCT03243084|470955483|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
130815845|NCT02095106|470955484|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
130815846|NCT02095106|470955485|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
130815847|NCT00553254|470955488|FG000|Overall Study|Death|3|||
130815848|NCT00553254|470955489|FG001|Overall Study|Death|6|||
130815849|NCT00553254|470955490|FG002|Overall Study|Death|25|||
130815850|NCT00553254|470955488|FG000|Overall Study|Lost to Follow-up|0|||
130815851|NCT00553254|470955489|FG001|Overall Study|Lost to Follow-up|0|||
130815852|NCT00553254|470955490|FG002|Overall Study|Lost to Follow-up|2|||
130815853|NCT00553254|470955488|FG000|Overall Study|Withdrawal by Subject|2|||
130815854|NCT00553254|470955489|FG001|Overall Study|Withdrawal by Subject|0|||
130815855|NCT00553254|470955490|FG002|Overall Study|Withdrawal by Subject|2|||
130815856|NCT00553254|470955488|FG000|Overall Study|Study terminated by Sponsor|0|||
130815857|NCT00553254|470955489|FG001|Overall Study|Study terminated by Sponsor|0|||
130815858|NCT00553254|470955490|FG002|Overall Study|Study terminated by Sponsor|1|||
130815859|NCT00553254|470955488|FG000|Overall Study|Other|1|||
130815860|NCT00553254|470955489|FG001|Overall Study|Other|0|||
130815861|NCT00553254|470955490|FG002|Overall Study|Other|13|||
130815862|NCT02300233|470955498|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
130815863|NCT02300233|470955499|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130815864|NCT02300233|470955500|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
130815865|NCT02300233|470955498|FG000|Overall Study|Withdrawal by Subject|1|||
130815866|NCT02300233|470955499|FG001|Overall Study|Withdrawal by Subject|0|||
130815867|NCT02300233|470955500|FG002|Overall Study|Withdrawal by Subject|3|||
130815868|NCT02300233|470955498|FG000|Overall Study|Investigator Judgement|0|||
130815869|NCT02300233|470955499|FG001|Overall Study|Investigator Judgement|0|||
130815870|NCT02300233|470955500|FG002|Overall Study|Investigator Judgement|1|||
130815871|NCT02300233|470955498|FG000|Overall Study|Reason Not Specified|0|||
130815872|NCT02300233|470955499|FG001|Overall Study|Reason Not Specified|0|||
130815873|NCT02300233|470955500|FG002|Overall Study|Reason Not Specified|5|||
130815874|NCT00833690|470955501|FG000|Overall Study|Withdrawal by Subject|1|||
130815875|NCT00833690|470955502|FG001|Overall Study|Withdrawal by Subject|0|||
130815876|NCT00833690|470955503|FG002|Overall Study|Withdrawal by Subject|0|||
130815877|NCT00833690|470955501|FG000|Overall Study|Discontinued study drug|3|||
130815878|NCT00833690|470955502|FG001|Overall Study|Discontinued study drug|2|||
130815879|NCT00833690|470955503|FG002|Overall Study|Discontinued study drug|0|||
130815880|NCT05448950|470955504|FG000|Overall Study|Death|2|||
130815881|NCT05448950|470955504|FG000|Overall Study|Withdrawal by Subject|1|||
130815882|NCT05448950|470955504|FG000|Overall Study|AVG abandoned|4|||
130815883|NCT04752566|470955505|FG000|Overall Study|Protocol Violation|0|||
130815884|NCT04752566|470955506|FG001|Overall Study|Protocol Violation|1|||
130815885|NCT04752566|470955505|FG000|Overall Study|Death|1|||
130815886|NCT04752566|470955506|FG001|Overall Study|Death|0|||
130815887|NCT04752566|470955505|FG000|Overall Study|Adverse Event|1|||
130815888|NCT04752566|470955506|FG001|Overall Study|Adverse Event|0|||
130815889|NCT04752566|470955505|FG000|Overall Study|Withdrawal by Subject|2|||
130815890|NCT04752566|470955506|FG001|Overall Study|Withdrawal by Subject|0|||
130815891|NCT04752566|470955505|FG000|Overall Study|Physician Decision|1|||
130815892|NCT04752566|470955506|FG001|Overall Study|Physician Decision|1|||
130815893|NCT01153516|470955507|FG000|Overall Study|Both subjects refused surgery|2|||
130815894|NCT01153516|470955508|FG001|Overall Study|Both subjects refused surgery|0|||
130815895|NCT03773484|470955509|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
130815896|NCT01380080|470955510|FG000|Overall Study|Death|36|||
130815897|NCT01380080|470955511|FG001|Overall Study|Death|44|||
130815898|NCT01380080|470955510|FG000|Overall Study|Site is closing|28|||
130815899|NCT01380080|470955511|FG001|Overall Study|Site is closing|31|||
130815900|NCT01380080|470955510|FG000|Overall Study|Not able to get to clinic|7|||
130815901|NCT01380080|470955511|FG001|Overall Study|Not able to get to clinic|1|||
130815902|NCT01380080|470955510|FG000|Overall Study|Not willing to adhere to requirements|6|||
130815903|NCT01380080|470955511|FG001|Overall Study|Not willing to adhere to requirements|2|||
130815904|NCT01380080|470955510|FG000|Overall Study|Withdrawal by Subject|5|||
130815905|NCT01380080|470955511|FG001|Overall Study|Withdrawal by Subject|2|||
130815906|NCT01380080|470955510|FG000|Overall Study|Lost to Follow-up|3|||
130815907|NCT01380080|470955511|FG001|Overall Study|Lost to Follow-up|3|||
130815908|NCT04251533|470955512|FG000|Overall Study|Progressive disease|33|||
130815909|NCT04251533|470955513|FG001|Overall Study|Progressive disease|29|||
130815910|NCT04251533|470955514|FG002|Overall Study|Progressive disease|22|||
130815911|NCT04251533|470955512|FG000|Overall Study|Death|5|||
130815912|NCT04251533|470955513|FG001|Overall Study|Death|1|||
130815913|NCT04251533|470955514|FG002|Overall Study|Death|3|||
130815914|NCT04251533|470955512|FG000|Overall Study|Physician Decision|3|||
130815915|NCT04251533|470955513|FG001|Overall Study|Physician Decision|2|||
130815916|NCT04251533|470955514|FG002|Overall Study|Physician Decision|4|||
130815917|NCT04251533|470955512|FG000|Overall Study|Participant decision|1|||
130815918|NCT04251533|470955513|FG001|Overall Study|Participant decision|3|||
130815919|NCT04251533|470955514|FG002|Overall Study|Participant decision|1|||
130815920|NCT04251533|470955512|FG000|Overall Study|Adverse Event|2|||
130815921|NCT04251533|470955513|FG001|Overall Study|Adverse Event|1|||
130815922|NCT04251533|470955514|FG002|Overall Study|Adverse Event|1|||
130815923|NCT00210132|470955519|FG000|Overall Study|Protocol Violation|1|||
130815924|NCT00210132|470955520|FG001|Overall Study|Protocol Violation|4|||
130815925|NCT01889251|470955521|FG000|Overall Study|Adverse Event|1|||
130815926|NCT01889251|470955522|FG001|Overall Study|Adverse Event|0|||
130815927|NCT01722669|470955529|FG000|Overall Study|Withdrawal by Subject|0|||
130815928|NCT01722669|470955530|FG001|Overall Study|Withdrawal by Subject|0|||
130815929|NCT01722669|470955531|FG002|Overall Study|Withdrawal by Subject|0|||
130815930|NCT01722669|470955532|FG003|Overall Study|Withdrawal by Subject|0|||
130815931|NCT01722669|470955533|FG004|Overall Study|Withdrawal by Subject|0|||
130815932|NCT01722669|470955534|FG005|Overall Study|Withdrawal by Subject|2|||
130815933|NCT01344226|470955537|FG000|Overall Study|Protocol Violation|2|||
130815934|NCT01344226|470955537|FG000|Overall Study|Withdrawal by Subject|3|||
130815935|NCT01344226|470955537|FG000|Overall Study|Lack of Efficacy|3|||
130815936|NCT03211416|470955539|FG000|Overall Study|Adverse Event|7|||
130815937|NCT03211416|470955539|FG000|Overall Study|Lack of Efficacy|2|||
130815938|NCT03211416|470955539|FG000|Overall Study|Physician Decision|1|||
130815939|NCT02302222|470955541|FG000|Overall Study|Physician Decision|0|||
130815940|NCT02302222|470955542|FG001|Overall Study|Physician Decision|4|||
130815941|NCT02302222|470955541|FG000|Overall Study|Lost to Follow-up|1|||
130815942|NCT02302222|470955542|FG001|Overall Study|Lost to Follow-up|0|||
130815943|NCT02302222|470955541|FG000|Overall Study|Treatment discontinued before day 5|0|||
130815944|NCT02302222|470955542|FG001|Overall Study|Treatment discontinued before day 5|1|||
130815945|NCT02302222|470955541|FG000|Overall Study|Withdrawn prior to any treatment|0|||
130815946|NCT02302222|470955542|FG001|Overall Study|Withdrawn prior to any treatment|1|||
130815947|NCT03781570|470955548|FG000|Overall Study|Technical Issues (equipment failure)|31|||
130815948|NCT03781570|470955548|FG000|Overall Study|Withdrawal by Subject|7|||
130815949|NCT03781570|470955548|FG000|Overall Study|Physical Constraints|11|||
130815950|NCT01107496|470955549|FG000|Overall Study|Adverse Event|1|||
130815951|NCT01107496|470955550|FG001|Overall Study|Adverse Event|0|||
130815952|NCT01107496|470955549|FG000|Overall Study|Lack of Efficacy|1|||
130815953|NCT01107496|470955550|FG001|Overall Study|Lack of Efficacy|0|||
130815954|NCT01107496|470955549|FG000|Overall Study|Protocol Violation|0|||
130815955|NCT01107496|470955550|FG001|Overall Study|Protocol Violation|1|||
130815956|NCT01107496|470955549|FG000|Overall Study|Lost to Follow-up|0|||
130815957|NCT01107496|470955550|FG001|Overall Study|Lost to Follow-up|1|||
130815958|NCT03709472|470955551|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
130815959|NCT03709472|470955552|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
130815960|NCT03709472|470955551|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
130815961|NCT03709472|470955552|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
130815962|NCT03559556|470955553|FG000|Overall Study|Withdrawal by Subject|1|||
130815963|NCT02496000|470955555|FG000|Overall Study|Withdrawal by Subject|1|||
130815964|NCT02496000|470955556|FG001|Overall Study|Withdrawal by Subject|2|||
130815965|NCT02496000|470955557|FG002|Overall Study|Withdrawal by Subject|0|||
130815966|NCT02496000|470955555|FG000|Overall Study|Lost to Follow-up|1|||
130815967|NCT02496000|470955556|FG001|Overall Study|Lost to Follow-up|0|||
130815968|NCT02496000|470955557|FG002|Overall Study|Lost to Follow-up|1|||
130815969|NCT02496000|470955555|FG000|Overall Study|Protocol Violation|0|||
130815970|NCT02496000|470955556|FG001|Overall Study|Protocol Violation|0|||
130815971|NCT02496000|470955557|FG002|Overall Study|Protocol Violation|1|||
130815972|NCT02496000|470955555|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
130815973|NCT02496000|470955556|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
130815974|NCT02496000|470955557|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
130815975|NCT02496000|470955555|FG000|Overall Study|undetermined|0|||
130815976|NCT02496000|470955556|FG001|Overall Study|undetermined|1|||
130815977|NCT02496000|470955557|FG002|Overall Study|undetermined|0|||
130815978|NCT01587196|470955561|FG000|Overall Study|Lost to Follow-up|50|||
130815979|NCT01587196|470955561|FG000|Overall Study|Withdrawal by Subject|4|||
130815980|NCT03814044|470955562|FG000|Overall Study|Protocol deviation|1|||
130815981|NCT03274466|470955563|FG000|Overall Study|Withdrawal by Subject|7|||
130815982|NCT03274466|470955564|FG001|Overall Study|Withdrawal by Subject|3|||
130815983|NCT03274466|470955563|FG000|Overall Study|Protocol Specified Withdrawal|5|||
130815984|NCT03274466|470955564|FG001|Overall Study|Protocol Specified Withdrawal|11|||
130815985|NCT03274466|470955563|FG000|Overall Study|Lost to Follow-up|5|||
130815986|NCT03274466|470955564|FG001|Overall Study|Lost to Follow-up|7|||
130815987|NCT03274466|470955563|FG000|Overall Study|Subject Non-compliance|0|||
130815988|NCT03274466|470955564|FG001|Overall Study|Subject Non-compliance|1|||
130815989|NCT03274466|470955563|FG000|Overall Study|Adverse Event|3|||
130815990|NCT03274466|470955564|FG001|Overall Study|Adverse Event|3|||
130815991|NCT03274466|470955563|FG000|Overall Study|Physician Decision|0|||
130815992|NCT03274466|470955564|FG001|Overall Study|Physician Decision|1|||
130815993|NCT03274466|470955563|FG000|Overall Study|Protocol Violation|3|||
130815994|NCT03274466|470955564|FG001|Overall Study|Protocol Violation|3|||
130815995|NCT00618787|470955565|FG000|Overall Study|Adverse Event|0|||
130815996|NCT00618787|470955566|FG001|Overall Study|Adverse Event|1|||
130815997|NCT00618787|470955565|FG000|Overall Study|Withdrawal by Subject|2|||
130815998|NCT00618787|470955566|FG001|Overall Study|Withdrawal by Subject|1|||
130815999|NCT00618787|470955565|FG000|Overall Study|Lost to Follow-up|1|||
130816000|NCT00618787|470955566|FG001|Overall Study|Lost to Follow-up|0|||
130816001|NCT01107886|470955567|FG000|Overall Study|Lost to Follow-up|15|||
130816002|NCT01107886|470955568|FG001|Overall Study|Lost to Follow-up|13|||
130816003|NCT01107886|470955567|FG000|Overall Study|Withdrawal by Subject|180|||
130816004|NCT01107886|470955568|FG001|Overall Study|Withdrawal by Subject|196|||
130816005|NCT01107886|470955567|FG000|Overall Study|Administrative withdrawal of consent|7|||
130816006|NCT01107886|470955568|FG001|Overall Study|Administrative withdrawal of consent|5|||
130816007|NCT01649869|470955573|FG000|Overall Study|Family member illness|1|||
130816008|NCT01649869|470955574|FG001|Overall Study|Family member illness|0|||
130816009|NCT01649869|470955573|FG000|Overall Study|Required treatment outside protocol|1|||
130816010|NCT01649869|470955574|FG001|Overall Study|Required treatment outside protocol|0|||
130816011|NCT01649869|470955573|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
130816012|NCT01649869|470955574|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
130816013|NCT02333799|470958057|FG000|Treatment Period|Withdrawal by Subject|1|||
130816014|NCT02333799|470958057|FG000|Treatment Period|Death|6|||
130816015|NCT02333799|470958057|FG000|6 Month Follow Up Period|Physician Decision|1|||
130816016|NCT02333799|470958057|FG000|6 Month Follow Up Period|Death|1|||
130816017|NCT02333799|470958057|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
130816018|NCT02333799|470958057|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
130816019|NCT00730327|470958061|FG000|Overall Study|Lost to Follow-up|14|||
130816020|NCT00730327|470958062|FG001|Overall Study|Lost to Follow-up|16|||
130816021|NCT00730327|470958061|FG000|Overall Study|Adverse Event|8|||
130816022|NCT00730327|470958062|FG001|Overall Study|Adverse Event|1|||
130816023|NCT00730327|470958061|FG000|Overall Study|Withdrawal by Subject|3|||
130816024|NCT00730327|470958062|FG001|Overall Study|Withdrawal by Subject|13|||
130816025|NCT00730327|470958061|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
130816026|NCT00730327|470958062|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
130816027|NCT02552225|470958063|FG000|Overall Study|Withdrawal by Subject|1|||
130816028|NCT02552225|470958064|FG001|Overall Study|Withdrawal by Subject|0|||
130816029|NCT02297516|470958065|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
130816030|NCT02297516|470958066|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
130816031|NCT02297516|470958065|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
130816032|NCT02297516|470958066|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
130816033|NCT02297516|470958065|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
130816034|NCT02297516|470958066|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
130816035|NCT03674281|470958067|FG000|Overall Study|screen failure|2|||
130816036|NCT03674281|470958068|FG001|Overall Study|screen failure|0|||
130816037|NCT03674281|470958069|FG002|Overall Study|screen failure|0|||
130816038|NCT03674281|470958067|FG000|Overall Study|Withdrawal by Subject|1|||
130816039|NCT03674281|470958068|FG001|Overall Study|Withdrawal by Subject|3|||
130816040|NCT03674281|470958069|FG002|Overall Study|Withdrawal by Subject|3|||
130816041|NCT00366457|470958072|FG000|Overall Study|never began study therapy|2|||
130816042|NCT00189423|470958073|FG000|Overall Study|Death|746|||
130816043|NCT00189423|470958074|FG001|Overall Study|Death|747|||
130816044|NCT00189423|470958073|FG000|Overall Study|Withdrawal by Subject|9|||
130816045|NCT00189423|470958074|FG001|Overall Study|Withdrawal by Subject|9|||
130816046|NCT00189423|470958073|FG000|Overall Study|Lost to Follow-up|10|||
130816047|NCT00189423|470958074|FG001|Overall Study|Lost to Follow-up|10|||
130816048|NCT04622592|470958076|FG000|Overall Study|Death|0|||
130816049|NCT04622592|470958077|FG001|Overall Study|Death|0|||
130816050|NCT04622592|470958078|FG002|Overall Study|Death|1|||
130816051|NCT04622592|470958079|FG003|Overall Study|Death|0|||
130816052|NCT04622592|470958080|FG004|Overall Study|Death|0|||
130816053|NCT04622592|470958081|FG005|Overall Study|Death|0|||
130816054|NCT04622592|470958082|FG006|Overall Study|Death|0|||
130816055|NCT04622592|470958083|FG007|Overall Study|Death|1|||
130816056|NCT04622592|470958076|FG000|Overall Study|Lost to Follow-up|0|||
130816057|NCT04622592|470958077|FG001|Overall Study|Lost to Follow-up|0|||
130816058|NCT04622592|470958078|FG002|Overall Study|Lost to Follow-up|0|||
130816059|NCT04622592|470958079|FG003|Overall Study|Lost to Follow-up|3|||
130816060|NCT04622592|470958080|FG004|Overall Study|Lost to Follow-up|1|||
130816061|NCT04622592|470958081|FG005|Overall Study|Lost to Follow-up|0|||
130816062|NCT04622592|470958082|FG006|Overall Study|Lost to Follow-up|2|||
130816063|NCT04622592|470958083|FG007|Overall Study|Lost to Follow-up|2|||
130816064|NCT04622592|470958076|FG000|Overall Study|Physician Decision|0|||
130816065|NCT04622592|470958077|FG001|Overall Study|Physician Decision|0|||
130816066|NCT04622592|470958078|FG002|Overall Study|Physician Decision|0|||
130816067|NCT04622592|470958079|FG003|Overall Study|Physician Decision|0|||
130816068|NCT04622592|470958080|FG004|Overall Study|Physician Decision|1|||
130816069|NCT04622592|470958081|FG005|Overall Study|Physician Decision|0|||
130816070|NCT04622592|470958082|FG006|Overall Study|Physician Decision|0|||
130816071|NCT04622592|470958083|FG007|Overall Study|Physician Decision|0|||
130816072|NCT04622592|470958076|FG000|Overall Study|Withdrawal by Subject|1|||
130816073|NCT04622592|470958077|FG001|Overall Study|Withdrawal by Subject|0|||
130816074|NCT04622592|470958078|FG002|Overall Study|Withdrawal by Subject|2|||
130816075|NCT04622592|470958079|FG003|Overall Study|Withdrawal by Subject|0|||
130816076|NCT04622592|470958080|FG004|Overall Study|Withdrawal by Subject|0|||
130816077|NCT04622592|470958081|FG005|Overall Study|Withdrawal by Subject|0|||
130816078|NCT04622592|470958082|FG006|Overall Study|Withdrawal by Subject|1|||
130816079|NCT04622592|470958083|FG007|Overall Study|Withdrawal by Subject|4|||
130816080|NCT04622592|470958076|FG000|Overall Study|Other than specified above|0|||
130816081|NCT04622592|470958077|FG001|Overall Study|Other than specified above|0|||
130816082|NCT04622592|470958078|FG002|Overall Study|Other than specified above|1|||
130816083|NCT04622592|470958079|FG003|Overall Study|Other than specified above|0|||
130816084|NCT04622592|470958080|FG004|Overall Study|Other than specified above|0|||
130816085|NCT04622592|470958081|FG005|Overall Study|Other than specified above|0|||
130816086|NCT04622592|470958082|FG006|Overall Study|Other than specified above|0|||
130816087|NCT04622592|470958083|FG007|Overall Study|Other than specified above|0|||
130816088|NCT01497197|470958084|FG000|Overall Study|Lost to Follow-up|1|||
130816089|NCT01497197|470958085|FG001|Overall Study|Lost to Follow-up|0|||
130816090|NCT01497197|470958084|FG000|Overall Study|Protocol Violation|0|||
130816091|NCT01497197|470958085|FG001|Overall Study|Protocol Violation|2|||
130816092|NCT01497197|470958084|FG000|Overall Study|Withdrawal by Subject|2|||
130816093|NCT01497197|470958085|FG001|Overall Study|Withdrawal by Subject|1|||
130816094|NCT01497197|470958084|FG000|Overall Study|Excessive/lack of response to treatment|1|||
130816095|NCT01497197|470958085|FG001|Overall Study|Excessive/lack of response to treatment|0|||
130816096|NCT01497197|470958084|FG000|Overall Study|Risk of OHSS|1|||
130816097|NCT01497197|470958085|FG001|Overall Study|Risk of OHSS|0|||
130816098|NCT01497197|470958084|FG000|Overall Study|No oocytes retrieved|3|||
130816099|NCT01497197|470958085|FG001|Overall Study|No oocytes retrieved|2|||
130816100|NCT01497197|470958084|FG000|Overall Study|No fertilisation|6|||
130816101|NCT01497197|470958085|FG001|Overall Study|No fertilisation|5|||
130816102|NCT01497197|470958084|FG000|Overall Study|Intention to freeze all embryos|0|||
130816103|NCT01497197|470958085|FG001|Overall Study|Intention to freeze all embryos|1|||
130816104|NCT01497197|470958084|FG000|Overall Study|All embryos discarded|0|||
130816105|NCT01497197|470958085|FG001|Overall Study|All embryos discarded|3|||
130816106|NCT01497197|470958084|FG000|Overall Study|Other|3|||
130816107|NCT01497197|470958085|FG001|Overall Study|Other|1|||
130816108|NCT00183248|470958092|FG000|Overall Study|Lost to Follow-up|0|||
130816109|NCT00183248|470958093|FG001|Overall Study|Lost to Follow-up|1|||
130816110|NCT00183248|470958092|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
130816111|NCT00183248|470958093|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
130816112|NCT03309202|470958094|FG000|Overall Study|Lost to Follow-up|1|||
130816113|NCT03309202|470958095|FG001|Overall Study|Lost to Follow-up|0|||
130816114|NCT03309202|470958096|FG002|Overall Study|Lost to Follow-up|0|||
130816115|NCT03309202|470958097|FG003|Overall Study|Lost to Follow-up|0|||
130816116|NCT00415636|470958098|FG000|Overall Study|Symptomatic deterioration|1|||
130816117|NCT00415636|470958099|FG001|Overall Study|Symptomatic deterioration|0|||
130816118|NCT00415636|470958100|FG002|Overall Study|Symptomatic deterioration|1|||
130816119|NCT00415636|470958101|FG003|Overall Study|Symptomatic deterioration|2|||
130816120|NCT00415636|470958102|FG004|Overall Study|Symptomatic deterioration|0|||
130816121|NCT00415636|470958103|FG005|Overall Study|Symptomatic deterioration|1|||
130816122|NCT00415636|470958098|FG000|Overall Study|Adverse Event|0|||
130816123|NCT00415636|470958099|FG001|Overall Study|Adverse Event|0|||
130816124|NCT00415636|470958100|FG002|Overall Study|Adverse Event|0|||
130816125|NCT00415636|470958101|FG003|Overall Study|Adverse Event|1|||
130816126|NCT00415636|470958102|FG004|Overall Study|Adverse Event|1|||
130816127|NCT00415636|470958103|FG005|Overall Study|Adverse Event|0|||
130816128|NCT00415636|470958098|FG000|Overall Study|Withdrawal by Subject|0|||
130816129|NCT00415636|470958099|FG001|Overall Study|Withdrawal by Subject|0|||
130816130|NCT00415636|470958100|FG002|Overall Study|Withdrawal by Subject|0|||
130816131|NCT00415636|470958101|FG003|Overall Study|Withdrawal by Subject|0|||
130816132|NCT00415636|470958102|FG004|Overall Study|Withdrawal by Subject|1|||
130816133|NCT00415636|470958103|FG005|Overall Study|Withdrawal by Subject|0|||
130816134|NCT00415636|470958098|FG000|Overall Study|Disease progression|0|||
130816135|NCT00415636|470958099|FG001|Overall Study|Disease progression|0|||
130816136|NCT00415636|470958100|FG002|Overall Study|Disease progression|0|||
130816137|NCT00415636|470958101|FG003|Overall Study|Disease progression|3|||
130816138|NCT00415636|470958102|FG004|Overall Study|Disease progression|0|||
130816139|NCT00415636|470958103|FG005|Overall Study|Disease progression|1|||
130816140|NCT04734210|470958104|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
130816141|NCT04734210|470958105|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
130816142|NCT04734210|470958106|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
130816143|NCT04734210|470958104|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
130816144|NCT04734210|470958105|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
130816145|NCT04734210|470958106|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
130816146|NCT04734210|470958104|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
130816147|NCT04734210|470958105|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
130816148|NCT04734210|470958106|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
130816149|NCT04734210|470958104|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
130816150|NCT04734210|470958105|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
130816151|NCT04734210|470958106|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
130816152|NCT02138825|470958107|FG000|Main Study Treatment|Adverse Event|11|||
130816153|NCT02138825|470958108|FG001|Main Study Treatment|Adverse Event|3|||
130816154|NCT02138825|470958107|FG000|Main Study Treatment|Death|1|||
130816155|NCT02138825|470958108|FG001|Main Study Treatment|Death|2|||
130816156|NCT02138825|470958107|FG000|Main Study Treatment|Protocol Violation|2|||
130816157|NCT02138825|470958108|FG001|Main Study Treatment|Protocol Violation|2|||
130816158|NCT02138825|470958107|FG000|Main Study Treatment|Sponsor decision|12|||
130816159|NCT02138825|470958108|FG001|Main Study Treatment|Sponsor decision|18|||
130816160|NCT02138825|470958107|FG000|Main Study Treatment|Study terminated by sponsor|10|||
130816161|NCT02138825|470958108|FG001|Main Study Treatment|Study terminated by sponsor|9|||
130816162|NCT02138825|470958107|FG000|Main Study Treatment|Withdrawal by Subject|3|||
130816163|NCT02138825|470958108|FG001|Main Study Treatment|Withdrawal by Subject|1|||
130816164|NCT02138825|470958107|FG000|Main Study Treatment|Medical decision|1|||
130816165|NCT02138825|470958108|FG001|Main Study Treatment|Medical decision|0|||
130816166|NCT02138825|470958107|FG000|Long-term Extension|Study termination by sponsor|32|||
130816167|NCT02138825|470958108|FG001|Long-term Extension|Study termination by sponsor|38|||
130816168|NCT02138825|470958107|FG000|Safety Follow-up|Adverse Event|4|||
130816169|NCT02138825|470958108|FG001|Safety Follow-up|Adverse Event|3|||
130816170|NCT02138825|470958107|FG000|Safety Follow-up|Death|11|||
130816171|NCT02138825|470958108|FG001|Safety Follow-up|Death|5|||
130816172|NCT02138825|470958107|FG000|Safety Follow-up|Withdrawal by Subject|5|||
130816173|NCT02138825|470958108|FG001|Safety Follow-up|Withdrawal by Subject|3|||
130816174|NCT02138825|470958107|FG000|Safety Follow-up|clinic worsening|1|||
130816175|NCT02138825|470958108|FG001|Safety Follow-up|clinic worsening|0|||
130816176|NCT02138825|470958107|FG000|Safety Follow-up|withdrawal by PI|1|||
130816177|NCT02138825|470958108|FG001|Safety Follow-up|withdrawal by PI|0|||
130816178|NCT02138825|470958107|FG000|Safety Follow-up|logistical difficulties|0|||
130816179|NCT02138825|470958108|FG001|Safety Follow-up|logistical difficulties|1|||
130816180|NCT02138825|470958107|FG000|Safety Follow-up|progressive disease|0|||
130816181|NCT02138825|470958108|FG001|Safety Follow-up|progressive disease|2|||
130816182|NCT02138825|470958107|FG000|Safety Follow-up|too unwell to attend the visit|0|||
130816183|NCT02138825|470958108|FG001|Safety Follow-up|too unwell to attend the visit|1|||
130816184|NCT02138825|470958107|FG000|Safety Follow-up|treatment unblinded|0|||
130816185|NCT02138825|470958108|FG001|Safety Follow-up|treatment unblinded|1|||
130816186|NCT02138825|470958107|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
130816187|NCT02138825|470958108|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
130816188|NCT05201807|470958114|FG000|Overall Study|Adverse Event|1|||
130816189|NCT05201807|470958114|FG000|Overall Study|COVID-19 Related|1|||
130816190|NCT01209767|470958115|FG000|Overall Study|Withdrawal by Subject|1|||
130816191|NCT01209767|470958115|FG000|Overall Study|Lost to Follow-up|3|||
130816192|NCT01702298|470958116|FG000|Overall Study|Withdrawal by Subject|1|||
130816193|NCT04507204|470958117|FG000|Overall Study|Adverse Event|8|||
130816194|NCT04507204|470958118|FG001|Overall Study|Adverse Event|13|||
130816195|NCT04507204|470958117|FG000|Overall Study|Death|0|||
130816196|NCT04507204|470958118|FG001|Overall Study|Death|1|||
130763978|NCT00622336|470758731|FG000|Extension Phase|Lack of therapeutic effect|2|||
130763979|NCT00622336|470758731|FG000|Extension Phase|Withdrawal by Subject|1|||
130763980|NCT00622336|470758731|FG000|Extension Phase|Lost to Follow-up|1|||
130763981|NCT00622336|470758731|FG000|Extension Phase|Other|9|||
130763982|NCT04506905|470758734|FG000|Overall Study|Lost to Follow-up|1|||
130763983|NCT04506905|470758735|FG001|Overall Study|Lost to Follow-up|0|||
130763984|NCT04506905|470758736|FG002|Overall Study|Lost to Follow-up|0|||
130763985|NCT04506905|470758737|FG003|Overall Study|Lost to Follow-up|1|||
130763986|NCT04506905|470758738|FG004|Overall Study|Lost to Follow-up|0|||
130763987|NCT04506905|470758739|FG005|Overall Study|Lost to Follow-up|0|||
130816197|NCT04507204|470958117|FG000|Overall Study|Lost to Follow-up|15|||
130816198|NCT04507204|470958118|FG001|Overall Study|Lost to Follow-up|14|||
130816199|NCT04507204|470958117|FG000|Overall Study|Poor Compliance with Protocol|2|||
130816200|NCT04507204|470958118|FG001|Overall Study|Poor Compliance with Protocol|4|||
130816201|NCT04507204|470958117|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
130816202|NCT04507204|470958118|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
130816203|NCT04507204|470958117|FG000|Overall Study|Withdrawal of Patient Consent|21|||
130816204|NCT04507204|470958118|FG001|Overall Study|Withdrawal of Patient Consent|13|||
130816205|NCT03580044|470958122|FG000|Overall Study|Death|2|||
130816206|NCT03580044|470958123|FG001|Overall Study|Death|1|||
130816207|NCT03580044|470958122|FG000|Overall Study|Withdrawal by Subject|1|||
130816208|NCT03580044|470958123|FG001|Overall Study|Withdrawal by Subject|1|||
130816209|NCT01664624|470958126|FG000|Overall Study|Adverse Event|0|||
130816210|NCT01664624|470958127|FG001|Overall Study|Adverse Event|1|||
130816211|NCT01664624|470958128|FG002|Overall Study|Adverse Event|0|||
130816212|NCT01664624|470958129|FG003|Overall Study|Adverse Event|0|||
130816213|NCT01206517|470958130|FG000|Overall Study|Withdrawal by Subject|0|||
130816214|NCT01206517|470958131|FG001|Overall Study|Withdrawal by Subject|0|||
130816215|NCT01206517|470958132|FG002|Overall Study|Withdrawal by Subject|2|||
130816216|NCT01206517|470958133|FG003|Overall Study|Withdrawal by Subject|0|||
130816217|NCT01206517|470958134|FG004|Overall Study|Withdrawal by Subject|1|||
130816218|NCT01206517|470958135|FG005|Overall Study|Withdrawal by Subject|0|||
130816219|NCT03493958|470958136|FG000|Overall Study|Withdrawal by Subject|6|||
130816220|NCT03493958|470958136|FG000|Overall Study|Lost to Follow-up|7|||
130816221|NCT03493958|470958136|FG000|Overall Study|Did not complete all required study procedures|2|||
130816222|NCT01029535|470958137|FG000|Overall Study|Lost to Follow-up|24|||
130816223|NCT01029535|470958137|FG000|Overall Study|Protocol Violation|2|||
130816224|NCT01029535|470958137|FG000|Overall Study|Participant Withdrew Consent|2|||
130816225|NCT01029535|470958137|FG000|Overall Study|Adverse Event|1|||
130816226|NCT01029535|470958137|FG000|Overall Study|Use of Another Treatment|1|||
130816227|NCT01029535|470958137|FG000|Overall Study|Death|1|||
130816228|NCT00904371|470958141|FG000|Overall Study|Adverse Event|2|||
130816229|NCT00904371|470958141|FG000|Overall Study|Lost to Follow-up|4|||
130816230|NCT00904371|470958141|FG000|Overall Study|Discontinued at target blood pressure|2|||
130816231|NCT00904371|470958141|FG000|Overall Study|Continued with Tritace|1|||
130816232|NCT00583219|470958146|FG000|Phase 2|Withdrawal by Subject|1|||
130816233|NCT02090764|470958147|FG000|Overall Study|Adverse Event|1|||
130816234|NCT02090764|470958148|FG001|Overall Study|Adverse Event|3|||
130816235|NCT02090764|470958147|FG000|Overall Study|Lack of Efficacy|0|||
130816236|NCT02090764|470958148|FG001|Overall Study|Lack of Efficacy|13|||
130816237|NCT02090764|470958147|FG000|Overall Study|Withdrawal by Subject|2|||
130816238|NCT02090764|470958148|FG001|Overall Study|Withdrawal by Subject|1|||
130816239|NCT02090764|470958147|FG000|Overall Study|Intercurrent illness and other|1|||
130816240|NCT02090764|470958148|FG001|Overall Study|Intercurrent illness and other|1|||
130816241|NCT02090764|470958147|FG000|Overall Study|Lost to Follow-up|2|||
130816242|NCT02090764|470958148|FG001|Overall Study|Lost to Follow-up|2|||
130816243|NCT00754572|470958149|FG000|Overall Study|Adverse Event|19|||
130816244|NCT00754572|470958149|FG000|Overall Study|Other|39|||
130816245|NCT00754572|470958149|FG000|Overall Study|Protocol Violation|3|||
130816246|NCT00754572|470958149|FG000|Overall Study|Withdrawal by Subject|3|||
130816247|NCT00754572|470958149|FG000|Overall Study|Lack of Efficacy|2|||
130816248|NCT00754572|470958149|FG000|Overall Study|Death|1|||
130816249|NCT00754572|470958149|FG000|Overall Study|Administrative Reason|3|||
130816250|NCT00754572|470958149|FG000|Overall Study|Lost to Follow-up|1|||
130816251|NCT04067011|470958155|FG000|Overall Study|Not Treated|8|||
130816252|NCT04067011|470958156|FG001|Overall Study|Not Treated|7|||
130816253|NCT04067011|470958157|FG002|Overall Study|Not Treated|5|||
130816254|NCT04067011|470958155|FG000|Overall Study|Adverse Event|2|||
130816255|NCT04067011|470958156|FG001|Overall Study|Adverse Event|1|||
130816256|NCT04067011|470958157|FG002|Overall Study|Adverse Event|0|||
130816257|NCT04067011|470958155|FG000|Overall Study|Withdrawal by Subject|6|||
130816258|NCT04067011|470958156|FG001|Overall Study|Withdrawal by Subject|2|||
130816259|NCT04067011|470958157|FG002|Overall Study|Withdrawal by Subject|1|||
130816260|NCT04067011|470958155|FG000|Overall Study|Lost to Follow-up|0|||
130816261|NCT04067011|470958156|FG001|Overall Study|Lost to Follow-up|0|||
130816262|NCT04067011|470958157|FG002|Overall Study|Lost to Follow-up|1|||
130816263|NCT04067011|470958155|FG000|Overall Study|Physician Decision|1|||
130816264|NCT04067011|470958156|FG001|Overall Study|Physician Decision|1|||
130816265|NCT04067011|470958157|FG002|Overall Study|Physician Decision|0|||
130816266|NCT04067011|470958155|FG000|Overall Study|Other Reasons|2|||
130816267|NCT04067011|470958156|FG001|Overall Study|Other Reasons|0|||
130816268|NCT04067011|470958157|FG002|Overall Study|Other Reasons|1|||
130816269|NCT04067011|470958155|FG000|Overall Study|Missing|0|||
130816270|NCT04067011|470958156|FG001|Overall Study|Missing|2|||
130816271|NCT04067011|470958157|FG002|Overall Study|Missing|0|||
130816272|NCT03746015|470958158|FG000|Overall Study|Withdrawal of Consent|1|||
130816273|NCT03746015|470958159|FG001|Overall Study|Withdrawal of Consent|0|||
130816274|NCT03746015|470958160|FG002|Overall Study|Withdrawal of Consent|0|||
130816275|NCT05209386|470958161|FG000|Overall Study|Withdrawal by Subject|8|||
130816276|NCT05209386|470958161|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
130816277|NCT02836249|470958162|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130816278|NCT02836249|470958163|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
130816279|NCT02836249|470958164|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130816280|NCT02836249|470958165|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130816281|NCT02836249|470958162|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
130816282|NCT02836249|470958163|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
130816283|NCT02836249|470958164|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
130816284|NCT02836249|470958165|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
130816285|NCT02836249|470958162|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
130816286|NCT02836249|470958163|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
130816287|NCT02836249|470958164|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
130816288|NCT02836249|470958165|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
130816289|NCT02836249|470958162|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130816290|NCT02836249|470958163|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130816291|NCT02836249|470958164|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130816292|NCT02836249|470958165|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130816293|NCT02836249|470958162|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
130816294|NCT02836249|470958163|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
130816295|NCT02836249|470958164|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
130816296|NCT02836249|470958165|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
130816297|NCT02836249|470958162|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
130816298|NCT02836249|470958163|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130816299|NCT02836249|470958164|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130816300|NCT02836249|470958165|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130816301|NCT02836249|470958162|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130816302|NCT02836249|470958163|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130816303|NCT02836249|470958164|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
130816304|NCT02836249|470958165|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
130816305|NCT02836249|470958162|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130816306|NCT02836249|470958163|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130816307|NCT02836249|470958164|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
130816308|NCT02836249|470958165|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
130816309|NCT02836249|470958162|FG000|Open-Label TAF Treatment Phase|Death|0|||
130816310|NCT02836249|470958163|FG001|Open-Label TAF Treatment Phase|Death|0|||
130816311|NCT02836249|470958164|FG002|Open-Label TAF Treatment Phase|Death|1|||
130816312|NCT02836249|470958165|FG003|Open-Label TAF Treatment Phase|Death|0|||
130816313|NCT02836249|470958162|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
130816314|NCT02836249|470958163|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
130816315|NCT02836249|470958164|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
130816316|NCT02836249|470958165|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
130816317|NCT02836249|470958162|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
130816318|NCT02836249|470958163|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
130816319|NCT02836249|470958164|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
130816320|NCT02836249|470958165|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
130816321|NCT05134649|470958166|FG000|Overall Study|Lost to Follow-up|12|||
130816322|NCT05134649|470958166|FG000|Overall Study|Withdrawal by Subject|14|||
130816323|NCT05134649|470958166|FG000|Overall Study|Pregnancy|1|||
130816324|NCT05134649|470958166|FG000|Overall Study|Other, not specified|3|||
130816325|NCT02958865|470958167|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816326|NCT02958865|470958168|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
130816327|NCT02958865|470958169|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816328|NCT02958865|470958170|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
130816329|NCT02958865|470958171|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
130816330|NCT02958865|470958172|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
130816331|NCT02958865|470958173|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
130816332|NCT02958865|470958174|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816333|NCT02958865|470958175|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816334|NCT02958865|470958176|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816335|NCT02958865|470958177|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816336|NCT02958865|470958178|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816337|NCT02958865|470958179|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816338|NCT02958865|470958180|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816339|NCT02958865|470958181|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816340|NCT02958865|470958182|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130816341|NCT02958865|470958167|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
130816342|NCT02958865|470958168|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
130816343|NCT02958865|470958169|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
130816344|NCT02958865|470958170|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
130816345|NCT02958865|470958171|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
130816346|NCT02958865|470958172|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
130816347|NCT02958865|470958173|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
130816348|NCT02958865|470958174|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
130816349|NCT02958865|470958175|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
130816350|NCT02958865|470958176|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
130816351|NCT02958865|470958177|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
130816352|NCT02958865|470958178|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
130816353|NCT02958865|470958179|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
130816354|NCT02958865|470958180|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
130816355|NCT02958865|470958181|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
130816356|NCT02958865|470958182|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
130816357|NCT02958865|470958167|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
130816358|NCT02958865|470958168|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
130816359|NCT02958865|470958169|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816360|NCT02958865|470958170|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816361|NCT02958865|470958171|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816362|NCT02958865|470958172|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816363|NCT02958865|470958173|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816364|NCT02958865|470958174|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816365|NCT02958865|470958175|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816366|NCT02958865|470958176|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816367|NCT02958865|470958177|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816368|NCT02958865|470958178|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816369|NCT02958865|470958179|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816370|NCT02958865|470958180|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816371|NCT02958865|470958181|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816372|NCT02958865|470958182|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130816373|NCT02958865|470958167|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
130816374|NCT02958865|470958168|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130816375|NCT02958865|470958169|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
130816376|NCT02958865|470958170|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130816377|NCT02958865|470958171|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130816378|NCT02958865|470958172|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130816379|NCT02958865|470958173|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130816380|NCT02958865|470958174|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130816381|NCT02958865|470958175|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130816382|NCT02958865|470958176|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130816383|NCT02958865|470958177|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130816384|NCT02958865|470958178|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130816385|NCT02958865|470958179|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130816386|NCT02958865|470958180|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130816387|NCT02958865|470958181|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130816388|NCT02958865|470958182|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130816389|NCT02958865|470958167|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816390|NCT02958865|470958168|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816391|NCT02958865|470958169|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816392|NCT02958865|470958170|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
130816393|NCT02958865|470958171|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816394|NCT02958865|470958172|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816395|NCT02958865|470958173|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
130816396|NCT02958865|470958174|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816397|NCT02958865|470958175|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816398|NCT02958865|470958176|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816399|NCT02958865|470958177|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816400|NCT02958865|470958178|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816401|NCT02958865|470958179|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816402|NCT02958865|470958180|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816403|NCT02958865|470958181|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816404|NCT02958865|470958182|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130816405|NCT02958865|470958167|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816406|NCT02958865|470958168|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816407|NCT02958865|470958169|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
130816408|NCT02958865|470958170|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816409|NCT02958865|470958171|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816410|NCT02958865|470958172|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816411|NCT02958865|470958173|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816412|NCT02958865|470958174|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816413|NCT02958865|470958175|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816414|NCT02958865|470958176|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816415|NCT02958865|470958177|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816416|NCT02958865|470958178|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816417|NCT02958865|470958179|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816418|NCT02958865|470958180|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816419|NCT02958865|470958181|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816420|NCT02958865|470958182|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130816421|NCT02958865|470958167|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130816422|NCT02958865|470958168|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130816423|NCT02958865|470958169|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130816424|NCT02958865|470958170|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816425|NCT02958865|470958171|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816426|NCT02958865|470958172|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816427|NCT02958865|470958173|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816428|NCT02958865|470958174|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816429|NCT02958865|470958175|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816430|NCT02958865|470958176|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816431|NCT02958865|470958177|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816432|NCT02958865|470958178|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816433|NCT02958865|470958179|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816434|NCT02958865|470958180|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816435|NCT02958865|470958181|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816436|NCT02958865|470958182|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130816437|NCT02958865|470958167|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
130816438|NCT02958865|470958168|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
130816439|NCT02958865|470958169|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
130816440|NCT02958865|470958170|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
130816441|NCT02958865|470958171|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
130816442|NCT02958865|470958172|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
130816443|NCT02958865|470958173|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
130816444|NCT02958865|470958174|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
130816445|NCT02958865|470958175|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
130816446|NCT02958865|470958176|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
130816447|NCT02958865|470958177|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
130816448|NCT02958865|470958178|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
130816449|NCT02958865|470958179|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
130816450|NCT02958865|470958180|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
130816451|NCT02958865|470958181|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
130816452|NCT02958865|470958182|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
130816453|NCT02958865|470958167|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816454|NCT02958865|470958168|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816455|NCT02958865|470958169|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816456|NCT02958865|470958170|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816457|NCT02958865|470958171|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
130816458|NCT02958865|470958172|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816459|NCT02958865|470958173|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816460|NCT02958865|470958174|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816461|NCT02958865|470958175|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816462|NCT02958865|470958176|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816463|NCT02958865|470958177|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816464|NCT02958865|470958178|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816465|NCT02958865|470958179|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816466|NCT02958865|470958180|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816467|NCT02958865|470958181|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816468|NCT02958865|470958182|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130816469|NCT02958865|470958167|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130816470|NCT02958865|470958168|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130816471|NCT02958865|470958169|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130816472|NCT02958865|470958170|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130816473|NCT02958865|470958171|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130816474|NCT02958865|470958172|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130816475|NCT02958865|470958173|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130816476|NCT02958865|470958174|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130816477|NCT02958865|470958175|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130816478|NCT02958865|470958176|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
130816479|NCT02958865|470958177|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130816480|NCT02958865|470958178|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130816481|NCT02958865|470958179|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
130816482|NCT02958865|470958180|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130816483|NCT02958865|470958181|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130816484|NCT02958865|470958182|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
130816485|NCT02958865|470958167|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816486|NCT02958865|470958168|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816487|NCT02958865|470958169|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816488|NCT02958865|470958170|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816489|NCT02958865|470958171|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816490|NCT02958865|470958172|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816491|NCT02958865|470958173|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816492|NCT02958865|470958174|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816493|NCT02958865|470958175|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
130816494|NCT02958865|470958176|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
130816495|NCT02958865|470958177|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816496|NCT02958865|470958178|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
130816497|NCT02958865|470958179|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816498|NCT02958865|470958180|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
130816499|NCT02958865|470958181|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130816500|NCT02958865|470958182|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
130816501|NCT02958865|470958167|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816502|NCT02958865|470958168|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816503|NCT02958865|470958169|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816504|NCT02958865|470958170|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816505|NCT02958865|470958171|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816506|NCT02958865|470958172|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816507|NCT02958865|470958173|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816508|NCT02958865|470958174|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816509|NCT02958865|470958175|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816510|NCT02958865|470958176|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
130816511|NCT02958865|470958177|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816512|NCT02958865|470958178|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816513|NCT02958865|470958179|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816514|NCT02958865|470958180|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816515|NCT02958865|470958181|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130816516|NCT02958865|470958182|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
130816517|NCT02958865|470958167|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816518|NCT02958865|470958168|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816519|NCT02958865|470958169|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816520|NCT02958865|470958170|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816521|NCT02958865|470958171|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816522|NCT02958865|470958172|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816523|NCT02958865|470958173|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816524|NCT02958865|470958174|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816525|NCT02958865|470958175|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816526|NCT02958865|470958176|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816527|NCT02958865|470958177|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130816528|NCT02958865|470958178|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
130816529|NCT02958865|470958179|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
130816530|NCT02958865|470958180|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
130816531|NCT02958865|470958181|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
130816532|NCT02958865|470958182|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
130816533|NCT02958865|470958167|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
130816534|NCT02958865|470958168|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
130816535|NCT02958865|470958169|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
130816536|NCT02958865|470958170|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
130816537|NCT02958865|470958171|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
130816538|NCT02958865|470958172|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
130816539|NCT02958865|470958173|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
130816540|NCT02958865|470958174|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
130816541|NCT02958865|470958175|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
130816542|NCT02958865|470958176|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
130816543|NCT02958865|470958177|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
130816544|NCT02958865|470958178|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
130816545|NCT02958865|470958179|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
130816546|NCT02958865|470958180|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
130816547|NCT02958865|470958181|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
130816548|NCT02958865|470958182|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
130816549|NCT02958865|470958167|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816550|NCT02958865|470958168|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816551|NCT02958865|470958169|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816552|NCT02958865|470958170|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816553|NCT02958865|470958171|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816554|NCT02958865|470958172|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816555|NCT02958865|470958173|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816556|NCT02958865|470958174|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816557|NCT02958865|470958175|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816558|NCT02958865|470958176|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816559|NCT02958865|470958177|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816560|NCT02958865|470958178|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816561|NCT02958865|470958179|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816562|NCT02958865|470958180|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
130816563|NCT02958865|470958181|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816564|NCT02958865|470958182|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130816565|NCT02958865|470958167|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816566|NCT02958865|470958168|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816567|NCT02958865|470958169|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816568|NCT02958865|470958170|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816569|NCT02958865|470958171|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816570|NCT02958865|470958172|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816571|NCT02958865|470958173|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816572|NCT02958865|470958174|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816573|NCT02958865|470958175|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816574|NCT02958865|470958176|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816575|NCT02958865|470958177|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816576|NCT02958865|470958178|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816577|NCT02958865|470958179|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816578|NCT02958865|470958180|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
130816579|NCT02958865|470958181|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816580|NCT02958865|470958182|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130816581|NCT02958865|470958167|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816582|NCT02958865|470958168|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816583|NCT02958865|470958169|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816584|NCT02958865|470958170|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816585|NCT02958865|470958171|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816586|NCT02958865|470958172|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816587|NCT02958865|470958173|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816588|NCT02958865|470958174|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816589|NCT02958865|470958175|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816590|NCT02958865|470958176|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
130816591|NCT02958865|470958177|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816592|NCT02958865|470958178|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816593|NCT02958865|470958179|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816594|NCT02958865|470958180|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816595|NCT02958865|470958181|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816596|NCT02958865|470958182|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130816597|NCT02661815|470958183|FG000|Overall Study|Withdrawal by Subject|1|||
130816598|NCT02661815|470958184|FG001|Overall Study|Withdrawal by Subject|0|||
130816599|NCT02661815|470958185|FG002|Overall Study|Withdrawal by Subject|0|||
130816600|NCT02661815|470958186|FG003|Overall Study|Withdrawal by Subject|0|||
130816601|NCT01728246|470958189|FG000|Overall Study|Participant needed rescue medication|1|||
130816602|NCT01728246|470958190|FG001|Overall Study|Participant needed rescue medication|5|||
130816603|NCT01728246|470958189|FG000|Overall Study|Protocol Violation|1|||
130816604|NCT01728246|470958190|FG001|Overall Study|Protocol Violation|0|||
130816605|NCT01728246|470958189|FG000|Overall Study|Withdrawal by Subject|2|||
130816606|NCT01728246|470958190|FG001|Overall Study|Withdrawal by Subject|3|||
130816607|NCT01728246|470958189|FG000|Overall Study|Lost to Follow-up|23|||
130816608|NCT01728246|470958190|FG001|Overall Study|Lost to Follow-up|22|||
130816609|NCT01728246|470958189|FG000|Overall Study|Lack of Efficacy|1|||
130816610|NCT01728246|470958190|FG001|Overall Study|Lack of Efficacy|1|||
130816611|NCT01728246|470958189|FG000|Overall Study|Adverse Event|8|||
130816612|NCT01728246|470958190|FG001|Overall Study|Adverse Event|5|||
130816613|NCT01983111|470958191|FG000|Overall Study|Withdrawal by Subject|8|||
130816614|NCT01983111|470958192|FG001|Overall Study|Withdrawal by Subject|6|||
130816615|NCT01983111|470958191|FG000|Overall Study|Adverse Event|4|||
130816616|NCT01983111|470958192|FG001|Overall Study|Adverse Event|0|||
130816617|NCT01983111|470958191|FG000|Overall Study|Protocol Violation|0|||
130816618|NCT01983111|470958192|FG001|Overall Study|Protocol Violation|1|||
130816619|NCT00855335|470958193|FG000|Overall Study|Lost to Follow-up|0|||
130816620|NCT00855335|470958194|FG001|Overall Study|Lost to Follow-up|0|||
130816621|NCT00855335|470958195|FG002|Overall Study|Lost to Follow-up|3|||
130816622|NCT00855335|470958196|FG003|Overall Study|Lost to Follow-up|1|||
130816623|NCT00855335|470958197|FG004|Overall Study|Lost to Follow-up|0|||
130816624|NCT00855335|470958193|FG000|Overall Study|Withdrawal by Subject|0|||
130816625|NCT00855335|470958194|FG001|Overall Study|Withdrawal by Subject|0|||
130816626|NCT00855335|470958195|FG002|Overall Study|Withdrawal by Subject|0|||
130816627|NCT00855335|470958196|FG003|Overall Study|Withdrawal by Subject|1|||
130816628|NCT00855335|470958197|FG004|Overall Study|Withdrawal by Subject|0|||
130816629|NCT00855335|470958193|FG000|Overall Study|Adverse Event|2|||
130816630|NCT00855335|470958194|FG001|Overall Study|Adverse Event|0|||
130816631|NCT00855335|470958195|FG002|Overall Study|Adverse Event|0|||
130816632|NCT00855335|470958196|FG003|Overall Study|Adverse Event|0|||
130816633|NCT00855335|470958197|FG004|Overall Study|Adverse Event|0|||
130816634|NCT00855335|470958193|FG000|Overall Study|Physician Decision|1|||
130816635|NCT00855335|470958194|FG001|Overall Study|Physician Decision|1|||
130816636|NCT00855335|470958195|FG002|Overall Study|Physician Decision|0|||
130816637|NCT00855335|470958196|FG003|Overall Study|Physician Decision|0|||
130816638|NCT00855335|470958197|FG004|Overall Study|Physician Decision|0|||
130816639|NCT00855335|470958193|FG000|Overall Study|Other|2|||
130816640|NCT00855335|470958194|FG001|Overall Study|Other|1|||
130816641|NCT00855335|470958195|FG002|Overall Study|Other|2|||
130816642|NCT00855335|470958196|FG003|Overall Study|Other|5|||
130816643|NCT00855335|470958197|FG004|Overall Study|Other|1|||
130816644|NCT03502200|470958198|FG000|Overall Study|Adverse Event|1|||
130816645|NCT03502200|470958199|FG001|Overall Study|Adverse Event|0|||
130816646|NCT03502200|470958198|FG000|Overall Study|Lost to Follow-up|36|||
130816647|NCT03502200|470958199|FG001|Overall Study|Lost to Follow-up|38|||
130816648|NCT03502200|470958198|FG000|Overall Study|Study Team Decision|1|||
130816649|NCT03502200|470958199|FG001|Overall Study|Study Team Decision|1|||
130816650|NCT03502200|470958198|FG000|Overall Study|Withdrawal by Subject|5|||
130816651|NCT03502200|470958199|FG001|Overall Study|Withdrawal by Subject|7|||
130816652|NCT03502200|470958198|FG000|Overall Study|Death|0|||
130816653|NCT03502200|470958199|FG001|Overall Study|Death|2|||
130816654|NCT04380142|470958203|FG000|LD/CD Stabilization Period|Adverse Event|3|||
130816655|NCT04380142|470958204|FG001|LD/CD Stabilization Period|Adverse Event|0|||
130816656|NCT04380142|470958205|FG002|LD/CD Stabilization Period|Adverse Event|0|||
130816657|NCT04380142|470958203|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
130816658|NCT04380142|470958204|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
130816659|NCT04380142|470958205|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
130816660|NCT04380142|470958203|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
130816661|NCT04380142|470958204|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
130816662|NCT04380142|470958205|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
130816663|NCT04380142|470958203|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
130816664|NCT04380142|470958204|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
130816665|NCT04380142|470958205|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
130816666|NCT04380142|470958203|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
130816667|NCT04380142|470958204|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
130816668|NCT04380142|470958205|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
130816669|NCT04380142|470958203|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
130816670|NCT04380142|470958204|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
130816671|NCT04380142|470958205|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
130816672|NCT04380142|470958203|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130816673|NCT04380142|470958204|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130816674|NCT04380142|470958205|FG002|Double-Blind Treatment Period|Adverse Event|14|||
130816675|NCT04380142|470958203|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
130816676|NCT04380142|470958204|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
130816677|NCT04380142|470958205|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
130816678|NCT04380142|470958203|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130816679|NCT04380142|470958204|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
130816680|NCT04380142|470958205|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
130816681|NCT04380142|470958203|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
130816682|NCT04380142|470958204|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
130816683|NCT04380142|470958205|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
130816684|NCT04380142|470958203|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
130816685|NCT04380142|470958204|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
130816686|NCT04380142|470958205|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
130816687|NCT04380142|470958203|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
130816688|NCT04380142|470958204|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
130816689|NCT04380142|470958205|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
130816690|NCT00787150|470958206|FG000|Overall Study|Adverse Event|4|||
130816691|NCT00787150|470958207|FG001|Overall Study|Adverse Event|4|||
130816692|NCT00787150|470958208|FG002|Overall Study|Adverse Event|4|||
130816693|NCT00787150|470958206|FG000|Overall Study|Physician Decision|1|||
130816694|NCT00787150|470958207|FG001|Overall Study|Physician Decision|2|||
130816695|NCT00787150|470958208|FG002|Overall Study|Physician Decision|1|||
130816696|NCT00787150|470958206|FG000|Overall Study|Withdrawal by Subject|2|||
130816697|NCT00787150|470958207|FG001|Overall Study|Withdrawal by Subject|1|||
130816698|NCT00787150|470958208|FG002|Overall Study|Withdrawal by Subject|0|||
130816699|NCT00787150|470958206|FG000|Overall Study|Dosing incorrect study durg|2|||
130816700|NCT00787150|470958207|FG001|Overall Study|Dosing incorrect study durg|0|||
130816701|NCT00787150|470958208|FG002|Overall Study|Dosing incorrect study durg|0|||
130816702|NCT01849276|470958215|FG000|Followed for Survival for 5 Years|Death|1|||
130816703|NCT01849276|470958215|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
130816704|NCT00879398|470958218|FG000|Overall Study|Visit Stop|399|||
130816705|NCT00879398|470958218|FG000|Overall Study|Lack of Efficacy|64|||
130816706|NCT00879398|470958218|FG000|Overall Study|Adverse Event|41|||
130816707|NCT00879398|470958218|FG000|Overall Study|Other Reasons|171|||
130816708|NCT03448393|470958220|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130816709|NCT03448393|470958221|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130816710|NCT03448393|470958222|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
130816711|NCT03448393|470958223|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130816712|NCT03448393|470958224|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130816713|NCT03448393|470958225|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130816714|NCT03448393|470958226|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130816715|NCT03448393|470958227|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130816716|NCT03448393|470958228|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
130816717|NCT03448393|470958220|FG000|Dose Expansion|Not treated - screen failure|0|||
130816718|NCT03448393|470958221|FG001|Dose Expansion|Not treated - screen failure|0|||
130816719|NCT03448393|470958222|FG002|Dose Expansion|Not treated - screen failure|0|||
130816720|NCT03448393|470958223|FG003|Dose Expansion|Not treated - screen failure|0|||
130816721|NCT03448393|470958224|FG004|Dose Expansion|Not treated - screen failure|0|||
130816722|NCT03448393|470958225|FG005|Dose Expansion|Not treated - screen failure|0|||
130816723|NCT03448393|470958226|FG006|Dose Expansion|Not treated - screen failure|0|||
130816724|NCT03448393|470958227|FG007|Dose Expansion|Not treated - screen failure|0|||
130816725|NCT03448393|470958228|FG008|Dose Expansion|Not treated - screen failure|7|||
130816726|NCT00643279|470958234|FG000|Overall Study|Death|13|||
130816727|NCT00643279|470958235|FG001|Overall Study|Death|11|||
130816728|NCT00643279|470958234|FG000|Overall Study|Withdrawal by Subject|3|||
130816729|NCT00643279|470958235|FG001|Overall Study|Withdrawal by Subject|0|||
130816730|NCT00643279|470958234|FG000|Overall Study|Lost to Follow-up|0|||
130816731|NCT00643279|470958235|FG001|Overall Study|Lost to Follow-up|1|||
130816732|NCT00643279|470958234|FG000|Overall Study|Physician Decision|0|||
130816733|NCT00643279|470958235|FG001|Overall Study|Physician Decision|1|||
130816734|NCT05715827|470958236|FG000|Overall Study|Physician Decision|0|||
130816735|NCT05715827|470958237|FG001|Overall Study|Physician Decision|1|||
130816736|NCT05715827|470958236|FG000|Overall Study|console communication error|0|||
130816737|NCT05715827|470958237|FG001|Overall Study|console communication error|1|||
130816738|NCT03557502|470958238|FG000|Protocol 2|Withdrawal by Subject|1|||
130816739|NCT03557502|470958239|FG001|Protocol 2|Withdrawal by Subject|1|||
130816740|NCT03557502|470958238|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
130816741|NCT03557502|470958239|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
130816742|NCT03021486|470959501|FG000|Overall Study|Withdrawal by Subject|1|||
130816743|NCT03021486|470959502|FG001|Overall Study|Withdrawal by Subject|1|||
130816744|NCT03021486|470959503|FG002|Overall Study|Withdrawal by Subject|3|||
130816745|NCT03021486|470959501|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
130816746|NCT03021486|470959502|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
130816747|NCT03021486|470959503|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
130816748|NCT04795531|470959504|FG000|Overall Study|Withdrawal by Subject|4|||
130816749|NCT04795531|470959505|FG001|Overall Study|Withdrawal by Subject|4|||
130816750|NCT04795531|470959504|FG000|Overall Study|Lost to Follow-up|0|||
130816751|NCT04795531|470959505|FG001|Overall Study|Lost to Follow-up|1|||
130816752|NCT04795531|470959504|FG000|Overall Study|Physician Decision|0|||
130816753|NCT04795531|470959505|FG001|Overall Study|Physician Decision|2|||
130816754|NCT04795531|470959504|FG000|Overall Study|Death|2|||
130816755|NCT04795531|470959505|FG001|Overall Study|Death|1|||
130816756|NCT04887831|470959506|FG000|Overall Study|Death|26|||
130816757|NCT04887831|470959507|FG001|Overall Study|Death|26|||
130816758|NCT04887831|470959506|FG000|Overall Study|Lost to Follow-up|0|||
130816759|NCT04887831|470959507|FG001|Overall Study|Lost to Follow-up|1|||
130816760|NCT04887831|470959506|FG000|Overall Study|Withdrawal by Subject|2|||
130816761|NCT04887831|470959507|FG001|Overall Study|Withdrawal by Subject|1|||
130816762|NCT04887831|470959506|FG000|Overall Study|Study Terminated by Sponsor|18|||
130816763|NCT04887831|470959507|FG001|Overall Study|Study Terminated by Sponsor|17|||
130816764|NCT04887831|470959506|FG000|Overall Study|Other|1|||
130816765|NCT04887831|470959507|FG001|Overall Study|Other|0|||
130816766|NCT04043286|470959508|FG000|Overall Study|Withdrawal by Subject|2|||
130816767|NCT04043286|470959509|FG001|Overall Study|Withdrawal by Subject|2|||
130816768|NCT01323192|470959510|FG000|Overall Study|Adverse Event|6|||
130816769|NCT01323192|470959511|FG001|Overall Study|Adverse Event|1|||
130816770|NCT01323192|470959510|FG000|Overall Study|Withdrawal by Subject|3|||
130816771|NCT01323192|470959511|FG001|Overall Study|Withdrawal by Subject|1|||
130816772|NCT01323192|470959510|FG000|Overall Study|Noncompliance with study medication|0|||
130816773|NCT01323192|470959511|FG001|Overall Study|Noncompliance with study medication|3|||
130816774|NCT01323192|470959510|FG000|Overall Study|Nonmedical reasons|0|||
130816775|NCT01323192|470959511|FG001|Overall Study|Nonmedical reasons|1|||
130816776|NCT02296476|470959512|FG000|Overall Study|Disease Progression|6|||
130816777|NCT02296476|470959513|FG001|Overall Study|Disease Progression|4|||
130816778|NCT02296476|470959514|FG002|Overall Study|Disease Progression|2|||
130816779|NCT00442702|470959515|FG000|Titration Period|Adverse Event|2|||
130816780|NCT00442702|470959516|FG001|Titration Period|Adverse Event|0|||
130816781|NCT00442702|470959515|FG000|Titration Period|Death|3|||
130816782|NCT00442702|470959516|FG001|Titration Period|Death|2|||
130816783|NCT00442702|470959515|FG000|Titration Period|Insufficient Therapeutic Response|1|||
130816784|NCT00442702|470959516|FG001|Titration Period|Insufficient Therapeutic Response|0|||
130816785|NCT00442702|470959515|FG000|Titration Period|Refused Treatment|4|||
130816786|NCT00442702|470959516|FG001|Titration Period|Refused Treatment|1|||
130816787|NCT00442702|470959515|FG000|Titration Period|Failure to return|1|||
130816788|NCT00442702|470959516|FG001|Titration Period|Failure to return|0|||
130816789|NCT00442702|470959515|FG000|Titration Period|Hospitalized in another hospital|1|||
130816790|NCT00442702|470959516|FG001|Titration Period|Hospitalized in another hospital|0|||
130816791|NCT00442702|470959515|FG000|Evaluation Period|Adverse Event|1|||
130816792|NCT00442702|470959516|FG001|Evaluation Period|Adverse Event|0|||
130816793|NCT00442702|470959515|FG000|Evaluation Period|Death|1|||
130816794|NCT00442702|470959516|FG001|Evaluation Period|Death|1|||
130816795|NCT00442702|470959515|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
130816796|NCT00442702|470959516|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
130816797|NCT00442702|470959515|FG000|Evaluation Period|Refused treatment|1|||
130816798|NCT00442702|470959516|FG001|Evaluation Period|Refused treatment|1|||
130816799|NCT00442702|470959515|FG000|Evaluation Period|Renal transplant|0|||
130816800|NCT00442702|470959516|FG001|Evaluation Period|Renal transplant|1|||
130816801|NCT00442702|470959515|FG000|Evaluation Period|Failure to return|1|||
130816802|NCT00442702|470959516|FG001|Evaluation Period|Failure to return|0|||
130816803|NCT00442702|470959515|FG000|Evaluation Period|Site closure|0|||
130816804|NCT00442702|470959516|FG001|Evaluation Period|Site closure|1|||
130816805|NCT03122184|470959523|FG000|Overall Study|Lost to Follow-up|4|||
130816806|NCT03122184|470959524|FG001|Overall Study|Lost to Follow-up|6|||
130816807|NCT03122184|470959523|FG000|Overall Study|Withdrawal by Subject|3|||
130816808|NCT03122184|470959524|FG001|Overall Study|Withdrawal by Subject|0|||
130816809|NCT03122184|470959523|FG000|Overall Study|Terminated due to cognitive problem|1|||
130816810|NCT03122184|470959524|FG001|Overall Study|Terminated due to cognitive problem|0|||
130816811|NCT02835690|470959525|FG000|Overall Study|Death|12|||
130816812|NCT02835690|470959526|FG001|Overall Study|Death|11|||
130816813|NCT02835690|470959527|FG002|Overall Study|Death|13|||
130816814|NCT02835690|470959525|FG000|Overall Study|Transferred to Extension Study|2|||
130816815|NCT02835690|470959526|FG001|Overall Study|Transferred to Extension Study|2|||
130816816|NCT02835690|470959527|FG002|Overall Study|Transferred to Extension Study|1|||
130816817|NCT02835690|470959525|FG000|Overall Study|Did Not Continue on Extension Study|0|||
130816818|NCT02835690|470959526|FG001|Overall Study|Did Not Continue on Extension Study|0|||
130816819|NCT02835690|470959527|FG002|Overall Study|Did Not Continue on Extension Study|1|||
130816820|NCT02835690|470959525|FG000|Overall Study|Not Treated|0|||
130816821|NCT02835690|470959526|FG001|Overall Study|Not Treated|2|||
130816822|NCT02835690|470959527|FG002|Overall Study|Not Treated|0|||
130816823|NCT00710593|470959528|FG000|Overall Study|Incarceration|1|||
130816824|NCT00710593|470959529|FG001|Overall Study|Incarceration|0|||
130816825|NCT00710593|470959528|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
130816826|NCT00710593|470959529|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
130816827|NCT00710593|470959528|FG000|Overall Study|Lost to Follow-up|3|||
130816828|NCT00710593|470959529|FG001|Overall Study|Lost to Follow-up|1|||
130816829|NCT00710593|470959528|FG000|Overall Study|Moved out of area|1|||
130816830|NCT00710593|470959529|FG001|Overall Study|Moved out of area|0|||
130816831|NCT00710593|470959528|FG000|Overall Study|Failure to adhere or complete study eval|1|||
130816832|NCT00710593|470959529|FG001|Overall Study|Failure to adhere or complete study eval|1|||
130816833|NCT00710593|470959528|FG000|Overall Study|Protocol Violation|1|||
130816834|NCT00710593|470959529|FG001|Overall Study|Protocol Violation|1|||
130816835|NCT00710593|470959528|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
130816836|NCT00710593|470959529|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
130816837|NCT04490278|470959530|FG000|Overall Study|Lost to Follow-up|6|||
130816838|NCT02829996|470959531|FG000|Overall Study|Withdrawal by Subject|1|||
130816839|NCT02829996|470959532|FG001|Overall Study|Withdrawal by Subject|0|||
130816840|NCT02829996|470959533|FG002|Overall Study|Withdrawal by Subject|0|||
130816841|NCT02829996|470959534|FG003|Overall Study|Withdrawal by Subject|0|||
130816842|NCT02829996|470959535|FG004|Overall Study|Withdrawal by Subject|0|||
130816843|NCT01263119|470959536|FG000|Period 1|Protocol Violation|2|||
130816844|NCT01263119|470959536|FG000|Period 2|Adverse Event|2|||
130816845|NCT04573972|470959539|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
130816846|NCT04573972|470959540|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
130816847|NCT01198587|470959543|FG000|Overall Study|Lost to Follow-up|8|||
130816848|NCT01198587|470959544|FG001|Overall Study|Lost to Follow-up|0|||
130816849|NCT01198587|470959545|FG002|Overall Study|Lost to Follow-up|9|||
130816850|NCT01198587|470959546|FG003|Overall Study|Lost to Follow-up|0|||
130816851|NCT00573768|470959547|FG000|Overall Study|Adverse Event|1|||
130816852|NCT00573768|470959548|FG001|Overall Study|Adverse Event|1|||
130816853|NCT00573768|470959549|FG002|Overall Study|Adverse Event|2|||
130816854|NCT00573768|470959547|FG000|Overall Study|Protocol Violation|1|||
130816855|NCT00573768|470959548|FG001|Overall Study|Protocol Violation|0|||
130816856|NCT00573768|470959549|FG002|Overall Study|Protocol Violation|1|||
130816857|NCT00573768|470959547|FG000|Overall Study|Withdrawal by Subject|0|||
130816858|NCT00573768|470959548|FG001|Overall Study|Withdrawal by Subject|1|||
130816859|NCT00573768|470959549|FG002|Overall Study|Withdrawal by Subject|0|||
130816860|NCT00573768|470959547|FG000|Overall Study|Lost to Follow-up|0|||
130816861|NCT00573768|470959548|FG001|Overall Study|Lost to Follow-up|0|||
130816862|NCT00573768|470959549|FG002|Overall Study|Lost to Follow-up|1|||
130816863|NCT00335829|470959552|FG000|Overall Study|Withdrawal by Subject|1|||
130816864|NCT00335829|470959552|FG000|Overall Study|Lost to Follow-up|1|||
130816865|NCT00335829|470959552|FG000|Overall Study|Adverse Event|1|||
130816866|NCT01559935|470959553|FG000|Car Phase|Toxicity|4|||
130816867|NCT01559935|470959553|FG000|Car Phase|Death|1|||
130816868|NCT01559935|470959553|FG000|Car Phase|Lack of Efficacy|2|||
130816869|NCT01559935|470959553|FG000|Car Phase|Lost to Follow-up|1|||
130816870|NCT01559935|470959553|FG000|Car Phase|Physician Decision|1|||
130816871|NCT01559935|470959553|FG000|Car Phase|Withdrawal by Subject|2|||
130816872|NCT01559935|470959553|FG000|Car Phase|Per protocol|1|||
130816873|NCT01559935|470959553|FG000|Car Phase|Insurance|1|||
130816874|NCT01559935|470959553|FG000|Car Phase|non-compliance|1|||
130816875|NCT01559935|470959553|FG000|BiRD Phase|Toxicity|1|||
130816876|NCT01559935|470959553|FG000|BiRD Phase|Lack of Efficacy|1|||
130816877|NCT01559935|470959553|FG000|BiRD Phase|Withdrawal by Subject|2|||
130816878|NCT01559935|470959553|FG000|Maintenance Phase|Remains on study|28|||
130816879|NCT01559935|470959553|FG000|Maintenance Phase|Toxicity|1|||
130816880|NCT01559935|470959553|FG000|Maintenance Phase|Lack of Efficacy|18|||
130816881|NCT01559935|470959553|FG000|Maintenance Phase|Withdrawal by Subject|5|||
130816882|NCT01559935|470959553|FG000|Maintenance Phase|Non-compliance|2|||
130816883|NCT01143402|470959557|FG000|Overall Study|Rapid clinical decline|1|||
130816884|NCT01143402|470959558|FG001|Overall Study|Rapid clinical decline|1|||
130816885|NCT01143402|470959559|FG002|Overall Study|Rapid clinical decline|0|||
130816886|NCT01143402|470959557|FG000|Overall Study|Not Treated|0|||
130816887|NCT01143402|470959558|FG001|Overall Study|Not Treated|0|||
130816888|NCT01143402|470959559|FG002|Overall Study|Not Treated|1|||
130816889|NCT02526290|470959560|FG000|Overall Study|Adverse Event|3|||
130816890|NCT02526290|470959560|FG000|Overall Study|Withdrawal by Subject|4|||
130816891|NCT02526290|470959560|FG000|Overall Study|Physician Decision|1|||
130816892|NCT02706392|470959561|FG000|Overall Study|Death|1|||
130816893|NCT02706392|470959562|FG001|Overall Study|Death|0|||
130816894|NCT02706392|470959563|FG002|Overall Study|Death|2|||
130816895|NCT02706392|470959564|FG003|Overall Study|Death|2|||
130816896|NCT02706392|470959565|FG004|Overall Study|Death|5|||
130816897|NCT02706392|470959566|FG005|Overall Study|Death|2|||
130816898|NCT00619866|470959569|FG000|Weeks 1 - 12|Adverse Event|0|||
130816899|NCT00619866|470959570|FG001|Weeks 1 - 12|Adverse Event|1|||
130816900|NCT00619866|470959571|FG002|Weeks 1 - 12|Adverse Event|2|||
130816901|NCT00619866|470959572|FG003|Weeks 1 - 12|Adverse Event|0|||
130816902|NCT00619866|470959573|FG004|Weeks 1 - 12|Adverse Event|0|||
130816903|NCT00619866|470959569|FG000|Weeks 1 - 12|Non-compliance|0|||
130816904|NCT00619866|470959570|FG001|Weeks 1 - 12|Non-compliance|0|||
130816905|NCT00619866|470959571|FG002|Weeks 1 - 12|Non-compliance|1|||
130816906|NCT00619866|470959572|FG003|Weeks 1 - 12|Non-compliance|0|||
130816907|NCT00619866|470959573|FG004|Weeks 1 - 12|Non-compliance|0|||
130816908|NCT00619866|470959569|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
130816909|NCT00619866|470959570|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
130816910|NCT00619866|470959571|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
130816911|NCT00619866|470959572|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
130816912|NCT00619866|470959573|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
130816913|NCT00619866|470959569|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
130816914|NCT00619866|470959570|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
130816915|NCT00619866|470959571|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
130816916|NCT00619866|470959572|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
130816917|NCT00619866|470959573|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
130816918|NCT00619866|470959569|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
130816919|NCT00619866|470959570|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
130816920|NCT00619866|470959571|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
130816921|NCT00619866|470959572|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
130816922|NCT00619866|470959573|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
130816923|NCT00619866|470959569|FG000|Weeks 1 - 12|Sponsor Decision|0|||
130816924|NCT00619866|470959570|FG001|Weeks 1 - 12|Sponsor Decision|1|||
130816925|NCT00619866|470959571|FG002|Weeks 1 - 12|Sponsor Decision|0|||
130816926|NCT00619866|470959572|FG003|Weeks 1 - 12|Sponsor Decision|0|||
130816927|NCT00619866|470959573|FG004|Weeks 1 - 12|Sponsor Decision|0|||
130816928|NCT00619866|470959569|FG000|Weeks 13 - 24|Adverse Event|0|||
130816929|NCT00619866|470959570|FG001|Weeks 13 - 24|Adverse Event|0|||
130816930|NCT00619866|470959571|FG002|Weeks 13 - 24|Adverse Event|2|||
130816931|NCT00619866|470959572|FG003|Weeks 13 - 24|Adverse Event|1|||
130816932|NCT00619866|470959573|FG004|Weeks 13 - 24|Adverse Event|0|||
130816933|NCT00619866|470959569|FG000|Weeks 13 - 24|Protocol Deviation|0|||
130816934|NCT00619866|470959570|FG001|Weeks 13 - 24|Protocol Deviation|0|||
130816935|NCT00619866|470959571|FG002|Weeks 13 - 24|Protocol Deviation|0|||
130816936|NCT00619866|470959572|FG003|Weeks 13 - 24|Protocol Deviation|1|||
130816937|NCT00619866|470959573|FG004|Weeks 13 - 24|Protocol Deviation|0|||
130816938|NCT00619866|470959569|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
130816939|NCT00619866|470959570|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
130816940|NCT00619866|470959571|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
130816941|NCT00619866|470959572|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
130816942|NCT00619866|470959573|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
130816943|NCT00619866|470959569|FG000|Weeks 13 - 24|Non-compliance|0|||
130816944|NCT00619866|470959570|FG001|Weeks 13 - 24|Non-compliance|1|||
130816945|NCT00619866|470959571|FG002|Weeks 13 - 24|Non-compliance|1|||
130816946|NCT00619866|470959572|FG003|Weeks 13 - 24|Non-compliance|0|||
130816947|NCT00619866|470959573|FG004|Weeks 13 - 24|Non-compliance|0|||
130816948|NCT00619866|470959569|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
130816949|NCT00619866|470959570|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
130816950|NCT00619866|470959571|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
130816951|NCT00619866|470959572|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
130816952|NCT00619866|470959573|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
130816953|NCT01968980|470959577|FG000|Overall Study|Death|0|||
130816954|NCT01968980|470959578|FG001|Overall Study|Death|1|||
130816955|NCT01968980|470959577|FG000|Overall Study|Adverse Event|1|||
130816956|NCT01968980|470959578|FG001|Overall Study|Adverse Event|3|||
130816957|NCT01968980|470959577|FG000|Overall Study|Does not meet entry criteria|1|||
130816958|NCT01968980|470959578|FG001|Overall Study|Does not meet entry criteria|3|||
130816959|NCT01968980|470959577|FG000|Overall Study|Withdrawal by Subject|13|||
130816960|NCT01968980|470959578|FG001|Overall Study|Withdrawal by Subject|5|||
130816961|NCT01968980|470959577|FG000|Overall Study|Other unspecified|1|||
130816962|NCT01968980|470959578|FG001|Overall Study|Other unspecified|2|||
130816963|NCT02589938|470959584|FG000|Overall Study|Withdrawal by Subject|11|||
130816964|NCT02589938|470959585|FG001|Overall Study|Withdrawal by Subject|5|||
130816965|NCT02589938|470959586|FG002|Overall Study|Withdrawal by Subject|6|||
130816966|NCT02589938|470959584|FG000|Overall Study|Lost to Follow-up|3|||
130816967|NCT02589938|470959585|FG001|Overall Study|Lost to Follow-up|3|||
130816968|NCT02589938|470959586|FG002|Overall Study|Lost to Follow-up|3|||
130816969|NCT02589938|470959584|FG000|Overall Study|Death|1|||
130816970|NCT02589938|470959585|FG001|Overall Study|Death|0|||
130816971|NCT02589938|470959586|FG002|Overall Study|Death|1|||
130816972|NCT02589938|470959584|FG000|Overall Study|Protocol Violation|6|||
130816973|NCT02589938|470959585|FG001|Overall Study|Protocol Violation|2|||
130816974|NCT02589938|470959586|FG002|Overall Study|Protocol Violation|3|||
130816975|NCT02589938|470959584|FG000|Overall Study|Physician Decision|1|||
130816976|NCT02589938|470959585|FG001|Overall Study|Physician Decision|0|||
130816977|NCT02589938|470959586|FG002|Overall Study|Physician Decision|0|||
130816978|NCT02589938|470959584|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
130816979|NCT02589938|470959585|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
130816980|NCT02589938|470959586|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
130816981|NCT02521285|470959587|FG000|Overall Study|Lost to Follow-up|1|||
130816982|NCT02521285|470959588|FG001|Overall Study|Lost to Follow-up|1|||
130816983|NCT02521285|470959587|FG000|Overall Study|Withdrawal by Subject|1|||
130816984|NCT02521285|470959588|FG001|Overall Study|Withdrawal by Subject|1|||
130816985|NCT02521285|470959587|FG000|Overall Study|Adverse Event|0|||
130816986|NCT02521285|470959588|FG001|Overall Study|Adverse Event|1|||
130816987|NCT01121757|470959589|FG000|First Drug|Death|1|||
130816988|NCT01121757|470959590|FG001|First Drug|Death|0|||
130816989|NCT01121757|470959589|FG000|First Drug|Disease Progression|0|||
130816990|NCT01121757|470959590|FG001|First Drug|Disease Progression|2|||
130816991|NCT01121757|470959589|FG000|Combination|Physician Decision|0|||
130816992|NCT01121757|470959590|FG001|Combination|Physician Decision|1|||
130816993|NCT01121757|470959589|FG000|Combination|Disease Progression|2|||
130816994|NCT01121757|470959590|FG001|Combination|Disease Progression|0|||
130816995|NCT03636022|470959591|FG000|Overall Study|Withdrawal by Subject|1|||
130816996|NCT03636022|470959592|FG001|Overall Study|Withdrawal by Subject|3|||
130816997|NCT03189719|470959593|FG000|Overall Study|Death|325|||
130816998|NCT03189719|470959594|FG001|Overall Study|Death|361|||
130816999|NCT03189719|470959593|FG000|Overall Study|Physician Decision|1|||
130817000|NCT03189719|470959594|FG001|Overall Study|Physician Decision|0|||
130817001|NCT03189719|470959593|FG000|Overall Study|Sponsor Decision|40|||
130817002|NCT03189719|470959594|FG001|Overall Study|Sponsor Decision|12|||
130817003|NCT03189719|470959593|FG000|Overall Study|Withdrawal by Subject|7|||
130817004|NCT03189719|470959594|FG001|Overall Study|Withdrawal by Subject|3|||
130817005|NCT03012880|470959595|FG000|Overall Study|Withdrawal by Subject|1|||
130817006|NCT03012880|470959596|FG001|Overall Study|Withdrawal by Subject|0|||
130817007|NCT03012880|470959595|FG000|Overall Study|Ineligible|1|||
130817008|NCT03012880|470959596|FG001|Overall Study|Ineligible|0|||
130817009|NCT00642759|470959597|FG000|Overall Study|Protocol Violation|1|||
130817010|NCT03510715|470959598|FG000|Overall Study|Adverse Event|1|||
130817011|NCT03510715|470959599|FG001|Overall Study|Adverse Event|0|||
130817012|NCT03612570|470959606|FG000|Overall Study|Lost to Follow-up|1|||
130817013|NCT04569084|470959607|FG000|Overall Study|Adverse Event|10|||
130817014|NCT04569084|470959608|FG001|Overall Study|Adverse Event|14|||
130817015|NCT04569084|470959607|FG000|Overall Study|Death|2|||
130817016|NCT04569084|470959608|FG001|Overall Study|Death|3|||
130817017|NCT04569084|470959607|FG000|Overall Study|Lost to Follow-up|1|||
130817018|NCT04569084|470959608|FG001|Overall Study|Lost to Follow-up|1|||
130817019|NCT04569084|470959607|FG000|Overall Study|Physician Decision|3|||
130817020|NCT04569084|470959608|FG001|Overall Study|Physician Decision|3|||
130817021|NCT04569084|470959607|FG000|Overall Study|Protocol Violation|2|||
130817022|NCT04569084|470959608|FG001|Overall Study|Protocol Violation|1|||
130817023|NCT04569084|470959607|FG000|Overall Study|Withdrawal by Subject|20|||
130817024|NCT04569084|470959608|FG001|Overall Study|Withdrawal by Subject|21|||
130817025|NCT04569084|470959607|FG000|Overall Study|Study terminated by sponsor|26|||
130817026|NCT04569084|470959608|FG001|Overall Study|Study terminated by sponsor|23|||
130817027|NCT04569084|470959607|FG000|Overall Study|Other|3|||
130817028|NCT04569084|470959608|FG001|Overall Study|Other|5|||
130817029|NCT01994876|470959609|FG000|Test Period 1|Withdrawal by Subject|0|||
130817030|NCT01994876|470959610|FG001|Test Period 1|Withdrawal by Subject|1|||
130817031|NCT01994876|470959609|FG000|Test Period 1|Adverse Event|0|||
130817032|NCT01994876|470959610|FG001|Test Period 1|Adverse Event|1|||
130817033|NCT01994876|470959609|FG000|Test Period 2|Adverse Event|1|||
130817034|NCT01994876|470959610|FG001|Test Period 2|Adverse Event|0|||
130817035|NCT01994876|470959609|FG000|Test Period 2|Protocol Violation|0|||
130817036|NCT01994876|470959610|FG001|Test Period 2|Protocol Violation|1|||
130817037|NCT01346176|470959611|FG000|Recruited|Protocol Violation|1|||
130817038|NCT01346176|470959612|FG001|Recruited|Protocol Violation|0|||
130817039|NCT01346176|470959613|FG002|Recruited|Protocol Violation|0|||
130817040|NCT01346176|470959611|FG000|Completed Advance Directive|Death|3|||
130817041|NCT01346176|470959612|FG001|Completed Advance Directive|Death|2|||
130817042|NCT01346176|470959613|FG002|Completed Advance Directive|Death|2|||
130817043|NCT01346176|470959611|FG000|Completed Advance Directive|Became Ineligible|3|||
130817044|NCT01346176|470959612|FG001|Completed Advance Directive|Became Ineligible|0|||
130817045|NCT01346176|470959613|FG002|Completed Advance Directive|Became Ineligible|1|||
130817046|NCT01346176|470959611|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
130817047|NCT01346176|470959612|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
130817048|NCT01346176|470959613|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
130817049|NCT01346176|470959611|FG000|Completed Satisfaction Survey|Death|3|||
130817050|NCT01346176|470959612|FG001|Completed Satisfaction Survey|Death|0|||
130817051|NCT01346176|470959613|FG002|Completed Satisfaction Survey|Death|2|||
130817052|NCT01346176|470959611|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
130817053|NCT01346176|470959612|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
130817054|NCT01346176|470959613|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
130763988|NCT04506905|470758740|FG006|Overall Study|Lost to Follow-up|0|||
130817055|NCT03186638|470961106|FG000|Overall Study|Withdrawal by Subject|4|||
130817056|NCT03186638|470961107|FG001|Overall Study|Withdrawal by Subject|4|||
130817057|NCT03186638|470961106|FG000|Overall Study|Withdrawn due to medical problem|3|||
130763989|NCT04506905|470758741|FG007|Overall Study|Lost to Follow-up|0|||
130763990|NCT04506905|470758742|FG008|Overall Study|Lost to Follow-up|0|||
130763991|NCT04506905|470758734|FG000|Overall Study|Withdrawal by Subject|0|||
130763992|NCT04506905|470758735|FG001|Overall Study|Withdrawal by Subject|0|||
130763993|NCT04506905|470758736|FG002|Overall Study|Withdrawal by Subject|0|||
130763994|NCT04506905|470758737|FG003|Overall Study|Withdrawal by Subject|2|||
130763995|NCT04506905|470758738|FG004|Overall Study|Withdrawal by Subject|0|||
130763996|NCT04506905|470758739|FG005|Overall Study|Withdrawal by Subject|0|||
130763997|NCT04506905|470758740|FG006|Overall Study|Withdrawal by Subject|0|||
130763998|NCT04506905|470758741|FG007|Overall Study|Withdrawal by Subject|0|||
130763999|NCT04506905|470758742|FG008|Overall Study|Withdrawal by Subject|0|||
130817058|NCT03186638|470961107|FG001|Overall Study|Withdrawn due to medical problem|2|||
130817059|NCT03186638|470961106|FG000|Overall Study|Lost to Follow-up|1|||
130817060|NCT03186638|470961107|FG001|Overall Study|Lost to Follow-up|0|||
130817061|NCT04047446|470961108|FG000|Overall Study|Physician Decision|1|||
130817062|NCT04047446|470961109|FG001|Overall Study|Physician Decision|0|||
130817063|NCT02367456|470961110|FG000|Overall Study|Death|8|||
130817064|NCT02367456|470961111|FG001|Overall Study|Death|24|||
130817065|NCT02367456|470961112|FG002|Overall Study|Death|17|||
130817066|NCT02367456|470961110|FG000|Overall Study|Lost to Follow-up|1|||
130817067|NCT02367456|470961111|FG001|Overall Study|Lost to Follow-up|3|||
130817068|NCT02367456|470961112|FG002|Overall Study|Lost to Follow-up|1|||
130817069|NCT02367456|470961110|FG000|Overall Study|Other reason|3|||
130817070|NCT02367456|470961111|FG001|Overall Study|Other reason|3|||
130817071|NCT02367456|470961112|FG002|Overall Study|Other reason|9|||
130817072|NCT02367456|470961110|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
130817073|NCT02367456|470961111|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
130817074|NCT02367456|470961112|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
130817075|NCT01517984|470961113|FG000|Overall Study|Lost to Follow-up|0|||
130817076|NCT01517984|470961114|FG001|Overall Study|Lost to Follow-up|1|||
130817077|NCT01517984|470961115|FG002|Overall Study|Lost to Follow-up|0|||
130817078|NCT01517984|470961116|FG003|Overall Study|Lost to Follow-up|0|||
130817079|NCT01517984|470961113|FG000|Overall Study|Withdrawal by Subject|1|||
130817080|NCT01517984|470961114|FG001|Overall Study|Withdrawal by Subject|8|||
130817081|NCT01517984|470961115|FG002|Overall Study|Withdrawal by Subject|4|||
130817082|NCT01517984|470961116|FG003|Overall Study|Withdrawal by Subject|1|||
130817083|NCT01517984|470961113|FG000|Overall Study|Screen Failure|4|||
130817084|NCT01517984|470961114|FG001|Overall Study|Screen Failure|0|||
130817085|NCT01517984|470961115|FG002|Overall Study|Screen Failure|0|||
130817086|NCT01517984|470961116|FG003|Overall Study|Screen Failure|0|||
130817087|NCT01517984|470961113|FG000|Overall Study|Ineligible for randomization|0|||
130817088|NCT01517984|470961114|FG001|Overall Study|Ineligible for randomization|14|||
130817089|NCT01517984|470961115|FG002|Overall Study|Ineligible for randomization|0|||
130817090|NCT01517984|470961116|FG003|Overall Study|Ineligible for randomization|0|||
130817091|NCT01500317|470961117|FG000|Overall Study|Withdrawal by Subject|3|||
130817092|NCT01500317|470961118|FG001|Overall Study|Withdrawal by Subject|2|||
130817093|NCT01500317|470961119|FG002|Overall Study|Withdrawal by Subject|0|||
130817094|NCT01170663|470961120|FG000|Overall Study|Lost to Follow-up|3|||
130817095|NCT01170663|470961121|FG001|Overall Study|Lost to Follow-up|9|||
130817096|NCT01170663|470961120|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
130817097|NCT01170663|470961121|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
130817098|NCT02303262|470961125|FG000|Overall Study|Withdrawal by Subject|2|||
130817099|NCT01038323|470961128|FG000|Overall Study|Withdrawal by Subject|3|||
130817100|NCT01038323|470961129|FG001|Overall Study|Withdrawal by Subject|2|||
130817101|NCT01038323|470961130|FG002|Overall Study|Withdrawal by Subject|4|||
130817102|NCT04462471|470961131|FG000|Overall Study|Adverse Event|0|||
130817103|NCT04462471|470961132|FG001|Overall Study|Adverse Event|1|||
130817104|NCT04462471|470961133|FG002|Overall Study|Adverse Event|0|||
130817105|NCT04462471|470961134|FG003|Overall Study|Adverse Event|0|||
130817106|NCT04462471|470961131|FG000|Overall Study|Disease progression|1|||
130817107|NCT04462471|470961132|FG001|Overall Study|Disease progression|0|||
130817108|NCT04462471|470961133|FG002|Overall Study|Disease progression|0|||
130817109|NCT04462471|470961134|FG003|Overall Study|Disease progression|0|||
130817110|NCT04138056|470961140|FG000|Primary Study|Lost to Follow-up|3|||
130817111|NCT04138056|470961141|FG001|Primary Study|Lost to Follow-up|4|||
130817112|NCT04138056|470961142|FG002|Primary Study|Lost to Follow-up|1|||
130817113|NCT04138056|470961143|FG003|Primary Study|Lost to Follow-up|1|||
130817114|NCT04138056|470961144|FG004|Primary Study|Lost to Follow-up|4|||
130817115|NCT04138056|470961140|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
130817116|NCT04138056|470961141|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
130817117|NCT04138056|470961142|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
130817118|NCT04138056|470961143|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
130817119|NCT04138056|470961144|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
130817120|NCT04138056|470961140|FG000|Extension Study|Lost to Follow-up|1|||
130817121|NCT04138056|470961141|FG001|Extension Study|Lost to Follow-up|2|||
130817122|NCT04138056|470961142|FG002|Extension Study|Lost to Follow-up|1|||
130817123|NCT04138056|470961143|FG003|Extension Study|Lost to Follow-up|0|||
130817124|NCT04138056|470961144|FG004|Extension Study|Lost to Follow-up|1|||
130817125|NCT01656161|470961145|FG000|Overall Study|Death|3|||
130817126|NCT01656161|470961145|FG000|Overall Study|Adverse Event|2|||
130817127|NCT01656161|470961145|FG000|Overall Study|Protocol Violation|1|||
130817128|NCT01656161|470961145|FG000|Overall Study|Withdrawal by Subject|1|||
130817129|NCT01215851|470961146|FG000|Treatment Period|Adverse Event|1|||
130817130|NCT01215851|470961147|FG001|Treatment Period|Adverse Event|1|||
130817131|NCT01215851|470961148|FG002|Treatment Period|Adverse Event|1|||
130817132|NCT01215851|470961149|FG003|Treatment Period|Adverse Event|3|||
130817133|NCT01215851|470961150|FG004|Treatment Period|Adverse Event|0|||
130817134|NCT01215851|470961151|FG005|Treatment Period|Adverse Event|1|||
130817135|NCT01215851|470961146|FG000|Follow up Period|Lost to Follow-up|0|||
130817136|NCT01215851|470961147|FG001|Follow up Period|Lost to Follow-up|0|||
130817137|NCT01215851|470961148|FG002|Follow up Period|Lost to Follow-up|0|||
130817138|NCT01215851|470961149|FG003|Follow up Period|Lost to Follow-up|0|||
130817139|NCT01215851|470961150|FG004|Follow up Period|Lost to Follow-up|0|||
130817140|NCT01215851|470961151|FG005|Follow up Period|Lost to Follow-up|1|||
130817141|NCT03510273|470961152|FG000|Overall Study|Withdrawal by Subject|2|||
130817142|NCT03510273|470961152|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
130817143|NCT03510273|470961152|FG000|Overall Study|Moved away from study area|4|||
130817144|NCT01276106|470961155|FG000|Overall Study|Adverse Event|3|||
130817145|NCT01276106|470961156|FG001|Overall Study|Adverse Event|3|||
130817146|NCT01276106|470961157|FG002|Overall Study|Adverse Event|11|||
130817147|NCT01276106|470961158|FG003|Overall Study|Adverse Event|3|||
130817148|NCT01276106|470961155|FG000|Overall Study|Withdrawal by Subject|6|||
130817149|NCT01276106|470961156|FG001|Overall Study|Withdrawal by Subject|3|||
130817150|NCT01276106|470961157|FG002|Overall Study|Withdrawal by Subject|1|||
130817151|NCT01276106|470961158|FG003|Overall Study|Withdrawal by Subject|6|||
130817152|NCT01276106|470961155|FG000|Overall Study|Lack of Efficacy|0|||
130817153|NCT01276106|470961156|FG001|Overall Study|Lack of Efficacy|1|||
130817154|NCT01276106|470961157|FG002|Overall Study|Lack of Efficacy|0|||
130817155|NCT01276106|470961158|FG003|Overall Study|Lack of Efficacy|1|||
130817156|NCT01276106|470961155|FG000|Overall Study|Lost to Follow-up|2|||
130817157|NCT01276106|470961156|FG001|Overall Study|Lost to Follow-up|1|||
130817158|NCT01276106|470961157|FG002|Overall Study|Lost to Follow-up|1|||
130817159|NCT01276106|470961158|FG003|Overall Study|Lost to Follow-up|0|||
130817160|NCT01276106|470961155|FG000|Overall Study|Physician Decision|0|||
130817161|NCT01276106|470961156|FG001|Overall Study|Physician Decision|0|||
130817162|NCT01276106|470961157|FG002|Overall Study|Physician Decision|1|||
130817163|NCT01276106|470961158|FG003|Overall Study|Physician Decision|1|||
130817164|NCT01276106|470961155|FG000|Overall Study|Protocol Violation|1|||
130817165|NCT01276106|470961156|FG001|Overall Study|Protocol Violation|1|||
130817166|NCT01276106|470961157|FG002|Overall Study|Protocol Violation|0|||
130817167|NCT01276106|470961158|FG003|Overall Study|Protocol Violation|2|||
130817168|NCT01276106|470961155|FG000|Overall Study|Insufficient therapeutic effects|0|||
130817169|NCT01276106|470961156|FG001|Overall Study|Insufficient therapeutic effects|0|||
130817170|NCT01276106|470961157|FG002|Overall Study|Insufficient therapeutic effects|2|||
130817171|NCT01276106|470961158|FG003|Overall Study|Insufficient therapeutic effects|0|||
130817172|NCT00862940|470961162|FG000|Overall Study|Adverse Event|15|||
130817173|NCT00862940|470961163|FG001|Overall Study|Adverse Event|12|||
130817174|NCT00862940|470961162|FG000|Overall Study|Lack of Efficacy|1|||
130817175|NCT00862940|470961163|FG001|Overall Study|Lack of Efficacy|3|||
130817176|NCT00862940|470961162|FG000|Overall Study|Protocol Violation|2|||
130817177|NCT00862940|470961163|FG001|Overall Study|Protocol Violation|5|||
130817178|NCT00862940|470961162|FG000|Overall Study|Withdrawal by Subject|4|||
130817179|NCT00862940|470961163|FG001|Overall Study|Withdrawal by Subject|6|||
130817180|NCT00862940|470961162|FG000|Overall Study|Non-compliance|4|||
130817181|NCT00862940|470961163|FG001|Overall Study|Non-compliance|0|||
130817182|NCT00862940|470961162|FG000|Overall Study|Lost to Follow-up|0|||
130817183|NCT00862940|470961163|FG001|Overall Study|Lost to Follow-up|1|||
130817184|NCT00862940|470961162|FG000|Overall Study|Administrative or other reason(s)|4|||
130817185|NCT00862940|470961163|FG001|Overall Study|Administrative or other reason(s)|3|||
130817186|NCT05552859|470961166|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
130817187|NCT05552859|470961167|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
130817188|NCT05901636|470961168|FG000|Overall Study|Lost to Follow-up|0|||
130817189|NCT05901636|470961169|FG001|Overall Study|Lost to Follow-up|1|||
130817190|NCT05901636|470961170|FG002|Overall Study|Lost to Follow-up|0|||
130817191|NCT05901636|470961171|FG003|Overall Study|Lost to Follow-up|1|||
130817192|NCT05901636|470961172|FG004|Overall Study|Lost to Follow-up|1|||
130817193|NCT05901636|470961173|FG005|Overall Study|Lost to Follow-up|3|||
130817194|NCT05901636|470961174|FG006|Overall Study|Lost to Follow-up|1|||
130817195|NCT05901636|470961168|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
130817196|NCT05901636|470961169|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
130817197|NCT05901636|470961170|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
130817198|NCT05901636|470961171|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
130817199|NCT05901636|470961172|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
130817200|NCT05901636|470961173|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
130817201|NCT05901636|470961174|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
130817202|NCT05901636|470961168|FG000|Overall Study|Withdrawal by Subject|1|||
130817203|NCT05901636|470961169|FG001|Overall Study|Withdrawal by Subject|1|||
130817204|NCT05901636|470961170|FG002|Overall Study|Withdrawal by Subject|0|||
130817205|NCT05901636|470961171|FG003|Overall Study|Withdrawal by Subject|0|||
130817206|NCT05901636|470961172|FG004|Overall Study|Withdrawal by Subject|1|||
130817207|NCT05901636|470961173|FG005|Overall Study|Withdrawal by Subject|1|||
130817208|NCT05901636|470961174|FG006|Overall Study|Withdrawal by Subject|0|||
130817209|NCT05901636|470961168|FG000|Overall Study|Other|0|||
130817210|NCT05901636|470961169|FG001|Overall Study|Other|0|||
130817211|NCT05901636|470961170|FG002|Overall Study|Other|1|||
130817212|NCT05901636|470961171|FG003|Overall Study|Other|1|||
130817213|NCT05901636|470961172|FG004|Overall Study|Other|0|||
130817214|NCT05901636|470961173|FG005|Overall Study|Other|0|||
130817215|NCT05901636|470961174|FG006|Overall Study|Other|0|||
130817216|NCT04583618|470961175|FG000|Overall Study|Adverse Event|0|||
130817217|NCT04583618|470961176|FG001|Overall Study|Adverse Event|0|||
130817218|NCT04583618|470961177|FG002|Overall Study|Adverse Event|1|||
130817219|NCT04583618|470961178|FG003|Overall Study|Adverse Event|0|||
130817220|NCT04583618|470961179|FG004|Overall Study|Adverse Event|0|||
130817221|NCT04583618|470961175|FG000|Overall Study|Protocol deviation|1|||
130817222|NCT04583618|470961176|FG001|Overall Study|Protocol deviation|1|||
130817223|NCT04583618|470961177|FG002|Overall Study|Protocol deviation|1|||
130817224|NCT04583618|470961178|FG003|Overall Study|Protocol deviation|0|||
130817225|NCT04583618|470961179|FG004|Overall Study|Protocol deviation|0|||
130817226|NCT04583618|470961175|FG000|Overall Study|Withdrawal by Subject|2|||
130817227|NCT04583618|470961176|FG001|Overall Study|Withdrawal by Subject|1|||
130817228|NCT04583618|470961177|FG002|Overall Study|Withdrawal by Subject|3|||
130817229|NCT04583618|470961178|FG003|Overall Study|Withdrawal by Subject|1|||
130817230|NCT04583618|470961179|FG004|Overall Study|Withdrawal by Subject|1|||
130817231|NCT04583618|470961175|FG000|Overall Study|Lost to Follow-up|0|||
130817232|NCT04583618|470961176|FG001|Overall Study|Lost to Follow-up|1|||
130817233|NCT04583618|470961177|FG002|Overall Study|Lost to Follow-up|3|||
130817234|NCT04583618|470961178|FG003|Overall Study|Lost to Follow-up|1|||
130817235|NCT04583618|470961179|FG004|Overall Study|Lost to Follow-up|1|||
130817236|NCT02711202|470961180|FG000|Overall Study|Adverse Event|3|||
130817237|NCT02711202|470961181|FG001|Overall Study|Adverse Event|0|||
130817238|NCT02711202|470961180|FG000|Overall Study|graft loss|1|||
130817239|NCT02711202|470961181|FG001|Overall Study|graft loss|0|||
130817240|NCT00432965|470961182|FG000|Overall Study|Lost to Follow-up|22|||
130817241|NCT00432965|470961183|FG001|Overall Study|Lost to Follow-up|19|||
130817242|NCT00432965|470961182|FG000|Overall Study|Withdrawal by Subject|13|||
130817243|NCT00432965|470961183|FG001|Overall Study|Withdrawal by Subject|13|||
130817244|NCT00432965|470961182|FG000|Overall Study|Physician Decision|14|||
130817245|NCT00432965|470961183|FG001|Overall Study|Physician Decision|13|||
130817246|NCT00432965|470961182|FG000|Overall Study|Lack of Efficacy|8|||
130817247|NCT00432965|470961183|FG001|Overall Study|Lack of Efficacy|13|||
130817248|NCT00432965|470961182|FG000|Overall Study|Non-compliance|7|||
130817249|NCT00432965|470961183|FG001|Overall Study|Non-compliance|0|||
130817250|NCT00432965|470961182|FG000|Overall Study|Adverse Event|22|||
130817251|NCT00432965|470961183|FG001|Overall Study|Adverse Event|19|||
130817252|NCT00432965|470961182|FG000|Overall Study|Death|3|||
130817253|NCT00432965|470961183|FG001|Overall Study|Death|4|||
130817254|NCT00432965|470961182|FG000|Overall Study|Exclusionary Methods|1|||
130817255|NCT00432965|470961183|FG001|Overall Study|Exclusionary Methods|2|||
130817256|NCT00432965|470961182|FG000|Overall Study|Incomplete Data|4|||
130817257|NCT00432965|470961183|FG001|Overall Study|Incomplete Data|3|||
130817258|NCT03330847|470961195|FG000|Overall Study|Patients ongoing study|62|||
130817259|NCT03330847|470961196|FG001|Overall Study|Patients ongoing study|65|||
130817260|NCT03330847|470961197|FG002|Overall Study|Patients ongoing study|15|||
130817261|NCT01355627|470961198|FG000|Overall Study|Request By the Patient to Discontinue|5|||
130817262|NCT01355627|470961199|FG001|Overall Study|Request By the Patient to Discontinue|7|||
130817263|NCT01355627|470961198|FG000|Overall Study|Lost to Follow-up|8|||
130817264|NCT01355627|470961199|FG001|Overall Study|Lost to Follow-up|7|||
130817265|NCT01355627|470961198|FG000|Overall Study|Fatal Adverse Event|19|||
130817266|NCT01355627|470961199|FG001|Overall Study|Fatal Adverse Event|23|||
130817267|NCT01355627|470961198|FG000|Overall Study|Other|1|||
130817268|NCT01355627|470961199|FG001|Overall Study|Other|1|||
130817269|NCT02293551|470961202|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
130817270|NCT02293551|470961203|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
130817271|NCT02293551|470961204|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
130817272|NCT02293551|470961205|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
130817273|NCT02293551|470961206|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
130817274|NCT02293551|470961207|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
130817275|NCT02293551|470961202|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
130817276|NCT02293551|470961203|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
130817277|NCT02293551|470961204|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
130817278|NCT02293551|470961205|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
130817279|NCT02293551|470961206|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
130817280|NCT02293551|470961207|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
130817281|NCT02293551|470961202|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
130817282|NCT02293551|470961203|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
130817283|NCT02293551|470961204|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
130817284|NCT02293551|470961205|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
130817285|NCT02293551|470961206|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
130817286|NCT02293551|470961207|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
130817287|NCT04532749|470961208|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
130817288|NCT04532749|470961209|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
130817289|NCT04532749|470961208|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
130817290|NCT04532749|470961209|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
130817291|NCT04532749|470961208|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
130817292|NCT04532749|470961209|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
130817293|NCT04532749|470961208|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
130817294|NCT04532749|470961209|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
130817295|NCT04532749|470961208|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
130817296|NCT04532749|470961209|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
130817297|NCT04532749|470961208|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
130817298|NCT04532749|470961209|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
130817299|NCT04532749|470961208|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
130817300|NCT04532749|470961209|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
130817301|NCT04532749|470961208|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
130817302|NCT04532749|470961209|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
130817303|NCT04532749|470961208|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
130817304|NCT04532749|470961209|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
130817305|NCT04532749|470961208|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
130817306|NCT04532749|470961209|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
130817307|NCT02769481|470961210|FG000|Overall Study|Protocol Violation|1|||
130817308|NCT02769481|470961211|FG001|Overall Study|Protocol Violation|0|||
130817309|NCT02769481|470961210|FG000|Overall Study|Adverse Event|3|||
130817310|NCT02769481|470961211|FG001|Overall Study|Adverse Event|6|||
130817311|NCT02769481|470961210|FG000|Overall Study|Entry Criteria Not Met|1|||
130817312|NCT02769481|470961211|FG001|Overall Study|Entry Criteria Not Met|2|||
130817313|NCT02769481|470961210|FG000|Overall Study|Withdrawal by Subject|14|||
130817314|NCT02769481|470961211|FG001|Overall Study|Withdrawal by Subject|16|||
130817315|NCT02769481|470961210|FG000|Overall Study|Lost to Follow-up|9|||
130817316|NCT02769481|470961211|FG001|Overall Study|Lost to Follow-up|9|||
130817317|NCT02769481|470961210|FG000|Overall Study|Physician Decision|0|||
130817318|NCT02769481|470961211|FG001|Overall Study|Physician Decision|1|||
130817319|NCT02769481|470961210|FG000|Overall Study|Terminated by Sponsor|1|||
130817320|NCT02769481|470961211|FG001|Overall Study|Terminated by Sponsor|0|||
130817321|NCT02769481|470961210|FG000|Overall Study|Death|0|||
130817322|NCT02769481|470961211|FG001|Overall Study|Death|1|||
130817323|NCT02769481|470961210|FG000|Overall Study|Undefined|4|||
130817324|NCT02769481|470961211|FG001|Overall Study|Undefined|1|||
130817325|NCT04756531|470961212|FG000|Overall Study|Adverse Event|0|||
130817326|NCT04756531|470961213|FG001|Overall Study|Adverse Event|0|||
130817327|NCT04756531|470961214|FG002|Overall Study|Adverse Event|0|||
130817328|NCT04756531|470961215|FG003|Overall Study|Adverse Event|0|||
130817329|NCT04756531|470961216|FG004|Overall Study|Adverse Event|1|||
130817330|NCT04756531|470961217|FG005|Overall Study|Adverse Event|0|||
130817331|NCT04756531|470961218|FG006|Overall Study|Adverse Event|0|||
130817332|NCT04756531|470961219|FG007|Overall Study|Adverse Event|0|||
130817333|NCT04756531|470961220|FG008|Overall Study|Adverse Event|0|||
130817334|NCT04756531|470961221|FG009|Overall Study|Adverse Event|0|||
130817335|NCT04756531|470961222|FG010|Overall Study|Adverse Event|0|||
130817336|NCT04756531|470961223|FG011|Overall Study|Adverse Event|0|||
130817337|NCT04756531|470961224|FG012|Overall Study|Adverse Event|0|||
130817338|NCT04756531|470961225|FG013|Overall Study|Adverse Event|0|||
130817339|NCT04756531|470961226|FG014|Overall Study|Adverse Event|0|||
130817340|NCT04756531|470961227|FG015|Overall Study|Adverse Event|0|||
130817341|NCT04756531|470961228|FG016|Overall Study|Adverse Event|0|||
130817342|NCT04756531|470961229|FG017|Overall Study|Adverse Event|0|||
130817343|NCT04756531|470961212|FG000|Overall Study|Withdrawal by Subject|0|||
130817344|NCT04756531|470961213|FG001|Overall Study|Withdrawal by Subject|0|||
130817345|NCT04756531|470961214|FG002|Overall Study|Withdrawal by Subject|0|||
130817346|NCT04756531|470961215|FG003|Overall Study|Withdrawal by Subject|0|||
130817347|NCT04756531|470961216|FG004|Overall Study|Withdrawal by Subject|0|||
130817348|NCT04756531|470961217|FG005|Overall Study|Withdrawal by Subject|0|||
130817349|NCT04756531|470961218|FG006|Overall Study|Withdrawal by Subject|1|||
130817350|NCT04756531|470961219|FG007|Overall Study|Withdrawal by Subject|0|||
130817351|NCT04756531|470961220|FG008|Overall Study|Withdrawal by Subject|0|||
130817352|NCT04756531|470961221|FG009|Overall Study|Withdrawal by Subject|0|||
130817353|NCT04756531|470961222|FG010|Overall Study|Withdrawal by Subject|0|||
130817354|NCT04756531|470961223|FG011|Overall Study|Withdrawal by Subject|0|||
130817355|NCT04756531|470961224|FG012|Overall Study|Withdrawal by Subject|0|||
130817356|NCT04756531|470961225|FG013|Overall Study|Withdrawal by Subject|0|||
130817357|NCT04756531|470961226|FG014|Overall Study|Withdrawal by Subject|0|||
130817358|NCT04756531|470961227|FG015|Overall Study|Withdrawal by Subject|0|||
130817359|NCT04756531|470961228|FG016|Overall Study|Withdrawal by Subject|0|||
130817360|NCT04756531|470961229|FG017|Overall Study|Withdrawal by Subject|0|||
130817361|NCT05643495|470961230|FG000|Overall Study|Adverse Event|0|||
130817362|NCT05643495|470961231|FG001|Overall Study|Adverse Event|1|||
130817363|NCT05643495|470961230|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130817364|NCT05643495|470961231|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
130817365|NCT02257528|470961232|FG000|Overall Study|Never received study treatment|1|||
130817366|NCT06272383|470961233|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
130817367|NCT06272383|470961234|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
130817368|NCT01400412|470961235|FG000|Overall Study|Lost to Follow-up|4|||
130817369|NCT01400412|470961236|FG001|Overall Study|Lost to Follow-up|7|||
130817370|NCT01400412|470961235|FG000|Overall Study|Withdrawal by Subject|3|||
130817371|NCT01400412|470961236|FG001|Overall Study|Withdrawal by Subject|4|||
130817372|NCT01400412|470961235|FG000|Overall Study|Unable to complete|3|||
130817373|NCT01400412|470961236|FG001|Overall Study|Unable to complete|3|||
130817374|NCT01400412|470961235|FG000|Overall Study|Never started study treatment|0|||
130817375|NCT01400412|470961236|FG001|Overall Study|Never started study treatment|3|||
130817376|NCT04696146|470962341|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
130817377|NCT04696146|470962342|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
130817378|NCT04696146|470962341|FG000|Overall Study|Off hours issue with product|1|||
130817379|NCT04696146|470962342|FG001|Overall Study|Off hours issue with product|0|||
130817380|NCT00529633|470962347|FG000|Overall Study|Withdrawal by Subject|1|||
130817381|NCT00529633|470962348|FG001|Overall Study|Withdrawal by Subject|1|||
130817382|NCT01276704|470962353|FG000|Overall Study|Lost to Follow-up|2|||
130817383|NCT01276704|470962354|FG001|Overall Study|Lost to Follow-up|3|||
130817384|NCT01276704|470962353|FG000|Overall Study|Non-compliant|2|||
130817385|NCT01276704|470962354|FG001|Overall Study|Non-compliant|2|||
130817386|NCT01276704|470962353|FG000|Overall Study|Withdrawal by Subject|7|||
130817387|NCT01276704|470962354|FG001|Overall Study|Withdrawal by Subject|1|||
130817388|NCT01276704|470962353|FG000|Overall Study|Physician Decision|3|||
130817389|NCT01276704|470962354|FG001|Overall Study|Physician Decision|5|||
130817390|NCT01441960|470962355|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
130817391|NCT01441960|470962356|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
130817392|NCT01441960|470962355|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
130817393|NCT01441960|470962356|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
130817394|NCT01441960|470962355|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
130817395|NCT01441960|470962356|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
130817396|NCT02986074|470962357|FG000|First Trial Period|Adverse Event|1|||
130817397|NCT02986074|470962358|FG001|First Trial Period|Adverse Event|0|||
130817398|NCT02986074|470962359|FG002|First Trial Period|Adverse Event|0|||
130817399|NCT02986074|470962360|FG003|First Trial Period|Adverse Event|0|||
130817400|NCT02986074|470962357|FG000|Follow up Period|system explant|0|||
130817401|NCT02986074|470962358|FG001|Follow up Period|system explant|0|||
130817402|NCT02986074|470962359|FG002|Follow up Period|system explant|1|||
130817403|NCT02986074|470962360|FG003|Follow up Period|system explant|2|||
130817404|NCT02986074|470962357|FG000|Follow up Period|Physician Decision|0|||
130817405|NCT02986074|470962358|FG001|Follow up Period|Physician Decision|0|||
130817406|NCT02986074|470962359|FG002|Follow up Period|Physician Decision|0|||
130817407|NCT02986074|470962360|FG003|Follow up Period|Physician Decision|1|||
130817408|NCT00069641|470962365|FG000|Overall Study|Death|1|||
130817409|NCT00069641|470962366|FG001|Overall Study|Death|0|||
130817410|NCT00069641|470962367|FG002|Overall Study|Death|1|||
130817411|NCT01645176|470962368|FG000|Overall Study|Lack of Efficacy|4|||
130817412|NCT01645176|470962368|FG000|Overall Study|did not complete final MRI|1|||
130817413|NCT01948427|470962369|FG000|Overall Study|Serious Adverse Event|3|||
130817414|NCT01948427|470962370|FG001|Overall Study|Serious Adverse Event|0|||
130817415|NCT01948427|470962371|FG002|Overall Study|Serious Adverse Event|0|||
130817416|NCT01948427|470962372|FG003|Overall Study|Serious Adverse Event|0|||
130817417|NCT01948427|470962373|FG004|Overall Study|Serious Adverse Event|1|||
130817418|NCT01948427|470962369|FG000|Overall Study|Investigator Request|0|||
130817419|NCT01948427|470962370|FG001|Overall Study|Investigator Request|8|||
130817420|NCT01948427|470962371|FG002|Overall Study|Investigator Request|0|||
130817421|NCT01948427|470962372|FG003|Overall Study|Investigator Request|0|||
130817422|NCT01948427|470962373|FG004|Overall Study|Investigator Request|6|||
130817423|NCT01948427|470962369|FG000|Overall Study|Lost to Follow-up|1|||
130817424|NCT01948427|470962370|FG001|Overall Study|Lost to Follow-up|0|||
130817425|NCT01948427|470962371|FG002|Overall Study|Lost to Follow-up|0|||
130817426|NCT01948427|470962372|FG003|Overall Study|Lost to Follow-up|0|||
130817427|NCT01948427|470962373|FG004|Overall Study|Lost to Follow-up|4|||
130817428|NCT01948427|470962369|FG000|Overall Study|Withdrawal by Subject|2|||
130817429|NCT01948427|470962370|FG001|Overall Study|Withdrawal by Subject|0|||
130817430|NCT01948427|470962371|FG002|Overall Study|Withdrawal by Subject|0|||
130817431|NCT01948427|470962372|FG003|Overall Study|Withdrawal by Subject|0|||
130817432|NCT01948427|470962373|FG004|Overall Study|Withdrawal by Subject|1|||
130817433|NCT01948427|470962369|FG000|Overall Study|Other, Not Specified|1|||
130817434|NCT01948427|470962370|FG001|Overall Study|Other, Not Specified|9|||
130817435|NCT01948427|470962371|FG002|Overall Study|Other, Not Specified|0|||
130817436|NCT01948427|470962372|FG003|Overall Study|Other, Not Specified|0|||
130817437|NCT01948427|470962373|FG004|Overall Study|Other, Not Specified|2|||
130817438|NCT00402987|470962374|FG000|Overall Study|Lack of Efficacy|0|||
130817439|NCT00402987|470962375|FG001|Overall Study|Lack of Efficacy|0|||
130817440|NCT00402987|470962376|FG002|Overall Study|Lack of Efficacy|1|||
130817441|NCT00402987|470962377|FG003|Overall Study|Lack of Efficacy|0|||
130817442|NCT01668004|470962378|FG000|Overall Study|Adverse Event|7|||
130817443|NCT01668004|470962378|FG000|Overall Study|Withdrawal by Subject|2|||
130817444|NCT01668004|470962378|FG000|Overall Study|Lost to Follow-up|5|||
130817445|NCT01668004|470962378|FG000|Overall Study|Lack of Efficacy|9|||
130817446|NCT01668004|470962378|FG000|Overall Study|Non-compliance with treatment|2|||
130817447|NCT02448381|470962383|FG000|Overall Study|Adverse Event|2|||
130817448|NCT02448381|470962384|FG001|Overall Study|Adverse Event|0|||
130817449|NCT02448381|470962383|FG000|Overall Study|Lost to Follow-up|16|||
130817450|NCT02448381|470962384|FG001|Overall Study|Lost to Follow-up|9|||
130817451|NCT02448381|470962383|FG000|Overall Study|Physician Decision|1|||
130817452|NCT02448381|470962384|FG001|Overall Study|Physician Decision|1|||
130817453|NCT02448381|470962383|FG000|Overall Study|Pregnancy|1|||
130817454|NCT02448381|470962384|FG001|Overall Study|Pregnancy|0|||
130817455|NCT02448381|470962383|FG000|Overall Study|Withdrawal by Subject|13|||
130817456|NCT02448381|470962384|FG001|Overall Study|Withdrawal by Subject|9|||
130817457|NCT02448381|470962383|FG000|Overall Study|Noncompliance with Study Procedures|2|||
130817458|NCT02448381|470962384|FG001|Overall Study|Noncompliance with Study Procedures|0|||
130817459|NCT01242514|470962390|FG000|Overall Study|e.g., project closure|1042|||
130817460|NCT01242514|470962391|FG001|Overall Study|e.g., project closure|305|||
130817461|NCT01242514|470962392|FG002|Overall Study|e.g., project closure|171|||
130817462|NCT01242514|470962390|FG000|Overall Study|Subject decision|33|||
130817463|NCT01242514|470962391|FG001|Overall Study|Subject decision|8|||
130817464|NCT01242514|470962392|FG002|Overall Study|Subject decision|2|||
130817465|NCT01242514|470962390|FG000|Overall Study|Severe non-compliance to protocol|5|||
130817466|NCT01242514|470962391|FG001|Overall Study|Severe non-compliance to protocol|2|||
130817467|NCT01242514|470962392|FG002|Overall Study|Severe non-compliance to protocol|1|||
130817468|NCT01242514|470962390|FG000|Overall Study|Lack of therapeutic response|99|||
130817469|NCT01242514|470962391|FG001|Overall Study|Lack of therapeutic response|16|||
130817470|NCT01242514|470962392|FG002|Overall Study|Lack of therapeutic response|10|||
130817471|NCT01242514|470962390|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
130817472|NCT01242514|470962391|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
130817473|NCT01242514|470962392|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
130817474|NCT01242514|470962390|FG000|Overall Study|Lost to Follow-up|14|||
130817475|NCT01242514|470962391|FG001|Overall Study|Lost to Follow-up|5|||
130817476|NCT01242514|470962392|FG002|Overall Study|Lost to Follow-up|4|||
130817477|NCT01242514|470962390|FG000|Overall Study|Adverse Event|129|||
130817478|NCT01242514|470962391|FG001|Overall Study|Adverse Event|18|||
130817479|NCT01242514|470962392|FG002|Overall Study|Adverse Event|19|||
130817480|NCT04079738|470962406|FG000|Study Treatment|Death|1|||
130817481|NCT04079738|470962407|FG001|Study Treatment|Death|0|||
130817482|NCT04079738|470962408|FG002|Study Treatment|Death|0|||
130817483|NCT04079738|470962409|FG003|Study Treatment|Death|0|||
130817484|NCT04079738|470962406|FG000|Study Treatment|Adverse Event|2|||
130817485|NCT04079738|470962407|FG001|Study Treatment|Adverse Event|0|||
130817486|NCT04079738|470962408|FG002|Study Treatment|Adverse Event|0|||
130817487|NCT04079738|470962409|FG003|Study Treatment|Adverse Event|0|||
130817488|NCT04079738|470962406|FG000|Study Treatment|withdrawal before treatment|1|||
130817489|NCT04079738|470962407|FG001|Study Treatment|withdrawal before treatment|0|||
130817490|NCT04079738|470962408|FG002|Study Treatment|withdrawal before treatment|0|||
130817491|NCT04079738|470962409|FG003|Study Treatment|withdrawal before treatment|0|||
130817492|NCT04079738|470962406|FG000|Study Treatment|symptomatic deterioration|2|||
130817493|NCT04079738|470962407|FG001|Study Treatment|symptomatic deterioration|0|||
130817494|NCT04079738|470962408|FG002|Study Treatment|symptomatic deterioration|0|||
130817495|NCT04079738|470962409|FG003|Study Treatment|symptomatic deterioration|0|||
130817496|NCT04079738|470962406|FG000|Study Treatment|Disease Progression|1|||
130817497|NCT04079738|470962407|FG001|Study Treatment|Disease Progression|0|||
130817498|NCT04079738|470962408|FG002|Study Treatment|Disease Progression|0|||
130817499|NCT04079738|470962409|FG003|Study Treatment|Disease Progression|0|||
130817500|NCT04079738|470962406|FG000|Study Treatment|withdrawal after treatment|1|||
130817501|NCT04079738|470962407|FG001|Study Treatment|withdrawal after treatment|0|||
130817502|NCT04079738|470962408|FG002|Study Treatment|withdrawal after treatment|0|||
130817503|NCT04079738|470962409|FG003|Study Treatment|withdrawal after treatment|0|||
130817504|NCT04079738|470962406|FG000|Follow up|Withdrawal by Subject|3|||
130817505|NCT04079738|470962407|FG001|Follow up|Withdrawal by Subject|0|||
130817506|NCT04079738|470962408|FG002|Follow up|Withdrawal by Subject|0|||
130817507|NCT04079738|470962409|FG003|Follow up|Withdrawal by Subject|0|||
130817508|NCT04079738|470962406|FG000|Follow up|Death|5|||
130817509|NCT04079738|470962407|FG001|Follow up|Death|0|||
130817510|NCT04079738|470962408|FG002|Follow up|Death|0|||
130817511|NCT04079738|470962409|FG003|Follow up|Death|0|||
130817512|NCT00789555|470962412|FG000|Overall Study|Protocol Amendment|78|||
130817513|NCT00789555|470962413|FG001|Overall Study|Protocol Amendment|76|||
130817514|NCT00789555|470962414|FG002|Overall Study|Protocol Amendment|80|||
130817515|NCT00789555|470962412|FG000|Overall Study|Adverse Event|17|||
130817516|NCT00789555|470962413|FG001|Overall Study|Adverse Event|7|||
130817517|NCT00789555|470962414|FG002|Overall Study|Adverse Event|10|||
130817518|NCT00789555|470962412|FG000|Overall Study|Lost to Follow-up|9|||
130817519|NCT00789555|470962413|FG001|Overall Study|Lost to Follow-up|10|||
130817520|NCT00789555|470962414|FG002|Overall Study|Lost to Follow-up|18|||
130817521|NCT00789555|470962412|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
130817522|NCT00789555|470962413|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
130817523|NCT00789555|470962414|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
130817524|NCT00789555|470962412|FG000|Overall Study|Treatment failure|11|||
130817525|NCT00789555|470962413|FG001|Overall Study|Treatment failure|8|||
130817526|NCT00789555|470962414|FG002|Overall Study|Treatment failure|12|||
130817527|NCT00789555|470962412|FG000|Overall Study|Protocol Violation|6|||
130817528|NCT00789555|470962413|FG001|Overall Study|Protocol Violation|9|||
130817529|NCT00789555|470962414|FG002|Overall Study|Protocol Violation|13|||
130817530|NCT00404248|470962415|FG000|Overall Study|pts declining status|0|||
130817531|NCT00404248|470962416|FG001|Overall Study|pts declining status|1|||
130817532|NCT00404248|470962417|FG002|Overall Study|pts declining status|0|||
130817533|NCT00404248|470962418|FG003|Overall Study|pts declining status|0|||
130817534|NCT00404248|470962419|FG004|Overall Study|pts declining status|0|||
130817535|NCT00404248|470962420|FG005|Overall Study|pts declining status|0|||
130817536|NCT00404248|470962421|FG006|Overall Study|pts declining status|0|||
130817537|NCT00404248|470962422|FG007|Overall Study|pts declining status|0|||
130817538|NCT00404248|470962423|FG008|Overall Study|pts declining status|0|||
130817539|NCT04646005|470962427|FG000|Overall Study|Adverse Event|1|||
130817540|NCT04646005|470962427|FG000|Overall Study|Progressive Disease|71|||
130817541|NCT04646005|470962427|FG000|Overall Study|Death|20|||
130817542|NCT04646005|470962427|FG000|Overall Study|Withdrawal by Subject|12|||
130817543|NCT04646005|470962427|FG000|Overall Study|Sponsor Request|9|||
130817544|NCT04398706|470962429|FG000|Overall Study|Adverse Event|0|||
130817545|NCT04398706|470962430|FG001|Overall Study|Adverse Event|0|||
130817546|NCT04398706|470962431|FG002|Overall Study|Adverse Event|0|||
130817547|NCT04398706|470962432|FG003|Overall Study|Adverse Event|0|||
130817548|NCT04398706|470962433|FG004|Overall Study|Adverse Event|0|||
130817549|NCT04398706|470962434|FG005|Overall Study|Adverse Event|1|||
130817550|NCT04398706|470962435|FG006|Overall Study|Adverse Event|1|||
130817551|NCT04398706|470962436|FG007|Overall Study|Adverse Event|0|||
130817552|NCT04398706|470962429|FG000|Overall Study|Lost to Follow-up|0|||
130817553|NCT04398706|470962430|FG001|Overall Study|Lost to Follow-up|1|||
130817554|NCT04398706|470962431|FG002|Overall Study|Lost to Follow-up|2|||
130817555|NCT04398706|470962432|FG003|Overall Study|Lost to Follow-up|1|||
130817556|NCT04398706|470962433|FG004|Overall Study|Lost to Follow-up|6|||
130817557|NCT04398706|470962434|FG005|Overall Study|Lost to Follow-up|3|||
130817558|NCT04398706|470962435|FG006|Overall Study|Lost to Follow-up|8|||
130817559|NCT04398706|470962436|FG007|Overall Study|Lost to Follow-up|2|||
130817560|NCT04398706|470962429|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130817561|NCT04398706|470962430|FG001|Overall Study|Withdrawal by parent/guardian|2|||
130817562|NCT04398706|470962431|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130817563|NCT04398706|470962432|FG003|Overall Study|Withdrawal by parent/guardian|2|||
130817564|NCT04398706|470962433|FG004|Overall Study|Withdrawal by parent/guardian|19|||
130817565|NCT04398706|470962434|FG005|Overall Study|Withdrawal by parent/guardian|23|||
130817566|NCT04398706|470962435|FG006|Overall Study|Withdrawal by parent/guardian|13|||
130817567|NCT04398706|470962436|FG007|Overall Study|Withdrawal by parent/guardian|11|||
130817568|NCT04398706|470962429|FG000|Overall Study|Protocol deviation|0|||
130817569|NCT04398706|470962430|FG001|Overall Study|Protocol deviation|1|||
130817570|NCT04398706|470962431|FG002|Overall Study|Protocol deviation|0|||
130817571|NCT04398706|470962432|FG003|Overall Study|Protocol deviation|0|||
130817572|NCT04398706|470962433|FG004|Overall Study|Protocol deviation|6|||
130817573|NCT04398706|470962434|FG005|Overall Study|Protocol deviation|4|||
130817574|NCT04398706|470962435|FG006|Overall Study|Protocol deviation|6|||
130817575|NCT04398706|470962436|FG007|Overall Study|Protocol deviation|3|||
130817576|NCT04577404|470962437|FG000|Overall Study|Adverse Event|31|||
130817577|NCT04577404|470962437|FG000|Overall Study|Death|1|||
130817578|NCT04577404|470962437|FG000|Overall Study|Lack of Efficacy|3|||
130817579|NCT04577404|470962437|FG000|Overall Study|Physician Decision|7|||
130817580|NCT04577404|470962437|FG000|Overall Study|Withdrawal by Subject|21|||
130817581|NCT04577404|470962437|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
130817582|NCT04237584|470962438|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
130817583|NCT04237584|470962439|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
130817584|NCT04237584|470962440|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
130817585|NCT04237584|470962441|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
130817586|NCT04237584|470962438|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
130817587|NCT04237584|470962439|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
130817588|NCT04237584|470962440|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
130817589|NCT04237584|470962441|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
130817590|NCT04237584|470962438|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
130817591|NCT04237584|470962439|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
130817592|NCT04237584|470962440|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
130817593|NCT04237584|470962441|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
130817594|NCT04237584|470962438|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
130817595|NCT04237584|470962439|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
130817596|NCT04237584|470962440|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
130817597|NCT04237584|470962441|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
130817598|NCT04237584|470962438|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
130817599|NCT04237584|470962439|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
130817600|NCT04237584|470962440|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
130817601|NCT04237584|470962441|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
130817602|NCT03586973|470962442|FG000|Overall Study|Death|15|||
130817603|NCT03586973|470962443|FG001|Overall Study|Death|8|||
130817604|NCT03586973|470962442|FG000|Overall Study|Site Terminated by Sponsor|3|||
130817605|NCT03586973|470962443|FG001|Overall Study|Site Terminated by Sponsor|6|||
130817606|NCT03586973|470962442|FG000|Overall Study|Withdrawal by Subject|1|||
130817607|NCT03586973|470962443|FG001|Overall Study|Withdrawal by Subject|0|||
130817608|NCT03586973|470962442|FG000|Overall Study|Lost to Follow-up|1|||
130817609|NCT03586973|470962443|FG001|Overall Study|Lost to Follow-up|0|||
130817610|NCT03423979|470962449|FG000|Overall Study|Death|1|||
130817611|NCT05239221|470962450|FG000|Overall Study|Adverse Event|0|||
130817612|NCT05239221|470962451|FG001|Overall Study|Adverse Event|0|||
130817613|NCT05239221|470962452|FG002|Overall Study|Adverse Event|0|||
130817614|NCT05239221|470962453|FG003|Overall Study|Adverse Event|0|||
130817615|NCT05239221|470962454|FG004|Overall Study|Adverse Event|0|||
130817616|NCT05239221|470962455|FG005|Overall Study|Adverse Event|0|||
130817617|NCT05239221|470962456|FG006|Overall Study|Adverse Event|1|||
130817618|NCT05239221|470962457|FG007|Overall Study|Adverse Event|0|||
130817619|NCT05239221|470962458|FG008|Overall Study|Adverse Event|0|||
130817620|NCT05239221|470962459|FG009|Overall Study|Adverse Event|0|||
130817621|NCT05239221|470962460|FG010|Overall Study|Adverse Event|1|||
130817622|NCT05239221|470962461|FG011|Overall Study|Adverse Event|1|||
130817623|NCT05239221|470962462|FG012|Overall Study|Adverse Event|0|||
130817624|NCT05239221|470962463|FG013|Overall Study|Adverse Event|0|||
130817625|NCT05239221|470962464|FG014|Overall Study|Adverse Event|0|||
130817626|NCT05239221|470962465|FG015|Overall Study|Adverse Event|0|||
130817627|NCT05239221|470962450|FG000|Overall Study|Withdrawal by Subject|0|||
130817628|NCT05239221|470962451|FG001|Overall Study|Withdrawal by Subject|0|||
130817629|NCT05239221|470962452|FG002|Overall Study|Withdrawal by Subject|0|||
130817630|NCT05239221|470962453|FG003|Overall Study|Withdrawal by Subject|0|||
130817631|NCT05239221|470962454|FG004|Overall Study|Withdrawal by Subject|0|||
130817632|NCT05239221|470962455|FG005|Overall Study|Withdrawal by Subject|0|||
130817633|NCT05239221|470962456|FG006|Overall Study|Withdrawal by Subject|0|||
130817634|NCT05239221|470962457|FG007|Overall Study|Withdrawal by Subject|0|||
130817635|NCT05239221|470962458|FG008|Overall Study|Withdrawal by Subject|0|||
130817636|NCT05239221|470962459|FG009|Overall Study|Withdrawal by Subject|0|||
130817637|NCT05239221|470962460|FG010|Overall Study|Withdrawal by Subject|1|||
130817638|NCT05239221|470962461|FG011|Overall Study|Withdrawal by Subject|0|||
130817639|NCT05239221|470962462|FG012|Overall Study|Withdrawal by Subject|0|||
130817640|NCT05239221|470962463|FG013|Overall Study|Withdrawal by Subject|0|||
130817641|NCT05239221|470962464|FG014|Overall Study|Withdrawal by Subject|0|||
130817642|NCT05239221|470962465|FG015|Overall Study|Withdrawal by Subject|1|||
130817643|NCT02661672|470962466|FG000|Overall Study|Lost to Follow-up|1|||
130817644|NCT02661672|470962466|FG000|Overall Study|Death|4|||
130817645|NCT02581930|470962467|FG000|Overall Study|Withdrawal by Subject|1|||
130817646|NCT02581930|470962467|FG000|Overall Study|patient declined further treatment|1|||
130817647|NCT01576783|470964581|FG000|Overall Study|Change in Medical Care|1|||
130817648|NCT01576783|470964582|FG001|Overall Study|Change in Medical Care|0|||
130817649|NCT01576783|470964581|FG000|Overall Study|Lost to Follow-up|14|||
130817650|NCT01576783|470964582|FG001|Overall Study|Lost to Follow-up|16|||
130817651|NCT01576783|470964581|FG000|Overall Study|Withdrawal by Subject|5|||
130817652|NCT01576783|470964582|FG001|Overall Study|Withdrawal by Subject|1|||
130817653|NCT01897493|470964583|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
130817654|NCT05489328|470964584|FG000|Overall Study|Lost to Follow-up|0|||
130817655|NCT05489328|470964585|FG001|Overall Study|Lost to Follow-up|0|||
130817656|NCT05489328|470964586|FG002|Overall Study|Lost to Follow-up|1|||
130817657|NCT05489328|470964587|FG003|Overall Study|Lost to Follow-up|0|||
130817658|NCT05489328|470964588|FG004|Overall Study|Lost to Follow-up|2|||
130817659|NCT05489328|470964589|FG005|Overall Study|Lost to Follow-up|0|||
130817660|NCT05489328|470964590|FG006|Overall Study|Lost to Follow-up|0|||
130817661|NCT05489328|470964591|FG007|Overall Study|Lost to Follow-up|1|||
130817662|NCT05489328|470964592|FG008|Overall Study|Lost to Follow-up|0|||
130817663|NCT05489328|470964584|FG000|Overall Study|Withdrawal by Subject|0|||
130817664|NCT05489328|470964585|FG001|Overall Study|Withdrawal by Subject|0|||
130817665|NCT05489328|470964586|FG002|Overall Study|Withdrawal by Subject|0|||
130817666|NCT05489328|470964587|FG003|Overall Study|Withdrawal by Subject|0|||
130817667|NCT05489328|470964588|FG004|Overall Study|Withdrawal by Subject|0|||
130817668|NCT05489328|470964589|FG005|Overall Study|Withdrawal by Subject|0|||
130817669|NCT05489328|470964590|FG006|Overall Study|Withdrawal by Subject|1|||
130817670|NCT05489328|470964591|FG007|Overall Study|Withdrawal by Subject|1|||
130817671|NCT05489328|470964592|FG008|Overall Study|Withdrawal by Subject|0|||
130817672|NCT05489328|470964584|FG000|Overall Study|Other|0|||
130817673|NCT05489328|470964585|FG001|Overall Study|Other|0|||
130817674|NCT05489328|470964586|FG002|Overall Study|Other|0|||
130817675|NCT05489328|470964587|FG003|Overall Study|Other|0|||
130817676|NCT05489328|470964588|FG004|Overall Study|Other|0|||
130817677|NCT05489328|470964589|FG005|Overall Study|Other|0|||
130817678|NCT05489328|470964590|FG006|Overall Study|Other|0|||
130817679|NCT05489328|470964591|FG007|Overall Study|Other|1|||
130817680|NCT05489328|470964592|FG008|Overall Study|Other|1|||
130817681|NCT01083602|470964593|FG000|Overall Study|Adverse Event|11|||
130817682|NCT01083602|470964593|FG000|Overall Study|New Cancer Therapy|2|||
130817683|NCT01083602|470964593|FG000|Overall Study|Death|1|||
130817684|NCT01083602|470964593|FG000|Overall Study|Withdrawal by Subject|5|||
130817685|NCT01083602|470964593|FG000|Overall Study|Lack of Efficacy|36|||
130817686|NCT03698279|470964595|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130817687|NCT03698279|470964596|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130817688|NCT03698279|470964597|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130817689|NCT03698279|470964598|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130817690|NCT03698279|470964599|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130817691|NCT03698279|470964600|FG005|Overall Study|Withdrawal by parent/guardian|0|||
130817692|NCT03698279|470964595|FG000|Overall Study|Protocol deviation|1|||
130817693|NCT03698279|470964596|FG001|Overall Study|Protocol deviation|0|||
130817694|NCT03698279|470964597|FG002|Overall Study|Protocol deviation|1|||
130817695|NCT03698279|470964598|FG003|Overall Study|Protocol deviation|0|||
130817696|NCT03698279|470964599|FG004|Overall Study|Protocol deviation|0|||
130817697|NCT03698279|470964600|FG005|Overall Study|Protocol deviation|0|||
130817698|NCT03698279|470964595|FG000|Overall Study|Withdrawal by Subject|0|||
130817699|NCT03698279|470964596|FG001|Overall Study|Withdrawal by Subject|0|||
130817700|NCT03698279|470964597|FG002|Overall Study|Withdrawal by Subject|1|||
130817701|NCT03698279|470964598|FG003|Overall Study|Withdrawal by Subject|0|||
130817702|NCT03698279|470964599|FG004|Overall Study|Withdrawal by Subject|0|||
130817703|NCT03698279|470964600|FG005|Overall Study|Withdrawal by Subject|0|||
130817704|NCT03698279|470964595|FG000|Overall Study|Lost to Follow-up|3|||
130817705|NCT03698279|470964596|FG001|Overall Study|Lost to Follow-up|1|||
130817706|NCT03698279|470964597|FG002|Overall Study|Lost to Follow-up|4|||
130817707|NCT03698279|470964598|FG003|Overall Study|Lost to Follow-up|5|||
130817708|NCT03698279|470964599|FG004|Overall Study|Lost to Follow-up|0|||
130817709|NCT03698279|470964600|FG005|Overall Study|Lost to Follow-up|0|||
130817710|NCT02276040|470964603|FG000|Overall Study|Physician Decision|15|||
130817711|NCT02239926|470964604|FG000|Overall Study|Withdrawal by Subject|0|||
130817712|NCT02239926|470964605|FG001|Overall Study|Withdrawal by Subject|1|||
130817713|NCT03801525|470964606|FG000|Overall Study|Adverse Event|17|||
130817714|NCT03801525|470964607|FG001|Overall Study|Adverse Event|1|||
130817715|NCT03801525|470964608|FG002|Overall Study|Adverse Event|0|||
130817716|NCT03801525|470964606|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
130817717|NCT03801525|470964607|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
130817718|NCT03801525|470964608|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
130817719|NCT03801525|470964606|FG000|Overall Study|Death|29|||
130817720|NCT03801525|470964607|FG001|Overall Study|Death|1|||
130817721|NCT03801525|470964608|FG002|Overall Study|Death|4|||
130817722|NCT03801525|470964606|FG000|Overall Study|Disease Progression|6|||
130817723|NCT03801525|470964607|FG001|Overall Study|Disease Progression|0|||
130817724|NCT03801525|470964608|FG002|Overall Study|Disease Progression|1|||
130817725|NCT03801525|470964606|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
130817726|NCT03801525|470964607|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
130817727|NCT03801525|470964608|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
130817728|NCT03801525|470964606|FG000|Overall Study|Investigator Decision|18|||
130817729|NCT03801525|470964607|FG001|Overall Study|Investigator Decision|1|||
130817730|NCT03801525|470964608|FG002|Overall Study|Investigator Decision|0|||
130817731|NCT03801525|470964606|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
130817732|NCT03801525|470964607|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
130817733|NCT03801525|470964608|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
130817734|NCT03801525|470964606|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
130817735|NCT03801525|470964607|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
130817736|NCT03801525|470964608|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
130817737|NCT03801525|470964606|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
130817738|NCT03801525|470964607|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
130817739|NCT03801525|470964608|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
130817740|NCT03801525|470964606|FG000|Overall Study|Withdrawal of Subject Consent|38|||
130817741|NCT03801525|470964607|FG001|Overall Study|Withdrawal of Subject Consent|2|||
130817742|NCT03801525|470964608|FG002|Overall Study|Withdrawal of Subject Consent|1|||
130817743|NCT03801525|470964606|FG000|Overall Study|Reason not Specified|4|||
130817744|NCT03801525|470964607|FG001|Overall Study|Reason not Specified|0|||
130817745|NCT03801525|470964608|FG002|Overall Study|Reason not Specified|4|||
130817746|NCT04388826|470964612|FG000|Overall Study|Lost to Follow-up|3|||
130817747|NCT04388826|470964613|FG001|Overall Study|Lost to Follow-up|2|||
130817748|NCT04388826|470964612|FG000|Overall Study|Adverse Event|1|||
130817749|NCT04388826|470964613|FG001|Overall Study|Adverse Event|0|||
130817750|NCT00329420|470964614|FG000|Re-induction Phase|Lack of Efficacy|0|||
130817751|NCT00329420|470964615|FG001|Re-induction Phase|Lack of Efficacy|1|||
130817752|NCT00329420|470964616|FG002|Re-induction Phase|Lack of Efficacy|0|||
130817753|NCT00329420|470964614|FG000|Re-induction Phase|Withdrawal of Consent|0|||
130817754|NCT00329420|470964615|FG001|Re-induction Phase|Withdrawal of Consent|0|||
130817755|NCT00329420|470964616|FG002|Re-induction Phase|Withdrawal of Consent|1|||
130817756|NCT00329420|470964614|FG000|Re-induction Phase|Did not respond to re-induction|6|||
130817757|NCT00329420|470964615|FG001|Re-induction Phase|Did not respond to re-induction|5|||
130817758|NCT00329420|470964616|FG002|Re-induction Phase|Did not respond to re-induction|7|||
130817759|NCT00329420|470964614|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
130817760|NCT00329420|470964615|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
130817761|NCT00329420|470964616|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
130817762|NCT00329420|470964614|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
130817763|NCT00329420|470964615|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
130817764|NCT00329420|470964616|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
130817765|NCT00329420|470964614|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
130817766|NCT00329420|470964615|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
130817767|NCT00329420|470964616|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
130817768|NCT02862574|470964617|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130817769|NCT02862574|470964618|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130817770|NCT02862574|470964619|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130817771|NCT02862574|470964617|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
130817772|NCT02862574|470964618|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
130817773|NCT02862574|470964619|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
130817774|NCT02862574|470964617|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
130817775|NCT02862574|470964618|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
130817776|NCT02862574|470964619|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
130817777|NCT03983421|470964620|FG000|Overall Study|Lost to Follow-up|1|||
130817778|NCT03386773|470964621|FG000|Overall Study|Lost to Follow-up|24|||
130817779|NCT03386773|470964622|FG001|Overall Study|Lost to Follow-up|33|||
130817780|NCT03386773|470964621|FG000|Overall Study|Withdrawal by Subject|3|||
130817781|NCT03386773|470964622|FG001|Overall Study|Withdrawal by Subject|2|||
130817782|NCT03639610|470964623|FG000|Overall Study|Adverse Event|7|||
130817783|NCT03639610|470964624|FG001|Overall Study|Adverse Event|1|||
130817784|NCT03639610|470964625|FG002|Overall Study|Adverse Event|0|||
130817785|NCT03639610|470964623|FG000|Overall Study|Physician Decision|3|||
130817786|NCT03639610|470964624|FG001|Overall Study|Physician Decision|1|||
130817787|NCT03639610|470964625|FG002|Overall Study|Physician Decision|0|||
130817788|NCT03639610|470964623|FG000|Overall Study|Disease progression|8|||
130817789|NCT03639610|470964624|FG001|Overall Study|Disease progression|5|||
130817790|NCT03639610|470964625|FG002|Overall Study|Disease progression|3|||
130817791|NCT03639610|470964623|FG000|Overall Study|Study terminated by sponsor|2|||
130817792|NCT03639610|470964624|FG001|Overall Study|Study terminated by sponsor|1|||
130817793|NCT03639610|470964625|FG002|Overall Study|Study terminated by sponsor|1|||
130817794|NCT03639610|470964623|FG000|Overall Study|Patient request to stop treatment|1|||
130817795|NCT03639610|470964624|FG001|Overall Study|Patient request to stop treatment|2|||
130817796|NCT03639610|470964625|FG002|Overall Study|Patient request to stop treatment|0|||
130817797|NCT02410772|470964628|FG000|Overall Study|Death|3|||
130817798|NCT02410772|470964629|FG001|Overall Study|Death|4|||
130817799|NCT02410772|470964630|FG002|Overall Study|Death|8|||
130817800|NCT02410772|470964628|FG000|Overall Study|Lost to Follow-up|31|||
130817801|NCT02410772|470964629|FG001|Overall Study|Lost to Follow-up|23|||
130817802|NCT02410772|470964630|FG002|Overall Study|Lost to Follow-up|22|||
130817803|NCT02410772|470964628|FG000|Overall Study|Pregnancy|8|||
130817804|NCT02410772|470964629|FG001|Overall Study|Pregnancy|4|||
130817805|NCT02410772|470964630|FG002|Overall Study|Pregnancy|5|||
130817806|NCT02410772|470964628|FG000|Overall Study|Protocol Violation|8|||
130817807|NCT02410772|470964629|FG001|Overall Study|Protocol Violation|8|||
130817808|NCT02410772|470964630|FG002|Overall Study|Protocol Violation|4|||
130817809|NCT02410772|470964628|FG000|Overall Study|Baseline Drug Resistance|49|||
130817810|NCT02410772|470964629|FG001|Overall Study|Baseline Drug Resistance|40|||
130817811|NCT02410772|470964630|FG002|Overall Study|Baseline Drug Resistance|51|||
130817812|NCT02410772|470964628|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
130817813|NCT02410772|470964629|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
130817814|NCT02410772|470964630|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
130817815|NCT02410772|470964628|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
130817816|NCT02410772|470964629|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
130817817|NCT02410772|470964630|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
130817818|NCT05067335|470964633|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
130817819|NCT05067335|470964634|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
130817820|NCT05067335|470964635|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
130817821|NCT05067335|470964636|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
130817822|NCT05067335|470964633|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
130817823|NCT05067335|470964634|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
130817824|NCT05067335|470964635|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
130817825|NCT05067335|470964636|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
130817826|NCT05067335|470964633|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
130817827|NCT05067335|470964634|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
130817828|NCT05067335|470964635|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
130817829|NCT05067335|470964636|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
130817830|NCT05067335|470964633|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
130817831|NCT05067335|470964634|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
130817832|NCT05067335|470964635|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
130817833|NCT05067335|470964636|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
130817834|NCT05067335|470964633|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
130817835|NCT05067335|470964634|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
130817836|NCT05067335|470964635|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
130817837|NCT05067335|470964636|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
130817838|NCT05067335|470964633|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
130817839|NCT05067335|470964634|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
130817840|NCT05067335|470964635|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
130817841|NCT05067335|470964636|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
130817842|NCT05067335|470964633|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
130817843|NCT05067335|470964634|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
130817844|NCT05067335|470964635|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
130817845|NCT05067335|470964636|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
130817846|NCT05067335|470964633|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
130817847|NCT05067335|470964634|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
130817848|NCT05067335|470964635|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
130817849|NCT05067335|470964636|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
130817850|NCT05067335|470964633|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
130817851|NCT05067335|470964634|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
130817852|NCT05067335|470964635|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
130817853|NCT05067335|470964636|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
130817854|NCT05067335|470964633|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
130817855|NCT05067335|470964634|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
130817856|NCT05067335|470964635|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
130817857|NCT05067335|470964636|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
130817858|NCT02724839|470964637|FG000|Overall Study|Withdrawal by Subject|1|||
130817859|NCT02724839|470964638|FG001|Overall Study|Withdrawal by Subject|1|||
130817860|NCT02724839|470964639|FG002|Overall Study|Withdrawal by Subject|0|||
130817861|NCT02724839|470964637|FG000|Overall Study|Lost to Follow-up|0|||
130817862|NCT02724839|470964638|FG001|Overall Study|Lost to Follow-up|3|||
130817863|NCT02724839|470964639|FG002|Overall Study|Lost to Follow-up|2|||
130817864|NCT02724839|470964637|FG000|Overall Study|Physician Decision|0|||
130817865|NCT02724839|470964638|FG001|Overall Study|Physician Decision|0|||
130817866|NCT02724839|470964639|FG002|Overall Study|Physician Decision|3|||
130817867|NCT02234362|470964640|FG000|Overall Study|Not eligible after first screening visit|17|||
130817868|NCT02234362|470964640|FG000|Overall Study|Lost to Follow-up|6|||
130817869|NCT02234362|470964640|FG000|Overall Study|Withdrawal by Subject|3|||
130817870|NCT00560417|470964641|FG000|Overall Study|Adverse Event|3|||
130817871|NCT00560417|470964642|FG001|Overall Study|Adverse Event|2|||
130817872|NCT00560417|470964641|FG000|Overall Study|Entry Criteria Not Met|1|||
130817873|NCT00560417|470964642|FG001|Overall Study|Entry Criteria Not Met|0|||
130817874|NCT00560417|470964641|FG000|Overall Study|Lost to Follow-up|0|||
130817875|NCT00560417|470964642|FG001|Overall Study|Lost to Follow-up|1|||
130817876|NCT00560417|470964641|FG000|Overall Study|Physician Decision|2|||
130817877|NCT00560417|470964642|FG001|Overall Study|Physician Decision|6|||
130817878|NCT00560417|470964641|FG000|Overall Study|Protocol Violation|6|||
130817879|NCT00560417|470964642|FG001|Overall Study|Protocol Violation|5|||
130817880|NCT00560417|470964641|FG000|Overall Study|Sponsor Decision|2|||
130817881|NCT00560417|470964642|FG001|Overall Study|Sponsor Decision|0|||
130817882|NCT00560417|470964641|FG000|Overall Study|Withdrawal by Subject|3|||
130817883|NCT00560417|470964642|FG001|Overall Study|Withdrawal by Subject|3|||
130817884|NCT02164864|470964643|FG000|Overall Study|Trial disease worsening|7|||
130817885|NCT02164864|470964644|FG001|Overall Study|Trial disease worsening|5|||
130817886|NCT02164864|470964645|FG002|Overall Study|Trial disease worsening|1|||
130817887|NCT02164864|470964643|FG000|Overall Study|Other pre-existing disease worsening|6|||
130817888|NCT02164864|470964644|FG001|Overall Study|Other pre-existing disease worsening|4|||
130817889|NCT02164864|470964645|FG002|Overall Study|Other pre-existing disease worsening|9|||
130817890|NCT02164864|470964643|FG000|Overall Study|Other Adverse Event (AE)|52|||
130817891|NCT02164864|470964644|FG001|Overall Study|Other Adverse Event (AE)|32|||
130817892|NCT02164864|470964645|FG002|Overall Study|Other Adverse Event (AE)|49|||
130817893|NCT02164864|470964643|FG000|Overall Study|Protocol Violation|2|||
130817894|NCT02164864|470964644|FG001|Overall Study|Protocol Violation|4|||
130817895|NCT02164864|470964645|FG002|Overall Study|Protocol Violation|1|||
130817896|NCT02164864|470964643|FG000|Overall Study|Lost to Follow-up|4|||
130817897|NCT02164864|470964644|FG001|Overall Study|Lost to Follow-up|3|||
130817898|NCT02164864|470964645|FG002|Overall Study|Lost to Follow-up|2|||
130817899|NCT02164864|470964643|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
130817900|NCT02164864|470964644|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
130817901|NCT02164864|470964645|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
130817902|NCT02164864|470964643|FG000|Overall Study|Other than stated|3|||
130817903|NCT02164864|470964644|FG001|Overall Study|Other than stated|4|||
130817904|NCT02164864|470964645|FG002|Overall Study|Other than stated|14|||
130817905|NCT00557193|470964648|FG000|Induction|Adverse Event|2|||
130817906|NCT00557193|470964649|FG001|Induction|Adverse Event|0|||
130817907|NCT00557193|470964650|FG002|Induction|Adverse Event|0|||
130817908|NCT00557193|470964651|FG003|Induction|Adverse Event|0|||
130817909|NCT00557193|470964652|FG004|Induction|Adverse Event|0|||
130817910|NCT00557193|470964653|FG005|Induction|Adverse Event|0|||
130817911|NCT00557193|470964648|FG000|Induction|Death|6|||
130817912|NCT00557193|470964649|FG001|Induction|Death|0|||
130817913|NCT00557193|470964650|FG002|Induction|Death|0|||
130817914|NCT00557193|470964651|FG003|Induction|Death|0|||
130817915|NCT00557193|470964652|FG004|Induction|Death|0|||
130817916|NCT00557193|470964653|FG005|Induction|Death|0|||
130817917|NCT00557193|470964648|FG000|Induction|Physician Decision|3|||
130817918|NCT00557193|470964649|FG001|Induction|Physician Decision|0|||
130817919|NCT00557193|470964650|FG002|Induction|Physician Decision|0|||
130817920|NCT00557193|470964651|FG003|Induction|Physician Decision|0|||
130817921|NCT00557193|470964652|FG004|Induction|Physician Decision|0|||
130817922|NCT00557193|470964653|FG005|Induction|Physician Decision|0|||
130817923|NCT00557193|470964648|FG000|Induction|Withdrawal by Subject|1|||
130817924|NCT00557193|470964649|FG001|Induction|Withdrawal by Subject|0|||
130817925|NCT00557193|470964650|FG002|Induction|Withdrawal by Subject|0|||
130817926|NCT00557193|470964651|FG003|Induction|Withdrawal by Subject|0|||
130817927|NCT00557193|470964652|FG004|Induction|Withdrawal by Subject|0|||
130817928|NCT00557193|470964653|FG005|Induction|Withdrawal by Subject|0|||
130817929|NCT00557193|470964648|FG000|Induction|Refusal of Further Protocol Therapy|2|||
130817930|NCT00557193|470964649|FG001|Induction|Refusal of Further Protocol Therapy|0|||
130817931|NCT00557193|470964650|FG002|Induction|Refusal of Further Protocol Therapy|0|||
130817932|NCT00557193|470964651|FG003|Induction|Refusal of Further Protocol Therapy|0|||
130817933|NCT00557193|470964652|FG004|Induction|Refusal of Further Protocol Therapy|0|||
130817934|NCT00557193|470964653|FG005|Induction|Refusal of Further Protocol Therapy|0|||
130817935|NCT00557193|470964648|FG000|Induction|Ineligible|8|||
130817936|NCT00557193|470964649|FG001|Induction|Ineligible|0|||
130817937|NCT00557193|470964650|FG002|Induction|Ineligible|0|||
130817938|NCT00557193|470964651|FG003|Induction|Ineligible|0|||
130817939|NCT00557193|470964652|FG004|Induction|Ineligible|0|||
130817940|NCT00557193|470964653|FG005|Induction|Ineligible|0|||
130817941|NCT00557193|470964648|FG000|Induction|Inevaluable for post Induction|2|||
130817942|NCT00557193|470964649|FG001|Induction|Inevaluable for post Induction|0|||
130817943|NCT00557193|470964650|FG002|Induction|Inevaluable for post Induction|0|||
130817944|NCT00557193|470964651|FG003|Induction|Inevaluable for post Induction|0|||
130817945|NCT00557193|470964652|FG004|Induction|Inevaluable for post Induction|0|||
130817946|NCT00557193|470964653|FG005|Induction|Inevaluable for post Induction|0|||
130817947|NCT00557193|470964648|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
130817948|NCT00557193|470964649|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130817949|NCT00557193|470964650|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130817950|NCT00557193|470964651|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130817951|NCT00557193|470964652|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130817952|NCT00557193|470964653|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130817953|NCT00557193|470964648|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130817954|NCT00557193|470964649|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
130817955|NCT00557193|470964650|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
130817956|NCT00557193|470964651|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
130817957|NCT00557193|470964652|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130817958|NCT00557193|470964653|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
130817959|NCT00557193|470964648|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
130817960|NCT00557193|470964649|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
130817961|NCT00557193|470964650|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
130817962|NCT00557193|470964651|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
130817963|NCT00557193|470964652|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
130817964|NCT00557193|470964653|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
130817965|NCT00557193|470964648|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
130817966|NCT00557193|470964649|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
130817967|NCT00557193|470964650|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
130817968|NCT00557193|470964651|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
130817969|NCT00557193|470964652|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
130817970|NCT00557193|470964653|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
130817971|NCT00557193|470964648|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
130817972|NCT00557193|470964649|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
130817973|NCT00557193|470964650|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
130817974|NCT00557193|470964651|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
130817975|NCT00557193|470964652|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
130817976|NCT00557193|470964653|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
130817977|NCT00557193|470964648|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
130817978|NCT00557193|470964649|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
130817979|NCT00557193|470964650|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
130817980|NCT00557193|470964651|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
130817981|NCT00557193|470964652|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
130817982|NCT00557193|470964653|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
130817983|NCT00557193|470964648|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130817984|NCT00557193|470964649|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130817985|NCT00557193|470964650|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
130817986|NCT00557193|470964651|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130817987|NCT00557193|470964652|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130817988|NCT00557193|470964653|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130817989|NCT00557193|470964648|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130817990|NCT00557193|470964649|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130817991|NCT00557193|470964650|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
130817992|NCT00557193|470964651|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130817993|NCT00557193|470964652|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130817994|NCT00557193|470964653|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130817995|NCT00557193|470964648|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130817996|NCT00557193|470964649|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130817997|NCT00557193|470964650|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
130817998|NCT00557193|470964651|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130817999|NCT00557193|470964652|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130818000|NCT00557193|470964653|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
130818001|NCT02569853|470964654|FG000|Overall Study|Adverse Event|2|||
130818002|NCT02569853|470964655|FG001|Overall Study|Adverse Event|0|||
130818003|NCT02569853|470964654|FG000|Overall Study|Withdrawal by Subject|3|||
130818004|NCT02569853|470964655|FG001|Overall Study|Withdrawal by Subject|2|||
130818005|NCT02569853|470964654|FG000|Overall Study|Lost to Follow-up|3|||
130818006|NCT02569853|470964655|FG001|Overall Study|Lost to Follow-up|3|||
130818007|NCT02569853|470964654|FG000|Overall Study|Protocol Violation|1|||
130818008|NCT02569853|470964655|FG001|Overall Study|Protocol Violation|1|||
130818009|NCT02569853|470964654|FG000|Overall Study|Did not experience migraine attack|10|||
130818010|NCT02569853|470964655|FG001|Overall Study|Did not experience migraine attack|7|||
130818011|NCT02569853|470964654|FG000|Overall Study|Physician Decision|1|||
130818012|NCT02569853|470964655|FG001|Overall Study|Physician Decision|1|||
130818013|NCT00261833|470964656|FG000|Overall Study|Death|1|||
130818014|NCT00261833|470964657|FG001|Overall Study|Death|3|||
130818015|NCT00261833|470964656|FG000|Overall Study|Adverse Event|1|||
130818016|NCT00261833|470964657|FG001|Overall Study|Adverse Event|4|||
130818017|NCT00261833|470964656|FG000|Overall Study|Withdrawal by Subject|5|||
130818018|NCT00261833|470964657|FG001|Overall Study|Withdrawal by Subject|7|||
130818019|NCT00261833|470964656|FG000|Overall Study|Protocol Violation|0|||
130818020|NCT00261833|470964657|FG001|Overall Study|Protocol Violation|1|||
130818021|NCT00261833|470964656|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
130818022|NCT00261833|470964657|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
130818023|NCT00261833|470964656|FG000|Overall Study|Lung transplantation|1|||
130818024|NCT00261833|470964657|FG001|Overall Study|Lung transplantation|1|||
130818025|NCT00261833|470964656|FG000|Overall Study|Missing reason|1|||
130818026|NCT00261833|470964657|FG001|Overall Study|Missing reason|0|||
130818027|NCT00261833|470964656|FG000|Overall Study|Not interested in being participant|0|||
130818028|NCT00261833|470964657|FG001|Overall Study|Not interested in being participant|1|||
130818029|NCT00622726|470964658|FG000|March, 2008 to August, 2010|Death|5|||
130818030|NCT00622726|470964659|FG001|March, 2008 to August, 2010|Death|2|||
130818031|NCT00622726|470964658|FG000|August, 2010 to April, 2013|Death|1|||
130818032|NCT00622726|470964659|FG001|August, 2010 to April, 2013|Death|5|||
130818033|NCT02434081|470964662|FG000|Overall Study|Death (never started treatment)|2|||
130818034|NCT02434081|470964662|FG000|Overall Study|Death|2|||
130818035|NCT02434081|470964662|FG000|Overall Study|Progression|20|||
130818036|NCT02434081|470964662|FG000|Overall Study|Adverse Event|20|||
130818037|NCT02434081|470964662|FG000|Overall Study|Physician Decision|2|||
130818038|NCT02434081|470964662|FG000|Overall Study|Withdrawal by Subject|1|||
130818039|NCT02434081|470964662|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
130818040|NCT00419744|470964663|FG000|Overall Study|Adverse Event|39|||
130818041|NCT00419744|470964664|FG001|Overall Study|Adverse Event|40|||
130818042|NCT00419744|470964665|FG002|Overall Study|Adverse Event|50|||
130818043|NCT00419744|470964663|FG000|Overall Study|Withdrawal by Subject|45|||
130818044|NCT00419744|470964664|FG001|Overall Study|Withdrawal by Subject|49|||
130818045|NCT00419744|470964665|FG002|Overall Study|Withdrawal by Subject|52|||
130818046|NCT00419744|470964663|FG000|Overall Study|Lost to Follow-up|8|||
130818047|NCT00419744|470964664|FG001|Overall Study|Lost to Follow-up|10|||
130818048|NCT00419744|470964665|FG002|Overall Study|Lost to Follow-up|6|||
130818049|NCT00419744|470964663|FG000|Overall Study|Protocol Violation|4|||
130818050|NCT00419744|470964664|FG001|Overall Study|Protocol Violation|7|||
130818051|NCT00419744|470964665|FG002|Overall Study|Protocol Violation|8|||
130818052|NCT00419744|470964663|FG000|Overall Study|Randomized in error|9|||
130818053|NCT00419744|470964664|FG001|Overall Study|Randomized in error|6|||
130818054|NCT00419744|470964665|FG002|Overall Study|Randomized in error|7|||
130818055|NCT00419744|470964663|FG000|Overall Study|Moving out of state|2|||
130818056|NCT00419744|470964664|FG001|Overall Study|Moving out of state|0|||
130818057|NCT00419744|470964665|FG002|Overall Study|Moving out of state|1|||
130818058|NCT00419744|470964663|FG000|Overall Study|Physician Decision|10|||
130818059|NCT00419744|470964664|FG001|Overall Study|Physician Decision|5|||
130818060|NCT00419744|470964665|FG002|Overall Study|Physician Decision|6|||
130818061|NCT00419744|470964663|FG000|Overall Study|Spirometry mouthpiece issues|0|||
130818062|NCT00419744|470964664|FG001|Overall Study|Spirometry mouthpiece issues|1|||
130818063|NCT00419744|470964665|FG002|Overall Study|Spirometry mouthpiece issues|2|||
130818064|NCT00419744|470964663|FG000|Overall Study|Incorrect medication kit dispensed|0|||
130818065|NCT00419744|470964664|FG001|Overall Study|Incorrect medication kit dispensed|0|||
130818066|NCT00419744|470964665|FG002|Overall Study|Incorrect medication kit dispensed|1|||
130818067|NCT02037529|470964669|FG000|Overall Study|Withdrawal by Subject|1|||
130818068|NCT02037529|470964670|FG001|Overall Study|Withdrawal by Subject|3|||
130818069|NCT02037529|470964669|FG000|Overall Study|Adverse Event|0|||
130818070|NCT02037529|470964670|FG001|Overall Study|Adverse Event|1|||
130818071|NCT02131766|470964671|FG000|Overall Study|Withdrawal by Subject|4|||
130818072|NCT00718315|470964672|FG000|Overall Study|Adverse Event|1|||
130818073|NCT00718315|470964673|FG001|Overall Study|Adverse Event|2|||
130818074|NCT00718315|470964674|FG002|Overall Study|Adverse Event|3|||
130818075|NCT00718315|470964672|FG000|Overall Study|Death|6|||
130818076|NCT00718315|470964673|FG001|Overall Study|Death|6|||
130818077|NCT00718315|470964674|FG002|Overall Study|Death|5|||
130818078|NCT00718315|470964672|FG000|Overall Study|Lost to Follow-up|2|||
130818079|NCT00718315|470964673|FG001|Overall Study|Lost to Follow-up|3|||
130818080|NCT00718315|470964674|FG002|Overall Study|Lost to Follow-up|4|||
130818081|NCT00718315|470964672|FG000|Overall Study|Protocol Violation|5|||
130818082|NCT00718315|470964673|FG001|Overall Study|Protocol Violation|5|||
130818083|NCT00718315|470964674|FG002|Overall Study|Protocol Violation|3|||
130818084|NCT00718315|470964672|FG000|Overall Study|Erlotinib dose decreased|4|||
130818085|NCT00718315|470964673|FG001|Overall Study|Erlotinib dose decreased|3|||
130818086|NCT00718315|470964674|FG002|Overall Study|Erlotinib dose decreased|1|||
130818087|NCT00718315|470964672|FG000|Overall Study|Use of Minocyclin|1|||
130818088|NCT00718315|470964673|FG001|Overall Study|Use of Minocyclin|1|||
130818089|NCT00718315|470964674|FG002|Overall Study|Use of Minocyclin|1|||
130818090|NCT00718315|470964672|FG000|Overall Study|Disease progression|0|||
130818091|NCT00718315|470964673|FG001|Overall Study|Disease progression|1|||
130818092|NCT00718315|470964674|FG002|Overall Study|Disease progression|1|||
130818093|NCT00718315|470964672|FG000|Overall Study|Other|0|||
130818094|NCT00718315|470964673|FG001|Overall Study|Other|0|||
130818095|NCT00718315|470964674|FG002|Overall Study|Other|1|||
130818096|NCT00718315|470964672|FG000|Overall Study|Use of ATB and Corticoids|0|||
130818097|NCT00718315|470964673|FG001|Overall Study|Use of ATB and Corticoids|1|||
130818098|NCT00718315|470964674|FG002|Overall Study|Use of ATB and Corticoids|2|||
130818099|NCT02006927|470964677|FG000|Overall Study|Adverse Event|2|||
130818100|NCT02006927|470964677|FG000|Overall Study|Withdrawal by Subject|1|||
130818101|NCT02746809|470964682|FG000|Enrollment|Inclusion Exclusion not met|9|||
130818102|NCT02746809|470964682|FG000|Enrollment|Withdrawal by Subject|1|||
130818103|NCT02746809|470964682|FG000|Enrollment|Expected Enrollment Met|2|||
130818104|NCT02746809|470964682|FG000|Procedure|Death|1|||
130818105|NCT02746809|470964682|FG000|1-Month|Death|5|||
130818106|NCT02746809|470964682|FG000|6-Month|Death|2|||
130818107|NCT02746809|470964682|FG000|6-Month|Withdrawal by Subject|1|||
130818108|NCT02746809|470964682|FG000|12-Month|Death|3|||
130818109|NCT02746809|470964682|FG000|12-Month|Withdrawal by Subject|2|||
130818110|NCT02746809|470964682|FG000|24-Month|Death|1|||
130818111|NCT02746809|470964682|FG000|24-Month|Withdrawal by Subject|1|||
130818112|NCT02746809|470964682|FG000|36-Month|Death|8|||
130818113|NCT02746809|470964682|FG000|36-Month|Withdrawal by Subject|1|||
130818114|NCT02746809|470964682|FG000|48-Month|Death|7|||
130818115|NCT02746809|470964682|FG000|48-Month|Withdrawal by Subject|1|||
130818116|NCT02746809|470964682|FG000|60-Month|Death|1|||
130818117|NCT02746809|470964682|FG000|60-Month|Lost to Follow-up|2|||
130818118|NCT00673920|470964683|FG000|Baseline up to Week 48|Withdrew consent|1|||
130818119|NCT00673920|470964684|FG001|Baseline up to Week 48|Withdrew consent|0|||
130818120|NCT00673920|470964685|FG002|Baseline up to Week 48|Withdrew consent|2|||
130818121|NCT00673920|470964686|FG003|Baseline up to Week 48|Withdrew consent|0|||
130818122|NCT00673920|470964687|FG004|Baseline up to Week 48|Withdrew consent|0|||
130818123|NCT00673920|470964688|FG005|Baseline up to Week 48|Withdrew consent|0|||
130818124|NCT00673920|470964689|FG006|Baseline up to Week 48|Withdrew consent|0|||
130818125|NCT00673920|470964690|FG007|Baseline up to Week 48|Withdrew consent|0|||
130818126|NCT00673920|470964683|FG000|Baseline up to Week 48|Refused treatment|1|||
130818127|NCT00673920|470964684|FG001|Baseline up to Week 48|Refused treatment|0|||
130818128|NCT00673920|470964685|FG002|Baseline up to Week 48|Refused treatment|0|||
130818129|NCT00673920|470964686|FG003|Baseline up to Week 48|Refused treatment|0|||
130818130|NCT00673920|470964687|FG004|Baseline up to Week 48|Refused treatment|0|||
130818131|NCT00673920|470964688|FG005|Baseline up to Week 48|Refused treatment|0|||
130818132|NCT00673920|470964689|FG006|Baseline up to Week 48|Refused treatment|0|||
130818133|NCT00673920|470964690|FG007|Baseline up to Week 48|Refused treatment|0|||
130818134|NCT00673920|470964683|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
130818135|NCT00673920|470964684|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
130818136|NCT00673920|470964685|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
130818137|NCT00673920|470964686|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
130818138|NCT00673920|470964687|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
130818139|NCT00673920|470964688|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
130818140|NCT00673920|470964689|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
130818141|NCT00673920|470964690|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
130818142|NCT00673920|470964683|FG000|Baseline up to Week 48|Protocol Violation|0|||
130818143|NCT00673920|470964684|FG001|Baseline up to Week 48|Protocol Violation|0|||
130818144|NCT00673920|470964685|FG002|Baseline up to Week 48|Protocol Violation|1|||
130818145|NCT00673920|470964686|FG003|Baseline up to Week 48|Protocol Violation|0|||
130818146|NCT00673920|470964687|FG004|Baseline up to Week 48|Protocol Violation|0|||
130818147|NCT00673920|470964688|FG005|Baseline up to Week 48|Protocol Violation|0|||
130818148|NCT00673920|470964689|FG006|Baseline up to Week 48|Protocol Violation|0|||
130818149|NCT00673920|470964690|FG007|Baseline up to Week 48|Protocol Violation|0|||
130818150|NCT00673920|470964683|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130818151|NCT00673920|470964684|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130818152|NCT00673920|470964685|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
130818153|NCT00673920|470964686|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130818154|NCT00673920|470964687|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130818155|NCT00673920|470964688|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130818156|NCT00673920|470964689|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130818157|NCT00673920|470964690|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130818158|NCT00673920|470964683|FG000|Baseline up to Week 48|Administrative/Other|0|||
130818159|NCT00673920|470964684|FG001|Baseline up to Week 48|Administrative/Other|1|||
130818160|NCT00673920|470964685|FG002|Baseline up to Week 48|Administrative/Other|2|||
130818161|NCT00673920|470964686|FG003|Baseline up to Week 48|Administrative/Other|0|||
130818162|NCT00673920|470964687|FG004|Baseline up to Week 48|Administrative/Other|0|||
130818163|NCT00673920|470964688|FG005|Baseline up to Week 48|Administrative/Other|0|||
130818164|NCT00673920|470964689|FG006|Baseline up to Week 48|Administrative/Other|0|||
130818165|NCT00673920|470964690|FG007|Baseline up to Week 48|Administrative/Other|0|||
130818166|NCT00673920|470964683|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130818167|NCT00673920|470964684|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
130818168|NCT00673920|470964685|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
130818169|NCT00673920|470964686|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130818170|NCT00673920|470964687|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130818171|NCT00673920|470964688|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130818172|NCT00673920|470964689|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130818173|NCT00673920|470964690|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130818174|NCT00673920|470964683|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130818175|NCT00673920|470964684|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130818176|NCT00673920|470964685|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130818177|NCT00673920|470964686|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130818178|NCT00673920|470964687|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130818179|NCT00673920|470964688|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130818180|NCT00673920|470964689|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
130818181|NCT00673920|470964690|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130818182|NCT00673920|470964683|FG000|Week 24 to Week 48|Failure to return|0|||
130818183|NCT00673920|470964684|FG001|Week 24 to Week 48|Failure to return|0|||
130818184|NCT00673920|470964685|FG002|Week 24 to Week 48|Failure to return|0|||
130818185|NCT00673920|470964686|FG003|Week 24 to Week 48|Failure to return|0|||
130818186|NCT00673920|470964687|FG004|Week 24 to Week 48|Failure to return|0|||
130818187|NCT00673920|470964688|FG005|Week 24 to Week 48|Failure to return|1|||
130818188|NCT00673920|470964689|FG006|Week 24 to Week 48|Failure to return|0|||
130818189|NCT00673920|470964690|FG007|Week 24 to Week 48|Failure to return|0|||
130818190|NCT00673920|470964683|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
130818191|NCT00673920|470964684|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
130818192|NCT00673920|470964685|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
130818193|NCT00673920|470964686|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
130818194|NCT00673920|470964687|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
130818195|NCT00673920|470964688|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
130818196|NCT00673920|470964689|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
130818197|NCT00673920|470964690|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
130818198|NCT00673920|470964683|FG000|Week 24 to Week 48|Death|0|||
130818199|NCT00673920|470964684|FG001|Week 24 to Week 48|Death|0|||
130818200|NCT00673920|470964685|FG002|Week 24 to Week 48|Death|0|||
130818201|NCT00673920|470964686|FG003|Week 24 to Week 48|Death|0|||
130818202|NCT00673920|470964687|FG004|Week 24 to Week 48|Death|0|||
130818203|NCT00673920|470964688|FG005|Week 24 to Week 48|Death|1|||
130818204|NCT00673920|470964689|FG006|Week 24 to Week 48|Death|0|||
130818205|NCT00673920|470964690|FG007|Week 24 to Week 48|Death|0|||
130818206|NCT00673920|470964683|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
130818207|NCT00673920|470964684|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
130818208|NCT00673920|470964685|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
130818209|NCT00673920|470964686|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
130818210|NCT00673920|470964687|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
130818211|NCT00673920|470964688|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
130818212|NCT00673920|470964689|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
130818213|NCT00673920|470964690|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
130818214|NCT01164007|470964695|FG000|Overall Study|Adverse Event|5|||
130818215|NCT01164007|470964695|FG000|Overall Study|Progression of Disease|30|||
130818216|NCT01164007|470964695|FG000|Overall Study|Protocol Violation|1|||
130818217|NCT01164007|470964695|FG000|Overall Study|Withdrawal by Subject|1|||
130818218|NCT01164007|470964695|FG000|Overall Study|Medical Decision|3|||
130818219|NCT00894387|470964696|FG000|Overall Study|Adverse Event|44|||
130818220|NCT00894387|470964697|FG001|Overall Study|Adverse Event|45|||
130818221|NCT00894387|470964696|FG000|Overall Study|Abnormal Laboratory values|2|||
130818222|NCT00894387|470964697|FG001|Overall Study|Abnormal Laboratory values|2|||
130818223|NCT00894387|470964696|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130818224|NCT00894387|470964697|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130818225|NCT00894387|470964696|FG000|Overall Study|Lost to Follow-up|3|||
130818226|NCT00894387|470964697|FG001|Overall Study|Lost to Follow-up|5|||
130818227|NCT00894387|470964696|FG000|Overall Study|Administrative problems|2|||
130818228|NCT00894387|470964697|FG001|Overall Study|Administrative problems|2|||
130818229|NCT00894387|470964696|FG000|Overall Study|Death|77|||
130818230|NCT00894387|470964697|FG001|Overall Study|Death|76|||
130818231|NCT00894387|470964696|FG000|Overall Study|Protocol Deviation|4|||
130818232|NCT00894387|470964697|FG001|Overall Study|Protocol Deviation|0|||
130818233|NCT00894387|470964696|FG000|Overall Study|Patient's request|25|||
130818234|NCT00894387|470964697|FG001|Overall Study|Patient's request|30|||
130818235|NCT00894387|470964696|FG000|Overall Study|Other (Missing)|5|||
130818236|NCT00894387|470964697|FG001|Overall Study|Other (Missing)|3|||
130818237|NCT00894387|470964696|FG000|Overall Study|Mis-randomized|13|||
130818238|NCT00894387|470964697|FG001|Overall Study|Mis-randomized|9|||
130818239|NCT00894387|470964696|FG000|Overall Study|GCP non-compliance|0|||
130818240|NCT00894387|470964697|FG001|Overall Study|GCP non-compliance|2|||
130818241|NCT04856527|470964698|FG000|Overall Study|Unable to complete experimental task|2|||
130818242|NCT04856527|470964699|FG001|Overall Study|Unable to complete experimental task|0|||
130818243|NCT01816295|470964700|FG000|Double Blind Phase|Adverse Event|11|||
130818244|NCT01816295|470964701|FG001|Double Blind Phase|Adverse Event|8|||
130818245|NCT01816295|470964700|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
130818246|NCT01816295|470964701|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
130818247|NCT01816295|470964700|FG000|Double Blind Phase|Lost to Follow-up|3|||
130818248|NCT01816295|470964701|FG001|Double Blind Phase|Lost to Follow-up|5|||
130818249|NCT01816295|470964700|FG000|Double Blind Phase|Physician Decision|2|||
130818250|NCT01816295|470964701|FG001|Double Blind Phase|Physician Decision|2|||
130818251|NCT01816295|470964700|FG000|Double Blind Phase|Protocol Violation|17|||
130818252|NCT01816295|470964701|FG001|Double Blind Phase|Protocol Violation|11|||
130818253|NCT01816295|470964700|FG000|Double Blind Phase|Sponsor Decision|8|||
130818254|NCT01816295|470964701|FG001|Double Blind Phase|Sponsor Decision|8|||
130818255|NCT01816295|470964700|FG000|Double Blind Phase|Withdrawal by Subject|22|||
130818256|NCT01816295|470964701|FG001|Double Blind Phase|Withdrawal by Subject|20|||
130818257|NCT01816295|470964700|FG000|OLE Phase|Adverse Event|17|||
130818258|NCT01816295|470964701|FG001|OLE Phase|Adverse Event|15|||
130818259|NCT01816295|470964700|FG000|OLE Phase|Death|1|||
130818260|NCT01816295|470964701|FG001|OLE Phase|Death|0|||
130818261|NCT01816295|470964700|FG000|OLE Phase|Entry Criteria Not Met|3|||
130818262|NCT01816295|470964701|FG001|OLE Phase|Entry Criteria Not Met|5|||
130818263|NCT01816295|470964700|FG000|OLE Phase|Lost to Follow-up|5|||
130818264|NCT01816295|470964701|FG001|OLE Phase|Lost to Follow-up|5|||
130818265|NCT01816295|470964700|FG000|OLE Phase|Physician Decision|3|||
130818266|NCT01816295|470964701|FG001|OLE Phase|Physician Decision|1|||
130818267|NCT01816295|470964700|FG000|OLE Phase|Protocol Violation|4|||
130818268|NCT01816295|470964701|FG001|OLE Phase|Protocol Violation|4|||
130818269|NCT01816295|470964700|FG000|OLE Phase|Sponsor Decision|7|||
130818270|NCT01816295|470964701|FG001|OLE Phase|Sponsor Decision|9|||
130818271|NCT01816295|470964700|FG000|OLE Phase|Withdrawal by Subject|10|||
130818272|NCT01816295|470964701|FG001|OLE Phase|Withdrawal by Subject|10|||
130818273|NCT01816295|470964700|FG000|OLE Phase|Lack of Efficacy|3|||
130818274|NCT01816295|470964701|FG001|OLE Phase|Lack of Efficacy|7|||
130818275|NCT04165824|470964702|FG000|Overall Study|Adverse Event|23|||
130818276|NCT04165824|470964702|FG000|Overall Study|Physician Decision|1|||
130818277|NCT04165824|470964702|FG000|Overall Study|Withdrawal by Subject|17|||
130818278|NCT04165824|470964702|FG000|Overall Study|Other|5|||
130818279|NCT05200845|470964709|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
130818280|NCT05200845|470964710|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
130818281|NCT05200845|470964711|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
130818282|NCT05200845|470964712|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
130818283|NCT05200845|470964709|FG000|Overall Study|Withdrawal by Subject|0|||
130818284|NCT05200845|470964710|FG001|Overall Study|Withdrawal by Subject|1|||
130818285|NCT05200845|470964711|FG002|Overall Study|Withdrawal by Subject|1|||
130818286|NCT05200845|470964712|FG003|Overall Study|Withdrawal by Subject|0|||
130818287|NCT02412670|470964713|FG000|Overall Study|Adverse Event|4|||
130818288|NCT02412670|470964714|FG001|Overall Study|Adverse Event|1|||
130818289|NCT02412670|470964713|FG000|Overall Study|Physician Decision|1|||
130818290|NCT02412670|470964714|FG001|Overall Study|Physician Decision|0|||
130818291|NCT02412670|470964713|FG000|Overall Study|Withdrawal by Subject|1|||
130818292|NCT02412670|470964714|FG001|Overall Study|Withdrawal by Subject|0|||
130818293|NCT02412670|470964713|FG000|Overall Study|Ineligible|1|||
130818294|NCT02412670|470964714|FG001|Overall Study|Ineligible|0|||
130818295|NCT02921256|470964718|FG000|Arm 1a v. Arm II|Adverse Event|6|||
130818296|NCT02921256|470964719|FG001|Arm 1a v. Arm II|Adverse Event|15|||
130818297|NCT02921256|470964720|FG002|Arm 1a v. Arm II|Adverse Event|0|||
130818298|NCT02921256|470964718|FG000|Arm 1a v. Arm II|Death|0|||
130818299|NCT02921256|470964719|FG001|Arm 1a v. Arm II|Death|2|||
130818300|NCT02921256|470964720|FG002|Arm 1a v. Arm II|Death|0|||
130818301|NCT02921256|470964718|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
130818302|NCT02921256|470964719|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
130818303|NCT02921256|470964720|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
130818304|NCT02921256|470964718|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
130818305|NCT02921256|470964719|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
130818306|NCT02921256|470964720|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
130818307|NCT02921256|470964718|FG000|Arm 1a v. Arm II|Physician Decision|1|||
130818308|NCT02921256|470964719|FG001|Arm 1a v. Arm II|Physician Decision|1|||
130818309|NCT02921256|470964720|FG002|Arm 1a v. Arm II|Physician Decision|0|||
130818310|NCT02921256|470964718|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
130818311|NCT02921256|470964719|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
130818312|NCT02921256|470964720|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
130818313|NCT02921256|470964718|FG000|Arm Ib v Arm III|Adverse Event|9|||
130818314|NCT02921256|470964719|FG001|Arm Ib v Arm III|Adverse Event|0|||
130818315|NCT02921256|470964720|FG002|Arm Ib v Arm III|Adverse Event|4|||
130818316|NCT02921256|470964718|FG000|Arm Ib v Arm III|Death|1|||
130818317|NCT02921256|470964719|FG001|Arm Ib v Arm III|Death|0|||
130818318|NCT02921256|470964720|FG002|Arm Ib v Arm III|Death|1|||
130818319|NCT02921256|470964718|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
130818320|NCT02921256|470964719|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
130818321|NCT02921256|470964720|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
130818322|NCT02921256|470964718|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
130818323|NCT02921256|470964719|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
130818324|NCT02921256|470964720|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
130818325|NCT02921256|470964718|FG000|Arm Ib v Arm III|Physician Decision|4|||
130818326|NCT02921256|470964719|FG001|Arm Ib v Arm III|Physician Decision|0|||
130818327|NCT02921256|470964720|FG002|Arm Ib v Arm III|Physician Decision|1|||
130818328|NCT02921256|470964718|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
130818329|NCT02921256|470964719|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
130818330|NCT02921256|470964720|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
130818331|NCT02943473|470964721|FG000|Overall Study|enrolled but not dosed|1|||
130818332|NCT02943473|470964721|FG000|Overall Study|screen failure|1|||
130818333|NCT02943473|470964721|FG000|Overall Study|Physician Decision|4|||
130818334|NCT04211363|470964724|FG000|Overall Study|Adverse Event|5|||
130818335|NCT04211363|470964725|FG001|Overall Study|Adverse Event|2|||
130818336|NCT04211363|470964724|FG000|Overall Study|Physician Decision|0|||
130818337|NCT04211363|470964725|FG001|Overall Study|Physician Decision|1|||
130818338|NCT04211363|470964724|FG000|Overall Study|Protocol Violation|1|||
130818339|NCT04211363|470964725|FG001|Overall Study|Protocol Violation|0|||
130818340|NCT04211363|470964724|FG000|Overall Study|Pregnancy|1|||
130818341|NCT04211363|470964725|FG001|Overall Study|Pregnancy|0|||
130818342|NCT04211363|470964724|FG000|Overall Study|Lost to Follow-up|12|||
130818343|NCT04211363|470964725|FG001|Overall Study|Lost to Follow-up|4|||
130818344|NCT04211363|470964724|FG000|Overall Study|Withdrawal by Subject|11|||
130818345|NCT04211363|470964725|FG001|Overall Study|Withdrawal by Subject|11|||
130818346|NCT04211363|470964724|FG000|Overall Study|Other|1|||
130818347|NCT04211363|470964725|FG001|Overall Study|Other|2|||
130818348|NCT03097289|470964726|FG000|Overall Study|Adverse Event|1|||
130818349|NCT03097289|470964726|FG000|Overall Study|Equipment failure|2|||
130818350|NCT03097289|470964726|FG000|Overall Study|Collected platelet product unusable|3|||
130818351|NCT01823289|470964727|FG000|Overall Study|Lost to Follow-up|5|||
130818352|NCT01823289|470964727|FG000|Overall Study|Adverse Event|5|||
130818353|NCT01823289|470964727|FG000|Overall Study|Lack of Efficacy|1|||
130818354|NCT01823289|470964727|FG000|Overall Study|Physician Decision|9|||
130818355|NCT01823289|470964727|FG000|Overall Study|Administered contraindicated medicine|1|||
130818356|NCT01823289|470964727|FG000|Overall Study|Transaminase increased more than 3 times|1|||
130818357|NCT01823289|470964727|FG000|Overall Study|Drug affected efficacy and safety|1|||
130818358|NCT01823289|470964727|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
130818359|NCT01736917|470964732|FG000|Overall Study|Adverse Event|1|||
130818360|NCT01736917|470964732|FG000|Overall Study|Protocol Violation|10|||
130818361|NCT01911260|470964733|FG000|Supplementation Period|transference or evasion of school|7|||
130818362|NCT01911260|470964734|FG001|Supplementation Period|transference or evasion of school|9|||
130818363|NCT01911260|470964735|FG002|Supplementation Period|transference or evasion of school|7|||
130818364|NCT01911260|470964736|FG003|Supplementation Period|transference or evasion of school|6|||
130818365|NCT01911260|470964733|FG000|Supplementation Period|Adverse Event|2|||
130818366|NCT01911260|470964734|FG001|Supplementation Period|Adverse Event|0|||
130818367|NCT01911260|470964735|FG002|Supplementation Period|Adverse Event|1|||
130818368|NCT01911260|470964736|FG003|Supplementation Period|Adverse Event|0|||
130818369|NCT01911260|470964733|FG000|Supplementation Period|refused to receive supplement|1|||
130818370|NCT01911260|470964734|FG001|Supplementation Period|refused to receive supplement|0|||
130818371|NCT01911260|470964735|FG002|Supplementation Period|refused to receive supplement|1|||
130818372|NCT01911260|470964736|FG003|Supplementation Period|refused to receive supplement|0|||
130818373|NCT01911260|470964733|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
130818374|NCT01911260|470964734|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
130818375|NCT01911260|470964735|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
130818376|NCT01911260|470964736|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
130818377|NCT01911260|470964733|FG000|Follow-up Period|transference or evasion of school|13|||
130818378|NCT01911260|470964734|FG001|Follow-up Period|transference or evasion of school|20|||
130818379|NCT01911260|470964735|FG002|Follow-up Period|transference or evasion of school|15|||
130818380|NCT01911260|470964736|FG003|Follow-up Period|transference or evasion of school|12|||
130818381|NCT01734902|470964744|FG000|Overall Study|Other than listed|0|||
130818382|NCT01734902|470964745|FG001|Overall Study|Other than listed|2|||
130818383|NCT00060944|470964746|FG000|Overall Study|Adverse Event|12|||
130818384|NCT00060944|470964747|FG001|Overall Study|Adverse Event|10|||
130818385|NCT00060944|470964746|FG000|Overall Study|Death|2|||
130818386|NCT00060944|470964747|FG001|Overall Study|Death|3|||
130818387|NCT00060944|470964746|FG000|Overall Study|Withdrawal by Subject|18|||
130818388|NCT00060944|470964747|FG001|Overall Study|Withdrawal by Subject|5|||
130818389|NCT00060944|470964746|FG000|Overall Study|Disease Progression|93|||
130818390|NCT00060944|470964747|FG001|Overall Study|Disease Progression|94|||
130818391|NCT00060944|470964746|FG000|Overall Study|Lost to Follow-up|1|||
130818392|NCT00060944|470964747|FG001|Overall Study|Lost to Follow-up|0|||
130818393|NCT00060944|470964746|FG000|Overall Study|Subject Ineligible To Continue|2|||
130818394|NCT00060944|470964747|FG001|Overall Study|Subject Ineligible To Continue|1|||
130818395|NCT00060944|470964746|FG000|Overall Study|Treatment Switch|0|||
130818396|NCT00060944|470964747|FG001|Overall Study|Treatment Switch|13|||
130818397|NCT00060944|470964746|FG000|Overall Study|Other|2|||
130818398|NCT00060944|470964747|FG001|Overall Study|Other|4|||
130818399|NCT00060944|470964746|FG000|Overall Study|randomized but not treated|6|||
130818400|NCT00060944|470964747|FG001|Overall Study|randomized but not treated|4|||
130818401|NCT04549454|470964749|FG000|T1 to T2|Lost to Follow-up|22|||
130818402|NCT04549454|470964750|FG001|T1 to T2|Lost to Follow-up|26|||
130818403|NCT04549454|470964749|FG000|T1 to T3|Lost to Follow-up|31|||
130818404|NCT04549454|470964750|FG001|T1 to T3|Lost to Follow-up|36|||
130818405|NCT00867035|470964751|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
130818406|NCT00867035|470964752|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
130818407|NCT00867035|470964751|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
130818408|NCT00867035|470964752|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
130818409|NCT00016354|470964753|FG000|Overall Study|Lack of Efficacy|0|||
130818410|NCT00016354|470964754|FG001|Overall Study|Lack of Efficacy|0|||
130818411|NCT00016354|470964755|FG002|Overall Study|Lack of Efficacy|0|||
130818412|NCT00016354|470964756|FG003|Overall Study|Lack of Efficacy|0|||
130818413|NCT00016354|470964757|FG004|Overall Study|Lack of Efficacy|0|||
130818414|NCT00016354|470964758|FG005|Overall Study|Lack of Efficacy|0|||
130818415|NCT00016354|470964759|FG006|Overall Study|Lack of Efficacy|0|||
130818416|NCT00016354|470964760|FG007|Overall Study|Lack of Efficacy|1|||
130818417|NCT03110562|470964761|FG000|Initial Treatment Period|Disease Progression|1|||
130818418|NCT03110562|470964762|FG001|Initial Treatment Period|Disease Progression|1|||
130818419|NCT03110562|470964763|FG002|Initial Treatment Period|Disease Progression|0|||
130818420|NCT03110562|470964764|FG003|Initial Treatment Period|Disease Progression|0|||
130818421|NCT03110562|470964761|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
130818422|NCT03110562|470964762|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
130818423|NCT03110562|470964763|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
130818424|NCT03110562|470964764|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
130818425|NCT03110562|470964761|FG000|Initial Treatment Period|Adverse Event|1|||
130818426|NCT03110562|470964762|FG001|Initial Treatment Period|Adverse Event|0|||
130818427|NCT03110562|470964763|FG002|Initial Treatment Period|Adverse Event|0|||
130818428|NCT03110562|470964764|FG003|Initial Treatment Period|Adverse Event|0|||
130818429|NCT03110562|470964761|FG000|Initial Treatment Period|Death|74|||
130818430|NCT03110562|470964762|FG001|Initial Treatment Period|Death|82|||
130818431|NCT03110562|470964763|FG002|Initial Treatment Period|Death|0|||
130818432|NCT03110562|470964764|FG003|Initial Treatment Period|Death|0|||
130818433|NCT03110562|470964761|FG000|Initial Treatment Period|Lost to Follow-up|13|||
130818434|NCT03110562|470964762|FG001|Initial Treatment Period|Lost to Follow-up|8|||
130818435|NCT03110562|470964763|FG002|Initial Treatment Period|Lost to Follow-up|0|||
130818436|NCT03110562|470964764|FG003|Initial Treatment Period|Lost to Follow-up|0|||
130818437|NCT03110562|470964761|FG000|Initial Treatment Period|Protocol Deviation|1|||
130818438|NCT03110562|470964762|FG001|Initial Treatment Period|Protocol Deviation|0|||
130818439|NCT03110562|470964763|FG002|Initial Treatment Period|Protocol Deviation|0|||
130818440|NCT03110562|470964764|FG003|Initial Treatment Period|Protocol Deviation|0|||
130818441|NCT03110562|470964761|FG000|Initial Treatment Period|Physician Decision|2|||
130818442|NCT03110562|470964762|FG001|Initial Treatment Period|Physician Decision|1|||
130818443|NCT03110562|470964763|FG002|Initial Treatment Period|Physician Decision|0|||
130818444|NCT03110562|470964764|FG003|Initial Treatment Period|Physician Decision|0|||
130818445|NCT03110562|470964761|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
130818446|NCT03110562|470964762|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
130818447|NCT03110562|470964763|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
130818448|NCT03110562|470964764|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
130818449|NCT03110562|470964761|FG000|Initial Treatment Period|Other|5|||
130818450|NCT03110562|470964762|FG001|Initial Treatment Period|Other|4|||
130818451|NCT03110562|470964763|FG002|Initial Treatment Period|Other|0|||
130818452|NCT03110562|470964764|FG003|Initial Treatment Period|Other|0|||
130818453|NCT03110562|470964761|FG000|Initial Treatment Period|Randomized but never treated|0|||
130818454|NCT03110562|470964762|FG001|Initial Treatment Period|Randomized but never treated|3|||
130818455|NCT03110562|470964763|FG002|Initial Treatment Period|Randomized but never treated|0|||
130818456|NCT03110562|470964764|FG003|Initial Treatment Period|Randomized but never treated|0|||
130818457|NCT03110562|470964761|FG000|Crossover Period|Disease Progression|0|||
130818458|NCT03110562|470964762|FG001|Crossover Period|Disease Progression|0|||
130818459|NCT03110562|470964763|FG002|Crossover Period|Disease Progression|1|||
130818460|NCT03110562|470964764|FG003|Crossover Period|Disease Progression|0|||
130818461|NCT03110562|470964761|FG000|Crossover Period|Withdrawal by Subject|0|||
130818462|NCT03110562|470964762|FG001|Crossover Period|Withdrawal by Subject|0|||
130818463|NCT03110562|470964763|FG002|Crossover Period|Withdrawal by Subject|8|||
130818464|NCT03110562|470964764|FG003|Crossover Period|Withdrawal by Subject|6|||
130818465|NCT03110562|470964761|FG000|Crossover Period|Death|0|||
130818466|NCT03110562|470964762|FG001|Crossover Period|Death|0|||
130818467|NCT03110562|470964763|FG002|Crossover Period|Death|37|||
130818468|NCT03110562|470964764|FG003|Crossover Period|Death|3|||
130818469|NCT03110562|470964761|FG000|Crossover Period|Lost to Follow-up|0|||
130818470|NCT03110562|470964762|FG001|Crossover Period|Lost to Follow-up|0|||
130818471|NCT03110562|470964763|FG002|Crossover Period|Lost to Follow-up|0|||
130818472|NCT03110562|470964764|FG003|Crossover Period|Lost to Follow-up|1|||
130818473|NCT03110562|470964761|FG000|Crossover Period|Other|0|||
130818474|NCT03110562|470964762|FG001|Crossover Period|Other|0|||
130818475|NCT03110562|470964763|FG002|Crossover Period|Other|1|||
130818476|NCT03110562|470964764|FG003|Crossover Period|Other|1|||
130818477|NCT03110562|470964761|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
130818478|NCT03110562|470964762|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
130818479|NCT03110562|470964763|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
130818480|NCT03110562|470964764|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
130818481|NCT02936323|470964767|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130818482|NCT02936323|470964768|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130818483|NCT02936323|470964769|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130818484|NCT02936323|470964770|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130818485|NCT02936323|470964771|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130818486|NCT02936323|470964772|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130818487|NCT02936323|470964773|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130818488|NCT02936323|470964774|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130818489|NCT02936323|470964775|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130818490|NCT02936323|470964776|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130818491|NCT02936323|470964767|FG000|Phase 1 Dose Escalation|Death|2|||
130818492|NCT02936323|470964768|FG001|Phase 1 Dose Escalation|Death|1|||
130818493|NCT02936323|470964769|FG002|Phase 1 Dose Escalation|Death|3|||
130818494|NCT02936323|470964770|FG003|Phase 1 Dose Escalation|Death|1|||
130818495|NCT02936323|470964771|FG004|Phase 1 Dose Escalation|Death|2|||
130818496|NCT02936323|470964772|FG005|Phase 1 Dose Escalation|Death|3|||
130818497|NCT02936323|470964773|FG006|Phase 1 Dose Escalation|Death|3|||
130818498|NCT02936323|470964774|FG007|Phase 1 Dose Escalation|Death|0|||
130818499|NCT02936323|470964775|FG008|Phase 1 Dose Escalation|Death|0|||
130818500|NCT02936323|470964776|FG009|Phase 1 Dose Escalation|Death|0|||
130818501|NCT02936323|470964767|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130818502|NCT02936323|470964768|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130818503|NCT02936323|470964769|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130818504|NCT02936323|470964770|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130818505|NCT02936323|470964771|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130818506|NCT02936323|470964772|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
130818507|NCT02936323|470964773|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130818508|NCT02936323|470964774|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130818509|NCT02936323|470964775|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130818510|NCT02936323|470964776|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130818511|NCT02936323|470964767|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130818512|NCT02936323|470964768|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130818513|NCT02936323|470964769|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130818514|NCT02936323|470964770|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130818515|NCT02936323|470964771|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130818516|NCT02936323|470964772|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130818517|NCT02936323|470964773|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130818518|NCT02936323|470964774|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
130818519|NCT02936323|470964775|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
130818520|NCT02936323|470964776|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
130818521|NCT02936323|470964767|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
130818522|NCT02936323|470964768|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
130818523|NCT02936323|470964769|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
130818524|NCT02936323|470964770|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
130818525|NCT02936323|470964771|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
130818526|NCT02936323|470964772|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
130818527|NCT02936323|470964773|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
130818528|NCT02936323|470964774|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
130818529|NCT02936323|470964775|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
130818530|NCT02936323|470964776|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
130818531|NCT02936323|470964767|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130818532|NCT02936323|470964768|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130818533|NCT02936323|470964769|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130818534|NCT02936323|470964770|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130818535|NCT02936323|470964771|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130818536|NCT02936323|470964772|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130818537|NCT02936323|470964773|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130818538|NCT02936323|470964774|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
130818539|NCT02936323|470964775|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
130818540|NCT02936323|470964776|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130818541|NCT02936323|470964767|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130818542|NCT02936323|470964768|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130818543|NCT02936323|470964769|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130818544|NCT02936323|470964770|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130818545|NCT02936323|470964771|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130818546|NCT02936323|470964772|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130818547|NCT02936323|470964773|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130818548|NCT02936323|470964774|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130818549|NCT02936323|470964775|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130818550|NCT02936323|470964776|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
130818551|NCT02936323|470964767|FG000|Phase 2a Dose Expansion|Death|0|||
130818552|NCT02936323|470964768|FG001|Phase 2a Dose Expansion|Death|0|||
130818553|NCT02936323|470964769|FG002|Phase 2a Dose Expansion|Death|0|||
130818554|NCT02936323|470964770|FG003|Phase 2a Dose Expansion|Death|0|||
130818555|NCT02936323|470964771|FG004|Phase 2a Dose Expansion|Death|0|||
130818556|NCT02936323|470964772|FG005|Phase 2a Dose Expansion|Death|0|||
130818557|NCT02936323|470964773|FG006|Phase 2a Dose Expansion|Death|0|||
130818558|NCT02936323|470964774|FG007|Phase 2a Dose Expansion|Death|4|||
130818559|NCT02936323|470964775|FG008|Phase 2a Dose Expansion|Death|8|||
130818560|NCT02936323|470964776|FG009|Phase 2a Dose Expansion|Death|10|||
130818561|NCT00805389|470966092|FG000|Overall Study|Adverse Event|0|||
130818562|NCT00805389|470966093|FG001|Overall Study|Adverse Event|0|||
130818563|NCT00805389|470966094|FG002|Overall Study|Adverse Event|1|||
130818564|NCT00805389|470966095|FG003|Overall Study|Adverse Event|2|||
130818565|NCT00805389|470966096|FG004|Overall Study|Adverse Event|0|||
130818566|NCT00805389|470966092|FG000|Overall Study|Lost to Follow-up|4|||
130818567|NCT00805389|470966093|FG001|Overall Study|Lost to Follow-up|3|||
130818568|NCT00805389|470966094|FG002|Overall Study|Lost to Follow-up|6|||
130818569|NCT00805389|470966095|FG003|Overall Study|Lost to Follow-up|10|||
130818570|NCT00805389|470966096|FG004|Overall Study|Lost to Follow-up|9|||
130818571|NCT00805389|470966092|FG000|Overall Study|Protocol Violation|0|||
130818572|NCT00805389|470966093|FG001|Overall Study|Protocol Violation|0|||
130818573|NCT00805389|470966094|FG002|Overall Study|Protocol Violation|1|||
130818574|NCT00805389|470966095|FG003|Overall Study|Protocol Violation|0|||
130818575|NCT00805389|470966096|FG004|Overall Study|Protocol Violation|0|||
130818576|NCT00805389|470966092|FG000|Overall Study|Withdrawal by Subject|3|||
130818577|NCT00805389|470966093|FG001|Overall Study|Withdrawal by Subject|2|||
130818578|NCT00805389|470966094|FG002|Overall Study|Withdrawal by Subject|4|||
130818579|NCT00805389|470966095|FG003|Overall Study|Withdrawal by Subject|5|||
130818580|NCT00805389|470966096|FG004|Overall Study|Withdrawal by Subject|4|||
130818581|NCT03984825|470966099|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
130818582|NCT03984825|470966099|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
130818583|NCT03984825|470966099|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
130818584|NCT00976456|470966102|FG000|Overall Study|Adverse Event|17|||
130818585|NCT00976456|470966103|FG001|Overall Study|Adverse Event|22|||
130818586|NCT00976456|470966102|FG000|Overall Study|Death|7|||
130818587|NCT00976456|470966103|FG001|Overall Study|Death|9|||
130818588|NCT00976456|470966102|FG000|Overall Study|Lack of Efficacy|5|||
130818589|NCT00976456|470966103|FG001|Overall Study|Lack of Efficacy|2|||
130818590|NCT00976456|470966102|FG000|Overall Study|Withdrawal by Subject|3|||
130818591|NCT00976456|470966103|FG001|Overall Study|Withdrawal by Subject|1|||
130818592|NCT00976456|470966102|FG000|Overall Study|screening failure, unknown|11|||
130818593|NCT00976456|470966103|FG001|Overall Study|screening failure, unknown|4|||
130818594|NCT02735200|470966106|FG000|Overall Study|Lost to Follow-up|0|||
130818595|NCT02735200|470966107|FG001|Overall Study|Lost to Follow-up|5|||
130818596|NCT02735200|470966106|FG000|Overall Study|Withdrawal by Subject|8|||
130818597|NCT02735200|470966107|FG001|Overall Study|Withdrawal by Subject|0|||
130818598|NCT02493764|470966110|FG000|Overall Study|Adverse Event|2|||
130818599|NCT02493764|470966111|FG001|Overall Study|Adverse Event|2|||
130818600|NCT02493764|470966110|FG000|Overall Study|Death|44|||
130818601|NCT02493764|470966111|FG001|Overall Study|Death|58|||
130818602|NCT02493764|470966110|FG000|Overall Study|Lost to Follow-up|2|||
130818603|NCT02493764|470966111|FG001|Overall Study|Lost to Follow-up|1|||
130818604|NCT02493764|470966110|FG000|Overall Study|Protocol Violation|6|||
130818605|NCT02493764|470966111|FG001|Overall Study|Protocol Violation|7|||
130818606|NCT02493764|470966110|FG000|Overall Study|Physician Decision|1|||
130818607|NCT02493764|470966111|FG001|Overall Study|Physician Decision|1|||
130818608|NCT02493764|470966110|FG000|Overall Study|Participant moved|17|||
130818609|NCT02493764|470966111|FG001|Overall Study|Participant moved|5|||
130818610|NCT02493764|470966110|FG000|Overall Study|Withdrawal parent/guardian|0|||
130818611|NCT02493764|470966111|FG001|Overall Study|Withdrawal parent/guardian|1|||
130818612|NCT02493764|470966110|FG000|Overall Study|Withdrawal by Subject|11|||
130818613|NCT02493764|470966111|FG001|Overall Study|Withdrawal by Subject|7|||
130818614|NCT01561976|470966112|FG000|Period 1|Adverse Event|0|||
130818615|NCT01561976|470966113|FG001|Period 1|Adverse Event|0|||
130818616|NCT01561976|470966114|FG002|Period 1|Adverse Event|1|||
130818617|NCT01561976|470966115|FG003|Period 1|Adverse Event|0|||
130818618|NCT01561976|470966116|FG004|Period 1|Adverse Event|0|||
130818619|NCT01561976|470966117|FG005|Period 1|Adverse Event|0|||
130818620|NCT01561976|470966112|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
130818621|NCT01561976|470966113|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
130818622|NCT01561976|470966114|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
130818623|NCT01561976|470966115|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
130818624|NCT01561976|470966116|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
130818625|NCT01561976|470966117|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
130818626|NCT01561976|470966112|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130818627|NCT01561976|470966113|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130818628|NCT01561976|470966114|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130818629|NCT01561976|470966115|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130818630|NCT01561976|470966116|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130818631|NCT01561976|470966117|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130818632|NCT01561976|470966112|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
130818633|NCT01561976|470966113|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
130818634|NCT01561976|470966114|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
130818635|NCT01561976|470966115|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
130818636|NCT01561976|470966116|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
130818637|NCT01561976|470966117|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
130818638|NCT05136170|470966118|FG000|Overall Study|Withdrawal by Subject|2|||
130818639|NCT05136170|470966119|FG001|Overall Study|Withdrawal by Subject|2|||
130818640|NCT05136170|470966118|FG000|Overall Study|Can no longer make office visits|1|||
130818641|NCT05136170|470966119|FG001|Overall Study|Can no longer make office visits|0|||
130818642|NCT01463527|470966120|FG000|Overall Study|Protocol Violation|1|||
130818643|NCT01463527|470966121|FG001|Overall Study|Protocol Violation|1|||
130818644|NCT01463527|470966120|FG000|Overall Study|Crying >20% of sedation|5|||
130818645|NCT01463527|470966121|FG001|Overall Study|Crying >20% of sedation|6|||
130818646|NCT01493414|470966124|FG000|Overall Study|Adverse Event|405|||
130818647|NCT01493414|470966124|FG000|Overall Study|Disease progression|204|||
130818648|NCT01493414|470966124|FG000|Overall Study|Death|101|||
130818649|NCT01493414|470966124|FG000|Overall Study|Physician Decision|93|||
130818650|NCT01493414|470966124|FG000|Overall Study|Withdrawal by Subject|79|||
130818651|NCT01493414|470966124|FG000|Overall Study|Protocol deviation|27|||
130818652|NCT01493414|470966124|FG000|Overall Study|Administrative problems|25|||
130818653|NCT01493414|470966124|FG000|Overall Study|Lost to Follow-up|16|||
130818654|NCT01977222|470966129|FG000|Overall Study|Withdrawal by Subject|1|||
130818655|NCT04403919|470966132|FG000|Overall Study|Lost to Follow-up|0|||
130818656|NCT04403919|470966133|FG001|Overall Study|Lost to Follow-up|0|||
130818657|NCT04403919|470966134|FG002|Overall Study|Lost to Follow-up|0|||
130818658|NCT04403919|470966135|FG003|Overall Study|Lost to Follow-up|1|||
130818659|NCT01612676|470966136|FG000|Overall Study|Adverse Event|2|||
130818660|NCT01612676|470966137|FG001|Overall Study|Adverse Event|3|||
130818661|NCT01612676|470966138|FG002|Overall Study|Adverse Event|1|||
130818662|NCT01612676|470966139|FG003|Overall Study|Adverse Event|3|||
130818663|NCT01612676|470966136|FG000|Overall Study|Protocol Violation|0|||
130818664|NCT01612676|470966137|FG001|Overall Study|Protocol Violation|1|||
130818665|NCT01612676|470966138|FG002|Overall Study|Protocol Violation|0|||
130818666|NCT01612676|470966139|FG003|Overall Study|Protocol Violation|0|||
130818667|NCT01156844|470966142|FG000|Overall Study|Adverse Event|0|||
130818668|NCT01156844|470966143|FG001|Overall Study|Adverse Event|0|||
130818669|NCT01156844|470966144|FG002|Overall Study|Adverse Event|1|||
130818670|NCT01156844|470966145|FG003|Overall Study|Adverse Event|1|||
130818671|NCT01156844|470966142|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130818672|NCT01156844|470966143|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130818673|NCT01156844|470966144|FG002|Overall Study|Abnormal test procedure result(s)|2|||
130818674|NCT01156844|470966145|FG003|Overall Study|Abnormal test procedure result(s)|2|||
130818675|NCT01156844|470966142|FG000|Overall Study|Withdrawal by Subject|0|||
130818676|NCT01156844|470966143|FG001|Overall Study|Withdrawal by Subject|0|||
130818677|NCT01156844|470966144|FG002|Overall Study|Withdrawal by Subject|2|||
130818678|NCT01156844|470966145|FG003|Overall Study|Withdrawal by Subject|2|||
130818679|NCT01156844|470966142|FG000|Overall Study|Lost to Follow-up|0|||
130818680|NCT01156844|470966143|FG001|Overall Study|Lost to Follow-up|0|||
130818681|NCT01156844|470966144|FG002|Overall Study|Lost to Follow-up|1|||
130818682|NCT01156844|470966145|FG003|Overall Study|Lost to Follow-up|0|||
130818683|NCT01156844|470966142|FG000|Overall Study|Administrative problems|0|||
130818684|NCT01156844|470966143|FG001|Overall Study|Administrative problems|1|||
130818685|NCT01156844|470966144|FG002|Overall Study|Administrative problems|0|||
130818686|NCT01156844|470966145|FG003|Overall Study|Administrative problems|1|||
130818687|NCT01156844|470966142|FG000|Overall Study|Protocol deviation|2|||
130818688|NCT01156844|470966143|FG001|Overall Study|Protocol deviation|0|||
130818689|NCT01156844|470966144|FG002|Overall Study|Protocol deviation|0|||
130818690|NCT01156844|470966145|FG003|Overall Study|Protocol deviation|0|||
130818691|NCT00107276|470966149|FG000|Overall Study|Progression|46|||
130818692|NCT00107276|470966149|FG000|Overall Study|Adverse Event|6|||
130818693|NCT00107276|470966149|FG000|Overall Study|M.D. decision|2|||
130818694|NCT00107276|470966149|FG000|Overall Study|Patient refusal|1|||
130818695|NCT00107276|470966149|FG000|Overall Study|Death|1|||
130818696|NCT00107276|470966149|FG000|Overall Study|Ineligible|16|||
130818697|NCT04846231|470966150|FG000|Overall Study|Lost to Follow-up|1|||
130818698|NCT04846231|470966151|FG001|Overall Study|Lost to Follow-up|0|||
130818699|NCT04846231|470966152|FG002|Overall Study|Lost to Follow-up|0|||
130818700|NCT04846231|470966153|FG003|Overall Study|Lost to Follow-up|0|||
130818701|NCT04846231|470966154|FG004|Overall Study|Lost to Follow-up|0|||
130818702|NCT04846231|470966155|FG005|Overall Study|Lost to Follow-up|0|||
130818703|NCT04846231|470966156|FG006|Overall Study|Lost to Follow-up|0|||
130818704|NCT04846231|470966157|FG007|Overall Study|Lost to Follow-up|1|||
130818705|NCT04846231|470966150|FG000|Overall Study|Withdrawal by Subject|0|||
130818706|NCT04846231|470966151|FG001|Overall Study|Withdrawal by Subject|1|||
130818707|NCT04846231|470966152|FG002|Overall Study|Withdrawal by Subject|2|||
130818708|NCT04846231|470966153|FG003|Overall Study|Withdrawal by Subject|1|||
130818709|NCT04846231|470966154|FG004|Overall Study|Withdrawal by Subject|0|||
130818710|NCT04846231|470966155|FG005|Overall Study|Withdrawal by Subject|0|||
130818711|NCT04846231|470966156|FG006|Overall Study|Withdrawal by Subject|0|||
130818712|NCT04846231|470966157|FG007|Overall Study|Withdrawal by Subject|0|||
130818713|NCT04846231|470966150|FG000|Overall Study|Protocol Violation|0|||
130818714|NCT04846231|470966151|FG001|Overall Study|Protocol Violation|1|||
130818715|NCT04846231|470966152|FG002|Overall Study|Protocol Violation|0|||
130818716|NCT04846231|470966153|FG003|Overall Study|Protocol Violation|0|||
130818717|NCT04846231|470966154|FG004|Overall Study|Protocol Violation|0|||
130818718|NCT04846231|470966155|FG005|Overall Study|Protocol Violation|0|||
130818719|NCT04846231|470966156|FG006|Overall Study|Protocol Violation|0|||
130818720|NCT04846231|470966157|FG007|Overall Study|Protocol Violation|0|||
130818721|NCT04846231|470966150|FG000|Overall Study|Adverse Event|0|||
130818722|NCT04846231|470966151|FG001|Overall Study|Adverse Event|0|||
130818723|NCT04846231|470966152|FG002|Overall Study|Adverse Event|0|||
130818724|NCT04846231|470966153|FG003|Overall Study|Adverse Event|0|||
130818725|NCT04846231|470966154|FG004|Overall Study|Adverse Event|0|||
130818726|NCT04846231|470966155|FG005|Overall Study|Adverse Event|0|||
130818727|NCT04846231|470966156|FG006|Overall Study|Adverse Event|1|||
130818728|NCT04846231|470966157|FG007|Overall Study|Adverse Event|1|||
130818729|NCT02980107|470966158|FG000|Overall Study|Withdrawal by Subject|51|||
130818730|NCT02980107|470966159|FG001|Overall Study|Withdrawal by Subject|62|||
130818731|NCT00945659|470966160|FG000|Overall Study|Lost to Follow-up|7|||
130818732|NCT00945659|470966161|FG001|Overall Study|Lost to Follow-up|20|||
130818733|NCT00945659|470966162|FG002|Overall Study|Lost to Follow-up|17|||
130818734|NCT04562116|470966163|FG000|Overall Study|Lost to Follow-up|1|||
130818735|NCT04562116|470966163|FG000|Overall Study|Withdrawal by Subject|3|||
130818736|NCT00776230|470966168|FG000|Overall Study|Lost to Follow-up|2|||
130818737|NCT00776230|470966169|FG001|Overall Study|Lost to Follow-up|1|||
130818738|NCT00776230|470966170|FG002|Overall Study|Lost to Follow-up|5|||
130818739|NCT00776230|470966168|FG000|Overall Study|Not vaccinated at Day 0|1|||
130818740|NCT00776230|470966169|FG001|Overall Study|Not vaccinated at Day 0|0|||
130818741|NCT00776230|470966170|FG002|Overall Study|Not vaccinated at Day 0|0|||
130818742|NCT00776230|470966168|FG000|Overall Study|Withdrawal by Subject|0|||
130818743|NCT00776230|470966169|FG001|Overall Study|Withdrawal by Subject|1|||
130818744|NCT00776230|470966170|FG002|Overall Study|Withdrawal by Subject|0|||
130818745|NCT00776230|470966168|FG000|Overall Study|Subject missed Visit 4|0|||
130818746|NCT00776230|470966169|FG001|Overall Study|Subject missed Visit 4|1|||
130818747|NCT00776230|470966170|FG002|Overall Study|Subject missed Visit 4|0|||
130818748|NCT00746811|470966171|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
130818749|NCT00746811|470966172|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
130818750|NCT03213509|470966173|FG000|Overall Study|Did not consent for verbal autopsy|4|||
130818751|NCT03213509|470966174|FG001|Overall Study|Did not consent for verbal autopsy|5|||
130818752|NCT00545779|470966179|FG000|Overall Study|Violation of selection criteria at entry|8|||
130818753|NCT00545779|470966179|FG000|Overall Study|Other protocol violation|1|||
130818754|NCT00545779|470966179|FG000|Overall Study|Did not cooperate|7|||
130818755|NCT00545779|470966179|FG000|Overall Study|Withdrawal by Subject|20|||
130818756|NCT00545779|470966179|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
130818757|NCT00545779|470966179|FG000|Overall Study|Failure to return|3|||
130818758|NCT00829998|470966180|FG000|Washout|Adverse Event|0|||
130818759|NCT00829998|470966181|FG001|Washout|Adverse Event|1|||
130818760|NCT05788991|470966182|FG000|Overall Study|Not treated with study medication|1|||
130818761|NCT05788991|470966183|FG001|Overall Study|Not treated with study medication|3|||
130818762|NCT05788991|470966182|FG000|Overall Study|Withdrawal by Subject|1|||
130818763|NCT05788991|470966183|FG001|Overall Study|Withdrawal by Subject|0|||
130818764|NCT05788991|470966182|FG000|Overall Study|Lack of Efficacy|0|||
130818765|NCT05788991|470966183|FG001|Overall Study|Lack of Efficacy|1|||
130818766|NCT05788991|470966182|FG000|Overall Study|Protocol Violation|1|||
130818767|NCT05788991|470966183|FG001|Overall Study|Protocol Violation|2|||
130818768|NCT05270863|470966184|FG000|Visit 2 First Intervention|Randomization error|0|||
130818769|NCT05270863|470966185|FG001|Visit 2 First Intervention|Randomization error|0|||
130818770|NCT05270863|470966186|FG002|Visit 2 First Intervention|Randomization error|0|||
130818771|NCT05270863|470966187|FG003|Visit 2 First Intervention|Randomization error|1|||
130818772|NCT05270863|470966188|FG004|Visit 2 First Intervention|Randomization error|0|||
130818773|NCT05270863|470966189|FG005|Visit 2 First Intervention|Randomization error|0|||
130818774|NCT05270863|470966184|FG000|First Washout|Withdrawal by Subject|0|||
130818775|NCT05270863|470966185|FG001|First Washout|Withdrawal by Subject|0|||
130818776|NCT05270863|470966186|FG002|First Washout|Withdrawal by Subject|0|||
130818777|NCT05270863|470966187|FG003|First Washout|Withdrawal by Subject|0|||
130818778|NCT05270863|470966188|FG004|First Washout|Withdrawal by Subject|1|||
130818779|NCT05270863|470966189|FG005|First Washout|Withdrawal by Subject|1|||
130818780|NCT05270863|470966184|FG000|First Washout|Lost to Follow-up|0|||
130818781|NCT05270863|470966185|FG001|First Washout|Lost to Follow-up|0|||
130818782|NCT05270863|470966186|FG002|First Washout|Lost to Follow-up|0|||
130818783|NCT05270863|470966187|FG003|First Washout|Lost to Follow-up|0|||
130818784|NCT05270863|470966188|FG004|First Washout|Lost to Follow-up|0|||
130818785|NCT05270863|470966189|FG005|First Washout|Lost to Follow-up|1|||
130818786|NCT05270863|470966184|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
130818787|NCT05270863|470966185|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
130818788|NCT05270863|470966186|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
130818789|NCT05270863|470966187|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
130818790|NCT05270863|470966188|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
130818791|NCT05270863|470966189|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
130818792|NCT05270863|470966184|FG000|Second Washout|Withdrawal by Subject|1|||
130818793|NCT05270863|470966185|FG001|Second Washout|Withdrawal by Subject|1|||
130818794|NCT05270863|470966186|FG002|Second Washout|Withdrawal by Subject|0|||
130818795|NCT05270863|470966187|FG003|Second Washout|Withdrawal by Subject|0|||
130818796|NCT05270863|470966188|FG004|Second Washout|Withdrawal by Subject|0|||
130818797|NCT05270863|470966189|FG005|Second Washout|Withdrawal by Subject|0|||
130818798|NCT05270863|470966184|FG000|Second Washout|Lost to Follow-up|0|||
130818799|NCT05270863|470966185|FG001|Second Washout|Lost to Follow-up|0|||
130818800|NCT05270863|470966186|FG002|Second Washout|Lost to Follow-up|0|||
130818801|NCT05270863|470966187|FG003|Second Washout|Lost to Follow-up|1|||
130818802|NCT05270863|470966188|FG004|Second Washout|Lost to Follow-up|0|||
130818803|NCT05270863|470966189|FG005|Second Washout|Lost to Follow-up|0|||
130818804|NCT04464473|470966190|FG000|Overall Study|New piercing could not be removed for scanning|0|||
130818805|NCT04464473|470966191|FG001|Overall Study|New piercing could not be removed for scanning|0|||
130818806|NCT04464473|470966192|FG002|Overall Study|New piercing could not be removed for scanning|0|||
130818807|NCT04464473|470966193|FG003|Overall Study|New piercing could not be removed for scanning|1|||
130818808|NCT04464473|470966194|FG004|Overall Study|New piercing could not be removed for scanning|0|||
130818809|NCT04464473|470966195|FG005|Overall Study|New piercing could not be removed for scanning|0|||
130818810|NCT04464473|470966190|FG000|Overall Study|Adverse Event|0|||
130818811|NCT04464473|470966191|FG001|Overall Study|Adverse Event|0|||
130818812|NCT04464473|470966192|FG002|Overall Study|Adverse Event|0|||
130818813|NCT04464473|470966193|FG003|Overall Study|Adverse Event|1|||
130818814|NCT04464473|470966194|FG004|Overall Study|Adverse Event|0|||
130818815|NCT04464473|470966195|FG005|Overall Study|Adverse Event|0|||
130818816|NCT04464473|470966190|FG000|Overall Study|Lost to Follow-up|0|||
130818817|NCT04464473|470966191|FG001|Overall Study|Lost to Follow-up|0|||
130818818|NCT04464473|470966192|FG002|Overall Study|Lost to Follow-up|0|||
130818819|NCT04464473|470966193|FG003|Overall Study|Lost to Follow-up|1|||
130818820|NCT04464473|470966194|FG004|Overall Study|Lost to Follow-up|0|||
130818821|NCT04464473|470966195|FG005|Overall Study|Lost to Follow-up|0|||
130818822|NCT01334918|470967555|FG000|Overall Study|Did not receive study drug|6|||
130818823|NCT01334918|470967556|FG001|Overall Study|Did not receive study drug|0|||
130818824|NCT01334918|470967555|FG000|Overall Study|Adverse Event|2|||
130818825|NCT01334918|470967556|FG001|Overall Study|Adverse Event|0|||
130818826|NCT01334918|470967555|FG000|Overall Study|Withdrawal by Subject|0|||
130818827|NCT01334918|470967556|FG001|Overall Study|Withdrawal by Subject|1|||
130818828|NCT02114177|470967557|FG000|Overall Study|Lost to Follow-up|1|||
130818829|NCT02114177|470967558|FG001|Overall Study|Lost to Follow-up|2|||
130818830|NCT02114177|470967557|FG000|Overall Study|Withdrawal by Subject|6|||
130818831|NCT02114177|470967558|FG001|Overall Study|Withdrawal by Subject|1|||
130818832|NCT02114177|470967557|FG000|Overall Study|Other|2|||
130818833|NCT02114177|470967558|FG001|Overall Study|Other|1|||
130818834|NCT01585025|470967559|FG000|Overall Study|Withdrawal by Subject|0|||
130818835|NCT01585025|470967560|FG001|Overall Study|Withdrawal by Subject|3|||
130818836|NCT01585025|470967561|FG002|Overall Study|Withdrawal by Subject|4|||
130818837|NCT00503984|470967562|FG000|Overall Study|Protocol Violation|0|||
130818838|NCT00503984|470967563|FG001|Overall Study|Protocol Violation|1|||
130818839|NCT00503984|470967564|FG002|Overall Study|Protocol Violation|0|||
130818840|NCT00503984|470967565|FG003|Overall Study|Protocol Violation|0|||
130818841|NCT00503984|470967566|FG004|Overall Study|Protocol Violation|0|||
130818842|NCT00503984|470967567|FG005|Overall Study|Protocol Violation|0|||
130818843|NCT00503984|470967562|FG000|Overall Study|Adverse Event|0|||
130818844|NCT00503984|470967563|FG001|Overall Study|Adverse Event|1|||
130818845|NCT00503984|470967564|FG002|Overall Study|Adverse Event|0|||
130818846|NCT00503984|470967565|FG003|Overall Study|Adverse Event|0|||
130818847|NCT00503984|470967566|FG004|Overall Study|Adverse Event|0|||
130818848|NCT00503984|470967567|FG005|Overall Study|Adverse Event|0|||
130818849|NCT00503984|470967562|FG000|Overall Study|Death|0|||
130818850|NCT00503984|470967563|FG001|Overall Study|Death|0|||
130818851|NCT00503984|470967564|FG002|Overall Study|Death|0|||
130818852|NCT00503984|470967565|FG003|Overall Study|Death|0|||
130818853|NCT00503984|470967566|FG004|Overall Study|Death|1|||
130818854|NCT00503984|470967567|FG005|Overall Study|Death|0|||
130818855|NCT01246960|470967570|FG000|Overall Study|Lost to Follow-up|3|||
130818856|NCT01246960|470967571|FG001|Overall Study|Lost to Follow-up|1|||
130818857|NCT01246960|470967570|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
130818858|NCT01246960|470967571|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
130818859|NCT00140140|470967576|FG000|Overall Study|Unacceptable toxicity|1|||
130818860|NCT00140140|470967577|FG001|Overall Study|Unacceptable toxicity|1|||
130818861|NCT00140140|470967578|FG002|Overall Study|Unacceptable toxicity|2|||
130818862|NCT00140140|470967576|FG000|Overall Study|Physician Decision|1|||
130818863|NCT00140140|470967577|FG001|Overall Study|Physician Decision|1|||
130818864|NCT00140140|470967578|FG002|Overall Study|Physician Decision|0|||
130818865|NCT03376516|470967579|FG000|Overall Study|Not treated|1|||
130818866|NCT03376516|470967579|FG000|Overall Study|Consent withdrawn|1|||
130818867|NCT01359956|470967580|FG000|Overall Study|Death|58|||
130818868|NCT01359956|470967581|FG001|Overall Study|Death|60|||
130818869|NCT01359956|470967582|FG002|Overall Study|Death|66|||
130818870|NCT01359956|470967583|FG003|Overall Study|Death|57|||
130818871|NCT01359956|470967580|FG000|Overall Study|Lost to Follow-up|3|||
130818872|NCT01359956|470967581|FG001|Overall Study|Lost to Follow-up|4|||
130818873|NCT01359956|470967582|FG002|Overall Study|Lost to Follow-up|1|||
130818874|NCT01359956|470967583|FG003|Overall Study|Lost to Follow-up|1|||
130818875|NCT00582907|470967584|FG000|1st Course|Withdrawal by Subject|1|||
130818876|NCT00582907|470967585|FG001|1st Course|Withdrawal by Subject|0|||
130818877|NCT00582907|470967586|FG002|1st Course|Withdrawal by Subject|0|||
130818878|NCT00582907|470967587|FG003|1st Course|Withdrawal by Subject|0|||
130818879|NCT00582907|470967584|FG000|1st Course|Lost to Follow-up|0|||
130818880|NCT00582907|470967585|FG001|1st Course|Lost to Follow-up|0|||
130818881|NCT00582907|470967586|FG002|1st Course|Lost to Follow-up|0|||
130818882|NCT00582907|470967587|FG003|1st Course|Lost to Follow-up|1|||
130818883|NCT00582907|470967584|FG000|2nd Course|Lack of Efficacy|1|||
130818884|NCT00582907|470967585|FG001|2nd Course|Lack of Efficacy|0|||
130818885|NCT00582907|470967586|FG002|2nd Course|Lack of Efficacy|0|||
130818886|NCT00582907|470967587|FG003|2nd Course|Lack of Efficacy|0|||
130818887|NCT00370292|470967588|FG000|Overall Study|Disease Progression|4|||
130818888|NCT00370292|470967588|FG000|Overall Study|Adverse Event|7|||
130818889|NCT00370292|470967588|FG000|Overall Study|Physician Decision|2|||
130818890|NCT02704208|470967589|FG000|Overall Study|Lost to Follow-up|42|||
130818891|NCT02704208|470967590|FG001|Overall Study|Lost to Follow-up|37|||
130818892|NCT00598650|470967591|FG000|Overall Study|Withdrawal by Subject|3|||
130818893|NCT00598650|470967591|FG000|Overall Study|Adverse Event|18|||
130818894|NCT00598650|470967591|FG000|Overall Study|No treatment for 3 weeks|1|||
130818895|NCT00598650|470967591|FG000|Overall Study|Not eligible|1|||
130818896|NCT00598650|470967591|FG000|Overall Study|Prohibited Concomitant Medication|2|||
130818897|NCT00598650|470967591|FG000|Overall Study|Physician Decision|2|||
130818898|NCT03545672|470967592|FG000|Overall Study|Uncertain diagnosis|2|||
130818899|NCT03545672|470967593|FG001|Overall Study|Uncertain diagnosis|1|||
130818900|NCT03545672|470967592|FG000|Overall Study|Protocol Violation|2|||
130818901|NCT03545672|470967593|FG001|Overall Study|Protocol Violation|2|||
130818902|NCT01628913|470967594|FG000|Overall Study|Adverse Event|12|||
130818903|NCT01628913|470967595|FG001|Overall Study|Adverse Event|5|||
130818904|NCT01628913|470967594|FG000|Overall Study|Disease Progression|11|||
130818905|NCT01628913|470967595|FG001|Overall Study|Disease Progression|14|||
130818906|NCT01628913|470967594|FG000|Overall Study|Protocol Violation|1|||
130818907|NCT01628913|470967595|FG001|Overall Study|Protocol Violation|0|||
130818908|NCT01628913|470967594|FG000|Overall Study|Death|1|||
130818909|NCT01628913|470967595|FG001|Overall Study|Death|0|||
130818910|NCT01628913|470967594|FG000|Overall Study|study terminated by Sponsor|4|||
130818911|NCT01628913|470967595|FG001|Overall Study|study terminated by Sponsor|9|||
130818912|NCT01628913|470967594|FG000|Overall Study|Withdrawal by Subject|1|||
130818913|NCT01628913|470967595|FG001|Overall Study|Withdrawal by Subject|0|||
130818914|NCT01628913|470967594|FG000|Overall Study|Physician Decision|1|||
130818915|NCT01628913|470967595|FG001|Overall Study|Physician Decision|3|||
130818916|NCT02935192|470967597|FG000|Overall Study|Withdrawal by Subject|8|||
130818917|NCT02935192|470967598|FG001|Overall Study|Withdrawal by Subject|4|||
130818918|NCT00560508|470967599|FG000|12 Week Double-blind Period|Adverse Event|3|||
130818919|NCT00560508|470967600|FG001|12 Week Double-blind Period|Adverse Event|2|||
130818920|NCT00560508|470967599|FG000|12 Week Double-blind Period|Protocol Violation|1|||
130818921|NCT00560508|470967600|FG001|12 Week Double-blind Period|Protocol Violation|0|||
130818922|NCT00560508|470967599|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
130818923|NCT00560508|470967600|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
130818924|NCT00560508|470967599|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
130818925|NCT00560508|470967600|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
130818926|NCT00560508|470967599|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
130818927|NCT00560508|470967600|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
130818928|NCT00560508|470967599|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
130818929|NCT00560508|470967600|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
130818930|NCT00560508|470967599|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
130818931|NCT00560508|470967600|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
130818932|NCT04102007|470967601|FG000|Overall Study|Adverse Event|4|||
130818933|NCT04102007|470967601|FG000|Overall Study|Lost to Follow-up|3|||
130818934|NCT04102007|470967601|FG000|Overall Study|Withdrawal by Subject|12|||
130818935|NCT04102007|470967601|FG000|Overall Study|Eligibility Violation|5|||
130818936|NCT04102007|470967601|FG000|Overall Study|Lack of Efficacy|6|||
130818937|NCT04102007|470967601|FG000|Overall Study|Protocol Deviation|5|||
130818938|NCT04102007|470967601|FG000|Overall Study|Protocol Compliance|1|||
130818939|NCT04102007|470967601|FG000|Overall Study|Withdrew Treatment|2|||
130818940|NCT04102007|470967601|FG000|Overall Study|Pregnancy|1|||
130818941|NCT00892008|470967605|FG000|Overall Study|Death|5|||
130818942|NCT00892008|470967605|FG000|Overall Study|Lack of Efficacy|3|||
130818943|NCT00892008|470967605|FG000|Overall Study|Lost to Follow-up|142|||
130818944|NCT00892008|470967605|FG000|Overall Study|Other|378|||
130818945|NCT00892008|470967605|FG000|Overall Study|Adverse Event|37|||
130818946|NCT05878067|470967610|FG000|Overall Study|Lost to Follow-up|2|||
130818947|NCT00949533|470967611|FG000|Overall Study|Lost to Follow-up|0|||
130818948|NCT00949533|470967612|FG001|Overall Study|Lost to Follow-up|1|||
130818949|NCT01959529|470967613|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
130818950|NCT01959529|470967614|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
130818951|NCT01959529|470967613|FG000|Overall Study|Lost to Follow-up|4|||
130818952|NCT01959529|470967614|FG001|Overall Study|Lost to Follow-up|1|||
130818953|NCT01959529|470967613|FG000|Overall Study|Other|70|||
130818954|NCT01959529|470967614|FG001|Overall Study|Other|68|||
130818955|NCT01959529|470967613|FG000|Overall Study|Hypoglycaemia|1|||
130818956|NCT01959529|470967614|FG001|Overall Study|Hypoglycaemia|1|||
130818957|NCT01959529|470967613|FG000|Overall Study|Lack of glycaemic control|1|||
130818958|NCT01959529|470967614|FG001|Overall Study|Lack of glycaemic control|1|||
130818959|NCT00399035|470967622|FG000|Overall Study|Death|289|||
130818960|NCT00399035|470967623|FG001|Overall Study|Death|141|||
130818961|NCT00399035|470967624|FG002|Overall Study|Death|234|||
130818962|NCT00399035|470967622|FG000|Overall Study|Lost to Follow-up|2|||
130818963|NCT00399035|470967623|FG001|Overall Study|Lost to Follow-up|1|||
130818964|NCT00399035|470967624|FG002|Overall Study|Lost to Follow-up|5|||
130818965|NCT00399035|470967622|FG000|Overall Study|Withdrawal by Subject|19|||
130818966|NCT00399035|470967623|FG001|Overall Study|Withdrawal by Subject|15|||
130818967|NCT00399035|470967624|FG002|Overall Study|Withdrawal by Subject|12|||
130818968|NCT00399035|470967622|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
130818969|NCT00399035|470967623|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
130818970|NCT00399035|470967624|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
130818971|NCT00399035|470967622|FG000|Overall Study|Severe non-compliance with protocol|2|||
130818972|NCT00399035|470967623|FG001|Overall Study|Severe non-compliance with protocol|1|||
130818973|NCT00399035|470967624|FG002|Overall Study|Severe non-compliance with protocol|0|||
130818974|NCT00854360|470967625|FG000|Overall Study|Adverse Event|0|||
130818975|NCT00854360|470967626|FG001|Overall Study|Adverse Event|1|||
130818976|NCT00854360|470967627|FG002|Overall Study|Adverse Event|2|||
130818977|NCT00854360|470967628|FG003|Overall Study|Adverse Event|6|||
130818978|NCT00854360|470967625|FG000|Overall Study|Withdrawal by Subject|0|||
130818979|NCT00854360|470967626|FG001|Overall Study|Withdrawal by Subject|0|||
130818980|NCT00854360|470967627|FG002|Overall Study|Withdrawal by Subject|0|||
130818981|NCT00854360|470967628|FG003|Overall Study|Withdrawal by Subject|1|||
130818982|NCT00854360|470967625|FG000|Overall Study|Pregnancy|0|||
130818983|NCT00854360|470967626|FG001|Overall Study|Pregnancy|1|||
130818984|NCT00854360|470967627|FG002|Overall Study|Pregnancy|0|||
130818985|NCT00854360|470967628|FG003|Overall Study|Pregnancy|0|||
130818986|NCT00854360|470967625|FG000|Overall Study|Lack of Efficacy|2|||
130818987|NCT00854360|470967626|FG001|Overall Study|Lack of Efficacy|1|||
130818988|NCT00854360|470967627|FG002|Overall Study|Lack of Efficacy|0|||
130818989|NCT00854360|470967628|FG003|Overall Study|Lack of Efficacy|0|||
130818990|NCT00854360|470967625|FG000|Overall Study|Other|0|||
130818991|NCT00854360|470967626|FG001|Overall Study|Other|0|||
130818992|NCT00854360|470967627|FG002|Overall Study|Other|0|||
130818993|NCT00854360|470967628|FG003|Overall Study|Other|3|||
130818994|NCT01128569|470967632|FG000|Washout Period 1|Adverse Event|0|||
130818995|NCT01128569|470967633|FG001|Washout Period 1|Adverse Event|0|||
130818996|NCT01128569|470967634|FG002|Washout Period 1|Adverse Event|1|||
130818997|NCT01128569|470967635|FG003|Washout Period 1|Adverse Event|0|||
130818998|NCT01128569|470967636|FG004|Washout Period 1|Adverse Event|0|||
130818999|NCT01128569|470967637|FG005|Washout Period 1|Adverse Event|0|||
130819000|NCT01128569|470967632|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130819001|NCT01128569|470967633|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130819002|NCT01128569|470967634|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130819003|NCT01128569|470967635|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130819004|NCT01128569|470967636|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130819005|NCT01128569|470967637|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130819006|NCT00565409|470967641|FG000|Period 1 Open Label|Adverse Event|17|||
130819007|NCT00565409|470967642|FG001|Period 1 Open Label|Adverse Event|0|||
130819008|NCT00565409|470967643|FG002|Period 1 Open Label|Adverse Event|0|||
130819009|NCT00565409|470967644|FG003|Period 1 Open Label|Adverse Event|0|||
130819010|NCT00565409|470967641|FG000|Period 1 Open Label|Death|2|||
130819011|NCT00565409|470967642|FG001|Period 1 Open Label|Death|0|||
130819012|NCT00565409|470967643|FG002|Period 1 Open Label|Death|0|||
130819013|NCT00565409|470967644|FG003|Period 1 Open Label|Death|0|||
130819014|NCT00565409|470967641|FG000|Period 1 Open Label|Lost to Follow-up|1|||
130819015|NCT00565409|470967642|FG001|Period 1 Open Label|Lost to Follow-up|0|||
130819016|NCT00565409|470967643|FG002|Period 1 Open Label|Lost to Follow-up|0|||
130819017|NCT00565409|470967644|FG003|Period 1 Open Label|Lost to Follow-up|0|||
130819018|NCT00565409|470967641|FG000|Period 1 Open Label|Other|21|||
130819019|NCT00565409|470967642|FG001|Period 1 Open Label|Other|0|||
130819020|NCT00565409|470967643|FG002|Period 1 Open Label|Other|0|||
130819021|NCT00565409|470967644|FG003|Period 1 Open Label|Other|0|||
130819022|NCT00565409|470967641|FG000|Period 1 Open Label|Protocol Violation|14|||
130819023|NCT00565409|470967642|FG001|Period 1 Open Label|Protocol Violation|0|||
130819024|NCT00565409|470967643|FG002|Period 1 Open Label|Protocol Violation|0|||
130819025|NCT00565409|470967644|FG003|Period 1 Open Label|Protocol Violation|0|||
130819026|NCT00565409|470967641|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
130819027|NCT00565409|470967642|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
130819028|NCT00565409|470967643|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
130819029|NCT00565409|470967644|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
130819030|NCT00565409|470967641|FG000|Period 1 Open Label|no conclusion of participation record|1|||
130819031|NCT00565409|470967642|FG001|Period 1 Open Label|no conclusion of participation record|0|||
130819032|NCT00565409|470967643|FG002|Period 1 Open Label|no conclusion of participation record|0|||
130819033|NCT00565409|470967644|FG003|Period 1 Open Label|no conclusion of participation record|0|||
130819034|NCT00565409|470967641|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
130819035|NCT00565409|470967642|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
130819036|NCT00565409|470967643|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
130819037|NCT00565409|470967644|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
130819038|NCT00565409|470967641|FG000|Period 2 Double-Blind|Adverse Event|0|||
130819039|NCT00565409|470967642|FG001|Period 2 Double-Blind|Adverse Event|7|||
130819040|NCT00565409|470967643|FG002|Period 2 Double-Blind|Adverse Event|4|||
130819041|NCT00565409|470967644|FG003|Period 2 Double-Blind|Adverse Event|5|||
130819042|NCT00565409|470967641|FG000|Period 2 Double-Blind|Death|0|||
130819043|NCT00565409|470967642|FG001|Period 2 Double-Blind|Death|2|||
130819044|NCT00565409|470967643|FG002|Period 2 Double-Blind|Death|0|||
130819045|NCT00565409|470967644|FG003|Period 2 Double-Blind|Death|0|||
130819046|NCT00565409|470967641|FG000|Period 2 Double-Blind|Protocol Violation|0|||
130819047|NCT00565409|470967642|FG001|Period 2 Double-Blind|Protocol Violation|4|||
130819048|NCT00565409|470967643|FG002|Period 2 Double-Blind|Protocol Violation|6|||
130819049|NCT00565409|470967644|FG003|Period 2 Double-Blind|Protocol Violation|2|||
130819050|NCT00565409|470967641|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
130819051|NCT00565409|470967642|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
130819052|NCT00565409|470967643|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
130819053|NCT00565409|470967644|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
130819054|NCT00565409|470967641|FG000|Period 2 Double-Blind|Other|0|||
130819055|NCT00565409|470967642|FG001|Period 2 Double-Blind|Other|4|||
130819056|NCT00565409|470967643|FG002|Period 2 Double-Blind|Other|5|||
130819057|NCT00565409|470967644|FG003|Period 2 Double-Blind|Other|9|||
130819058|NCT00565409|470967641|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
130819059|NCT00565409|470967642|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
130819060|NCT00565409|470967643|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
130819061|NCT00565409|470967644|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
130819062|NCT01448616|470967646|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
130819063|NCT01448616|470967647|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
130819064|NCT01448616|470967648|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
130819065|NCT01448616|470967649|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
130819066|NCT01448616|470967646|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
130819067|NCT01448616|470967647|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
130819068|NCT01448616|470967648|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
130819069|NCT01448616|470967649|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
130819070|NCT01448616|470967646|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
130819071|NCT01448616|470967647|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
130819072|NCT01448616|470967648|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
130819073|NCT01448616|470967649|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
130819074|NCT01448616|470967646|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
130819075|NCT01448616|470967647|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
130819076|NCT01448616|470967648|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
130819077|NCT01448616|470967649|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
130819078|NCT01448616|470967646|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
130819079|NCT01448616|470967647|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
130819080|NCT01448616|470967648|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
130819081|NCT01448616|470967649|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
130819082|NCT02170064|470967652|FG000|Overall Study|Withdrawal by Subject|5|||
130819083|NCT02170064|470967653|FG001|Overall Study|Withdrawal by Subject|1|||
130819084|NCT02170064|470967654|FG002|Overall Study|Withdrawal by Subject|1|||
130819085|NCT02170064|470967652|FG000|Overall Study|Physician Decision|1|||
130819086|NCT02170064|470967653|FG001|Overall Study|Physician Decision|1|||
130819087|NCT02170064|470967654|FG002|Overall Study|Physician Decision|0|||
130819088|NCT03323164|470967655|FG000|Overall Study|Poor quality imaging/scans|2|||
130819089|NCT03323164|470967656|FG001|Overall Study|Poor quality imaging/scans|2|||
130819090|NCT00654732|470967657|FG000|Overall Study|Adverse Event|4|||
130819091|NCT00654732|470967658|FG001|Overall Study|Adverse Event|6|||
130819092|NCT01959932|470967659|FG000|Overall Study|Withdrawal by Subject|1|||
130819093|NCT01959932|470967660|FG001|Overall Study|Withdrawal by Subject|0|||
130819094|NCT01959932|470967661|FG002|Overall Study|Withdrawal by Subject|0|||
130819095|NCT00397540|470967662|FG000|Overall Study|short follow-up duration < 12 months|1|||
130819096|NCT00397540|470967663|FG001|Overall Study|short follow-up duration < 12 months|0|||
130819097|NCT02297412|470967666|FG000|Overall Study|Canceled|1|||
130819098|NCT02297412|470967667|FG001|Overall Study|Canceled|1|||
130819099|NCT02993263|470967680|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
130819100|NCT01405196|470967681|FG000|Overall Study|Study Terminated by Sponsor|0|||
130819101|NCT01405196|470967682|FG001|Overall Study|Study Terminated by Sponsor|0|||
130819102|NCT01405196|470967683|FG002|Overall Study|Study Terminated by Sponsor|9|||
130819103|NCT01405196|470967684|FG003|Overall Study|Study Terminated by Sponsor|0|||
130819104|NCT01405196|470967681|FG000|Overall Study|Other|2|||
130819105|NCT01405196|470967682|FG001|Overall Study|Other|2|||
130819106|NCT01405196|470967683|FG002|Overall Study|Other|5|||
130819107|NCT01405196|470967684|FG003|Overall Study|Other|0|||
130819108|NCT01405196|470967681|FG000|Overall Study|Withdrawal by Subject|4|||
130819109|NCT01405196|470967682|FG001|Overall Study|Withdrawal by Subject|6|||
130819110|NCT01405196|470967683|FG002|Overall Study|Withdrawal by Subject|3|||
130819111|NCT01405196|470967684|FG003|Overall Study|Withdrawal by Subject|6|||
130819112|NCT01405196|470967681|FG000|Overall Study|Adverse Event|2|||
130819113|NCT01405196|470967682|FG001|Overall Study|Adverse Event|2|||
130819114|NCT01405196|470967683|FG002|Overall Study|Adverse Event|0|||
130819115|NCT01405196|470967684|FG003|Overall Study|Adverse Event|2|||
130819116|NCT01405196|470967681|FG000|Overall Study|Death|1|||
130819117|NCT01405196|470967682|FG001|Overall Study|Death|0|||
130819118|NCT01405196|470967683|FG002|Overall Study|Death|3|||
130819119|NCT01405196|470967684|FG003|Overall Study|Death|0|||
130819120|NCT01405196|470967681|FG000|Overall Study|Lost to Follow-up|2|||
130819121|NCT01405196|470967682|FG001|Overall Study|Lost to Follow-up|2|||
130819122|NCT01405196|470967683|FG002|Overall Study|Lost to Follow-up|3|||
130819123|NCT01405196|470967684|FG003|Overall Study|Lost to Follow-up|1|||
130819124|NCT01729039|470967687|FG000|Overall Study|disqualified|2|||
130819125|NCT01729039|470967688|FG001|Overall Study|disqualified|5|||
130819126|NCT01729039|470967687|FG000|Overall Study|Withdrawal by Subject|8|||
130819127|NCT01729039|470967688|FG001|Overall Study|Withdrawal by Subject|7|||
130819128|NCT00698841|470967689|FG000|Overall Study|Withdrawal by Subject|2|||
130819129|NCT00698841|470967689|FG000|Overall Study|Adverse Event|3|||
130819130|NCT00698841|470967689|FG000|Overall Study|Disease progression|7|||
130819131|NCT00698841|470967689|FG000|Overall Study|Failure to meet eligibility criteria|2|||
130819132|NCT00698841|470967689|FG000|Overall Study|Study drug toxicity|2|||
130819133|NCT00698841|470967689|FG000|Overall Study|Other|2|||
130819134|NCT02611037|470967690|FG000|Overall Study|Withdrawal prior to treatment|2|||
130819135|NCT02611037|470967691|FG001|Overall Study|Withdrawal prior to treatment|0|||
130819136|NCT04712669|470967694|FG000|Double Blind Phase|Adverse Event|4|||
130819137|NCT04712669|470967695|FG001|Double Blind Phase|Adverse Event|4|||
130819138|NCT04712669|470967696|FG002|Double Blind Phase|Adverse Event|3|||
130819139|NCT04712669|470967697|FG003|Double Blind Phase|Adverse Event|0|||
130819140|NCT04712669|470967698|FG004|Double Blind Phase|Adverse Event|0|||
130819141|NCT04712669|470967699|FG005|Double Blind Phase|Adverse Event|0|||
130819142|NCT04712669|470967700|FG006|Double Blind Phase|Adverse Event|0|||
130819143|NCT04712669|470967701|FG007|Double Blind Phase|Adverse Event|0|||
130819144|NCT04712669|470967694|FG000|Double Blind Phase|Physician Decision|1|||
130819145|NCT04712669|470967695|FG001|Double Blind Phase|Physician Decision|0|||
130819146|NCT04712669|470967696|FG002|Double Blind Phase|Physician Decision|0|||
130819147|NCT04712669|470967697|FG003|Double Blind Phase|Physician Decision|0|||
130819148|NCT04712669|470967698|FG004|Double Blind Phase|Physician Decision|0|||
130819149|NCT04712669|470967699|FG005|Double Blind Phase|Physician Decision|0|||
130819150|NCT04712669|470967700|FG006|Double Blind Phase|Physician Decision|0|||
130819151|NCT04712669|470967701|FG007|Double Blind Phase|Physician Decision|0|||
130819152|NCT04712669|470967694|FG000|Double Blind Phase|Withdrawal by Subject|3|||
130819153|NCT04712669|470967695|FG001|Double Blind Phase|Withdrawal by Subject|6|||
130819154|NCT04712669|470967696|FG002|Double Blind Phase|Withdrawal by Subject|0|||
130819155|NCT04712669|470967697|FG003|Double Blind Phase|Withdrawal by Subject|0|||
130819156|NCT04712669|470967698|FG004|Double Blind Phase|Withdrawal by Subject|0|||
130819157|NCT04712669|470967699|FG005|Double Blind Phase|Withdrawal by Subject|0|||
130819158|NCT04712669|470967700|FG006|Double Blind Phase|Withdrawal by Subject|0|||
130819159|NCT04712669|470967701|FG007|Double Blind Phase|Withdrawal by Subject|0|||
130819160|NCT04712669|470967694|FG000|Double Blind Phase|Termination by Sponsor|0|||
130819161|NCT04712669|470967695|FG001|Double Blind Phase|Termination by Sponsor|0|||
130819162|NCT04712669|470967696|FG002|Double Blind Phase|Termination by Sponsor|1|||
130819163|NCT04712669|470967697|FG003|Double Blind Phase|Termination by Sponsor|0|||
130819164|NCT04712669|470967698|FG004|Double Blind Phase|Termination by Sponsor|0|||
130819165|NCT04712669|470967699|FG005|Double Blind Phase|Termination by Sponsor|0|||
130819166|NCT04712669|470967700|FG006|Double Blind Phase|Termination by Sponsor|0|||
130819167|NCT04712669|470967701|FG007|Double Blind Phase|Termination by Sponsor|0|||
130819168|NCT04712669|470967694|FG000|Open Label Phase|Adverse Event|0|||
130819169|NCT04712669|470967695|FG001|Open Label Phase|Adverse Event|0|||
130819170|NCT04712669|470967696|FG002|Open Label Phase|Adverse Event|0|||
130819171|NCT04712669|470967697|FG003|Open Label Phase|Adverse Event|1|||
130819172|NCT04712669|470967698|FG004|Open Label Phase|Adverse Event|1|||
130819173|NCT04712669|470967699|FG005|Open Label Phase|Adverse Event|3|||
130819174|NCT04712669|470967700|FG006|Open Label Phase|Adverse Event|1|||
130819175|NCT04712669|470967701|FG007|Open Label Phase|Adverse Event|2|||
130819176|NCT04712669|470967694|FG000|Open Label Phase|Death|0|||
130819177|NCT04712669|470967695|FG001|Open Label Phase|Death|0|||
130819178|NCT04712669|470967696|FG002|Open Label Phase|Death|0|||
130819179|NCT04712669|470967697|FG003|Open Label Phase|Death|1|||
130819180|NCT04712669|470967698|FG004|Open Label Phase|Death|0|||
130819181|NCT04712669|470967699|FG005|Open Label Phase|Death|0|||
130819182|NCT04712669|470967700|FG006|Open Label Phase|Death|0|||
130819183|NCT04712669|470967701|FG007|Open Label Phase|Death|0|||
130819184|NCT04712669|470967694|FG000|Open Label Phase|Lack of Efficacy|0|||
130819185|NCT04712669|470967695|FG001|Open Label Phase|Lack of Efficacy|0|||
130819186|NCT04712669|470967696|FG002|Open Label Phase|Lack of Efficacy|0|||
130819187|NCT04712669|470967697|FG003|Open Label Phase|Lack of Efficacy|0|||
130819188|NCT04712669|470967698|FG004|Open Label Phase|Lack of Efficacy|1|||
130819189|NCT04712669|470967699|FG005|Open Label Phase|Lack of Efficacy|0|||
130819190|NCT04712669|470967700|FG006|Open Label Phase|Lack of Efficacy|0|||
130819191|NCT04712669|470967701|FG007|Open Label Phase|Lack of Efficacy|0|||
130819192|NCT04712669|470967694|FG000|Open Label Phase|Lost to Follow-up|0|||
130819193|NCT04712669|470967695|FG001|Open Label Phase|Lost to Follow-up|0|||
130819194|NCT04712669|470967696|FG002|Open Label Phase|Lost to Follow-up|0|||
130819195|NCT04712669|470967697|FG003|Open Label Phase|Lost to Follow-up|0|||
130819196|NCT04712669|470967698|FG004|Open Label Phase|Lost to Follow-up|0|||
130819197|NCT04712669|470967699|FG005|Open Label Phase|Lost to Follow-up|0|||
130819198|NCT04712669|470967700|FG006|Open Label Phase|Lost to Follow-up|1|||
130819199|NCT04712669|470967701|FG007|Open Label Phase|Lost to Follow-up|1|||
130819200|NCT04712669|470967694|FG000|Open Label Phase|Physician Decision|0|||
130819201|NCT04712669|470967695|FG001|Open Label Phase|Physician Decision|0|||
130819202|NCT04712669|470967696|FG002|Open Label Phase|Physician Decision|0|||
130819203|NCT04712669|470967697|FG003|Open Label Phase|Physician Decision|1|||
130819204|NCT04712669|470967698|FG004|Open Label Phase|Physician Decision|0|||
130819205|NCT04712669|470967699|FG005|Open Label Phase|Physician Decision|0|||
130819206|NCT04712669|470967700|FG006|Open Label Phase|Physician Decision|0|||
130819207|NCT04712669|470967701|FG007|Open Label Phase|Physician Decision|0|||
130819208|NCT04712669|470967694|FG000|Open Label Phase|Withdrawal by Subject|0|||
130819209|NCT04712669|470967695|FG001|Open Label Phase|Withdrawal by Subject|0|||
130819210|NCT04712669|470967696|FG002|Open Label Phase|Withdrawal by Subject|0|||
130819211|NCT04712669|470967697|FG003|Open Label Phase|Withdrawal by Subject|1|||
130819212|NCT04712669|470967698|FG004|Open Label Phase|Withdrawal by Subject|5|||
130819213|NCT04712669|470967699|FG005|Open Label Phase|Withdrawal by Subject|5|||
130819214|NCT04712669|470967700|FG006|Open Label Phase|Withdrawal by Subject|0|||
130819215|NCT04712669|470967701|FG007|Open Label Phase|Withdrawal by Subject|4|||
130819216|NCT04712669|470967694|FG000|Open Label Phase|Termination by Sponsor|0|||
130819217|NCT04712669|470967695|FG001|Open Label Phase|Termination by Sponsor|0|||
130819218|NCT04712669|470967696|FG002|Open Label Phase|Termination by Sponsor|0|||
130819219|NCT04712669|470967697|FG003|Open Label Phase|Termination by Sponsor|11|||
130819220|NCT04712669|470967698|FG004|Open Label Phase|Termination by Sponsor|9|||
130819221|NCT04712669|470967699|FG005|Open Label Phase|Termination by Sponsor|14|||
130819222|NCT04712669|470967700|FG006|Open Label Phase|Termination by Sponsor|0|||
130819223|NCT04712669|470967701|FG007|Open Label Phase|Termination by Sponsor|14|||
130819224|NCT03802396|470967702|FG000|Overall Study|Withdrawal by Subject|2|||
130819225|NCT03802396|470967703|FG001|Overall Study|Withdrawal by Subject|0|||
130819226|NCT03802396|470967702|FG000|Overall Study|Surgery Cancelled|1|||
130819227|NCT03802396|470967703|FG001|Overall Study|Surgery Cancelled|0|||
130819228|NCT02561962|470967707|FG000|Overall Study|Withdrawal by Subject|1|||
130819229|NCT02561962|470967708|FG001|Overall Study|Withdrawal by Subject|0|||
130819230|NCT02561962|470967709|FG002|Overall Study|Withdrawal by Subject|0|||
130819231|NCT02561962|470967710|FG003|Overall Study|Withdrawal by Subject|0|||
130819232|NCT02561962|470967711|FG004|Overall Study|Withdrawal by Subject|1|||
130819233|NCT02561962|470967712|FG005|Overall Study|Withdrawal by Subject|1|||
130819234|NCT02561962|470967713|FG006|Overall Study|Withdrawal by Subject|2|||
130819235|NCT02561962|470967714|FG007|Overall Study|Withdrawal by Subject|1|||
130819236|NCT02561962|470967715|FG008|Overall Study|Withdrawal by Subject|0|||
130819237|NCT02561962|470967707|FG000|Overall Study|Decision by sponsor|0|||
130819238|NCT02561962|470967708|FG001|Overall Study|Decision by sponsor|0|||
130819239|NCT02561962|470967709|FG002|Overall Study|Decision by sponsor|0|||
130819240|NCT02561962|470967710|FG003|Overall Study|Decision by sponsor|0|||
130819241|NCT02561962|470967711|FG004|Overall Study|Decision by sponsor|1|||
130819242|NCT02561962|470967712|FG005|Overall Study|Decision by sponsor|1|||
130819243|NCT02561962|470967713|FG006|Overall Study|Decision by sponsor|0|||
130819244|NCT02561962|470967714|FG007|Overall Study|Decision by sponsor|3|||
130819245|NCT02561962|470967715|FG008|Overall Study|Decision by sponsor|0|||
130819246|NCT02561962|470967707|FG000|Overall Study|Lost to Follow-up|0|||
130819247|NCT02561962|470967708|FG001|Overall Study|Lost to Follow-up|0|||
130819248|NCT02561962|470967709|FG002|Overall Study|Lost to Follow-up|0|||
130819249|NCT02561962|470967710|FG003|Overall Study|Lost to Follow-up|0|||
130819250|NCT02561962|470967711|FG004|Overall Study|Lost to Follow-up|0|||
130819251|NCT02561962|470967712|FG005|Overall Study|Lost to Follow-up|1|||
130819252|NCT02561962|470967713|FG006|Overall Study|Lost to Follow-up|0|||
130819253|NCT02561962|470967714|FG007|Overall Study|Lost to Follow-up|0|||
130819254|NCT02561962|470967715|FG008|Overall Study|Lost to Follow-up|0|||
130819255|NCT01819272|470969472|FG000|Overall Study|Adverse Event|1|||
130819256|NCT01819272|470969473|FG001|Overall Study|Adverse Event|0|||
130819257|NCT01819272|470969474|FG002|Overall Study|Adverse Event|0|||
130819258|NCT01819272|470969475|FG003|Overall Study|Adverse Event|2|||
130819259|NCT01819272|470969476|FG004|Overall Study|Adverse Event|0|||
130819260|NCT01819272|470969477|FG005|Overall Study|Adverse Event|0|||
130819261|NCT01819272|470969472|FG000|Overall Study|Lost to Follow-up|3|||
130819262|NCT01819272|470969473|FG001|Overall Study|Lost to Follow-up|0|||
130819263|NCT01819272|470969474|FG002|Overall Study|Lost to Follow-up|1|||
130819264|NCT01819272|470969475|FG003|Overall Study|Lost to Follow-up|0|||
130819265|NCT01819272|470969476|FG004|Overall Study|Lost to Follow-up|0|||
130819266|NCT01819272|470969477|FG005|Overall Study|Lost to Follow-up|3|||
130819267|NCT01819272|470969472|FG000|Overall Study|Protocol Violation|0|||
130819268|NCT01819272|470969473|FG001|Overall Study|Protocol Violation|0|||
130819269|NCT01819272|470969474|FG002|Overall Study|Protocol Violation|0|||
130819270|NCT01819272|470969475|FG003|Overall Study|Protocol Violation|1|||
130819271|NCT01819272|470969476|FG004|Overall Study|Protocol Violation|2|||
130819272|NCT01819272|470969477|FG005|Overall Study|Protocol Violation|3|||
130819273|NCT01819272|470969472|FG000|Overall Study|Physician Decision|0|||
130819274|NCT01819272|470969473|FG001|Overall Study|Physician Decision|1|||
130819275|NCT01819272|470969474|FG002|Overall Study|Physician Decision|0|||
130819276|NCT01819272|470969475|FG003|Overall Study|Physician Decision|0|||
130819277|NCT01819272|470969476|FG004|Overall Study|Physician Decision|0|||
130819278|NCT01819272|470969477|FG005|Overall Study|Physician Decision|0|||
130819279|NCT01819272|470969472|FG000|Overall Study|Withdrawal of Consent|0|||
130819280|NCT01819272|470969473|FG001|Overall Study|Withdrawal of Consent|1|||
130819281|NCT01819272|470969474|FG002|Overall Study|Withdrawal of Consent|2|||
130819282|NCT01819272|470969475|FG003|Overall Study|Withdrawal of Consent|1|||
130819283|NCT01819272|470969476|FG004|Overall Study|Withdrawal of Consent|0|||
130819284|NCT01819272|470969477|FG005|Overall Study|Withdrawal of Consent|1|||
130819285|NCT01819272|470969472|FG000|Overall Study|Loss of Glucose Control|2|||
130819286|NCT01819272|470969473|FG001|Overall Study|Loss of Glucose Control|1|||
130819287|NCT01819272|470969474|FG002|Overall Study|Loss of Glucose Control|0|||
130819288|NCT01819272|470969475|FG003|Overall Study|Loss of Glucose Control|1|||
130819289|NCT01819272|470969476|FG004|Overall Study|Loss of Glucose Control|2|||
130819290|NCT01819272|470969477|FG005|Overall Study|Loss of Glucose Control|0|||
130819291|NCT03610048|470969481|FG000|Overall Study|Study terminated by sponsor|84|||
130819292|NCT03610048|470969481|FG000|Overall Study|Adverse Event|32|||
130819293|NCT03610048|470969481|FG000|Overall Study|Withdrawal by Subject|31|||
130819294|NCT03610048|470969481|FG000|Overall Study|Lost to Follow-up|8|||
130819295|NCT03610048|470969481|FG000|Overall Study|Other|4|||
130819296|NCT03610048|470969481|FG000|Overall Study|Physician Decision|1|||
130819297|NCT03610048|470969481|FG000|Overall Study|Pregnancy|1|||
130819298|NCT01155050|470969482|FG000|Overall Study|Lost to Follow-up|15|||
130819299|NCT01155050|470969483|FG001|Overall Study|Lost to Follow-up|20|||
130819300|NCT01155050|470969484|FG002|Overall Study|Lost to Follow-up|19|||
130819301|NCT01155050|470969485|FG003|Overall Study|Lost to Follow-up|22|||
130819302|NCT01146613|470969486|FG000|Overall Study|Lost to Follow-up|3|||
130819303|NCT01146613|470969487|FG001|Overall Study|Lost to Follow-up|8|||
130819304|NCT01146613|470969486|FG000|Overall Study|Lack of Efficacy|0|||
130819305|NCT01146613|470969487|FG001|Overall Study|Lack of Efficacy|1|||
130819306|NCT01146613|470969486|FG000|Overall Study|Death|1|||
130819307|NCT01146613|470969487|FG001|Overall Study|Death|0|||
130819308|NCT01146613|470969486|FG000|Overall Study|Physician Decision|1|||
130819309|NCT01146613|470969487|FG001|Overall Study|Physician Decision|0|||
130819310|NCT01146613|470969486|FG000|Overall Study|Withdrawal by Subject|0|||
130819311|NCT01146613|470969487|FG001|Overall Study|Withdrawal by Subject|3|||
130819312|NCT01146613|470969486|FG000|Overall Study|schedule conflict|1|||
130819313|NCT01146613|470969487|FG001|Overall Study|schedule conflict|0|||
130819314|NCT01146613|470969486|FG000|Overall Study|Outpatient detox|1|||
130819315|NCT01146613|470969487|FG001|Overall Study|Outpatient detox|0|||
130819316|NCT00652834|470969488|FG000|Overall Study|Withdrawal by Subject|3|||
130819317|NCT00652834|470969488|FG000|Overall Study|Lost to Follow-up|2|||
130819318|NCT00320606|470969489|FG000|Overall Study|Adverse Event|1|||
130819319|NCT00320606|470969489|FG000|Overall Study|Protocol Violation|1|||
130819320|NCT00320606|470969489|FG000|Overall Study|Withdrawal by Subject|1|||
130819321|NCT02441218|470969492|FG000|Overall Study|Death|503|||
130819322|NCT02441218|470969493|FG001|Overall Study|Death|553|||
130819323|NCT02441218|470969492|FG000|Overall Study|Withdrawal by Subject|73|||
130819324|NCT02441218|470969493|FG001|Overall Study|Withdrawal by Subject|58|||
130819325|NCT02441218|470969492|FG000|Overall Study|Lost to Follow-up|2|||
130819326|NCT02441218|470969493|FG001|Overall Study|Lost to Follow-up|1|||
130819327|NCT02271880|470969494|FG000|Overall Study|Premature discontinuation of study|3|||
130819328|NCT02271880|470969495|FG001|Overall Study|Premature discontinuation of study|4|||
130819329|NCT00806585|470969496|FG000|Overall Study|Study terminated by Sponsor|0|||
130819330|NCT00806585|470969497|FG001|Overall Study|Study terminated by Sponsor|0|||
130819331|NCT00806585|470969498|FG002|Overall Study|Study terminated by Sponsor|1|||
130819332|NCT00806585|470969499|FG003|Overall Study|Study terminated by Sponsor|2|||
130819333|NCT00806585|470969500|FG004|Overall Study|Study terminated by Sponsor|0|||
130819334|NCT00806585|470969496|FG000|Overall Study|Protocol Violation|3|||
130819335|NCT00806585|470969497|FG001|Overall Study|Protocol Violation|1|||
130819336|NCT00806585|470969498|FG002|Overall Study|Protocol Violation|2|||
130819337|NCT00806585|470969499|FG003|Overall Study|Protocol Violation|0|||
130819338|NCT00806585|470969500|FG004|Overall Study|Protocol Violation|0|||
130819339|NCT00806585|470969496|FG000|Overall Study|Physician Decision|0|||
130819340|NCT00806585|470969497|FG001|Overall Study|Physician Decision|2|||
130819341|NCT00806585|470969498|FG002|Overall Study|Physician Decision|3|||
130819342|NCT00806585|470969499|FG003|Overall Study|Physician Decision|0|||
130819343|NCT00806585|470969500|FG004|Overall Study|Physician Decision|1|||
130819344|NCT00806585|470969496|FG000|Overall Study|Lost to Follow-up|2|||
130819345|NCT00806585|470969497|FG001|Overall Study|Lost to Follow-up|1|||
130819346|NCT00806585|470969498|FG002|Overall Study|Lost to Follow-up|2|||
130819347|NCT00806585|470969499|FG003|Overall Study|Lost to Follow-up|2|||
130819348|NCT00806585|470969500|FG004|Overall Study|Lost to Follow-up|5|||
130819349|NCT00806585|470969496|FG000|Overall Study|Lack of Efficacy|1|||
130819350|NCT00806585|470969497|FG001|Overall Study|Lack of Efficacy|0|||
130819351|NCT00806585|470969498|FG002|Overall Study|Lack of Efficacy|0|||
130819352|NCT00806585|470969499|FG003|Overall Study|Lack of Efficacy|0|||
130819353|NCT00806585|470969500|FG004|Overall Study|Lack of Efficacy|0|||
130819354|NCT00806585|470969496|FG000|Overall Study|Adverse Event|1|||
130819355|NCT00806585|470969497|FG001|Overall Study|Adverse Event|5|||
130819356|NCT00806585|470969498|FG002|Overall Study|Adverse Event|3|||
130819357|NCT00806585|470969499|FG003|Overall Study|Adverse Event|4|||
130819358|NCT00806585|470969500|FG004|Overall Study|Adverse Event|2|||
130819359|NCT00806585|470969496|FG000|Overall Study|Withdrawal by Subject|10|||
130819360|NCT00806585|470969497|FG001|Overall Study|Withdrawal by Subject|8|||
130819361|NCT00806585|470969498|FG002|Overall Study|Withdrawal by Subject|9|||
130819362|NCT00806585|470969499|FG003|Overall Study|Withdrawal by Subject|3|||
130819363|NCT00806585|470969500|FG004|Overall Study|Withdrawal by Subject|11|||
130819364|NCT00806585|470969496|FG000|Overall Study|Completion status unknown|15|||
130819365|NCT00806585|470969497|FG001|Overall Study|Completion status unknown|14|||
130819366|NCT00806585|470969498|FG002|Overall Study|Completion status unknown|12|||
130819367|NCT00806585|470969499|FG003|Overall Study|Completion status unknown|4|||
130819368|NCT00806585|470969500|FG004|Overall Study|Completion status unknown|12|||
130819369|NCT00474903|470969501|FG000|Overall Study|Protocol Violation|1|||
130819370|NCT00474903|470969502|FG001|Overall Study|Protocol Violation|5|||
130819371|NCT00474903|470969503|FG002|Overall Study|Protocol Violation|2|||
130819372|NCT00399529|470969504|FG000|Overall Study|Off Study Prior to Treatment|2|||
130819373|NCT01936831|470969505|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130819374|NCT01936831|470969506|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130819375|NCT01936831|470969507|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130819376|NCT01936831|470969508|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130819377|NCT01936831|470969509|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130819378|NCT01936831|470969510|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
130819379|NCT01936831|470969511|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130819380|NCT01936831|470969512|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130819381|NCT01936831|470969513|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130819382|NCT03435380|470969519|FG000|Overall Study|Death|1|||
130819383|NCT03435380|470969520|FG001|Overall Study|Death|2|||
130819384|NCT03435380|470969521|FG002|Overall Study|Death|1|||
130819385|NCT03435380|470969519|FG000|Overall Study|Lost to Follow-up|12|||
130819386|NCT03435380|470969520|FG001|Overall Study|Lost to Follow-up|8|||
130819387|NCT03435380|470969521|FG002|Overall Study|Lost to Follow-up|6|||
130819388|NCT03435380|470969519|FG000|Overall Study|Physician Decision|1|||
130819389|NCT03435380|470969520|FG001|Overall Study|Physician Decision|0|||
130819390|NCT03435380|470969521|FG002|Overall Study|Physician Decision|0|||
130819391|NCT03435380|470969519|FG000|Overall Study|Withdrawal by Subject|0|||
130819392|NCT03435380|470969520|FG001|Overall Study|Withdrawal by Subject|1|||
130819393|NCT03435380|470969521|FG002|Overall Study|Withdrawal by Subject|1|||
130819394|NCT03435380|470969519|FG000|Overall Study|Ineligible|0|||
130819395|NCT03435380|470969520|FG001|Overall Study|Ineligible|1|||
130819396|NCT03435380|470969521|FG002|Overall Study|Ineligible|1|||
130819397|NCT02133573|470969522|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
130819398|NCT02133573|470969523|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
130819399|NCT02133573|470969522|FG000|Overall Study|Child Deaths|3|||
130819400|NCT02133573|470969523|FG001|Overall Study|Child Deaths|5|||
130819401|NCT02133573|470969522|FG000|Overall Study|Child Declined Follow Ups|2|||
130819402|NCT02133573|470969523|FG001|Overall Study|Child Declined Follow Ups|1|||
130819403|NCT02133573|470969522|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
130819404|NCT02133573|470969523|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
130819405|NCT02431325|470969524|FG000|Overall Study|Adverse Event|3|||
130819406|NCT02431325|470969525|FG001|Overall Study|Adverse Event|0|||
130819407|NCT02431325|470969524|FG000|Overall Study|Lost to Follow-up|0|||
130819408|NCT02431325|470969525|FG001|Overall Study|Lost to Follow-up|1|||
130819409|NCT02431325|470969524|FG000|Overall Study|Withdrawal by Subject|1|||
130819410|NCT02431325|470969525|FG001|Overall Study|Withdrawal by Subject|2|||
130819411|NCT02431325|470969524|FG000|Overall Study|Declined to take study medication|1|||
130819412|NCT02431325|470969525|FG001|Overall Study|Declined to take study medication|0|||
130819413|NCT02431325|470969524|FG000|Overall Study|Withdrew before starting study medication|1|||
130819414|NCT02431325|470969525|FG001|Overall Study|Withdrew before starting study medication|0|||
130819415|NCT02431325|470969524|FG000|Overall Study|Placebo shortage|2|||
130819416|NCT02431325|470969525|FG001|Overall Study|Placebo shortage|0|||
130819417|NCT02519842|470969526|FG000|Base Study: Cycle 1|Screening Failure|1|||
130819418|NCT02519842|470969527|FG001|Base Study: Cycle 1|Screening Failure|1|||
130819419|NCT02519842|470969528|FG002|Base Study: Cycle 1|Screening Failure|0|||
130819420|NCT02519842|470969526|FG000|Base Study: Cycle 1|Adverse Event|1|||
130819421|NCT02519842|470969527|FG001|Base Study: Cycle 1|Adverse Event|0|||
130819422|NCT02519842|470969528|FG002|Base Study: Cycle 1|Adverse Event|0|||
130819423|NCT02519842|470969526|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
130819424|NCT02519842|470969527|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
130819425|NCT02519842|470969528|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
130819426|NCT02519842|470969526|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
130819427|NCT02519842|470969527|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
130819428|NCT02519842|470969528|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
130819429|NCT02519842|470969526|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
130819430|NCT02519842|470969527|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
130819431|NCT02519842|470969528|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
130819432|NCT02519842|470969526|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
130819433|NCT02519842|470969527|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
130819434|NCT02519842|470969528|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
130819435|NCT02519842|470969526|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130819436|NCT02519842|470969527|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130819437|NCT02519842|470969528|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
130819438|NCT02519842|470969526|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
130819439|NCT02519842|470969527|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
130819440|NCT02519842|470969528|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
130819441|NCT02519842|470969526|FG000|Optional Extension: Cycles 2-6|Death|0|||
130819442|NCT02519842|470969527|FG001|Optional Extension: Cycles 2-6|Death|0|||
130819443|NCT02519842|470969528|FG002|Optional Extension: Cycles 2-6|Death|1|||
130819444|NCT02519842|470969526|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
130819445|NCT02519842|470969527|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
130819446|NCT02519842|470969528|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
130819447|NCT02519842|470969526|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
130819448|NCT02519842|470969527|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
130819449|NCT02519842|470969528|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
130819450|NCT02519842|470969526|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
130819451|NCT02519842|470969527|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
130819452|NCT02519842|470969528|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
130819453|NCT02519842|470969526|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
130819454|NCT02519842|470969527|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
130819455|NCT02519842|470969528|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
130819456|NCT02115321|470969531|FG000|Overall Study|Death|1|||
130819457|NCT02115321|470969532|FG001|Overall Study|Death|0|||
130819458|NCT01307449|470969533|FG000|Overall Study|Adverse Event|1|||
130819459|NCT01307449|470969534|FG001|Overall Study|Adverse Event|0|||
130819460|NCT01307449|470969535|FG002|Overall Study|Adverse Event|0|||
130819461|NCT01307449|470969536|FG003|Overall Study|Adverse Event|0|||
130819462|NCT03218917|470969537|FG000|Overall Study|Adverse Event|3|||
130819463|NCT03218917|470969538|FG001|Overall Study|Adverse Event|3|||
130819464|NCT03218917|470969539|FG002|Overall Study|Adverse Event|2|||
130819465|NCT03218917|470969537|FG000|Overall Study|Subject withdrew consent|2|||
130819466|NCT03218917|470969538|FG001|Overall Study|Subject withdrew consent|4|||
130819467|NCT03218917|470969539|FG002|Overall Study|Subject withdrew consent|10|||
130819468|NCT03218917|470969537|FG000|Overall Study|Physician Decision|0|||
130819469|NCT03218917|470969538|FG001|Overall Study|Physician Decision|1|||
130819470|NCT03218917|470969539|FG002|Overall Study|Physician Decision|1|||
130819471|NCT03218917|470969537|FG000|Overall Study|Lost to Follow-up|1|||
130819472|NCT03218917|470969538|FG001|Overall Study|Lost to Follow-up|0|||
130819473|NCT03218917|470969539|FG002|Overall Study|Lost to Follow-up|0|||
130819474|NCT03218917|470969537|FG000|Overall Study|Reason Missing|0|||
130819475|NCT03218917|470969538|FG001|Overall Study|Reason Missing|2|||
130819476|NCT03218917|470969539|FG002|Overall Study|Reason Missing|0|||
130819477|NCT03218917|470969537|FG000|Overall Study|Death|0|||
130819478|NCT03218917|470969538|FG001|Overall Study|Death|1|||
130819479|NCT03218917|470969539|FG002|Overall Study|Death|0|||
130819480|NCT03218917|470969537|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130819481|NCT03218917|470969538|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130819482|NCT03218917|470969539|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130819483|NCT01788943|470969542|FG000|Overall Study|Withdrawal by Subject|1|||
130819484|NCT01788943|470969543|FG001|Overall Study|Withdrawal by Subject|0|||
130819485|NCT01119287|470969544|FG000|Overall Study|Patient Decision, not related to AE|0|||
130819486|NCT01119287|470969545|FG001|Overall Study|Patient Decision, not related to AE|0|||
130819487|NCT01119287|470969546|FG002|Overall Study|Patient Decision, not related to AE|2|||
130819488|NCT01119287|470969547|FG003|Overall Study|Patient Decision, not related to AE|2|||
130819489|NCT01119287|470969548|FG004|Overall Study|Patient Decision, not related to AE|1|||
130819490|NCT01119287|470969549|FG005|Overall Study|Patient Decision, not related to AE|0|||
130819491|NCT04661033|470969555|FG000|Overall Study|Adverse Event|0|||
130819492|NCT04661033|470969556|FG001|Overall Study|Adverse Event|0|||
130819493|NCT04661033|470969557|FG002|Overall Study|Adverse Event|1|||
130819494|NCT04661033|470969558|FG003|Overall Study|Adverse Event|0|||
130819495|NCT04661033|470969555|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
130819496|NCT04661033|470969556|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
130819497|NCT04661033|470969557|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
130819498|NCT04661033|470969558|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
130819499|NCT04661033|470969555|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
130819500|NCT04661033|470969556|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
130819501|NCT04661033|470969557|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
130819502|NCT04661033|470969558|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
130819503|NCT04661033|470969555|FG000|Overall Study|Early discontinuation as per PI|1|||
130819504|NCT04661033|470969556|FG001|Overall Study|Early discontinuation as per PI|0|||
130819505|NCT04661033|470969557|FG002|Overall Study|Early discontinuation as per PI|0|||
130819506|NCT04661033|470969558|FG003|Overall Study|Early discontinuation as per PI|0|||
130819507|NCT04064905|470969561|FG000|Overall Study|Lost to Follow-up|0|||
130819508|NCT04064905|470969562|FG001|Overall Study|Lost to Follow-up|3|||
130819509|NCT04064905|470969563|FG002|Overall Study|Lost to Follow-up|1|||
130819510|NCT04064905|470969564|FG003|Overall Study|Lost to Follow-up|4|||
130819511|NCT04064905|470969565|FG004|Overall Study|Lost to Follow-up|2|||
130819512|NCT02257684|470969566|FG000|Overall Study|Adverse Event|2|||
130819513|NCT02257684|470969566|FG000|Overall Study|Lack of Efficacy|1|||
130819514|NCT02257684|470969566|FG000|Overall Study|Sponsor's Decision|1|||
130819515|NCT01570387|470969567|FG000|Overall Study|Adverse Event|1|||
130819516|NCT01570387|470969568|FG001|Overall Study|Adverse Event|0|||
130819517|NCT01570387|470969569|FG002|Overall Study|Adverse Event|0|||
130819518|NCT01570387|470969570|FG003|Overall Study|Adverse Event|0|||
130819519|NCT01570387|470969567|FG000|Overall Study|Death|0|||
130819520|NCT01570387|470969568|FG001|Overall Study|Death|0|||
130819521|NCT01570387|470969569|FG002|Overall Study|Death|0|||
130819522|NCT01570387|470969570|FG003|Overall Study|Death|1|||
130819523|NCT01570387|470969567|FG000|Overall Study|Withdrawal by Subject|0|||
130819524|NCT01570387|470969568|FG001|Overall Study|Withdrawal by Subject|0|||
130819525|NCT01570387|470969569|FG002|Overall Study|Withdrawal by Subject|0|||
130819526|NCT01570387|470969570|FG003|Overall Study|Withdrawal by Subject|1|||
130819527|NCT01987557|470969571|FG000|Overall Study|Protocol Violation|1|||
130819528|NCT01987557|470969572|FG001|Overall Study|Protocol Violation|0|||
130819529|NCT01987557|470969573|FG002|Overall Study|Protocol Violation|1|||
130819530|NCT01987557|470969571|FG000|Overall Study|Withdrawal by Subject|2|||
130819531|NCT01987557|470969572|FG001|Overall Study|Withdrawal by Subject|1|||
130819532|NCT01987557|470969573|FG002|Overall Study|Withdrawal by Subject|2|||
130819533|NCT01987557|470969571|FG000|Overall Study|Adverse Event|0|||
130819534|NCT01987557|470969572|FG001|Overall Study|Adverse Event|2|||
130819535|NCT01987557|470969573|FG002|Overall Study|Adverse Event|0|||
130819536|NCT01567722|470969580|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
130819537|NCT01567722|470969581|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
130819538|NCT01567722|470969582|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
130819539|NCT01567722|470969580|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
130819540|NCT01567722|470969581|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
130819541|NCT01567722|470969582|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
130819542|NCT01567722|470969580|FG000|Overall Study|Protocol closure by the OCG|2|||
130819543|NCT01567722|470969581|FG001|Overall Study|Protocol closure by the OCG|0|||
130819544|NCT01567722|470969582|FG002|Overall Study|Protocol closure by the OCG|0|||
130819545|NCT01567722|470969580|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
130819546|NCT01567722|470969581|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
130819547|NCT01567722|470969582|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
130819548|NCT00431964|470969583|FG000|Overall Study|Adverse Event|1|||
130819549|NCT00431964|470969584|FG001|Overall Study|Adverse Event|0|||
130819550|NCT00431964|470969583|FG000|Overall Study|Lost to Follow-up|1|||
130819551|NCT00431964|470969584|FG001|Overall Study|Lost to Follow-up|2|||
130819552|NCT00431964|470969583|FG000|Overall Study|Physician Decision|2|||
130819553|NCT00431964|470969584|FG001|Overall Study|Physician Decision|2|||
130819554|NCT00431964|470969583|FG000|Overall Study|Withdrawal by Subject|2|||
130819555|NCT00431964|470969584|FG001|Overall Study|Withdrawal by Subject|1|||
130819556|NCT00431964|470969583|FG000|Overall Study|Parental Consent Withdrawn|0|||
130819557|NCT00431964|470969584|FG001|Overall Study|Parental Consent Withdrawn|2|||
130819558|NCT00431964|470969583|FG000|Overall Study|Due to Unstable Health|0|||
130819559|NCT00431964|470969584|FG001|Overall Study|Due to Unstable Health|1|||
130819560|NCT03434834|470969591|FG000|Overall Study|unable to swallow OCT probe|16|||
130819561|NCT00518180|470969596|FG000|Overall Study|Withdrawal by Subject|29|||
130819562|NCT00518180|470969597|FG001|Overall Study|Withdrawal by Subject|30|||
130819563|NCT00518180|470969598|FG002|Overall Study|Withdrawal by Subject|42|||
130819564|NCT00518180|470969596|FG000|Overall Study|Lost to Follow-up|30|||
130819565|NCT00518180|470969597|FG001|Overall Study|Lost to Follow-up|28|||
130819566|NCT00518180|470969598|FG002|Overall Study|Lost to Follow-up|34|||
130819567|NCT00518180|470969596|FG000|Overall Study|Administrative reason|0|||
130819568|NCT00518180|470969597|FG001|Overall Study|Administrative reason|2|||
130819569|NCT00518180|470969598|FG002|Overall Study|Administrative reason|2|||
130819570|NCT00518180|470969596|FG000|Overall Study|Protocol Violation|5|||
130819571|NCT00518180|470969597|FG001|Overall Study|Protocol Violation|7|||
130819572|NCT00518180|470969598|FG002|Overall Study|Protocol Violation|4|||
130819573|NCT00518180|470969596|FG000|Overall Study|Unable to classify|0|||
130819574|NCT00518180|470969597|FG001|Overall Study|Unable to classify|2|||
130819575|NCT00518180|470969598|FG002|Overall Study|Unable to classify|0|||
130819576|NCT00518180|470969596|FG000|Overall Study|Adverse Event|1|||
130819577|NCT00518180|470969597|FG001|Overall Study|Adverse Event|0|||
130819578|NCT00518180|470969598|FG002|Overall Study|Adverse Event|0|||
130819579|NCT00956293|470969601|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
130819580|NCT00956293|470969602|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
130819581|NCT00956293|470969603|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
130819582|NCT00956293|470969601|FG000|Main Period (Pre-randomization)|Death|0|||
130819583|NCT00956293|470969602|FG001|Main Period (Pre-randomization)|Death|0|||
130819584|NCT00956293|470969603|FG002|Main Period (Pre-randomization)|Death|1|||
130819585|NCT00956293|470969601|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
130819586|NCT00956293|470969602|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
130819587|NCT00956293|470969603|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
130819588|NCT00956293|470969601|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
130819589|NCT00956293|470969602|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
130819590|NCT00956293|470969603|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
130819591|NCT00956293|470969601|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
130819592|NCT00956293|470969602|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
130819593|NCT00956293|470969603|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
130819594|NCT00956293|470969601|FG000|Main Period (Pre-randomization)|Graft loss|0|||
130819595|NCT00956293|470969602|FG001|Main Period (Pre-randomization)|Graft loss|0|||
130819596|NCT00956293|470969603|FG002|Main Period (Pre-randomization)|Graft loss|7|||
130819597|NCT00956293|470969601|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
130819598|NCT00956293|470969602|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
130819599|NCT00956293|470969603|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
130819600|NCT00956293|470969601|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
130819601|NCT00956293|470969602|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
130819602|NCT00956293|470969603|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
130819603|NCT00956293|470969601|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
130819604|NCT00956293|470969602|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
130819605|NCT00956293|470969603|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
130819606|NCT00956293|470969601|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
130819607|NCT00956293|470969602|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
130819608|NCT00956293|470969603|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
130819609|NCT00956293|470969601|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
130819610|NCT00956293|470969602|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
130819611|NCT00956293|470969603|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
130819612|NCT00956293|470969601|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
130819613|NCT00956293|470969602|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
130819614|NCT00956293|470969603|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
130819615|NCT00956293|470969601|FG000|Main Period (Randomization)|Adverse Event|0|||
130819616|NCT00956293|470969602|FG001|Main Period (Randomization)|Adverse Event|15|||
130819617|NCT00956293|470969603|FG002|Main Period (Randomization)|Adverse Event|0|||
130819618|NCT00956293|470969601|FG000|Follow-up Period|Follow-up period was terminated.|20|||
130819619|NCT00956293|470969602|FG001|Follow-up Period|Follow-up period was terminated.|32|||
130819620|NCT00956293|470969603|FG002|Follow-up Period|Follow-up period was terminated.|0|||
130819621|NCT03507127|470969604|FG000|Overall Study|Withdrawal by Subject|1|||
130819622|NCT03507127|470969605|FG001|Overall Study|Withdrawal by Subject|0|||
130819623|NCT03507127|470969604|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
130819624|NCT03507127|470969605|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
130819625|NCT03508050|470969606|FG000|Overall Study|Pleural adhesions|1|||
130819626|NCT03508050|470969607|FG001|Overall Study|Pleural adhesions|0|||
130819627|NCT03508050|470969606|FG000|Overall Study|Mucus plug|1|||
130819628|NCT03508050|470969607|FG001|Overall Study|Mucus plug|0|||
130819629|NCT03508050|470969606|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
130819630|NCT03508050|470969607|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
130819631|NCT03508050|470969606|FG000|Overall Study|Sustained desaturation|0|||
130819632|NCT03508050|470969607|FG001|Overall Study|Sustained desaturation|1|||
130819633|NCT01240863|470969608|FG000|Open-label Titration Period|Adverse Event|47|||
130819634|NCT01240863|470969609|FG001|Open-label Titration Period|Adverse Event|0|||
130819635|NCT01240863|470969610|FG002|Open-label Titration Period|Adverse Event|0|||
130819636|NCT01240863|470969608|FG000|Open-label Titration Period|Lack of Efficacy|19|||
130819637|NCT01240863|470969609|FG001|Open-label Titration Period|Lack of Efficacy|0|||
130819638|NCT01240863|470969610|FG002|Open-label Titration Period|Lack of Efficacy|0|||
130819639|NCT01240863|470969608|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
130819640|NCT01240863|470969609|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
130819641|NCT01240863|470969610|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
130819642|NCT01240863|470969608|FG000|Open-label Titration Period|Protocol Violation|7|||
130819643|NCT01240863|470969609|FG001|Open-label Titration Period|Protocol Violation|0|||
130819644|NCT01240863|470969610|FG002|Open-label Titration Period|Protocol Violation|0|||
130819645|NCT01240863|470969608|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
130819646|NCT01240863|470969609|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
130819647|NCT01240863|470969610|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
130819648|NCT01240863|470969608|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
130819649|NCT01240863|470969609|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
130819650|NCT01240863|470969610|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
130819651|NCT01240863|470969608|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
130819652|NCT01240863|470969609|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
130819653|NCT01240863|470969610|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
130819654|NCT01240863|470969608|FG000|Open-label Titration Period|Other|7|||
130819655|NCT01240863|470969609|FG001|Open-label Titration Period|Other|0|||
130819656|NCT01240863|470969610|FG002|Open-label Titration Period|Other|0|||
130819657|NCT01240863|470969608|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
130819658|NCT01240863|470969609|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
130819659|NCT01240863|470969610|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
130819660|NCT01240863|470969608|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130819661|NCT01240863|470969609|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
130819662|NCT01240863|470969610|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
130819663|NCT01240863|470969608|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130819664|NCT01240863|470969609|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
130819665|NCT01240863|470969610|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
130819666|NCT01240863|470969608|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130819667|NCT01240863|470969609|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
130819668|NCT01240863|470969610|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
130819669|NCT01240863|470969608|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
130819670|NCT01240863|470969609|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
130819671|NCT01240863|470969610|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
130819672|NCT01240863|470969608|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
130819673|NCT01240863|470969609|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
130819674|NCT01240863|470969610|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
130819675|NCT01240863|470969608|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
130819676|NCT01240863|470969609|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
130819677|NCT01240863|470969610|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
130819678|NCT01240863|470969608|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
130819679|NCT01240863|470969609|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
130819680|NCT01240863|470969610|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
130819681|NCT00485173|470969613|FG000|Overall Study|Death|4|||
130819682|NCT00485173|470969614|FG001|Overall Study|Death|3|||
130819683|NCT00485173|470969613|FG000|Overall Study|Lost to Follow-up|32|||
130819684|NCT00485173|470969614|FG001|Overall Study|Lost to Follow-up|61|||
130819685|NCT00659425|470969617|FG000|Overall Study|Disease progression|1|||
130819686|NCT00659425|470969618|FG001|Overall Study|Disease progression|0|||
130819687|NCT00659425|470969619|FG002|Overall Study|Disease progression|0|||
130819688|NCT00659425|470969620|FG003|Overall Study|Disease progression|1|||
130819689|NCT00659425|470969621|FG004|Overall Study|Disease progression|0|||
130819690|NCT00659425|470969622|FG005|Overall Study|Disease progression|2|||
130819691|NCT00659425|470969623|FG006|Overall Study|Disease progression|4|||
130819692|NCT00659425|470969624|FG007|Overall Study|Disease progression|3|||
130819693|NCT00659425|470969625|FG008|Overall Study|Disease progression|5|||
130819694|NCT00659425|470969626|FG009|Overall Study|Disease progression|3|||
130819695|NCT00659425|470969617|FG000|Overall Study|Death|0|||
130819696|NCT00659425|470969618|FG001|Overall Study|Death|0|||
130819697|NCT00659425|470969619|FG002|Overall Study|Death|0|||
130819698|NCT00659425|470969620|FG003|Overall Study|Death|1|||
130819699|NCT00659425|470969621|FG004|Overall Study|Death|0|||
130819700|NCT00659425|470969622|FG005|Overall Study|Death|0|||
130819701|NCT00659425|470969623|FG006|Overall Study|Death|1|||
130819702|NCT00659425|470969624|FG007|Overall Study|Death|0|||
130819703|NCT00659425|470969625|FG008|Overall Study|Death|0|||
130819704|NCT00659425|470969626|FG009|Overall Study|Death|0|||
130819705|NCT00659425|470969617|FG000|Overall Study|Adverse Event|0|||
130819706|NCT00659425|470969618|FG001|Overall Study|Adverse Event|0|||
130819707|NCT00659425|470969619|FG002|Overall Study|Adverse Event|0|||
130819708|NCT00659425|470969620|FG003|Overall Study|Adverse Event|0|||
130819709|NCT00659425|470969621|FG004|Overall Study|Adverse Event|0|||
130819710|NCT00659425|470969622|FG005|Overall Study|Adverse Event|1|||
130819711|NCT00659425|470969623|FG006|Overall Study|Adverse Event|0|||
130819712|NCT00659425|470969624|FG007|Overall Study|Adverse Event|3|||
130819713|NCT00659425|470969625|FG008|Overall Study|Adverse Event|1|||
130819714|NCT00659425|470969626|FG009|Overall Study|Adverse Event|4|||
130819715|NCT00659425|470969617|FG000|Overall Study|Investigator Discretion|0|||
130819716|NCT00659425|470969618|FG001|Overall Study|Investigator Discretion|0|||
130819717|NCT00659425|470969619|FG002|Overall Study|Investigator Discretion|0|||
130819718|NCT00659425|470969620|FG003|Overall Study|Investigator Discretion|0|||
130819719|NCT00659425|470969621|FG004|Overall Study|Investigator Discretion|0|||
130819720|NCT00659425|470969622|FG005|Overall Study|Investigator Discretion|1|||
130819721|NCT00659425|470969623|FG006|Overall Study|Investigator Discretion|0|||
130819722|NCT00659425|470969624|FG007|Overall Study|Investigator Discretion|3|||
130819723|NCT00659425|470969625|FG008|Overall Study|Investigator Discretion|0|||
130819724|NCT00659425|470969626|FG009|Overall Study|Investigator Discretion|0|||
130819725|NCT00659425|470969617|FG000|Overall Study|Other|0|||
130819726|NCT00659425|470969618|FG001|Overall Study|Other|1|||
130819727|NCT00659425|470969619|FG002|Overall Study|Other|1|||
130819728|NCT00659425|470969620|FG003|Overall Study|Other|2|||
130819729|NCT00659425|470969621|FG004|Overall Study|Other|4|||
130819730|NCT00659425|470969622|FG005|Overall Study|Other|0|||
130819731|NCT00659425|470969623|FG006|Overall Study|Other|3|||
130819732|NCT00659425|470969624|FG007|Overall Study|Other|2|||
130819733|NCT00659425|470969625|FG008|Overall Study|Other|0|||
130819734|NCT00659425|470969626|FG009|Overall Study|Other|6|||
130819735|NCT00829244|470969627|FG000|Overall Study|Adverse Event|1|||
130819736|NCT00829244|470969628|FG001|Overall Study|Adverse Event|3|||
130819737|NCT00829244|470969627|FG000|Overall Study|Protocol Violation|1|||
130819738|NCT00829244|470969628|FG001|Overall Study|Protocol Violation|0|||
130819739|NCT00829244|470969627|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
130819740|NCT00829244|470969628|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
130819741|NCT00829244|470969627|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
130819742|NCT00829244|470969628|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
130819743|NCT00829244|470969627|FG000|Overall Study|No fertilization|2|||
130819744|NCT00829244|470969628|FG001|Overall Study|No fertilization|2|||
130819745|NCT00829244|470969627|FG000|Overall Study|All embryos discarded|0|||
130819746|NCT00829244|470969628|FG001|Overall Study|All embryos discarded|3|||
130819747|NCT00829244|470969627|FG000|Overall Study|No embryo cleavage|0|||
130819748|NCT00829244|470969628|FG001|Overall Study|No embryo cleavage|2|||
130819749|NCT03342560|470969629|FG000|Overall Study|Lost to Follow-up|2|||
130819750|NCT02604511|470969630|FG000|Overall Study|Adverse Event|3|||
130819751|NCT02604511|470969630|FG000|Overall Study|Disease Progression|4|||
130819752|NCT02604511|470969630|FG000|Overall Study|Withdrawal by Subject|3|||
130819753|NCT02604511|470969630|FG000|Overall Study|Participant ineligible|1|||
130819754|NCT02604511|470969630|FG000|Overall Study|Intercurrent illness|1|||
130819755|NCT03770286|470969631|FG000|Overall Study|Lost to Follow-up|6|||
130819756|NCT03770286|470969632|FG001|Overall Study|Lost to Follow-up|4|||
130819757|NCT03770286|470969633|FG002|Overall Study|Lost to Follow-up|3|||
130819758|NCT03770286|470969631|FG000|Overall Study|Protocol Violation|1|||
130819759|NCT03770286|470969632|FG001|Overall Study|Protocol Violation|0|||
130819760|NCT03770286|470969633|FG002|Overall Study|Protocol Violation|2|||
130819761|NCT02505425|470969634|FG000|Overall Study|Lost to Follow-up|41|||
130819762|NCT02505425|470969635|FG001|Overall Study|Lost to Follow-up|61|||
130819763|NCT02505425|470969636|FG002|Overall Study|Lost to Follow-up|31|||
130819764|NCT02505425|470969637|FG003|Overall Study|Lost to Follow-up|19|||
130819765|NCT02505425|470969634|FG000|Overall Study|Withdrawal by Subject|39|||
130819766|NCT02505425|470969635|FG001|Overall Study|Withdrawal by Subject|9|||
130819767|NCT02505425|470969636|FG002|Overall Study|Withdrawal by Subject|19|||
130819768|NCT02505425|470969637|FG003|Overall Study|Withdrawal by Subject|7|||
130819769|NCT02505425|470969634|FG000|Overall Study|Death|8|||
130819770|NCT02505425|470969635|FG001|Overall Study|Death|12|||
130819771|NCT02505425|470969636|FG002|Overall Study|Death|0|||
130819772|NCT02505425|470969637|FG003|Overall Study|Death|0|||
130819773|NCT02031302|470969638|FG000|Overall Study|Death|115|||
130819774|NCT02031302|470969639|FG001|Overall Study|Death|0|||
130819775|NCT02031302|470969638|FG000|Overall Study|Not treated with study valve system|18|||
130819776|NCT02031302|470969639|FG001|Overall Study|Not treated with study valve system|0|||
130819777|NCT02031302|470969638|FG000|Overall Study|Missed Follow Up|27|||
130819778|NCT02031302|470969639|FG001|Overall Study|Missed Follow Up|0|||
130819779|NCT02031302|470969638|FG000|Overall Study|Lost to Follow-up|4|||
130819780|NCT02031302|470969639|FG001|Overall Study|Lost to Follow-up|0|||
130819781|NCT02781558|470969644|FG000|Overall Study|Lost to Follow-up|2|||
130819782|NCT02781558|470969645|FG001|Overall Study|Lost to Follow-up|2|||
130819783|NCT02781558|470969644|FG000|Overall Study|Adverse Event|1|||
130819784|NCT02781558|470969645|FG001|Overall Study|Adverse Event|0|||
130819785|NCT01150357|470969646|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
130819786|NCT01150357|470969647|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
130819787|NCT01150357|470969648|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
130819788|NCT01150357|470969646|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
130819789|NCT01150357|470969647|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
130819790|NCT01150357|470969648|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
130819791|NCT01150357|470969646|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
130819792|NCT01150357|470969647|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
130819793|NCT01150357|470969648|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
130819794|NCT01150357|470969646|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
130819795|NCT01150357|470969647|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
130819796|NCT01150357|470969648|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
130819797|NCT01150357|470969646|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
130819798|NCT01150357|470969647|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
130819799|NCT01150357|470969648|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
130819800|NCT01150357|470969646|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
130819801|NCT01150357|470969647|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
130819802|NCT01150357|470969648|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
130819803|NCT01150357|470969646|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
130819804|NCT01150357|470969647|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
130819805|NCT01150357|470969648|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
130819806|NCT01173679|470970967|FG000|Overall Study|Death|1|||
130819807|NCT02777086|470970968|FG000|Overall Study|Lost to Follow-up|96|||
130819808|NCT02777086|470970969|FG001|Overall Study|Lost to Follow-up|99|||
130819809|NCT01133665|470970970|FG000|Overall Study|Physician Decision|2|||
130819810|NCT01732536|470970971|FG000|Overall Study|Withdrawal by Subject|1|||
130819811|NCT01732536|470970972|FG001|Overall Study|Withdrawal by Subject|1|||
130819812|NCT02122380|470970973|FG000|First Intervention (30 Days)|Adverse Event|1|||
130819813|NCT02122380|470970974|FG001|First Intervention (30 Days)|Adverse Event|0|||
130819814|NCT02122380|470970973|FG000|First Intervention (30 Days)|Physician Decision|0|||
130819815|NCT02122380|470970974|FG001|First Intervention (30 Days)|Physician Decision|1|||
130819816|NCT02122380|470970973|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
130819817|NCT02122380|470970974|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
130819818|NCT02122380|470970973|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
130819819|NCT02122380|470970974|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
130819820|NCT02122380|470970973|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
130819821|NCT02122380|470970974|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
130819822|NCT01581684|470970977|FG000|Overall Study|Other reason not defined|0|||
130819823|NCT01581684|470970978|FG001|Overall Study|Other reason not defined|0|||
130819824|NCT01581684|470970979|FG002|Overall Study|Other reason not defined|0|||
130819825|NCT01581684|470970980|FG003|Overall Study|Other reason not defined|0|||
130819826|NCT01581684|470970981|FG004|Overall Study|Other reason not defined|0|||
130819827|NCT01581684|470970982|FG005|Overall Study|Other reason not defined|0|||
130819828|NCT01581684|470970983|FG006|Overall Study|Other reason not defined|0|||
130819829|NCT01581684|470970984|FG007|Overall Study|Other reason not defined|0|||
130819830|NCT01581684|470970985|FG008|Overall Study|Other reason not defined|1|||
130819831|NCT01581684|470970986|FG009|Overall Study|Other reason not defined|0|||
130819832|NCT03728933|470970987|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130819833|NCT03728933|470970988|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130819834|NCT03728933|470970989|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130819835|NCT03728933|470970987|FG000|Overall Study|Withdrawal by Subject|0|||
130819836|NCT03728933|470970988|FG001|Overall Study|Withdrawal by Subject|0|||
130819837|NCT03728933|470970989|FG002|Overall Study|Withdrawal by Subject|1|||
130819838|NCT03728933|470970987|FG000|Overall Study|Lost to Follow-up|0|||
130819839|NCT03728933|470970988|FG001|Overall Study|Lost to Follow-up|1|||
130819840|NCT03728933|470970989|FG002|Overall Study|Lost to Follow-up|0|||
130819841|NCT03728933|470970987|FG000|Overall Study|Adverse Event|1|||
130819842|NCT03728933|470970988|FG001|Overall Study|Adverse Event|0|||
130819843|NCT03728933|470970989|FG002|Overall Study|Adverse Event|0|||
130819844|NCT01784029|470970990|FG000|Overall Study|Lost to Follow-up|19|||
130819845|NCT01784029|470970991|FG001|Overall Study|Lost to Follow-up|20|||
130819846|NCT01784029|470970992|FG002|Overall Study|Lost to Follow-up|22|||
130819847|NCT00639457|470970993|FG000|Overall Study|Withdrawal by Subject|2|||
130819848|NCT00639457|470970994|FG001|Overall Study|Withdrawal by Subject|3|||
130819849|NCT03235050|470970995|FG000|Overall Study|Adverse Event|0|||
130819850|NCT03235050|470970996|FG001|Overall Study|Adverse Event|0|||
130819851|NCT03235050|470970997|FG002|Overall Study|Adverse Event|1|||
130819852|NCT03235050|470970998|FG003|Overall Study|Adverse Event|4|||
130819853|NCT03235050|470970999|FG004|Overall Study|Adverse Event|1|||
130819854|NCT03235050|470970995|FG000|Overall Study|Death|0|||
130819855|NCT03235050|470970996|FG001|Overall Study|Death|0|||
130819856|NCT03235050|470970997|FG002|Overall Study|Death|0|||
130819857|NCT03235050|470970998|FG003|Overall Study|Death|2|||
130819858|NCT03235050|470970999|FG004|Overall Study|Death|1|||
130819859|NCT03235050|470970995|FG000|Overall Study|Lost to Follow-up|1|||
130819860|NCT03235050|470970996|FG001|Overall Study|Lost to Follow-up|2|||
130819861|NCT03235050|470970997|FG002|Overall Study|Lost to Follow-up|1|||
130819862|NCT03235050|470970998|FG003|Overall Study|Lost to Follow-up|2|||
130819863|NCT03235050|470970999|FG004|Overall Study|Lost to Follow-up|0|||
130819864|NCT03235050|470970995|FG000|Overall Study|Withdrawal by Subject|3|||
130819865|NCT03235050|470970996|FG001|Overall Study|Withdrawal by Subject|2|||
130819866|NCT03235050|470970997|FG002|Overall Study|Withdrawal by Subject|2|||
130819867|NCT03235050|470970998|FG003|Overall Study|Withdrawal by Subject|5|||
130819868|NCT03235050|470970999|FG004|Overall Study|Withdrawal by Subject|7|||
130819869|NCT03235050|470970995|FG000|Overall Study|Other reasons|0|||
130819870|NCT03235050|470970996|FG001|Overall Study|Other reasons|1|||
130819871|NCT03235050|470970997|FG002|Overall Study|Other reasons|0|||
130819872|NCT03235050|470970998|FG003|Overall Study|Other reasons|1|||
130819873|NCT03235050|470970999|FG004|Overall Study|Other reasons|2|||
130819874|NCT00276419|470971000|FG000|First Intervention|Adverse Event|1|||
130819875|NCT00276419|470971001|FG001|First Intervention|Adverse Event|0|||
130819876|NCT00276419|470971000|FG000|First Intervention|Withdrawal by Subject|0|||
130819877|NCT00276419|470971001|FG001|First Intervention|Withdrawal by Subject|2|||
130819878|NCT02415556|470971004|FG000|Overall Study|Adverse Event|3|||
130819879|NCT02415556|470971005|FG001|Overall Study|Adverse Event|4|||
130819880|NCT02415556|470971006|FG002|Overall Study|Adverse Event|2|||
130819881|NCT02415556|470971007|FG003|Overall Study|Adverse Event|4|||
130819882|NCT02415556|470971004|FG000|Overall Study|Lost to Follow-up|4|||
130819883|NCT02415556|470971005|FG001|Overall Study|Lost to Follow-up|5|||
130819884|NCT02415556|470971006|FG002|Overall Study|Lost to Follow-up|4|||
130819885|NCT02415556|470971007|FG003|Overall Study|Lost to Follow-up|1|||
130819886|NCT02415556|470971004|FG000|Overall Study|Withdrawal by Subject|13|||
130819887|NCT02415556|470971005|FG001|Overall Study|Withdrawal by Subject|4|||
130819888|NCT02415556|470971006|FG002|Overall Study|Withdrawal by Subject|14|||
130819889|NCT02415556|470971007|FG003|Overall Study|Withdrawal by Subject|12|||
130819890|NCT02415556|470971004|FG000|Overall Study|Physician Decision|1|||
130819891|NCT02415556|470971005|FG001|Overall Study|Physician Decision|3|||
130819892|NCT02415556|470971006|FG002|Overall Study|Physician Decision|1|||
130819893|NCT02415556|470971007|FG003|Overall Study|Physician Decision|2|||
130819894|NCT02415556|470971004|FG000|Overall Study|Censored - study completion|4|||
130819895|NCT02415556|470971005|FG001|Overall Study|Censored - study completion|5|||
130819896|NCT02415556|470971006|FG002|Overall Study|Censored - study completion|1|||
130819897|NCT02415556|470971007|FG003|Overall Study|Censored - study completion|0|||
130819898|NCT02415556|470971004|FG000|Overall Study|Family-related issues|0|||
130819899|NCT02415556|470971005|FG001|Overall Study|Family-related issues|0|||
130819900|NCT02415556|470971006|FG002|Overall Study|Family-related issues|0|||
130819901|NCT02415556|470971007|FG003|Overall Study|Family-related issues|1|||
130819902|NCT01621178|470971008|FG000|Overall Study|Adverse Event|5|||
130819903|NCT01621178|470971009|FG001|Overall Study|Adverse Event|2|||
130819904|NCT01621178|470971010|FG002|Overall Study|Adverse Event|8|||
130819905|NCT01621178|470971008|FG000|Overall Study|Death|6|||
130819906|NCT01621178|470971009|FG001|Overall Study|Death|7|||
130819907|NCT01621178|470971010|FG002|Overall Study|Death|2|||
130819908|NCT01621178|470971008|FG000|Overall Study|Lost to Follow-up|1|||
130819909|NCT01621178|470971009|FG001|Overall Study|Lost to Follow-up|2|||
130819910|NCT01621178|470971010|FG002|Overall Study|Lost to Follow-up|1|||
130819911|NCT01621178|470971008|FG000|Overall Study|Withdrawal by Subject|14|||
130819912|NCT01621178|470971009|FG001|Overall Study|Withdrawal by Subject|17|||
130819913|NCT01621178|470971010|FG002|Overall Study|Withdrawal by Subject|18|||
130819914|NCT01621178|470971008|FG000|Overall Study|Physician Decision|5|||
130819915|NCT01621178|470971009|FG001|Overall Study|Physician Decision|2|||
130819916|NCT01621178|470971010|FG002|Overall Study|Physician Decision|7|||
130819917|NCT00105534|470971011|FG000|Overall Study|Adverse Event|2|||
130819918|NCT00105534|470971012|FG001|Overall Study|Adverse Event|5|||
130819919|NCT00105534|470971011|FG000|Overall Study|Protocol Violation|1|||
130819920|NCT00105534|470971012|FG001|Overall Study|Protocol Violation|4|||
130819921|NCT00105534|470971011|FG000|Overall Study|Withdrawal by Subject|6|||
130819922|NCT00105534|470971012|FG001|Overall Study|Withdrawal by Subject|6|||
130819923|NCT00105534|470971011|FG000|Overall Study|Lost to Follow-up|5|||
130819924|NCT00105534|470971012|FG001|Overall Study|Lost to Follow-up|1|||
130819925|NCT00105534|470971011|FG000|Overall Study|Lack of Efficacy|7|||
130819926|NCT00105534|470971012|FG001|Overall Study|Lack of Efficacy|15|||
130819927|NCT00105534|470971011|FG000|Overall Study|Treatment unmasked|1|||
130819928|NCT00105534|470971012|FG001|Overall Study|Treatment unmasked|0|||
130819929|NCT00105534|470971011|FG000|Overall Study|Other Reason|0|||
130819930|NCT00105534|470971012|FG001|Overall Study|Other Reason|2|||
130819931|NCT02896257|470971013|FG000|Providers|Without eligible patients|21|||
130819932|NCT02896257|470971014|FG001|Providers|Without eligible patients|28|||
130819933|NCT02896257|470971013|FG000|Patients|PFT entry criteria not met|43|||
130819934|NCT02896257|470971014|FG001|Patients|PFT entry criteria not met|50|||
130819935|NCT02896257|470971013|FG000|Patients|No capacity to review|8|||
130819936|NCT02896257|470971014|FG001|Patients|No capacity to review|11|||
130819937|NCT02896257|470971013|FG000|Patients|Appointment rescheduled/cancelled|5|||
130819938|NCT02896257|470971014|FG001|Patients|Appointment rescheduled/cancelled|7|||
130819939|NCT02896257|470971013|FG000|Patients|PCP not assigned a clinic|4|||
130819940|NCT02896257|470971014|FG001|Patients|PCP not assigned a clinic|0|||
130819941|NCT02896257|470971013|FG000|Patients|No history of COPD|0|||
130819942|NCT02896257|470971014|FG001|Patients|No history of COPD|1|||
130819943|NCT02896257|470971013|FG000|Patients|Deceased between review and index date|0|||
130819944|NCT02896257|470971014|FG001|Patients|Deceased between review and index date|1|||
130819945|NCT02896257|470971013|FG000|Patients|No ICS Rx upon review|1|||
130819946|NCT02896257|470971014|FG001|Patients|No ICS Rx upon review|1|||
130819947|NCT02896257|470971013|FG000|Patients|Protocol Violation|2|||
130819948|NCT02896257|470971014|FG001|Patients|Protocol Violation|1|||
130819949|NCT02896257|470971013|FG000|Patients|Hospice care|0|||
130819950|NCT02896257|470971014|FG001|Patients|Hospice care|1|||
130819951|NCT04778592|470971018|FG000|Overall Study|Adverse Event|1|||
130819952|NCT04778592|470971019|FG001|Overall Study|Adverse Event|2|||
130819953|NCT04778592|470971018|FG000|Overall Study|Withdrawal by Subject|1|||
130819954|NCT04778592|470971019|FG001|Overall Study|Withdrawal by Subject|2|||
130819955|NCT01192126|470971020|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
130819956|NCT01192126|470971021|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
130819957|NCT01192126|470971020|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
130819958|NCT01192126|470971021|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
130819959|NCT02660229|470971025|FG000|Overall Study|Adverse Event|2|||
130819960|NCT02660229|470971026|FG001|Overall Study|Adverse Event|0|||
130819961|NCT02660229|470971025|FG000|Overall Study|Withdrawal by Subject|0|||
130819962|NCT02660229|470971026|FG001|Overall Study|Withdrawal by Subject|1|||
130819963|NCT00329030|470971027|FG000|Overall Study|Withdrawal by Subject|1|||
130819964|NCT00329030|470971028|FG001|Overall Study|Withdrawal by Subject|3|||
130819965|NCT00329030|470971027|FG000|Overall Study|Progressive Disease|6|||
130819966|NCT00329030|470971028|FG001|Overall Study|Progressive Disease|2|||
130819967|NCT00329030|470971027|FG000|Overall Study|Ineligible Pathology|1|||
130819968|NCT00329030|470971028|FG001|Overall Study|Ineligible Pathology|1|||
130819969|NCT03012334|470971029|FG000|Period 1|Withdrawal by Subject|0|||
130819970|NCT03012334|470971030|FG001|Period 1|Withdrawal by Subject|0|||
130819971|NCT03012334|470971031|FG002|Period 1|Withdrawal by Subject|0|||
130819972|NCT03012334|470971032|FG003|Period 1|Withdrawal by Subject|0|||
130819973|NCT03012334|470971033|FG004|Period 1|Withdrawal by Subject|0|||
130819974|NCT03012334|470971034|FG005|Period 1|Withdrawal by Subject|0|||
130819975|NCT03012334|470971035|FG006|Period 1|Withdrawal by Subject|0|||
130819976|NCT03012334|470971036|FG007|Period 1|Withdrawal by Subject|0|||
130819977|NCT03012334|470971037|FG008|Period 1|Withdrawal by Subject|0|||
130819978|NCT03012334|470971038|FG009|Period 1|Withdrawal by Subject|1|||
130819979|NCT03012334|470971029|FG000|Period 2|Withdrawal by Subject|0|||
130819980|NCT03012334|470971030|FG001|Period 2|Withdrawal by Subject|1|||
130819981|NCT03012334|470971031|FG002|Period 2|Withdrawal by Subject|0|||
130819982|NCT03012334|470971032|FG003|Period 2|Withdrawal by Subject|0|||
130819983|NCT03012334|470971033|FG004|Period 2|Withdrawal by Subject|0|||
130819984|NCT03012334|470971034|FG005|Period 2|Withdrawal by Subject|0|||
130819985|NCT03012334|470971035|FG006|Period 2|Withdrawal by Subject|0|||
130819986|NCT03012334|470971036|FG007|Period 2|Withdrawal by Subject|0|||
130819987|NCT03012334|470971037|FG008|Period 2|Withdrawal by Subject|0|||
130819988|NCT03012334|470971038|FG009|Period 2|Withdrawal by Subject|0|||
130819989|NCT03012334|470971029|FG000|Period 2|Protocol Violation|0|||
130819990|NCT03012334|470971030|FG001|Period 2|Protocol Violation|0|||
130819991|NCT03012334|470971031|FG002|Period 2|Protocol Violation|1|||
130819992|NCT03012334|470971032|FG003|Period 2|Protocol Violation|0|||
130819993|NCT03012334|470971033|FG004|Period 2|Protocol Violation|0|||
130819994|NCT03012334|470971034|FG005|Period 2|Protocol Violation|0|||
130819995|NCT03012334|470971035|FG006|Period 2|Protocol Violation|0|||
130819996|NCT03012334|470971036|FG007|Period 2|Protocol Violation|1|||
130819997|NCT03012334|470971037|FG008|Period 2|Protocol Violation|0|||
130819998|NCT03012334|470971038|FG009|Period 2|Protocol Violation|0|||
130819999|NCT03012334|470971029|FG000|Period 4|Non-Compliance|0|||
130820000|NCT03012334|470971030|FG001|Period 4|Non-Compliance|0|||
130820001|NCT03012334|470971031|FG002|Period 4|Non-Compliance|0|||
130820002|NCT03012334|470971032|FG003|Period 4|Non-Compliance|0|||
130820003|NCT03012334|470971033|FG004|Period 4|Non-Compliance|0|||
130820004|NCT03012334|470971034|FG005|Period 4|Non-Compliance|0|||
130820005|NCT03012334|470971035|FG006|Period 4|Non-Compliance|1|||
130820006|NCT03012334|470971036|FG007|Period 4|Non-Compliance|0|||
130820007|NCT03012334|470971037|FG008|Period 4|Non-Compliance|0|||
130820008|NCT03012334|470971038|FG009|Period 4|Non-Compliance|0|||
130820009|NCT03012334|470971029|FG000|Period 4|Adverse Event|0|||
130820010|NCT03012334|470971030|FG001|Period 4|Adverse Event|0|||
130820011|NCT03012334|470971031|FG002|Period 4|Adverse Event|0|||
130820012|NCT03012334|470971032|FG003|Period 4|Adverse Event|0|||
130820013|NCT03012334|470971033|FG004|Period 4|Adverse Event|0|||
130820014|NCT03012334|470971034|FG005|Period 4|Adverse Event|0|||
130820015|NCT03012334|470971035|FG006|Period 4|Adverse Event|0|||
130820016|NCT03012334|470971036|FG007|Period 4|Adverse Event|0|||
130820017|NCT03012334|470971037|FG008|Period 4|Adverse Event|1|||
130820018|NCT03012334|470971038|FG009|Period 4|Adverse Event|0|||
130820019|NCT01541371|470971045|FG000|Overall Study|Withdrawal by Subject|14|||
130820020|NCT01541371|470971045|FG000|Overall Study|Lost to Follow-up|21|||
130820021|NCT01541371|470971045|FG000|Overall Study|Adverse Event|15|||
130820022|NCT01541371|470971045|FG000|Overall Study|Lack of Efficacy|12|||
130820023|NCT01541371|470971045|FG000|Overall Study|Protocol Violation|6|||
130820024|NCT01541371|470971045|FG000|Overall Study|Study medication non-compliance|3|||
130820025|NCT01541371|470971045|FG000|Overall Study|Other|6|||
130820026|NCT00744861|470971048|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
130820027|NCT00744861|470971049|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
130820028|NCT00744861|470971050|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
130820029|NCT00744861|470971051|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
130820030|NCT00744861|470971048|FG000|Feasibility Stage 1|Pregnancy|0|||
130820031|NCT00744861|470971049|FG001|Feasibility Stage 1|Pregnancy|1|||
130820032|NCT00744861|470971050|FG002|Feasibility Stage 1|Pregnancy|0|||
130820033|NCT00744861|470971051|FG003|Feasibility Stage 1|Pregnancy|0|||
130820034|NCT00744861|470971048|FG000|Pivotal Stage 2|Adverse Event|0|||
130820035|NCT00744861|470971049|FG001|Pivotal Stage 2|Adverse Event|0|||
130820036|NCT00744861|470971050|FG002|Pivotal Stage 2|Adverse Event|6|||
130820037|NCT00744861|470971051|FG003|Pivotal Stage 2|Adverse Event|11|||
130820038|NCT00744861|470971048|FG000|Pivotal Stage 2|Death|0|||
130820039|NCT00744861|470971049|FG001|Pivotal Stage 2|Death|0|||
130820040|NCT00744861|470971050|FG002|Pivotal Stage 2|Death|0|||
130820041|NCT00744861|470971051|FG003|Pivotal Stage 2|Death|1|||
130820042|NCT00744861|470971048|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
130820043|NCT00744861|470971049|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
130820044|NCT00744861|470971050|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
130820045|NCT00744861|470971051|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
130820046|NCT00744861|470971048|FG000|Pivotal Stage 2|Physician Decision|0|||
130820047|NCT00744861|470971049|FG001|Pivotal Stage 2|Physician Decision|0|||
130820048|NCT00744861|470971050|FG002|Pivotal Stage 2|Physician Decision|3|||
130820049|NCT00744861|470971051|FG003|Pivotal Stage 2|Physician Decision|1|||
130820050|NCT00744861|470971048|FG000|Pivotal Stage 2|Protocol Violation|0|||
130820051|NCT00744861|470971049|FG001|Pivotal Stage 2|Protocol Violation|0|||
130820052|NCT00744861|470971050|FG002|Pivotal Stage 2|Protocol Violation|0|||
130820053|NCT00744861|470971051|FG003|Pivotal Stage 2|Protocol Violation|1|||
130820054|NCT00744861|470971048|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
130820055|NCT00744861|470971049|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
130820056|NCT00744861|470971050|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
130820057|NCT00744861|470971051|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
130820058|NCT00744861|470971048|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
130820059|NCT00744861|470971049|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
130820060|NCT00744861|470971050|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
130820061|NCT00744861|470971051|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
130820062|NCT00186628|470971052|FG000|Overall Study|Death|2|||
130820063|NCT00186628|470971052|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
130820064|NCT00181844|470971053|FG000|Signed Consent|Withdrawal by Subject|5|||
130820065|NCT00181844|470971053|FG000|Signed Consent|Did not meet entrance criteria|7|||
130820066|NCT00181844|470971053|FG000|Exposed to Study Medication|Adverse Event|10|||
130820067|NCT00181844|470971053|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
130820068|NCT00181844|470971053|FG000|Exposed to Study Medication|Non-compliance|2|||
130820069|NCT00181844|470971053|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
130820070|NCT00181844|470971053|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
130820071|NCT00760552|470971062|FG000|Overall Study|Death|2|||
130820072|NCT00760552|470971063|FG001|Overall Study|Death|0|||
130820073|NCT00760552|470971062|FG000|Overall Study|Lost to Follow-up|11|||
130820074|NCT00760552|470971063|FG001|Overall Study|Lost to Follow-up|10|||
130820075|NCT00382174|470971064|FG000|Overall Study|Lost to Follow-up|1|||
130820076|NCT00382174|470971065|FG001|Overall Study|Lost to Follow-up|4|||
130820077|NCT00382174|470971066|FG002|Overall Study|Lost to Follow-up|5|||
130820078|NCT00382174|470971064|FG000|Overall Study|Adverse Event|1|||
130820079|NCT00382174|470971065|FG001|Overall Study|Adverse Event|4|||
130820080|NCT00382174|470971066|FG002|Overall Study|Adverse Event|5|||
130820081|NCT00382174|470971064|FG000|Overall Study|Withdrawal by Subject|1|||
130820082|NCT00382174|470971065|FG001|Overall Study|Withdrawal by Subject|4|||
130820083|NCT00382174|470971066|FG002|Overall Study|Withdrawal by Subject|5|||
130820084|NCT00382174|470971064|FG000|Overall Study|Non compliance|1|||
130820085|NCT00382174|470971065|FG001|Overall Study|Non compliance|0|||
130820086|NCT00382174|470971066|FG002|Overall Study|Non compliance|1|||
130820087|NCT00382174|470971064|FG000|Overall Study|Physician Decision|0|||
130820088|NCT00382174|470971065|FG001|Overall Study|Physician Decision|2|||
130820089|NCT00382174|470971066|FG002|Overall Study|Physician Decision|2|||
130820090|NCT00382174|470971064|FG000|Overall Study|Failed to meet criteria|0|||
130820091|NCT00382174|470971065|FG001|Overall Study|Failed to meet criteria|1|||
130820092|NCT00382174|470971066|FG002|Overall Study|Failed to meet criteria|1|||
130820093|NCT00382174|470971064|FG000|Overall Study|Wounds merged|0|||
130820094|NCT00382174|470971065|FG001|Overall Study|Wounds merged|2|||
130820095|NCT00382174|470971066|FG002|Overall Study|Wounds merged|2|||
130820096|NCT02536664|470971078|FG000|Overall Study|Inadequate completion of documentation|2|||
130820097|NCT02536664|470971079|FG001|Overall Study|Inadequate completion of documentation|4|||
130820098|NCT02536664|470971078|FG000|Overall Study|Progression|13|||
130820099|NCT02536664|470971079|FG001|Overall Study|Progression|18|||
130820100|NCT02536664|470971078|FG000|Overall Study|Death due to lymphoma|2|||
130820101|NCT02536664|470971079|FG001|Overall Study|Death due to lymphoma|1|||
130820102|NCT02536664|470971078|FG000|Overall Study|Death due to other reason|3|||
130820103|NCT02536664|470971079|FG001|Overall Study|Death due to other reason|2|||
130820104|NCT02536664|470971078|FG000|Overall Study|Intolerability|8|||
130820105|NCT02536664|470971079|FG001|Overall Study|Intolerability|6|||
130820106|NCT02536664|470971078|FG000|Overall Study|Withdrawal by Subject|8|||
130820107|NCT02536664|470971079|FG001|Overall Study|Withdrawal by Subject|5|||
130820108|NCT02536664|470971078|FG000|Overall Study|Other|18|||
130820109|NCT02536664|470971079|FG001|Overall Study|Other|24|||
130820110|NCT02536664|470971078|FG000|Overall Study|Missing|53|||
130820111|NCT02536664|470971079|FG001|Overall Study|Missing|20|||
130820112|NCT03383666|470971080|FG000|Overall Study|Withdrawal by Subject|2|||
130820113|NCT03383666|470971080|FG000|Overall Study|Lost to Follow-up|2|||
130820114|NCT03961308|470971095|FG000|Overall Study|Withdrawal by Subject|1|||
130820115|NCT03961308|470971096|FG001|Overall Study|Withdrawal by Subject|0|||
130820116|NCT03961308|470971095|FG000|Overall Study|Other|1|||
130820117|NCT03961308|470971096|FG001|Overall Study|Other|0|||
130820118|NCT03961308|470971095|FG000|Overall Study|Lost to Follow-up|0|||
130820119|NCT03961308|470971096|FG001|Overall Study|Lost to Follow-up|1|||
130820120|NCT03961308|470971095|FG000|Overall Study|Adverse Event|0|||
130820121|NCT03961308|470971096|FG001|Overall Study|Adverse Event|1|||
130820122|NCT00570713|470971097|FG000|Overall Study|Adverse Event|16|||
130820123|NCT00570713|470971098|FG001|Overall Study|Adverse Event|9|||
130820124|NCT00570713|470971097|FG000|Overall Study|Death|7|||
130820125|NCT00570713|470971098|FG001|Overall Study|Death|7|||
130820126|NCT00570713|470971097|FG000|Overall Study|Lack of Efficacy|40|||
130820127|NCT00570713|470971098|FG001|Overall Study|Lack of Efficacy|49|||
130820128|NCT00570713|470971097|FG000|Overall Study|Physician Decision|2|||
130820129|NCT00570713|470971098|FG001|Overall Study|Physician Decision|2|||
130820130|NCT00570713|470971097|FG000|Overall Study|Withdrawal by Subject|3|||
130820131|NCT00570713|470971098|FG001|Overall Study|Withdrawal by Subject|3|||
130820132|NCT00570713|470971097|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
130820133|NCT00570713|470971098|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
130820134|NCT02081586|470971099|FG000|Overall Study|Lost to Follow-up|0|||
130820135|NCT02081586|470971100|FG001|Overall Study|Lost to Follow-up|1|||
130820136|NCT02081586|470971101|FG002|Overall Study|Lost to Follow-up|0|||
130820137|NCT02081586|470971102|FG003|Overall Study|Lost to Follow-up|1|||
130820138|NCT02081586|470971099|FG000|Overall Study|Head injury not related to study|0|||
130820139|NCT02081586|470971100|FG001|Overall Study|Head injury not related to study|0|||
130820140|NCT02081586|470971101|FG002|Overall Study|Head injury not related to study|1|||
130820141|NCT02081586|470971102|FG003|Overall Study|Head injury not related to study|0|||
130820142|NCT01677988|470971103|FG000|Overall Study|Lack of Efficacy|2|||
130820143|NCT00271544|470971107|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
130820144|NCT00271544|470971107|FG000|Overall Study|Model 4196 lead not attempted|9|||
130820145|NCT00271544|470971107|FG000|Overall Study|Implant not attempted|4|||
130820146|NCT03358030|470971108|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
130820147|NCT03358030|470971109|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
130820148|NCT03358030|470971110|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
130820149|NCT03358030|470971111|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
130820150|NCT03358030|470971108|FG000|Overall Study|Ineligibility|0|||
130820151|NCT03358030|470971109|FG001|Overall Study|Ineligibility|0|||
130820152|NCT03358030|470971110|FG002|Overall Study|Ineligibility|0|||
130820153|NCT03358030|470971111|FG003|Overall Study|Ineligibility|2|||
130820154|NCT03358030|470971108|FG000|Overall Study|Voluntary Withdrawal|1|||
130820155|NCT03358030|470971109|FG001|Overall Study|Voluntary Withdrawal|1|||
130820156|NCT03358030|470971110|FG002|Overall Study|Voluntary Withdrawal|3|||
130820157|NCT03358030|470971111|FG003|Overall Study|Voluntary Withdrawal|1|||
130820158|NCT03358030|470971108|FG000|Overall Study|Other|0|||
130820159|NCT03358030|470971109|FG001|Overall Study|Other|0|||
130820160|NCT03358030|470971110|FG002|Overall Study|Other|1|||
130820161|NCT03358030|470971111|FG003|Overall Study|Other|0|||
130820162|NCT01280968|470971112|FG000|Overall Study|Lost to Follow-up|8|||
130820163|NCT01280968|470971113|FG001|Overall Study|Lost to Follow-up|2|||
130820164|NCT01280968|470971112|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
130820165|NCT01280968|470971113|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
130820166|NCT01280968|470971112|FG000|Overall Study|Commuting Problems|2|||
130820167|NCT01280968|470971113|FG001|Overall Study|Commuting Problems|0|||
130820168|NCT01280968|470971112|FG000|Overall Study|Anxiety|2|||
130820169|NCT01280968|470971113|FG001|Overall Study|Anxiety|0|||
130820170|NCT01280968|470971112|FG000|Overall Study|Adverse Event|1|||
130820171|NCT01280968|470971113|FG001|Overall Study|Adverse Event|0|||
130820172|NCT01280968|470971112|FG000|Overall Study|Scheduling Conflicts|1|||
130820173|NCT01280968|470971113|FG001|Overall Study|Scheduling Conflicts|1|||
130820174|NCT01280968|470971112|FG000|Overall Study|Pre-existing Neurological Condition|1|||
130820175|NCT01280968|470971113|FG001|Overall Study|Pre-existing Neurological Condition|0|||
130820176|NCT01280968|470971112|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
130820177|NCT01280968|470971113|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
130820178|NCT04704193|470971114|FG000|Overall Study|Withdrawal by Subject|1|||
130820179|NCT00542178|470971115|FG000|Overall Study|did not complete year 4 follow-up|75|||
130820180|NCT00542178|470971116|FG001|Overall Study|did not complete year 4 follow-up|80|||
130820181|NCT00542178|470971117|FG002|Overall Study|did not complete year 4 follow-up|74|||
130820182|NCT00542178|470971118|FG003|Overall Study|did not complete year 4 follow-up|62|||
130820183|NCT00542178|470971119|FG004|Overall Study|did not complete year 4 follow-up|64|||
130820184|NCT00542178|470971120|FG005|Overall Study|did not complete year 4 follow-up|89|||
130820185|NCT00542178|470971121|FG006|Overall Study|did not complete year 4 follow-up|87|||
130820186|NCT00542178|470971122|FG007|Overall Study|did not complete year 4 follow-up|85|||
130820187|NCT01492426|470972531|FG000|Treatment|Death|0|||
130820188|NCT01492426|470972532|FG001|Treatment|Death|1|||
130820189|NCT01492426|470972531|FG000|Treatment|Other|1|||
130820190|NCT01492426|470972532|FG001|Treatment|Other|0|||
130820191|NCT01492426|470972531|FG000|Treatment|Adverse Event|25|||
130820192|NCT01492426|470972532|FG001|Treatment|Adverse Event|25|||
130820193|NCT01492426|470972531|FG000|Treatment|Lack of Efficacy|38|||
130820194|NCT01492426|470972532|FG001|Treatment|Lack of Efficacy|5|||
130820195|NCT01492426|470972531|FG000|Treatment|Participant withdrew consent|1|||
130820196|NCT01492426|470972532|FG001|Treatment|Participant withdrew consent|2|||
130820197|NCT01492426|470972531|FG000|Treatment|Poor compliance/noncompliance|1|||
130820198|NCT01492426|470972532|FG001|Treatment|Poor compliance/noncompliance|0|||
130820199|NCT01492426|470972531|FG000|Treatment|Subject requested discontinue study drug|7|||
130820200|NCT01492426|470972532|FG001|Treatment|Subject requested discontinue study drug|3|||
130820201|NCT01492426|470972531|FG000|Treatment|Lost to Follow-up|9|||
130820202|NCT01492426|470972532|FG001|Treatment|Lost to Follow-up|4|||
130820203|NCT01492426|470972531|FG000|Treatment|Participant does not meet study criteria|1|||
130820204|NCT01492426|470972532|FG001|Treatment|Participant does not meet study criteria|0|||
130820205|NCT01492426|470972531|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
130820206|NCT01492426|470972532|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
130820207|NCT01492426|470972531|FG000|Follow-Up|Death|1|||
130820208|NCT01492426|470972532|FG001|Follow-Up|Death|0|||
130820209|NCT01492426|470972531|FG000|Follow-Up|Other|4|||
130820210|NCT01492426|470972532|FG001|Follow-Up|Other|2|||
130820211|NCT01492426|470972531|FG000|Follow-Up|Participant Withdrew Consent|6|||
130820212|NCT01492426|470972532|FG001|Follow-Up|Participant Withdrew Consent|1|||
130820213|NCT01492426|470972531|FG000|Follow-Up|Lost to Follow-up|12|||
130820214|NCT01492426|470972532|FG001|Follow-Up|Lost to Follow-up|6|||
130820215|NCT00652743|470972533|FG000|Months 12-18|Lost to Follow-up|1|||
130820216|NCT00652743|470972534|FG001|Months 12-18|Lost to Follow-up|2|||
130820217|NCT00652743|470972535|FG002|Months 12-18|Lost to Follow-up|7|||
130820218|NCT00652743|470972533|FG000|Months 24-30|Other|5|||
130820219|NCT00652743|470972534|FG001|Months 24-30|Other|1|||
130820220|NCT00652743|470972535|FG002|Months 24-30|Other|11|||
130820221|NCT00652743|470972533|FG000|Months 36-42|Serious Adverse Events|0|||
130820222|NCT00652743|470972534|FG001|Months 36-42|Serious Adverse Events|1|||
130820223|NCT00652743|470972535|FG002|Months 36-42|Serious Adverse Events|1|||
130820224|NCT00652743|470972533|FG000|Months 36-42|Withdrawal by Subject|1|||
130820225|NCT00652743|470972534|FG001|Months 36-42|Withdrawal by Subject|1|||
130820226|NCT00652743|470972535|FG002|Months 36-42|Withdrawal by Subject|0|||
130820227|NCT00652743|470972533|FG000|Months 36-42|Lost to Follow-up|0|||
130820228|NCT00652743|470972534|FG001|Months 36-42|Lost to Follow-up|1|||
130820229|NCT00652743|470972535|FG002|Months 36-42|Lost to Follow-up|0|||
130820230|NCT00652743|470972533|FG000|Months 36-42|Migrated/moved from study area|1|||
130820231|NCT00652743|470972534|FG001|Months 36-42|Migrated/moved from study area|0|||
130820232|NCT00652743|470972535|FG002|Months 36-42|Migrated/moved from study area|0|||
130820233|NCT00652743|470972533|FG000|Months 36-42|Other|4|||
130820234|NCT00652743|470972534|FG001|Months 36-42|Other|2|||
130820235|NCT00652743|470972535|FG002|Months 36-42|Other|8|||
130820236|NCT01978145|470972536|FG000|Treatment Period 1|Adverse Event|1|||
130820237|NCT01978145|470972537|FG001|Treatment Period 1|Adverse Event|9|||
130820238|NCT01978145|470972536|FG000|Treatment Period 1|Physician Decision|1|||
130820239|NCT01978145|470972537|FG001|Treatment Period 1|Physician Decision|0|||
130820240|NCT01978145|470972536|FG000|Treatment Period 1|Withdrawal by Subject|5|||
130820241|NCT01978145|470972537|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130820242|NCT01978145|470972536|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
130820243|NCT01978145|470972537|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
130820244|NCT01978145|470972536|FG000|Washout Period 1|Adverse Event|0|||
130820245|NCT01978145|470972537|FG001|Washout Period 1|Adverse Event|1|||
130820246|NCT01978145|470972536|FG000|Washout Period 1|Withdrawal by Subject|1|||
130820247|NCT01978145|470972537|FG001|Washout Period 1|Withdrawal by Subject|1|||
130820248|NCT01978145|470972536|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
130820249|NCT01978145|470972537|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
130820250|NCT01978145|470972536|FG000|Treatment Period 2|Adverse Event|3|||
130820251|NCT01978145|470972537|FG001|Treatment Period 2|Adverse Event|3|||
130820252|NCT01978145|470972536|FG000|Treatment Period 2|Protocol Violation|0|||
130820253|NCT01978145|470972537|FG001|Treatment Period 2|Protocol Violation|1|||
130820254|NCT01978145|470972536|FG000|Treatment Period 2|Lost to Follow-up|1|||
130820255|NCT01978145|470972537|FG001|Treatment Period 2|Lost to Follow-up|1|||
130820256|NCT01978145|470972536|FG000|Treatment Period 2|Withdrawal by Subject|7|||
130820257|NCT01978145|470972537|FG001|Treatment Period 2|Withdrawal by Subject|4|||
130820258|NCT01978145|470972536|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
130820259|NCT01978145|470972537|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
130820260|NCT01250054|470972538|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
130820261|NCT01250054|470972539|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
130820262|NCT00272792|470972546|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
130820263|NCT00272792|470972547|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
130820264|NCT00272792|470972546|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
130820265|NCT00272792|470972547|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
130820266|NCT00272792|470972546|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
130820267|NCT00272792|470972547|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
130820268|NCT00272792|470972546|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
130820269|NCT00272792|470972547|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
130820270|NCT05111145|470972548|FG000|Overall Study|Commercial drug is available for participant|76|||
130820271|NCT05111145|470972548|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
130820272|NCT02336815|470972549|FG000|Overall Study|Disease Progression|45|||
130820273|NCT02336815|470972550|FG001|Overall Study|Disease Progression|70|||
130820274|NCT02336815|470972549|FG000|Overall Study|Adverse Event|18|||
130820275|NCT02336815|470972550|FG001|Overall Study|Adverse Event|39|||
130820276|NCT02336815|470972549|FG000|Overall Study|Physician Decision|11|||
130820277|NCT02336815|470972550|FG001|Overall Study|Physician Decision|4|||
130820278|NCT02336815|470972549|FG000|Overall Study|Withdrawal by Subject|3|||
130820279|NCT02336815|470972550|FG001|Overall Study|Withdrawal by Subject|2|||
130820280|NCT02336815|470972549|FG000|Overall Study|Lost to Follow-up|1|||
130820281|NCT02336815|470972550|FG001|Overall Study|Lost to Follow-up|3|||
130820282|NCT02336815|470972549|FG000|Overall Study|Other|1|||
130820283|NCT02336815|470972550|FG001|Overall Study|Other|5|||
130820284|NCT02465931|470972551|FG000|Overall Study|Lost to Follow-up|9|||
130820285|NCT02465931|470972552|FG001|Overall Study|Lost to Follow-up|11|||
130820286|NCT02465931|470972551|FG000|Overall Study|Protocol Violation|1|||
130820287|NCT02465931|470972552|FG001|Overall Study|Protocol Violation|0|||
130820288|NCT02465931|470972551|FG000|Overall Study|Withdrawal by Subject|1|||
130820289|NCT02465931|470972552|FG001|Overall Study|Withdrawal by Subject|0|||
130820290|NCT00492557|470972553|FG000|Overall Study|Subject request|12|||
130820291|NCT00492557|470972554|FG001|Overall Study|Subject request|11|||
130820292|NCT00492557|470972553|FG000|Overall Study|Protocol Violation|7|||
130820293|NCT00492557|470972554|FG001|Overall Study|Protocol Violation|8|||
130820294|NCT00492557|470972553|FG000|Overall Study|Other|2|||
130820295|NCT00492557|470972554|FG001|Overall Study|Other|2|||
130820296|NCT00492557|470972553|FG000|Overall Study|Death|1|||
130820297|NCT00492557|470972554|FG001|Overall Study|Death|1|||
130820298|NCT00492557|470972553|FG000|Overall Study|Adverse Event|1|||
130820299|NCT00492557|470972554|FG001|Overall Study|Adverse Event|0|||
130820300|NCT00492557|470972553|FG000|Overall Study|Failed to return|1|||
130820301|NCT00492557|470972554|FG001|Overall Study|Failed to return|0|||
130820302|NCT00492557|470972553|FG000|Overall Study|Lost to Follow-up|0|||
130820303|NCT00492557|470972554|FG001|Overall Study|Lost to Follow-up|1|||
130820304|NCT03423602|470972556|FG000|Overall Study|Death|1|||
130820305|NCT03423602|470972556|FG000|Overall Study|Lost to Follow-up|6|||
130820306|NCT03423602|470972556|FG000|Overall Study|Protocol Violation|1|||
130820307|NCT03423602|470972556|FG000|Overall Study|Withdrawal by Subject|4|||
130820308|NCT03423121|470972557|FG000|Overall Study|Lost to Follow-up|2|||
130820309|NCT03423121|470972558|FG001|Overall Study|Lost to Follow-up|6|||
130820310|NCT03423121|470972557|FG000|Overall Study|Adverse Event|1|||
130820311|NCT03423121|470972558|FG001|Overall Study|Adverse Event|0|||
130820312|NCT00948688|470972559|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
130820313|NCT00948688|470972560|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
130820314|NCT00948688|470972559|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
130820315|NCT00948688|470972560|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
130820316|NCT00948688|470972559|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
130820317|NCT00948688|470972560|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
130820318|NCT01135992|470972561|FG000|Overall Study|Adverse Event|1|||
130820319|NCT01135992|470972561|FG000|Overall Study|Lack of Efficacy|1|||
130820320|NCT01135992|470972561|FG000|Overall Study|Protocol Violation|2|||
130820321|NCT01135992|470972561|FG000|Overall Study|Withdrawal criteria|10|||
130820322|NCT01135992|470972561|FG000|Overall Study|Unclassified|7|||
130820323|NCT02136914|470972564|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
130820324|NCT02136914|470972565|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
130820325|NCT02136914|470972564|FG000|Overall Study|Withdrawal by Subject|3|||
130820326|NCT02136914|470972565|FG001|Overall Study|Withdrawal by Subject|10|||
130820327|NCT02136914|470972564|FG000|Overall Study|Subject Unwilling to Proceed|7|||
130820328|NCT02136914|470972565|FG001|Overall Study|Subject Unwilling to Proceed|2|||
130820329|NCT02136914|470972564|FG000|Overall Study|Lost to Follow-up|1|||
130820330|NCT02136914|470972565|FG001|Overall Study|Lost to Follow-up|1|||
130820331|NCT02136914|470972564|FG000|Overall Study|Did Not Receive Study Drug|2|||
130820332|NCT02136914|470972565|FG001|Overall Study|Did Not Receive Study Drug|0|||
130820333|NCT02136914|470972564|FG000|Overall Study|Lack of Efficacy|1|||
130820334|NCT02136914|470972565|FG001|Overall Study|Lack of Efficacy|0|||
130820335|NCT02136914|470972564|FG000|Overall Study|Death|0|||
130820336|NCT02136914|470972565|FG001|Overall Study|Death|1|||
130820337|NCT01493089|470972568|FG000|Overall Study|Protocol Violation|2|||
130820338|NCT01493089|470972569|FG001|Overall Study|Protocol Violation|2|||
130820339|NCT01493089|470972568|FG000|Overall Study|Withdrawal by Subject|1|||
130820340|NCT01493089|470972569|FG001|Overall Study|Withdrawal by Subject|0|||
130820341|NCT01493089|470972568|FG000|Overall Study|Physician Decision|0|||
130820342|NCT01493089|470972569|FG001|Overall Study|Physician Decision|1|||
130820343|NCT00325143|470972570|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
130820344|NCT00325143|470972570|FG000|Overall Study|Migrated/moved from study area|1|||
130820345|NCT00325143|470972570|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
130820346|NCT00325143|470972570|FG000|Overall Study|Withdrawal by Subject|8|||
130820347|NCT02286895|470972571|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
130820348|NCT02286895|470972572|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
130820349|NCT02286895|470972571|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
130820350|NCT02286895|470972572|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
130820351|NCT02286895|470972571|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
130820352|NCT02286895|470972572|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
130820353|NCT01073293|470972573|FG000|Overall Study|Lost to Follow-up|0|||
130820354|NCT01073293|470972574|FG001|Overall Study|Lost to Follow-up|1|||
130820355|NCT01073293|470972573|FG000|Overall Study|Withdrawal by Subject|5|||
130820356|NCT01073293|470972574|FG001|Overall Study|Withdrawal by Subject|10|||
130820357|NCT00256126|470972575|FG000|Overall Study|Adverse Event|1|||
130820358|NCT00256126|470972576|FG001|Overall Study|Adverse Event|0|||
130820359|NCT00256126|470972575|FG000|Overall Study|Other|1|||
130820360|NCT00256126|470972576|FG001|Overall Study|Other|2|||
130820361|NCT02154061|470972577|FG000|Overall Study|Pregnancy|1|||
130820362|NCT02154061|470972578|FG001|Overall Study|Pregnancy|0|||
130820363|NCT02154061|470972577|FG000|Overall Study|enrolled but not vaccinated|1|||
130820364|NCT02154061|470972578|FG001|Overall Study|enrolled but not vaccinated|0|||
130820365|NCT00506142|470972579|FG000|Overall Study|Adverse Event|8|||
130820366|NCT00506142|470972580|FG001|Overall Study|Adverse Event|7|||
130820367|NCT00506142|470972579|FG000|Overall Study|Lack of Efficacy|21|||
130820368|NCT00506142|470972580|FG001|Overall Study|Lack of Efficacy|7|||
130820369|NCT00506142|470972579|FG000|Overall Study|Withdrawal by Subject|4|||
130820370|NCT00506142|470972580|FG001|Overall Study|Withdrawal by Subject|5|||
130820371|NCT00506142|470972579|FG000|Overall Study|Physician Decision|1|||
130820372|NCT00506142|470972580|FG001|Overall Study|Physician Decision|0|||
130820373|NCT00506142|470972579|FG000|Overall Study|New health condition|1|||
130820374|NCT00506142|470972580|FG001|Overall Study|New health condition|0|||
130820375|NCT00454116|470972581|FG000|Overall Study|Adverse Event|5|||
130820376|NCT00454116|470972582|FG001|Overall Study|Adverse Event|11|||
130820377|NCT00454116|470972583|FG002|Overall Study|Adverse Event|9|||
130820378|NCT00454116|470972581|FG000|Overall Study|Condition under investigation worsened|17|||
130820379|NCT00454116|470972582|FG001|Overall Study|Condition under investigation worsened|13|||
130820380|NCT00454116|470972583|FG002|Overall Study|Condition under investigation worsened|18|||
130820381|NCT00454116|470972581|FG000|Overall Study|Withdrawal by Subject|3|||
130820382|NCT00454116|470972582|FG001|Overall Study|Withdrawal by Subject|3|||
130820383|NCT00454116|470972583|FG002|Overall Study|Withdrawal by Subject|1|||
130820384|NCT00454116|470972581|FG000|Overall Study|Other|2|||
130820385|NCT00454116|470972582|FG001|Overall Study|Other|2|||
130820386|NCT00454116|470972583|FG002|Overall Study|Other|0|||
130820387|NCT01008618|470972588|FG000|Period 1 (Titration Period)|Physician Decision|2|||
130820388|NCT01008618|470972589|FG001|Period 1 (Titration Period)|Physician Decision|0|||
130820389|NCT01008618|470972590|FG002|Period 1 (Titration Period)|Physician Decision|0|||
130820390|NCT01008618|470972588|FG000|Period 1 (Titration Period)|Adverse Event|33|||
130820391|NCT01008618|470972589|FG001|Period 1 (Titration Period)|Adverse Event|0|||
130820392|NCT01008618|470972590|FG002|Period 1 (Titration Period)|Adverse Event|0|||
130820393|NCT01008618|470972588|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
130820394|NCT01008618|470972589|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
130820395|NCT01008618|470972590|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
130820396|NCT01008618|470972588|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
130820397|NCT01008618|470972589|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
130820398|NCT01008618|470972590|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
130820399|NCT01008618|470972588|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
130820400|NCT01008618|470972589|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
130820401|NCT01008618|470972590|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
130820402|NCT01008618|470972588|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
130820403|NCT01008618|470972589|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
130820404|NCT01008618|470972590|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
130820405|NCT01008618|470972588|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
130820406|NCT01008618|470972589|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
130820407|NCT01008618|470972590|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
130820408|NCT01008618|470972588|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
130820409|NCT01008618|470972589|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
130820410|NCT01008618|470972590|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
130820411|NCT01008618|470972588|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
130820412|NCT01008618|470972589|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
130820413|NCT01008618|470972590|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
130820414|NCT01008618|470972588|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
130820415|NCT01008618|470972589|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
130820416|NCT01008618|470972590|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
130820417|NCT01008618|470972588|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
130820418|NCT01008618|470972589|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
130820419|NCT01008618|470972590|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
130820420|NCT01008618|470972588|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
130820421|NCT01008618|470972589|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
130820422|NCT01008618|470972590|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
130820423|NCT00742625|470972591|FG000|Remission Induction|Progression|6|||
130820424|NCT00742625|470972591|FG000|Remission Induction|Failed induction|8|||
130820425|NCT00742625|470972591|FG000|Remission Induction|Adverse Event|3|||
130820426|NCT00742625|470972591|FG000|Remission Induction|Death|10|||
130820427|NCT00742625|470972591|FG000|Remission Induction|Refusal|5|||
130820428|NCT00742625|470972591|FG000|Remission Induction|Non protocol treatment|17|||
130820429|NCT00742625|470972591|FG000|Remission Induction|Other, not specified|5|||
130820430|NCT00742625|470972591|FG000|Consolidation|Progression|5|||
130820431|NCT00742625|470972591|FG000|Consolidation|Adverse Event|1|||
130820432|NCT00742625|470972591|FG000|Consolidation|Death|1|||
130820433|NCT00742625|470972591|FG000|Consolidation|Refused|1|||
130820434|NCT00742625|470972591|FG000|Consolidation|Non protocol therapy|13|||
130820435|NCT03338400|470972592|FG000|Overall Study|Lost to Follow-up|1|||
130820436|NCT03338400|470972593|FG001|Overall Study|Lost to Follow-up|2|||
130820437|NCT01865487|470972596|FG000|Overall Study|Lost to Follow-up|0|||
130820438|NCT01865487|470972597|FG001|Overall Study|Lost to Follow-up|0|||
130820439|NCT01865487|470972598|FG002|Overall Study|Lost to Follow-up|0|||
130820440|NCT01865487|470972599|FG003|Overall Study|Lost to Follow-up|1|||
130820441|NCT01865487|470972600|FG004|Overall Study|Lost to Follow-up|0|||
130820442|NCT01865487|470972601|FG005|Overall Study|Lost to Follow-up|0|||
130820443|NCT01865487|470972602|FG006|Overall Study|Lost to Follow-up|1|||
130820444|NCT01865487|470972603|FG007|Overall Study|Lost to Follow-up|0|||
130820445|NCT01865487|470972604|FG008|Overall Study|Lost to Follow-up|0|||
130820446|NCT01865487|470972605|FG009|Overall Study|Lost to Follow-up|0|||
130820447|NCT01865487|470972596|FG000|Overall Study|Withdrawal by Subject|0|||
130820448|NCT01865487|470972597|FG001|Overall Study|Withdrawal by Subject|0|||
130820449|NCT01865487|470972598|FG002|Overall Study|Withdrawal by Subject|0|||
130820450|NCT01865487|470972599|FG003|Overall Study|Withdrawal by Subject|0|||
130820451|NCT01865487|470972600|FG004|Overall Study|Withdrawal by Subject|1|||
130820452|NCT01865487|470972601|FG005|Overall Study|Withdrawal by Subject|0|||
130820453|NCT01865487|470972602|FG006|Overall Study|Withdrawal by Subject|0|||
130820454|NCT01865487|470972603|FG007|Overall Study|Withdrawal by Subject|0|||
130820455|NCT01865487|470972604|FG008|Overall Study|Withdrawal by Subject|0|||
130820456|NCT01865487|470972605|FG009|Overall Study|Withdrawal by Subject|0|||
130820457|NCT01213082|470972606|FG000|Overall Study|Lost to Follow-up|6|||
130820458|NCT01213082|470972607|FG001|Overall Study|Lost to Follow-up|7|||
130820459|NCT01213082|470972608|FG002|Overall Study|Lost to Follow-up|4|||
130820460|NCT01213082|470972606|FG000|Overall Study|Physician Decision|0|||
130820461|NCT01213082|470972607|FG001|Overall Study|Physician Decision|0|||
130820462|NCT01213082|470972608|FG002|Overall Study|Physician Decision|1|||
130820463|NCT01627691|470972609|FG000|Overall Study|Death|11|||
130820464|NCT01627691|470972609|FG000|Overall Study|Lost to Follow-up|3|||
130820465|NCT01627691|470972609|FG000|Overall Study|Withdrawal by Subject|1|||
130820466|NCT01627691|470972609|FG000|Overall Study|Missed the visit|3|||
130820467|NCT03848416|470972612|FG000|Overall Study|Withdrawal by Subject|1|||
130820468|NCT03848416|470972613|FG001|Overall Study|Withdrawal by Subject|0|||
130820469|NCT03848416|470972614|FG002|Overall Study|Withdrawal by Subject|0|||
130820470|NCT03848416|470972612|FG000|Overall Study|Death|0|||
130820471|NCT03848416|470972613|FG001|Overall Study|Death|0|||
130820472|NCT03848416|470972614|FG002|Overall Study|Death|1|||
130820473|NCT01908140|470972615|FG000|Overall Study|Other or Progressive Disease|5|||
130820474|NCT01908140|470972616|FG001|Overall Study|Other or Progressive Disease|12|||
130820475|NCT01908140|470972615|FG000|Overall Study|Lack of Efficacy|7|||
130820476|NCT01908140|470972616|FG001|Overall Study|Lack of Efficacy|5|||
130820477|NCT01908140|470972615|FG000|Overall Study|Withdrawal by Subject|23|||
130820478|NCT01908140|470972616|FG001|Overall Study|Withdrawal by Subject|24|||
130820479|NCT01908140|470972615|FG000|Overall Study|Lost to Follow-up|1|||
130820480|NCT01908140|470972616|FG001|Overall Study|Lost to Follow-up|6|||
130820481|NCT01908140|470972615|FG000|Overall Study|Protocol Violation|8|||
130820482|NCT01908140|470972616|FG001|Overall Study|Protocol Violation|9|||
130820483|NCT01908140|470972615|FG000|Overall Study|Adverse Event|22|||
130820484|NCT01908140|470972616|FG001|Overall Study|Adverse Event|23|||
130820485|NCT02639390|470972617|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
130820486|NCT02639390|470972618|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
130820487|NCT02927795|470972623|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
130820488|NCT02927795|470972623|FG000|Overall Study|Not Treated|4|||
130820489|NCT01076010|470972624|FG000|Overall Study|Death|15|||
130820490|NCT01076010|470972625|FG001|Overall Study|Death|1|||
130820491|NCT01076010|470972626|FG002|Overall Study|Death|0|||
130820492|NCT01076010|470972624|FG000|Overall Study|Adverse Event|7|||
130820493|NCT01076010|470972625|FG001|Overall Study|Adverse Event|2|||
130820494|NCT01076010|470972626|FG002|Overall Study|Adverse Event|0|||
130820495|NCT01076010|470972624|FG000|Overall Study|Progressive disease|90|||
130820496|NCT01076010|470972625|FG001|Overall Study|Progressive disease|30|||
130820497|NCT01076010|470972626|FG002|Overall Study|Progressive disease|1|||
130820498|NCT01076010|470972624|FG000|Overall Study|Lack of Efficacy|4|||
130820499|NCT01076010|470972625|FG001|Overall Study|Lack of Efficacy|0|||
130820500|NCT01076010|470972626|FG002|Overall Study|Lack of Efficacy|0|||
130820501|NCT01076010|470972624|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
130820502|NCT01076010|470972625|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
130820503|NCT01076010|470972626|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
130820504|NCT01076010|470972624|FG000|Overall Study|Significant Surgical Procedure|0|||
130820505|NCT01076010|470972625|FG001|Overall Study|Significant Surgical Procedure|1|||
130820506|NCT01076010|470972626|FG002|Overall Study|Significant Surgical Procedure|0|||
130820507|NCT01076010|470972624|FG000|Overall Study|Protocol Violation|0|||
130820508|NCT01076010|470972625|FG001|Overall Study|Protocol Violation|1|||
130820509|NCT01076010|470972626|FG002|Overall Study|Protocol Violation|0|||
130820510|NCT01076010|470972624|FG000|Overall Study|Noncompliance|1|||
130820511|NCT01076010|470972625|FG001|Overall Study|Noncompliance|1|||
130820512|NCT01076010|470972626|FG002|Overall Study|Noncompliance|0|||
130820513|NCT01076010|470972624|FG000|Overall Study|Withdrawal by Subject|3|||
130820514|NCT01076010|470972625|FG001|Overall Study|Withdrawal by Subject|0|||
130820515|NCT01076010|470972626|FG002|Overall Study|Withdrawal by Subject|1|||
130820516|NCT01076010|470972624|FG000|Overall Study|Other|5|||
130820517|NCT01076010|470972625|FG001|Overall Study|Other|2|||
130820518|NCT01076010|470972626|FG002|Overall Study|Other|0|||
130820519|NCT03710889|470972644|FG000|Overall Study|Adverse Event|2|||
130820520|NCT03710889|470972644|FG000|Overall Study|Protocol Deviation|1|||
130820521|NCT04881760|470972645|FG000|Overall Study|Adverse Event|0|||
130820522|NCT04881760|470972646|FG001|Overall Study|Adverse Event|1|||
130820523|NCT04881760|470972647|FG002|Overall Study|Adverse Event|1|||
130820524|NCT04881760|470972648|FG003|Overall Study|Adverse Event|0|||
130820525|NCT04881760|470972649|FG004|Overall Study|Adverse Event|1|||
130820526|NCT04881760|470972650|FG005|Overall Study|Adverse Event|1|||
130820527|NCT04881760|470972651|FG006|Overall Study|Adverse Event|2|||
130820528|NCT04881760|470972645|FG000|Overall Study|Death|0|||
130820529|NCT04881760|470972646|FG001|Overall Study|Death|0|||
130820530|NCT04881760|470972647|FG002|Overall Study|Death|0|||
130820531|NCT04881760|470972648|FG003|Overall Study|Death|1|||
130820532|NCT04881760|470972649|FG004|Overall Study|Death|0|||
130820533|NCT04881760|470972650|FG005|Overall Study|Death|0|||
130820534|NCT04881760|470972651|FG006|Overall Study|Death|0|||
130820535|NCT04881760|470972645|FG000|Overall Study|Lost to Follow-up|5|||
130820536|NCT04881760|470972646|FG001|Overall Study|Lost to Follow-up|7|||
130820537|NCT04881760|470972647|FG002|Overall Study|Lost to Follow-up|5|||
130820538|NCT04881760|470972648|FG003|Overall Study|Lost to Follow-up|1|||
130820539|NCT04881760|470972649|FG004|Overall Study|Lost to Follow-up|2|||
130820540|NCT04881760|470972650|FG005|Overall Study|Lost to Follow-up|4|||
130820541|NCT04881760|470972651|FG006|Overall Study|Lost to Follow-up|4|||
130820542|NCT04881760|470972645|FG000|Overall Study|Withdrawal by Subject|13|||
130820543|NCT04881760|470972646|FG001|Overall Study|Withdrawal by Subject|1|||
130820544|NCT04881760|470972647|FG002|Overall Study|Withdrawal by Subject|1|||
130820545|NCT04881760|470972648|FG003|Overall Study|Withdrawal by Subject|4|||
130820546|NCT04881760|470972649|FG004|Overall Study|Withdrawal by Subject|2|||
130820547|NCT04881760|470972650|FG005|Overall Study|Withdrawal by Subject|1|||
130820548|NCT04881760|470972651|FG006|Overall Study|Withdrawal by Subject|2|||
130820549|NCT04881760|470972645|FG000|Overall Study|Randomized but Never Treated|0|||
130820550|NCT04881760|470972646|FG001|Overall Study|Randomized but Never Treated|0|||
130820551|NCT04881760|470972647|FG002|Overall Study|Randomized but Never Treated|0|||
130820552|NCT04881760|470972648|FG003|Overall Study|Randomized but Never Treated|1|||
130820553|NCT04881760|470972649|FG004|Overall Study|Randomized but Never Treated|0|||
130820554|NCT04881760|470972650|FG005|Overall Study|Randomized but Never Treated|0|||
130820555|NCT04881760|470972651|FG006|Overall Study|Randomized but Never Treated|0|||
130820556|NCT04881760|470972645|FG000|Overall Study|Inadvertent Enrollment|2|||
130820557|NCT04881760|470972646|FG001|Overall Study|Inadvertent Enrollment|0|||
130820558|NCT04881760|470972647|FG002|Overall Study|Inadvertent Enrollment|0|||
130820559|NCT04881760|470972648|FG003|Overall Study|Inadvertent Enrollment|0|||
130820560|NCT04881760|470972649|FG004|Overall Study|Inadvertent Enrollment|0|||
130820561|NCT04881760|470972650|FG005|Overall Study|Inadvertent Enrollment|0|||
130820562|NCT04881760|470972651|FG006|Overall Study|Inadvertent Enrollment|0|||
130820563|NCT04881760|470972645|FG000|Overall Study|Site Closure|0|||
130820564|NCT04881760|470972646|FG001|Overall Study|Site Closure|0|||
130820565|NCT04881760|470972647|FG002|Overall Study|Site Closure|0|||
130820566|NCT04881760|470972648|FG003|Overall Study|Site Closure|1|||
130820567|NCT04881760|470972649|FG004|Overall Study|Site Closure|0|||
130820568|NCT04881760|470972650|FG005|Overall Study|Site Closure|0|||
130820569|NCT04881760|470972651|FG006|Overall Study|Site Closure|0|||
130820570|NCT01538199|470972655|FG000|Overall Study|Lost to Follow-up|1|||
130820571|NCT01538199|470972656|FG001|Overall Study|Lost to Follow-up|2|||
130820572|NCT01538199|470972657|FG002|Overall Study|Lost to Follow-up|1|||
130820573|NCT01538199|470972658|FG003|Overall Study|Lost to Follow-up|0|||
130820574|NCT01538199|470972655|FG000|Overall Study|participant did not have time|1|||
130820575|NCT01538199|470972656|FG001|Overall Study|participant did not have time|0|||
130820576|NCT01538199|470972657|FG002|Overall Study|participant did not have time|0|||
130820577|NCT01538199|470972658|FG003|Overall Study|participant did not have time|2|||
130820578|NCT01538199|470972655|FG000|Overall Study|Lack of Efficacy|0|||
130820579|NCT01538199|470972656|FG001|Overall Study|Lack of Efficacy|1|||
130820580|NCT01538199|470972657|FG002|Overall Study|Lack of Efficacy|0|||
130820581|NCT01538199|470972658|FG003|Overall Study|Lack of Efficacy|0|||
130820582|NCT05899829|470972661|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
130820583|NCT05899829|470972662|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
130820584|NCT05899829|470972661|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
130820585|NCT05899829|470972662|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
130820586|NCT00636181|470972663|FG000|Overall Study|Withdrawal by Subject|8|||
130820587|NCT00636181|470972664|FG001|Overall Study|Withdrawal by Subject|6|||
130820588|NCT00636181|470972665|FG002|Overall Study|Withdrawal by Subject|10|||
130820589|NCT05076045|470972668|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
130820590|NCT05076045|470972669|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
130820591|NCT03402841|470972676|FG000|Overall Study|Withdrawal by Subject|3|||
130820592|NCT03402841|470972676|FG000|Overall Study|Lost to Follow-up|2|||
130820593|NCT03402841|470972676|FG000|Overall Study|Death|146|||
130820594|NCT03984188|470972684|FG000|Overall Study|Death|2|||
130820595|NCT03984188|470972685|FG001|Overall Study|Death|4|||
130820596|NCT03984188|470972684|FG000|Overall Study|Physician Decision|0|||
130820597|NCT03984188|470972685|FG001|Overall Study|Physician Decision|2|||
130820598|NCT03984188|470972684|FG000|Overall Study|Lost to Follow-up|3|||
130820599|NCT03984188|470972685|FG001|Overall Study|Lost to Follow-up|2|||
130820600|NCT03984188|470972684|FG000|Overall Study|Withdrawal by Subject|6|||
130820601|NCT03984188|470972685|FG001|Overall Study|Withdrawal by Subject|0|||
130820602|NCT00269113|470974506|FG000|Overall Study|Adverse Event|14|||
130820603|NCT00269113|470974507|FG001|Overall Study|Adverse Event|7|||
130820604|NCT00269113|470974506|FG000|Overall Study|Lack of Efficacy|35|||
130820605|NCT00269113|470974507|FG001|Overall Study|Lack of Efficacy|18|||
130820606|NCT00269113|470974506|FG000|Overall Study|Early Improvement|2|||
130820607|NCT00269113|470974507|FG001|Overall Study|Early Improvement|0|||
130820608|NCT00269113|470974506|FG000|Overall Study|Withdrawal by Subject|0|||
130820609|NCT00269113|470974507|FG001|Overall Study|Withdrawal by Subject|2|||
130820610|NCT00269113|470974506|FG000|Overall Study|Death|6|||
130820611|NCT00269113|470974507|FG001|Overall Study|Death|2|||
130820612|NCT00269113|470974506|FG000|Overall Study|Lost to Follow-up|2|||
130820613|NCT00269113|470974507|FG001|Overall Study|Lost to Follow-up|1|||
130820614|NCT00269113|470974506|FG000|Overall Study|Protocol Violation|15|||
130820615|NCT00269113|470974507|FG001|Overall Study|Protocol Violation|5|||
130820616|NCT00269113|470974506|FG000|Overall Study|Other|0|||
130820617|NCT00269113|470974507|FG001|Overall Study|Other|2|||
130820618|NCT00322049|470974508|FG000|Overall Study|Moved out of area|0|||
130820619|NCT00322049|470974509|FG001|Overall Study|Moved out of area|0|||
130820620|NCT00322049|470974510|FG002|Overall Study|Moved out of area|0|||
130820621|NCT00322049|470974511|FG003|Overall Study|Moved out of area|1|||
130820622|NCT00322049|470974508|FG000|Overall Study|Infected with Dengue during study|0|||
130820623|NCT00322049|470974509|FG001|Overall Study|Infected with Dengue during study|1|||
130820624|NCT00322049|470974510|FG002|Overall Study|Infected with Dengue during study|0|||
130820625|NCT00322049|470974511|FG003|Overall Study|Infected with Dengue during study|0|||
130820626|NCT02026011|470974512|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
130820627|NCT02026011|470974513|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
130820628|NCT02026011|470974512|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
130820629|NCT02026011|470974513|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
130820630|NCT02026011|470974512|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
130820631|NCT02026011|470974513|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
130820632|NCT02026011|470974512|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
130820633|NCT02026011|470974513|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
130820634|NCT01770743|470974514|FG000|Overall Study|Adverse Event|1|||
130820635|NCT01770743|470974515|FG001|Overall Study|Adverse Event|0|||
130820636|NCT01770743|470974516|FG002|Overall Study|Adverse Event|0|||
130820637|NCT01770743|470974517|FG003|Overall Study|Adverse Event|0|||
130820638|NCT01770743|470974518|FG004|Overall Study|Adverse Event|0|||
130820639|NCT01770743|470974514|FG000|Overall Study|Withdrawal by Subject|0|||
130820640|NCT01770743|470974515|FG001|Overall Study|Withdrawal by Subject|0|||
130820641|NCT01770743|470974516|FG002|Overall Study|Withdrawal by Subject|1|||
130820642|NCT01770743|470974517|FG003|Overall Study|Withdrawal by Subject|1|||
130820643|NCT01770743|470974518|FG004|Overall Study|Withdrawal by Subject|1|||
130820644|NCT01770743|470974514|FG000|Overall Study|Lost to Follow-up|0|||
130820645|NCT01770743|470974515|FG001|Overall Study|Lost to Follow-up|2|||
130820646|NCT01770743|470974516|FG002|Overall Study|Lost to Follow-up|0|||
130820647|NCT01770743|470974517|FG003|Overall Study|Lost to Follow-up|0|||
130820648|NCT01770743|470974518|FG004|Overall Study|Lost to Follow-up|1|||
130820649|NCT01770743|470974514|FG000|Overall Study|Sponsor Terminated Subject|1|||
130820650|NCT01770743|470974515|FG001|Overall Study|Sponsor Terminated Subject|0|||
130820651|NCT01770743|470974516|FG002|Overall Study|Sponsor Terminated Subject|0|||
130820652|NCT01770743|470974517|FG003|Overall Study|Sponsor Terminated Subject|1|||
130820653|NCT01770743|470974518|FG004|Overall Study|Sponsor Terminated Subject|0|||
130820654|NCT01770743|470974514|FG000|Overall Study|Moving Out of State|0|||
130820655|NCT01770743|470974515|FG001|Overall Study|Moving Out of State|1|||
130820656|NCT01770743|470974516|FG002|Overall Study|Moving Out of State|0|||
130820657|NCT01770743|470974517|FG003|Overall Study|Moving Out of State|0|||
130820658|NCT01770743|470974518|FG004|Overall Study|Moving Out of State|0|||
130820659|NCT00755807|470974521|FG000|Acute Phase|Adverse Event|16|||
130820660|NCT00755807|470974522|FG001|Acute Phase|Adverse Event|5|||
130820661|NCT00755807|470974521|FG000|Acute Phase|Protocol Violation|1|||
130820662|NCT00755807|470974522|FG001|Acute Phase|Protocol Violation|3|||
130820663|NCT00755807|470974521|FG000|Acute Phase|Withdrawal by Subject|1|||
130820664|NCT00755807|470974522|FG001|Acute Phase|Withdrawal by Subject|2|||
130820665|NCT00755807|470974521|FG000|Acute Phase|Lack of Efficacy|0|||
130820666|NCT00755807|470974522|FG001|Acute Phase|Lack of Efficacy|1|||
130820667|NCT00755807|470974521|FG000|Acute Phase|Physician Decision|0|||
130820668|NCT00755807|470974522|FG001|Acute Phase|Physician Decision|1|||
130820669|NCT00755807|470974521|FG000|Open-label Extension Phase|Adverse Event|7|||
130820670|NCT00755807|470974522|FG001|Open-label Extension Phase|Adverse Event|7|||
130820671|NCT00755807|470974521|FG000|Open-label Extension Phase|Protocol Violation|5|||
130820672|NCT00755807|470974522|FG001|Open-label Extension Phase|Protocol Violation|2|||
130820673|NCT00755807|470974521|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
130820674|NCT00755807|470974522|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
130820675|NCT00755807|470974521|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
130820676|NCT00755807|470974522|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
130820677|NCT00755807|470974521|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
130820678|NCT00755807|470974522|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
130820679|NCT00755807|470974521|FG000|Open-label Extension Phase|Sponsor Decision|0|||
130820680|NCT00755807|470974522|FG001|Open-label Extension Phase|Sponsor Decision|1|||
130820681|NCT00529243|470974525|FG000|Overall Study|Adverse Event|1|||
130820682|NCT00529243|470974525|FG000|Overall Study|Death|1|||
130820683|NCT00529243|470974525|FG000|Overall Study|Relocated|1|||
130820684|NCT00952705|470974530|FG000|Overall Study|Lost to Follow-up|24|||
130820685|NCT00952705|470974531|FG001|Overall Study|Lost to Follow-up|8|||
130820686|NCT00952705|470974532|FG002|Overall Study|Lost to Follow-up|9|||
130820687|NCT00952705|470974530|FG000|Overall Study|Withdrawal by Subject|2|||
130820688|NCT00952705|470974531|FG001|Overall Study|Withdrawal by Subject|1|||
130820689|NCT00952705|470974532|FG002|Overall Study|Withdrawal by Subject|1|||
130820690|NCT00952705|470974530|FG000|Overall Study|Death|2|||
130820691|NCT00952705|470974531|FG001|Overall Study|Death|0|||
130820692|NCT00952705|470974532|FG002|Overall Study|Death|0|||
130820693|NCT00952705|470974530|FG000|Overall Study|Incarcerated post dose|5|||
130820694|NCT00952705|470974531|FG001|Overall Study|Incarcerated post dose|0|||
130820695|NCT00952705|470974532|FG002|Overall Study|Incarcerated post dose|0|||
130820696|NCT00952705|470974530|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
130820697|NCT00952705|470974531|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
130820698|NCT00952705|470974532|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
130820699|NCT02921789|470974533|FG000|Overall Study|Adverse Event|0|||
130820700|NCT02921789|470974534|FG001|Overall Study|Adverse Event|1|||
130820701|NCT02921789|470974533|FG000|Overall Study|Lost to Follow-up|1|||
130820702|NCT02921789|470974534|FG001|Overall Study|Lost to Follow-up|0|||
130820703|NCT02921789|470974533|FG000|Overall Study|Protocol Deviation|2|||
130820704|NCT02921789|470974534|FG001|Overall Study|Protocol Deviation|0|||
130820705|NCT02921789|470974533|FG000|Overall Study|Withdrawal by Subject|2|||
130820706|NCT02921789|470974534|FG001|Overall Study|Withdrawal by Subject|1|||
130820707|NCT02921789|470974533|FG000|Overall Study|Miscellaneous|3|||
130820708|NCT02921789|470974534|FG001|Overall Study|Miscellaneous|2|||
130820709|NCT04099277|470974535|FG000|Overall Study|Physician Decision|1|||
130820710|NCT04099277|470974535|FG000|Overall Study|Withdrawal by Subject|1|||
130820711|NCT01354223|470974538|FG000|Overall Study|Withdrawal by Subject|3|||
130820712|NCT01354223|470974539|FG001|Overall Study|Withdrawal by Subject|1|||
130820713|NCT03759600|470974544|FG000|Overall Study|Adverse Event|2|||
130820714|NCT03759600|470974544|FG000|Overall Study|Progressive Disease|15|||
130820715|NCT03759600|470974544|FG000|Overall Study|Site Terminated by Sponsor|3|||
130820716|NCT05173974|470974545|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
130820717|NCT05173974|470974546|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
130820718|NCT05173974|470974547|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
130820719|NCT05173974|470974548|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
130820720|NCT05173974|470974545|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
130820721|NCT05173974|470974546|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
130820722|NCT05173974|470974547|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
130820723|NCT05173974|470974548|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
130820724|NCT03289143|470974550|FG000|Overall Study|Caregiver Unavailability|1|||
130820725|NCT03289143|470974551|FG001|Overall Study|Caregiver Unavailability|1|||
130820726|NCT03289143|470974552|FG002|Overall Study|Caregiver Unavailability|0|||
130820727|NCT03289143|470974553|FG003|Overall Study|Caregiver Unavailability|0|||
130820728|NCT03289143|470974550|FG000|Overall Study|Research Department Closure|0|||
130820729|NCT03289143|470974551|FG001|Overall Study|Research Department Closure|0|||
130820730|NCT03289143|470974552|FG002|Overall Study|Research Department Closure|1|||
130820731|NCT03289143|470974553|FG003|Overall Study|Research Department Closure|0|||
130820732|NCT03289143|470974550|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
130820733|NCT03289143|470974551|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
130820734|NCT03289143|470974552|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
130820735|NCT03289143|470974553|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
130820736|NCT03289143|470974550|FG000|Overall Study|Medical Monitor Decision|1|||
130820737|NCT03289143|470974551|FG001|Overall Study|Medical Monitor Decision|0|||
130820738|NCT03289143|470974552|FG002|Overall Study|Medical Monitor Decision|0|||
130820739|NCT03289143|470974553|FG003|Overall Study|Medical Monitor Decision|0|||
130820740|NCT03289143|470974550|FG000|Overall Study|Participant Non-Compliance|0|||
130820741|NCT03289143|470974551|FG001|Overall Study|Participant Non-Compliance|0|||
130820742|NCT03289143|470974552|FG002|Overall Study|Participant Non-Compliance|1|||
130820743|NCT03289143|470974553|FG003|Overall Study|Participant Non-Compliance|0|||
130820744|NCT03289143|470974550|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
130820745|NCT03289143|470974551|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
130820746|NCT03289143|470974552|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
130820747|NCT03289143|470974553|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
130820748|NCT03289143|470974550|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
130820749|NCT03289143|470974551|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
130820750|NCT03289143|470974552|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
130820751|NCT03289143|470974553|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
130820752|NCT03289143|470974550|FG000|Overall Study|Caregiver Passed Away|1|||
130820753|NCT03289143|470974551|FG001|Overall Study|Caregiver Passed Away|0|||
130820754|NCT03289143|470974552|FG002|Overall Study|Caregiver Passed Away|0|||
130820755|NCT03289143|470974553|FG003|Overall Study|Caregiver Passed Away|0|||
130820756|NCT03289143|470974550|FG000|Overall Study|Physician Decision|0|||
130820757|NCT03289143|470974551|FG001|Overall Study|Physician Decision|2|||
130820758|NCT03289143|470974552|FG002|Overall Study|Physician Decision|2|||
130820759|NCT03289143|470974553|FG003|Overall Study|Physician Decision|2|||
130820760|NCT03289143|470974550|FG000|Overall Study|Protocol Deviation|2|||
130820761|NCT03289143|470974551|FG001|Overall Study|Protocol Deviation|1|||
130820762|NCT03289143|470974552|FG002|Overall Study|Protocol Deviation|3|||
130820763|NCT03289143|470974553|FG003|Overall Study|Protocol Deviation|1|||
130820764|NCT03289143|470974550|FG000|Overall Study|Study Terminated By Sponsor|101|||
130820765|NCT03289143|470974551|FG001|Overall Study|Study Terminated By Sponsor|75|||
130820766|NCT03289143|470974552|FG002|Overall Study|Study Terminated By Sponsor|100|||
130820767|NCT03289143|470974553|FG003|Overall Study|Study Terminated By Sponsor|69|||
130820768|NCT03289143|470974550|FG000|Overall Study|Withdrawal by Subject|14|||
130820769|NCT03289143|470974551|FG001|Overall Study|Withdrawal by Subject|6|||
130820770|NCT03289143|470974552|FG002|Overall Study|Withdrawal by Subject|14|||
130820771|NCT03289143|470974553|FG003|Overall Study|Withdrawal by Subject|12|||
130820772|NCT03289143|470974550|FG000|Overall Study|Adverse Event|10|||
130820773|NCT03289143|470974551|FG001|Overall Study|Adverse Event|7|||
130820774|NCT03289143|470974552|FG002|Overall Study|Adverse Event|6|||
130820775|NCT03289143|470974553|FG003|Overall Study|Adverse Event|5|||
130820776|NCT03289143|470974550|FG000|Overall Study|Death|2|||
130820777|NCT03289143|470974551|FG001|Overall Study|Death|0|||
130820778|NCT03289143|470974552|FG002|Overall Study|Death|2|||
130820779|NCT03289143|470974553|FG003|Overall Study|Death|1|||
130820780|NCT03289143|470974550|FG000|Overall Study|Lost to Follow-up|2|||
130820781|NCT03289143|470974551|FG001|Overall Study|Lost to Follow-up|1|||
130820782|NCT03289143|470974552|FG002|Overall Study|Lost to Follow-up|1|||
130820783|NCT03289143|470974553|FG003|Overall Study|Lost to Follow-up|0|||
130820784|NCT03289143|470974550|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
130820785|NCT03289143|470974551|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
130820786|NCT03289143|470974552|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
130820787|NCT03289143|470974553|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
130820788|NCT03289143|470974550|FG000|Overall Study|Withdrawal by Caregiver|0|||
130820789|NCT03289143|470974551|FG001|Overall Study|Withdrawal by Caregiver|1|||
130820790|NCT03289143|470974552|FG002|Overall Study|Withdrawal by Caregiver|0|||
130820791|NCT03289143|470974553|FG003|Overall Study|Withdrawal by Caregiver|0|||
130820792|NCT03289143|470974550|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
130820793|NCT03289143|470974551|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
130820794|NCT03289143|470974552|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
130820795|NCT03289143|470974553|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
130820796|NCT03289143|470974550|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
130820797|NCT03289143|470974551|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
130820798|NCT03289143|470974552|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
130820799|NCT03289143|470974553|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
130820800|NCT00730756|470974554|FG000|Overall Study|Adverse Event|2|||
130820801|NCT00730756|470974555|FG001|Overall Study|Adverse Event|0|||
130820802|NCT00730756|470974554|FG000|Overall Study|Lack of Efficacy|1|||
130820803|NCT00730756|470974555|FG001|Overall Study|Lack of Efficacy|1|||
130820804|NCT00730756|470974554|FG000|Overall Study|Protocol Deviation|1|||
130820805|NCT00730756|470974555|FG001|Overall Study|Protocol Deviation|2|||
130820806|NCT00730756|470974554|FG000|Overall Study|Lost to Follow-up|0|||
130820807|NCT00730756|470974555|FG001|Overall Study|Lost to Follow-up|1|||
130820808|NCT00730756|470974554|FG000|Overall Study|Withdrew Consent|0|||
130820809|NCT00730756|470974555|FG001|Overall Study|Withdrew Consent|1|||
130820810|NCT00305877|470974556|FG000|Overall Study|Lack of Efficacy|6|||
130820811|NCT00305877|470974557|FG001|Overall Study|Lack of Efficacy|9|||
130820812|NCT00305877|470974556|FG000|Overall Study|Adverse Event|9|||
130820813|NCT00305877|470974557|FG001|Overall Study|Adverse Event|14|||
130820814|NCT00305877|470974556|FG000|Overall Study|Death|0|||
130820815|NCT00305877|470974557|FG001|Overall Study|Death|1|||
130820816|NCT00305877|470974556|FG000|Overall Study|Withdrawal by Subject|4|||
130820817|NCT00305877|470974557|FG001|Overall Study|Withdrawal by Subject|2|||
130820818|NCT00305877|470974556|FG000|Overall Study|Physician Decision|1|||
130820819|NCT00305877|470974557|FG001|Overall Study|Physician Decision|1|||
130820820|NCT00305877|470974556|FG000|Overall Study|Never start treatment|2|||
130820821|NCT00305877|470974557|FG001|Overall Study|Never start treatment|5|||
130820822|NCT00305877|470974556|FG000|Overall Study|Ineligible|2|||
130820823|NCT00305877|470974557|FG001|Overall Study|Ineligible|1|||
130820824|NCT00305877|470974556|FG000|Overall Study|Transportation issue with daily RT|0|||
130820825|NCT00305877|470974557|FG001|Overall Study|Transportation issue with daily RT|1|||
130820826|NCT01126190|470974558|FG000|Double-Blind Phase|Death|0|||
130820827|NCT01126190|470974559|FG001|Double-Blind Phase|Death|1|||
130820828|NCT01126190|470974560|FG002|Double-Blind Phase|Death|0|||
130820829|NCT01126190|470974558|FG000|Double-Blind Phase|Adverse Event|1|||
130820830|NCT01126190|470974559|FG001|Double-Blind Phase|Adverse Event|2|||
130820831|NCT01126190|470974560|FG002|Double-Blind Phase|Adverse Event|0|||
130820832|NCT01126190|470974558|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130820833|NCT01126190|470974559|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
130820834|NCT01126190|470974560|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130820835|NCT01126190|470974558|FG000|Double-Blind Phase|Request of Investigator|1|||
130820836|NCT01126190|470974559|FG001|Double-Blind Phase|Request of Investigator|0|||
130820837|NCT01126190|470974560|FG002|Double-Blind Phase|Request of Investigator|0|||
130820838|NCT01126190|470974558|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
130820839|NCT01126190|470974559|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
130820840|NCT01126190|470974560|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
130820841|NCT01126190|470974558|FG000|Double-Blind Phase|Non-compliance|1|||
130820842|NCT01126190|470974559|FG001|Double-Blind Phase|Non-compliance|0|||
130820843|NCT01126190|470974560|FG002|Double-Blind Phase|Non-compliance|0|||
130820844|NCT01126190|470974558|FG000|Double-Blind Phase|Lost to Follow-up|1|||
130820845|NCT01126190|470974559|FG001|Double-Blind Phase|Lost to Follow-up|3|||
130820846|NCT01126190|470974560|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130820847|NCT01126190|470974558|FG000|Open-Label Phase|Death|0|||
130820848|NCT01126190|470974559|FG001|Open-Label Phase|Death|0|||
130820849|NCT01126190|470974560|FG002|Open-Label Phase|Death|1|||
130820850|NCT01126190|470974558|FG000|Open-Label Phase|Adverse Event|0|||
130820851|NCT01126190|470974559|FG001|Open-Label Phase|Adverse Event|0|||
130820852|NCT01126190|470974560|FG002|Open-Label Phase|Adverse Event|4|||
130820853|NCT01126190|470974558|FG000|Open-Label Phase|Withdrawal by Subject|0|||
130820854|NCT01126190|470974559|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130820855|NCT01126190|470974560|FG002|Open-Label Phase|Withdrawal by Subject|6|||
130820856|NCT00524121|470974563|FG000|Overall Study|Disease progression|6|||
130820857|NCT00524121|470974563|FG000|Overall Study|Adverse Event|4|||
130820858|NCT00524121|470974563|FG000|Overall Study|Patient refused|2|||
130820859|NCT00524121|470974563|FG000|Overall Study|Other|1|||
130820860|NCT00524121|470974563|FG000|Overall Study|Death|1|||
130820861|NCT00524121|470974563|FG000|Overall Study|Not treated (became ineligible)|4|||
130820862|NCT00524121|470974563|FG000|Overall Study|Not treated (changed mind)|1|||
130820863|NCT02727322|470974564|FG000|Overall Study|Withdrawal by Subject|1|||
130820864|NCT02727322|470974565|FG001|Overall Study|Withdrawal by Subject|1|||
130820865|NCT02727322|470974564|FG000|Overall Study|Protocol Violation|1|||
130820866|NCT02727322|470974565|FG001|Overall Study|Protocol Violation|0|||
130820867|NCT02852967|470974566|FG000|Overall Study|Adverse Event|3|||
130820868|NCT02852967|470974567|FG001|Overall Study|Adverse Event|1|||
130820869|NCT02852967|470974568|FG002|Overall Study|Adverse Event|0|||
130820870|NCT02852967|470974569|FG003|Overall Study|Adverse Event|1|||
130820871|NCT02852967|470974570|FG004|Overall Study|Adverse Event|0|||
130820872|NCT02852967|470974566|FG000|Overall Study|Death|1|||
130820873|NCT02852967|470974567|FG001|Overall Study|Death|0|||
130820874|NCT02852967|470974568|FG002|Overall Study|Death|0|||
130820875|NCT02852967|470974569|FG003|Overall Study|Death|0|||
130820876|NCT02852967|470974570|FG004|Overall Study|Death|0|||
130820877|NCT02852967|470974566|FG000|Overall Study|Lost to Follow-up|1|||
130820878|NCT02852967|470974567|FG001|Overall Study|Lost to Follow-up|2|||
130820879|NCT02852967|470974568|FG002|Overall Study|Lost to Follow-up|3|||
130820880|NCT02852967|470974569|FG003|Overall Study|Lost to Follow-up|4|||
130820881|NCT02852967|470974570|FG004|Overall Study|Lost to Follow-up|4|||
130820882|NCT02852967|470974566|FG000|Overall Study|Withdrawal by Subject|6|||
130820883|NCT02852967|470974567|FG001|Overall Study|Withdrawal by Subject|12|||
130820884|NCT02852967|470974568|FG002|Overall Study|Withdrawal by Subject|7|||
130820885|NCT02852967|470974569|FG003|Overall Study|Withdrawal by Subject|10|||
130820886|NCT02852967|470974570|FG004|Overall Study|Withdrawal by Subject|10|||
130820887|NCT02852967|470974566|FG000|Overall Study|SAE|0|||
130820888|NCT02852967|470974567|FG001|Overall Study|SAE|0|||
130820889|NCT02852967|470974568|FG002|Overall Study|SAE|0|||
130820890|NCT02852967|470974569|FG003|Overall Study|SAE|3|||
130820891|NCT02852967|470974570|FG004|Overall Study|SAE|0|||
130820892|NCT02852967|470974566|FG000|Overall Study|Elevated Liver Enzymes|2|||
130820893|NCT02852967|470974567|FG001|Overall Study|Elevated Liver Enzymes|0|||
130820894|NCT02852967|470974568|FG002|Overall Study|Elevated Liver Enzymes|0|||
130820895|NCT02852967|470974569|FG003|Overall Study|Elevated Liver Enzymes|2|||
130820896|NCT02852967|470974570|FG004|Overall Study|Elevated Liver Enzymes|2|||
130820897|NCT02852967|470974566|FG000|Overall Study|Physician Decision|0|||
130820898|NCT02852967|470974567|FG001|Overall Study|Physician Decision|0|||
130820899|NCT02852967|470974568|FG002|Overall Study|Physician Decision|0|||
130820900|NCT02852967|470974569|FG003|Overall Study|Physician Decision|1|||
130820901|NCT02852967|470974570|FG004|Overall Study|Physician Decision|0|||
130820902|NCT02852967|470974566|FG000|Overall Study|Lack of Efficacy|0|||
130820903|NCT02852967|470974567|FG001|Overall Study|Lack of Efficacy|1|||
130820904|NCT02852967|470974568|FG002|Overall Study|Lack of Efficacy|0|||
130820905|NCT02852967|470974569|FG003|Overall Study|Lack of Efficacy|0|||
130820906|NCT02852967|470974570|FG004|Overall Study|Lack of Efficacy|0|||
130820907|NCT02852967|470974566|FG000|Overall Study|Non-compliance|0|||
130820908|NCT02852967|470974567|FG001|Overall Study|Non-compliance|0|||
130820909|NCT02852967|470974568|FG002|Overall Study|Non-compliance|1|||
130820910|NCT02852967|470974569|FG003|Overall Study|Non-compliance|1|||
130820911|NCT02852967|470974570|FG004|Overall Study|Non-compliance|0|||
130820912|NCT02852967|470974566|FG000|Overall Study|Dispensing Drug Violation|0|||
130820913|NCT02852967|470974567|FG001|Overall Study|Dispensing Drug Violation|0|||
130820914|NCT02852967|470974568|FG002|Overall Study|Dispensing Drug Violation|1|||
130820915|NCT02852967|470974569|FG003|Overall Study|Dispensing Drug Violation|0|||
130820916|NCT02852967|470974570|FG004|Overall Study|Dispensing Drug Violation|0|||
130820917|NCT02852967|470974566|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
130820918|NCT02852967|470974567|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
130820919|NCT02852967|470974568|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
130820920|NCT02852967|470974569|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
130820921|NCT02852967|470974570|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
130820922|NCT00339040|470974571|FG000|Stage I|Not able to attend clinic|1|||
130820923|NCT00339040|470974572|FG001|Stage I|Not able to attend clinic|0|||
130820924|NCT00339040|470974571|FG000|Stage I|Protocol Violation|1|||
130820925|NCT00339040|470974572|FG001|Stage I|Protocol Violation|1|||
130820926|NCT00339040|470974571|FG000|Stage II|Lost to Follow-up|3|||
130820927|NCT00339040|470974572|FG001|Stage II|Lost to Follow-up|0|||
130820928|NCT00339040|470974571|FG000|Stage II|Withdrawal by Subject|1|||
130820929|NCT00339040|470974572|FG001|Stage II|Withdrawal by Subject|2|||
130820930|NCT00339040|470974571|FG000|Stage II|Protocol Violation|3|||
130820931|NCT00339040|470974572|FG001|Stage II|Protocol Violation|0|||
130820932|NCT00339040|470974571|FG000|Stage II|Not able to attend clinic|1|||
130820933|NCT00339040|470974572|FG001|Stage II|Not able to attend clinic|0|||
130820934|NCT00339040|470974571|FG000|Stage II|Site closing|2|||
130820935|NCT00339040|470974572|FG001|Stage II|Site closing|0|||
130820936|NCT01693367|470974573|FG000|Overall Study|Withdrawal by Subject|1|||
130820937|NCT01693367|470974574|FG001|Overall Study|Withdrawal by Subject|1|||
130820938|NCT01693367|470974573|FG000|Overall Study|Physician Decision|0|||
130820939|NCT01693367|470974574|FG001|Overall Study|Physician Decision|1|||
130820940|NCT03046446|470974577|FG000|Overall Study|Lack of Efficacy|7|||
130820941|NCT03046446|470974577|FG000|Overall Study|Adverse Event|6|||
130820942|NCT03046446|470974577|FG000|Overall Study|Lost to Follow-up|3|||
130820943|NCT03046446|470974577|FG000|Overall Study|Withdrawal by Subject|14|||
130820944|NCT03046446|470974577|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
130820945|NCT03046446|470974577|FG000|Overall Study|Disease Progression (see caveats)|25|||
130820946|NCT03046446|470974577|FG000|Overall Study|Non OA related knee surgery|1|||
130820947|NCT02808897|470974578|FG000|Overall Study|Lost to Follow-up|9|||
130820948|NCT02808897|470974579|FG001|Overall Study|Lost to Follow-up|11|||
130820949|NCT01870869|470974580|FG000|Overall Study|Implanted with nonstudy device|1|||
130820950|NCT01870869|470974581|FG001|Overall Study|Implanted with nonstudy device|3|||
130820951|NCT01870869|470974582|FG002|Overall Study|Implanted with nonstudy device|14|||
130820952|NCT01870869|470974583|FG003|Overall Study|Implanted with nonstudy device|4|||
130820953|NCT01870869|470974580|FG000|Overall Study|Death|0|||
130820954|NCT01870869|470974581|FG001|Overall Study|Death|0|||
130820955|NCT01870869|470974582|FG002|Overall Study|Death|7|||
130820956|NCT01870869|470974583|FG003|Overall Study|Death|1|||
130820957|NCT01870869|470974580|FG000|Overall Study|Subject choice|6|||
130820958|NCT01870869|470974581|FG001|Overall Study|Subject choice|2|||
130820959|NCT01870869|470974582|FG002|Overall Study|Subject choice|22|||
130820960|NCT01870869|470974583|FG003|Overall Study|Subject choice|8|||
130820961|NCT01870869|470974580|FG000|Overall Study|Lost to Follow-up|10|||
130820962|NCT01870869|470974581|FG001|Overall Study|Lost to Follow-up|2|||
130820963|NCT01870869|470974582|FG002|Overall Study|Lost to Follow-up|25|||
130820964|NCT01870869|470974583|FG003|Overall Study|Lost to Follow-up|3|||
130820965|NCT01870869|470974580|FG000|Overall Study|Reason not Specified|1|||
130820966|NCT01870869|470974581|FG001|Overall Study|Reason not Specified|2|||
130820967|NCT01870869|470974582|FG002|Overall Study|Reason not Specified|20|||
130820968|NCT01870869|470974583|FG003|Overall Study|Reason not Specified|4|||
130820969|NCT01870869|470974580|FG000|Overall Study|Not evaluable|10|||
130820970|NCT01870869|470974581|FG001|Overall Study|Not evaluable|5|||
130820971|NCT01870869|470974582|FG002|Overall Study|Not evaluable|42|||
130820972|NCT01870869|470974583|FG003|Overall Study|Not evaluable|10|||
130820973|NCT03036852|470974584|FG000|Overall Study|Death|2|||
130820974|NCT03036852|470974584|FG000|Overall Study|Lack of Efficacy|2|||
130820975|NCT03036852|470974584|FG000|Overall Study|Adverse Event|1|||
130820976|NCT03036852|470974584|FG000|Overall Study|Lost to Follow-up|1|||
130820977|NCT02949011|470974587|FG000|Overall Study|Adverse Event|6|||
130820978|NCT02949011|470974588|FG001|Overall Study|Adverse Event|7|||
130820979|NCT02949011|470974589|FG002|Overall Study|Adverse Event|3|||
130820980|NCT02949011|470974587|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130820981|NCT02949011|470974588|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130820982|NCT02949011|470974589|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
130820983|NCT02949011|470974587|FG000|Overall Study|Protocol Deviation|5|||
130820984|NCT02949011|470974588|FG001|Overall Study|Protocol Deviation|3|||
130820985|NCT02949011|470974589|FG002|Overall Study|Protocol Deviation|3|||
130820986|NCT02949011|470974587|FG000|Overall Study|Lack of Efficacy|0|||
130820987|NCT02949011|470974588|FG001|Overall Study|Lack of Efficacy|2|||
130820988|NCT02949011|470974589|FG002|Overall Study|Lack of Efficacy|0|||
130820989|NCT02949011|470974587|FG000|Overall Study|Withdrawal by Subject|13|||
130820990|NCT02949011|470974588|FG001|Overall Study|Withdrawal by Subject|13|||
130820991|NCT02949011|470974589|FG002|Overall Study|Withdrawal by Subject|21|||
130820992|NCT02949011|470974587|FG000|Overall Study|Lost to Follow-up|7|||
130820993|NCT02949011|470974588|FG001|Overall Study|Lost to Follow-up|5|||
130820994|NCT02949011|470974589|FG002|Overall Study|Lost to Follow-up|5|||
130820995|NCT02949011|470974587|FG000|Overall Study|Death|0|||
130820996|NCT02949011|470974588|FG001|Overall Study|Death|0|||
130820997|NCT02949011|470974589|FG002|Overall Study|Death|1|||
130820998|NCT02949011|470974587|FG000|Overall Study|Miscellaneous|2|||
130820999|NCT02949011|470974588|FG001|Overall Study|Miscellaneous|4|||
130821000|NCT02949011|470974589|FG002|Overall Study|Miscellaneous|6|||
130821001|NCT00163189|470974590|FG000|Overall Study|Other|6|||
130821002|NCT00163189|470974590|FG000|Overall Study|Lost to Follow-up|1|||
130821003|NCT00163189|470974590|FG000|Overall Study|Protocol Violation|2|||
130821004|NCT00163189|470974590|FG000|Overall Study|Death|3|||
130821005|NCT00163189|470974590|FG000|Overall Study|Adverse Event|6|||
130821006|NCT00163189|470974590|FG000|Overall Study|Lack of Efficacy|7|||
130821007|NCT00163189|470974590|FG000|Overall Study|Study terminated by sponsor|11|||
130821008|NCT00163189|470974590|FG000|Overall Study|Withdrawal by Subject|11|||
130821009|NCT00163189|470974590|FG000|Overall Study|Did not meet continuation criterion|16|||
130821010|NCT01917318|470974592|FG000|First Treatment|Withdrawal by Subject|0|||
130821011|NCT01917318|470974593|FG001|First Treatment|Withdrawal by Subject|1|||
130821012|NCT02013609|470974597|FG000|Overall Study|Withdrawal by Subject|9|||
130821013|NCT02013609|470974597|FG000|Overall Study|Lost to Follow-up|3|||
130821014|NCT02013609|470974597|FG000|Overall Study|Adverse Event|3|||
130821015|NCT02013609|470974597|FG000|Overall Study|Met Withdrawal Criteria|3|||
130821016|NCT00783432|470974598|FG000|Overall Study|Adverse Event|22|||
130821017|NCT00783432|470974599|FG001|Overall Study|Adverse Event|17|||
130821018|NCT00783432|470974598|FG000|Overall Study|Lack of Efficacy|20|||
130821019|NCT00783432|470974599|FG001|Overall Study|Lack of Efficacy|21|||
130821020|NCT00783432|470974598|FG000|Overall Study|Lost to Follow-up|11|||
130821021|NCT00783432|470974599|FG001|Overall Study|Lost to Follow-up|6|||
130821022|NCT00783432|470974598|FG000|Overall Study|Withdrawal by Subject|23|||
130821023|NCT00783432|470974599|FG001|Overall Study|Withdrawal by Subject|20|||
130821024|NCT00783432|470974598|FG000|Overall Study|subject moved|3|||
130821025|NCT00783432|470974599|FG001|Overall Study|subject moved|5|||
130821026|NCT00783432|470974598|FG000|Overall Study|Protocol Violation|6|||
130821027|NCT00783432|470974599|FG001|Overall Study|Protocol Violation|9|||
130821028|NCT01436110|470974600|FG000|Overall Study|Lack of Efficacy|23|||
130821029|NCT01436110|470974601|FG001|Overall Study|Lack of Efficacy|14|||
130821030|NCT01436110|470974602|FG002|Overall Study|Lack of Efficacy|9|||
130821031|NCT01436110|470974600|FG000|Overall Study|Withdrawal by Subject|6|||
130821032|NCT01436110|470974601|FG001|Overall Study|Withdrawal by Subject|8|||
130821033|NCT01436110|470974602|FG002|Overall Study|Withdrawal by Subject|4|||
130821034|NCT01436110|470974600|FG000|Overall Study|Adverse Event|2|||
130821035|NCT01436110|470974601|FG001|Overall Study|Adverse Event|1|||
130821036|NCT01436110|470974602|FG002|Overall Study|Adverse Event|2|||
130821037|NCT01436110|470974600|FG000|Overall Study|Physician Decision|3|||
130821038|NCT01436110|470974601|FG001|Overall Study|Physician Decision|1|||
130821039|NCT01436110|470974602|FG002|Overall Study|Physician Decision|1|||
130821040|NCT01436110|470974600|FG000|Overall Study|Lost to Follow-up|1|||
130821041|NCT01436110|470974601|FG001|Overall Study|Lost to Follow-up|1|||
130821042|NCT01436110|470974602|FG002|Overall Study|Lost to Follow-up|3|||
130821043|NCT01436110|470974600|FG000|Overall Study|Protocol Violation|3|||
130821044|NCT01436110|470974601|FG001|Overall Study|Protocol Violation|1|||
130821045|NCT01436110|470974602|FG002|Overall Study|Protocol Violation|1|||
130821046|NCT01436110|470974600|FG000|Overall Study|Did Not Receive Trial Medication|1|||
130821047|NCT01436110|470974601|FG001|Overall Study|Did Not Receive Trial Medication|0|||
130821048|NCT01436110|470974602|FG002|Overall Study|Did Not Receive Trial Medication|3|||
130821049|NCT03273907|470974604|FG000|Overall Study|Death|1|||
130821050|NCT03273907|470974604|FG000|Overall Study|Lost to Follow-up|4|||
130821051|NCT03273907|470974604|FG000|Overall Study|Withdrawal by Subject|2|||
130821052|NCT03273907|470974604|FG000|Overall Study|COVID 19|2|||
130821053|NCT01088503|470974605|FG000|Overall Study|Withdrawal by Subject|118|||
130821054|NCT01088503|470974606|FG001|Overall Study|Withdrawal by Subject|327|||
130821055|NCT01088503|470974607|FG002|Overall Study|Withdrawal by Subject|10|||
130821056|NCT01088503|470974605|FG000|Overall Study|Death|64|||
130821057|NCT01088503|470974606|FG001|Overall Study|Death|358|||
130821058|NCT01088503|470974607|FG002|Overall Study|Death|7|||
130821059|NCT00110214|470974608|FG000|Overall Study|Never started treatment|21|||
130821060|NCT00110214|470974609|FG001|Overall Study|Never started treatment|20|||
130821061|NCT00110214|470974608|FG000|Overall Study|Disease progression or death|260|||
130821062|NCT00110214|470974609|FG001|Overall Study|Disease progression or death|151|||
130821063|NCT00110214|470974608|FG000|Overall Study|Adverse Event|115|||
130821064|NCT00110214|470974609|FG001|Overall Study|Adverse Event|192|||
130821065|NCT00110214|470974608|FG000|Overall Study|Refused further treatment|52|||
130821066|NCT00110214|470974609|FG001|Overall Study|Refused further treatment|65|||
130821067|NCT00110214|470974608|FG000|Overall Study|Other (not specified)|61|||
130821068|NCT00110214|470974609|FG001|Overall Study|Other (not specified)|75|||
130821069|NCT01016067|470974610|FG000|Overall Study|Lost to Follow-up|1|||
130821070|NCT01016067|470974611|FG001|Overall Study|Lost to Follow-up|2|||
130821071|NCT01016067|470974610|FG000|Overall Study|Physician Decision|1|||
130821072|NCT01016067|470974611|FG001|Overall Study|Physician Decision|1|||
130821073|NCT01016067|470974610|FG000|Overall Study|Withdrew due to Relocation|0|||
130821074|NCT01016067|470974611|FG001|Overall Study|Withdrew due to Relocation|1|||
130821075|NCT01531998|470974612|FG000|Overall Study|Withdrawal by Subject|3|||
130821076|NCT02581891|470974614|FG000|Overall Study|Adverse Event|4|||
130821077|NCT02581891|470974615|FG001|Overall Study|Adverse Event|6|||
130821078|NCT02581891|470974614|FG000|Overall Study|Death|3|||
130821079|NCT02581891|470974615|FG001|Overall Study|Death|4|||
130821080|NCT02581891|470974614|FG000|Overall Study|Lost to Follow-up|1|||
130821081|NCT02581891|470974615|FG001|Overall Study|Lost to Follow-up|2|||
130821082|NCT02581891|470974614|FG000|Overall Study|Physician Decision|0|||
130821083|NCT02581891|470974615|FG001|Overall Study|Physician Decision|1|||
130821084|NCT02581891|470974614|FG000|Overall Study|Withdrawal by Subject|4|||
130821085|NCT02581891|470974615|FG001|Overall Study|Withdrawal by Subject|5|||
130821086|NCT02581891|470974614|FG000|Overall Study|Other Reasons|3|||
130821087|NCT02581891|470974615|FG001|Overall Study|Other Reasons|1|||
130821088|NCT02581891|470974614|FG000|Overall Study|Discontinued during followup|1|||
130821089|NCT02581891|470974615|FG001|Overall Study|Discontinued during followup|0|||
130821090|NCT03440008|470974616|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
130821091|NCT03440008|470974617|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
130821092|NCT03440008|470974616|FG000|Overall Study|Withdrawal by Subject|1|||
130821093|NCT03440008|470974617|FG001|Overall Study|Withdrawal by Subject|0|||
130821094|NCT03498716|470974625|FG000|Overall Study|Withdrawal by Subject|88|||
130821095|NCT03498716|470974626|FG001|Overall Study|Withdrawal by Subject|73|||
130821096|NCT03498716|470974625|FG000|Overall Study|Study Terminated By Sponsor|933|||
130821097|NCT03498716|470974626|FG001|Overall Study|Study Terminated By Sponsor|927|||
130821098|NCT03498716|470974625|FG000|Overall Study|Lost to Follow-up|15|||
130821099|NCT03498716|470974626|FG001|Overall Study|Lost to Follow-up|26|||
130821100|NCT03498716|470974625|FG000|Overall Study|Disease Relapse|0|||
130821101|NCT03498716|470974626|FG001|Overall Study|Disease Relapse|1|||
130821102|NCT03498716|470974625|FG000|Overall Study|Death|58|||
130821103|NCT03498716|470974626|FG001|Overall Study|Death|72|||
130821104|NCT03498716|470974625|FG000|Overall Study|Physician Decision|4|||
130821105|NCT03498716|470974626|FG001|Overall Study|Physician Decision|2|||
130821106|NCT01188967|470974627|FG000|Overall Study|Withdrawal by Subject|1|||
130821107|NCT01188967|470974628|FG001|Overall Study|Withdrawal by Subject|1|||
130821108|NCT01188967|470974627|FG000|Overall Study|Physician Decision|1|||
130821109|NCT01188967|470974628|FG001|Overall Study|Physician Decision|1|||
130821110|NCT01188967|470974627|FG000|Overall Study|Lost to Follow-up|3|||
130821111|NCT01188967|470974628|FG001|Overall Study|Lost to Follow-up|2|||
130821112|NCT01657305|470974632|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
130821113|NCT01657305|470974632|FG000|Overall Study|Withdrawal by Subject|4|||
130821114|NCT01657305|470974632|FG000|Overall Study|Adverse Event|1|||
130821115|NCT01657305|470974632|FG000|Overall Study|Lost to Follow-up|1|||
130821116|NCT01657305|470974632|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
130821117|NCT04103450|470974633|FG000|Overall Study|Adverse Event|4|||
130821118|NCT04103450|470974634|FG001|Overall Study|Adverse Event|2|||
130821119|NCT04103450|470974633|FG000|Overall Study|Lack of Efficacy|3|||
130821120|NCT04103450|470974634|FG001|Overall Study|Lack of Efficacy|0|||
130821121|NCT04103450|470974633|FG000|Overall Study|Withdrawal by Subject|5|||
130821122|NCT04103450|470974634|FG001|Overall Study|Withdrawal by Subject|3|||
130821123|NCT04103450|470974633|FG000|Overall Study|Lost to Follow-up|1|||
130821124|NCT04103450|470974634|FG001|Overall Study|Lost to Follow-up|2|||
130821125|NCT04103450|470974633|FG000|Overall Study|Physician Decision|1|||
130821126|NCT04103450|470974634|FG001|Overall Study|Physician Decision|2|||
130821127|NCT04103450|470974633|FG000|Overall Study|Protocol Violation|1|||
130821128|NCT04103450|470974634|FG001|Overall Study|Protocol Violation|0|||
130821129|NCT04103450|470974633|FG000|Overall Study|Other|1|||
130821130|NCT04103450|470974634|FG001|Overall Study|Other|1|||
130821131|NCT01696643|470974639|FG000|Overall Study|Adverse Event|15|||
130821132|NCT01696643|470974640|FG001|Overall Study|Adverse Event|7|||
130821133|NCT01696643|470974639|FG000|Overall Study|Death|1|||
130821134|NCT01696643|470974640|FG001|Overall Study|Death|2|||
130821135|NCT01696643|470974639|FG000|Overall Study|Lack of Efficacy|3|||
130821136|NCT01696643|470974640|FG001|Overall Study|Lack of Efficacy|0|||
130821137|NCT01696643|470974639|FG000|Overall Study|Lost to Follow-up|67|||
130821138|NCT01696643|470974640|FG001|Overall Study|Lost to Follow-up|67|||
130821139|NCT01696643|470974639|FG000|Overall Study|Physician Decision|3|||
130821140|NCT01696643|470974640|FG001|Overall Study|Physician Decision|2|||
130821141|NCT01696643|470974639|FG000|Overall Study|Pregnancy|0|||
130821142|NCT01696643|470974640|FG001|Overall Study|Pregnancy|1|||
130821143|NCT01696643|470974639|FG000|Overall Study|Protocol Violation|7|||
130821144|NCT01696643|470974640|FG001|Overall Study|Protocol Violation|7|||
130821145|NCT01696643|470974639|FG000|Overall Study|Study Terminated by Sponsor|286|||
130821146|NCT01696643|470974640|FG001|Overall Study|Study Terminated by Sponsor|294|||
130821147|NCT01696643|470974639|FG000|Overall Study|Withdrawal by Subject|142|||
130821148|NCT01696643|470974640|FG001|Overall Study|Withdrawal by Subject|149|||
130821149|NCT01696643|470974639|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
130821150|NCT01696643|470974640|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
130821151|NCT01696643|470974639|FG000|Overall Study|Site Error|2|||
130821152|NCT01696643|470974640|FG001|Overall Study|Site Error|1|||
130821153|NCT01696643|470974639|FG000|Overall Study|Participant Incarcerated|0|||
130821154|NCT01696643|470974640|FG001|Overall Study|Participant Incarcerated|1|||
130821155|NCT01696643|470974639|FG000|Overall Study|Medical Monitor Decision|0|||
130821156|NCT01696643|470974640|FG001|Overall Study|Medical Monitor Decision|2|||
130821157|NCT01696643|470974639|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
130821158|NCT01696643|470974640|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
130821159|NCT02271529|470974643|FG000|Overall Study|Withdrawal by Subject|1|||
130821160|NCT03768427|470974644|FG000|Overall Study|Death|0|||
130821161|NCT03768427|470974645|FG001|Overall Study|Death|0|||
130821162|NCT03768427|470974646|FG002|Overall Study|Death|1|||
130821163|NCT03768427|470974647|FG003|Overall Study|Death|0|||
130821164|NCT03768427|470974644|FG000|Overall Study|Lost to Follow-up|2|||
130821165|NCT03768427|470974645|FG001|Overall Study|Lost to Follow-up|0|||
130821166|NCT03768427|470974646|FG002|Overall Study|Lost to Follow-up|0|||
130821167|NCT03768427|470974647|FG003|Overall Study|Lost to Follow-up|0|||
130821168|NCT03768427|470974644|FG000|Overall Study|Physician Decision|3|||
130821169|NCT03768427|470974645|FG001|Overall Study|Physician Decision|2|||
130821170|NCT03768427|470974646|FG002|Overall Study|Physician Decision|4|||
130821171|NCT03768427|470974647|FG003|Overall Study|Physician Decision|4|||
130821172|NCT03768427|470974644|FG000|Overall Study|Withdrawal by Subject|7|||
130821173|NCT03768427|470974645|FG001|Overall Study|Withdrawal by Subject|2|||
130821174|NCT03768427|470974646|FG002|Overall Study|Withdrawal by Subject|6|||
130821175|NCT03768427|470974647|FG003|Overall Study|Withdrawal by Subject|7|||
130821176|NCT00902330|470974657|FG000|Overall Study|Too overwhelmed by treatment|2|||
130821177|NCT00902330|470974658|FG001|Overall Study|Too overwhelmed by treatment|5|||
130821178|NCT00902330|470974657|FG000|Overall Study|Adverse Event|1|||
130821179|NCT00902330|470974658|FG001|Overall Study|Adverse Event|0|||
130821180|NCT00902330|470974657|FG000|Overall Study|No post baseline data|1|||
130821181|NCT00902330|470974658|FG001|Overall Study|No post baseline data|0|||
130821182|NCT03950856|470974659|FG000|Overall Study|Death|1|||
130821183|NCT03950856|470974660|FG001|Overall Study|Death|2|||
130821184|NCT03950856|470974661|FG002|Overall Study|Death|0|||
130821185|NCT03950856|470974662|FG003|Overall Study|Death|0|||
130821186|NCT03950856|470974659|FG000|Overall Study|Lost to Follow-up|5|||
130821187|NCT03950856|470974660|FG001|Overall Study|Lost to Follow-up|6|||
130821188|NCT03950856|470974661|FG002|Overall Study|Lost to Follow-up|8|||
130821189|NCT03950856|470974662|FG003|Overall Study|Lost to Follow-up|2|||
130821190|NCT03950856|470974659|FG000|Overall Study|Protocol Violation|2|||
130821191|NCT03950856|470974660|FG001|Overall Study|Protocol Violation|0|||
130821192|NCT03950856|470974661|FG002|Overall Study|Protocol Violation|0|||
130821193|NCT03950856|470974662|FG003|Overall Study|Protocol Violation|1|||
130821194|NCT03950856|470974659|FG000|Overall Study|Withdrawal by Subject|4|||
130821195|NCT03950856|470974660|FG001|Overall Study|Withdrawal by Subject|1|||
130821196|NCT03950856|470974661|FG002|Overall Study|Withdrawal by Subject|3|||
130821197|NCT03950856|470974662|FG003|Overall Study|Withdrawal by Subject|1|||
130821198|NCT03950856|470974659|FG000|Overall Study|Unable to phone|7|||
130821199|NCT03950856|470974660|FG001|Overall Study|Unable to phone|6|||
130821200|NCT03950856|470974661|FG002|Overall Study|Unable to phone|7|||
130821201|NCT03950856|470974662|FG003|Overall Study|Unable to phone|2|||
130821202|NCT01816984|470974663|FG000|Overall Study|declining health status|1|||
130821203|NCT02121509|470974664|FG000|Washout Period (35 Days)|Adverse Event|1|||
130821204|NCT02121509|470974665|FG001|Washout Period (35 Days)|Adverse Event|1|||
130821205|NCT02121509|470974666|FG002|Washout Period (35 Days)|Adverse Event|0|||
130821206|NCT02121509|470974667|FG003|Washout Period (35 Days)|Adverse Event|0|||
130821207|NCT02121509|470974664|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
130821208|NCT02121509|470974665|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
130821209|NCT02121509|470974666|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
130821210|NCT02121509|470974667|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
130821211|NCT02121509|470974664|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
130821212|NCT02121509|470974665|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
130821213|NCT02121509|470974666|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
130821214|NCT02121509|470974667|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
130821215|NCT04021290|470974670|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
130821216|NCT04021290|470974671|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
130821217|NCT04021290|470974672|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
130821218|NCT04021290|470974670|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
130821219|NCT04021290|470974671|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
130821220|NCT04021290|470974672|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
130821221|NCT04021290|470974670|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
130821222|NCT04021290|470974671|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
130821223|NCT04021290|470974672|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
130821224|NCT04021290|470974670|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
130821225|NCT04021290|470974671|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
130821226|NCT04021290|470974672|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
130821227|NCT04021290|470974670|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
130821228|NCT04021290|470974671|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
130821229|NCT04021290|470974672|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
130821230|NCT04021290|470974670|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
130821231|NCT04021290|470974671|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
130821232|NCT04021290|470974672|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
130821233|NCT04021290|470974670|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
130821234|NCT04021290|470974671|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
130821235|NCT04021290|470974672|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
130821236|NCT04021290|470974670|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
130821237|NCT04021290|470974671|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
130821238|NCT04021290|470974672|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
130821239|NCT04021290|470974670|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
130821240|NCT04021290|470974671|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
130821241|NCT04021290|470974672|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
130821242|NCT04021290|470974670|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
130821243|NCT04021290|470974671|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
130821244|NCT04021290|470974672|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
130821245|NCT04021290|470974670|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
130821246|NCT04021290|470974671|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
130821247|NCT04021290|470974672|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
130821248|NCT04021290|470974670|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
130821249|NCT04021290|470974671|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
130821250|NCT04021290|470974672|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
130821251|NCT01174563|470974678|FG000|Overall Study|Progressive Disease|45|||
130821252|NCT01174563|470974678|FG000|Overall Study|Death|5|||
130821253|NCT01174563|470974678|FG000|Overall Study|Investigator's Discretion|5|||
130821254|NCT01174563|470974678|FG000|Overall Study|Participant Withdrew Consent|3|||
130821255|NCT01174563|470974678|FG000|Overall Study|Rash Adverse Event|1|||
130821256|NCT01174563|470974678|FG000|Overall Study|Sponsor's decision|1|||
130821257|NCT01542788|470974679|FG000|Overall Study|Randomized but Not Treated|2|||
130821258|NCT01542788|470974680|FG001|Overall Study|Randomized but Not Treated|0|||
130821259|NCT01542788|470974679|FG000|Overall Study|Lack of Efficacy|41|||
130821260|NCT01542788|470974680|FG001|Overall Study|Lack of Efficacy|71|||
130821261|NCT01542788|470974679|FG000|Overall Study|Lost to Follow-up|5|||
130821262|NCT01542788|470974680|FG001|Overall Study|Lost to Follow-up|0|||
130821263|NCT01542788|470974679|FG000|Overall Study|Death|3|||
130821264|NCT01542788|470974680|FG001|Overall Study|Death|0|||
130821265|NCT01542788|470974679|FG000|Overall Study|Protocol Violation|2|||
130821266|NCT01542788|470974680|FG001|Overall Study|Protocol Violation|0|||
130821267|NCT01542788|470974679|FG000|Overall Study|Physician Decision|1|||
130821268|NCT01542788|470974680|FG001|Overall Study|Physician Decision|0|||
130821269|NCT01542788|470974679|FG000|Overall Study|Withdrawal by Subject|1|||
130821270|NCT01542788|470974680|FG001|Overall Study|Withdrawal by Subject|0|||
130822789|NCT01815424|470980598|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
130822790|NCT01815424|470980599|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
130822791|NCT01815424|470980600|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
130822792|NCT01815424|470980601|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
130822793|NCT01815424|470980597|FG000|Week 16 to 52|Other|0|||
130822794|NCT01815424|470980598|FG001|Week 16 to 52|Other|1|||
130822795|NCT01815424|470980599|FG002|Week 16 to 52|Other|0|||
130822796|NCT01815424|470980600|FG003|Week 16 to 52|Other|0|||
130822797|NCT01815424|470980601|FG004|Week 16 to 52|Other|0|||
130822798|NCT01815424|470980597|FG000|Week 16 to 52|Adverse Event|0|||
130822799|NCT01815424|470980598|FG001|Week 16 to 52|Adverse Event|0|||
130822800|NCT01815424|470980599|FG002|Week 16 to 52|Adverse Event|0|||
130822801|NCT01815424|470980600|FG003|Week 16 to 52|Adverse Event|0|||
130822802|NCT01815424|470980601|FG004|Week 16 to 52|Adverse Event|1|||
130822803|NCT01815424|470980597|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
130822804|NCT01815424|470980598|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
130822805|NCT01815424|470980599|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
130822806|NCT01815424|470980600|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
130822807|NCT01815424|470980601|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
130822808|NCT01815424|470980597|FG000|Week 16 to 52|Lost to Follow-up|0|||
130822809|NCT01815424|470980598|FG001|Week 16 to 52|Lost to Follow-up|2|||
130822810|NCT01815424|470980599|FG002|Week 16 to 52|Lost to Follow-up|0|||
130822811|NCT01815424|470980600|FG003|Week 16 to 52|Lost to Follow-up|2|||
130822812|NCT01815424|470980601|FG004|Week 16 to 52|Lost to Follow-up|1|||
130822813|NCT01815424|470980597|FG000|Week 16 to 52|Withdrawal by Subject|1|||
130822814|NCT01815424|470980598|FG001|Week 16 to 52|Withdrawal by Subject|2|||
130822815|NCT01815424|470980599|FG002|Week 16 to 52|Withdrawal by Subject|0|||
130822816|NCT01815424|470980600|FG003|Week 16 to 52|Withdrawal by Subject|0|||
130822817|NCT01815424|470980601|FG004|Week 16 to 52|Withdrawal by Subject|0|||
130822818|NCT01309204|470980604|FG000|Overall Study|Adverse Event|48|||
130822819|NCT01309204|470980605|FG001|Overall Study|Adverse Event|58|||
130822820|NCT01309204|470980604|FG000|Overall Study|Lost to Follow-up|2|||
130822821|NCT01309204|470980605|FG001|Overall Study|Lost to Follow-up|2|||
130822822|NCT01309204|470980604|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
130822823|NCT01309204|470980605|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
130822824|NCT01309204|470980604|FG000|Overall Study|Inadequate control of IOP|4|||
130822825|NCT01309204|470980605|FG001|Overall Study|Inadequate control of IOP|4|||
130822826|NCT01309204|470980604|FG000|Overall Study|Other|4|||
130822827|NCT01309204|470980605|FG001|Overall Study|Other|1|||
130822828|NCT03374358|470980606|FG000|Overall Study|Withdrawal by Subject|0|||
130822829|NCT03374358|470980607|FG001|Overall Study|Withdrawal by Subject|2|||
130822830|NCT03183063|470980608|FG000|Overall Study|Withdrawal by Subject|2|||
130822831|NCT03183063|470980609|FG001|Overall Study|Withdrawal by Subject|0|||
130822832|NCT03183063|470980610|FG002|Overall Study|Withdrawal by Subject|0|||
130822833|NCT03183063|470980608|FG000|Overall Study|Physician Decision|3|||
130822834|NCT03183063|470980609|FG001|Overall Study|Physician Decision|4|||
130822835|NCT03183063|470980610|FG002|Overall Study|Physician Decision|4|||
130822836|NCT01127633|470980611|FG000|Overall Study|Adverse Event|74|||
130822837|NCT01127633|470980612|FG001|Overall Study|Adverse Event|73|||
130822838|NCT01127633|470980611|FG000|Overall Study|Death|40|||
130822839|NCT01127633|470980612|FG001|Overall Study|Death|43|||
130822840|NCT01127633|470980611|FG000|Overall Study|Lost to Follow-up|4|||
130822841|NCT01127633|470980612|FG001|Overall Study|Lost to Follow-up|0|||
130822842|NCT01127633|470980611|FG000|Overall Study|Parent/Caregiver Decision|246|||
130822843|NCT01127633|470980612|FG001|Overall Study|Parent/Caregiver Decision|228|||
130822844|NCT01127633|470980611|FG000|Overall Study|Physician Decision|60|||
130821271|NCT01114737|470976668|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
130821272|NCT01114737|470976669|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
130821273|NCT01114737|470976668|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
130821274|NCT01114737|470976669|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
130821275|NCT01114737|470976668|FG000|Randomized Treatment Period|Pregnancy|1|||
130821276|NCT01114737|470976669|FG001|Randomized Treatment Period|Pregnancy|0|||
130821277|NCT01114737|470976668|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
130821278|NCT01114737|470976669|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
130821279|NCT01114737|470976668|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
130821280|NCT01114737|470976669|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
130821281|NCT01114737|470976668|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
130821282|NCT01114737|470976669|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
130821283|NCT01446874|470976670|FG000|Overall Study|Not eligible|1|||
130821284|NCT01446874|470976671|FG001|Overall Study|Not eligible|0|||
130821285|NCT01446874|470976672|FG002|Overall Study|Not eligible|0|||
130821286|NCT01446874|470976670|FG000|Overall Study|No surgery/No qualifying surgery|1|||
130821287|NCT01446874|470976671|FG001|Overall Study|No surgery/No qualifying surgery|0|||
130821288|NCT01446874|470976672|FG002|Overall Study|No surgery/No qualifying surgery|12|||
130821289|NCT01446874|470976670|FG000|Overall Study|Non-compliance|0|||
130821290|NCT01446874|470976671|FG001|Overall Study|Non-compliance|4|||
130821291|NCT01446874|470976672|FG002|Overall Study|Non-compliance|0|||
130821292|NCT01446874|470976670|FG000|Overall Study|Antibiotics for pre-op infection|0|||
130821293|NCT01446874|470976671|FG001|Overall Study|Antibiotics for pre-op infection|0|||
130821294|NCT01446874|470976672|FG002|Overall Study|Antibiotics for pre-op infection|2|||
130821295|NCT01446874|470976670|FG000|Overall Study|Withdrawal by Subject|0|||
130821296|NCT01446874|470976671|FG001|Overall Study|Withdrawal by Subject|0|||
130821297|NCT01446874|470976672|FG002|Overall Study|Withdrawal by Subject|4|||
130821298|NCT00457392|470976673|FG000|Overall Study|Objective Progression or Relapse|229|||
130821299|NCT00457392|470976674|FG001|Overall Study|Objective Progression or Relapse|296|||
130821300|NCT00457392|470976673|FG000|Overall Study|Death|106|||
130821301|NCT00457392|470976674|FG001|Overall Study|Death|106|||
130821302|NCT00457392|470976673|FG000|Overall Study|Adverse Event|84|||
130821303|NCT00457392|470976674|FG001|Overall Study|Adverse Event|41|||
130821304|NCT00457392|470976673|FG000|Overall Study|Global Deterioration of Health Status|22|||
130821305|NCT00457392|470976674|FG001|Overall Study|Global Deterioration of Health Status|8|||
130821306|NCT00457392|470976673|FG000|Overall Study|Withdrawal by Subject|14|||
130821307|NCT00457392|470976674|FG001|Overall Study|Withdrawal by Subject|8|||
130821308|NCT00457392|470976673|FG000|Overall Study|Lost to Follow-up|6|||
130821309|NCT00457392|470976674|FG001|Overall Study|Lost to Follow-up|7|||
130821310|NCT00457392|470976673|FG000|Overall Study|Protocol Violation|4|||
130821311|NCT00457392|470976674|FG001|Overall Study|Protocol Violation|3|||
130821312|NCT00457392|470976673|FG000|Overall Study|Other|7|||
130821313|NCT00457392|470976674|FG001|Overall Study|Other|4|||
130821314|NCT00457392|470976673|FG000|Overall Study|Study Terminated by Sponsor|1|||
130821315|NCT00457392|470976674|FG001|Overall Study|Study Terminated by Sponsor|4|||
130821316|NCT00457392|470976673|FG000|Overall Study|Randomized, Not Treated|7|||
130821317|NCT00457392|470976674|FG001|Overall Study|Randomized, Not Treated|3|||
130821318|NCT01466491|470976676|FG000|Overall Study|Protocol Violation|0|||
130821319|NCT01466491|470976677|FG001|Overall Study|Protocol Violation|3|||
130821320|NCT01466491|470976678|FG002|Overall Study|Protocol Violation|2|||
130821321|NCT01466491|470976679|FG003|Overall Study|Protocol Violation|0|||
130821322|NCT01466491|470976676|FG000|Overall Study|Missing Data|0|||
130821323|NCT01466491|470976677|FG001|Overall Study|Missing Data|0|||
130821324|NCT01466491|470976678|FG002|Overall Study|Missing Data|1|||
130821325|NCT01466491|470976679|FG003|Overall Study|Missing Data|0|||
130821326|NCT00305448|470976680|FG000|Overall Study|Protocol Violation|0|||
130821327|NCT00305448|470976681|FG001|Overall Study|Protocol Violation|1|||
130821328|NCT00305448|470976682|FG002|Overall Study|Protocol Violation|0|||
130821329|NCT00305448|470976680|FG000|Overall Study|Withdrawal by Subject|2|||
130821330|NCT00305448|470976681|FG001|Overall Study|Withdrawal by Subject|0|||
130821331|NCT00305448|470976682|FG002|Overall Study|Withdrawal by Subject|1|||
130821332|NCT00305448|470976680|FG000|Overall Study|Adverse Event|1|||
130821333|NCT00305448|470976681|FG001|Overall Study|Adverse Event|0|||
130821334|NCT00305448|470976682|FG002|Overall Study|Adverse Event|1|||
130821335|NCT00305448|470976680|FG000|Overall Study|Disease Progression|27|||
130821336|NCT00305448|470976681|FG001|Overall Study|Disease Progression|31|||
130821337|NCT00305448|470976682|FG002|Overall Study|Disease Progression|28|||
130821338|NCT00305448|470976680|FG000|Overall Study|Subjective Disease Progression|1|||
130821339|NCT00305448|470976681|FG001|Overall Study|Subjective Disease Progression|2|||
130821340|NCT00305448|470976682|FG002|Overall Study|Subjective Disease Progression|2|||
130821341|NCT00305448|470976680|FG000|Overall Study|Tumor Marker Elevation|0|||
130821342|NCT00305448|470976681|FG001|Overall Study|Tumor Marker Elevation|0|||
130821343|NCT00305448|470976682|FG002|Overall Study|Tumor Marker Elevation|1|||
130821344|NCT00002766|470976683|FG000|Overall Study|Withdrawal by Subject|0|||
130821345|NCT00002766|470976684|FG001|Overall Study|Withdrawal by Subject|1|||
130821346|NCT00002766|470976683|FG000|Overall Study|Patient Not Treated|1|||
130821347|NCT00002766|470976684|FG001|Overall Study|Patient Not Treated|2|||
130821348|NCT00002766|470976683|FG000|Overall Study|Adverse Event|1|||
130821349|NCT00002766|470976684|FG001|Overall Study|Adverse Event|1|||
130821350|NCT00002766|470976683|FG000|Overall Study|Protocol Violation|1|||
130821351|NCT00002766|470976684|FG001|Overall Study|Protocol Violation|0|||
130821352|NCT00328172|470976687|FG000|Overall Study|Adverse Event|3|||
130821353|NCT00328172|470976688|FG001|Overall Study|Adverse Event|2|||
130821354|NCT00328172|470976689|FG002|Overall Study|Adverse Event|1|||
130821355|NCT00328172|470976690|FG003|Overall Study|Adverse Event|2|||
130821356|NCT00328172|470976691|FG004|Overall Study|Adverse Event|1|||
130821357|NCT00328172|470976687|FG000|Overall Study|Protocol Violation|0|||
130821358|NCT00328172|470976688|FG001|Overall Study|Protocol Violation|1|||
130821359|NCT00328172|470976689|FG002|Overall Study|Protocol Violation|1|||
130821360|NCT00328172|470976690|FG003|Overall Study|Protocol Violation|0|||
130821361|NCT00328172|470976691|FG004|Overall Study|Protocol Violation|0|||
130821362|NCT00328172|470976687|FG000|Overall Study|Lost to Follow-up|1|||
130821363|NCT00328172|470976688|FG001|Overall Study|Lost to Follow-up|1|||
130821364|NCT00328172|470976689|FG002|Overall Study|Lost to Follow-up|2|||
130821365|NCT00328172|470976690|FG003|Overall Study|Lost to Follow-up|1|||
130821366|NCT00328172|470976691|FG004|Overall Study|Lost to Follow-up|1|||
130821367|NCT00328172|470976687|FG000|Overall Study|Withdrawal by Subject|1|||
130821368|NCT00328172|470976688|FG001|Overall Study|Withdrawal by Subject|1|||
130821369|NCT00328172|470976689|FG002|Overall Study|Withdrawal by Subject|1|||
130821370|NCT00328172|470976690|FG003|Overall Study|Withdrawal by Subject|6|||
130821371|NCT00328172|470976691|FG004|Overall Study|Withdrawal by Subject|0|||
130821372|NCT00328172|470976687|FG000|Overall Study|Lack of Efficacy|14|||
130821373|NCT00328172|470976688|FG001|Overall Study|Lack of Efficacy|9|||
130821374|NCT00328172|470976689|FG002|Overall Study|Lack of Efficacy|4|||
130821375|NCT00328172|470976690|FG003|Overall Study|Lack of Efficacy|4|||
130821376|NCT00328172|470976691|FG004|Overall Study|Lack of Efficacy|3|||
130821377|NCT00328172|470976687|FG000|Overall Study|Other reason (not specified)|3|||
130821378|NCT00328172|470976688|FG001|Overall Study|Other reason (not specified)|0|||
130821379|NCT00328172|470976689|FG002|Overall Study|Other reason (not specified)|1|||
130821380|NCT00328172|470976690|FG003|Overall Study|Other reason (not specified)|0|||
130821381|NCT00328172|470976691|FG004|Overall Study|Other reason (not specified)|0|||
130821382|NCT00077974|470976692|FG000|Overall Study|Adverse Event|22|||
130821383|NCT00077974|470976692|FG000|Overall Study|Protocol Violation|1|||
130821384|NCT00077974|470976692|FG000|Overall Study|Withdrawal by Subject|3|||
130821385|NCT00077974|470976692|FG000|Overall Study|Lack of Efficacy|76|||
130821386|NCT00077974|470976692|FG000|Overall Study|Decision of Sponsor|2|||
130821387|NCT00558636|470976703|FG000|Treatment|Adverse Event|9|||
130821388|NCT00558636|470976704|FG001|Treatment|Adverse Event|2|||
130821389|NCT00558636|470976703|FG000|Treatment|Withdrawal by Subject|2|||
130821390|NCT00558636|470976704|FG001|Treatment|Withdrawal by Subject|0|||
130821391|NCT00558636|470976703|FG000|Treatment|Premature termination of the study|35|||
130821392|NCT00558636|470976704|FG001|Treatment|Premature termination of the study|37|||
130821393|NCT00558636|470976703|FG000|Treatment|Disease progression|1|||
130821394|NCT00558636|470976704|FG001|Treatment|Disease progression|5|||
130821395|NCT00558636|470976703|FG000|Follow-up|Premature termination of the study|12|||
130821396|NCT00558636|470976704|FG001|Follow-up|Premature termination of the study|7|||
130821397|NCT04108273|470976705|FG000|Overall Study|COVID Pandemic|1|||
130821398|NCT04108273|470976706|FG001|Overall Study|COVID Pandemic|0|||
130821399|NCT02808429|470976711|FG000|Overall Study|Lost to Follow-up|1|||
130821400|NCT02808429|470976712|FG001|Overall Study|Lost to Follow-up|0|||
130821401|NCT02808429|470976713|FG002|Overall Study|Lost to Follow-up|0|||
130821402|NCT02808429|470976711|FG000|Overall Study|Protocol Violation|0|||
130821403|NCT02808429|470976712|FG001|Overall Study|Protocol Violation|1|||
130821404|NCT02808429|470976713|FG002|Overall Study|Protocol Violation|0|||
130821405|NCT02808429|470976711|FG000|Overall Study|Premature study termination by sponsor|2|||
130821406|NCT02808429|470976712|FG001|Overall Study|Premature study termination by sponsor|0|||
130821407|NCT02808429|470976713|FG002|Overall Study|Premature study termination by sponsor|1|||
130821408|NCT02808429|470976711|FG000|Overall Study|Relocation|0|||
130821409|NCT02808429|470976712|FG001|Overall Study|Relocation|0|||
130821410|NCT02808429|470976713|FG002|Overall Study|Relocation|1|||
130821411|NCT00698828|470976714|FG000|Overall Study|Adverse Event|3|||
130821412|NCT00698828|470976715|FG001|Overall Study|Adverse Event|4|||
130821413|NCT00698828|470976716|FG002|Overall Study|Adverse Event|4|||
130821414|NCT00698828|470976714|FG000|Overall Study|Death|0|||
130821415|NCT00698828|470976715|FG001|Overall Study|Death|0|||
130821416|NCT00698828|470976716|FG002|Overall Study|Death|1|||
130821417|NCT00698828|470976714|FG000|Overall Study|Exacerbation of COPD|1|||
130821418|NCT00698828|470976715|FG001|Overall Study|Exacerbation of COPD|3|||
130821419|NCT00698828|470976716|FG002|Overall Study|Exacerbation of COPD|0|||
130821420|NCT00698828|470976714|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
130821421|NCT00698828|470976715|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
130821422|NCT00698828|470976716|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
130821423|NCT00698828|470976714|FG000|Overall Study|Investigator/Sponsor decision|1|||
130821424|NCT00698828|470976715|FG001|Overall Study|Investigator/Sponsor decision|0|||
130821425|NCT00698828|470976716|FG002|Overall Study|Investigator/Sponsor decision|2|||
130821426|NCT00698828|470976714|FG000|Overall Study|Lost to Follow-up|1|||
130821427|NCT00698828|470976715|FG001|Overall Study|Lost to Follow-up|1|||
130821428|NCT00698828|470976716|FG002|Overall Study|Lost to Follow-up|0|||
130821429|NCT00698828|470976714|FG000|Overall Study|Withdrew consent|0|||
130821430|NCT00698828|470976715|FG001|Overall Study|Withdrew consent|7|||
130821431|NCT00698828|470976716|FG002|Overall Study|Withdrew consent|4|||
130821432|NCT00698828|470976714|FG000|Overall Study|Withdrew consent (not treated)|2|||
130821433|NCT00698828|470976715|FG001|Overall Study|Withdrew consent (not treated)|0|||
130821434|NCT00698828|470976716|FG002|Overall Study|Withdrew consent (not treated)|0|||
130821435|NCT00856609|470976717|FG000|Overall Study|Adverse Event|1|||
130821436|NCT00856609|470976718|FG001|Overall Study|Adverse Event|0|||
130821437|NCT00811954|470976719|FG000|Overall Study|Death|10|||
130821438|NCT00811954|470976720|FG001|Overall Study|Death|6|||
130821439|NCT00811954|470976721|FG002|Overall Study|Death|13|||
130821440|NCT00811954|470976719|FG000|Overall Study|Lost to Follow-up|29|||
130821441|NCT00811954|470976720|FG001|Overall Study|Lost to Follow-up|23|||
130821442|NCT00811954|470976721|FG002|Overall Study|Lost to Follow-up|34|||
130821443|NCT00811954|470976719|FG000|Overall Study|Not able to get to clinic|28|||
130821444|NCT00811954|470976720|FG001|Overall Study|Not able to get to clinic|35|||
130821445|NCT00811954|470976721|FG002|Overall Study|Not able to get to clinic|30|||
130821446|NCT00811954|470976719|FG000|Overall Study|Not willing to adhere to requirements|12|||
130821447|NCT00811954|470976720|FG001|Overall Study|Not willing to adhere to requirements|2|||
130821448|NCT00811954|470976721|FG002|Overall Study|Not willing to adhere to requirements|16|||
130821449|NCT00811954|470976719|FG000|Overall Study|Withdraw consent prior study completion|4|||
130821450|NCT00811954|470976720|FG001|Overall Study|Withdraw consent prior study completion|6|||
130821451|NCT00811954|470976721|FG002|Overall Study|Withdraw consent prior study completion|5|||
130821452|NCT00811954|470976719|FG000|Overall Study|Site Closure|4|||
130821453|NCT00811954|470976720|FG001|Overall Study|Site Closure|0|||
130821454|NCT00811954|470976721|FG002|Overall Study|Site Closure|1|||
130821455|NCT00811954|470976719|FG000|Overall Study|Severe Debilitation|2|||
130821456|NCT00811954|470976720|FG001|Overall Study|Severe Debilitation|0|||
130821457|NCT00811954|470976721|FG002|Overall Study|Severe Debilitation|1|||
130821458|NCT00811954|470976719|FG000|Overall Study|Complete Protocol: No follow-up|0|||
130821459|NCT00811954|470976720|FG001|Overall Study|Complete Protocol: No follow-up|0|||
130821460|NCT00811954|470976721|FG002|Overall Study|Complete Protocol: No follow-up|1|||
130821461|NCT01534481|470976727|FG000|Overall Study|Lost to Follow-up|29|||
130821462|NCT01534481|470976728|FG001|Overall Study|Lost to Follow-up|24|||
130821463|NCT01534481|470976727|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
130821464|NCT01534481|470976728|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
130821465|NCT01130337|470976729|FG000|Overall Study|Withdrawal by Subject|3|||
130821466|NCT01130337|470976729|FG000|Overall Study|Principal investigator decision|1|||
130821467|NCT01130337|470976729|FG000|Overall Study|Death|1|||
130821468|NCT01130337|470976729|FG000|Overall Study|Disease progression|1|||
130821469|NCT01130337|470976729|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
130821470|NCT01130337|470976729|FG000|Overall Study|Surgical resection (R2)|1|||
130821471|NCT05525910|470976730|FG000|Period 4|Per sponsor due to study timelines|0|||
130821472|NCT05525910|470976731|FG001|Period 4|Per sponsor due to study timelines|0|||
130821473|NCT05525910|470976732|FG002|Period 4|Per sponsor due to study timelines|1|||
130821474|NCT05525910|470976733|FG003|Period 4|Per sponsor due to study timelines|1|||
130821475|NCT05525910|470976734|FG004|Period 4|Per sponsor due to study timelines|1|||
130821476|NCT03886493|470976735|FG000|Overall Study|Adverse Event|1|||
130821477|NCT03179761|470976737|FG000|Overall Study|Death|2|||
130821478|NCT03179761|470976738|FG001|Overall Study|Death|5|||
130821479|NCT03179761|470976737|FG000|Overall Study|Lost to Follow-up|2|||
130821480|NCT03179761|470976738|FG001|Overall Study|Lost to Follow-up|2|||
130821481|NCT03179761|470976737|FG000|Overall Study|Protocol Violation|1|||
130821482|NCT03179761|470976738|FG001|Overall Study|Protocol Violation|0|||
130821483|NCT03179761|470976737|FG000|Overall Study|Withdrawal by Subject|1|||
130821484|NCT03179761|470976738|FG001|Overall Study|Withdrawal by Subject|4|||
130821485|NCT03179761|470976737|FG000|Overall Study|Investigator Request|0|||
130821486|NCT03179761|470976738|FG001|Overall Study|Investigator Request|2|||
130821487|NCT00448448|470976739|FG000|Overall Study|Withdrawal by Subject|13|||
130821488|NCT00448448|470976740|FG001|Overall Study|Withdrawal by Subject|2|||
130821489|NCT00448448|470976739|FG000|Overall Study|On protocol when study ended|83|||
130821490|NCT00448448|470976740|FG001|Overall Study|On protocol when study ended|36|||
130821491|NCT00448448|470976739|FG000|Overall Study|Lost to Follow-up|2|||
130821492|NCT00448448|470976740|FG001|Overall Study|Lost to Follow-up|1|||
130821493|NCT00448448|470976739|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
130821494|NCT00448448|470976740|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
130821495|NCT00448448|470976739|FG000|Overall Study|Signed consent lost|0|||
130821496|NCT00448448|470976740|FG001|Overall Study|Signed consent lost|1|||
130821497|NCT02284191|470976741|FG000|Overall Study|Withdrawal by Subject|1|||
130821498|NCT02284191|470976742|FG001|Overall Study|Withdrawal by Subject|3|||
130821499|NCT02284191|470976741|FG000|Overall Study|Lost to Follow-up|1|||
130821500|NCT02284191|470976742|FG001|Overall Study|Lost to Follow-up|0|||
130821501|NCT01832727|470976745|FG000|Overall Study|Adverse Event|4|||
130821502|NCT01832727|470976746|FG001|Overall Study|Adverse Event|6|||
130821503|NCT01832727|470976747|FG002|Overall Study|Adverse Event|1|||
130821504|NCT01832727|470976748|FG003|Overall Study|Adverse Event|0|||
130821505|NCT01832727|470976749|FG004|Overall Study|Adverse Event|1|||
130821506|NCT01832727|470976750|FG005|Overall Study|Adverse Event|1|||
130821507|NCT01832727|470976751|FG006|Overall Study|Adverse Event|2|||
130821508|NCT01832727|470976752|FG007|Overall Study|Adverse Event|1|||
130821509|NCT01832727|470976753|FG008|Overall Study|Adverse Event|9|||
130821510|NCT01832727|470976745|FG000|Overall Study|Disease progression|3|||
130821511|NCT01832727|470976746|FG001|Overall Study|Disease progression|0|||
130821512|NCT01832727|470976747|FG002|Overall Study|Disease progression|2|||
130821513|NCT01832727|470976748|FG003|Overall Study|Disease progression|1|||
130821514|NCT01832727|470976749|FG004|Overall Study|Disease progression|3|||
130821515|NCT01832727|470976750|FG005|Overall Study|Disease progression|3|||
130821516|NCT01832727|470976751|FG006|Overall Study|Disease progression|6|||
130821517|NCT01832727|470976752|FG007|Overall Study|Disease progression|2|||
130821518|NCT01832727|470976753|FG008|Overall Study|Disease progression|7|||
130821519|NCT01832727|470976745|FG000|Overall Study|Lost to Follow-up|0|||
130821520|NCT01832727|470976746|FG001|Overall Study|Lost to Follow-up|0|||
130821521|NCT01832727|470976747|FG002|Overall Study|Lost to Follow-up|0|||
130821522|NCT01832727|470976748|FG003|Overall Study|Lost to Follow-up|1|||
130821523|NCT01832727|470976749|FG004|Overall Study|Lost to Follow-up|0|||
130821524|NCT01832727|470976750|FG005|Overall Study|Lost to Follow-up|0|||
130821525|NCT01832727|470976751|FG006|Overall Study|Lost to Follow-up|0|||
130821526|NCT01832727|470976752|FG007|Overall Study|Lost to Follow-up|0|||
130821527|NCT01832727|470976753|FG008|Overall Study|Lost to Follow-up|0|||
130821528|NCT01832727|470976745|FG000|Overall Study|Physician Decision|1|||
130821529|NCT01832727|470976746|FG001|Overall Study|Physician Decision|0|||
130821530|NCT01832727|470976747|FG002|Overall Study|Physician Decision|0|||
130821531|NCT01832727|470976748|FG003|Overall Study|Physician Decision|1|||
130821532|NCT01832727|470976749|FG004|Overall Study|Physician Decision|0|||
130821533|NCT01832727|470976750|FG005|Overall Study|Physician Decision|1|||
130821534|NCT01832727|470976751|FG006|Overall Study|Physician Decision|0|||
130821535|NCT01832727|470976752|FG007|Overall Study|Physician Decision|0|||
130821536|NCT01832727|470976753|FG008|Overall Study|Physician Decision|0|||
130821537|NCT01832727|470976745|FG000|Overall Study|Withdrawal by Subject|1|||
130821538|NCT01832727|470976746|FG001|Overall Study|Withdrawal by Subject|1|||
130821539|NCT01832727|470976747|FG002|Overall Study|Withdrawal by Subject|0|||
130821540|NCT01832727|470976748|FG003|Overall Study|Withdrawal by Subject|1|||
130821541|NCT01832727|470976749|FG004|Overall Study|Withdrawal by Subject|0|||
130821542|NCT01832727|470976750|FG005|Overall Study|Withdrawal by Subject|1|||
130821543|NCT01832727|470976751|FG006|Overall Study|Withdrawal by Subject|0|||
130821544|NCT01832727|470976752|FG007|Overall Study|Withdrawal by Subject|2|||
130821545|NCT01832727|470976753|FG008|Overall Study|Withdrawal by Subject|1|||
130821546|NCT01832727|470976745|FG000|Overall Study|Study terminated by sponsor|0|||
130821547|NCT01832727|470976746|FG001|Overall Study|Study terminated by sponsor|0|||
130821548|NCT01832727|470976747|FG002|Overall Study|Study terminated by sponsor|0|||
130821549|NCT01832727|470976748|FG003|Overall Study|Study terminated by sponsor|0|||
130821550|NCT01832727|470976749|FG004|Overall Study|Study terminated by sponsor|0|||
130821551|NCT01832727|470976750|FG005|Overall Study|Study terminated by sponsor|0|||
130821552|NCT01832727|470976751|FG006|Overall Study|Study terminated by sponsor|0|||
130821553|NCT01832727|470976752|FG007|Overall Study|Study terminated by sponsor|1|||
130821554|NCT01832727|470976753|FG008|Overall Study|Study terminated by sponsor|1|||
130821555|NCT02216526|470976754|FG000|Overall Study|Adverse Event|1|||
130821556|NCT02216526|470976755|FG001|Overall Study|Adverse Event|1|||
130821557|NCT02216526|470976756|FG002|Overall Study|Adverse Event|0|||
130821558|NCT02216526|470976754|FG000|Overall Study|Death|0|||
130821559|NCT02216526|470976755|FG001|Overall Study|Death|1|||
130821560|NCT02216526|470976756|FG002|Overall Study|Death|3|||
130821561|NCT02216526|470976754|FG000|Overall Study|Protocol Violation|2|||
130821562|NCT02216526|470976755|FG001|Overall Study|Protocol Violation|0|||
130821563|NCT02216526|470976756|FG002|Overall Study|Protocol Violation|2|||
130821564|NCT02216526|470976754|FG000|Overall Study|Hospitalization|2|||
130821565|NCT02216526|470976755|FG001|Overall Study|Hospitalization|1|||
130821566|NCT02216526|470976756|FG002|Overall Study|Hospitalization|3|||
130821567|NCT01133847|470976763|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
130821568|NCT01133847|470976764|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
130821569|NCT01133847|470976765|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
130821570|NCT01133847|470976763|FG000|Follow-Up Phase|Lost to Follow-up|1|||
130821571|NCT01133847|470976764|FG001|Follow-Up Phase|Lost to Follow-up|3|||
130821572|NCT01133847|470976765|FG002|Follow-Up Phase|Lost to Follow-up|7|||
130821573|NCT04436744|470976766|FG000|Overall Study|Adverse Event|1|||
130821574|NCT04436744|470976767|FG001|Overall Study|Adverse Event|1|||
130821575|NCT04436744|470976766|FG000|Overall Study|Death|1|||
130821576|NCT04436744|470976767|FG001|Overall Study|Death|0|||
130821577|NCT04436744|470976766|FG000|Overall Study|Lost to Follow-up|0|||
130821578|NCT04436744|470976767|FG001|Overall Study|Lost to Follow-up|2|||
130821579|NCT04436744|470976766|FG000|Overall Study|Physician Decision|0|||
130821580|NCT04436744|470976767|FG001|Overall Study|Physician Decision|1|||
130821581|NCT04436744|470976766|FG000|Overall Study|Progressive Disease|0|||
130821582|NCT04436744|470976767|FG001|Overall Study|Progressive Disease|4|||
130821583|NCT04436744|470976766|FG000|Overall Study|Protocol Deviation|1|||
130821584|NCT04436744|470976767|FG001|Overall Study|Protocol Deviation|1|||
130821585|NCT04436744|470976766|FG000|Overall Study|Withdrawal by Subject|1|||
130821586|NCT04436744|470976767|FG001|Overall Study|Withdrawal by Subject|2|||
130821587|NCT01463033|470976768|FG000|Overall Study|Lost to Follow-up|4|||
130821588|NCT01463033|470976769|FG001|Overall Study|Lost to Follow-up|4|||
130821589|NCT01463033|470976768|FG000|Overall Study|Death|3|||
130821590|NCT01463033|470976769|FG001|Overall Study|Death|2|||
130821591|NCT00967616|470976770|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
130821592|NCT00967616|470976771|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
130821593|NCT00967616|470976770|FG000|Overall Study|Death|0|||
130821594|NCT00967616|470976771|FG001|Overall Study|Death|3|||
130821595|NCT00967616|470976770|FG000|Overall Study|Withdrawal by Subject|8|||
130821596|NCT00967616|470976771|FG001|Overall Study|Withdrawal by Subject|4|||
130821597|NCT00967616|470976770|FG000|Overall Study|Progressive Disease|31|||
130821598|NCT00967616|470976771|FG001|Overall Study|Progressive Disease|18|||
130821599|NCT00967616|470976770|FG000|Overall Study|Other|8|||
130821600|NCT00967616|470976771|FG001|Overall Study|Other|8|||
130821601|NCT00967616|470976770|FG000|Overall Study|Protocol Violation|1|||
130821602|NCT00967616|470976771|FG001|Overall Study|Protocol Violation|0|||
130821603|NCT00575666|470976772|FG000|Overall Study|Withdrawal by Subject|3|||
130821604|NCT00575666|470976773|FG001|Overall Study|Withdrawal by Subject|2|||
130821605|NCT00575666|470976772|FG000|Overall Study|Physician Decision|1|||
130821606|NCT00575666|470976773|FG001|Overall Study|Physician Decision|1|||
130821607|NCT01368614|470976774|FG000|Screening Period|Screen Failure|58|||
130821608|NCT01368614|470976775|FG001|Screening Period|Screen Failure|0|||
130821609|NCT01368614|470976776|FG002|Screening Period|Screen Failure|0|||
130821610|NCT01368614|470976777|FG003|Screening Period|Screen Failure|0|||
130821611|NCT01368614|470976774|FG000|Study Period|Withdrawal by Subject|0|||
130821612|NCT01368614|470976775|FG001|Study Period|Withdrawal by Subject|1|||
130821613|NCT01368614|470976776|FG002|Study Period|Withdrawal by Subject|1|||
130821614|NCT01368614|470976777|FG003|Study Period|Withdrawal by Subject|3|||
130821615|NCT01368614|470976774|FG000|Study Period|Lost to Follow-up|0|||
130821616|NCT01368614|470976775|FG001|Study Period|Lost to Follow-up|0|||
130821617|NCT01368614|470976776|FG002|Study Period|Lost to Follow-up|1|||
130821618|NCT01368614|470976777|FG003|Study Period|Lost to Follow-up|0|||
130821619|NCT02951780|470976778|FG000|Period 1|Adverse Event|0|||
130821620|NCT02951780|470976779|FG001|Period 1|Adverse Event|0|||
130821621|NCT02951780|470976780|FG002|Period 1|Adverse Event|0|||
130821622|NCT02951780|470976781|FG003|Period 1|Adverse Event|1|||
130821623|NCT02951780|470976782|FG004|Period 1|Adverse Event|0|||
130821624|NCT02951780|470976783|FG005|Period 1|Adverse Event|0|||
130821625|NCT02951780|470976784|FG006|Period 1|Adverse Event|0|||
130821626|NCT02951780|470976785|FG007|Period 1|Adverse Event|0|||
130821627|NCT02951780|470976786|FG008|Period 1|Adverse Event|0|||
130821628|NCT02951780|470976778|FG000|Period 1|Scheduling Conflicts|0|||
130821629|NCT02951780|470976779|FG001|Period 1|Scheduling Conflicts|0|||
130821630|NCT02951780|470976780|FG002|Period 1|Scheduling Conflicts|0|||
130821631|NCT02951780|470976781|FG003|Period 1|Scheduling Conflicts|0|||
130821632|NCT02951780|470976782|FG004|Period 1|Scheduling Conflicts|0|||
130821633|NCT02951780|470976783|FG005|Period 1|Scheduling Conflicts|0|||
130821634|NCT02951780|470976784|FG006|Period 1|Scheduling Conflicts|0|||
130821635|NCT02951780|470976785|FG007|Period 1|Scheduling Conflicts|1|||
130821636|NCT02951780|470976786|FG008|Period 1|Scheduling Conflicts|0|||
130821637|NCT02951780|470976778|FG000|Period 2|Scheduling Conflicts|0|||
130821638|NCT02951780|470976779|FG001|Period 2|Scheduling Conflicts|0|||
130821639|NCT02951780|470976780|FG002|Period 2|Scheduling Conflicts|0|||
130821640|NCT02951780|470976781|FG003|Period 2|Scheduling Conflicts|0|||
130821641|NCT02951780|470976782|FG004|Period 2|Scheduling Conflicts|0|||
130821642|NCT02951780|470976783|FG005|Period 2|Scheduling Conflicts|0|||
130821643|NCT02951780|470976784|FG006|Period 2|Scheduling Conflicts|0|||
130821644|NCT02951780|470976785|FG007|Period 2|Scheduling Conflicts|1|||
130821645|NCT02951780|470976786|FG008|Period 2|Scheduling Conflicts|0|||
130821646|NCT00508482|470976787|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
130821647|NCT00508482|470976788|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
130821648|NCT00508482|470976789|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
130821649|NCT00508482|470976787|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
130821650|NCT00508482|470976788|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
130822845|NCT01127633|470980612|FG001|Overall Study|Physician Decision|45|||
130821651|NCT00508482|470976789|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
130821652|NCT00508482|470976787|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
130821653|NCT00508482|470976788|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
130821654|NCT00508482|470976789|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
130821655|NCT01374425|470976790|FG000|Overall Study|Radiographic Disease Progression|86|||
130821656|NCT01374425|470976791|FG001|Overall Study|Radiographic Disease Progression|81|||
130821657|NCT01374425|470976790|FG000|Overall Study|Clinical Disease Progression|9|||
130821658|NCT01374425|470976791|FG001|Overall Study|Clinical Disease Progression|6|||
130821659|NCT01374425|470976790|FG000|Overall Study|Adverse Event|29|||
130821660|NCT01374425|470976791|FG001|Overall Study|Adverse Event|18|||
130821661|NCT01374425|470976790|FG000|Overall Study|Death (Progression of Disease)|1|||
130821662|NCT01374425|470976791|FG001|Overall Study|Death (Progression of Disease)|0|||
130821663|NCT01374425|470976790|FG000|Overall Study|Death (Adverse Event)|2|||
130821664|NCT01374425|470976791|FG001|Overall Study|Death (Adverse Event)|4|||
130821665|NCT01374425|470976790|FG000|Overall Study|Withdrawal by Subject|6|||
130821666|NCT01374425|470976791|FG001|Overall Study|Withdrawal by Subject|7|||
130821667|NCT01374425|470976790|FG000|Overall Study|Refused Treatment|10|||
130821668|NCT01374425|470976791|FG001|Overall Study|Refused Treatment|24|||
130821669|NCT01374425|470976790|FG000|Overall Study|Protocol Violation|2|||
130821670|NCT01374425|470976791|FG001|Overall Study|Protocol Violation|3|||
130821671|NCT01374425|470976790|FG000|Overall Study|Sponsor Decision|0|||
130821672|NCT01374425|470976791|FG001|Overall Study|Sponsor Decision|1|||
130821673|NCT01374425|470976790|FG000|Overall Study|Lost to Follow-up|2|||
130821674|NCT01374425|470976791|FG001|Overall Study|Lost to Follow-up|1|||
130821675|NCT01374425|470976790|FG000|Overall Study|Other|41|||
130821676|NCT01374425|470976791|FG001|Overall Study|Other|43|||
130821677|NCT02359903|470976792|FG000|Overall Study|Adverse Event|0|||
130821678|NCT02359903|470976793|FG001|Overall Study|Adverse Event|2|||
130821679|NCT02289469|470976794|FG000|Overall Study|Unable to match a control|6|||
130821680|NCT02289469|470976795|FG001|Overall Study|Unable to match a control|0|||
130821681|NCT00546481|470976796|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
130821682|NCT00546481|470976797|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
130821683|NCT00546481|470976798|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
130821684|NCT00546481|470976796|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
130821685|NCT00546481|470976797|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
130821686|NCT00546481|470976798|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
130821687|NCT00546481|470976796|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
130821688|NCT00546481|470976797|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
130821689|NCT00546481|470976798|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
130821690|NCT00546481|470976796|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
130821691|NCT00546481|470976797|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
130821692|NCT00546481|470976798|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
130821693|NCT00546481|470976796|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
130821694|NCT00546481|470976797|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
130821695|NCT00546481|470976798|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
130821696|NCT00546481|470976796|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
130821697|NCT00546481|470976797|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
130821698|NCT00546481|470976798|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
130821699|NCT00546481|470976796|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
130821700|NCT00546481|470976797|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
130821701|NCT00546481|470976798|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
130821702|NCT00546481|470976796|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
130821703|NCT00546481|470976797|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
130821704|NCT00546481|470976798|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
130821705|NCT00546481|470976796|FG000|Maintenance Phase (CERA)|Other Reason|0|||
130821706|NCT00546481|470976797|FG001|Maintenance Phase (CERA)|Other Reason|0|||
130821707|NCT00546481|470976798|FG002|Maintenance Phase (CERA)|Other Reason|1|||
130821708|NCT01077063|470976802|FG000|Overall Study|Adverse Event|3|||
130821709|NCT01077063|470976803|FG001|Overall Study|Adverse Event|0|||
130821710|NCT01077063|470976802|FG000|Overall Study|Death|1|||
130821711|NCT01077063|470976803|FG001|Overall Study|Death|1|||
130821712|NCT01077063|470976802|FG000|Overall Study|Withdrawal by Subject|0|||
130821713|NCT01077063|470976803|FG001|Overall Study|Withdrawal by Subject|2|||
130821714|NCT02750930|470976804|FG000|Overall Study|Study closed/terminated|8|||
130821715|NCT02761642|470976806|FG000|Overall Study|Did not Receive Study Treatment|3|||
130821716|NCT02761642|470976806|FG000|Overall Study|Adverse Event|13|||
130821717|NCT02761642|470976806|FG000|Overall Study|Withdrawal by Subject|2|||
130821718|NCT02761642|470976806|FG000|Overall Study|Non-compliant|7|||
130821719|NCT02761642|470976806|FG000|Overall Study|Death|3|||
130821720|NCT02761642|470976806|FG000|Overall Study|Lack of Efficacy|20|||
130821721|NCT02761642|470976806|FG000|Overall Study|Physician Decision|1|||
130821722|NCT02761642|470976806|FG000|Overall Study|Reason Unspecified|21|||
130821723|NCT03783780|470976813|FG000|Overall Study|Withdrawn prior to completion|1|||
130821724|NCT02756403|470976816|FG000|Overall Study|Unable to swallow medication|0|||
130821725|NCT02756403|470976817|FG001|Overall Study|Unable to swallow medication|1|||
130821726|NCT02756403|470976818|FG002|Overall Study|Unable to swallow medication|1|||
130821727|NCT02756403|470976819|FG003|Overall Study|Unable to swallow medication|1|||
130821728|NCT02756403|470976816|FG000|Overall Study|Did not complete Procedure|0|||
130821729|NCT02756403|470976817|FG001|Overall Study|Did not complete Procedure|1|||
130821730|NCT02756403|470976818|FG002|Overall Study|Did not complete Procedure|0|||
130821731|NCT02756403|470976819|FG003|Overall Study|Did not complete Procedure|0|||
130821732|NCT02756403|470976816|FG000|Overall Study|Changed Mind About Procedure|0|||
130821733|NCT02756403|470976817|FG001|Overall Study|Changed Mind About Procedure|0|||
130821734|NCT02756403|470976818|FG002|Overall Study|Changed Mind About Procedure|1|||
130821735|NCT02756403|470976819|FG003|Overall Study|Changed Mind About Procedure|0|||
130821736|NCT02756403|470976816|FG000|Overall Study|Protocol Violation|0|||
130821737|NCT02756403|470976817|FG001|Overall Study|Protocol Violation|1|||
130821738|NCT02756403|470976818|FG002|Overall Study|Protocol Violation|0|||
130821739|NCT02756403|470976819|FG003|Overall Study|Protocol Violation|1|||
130821740|NCT01644643|470976820|FG000|Overall Study|Death|1|||
130821741|NCT01644643|470976821|FG001|Overall Study|Death|0|||
130821742|NCT01644643|470976822|FG002|Overall Study|Death|3|||
130821743|NCT01644643|470976823|FG003|Overall Study|Death|3|||
130821744|NCT01644643|470976820|FG000|Overall Study|Lost to Follow-up|0|||
130821745|NCT01644643|470976821|FG001|Overall Study|Lost to Follow-up|0|||
130821746|NCT01644643|470976822|FG002|Overall Study|Lost to Follow-up|0|||
130821747|NCT01644643|470976823|FG003|Overall Study|Lost to Follow-up|4|||
130821748|NCT01644643|470976820|FG000|Overall Study|Withdrawal by Subject|1|||
130821749|NCT01644643|470976821|FG001|Overall Study|Withdrawal by Subject|0|||
130821750|NCT01644643|470976822|FG002|Overall Study|Withdrawal by Subject|2|||
130821751|NCT01644643|470976823|FG003|Overall Study|Withdrawal by Subject|1|||
130821752|NCT01644643|470976820|FG000|Overall Study|Other Eligibility criteria|0|||
130821753|NCT01644643|470976821|FG001|Overall Study|Other Eligibility criteria|0|||
130821754|NCT01644643|470976822|FG002|Overall Study|Other Eligibility criteria|0|||
130821755|NCT01644643|470976823|FG003|Overall Study|Other Eligibility criteria|2|||
130821756|NCT00776789|470976828|FG000|Overall Study|Consent refusal|2|||
130821757|NCT00776789|470976829|FG001|Overall Study|Consent refusal|2|||
130821758|NCT00776789|470976828|FG000|Overall Study|Poor quality video|1|||
130821759|NCT00776789|470976829|FG001|Overall Study|Poor quality video|1|||
130821760|NCT02850978|470976832|FG000|Overall Study|Uncollectable CRF|27|||
130821761|NCT02850978|470976832|FG000|Overall Study|No visit since the first visit|35|||
130821762|NCT02850978|470976832|FG000|Overall Study|Adverse Event|81|||
130821763|NCT02850978|470976832|FG000|Overall Study|Lack of Efficacy|40|||
130821764|NCT02850978|470976832|FG000|Overall Study|Improvement in condition|34|||
130821765|NCT02850978|470976832|FG000|Overall Study|Lost to Follow-up|121|||
130821766|NCT02850978|470976832|FG000|Overall Study|Reason not listed|88|||
130821767|NCT02629861|470976836|FG000|Overall Study|Adverse Event|7|||
130821768|NCT02629861|470976837|FG001|Overall Study|Adverse Event|5|||
130821769|NCT02629861|470976838|FG002|Overall Study|Adverse Event|4|||
130821770|NCT02629861|470976836|FG000|Overall Study|Withdrawal by Subject|5|||
130821771|NCT02629861|470976837|FG001|Overall Study|Withdrawal by Subject|8|||
130821772|NCT02629861|470976838|FG002|Overall Study|Withdrawal by Subject|13|||
130821773|NCT02629861|470976836|FG000|Overall Study|Protocol Violation|2|||
130821774|NCT02629861|470976837|FG001|Overall Study|Protocol Violation|3|||
130821775|NCT02629861|470976838|FG002|Overall Study|Protocol Violation|7|||
130821776|NCT02629861|470976836|FG000|Overall Study|Lost to Follow-up|12|||
130821777|NCT02629861|470976837|FG001|Overall Study|Lost to Follow-up|9|||
130821778|NCT02629861|470976838|FG002|Overall Study|Lost to Follow-up|4|||
130821779|NCT02629861|470976836|FG000|Overall Study|Other|1|||
130821780|NCT02629861|470976837|FG001|Overall Study|Other|1|||
130821781|NCT02629861|470976838|FG002|Overall Study|Other|0|||
130821782|NCT02629861|470976836|FG000|Overall Study|Pregnancy|2|||
130821783|NCT02629861|470976837|FG001|Overall Study|Pregnancy|1|||
130821784|NCT02629861|470976838|FG002|Overall Study|Pregnancy|0|||
130821785|NCT00907621|470976839|FG000|Overall Study|Lost to Follow-up|6|||
130821786|NCT00907621|470976840|FG001|Overall Study|Lost to Follow-up|3|||
130821787|NCT00907621|470976839|FG000|Overall Study|intercurrent febrile illness|1|||
130821788|NCT00907621|470976840|FG001|Overall Study|intercurrent febrile illness|1|||
130821789|NCT00165789|470976843|FG000|Overall Study|Adverse Event|0|||
130821790|NCT00165789|470976844|FG001|Overall Study|Adverse Event|3|||
130821791|NCT00165789|470976845|FG002|Overall Study|Adverse Event|0|||
130821792|NCT00165789|470976846|FG003|Overall Study|Adverse Event|12|||
130821793|NCT00165789|470976843|FG000|Overall Study|Withdrawal by Subject|0|||
130821794|NCT00165789|470976844|FG001|Overall Study|Withdrawal by Subject|1|||
130821795|NCT00165789|470976845|FG002|Overall Study|Withdrawal by Subject|1|||
130821796|NCT00165789|470976846|FG003|Overall Study|Withdrawal by Subject|2|||
130821797|NCT01816048|470976847|FG000|Overall Study|Adverse Event|1|||
130821798|NCT01816048|470976847|FG000|Overall Study|Death|1|||
130821799|NCT01816048|470976847|FG000|Overall Study|Withdrawal by Subject|1|||
130821800|NCT01816048|470976847|FG000|Overall Study|Disease Progression|3|||
130821801|NCT03069716|470976849|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
130821802|NCT03069716|470976850|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
130821803|NCT03069716|470976851|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
130821804|NCT03069716|470976849|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
130821805|NCT03069716|470976850|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
130821806|NCT03069716|470976851|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
130821807|NCT03069716|470976849|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
130821808|NCT03069716|470976850|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
130821809|NCT03069716|470976851|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
130821810|NCT03069716|470976849|FG000|Randomized Treatment|Withdrawal by Subject|0|||
130821811|NCT03069716|470976850|FG001|Randomized Treatment|Withdrawal by Subject|2|||
130821812|NCT03069716|470976851|FG002|Randomized Treatment|Withdrawal by Subject|0|||
130821813|NCT01088906|470976855|FG000|Overall Study|Inclusion error|1|||
130821814|NCT01088906|470976855|FG000|Overall Study|Did not receive study treatment|3|||
130821815|NCT01088906|470976855|FG000|Overall Study|Missing data|1|||
130821816|NCT00457626|470976856|FG000|Overall Study|Adverse Event|3|||
130821817|NCT00457626|470976856|FG000|Overall Study|Administrative Problems|2|||
130821818|NCT00457626|470976856|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
130821819|NCT03384875|470976857|FG000|Overall Study|Death|1|||
130821820|NCT03384875|470976858|FG001|Overall Study|Death|1|||
130821821|NCT03384875|470976859|FG002|Overall Study|Death|0|||
130821822|NCT03384875|470976857|FG000|Overall Study|Reason not provided|1|||
130821823|NCT03384875|470976858|FG001|Overall Study|Reason not provided|0|||
130821824|NCT03384875|470976859|FG002|Overall Study|Reason not provided|0|||
130821825|NCT03549338|470978841|FG000|Overall Study|Progressive Disease|1|||
130821826|NCT03549338|470978842|FG001|Overall Study|Progressive Disease|0|||
130821827|NCT03549338|470978843|FG002|Overall Study|Progressive Disease|0|||
130821828|NCT03549338|470978841|FG000|Overall Study|Clinical Progression|0|||
130821829|NCT03549338|470978842|FG001|Overall Study|Clinical Progression|1|||
130821830|NCT03549338|470978843|FG002|Overall Study|Clinical Progression|0|||
130821831|NCT01944020|470978845|FG000|Overall Study|Withdrawal by Subject|5|||
130821832|NCT01944020|470978846|FG001|Overall Study|Withdrawal by Subject|0|||
130821833|NCT03257358|470978851|FG000|Overall Study|Adverse Event|25|||
130821834|NCT03257358|470978852|FG001|Overall Study|Adverse Event|12|||
130821835|NCT03257358|470978851|FG000|Overall Study|Lack of Efficacy|1|||
130821836|NCT03257358|470978852|FG001|Overall Study|Lack of Efficacy|1|||
130821837|NCT03257358|470978851|FG000|Overall Study|Lost to Follow-up|12|||
130821838|NCT03257358|470978852|FG001|Overall Study|Lost to Follow-up|4|||
130821839|NCT03257358|470978851|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
130821840|NCT03257358|470978852|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
130821841|NCT03257358|470978851|FG000|Overall Study|Physician Decision|2|||
130821842|NCT03257358|470978852|FG001|Overall Study|Physician Decision|2|||
130821843|NCT03257358|470978851|FG000|Overall Study|Protocol Violation|5|||
130821844|NCT03257358|470978852|FG001|Overall Study|Protocol Violation|3|||
130821845|NCT03257358|470978851|FG000|Overall Study|Technical problems|4|||
130821846|NCT03257358|470978852|FG001|Overall Study|Technical problems|1|||
130821847|NCT03257358|470978851|FG000|Overall Study|Withdrawal by Subject|8|||
130821848|NCT03257358|470978852|FG001|Overall Study|Withdrawal by Subject|3|||
130821849|NCT03257358|470978851|FG000|Overall Study|Withdrawal of informed consent|9|||
130821850|NCT03257358|470978852|FG001|Overall Study|Withdrawal of informed consent|5|||
130821851|NCT03257358|470978851|FG000|Overall Study|New therapy for study indication|1|||
130821852|NCT03257358|470978852|FG001|Overall Study|New therapy for study indication|0|||
130821853|NCT03257358|470978851|FG000|Overall Study|No longer requires treatment|0|||
130821854|NCT03257358|470978852|FG001|Overall Study|No longer requires treatment|1|||
130821855|NCT01977898|470978853|FG000|Overall Study|Non functioning catheter|1|||
130821856|NCT01977898|470978854|FG001|Overall Study|Non functioning catheter|1|||
130821857|NCT01049373|470978855|FG000|Overall Study|Protocol Violation|9|||
130821858|NCT01049373|470978856|FG001|Overall Study|Protocol Violation|9|||
130821859|NCT01049373|470978855|FG000|Overall Study|Withdrawal by Subject|8|||
130821860|NCT01049373|470978856|FG001|Overall Study|Withdrawal by Subject|5|||
130821861|NCT01049373|470978855|FG000|Overall Study|Adverse Event|3|||
130821862|NCT01049373|470978856|FG001|Overall Study|Adverse Event|3|||
130821863|NCT01049373|470978855|FG000|Overall Study|Lost to Follow-up|9|||
130821864|NCT01049373|470978856|FG001|Overall Study|Lost to Follow-up|4|||
130821865|NCT01049373|470978855|FG000|Overall Study|no evaluable study values|9|||
130821866|NCT01049373|470978856|FG001|Overall Study|no evaluable study values|21|||
130821867|NCT01049373|470978855|FG000|Overall Study|Other|1|||
130821868|NCT01049373|470978856|FG001|Overall Study|Other|1|||
130821869|NCT01049373|470978855|FG000|Overall Study|Non-cooperation|0|||
130821870|NCT01049373|470978856|FG001|Overall Study|Non-cooperation|1|||
130821871|NCT02391311|470978857|FG000|Overall Study|Lost to Follow-up|2|||
130821872|NCT02391311|470978858|FG001|Overall Study|Lost to Follow-up|1|||
130821873|NCT02391311|470978857|FG000|Overall Study|deemed ineligible after baseline|1|||
130821874|NCT02391311|470978858|FG001|Overall Study|deemed ineligible after baseline|1|||
130821875|NCT01343888|470978859|FG000|Overall Study|Adverse Event|12|||
130821876|NCT01343888|470978860|FG001|Overall Study|Adverse Event|22|||
130821877|NCT01343888|470978861|FG002|Overall Study|Adverse Event|5|||
130821878|NCT01343888|470978859|FG000|Overall Study|Lack of Efficacy|9|||
130821879|NCT01343888|470978860|FG001|Overall Study|Lack of Efficacy|9|||
130821880|NCT01343888|470978861|FG002|Overall Study|Lack of Efficacy|13|||
130821881|NCT01343888|470978859|FG000|Overall Study|Lost to Follow-up|0|||
130821882|NCT01343888|470978860|FG001|Overall Study|Lost to Follow-up|2|||
130821883|NCT01343888|470978861|FG002|Overall Study|Lost to Follow-up|1|||
130821884|NCT01343888|470978859|FG000|Overall Study|Protocol Violation|0|||
130821885|NCT01343888|470978860|FG001|Overall Study|Protocol Violation|2|||
130821886|NCT01343888|470978861|FG002|Overall Study|Protocol Violation|0|||
130821887|NCT01343888|470978859|FG000|Overall Study|Withdrawal by Subject|4|||
130821888|NCT01343888|470978860|FG001|Overall Study|Withdrawal by Subject|4|||
130821889|NCT01343888|470978861|FG002|Overall Study|Withdrawal by Subject|2|||
130821890|NCT01343888|470978859|FG000|Overall Study|other than stated above|0|||
130821891|NCT01343888|470978860|FG001|Overall Study|other than stated above|0|||
130821892|NCT01343888|470978861|FG002|Overall Study|other than stated above|1|||
130821893|NCT01990742|470978862|FG000|Overall Study|Withdrawal by facility|407|||
130821894|NCT01990742|470978863|FG001|Overall Study|Withdrawal by facility|1083|||
130821895|NCT01990742|470978862|FG000|Overall Study|Facility closed|0|||
130821896|NCT01990742|470978863|FG001|Overall Study|Facility closed|270|||
130821897|NCT03443687|470978864|FG000|Overall Study|Lost to Follow-up|3|||
130821898|NCT03443687|470978865|FG001|Overall Study|Lost to Follow-up|5|||
130821899|NCT03443687|470978864|FG000|Overall Study|Withdrawal by Subject|1|||
130821900|NCT03443687|470978865|FG001|Overall Study|Withdrawal by Subject|0|||
130821901|NCT03443687|470978864|FG000|Overall Study|Discontinued intervention|1|||
130821902|NCT03443687|470978865|FG001|Overall Study|Discontinued intervention|1|||
130821903|NCT00800735|470978867|FG000|Overall Study|Administrative/Other|2|||
130821904|NCT00800735|470978867|FG000|Overall Study|Insufficient Therapeutic Response|2|||
130821905|NCT00800735|470978867|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
130821906|NCT00800735|470978867|FG000|Overall Study|Withdrew Consent|3|||
130821907|NCT02805790|470978868|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
130821908|NCT02805790|470978869|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
130821909|NCT04460183|470978872|FG000|Overall Study|Lost to Follow-up|3|||
130821910|NCT04460183|470978873|FG001|Overall Study|Lost to Follow-up|1|||
130821911|NCT04460183|470978872|FG000|Overall Study|Withdrawal by Subject|1|||
130821912|NCT04460183|470978873|FG001|Overall Study|Withdrawal by Subject|0|||
130821913|NCT02897115|470978874|FG000|Overall Study|Early termination of study by sponsor|11|||
130821914|NCT02897115|470978875|FG001|Overall Study|Early termination of study by sponsor|8|||
130821915|NCT00487981|470978876|FG000|Overall Study|Hypothyroidism diagnosis|1|||
130821916|NCT00856323|470978877|FG000|Overall Study|Withdrawal by Subject|2|||
130821917|NCT01063348|470978885|FG000|Overall Study|Lost to Follow-up|3|||
130821918|NCT01063348|470978886|FG001|Overall Study|Lost to Follow-up|10|||
130821919|NCT05518461|470978887|FG000|Overall Study|Lost to Follow-up|25|||
130821920|NCT04828707|470978888|FG000|Overall Study|Lost to Follow-up|3|||
130821921|NCT04828707|470978889|FG001|Overall Study|Lost to Follow-up|2|||
130821922|NCT04828707|470978888|FG000|Overall Study|Withdrawal by Subject|2|||
130821923|NCT04828707|470978889|FG001|Overall Study|Withdrawal by Subject|1|||
130821924|NCT03139448|470978890|FG000|Overall Study|Lack of Efficacy|6|||
130821925|NCT03139448|470978891|FG001|Overall Study|Lack of Efficacy|7|||
130821926|NCT03139448|470978890|FG000|Overall Study|Location of procedure changed|2|||
130821927|NCT03139448|470978891|FG001|Overall Study|Location of procedure changed|8|||
130821928|NCT03139448|470978890|FG000|Overall Study|Withdrawal by Subject|3|||
130821929|NCT03139448|470978891|FG001|Overall Study|Withdrawal by Subject|6|||
130821930|NCT03139448|470978890|FG000|Overall Study|Screen fail|1|||
130821931|NCT03139448|470978891|FG001|Overall Study|Screen fail|3|||
130821932|NCT03139448|470978890|FG000|Overall Study|Physician Decision|0|||
130821933|NCT03139448|470978891|FG001|Overall Study|Physician Decision|2|||
130821934|NCT00523978|470978892|FG000|Overall Study|Withdrawal by Subject|3|||
130821935|NCT00523978|470978893|FG001|Overall Study|Withdrawal by Subject|7|||
130821936|NCT00523978|470978892|FG000|Overall Study|Screen Failures|5|||
130821937|NCT00523978|470978893|FG001|Overall Study|Screen Failures|1|||
130821938|NCT00523978|470978892|FG000|Overall Study|Death|1|||
130821939|NCT00523978|470978893|FG001|Overall Study|Death|0|||
130821940|NCT00332696|470978896|FG000|Overall Study|Death|24|||
130821941|NCT00332696|470978897|FG001|Overall Study|Death|14|||
130821942|NCT00332696|470978896|FG000|Overall Study|Insufficient therapeutic effect|4|||
130821943|NCT00332696|470978897|FG001|Overall Study|Insufficient therapeutic effect|11|||
130821944|NCT00332696|470978896|FG000|Overall Study|Adverse Event|1|||
130821945|NCT00332696|470978897|FG001|Overall Study|Adverse Event|2|||
130821946|NCT00332696|470978896|FG000|Overall Study|Condition does not justify treatment|0|||
130821947|NCT00332696|470978897|FG001|Overall Study|Condition does not justify treatment|2|||
130821948|NCT00332696|470978896|FG000|Overall Study|Lost to Follow-up|0|||
130821949|NCT00332696|470978897|FG001|Overall Study|Lost to Follow-up|1|||
130821950|NCT00332696|470978896|FG000|Overall Study|Withdrawal by Subject|1|||
130821951|NCT00332696|470978897|FG001|Overall Study|Withdrawal by Subject|0|||
130821952|NCT02394561|470978899|FG000|CORE Phase|Adverse Event|7|||
130821953|NCT02394561|470978900|FG001|CORE Phase|Adverse Event|9|||
130821954|NCT02394561|470978899|FG000|CORE Phase|Death|0|||
130821955|NCT02394561|470978900|FG001|CORE Phase|Death|1|||
130821956|NCT02394561|470978899|FG000|CORE Phase|Pregnancy|1|||
130821957|NCT02394561|470978900|FG001|CORE Phase|Pregnancy|0|||
130821958|NCT02394561|470978899|FG000|CORE Phase|Lost to Follow-up|1|||
130821959|NCT02394561|470978900|FG001|CORE Phase|Lost to Follow-up|0|||
130821960|NCT02394561|470978899|FG000|CORE Phase|Physician Decision|1|||
130821961|NCT02394561|470978900|FG001|CORE Phase|Physician Decision|1|||
130821962|NCT02394561|470978899|FG000|CORE Phase|Withdrawal by Subject|2|||
130821963|NCT02394561|470978900|FG001|CORE Phase|Withdrawal by Subject|2|||
130821964|NCT02394561|470978899|FG000|CORE Phase|Lack of Efficacy|1|||
130821965|NCT02394561|470978900|FG001|CORE Phase|Lack of Efficacy|6|||
130821966|NCT02394561|470978899|FG000|Extension Phase|Adverse Event|6|||
130821967|NCT02394561|470978900|FG001|Extension Phase|Adverse Event|1|||
130821968|NCT02394561|470978899|FG000|Extension Phase|Death|0|||
130821969|NCT02394561|470978900|FG001|Extension Phase|Death|1|||
130821970|NCT02394561|470978899|FG000|Extension Phase|Protocol Violation|1|||
130821971|NCT02394561|470978900|FG001|Extension Phase|Protocol Violation|0|||
130821972|NCT02394561|470978899|FG000|Extension Phase|Lost to Follow-up|1|||
130821973|NCT02394561|470978900|FG001|Extension Phase|Lost to Follow-up|0|||
130821974|NCT02394561|470978899|FG000|Extension Phase|Physician Decision|0|||
130821975|NCT02394561|470978900|FG001|Extension Phase|Physician Decision|2|||
130821976|NCT02394561|470978899|FG000|Extension Phase|Withdrawal by Subject|0|||
130821977|NCT02394561|470978900|FG001|Extension Phase|Withdrawal by Subject|5|||
130821978|NCT02394561|470978899|FG000|Extension Phase|Lack of Efficacy|3|||
130821979|NCT02394561|470978900|FG001|Extension Phase|Lack of Efficacy|3|||
130821980|NCT00501644|470978901|FG000|Overall Study|Adverse Event|4|||
130821981|NCT00501644|470978901|FG000|Overall Study|Withdrawal by Subject|1|||
130821982|NCT02750514|470978902|FG000|Track 1|Disease progression|20|||
130821983|NCT02750514|470978903|FG001|Track 1|Disease progression|1|||
130821984|NCT02750514|470978904|FG002|Track 1|Disease progression|0|||
130821985|NCT02750514|470978905|FG003|Track 1|Disease progression|1|||
130821986|NCT02750514|470978906|FG004|Track 1|Disease progression|0|||
130821987|NCT02750514|470978902|FG000|Track 1|Adverse event unrelated to study drug|1|||
130821988|NCT02750514|470978903|FG001|Track 1|Adverse event unrelated to study drug|0|||
130821989|NCT02750514|470978904|FG002|Track 1|Adverse event unrelated to study drug|0|||
130821990|NCT02750514|470978905|FG003|Track 1|Adverse event unrelated to study drug|0|||
130821991|NCT02750514|470978906|FG004|Track 1|Adverse event unrelated to study drug|0|||
130821992|NCT02750514|470978902|FG000|Track 1|Study drug toxicity|4|||
130821993|NCT02750514|470978903|FG001|Track 1|Study drug toxicity|1|||
130821994|NCT02750514|470978904|FG002|Track 1|Study drug toxicity|0|||
130821995|NCT02750514|470978905|FG003|Track 1|Study drug toxicity|1|||
130821996|NCT02750514|470978906|FG004|Track 1|Study drug toxicity|0|||
130821997|NCT02750514|470978902|FG000|Track 1|Participant request to discontinue|1|||
130821998|NCT02750514|470978903|FG001|Track 1|Participant request to discontinue|0|||
130821999|NCT02750514|470978904|FG002|Track 1|Participant request to discontinue|0|||
130822000|NCT02750514|470978905|FG003|Track 1|Participant request to discontinue|0|||
130822001|NCT02750514|470978906|FG004|Track 1|Participant request to discontinue|0|||
130822002|NCT02750514|470978902|FG000|Track 1|Other reasons|1|||
130822003|NCT02750514|470978903|FG001|Track 1|Other reasons|0|||
130822004|NCT02750514|470978904|FG002|Track 1|Other reasons|0|||
130822005|NCT02750514|470978905|FG003|Track 1|Other reasons|0|||
130822006|NCT02750514|470978906|FG004|Track 1|Other reasons|0|||
130822007|NCT02750514|470978902|FG000|Track 2|Disease progression|4|||
130822008|NCT02750514|470978903|FG001|Track 2|Disease progression|5|||
130822009|NCT02750514|470978904|FG002|Track 2|Disease progression|2|||
130822010|NCT02750514|470978905|FG003|Track 2|Disease progression|5|||
130822011|NCT02750514|470978906|FG004|Track 2|Disease progression|0|||
130822012|NCT02750514|470978902|FG000|Track 2|Adverse event unrelated to study drug|1|||
130822013|NCT02750514|470978903|FG001|Track 2|Adverse event unrelated to study drug|0|||
130822014|NCT02750514|470978904|FG002|Track 2|Adverse event unrelated to study drug|0|||
130822015|NCT02750514|470978905|FG003|Track 2|Adverse event unrelated to study drug|0|||
130822016|NCT02750514|470978906|FG004|Track 2|Adverse event unrelated to study drug|0|||
130822017|NCT02750514|470978902|FG000|Track 2|Study drug toxicity|1|||
130822018|NCT02750514|470978903|FG001|Track 2|Study drug toxicity|2|||
130822019|NCT02750514|470978904|FG002|Track 2|Study drug toxicity|0|||
130822020|NCT02750514|470978905|FG003|Track 2|Study drug toxicity|2|||
130822021|NCT02750514|470978906|FG004|Track 2|Study drug toxicity|0|||
130822022|NCT02750514|470978902|FG000|Track 2|Participant withdrew consent|0|||
130822023|NCT02750514|470978903|FG001|Track 2|Participant withdrew consent|1|||
130822024|NCT02750514|470978904|FG002|Track 2|Participant withdrew consent|0|||
130822025|NCT02750514|470978905|FG003|Track 2|Participant withdrew consent|0|||
130822026|NCT02750514|470978906|FG004|Track 2|Participant withdrew consent|0|||
130822027|NCT02750514|470978902|FG000|Track 3|Disease progression|0|||
130822028|NCT02750514|470978903|FG001|Track 3|Disease progression|24|||
130822029|NCT02750514|470978904|FG002|Track 3|Disease progression|13|||
130822030|NCT02750514|470978905|FG003|Track 3|Disease progression|14|||
130822031|NCT02750514|470978906|FG004|Track 3|Disease progression|0|||
130822032|NCT02750514|470978902|FG000|Track 3|Adverse event unrelated to study drug|0|||
130822033|NCT02750514|470978903|FG001|Track 3|Adverse event unrelated to study drug|1|||
130822034|NCT02750514|470978904|FG002|Track 3|Adverse event unrelated to study drug|1|||
130822035|NCT02750514|470978905|FG003|Track 3|Adverse event unrelated to study drug|1|||
130822036|NCT02750514|470978906|FG004|Track 3|Adverse event unrelated to study drug|0|||
130822037|NCT02750514|470978902|FG000|Track 3|Study drug toxicity|0|||
130822038|NCT02750514|470978903|FG001|Track 3|Study drug toxicity|3|||
130822039|NCT02750514|470978904|FG002|Track 3|Study drug toxicity|0|||
130822040|NCT02750514|470978905|FG003|Track 3|Study drug toxicity|1|||
130822041|NCT02750514|470978906|FG004|Track 3|Study drug toxicity|0|||
130822042|NCT02750514|470978902|FG000|Track 3|Participant request to discontinue|0|||
130822043|NCT02750514|470978903|FG001|Track 3|Participant request to discontinue|2|||
130822044|NCT02750514|470978904|FG002|Track 3|Participant request to discontinue|0|||
130822045|NCT02750514|470978905|FG003|Track 3|Participant request to discontinue|0|||
130822046|NCT02750514|470978906|FG004|Track 3|Participant request to discontinue|0|||
130822047|NCT02750514|470978902|FG000|Track 3|Participant withdrew consent|0|||
130822048|NCT02750514|470978903|FG001|Track 3|Participant withdrew consent|3|||
130822049|NCT02750514|470978904|FG002|Track 3|Participant withdrew consent|1|||
130822050|NCT02750514|470978905|FG003|Track 3|Participant withdrew consent|0|||
130822051|NCT02750514|470978906|FG004|Track 3|Participant withdrew consent|0|||
130822052|NCT02750514|470978902|FG000|Track 3|Other reasons|0|||
130822053|NCT02750514|470978903|FG001|Track 3|Other reasons|3|||
130822054|NCT02750514|470978904|FG002|Track 3|Other reasons|0|||
130822055|NCT02750514|470978905|FG003|Track 3|Other reasons|0|||
130822056|NCT02750514|470978906|FG004|Track 3|Other reasons|0|||
130822057|NCT02750514|470978902|FG000|Track 4|Study drug toxicity|0|||
130822058|NCT02750514|470978903|FG001|Track 4|Study drug toxicity|6|||
130822059|NCT02750514|470978904|FG002|Track 4|Study drug toxicity|0|||
130822060|NCT02750514|470978905|FG003|Track 4|Study drug toxicity|5|||
130822061|NCT02750514|470978906|FG004|Track 4|Study drug toxicity|0|||
130822062|NCT02750514|470978902|FG000|Track 4|Participant request to discontinue|0|||
130822063|NCT02750514|470978903|FG001|Track 4|Participant request to discontinue|1|||
130822064|NCT02750514|470978904|FG002|Track 4|Participant request to discontinue|0|||
130822065|NCT02750514|470978905|FG003|Track 4|Participant request to discontinue|1|||
130822066|NCT02750514|470978906|FG004|Track 4|Participant request to discontinue|0|||
130822067|NCT02750514|470978902|FG000|Track 4|Participant withdrew consent|0|||
130822068|NCT02750514|470978903|FG001|Track 4|Participant withdrew consent|1|||
130822069|NCT02750514|470978904|FG002|Track 4|Participant withdrew consent|0|||
130822070|NCT02750514|470978905|FG003|Track 4|Participant withdrew consent|0|||
130822071|NCT02750514|470978906|FG004|Track 4|Participant withdrew consent|0|||
130822072|NCT02750514|470978902|FG000|Track 4|Other reasons|0|||
130822073|NCT02750514|470978903|FG001|Track 4|Other reasons|5|||
130822074|NCT02750514|470978904|FG002|Track 4|Other reasons|0|||
130822075|NCT02750514|470978905|FG003|Track 4|Other reasons|3|||
130822076|NCT02750514|470978906|FG004|Track 4|Other reasons|0|||
130822077|NCT02750514|470978902|FG000|Track 4|Disease progression|0|||
130822078|NCT02750514|470978903|FG001|Track 4|Disease progression|33|||
130822079|NCT02750514|470978904|FG002|Track 4|Disease progression|0|||
130822080|NCT02750514|470978905|FG003|Track 4|Disease progression|32|||
130822081|NCT02750514|470978906|FG004|Track 4|Disease progression|0|||
130822082|NCT02750514|470978902|FG000|Track 4|Adverse event unrelated to study drug|0|||
130822083|NCT02750514|470978903|FG001|Track 4|Adverse event unrelated to study drug|5|||
130822084|NCT02750514|470978904|FG002|Track 4|Adverse event unrelated to study drug|0|||
130822085|NCT02750514|470978905|FG003|Track 4|Adverse event unrelated to study drug|0|||
130822086|NCT02750514|470978906|FG004|Track 4|Adverse event unrelated to study drug|0|||
130822087|NCT02750514|470978902|FG000|Track 4|Death|0|||
130822088|NCT02750514|470978903|FG001|Track 4|Death|0|||
130822089|NCT02750514|470978904|FG002|Track 4|Death|0|||
130822090|NCT02750514|470978905|FG003|Track 4|Death|1|||
130822091|NCT02750514|470978906|FG004|Track 4|Death|0|||
130822092|NCT02750514|470978902|FG000|Track 5|Disease progression|0|||
130822093|NCT02750514|470978903|FG001|Track 5|Disease progression|0|||
130822094|NCT02750514|470978904|FG002|Track 5|Disease progression|0|||
130822095|NCT02750514|470978905|FG003|Track 5|Disease progression|0|||
130822096|NCT02750514|470978906|FG004|Track 5|Disease progression|34|||
130822097|NCT02750514|470978902|FG000|Track 5|Adverse event unrelated to study drug|0|||
130822098|NCT02750514|470978903|FG001|Track 5|Adverse event unrelated to study drug|0|||
130822099|NCT02750514|470978904|FG002|Track 5|Adverse event unrelated to study drug|0|||
130822100|NCT02750514|470978905|FG003|Track 5|Adverse event unrelated to study drug|0|||
130822101|NCT02750514|470978906|FG004|Track 5|Adverse event unrelated to study drug|2|||
130822102|NCT02750514|470978902|FG000|Track 5|Study drug toxicity|0|||
130822103|NCT02750514|470978903|FG001|Track 5|Study drug toxicity|0|||
130822104|NCT02750514|470978904|FG002|Track 5|Study drug toxicity|0|||
130822105|NCT02750514|470978905|FG003|Track 5|Study drug toxicity|0|||
130822106|NCT02750514|470978906|FG004|Track 5|Study drug toxicity|2|||
130822107|NCT02750514|470978902|FG000|Track 5|Participant request to discontinue|0|||
130822108|NCT02750514|470978903|FG001|Track 5|Participant request to discontinue|0|||
130822109|NCT02750514|470978904|FG002|Track 5|Participant request to discontinue|0|||
130822110|NCT02750514|470978905|FG003|Track 5|Participant request to discontinue|0|||
130822111|NCT02750514|470978906|FG004|Track 5|Participant request to discontinue|3|||
130822112|NCT02750514|470978902|FG000|Track 5|Other reasons|0|||
130822113|NCT02750514|470978903|FG001|Track 5|Other reasons|0|||
130822114|NCT02750514|470978904|FG002|Track 5|Other reasons|0|||
130822115|NCT02750514|470978905|FG003|Track 5|Other reasons|0|||
130822116|NCT02750514|470978906|FG004|Track 5|Other reasons|2|||
130822117|NCT02553629|470978907|FG000|Overall Study|Logistic reasons|3|||
130822118|NCT02553629|470978908|FG001|Overall Study|Logistic reasons|6|||
130822119|NCT01812057|470978909|FG000|Overall Study|Protocol Violation|1|||
130822120|NCT01812057|470978910|FG001|Overall Study|Protocol Violation|0|||
130822121|NCT01812057|470978909|FG000|Overall Study|Physician Decision|1|||
130822122|NCT01812057|470978910|FG001|Overall Study|Physician Decision|0|||
130822123|NCT01882465|470978913|FG000|Period 1|Lens Discomfort|0|||
130822124|NCT01882465|470978914|FG001|Period 1|Lens Discomfort|0|||
130822125|NCT01882465|470978915|FG002|Period 1|Lens Discomfort|0|||
130822126|NCT01882465|470978916|FG003|Period 1|Lens Discomfort|1|||
130822127|NCT01882465|470978917|FG004|Period 1|Lens Discomfort|0|||
130822128|NCT01882465|470978918|FG005|Period 1|Lens Discomfort|0|||
130822129|NCT01882465|470978919|FG006|Period 1|Lens Discomfort|0|||
130822130|NCT01882465|470978913|FG000|Period 1|Withdrawal by Subject|0|||
130822131|NCT01882465|470978914|FG001|Period 1|Withdrawal by Subject|0|||
130822132|NCT01882465|470978915|FG002|Period 1|Withdrawal by Subject|0|||
130822133|NCT01882465|470978916|FG003|Period 1|Withdrawal by Subject|0|||
130822134|NCT01882465|470978917|FG004|Period 1|Withdrawal by Subject|0|||
130822135|NCT01882465|470978918|FG005|Period 1|Withdrawal by Subject|0|||
130822136|NCT01882465|470978919|FG006|Period 1|Withdrawal by Subject|1|||
130822137|NCT01882465|470978913|FG000|Period 2|Protocol Violation|0|||
130822138|NCT01882465|470978914|FG001|Period 2|Protocol Violation|0|||
130822139|NCT01882465|470978915|FG002|Period 2|Protocol Violation|0|||
130822140|NCT01882465|470978916|FG003|Period 2|Protocol Violation|0|||
130822141|NCT01882465|470978917|FG004|Period 2|Protocol Violation|1|||
130822142|NCT01882465|470978918|FG005|Period 2|Protocol Violation|0|||
130822143|NCT01882465|470978919|FG006|Period 2|Protocol Violation|0|||
130822144|NCT00696878|470978923|FG000|Overall Study|Adverse Event|8|||
130822145|NCT00696878|470978923|FG000|Overall Study|Withdrawal by Subject|87|||
130822146|NCT00696878|470978923|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
130822147|NCT00696878|470978923|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
130822148|NCT00696878|470978923|FG000|Overall Study|Trial stopped|32|||
130822149|NCT00696878|470978923|FG000|Overall Study|Other reason (not specified)|55|||
130822150|NCT02259114|470978924|FG000|Overall Study|Progressive Disease|14|||
130822151|NCT02259114|470978925|FG001|Overall Study|Progressive Disease|2|||
130822152|NCT02259114|470978926|FG002|Overall Study|Progressive Disease|10|||
130822153|NCT02259114|470978927|FG003|Overall Study|Progressive Disease|2|||
130822154|NCT02259114|470978928|FG004|Overall Study|Progressive Disease|5|||
130822155|NCT02259114|470978924|FG000|Overall Study|Adverse Event|2|||
130822156|NCT02259114|470978925|FG001|Overall Study|Adverse Event|1|||
130822157|NCT02259114|470978926|FG002|Overall Study|Adverse Event|0|||
130822158|NCT02259114|470978927|FG003|Overall Study|Adverse Event|0|||
130822159|NCT02259114|470978928|FG004|Overall Study|Adverse Event|1|||
130822160|NCT02259114|470978924|FG000|Overall Study|Death|3|||
130822161|NCT02259114|470978925|FG001|Overall Study|Death|0|||
130822162|NCT02259114|470978926|FG002|Overall Study|Death|1|||
130822163|NCT02259114|470978927|FG003|Overall Study|Death|0|||
130822164|NCT02259114|470978928|FG004|Overall Study|Death|0|||
130822165|NCT02259114|470978924|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130822166|NCT02259114|470978925|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130822167|NCT02259114|470978926|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
130822168|NCT02259114|470978927|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130822169|NCT02259114|470978928|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130822170|NCT02259114|470978924|FG000|Overall Study|Withdrawal by Subject|0|||
130822171|NCT02259114|470978925|FG001|Overall Study|Withdrawal by Subject|0|||
130822172|NCT02259114|470978926|FG002|Overall Study|Withdrawal by Subject|1|||
130822173|NCT02259114|470978927|FG003|Overall Study|Withdrawal by Subject|1|||
130822174|NCT02259114|470978928|FG004|Overall Study|Withdrawal by Subject|0|||
130822175|NCT02259114|470978924|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
130822176|NCT02259114|470978925|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
130822177|NCT02259114|470978926|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
130822178|NCT02259114|470978927|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
130822179|NCT02259114|470978928|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
130822180|NCT02259114|470978924|FG000|Overall Study|Not Treated|1|||
130822181|NCT02259114|470978925|FG001|Overall Study|Not Treated|0|||
130822182|NCT02259114|470978926|FG002|Overall Study|Not Treated|0|||
130822183|NCT02259114|470978927|FG003|Overall Study|Not Treated|0|||
130822184|NCT02259114|470978928|FG004|Overall Study|Not Treated|0|||
130822185|NCT03937479|470978929|FG000|Overall Study|Adverse Event|2|||
130822186|NCT03937479|470978930|FG001|Overall Study|Adverse Event|3|||
130822187|NCT03937479|470978931|FG002|Overall Study|Adverse Event|0|||
130822188|NCT03937479|470978932|FG003|Overall Study|Adverse Event|0|||
130822189|NCT03937479|470978933|FG004|Overall Study|Adverse Event|1|||
130822190|NCT03937479|470978929|FG000|Overall Study|Withdrawal by Subject|3|||
130822191|NCT03937479|470978930|FG001|Overall Study|Withdrawal by Subject|5|||
130822192|NCT03937479|470978931|FG002|Overall Study|Withdrawal by Subject|2|||
130822193|NCT03937479|470978932|FG003|Overall Study|Withdrawal by Subject|2|||
130822194|NCT03937479|470978933|FG004|Overall Study|Withdrawal by Subject|1|||
130822195|NCT03937479|470978929|FG000|Overall Study|Protocol Violation|5|||
130822196|NCT03937479|470978930|FG001|Overall Study|Protocol Violation|6|||
130822197|NCT03937479|470978931|FG002|Overall Study|Protocol Violation|4|||
130822198|NCT03937479|470978932|FG003|Overall Study|Protocol Violation|3|||
130822199|NCT03937479|470978933|FG004|Overall Study|Protocol Violation|2|||
130822200|NCT03937479|470978929|FG000|Overall Study|Lost to Follow-up|0|||
130822201|NCT03937479|470978930|FG001|Overall Study|Lost to Follow-up|1|||
130822202|NCT03937479|470978931|FG002|Overall Study|Lost to Follow-up|0|||
130822203|NCT03937479|470978932|FG003|Overall Study|Lost to Follow-up|1|||
130822204|NCT03937479|470978933|FG004|Overall Study|Lost to Follow-up|0|||
130822205|NCT03937479|470978929|FG000|Overall Study|Physician Decision|0|||
130822206|NCT03937479|470978930|FG001|Overall Study|Physician Decision|0|||
130822207|NCT03937479|470978931|FG002|Overall Study|Physician Decision|1|||
130822208|NCT03937479|470978932|FG003|Overall Study|Physician Decision|0|||
130822209|NCT03937479|470978933|FG004|Overall Study|Physician Decision|1|||
130822210|NCT02712788|470978936|FG000|Overall Study|Physician Decision|1|||
130822211|NCT02712788|470978937|FG001|Overall Study|Physician Decision|0|||
130822212|NCT02712788|470978936|FG000|Overall Study|Protocol Violation|1|||
130822213|NCT02712788|470978937|FG001|Overall Study|Protocol Violation|0|||
130822214|NCT01880957|470978938|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
130822215|NCT01880957|470978939|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
130822216|NCT01880957|470978938|FG000|Overall Study|Lost to Follow-up|11|||
130822217|NCT01880957|470978939|FG001|Overall Study|Lost to Follow-up|0|||
130822218|NCT01880957|470978938|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
130822219|NCT01880957|470978939|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
130822220|NCT00940602|470978940|FG000|Overall Study|Administrative problems|1|||
130822221|NCT00940602|470978941|FG001|Overall Study|Administrative problems|1|||
130822222|NCT00940602|470978940|FG000|Overall Study|Patient/guardian decision|13|||
130822223|NCT00940602|470978941|FG001|Overall Study|Patient/guardian decision|28|||
130822224|NCT00940602|470978940|FG000|Overall Study|Physician Decision|8|||
130822225|NCT00940602|470978941|FG001|Overall Study|Physician Decision|5|||
130822226|NCT00940602|470978940|FG000|Overall Study|Pregnancy|1|||
130822227|NCT00940602|470978941|FG001|Overall Study|Pregnancy|0|||
130822228|NCT00940602|470978940|FG000|Overall Study|Protocol Deviation (untreated)|1|||
130822229|NCT00940602|470978941|FG001|Overall Study|Protocol Deviation (untreated)|0|||
130822230|NCT00940602|470978940|FG000|Overall Study|Disease progression|8|||
130822231|NCT00940602|470978941|FG001|Overall Study|Disease progression|2|||
130822232|NCT00940602|470978940|FG000|Overall Study|Death|38|||
130822233|NCT00940602|470978941|FG001|Overall Study|Death|19|||
130822234|NCT00940602|470978940|FG000|Overall Study|Lost to Follow-up|3|||
130822235|NCT00940602|470978941|FG001|Overall Study|Lost to Follow-up|1|||
130822236|NCT00940602|470978940|FG000|Overall Study|Patient withdrew consent|26|||
130822237|NCT00940602|470978941|FG001|Overall Study|Patient withdrew consent|13|||
130822238|NCT00940602|470978940|FG000|Overall Study|Adverse Event|7|||
130822239|NCT00940602|470978941|FG001|Overall Study|Adverse Event|2|||
130822240|NCT00940602|470978940|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
130822241|NCT00940602|470978941|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
130822242|NCT01854528|470978945|FG000|Overall Study|Adverse Event|0|||
130822243|NCT01854528|470978946|FG001|Overall Study|Adverse Event|4|||
130822244|NCT01854528|470978945|FG000|Overall Study|Withdrawal by Subject|0|||
130822245|NCT01854528|470978946|FG001|Overall Study|Withdrawal by Subject|2|||
130822246|NCT01854528|470978945|FG000|Overall Study|Virologic Failure|0|||
130822247|NCT01854528|470978946|FG001|Overall Study|Virologic Failure|9|||
130822248|NCT03789292|470978947|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
130822249|NCT03789292|470978948|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
130822250|NCT03789292|470978949|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
130822251|NCT03789292|470978947|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
130822252|NCT03789292|470978948|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
130822253|NCT03789292|470978949|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
130822254|NCT03789292|470978947|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
130822255|NCT03789292|470978948|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
130822256|NCT03789292|470978949|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
130822257|NCT03789292|470978947|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
130822258|NCT03789292|470978948|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
130822259|NCT03789292|470978949|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
130822260|NCT03789292|470978947|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
130822261|NCT03789292|470978948|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
130822262|NCT03789292|470978949|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
130822263|NCT03789292|470978947|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
130822264|NCT03789292|470978948|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
130822265|NCT03789292|470978949|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
130822266|NCT03789292|470978947|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
130822267|NCT03789292|470978948|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
130822268|NCT03789292|470978949|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
130822269|NCT03789292|470978947|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
130822270|NCT03789292|470978948|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
130822271|NCT03789292|470978949|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
130822272|NCT03789292|470978947|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
130822273|NCT03789292|470978948|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
130822274|NCT03789292|470978949|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
130822275|NCT03789292|470978947|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
130822276|NCT03789292|470978948|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
130822277|NCT03789292|470978949|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
130822278|NCT03789292|470978947|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
130822279|NCT03789292|470978948|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
130822280|NCT03789292|470978949|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
130822281|NCT03789292|470978947|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
130822282|NCT03789292|470978948|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
130822283|NCT03789292|470978949|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
130822284|NCT03789292|470978947|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
130822285|NCT03789292|470978948|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
130822286|NCT03789292|470978949|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
130822287|NCT01904721|470978951|FG000|Overall Study|Other Reasons|0|||
130822288|NCT01904721|470978952|FG001|Overall Study|Other Reasons|0|||
130822289|NCT01904721|470978953|FG002|Overall Study|Other Reasons|1|||
130822290|NCT01904721|470978954|FG003|Overall Study|Other Reasons|1|||
130822291|NCT01904721|470978955|FG004|Overall Study|Other Reasons|2|||
130822292|NCT01904721|470978956|FG005|Overall Study|Other Reasons|2|||
130822293|NCT01904721|470978957|FG006|Overall Study|Other Reasons|2|||
130822294|NCT01904721|470978951|FG000|Overall Study|Personal Reasons|0|||
130822295|NCT01904721|470978952|FG001|Overall Study|Personal Reasons|0|||
130822296|NCT01904721|470978953|FG002|Overall Study|Personal Reasons|0|||
130822297|NCT01904721|470978954|FG003|Overall Study|Personal Reasons|0|||
130822298|NCT01904721|470978955|FG004|Overall Study|Personal Reasons|2|||
130822299|NCT01904721|470978956|FG005|Overall Study|Personal Reasons|3|||
130822300|NCT01904721|470978957|FG006|Overall Study|Personal Reasons|3|||
130822301|NCT01904721|470978951|FG000|Overall Study|Lost to Follow-up|0|||
130822302|NCT01904721|470978952|FG001|Overall Study|Lost to Follow-up|0|||
130822303|NCT01904721|470978953|FG002|Overall Study|Lost to Follow-up|0|||
130822304|NCT01904721|470978954|FG003|Overall Study|Lost to Follow-up|0|||
130822305|NCT01904721|470978955|FG004|Overall Study|Lost to Follow-up|1|||
130822306|NCT01904721|470978956|FG005|Overall Study|Lost to Follow-up|3|||
130822307|NCT01904721|470978957|FG006|Overall Study|Lost to Follow-up|1|||
130822308|NCT01904721|470978951|FG000|Overall Study|Lack of Efficacy|0|||
130822309|NCT01904721|470978952|FG001|Overall Study|Lack of Efficacy|0|||
130822310|NCT01904721|470978953|FG002|Overall Study|Lack of Efficacy|0|||
130822311|NCT01904721|470978954|FG003|Overall Study|Lack of Efficacy|0|||
130822312|NCT01904721|470978955|FG004|Overall Study|Lack of Efficacy|0|||
130822313|NCT01904721|470978956|FG005|Overall Study|Lack of Efficacy|0|||
130822314|NCT01904721|470978957|FG006|Overall Study|Lack of Efficacy|1|||
130822315|NCT01904721|470978951|FG000|Overall Study|Adverse Event|0|||
130822316|NCT01904721|470978952|FG001|Overall Study|Adverse Event|0|||
130822317|NCT01904721|470978953|FG002|Overall Study|Adverse Event|0|||
130822318|NCT01904721|470978954|FG003|Overall Study|Adverse Event|0|||
130822319|NCT01904721|470978955|FG004|Overall Study|Adverse Event|3|||
130822320|NCT01904721|470978956|FG005|Overall Study|Adverse Event|1|||
130822321|NCT01904721|470978957|FG006|Overall Study|Adverse Event|0|||
130822322|NCT01957865|470978958|FG000|Overall Study|Found HIV negative|0|||
130822323|NCT01957865|470978959|FG001|Overall Study|Found HIV negative|0|||
130822324|NCT01957865|470978960|FG002|Overall Study|Found HIV negative|1|||
130822325|NCT01957865|470978958|FG000|Overall Study|Lost to Follow-up|0|||
130822326|NCT01957865|470978959|FG001|Overall Study|Lost to Follow-up|2|||
130822327|NCT01957865|470978960|FG002|Overall Study|Lost to Follow-up|2|||
130822328|NCT01082614|470978961|FG000|Overall Study|Adverse Event|1|||
130822329|NCT01082614|470978962|FG001|Overall Study|Adverse Event|4|||
130822330|NCT01082614|470978961|FG000|Overall Study|Equipment Malfunction|0|||
130822331|NCT01082614|470978962|FG001|Overall Study|Equipment Malfunction|1|||
130822332|NCT01082614|470978961|FG000|Overall Study|Physician Decision|2|||
130822333|NCT01082614|470978962|FG001|Overall Study|Physician Decision|0|||
130822334|NCT00811720|470978966|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
130822335|NCT00811720|470978967|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
130822336|NCT00811720|470978966|FG000|All Treated Patients|Adverse Event|20|||
130822337|NCT00811720|470978967|FG001|All Treated Patients|Adverse Event|62|||
130822338|NCT00811720|470978966|FG000|All Treated Patients|Lack of Efficacy|22|||
130822339|NCT00811720|470978967|FG001|All Treated Patients|Lack of Efficacy|18|||
130822340|NCT00811720|470978966|FG000|All Treated Patients|Non-compliance|0|||
130822341|NCT00811720|470978967|FG001|All Treated Patients|Non-compliance|14|||
130822342|NCT00811720|470978966|FG000|All Treated Patients|Protocol Violation|9|||
130822343|NCT00811720|470978967|FG001|All Treated Patients|Protocol Violation|16|||
130822344|NCT00811720|470978966|FG000|All Treated Patients|Withdrawal by Subject|28|||
130822345|NCT00811720|470978967|FG001|All Treated Patients|Withdrawal by Subject|34|||
130822346|NCT00811720|470978966|FG000|All Treated Patients|Lost to Follow-up|10|||
130822347|NCT00811720|470978967|FG001|All Treated Patients|Lost to Follow-up|16|||
130822348|NCT00811720|470978966|FG000|All Treated Patients|Other Reason|7|||
130822349|NCT00811720|470978967|FG001|All Treated Patients|Other Reason|4|||
130822350|NCT00553631|470978968|FG000|Overall Study|Withdrawal by Subject|0|||
130822351|NCT00553631|470978969|FG001|Overall Study|Withdrawal by Subject|1|||
130822352|NCT00553631|470978968|FG000|Overall Study|Lost to Follow-up|1|||
130822353|NCT00553631|470978969|FG001|Overall Study|Lost to Follow-up|0|||
130822354|NCT01055613|470978970|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
130822355|NCT01055613|470978971|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130822356|NCT01055613|470978970|FG000|Overall Study|Unacceptable lens fit|1|||
130822357|NCT01055613|470978971|FG001|Overall Study|Unacceptable lens fit|0|||
130822358|NCT01055613|470978970|FG000|Overall Study|Discomfort|2|||
130822359|NCT01055613|470978971|FG001|Overall Study|Discomfort|1|||
130822360|NCT01055613|470978970|FG000|Overall Study|Lost to Follow-up|1|||
130822361|NCT01055613|470978971|FG001|Overall Study|Lost to Follow-up|1|||
130822362|NCT01055613|470978970|FG000|Overall Study|Protocol Violation|1|||
130822363|NCT01055613|470978971|FG001|Overall Study|Protocol Violation|1|||
130822364|NCT01055613|470978970|FG000|Overall Study|Subject Disinterest|1|||
130822365|NCT01055613|470978971|FG001|Overall Study|Subject Disinterest|1|||
130822366|NCT02765399|470978974|FG000|Overall Study|Nausea|1|||
130822367|NCT02765399|470978975|FG001|Overall Study|Nausea|0|||
130822368|NCT00656370|470978979|FG000|Overall Study|Screen Failures|7|||
130822369|NCT00656370|470978979|FG000|Overall Study|Alternates|3|||
130822370|NCT01342094|470978980|FG000|Overall Study|Adverse Event|5|||
130822371|NCT01342094|470978981|FG001|Overall Study|Adverse Event|0|||
130822372|NCT01342094|470978980|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130822373|NCT01342094|470978981|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130822374|NCT01342094|470978980|FG000|Overall Study|Withdrawal by Subject|0|||
130822375|NCT01342094|470978981|FG001|Overall Study|Withdrawal by Subject|2|||
130822376|NCT03391882|470978986|FG000|Study Overall|Adverse Event|3|||
130822377|NCT03391882|470978987|FG001|Study Overall|Adverse Event|6|||
130822378|NCT03391882|470978988|FG002|Study Overall|Adverse Event|1|||
130822379|NCT03391882|470978989|FG003|Study Overall|Adverse Event|1|||
130822380|NCT03391882|470978990|FG004|Study Overall|Adverse Event|3|||
130822381|NCT03391882|470978991|FG005|Study Overall|Adverse Event|1|||
130822382|NCT03391882|470978986|FG000|Study Overall|Lack of Efficacy|13|||
130822383|NCT03391882|470978987|FG001|Study Overall|Lack of Efficacy|9|||
130822384|NCT03391882|470978988|FG002|Study Overall|Lack of Efficacy|0|||
130822385|NCT03391882|470978989|FG003|Study Overall|Lack of Efficacy|0|||
130822386|NCT03391882|470978990|FG004|Study Overall|Lack of Efficacy|0|||
130822387|NCT03391882|470978991|FG005|Study Overall|Lack of Efficacy|0|||
130822388|NCT03391882|470978986|FG000|Study Overall|Withdrawal by Subject|3|||
130822389|NCT03391882|470978987|FG001|Study Overall|Withdrawal by Subject|3|||
130822390|NCT03391882|470978988|FG002|Study Overall|Withdrawal by Subject|2|||
130822391|NCT03391882|470978989|FG003|Study Overall|Withdrawal by Subject|2|||
130822392|NCT03391882|470978990|FG004|Study Overall|Withdrawal by Subject|1|||
130822393|NCT03391882|470978991|FG005|Study Overall|Withdrawal by Subject|3|||
130822394|NCT03391882|470978986|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130822395|NCT03391882|470978987|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
130822396|NCT03391882|470978988|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130822397|NCT03391882|470978989|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130822398|NCT03391882|470978990|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130822399|NCT03391882|470978991|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130822400|NCT03391882|470978986|FG000|Study Overall|Protocol Violation|1|||
130822401|NCT03391882|470978987|FG001|Study Overall|Protocol Violation|0|||
130822402|NCT03391882|470978988|FG002|Study Overall|Protocol Violation|0|||
130822403|NCT03391882|470978989|FG003|Study Overall|Protocol Violation|0|||
130822404|NCT03391882|470978990|FG004|Study Overall|Protocol Violation|0|||
130822405|NCT03391882|470978991|FG005|Study Overall|Protocol Violation|0|||
130822406|NCT03391882|470978986|FG000|Part A - Titration Phase|Adverse Event|3|||
130822407|NCT03391882|470978987|FG001|Part A - Titration Phase|Adverse Event|6|||
130822408|NCT03391882|470978988|FG002|Part A - Titration Phase|Adverse Event|0|||
130822409|NCT03391882|470978989|FG003|Part A - Titration Phase|Adverse Event|0|||
130822410|NCT03391882|470978990|FG004|Part A - Titration Phase|Adverse Event|0|||
130822411|NCT03391882|470978991|FG005|Part A - Titration Phase|Adverse Event|0|||
130822412|NCT03391882|470978986|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
130822413|NCT03391882|470978987|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
130822414|NCT03391882|470978988|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
130822415|NCT03391882|470978989|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
130822416|NCT03391882|470978990|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
130822417|NCT03391882|470978991|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
130822418|NCT03391882|470978986|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
130822419|NCT03391882|470978987|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
130822420|NCT03391882|470978988|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
130822421|NCT03391882|470978989|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
130822422|NCT03391882|470978990|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
130822423|NCT03391882|470978991|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
130822424|NCT03391882|470978986|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130822425|NCT03391882|470978987|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
130822426|NCT03391882|470978988|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130822427|NCT03391882|470978989|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130822428|NCT03391882|470978990|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130822429|NCT03391882|470978991|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130822430|NCT03391882|470978986|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
130822431|NCT03391882|470978987|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
130822432|NCT03391882|470978988|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
130822433|NCT03391882|470978989|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
130822434|NCT03391882|470978990|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
130822435|NCT03391882|470978991|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
130822436|NCT03391882|470978986|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
130822437|NCT03391882|470978987|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
130822438|NCT03391882|470978988|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
130822439|NCT03391882|470978989|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
130822440|NCT03391882|470978990|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
130822441|NCT03391882|470978991|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
130822442|NCT03391882|470978986|FG000|Part B - Treatment Phase|Adverse Event|0|||
130822443|NCT03391882|470978987|FG001|Part B - Treatment Phase|Adverse Event|0|||
130822444|NCT03391882|470978988|FG002|Part B - Treatment Phase|Adverse Event|1|||
130822445|NCT03391882|470978989|FG003|Part B - Treatment Phase|Adverse Event|1|||
130822446|NCT03391882|470978990|FG004|Part B - Treatment Phase|Adverse Event|3|||
130822447|NCT03391882|470978991|FG005|Part B - Treatment Phase|Adverse Event|1|||
130822448|NCT03391882|470978986|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
130822449|NCT03391882|470978987|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
130822450|NCT03391882|470978988|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
130822451|NCT03391882|470978989|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
130822452|NCT03391882|470978990|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
130822453|NCT03391882|470978991|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
130822454|NCT03913130|470978992|FG000|Overall Study|Sponsor Decision|1|||
130822455|NCT01085214|470978995|FG000|Overall Study|Alternate treatment required|1|||
130822456|NCT01634152|470979009|FG000|Overall Study|Adverse Event|2|||
130822457|NCT01634152|470979010|FG001|Overall Study|Adverse Event|0|||
130822458|NCT01634152|470979011|FG002|Overall Study|Adverse Event|2|||
130822459|NCT01634152|470979009|FG000|Overall Study|Consent withdrawn not due to AE|1|||
130822460|NCT01634152|470979010|FG001|Overall Study|Consent withdrawn not due to AE|0|||
130822461|NCT01634152|470979011|FG002|Overall Study|Consent withdrawn not due to AE|1|||
130822462|NCT01634152|470979009|FG000|Overall Study|Not treated|0|||
130822463|NCT01634152|470979010|FG001|Overall Study|Not treated|1|||
130822464|NCT01634152|470979011|FG002|Overall Study|Not treated|0|||
130822465|NCT01634152|470979009|FG000|Overall Study|Other reason not defined above|1|||
130822466|NCT01634152|470979010|FG001|Overall Study|Other reason not defined above|0|||
130822467|NCT01634152|470979011|FG002|Overall Study|Other reason not defined above|1|||
130822468|NCT01985022|470979012|FG000|Overall Study|Lost to Follow-up|0|||
130822469|NCT01985022|470979013|FG001|Overall Study|Lost to Follow-up|1|||
130822470|NCT01985022|470979012|FG000|Overall Study|Protocol Violation|0|||
130822471|NCT01985022|470979013|FG001|Overall Study|Protocol Violation|1|||
130822472|NCT01985022|470979012|FG000|Overall Study|Withdrawal by Subject|4|||
130822473|NCT01985022|470979013|FG001|Overall Study|Withdrawal by Subject|1|||
130822474|NCT01152437|470979014|FG000|Overall Study|Other Adverse Event|8|||
130822475|NCT01152437|470979015|FG001|Overall Study|Other Adverse Event|1|||
130822476|NCT01152437|470979016|FG002|Overall Study|Other Adverse Event|7|||
130822477|NCT01152437|470979014|FG000|Overall Study|Not treated|0|||
130822478|NCT01152437|470979015|FG001|Overall Study|Not treated|1|||
130822479|NCT01152437|470979016|FG002|Overall Study|Not treated|2|||
130822480|NCT01152437|470979014|FG000|Overall Study|Progressive disease|27|||
130822481|NCT01152437|470979015|FG001|Overall Study|Progressive disease|13|||
130822482|NCT01152437|470979016|FG002|Overall Study|Progressive disease|32|||
130822483|NCT01152437|470979014|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
130822484|NCT01152437|470979015|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
130822485|NCT01152437|470979016|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
130822486|NCT02317627|470979019|FG000|Overall Study|Withdrawal by Subject|0|||
130822487|NCT02317627|470979020|FG001|Overall Study|Withdrawal by Subject|1|||
130822488|NCT02317627|470979021|FG002|Overall Study|Withdrawal by Subject|1|||
130822489|NCT02317627|470979019|FG000|Overall Study|Lost to Follow-up|2|||
130822490|NCT02317627|470979020|FG001|Overall Study|Lost to Follow-up|0|||
130822491|NCT02317627|470979021|FG002|Overall Study|Lost to Follow-up|0|||
130822492|NCT02317627|470979019|FG000|Overall Study|Stopped by Investigator|0|||
130822493|NCT02317627|470979020|FG001|Overall Study|Stopped by Investigator|1|||
130822494|NCT02317627|470979021|FG002|Overall Study|Stopped by Investigator|0|||
130822495|NCT02317627|470979019|FG000|Overall Study|Adverse Event|0|||
130822496|NCT02317627|470979020|FG001|Overall Study|Adverse Event|2|||
130822497|NCT02317627|470979021|FG002|Overall Study|Adverse Event|3|||
130822498|NCT02317627|470979019|FG000|Overall Study|Non-compliance with study drug|0|||
130822499|NCT02317627|470979020|FG001|Overall Study|Non-compliance with study drug|1|||
130822500|NCT02317627|470979021|FG002|Overall Study|Non-compliance with study drug|0|||
130822501|NCT00279214|470979022|FG000|Overall Study|Physician Decision|3|||
130822502|NCT00279214|470979023|FG001|Overall Study|Physician Decision|2|||
130822503|NCT01214837|470979025|FG000|Overall Study|Death|0|||
130822504|NCT01214837|470979026|FG001|Overall Study|Death|0|||
130822505|NCT01214837|470979027|FG002|Overall Study|Death|1|||
130822506|NCT01214837|470979025|FG000|Overall Study|Adverse Event|1|||
130822507|NCT01214837|470979026|FG001|Overall Study|Adverse Event|2|||
130822508|NCT01214837|470979027|FG002|Overall Study|Adverse Event|1|||
130822509|NCT01214837|470979025|FG000|Overall Study|Withdrawal by Subject|27|||
130822510|NCT01214837|470979026|FG001|Overall Study|Withdrawal by Subject|36|||
130822511|NCT01214837|470979027|FG002|Overall Study|Withdrawal by Subject|28|||
130822512|NCT01214837|470979025|FG000|Overall Study|Lost to Follow-up|20|||
130822513|NCT01214837|470979026|FG001|Overall Study|Lost to Follow-up|15|||
130822514|NCT01214837|470979027|FG002|Overall Study|Lost to Follow-up|21|||
130822515|NCT01214837|470979025|FG000|Overall Study|Inappropriate Enrolment|0|||
130822516|NCT01214837|470979026|FG001|Overall Study|Inappropriate Enrolment|1|||
130822517|NCT01214837|470979027|FG002|Overall Study|Inappropriate Enrolment|2|||
130822518|NCT01214837|470979025|FG000|Overall Study|Administrative Reason|2|||
130822519|NCT01214837|470979026|FG001|Overall Study|Administrative Reason|6|||
130822520|NCT01214837|470979027|FG002|Overall Study|Administrative Reason|4|||
130822521|NCT01214837|470979025|FG000|Overall Study|Protocol Violation|3|||
130822522|NCT01214837|470979026|FG001|Overall Study|Protocol Violation|1|||
130822523|NCT01214837|470979027|FG002|Overall Study|Protocol Violation|5|||
130822524|NCT01214837|470979025|FG000|Overall Study|Unable to Classify|1|||
130822525|NCT01214837|470979026|FG001|Overall Study|Unable to Classify|3|||
130822526|NCT01214837|470979027|FG002|Overall Study|Unable to Classify|0|||
130822527|NCT00027560|470979028|FG000|Overall Study|Withdrawal by Subject|1|||
130822528|NCT02735421|470980522|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
130822529|NCT02735421|470980522|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
130822530|NCT02735421|470980522|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
130822531|NCT02735421|470980522|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
130822532|NCT02735421|470980522|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
130822533|NCT02735421|470980522|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
130822534|NCT02735421|470980522|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
130822535|NCT00939107|470980523|FG000|Overall Study|Lost to Follow-up|14|||
130822536|NCT00939107|470980524|FG001|Overall Study|Lost to Follow-up|12|||
130822537|NCT05010070|470980525|FG000|Overall Study|Lost to Follow-up|1|||
130822538|NCT05010070|470980525|FG000|Overall Study|Withdrawal by Subject|1|||
130822539|NCT03247829|470980527|FG000|Overall Study|Death|3|||
130822540|NCT03247829|470980528|FG001|Overall Study|Death|4|||
130822541|NCT03247829|470980527|FG000|Overall Study|Enter Hospice Care|1|||
130822542|NCT03247829|470980528|FG001|Overall Study|Enter Hospice Care|0|||
130822543|NCT03247829|470980527|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
130822544|NCT03247829|470980528|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
130822545|NCT03247829|470980527|FG000|Overall Study|LVAD Explant|1|||
130822546|NCT03247829|470980528|FG001|Overall Study|LVAD Explant|1|||
130822547|NCT03247829|470980527|FG000|Overall Study|Transplant|1|||
130822548|NCT03247829|470980528|FG001|Overall Study|Transplant|1|||
130822549|NCT01783444|470980529|FG000|Treatment Phase|Adverse Event|9|||
130822550|NCT01783444|470980530|FG001|Treatment Phase|Adverse Event|20|||
130822551|NCT01783444|470980531|FG002|Treatment Phase|Adverse Event|19|||
130822552|NCT01783444|470980529|FG000|Treatment Phase|Disease Progression|76|||
130822553|NCT01783444|470980530|FG001|Treatment Phase|Disease Progression|66|||
130822554|NCT01783444|470980531|FG002|Treatment Phase|Disease Progression|64|||
130822555|NCT01783444|470980529|FG000|Treatment Phase|Death|2|||
130822556|NCT01783444|470980530|FG001|Treatment Phase|Death|2|||
130822557|NCT01783444|470980531|FG002|Treatment Phase|Death|2|||
130822558|NCT01783444|470980529|FG000|Treatment Phase|Protocol Violation|1|||
130822559|NCT01783444|470980530|FG001|Treatment Phase|Protocol Violation|1|||
130822560|NCT01783444|470980531|FG002|Treatment Phase|Protocol Violation|2|||
130822561|NCT01783444|470980529|FG000|Treatment Phase|Withdrawal by Subject|6|||
130822562|NCT01783444|470980530|FG001|Treatment Phase|Withdrawal by Subject|8|||
130822563|NCT01783444|470980531|FG002|Treatment Phase|Withdrawal by Subject|9|||
130822564|NCT01783444|470980529|FG000|Treatment Phase|Administrative problems|2|||
130822565|NCT01783444|470980530|FG001|Treatment Phase|Administrative problems|0|||
130822566|NCT01783444|470980531|FG002|Treatment Phase|Administrative problems|1|||
130822567|NCT01783444|470980529|FG000|Treatment Phase|Physician Decision|8|||
130822568|NCT01783444|470980530|FG001|Treatment Phase|Physician Decision|6|||
130822569|NCT01783444|470980531|FG002|Treatment Phase|Physician Decision|5|||
130822570|NCT01783444|470980529|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
130822571|NCT01783444|470980530|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
130822572|NCT01783444|470980531|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
130822573|NCT01783444|470980529|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
130822574|NCT01783444|470980530|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
130822575|NCT01783444|470980531|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
130822576|NCT01783444|470980529|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
130822577|NCT01783444|470980530|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
130822578|NCT01783444|470980531|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
130822579|NCT01783444|470980529|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
130822580|NCT01783444|470980530|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
130822581|NCT01783444|470980531|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
130822582|NCT01783444|470980529|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
130822583|NCT01783444|470980530|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
130822584|NCT01783444|470980531|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
130822585|NCT01783444|470980529|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
130822586|NCT01783444|470980530|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
130822587|NCT01783444|470980531|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
130822588|NCT01047007|470980537|FG000|Overall Study|Adverse Event|0|||
130822589|NCT01047007|470980538|FG001|Overall Study|Adverse Event|2|||
130822590|NCT01047007|470980539|FG002|Overall Study|Adverse Event|1|||
130822591|NCT01047007|470980540|FG003|Overall Study|Adverse Event|0|||
130822592|NCT01047007|470980537|FG000|Overall Study|Progressive Disease|2|||
130822593|NCT01047007|470980538|FG001|Overall Study|Progressive Disease|4|||
130822594|NCT01047007|470980539|FG002|Overall Study|Progressive Disease|1|||
130822595|NCT01047007|470980540|FG003|Overall Study|Progressive Disease|0|||
130822596|NCT01334554|470980541|FG000|Overall Study|Adverse Event|4|||
130822597|NCT01334554|470980542|FG001|Overall Study|Adverse Event|2|||
130822598|NCT02393859|470980543|FG000|Overall Study|Decision by Sponsor|2|||
130822599|NCT02393859|470980544|FG001|Overall Study|Decision by Sponsor|4|||
130822600|NCT02393859|470980543|FG000|Overall Study|Withdrawal by Subject|11|||
130822601|NCT02393859|470980544|FG001|Overall Study|Withdrawal by Subject|6|||
130822602|NCT02393859|470980543|FG000|Overall Study|Death|27|||
130822603|NCT02393859|470980544|FG001|Overall Study|Death|10|||
130822604|NCT02393859|470980543|FG000|Overall Study|Lost to Follow-up|1|||
130822605|NCT02393859|470980544|FG001|Overall Study|Lost to Follow-up|1|||
130822606|NCT00954447|470980545|FG000|Overall Study|Adverse Event|33|||
130822607|NCT00954447|470980546|FG001|Overall Study|Adverse Event|25|||
130822608|NCT00954447|470980545|FG000|Overall Study|Lack of Efficacy|17|||
130822609|NCT00954447|470980546|FG001|Overall Study|Lack of Efficacy|3|||
130822610|NCT00954447|470980545|FG000|Overall Study|Protocol Violation|5|||
130822611|NCT00954447|470980546|FG001|Overall Study|Protocol Violation|7|||
130822612|NCT00954447|470980545|FG000|Overall Study|Lost to Follow-up|8|||
130822613|NCT00954447|470980546|FG001|Overall Study|Lost to Follow-up|14|||
130822614|NCT00954447|470980545|FG000|Overall Study|Withdrawal by Subject|26|||
130822615|NCT00954447|470980546|FG001|Overall Study|Withdrawal by Subject|21|||
130822616|NCT00954447|470980545|FG000|Overall Study|Other|21|||
130822617|NCT00954447|470980546|FG001|Overall Study|Other|18|||
130822618|NCT04592341|470980547|FG000|Overall Study|Physician Decision|5|||
130822619|NCT04592341|470980547|FG000|Overall Study|Study Terminated by Sponsor|5|||
130822620|NCT04592341|470980547|FG000|Overall Study|Withdrawal by Subject|53|||
130822621|NCT04592341|470980547|FG000|Overall Study|Lost to Follow-up|3|||
130822622|NCT04592341|470980547|FG000|Overall Study|Death|1|||
130822623|NCT04592341|470980547|FG000|Overall Study|Adverse Event|5|||
130822624|NCT04592341|470980547|FG000|Overall Study|other|4|||
130822625|NCT00692003|470980548|FG000|Overall Study|Sponsor Decision|5|||
130822626|NCT00692003|470980549|FG001|Overall Study|Sponsor Decision|1|||
130822627|NCT01248793|470980550|FG000|Overall Study|Lost to Follow-up|0|||
130822628|NCT01248793|470980551|FG001|Overall Study|Lost to Follow-up|1|||
130822629|NCT01248793|470980550|FG000|Overall Study|Adverse Event|1|||
130822630|NCT01248793|470980551|FG001|Overall Study|Adverse Event|1|||
130822631|NCT01248793|470980550|FG000|Overall Study|Protocol Violation|0|||
130822632|NCT01248793|470980551|FG001|Overall Study|Protocol Violation|1|||
130822633|NCT01248793|470980550|FG000|Overall Study|Withdrawal by Subject|3|||
130822634|NCT01248793|470980551|FG001|Overall Study|Withdrawal by Subject|3|||
130822635|NCT01840943|470980552|FG000|Overall Study|Withdrawal by Subject|5|||
130822636|NCT01840943|470980553|FG001|Overall Study|Withdrawal by Subject|6|||
130822637|NCT01840943|470980552|FG000|Overall Study|Physician Decision|4|||
130822638|NCT01840943|470980553|FG001|Overall Study|Physician Decision|2|||
130822639|NCT01840943|470980552|FG000|Overall Study|Lost to Follow-up|4|||
130822640|NCT01840943|470980553|FG001|Overall Study|Lost to Follow-up|4|||
130822641|NCT02580877|470980556|FG000|Overall Study|Withdrawal by Subject|1|||
130822642|NCT02580877|470980557|FG001|Overall Study|Withdrawal by Subject|3|||
130822643|NCT02580877|470980556|FG000|Overall Study|Adverse Event|0|||
130822644|NCT02580877|470980557|FG001|Overall Study|Adverse Event|1|||
130822645|NCT02903823|470980558|FG000|Overall Study|Physician Decision|5|||
130822646|NCT02903823|470980558|FG000|Overall Study|Could not advance catheter|1|||
130822647|NCT02903823|470980558|FG000|Overall Study|Catheter dislodgement|1|||
130822648|NCT01123148|470980565|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
130822649|NCT01123148|470980565|FG000|Overall Study|Didn't meet milestone criteria|1|||
130822650|NCT00355030|470980566|FG000|Study Period 1 Treatment|Adverse Event|1|||
130822651|NCT00355030|470980567|FG001|Study Period 1 Treatment|Adverse Event|1|||
130822652|NCT00355030|470980566|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
130822653|NCT00355030|470980567|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
130822654|NCT00355030|470980566|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
130822655|NCT00355030|470980567|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
130822656|NCT00355030|470980566|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
130822657|NCT00355030|470980567|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
130822658|NCT00355030|470980566|FG000|Study Period 1 Treatment|Physician Decision|0|||
130822659|NCT00355030|470980567|FG001|Study Period 1 Treatment|Physician Decision|1|||
130822660|NCT00355030|470980566|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
130822661|NCT00355030|470980567|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
130822662|NCT00355030|470980566|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
130822663|NCT00355030|470980567|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
130822664|NCT00355030|470980566|FG000|Study Period 1 Treatment|Other|2|||
130822665|NCT00355030|470980567|FG001|Study Period 1 Treatment|Other|6|||
130822666|NCT00355030|470980566|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
130822667|NCT00355030|470980567|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
130822668|NCT00355030|470980566|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
130822669|NCT00355030|470980567|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
130822670|NCT01747915|470980568|FG000|Overall Study|Other|1|||
130822671|NCT01747915|470980569|FG001|Overall Study|Other|1|||
130822672|NCT01747915|470980570|FG002|Overall Study|Other|1|||
130822673|NCT01747915|470980568|FG000|Overall Study|Adverse Event|8|||
130822674|NCT01747915|470980569|FG001|Overall Study|Adverse Event|5|||
130822675|NCT01747915|470980570|FG002|Overall Study|Adverse Event|2|||
130822676|NCT01747915|470980568|FG000|Overall Study|Death|0|||
130822677|NCT01747915|470980569|FG001|Overall Study|Death|0|||
130822678|NCT01747915|470980570|FG002|Overall Study|Death|1|||
130822679|NCT01747915|470980568|FG000|Overall Study|Lack of Efficacy|0|||
130822680|NCT01747915|470980569|FG001|Overall Study|Lack of Efficacy|1|||
130822681|NCT01747915|470980570|FG002|Overall Study|Lack of Efficacy|0|||
130822682|NCT01747915|470980568|FG000|Overall Study|Lost to Follow-up|1|||
130822683|NCT01747915|470980569|FG001|Overall Study|Lost to Follow-up|0|||
130822684|NCT01747915|470980570|FG002|Overall Study|Lost to Follow-up|0|||
130822685|NCT01747915|470980568|FG000|Overall Study|Withdrawal by Subject|4|||
130822686|NCT01747915|470980569|FG001|Overall Study|Withdrawal by Subject|4|||
130822687|NCT01747915|470980570|FG002|Overall Study|Withdrawal by Subject|1|||
130822688|NCT01747915|470980568|FG000|Overall Study|Protocol Violation|1|||
130822689|NCT01747915|470980569|FG001|Overall Study|Protocol Violation|0|||
130822690|NCT01747915|470980570|FG002|Overall Study|Protocol Violation|0|||
130822691|NCT01747915|470980568|FG000|Overall Study|Pregnancy|0|||
130822692|NCT01747915|470980569|FG001|Overall Study|Pregnancy|0|||
130822693|NCT01747915|470980570|FG002|Overall Study|Pregnancy|1|||
130822694|NCT03341637|470980571|FG000|Overall Study|Lost to Follow-up|1|||
130822695|NCT03341637|470980572|FG001|Overall Study|Lost to Follow-up|0|||
130822696|NCT03341637|470980571|FG000|Overall Study|Withdrawal by Subject|3|||
130822697|NCT03341637|470980572|FG001|Overall Study|Withdrawal by Subject|3|||
130822698|NCT03341637|470980571|FG000|Overall Study|Reason not Specified|1|||
130822699|NCT03341637|470980572|FG001|Overall Study|Reason not Specified|1|||
130822700|NCT00887159|470980583|FG000|Overall Study|Disease progression|6|||
130822701|NCT00887159|470980584|FG001|Overall Study|Disease progression|39|||
130822702|NCT00887159|470980585|FG002|Overall Study|Disease progression|33|||
130822703|NCT00887159|470980583|FG000|Overall Study|Adverse Event|3|||
130822704|NCT00887159|470980584|FG001|Overall Study|Adverse Event|4|||
130822705|NCT00887159|470980585|FG002|Overall Study|Adverse Event|17|||
130822706|NCT00887159|470980583|FG000|Overall Study|Death|2|||
130822707|NCT00887159|470980584|FG001|Overall Study|Death|2|||
130822708|NCT00887159|470980585|FG002|Overall Study|Death|0|||
130822709|NCT00887159|470980583|FG000|Overall Study|Withdrawal by Subject|4|||
130822710|NCT00887159|470980584|FG001|Overall Study|Withdrawal by Subject|4|||
130822711|NCT00887159|470980585|FG002|Overall Study|Withdrawal by Subject|2|||
130822712|NCT00887159|470980583|FG000|Overall Study|Alternative therapy|2|||
130822713|NCT00887159|470980584|FG001|Overall Study|Alternative therapy|0|||
130822714|NCT00887159|470980585|FG002|Overall Study|Alternative therapy|0|||
130822715|NCT00887159|470980583|FG000|Overall Study|Physician Decision|1|||
130822716|NCT00887159|470980584|FG001|Overall Study|Physician Decision|1|||
130822717|NCT00887159|470980585|FG002|Overall Study|Physician Decision|0|||
130822718|NCT00887159|470980583|FG000|Overall Study|Sympomatic deterioration|1|||
130822719|NCT00887159|470980584|FG001|Overall Study|Sympomatic deterioration|0|||
130822720|NCT00887159|470980585|FG002|Overall Study|Sympomatic deterioration|0|||
130822721|NCT00887159|470980583|FG000|Overall Study|Treatment delayed|1|||
130822722|NCT00887159|470980584|FG001|Overall Study|Treatment delayed|1|||
130822723|NCT00887159|470980585|FG002|Overall Study|Treatment delayed|0|||
130822724|NCT00887159|470980583|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
130822846|NCT01127633|470980611|FG000|Overall Study|Withdrawal by Subject|57|||
130822847|NCT01127633|470980612|FG001|Overall Study|Withdrawal by Subject|72|||
130822848|NCT01127633|470980611|FG000|Overall Study|Sponsor Decision|163|||
130822849|NCT01127633|470980612|FG001|Overall Study|Sponsor Decision|195|||
130822850|NCT01127633|470980611|FG000|Overall Study|Protocol Violation|8|||
130822851|NCT01127633|470980612|FG001|Overall Study|Protocol Violation|16|||
130822852|NCT01127633|470980611|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
130822853|NCT01127633|470980612|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
130822854|NCT01127633|470980611|FG000|Overall Study|Not treated|1|||
130822855|NCT01127633|470980612|FG001|Overall Study|Not treated|0|||
130822856|NCT00688467|470980614|FG000|Treatment Period 1|Adverse Event|2|||
130822857|NCT00688467|470980615|FG001|Treatment Period 1|Adverse Event|1|||
130822858|NCT00688467|470980614|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
130822859|NCT00688467|470980615|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
130822860|NCT00688467|470980614|FG000|Treatment Period 2|Protocol Violation|0|||
130822861|NCT00688467|470980615|FG001|Treatment Period 2|Protocol Violation|1|||
130822862|NCT00688467|470980614|FG000|Treatment Period 2|Adverse Event|0|||
130822863|NCT00688467|470980615|FG001|Treatment Period 2|Adverse Event|1|||
130822864|NCT00925002|470980616|FG000|Overall Study|Other|1|||
130822865|NCT00925002|470980617|FG001|Overall Study|Other|4|||
130822866|NCT00925002|470980618|FG002|Overall Study|Other|0|||
130822867|NCT00925002|470980616|FG000|Overall Study|Death|1|||
130822868|NCT00925002|470980617|FG001|Overall Study|Death|1|||
130822869|NCT00925002|470980618|FG002|Overall Study|Death|5|||
130822870|NCT00925002|470980616|FG000|Overall Study|Adverse Event|3|||
130822871|NCT00925002|470980617|FG001|Overall Study|Adverse Event|1|||
130822872|NCT00925002|470980618|FG002|Overall Study|Adverse Event|2|||
130822873|NCT00925002|470980616|FG000|Overall Study|Participant withdrew consent|1|||
130822874|NCT00925002|470980617|FG001|Overall Study|Participant withdrew consent|3|||
130822875|NCT00925002|470980618|FG002|Overall Study|Participant withdrew consent|3|||
130822876|NCT00690794|470980621|FG000|Overall Study|Adverse Event|12|||
130822877|NCT00690794|470980622|FG001|Overall Study|Adverse Event|10|||
130822878|NCT00690794|470980621|FG000|Overall Study|Lost to Follow-up|1|||
130822879|NCT00690794|470980622|FG001|Overall Study|Lost to Follow-up|4|||
130822880|NCT00690794|470980621|FG000|Overall Study|Withdrawal by Subject|0|||
130822881|NCT00690794|470980622|FG001|Overall Study|Withdrawal by Subject|9|||
130822882|NCT00690794|470980621|FG000|Overall Study|Protocol Violation|6|||
130822883|NCT00690794|470980622|FG001|Overall Study|Protocol Violation|7|||
130822884|NCT00690794|470980621|FG000|Overall Study|Noncompliance|1|||
130822885|NCT00690794|470980622|FG001|Overall Study|Noncompliance|2|||
130822886|NCT00690794|470980621|FG000|Overall Study|Other not specified|1|||
130822887|NCT00690794|470980622|FG001|Overall Study|Other not specified|3|||
130822888|NCT01496287|470980623|FG000|Overall Study|Lost to Follow-up|1|||
130822889|NCT01496287|470980623|FG000|Overall Study|Incomplete anesthesia|5|||
130822890|NCT01823107|470980624|FG000|Overall Study|Withdrawal by Subject|1|||
130822891|NCT01847092|470980626|FG000|Overall Study|Adverse Event|12|||
130822892|NCT01847092|470980627|FG001|Overall Study|Adverse Event|3|||
130822893|NCT01847092|470980626|FG000|Overall Study|Withdrawal by Subject|5|||
130822894|NCT01847092|470980627|FG001|Overall Study|Withdrawal by Subject|5|||
130822895|NCT01847092|470980626|FG000|Overall Study|Protocol Specified|8|||
130822896|NCT01847092|470980627|FG001|Overall Study|Protocol Specified|0|||
130822897|NCT01847092|470980626|FG000|Overall Study|Physician Decision|1|||
130822898|NCT01847092|470980627|FG001|Overall Study|Physician Decision|1|||
130822899|NCT01847092|470980626|FG000|Overall Study|Protocol Violation|0|||
130822900|NCT01847092|470980627|FG001|Overall Study|Protocol Violation|2|||
130822901|NCT00825994|470980628|FG000|Overall Study|Withdrawal by Subject|2|||
130822902|NCT00825994|470980628|FG000|Overall Study|Lost to Follow-up|1|||
130822903|NCT00825994|470980628|FG000|Overall Study|Protocol Violation|1|||
130822904|NCT00825994|470980628|FG000|Overall Study|Placebo Responder at V2|1|||
130822905|NCT01378117|470980630|FG000|Overall Study|withdrawal|2|||
130822906|NCT01378117|470980631|FG001|Overall Study|withdrawal|1|||
130822907|NCT01378117|470980632|FG002|Overall Study|withdrawal|2|||
130822908|NCT01378117|470980630|FG000|Overall Study|discharged before med given|2|||
130822909|NCT01378117|470980631|FG001|Overall Study|discharged before med given|0|||
130822910|NCT01378117|470980632|FG002|Overall Study|discharged before med given|1|||
130822911|NCT02961244|470980633|FG000|Overall Study|Protocol Violation|0|||
130822912|NCT02961244|470980634|FG001|Overall Study|Protocol Violation|1|||
130822913|NCT02961244|470980633|FG000|Overall Study|Withdrawal by Subject|1|||
130822914|NCT02961244|470980634|FG001|Overall Study|Withdrawal by Subject|2|||
130822915|NCT02961244|470980633|FG000|Overall Study|Surgery plan change after study approval|0|||
130822916|NCT02961244|470980634|FG001|Overall Study|Surgery plan change after study approval|2|||
130822917|NCT02961244|470980633|FG000|Overall Study|Lost to Follow-up|0|||
130822918|NCT02961244|470980634|FG001|Overall Study|Lost to Follow-up|2|||
130822919|NCT02961244|470980633|FG000|Overall Study|İnadequate data|0|||
130822920|NCT02961244|470980634|FG001|Overall Study|İnadequate data|2|||
130822921|NCT01182298|470980639|FG000|Overall Study|Lack of Efficacy|4|||
130822922|NCT01182298|470980639|FG000|Overall Study|Withdrawal by Subject|2|||
130822923|NCT01822665|470980655|FG000|Overall Study|Adverse Event|3|||
130822924|NCT01822665|470980655|FG000|Overall Study|Other Reason|5|||
130822925|NCT04540367|470980656|FG000|Overall Study|Withdrawal by Subject|0|||
130822926|NCT04540367|470980657|FG001|Overall Study|Withdrawal by Subject|0|||
130822927|NCT04540367|470980658|FG002|Overall Study|Withdrawal by Subject|0|||
130822928|NCT04540367|470980659|FG003|Overall Study|Withdrawal by Subject|2|||
130822929|NCT04540367|470980656|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
130822930|NCT04540367|470980657|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
130822931|NCT04540367|470980658|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
130822932|NCT04540367|470980659|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
130822933|NCT04540367|470980656|FG000|Overall Study|Adverse Event|0|||
130822934|NCT04540367|470980657|FG001|Overall Study|Adverse Event|0|||
130822935|NCT04540367|470980658|FG002|Overall Study|Adverse Event|1|||
130822936|NCT04540367|470980659|FG003|Overall Study|Adverse Event|1|||
130822937|NCT00959907|470980662|FG000|Overall Study|Protocol Violation|0|||
130822938|NCT00959907|470980663|FG001|Overall Study|Protocol Violation|1|||
130822939|NCT00959907|470980662|FG000|Overall Study|Adverse Event|1|||
130822940|NCT00959907|470980663|FG001|Overall Study|Adverse Event|0|||
130822941|NCT00959907|470980662|FG000|Overall Study|Withdrawal by Subject|2|||
130822942|NCT00959907|470980663|FG001|Overall Study|Withdrawal by Subject|0|||
130822943|NCT03958331|470980664|FG000|Overall Study|Withdrawal by Subject|3|||
130822944|NCT03958331|470980665|FG001|Overall Study|Withdrawal by Subject|1|||
130822945|NCT03958331|470980666|FG002|Overall Study|Withdrawal by Subject|5|||
130822946|NCT03958331|470980664|FG000|Overall Study|Weaned from medicine|2|||
130822947|NCT03958331|470980665|FG001|Overall Study|Weaned from medicine|0|||
130822948|NCT03958331|470980666|FG002|Overall Study|Weaned from medicine|0|||
130822949|NCT03958331|470980664|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
130822950|NCT03958331|470980665|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
130822951|NCT03958331|470980666|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
130822952|NCT04290624|470980667|FG000|Overall Study|Adverse Event|1|||
130822953|NCT04290624|470980668|FG001|Overall Study|Adverse Event|0|||
130822954|NCT04422431|470980669|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
130822955|NCT04422431|470980669|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
130822956|NCT04422431|470980669|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
130822957|NCT04422431|470980669|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
130822958|NCT04422431|470980669|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
130822959|NCT04422431|470980669|FG000|Extension Period (48 Weeks)|Other than specified|2|||
130822960|NCT00937495|470982129|FG000|Overall Study|Protocol Violation|2|||
130822961|NCT00441272|470982130|FG000|Overall Study|Study terminated prior to enrollment|25|||
130822962|NCT00441272|470982131|FG001|Overall Study|Study terminated prior to enrollment|25|||
130822963|NCT01856322|470982132|FG000|Overall Study|off study due to lack of accrual|0|||
130822964|NCT01856322|470982133|FG001|Overall Study|off study due to lack of accrual|0|||
130822965|NCT01856322|470982134|FG002|Overall Study|off study due to lack of accrual|3|||
130822966|NCT00427011|470982135|FG000|Overall Study|Adverse Event|10|||
130822967|NCT00427011|470982135|FG000|Overall Study|Withdrawal by Subject|1|||
130822968|NCT00427011|470982135|FG000|Overall Study|Lack of Efficacy|2|||
130822969|NCT00427011|470982135|FG000|Overall Study|Other|12|||
130822970|NCT00288015|470982139|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
130822971|NCT00288015|470982139|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
130822972|NCT00288015|470982139|FG000|First Response Assessment|Withdrawal by Subject|1|||
130822973|NCT00288015|470982139|FG000|First Response Assessment|Death|1|||
130822974|NCT00288015|470982139|FG000|First Response Assessment|Physician Decision|2|||
130822975|NCT00288015|470982139|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
130822976|NCT00288015|470982139|FG000|Follow up for Survival x 2 Years|Death|13|||
130822977|NCT00288015|470982139|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
130822978|NCT00288015|470982139|FG000|Follow up for Survival x 2 Years|Other|9|||
130822979|NCT01333722|470982140|FG000|Overall Study|Lack of Efficacy|0|||
130822980|NCT01333722|470982141|FG001|Overall Study|Lack of Efficacy|2|||
130822981|NCT01333722|470982140|FG000|Overall Study|Withdrawal by Subject|0|||
130822982|NCT01333722|470982141|FG001|Overall Study|Withdrawal by Subject|1|||
130822983|NCT00443703|470982142|FG000|Overall Study|Never Treated|3|||
130822984|NCT00443703|470982143|FG001|Overall Study|Never Treated|1|||
130822985|NCT00443703|470982142|FG000|Overall Study|Adverse Event|7|||
130822986|NCT00443703|470982143|FG001|Overall Study|Adverse Event|3|||
130822987|NCT00443703|470982142|FG000|Overall Study|Lack of Efficacy|3|||
130822988|NCT00443703|470982143|FG001|Overall Study|Lack of Efficacy|1|||
130822989|NCT00443703|470982142|FG000|Overall Study|Lost to Follow-up|0|||
130822990|NCT00443703|470982143|FG001|Overall Study|Lost to Follow-up|4|||
130822991|NCT00443703|470982142|FG000|Overall Study|Physician Decision|4|||
130822992|NCT00443703|470982143|FG001|Overall Study|Physician Decision|2|||
130822993|NCT00443703|470982142|FG000|Overall Study|Protocol Violation|1|||
130822994|NCT00443703|470982143|FG001|Overall Study|Protocol Violation|1|||
130822995|NCT00443703|470982142|FG000|Overall Study|Withdrawal by Subject|9|||
130822996|NCT00443703|470982143|FG001|Overall Study|Withdrawal by Subject|6|||
130822997|NCT00443703|470982142|FG000|Overall Study|Progressive Disease|1|||
130822998|NCT00443703|470982143|FG001|Overall Study|Progressive Disease|0|||
130822999|NCT04776161|470982145|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
130823000|NCT04776161|470982146|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
130823001|NCT04776161|470982147|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
130823002|NCT04776161|470982145|FG000|Overall Study|Withdrawal by Subject|1|||
130823003|NCT04776161|470982146|FG001|Overall Study|Withdrawal by Subject|0|||
130823004|NCT04776161|470982147|FG002|Overall Study|Withdrawal by Subject|1|||
130823005|NCT04776161|470982145|FG000|Overall Study|Adverse Event|0|||
130823006|NCT04776161|470982146|FG001|Overall Study|Adverse Event|1|||
130823007|NCT04776161|470982147|FG002|Overall Study|Adverse Event|1|||
130823008|NCT00661830|470982151|FG000|Overall Study|Death|37|||
130823009|NCT00661830|470982152|FG001|Overall Study|Death|33|||
130823010|NCT00661830|470982151|FG000|Overall Study|Lost to Follow-up|1|||
130823011|NCT00661830|470982152|FG001|Overall Study|Lost to Follow-up|3|||
130823012|NCT00661830|470982151|FG000|Overall Study|Withdrawal by Subject|1|||
130823013|NCT00661830|470982152|FG001|Overall Study|Withdrawal by Subject|1|||
130823014|NCT00661830|470982151|FG000|Overall Study|Other reason|1|||
130823015|NCT00661830|470982152|FG001|Overall Study|Other reason|5|||
130823016|NCT00488514|470982153|FG000|Overall Study|Adverse Event|41|||
130823017|NCT00488514|470982153|FG000|Overall Study|Lost to Follow-up|44|||
130823018|NCT00488514|470982153|FG000|Overall Study|Protocol Violation|32|||
130823019|NCT00488514|470982153|FG000|Overall Study|Withdrawal by Subject|106|||
130823020|NCT00488514|470982153|FG000|Overall Study|Lack of Efficacy|28|||
130823021|NCT00488514|470982153|FG000|Overall Study|Did not meet criteria for treatment|30|||
130823022|NCT00488514|470982153|FG000|Overall Study|Postive drug screen|1|||
130823023|NCT00488514|470982153|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
130823024|NCT00488514|470982153|FG000|Overall Study|Investigator decision|1|||
130823025|NCT00488514|470982153|FG000|Overall Study|Participant had too few migraines|5|||
130823026|NCT00488514|470982153|FG000|Overall Study|Increase in number of migraines|2|||
130823027|NCT00488514|470982153|FG000|Overall Study|Increased use of concomitant medication|1|||
130823028|NCT00517699|470982154|FG000|Overall Study|Withdrawal by Subject|1|||
130823029|NCT00517699|470982154|FG000|Overall Study|Lack of Efficacy|1|||
130823030|NCT00517699|470982154|FG000|Overall Study|Administrative error|1|||
130823031|NCT00517699|470982154|FG000|Overall Study|Study terminated by Sponsor|2|||
130823032|NCT02332187|470982155|FG000|Overall Study|Withdrawal by Subject|2|||
130823033|NCT02332187|470982156|FG001|Overall Study|Withdrawal by Subject|2|||
130823034|NCT02332187|470982155|FG000|Overall Study|Adverse Event|0|||
130823035|NCT02332187|470982156|FG001|Overall Study|Adverse Event|1|||
130823036|NCT00980148|470982157|FG000|Overall Study|Discharged from facility|89|||
130823037|NCT00980148|470982158|FG001|Overall Study|Discharged from facility|96|||
130823038|NCT00980148|470982157|FG000|Overall Study|Received other antichlamydia treatment|20|||
130823039|NCT00980148|470982158|FG001|Overall Study|Received other antichlamydia treatment|14|||
130823040|NCT00980148|470982157|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
130823041|NCT00980148|470982158|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
130823042|NCT00980148|470982157|FG000|Overall Study|Various other reasons|8|||
130823043|NCT00980148|470982158|FG001|Overall Study|Various other reasons|9|||
130823044|NCT03500211|470982159|FG000|Overall Study|Withdrawal by Subject|1|||
130823045|NCT03500211|470982160|FG001|Overall Study|Withdrawal by Subject|1|||
130823046|NCT01119443|470982164|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
130823047|NCT01119443|470982165|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
130823048|NCT02329743|470982168|FG000|Overall Study|Adverse Event|1|||
130823049|NCT02329743|470982169|FG001|Overall Study|Adverse Event|1|||
130823050|NCT02329743|470982170|FG002|Overall Study|Adverse Event|3|||
130823051|NCT02329743|470982168|FG000|Overall Study|Lost to Follow-up|1|||
130823052|NCT02329743|470982169|FG001|Overall Study|Lost to Follow-up|0|||
130823053|NCT02329743|470982170|FG002|Overall Study|Lost to Follow-up|1|||
130823054|NCT02329743|470982168|FG000|Overall Study|Withdrawal by Subject|4|||
130823055|NCT02329743|470982169|FG001|Overall Study|Withdrawal by Subject|4|||
130823056|NCT02329743|470982170|FG002|Overall Study|Withdrawal by Subject|1|||
130823057|NCT02329743|470982168|FG000|Overall Study|Other|0|||
130823058|NCT02329743|470982169|FG001|Overall Study|Other|2|||
130823059|NCT02329743|470982170|FG002|Overall Study|Other|3|||
130823060|NCT00775268|470982174|FG000|Baseline|Drug not synthesize dose|1|||
130823061|NCT00775268|470982175|FG001|Baseline|Drug not synthesize dose|0|||
130823062|NCT00775268|470982174|FG000|Baseline|Not treated-ineligible per CT|0|||
130823063|NCT00775268|470982175|FG001|Baseline|Not treated-ineligible per CT|1|||
130823064|NCT00775268|470982174|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
130823065|NCT00775268|470982175|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
130823066|NCT00775268|470982174|FG000|After Completion|Participant missed scan appointment|1|||
130823067|NCT00775268|470982175|FG001|After Completion|Participant missed scan appointment|0|||
130823068|NCT03604497|470982176|FG000|Overall Study|Protocol Violation|52|||
130823069|NCT01331681|470982182|FG000|Overall Study|Adverse Event|10|||
130823070|NCT01331681|470982183|FG001|Overall Study|Adverse Event|13|||
130823071|NCT01331681|470982184|FG002|Overall Study|Adverse Event|10|||
130823072|NCT01331681|470982182|FG000|Overall Study|Death|6|||
130823073|NCT01331681|470982183|FG001|Overall Study|Death|6|||
130823074|NCT01331681|470982184|FG002|Overall Study|Death|2|||
130823075|NCT01331681|470982182|FG000|Overall Study|Lack of Efficacy|0|||
130823076|NCT01331681|470982183|FG001|Overall Study|Lack of Efficacy|1|||
130823077|NCT01331681|470982184|FG002|Overall Study|Lack of Efficacy|0|||
130823078|NCT01331681|470982182|FG000|Overall Study|Withdrawal by Subject|12|||
130823079|NCT01331681|470982183|FG001|Overall Study|Withdrawal by Subject|8|||
130823080|NCT01331681|470982184|FG002|Overall Study|Withdrawal by Subject|15|||
130823081|NCT01331681|470982182|FG000|Overall Study|Protocol Violation|1|||
130823082|NCT01331681|470982183|FG001|Overall Study|Protocol Violation|1|||
130823083|NCT01331681|470982184|FG002|Overall Study|Protocol Violation|0|||
130823084|NCT01331681|470982182|FG000|Overall Study|Lost to Follow-up|2|||
130823085|NCT01331681|470982183|FG001|Overall Study|Lost to Follow-up|4|||
130823086|NCT01331681|470982184|FG002|Overall Study|Lost to Follow-up|1|||
130823087|NCT01331681|470982182|FG000|Overall Study|Physician Decision|2|||
130823088|NCT01331681|470982183|FG001|Overall Study|Physician Decision|0|||
130823089|NCT01331681|470982184|FG002|Overall Study|Physician Decision|4|||
130823090|NCT01331681|470982182|FG000|Overall Study|Therapeutic procedure required|1|||
130823091|NCT01331681|470982183|FG001|Overall Study|Therapeutic procedure required|0|||
130823092|NCT01331681|470982184|FG002|Overall Study|Therapeutic procedure required|0|||
130823093|NCT01331681|470982182|FG000|Overall Study|Sponsor decision|1|||
130823094|NCT01331681|470982183|FG001|Overall Study|Sponsor decision|1|||
130823095|NCT01331681|470982184|FG002|Overall Study|Sponsor decision|0|||
130823096|NCT01331681|470982182|FG000|Overall Study|Switching to other therapy|0|||
130823097|NCT01331681|470982183|FG001|Overall Study|Switching to other therapy|0|||
130823098|NCT01331681|470982184|FG002|Overall Study|Switching to other therapy|1|||
130823099|NCT01331681|470982182|FG000|Overall Study|Not Received Study Treatment|0|||
130823100|NCT01331681|470982183|FG001|Overall Study|Not Received Study Treatment|0|||
130823101|NCT01331681|470982184|FG002|Overall Study|Not Received Study Treatment|2|||
130823102|NCT00658541|470982186|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
130823103|NCT00658541|470982187|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130823104|NCT00658541|470982186|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130823105|NCT00658541|470982187|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130823106|NCT01194245|470982188|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
130823107|NCT01194245|470982189|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130823108|NCT01194245|470982190|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130823109|NCT01194245|470982191|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130823110|NCT01194245|470982192|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130823111|NCT01194245|470982188|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
130823112|NCT01194245|470982189|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130823113|NCT01194245|470982190|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130823114|NCT01194245|470982191|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130823115|NCT01194245|470982192|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130823116|NCT01194245|470982188|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
130823117|NCT01194245|470982189|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130823118|NCT01194245|470982190|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130823119|NCT01194245|470982191|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130823120|NCT01194245|470982192|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130823121|NCT01194245|470982188|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
130823122|NCT01194245|470982189|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130823123|NCT01194245|470982190|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130823124|NCT01194245|470982191|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130823125|NCT01194245|470982192|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130823126|NCT01194245|470982188|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130823127|NCT01194245|470982189|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130823128|NCT01194245|470982190|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130823129|NCT01194245|470982191|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130823130|NCT01194245|470982192|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
130823131|NCT01194245|470982188|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130823132|NCT01194245|470982189|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130823133|NCT01194245|470982190|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
130823134|NCT01194245|470982191|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
130823135|NCT01194245|470982192|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
130823136|NCT00269087|470982193|FG000|Overall Study|Adverse Event|20|||
130823137|NCT00269087|470982193|FG000|Overall Study|Withdrawal by Subject|1|||
130823138|NCT00269087|470982193|FG000|Overall Study|Exacerbation of COPD|13|||
130823139|NCT03326063|470982194|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
130823140|NCT03326063|470982195|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
130823141|NCT01876381|470982196|FG000|Overall Study|Lack of Efficacy|5|||
130823142|NCT01876381|470982196|FG000|Overall Study|Physician Decision|1|||
130823143|NCT01876381|470982196|FG000|Overall Study|Withdrawal by Subject|1|||
130823144|NCT00461708|470982197|FG000|Overall Study|Adverse Event|17|||
130823145|NCT00461708|470982198|FG001|Overall Study|Adverse Event|7|||
130823146|NCT00461708|470982197|FG000|Overall Study|Lack of Efficacy|68|||
130823147|NCT00461708|470982198|FG001|Overall Study|Lack of Efficacy|20|||
130823148|NCT00461708|470982197|FG000|Overall Study|Physician Decision|10|||
130823149|NCT00461708|470982198|FG001|Overall Study|Physician Decision|4|||
130823150|NCT00461708|470982197|FG000|Overall Study|Withdrawal by Subject|8|||
130823151|NCT00461708|470982198|FG001|Overall Study|Withdrawal by Subject|2|||
130823152|NCT00461708|470982197|FG000|Overall Study|Other|4|||
130823153|NCT00461708|470982198|FG001|Overall Study|Other|4|||
130823154|NCT00461708|470982197|FG000|Overall Study|Death|8|||
130823155|NCT00461708|470982198|FG001|Overall Study|Death|1|||
130823156|NCT02803203|470982199|FG000|Overall Study|Adverse Event|4|||
130823157|NCT02803203|470982199|FG000|Overall Study|Death|4|||
130823158|NCT02803203|470982199|FG000|Overall Study|Progressive disease|29|||
130823159|NCT02803203|470982199|FG000|Overall Study|Withdrawal by Subject|8|||
130823160|NCT02803203|470982199|FG000|Overall Study|Complete resection of target disease|2|||
130823161|NCT02803203|470982199|FG000|Overall Study|Switched to commercial Osi|1|||
130823162|NCT02803203|470982199|FG000|Overall Study|Participant moved away|1|||
130823163|NCT04577781|470982200|FG000|Overall Study|Adverse Event|2|||
130823164|NCT04577781|470982201|FG001|Overall Study|Adverse Event|2|||
130823165|NCT04577781|470982200|FG000|Overall Study|Physician Decision|1|||
130823166|NCT04577781|470982201|FG001|Overall Study|Physician Decision|0|||
130823167|NCT03894891|470982202|FG000|Overall Study|Withdrawal by Subject|1|||
130823168|NCT03894891|470982202|FG000|Overall Study|Completed protocol treatment per protocol|5|||
130823169|NCT00950651|470982206|FG000|Overall Study|Adverse Event|17|||
130823170|NCT00950651|470982207|FG001|Overall Study|Adverse Event|20|||
130823171|NCT00950651|470982206|FG000|Overall Study|Death|1|||
130823172|NCT00950651|470982207|FG001|Overall Study|Death|0|||
130823173|NCT00950651|470982206|FG000|Overall Study|Lack of Efficacy|2|||
130823174|NCT00950651|470982207|FG001|Overall Study|Lack of Efficacy|2|||
130823175|NCT00950651|470982206|FG000|Overall Study|Protocol Violation|3|||
130823176|NCT00950651|470982207|FG001|Overall Study|Protocol Violation|4|||
130823177|NCT00950651|470982206|FG000|Overall Study|Withdrawal by Subject|8|||
130823178|NCT00950651|470982207|FG001|Overall Study|Withdrawal by Subject|9|||
130823179|NCT01824290|470982209|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
130823180|NCT01824290|470982210|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
130823181|NCT01824290|470982211|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
130823182|NCT01824290|470982212|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
130823183|NCT01824290|470982209|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
130823184|NCT01824290|470982210|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
130823185|NCT01824290|470982211|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
130823186|NCT01824290|470982212|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
130823187|NCT01824290|470982209|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
130823188|NCT01824290|470982210|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
130823189|NCT01824290|470982211|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
130823190|NCT01824290|470982212|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
130823191|NCT01824290|470982209|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
130823192|NCT01824290|470982210|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
130823193|NCT01824290|470982211|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
130823194|NCT01824290|470982212|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
130823195|NCT01824290|470982209|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
130823196|NCT01824290|470982210|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
130823197|NCT01824290|470982211|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
130823198|NCT01824290|470982212|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
130823199|NCT01824290|470982209|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
130823200|NCT01824290|470982210|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
130823201|NCT01824290|470982211|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
130823202|NCT01824290|470982212|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
130823203|NCT00527618|470982213|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
130823204|NCT00527618|470982214|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
130823205|NCT00527618|470982213|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
130823206|NCT00527618|470982214|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
130823207|NCT00527618|470982213|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
130823208|NCT00527618|470982214|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
130823209|NCT00527618|470982213|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
130823210|NCT00527618|470982214|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
130823211|NCT00527618|470982213|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
130823212|NCT00527618|470982214|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
130823213|NCT00527618|470982213|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
130823214|NCT00527618|470982214|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
130823215|NCT00114127|470982218|FG000|Overall Study|Adverse Event|2|||
130823216|NCT00114127|470982219|FG001|Overall Study|Adverse Event|1|||
130823217|NCT00114127|470982218|FG000|Overall Study|Lost to Follow-up|1|||
130823218|NCT00114127|470982219|FG001|Overall Study|Lost to Follow-up|0|||
130823219|NCT00114127|470982218|FG000|Overall Study|Withdrawal by Subject|1|||
130823220|NCT00114127|470982219|FG001|Overall Study|Withdrawal by Subject|3|||
130823221|NCT03188263|470982220|FG000|Overall Study|Withdrawal by Subject|3|||
130823222|NCT03188263|470982221|FG001|Overall Study|Withdrawal by Subject|0|||
130823223|NCT03188263|470982220|FG000|Overall Study|Physician Decision|1|||
130823224|NCT03188263|470982221|FG001|Overall Study|Physician Decision|0|||
130823225|NCT00881894|470982222|FG000|Overall Study|Consent withdrawn|0|||
130823226|NCT00881894|470982223|FG001|Overall Study|Consent withdrawn|1|||
130823227|NCT00881894|470982222|FG000|Overall Study|Other reasons for premature termination|1|||
130823228|NCT00881894|470982223|FG001|Overall Study|Other reasons for premature termination|2|||
130823229|NCT00421148|470982224|FG000|Overall Study|Lost to Follow-up|0|||
130823230|NCT00421148|470982225|FG001|Overall Study|Lost to Follow-up|0|||
130823231|NCT00421148|470982226|FG002|Overall Study|Lost to Follow-up|0|||
130823232|NCT00421148|470982227|FG003|Overall Study|Lost to Follow-up|0|||
130823233|NCT00421148|470982228|FG004|Overall Study|Lost to Follow-up|0|||
130823234|NCT00421148|470982229|FG005|Overall Study|Lost to Follow-up|0|||
130823235|NCT00421148|470982230|FG006|Overall Study|Lost to Follow-up|0|||
130823236|NCT00421148|470982231|FG007|Overall Study|Lost to Follow-up|0|||
130823237|NCT00421148|470982232|FG008|Overall Study|Lost to Follow-up|0|||
130823238|NCT00421148|470982233|FG009|Overall Study|Lost to Follow-up|0|||
130823239|NCT00421148|470982234|FG010|Overall Study|Lost to Follow-up|0|||
130823240|NCT00421148|470982235|FG011|Overall Study|Lost to Follow-up|0|||
130823241|NCT00421148|470982236|FG012|Overall Study|Lost to Follow-up|0|||
130823242|NCT00421148|470982237|FG013|Overall Study|Lost to Follow-up|0|||
130823243|NCT00421148|470982238|FG014|Overall Study|Lost to Follow-up|0|||
130823244|NCT00421148|470982239|FG015|Overall Study|Lost to Follow-up|0|||
130823245|NCT00421148|470982240|FG016|Overall Study|Lost to Follow-up|0|||
130823246|NCT00421148|470982241|FG017|Overall Study|Lost to Follow-up|1|||
130823247|NCT00421148|470982242|FG018|Overall Study|Lost to Follow-up|0|||
130823248|NCT00421148|470982243|FG019|Overall Study|Lost to Follow-up|0|||
130823249|NCT00421148|470982224|FG000|Overall Study|Withdrawal by Subject|0|||
130823250|NCT00421148|470982225|FG001|Overall Study|Withdrawal by Subject|0|||
130823251|NCT00421148|470982226|FG002|Overall Study|Withdrawal by Subject|0|||
130823252|NCT00421148|470982227|FG003|Overall Study|Withdrawal by Subject|0|||
130823253|NCT00421148|470982228|FG004|Overall Study|Withdrawal by Subject|0|||
130823254|NCT00421148|470982229|FG005|Overall Study|Withdrawal by Subject|0|||
130823255|NCT00421148|470982230|FG006|Overall Study|Withdrawal by Subject|0|||
130823256|NCT00421148|470982231|FG007|Overall Study|Withdrawal by Subject|0|||
130823257|NCT00421148|470982232|FG008|Overall Study|Withdrawal by Subject|0|||
130823258|NCT00421148|470982233|FG009|Overall Study|Withdrawal by Subject|0|||
130823259|NCT00421148|470982234|FG010|Overall Study|Withdrawal by Subject|0|||
130823260|NCT00421148|470982235|FG011|Overall Study|Withdrawal by Subject|0|||
130823261|NCT00421148|470982236|FG012|Overall Study|Withdrawal by Subject|0|||
130823262|NCT00421148|470982237|FG013|Overall Study|Withdrawal by Subject|0|||
130823263|NCT00421148|470982238|FG014|Overall Study|Withdrawal by Subject|0|||
130823264|NCT00421148|470982239|FG015|Overall Study|Withdrawal by Subject|0|||
130823265|NCT00421148|470982240|FG016|Overall Study|Withdrawal by Subject|0|||
130823266|NCT00421148|470982241|FG017|Overall Study|Withdrawal by Subject|1|||
130823267|NCT00421148|470982242|FG018|Overall Study|Withdrawal by Subject|0|||
130823268|NCT00421148|470982243|FG019|Overall Study|Withdrawal by Subject|0|||
130823269|NCT00421148|470982224|FG000|Overall Study|Protocol Violation|0|||
130823270|NCT00421148|470982225|FG001|Overall Study|Protocol Violation|0|||
130823271|NCT00421148|470982226|FG002|Overall Study|Protocol Violation|0|||
130823272|NCT00421148|470982227|FG003|Overall Study|Protocol Violation|0|||
130823273|NCT00421148|470982228|FG004|Overall Study|Protocol Violation|0|||
130823274|NCT00421148|470982229|FG005|Overall Study|Protocol Violation|1|||
130823275|NCT00421148|470982230|FG006|Overall Study|Protocol Violation|0|||
130823276|NCT00421148|470982231|FG007|Overall Study|Protocol Violation|0|||
130823277|NCT00421148|470982232|FG008|Overall Study|Protocol Violation|0|||
130823278|NCT00421148|470982233|FG009|Overall Study|Protocol Violation|0|||
130823279|NCT00421148|470982234|FG010|Overall Study|Protocol Violation|0|||
130823280|NCT00421148|470982235|FG011|Overall Study|Protocol Violation|0|||
130823281|NCT00421148|470982236|FG012|Overall Study|Protocol Violation|0|||
130823282|NCT00421148|470982237|FG013|Overall Study|Protocol Violation|0|||
130823283|NCT00421148|470982238|FG014|Overall Study|Protocol Violation|0|||
130823284|NCT00421148|470982239|FG015|Overall Study|Protocol Violation|0|||
130823285|NCT00421148|470982240|FG016|Overall Study|Protocol Violation|0|||
130823286|NCT00421148|470982241|FG017|Overall Study|Protocol Violation|0|||
130823287|NCT00421148|470982242|FG018|Overall Study|Protocol Violation|1|||
130823288|NCT00421148|470982243|FG019|Overall Study|Protocol Violation|0|||
130823289|NCT00469833|470982244|FG000|Overall Study|No IV access|2|||
130823290|NCT01253369|470982245|FG000|Overall Study|Adverse Event|4|||
130823291|NCT01253369|470982245|FG000|Overall Study|Withdrawal by Subject|2|||
130823292|NCT01253369|470982245|FG000|Overall Study|Death|1|||
130823293|NCT01253369|470982245|FG000|Overall Study|Progressive disease|23|||
130823294|NCT01253369|470982245|FG000|Overall Study|Not Evaluable|3|||
130823295|NCT03289533|470982246|FG000|Overall Study|Death|12|||
130823296|NCT03289533|470982246|FG000|Overall Study|Terminated from study by sponsor|10|||
130823297|NCT01030822|470982247|FG000|Overall Study|Moved/migrated from study area|6|||
130823298|NCT01030822|470982248|FG001|Overall Study|Moved/migrated from study area|7|||
130823299|NCT01030822|470982249|FG002|Overall Study|Moved/migrated from study area|3|||
130823300|NCT01030822|470982247|FG000|Overall Study|Withdrawal by Subject|16|||
130823301|NCT01030822|470982248|FG001|Overall Study|Withdrawal by Subject|13|||
130823302|NCT01030822|470982249|FG002|Overall Study|Withdrawal by Subject|16|||
130823303|NCT01030822|470982247|FG000|Overall Study|Lost to Follow-up|9|||
130823304|NCT01030822|470982248|FG001|Overall Study|Lost to Follow-up|4|||
130823305|NCT01030822|470982249|FG002|Overall Study|Lost to Follow-up|7|||
130823306|NCT00539240|470982250|FG000|Overall Study|Withdrawal by Subject|0|||
130823307|NCT00539240|470982251|FG001|Overall Study|Withdrawal by Subject|2|||
130823308|NCT00539240|470982252|FG002|Overall Study|Withdrawal by Subject|0|||
130823309|NCT00539240|470982250|FG000|Overall Study|Protocol Violation|1|||
130823310|NCT00539240|470982251|FG001|Overall Study|Protocol Violation|1|||
130823311|NCT00539240|470982252|FG002|Overall Study|Protocol Violation|4|||
130823312|NCT00539240|470982250|FG000|Overall Study|Lost to Follow-up|2|||
130823313|NCT00539240|470982251|FG001|Overall Study|Lost to Follow-up|3|||
130823314|NCT00539240|470982252|FG002|Overall Study|Lost to Follow-up|1|||
130823315|NCT00539240|470982250|FG000|Overall Study|Adverse Event|3|||
130823316|NCT00539240|470982251|FG001|Overall Study|Adverse Event|1|||
130823317|NCT00539240|470982252|FG002|Overall Study|Adverse Event|10|||
130823318|NCT00363311|470982253|FG000|Overall Study|Adverse Event|6|||
130823319|NCT00363311|470982254|FG001|Overall Study|Adverse Event|4|||
130823320|NCT00363311|470982253|FG000|Overall Study|Lost to Follow-up|3|||
130823321|NCT00363311|470982254|FG001|Overall Study|Lost to Follow-up|0|||
130823322|NCT00363311|470982253|FG000|Overall Study|Protocol Violation|1|||
130823323|NCT00363311|470982254|FG001|Overall Study|Protocol Violation|2|||
130823324|NCT00363311|470982253|FG000|Overall Study|Withdrawal by Subject|12|||
130823325|NCT00363311|470982254|FG001|Overall Study|Withdrawal by Subject|6|||
130823326|NCT00363311|470982253|FG000|Overall Study|Physician Decision|1|||
130823327|NCT00363311|470982254|FG001|Overall Study|Physician Decision|1|||
130823328|NCT00363311|470982253|FG000|Overall Study|Sponsor Terminated Study|2|||
130823329|NCT00363311|470982254|FG001|Overall Study|Sponsor Terminated Study|2|||
130823330|NCT00363311|470982253|FG000|Overall Study|Disease Progression|46|||
130823331|NCT00363311|470982254|FG001|Overall Study|Disease Progression|26|||
130823332|NCT00363311|470982253|FG000|Overall Study|Non-Compliance|1|||
130823333|NCT00363311|470982254|FG001|Overall Study|Non-Compliance|1|||
130823334|NCT00363311|470982253|FG000|Overall Study|Participant Refused Biopsy|1|||
130823335|NCT00363311|470982254|FG001|Overall Study|Participant Refused Biopsy|0|||
130823336|NCT00363311|470982253|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
130823337|NCT00363311|470982254|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
130823338|NCT00363311|470982253|FG000|Overall Study|Participant Opted for Treatment|1|||
130823339|NCT00363311|470982254|FG001|Overall Study|Participant Opted for Treatment|0|||
130823340|NCT00363311|470982253|FG000|Overall Study|Participant Moved to Another Country|1|||
130823341|NCT00363311|470982254|FG001|Overall Study|Participant Moved to Another Country|0|||
130823342|NCT00363311|470982253|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
130823343|NCT00363311|470982254|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
130823344|NCT00363311|470982253|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
130823345|NCT00363311|470982254|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
130823346|NCT00363311|470982253|FG000|Overall Study|Participant Moved to Louisiana|0|||
130823347|NCT00363311|470982254|FG001|Overall Study|Participant Moved to Louisiana|1|||
130823348|NCT01595529|470982255|FG000|Overall Study|Adverse Event|2|||
130823349|NCT01595529|470982256|FG001|Overall Study|Adverse Event|0|||
130823350|NCT01595529|470982255|FG000|Overall Study|Subject Non-Compliant|2|||
130823351|NCT01595529|470982256|FG001|Overall Study|Subject Non-Compliant|0|||
130823352|NCT01595529|470982255|FG000|Overall Study|Lost to Follow-up|8|||
130823353|NCT01595529|470982256|FG001|Overall Study|Lost to Follow-up|14|||
130823354|NCT01595529|470982255|FG000|Overall Study|Protocol Violation|1|||
130823355|NCT01595529|470982256|FG001|Overall Study|Protocol Violation|2|||
130823356|NCT01595529|470982255|FG000|Overall Study|Physician Decision|1|||
130823357|NCT01595529|470982256|FG001|Overall Study|Physician Decision|0|||
130823358|NCT01595529|470982255|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
130823359|NCT01595529|470982256|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
130823360|NCT01595529|470982255|FG000|Overall Study|Administrative Decision|1|||
130823361|NCT01595529|470982256|FG001|Overall Study|Administrative Decision|0|||
130823362|NCT01595529|470982255|FG000|Overall Study|Entry Failure/Screening Failure|6|||
130823363|NCT01595529|470982256|FG001|Overall Study|Entry Failure/Screening Failure|1|||
130823364|NCT04016714|470982257|FG000|Overall Study|Death|1|||
130823365|NCT04016714|470982258|FG001|Overall Study|Death|0|||
130823366|NCT04016714|470982257|FG000|Overall Study|Lost to Follow-up|3|||
130823367|NCT04016714|470982258|FG001|Overall Study|Lost to Follow-up|1|||
130823368|NCT04016714|470982257|FG000|Overall Study|Physician Decision|3|||
130823369|NCT04016714|470982258|FG001|Overall Study|Physician Decision|3|||
130823370|NCT04016714|470982257|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
130823371|NCT04016714|470982258|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
130823372|NCT00730886|470982261|FG000|Overall Study|Lost to Follow-up|1|||
130823373|NCT00730886|470982262|FG001|Overall Study|Lost to Follow-up|0|||
130823374|NCT00730886|470982261|FG000|Overall Study|Physician Decision|1|||
130823375|NCT00730886|470982262|FG001|Overall Study|Physician Decision|0|||
130823376|NCT01991483|470982263|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
130823377|NCT01991483|470982264|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
130823378|NCT01991483|470982265|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
130823379|NCT01991483|470982266|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
130823380|NCT01991483|470982263|FG000|Dose Level 600 mg|Physician Decision|0|||
130823381|NCT01991483|470982264|FG001|Dose Level 600 mg|Physician Decision|0|||
130823382|NCT01991483|470982265|FG002|Dose Level 600 mg|Physician Decision|1|||
130823383|NCT01991483|470982266|FG003|Dose Level 600 mg|Physician Decision|0|||
130823384|NCT01991483|470982263|FG000|Dose Level 1000 mg|Protocol Violation|0|||
130823385|NCT01991483|470982264|FG001|Dose Level 1000 mg|Protocol Violation|0|||
130823386|NCT01991483|470982265|FG002|Dose Level 1000 mg|Protocol Violation|0|||
130823387|NCT01991483|470982266|FG003|Dose Level 1000 mg|Protocol Violation|1|||
130823388|NCT01932788|470982274|FG000|Overall Study|Protocol Violation|18|||
130823389|NCT01932788|470982275|FG001|Overall Study|Protocol Violation|0|||
130823390|NCT01932788|470982274|FG000|Overall Study|Lost to Follow-up|18|||
130823391|NCT01932788|470982275|FG001|Overall Study|Lost to Follow-up|46|||
130823392|NCT01932788|470982274|FG000|Overall Study|Lack of Efficacy|2|||
130823393|NCT01932788|470982275|FG001|Overall Study|Lack of Efficacy|0|||
130823394|NCT01932788|470982274|FG000|Overall Study|Withdrawal by Subject|0|||
130823395|NCT01932788|470982275|FG001|Overall Study|Withdrawal by Subject|5|||
130823396|NCT01171677|470982276|FG000|Overall Study|Withdrawal by Subject|0|||
130823397|NCT01171677|470982277|FG001|Overall Study|Withdrawal by Subject|3|||
130823398|NCT01171677|470982276|FG000|Overall Study|Adverse Event|1|||
130823399|NCT01171677|470982277|FG001|Overall Study|Adverse Event|0|||
130823400|NCT01171677|470982276|FG000|Overall Study|completed <70% IntenSati classes|5|||
130823401|NCT01171677|470982277|FG001|Overall Study|completed <70% IntenSati classes|0|||
130823402|NCT01847443|470982278|FG000|Study Period 1|Withdrawal by Subject|0|||
130823403|NCT01847443|470982279|FG001|Study Period 1|Withdrawal by Subject|1|||
130823404|NCT01847443|470982280|FG002|Study Period 1|Withdrawal by Subject|0|||
130823405|NCT01847443|470982281|FG003|Study Period 1|Withdrawal by Subject|0|||
130823406|NCT01847443|470982278|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
130823407|NCT01847443|470982279|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
130823408|NCT01847443|470982280|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
130823409|NCT01847443|470982281|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
130823410|NCT01847443|470982278|FG000|Washout Period Before Study Period 2|Other reason|1|||
130823411|NCT01847443|470982279|FG001|Washout Period Before Study Period 2|Other reason|0|||
130823412|NCT01847443|470982280|FG002|Washout Period Before Study Period 2|Other reason|0|||
130823413|NCT01847443|470982281|FG003|Washout Period Before Study Period 2|Other reason|0|||
130823414|NCT01847443|470982278|FG000|Washout Period Before Study Period 3|Other reason|1|||
130823415|NCT01847443|470982279|FG001|Washout Period Before Study Period 3|Other reason|0|||
130823416|NCT01847443|470982280|FG002|Washout Period Before Study Period 3|Other reason|0|||
130823417|NCT01847443|470982281|FG003|Washout Period Before Study Period 3|Other reason|0|||
130823418|NCT01847443|470982278|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
130823419|NCT01847443|470982279|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
130823420|NCT01847443|470982280|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
130823421|NCT01847443|470982281|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
130823422|NCT01847443|470982278|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
130823423|NCT01847443|470982279|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
130823424|NCT01847443|470982280|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
130823425|NCT01847443|470982281|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
130823426|NCT03571971|470982282|FG000|Overall Study|Lost to Follow-up|2|||
130823427|NCT03571971|470982283|FG001|Overall Study|Lost to Follow-up|2|||
130823428|NCT03571971|470982282|FG000|Overall Study|Protocol Violation|2|||
130823429|NCT03571971|470982283|FG001|Overall Study|Protocol Violation|3|||
130823430|NCT03571971|470982282|FG000|Overall Study|Withdrawal by Subject|2|||
130823431|NCT03571971|470982283|FG001|Overall Study|Withdrawal by Subject|0|||
130823432|NCT03571971|470982282|FG000|Overall Study|Incomplete primary outcome data|2|||
130823433|NCT03571971|470982283|FG001|Overall Study|Incomplete primary outcome data|0|||
130823434|NCT02806414|470982291|FG000|Overall Study|Lost to Follow-up|2|||
130823435|NCT00038948|470982296|FG000|Overall Study|Adverse Event|131|||
130823436|NCT00038948|470982297|FG001|Overall Study|Adverse Event|43|||
130823437|NCT00038948|470982296|FG000|Overall Study|Lost to Follow-up|4|||
130823438|NCT00038948|470982297|FG001|Overall Study|Lost to Follow-up|4|||
130823439|NCT00038948|470982296|FG000|Overall Study|Nonmedical event|5|||
130823440|NCT00038948|470982297|FG001|Overall Study|Nonmedical event|7|||
130823441|NCT00038948|470982296|FG000|Overall Study|Withdrawal by Subject|23|||
130823442|NCT00038948|470982297|FG001|Overall Study|Withdrawal by Subject|10|||
130823443|NCT00038948|470982296|FG000|Overall Study|Protocol Violation|3|||
130823444|NCT00038948|470982297|FG001|Overall Study|Protocol Violation|7|||
130823445|NCT00038948|470982296|FG000|Overall Study|Lack of Efficacy|3|||
130823446|NCT00038948|470982297|FG001|Overall Study|Lack of Efficacy|6|||
130823447|NCT04472650|470983971|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
130823448|NCT04472650|470983972|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
130823449|NCT02651116|470983975|FG000|Overall Study|Adverse Event|0|||
130823450|NCT02651116|470983976|FG001|Overall Study|Adverse Event|1|||
130823451|NCT02651116|470983975|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
130823452|NCT02651116|470983976|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
130823453|NCT00041470|470983985|FG000|Overall Study|Loss of Funding|38|||
130823454|NCT01193101|470983989|FG000|Overall Study|Adverse Event|0|||
130823455|NCT01193101|470983990|FG001|Overall Study|Adverse Event|1|||
130823456|NCT01193101|470983991|FG002|Overall Study|Adverse Event|1|||
130823457|NCT01193101|470983992|FG003|Overall Study|Adverse Event|3|||
130823458|NCT01193101|470983989|FG000|Overall Study|Lack of Efficacy|3|||
130823459|NCT01193101|470983990|FG001|Overall Study|Lack of Efficacy|1|||
130823460|NCT01193101|470983991|FG002|Overall Study|Lack of Efficacy|0|||
130823461|NCT01193101|470983992|FG003|Overall Study|Lack of Efficacy|8|||
130823462|NCT01193101|470983989|FG000|Overall Study|Withdrawal by Subject|2|||
130823463|NCT01193101|470983990|FG001|Overall Study|Withdrawal by Subject|4|||
130823464|NCT01193101|470983991|FG002|Overall Study|Withdrawal by Subject|1|||
130823465|NCT01193101|470983992|FG003|Overall Study|Withdrawal by Subject|1|||
130823466|NCT01193101|470983989|FG000|Overall Study|Administrative problems|0|||
130823467|NCT01193101|470983990|FG001|Overall Study|Administrative problems|0|||
130823468|NCT01193101|470983991|FG002|Overall Study|Administrative problems|1|||
130823469|NCT01193101|470983992|FG003|Overall Study|Administrative problems|0|||
130823470|NCT01193101|470983989|FG000|Overall Study|Abnormal test procedure results|0|||
130823471|NCT01193101|470983990|FG001|Overall Study|Abnormal test procedure results|1|||
130823472|NCT01193101|470983991|FG002|Overall Study|Abnormal test procedure results|0|||
130823473|NCT01193101|470983992|FG003|Overall Study|Abnormal test procedure results|0|||
130823474|NCT02347085|470983995|FG000|Overall Study|Adverse Event|2|||
130823475|NCT02347085|470983995|FG000|Overall Study|Lack of Efficacy|1|||
130823476|NCT02347085|470983995|FG000|Overall Study|Withdrawal by Subject|4|||
130823477|NCT02347085|470983995|FG000|Overall Study|Lost to Follow-up|1|||
130823478|NCT02347085|470983995|FG000|Overall Study|Protocol Criteria|2|||
130823479|NCT04389866|470983997|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
130823480|NCT04389866|470983998|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
130823481|NCT00800982|470984002|FG000|Overall Study|Lost to Follow-up|1|||
130823482|NCT00800982|470984003|FG001|Overall Study|Lost to Follow-up|2|||
130823483|NCT00800982|470984002|FG000|Overall Study|Withdrawal by Subject|0|||
130823484|NCT00800982|470984003|FG001|Overall Study|Withdrawal by Subject|1|||
130823485|NCT00800982|470984002|FG000|Overall Study|Patient moved out of state|1|||
130823486|NCT00800982|470984003|FG001|Overall Study|Patient moved out of state|0|||
130823487|NCT01490918|470984004|FG000|Overall Study|Lost to Follow-up|2|||
130823488|NCT01490918|470984005|FG001|Overall Study|Lost to Follow-up|1|||
130823489|NCT01490918|470984006|FG002|Overall Study|Lost to Follow-up|0|||
130823490|NCT01490918|470984004|FG000|Overall Study|Withdrawal by Subject|7|||
130823491|NCT01490918|470984005|FG001|Overall Study|Withdrawal by Subject|8|||
130823492|NCT01490918|470984006|FG002|Overall Study|Withdrawal by Subject|3|||
130823493|NCT01490918|470984004|FG000|Overall Study|Adverse Event|0|||
130823494|NCT01490918|470984005|FG001|Overall Study|Adverse Event|0|||
130823495|NCT01490918|470984006|FG002|Overall Study|Adverse Event|1|||
130823496|NCT01490918|470984004|FG000|Overall Study|other cause|4|||
130823497|NCT01490918|470984005|FG001|Overall Study|other cause|5|||
130823498|NCT01490918|470984006|FG002|Overall Study|other cause|8|||
130823499|NCT00648037|470984009|FG000|Overall Study|Not Treated|1|||
130823500|NCT00648037|470984009|FG000|Overall Study|Withdrawal by Subject|1|||
130823501|NCT00648037|470984009|FG000|Overall Study|Adverse Event|11|||
130823502|NCT00648037|470984009|FG000|Overall Study|Relapse|2|||
130823503|NCT00648037|470984009|FG000|Overall Study|Other|1|||
130823504|NCT02967679|470984011|FG000|Overall Study|Adverse Event|1|||
130823505|NCT00600067|470984023|FG000|Overall Study|Adverse Event|0|||
130823506|NCT00600067|470984024|FG001|Overall Study|Adverse Event|1|||
130823507|NCT00600067|470984023|FG000|Overall Study|Lost to Follow-up|2|||
130823508|NCT00600067|470984024|FG001|Overall Study|Lost to Follow-up|3|||
130823509|NCT00600067|470984023|FG000|Overall Study|protocol non-compliance|0|||
130823510|NCT00600067|470984024|FG001|Overall Study|protocol non-compliance|3|||
130823511|NCT00600067|470984023|FG000|Overall Study|Lack of Efficacy|1|||
130823512|NCT00600067|470984024|FG001|Overall Study|Lack of Efficacy|0|||
130823513|NCT00003631|470984025|FG000|Overall Study|Patient not treated|1|||
130823514|NCT00003631|470984026|FG001|Overall Study|Patient not treated|0|||
130823515|NCT00003631|470984027|FG002|Overall Study|Patient not treated|1|||
130823516|NCT00003631|470984025|FG000|Overall Study|Protocol Violation|1|||
130823517|NCT00003631|470984026|FG001|Overall Study|Protocol Violation|0|||
130823518|NCT00003631|470984027|FG002|Overall Study|Protocol Violation|0|||
130823519|NCT00003631|470984025|FG000|Overall Study|Adverse Event|1|||
130823520|NCT00003631|470984026|FG001|Overall Study|Adverse Event|1|||
130823521|NCT00003631|470984027|FG002|Overall Study|Adverse Event|5|||
130823522|NCT00003631|470984025|FG000|Overall Study|Death|0|||
130823523|NCT00003631|470984026|FG001|Overall Study|Death|0|||
130823524|NCT00003631|470984027|FG002|Overall Study|Death|1|||
130823525|NCT00003631|470984025|FG000|Overall Study|Evaluable for toxicity only|0|||
130823526|NCT00003631|470984026|FG001|Overall Study|Evaluable for toxicity only|0|||
130823527|NCT00003631|470984027|FG002|Overall Study|Evaluable for toxicity only|2|||
130823528|NCT04339413|470984031|FG000|Overall Study|Reason Not Specified|2|||
130823529|NCT04339413|470984032|FG001|Overall Study|Reason Not Specified|7|||
130823530|NCT04339413|470984031|FG000|Overall Study|Study Terminated by Sponsor|30|||
130823531|NCT04339413|470984032|FG001|Overall Study|Study Terminated by Sponsor|33|||
130823532|NCT04339413|470984031|FG000|Overall Study|Progressive Disease|9|||
130823533|NCT04339413|470984032|FG001|Overall Study|Progressive Disease|6|||
130823534|NCT04339413|470984031|FG000|Overall Study|Withdrawal by Subject|9|||
130823535|NCT04339413|470984032|FG001|Overall Study|Withdrawal by Subject|10|||
130823536|NCT04339413|470984031|FG000|Overall Study|Physician Decision|3|||
130823537|NCT04339413|470984032|FG001|Overall Study|Physician Decision|1|||
130823538|NCT04339413|470984031|FG000|Overall Study|Death|2|||
130823539|NCT04339413|470984032|FG001|Overall Study|Death|0|||
130823540|NCT04339413|470984031|FG000|Overall Study|Adverse Event|3|||
130823541|NCT04339413|470984032|FG001|Overall Study|Adverse Event|0|||
130823542|NCT00699413|470984037|FG000|Overall Study|Withdrawal by Subject|0|||
130823543|NCT00699413|470984038|FG001|Overall Study|Withdrawal by Subject|2|||
130823544|NCT00699413|470984037|FG000|Overall Study|Study terminated by sponsor|4|||
130823545|NCT00699413|470984038|FG001|Overall Study|Study terminated by sponsor|2|||
130823546|NCT00251693|470984039|FG000|Overall Study|Adverse Event|17|||
130823547|NCT00251693|470984040|FG001|Overall Study|Adverse Event|9|||
130823548|NCT00251693|470984041|FG002|Overall Study|Adverse Event|9|||
130823549|NCT00251693|470984039|FG000|Overall Study|Protocol Violation|2|||
130823550|NCT00251693|470984040|FG001|Overall Study|Protocol Violation|0|||
130823551|NCT00251693|470984041|FG002|Overall Study|Protocol Violation|2|||
130823552|NCT00251693|470984039|FG000|Overall Study|Lost to Follow-up|12|||
130823553|NCT00251693|470984040|FG001|Overall Study|Lost to Follow-up|7|||
130823554|NCT00251693|470984041|FG002|Overall Study|Lost to Follow-up|8|||
130823555|NCT00251693|470984039|FG000|Overall Study|Withdrawal by Subject|11|||
130823556|NCT00251693|470984040|FG001|Overall Study|Withdrawal by Subject|17|||
130823557|NCT00251693|470984041|FG002|Overall Study|Withdrawal by Subject|14|||
130823558|NCT00251693|470984039|FG000|Overall Study|Lack of Efficacy|0|||
130823559|NCT00251693|470984040|FG001|Overall Study|Lack of Efficacy|1|||
130823560|NCT00251693|470984041|FG002|Overall Study|Lack of Efficacy|0|||
130823561|NCT00251693|470984039|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
130823562|NCT00251693|470984040|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
130823563|NCT00251693|470984041|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
130823564|NCT00251693|470984039|FG000|Overall Study|Noncompliant|0|||
130823565|NCT00251693|470984040|FG001|Overall Study|Noncompliant|0|||
130823566|NCT00251693|470984041|FG002|Overall Study|Noncompliant|2|||
130823567|NCT00251693|470984039|FG000|Overall Study|Possible Barrett's esophagus|3|||
130823568|NCT00251693|470984040|FG001|Overall Study|Possible Barrett's esophagus|5|||
130823569|NCT00251693|470984041|FG002|Overall Study|Possible Barrett's esophagus|2|||
130823570|NCT00251693|470984039|FG000|Overall Study|Subject request/subject unavailable|1|||
130823571|NCT00251693|470984040|FG001|Overall Study|Subject request/subject unavailable|2|||
130823572|NCT00251693|470984041|FG002|Overall Study|Subject request/subject unavailable|0|||
130823573|NCT00251693|470984039|FG000|Overall Study|Abnormal laboratory findings|0|||
130823574|NCT00251693|470984040|FG001|Overall Study|Abnormal laboratory findings|0|||
130823575|NCT00251693|470984041|FG002|Overall Study|Abnormal laboratory findings|1|||
130823576|NCT01284959|470984043|FG000|Overall Study|Withdrawal by Subject|1|||
130823577|NCT01284959|470984044|FG001|Overall Study|Withdrawal by Subject|0|||
130823578|NCT01284959|470984045|FG002|Overall Study|Withdrawal by Subject|0|||
130823579|NCT01284959|470984043|FG000|Overall Study|Adverse Event|0|||
130823580|NCT01284959|470984044|FG001|Overall Study|Adverse Event|0|||
130823581|NCT01284959|470984045|FG002|Overall Study|Adverse Event|1|||
130823582|NCT00401843|470984046|FG000|Overall Study|Achieved Complete Response|1|||
130823583|NCT00401843|470984047|FG001|Overall Study|Achieved Complete Response|5|||
130823584|NCT00401843|470984048|FG002|Overall Study|Achieved Complete Response|11|||
130823585|NCT00401843|470984046|FG000|Overall Study|Adverse Event|7|||
130823586|NCT00401843|470984047|FG001|Overall Study|Adverse Event|26|||
130823587|NCT00401843|470984048|FG002|Overall Study|Adverse Event|27|||
130823588|NCT00401843|470984046|FG000|Overall Study|Death|0|||
130823589|NCT00401843|470984047|FG001|Overall Study|Death|8|||
130823590|NCT00401843|470984048|FG002|Overall Study|Death|10|||
130823591|NCT00401843|470984046|FG000|Overall Study|Disease progression|10|||
130823592|NCT00401843|470984047|FG001|Overall Study|Disease progression|60|||
130823593|NCT00401843|470984048|FG002|Overall Study|Disease progression|49|||
130823594|NCT00401843|470984046|FG000|Overall Study|End of Study|1|||
130823595|NCT00401843|470984047|FG001|Overall Study|End of Study|1|||
130823596|NCT00401843|470984048|FG002|Overall Study|End of Study|2|||
130823597|NCT00401843|470984046|FG000|Overall Study|Lost to Follow-up|0|||
130823598|NCT00401843|470984047|FG001|Overall Study|Lost to Follow-up|0|||
130823599|NCT00401843|470984048|FG002|Overall Study|Lost to Follow-up|2|||
130823600|NCT00401843|470984046|FG000|Overall Study|Other Unspecified|0|||
130823601|NCT00401843|470984047|FG001|Overall Study|Other Unspecified|3|||
130823602|NCT00401843|470984048|FG002|Overall Study|Other Unspecified|5|||
130823603|NCT00401843|470984046|FG000|Overall Study|Physician Decision|0|||
130823604|NCT00401843|470984047|FG001|Overall Study|Physician Decision|16|||
130823605|NCT00401843|470984048|FG002|Overall Study|Physician Decision|10|||
130823606|NCT00401843|470984046|FG000|Overall Study|Protocol Violation|0|||
130823607|NCT00401843|470984047|FG001|Overall Study|Protocol Violation|0|||
130823608|NCT00401843|470984048|FG002|Overall Study|Protocol Violation|1|||
130823609|NCT00401843|470984046|FG000|Overall Study|Withdrawal by Subject|1|||
130823610|NCT00401843|470984047|FG001|Overall Study|Withdrawal by Subject|5|||
130823611|NCT00401843|470984048|FG002|Overall Study|Withdrawal by Subject|5|||
130823612|NCT00401843|470984046|FG000|Overall Study|Withdrawal of consent to study agent|1|||
130823613|NCT00401843|470984047|FG001|Overall Study|Withdrawal of consent to study agent|15|||
130823614|NCT00401843|470984048|FG002|Overall Study|Withdrawal of consent to study agent|17|||
130823615|NCT00401843|470984046|FG000|Overall Study|Randomized but not Treated|0|||
130823616|NCT00401843|470984047|FG001|Overall Study|Randomized but not Treated|2|||
130823617|NCT00401843|470984048|FG002|Overall Study|Randomized but not Treated|3|||
130823618|NCT00401843|470984046|FG000|Overall Study|Received incorrect treatment|0|||
130823619|NCT00401843|470984047|FG001|Overall Study|Received incorrect treatment|3|||
130823620|NCT00401843|470984048|FG002|Overall Study|Received incorrect treatment|0|||
130823621|NCT02103062|470984051|FG000|Overall Study|Adverse Event|1|||
130823622|NCT02103062|470984052|FG001|Overall Study|Adverse Event|2|||
130823623|NCT02103062|470984051|FG000|Overall Study|Progressive Disease|17|||
130823624|NCT02103062|470984052|FG001|Overall Study|Progressive Disease|20|||
130823625|NCT02103062|470984051|FG000|Overall Study|Death|0|||
130823626|NCT02103062|470984052|FG001|Overall Study|Death|1|||
130823627|NCT00120627|470984053|FG000|Overall Study|Withdrawal by Subject|5|||
130823628|NCT00120627|470984054|FG001|Overall Study|Withdrawal by Subject|5|||
130823629|NCT01508910|470984055|FG000|Treatment|Death|2|||
130823630|NCT01508910|470984056|FG001|Treatment|Death|3|||
130823631|NCT01508910|470984057|FG002|Treatment|Death|2|||
130823632|NCT01508910|470984058|FG003|Treatment|Death|0|||
130823633|NCT01508910|470984055|FG000|Treatment|Lost to Follow-up|0|||
130823634|NCT01508910|470984056|FG001|Treatment|Lost to Follow-up|0|||
130823635|NCT01508910|470984057|FG002|Treatment|Lost to Follow-up|2|||
130823636|NCT01508910|470984058|FG003|Treatment|Lost to Follow-up|1|||
130823637|NCT01508910|470984055|FG000|Treatment|Withdrawal by Subject|0|||
130823638|NCT01508910|470984056|FG001|Treatment|Withdrawal by Subject|1|||
130823639|NCT01508910|470984057|FG002|Treatment|Withdrawal by Subject|6|||
130823640|NCT01508910|470984058|FG003|Treatment|Withdrawal by Subject|1|||
130823641|NCT01508910|470984055|FG000|Treatment|Sponsor Decision|0|||
130823642|NCT01508910|470984056|FG001|Treatment|Sponsor Decision|0|||
130823643|NCT01508910|470984057|FG002|Treatment|Sponsor Decision|0|||
130823644|NCT01508910|470984058|FG003|Treatment|Sponsor Decision|1|||
130823645|NCT02030821|470984061|FG000|Overall Study|Physician Decision|2|||
130823646|NCT02030821|470984062|FG001|Overall Study|Physician Decision|2|||
130823647|NCT02030821|470984063|FG002|Overall Study|Physician Decision|5|||
130823648|NCT02030821|470984064|FG003|Overall Study|Physician Decision|2|||
130823649|NCT02737501|470984067|FG000|Randomized Phase|Died|41|||
130823650|NCT02737501|470984068|FG001|Randomized Phase|Died|29|||
130823651|NCT02737501|470984069|FG002|Randomized Phase|Died|0|||
130823652|NCT02737501|470984067|FG000|Randomized Phase|Withdrawal by Subject|16|||
130823653|NCT02737501|470984068|FG001|Randomized Phase|Withdrawal by Subject|6|||
130823654|NCT02737501|470984069|FG002|Randomized Phase|Withdrawal by Subject|0|||
130823655|NCT02737501|470984067|FG000|Randomized Phase|Lost to Follow-up|0|||
130823656|NCT02737501|470984068|FG001|Randomized Phase|Lost to Follow-up|1|||
130823657|NCT02737501|470984069|FG002|Randomized Phase|Lost to Follow-up|0|||
130823658|NCT02737501|470984067|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
130823659|NCT02737501|470984068|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
130823660|NCT02737501|470984069|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
130823661|NCT02737501|470984067|FG000|Randomized Phase|Reason not Specified|1|||
130823662|NCT02737501|470984068|FG001|Randomized Phase|Reason not Specified|1|||
130823663|NCT02737501|470984069|FG002|Randomized Phase|Reason not Specified|0|||
130823664|NCT02737501|470984067|FG000|Randomized Phase|Never Treated|1|||
130823665|NCT02737501|470984068|FG001|Randomized Phase|Never Treated|1|||
130823666|NCT02737501|470984069|FG002|Randomized Phase|Never Treated|0|||
130823667|NCT02737501|470984067|FG000|Crossover Phase|Died|0|||
130823668|NCT02737501|470984068|FG001|Crossover Phase|Died|0|||
130823669|NCT02737501|470984069|FG002|Crossover Phase|Died|22|||
130823670|NCT02737501|470984067|FG000|Crossover Phase|Withdrew Consent|0|||
130823671|NCT02737501|470984068|FG001|Crossover Phase|Withdrew Consent|0|||
130823672|NCT02737501|470984069|FG002|Crossover Phase|Withdrew Consent|9|||
130823673|NCT02737501|470984067|FG000|Crossover Phase|Physician Decision|0|||
130823674|NCT02737501|470984068|FG001|Crossover Phase|Physician Decision|0|||
130823675|NCT02737501|470984069|FG002|Crossover Phase|Physician Decision|1|||
130823676|NCT02737501|470984067|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
130823677|NCT02737501|470984068|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
130823678|NCT02737501|470984069|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
130823679|NCT00716274|470984070|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
130823680|NCT00716274|470984071|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130823681|NCT00716274|470984072|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130823682|NCT00716274|470984073|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130823683|NCT00716274|470984074|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130823684|NCT00716274|470984075|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130823685|NCT00716274|470984070|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
130823686|NCT00716274|470984071|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
130823687|NCT00716274|470984072|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
130823688|NCT00716274|470984073|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
130823689|NCT00716274|470984074|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
130823690|NCT00716274|470984075|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
130823691|NCT00716274|470984070|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
130823692|NCT00716274|470984071|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130823693|NCT00716274|470984072|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130823694|NCT00716274|470984073|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130823695|NCT00716274|470984074|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130823696|NCT00716274|470984075|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130823697|NCT00716274|470984070|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
130823698|NCT00716274|470984071|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
130823699|NCT00716274|470984072|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
130823700|NCT00716274|470984073|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
130823701|NCT00716274|470984074|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
130823702|NCT00716274|470984075|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
130823703|NCT00716274|470984070|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
130823704|NCT00716274|470984071|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
130823705|NCT00716274|470984072|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130823706|NCT00716274|470984073|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130823707|NCT00716274|470984074|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130823708|NCT00716274|470984075|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130823709|NCT00716274|470984070|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130823710|NCT00716274|470984071|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
130823711|NCT00716274|470984072|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130823712|NCT00716274|470984073|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130823713|NCT00716274|470984074|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130823714|NCT00716274|470984075|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130823715|NCT00716274|470984070|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130823716|NCT00716274|470984071|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130823717|NCT00716274|470984072|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
130823718|NCT00716274|470984073|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130823719|NCT00716274|470984074|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130823720|NCT00716274|470984075|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130823721|NCT00716274|470984070|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
130823722|NCT00716274|470984071|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
130823723|NCT00716274|470984072|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
130823724|NCT00716274|470984073|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
130823725|NCT00716274|470984074|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
130823726|NCT00716274|470984075|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
130823727|NCT00716274|470984070|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130823728|NCT00716274|470984071|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130823729|NCT00716274|470984072|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130823730|NCT00716274|470984073|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
130823731|NCT00716274|470984074|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
130823732|NCT00716274|470984075|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130823733|NCT00716274|470984070|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
130823734|NCT00716274|470984071|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
130823735|NCT00716274|470984072|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
130823736|NCT00716274|470984073|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
130823737|NCT00716274|470984074|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
130823738|NCT00716274|470984075|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
130823739|NCT04067492|470984076|FG000|Overall Study|Lost to Follow-up|0|||
130823740|NCT04067492|470984077|FG001|Overall Study|Lost to Follow-up|0|||
130823741|NCT04067492|470984078|FG002|Overall Study|Lost to Follow-up|0|||
130823742|NCT04067492|470984079|FG003|Overall Study|Lost to Follow-up|0|||
130823743|NCT04067492|470984080|FG004|Overall Study|Lost to Follow-up|0|||
130823744|NCT04067492|470984081|FG005|Overall Study|Lost to Follow-up|1|||
130823745|NCT04067492|470984076|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130823746|NCT04067492|470984077|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
130823747|NCT04067492|470984078|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130823748|NCT04067492|470984079|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130823749|NCT04067492|470984080|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130823750|NCT04067492|470984081|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130823751|NCT04067492|470984076|FG000|Overall Study|COVID-19 epidemiological situation|0|||
130823752|NCT04067492|470984077|FG001|Overall Study|COVID-19 epidemiological situation|0|||
130823753|NCT04067492|470984078|FG002|Overall Study|COVID-19 epidemiological situation|0|||
130823754|NCT04067492|470984079|FG003|Overall Study|COVID-19 epidemiological situation|1|||
130823755|NCT04067492|470984080|FG004|Overall Study|COVID-19 epidemiological situation|0|||
130823756|NCT04067492|470984081|FG005|Overall Study|COVID-19 epidemiological situation|0|||
130823757|NCT00833027|470984082|FG000|Overall Study|Adverse Event|33|||
130823758|NCT00833027|470984082|FG000|Overall Study|Death|1|||
130823759|NCT00833027|470984082|FG000|Overall Study|Lack of Efficacy|12|||
130823760|NCT00833027|470984082|FG000|Overall Study|Lost to Follow-up|24|||
130823761|NCT00833027|470984082|FG000|Overall Study|Protocol Violation|115|||
130823762|NCT00833027|470984082|FG000|Overall Study|Withdrawal by Subject|16|||
130823763|NCT00833027|470984082|FG000|Overall Study|Missing|10|||
130823764|NCT03092479|470984094|FG000|Overall Study|Lost to Follow-up|3|||
130823765|NCT03092479|470984095|FG001|Overall Study|Lost to Follow-up|2|||
130823766|NCT03092479|470984094|FG000|Overall Study|Withdrawal by Subject|4|||
130823767|NCT03092479|470984095|FG001|Overall Study|Withdrawal by Subject|0|||
130823768|NCT00543985|470984098|FG000|Overall Study|Withdrawal by Subject|4|||
130823769|NCT00444106|470984099|FG000|Overall Study|Lost to Follow-up|2|||
130823770|NCT00444106|470984100|FG001|Overall Study|Lost to Follow-up|1|||
130823771|NCT00444106|470984101|FG002|Overall Study|Lost to Follow-up|0|||
130823772|NCT00444106|470984099|FG000|Overall Study|Abnormal Test Procedure Results|0|||
130823773|NCT00444106|470984100|FG001|Overall Study|Abnormal Test Procedure Results|0|||
130823774|NCT00444106|470984101|FG002|Overall Study|Abnormal Test Procedure Results|1|||
130823775|NCT02015039|470984102|FG000|Overall Study|Not eligible|0|||
130823776|NCT02015039|470984103|FG001|Overall Study|Not eligible|1|||
130823777|NCT04046939|470984107|FG000|Primary Assessment Period|Adverse Event|1|||
130823778|NCT04046939|470984108|FG001|Primary Assessment Period|Adverse Event|0|||
130823779|NCT04046939|470984109|FG002|Primary Assessment Period|Adverse Event|0|||
130823780|NCT04046939|470984110|FG003|Primary Assessment Period|Adverse Event|0|||
130823781|NCT04046939|470984107|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
130823782|NCT04046939|470984108|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
130823783|NCT04046939|470984109|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
130823784|NCT04046939|470984110|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
130823785|NCT04046939|470984107|FG000|Primary Assessment Period|Physician Decision|0|||
130823786|NCT04046939|470984108|FG001|Primary Assessment Period|Physician Decision|0|||
130823787|NCT04046939|470984109|FG002|Primary Assessment Period|Physician Decision|1|||
130823788|NCT04046939|470984110|FG003|Primary Assessment Period|Physician Decision|0|||
130823789|NCT04046939|470984107|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
130823790|NCT04046939|470984108|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
130823791|NCT04046939|470984109|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
130823792|NCT04046939|470984110|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
130823793|NCT00403130|470984111|FG000|2 Years From Start of Treatment|Not Eligible|3|||
130823794|NCT00403130|470984111|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
130823795|NCT00403130|470984111|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
130823796|NCT00403130|470984111|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
130823797|NCT00806260|470984112|FG000|Period 1 (1 Day)|Adverse Event|0|||
130823798|NCT00806260|470984113|FG001|Period 1 (1 Day)|Adverse Event|0|||
130823799|NCT00806260|470984114|FG002|Period 1 (1 Day)|Adverse Event|0|||
130823800|NCT00806260|470984115|FG003|Period 1 (1 Day)|Adverse Event|0|||
130823801|NCT00806260|470984116|FG004|Period 1 (1 Day)|Adverse Event|3|||
130823802|NCT00806260|470984117|FG005|Period 1 (1 Day)|Adverse Event|0|||
130823803|NCT00806260|470984112|FG000|Period 2|Adverse Event|0|||
130823804|NCT00806260|470984113|FG001|Period 2|Adverse Event|0|||
130823805|NCT00806260|470984114|FG002|Period 2|Adverse Event|0|||
130823806|NCT00806260|470984115|FG003|Period 2|Adverse Event|1|||
130823807|NCT00806260|470984116|FG004|Period 2|Adverse Event|0|||
130823808|NCT00806260|470984117|FG005|Period 2|Adverse Event|0|||
130823809|NCT00806260|470984112|FG000|Period 2|Protocol Violation|1|||
130823810|NCT00806260|470984113|FG001|Period 2|Protocol Violation|0|||
130823811|NCT00806260|470984114|FG002|Period 2|Protocol Violation|1|||
130823812|NCT00806260|470984115|FG003|Period 2|Protocol Violation|0|||
130823813|NCT00806260|470984116|FG004|Period 2|Protocol Violation|0|||
130823814|NCT00806260|470984117|FG005|Period 2|Protocol Violation|0|||
130823815|NCT00806260|470984112|FG000|Period 2|Need to take concomitant medication|1|||
130823816|NCT00806260|470984113|FG001|Period 2|Need to take concomitant medication|0|||
130823817|NCT00806260|470984114|FG002|Period 2|Need to take concomitant medication|0|||
130823818|NCT00806260|470984115|FG003|Period 2|Need to take concomitant medication|0|||
130823819|NCT00806260|470984116|FG004|Period 2|Need to take concomitant medication|0|||
130823820|NCT00806260|470984117|FG005|Period 2|Need to take concomitant medication|0|||
130823821|NCT00806260|470984112|FG000|Period 2|sponsor request|0|||
130823822|NCT00806260|470984113|FG001|Period 2|sponsor request|0|||
130823823|NCT00806260|470984114|FG002|Period 2|sponsor request|1|||
130823824|NCT00806260|470984115|FG003|Period 2|sponsor request|1|||
130823825|NCT00806260|470984116|FG004|Period 2|sponsor request|0|||
130823826|NCT00806260|470984117|FG005|Period 2|sponsor request|0|||
130823827|NCT00806260|470984112|FG000|Period 3|Protocol Violation|0|||
130823828|NCT00806260|470984113|FG001|Period 3|Protocol Violation|1|||
130823829|NCT00806260|470984114|FG002|Period 3|Protocol Violation|1|||
130823830|NCT00806260|470984115|FG003|Period 3|Protocol Violation|0|||
130823831|NCT00806260|470984116|FG004|Period 3|Protocol Violation|0|||
130823832|NCT00806260|470984117|FG005|Period 3|Protocol Violation|0|||
130823833|NCT00806260|470984112|FG000|Period 3|Pregnancy|1|||
130823834|NCT00806260|470984113|FG001|Period 3|Pregnancy|0|||
130823835|NCT00806260|470984114|FG002|Period 3|Pregnancy|0|||
130823836|NCT00806260|470984115|FG003|Period 3|Pregnancy|0|||
130823837|NCT00806260|470984116|FG004|Period 3|Pregnancy|0|||
130823838|NCT00806260|470984117|FG005|Period 3|Pregnancy|0|||
130823839|NCT00237042|470984120|FG000|Treatment|Became ineligible post-randomization|0|||
130823840|NCT00237042|470984121|FG001|Treatment|Became ineligible post-randomization|1|||
130823841|NCT00237042|470984122|FG002|Treatment|Became ineligible post-randomization|16|||
130823842|NCT00237042|470984120|FG000|Treatment|Moved out of state|1|||
130823843|NCT00237042|470984121|FG001|Treatment|Moved out of state|1|||
130823844|NCT00237042|470984122|FG002|Treatment|Moved out of state|1|||
130823845|NCT00237042|470984120|FG000|Treatment|Completed no treatment|5|||
130823846|NCT00237042|470984121|FG001|Treatment|Completed no treatment|5|||
130823847|NCT00237042|470984122|FG002|Treatment|Completed no treatment|21|||
130823848|NCT00237042|470984120|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
130823849|NCT00237042|470984121|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
130823850|NCT00237042|470984122|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
130823851|NCT00237042|470984120|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
130823852|NCT00237042|470984121|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
130823853|NCT00237042|470984122|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
130823854|NCT01897532|470984127|FG000|Discontinuation From Treatment|Not Treated|7|||
130823855|NCT01897532|470984128|FG001|Discontinuation From Treatment|Not Treated|5|||
130823856|NCT01897532|470984127|FG000|Discontinuation From Treatment|Other reason than specified|196|||
130823857|NCT01897532|470984128|FG001|Discontinuation From Treatment|Other reason than specified|176|||
130823858|NCT01897532|470984127|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
130823859|NCT01897532|470984128|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
130823860|NCT01897532|470984127|FG000|Discontinuation From Treatment|Non compliance|24|||
130823861|NCT01897532|470984128|FG001|Discontinuation From Treatment|Non compliance|15|||
130823862|NCT01897532|470984127|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
130823863|NCT01897532|470984128|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
130823864|NCT01897532|470984127|FG000|Discontinuation From Trial|Not Treated|7|||
130823865|NCT01897532|470984128|FG001|Discontinuation From Trial|Not Treated|5|||
130823866|NCT01897532|470984127|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
130823867|NCT01897532|470984128|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
130823868|NCT01074931|470984129|FG000|Overall Study|Economic reasons|1|||
130823869|NCT01074931|470984129|FG000|Overall Study|Death|5|||
130823870|NCT03132467|470984130|FG000|Overall Study|Adverse Event|2|||
130823871|NCT03132467|470984130|FG000|Overall Study|Withdrawal by Subject|2|||
130823872|NCT02670473|470984133|FG000|Overall Study|Withdrawal by Subject|1|||
130823873|NCT05223673|470984134|FG000|Overall Study|Protocol Violation|1|||
130823874|NCT05223673|470984134|FG000|Overall Study|Study termination|6|||
130823875|NCT03559270|470984135|FG000|Overall Study|Adverse Event|6|||
130823876|NCT03559270|470984136|FG001|Overall Study|Adverse Event|5|||
130823877|NCT03559270|470984137|FG002|Overall Study|Adverse Event|3|||
130823878|NCT03559270|470984138|FG003|Overall Study|Adverse Event|0|||
130823879|NCT03559270|470984135|FG000|Overall Study|Lack of Efficacy|34|||
130823880|NCT03559270|470984136|FG001|Overall Study|Lack of Efficacy|52|||
130823881|NCT03559270|470984137|FG002|Overall Study|Lack of Efficacy|37|||
130823882|NCT03559270|470984138|FG003|Overall Study|Lack of Efficacy|2|||
130823883|NCT03559270|470984135|FG000|Overall Study|Death|0|||
130823884|NCT03559270|470984136|FG001|Overall Study|Death|2|||
130823885|NCT03559270|470984137|FG002|Overall Study|Death|0|||
130823886|NCT03559270|470984138|FG003|Overall Study|Death|0|||
130823887|NCT03559270|470984135|FG000|Overall Study|Lost to Follow-up|16|||
130823888|NCT03559270|470984136|FG001|Overall Study|Lost to Follow-up|4|||
130823889|NCT03559270|470984137|FG002|Overall Study|Lost to Follow-up|12|||
130823890|NCT03559270|470984138|FG003|Overall Study|Lost to Follow-up|3|||
130823891|NCT03559270|470984135|FG000|Overall Study|Sponsor Decision|38|||
130823892|NCT03559270|470984136|FG001|Overall Study|Sponsor Decision|31|||
130823893|NCT03559270|470984137|FG002|Overall Study|Sponsor Decision|35|||
130823894|NCT03559270|470984138|FG003|Overall Study|Sponsor Decision|18|||
130823895|NCT03559270|470984135|FG000|Overall Study|Withdrawal by Subject|19|||
130823896|NCT03559270|470984136|FG001|Overall Study|Withdrawal by Subject|21|||
130823897|NCT03559270|470984137|FG002|Overall Study|Withdrawal by Subject|18|||
130823898|NCT03559270|470984138|FG003|Overall Study|Withdrawal by Subject|7|||
130823899|NCT03559270|470984135|FG000|Overall Study|Physician Decision|3|||
130823900|NCT03559270|470984136|FG001|Overall Study|Physician Decision|2|||
130823901|NCT03559270|470984137|FG002|Overall Study|Physician Decision|1|||
130823902|NCT03559270|470984138|FG003|Overall Study|Physician Decision|0|||
130823903|NCT03559270|470984135|FG000|Overall Study|Pregnancy|0|||
130823904|NCT03559270|470984136|FG001|Overall Study|Pregnancy|1|||
130823905|NCT03559270|470984137|FG002|Overall Study|Pregnancy|0|||
130823906|NCT03559270|470984138|FG003|Overall Study|Pregnancy|0|||
130823907|NCT03559270|470984135|FG000|Overall Study|Protocol Violation|1|||
130823908|NCT03559270|470984136|FG001|Overall Study|Protocol Violation|0|||
130823909|NCT03559270|470984137|FG002|Overall Study|Protocol Violation|2|||
130823910|NCT03559270|470984138|FG003|Overall Study|Protocol Violation|0|||
130823911|NCT01669902|470986004|FG000|Overall Study|Adverse Event|11|||
130823912|NCT01669902|470986004|FG000|Overall Study|Lack of Efficacy|10|||
130823913|NCT01669902|470986004|FG000|Overall Study|Other|8|||
130823914|NCT01535287|470986007|FG000|Overall Study|drug not prepared in time|5|||
130823915|NCT01535287|470986008|FG001|Overall Study|drug not prepared in time|6|||
130823916|NCT00551031|470986011|FG000|Overall Study|Adverse Event|0|||
130823917|NCT00551031|470986012|FG001|Overall Study|Adverse Event|1|||
130823918|NCT00551031|470986013|FG002|Overall Study|Adverse Event|0|||
130823919|NCT00551031|470986014|FG003|Overall Study|Adverse Event|0|||
130823920|NCT00551031|470986015|FG004|Overall Study|Adverse Event|0|||
130823921|NCT00551031|470986011|FG000|Overall Study|Protocol Violation|1|||
130823922|NCT00551031|470986012|FG001|Overall Study|Protocol Violation|1|||
130823923|NCT00551031|470986013|FG002|Overall Study|Protocol Violation|0|||
130823924|NCT00551031|470986014|FG003|Overall Study|Protocol Violation|0|||
130823925|NCT00551031|470986015|FG004|Overall Study|Protocol Violation|0|||
130823926|NCT00551031|470986011|FG000|Overall Study|Lost to Follow-up|0|||
130823927|NCT00551031|470986012|FG001|Overall Study|Lost to Follow-up|1|||
130823928|NCT00551031|470986013|FG002|Overall Study|Lost to Follow-up|0|||
130823929|NCT00551031|470986014|FG003|Overall Study|Lost to Follow-up|1|||
130823930|NCT00551031|470986015|FG004|Overall Study|Lost to Follow-up|1|||
130823931|NCT00551031|470986011|FG000|Overall Study|Withdrawal by Subject|0|||
130823932|NCT00551031|470986012|FG001|Overall Study|Withdrawal by Subject|4|||
130823933|NCT00551031|470986013|FG002|Overall Study|Withdrawal by Subject|1|||
130823934|NCT00551031|470986014|FG003|Overall Study|Withdrawal by Subject|2|||
130823935|NCT00551031|470986015|FG004|Overall Study|Withdrawal by Subject|0|||
130823936|NCT00551031|470986011|FG000|Overall Study|Serious Adverse Event|0|||
130823937|NCT00551031|470986012|FG001|Overall Study|Serious Adverse Event|2|||
130823938|NCT00551031|470986013|FG002|Overall Study|Serious Adverse Event|1|||
130823939|NCT00551031|470986014|FG003|Overall Study|Serious Adverse Event|0|||
130823940|NCT00551031|470986015|FG004|Overall Study|Serious Adverse Event|0|||
130823941|NCT00551031|470986011|FG000|Overall Study|Did not receive vaccine|1|||
130823942|NCT00551031|470986012|FG001|Overall Study|Did not receive vaccine|2|||
130823943|NCT00551031|470986013|FG002|Overall Study|Did not receive vaccine|0|||
130823944|NCT00551031|470986014|FG003|Overall Study|Did not receive vaccine|0|||
130823945|NCT00551031|470986015|FG004|Overall Study|Did not receive vaccine|0|||
130823946|NCT04567524|470986016|FG000|Overall Study|Adverse Event|1|||
130823947|NCT04567524|470986017|FG001|Overall Study|Adverse Event|1|||
130823948|NCT04567524|470986018|FG002|Overall Study|Adverse Event|0|||
130823949|NCT04567524|470986019|FG003|Overall Study|Adverse Event|0|||
130823950|NCT04567524|470986016|FG000|Overall Study|Withdrawal by Subject|2|||
130823951|NCT04567524|470986017|FG001|Overall Study|Withdrawal by Subject|0|||
130823952|NCT04567524|470986018|FG002|Overall Study|Withdrawal by Subject|0|||
130823953|NCT04567524|470986019|FG003|Overall Study|Withdrawal by Subject|1|||
130823954|NCT02078752|470986029|FG000|Overall Study|Death|0|||
130823955|NCT02078752|470986030|FG001|Overall Study|Death|3|||
130823956|NCT02078752|470986031|FG002|Overall Study|Death|0|||
130823957|NCT02078752|470986032|FG003|Overall Study|Death|0|||
130823958|NCT02078752|470986033|FG004|Overall Study|Death|0|||
130823959|NCT02078752|470986034|FG005|Overall Study|Death|1|||
130823960|NCT02078752|470986035|FG006|Overall Study|Death|0|||
130823961|NCT02078752|470986036|FG007|Overall Study|Death|1|||
130823962|NCT02078752|470986037|FG008|Overall Study|Death|0|||
130823963|NCT02078752|470986038|FG009|Overall Study|Death|4|||
130823964|NCT02078752|470986029|FG000|Overall Study|Lost to Follow-up|1|||
130823965|NCT02078752|470986030|FG001|Overall Study|Lost to Follow-up|0|||
130823966|NCT02078752|470986031|FG002|Overall Study|Lost to Follow-up|0|||
130823967|NCT02078752|470986032|FG003|Overall Study|Lost to Follow-up|1|||
130823968|NCT02078752|470986033|FG004|Overall Study|Lost to Follow-up|0|||
130823969|NCT02078752|470986034|FG005|Overall Study|Lost to Follow-up|0|||
130823970|NCT02078752|470986035|FG006|Overall Study|Lost to Follow-up|0|||
130823971|NCT02078752|470986036|FG007|Overall Study|Lost to Follow-up|0|||
130823972|NCT02078752|470986037|FG008|Overall Study|Lost to Follow-up|0|||
130823973|NCT02078752|470986038|FG009|Overall Study|Lost to Follow-up|0|||
130823974|NCT02078752|470986029|FG000|Overall Study|Withdrawal by Subject|1|||
130823975|NCT02078752|470986030|FG001|Overall Study|Withdrawal by Subject|1|||
130823976|NCT02078752|470986031|FG002|Overall Study|Withdrawal by Subject|1|||
130823977|NCT02078752|470986032|FG003|Overall Study|Withdrawal by Subject|1|||
130823978|NCT02078752|470986033|FG004|Overall Study|Withdrawal by Subject|0|||
130823979|NCT02078752|470986034|FG005|Overall Study|Withdrawal by Subject|3|||
130823980|NCT02078752|470986035|FG006|Overall Study|Withdrawal by Subject|2|||
130823981|NCT02078752|470986036|FG007|Overall Study|Withdrawal by Subject|1|||
130823982|NCT02078752|470986037|FG008|Overall Study|Withdrawal by Subject|0|||
130823983|NCT02078752|470986038|FG009|Overall Study|Withdrawal by Subject|1|||
130823984|NCT02078752|470986029|FG000|Overall Study|Other|0|||
130823985|NCT02078752|470986030|FG001|Overall Study|Other|3|||
130823986|NCT02078752|470986031|FG002|Overall Study|Other|0|||
130823987|NCT02078752|470986032|FG003|Overall Study|Other|0|||
130823988|NCT02078752|470986033|FG004|Overall Study|Other|1|||
130823989|NCT02078752|470986034|FG005|Overall Study|Other|0|||
130823990|NCT02078752|470986035|FG006|Overall Study|Other|0|||
130823991|NCT02078752|470986036|FG007|Overall Study|Other|1|||
130823992|NCT02078752|470986037|FG008|Overall Study|Other|0|||
130823993|NCT02078752|470986038|FG009|Overall Study|Other|0|||
130823994|NCT02078752|470986029|FG000|Overall Study|Study terminated by sponsor|0|||
130823995|NCT02078752|470986030|FG001|Overall Study|Study terminated by sponsor|0|||
130823996|NCT02078752|470986031|FG002|Overall Study|Study terminated by sponsor|0|||
130823997|NCT02078752|470986032|FG003|Overall Study|Study terminated by sponsor|0|||
130823998|NCT02078752|470986033|FG004|Overall Study|Study terminated by sponsor|0|||
130823999|NCT02078752|470986034|FG005|Overall Study|Study terminated by sponsor|0|||
130824000|NCT02078752|470986035|FG006|Overall Study|Study terminated by sponsor|0|||
130824001|NCT02078752|470986036|FG007|Overall Study|Study terminated by sponsor|0|||
130824002|NCT02078752|470986037|FG008|Overall Study|Study terminated by sponsor|0|||
130824003|NCT02078752|470986038|FG009|Overall Study|Study terminated by sponsor|5|||
130824004|NCT02383862|470986045|FG000|3 Month Follow up|Lost to Follow-up|23|||
130824005|NCT02383862|470986046|FG001|3 Month Follow up|Lost to Follow-up|21|||
130824006|NCT01833494|470986047|FG000|Overall Study|Adverse Event|24|||
130824007|NCT01833494|470986047|FG000|Overall Study|Physician Decision|6|||
130824008|NCT01833494|470986047|FG000|Overall Study|Withdrawal by Subject|6|||
130824009|NCT01833494|470986047|FG000|Overall Study|Decrease in serum phosphorus|4|||
130824010|NCT01833494|470986047|FG000|Overall Study|Decrease in serum calcium|4|||
130824011|NCT01833494|470986047|FG000|Overall Study|Increase in serum ferritin|1|||
130824012|NCT01694433|470986048|FG000|Overall Study|Adverse Event|7|||
130824013|NCT01694433|470986049|FG001|Overall Study|Adverse Event|0|||
130824014|NCT01694433|470986048|FG000|Overall Study|Physician Decision|1|||
130824015|NCT01694433|470986049|FG001|Overall Study|Physician Decision|0|||
130824016|NCT01694433|470986048|FG000|Overall Study|Withdrawal by Subject|3|||
130824017|NCT01694433|470986049|FG001|Overall Study|Withdrawal by Subject|4|||
130824018|NCT00374595|470986052|FG000|Overall Study|Death|23|||
130824019|NCT00374595|470986052|FG000|Overall Study|Withdrawal by Subject|39|||
130824020|NCT00374595|470986052|FG000|Overall Study|Lost to Follow-up|3|||
130824021|NCT00374595|470986052|FG000|Overall Study|too much time commitment|1|||
130824022|NCT00374595|470986052|FG000|Overall Study|transfer care to other clinical site|1|||
130824023|NCT00374595|470986052|FG000|Overall Study|relocation|3|||
130824024|NCT03745768|470986054|FG000|Overall Study|discontinued study|2|||
130824025|NCT03745768|470986055|FG001|Overall Study|discontinued study|0|||
130824026|NCT00616642|470986057|FG000|Overall Study|Withdrawal by Subject|0|||
130824027|NCT00616642|470986058|FG001|Overall Study|Withdrawal by Subject|1|||
130824028|NCT01023217|470986069|FG000|Overall Study|Withdrawal by Subject|1|||
130824029|NCT01023217|470986070|FG001|Overall Study|Withdrawal by Subject|0|||
130824030|NCT00589797|470986071|FG000|Overall Study|Death|1|||
130824031|NCT00589797|470986072|FG001|Overall Study|Death|0|||
130824032|NCT00589797|470986071|FG000|Overall Study|Lost to Follow-up|12|||
130824033|NCT00589797|470986072|FG001|Overall Study|Lost to Follow-up|9|||
130824034|NCT00589797|470986071|FG000|Overall Study|Physician Decision|8|||
130824035|NCT00589797|470986072|FG001|Overall Study|Physician Decision|3|||
130824036|NCT00589797|470986071|FG000|Overall Study|Withdrawal by Subject|6|||
130824037|NCT00589797|470986072|FG001|Overall Study|Withdrawal by Subject|5|||
130824038|NCT00589797|470986071|FG000|Overall Study|Non-Randomized Training Subjects|46|||
130824039|NCT00589797|470986072|FG001|Overall Study|Non-Randomized Training Subjects|6|||
130824040|NCT01673646|470986076|FG000|Overall Study|Adverse Event|2|||
130824041|NCT01673646|470986077|FG001|Overall Study|Adverse Event|1|||
130824042|NCT01673646|470986078|FG002|Overall Study|Adverse Event|1|||
130824043|NCT01673646|470986076|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130824044|NCT01673646|470986077|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130824045|NCT01673646|470986078|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130824046|NCT01673646|470986076|FG000|Overall Study|Condition no longer requires study drug|0|||
130824047|NCT01673646|470986077|FG001|Overall Study|Condition no longer requires study drug|1|||
130824048|NCT01673646|470986078|FG002|Overall Study|Condition no longer requires study drug|0|||
130824049|NCT01673646|470986076|FG000|Overall Study|Withdrawal by Subject|0|||
130824050|NCT01673646|470986077|FG001|Overall Study|Withdrawal by Subject|2|||
130824051|NCT01673646|470986078|FG002|Overall Study|Withdrawal by Subject|2|||
130824052|NCT01673646|470986076|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
130824053|NCT01673646|470986077|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
130824054|NCT01673646|470986078|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
130824055|NCT01881009|470986079|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
130824056|NCT01881009|470986080|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
130824057|NCT03064074|470986081|FG000|Overall Study|Physician Decision|0|||
130824058|NCT03064074|470986082|FG001|Overall Study|Physician Decision|0|||
130824059|NCT03064074|470986083|FG002|Overall Study|Physician Decision|0|||
130824060|NCT03064074|470986084|FG003|Overall Study|Physician Decision|1|||
130824061|NCT02457247|470986088|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
130824062|NCT02457247|470986089|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
130824063|NCT02457247|470986090|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
130824064|NCT02457247|470986091|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
130824065|NCT02457247|470986088|FG000|Period 1|Significant Protocol Deviation|1|||
130824066|NCT02457247|470986089|FG001|Period 1|Significant Protocol Deviation|1|||
130824067|NCT02457247|470986090|FG002|Period 1|Significant Protocol Deviation|0|||
130824068|NCT02457247|470986091|FG003|Period 1|Significant Protocol Deviation|0|||
130824069|NCT02457247|470986088|FG000|Period 1|Voluntary Withdrawal|1|||
130824070|NCT02457247|470986089|FG001|Period 1|Voluntary Withdrawal|0|||
130824071|NCT02457247|470986090|FG002|Period 1|Voluntary Withdrawal|0|||
130824072|NCT02457247|470986091|FG003|Period 1|Voluntary Withdrawal|0|||
130824073|NCT02457247|470986088|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
130824074|NCT02457247|470986089|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
130824075|NCT02457247|470986090|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
130824076|NCT02457247|470986091|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
130824077|NCT02457247|470986088|FG000|Period 2|Significant Protocol Deviation|1|||
130824078|NCT02457247|470986089|FG001|Period 2|Significant Protocol Deviation|0|||
130824079|NCT02457247|470986090|FG002|Period 2|Significant Protocol Deviation|0|||
130824080|NCT02457247|470986091|FG003|Period 2|Significant Protocol Deviation|0|||
130824081|NCT02457247|470986088|FG000|Period 2|Lost to Follow-up|0|||
130824082|NCT02457247|470986089|FG001|Period 2|Lost to Follow-up|1|||
130824083|NCT02457247|470986090|FG002|Period 2|Lost to Follow-up|0|||
130824084|NCT02457247|470986091|FG003|Period 2|Lost to Follow-up|0|||
130824085|NCT02457247|470986088|FG000|Period 2|Voluntary Withdrawal|1|||
130824086|NCT02457247|470986089|FG001|Period 2|Voluntary Withdrawal|1|||
130824087|NCT02457247|470986090|FG002|Period 2|Voluntary Withdrawal|0|||
130824088|NCT02457247|470986091|FG003|Period 2|Voluntary Withdrawal|0|||
130824089|NCT01061385|470986092|FG000|Overall Study|Lost to Follow-up|1|||
130824090|NCT01061385|470986093|FG001|Overall Study|Lost to Follow-up|0|||
130824091|NCT01061385|470986092|FG000|Overall Study|subject decision not related to AE|0|||
130824092|NCT01061385|470986093|FG001|Overall Study|subject decision not related to AE|1|||
130824093|NCT01492088|470986094|FG000|Overall Study|Withdrawal by Patient|0|||
130824094|NCT01492088|470986095|FG001|Overall Study|Withdrawal by Patient|2|||
130824095|NCT01492088|470986096|FG002|Overall Study|Withdrawal by Patient|0|||
130824096|NCT01492088|470986094|FG000|Overall Study|Death|1|||
130824097|NCT01492088|470986095|FG001|Overall Study|Death|6|||
130824098|NCT01492088|470986096|FG002|Overall Study|Death|2|||
130824099|NCT01492088|470986094|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
130824100|NCT01492088|470986095|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
130824101|NCT01492088|470986096|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
130824102|NCT01492088|470986094|FG000|Overall Study|Alive at Last Follow-up|0|||
130824103|NCT01492088|470986095|FG001|Overall Study|Alive at Last Follow-up|6|||
130824104|NCT01492088|470986096|FG002|Overall Study|Alive at Last Follow-up|11|||
130824105|NCT00533429|470986097|FG000|Overall Study|Adverse Event|3|||
130824106|NCT00533429|470986098|FG001|Overall Study|Adverse Event|1|||
130824107|NCT00533429|470986097|FG000|Overall Study|Death|1|||
130824108|NCT00533429|470986098|FG001|Overall Study|Death|0|||
130824109|NCT00533429|470986097|FG000|Overall Study|Withdrawal by Subject|2|||
130824110|NCT00533429|470986098|FG001|Overall Study|Withdrawal by Subject|0|||
130824111|NCT00533429|470986097|FG000|Overall Study|Progressive Disease|12|||
130824112|NCT00533429|470986098|FG001|Overall Study|Progressive Disease|13|||
130824113|NCT00533429|470986097|FG000|Overall Study|Symptomatic deterioration|1|||
130824114|NCT00533429|470986098|FG001|Overall Study|Symptomatic deterioration|2|||
130824115|NCT01464879|470986099|FG000|Overall Study|Physician Decision|1|||
130824116|NCT01464879|470986099|FG000|Overall Study|Non-compliance|1|||
130824117|NCT02230189|470986106|FG000|Overall Study|Withdrawal by Subject|3|||
130824118|NCT02230189|470986107|FG001|Overall Study|Withdrawal by Subject|0|||
130824119|NCT02230189|470986108|FG002|Overall Study|Withdrawal by Subject|1|||
130824120|NCT02230189|470986106|FG000|Overall Study|Lost to Follow-up|1|||
130824121|NCT02230189|470986107|FG001|Overall Study|Lost to Follow-up|0|||
130824122|NCT02230189|470986108|FG002|Overall Study|Lost to Follow-up|0|||
130824123|NCT02230189|470986106|FG000|Overall Study|Physician Decision|1|||
130824124|NCT02230189|470986107|FG001|Overall Study|Physician Decision|0|||
130824125|NCT02230189|470986108|FG002|Overall Study|Physician Decision|0|||
130824126|NCT03824392|470986109|FG000|Overall Study|Adverse Event|1|||
130824127|NCT03824392|470986110|FG001|Overall Study|Adverse Event|0|||
130824128|NCT03824392|470986111|FG002|Overall Study|Adverse Event|0|||
130824129|NCT03824392|470986112|FG003|Overall Study|Adverse Event|0|||
130824130|NCT03824392|470986109|FG000|Overall Study|Investigator Decision|0|||
130824131|NCT03824392|470986110|FG001|Overall Study|Investigator Decision|1|||
130824132|NCT03824392|470986111|FG002|Overall Study|Investigator Decision|0|||
130824133|NCT03824392|470986112|FG003|Overall Study|Investigator Decision|0|||
130824134|NCT03824392|470986109|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
130824135|NCT03824392|470986110|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
130824136|NCT03824392|470986111|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
130824137|NCT03824392|470986112|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
130824138|NCT01887717|470986113|FG000|Overall Study|Withdrawal by Subject|1|||
130824139|NCT01887717|470986114|FG001|Overall Study|Withdrawal by Subject|7|||
130824140|NCT01887717|470986113|FG000|Overall Study|Physician Decision|0|||
130824141|NCT01887717|470986114|FG001|Overall Study|Physician Decision|2|||
130824142|NCT01887717|470986113|FG000|Overall Study|Administrative reasons|5|||
130824143|NCT01887717|470986114|FG001|Overall Study|Administrative reasons|2|||
130824144|NCT00244621|470986115|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130824145|NCT00244621|470986116|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130824146|NCT00244621|470986117|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
130824147|NCT00244621|470986115|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
130824148|NCT00244621|470986116|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
130824149|NCT00244621|470986117|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130824150|NCT00244621|470986115|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130824151|NCT00244621|470986116|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
130824152|NCT00244621|470986117|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
130824153|NCT00244621|470986115|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
130824154|NCT00244621|470986116|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
130824155|NCT00244621|470986117|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
130824156|NCT00244621|470986115|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130824157|NCT00244621|470986116|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
130824158|NCT00244621|470986117|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
130824159|NCT00244621|470986115|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
130824160|NCT00244621|470986116|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130824161|NCT00244621|470986117|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
130824162|NCT00244621|470986115|FG000|Open-label Treatment Period|Adverse Event|0|||
130824163|NCT00244621|470986116|FG001|Open-label Treatment Period|Adverse Event|0|||
130824164|NCT00244621|470986117|FG002|Open-label Treatment Period|Adverse Event|1|||
130824165|NCT00244621|470986115|FG000|Open-label Treatment Period|Moved abroad|0|||
130824166|NCT00244621|470986116|FG001|Open-label Treatment Period|Moved abroad|0|||
130824167|NCT00244621|470986117|FG002|Open-label Treatment Period|Moved abroad|1|||
130824168|NCT02834819|470986118|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
130824169|NCT02834819|470986119|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
130824170|NCT03465722|470986122|FG000|Overall Study|Withdrawal by Subject|21|||
130824171|NCT03465722|470986123|FG001|Overall Study|Withdrawal by Subject|14|||
130824172|NCT03465722|470986122|FG000|Overall Study|Death|89|||
130824173|NCT03465722|470986123|FG001|Overall Study|Death|87|||
130824174|NCT03465722|470986122|FG000|Overall Study|Lost to Follow-up|5|||
130824175|NCT03465722|470986123|FG001|Overall Study|Lost to Follow-up|3|||
130824176|NCT03465722|470986122|FG000|Overall Study|Administrative/Other|33|||
130824177|NCT03465722|470986123|FG001|Overall Study|Administrative/Other|32|||
130824178|NCT03465722|470986122|FG000|Overall Study|Not treated|1|||
130824179|NCT03465722|470986123|FG001|Overall Study|Not treated|2|||
130824180|NCT03465722|470986122|FG000|Overall Study|Sponsor decision|91|||
130824181|NCT03465722|470986123|FG001|Overall Study|Sponsor decision|98|||
130824182|NCT04940130|470986124|FG000|Overall Study|Travel|1|||
130824183|NCT04940130|470986125|FG001|Overall Study|Travel|0|||
130824184|NCT04940130|470986126|FG002|Overall Study|Travel|2|||
130824185|NCT04940130|470986124|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
130824186|NCT04940130|470986125|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
130824187|NCT04940130|470986126|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
130824188|NCT04940130|470986124|FG000|Overall Study|Adverse Event|0|||
130824189|NCT04940130|470986125|FG001|Overall Study|Adverse Event|0|||
130824190|NCT04940130|470986126|FG002|Overall Study|Adverse Event|2|||
130824191|NCT04940130|470986124|FG000|Overall Study|Disease progression/treatment failure|0|||
130824192|NCT04940130|470986125|FG001|Overall Study|Disease progression/treatment failure|0|||
130824193|NCT04940130|470986126|FG002|Overall Study|Disease progression/treatment failure|1|||
130824194|NCT04940130|470986124|FG000|Overall Study|Participant refusal|0|||
130824195|NCT04940130|470986125|FG001|Overall Study|Participant refusal|0|||
130824196|NCT04940130|470986126|FG002|Overall Study|Participant refusal|1|||
130824197|NCT02240121|470986129|FG000|Overall Study|Protocol Violation|1|||
130824198|NCT02240121|470986130|FG001|Overall Study|Protocol Violation|2|||
130824199|NCT02240121|470986129|FG000|Overall Study|Physician Decision|0|||
130824200|NCT02240121|470986130|FG001|Overall Study|Physician Decision|1|||
130824201|NCT02240121|470986129|FG000|Overall Study|Change in protocol interpretation|1|||
130824202|NCT02240121|470986130|FG001|Overall Study|Change in protocol interpretation|0|||
130824203|NCT02240121|470986129|FG000|Overall Study|Lack of Efficacy|2|||
130824204|NCT02240121|470986130|FG001|Overall Study|Lack of Efficacy|3|||
130824205|NCT02240121|470986129|FG000|Overall Study|Site closed|1|||
130824206|NCT02240121|470986130|FG001|Overall Study|Site closed|1|||
130824207|NCT02240121|470986129|FG000|Overall Study|Pregnancy|1|||
130824208|NCT02240121|470986130|FG001|Overall Study|Pregnancy|0|||
130824209|NCT02240121|470986129|FG000|Overall Study|Adverse Event|2|||
130824210|NCT02240121|470986130|FG001|Overall Study|Adverse Event|4|||
130824211|NCT02240121|470986129|FG000|Overall Study|Withdrawal by Subject|6|||
130824212|NCT02240121|470986130|FG001|Overall Study|Withdrawal by Subject|2|||
130824213|NCT02240121|470986129|FG000|Overall Study|Lost to Follow-up|3|||
130824214|NCT02240121|470986130|FG001|Overall Study|Lost to Follow-up|4|||
130824215|NCT02240121|470986129|FG000|Overall Study|Other than specified|1|||
130824216|NCT02240121|470986130|FG001|Overall Study|Other than specified|3|||
130824217|NCT01925768|470986131|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
130824218|NCT01925768|470986132|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130824219|NCT01925768|470986131|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
130824220|NCT01925768|470986132|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
130824221|NCT01925768|470986131|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
130824222|NCT01925768|470986132|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
130824223|NCT01925768|470986131|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
130824224|NCT01925768|470986132|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
130824225|NCT01925768|470986131|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
130824226|NCT01925768|470986132|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
130824227|NCT01925768|470986131|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
130824228|NCT01925768|470986132|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
130824229|NCT01925768|470986131|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
130824230|NCT01925768|470986132|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
130824231|NCT01925768|470986131|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
130824232|NCT01925768|470986132|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
130824233|NCT01925768|470986131|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
130824234|NCT01925768|470986132|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
130824235|NCT01925768|470986131|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
130824236|NCT01925768|470986132|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
130824237|NCT01925768|470986131|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
130824238|NCT01925768|470986132|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
130824239|NCT02779777|470986133|FG000|Overall Study|Disease Progression|1|||
130824240|NCT02779777|470986134|FG001|Overall Study|Disease Progression|0|||
130824241|NCT02779777|470986135|FG002|Overall Study|Disease Progression|0|||
130824242|NCT02779777|470986133|FG000|Overall Study|Adverse Event|3|||
130824243|NCT02779777|470986134|FG001|Overall Study|Adverse Event|1|||
130824244|NCT02779777|470986135|FG002|Overall Study|Adverse Event|0|||
130824245|NCT02779777|470986133|FG000|Overall Study|Physician Decision|9|||
130824246|NCT02779777|470986134|FG001|Overall Study|Physician Decision|0|||
130824247|NCT02779777|470986135|FG002|Overall Study|Physician Decision|1|||
130824248|NCT02779777|470986133|FG000|Overall Study|Withdrawal by Subject|1|||
130824249|NCT02779777|470986134|FG001|Overall Study|Withdrawal by Subject|0|||
130824250|NCT02779777|470986135|FG002|Overall Study|Withdrawal by Subject|0|||
130824251|NCT04571060|470986136|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
130824252|NCT04571060|470986137|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
130824253|NCT04571060|470986136|FG000|Overall Study|Never treated migraine|47|||
130824254|NCT04571060|470986137|FG001|Overall Study|Never treated migraine|36|||
130824255|NCT04571060|470986136|FG000|Overall Study|Protocol Violation|4|||
130824256|NCT04571060|470986137|FG001|Overall Study|Protocol Violation|2|||
130824257|NCT04571060|470986136|FG000|Overall Study|Withdrawal by Subject|6|||
130824258|NCT04571060|470986137|FG001|Overall Study|Withdrawal by Subject|2|||
130824259|NCT04571060|470986136|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
130824260|NCT04571060|470986137|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
130824261|NCT00442416|470986138|FG000|Overall Study|Adverse Event|4|||
130824262|NCT00442416|470986139|FG001|Overall Study|Adverse Event|1|||
130824263|NCT00442416|470986138|FG000|Overall Study|Death|1|||
130824264|NCT00442416|470986139|FG001|Overall Study|Death|0|||
130824265|NCT00442416|470986138|FG000|Overall Study|Lack of Efficacy|2|||
130824266|NCT00442416|470986139|FG001|Overall Study|Lack of Efficacy|0|||
130824267|NCT00442416|470986138|FG000|Overall Study|Protocol Violation|2|||
130824268|NCT00442416|470986139|FG001|Overall Study|Protocol Violation|3|||
130824269|NCT00442416|470986138|FG000|Overall Study|Withdrew consent|1|||
130824270|NCT00442416|470986139|FG001|Overall Study|Withdrew consent|2|||
130824271|NCT00442416|470986138|FG000|Overall Study|Administrative/Other|27|||
130824272|NCT00442416|470986139|FG001|Overall Study|Administrative/Other|33|||
130824273|NCT00087698|470986140|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
130824274|NCT00087698|470986140|FG000|Overall Study|Death from Other Causes|3|||
130824275|NCT00087698|470986140|FG000|Overall Study|Adverse Event|4|||
130824276|NCT00087698|470986140|FG000|Overall Study|Withdrawal by Subject|4|||
130824277|NCT00087698|470986140|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
130824278|NCT00087698|470986140|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
130824279|NCT00087698|470986140|FG000|Overall Study|Clinical Relapse|1|||
130824280|NCT00087698|470986140|FG000|Overall Study|Death from Study Disease|2|||
130824281|NCT00087698|470986140|FG000|Overall Study|Death from Study Drug Toxicity|2|||
130824282|NCT00087698|470986140|FG000|Overall Study|Protocol Violation|1|||
130824283|NCT03192137|470986144|FG000|Overall Study|Adverse Event|10|||
130824284|NCT03192137|470986145|FG001|Overall Study|Adverse Event|11|||
130824285|NCT03192137|470986144|FG000|Overall Study|Physician Decision|1|||
130824286|NCT03192137|470986145|FG001|Overall Study|Physician Decision|0|||
130824287|NCT03192137|470986144|FG000|Overall Study|Lack of Efficacy|20|||
130824288|NCT03192137|470986145|FG001|Overall Study|Lack of Efficacy|37|||
130824289|NCT03192137|470986144|FG000|Overall Study|Withdrawal by Subject|3|||
130824290|NCT03192137|470986145|FG001|Overall Study|Withdrawal by Subject|3|||
130824291|NCT03192137|470986144|FG000|Overall Study|Protocol Violation|4|||
130824292|NCT03192137|470986145|FG001|Overall Study|Protocol Violation|3|||
130824293|NCT03192137|470986144|FG000|Overall Study|Surgery Cancelled|4|||
130824294|NCT03192137|470986145|FG001|Overall Study|Surgery Cancelled|1|||
130824295|NCT03192137|470986144|FG000|Overall Study|Other - Various Administrative Reasons|8|||
130824296|NCT03192137|470986145|FG001|Overall Study|Other - Various Administrative Reasons|3|||
130824297|NCT00657267|470986146|FG000|Overall Study|Progressive disease|45|||
130824298|NCT00657267|470986146|FG000|Overall Study|Adverse Event|9|||
130824299|NCT01261975|470986150|FG000|Overall Study|Surgical complication|1|||
130824300|NCT04819113|470986153|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130824301|NCT04819113|470986153|FG000|Overall Study|Lost to Follow-up|1|||
130824302|NCT04819113|470986153|FG000|Overall Study|Withdrawn before vaccination|2|||
130824303|NCT00786422|470986155|FG000|Rivaroxaban Treatment|Death|2|||
130824304|NCT00786422|470986155|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
130824305|NCT00786422|470986155|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
130824306|NCT00786422|470986155|FG000|Rivaroxaban Treatment|Physician Decision|1|||
130824307|NCT00786422|470986155|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
130824308|NCT00786422|470986155|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
130824309|NCT00786422|470986155|FG000|Rivaroxaban Treatment|Adverse Event|2|||
130824310|NCT00786422|470986155|FG000|Follow-up Period|Death|1|||
130824311|NCT00786422|470986155|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
130824312|NCT04570384|470986162|FG000|Overall Study|Adverse Event|2|||
130824313|NCT04570384|470986163|FG001|Overall Study|Adverse Event|1|||
130824314|NCT04570384|470986162|FG000|Overall Study|Death|2|||
130824315|NCT04570384|470986163|FG001|Overall Study|Death|5|||
130824316|NCT04570384|470986162|FG000|Overall Study|Lost to Follow-up|1|||
130824317|NCT04570384|470986163|FG001|Overall Study|Lost to Follow-up|0|||
130824318|NCT04570384|470986162|FG000|Overall Study|Other|1|||
130824319|NCT04570384|470986163|FG001|Overall Study|Other|0|||
130824320|NCT04570384|470986162|FG000|Overall Study|Protocol Violation|0|||
130824321|NCT04570384|470986163|FG001|Overall Study|Protocol Violation|1|||
130824322|NCT04570384|470986162|FG000|Overall Study|Sponsor Decision|1|||
130824323|NCT04570384|470986163|FG001|Overall Study|Sponsor Decision|0|||
130824324|NCT04570384|470986162|FG000|Overall Study|Withdrawal by Subject|4|||
130824325|NCT04570384|470986163|FG001|Overall Study|Withdrawal by Subject|2|||
130824326|NCT01900665|470986164|FG000|Placebo Controlled Period|Death|9|||
130824327|NCT01900665|470986165|FG001|Placebo Controlled Period|Death|16|||
130824328|NCT01900665|470986164|FG000|Placebo Controlled Period|Adverse Event|48|||
130824329|NCT01900665|470986165|FG001|Placebo Controlled Period|Adverse Event|39|||
130824330|NCT01900665|470986164|FG000|Placebo Controlled Period|Protocol Violation|1|||
130824331|NCT01900665|470986165|FG001|Placebo Controlled Period|Protocol Violation|7|||
130824332|NCT01900665|470986164|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
130824333|NCT01900665|470986165|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
130824334|NCT01900665|470986164|FG000|Placebo Controlled Period|Physician Decision|11|||
130824335|NCT01900665|470986165|FG001|Placebo Controlled Period|Physician Decision|7|||
130824336|NCT01900665|470986164|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
130824337|NCT01900665|470986165|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
130824338|NCT01900665|470986164|FG000|Placebo Controlled Period|Caregiver Decision|33|||
130824339|NCT01900665|470986165|FG001|Placebo Controlled Period|Caregiver Decision|41|||
130824340|NCT01900665|470986164|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
130824341|NCT01900665|470986165|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
130824342|NCT01900665|470986164|FG000|Open Label Period|Adverse Event|16|||
130824343|NCT01900665|470986165|FG001|Open Label Period|Adverse Event|20|||
130824344|NCT01900665|470986164|FG000|Open Label Period|Death|5|||
130824345|NCT01900665|470986165|FG001|Open Label Period|Death|6|||
130824346|NCT01900665|470986164|FG000|Open Label Period|Lost to Follow-up|1|||
130824347|NCT01900665|470986165|FG001|Open Label Period|Lost to Follow-up|1|||
130824348|NCT01900665|470986164|FG000|Open Label Period|Parent/Caregiver Decision|33|||
130824349|NCT01900665|470986165|FG001|Open Label Period|Parent/Caregiver Decision|34|||
130824350|NCT01900665|470986164|FG000|Open Label Period|Physician Decision|4|||
130824351|NCT01900665|470986165|FG001|Open Label Period|Physician Decision|4|||
130824352|NCT01900665|470986164|FG000|Open Label Period|Protocol Violation|0|||
130824353|NCT01900665|470986165|FG001|Open Label Period|Protocol Violation|1|||
130824354|NCT01900665|470986164|FG000|Open Label Period|Sponsor Decision|802|||
130824355|NCT01900665|470986165|FG001|Open Label Period|Sponsor Decision|765|||
130824356|NCT01900665|470986164|FG000|Open Label Period|Withdrawal by Subject|20|||
130824357|NCT01900665|470986165|FG001|Open Label Period|Withdrawal by Subject|28|||
130824358|NCT04749914|470986168|FG000|Period 1|Adverse Event|1|||
130824359|NCT04749914|470986169|FG001|Period 1|Adverse Event|0|||
130824360|NCT04749914|470986170|FG002|Period 1|Adverse Event|0|||
130824361|NCT04749914|470986171|FG003|Period 1|Adverse Event|0|||
130824362|NCT04749914|470986168|FG000|Period 1|Withdrawal by Subject|1|||
130824363|NCT04749914|470986169|FG001|Period 1|Withdrawal by Subject|0|||
130824364|NCT04749914|470986170|FG002|Period 1|Withdrawal by Subject|1|||
130824365|NCT04749914|470986171|FG003|Period 1|Withdrawal by Subject|0|||
130824366|NCT01673126|470986172|FG000|Overall Study|change of diagnosis|4|||
130824367|NCT01673126|470986173|FG001|Overall Study|change of diagnosis|3|||
130824368|NCT00953706|470986175|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
130824369|NCT00953706|470986176|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
130824370|NCT00953706|470986177|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
130824371|NCT00953706|470986178|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
130824372|NCT00953706|470986175|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
130824373|NCT00953706|470986176|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
130824374|NCT00953706|470986177|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
130824375|NCT00953706|470986178|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
130824376|NCT00953706|470986175|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
130824377|NCT00953706|470986176|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
130824378|NCT00953706|470986177|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
130824379|NCT00953706|470986178|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
130824380|NCT00953706|470986175|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
130824381|NCT00953706|470986176|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
130824382|NCT00953706|470986177|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
130824383|NCT00953706|470986178|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
130824384|NCT00953706|470986175|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
130824385|NCT00953706|470986176|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
130824386|NCT00953706|470986177|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
130824387|NCT00953706|470986178|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
130824388|NCT00953706|470986175|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
130824389|NCT00953706|470986176|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
130824390|NCT00953706|470986177|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
130824391|NCT00953706|470986178|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
130824392|NCT00953706|470986175|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
130824393|NCT00953706|470986176|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
130824394|NCT00953706|470986177|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
130824395|NCT00953706|470986178|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
130824396|NCT00953706|470986175|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
130824397|NCT00953706|470986176|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
130824398|NCT00953706|470986177|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
130824399|NCT00953706|470986178|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
130824400|NCT00953706|470986175|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
130824401|NCT00953706|470986176|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
130824402|NCT00953706|470986177|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
130824403|NCT00953706|470986178|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
130824404|NCT00953706|470986175|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
130824405|NCT00953706|470986176|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
130824406|NCT00953706|470986177|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
130824407|NCT00953706|470986178|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
130824408|NCT00953706|470986175|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
130824409|NCT00953706|470986176|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
130824410|NCT00953706|470986177|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
130824411|NCT00953706|470986178|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
130824412|NCT01404234|470986179|FG000|Overall Study|Withdrawal by Subject|2|||
130824413|NCT00756275|470987696|FG000|Overall Study|Lost to Follow-up|25|||
130824414|NCT00756275|470987697|FG001|Overall Study|Lost to Follow-up|21|||
130824415|NCT00756275|470987696|FG000|Overall Study|Withdrawal by Subject|4|||
130824416|NCT00756275|470987697|FG001|Overall Study|Withdrawal by Subject|7|||
130824417|NCT00938912|470987704|FG000|Overall Study|Withdrawal by Subject|28|||
130824418|NCT00938912|470987704|FG000|Overall Study|Lost to Follow-up|4|||
130824419|NCT00938912|470987704|FG000|Overall Study|Lack of Efficacy|43|||
130824420|NCT00938912|470987704|FG000|Overall Study|Adverse event, non-fatal|24|||
130824421|NCT00938912|470987704|FG000|Overall Study|Adverse event, fatal|1|||
130824422|NCT00938912|470987704|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
130824423|NCT00938912|470987704|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
130824424|NCT00938912|470987704|FG000|Overall Study|Participant needed prohibit medication|1|||
130824425|NCT00938912|470987704|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
130824426|NCT00938912|470987704|FG000|Overall Study|Did not meet Eligibility criteria|1|||
130824427|NCT00938912|470987704|FG000|Overall Study|Participant relocated not related to AE|1|||
130824428|NCT00938912|470987704|FG000|Overall Study|Participant moved to another city|1|||
130824429|NCT00938912|470987704|FG000|Overall Study|Participant experienced break through seizures|1|||
130824430|NCT00938912|470987704|FG000|Overall Study|No longer wished to participate in the study|1|||
130824431|NCT00938912|470987704|FG000|Overall Study|Protocol Deviation|2|||
130824432|NCT01475721|470987708|FG000|Overall Study|Death|3|||
130824433|NCT01475721|470987709|FG001|Overall Study|Death|6|||
130824434|NCT01475721|470987708|FG000|Overall Study|Withdrawal by Subject|8|||
130824435|NCT01475721|470987709|FG001|Overall Study|Withdrawal by Subject|8|||
130824436|NCT00803738|470987711|FG000|Overall Study|Adverse Event|3|||
130824437|NCT00803738|470987712|FG001|Overall Study|Adverse Event|5|||
130824438|NCT00803738|470987711|FG000|Overall Study|Lost to Follow-up|4|||
130824439|NCT00803738|470987712|FG001|Overall Study|Lost to Follow-up|4|||
130824440|NCT00803738|470987711|FG000|Overall Study|Protocol Violation|18|||
130824441|NCT00803738|470987712|FG001|Overall Study|Protocol Violation|10|||
130824442|NCT00803738|470987711|FG000|Overall Study|Withdrawal by Subject|1|||
130824443|NCT00803738|470987712|FG001|Overall Study|Withdrawal by Subject|4|||
130824444|NCT00803738|470987711|FG000|Overall Study|Lack of Efficacy|10|||
130824445|NCT00803738|470987712|FG001|Overall Study|Lack of Efficacy|16|||
130824446|NCT00803738|470987711|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
130824447|NCT00803738|470987712|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
130824448|NCT00803738|470987711|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
130824449|NCT00803738|470987712|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
130824450|NCT06164691|470987713|FG000|Overall Study|Withdrawal by Subject|2|||
130824451|NCT06164691|470987714|FG001|Overall Study|Withdrawal by Subject|0|||
130824452|NCT06164691|470987715|FG002|Overall Study|Withdrawal by Subject|0|||
130824453|NCT02364037|470987716|FG000|Overall Study|Withdrawal by Subject|7|||
130824454|NCT02364037|470987717|FG001|Overall Study|Withdrawal by Subject|4|||
130824455|NCT02364037|470987716|FG000|Overall Study|Lost to Follow-up|37|||
130824456|NCT02364037|470987717|FG001|Overall Study|Lost to Follow-up|49|||
130824457|NCT00387088|470987722|FG000|Overall Study|Adverse Event|143|||
130824458|NCT00387088|470987723|FG001|Overall Study|Adverse Event|156|||
130824459|NCT00387088|470987722|FG000|Overall Study|Protocol Violation|47|||
130824460|NCT00387088|470987723|FG001|Overall Study|Protocol Violation|35|||
130824461|NCT00387088|470987722|FG000|Overall Study|Withdrawal by Subject|20|||
130824462|NCT00387088|470987723|FG001|Overall Study|Withdrawal by Subject|35|||
130824463|NCT00387088|470987722|FG000|Overall Study|Lack of Efficacy|28|||
130824464|NCT00387088|470987723|FG001|Overall Study|Lack of Efficacy|67|||
130824465|NCT00387088|470987722|FG000|Overall Study|Lost to Follow-up|22|||
130824466|NCT00387088|470987723|FG001|Overall Study|Lost to Follow-up|28|||
130824467|NCT00387088|470987722|FG000|Overall Study|Other|58|||
130824468|NCT00387088|470987723|FG001|Overall Study|Other|52|||
130824469|NCT02848092|470987726|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
130824470|NCT02848092|470987727|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
130824471|NCT02848092|470987726|FG000|1-month Post-training Follow-up|Adverse Event|2|||
130824472|NCT02848092|470987727|FG001|1-month Post-training Follow-up|Adverse Event|1|||
130824473|NCT02848092|470987726|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
130824474|NCT02848092|470987727|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
130824475|NCT02848092|470987726|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
130824476|NCT02848092|470987727|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
130824477|NCT02848092|470987726|FG000|1-month Post-training Follow-up|fatigue|0|||
130824478|NCT02848092|470987727|FG001|1-month Post-training Follow-up|fatigue|1|||
130824479|NCT02848092|470987726|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
130824480|NCT02848092|470987727|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
130824481|NCT02848092|470987726|FG000|6-month Post-training Follow-up|Adverse Event|1|||
130824482|NCT02848092|470987727|FG001|6-month Post-training Follow-up|Adverse Event|1|||
130824483|NCT02848092|470987726|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
130824484|NCT02848092|470987727|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
130824485|NCT02848092|470987726|FG000|6-month Post-training Follow-up|frustrated with task|1|||
130824486|NCT02848092|470987727|FG001|6-month Post-training Follow-up|frustrated with task|0|||
130824487|NCT02848092|470987726|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
130824488|NCT02848092|470987727|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
130824489|NCT02848092|470987726|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
130824490|NCT02848092|470987727|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
130824491|NCT01639469|470987728|FG000|Overall Study|Death|4|||
130824492|NCT01639469|470987729|FG001|Overall Study|Death|2|||
130824493|NCT01639469|470987728|FG000|Overall Study|Lost to Follow-up|1|||
130824494|NCT01639469|470987729|FG001|Overall Study|Lost to Follow-up|1|||
130824495|NCT00420381|470987732|FG000|Overall Study|Protocol Violation|1|||
130824496|NCT00592631|470987737|FG000|Overall Study|Lost to Follow-up|0|||
130824497|NCT00592631|470987738|FG001|Overall Study|Lost to Follow-up|2|||
130824498|NCT00443118|470987739|FG000|Overall Study|unknown primary outcome|3|||
130824499|NCT00443118|470987740|FG001|Overall Study|unknown primary outcome|1|||
130824500|NCT00443118|470987741|FG002|Overall Study|unknown primary outcome|0|||
130824501|NCT00443118|470987739|FG000|Overall Study|Withdrawal by Subject|1|||
130824502|NCT00443118|470987740|FG001|Overall Study|Withdrawal by Subject|0|||
130824503|NCT00443118|470987741|FG002|Overall Study|Withdrawal by Subject|0|||
130824504|NCT01664247|470987745|FG000|Overall Study|Adverse Event|5|||
130824505|NCT01664247|470987746|FG001|Overall Study|Adverse Event|3|||
130824506|NCT01664247|470987745|FG000|Overall Study|Protocol Violation|3|||
130824507|NCT01664247|470987746|FG001|Overall Study|Protocol Violation|5|||
130824508|NCT01664247|470987745|FG000|Overall Study|Withdrawal Criteria|1|||
130824509|NCT01664247|470987746|FG001|Overall Study|Withdrawal Criteria|4|||
130824510|NCT01664247|470987745|FG000|Overall Study|Unclassified|5|||
130824511|NCT01664247|470987746|FG001|Overall Study|Unclassified|29|||
130824512|NCT01106157|470987747|FG000|Overall Study|Withdrawal by Subject|1|||
130824513|NCT01106157|470987748|FG001|Overall Study|Withdrawal by Subject|0|||
130824514|NCT02298868|470987749|FG000|Overall Study|Adverse Event|1|||
130824515|NCT02298868|470987749|FG000|Overall Study|Death|1|||
130824516|NCT02298868|470987749|FG000|Overall Study|Patient underwent transplant|1|||
130824517|NCT02141672|470987750|FG000|Overall Study|Adverse Event|0|||
130824518|NCT02141672|470987751|FG001|Overall Study|Adverse Event|1|||
130824519|NCT02141672|470987752|FG002|Overall Study|Adverse Event|0|||
130824520|NCT02141672|470987750|FG000|Overall Study|Death|10|||
130824521|NCT02141672|470987751|FG001|Overall Study|Death|2|||
130824522|NCT02141672|470987752|FG002|Overall Study|Death|1|||
130824523|NCT02141672|470987750|FG000|Overall Study|Lack of Efficacy|0|||
130824524|NCT02141672|470987751|FG001|Overall Study|Lack of Efficacy|0|||
130824525|NCT02141672|470987752|FG002|Overall Study|Lack of Efficacy|2|||
130824526|NCT02141672|470987750|FG000|Overall Study|Lost to Follow-up|1|||
130824527|NCT02141672|470987751|FG001|Overall Study|Lost to Follow-up|1|||
130824528|NCT02141672|470987752|FG002|Overall Study|Lost to Follow-up|3|||
130824529|NCT02141672|470987750|FG000|Overall Study|Physician Decision|1|||
130824530|NCT02141672|470987751|FG001|Overall Study|Physician Decision|2|||
130824531|NCT02141672|470987752|FG002|Overall Study|Physician Decision|5|||
130824532|NCT02141672|470987750|FG000|Overall Study|Protocol Violation|0|||
130824533|NCT02141672|470987751|FG001|Overall Study|Protocol Violation|0|||
130824534|NCT02141672|470987752|FG002|Overall Study|Protocol Violation|1|||
130824535|NCT02141672|470987750|FG000|Overall Study|Withdrawal by Subject|3|||
130824536|NCT02141672|470987751|FG001|Overall Study|Withdrawal by Subject|2|||
130824537|NCT02141672|470987752|FG002|Overall Study|Withdrawal by Subject|5|||
130824538|NCT02141672|470987750|FG000|Overall Study|refused to follow-up|1|||
130824539|NCT02141672|470987751|FG001|Overall Study|refused to follow-up|0|||
130824540|NCT02141672|470987752|FG002|Overall Study|refused to follow-up|1|||
130824541|NCT01118780|470987753|FG000|Overall Study|Adverse Event|15|||
130824542|NCT01118780|470987754|FG001|Overall Study|Adverse Event|15|||
130824543|NCT01118780|470987753|FG000|Overall Study|Death|1|||
130824544|NCT01118780|470987754|FG001|Overall Study|Death|0|||
130824545|NCT01118780|470987753|FG000|Overall Study|Lack of Efficacy|2|||
130824546|NCT01118780|470987754|FG001|Overall Study|Lack of Efficacy|6|||
130824547|NCT01118780|470987753|FG000|Overall Study|Physician Decision|2|||
130824548|NCT01118780|470987754|FG001|Overall Study|Physician Decision|0|||
130824549|NCT01118780|470987753|FG000|Overall Study|Protocol Violation|3|||
130824550|NCT01118780|470987754|FG001|Overall Study|Protocol Violation|6|||
130824551|NCT01118780|470987753|FG000|Overall Study|Withdrawal by Subject|13|||
130824552|NCT01118780|470987754|FG001|Overall Study|Withdrawal by Subject|8|||
130824553|NCT03962855|470987762|FG000|Overall Study|Death|0|||
130824554|NCT03962855|470987763|FG001|Overall Study|Death|1|||
130824555|NCT03962855|470987762|FG000|Overall Study|Lost to Follow-up|0|||
130824556|NCT03962855|470987763|FG001|Overall Study|Lost to Follow-up|1|||
130824557|NCT03962855|470987762|FG000|Overall Study|Adverse Event|0|||
130824558|NCT03962855|470987763|FG001|Overall Study|Adverse Event|1|||
130824559|NCT03962855|470987762|FG000|Overall Study|Physician Decision|0|||
130824560|NCT03962855|470987763|FG001|Overall Study|Physician Decision|2|||
130824561|NCT00127855|470987764|FG000|Primary Vaccination Course|Adverse Event|0|||
130824562|NCT00127855|470987765|FG001|Primary Vaccination Course|Adverse Event|0|||
130824563|NCT00127855|470987766|FG002|Primary Vaccination Course|Adverse Event|1|||
130824564|NCT00127855|470987767|FG003|Primary Vaccination Course|Adverse Event|0|||
130824565|NCT00127855|470987768|FG004|Primary Vaccination Course|Adverse Event|0|||
130824566|NCT00127855|470987764|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
130824567|NCT00127855|470987765|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
130824568|NCT00127855|470987766|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
130824569|NCT00127855|470987767|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
130824570|NCT00127855|470987768|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
130824571|NCT00127855|470987764|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
130824572|NCT00127855|470987765|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
130824573|NCT00127855|470987766|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
130824574|NCT00127855|470987767|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
130824575|NCT00127855|470987768|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
130824576|NCT00127855|470987764|FG000|Primary Vaccination Course|Other|0|||
130824577|NCT00127855|470987765|FG001|Primary Vaccination Course|Other|0|||
130824578|NCT00127855|470987766|FG002|Primary Vaccination Course|Other|0|||
130824579|NCT00127855|470987767|FG003|Primary Vaccination Course|Other|0|||
130824580|NCT00127855|470987768|FG004|Primary Vaccination Course|Other|1|||
130824581|NCT02343302|470987769|FG000|Overall Study|Physician Decision|1|||
130824582|NCT02343302|470987770|FG001|Overall Study|Physician Decision|1|||
130824583|NCT02655887|470987771|FG000|Overall Study|Lost to Follow-up|3|||
130824584|NCT02655887|470987771|FG000|Overall Study|Death|4|||
130824585|NCT02655887|470987771|FG000|Overall Study|Withdrawal by Subject|3|||
130824586|NCT02655887|470987771|FG000|Overall Study|Missed 12-month follow-up visit|4|||
130824587|NCT03637491|470987774|FG000|Overall Study|Death|9|||
130824588|NCT03637491|470987775|FG001|Overall Study|Death|9|||
130824589|NCT03637491|470987776|FG002|Overall Study|Death|5|||
130824590|NCT03637491|470987777|FG003|Overall Study|Death|3|||
130824591|NCT03637491|470987774|FG000|Overall Study|Lost to Follow-up|0|||
130824592|NCT03637491|470987775|FG001|Overall Study|Lost to Follow-up|1|||
130824593|NCT03637491|470987776|FG002|Overall Study|Lost to Follow-up|0|||
130824594|NCT03637491|470987777|FG003|Overall Study|Lost to Follow-up|1|||
130824595|NCT03637491|470987774|FG000|Overall Study|Study Terminated By Sponsor|0|||
130824596|NCT03637491|470987775|FG001|Overall Study|Study Terminated By Sponsor|2|||
130824597|NCT03637491|470987776|FG002|Overall Study|Study Terminated By Sponsor|1|||
130824598|NCT03637491|470987777|FG003|Overall Study|Study Terminated By Sponsor|0|||
130824599|NCT03637491|470987774|FG000|Overall Study|Withdrawal by Subject|1|||
130824600|NCT03637491|470987775|FG001|Overall Study|Withdrawal by Subject|0|||
130824601|NCT03637491|470987776|FG002|Overall Study|Withdrawal by Subject|1|||
130824602|NCT03637491|470987777|FG003|Overall Study|Withdrawal by Subject|2|||
130824603|NCT00532844|470987778|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
130824604|NCT00532844|470987779|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
130824605|NCT00532844|470987778|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
130824606|NCT00532844|470987779|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
130824607|NCT00532844|470987778|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
130824608|NCT00532844|470987779|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
130824609|NCT00532844|470987778|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
130824610|NCT00532844|470987779|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
130824611|NCT00532844|470987778|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
130824612|NCT00532844|470987779|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
130824613|NCT04419467|470987786|FG000|Overall Study|Not treated with IP|0|||
130824614|NCT04419467|470987787|FG001|Overall Study|Not treated with IP|0|||
130824615|NCT04419467|470987788|FG002|Overall Study|Not treated with IP|2|||
130824616|NCT04419467|470987786|FG000|Overall Study|Adverse Event|0|||
130824617|NCT04419467|470987787|FG001|Overall Study|Adverse Event|2|||
130824618|NCT04419467|470987788|FG002|Overall Study|Adverse Event|0|||
130824619|NCT04419467|470987786|FG000|Overall Study|Death|1|||
130824620|NCT04419467|470987787|FG001|Overall Study|Death|0|||
130824621|NCT04419467|470987788|FG002|Overall Study|Death|0|||
130824622|NCT04419467|470987786|FG000|Overall Study|Lost to Follow-up|0|||
130824623|NCT04419467|470987787|FG001|Overall Study|Lost to Follow-up|1|||
130824624|NCT04419467|470987788|FG002|Overall Study|Lost to Follow-up|2|||
130824625|NCT04419467|470987786|FG000|Overall Study|Withdrawal by Subject|0|||
130824626|NCT04419467|470987787|FG001|Overall Study|Withdrawal by Subject|0|||
130824627|NCT04419467|470987788|FG002|Overall Study|Withdrawal by Subject|4|||
130824628|NCT04419467|470987786|FG000|Overall Study|Pandemic related|0|||
130824629|NCT04419467|470987787|FG001|Overall Study|Pandemic related|0|||
130824630|NCT04419467|470987788|FG002|Overall Study|Pandemic related|1|||
130824631|NCT04419467|470987786|FG000|Overall Study|Reason not known|1|||
130824632|NCT04419467|470987787|FG001|Overall Study|Reason not known|0|||
130824633|NCT04419467|470987788|FG002|Overall Study|Reason not known|0|||
130824634|NCT00003869|470987795|FG000|Overall Study|Adverse Event|14|||
130824635|NCT00003869|470987796|FG001|Overall Study|Adverse Event|3|||
130824636|NCT00003869|470987795|FG000|Overall Study|Withdrawal by Subject|21|||
130824637|NCT00003869|470987796|FG001|Overall Study|Withdrawal by Subject|3|||
130824638|NCT00003869|470987795|FG000|Overall Study|Death|1|||
130824639|NCT00003869|470987796|FG001|Overall Study|Death|2|||
130824640|NCT00003869|470987795|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
130824641|NCT00003869|470987796|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
130824642|NCT03364231|470987797|FG000|Overall Study|Adverse Event|1|||
130824643|NCT03364231|470987798|FG001|Overall Study|Adverse Event|4|||
130824644|NCT03364231|470987797|FG000|Overall Study|Death|1|||
130824645|NCT03364231|470987798|FG001|Overall Study|Death|0|||
130824646|NCT03364231|470987797|FG000|Overall Study|Investigator Decision|2|||
130824647|NCT03364231|470987798|FG001|Overall Study|Investigator Decision|2|||
130824648|NCT03364231|470987797|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
130824649|NCT03364231|470987798|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
130824650|NCT03364231|470987797|FG000|Overall Study|Withdrawal of Subject Consent|1|||
130824651|NCT03364231|470987798|FG001|Overall Study|Withdrawal of Subject Consent|0|||
130824652|NCT03364231|470987797|FG000|Overall Study|Reason Not Specified|1|||
130824653|NCT03364231|470987798|FG001|Overall Study|Reason Not Specified|0|||
130824654|NCT03364231|470987797|FG000|Overall Study|Disease Progression|0|||
130824655|NCT03364231|470987798|FG001|Overall Study|Disease Progression|6|||
130824656|NCT01070979|470987799|FG000|Overall Study|Adverse Event|2|||
130824657|NCT01070979|470987800|FG001|Overall Study|Adverse Event|3|||
130824658|NCT01070979|470987801|FG002|Overall Study|Adverse Event|3|||
130824659|NCT01070979|470987799|FG000|Overall Study|Lost to Follow-up|2|||
130824660|NCT01070979|470987800|FG001|Overall Study|Lost to Follow-up|1|||
130824661|NCT01070979|470987801|FG002|Overall Study|Lost to Follow-up|1|||
130824662|NCT01070979|470987799|FG000|Overall Study|Protocol Violation|0|||
130824663|NCT01070979|470987800|FG001|Overall Study|Protocol Violation|2|||
130824664|NCT01070979|470987801|FG002|Overall Study|Protocol Violation|6|||
130824665|NCT01070979|470987799|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
130824666|NCT01070979|470987800|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
130824667|NCT01070979|470987801|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
130824668|NCT01070979|470987799|FG000|Overall Study|Withdrawal by Subject|3|||
130824669|NCT01070979|470987800|FG001|Overall Study|Withdrawal by Subject|1|||
130824670|NCT01070979|470987801|FG002|Overall Study|Withdrawal by Subject|1|||
130824671|NCT01070979|470987799|FG000|Overall Study|No study drug taken|0|||
130824672|NCT01070979|470987800|FG001|Overall Study|No study drug taken|1|||
130824673|NCT01070979|470987801|FG002|Overall Study|No study drug taken|0|||
130824674|NCT00142792|470987802|FG000|Overall Study|Death|0|||
130824675|NCT00142792|470987803|FG001|Overall Study|Death|0|||
130824676|NCT00142792|470987804|FG002|Overall Study|Death|1|||
130824677|NCT00142792|470987802|FG000|Overall Study|Withdrawal by Subject|3|||
130824678|NCT00142792|470987803|FG001|Overall Study|Withdrawal by Subject|2|||
130824679|NCT00142792|470987804|FG002|Overall Study|Withdrawal by Subject|3|||
130824680|NCT00142792|470987802|FG000|Overall Study|Lost to Follow-up|8|||
130824681|NCT00142792|470987803|FG001|Overall Study|Lost to Follow-up|11|||
130824682|NCT00142792|470987804|FG002|Overall Study|Lost to Follow-up|7|||
130824683|NCT00142792|470987802|FG000|Overall Study|No category|1|||
130824684|NCT00142792|470987803|FG001|Overall Study|No category|2|||
130824685|NCT00142792|470987804|FG002|Overall Study|No category|1|||
130824686|NCT05653700|470987805|FG000|Overall Study|Non Responders|9|||
130824687|NCT05653700|470987806|FG001|Overall Study|Non Responders|0|||
130824688|NCT02573948|470987807|FG000|Longitudinal Cohort|Death|9|||
130824689|NCT02573948|470987807|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
130824690|NCT02573948|470987807|FG000|Longitudinal Cohort|Incarcerated|25|||
130824691|NCT00707993|470987808|FG000|Overall Study|Adverse Event|16|||
130824692|NCT00707993|470987809|FG001|Overall Study|Adverse Event|20|||
130824693|NCT00707993|470987808|FG000|Overall Study|Protocol Violation|4|||
130824694|NCT00707993|470987809|FG001|Overall Study|Protocol Violation|7|||
130824695|NCT00707993|470987808|FG000|Overall Study|Lost to Follow-up|0|||
130824696|NCT00707993|470987809|FG001|Overall Study|Lost to Follow-up|4|||
130824697|NCT00707993|470987808|FG000|Overall Study|Withdrawal by Subject|12|||
130824698|NCT00707993|470987809|FG001|Overall Study|Withdrawal by Subject|16|||
130824699|NCT00707993|470987808|FG000|Overall Study|Hyperglycemic Rescue|55|||
130824700|NCT00707993|470987809|FG001|Overall Study|Hyperglycemic Rescue|47|||
130824701|NCT00707993|470987808|FG000|Overall Study|Other|2|||
130824702|NCT00707993|470987809|FG001|Overall Study|Other|0|||
130824703|NCT01913327|470987814|FG000|Overall Study|Withdrawal by Subject|0|||
130824704|NCT01913327|470987815|FG001|Overall Study|Withdrawal by Subject|1|||
130824705|NCT05414175|470987821|FG000|Overall Study|Withdrawal by Subject|1|||
130824706|NCT05414175|470987821|FG000|Overall Study|Other Reasons|1|||
130824707|NCT03816176|470987822|FG000|Overall Study|Miscellaneous|5|||
130824708|NCT03816176|470987822|FG000|Overall Study|Lack of Efficacy|4|||
130824709|NCT03816176|470987822|FG000|Overall Study|Adverse Event|3|||
130824710|NCT00552071|470988946|FG000|Overall Study|Adverse Event|1|||
130824711|NCT00552071|470988947|FG001|Overall Study|Adverse Event|0|||
130824712|NCT00552071|470988946|FG000|Overall Study|Lack of Efficacy|1|||
130824713|NCT00552071|470988947|FG001|Overall Study|Lack of Efficacy|0|||
130824714|NCT00552071|470988946|FG000|Overall Study|Physician Decision|1|||
130824715|NCT00552071|470988947|FG001|Overall Study|Physician Decision|0|||
130824716|NCT00552071|470988946|FG000|Overall Study|Pregnancy|1|||
130824717|NCT00552071|470988947|FG001|Overall Study|Pregnancy|0|||
130824718|NCT00552071|470988946|FG000|Overall Study|Death|0|||
130824719|NCT00552071|470988947|FG001|Overall Study|Death|1|||
130824720|NCT00552071|470988946|FG000|Overall Study|Withdrawal by Subject|0|||
130824721|NCT00552071|470988947|FG001|Overall Study|Withdrawal by Subject|1|||
130824722|NCT01979614|470988948|FG000|Overall Study|Adverse Event|1|||
130824723|NCT01979614|470988949|FG001|Overall Study|Adverse Event|1|||
130824724|NCT00456755|470988951|FG000|Overall Study|Lost to Follow-up|2|||
130824725|NCT00456755|470988952|FG001|Overall Study|Lost to Follow-up|1|||
130824726|NCT03333928|470988953|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
130824727|NCT03333928|470988954|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
130824728|NCT03333928|470988955|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
130824729|NCT03333928|470988953|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
130824730|NCT03333928|470988954|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
130824731|NCT03333928|470988955|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
130824732|NCT03333928|470988953|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
130824733|NCT03333928|470988954|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
130824734|NCT03333928|470988955|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
130824735|NCT03333928|470988953|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
130824736|NCT03333928|470988954|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
130824737|NCT03333928|470988955|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
130824738|NCT03333928|470988953|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
130824739|NCT03333928|470988954|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
130824740|NCT03333928|470988955|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
130824741|NCT03333928|470988953|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
130824742|NCT03333928|470988954|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
130824743|NCT03333928|470988955|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
130824744|NCT03333928|470988953|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
130824745|NCT03333928|470988954|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
130824746|NCT03333928|470988955|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
130824747|NCT03333928|470988953|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
130824748|NCT03333928|470988954|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
130824749|NCT03333928|470988955|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
130824750|NCT04072835|470988956|FG000|Overall Study|Overall trial ended|603|||
130824751|NCT04072835|470988956|FG000|Overall Study|Ablation|97|||
130824752|NCT04072835|470988956|FG000|Overall Study|Withdrawal of consent|66|||
130824753|NCT04072835|470988956|FG000|Overall Study|Physician Decision|50|||
130824754|NCT04072835|470988956|FG000|Overall Study|Lost to Follow-up|39|||
130824755|NCT04072835|470988956|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
130824756|NCT04072835|470988956|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
130824757|NCT04072835|470988956|FG000|Overall Study|Adverse Event|25|||
130824758|NCT04072835|470988956|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
130824759|NCT04072835|470988956|FG000|Overall Study|Death|11|||
130824760|NCT04072835|470988956|FG000|Overall Study|Participant felt the drug did not work|8|||
130824761|NCT04072835|470988956|FG000|Overall Study|Participant tolerability|5|||
130824762|NCT04072835|470988956|FG000|Overall Study|Missing|5|||
130824763|NCT04072835|470988956|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
130824764|NCT04072835|470988956|FG000|Overall Study|Pregnancy|3|||
130824765|NCT04723355|470988957|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
130824766|NCT04723355|470988957|FG000|Overall Study|Errors in the informed consent form|2|||
130824767|NCT00841776|470988960|FG000|Overall Study|Lack of Efficacy|0|||
130824768|NCT00841776|470988961|FG001|Overall Study|Lack of Efficacy|1|||
130824769|NCT00841776|470988960|FG000|Overall Study|Lost to Follow-up|2|||
130824770|NCT00841776|470988961|FG001|Overall Study|Lost to Follow-up|1|||
130824771|NCT00841776|470988960|FG000|Overall Study|Withdrawal by Subject|0|||
130824772|NCT00841776|470988961|FG001|Overall Study|Withdrawal by Subject|1|||
130824773|NCT02477527|470988962|FG000|Overall Study|Lost to Follow-up|2|||
130824774|NCT02477527|470988962|FG000|Overall Study|Withdrawal by Subject|1|||
130824775|NCT02477527|470988962|FG000|Overall Study|Screen Failure|3|||
130824776|NCT01428219|470988974|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
130824777|NCT02479880|470988975|FG000|Overall Study|Study Terminated by Sponsor|13|||
130824778|NCT02479880|470988976|FG001|Overall Study|Study Terminated by Sponsor|12|||
130824779|NCT02479880|470988975|FG000|Overall Study|Pregnancy|0|||
130824780|NCT02479880|470988976|FG001|Overall Study|Pregnancy|1|||
130824781|NCT03432494|470988990|FG000|Overall Study|Death|1|||
130824782|NCT03432494|470988990|FG000|Overall Study|Noncompliance|1|||
130824785|NCT00347932|470988995|FG000|Overall Study|Adverse Event|4|||
130824786|NCT00347932|470988996|FG001|Overall Study|Adverse Event|5|||
130824787|NCT00347932|470988995|FG000|Overall Study|Lack of Efficacy|3|||
130824788|NCT00347932|470988996|FG001|Overall Study|Lack of Efficacy|14|||
130824789|NCT00347932|470988995|FG000|Overall Study|Lost to Follow-up|10|||
130824790|NCT00347932|470988996|FG001|Overall Study|Lost to Follow-up|9|||
130824791|NCT00347932|470988995|FG000|Overall Study|Withdrawal by Subject|10|||
130824792|NCT00347932|470988996|FG001|Overall Study|Withdrawal by Subject|16|||
130824793|NCT00347932|470988995|FG000|Overall Study|Did not meet inclusion criteria|4|||
130824794|NCT00347932|470988996|FG001|Overall Study|Did not meet inclusion criteria|8|||
130824795|NCT04512001|470988997|FG000|Week 0 to Week 24|Adverse Event|14|||
130824796|NCT04512001|470988998|FG001|Week 0 to Week 24|Adverse Event|10|||
130824797|NCT04512001|470988999|FG002|Week 0 to Week 24|Adverse Event|0|||
130824798|NCT04512001|470989000|FG003|Week 0 to Week 24|Adverse Event|0|||
130824799|NCT04512001|470989001|FG004|Week 0 to Week 24|Adverse Event|0|||
130824800|NCT04512001|470988997|FG000|Week 0 to Week 24|Death|0|||
130824801|NCT04512001|470988998|FG001|Week 0 to Week 24|Death|2|||
130824802|NCT04512001|470988999|FG002|Week 0 to Week 24|Death|0|||
130824803|NCT04512001|470989000|FG003|Week 0 to Week 24|Death|0|||
130824804|NCT04512001|470989001|FG004|Week 0 to Week 24|Death|0|||
130824805|NCT04512001|470988997|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
130824806|NCT04512001|470988998|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
130824807|NCT04512001|470988999|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
130824808|NCT04512001|470989000|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
130824809|NCT04512001|470989001|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
130824810|NCT04512001|470988997|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
130824811|NCT04512001|470988998|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
130824812|NCT04512001|470988999|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
130824813|NCT04512001|470989000|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
130824814|NCT04512001|470989001|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
130824815|NCT04512001|470988997|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
130824816|NCT04512001|470988998|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130824817|NCT04512001|470988999|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130824818|NCT04512001|470989000|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130824819|NCT04512001|470989001|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130824820|NCT04512001|470988997|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130824821|NCT04512001|470988998|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
130824822|NCT04512001|470988999|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130824823|NCT04512001|470989000|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130824824|NCT04512001|470989001|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130824825|NCT04512001|470988997|FG000|Week 24 to Week 63|Adverse Event|0|||
130824826|NCT04512001|470988998|FG001|Week 24 to Week 63|Adverse Event|0|||
130824827|NCT04512001|470988999|FG002|Week 24 to Week 63|Adverse Event|13|||
130824828|NCT04512001|470989000|FG003|Week 24 to Week 63|Adverse Event|8|||
130824829|NCT04512001|470989001|FG004|Week 24 to Week 63|Adverse Event|6|||
130824830|NCT04512001|470988997|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
130824831|NCT04512001|470988998|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
130824832|NCT04512001|470988999|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
130824833|NCT04512001|470989000|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
130824834|NCT04512001|470989001|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
130824835|NCT04512001|470988997|FG000|Week 24 to Week 63|Death|0|||
130824836|NCT04512001|470988998|FG001|Week 24 to Week 63|Death|0|||
130824837|NCT04512001|470988999|FG002|Week 24 to Week 63|Death|0|||
130824838|NCT04512001|470989000|FG003|Week 24 to Week 63|Death|1|||
130824839|NCT04512001|470989001|FG004|Week 24 to Week 63|Death|1|||
130824840|NCT04512001|470988997|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
130824841|NCT04512001|470988998|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
130824842|NCT04512001|470988999|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
130824843|NCT04512001|470989000|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
130824844|NCT04512001|470989001|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
130824845|NCT04512001|470988997|FG000|Week 24 to Week 63|Miscellaneous|0|||
130824846|NCT04512001|470988998|FG001|Week 24 to Week 63|Miscellaneous|0|||
130824847|NCT04512001|470988999|FG002|Week 24 to Week 63|Miscellaneous|3|||
130824848|NCT04512001|470989000|FG003|Week 24 to Week 63|Miscellaneous|2|||
130824849|NCT04512001|470989001|FG004|Week 24 to Week 63|Miscellaneous|1|||
130824850|NCT02776683|470989002|FG000|Pre-switch Period|Protocol Violation|1|||
130824851|NCT02776683|470989003|FG001|Pre-switch Period|Protocol Violation|0|||
130824852|NCT02776683|470989002|FG000|Pre-switch Period|Adverse Event|21|||
130824853|NCT02776683|470989003|FG001|Pre-switch Period|Adverse Event|0|||
130824854|NCT02776683|470989002|FG000|Pre-switch Period|Withdrawal by Subject|9|||
130824855|NCT02776683|470989003|FG001|Pre-switch Period|Withdrawal by Subject|0|||
130824856|NCT02776683|470989002|FG000|Pre-switch Period|Physician Decision|7|||
130824857|NCT02776683|470989003|FG001|Pre-switch Period|Physician Decision|0|||
130824858|NCT02776683|470989002|FG000|Pre-switch Period|Progressive disease|39|||
130824859|NCT02776683|470989003|FG001|Pre-switch Period|Progressive disease|0|||
130824860|NCT02776683|470989002|FG000|Pre-switch Period|Other than listed|3|||
130824861|NCT02776683|470989003|FG001|Pre-switch Period|Other than listed|0|||
130824862|NCT02776683|470989002|FG000|Post-switch Period|Adverse Event|0|||
130824863|NCT02776683|470989003|FG001|Post-switch Period|Adverse Event|3|||
130824864|NCT02776683|470989002|FG000|Post-switch Period|Withdrawal by Subject|0|||
130824865|NCT02776683|470989003|FG001|Post-switch Period|Withdrawal by Subject|2|||
130824866|NCT02776683|470989002|FG000|Post-switch Period|Physician Decision|0|||
130824867|NCT02776683|470989003|FG001|Post-switch Period|Physician Decision|3|||
130824868|NCT02776683|470989002|FG000|Post-switch Period|Progressive disease|0|||
130824869|NCT02776683|470989003|FG001|Post-switch Period|Progressive disease|20|||
130824870|NCT02776683|470989002|FG000|Post-switch Period|Other than listed|0|||
130824871|NCT02776683|470989003|FG001|Post-switch Period|Other than listed|15|||
130824872|NCT04232943|470989006|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
130824873|NCT04232943|470989007|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
130824874|NCT04232943|470989008|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
130824875|NCT04232943|470989006|FG000|Overall Study|Withdrawal by Subject|1|||
130824876|NCT04232943|470989007|FG001|Overall Study|Withdrawal by Subject|1|||
130824877|NCT04232943|470989008|FG002|Overall Study|Withdrawal by Subject|0|||
130824878|NCT01000506|470989009|FG000|Overall Study|Adverse Event|6|||
130824879|NCT01000506|470989010|FG001|Overall Study|Adverse Event|5|||
130824880|NCT01000506|470989011|FG002|Overall Study|Adverse Event|8|||
130824881|NCT01000506|470989012|FG003|Overall Study|Adverse Event|9|||
130824882|NCT01000506|470989009|FG000|Overall Study|Lack of Efficacy|8|||
130824883|NCT01000506|470989010|FG001|Overall Study|Lack of Efficacy|6|||
130824884|NCT01000506|470989011|FG002|Overall Study|Lack of Efficacy|4|||
130824885|NCT01000506|470989012|FG003|Overall Study|Lack of Efficacy|4|||
130824886|NCT01000506|470989009|FG000|Overall Study|Protocol Violation|1|||
130824887|NCT01000506|470989010|FG001|Overall Study|Protocol Violation|1|||
130824888|NCT01000506|470989011|FG002|Overall Study|Protocol Violation|0|||
130824889|NCT01000506|470989012|FG003|Overall Study|Protocol Violation|0|||
130824890|NCT01000506|470989009|FG000|Overall Study|Lost to Follow-up|1|||
130824891|NCT01000506|470989010|FG001|Overall Study|Lost to Follow-up|1|||
130824892|NCT01000506|470989011|FG002|Overall Study|Lost to Follow-up|4|||
130824893|NCT01000506|470989012|FG003|Overall Study|Lost to Follow-up|0|||
130824894|NCT01000506|470989009|FG000|Overall Study|Physician Decision|1|||
130824895|NCT01000506|470989010|FG001|Overall Study|Physician Decision|3|||
130824896|NCT01000506|470989011|FG002|Overall Study|Physician Decision|3|||
130824897|NCT01000506|470989012|FG003|Overall Study|Physician Decision|3|||
130824898|NCT01000506|470989009|FG000|Overall Study|Withdrawal by Subject|11|||
130824899|NCT01000506|470989010|FG001|Overall Study|Withdrawal by Subject|8|||
130824900|NCT01000506|470989011|FG002|Overall Study|Withdrawal by Subject|2|||
130824901|NCT01000506|470989012|FG003|Overall Study|Withdrawal by Subject|7|||
130824902|NCT02379052|470989013|FG000|Overall Study|Protocol Violation|0|||
130824903|NCT02379052|470989014|FG001|Overall Study|Protocol Violation|1|||
130824904|NCT02379052|470989013|FG000|Overall Study|Adverse Event|0|||
130824905|NCT02379052|470989014|FG001|Overall Study|Adverse Event|1|||
130824906|NCT02379052|470989013|FG000|Overall Study|Physician Decision|1|||
130824907|NCT02379052|470989014|FG001|Overall Study|Physician Decision|1|||
130824908|NCT02379052|470989013|FG000|Overall Study|Withdrawal by Subject|2|||
130824909|NCT02379052|470989014|FG001|Overall Study|Withdrawal by Subject|0|||
130824910|NCT02379052|470989013|FG000|Overall Study|Lost to Follow-up|2|||
130824911|NCT02379052|470989014|FG001|Overall Study|Lost to Follow-up|1|||
130824912|NCT02379052|470989013|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
130824913|NCT02379052|470989014|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
130824914|NCT02379052|470989013|FG000|Overall Study|Subject was Incarcerated|0|||
130824915|NCT02379052|470989014|FG001|Overall Study|Subject was Incarcerated|1|||
130824916|NCT01847755|470989015|FG000|Overall Study|Adverse Event|2|||
130824917|NCT01847755|470989015|FG000|Overall Study|Withdrawal by Subject|2|||
130824918|NCT01847755|470989015|FG000|Overall Study|Physician Decision|1|||
130824919|NCT04068922|470989023|FG000|Overall Study|Lost to Follow-up|5|||
130824920|NCT04068922|470989023|FG000|Overall Study|Withdrawal by Subject|7|||
130824921|NCT04068922|470989023|FG000|Overall Study|Adverse Event|1|||
130824922|NCT03542266|470989024|FG000|Treatment Phase|Withdrawal by Subject|1|||
130824923|NCT03542266|470989024|FG000|Treatment Phase|Adverse Event|1|||
130824924|NCT03542266|470989024|FG000|Treatment Phase|PD|1|||
130824925|NCT00437268|470989036|FG000|Overall Study|Adverse Event|1|||
130824926|NCT00437268|470989037|FG001|Overall Study|Adverse Event|1|||
130824927|NCT00437268|470989036|FG000|Overall Study|Withdrawal by Subject|2|||
130824928|NCT00437268|470989037|FG001|Overall Study|Withdrawal by Subject|2|||
130824929|NCT00437268|470989036|FG000|Overall Study|Progressive disease|9|||
130824930|NCT00437268|470989037|FG001|Overall Study|Progressive disease|9|||
130824931|NCT00437268|470989036|FG000|Overall Study|Physician Decision|1|||
130824932|NCT00437268|470989037|FG001|Overall Study|Physician Decision|0|||
130824933|NCT00437268|470989036|FG000|Overall Study|Death|0|||
130824934|NCT00437268|470989037|FG001|Overall Study|Death|1|||
130824935|NCT00444925|470989038|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
130824936|NCT00444925|470989039|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
130824937|NCT00444925|470989040|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
130824938|NCT00444925|470989038|FG000|Double-blind Treatment Period|Death|2|||
130824939|NCT00444925|470989039|FG001|Double-blind Treatment Period|Death|0|||
130824940|NCT00444925|470989040|FG002|Double-blind Treatment Period|Death|0|||
130824941|NCT00444925|470989038|FG000|Double-blind Treatment Period|Adverse Event|6|||
130824942|NCT00444925|470989039|FG001|Double-blind Treatment Period|Adverse Event|28|||
130824943|NCT00444925|470989040|FG002|Double-blind Treatment Period|Adverse Event|44|||
130824944|NCT00444925|470989038|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
130824945|NCT00444925|470989039|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
130824946|NCT00444925|470989040|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
130824947|NCT00444925|470989038|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
130824948|NCT00444925|470989039|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
130824949|NCT00444925|470989040|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
130824950|NCT00444925|470989038|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
130824951|NCT00444925|470989039|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
130824952|NCT00444925|470989040|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
130824953|NCT00444925|470989038|FG000|Double-blind Treatment Period|Other|7|||
130824954|NCT00444925|470989039|FG001|Double-blind Treatment Period|Other|7|||
130824955|NCT00444925|470989040|FG002|Double-blind Treatment Period|Other|12|||
130824956|NCT03484429|470989046|FG000|Overall Study|Withdrawal by Subject|1|||
130824957|NCT03484429|470989047|FG001|Overall Study|Withdrawal by Subject|0|||
130824958|NCT03484429|470989046|FG000|Overall Study|Adverse Event|2|||
130824959|NCT03484429|470989047|FG001|Overall Study|Adverse Event|0|||
130824960|NCT00714948|470989048|FG000|Overall Study|Adverse Event|2|||
130824961|NCT02112656|470989055|FG000|Overall Study|Death|78|||
130824962|NCT02112656|470989056|FG001|Overall Study|Death|82|||
130824963|NCT02112656|470989055|FG000|Overall Study|Withdrawal by Subject|9|||
130824964|NCT02112656|470989056|FG001|Overall Study|Withdrawal by Subject|11|||
130824965|NCT02112656|470989055|FG000|Overall Study|Lost to Follow-up|2|||
130824966|NCT02112656|470989056|FG001|Overall Study|Lost to Follow-up|4|||
130824967|NCT02112656|470989055|FG000|Overall Study|Noncompliance|1|||
130824968|NCT02112656|470989056|FG001|Overall Study|Noncompliance|2|||
130824969|NCT03761056|470989057|FG000|Overall Study|Death|8|||
130824970|NCT03761056|470989057|FG000|Overall Study|Enrolled but never treated|2|||
130824971|NCT03761056|470989057|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
130824972|NCT03761056|470989057|FG000|Overall Study|Investigator decision|1|||
130824973|NCT04749745|470989058|FG000|Overall Study|Withdrawal by Subject|1|||
130824974|NCT04749745|470989059|FG001|Overall Study|Withdrawal by Subject|0|||
130824975|NCT03965403|470989066|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
130824976|NCT00678288|470990766|FG000|Overall Study|Adverse Event|0|||
130824977|NCT00678288|470990767|FG001|Overall Study|Adverse Event|2|||
130824978|NCT00678288|470990766|FG000|Overall Study|Withdrawal by Subject|1|||
130824979|NCT00678288|470990767|FG001|Overall Study|Withdrawal by Subject|1|||
130824980|NCT00678288|470990766|FG000|Overall Study|Study terminated by the sponsor|2|||
130824981|NCT00678288|470990767|FG001|Overall Study|Study terminated by the sponsor|0|||
130824982|NCT00678288|470990766|FG000|Overall Study|Not compliant with study medication|0|||
130824983|NCT00678288|470990767|FG001|Overall Study|Not compliant with study medication|1|||
130824984|NCT00678288|470990766|FG000|Overall Study|Switch to commercial drug|0|||
130824985|NCT00678288|470990767|FG001|Overall Study|Switch to commercial drug|1|||
130824986|NCT00678288|470990766|FG000|Overall Study|Reason not reported|1|||
130824987|NCT00678288|470990767|FG001|Overall Study|Reason not reported|0|||
130824988|NCT00678288|470990766|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
130824989|NCT00678288|470990767|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
130824990|NCT02549989|470990768|FG000|Overall Study|Adverse Event|4|||
130824991|NCT02549989|470990768|FG000|Overall Study|Death|1|||
130824992|NCT02549989|470990768|FG000|Overall Study|Lack of Efficacy|19|||
130824993|NCT02549989|470990768|FG000|Overall Study|Withdrawal by Subject|3|||
130824994|NCT00972023|470990769|FG000|Overall Study|Withdrawal by Subject|1|||
130824995|NCT02628444|470990770|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
130824996|NCT02628444|470990771|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130824997|NCT02628444|470990772|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130824998|NCT02628444|470990773|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130824999|NCT02628444|470990774|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130825000|NCT02628444|470990775|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130825001|NCT02628444|470990776|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130825002|NCT02628444|470990777|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130825003|NCT02628444|470990778|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130825004|NCT02628444|470990770|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130825005|NCT02628444|470990771|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
130825006|NCT02628444|470990772|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
130825007|NCT02628444|470990773|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130825008|NCT02628444|470990774|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130825009|NCT02628444|470990775|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130825010|NCT02628444|470990776|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130825011|NCT02628444|470990777|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130825012|NCT02628444|470990778|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130825013|NCT02628444|470990770|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
130825014|NCT02628444|470990771|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
130825015|NCT02628444|470990772|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
130825016|NCT02628444|470990773|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130825017|NCT02628444|470990774|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130825018|NCT02628444|470990775|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130825019|NCT02628444|470990776|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130825020|NCT02628444|470990777|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130825021|NCT02628444|470990778|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130825022|NCT02628444|470990770|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
130825023|NCT02628444|470990771|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
130825024|NCT02628444|470990772|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
130825025|NCT02628444|470990773|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130825026|NCT02628444|470990774|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130825027|NCT02628444|470990775|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130825028|NCT02628444|470990776|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130825029|NCT02628444|470990777|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130825030|NCT02628444|470990778|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130825031|NCT02628444|470990770|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
130825032|NCT02628444|470990771|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
130825033|NCT02628444|470990772|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
130825034|NCT02628444|470990773|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130825035|NCT02628444|470990774|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130825036|NCT02628444|470990775|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130825037|NCT02628444|470990776|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130825038|NCT02628444|470990777|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130825039|NCT02628444|470990778|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130825040|NCT02628444|470990770|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130825041|NCT02628444|470990771|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130825042|NCT02628444|470990772|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130825043|NCT02628444|470990773|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
130825044|NCT02628444|470990774|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130825045|NCT02628444|470990775|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130825046|NCT02628444|470990776|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130825047|NCT02628444|470990777|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130825048|NCT02628444|470990778|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130825049|NCT02628444|470990770|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
130825050|NCT02628444|470990771|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
130825051|NCT02628444|470990772|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
130825052|NCT02628444|470990773|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
130825053|NCT02628444|470990774|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
130825054|NCT02628444|470990775|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
130825055|NCT02628444|470990776|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
130825056|NCT02628444|470990777|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
130825057|NCT02628444|470990778|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
130825058|NCT02628444|470990770|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
130825059|NCT02628444|470990771|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
130825060|NCT02628444|470990772|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
130825061|NCT02628444|470990773|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
130825062|NCT02628444|470990774|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
130825063|NCT02628444|470990775|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
130825064|NCT02628444|470990776|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
130825065|NCT02628444|470990777|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
130825066|NCT02628444|470990778|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
130825067|NCT02628444|470990770|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130825068|NCT02628444|470990771|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130825069|NCT02628444|470990772|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130825070|NCT02628444|470990773|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130825071|NCT02628444|470990774|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
130825072|NCT02628444|470990775|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130825073|NCT02628444|470990776|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130825074|NCT02628444|470990777|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
130825075|NCT02628444|470990778|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
130825076|NCT02628444|470990770|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
130825077|NCT02628444|470990771|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
130825078|NCT02628444|470990772|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
130825079|NCT02628444|470990773|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
130825080|NCT02628444|470990774|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
130825081|NCT02628444|470990775|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
130825082|NCT02628444|470990776|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
130825083|NCT02628444|470990777|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
130825084|NCT02628444|470990778|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
130825085|NCT00532129|470990779|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
130825086|NCT00532129|470990779|FG000|Treatment Period|Physician Decision|15|||
130825087|NCT00532129|470990779|FG000|Treatment Period|Disease progression|3|||
130825088|NCT00532129|470990779|FG000|Treatment Period|Protocol Violation|1|||
130825089|NCT00532129|470990779|FG000|Treatment Period|Other|5|||
130825090|NCT00532129|470990779|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
130825091|NCT00532129|470990779|FG000|Follow-up Period|Disease progression|57|||
130825092|NCT00532129|470990779|FG000|Follow-up Period|Lost to Follow-up|1|||
130825093|NCT00532129|470990779|FG000|Follow-up Period|Other|6|||
130825094|NCT00784368|470990782|FG000|Overall Study|Physician Decision|0|||
130825095|NCT00784368|470990783|FG001|Overall Study|Physician Decision|0|||
130825096|NCT00784368|470990784|FG002|Overall Study|Physician Decision|6|||
130825097|NCT00784368|470990782|FG000|Overall Study|Lack of Efficacy|2|||
130825098|NCT00784368|470990783|FG001|Overall Study|Lack of Efficacy|0|||
130825099|NCT00784368|470990784|FG002|Overall Study|Lack of Efficacy|1|||
130825100|NCT00784368|470990782|FG000|Overall Study|Adverse Event|6|||
130825101|NCT00784368|470990783|FG001|Overall Study|Adverse Event|9|||
130825102|NCT00784368|470990784|FG002|Overall Study|Adverse Event|2|||
130825103|NCT00784368|470990782|FG000|Overall Study|Diagnosis of fever|0|||
130825104|NCT00784368|470990783|FG001|Overall Study|Diagnosis of fever|0|||
130825105|NCT00784368|470990784|FG002|Overall Study|Diagnosis of fever|1|||
130825106|NCT00784368|470990782|FG000|Overall Study|Worsening of complications|0|||
130825107|NCT00784368|470990783|FG001|Overall Study|Worsening of complications|0|||
130825108|NCT00784368|470990784|FG002|Overall Study|Worsening of complications|1|||
130825109|NCT00784368|470990782|FG000|Overall Study|Worsening of symptoms|0|||
130825110|NCT00784368|470990783|FG001|Overall Study|Worsening of symptoms|1|||
130825111|NCT00784368|470990784|FG002|Overall Study|Worsening of symptoms|0|||
130825112|NCT00784368|470990782|FG000|Overall Study|Withdrawal of informed consent|0|||
130825113|NCT00784368|470990783|FG001|Overall Study|Withdrawal of informed consent|1|||
130825114|NCT00784368|470990784|FG002|Overall Study|Withdrawal of informed consent|0|||
130825115|NCT02237001|470990785|FG000|Overall Study|Lost to Follow-up|2|||
130825116|NCT02237001|470990785|FG000|Overall Study|Withdrawal by Subject|1|||
130825117|NCT02237001|470990785|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
130825118|NCT02237001|470990785|FG000|Overall Study|Re-operation|4|||
130825119|NCT02237001|470990785|FG000|Overall Study|Incarceration|1|||
130825120|NCT01713582|470990786|FG000|Overall Study|Disease progression|3|||
130825121|NCT01713582|470990787|FG001|Overall Study|Disease progression|3|||
130825122|NCT01713582|470990788|FG002|Overall Study|Disease progression|3|||
130825123|NCT01713582|470990789|FG003|Overall Study|Disease progression|2|||
130825124|NCT01713582|470990790|FG004|Overall Study|Disease progression|3|||
130825125|NCT01713582|470990791|FG005|Overall Study|Disease progression|3|||
130825126|NCT01713582|470990792|FG006|Overall Study|Disease progression|3|||
130825127|NCT01713582|470990793|FG007|Overall Study|Disease progression|3|||
130825128|NCT01713582|470990794|FG008|Overall Study|Disease progression|3|||
130825129|NCT01713582|470990795|FG009|Overall Study|Disease progression|11|||
130825130|NCT01713582|470990796|FG010|Overall Study|Disease progression|10|||
130825131|NCT01713582|470990797|FG011|Overall Study|Disease progression|5|||
130825132|NCT01713582|470990798|FG012|Overall Study|Disease progression|3|||
130825133|NCT01713582|470990799|FG013|Overall Study|Disease progression|3|||
130825134|NCT01713582|470990800|FG014|Overall Study|Disease progression|6|||
130825135|NCT01713582|470990801|FG015|Overall Study|Disease progression|6|||
130825136|NCT01713582|470990802|FG016|Overall Study|Disease progression|5|||
130825137|NCT01713582|470990803|FG017|Overall Study|Disease progression|2|||
130825138|NCT01713582|470990804|FG018|Overall Study|Disease progression|3|||
130825139|NCT01713582|470990805|FG019|Overall Study|Disease progression|5|||
130825140|NCT01713582|470990806|FG020|Overall Study|Disease progression|15|||
130825141|NCT01713582|470990786|FG000|Overall Study|Death|0|||
130825142|NCT01713582|470990787|FG001|Overall Study|Death|0|||
130825143|NCT01713582|470990788|FG002|Overall Study|Death|0|||
130825144|NCT01713582|470990789|FG003|Overall Study|Death|1|||
130825145|NCT01713582|470990790|FG004|Overall Study|Death|1|||
130825146|NCT01713582|470990791|FG005|Overall Study|Death|3|||
130825147|NCT01713582|470990792|FG006|Overall Study|Death|3|||
130825148|NCT01713582|470990793|FG007|Overall Study|Death|2|||
130825149|NCT01713582|470990794|FG008|Overall Study|Death|3|||
130825150|NCT01713582|470990795|FG009|Overall Study|Death|4|||
130825151|NCT01713582|470990796|FG010|Overall Study|Death|3|||
130825152|NCT01713582|470990797|FG011|Overall Study|Death|0|||
130825153|NCT01713582|470990798|FG012|Overall Study|Death|0|||
130825154|NCT01713582|470990799|FG013|Overall Study|Death|0|||
130825155|NCT01713582|470990800|FG014|Overall Study|Death|0|||
130825156|NCT01713582|470990801|FG015|Overall Study|Death|0|||
130825157|NCT01713582|470990802|FG016|Overall Study|Death|0|||
130825158|NCT01713582|470990803|FG017|Overall Study|Death|0|||
130825159|NCT01713582|470990804|FG018|Overall Study|Death|0|||
130825160|NCT01713582|470990805|FG019|Overall Study|Death|0|||
130825161|NCT01713582|470990806|FG020|Overall Study|Death|0|||
130825162|NCT01713582|470990786|FG000|Overall Study|Adverse event-related|0|||
130825163|NCT01713582|470990787|FG001|Overall Study|Adverse event-related|0|||
130825164|NCT01713582|470990788|FG002|Overall Study|Adverse event-related|0|||
130825165|NCT01713582|470990789|FG003|Overall Study|Adverse event-related|0|||
130825166|NCT01713582|470990790|FG004|Overall Study|Adverse event-related|0|||
130825167|NCT01713582|470990791|FG005|Overall Study|Adverse event-related|0|||
130825168|NCT01713582|470990792|FG006|Overall Study|Adverse event-related|0|||
130825169|NCT01713582|470990793|FG007|Overall Study|Adverse event-related|0|||
130825170|NCT01713582|470990794|FG008|Overall Study|Adverse event-related|0|||
130825171|NCT01713582|470990795|FG009|Overall Study|Adverse event-related|1|||
130825172|NCT01713582|470990796|FG010|Overall Study|Adverse event-related|1|||
130825173|NCT01713582|470990797|FG011|Overall Study|Adverse event-related|0|||
130825174|NCT01713582|470990798|FG012|Overall Study|Adverse event-related|0|||
130825175|NCT01713582|470990799|FG013|Overall Study|Adverse event-related|0|||
130825176|NCT01713582|470990800|FG014|Overall Study|Adverse event-related|0|||
130825177|NCT01713582|470990801|FG015|Overall Study|Adverse event-related|0|||
130825178|NCT01713582|470990802|FG016|Overall Study|Adverse event-related|0|||
130825179|NCT01713582|470990803|FG017|Overall Study|Adverse event-related|0|||
130825180|NCT01713582|470990804|FG018|Overall Study|Adverse event-related|1|||
130825181|NCT01713582|470990805|FG019|Overall Study|Adverse event-related|0|||
130825182|NCT01713582|470990806|FG020|Overall Study|Adverse event-related|0|||
130825183|NCT01713582|470990786|FG000|Overall Study|Adverse event-unrelated|0|||
130825184|NCT01713582|470990787|FG001|Overall Study|Adverse event-unrelated|0|||
130825185|NCT01713582|470990788|FG002|Overall Study|Adverse event-unrelated|0|||
130825186|NCT01713582|470990789|FG003|Overall Study|Adverse event-unrelated|0|||
130825187|NCT01713582|470990790|FG004|Overall Study|Adverse event-unrelated|0|||
130825188|NCT01713582|470990791|FG005|Overall Study|Adverse event-unrelated|1|||
130825189|NCT01713582|470990792|FG006|Overall Study|Adverse event-unrelated|1|||
130825190|NCT01713582|470990793|FG007|Overall Study|Adverse event-unrelated|1|||
130825191|NCT01713582|470990794|FG008|Overall Study|Adverse event-unrelated|0|||
130825192|NCT01713582|470990795|FG009|Overall Study|Adverse event-unrelated|0|||
130825193|NCT01713582|470990796|FG010|Overall Study|Adverse event-unrelated|0|||
130825194|NCT01713582|470990797|FG011|Overall Study|Adverse event-unrelated|0|||
130825195|NCT01713582|470990798|FG012|Overall Study|Adverse event-unrelated|0|||
130825196|NCT01713582|470990799|FG013|Overall Study|Adverse event-unrelated|1|||
130825197|NCT01713582|470990800|FG014|Overall Study|Adverse event-unrelated|1|||
130825198|NCT01713582|470990801|FG015|Overall Study|Adverse event-unrelated|0|||
130825199|NCT01713582|470990802|FG016|Overall Study|Adverse event-unrelated|0|||
130825200|NCT01713582|470990803|FG017|Overall Study|Adverse event-unrelated|0|||
130825201|NCT01713582|470990804|FG018|Overall Study|Adverse event-unrelated|0|||
130825202|NCT01713582|470990805|FG019|Overall Study|Adverse event-unrelated|0|||
130825203|NCT01713582|470990806|FG020|Overall Study|Adverse event-unrelated|0|||
130825204|NCT01713582|470990786|FG000|Overall Study|Withdrawal of consent|0|||
130825205|NCT01713582|470990787|FG001|Overall Study|Withdrawal of consent|0|||
130825206|NCT01713582|470990788|FG002|Overall Study|Withdrawal of consent|1|||
130825207|NCT01713582|470990789|FG003|Overall Study|Withdrawal of consent|0|||
130825208|NCT01713582|470990790|FG004|Overall Study|Withdrawal of consent|0|||
130825209|NCT01713582|470990791|FG005|Overall Study|Withdrawal of consent|1|||
130825210|NCT01713582|470990792|FG006|Overall Study|Withdrawal of consent|0|||
130825211|NCT01713582|470990793|FG007|Overall Study|Withdrawal of consent|0|||
130825212|NCT01713582|470990794|FG008|Overall Study|Withdrawal of consent|0|||
130825213|NCT01713582|470990795|FG009|Overall Study|Withdrawal of consent|1|||
130825214|NCT01713582|470990796|FG010|Overall Study|Withdrawal of consent|0|||
130825215|NCT01713582|470990797|FG011|Overall Study|Withdrawal of consent|0|||
130825216|NCT01713582|470990798|FG012|Overall Study|Withdrawal of consent|0|||
130825217|NCT01713582|470990799|FG013|Overall Study|Withdrawal of consent|0|||
130825218|NCT01713582|470990800|FG014|Overall Study|Withdrawal of consent|0|||
130825219|NCT01713582|470990801|FG015|Overall Study|Withdrawal of consent|0|||
130825220|NCT01713582|470990802|FG016|Overall Study|Withdrawal of consent|0|||
130825221|NCT01713582|470990803|FG017|Overall Study|Withdrawal of consent|0|||
130825222|NCT01713582|470990804|FG018|Overall Study|Withdrawal of consent|1|||
130825223|NCT01713582|470990805|FG019|Overall Study|Withdrawal of consent|0|||
130825224|NCT01713582|470990806|FG020|Overall Study|Withdrawal of consent|0|||
130825225|NCT01713582|470990786|FG000|Overall Study|Lack of Efficacy|0|||
130825226|NCT01713582|470990787|FG001|Overall Study|Lack of Efficacy|0|||
130825227|NCT01713582|470990788|FG002|Overall Study|Lack of Efficacy|0|||
130825228|NCT01713582|470990789|FG003|Overall Study|Lack of Efficacy|0|||
130825229|NCT01713582|470990790|FG004|Overall Study|Lack of Efficacy|0|||
130825230|NCT01713582|470990791|FG005|Overall Study|Lack of Efficacy|0|||
130825231|NCT01713582|470990792|FG006|Overall Study|Lack of Efficacy|0|||
130825232|NCT01713582|470990793|FG007|Overall Study|Lack of Efficacy|0|||
130825233|NCT01713582|470990794|FG008|Overall Study|Lack of Efficacy|0|||
130825234|NCT01713582|470990795|FG009|Overall Study|Lack of Efficacy|1|||
130825235|NCT01713582|470990796|FG010|Overall Study|Lack of Efficacy|2|||
130825236|NCT01713582|470990797|FG011|Overall Study|Lack of Efficacy|0|||
130825237|NCT01713582|470990798|FG012|Overall Study|Lack of Efficacy|0|||
130825238|NCT01713582|470990799|FG013|Overall Study|Lack of Efficacy|0|||
130825239|NCT01713582|470990800|FG014|Overall Study|Lack of Efficacy|0|||
130825240|NCT01713582|470990801|FG015|Overall Study|Lack of Efficacy|0|||
130825241|NCT01713582|470990802|FG016|Overall Study|Lack of Efficacy|0|||
130825242|NCT01713582|470990803|FG017|Overall Study|Lack of Efficacy|0|||
130825243|NCT01713582|470990804|FG018|Overall Study|Lack of Efficacy|0|||
130825244|NCT01713582|470990805|FG019|Overall Study|Lack of Efficacy|0|||
130825245|NCT01713582|470990806|FG020|Overall Study|Lack of Efficacy|0|||
130825246|NCT01713582|470990786|FG000|Overall Study|Withdrawal by Subject|0|||
130825247|NCT01713582|470990787|FG001|Overall Study|Withdrawal by Subject|0|||
130825248|NCT01713582|470990788|FG002|Overall Study|Withdrawal by Subject|0|||
130825249|NCT01713582|470990789|FG003|Overall Study|Withdrawal by Subject|0|||
130825250|NCT01713582|470990790|FG004|Overall Study|Withdrawal by Subject|0|||
130825251|NCT01713582|470990791|FG005|Overall Study|Withdrawal by Subject|0|||
130825252|NCT01713582|470990792|FG006|Overall Study|Withdrawal by Subject|0|||
130825253|NCT01713582|470990793|FG007|Overall Study|Withdrawal by Subject|0|||
130825254|NCT01713582|470990794|FG008|Overall Study|Withdrawal by Subject|0|||
130825255|NCT01713582|470990795|FG009|Overall Study|Withdrawal by Subject|0|||
130825256|NCT01713582|470990796|FG010|Overall Study|Withdrawal by Subject|0|||
130825257|NCT01713582|470990797|FG011|Overall Study|Withdrawal by Subject|0|||
130825258|NCT01713582|470990798|FG012|Overall Study|Withdrawal by Subject|0|||
130825259|NCT01713582|470990799|FG013|Overall Study|Withdrawal by Subject|0|||
130825260|NCT01713582|470990800|FG014|Overall Study|Withdrawal by Subject|0|||
130825261|NCT01713582|470990801|FG015|Overall Study|Withdrawal by Subject|0|||
130825262|NCT01713582|470990802|FG016|Overall Study|Withdrawal by Subject|0|||
130825263|NCT01713582|470990803|FG017|Overall Study|Withdrawal by Subject|1|||
130825264|NCT01713582|470990804|FG018|Overall Study|Withdrawal by Subject|0|||
130825265|NCT01713582|470990805|FG019|Overall Study|Withdrawal by Subject|0|||
130825266|NCT01713582|470990806|FG020|Overall Study|Withdrawal by Subject|0|||
130825267|NCT01713582|470990786|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
130825268|NCT01713582|470990787|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
130825269|NCT01713582|470990788|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
130825270|NCT01713582|470990789|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
130825271|NCT01713582|470990790|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
130825272|NCT01713582|470990791|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
130825273|NCT01713582|470990792|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
130825274|NCT01713582|470990793|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
130825275|NCT01713582|470990794|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
130825276|NCT01713582|470990795|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
130825277|NCT01713582|470990796|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
130825278|NCT01713582|470990797|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
130825279|NCT01713582|470990798|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
130825280|NCT01713582|470990799|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
130825281|NCT01713582|470990800|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
130825282|NCT01713582|470990801|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
130825283|NCT01713582|470990802|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
130825284|NCT01713582|470990803|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
130825285|NCT01713582|470990804|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
130825286|NCT01713582|470990805|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
130825287|NCT01713582|470990806|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
130825288|NCT01713582|470990786|FG000|Overall Study|Disease progression and adverse event|0|||
130825289|NCT01713582|470990787|FG001|Overall Study|Disease progression and adverse event|0|||
130825290|NCT01713582|470990788|FG002|Overall Study|Disease progression and adverse event|0|||
130825291|NCT01713582|470990789|FG003|Overall Study|Disease progression and adverse event|0|||
130825292|NCT01713582|470990790|FG004|Overall Study|Disease progression and adverse event|0|||
130825293|NCT01713582|470990791|FG005|Overall Study|Disease progression and adverse event|0|||
130825294|NCT01713582|470990792|FG006|Overall Study|Disease progression and adverse event|0|||
130825295|NCT01713582|470990793|FG007|Overall Study|Disease progression and adverse event|0|||
130825296|NCT01713582|470990794|FG008|Overall Study|Disease progression and adverse event|0|||
130825297|NCT01713582|470990795|FG009|Overall Study|Disease progression and adverse event|0|||
130825298|NCT01713582|470990796|FG010|Overall Study|Disease progression and adverse event|0|||
130825299|NCT01713582|470990797|FG011|Overall Study|Disease progression and adverse event|0|||
130825300|NCT01713582|470990798|FG012|Overall Study|Disease progression and adverse event|0|||
130825301|NCT01713582|470990799|FG013|Overall Study|Disease progression and adverse event|0|||
130825302|NCT01713582|470990800|FG014|Overall Study|Disease progression and adverse event|0|||
130825303|NCT01713582|470990801|FG015|Overall Study|Disease progression and adverse event|0|||
130825304|NCT01713582|470990802|FG016|Overall Study|Disease progression and adverse event|1|||
130825305|NCT01713582|470990803|FG017|Overall Study|Disease progression and adverse event|0|||
130825306|NCT01713582|470990804|FG018|Overall Study|Disease progression and adverse event|0|||
130825307|NCT01713582|470990805|FG019|Overall Study|Disease progression and adverse event|0|||
130825308|NCT01713582|470990806|FG020|Overall Study|Disease progression and adverse event|0|||
130825309|NCT00342628|470990807|FG000|Overall Study|Withdrawal by Subject|19|||
130825310|NCT00342628|470990808|FG001|Overall Study|Withdrawal by Subject|19|||
130825311|NCT00342628|470990809|FG002|Overall Study|Withdrawal by Subject|18|||
130825312|NCT00342628|470990807|FG000|Overall Study|Death|1|||
130825313|NCT00342628|470990808|FG001|Overall Study|Death|1|||
130825314|NCT00342628|470990809|FG002|Overall Study|Death|0|||
130825315|NCT00342628|470990807|FG000|Overall Study|moved residence|0|||
130825316|NCT00342628|470990808|FG001|Overall Study|moved residence|1|||
130825317|NCT00342628|470990809|FG002|Overall Study|moved residence|1|||
130825318|NCT04551898|470990810|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
130825319|NCT04551898|470990811|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
130825320|NCT04551898|470990812|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
130825321|NCT04551898|470990813|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
130825322|NCT04551898|470990810|FG000|Overall Study|Withdrawal by Subject|5|||
130825323|NCT04551898|470990811|FG001|Overall Study|Withdrawal by Subject|1|||
130825324|NCT04551898|470990812|FG002|Overall Study|Withdrawal by Subject|2|||
130825325|NCT04551898|470990813|FG003|Overall Study|Withdrawal by Subject|2|||
130825326|NCT04551898|470990810|FG000|Overall Study|Lost to Follow-up|2|||
130825327|NCT04551898|470990811|FG001|Overall Study|Lost to Follow-up|1|||
130825328|NCT04551898|470990812|FG002|Overall Study|Lost to Follow-up|2|||
130825329|NCT04551898|470990813|FG003|Overall Study|Lost to Follow-up|2|||
130825330|NCT04551898|470990810|FG000|Overall Study|Death|1|||
130825331|NCT04551898|470990811|FG001|Overall Study|Death|0|||
130825332|NCT04551898|470990812|FG002|Overall Study|Death|0|||
130825333|NCT04551898|470990813|FG003|Overall Study|Death|0|||
130825334|NCT04551898|470990810|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
130825335|NCT04551898|470990811|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
130825336|NCT04551898|470990812|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
130825337|NCT04551898|470990813|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
130825338|NCT03427814|470990814|FG000|Overall Study|Withdrawal by Subject|4|||
130825339|NCT03427814|470990815|FG001|Overall Study|Withdrawal by Subject|4|||
130825340|NCT03427814|470990814|FG000|Overall Study|Lost to Follow-up|0|||
130825341|NCT03427814|470990815|FG001|Overall Study|Lost to Follow-up|2|||
130825342|NCT03427814|470990814|FG000|Overall Study|Death|42|||
130825343|NCT03427814|470990815|FG001|Overall Study|Death|31|||
130825344|NCT03427814|470990814|FG000|Overall Study|Sponsor's Decision|1|||
130825345|NCT03427814|470990815|FG001|Overall Study|Sponsor's Decision|0|||
130825346|NCT03427814|470990814|FG000|Overall Study|Investigator's Decision|1|||
130825347|NCT03427814|470990815|FG001|Overall Study|Investigator's Decision|2|||
130825348|NCT03427814|470990814|FG000|Overall Study|Disease progression|1|||
130825349|NCT03427814|470990815|FG001|Overall Study|Disease progression|0|||
130825350|NCT03427814|470990814|FG000|Overall Study|Treatment Completed|0|||
130825351|NCT03427814|470990815|FG001|Overall Study|Treatment Completed|1|||
130825352|NCT03427814|470990814|FG000|Overall Study|Sponsor's Decision to End study|21|||
130825353|NCT03427814|470990815|FG001|Overall Study|Sponsor's Decision to End study|25|||
130825354|NCT03427814|470990814|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
130825355|NCT03427814|470990815|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
130825356|NCT03846427|470990816|FG000|Overall Study|Death|13|||
130825357|NCT03846427|470990816|FG000|Overall Study|Withdrawal by Subject|3|||
130825358|NCT03846427|470990816|FG000|Overall Study|Physician Decision|1|||
130825359|NCT04971967|470990819|FG000|Overall Study|Lost to Follow-up|6|||
130825360|NCT04971967|470990820|FG001|Overall Study|Lost to Follow-up|7|||
130825361|NCT00682929|470990823|FG000|Overall Study|Adverse Event|4|||
130825362|NCT00682929|470990824|FG001|Overall Study|Adverse Event|1|||
130825363|NCT00682929|470990825|FG002|Overall Study|Adverse Event|1|||
130825364|NCT00682929|470990823|FG000|Overall Study|Withdrawal by Subject|1|||
130825365|NCT00682929|470990824|FG001|Overall Study|Withdrawal by Subject|2|||
130825366|NCT00682929|470990825|FG002|Overall Study|Withdrawal by Subject|1|||
130825367|NCT00682929|470990823|FG000|Overall Study|dosing compliance < 80%|0|||
130825368|NCT00682929|470990824|FG001|Overall Study|dosing compliance < 80%|2|||
130825369|NCT00682929|470990825|FG002|Overall Study|dosing compliance < 80%|0|||
130825370|NCT00682929|470990823|FG000|Overall Study|lag in DEA renewal|1|||
130825371|NCT00682929|470990824|FG001|Overall Study|lag in DEA renewal|0|||
130825372|NCT00682929|470990825|FG002|Overall Study|lag in DEA renewal|0|||
130825373|NCT01462929|470990826|FG000|Overall Study|Adverse Event|3|||
130825374|NCT01462929|470990827|FG001|Overall Study|Adverse Event|3|||
130825375|NCT01462929|470990828|FG002|Overall Study|Adverse Event|4|||
130825376|NCT01462929|470990826|FG000|Overall Study|Withdrawal by Subject|2|||
130825377|NCT01462929|470990827|FG001|Overall Study|Withdrawal by Subject|1|||
130825378|NCT01462929|470990828|FG002|Overall Study|Withdrawal by Subject|0|||
130825379|NCT01462929|470990826|FG000|Overall Study|Lack of Efficacy|0|||
130825380|NCT01462929|470990827|FG001|Overall Study|Lack of Efficacy|0|||
130825381|NCT01462929|470990828|FG002|Overall Study|Lack of Efficacy|1|||
130825382|NCT00399568|470990829|FG000|Overall Study|Adverse Event|1|||
130825383|NCT00399568|470990830|FG001|Overall Study|Adverse Event|2|||
130825384|NCT00399568|470990829|FG000|Overall Study|Withdrawal by Subject|7|||
130825385|NCT00399568|470990830|FG001|Overall Study|Withdrawal by Subject|3|||
130825386|NCT00399568|470990829|FG000|Overall Study|Protocol non-compliance|2|||
130825387|NCT00399568|470990830|FG001|Overall Study|Protocol non-compliance|2|||
130825388|NCT00399568|470990829|FG000|Overall Study|Lost to Follow-up|2|||
130825389|NCT00399568|470990830|FG001|Overall Study|Lost to Follow-up|2|||
130825390|NCT00856635|470990831|FG000|Overall Study|Lost to Follow-up|2|||
130825391|NCT00856635|470990832|FG001|Overall Study|Lost to Follow-up|5|||
130825392|NCT00856635|470990831|FG000|Overall Study|Pregnancy|1|||
130825393|NCT00856635|470990832|FG001|Overall Study|Pregnancy|0|||
130825394|NCT00856635|470990831|FG000|Overall Study|Withdrawal by Subject|3|||
130825395|NCT00856635|470990832|FG001|Overall Study|Withdrawal by Subject|1|||
130825396|NCT00856635|470990831|FG000|Overall Study|Serious Adverse Event|1|||
130825397|NCT00856635|470990832|FG001|Overall Study|Serious Adverse Event|0|||
130825398|NCT00856635|470990831|FG000|Overall Study|Other|1|||
130825399|NCT00856635|470990832|FG001|Overall Study|Other|0|||
130825400|NCT00856635|470990831|FG000|Overall Study|Discontinued at Randomization|2|||
130825401|NCT00856635|470990832|FG001|Overall Study|Discontinued at Randomization|2|||
130825402|NCT01244035|470990833|FG000|Part 1: Period 1|Adverse Event|0|||
130825403|NCT01244035|470990834|FG001|Part 1: Period 1|Adverse Event|0|||
130825404|NCT01244035|470990835|FG002|Part 1: Period 1|Adverse Event|0|||
130825405|NCT01244035|470990836|FG003|Part 1: Period 1|Adverse Event|0|||
130825406|NCT01244035|470990837|FG004|Part 1: Period 1|Adverse Event|0|||
130825407|NCT01244035|470990838|FG005|Part 1: Period 1|Adverse Event|1|||
130825408|NCT01244035|470990833|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
130825409|NCT01244035|470990834|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
130825410|NCT01244035|470990835|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
130825411|NCT01244035|470990836|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
130825412|NCT01244035|470990837|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
130825413|NCT01244035|470990838|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
130825414|NCT01244035|470990833|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
130825415|NCT01244035|470990834|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
130825416|NCT01244035|470990835|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
130825417|NCT01244035|470990836|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
130825418|NCT01244035|470990837|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
130825419|NCT01244035|470990838|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
130825420|NCT01244035|470990833|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130825421|NCT01244035|470990834|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130825422|NCT01244035|470990835|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
130825423|NCT01244035|470990836|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130825424|NCT01244035|470990837|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130825425|NCT01244035|470990838|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130825426|NCT01244035|470990833|FG000|Part 1: Period 3|Adverse Event|0|||
130825427|NCT01244035|470990834|FG001|Part 1: Period 3|Adverse Event|0|||
130825428|NCT01244035|470990835|FG002|Part 1: Period 3|Adverse Event|0|||
130825429|NCT01244035|470990836|FG003|Part 1: Period 3|Adverse Event|0|||
130825430|NCT01244035|470990837|FG004|Part 1: Period 3|Adverse Event|0|||
130825431|NCT01244035|470990838|FG005|Part 1: Period 3|Adverse Event|1|||
130825432|NCT01244035|470990833|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
130825433|NCT01244035|470990834|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
130825434|NCT01244035|470990835|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
130825435|NCT01244035|470990836|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
130825436|NCT01244035|470990837|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
130825437|NCT01244035|470990838|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
130825438|NCT01244035|470990833|FG000|Part 1: Period 3|Protocol Deviation|0|||
130825439|NCT01244035|470990834|FG001|Part 1: Period 3|Protocol Deviation|1|||
130825440|NCT01244035|470990835|FG002|Part 1: Period 3|Protocol Deviation|0|||
130825441|NCT01244035|470990836|FG003|Part 1: Period 3|Protocol Deviation|0|||
130825442|NCT01244035|470990837|FG004|Part 1: Period 3|Protocol Deviation|0|||
130825443|NCT01244035|470990838|FG005|Part 1: Period 3|Protocol Deviation|0|||
130825444|NCT03688919|470990841|FG000|Overall Study|Lost to Follow-up|2|||
130825445|NCT03688919|470990842|FG001|Overall Study|Lost to Follow-up|1|||
130825446|NCT03688919|470990841|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
130825447|NCT03688919|470990842|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
130825448|NCT02370368|470990843|FG000|Overall Study|Adverse Event|1|||
130825449|NCT02370368|470990844|FG001|Overall Study|Adverse Event|2|||
130825450|NCT02370368|470990843|FG000|Overall Study|Withdrawal by Subject|5|||
130825451|NCT02370368|470990844|FG001|Overall Study|Withdrawal by Subject|4|||
130825452|NCT03389308|470990847|FG000|Overall Study|Withdrawal by Subject|5|||
130825453|NCT03389308|470990847|FG000|Overall Study|Lost to Follow-up|3|||
130825454|NCT03389308|470990847|FG000|Overall Study|Adverse Event|2|||
130825455|NCT03389308|470990847|FG000|Overall Study|Sponsor Request|2|||
130825456|NCT03198767|470990849|FG000|Overall Study|Protocol Violation|0|||
130825457|NCT03198767|470990850|FG001|Overall Study|Protocol Violation|0|||
130825458|NCT03198767|470990851|FG002|Overall Study|Protocol Violation|0|||
130825459|NCT03198767|470990852|FG003|Overall Study|Protocol Violation|6|||
130825460|NCT03198767|470990853|FG004|Overall Study|Protocol Violation|0|||
130825461|NCT03198767|470990854|FG005|Overall Study|Protocol Violation|0|||
130825462|NCT03198767|470990855|FG006|Overall Study|Protocol Violation|0|||
130825463|NCT00570323|470990856|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
130825464|NCT00570323|470990857|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
130825465|NCT00570323|470990856|FG000|Started Treatment After Randomization|Protocol Violation|1|||
130825466|NCT00570323|470990857|FG001|Started Treatment After Randomization|Protocol Violation|0|||
130825467|NCT00570323|470990856|FG000|Started Treatment After Randomization|Physician Decision|1|||
130825468|NCT00570323|470990857|FG001|Started Treatment After Randomization|Physician Decision|0|||
130825469|NCT00570323|470990856|FG000|Complete Study After Start|Lost to Follow-up|0|||
130825470|NCT00570323|470990857|FG001|Complete Study After Start|Lost to Follow-up|1|||
130825471|NCT00570323|470990856|FG000|Complete Study After Start|Withdrawal by Subject|2|||
130825472|NCT00570323|470990857|FG001|Complete Study After Start|Withdrawal by Subject|0|||
130825473|NCT00570323|470990856|FG000|Complete Study After Start|Physician Decision|1|||
130825474|NCT00570323|470990857|FG001|Complete Study After Start|Physician Decision|0|||
130825475|NCT03896477|470990858|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
130825476|NCT03896477|470990859|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
130825477|NCT03896477|470990860|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
130825478|NCT03896477|470990858|FG000|Overall Study|Parent Requested Withdrawal|8|||
130825479|NCT03896477|470990859|FG001|Overall Study|Parent Requested Withdrawal|12|||
130825480|NCT03896477|470990860|FG002|Overall Study|Parent Requested Withdrawal|9|||
130825481|NCT03896477|470990858|FG000|Overall Study|Adverse Event|0|||
130825482|NCT03896477|470990859|FG001|Overall Study|Adverse Event|0|||
130825483|NCT03896477|470990860|FG002|Overall Study|Adverse Event|1|||
130825484|NCT03896477|470990858|FG000|Overall Study|Death|1|||
130825485|NCT03896477|470990859|FG001|Overall Study|Death|0|||
130825486|NCT03896477|470990860|FG002|Overall Study|Death|0|||
130825487|NCT03896477|470990858|FG000|Overall Study|Other|5|||
130825488|NCT03896477|470990859|FG001|Overall Study|Other|6|||
130825489|NCT03896477|470990860|FG002|Overall Study|Other|7|||
130825490|NCT03896477|470990858|FG000|Overall Study|Lost to Follow-up|2|||
130825491|NCT03896477|470990859|FG001|Overall Study|Lost to Follow-up|1|||
130825492|NCT03896477|470990860|FG002|Overall Study|Lost to Follow-up|1|||
130825493|NCT01791517|470990861|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
130825494|NCT01791517|470990862|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
130825495|NCT01791517|470990863|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
130825496|NCT01791517|470990864|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
130825497|NCT01791517|470990865|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
130825498|NCT01791517|470990866|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
130825499|NCT01791517|470990867|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
130825500|NCT01791517|470990868|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
130825501|NCT01791517|470990869|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
130825502|NCT01791517|470990870|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
130825503|NCT01791517|470990871|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
130825504|NCT01791517|470990872|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
130825505|NCT01791517|470990861|FG000|Phase I: Period 1|Adverse Event|0|||
130825506|NCT01791517|470990862|FG001|Phase I: Period 1|Adverse Event|0|||
130825507|NCT01791517|470990863|FG002|Phase I: Period 1|Adverse Event|1|||
130825508|NCT01791517|470990864|FG003|Phase I: Period 1|Adverse Event|1|||
130825509|NCT01791517|470990865|FG004|Phase I: Period 1|Adverse Event|0|||
130825510|NCT01791517|470990866|FG005|Phase I: Period 1|Adverse Event|0|||
130825511|NCT01791517|470990867|FG006|Phase I: Period 1|Adverse Event|0|||
130825512|NCT01791517|470990868|FG007|Phase I: Period 1|Adverse Event|0|||
130825513|NCT01791517|470990869|FG008|Phase I: Period 1|Adverse Event|0|||
130825514|NCT01791517|470990870|FG009|Phase I: Period 1|Adverse Event|0|||
130825515|NCT01791517|470990871|FG010|Phase I: Period 1|Adverse Event|0|||
130825516|NCT01791517|470990872|FG011|Phase I: Period 1|Adverse Event|0|||
130825517|NCT01791517|470990861|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
130825518|NCT01791517|470990862|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825519|NCT01791517|470990863|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825520|NCT01791517|470990864|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825521|NCT01791517|470990865|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825522|NCT01791517|470990866|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825523|NCT01791517|470990867|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825524|NCT01791517|470990868|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825525|NCT01791517|470990869|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825526|NCT01791517|470990870|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825527|NCT01791517|470990871|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825528|NCT01791517|470990872|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130825529|NCT01791517|470990861|FG000|Phase I: Period 1|Protocol Violation|0|||
130825530|NCT01791517|470990862|FG001|Phase I: Period 1|Protocol Violation|1|||
130825531|NCT01791517|470990863|FG002|Phase I: Period 1|Protocol Violation|0|||
130825532|NCT01791517|470990864|FG003|Phase I: Period 1|Protocol Violation|0|||
130825533|NCT01791517|470990865|FG004|Phase I: Period 1|Protocol Violation|0|||
130825534|NCT01791517|470990866|FG005|Phase I: Period 1|Protocol Violation|0|||
130825535|NCT01791517|470990867|FG006|Phase I: Period 1|Protocol Violation|0|||
130825536|NCT01791517|470990868|FG007|Phase I: Period 1|Protocol Violation|0|||
130825537|NCT01791517|470990869|FG008|Phase I: Period 1|Protocol Violation|0|||
130825538|NCT01791517|470990870|FG009|Phase I: Period 1|Protocol Violation|0|||
130825539|NCT01791517|470990871|FG010|Phase I: Period 1|Protocol Violation|0|||
130825540|NCT01791517|470990872|FG011|Phase I: Period 1|Protocol Violation|0|||
130825541|NCT01791517|470990861|FG000|Phase I: Period 1|Lost to Follow-up|0|||
130825542|NCT01791517|470990862|FG001|Phase I: Period 1|Lost to Follow-up|0|||
130825543|NCT01791517|470990863|FG002|Phase I: Period 1|Lost to Follow-up|0|||
130825544|NCT01791517|470990864|FG003|Phase I: Period 1|Lost to Follow-up|1|||
130825545|NCT01791517|470990865|FG004|Phase I: Period 1|Lost to Follow-up|0|||
130825546|NCT01791517|470990866|FG005|Phase I: Period 1|Lost to Follow-up|0|||
130825547|NCT01791517|470990867|FG006|Phase I: Period 1|Lost to Follow-up|1|||
130825548|NCT01791517|470990868|FG007|Phase I: Period 1|Lost to Follow-up|0|||
130825549|NCT01791517|470990869|FG008|Phase I: Period 1|Lost to Follow-up|1|||
130825550|NCT01791517|470990870|FG009|Phase I: Period 1|Lost to Follow-up|1|||
130825551|NCT01791517|470990871|FG010|Phase I: Period 1|Lost to Follow-up|0|||
130825552|NCT01791517|470990872|FG011|Phase I: Period 1|Lost to Follow-up|0|||
130825553|NCT01791517|470990861|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825554|NCT01791517|470990862|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825555|NCT01791517|470990863|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825556|NCT01791517|470990864|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825557|NCT01791517|470990865|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825558|NCT01791517|470990866|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825559|NCT01791517|470990867|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825560|NCT01791517|470990868|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825561|NCT01791517|470990869|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825562|NCT01791517|470990870|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825563|NCT01791517|470990871|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
130825564|NCT01791517|470990872|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
130825565|NCT01791517|470990861|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
130825566|NCT01791517|470990862|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825567|NCT01791517|470990863|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825568|NCT01791517|470990864|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825569|NCT01791517|470990865|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825570|NCT01791517|470990866|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825571|NCT01791517|470990867|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825572|NCT01791517|470990868|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825573|NCT01791517|470990869|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825574|NCT01791517|470990870|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825575|NCT01791517|470990871|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825576|NCT01791517|470990872|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130825577|NCT01791517|470990861|FG000|Phase I: Period 2|Protocol Violation|0|||
130825578|NCT01791517|470990862|FG001|Phase I: Period 2|Protocol Violation|0|||
130825579|NCT01791517|470990863|FG002|Phase I: Period 2|Protocol Violation|0|||
130825580|NCT01791517|470990864|FG003|Phase I: Period 2|Protocol Violation|1|||
130825581|NCT01791517|470990865|FG004|Phase I: Period 2|Protocol Violation|0|||
130825582|NCT01791517|470990866|FG005|Phase I: Period 2|Protocol Violation|0|||
130825583|NCT01791517|470990867|FG006|Phase I: Period 2|Protocol Violation|0|||
130825584|NCT01791517|470990868|FG007|Phase I: Period 2|Protocol Violation|0|||
130825585|NCT01791517|470990869|FG008|Phase I: Period 2|Protocol Violation|0|||
130825586|NCT01791517|470990870|FG009|Phase I: Period 2|Protocol Violation|0|||
130825587|NCT01791517|470990871|FG010|Phase I: Period 2|Protocol Violation|0|||
130825588|NCT01791517|470990872|FG011|Phase I: Period 2|Protocol Violation|0|||
130825589|NCT01791517|470990861|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
130825590|NCT01791517|470990862|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
130825591|NCT01791517|470990863|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
130825592|NCT01791517|470990864|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
130825593|NCT01791517|470990865|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
130825594|NCT01791517|470990866|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
130825595|NCT01791517|470990867|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
130825596|NCT01791517|470990868|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
130825597|NCT01791517|470990869|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
130825598|NCT01791517|470990870|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
130825599|NCT01791517|470990871|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
130825600|NCT01791517|470990872|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
130825601|NCT01791517|470990861|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825602|NCT01791517|470990862|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825603|NCT01791517|470990863|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825604|NCT01791517|470990864|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825605|NCT01791517|470990865|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825606|NCT01791517|470990866|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825607|NCT01791517|470990867|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825608|NCT01791517|470990868|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825609|NCT01791517|470990869|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825610|NCT01791517|470990870|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825611|NCT01791517|470990871|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
130825612|NCT01791517|470990872|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130825613|NCT01791517|470990861|FG000|Phase I: Period 2|Lens Discomfort|0|||
130825614|NCT01791517|470990862|FG001|Phase I: Period 2|Lens Discomfort|0|||
130825615|NCT01791517|470990863|FG002|Phase I: Period 2|Lens Discomfort|0|||
130825616|NCT01791517|470990864|FG003|Phase I: Period 2|Lens Discomfort|0|||
130825617|NCT01791517|470990865|FG004|Phase I: Period 2|Lens Discomfort|0|||
130825618|NCT01791517|470990866|FG005|Phase I: Period 2|Lens Discomfort|1|||
130825619|NCT01791517|470990867|FG006|Phase I: Period 2|Lens Discomfort|0|||
130825620|NCT01791517|470990868|FG007|Phase I: Period 2|Lens Discomfort|0|||
130825621|NCT01791517|470990869|FG008|Phase I: Period 2|Lens Discomfort|0|||
130825622|NCT01791517|470990870|FG009|Phase I: Period 2|Lens Discomfort|0|||
130825623|NCT01791517|470990871|FG010|Phase I: Period 2|Lens Discomfort|0|||
130825624|NCT01791517|470990872|FG011|Phase I: Period 2|Lens Discomfort|0|||
130825625|NCT01791517|470990861|FG000|Phase I: Period 2|Lost to Follow-up|0|||
130825626|NCT01791517|470990862|FG001|Phase I: Period 2|Lost to Follow-up|3|||
130825627|NCT01791517|470990863|FG002|Phase I: Period 2|Lost to Follow-up|2|||
130825628|NCT01791517|470990864|FG003|Phase I: Period 2|Lost to Follow-up|0|||
130825629|NCT01791517|470990865|FG004|Phase I: Period 2|Lost to Follow-up|0|||
130825630|NCT01791517|470990866|FG005|Phase I: Period 2|Lost to Follow-up|0|||
130825631|NCT01791517|470990867|FG006|Phase I: Period 2|Lost to Follow-up|0|||
130825632|NCT01791517|470990868|FG007|Phase I: Period 2|Lost to Follow-up|0|||
130825633|NCT01791517|470990869|FG008|Phase I: Period 2|Lost to Follow-up|0|||
130825634|NCT01791517|470990870|FG009|Phase I: Period 2|Lost to Follow-up|0|||
130825635|NCT01791517|470990871|FG010|Phase I: Period 2|Lost to Follow-up|0|||
130825636|NCT01791517|470990872|FG011|Phase I: Period 2|Lost to Follow-up|0|||
130825637|NCT01791517|470990861|FG000|Phase I: Period 3|Lens Discomfort|0|||
130825638|NCT01791517|470990862|FG001|Phase I: Period 3|Lens Discomfort|0|||
130825639|NCT01791517|470990863|FG002|Phase I: Period 3|Lens Discomfort|0|||
130825640|NCT01791517|470990864|FG003|Phase I: Period 3|Lens Discomfort|0|||
130825641|NCT01791517|470990865|FG004|Phase I: Period 3|Lens Discomfort|0|||
130825642|NCT01791517|470990866|FG005|Phase I: Period 3|Lens Discomfort|0|||
130825643|NCT01791517|470990867|FG006|Phase I: Period 3|Lens Discomfort|0|||
130825644|NCT01791517|470990868|FG007|Phase I: Period 3|Lens Discomfort|0|||
130825645|NCT01791517|470990869|FG008|Phase I: Period 3|Lens Discomfort|0|||
130825646|NCT01791517|470990870|FG009|Phase I: Period 3|Lens Discomfort|0|||
130825647|NCT01791517|470990871|FG010|Phase I: Period 3|Lens Discomfort|0|||
130825648|NCT01791517|470990872|FG011|Phase I: Period 3|Lens Discomfort|1|||
130825649|NCT01791517|470990861|FG000|Phase I: Period 3|Lost to Follow-up|0|||
130825650|NCT01791517|470990862|FG001|Phase I: Period 3|Lost to Follow-up|1|||
130825651|NCT01791517|470990863|FG002|Phase I: Period 3|Lost to Follow-up|0|||
130825652|NCT01791517|470990864|FG003|Phase I: Period 3|Lost to Follow-up|0|||
130825653|NCT01791517|470990865|FG004|Phase I: Period 3|Lost to Follow-up|1|||
130825654|NCT01791517|470990866|FG005|Phase I: Period 3|Lost to Follow-up|0|||
130825655|NCT01791517|470990867|FG006|Phase I: Period 3|Lost to Follow-up|0|||
130825656|NCT01791517|470990868|FG007|Phase I: Period 3|Lost to Follow-up|0|||
130825657|NCT01791517|470990869|FG008|Phase I: Period 3|Lost to Follow-up|0|||
130825658|NCT01791517|470990870|FG009|Phase I: Period 3|Lost to Follow-up|0|||
130825659|NCT01791517|470990871|FG010|Phase I: Period 3|Lost to Follow-up|0|||
130825660|NCT01791517|470990872|FG011|Phase I: Period 3|Lost to Follow-up|0|||
130825661|NCT01791517|470990861|FG000|Phase I: Period 3|Adverse Event|0|||
130825662|NCT01791517|470990862|FG001|Phase I: Period 3|Adverse Event|0|||
130825663|NCT01791517|470990863|FG002|Phase I: Period 3|Adverse Event|0|||
130825664|NCT01791517|470990864|FG003|Phase I: Period 3|Adverse Event|1|||
130825665|NCT01791517|470990865|FG004|Phase I: Period 3|Adverse Event|0|||
130825666|NCT01791517|470990866|FG005|Phase I: Period 3|Adverse Event|0|||
130825667|NCT01791517|470990867|FG006|Phase I: Period 3|Adverse Event|0|||
130825668|NCT01791517|470990868|FG007|Phase I: Period 3|Adverse Event|0|||
130825669|NCT01791517|470990869|FG008|Phase I: Period 3|Adverse Event|0|||
130825670|NCT01791517|470990870|FG009|Phase I: Period 3|Adverse Event|0|||
130825671|NCT01791517|470990871|FG010|Phase I: Period 3|Adverse Event|0|||
130825672|NCT01791517|470990872|FG011|Phase I: Period 3|Adverse Event|0|||
130825673|NCT01791517|470990861|FG000|Phase II|Lost to Follow-up|1|||
130825674|NCT01791517|470990862|FG001|Phase II|Lost to Follow-up|0|||
130825675|NCT01791517|470990863|FG002|Phase II|Lost to Follow-up|1|||
130825676|NCT01791517|470990864|FG003|Phase II|Lost to Follow-up|0|||
130825677|NCT01791517|470990865|FG004|Phase II|Lost to Follow-up|1|||
130825678|NCT01791517|470990866|FG005|Phase II|Lost to Follow-up|2|||
130825679|NCT01791517|470990867|FG006|Phase II|Lost to Follow-up|0|||
130825680|NCT01791517|470990868|FG007|Phase II|Lost to Follow-up|1|||
130825681|NCT01791517|470990869|FG008|Phase II|Lost to Follow-up|1|||
130825682|NCT01791517|470990870|FG009|Phase II|Lost to Follow-up|1|||
130825683|NCT01791517|470990871|FG010|Phase II|Lost to Follow-up|0|||
130825684|NCT01791517|470990872|FG011|Phase II|Lost to Follow-up|0|||
130825685|NCT01791517|470990861|FG000|Phase II|Withdrawal by Subject|1|||
130825686|NCT01791517|470990862|FG001|Phase II|Withdrawal by Subject|0|||
130825687|NCT01791517|470990863|FG002|Phase II|Withdrawal by Subject|0|||
130825688|NCT01791517|470990864|FG003|Phase II|Withdrawal by Subject|0|||
130825689|NCT01791517|470990865|FG004|Phase II|Withdrawal by Subject|0|||
130825690|NCT01791517|470990866|FG005|Phase II|Withdrawal by Subject|2|||
130825691|NCT01791517|470990867|FG006|Phase II|Withdrawal by Subject|0|||
130825692|NCT01791517|470990868|FG007|Phase II|Withdrawal by Subject|1|||
130825693|NCT01791517|470990869|FG008|Phase II|Withdrawal by Subject|0|||
130825694|NCT01791517|470990870|FG009|Phase II|Withdrawal by Subject|0|||
130825695|NCT01791517|470990871|FG010|Phase II|Withdrawal by Subject|1|||
130825696|NCT01791517|470990872|FG011|Phase II|Withdrawal by Subject|0|||
130825697|NCT01791517|470990861|FG000|Phase II|Lack of Efficacy|0|||
130825698|NCT01791517|470990862|FG001|Phase II|Lack of Efficacy|0|||
130825699|NCT01791517|470990863|FG002|Phase II|Lack of Efficacy|0|||
130825700|NCT01791517|470990864|FG003|Phase II|Lack of Efficacy|0|||
130825701|NCT01791517|470990865|FG004|Phase II|Lack of Efficacy|1|||
130825702|NCT01791517|470990866|FG005|Phase II|Lack of Efficacy|0|||
130825703|NCT01791517|470990867|FG006|Phase II|Lack of Efficacy|0|||
130825704|NCT01791517|470990868|FG007|Phase II|Lack of Efficacy|0|||
130825705|NCT01791517|470990869|FG008|Phase II|Lack of Efficacy|0|||
130825706|NCT01791517|470990870|FG009|Phase II|Lack of Efficacy|0|||
130825707|NCT01791517|470990871|FG010|Phase II|Lack of Efficacy|0|||
130825708|NCT01791517|470990872|FG011|Phase II|Lack of Efficacy|0|||
130825709|NCT01791517|470990861|FG000|Phase II|Adverse Event|0|||
130825710|NCT01791517|470990862|FG001|Phase II|Adverse Event|0|||
130825711|NCT01791517|470990863|FG002|Phase II|Adverse Event|0|||
130825712|NCT01791517|470990864|FG003|Phase II|Adverse Event|0|||
130825713|NCT01791517|470990865|FG004|Phase II|Adverse Event|0|||
130825714|NCT01791517|470990866|FG005|Phase II|Adverse Event|0|||
130825715|NCT01791517|470990867|FG006|Phase II|Adverse Event|2|||
130825716|NCT01791517|470990868|FG007|Phase II|Adverse Event|1|||
130825717|NCT01791517|470990869|FG008|Phase II|Adverse Event|0|||
130825718|NCT01791517|470990870|FG009|Phase II|Adverse Event|1|||
130825719|NCT01791517|470990871|FG010|Phase II|Adverse Event|0|||
130825720|NCT01791517|470990872|FG011|Phase II|Adverse Event|0|||
130825721|NCT01791517|470990861|FG000|Phase II|Lens Handling Difficulties|0|||
130825722|NCT01791517|470990862|FG001|Phase II|Lens Handling Difficulties|0|||
130825723|NCT01791517|470990863|FG002|Phase II|Lens Handling Difficulties|0|||
130825724|NCT01791517|470990864|FG003|Phase II|Lens Handling Difficulties|0|||
130825725|NCT01791517|470990865|FG004|Phase II|Lens Handling Difficulties|0|||
130825726|NCT01791517|470990866|FG005|Phase II|Lens Handling Difficulties|0|||
130825727|NCT01791517|470990867|FG006|Phase II|Lens Handling Difficulties|0|||
130825728|NCT01791517|470990868|FG007|Phase II|Lens Handling Difficulties|0|||
130825729|NCT01791517|470990869|FG008|Phase II|Lens Handling Difficulties|1|||
130825730|NCT01791517|470990870|FG009|Phase II|Lens Handling Difficulties|0|||
130825731|NCT01791517|470990871|FG010|Phase II|Lens Handling Difficulties|0|||
130825732|NCT01791517|470990872|FG011|Phase II|Lens Handling Difficulties|0|||
130825733|NCT01791517|470990861|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
130825734|NCT01791517|470990862|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
130825735|NCT01791517|470990863|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
130825736|NCT01791517|470990864|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
130825737|NCT01791517|470990865|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
130825738|NCT01791517|470990866|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
130825739|NCT01791517|470990867|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
130825740|NCT01791517|470990868|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
130825741|NCT01791517|470990869|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
130825742|NCT01791517|470990870|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
130825743|NCT01791517|470990871|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
130825744|NCT01791517|470990872|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
130825745|NCT01791517|470990861|FG000|Phase II|Pre-Existing Ocular Issue|0|||
130825746|NCT01791517|470990862|FG001|Phase II|Pre-Existing Ocular Issue|0|||
130825747|NCT01791517|470990863|FG002|Phase II|Pre-Existing Ocular Issue|0|||
130825748|NCT01791517|470990864|FG003|Phase II|Pre-Existing Ocular Issue|0|||
130825749|NCT01791517|470990865|FG004|Phase II|Pre-Existing Ocular Issue|0|||
130825750|NCT01791517|470990866|FG005|Phase II|Pre-Existing Ocular Issue|0|||
130825751|NCT01791517|470990867|FG006|Phase II|Pre-Existing Ocular Issue|0|||
130825752|NCT01791517|470990868|FG007|Phase II|Pre-Existing Ocular Issue|0|||
130825753|NCT01791517|470990869|FG008|Phase II|Pre-Existing Ocular Issue|0|||
130825754|NCT01791517|470990870|FG009|Phase II|Pre-Existing Ocular Issue|0|||
130825755|NCT01791517|470990871|FG010|Phase II|Pre-Existing Ocular Issue|0|||
130825756|NCT01791517|470990872|FG011|Phase II|Pre-Existing Ocular Issue|1|||
130825757|NCT04011735|470990873|FG000|Overall Study|Withdrawal by Subject|1|||
130825758|NCT04011735|470990874|FG001|Overall Study|Withdrawal by Subject|0|||
130825759|NCT04011735|470990875|FG002|Overall Study|Withdrawal by Subject|1|||
130825760|NCT04011735|470990873|FG000|Overall Study|Met exclusion criteria after study entry|0|||
130825761|NCT04011735|470990874|FG001|Overall Study|Met exclusion criteria after study entry|1|||
130825762|NCT04011735|470990875|FG002|Overall Study|Met exclusion criteria after study entry|0|||
130825763|NCT00739310|470990880|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
130825764|NCT00739310|470990880|FG000|Overall Study|Withdrawal by Subject|1|||
130825765|NCT00739310|470990880|FG000|Overall Study|Lost to Follow-up|2|||
130825766|NCT02954887|470990881|FG000|Overall Study|Withdrawal by Subject|3|||
130825767|NCT02954887|470990881|FG000|Overall Study|Lack of Efficacy|3|||
130825768|NCT02954887|470990881|FG000|Overall Study|Other|1|||
130825769|NCT01071954|470990882|FG000|Overall Study|Noncompliance|4|||
130825770|NCT01071954|470990882|FG000|Overall Study|Adverse Event|1|||
130825771|NCT01071954|470990882|FG000|Overall Study|Withdrawal by Subject|11|||
130825772|NCT01071954|470990882|FG000|Overall Study|Requirement for Alternative Therapy|5|||
130825773|NCT01071954|470990882|FG000|Overall Study|Administrative Decision|5|||
130825774|NCT01071954|470990882|FG000|Overall Study|Protocol Specified Criteria|1|||
130825775|NCT01459666|470990883|FG000|Overall Study|PI left institution|5|||
130825776|NCT01459666|470990884|FG001|Overall Study|PI left institution|4|||
130825777|NCT00590967|470990886|FG000|Overall Study|Withdrawal by Subject|1|||
130825778|NCT00590967|470990887|FG001|Overall Study|Withdrawal by Subject|1|||
130825779|NCT00590967|470990886|FG000|Overall Study|Ineligible|1|||
130825780|NCT00590967|470990887|FG001|Overall Study|Ineligible|0|||
130825781|NCT00590967|470990886|FG000|Overall Study|Poor performance status|0|||
130825782|NCT00590967|470990887|FG001|Overall Study|Poor performance status|1|||
130825783|NCT00590967|470990886|FG000|Overall Study|Non-compliant|0|||
130825784|NCT00590967|470990887|FG001|Overall Study|Non-compliant|2|||
130825785|NCT00590967|470990886|FG000|Overall Study|Did not sign consent form|0|||
130825786|NCT00590967|470990887|FG001|Overall Study|Did not sign consent form|1|||
130825787|NCT00590967|470990886|FG000|Overall Study|Did not receive chemo per protocol|1|||
130825788|NCT00590967|470990887|FG001|Overall Study|Did not receive chemo per protocol|0|||
130825789|NCT00920556|470990890|FG000|Overall Study|Adverse Event|16|||
130825790|NCT00920556|470990890|FG000|Overall Study|Physician Decision|7|||
130825791|NCT00920556|470990890|FG000|Overall Study|Withdrawal by Subject|1|||
130825792|NCT01299389|470990891|FG000|Double-blind|Adverse Event|45|||
130825793|NCT01299389|470990892|FG001|Double-blind|Adverse Event|27|||
130825794|NCT01299389|470990893|FG002|Double-blind|Adverse Event|0|||
130825795|NCT01299389|470990894|FG003|Double-blind|Adverse Event|0|||
130825796|NCT01299389|470990891|FG000|Double-blind|Lack of Efficacy|45|||
130825797|NCT01299389|470990892|FG001|Double-blind|Lack of Efficacy|21|||
130825798|NCT01299389|470990893|FG002|Double-blind|Lack of Efficacy|0|||
130825799|NCT01299389|470990894|FG003|Double-blind|Lack of Efficacy|0|||
130825800|NCT01299389|470990891|FG000|Double-blind|Lost to Follow-up|2|||
130825801|NCT01299389|470990892|FG001|Double-blind|Lost to Follow-up|1|||
130825802|NCT01299389|470990893|FG002|Double-blind|Lost to Follow-up|0|||
130825803|NCT01299389|470990894|FG003|Double-blind|Lost to Follow-up|0|||
130825804|NCT01299389|470990891|FG000|Double-blind|Withdrawal by Subject|16|||
130825805|NCT01299389|470990892|FG001|Double-blind|Withdrawal by Subject|13|||
130825806|NCT01299389|470990893|FG002|Double-blind|Withdrawal by Subject|0|||
130825807|NCT01299389|470990894|FG003|Double-blind|Withdrawal by Subject|0|||
130825808|NCT01299389|470990891|FG000|Double-blind|Other|1|||
130825809|NCT01299389|470990892|FG001|Double-blind|Other|1|||
130825810|NCT01299389|470990893|FG002|Double-blind|Other|0|||
130825811|NCT01299389|470990894|FG003|Double-blind|Other|0|||
130825812|NCT01299389|470990891|FG000|Double-blind|"fail to meet study population criteria"|0|||
130825813|NCT01299389|470990892|FG001|Double-blind|"fail to meet study population criteria"|1|||
130825814|NCT01299389|470990893|FG002|Double-blind|"fail to meet study population criteria"|0|||
130825815|NCT01299389|470990894|FG003|Double-blind|"fail to meet study population criteria"|0|||
130825816|NCT01299389|470990891|FG000|Post-observational|Other|0|||
130825817|NCT01299389|470990892|FG001|Post-observational|Other|0|||
130825818|NCT01299389|470990893|FG002|Post-observational|Other|12|||
130825819|NCT01299389|470990894|FG003|Post-observational|Other|6|||
130825820|NCT04245709|470990895|FG000|Overall Study|Adverse Event|13|||
130825821|NCT04245709|470990895|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
130825822|NCT00889707|470990899|FG000|Overall Study|Adverse Event|1|||
130825823|NCT00889707|470990900|FG001|Overall Study|Adverse Event|0|||
130825824|NCT00889707|470990899|FG000|Overall Study|Withdrawal by Subject|4|||
130825825|NCT00889707|470990900|FG001|Overall Study|Withdrawal by Subject|3|||
130825826|NCT00889707|470990899|FG000|Overall Study|Lost to Follow-up|0|||
130825827|NCT00889707|470990900|FG001|Overall Study|Lost to Follow-up|2|||
130825828|NCT00889707|470990899|FG000|Overall Study|Lack of Efficacy|2|||
130825829|NCT00889707|470990900|FG001|Overall Study|Lack of Efficacy|5|||
130825830|NCT02185534|470990901|FG000|First Period|Withdrawal by Subject|0|||
130825831|NCT02185534|470990902|FG001|First Period|Withdrawal by Subject|0|||
130825832|NCT02185534|470990903|FG002|First Period|Withdrawal by Subject|0|||
130825833|NCT02185534|470990904|FG003|First Period|Withdrawal by Subject|1|||
130825834|NCT02185534|470990905|FG004|First Period|Withdrawal by Subject|0|||
130825835|NCT02185534|470990906|FG005|First Period|Withdrawal by Subject|0|||
130825836|NCT02185534|470990901|FG000|First Washout Period|Withdrawal by Subject|1|||
130825837|NCT02185534|470990902|FG001|First Washout Period|Withdrawal by Subject|0|||
130825838|NCT02185534|470990903|FG002|First Washout Period|Withdrawal by Subject|0|||
130825839|NCT02185534|470990904|FG003|First Washout Period|Withdrawal by Subject|0|||
130825840|NCT02185534|470990905|FG004|First Washout Period|Withdrawal by Subject|1|||
130825841|NCT02185534|470990906|FG005|First Washout Period|Withdrawal by Subject|0|||
130825842|NCT02185534|470990901|FG000|First Washout Period|Protocol Violation|0|||
130825843|NCT02185534|470990902|FG001|First Washout Period|Protocol Violation|0|||
130825844|NCT02185534|470990903|FG002|First Washout Period|Protocol Violation|0|||
130825845|NCT02185534|470990904|FG003|First Washout Period|Protocol Violation|0|||
130825846|NCT02185534|470990905|FG004|First Washout Period|Protocol Violation|0|||
130825847|NCT02185534|470990906|FG005|First Washout Period|Protocol Violation|1|||
130825848|NCT02948582|470990907|FG000|Washout Period 1|Adverse Event|0|||
130825849|NCT02948582|470990908|FG001|Washout Period 1|Adverse Event|2|||
130825850|NCT02948582|470990909|FG002|Washout Period 1|Adverse Event|0|||
130825851|NCT02948582|470990910|FG003|Washout Period 1|Adverse Event|0|||
130825852|NCT02948582|470990911|FG004|Washout Period 1|Adverse Event|0|||
130825853|NCT02948582|470990912|FG005|Washout Period 1|Adverse Event|0|||
130825854|NCT02948582|470990907|FG000|Washout Period 1|Protocol Violation|0|||
130825855|NCT02948582|470990908|FG001|Washout Period 1|Protocol Violation|0|||
130825856|NCT02948582|470990909|FG002|Washout Period 1|Protocol Violation|0|||
130825857|NCT02948582|470990910|FG003|Washout Period 1|Protocol Violation|0|||
130825858|NCT02948582|470990911|FG004|Washout Period 1|Protocol Violation|0|||
130825859|NCT02948582|470990912|FG005|Washout Period 1|Protocol Violation|1|||
130825860|NCT02948582|470990907|FG000|Washout Period 2|Adverse Event|0|||
130825861|NCT02948582|470990908|FG001|Washout Period 2|Adverse Event|1|||
130825862|NCT02948582|470990909|FG002|Washout Period 2|Adverse Event|0|||
130825863|NCT02948582|470990910|FG003|Washout Period 2|Adverse Event|0|||
130825864|NCT02948582|470990911|FG004|Washout Period 2|Adverse Event|0|||
130825865|NCT02948582|470990912|FG005|Washout Period 2|Adverse Event|0|||
130825866|NCT02948582|470990907|FG000|Washout Period 2|personal reasons|0|||
130825867|NCT02948582|470990908|FG001|Washout Period 2|personal reasons|0|||
130825868|NCT02948582|470990909|FG002|Washout Period 2|personal reasons|0|||
130825869|NCT02948582|470990910|FG003|Washout Period 2|personal reasons|1|||
130825870|NCT02948582|470990911|FG004|Washout Period 2|personal reasons|0|||
130825871|NCT02948582|470990912|FG005|Washout Period 2|personal reasons|0|||
130825872|NCT02948582|470990907|FG000|Washout Period 4|Adverse Event|1|||
130825873|NCT02948582|470990908|FG001|Washout Period 4|Adverse Event|0|||
130825874|NCT02948582|470990909|FG002|Washout Period 4|Adverse Event|1|||
130825875|NCT02948582|470990910|FG003|Washout Period 4|Adverse Event|0|||
130825876|NCT02948582|470990911|FG004|Washout Period 4|Adverse Event|0|||
130825877|NCT02948582|470990912|FG005|Washout Period 4|Adverse Event|0|||
130825878|NCT01151020|470990916|FG000|Overall Study|Death|25|||
130825879|NCT01151020|470990916|FG000|Overall Study|Conversion to open repair|1|||
130825880|NCT01151020|470990916|FG000|Overall Study|Lost to Follow-up|4|||
130825881|NCT01151020|470990916|FG000|Overall Study|Withdrawal by Subject|22|||
130825882|NCT01151020|470990916|FG000|Overall Study|Patients did not receive the device|2|||
130825883|NCT02389465|470990917|FG000|Overall Study|Lost to Follow-up|1|||
130825884|NCT02389465|470990918|FG001|Overall Study|Lost to Follow-up|3|||
130825885|NCT02389465|470990919|FG002|Overall Study|Lost to Follow-up|3|||
130825886|NCT02389465|470990920|FG003|Overall Study|Lost to Follow-up|0|||
130825887|NCT02389465|470990917|FG000|Overall Study|Physician Decision|0|||
130825888|NCT02389465|470990918|FG001|Overall Study|Physician Decision|0|||
130825889|NCT02389465|470990919|FG002|Overall Study|Physician Decision|0|||
130825890|NCT02389465|470990920|FG003|Overall Study|Physician Decision|1|||
130825891|NCT02389465|470990917|FG000|Overall Study|Withdrawal by Subject|0|||
130825892|NCT02389465|470990918|FG001|Overall Study|Withdrawal by Subject|1|||
130825893|NCT02389465|470990919|FG002|Overall Study|Withdrawal by Subject|2|||
130825894|NCT02389465|470990920|FG003|Overall Study|Withdrawal by Subject|2|||
130825895|NCT00846846|470990921|FG000|Overall Study|Death|56|||
130825896|NCT00846846|470990921|FG000|Overall Study|Withdrawal by Subject|19|||
130825897|NCT01220401|470990925|FG000|Overall Study|Withdrawal by Subject|2|||
130825898|NCT01220401|470990925|FG000|Overall Study|Protocol Violation|1|||
130825899|NCT04179305|470990927|FG000|Overall Study|Death|1|||
130825900|NCT04179305|470990928|FG001|Overall Study|Death|1|||
130825901|NCT04179305|470990929|FG002|Overall Study|Death|0|||
130825902|NCT04179305|470990930|FG003|Overall Study|Death|0|||
130825903|NCT04179305|470990927|FG000|Overall Study|Lost to Follow-up|1|||
130825904|NCT04179305|470990928|FG001|Overall Study|Lost to Follow-up|1|||
130825905|NCT04179305|470990929|FG002|Overall Study|Lost to Follow-up|0|||
130825906|NCT04179305|470990930|FG003|Overall Study|Lost to Follow-up|0|||
130825907|NCT04179305|470990927|FG000|Overall Study|Withdrawal by Subject|0|||
130825908|NCT04179305|470990928|FG001|Overall Study|Withdrawal by Subject|1|||
130825909|NCT04179305|470990929|FG002|Overall Study|Withdrawal by Subject|0|||
130825910|NCT04179305|470990930|FG003|Overall Study|Withdrawal by Subject|0|||
130825911|NCT04179305|470990927|FG000|Overall Study|Did not have scan|1|||
130825912|NCT04179305|470990928|FG001|Overall Study|Did not have scan|0|||
130825913|NCT04179305|470990929|FG002|Overall Study|Did not have scan|0|||
130825914|NCT04179305|470990930|FG003|Overall Study|Did not have scan|0|||
130825915|NCT04179305|470990927|FG000|Overall Study|In hospice care|3|||
130825916|NCT04179305|470990928|FG001|Overall Study|In hospice care|0|||
130825917|NCT04179305|470990929|FG002|Overall Study|In hospice care|0|||
130825918|NCT04179305|470990930|FG003|Overall Study|In hospice care|0|||
130825919|NCT00503425|470990933|FG000|Overall Study|Participant files lost|6|||
130825920|NCT00503425|470990933|FG000|Overall Study|Adverse Event|5|||
130825921|NCT00503425|470990933|FG000|Overall Study|Lack of Efficacy|25|||
130825922|NCT00503425|470990933|FG000|Overall Study|Withdrawal by Subject|8|||
130825923|NCT00503425|470990933|FG000|Overall Study|Lost to Follow-up|3|||
130825924|NCT00503425|470990933|FG000|Overall Study|Death|3|||
130825925|NCT00503425|470990933|FG000|Overall Study|Missing Data/Unknown|4|||
130825926|NCT00326599|470990934|FG000|Overall Study|Withdrawal by Subject|1|||
130825927|NCT00326599|470990935|FG001|Overall Study|Withdrawal by Subject|0|||
130825928|NCT00326599|470990936|FG002|Overall Study|Withdrawal by Subject|5|||
130825929|NCT00326599|470990937|FG003|Overall Study|Withdrawal by Subject|2|||
130825930|NCT00326599|470990934|FG000|Overall Study|Adverse Event|1|||
130825931|NCT00326599|470990935|FG001|Overall Study|Adverse Event|0|||
130825932|NCT00326599|470990936|FG002|Overall Study|Adverse Event|32|||
130825933|NCT00326599|470990937|FG003|Overall Study|Adverse Event|3|||
130825934|NCT00326599|470990934|FG000|Overall Study|Disease Progression|3|||
130825935|NCT00326599|470990935|FG001|Overall Study|Disease Progression|1|||
130825936|NCT00326599|470990936|FG002|Overall Study|Disease Progression|13|||
130825937|NCT00326599|470990937|FG003|Overall Study|Disease Progression|11|||
130825938|NCT00326599|470990934|FG000|Overall Study|Alternate Treatment|1|||
130825939|NCT00326599|470990935|FG001|Overall Study|Alternate Treatment|0|||
130825940|NCT00326599|470990936|FG002|Overall Study|Alternate Treatment|0|||
130825941|NCT00326599|470990937|FG003|Overall Study|Alternate Treatment|0|||
130825942|NCT00326599|470990934|FG000|Overall Study|Death|0|||
130825943|NCT00326599|470990935|FG001|Overall Study|Death|0|||
130825944|NCT00326599|470990936|FG002|Overall Study|Death|1|||
130825945|NCT00326599|470990937|FG003|Overall Study|Death|2|||
130825946|NCT00326599|470990934|FG000|Overall Study|Other Unspecified Reason|0|||
130825947|NCT00326599|470990935|FG001|Overall Study|Other Unspecified Reason|0|||
130825948|NCT00326599|470990936|FG002|Overall Study|Other Unspecified Reason|2|||
130825949|NCT00326599|470990937|FG003|Overall Study|Other Unspecified Reason|1|||
130825950|NCT00943761|470990946|FG000|Overall Study|Lost to Follow-up|2|||
130825951|NCT00943761|470990947|FG001|Overall Study|Lost to Follow-up|0|||
130825952|NCT00943761|470990946|FG000|Overall Study|Withdrawal by Subject|2|||
130825953|NCT00943761|470990947|FG001|Overall Study|Withdrawal by Subject|1|||
130825954|NCT02268383|470990948|FG000|Overall Study|Death|12|||
130825955|NCT02268383|470990948|FG000|Overall Study|Lost to Follow-up|2|||
130825956|NCT02268383|470990948|FG000|Overall Study|Withdrawal by Subject|9|||
130825957|NCT02268383|470990948|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
130825958|NCT02268383|470990948|FG000|Overall Study|Protocol deviation|3|||
130825959|NCT02268383|470990948|FG000|Overall Study|Sponsor decision|22|||
130825960|NCT02268383|470990948|FG000|Overall Study|Not reported|12|||
130825961|NCT02708680|470990949|FG000|Overall Study|Withdrawal by Subject|4|||
130825962|NCT02708680|470990950|FG001|Overall Study|Withdrawal by Subject|12|||
130825963|NCT02708680|470990951|FG002|Overall Study|Withdrawal by Subject|12|||
130825964|NCT02708680|470990949|FG000|Overall Study|Death|4|||
130825965|NCT02708680|470990950|FG001|Overall Study|Death|19|||
130825966|NCT02708680|470990951|FG002|Overall Study|Death|21|||
130825967|NCT02708680|470990949|FG000|Overall Study|Lost to Follow-up|0|||
130825968|NCT02708680|470990950|FG001|Overall Study|Lost to Follow-up|3|||
130825969|NCT02708680|470990951|FG002|Overall Study|Lost to Follow-up|3|||
130825970|NCT02708680|470990949|FG000|Overall Study|Study Terminated By Sponsor|0|||
130825971|NCT02708680|470990950|FG001|Overall Study|Study Terminated By Sponsor|5|||
130825972|NCT02708680|470990951|FG002|Overall Study|Study Terminated By Sponsor|4|||
130825973|NCT02708680|470990949|FG000|Overall Study|Other than Specified|0|||
130825974|NCT02708680|470990950|FG001|Overall Study|Other than Specified|0|||
130825975|NCT02708680|470990951|FG002|Overall Study|Other than Specified|1|||
130825976|NCT02708680|470990949|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
130825977|NCT02708680|470990950|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
130825978|NCT02708680|470990951|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
130825979|NCT01342926|470990952|FG000|Overall Study|Adverse Event|5|||
130825980|NCT01342926|470990953|FG001|Overall Study|Adverse Event|8|||
130825981|NCT01342926|470990954|FG002|Overall Study|Adverse Event|10|||
130825982|NCT01342926|470990955|FG003|Overall Study|Adverse Event|7|||
130825983|NCT01342926|470990952|FG000|Overall Study|Lost to Follow-up|0|||
130825984|NCT01342926|470990953|FG001|Overall Study|Lost to Follow-up|1|||
130825985|NCT01342926|470990954|FG002|Overall Study|Lost to Follow-up|1|||
130825986|NCT01342926|470990955|FG003|Overall Study|Lost to Follow-up|0|||
130825987|NCT01342926|470990952|FG000|Overall Study|Investigator Discretion|2|||
130825988|NCT01342926|470990953|FG001|Overall Study|Investigator Discretion|2|||
130825989|NCT01342926|470990954|FG002|Overall Study|Investigator Discretion|0|||
130825990|NCT01342926|470990955|FG003|Overall Study|Investigator Discretion|0|||
130825991|NCT01342926|470990952|FG000|Overall Study|Withdrawal by Subject|2|||
130825992|NCT01342926|470990953|FG001|Overall Study|Withdrawal by Subject|4|||
130825993|NCT01342926|470990954|FG002|Overall Study|Withdrawal by Subject|3|||
130825994|NCT01342926|470990955|FG003|Overall Study|Withdrawal by Subject|5|||
130825995|NCT04162470|470990956|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
130825996|NCT03382912|470990957|FG000|Overall Study|Physician Decision|0|||
130825997|NCT03382912|470990958|FG001|Overall Study|Physician Decision|1|||
130825998|NCT03382912|470990957|FG000|Overall Study|Sponsor Decision|6|||
130825999|NCT03382912|470990958|FG001|Overall Study|Sponsor Decision|6|||
130826000|NCT03382912|470990957|FG000|Overall Study|Withdrawal by Subject|0|||
130826001|NCT03382912|470990958|FG001|Overall Study|Withdrawal by Subject|5|||
130826002|NCT05588440|470990961|FG000|Overall Study|Sponsor Decision|2|||
130826003|NCT05588440|470990962|FG001|Overall Study|Sponsor Decision|0|||
130826004|NCT05588440|470990963|FG002|Overall Study|Sponsor Decision|1|||
130826005|NCT05588440|470990961|FG000|Overall Study|Death|1|||
130826006|NCT05588440|470990962|FG001|Overall Study|Death|1|||
130826007|NCT05588440|470990963|FG002|Overall Study|Death|1|||
130826008|NCT05588440|470990961|FG000|Overall Study|Screen Fail|0|||
130826009|NCT05588440|470990962|FG001|Overall Study|Screen Fail|1|||
130826010|NCT05588440|470990963|FG002|Overall Study|Screen Fail|1|||
130826011|NCT05588440|470990961|FG000|Overall Study|Withdrawal by Subject|0|||
130826012|NCT05588440|470990962|FG001|Overall Study|Withdrawal by Subject|0|||
130826013|NCT05588440|470990963|FG002|Overall Study|Withdrawal by Subject|1|||
130826014|NCT02137070|470990964|FG000|Overall Study|Adverse Event|12|||
130826015|NCT02137070|470990965|FG001|Overall Study|Adverse Event|3|||
130826016|NCT02137070|470990964|FG000|Overall Study|Death|2|||
130826017|NCT02137070|470990965|FG001|Overall Study|Death|0|||
130826018|NCT02137070|470990964|FG000|Overall Study|Lost to Follow-up|24|||
130826019|NCT02137070|470990965|FG001|Overall Study|Lost to Follow-up|9|||
130826020|NCT02137070|470990964|FG000|Overall Study|Physician Decision|0|||
130826021|NCT02137070|470990965|FG001|Overall Study|Physician Decision|1|||
130826022|NCT02137070|470990964|FG000|Overall Study|Protocol Violation|18|||
130826023|NCT02137070|470990965|FG001|Overall Study|Protocol Violation|4|||
130826024|NCT02137070|470990964|FG000|Overall Study|Withdrawal by Subject|18|||
130826025|NCT02137070|470990965|FG001|Overall Study|Withdrawal by Subject|1|||
130826026|NCT04790279|470992941|FG000|Overall Study|Did not meet medication start criteria|27|||
130826027|NCT04790279|470992942|FG001|Overall Study|Did not meet medication start criteria|15|||
130826028|NCT04790279|470992941|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
130826029|NCT04790279|470992942|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
130826030|NCT04790279|470992941|FG000|Overall Study|Protocol Violation|8|||
130826031|NCT04790279|470992942|FG001|Overall Study|Protocol Violation|3|||
130826032|NCT04790279|470992941|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
130826033|NCT04790279|470992942|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
130826034|NCT02079909|470992957|FG000|Overall Study|Adverse Event|23|||
130826035|NCT02079909|470992958|FG001|Overall Study|Adverse Event|23|||
130826036|NCT02079909|470992959|FG002|Overall Study|Adverse Event|7|||
130826037|NCT02079909|470992957|FG000|Overall Study|Withdrawal by Subject|9|||
130826038|NCT02079909|470992958|FG001|Overall Study|Withdrawal by Subject|17|||
130826039|NCT02079909|470992959|FG002|Overall Study|Withdrawal by Subject|4|||
130826040|NCT02079909|470992957|FG000|Overall Study|Lost to Follow-up|2|||
130826041|NCT02079909|470992958|FG001|Overall Study|Lost to Follow-up|3|||
130826042|NCT02079909|470992959|FG002|Overall Study|Lost to Follow-up|1|||
130826043|NCT02079909|470992957|FG000|Overall Study|Death|2|||
130826044|NCT02079909|470992958|FG001|Overall Study|Death|2|||
130826045|NCT02079909|470992959|FG002|Overall Study|Death|0|||
130826046|NCT02079909|470992957|FG000|Overall Study|Lack of Efficacy|0|||
130826047|NCT02079909|470992958|FG001|Overall Study|Lack of Efficacy|0|||
130826048|NCT02079909|470992959|FG002|Overall Study|Lack of Efficacy|1|||
130826049|NCT02079909|470992957|FG000|Overall Study|Protocol Violation|0|||
130826050|NCT02079909|470992958|FG001|Overall Study|Protocol Violation|1|||
130826051|NCT02079909|470992959|FG002|Overall Study|Protocol Violation|1|||
130826052|NCT02079909|470992957|FG000|Overall Study|Physician Decision|0|||
130826053|NCT02079909|470992958|FG001|Overall Study|Physician Decision|1|||
130826054|NCT02079909|470992959|FG002|Overall Study|Physician Decision|1|||
130826055|NCT02079909|470992957|FG000|Overall Study|Relocation etc.|2|||
130826056|NCT02079909|470992958|FG001|Overall Study|Relocation etc.|2|||
130826057|NCT02079909|470992959|FG002|Overall Study|Relocation etc.|3|||
130826058|NCT00720356|470992964|FG000|Registration to Study|Determined to have methylated MGMT|67|||
130826059|NCT00720356|470992964|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
130826060|NCT00720356|470992964|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
130826061|NCT00720356|470992964|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
130826062|NCT00720356|470992964|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
130826063|NCT00720356|470992964|FG000|Follow up Until Death|Withdrawal by Subject|1|||
130826064|NCT00720356|470992964|FG000|Follow up Until Death|Alive at last data collection|4|||
130826065|NCT01048242|470992969|FG000|Overall Study|See study flow chart|4|||
130826066|NCT01048242|470992970|FG001|Overall Study|See study flow chart|2|||
130826067|NCT02964273|470992971|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
130826068|NCT02964273|470992972|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
130826069|NCT02964273|470992973|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
130826070|NCT02964273|470992974|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
130826071|NCT02964273|470992971|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
130826072|NCT02964273|470992972|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
130826073|NCT02964273|470992973|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
130826074|NCT02964273|470992974|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
130826075|NCT02964273|470992971|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
130826076|NCT02964273|470992972|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
130826077|NCT02964273|470992973|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
130826078|NCT02964273|470992974|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
130826079|NCT02964273|470992971|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
130826080|NCT02964273|470992972|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
130826081|NCT02964273|470992973|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
130826082|NCT02964273|470992974|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
130826083|NCT02964273|470992971|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
130826084|NCT02964273|470992972|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
130826085|NCT02964273|470992973|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
130826086|NCT02964273|470992974|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
130826087|NCT02964273|470992971|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
130826088|NCT02964273|470992972|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
130826089|NCT02964273|470992973|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
130826090|NCT02964273|470992974|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
130826091|NCT00559104|470992976|FG000|Overall Study|Lack of Efficacy|9|||
130826092|NCT00559104|470992977|FG001|Overall Study|Lack of Efficacy|0|||
130826093|NCT01336712|470992978|FG000|Overall Study|Death|2|||
130826094|NCT01336712|470992978|FG000|Overall Study|Lack of Efficacy|1|||
130826095|NCT00506779|470992980|FG000|Overall Study|Withdrawal by Subject|1|||
130826096|NCT00506779|470992981|FG001|Overall Study|Withdrawal by Subject|0|||
130826097|NCT00506779|470992982|FG002|Overall Study|Withdrawal by Subject|1|||
130826098|NCT00506779|470992983|FG003|Overall Study|Withdrawal by Subject|0|||
130826099|NCT00506779|470992980|FG000|Overall Study|Adverse Event|0|||
130826100|NCT00506779|470992981|FG001|Overall Study|Adverse Event|1|||
130826101|NCT00506779|470992982|FG002|Overall Study|Adverse Event|1|||
130826102|NCT00506779|470992983|FG003|Overall Study|Adverse Event|1|||
130826103|NCT02639247|470992986|FG000|Overall Study|Lost to Follow-up|2|||
130826104|NCT02639247|470992987|FG001|Overall Study|Lost to Follow-up|1|||
130826105|NCT02639247|470992986|FG000|Overall Study|Death|2|||
130826106|NCT02639247|470992987|FG001|Overall Study|Death|0|||
130826107|NCT02639247|470992986|FG000|Overall Study|Withdrew Consent|0|||
130826108|NCT02639247|470992987|FG001|Overall Study|Withdrew Consent|1|||
130826109|NCT02639247|470992986|FG000|Overall Study|Protocol Violation|1|||
130826110|NCT02639247|470992987|FG001|Overall Study|Protocol Violation|0|||
130826111|NCT03462758|470992988|FG000|Overall Study|Chose no or other method of contraception|20|||
130826112|NCT03462758|470992989|FG001|Overall Study|Chose no or other method of contraception|23|||
130826113|NCT03462758|470992988|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
130826114|NCT03462758|470992989|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
130826115|NCT03462758|470992988|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
130826116|NCT03462758|470992989|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
130826117|NCT03462758|470992988|FG000|Overall Study|Medical contraindication|2|||
130826118|NCT03462758|470992989|FG001|Overall Study|Medical contraindication|2|||
130826119|NCT03462758|470992988|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
130826120|NCT03462758|470992989|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
130826121|NCT02820844|470992990|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
130826122|NCT02820844|470992991|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
130826123|NCT02820844|470992992|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130826124|NCT02820844|470992993|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130826125|NCT02820844|470992994|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130826126|NCT02820844|470992995|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130826127|NCT02820844|470992990|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
130826128|NCT02820844|470992991|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
130826129|NCT02820844|470992992|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130826130|NCT02820844|470992993|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130826131|NCT02820844|470992994|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130826132|NCT02820844|470992995|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130826133|NCT02820844|470992990|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130826134|NCT02820844|470992991|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
130826135|NCT02820844|470992992|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130826136|NCT02820844|470992993|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130826137|NCT02820844|470992994|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130826138|NCT02820844|470992995|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130826139|NCT02820844|470992990|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
130826140|NCT02820844|470992991|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
130826141|NCT02820844|470992992|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130826142|NCT02820844|470992993|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130826143|NCT02820844|470992994|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130826144|NCT02820844|470992995|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130826145|NCT02820844|470992990|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
130826146|NCT02820844|470992991|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130826147|NCT02820844|470992992|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130826148|NCT02820844|470992993|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130826149|NCT02820844|470992994|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130826150|NCT02820844|470992995|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130826151|NCT02820844|470992990|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130826152|NCT02820844|470992991|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130826153|NCT02820844|470992992|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
130826154|NCT02820844|470992993|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
130826155|NCT02820844|470992994|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130826156|NCT02820844|470992995|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130826157|NCT02820844|470992990|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130826158|NCT02820844|470992991|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130826159|NCT02820844|470992992|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
130826160|NCT02820844|470992993|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130826161|NCT02820844|470992994|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130826162|NCT02820844|470992995|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130826163|NCT02820844|470992990|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130826164|NCT02820844|470992991|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130826165|NCT02820844|470992992|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
130826166|NCT02820844|470992993|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
130826167|NCT02820844|470992994|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130826168|NCT02820844|470992995|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130826169|NCT02820844|470992990|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130826170|NCT02820844|470992991|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130826171|NCT02820844|470992992|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130826172|NCT02820844|470992993|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130826173|NCT02820844|470992994|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
130826174|NCT02820844|470992995|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130826175|NCT02820844|470992990|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130826176|NCT02820844|470992991|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130826177|NCT02820844|470992992|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130826178|NCT02820844|470992993|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130826179|NCT02820844|470992994|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130826180|NCT02820844|470992995|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
130826181|NCT02266147|470992997|FG000|PART 1: Dose Escalation|Physician Decision|0|||
130826182|NCT02266147|470992998|FG001|PART 1: Dose Escalation|Physician Decision|0|||
130826183|NCT02266147|470992999|FG002|PART 1: Dose Escalation|Physician Decision|1|||
130826184|NCT02266147|470993000|FG003|PART 1: Dose Escalation|Physician Decision|0|||
130826185|NCT02266147|470992997|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
130826186|NCT02266147|470992998|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
130826187|NCT02266147|470992999|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
130826188|NCT02266147|470993000|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
130826189|NCT02266147|470992997|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
130826190|NCT02266147|470992998|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
130826191|NCT02266147|470992999|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
130826192|NCT02266147|470993000|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
130826193|NCT02266147|470992997|FG000|PART 1: Dose Escalation|Other|1|||
130826194|NCT02266147|470992998|FG001|PART 1: Dose Escalation|Other|1|||
130826195|NCT02266147|470992999|FG002|PART 1: Dose Escalation|Other|0|||
130826196|NCT02266147|470993000|FG003|PART 1: Dose Escalation|Other|0|||
130826197|NCT02266147|470992997|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
130826198|NCT02266147|470992998|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
130826199|NCT02266147|470992999|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
130826200|NCT02266147|470993000|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
130826201|NCT02266147|470992997|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
130826202|NCT02266147|470992998|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
130826203|NCT02266147|470992999|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
130826204|NCT02266147|470993000|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
130826205|NCT01456130|470993001|FG000|Overall Study|Adverse Event|4|||
130826206|NCT01456130|470993001|FG000|Overall Study|Voluntary Withdrawal|1|||
130826207|NCT01456130|470993001|FG000|Overall Study|Lack of Efficacy|4|||
130826208|NCT01456130|470993001|FG000|Overall Study|Other|1|||
130826209|NCT00413660|470993004|FG000|Up To Week 12|Adverse Event|1|||
130826210|NCT00413660|470993005|FG001|Up To Week 12|Adverse Event|3|||
130826211|NCT00413660|470993006|FG002|Up To Week 12|Adverse Event|1|||
130826212|NCT00413660|470993007|FG003|Up To Week 12|Adverse Event|4|||
130826213|NCT00413660|470993008|FG004|Up To Week 12|Adverse Event|6|||
130826214|NCT00413660|470993009|FG005|Up To Week 12|Adverse Event|4|||
130826215|NCT00413660|470993010|FG006|Up To Week 12|Adverse Event|1|||
130826216|NCT00413660|470993011|FG007|Up To Week 12|Adverse Event|0|||
130826217|NCT00413660|470993012|FG008|Up To Week 12|Adverse Event|0|||
130826218|NCT00413660|470993013|FG009|Up To Week 12|Adverse Event|0|||
130826219|NCT00413660|470993014|FG010|Up To Week 12|Adverse Event|0|||
130826220|NCT00413660|470993004|FG000|Up To Week 12|Lack of Efficacy|2|||
130826221|NCT00413660|470993005|FG001|Up To Week 12|Lack of Efficacy|0|||
130826222|NCT00413660|470993006|FG002|Up To Week 12|Lack of Efficacy|0|||
130826223|NCT00413660|470993007|FG003|Up To Week 12|Lack of Efficacy|0|||
130826224|NCT00413660|470993008|FG004|Up To Week 12|Lack of Efficacy|0|||
130826225|NCT00413660|470993009|FG005|Up To Week 12|Lack of Efficacy|0|||
130826226|NCT00413660|470993010|FG006|Up To Week 12|Lack of Efficacy|5|||
130826227|NCT00413660|470993011|FG007|Up To Week 12|Lack of Efficacy|0|||
130826228|NCT00413660|470993012|FG008|Up To Week 12|Lack of Efficacy|0|||
130826229|NCT00413660|470993013|FG009|Up To Week 12|Lack of Efficacy|0|||
130826230|NCT00413660|470993014|FG010|Up To Week 12|Lack of Efficacy|0|||
130826231|NCT00413660|470993004|FG000|Up To Week 12|Lost to Follow-up|0|||
130826232|NCT00413660|470993005|FG001|Up To Week 12|Lost to Follow-up|1|||
130826233|NCT00413660|470993006|FG002|Up To Week 12|Lost to Follow-up|0|||
130826234|NCT00413660|470993007|FG003|Up To Week 12|Lost to Follow-up|0|||
130826235|NCT00413660|470993008|FG004|Up To Week 12|Lost to Follow-up|1|||
130826236|NCT00413660|470993009|FG005|Up To Week 12|Lost to Follow-up|0|||
130826237|NCT00413660|470993010|FG006|Up To Week 12|Lost to Follow-up|0|||
130826238|NCT00413660|470993011|FG007|Up To Week 12|Lost to Follow-up|0|||
130826239|NCT00413660|470993012|FG008|Up To Week 12|Lost to Follow-up|0|||
130826240|NCT00413660|470993013|FG009|Up To Week 12|Lost to Follow-up|0|||
130826241|NCT00413660|470993014|FG010|Up To Week 12|Lost to Follow-up|0|||
130826242|NCT00413660|470993004|FG000|Up To Week 12|Withdrawal by Subject|0|||
130826243|NCT00413660|470993005|FG001|Up To Week 12|Withdrawal by Subject|2|||
130826244|NCT00413660|470993006|FG002|Up To Week 12|Withdrawal by Subject|0|||
130826245|NCT00413660|470993007|FG003|Up To Week 12|Withdrawal by Subject|2|||
130826246|NCT00413660|470993008|FG004|Up To Week 12|Withdrawal by Subject|0|||
130826247|NCT00413660|470993009|FG005|Up To Week 12|Withdrawal by Subject|2|||
130826248|NCT00413660|470993010|FG006|Up To Week 12|Withdrawal by Subject|2|||
130826249|NCT00413660|470993011|FG007|Up To Week 12|Withdrawal by Subject|0|||
130826250|NCT00413660|470993012|FG008|Up To Week 12|Withdrawal by Subject|0|||
130826251|NCT00413660|470993013|FG009|Up To Week 12|Withdrawal by Subject|0|||
130826252|NCT00413660|470993014|FG010|Up To Week 12|Withdrawal by Subject|0|||
130826253|NCT00413660|470993004|FG000|Up To Week 12|Randomized, Not Treated|1|||
130826254|NCT00413660|470993005|FG001|Up To Week 12|Randomized, Not Treated|0|||
130826255|NCT00413660|470993006|FG002|Up To Week 12|Randomized, Not Treated|0|||
130826256|NCT00413660|470993007|FG003|Up To Week 12|Randomized, Not Treated|1|||
130826257|NCT00413660|470993008|FG004|Up To Week 12|Randomized, Not Treated|0|||
130826258|NCT00413660|470993009|FG005|Up To Week 12|Randomized, Not Treated|0|||
130826259|NCT00413660|470993010|FG006|Up To Week 12|Randomized, Not Treated|0|||
130826260|NCT00413660|470993011|FG007|Up To Week 12|Randomized, Not Treated|0|||
130826261|NCT00413660|470993012|FG008|Up To Week 12|Randomized, Not Treated|0|||
130826262|NCT00413660|470993013|FG009|Up To Week 12|Randomized, Not Treated|0|||
130826263|NCT00413660|470993014|FG010|Up To Week 12|Randomized, Not Treated|0|||
130826264|NCT00413660|470993004|FG000|Up To Week 12|Other|3|||
130826265|NCT00413660|470993005|FG001|Up To Week 12|Other|1|||
130826266|NCT00413660|470993006|FG002|Up To Week 12|Other|6|||
130826267|NCT00413660|470993007|FG003|Up To Week 12|Other|1|||
130826268|NCT00413660|470993008|FG004|Up To Week 12|Other|2|||
130826269|NCT00413660|470993009|FG005|Up To Week 12|Other|4|||
130826270|NCT00413660|470993010|FG006|Up To Week 12|Other|3|||
130826271|NCT00413660|470993011|FG007|Up To Week 12|Other|0|||
130826272|NCT00413660|470993012|FG008|Up To Week 12|Other|0|||
130826273|NCT00413660|470993013|FG009|Up To Week 12|Other|0|||
130826274|NCT00413660|470993014|FG010|Up To Week 12|Other|0|||
130826275|NCT00413660|470993004|FG000|Post Week 12|Adverse Event|2|||
130826276|NCT00413660|470993005|FG001|Post Week 12|Adverse Event|0|||
130826277|NCT00413660|470993006|FG002|Post Week 12|Adverse Event|2|||
130826278|NCT00413660|470993007|FG003|Post Week 12|Adverse Event|1|||
130826279|NCT00413660|470993008|FG004|Post Week 12|Adverse Event|4|||
130826280|NCT00413660|470993009|FG005|Post Week 12|Adverse Event|2|||
130826281|NCT00413660|470993010|FG006|Post Week 12|Adverse Event|2|||
130826282|NCT00413660|470993011|FG007|Post Week 12|Adverse Event|0|||
130826283|NCT00413660|470993012|FG008|Post Week 12|Adverse Event|0|||
130826284|NCT00413660|470993013|FG009|Post Week 12|Adverse Event|0|||
130826285|NCT00413660|470993014|FG010|Post Week 12|Adverse Event|0|||
130826286|NCT00413660|470993004|FG000|Post Week 12|Lack of Efficacy|0|||
130826287|NCT00413660|470993005|FG001|Post Week 12|Lack of Efficacy|0|||
130826288|NCT00413660|470993006|FG002|Post Week 12|Lack of Efficacy|1|||
130826289|NCT00413660|470993007|FG003|Post Week 12|Lack of Efficacy|0|||
130826290|NCT00413660|470993008|FG004|Post Week 12|Lack of Efficacy|0|||
130826291|NCT00413660|470993009|FG005|Post Week 12|Lack of Efficacy|0|||
130826292|NCT00413660|470993010|FG006|Post Week 12|Lack of Efficacy|0|||
130826293|NCT00413660|470993011|FG007|Post Week 12|Lack of Efficacy|0|||
130826294|NCT00413660|470993012|FG008|Post Week 12|Lack of Efficacy|0|||
130826295|NCT00413660|470993013|FG009|Post Week 12|Lack of Efficacy|1|||
130826296|NCT00413660|470993014|FG010|Post Week 12|Lack of Efficacy|0|||
130826297|NCT00413660|470993004|FG000|Post Week 12|Lost to Follow-up|0|||
130826298|NCT00413660|470993005|FG001|Post Week 12|Lost to Follow-up|1|||
130826299|NCT00413660|470993006|FG002|Post Week 12|Lost to Follow-up|1|||
130826300|NCT00413660|470993007|FG003|Post Week 12|Lost to Follow-up|0|||
130826301|NCT00413660|470993008|FG004|Post Week 12|Lost to Follow-up|0|||
130826302|NCT00413660|470993009|FG005|Post Week 12|Lost to Follow-up|0|||
130826303|NCT00413660|470993010|FG006|Post Week 12|Lost to Follow-up|0|||
130826304|NCT00413660|470993011|FG007|Post Week 12|Lost to Follow-up|0|||
130826305|NCT00413660|470993012|FG008|Post Week 12|Lost to Follow-up|0|||
130826306|NCT00413660|470993013|FG009|Post Week 12|Lost to Follow-up|0|||
130826307|NCT00413660|470993014|FG010|Post Week 12|Lost to Follow-up|0|||
130826308|NCT00413660|470993004|FG000|Post Week 12|Withdrawal by Subject|0|||
130826309|NCT00413660|470993005|FG001|Post Week 12|Withdrawal by Subject|1|||
130826310|NCT00413660|470993006|FG002|Post Week 12|Withdrawal by Subject|1|||
130826311|NCT00413660|470993007|FG003|Post Week 12|Withdrawal by Subject|0|||
130826312|NCT00413660|470993008|FG004|Post Week 12|Withdrawal by Subject|1|||
130826313|NCT00413660|470993009|FG005|Post Week 12|Withdrawal by Subject|0|||
130826314|NCT00413660|470993010|FG006|Post Week 12|Withdrawal by Subject|0|||
130826315|NCT00413660|470993011|FG007|Post Week 12|Withdrawal by Subject|0|||
130826316|NCT00413660|470993012|FG008|Post Week 12|Withdrawal by Subject|0|||
130826317|NCT00413660|470993013|FG009|Post Week 12|Withdrawal by Subject|0|||
130826318|NCT00413660|470993014|FG010|Post Week 12|Withdrawal by Subject|1|||
130826319|NCT00413660|470993004|FG000|Post Week 12|Other|1|||
130826320|NCT00413660|470993005|FG001|Post Week 12|Other|2|||
130826321|NCT00413660|470993006|FG002|Post Week 12|Other|3|||
130826322|NCT00413660|470993007|FG003|Post Week 12|Other|0|||
130826323|NCT00413660|470993008|FG004|Post Week 12|Other|1|||
130826324|NCT00413660|470993009|FG005|Post Week 12|Other|1|||
130826325|NCT00413660|470993010|FG006|Post Week 12|Other|1|||
130826326|NCT00413660|470993011|FG007|Post Week 12|Other|0|||
130826327|NCT00413660|470993012|FG008|Post Week 12|Other|0|||
130826328|NCT00413660|470993013|FG009|Post Week 12|Other|0|||
130826329|NCT00413660|470993014|FG010|Post Week 12|Other|0|||
130826330|NCT00400517|470993018|FG000|Overall Study|Withdrawal by Subject|1|||
130826331|NCT00400517|470993018|FG000|Overall Study|Physician Decision|1|||
130826332|NCT02831855|470993023|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
130826333|NCT02831855|470993024|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
130826334|NCT02831855|470993025|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
130826335|NCT02831855|470993023|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
130826336|NCT02831855|470993024|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
130826337|NCT02831855|470993025|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
130826338|NCT02831855|470993023|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
130826339|NCT02831855|470993024|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
130826340|NCT02831855|470993025|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
130826341|NCT02831855|470993023|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
130826342|NCT02831855|470993024|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
130826343|NCT02831855|470993025|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
130826344|NCT02831855|470993023|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
130826345|NCT02831855|470993024|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
130826346|NCT02831855|470993025|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
130826347|NCT02831855|470993023|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
130826348|NCT02831855|470993024|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
130826349|NCT02831855|470993025|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
130826350|NCT02831855|470993023|FG000|Open Label Phase (24 Weeks)|Other|4|||
130826351|NCT02831855|470993024|FG001|Open Label Phase (24 Weeks)|Other|0|||
130826352|NCT02831855|470993025|FG002|Open Label Phase (24 Weeks)|Other|0|||
130826353|NCT02831855|470993023|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
130826354|NCT02831855|470993024|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
130826355|NCT02831855|470993025|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
130826356|NCT02831855|470993023|FG000|Double Blind Phase (24 Weeks)|Death|0|||
130826357|NCT02831855|470993024|FG001|Double Blind Phase (24 Weeks)|Death|0|||
130826358|NCT02831855|470993025|FG002|Double Blind Phase (24 Weeks)|Death|2|||
130826359|NCT02831855|470993023|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
130826360|NCT02831855|470993024|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
130826361|NCT02831855|470993025|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
130826362|NCT02831855|470993023|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
130826363|NCT02831855|470993024|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
130826364|NCT02831855|470993025|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
130826365|NCT02831855|470993023|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
130826366|NCT02831855|470993024|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
130826367|NCT02831855|470993025|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
130826368|NCT02831855|470993023|FG000|Double Blind Phase (24 Weeks)|Other|0|||
130826369|NCT02831855|470993024|FG001|Double Blind Phase (24 Weeks)|Other|2|||
130826370|NCT02831855|470993025|FG002|Double Blind Phase (24 Weeks)|Other|5|||
130826371|NCT02831855|470993023|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
130826372|NCT02831855|470993024|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
130826373|NCT02831855|470993025|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
130826374|NCT02831855|470993023|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
130826375|NCT02831855|470993024|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
130826376|NCT02831855|470993025|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
130826377|NCT02831855|470993023|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
130826378|NCT02831855|470993024|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
130826379|NCT02831855|470993025|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
130826380|NCT01722994|470993026|FG000|Overall Study|Missing data|25|||
130826381|NCT01722994|470993027|FG001|Overall Study|Missing data|17|||
130826382|NCT01803880|470993031|FG000|Overall Study|Adverse Event|1|||
130826383|NCT01803880|470993032|FG001|Overall Study|Adverse Event|0|||
130826384|NCT01803880|470993033|FG002|Overall Study|Adverse Event|0|||
130826385|NCT01803880|470993031|FG000|Overall Study|Withdrawal by Subject|1|||
130826386|NCT01803880|470993032|FG001|Overall Study|Withdrawal by Subject|1|||
130826387|NCT01803880|470993033|FG002|Overall Study|Withdrawal by Subject|4|||
130826388|NCT01803880|470993031|FG000|Overall Study|Physician Decision|0|||
130826389|NCT01803880|470993032|FG001|Overall Study|Physician Decision|0|||
130826390|NCT01803880|470993033|FG002|Overall Study|Physician Decision|1|||
130826391|NCT01803880|470993031|FG000|Overall Study|Unable to return for follow-up visits|0|||
130826392|NCT01803880|470993032|FG001|Overall Study|Unable to return for follow-up visits|1|||
130826393|NCT01803880|470993033|FG002|Overall Study|Unable to return for follow-up visits|2|||
130826394|NCT01803880|470993031|FG000|Overall Study|Lost to Follow-up|1|||
130826395|NCT01803880|470993032|FG001|Overall Study|Lost to Follow-up|2|||
130826396|NCT01803880|470993033|FG002|Overall Study|Lost to Follow-up|3|||
130826397|NCT01803880|470993031|FG000|Overall Study|Protocol Violation|1|||
130826398|NCT01803880|470993032|FG001|Overall Study|Protocol Violation|0|||
130826399|NCT01803880|470993033|FG002|Overall Study|Protocol Violation|0|||
130826400|NCT01803880|470993031|FG000|Overall Study|Early study termination|0|||
130826401|NCT01803880|470993032|FG001|Overall Study|Early study termination|6|||
130826402|NCT01803880|470993033|FG002|Overall Study|Early study termination|5|||
130826403|NCT01803880|470993031|FG000|Overall Study|Incomplete data entry by sites|2|||
130826404|NCT01803880|470993032|FG001|Overall Study|Incomplete data entry by sites|0|||
130826405|NCT01803880|470993033|FG002|Overall Study|Incomplete data entry by sites|0|||
130826406|NCT05384834|470993034|FG000|Overall Study|Lost to Follow-up|43|||
130826407|NCT05384834|470993034|FG000|Overall Study|Withdrawal by Subject|5|||
130826408|NCT01881789|470993036|FG000|Overall Study|Withdrawal by Subject|0|||
130826409|NCT01881789|470993037|FG001|Overall Study|Withdrawal by Subject|2|||
130826410|NCT01881789|470993038|FG002|Overall Study|Withdrawal by Subject|1|||
130826411|NCT01881789|470993039|FG003|Overall Study|Withdrawal by Subject|0|||
130826412|NCT01881789|470993040|FG004|Overall Study|Withdrawal by Subject|1|||
130826413|NCT01881789|470993041|FG005|Overall Study|Withdrawal by Subject|1|||
130826414|NCT01881789|470993036|FG000|Overall Study|Study Terminated by Sponsor|0|||
130826415|NCT01881789|470993037|FG001|Overall Study|Study Terminated by Sponsor|0|||
130826416|NCT01881789|470993038|FG002|Overall Study|Study Terminated by Sponsor|0|||
130826417|NCT01881789|470993039|FG003|Overall Study|Study Terminated by Sponsor|0|||
130826418|NCT01881789|470993040|FG004|Overall Study|Study Terminated by Sponsor|0|||
130826419|NCT01881789|470993041|FG005|Overall Study|Study Terminated by Sponsor|1|||
130826420|NCT01881789|470993036|FG000|Overall Study|Other|3|||
130826421|NCT01881789|470993037|FG001|Overall Study|Other|5|||
130826422|NCT01881789|470993038|FG002|Overall Study|Other|2|||
130826423|NCT01881789|470993039|FG003|Overall Study|Other|3|||
130826424|NCT01881789|470993040|FG004|Overall Study|Other|1|||
130826425|NCT01881789|470993041|FG005|Overall Study|Other|1|||
130826426|NCT02041299|470993044|FG000|Overall Study|Adverse Event|9|||
130826427|NCT02041299|470993045|FG001|Overall Study|Adverse Event|3|||
130826428|NCT02041299|470993044|FG000|Overall Study|Lost to Follow-up|4|||
130826429|NCT02041299|470993045|FG001|Overall Study|Lost to Follow-up|1|||
130826430|NCT02041299|470993044|FG000|Overall Study|Physician Decision|1|||
130826431|NCT02041299|470993045|FG001|Overall Study|Physician Decision|1|||
130826432|NCT02041299|470993044|FG000|Overall Study|Withdrawal by Subject|13|||
130826433|NCT02041299|470993045|FG001|Overall Study|Withdrawal by Subject|7|||
130826434|NCT02041299|470993044|FG000|Overall Study|Protocol Violation|11|||
130826435|NCT02041299|470993045|FG001|Overall Study|Protocol Violation|4|||
130826436|NCT02041299|470993044|FG000|Overall Study|Termination of the study|7|||
130826437|NCT02041299|470993045|FG001|Overall Study|Termination of the study|3|||
130826438|NCT02041299|470993044|FG000|Overall Study|Required bone marrow transplant|0|||
130826439|NCT02041299|470993045|FG001|Overall Study|Required bone marrow transplant|1|||
130826440|NCT02041299|470993044|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
130826441|NCT02041299|470993045|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
130826442|NCT01635998|470993046|FG000|Overall Study|Death|1|||
130826443|NCT01635998|470993047|FG001|Overall Study|Death|1|||
130826444|NCT01635998|470993046|FG000|Overall Study|Lost to Follow-up|2|||
130826445|NCT01635998|470993047|FG001|Overall Study|Lost to Follow-up|1|||
130826446|NCT01635998|470993046|FG000|Overall Study|Withdrawal by Subject|1|||
130826447|NCT01635998|470993047|FG001|Overall Study|Withdrawal by Subject|5|||
130826448|NCT01964378|470993051|FG000|Overall Study|Disc. due to death before first dosing|0|||
130826449|NCT01964378|470993052|FG001|Overall Study|Disc. due to death before first dosing|1|||
130826450|NCT01964378|470993051|FG000|Overall Study|Disc. due to AE before first dosing|1|||
130826451|NCT01964378|470993052|FG001|Overall Study|Disc. due to AE before first dosing|0|||
130826452|NCT01964378|470993051|FG000|Overall Study|Death|3|||
130826453|NCT01964378|470993052|FG001|Overall Study|Death|2|||
130826454|NCT01964378|470993051|FG000|Overall Study|Adverse Event|12|||
130826455|NCT01964378|470993052|FG001|Overall Study|Adverse Event|5|||
130826456|NCT01964378|470993051|FG000|Overall Study|Lack of Efficacy|0|||
130826457|NCT01964378|470993052|FG001|Overall Study|Lack of Efficacy|1|||
130826458|NCT01964378|470993051|FG000|Overall Study|Protocol Violation|0|||
130826459|NCT01964378|470993052|FG001|Overall Study|Protocol Violation|1|||
130826460|NCT01964378|470993051|FG000|Overall Study|Lost to Follow-up|0|||
130826461|NCT01964378|470993052|FG001|Overall Study|Lost to Follow-up|1|||
130826462|NCT01964378|470993051|FG000|Overall Study|Withdrawal by Subject|7|||
130826463|NCT01964378|470993052|FG001|Overall Study|Withdrawal by Subject|5|||
130826464|NCT01964378|470993051|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
130826465|NCT01964378|470993052|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
130826466|NCT01964378|470993051|FG000|Overall Study|Other|1|||
130826467|NCT01964378|470993052|FG001|Overall Study|Other|2|||
130826468|NCT01162473|470993053|FG000|Overall Study|Adverse Event|2|||
130826469|NCT01162473|470993054|FG001|Overall Study|Adverse Event|1|||
130826470|NCT01162473|470993053|FG000|Overall Study|Withdrawal by Subject|0|||
130826471|NCT01162473|470993054|FG001|Overall Study|Withdrawal by Subject|4|||
130826472|NCT01544348|470993067|FG000|Overall Study|Lost to Follow-up|1|||
130826473|NCT01544348|470993068|FG001|Overall Study|Lost to Follow-up|0|||
130826474|NCT01544348|470993069|FG002|Overall Study|Lost to Follow-up|0|||
130826475|NCT01544348|470993070|FG003|Overall Study|Lost to Follow-up|0|||
130826476|NCT01544348|470993071|FG004|Overall Study|Lost to Follow-up|0|||
130826477|NCT01544348|470993072|FG005|Overall Study|Lost to Follow-up|0|||
130826478|NCT01544348|470993073|FG006|Overall Study|Lost to Follow-up|1|||
130826479|NCT01544348|470993074|FG007|Overall Study|Lost to Follow-up|0|||
130826480|NCT01544348|470993067|FG000|Overall Study|Withdrawal by Subject|1|||
130826481|NCT01544348|470993068|FG001|Overall Study|Withdrawal by Subject|0|||
130826482|NCT01544348|470993069|FG002|Overall Study|Withdrawal by Subject|0|||
130826483|NCT01544348|470993070|FG003|Overall Study|Withdrawal by Subject|0|||
130826484|NCT01544348|470993071|FG004|Overall Study|Withdrawal by Subject|1|||
130826485|NCT01544348|470993072|FG005|Overall Study|Withdrawal by Subject|2|||
130826486|NCT01544348|470993073|FG006|Overall Study|Withdrawal by Subject|1|||
130826487|NCT01544348|470993074|FG007|Overall Study|Withdrawal by Subject|0|||
130826488|NCT01544348|470993067|FG000|Overall Study|Physician Decision|0|||
130826489|NCT01544348|470993068|FG001|Overall Study|Physician Decision|0|||
130826490|NCT01544348|470993069|FG002|Overall Study|Physician Decision|0|||
130826491|NCT01544348|470993070|FG003|Overall Study|Physician Decision|0|||
130826492|NCT01544348|470993071|FG004|Overall Study|Physician Decision|0|||
130826493|NCT01544348|470993072|FG005|Overall Study|Physician Decision|1|||
130826494|NCT01544348|470993073|FG006|Overall Study|Physician Decision|0|||
130826495|NCT01544348|470993074|FG007|Overall Study|Physician Decision|0|||
130826496|NCT01928433|470993075|FG000|Overall Study|Adverse Event|5|||
130826497|NCT01928433|470993076|FG001|Overall Study|Adverse Event|2|||
130826498|NCT01928433|470993077|FG002|Overall Study|Adverse Event|5|||
130826499|NCT01928433|470993075|FG000|Overall Study|Protocol Violation|0|||
130826500|NCT01928433|470993076|FG001|Overall Study|Protocol Violation|0|||
130826501|NCT01928433|470993077|FG002|Overall Study|Protocol Violation|2|||
130826502|NCT01928433|470993075|FG000|Overall Study|Lack of Efficacy|5|||
130826503|NCT01928433|470993076|FG001|Overall Study|Lack of Efficacy|4|||
130826504|NCT01928433|470993077|FG002|Overall Study|Lack of Efficacy|4|||
130826505|NCT01928433|470993075|FG000|Overall Study|Withdrawal by Subject|0|||
130826506|NCT01928433|470993076|FG001|Overall Study|Withdrawal by Subject|4|||
130826507|NCT01928433|470993077|FG002|Overall Study|Withdrawal by Subject|0|||
130826508|NCT01928433|470993075|FG000|Overall Study|Negative screening urine culture|7|||
130826509|NCT01928433|470993076|FG001|Overall Study|Negative screening urine culture|6|||
130826510|NCT01928433|470993077|FG002|Overall Study|Negative screening urine culture|10|||
130826511|NCT01928433|470993075|FG000|Overall Study|Lost to Follow-up|0|||
130826512|NCT01928433|470993076|FG001|Overall Study|Lost to Follow-up|2|||
130826513|NCT01928433|470993077|FG002|Overall Study|Lost to Follow-up|3|||
130826514|NCT01928433|470993075|FG000|Overall Study|Other reasons|3|||
130826515|NCT01928433|470993076|FG001|Overall Study|Other reasons|3|||
130826516|NCT01928433|470993077|FG002|Overall Study|Other reasons|4|||
130826517|NCT01445847|470993078|FG000|Overall Study|Protocol Violation|13|||
130826518|NCT01445847|470993079|FG001|Overall Study|Protocol Violation|14|||
130826519|NCT01445847|470993078|FG000|Overall Study|Missed Data|1|||
130826520|NCT01445847|470993079|FG001|Overall Study|Missed Data|0|||
130826521|NCT01392573|470993082|FG000|Overall Study|Adverse Event|1|||
130826522|NCT01392573|470993083|FG001|Overall Study|Adverse Event|3|||
130826523|NCT01392573|470993082|FG000|Overall Study|Lack of Efficacy|1|||
130826524|NCT01392573|470993083|FG001|Overall Study|Lack of Efficacy|2|||
130826525|NCT01392573|470993082|FG000|Overall Study|Protocol Violation|0|||
130826526|NCT01392573|470993083|FG001|Overall Study|Protocol Violation|2|||
130826527|NCT01392573|470993082|FG000|Overall Study|Withdrawal Criteria|13|||
130826528|NCT01392573|470993083|FG001|Overall Study|Withdrawal Criteria|15|||
130826529|NCT01392573|470993082|FG000|Overall Study|Site closure|8|||
130826530|NCT01392573|470993083|FG001|Overall Study|Site closure|7|||
130826531|NCT01392573|470993082|FG000|Overall Study|Unclassified|9|||
130826532|NCT01392573|470993083|FG001|Overall Study|Unclassified|6|||
130826533|NCT00436436|470993084|FG000|Overall Study|Progression|4|||
130826534|NCT00436436|470993084|FG000|Overall Study|Adverse Event|2|||
130826535|NCT00436436|470993084|FG000|Overall Study|Death|6|||
130826536|NCT01102491|470993091|FG000|Overall Study|Protocol Violation|11|||
130826537|NCT01102491|470993092|FG001|Overall Study|Protocol Violation|12|||
130826538|NCT03008070|470993093|FG000|Overall Study|Adverse Event|3|||
130826539|NCT03008070|470993094|FG001|Overall Study|Adverse Event|3|||
130826540|NCT03008070|470993095|FG002|Overall Study|Adverse Event|3|||
130826541|NCT03008070|470993093|FG000|Overall Study|Lost to Follow-up|1|||
130826542|NCT03008070|470993094|FG001|Overall Study|Lost to Follow-up|1|||
130826543|NCT03008070|470993095|FG002|Overall Study|Lost to Follow-up|0|||
130826544|NCT03008070|470993093|FG000|Overall Study|Non compliance|0|||
130826545|NCT03008070|470993094|FG001|Overall Study|Non compliance|1|||
130826546|NCT03008070|470993095|FG002|Overall Study|Non compliance|1|||
130826547|NCT03008070|470993093|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
130826548|NCT03008070|470993094|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
130826549|NCT03008070|470993095|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
130826550|NCT03008070|470993093|FG000|Overall Study|Withdrawal by Subject|2|||
130826551|NCT03008070|470993094|FG001|Overall Study|Withdrawal by Subject|0|||
130826552|NCT03008070|470993095|FG002|Overall Study|Withdrawal by Subject|1|||
130826553|NCT03008070|470993093|FG000|Overall Study|Use of prohibited drug|0|||
130826554|NCT03008070|470993094|FG001|Overall Study|Use of prohibited drug|0|||
130826555|NCT03008070|470993095|FG002|Overall Study|Use of prohibited drug|2|||
130826556|NCT04409834|470993098|FG000|Overall Study|Death|55|||
130826557|NCT04409834|470993099|FG001|Overall Study|Death|62|||
130826558|NCT02151786|470993100|FG000|Overall Study|Unavailability of Case Report Form|26|||
130826559|NCT02151786|470993100|FG000|Overall Study|Outside the Contract Period|1|||
130826560|NCT02151786|470993100|FG000|Overall Study|Randomized, not Treated|1|||
130826561|NCT02151786|470993100|FG000|Overall Study|Unavailability of Information|8|||
130826562|NCT01365455|470993101|FG000|Induction Period|Adverse Event|5|||
130826563|NCT01365455|470993102|FG001|Induction Period|Adverse Event|3|||
130826564|NCT01365455|470993103|FG002|Induction Period|Adverse Event|4|||
130826565|NCT01365455|470993104|FG003|Induction Period|Adverse Event|0|||
130826566|NCT01365455|470993105|FG004|Induction Period|Adverse Event|0|||
130826567|NCT01365455|470993101|FG000|Induction Period|Lack of Efficacy|1|||
130826568|NCT01365455|470993102|FG001|Induction Period|Lack of Efficacy|1|||
130826569|NCT01365455|470993103|FG002|Induction Period|Lack of Efficacy|0|||
130826570|NCT01365455|470993104|FG003|Induction Period|Lack of Efficacy|0|||
130826571|NCT01365455|470993105|FG004|Induction Period|Lack of Efficacy|0|||
130826572|NCT01365455|470993101|FG000|Induction Period|Pregnancy|0|||
130826573|NCT01365455|470993102|FG001|Induction Period|Pregnancy|1|||
130826574|NCT01365455|470993103|FG002|Induction Period|Pregnancy|0|||
130826575|NCT01365455|470993104|FG003|Induction Period|Pregnancy|0|||
130826576|NCT01365455|470993105|FG004|Induction Period|Pregnancy|0|||
130826577|NCT01365455|470993101|FG000|Induction Period|Protocol deviation|0|||
130826578|NCT01365455|470993102|FG001|Induction Period|Protocol deviation|1|||
130826579|NCT01365455|470993103|FG002|Induction Period|Protocol deviation|1|||
130826580|NCT01365455|470993104|FG003|Induction Period|Protocol deviation|0|||
130826581|NCT01365455|470993105|FG004|Induction Period|Protocol deviation|0|||
130826582|NCT01365455|470993101|FG000|Induction Period|Subject/guardian decision|9|||
130826583|NCT01365455|470993102|FG001|Induction Period|Subject/guardian decision|1|||
130826584|NCT01365455|470993103|FG002|Induction Period|Subject/guardian decision|8|||
130826585|NCT01365455|470993104|FG003|Induction Period|Subject/guardian decision|0|||
130826586|NCT01365455|470993105|FG004|Induction Period|Subject/guardian decision|0|||
130826587|NCT01365455|470993101|FG000|Induction Period|Lost to Follow-up|0|||
130826588|NCT01365455|470993102|FG001|Induction Period|Lost to Follow-up|0|||
130826589|NCT01365455|470993103|FG002|Induction Period|Lost to Follow-up|3|||
130826590|NCT01365455|470993104|FG003|Induction Period|Lost to Follow-up|0|||
130826591|NCT01365455|470993105|FG004|Induction Period|Lost to Follow-up|0|||
130826592|NCT01365455|470993101|FG000|Maintenance Period|Adverse Event|12|||
130826593|NCT01365455|470993102|FG001|Maintenance Period|Adverse Event|5|||
130826594|NCT01365455|470993103|FG002|Maintenance Period|Adverse Event|1|||
130826595|NCT01365455|470993104|FG003|Maintenance Period|Adverse Event|2|||
130826596|NCT01365455|470993105|FG004|Maintenance Period|Adverse Event|4|||
130826597|NCT01365455|470993101|FG000|Maintenance Period|Lack of Efficacy|10|||
130826598|NCT01365455|470993102|FG001|Maintenance Period|Lack of Efficacy|2|||
130826599|NCT01365455|470993103|FG002|Maintenance Period|Lack of Efficacy|0|||
130826600|NCT01365455|470993104|FG003|Maintenance Period|Lack of Efficacy|2|||
130826601|NCT01365455|470993105|FG004|Maintenance Period|Lack of Efficacy|2|||
130826602|NCT01365455|470993101|FG000|Maintenance Period|Lost to Follow-up|2|||
130826603|NCT01365455|470993102|FG001|Maintenance Period|Lost to Follow-up|4|||
130826604|NCT01365455|470993103|FG002|Maintenance Period|Lost to Follow-up|0|||
130826605|NCT01365455|470993104|FG003|Maintenance Period|Lost to Follow-up|0|||
130826606|NCT01365455|470993105|FG004|Maintenance Period|Lost to Follow-up|3|||
130826607|NCT01365455|470993101|FG000|Maintenance Period|Non-compliance with study treatment|0|||
130826608|NCT01365455|470993102|FG001|Maintenance Period|Non-compliance with study treatment|0|||
130826609|NCT01365455|470993103|FG002|Maintenance Period|Non-compliance with study treatment|0|||
130826610|NCT01365455|470993104|FG003|Maintenance Period|Non-compliance with study treatment|1|||
130826611|NCT01365455|470993105|FG004|Maintenance Period|Non-compliance with study treatment|0|||
130826612|NCT01365455|470993101|FG000|Maintenance Period|Physician Decision|0|||
130826613|NCT01365455|470993102|FG001|Maintenance Period|Physician Decision|1|||
130826614|NCT01365455|470993103|FG002|Maintenance Period|Physician Decision|0|||
130826615|NCT01365455|470993104|FG003|Maintenance Period|Physician Decision|0|||
130826616|NCT01365455|470993105|FG004|Maintenance Period|Physician Decision|1|||
130826617|NCT01365455|470993101|FG000|Maintenance Period|Pregnancy|0|||
130826618|NCT01365455|470993102|FG001|Maintenance Period|Pregnancy|4|||
130826619|NCT01365455|470993103|FG002|Maintenance Period|Pregnancy|0|||
130826620|NCT01365455|470993104|FG003|Maintenance Period|Pregnancy|0|||
130826621|NCT01365455|470993105|FG004|Maintenance Period|Pregnancy|2|||
130826622|NCT01365455|470993101|FG000|Maintenance Period|Protocol deviation|1|||
130826623|NCT01365455|470993102|FG001|Maintenance Period|Protocol deviation|1|||
130826624|NCT01365455|470993103|FG002|Maintenance Period|Protocol deviation|0|||
130826625|NCT01365455|470993104|FG003|Maintenance Period|Protocol deviation|0|||
130826626|NCT01365455|470993105|FG004|Maintenance Period|Protocol deviation|0|||
130826627|NCT01365455|470993101|FG000|Maintenance Period|Subject/guardian decision|4|||
130826628|NCT01365455|470993102|FG001|Maintenance Period|Subject/guardian decision|6|||
130826629|NCT01365455|470993103|FG002|Maintenance Period|Subject/guardian decision|2|||
130826630|NCT01365455|470993104|FG003|Maintenance Period|Subject/guardian decision|4|||
130826631|NCT01365455|470993105|FG004|Maintenance Period|Subject/guardian decision|1|||
130826632|NCT00928187|470993106|FG000|Overall Study|Death|1|||
130826633|NCT00928187|470993107|FG001|Overall Study|Death|2|||
130826634|NCT00928187|470993108|FG002|Overall Study|Death|3|||
130826635|NCT00928187|470993106|FG000|Overall Study|Lost to Follow-up|1|||
130826636|NCT00928187|470993107|FG001|Overall Study|Lost to Follow-up|2|||
130826637|NCT00928187|470993108|FG002|Overall Study|Lost to Follow-up|1|||
130826638|NCT00928187|470993106|FG000|Overall Study|Withdrawal by Subject|0|||
130826639|NCT00928187|470993107|FG001|Overall Study|Withdrawal by Subject|1|||
130826640|NCT00928187|470993108|FG002|Overall Study|Withdrawal by Subject|1|||
130826641|NCT00928187|470993106|FG000|Overall Study|Protocol Violation|0|||
130826642|NCT00928187|470993107|FG001|Overall Study|Protocol Violation|1|||
130826643|NCT00928187|470993108|FG002|Overall Study|Protocol Violation|0|||
130826644|NCT00810277|470994481|FG000|Overall Study|Adverse Event|1|||
130826645|NCT03145064|470994484|FG000|Overall Study|Death|24|||
130826646|NCT03145064|470994484|FG000|Overall Study|Lost to Follow-up|3|||
130826647|NCT03145064|470994484|FG000|Overall Study|Withdrawal by Subject|6|||
130826648|NCT03145064|470994484|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
130826649|NCT03145064|470994484|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
130826650|NCT01693250|470994485|FG000|Overall Study|Lost to Follow-up|2|||
130826651|NCT01693250|470994486|FG001|Overall Study|Lost to Follow-up|2|||
130826652|NCT00628446|470994489|FG000|Overall Study|Lost to Follow-up|3|||
130826653|NCT00628446|470994489|FG000|Overall Study|Withdrawal by Subject|1|||
130826654|NCT00628446|470994489|FG000|Overall Study|Protocol Violation|3|||
130826655|NCT01396187|470994490|FG000|Overall Study|Adverse Event|0|||
130826656|NCT01396187|470994491|FG001|Overall Study|Adverse Event|1|||
130826657|NCT01396187|470994492|FG002|Overall Study|Adverse Event|0|||
130826658|NCT01396187|470994493|FG003|Overall Study|Adverse Event|0|||
130826659|NCT01396187|470994494|FG004|Overall Study|Adverse Event|0|||
130826660|NCT01396187|470994490|FG000|Overall Study|Withdrawal by Subject|0|||
130826661|NCT01396187|470994491|FG001|Overall Study|Withdrawal by Subject|1|||
130826662|NCT01396187|470994492|FG002|Overall Study|Withdrawal by Subject|1|||
130826663|NCT01396187|470994493|FG003|Overall Study|Withdrawal by Subject|0|||
130826664|NCT01396187|470994494|FG004|Overall Study|Withdrawal by Subject|0|||
130826665|NCT01396187|470994490|FG000|Overall Study|Other|1|||
130826666|NCT01396187|470994491|FG001|Overall Study|Other|1|||
130826667|NCT01396187|470994492|FG002|Overall Study|Other|0|||
130826668|NCT01396187|470994493|FG003|Overall Study|Other|0|||
130826669|NCT01396187|470994494|FG004|Overall Study|Other|1|||
130826670|NCT01898286|470994495|FG000|Overall Study|Withdrawal by Subject|1|||
130826671|NCT01898286|470994495|FG000|Overall Study|Protocol Violation|1|||
130826672|NCT01898286|470994495|FG000|Overall Study|Lost to Follow-up|1|||
130826673|NCT02257242|470994496|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
130826674|NCT02257242|470994497|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130826675|NCT02257242|470994498|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130826676|NCT02257242|470994499|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130826677|NCT02257242|470994500|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130826678|NCT02257242|470994501|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130826679|NCT02257242|470994502|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130826680|NCT02257242|470994503|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130826681|NCT02257242|470994504|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130826682|NCT01650831|470994511|FG000|Overall Study|Screen failure|1|||
130826683|NCT01453036|470994512|FG000|Overall Study|Lost to Follow-up|26|||
130826684|NCT01453036|470994513|FG001|Overall Study|Lost to Follow-up|115|||
130826685|NCT01453036|470994514|FG002|Overall Study|Lost to Follow-up|31|||
130826686|NCT00620373|470994515|FG000|Overall Study|Unverified cancer status|33|||
130826687|NCT03073525|470994516|FG000|Overall Study|Withdrawal by Subject|0|||
130826688|NCT03073525|470994517|FG001|Overall Study|Withdrawal by Subject|0|||
130826689|NCT03073525|470994518|FG002|Overall Study|Withdrawal by Subject|3|||
130826690|NCT01273038|470994519|FG000|Second Intervention (14 Days)|Adverse Event|0|||
130826691|NCT01273038|470994520|FG001|Second Intervention (14 Days)|Adverse Event|1|||
130826692|NCT01273038|470994519|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
130826693|NCT01273038|470994520|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
130826694|NCT01976299|470994521|FG000|Overall Study|Withdrawal by Subject|3|||
130826695|NCT01976299|470994522|FG001|Overall Study|Withdrawal by Subject|1|||
130826696|NCT01976299|470994521|FG000|Overall Study|Death|4|||
130826697|NCT01976299|470994522|FG001|Overall Study|Death|2|||
130826698|NCT01976299|470994521|FG000|Overall Study|Lost to Follow-up|7|||
130826699|NCT01976299|470994522|FG001|Overall Study|Lost to Follow-up|1|||
130826700|NCT01976299|470994521|FG000|Overall Study|See clarification above in comments|9|||
130826701|NCT01976299|470994522|FG001|Overall Study|See clarification above in comments|2|||
130826702|NCT03692403|470994523|FG000|Overall Study|Withdrawal by Subject|1|||
130826703|NCT03692403|470994524|FG001|Overall Study|Withdrawal by Subject|0|||
130826704|NCT03692403|470994525|FG002|Overall Study|Withdrawal by Subject|1|||
130826705|NCT03692403|470994526|FG003|Overall Study|Withdrawal by Subject|0|||
130826706|NCT03692403|470994523|FG000|Overall Study|Adverse Event|0|||
130826707|NCT03692403|470994524|FG001|Overall Study|Adverse Event|0|||
130826708|NCT03692403|470994525|FG002|Overall Study|Adverse Event|0|||
130826709|NCT03692403|470994526|FG003|Overall Study|Adverse Event|1|||
130826710|NCT03692403|470994523|FG000|Overall Study|Pregnancy|0|||
130826711|NCT03692403|470994524|FG001|Overall Study|Pregnancy|1|||
130826712|NCT03692403|470994525|FG002|Overall Study|Pregnancy|0|||
130826713|NCT03692403|470994526|FG003|Overall Study|Pregnancy|0|||
130826714|NCT03692403|470994523|FG000|Overall Study|Other|0|||
130826715|NCT03692403|470994524|FG001|Overall Study|Other|0|||
130826716|NCT03692403|470994525|FG002|Overall Study|Other|1|||
130826717|NCT03692403|470994526|FG003|Overall Study|Other|0|||
130826718|NCT01306643|470994527|FG000|Overall Study|Adverse Event|5|||
130826719|NCT01306643|470994527|FG000|Overall Study|Disease Progression|7|||
130826720|NCT01306643|470994527|FG000|Overall Study|Other: Change in Eligibility Status|1|||
130826721|NCT01147393|470994530|FG000|Dose Level 1|Dose limiting Toxicity|2|||
130826722|NCT01147393|470994530|FG000|Dose Level -1|Dose Limited Toxicity|1|||
130826723|NCT02071771|470994531|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
130826724|NCT02071771|470994532|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
130826725|NCT02071771|470994531|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
130826726|NCT02071771|470994532|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
130826727|NCT00355368|470994536|FG000|Overall Study|Protocol Violation|8|||
130826728|NCT00355368|470994537|FG001|Overall Study|Protocol Violation|7|||
130826729|NCT00355368|470994536|FG000|Overall Study|cardiac arrest prior to intubation|2|||
130826730|NCT00355368|470994537|FG001|Overall Study|cardiac arrest prior to intubation|2|||
130826731|NCT01152788|470994541|FG000|Overall Study|Withdrawal by Subject|0|||
130826732|NCT01152788|470994542|FG001|Overall Study|Withdrawal by Subject|3|||
130826733|NCT01152788|470994541|FG000|Overall Study|No treatment|0|||
130826734|NCT01152788|470994542|FG001|Overall Study|No treatment|1|||
130826735|NCT01282866|470994543|FG000|Overall Study|Adverse Event|1|||
130826736|NCT03810014|470994544|FG000|Overall Study|Pregnancy|2|||
130826737|NCT03810014|470994545|FG001|Overall Study|Pregnancy|2|||
130826738|NCT03810014|470994546|FG002|Overall Study|Pregnancy|0|||
130826739|NCT03810014|470994547|FG003|Overall Study|Pregnancy|2|||
130826740|NCT03606486|470994548|FG000|Overall Study|Unable to collect sample|5|||
130826741|NCT01853462|470994557|FG000|Overall Study|Withdrawal by Subject|1|||
130826742|NCT01853462|470994558|FG001|Overall Study|Withdrawal by Subject|1|||
130826743|NCT03943290|470994559|FG000|Overall Study|Sponsor Terminated Study|6|||
130826744|NCT03943290|470994560|FG001|Overall Study|Sponsor Terminated Study|1|||
130826745|NCT03943290|470994561|FG002|Overall Study|Sponsor Terminated Study|11|||
130826746|NCT03943290|470994562|FG003|Overall Study|Sponsor Terminated Study|6|||
130826747|NCT03943290|470994563|FG004|Overall Study|Sponsor Terminated Study|7|||
130826748|NCT03943290|470994564|FG005|Overall Study|Sponsor Terminated Study|6|||
130826749|NCT03943290|470994565|FG006|Overall Study|Sponsor Terminated Study|6|||
130826750|NCT03943290|470994566|FG007|Overall Study|Sponsor Terminated Study|7|||
130826751|NCT03943290|470994567|FG008|Overall Study|Sponsor Terminated Study|8|||
130826752|NCT03943290|470994559|FG000|Overall Study|Lost to Follow-up|1|||
130826753|NCT03943290|470994560|FG001|Overall Study|Lost to Follow-up|0|||
130826754|NCT03943290|470994561|FG002|Overall Study|Lost to Follow-up|1|||
130826755|NCT03943290|470994562|FG003|Overall Study|Lost to Follow-up|0|||
130826756|NCT03943290|470994563|FG004|Overall Study|Lost to Follow-up|0|||
130826757|NCT03943290|470994564|FG005|Overall Study|Lost to Follow-up|0|||
130826758|NCT03943290|470994565|FG006|Overall Study|Lost to Follow-up|0|||
130826759|NCT03943290|470994566|FG007|Overall Study|Lost to Follow-up|1|||
130826760|NCT03943290|470994567|FG008|Overall Study|Lost to Follow-up|0|||
130826761|NCT03943290|470994559|FG000|Overall Study|Withdrawal by Subject|0|||
130826762|NCT03943290|470994560|FG001|Overall Study|Withdrawal by Subject|0|||
130826763|NCT03943290|470994561|FG002|Overall Study|Withdrawal by Subject|1|||
130826764|NCT03943290|470994562|FG003|Overall Study|Withdrawal by Subject|0|||
130826765|NCT03943290|470994563|FG004|Overall Study|Withdrawal by Subject|0|||
130826766|NCT03943290|470994564|FG005|Overall Study|Withdrawal by Subject|0|||
130826767|NCT03943290|470994565|FG006|Overall Study|Withdrawal by Subject|0|||
130826768|NCT03943290|470994566|FG007|Overall Study|Withdrawal by Subject|0|||
130826769|NCT03943290|470994567|FG008|Overall Study|Withdrawal by Subject|0|||
130826770|NCT00955474|470994568|FG000|Overall Study|Physician Decision|7|||
130826771|NCT00955474|470994569|FG001|Overall Study|Physician Decision|5|||
130826772|NCT01737762|470994570|FG000|Overall Study|Adverse Event|2|||
130826773|NCT01737762|470994571|FG001|Overall Study|Adverse Event|2|||
130826774|NCT01737762|470994570|FG000|Overall Study|Lost to Follow-up|1|||
130826775|NCT01737762|470994571|FG001|Overall Study|Lost to Follow-up|0|||
130826776|NCT01737762|470994570|FG000|Overall Study|Withdrawal by Subject|2|||
130826777|NCT01737762|470994571|FG001|Overall Study|Withdrawal by Subject|2|||
130826778|NCT01737762|470994570|FG000|Overall Study|Progressive disease|1|||
130826779|NCT01737762|470994571|FG001|Overall Study|Progressive disease|2|||
130826780|NCT01737762|470994570|FG000|Overall Study|Physician Decision|1|||
130826781|NCT01737762|470994571|FG001|Overall Study|Physician Decision|1|||
130826782|NCT01737762|470994570|FG000|Overall Study|Moved from area|2|||
130826783|NCT01737762|470994571|FG001|Overall Study|Moved from area|1|||
130826784|NCT01737762|470994570|FG000|Overall Study|Trial termination|11|||
130826785|NCT01737762|470994571|FG001|Overall Study|Trial termination|9|||
130826786|NCT02148263|470994572|FG000|Overall Study|Withdrawal by Subject|3|||
130826787|NCT02148263|470994573|FG001|Overall Study|Withdrawal by Subject|2|||
130826788|NCT03386435|470994574|FG000|Overall Study|Protocol Violation|5|||
130826789|NCT03386435|470994575|FG001|Overall Study|Protocol Violation|7|||
130826790|NCT00625586|470994576|FG000|Overall Study|Adverse Event|1|||
130826791|NCT00625586|470994576|FG000|Overall Study|Progressive disease|1|||
130826792|NCT03929913|470994577|FG000|Overall Study|Death|4|||
130826793|NCT03929913|470994577|FG000|Overall Study|Lost to Follow-up|1|||
130826794|NCT03929913|470994577|FG000|Overall Study|Failed Procedure|2|||
130826795|NCT02891226|470994578|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
130826796|NCT02891226|470994579|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
130826797|NCT02891226|470994580|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
130826798|NCT02891226|470994581|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826799|NCT02891226|470994582|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826800|NCT02891226|470994583|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826801|NCT02891226|470994584|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826802|NCT02891226|470994585|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826803|NCT02891226|470994586|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826804|NCT02891226|470994587|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826805|NCT02891226|470994588|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826806|NCT02891226|470994589|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826807|NCT02891226|470994590|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826808|NCT02891226|470994591|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826809|NCT02891226|470994592|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826810|NCT02891226|470994593|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130826811|NCT02891226|470994578|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
130826812|NCT02891226|470994579|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
130826813|NCT02891226|470994580|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826814|NCT02891226|470994581|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826815|NCT02891226|470994582|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826816|NCT02891226|470994583|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826817|NCT02891226|470994584|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826818|NCT02891226|470994585|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826819|NCT02891226|470994586|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826820|NCT02891226|470994587|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826821|NCT02891226|470994588|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826822|NCT02891226|470994589|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826823|NCT02891226|470994590|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826824|NCT02891226|470994591|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826825|NCT02891226|470994592|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826826|NCT02891226|470994593|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130826827|NCT02891226|470994578|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826828|NCT02891226|470994579|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826829|NCT02891226|470994580|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826830|NCT02891226|470994581|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
130826831|NCT02891226|470994582|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826832|NCT02891226|470994583|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826833|NCT02891226|470994584|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826834|NCT02891226|470994585|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826835|NCT02891226|470994586|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826836|NCT02891226|470994587|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826837|NCT02891226|470994588|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826838|NCT02891226|470994589|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826839|NCT02891226|470994590|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826840|NCT02891226|470994591|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826841|NCT02891226|470994592|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826842|NCT02891226|470994593|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130826843|NCT02891226|470994578|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826844|NCT02891226|470994579|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826845|NCT02891226|470994580|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
130826846|NCT02891226|470994581|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826847|NCT02891226|470994582|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826848|NCT02891226|470994583|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826849|NCT02891226|470994584|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826850|NCT02891226|470994585|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826851|NCT02891226|470994586|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826852|NCT02891226|470994587|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826853|NCT02891226|470994588|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826854|NCT02891226|470994589|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826855|NCT02891226|470994590|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826856|NCT02891226|470994591|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826857|NCT02891226|470994592|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826858|NCT02891226|470994593|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130826859|NCT02891226|470994578|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826860|NCT02891226|470994579|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826861|NCT02891226|470994580|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826862|NCT02891226|470994581|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
130826863|NCT02891226|470994582|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826864|NCT02891226|470994583|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826865|NCT02891226|470994584|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826866|NCT02891226|470994585|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826867|NCT02891226|470994586|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826868|NCT02891226|470994587|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826869|NCT02891226|470994588|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826870|NCT02891226|470994589|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826871|NCT02891226|470994590|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826872|NCT02891226|470994591|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826873|NCT02891226|470994592|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826874|NCT02891226|470994593|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130826875|NCT02891226|470994578|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826876|NCT02891226|470994579|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826877|NCT02891226|470994580|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826878|NCT02891226|470994581|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
130826879|NCT02891226|470994582|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826880|NCT02891226|470994583|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826881|NCT02891226|470994584|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826882|NCT02891226|470994585|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826883|NCT02891226|470994586|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826884|NCT02891226|470994587|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826885|NCT02891226|470994588|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826886|NCT02891226|470994589|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826887|NCT02891226|470994590|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826888|NCT02891226|470994591|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826889|NCT02891226|470994592|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826890|NCT02891226|470994593|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130826891|NCT02891226|470994578|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826892|NCT02891226|470994579|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826893|NCT02891226|470994580|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826894|NCT02891226|470994581|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826895|NCT02891226|470994582|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826896|NCT02891226|470994583|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826897|NCT02891226|470994584|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
130826898|NCT02891226|470994585|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
130826899|NCT02891226|470994586|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
130826900|NCT02891226|470994587|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
130826901|NCT02891226|470994588|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826902|NCT02891226|470994589|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826903|NCT02891226|470994590|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826904|NCT02891226|470994591|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826905|NCT02891226|470994592|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826906|NCT02891226|470994593|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130826907|NCT02891226|470994578|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826908|NCT02891226|470994579|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826909|NCT02891226|470994580|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826910|NCT02891226|470994581|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826911|NCT02891226|470994582|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826912|NCT02891226|470994583|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
130826913|NCT02891226|470994584|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826914|NCT02891226|470994585|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826915|NCT02891226|470994586|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826916|NCT02891226|470994587|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
130826917|NCT02891226|470994588|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826918|NCT02891226|470994589|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826919|NCT02891226|470994590|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826920|NCT02891226|470994591|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826921|NCT02891226|470994592|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826922|NCT02891226|470994593|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130826923|NCT02891226|470994578|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826924|NCT02891226|470994579|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826925|NCT02891226|470994580|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826926|NCT02891226|470994581|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826927|NCT02891226|470994582|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826928|NCT02891226|470994583|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826929|NCT02891226|470994584|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
130826930|NCT02891226|470994585|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
130826931|NCT02891226|470994586|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
130826932|NCT02891226|470994587|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
130826933|NCT02891226|470994588|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826934|NCT02891226|470994589|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826935|NCT02891226|470994590|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826936|NCT02891226|470994591|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826937|NCT02891226|470994592|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826938|NCT02891226|470994593|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130826939|NCT02891226|470994578|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826940|NCT02891226|470994579|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826941|NCT02891226|470994580|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826942|NCT02891226|470994581|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826943|NCT02891226|470994582|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
130826944|NCT02891226|470994583|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826945|NCT02891226|470994584|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826946|NCT02891226|470994585|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826947|NCT02891226|470994586|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826948|NCT02891226|470994587|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826949|NCT02891226|470994588|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826950|NCT02891226|470994589|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826951|NCT02891226|470994590|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826952|NCT02891226|470994591|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826953|NCT02891226|470994592|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826954|NCT02891226|470994593|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130826955|NCT02891226|470994578|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826956|NCT02891226|470994579|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826957|NCT02891226|470994580|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826958|NCT02891226|470994581|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826959|NCT02891226|470994582|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826960|NCT02891226|470994583|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826961|NCT02891226|470994584|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
130826962|NCT02891226|470994585|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826963|NCT02891226|470994586|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826964|NCT02891226|470994587|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826965|NCT02891226|470994588|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826966|NCT02891226|470994589|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826967|NCT02891226|470994590|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826968|NCT02891226|470994591|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826969|NCT02891226|470994592|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826970|NCT02891226|470994593|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130826971|NCT02891226|470994578|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826972|NCT02891226|470994579|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826973|NCT02891226|470994580|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826974|NCT02891226|470994581|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826975|NCT02891226|470994582|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826976|NCT02891226|470994583|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826977|NCT02891226|470994584|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826978|NCT02891226|470994585|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
130826979|NCT02891226|470994586|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
130826980|NCT02891226|470994587|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
130826981|NCT02891226|470994588|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826982|NCT02891226|470994589|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826983|NCT02891226|470994590|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826984|NCT02891226|470994591|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826985|NCT02891226|470994592|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826986|NCT02891226|470994593|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130826987|NCT02891226|470994578|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826988|NCT02891226|470994579|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826989|NCT02891226|470994580|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826990|NCT02891226|470994581|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826991|NCT02891226|470994582|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826992|NCT02891226|470994583|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826993|NCT02891226|470994584|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826994|NCT02891226|470994585|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
130826995|NCT02891226|470994586|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826996|NCT02891226|470994587|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826997|NCT02891226|470994588|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826998|NCT02891226|470994589|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130826999|NCT02891226|470994590|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130827000|NCT02891226|470994591|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130827001|NCT02891226|470994592|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130827002|NCT02891226|470994593|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130827003|NCT02891226|470994578|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827004|NCT02891226|470994579|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827005|NCT02891226|470994580|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827006|NCT02891226|470994581|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827007|NCT02891226|470994582|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827008|NCT02891226|470994583|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827009|NCT02891226|470994584|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827010|NCT02891226|470994585|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827011|NCT02891226|470994586|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
130827012|NCT02891226|470994587|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827013|NCT02891226|470994588|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827014|NCT02891226|470994589|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827015|NCT02891226|470994590|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827016|NCT02891226|470994591|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827017|NCT02891226|470994592|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827018|NCT02891226|470994593|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130827019|NCT02891226|470994578|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827020|NCT02891226|470994579|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827021|NCT02891226|470994580|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827022|NCT02891226|470994581|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827023|NCT02891226|470994582|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827024|NCT02891226|470994583|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827025|NCT02891226|470994584|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827026|NCT02891226|470994585|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827027|NCT02891226|470994586|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827028|NCT02891226|470994587|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
130827029|NCT02891226|470994588|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827030|NCT02891226|470994589|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827031|NCT02891226|470994590|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827032|NCT02891226|470994591|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827033|NCT02891226|470994592|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827034|NCT02891226|470994593|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130827035|NCT02891226|470994578|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827036|NCT02891226|470994579|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827037|NCT02891226|470994580|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827038|NCT02891226|470994581|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827039|NCT02891226|470994582|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827040|NCT02891226|470994583|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827041|NCT02891226|470994584|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827042|NCT02891226|470994585|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827043|NCT02891226|470994586|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827044|NCT02891226|470994587|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
130827045|NCT02891226|470994588|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827046|NCT02891226|470994589|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827047|NCT02891226|470994590|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827048|NCT02891226|470994591|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827049|NCT02891226|470994592|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827050|NCT02891226|470994593|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130827051|NCT02891226|470994578|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827052|NCT02891226|470994579|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827053|NCT02891226|470994580|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827054|NCT02891226|470994581|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827055|NCT02891226|470994582|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827056|NCT02891226|470994583|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827057|NCT02891226|470994584|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827058|NCT02891226|470994585|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827059|NCT02891226|470994586|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827060|NCT02891226|470994587|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827061|NCT02891226|470994588|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
130827062|NCT02891226|470994589|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827063|NCT02891226|470994590|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827064|NCT02891226|470994591|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827065|NCT02891226|470994592|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827066|NCT02891226|470994593|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130827067|NCT02891226|470994578|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827068|NCT02891226|470994579|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827069|NCT02891226|470994580|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827070|NCT02891226|470994581|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827071|NCT02891226|470994582|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827072|NCT02891226|470994583|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827073|NCT02891226|470994584|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827074|NCT02891226|470994585|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827075|NCT02891226|470994586|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827076|NCT02891226|470994587|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827077|NCT02891226|470994588|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
130827078|NCT02891226|470994589|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827079|NCT02891226|470994590|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827080|NCT02891226|470994591|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827081|NCT02891226|470994592|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827082|NCT02891226|470994593|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130827083|NCT02891226|470994578|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827084|NCT02891226|470994579|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827085|NCT02891226|470994580|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827086|NCT02891226|470994581|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827087|NCT02891226|470994582|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827088|NCT02891226|470994583|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827089|NCT02891226|470994584|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827090|NCT02891226|470994585|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827091|NCT02891226|470994586|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827092|NCT02891226|470994587|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827093|NCT02891226|470994588|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
130827094|NCT02891226|470994589|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827095|NCT02891226|470994590|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827096|NCT02891226|470994591|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827097|NCT02891226|470994592|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827098|NCT02891226|470994593|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130827099|NCT02891226|470994578|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827100|NCT02891226|470994579|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827101|NCT02891226|470994580|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827102|NCT02891226|470994581|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827103|NCT02891226|470994582|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827104|NCT02891226|470994583|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827105|NCT02891226|470994584|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827106|NCT02891226|470994585|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827107|NCT02891226|470994586|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827108|NCT02891226|470994587|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827109|NCT02891226|470994588|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
130827110|NCT02891226|470994589|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827111|NCT02891226|470994590|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827112|NCT02891226|470994591|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827113|NCT02891226|470994592|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827114|NCT02891226|470994593|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130827115|NCT02891226|470994578|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827116|NCT02891226|470994579|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827117|NCT02891226|470994580|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827118|NCT02891226|470994581|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827119|NCT02891226|470994582|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827120|NCT02891226|470994583|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827121|NCT02891226|470994584|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827122|NCT02891226|470994585|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827123|NCT02891226|470994586|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827124|NCT02891226|470994587|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827125|NCT02891226|470994588|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
130827126|NCT02891226|470994589|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827127|NCT02891226|470994590|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827128|NCT02891226|470994591|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827129|NCT02891226|470994592|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827130|NCT02891226|470994593|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130827131|NCT02891226|470994578|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827132|NCT02891226|470994579|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827133|NCT02891226|470994580|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827134|NCT02891226|470994581|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827135|NCT02891226|470994582|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827136|NCT02891226|470994583|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827137|NCT02891226|470994584|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827138|NCT02891226|470994585|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827139|NCT02891226|470994586|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827140|NCT02891226|470994587|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827141|NCT02891226|470994588|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
130827142|NCT02891226|470994589|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827143|NCT02891226|470994590|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827144|NCT02891226|470994591|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827145|NCT02891226|470994592|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827146|NCT02891226|470994593|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130827147|NCT02891226|470994578|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827148|NCT02891226|470994579|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827149|NCT02891226|470994580|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827150|NCT02891226|470994581|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827151|NCT02891226|470994582|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827152|NCT02891226|470994583|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827153|NCT02891226|470994584|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827154|NCT02891226|470994585|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827155|NCT02891226|470994586|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827156|NCT02891226|470994587|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827157|NCT02891226|470994588|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
130827158|NCT02891226|470994589|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827159|NCT02891226|470994590|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827160|NCT02891226|470994591|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827161|NCT02891226|470994592|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827162|NCT02891226|470994593|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130827163|NCT02891226|470994578|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827164|NCT02891226|470994579|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827165|NCT02891226|470994580|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827166|NCT02891226|470994581|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827167|NCT02891226|470994582|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827168|NCT02891226|470994583|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827169|NCT02891226|470994584|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827170|NCT02891226|470994585|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827171|NCT02891226|470994586|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827172|NCT02891226|470994587|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827173|NCT02891226|470994588|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
130827174|NCT02891226|470994589|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827175|NCT02891226|470994590|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827176|NCT02891226|470994591|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827177|NCT02891226|470994592|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827178|NCT02891226|470994593|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130827179|NCT02891226|470994578|FG000|Follow-up Period|Withdrawal by Subject|0|||
130827180|NCT02891226|470994579|FG001|Follow-up Period|Withdrawal by Subject|0|||
130827181|NCT02891226|470994580|FG002|Follow-up Period|Withdrawal by Subject|0|||
130827182|NCT02891226|470994581|FG003|Follow-up Period|Withdrawal by Subject|0|||
130827183|NCT02891226|470994582|FG004|Follow-up Period|Withdrawal by Subject|0|||
130827184|NCT02891226|470994583|FG005|Follow-up Period|Withdrawal by Subject|0|||
130827185|NCT02891226|470994584|FG006|Follow-up Period|Withdrawal by Subject|0|||
130827186|NCT02891226|470994585|FG007|Follow-up Period|Withdrawal by Subject|0|||
130827187|NCT02891226|470994586|FG008|Follow-up Period|Withdrawal by Subject|0|||
130827188|NCT02891226|470994587|FG009|Follow-up Period|Withdrawal by Subject|0|||
130827189|NCT02891226|470994588|FG010|Follow-up Period|Withdrawal by Subject|0|||
130827190|NCT02891226|470994589|FG011|Follow-up Period|Withdrawal by Subject|1|||
130827191|NCT02891226|470994590|FG012|Follow-up Period|Withdrawal by Subject|0|||
130827192|NCT02891226|470994591|FG013|Follow-up Period|Withdrawal by Subject|0|||
130827193|NCT02891226|470994592|FG014|Follow-up Period|Withdrawal by Subject|1|||
130827194|NCT02891226|470994593|FG015|Follow-up Period|Withdrawal by Subject|1|||
130827195|NCT03381287|470994594|FG000|Overall Study|Withdrawal by Subject|0|||
130827196|NCT03381287|470994595|FG001|Overall Study|Withdrawal by Subject|1|||
130827197|NCT03381287|470994596|FG002|Overall Study|Withdrawal by Subject|0|||
130827198|NCT03381287|470994597|FG003|Overall Study|Withdrawal by Subject|0|||
130827199|NCT03381287|470994594|FG000|Overall Study|Adverse Event|0|||
130827200|NCT03381287|470994595|FG001|Overall Study|Adverse Event|0|||
130827201|NCT03381287|470994596|FG002|Overall Study|Adverse Event|0|||
130827202|NCT03381287|470994597|FG003|Overall Study|Adverse Event|1|||
130827203|NCT03381287|470994594|FG000|Overall Study|Physician Decision|0|||
130827204|NCT03381287|470994595|FG001|Overall Study|Physician Decision|0|||
130827205|NCT03381287|470994596|FG002|Overall Study|Physician Decision|0|||
130827206|NCT03381287|470994597|FG003|Overall Study|Physician Decision|1|||
130827207|NCT01265992|470994598|FG000|Overall Study|Lost to Follow-up|1|||
130827208|NCT01265992|470994598|FG000|Overall Study|Withdrawal by Subject|1|||
130827209|NCT01265992|470994598|FG000|Overall Study|Adverse Event|1|||
130827210|NCT01265992|470994598|FG000|Overall Study|Administrative reasons|2|||
130827211|NCT01265992|470994598|FG000|Overall Study|Stopped treatment|3|||
130827212|NCT01265992|470994598|FG000|Overall Study|Did not receive treatment|1|||
130827213|NCT03533660|470994599|FG000|Overall Study|Withdrawal by Subject|2|||
130827214|NCT03533660|470994600|FG001|Overall Study|Withdrawal by Subject|2|||
130827215|NCT03533660|470994599|FG000|Overall Study|Death|2|||
130827216|NCT03533660|470994600|FG001|Overall Study|Death|4|||
130827217|NCT03533660|470994599|FG000|Overall Study|Adverse Event|0|||
130827218|NCT03533660|470994600|FG001|Overall Study|Adverse Event|2|||
130827219|NCT00996658|470994601|FG000|Overall Study|Adverse Event|2|||
130827220|NCT00996658|470994602|FG001|Overall Study|Adverse Event|5|||
130827221|NCT00996658|470994601|FG000|Overall Study|Protocol Violation|0|||
130827222|NCT00996658|470994602|FG001|Overall Study|Protocol Violation|1|||
130827223|NCT00996658|470994601|FG000|Overall Study|Lost to Follow-up|2|||
130827224|NCT00996658|470994602|FG001|Overall Study|Lost to Follow-up|5|||
130827225|NCT00996658|470994601|FG000|Overall Study|Non-compliance issues|3|||
130827226|NCT00996658|470994602|FG001|Overall Study|Non-compliance issues|3|||
130827227|NCT00996658|470994601|FG000|Overall Study|Other|9|||
130827228|NCT00996658|470994602|FG001|Overall Study|Other|7|||
130827229|NCT04245449|470996479|FG000|Overall Study|COVID shutdown|7|||
130827230|NCT02197572|470996482|FG000|Overall Study|Progressive Disease|28|||
130827231|NCT02197572|470996482|FG000|Overall Study|Withdrawal by Subject|9|||
130827232|NCT02197572|470996482|FG000|Overall Study|Adverse Event|3|||
130827233|NCT02197572|470996482|FG000|Overall Study|Reason Not Specified|4|||
130827234|NCT01408277|470996486|FG000|Overall Study|Adverse Event|3|||
130827235|NCT01408277|470996487|FG001|Overall Study|Adverse Event|4|||
130827236|NCT01408277|470996486|FG000|Overall Study|Lost to Follow-up|1|||
130827237|NCT01408277|470996487|FG001|Overall Study|Lost to Follow-up|0|||
130827238|NCT01408277|470996486|FG000|Overall Study|Withdrawal by Subject|2|||
130827239|NCT01408277|470996487|FG001|Overall Study|Withdrawal by Subject|0|||
130827240|NCT01408277|470996486|FG000|Overall Study|Protocol Violation|2|||
130827241|NCT01408277|470996487|FG001|Overall Study|Protocol Violation|0|||
130827242|NCT01349673|470996488|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
130827243|NCT01349673|470996488|FG000|Overall Study|No Longer Qualified For Study|1|||
130827244|NCT01349673|470996488|FG000|Overall Study|Site Closure|10|||
130827245|NCT01349673|470996488|FG000|Overall Study|Withdrawal by Subject|21|||
130827246|NCT01349673|470996488|FG000|Overall Study|Lost to Follow-up|6|||
130827247|NCT01349673|470996488|FG000|Overall Study|Adverse Event|17|||
130827248|NCT01349673|470996488|FG000|Overall Study|Study Terminated By Sponsor|50|||
130827249|NCT01349673|470996488|FG000|Overall Study|Lack of Efficacy|8|||
130827250|NCT03801928|470996491|FG000|Overall Study|Adverse Event|1|||
130827251|NCT03801928|470996492|FG001|Overall Study|Adverse Event|0|||
130827252|NCT03801928|470996493|FG002|Overall Study|Adverse Event|1|||
130827253|NCT03801928|470996494|FG003|Overall Study|Adverse Event|2|||
130827254|NCT03801928|470996495|FG004|Overall Study|Adverse Event|0|||
130827255|NCT03801928|470996496|FG005|Overall Study|Adverse Event|2|||
130827256|NCT03801928|470996491|FG000|Overall Study|Lack of Efficacy|0|||
130827257|NCT03801928|470996492|FG001|Overall Study|Lack of Efficacy|0|||
130827258|NCT03801928|470996493|FG002|Overall Study|Lack of Efficacy|1|||
130827259|NCT03801928|470996494|FG003|Overall Study|Lack of Efficacy|0|||
130827260|NCT03801928|470996495|FG004|Overall Study|Lack of Efficacy|0|||
130827261|NCT03801928|470996496|FG005|Overall Study|Lack of Efficacy|0|||
130827262|NCT03801928|470996491|FG000|Overall Study|Lost to Follow-up|5|||
130827263|NCT03801928|470996492|FG001|Overall Study|Lost to Follow-up|1|||
130827264|NCT03801928|470996493|FG002|Overall Study|Lost to Follow-up|1|||
130827265|NCT03801928|470996494|FG003|Overall Study|Lost to Follow-up|4|||
130827266|NCT03801928|470996495|FG004|Overall Study|Lost to Follow-up|4|||
130827267|NCT03801928|470996496|FG005|Overall Study|Lost to Follow-up|2|||
130827268|NCT03801928|470996491|FG000|Overall Study|Withdrawal by Subject|0|||
130827269|NCT03801928|470996492|FG001|Overall Study|Withdrawal by Subject|0|||
130827270|NCT03801928|470996493|FG002|Overall Study|Withdrawal by Subject|2|||
130827271|NCT03801928|470996494|FG003|Overall Study|Withdrawal by Subject|1|||
130827272|NCT03801928|470996495|FG004|Overall Study|Withdrawal by Subject|0|||
130827273|NCT03801928|470996496|FG005|Overall Study|Withdrawal by Subject|0|||
130827274|NCT03801928|470996491|FG000|Overall Study|Other|0|||
130827275|NCT03801928|470996492|FG001|Overall Study|Other|2|||
130827276|NCT03801928|470996493|FG002|Overall Study|Other|0|||
130827277|NCT03801928|470996494|FG003|Overall Study|Other|1|||
130827278|NCT03801928|470996495|FG004|Overall Study|Other|0|||
130827279|NCT03801928|470996496|FG005|Overall Study|Other|1|||
130827280|NCT01014767|470996501|FG000|Overall Study|PI left institution, data unavailable|12|||
130827281|NCT01014767|470996502|FG001|Overall Study|PI left institution, data unavailable|1|||
130827282|NCT01014767|470996503|FG002|Overall Study|PI left institution, data unavailable|4|||
130827283|NCT01014767|470996504|FG003|Overall Study|PI left institution, data unavailable|1|||
130827284|NCT00564733|470996505|FG000|Overall Study|Withdrawal by Subject|4|||
130827285|NCT00564733|470996505|FG000|Overall Study|Ineligible|5|||
130827286|NCT01484496|470996506|FG000|Period 1|Protocol Violation|3|||
130827287|NCT01484496|470996507|FG001|Period 1|Protocol Violation|4|||
130827288|NCT01484496|470996508|FG002|Period 1|Protocol Violation|0|||
130827289|NCT01484496|470996509|FG003|Period 1|Protocol Violation|0|||
130827290|NCT01484496|470996506|FG000|Period 1|Physician Decision|5|||
130827291|NCT01484496|470996507|FG001|Period 1|Physician Decision|1|||
130827292|NCT01484496|470996508|FG002|Period 1|Physician Decision|0|||
130827293|NCT01484496|470996509|FG003|Period 1|Physician Decision|0|||
130827294|NCT01484496|470996506|FG000|Period 1|Lack of Efficacy|10|||
130827295|NCT01484496|470996507|FG001|Period 1|Lack of Efficacy|15|||
130827296|NCT01484496|470996508|FG002|Period 1|Lack of Efficacy|0|||
130827297|NCT01484496|470996509|FG003|Period 1|Lack of Efficacy|0|||
130827298|NCT01484496|470996506|FG000|Period 1|Adverse Event|25|||
130827299|NCT01484496|470996507|FG001|Period 1|Adverse Event|40|||
130827300|NCT01484496|470996508|FG002|Period 1|Adverse Event|0|||
130827301|NCT01484496|470996509|FG003|Period 1|Adverse Event|0|||
130827302|NCT01484496|470996506|FG000|Period 1|Withdrawal by Subject|15|||
130827303|NCT01484496|470996507|FG001|Period 1|Withdrawal by Subject|12|||
130827304|NCT01484496|470996508|FG002|Period 1|Withdrawal by Subject|0|||
130827305|NCT01484496|470996509|FG003|Period 1|Withdrawal by Subject|0|||
130827306|NCT01484496|470996506|FG000|Period 1|Lost to Follow-up|2|||
130827307|NCT01484496|470996507|FG001|Period 1|Lost to Follow-up|6|||
130827308|NCT01484496|470996508|FG002|Period 1|Lost to Follow-up|0|||
130827309|NCT01484496|470996509|FG003|Period 1|Lost to Follow-up|0|||
130827310|NCT01484496|470996506|FG000|Period 1|Positive Pregnancy|1|||
130827311|NCT01484496|470996507|FG001|Period 1|Positive Pregnancy|6|||
130827312|NCT01484496|470996508|FG002|Period 1|Positive Pregnancy|0|||
130827313|NCT01484496|470996509|FG003|Period 1|Positive Pregnancy|0|||
130827314|NCT01484496|470996506|FG000|Period 1|Treatment Failure|3|||
130827315|NCT01484496|470996507|FG001|Period 1|Treatment Failure|6|||
130827316|NCT01484496|470996508|FG002|Period 1|Treatment Failure|0|||
130827317|NCT01484496|470996509|FG003|Period 1|Treatment Failure|0|||
130827318|NCT01484496|470996506|FG000|Period 1|Lack of Compliance|2|||
130827319|NCT01484496|470996507|FG001|Period 1|Lack of Compliance|1|||
130827320|NCT01484496|470996508|FG002|Period 1|Lack of Compliance|0|||
130827321|NCT01484496|470996509|FG003|Period 1|Lack of Compliance|0|||
130827322|NCT01484496|470996506|FG000|Period 1|Unable to Visit Site|0|||
130827323|NCT01484496|470996507|FG001|Period 1|Unable to Visit Site|2|||
130827324|NCT01484496|470996508|FG002|Period 1|Unable to Visit Site|0|||
130827325|NCT01484496|470996509|FG003|Period 1|Unable to Visit Site|0|||
130827326|NCT01484496|470996506|FG000|Period 2|Lack of Efficacy|0|||
130827327|NCT01484496|470996507|FG001|Period 2|Lack of Efficacy|0|||
130827328|NCT01484496|470996508|FG002|Period 2|Lack of Efficacy|1|||
130827329|NCT01484496|470996509|FG003|Period 2|Lack of Efficacy|3|||
130827330|NCT01484496|470996506|FG000|Period 2|Adverse Event|0|||
130827331|NCT01484496|470996507|FG001|Period 2|Adverse Event|0|||
130827332|NCT01484496|470996508|FG002|Period 2|Adverse Event|5|||
130827333|NCT01484496|470996509|FG003|Period 2|Adverse Event|13|||
130827334|NCT01484496|470996506|FG000|Period 2|Other|0|||
130827335|NCT01484496|470996507|FG001|Period 2|Other|0|||
130827336|NCT01484496|470996508|FG002|Period 2|Other|9|||
130827337|NCT01484496|470996509|FG003|Period 2|Other|6|||
130827338|NCT01645735|470996510|FG000|Overall Study|Physician Decision|2|||
130827339|NCT01645735|470996511|FG001|Overall Study|Physician Decision|0|||
130827340|NCT01645735|470996510|FG000|Overall Study|Withdrawal by Subject|1|||
130827341|NCT01645735|470996511|FG001|Overall Study|Withdrawal by Subject|0|||
130827342|NCT01645735|470996510|FG000|Overall Study|Protocol Violation|1|||
130827343|NCT01645735|470996511|FG001|Overall Study|Protocol Violation|0|||
130827344|NCT01645735|470996510|FG000|Overall Study|Adverse Event|0|||
130827345|NCT01645735|470996511|FG001|Overall Study|Adverse Event|1|||
130827346|NCT04263766|470996514|FG000|Overall Study|Withdrawal by Subject|6|||
130827347|NCT04263766|470996515|FG001|Overall Study|Withdrawal by Subject|4|||
130827348|NCT04263766|470996514|FG000|Overall Study|Lack of Efficacy|1|||
130827349|NCT04263766|470996515|FG001|Overall Study|Lack of Efficacy|3|||
130827350|NCT01891396|470996517|FG000|Overall Study|Withdrawal by Subject|4|||
130827351|NCT01891396|470996518|FG001|Overall Study|Withdrawal by Subject|4|||
130827352|NCT01891396|470996519|FG002|Overall Study|Withdrawal by Subject|3|||
130827353|NCT01891396|470996517|FG000|Overall Study|Lost to Follow-up|0|||
130827354|NCT01891396|470996518|FG001|Overall Study|Lost to Follow-up|1|||
130827355|NCT01891396|470996519|FG002|Overall Study|Lost to Follow-up|0|||
130827356|NCT00540592|470996520|FG000|Overall Study|Adverse Event|0|||
130827357|NCT00540592|470996521|FG001|Overall Study|Adverse Event|1|||
130827358|NCT00540592|470996522|FG002|Overall Study|Adverse Event|0|||
130827359|NCT00540592|470996523|FG003|Overall Study|Adverse Event|0|||
130827360|NCT00540592|470996524|FG004|Overall Study|Adverse Event|1|||
130827361|NCT00540592|470996525|FG005|Overall Study|Adverse Event|0|||
130827362|NCT00540592|470996526|FG006|Overall Study|Adverse Event|0|||
130827363|NCT00540592|470996527|FG007|Overall Study|Adverse Event|1|||
130827364|NCT00540592|470996528|FG008|Overall Study|Adverse Event|1|||
130827365|NCT00540592|470996529|FG009|Overall Study|Adverse Event|2|||
130827366|NCT00540592|470996520|FG000|Overall Study|Lost to Follow-up|2|||
130827367|NCT00540592|470996521|FG001|Overall Study|Lost to Follow-up|0|||
130827368|NCT00540592|470996522|FG002|Overall Study|Lost to Follow-up|0|||
130827369|NCT00540592|470996523|FG003|Overall Study|Lost to Follow-up|0|||
130827370|NCT00540592|470996524|FG004|Overall Study|Lost to Follow-up|0|||
130827371|NCT00540592|470996525|FG005|Overall Study|Lost to Follow-up|0|||
130827372|NCT00540592|470996526|FG006|Overall Study|Lost to Follow-up|0|||
130827373|NCT00540592|470996527|FG007|Overall Study|Lost to Follow-up|0|||
130827374|NCT00540592|470996528|FG008|Overall Study|Lost to Follow-up|0|||
130827375|NCT00540592|470996529|FG009|Overall Study|Lost to Follow-up|0|||
130827376|NCT00540592|470996520|FG000|Overall Study|Withdrawal by Subject|0|||
130827377|NCT00540592|470996521|FG001|Overall Study|Withdrawal by Subject|0|||
130827378|NCT00540592|470996522|FG002|Overall Study|Withdrawal by Subject|1|||
130827379|NCT00540592|470996523|FG003|Overall Study|Withdrawal by Subject|1|||
130827380|NCT00540592|470996524|FG004|Overall Study|Withdrawal by Subject|0|||
130827381|NCT00540592|470996525|FG005|Overall Study|Withdrawal by Subject|0|||
130827382|NCT00540592|470996526|FG006|Overall Study|Withdrawal by Subject|0|||
130827383|NCT00540592|470996527|FG007|Overall Study|Withdrawal by Subject|0|||
130827384|NCT00540592|470996528|FG008|Overall Study|Withdrawal by Subject|0|||
130827385|NCT00540592|470996529|FG009|Overall Study|Withdrawal by Subject|0|||
130827386|NCT00573391|470996530|FG000|Overall Study|study stopped|2|||
130827387|NCT00573391|470996531|FG001|Overall Study|study stopped|2|||
130827388|NCT00573391|470996530|FG000|Overall Study|Death|1|||
130827389|NCT00573391|470996531|FG001|Overall Study|Death|0|||
130827390|NCT01766037|470996532|FG000|Overall Study|Adverse Event|1|||
130827391|NCT01766037|470996533|FG001|Overall Study|Adverse Event|0|||
130827392|NCT01766037|470996532|FG000|Overall Study|Lack of Efficacy|1|||
130827393|NCT01766037|470996533|FG001|Overall Study|Lack of Efficacy|0|||
130827394|NCT01766037|470996532|FG000|Overall Study|Lost to Follow-up|0|||
130827395|NCT01766037|470996533|FG001|Overall Study|Lost to Follow-up|10|||
130827396|NCT01766037|470996532|FG000|Overall Study|Physician Decision|0|||
130827397|NCT01766037|470996533|FG001|Overall Study|Physician Decision|1|||
130827398|NCT01766037|470996532|FG000|Overall Study|Withdrawal by Subject|18|||
130827399|NCT01766037|470996533|FG001|Overall Study|Withdrawal by Subject|16|||
130827400|NCT01766037|470996532|FG000|Overall Study|Moved from area|5|||
130827401|NCT01766037|470996533|FG001|Overall Study|Moved from area|0|||
130827402|NCT01766037|470996532|FG000|Overall Study|medical - unrelated|1|||
130827403|NCT01766037|470996533|FG001|Overall Study|medical - unrelated|2|||
130827404|NCT01766037|470996532|FG000|Overall Study|nausea / discomfort|3|||
130827405|NCT01766037|470996533|FG001|Overall Study|nausea / discomfort|0|||
130827406|NCT02413996|470996534|FG000|Overall Study|not comfortable with the intervention|9|||
130827407|NCT02413996|470996535|FG001|Overall Study|not comfortable with the intervention|2|||
130827408|NCT01871545|470996536|FG000|Overall Study|Death|2|||
130827409|NCT01871545|470996537|FG001|Overall Study|Death|0|||
130827410|NCT01871545|470996536|FG000|Overall Study|Lack of Efficacy|11|||
130827411|NCT01871545|470996537|FG001|Overall Study|Lack of Efficacy|2|||
130827412|NCT01871545|470996536|FG000|Overall Study|Physician Decision|4|||
130827413|NCT01871545|470996537|FG001|Overall Study|Physician Decision|0|||
130827414|NCT01871545|470996536|FG000|Overall Study|Withdrawal by Subject|0|||
130827415|NCT01871545|470996537|FG001|Overall Study|Withdrawal by Subject|1|||
130827416|NCT01467466|470996546|FG000|Overall Study|Withdrawal by Subject|15|||
130827417|NCT01467466|470996547|FG001|Overall Study|Withdrawal by Subject|18|||
130827418|NCT01467466|470996548|FG002|Overall Study|Withdrawal by Subject|13|||
130827419|NCT01467466|470996549|FG003|Overall Study|Withdrawal by Subject|11|||
130827420|NCT01467466|470996546|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
130827421|NCT01467466|470996547|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
130827422|NCT01467466|470996548|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
130827423|NCT01467466|470996549|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
130827424|NCT01467466|470996546|FG000|Overall Study|Procedure Cancelled|46|||
130827425|NCT01467466|470996547|FG001|Overall Study|Procedure Cancelled|45|||
130827426|NCT01467466|470996548|FG002|Overall Study|Procedure Cancelled|25|||
130827427|NCT01467466|470996549|FG003|Overall Study|Procedure Cancelled|29|||
130827428|NCT01467466|470996546|FG000|Overall Study|No Endpoint Blood Draw|38|||
130827429|NCT01467466|470996547|FG001|Overall Study|No Endpoint Blood Draw|32|||
130827430|NCT01467466|470996548|FG002|Overall Study|No Endpoint Blood Draw|51|||
130827431|NCT01467466|470996549|FG003|Overall Study|No Endpoint Blood Draw|43|||
130827432|NCT01144416|470996554|FG000|Intervention Period|Adverse Event|5|||
130827433|NCT01144416|470996555|FG001|Intervention Period|Adverse Event|6|||
130827434|NCT01144416|470996554|FG000|Intervention Period|Insufficient ovarian response|11|||
130827435|NCT01144416|470996555|FG001|Intervention Period|Insufficient ovarian response|17|||
130827436|NCT01144416|470996554|FG000|Intervention Period|Risk of OHSS|0|||
130827437|NCT01144416|470996555|FG001|Intervention Period|Risk of OHSS|1|||
130827438|NCT01144416|470996554|FG000|Intervention Period|Too high ovarian response|4|||
130827439|NCT01144416|470996555|FG001|Intervention Period|Too high ovarian response|2|||
130827440|NCT01144416|470996554|FG000|Intervention Period|No/too few/bad oocytes|7|||
130827441|NCT01144416|470996555|FG001|Intervention Period|No/too few/bad oocytes|5|||
130827442|NCT01144416|470996554|FG000|Intervention Period|No or abnormal fertilization|25|||
130827443|NCT01144416|470996555|FG001|Intervention Period|No or abnormal fertilization|10|||
130827444|NCT01144416|470996554|FG000|Intervention Period|No/too few/bad quality embryos|3|||
130827445|NCT01144416|470996555|FG001|Intervention Period|No/too few/bad quality embryos|3|||
130827446|NCT01144416|470996554|FG000|Intervention Period|Other|7|||
130827447|NCT01144416|470996555|FG001|Intervention Period|Other|5|||
130827448|NCT00124072|470996556|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
130827449|NCT00124072|470996557|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
130827450|NCT00124072|470996558|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
130827451|NCT00124072|470996559|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
130827452|NCT00124072|470996556|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
130827453|NCT00124072|470996557|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
130827454|NCT00124072|470996558|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
130827455|NCT00124072|470996559|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
130827456|NCT00124072|470996556|FG000|Overall Study|Death|499|||
130827457|NCT00124072|470996557|FG001|Overall Study|Death|484|||
130827458|NCT00124072|470996558|FG002|Overall Study|Death|471|||
130827459|NCT00124072|470996559|FG003|Overall Study|Death|480|||
130827460|NCT02534883|470996560|FG000|Overall Study|Early Termination|8|||
130827461|NCT02534883|470996561|FG001|Overall Study|Early Termination|3|||
130827462|NCT03328832|470996562|FG000|Overall Study|Lost to Follow-up|0|||
130827463|NCT03328832|470996563|FG001|Overall Study|Lost to Follow-up|1|||
130827464|NCT00886769|470996564|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130827465|NCT00886769|470996565|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
130827466|NCT00778336|470996568|FG000|Index Procedure-Discharge|Death|6|||
130827467|NCT00778336|470996569|FG001|Index Procedure-Discharge|Death|3|||
130827468|NCT00778336|470996570|FG002|Index Procedure-Discharge|Death|2|||
130827469|NCT00778336|470996571|FG003|Index Procedure-Discharge|Death|0|||
130827470|NCT00778336|470996568|FG000|3 Month Follow Up|Lost to Follow-up|15|||
130827471|NCT00778336|470996569|FG001|3 Month Follow Up|Lost to Follow-up|20|||
130827472|NCT00778336|470996570|FG002|3 Month Follow Up|Lost to Follow-up|3|||
130827473|NCT00778336|470996571|FG003|3 Month Follow Up|Lost to Follow-up|0|||
130827474|NCT00778336|470996568|FG000|3 Month Follow Up|Death|8|||
130827475|NCT00778336|470996569|FG001|3 Month Follow Up|Death|3|||
130827476|NCT00778336|470996570|FG002|3 Month Follow Up|Death|2|||
130827477|NCT00778336|470996571|FG003|3 Month Follow Up|Death|0|||
130827478|NCT00414076|470996572|FG000|Overall Study|Progression|1|||
130827479|NCT00414076|470996573|FG001|Overall Study|Progression|2|||
130827480|NCT00414076|470996572|FG000|Overall Study|Withdrawal by Subject|1|||
130827481|NCT00414076|470996573|FG001|Overall Study|Withdrawal by Subject|3|||
130827482|NCT00414076|470996572|FG000|Overall Study|Adverse Event|1|||
130827483|NCT00414076|470996573|FG001|Overall Study|Adverse Event|0|||
130827484|NCT00049257|470996574|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
130827485|NCT00049257|470996574|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
130827486|NCT00049257|470996574|FG000|Carboplatin, Paclitaxel|Death|2|||
130827487|NCT00049257|470996574|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
130827488|NCT04721158|470996575|FG000|Overall Study|Lost to Follow-up|4|||
130827489|NCT04721158|470996575|FG000|Overall Study|Device did not connect|1|||
130827490|NCT04872569|470996576|FG000|Overall Study|Withdrawal by Subject|2|||
130827491|NCT04466384|470996582|FG000|First Phase|Protocol Violation|1|||
130827492|NCT04466384|470996583|FG001|First Phase|Protocol Violation|0|||
130827493|NCT04466384|470996582|FG000|First Phase|Missing data|1|||
130827494|NCT04466384|470996583|FG001|First Phase|Missing data|0|||
130827495|NCT04466384|470996582|FG000|Cross Over Phase|Physician Decision|1|||
130827496|NCT04466384|470996583|FG001|Cross Over Phase|Physician Decision|0|||
130827497|NCT04466384|470996582|FG000|Cross Over Phase|Withdrawal by Subject|0|||
130827498|NCT04466384|470996583|FG001|Cross Over Phase|Withdrawal by Subject|1|||
130827499|NCT03666988|470996584|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
130827500|NCT03666988|470996585|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
130827501|NCT03666988|470996586|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
130827502|NCT03666988|470996587|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
130827503|NCT03666988|470996588|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
130827504|NCT03666988|470996589|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
130827505|NCT03666988|470996584|FG000|Part 1 (Up to 28 Months)|Other|0|||
130827506|NCT03666988|470996585|FG001|Part 1 (Up to 28 Months)|Other|1|||
130827507|NCT03666988|470996586|FG002|Part 1 (Up to 28 Months)|Other|1|||
130827508|NCT03666988|470996587|FG003|Part 1 (Up to 28 Months)|Other|0|||
130827509|NCT03666988|470996588|FG004|Part 1 (Up to 28 Months)|Other|0|||
130827510|NCT03666988|470996589|FG005|Part 1 (Up to 28 Months)|Other|0|||
130827511|NCT03666988|470996584|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
130827512|NCT03666988|470996585|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
130827513|NCT03666988|470996586|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
130827514|NCT03666988|470996587|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
130827515|NCT03666988|470996588|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
130827516|NCT03666988|470996589|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
130827517|NCT03666988|470996584|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
130827518|NCT03666988|470996585|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
130827519|NCT03666988|470996586|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
130827520|NCT03666988|470996587|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
130827521|NCT03666988|470996588|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
130827522|NCT03666988|470996589|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
130827523|NCT03666988|470996584|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
130827524|NCT03666988|470996585|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130827525|NCT03666988|470996586|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130827526|NCT03666988|470996587|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130827527|NCT03666988|470996588|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130827528|NCT03666988|470996589|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130827529|NCT01402869|470996598|FG000|Overall Study|Required Tooth Extraction|0|||
130827530|NCT01402869|470996599|FG001|Overall Study|Required Tooth Extraction|0|||
130827531|NCT01402869|470996600|FG002|Overall Study|Required Tooth Extraction|1|||
130827532|NCT00145626|470996601|FG000|Overall Study|Did not have NK infusions|2|||
130827533|NCT00145626|470996601|FG000|Overall Study|Turned 2 years old before treatment|1|||
130827534|NCT00145626|470996601|FG000|Overall Study|Death|1|||
130827535|NCT00145626|470996601|FG000|Overall Study|Withdrawal by Subject|1|||
130827536|NCT03654274|470996602|FG000|Overall Study|Adverse Event|19|||
130827537|NCT03654274|470996603|FG001|Overall Study|Adverse Event|23|||
130827538|NCT03654274|470996604|FG002|Overall Study|Adverse Event|24|||
130827539|NCT03654274|470996602|FG000|Overall Study|Protocol Deviation|0|||
130827540|NCT03654274|470996603|FG001|Overall Study|Protocol Deviation|2|||
130827541|NCT03654274|470996604|FG002|Overall Study|Protocol Deviation|0|||
130827542|NCT03654274|470996602|FG000|Overall Study|Lost to Follow-up|8|||
130827543|NCT03654274|470996603|FG001|Overall Study|Lost to Follow-up|6|||
130827544|NCT03654274|470996604|FG002|Overall Study|Lost to Follow-up|5|||
130827545|NCT03654274|470996602|FG000|Overall Study|Withdrawal by Subject|46|||
130827546|NCT03654274|470996603|FG001|Overall Study|Withdrawal by Subject|25|||
130827547|NCT03654274|470996604|FG002|Overall Study|Withdrawal by Subject|33|||
130827548|NCT03654274|470996602|FG000|Overall Study|Lack of Efficacy|4|||
130827549|NCT03654274|470996603|FG001|Overall Study|Lack of Efficacy|5|||
130827550|NCT03654274|470996604|FG002|Overall Study|Lack of Efficacy|7|||
130827551|NCT03654274|470996602|FG000|Overall Study|Pregnancy|2|||
130827552|NCT03654274|470996603|FG001|Overall Study|Pregnancy|2|||
130827553|NCT03654274|470996604|FG002|Overall Study|Pregnancy|1|||
130827554|NCT03654274|470996602|FG000|Overall Study|Other|27|||
130827555|NCT03654274|470996603|FG001|Overall Study|Other|29|||
130827556|NCT03654274|470996604|FG002|Overall Study|Other|32|||
130827557|NCT03654274|470996602|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
130827558|NCT03654274|470996603|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
130827559|NCT03654274|470996604|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
130827560|NCT05005273|470996605|FG000|Overall Study|Study Terminated|1|||
130827561|NCT05005273|470996606|FG001|Overall Study|Study Terminated|0|||
130827562|NCT02685826|470996609|FG000|Overall Study|Adverse Event|2|||
130827563|NCT02685826|470996610|FG001|Overall Study|Adverse Event|0|||
130827564|NCT02685826|470996611|FG002|Overall Study|Adverse Event|1|||
130827565|NCT02685826|470996609|FG000|Overall Study|Progressive Disease|2|||
130827566|NCT02685826|470996610|FG001|Overall Study|Progressive Disease|1|||
130827567|NCT02685826|470996611|FG002|Overall Study|Progressive Disease|0|||
130827568|NCT02685826|470996609|FG000|Overall Study|Withdrawal by Subject|2|||
130827569|NCT02685826|470996610|FG001|Overall Study|Withdrawal by Subject|0|||
130827570|NCT02685826|470996611|FG002|Overall Study|Withdrawal by Subject|0|||
130827571|NCT02685826|470996609|FG000|Overall Study|Full Clinical Hold by FDA|19|||
130827572|NCT02685826|470996610|FG001|Overall Study|Full Clinical Hold by FDA|9|||
130827573|NCT02685826|470996611|FG002|Overall Study|Full Clinical Hold by FDA|20|||
130827574|NCT03154476|470996612|FG000|Overall Study|Lost to Follow-up|4|||
130827575|NCT03154476|470996613|FG001|Overall Study|Lost to Follow-up|4|||
130827576|NCT00200967|470996616|FG000|First Treatment Period|Withdrawal by Subject|5|||
130827577|NCT00200967|470996617|FG001|First Treatment Period|Withdrawal by Subject|1|||
130827578|NCT00200967|470996616|FG000|First Treatment Period|Pregnancy|1|||
130827579|NCT00200967|470996617|FG001|First Treatment Period|Pregnancy|0|||
130827580|NCT00200967|470996616|FG000|Wash-out Period|Lost to Follow-up|0|||
130827581|NCT00200967|470996617|FG001|Wash-out Period|Lost to Follow-up|1|||
130827582|NCT00200967|470996616|FG000|Second Treatment Period|Withdrawal by Subject|1|||
130827583|NCT00200967|470996617|FG001|Second Treatment Period|Withdrawal by Subject|2|||
130827584|NCT00200967|470996616|FG000|Run-out Period|Lost to Follow-up|1|||
130827585|NCT00200967|470996617|FG001|Run-out Period|Lost to Follow-up|0|||
130827586|NCT01444430|470996620|FG000|Overall Study|Withdrawal by Subject|53|||
130827587|NCT01444430|470996621|FG001|Overall Study|Withdrawal by Subject|72|||
130827588|NCT01444430|470996620|FG000|Overall Study|Death|6|||
130827589|NCT01444430|470996621|FG001|Overall Study|Death|8|||
130827590|NCT01444430|470996620|FG000|Overall Study|Lost to Follow-up|2|||
130827591|NCT01444430|470996621|FG001|Overall Study|Lost to Follow-up|0|||
130827592|NCT01444430|470996620|FG000|Overall Study|CRF termination module not completed.|0|||
130827593|NCT01444430|470996621|FG001|Overall Study|CRF termination module not completed.|1|||
130827594|NCT02840253|470997705|FG000|Overall Study|Unsuccessful block|4|||
130827595|NCT03783962|470997706|FG000|Overall Study|Lost to Follow-up|3|||
130827596|NCT03783962|470997707|FG001|Overall Study|Lost to Follow-up|6|||
130827597|NCT03783962|470997706|FG000|Overall Study|Protocol Violation|0|||
130827598|NCT03783962|470997707|FG001|Overall Study|Protocol Violation|1|||
130827599|NCT01724216|470997708|FG000|Overall Study|Scan was not completed|1|||
130827600|NCT00175916|470997709|FG000|Overall Study|Death|19|||
130827601|NCT00175916|470997709|FG000|Overall Study|Adverse Event|81|||
130827602|NCT00175916|470997709|FG000|Overall Study|Lack of Efficacy|354|||
130827603|NCT00175916|470997709|FG000|Overall Study|Lost to Follow-up|17|||
130827604|NCT00175916|470997709|FG000|Overall Study|Subject Choice|98|||
130827605|NCT00175916|470997709|FG000|Overall Study|Lack of compliance|8|||
130827606|NCT00175916|470997709|FG000|Overall Study|Patient cannot record seizures|1|||
130827607|NCT00175916|470997709|FG000|Overall Study|Sponsor decision|17|||
130827608|NCT00175916|470997709|FG000|Overall Study|Vigabatrin intake|1|||
130827609|NCT00175916|470997709|FG000|Overall Study|Suicidal behaviour|1|||
130827610|NCT00175916|470997709|FG000|Overall Study|Withdrawal by Subject|1|||
130827611|NCT00175916|470997709|FG000|Overall Study|Seizure - free|4|||
130827612|NCT00175916|470997709|FG000|Overall Study|Administrative reason|1|||
130827613|NCT00175916|470997709|FG000|Overall Study|Pregnancy|1|||
130827614|NCT00175916|470997709|FG000|Overall Study|Patient's request|2|||
130827615|NCT00175916|470997709|FG000|Overall Study|Treating physiciant's choice|1|||
130827616|NCT00175916|470997709|FG000|Overall Study|Moved overseas|1|||
130827617|NCT00175916|470997709|FG000|Overall Study|Loss of job and economic burden|1|||
130827618|NCT00175916|470997709|FG000|Overall Study|Site was closed|9|||
130827619|NCT00175916|470997709|FG000|Overall Study|Patient went to prison|1|||
130827620|NCT03650413|470997710|FG000|Overall Study|Adverse Event|1|||
130827621|NCT03650413|470997710|FG000|Overall Study|Lack of Efficacy|17|||
130827622|NCT03650413|470997710|FG000|Overall Study|Other|9|||
130827623|NCT03650413|470997710|FG000|Overall Study|Physician Decision|2|||
130827624|NCT03650413|470997710|FG000|Overall Study|Study Terminated By Sponsor|16|||
130827625|NCT03650413|470997710|FG000|Overall Study|Withdrawal by Subject|16|||
130827626|NCT03654040|470997711|FG000|Overall Study|Death|1|||
130827627|NCT03654040|470997712|FG001|Overall Study|Death|0|||
130827628|NCT03654040|470997711|FG000|Overall Study|Withdrawal by Subject|1|||
130827629|NCT03654040|470997712|FG001|Overall Study|Withdrawal by Subject|0|||
130827630|NCT03654040|470997711|FG000|Overall Study|Study terminated by sponsor|8|||
130827631|NCT03654040|470997712|FG001|Overall Study|Study terminated by sponsor|2|||
130827632|NCT03654040|470997711|FG000|Overall Study|Failure to initiate study therapy|2|||
130827633|NCT03654040|470997712|FG001|Overall Study|Failure to initiate study therapy|0|||
130827634|NCT03654040|470997711|FG000|Overall Study|Transplanted at another center|2|||
130827635|NCT03654040|470997712|FG001|Overall Study|Transplanted at another center|0|||
130827636|NCT03654040|470997711|FG000|Overall Study|Failure to meet eligibility criteria|14|||
130827637|NCT03654040|470997712|FG001|Overall Study|Failure to meet eligibility criteria|2|||
130827638|NCT03654040|470997711|FG000|Overall Study|No longer transplant candidate|1|||
130827639|NCT03654040|470997712|FG001|Overall Study|No longer transplant candidate|0|||
130827640|NCT03654040|470997711|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
130827641|NCT03654040|470997712|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
130827642|NCT03654040|470997711|FG000|Overall Study|Recipient ineligible|0|||
130827643|NCT03654040|470997712|FG001|Overall Study|Recipient ineligible|2|||
130827644|NCT03654040|470997711|FG000|Overall Study|Received deceased liver|0|||
130827645|NCT03654040|470997712|FG001|Overall Study|Received deceased liver|1|||
130827646|NCT03369665|470997713|FG000|Overall Study|Adverse Event|3|||
130827647|NCT03369665|470997713|FG000|Overall Study|Lost to Follow-up|7|||
130827648|NCT03369665|470997713|FG000|Overall Study|Withdrawal by Subject|15|||
130827649|NCT03369665|470997713|FG000|Overall Study|Progression Disease|2|||
130827650|NCT03369665|470997713|FG000|Overall Study|Not classified|3|||
130827651|NCT02553928|470997714|FG000|Overall Study|Adverse Event|2|||
130827652|NCT02553928|470997715|FG001|Overall Study|Adverse Event|1|||
130827653|NCT02553928|470997714|FG000|Overall Study|Lost to Follow-up|0|||
130827654|NCT02553928|470997715|FG001|Overall Study|Lost to Follow-up|1|||
130827655|NCT02553928|470997714|FG000|Overall Study|Administrative reason(s)|0|||
130827656|NCT02553928|470997715|FG001|Overall Study|Administrative reason(s)|1|||
130827657|NCT01206140|470997721|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
130827658|NCT01206140|470997722|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
130827659|NCT02688192|470997723|FG000|Overall Study|Lost to Follow-up|11|||
130827660|NCT02688192|470997724|FG001|Overall Study|Lost to Follow-up|5|||
130827661|NCT02688192|470997723|FG000|Overall Study|Physician Decision|1|||
130827662|NCT02688192|470997724|FG001|Overall Study|Physician Decision|0|||
130827663|NCT00075764|470997725|FG000|Overall Study|Adverse Event|5|||
130827664|NCT00075764|470997726|FG001|Overall Study|Adverse Event|12|||
130827665|NCT00075764|470997725|FG000|Overall Study|Death|4|||
130827666|NCT00075764|470997726|FG001|Overall Study|Death|8|||
130827667|NCT00075764|470997725|FG000|Overall Study|Withdrawal by Subject|28|||
130827668|NCT00075764|470997726|FG001|Overall Study|Withdrawal by Subject|18|||
130827669|NCT00075764|470997725|FG000|Overall Study|Progression|269|||
130827670|NCT00075764|470997726|FG001|Overall Study|Progression|274|||
130827671|NCT00075764|470997725|FG000|Overall Study|Still on treatment|8|||
130827672|NCT00075764|470997726|FG001|Overall Study|Still on treatment|15|||
130827673|NCT00075764|470997725|FG000|Overall Study|Delinquent|4|||
130827674|NCT00075764|470997726|FG001|Overall Study|Delinquent|2|||
130827675|NCT00075764|470997725|FG000|Overall Study|Not protocol specified|27|||
130827676|NCT00075764|470997726|FG001|Overall Study|Not protocol specified|19|||
130827677|NCT00075764|470997725|FG000|Overall Study|Under review|0|||
130827678|NCT00075764|470997726|FG001|Overall Study|Under review|1|||
130827679|NCT02817594|470997727|FG000|Overall Study|Withdrawal by Subject|1|||
130827680|NCT02817594|470997727|FG000|Overall Study|Other|1|||
130827681|NCT02817594|470997727|FG000|Overall Study|Did Not Receive Treatment|1|||
130827682|NCT02010593|470997728|FG000|Overall Study|Lost to Follow-up|1|||
130827683|NCT02010593|470997729|FG001|Overall Study|Lost to Follow-up|0|||
130827684|NCT02010593|470997728|FG000|Overall Study|Physician Decision|1|||
130827685|NCT02010593|470997729|FG001|Overall Study|Physician Decision|0|||
130827686|NCT02010593|470997728|FG000|Overall Study|Unable to adhere to visit schedule|0|||
130827687|NCT02010593|470997729|FG001|Overall Study|Unable to adhere to visit schedule|2|||
130827688|NCT01773967|470997730|FG000|Overall Study|Lost to Follow-up|15|||
130827689|NCT01773967|470997731|FG001|Overall Study|Lost to Follow-up|13|||
130827690|NCT01135459|470997732|FG000|Overall Study|Adverse Event|8|||
130827691|NCT01135459|470997733|FG001|Overall Study|Adverse Event|10|||
130827692|NCT01135459|470997732|FG000|Overall Study|Lack of Efficacy|3|||
130827693|NCT01135459|470997733|FG001|Overall Study|Lack of Efficacy|1|||
130827694|NCT01135459|470997732|FG000|Overall Study|Withdrawal by Subject|2|||
130827695|NCT01135459|470997733|FG001|Overall Study|Withdrawal by Subject|3|||
130827696|NCT01135459|470997732|FG000|Overall Study|Protocol Violation|5|||
130827697|NCT01135459|470997733|FG001|Overall Study|Protocol Violation|3|||
130827698|NCT01135459|470997732|FG000|Overall Study|Lost to Follow-up|2|||
130827699|NCT01135459|470997733|FG001|Overall Study|Lost to Follow-up|1|||
130827700|NCT01135459|470997732|FG000|Overall Study|Non-compliance to study procedures|0|||
130827701|NCT01135459|470997733|FG001|Overall Study|Non-compliance to study procedures|1|||
130827702|NCT01135459|470997732|FG000|Overall Study|Other than specified|1|||
130827703|NCT01135459|470997733|FG001|Overall Study|Other than specified|1|||
130827704|NCT00770562|470997735|FG000|Overall Study|Did not take treatment|1|||
130827705|NCT00770562|470997736|FG001|Overall Study|Did not take treatment|1|||
130827706|NCT01643408|470997739|FG000|Overall Study|Adverse Event|12|||
130827707|NCT01643408|470997739|FG000|Overall Study|Other|2|||
130827708|NCT01194219|470997740|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
130827709|NCT01194219|470997741|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
130827710|NCT01194219|470997742|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130827711|NCT01194219|470997743|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130827712|NCT01194219|470997744|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130827713|NCT01194219|470997745|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130827714|NCT01194219|470997746|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130827715|NCT01194219|470997747|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130827716|NCT01194219|470997748|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130827717|NCT01194219|470997749|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130827718|NCT01194219|470997740|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
130827719|NCT01194219|470997741|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
130827720|NCT01194219|470997742|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130827721|NCT01194219|470997743|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130827722|NCT01194219|470997744|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130827723|NCT01194219|470997745|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130827724|NCT01194219|470997746|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130827725|NCT01194219|470997747|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130827726|NCT01194219|470997748|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130827727|NCT01194219|470997749|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130827728|NCT01194219|470997740|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
130827729|NCT01194219|470997741|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130827730|NCT01194219|470997742|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130827731|NCT01194219|470997743|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130827732|NCT01194219|470997744|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130827733|NCT01194219|470997745|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130827734|NCT01194219|470997746|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130827735|NCT01194219|470997747|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130827736|NCT01194219|470997748|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130827737|NCT01194219|470997749|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130827738|NCT01194219|470997740|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
130827739|NCT01194219|470997741|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
130827740|NCT01194219|470997742|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130827741|NCT01194219|470997743|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130827742|NCT01194219|470997744|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130827743|NCT01194219|470997745|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130827744|NCT01194219|470997746|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130827745|NCT01194219|470997747|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130827746|NCT01194219|470997748|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130827747|NCT01194219|470997749|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130827748|NCT01194219|470997740|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130827749|NCT01194219|470997741|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
130827750|NCT01194219|470997742|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130827751|NCT01194219|470997743|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130827752|NCT01194219|470997744|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130827753|NCT01194219|470997745|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130827754|NCT01194219|470997746|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130827755|NCT01194219|470997747|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130827756|NCT01194219|470997748|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130827757|NCT01194219|470997749|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130827758|NCT01194219|470997740|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
130827759|NCT01194219|470997741|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
130827760|NCT01194219|470997742|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130827761|NCT01194219|470997743|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130827762|NCT01194219|470997744|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130827763|NCT01194219|470997745|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130827764|NCT01194219|470997746|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130827765|NCT01194219|470997747|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130827766|NCT01194219|470997748|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130827767|NCT01194219|470997749|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130827768|NCT01194219|470997740|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
130827769|NCT01194219|470997741|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
130827770|NCT01194219|470997742|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130827771|NCT01194219|470997743|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130827772|NCT01194219|470997744|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130827773|NCT01194219|470997745|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130827774|NCT01194219|470997746|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130827775|NCT01194219|470997747|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130827776|NCT01194219|470997748|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130827777|NCT01194219|470997749|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130827778|NCT01194219|470997740|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
130827779|NCT01194219|470997741|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
130827780|NCT01194219|470997742|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130827781|NCT01194219|470997743|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130827782|NCT01194219|470997744|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130827783|NCT01194219|470997745|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130827784|NCT01194219|470997746|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130827785|NCT01194219|470997747|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130827786|NCT01194219|470997748|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130827787|NCT01194219|470997749|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130827788|NCT01194219|470997740|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
130827789|NCT01194219|470997741|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
130827790|NCT01194219|470997742|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
130827791|NCT01194219|470997743|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
130827792|NCT01194219|470997744|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
130827793|NCT01194219|470997745|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
130827794|NCT01194219|470997746|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
130827795|NCT01194219|470997747|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
130827796|NCT01194219|470997748|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
130827797|NCT01194219|470997749|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
130827798|NCT01194219|470997740|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130827799|NCT01194219|470997741|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130827800|NCT01194219|470997742|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
130827801|NCT01194219|470997743|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
130827802|NCT01194219|470997744|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130827803|NCT01194219|470997745|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130827804|NCT01194219|470997746|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130827805|NCT01194219|470997747|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130827806|NCT01194219|470997748|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130827807|NCT01194219|470997749|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130827808|NCT01194219|470997740|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130827809|NCT01194219|470997741|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130827810|NCT01194219|470997742|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
130827811|NCT01194219|470997743|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
130827812|NCT01194219|470997744|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130827813|NCT01194219|470997745|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130827814|NCT01194219|470997746|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130827815|NCT01194219|470997747|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130827816|NCT01194219|470997748|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130827817|NCT01194219|470997749|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130827818|NCT01194219|470997740|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130827819|NCT01194219|470997741|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130827820|NCT01194219|470997742|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
130827821|NCT01194219|470997743|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
130827822|NCT01194219|470997744|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130827823|NCT01194219|470997745|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130827824|NCT01194219|470997746|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130827825|NCT01194219|470997747|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130827826|NCT01194219|470997748|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130827827|NCT01194219|470997749|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130827828|NCT01194219|470997740|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130827829|NCT01194219|470997741|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130827830|NCT01194219|470997742|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
130827831|NCT01194219|470997743|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130827832|NCT01194219|470997744|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130827833|NCT01194219|470997745|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130827834|NCT01194219|470997746|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130827835|NCT01194219|470997747|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130827836|NCT01194219|470997748|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130827837|NCT01194219|470997749|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130827838|NCT01194219|470997740|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130827839|NCT01194219|470997741|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130827840|NCT01194219|470997742|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130827841|NCT01194219|470997743|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
130827842|NCT01194219|470997744|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130827843|NCT01194219|470997745|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130827844|NCT01194219|470997746|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130827845|NCT01194219|470997747|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130827846|NCT01194219|470997748|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130827847|NCT01194219|470997749|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130827848|NCT01194219|470997740|FG000|Maintenance Phase Weeks16-32|Other|0|||
130827849|NCT01194219|470997741|FG001|Maintenance Phase Weeks16-32|Other|0|||
130827850|NCT01194219|470997742|FG002|Maintenance Phase Weeks16-32|Other|2|||
130827851|NCT01194219|470997743|FG003|Maintenance Phase Weeks16-32|Other|1|||
130827852|NCT01194219|470997744|FG004|Maintenance Phase Weeks16-32|Other|0|||
130827853|NCT01194219|470997745|FG005|Maintenance Phase Weeks16-32|Other|0|||
130827854|NCT01194219|470997746|FG006|Maintenance Phase Weeks16-32|Other|0|||
130827855|NCT01194219|470997747|FG007|Maintenance Phase Weeks16-32|Other|0|||
130827856|NCT01194219|470997748|FG008|Maintenance Phase Weeks16-32|Other|0|||
130827857|NCT01194219|470997749|FG009|Maintenance Phase Weeks16-32|Other|0|||
130827858|NCT01194219|470997740|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130827859|NCT01194219|470997741|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130827860|NCT01194219|470997742|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130827861|NCT01194219|470997743|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130827862|NCT01194219|470997744|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130827863|NCT01194219|470997745|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
130827864|NCT01194219|470997746|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
130827865|NCT01194219|470997747|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
130827866|NCT01194219|470997748|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130827867|NCT01194219|470997749|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130827868|NCT01194219|470997740|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130827869|NCT01194219|470997741|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130827870|NCT01194219|470997742|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130827871|NCT01194219|470997743|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130827872|NCT01194219|470997744|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
130827873|NCT01194219|470997745|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
130827874|NCT01194219|470997746|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
130827875|NCT01194219|470997747|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
130827876|NCT01194219|470997748|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130827877|NCT01194219|470997749|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130827878|NCT01194219|470997740|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130827879|NCT01194219|470997741|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130827880|NCT01194219|470997742|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130827881|NCT01194219|470997743|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130827882|NCT01194219|470997744|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
130827883|NCT01194219|470997745|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130827884|NCT01194219|470997746|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
130827885|NCT01194219|470997747|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130827886|NCT01194219|470997748|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130827887|NCT01194219|470997749|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130827888|NCT01194219|470997740|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130827889|NCT01194219|470997741|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130827890|NCT01194219|470997742|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130827891|NCT01194219|470997743|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130827892|NCT01194219|470997744|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
130827893|NCT01194219|470997745|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130827894|NCT01194219|470997746|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
130827895|NCT01194219|470997747|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
130827896|NCT01194219|470997748|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130827897|NCT01194219|470997749|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130827898|NCT01194219|470997740|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130827899|NCT01194219|470997741|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130827900|NCT01194219|470997742|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130827901|NCT01194219|470997743|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130827902|NCT01194219|470997744|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
130827903|NCT01194219|470997745|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
130827904|NCT01194219|470997746|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
130827905|NCT01194219|470997747|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130827906|NCT01194219|470997748|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130827907|NCT01194219|470997749|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130827908|NCT01194219|470997740|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130827909|NCT01194219|470997741|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130827910|NCT01194219|470997742|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130827911|NCT01194219|470997743|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130827912|NCT01194219|470997744|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130827913|NCT01194219|470997745|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130827914|NCT01194219|470997746|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130827915|NCT01194219|470997747|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
130827916|NCT01194219|470997748|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130827917|NCT01194219|470997749|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130827918|NCT01194219|470997740|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130827919|NCT01194219|470997741|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130827920|NCT01194219|470997742|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130827921|NCT01194219|470997743|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130827922|NCT01194219|470997744|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130827923|NCT01194219|470997745|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130827924|NCT01194219|470997746|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
130827925|NCT01194219|470997747|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130827926|NCT01194219|470997748|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130827927|NCT01194219|470997749|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130827928|NCT01194219|470997740|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130827929|NCT01194219|470997741|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130827930|NCT01194219|470997742|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130827931|NCT01194219|470997743|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130827932|NCT01194219|470997744|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130827933|NCT01194219|470997745|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130827934|NCT01194219|470997746|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130827935|NCT01194219|470997747|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130827936|NCT01194219|470997748|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
130827937|NCT01194219|470997749|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
130827938|NCT01194219|470997740|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130827939|NCT01194219|470997741|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130827940|NCT01194219|470997742|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130827941|NCT01194219|470997743|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130827942|NCT01194219|470997744|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130827943|NCT01194219|470997745|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130827944|NCT01194219|470997746|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130827945|NCT01194219|470997747|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130827946|NCT01194219|470997748|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
130827947|NCT01194219|470997749|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
130827948|NCT01194219|470997740|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130827949|NCT01194219|470997741|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130827950|NCT01194219|470997742|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130827951|NCT01194219|470997743|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130827952|NCT01194219|470997744|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130827953|NCT01194219|470997745|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130827954|NCT01194219|470997746|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130827955|NCT01194219|470997747|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130827956|NCT01194219|470997748|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
130827957|NCT01194219|470997749|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
130827958|NCT01194219|470997740|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130827959|NCT01194219|470997741|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130827960|NCT01194219|470997742|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130827961|NCT01194219|470997743|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130827962|NCT01194219|470997744|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130827963|NCT01194219|470997745|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130827964|NCT01194219|470997746|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130827965|NCT01194219|470997747|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130827966|NCT01194219|470997748|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
130827967|NCT01194219|470997749|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
130827968|NCT01194219|470997740|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
130827969|NCT01194219|470997741|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
130827970|NCT01194219|470997742|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
130827971|NCT01194219|470997743|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
130827972|NCT01194219|470997744|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
130827973|NCT01194219|470997745|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
130827974|NCT01194219|470997746|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
130827975|NCT01194219|470997747|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
130827976|NCT01194219|470997748|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
130827977|NCT01194219|470997749|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
130827978|NCT01194219|470997740|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130827979|NCT01194219|470997741|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130827980|NCT01194219|470997742|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130827981|NCT01194219|470997743|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130827982|NCT01194219|470997744|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130827983|NCT01194219|470997745|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130827984|NCT01194219|470997746|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130827985|NCT01194219|470997747|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130827986|NCT01194219|470997748|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
130827987|NCT01194219|470997749|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
130827988|NCT01194219|470997740|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130827989|NCT01194219|470997741|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130827990|NCT01194219|470997742|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130827991|NCT01194219|470997743|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130827992|NCT01194219|470997744|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130827993|NCT01194219|470997745|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130827994|NCT01194219|470997746|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130827995|NCT01194219|470997747|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130827996|NCT01194219|470997748|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
130827997|NCT01194219|470997749|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130827998|NCT01194219|470997740|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130827999|NCT01194219|470997741|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130828000|NCT01194219|470997742|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130828001|NCT01194219|470997743|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130828002|NCT01194219|470997744|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130828003|NCT01194219|470997745|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130828004|NCT01194219|470997746|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130828005|NCT01194219|470997747|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130828006|NCT01194219|470997748|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
130828007|NCT01194219|470997749|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
130828008|NCT00292045|470997752|FG000|Core Study (Through Week 13)|Adverse Event|1|||
130828009|NCT00292045|470997752|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
130828010|NCT04474197|470997753|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
130828011|NCT04474197|470997754|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
130828012|NCT04474197|470997755|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
130828013|NCT04474197|470997756|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
130828014|NCT01057693|470997757|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
130828015|NCT01057693|470997758|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
130828016|NCT01057693|470997759|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
130828017|NCT01057693|470997757|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
130828018|NCT01057693|470997758|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
130828019|NCT01057693|470997759|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
130828020|NCT01057693|470997757|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
130828021|NCT01057693|470997758|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
130828022|NCT01057693|470997759|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
130828023|NCT01057693|470997757|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
130828024|NCT01057693|470997758|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
130828025|NCT01057693|470997759|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
130828026|NCT01057693|470997757|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
130828027|NCT01057693|470997758|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
130828028|NCT01057693|470997759|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
130828029|NCT01057693|470997757|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
130828030|NCT01057693|470997758|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
130828031|NCT01057693|470997759|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
130828032|NCT01057693|470997757|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
130828033|NCT01057693|470997758|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
130828034|NCT01057693|470997759|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
130828035|NCT01057693|470997757|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
130828036|NCT01057693|470997758|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
130828037|NCT01057693|470997759|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
130828038|NCT01057693|470997757|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
130828039|NCT01057693|470997758|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
130828040|NCT01057693|470997759|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
130828041|NCT01057693|470997757|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
130828042|NCT01057693|470997758|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
130828043|NCT01057693|470997759|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
130828044|NCT01057693|470997757|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
130828045|NCT01057693|470997758|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
130828046|NCT01057693|470997759|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
130828047|NCT01057693|470997757|FG000|Between Single-Blind and Double-Blind|Other|6|||
130828048|NCT01057693|470997758|FG001|Between Single-Blind and Double-Blind|Other|0|||
130828049|NCT01057693|470997759|FG002|Between Single-Blind and Double-Blind|Other|0|||
130828050|NCT01057693|470997757|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
130828051|NCT01057693|470997758|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
130828052|NCT01057693|470997759|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
130828053|NCT01057693|470997757|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
130828054|NCT01057693|470997758|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
130828055|NCT01057693|470997759|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
130828056|NCT01057693|470997757|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
130828057|NCT01057693|470997758|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
130828058|NCT01057693|470997759|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
130828059|NCT01057693|470997757|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
130828060|NCT01057693|470997758|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
130828061|NCT01057693|470997759|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
130828062|NCT01057693|470997757|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
130828063|NCT01057693|470997758|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
130828064|NCT01057693|470997759|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
130828065|NCT01057693|470997757|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
130828066|NCT01057693|470997758|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
130828067|NCT01057693|470997759|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
130828068|NCT01057693|470997757|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
130828069|NCT01057693|470997758|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
130828070|NCT01057693|470997759|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
130828071|NCT01672879|470997766|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
130828072|NCT01672879|470997767|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
130828073|NCT01672879|470997768|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
130828074|NCT01672879|470997766|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
130828075|NCT01672879|470997767|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
130828076|NCT01672879|470997768|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
130828077|NCT01672879|470997766|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
130828078|NCT01672879|470997767|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
130828079|NCT01672879|470997768|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
130828080|NCT01672879|470997766|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
130828081|NCT01672879|470997767|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
130828082|NCT01672879|470997768|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
130828083|NCT01672879|470997766|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
130828084|NCT01672879|470997767|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
130828085|NCT01672879|470997768|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
130828086|NCT01672879|470997766|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
130828087|NCT01672879|470997767|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
130828088|NCT01672879|470997768|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
130828089|NCT01672879|470997766|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
130828090|NCT01672879|470997767|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
130828091|NCT01672879|470997768|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
130828092|NCT01672879|470997766|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
130828093|NCT01672879|470997767|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
130828094|NCT01672879|470997768|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
130828095|NCT01672879|470997766|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
130828096|NCT01672879|470997767|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
130828097|NCT01672879|470997768|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
130828098|NCT01672879|470997766|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
130828099|NCT01672879|470997767|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
130828100|NCT01672879|470997768|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
130828101|NCT01672879|470997766|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
130828102|NCT01672879|470997767|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
130828103|NCT01672879|470997768|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
130828104|NCT01672879|470997766|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
130828105|NCT01672879|470997767|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
130828106|NCT01672879|470997768|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
130828107|NCT01672879|470997766|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
130828108|NCT01672879|470997767|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
130828109|NCT01672879|470997768|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
130828110|NCT04860869|470997769|FG000|Overall Study|Withdrawal by Subject|1|||
130828111|NCT04860869|470997770|FG001|Overall Study|Withdrawal by Subject|0|||
130828112|NCT03951766|470997771|FG000|Treatment Phase|Lost to Follow-up|1|||
130828113|NCT03951766|470997771|FG000|Follow-up Phase|Lost to Follow-up|10|||
130828114|NCT04834726|470997774|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
130828115|NCT04834726|470997775|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
130828116|NCT04834726|470997776|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
130828117|NCT04834726|470997777|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
130828118|NCT04834726|470997778|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
130828119|NCT04834726|470997779|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
130828120|NCT04834726|470997780|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
130828121|NCT04834726|470997781|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
130828122|NCT04834726|470997782|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
130828123|NCT00363142|470997784|FG000|Overall Study|Adverse Event|2|||
130828124|NCT00363142|470997785|FG001|Overall Study|Adverse Event|0|||
130828125|NCT00363142|470997784|FG000|Overall Study|Lack of Efficacy|0|||
130828126|NCT00363142|470997785|FG001|Overall Study|Lack of Efficacy|1|||
130828127|NCT00363142|470997784|FG000|Overall Study|Lost to Follow-up|1|||
130828128|NCT00363142|470997785|FG001|Overall Study|Lost to Follow-up|0|||
130828129|NCT00363142|470997784|FG000|Overall Study|Non-compliance|1|||
130828130|NCT00363142|470997785|FG001|Overall Study|Non-compliance|1|||
130828131|NCT00363142|470997784|FG000|Overall Study|Withdrawal by Subject|3|||
130828132|NCT00363142|470997785|FG001|Overall Study|Withdrawal by Subject|1|||
130828133|NCT00132301|470997792|FG000|Overall Study|Death|7|||
130828134|NCT00132301|470997793|FG001|Overall Study|Death|6|||
130828135|NCT00132301|470997792|FG000|Overall Study|Withdrawal by Subject|5|||
130828136|NCT00132301|470997793|FG001|Overall Study|Withdrawal by Subject|2|||
130828137|NCT00132301|470997792|FG000|Overall Study|Physician Decision|1|||
130828138|NCT00132301|470997793|FG001|Overall Study|Physician Decision|1|||
130828139|NCT00132301|470997792|FG000|Overall Study|Lost to Follow-up|5|||
130828140|NCT00132301|470997793|FG001|Overall Study|Lost to Follow-up|3|||
130828141|NCT00132301|470997792|FG000|Overall Study|Other|1|||
130828142|NCT00132301|470997793|FG001|Overall Study|Other|1|||
130828143|NCT00132301|470997792|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
130828144|NCT00132301|470997793|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
130828145|NCT02012218|470997794|FG000|Overall Study|Withdrawal by Subject|1|||
130828146|NCT02012218|470997795|FG001|Overall Study|Withdrawal by Subject|0|||
130828147|NCT02012218|470997796|FG002|Overall Study|Withdrawal by Subject|1|||
130828148|NCT02012218|470997797|FG003|Overall Study|Withdrawal by Subject|1|||
130828149|NCT02012218|470997798|FG004|Overall Study|Withdrawal by Subject|1|||
130828150|NCT02012218|470997794|FG000|Overall Study|Adverse Event|1|||
130828151|NCT02012218|470997795|FG001|Overall Study|Adverse Event|0|||
130828152|NCT02012218|470997796|FG002|Overall Study|Adverse Event|0|||
130828153|NCT02012218|470997797|FG003|Overall Study|Adverse Event|1|||
130828154|NCT02012218|470997798|FG004|Overall Study|Adverse Event|0|||
130828155|NCT02012218|470997794|FG000|Overall Study|Lost to Follow-up|0|||
130828156|NCT02012218|470997795|FG001|Overall Study|Lost to Follow-up|1|||
130828157|NCT02012218|470997796|FG002|Overall Study|Lost to Follow-up|1|||
130828158|NCT02012218|470997797|FG003|Overall Study|Lost to Follow-up|0|||
130828159|NCT02012218|470997798|FG004|Overall Study|Lost to Follow-up|0|||
130828160|NCT02012218|470997794|FG000|Overall Study|Protocol Specified|1|||
130828161|NCT02012218|470997795|FG001|Overall Study|Protocol Specified|0|||
130828162|NCT02012218|470997796|FG002|Overall Study|Protocol Specified|0|||
130828163|NCT02012218|470997797|FG003|Overall Study|Protocol Specified|0|||
130828164|NCT02012218|470997798|FG004|Overall Study|Protocol Specified|0|||
130828165|NCT02012218|470997794|FG000|Overall Study|Protocol Deviation|1|||
130828166|NCT02012218|470997795|FG001|Overall Study|Protocol Deviation|0|||
130828167|NCT02012218|470997796|FG002|Overall Study|Protocol Deviation|0|||
130828168|NCT02012218|470997797|FG003|Overall Study|Protocol Deviation|0|||
130828169|NCT02012218|470997798|FG004|Overall Study|Protocol Deviation|0|||
130828170|NCT02382991|470997802|FG000|Overall Study|Adverse Event|1|||
130828171|NCT02382991|470997803|FG001|Overall Study|Adverse Event|2|||
130828172|NCT02382991|470997802|FG000|Overall Study|Lost to Follow-up|1|||
130828173|NCT02382991|470997803|FG001|Overall Study|Lost to Follow-up|0|||
130828174|NCT02382991|470997802|FG000|Overall Study|Withdrawal by Subject|0|||
130828175|NCT02382991|470997803|FG001|Overall Study|Withdrawal by Subject|1|||
130828176|NCT01890265|470997805|FG000|Overall Study|Other (Unspecified reason)|0|||
130828177|NCT01890265|470997806|FG001|Overall Study|Other (Unspecified reason)|1|||
130828178|NCT01890265|470997807|FG002|Overall Study|Other (Unspecified reason)|0|||
130828179|NCT01890265|470997808|FG003|Overall Study|Other (Unspecified reason)|0|||
130828180|NCT01890265|470997809|FG004|Overall Study|Other (Unspecified reason)|0|||
130828181|NCT01890265|470997810|FG005|Overall Study|Other (Unspecified reason)|0|||
130828182|NCT01890265|470997805|FG000|Overall Study|Progressive disease|6|||
130828183|NCT01890265|470997806|FG001|Overall Study|Progressive disease|6|||
130828184|NCT01890265|470997807|FG002|Overall Study|Progressive disease|0|||
130828185|NCT01890265|470997808|FG003|Overall Study|Progressive disease|0|||
130828186|NCT01890265|470997809|FG004|Overall Study|Progressive disease|0|||
130828187|NCT01890265|470997810|FG005|Overall Study|Progressive disease|0|||
130828188|NCT01890265|470997805|FG000|Overall Study|Adverse Event|2|||
130828189|NCT01890265|470997806|FG001|Overall Study|Adverse Event|1|||
130828190|NCT01890265|470997807|FG002|Overall Study|Adverse Event|0|||
130828191|NCT01890265|470997808|FG003|Overall Study|Adverse Event|0|||
130828192|NCT01890265|470997809|FG004|Overall Study|Adverse Event|0|||
130828193|NCT01890265|470997810|FG005|Overall Study|Adverse Event|0|||
130828194|NCT01890265|470997805|FG000|Overall Study|Death|2|||
130828195|NCT01890265|470997806|FG001|Overall Study|Death|3|||
130828196|NCT01890265|470997807|FG002|Overall Study|Death|1|||
130828197|NCT01890265|470997808|FG003|Overall Study|Death|0|||
130828198|NCT01890265|470997809|FG004|Overall Study|Death|0|||
130828199|NCT01890265|470997810|FG005|Overall Study|Death|0|||
130828200|NCT01890265|470997805|FG000|Overall Study|Withdrawal by Subject|0|||
130828201|NCT01890265|470997806|FG001|Overall Study|Withdrawal by Subject|2|||
130828202|NCT01890265|470997807|FG002|Overall Study|Withdrawal by Subject|3|||
130828203|NCT01890265|470997808|FG003|Overall Study|Withdrawal by Subject|0|||
130828204|NCT01890265|470997809|FG004|Overall Study|Withdrawal by Subject|2|||
130828205|NCT01890265|470997810|FG005|Overall Study|Withdrawal by Subject|0|||
130828206|NCT01445613|470997811|FG000|30-day Follow-up|Withdrawal by Subject|6|||
130828207|NCT01445613|470997811|FG000|30-day Follow-up|Physician Decision|3|||
130828208|NCT01445613|470997811|FG000|30-day Follow-up|Missed visit|23|||
130828209|NCT01445613|470997811|FG000|30-day Follow-up|Death|3|||
130828210|NCT01445613|470997811|FG000|1-year Follow-up|Withdrawal by Subject|12|||
130828211|NCT01445613|470997811|FG000|1-year Follow-up|Missed visit|29|||
130828212|NCT01445613|470997811|FG000|1-year Follow-up|Lost to Follow-up|2|||
130828213|NCT01445613|470997811|FG000|1-year Follow-up|Death|30|||
130828214|NCT01445613|470997811|FG000|1-year Follow-up|Physician Decision|2|||
130828215|NCT01445613|470997811|FG000|1-year Follow-up|Received a non-study stent|2|||
130828216|NCT03554018|470997812|FG000|Overall Study|Lost to Follow-up|3|||
130828217|NCT03554018|470997813|FG001|Overall Study|Lost to Follow-up|7|||
130828218|NCT01154452|470997814|FG000|Phase Ib|Not Treated|1|||
130828219|NCT01154452|470997815|FG001|Phase Ib|Not Treated|0|||
130828220|NCT01154452|470997816|FG002|Phase Ib|Not Treated|0|||
130828221|NCT01154452|470997817|FG003|Phase Ib|Not Treated|0|||
130828222|NCT01154452|470997814|FG000|Phase Ib|Adverse Event|2|||
130828223|NCT01154452|470997815|FG001|Phase Ib|Adverse Event|1|||
130828224|NCT01154452|470997816|FG002|Phase Ib|Adverse Event|0|||
130828225|NCT01154452|470997817|FG003|Phase Ib|Adverse Event|0|||
130828226|NCT01154452|470997814|FG000|Phase II|Withdrawal by Subject|0|||
130828227|NCT01154452|470997815|FG001|Phase II|Withdrawal by Subject|0|||
130828228|NCT01154452|470997816|FG002|Phase II|Withdrawal by Subject|1|||
130828229|NCT01154452|470997817|FG003|Phase II|Withdrawal by Subject|2|||
130828230|NCT01154452|470997814|FG000|Phase II|Adverse Event|0|||
130828231|NCT01154452|470997815|FG001|Phase II|Adverse Event|0|||
130828232|NCT01154452|470997816|FG002|Phase II|Adverse Event|4|||
130828233|NCT01154452|470997817|FG003|Phase II|Adverse Event|4|||
130828234|NCT01740687|470997821|FG000|Overall Study|Lost to Follow-up|11|||
130828235|NCT01740687|470997821|FG000|Overall Study|Withdrawal by Subject|2|||
130828236|NCT01740687|470997821|FG000|Overall Study|other reason|22|||
130828237|NCT01740687|470997821|FG000|Overall Study|treatment not received|2|||
130828238|NCT01837680|470997824|FG000|Overall Study|Lost to Follow-up|2|||
130828239|NCT01837680|470997825|FG001|Overall Study|Lost to Follow-up|2|||
130828240|NCT01837680|470997824|FG000|Overall Study|lack of insurance|0|||
130828241|NCT01837680|470997825|FG001|Overall Study|lack of insurance|2|||
130828242|NCT01837680|470997824|FG000|Overall Study|allergic reaction|6|||
130828243|NCT01837680|470997825|FG001|Overall Study|allergic reaction|0|||
130828244|NCT01837680|470997824|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
130828245|NCT01837680|470997825|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
130828246|NCT00326001|470997826|FG000|Overall Study|Adverse Event|4|||
130828247|NCT00326001|470997827|FG001|Overall Study|Adverse Event|5|||
130828248|NCT00326001|470997826|FG000|Overall Study|Physician Decision|3|||
130828249|NCT00326001|470997827|FG001|Overall Study|Physician Decision|3|||
130828250|NCT02297815|470998990|FG000|Overall Study|Lost to Follow-up|236|||
130828251|NCT02297815|470998991|FG001|Overall Study|Lost to Follow-up|140|||
130828252|NCT00662831|470998992|FG000|Overall Study|Death|4|||
130828253|NCT00662831|470998993|FG001|Overall Study|Death|1|||
130828254|NCT00662831|470998992|FG000|Overall Study|Lack of Efficacy|6|||
130828255|NCT00662831|470998993|FG001|Overall Study|Lack of Efficacy|6|||
130828256|NCT00662831|470998992|FG000|Overall Study|Lost to Follow-up|1|||
130828257|NCT00662831|470998993|FG001|Overall Study|Lost to Follow-up|0|||
130828258|NCT00662831|470998992|FG000|Overall Study|Withdrawal by Subject|2|||
130828259|NCT00662831|470998993|FG001|Overall Study|Withdrawal by Subject|1|||
130828260|NCT00662831|470998992|FG000|Overall Study|Other|62|||
130828261|NCT00662831|470998993|FG001|Overall Study|Other|31|||
130828262|NCT00662831|470998992|FG000|Overall Study|Protocol Violation|8|||
130828263|NCT00662831|470998993|FG001|Overall Study|Protocol Violation|4|||
130828264|NCT00662831|470998992|FG000|Overall Study|Adverse Event|23|||
130828265|NCT00662831|470998993|FG001|Overall Study|Adverse Event|16|||
130828266|NCT00600106|470998994|FG000|Overall Study|Withdrawal by Subject|1|||
130828267|NCT00600106|470998995|FG001|Overall Study|Withdrawal by Subject|1|||
130828268|NCT01061723|470998998|FG000|Overall Study|Adverse Event|0|||
130828269|NCT01061723|470998999|FG001|Overall Study|Adverse Event|2|||
130828270|NCT01061723|470999000|FG002|Overall Study|Adverse Event|5|||
130828271|NCT01061723|470999001|FG003|Overall Study|Adverse Event|5|||
130828272|NCT01061723|470999002|FG004|Overall Study|Adverse Event|2|||
130828273|NCT01061723|470999003|FG005|Overall Study|Adverse Event|6|||
130828274|NCT01061723|470998998|FG000|Overall Study|Lack of Efficacy|2|||
130828275|NCT01061723|470998999|FG001|Overall Study|Lack of Efficacy|3|||
130828276|NCT01061723|470999000|FG002|Overall Study|Lack of Efficacy|4|||
130828277|NCT01061723|470999001|FG003|Overall Study|Lack of Efficacy|2|||
130828278|NCT01061723|470999002|FG004|Overall Study|Lack of Efficacy|1|||
130828279|NCT01061723|470999003|FG005|Overall Study|Lack of Efficacy|1|||
130828280|NCT01061723|470998998|FG000|Overall Study|Randomized but not treated|0|||
130828281|NCT01061723|470998999|FG001|Overall Study|Randomized but not treated|0|||
130828282|NCT01061723|470999000|FG002|Overall Study|Randomized but not treated|0|||
130828283|NCT01061723|470999001|FG003|Overall Study|Randomized but not treated|0|||
130828284|NCT01061723|470999002|FG004|Overall Study|Randomized but not treated|0|||
130828285|NCT01061723|470999003|FG005|Overall Study|Randomized but not treated|1|||
130828286|NCT01061723|470998998|FG000|Overall Study|Other than specified above|2|||
130828287|NCT01061723|470998999|FG001|Overall Study|Other than specified above|1|||
130828288|NCT01061723|470999000|FG002|Overall Study|Other than specified above|1|||
130828289|NCT01061723|470999001|FG003|Overall Study|Other than specified above|1|||
130828290|NCT01061723|470999002|FG004|Overall Study|Other than specified above|0|||
130828291|NCT01061723|470999003|FG005|Overall Study|Other than specified above|1|||
130828292|NCT01734785|470999004|FG000|Open-Label Period|Adverse Event|0|||
130828293|NCT01734785|470999005|FG001|Open-Label Period|Adverse Event|0|||
130828294|NCT01734785|470999006|FG002|Open-Label Period|Adverse Event|0|||
130828295|NCT01734785|470999007|FG003|Open-Label Period|Adverse Event|9|||
130828296|NCT01734785|470999004|FG000|Open-Label Period|Lack of Efficacy|0|||
130828297|NCT01734785|470999005|FG001|Open-Label Period|Lack of Efficacy|0|||
130828298|NCT01734785|470999006|FG002|Open-Label Period|Lack of Efficacy|0|||
130828299|NCT01734785|470999007|FG003|Open-Label Period|Lack of Efficacy|1|||
130828300|NCT01734785|470999004|FG000|Open-Label Period|Protocol Violation|0|||
130828301|NCT01734785|470999005|FG001|Open-Label Period|Protocol Violation|0|||
130828302|NCT01734785|470999006|FG002|Open-Label Period|Protocol Violation|0|||
130828303|NCT01734785|470999007|FG003|Open-Label Period|Protocol Violation|13|||
130828304|NCT01734785|470999004|FG000|Open-Label Period|Lost to Follow-up|0|||
130828305|NCT01734785|470999005|FG001|Open-Label Period|Lost to Follow-up|0|||
130828306|NCT01734785|470999006|FG002|Open-Label Period|Lost to Follow-up|0|||
130828307|NCT01734785|470999007|FG003|Open-Label Period|Lost to Follow-up|14|||
130828308|NCT01734785|470999004|FG000|Open-Label Period|Withdrawal by Subject|0|||
130828309|NCT01734785|470999005|FG001|Open-Label Period|Withdrawal by Subject|0|||
130828310|NCT01734785|470999006|FG002|Open-Label Period|Withdrawal by Subject|0|||
130828311|NCT01734785|470999007|FG003|Open-Label Period|Withdrawal by Subject|12|||
130828312|NCT01734785|470999004|FG000|Open-Label Period|Other Reasons|0|||
130828313|NCT01734785|470999005|FG001|Open-Label Period|Other Reasons|0|||
130828314|NCT01734785|470999006|FG002|Open-Label Period|Other Reasons|0|||
130828315|NCT01734785|470999007|FG003|Open-Label Period|Other Reasons|224|||
130828316|NCT01734785|470999004|FG000|Double-Blind Period|Adverse Event|0|||
130828317|NCT01734785|470999005|FG001|Double-Blind Period|Adverse Event|3|||
130828318|NCT01734785|470999006|FG002|Double-Blind Period|Adverse Event|2|||
130828319|NCT01734785|470999007|FG003|Double-Blind Period|Adverse Event|0|||
130828320|NCT01734785|470999004|FG000|Double-Blind Period|Lack of Efficacy|0|||
130828321|NCT01734785|470999005|FG001|Double-Blind Period|Lack of Efficacy|1|||
130828322|NCT01734785|470999006|FG002|Double-Blind Period|Lack of Efficacy|0|||
130828323|NCT01734785|470999007|FG003|Double-Blind Period|Lack of Efficacy|0|||
130828324|NCT01734785|470999004|FG000|Double-Blind Period|Protocol Violation|0|||
130828325|NCT01734785|470999005|FG001|Double-Blind Period|Protocol Violation|1|||
130828326|NCT01734785|470999006|FG002|Double-Blind Period|Protocol Violation|1|||
130828327|NCT01734785|470999007|FG003|Double-Blind Period|Protocol Violation|0|||
130828328|NCT01734785|470999004|FG000|Double-Blind Period|Lost to Follow-up|2|||
130828329|NCT01734785|470999005|FG001|Double-Blind Period|Lost to Follow-up|4|||
130828330|NCT01734785|470999006|FG002|Double-Blind Period|Lost to Follow-up|2|||
130828331|NCT01734785|470999007|FG003|Double-Blind Period|Lost to Follow-up|0|||
130828332|NCT01734785|470999004|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130828333|NCT01734785|470999005|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130828334|NCT01734785|470999006|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130828335|NCT01734785|470999007|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130828336|NCT01734785|470999004|FG000|Double-Blind Period|Not treated|1|||
130828337|NCT01734785|470999005|FG001|Double-Blind Period|Not treated|0|||
130828338|NCT01734785|470999006|FG002|Double-Blind Period|Not treated|0|||
130828339|NCT01734785|470999007|FG003|Double-Blind Period|Not treated|0|||
130828340|NCT00566982|470999008|FG000|Overall Study|Adverse Event|6|||
130828341|NCT00566982|470999009|FG001|Overall Study|Adverse Event|48|||
130828342|NCT00566982|470999008|FG000|Overall Study|Withdrawal by Subject|1|||
130828343|NCT00566982|470999009|FG001|Overall Study|Withdrawal by Subject|14|||
130828344|NCT00566982|470999008|FG000|Overall Study|Protocol Violation|1|||
130828345|NCT00566982|470999009|FG001|Overall Study|Protocol Violation|4|||
130828346|NCT00566982|470999008|FG000|Overall Study|Lost to Follow-up|0|||
130828347|NCT00566982|470999009|FG001|Overall Study|Lost to Follow-up|1|||
130828348|NCT00566982|470999008|FG000|Overall Study|Other-family problems & doctor's request|0|||
130828349|NCT00566982|470999009|FG001|Overall Study|Other-family problems & doctor's request|2|||
130828350|NCT02013778|470999015|FG000|Overall Study|Death|4|||
130828351|NCT02013778|470999015|FG000|Overall Study|Withdrawal by Subject|1|||
130828352|NCT02013778|470999015|FG000|Overall Study|Physician Decision|1|||
130828353|NCT02013778|470999015|FG000|Overall Study|Adverse Event|1|||
130828354|NCT00293813|470999016|FG000|Overall Study|Physician Decision|0|||
130828355|NCT00293813|470999017|FG001|Overall Study|Physician Decision|1|||
130828356|NCT00293813|470999018|FG002|Overall Study|Physician Decision|0|||
130828357|NCT00293813|470999016|FG000|Overall Study|Adverse Event|3|||
130828358|NCT00293813|470999017|FG001|Overall Study|Adverse Event|1|||
130828359|NCT00293813|470999018|FG002|Overall Study|Adverse Event|1|||
130828360|NCT00293813|470999016|FG000|Overall Study|Withdrawal by Subject|7|||
130828361|NCT00293813|470999017|FG001|Overall Study|Withdrawal by Subject|4|||
130828362|NCT00293813|470999018|FG002|Overall Study|Withdrawal by Subject|4|||
130828363|NCT00293813|470999016|FG000|Overall Study|Lost to Follow-up|3|||
130828364|NCT00293813|470999017|FG001|Overall Study|Lost to Follow-up|2|||
130828365|NCT00293813|470999018|FG002|Overall Study|Lost to Follow-up|3|||
130828366|NCT00293813|470999016|FG000|Overall Study|Noncompliance|0|||
130828367|NCT00293813|470999017|FG001|Overall Study|Noncompliance|1|||
130828368|NCT00293813|470999018|FG002|Overall Study|Noncompliance|0|||
130828369|NCT01465386|470999022|FG000|Overall Study|Lack of Efficacy|3|||
130828370|NCT01465386|470999022|FG000|Overall Study|Adverse Event|1|||
130828371|NCT03458325|470999023|FG000|Overall Study|Withdrawal by Subject|1|||
130828372|NCT00460655|470999028|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
130828373|NCT00460655|470999029|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130828374|NCT00460655|470999030|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130828375|NCT00460655|470999031|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130828376|NCT00460655|470999028|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
130828377|NCT00460655|470999029|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130828378|NCT00460655|470999030|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130828379|NCT00460655|470999031|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130828380|NCT00460655|470999028|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
130828381|NCT00460655|470999029|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
130828382|NCT00460655|470999030|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
130828383|NCT00460655|470999031|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
130828384|NCT00460655|470999028|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130828385|NCT00460655|470999029|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130828386|NCT00460655|470999030|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
130828387|NCT00460655|470999031|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
130828388|NCT00460655|470999028|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130828389|NCT00460655|470999029|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130828390|NCT00460655|470999030|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
130828391|NCT00460655|470999031|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
130828392|NCT00460655|470999028|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
130828393|NCT00460655|470999029|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
130828394|NCT00460655|470999030|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
130828395|NCT00460655|470999031|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
130828396|NCT00310375|470999037|FG000|Primary Reporting Phase|Adverse Event|28|||
130828397|NCT00310375|470999038|FG001|Primary Reporting Phase|Adverse Event|22|||
130828398|NCT00310375|470999039|FG002|Primary Reporting Phase|Adverse Event|0|||
130828399|NCT00310375|470999037|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
130828400|NCT00310375|470999038|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
130828401|NCT00310375|470999039|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
130828402|NCT00310375|470999037|FG000|Primary Reporting Phase|Pregnancy|2|||
130828403|NCT00310375|470999038|FG001|Primary Reporting Phase|Pregnancy|2|||
130828404|NCT00310375|470999039|FG002|Primary Reporting Phase|Pregnancy|0|||
130828405|NCT00310375|470999037|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
130828406|NCT00310375|470999038|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
130828407|NCT00310375|470999039|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
130828408|NCT00310375|470999037|FG000|Primary Reporting Phase|Protocol Violation|8|||
130828409|NCT00310375|470999038|FG001|Primary Reporting Phase|Protocol Violation|5|||
130828410|NCT00310375|470999039|FG002|Primary Reporting Phase|Protocol Violation|0|||
130828411|NCT00310375|470999037|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
130828412|NCT00310375|470999038|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
130828413|NCT00310375|470999039|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
130828414|NCT00310375|470999037|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
130828415|NCT00310375|470999038|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
130828416|NCT00310375|470999039|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
130828417|NCT00310375|470999037|FG000|Primary Reporting Phase|Physician Decision|5|||
130828418|NCT00310375|470999038|FG001|Primary Reporting Phase|Physician Decision|3|||
130828419|NCT00310375|470999039|FG002|Primary Reporting Phase|Physician Decision|0|||
130828420|NCT00310375|470999037|FG000|Primary Reporting Phase|Request of the sponsor|2|||
130828421|NCT00310375|470999038|FG001|Primary Reporting Phase|Request of the sponsor|2|||
130828422|NCT00310375|470999039|FG002|Primary Reporting Phase|Request of the sponsor|0|||
130828423|NCT00310375|470999037|FG000|Primary Reporting Phase|Failed to return|1|||
130828424|NCT00310375|470999038|FG001|Primary Reporting Phase|Failed to return|3|||
130828425|NCT00310375|470999039|FG002|Primary Reporting Phase|Failed to return|0|||
130828426|NCT00310375|470999037|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
130828427|NCT00310375|470999038|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
130828428|NCT00310375|470999039|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
130828429|NCT00310375|470999037|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
130828430|NCT00310375|470999038|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
130828431|NCT00310375|470999039|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
130828432|NCT00310375|470999037|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
130828433|NCT00310375|470999038|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
130828434|NCT00310375|470999039|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
130828435|NCT00310375|470999037|FG000|Primary Reporting Phase|Site closure|3|||
130828436|NCT00310375|470999038|FG001|Primary Reporting Phase|Site closure|0|||
130828437|NCT00310375|470999039|FG002|Primary Reporting Phase|Site closure|0|||
130828438|NCT00310375|470999037|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
130828439|NCT00310375|470999038|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
130828440|NCT00310375|470999039|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
130828441|NCT00310375|470999037|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
130828442|NCT00310375|470999038|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
130828443|NCT00310375|470999039|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
130828444|NCT00310375|470999037|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
130828445|NCT00310375|470999038|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
130828446|NCT00310375|470999039|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
130828447|NCT00310375|470999037|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
130828448|NCT00310375|470999038|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
130828449|NCT00310375|470999039|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
130828450|NCT00131352|470999040|FG000|Initial Treatment Period|Adverse Event|1|||
130828451|NCT00131352|470999041|FG001|Initial Treatment Period|Adverse Event|3|||
130828452|NCT00131352|470999040|FG000|Initial Treatment Period|Non-compliant|1|||
130828453|NCT00131352|470999041|FG001|Initial Treatment Period|Non-compliant|2|||
130828454|NCT00131352|470999040|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
130828455|NCT00131352|470999041|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
130828456|NCT00131352|470999040|FG000|Initial Treatment Period|Lack of Efficacy|6|||
130828457|NCT00131352|470999041|FG001|Initial Treatment Period|Lack of Efficacy|4|||
130828458|NCT00131352|470999040|FG000|Initial Treatment Period|Other|0|||
130828459|NCT00131352|470999041|FG001|Initial Treatment Period|Other|2|||
130828460|NCT00131352|470999040|FG000|Repeat Treatment Period|Adverse Event|1|||
130828461|NCT00131352|470999041|FG001|Repeat Treatment Period|Adverse Event|0|||
130828462|NCT00131352|470999040|FG000|Repeat Treatment Period|Other|1|||
130828463|NCT00131352|470999041|FG001|Repeat Treatment Period|Other|0|||
130828464|NCT03230318|470999042|FG000|Overall Study|Radiographic disease progression|72|||
130828465|NCT03230318|470999043|FG001|Overall Study|Radiographic disease progression|19|||
130828466|NCT03230318|470999042|FG000|Overall Study|Clinical progression|17|||
130828467|NCT03230318|470999043|FG001|Overall Study|Clinical progression|7|||
130828468|NCT03230318|470999042|FG000|Overall Study|Adverse Event|5|||
130828469|NCT03230318|470999043|FG001|Overall Study|Adverse Event|3|||
130828470|NCT03230318|470999042|FG000|Overall Study|Physician Decision|2|||
130828471|NCT03230318|470999043|FG001|Overall Study|Physician Decision|3|||
130828472|NCT03230318|470999042|FG000|Overall Study|Death|3|||
130828473|NCT03230318|470999043|FG001|Overall Study|Death|2|||
130828474|NCT03230318|470999042|FG000|Overall Study|Lost to Follow-up|1|||
130828475|NCT03230318|470999043|FG001|Overall Study|Lost to Follow-up|0|||
130828476|NCT03230318|470999042|FG000|Overall Study|Withdrawal by Subject|1|||
130828477|NCT03230318|470999043|FG001|Overall Study|Withdrawal by Subject|3|||
130828478|NCT03230318|470999042|FG000|Overall Study|Other|3|||
130828479|NCT03230318|470999043|FG001|Overall Study|Other|7|||
130828480|NCT00211172|470999045|FG000|Overall Study|Died or lost health plan eligibility|39|||
130828481|NCT00211172|470999046|FG001|Overall Study|Died or lost health plan eligibility|32|||
130828482|NCT02443337|470999049|FG000|Overall Study|Adverse Event|0|||
130828483|NCT02443337|470999050|FG001|Overall Study|Adverse Event|1|||
130828484|NCT02443337|470999049|FG000|Overall Study|Clinical Progressive Disease|3|||
130828485|NCT02443337|470999050|FG001|Overall Study|Clinical Progressive Disease|0|||
130828486|NCT02443337|470999049|FG000|Overall Study|Withdrawal by Subject|2|||
130828487|NCT02443337|470999050|FG001|Overall Study|Withdrawal by Subject|1|||
130828488|NCT00709319|470999051|FG000|Overall Study|Death|4|||
130828489|NCT00709319|470999051|FG000|Overall Study|Withdrawal by Subject|2|||
130828490|NCT00579553|470999052|FG000|Overall Study|Lost to Follow-up|16|||
130828491|NCT00579553|470999053|FG001|Overall Study|Lost to Follow-up|13|||
130828492|NCT00635349|470999054|FG000|Overall Study|Other|8|||
130828493|NCT00635349|470999055|FG001|Overall Study|Other|6|||
130828494|NCT00635349|470999054|FG000|Overall Study|Protocol Violation|18|||
130828495|NCT00635349|470999055|FG001|Overall Study|Protocol Violation|22|||
130828496|NCT00635349|470999054|FG000|Overall Study|Withdrawal by Subject|3|||
130828497|NCT00635349|470999055|FG001|Overall Study|Withdrawal by Subject|8|||
130828498|NCT00635349|470999054|FG000|Overall Study|Lost to Follow-up|4|||
130828499|NCT00635349|470999055|FG001|Overall Study|Lost to Follow-up|3|||
130828500|NCT00635349|470999054|FG000|Overall Study|Adverse Event|11|||
130828501|NCT00635349|470999055|FG001|Overall Study|Adverse Event|9|||
130828502|NCT01541865|470999058|FG000|Overall Study|Lost to Follow-up|11|||
130828503|NCT01541865|470999058|FG000|Overall Study|Withdrawal by Subject|9|||
130828504|NCT01541865|470999058|FG000|Overall Study|Adverse Event|1|||
130828505|NCT01541865|470999058|FG000|Overall Study|Protocol Violation|1|||
130828506|NCT00049322|470999060|FG000|Overall Study|disease burden|0|||
130828507|NCT00049322|470999061|FG001|Overall Study|disease burden|3|||
130828508|NCT00049322|470999060|FG000|Overall Study|Adverse Event|1|||
130828509|NCT00049322|470999061|FG001|Overall Study|Adverse Event|0|||
130828510|NCT00049322|470999060|FG000|Overall Study|refused angio|0|||
130828511|NCT00049322|470999061|FG001|Overall Study|refused angio|3|||
130828512|NCT01340664|470999062|FG000|Overall Study|Adverse Event|0|||
130828513|NCT01340664|470999063|FG001|Overall Study|Adverse Event|1|||
130828514|NCT01340664|470999064|FG002|Overall Study|Adverse Event|7|||
130828515|NCT01340664|470999062|FG000|Overall Study|Lost to Follow-up|2|||
130828516|NCT01340664|470999063|FG001|Overall Study|Lost to Follow-up|0|||
130828517|NCT01340664|470999064|FG002|Overall Study|Lost to Follow-up|2|||
130828518|NCT01340664|470999062|FG000|Overall Study|Withdrawal by Subject|2|||
130828519|NCT01340664|470999063|FG001|Overall Study|Withdrawal by Subject|4|||
130828520|NCT01340664|470999064|FG002|Overall Study|Withdrawal by Subject|0|||
130828521|NCT01340664|470999062|FG000|Overall Study|Glycemic withdrawal criteria|2|||
130828522|NCT01340664|470999063|FG001|Overall Study|Glycemic withdrawal criteria|0|||
130828523|NCT01340664|470999064|FG002|Overall Study|Glycemic withdrawal criteria|0|||
130828524|NCT01340664|470999062|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
130828525|NCT01340664|470999063|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
130828526|NCT01340664|470999064|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
130828527|NCT01340664|470999062|FG000|Overall Study|Other|1|||
130828528|NCT01340664|470999063|FG001|Overall Study|Other|2|||
130828529|NCT01340664|470999064|FG002|Overall Study|Other|2|||
130828530|NCT00295646|470999067|FG000|Overall Study|Protocol Violation|18|||
130828531|NCT00295646|470999068|FG001|Overall Study|Protocol Violation|20|||
130828532|NCT00295646|470999069|FG002|Overall Study|Protocol Violation|20|||
130828533|NCT00295646|470999070|FG003|Overall Study|Protocol Violation|18|||
130828534|NCT00295646|470999067|FG000|Overall Study|Withdrawal by Subject|8|||
130828535|NCT00295646|470999068|FG001|Overall Study|Withdrawal by Subject|9|||
130828536|NCT00295646|470999069|FG002|Overall Study|Withdrawal by Subject|11|||
130828537|NCT00295646|470999070|FG003|Overall Study|Withdrawal by Subject|14|||
130828538|NCT00295646|470999067|FG000|Overall Study|Lost to Follow-up|0|||
130828539|NCT00295646|470999068|FG001|Overall Study|Lost to Follow-up|5|||
130828540|NCT00295646|470999069|FG002|Overall Study|Lost to Follow-up|1|||
130828541|NCT00295646|470999070|FG003|Overall Study|Lost to Follow-up|5|||
130828542|NCT00295646|470999067|FG000|Overall Study|Death|9|||
130828543|NCT00295646|470999068|FG001|Overall Study|Death|7|||
130828544|NCT00295646|470999069|FG002|Overall Study|Death|18|||
130828545|NCT00295646|470999070|FG003|Overall Study|Death|8|||
130828546|NCT00995436|470999075|FG000|Overall Study|Withdrawal by Subject|2|||
130828547|NCT00995436|470999076|FG001|Overall Study|Withdrawal by Subject|5|||
130828548|NCT00995436|470999077|FG002|Overall Study|Withdrawal by Subject|0|||
130828549|NCT01232127|470999078|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
130828550|NCT01232127|470999079|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
130828551|NCT01232127|470999080|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
130828552|NCT02720523|470999081|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
130828553|NCT02720523|470999082|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
130828554|NCT02720523|470999083|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
130828555|NCT02720523|470999084|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
130828556|NCT02720523|470999085|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
130828557|NCT02720523|470999086|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
130828558|NCT02720523|470999087|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
130828559|NCT02720523|470999081|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
130828560|NCT02720523|470999082|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130828561|NCT02720523|470999083|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130828562|NCT02720523|470999084|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130828563|NCT02720523|470999085|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130828564|NCT02720523|470999086|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130828565|NCT02720523|470999087|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130828566|NCT02720523|470999081|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
130828567|NCT02720523|470999082|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130828568|NCT02720523|470999083|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130828569|NCT02720523|470999084|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130828570|NCT02720523|470999085|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130828571|NCT02720523|470999086|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130828572|NCT02720523|470999087|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130828573|NCT02720523|470999081|FG000|Period 1: Placebo-controlled Period|Other|0|||
130828574|NCT02720523|470999082|FG001|Period 1: Placebo-controlled Period|Other|0|||
130828575|NCT02720523|470999083|FG002|Period 1: Placebo-controlled Period|Other|1|||
130828576|NCT02720523|470999084|FG003|Period 1: Placebo-controlled Period|Other|1|||
130828577|NCT02720523|470999085|FG004|Period 1: Placebo-controlled Period|Other|0|||
130828578|NCT02720523|470999086|FG005|Period 1: Placebo-controlled Period|Other|0|||
130828579|NCT02720523|470999087|FG006|Period 1: Placebo-controlled Period|Other|0|||
130828580|NCT02720523|470999081|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
130828581|NCT02720523|470999082|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
130828582|NCT02720523|470999083|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
130828583|NCT02720523|470999084|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
130828584|NCT02720523|470999085|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
130828585|NCT02720523|470999086|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
130828586|NCT02720523|470999087|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
130828587|NCT02720523|470999081|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
130828588|NCT02720523|470999082|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
130828589|NCT02720523|470999083|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
130828590|NCT02720523|470999084|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
130828591|NCT02720523|470999085|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
130828592|NCT02720523|470999086|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
130828593|NCT02720523|470999087|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
130828594|NCT02720523|470999081|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130828595|NCT02720523|470999082|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130828596|NCT02720523|470999083|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130828597|NCT02720523|470999084|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130828598|NCT02720523|470999085|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
130828599|NCT02720523|470999086|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
130828600|NCT02720523|470999087|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
130828601|NCT02720523|470999081|FG000|Period 2: Long-term Extension Period|Other|0|||
130828602|NCT02720523|470999082|FG001|Period 2: Long-term Extension Period|Other|0|||
130828603|NCT02720523|470999083|FG002|Period 2: Long-term Extension Period|Other|0|||
130828604|NCT02720523|470999084|FG003|Period 2: Long-term Extension Period|Other|0|||
130828605|NCT02720523|470999085|FG004|Period 2: Long-term Extension Period|Other|2|||
130828606|NCT02720523|470999086|FG005|Period 2: Long-term Extension Period|Other|0|||
130828607|NCT02720523|470999087|FG006|Period 2: Long-term Extension Period|Other|3|||
130828608|NCT00809926|470999094|FG000|Overall Study|Adverse Event|18|||
130828609|NCT00809926|470999095|FG001|Overall Study|Adverse Event|10|||
130828610|NCT00809926|470999094|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130828611|NCT00809926|470999095|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130828612|NCT00809926|470999094|FG000|Overall Study|Patient withdrew consent|8|||
130828613|NCT00809926|470999095|FG001|Overall Study|Patient withdrew consent|6|||
130828614|NCT00809926|470999094|FG000|Overall Study|Lost to Follow-up|2|||
130828615|NCT00809926|470999095|FG001|Overall Study|Lost to Follow-up|1|||
130828616|NCT00809926|470999094|FG000|Overall Study|Administrative Problems|0|||
130828617|NCT00809926|470999095|FG001|Overall Study|Administrative Problems|1|||
130828618|NCT00809926|470999094|FG000|Overall Study|Protocol deviation|0|||
130828619|NCT00809926|470999095|FG001|Overall Study|Protocol deviation|2|||
130828620|NCT00130039|470999096|FG000|Overall Study|Withdrawal by Subject|15|||
130828621|NCT00130039|470999097|FG001|Overall Study|Withdrawal by Subject|11|||
130828622|NCT00130039|470999096|FG000|Overall Study|Lost to Follow-up|3|||
130828623|NCT00130039|470999097|FG001|Overall Study|Lost to Follow-up|1|||
130828624|NCT00130039|470999096|FG000|Overall Study|Adverse Event|4|||
130828625|NCT00130039|470999097|FG001|Overall Study|Adverse Event|2|||
130828626|NCT00130039|470999096|FG000|Overall Study|Physician Decision|3|||
130828627|NCT00130039|470999097|FG001|Overall Study|Physician Decision|0|||
130828628|NCT00130039|470999096|FG000|Overall Study|clinical events without follow up MRI|5|||
130828629|NCT00130039|470999097|FG001|Overall Study|clinical events without follow up MRI|4|||
130828630|NCT00100802|470999098|FG000|Overall Study|Adverse Event|9|||
130828631|NCT00100802|470999098|FG000|Overall Study|Death|1|||
130828632|NCT00100802|470999098|FG000|Overall Study|Lack of Efficacy|47|||
130828633|NCT00100802|470999098|FG000|Overall Study|Physician Decision|5|||
130828634|NCT00100802|470999098|FG000|Overall Study|Protocol Violation|1|||
130828635|NCT00100802|470999098|FG000|Overall Study|Withdrawal by Subject|5|||
130828636|NCT00100802|470999098|FG000|Overall Study|Ineligible|12|||
130828637|NCT02712996|470999099|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
130828638|NCT02712996|470999100|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
130828639|NCT03265145|470999102|FG000|Overall Study|Protocol Violation|2|||
130828640|NCT03265145|470999103|FG001|Overall Study|Protocol Violation|0|||
130828641|NCT03265145|470999102|FG000|Overall Study|Adverse Event|1|||
130828642|NCT03265145|470999103|FG001|Overall Study|Adverse Event|0|||
130828643|NCT03265145|470999102|FG000|Overall Study|Withdrawal by Subject|23|||
130828644|NCT03265145|470999103|FG001|Overall Study|Withdrawal by Subject|19|||
130828645|NCT03265145|470999102|FG000|Overall Study|Death|12|||
130828646|NCT03265145|470999103|FG001|Overall Study|Death|12|||
130828647|NCT03265145|470999102|FG000|Overall Study|Lost to Follow-up|13|||
130828648|NCT03265145|470999103|FG001|Overall Study|Lost to Follow-up|9|||
130828649|NCT03265145|470999102|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
130828650|NCT03265145|470999103|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
130828651|NCT03265145|470999102|FG000|Overall Study|Switched back to previous medication|1|||
130828652|NCT03265145|470999103|FG001|Overall Study|Switched back to previous medication|0|||
130828653|NCT03265145|470999102|FG000|Overall Study|Did not want to take medication|1|||
130828654|NCT03265145|470999103|FG001|Overall Study|Did not want to take medication|0|||
130828655|NCT03265145|470999102|FG000|Overall Study|Subject could not afford medication|0|||
130828656|NCT03265145|470999103|FG001|Overall Study|Subject could not afford medication|1|||
130828657|NCT03265145|470999102|FG000|Overall Study|Site closed|2|||
130828658|NCT03265145|470999103|FG001|Overall Study|Site closed|3|||
130828659|NCT03265145|470999102|FG000|Overall Study|Incorrectly randomized|16|||
130828660|NCT03265145|470999103|FG001|Overall Study|Incorrectly randomized|6|||
130828661|NCT03265145|470999102|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
130828662|NCT03265145|470999103|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
130828663|NCT03265145|470999102|FG000|Overall Study|Physician Decision|0|||
130828664|NCT03265145|470999103|FG001|Overall Study|Physician Decision|3|||
130828665|NCT03265145|470999102|FG000|Overall Study|Subject transferred to another facility|0|||
130828666|NCT03265145|470999103|FG001|Overall Study|Subject transferred to another facility|1|||
130828667|NCT00104728|470999104|FG000|Overall Study|screen failures|19|||
130828668|NCT01963767|470999105|FG000|Overall Study|Withdrawal by Subject|4|||
130828669|NCT01963767|470999106|FG001|Overall Study|Withdrawal by Subject|2|||
130828670|NCT01963767|470999105|FG000|Overall Study|Adverse Event|2|||
130828671|NCT01963767|470999106|FG001|Overall Study|Adverse Event|0|||
130828672|NCT03960684|470999107|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
130828673|NCT03941483|470999111|FG000|Overall Study|Miscellaneous|2|||
130828674|NCT03941483|470999112|FG001|Overall Study|Miscellaneous|3|||
130828675|NCT03941483|470999113|FG002|Overall Study|Miscellaneous|0|||
130828676|NCT03941483|470999111|FG000|Overall Study|Study Terminated by Sponsor|1|||
130828677|NCT03941483|470999112|FG001|Overall Study|Study Terminated by Sponsor|0|||
130828678|NCT03941483|470999113|FG002|Overall Study|Study Terminated by Sponsor|0|||
130828679|NCT03941483|470999111|FG000|Overall Study|Withdrawal by Subject|1|||
130828680|NCT03941483|470999112|FG001|Overall Study|Withdrawal by Subject|4|||
130828681|NCT03941483|470999113|FG002|Overall Study|Withdrawal by Subject|1|||
130828682|NCT03941483|470999111|FG000|Overall Study|Lost to Follow-up|2|||
130828683|NCT03941483|470999112|FG001|Overall Study|Lost to Follow-up|1|||
130828684|NCT03941483|470999113|FG002|Overall Study|Lost to Follow-up|8|||
130828685|NCT03941483|470999111|FG000|Overall Study|Death|3|||
130828686|NCT03941483|470999112|FG001|Overall Study|Death|2|||
130828687|NCT03941483|470999113|FG002|Overall Study|Death|6|||
130828688|NCT01082081|470999114|FG000|Overall Study|Lost to Follow-up|0|||
130828689|NCT01082081|470999115|FG001|Overall Study|Lost to Follow-up|0|||
130828690|NCT01082081|470999116|FG002|Overall Study|Lost to Follow-up|1|||
130828691|NCT01082081|470999114|FG000|Overall Study|Withdrawal by Subject|0|||
130828692|NCT01082081|470999115|FG001|Overall Study|Withdrawal by Subject|0|||
130828693|NCT01082081|470999116|FG002|Overall Study|Withdrawal by Subject|1|||
130828694|NCT01082081|470999114|FG000|Overall Study|Other Reason|0|||
130828695|NCT01082081|470999115|FG001|Overall Study|Other Reason|1|||
130828696|NCT01082081|470999116|FG002|Overall Study|Other Reason|0|||
130828697|NCT00670930|470999119|FG000|Overall Study|Adminstrative Problem|0|||
130828698|NCT00670930|470999120|FG001|Overall Study|Adminstrative Problem|1|||
130828699|NCT00670930|470999119|FG000|Overall Study|Lost to Follow-up|1|||
130828700|NCT00670930|470999120|FG001|Overall Study|Lost to Follow-up|0|||
130828701|NCT00283803|471000610|FG000|Overall Study|Physician Decision|9|||
130828702|NCT00283803|471000610|FG000|Overall Study|Withdrawal by Subject|4|||
130828703|NCT03493451|471000611|FG000|Overall Study|Death|11|||
130828704|NCT03493451|471000612|FG001|Overall Study|Death|26|||
130828705|NCT03493451|471000613|FG002|Overall Study|Death|3|||
130828706|NCT03493451|471000611|FG000|Overall Study|Lost to Follow-up|1|||
130828707|NCT03493451|471000612|FG001|Overall Study|Lost to Follow-up|4|||
130828708|NCT03493451|471000613|FG002|Overall Study|Lost to Follow-up|1|||
130828709|NCT03493451|471000611|FG000|Overall Study|Withdrawal by Subject|1|||
130828710|NCT03493451|471000612|FG001|Overall Study|Withdrawal by Subject|1|||
130828711|NCT03493451|471000613|FG002|Overall Study|Withdrawal by Subject|2|||
130828712|NCT03493451|471000611|FG000|Overall Study|Progressive Disease|1|||
130828713|NCT03493451|471000612|FG001|Overall Study|Progressive Disease|0|||
130828714|NCT03493451|471000613|FG002|Overall Study|Progressive Disease|0|||
130828715|NCT03493451|471000611|FG000|Overall Study|Transferred to long term extension study|8|||
130828716|NCT03493451|471000612|FG001|Overall Study|Transferred to long term extension study|13|||
130828717|NCT03493451|471000613|FG002|Overall Study|Transferred to long term extension study|5|||
130828718|NCT01238991|471000614|FG000|Overall Study|Adverse Event|1|||
130828719|NCT01238991|471000615|FG001|Overall Study|Adverse Event|0|||
130828720|NCT01238991|471000616|FG002|Overall Study|Adverse Event|3|||
130828721|NCT01238991|471000617|FG003|Overall Study|Adverse Event|1|||
130828722|NCT01238991|471000618|FG004|Overall Study|Adverse Event|1|||
130828723|NCT01238991|471000619|FG005|Overall Study|Adverse Event|0|||
130828724|NCT01238991|471000620|FG006|Overall Study|Adverse Event|1|||
130828725|NCT01238991|471000621|FG007|Overall Study|Adverse Event|1|||
130828726|NCT01238991|471000622|FG008|Overall Study|Adverse Event|0|||
130828727|NCT01238991|471000623|FG009|Overall Study|Adverse Event|0|||
130828728|NCT01238991|471000614|FG000|Overall Study|Death|0|||
130828729|NCT01238991|471000615|FG001|Overall Study|Death|0|||
130828730|NCT01238991|471000616|FG002|Overall Study|Death|0|||
130828731|NCT01238991|471000617|FG003|Overall Study|Death|1|||
130828732|NCT01238991|471000618|FG004|Overall Study|Death|0|||
130828733|NCT01238991|471000619|FG005|Overall Study|Death|0|||
130828734|NCT01238991|471000620|FG006|Overall Study|Death|0|||
130828735|NCT01238991|471000621|FG007|Overall Study|Death|0|||
130828736|NCT01238991|471000622|FG008|Overall Study|Death|0|||
130828737|NCT01238991|471000623|FG009|Overall Study|Death|0|||
130828738|NCT01238991|471000614|FG000|Overall Study|Lack of Efficacy|0|||
130828739|NCT01238991|471000615|FG001|Overall Study|Lack of Efficacy|0|||
130828740|NCT01238991|471000616|FG002|Overall Study|Lack of Efficacy|1|||
130828741|NCT01238991|471000617|FG003|Overall Study|Lack of Efficacy|0|||
130828742|NCT01238991|471000618|FG004|Overall Study|Lack of Efficacy|0|||
130828743|NCT01238991|471000619|FG005|Overall Study|Lack of Efficacy|0|||
130828744|NCT01238991|471000620|FG006|Overall Study|Lack of Efficacy|0|||
130828745|NCT01238991|471000621|FG007|Overall Study|Lack of Efficacy|0|||
130828746|NCT01238991|471000622|FG008|Overall Study|Lack of Efficacy|1|||
130828747|NCT01238991|471000623|FG009|Overall Study|Lack of Efficacy|0|||
130828748|NCT01238991|471000614|FG000|Overall Study|Withdrawal by Subject|0|||
130828749|NCT01238991|471000615|FG001|Overall Study|Withdrawal by Subject|0|||
130828750|NCT01238991|471000616|FG002|Overall Study|Withdrawal by Subject|1|||
130828751|NCT01238991|471000617|FG003|Overall Study|Withdrawal by Subject|0|||
130828752|NCT01238991|471000618|FG004|Overall Study|Withdrawal by Subject|0|||
130828753|NCT01238991|471000619|FG005|Overall Study|Withdrawal by Subject|0|||
130828754|NCT01238991|471000620|FG006|Overall Study|Withdrawal by Subject|0|||
130828755|NCT01238991|471000621|FG007|Overall Study|Withdrawal by Subject|0|||
130828756|NCT01238991|471000622|FG008|Overall Study|Withdrawal by Subject|0|||
130828757|NCT01238991|471000623|FG009|Overall Study|Withdrawal by Subject|0|||
130828758|NCT01238991|471000614|FG000|Overall Study|Study Terminated by Sponsor|0|||
130828759|NCT01238991|471000615|FG001|Overall Study|Study Terminated by Sponsor|0|||
130828760|NCT01238991|471000616|FG002|Overall Study|Study Terminated by Sponsor|0|||
130828761|NCT01238991|471000617|FG003|Overall Study|Study Terminated by Sponsor|0|||
130828762|NCT01238991|471000618|FG004|Overall Study|Study Terminated by Sponsor|1|||
130828763|NCT01238991|471000619|FG005|Overall Study|Study Terminated by Sponsor|0|||
130828764|NCT01238991|471000620|FG006|Overall Study|Study Terminated by Sponsor|7|||
130828765|NCT01238991|471000621|FG007|Overall Study|Study Terminated by Sponsor|4|||
130828766|NCT01238991|471000622|FG008|Overall Study|Study Terminated by Sponsor|2|||
130828767|NCT01238991|471000623|FG009|Overall Study|Study Terminated by Sponsor|2|||
130828768|NCT01238991|471000614|FG000|Overall Study|Caregiver's request|0|||
130828769|NCT01238991|471000615|FG001|Overall Study|Caregiver's request|0|||
130828770|NCT01238991|471000616|FG002|Overall Study|Caregiver's request|0|||
130828771|NCT01238991|471000617|FG003|Overall Study|Caregiver's request|0|||
130828772|NCT01238991|471000618|FG004|Overall Study|Caregiver's request|0|||
130828773|NCT01238991|471000619|FG005|Overall Study|Caregiver's request|0|||
130828774|NCT01238991|471000620|FG006|Overall Study|Caregiver's request|0|||
130828775|NCT01238991|471000621|FG007|Overall Study|Caregiver's request|0|||
130828776|NCT01238991|471000622|FG008|Overall Study|Caregiver's request|1|||
130828777|NCT01238991|471000623|FG009|Overall Study|Caregiver's request|0|||
130828778|NCT01238991|471000614|FG000|Overall Study|Admission to a nursing home|1|||
130828779|NCT01238991|471000615|FG001|Overall Study|Admission to a nursing home|0|||
130828780|NCT01238991|471000616|FG002|Overall Study|Admission to a nursing home|1|||
130828781|NCT01238991|471000617|FG003|Overall Study|Admission to a nursing home|0|||
130828782|NCT01238991|471000618|FG004|Overall Study|Admission to a nursing home|0|||
130828783|NCT01238991|471000619|FG005|Overall Study|Admission to a nursing home|0|||
130828784|NCT01238991|471000620|FG006|Overall Study|Admission to a nursing home|0|||
130828785|NCT01238991|471000621|FG007|Overall Study|Admission to a nursing home|0|||
130828786|NCT01238991|471000622|FG008|Overall Study|Admission to a nursing home|0|||
130828787|NCT01238991|471000623|FG009|Overall Study|Admission to a nursing home|0|||
130828788|NCT03370419|471000624|FG000|Overall Study|Lost to Follow-up|16|||
130828789|NCT01897727|471000627|FG000|Overall Study|Exclusion: central sleep apnea|0|||
130828790|NCT01897727|471000628|FG001|Overall Study|Exclusion: central sleep apnea|1|||
130828791|NCT03015363|471000629|FG000|Overall Study|Physician Decision|14|||
130828792|NCT03015363|471000629|FG000|Overall Study|Withdrawal by Subject|3|||
130828793|NCT00078806|471000630|FG000|Part 1A|Adverse Event|2|||
130828794|NCT00078806|471000631|FG001|Part 1A|Adverse Event|0|||
130828795|NCT00078806|471000632|FG002|Part 1A|Adverse Event|0|||
130828796|NCT00078806|471000633|FG003|Part 1A|Adverse Event|0|||
130828797|NCT00078806|471000630|FG000|Part 1A|Lack of Efficacy|7|||
130828798|NCT00078806|471000631|FG001|Part 1A|Lack of Efficacy|0|||
130828799|NCT00078806|471000632|FG002|Part 1A|Lack of Efficacy|0|||
130828800|NCT00078806|471000633|FG003|Part 1A|Lack of Efficacy|0|||
130828801|NCT00078806|471000630|FG000|Part 1A|Other|1|||
130828802|NCT00078806|471000631|FG001|Part 1A|Other|0|||
130828803|NCT00078806|471000632|FG002|Part 1A|Other|0|||
130828804|NCT00078806|471000633|FG003|Part 1A|Other|0|||
130828805|NCT00078806|471000630|FG000|Part 1B|Adverse Event|1|||
130828806|NCT00078806|471000631|FG001|Part 1B|Adverse Event|0|||
130828807|NCT00078806|471000632|FG002|Part 1B|Adverse Event|0|||
130828808|NCT00078806|471000633|FG003|Part 1B|Adverse Event|0|||
130828809|NCT00078806|471000630|FG000|Part 1B|Lack of Efficacy|7|||
130828810|NCT00078806|471000631|FG001|Part 1B|Lack of Efficacy|0|||
130828811|NCT00078806|471000632|FG002|Part 1B|Lack of Efficacy|0|||
130828812|NCT00078806|471000633|FG003|Part 1B|Lack of Efficacy|0|||
130828813|NCT00078806|471000630|FG000|Part 2|Adverse Event|0|||
130828814|NCT00078806|471000631|FG001|Part 2|Adverse Event|1|||
130828815|NCT00078806|471000632|FG002|Part 2|Adverse Event|0|||
130828816|NCT00078806|471000633|FG003|Part 2|Adverse Event|0|||
130828817|NCT00473889|471000636|FG000|Overall Study|Did not receive study medication|1|||
130828818|NCT00473889|471000637|FG001|Overall Study|Did not receive study medication|4|||
130828819|NCT00473889|471000636|FG000|Overall Study|Adverse Event|30|||
130828820|NCT00473889|471000637|FG001|Overall Study|Adverse Event|17|||
130828821|NCT00473889|471000636|FG000|Overall Study|Protocol Violation|4|||
130828822|NCT00473889|471000637|FG001|Overall Study|Protocol Violation|2|||
130828823|NCT00473889|471000636|FG000|Overall Study|Lack of Efficacy|28|||
130828824|NCT00473889|471000637|FG001|Overall Study|Lack of Efficacy|29|||
130828825|NCT00473889|471000636|FG000|Overall Study|Lost to Follow-up|2|||
130828826|NCT00473889|471000637|FG001|Overall Study|Lost to Follow-up|1|||
130828827|NCT00473889|471000636|FG000|Overall Study|Physician Decision|10|||
130828828|NCT00473889|471000637|FG001|Overall Study|Physician Decision|5|||
130828829|NCT00473889|471000636|FG000|Overall Study|Trial Terminated|3|||
130828830|NCT00473889|471000637|FG001|Overall Study|Trial Terminated|6|||
130828831|NCT00473889|471000636|FG000|Overall Study|Withdrawal by Subject|5|||
130828832|NCT00473889|471000637|FG001|Overall Study|Withdrawal by Subject|0|||
130828833|NCT00833469|471000638|FG000|Overall Study|Withdrawal by Subject|1|||
130828834|NCT00833469|471000638|FG000|Overall Study|Lost to Follow-up|1|||
130828835|NCT03592771|471000639|FG000|Overall Study|Adverse Event|2|||
130828836|NCT03592771|471000640|FG001|Overall Study|Adverse Event|0|||
130828837|NCT03592771|471000641|FG002|Overall Study|Adverse Event|1|||
130828838|NCT03592771|471000639|FG000|Overall Study|Death|0|||
130828839|NCT03592771|471000640|FG001|Overall Study|Death|1|||
130828840|NCT03592771|471000641|FG002|Overall Study|Death|1|||
130828841|NCT03592771|471000639|FG000|Overall Study|Lost to Follow-up|5|||
130828842|NCT03592771|471000640|FG001|Overall Study|Lost to Follow-up|11|||
130828843|NCT03592771|471000641|FG002|Overall Study|Lost to Follow-up|15|||
130828844|NCT03592771|471000639|FG000|Overall Study|Withdrawal by Subject|0|||
130828845|NCT03592771|471000640|FG001|Overall Study|Withdrawal by Subject|2|||
130828846|NCT03592771|471000641|FG002|Overall Study|Withdrawal by Subject|0|||
130828847|NCT01665911|471000642|FG000|Overall Study|Protocol Violation|4|||
130828848|NCT01665911|471000642|FG000|Overall Study|Withdrawal by Subject|1|||
130828849|NCT01665911|471000642|FG000|Overall Study|Adverse Event|1|||
130828850|NCT00735553|471000643|FG000|Overall Study|Study prematurely terminated|77|||
130828851|NCT04830215|471000644|FG000|Overall Study|Adverse Event|6|||
130828852|NCT04830215|471000644|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
130828853|NCT04830215|471000644|FG000|Overall Study|Withdrawal by Subject|3|||
130828854|NCT04830215|471000644|FG000|Overall Study|Protocol Deviation|1|||
130828855|NCT02236572|471000646|FG000|Overall Study|Withdrawal by Subject|1|||
130828856|NCT02236572|471000646|FG000|Overall Study|Protocol Violation|1|||
130828857|NCT02236572|471000646|FG000|Overall Study|Lost to Follow-up|1|||
130828858|NCT03726658|471000647|FG000|Overall Study|Lost to Follow-up|0|||
130828859|NCT03726658|471000648|FG001|Overall Study|Lost to Follow-up|0|||
130828860|NCT03726658|471000649|FG002|Overall Study|Lost to Follow-up|2|||
130828861|NCT03726658|471000650|FG003|Overall Study|Lost to Follow-up|0|||
130828862|NCT03726658|471000651|FG004|Overall Study|Lost to Follow-up|0|||
130828863|NCT03726658|471000652|FG005|Overall Study|Lost to Follow-up|1|||
130828864|NCT03726658|471000653|FG006|Overall Study|Lost to Follow-up|1|||
130828865|NCT03726658|471000647|FG000|Overall Study|Withdrawal by Subject|1|||
130828866|NCT03726658|471000648|FG001|Overall Study|Withdrawal by Subject|0|||
130828867|NCT03726658|471000649|FG002|Overall Study|Withdrawal by Subject|0|||
130828868|NCT03726658|471000650|FG003|Overall Study|Withdrawal by Subject|0|||
130828869|NCT03726658|471000651|FG004|Overall Study|Withdrawal by Subject|6|||
130828870|NCT03726658|471000652|FG005|Overall Study|Withdrawal by Subject|4|||
130828871|NCT03726658|471000653|FG006|Overall Study|Withdrawal by Subject|2|||
130828872|NCT03726658|471000647|FG000|Overall Study|Pregnancy|0|||
130828873|NCT03726658|471000648|FG001|Overall Study|Pregnancy|0|||
130828874|NCT03726658|471000649|FG002|Overall Study|Pregnancy|0|||
130828875|NCT03726658|471000650|FG003|Overall Study|Pregnancy|0|||
130828876|NCT03726658|471000651|FG004|Overall Study|Pregnancy|0|||
130828877|NCT03726658|471000652|FG005|Overall Study|Pregnancy|0|||
130828878|NCT03726658|471000653|FG006|Overall Study|Pregnancy|1|||
130828879|NCT03726658|471000647|FG000|Overall Study|Not Reported|0|||
130828880|NCT03726658|471000648|FG001|Overall Study|Not Reported|0|||
130828881|NCT03726658|471000649|FG002|Overall Study|Not Reported|0|||
130828882|NCT03726658|471000650|FG003|Overall Study|Not Reported|0|||
130828883|NCT03726658|471000651|FG004|Overall Study|Not Reported|0|||
130828884|NCT03726658|471000652|FG005|Overall Study|Not Reported|0|||
130828885|NCT03726658|471000653|FG006|Overall Study|Not Reported|1|||
130828886|NCT00090779|471000654|FG000|Step 1|Withdrawal by Subject|4|||
130828887|NCT00090779|471000655|FG001|Step 1|Withdrawal by Subject|2|||
130828888|NCT00090779|471000654|FG000|Step 1|Lost to Follow-up|3|||
130828889|NCT00090779|471000655|FG001|Step 1|Lost to Follow-up|2|||
130828890|NCT00090779|471000654|FG000|Step 1|Death|0|||
130828891|NCT00090779|471000655|FG001|Step 1|Death|2|||
130828892|NCT00090779|471000654|FG000|Step 1|Physician Decision|1|||
130828893|NCT00090779|471000655|FG001|Step 1|Physician Decision|0|||
130828894|NCT00090779|471000654|FG000|Step 1|Pregnancy|1|||
130828895|NCT00090779|471000655|FG001|Step 1|Pregnancy|0|||
130828896|NCT00090779|471000654|FG000|Step 1|Non-compliance to study requirements|0|||
130828897|NCT00090779|471000655|FG001|Step 1|Non-compliance to study requirements|1|||
130828898|NCT00090779|471000654|FG000|Step 1|Subject relocated|2|||
130828899|NCT00090779|471000655|FG001|Step 1|Subject relocated|8|||
130828900|NCT00090779|471000654|FG000|Step 2|Off study per study closure|6|||
130828901|NCT00090779|471000655|FG001|Step 2|Off study per study closure|16|||
130828902|NCT00090779|471000654|FG000|Step 2|Subject relocated|0|||
130828903|NCT00090779|471000655|FG001|Step 2|Subject relocated|1|||
130828904|NCT00090779|471000654|FG000|Step 2|Non-compliance to study requirements|0|||
130828905|NCT00090779|471000655|FG001|Step 2|Non-compliance to study requirements|1|||
130828906|NCT00090779|471000654|FG000|Step 3|Initiation of ART and off extended study|3|||
130828907|NCT00090779|471000655|FG001|Step 3|Initiation of ART and off extended study|2|||
130828908|NCT00090779|471000654|FG000|Step 3|Off extended study due to study closure|4|||
130828909|NCT00090779|471000655|FG001|Step 3|Off extended study due to study closure|3|||
130828910|NCT01318135|471000656|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
130828911|NCT01318135|471000657|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130828912|NCT01318135|471000658|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130828913|NCT01318135|471000659|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130828914|NCT01318135|471000660|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130828915|NCT01318135|471000661|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130828916|NCT01318135|471000662|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130828917|NCT01318135|471000663|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130828918|NCT01318135|471000656|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
130828919|NCT01318135|471000657|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130828920|NCT01318135|471000658|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130828921|NCT01318135|471000659|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130828922|NCT01318135|471000660|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130828923|NCT01318135|471000661|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130828924|NCT01318135|471000662|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130828925|NCT01318135|471000663|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130828926|NCT01318135|471000656|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
130828927|NCT01318135|471000657|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
130828928|NCT01318135|471000658|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
130828929|NCT01318135|471000659|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
130828930|NCT01318135|471000660|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
130828931|NCT01318135|471000661|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
130828932|NCT01318135|471000662|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
130828933|NCT01318135|471000663|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
130828934|NCT01318135|471000656|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
130828935|NCT01318135|471000657|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
130828936|NCT01318135|471000658|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
130828937|NCT01318135|471000659|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
130828938|NCT01318135|471000660|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
130828939|NCT01318135|471000661|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
130828940|NCT01318135|471000662|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
130828941|NCT01318135|471000663|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
130828942|NCT01318135|471000656|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130828943|NCT01318135|471000657|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130828944|NCT01318135|471000658|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130828945|NCT01318135|471000659|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130828946|NCT01318135|471000660|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130828947|NCT01318135|471000661|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130828948|NCT01318135|471000662|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130828949|NCT01318135|471000663|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130828950|NCT01318135|471000656|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
130828951|NCT01318135|471000657|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
130828952|NCT01318135|471000658|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130828953|NCT01318135|471000659|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
130828954|NCT01318135|471000660|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130828955|NCT01318135|471000661|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130828956|NCT01318135|471000662|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
130828957|NCT01318135|471000663|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
130828958|NCT01318135|471000656|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130828959|NCT01318135|471000657|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130828960|NCT01318135|471000658|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130828961|NCT01318135|471000659|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130828962|NCT01318135|471000660|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130828963|NCT01318135|471000661|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130828964|NCT01318135|471000662|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130828965|NCT01318135|471000663|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
130828966|NCT01775553|471000668|FG000|Overall Study|Adverse Event|1|||
130828967|NCT01775553|471000668|FG000|Overall Study|Disease Progression|12|||
130828968|NCT01523743|471000669|FG000|Period 1|Adverse Event|1|||
130828969|NCT01523743|471000670|FG001|Period 1|Adverse Event|0|||
130828970|NCT01523743|471000669|FG000|Period 1|Withdrawal by Subject|6|||
130828971|NCT01523743|471000670|FG001|Period 1|Withdrawal by Subject|2|||
130828972|NCT01523743|471000669|FG000|Period 1|Lost to Follow-up|1|||
130828973|NCT01523743|471000670|FG001|Period 1|Lost to Follow-up|0|||
130828974|NCT01523743|471000669|FG000|Period 1|Lack of Efficacy|1|||
130828975|NCT01523743|471000670|FG001|Period 1|Lack of Efficacy|0|||
130828976|NCT01523743|471000669|FG000|Period 1|Felt unable to empty bladder|1|||
130828977|NCT01523743|471000670|FG001|Period 1|Felt unable to empty bladder|0|||
130828978|NCT01523743|471000669|FG000|Period 2|Withdrawal by Subject|0|||
130828979|NCT01523743|471000670|FG001|Period 2|Withdrawal by Subject|2|||
130828980|NCT01523743|471000669|FG000|Period 2|Adverse Event|1|||
130828981|NCT01523743|471000670|FG001|Period 2|Adverse Event|0|||
130828982|NCT02569476|471000671|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
130828983|NCT02569476|471000671|FG000|Overall Study|Death|33|||
130828984|NCT02569476|471000671|FG000|Overall Study|Withdrawal by Subject|9|||
130828985|NCT02569476|471000671|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
130828986|NCT02569476|471000671|FG000|Overall Study|Palliative care|1|||
130828987|NCT02569476|471000671|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
130828988|NCT02569476|471000671|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
130828989|NCT01434654|471000672|FG000|Overall Study|Withdrawal by Subject|1|||
130828990|NCT01434654|471000673|FG001|Overall Study|Withdrawal by Subject|0|||
130828991|NCT01434654|471000672|FG000|Overall Study|Lost to Follow-up|1|||
130828992|NCT01434654|471000673|FG001|Overall Study|Lost to Follow-up|0|||
130828993|NCT00703963|471000676|FG000|Overall Study|Withdrawal by Subject|7|||
130828994|NCT00703963|471000677|FG001|Overall Study|Withdrawal by Subject|13|||
130828995|NCT00703963|471000676|FG000|Overall Study|Physician Decision|0|||
130828996|NCT00703963|471000677|FG001|Overall Study|Physician Decision|1|||
130828997|NCT03072043|471000678|FG000|Overall Study|Death|0|||
130828998|NCT03072043|471000679|FG001|Overall Study|Death|0|||
130828999|NCT03072043|471000680|FG002|Overall Study|Death|3|||
130829000|NCT03072043|471000678|FG000|Overall Study|Adverse Event|0|||
130829001|NCT03072043|471000679|FG001|Overall Study|Adverse Event|0|||
130829002|NCT03072043|471000680|FG002|Overall Study|Adverse Event|2|||
130829003|NCT03072043|471000678|FG000|Overall Study|Withdrawal by Subject|0|||
130829004|NCT03072043|471000679|FG001|Overall Study|Withdrawal by Subject|0|||
130829005|NCT03072043|471000680|FG002|Overall Study|Withdrawal by Subject|4|||
130829006|NCT00402324|471000681|FG000|Overall Study|Lost to Follow-up|11|||
130829007|NCT00402324|471000682|FG001|Overall Study|Lost to Follow-up|11|||
130829008|NCT00402324|471000681|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
130829009|NCT00402324|471000682|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
130829010|NCT00402324|471000681|FG000|Overall Study|Protocol Violation|8|||
130829011|NCT00402324|471000682|FG001|Overall Study|Protocol Violation|7|||
130829012|NCT00402324|471000681|FG000|Overall Study|Withdrawal by Subject|5|||
130829013|NCT00402324|471000682|FG001|Overall Study|Withdrawal by Subject|2|||
130829014|NCT00402324|471000681|FG000|Overall Study|Physician Decision|2|||
130829015|NCT00402324|471000682|FG001|Overall Study|Physician Decision|4|||
130829016|NCT00402324|471000681|FG000|Overall Study|Sponsor Decision|4|||
130829017|NCT00402324|471000682|FG001|Overall Study|Sponsor Decision|5|||
130829018|NCT00402324|471000681|FG000|Overall Study|Lack of Efficacy|1|||
130829019|NCT00402324|471000682|FG001|Overall Study|Lack of Efficacy|4|||
130829020|NCT00402324|471000681|FG000|Overall Study|Adverse Event|6|||
130829021|NCT00402324|471000682|FG001|Overall Study|Adverse Event|4|||
130829022|NCT00402324|471000681|FG000|Overall Study|Death|1|||
130829023|NCT00402324|471000682|FG001|Overall Study|Death|0|||
130829024|NCT03994211|471000683|FG000|Core Phase|Adverse Event|0|||
130829025|NCT03994211|471000684|FG001|Core Phase|Adverse Event|1|||
130829026|NCT03994211|471000685|FG002|Core Phase|Adverse Event|0|||
130829027|NCT03994211|471000683|FG000|Extension Phase|Adverse Event|0|||
130829028|NCT03994211|471000684|FG001|Extension Phase|Adverse Event|0|||
130829029|NCT03994211|471000685|FG002|Extension Phase|Adverse Event|1|||
130829030|NCT03994211|471000683|FG000|Extension Phase|Physician Decision|0|||
130829031|NCT03994211|471000684|FG001|Extension Phase|Physician Decision|0|||
130829032|NCT03994211|471000685|FG002|Extension Phase|Physician Decision|1|||
130829033|NCT03994211|471000683|FG000|Extension Phase|Progressive Disease|0|||
130829034|NCT03994211|471000684|FG001|Extension Phase|Progressive Disease|0|||
130829035|NCT03994211|471000685|FG002|Extension Phase|Progressive Disease|20|||
130829036|NCT03994211|471000683|FG000|Extension Phase|Withdrawal by Subject|0|||
130829037|NCT03994211|471000684|FG001|Extension Phase|Withdrawal by Subject|0|||
130829038|NCT03994211|471000685|FG002|Extension Phase|Withdrawal by Subject|2|||
130829039|NCT02625220|471000686|FG000|Overall Study|Adverse Event|2|||
130829040|NCT02625220|471000686|FG000|Overall Study|Lost to Follow-up|2|||
130829041|NCT02625220|471000686|FG000|Overall Study|Protocol Violation|1|||
130829042|NCT02625220|471000686|FG000|Overall Study|Study discontinued at site|2|||
130829043|NCT01140867|471000687|FG000|Overall Study|Adverse Event|22|||
130829044|NCT01140867|471000687|FG000|Overall Study|Lack of Efficacy|3|||
130829045|NCT01140867|471000687|FG000|Overall Study|Lost to Follow-up|2|||
130829046|NCT01140867|471000687|FG000|Overall Study|Withdrawal by Subject|1|||
130829047|NCT01140867|471000687|FG000|Overall Study|Protocol Violation|1|||
130829048|NCT01140867|471000687|FG000|Overall Study|Uncooperative patient|2|||
130829049|NCT01140867|471000687|FG000|Overall Study|Medication Noncompliance|2|||
130829050|NCT02997865|471000691|FG000|Overall Study|Death|2|||
130829051|NCT02997865|471000692|FG001|Overall Study|Death|1|||
130829052|NCT02997865|471000691|FG000|Overall Study|Lost to Follow-up|6|||
130829053|NCT02997865|471000692|FG001|Overall Study|Lost to Follow-up|3|||
130829054|NCT02997865|471000691|FG000|Overall Study|Withdrawal by Subject|5|||
130829055|NCT02997865|471000692|FG001|Overall Study|Withdrawal by Subject|0|||
130829056|NCT01926444|471000693|FG000|Overall Study|Colonoscopy not performed|0|||
130829057|NCT01926444|471000694|FG001|Overall Study|Colonoscopy not performed|0|||
130829058|NCT01926444|471000695|FG002|Overall Study|Colonoscopy not performed|4|||
130829059|NCT01926444|471000696|FG003|Overall Study|Colonoscopy not performed|2|||
130829060|NCT02441101|471000703|FG000|Overall Study|Withdrawal by Subject|1|||
130829061|NCT02441101|471000704|FG001|Overall Study|Withdrawal by Subject|0|||
130829062|NCT02441101|471000703|FG000|Overall Study|Lost to Follow-up|1|||
130829063|NCT02441101|471000704|FG001|Overall Study|Lost to Follow-up|0|||
130829064|NCT02441101|471000703|FG000|Overall Study|PI relocated and study terminated|1|||
130829065|NCT02441101|471000704|FG001|Overall Study|PI relocated and study terminated|0|||
130829066|NCT02528942|471000706|FG000|Overall Study|Did not meet imaging criteria|9|||
130829067|NCT02528942|471000706|FG000|Overall Study|Lost to Follow-up|25|||
130829068|NCT00881530|471000707|FG000|Overall Study|Adverse Event|5|||
130829069|NCT00881530|471000708|FG001|Overall Study|Adverse Event|1|||
130829070|NCT00881530|471000709|FG002|Overall Study|Adverse Event|1|||
130829071|NCT00881530|471000710|FG003|Overall Study|Adverse Event|4|||
130829072|NCT00881530|471000711|FG004|Overall Study|Adverse Event|10|||
130829073|NCT00881530|471000712|FG005|Overall Study|Adverse Event|2|||
130829074|NCT00881530|471000707|FG000|Overall Study|Lack of Efficacy|1|||
130829075|NCT00881530|471000708|FG001|Overall Study|Lack of Efficacy|0|||
130829076|NCT00881530|471000709|FG002|Overall Study|Lack of Efficacy|0|||
130829077|NCT00881530|471000710|FG003|Overall Study|Lack of Efficacy|0|||
130829078|NCT00881530|471000711|FG004|Overall Study|Lack of Efficacy|1|||
130829079|NCT00881530|471000712|FG005|Overall Study|Lack of Efficacy|1|||
130829080|NCT00881530|471000707|FG000|Overall Study|Not compliant with the protocol|0|||
130829081|NCT00881530|471000708|FG001|Overall Study|Not compliant with the protocol|0|||
130829082|NCT00881530|471000709|FG002|Overall Study|Not compliant with the protocol|0|||
130829083|NCT00881530|471000710|FG003|Overall Study|Not compliant with the protocol|0|||
130829084|NCT00881530|471000711|FG004|Overall Study|Not compliant with the protocol|2|||
130829085|NCT00881530|471000712|FG005|Overall Study|Not compliant with the protocol|0|||
130829086|NCT00881530|471000707|FG000|Overall Study|Lost to Follow-up|0|||
130829087|NCT00881530|471000708|FG001|Overall Study|Lost to Follow-up|1|||
130829088|NCT00881530|471000709|FG002|Overall Study|Lost to Follow-up|1|||
130829089|NCT00881530|471000710|FG003|Overall Study|Lost to Follow-up|3|||
130829090|NCT00881530|471000711|FG004|Overall Study|Lost to Follow-up|1|||
130829091|NCT00881530|471000712|FG005|Overall Study|Lost to Follow-up|0|||
130829092|NCT00881530|471000707|FG000|Overall Study|Refused to continue medication|7|||
130829093|NCT00881530|471000708|FG001|Overall Study|Refused to continue medication|2|||
130829094|NCT00881530|471000709|FG002|Overall Study|Refused to continue medication|1|||
130829095|NCT00881530|471000710|FG003|Overall Study|Refused to continue medication|2|||
130829096|NCT00881530|471000711|FG004|Overall Study|Refused to continue medication|0|||
130829097|NCT00881530|471000712|FG005|Overall Study|Refused to continue medication|0|||
130829098|NCT00881530|471000707|FG000|Overall Study|Other reason not defined above|1|||
130829099|NCT00881530|471000708|FG001|Overall Study|Other reason not defined above|1|||
130829100|NCT00881530|471000709|FG002|Overall Study|Other reason not defined above|2|||
130829101|NCT00881530|471000710|FG003|Overall Study|Other reason not defined above|0|||
130829102|NCT00881530|471000711|FG004|Overall Study|Other reason not defined above|0|||
130829103|NCT00881530|471000712|FG005|Overall Study|Other reason not defined above|2|||
130829104|NCT01509846|471000713|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
130829105|NCT01509846|471000714|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
130829106|NCT01509846|471000715|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
130829107|NCT01509846|471000716|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
130829108|NCT01509846|471000717|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
130829109|NCT01509846|471000713|FG000|Received Vaccination 2|Illness|0|||
130829110|NCT01509846|471000714|FG001|Received Vaccination 2|Illness|0|||
130829111|NCT01509846|471000715|FG002|Received Vaccination 2|Illness|0|||
130829112|NCT01509846|471000716|FG003|Received Vaccination 2|Illness|0|||
130829113|NCT01509846|471000717|FG004|Received Vaccination 2|Illness|1|||
130829114|NCT01509846|471000713|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
130829115|NCT01509846|471000714|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
130829116|NCT01509846|471000715|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
130829117|NCT01509846|471000716|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
130829118|NCT01509846|471000717|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
130829119|NCT01509846|471000713|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
130829120|NCT01509846|471000714|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
130829121|NCT01509846|471000715|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
130829122|NCT01509846|471000716|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
130829123|NCT01509846|471000717|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
130829124|NCT01509846|471000713|FG000|Received Vaccination 3|Pregnancy|0|||
130829125|NCT01509846|471000714|FG001|Received Vaccination 3|Pregnancy|0|||
130829126|NCT01509846|471000715|FG002|Received Vaccination 3|Pregnancy|0|||
130829127|NCT01509846|471000716|FG003|Received Vaccination 3|Pregnancy|1|||
130829128|NCT01509846|471000717|FG004|Received Vaccination 3|Pregnancy|0|||
130829129|NCT01509846|471000713|FG000|Received Vaccination 3|Lost to Follow-up|0|||
130829130|NCT01509846|471000714|FG001|Received Vaccination 3|Lost to Follow-up|0|||
130829131|NCT01509846|471000715|FG002|Received Vaccination 3|Lost to Follow-up|1|||
130829132|NCT01509846|471000716|FG003|Received Vaccination 3|Lost to Follow-up|0|||
130829133|NCT01509846|471000717|FG004|Received Vaccination 3|Lost to Follow-up|0|||
130829134|NCT01637584|471000718|FG000|Overall Study|Withdrawal by Subject|1|||
130829135|NCT01637584|471000719|FG001|Overall Study|Withdrawal by Subject|3|||
130829136|NCT02484443|471000721|FG000|Overall Study|Lack of Efficacy|28|||
130829137|NCT02484443|471000721|FG000|Overall Study|Physician Decision|2|||
130829138|NCT02484443|471000721|FG000|Overall Study|Ineligible|2|||
130829139|NCT02969915|471000722|FG000|Overall Study|Death|104|||
130829140|NCT02969915|471000723|FG001|Overall Study|Death|125|||
130829141|NCT02969915|471000722|FG000|Overall Study|Lost to Follow-up|108|||
130829142|NCT02969915|471000723|FG001|Overall Study|Lost to Follow-up|112|||
130829143|NCT02969915|471000722|FG000|Overall Study|Censored due to COVID-19|481|||
130829144|NCT02969915|471000723|FG001|Overall Study|Censored due to COVID-19|471|||
130829145|NCT01393899|471000726|FG000|Overall Study|Study terminated by sponsor|1|||
130829146|NCT01393899|471000727|FG001|Overall Study|Study terminated by sponsor|0|||
130829147|NCT01393899|471000728|FG002|Overall Study|Study terminated by sponsor|1|||
130829148|NCT01393899|471000726|FG000|Overall Study|Other|1|||
130829149|NCT01393899|471000727|FG001|Overall Study|Other|0|||
130829150|NCT01393899|471000728|FG002|Overall Study|Other|0|||
130829151|NCT01393899|471000726|FG000|Overall Study|Withdrawal by Subject|2|||
130829152|NCT01393899|471000727|FG001|Overall Study|Withdrawal by Subject|2|||
130829153|NCT01393899|471000728|FG002|Overall Study|Withdrawal by Subject|1|||
130829154|NCT01393899|471000726|FG000|Overall Study|Lost to Follow-up|0|||
130829155|NCT01393899|471000727|FG001|Overall Study|Lost to Follow-up|0|||
130829156|NCT01393899|471000728|FG002|Overall Study|Lost to Follow-up|1|||
130829157|NCT01393899|471000726|FG000|Overall Study|Does not meet entrance criteria|1|||
130829158|NCT01393899|471000727|FG001|Overall Study|Does not meet entrance criteria|0|||
130829159|NCT01393899|471000728|FG002|Overall Study|Does not meet entrance criteria|1|||
130829160|NCT01393899|471000726|FG000|Overall Study|Lack of Efficacy|26|||
130829161|NCT01393899|471000727|FG001|Overall Study|Lack of Efficacy|21|||
130829162|NCT01393899|471000728|FG002|Overall Study|Lack of Efficacy|16|||
130829163|NCT01393899|471000726|FG000|Overall Study|Adverse Event|1|||
130829164|NCT01393899|471000727|FG001|Overall Study|Adverse Event|5|||
130829165|NCT01393899|471000728|FG002|Overall Study|Adverse Event|3|||
130829166|NCT02503085|471000729|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
130829167|NCT02503085|471000730|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
130829168|NCT02503085|471000731|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
130829169|NCT02503085|471000732|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
130829170|NCT02131662|471000733|FG000|Overall Study|Protocol Violation|1|||
130829171|NCT02131662|471000734|FG001|Overall Study|Protocol Violation|0|||
130829172|NCT02131662|471000735|FG002|Overall Study|Protocol Violation|0|||
130829173|NCT02131662|471000736|FG003|Overall Study|Protocol Violation|0|||
130829174|NCT02131662|471000737|FG004|Overall Study|Protocol Violation|0|||
130829175|NCT02131662|471000733|FG000|Overall Study|Other|2|||
130829176|NCT02131662|471000734|FG001|Overall Study|Other|4|||
130829177|NCT02131662|471000735|FG002|Overall Study|Other|3|||
130829178|NCT02131662|471000736|FG003|Overall Study|Other|3|||
130829179|NCT02131662|471000737|FG004|Overall Study|Other|4|||
130829180|NCT02131662|471000733|FG000|Overall Study|Adverse Event|0|||
130829181|NCT02131662|471000734|FG001|Overall Study|Adverse Event|1|||
130829182|NCT02131662|471000735|FG002|Overall Study|Adverse Event|1|||
130829183|NCT02131662|471000736|FG003|Overall Study|Adverse Event|1|||
130829184|NCT02131662|471000737|FG004|Overall Study|Adverse Event|3|||
130829185|NCT02131662|471000733|FG000|Overall Study|Pregnancy|0|||
130829186|NCT02131662|471000734|FG001|Overall Study|Pregnancy|1|||
130829187|NCT02131662|471000735|FG002|Overall Study|Pregnancy|0|||
130829188|NCT02131662|471000736|FG003|Overall Study|Pregnancy|1|||
130829189|NCT02131662|471000737|FG004|Overall Study|Pregnancy|0|||
130829190|NCT02131662|471000733|FG000|Overall Study|Wish for pregnancy|0|||
130829191|NCT02131662|471000734|FG001|Overall Study|Wish for pregnancy|0|||
130829192|NCT02131662|471000735|FG002|Overall Study|Wish for pregnancy|0|||
130829193|NCT02131662|471000736|FG003|Overall Study|Wish for pregnancy|0|||
130829194|NCT02131662|471000737|FG004|Overall Study|Wish for pregnancy|1|||
130829195|NCT02131662|471000733|FG000|Overall Study|Lack of Efficacy|1|||
130829196|NCT02131662|471000734|FG001|Overall Study|Lack of Efficacy|0|||
130829197|NCT02131662|471000735|FG002|Overall Study|Lack of Efficacy|0|||
130829198|NCT02131662|471000736|FG003|Overall Study|Lack of Efficacy|0|||
130829199|NCT02131662|471000737|FG004|Overall Study|Lack of Efficacy|1|||
130829200|NCT02131662|471000733|FG000|Overall Study|Withdrawal by Subject|1|||
130829201|NCT02131662|471000734|FG001|Overall Study|Withdrawal by Subject|5|||
130829202|NCT02131662|471000735|FG002|Overall Study|Withdrawal by Subject|1|||
130829203|NCT02131662|471000736|FG003|Overall Study|Withdrawal by Subject|5|||
130829204|NCT02131662|471000737|FG004|Overall Study|Withdrawal by Subject|6|||
130829205|NCT02131662|471000733|FG000|Overall Study|Lost to Follow-up|1|||
130829206|NCT02131662|471000734|FG001|Overall Study|Lost to Follow-up|3|||
130829207|NCT02131662|471000735|FG002|Overall Study|Lost to Follow-up|0|||
130829208|NCT02131662|471000736|FG003|Overall Study|Lost to Follow-up|9|||
130829209|NCT02131662|471000737|FG004|Overall Study|Lost to Follow-up|0|||
130829210|NCT02131662|471000733|FG000|Overall Study|Not treated|2|||
130829211|NCT02131662|471000734|FG001|Overall Study|Not treated|0|||
130829212|NCT02131662|471000735|FG002|Overall Study|Not treated|2|||
130829213|NCT02131662|471000736|FG003|Overall Study|Not treated|2|||
130829214|NCT02131662|471000737|FG004|Overall Study|Not treated|3|||
130829215|NCT00642707|471000743|FG000|Overall Study|Adverse Event|0|||
130829216|NCT00642707|471000744|FG001|Overall Study|Adverse Event|0|||
130829217|NCT00642707|471000745|FG002|Overall Study|Adverse Event|0|||
130829218|NCT00642707|471000746|FG003|Overall Study|Adverse Event|2|||
130829219|NCT00642707|471000743|FG000|Overall Study|Withdrawal by Subject|1|||
130829220|NCT00642707|471000744|FG001|Overall Study|Withdrawal by Subject|0|||
130829221|NCT00642707|471000745|FG002|Overall Study|Withdrawal by Subject|0|||
130829222|NCT00642707|471000746|FG003|Overall Study|Withdrawal by Subject|0|||
130829223|NCT02709720|471000758|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
130829224|NCT02709720|471000758|FG000|Overall Study|Protocol Violation|1|||
130829225|NCT02709720|471000758|FG000|Overall Study|Not take study medication|1|||
130829226|NCT01198574|471000765|FG000|Overall Study|Resigned from schools|4|||
130829227|NCT01198574|471000766|FG001|Overall Study|Resigned from schools|1|||
130829228|NCT01198574|471000767|FG002|Overall Study|Resigned from schools|1|||
130829229|NCT01198574|471000768|FG003|Overall Study|Resigned from schools|4|||
130829230|NCT02100423|471000770|FG000|Overall Study|Death|1|||
130829231|NCT02100423|471000770|FG000|Overall Study|Withdrawal by Subject|3|||
130829232|NCT02100423|471000770|FG000|Overall Study|Adverse Event|1|||
130829233|NCT02100423|471000770|FG000|Overall Study|Physician Decision|1|||
130829234|NCT00325130|471000771|FG000|Overall Study|Lost to Follow-up|6|||
130829235|NCT00325130|471000772|FG001|Overall Study|Lost to Follow-up|14|||
130829236|NCT00325130|471000771|FG000|Overall Study|Withdrawal by Subject|12|||
130829237|NCT00325130|471000772|FG001|Overall Study|Withdrawal by Subject|14|||
130829238|NCT00325130|471000771|FG000|Overall Study|Protocol Deviation|0|||
130829239|NCT00325130|471000772|FG001|Overall Study|Protocol Deviation|1|||
130829240|NCT00325130|471000771|FG000|Overall Study|Moved|0|||
130829241|NCT00325130|471000772|FG001|Overall Study|Moved|1|||
130829242|NCT00325130|471000771|FG000|Overall Study|Patient Discontinued for Other|1|||
130829243|NCT00325130|471000772|FG001|Overall Study|Patient Discontinued for Other|0|||
130829244|NCT02949024|471000775|FG000|Overall Study|Withdrawal by Subject|0|||
130829245|NCT02949024|471000776|FG001|Overall Study|Withdrawal by Subject|1|||
130829246|NCT03159468|471000777|FG000|Overall Study|Withdrawal by Subject|0|||
130829247|NCT03159468|471000778|FG001|Overall Study|Withdrawal by Subject|0|||
130829248|NCT03159468|471000779|FG002|Overall Study|Withdrawal by Subject|3|||
130829249|NCT03159468|471000780|FG003|Overall Study|Withdrawal by Subject|0|||
130829250|NCT03159468|471000781|FG004|Overall Study|Withdrawal by Subject|0|||
130829251|NCT03159468|471000782|FG005|Overall Study|Withdrawal by Subject|0|||
130829252|NCT02524145|471000783|FG000|Overall Study|Withdrawal by Subject|2|||
130829253|NCT02524145|471000784|FG001|Overall Study|Withdrawal by Subject|2|||
130829254|NCT02524145|471000785|FG002|Overall Study|Withdrawal by Subject|3|||
130829255|NCT01127607|471003032|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
130829256|NCT01127607|471003033|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
130829257|NCT01127607|471003032|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
130829258|NCT01127607|471003033|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
130829259|NCT03640325|471003034|FG000|Overall Study|Withdrawal by Subject|4|||
130829260|NCT03640325|471003035|FG001|Overall Study|Withdrawal by Subject|1|||
130829261|NCT03640325|471003036|FG002|Overall Study|Withdrawal by Subject|0|||
130829262|NCT03640325|471003034|FG000|Overall Study|Lost to Follow-up|4|||
130829263|NCT03640325|471003035|FG001|Overall Study|Lost to Follow-up|5|||
130829264|NCT03640325|471003036|FG002|Overall Study|Lost to Follow-up|21|||
130829265|NCT03640325|471003034|FG000|Overall Study|Death|5|||
130829266|NCT03640325|471003035|FG001|Overall Study|Death|5|||
130829267|NCT03640325|471003036|FG002|Overall Study|Death|0|||
130829268|NCT01133756|471003040|FG000|Overall Study|Adverse Event|1|||
130829269|NCT01133756|471003041|FG001|Overall Study|Adverse Event|2|||
130829270|NCT01133756|471003042|FG002|Overall Study|Adverse Event|1|||
130829271|NCT01133756|471003040|FG000|Overall Study|Investigator Decision|1|||
130829272|NCT01133756|471003041|FG001|Overall Study|Investigator Decision|0|||
130829273|NCT01133756|471003042|FG002|Overall Study|Investigator Decision|0|||
130829274|NCT01133756|471003040|FG000|Overall Study|Withdrawal by Subject|0|||
130829275|NCT01133756|471003041|FG001|Overall Study|Withdrawal by Subject|1|||
130829276|NCT01133756|471003042|FG002|Overall Study|Withdrawal by Subject|0|||
130829277|NCT01133756|471003040|FG000|Overall Study|Progression of Disease|0|||
130829278|NCT01133756|471003041|FG001|Overall Study|Progression of Disease|0|||
130829279|NCT01133756|471003042|FG002|Overall Study|Progression of Disease|1|||
130829280|NCT01566149|471003043|FG000|Overall Study|Adverse Event|0|||
130829281|NCT01566149|471003044|FG001|Overall Study|Adverse Event|1|||
130829282|NCT01566149|471003043|FG000|Overall Study|Non-compliance with study medication|2|||
130829283|NCT01566149|471003044|FG001|Overall Study|Non-compliance with study medication|0|||
130829284|NCT01566149|471003043|FG000|Overall Study|Protocol Violation|0|||
130829285|NCT01566149|471003044|FG001|Overall Study|Protocol Violation|1|||
130829286|NCT01566149|471003043|FG000|Overall Study|Withdrawal by Subject|1|||
130829287|NCT01566149|471003044|FG001|Overall Study|Withdrawal by Subject|0|||
130829288|NCT03276728|471003048|FG000|Overall Study|Lost to Follow-up|0|||
130829289|NCT03276728|471003049|FG001|Overall Study|Lost to Follow-up|0|||
130829290|NCT03276728|471003050|FG002|Overall Study|Lost to Follow-up|2|||
130829291|NCT03276728|471003051|FG003|Overall Study|Lost to Follow-up|2|||
130829292|NCT03276728|471003052|FG004|Overall Study|Lost to Follow-up|0|||
130829293|NCT03276728|471003053|FG005|Overall Study|Lost to Follow-up|0|||
130829294|NCT03276728|471003054|FG006|Overall Study|Lost to Follow-up|0|||
130829295|NCT03276728|471003055|FG007|Overall Study|Lost to Follow-up|0|||
130829296|NCT03276728|471003048|FG000|Overall Study|Withdrawal by Subject|0|||
130829297|NCT03276728|471003049|FG001|Overall Study|Withdrawal by Subject|0|||
130829298|NCT03276728|471003050|FG002|Overall Study|Withdrawal by Subject|0|||
130829299|NCT03276728|471003051|FG003|Overall Study|Withdrawal by Subject|3|||
130829300|NCT03276728|471003052|FG004|Overall Study|Withdrawal by Subject|0|||
130829301|NCT03276728|471003053|FG005|Overall Study|Withdrawal by Subject|0|||
130829302|NCT03276728|471003054|FG006|Overall Study|Withdrawal by Subject|0|||
130829303|NCT03276728|471003055|FG007|Overall Study|Withdrawal by Subject|0|||
130829304|NCT03276728|471003048|FG000|Overall Study|Decision by sponsor|0|||
130829305|NCT03276728|471003049|FG001|Overall Study|Decision by sponsor|0|||
130829306|NCT03276728|471003050|FG002|Overall Study|Decision by sponsor|0|||
130829307|NCT03276728|471003051|FG003|Overall Study|Decision by sponsor|0|||
130829308|NCT03276728|471003052|FG004|Overall Study|Decision by sponsor|1|||
130829309|NCT03276728|471003053|FG005|Overall Study|Decision by sponsor|0|||
130829310|NCT03276728|471003054|FG006|Overall Study|Decision by sponsor|2|||
130829311|NCT03276728|471003055|FG007|Overall Study|Decision by sponsor|1|||
130829312|NCT03941873|471003062|FG000|Overall Study|Death|0|||
130829313|NCT03941873|471003063|FG001|Overall Study|Death|12|||
130829314|NCT03941873|471003064|FG002|Overall Study|Death|2|||
130829315|NCT03941873|471003065|FG003|Overall Study|Death|53|||
130829316|NCT03941873|471003062|FG000|Overall Study|Withdrawal by Subject|1|||
130829317|NCT03941873|471003063|FG001|Overall Study|Withdrawal by Subject|1|||
130829318|NCT03941873|471003064|FG002|Overall Study|Withdrawal by Subject|0|||
130829319|NCT03941873|471003065|FG003|Overall Study|Withdrawal by Subject|5|||
130829320|NCT03941873|471003062|FG000|Overall Study|Lost to Follow-up|1|||
130829321|NCT03941873|471003063|FG001|Overall Study|Lost to Follow-up|2|||
130829322|NCT03941873|471003064|FG002|Overall Study|Lost to Follow-up|0|||
130829323|NCT03941873|471003065|FG003|Overall Study|Lost to Follow-up|0|||
130829324|NCT03941873|471003062|FG000|Overall Study|Sponsor Decision|0|||
130829325|NCT03941873|471003063|FG001|Overall Study|Sponsor Decision|6|||
130829326|NCT03941873|471003064|FG002|Overall Study|Sponsor Decision|0|||
130829327|NCT03941873|471003065|FG003|Overall Study|Sponsor Decision|15|||
130829328|NCT02982772|471003068|FG000|Intervention|Lost to Follow-up|19|||
130829329|NCT02982772|471003069|FG001|Intervention|Lost to Follow-up|13|||
130829330|NCT02982772|471003068|FG000|1M Follow-Up|Lost to Follow-up|21|||
130829331|NCT02982772|471003069|FG001|1M Follow-Up|Lost to Follow-up|18|||
130829332|NCT02982772|471003068|FG000|3M Follow-Up|Lost to Follow-up|17|||
130829333|NCT02982772|471003069|FG001|3M Follow-Up|Lost to Follow-up|11|||
130829334|NCT02982772|471003068|FG000|6M Follow-Up|Lost to Follow-up|11|||
130829335|NCT02982772|471003069|FG001|6M Follow-Up|Lost to Follow-up|9|||
130829336|NCT02982772|471003068|FG000|12M Follow-Up|Lost to Follow-up|11|||
130829337|NCT02982772|471003069|FG001|12M Follow-Up|Lost to Follow-up|5|||
130829338|NCT01234480|471003070|FG000|Overall Study|Pregnancy|88|||
130829339|NCT01234480|471003070|FG000|Overall Study|>36/Normal History|50|||
130829340|NCT01234480|471003070|FG000|Overall Study|Age|3|||
130829341|NCT01234480|471003070|FG000|Overall Study|HPV Vaccine History|28|||
130829342|NCT01234480|471003070|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
130829343|NCT01234480|471003070|FG000|Overall Study|Hysterectomy|2|||
130829344|NCT01234480|471003070|FG000|Overall Study|Hysterectomy post enrollment|1|||
130829345|NCT01234480|471003070|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
130829346|NCT01234480|471003070|FG000|Overall Study|Informed Consent Form Violation|30|||
130829347|NCT01234480|471003070|FG000|Overall Study|Incorrect Visit|3|||
130829348|NCT01234480|471003070|FG000|Overall Study|No Florida Lab License|20|||
130829349|NCT01234480|471003070|FG000|Overall Study|Out of Window|42|||
130829350|NCT01234480|471003070|FG000|Overall Study|Sample Processing/Storage|92|||
130829351|NCT01234480|471003070|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
130829352|NCT01234480|471003070|FG000|Overall Study|Site/Subject non-compliance|44|||
130829353|NCT01234480|471003070|FG000|Overall Study|Missing Sample|9|||
130829354|NCT02974140|471003071|FG000|Overall Study|Adverse Event|2|||
130829355|NCT02974140|471003071|FG000|Overall Study|Lost to Follow-up|1|||
130829356|NCT02974140|471003071|FG000|Overall Study|Study Terminated by Sponsor|36|||
130829357|NCT00617084|471003074|FG000|Overall Study|Withdrawal by Subject|5|||
130829358|NCT00617084|471003075|FG001|Overall Study|Withdrawal by Subject|7|||
130829359|NCT00617084|471003074|FG000|Overall Study|Missed 12 Months visit|16|||
130829360|NCT00617084|471003075|FG001|Overall Study|Missed 12 Months visit|19|||
130829361|NCT02522429|471003078|FG000|Overall Study|Lost to Follow-up|8|||
130829362|NCT02522429|471003078|FG000|Overall Study|Adverse Event|2|||
130829363|NCT02522429|471003078|FG000|Overall Study|Death|1|||
130829364|NCT02522429|471003078|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
130829365|NCT01521923|471003084|FG000|Overall Study|AE, serious fatal|1|||
130829366|NCT01521923|471003085|FG001|Overall Study|AE, serious fatal|0|||
130829367|NCT01521923|471003086|FG002|Overall Study|AE, serious fatal|0|||
130829368|NCT01521923|471003087|FG003|Overall Study|AE, serious fatal|0|||
130829369|NCT01521923|471003084|FG000|Overall Study|SAE, non-fatal|0|||
130829370|NCT01521923|471003085|FG001|Overall Study|SAE, non-fatal|2|||
130829371|NCT01521923|471003086|FG002|Overall Study|SAE, non-fatal|2|||
130829372|NCT01521923|471003087|FG003|Overall Study|SAE, non-fatal|0|||
130829373|NCT01521923|471003084|FG000|Overall Study|AE, non-serious, non-fatal|1|||
130829374|NCT01521923|471003085|FG001|Overall Study|AE, non-serious, non-fatal|3|||
130829375|NCT01521923|471003086|FG002|Overall Study|AE, non-serious, non-fatal|6|||
130829376|NCT01521923|471003087|FG003|Overall Study|AE, non-serious, non-fatal|2|||
130829377|NCT01521923|471003084|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
130829378|NCT01521923|471003085|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
130829379|NCT01521923|471003086|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
130829380|NCT01521923|471003087|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
130829381|NCT01521923|471003084|FG000|Overall Study|Lack of Efficacy|1|||
130829382|NCT01521923|471003085|FG001|Overall Study|Lack of Efficacy|1|||
130829383|NCT01521923|471003086|FG002|Overall Study|Lack of Efficacy|0|||
130829384|NCT01521923|471003087|FG003|Overall Study|Lack of Efficacy|0|||
130829385|NCT01521923|471003084|FG000|Overall Study|Protocol Violation|0|||
130829386|NCT01521923|471003085|FG001|Overall Study|Protocol Violation|0|||
130829387|NCT01521923|471003086|FG002|Overall Study|Protocol Violation|1|||
130829388|NCT01521923|471003087|FG003|Overall Study|Protocol Violation|0|||
130829389|NCT01521923|471003084|FG000|Overall Study|Lost to Follow-up|1|||
130829390|NCT01521923|471003085|FG001|Overall Study|Lost to Follow-up|0|||
130829391|NCT01521923|471003086|FG002|Overall Study|Lost to Follow-up|2|||
130829392|NCT01521923|471003087|FG003|Overall Study|Lost to Follow-up|1|||
130829393|NCT01521923|471003084|FG000|Overall Study|Withdrawal by Subject|1|||
130829394|NCT01521923|471003085|FG001|Overall Study|Withdrawal by Subject|1|||
130829395|NCT01521923|471003086|FG002|Overall Study|Withdrawal by Subject|1|||
130829396|NCT01521923|471003087|FG003|Overall Study|Withdrawal by Subject|2|||
130829397|NCT01521923|471003084|FG000|Overall Study|Other|2|||
130829398|NCT01521923|471003085|FG001|Overall Study|Other|1|||
130829399|NCT01521923|471003086|FG002|Overall Study|Other|3|||
130829400|NCT01521923|471003087|FG003|Overall Study|Other|6|||
130829401|NCT01521923|471003084|FG000|Overall Study|AE, captured in Period 1|0|||
130829402|NCT01521923|471003085|FG001|Overall Study|AE, captured in Period 1|1|||
130829403|NCT01521923|471003086|FG002|Overall Study|AE, captured in Period 1|0|||
130829404|NCT01521923|471003087|FG003|Overall Study|AE, captured in Period 1|1|||
130829405|NCT01279044|471003088|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
130829406|NCT01279044|471003089|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
130829407|NCT01279044|471003090|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
130829408|NCT01279044|471003088|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
130829409|NCT01279044|471003089|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
130829410|NCT01279044|471003090|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
130829411|NCT01279044|471003088|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
130829412|NCT01279044|471003089|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
130829413|NCT01279044|471003090|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
130829414|NCT01582009|471003091|FG000|Overall Study|Withdrawal by Subject|1|||
130829415|NCT01582009|471003091|FG000|Overall Study|Physician Decision|1|||
130829416|NCT04556591|471003092|FG000|Overall Study|Lost to Follow-up|1|||
130829417|NCT04556591|471003093|FG001|Overall Study|Lost to Follow-up|0|||
130829418|NCT04556591|471003092|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
130829419|NCT04556591|471003093|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
130829420|NCT03332173|471003094|FG000|Overall Study|Death|7|||
130829421|NCT03332173|471003094|FG000|Overall Study|Withdrawal by Subject|6|||
130829422|NCT03332173|471003094|FG000|Overall Study|Lost to Follow-up|2|||
130829423|NCT03332173|471003094|FG000|Overall Study|Transferred to long-term extension study|29|||
130829424|NCT02168101|471003095|FG000|Overall Study|Death|2|||
130829425|NCT02168101|471003096|FG001|Overall Study|Death|2|||
130829426|NCT02168101|471003097|FG002|Overall Study|Death|1|||
130829427|NCT05507567|471003098|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
130829428|NCT05507567|471003099|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
130829429|NCT05507567|471003100|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
130829430|NCT05507567|471003098|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
130829431|NCT05507567|471003099|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
130829432|NCT05507567|471003100|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
130829433|NCT05507567|471003098|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
130829434|NCT05507567|471003099|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
130829435|NCT05507567|471003100|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
130829436|NCT05507567|471003098|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
130829437|NCT05507567|471003099|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
130829438|NCT05507567|471003100|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
130829439|NCT00910910|471003101|FG000|Overall Study|Adverse Event|63|||
130829440|NCT00910910|471003102|FG001|Overall Study|Adverse Event|35|||
130829441|NCT00910910|471003101|FG000|Overall Study|PD without histologic change|27|||
130829442|NCT00910910|471003102|FG001|Overall Study|PD without histologic change|23|||
130829443|NCT00910910|471003101|FG000|Overall Study|PD with histologic change|0|||
130829444|NCT00910910|471003102|FG001|Overall Study|PD with histologic change|2|||
130829445|NCT00910910|471003101|FG000|Overall Study|Withdrawal by Subject|7|||
130829446|NCT00910910|471003102|FG001|Overall Study|Withdrawal by Subject|5|||
130829447|NCT00910910|471003101|FG000|Overall Study|Lost to Follow-up|2|||
130829448|NCT00910910|471003102|FG001|Overall Study|Lost to Follow-up|2|||
130829449|NCT00910910|471003101|FG000|Overall Study|Death|9|||
130829450|NCT00910910|471003102|FG001|Overall Study|Death|3|||
130829451|NCT00910910|471003101|FG000|Overall Study|Protocol Violation|2|||
130829452|NCT00910910|471003102|FG001|Overall Study|Protocol Violation|2|||
130829453|NCT00910910|471003101|FG000|Overall Study|Completed 13 cycles of treatment|0|||
130829454|NCT00910910|471003102|FG001|Overall Study|Completed 13 cycles of treatment|118|||
130829455|NCT00910910|471003101|FG000|Overall Study|Other|114|||
130829456|NCT00910910|471003102|FG001|Overall Study|Other|32|||
130829457|NCT00910910|471003101|FG000|Overall Study|Untreated before cycle 1|1|||
130829458|NCT00910910|471003102|FG001|Overall Study|Untreated before cycle 1|2|||
130829459|NCT01973231|471003103|FG000|Overall Study|Protocol Violation|1|||
130829460|NCT01973231|471003104|FG001|Overall Study|Protocol Violation|1|||
130829461|NCT01973231|471003103|FG000|Overall Study|Lost to Follow-up|1|||
130829462|NCT01973231|471003104|FG001|Overall Study|Lost to Follow-up|1|||
130829463|NCT01973231|471003103|FG000|Overall Study|unclassified|2|||
130829464|NCT01973231|471003104|FG001|Overall Study|unclassified|1|||
130829465|NCT01973231|471003103|FG000|Overall Study|Withdrawal by Subject|7|||
130829466|NCT01973231|471003104|FG001|Overall Study|Withdrawal by Subject|9|||
130829467|NCT00988052|471003111|FG000|Overall Study|Missing|1|||
130829468|NCT00988052|471003112|FG001|Overall Study|Missing|0|||
130829469|NCT00988052|471003111|FG000|Overall Study|Teva requested subject withdrawal|3|||
130829470|NCT00988052|471003112|FG001|Overall Study|Teva requested subject withdrawal|1|||
130829471|NCT00988052|471003111|FG000|Overall Study|Death|1|||
130829472|NCT00988052|471003112|FG001|Overall Study|Death|3|||
130829473|NCT00988052|471003111|FG000|Overall Study|Protocol Violation|6|||
130829474|NCT00988052|471003112|FG001|Overall Study|Protocol Violation|5|||
130829475|NCT00988052|471003111|FG000|Overall Study|Pregnancy|6|||
130829476|NCT00988052|471003112|FG001|Overall Study|Pregnancy|6|||
130829477|NCT00988052|471003111|FG000|Overall Study|Lack of Efficacy|8|||
130829478|NCT00988052|471003112|FG001|Overall Study|Lack of Efficacy|7|||
130829479|NCT00988052|471003111|FG000|Overall Study|Lost to Follow-up|6|||
130829480|NCT00988052|471003112|FG001|Overall Study|Lost to Follow-up|11|||
130829481|NCT00988052|471003111|FG000|Overall Study|Physician Decision|27|||
130829482|NCT00988052|471003112|FG001|Overall Study|Physician Decision|28|||
130829483|NCT00988052|471003111|FG000|Overall Study|Adverse Event|35|||
130829484|NCT00988052|471003112|FG001|Overall Study|Adverse Event|28|||
130829485|NCT00988052|471003111|FG000|Overall Study|Withdrawal by Subject|90|||
130829486|NCT00988052|471003112|FG001|Overall Study|Withdrawal by Subject|91|||
130829487|NCT00988052|471003111|FG000|Overall Study|Study terminated by sponsor|240|||
130829488|NCT00988052|471003112|FG001|Overall Study|Study terminated by sponsor|236|||
130829489|NCT03782064|471003115|FG000|Overall Study|Lack of Efficacy|2|||
130829490|NCT03782064|471003115|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
130829491|NCT02446769|471003116|FG000|Screening Period|Screen Failure|11|||
130829492|NCT02446769|471003117|FG001|Screening Period|Screen Failure|0|||
130829493|NCT02446769|471003118|FG002|Screening Period|Screen Failure|0|||
130829494|NCT02446769|471003116|FG000|Study Period|Randomized in Error|0|||
130829495|NCT02446769|471003117|FG001|Study Period|Randomized in Error|2|||
130829496|NCT02446769|471003118|FG002|Study Period|Randomized in Error|0|||
130829497|NCT00645840|471003119|FG000|Overall Study|Protocol Violation|3|||
130829498|NCT01277822|471003120|FG000|Overall Study|Adverse Event|2|||
130829499|NCT01277822|471003121|FG001|Overall Study|Adverse Event|1|||
130829500|NCT01277822|471003120|FG000|Overall Study|Withdrawal by Subject|6|||
130829501|NCT01277822|471003121|FG001|Overall Study|Withdrawal by Subject|7|||
130829502|NCT01277822|471003120|FG000|Overall Study|Physician Decision|1|||
130829503|NCT01277822|471003121|FG001|Overall Study|Physician Decision|1|||
130829504|NCT01277822|471003120|FG000|Overall Study|Protocol Violation|1|||
130829505|NCT01277822|471003121|FG001|Overall Study|Protocol Violation|0|||
130829506|NCT01277822|471003120|FG000|Overall Study|Lost to Follow-up|2|||
130829507|NCT01277822|471003121|FG001|Overall Study|Lost to Follow-up|1|||
130829508|NCT01277822|471003120|FG000|Overall Study|Contraindicated medication used|2|||
130829509|NCT01277822|471003121|FG001|Overall Study|Contraindicated medication used|1|||
130829510|NCT01277822|471003120|FG000|Overall Study|Participant moved|1|||
130829511|NCT01277822|471003121|FG001|Overall Study|Participant moved|0|||
130829512|NCT02923531|471003122|FG000|Overall Study|Adverse Event|4|||
130829513|NCT02923531|471003122|FG000|Overall Study|Clinical Deterioration|1|||
130829514|NCT02923531|471003122|FG000|Overall Study|Disease Progression|3|||
130829515|NCT02923531|471003122|FG000|Overall Study|Study Termination|1|||
130829516|NCT00997984|471003123|FG000|Overall Study|Adverse Event|1|||
130829517|NCT00997984|471003124|FG001|Overall Study|Adverse Event|8|||
130829518|NCT00997984|471003125|FG002|Overall Study|Adverse Event|8|||
130829519|NCT00997984|471003123|FG000|Overall Study|Protocol Violation|1|||
130829520|NCT00997984|471003124|FG001|Overall Study|Protocol Violation|3|||
130829521|NCT00997984|471003125|FG002|Overall Study|Protocol Violation|0|||
130829522|NCT00997984|471003123|FG000|Overall Study|Withdrawal by Subject|6|||
130829523|NCT00997984|471003124|FG001|Overall Study|Withdrawal by Subject|9|||
130829524|NCT00997984|471003125|FG002|Overall Study|Withdrawal by Subject|5|||
130829525|NCT00997984|471003123|FG000|Overall Study|Lost to Follow-up|8|||
130829526|NCT00997984|471003124|FG001|Overall Study|Lost to Follow-up|5|||
130829527|NCT00997984|471003125|FG002|Overall Study|Lost to Follow-up|4|||
130829528|NCT00997984|471003123|FG000|Overall Study|Lack of Efficacy|20|||
130829529|NCT00997984|471003124|FG001|Overall Study|Lack of Efficacy|6|||
130829530|NCT00997984|471003125|FG002|Overall Study|Lack of Efficacy|3|||
130829531|NCT00997984|471003123|FG000|Overall Study|Met exclusion criteria|1|||
130829532|NCT00997984|471003124|FG001|Overall Study|Met exclusion criteria|0|||
130829533|NCT00997984|471003125|FG002|Overall Study|Met exclusion criteria|0|||
130829534|NCT00997984|471003123|FG000|Overall Study|non-compliance|0|||
130829535|NCT00997984|471003124|FG001|Overall Study|non-compliance|2|||
130829536|NCT00997984|471003125|FG002|Overall Study|non-compliance|3|||
130829537|NCT00997984|471003123|FG000|Overall Study|Wrong medication dispensed|0|||
130829538|NCT00997984|471003124|FG001|Overall Study|Wrong medication dispensed|1|||
130829539|NCT00997984|471003125|FG002|Overall Study|Wrong medication dispensed|0|||
130829540|NCT00997984|471003123|FG000|Overall Study|Suicidal ideation|0|||
130829541|NCT00997984|471003124|FG001|Overall Study|Suicidal ideation|0|||
130829542|NCT00997984|471003125|FG002|Overall Study|Suicidal ideation|1|||
130829543|NCT00997984|471003123|FG000|Overall Study|Work schedule|0|||
130829544|NCT00997984|471003124|FG001|Overall Study|Work schedule|0|||
130829545|NCT00997984|471003125|FG002|Overall Study|Work schedule|2|||
130829546|NCT01119066|471003127|FG000|Overall Study|Withdrawal by Subject|4|||
130829547|NCT01119066|471003128|FG001|Overall Study|Withdrawal by Subject|6|||
130829548|NCT01119066|471003129|FG002|Overall Study|Withdrawal by Subject|0|||
130829549|NCT01119066|471003130|FG003|Overall Study|Withdrawal by Subject|0|||
130829550|NCT01119066|471003127|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
130829551|NCT01119066|471003128|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
130829552|NCT01119066|471003129|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
130829553|NCT01119066|471003130|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
130829554|NCT01119066|471003127|FG000|Overall Study|Relapse identified before transplant|1|||
130829555|NCT01119066|471003128|FG001|Overall Study|Relapse identified before transplant|0|||
130829556|NCT01119066|471003129|FG002|Overall Study|Relapse identified before transplant|0|||
130829557|NCT01119066|471003130|FG003|Overall Study|Relapse identified before transplant|0|||
130829558|NCT01119066|471003127|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
130829559|NCT01119066|471003128|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
130829560|NCT01119066|471003129|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
130829561|NCT01119066|471003130|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
130829562|NCT01119066|471003127|FG000|Overall Study|Relapse identified before transplant|0|||
130829563|NCT01119066|471003128|FG001|Overall Study|Relapse identified before transplant|4|||
130829564|NCT01119066|471003129|FG002|Overall Study|Relapse identified before transplant|0|||
130829565|NCT01119066|471003130|FG003|Overall Study|Relapse identified before transplant|0|||
130829566|NCT04599803|471003133|FG000|Overall Study|Withdrawal by Subject|5|||
130829567|NCT04599803|471003133|FG000|Overall Study|Lost to Follow-up|26|||
130829568|NCT04677543|471003134|FG000|Overall Study|Withdrawal by Subject|4|||
130829569|NCT04677543|471003135|FG001|Overall Study|Withdrawal by Subject|1|||
130829570|NCT04677543|471003134|FG000|Overall Study|Physician Decision|0|||
130829571|NCT04677543|471003135|FG001|Overall Study|Physician Decision|1|||
130829572|NCT04677543|471003134|FG000|Overall Study|Adverse Event|0|||
130829573|NCT04677543|471003135|FG001|Overall Study|Adverse Event|1|||
130829574|NCT03799952|471003136|FG000|Overall Study|Program was too easy, discontinued|1|||
130829575|NCT03799952|471003137|FG001|Overall Study|Program was too easy, discontinued|0|||
130829576|NCT03799952|471003136|FG000|Overall Study|Lost to Follow-up|0|||
130829577|NCT03799952|471003137|FG001|Overall Study|Lost to Follow-up|2|||
130829578|NCT02595866|471003138|FG000|Overall Study|Adverse Event|2|||
130829579|NCT02595866|471003139|FG001|Overall Study|Adverse Event|5|||
130829580|NCT02595866|471003138|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
130829581|NCT02595866|471003139|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
130829582|NCT02595866|471003138|FG000|Overall Study|Death|0|||
130829583|NCT02595866|471003139|FG001|Overall Study|Death|1|||
130829584|NCT02595866|471003138|FG000|Overall Study|Incarceration|1|||
130829585|NCT02595866|471003139|FG001|Overall Study|Incarceration|0|||
130829586|NCT02595866|471003138|FG000|Overall Study|Lack of Efficacy|17|||
130829587|NCT02595866|471003139|FG001|Overall Study|Lack of Efficacy|7|||
130829588|NCT02595866|471003138|FG000|Overall Study|Physician Decision|4|||
130829589|NCT02595866|471003139|FG001|Overall Study|Physician Decision|3|||
130829590|NCT02595866|471003138|FG000|Overall Study|Switched to Alternative Treatment|1|||
130829591|NCT02595866|471003139|FG001|Overall Study|Switched to Alternative Treatment|0|||
130829592|NCT02595866|471003138|FG000|Overall Study|Study Terminated|0|||
130829593|NCT02595866|471003139|FG001|Overall Study|Study Terminated|4|||
130829594|NCT02595866|471003138|FG000|Overall Study|Withdrawal by Subject|6|||
130829595|NCT02595866|471003139|FG001|Overall Study|Withdrawal by Subject|1|||
130829596|NCT02520388|471003140|FG000|Overall Study|Physician Decision|1|||
130829597|NCT02520388|471003141|FG001|Overall Study|Physician Decision|0|||
130829598|NCT02520388|471003140|FG000|Overall Study|Subject or parent/guardian request|0|||
130829599|NCT02520388|471003141|FG001|Overall Study|Subject or parent/guardian request|6|||
130829600|NCT02520388|471003140|FG000|Overall Study|Adverse Event|1|||
130829601|NCT02520388|471003141|FG001|Overall Study|Adverse Event|4|||
130829602|NCT02520388|471003140|FG000|Overall Study|Lost to Follow-up|3|||
130829603|NCT02520388|471003141|FG001|Overall Study|Lost to Follow-up|2|||
130829604|NCT02520388|471003140|FG000|Overall Study|Other (reason not defined)|4|||
130829605|NCT02520388|471003141|FG001|Overall Study|Other (reason not defined)|4|||
130829606|NCT01437111|471003142|FG000|Overall Study|Adverse Event|2|||
130829607|NCT01437111|471003142|FG000|Overall Study|Withdrawal by Subject|4|||
130829608|NCT01437111|471003142|FG000|Overall Study|Not reported|5|||
130829609|NCT01437111|471003142|FG000|Overall Study|Physician Decision|1|||
130829610|NCT01437111|471003142|FG000|Overall Study|Lost to Follow-up|5|||
130829611|NCT01437111|471003142|FG000|Overall Study|Protocol Violation|1|||
130829612|NCT02131311|471003144|FG000|Overall Study|Adverse Event|2|||
130829613|NCT02131311|471003144|FG000|Overall Study|Protocol Violation|1|||
130829614|NCT02131311|471003144|FG000|Overall Study|Lost to Follow-up|1|||
130829615|NCT03162796|471003146|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
130829616|NCT03162796|471003147|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
130829617|NCT03162796|471003148|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
130829618|NCT03162796|471003146|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
130829619|NCT03162796|471003147|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
130829620|NCT03162796|471003148|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
130829621|NCT03162796|471003146|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
130829622|NCT03162796|471003147|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
130829623|NCT03162796|471003148|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
130829624|NCT03162796|471003146|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
130829625|NCT03162796|471003147|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130829626|NCT03162796|471003148|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130829627|NCT03162796|471003146|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
130829628|NCT03162796|471003147|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
130829629|NCT03162796|471003148|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
130829630|NCT03162796|471003146|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
130829631|NCT03162796|471003147|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
130829632|NCT03162796|471003148|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
130829633|NCT03162796|471003146|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
130829634|NCT03162796|471003147|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
130829635|NCT03162796|471003148|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
130829636|NCT03162796|471003146|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
130829637|NCT03162796|471003147|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
130829638|NCT03162796|471003148|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
130829639|NCT03162796|471003146|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
130829640|NCT03162796|471003147|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
130829641|NCT03162796|471003148|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
130829642|NCT03162796|471003146|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
130829643|NCT03162796|471003147|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
130829644|NCT03162796|471003148|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
130829645|NCT03162796|471003146|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
130829646|NCT03162796|471003147|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
130829647|NCT03162796|471003148|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
130829648|NCT03035864|471003152|FG000|Treatment Period|Adverse Event|1|||
130829649|NCT03035864|471003153|FG001|Treatment Period|Adverse Event|0|||
130829650|NCT03035864|471003152|FG000|Treatment Period|Other|3|||
130829651|NCT03035864|471003153|FG001|Treatment Period|Other|1|||
130829652|NCT03035864|471003152|FG000|Follow-up Period|Adverse Event|1|||
130829653|NCT03035864|471003153|FG001|Follow-up Period|Adverse Event|0|||
130829654|NCT03035864|471003152|FG000|Follow-up Period|Lost to Follow-up|6|||
130829655|NCT03035864|471003153|FG001|Follow-up Period|Lost to Follow-up|2|||
130829656|NCT03035864|471003152|FG000|Follow-up Period|Physician Decision|1|||
130829657|NCT03035864|471003153|FG001|Follow-up Period|Physician Decision|0|||
130829658|NCT03035864|471003152|FG000|Follow-up Period|Other|3|||
130829659|NCT03035864|471003153|FG001|Follow-up Period|Other|2|||
130829660|NCT02342288|471003154|FG000|Overall Study|no protocol anesthesiologist available|3|||
130829661|NCT02342288|471003155|FG001|Overall Study|no protocol anesthesiologist available|2|||
130829662|NCT02342288|471003154|FG000|Overall Study|anesthesia leak in system|1|||
130829663|NCT02342288|471003155|FG001|Overall Study|anesthesia leak in system|0|||
130829664|NCT02342288|471003154|FG000|Overall Study|Withdrawal by Subject|1|||
130829665|NCT02342288|471003155|FG001|Overall Study|Withdrawal by Subject|0|||
130829666|NCT02342288|471003154|FG000|Overall Study|coordinator contaminated with blood|0|||
130829667|NCT02342288|471003155|FG001|Overall Study|coordinator contaminated with blood|1|||
130829668|NCT02342288|471003154|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
130829669|NCT02342288|471003155|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
130829670|NCT02342288|471003154|FG000|Overall Study|coordinator not available|0|||
130829671|NCT02342288|471003155|FG001|Overall Study|coordinator not available|2|||
130829672|NCT03082677|471003156|FG000|Overall Study|Not Treated|2|||
130829673|NCT02375373|471003159|FG000|Overall Study|Withdrawal by Subject|11|||
130829674|NCT00407602|471003160|FG000|Overall Study|Death - unrelated to device|1|||
130829675|NCT00407602|471003160|FG000|Overall Study|Device explanted|5|||
130829676|NCT00407602|471003160|FG000|Overall Study|Withdrawal by Subject|1|||
130829677|NCT00577707|471003161|FG000|Overall Study|Withdrawal by Subject|3|||
130829678|NCT03299244|471003162|FG000|Overall Study|Withdrawal by Subject|34|||
130829679|NCT03299244|471003163|FG001|Overall Study|Withdrawal by Subject|29|||
130829680|NCT03299244|471003162|FG000|Overall Study|Decision by Sponsor|4|||
130829681|NCT03299244|471003163|FG001|Overall Study|Decision by Sponsor|5|||
130829682|NCT03299244|471003162|FG000|Overall Study|Death|9|||
130829683|NCT03299244|471003163|FG001|Overall Study|Death|4|||
130829684|NCT00431444|471003164|FG000|Overall Study|Protocol Violation|1|||
130829685|NCT00431444|471003165|FG001|Overall Study|Protocol Violation|4|||
130829686|NCT00431444|471003164|FG000|Overall Study|Adverse Event|2|||
130829687|NCT00431444|471003165|FG001|Overall Study|Adverse Event|1|||
130829688|NCT00431444|471003164|FG000|Overall Study|Withdrawal by Subject|1|||
130829689|NCT00431444|471003165|FG001|Overall Study|Withdrawal by Subject|1|||
130829690|NCT00431444|471003164|FG000|Overall Study|Lost to Follow-up|1|||
130829691|NCT00431444|471003165|FG001|Overall Study|Lost to Follow-up|0|||
130829692|NCT00431444|471003164|FG000|Overall Study|Administrative Problems|0|||
130829693|NCT00431444|471003165|FG001|Overall Study|Administrative Problems|1|||
130829694|NCT01603043|471003166|FG000|Overall Study|Study Futility|7|||
130829695|NCT01603043|471003167|FG001|Overall Study|Study Futility|3|||
130829696|NCT02517398|471003182|FG000|Overall Study|Death|2|||
130829697|NCT02517398|471003183|FG001|Overall Study|Death|3|||
130829698|NCT02517398|471003184|FG002|Overall Study|Death|4|||
130829699|NCT02517398|471003185|FG003|Overall Study|Death|2|||
130829700|NCT02517398|471003186|FG004|Overall Study|Death|3|||
130829701|NCT02517398|471003187|FG005|Overall Study|Death|8|||
130829702|NCT02517398|471003188|FG006|Overall Study|Death|3|||
130829703|NCT02517398|471003189|FG007|Overall Study|Death|2|||
130829704|NCT02517398|471003190|FG008|Overall Study|Death|6|||
130829705|NCT02517398|471003191|FG009|Overall Study|Death|24|||
130829706|NCT02517398|471003192|FG010|Overall Study|Death|53|||
130829707|NCT02517398|471003193|FG011|Overall Study|Death|25|||
130829708|NCT02517398|471003194|FG012|Overall Study|Death|73|||
130829709|NCT02517398|471003195|FG013|Overall Study|Death|29|||
130829710|NCT02517398|471003196|FG014|Overall Study|Death|26|||
130829711|NCT02517398|471003197|FG015|Overall Study|Death|23|||
130829712|NCT02517398|471003198|FG016|Overall Study|Death|26|||
130829713|NCT02517398|471003199|FG017|Overall Study|Death|25|||
130829714|NCT02517398|471003200|FG018|Overall Study|Death|22|||
130829715|NCT02517398|471003201|FG019|Overall Study|Death|7|||
130829716|NCT02517398|471003202|FG020|Overall Study|Death|26|||
130829717|NCT02517398|471003203|FG021|Overall Study|Death|30|||
130829718|NCT02517398|471003204|FG022|Overall Study|Death|20|||
130829719|NCT02517398|471003182|FG000|Overall Study|Other|0|||
130829720|NCT02517398|471003183|FG001|Overall Study|Other|0|||
130829721|NCT02517398|471003184|FG002|Overall Study|Other|0|||
130829722|NCT02517398|471003185|FG003|Overall Study|Other|1|||
130829723|NCT02517398|471003186|FG004|Overall Study|Other|0|||
130829724|NCT02517398|471003187|FG005|Overall Study|Other|0|||
130829725|NCT02517398|471003188|FG006|Overall Study|Other|0|||
130829726|NCT02517398|471003189|FG007|Overall Study|Other|0|||
130829727|NCT02517398|471003190|FG008|Overall Study|Other|0|||
130829728|NCT02517398|471003191|FG009|Overall Study|Other|1|||
130829729|NCT02517398|471003192|FG010|Overall Study|Other|0|||
130829730|NCT02517398|471003193|FG011|Overall Study|Other|0|||
130829731|NCT02517398|471003194|FG012|Overall Study|Other|0|||
130829732|NCT02517398|471003195|FG013|Overall Study|Other|1|||
130829733|NCT02517398|471003196|FG014|Overall Study|Other|0|||
130829734|NCT02517398|471003197|FG015|Overall Study|Other|1|||
130829735|NCT02517398|471003198|FG016|Overall Study|Other|1|||
130829736|NCT02517398|471003199|FG017|Overall Study|Other|0|||
130829737|NCT02517398|471003200|FG018|Overall Study|Other|0|||
130829738|NCT02517398|471003201|FG019|Overall Study|Other|1|||
130829739|NCT02517398|471003202|FG020|Overall Study|Other|0|||
130829740|NCT02517398|471003203|FG021|Overall Study|Other|0|||
130829741|NCT02517398|471003204|FG022|Overall Study|Other|0|||
130829742|NCT02517398|471003182|FG000|Overall Study|Lost to Follow-up|0|||
130829743|NCT02517398|471003183|FG001|Overall Study|Lost to Follow-up|0|||
130829744|NCT02517398|471003184|FG002|Overall Study|Lost to Follow-up|0|||
130829745|NCT02517398|471003185|FG003|Overall Study|Lost to Follow-up|0|||
130829746|NCT02517398|471003186|FG004|Overall Study|Lost to Follow-up|0|||
130829747|NCT02517398|471003187|FG005|Overall Study|Lost to Follow-up|0|||
130829748|NCT02517398|471003188|FG006|Overall Study|Lost to Follow-up|0|||
130829749|NCT02517398|471003189|FG007|Overall Study|Lost to Follow-up|0|||
130829750|NCT02517398|471003190|FG008|Overall Study|Lost to Follow-up|0|||
130829751|NCT02517398|471003191|FG009|Overall Study|Lost to Follow-up|1|||
130829752|NCT02517398|471003192|FG010|Overall Study|Lost to Follow-up|0|||
130829753|NCT02517398|471003193|FG011|Overall Study|Lost to Follow-up|2|||
130829754|NCT02517398|471003194|FG012|Overall Study|Lost to Follow-up|2|||
130829755|NCT02517398|471003195|FG013|Overall Study|Lost to Follow-up|0|||
130829756|NCT02517398|471003196|FG014|Overall Study|Lost to Follow-up|1|||
130829757|NCT02517398|471003197|FG015|Overall Study|Lost to Follow-up|1|||
130829758|NCT02517398|471003198|FG016|Overall Study|Lost to Follow-up|0|||
130829759|NCT02517398|471003199|FG017|Overall Study|Lost to Follow-up|3|||
130829760|NCT02517398|471003200|FG018|Overall Study|Lost to Follow-up|1|||
130829761|NCT02517398|471003201|FG019|Overall Study|Lost to Follow-up|0|||
130829762|NCT02517398|471003202|FG020|Overall Study|Lost to Follow-up|1|||
130829763|NCT02517398|471003203|FG021|Overall Study|Lost to Follow-up|0|||
130829764|NCT02517398|471003204|FG022|Overall Study|Lost to Follow-up|2|||
130829765|NCT02517398|471003182|FG000|Overall Study|Withdrew Consent|0|||
130829766|NCT02517398|471003183|FG001|Overall Study|Withdrew Consent|0|||
130829767|NCT02517398|471003184|FG002|Overall Study|Withdrew Consent|0|||
130829768|NCT02517398|471003185|FG003|Overall Study|Withdrew Consent|0|||
130829769|NCT02517398|471003186|FG004|Overall Study|Withdrew Consent|0|||
130829770|NCT02517398|471003187|FG005|Overall Study|Withdrew Consent|0|||
130829771|NCT02517398|471003188|FG006|Overall Study|Withdrew Consent|1|||
130829772|NCT02517398|471003189|FG007|Overall Study|Withdrew Consent|0|||
130829773|NCT02517398|471003190|FG008|Overall Study|Withdrew Consent|0|||
130829774|NCT02517398|471003191|FG009|Overall Study|Withdrew Consent|2|||
130829775|NCT02517398|471003192|FG010|Overall Study|Withdrew Consent|7|||
130829776|NCT02517398|471003193|FG011|Overall Study|Withdrew Consent|1|||
130829777|NCT02517398|471003194|FG012|Overall Study|Withdrew Consent|5|||
130829778|NCT02517398|471003195|FG013|Overall Study|Withdrew Consent|4|||
130829779|NCT02517398|471003196|FG014|Overall Study|Withdrew Consent|2|||
130829780|NCT02517398|471003197|FG015|Overall Study|Withdrew Consent|5|||
130829781|NCT02517398|471003198|FG016|Overall Study|Withdrew Consent|4|||
130829782|NCT02517398|471003199|FG017|Overall Study|Withdrew Consent|2|||
130829783|NCT02517398|471003200|FG018|Overall Study|Withdrew Consent|3|||
130829784|NCT02517398|471003201|FG019|Overall Study|Withdrew Consent|2|||
130829785|NCT02517398|471003202|FG020|Overall Study|Withdrew Consent|9|||
130829786|NCT02517398|471003203|FG021|Overall Study|Withdrew Consent|3|||
130829787|NCT02517398|471003204|FG022|Overall Study|Withdrew Consent|1|||
130829788|NCT01016132|471003205|FG000|Overall Study|Discomfort|1|||
130829789|NCT01451749|471003206|FG000|Overall Study|Protocol Violation|14|||
130829790|NCT01451749|471003207|FG001|Overall Study|Protocol Violation|7|||
130829791|NCT01451749|471003206|FG000|Overall Study|Lost to Follow-up|15|||
130829792|NCT01451749|471003207|FG001|Overall Study|Lost to Follow-up|5|||
130829793|NCT01451749|471003206|FG000|Overall Study|Meet the exclusion criteria,and|1|||
130829794|NCT01451749|471003207|FG001|Overall Study|Meet the exclusion criteria,and|1|||
130829795|NCT01451749|471003206|FG000|Overall Study|Adverse Event|2|||
130829796|NCT01451749|471003207|FG001|Overall Study|Adverse Event|0|||
130829797|NCT01451749|471003206|FG000|Overall Study|Withdrawal by Subject|0|||
130829798|NCT01451749|471003207|FG001|Overall Study|Withdrawal by Subject|1|||
130829799|NCT00556439|471003240|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
130829800|NCT00556439|471003241|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
130829801|NCT00556439|471003242|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
130829802|NCT00556439|471003243|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
130829803|NCT00556439|471003240|FG000|Study Entry to Week 12|Physician Decision|1|||
130829804|NCT00556439|471003241|FG001|Study Entry to Week 12|Physician Decision|0|||
130829805|NCT00556439|471003242|FG002|Study Entry to Week 12|Physician Decision|0|||
130829806|NCT00556439|471003243|FG003|Study Entry to Week 12|Physician Decision|0|||
130829807|NCT00556439|471003240|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
130829808|NCT00556439|471003241|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
130829809|NCT00556439|471003242|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
130829810|NCT00556439|471003243|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
130829811|NCT00556439|471003240|FG000|Study Entry to Week 12|Recurrent infection|1|||
130829812|NCT00556439|471003241|FG001|Study Entry to Week 12|Recurrent infection|0|||
130829813|NCT00556439|471003242|FG002|Study Entry to Week 12|Recurrent infection|0|||
130829814|NCT00556439|471003243|FG003|Study Entry to Week 12|Recurrent infection|0|||
130829815|NCT00556439|471003240|FG000|Study Entry to Week 12|Malignancy|0|||
130829816|NCT00556439|471003241|FG001|Study Entry to Week 12|Malignancy|0|||
130829817|NCT00556439|471003242|FG002|Study Entry to Week 12|Malignancy|1|||
130829818|NCT00556439|471003243|FG003|Study Entry to Week 12|Malignancy|0|||
130829819|NCT00556439|471003240|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
130829820|NCT00556439|471003241|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
130829821|NCT00556439|471003242|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
130829822|NCT00556439|471003243|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
130829823|NCT00556439|471003240|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
130829824|NCT00556439|471003241|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
130829825|NCT00556439|471003242|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
130829826|NCT00556439|471003243|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
130829827|NCT00556439|471003240|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
130829828|NCT00556439|471003241|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
130829829|NCT00556439|471003242|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
130829830|NCT00556439|471003243|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
130829831|NCT00556439|471003240|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
130829832|NCT00556439|471003241|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
130829833|NCT00556439|471003242|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
130829834|NCT00556439|471003243|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
130829835|NCT02454530|471003244|FG000|Overall Study|Other|8|||
130829836|NCT02454530|471003245|FG001|Overall Study|Other|13|||
130829837|NCT02454530|471003244|FG000|Overall Study|Missing information|56|||
130829838|NCT02454530|471003245|FG001|Overall Study|Missing information|69|||
130829839|NCT02454530|471003244|FG000|Overall Study|Death|2|||
130829840|NCT02454530|471003245|FG001|Overall Study|Death|41|||
130829841|NCT02454530|471003244|FG000|Overall Study|Lost to Follow-up|4|||
130829842|NCT02454530|471003245|FG001|Overall Study|Lost to Follow-up|4|||
130829843|NCT00500357|471004559|FG000|Overall Study|Death|1|||
130829844|NCT00161616|471004560|FG000|Overall Study|Withdrawal by Subject|6|||
130829845|NCT00161616|471004561|FG001|Overall Study|Withdrawal by Subject|5|||
130829846|NCT00161616|471004560|FG000|Overall Study|Physician Decision|1|||
130829847|NCT00161616|471004561|FG001|Overall Study|Physician Decision|0|||
130829848|NCT00161616|471004560|FG000|Overall Study|Death|1|||
130829849|NCT00161616|471004561|FG001|Overall Study|Death|1|||
130829850|NCT00161616|471004560|FG000|Overall Study|Lost to Follow-up|17|||
130829851|NCT00161616|471004561|FG001|Overall Study|Lost to Follow-up|13|||
130829852|NCT00161616|471004560|FG000|Overall Study|Protocol deviation|1|||
130829853|NCT00161616|471004561|FG001|Overall Study|Protocol deviation|0|||
130829854|NCT00854724|471004562|FG000|First Intervention|Withdrawal by Subject|1|||
130829855|NCT00854724|471004563|FG001|First Intervention|Withdrawal by Subject|1|||
130829856|NCT00854724|471004562|FG000|Washout|Protocol Violation|1|||
130829857|NCT00854724|471004563|FG001|Washout|Protocol Violation|0|||
130829858|NCT00854724|471004562|FG000|Washout|Withdrawal by Subject|0|||
130829859|NCT00854724|471004563|FG001|Washout|Withdrawal by Subject|1|||
130829860|NCT00854724|471004562|FG000|Second Intervention|Protocol Violation|1|||
130829861|NCT00854724|471004563|FG001|Second Intervention|Protocol Violation|0|||
130829862|NCT00854724|471004562|FG000|Second Intervention|Physician Decision|0|||
130829863|NCT00854724|471004563|FG001|Second Intervention|Physician Decision|1|||
130829864|NCT00861757|471004564|FG000|Overall Study|Adverse Event|1|||
130829865|NCT00861757|471004565|FG001|Overall Study|Adverse Event|5|||
130829866|NCT00861757|471004566|FG002|Overall Study|Adverse Event|7|||
130829867|NCT00861757|471004567|FG003|Overall Study|Adverse Event|2|||
130829868|NCT00861757|471004564|FG000|Overall Study|Entry Criteria Not Met|1|||
130829869|NCT00861757|471004565|FG001|Overall Study|Entry Criteria Not Met|2|||
130829870|NCT00861757|471004566|FG002|Overall Study|Entry Criteria Not Met|1|||
130829871|NCT00861757|471004567|FG003|Overall Study|Entry Criteria Not Met|1|||
130829872|NCT00861757|471004564|FG000|Overall Study|Lack of Efficacy|3|||
130829873|NCT00861757|471004565|FG001|Overall Study|Lack of Efficacy|1|||
130829874|NCT00861757|471004566|FG002|Overall Study|Lack of Efficacy|0|||
130829875|NCT00861757|471004567|FG003|Overall Study|Lack of Efficacy|1|||
130829876|NCT00861757|471004564|FG000|Overall Study|Lost to Follow-up|1|||
130829877|NCT00861757|471004565|FG001|Overall Study|Lost to Follow-up|0|||
130829878|NCT00861757|471004566|FG002|Overall Study|Lost to Follow-up|1|||
130829879|NCT00861757|471004567|FG003|Overall Study|Lost to Follow-up|1|||
130829880|NCT00861757|471004564|FG000|Overall Study|Physician Decision|0|||
130829881|NCT00861757|471004565|FG001|Overall Study|Physician Decision|0|||
130829882|NCT00861757|471004566|FG002|Overall Study|Physician Decision|0|||
130829883|NCT00861757|471004567|FG003|Overall Study|Physician Decision|1|||
130829884|NCT00861757|471004564|FG000|Overall Study|Protocol Violation|2|||
130829885|NCT00861757|471004565|FG001|Overall Study|Protocol Violation|2|||
130829886|NCT00861757|471004566|FG002|Overall Study|Protocol Violation|4|||
130829887|NCT00861757|471004567|FG003|Overall Study|Protocol Violation|1|||
130829888|NCT00861757|471004564|FG000|Overall Study|Withdrawal by Subject|1|||
130829889|NCT00861757|471004565|FG001|Overall Study|Withdrawal by Subject|5|||
130829890|NCT00861757|471004566|FG002|Overall Study|Withdrawal by Subject|5|||
130829891|NCT00861757|471004567|FG003|Overall Study|Withdrawal by Subject|2|||
130829892|NCT03308968|471004568|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
130829893|NCT03308968|471004569|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
130829894|NCT03308968|471004570|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
130829895|NCT03308968|471004568|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
130829896|NCT03308968|471004569|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
130829897|NCT03308968|471004570|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
130829898|NCT03308968|471004568|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
130829899|NCT03308968|471004569|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
130829900|NCT03308968|471004570|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
130829901|NCT03308968|471004568|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
130829902|NCT03308968|471004569|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
130829903|NCT03308968|471004570|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
130829904|NCT03308968|471004568|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
130829905|NCT03308968|471004569|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
130829906|NCT03308968|471004570|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
130829907|NCT03308968|471004568|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
130829908|NCT03308968|471004569|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
130829909|NCT03308968|471004570|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
130829910|NCT03308968|471004568|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
130829911|NCT03308968|471004569|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
130829912|NCT03308968|471004570|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
130829913|NCT03308968|471004568|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
130829914|NCT03308968|471004569|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
130829915|NCT03308968|471004570|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
130829916|NCT03308968|471004568|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
130829917|NCT03308968|471004569|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
130829918|NCT03308968|471004570|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
130829919|NCT03308968|471004568|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
130829920|NCT03308968|471004569|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
130829921|NCT03308968|471004570|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
130829922|NCT03308968|471004568|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
130829923|NCT03308968|471004569|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
130829924|NCT03308968|471004570|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
130829925|NCT03308968|471004568|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
130829926|NCT03308968|471004569|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
130829927|NCT03308968|471004570|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
130829928|NCT03308968|471004568|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
130829929|NCT03308968|471004569|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
130829930|NCT03308968|471004570|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
130829931|NCT03308968|471004568|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
130829932|NCT03308968|471004569|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
130829933|NCT03308968|471004570|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
130829934|NCT01961297|471004576|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
130829935|NCT01961297|471004577|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
130829936|NCT02482298|471004578|FG000|Overall Study|Withdrawal by Subject|2|||
130829937|NCT02482298|471004579|FG001|Overall Study|Withdrawal by Subject|1|||
130829938|NCT02482298|471004580|FG002|Overall Study|Withdrawal by Subject|2|||
130829939|NCT02482298|471004578|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
130829940|NCT02482298|471004579|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
130829941|NCT02482298|471004580|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
130829942|NCT02482298|471004578|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
130829943|NCT02482298|471004579|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
130829944|NCT02482298|471004580|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
130829945|NCT02482298|471004578|FG000|Overall Study|Lost to Follow-up|0|||
130829946|NCT02482298|471004579|FG001|Overall Study|Lost to Follow-up|1|||
130829947|NCT02482298|471004580|FG002|Overall Study|Lost to Follow-up|0|||
130829948|NCT02141633|471004581|FG000|Overall Study|Physician Decision|1|||
130829949|NCT02141633|471004582|FG001|Overall Study|Physician Decision|0|||
130829950|NCT02140970|471004592|FG000|Overall Study|Lost to Follow-up|1|||
130829951|NCT02140970|471004593|FG001|Overall Study|Lost to Follow-up|2|||
130829952|NCT02140970|471004592|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
130829953|NCT02140970|471004593|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
130829954|NCT02140970|471004592|FG000|Overall Study|Did not meet inclusion criteria|0|||
130829955|NCT02140970|471004593|FG001|Overall Study|Did not meet inclusion criteria|1|||
130829956|NCT01947283|471004597|FG000|Overall Study|Death|1|||
130829957|NCT01947283|471004598|FG001|Overall Study|Death|1|||
130829958|NCT01947283|471004599|FG002|Overall Study|Death|1|||
130829959|NCT01947283|471004600|FG003|Overall Study|Death|0|||
130829960|NCT01947283|471004601|FG004|Overall Study|Death|0|||
130829961|NCT01947283|471004602|FG005|Overall Study|Death|0|||
130829962|NCT01947283|471004603|FG006|Overall Study|Death|0|||
130829963|NCT01947283|471004597|FG000|Overall Study|Lost to Follow-up|4|||
130829964|NCT01947283|471004598|FG001|Overall Study|Lost to Follow-up|6|||
130829965|NCT01947283|471004599|FG002|Overall Study|Lost to Follow-up|5|||
130829966|NCT01947283|471004600|FG003|Overall Study|Lost to Follow-up|5|||
130829967|NCT01947283|471004601|FG004|Overall Study|Lost to Follow-up|0|||
130829968|NCT01947283|471004602|FG005|Overall Study|Lost to Follow-up|2|||
130829969|NCT01947283|471004603|FG006|Overall Study|Lost to Follow-up|5|||
130829970|NCT01947283|471004597|FG000|Overall Study|Withdrawal by Subject|10|||
130829971|NCT01947283|471004598|FG001|Overall Study|Withdrawal by Subject|8|||
130829972|NCT01947283|471004599|FG002|Overall Study|Withdrawal by Subject|4|||
130829973|NCT01947283|471004600|FG003|Overall Study|Withdrawal by Subject|1|||
130829974|NCT01947283|471004601|FG004|Overall Study|Withdrawal by Subject|0|||
130829975|NCT01947283|471004602|FG005|Overall Study|Withdrawal by Subject|0|||
130829976|NCT01947283|471004603|FG006|Overall Study|Withdrawal by Subject|2|||
130829977|NCT01947283|471004597|FG000|Overall Study|No Clinical Recording|12|||
130829978|NCT01947283|471004598|FG001|Overall Study|No Clinical Recording|6|||
130829979|NCT01947283|471004599|FG002|Overall Study|No Clinical Recording|8|||
130829980|NCT01947283|471004600|FG003|Overall Study|No Clinical Recording|10|||
130829981|NCT01947283|471004601|FG004|Overall Study|No Clinical Recording|0|||
130829982|NCT01947283|471004602|FG005|Overall Study|No Clinical Recording|0|||
130829983|NCT01947283|471004603|FG006|Overall Study|No Clinical Recording|0|||
130829984|NCT01947283|471004597|FG000|Overall Study|Non-coding Clinical Recording language|0|||
130829985|NCT01947283|471004598|FG001|Overall Study|Non-coding Clinical Recording language|0|||
130829986|NCT01947283|471004599|FG002|Overall Study|Non-coding Clinical Recording language|0|||
130829987|NCT01947283|471004600|FG003|Overall Study|Non-coding Clinical Recording language|1|||
130829988|NCT01947283|471004601|FG004|Overall Study|Non-coding Clinical Recording language|0|||
130829989|NCT01947283|471004602|FG005|Overall Study|Non-coding Clinical Recording language|0|||
130829990|NCT01947283|471004603|FG006|Overall Study|Non-coding Clinical Recording language|0|||
130829991|NCT01947283|471004597|FG000|Overall Study|Missing Follow-up Assessment|2|||
130829992|NCT01947283|471004598|FG001|Overall Study|Missing Follow-up Assessment|2|||
130829993|NCT01947283|471004599|FG002|Overall Study|Missing Follow-up Assessment|3|||
130829994|NCT01947283|471004600|FG003|Overall Study|Missing Follow-up Assessment|0|||
130829995|NCT01947283|471004601|FG004|Overall Study|Missing Follow-up Assessment|0|||
130829996|NCT01947283|471004602|FG005|Overall Study|Missing Follow-up Assessment|2|||
130829997|NCT01947283|471004603|FG006|Overall Study|Missing Follow-up Assessment|0|||
130829998|NCT01947283|471004597|FG000|Overall Study|No patients were enrolled in study|0|||
130829999|NCT01947283|471004598|FG001|Overall Study|No patients were enrolled in study|0|||
130830000|NCT01947283|471004599|FG002|Overall Study|No patients were enrolled in study|0|||
130830001|NCT01947283|471004600|FG003|Overall Study|No patients were enrolled in study|0|||
130830002|NCT01947283|471004601|FG004|Overall Study|No patients were enrolled in study|0|||
130830003|NCT01947283|471004602|FG005|Overall Study|No patients were enrolled in study|3|||
130830004|NCT01947283|471004603|FG006|Overall Study|No patients were enrolled in study|1|||
130830005|NCT03782259|471004604|FG000|Overall Study|Lost to Follow-up|1|||
130830006|NCT03782259|471004605|FG001|Overall Study|Lost to Follow-up|1|||
130830007|NCT03782259|471004604|FG000|Overall Study|Moved out of state|0|||
130830008|NCT03782259|471004605|FG001|Overall Study|Moved out of state|2|||
130830009|NCT03782259|471004604|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
130830010|NCT03782259|471004605|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
130830011|NCT03782259|471004604|FG000|Overall Study|Subject discontinued intervention|1|||
130830012|NCT03782259|471004605|FG001|Overall Study|Subject discontinued intervention|0|||
130830013|NCT00603941|471004609|FG000|Overall Study|Disease progression|6|||
130830014|NCT00603941|471004610|FG001|Overall Study|Disease progression|7|||
130830015|NCT00603941|471004611|FG002|Overall Study|Disease progression|1|||
130830016|NCT00603941|471004609|FG000|Overall Study|Adverse Event|1|||
130830017|NCT00603941|471004610|FG001|Overall Study|Adverse Event|0|||
130830018|NCT00603941|471004611|FG002|Overall Study|Adverse Event|1|||
130830019|NCT00603941|471004609|FG000|Overall Study|Physician Decision|0|||
130830020|NCT00603941|471004610|FG001|Overall Study|Physician Decision|1|||
130830021|NCT00603941|471004611|FG002|Overall Study|Physician Decision|0|||
130830022|NCT00603941|471004609|FG000|Overall Study|Withdrawal by Subject|0|||
130830023|NCT00603941|471004610|FG001|Overall Study|Withdrawal by Subject|2|||
130830024|NCT00603941|471004611|FG002|Overall Study|Withdrawal by Subject|0|||
130830025|NCT05069597|471004612|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
130830026|NCT05069597|471004613|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
130830027|NCT02705105|471004614|FG000|Treatment|Objective Disease Progression|1|||
130830028|NCT02705105|471004615|FG001|Treatment|Objective Disease Progression|50|||
130830029|NCT02705105|471004614|FG000|Treatment|Withdrawal by Subject|3|||
130830030|NCT02705105|471004615|FG001|Treatment|Withdrawal by Subject|5|||
130830031|NCT02705105|471004614|FG000|Treatment|Adverse Event|0|||
130830032|NCT02705105|471004615|FG001|Treatment|Adverse Event|17|||
130830033|NCT02705105|471004614|FG000|Treatment|Clinical Disease Progression|0|||
130830034|NCT02705105|471004615|FG001|Treatment|Clinical Disease Progression|32|||
130830035|NCT02705105|471004614|FG000|Treatment|Physician Decision|0|||
130830036|NCT02705105|471004615|FG001|Treatment|Physician Decision|3|||
130830037|NCT02705105|471004614|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
130830038|NCT02705105|471004615|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
130830039|NCT02705105|471004614|FG000|Follow-Up|Death|3|||
130830040|NCT02705105|471004615|FG001|Follow-Up|Death|68|||
130830041|NCT02705105|471004614|FG000|Follow-Up|Withdrawal by Subject|1|||
130830042|NCT02705105|471004615|FG001|Follow-Up|Withdrawal by Subject|14|||
130830043|NCT02705105|471004614|FG000|Follow-Up|Study Terminated|0|||
130830044|NCT02705105|471004615|FG001|Follow-Up|Study Terminated|26|||
130830045|NCT02705105|471004614|FG000|Follow-Up|Discontinued per Amendment 3|0|||
130830046|NCT02705105|471004615|FG001|Follow-Up|Discontinued per Amendment 3|2|||
130830047|NCT01709110|471004618|FG000|Overall Study|Adverse Event|56|||
130830048|NCT01709110|471004619|FG001|Overall Study|Adverse Event|48|||
130830049|NCT01709110|471004618|FG000|Overall Study|Death|14|||
130830050|NCT01709110|471004619|FG001|Overall Study|Death|6|||
130830051|NCT01709110|471004618|FG000|Overall Study|Lost to Follow-up|7|||
130830052|NCT01709110|471004619|FG001|Overall Study|Lost to Follow-up|5|||
130830053|NCT01709110|471004618|FG000|Overall Study|Protocol Violation|4|||
130830054|NCT01709110|471004619|FG001|Overall Study|Protocol Violation|6|||
130830055|NCT01709110|471004618|FG000|Overall Study|Withdrawal by Subject|96|||
130830056|NCT01709110|471004619|FG001|Overall Study|Withdrawal by Subject|89|||
130830057|NCT01709110|471004618|FG000|Overall Study|Physician Decision|4|||
130830058|NCT01709110|471004619|FG001|Overall Study|Physician Decision|10|||
130830059|NCT01709110|471004618|FG000|Overall Study|Sponsor Decision|2|||
130830060|NCT01709110|471004619|FG001|Overall Study|Sponsor Decision|2|||
130830061|NCT01709110|471004618|FG000|Overall Study|Lack of Efficacy|1|||
130830062|NCT01709110|471004619|FG001|Overall Study|Lack of Efficacy|1|||
130830063|NCT01709110|471004618|FG000|Overall Study|Caregiver Decision|1|||
130830064|NCT01709110|471004619|FG001|Overall Study|Caregiver Decision|1|||
130830065|NCT00271856|471004624|FG000|Overall Study|Withdrawal by Subject|1|||
130830066|NCT00271856|471004625|FG001|Overall Study|Withdrawal by Subject|7|||
130830067|NCT00271856|471004624|FG000|Overall Study|Lost to Follow-up|10|||
130830068|NCT00271856|471004625|FG001|Overall Study|Lost to Follow-up|11|||
130830069|NCT03012828|471004626|FG000|Overall Study|Lost to Follow-up|1|||
130830070|NCT03012828|471004627|FG001|Overall Study|Lost to Follow-up|0|||
130830071|NCT03012828|471004628|FG002|Overall Study|Lost to Follow-up|1|||
130830072|NCT03012828|471004629|FG003|Overall Study|Lost to Follow-up|0|||
130830073|NCT03012828|471004630|FG004|Overall Study|Lost to Follow-up|1|||
130830074|NCT03012828|471004631|FG005|Overall Study|Lost to Follow-up|0|||
130830075|NCT03012828|471004626|FG000|Overall Study|Withdrawal by Subject|0|||
130830076|NCT03012828|471004627|FG001|Overall Study|Withdrawal by Subject|0|||
130830077|NCT03012828|471004628|FG002|Overall Study|Withdrawal by Subject|1|||
130830078|NCT03012828|471004629|FG003|Overall Study|Withdrawal by Subject|0|||
130830079|NCT03012828|471004630|FG004|Overall Study|Withdrawal by Subject|0|||
130830080|NCT03012828|471004631|FG005|Overall Study|Withdrawal by Subject|1|||
130830081|NCT03012828|471004626|FG000|Overall Study|Non-compliance with protocol|0|||
130830082|NCT03012828|471004627|FG001|Overall Study|Non-compliance with protocol|0|||
130830083|NCT03012828|471004628|FG002|Overall Study|Non-compliance with protocol|0|||
130830084|NCT03012828|471004629|FG003|Overall Study|Non-compliance with protocol|0|||
130830085|NCT03012828|471004630|FG004|Overall Study|Non-compliance with protocol|1|||
130830086|NCT03012828|471004631|FG005|Overall Study|Non-compliance with protocol|0|||
130830087|NCT03012828|471004626|FG000|Overall Study|Delay to last visit would delay DBL|0|||
130830088|NCT03012828|471004627|FG001|Overall Study|Delay to last visit would delay DBL|0|||
130830089|NCT03012828|471004628|FG002|Overall Study|Delay to last visit would delay DBL|0|||
130830090|NCT03012828|471004629|FG003|Overall Study|Delay to last visit would delay DBL|0|||
130830091|NCT03012828|471004630|FG004|Overall Study|Delay to last visit would delay DBL|0|||
130830092|NCT03012828|471004631|FG005|Overall Study|Delay to last visit would delay DBL|1|||
130830093|NCT00763256|471004634|FG000|Overall Study|Didn't return for appointments|7|||
130830094|NCT00763256|471004635|FG001|Overall Study|Didn't return for appointments|10|||
130830095|NCT02544750|471004636|FG000|Overall Study|Physician Decision|3|||
130830096|NCT02544750|471004637|FG001|Overall Study|Physician Decision|1|||
130830097|NCT02544750|471004636|FG000|Overall Study|Other reasons|69|||
130830098|NCT02544750|471004637|FG001|Overall Study|Other reasons|39|||
130830099|NCT02544750|471004636|FG000|Overall Study|Met withdrawal criteria|2|||
130830100|NCT02544750|471004637|FG001|Overall Study|Met withdrawal criteria|2|||
130830101|NCT02544750|471004636|FG000|Overall Study|Transition To Commercial Product|1|||
130830102|NCT02544750|471004637|FG001|Overall Study|Transition To Commercial Product|0|||
130830103|NCT02544750|471004636|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
130830104|NCT02544750|471004637|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
130830105|NCT02544750|471004636|FG000|Overall Study|Adverse Event|8|||
130830106|NCT02544750|471004637|FG001|Overall Study|Adverse Event|10|||
130830107|NCT02544750|471004636|FG000|Overall Study|Withdrawal by Subject|10|||
130830108|NCT02544750|471004637|FG001|Overall Study|Withdrawal by Subject|4|||
130830109|NCT02544750|471004636|FG000|Overall Study|Lost to Follow-up|1|||
130830110|NCT02544750|471004637|FG001|Overall Study|Lost to Follow-up|0|||
130830111|NCT04396795|471004640|FG000|Month 1|Lost to Follow-up|2|||
130830112|NCT04396795|471004641|FG001|Month 1|Lost to Follow-up|3|||
130830113|NCT04396795|471004640|FG000|Month 3|Lost to Follow-up|1|||
130830114|NCT04396795|471004641|FG001|Month 3|Lost to Follow-up|3|||
130830115|NCT04396795|471004640|FG000|Month 6|Lost to Follow-up|3|||
130830116|NCT04396795|471004641|FG001|Month 6|Lost to Follow-up|3|||
130830117|NCT02366923|471004642|FG000|Overall Study|Withdrawal by Subject|1|||
130830118|NCT02366923|471004642|FG000|Overall Study|Positive Slit Lamp Findings|2|||
130830119|NCT02366923|471004642|FG000|Overall Study|High Astigmatism|3|||
130830120|NCT02623205|471004647|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
130830121|NCT02623205|471004648|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
130830122|NCT01916824|471004653|FG000|Overall Study|Lost to Follow-up|3|||
130830123|NCT01916824|471004654|FG001|Overall Study|Lost to Follow-up|6|||
130830124|NCT01916824|471004653|FG000|Overall Study|Physician Decision|2|||
130830125|NCT01916824|471004654|FG001|Overall Study|Physician Decision|0|||
130830126|NCT01916824|471004653|FG000|Overall Study|Withdrawal by Subject|2|||
130830127|NCT01916824|471004654|FG001|Overall Study|Withdrawal by Subject|3|||
130830128|NCT00771927|471004655|FG000|Overall Study|Adverse Event|100|||
130830129|NCT00771927|471004656|FG001|Overall Study|Adverse Event|105|||
130830130|NCT00771927|471004655|FG000|Overall Study|Lack of Efficacy|70|||
130830131|NCT00771927|471004656|FG001|Overall Study|Lack of Efficacy|42|||
130830132|NCT00771927|471004655|FG000|Overall Study|Lost to Follow-up|46|||
130830133|NCT00771927|471004656|FG001|Overall Study|Lost to Follow-up|46|||
130830134|NCT00771927|471004655|FG000|Overall Study|Withdrawal by Subject|16|||
130830135|NCT00771927|471004656|FG001|Overall Study|Withdrawal by Subject|17|||
130830136|NCT00771927|471004655|FG000|Overall Study|Other reason|23|||
130830137|NCT00771927|471004656|FG001|Overall Study|Other reason|27|||
130830138|NCT03711370|471004657|FG000|Overall Study|Lost to Follow-up|16|||
130830139|NCT03711370|471004658|FG001|Overall Study|Lost to Follow-up|10|||
130830140|NCT03711370|471004657|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
130830141|NCT03711370|471004658|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
130830142|NCT02063984|471004659|FG000|Overall Study|Lost to Follow-up|6|||
130830143|NCT02063984|471004660|FG001|Overall Study|Lost to Follow-up|5|||
130830144|NCT02455336|471004661|FG000|Overall Study|Withdrawal by Subject|0|||
130830145|NCT02455336|471004662|FG001|Overall Study|Withdrawal by Subject|2|||
130830146|NCT02455336|471004661|FG000|Overall Study|Adverse Event|3|||
130830147|NCT02455336|471004662|FG001|Overall Study|Adverse Event|0|||
130830148|NCT02455336|471004661|FG000|Overall Study|Non-responder to treatment|2|||
130830149|NCT02455336|471004662|FG001|Overall Study|Non-responder to treatment|0|||
130830150|NCT00391430|471004663|FG000|Overall Study|Withdrawal by Subject|3|||
130830151|NCT00391430|471004664|FG001|Overall Study|Withdrawal by Subject|0|||
130830152|NCT00391430|471004665|FG002|Overall Study|Withdrawal by Subject|12|||
130830153|NCT02467192|471004666|FG000|Overall Study|Death|1|||
130830154|NCT02467192|471004666|FG000|Overall Study|revealed to have pneumonia before|2|||
130830155|NCT03146663|471004670|FG000|Overall Study|Did not receive study treatment|1|||
130830156|NCT03146663|471004671|FG001|Overall Study|Did not receive study treatment|1|||
130830157|NCT03089047|471004672|FG000|Overall Study|Lost to Follow-up|1|||
130830158|NCT03089047|471004673|FG001|Overall Study|Lost to Follow-up|0|||
130830159|NCT03599518|471004674|FG000|Overall Study|Clinical progression|0|||
130830160|NCT03599518|471004675|FG001|Overall Study|Clinical progression|0|||
130830161|NCT03599518|471004676|FG002|Overall Study|Clinical progression|0|||
130830162|NCT03599518|471004677|FG003|Overall Study|Clinical progression|0|||
130830163|NCT03599518|471004678|FG004|Overall Study|Clinical progression|1|||
130830164|NCT03599518|471004674|FG000|Overall Study|Adverse Event|0|||
130830165|NCT03599518|471004675|FG001|Overall Study|Adverse Event|0|||
130830166|NCT03599518|471004676|FG002|Overall Study|Adverse Event|0|||
130830167|NCT03599518|471004677|FG003|Overall Study|Adverse Event|0|||
130830168|NCT03599518|471004678|FG004|Overall Study|Adverse Event|1|||
130830169|NCT03599518|471004674|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
130830170|NCT03599518|471004675|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
130830171|NCT03599518|471004676|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
130830172|NCT03599518|471004677|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
130830173|NCT03599518|471004678|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
130830174|NCT03599518|471004674|FG000|Overall Study|Participant withdrawal from study treatment|0|||
130830175|NCT03599518|471004675|FG001|Overall Study|Participant withdrawal from study treatment|0|||
130830176|NCT03599518|471004676|FG002|Overall Study|Participant withdrawal from study treatment|1|||
130830177|NCT03599518|471004677|FG003|Overall Study|Participant withdrawal from study treatment|0|||
130830178|NCT03599518|471004678|FG004|Overall Study|Participant withdrawal from study treatment|0|||
130830179|NCT00005947|471004684|FG000|Overall Study|Death|54|||
130830180|NCT00005947|471004685|FG001|Overall Study|Death|40|||
130830181|NCT00005947|471004684|FG000|Overall Study|Patient Refused to Continue|2|||
130830182|NCT00005947|471004685|FG001|Overall Study|Patient Refused to Continue|1|||
130830183|NCT00005947|471004684|FG000|Overall Study|Site Closure|1|||
130830184|NCT00005947|471004685|FG001|Overall Study|Site Closure|0|||
130830185|NCT00429182|471004686|FG000|Overall Study|Not evaluable, Disease Progression|2|||
130830186|NCT00429182|471004686|FG000|Overall Study|Not eligible|5|||
130830187|NCT00790582|471004688|FG000|Overall Study|Death|14|||
130830188|NCT00790582|471004689|FG001|Overall Study|Death|32|||
130830189|NCT00790582|471004688|FG000|Overall Study|Physician Decision|7|||
130830190|NCT00790582|471004689|FG001|Overall Study|Physician Decision|1|||
130830191|NCT00790582|471004688|FG000|Overall Study|Lost to Follow-up|3|||
130830192|NCT00790582|471004689|FG001|Overall Study|Lost to Follow-up|3|||
130830193|NCT00790582|471004688|FG000|Overall Study|Withdrawal by Subject|7|||
130830194|NCT00790582|471004689|FG001|Overall Study|Withdrawal by Subject|51|||
130830195|NCT02195700|471004691|FG000|Overall Study|Protocol Violation|0|||
130830196|NCT02195700|471004692|FG001|Overall Study|Protocol Violation|2|||
130830197|NCT02195700|471004691|FG000|Overall Study|Noncompliance|1|||
130830198|NCT02195700|471004692|FG001|Overall Study|Noncompliance|0|||
130830199|NCT02195700|471004691|FG000|Overall Study|Adverse Event|1|||
130830200|NCT02195700|471004692|FG001|Overall Study|Adverse Event|2|||
130830201|NCT02195700|471004691|FG000|Overall Study|Withdrawal by Subject|3|||
130830202|NCT02195700|471004692|FG001|Overall Study|Withdrawal by Subject|2|||
130830203|NCT02195700|471004691|FG000|Overall Study|Lost to Follow-up|1|||
130830204|NCT02195700|471004692|FG001|Overall Study|Lost to Follow-up|1|||
130830205|NCT02931838|471004693|FG000|Overall Study|Reason not provided by investigator|1|||
130830206|NCT02931838|471004694|FG001|Overall Study|Reason not provided by investigator|0|||
130830207|NCT02931838|471004695|FG002|Overall Study|Reason not provided by investigator|1|||
130830208|NCT02931838|471004696|FG003|Overall Study|Reason not provided by investigator|0|||
130830209|NCT02931838|471004697|FG004|Overall Study|Reason not provided by investigator|0|||
130830210|NCT02931838|471004698|FG005|Overall Study|Reason not provided by investigator|0|||
130830211|NCT02931838|471004693|FG000|Overall Study|Poor/non-compliance|0|||
130830212|NCT02931838|471004694|FG001|Overall Study|Poor/non-compliance|0|||
130830213|NCT02931838|471004695|FG002|Overall Study|Poor/non-compliance|1|||
130830214|NCT02931838|471004696|FG003|Overall Study|Poor/non-compliance|0|||
130830215|NCT02931838|471004697|FG004|Overall Study|Poor/non-compliance|0|||
130830216|NCT02931838|471004698|FG005|Overall Study|Poor/non-compliance|0|||
130830217|NCT02931838|471004693|FG000|Overall Study|Lack of Efficacy|5|||
130830218|NCT02931838|471004694|FG001|Overall Study|Lack of Efficacy|4|||
130830219|NCT02931838|471004695|FG002|Overall Study|Lack of Efficacy|0|||
130830220|NCT02931838|471004696|FG003|Overall Study|Lack of Efficacy|0|||
130830221|NCT02931838|471004697|FG004|Overall Study|Lack of Efficacy|0|||
130830222|NCT02931838|471004698|FG005|Overall Study|Lack of Efficacy|1|||
130830223|NCT02931838|471004693|FG000|Overall Study|Lost to Follow-up|1|||
130830224|NCT02931838|471004694|FG001|Overall Study|Lost to Follow-up|0|||
130830225|NCT02931838|471004695|FG002|Overall Study|Lost to Follow-up|1|||
130830226|NCT02931838|471004696|FG003|Overall Study|Lost to Follow-up|1|||
130830227|NCT02931838|471004697|FG004|Overall Study|Lost to Follow-up|2|||
130830228|NCT02931838|471004698|FG005|Overall Study|Lost to Follow-up|0|||
130830229|NCT02931838|471004693|FG000|Overall Study|Subject request to discontinue treatment|4|||
130830230|NCT02931838|471004694|FG001|Overall Study|Subject request to discontinue treatment|3|||
130830231|NCT02931838|471004695|FG002|Overall Study|Subject request to discontinue treatment|3|||
130830232|NCT02931838|471004696|FG003|Overall Study|Subject request to discontinue treatment|0|||
130830233|NCT02931838|471004697|FG004|Overall Study|Subject request to discontinue treatment|1|||
130830234|NCT02931838|471004698|FG005|Overall Study|Subject request to discontinue treatment|0|||
130830235|NCT02931838|471004693|FG000|Overall Study|Withdrawal by Subject|1|||
130830236|NCT02931838|471004694|FG001|Overall Study|Withdrawal by Subject|2|||
130830237|NCT02931838|471004695|FG002|Overall Study|Withdrawal by Subject|0|||
130830238|NCT02931838|471004696|FG003|Overall Study|Withdrawal by Subject|1|||
130830239|NCT02931838|471004697|FG004|Overall Study|Withdrawal by Subject|0|||
130830240|NCT02931838|471004698|FG005|Overall Study|Withdrawal by Subject|0|||
130830241|NCT02931838|471004693|FG000|Overall Study|Adverse Event|2|||
130830242|NCT02931838|471004694|FG001|Overall Study|Adverse Event|1|||
130830243|NCT02931838|471004695|FG002|Overall Study|Adverse Event|2|||
130830244|NCT02931838|471004696|FG003|Overall Study|Adverse Event|1|||
130830245|NCT02931838|471004697|FG004|Overall Study|Adverse Event|3|||
130830246|NCT02931838|471004698|FG005|Overall Study|Adverse Event|1|||
130830247|NCT01027650|471004699|FG000|Overall Study|Personal Reasons|0|||
130830248|NCT01027650|471004700|FG001|Overall Study|Personal Reasons|0|||
130830249|NCT01027650|471004701|FG002|Overall Study|Personal Reasons|0|||
130830250|NCT01027650|471004702|FG003|Overall Study|Personal Reasons|0|||
130830251|NCT01027650|471004703|FG004|Overall Study|Personal Reasons|2|||
130830252|NCT01027650|471004704|FG005|Overall Study|Personal Reasons|1|||
130830253|NCT01027650|471004705|FG006|Overall Study|Personal Reasons|0|||
130830254|NCT01027650|471004706|FG007|Overall Study|Personal Reasons|0|||
130830255|NCT01027650|471004699|FG000|Overall Study|Lost to Follow-up|0|||
130830256|NCT01027650|471004700|FG001|Overall Study|Lost to Follow-up|0|||
130830257|NCT01027650|471004701|FG002|Overall Study|Lost to Follow-up|0|||
130830258|NCT01027650|471004702|FG003|Overall Study|Lost to Follow-up|0|||
130830259|NCT01027650|471004703|FG004|Overall Study|Lost to Follow-up|0|||
130830260|NCT01027650|471004704|FG005|Overall Study|Lost to Follow-up|0|||
130830261|NCT01027650|471004705|FG006|Overall Study|Lost to Follow-up|1|||
130830262|NCT01027650|471004706|FG007|Overall Study|Lost to Follow-up|0|||
130830263|NCT01027650|471004699|FG000|Overall Study|Lack of Efficacy|0|||
130830264|NCT01027650|471004700|FG001|Overall Study|Lack of Efficacy|0|||
130830265|NCT01027650|471004701|FG002|Overall Study|Lack of Efficacy|0|||
130830266|NCT01027650|471004702|FG003|Overall Study|Lack of Efficacy|0|||
130830267|NCT01027650|471004703|FG004|Overall Study|Lack of Efficacy|0|||
130830268|NCT01027650|471004704|FG005|Overall Study|Lack of Efficacy|1|||
130830269|NCT01027650|471004705|FG006|Overall Study|Lack of Efficacy|0|||
130830270|NCT01027650|471004706|FG007|Overall Study|Lack of Efficacy|0|||
130830271|NCT03110029|471004707|FG000|Overall Study|Withdrawal by Subject|1|||
130830272|NCT03110029|471004708|FG001|Overall Study|Withdrawal by Subject|1|||
130830273|NCT01042158|471004709|FG000|Overall Study|Physician Decision|1|||
130830274|NCT00912782|471004713|FG000|Overall Study|Death|2|||
130830275|NCT00912782|471004714|FG001|Overall Study|Death|1|||
130830276|NCT00912782|471004713|FG000|Overall Study|Lost to Follow-up|0|||
130830277|NCT00912782|471004714|FG001|Overall Study|Lost to Follow-up|1|||
130830278|NCT00912782|471004713|FG000|Overall Study|Did not receive vascular access type|1|||
130830279|NCT00912782|471004714|FG001|Overall Study|Did not receive vascular access type|2|||
130830280|NCT00912782|471004713|FG000|Overall Study|Relocated before study completion|0|||
130830281|NCT00912782|471004714|FG001|Overall Study|Relocated before study completion|1|||
130830282|NCT05823974|471007096|FG000|Overall Study|Lost to Follow-up|0|||
130830283|NCT05823974|471007097|FG001|Overall Study|Lost to Follow-up|3|||
130830284|NCT05823974|471007098|FG002|Overall Study|Lost to Follow-up|1|||
130830285|NCT05823974|471007099|FG003|Overall Study|Lost to Follow-up|0|||
130830286|NCT05823974|471007100|FG004|Overall Study|Lost to Follow-up|1|||
130830287|NCT05823974|471007101|FG005|Overall Study|Lost to Follow-up|0|||
130830288|NCT05823974|471007102|FG006|Overall Study|Lost to Follow-up|1|||
130830289|NCT05823974|471007103|FG007|Overall Study|Lost to Follow-up|0|||
130830290|NCT05823974|471007104|FG008|Overall Study|Lost to Follow-up|0|||
130830291|NCT05823974|471007105|FG009|Overall Study|Lost to Follow-up|1|||
130830292|NCT05823974|471007106|FG010|Overall Study|Lost to Follow-up|1|||
130830293|NCT05823974|471007107|FG011|Overall Study|Lost to Follow-up|0|||
130830294|NCT05823974|471007108|FG012|Overall Study|Lost to Follow-up|1|||
130830295|NCT05823974|471007109|FG013|Overall Study|Lost to Follow-up|2|||
130830296|NCT05823974|471007110|FG014|Overall Study|Lost to Follow-up|1|||
130830297|NCT05823974|471007111|FG015|Overall Study|Lost to Follow-up|1|||
130830298|NCT05823974|471007112|FG016|Overall Study|Lost to Follow-up|1|||
130830299|NCT05823974|471007113|FG017|Overall Study|Lost to Follow-up|0|||
130830300|NCT05823974|471007114|FG018|Overall Study|Lost to Follow-up|0|||
130830301|NCT05823974|471007115|FG019|Overall Study|Lost to Follow-up|2|||
130830302|NCT05823974|471007116|FG020|Overall Study|Lost to Follow-up|0|||
130830303|NCT05823974|471007096|FG000|Overall Study|Physician Decision|0|||
130830304|NCT05823974|471007097|FG001|Overall Study|Physician Decision|0|||
130830305|NCT05823974|471007098|FG002|Overall Study|Physician Decision|0|||
130830306|NCT05823974|471007099|FG003|Overall Study|Physician Decision|0|||
130830307|NCT05823974|471007100|FG004|Overall Study|Physician Decision|0|||
130830308|NCT05823974|471007101|FG005|Overall Study|Physician Decision|0|||
130830309|NCT05823974|471007102|FG006|Overall Study|Physician Decision|0|||
130830310|NCT05823974|471007103|FG007|Overall Study|Physician Decision|0|||
130830311|NCT05823974|471007104|FG008|Overall Study|Physician Decision|0|||
130830312|NCT05823974|471007105|FG009|Overall Study|Physician Decision|0|||
130830313|NCT05823974|471007106|FG010|Overall Study|Physician Decision|0|||
130830314|NCT05823974|471007107|FG011|Overall Study|Physician Decision|0|||
130830315|NCT05823974|471007108|FG012|Overall Study|Physician Decision|0|||
130830316|NCT05823974|471007109|FG013|Overall Study|Physician Decision|0|||
130830317|NCT05823974|471007110|FG014|Overall Study|Physician Decision|0|||
130830318|NCT05823974|471007111|FG015|Overall Study|Physician Decision|1|||
130830319|NCT05823974|471007112|FG016|Overall Study|Physician Decision|0|||
130830320|NCT05823974|471007113|FG017|Overall Study|Physician Decision|1|||
130830321|NCT05823974|471007114|FG018|Overall Study|Physician Decision|1|||
130830322|NCT05823974|471007115|FG019|Overall Study|Physician Decision|0|||
130830323|NCT05823974|471007116|FG020|Overall Study|Physician Decision|0|||
130830324|NCT05823974|471007096|FG000|Overall Study|Withdrawal by Subject|1|||
130830325|NCT05823974|471007097|FG001|Overall Study|Withdrawal by Subject|1|||
130830326|NCT05823974|471007098|FG002|Overall Study|Withdrawal by Subject|2|||
130830327|NCT05823974|471007099|FG003|Overall Study|Withdrawal by Subject|0|||
130830328|NCT05823974|471007100|FG004|Overall Study|Withdrawal by Subject|2|||
130830329|NCT05823974|471007101|FG005|Overall Study|Withdrawal by Subject|3|||
130830330|NCT05823974|471007102|FG006|Overall Study|Withdrawal by Subject|1|||
130830331|NCT05823974|471007103|FG007|Overall Study|Withdrawal by Subject|1|||
130830332|NCT05823974|471007104|FG008|Overall Study|Withdrawal by Subject|2|||
130830333|NCT05823974|471007105|FG009|Overall Study|Withdrawal by Subject|1|||
130830334|NCT05823974|471007106|FG010|Overall Study|Withdrawal by Subject|1|||
130830335|NCT05823974|471007107|FG011|Overall Study|Withdrawal by Subject|0|||
130830336|NCT05823974|471007108|FG012|Overall Study|Withdrawal by Subject|0|||
130830337|NCT05823974|471007109|FG013|Overall Study|Withdrawal by Subject|1|||
130830338|NCT05823974|471007110|FG014|Overall Study|Withdrawal by Subject|1|||
130830339|NCT05823974|471007111|FG015|Overall Study|Withdrawal by Subject|3|||
130830340|NCT05823974|471007112|FG016|Overall Study|Withdrawal by Subject|0|||
130830341|NCT05823974|471007113|FG017|Overall Study|Withdrawal by Subject|2|||
130830342|NCT05823974|471007114|FG018|Overall Study|Withdrawal by Subject|2|||
130830343|NCT05823974|471007115|FG019|Overall Study|Withdrawal by Subject|0|||
130830344|NCT05823974|471007116|FG020|Overall Study|Withdrawal by Subject|1|||
130830345|NCT05823974|471007096|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830346|NCT05823974|471007097|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830347|NCT05823974|471007098|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130830348|NCT05823974|471007099|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830349|NCT05823974|471007100|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830350|NCT05823974|471007101|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830351|NCT05823974|471007102|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830352|NCT05823974|471007103|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830353|NCT05823974|471007104|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830354|NCT05823974|471007105|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830355|NCT05823974|471007106|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830356|NCT05823974|471007107|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830357|NCT05823974|471007108|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830358|NCT05823974|471007109|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830359|NCT05823974|471007110|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130830360|NCT05823974|471007111|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830361|NCT05823974|471007112|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830362|NCT05823974|471007113|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830363|NCT05823974|471007114|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830364|NCT05823974|471007115|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830365|NCT05823974|471007116|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130830366|NCT05823974|471007096|FG000|Overall Study|Other|0|||
130830367|NCT05823974|471007097|FG001|Overall Study|Other|1|||
130830368|NCT05823974|471007098|FG002|Overall Study|Other|1|||
130830369|NCT05823974|471007099|FG003|Overall Study|Other|1|||
130830370|NCT05823974|471007100|FG004|Overall Study|Other|0|||
130830371|NCT05823974|471007101|FG005|Overall Study|Other|1|||
130830372|NCT05823974|471007102|FG006|Overall Study|Other|1|||
130830373|NCT05823974|471007103|FG007|Overall Study|Other|1|||
130830374|NCT05823974|471007104|FG008|Overall Study|Other|1|||
130830375|NCT05823974|471007105|FG009|Overall Study|Other|0|||
130830376|NCT05823974|471007106|FG010|Overall Study|Other|0|||
130830377|NCT05823974|471007107|FG011|Overall Study|Other|0|||
130830378|NCT05823974|471007108|FG012|Overall Study|Other|2|||
130830379|NCT05823974|471007109|FG013|Overall Study|Other|1|||
130830380|NCT05823974|471007110|FG014|Overall Study|Other|0|||
130830381|NCT05823974|471007111|FG015|Overall Study|Other|1|||
130830382|NCT05823974|471007112|FG016|Overall Study|Other|0|||
130830383|NCT05823974|471007113|FG017|Overall Study|Other|0|||
130830384|NCT05823974|471007114|FG018|Overall Study|Other|0|||
130830385|NCT05823974|471007115|FG019|Overall Study|Other|0|||
130830386|NCT05823974|471007116|FG020|Overall Study|Other|0|||
130830387|NCT00316706|471007117|FG000|Overall Study|Lost to Follow-up|38|||
130830388|NCT00316706|471007118|FG001|Overall Study|Lost to Follow-up|48|||
130830389|NCT02220855|471007119|FG000|Overall Study|Adverse Event|8|||
130830390|NCT02220855|471007119|FG000|Overall Study|Disease Progression|5|||
130830391|NCT02220855|471007119|FG000|Overall Study|Withdrawal by Subject|1|||
130830392|NCT03280303|471007120|FG000|Overall Study|Death|505|||
130830393|NCT03280303|471007120|FG000|Overall Study|Study terminated by sponsor|383|||
130830394|NCT03280303|471007120|FG000|Overall Study|Other|148|||
130830395|NCT03280303|471007120|FG000|Overall Study|No longer willing to participate in study|101|||
130830396|NCT03280303|471007120|FG000|Overall Study|Lost to follow up|39|||
130830397|NCT03280303|471007120|FG000|Overall Study|Adverse Event|20|||
130830398|NCT03419897|471007121|FG000|Overall Study|Death|180|||
130830399|NCT03419897|471007121|FG000|Overall Study|Lost to Follow-up|1|||
130830400|NCT03419897|471007121|FG000|Overall Study|Withdrawal by Subject|6|||
130830401|NCT03419897|471007121|FG000|Overall Study|Sponsor Decision|61|||
130830402|NCT03419897|471007121|FG000|Overall Study|Physician Decision|1|||
130830403|NCT02222688|471007134|FG000|Overall Study|Withdrawal by Subject|0|||
130830404|NCT02222688|471007135|FG001|Overall Study|Withdrawal by Subject|0|||
130830405|NCT02222688|471007136|FG002|Overall Study|Withdrawal by Subject|0|||
130830406|NCT02222688|471007137|FG003|Overall Study|Withdrawal by Subject|2|||
130830407|NCT02222688|471007138|FG004|Overall Study|Withdrawal by Subject|1|||
130830408|NCT02222688|471007139|FG005|Overall Study|Withdrawal by Subject|0|||
130830409|NCT02222688|471007140|FG006|Overall Study|Withdrawal by Subject|1|||
130830410|NCT02222688|471007134|FG000|Overall Study|Disease progression|1|||
130830411|NCT02222688|471007135|FG001|Overall Study|Disease progression|0|||
130830412|NCT02222688|471007136|FG002|Overall Study|Disease progression|0|||
130830413|NCT02222688|471007137|FG003|Overall Study|Disease progression|0|||
130830414|NCT02222688|471007138|FG004|Overall Study|Disease progression|0|||
130830415|NCT02222688|471007139|FG005|Overall Study|Disease progression|0|||
130830416|NCT02222688|471007140|FG006|Overall Study|Disease progression|0|||
130830417|NCT00294671|471007149|FG000|Overall Study|Lack of Efficacy|11|||
130830418|NCT00294671|471007150|FG001|Overall Study|Lack of Efficacy|23|||
130830419|NCT00294671|471007149|FG000|Overall Study|Liver transplant|7|||
130830420|NCT00294671|471007150|FG001|Overall Study|Liver transplant|9|||
130830421|NCT00294671|471007149|FG000|Overall Study|Drug related adverse event (AE)|4|||
130830422|NCT00294671|471007150|FG001|Overall Study|Drug related adverse event (AE)|2|||
130830423|NCT00294671|471007149|FG000|Overall Study|Non-drug related AE|3|||
130830424|NCT00294671|471007150|FG001|Overall Study|Non-drug related AE|2|||
130830425|NCT00294671|471007149|FG000|Overall Study|Lost to Follow-up|1|||
130830426|NCT00294671|471007150|FG001|Overall Study|Lost to Follow-up|3|||
130830427|NCT00294671|471007149|FG000|Overall Study|Non-compliance|1|||
130830428|NCT00294671|471007150|FG001|Overall Study|Non-compliance|0|||
130830429|NCT00294671|471007149|FG000|Overall Study|Death|0|||
130830430|NCT00294671|471007150|FG001|Overall Study|Death|1|||
130830431|NCT00958360|471007160|FG000|Overall Study|Withdrawal by Subject|3|||
130830432|NCT00958360|471007161|FG001|Overall Study|Withdrawal by Subject|1|||
130830433|NCT00958360|471007160|FG000|Overall Study|Death|6|||
130830434|NCT00958360|471007161|FG001|Overall Study|Death|7|||
130830435|NCT00958360|471007160|FG000|Overall Study|Physician Decision|2|||
130830436|NCT00958360|471007161|FG001|Overall Study|Physician Decision|1|||
130830437|NCT00958360|471007160|FG000|Overall Study|Lost to Follow-up|0|||
130830438|NCT00958360|471007161|FG001|Overall Study|Lost to Follow-up|1|||
130830439|NCT03107052|471007162|FG000|Overall Study|Adverse Event|6|||
130830440|NCT03107052|471007163|FG001|Overall Study|Adverse Event|1|||
130830441|NCT03107052|471007164|FG002|Overall Study|Adverse Event|2|||
130830442|NCT03107052|471007162|FG000|Overall Study|Withdrawal by Subject|9|||
130830443|NCT03107052|471007163|FG001|Overall Study|Withdrawal by Subject|5|||
130830444|NCT03107052|471007164|FG002|Overall Study|Withdrawal by Subject|8|||
130830445|NCT03107052|471007162|FG000|Overall Study|Protocol Violation|6|||
130830446|NCT03107052|471007163|FG001|Overall Study|Protocol Violation|0|||
130830447|NCT03107052|471007164|FG002|Overall Study|Protocol Violation|3|||
130830448|NCT03107052|471007162|FG000|Overall Study|Lost to Follow-up|4|||
130830449|NCT03107052|471007163|FG001|Overall Study|Lost to Follow-up|0|||
130830450|NCT03107052|471007164|FG002|Overall Study|Lost to Follow-up|1|||
130830451|NCT03107052|471007162|FG000|Overall Study|Lack of Efficacy|23|||
130830452|NCT03107052|471007163|FG001|Overall Study|Lack of Efficacy|7|||
130830453|NCT03107052|471007164|FG002|Overall Study|Lack of Efficacy|4|||
130830454|NCT03107052|471007162|FG000|Overall Study|Other than specified|4|||
130830455|NCT03107052|471007163|FG001|Overall Study|Other than specified|2|||
130830456|NCT03107052|471007164|FG002|Overall Study|Other than specified|0|||
130830457|NCT03107052|471007162|FG000|Overall Study|Study terminated due to futility|67|||
130830458|NCT03107052|471007163|FG001|Overall Study|Study terminated due to futility|31|||
130830459|NCT03107052|471007164|FG002|Overall Study|Study terminated due to futility|23|||
130830460|NCT02263326|471007165|FG000|Overall Study|Lost to Follow-up|1|||
130830461|NCT02263326|471007166|FG001|Overall Study|Lost to Follow-up|1|||
130830462|NCT01893411|471007167|FG000|Overall Study|Protocol Violation|1|||
130830463|NCT01893411|471007168|FG001|Overall Study|Protocol Violation|0|||
130830464|NCT01893411|471007169|FG002|Overall Study|Protocol Violation|0|||
130830465|NCT01893411|471007167|FG000|Overall Study|Physician Decision|1|||
130830466|NCT01893411|471007168|FG001|Overall Study|Physician Decision|1|||
130830467|NCT01893411|471007169|FG002|Overall Study|Physician Decision|2|||
130830468|NCT01893411|471007167|FG000|Overall Study|Lack of Efficacy|2|||
130830469|NCT01893411|471007168|FG001|Overall Study|Lack of Efficacy|1|||
130830470|NCT01893411|471007169|FG002|Overall Study|Lack of Efficacy|0|||
130830471|NCT01893411|471007167|FG000|Overall Study|Other|3|||
130830472|NCT01893411|471007168|FG001|Overall Study|Other|1|||
130830473|NCT01893411|471007169|FG002|Overall Study|Other|3|||
130830474|NCT01893411|471007167|FG000|Overall Study|Adverse Event|1|||
130830475|NCT01893411|471007168|FG001|Overall Study|Adverse Event|0|||
130830476|NCT01893411|471007169|FG002|Overall Study|Adverse Event|0|||
130830477|NCT01893411|471007167|FG000|Overall Study|Withdrawal by Subject|7|||
130830478|NCT01893411|471007168|FG001|Overall Study|Withdrawal by Subject|4|||
130830479|NCT01893411|471007169|FG002|Overall Study|Withdrawal by Subject|3|||
130830480|NCT01893411|471007167|FG000|Overall Study|Lost to Follow-up|2|||
130830481|NCT01893411|471007168|FG001|Overall Study|Lost to Follow-up|0|||
130830482|NCT01893411|471007169|FG002|Overall Study|Lost to Follow-up|1|||
130830483|NCT02397915|471007170|FG000|Period 1|Protocol Violation|0|||
130830484|NCT02397915|471007171|FG001|Period 1|Protocol Violation|1|||
130830485|NCT02397915|471007172|FG002|Period 1|Protocol Violation|0|||
130830486|NCT02397915|471007173|FG003|Period 1|Protocol Violation|0|||
130830487|NCT02397915|471007170|FG000|Period 1|Physician Decision|1|||
130830488|NCT02397915|471007171|FG001|Period 1|Physician Decision|0|||
130830489|NCT02397915|471007172|FG002|Period 1|Physician Decision|0|||
130830490|NCT02397915|471007173|FG003|Period 1|Physician Decision|0|||
130830491|NCT03292874|471007174|FG000|Overall Study|Due to pandemic|5|||
130830492|NCT00933608|471007176|FG000|Overall Study|Adverse Event|4|||
130830493|NCT00933608|471007177|FG001|Overall Study|Adverse Event|2|||
130830494|NCT00933608|471007176|FG000|Overall Study|Physician Decision|1|||
130830495|NCT00933608|471007177|FG001|Overall Study|Physician Decision|0|||
130830496|NCT02719691|471007178|FG000|Overall Study|Physician Decision|0|||
130830497|NCT02719691|471007179|FG001|Overall Study|Physician Decision|0|||
130830498|NCT02719691|471007180|FG002|Overall Study|Physician Decision|1|||
130830499|NCT02719691|471007181|FG003|Overall Study|Physician Decision|0|||
130830500|NCT02719691|471007182|FG004|Overall Study|Physician Decision|0|||
130830501|NCT02719691|471007183|FG005|Overall Study|Physician Decision|0|||
130830502|NCT02719691|471007184|FG006|Overall Study|Physician Decision|0|||
130830503|NCT02719691|471007178|FG000|Overall Study|Withdrawal by Subject|0|||
130830504|NCT02719691|471007179|FG001|Overall Study|Withdrawal by Subject|0|||
130830505|NCT02719691|471007180|FG002|Overall Study|Withdrawal by Subject|0|||
130830506|NCT02719691|471007181|FG003|Overall Study|Withdrawal by Subject|0|||
130830507|NCT02719691|471007182|FG004|Overall Study|Withdrawal by Subject|0|||
130830508|NCT02719691|471007183|FG005|Overall Study|Withdrawal by Subject|1|||
130830509|NCT02719691|471007184|FG006|Overall Study|Withdrawal by Subject|0|||
130830510|NCT00336284|471007185|FG000|Overall Study|Death|52|||
130830511|NCT00336284|471007186|FG001|Overall Study|Death|26|||
130830512|NCT00336284|471007185|FG000|Overall Study|Lost to Follow-up|82|||
130830513|NCT00336284|471007186|FG001|Overall Study|Lost to Follow-up|61|||
130830514|NCT00336284|471007185|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
130830515|NCT00336284|471007186|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
130830516|NCT03053440|471007193|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
130830517|NCT03053440|471007194|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
130830518|NCT03053440|471007193|FG000|Overall Study|Death|18|||
130830519|NCT03053440|471007194|FG001|Overall Study|Death|14|||
130830520|NCT03053440|471007193|FG000|Overall Study|Withdrawal by Subject|9|||
130830521|NCT03053440|471007194|FG001|Overall Study|Withdrawal by Subject|8|||
130830522|NCT03053440|471007193|FG000|Overall Study|Lost to Follow-up|1|||
130830523|NCT03053440|471007194|FG001|Overall Study|Lost to Follow-up|0|||
130830524|NCT03053440|471007193|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
130830525|NCT03053440|471007194|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
130830526|NCT03053440|471007193|FG000|Overall Study|Physician Decision|2|||
130830527|NCT03053440|471007194|FG001|Overall Study|Physician Decision|1|||
130830528|NCT03053440|471007193|FG000|Overall Study|Participant Randomized but died before dosing|1|||
130830529|NCT03053440|471007194|FG001|Overall Study|Participant Randomized but died before dosing|0|||
130830530|NCT01188551|471007195|FG000|Overall Study|Pharmacy issues|1|||
130830531|NCT01188551|471007196|FG001|Overall Study|Pharmacy issues|0|||
130830532|NCT01188551|471007197|FG002|Overall Study|Pharmacy issues|0|||
130830533|NCT01188551|471007198|FG003|Overall Study|Pharmacy issues|0|||
130830534|NCT00391053|471007199|FG000|Overall Study|Serious Adverse Events|1|||
130830535|NCT00391053|471007200|FG001|Overall Study|Serious Adverse Events|0|||
130830536|NCT00391053|471007201|FG002|Overall Study|Serious Adverse Events|1|||
130830537|NCT00391053|471007202|FG003|Overall Study|Serious Adverse Events|4|||
130830538|NCT00391053|471007199|FG000|Overall Study|Protocol Violation|2|||
130830539|NCT00391053|471007200|FG001|Overall Study|Protocol Violation|0|||
130830540|NCT00391053|471007201|FG002|Overall Study|Protocol Violation|0|||
130830541|NCT00391053|471007202|FG003|Overall Study|Protocol Violation|0|||
130830542|NCT00391053|471007199|FG000|Overall Study|Lost to Follow-up|1|||
130830543|NCT00391053|471007200|FG001|Overall Study|Lost to Follow-up|0|||
130830544|NCT00391053|471007201|FG002|Overall Study|Lost to Follow-up|0|||
130830545|NCT00391053|471007202|FG003|Overall Study|Lost to Follow-up|5|||
130830546|NCT00391053|471007199|FG000|Overall Study|Withdrawal by Subject|5|||
130830547|NCT00391053|471007200|FG001|Overall Study|Withdrawal by Subject|1|||
130830548|NCT00391053|471007201|FG002|Overall Study|Withdrawal by Subject|1|||
130830549|NCT00391053|471007202|FG003|Overall Study|Withdrawal by Subject|1|||
130830550|NCT05002985|471007203|FG000|Overall Study|Withdrawal by Subject|1|||
130830551|NCT02943070|471007204|FG000|Overall Study|Physician Decision|1|||
130830552|NCT02943070|471007204|FG000|Overall Study|Adverse Event|2|||
130830553|NCT02943070|471007204|FG000|Overall Study|Death|2|||
130830554|NCT02943070|471007204|FG000|Overall Study|Withdrawal by Subject|3|||
130830555|NCT02943070|471007204|FG000|Overall Study|Lost to Follow-up|4|||
130830556|NCT02943070|471007204|FG000|Overall Study|Retreatment or TURP|13|||
130830557|NCT02943070|471007204|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
130830558|NCT04123093|471007205|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
130830559|NCT04123093|471007206|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
130830560|NCT04123093|471007205|FG000|Phase 2|Physician Decision|0|||
130830561|NCT04123093|471007206|FG001|Phase 2|Physician Decision|1|||
130830562|NCT04123093|471007205|FG000|Phase 2|Withdrawal by Subject|0|||
130830563|NCT04123093|471007206|FG001|Phase 2|Withdrawal by Subject|1|||
130830564|NCT01485796|471007208|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
130830565|NCT01485796|471007208|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
130830566|NCT01485796|471007208|FG000|Period 2: Epoch 2|Adverse Event|3|||
130830567|NCT01485796|471007208|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
130830568|NCT01485796|471007208|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
130830569|NCT01485796|471007208|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
130830570|NCT01485796|471007208|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
130830571|NCT01485796|471007208|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
130830572|NCT02526212|471007218|FG000|Overall Study|Incarceration|1|||
130830573|NCT02526212|471007219|FG001|Overall Study|Incarceration|0|||
130830574|NCT02526212|471007218|FG000|Overall Study|Lost to Follow-up|1|||
130830575|NCT02526212|471007219|FG001|Overall Study|Lost to Follow-up|0|||
130830576|NCT02526212|471007218|FG000|Overall Study|Death|0|||
130830577|NCT02526212|471007219|FG001|Overall Study|Death|1|||
130830578|NCT00606411|471007220|FG000|Overall Study|Adverse Event|1|||
130830579|NCT00606411|471007221|FG001|Overall Study|Adverse Event|2|||
130830580|NCT00606411|471007220|FG000|Overall Study|Lack of Adherence|1|||
130830581|NCT00606411|471007221|FG001|Overall Study|Lack of Adherence|1|||
130830582|NCT00606411|471007220|FG000|Overall Study|Lack of Efficacy|1|||
130830583|NCT00606411|471007221|FG001|Overall Study|Lack of Efficacy|1|||
130830584|NCT00606411|471007220|FG000|Overall Study|Withdrawal by Subject|2|||
130830585|NCT00606411|471007221|FG001|Overall Study|Withdrawal by Subject|0|||
130830586|NCT00606411|471007220|FG000|Overall Study|Lost to Follow-up|1|||
130830587|NCT00606411|471007221|FG001|Overall Study|Lost to Follow-up|2|||
130830588|NCT00606411|471007220|FG000|Overall Study|Move out of state|0|||
130830589|NCT00606411|471007221|FG001|Overall Study|Move out of state|1|||
130830590|NCT01390298|471007222|FG000|Overall Study|Death|1|||
130830591|NCT01390298|471007222|FG000|Overall Study|long term ICU admission|1|||
130830592|NCT01390298|471007222|FG000|Overall Study|Withdrawal by Subject|14|||
130830593|NCT01390298|471007222|FG000|Overall Study|Lost to Follow-up|7|||
130830594|NCT01390298|471007222|FG000|Overall Study|Surgery cancelled|1|||
130830595|NCT00040742|471007229|FG000|Overall Study|Death|0|||
130830596|NCT00040742|471007230|FG001|Overall Study|Death|0|||
130830597|NCT00040742|471007231|FG002|Overall Study|Death|1|||
130830598|NCT00040742|471007232|FG003|Overall Study|Death|0|||
130830599|NCT00040742|471007229|FG000|Overall Study|Adverse Event|15|||
130830600|NCT00040742|471007230|FG001|Overall Study|Adverse Event|16|||
130830601|NCT00040742|471007231|FG002|Overall Study|Adverse Event|21|||
130830602|NCT00040742|471007232|FG003|Overall Study|Adverse Event|9|||
130830603|NCT00040742|471007229|FG000|Overall Study|Withdrawal by Subject|7|||
130830604|NCT00040742|471007230|FG001|Overall Study|Withdrawal by Subject|15|||
130830605|NCT00040742|471007231|FG002|Overall Study|Withdrawal by Subject|10|||
130830606|NCT00040742|471007232|FG003|Overall Study|Withdrawal by Subject|13|||
130830607|NCT00040742|471007229|FG000|Overall Study|Chemotoxicity|4|||
130830608|NCT00040742|471007230|FG001|Overall Study|Chemotoxicity|3|||
130830609|NCT00040742|471007231|FG002|Overall Study|Chemotoxicity|5|||
130830610|NCT00040742|471007232|FG003|Overall Study|Chemotoxicity|2|||
130830611|NCT00040742|471007229|FG000|Overall Study|Incomplete Forms|6|||
130830612|NCT00040742|471007230|FG001|Overall Study|Incomplete Forms|10|||
130830613|NCT00040742|471007231|FG002|Overall Study|Incomplete Forms|4|||
130830614|NCT00040742|471007232|FG003|Overall Study|Incomplete Forms|5|||
130830615|NCT00040742|471007229|FG000|Overall Study|Other medical|7|||
130830616|NCT00040742|471007230|FG001|Overall Study|Other medical|5|||
130830617|NCT00040742|471007231|FG002|Overall Study|Other medical|5|||
130830618|NCT00040742|471007232|FG003|Overall Study|Other medical|5|||
130830619|NCT03520920|471007235|FG000|Overall Study|Death|13|||
130830620|NCT03520920|471007236|FG001|Overall Study|Death|1|||
130830621|NCT03520920|471007237|FG002|Overall Study|Death|0|||
130830622|NCT03520920|471007235|FG000|Overall Study|Withdrawal by Subject|2|||
130830623|NCT03520920|471007236|FG001|Overall Study|Withdrawal by Subject|1|||
130830624|NCT03520920|471007237|FG002|Overall Study|Withdrawal by Subject|0|||
130830625|NCT03520920|471007235|FG000|Overall Study|Study Terminated by the Sponsor|5|||
130830626|NCT03520920|471007236|FG001|Overall Study|Study Terminated by the Sponsor|14|||
130830627|NCT03520920|471007237|FG002|Overall Study|Study Terminated by the Sponsor|5|||
130830628|NCT00405392|471007238|FG000|Overall Study|Adverse Event|15|||
130830629|NCT00405392|471007239|FG001|Overall Study|Adverse Event|14|||
130830630|NCT00405392|471007238|FG000|Overall Study|Did not meet Eligibility criteria|7|||
130830631|NCT00405392|471007239|FG001|Overall Study|Did not meet Eligibility criteria|2|||
130830632|NCT00405392|471007238|FG000|Overall Study|Withdrawal by Subject|4|||
130830633|NCT00405392|471007239|FG001|Overall Study|Withdrawal by Subject|3|||
130830634|NCT00405392|471007238|FG000|Overall Study|Lost to Follow-up|1|||
130830635|NCT00405392|471007239|FG001|Overall Study|Lost to Follow-up|2|||
130830636|NCT00405392|471007238|FG000|Overall Study|Data missing|2|||
130830637|NCT00405392|471007239|FG001|Overall Study|Data missing|0|||
130830638|NCT00405392|471007238|FG000|Overall Study|Non-compliance|0|||
130830639|NCT00405392|471007239|FG001|Overall Study|Non-compliance|1|||
130830640|NCT00405392|471007238|FG000|Overall Study|Other|1|||
130830641|NCT00405392|471007239|FG001|Overall Study|Other|5|||
130830642|NCT00412958|471007240|FG000|Overall Study|Withdrawal by Subject|3|||
130830643|NCT00412958|471007241|FG001|Overall Study|Withdrawal by Subject|0|||
130830644|NCT00412958|471007242|FG002|Overall Study|Withdrawal by Subject|0|||
130830645|NCT00412958|471007243|FG003|Overall Study|Withdrawal by Subject|1|||
130830646|NCT00412958|471007240|FG000|Overall Study|Adverse Event|0|||
130830647|NCT00412958|471007241|FG001|Overall Study|Adverse Event|1|||
130830648|NCT00412958|471007242|FG002|Overall Study|Adverse Event|0|||
130830649|NCT00412958|471007243|FG003|Overall Study|Adverse Event|0|||
130830650|NCT00412958|471007240|FG000|Overall Study|Lost to Follow-up|0|||
130830651|NCT00412958|471007241|FG001|Overall Study|Lost to Follow-up|1|||
130830652|NCT00412958|471007242|FG002|Overall Study|Lost to Follow-up|0|||
130830653|NCT00412958|471007243|FG003|Overall Study|Lost to Follow-up|0|||
130830654|NCT00412958|471007240|FG000|Overall Study|Death|0|||
130830655|NCT00412958|471007241|FG001|Overall Study|Death|1|||
130830656|NCT00412958|471007242|FG002|Overall Study|Death|0|||
130830657|NCT00412958|471007243|FG003|Overall Study|Death|0|||
130830658|NCT00412958|471007240|FG000|Overall Study|Transport issue|0|||
130830659|NCT00412958|471007241|FG001|Overall Study|Transport issue|1|||
130830660|NCT00412958|471007242|FG002|Overall Study|Transport issue|0|||
130830661|NCT00412958|471007243|FG003|Overall Study|Transport issue|0|||
130830662|NCT01703091|471007254|FG000|Overall Study|Adverse Event|5|||
130830663|NCT01703091|471007255|FG001|Overall Study|Adverse Event|3|||
130830664|NCT01703091|471007254|FG000|Overall Study|Physician Decision|2|||
130830665|NCT01703091|471007255|FG001|Overall Study|Physician Decision|1|||
130830666|NCT01703091|471007254|FG000|Overall Study|Withdrawal by Subject|1|||
130830667|NCT01703091|471007255|FG001|Overall Study|Withdrawal by Subject|0|||
130830668|NCT01703091|471007254|FG000|Overall Study|Sponsor Decision|1|||
130830669|NCT01703091|471007255|FG001|Overall Study|Sponsor Decision|0|||
130830670|NCT03900728|471007263|FG000|Overall Study|No text responses|0|||
130830671|NCT03900728|471007264|FG001|Overall Study|No text responses|0|||
130830672|NCT03900728|471007265|FG002|Overall Study|No text responses|4|||
130830673|NCT03902392|471007269|FG000|Overall Study|Lost to Follow-up|7|||
130830674|NCT03902392|471007270|FG001|Overall Study|Lost to Follow-up|7|||
130830675|NCT00244725|471007271|FG000|Overall Study|Lost to Follow-up|3|||
130830676|NCT00244725|471007272|FG001|Overall Study|Lost to Follow-up|4|||
130830677|NCT00244725|471007273|FG002|Overall Study|Lost to Follow-up|9|||
130830678|NCT00244725|471007274|FG003|Overall Study|Lost to Follow-up|2|||
130830679|NCT00244725|471007271|FG000|Overall Study|Withdrawal by Subject|9|||
130830680|NCT00244725|471007272|FG001|Overall Study|Withdrawal by Subject|7|||
130830681|NCT00244725|471007273|FG002|Overall Study|Withdrawal by Subject|7|||
130830682|NCT00244725|471007274|FG003|Overall Study|Withdrawal by Subject|8|||
130830683|NCT00244725|471007271|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
130830684|NCT00244725|471007272|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
130830685|NCT00244725|471007273|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
130830686|NCT00244725|471007274|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
130830687|NCT00244725|471007271|FG000|Overall Study|Physician Decision|3|||
130830688|NCT00244725|471007272|FG001|Overall Study|Physician Decision|0|||
130830689|NCT00244725|471007273|FG002|Overall Study|Physician Decision|1|||
130830690|NCT00244725|471007274|FG003|Overall Study|Physician Decision|2|||
130830691|NCT00244725|471007271|FG000|Overall Study|Adverse Events|3|||
130830692|NCT00244725|471007272|FG001|Overall Study|Adverse Events|1|||
130830693|NCT00244725|471007273|FG002|Overall Study|Adverse Events|4|||
130830694|NCT00244725|471007274|FG003|Overall Study|Adverse Events|4|||
130830695|NCT00244725|471007271|FG000|Overall Study|Withdrwal by participant|1|||
130830696|NCT00244725|471007272|FG001|Overall Study|Withdrwal by participant|0|||
130830697|NCT00244725|471007273|FG002|Overall Study|Withdrwal by participant|0|||
130830698|NCT00244725|471007274|FG003|Overall Study|Withdrwal by participant|1|||
130830699|NCT00244725|471007271|FG000|Overall Study|Liver function test abnormality|2|||
130830700|NCT00244725|471007272|FG001|Overall Study|Liver function test abnormality|0|||
130830701|NCT00244725|471007273|FG002|Overall Study|Liver function test abnormality|0|||
130830702|NCT00244725|471007274|FG003|Overall Study|Liver function test abnormality|1|||
130830703|NCT00244725|471007271|FG000|Overall Study|Sponsor withdrew the participant|1|||
130830704|NCT00244725|471007272|FG001|Overall Study|Sponsor withdrew the participant|0|||
130830705|NCT00244725|471007273|FG002|Overall Study|Sponsor withdrew the participant|0|||
130830706|NCT00244725|471007274|FG003|Overall Study|Sponsor withdrew the participant|1|||
130830707|NCT00244725|471007271|FG000|Overall Study|Mediciation Error|0|||
130830708|NCT00244725|471007272|FG001|Overall Study|Mediciation Error|1|||
130830709|NCT00244725|471007273|FG002|Overall Study|Mediciation Error|0|||
130830710|NCT00244725|471007274|FG003|Overall Study|Mediciation Error|0|||
130830711|NCT00244725|471007271|FG000|Overall Study|Rehab Refused to allow participantion|0|||
130830712|NCT00244725|471007272|FG001|Overall Study|Rehab Refused to allow participantion|1|||
130830713|NCT00244725|471007273|FG002|Overall Study|Rehab Refused to allow participantion|0|||
130830714|NCT00244725|471007274|FG003|Overall Study|Rehab Refused to allow participantion|0|||
130830715|NCT00244725|471007271|FG000|Overall Study|Headache|0|||
130830716|NCT00244725|471007272|FG001|Overall Study|Headache|1|||
130830717|NCT00244725|471007273|FG002|Overall Study|Headache|0|||
130830718|NCT00244725|471007274|FG003|Overall Study|Headache|0|||
130830719|NCT00244725|471007271|FG000|Overall Study|Received prohibited medication|0|||
130830720|NCT00244725|471007272|FG001|Overall Study|Received prohibited medication|1|||
130830721|NCT00244725|471007273|FG002|Overall Study|Received prohibited medication|0|||
130830722|NCT00244725|471007274|FG003|Overall Study|Received prohibited medication|1|||
130830723|NCT00244725|471007271|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
130830724|NCT00244725|471007272|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
130830725|NCT00244725|471007273|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
130830726|NCT00244725|471007274|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
130830727|NCT00244725|471007271|FG000|Overall Study|Administrative reason|0|||
130830728|NCT00244725|471007272|FG001|Overall Study|Administrative reason|0|||
130830729|NCT00244725|471007273|FG002|Overall Study|Administrative reason|1|||
130830730|NCT00244725|471007274|FG003|Overall Study|Administrative reason|0|||
130830731|NCT00244725|471007271|FG000|Overall Study|Vomit|0|||
130830732|NCT00244725|471007272|FG001|Overall Study|Vomit|0|||
130830733|NCT00244725|471007273|FG002|Overall Study|Vomit|1|||
130830734|NCT00244725|471007274|FG003|Overall Study|Vomit|0|||
130830735|NCT00244725|471007271|FG000|Overall Study|Failed to follow-up|0|||
130830736|NCT00244725|471007272|FG001|Overall Study|Failed to follow-up|0|||
130830737|NCT00244725|471007273|FG002|Overall Study|Failed to follow-up|1|||
130830738|NCT00244725|471007274|FG003|Overall Study|Failed to follow-up|1|||
130830739|NCT03248167|471007275|FG000|Overall Study|Withdrawal by Subject|2|||
130830740|NCT03248167|471007276|FG001|Overall Study|Withdrawal by Subject|2|||
130830741|NCT03248167|471007275|FG000|Overall Study|Physician Decision|0|||
130830742|NCT03248167|471007276|FG001|Overall Study|Physician Decision|1|||
130830743|NCT03248167|471007275|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
130830744|NCT03248167|471007276|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
130830745|NCT03248167|471007275|FG000|Overall Study|Lost to Follow-up|1|||
130830746|NCT03248167|471007276|FG001|Overall Study|Lost to Follow-up|0|||
130830747|NCT02122146|471007277|FG000|Part 1: Dose Escalation|Death|0|||
130830748|NCT02122146|471007278|FG001|Part 1: Dose Escalation|Death|1|||
130830749|NCT02122146|471007279|FG002|Part 1: Dose Escalation|Death|1|||
130830750|NCT02122146|471007280|FG003|Part 1: Dose Escalation|Death|0|||
130830751|NCT02122146|471007281|FG004|Part 1: Dose Escalation|Death|0|||
130830752|NCT02122146|471007282|FG005|Part 1: Dose Escalation|Death|0|||
130830753|NCT02122146|471007283|FG006|Part 1: Dose Escalation|Death|0|||
130830754|NCT02122146|471007284|FG007|Part 1: Dose Escalation|Death|0|||
130830755|NCT02122146|471007277|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
130830756|NCT02122146|471007278|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
130830757|NCT02122146|471007279|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
130830758|NCT02122146|471007280|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
130830759|NCT02122146|471007281|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
130830760|NCT02122146|471007282|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
130830761|NCT02122146|471007283|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
130830762|NCT02122146|471007284|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
130830763|NCT02122146|471007277|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130830764|NCT02122146|471007278|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130830765|NCT02122146|471007279|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130830766|NCT02122146|471007280|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
130830767|NCT02122146|471007281|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130830768|NCT02122146|471007282|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130830769|NCT02122146|471007283|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130830770|NCT02122146|471007284|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130830771|NCT02122146|471007277|FG000|Part 1: Dose Escalation|Other|1|||
130830772|NCT02122146|471007278|FG001|Part 1: Dose Escalation|Other|0|||
130830773|NCT02122146|471007279|FG002|Part 1: Dose Escalation|Other|0|||
130830774|NCT02122146|471007280|FG003|Part 1: Dose Escalation|Other|0|||
130830775|NCT02122146|471007281|FG004|Part 1: Dose Escalation|Other|0|||
130830776|NCT02122146|471007282|FG005|Part 1: Dose Escalation|Other|1|||
130830777|NCT02122146|471007283|FG006|Part 1: Dose Escalation|Other|1|||
130830778|NCT02122146|471007284|FG007|Part 1: Dose Escalation|Other|2|||
130830779|NCT03472495|471007285|FG000|Overall Study|Treatment no longer indicated|1|||
130830780|NCT03472495|471007286|FG001|Overall Study|Treatment no longer indicated|2|||
130830781|NCT03472495|471007285|FG000|Overall Study|Physician Decision|0|||
130830782|NCT03472495|471007286|FG001|Overall Study|Physician Decision|2|||
130830783|NCT01107392|471007288|FG000|Overall Study|Adverse Event|2|||
130830784|NCT01107392|471007289|FG001|Overall Study|Adverse Event|0|||
130830785|NCT01107392|471007288|FG000|Overall Study|Personal Reasons|2|||
130830786|NCT01107392|471007289|FG001|Overall Study|Personal Reasons|3|||
130830787|NCT01107392|471007288|FG000|Overall Study|Administrative decision|1|||
130830788|NCT01107392|471007289|FG001|Overall Study|Administrative decision|0|||
130830789|NCT02998671|471007292|FG000|Period 1|Study Terminated By Sponsor|2|||
130830790|NCT02998671|471007293|FG001|Period 1|Study Terminated By Sponsor|1|||
130830791|NCT02998671|471007294|FG002|Period 1|Study Terminated By Sponsor|0|||
130830792|NCT02998671|471007295|FG003|Period 1|Study Terminated By Sponsor|0|||
130830793|NCT02998671|471007296|FG004|Period 1|Study Terminated By Sponsor|1|||
130830794|NCT02998671|471007292|FG000|Period 1|Withdrawal by Subject|1|||
130830795|NCT02998671|471007293|FG001|Period 1|Withdrawal by Subject|2|||
130830796|NCT02998671|471007294|FG002|Period 1|Withdrawal by Subject|0|||
130830797|NCT02998671|471007295|FG003|Period 1|Withdrawal by Subject|0|||
130830798|NCT02998671|471007296|FG004|Period 1|Withdrawal by Subject|2|||
130830799|NCT02998671|471007292|FG000|Period 1|Pregnancy|1|||
130830800|NCT02998671|471007293|FG001|Period 1|Pregnancy|0|||
130830801|NCT02998671|471007294|FG002|Period 1|Pregnancy|0|||
130830802|NCT02998671|471007295|FG003|Period 1|Pregnancy|0|||
130830803|NCT02998671|471007296|FG004|Period 1|Pregnancy|0|||
130830804|NCT02998671|471007292|FG000|Period 1|Adverse Event|0|||
130830805|NCT02998671|471007293|FG001|Period 1|Adverse Event|0|||
130830806|NCT02998671|471007294|FG002|Period 1|Adverse Event|0|||
130830807|NCT02998671|471007295|FG003|Period 1|Adverse Event|0|||
130830808|NCT02998671|471007296|FG004|Period 1|Adverse Event|1|||
130830809|NCT02998671|471007292|FG000|Period 2|Adverse Event|0|||
130830810|NCT02998671|471007293|FG001|Period 2|Adverse Event|1|||
130830811|NCT02998671|471007294|FG002|Period 2|Adverse Event|0|||
130830812|NCT02998671|471007295|FG003|Period 2|Adverse Event|0|||
130830813|NCT02998671|471007296|FG004|Period 2|Adverse Event|0|||
130830814|NCT02998671|471007292|FG000|Period 2|Study Terminated By Sponsor|3|||
130830815|NCT02998671|471007293|FG001|Period 2|Study Terminated By Sponsor|5|||
130830816|NCT02998671|471007294|FG002|Period 2|Study Terminated By Sponsor|1|||
130830817|NCT02998671|471007295|FG003|Period 2|Study Terminated By Sponsor|3|||
130830818|NCT02998671|471007296|FG004|Period 2|Study Terminated By Sponsor|0|||
130830819|NCT02998671|471007292|FG000|Period 2|Withdrawal by Subject|0|||
130830820|NCT02998671|471007293|FG001|Period 2|Withdrawal by Subject|1|||
130830821|NCT02998671|471007294|FG002|Period 2|Withdrawal by Subject|0|||
130830822|NCT02998671|471007295|FG003|Period 2|Withdrawal by Subject|0|||
130830823|NCT02998671|471007296|FG004|Period 2|Withdrawal by Subject|0|||
130830824|NCT02998671|471007292|FG000|Period 2|Lost to Follow-up|0|||
130830825|NCT02998671|471007293|FG001|Period 2|Lost to Follow-up|0|||
130830826|NCT02998671|471007294|FG002|Period 2|Lost to Follow-up|0|||
130830827|NCT02998671|471007295|FG003|Period 2|Lost to Follow-up|1|||
130830828|NCT02998671|471007296|FG004|Period 2|Lost to Follow-up|0|||
130830829|NCT02038946|471007298|FG000|Overall Study|Death|5|||
130830830|NCT02038946|471007298|FG000|Overall Study|Withdrawal by Subject|3|||
130830831|NCT02038946|471007298|FG000|Overall Study|Lost to Follow-up|2|||
130830832|NCT02038946|471007298|FG000|Overall Study|Other reasons|2|||
130830833|NCT02473471|471007299|FG000|Overall Study|poor oral hygiene|2|||
130830834|NCT02473471|471007299|FG000|Overall Study|Lost to Follow-up|1|||
130830835|NCT02725476|471007302|FG000|Overall Study|Physician Decision|2|||
130830836|NCT02725476|471007303|FG001|Overall Study|Physician Decision|0|||
130830837|NCT02725476|471007302|FG000|Overall Study|Adverse Event|1|||
130830838|NCT02725476|471007303|FG001|Overall Study|Adverse Event|1|||
130830839|NCT02701764|471007308|FG000|Overall Study|Lost to Follow-up|0|||
130830840|NCT02701764|471007309|FG001|Overall Study|Lost to Follow-up|1|||
130830841|NCT00485758|471009029|FG000|Overall Study|Adverse Event|102|||
130830842|NCT00485758|471009030|FG001|Overall Study|Adverse Event|31|||
130830843|NCT00485758|471009029|FG000|Overall Study|Death|0|||
130830844|NCT00485758|471009030|FG001|Overall Study|Death|1|||
130830845|NCT00485758|471009029|FG000|Overall Study|Lost to Follow-up|5|||
130830846|NCT00485758|471009030|FG001|Overall Study|Lost to Follow-up|1|||
130830847|NCT00485758|471009029|FG000|Overall Study|Physician Decision|3|||
130830848|NCT00485758|471009030|FG001|Overall Study|Physician Decision|3|||
130830849|NCT00485758|471009029|FG000|Overall Study|Protocol Violation|11|||
130830850|NCT00485758|471009030|FG001|Overall Study|Protocol Violation|2|||
130830851|NCT00485758|471009029|FG000|Overall Study|Withdrawal by Subject|32|||
130830852|NCT00485758|471009030|FG001|Overall Study|Withdrawal by Subject|27|||
130830853|NCT00485758|471009029|FG000|Overall Study|Study Terminated by Sponsor|3|||
130830854|NCT00485758|471009030|FG001|Overall Study|Study Terminated by Sponsor|0|||
130830855|NCT04551963|471009031|FG000|Overall Study|Physician Decision|1|||
130830856|NCT04551963|471009032|FG001|Overall Study|Physician Decision|1|||
130830857|NCT04551963|471009031|FG000|Overall Study|Death|1|||
130830858|NCT04551963|471009032|FG001|Overall Study|Death|0|||
130830859|NCT03379259|471009033|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
130830860|NCT03379259|471009034|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
130830861|NCT03379259|471009035|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
130830862|NCT03379259|471009036|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
130830863|NCT03379259|471009037|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
130830864|NCT03379259|471009038|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
130830865|NCT03379259|471009033|FG000|Overall Study|Death|0|||
130830866|NCT03379259|471009034|FG001|Overall Study|Death|1|||
130830867|NCT03379259|471009035|FG002|Overall Study|Death|2|||
130830868|NCT03379259|471009036|FG003|Overall Study|Death|1|||
130830869|NCT03379259|471009037|FG004|Overall Study|Death|4|||
130830870|NCT03379259|471009038|FG005|Overall Study|Death|2|||
130830871|NCT03379259|471009033|FG000|Overall Study|Withdrawal by Subject|0|||
130830872|NCT03379259|471009034|FG001|Overall Study|Withdrawal by Subject|0|||
130830873|NCT03379259|471009035|FG002|Overall Study|Withdrawal by Subject|1|||
130830874|NCT03379259|471009036|FG003|Overall Study|Withdrawal by Subject|0|||
130830875|NCT03379259|471009037|FG004|Overall Study|Withdrawal by Subject|2|||
130830876|NCT03379259|471009038|FG005|Overall Study|Withdrawal by Subject|0|||
130830877|NCT03379259|471009033|FG000|Overall Study|Study terminated by sponsor|0|||
130830878|NCT03379259|471009034|FG001|Overall Study|Study terminated by sponsor|0|||
130830879|NCT03379259|471009035|FG002|Overall Study|Study terminated by sponsor|0|||
130830880|NCT03379259|471009036|FG003|Overall Study|Study terminated by sponsor|1|||
130830881|NCT03379259|471009037|FG004|Overall Study|Study terminated by sponsor|1|||
130830882|NCT03379259|471009038|FG005|Overall Study|Study terminated by sponsor|4|||
130830883|NCT03379259|471009033|FG000|Overall Study|Disease progression|0|||
130830884|NCT03379259|471009034|FG001|Overall Study|Disease progression|0|||
130830885|NCT03379259|471009035|FG002|Overall Study|Disease progression|0|||
130830886|NCT03379259|471009036|FG003|Overall Study|Disease progression|1|||
130830887|NCT03379259|471009037|FG004|Overall Study|Disease progression|0|||
130830888|NCT03379259|471009038|FG005|Overall Study|Disease progression|1|||
130830889|NCT03379259|471009033|FG000|Overall Study|Lost to Follow-up|0|||
130830890|NCT03379259|471009034|FG001|Overall Study|Lost to Follow-up|0|||
130830891|NCT03379259|471009035|FG002|Overall Study|Lost to Follow-up|0|||
130830892|NCT03379259|471009036|FG003|Overall Study|Lost to Follow-up|0|||
130830893|NCT03379259|471009037|FG004|Overall Study|Lost to Follow-up|1|||
130830894|NCT03379259|471009038|FG005|Overall Study|Lost to Follow-up|0|||
130830895|NCT03379259|471009033|FG000|Overall Study|Deteriorating condition|0|||
130830896|NCT03379259|471009034|FG001|Overall Study|Deteriorating condition|0|||
130830897|NCT03379259|471009035|FG002|Overall Study|Deteriorating condition|0|||
130830898|NCT03379259|471009036|FG003|Overall Study|Deteriorating condition|0|||
130830899|NCT03379259|471009037|FG004|Overall Study|Deteriorating condition|1|||
130830900|NCT03379259|471009038|FG005|Overall Study|Deteriorating condition|0|||
130830901|NCT00700622|471009039|FG000|Overall Study|Adverse Event|4|||
130830902|NCT00700622|471009040|FG001|Overall Study|Adverse Event|0|||
130830903|NCT00700622|471009039|FG000|Overall Study|Lost to Follow-up|0|||
130830904|NCT00700622|471009040|FG001|Overall Study|Lost to Follow-up|1|||
130830905|NCT00700622|471009039|FG000|Overall Study|Physician Decision|2|||
130830906|NCT00700622|471009040|FG001|Overall Study|Physician Decision|1|||
130830907|NCT00700622|471009039|FG000|Overall Study|Protocol Violation|0|||
130830908|NCT00700622|471009040|FG001|Overall Study|Protocol Violation|1|||
130830909|NCT00700622|471009039|FG000|Overall Study|Withdrawal by Subject|4|||
130830910|NCT00700622|471009040|FG001|Overall Study|Withdrawal by Subject|1|||
130830911|NCT00700622|471009039|FG000|Overall Study|Other|3|||
130830912|NCT00700622|471009040|FG001|Overall Study|Other|1|||
130830913|NCT01532921|471009041|FG000|Overall Study|Death|3|||
130830914|NCT01532921|471009041|FG000|Overall Study|Withdrawal by Subject|2|||
130830915|NCT01532921|471009041|FG000|Overall Study|Lost to Follow-up|3|||
130830916|NCT01532921|471009041|FG000|Overall Study|Physician Decision|7|||
130830917|NCT01532921|471009041|FG000|Overall Study|Device was explanted during procedure|1|||
130830918|NCT00070109|471009042|FG000|Overall Study|Death|1|||
130830919|NCT00070109|471009043|FG001|Overall Study|Death|1|||
130830920|NCT00070109|471009044|FG002|Overall Study|Death|0|||
130830921|NCT00070109|471009045|FG003|Overall Study|Death|0|||
130830922|NCT00070109|471009046|FG004|Overall Study|Death|1|||
130830923|NCT00070109|471009042|FG000|Overall Study|Lack of Efficacy|6|||
130830924|NCT00070109|471009043|FG001|Overall Study|Lack of Efficacy|4|||
130830925|NCT00070109|471009044|FG002|Overall Study|Lack of Efficacy|5|||
130830926|NCT00070109|471009045|FG003|Overall Study|Lack of Efficacy|15|||
130830927|NCT00070109|471009046|FG004|Overall Study|Lack of Efficacy|5|||
130830928|NCT00070109|471009042|FG000|Overall Study|Physician Decision|1|||
130830929|NCT00070109|471009043|FG001|Overall Study|Physician Decision|0|||
130830930|NCT00070109|471009044|FG002|Overall Study|Physician Decision|0|||
130830931|NCT00070109|471009045|FG003|Overall Study|Physician Decision|0|||
130830932|NCT00070109|471009046|FG004|Overall Study|Physician Decision|0|||
130830933|NCT00070109|471009042|FG000|Overall Study|Withdrawal by Subject|0|||
130830934|NCT00070109|471009043|FG001|Overall Study|Withdrawal by Subject|1|||
130830935|NCT00070109|471009044|FG002|Overall Study|Withdrawal by Subject|1|||
130830936|NCT00070109|471009045|FG003|Overall Study|Withdrawal by Subject|0|||
130830937|NCT00070109|471009046|FG004|Overall Study|Withdrawal by Subject|0|||
130830938|NCT00070109|471009042|FG000|Overall Study|Adverse Event|0|||
130830939|NCT00070109|471009043|FG001|Overall Study|Adverse Event|0|||
130830940|NCT00070109|471009044|FG002|Overall Study|Adverse Event|2|||
130830941|NCT00070109|471009045|FG003|Overall Study|Adverse Event|4|||
130830942|NCT00070109|471009046|FG004|Overall Study|Adverse Event|2|||
130830943|NCT00070109|471009042|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
130830944|NCT00070109|471009043|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
130830945|NCT00070109|471009044|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
130830946|NCT00070109|471009045|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
130830947|NCT00070109|471009046|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
130830948|NCT02550288|471009049|FG000|Overall Study|Adverse Event|0|||
130830949|NCT02550288|471009050|FG001|Overall Study|Adverse Event|1|||
130830950|NCT02550288|471009051|FG002|Overall Study|Adverse Event|0|||
130830951|NCT02550288|471009052|FG003|Overall Study|Adverse Event|0|||
130830952|NCT02550288|471009053|FG004|Overall Study|Adverse Event|0|||
130830953|NCT02550288|471009049|FG000|Overall Study|Physician Decision|0|||
130830954|NCT02550288|471009050|FG001|Overall Study|Physician Decision|0|||
130830955|NCT02550288|471009051|FG002|Overall Study|Physician Decision|0|||
130830956|NCT02550288|471009052|FG003|Overall Study|Physician Decision|1|||
130830957|NCT02550288|471009053|FG004|Overall Study|Physician Decision|0|||
130830958|NCT02550288|471009049|FG000|Overall Study|Protocol Violation|2|||
130830959|NCT02550288|471009050|FG001|Overall Study|Protocol Violation|2|||
130830960|NCT02550288|471009051|FG002|Overall Study|Protocol Violation|1|||
130830961|NCT02550288|471009052|FG003|Overall Study|Protocol Violation|0|||
130830962|NCT02550288|471009053|FG004|Overall Study|Protocol Violation|3|||
130830963|NCT02550288|471009049|FG000|Overall Study|Participant moved|0|||
130830964|NCT02550288|471009050|FG001|Overall Study|Participant moved|0|||
130830965|NCT02550288|471009051|FG002|Overall Study|Participant moved|0|||
130830966|NCT02550288|471009052|FG003|Overall Study|Participant moved|1|||
130830967|NCT02550288|471009053|FG004|Overall Study|Participant moved|0|||
130830968|NCT02550288|471009049|FG000|Overall Study|Withdrawal by Subject|0|||
130830969|NCT02550288|471009050|FG001|Overall Study|Withdrawal by Subject|0|||
130830970|NCT02550288|471009051|FG002|Overall Study|Withdrawal by Subject|0|||
130830971|NCT02550288|471009052|FG003|Overall Study|Withdrawal by Subject|1|||
130830972|NCT02550288|471009053|FG004|Overall Study|Withdrawal by Subject|0|||
130830973|NCT02819297|471009055|FG000|Overall Study|Withdrawal by Subject|25|||
130830974|NCT02819297|471009056|FG001|Overall Study|Withdrawal by Subject|13|||
130830975|NCT02819297|471009055|FG000|Overall Study|Lost to Follow-up|12|||
130830976|NCT02819297|471009056|FG001|Overall Study|Lost to Follow-up|14|||
130830977|NCT02819297|471009055|FG000|Overall Study|Adverse Event|12|||
130830978|NCT02819297|471009056|FG001|Overall Study|Adverse Event|10|||
130830979|NCT02819297|471009055|FG000|Overall Study|Physician Decision|5|||
130830980|NCT02819297|471009056|FG001|Overall Study|Physician Decision|5|||
130830981|NCT02819297|471009055|FG000|Overall Study|Lack of Efficacy|5|||
130830982|NCT02819297|471009056|FG001|Overall Study|Lack of Efficacy|8|||
130830983|NCT02819297|471009055|FG000|Overall Study|Protocol Violation|1|||
130830984|NCT02819297|471009056|FG001|Overall Study|Protocol Violation|2|||
130830985|NCT02858440|471009057|FG000|Overall Study|Lost to Follow-up|3|||
130830986|NCT02858440|471009057|FG000|Overall Study|Protocol Violation|2|||
130830987|NCT02858440|471009057|FG000|Overall Study|Consent withdrawal|3|||
130830988|NCT02858440|471009057|FG000|Overall Study|Migrated/moved from study area|4|||
130830989|NCT01670279|471009058|FG000|Overall Study|Adverse Event|0|||
130830990|NCT01670279|471009059|FG001|Overall Study|Adverse Event|1|||
130830991|NCT01670279|471009060|FG002|Overall Study|Adverse Event|0|||
130830992|NCT01670279|471009061|FG003|Overall Study|Adverse Event|0|||
130830993|NCT01670279|471009058|FG000|Overall Study|Physician Decision|0|||
130830994|NCT01670279|471009059|FG001|Overall Study|Physician Decision|1|||
130830995|NCT01670279|471009060|FG002|Overall Study|Physician Decision|0|||
130830996|NCT01670279|471009061|FG003|Overall Study|Physician Decision|0|||
130830997|NCT01670279|471009058|FG000|Overall Study|Participant met withdrawal criteria|0|||
130830998|NCT01670279|471009059|FG001|Overall Study|Participant met withdrawal criteria|0|||
130830999|NCT01670279|471009060|FG002|Overall Study|Participant met withdrawal criteria|0|||
130831000|NCT01670279|471009061|FG003|Overall Study|Participant met withdrawal criteria|1|||
130831001|NCT01901614|471009062|FG000|Overall Study|Adverse Event|0|||
130831002|NCT01901614|471009063|FG001|Overall Study|Adverse Event|1|||
130831003|NCT01901614|471009062|FG000|Overall Study|Lost to Follow-up|1|||
130831004|NCT01901614|471009063|FG001|Overall Study|Lost to Follow-up|0|||
130831005|NCT01901614|471009062|FG000|Overall Study|Screen Fail|1|||
130831006|NCT01901614|471009063|FG001|Overall Study|Screen Fail|0|||
130831007|NCT01823198|471009065|FG000|Overall Study|Physician Decision|0|||
130831008|NCT01823198|471009066|FG001|Overall Study|Physician Decision|1|||
130831009|NCT01823198|471009067|FG002|Overall Study|Physician Decision|0|||
130831010|NCT01823198|471009068|FG003|Overall Study|Physician Decision|0|||
130831011|NCT01823198|471009069|FG004|Overall Study|Physician Decision|0|||
130831012|NCT01823198|471009070|FG005|Overall Study|Physician Decision|3|||
130831013|NCT01823198|471009071|FG006|Overall Study|Physician Decision|3|||
130831014|NCT01262638|471009072|FG000|Overall Study|Adverse Event|3|||
130831015|NCT01262638|471009073|FG001|Overall Study|Adverse Event|4|||
130831016|NCT01262638|471009074|FG002|Overall Study|Adverse Event|3|||
130831017|NCT01262638|471009075|FG003|Overall Study|Adverse Event|4|||
130831018|NCT01262638|471009072|FG000|Overall Study|Protocol Violation|1|||
130831019|NCT01262638|471009073|FG001|Overall Study|Protocol Violation|0|||
130831020|NCT01262638|471009074|FG002|Overall Study|Protocol Violation|0|||
130831021|NCT01262638|471009075|FG003|Overall Study|Protocol Violation|1|||
130831022|NCT01262638|471009072|FG000|Overall Study|Withdrawal by Subject|2|||
130831023|NCT01262638|471009073|FG001|Overall Study|Withdrawal by Subject|1|||
130831024|NCT01262638|471009074|FG002|Overall Study|Withdrawal by Subject|0|||
130831025|NCT01262638|471009075|FG003|Overall Study|Withdrawal by Subject|1|||
130831026|NCT01262638|471009072|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130831027|NCT01262638|471009073|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130831028|NCT01262638|471009074|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
130831029|NCT01262638|471009075|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130831030|NCT01262638|471009072|FG000|Overall Study|Lost to Follow-up|1|||
130831031|NCT01262638|471009073|FG001|Overall Study|Lost to Follow-up|1|||
130831032|NCT01262638|471009074|FG002|Overall Study|Lost to Follow-up|1|||
130831033|NCT01262638|471009075|FG003|Overall Study|Lost to Follow-up|1|||
130831034|NCT01262638|471009072|FG000|Overall Study|Participant Went Out of Town|0|||
130831035|NCT01262638|471009073|FG001|Overall Study|Participant Went Out of Town|0|||
130831036|NCT01262638|471009074|FG002|Overall Study|Participant Went Out of Town|1|||
130831037|NCT01262638|471009075|FG003|Overall Study|Participant Went Out of Town|0|||
130831038|NCT02243371|471009080|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
130831039|NCT02243371|471009081|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
130831040|NCT02243371|471009080|FG000|Overall Study|Death (unrelated)|2|||
130831041|NCT02243371|471009081|FG001|Overall Study|Death (unrelated)|4|||
130831042|NCT02243371|471009080|FG000|Overall Study|Adverse Event (unrelated)|0|||
130831043|NCT02243371|471009081|FG001|Overall Study|Adverse Event (unrelated)|1|||
130831044|NCT02243371|471009080|FG000|Overall Study|Lack of Clinical Benefit|0|||
130831045|NCT02243371|471009081|FG001|Overall Study|Lack of Clinical Benefit|1|||
130831046|NCT02243371|471009080|FG000|Overall Study|Withdrawal by Subject|0|||
130831047|NCT02243371|471009081|FG001|Overall Study|Withdrawal by Subject|2|||
130831048|NCT01369199|471009082|FG000|Overall Study|Withdrawal by Subject|1|||
130831049|NCT01369199|471009082|FG000|Overall Study|Lost to Follow-up|2|||
130831050|NCT01071252|471009083|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
130831051|NCT01071252|471009084|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
130831052|NCT01071252|471009085|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
130831053|NCT01071252|471009086|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
130831054|NCT01071252|471009087|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
130831055|NCT01071252|471009083|FG000|Overall Study|Withdrawal by Subject|8|||
130831056|NCT01071252|471009084|FG001|Overall Study|Withdrawal by Subject|2|||
130831057|NCT01071252|471009085|FG002|Overall Study|Withdrawal by Subject|1|||
130831058|NCT01071252|471009086|FG003|Overall Study|Withdrawal by Subject|2|||
130831059|NCT01071252|471009087|FG004|Overall Study|Withdrawal by Subject|3|||
130831060|NCT01071252|471009083|FG000|Overall Study|administrative problems|1|||
130831061|NCT01071252|471009084|FG001|Overall Study|administrative problems|1|||
130831062|NCT01071252|471009085|FG002|Overall Study|administrative problems|0|||
130831063|NCT01071252|471009086|FG003|Overall Study|administrative problems|2|||
130831064|NCT01071252|471009087|FG004|Overall Study|administrative problems|1|||
130831065|NCT01071252|471009083|FG000|Overall Study|Lost to Follow-up|1|||
130831066|NCT01071252|471009084|FG001|Overall Study|Lost to Follow-up|0|||
130831067|NCT01071252|471009085|FG002|Overall Study|Lost to Follow-up|1|||
130831068|NCT01071252|471009086|FG003|Overall Study|Lost to Follow-up|2|||
130831069|NCT01071252|471009087|FG004|Overall Study|Lost to Follow-up|0|||
130831070|NCT01071252|471009083|FG000|Overall Study|Adverse Event|1|||
130831071|NCT01071252|471009084|FG001|Overall Study|Adverse Event|1|||
130831072|NCT01071252|471009085|FG002|Overall Study|Adverse Event|0|||
130831073|NCT01071252|471009086|FG003|Overall Study|Adverse Event|1|||
130831074|NCT01071252|471009087|FG004|Overall Study|Adverse Event|0|||
130831075|NCT01071252|471009083|FG000|Overall Study|Death|0|||
130831076|NCT01071252|471009084|FG001|Overall Study|Death|0|||
130831077|NCT01071252|471009085|FG002|Overall Study|Death|0|||
130831078|NCT01071252|471009086|FG003|Overall Study|Death|0|||
130831079|NCT01071252|471009087|FG004|Overall Study|Death|1|||
130831080|NCT03928418|471009088|FG000|Overall Study|Lost to Follow-up|5|||
130831081|NCT03928418|471009089|FG001|Overall Study|Lost to Follow-up|3|||
130831082|NCT03928418|471009090|FG002|Overall Study|Lost to Follow-up|5|||
130831083|NCT03928418|471009088|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
130831084|NCT03928418|471009089|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
130831085|NCT03928418|471009090|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
130831086|NCT00470262|471009091|FG000|Overall Study|Withdrawal by Subject|2|||
130831087|NCT00470262|471009092|FG001|Overall Study|Withdrawal by Subject|0|||
130831088|NCT03835481|471009095|FG000|Double-blind Period|Other not stated below|0|||
130831089|NCT03835481|471009096|FG001|Double-blind Period|Other not stated below|0|||
130831090|NCT03835481|471009097|FG002|Double-blind Period|Other not stated below|0|||
130831091|NCT03835481|471009098|FG003|Double-blind Period|Other not stated below|1|||
130831092|NCT03835481|471009099|FG004|Double-blind Period|Other not stated below|1|||
130831093|NCT03835481|471009095|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
130831094|NCT03835481|471009096|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
130831095|NCT03835481|471009097|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
130831096|NCT03835481|471009098|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
130831097|NCT03835481|471009099|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
130831098|NCT03835481|471009095|FG000|Double-blind Period|Withdrawal by Subject|0|||
130831099|NCT03835481|471009096|FG001|Double-blind Period|Withdrawal by Subject|0|||
130831100|NCT03835481|471009097|FG002|Double-blind Period|Withdrawal by Subject|1|||
130831101|NCT03835481|471009098|FG003|Double-blind Period|Withdrawal by Subject|0|||
130831102|NCT03835481|471009099|FG004|Double-blind Period|Withdrawal by Subject|5|||
130831103|NCT03835481|471009095|FG000|Double-blind Period|Lost to Follow-up|0|||
130831104|NCT03835481|471009096|FG001|Double-blind Period|Lost to Follow-up|0|||
130831105|NCT03835481|471009097|FG002|Double-blind Period|Lost to Follow-up|0|||
130831106|NCT03835481|471009098|FG003|Double-blind Period|Lost to Follow-up|1|||
130831107|NCT03835481|471009099|FG004|Double-blind Period|Lost to Follow-up|0|||
130831108|NCT03835481|471009095|FG000|Double-blind Period|Protocol Violation|0|||
130831109|NCT03835481|471009096|FG001|Double-blind Period|Protocol Violation|2|||
130831110|NCT03835481|471009097|FG002|Double-blind Period|Protocol Violation|0|||
130831111|NCT03835481|471009098|FG003|Double-blind Period|Protocol Violation|1|||
130831112|NCT03835481|471009099|FG004|Double-blind Period|Protocol Violation|0|||
130831113|NCT03835481|471009095|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
130831114|NCT03835481|471009096|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
130831115|NCT03835481|471009097|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
130831116|NCT03835481|471009098|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
130831117|NCT03835481|471009099|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
130831118|NCT03835481|471009095|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
130831119|NCT03835481|471009096|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
130831120|NCT03835481|471009097|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
130831121|NCT03835481|471009098|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
130831122|NCT03835481|471009099|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
130831123|NCT03835481|471009095|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
130831124|NCT03835481|471009096|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
130831125|NCT03835481|471009097|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
130831126|NCT03835481|471009098|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
130831127|NCT03835481|471009099|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
130831128|NCT03835481|471009095|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
130831129|NCT03835481|471009096|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
130831130|NCT03835481|471009097|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
130831131|NCT03835481|471009098|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
130831132|NCT03835481|471009099|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
130831133|NCT03835481|471009095|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130831134|NCT03835481|471009096|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130831135|NCT03835481|471009097|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130831136|NCT03835481|471009098|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
130831137|NCT03835481|471009099|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130831138|NCT03835481|471009095|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
130831139|NCT03835481|471009096|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
130831140|NCT03835481|471009097|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
130831141|NCT03835481|471009098|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
130831142|NCT03835481|471009099|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
130831143|NCT00255723|471009102|FG000|Overall Study|Adverse Event|1|||
130831144|NCT00255723|471009103|FG001|Overall Study|Adverse Event|1|||
130831145|NCT00255723|471009102|FG000|Overall Study|Death|0|||
130831146|NCT00255723|471009103|FG001|Overall Study|Death|1|||
130831147|NCT00255723|471009102|FG000|Overall Study|Response Data Not Available|1|||
130831148|NCT00255723|471009103|FG001|Overall Study|Response Data Not Available|0|||
130831149|NCT01169701|471009107|FG000|Overall Study|Lost to Follow-up|1|||
130831150|NCT01169701|471009108|FG001|Overall Study|Lost to Follow-up|1|||
130831151|NCT01169701|471009107|FG000|Overall Study|Withdrawal by Subject|1|||
130831152|NCT01169701|471009108|FG001|Overall Study|Withdrawal by Subject|3|||
130831153|NCT01169701|471009107|FG000|Overall Study|Adverse Event|1|||
130831154|NCT01169701|471009108|FG001|Overall Study|Adverse Event|2|||
130831155|NCT01169701|471009107|FG000|Overall Study|Exclusion criteria|2|||
130831156|NCT01169701|471009108|FG001|Overall Study|Exclusion criteria|0|||
130831157|NCT01169701|471009107|FG000|Overall Study|Death|0|||
130831158|NCT01169701|471009108|FG001|Overall Study|Death|1|||
130831159|NCT01169701|471009107|FG000|Overall Study|Administrative problems|0|||
130831160|NCT01169701|471009108|FG001|Overall Study|Administrative problems|1|||
130831161|NCT01169701|471009107|FG000|Overall Study|Serious adverse event|0|||
130831162|NCT01169701|471009108|FG001|Overall Study|Serious adverse event|1|||
130831163|NCT01169701|471009107|FG000|Overall Study|Sponsor decision|0|||
130831164|NCT01169701|471009108|FG001|Overall Study|Sponsor decision|1|||
130831165|NCT00553436|471009109|FG000|Overall Study|Conversion to another procedure|1|||
130831166|NCT04188834|471009110|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
130831167|NCT01030952|471009111|FG000|Overall Study|Protocol Violation|0|||
130831168|NCT01030952|471009112|FG001|Overall Study|Protocol Violation|1|||
130831169|NCT01030952|471009111|FG000|Overall Study|Informed consent withdrawal|1|||
130831170|NCT01030952|471009112|FG001|Overall Study|Informed consent withdrawal|0|||
130831171|NCT01030952|471009111|FG000|Overall Study|Lost to Follow-up|0|||
130831172|NCT01030952|471009112|FG001|Overall Study|Lost to Follow-up|1|||
130831173|NCT01030952|471009111|FG000|Overall Study|Unexplained|1|||
130831174|NCT01030952|471009112|FG001|Overall Study|Unexplained|1|||
130831175|NCT01814046|471009117|FG000|Drug Administration|Death due to complications of RSV|1|||
130831176|NCT01814046|471009118|FG001|Drug Administration|Death due to complications of RSV|0|||
130831177|NCT01814046|471009119|FG002|Drug Administration|Death due to complications of RSV|0|||
130831178|NCT00958347|471009120|FG000|Overall Study|Death|43|||
130831179|NCT00958347|471009120|FG000|Overall Study|Withdrawal by Subject|23|||
130831180|NCT00958347|471009120|FG000|Overall Study|Lost to Follow-up|15|||
130831181|NCT00958347|471009120|FG000|Overall Study|revision/removal|10|||
130831182|NCT00958347|471009120|FG000|Overall Study|study termination|135|||
130831183|NCT01831466|471009130|FG000|Overall Study|Protocol Violation|1|||
130831184|NCT01831466|471009131|FG001|Overall Study|Protocol Violation|1|||
130831185|NCT01831466|471009132|FG002|Overall Study|Protocol Violation|2|||
130831186|NCT01831466|471009133|FG003|Overall Study|Protocol Violation|0|||
130831187|NCT01831466|471009134|FG004|Overall Study|Protocol Violation|0|||
130831188|NCT01831466|471009135|FG005|Overall Study|Protocol Violation|1|||
130831189|NCT01831466|471009136|FG006|Overall Study|Protocol Violation|0|||
130831190|NCT01831466|471009137|FG007|Overall Study|Protocol Violation|0|||
130831191|NCT01831466|471009138|FG008|Overall Study|Protocol Violation|0|||
130831192|NCT01831466|471009139|FG009|Overall Study|Protocol Violation|0|||
130831193|NCT01831466|471009140|FG010|Overall Study|Protocol Violation|0|||
130831194|NCT01831466|471009141|FG011|Overall Study|Protocol Violation|0|||
130831195|NCT01831466|471009130|FG000|Overall Study|Other|2|||
130831196|NCT01831466|471009131|FG001|Overall Study|Other|3|||
130831197|NCT01831466|471009132|FG002|Overall Study|Other|2|||
130831198|NCT01831466|471009133|FG003|Overall Study|Other|2|||
130831199|NCT01831466|471009134|FG004|Overall Study|Other|2|||
130831200|NCT01831466|471009135|FG005|Overall Study|Other|1|||
130831201|NCT01831466|471009136|FG006|Overall Study|Other|0|||
130831202|NCT01831466|471009137|FG007|Overall Study|Other|0|||
130831203|NCT01831466|471009138|FG008|Overall Study|Other|0|||
130831204|NCT01831466|471009139|FG009|Overall Study|Other|0|||
130831205|NCT01831466|471009140|FG010|Overall Study|Other|0|||
130831206|NCT01831466|471009141|FG011|Overall Study|Other|0|||
130831207|NCT01831466|471009130|FG000|Overall Study|Non-compliance with study treatment|2|||
130831208|NCT01831466|471009131|FG001|Overall Study|Non-compliance with study treatment|1|||
130831209|NCT01831466|471009132|FG002|Overall Study|Non-compliance with study treatment|1|||
130831210|NCT01831466|471009133|FG003|Overall Study|Non-compliance with study treatment|0|||
130831211|NCT01831466|471009134|FG004|Overall Study|Non-compliance with study treatment|0|||
130831212|NCT01831466|471009135|FG005|Overall Study|Non-compliance with study treatment|1|||
130831213|NCT01831466|471009136|FG006|Overall Study|Non-compliance with study treatment|0|||
130831214|NCT01831466|471009137|FG007|Overall Study|Non-compliance with study treatment|0|||
130831215|NCT01831466|471009138|FG008|Overall Study|Non-compliance with study treatment|0|||
130831216|NCT01831466|471009139|FG009|Overall Study|Non-compliance with study treatment|0|||
130831217|NCT01831466|471009140|FG010|Overall Study|Non-compliance with study treatment|0|||
130831218|NCT01831466|471009141|FG011|Overall Study|Non-compliance with study treatment|0|||
130831219|NCT01831466|471009130|FG000|Overall Study|Death|0|||
130831220|NCT01831466|471009131|FG001|Overall Study|Death|1|||
130831221|NCT01831466|471009132|FG002|Overall Study|Death|0|||
130831222|NCT01831466|471009133|FG003|Overall Study|Death|0|||
130831223|NCT01831466|471009134|FG004|Overall Study|Death|0|||
130831224|NCT01831466|471009135|FG005|Overall Study|Death|0|||
130831225|NCT01831466|471009136|FG006|Overall Study|Death|0|||
130831226|NCT01831466|471009137|FG007|Overall Study|Death|0|||
130831227|NCT01831466|471009138|FG008|Overall Study|Death|0|||
130831228|NCT01831466|471009139|FG009|Overall Study|Death|0|||
130831229|NCT01831466|471009140|FG010|Overall Study|Death|0|||
130831230|NCT01831466|471009141|FG011|Overall Study|Death|0|||
130831231|NCT01831466|471009130|FG000|Overall Study|Withdrawal by Subject|6|||
130831232|NCT01831466|471009131|FG001|Overall Study|Withdrawal by Subject|3|||
130831233|NCT01831466|471009132|FG002|Overall Study|Withdrawal by Subject|3|||
130831234|NCT01831466|471009133|FG003|Overall Study|Withdrawal by Subject|3|||
130831235|NCT01831466|471009134|FG004|Overall Study|Withdrawal by Subject|3|||
130831236|NCT01831466|471009135|FG005|Overall Study|Withdrawal by Subject|5|||
130831237|NCT01831466|471009136|FG006|Overall Study|Withdrawal by Subject|0|||
130831238|NCT01831466|471009137|FG007|Overall Study|Withdrawal by Subject|0|||
130831239|NCT01831466|471009138|FG008|Overall Study|Withdrawal by Subject|0|||
130831240|NCT01831466|471009139|FG009|Overall Study|Withdrawal by Subject|1|||
130831241|NCT01831466|471009140|FG010|Overall Study|Withdrawal by Subject|0|||
130831242|NCT01831466|471009141|FG011|Overall Study|Withdrawal by Subject|1|||
130831243|NCT01831466|471009130|FG000|Overall Study|Lost to Follow-up|0|||
130831244|NCT01831466|471009131|FG001|Overall Study|Lost to Follow-up|1|||
130831245|NCT01831466|471009132|FG002|Overall Study|Lost to Follow-up|4|||
130831246|NCT01831466|471009133|FG003|Overall Study|Lost to Follow-up|2|||
130831247|NCT01831466|471009134|FG004|Overall Study|Lost to Follow-up|0|||
130831248|NCT01831466|471009135|FG005|Overall Study|Lost to Follow-up|3|||
130831249|NCT01831466|471009136|FG006|Overall Study|Lost to Follow-up|0|||
130831250|NCT01831466|471009137|FG007|Overall Study|Lost to Follow-up|0|||
130831251|NCT01831466|471009138|FG008|Overall Study|Lost to Follow-up|0|||
130831252|NCT01831466|471009139|FG009|Overall Study|Lost to Follow-up|1|||
130831253|NCT01831466|471009140|FG010|Overall Study|Lost to Follow-up|0|||
130831254|NCT01831466|471009141|FG011|Overall Study|Lost to Follow-up|1|||
130831255|NCT01831466|471009130|FG000|Overall Study|Lack of Efficacy|5|||
130831256|NCT01831466|471009131|FG001|Overall Study|Lack of Efficacy|8|||
130831257|NCT01831466|471009132|FG002|Overall Study|Lack of Efficacy|7|||
130831258|NCT01831466|471009133|FG003|Overall Study|Lack of Efficacy|6|||
130831259|NCT01831466|471009134|FG004|Overall Study|Lack of Efficacy|9|||
130831260|NCT01831466|471009135|FG005|Overall Study|Lack of Efficacy|8|||
130831261|NCT01831466|471009136|FG006|Overall Study|Lack of Efficacy|1|||
130831262|NCT01831466|471009137|FG007|Overall Study|Lack of Efficacy|1|||
130831263|NCT01831466|471009138|FG008|Overall Study|Lack of Efficacy|2|||
130831264|NCT01831466|471009139|FG009|Overall Study|Lack of Efficacy|2|||
130831265|NCT01831466|471009140|FG010|Overall Study|Lack of Efficacy|2|||
130831266|NCT01831466|471009141|FG011|Overall Study|Lack of Efficacy|0|||
130831267|NCT01831466|471009130|FG000|Overall Study|Adverse Event|0|||
130831268|NCT01831466|471009131|FG001|Overall Study|Adverse Event|0|||
130831269|NCT01831466|471009132|FG002|Overall Study|Adverse Event|4|||
130831270|NCT01831466|471009133|FG003|Overall Study|Adverse Event|6|||
130831271|NCT01831466|471009134|FG004|Overall Study|Adverse Event|3|||
130831272|NCT01831466|471009135|FG005|Overall Study|Adverse Event|7|||
130831273|NCT01831466|471009136|FG006|Overall Study|Adverse Event|0|||
130831274|NCT01831466|471009137|FG007|Overall Study|Adverse Event|1|||
130831275|NCT01831466|471009138|FG008|Overall Study|Adverse Event|1|||
130831276|NCT01831466|471009139|FG009|Overall Study|Adverse Event|1|||
130831277|NCT01831466|471009140|FG010|Overall Study|Adverse Event|0|||
130831278|NCT01831466|471009141|FG011|Overall Study|Adverse Event|2|||
130831279|NCT03497039|471009145|FG000|Overall Study|Withdrawal by Subject|1|||
130831280|NCT03497039|471009146|FG001|Overall Study|Withdrawal by Subject|0|||
130831281|NCT03497039|471009145|FG000|Overall Study|Protocol Violation|0|||
130831282|NCT03497039|471009146|FG001|Overall Study|Protocol Violation|1|||
130831283|NCT02146131|471009147|FG000|Overall Study|Physician Decision|61|||
130831284|NCT02146131|471009148|FG001|Overall Study|Physician Decision|56|||
130831285|NCT00465972|471009151|FG000|Overall Study|Withdrawal by Subject|2|||
130831286|NCT00465972|471009152|FG001|Overall Study|Withdrawal by Subject|1|||
130831287|NCT00861692|471009157|FG000|Overall Study|Death|6|||
130831288|NCT03292640|471009158|FG000|Overall Study|Withdrawal by Subject|17|||
130831289|NCT03292640|471009159|FG001|Overall Study|Withdrawal by Subject|16|||
130831290|NCT03292640|471009158|FG000|Overall Study|Adverse Event|20|||
130831291|NCT03292640|471009159|FG001|Overall Study|Adverse Event|2|||
130831292|NCT03292640|471009158|FG000|Overall Study|Lost to Follow-up|24|||
130831293|NCT03292640|471009159|FG001|Overall Study|Lost to Follow-up|24|||
130831294|NCT02218697|471009160|FG000|Overall Study|Adverse Event|0|||
130831295|NCT02218697|471009161|FG001|Overall Study|Adverse Event|2|||
130831296|NCT02218697|471009160|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
130831297|NCT02218697|471009161|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
130831298|NCT02218697|471009160|FG000|Overall Study|Withdrawal by Subject|2|||
130831299|NCT02218697|471009161|FG001|Overall Study|Withdrawal by Subject|3|||
130831300|NCT04380753|471009164|FG000|Overall Study|Participants continuing study|4|||
130831301|NCT04380753|471009164|FG000|Overall Study|Death|2|||
130831302|NCT02311881|471009170|FG000|Overall Study|Did not meet the study criteria|2|||
130831303|NCT02311881|471009171|FG001|Overall Study|Did not meet the study criteria|2|||
130831304|NCT02311881|471009172|FG002|Overall Study|Did not meet the study criteria|0|||
130831305|NCT02311881|471009170|FG000|Overall Study|Adverse Event|7|||
130831306|NCT02311881|471009171|FG001|Overall Study|Adverse Event|15|||
130831307|NCT02311881|471009172|FG002|Overall Study|Adverse Event|8|||
130831308|NCT02311881|471009170|FG000|Overall Study|Lost to Follow-up|3|||
130831309|NCT02311881|471009171|FG001|Overall Study|Lost to Follow-up|3|||
130831310|NCT02311881|471009172|FG002|Overall Study|Lost to Follow-up|2|||
130831311|NCT02311881|471009170|FG000|Overall Study|Protocol Violation|1|||
130831312|NCT02311881|471009171|FG001|Overall Study|Protocol Violation|2|||
130831313|NCT02311881|471009172|FG002|Overall Study|Protocol Violation|3|||
130831314|NCT02311881|471009170|FG000|Overall Study|Withdrawal of consent|14|||
130831315|NCT02311881|471009171|FG001|Overall Study|Withdrawal of consent|16|||
130831316|NCT02311881|471009172|FG002|Overall Study|Withdrawal of consent|17|||
130831317|NCT02311881|471009170|FG000|Overall Study|Other|0|||
130831318|NCT02311881|471009171|FG001|Overall Study|Other|0|||
130831319|NCT02311881|471009172|FG002|Overall Study|Other|1|||
130831320|NCT02311881|471009170|FG000|Overall Study|Lack of Efficacy|1|||
130831321|NCT02311881|471009171|FG001|Overall Study|Lack of Efficacy|2|||
130831322|NCT02311881|471009172|FG002|Overall Study|Lack of Efficacy|0|||
130831323|NCT02311881|471009170|FG000|Overall Study|Subject has border line pregnancy test|1|||
130831324|NCT02311881|471009171|FG001|Overall Study|Subject has border line pregnancy test|0|||
130831325|NCT02311881|471009172|FG002|Overall Study|Subject has border line pregnancy test|0|||
130831326|NCT02311881|471009170|FG000|Overall Study|Withdrawal by Subject|3|||
130831327|NCT02311881|471009171|FG001|Overall Study|Withdrawal by Subject|1|||
130831328|NCT02311881|471009172|FG002|Overall Study|Withdrawal by Subject|4|||
130831329|NCT02311881|471009170|FG000|Overall Study|Sponsor Decision|1|||
130831330|NCT02311881|471009171|FG001|Overall Study|Sponsor Decision|1|||
130831331|NCT02311881|471009172|FG002|Overall Study|Sponsor Decision|1|||
130831332|NCT02311881|471009170|FG000|Overall Study|Protocol Deviation|1|||
130831333|NCT02311881|471009171|FG001|Overall Study|Protocol Deviation|0|||
130831334|NCT02311881|471009172|FG002|Overall Study|Protocol Deviation|0|||
130831335|NCT02311881|471009170|FG000|Overall Study|Non-Compliance|1|||
130831336|NCT02311881|471009171|FG001|Overall Study|Non-Compliance|0|||
130831337|NCT02311881|471009172|FG002|Overall Study|Non-Compliance|2|||
130831338|NCT02311881|471009170|FG000|Overall Study|Physician Decision|0|||
130831339|NCT02311881|471009171|FG001|Overall Study|Physician Decision|0|||
130831340|NCT02311881|471009172|FG002|Overall Study|Physician Decision|1|||
130831341|NCT02311881|471009170|FG000|Overall Study|Medical Monitor Discretion|0|||
130831342|NCT02311881|471009171|FG001|Overall Study|Medical Monitor Discretion|0|||
130831343|NCT02311881|471009172|FG002|Overall Study|Medical Monitor Discretion|1|||
130831344|NCT02311881|471009170|FG000|Overall Study|Participant taking another medication|0|||
130831345|NCT02311881|471009171|FG001|Overall Study|Participant taking another medication|0|||
130831346|NCT02311881|471009172|FG002|Overall Study|Participant taking another medication|1|||
130831347|NCT02311881|471009170|FG000|Overall Study|Serious Adverse Event|0|||
130831348|NCT02311881|471009171|FG001|Overall Study|Serious Adverse Event|1|||
130831349|NCT02311881|471009172|FG002|Overall Study|Serious Adverse Event|0|||
130831350|NCT03306433|471009175|FG000|Overall Study|Lost to Follow-up|3|||
130831351|NCT03306433|471009175|FG000|Overall Study|Patient did not have teeth extracted|1|||
130831352|NCT03306433|471009175|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
130831353|NCT00819156|471009176|FG000|Overall Study|Adverse Event|1|||
130831354|NCT00819156|471009177|FG001|Overall Study|Adverse Event|4|||
130831355|NCT00819156|471009178|FG002|Overall Study|Adverse Event|2|||
130831356|NCT00819156|471009179|FG003|Overall Study|Adverse Event|1|||
130831357|NCT00819156|471009180|FG004|Overall Study|Adverse Event|2|||
130831358|NCT00819156|471009181|FG005|Overall Study|Adverse Event|3|||
130831359|NCT00819156|471009176|FG000|Overall Study|Withdrawal by Subject|0|||
130831360|NCT00819156|471009177|FG001|Overall Study|Withdrawal by Subject|3|||
130831361|NCT00819156|471009178|FG002|Overall Study|Withdrawal by Subject|2|||
130831362|NCT00819156|471009179|FG003|Overall Study|Withdrawal by Subject|0|||
130831363|NCT00819156|471009180|FG004|Overall Study|Withdrawal by Subject|1|||
130831364|NCT00819156|471009181|FG005|Overall Study|Withdrawal by Subject|0|||
130831365|NCT00819156|471009176|FG000|Overall Study|Protocol Violation|1|||
130831366|NCT00819156|471009177|FG001|Overall Study|Protocol Violation|0|||
130831367|NCT00819156|471009178|FG002|Overall Study|Protocol Violation|1|||
130831368|NCT00819156|471009179|FG003|Overall Study|Protocol Violation|0|||
130831369|NCT00819156|471009180|FG004|Overall Study|Protocol Violation|0|||
130831370|NCT00819156|471009181|FG005|Overall Study|Protocol Violation|1|||
130831371|NCT00819156|471009176|FG000|Overall Study|Lost to Follow-up|0|||
130831372|NCT00819156|471009177|FG001|Overall Study|Lost to Follow-up|1|||
130831373|NCT00819156|471009178|FG002|Overall Study|Lost to Follow-up|0|||
130831374|NCT00819156|471009179|FG003|Overall Study|Lost to Follow-up|0|||
130831375|NCT00819156|471009180|FG004|Overall Study|Lost to Follow-up|0|||
130831376|NCT00819156|471009181|FG005|Overall Study|Lost to Follow-up|2|||
130831377|NCT00819156|471009176|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
130831378|NCT00819156|471009177|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
130831379|NCT00819156|471009178|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
130831380|NCT00819156|471009179|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
130831381|NCT00819156|471009180|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
130831382|NCT00819156|471009181|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
130831383|NCT00819156|471009176|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
130831384|NCT00819156|471009177|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130831385|NCT00819156|471009178|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130831386|NCT00819156|471009179|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130831387|NCT00819156|471009180|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
130831388|NCT00819156|471009181|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130831389|NCT00819156|471009176|FG000|Overall Study|Prostate-specific antigen progression|0|||
130831390|NCT00819156|471009177|FG001|Overall Study|Prostate-specific antigen progression|0|||
130831391|NCT00819156|471009178|FG002|Overall Study|Prostate-specific antigen progression|0|||
130831392|NCT00819156|471009179|FG003|Overall Study|Prostate-specific antigen progression|0|||
130831393|NCT00819156|471009180|FG004|Overall Study|Prostate-specific antigen progression|1|||
130831394|NCT00819156|471009181|FG005|Overall Study|Prostate-specific antigen progression|0|||
130831395|NCT00803595|471009182|FG000|Overall Study|Adverse Event|3|||
130831396|NCT00803595|471009183|FG001|Overall Study|Adverse Event|4|||
130831397|NCT00803595|471009184|FG002|Overall Study|Adverse Event|1|||
130831398|NCT00803595|471009182|FG000|Overall Study|Protocol Violation|7|||
130831399|NCT00803595|471009183|FG001|Overall Study|Protocol Violation|2|||
130831400|NCT00803595|471009184|FG002|Overall Study|Protocol Violation|12|||
130831401|NCT00803595|471009182|FG000|Overall Study|Withdrawal by Subject|5|||
130831402|NCT00803595|471009183|FG001|Overall Study|Withdrawal by Subject|2|||
130831403|NCT00803595|471009184|FG002|Overall Study|Withdrawal by Subject|3|||
130831404|NCT01597908|471009186|FG000|Randomized Phase|Death|217|||
130831405|NCT01597908|471009187|FG001|Randomized Phase|Death|238|||
130831406|NCT01597908|471009188|FG002|Randomized Phase|Death|0|||
130831407|NCT01597908|471009186|FG000|Randomized Phase|Sponsor Decision|93|||
130831408|NCT01597908|471009187|FG001|Randomized Phase|Sponsor Decision|39|||
130831409|NCT01597908|471009188|FG002|Randomized Phase|Sponsor Decision|0|||
130831410|NCT01597908|471009186|FG000|Randomized Phase|Lost to Follow-up|9|||
130831411|NCT01597908|471009187|FG001|Randomized Phase|Lost to Follow-up|16|||
130831412|NCT01597908|471009188|FG002|Randomized Phase|Lost to Follow-up|0|||
130831413|NCT01597908|471009186|FG000|Randomized Phase|Physician Decision|6|||
130831414|NCT01597908|471009187|FG001|Randomized Phase|Physician Decision|3|||
130831415|NCT01597908|471009188|FG002|Randomized Phase|Physician Decision|0|||
130831416|NCT01597908|471009186|FG000|Randomized Phase|Withdrawal by Subject|26|||
130831417|NCT01597908|471009187|FG001|Randomized Phase|Withdrawal by Subject|22|||
130831418|NCT01597908|471009188|FG002|Randomized Phase|Withdrawal by Subject|0|||
130831419|NCT01597908|471009186|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
130831420|NCT01597908|471009187|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
130831421|NCT01597908|471009188|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
130831422|NCT01597908|471009186|FG000|Crossover Phase|Death|0|||
130831423|NCT01597908|471009187|FG001|Crossover Phase|Death|0|||
130831424|NCT01597908|471009188|FG002|Crossover Phase|Death|11|||
130831425|NCT01597908|471009186|FG000|Crossover Phase|Withdrawal by Subject|0|||
130831426|NCT01597908|471009187|FG001|Crossover Phase|Withdrawal by Subject|0|||
130831427|NCT01597908|471009188|FG002|Crossover Phase|Withdrawal by Subject|3|||
130831428|NCT01597908|471009186|FG000|Crossover Phase|Sponsor Decision|0|||
130831429|NCT01597908|471009187|FG001|Crossover Phase|Sponsor Decision|0|||
130831430|NCT01597908|471009188|FG002|Crossover Phase|Sponsor Decision|20|||
130831431|NCT02709577|471009189|FG000|Overall Study|non-accommodating anatomy|0|||
130831432|NCT02709577|471009190|FG001|Overall Study|non-accommodating anatomy|1|||
130831433|NCT02709577|471009191|FG002|Overall Study|non-accommodating anatomy|0|||
130831434|NCT02709577|471009192|FG003|Overall Study|non-accommodating anatomy|0|||
130831435|NCT02709577|471009189|FG000|Overall Study|procedural complication|0|||
130831436|NCT02709577|471009190|FG001|Overall Study|procedural complication|1|||
130831437|NCT02709577|471009191|FG002|Overall Study|procedural complication|0|||
130831438|NCT02709577|471009192|FG003|Overall Study|procedural complication|0|||
130831439|NCT02709577|471009189|FG000|Overall Study|Withdrawal by Subject|2|||
130831440|NCT02709577|471009190|FG001|Overall Study|Withdrawal by Subject|3|||
130831441|NCT02709577|471009191|FG002|Overall Study|Withdrawal by Subject|2|||
130831442|NCT02709577|471009192|FG003|Overall Study|Withdrawal by Subject|0|||
130831443|NCT01575808|471009194|FG000|Overall Study|Death|2|||
130831444|NCT01575808|471009195|FG001|Overall Study|Death|0|||
130831445|NCT01575808|471009194|FG000|Overall Study|Withdrawal by Subject|1|||
130831446|NCT01575808|471009195|FG001|Overall Study|Withdrawal by Subject|0|||
130831447|NCT02403817|471010797|FG000|Overall Study|Withdrawal by Subject|5|||
130831448|NCT02403817|471010798|FG001|Overall Study|Withdrawal by Subject|0|||
130831449|NCT04908384|471010799|FG000|Overall Study|Lost to Follow-up|4|||
130831450|NCT04908384|471010800|FG001|Overall Study|Lost to Follow-up|4|||
130831451|NCT04908384|471010801|FG002|Overall Study|Lost to Follow-up|0|||
130831452|NCT04908384|471010802|FG003|Overall Study|Lost to Follow-up|0|||
130831453|NCT00430989|471010803|FG000|Overall Study|Lost to Follow-up|2|||
130831454|NCT00430989|471010804|FG001|Overall Study|Lost to Follow-up|3|||
130831455|NCT00430989|471010803|FG000|Overall Study|Withdrawal by Subject|15|||
130831456|NCT00430989|471010804|FG001|Overall Study|Withdrawal by Subject|14|||
130831457|NCT00430989|471010803|FG000|Overall Study|Protocol Violation|30|||
130831458|NCT00430989|471010804|FG001|Overall Study|Protocol Violation|37|||
130831459|NCT00430989|471010803|FG000|Overall Study|Not eligible|13|||
130831460|NCT00430989|471010804|FG001|Overall Study|Not eligible|6|||
130831461|NCT03050450|471010805|FG000|Overall Study|Physician Decision|1|||
130831462|NCT03050450|471010806|FG001|Overall Study|Physician Decision|0|||
130831463|NCT03050450|471010807|FG002|Overall Study|Physician Decision|0|||
130831464|NCT03050450|471010808|FG003|Overall Study|Physician Decision|0|||
130831465|NCT03050450|471010809|FG004|Overall Study|Physician Decision|0|||
130831466|NCT01642901|471010810|FG000|12-month Follow-up|Withdrawal by Subject|1|||
130831467|NCT01642901|471010811|FG001|12-month Follow-up|Withdrawal by Subject|0|||
130831468|NCT01701362|471010813|FG000|Overall Study|Adverse events not related to study drug|1|||
130831469|NCT01701362|471010814|FG001|Overall Study|Adverse events not related to study drug|6|||
130831470|NCT01701362|471010813|FG000|Overall Study|Adverse events related to study drug|12|||
130831471|NCT01701362|471010814|FG001|Overall Study|Adverse events related to study drug|10|||
130831472|NCT01701362|471010813|FG000|Overall Study|Protocol Violation|5|||
130831473|NCT01701362|471010814|FG001|Overall Study|Protocol Violation|3|||
130831474|NCT01701362|471010813|FG000|Overall Study|No longer willing to participate|8|||
130831475|NCT01701362|471010814|FG001|Overall Study|No longer willing to participate|14|||
130831476|NCT01701362|471010813|FG000|Overall Study|Lost to Follow-up|6|||
130831477|NCT01701362|471010814|FG001|Overall Study|Lost to Follow-up|9|||
130831478|NCT01701362|471010813|FG000|Overall Study|Insufficient clinical response|6|||
130831479|NCT01701362|471010814|FG001|Overall Study|Insufficient clinical response|6|||
130831480|NCT01701362|471010813|FG000|Overall Study|Death|0|||
130831481|NCT01701362|471010814|FG001|Overall Study|Death|1|||
130831482|NCT01701362|471010813|FG000|Overall Study|Randomized but not treated|1|||
130831483|NCT01701362|471010814|FG001|Overall Study|Randomized but not treated|2|||
130831484|NCT01701362|471010813|FG000|Overall Study|Reasons other than those mentioned above|3|||
130831485|NCT01701362|471010814|FG001|Overall Study|Reasons other than those mentioned above|5|||
130831486|NCT00570778|471010815|FG000|Overall Study|Protocol deviation|2|||
130831487|NCT00570778|471010816|FG001|Overall Study|Protocol deviation|1|||
130831488|NCT00570778|471010817|FG002|Overall Study|Protocol deviation|2|||
130831489|NCT00570778|471010818|FG003|Overall Study|Protocol deviation|2|||
130831490|NCT00570778|471010815|FG000|Overall Study|Adverse Event|0|||
130831491|NCT00570778|471010816|FG001|Overall Study|Adverse Event|1|||
130831492|NCT00570778|471010817|FG002|Overall Study|Adverse Event|4|||
130831493|NCT00570778|471010818|FG003|Overall Study|Adverse Event|1|||
130831494|NCT00570778|471010815|FG000|Overall Study|Subject withdrew consent|0|||
130831495|NCT00570778|471010816|FG001|Overall Study|Subject withdrew consent|1|||
130831496|NCT00570778|471010817|FG002|Overall Study|Subject withdrew consent|0|||
130831497|NCT00570778|471010818|FG003|Overall Study|Subject withdrew consent|1|||
130831498|NCT00570778|471010815|FG000|Overall Study|Abnormal test procedure|1|||
130831499|NCT00570778|471010816|FG001|Overall Study|Abnormal test procedure|0|||
130831500|NCT00570778|471010817|FG002|Overall Study|Abnormal test procedure|0|||
130831501|NCT00570778|471010818|FG003|Overall Study|Abnormal test procedure|0|||
130831502|NCT00570778|471010815|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130831503|NCT00570778|471010816|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130831504|NCT00570778|471010817|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130831505|NCT00570778|471010818|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130831506|NCT00570778|471010815|FG000|Overall Study|Lost to Follow-up|0|||
130831507|NCT00570778|471010816|FG001|Overall Study|Lost to Follow-up|0|||
130831508|NCT00570778|471010817|FG002|Overall Study|Lost to Follow-up|1|||
130831509|NCT00570778|471010818|FG003|Overall Study|Lost to Follow-up|0|||
130831510|NCT00570778|471010815|FG000|Overall Study|Subject no longer requires study drug|0|||
130831511|NCT00570778|471010816|FG001|Overall Study|Subject no longer requires study drug|1|||
130831512|NCT00570778|471010817|FG002|Overall Study|Subject no longer requires study drug|0|||
130831513|NCT00570778|471010818|FG003|Overall Study|Subject no longer requires study drug|0|||
130831514|NCT00711594|471010819|FG000|Overall Study|Progressive disease|2|||
130831515|NCT00711594|471010820|FG001|Overall Study|Progressive disease|2|||
130831516|NCT00711594|471010821|FG002|Overall Study|Progressive disease|6|||
130831517|NCT00711594|471010822|FG003|Overall Study|Progressive disease|44|||
130831518|NCT00711594|471010819|FG000|Overall Study|Other Adverse Event|1|||
130831519|NCT00711594|471010820|FG001|Overall Study|Other Adverse Event|0|||
130831520|NCT00711594|471010821|FG002|Overall Study|Other Adverse Event|0|||
130831521|NCT00711594|471010822|FG003|Overall Study|Other Adverse Event|16|||
130831522|NCT00711594|471010819|FG000|Overall Study|Withdrawal by Subject|0|||
130831523|NCT00711594|471010820|FG001|Overall Study|Withdrawal by Subject|1|||
130831524|NCT00711594|471010821|FG002|Overall Study|Withdrawal by Subject|0|||
130831525|NCT00711594|471010822|FG003|Overall Study|Withdrawal by Subject|2|||
130831526|NCT00443872|471010823|FG000|Overall Study|Protocol Violation|7|||
130831527|NCT00443872|471010823|FG000|Overall Study|Lost to Follow-up|2|||
130831528|NCT00443872|471010823|FG000|Overall Study|Adverse Event|8|||
130831529|NCT00383331|471010826|FG000|Overall Study|Protocol Violation|0|||
130831530|NCT00383331|471010827|FG001|Overall Study|Protocol Violation|1|||
130831531|NCT00375427|471010828|FG000|Overall Study|Adverse Event|21|||
130831532|NCT00375427|471010829|FG001|Overall Study|Adverse Event|27|||
130831533|NCT00375427|471010828|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130831534|NCT00375427|471010829|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130831535|NCT00375427|471010828|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130831536|NCT00375427|471010829|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130831537|NCT00375427|471010828|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130831538|NCT00375427|471010829|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130831539|NCT00375427|471010828|FG000|Overall Study|Patient no longer requires study drug|3|||
130831540|NCT00375427|471010829|FG001|Overall Study|Patient no longer requires study drug|7|||
130831541|NCT00375427|471010828|FG000|Overall Study|Protocol Violation|10|||
130831542|NCT00375427|471010829|FG001|Overall Study|Protocol Violation|8|||
130831543|NCT00375427|471010828|FG000|Overall Study|Withdrawal by Subject|9|||
130831544|NCT00375427|471010829|FG001|Overall Study|Withdrawal by Subject|13|||
130831545|NCT00375427|471010828|FG000|Overall Study|Lost to Follow-up|1|||
130831546|NCT00375427|471010829|FG001|Overall Study|Lost to Follow-up|1|||
130831547|NCT00375427|471010828|FG000|Overall Study|Administrative reasons|0|||
130831548|NCT00375427|471010829|FG001|Overall Study|Administrative reasons|1|||
130831549|NCT00375427|471010828|FG000|Overall Study|Death|11|||
130831550|NCT00375427|471010829|FG001|Overall Study|Death|10|||
130831551|NCT03850093|471010830|FG000|Overall Study|Withdrawal by Subject|1|||
130831552|NCT03850093|471010831|FG001|Overall Study|Withdrawal by Subject|0|||
130831553|NCT03850093|471010832|FG002|Overall Study|Withdrawal by Subject|2|||
130831554|NCT03226249|471010838|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
130831555|NCT03226249|471010838|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
130831556|NCT03226249|471010838|FG000|Survival Follow-up|Patients still in follow-up.|30|||
130831557|NCT00624468|471010842|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
130831558|NCT00624468|471010843|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
130831559|NCT00624468|471010844|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
130831560|NCT00624468|471010845|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
130831561|NCT00624468|471010842|FG000|Double-blind Period|Withdrew Prematurely|1|||
130831562|NCT00624468|471010843|FG001|Double-blind Period|Withdrew Prematurely|1|||
130831563|NCT00624468|471010844|FG002|Double-blind Period|Withdrew Prematurely|0|||
130831564|NCT00624468|471010845|FG003|Double-blind Period|Withdrew Prematurely|0|||
130831565|NCT00624468|471010842|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
130831566|NCT00624468|471010843|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
130831567|NCT00624468|471010844|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
130831568|NCT00624468|471010845|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
130831569|NCT00624468|471010842|FG000|Safety Follow-up (SFU) Period|Other|0|||
130831570|NCT00624468|471010843|FG001|Safety Follow-up (SFU) Period|Other|0|||
130831571|NCT00624468|471010844|FG002|Safety Follow-up (SFU) Period|Other|1|||
130831572|NCT00624468|471010845|FG003|Safety Follow-up (SFU) Period|Other|1|||
130831573|NCT00803361|471010854|FG000|Overall Study|Adverse Event|13|||
130831574|NCT00803361|471010855|FG001|Overall Study|Adverse Event|3|||
130831575|NCT00803361|471010854|FG000|Overall Study|Lack of Efficacy|4|||
130831576|NCT00803361|471010855|FG001|Overall Study|Lack of Efficacy|13|||
130831577|NCT00803361|471010854|FG000|Overall Study|Lost to Follow-up|1|||
130831578|NCT00803361|471010855|FG001|Overall Study|Lost to Follow-up|2|||
130831579|NCT00803361|471010854|FG000|Overall Study|Physician Decision|1|||
130831580|NCT00803361|471010855|FG001|Overall Study|Physician Decision|0|||
130831581|NCT00803361|471010854|FG000|Overall Study|Protocol Violation|2|||
130831582|NCT00803361|471010855|FG001|Overall Study|Protocol Violation|4|||
130831583|NCT00803361|471010854|FG000|Overall Study|Withdrawal by Subject|5|||
130831584|NCT00803361|471010855|FG001|Overall Study|Withdrawal by Subject|6|||
130831585|NCT04482439|471010856|FG000|Overall Study|Lost to Follow-up|1|||
130831586|NCT04482439|471010856|FG000|Overall Study|Unrelated illness|1|||
130831587|NCT03629223|471010857|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
130831588|NCT03629223|471010858|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
130831589|NCT03629223|471010859|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
130831590|NCT03629223|471010860|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
130831591|NCT03629223|471010861|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
130831592|NCT03629223|471010862|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
130831593|NCT03629223|471010857|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130831594|NCT03629223|471010858|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130831595|NCT03629223|471010859|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130831596|NCT03629223|471010860|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
130831597|NCT03629223|471010861|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130831598|NCT03629223|471010862|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130831599|NCT03629223|471010857|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130831600|NCT03629223|471010858|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
130831601|NCT03629223|471010859|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130831602|NCT03629223|471010860|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130831603|NCT03629223|471010861|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130831604|NCT03629223|471010862|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130831605|NCT03629223|471010857|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130831606|NCT03629223|471010858|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
130831607|NCT03629223|471010859|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130831608|NCT03629223|471010860|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130831609|NCT03629223|471010861|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130831610|NCT03629223|471010862|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130831611|NCT03629223|471010857|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
130831612|NCT03629223|471010858|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130831613|NCT03629223|471010859|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130831614|NCT03629223|471010860|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130831615|NCT03629223|471010861|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130831616|NCT03629223|471010862|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130831617|NCT01534351|471010863|FG000|Overall Study|Study Terminated Early|1|||
130831618|NCT01534351|471010864|FG001|Overall Study|Study Terminated Early|0|||
130831619|NCT01534351|471010865|FG002|Overall Study|Study Terminated Early|0|||
130831620|NCT02702609|471010866|FG000|Overall Study|Lost to Follow-up|8|||
130831621|NCT02702609|471010867|FG001|Overall Study|Lost to Follow-up|4|||
130831622|NCT02702609|471010866|FG000|Overall Study|Physician Decision|1|||
130831623|NCT02702609|471010867|FG001|Overall Study|Physician Decision|0|||
130831624|NCT02674464|471010868|FG000|Overall Study|Death|10|||
130831625|NCT02674464|471010869|FG001|Overall Study|Death|21|||
130831626|NCT02674464|471010868|FG000|Overall Study|Withdrawal by Subject|24|||
130831627|NCT02674464|471010869|FG001|Overall Study|Withdrawal by Subject|44|||
130831628|NCT02674464|471010868|FG000|Overall Study|Lost to Follow-up|97|||
130831629|NCT02674464|471010869|FG001|Overall Study|Lost to Follow-up|92|||
130831630|NCT02674464|471010868|FG000|Overall Study|Outside survey window|6|||
130831631|NCT02674464|471010869|FG001|Overall Study|Outside survey window|3|||
130831632|NCT00783835|471010870|FG000|Overall Study|Adverse Event|3|||
130831633|NCT00783835|471010870|FG000|Overall Study|Medical Criteria|1|||
130831634|NCT00783835|471010870|FG000|Overall Study|Withdrawal by Subject|2|||
130831635|NCT00783835|471010870|FG000|Overall Study|Lost to Follow-up|1|||
130831636|NCT00783835|471010870|FG000|Overall Study|Participant not Adherent|3|||
130831637|NCT04660552|471010871|FG000|Overall Study|Withdrawal by Subject|3|||
130831638|NCT04660552|471010872|FG001|Overall Study|Withdrawal by Subject|1|||
130831639|NCT02125838|471010873|FG000|Overall Study|Lost to Follow-up|4|||
130831640|NCT02125838|471010874|FG001|Overall Study|Lost to Follow-up|4|||
130831641|NCT00787839|471010875|FG000|Overall Study|Failure to have the OGTT was most common|404|||
130831642|NCT01970241|471010880|FG000|Overall Study|Withdrawal by Subject|2|||
130831643|NCT01970241|471010881|FG001|Overall Study|Withdrawal by Subject|0|||
130831644|NCT01970241|471010880|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
130831645|NCT01970241|471010881|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
130831646|NCT01001767|471010882|FG000|Overall Study|no baseline study performed|1|||
130831647|NCT01001767|471010883|FG001|Overall Study|no baseline study performed|0|||
130831648|NCT01001767|471010882|FG000|Overall Study|Protocol Violation|1|||
130831649|NCT01001767|471010883|FG001|Overall Study|Protocol Violation|0|||
130831650|NCT01001767|471010882|FG000|Overall Study|Lost to Follow-up|1|||
130831651|NCT01001767|471010883|FG001|Overall Study|Lost to Follow-up|0|||
130831652|NCT01001767|471010882|FG000|Overall Study|Physician Decision|1|||
130831653|NCT01001767|471010883|FG001|Overall Study|Physician Decision|0|||
130831654|NCT01667133|471010884|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
130831655|NCT01667133|471010885|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
130831656|NCT01667133|471010886|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
130831657|NCT01667133|471010887|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
130831658|NCT01667133|471010888|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
130831659|NCT01667133|471010889|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
130831660|NCT01667133|471010890|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
130831661|NCT01667133|471010891|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
130831662|NCT01667133|471010892|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
130831663|NCT01667133|471010893|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
130831664|NCT01667133|471010894|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
130831665|NCT01667133|471010895|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
130831666|NCT01667133|471010884|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831667|NCT01667133|471010885|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831668|NCT01667133|471010886|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
130831669|NCT01667133|471010887|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831670|NCT01667133|471010888|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831671|NCT01667133|471010889|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831672|NCT01667133|471010890|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831673|NCT01667133|471010891|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831674|NCT01667133|471010892|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831675|NCT01667133|471010893|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831676|NCT01667133|471010894|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831677|NCT01667133|471010895|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130831678|NCT01667133|471010884|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
130831679|NCT01667133|471010885|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
130831680|NCT01667133|471010886|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
130831681|NCT01667133|471010887|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
130831682|NCT01667133|471010888|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
130831683|NCT01667133|471010889|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
130831684|NCT01667133|471010890|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
130831685|NCT01667133|471010891|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
130831686|NCT01667133|471010892|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
130831687|NCT01667133|471010893|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
130831688|NCT01667133|471010894|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
130831689|NCT01667133|471010895|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
130831690|NCT01667133|471010884|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831691|NCT01667133|471010885|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831692|NCT01667133|471010886|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831693|NCT01667133|471010887|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
130831694|NCT01667133|471010888|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831695|NCT01667133|471010889|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831696|NCT01667133|471010890|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831697|NCT01667133|471010891|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831698|NCT01667133|471010892|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831699|NCT01667133|471010893|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831700|NCT01667133|471010894|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831701|NCT01667133|471010895|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130831702|NCT01667133|471010884|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
130831703|NCT01667133|471010885|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
130831704|NCT01667133|471010886|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
130831705|NCT01667133|471010887|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
130831706|NCT01667133|471010888|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
130831707|NCT01667133|471010889|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
130831708|NCT01667133|471010890|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
130831709|NCT01667133|471010891|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
130831710|NCT01667133|471010892|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
130831711|NCT01667133|471010893|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
130831712|NCT01667133|471010894|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
130831713|NCT01667133|471010895|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
130831714|NCT01667133|471010884|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831715|NCT01667133|471010885|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831716|NCT01667133|471010886|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831717|NCT01667133|471010887|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831718|NCT01667133|471010888|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831719|NCT01667133|471010889|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831720|NCT01667133|471010890|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831721|NCT01667133|471010891|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831722|NCT01667133|471010892|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831723|NCT01667133|471010893|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
130831724|NCT01667133|471010894|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831725|NCT01667133|471010895|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130831726|NCT01667133|471010884|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
130831727|NCT01667133|471010885|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
130831728|NCT01667133|471010886|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
130831729|NCT01667133|471010887|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
130831730|NCT01667133|471010888|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
130831731|NCT01667133|471010889|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
130831732|NCT01667133|471010890|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
130831733|NCT01667133|471010891|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
130831734|NCT01667133|471010892|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
130831735|NCT01667133|471010893|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
130831736|NCT01667133|471010894|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
130831737|NCT01667133|471010895|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
130831738|NCT01667133|471010884|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831739|NCT01667133|471010885|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831740|NCT01667133|471010886|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831741|NCT01667133|471010887|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831742|NCT01667133|471010888|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831743|NCT01667133|471010889|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831744|NCT01667133|471010890|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831745|NCT01667133|471010891|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831746|NCT01667133|471010892|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831747|NCT01667133|471010893|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
130831748|NCT01667133|471010894|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831749|NCT01667133|471010895|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130831750|NCT01667133|471010884|FG000|Phase 2: Dose-expansion|Death|0|||
130831751|NCT01667133|471010885|FG001|Phase 2: Dose-expansion|Death|0|||
130831752|NCT01667133|471010886|FG002|Phase 2: Dose-expansion|Death|0|||
130831753|NCT01667133|471010887|FG003|Phase 2: Dose-expansion|Death|0|||
130831754|NCT01667133|471010888|FG004|Phase 2: Dose-expansion|Death|0|||
130831755|NCT01667133|471010889|FG005|Phase 2: Dose-expansion|Death|0|||
130831756|NCT01667133|471010890|FG006|Phase 2: Dose-expansion|Death|0|||
130831757|NCT01667133|471010891|FG007|Phase 2: Dose-expansion|Death|0|||
130831758|NCT01667133|471010892|FG008|Phase 2: Dose-expansion|Death|0|||
130831759|NCT01667133|471010893|FG009|Phase 2: Dose-expansion|Death|1|||
130831760|NCT01667133|471010894|FG010|Phase 2: Dose-expansion|Death|0|||
130831761|NCT01667133|471010895|FG011|Phase 2: Dose-expansion|Death|0|||
130831762|NCT01667133|471010884|FG000|Phase 2: Dose-expansion|Other|0|||
130831763|NCT01667133|471010885|FG001|Phase 2: Dose-expansion|Other|0|||
130831764|NCT01667133|471010886|FG002|Phase 2: Dose-expansion|Other|0|||
130831765|NCT01667133|471010887|FG003|Phase 2: Dose-expansion|Other|0|||
130831766|NCT01667133|471010888|FG004|Phase 2: Dose-expansion|Other|0|||
130831767|NCT01667133|471010889|FG005|Phase 2: Dose-expansion|Other|0|||
130831768|NCT01667133|471010890|FG006|Phase 2: Dose-expansion|Other|0|||
130831769|NCT01667133|471010891|FG007|Phase 2: Dose-expansion|Other|0|||
130831770|NCT01667133|471010892|FG008|Phase 2: Dose-expansion|Other|0|||
130831771|NCT01667133|471010893|FG009|Phase 2: Dose-expansion|Other|0|||
130831772|NCT01667133|471010894|FG010|Phase 2: Dose-expansion|Other|0|||
130831773|NCT01667133|471010895|FG011|Phase 2: Dose-expansion|Other|1|||
130831774|NCT00191945|471010899|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
130831775|NCT00191945|471010900|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
130831776|NCT00191945|471010899|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
130831777|NCT00191945|471010900|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
130831778|NCT00191945|471010899|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
130831779|NCT00191945|471010900|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
130831780|NCT00191945|471010899|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
130831781|NCT00191945|471010900|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
130831782|NCT00289289|471010904|FG000|Overall Study|Withdrawal by Subject|5|||
130831783|NCT00289289|471010905|FG001|Overall Study|Withdrawal by Subject|3|||
130831784|NCT00289289|471010906|FG002|Overall Study|Withdrawal by Subject|15|||
130831785|NCT00289289|471010904|FG000|Overall Study|Lost to Follow-up|1|||
130831786|NCT00289289|471010905|FG001|Overall Study|Lost to Follow-up|0|||
130831787|NCT00289289|471010906|FG002|Overall Study|Lost to Follow-up|1|||
130831788|NCT00289289|471010904|FG000|Overall Study|Death|4|||
130831789|NCT00289289|471010905|FG001|Overall Study|Death|2|||
130831790|NCT00289289|471010906|FG002|Overall Study|Death|5|||
130831791|NCT00289289|471010904|FG000|Overall Study|No implant attempted|0|||
130831792|NCT00289289|471010905|FG001|Overall Study|No implant attempted|0|||
130831793|NCT00289289|471010906|FG002|Overall Study|No implant attempted|1|||
130831794|NCT00289289|471010904|FG000|Overall Study|Physician Decision|1|||
130831795|NCT00289289|471010905|FG001|Overall Study|Physician Decision|0|||
130831796|NCT00289289|471010906|FG002|Overall Study|Physician Decision|6|||
130831797|NCT00289289|471010904|FG000|Overall Study|Non-study device implanted|2|||
130831798|NCT00289289|471010905|FG001|Overall Study|Non-study device implanted|1|||
130831799|NCT00289289|471010906|FG002|Overall Study|Non-study device implanted|3|||
130831800|NCT00289289|471010904|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
130831801|NCT00289289|471010905|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
130831802|NCT00289289|471010906|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
130831803|NCT00289289|471010904|FG000|Overall Study|Other Exit Reason|6|||
130831804|NCT00289289|471010905|FG001|Overall Study|Other Exit Reason|4|||
130831805|NCT00289289|471010906|FG002|Overall Study|Other Exit Reason|12|||
130831806|NCT00564902|471010914|FG000|Overall Study|Withdrawal by Subject|0|||
130831807|NCT00564902|471010915|FG001|Overall Study|Withdrawal by Subject|3|||
130831808|NCT00564902|471010916|FG002|Overall Study|Withdrawal by Subject|4|||
130831809|NCT00564902|471010914|FG000|Overall Study|Death|1|||
130831810|NCT00564902|471010915|FG001|Overall Study|Death|1|||
130831811|NCT00564902|471010916|FG002|Overall Study|Death|0|||
130831812|NCT03583359|471010919|FG000|Overall Study|Withdrawal by Subject|15|||
130831813|NCT03583359|471010920|FG001|Overall Study|Withdrawal by Subject|6|||
130831814|NCT03583359|471010919|FG000|Overall Study|Lost to Follow-up|12|||
130831815|NCT03583359|471010920|FG001|Overall Study|Lost to Follow-up|3|||
130831816|NCT03583359|471010919|FG000|Overall Study|Adverse Event|0|||
130831817|NCT03583359|471010920|FG001|Overall Study|Adverse Event|1|||
130831818|NCT03583359|471010919|FG000|Overall Study|Protocol Violation|0|||
130831819|NCT03583359|471010920|FG001|Overall Study|Protocol Violation|1|||
130831820|NCT03583359|471010919|FG000|Overall Study|Other|2|||
130831821|NCT03583359|471010920|FG001|Overall Study|Other|1|||
130831822|NCT00375505|471010921|FG000|Overall Study|Adverse Event|1|||
130831823|NCT00375505|471010922|FG001|Overall Study|Adverse Event|2|||
130831824|NCT02470585|471010923|FG000|Overall Study|Death|224|||
130831825|NCT02470585|471010924|FG001|Overall Study|Death|227|||
130831826|NCT02470585|471010925|FG002|Overall Study|Death|199|||
130831827|NCT02470585|471010923|FG000|Overall Study|Withdrew consent|21|||
130831828|NCT02470585|471010924|FG001|Overall Study|Withdrew consent|22|||
130831829|NCT02470585|471010925|FG002|Overall Study|Withdrew consent|31|||
130831830|NCT02470585|471010923|FG000|Overall Study|Lost to Follow-up|8|||
130831831|NCT02470585|471010924|FG001|Overall Study|Lost to Follow-up|15|||
130831832|NCT02470585|471010925|FG002|Overall Study|Lost to Follow-up|13|||
130831833|NCT02470585|471010923|FG000|Overall Study|Sponsor discontinued study|117|||
130831834|NCT02470585|471010924|FG001|Overall Study|Sponsor discontinued study|110|||
130831835|NCT02470585|471010925|FG002|Overall Study|Sponsor discontinued study|122|||
130831836|NCT02470585|471010923|FG000|Overall Study|Other, not specified|5|||
130831837|NCT02470585|471010924|FG001|Overall Study|Other, not specified|7|||
130831838|NCT02470585|471010925|FG002|Overall Study|Other, not specified|14|||
130831839|NCT02470585|471010923|FG000|Overall Study|Missing due to site non-compliance|0|||
130831840|NCT02470585|471010924|FG001|Overall Study|Missing due to site non-compliance|2|||
130831841|NCT02470585|471010925|FG002|Overall Study|Missing due to site non-compliance|3|||
130831842|NCT00349349|471010927|FG000|Overall Study|Adverse Event|5|||
130831843|NCT00349349|471010928|FG001|Overall Study|Adverse Event|6|||
130831844|NCT00349349|471010929|FG002|Overall Study|Adverse Event|2|||
130831845|NCT00349349|471010927|FG000|Overall Study|Withdrawal by Subject|5|||
130831846|NCT00349349|471010928|FG001|Overall Study|Withdrawal by Subject|2|||
130831847|NCT00349349|471010929|FG002|Overall Study|Withdrawal by Subject|1|||
130831848|NCT00349349|471010927|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
130831849|NCT00349349|471010928|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
130831850|NCT00349349|471010929|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
130831851|NCT00349349|471010927|FG000|Overall Study|Death|13|||
130831852|NCT00349349|471010928|FG001|Overall Study|Death|10|||
130831853|NCT00349349|471010929|FG002|Overall Study|Death|1|||
130831854|NCT00349349|471010927|FG000|Overall Study|Other Treatment Selected|2|||
130831855|NCT00349349|471010928|FG001|Overall Study|Other Treatment Selected|0|||
130831856|NCT00349349|471010929|FG002|Overall Study|Other Treatment Selected|0|||
130831857|NCT00349349|471010927|FG000|Overall Study|Participant Reduced General Condition|0|||
130831858|NCT00349349|471010928|FG001|Overall Study|Participant Reduced General Condition|1|||
130831859|NCT00349349|471010929|FG002|Overall Study|Participant Reduced General Condition|0|||
130831860|NCT00349349|471010927|FG000|Overall Study|Physician Decision|1|||
130831861|NCT00349349|471010928|FG001|Overall Study|Physician Decision|2|||
130831862|NCT00349349|471010929|FG002|Overall Study|Physician Decision|1|||
130831863|NCT00349349|471010927|FG000|Overall Study|No Response|0|||
130831864|NCT00349349|471010928|FG001|Overall Study|No Response|3|||
130831865|NCT00349349|471010929|FG002|Overall Study|No Response|0|||
130831866|NCT00349349|471010927|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
130831867|NCT00349349|471010928|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
130831868|NCT00349349|471010929|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
130831869|NCT01854775|471010932|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
130831870|NCT01854775|471010933|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
130831871|NCT01854775|471010934|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
130831872|NCT01854775|471010932|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
130831873|NCT01854775|471010933|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
130831874|NCT01854775|471010934|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
130831875|NCT01854775|471010932|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
130831876|NCT01854775|471010933|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
130831877|NCT01854775|471010934|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
130831878|NCT01854775|471010932|FG000|Extension Phase|Pregnancy|3|||
130831879|NCT01854775|471010933|FG001|Extension Phase|Pregnancy|0|||
130831880|NCT01854775|471010934|FG002|Extension Phase|Pregnancy|0|||
130831881|NCT01854775|471010932|FG000|Extension Phase|Investigator's Discretion|1|||
130831882|NCT01854775|471010933|FG001|Extension Phase|Investigator's Discretion|0|||
130831883|NCT01854775|471010934|FG002|Extension Phase|Investigator's Discretion|0|||
130831884|NCT01854775|471010932|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
130831885|NCT01854775|471010933|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
130831886|NCT01854775|471010934|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
130831887|NCT01854775|471010932|FG000|Extension Phase|Lost to Follow-up|2|||
130831888|NCT01854775|471010933|FG001|Extension Phase|Lost to Follow-up|0|||
130831889|NCT01854775|471010934|FG002|Extension Phase|Lost to Follow-up|0|||
130831890|NCT01854775|471010932|FG000|Extension Phase|Still on Study|32|||
130831891|NCT01854775|471010933|FG001|Extension Phase|Still on Study|47|||
130831892|NCT01854775|471010934|FG002|Extension Phase|Still on Study|18|||
130831893|NCT05111002|471010935|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
130831894|NCT05111002|471010936|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
130831895|NCT05111002|471010935|FG000|Secondary Outcome|Lost to Follow-up|1|||
130831896|NCT05111002|471010936|FG001|Secondary Outcome|Lost to Follow-up|0|||
130831897|NCT04776720|471010939|FG000|Overall Study|COVID Related|4|||
130831898|NCT04776720|471010940|FG001|Overall Study|COVID Related|2|||
130831899|NCT04776720|471010939|FG000|Overall Study|Adverse Event|2|||
130831900|NCT04776720|471010940|FG001|Overall Study|Adverse Event|0|||
130831901|NCT04776720|471010939|FG000|Overall Study|Serious Adverse Event|0|||
130831902|NCT04776720|471010940|FG001|Overall Study|Serious Adverse Event|1|||
130831903|NCT04776720|471010939|FG000|Overall Study|Too Busy|3|||
130831904|NCT04776720|471010940|FG001|Overall Study|Too Busy|1|||
130831905|NCT04776720|471010939|FG000|Overall Study|Lost to Follow-up|1|||
130831906|NCT04776720|471010940|FG001|Overall Study|Lost to Follow-up|2|||
130831907|NCT04776720|471010939|FG000|Overall Study|Family|2|||
130831908|NCT04776720|471010940|FG001|Overall Study|Family|2|||
130831909|NCT04776720|471010939|FG000|Overall Study|No remote technology access|0|||
130831910|NCT04776720|471010940|FG001|Overall Study|No remote technology access|1|||
130831911|NCT04776720|471010939|FG000|Overall Study|Withdrawal by Subject|1|||
130831912|NCT04776720|471010940|FG001|Overall Study|Withdrawal by Subject|0|||
130831913|NCT04776720|471010939|FG000|Overall Study|Cannot tolerate intervention|1|||
130831914|NCT04776720|471010940|FG001|Overall Study|Cannot tolerate intervention|0|||
130831915|NCT04776720|471010939|FG000|Overall Study|Incomplete outcome data|6|||
130831916|NCT04776720|471010940|FG001|Overall Study|Incomplete outcome data|1|||
130831917|NCT05356910|471010941|FG000|Overall Study|Lost to Follow-up|10|||
130831918|NCT05356910|471010942|FG001|Overall Study|Lost to Follow-up|19|||
130831919|NCT05356910|471010943|FG002|Overall Study|Lost to Follow-up|0|||
130831920|NCT05356910|471010944|FG003|Overall Study|Lost to Follow-up|0|||
130831921|NCT05356910|471010941|FG000|Overall Study|Withdrawal by Subject|4|||
130831922|NCT05356910|471010942|FG001|Overall Study|Withdrawal by Subject|2|||
130831923|NCT05356910|471010943|FG002|Overall Study|Withdrawal by Subject|0|||
130831924|NCT05356910|471010944|FG003|Overall Study|Withdrawal by Subject|0|||
130831925|NCT03122145|471010946|FG000|Overall Study|Concurrent respiratory disease|3|||
130831926|NCT03122145|471010947|FG001|Overall Study|Concurrent respiratory disease|0|||
130831927|NCT00837161|471010948|FG000|Overall Study|refused hysterectomy|2|||
130831928|NCT01659996|471010951|FG000|Overall Study|Protocol Violation|3|||
130831929|NCT01659996|471010952|FG001|Overall Study|Protocol Violation|3|||
130831930|NCT01659996|471010953|FG002|Overall Study|Protocol Violation|3|||
130831931|NCT01659996|471010951|FG000|Overall Study|Lost to Follow-up|1|||
130831932|NCT01659996|471010952|FG001|Overall Study|Lost to Follow-up|3|||
130831933|NCT01659996|471010953|FG002|Overall Study|Lost to Follow-up|2|||
130831934|NCT01659996|471010951|FG000|Overall Study|Adverse Event|0|||
130831935|NCT01659996|471010952|FG001|Overall Study|Adverse Event|0|||
130831936|NCT01659996|471010953|FG002|Overall Study|Adverse Event|1|||
130831937|NCT01659996|471010951|FG000|Overall Study|Withdrawal by Subject|4|||
130831938|NCT01659996|471010952|FG001|Overall Study|Withdrawal by Subject|1|||
130831939|NCT01659996|471010953|FG002|Overall Study|Withdrawal by Subject|5|||
130831940|NCT00451958|471010956|FG000|CS21A (NCT00451958)|Adverse Event|21|||
130831941|NCT00451958|471010957|FG001|CS21A (NCT00451958)|Adverse Event|34|||
130831942|NCT00451958|471010958|FG002|CS21A (NCT00451958)|Adverse Event|14|||
130831943|NCT00451958|471010959|FG003|CS21A (NCT00451958)|Adverse Event|17|||
130831944|NCT00451958|471010960|FG004|CS21A (NCT00451958)|Adverse Event|0|||
130831945|NCT00451958|471010956|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
130831946|NCT00451958|471010957|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
130831947|NCT00451958|471010958|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
130831948|NCT00451958|471010959|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
130831949|NCT00451958|471010960|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
130831950|NCT00451958|471010956|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
130831951|NCT00451958|471010957|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
130831952|NCT00451958|471010958|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
130831953|NCT00451958|471010959|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
130831954|NCT00451958|471010960|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
130831955|NCT00451958|471010956|FG000|CS21A (NCT00451958)|Physician Decision|2|||
130831956|NCT00451958|471010957|FG001|CS21A (NCT00451958)|Physician Decision|4|||
130831957|NCT00451958|471010958|FG002|CS21A (NCT00451958)|Physician Decision|4|||
130831958|NCT00451958|471010959|FG003|CS21A (NCT00451958)|Physician Decision|4|||
130831959|NCT00451958|471010960|FG004|CS21A (NCT00451958)|Physician Decision|0|||
130831960|NCT00451958|471010956|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
130831961|NCT00451958|471010957|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
130831962|NCT00451958|471010958|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
130831963|NCT00451958|471010959|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
130831964|NCT00451958|471010960|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
130831965|NCT00451958|471010956|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
130831966|NCT00451958|471010957|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
130831967|NCT00451958|471010958|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
130831968|NCT00451958|471010959|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
130831969|NCT00451958|471010960|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
130831970|NCT03281629|471010961|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
130831971|NCT03281629|471010962|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
130831972|NCT03281629|471010961|FG000|Overall Study|Death|0|||
130831973|NCT03281629|471010962|FG001|Overall Study|Death|1|||
130831974|NCT03281629|471010961|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
130831975|NCT03281629|471010962|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
130831976|NCT02175277|471010963|FG000|Overall Study|Protocol-specified Criteria|1|||
130831977|NCT03744910|471012933|FG000|Overall Study|Withdrew Consent|1|||
130831978|NCT03744910|471012934|FG001|Overall Study|Withdrew Consent|8|||
130831979|NCT03744910|471012933|FG000|Overall Study|Physician Decision|5|||
130831980|NCT03744910|471012934|FG001|Overall Study|Physician Decision|4|||
130831981|NCT03744910|471012933|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
130831982|NCT03744910|471012934|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
130831983|NCT03744910|471012933|FG000|Overall Study|Lost to Follow-up|0|||
130831984|NCT03744910|471012934|FG001|Overall Study|Lost to Follow-up|1|||
130831985|NCT03744910|471012933|FG000|Overall Study|Other-unspecified|4|||
130831986|NCT03744910|471012934|FG001|Overall Study|Other-unspecified|1|||
130831987|NCT00064259|471012935|FG000|Overall Study|Adverse Event|1|||
130831988|NCT00064259|471012936|FG001|Overall Study|Adverse Event|0|||
130831989|NCT00064259|471012937|FG002|Overall Study|Adverse Event|0|||
130831990|NCT00064259|471012938|FG003|Overall Study|Adverse Event|1|||
130831991|NCT01132651|471012941|FG000|Overall Study|Lost to Follow-up|1|||
130831992|NCT01132651|471012942|FG001|Overall Study|Lost to Follow-up|1|||
130831993|NCT00948857|471012943|FG000|Overall Study|Lost to Follow-up|1|||
130831994|NCT00948857|471012944|FG001|Overall Study|Lost to Follow-up|0|||
130831995|NCT03430843|471012947|FG000|Overall Study|Death|233|||
130831996|NCT03430843|471012948|FG001|Overall Study|Death|233|||
130831997|NCT03430843|471012947|FG000|Overall Study|Sponsor Decision|17|||
130831998|NCT03430843|471012948|FG001|Overall Study|Sponsor Decision|6|||
130831999|NCT03430843|471012947|FG000|Overall Study|Withdrawal by Subject|5|||
130832000|NCT03430843|471012948|FG001|Overall Study|Withdrawal by Subject|14|||
130832001|NCT03430843|471012947|FG000|Overall Study|Lost to Follow-up|1|||
130832002|NCT03430843|471012948|FG001|Overall Study|Lost to Follow-up|3|||
130832003|NCT01905943|471012955|FG000|Overall Study|Withdrawal of consent|90|||
130832004|NCT01905943|471012955|FG000|Overall Study|Lost to Follow-up|16|||
130832005|NCT01905943|471012955|FG000|Overall Study|Investigator discretion|7|||
130832006|NCT01905943|471012955|FG000|Overall Study|Death|186|||
130832007|NCT01905943|471012955|FG000|Overall Study|Adverse Event|3|||
130832008|NCT01905943|471012955|FG000|Overall Study|Other|12|||
130832009|NCT02574078|471012956|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130832010|NCT02574078|471012957|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130832011|NCT02574078|471012958|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130832012|NCT02574078|471012959|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130832013|NCT02574078|471012960|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130832014|NCT02574078|471012961|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130832015|NCT02574078|471012962|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
130832016|NCT02574078|471012963|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130832017|NCT02574078|471012964|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130832018|NCT02574078|471012965|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130832019|NCT02574078|471012966|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130832020|NCT02574078|471012967|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130832021|NCT02574078|471012968|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130832022|NCT02574078|471012956|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
130832023|NCT02574078|471012957|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130832024|NCT02574078|471012958|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
130832025|NCT02574078|471012959|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
130832026|NCT02574078|471012960|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
130832027|NCT02574078|471012961|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
130832028|NCT02574078|471012962|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
130832029|NCT02574078|471012963|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
130832030|NCT02574078|471012964|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
130832031|NCT02574078|471012965|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
130832032|NCT02574078|471012966|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
130832033|NCT02574078|471012967|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
130832034|NCT02574078|471012968|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
130832035|NCT02574078|471012956|FG000|Pre-Treatment Period|Other reasons|0|||
130832036|NCT02574078|471012957|FG001|Pre-Treatment Period|Other reasons|0|||
130832037|NCT02574078|471012958|FG002|Pre-Treatment Period|Other reasons|0|||
130832038|NCT02574078|471012959|FG003|Pre-Treatment Period|Other reasons|0|||
130832039|NCT02574078|471012960|FG004|Pre-Treatment Period|Other reasons|0|||
130832040|NCT02574078|471012961|FG005|Pre-Treatment Period|Other reasons|0|||
130832041|NCT02574078|471012962|FG006|Pre-Treatment Period|Other reasons|2|||
130832042|NCT02574078|471012963|FG007|Pre-Treatment Period|Other reasons|0|||
130832043|NCT02574078|471012964|FG008|Pre-Treatment Period|Other reasons|0|||
130832044|NCT02574078|471012965|FG009|Pre-Treatment Period|Other reasons|0|||
130832045|NCT02574078|471012966|FG010|Pre-Treatment Period|Other reasons|2|||
130832046|NCT02574078|471012967|FG011|Pre-Treatment Period|Other reasons|0|||
130832047|NCT02574078|471012968|FG012|Pre-Treatment Period|Other reasons|0|||
130832048|NCT02574078|471012956|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
130832049|NCT02574078|471012957|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
130832050|NCT02574078|471012958|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
130832051|NCT02574078|471012959|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
130832052|NCT02574078|471012960|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
130832053|NCT02574078|471012961|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
130832054|NCT02574078|471012962|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
130832055|NCT02574078|471012963|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
130832056|NCT02574078|471012964|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
130832057|NCT02574078|471012965|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
130832058|NCT02574078|471012966|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
130832059|NCT02574078|471012967|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
130832060|NCT02574078|471012968|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
130832061|NCT02574078|471012956|FG000|Treatment Period|Disease progression|6|||
130832062|NCT02574078|471012957|FG001|Treatment Period|Disease progression|4|||
130832063|NCT02574078|471012958|FG002|Treatment Period|Disease progression|7|||
130832064|NCT02574078|471012959|FG003|Treatment Period|Disease progression|18|||
130832065|NCT02574078|471012960|FG004|Treatment Period|Disease progression|16|||
130832066|NCT02574078|471012961|FG005|Treatment Period|Disease progression|26|||
130832067|NCT02574078|471012962|FG006|Treatment Period|Disease progression|5|||
130832068|NCT02574078|471012963|FG007|Treatment Period|Disease progression|9|||
130832069|NCT02574078|471012964|FG008|Treatment Period|Disease progression|8|||
130832070|NCT02574078|471012965|FG009|Treatment Period|Disease progression|5|||
130832071|NCT02574078|471012966|FG010|Treatment Period|Disease progression|20|||
130832072|NCT02574078|471012967|FG011|Treatment Period|Disease progression|29|||
130832073|NCT02574078|471012968|FG012|Treatment Period|Disease progression|2|||
130832074|NCT02574078|471012956|FG000|Treatment Period|Study drug toxicity|1|||
130832075|NCT02574078|471012957|FG001|Treatment Period|Study drug toxicity|1|||
130832076|NCT02574078|471012958|FG002|Treatment Period|Study drug toxicity|0|||
130832077|NCT02574078|471012959|FG003|Treatment Period|Study drug toxicity|5|||
130832078|NCT02574078|471012960|FG004|Treatment Period|Study drug toxicity|3|||
130832079|NCT02574078|471012961|FG005|Treatment Period|Study drug toxicity|1|||
130832080|NCT02574078|471012962|FG006|Treatment Period|Study drug toxicity|2|||
130832081|NCT02574078|471012963|FG007|Treatment Period|Study drug toxicity|0|||
130832082|NCT02574078|471012964|FG008|Treatment Period|Study drug toxicity|2|||
130832083|NCT02574078|471012965|FG009|Treatment Period|Study drug toxicity|1|||
130832084|NCT02574078|471012966|FG010|Treatment Period|Study drug toxicity|16|||
130832085|NCT02574078|471012967|FG011|Treatment Period|Study drug toxicity|2|||
130832086|NCT02574078|471012968|FG012|Treatment Period|Study drug toxicity|4|||
130832087|NCT02574078|471012956|FG000|Treatment Period|Death|2|||
130832088|NCT02574078|471012957|FG001|Treatment Period|Death|0|||
130832089|NCT02574078|471012958|FG002|Treatment Period|Death|0|||
130832090|NCT02574078|471012959|FG003|Treatment Period|Death|0|||
130832091|NCT02574078|471012960|FG004|Treatment Period|Death|1|||
130832092|NCT02574078|471012961|FG005|Treatment Period|Death|1|||
130832093|NCT02574078|471012962|FG006|Treatment Period|Death|1|||
130832094|NCT02574078|471012963|FG007|Treatment Period|Death|1|||
130832095|NCT02574078|471012964|FG008|Treatment Period|Death|7|||
130832096|NCT02574078|471012965|FG009|Treatment Period|Death|1|||
130832097|NCT02574078|471012966|FG010|Treatment Period|Death|0|||
130832098|NCT02574078|471012967|FG011|Treatment Period|Death|2|||
130832099|NCT02574078|471012968|FG012|Treatment Period|Death|1|||
130832100|NCT02574078|471012956|FG000|Treatment Period|Adverse event unrelated to drug|0|||
130832101|NCT02574078|471012957|FG001|Treatment Period|Adverse event unrelated to drug|0|||
130832102|NCT02574078|471012958|FG002|Treatment Period|Adverse event unrelated to drug|1|||
130832103|NCT02574078|471012959|FG003|Treatment Period|Adverse event unrelated to drug|0|||
130832104|NCT02574078|471012960|FG004|Treatment Period|Adverse event unrelated to drug|2|||
130832105|NCT02574078|471012961|FG005|Treatment Period|Adverse event unrelated to drug|3|||
130832106|NCT02574078|471012962|FG006|Treatment Period|Adverse event unrelated to drug|0|||
130832107|NCT02574078|471012963|FG007|Treatment Period|Adverse event unrelated to drug|0|||
130832108|NCT02574078|471012964|FG008|Treatment Period|Adverse event unrelated to drug|1|||
130832109|NCT02574078|471012965|FG009|Treatment Period|Adverse event unrelated to drug|2|||
130832110|NCT02574078|471012966|FG010|Treatment Period|Adverse event unrelated to drug|4|||
130832111|NCT02574078|471012967|FG011|Treatment Period|Adverse event unrelated to drug|1|||
130832112|NCT02574078|471012968|FG012|Treatment Period|Adverse event unrelated to drug|0|||
130832113|NCT02574078|471012956|FG000|Treatment Period|Administrative reason by Sponsor|0|||
130832114|NCT02574078|471012957|FG001|Treatment Period|Administrative reason by Sponsor|1|||
130832115|NCT02574078|471012958|FG002|Treatment Period|Administrative reason by Sponsor|0|||
130832116|NCT02574078|471012959|FG003|Treatment Period|Administrative reason by Sponsor|0|||
130832117|NCT02574078|471012960|FG004|Treatment Period|Administrative reason by Sponsor|0|||
130832118|NCT02574078|471012961|FG005|Treatment Period|Administrative reason by Sponsor|0|||
130832119|NCT02574078|471012962|FG006|Treatment Period|Administrative reason by Sponsor|1|||
130832120|NCT02574078|471012963|FG007|Treatment Period|Administrative reason by Sponsor|0|||
130832121|NCT02574078|471012964|FG008|Treatment Period|Administrative reason by Sponsor|0|||
130832122|NCT02574078|471012965|FG009|Treatment Period|Administrative reason by Sponsor|0|||
130832123|NCT02574078|471012966|FG010|Treatment Period|Administrative reason by Sponsor|0|||
130832124|NCT02574078|471012967|FG011|Treatment Period|Administrative reason by Sponsor|0|||
130832125|NCT02574078|471012968|FG012|Treatment Period|Administrative reason by Sponsor|3|||
130832126|NCT02574078|471012956|FG000|Treatment Period|Other reasons|1|||
130832127|NCT02574078|471012957|FG001|Treatment Period|Other reasons|0|||
130832128|NCT02574078|471012958|FG002|Treatment Period|Other reasons|1|||
130832129|NCT02574078|471012959|FG003|Treatment Period|Other reasons|3|||
130832130|NCT02574078|471012960|FG004|Treatment Period|Other reasons|3|||
130832131|NCT02574078|471012961|FG005|Treatment Period|Other reasons|1|||
130832132|NCT02574078|471012962|FG006|Treatment Period|Other reasons|2|||
130832133|NCT02574078|471012963|FG007|Treatment Period|Other reasons|1|||
130832134|NCT02574078|471012964|FG008|Treatment Period|Other reasons|3|||
130832135|NCT02574078|471012965|FG009|Treatment Period|Other reasons|1|||
130832136|NCT02574078|471012966|FG010|Treatment Period|Other reasons|1|||
130832137|NCT02574078|471012967|FG011|Treatment Period|Other reasons|3|||
130832138|NCT02574078|471012968|FG012|Treatment Period|Other reasons|1|||
130832139|NCT02574078|471012956|FG000|Treatment Period|Participant request to stop drug|0|||
130832140|NCT02574078|471012957|FG001|Treatment Period|Participant request to stop drug|0|||
130832141|NCT02574078|471012958|FG002|Treatment Period|Participant request to stop drug|0|||
130832142|NCT02574078|471012959|FG003|Treatment Period|Participant request to stop drug|2|||
130832143|NCT02574078|471012960|FG004|Treatment Period|Participant request to stop drug|4|||
130832144|NCT02574078|471012961|FG005|Treatment Period|Participant request to stop drug|0|||
130832145|NCT02574078|471012962|FG006|Treatment Period|Participant request to stop drug|1|||
130832146|NCT02574078|471012963|FG007|Treatment Period|Participant request to stop drug|0|||
130832147|NCT02574078|471012964|FG008|Treatment Period|Participant request to stop drug|3|||
130832148|NCT02574078|471012965|FG009|Treatment Period|Participant request to stop drug|2|||
130832149|NCT02574078|471012966|FG010|Treatment Period|Participant request to stop drug|2|||
130832150|NCT02574078|471012967|FG011|Treatment Period|Participant request to stop drug|4|||
130832151|NCT02574078|471012968|FG012|Treatment Period|Participant request to stop drug|1|||
130832152|NCT02574078|471012956|FG000|Treatment Period|Participant withdrew consent|0|||
130832153|NCT02574078|471012957|FG001|Treatment Period|Participant withdrew consent|0|||
130832154|NCT02574078|471012958|FG002|Treatment Period|Participant withdrew consent|0|||
130832155|NCT02574078|471012959|FG003|Treatment Period|Participant withdrew consent|0|||
130832156|NCT02574078|471012960|FG004|Treatment Period|Participant withdrew consent|1|||
130832157|NCT02574078|471012961|FG005|Treatment Period|Participant withdrew consent|1|||
130832158|NCT02574078|471012962|FG006|Treatment Period|Participant withdrew consent|0|||
130832159|NCT02574078|471012963|FG007|Treatment Period|Participant withdrew consent|1|||
130832160|NCT02574078|471012964|FG008|Treatment Period|Participant withdrew consent|0|||
130832161|NCT02574078|471012965|FG009|Treatment Period|Participant withdrew consent|2|||
130832162|NCT02574078|471012966|FG010|Treatment Period|Participant withdrew consent|1|||
130832163|NCT02574078|471012967|FG011|Treatment Period|Participant withdrew consent|4|||
130832164|NCT02574078|471012968|FG012|Treatment Period|Participant withdrew consent|1|||
130832165|NCT02574078|471012956|FG000|Treatment Period|Participant no longer meets criteria|0|||
130832166|NCT02574078|471012957|FG001|Treatment Period|Participant no longer meets criteria|0|||
130832167|NCT02574078|471012958|FG002|Treatment Period|Participant no longer meets criteria|0|||
130832168|NCT02574078|471012959|FG003|Treatment Period|Participant no longer meets criteria|0|||
130832169|NCT02574078|471012960|FG004|Treatment Period|Participant no longer meets criteria|1|||
130832170|NCT02574078|471012961|FG005|Treatment Period|Participant no longer meets criteria|0|||
130832171|NCT02574078|471012962|FG006|Treatment Period|Participant no longer meets criteria|0|||
130832172|NCT02574078|471012963|FG007|Treatment Period|Participant no longer meets criteria|0|||
130832173|NCT02574078|471012964|FG008|Treatment Period|Participant no longer meets criteria|0|||
130832174|NCT02574078|471012965|FG009|Treatment Period|Participant no longer meets criteria|1|||
130832175|NCT02574078|471012966|FG010|Treatment Period|Participant no longer meets criteria|1|||
130832176|NCT02574078|471012967|FG011|Treatment Period|Participant no longer meets criteria|1|||
130832177|NCT02574078|471012968|FG012|Treatment Period|Participant no longer meets criteria|0|||
130832178|NCT02574078|471012956|FG000|Treatment Period|Lost to Follow-up|0|||
130832179|NCT02574078|471012957|FG001|Treatment Period|Lost to Follow-up|0|||
130832180|NCT02574078|471012958|FG002|Treatment Period|Lost to Follow-up|0|||
130832181|NCT02574078|471012959|FG003|Treatment Period|Lost to Follow-up|0|||
130832182|NCT02574078|471012960|FG004|Treatment Period|Lost to Follow-up|0|||
130832183|NCT02574078|471012961|FG005|Treatment Period|Lost to Follow-up|0|||
130832184|NCT02574078|471012962|FG006|Treatment Period|Lost to Follow-up|0|||
130832185|NCT02574078|471012963|FG007|Treatment Period|Lost to Follow-up|0|||
130832186|NCT02574078|471012964|FG008|Treatment Period|Lost to Follow-up|0|||
130832187|NCT02574078|471012965|FG009|Treatment Period|Lost to Follow-up|1|||
130832188|NCT02574078|471012966|FG010|Treatment Period|Lost to Follow-up|0|||
130832189|NCT02574078|471012967|FG011|Treatment Period|Lost to Follow-up|1|||
130832190|NCT02574078|471012968|FG012|Treatment Period|Lost to Follow-up|0|||
130832191|NCT02574078|471012956|FG000|Treatment Period|Maximum clinical benefit|0|||
130832192|NCT02574078|471012957|FG001|Treatment Period|Maximum clinical benefit|0|||
130832193|NCT02574078|471012958|FG002|Treatment Period|Maximum clinical benefit|0|||
130832194|NCT02574078|471012959|FG003|Treatment Period|Maximum clinical benefit|0|||
130832195|NCT02574078|471012960|FG004|Treatment Period|Maximum clinical benefit|0|||
130832196|NCT02574078|471012961|FG005|Treatment Period|Maximum clinical benefit|0|||
130832197|NCT02574078|471012962|FG006|Treatment Period|Maximum clinical benefit|0|||
130832198|NCT02574078|471012963|FG007|Treatment Period|Maximum clinical benefit|0|||
130832199|NCT02574078|471012964|FG008|Treatment Period|Maximum clinical benefit|0|||
130832200|NCT02574078|471012965|FG009|Treatment Period|Maximum clinical benefit|1|||
130832201|NCT02574078|471012966|FG010|Treatment Period|Maximum clinical benefit|0|||
130832202|NCT02574078|471012967|FG011|Treatment Period|Maximum clinical benefit|0|||
130832203|NCT02574078|471012968|FG012|Treatment Period|Maximum clinical benefit|0|||
130832204|NCT03037476|471012969|FG000|Overall Study|Lost to Follow-up|63|||
130832205|NCT03037476|471012970|FG001|Overall Study|Lost to Follow-up|46|||
130832206|NCT01498692|471012973|FG000|Overall Study|Death|4|||
130832207|NCT01498692|471012973|FG000|Overall Study|Withdrawal by Subject|1|||
130832208|NCT01498692|471012973|FG000|Overall Study|Missed 12-month visit|3|||
130832209|NCT00590122|471012974|FG000|Overall Study|swallowed oral dissolving dose|1|||
130832210|NCT00590122|471012975|FG001|Overall Study|swallowed oral dissolving dose|0|||
130832211|NCT01208324|471012976|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
130832212|NCT01208324|471012977|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
130832213|NCT01208324|471012978|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
130832214|NCT01208324|471012979|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
130832215|NCT02707965|471012980|FG000|Overall Study|Withdrawal by Subject|0|||
130832216|NCT02707965|471012981|FG001|Overall Study|Withdrawal by Subject|0|||
130832217|NCT02707965|471012982|FG002|Overall Study|Withdrawal by Subject|1|||
130832218|NCT02707965|471012983|FG003|Overall Study|Withdrawal by Subject|0|||
130832219|NCT02707965|471012984|FG004|Overall Study|Withdrawal by Subject|0|||
130832220|NCT02707965|471012985|FG005|Overall Study|Withdrawal by Subject|0|||
130832221|NCT02707965|471012986|FG006|Overall Study|Withdrawal by Subject|0|||
130832222|NCT02707965|471012987|FG007|Overall Study|Withdrawal by Subject|2|||
130832223|NCT02707965|471012988|FG008|Overall Study|Withdrawal by Subject|0|||
130832224|NCT02707965|471012989|FG009|Overall Study|Withdrawal by Subject|0|||
130832225|NCT02707965|471012990|FG010|Overall Study|Withdrawal by Subject|0|||
130832226|NCT02707965|471012991|FG011|Overall Study|Withdrawal by Subject|0|||
130832227|NCT02707965|471012992|FG012|Overall Study|Withdrawal by Subject|0|||
130832228|NCT02707965|471012993|FG013|Overall Study|Withdrawal by Subject|0|||
130832229|NCT02707965|471012994|FG014|Overall Study|Withdrawal by Subject|0|||
130832230|NCT02707965|471012995|FG015|Overall Study|Withdrawal by Subject|0|||
130832231|NCT02707965|471012980|FG000|Overall Study|PI decisions|0|||
130832232|NCT02707965|471012981|FG001|Overall Study|PI decisions|0|||
130832233|NCT02707965|471012982|FG002|Overall Study|PI decisions|0|||
130832234|NCT02707965|471012983|FG003|Overall Study|PI decisions|0|||
130832235|NCT02707965|471012984|FG004|Overall Study|PI decisions|0|||
130832236|NCT02707965|471012985|FG005|Overall Study|PI decisions|0|||
130832237|NCT02707965|471012986|FG006|Overall Study|PI decisions|0|||
130832238|NCT02707965|471012987|FG007|Overall Study|PI decisions|0|||
130832239|NCT02707965|471012988|FG008|Overall Study|PI decisions|0|||
130832240|NCT02707965|471012989|FG009|Overall Study|PI decisions|0|||
130832241|NCT02707965|471012990|FG010|Overall Study|PI decisions|0|||
130832242|NCT02707965|471012991|FG011|Overall Study|PI decisions|0|||
130832243|NCT02707965|471012992|FG012|Overall Study|PI decisions|0|||
130832244|NCT02707965|471012993|FG013|Overall Study|PI decisions|0|||
130832245|NCT02707965|471012994|FG014|Overall Study|PI decisions|2|||
130832246|NCT02707965|471012995|FG015|Overall Study|PI decisions|0|||
130832247|NCT02707965|471012980|FG000|Overall Study|Protocol deviation|1|||
130832248|NCT02707965|471012981|FG001|Overall Study|Protocol deviation|1|||
130832249|NCT02707965|471012982|FG002|Overall Study|Protocol deviation|0|||
130832250|NCT02707965|471012983|FG003|Overall Study|Protocol deviation|0|||
130832251|NCT02707965|471012984|FG004|Overall Study|Protocol deviation|0|||
130832252|NCT02707965|471012985|FG005|Overall Study|Protocol deviation|0|||
130832253|NCT02707965|471012986|FG006|Overall Study|Protocol deviation|0|||
130832254|NCT02707965|471012987|FG007|Overall Study|Protocol deviation|1|||
130832255|NCT02707965|471012988|FG008|Overall Study|Protocol deviation|0|||
130832256|NCT02707965|471012989|FG009|Overall Study|Protocol deviation|0|||
130832257|NCT02707965|471012990|FG010|Overall Study|Protocol deviation|0|||
130832258|NCT02707965|471012991|FG011|Overall Study|Protocol deviation|0|||
130832259|NCT02707965|471012992|FG012|Overall Study|Protocol deviation|0|||
130832260|NCT02707965|471012993|FG013|Overall Study|Protocol deviation|0|||
130832261|NCT02707965|471012994|FG014|Overall Study|Protocol deviation|0|||
130832262|NCT02707965|471012995|FG015|Overall Study|Protocol deviation|0|||
130832263|NCT00249808|471012996|FG000|Overall Study|Other|27|||
130832264|NCT00249808|471012996|FG000|Overall Study|Protocol Violation|3|||
130832265|NCT00249808|471012996|FG000|Overall Study|Lost to Follow-up|8|||
130832266|NCT00249808|471012996|FG000|Overall Study|Adverse Event|81|||
130832267|NCT00249808|471012996|FG000|Overall Study|Lack of Efficacy|52|||
130832268|NCT00249808|471012996|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
130832269|NCT02120781|471013000|FG000|Overall Study|Physician Decision|2|||
130832270|NCT02120781|471013001|FG001|Overall Study|Physician Decision|0|||
130832271|NCT02120781|471013000|FG000|Overall Study|Completion not documented|2|||
130832272|NCT02120781|471013001|FG001|Overall Study|Completion not documented|1|||
130832273|NCT00654745|471013004|FG000|Overall Study|Adverse Event|12|||
130832274|NCT00654745|471013004|FG000|Overall Study|Lost to Follow-up|7|||
130832275|NCT00654745|471013004|FG000|Overall Study|Protocol Violation|11|||
130832276|NCT00654745|471013004|FG000|Overall Study|Withdrawal by Subject|10|||
130832277|NCT00654745|471013004|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
130832278|NCT00984165|471013005|FG000|Overall Study|Death on study|2|||
130832279|NCT00984165|471013006|FG001|Overall Study|Death on study|0|||
130832280|NCT00984165|471013007|FG002|Overall Study|Death on study|0|||
130832281|NCT00984165|471013008|FG003|Overall Study|Death on study|0|||
130832282|NCT00984165|471013005|FG000|Overall Study|Disease progression on study|5|||
130832283|NCT00984165|471013006|FG001|Overall Study|Disease progression on study|1|||
130832284|NCT00984165|471013007|FG002|Overall Study|Disease progression on study|0|||
130832285|NCT00984165|471013008|FG003|Overall Study|Disease progression on study|0|||
130832286|NCT00984165|471013005|FG000|Overall Study|Death of recipient|0|||
130832287|NCT00984165|471013006|FG001|Overall Study|Death of recipient|0|||
130832288|NCT00984165|471013007|FG002|Overall Study|Death of recipient|0|||
130832289|NCT00984165|471013008|FG003|Overall Study|Death of recipient|1|||
130832290|NCT00984165|471013005|FG000|Overall Study|New protocol|0|||
130832291|NCT00984165|471013006|FG001|Overall Study|New protocol|0|||
130832292|NCT00984165|471013007|FG002|Overall Study|New protocol|0|||
130832293|NCT00984165|471013008|FG003|Overall Study|New protocol|1|||
130832294|NCT00984165|471013005|FG000|Overall Study|P+/donor pair removed from protocol|0|||
130832295|NCT00984165|471013006|FG001|Overall Study|P+/donor pair removed from protocol|0|||
130832296|NCT00984165|471013007|FG002|Overall Study|P+/donor pair removed from protocol|0|||
130832297|NCT00984165|471013008|FG003|Overall Study|P+/donor pair removed from protocol|1|||
130832298|NCT00984165|471013005|FG000|Overall Study|removed with a pair recipient|0|||
130832299|NCT00984165|471013006|FG001|Overall Study|removed with a pair recipient|0|||
130832300|NCT00984165|471013007|FG002|Overall Study|removed with a pair recipient|0|||
130832301|NCT00984165|471013008|FG003|Overall Study|removed with a pair recipient|1|||
130832302|NCT00466947|471013009|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
130832303|NCT00466947|471013010|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
130832304|NCT00466947|471013009|FG000|Study End Analysis Period|Adverse Event|35|||
130832305|NCT00466947|471013010|FG001|Study End Analysis Period|Adverse Event|43|||
130832306|NCT00466947|471013009|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
130832307|NCT00466947|471013010|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
130832308|NCT00466947|471013009|FG000|Study End Analysis Period|Physician Decision|29|||
130832309|NCT00466947|471013010|FG001|Study End Analysis Period|Physician Decision|29|||
130832310|NCT00466947|471013009|FG000|Study End Analysis Period|Protocol Violation|9|||
130832311|NCT00466947|471013010|FG001|Study End Analysis Period|Protocol Violation|17|||
130832312|NCT00466947|471013009|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
130832313|NCT00466947|471013010|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
130832314|NCT00466947|471013009|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
130832315|NCT00466947|471013010|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
130832316|NCT00466947|471013009|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
130832317|NCT00466947|471013010|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
130832318|NCT00466947|471013009|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
130832319|NCT00466947|471013010|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
130832320|NCT01995526|471013011|FG000|Overall Study|Physician Decision|1|||
130832321|NCT00135330|471013016|FG000|Overall Study|Adverse Event|2|||
130832322|NCT00135330|471013017|FG001|Overall Study|Adverse Event|5|||
130832323|NCT00135330|471013018|FG002|Overall Study|Adverse Event|1|||
130832324|NCT00135330|471013016|FG000|Overall Study|Lost to Follow-up|0|||
130832325|NCT00135330|471013017|FG001|Overall Study|Lost to Follow-up|2|||
130832326|NCT00135330|471013018|FG002|Overall Study|Lost to Follow-up|3|||
130832327|NCT00135330|471013016|FG000|Overall Study|Physician Decision|1|||
130832328|NCT00135330|471013017|FG001|Overall Study|Physician Decision|1|||
130832329|NCT00135330|471013018|FG002|Overall Study|Physician Decision|0|||
130832330|NCT00135330|471013016|FG000|Overall Study|Protocol Violation|4|||
130832331|NCT00135330|471013017|FG001|Overall Study|Protocol Violation|3|||
130832332|NCT00135330|471013018|FG002|Overall Study|Protocol Violation|3|||
130832333|NCT00135330|471013016|FG000|Overall Study|Patient Decision|5|||
130832334|NCT00135330|471013017|FG001|Overall Study|Patient Decision|1|||
130832335|NCT00135330|471013018|FG002|Overall Study|Patient Decision|4|||
130832336|NCT00135330|471013016|FG000|Overall Study|Sponsor Decision|0|||
130832337|NCT00135330|471013017|FG001|Overall Study|Sponsor Decision|1|||
130832338|NCT00135330|471013018|FG002|Overall Study|Sponsor Decision|0|||
130832339|NCT02229825|471013020|FG000|Overall Study|Personal Reasons|0|||
130832340|NCT02229825|471013021|FG001|Overall Study|Personal Reasons|1|||
130832341|NCT02229825|471013020|FG000|Overall Study|Refused continuing medication|7|||
130832342|NCT02229825|471013021|FG001|Overall Study|Refused continuing medication|6|||
130832343|NCT02229825|471013020|FG000|Overall Study|Lost to Follow-up|1|||
130832344|NCT02229825|471013021|FG001|Overall Study|Lost to Follow-up|2|||
130832345|NCT02229825|471013020|FG000|Overall Study|Protocol Violation|1|||
130832346|NCT02229825|471013021|FG001|Overall Study|Protocol Violation|1|||
130832347|NCT02229825|471013020|FG000|Overall Study|Lack of Efficacy|4|||
130832348|NCT02229825|471013021|FG001|Overall Study|Lack of Efficacy|10|||
130832349|NCT02229825|471013020|FG000|Overall Study|Adverse Event|11|||
130832350|NCT02229825|471013021|FG001|Overall Study|Adverse Event|9|||
130832351|NCT02229825|471013020|FG000|Overall Study|Not treated|0|||
130832352|NCT02229825|471013021|FG001|Overall Study|Not treated|1|||
130832353|NCT00104416|471013022|FG000|Double-Blind Phase|Adverse Event|2|||
130832354|NCT00104416|471013023|FG001|Double-Blind Phase|Adverse Event|1|||
130832355|NCT00104416|471013024|FG002|Double-Blind Phase|Adverse Event|0|||
130832356|NCT00104416|471013025|FG003|Double-Blind Phase|Adverse Event|0|||
130832357|NCT00104416|471013026|FG004|Double-Blind Phase|Adverse Event|0|||
130832358|NCT00104416|471013022|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130832359|NCT00104416|471013023|FG001|Double-Blind Phase|Lost to Follow-up|1|||
130832360|NCT00104416|471013024|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130832361|NCT00104416|471013025|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130832362|NCT00104416|471013026|FG004|Double-Blind Phase|Lost to Follow-up|0|||
130832363|NCT00104416|471013022|FG000|Double-Blind Phase|Protocol Violation|0|||
130832364|NCT00104416|471013023|FG001|Double-Blind Phase|Protocol Violation|1|||
130832365|NCT00104416|471013024|FG002|Double-Blind Phase|Protocol Violation|0|||
130832366|NCT00104416|471013025|FG003|Double-Blind Phase|Protocol Violation|0|||
130832367|NCT00104416|471013026|FG004|Double-Blind Phase|Protocol Violation|0|||
130832368|NCT00104416|471013022|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130832369|NCT00104416|471013023|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
130832370|NCT00104416|471013024|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130832371|NCT00104416|471013025|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130832372|NCT00104416|471013026|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130832373|NCT00104416|471013022|FG000|Double-Blind Phase|Pregnancy|1|||
130832374|NCT00104416|471013023|FG001|Double-Blind Phase|Pregnancy|0|||
130832375|NCT00104416|471013024|FG002|Double-Blind Phase|Pregnancy|0|||
130832376|NCT00104416|471013025|FG003|Double-Blind Phase|Pregnancy|0|||
130832377|NCT00104416|471013026|FG004|Double-Blind Phase|Pregnancy|0|||
130832378|NCT00104416|471013022|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
130832379|NCT00104416|471013023|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
130832380|NCT00104416|471013024|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
130832381|NCT00104416|471013025|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
130832382|NCT00104416|471013026|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
130832383|NCT00104416|471013022|FG000|Continuation Phase|Adverse Event|0|||
130832384|NCT00104416|471013023|FG001|Continuation Phase|Adverse Event|0|||
130832385|NCT00104416|471013024|FG002|Continuation Phase|Adverse Event|2|||
130832386|NCT00104416|471013025|FG003|Continuation Phase|Adverse Event|0|||
130832387|NCT00104416|471013026|FG004|Continuation Phase|Adverse Event|2|||
130832388|NCT00104416|471013022|FG000|Continuation Phase|Lost to Follow-up|0|||
130832389|NCT00104416|471013023|FG001|Continuation Phase|Lost to Follow-up|0|||
130832390|NCT00104416|471013024|FG002|Continuation Phase|Lost to Follow-up|1|||
130832391|NCT00104416|471013025|FG003|Continuation Phase|Lost to Follow-up|0|||
130832392|NCT00104416|471013026|FG004|Continuation Phase|Lost to Follow-up|1|||
130832393|NCT00104416|471013022|FG000|Continuation Phase|Withdrawal by Subject|0|||
130832394|NCT00104416|471013023|FG001|Continuation Phase|Withdrawal by Subject|0|||
130832395|NCT00104416|471013024|FG002|Continuation Phase|Withdrawal by Subject|2|||
130832396|NCT00104416|471013025|FG003|Continuation Phase|Withdrawal by Subject|1|||
130832397|NCT00104416|471013026|FG004|Continuation Phase|Withdrawal by Subject|1|||
130832398|NCT00104416|471013022|FG000|Continuation Phase|Pregnancy|0|||
130832399|NCT00104416|471013023|FG001|Continuation Phase|Pregnancy|0|||
130832400|NCT00104416|471013024|FG002|Continuation Phase|Pregnancy|1|||
130832401|NCT00104416|471013025|FG003|Continuation Phase|Pregnancy|1|||
130832402|NCT00104416|471013026|FG004|Continuation Phase|Pregnancy|0|||
130832403|NCT00104416|471013022|FG000|Continuation Phase|Non-compliance|0|||
130832404|NCT00104416|471013023|FG001|Continuation Phase|Non-compliance|0|||
130832405|NCT00104416|471013024|FG002|Continuation Phase|Non-compliance|0|||
130832406|NCT00104416|471013025|FG003|Continuation Phase|Non-compliance|0|||
130832407|NCT00104416|471013026|FG004|Continuation Phase|Non-compliance|1|||
130832408|NCT01309997|471013027|FG000|Overall Study|Adverse Event|1|||
130832409|NCT01309997|471013028|FG001|Overall Study|Adverse Event|0|||
130832410|NCT01309997|471013027|FG000|Overall Study|Death|1|||
130832411|NCT01309997|471013028|FG001|Overall Study|Death|3|||
130832412|NCT01309997|471013027|FG000|Overall Study|Lack of Efficacy|2|||
130832413|NCT01309997|471013028|FG001|Overall Study|Lack of Efficacy|2|||
130832414|NCT01309997|471013027|FG000|Overall Study|Withdrawal by Subject|1|||
130832415|NCT01309997|471013028|FG001|Overall Study|Withdrawal by Subject|1|||
130832416|NCT03462641|471013031|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
130832417|NCT03462641|471013032|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
130832418|NCT03462641|471013031|FG000|Visit 2|Withdrawal by Subject|0|||
130832419|NCT03462641|471013032|FG001|Visit 2|Withdrawal by Subject|1|||
130832420|NCT02096952|471013033|FG000|Overall Study|Adverse Event|1|||
130832421|NCT00372619|471013034|FG000|Overall Study|Ineligible|0|||
130832422|NCT00372619|471013035|FG001|Overall Study|Ineligible|0|||
130832423|NCT00372619|471013036|FG002|Overall Study|Ineligible|0|||
130832424|NCT00372619|471013037|FG003|Overall Study|Ineligible|0|||
130832425|NCT00372619|471013038|FG004|Overall Study|Ineligible|0|||
130832426|NCT00372619|471013039|FG005|Overall Study|Ineligible|2|||
130832427|NCT00372619|471013040|FG006|Overall Study|Ineligible|0|||
130832428|NCT00372619|471013034|FG000|Overall Study|Inevaluable|0|||
130832429|NCT00372619|471013035|FG001|Overall Study|Inevaluable|0|||
130832430|NCT00372619|471013036|FG002|Overall Study|Inevaluable|0|||
130832431|NCT00372619|471013037|FG003|Overall Study|Inevaluable|0|||
130832432|NCT00372619|471013038|FG004|Overall Study|Inevaluable|0|||
130832433|NCT00372619|471013039|FG005|Overall Study|Inevaluable|1|||
130832434|NCT00372619|471013040|FG006|Overall Study|Inevaluable|0|||
130832435|NCT00066222|471013041|FG000|Overall Study|No protocol treatment received|1|||
130832436|NCT02684617|471013042|FG000|Overall Study|Adverse Event|1|||
130832437|NCT02684617|471013043|FG001|Overall Study|Adverse Event|0|||
130832438|NCT02684617|471013044|FG002|Overall Study|Adverse Event|1|||
130832439|NCT02684617|471013042|FG000|Overall Study|Death|8|||
130832440|NCT02684617|471013043|FG001|Overall Study|Death|16|||
130832441|NCT02684617|471013044|FG002|Overall Study|Death|28|||
130832442|NCT02684617|471013042|FG000|Overall Study|Withdrawal by Subject|2|||
130832443|NCT02684617|471013043|FG001|Overall Study|Withdrawal by Subject|0|||
130832444|NCT02684617|471013044|FG002|Overall Study|Withdrawal by Subject|4|||
130832445|NCT02684617|471013042|FG000|Overall Study|Screen Failure|1|||
130832446|NCT02684617|471013043|FG001|Overall Study|Screen Failure|0|||
130832447|NCT02684617|471013044|FG002|Overall Study|Screen Failure|2|||
130832448|NCT02684617|471013042|FG000|Overall Study|Study Terminated by Sponsor|6|||
130832449|NCT02684617|471013043|FG001|Overall Study|Study Terminated by Sponsor|1|||
130832450|NCT02684617|471013044|FG002|Overall Study|Study Terminated by Sponsor|5|||
130832451|NCT01524224|471013051|FG000|Overall Study|Progressive Disease|1|||
130832452|NCT01524224|471013052|FG001|Overall Study|Progressive Disease|0|||
130832453|NCT01524224|471013053|FG002|Overall Study|Progressive Disease|2|||
130832454|NCT01524224|471013054|FG003|Overall Study|Progressive Disease|1|||
130832455|NCT01524224|471013055|FG004|Overall Study|Progressive Disease|2|||
130832456|NCT01524224|471013056|FG005|Overall Study|Progressive Disease|1|||
130832457|NCT01524224|471013057|FG006|Overall Study|Progressive Disease|1|||
130832458|NCT01524224|471013058|FG007|Overall Study|Progressive Disease|5|||
130832459|NCT01524224|471013051|FG000|Overall Study|Withdrawal by Subject|2|||
130832460|NCT01524224|471013052|FG001|Overall Study|Withdrawal by Subject|0|||
130832461|NCT01524224|471013053|FG002|Overall Study|Withdrawal by Subject|0|||
130832462|NCT01524224|471013054|FG003|Overall Study|Withdrawal by Subject|0|||
130832463|NCT01524224|471013055|FG004|Overall Study|Withdrawal by Subject|0|||
130832464|NCT01524224|471013056|FG005|Overall Study|Withdrawal by Subject|0|||
130832465|NCT01524224|471013057|FG006|Overall Study|Withdrawal by Subject|2|||
130832466|NCT01524224|471013058|FG007|Overall Study|Withdrawal by Subject|0|||
130832467|NCT01524224|471013051|FG000|Overall Study|Adverse Event|0|||
130832468|NCT01524224|471013052|FG001|Overall Study|Adverse Event|1|||
130832469|NCT01524224|471013053|FG002|Overall Study|Adverse Event|0|||
130832470|NCT01524224|471013054|FG003|Overall Study|Adverse Event|0|||
130832471|NCT01524224|471013055|FG004|Overall Study|Adverse Event|0|||
130832472|NCT01524224|471013056|FG005|Overall Study|Adverse Event|1|||
130832473|NCT01524224|471013057|FG006|Overall Study|Adverse Event|0|||
130832474|NCT01524224|471013058|FG007|Overall Study|Adverse Event|0|||
130832475|NCT01524224|471013051|FG000|Overall Study|Physician Decision|0|||
130832476|NCT01524224|471013052|FG001|Overall Study|Physician Decision|0|||
130832477|NCT01524224|471013053|FG002|Overall Study|Physician Decision|0|||
130832478|NCT01524224|471013054|FG003|Overall Study|Physician Decision|1|||
130832479|NCT01524224|471013055|FG004|Overall Study|Physician Decision|1|||
130832480|NCT01524224|471013056|FG005|Overall Study|Physician Decision|0|||
130832481|NCT01524224|471013057|FG006|Overall Study|Physician Decision|0|||
130832482|NCT01524224|471013058|FG007|Overall Study|Physician Decision|1|||
130832483|NCT01524224|471013051|FG000|Overall Study|Sponsor Decision|0|||
130832484|NCT01524224|471013052|FG001|Overall Study|Sponsor Decision|0|||
130832485|NCT01524224|471013053|FG002|Overall Study|Sponsor Decision|0|||
130832486|NCT01524224|471013054|FG003|Overall Study|Sponsor Decision|0|||
130832487|NCT01524224|471013055|FG004|Overall Study|Sponsor Decision|1|||
130832488|NCT01524224|471013056|FG005|Overall Study|Sponsor Decision|0|||
130832489|NCT01524224|471013057|FG006|Overall Study|Sponsor Decision|0|||
130832490|NCT01524224|471013058|FG007|Overall Study|Sponsor Decision|0|||
130832491|NCT05420961|471013060|FG000|Overall Study|Withdrawal by Subject|2|||
130832492|NCT05420961|471013061|FG001|Overall Study|Withdrawal by Subject|1|||
130832493|NCT05420961|471013062|FG002|Overall Study|Withdrawal by Subject|1|||
130832494|NCT05420961|471013063|FG003|Overall Study|Withdrawal by Subject|0|||
130832495|NCT05420961|471013064|FG004|Overall Study|Withdrawal by Subject|0|||
130832496|NCT05420961|471013060|FG000|Overall Study|Lost to Follow-up|0|||
130832497|NCT05420961|471013061|FG001|Overall Study|Lost to Follow-up|0|||
130832498|NCT05420961|471013062|FG002|Overall Study|Lost to Follow-up|1|||
130832499|NCT05420961|471013063|FG003|Overall Study|Lost to Follow-up|0|||
130832500|NCT05420961|471013064|FG004|Overall Study|Lost to Follow-up|0|||
130832501|NCT05420961|471013060|FG000|Overall Study|Randomized by mistake without study treatment|0|||
130832502|NCT05420961|471013061|FG001|Overall Study|Randomized by mistake without study treatment|0|||
130832503|NCT05420961|471013062|FG002|Overall Study|Randomized by mistake without study treatment|1|||
130832504|NCT05420961|471013063|FG003|Overall Study|Randomized by mistake without study treatment|0|||
130832505|NCT05420961|471013064|FG004|Overall Study|Randomized by mistake without study treatment|1|||
130832506|NCT04283656|471013065|FG000|Overall Study|Adverse Event|1|||
130832507|NCT04283656|471013066|FG001|Overall Study|Adverse Event|0|||
130832508|NCT04283656|471013065|FG000|Overall Study|Lost to Follow-up|0|||
130832509|NCT04283656|471013066|FG001|Overall Study|Lost to Follow-up|1|||
130832510|NCT02318368|471013067|FG000|Overall Study|Withdrawal by Subject|2|||
130832511|NCT02318368|471013068|FG001|Overall Study|Withdrawal by Subject|0|||
130832512|NCT02318368|471013067|FG000|Overall Study|Study terminated by the sponsor|5|||
130832513|NCT02318368|471013068|FG001|Overall Study|Study terminated by the sponsor|2|||
130832514|NCT02318368|471013067|FG000|Overall Study|Death|0|||
130832515|NCT02318368|471013068|FG001|Overall Study|Death|1|||
130832516|NCT02201329|471013069|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
130832517|NCT02201329|471013069|FG000|Overall Study|Withdrawal by Subject|2|||
130832518|NCT00935493|471013070|FG000|Overall Study|Lost to Follow-up|1|||
130832519|NCT00935493|471013071|FG001|Overall Study|Lost to Follow-up|1|||
130832520|NCT00935493|471013072|FG002|Overall Study|Lost to Follow-up|1|||
130832521|NCT00935493|471013070|FG000|Overall Study|Treatment Discontinued|0|||
130832522|NCT00935493|471013071|FG001|Overall Study|Treatment Discontinued|1|||
130832523|NCT00935493|471013072|FG002|Overall Study|Treatment Discontinued|0|||
130832524|NCT01555073|471013073|FG000|Overall Study|Lost to Follow-up|1|||
130832525|NCT01555073|471013074|FG001|Overall Study|Lost to Follow-up|2|||
130832526|NCT01555073|471013075|FG002|Overall Study|Lost to Follow-up|0|||
130832527|NCT01555073|471013076|FG003|Overall Study|Lost to Follow-up|5|||
130832528|NCT01945996|471013078|FG000|Overall Study|Lost to Follow-up|3|||
130832529|NCT01945996|471013079|FG001|Overall Study|Lost to Follow-up|5|||
130832530|NCT01066104|471013080|FG000|Overall Study|Adverse Event|1|||
130832531|NCT01066104|471013081|FG001|Overall Study|Adverse Event|1|||
130832532|NCT01066104|471013080|FG000|Overall Study|Protocol Violation|1|||
130832533|NCT01066104|471013081|FG001|Overall Study|Protocol Violation|0|||
130832534|NCT02091362|471013093|FG000|Period 1|Protocol Violation|1|||
130832535|NCT02091362|471013094|FG001|Period 1|Protocol Violation|0|||
130832536|NCT02091362|471013093|FG000|Period 1|Withdrawal by Subject|2|||
130832537|NCT02091362|471013094|FG001|Period 1|Withdrawal by Subject|3|||
130832538|NCT02091362|471013093|FG000|Period 1|Lost to Follow-up|0|||
130832539|NCT02091362|471013094|FG001|Period 1|Lost to Follow-up|1|||
130832540|NCT02091362|471013093|FG000|Period 1|Adverse Event|2|||
130832541|NCT02091362|471013094|FG001|Period 1|Adverse Event|0|||
130832542|NCT02091362|471013093|FG000|Wash-out|Lost to Follow-up|1|||
130832543|NCT02091362|471013094|FG001|Wash-out|Lost to Follow-up|1|||
130832544|NCT02091362|471013093|FG000|Wash-out|Withdrawal by Subject|0|||
130832545|NCT02091362|471013094|FG001|Wash-out|Withdrawal by Subject|2|||
130832546|NCT02091362|471013093|FG000|Period 2|Adverse Event|1|||
130832547|NCT02091362|471013094|FG001|Period 2|Adverse Event|0|||
130832548|NCT02091362|471013093|FG000|Period 2|Lost to Follow-up|0|||
130832549|NCT02091362|471013094|FG001|Period 2|Lost to Follow-up|1|||
130832550|NCT02091362|471013093|FG000|Period 2|Withdrawal by Subject|1|||
130832551|NCT02091362|471013094|FG001|Period 2|Withdrawal by Subject|1|||
130832552|NCT00690430|471013095|FG000|Core Phase|Abnormal Laboratory value|0|||
130832553|NCT00690430|471013096|FG001|Core Phase|Abnormal Laboratory value|1|||
130832554|NCT00690430|471013097|FG002|Core Phase|Abnormal Laboratory value|0|||
130832555|NCT00690430|471013095|FG000|Core Phase|Adverse Event|5|||
130832556|NCT00690430|471013096|FG001|Core Phase|Adverse Event|1|||
130832557|NCT00690430|471013097|FG002|Core Phase|Adverse Event|0|||
130832558|NCT00690430|471013095|FG000|Core Phase|Death|0|||
130832559|NCT00690430|471013096|FG001|Core Phase|Death|2|||
130832560|NCT00690430|471013097|FG002|Core Phase|Death|0|||
130832561|NCT00690430|471013095|FG000|Core Phase|Protocol Violation|1|||
130832562|NCT00690430|471013096|FG001|Core Phase|Protocol Violation|0|||
130832563|NCT00690430|471013097|FG002|Core Phase|Protocol Violation|0|||
130832564|NCT00690430|471013095|FG000|Core Phase|Withdrawal by Subject|3|||
130832565|NCT00690430|471013096|FG001|Core Phase|Withdrawal by Subject|3|||
130832566|NCT00690430|471013097|FG002|Core Phase|Withdrawal by Subject|0|||
130832567|NCT00690430|471013095|FG000|Core Phase|Subject no longer requires study drug|1|||
130832568|NCT00690430|471013096|FG001|Core Phase|Subject no longer requires study drug|0|||
130832569|NCT00690430|471013097|FG002|Core Phase|Subject no longer requires study drug|0|||
130832570|NCT00690430|471013095|FG000|Core Phase|Lack of Efficacy|8|||
130832571|NCT00690430|471013096|FG001|Core Phase|Lack of Efficacy|10|||
130832572|NCT00690430|471013097|FG002|Core Phase|Lack of Efficacy|0|||
130832573|NCT00690430|471013095|FG000|Core Phase|Administrative Problems|0|||
130832574|NCT00690430|471013096|FG001|Core Phase|Administrative Problems|1|||
130832575|NCT00690430|471013097|FG002|Core Phase|Administrative Problems|0|||
130832576|NCT00690430|471013095|FG000|Core Phase|Early Termination|0|||
130832577|NCT00690430|471013096|FG001|Core Phase|Early Termination|5|||
130832578|NCT00690430|471013097|FG002|Core Phase|Early Termination|0|||
130832579|NCT00690430|471013095|FG000|Extension Phase|Lack of Efficacy|3|||
130832580|NCT00690430|471013096|FG001|Extension Phase|Lack of Efficacy|1|||
130832581|NCT00690430|471013097|FG002|Extension Phase|Lack of Efficacy|4|||
130832582|NCT00690430|471013095|FG000|Extension Phase|Abnormal Lab Values|1|||
130832583|NCT00690430|471013096|FG001|Extension Phase|Abnormal Lab Values|0|||
130832584|NCT00690430|471013097|FG002|Extension Phase|Abnormal Lab Values|0|||
130832585|NCT00690430|471013095|FG000|Extension Phase|Abnormal test procedure results|1|||
130832586|NCT00690430|471013096|FG001|Extension Phase|Abnormal test procedure results|0|||
130832587|NCT00690430|471013097|FG002|Extension Phase|Abnormal test procedure results|0|||
130832588|NCT00690430|471013095|FG000|Extension Phase|Administrative Problems|0|||
130832589|NCT00690430|471013096|FG001|Extension Phase|Administrative Problems|1|||
130832590|NCT00690430|471013097|FG002|Extension Phase|Administrative Problems|1|||
130832591|NCT00690430|471013095|FG000|Extension Phase|Adverse Event|2|||
130832592|NCT00690430|471013096|FG001|Extension Phase|Adverse Event|1|||
130832593|NCT00690430|471013097|FG002|Extension Phase|Adverse Event|2|||
130832594|NCT00690430|471013095|FG000|Extension Phase|Death|1|||
130832595|NCT00690430|471013096|FG001|Extension Phase|Death|1|||
130832596|NCT00690430|471013097|FG002|Extension Phase|Death|1|||
130832597|NCT00690430|471013095|FG000|Extension Phase|Withdrawal by Subject|0|||
130832598|NCT00690430|471013096|FG001|Extension Phase|Withdrawal by Subject|0|||
130832599|NCT00690430|471013097|FG002|Extension Phase|Withdrawal by Subject|2|||
130832600|NCT00690430|471013095|FG000|Extension Phase|Early Termination|10|||
130832601|NCT00690430|471013096|FG001|Extension Phase|Early Termination|1|||
130832602|NCT00690430|471013097|FG002|Extension Phase|Early Termination|3|||
130832603|NCT02567799|471013110|FG000|Concurrent Chemoradiotherapy|Death|1|||
130832604|NCT02567799|471013111|FG001|Concurrent Chemoradiotherapy|Death|0|||
130832605|NCT02567799|471013112|FG002|Concurrent Chemoradiotherapy|Death|0|||
130832606|NCT02567799|471013110|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
130832607|NCT02567799|471013111|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
130832608|NCT02567799|471013112|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
130832609|NCT02567799|471013110|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
130832610|NCT02567799|471013111|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
130832611|NCT02567799|471013112|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
130832612|NCT02567799|471013110|FG000|Follow-up|Death|1|||
130832613|NCT02567799|471013111|FG001|Follow-up|Death|0|||
130832614|NCT02567799|471013112|FG002|Follow-up|Death|1|||
130832615|NCT02567799|471013110|FG000|Follow-up|Progressive Disease|1|||
130832616|NCT02567799|471013111|FG001|Follow-up|Progressive Disease|1|||
130832617|NCT02567799|471013112|FG002|Follow-up|Progressive Disease|3|||
130832618|NCT03108521|471013115|FG000|Overall Study|Lost to Follow-up|3|||
130832619|NCT03108521|471013116|FG001|Overall Study|Lost to Follow-up|0|||
130832620|NCT03108521|471013115|FG000|Overall Study|Lack of Efficacy|2|||
130832621|NCT03108521|471013116|FG001|Overall Study|Lack of Efficacy|0|||
130832622|NCT03108521|471013115|FG000|Overall Study|Physician Decision|4|||
130832623|NCT03108521|471013116|FG001|Overall Study|Physician Decision|0|||
130832624|NCT03108521|471013115|FG000|Overall Study|Adverse Event|3|||
130832625|NCT03108521|471013116|FG001|Overall Study|Adverse Event|0|||
130832626|NCT06899737|471013121|FG000|Overall Study|Lost to Follow-up|19|||
130832627|NCT06899737|471013122|FG001|Overall Study|Lost to Follow-up|7|||
130832628|NCT00375674|471013129|FG000|Overall Study|Other|26|||
130832629|NCT00375674|471013130|FG001|Overall Study|Other|18|||
130832630|NCT00375674|471013129|FG000|Overall Study|Death|67|||
130832631|NCT00375674|471013130|FG001|Overall Study|Death|76|||
130832632|NCT00375674|471013129|FG000|Overall Study|Participants refused further follow-up|31|||
130832633|NCT00375674|471013130|FG001|Overall Study|Participants refused further follow-up|30|||
130832634|NCT00375674|471013129|FG000|Overall Study|Lost to Follow-up|17|||
130832635|NCT00375674|471013130|FG001|Overall Study|Lost to Follow-up|15|||
130832636|NCT00375674|471013129|FG000|Overall Study|Enrolled but not treated|3|||
130832637|NCT00375674|471013130|FG001|Overall Study|Enrolled but not treated|2|||
130832638|NCT02789345|471015420|FG000|Overall Study|Adverse Event|0|||
130832639|NCT02789345|471015421|FG001|Overall Study|Adverse Event|0|||
130832640|NCT02789345|471015422|FG002|Overall Study|Adverse Event|1|||
130832641|NCT02789345|471015420|FG000|Overall Study|Death|0|||
130832642|NCT02789345|471015421|FG001|Overall Study|Death|0|||
130832643|NCT02789345|471015422|FG002|Overall Study|Death|1|||
130832644|NCT02789345|471015420|FG000|Overall Study|Physician Decision|2|||
130832645|NCT02789345|471015421|FG001|Overall Study|Physician Decision|0|||
130832646|NCT02789345|471015422|FG002|Overall Study|Physician Decision|1|||
130832647|NCT02789345|471015420|FG000|Overall Study|Progressive Disease|1|||
130832648|NCT02789345|471015421|FG001|Overall Study|Progressive Disease|3|||
130832649|NCT02789345|471015422|FG002|Overall Study|Progressive Disease|14|||
130832650|NCT00615719|471015423|FG000|Overall Study|Physician Decision|5|||
130832651|NCT03517371|471015424|FG000|Overall Study|Adverse Event|8|||
130832652|NCT03517371|471015425|FG001|Overall Study|Adverse Event|9|||
130832653|NCT03517371|471015424|FG000|Overall Study|Lost to Follow-up|1|||
130832654|NCT03517371|471015425|FG001|Overall Study|Lost to Follow-up|2|||
130832655|NCT03517371|471015424|FG000|Overall Study|Withdrawal by Subject|4|||
130832656|NCT03517371|471015425|FG001|Overall Study|Withdrawal by Subject|4|||
130832657|NCT03517371|471015424|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
130832658|NCT03517371|471015425|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
130832659|NCT03517371|471015424|FG000|Overall Study|COVID restrictions|2|||
130832660|NCT03517371|471015425|FG001|Overall Study|COVID restrictions|0|||
130832661|NCT03517371|471015424|FG000|Overall Study|Receiving DBS Surgery|0|||
130832662|NCT03517371|471015425|FG001|Overall Study|Receiving DBS Surgery|1|||
130832663|NCT03490292|471015430|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
130832664|NCT03490292|471015431|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
130832665|NCT03490292|471015430|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
130832666|NCT03490292|471015431|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
130832667|NCT03490292|471015430|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
130832668|NCT03490292|471015431|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
130832669|NCT03490292|471015430|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
130832670|NCT03490292|471015431|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
130832671|NCT03490292|471015430|FG000|1 Year Follow Up Post Last Dose|Death|1|||
130832672|NCT03490292|471015431|FG001|1 Year Follow Up Post Last Dose|Death|1|||
130832673|NCT00964002|471015432|FG000|Overall Study|Protocol Violation|8|||
130832674|NCT02565147|471015435|FG000|Overall Study|Withdrawal by Subject|5|||
130832675|NCT02565147|471015436|FG001|Overall Study|Withdrawal by Subject|1|||
130832676|NCT02565147|471015435|FG000|Overall Study|Lost to Follow-up|0|||
130832677|NCT02565147|471015436|FG001|Overall Study|Lost to Follow-up|1|||
130832678|NCT02565147|471015435|FG000|Overall Study|Death|1|||
130832679|NCT02565147|471015436|FG001|Overall Study|Death|1|||
130832680|NCT02936869|471015443|FG000|Overall Study|Lost to Follow-up|1|||
130832681|NCT02936869|471015444|FG001|Overall Study|Lost to Follow-up|3|||
130832682|NCT02936869|471015443|FG000|Overall Study|Death|0|||
130832683|NCT02936869|471015444|FG001|Overall Study|Death|1|||
130832684|NCT02936869|471015443|FG000|Overall Study|Legal Case|0|||
130832685|NCT02936869|471015444|FG001|Overall Study|Legal Case|1|||
130832686|NCT02936869|471015443|FG000|Overall Study|Protocol Violation|1|||
130832687|NCT02936869|471015444|FG001|Overall Study|Protocol Violation|0|||
130832688|NCT00335738|471015445|FG000|Overall Study|Physician Decision|6|||
130832689|NCT00335738|471015446|FG001|Overall Study|Physician Decision|0|||
130832690|NCT00335738|471015445|FG000|Overall Study|Withdrawal by Subject|2|||
130832691|NCT00335738|471015446|FG001|Overall Study|Withdrawal by Subject|0|||
130832692|NCT00335738|471015445|FG000|Overall Study|Ineligible|3|||
130832693|NCT00335738|471015446|FG001|Overall Study|Ineligible|4|||
130832694|NCT03423238|471015453|FG000|Overall Study|Lost to Follow-up|1|||
130832695|NCT03423238|471015454|FG001|Overall Study|Lost to Follow-up|0|||
130832696|NCT03423238|471015453|FG000|Overall Study|Withdrawal by Subject|1|||
130832697|NCT03423238|471015454|FG001|Overall Study|Withdrawal by Subject|0|||
130832698|NCT02036580|471015455|FG000|Overall Study|Withdrawal by Subject|0|||
130832699|NCT02036580|471015456|FG001|Overall Study|Withdrawal by Subject|1|||
130832700|NCT02036580|471015457|FG002|Overall Study|Withdrawal by Subject|0|||
130832701|NCT02036580|471015455|FG000|Overall Study|Adverse Event|1|||
130832702|NCT02036580|471015456|FG001|Overall Study|Adverse Event|0|||
130832703|NCT02036580|471015457|FG002|Overall Study|Adverse Event|0|||
130832704|NCT00992056|471015458|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
130832705|NCT00992056|471015459|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
130832706|NCT00992056|471015458|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
130832707|NCT00992056|471015459|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
130832708|NCT00506454|471015460|FG000|Overall Study|Withdrawal by Subject|1|||
130832709|NCT00506454|471015461|FG001|Overall Study|Withdrawal by Subject|1|||
130832710|NCT02584452|471015464|FG000|Overall Study|Physician Decision|1|||
130832711|NCT02584452|471015465|FG001|Overall Study|Physician Decision|1|||
130832712|NCT02584452|471015464|FG000|Overall Study|Lost to Follow-up|1|||
130832713|NCT02584452|471015465|FG001|Overall Study|Lost to Follow-up|1|||
130832714|NCT02689206|471015466|FG000|Overall Study|Adverse Event|0|||
130832715|NCT02689206|471015467|FG001|Overall Study|Adverse Event|0|||
130832716|NCT02689206|471015468|FG002|Overall Study|Adverse Event|1|||
130832717|NCT02689206|471015469|FG003|Overall Study|Adverse Event|0|||
130832718|NCT02689206|471015470|FG004|Overall Study|Adverse Event|2|||
130832719|NCT02689206|471015466|FG000|Overall Study|Protocol Violation|1|||
130832720|NCT02689206|471015467|FG001|Overall Study|Protocol Violation|0|||
130832721|NCT02689206|471015468|FG002|Overall Study|Protocol Violation|0|||
130832722|NCT02689206|471015469|FG003|Overall Study|Protocol Violation|1|||
130832723|NCT02689206|471015470|FG004|Overall Study|Protocol Violation|2|||
130832724|NCT02689206|471015466|FG000|Overall Study|Other: Reached stopping criteria|0|||
130832725|NCT02689206|471015467|FG001|Overall Study|Other: Reached stopping criteria|1|||
130832726|NCT02689206|471015468|FG002|Overall Study|Other: Reached stopping criteria|2|||
130832727|NCT02689206|471015469|FG003|Overall Study|Other: Reached stopping criteria|3|||
130832728|NCT02689206|471015470|FG004|Overall Study|Other: Reached stopping criteria|4|||
130832729|NCT02689206|471015466|FG000|Overall Study|Physician Decision|1|||
130832730|NCT02689206|471015467|FG001|Overall Study|Physician Decision|0|||
130832731|NCT02689206|471015468|FG002|Overall Study|Physician Decision|0|||
130832732|NCT02689206|471015469|FG003|Overall Study|Physician Decision|0|||
130832733|NCT02689206|471015470|FG004|Overall Study|Physician Decision|0|||
130832734|NCT02689206|471015466|FG000|Overall Study|Withdrawal by Subject|1|||
130832735|NCT02689206|471015467|FG001|Overall Study|Withdrawal by Subject|0|||
130832736|NCT02689206|471015468|FG002|Overall Study|Withdrawal by Subject|1|||
130832737|NCT02689206|471015469|FG003|Overall Study|Withdrawal by Subject|0|||
130832738|NCT02689206|471015470|FG004|Overall Study|Withdrawal by Subject|0|||
130832739|NCT01558596|471015473|FG000|Overall Study|Withdrawal by Subject|1|||
130832740|NCT01558596|471015474|FG001|Overall Study|Withdrawal by Subject|0|||
130832741|NCT01558596|471015473|FG000|Overall Study|surgery elsewhere or cancelled|1|||
130832742|NCT01558596|471015474|FG001|Overall Study|surgery elsewhere or cancelled|1|||
130832743|NCT01558596|471015473|FG000|Overall Study|Protocol Violation|1|||
130832744|NCT01558596|471015474|FG001|Overall Study|Protocol Violation|0|||
130832745|NCT00902850|471015476|FG000|Overall Study|Physician Decision|2|||
130832746|NCT00902850|471015477|FG001|Overall Study|Physician Decision|2|||
130832747|NCT03745638|471015478|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
130832748|NCT03745638|471015479|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
130832749|NCT03745638|471015480|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
130832750|NCT03745638|471015481|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130832751|NCT03745638|471015482|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130832752|NCT03745638|471015483|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130832753|NCT03745638|471015484|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130832754|NCT03745638|471015478|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130832755|NCT03745638|471015479|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130832756|NCT03745638|471015480|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130832757|NCT03745638|471015481|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130832758|NCT03745638|471015482|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130832759|NCT03745638|471015483|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130832760|NCT03745638|471015484|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130832761|NCT03745638|471015478|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
130832762|NCT03745638|471015479|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
130832763|NCT03745638|471015480|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
130832764|NCT03745638|471015481|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130832765|NCT03745638|471015482|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130832766|NCT03745638|471015483|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130832767|NCT03745638|471015484|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130832768|NCT03745638|471015478|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
130832769|NCT03745638|471015479|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
130832770|NCT03745638|471015480|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130832771|NCT03745638|471015481|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130832772|NCT03745638|471015482|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130832773|NCT03745638|471015483|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130832774|NCT03745638|471015484|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130832775|NCT03745638|471015478|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
130832776|NCT03745638|471015479|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130832777|NCT03745638|471015480|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130832778|NCT03745638|471015481|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130832779|NCT03745638|471015482|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130832780|NCT03745638|471015483|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130832781|NCT03745638|471015484|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130832782|NCT03745638|471015478|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130832783|NCT03745638|471015479|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
130832784|NCT03745638|471015480|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130832785|NCT03745638|471015481|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130832786|NCT03745638|471015482|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130832787|NCT03745638|471015483|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130832788|NCT03745638|471015484|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130832789|NCT03745638|471015478|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
130832790|NCT03745638|471015479|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
130832791|NCT03745638|471015480|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
130832792|NCT03745638|471015481|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130832793|NCT03745638|471015482|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130832794|NCT03745638|471015483|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130832795|NCT03745638|471015484|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130832796|NCT03745638|471015478|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
130832797|NCT03745638|471015479|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
130832798|NCT03745638|471015480|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130832799|NCT03745638|471015481|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130832800|NCT03745638|471015482|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130832801|NCT03745638|471015483|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130832802|NCT03745638|471015484|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130832803|NCT03745638|471015478|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130832804|NCT03745638|471015479|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130832805|NCT03745638|471015480|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130832806|NCT03745638|471015481|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130832807|NCT03745638|471015482|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130832808|NCT03745638|471015483|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
130832809|NCT03745638|471015484|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
130832810|NCT03745638|471015478|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130832811|NCT03745638|471015479|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130832812|NCT03745638|471015480|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130832813|NCT03745638|471015481|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
130832814|NCT03745638|471015482|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130832815|NCT03745638|471015483|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
130832816|NCT03745638|471015484|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
130832817|NCT03745638|471015478|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130832818|NCT03745638|471015479|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130832819|NCT03745638|471015480|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130832820|NCT03745638|471015481|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
130832821|NCT03745638|471015482|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
130832822|NCT03745638|471015483|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
130832823|NCT03745638|471015484|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
130832824|NCT03745638|471015478|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130832825|NCT03745638|471015479|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130832826|NCT03745638|471015480|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130832827|NCT03745638|471015481|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130832828|NCT03745638|471015482|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
130832829|NCT03745638|471015483|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
130832830|NCT03745638|471015484|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130832831|NCT03745638|471015478|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130832832|NCT03745638|471015479|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130832833|NCT03745638|471015480|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130832834|NCT03745638|471015481|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130832835|NCT03745638|471015482|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130832836|NCT03745638|471015483|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
130832837|NCT03745638|471015484|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130832838|NCT03745638|471015478|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130832839|NCT03745638|471015479|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130832840|NCT03745638|471015480|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130832841|NCT03745638|471015481|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
130832842|NCT03745638|471015482|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
130832843|NCT03745638|471015483|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
130832844|NCT03745638|471015484|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
130832845|NCT03745638|471015478|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130832846|NCT03745638|471015479|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130832847|NCT03745638|471015480|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130832848|NCT03745638|471015481|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130832849|NCT03745638|471015482|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130832850|NCT03745638|471015483|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
130832851|NCT03745638|471015484|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
130832852|NCT04470050|471015485|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130832853|NCT04470050|471015486|FG001|Double-blind Treatment Phase|Adverse Event|0|||
130832854|NCT04470050|471015487|FG002|Double-blind Treatment Phase|Adverse Event|0|||
130832855|NCT04470050|471015488|FG003|Double-blind Treatment Phase|Adverse Event|1|||
130832856|NCT04470050|471015489|FG004|Double-blind Treatment Phase|Adverse Event|0|||
130832857|NCT04470050|471015490|FG005|Double-blind Treatment Phase|Adverse Event|0|||
130832858|NCT04470050|471015491|FG006|Double-blind Treatment Phase|Adverse Event|0|||
130832859|NCT04470050|471015485|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130832860|NCT04470050|471015486|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
130832861|NCT04470050|471015487|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
130832862|NCT04470050|471015488|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
130832863|NCT04470050|471015489|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
130832864|NCT04470050|471015490|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
130832865|NCT04470050|471015491|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
130832866|NCT04470050|471015485|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
130832867|NCT04470050|471015486|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
130832868|NCT04470050|471015487|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
130832869|NCT04470050|471015488|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
130832870|NCT04470050|471015489|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
130832871|NCT04470050|471015490|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
130832872|NCT04470050|471015491|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
130832873|NCT03604172|471015493|FG000|Overall Study|Lost to Follow-up|1|||
130832874|NCT03604172|471015494|FG001|Overall Study|Lost to Follow-up|2|||
130832875|NCT02676895|471015495|FG000|Overall Study|Administrative reason|1|||
130832876|NCT02676895|471015496|FG001|Overall Study|Administrative reason|0|||
130832877|NCT02676895|471015497|FG002|Overall Study|Administrative reason|0|||
130832878|NCT02676895|471015495|FG000|Overall Study|Protocol Violation|1|||
130832879|NCT02676895|471015496|FG001|Overall Study|Protocol Violation|0|||
130832880|NCT02676895|471015497|FG002|Overall Study|Protocol Violation|0|||
130832881|NCT02676895|471015495|FG000|Overall Study|Adverse Event|0|||
130832882|NCT02676895|471015496|FG001|Overall Study|Adverse Event|3|||
130832883|NCT02676895|471015497|FG002|Overall Study|Adverse Event|1|||
130832884|NCT02676895|471015495|FG000|Overall Study|Lost to Follow-up|0|||
130832885|NCT02676895|471015496|FG001|Overall Study|Lost to Follow-up|0|||
130832886|NCT02676895|471015497|FG002|Overall Study|Lost to Follow-up|1|||
130832887|NCT02676895|471015495|FG000|Overall Study|Withdrawal by Subject|0|||
130832888|NCT02676895|471015496|FG001|Overall Study|Withdrawal by Subject|0|||
130832889|NCT02676895|471015497|FG002|Overall Study|Withdrawal by Subject|1|||
130832890|NCT00976716|471015503|FG000|Overall Study|Adverse Event|1|||
130832891|NCT03028129|471015506|FG000|Overall Study|Adverse Event|13|||
130832892|NCT03028129|471015507|FG001|Overall Study|Adverse Event|2|||
130832893|NCT03028129|471015506|FG000|Overall Study|Lost to Follow-up|50|||
130832894|NCT03028129|471015507|FG001|Overall Study|Lost to Follow-up|38|||
130832895|NCT03028129|471015506|FG000|Overall Study|Physician Decision|0|||
130832896|NCT03028129|471015507|FG001|Overall Study|Physician Decision|1|||
130832897|NCT03028129|471015506|FG000|Overall Study|Protocol Violation|1|||
130832898|NCT03028129|471015507|FG001|Overall Study|Protocol Violation|1|||
130832899|NCT03028129|471015506|FG000|Overall Study|Withdrawal by Subject|62|||
130832900|NCT03028129|471015507|FG001|Overall Study|Withdrawal by Subject|45|||
130832901|NCT04222699|471015511|FG000|Overall Study|Lost to Follow-up|2|||
130832902|NCT00923351|471015512|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
130832903|NCT00923351|471015513|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
130832904|NCT00923351|471015514|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
130832905|NCT01536561|471015519|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
130832906|NCT01536561|471015519|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
130832907|NCT01536561|471015519|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
130832908|NCT01536561|471015519|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
130832909|NCT01536561|471015519|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
130832910|NCT01536561|471015519|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
130832911|NCT01939977|471015525|FG000|Overall Study|Adverse Event|4|||
130832912|NCT01939977|471015526|FG001|Overall Study|Adverse Event|3|||
130832913|NCT01939977|471015525|FG000|Overall Study|Lack of Efficacy|3|||
130832914|NCT01939977|471015526|FG001|Overall Study|Lack of Efficacy|0|||
130832915|NCT01939977|471015525|FG000|Overall Study|Physician Decision|1|||
130832916|NCT01939977|471015526|FG001|Overall Study|Physician Decision|1|||
130832917|NCT01939977|471015525|FG000|Overall Study|Withdrawal by Subject|0|||
130832918|NCT01939977|471015526|FG001|Overall Study|Withdrawal by Subject|2|||
130832919|NCT01939977|471015525|FG000|Overall Study|Did not meet inclusion criteria|1|||
130832920|NCT01939977|471015526|FG001|Overall Study|Did not meet inclusion criteria|0|||
130832921|NCT01939977|471015525|FG000|Overall Study|Did not receive study medication|0|||
130832922|NCT01939977|471015526|FG001|Overall Study|Did not receive study medication|1|||
130832923|NCT04552288|471015530|FG000|Overall Study|Death|3|||
130832924|NCT04552288|471015530|FG000|Overall Study|Lost to Follow-up|6|||
130832925|NCT04552288|471015530|FG000|Overall Study|Physician Decision|3|||
130832926|NCT04552288|471015530|FG000|Overall Study|Protocol Violation|9|||
130832927|NCT04552288|471015530|FG000|Overall Study|Withdrawal by Subject|6|||
130832928|NCT04552288|471015530|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
130832929|NCT05285644|471015531|FG000|Overall Study|Adverse Event|3|||
130832930|NCT05285644|471015532|FG001|Overall Study|Adverse Event|3|||
130832931|NCT05285644|471015531|FG000|Overall Study|Withdrawal of Consent|2|||
130832932|NCT05285644|471015532|FG001|Overall Study|Withdrawal of Consent|5|||
130832933|NCT05285644|471015531|FG000|Overall Study|Noncompliance|0|||
130832934|NCT05285644|471015532|FG001|Overall Study|Noncompliance|4|||
130832935|NCT05285644|471015531|FG000|Overall Study|Lost to Follow-up|4|||
130832936|NCT05285644|471015532|FG001|Overall Study|Lost to Follow-up|6|||
130832937|NCT05285644|471015531|FG000|Overall Study|Disallowed Concurrent Medication|1|||
130832938|NCT05285644|471015532|FG001|Overall Study|Disallowed Concurrent Medication|1|||
130832939|NCT05285644|471015531|FG000|Overall Study|Investigator Decision|2|||
130832940|NCT05285644|471015532|FG001|Overall Study|Investigator Decision|0|||
130832941|NCT05285644|471015531|FG000|Overall Study|Protocol Deviation|1|||
130832942|NCT05285644|471015532|FG001|Overall Study|Protocol Deviation|0|||
130832943|NCT05285644|471015531|FG000|Overall Study|As specified in the Clinical Study Report|7|||
130832944|NCT05285644|471015532|FG001|Overall Study|As specified in the Clinical Study Report|3|||
130832945|NCT04532294|471015533|FG000|Overall Study|Withdrawal by Subject|0|||
130832946|NCT04532294|471015534|FG001|Overall Study|Withdrawal by Subject|0|||
130832947|NCT04532294|471015535|FG002|Overall Study|Withdrawal by Subject|1|||
130832948|NCT04532294|471015533|FG000|Overall Study|Participants Not Dosed|0|||
130832949|NCT04532294|471015534|FG001|Overall Study|Participants Not Dosed|0|||
130832950|NCT04532294|471015535|FG002|Overall Study|Participants Not Dosed|2|||
130832951|NCT04295759|471015536|FG000|Overall Study|Lack of Efficacy|9|||
130832952|NCT04295759|471015536|FG000|Overall Study|Death|1|||
130832953|NCT04295759|471015536|FG000|Overall Study|Withdrawal by Subject|2|||
130832954|NCT04295759|471015536|FG000|Overall Study|Deemed ineligible|1|||
130832955|NCT01696981|471015537|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
130832956|NCT01696981|471015538|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
130832957|NCT01696981|471015537|FG000|Overall Study|Died Before Randomization|3|||
130832958|NCT01696981|471015538|FG001|Overall Study|Died Before Randomization|8|||
130832959|NCT01696981|471015537|FG000|Overall Study|Died Before ASU (Control)|278|||
130832960|NCT01696981|471015538|FG001|Overall Study|Died Before ASU (Control)|0|||
130832961|NCT01696981|471015537|FG000|Overall Study|Refused ASU (Control)|920|||
130832962|NCT01696981|471015538|FG001|Overall Study|Refused ASU (Control)|0|||
130832963|NCT01696981|471015537|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
130832964|NCT01696981|471015538|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
130832965|NCT02798315|471015539|FG000|Overall Study|Failure to return|1|||
130832966|NCT03335150|471015541|FG000|Overall Study|Withdrawal by Subject|10|||
130832967|NCT03335150|471015542|FG001|Overall Study|Withdrawal by Subject|4|||
130832968|NCT03335150|471015541|FG000|Overall Study|Adverse Event|0|||
130832969|NCT03335150|471015542|FG001|Overall Study|Adverse Event|1|||
130832970|NCT02097719|471015543|FG000|Overall Study|Subject Withdrew Consent|1|||
130832971|NCT02097719|471015544|FG001|Overall Study|Subject Withdrew Consent|0|||
130832972|NCT02097719|471015543|FG000|Overall Study|Lost to Follow-up|0|||
130832973|NCT02097719|471015544|FG001|Overall Study|Lost to Follow-up|1|||
130832974|NCT02097719|471015543|FG000|Overall Study|Adverse Event|2|||
130832975|NCT02097719|471015544|FG001|Overall Study|Adverse Event|0|||
130832976|NCT00972517|471015545|FG000|Overall Study|Adverse Event|0|||
130832977|NCT00972517|471015546|FG001|Overall Study|Adverse Event|0|||
130832978|NCT00972517|471015547|FG002|Overall Study|Adverse Event|0|||
130832979|NCT00972517|471015548|FG003|Overall Study|Adverse Event|1|||
130832980|NCT00972517|471015549|FG004|Overall Study|Adverse Event|0|||
130832981|NCT00972517|471015550|FG005|Overall Study|Adverse Event|0|||
130832982|NCT00972517|471015545|FG000|Overall Study|Withdrawal by Subject|0|||
130832983|NCT00972517|471015546|FG001|Overall Study|Withdrawal by Subject|1|||
130832984|NCT00972517|471015547|FG002|Overall Study|Withdrawal by Subject|0|||
130832985|NCT00972517|471015548|FG003|Overall Study|Withdrawal by Subject|2|||
130832986|NCT00972517|471015549|FG004|Overall Study|Withdrawal by Subject|1|||
130832987|NCT00972517|471015550|FG005|Overall Study|Withdrawal by Subject|0|||
130832988|NCT00984594|471015551|FG000|Overall Study|Lost to Follow-up|1|||
130832989|NCT00984594|471015552|FG001|Overall Study|Lost to Follow-up|0|||
130832990|NCT00984594|471015551|FG000|Overall Study|Withdrawal by Subject|0|||
130832991|NCT00984594|471015552|FG001|Overall Study|Withdrawal by Subject|1|||
130832992|NCT00851890|471015553|FG000|Overall Study|Lost to Follow-up|0|||
130832993|NCT00851890|471015554|FG001|Overall Study|Lost to Follow-up|1|||
130832994|NCT00851890|471015555|FG002|Overall Study|Lost to Follow-up|0|||
130832995|NCT00851890|471015556|FG003|Overall Study|Lost to Follow-up|1|||
130832996|NCT03135431|471015557|FG000|Overall Study|Study Surgeon not available|2|||
130832997|NCT03135431|471015558|FG001|Overall Study|Study Surgeon not available|0|||
130832998|NCT04601532|471015559|FG000|Overall Study|Lost to Follow-up|1|||
130832999|NCT04601532|471015560|FG001|Overall Study|Lost to Follow-up|2|||
130833000|NCT04601532|471015559|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
130833001|NCT04601532|471015560|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
130833002|NCT00281099|471015563|FG000|Overall Study|Death|46|||
130833003|NCT00281099|471015564|FG001|Overall Study|Death|57|||
130833004|NCT00281099|471015563|FG000|Overall Study|Lost to Follow-up|10|||
130833005|NCT00281099|471015564|FG001|Overall Study|Lost to Follow-up|19|||
130833006|NCT00281099|471015563|FG000|Overall Study|Withdrawal by Subject|65|||
130833007|NCT00281099|471015564|FG001|Overall Study|Withdrawal by Subject|70|||
130833008|NCT00281099|471015563|FG000|Overall Study|Physician Decision|79|||
130833009|NCT00281099|471015564|FG001|Overall Study|Physician Decision|72|||
130833010|NCT00281099|471015563|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
130833011|NCT00281099|471015564|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
130833012|NCT03823287|471015565|FG000|Overall Study|Withdrawal by Subject|25|||
130833013|NCT03823287|471015566|FG001|Overall Study|Withdrawal by Subject|17|||
130833014|NCT03823287|471015565|FG000|Overall Study|Death|13|||
130833015|NCT03823287|471015566|FG001|Overall Study|Death|7|||
130833016|NCT03823287|471015565|FG000|Overall Study|Lost to Follow-up|7|||
130833017|NCT03823287|471015566|FG001|Overall Study|Lost to Follow-up|8|||
130833018|NCT03823287|471015565|FG000|Overall Study|Adverse Event|6|||
130833019|NCT03823287|471015566|FG001|Overall Study|Adverse Event|8|||
130833020|NCT03823287|471015565|FG000|Overall Study|Physician Decision|5|||
130833021|NCT03823287|471015566|FG001|Overall Study|Physician Decision|2|||
130833022|NCT03823287|471015565|FG000|Overall Study|Lack of Efficacy|2|||
130833023|NCT03823287|471015566|FG001|Overall Study|Lack of Efficacy|0|||
130833024|NCT03823287|471015565|FG000|Overall Study|Other|2|||
130833025|NCT03823287|471015566|FG001|Overall Study|Other|4|||
130833026|NCT01059864|471015571|FG000|Open-Label Run-In Phase|Adverse Event|7|||
130833027|NCT01059864|471015572|FG001|Open-Label Run-In Phase|Adverse Event|0|||
130833028|NCT01059864|471015573|FG002|Open-Label Run-In Phase|Adverse Event|0|||
130833029|NCT01059864|471015571|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
130833030|NCT01059864|471015572|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
130833031|NCT01059864|471015573|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
130833032|NCT01059864|471015571|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
130833033|NCT01059864|471015572|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
130833034|NCT01059864|471015573|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
130833035|NCT01059864|471015571|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
130833036|NCT01059864|471015572|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
130833037|NCT01059864|471015573|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
130833038|NCT01059864|471015571|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
130833039|NCT01059864|471015572|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
130833040|NCT01059864|471015573|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
130833041|NCT01059864|471015571|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130833042|NCT01059864|471015572|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
130833043|NCT01059864|471015573|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
130833044|NCT02744612|471017988|FG000|Overall Study|Withdrawal by Subject|0|||
130833045|NCT02744612|471017989|FG001|Overall Study|Withdrawal by Subject|2|||
130833046|NCT02712983|471017991|FG000|Treatment Phase|Adverse Event|3|||
130833047|NCT02712983|471017992|FG001|Treatment Phase|Adverse Event|1|||
130833048|NCT02712983|471017993|FG002|Treatment Phase|Adverse Event|1|||
130833049|NCT02712983|471017994|FG003|Treatment Phase|Adverse Event|4|||
130833050|NCT02712983|471017995|FG004|Treatment Phase|Adverse Event|3|||
130833051|NCT02712983|471017996|FG005|Treatment Phase|Adverse Event|0|||
130833052|NCT02712983|471017997|FG006|Treatment Phase|Adverse Event|6|||
130833053|NCT02712983|471017998|FG007|Treatment Phase|Adverse Event|6|||
130833054|NCT02712983|471017999|FG008|Treatment Phase|Adverse Event|1|||
130833055|NCT02712983|471017991|FG000|Treatment Phase|Protocol Deviation|0|||
130833056|NCT02712983|471017992|FG001|Treatment Phase|Protocol Deviation|0|||
130833057|NCT02712983|471017993|FG002|Treatment Phase|Protocol Deviation|0|||
130833058|NCT02712983|471017994|FG003|Treatment Phase|Protocol Deviation|2|||
130833059|NCT02712983|471017995|FG004|Treatment Phase|Protocol Deviation|0|||
130833060|NCT02712983|471017996|FG005|Treatment Phase|Protocol Deviation|0|||
130833061|NCT02712983|471017997|FG006|Treatment Phase|Protocol Deviation|1|||
130833062|NCT02712983|471017998|FG007|Treatment Phase|Protocol Deviation|0|||
130833063|NCT02712983|471017999|FG008|Treatment Phase|Protocol Deviation|0|||
130833064|NCT02712983|471017991|FG000|Treatment Phase|Technical Problems|0|||
130833065|NCT02712983|471017992|FG001|Treatment Phase|Technical Problems|0|||
130833066|NCT02712983|471017993|FG002|Treatment Phase|Technical Problems|0|||
130833067|NCT02712983|471017994|FG003|Treatment Phase|Technical Problems|0|||
130833068|NCT02712983|471017995|FG004|Treatment Phase|Technical Problems|0|||
130833069|NCT02712983|471017996|FG005|Treatment Phase|Technical Problems|0|||
130833070|NCT02712983|471017997|FG006|Treatment Phase|Technical Problems|1|||
130833071|NCT02712983|471017998|FG007|Treatment Phase|Technical Problems|0|||
130833072|NCT02712983|471017999|FG008|Treatment Phase|Technical Problems|0|||
130833073|NCT02712983|471017991|FG000|Treatment Phase|Physician Decision|0|||
130833074|NCT02712983|471017992|FG001|Treatment Phase|Physician Decision|0|||
130833075|NCT02712983|471017993|FG002|Treatment Phase|Physician Decision|0|||
130833076|NCT02712983|471017994|FG003|Treatment Phase|Physician Decision|0|||
130833077|NCT02712983|471017995|FG004|Treatment Phase|Physician Decision|0|||
130833078|NCT02712983|471017996|FG005|Treatment Phase|Physician Decision|0|||
130833079|NCT02712983|471017997|FG006|Treatment Phase|Physician Decision|0|||
130833080|NCT02712983|471017998|FG007|Treatment Phase|Physician Decision|1|||
130833081|NCT02712983|471017999|FG008|Treatment Phase|Physician Decision|1|||
130833082|NCT02712983|471017991|FG000|Treatment Phase|Subject Decision|2|||
130833083|NCT02712983|471017992|FG001|Treatment Phase|Subject Decision|0|||
130833084|NCT02712983|471017993|FG002|Treatment Phase|Subject Decision|0|||
130833085|NCT02712983|471017994|FG003|Treatment Phase|Subject Decision|2|||
130833086|NCT02712983|471017995|FG004|Treatment Phase|Subject Decision|1|||
130833087|NCT02712983|471017996|FG005|Treatment Phase|Subject Decision|0|||
130833088|NCT02712983|471017997|FG006|Treatment Phase|Subject Decision|1|||
130833089|NCT02712983|471017998|FG007|Treatment Phase|Subject Decision|2|||
130833090|NCT02712983|471017999|FG008|Treatment Phase|Subject Decision|0|||
130833091|NCT02712983|471017991|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130833092|NCT02712983|471017992|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
130833093|NCT02712983|471017993|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130833094|NCT02712983|471017994|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130833095|NCT02712983|471017995|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130833096|NCT02712983|471017996|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130833097|NCT02712983|471017997|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
130833098|NCT02712983|471017998|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
130833099|NCT02712983|471017999|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130833100|NCT02712983|471017991|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130833101|NCT02712983|471017992|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130833102|NCT02712983|471017993|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130833103|NCT02712983|471017994|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
130833104|NCT02712983|471017995|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130833105|NCT02712983|471017996|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130833106|NCT02712983|471017997|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130833107|NCT02712983|471017998|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130833108|NCT02712983|471017999|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130833109|NCT02712983|471017991|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130833110|NCT02712983|471017992|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130833111|NCT02712983|471017993|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130833112|NCT02712983|471017994|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130833113|NCT02712983|471017995|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
130833114|NCT02712983|471017996|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
130833115|NCT02712983|471017997|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
130833116|NCT02712983|471017998|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
130833117|NCT02712983|471017999|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130833118|NCT01945216|471018000|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
130833119|NCT01945216|471018000|FG000|Overall Study|Protocol Violation|42|||
130833120|NCT01945216|471018000|FG000|Overall Study|CRF not assured by investigators|5|||
130833121|NCT05360966|471018004|FG000|Overall Study|Adverse Event|5|||
130833122|NCT05360966|471018005|FG001|Overall Study|Adverse Event|5|||
130833123|NCT05360966|471018004|FG000|Overall Study|Withdrawal of Consent|5|||
130833124|NCT05360966|471018005|FG001|Overall Study|Withdrawal of Consent|3|||
130833125|NCT05360966|471018004|FG000|Overall Study|Noncompliance|2|||
130833126|NCT05360966|471018005|FG001|Overall Study|Noncompliance|1|||
130833127|NCT05360966|471018004|FG000|Overall Study|Lost to Follow-up|2|||
130833128|NCT05360966|471018005|FG001|Overall Study|Lost to Follow-up|3|||
130833129|NCT05360966|471018004|FG000|Overall Study|Protocol Deviation|2|||
130833130|NCT05360966|471018005|FG001|Overall Study|Protocol Deviation|1|||
130833131|NCT05360966|471018004|FG000|Overall Study|As specified in the Clinical Study Report|1|||
130833132|NCT05360966|471018005|FG001|Overall Study|As specified in the Clinical Study Report|3|||
130833133|NCT05396014|471018006|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
130833134|NCT05396014|471018007|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833135|NCT05396014|471018008|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833136|NCT05396014|471018009|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833137|NCT05396014|471018010|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833138|NCT05396014|471018011|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833139|NCT05396014|471018012|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833140|NCT05396014|471018013|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833141|NCT05396014|471018014|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833142|NCT05396014|471018015|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833143|NCT05396014|471018016|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833144|NCT05396014|471018017|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833145|NCT05396014|471018018|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833146|NCT05396014|471018019|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
130833147|NCT05396014|471018020|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833148|NCT05396014|471018021|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833149|NCT05396014|471018022|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833150|NCT05396014|471018023|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833151|NCT05396014|471018024|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833152|NCT05396014|471018025|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833153|NCT05396014|471018026|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833154|NCT05396014|471018027|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833155|NCT05396014|471018028|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833156|NCT05396014|471018029|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833157|NCT05396014|471018030|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833158|NCT05396014|471018031|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833159|NCT05396014|471018032|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
130833160|NCT05396014|471018033|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833161|NCT05396014|471018034|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833162|NCT05396014|471018035|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833163|NCT05396014|471018036|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833164|NCT05396014|471018037|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833165|NCT05396014|471018038|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833166|NCT05396014|471018039|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833167|NCT05396014|471018040|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833168|NCT05396014|471018041|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833169|NCT05396014|471018042|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833170|NCT05396014|471018043|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833171|NCT05396014|471018044|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833172|NCT05396014|471018045|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
130833173|NCT05396014|471018046|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833174|NCT05396014|471018047|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833175|NCT05396014|471018048|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130833176|NCT05396014|471018006|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
130833177|NCT05396014|471018007|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833178|NCT05396014|471018008|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833179|NCT05396014|471018009|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833180|NCT05396014|471018010|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833181|NCT05396014|471018011|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833182|NCT05396014|471018012|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833183|NCT05396014|471018013|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833184|NCT05396014|471018014|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833185|NCT05396014|471018015|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833186|NCT05396014|471018016|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833187|NCT05396014|471018017|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833188|NCT05396014|471018018|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833189|NCT05396014|471018019|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
130833190|NCT05396014|471018020|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833191|NCT05396014|471018021|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833192|NCT05396014|471018022|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833193|NCT05396014|471018023|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833194|NCT05396014|471018024|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833195|NCT05396014|471018025|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833196|NCT05396014|471018026|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833197|NCT05396014|471018027|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833198|NCT05396014|471018028|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833199|NCT05396014|471018029|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833200|NCT05396014|471018030|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833201|NCT05396014|471018031|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833202|NCT05396014|471018032|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
130833203|NCT05396014|471018033|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833204|NCT05396014|471018034|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833205|NCT05396014|471018035|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833206|NCT05396014|471018036|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833207|NCT05396014|471018037|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833208|NCT05396014|471018038|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833209|NCT05396014|471018039|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833210|NCT05396014|471018040|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833211|NCT05396014|471018041|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833212|NCT05396014|471018042|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833213|NCT05396014|471018043|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833214|NCT05396014|471018044|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833215|NCT05396014|471018045|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
130833216|NCT05396014|471018046|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833217|NCT05396014|471018047|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833218|NCT05396014|471018048|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130833219|NCT05396014|471018006|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
130833220|NCT05396014|471018007|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833221|NCT05396014|471018008|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833222|NCT05396014|471018009|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833223|NCT05396014|471018010|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833224|NCT05396014|471018011|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833225|NCT05396014|471018012|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833226|NCT05396014|471018013|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833227|NCT05396014|471018014|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833228|NCT05396014|471018015|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833229|NCT05396014|471018016|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833230|NCT05396014|471018017|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833231|NCT05396014|471018018|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833232|NCT05396014|471018019|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
130833233|NCT05396014|471018020|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833234|NCT05396014|471018021|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833235|NCT05396014|471018022|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833236|NCT05396014|471018023|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833237|NCT05396014|471018024|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833238|NCT05396014|471018025|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833239|NCT05396014|471018026|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833240|NCT05396014|471018027|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833241|NCT05396014|471018028|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833242|NCT05396014|471018029|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833243|NCT05396014|471018030|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833244|NCT05396014|471018031|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833245|NCT05396014|471018032|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
130833246|NCT05396014|471018033|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833247|NCT05396014|471018034|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833248|NCT05396014|471018035|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833249|NCT05396014|471018036|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833250|NCT05396014|471018037|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833251|NCT05396014|471018038|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833252|NCT05396014|471018039|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833253|NCT05396014|471018040|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833254|NCT05396014|471018041|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833255|NCT05396014|471018042|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833256|NCT05396014|471018043|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833257|NCT05396014|471018044|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833258|NCT05396014|471018045|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
130833259|NCT05396014|471018046|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833260|NCT05396014|471018047|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833261|NCT05396014|471018048|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130833262|NCT05396014|471018006|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833263|NCT05396014|471018007|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833264|NCT05396014|471018008|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833265|NCT05396014|471018009|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833266|NCT05396014|471018010|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833267|NCT05396014|471018011|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833268|NCT05396014|471018012|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833269|NCT05396014|471018013|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833270|NCT05396014|471018014|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833271|NCT05396014|471018015|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833272|NCT05396014|471018016|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833273|NCT05396014|471018017|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833274|NCT05396014|471018018|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833275|NCT05396014|471018019|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833276|NCT05396014|471018020|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833277|NCT05396014|471018021|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833278|NCT05396014|471018022|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833279|NCT05396014|471018023|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833280|NCT05396014|471018024|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833281|NCT05396014|471018025|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833282|NCT05396014|471018026|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833283|NCT05396014|471018027|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833284|NCT05396014|471018028|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833285|NCT05396014|471018029|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833286|NCT05396014|471018030|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833287|NCT05396014|471018031|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833288|NCT05396014|471018032|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
130833289|NCT05396014|471018033|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833290|NCT05396014|471018034|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833291|NCT05396014|471018035|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833292|NCT05396014|471018036|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833293|NCT05396014|471018037|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833294|NCT05396014|471018038|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833295|NCT05396014|471018039|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833296|NCT05396014|471018040|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833297|NCT05396014|471018041|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833298|NCT05396014|471018042|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833299|NCT05396014|471018043|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833300|NCT05396014|471018044|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833301|NCT05396014|471018045|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
130833302|NCT05396014|471018046|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833303|NCT05396014|471018047|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833304|NCT05396014|471018048|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130833305|NCT05396014|471018006|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833306|NCT05396014|471018007|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833307|NCT05396014|471018008|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833308|NCT05396014|471018009|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833309|NCT05396014|471018010|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833310|NCT05396014|471018011|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833311|NCT05396014|471018012|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833312|NCT05396014|471018013|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833313|NCT05396014|471018014|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833314|NCT05396014|471018015|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833315|NCT05396014|471018016|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833316|NCT05396014|471018017|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833317|NCT05396014|471018018|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833318|NCT05396014|471018019|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833319|NCT05396014|471018020|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833320|NCT05396014|471018021|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833321|NCT05396014|471018022|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833322|NCT05396014|471018023|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833323|NCT05396014|471018024|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833324|NCT05396014|471018025|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833325|NCT05396014|471018026|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833326|NCT05396014|471018027|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833327|NCT05396014|471018028|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833328|NCT05396014|471018029|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833329|NCT05396014|471018030|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833330|NCT05396014|471018031|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833331|NCT05396014|471018032|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
130833332|NCT05396014|471018033|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833333|NCT05396014|471018034|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833334|NCT05396014|471018035|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833335|NCT05396014|471018036|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833336|NCT05396014|471018037|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833337|NCT05396014|471018038|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833338|NCT05396014|471018039|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833339|NCT05396014|471018040|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833340|NCT05396014|471018041|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833341|NCT05396014|471018042|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833342|NCT05396014|471018043|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833343|NCT05396014|471018044|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833344|NCT05396014|471018045|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833345|NCT05396014|471018046|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833346|NCT05396014|471018047|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833347|NCT05396014|471018048|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130833348|NCT05396014|471018006|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833349|NCT05396014|471018007|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833350|NCT05396014|471018008|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833351|NCT05396014|471018009|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833352|NCT05396014|471018010|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833353|NCT05396014|471018011|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833354|NCT05396014|471018012|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833355|NCT05396014|471018013|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833356|NCT05396014|471018014|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833357|NCT05396014|471018015|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833358|NCT05396014|471018016|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833359|NCT05396014|471018017|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833360|NCT05396014|471018018|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833361|NCT05396014|471018019|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
130833362|NCT05396014|471018020|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833363|NCT05396014|471018021|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833364|NCT05396014|471018022|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833365|NCT05396014|471018023|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833366|NCT05396014|471018024|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833367|NCT05396014|471018025|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833368|NCT05396014|471018026|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833369|NCT05396014|471018027|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833370|NCT05396014|471018028|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833371|NCT05396014|471018029|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833372|NCT05396014|471018030|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833373|NCT05396014|471018031|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833374|NCT05396014|471018032|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833375|NCT05396014|471018033|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833376|NCT05396014|471018034|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833377|NCT05396014|471018035|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833378|NCT05396014|471018036|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833379|NCT05396014|471018037|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833380|NCT05396014|471018038|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833381|NCT05396014|471018039|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833382|NCT05396014|471018040|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833383|NCT05396014|471018041|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833384|NCT05396014|471018042|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833385|NCT05396014|471018043|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833386|NCT05396014|471018044|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833387|NCT05396014|471018045|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833388|NCT05396014|471018046|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833389|NCT05396014|471018047|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833390|NCT05396014|471018048|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130833391|NCT05396014|471018006|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
130833392|NCT05396014|471018007|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833393|NCT05396014|471018008|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833394|NCT05396014|471018009|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833395|NCT05396014|471018010|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833396|NCT05396014|471018011|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833397|NCT05396014|471018012|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833398|NCT05396014|471018013|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833399|NCT05396014|471018014|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833400|NCT05396014|471018015|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833401|NCT05396014|471018016|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833402|NCT05396014|471018017|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833403|NCT05396014|471018018|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833404|NCT05396014|471018019|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
130833405|NCT05396014|471018020|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833406|NCT05396014|471018021|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833407|NCT05396014|471018022|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833408|NCT05396014|471018023|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833409|NCT05396014|471018024|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833410|NCT05396014|471018025|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833411|NCT05396014|471018026|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833412|NCT05396014|471018027|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833413|NCT05396014|471018028|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833414|NCT05396014|471018029|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833415|NCT05396014|471018030|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833416|NCT05396014|471018031|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833417|NCT05396014|471018032|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833418|NCT05396014|471018033|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833419|NCT05396014|471018034|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833420|NCT05396014|471018035|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833421|NCT05396014|471018036|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833422|NCT05396014|471018037|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833423|NCT05396014|471018038|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833424|NCT05396014|471018039|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833425|NCT05396014|471018040|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833426|NCT05396014|471018041|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833427|NCT05396014|471018042|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833428|NCT05396014|471018043|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833429|NCT05396014|471018044|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833430|NCT05396014|471018045|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
130833431|NCT05396014|471018046|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833432|NCT05396014|471018047|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833433|NCT05396014|471018048|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130833434|NCT05396014|471018006|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
130833435|NCT05396014|471018007|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833436|NCT05396014|471018008|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833437|NCT05396014|471018009|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833438|NCT05396014|471018010|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833439|NCT05396014|471018011|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833440|NCT05396014|471018012|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833441|NCT05396014|471018013|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833442|NCT05396014|471018014|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833443|NCT05396014|471018015|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833444|NCT05396014|471018016|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833445|NCT05396014|471018017|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833446|NCT05396014|471018018|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833447|NCT05396014|471018019|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833448|NCT05396014|471018020|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833449|NCT05396014|471018021|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833450|NCT05396014|471018022|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833451|NCT05396014|471018023|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833452|NCT05396014|471018024|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833453|NCT05396014|471018025|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833454|NCT05396014|471018026|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833455|NCT05396014|471018027|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833456|NCT05396014|471018028|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833457|NCT05396014|471018029|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833458|NCT05396014|471018030|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833459|NCT05396014|471018031|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833460|NCT05396014|471018032|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
130833461|NCT05396014|471018033|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833462|NCT05396014|471018034|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833463|NCT05396014|471018035|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833464|NCT05396014|471018036|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833465|NCT05396014|471018037|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833466|NCT05396014|471018038|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833467|NCT05396014|471018039|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833468|NCT05396014|471018040|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833469|NCT05396014|471018041|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833470|NCT05396014|471018042|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833471|NCT05396014|471018043|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833472|NCT05396014|471018044|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833473|NCT05396014|471018045|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833474|NCT05396014|471018046|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833475|NCT05396014|471018047|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833476|NCT05396014|471018048|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130833477|NCT05396014|471018006|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833478|NCT05396014|471018007|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833479|NCT05396014|471018008|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833480|NCT05396014|471018009|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833481|NCT05396014|471018010|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833482|NCT05396014|471018011|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833483|NCT05396014|471018012|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833484|NCT05396014|471018013|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833485|NCT05396014|471018014|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833486|NCT05396014|471018015|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833487|NCT05396014|471018016|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833488|NCT05396014|471018017|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833489|NCT05396014|471018018|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833490|NCT05396014|471018019|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
130833491|NCT05396014|471018020|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833492|NCT05396014|471018021|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833493|NCT05396014|471018022|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833494|NCT05396014|471018023|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833495|NCT05396014|471018024|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833496|NCT05396014|471018025|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833497|NCT05396014|471018026|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833498|NCT05396014|471018027|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833499|NCT05396014|471018028|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833500|NCT05396014|471018029|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833501|NCT05396014|471018030|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833502|NCT05396014|471018031|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833503|NCT05396014|471018032|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833504|NCT05396014|471018033|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833505|NCT05396014|471018034|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833506|NCT05396014|471018035|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833507|NCT05396014|471018036|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833508|NCT05396014|471018037|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833509|NCT05396014|471018038|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833510|NCT05396014|471018039|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833511|NCT05396014|471018040|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833512|NCT05396014|471018041|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833513|NCT05396014|471018042|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833514|NCT05396014|471018043|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833515|NCT05396014|471018044|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833516|NCT05396014|471018045|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833517|NCT05396014|471018046|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833518|NCT05396014|471018047|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833519|NCT05396014|471018048|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130833520|NCT05396014|471018006|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833521|NCT05396014|471018007|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833522|NCT05396014|471018008|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833523|NCT05396014|471018009|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130833524|NCT05396014|471018010|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833525|NCT05396014|471018011|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833526|NCT05396014|471018012|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833527|NCT05396014|471018013|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833528|NCT05396014|471018014|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130833529|NCT05396014|471018015|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833530|NCT05396014|471018016|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833531|NCT05396014|471018017|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833532|NCT05396014|471018018|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833533|NCT05396014|471018019|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833534|NCT05396014|471018020|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833535|NCT05396014|471018021|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833536|NCT05396014|471018022|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833537|NCT05396014|471018023|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833538|NCT05396014|471018024|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833539|NCT05396014|471018025|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833540|NCT05396014|471018026|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833541|NCT05396014|471018027|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833542|NCT05396014|471018028|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833543|NCT05396014|471018029|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833544|NCT05396014|471018030|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833545|NCT05396014|471018031|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130833546|NCT05396014|471018032|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833547|NCT05396014|471018033|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833548|NCT05396014|471018034|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833549|NCT05396014|471018035|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833550|NCT05396014|471018036|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833551|NCT05396014|471018037|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833552|NCT05396014|471018038|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833553|NCT05396014|471018039|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833554|NCT05396014|471018040|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833555|NCT05396014|471018041|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833556|NCT05396014|471018042|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833557|NCT05396014|471018043|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833558|NCT05396014|471018044|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833559|NCT05396014|471018045|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130833560|NCT05396014|471018046|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
130833561|NCT05396014|471018047|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130833562|NCT05396014|471018048|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130833563|NCT05396014|471018006|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833564|NCT05396014|471018007|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833565|NCT05396014|471018008|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833566|NCT05396014|471018009|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833567|NCT05396014|471018010|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833568|NCT05396014|471018011|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833569|NCT05396014|471018012|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833570|NCT05396014|471018013|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833571|NCT05396014|471018014|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
130833572|NCT05396014|471018015|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833573|NCT05396014|471018016|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833574|NCT05396014|471018017|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833575|NCT05396014|471018018|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833576|NCT05396014|471018019|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833577|NCT05396014|471018020|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833578|NCT05396014|471018021|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833579|NCT05396014|471018022|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833580|NCT05396014|471018023|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833581|NCT05396014|471018024|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833582|NCT05396014|471018025|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833583|NCT05396014|471018026|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833584|NCT05396014|471018027|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833585|NCT05396014|471018028|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
130833586|NCT05396014|471018029|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833587|NCT05396014|471018030|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833588|NCT05396014|471018031|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833589|NCT05396014|471018032|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833590|NCT05396014|471018033|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833591|NCT05396014|471018034|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833592|NCT05396014|471018035|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833593|NCT05396014|471018036|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833594|NCT05396014|471018037|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833595|NCT05396014|471018038|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833596|NCT05396014|471018039|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833597|NCT05396014|471018040|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833598|NCT05396014|471018041|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
130833599|NCT05396014|471018042|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833600|NCT05396014|471018043|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833601|NCT05396014|471018044|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833602|NCT05396014|471018045|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130833603|NCT05396014|471018046|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833604|NCT05396014|471018047|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
130833605|NCT05396014|471018048|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130833606|NCT05396014|471018006|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833607|NCT05396014|471018007|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833608|NCT05396014|471018008|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833609|NCT05396014|471018009|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833610|NCT05396014|471018010|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833611|NCT05396014|471018011|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833612|NCT05396014|471018012|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833613|NCT05396014|471018013|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833614|NCT05396014|471018014|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833615|NCT05396014|471018015|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833616|NCT05396014|471018016|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833617|NCT05396014|471018017|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833618|NCT05396014|471018018|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833619|NCT05396014|471018019|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130833620|NCT05396014|471018020|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833621|NCT05396014|471018021|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833622|NCT05396014|471018022|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833623|NCT05396014|471018023|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833624|NCT05396014|471018024|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833625|NCT05396014|471018025|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833626|NCT05396014|471018026|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833627|NCT05396014|471018027|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833628|NCT05396014|471018028|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833629|NCT05396014|471018029|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833630|NCT05396014|471018030|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833631|NCT05396014|471018031|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833632|NCT05396014|471018032|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130833633|NCT05396014|471018033|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833634|NCT05396014|471018034|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833635|NCT05396014|471018035|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833636|NCT05396014|471018036|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833637|NCT05396014|471018037|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833638|NCT05396014|471018038|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833639|NCT05396014|471018039|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833640|NCT05396014|471018040|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130833641|NCT05396014|471018041|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833642|NCT05396014|471018042|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833643|NCT05396014|471018043|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833644|NCT05396014|471018044|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833645|NCT05396014|471018045|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833646|NCT05396014|471018046|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833647|NCT05396014|471018047|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130833648|NCT05396014|471018048|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130833649|NCT05396014|471018006|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833650|NCT05396014|471018007|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833651|NCT05396014|471018008|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833652|NCT05396014|471018009|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833653|NCT05396014|471018010|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833654|NCT05396014|471018011|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833655|NCT05396014|471018012|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833656|NCT05396014|471018013|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833657|NCT05396014|471018014|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833658|NCT05396014|471018015|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833659|NCT05396014|471018016|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833660|NCT05396014|471018017|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833661|NCT05396014|471018018|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833662|NCT05396014|471018019|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833663|NCT05396014|471018020|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833664|NCT05396014|471018021|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833665|NCT05396014|471018022|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833666|NCT05396014|471018023|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833667|NCT05396014|471018024|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833668|NCT05396014|471018025|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833669|NCT05396014|471018026|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833670|NCT05396014|471018027|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833671|NCT05396014|471018028|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833672|NCT05396014|471018029|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833673|NCT05396014|471018030|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833674|NCT05396014|471018031|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833675|NCT05396014|471018032|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
130833676|NCT05396014|471018033|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833677|NCT05396014|471018034|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833678|NCT05396014|471018035|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833679|NCT05396014|471018036|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833680|NCT05396014|471018037|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833681|NCT05396014|471018038|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833682|NCT05396014|471018039|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833683|NCT05396014|471018040|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833684|NCT05396014|471018041|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833685|NCT05396014|471018042|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833686|NCT05396014|471018043|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833687|NCT05396014|471018044|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833688|NCT05396014|471018045|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833689|NCT05396014|471018046|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833690|NCT05396014|471018047|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833691|NCT05396014|471018048|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130833692|NCT03062280|471018049|FG000|Overall Study|Adverse Event|1|||
130833693|NCT03062280|471018049|FG000|Overall Study|Death|1|||
130833694|NCT03062280|471018049|FG000|Overall Study|Fertility Treatment|2|||
130833695|NCT03062280|471018049|FG000|Overall Study|Physician Decision|2|||
130833696|NCT03062280|471018049|FG000|Overall Study|Pregnancy|5|||
130833697|NCT03062280|471018049|FG000|Overall Study|Withdrawal by Subject|11|||
130833698|NCT04299308|471018051|FG000|Overall Study|Withdrawal by Subject|1|||
130833699|NCT04299308|471018052|FG001|Overall Study|Withdrawal by Subject|0|||
130833700|NCT04299308|471018051|FG000|Overall Study|issue with PET image (1)|1|||
130833701|NCT04299308|471018052|FG001|Overall Study|issue with PET image (1)|0|||
130833702|NCT05258890|471018053|FG000|Overall Study|Patient withdrawal|6|||
130833703|NCT05258890|471018054|FG001|Overall Study|Patient withdrawal|7|||
130833704|NCT05258890|471018053|FG000|Overall Study|Patient lost to follow-up|10|||
130833705|NCT05258890|471018054|FG001|Overall Study|Patient lost to follow-up|3|||
130833706|NCT05258890|471018053|FG000|Overall Study|Social network member withdrawal|1|||
130833707|NCT05258890|471018054|FG001|Overall Study|Social network member withdrawal|0|||
130833708|NCT05258890|471018053|FG000|Overall Study|Social network member lost to follow-up|5|||
130833709|NCT05258890|471018054|FG001|Overall Study|Social network member lost to follow-up|0|||
130833715|NCT00516893|471018058|FG000|Overall Study|Lost to Follow-up|4|||
130833716|NCT00516893|471018058|FG000|Overall Study|Adverse Event|3|||
130833717|NCT00516893|471018058|FG000|Overall Study|Withdrawal by Subject|2|||
130833718|NCT00516893|471018058|FG000|Overall Study|Noncompliance|2|||
130833719|NCT00516893|471018058|FG000|Overall Study|Death|1|||
130833720|NCT00516893|471018058|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
130833721|NCT00516893|471018058|FG000|Overall Study|Relocated|1|||
130833722|NCT00516893|471018058|FG000|Overall Study|Pregnancy|1|||
130833723|NCT00516893|471018058|FG000|Overall Study|Received Medication From Another Study|1|||
130833724|NCT05935878|471018064|FG000|Overall Study|Death|1|||
130833725|NCT05935878|471018065|FG001|Overall Study|Death|2|||
130833726|NCT05935878|471018064|FG000|Overall Study|Withdrawal by Subject|5|||
130833727|NCT05935878|471018065|FG001|Overall Study|Withdrawal by Subject|5|||
130833728|NCT05935878|471018064|FG000|Overall Study|Revision of implant|1|||
130833729|NCT05935878|471018065|FG001|Overall Study|Revision of implant|1|||
130833730|NCT05935878|471018064|FG000|Overall Study|Mobile bearing dislocation|0|||
130833731|NCT05935878|471018065|FG001|Overall Study|Mobile bearing dislocation|1|||
130833732|NCT05924165|471018066|FG000|Overall Study|Physician Decision|2|||
130833733|NCT05924165|471018067|FG001|Overall Study|Physician Decision|3|||
130833734|NCT05959447|471018068|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
130833735|NCT05959447|471018069|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
130833736|NCT05959447|471018068|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
130833737|NCT05959447|471018069|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
130833738|NCT05959447|471018068|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
130833739|NCT05959447|471018069|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
130833740|NCT05959447|471018068|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
130833741|NCT05959447|471018069|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
130833742|NCT00301262|471018070|FG000|Double Blind Phase (DB)|Adverse Event|1|||
130833743|NCT00301262|471018071|FG001|Double Blind Phase (DB)|Adverse Event|0|||
130833744|NCT00301262|471018070|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
130833745|NCT00301262|471018071|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
130833746|NCT00301262|471018070|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
130833747|NCT00301262|471018071|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
130833748|NCT00301262|471018070|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
130833749|NCT00301262|471018071|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
130833750|NCT00301262|471018070|FG000|Double Blind Phase (DB)|Other|1|||
130833751|NCT00301262|471018071|FG001|Double Blind Phase (DB)|Other|4|||
130833752|NCT00301262|471018070|FG000|Open Label Phase (OL)|Adverse Event|1|||
130833753|NCT00301262|471018071|FG001|Open Label Phase (OL)|Adverse Event|0|||
130833754|NCT00301262|471018070|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
130833755|NCT00301262|471018071|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
130833756|NCT00301262|471018070|FG000|Open Label Phase (OL)|Other|2|||
130833757|NCT00301262|471018071|FG001|Open Label Phase (OL)|Other|0|||
130833758|NCT00368745|471018072|FG000|Double-blind Treatment Period|Adverse Event|6|||
130833759|NCT00368745|471018073|FG001|Double-blind Treatment Period|Adverse Event|6|||
130833760|NCT00368745|471018072|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
130833761|NCT00368745|471018073|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
130833762|NCT00368745|471018072|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130833763|NCT00368745|471018073|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130833764|NCT00368745|471018072|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
130833765|NCT00368745|471018073|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
130833766|NCT00368745|471018072|FG000|Double-blind Treatment Period|Other|7|||
130833767|NCT00368745|471018073|FG001|Double-blind Treatment Period|Other|6|||
130833768|NCT01436656|471018074|FG000|Dose Escalation|Death|1|||
130833769|NCT01436656|471018075|FG001|Dose Escalation|Death|3|||
130833770|NCT01436656|471018076|FG002|Dose Escalation|Death|1|||
130833771|NCT01436656|471018077|FG003|Dose Escalation|Death|0|||
130833772|NCT01436656|471018078|FG004|Dose Escalation|Death|2|||
130833773|NCT01436656|471018079|FG005|Dose Escalation|Death|1|||
130833774|NCT01436656|471018080|FG006|Dose Escalation|Death|1|||
130833775|NCT01436656|471018081|FG007|Dose Escalation|Death|1|||
130833776|NCT01436656|471018082|FG008|Dose Escalation|Death|1|||
130833777|NCT01436656|471018083|FG009|Dose Escalation|Death|0|||
130833778|NCT01436656|471018084|FG010|Dose Escalation|Death|0|||
130833779|NCT01436656|471018085|FG011|Dose Escalation|Death|0|||
130833780|NCT01436656|471018086|FG012|Dose Escalation|Death|0|||
130833781|NCT01436656|471018087|FG013|Dose Escalation|Death|0|||
130833782|NCT01436656|471018088|FG014|Dose Escalation|Death|0|||
130833783|NCT01436656|471018089|FG015|Dose Escalation|Death|0|||
130833784|NCT01436656|471018090|FG016|Dose Escalation|Death|0|||
130833785|NCT01436656|471018091|FG017|Dose Escalation|Death|0|||
130833786|NCT01436656|471018074|FG000|Dose Escalation|Protocol Violation|0|||
130833787|NCT01436656|471018075|FG001|Dose Escalation|Protocol Violation|0|||
130833788|NCT01436656|471018076|FG002|Dose Escalation|Protocol Violation|0|||
130833789|NCT01436656|471018077|FG003|Dose Escalation|Protocol Violation|0|||
130833790|NCT01436656|471018078|FG004|Dose Escalation|Protocol Violation|0|||
130833791|NCT01436656|471018079|FG005|Dose Escalation|Protocol Violation|1|||
130833792|NCT01436656|471018080|FG006|Dose Escalation|Protocol Violation|0|||
130833793|NCT01436656|471018081|FG007|Dose Escalation|Protocol Violation|0|||
130833794|NCT01436656|471018082|FG008|Dose Escalation|Protocol Violation|0|||
130833795|NCT01436656|471018083|FG009|Dose Escalation|Protocol Violation|0|||
130833796|NCT01436656|471018084|FG010|Dose Escalation|Protocol Violation|0|||
130833797|NCT01436656|471018085|FG011|Dose Escalation|Protocol Violation|0|||
130833798|NCT01436656|471018086|FG012|Dose Escalation|Protocol Violation|0|||
130833799|NCT01436656|471018087|FG013|Dose Escalation|Protocol Violation|0|||
130833800|NCT01436656|471018088|FG014|Dose Escalation|Protocol Violation|0|||
130833801|NCT01436656|471018089|FG015|Dose Escalation|Protocol Violation|0|||
130833802|NCT01436656|471018090|FG016|Dose Escalation|Protocol Violation|0|||
130833803|NCT01436656|471018091|FG017|Dose Escalation|Protocol Violation|0|||
130833804|NCT01436656|471018074|FG000|Dose Escalation|Withdrawal by Subject|0|||
130833805|NCT01436656|471018075|FG001|Dose Escalation|Withdrawal by Subject|0|||
130833806|NCT01436656|471018076|FG002|Dose Escalation|Withdrawal by Subject|0|||
130833807|NCT01436656|471018077|FG003|Dose Escalation|Withdrawal by Subject|0|||
130833808|NCT01436656|471018078|FG004|Dose Escalation|Withdrawal by Subject|1|||
130833809|NCT01436656|471018079|FG005|Dose Escalation|Withdrawal by Subject|0|||
130833810|NCT01436656|471018080|FG006|Dose Escalation|Withdrawal by Subject|0|||
130833811|NCT01436656|471018081|FG007|Dose Escalation|Withdrawal by Subject|2|||
130833812|NCT01436656|471018082|FG008|Dose Escalation|Withdrawal by Subject|0|||
130833813|NCT01436656|471018083|FG009|Dose Escalation|Withdrawal by Subject|1|||
130833814|NCT01436656|471018084|FG010|Dose Escalation|Withdrawal by Subject|1|||
130833815|NCT01436656|471018085|FG011|Dose Escalation|Withdrawal by Subject|0|||
130833816|NCT01436656|471018086|FG012|Dose Escalation|Withdrawal by Subject|0|||
130833817|NCT01436656|471018087|FG013|Dose Escalation|Withdrawal by Subject|0|||
130833818|NCT01436656|471018088|FG014|Dose Escalation|Withdrawal by Subject|0|||
130833819|NCT01436656|471018089|FG015|Dose Escalation|Withdrawal by Subject|0|||
130833820|NCT01436656|471018090|FG016|Dose Escalation|Withdrawal by Subject|0|||
130833821|NCT01436656|471018091|FG017|Dose Escalation|Withdrawal by Subject|0|||
130833822|NCT01436656|471018074|FG000|Dose Escalation|Administrative problems|0|||
130833823|NCT01436656|471018075|FG001|Dose Escalation|Administrative problems|1|||
130833824|NCT01436656|471018076|FG002|Dose Escalation|Administrative problems|0|||
130833825|NCT01436656|471018077|FG003|Dose Escalation|Administrative problems|0|||
130833826|NCT01436656|471018078|FG004|Dose Escalation|Administrative problems|0|||
130833827|NCT01436656|471018079|FG005|Dose Escalation|Administrative problems|0|||
130833828|NCT01436656|471018080|FG006|Dose Escalation|Administrative problems|0|||
130833829|NCT01436656|471018081|FG007|Dose Escalation|Administrative problems|0|||
130833830|NCT01436656|471018082|FG008|Dose Escalation|Administrative problems|0|||
130833831|NCT01436656|471018083|FG009|Dose Escalation|Administrative problems|0|||
130833832|NCT01436656|471018084|FG010|Dose Escalation|Administrative problems|0|||
130833833|NCT01436656|471018085|FG011|Dose Escalation|Administrative problems|0|||
130833834|NCT01436656|471018086|FG012|Dose Escalation|Administrative problems|0|||
130833835|NCT01436656|471018087|FG013|Dose Escalation|Administrative problems|0|||
130833836|NCT01436656|471018088|FG014|Dose Escalation|Administrative problems|0|||
130833837|NCT01436656|471018089|FG015|Dose Escalation|Administrative problems|0|||
130833838|NCT01436656|471018090|FG016|Dose Escalation|Administrative problems|0|||
130833839|NCT01436656|471018091|FG017|Dose Escalation|Administrative problems|0|||
130833840|NCT01436656|471018074|FG000|Dose Escalation|Lost to Follow-up|1|||
130833841|NCT01436656|471018075|FG001|Dose Escalation|Lost to Follow-up|0|||
130833842|NCT01436656|471018076|FG002|Dose Escalation|Lost to Follow-up|0|||
130833843|NCT01436656|471018077|FG003|Dose Escalation|Lost to Follow-up|0|||
130833844|NCT01436656|471018078|FG004|Dose Escalation|Lost to Follow-up|1|||
130833845|NCT01436656|471018079|FG005|Dose Escalation|Lost to Follow-up|0|||
130833846|NCT01436656|471018080|FG006|Dose Escalation|Lost to Follow-up|0|||
130833847|NCT01436656|471018081|FG007|Dose Escalation|Lost to Follow-up|0|||
130833848|NCT01436656|471018082|FG008|Dose Escalation|Lost to Follow-up|0|||
130833849|NCT01436656|471018083|FG009|Dose Escalation|Lost to Follow-up|0|||
130833850|NCT01436656|471018084|FG010|Dose Escalation|Lost to Follow-up|0|||
130833851|NCT01436656|471018085|FG011|Dose Escalation|Lost to Follow-up|0|||
130833852|NCT01436656|471018086|FG012|Dose Escalation|Lost to Follow-up|0|||
130833853|NCT01436656|471018087|FG013|Dose Escalation|Lost to Follow-up|0|||
130833854|NCT01436656|471018088|FG014|Dose Escalation|Lost to Follow-up|0|||
130833855|NCT01436656|471018089|FG015|Dose Escalation|Lost to Follow-up|0|||
130833856|NCT01436656|471018090|FG016|Dose Escalation|Lost to Follow-up|0|||
130833857|NCT01436656|471018091|FG017|Dose Escalation|Lost to Follow-up|0|||
130833858|NCT01436656|471018074|FG000|Dose Escalation|New anti-cancer therapy|1|||
130833859|NCT01436656|471018075|FG001|Dose Escalation|New anti-cancer therapy|0|||
130833860|NCT01436656|471018076|FG002|Dose Escalation|New anti-cancer therapy|0|||
130833861|NCT01436656|471018077|FG003|Dose Escalation|New anti-cancer therapy|0|||
130833862|NCT01436656|471018078|FG004|Dose Escalation|New anti-cancer therapy|0|||
130833863|NCT01436656|471018079|FG005|Dose Escalation|New anti-cancer therapy|0|||
130833864|NCT01436656|471018080|FG006|Dose Escalation|New anti-cancer therapy|0|||
130833865|NCT01436656|471018081|FG007|Dose Escalation|New anti-cancer therapy|0|||
130833866|NCT01436656|471018082|FG008|Dose Escalation|New anti-cancer therapy|1|||
130833867|NCT01436656|471018083|FG009|Dose Escalation|New anti-cancer therapy|1|||
130833868|NCT01436656|471018084|FG010|Dose Escalation|New anti-cancer therapy|0|||
130833869|NCT01436656|471018085|FG011|Dose Escalation|New anti-cancer therapy|0|||
130833870|NCT01436656|471018086|FG012|Dose Escalation|New anti-cancer therapy|0|||
130833871|NCT01436656|471018087|FG013|Dose Escalation|New anti-cancer therapy|0|||
130833872|NCT01436656|471018088|FG014|Dose Escalation|New anti-cancer therapy|0|||
130833873|NCT01436656|471018089|FG015|Dose Escalation|New anti-cancer therapy|0|||
130833874|NCT01436656|471018090|FG016|Dose Escalation|New anti-cancer therapy|0|||
130833875|NCT01436656|471018091|FG017|Dose Escalation|New anti-cancer therapy|0|||
130833876|NCT01436656|471018074|FG000|Dose Expansion|Adverse Event|0|||
130833877|NCT01436656|471018075|FG001|Dose Expansion|Adverse Event|0|||
130833878|NCT01436656|471018076|FG002|Dose Expansion|Adverse Event|0|||
130833879|NCT01436656|471018077|FG003|Dose Expansion|Adverse Event|0|||
130833880|NCT01436656|471018078|FG004|Dose Expansion|Adverse Event|0|||
130833881|NCT01436656|471018079|FG005|Dose Expansion|Adverse Event|0|||
130833882|NCT01436656|471018080|FG006|Dose Expansion|Adverse Event|0|||
130833883|NCT01436656|471018081|FG007|Dose Expansion|Adverse Event|0|||
130833884|NCT01436656|471018082|FG008|Dose Expansion|Adverse Event|0|||
130833885|NCT01436656|471018083|FG009|Dose Expansion|Adverse Event|0|||
130833886|NCT01436656|471018084|FG010|Dose Expansion|Adverse Event|0|||
130833887|NCT01436656|471018085|FG011|Dose Expansion|Adverse Event|1|||
130833888|NCT01436656|471018086|FG012|Dose Expansion|Adverse Event|0|||
130833889|NCT01436656|471018087|FG013|Dose Expansion|Adverse Event|0|||
130833890|NCT01436656|471018088|FG014|Dose Expansion|Adverse Event|0|||
130833891|NCT01436656|471018089|FG015|Dose Expansion|Adverse Event|0|||
130833892|NCT01436656|471018090|FG016|Dose Expansion|Adverse Event|0|||
130833893|NCT01436656|471018091|FG017|Dose Expansion|Adverse Event|0|||
130833894|NCT01436656|471018074|FG000|Dose Expansion|Withdrawal by Subject|0|||
130833895|NCT01436656|471018075|FG001|Dose Expansion|Withdrawal by Subject|0|||
130833896|NCT01436656|471018076|FG002|Dose Expansion|Withdrawal by Subject|0|||
130833897|NCT01436656|471018077|FG003|Dose Expansion|Withdrawal by Subject|0|||
130833898|NCT01436656|471018078|FG004|Dose Expansion|Withdrawal by Subject|0|||
130833899|NCT01436656|471018079|FG005|Dose Expansion|Withdrawal by Subject|0|||
130833900|NCT01436656|471018080|FG006|Dose Expansion|Withdrawal by Subject|0|||
130833901|NCT01436656|471018081|FG007|Dose Expansion|Withdrawal by Subject|0|||
130833902|NCT01436656|471018082|FG008|Dose Expansion|Withdrawal by Subject|0|||
130833903|NCT01436656|471018083|FG009|Dose Expansion|Withdrawal by Subject|0|||
130833904|NCT01436656|471018084|FG010|Dose Expansion|Withdrawal by Subject|0|||
130833905|NCT01436656|471018085|FG011|Dose Expansion|Withdrawal by Subject|1|||
130833906|NCT01436656|471018086|FG012|Dose Expansion|Withdrawal by Subject|3|||
130833907|NCT01436656|471018087|FG013|Dose Expansion|Withdrawal by Subject|1|||
130833908|NCT01436656|471018088|FG014|Dose Expansion|Withdrawal by Subject|2|||
130833909|NCT01436656|471018089|FG015|Dose Expansion|Withdrawal by Subject|0|||
130833910|NCT01436656|471018090|FG016|Dose Expansion|Withdrawal by Subject|1|||
130833911|NCT01436656|471018091|FG017|Dose Expansion|Withdrawal by Subject|1|||
130833912|NCT01436656|471018074|FG000|Dose Expansion|Death|0|||
130833913|NCT01436656|471018075|FG001|Dose Expansion|Death|0|||
130833914|NCT01436656|471018076|FG002|Dose Expansion|Death|0|||
130833915|NCT01436656|471018077|FG003|Dose Expansion|Death|0|||
130833916|NCT01436656|471018078|FG004|Dose Expansion|Death|0|||
130833917|NCT01436656|471018079|FG005|Dose Expansion|Death|0|||
130833918|NCT01436656|471018080|FG006|Dose Expansion|Death|0|||
130833919|NCT01436656|471018081|FG007|Dose Expansion|Death|0|||
130833920|NCT01436656|471018082|FG008|Dose Expansion|Death|0|||
130833921|NCT01436656|471018083|FG009|Dose Expansion|Death|0|||
130833922|NCT01436656|471018084|FG010|Dose Expansion|Death|0|||
130833923|NCT01436656|471018085|FG011|Dose Expansion|Death|0|||
130833924|NCT01436656|471018086|FG012|Dose Expansion|Death|1|||
130833925|NCT01436656|471018087|FG013|Dose Expansion|Death|0|||
130833926|NCT01436656|471018088|FG014|Dose Expansion|Death|3|||
130833927|NCT01436656|471018089|FG015|Dose Expansion|Death|0|||
130833928|NCT01436656|471018090|FG016|Dose Expansion|Death|3|||
130833929|NCT01436656|471018091|FG017|Dose Expansion|Death|3|||
130833930|NCT01436656|471018074|FG000|Dose Expansion|Lost to Follow-up|0|||
130833931|NCT01436656|471018075|FG001|Dose Expansion|Lost to Follow-up|0|||
130833932|NCT01436656|471018076|FG002|Dose Expansion|Lost to Follow-up|0|||
130833933|NCT01436656|471018077|FG003|Dose Expansion|Lost to Follow-up|0|||
130833934|NCT01436656|471018078|FG004|Dose Expansion|Lost to Follow-up|0|||
130833935|NCT01436656|471018079|FG005|Dose Expansion|Lost to Follow-up|0|||
130833936|NCT01436656|471018080|FG006|Dose Expansion|Lost to Follow-up|0|||
130833937|NCT01436656|471018081|FG007|Dose Expansion|Lost to Follow-up|0|||
130833938|NCT01436656|471018082|FG008|Dose Expansion|Lost to Follow-up|0|||
130833939|NCT01436656|471018083|FG009|Dose Expansion|Lost to Follow-up|0|||
130833940|NCT01436656|471018084|FG010|Dose Expansion|Lost to Follow-up|0|||
130833941|NCT01436656|471018085|FG011|Dose Expansion|Lost to Follow-up|0|||
130833942|NCT01436656|471018086|FG012|Dose Expansion|Lost to Follow-up|0|||
130833943|NCT01436656|471018087|FG013|Dose Expansion|Lost to Follow-up|0|||
130833944|NCT01436656|471018088|FG014|Dose Expansion|Lost to Follow-up|0|||
130833945|NCT01436656|471018089|FG015|Dose Expansion|Lost to Follow-up|0|||
130833946|NCT01436656|471018090|FG016|Dose Expansion|Lost to Follow-up|0|||
130833947|NCT01436656|471018091|FG017|Dose Expansion|Lost to Follow-up|3|||
130833948|NCT01436656|471018074|FG000|Dose Expansion|Disease progression|0|||
130833949|NCT01436656|471018075|FG001|Dose Expansion|Disease progression|0|||
130833950|NCT01436656|471018076|FG002|Dose Expansion|Disease progression|0|||
130833951|NCT01436656|471018077|FG003|Dose Expansion|Disease progression|0|||
130833952|NCT01436656|471018078|FG004|Dose Expansion|Disease progression|0|||
130833953|NCT01436656|471018079|FG005|Dose Expansion|Disease progression|0|||
130833954|NCT01436656|471018080|FG006|Dose Expansion|Disease progression|0|||
130833955|NCT01436656|471018081|FG007|Dose Expansion|Disease progression|0|||
130833956|NCT01436656|471018082|FG008|Dose Expansion|Disease progression|0|||
130833957|NCT01436656|471018083|FG009|Dose Expansion|Disease progression|0|||
130833958|NCT01436656|471018084|FG010|Dose Expansion|Disease progression|0|||
130833959|NCT01436656|471018085|FG011|Dose Expansion|Disease progression|3|||
130833960|NCT01436656|471018086|FG012|Dose Expansion|Disease progression|1|||
130833961|NCT01436656|471018087|FG013|Dose Expansion|Disease progression|0|||
130833962|NCT01436656|471018088|FG014|Dose Expansion|Disease progression|1|||
130833963|NCT01436656|471018089|FG015|Dose Expansion|Disease progression|0|||
130833964|NCT01436656|471018090|FG016|Dose Expansion|Disease progression|0|||
130833965|NCT01436656|471018091|FG017|Dose Expansion|Disease progression|1|||
130833966|NCT01436656|471018074|FG000|Dose Expansion|New cancer therapy|0|||
130833967|NCT01436656|471018075|FG001|Dose Expansion|New cancer therapy|0|||
130833968|NCT01436656|471018076|FG002|Dose Expansion|New cancer therapy|0|||
130833969|NCT01436656|471018077|FG003|Dose Expansion|New cancer therapy|0|||
130833970|NCT01436656|471018078|FG004|Dose Expansion|New cancer therapy|0|||
130833971|NCT01436656|471018079|FG005|Dose Expansion|New cancer therapy|0|||
130833972|NCT01436656|471018080|FG006|Dose Expansion|New cancer therapy|0|||
130833973|NCT01436656|471018081|FG007|Dose Expansion|New cancer therapy|0|||
130833974|NCT01436656|471018082|FG008|Dose Expansion|New cancer therapy|0|||
130833975|NCT01436656|471018083|FG009|Dose Expansion|New cancer therapy|0|||
130833976|NCT01436656|471018084|FG010|Dose Expansion|New cancer therapy|0|||
130833977|NCT01436656|471018085|FG011|Dose Expansion|New cancer therapy|1|||
130833978|NCT01436656|471018086|FG012|Dose Expansion|New cancer therapy|1|||
130833979|NCT01436656|471018087|FG013|Dose Expansion|New cancer therapy|0|||
130833980|NCT01436656|471018088|FG014|Dose Expansion|New cancer therapy|2|||
130833981|NCT01436656|471018089|FG015|Dose Expansion|New cancer therapy|0|||
130833982|NCT01436656|471018090|FG016|Dose Expansion|New cancer therapy|0|||
130833983|NCT01436656|471018091|FG017|Dose Expansion|New cancer therapy|0|||
130833984|NCT04729972|471018092|FG000|Overall Study|Adverse Event|1|||
130833985|NCT00576628|471018094|FG000|Overall Study|Adverse Event|11|||
130833986|NCT00576628|471018094|FG000|Overall Study|Death|2|||
130833987|NCT00576628|471018094|FG000|Overall Study|Failure to return|1|||
130833988|NCT00576628|471018094|FG000|Overall Study|Refused Treatment|8|||
130833989|NCT00576628|471018094|FG000|Overall Study|Pregnancy|1|||
130833990|NCT00576628|471018094|FG000|Overall Study|RBC transfusion|1|||
130833991|NCT00576628|471018094|FG000|Overall Study|Progression of Kidney Disease|1|||
130833992|NCT00576628|471018094|FG000|Overall Study|Progression of Renal Failure|1|||
130833993|NCT00576628|471018094|FG000|Overall Study|The patient move into other town|1|||
130833994|NCT00576628|471018094|FG000|Overall Study|Transplantation|1|||
130833995|NCT00576628|471018094|FG000|Overall Study|Dialysis|15|||
130833996|NCT03206970|471018095|FG000|Overall Study|Death|21|||
130833997|NCT03206970|471018095|FG000|Overall Study|Withdrawal by Subject|13|||
130833998|NCT03206970|471018095|FG000|Overall Study|Lost to Follow-up|3|||
130833999|NCT03206970|471018095|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
130834000|NCT02516982|471018096|FG000|Overall Study|Called in to antenatal appointment|32|||
130834001|NCT02516982|471018097|FG001|Overall Study|Called in to antenatal appointment|35|||
130834002|NCT02516982|471018098|FG002|Overall Study|Called in to antenatal appointment|0|||
130834003|NCT02516982|471018099|FG003|Overall Study|Called in to antenatal appointment|0|||
130834004|NCT02516982|471018096|FG000|Overall Study|Withdrawal by Subject|0|||
130834005|NCT02516982|471018097|FG001|Overall Study|Withdrawal by Subject|0|||
130834006|NCT02516982|471018098|FG002|Overall Study|Withdrawal by Subject|1|||
130834007|NCT02516982|471018099|FG003|Overall Study|Withdrawal by Subject|2|||
130834008|NCT02516982|471018096|FG000|Overall Study|Protocol Violation|0|||
130834009|NCT02516982|471018097|FG001|Overall Study|Protocol Violation|0|||
130834010|NCT02516982|471018098|FG002|Overall Study|Protocol Violation|1|||
130834011|NCT02516982|471018099|FG003|Overall Study|Protocol Violation|1|||
130834012|NCT02516982|471018096|FG000|Overall Study|Did not install the app|0|||
130834013|NCT02516982|471018097|FG001|Overall Study|Did not install the app|0|||
130834014|NCT02516982|471018098|FG002|Overall Study|Did not install the app|46|||
130834015|NCT02516982|471018099|FG003|Overall Study|Did not install the app|47|||
130834016|NCT00962741|471018105|FG000|Overall Study|Failed to return|3|||
130834017|NCT00962741|471018105|FG000|Overall Study|Lost to Follow-up|2|||
130834018|NCT00962741|471018105|FG000|Overall Study|Withdrawal by Subject|1|||
130834019|NCT00962741|471018105|FG000|Overall Study|Lack of Efficacy|1|||
130834020|NCT00962741|471018105|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
130834021|NCT01814878|471018106|FG000|Overall Study|Adverse Event|16|||
130834022|NCT01814878|471018107|FG001|Overall Study|Adverse Event|5|||
130834023|NCT01814878|471018106|FG000|Overall Study|Withdrawal by Subject|20|||
130834024|NCT01814878|471018107|FG001|Overall Study|Withdrawal by Subject|16|||
130834025|NCT01814878|471018106|FG000|Overall Study|Protocol Violation|5|||
130834026|NCT01814878|471018107|FG001|Overall Study|Protocol Violation|5|||
130834027|NCT01814878|471018106|FG000|Overall Study|Physician Decision|3|||
130834028|NCT01814878|471018107|FG001|Overall Study|Physician Decision|1|||
130834029|NCT01814878|471018106|FG000|Overall Study|Screening failure (drop-out)|0|||
130834030|NCT01814878|471018107|FG001|Overall Study|Screening failure (drop-out)|3|||
130834031|NCT01814878|471018106|FG000|Overall Study|Other|2|||
130834032|NCT01814878|471018107|FG001|Overall Study|Other|0|||
130834033|NCT03645421|471018108|FG000|Overall Study|Adverse Event|0|||
130834034|NCT03645421|471018109|FG001|Overall Study|Adverse Event|0|||
130834035|NCT03645421|471018110|FG002|Overall Study|Adverse Event|4|||
130834036|NCT03645421|471018111|FG003|Overall Study|Adverse Event|1|||
130834037|NCT03645421|471018108|FG000|Overall Study|Withdrawal by patient|0|||
130834038|NCT03645421|471018109|FG001|Overall Study|Withdrawal by patient|0|||
130834039|NCT03645421|471018110|FG002|Overall Study|Withdrawal by patient|0|||
130834040|NCT03645421|471018111|FG003|Overall Study|Withdrawal by patient|3|||
130834041|NCT03645421|471018108|FG000|Overall Study|Study specific withdrawal criteria|0|||
130834042|NCT03645421|471018109|FG001|Overall Study|Study specific withdrawal criteria|0|||
130834043|NCT03645421|471018110|FG002|Overall Study|Study specific withdrawal criteria|1|||
130834044|NCT03645421|471018111|FG003|Overall Study|Study specific withdrawal criteria|0|||
130834045|NCT00748618|471018114|FG000|Overall Study|Adverse Event|1|||
130834046|NCT00748618|471018115|FG001|Overall Study|Adverse Event|0|||
130834053|NCT01977729|471018121|FG000|Overall Study|Study terminated|1|||
130834054|NCT01268046|471018122|FG000|Overall Study|Withdrawal by Subject|1|||
130834055|NCT01268046|471018123|FG001|Overall Study|Withdrawal by Subject|0|||
130834056|NCT01268046|471018124|FG002|Overall Study|Withdrawal by Subject|0|||
130834057|NCT01268046|471018125|FG003|Overall Study|Withdrawal by Subject|1|||
130834058|NCT01268046|471018122|FG000|Overall Study|Lost to Follow-up|0|||
130834059|NCT01268046|471018123|FG001|Overall Study|Lost to Follow-up|0|||
130834060|NCT01268046|471018124|FG002|Overall Study|Lost to Follow-up|1|||
130834061|NCT01268046|471018125|FG003|Overall Study|Lost to Follow-up|0|||
130834062|NCT02253433|471018126|FG000|Overall Study|Unable to Contact|9|||
130834063|NCT02253433|471018127|FG001|Overall Study|Unable to Contact|16|||
130834064|NCT02253433|471018126|FG000|Overall Study|Death|1|||
130834065|NCT02253433|471018127|FG001|Overall Study|Death|1|||
130834066|NCT02253433|471018126|FG000|Overall Study|No Longer Interested|3|||
130834067|NCT02253433|471018127|FG001|Overall Study|No Longer Interested|15|||
130834068|NCT02253433|471018126|FG000|Overall Study|Out of Study Area|2|||
130834069|NCT02253433|471018127|FG001|Overall Study|Out of Study Area|7|||
130834070|NCT02253433|471018126|FG000|Overall Study|Uncomfortable with home visitors|0|||
130834071|NCT02253433|471018127|FG001|Overall Study|Uncomfortable with home visitors|3|||
130834072|NCT02253433|471018126|FG000|Overall Study|Unstable Housing/Homeless|0|||
130834073|NCT02253433|471018127|FG001|Overall Study|Unstable Housing/Homeless|7|||
130834074|NCT02253433|471018126|FG000|Overall Study|Too Busy|0|||
130834075|NCT02253433|471018127|FG001|Overall Study|Too Busy|4|||
130834076|NCT02253433|471018126|FG000|Overall Study|Medical or Other Concerns|1|||
130834077|NCT02253433|471018127|FG001|Overall Study|Medical or Other Concerns|2|||
130834078|NCT02836717|471018133|FG000|Test Phase|Lack of Efficacy|14|||
130834079|NCT02836717|471018134|FG001|Test Phase|Lack of Efficacy|8|||
130834080|NCT02836717|471018135|FG002|Test Phase|Lack of Efficacy|0|||
130834081|NCT02836717|471018133|FG000|Study Phase|Adverse Event|2|||
130834082|NCT02836717|471018134|FG001|Study Phase|Adverse Event|0|||
130834083|NCT02836717|471018135|FG002|Study Phase|Adverse Event|0|||
130834084|NCT02836717|471018133|FG000|Study Phase|Lack of Efficacy|8|||
130834085|NCT02836717|471018134|FG001|Study Phase|Lack of Efficacy|6|||
130834086|NCT02836717|471018135|FG002|Study Phase|Lack of Efficacy|1|||
130834087|NCT02836717|471018133|FG000|Study Phase|Withdrawal by Subject|1|||
130834088|NCT02836717|471018134|FG001|Study Phase|Withdrawal by Subject|0|||
130834089|NCT02836717|471018135|FG002|Study Phase|Withdrawal by Subject|0|||
130834090|NCT02836717|471018133|FG000|Study Phase|Death|1|||
130834091|NCT02836717|471018134|FG001|Study Phase|Death|0|||
130834092|NCT02836717|471018135|FG002|Study Phase|Death|0|||
130834093|NCT02836717|471018133|FG000|Study Phase|abdominal surgeries|2|||
130834094|NCT02836717|471018134|FG001|Study Phase|abdominal surgeries|1|||
130834095|NCT02836717|471018135|FG002|Study Phase|abdominal surgeries|0|||
130834096|NCT00224120|471018136|FG000|Overall Study|Adverse Event|10|||
130834097|NCT00224120|471018137|FG001|Overall Study|Adverse Event|4|||
130834098|NCT00224120|471018136|FG000|Overall Study|Protocol Violation|1|||
130834099|NCT00224120|471018137|FG001|Overall Study|Protocol Violation|0|||
130834100|NCT00224120|471018136|FG000|Overall Study|Withdrawal by Subject|5|||
130834101|NCT00224120|471018137|FG001|Overall Study|Withdrawal by Subject|10|||
130834102|NCT00224120|471018136|FG000|Overall Study|Lack of Efficacy|0|||
130834103|NCT00224120|471018137|FG001|Overall Study|Lack of Efficacy|2|||
130834104|NCT00224120|471018136|FG000|Overall Study|Lost to Follow-up|2|||
130834105|NCT00224120|471018137|FG001|Overall Study|Lost to Follow-up|3|||
130834106|NCT00224120|471018136|FG000|Overall Study|Other|4|||
130834107|NCT00224120|471018137|FG001|Overall Study|Other|5|||
130834108|NCT00438360|471018138|FG000|Overall Study|Adverse Event|6|||
130834109|NCT00438360|471018139|FG001|Overall Study|Adverse Event|1|||
130834110|NCT00438360|471018138|FG000|Overall Study|Lack of Efficacy|42|||
130834111|NCT00438360|471018139|FG001|Overall Study|Lack of Efficacy|27|||
130834112|NCT00438360|471018138|FG000|Overall Study|Other|24|||
130834113|NCT00438360|471018139|FG001|Overall Study|Other|15|||
130834114|NCT00282087|471018140|FG000|Overall Study|Death|1|||
130834115|NCT01804049|471018143|FG000|Overall Study|Adverse Event|2|||
130834116|NCT01804049|471018144|FG001|Overall Study|Adverse Event|10|||
130834117|NCT01804049|471018143|FG000|Overall Study|Lost to Follow-up|2|||
130834118|NCT01804049|471018144|FG001|Overall Study|Lost to Follow-up|1|||
130834119|NCT01804049|471018143|FG000|Overall Study|Decreased interest/personal|4|||
130834120|NCT01804049|471018144|FG001|Overall Study|Decreased interest/personal|5|||
130834121|NCT01804049|471018143|FG000|Overall Study|Other health concerns|2|||
130834122|NCT01804049|471018144|FG001|Overall Study|Other health concerns|7|||
130834123|NCT01804049|471018143|FG000|Overall Study|Moved out of area|0|||
130834124|NCT01804049|471018144|FG001|Overall Study|Moved out of area|7|||
130834125|NCT01804049|471018143|FG000|Overall Study|other MD recommended|1|||
130834126|NCT01804049|471018144|FG001|Overall Study|other MD recommended|1|||
130834127|NCT01804049|471018143|FG000|Overall Study|Enrollment in dual studies|0|||
130834128|NCT01804049|471018144|FG001|Overall Study|Enrollment in dual studies|1|||
130834129|NCT01147250|471018149|FG000|Overall Study|Lost to Follow-up|14|||
130834130|NCT01147250|471018150|FG001|Overall Study|Lost to Follow-up|11|||
130834131|NCT01147250|471018149|FG000|Overall Study|Withdrawal by Subject|83|||
130834132|NCT01147250|471018150|FG001|Overall Study|Withdrawal by Subject|88|||
130834133|NCT01147250|471018149|FG000|Overall Study|Site termination by sponsor|13|||
130834134|NCT01147250|471018150|FG001|Overall Study|Site termination by sponsor|5|||
130834135|NCT01147250|471018149|FG000|Overall Study|Other than specified|0|||
130834136|NCT01147250|471018150|FG001|Overall Study|Other than specified|1|||
130834137|NCT03985943|471018153|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130834138|NCT03985943|471018154|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
130834139|NCT03985943|471018155|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130834140|NCT03985943|471018156|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130834141|NCT03985943|471018157|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130834142|NCT03985943|471018158|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130834143|NCT03985943|471018153|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
130834144|NCT03985943|471018154|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
130834145|NCT03985943|471018155|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130834146|NCT03985943|471018156|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130834147|NCT03985943|471018157|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130834148|NCT03985943|471018158|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130834149|NCT03985943|471018153|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
130834150|NCT03985943|471018154|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
130834151|NCT03985943|471018155|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130834152|NCT03985943|471018156|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130834153|NCT03985943|471018157|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130834154|NCT03985943|471018158|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130834155|NCT03985943|471018153|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
130834156|NCT03985943|471018154|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
130834157|NCT03985943|471018155|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130834158|NCT03985943|471018156|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130834159|NCT03985943|471018157|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130834160|NCT03985943|471018158|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130834161|NCT03985943|471018153|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130834162|NCT03985943|471018154|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
130834163|NCT03985943|471018155|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130834164|NCT03985943|471018156|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130834165|NCT03985943|471018157|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130834166|NCT03985943|471018158|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130834167|NCT03985943|471018153|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
130834168|NCT03985943|471018154|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
130834169|NCT03985943|471018155|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130834170|NCT03985943|471018156|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130834171|NCT03985943|471018157|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130834172|NCT03985943|471018158|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130834173|NCT03985943|471018153|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130834174|NCT03985943|471018154|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
130834175|NCT03985943|471018155|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130834176|NCT03985943|471018156|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130834177|NCT03985943|471018157|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130834178|NCT03985943|471018158|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130834179|NCT03985943|471018153|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130834180|NCT03985943|471018154|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
130834181|NCT03985943|471018155|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130834182|NCT03985943|471018156|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130834183|NCT03985943|471018157|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130834184|NCT03985943|471018158|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130834185|NCT03985943|471018153|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130834186|NCT03985943|471018154|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130834187|NCT03985943|471018155|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
130834188|NCT03985943|471018156|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
130834189|NCT03985943|471018157|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
130834190|NCT03985943|471018158|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
130834191|NCT03985943|471018153|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130834192|NCT03985943|471018154|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130834193|NCT03985943|471018155|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
130834194|NCT03985943|471018156|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
130834195|NCT03985943|471018157|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
130834196|NCT03985943|471018158|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
130834197|NCT03985943|471018153|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
130834198|NCT03985943|471018154|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
130834199|NCT03985943|471018155|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
130834200|NCT03985943|471018156|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
130834201|NCT03985943|471018157|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
130834202|NCT03985943|471018158|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
130834203|NCT03985943|471018153|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130834204|NCT03985943|471018154|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130834205|NCT03985943|471018155|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130834206|NCT03985943|471018156|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130834207|NCT03985943|471018157|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130834208|NCT03985943|471018158|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130834209|NCT03985943|471018153|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130834210|NCT03985943|471018154|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130834211|NCT03985943|471018155|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
130834212|NCT03985943|471018156|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130834213|NCT03985943|471018157|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
130834214|NCT03985943|471018158|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130834215|NCT03985943|471018153|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
130834216|NCT03985943|471018154|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
130834217|NCT03985943|471018155|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
130834218|NCT03985943|471018156|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
130834219|NCT03985943|471018157|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
130834220|NCT03985943|471018158|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
130834221|NCT03985943|471018153|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
130834222|NCT03985943|471018154|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
130834223|NCT03985943|471018155|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
130834224|NCT03985943|471018156|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
130834225|NCT03985943|471018157|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
130834226|NCT03985943|471018158|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
130834227|NCT00338286|471018159|FG000|Overall Study|Withdrawal by Subject|50|||
130834228|NCT00338286|471018160|FG001|Overall Study|Withdrawal by Subject|54|||
130834229|NCT00338286|471018159|FG000|Overall Study|Lost to Follow-up|80|||
130834230|NCT00338286|471018160|FG001|Overall Study|Lost to Follow-up|66|||
130834231|NCT00338286|471018159|FG000|Overall Study|Other|103|||
130834232|NCT00338286|471018160|FG001|Overall Study|Other|93|||
130834233|NCT00022763|471018164|FG000|Overall Study|Adverse Event|1|||
130834234|NCT00022763|471018165|FG001|Overall Study|Adverse Event|2|||
130834235|NCT00022763|471018164|FG000|Overall Study|Injection Site Reactions|0|||
130834236|NCT00022763|471018165|FG001|Overall Study|Injection Site Reactions|2|||
130834237|NCT00022763|471018164|FG000|Overall Study|Death|0|||
130834238|NCT00022763|471018165|FG001|Overall Study|Death|1|||
130834239|NCT00022763|471018164|FG000|Overall Study|Lost to Follow-up|0|||
130834240|NCT00022763|471018165|FG001|Overall Study|Lost to Follow-up|3|||
130834241|NCT00022763|471018164|FG000|Overall Study|Withdrawal by Subject|4|||
130834242|NCT00022763|471018165|FG001|Overall Study|Withdrawal by Subject|7|||
130834243|NCT00022763|471018164|FG000|Overall Study|Insufficient Therapy|1|||
130834244|NCT00022763|471018165|FG001|Overall Study|Insufficient Therapy|0|||
130834245|NCT00022763|471018164|FG000|Overall Study|Admin|3|||
130834246|NCT00022763|471018165|FG001|Overall Study|Admin|2|||
130834247|NCT00716482|471018166|FG000|Overall Study|Lost to Follow-up|6|||
130834248|NCT00716482|471018166|FG000|Overall Study|Inadequate acquisition or analysis|50|||
130834249|NCT00716482|471018166|FG000|Overall Study|no pathology obtained|10|||
130834250|NCT00716482|471018166|FG000|Overall Study|technical/machine error|28|||
130834251|NCT00716482|471018166|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
130834252|NCT03248531|471018167|FG000|Overall Study|Adverse Event|0|||
130834253|NCT03248531|471018168|FG001|Overall Study|Adverse Event|0|||
130834254|NCT03248531|471018169|FG002|Overall Study|Adverse Event|1|||
130834255|NCT03248531|471018167|FG000|Overall Study|Lost to Follow-up|1|||
130834256|NCT03248531|471018168|FG001|Overall Study|Lost to Follow-up|0|||
130834257|NCT03248531|471018169|FG002|Overall Study|Lost to Follow-up|5|||
130834258|NCT03248531|471018167|FG000|Overall Study|Withdrawal by Subject|3|||
130834259|NCT03248531|471018168|FG001|Overall Study|Withdrawal by Subject|3|||
130834260|NCT03248531|471018169|FG002|Overall Study|Withdrawal by Subject|2|||
130834261|NCT03248531|471018167|FG000|Overall Study|Sponsor Request|0|||
130834262|NCT03248531|471018168|FG001|Overall Study|Sponsor Request|2|||
130834263|NCT03248531|471018169|FG002|Overall Study|Sponsor Request|0|||
130834264|NCT04075513|471018170|FG000|Overall Study|Withdrawal by Subject|2|||
130834265|NCT04075513|471018171|FG001|Overall Study|Withdrawal by Subject|2|||
130834266|NCT04075513|471018170|FG000|Overall Study|Lack of Efficacy|1|||
130834267|NCT04075513|471018171|FG001|Overall Study|Lack of Efficacy|0|||
130834268|NCT04075513|471018170|FG000|Overall Study|Lost to Follow-up|4|||
130834269|NCT04075513|471018171|FG001|Overall Study|Lost to Follow-up|2|||
130834270|NCT04075513|471018170|FG000|Overall Study|Switch to insulin pump|1|||
130834271|NCT04075513|471018171|FG001|Overall Study|Switch to insulin pump|0|||
130834272|NCT03748706|471018173|FG000|Overall Study|Lost to Follow-up|1|||
130834273|NCT04153981|471018176|FG000|Overall Study|Death|1|||
130834274|NCT04153981|471018176|FG000|Overall Study|Withdrawal by Subject|24|||
130834275|NCT04153981|471018176|FG000|Overall Study|Lost to Follow-up|1|||
130834276|NCT04153981|471018176|FG000|Overall Study|Physician Decision|1|||
130834277|NCT04153981|471018176|FG000|Overall Study|Due to Unavailable Glucometer|1|||
130834278|NCT04153981|471018176|FG000|Overall Study|Covid 19|52|||
130834279|NCT04153981|471018176|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
130834280|NCT04153981|471018176|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
130834281|NCT01355679|471018177|FG000|Overall Study|benign tumor types found at biopsy|2|||
130834282|NCT00904670|471018178|FG000|Open Label Phase|Withdrawal by Subject|2|||
130834283|NCT00904670|471018179|FG001|Open Label Phase|Withdrawal by Subject|0|||
130834284|NCT00904670|471018178|FG000|Open Label Phase|Adverse Event|2|||
130834285|NCT00904670|471018179|FG001|Open Label Phase|Adverse Event|0|||
130834286|NCT00904670|471018178|FG000|Open Label Phase|Lack of Efficacy|1|||
130834287|NCT00904670|471018179|FG001|Open Label Phase|Lack of Efficacy|0|||
130834288|NCT00904670|471018178|FG000|Open Label Phase|Lost to Follow-up|1|||
130834289|NCT00904670|471018179|FG001|Open Label Phase|Lost to Follow-up|0|||
130834290|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
130834291|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
130834292|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
130834293|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
130834294|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Death|58|||
130834295|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Death|65|||
130834296|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Adverse Event|28|||
130834297|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Adverse Event|40|||
130834298|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Disease Progression|22|||
130834299|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Disease Progression|35|||
130834300|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Other|25|||
130834301|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Other|33|||
130834302|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
130834303|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
130834304|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Noncompliance|8|||
130834305|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Noncompliance|8|||
130834306|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
130834307|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
130834308|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
130834309|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
130834310|NCT00286091|471018180|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
130834311|NCT00286091|471018181|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
130834312|NCT00286091|471018180|FG000|Open-label Treatment Phase|Physician Decision|24|||
130834313|NCT00286091|471018181|FG001|Open-label Treatment Phase|Physician Decision|21|||
130834314|NCT00286091|471018180|FG000|Open-label Treatment Phase|Adverse Event|5|||
130834315|NCT00286091|471018181|FG001|Open-label Treatment Phase|Adverse Event|16|||
130834316|NCT00286091|471018180|FG000|Open-label Treatment Phase|Other|11|||
130834317|NCT00286091|471018181|FG001|Open-label Treatment Phase|Other|11|||
130834318|NCT00286091|471018180|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
130834319|NCT00286091|471018181|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
130834320|NCT00286091|471018180|FG000|Open-label Treatment Phase|Death|10|||
130834321|NCT00286091|471018181|FG001|Open-label Treatment Phase|Death|7|||
130834322|NCT00286091|471018180|FG000|Open-label Treatment Phase|Disease Progression|9|||
130834323|NCT00286091|471018181|FG001|Open-label Treatment Phase|Disease Progression|3|||
130834324|NCT00286091|471018180|FG000|Open-label Treatment Phase|Noncompliance|3|||
130834325|NCT00286091|471018181|FG001|Open-label Treatment Phase|Noncompliance|1|||
130834326|NCT00286091|471018180|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
130834327|NCT00286091|471018181|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
130834328|NCT00286091|471018180|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
130834329|NCT00286091|471018181|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
130834330|NCT00286091|471018180|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
130834331|NCT00286091|471018181|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
130834332|NCT04004221|471018182|FG000|Overall Study|Death|89|||
130834333|NCT04004221|471018182|FG000|Overall Study|Withdrawal by Subject|5|||
130834334|NCT04004221|471018182|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
130834335|NCT04004221|471018182|FG000|Overall Study|Sponsor Decision|9|||
130834336|NCT04004221|471018182|FG000|Overall Study|Participant refused to enter LTE|1|||
130834337|NCT01479764|471018183|FG000|Randomized|Adverse Event|1|||
130834338|NCT01479764|471018184|FG001|Randomized|Adverse Event|1|||
130834339|NCT01479764|471018183|FG000|Randomized|Withdrawal by Subject|1|||
130834340|NCT01479764|471018184|FG001|Randomized|Withdrawal by Subject|0|||
130834341|NCT01479764|471018183|FG000|Treated|Lost to Follow-up|0|||
130834342|NCT01479764|471018184|FG001|Treated|Lost to Follow-up|2|||
130834343|NCT00260832|471018186|FG000|Overall Study|Adverse Event|26|||
130834344|NCT00260832|471018187|FG001|Overall Study|Adverse Event|19|||
130834345|NCT00260832|471018186|FG000|Overall Study|Progression|116|||
130834346|NCT00260832|471018187|FG001|Overall Study|Progression|96|||
130834347|NCT00260832|471018186|FG000|Overall Study|Withdrawal by Subject|15|||
130834348|NCT00260832|471018187|FG001|Overall Study|Withdrawal by Subject|17|||
130834349|NCT00260832|471018186|FG000|Overall Study|Physician Decision|15|||
130834350|NCT00260832|471018187|FG001|Overall Study|Physician Decision|9|||
130834351|NCT00260832|471018186|FG000|Overall Study|Death|43|||
130834352|NCT00260832|471018187|FG001|Overall Study|Death|62|||
130834353|NCT00260832|471018186|FG000|Overall Study|Other|10|||
130834354|NCT00260832|471018187|FG001|Overall Study|Other|7|||
130834355|NCT00260832|471018186|FG000|Overall Study|Protocol Violation|3|||
130834356|NCT00260832|471018187|FG001|Overall Study|Protocol Violation|1|||
130834357|NCT03098433|471018190|FG000|Overall Study|Withdrawal by Subject|10|||
130834358|NCT01104545|471018191|FG000|Overall Study|Adverse Event|0|||
130834359|NCT01104545|471018192|FG001|Overall Study|Adverse Event|1|||
130834360|NCT01104545|471018193|FG002|Overall Study|Adverse Event|2|||
130834361|NCT03585764|471018196|FG000|Overall Study|Death|3|||
130834362|NCT03585764|471018197|FG001|Overall Study|Death|2|||
130834363|NCT03585764|471018198|FG002|Overall Study|Death|3|||
130834364|NCT03585764|471018199|FG003|Overall Study|Death|0|||
130834365|NCT03585764|471018196|FG000|Overall Study|Lost to Follow-up|0|||
130834366|NCT03585764|471018197|FG001|Overall Study|Lost to Follow-up|1|||
130834367|NCT03585764|471018198|FG002|Overall Study|Lost to Follow-up|0|||
130834368|NCT03585764|471018199|FG003|Overall Study|Lost to Follow-up|0|||
130834369|NCT03585764|471018196|FG000|Overall Study|Physician Decision|0|||
130834370|NCT03585764|471018197|FG001|Overall Study|Physician Decision|0|||
130834371|NCT03585764|471018198|FG002|Overall Study|Physician Decision|2|||
130834372|NCT03585764|471018199|FG003|Overall Study|Physician Decision|0|||
130834373|NCT03640507|471018200|FG000|Overall Study|Withdrawal by Subject|0|||
130834374|NCT03640507|471018201|FG001|Overall Study|Withdrawal by Subject|0|||
130834375|NCT03640507|471018202|FG002|Overall Study|Withdrawal by Subject|1|||
130834376|NCT02993822|471018203|FG000|Overall Study|Lack of Efficacy|1|||
130834377|NCT02993822|471018204|FG001|Overall Study|Lack of Efficacy|1|||
130834378|NCT02993822|471018205|FG002|Overall Study|Lack of Efficacy|0|||
130834379|NCT02993822|471018206|FG003|Overall Study|Lack of Efficacy|0|||
130834380|NCT02993822|471018203|FG000|Overall Study|Protocol Violation|1|||
130834381|NCT02993822|471018204|FG001|Overall Study|Protocol Violation|0|||
130834382|NCT02993822|471018205|FG002|Overall Study|Protocol Violation|0|||
130834383|NCT02993822|471018206|FG003|Overall Study|Protocol Violation|0|||
130834384|NCT02993822|471018203|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
130834385|NCT02993822|471018204|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
130834386|NCT02993822|471018205|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
130834387|NCT02993822|471018206|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
130834388|NCT02993822|471018203|FG000|Overall Study|Adverse Event|3|||
130834389|NCT02993822|471018204|FG001|Overall Study|Adverse Event|1|||
130834390|NCT02993822|471018205|FG002|Overall Study|Adverse Event|7|||
130834391|NCT02993822|471018206|FG003|Overall Study|Adverse Event|0|||
130834392|NCT02993822|471018203|FG000|Overall Study|Withdrawal by Subject|4|||
130834393|NCT02993822|471018204|FG001|Overall Study|Withdrawal by Subject|2|||
130834394|NCT02993822|471018205|FG002|Overall Study|Withdrawal by Subject|2|||
130834395|NCT02993822|471018206|FG003|Overall Study|Withdrawal by Subject|3|||
130834396|NCT02993822|471018203|FG000|Overall Study|Lost to Follow-up|1|||
130834397|NCT02993822|471018204|FG001|Overall Study|Lost to Follow-up|0|||
130834398|NCT02993822|471018205|FG002|Overall Study|Lost to Follow-up|1|||
130834399|NCT02993822|471018206|FG003|Overall Study|Lost to Follow-up|0|||
130834400|NCT01221753|471018207|FG000|Overall Study|Adverse Event|1|||
130834401|NCT03522246|471019676|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
130834402|NCT03522246|471019677|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
130834403|NCT03522246|471019678|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
130834404|NCT03522246|471019679|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
130834405|NCT03522246|471019680|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
130834406|NCT04683029|471019681|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
130834407|NCT04683029|471019682|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
130834408|NCT04683029|471019683|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
130834409|NCT04683029|471019684|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
130834410|NCT04683029|471019681|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
130834411|NCT04683029|471019682|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
130834412|NCT04683029|471019683|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
130834413|NCT04683029|471019684|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
130834414|NCT04683029|471019681|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
130834415|NCT04683029|471019682|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
130834416|NCT04683029|471019683|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
130834417|NCT04683029|471019684|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
130834418|NCT00814580|471019685|FG000|Overall Study|Adverse Event|6|||
130834419|NCT00814580|471019686|FG001|Overall Study|Adverse Event|15|||
130834420|NCT00814580|471019685|FG000|Overall Study|Lack of Efficacy|18|||
130834421|NCT00814580|471019686|FG001|Overall Study|Lack of Efficacy|25|||
130834422|NCT00814580|471019685|FG000|Overall Study|Protocol Violation|2|||
130834423|NCT00814580|471019686|FG001|Overall Study|Protocol Violation|0|||
130834424|NCT00814580|471019685|FG000|Overall Study|Withdrawal by Subject|2|||
130834425|NCT00814580|471019686|FG001|Overall Study|Withdrawal by Subject|2|||
130834426|NCT00814580|471019685|FG000|Overall Study|Other|1|||
130834427|NCT00814580|471019686|FG001|Overall Study|Other|3|||
130834428|NCT00814580|471019685|FG000|Overall Study|Did Not Take Drug|2|||
130834429|NCT00814580|471019686|FG001|Overall Study|Did Not Take Drug|2|||
130834430|NCT00459875|471019687|FG000|Overall Study|Ineligible participant|1|||
130834431|NCT00459875|471019687|FG000|Overall Study|Adverse Event|2|||
130834432|NCT04560816|471019695|FG000|Overall Study|Withdrawal by Subject|1|||
130834433|NCT04560816|471019696|FG001|Overall Study|Withdrawal by Subject|1|||
130834434|NCT04560816|471019697|FG002|Overall Study|Withdrawal by Subject|1|||
130834435|NCT04560816|471019698|FG003|Overall Study|Withdrawal by Subject|0|||
130834436|NCT04560816|471019699|FG004|Overall Study|Withdrawal by Subject|3|||
130834437|NCT04560816|471019700|FG005|Overall Study|Withdrawal by Subject|0|||
130834438|NCT04560816|471019695|FG000|Overall Study|Lost to Follow-up|1|||
130834439|NCT04560816|471019696|FG001|Overall Study|Lost to Follow-up|0|||
130834440|NCT04560816|471019697|FG002|Overall Study|Lost to Follow-up|0|||
130834441|NCT04560816|471019698|FG003|Overall Study|Lost to Follow-up|0|||
130834442|NCT04560816|471019699|FG004|Overall Study|Lost to Follow-up|0|||
130834443|NCT04560816|471019700|FG005|Overall Study|Lost to Follow-up|0|||
130834444|NCT04560816|471019695|FG000|Overall Study|Protocol Violation|1|||
130834445|NCT04560816|471019696|FG001|Overall Study|Protocol Violation|0|||
130834446|NCT04560816|471019697|FG002|Overall Study|Protocol Violation|0|||
130834447|NCT04560816|471019698|FG003|Overall Study|Protocol Violation|0|||
130834448|NCT04560816|471019699|FG004|Overall Study|Protocol Violation|0|||
130834449|NCT04560816|471019700|FG005|Overall Study|Protocol Violation|0|||
130834450|NCT01265563|471019702|FG000|Overall Study|Withdrawal by Subject|0|||
130834451|NCT01265563|471019703|FG001|Overall Study|Withdrawal by Subject|1|||
130834452|NCT01265563|471019704|FG002|Overall Study|Withdrawal by Subject|1|||
130834453|NCT01265563|471019705|FG003|Overall Study|Withdrawal by Subject|0|||
130834454|NCT01265563|471019706|FG004|Overall Study|Withdrawal by Subject|2|||
130834455|NCT02141399|471019713|FG000|Overall Study|Adverse Event|158|||
130834456|NCT02141399|471019713|FG000|Overall Study|Lack of Efficacy|62|||
130834457|NCT02141399|471019713|FG000|Overall Study|Lost to Follow-up|151|||
130834458|NCT02141399|471019713|FG000|Overall Study|Non-compliance with study drug|18|||
130834459|NCT02141399|471019713|FG000|Overall Study|Other|45|||
130834460|NCT02141399|471019713|FG000|Overall Study|Physician Decision|17|||
130834461|NCT02141399|471019713|FG000|Overall Study|Pregnancy|3|||
130834462|NCT02141399|471019713|FG000|Overall Study|Protocol Violation|38|||
130834463|NCT02141399|471019713|FG000|Overall Study|Withdrawal by Subject|238|||
130834464|NCT02141399|471019713|FG000|Overall Study|Failure to meet eligibility criteria|14|||
130834465|NCT03249909|471019718|FG000|Overall Study|Withdrawal by Subject|3|||
130834466|NCT03249909|471019719|FG001|Overall Study|Withdrawal by Subject|0|||
130834467|NCT03249909|471019720|FG002|Overall Study|Withdrawal by Subject|0|||
130834468|NCT03249909|471019718|FG000|Overall Study|Adverse Event|3|||
130834469|NCT03249909|471019719|FG001|Overall Study|Adverse Event|0|||
130834470|NCT03249909|471019720|FG002|Overall Study|Adverse Event|0|||
130834471|NCT03249909|471019718|FG000|Overall Study|Lost to Follow-up|0|||
130834472|NCT03249909|471019719|FG001|Overall Study|Lost to Follow-up|1|||
130834473|NCT03249909|471019720|FG002|Overall Study|Lost to Follow-up|0|||
130834474|NCT05286658|471019722|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
130834475|NCT05286658|471019722|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
130834476|NCT01035463|471019723|FG000|Overall Study|Adverse Event|0|||
130834477|NCT01035463|471019724|FG001|Overall Study|Adverse Event|0|||
130834478|NCT01035463|471019725|FG002|Overall Study|Adverse Event|4|||
130834479|NCT01035463|471019726|FG003|Overall Study|Adverse Event|1|||
130834480|NCT01035463|471019727|FG004|Overall Study|Adverse Event|5|||
130834481|NCT01035463|471019728|FG005|Overall Study|Adverse Event|7|||
130834482|NCT01035463|471019723|FG000|Overall Study|Withdrawal by Subject|0|||
130834483|NCT01035463|471019724|FG001|Overall Study|Withdrawal by Subject|2|||
130834484|NCT01035463|471019725|FG002|Overall Study|Withdrawal by Subject|1|||
130834485|NCT01035463|471019726|FG003|Overall Study|Withdrawal by Subject|0|||
130834486|NCT01035463|471019727|FG004|Overall Study|Withdrawal by Subject|1|||
130834487|NCT01035463|471019728|FG005|Overall Study|Withdrawal by Subject|4|||
130834488|NCT01035463|471019723|FG000|Overall Study|Disease progression|0|||
130834489|NCT01035463|471019724|FG001|Overall Study|Disease progression|0|||
130834490|NCT01035463|471019725|FG002|Overall Study|Disease progression|0|||
130834491|NCT01035463|471019726|FG003|Overall Study|Disease progression|0|||
130834492|NCT01035463|471019727|FG004|Overall Study|Disease progression|0|||
130834493|NCT01035463|471019728|FG005|Overall Study|Disease progression|3|||
130834494|NCT01035463|471019723|FG000|Overall Study|Other Malignancy|0|||
130834495|NCT01035463|471019724|FG001|Overall Study|Other Malignancy|0|||
130834496|NCT01035463|471019725|FG002|Overall Study|Other Malignancy|0|||
130834497|NCT01035463|471019726|FG003|Overall Study|Other Malignancy|0|||
130834498|NCT01035463|471019727|FG004|Overall Study|Other Malignancy|0|||
130834499|NCT01035463|471019728|FG005|Overall Study|Other Malignancy|2|||
130834500|NCT01035463|471019723|FG000|Overall Study|Other|0|||
130834501|NCT01035463|471019724|FG001|Overall Study|Other|0|||
130834502|NCT01035463|471019725|FG002|Overall Study|Other|0|||
130834503|NCT01035463|471019726|FG003|Overall Study|Other|1|||
130834504|NCT01035463|471019727|FG004|Overall Study|Other|0|||
130834505|NCT01035463|471019728|FG005|Overall Study|Other|2|||
130834506|NCT01092780|471019729|FG000|Washout Period 1|Adverse Event|0|||
130834507|NCT01092780|471019730|FG001|Washout Period 1|Adverse Event|1|||
130834508|NCT01092780|471019731|FG002|Washout Period 1|Adverse Event|0|||
130834509|NCT01092780|471019732|FG003|Washout Period 1|Adverse Event|0|||
130834510|NCT01092780|471019729|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
130834511|NCT01092780|471019730|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
130834512|NCT01092780|471019731|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
130834513|NCT01092780|471019732|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
130834514|NCT01092780|471019729|FG000|Washout Period 2|Adverse Event|0|||
130834515|NCT01092780|471019730|FG001|Washout Period 2|Adverse Event|1|||
130834516|NCT01092780|471019731|FG002|Washout Period 2|Adverse Event|1|||
130834517|NCT01092780|471019732|FG003|Washout Period 2|Adverse Event|0|||
130834518|NCT05411822|471019742|FG000|Overall Study|Withdrawal by Subject|2|||
130834519|NCT05411822|471019743|FG001|Overall Study|Withdrawal by Subject|1|||
130834520|NCT02027311|471019744|FG000|Overall Study|Protocol Violation|3|||
130834521|NCT02027311|471019745|FG001|Overall Study|Protocol Violation|2|||
130834522|NCT00851552|471019746|FG000|Overall Study|Death|2|||
130834523|NCT00851552|471019746|FG000|Overall Study|Adverse Event|1|||
130834524|NCT00851552|471019746|FG000|Overall Study|Disease Progression|4|||
130834525|NCT01270880|471019748|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
130834526|NCT00182078|471019749|FG000|Overall Study|Withdrawal by Subject|1|||
130834527|NCT00182078|471019750|FG001|Overall Study|Withdrawal by Subject|0|||
130834528|NCT01076205|471019751|FG000|Overall Study|Adverse Drug Reaction|299|||
130834529|NCT01076205|471019751|FG000|Overall Study|Lack of Effectiveness|1423|||
130834530|NCT01076205|471019751|FG000|Overall Study|Other Reason|1075|||
130834531|NCT01076205|471019751|FG000|Overall Study|Unknown Reason|71|||
130834532|NCT01076205|471019751|FG000|Overall Study|Lost to Follow-up|3151|||
130834533|NCT01606176|471019753|FG000|Overall Study|Adverse Event|2|||
130834534|NCT01606176|471019754|FG001|Overall Study|Adverse Event|3|||
130834535|NCT01606176|471019753|FG000|Overall Study|Disease progression|1|||
130834536|NCT01606176|471019754|FG001|Overall Study|Disease progression|0|||
130834537|NCT01606176|471019753|FG000|Overall Study|Withdrawal by Subject|1|||
130834538|NCT01606176|471019754|FG001|Overall Study|Withdrawal by Subject|0|||
130834539|NCT01832493|471019755|FG000|Overall Study|Physician Decision|2|||
130834540|NCT01832493|471019755|FG000|Overall Study|Protocol Violation|4|||
130834541|NCT01832493|471019755|FG000|Overall Study|Unable to place LV lead|2|||
130834542|NCT01732510|471019760|FG000|Overall Study|Adverse Event|0|||
130834543|NCT01732510|471019761|FG001|Overall Study|Adverse Event|1|||
130834544|NCT01732510|471019762|FG002|Overall Study|Adverse Event|1|||
130834545|NCT01732510|471019763|FG003|Overall Study|Adverse Event|0|||
130834546|NCT01732510|471019764|FG004|Overall Study|Adverse Event|0|||
130834547|NCT01732510|471019765|FG005|Overall Study|Adverse Event|0|||
130834548|NCT01732510|471019766|FG006|Overall Study|Adverse Event|1|||
130834549|NCT01732510|471019760|FG000|Overall Study|Protocol Violation|0|||
130834550|NCT01732510|471019761|FG001|Overall Study|Protocol Violation|0|||
130834551|NCT01732510|471019762|FG002|Overall Study|Protocol Violation|0|||
130834552|NCT01732510|471019763|FG003|Overall Study|Protocol Violation|1|||
130834553|NCT01732510|471019764|FG004|Overall Study|Protocol Violation|0|||
130834554|NCT01732510|471019765|FG005|Overall Study|Protocol Violation|0|||
130834555|NCT01732510|471019766|FG006|Overall Study|Protocol Violation|0|||
130834556|NCT01732510|471019760|FG000|Overall Study|Withdrawal by Subject|1|||
130834557|NCT01732510|471019761|FG001|Overall Study|Withdrawal by Subject|3|||
130834558|NCT01732510|471019762|FG002|Overall Study|Withdrawal by Subject|2|||
130834559|NCT01732510|471019763|FG003|Overall Study|Withdrawal by Subject|1|||
130834560|NCT01732510|471019764|FG004|Overall Study|Withdrawal by Subject|5|||
130834561|NCT01732510|471019765|FG005|Overall Study|Withdrawal by Subject|0|||
130834562|NCT01732510|471019766|FG006|Overall Study|Withdrawal by Subject|1|||
130834563|NCT01732510|471019760|FG000|Overall Study|Lost to Follow-up|0|||
130834564|NCT01732510|471019761|FG001|Overall Study|Lost to Follow-up|0|||
130834565|NCT01732510|471019762|FG002|Overall Study|Lost to Follow-up|1|||
130834566|NCT01732510|471019763|FG003|Overall Study|Lost to Follow-up|1|||
130834567|NCT01732510|471019764|FG004|Overall Study|Lost to Follow-up|0|||
130834568|NCT01732510|471019765|FG005|Overall Study|Lost to Follow-up|1|||
130834569|NCT01732510|471019766|FG006|Overall Study|Lost to Follow-up|0|||
130834570|NCT01732510|471019760|FG000|Overall Study|Physician Decision|0|||
130834571|NCT01732510|471019761|FG001|Overall Study|Physician Decision|1|||
130834572|NCT01732510|471019762|FG002|Overall Study|Physician Decision|0|||
130834573|NCT01732510|471019763|FG003|Overall Study|Physician Decision|0|||
130834574|NCT01732510|471019764|FG004|Overall Study|Physician Decision|0|||
130834575|NCT01732510|471019765|FG005|Overall Study|Physician Decision|0|||
130834576|NCT01732510|471019766|FG006|Overall Study|Physician Decision|0|||
130834577|NCT01732510|471019760|FG000|Overall Study|Pregnancy|0|||
130834578|NCT01732510|471019761|FG001|Overall Study|Pregnancy|0|||
130834579|NCT01732510|471019762|FG002|Overall Study|Pregnancy|0|||
130834580|NCT01732510|471019763|FG003|Overall Study|Pregnancy|1|||
130834581|NCT01732510|471019764|FG004|Overall Study|Pregnancy|0|||
130834582|NCT01732510|471019765|FG005|Overall Study|Pregnancy|0|||
130834583|NCT01732510|471019766|FG006|Overall Study|Pregnancy|0|||
130834584|NCT01732510|471019760|FG000|Overall Study|Study Terminated By Sponsor|0|||
130834585|NCT01732510|471019761|FG001|Overall Study|Study Terminated By Sponsor|0|||
130834586|NCT01732510|471019762|FG002|Overall Study|Study Terminated By Sponsor|0|||
130834587|NCT01732510|471019763|FG003|Overall Study|Study Terminated By Sponsor|1|||
130834588|NCT01732510|471019764|FG004|Overall Study|Study Terminated By Sponsor|0|||
130834589|NCT01732510|471019765|FG005|Overall Study|Study Terminated By Sponsor|12|||
130834590|NCT01732510|471019766|FG006|Overall Study|Study Terminated By Sponsor|6|||
130834591|NCT01262560|471019778|FG000|Overall Study|Protocol Violation|0|||
130834592|NCT01262560|471019779|FG001|Overall Study|Protocol Violation|1|||
130834593|NCT01262560|471019780|FG002|Overall Study|Protocol Violation|2|||
130834594|NCT03213938|471019781|FG000|Overall Study|Lost to Follow-up|4|||
130834595|NCT03213938|471019782|FG001|Overall Study|Lost to Follow-up|3|||
130834596|NCT03213938|471019781|FG000|Overall Study|Lack of Efficacy|1|||
130834597|NCT03213938|471019782|FG001|Overall Study|Lack of Efficacy|0|||
130834598|NCT03213938|471019781|FG000|Overall Study|Decline to participate|5|||
130834599|NCT03213938|471019782|FG001|Overall Study|Decline to participate|4|||
130834600|NCT03213938|471019781|FG000|Overall Study|Without reason|4|||
130834601|NCT03213938|471019782|FG001|Overall Study|Without reason|5|||
130834602|NCT04238481|471019785|FG000|Overall Study|Miscellaneous|0|||
130834603|NCT04238481|471019786|FG001|Overall Study|Miscellaneous|1|||
130834604|NCT04238481|471019787|FG002|Overall Study|Miscellaneous|0|||
130834605|NCT04238481|471019788|FG003|Overall Study|Miscellaneous|0|||
130834606|NCT01932372|471019789|FG000|Overall Study|Not meeting eligibility criteria|33|||
130834607|NCT01932372|471019790|FG001|Overall Study|Not meeting eligibility criteria|179|||
130834608|NCT00673231|471019791|FG000|Overall Study|Withdrawal by Subject|14|||
130834609|NCT00673231|471019792|FG001|Overall Study|Withdrawal by Subject|10|||
130834610|NCT00673231|471019793|FG002|Overall Study|Withdrawal by Subject|8|||
130834611|NCT00673231|471019794|FG003|Overall Study|Withdrawal by Subject|6|||
130834612|NCT00673231|471019791|FG000|Overall Study|Adverse Event|6|||
130834613|NCT00673231|471019792|FG001|Overall Study|Adverse Event|5|||
130834614|NCT00673231|471019793|FG002|Overall Study|Adverse Event|9|||
130834615|NCT00673231|471019794|FG003|Overall Study|Adverse Event|6|||
130834616|NCT00673231|471019791|FG000|Overall Study|Lost to Follow-up|1|||
130834617|NCT00673231|471019792|FG001|Overall Study|Lost to Follow-up|2|||
130834618|NCT00673231|471019793|FG002|Overall Study|Lost to Follow-up|1|||
130834619|NCT00673231|471019794|FG003|Overall Study|Lost to Follow-up|2|||
130834620|NCT00673231|471019791|FG000|Overall Study|Death|0|||
130834621|NCT00673231|471019792|FG001|Overall Study|Death|0|||
130834622|NCT00673231|471019793|FG002|Overall Study|Death|1|||
130834623|NCT00673231|471019794|FG003|Overall Study|Death|0|||
130834624|NCT00673231|471019791|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
130834625|NCT00673231|471019792|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
130834626|NCT00673231|471019793|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
130834627|NCT00673231|471019794|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
130834628|NCT02952313|471019795|FG000|Primary Endpoint|Lost to Follow-up|4|||
130834629|NCT02952313|471019795|FG000|Primary Endpoint|Withdrawal by Subject|1|||
130834630|NCT02952313|471019795|FG000|Primary Endpoint|Lack of Efficacy|1|||
130834631|NCT02952313|471019795|FG000|Primary Endpoint|Missed visit|1|||
130834632|NCT02952313|471019795|FG000|Long-term Follow-up|Lost to Follow-up|12|||
130834633|NCT02952313|471019795|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
130834634|NCT02952313|471019795|FG000|Long-term Follow-up|Lack of Efficacy|6|||
130834635|NCT02952313|471019795|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
130834636|NCT02952313|471019795|FG000|Long-term Follow-up|Physician Decision|1|||
130834637|NCT02952313|471019795|FG000|Long-term Follow-up|Death|1|||
130834638|NCT03594747|471019796|FG000|Overall Study|Death|78|||
130834639|NCT03594747|471019797|FG001|Overall Study|Death|86|||
130834640|NCT03594747|471019798|FG002|Overall Study|Death|87|||
130834641|NCT03594747|471019796|FG000|Overall Study|Withdrawal by Subject|5|||
130834642|NCT03594747|471019797|FG001|Overall Study|Withdrawal by Subject|2|||
130834643|NCT03594747|471019798|FG002|Overall Study|Withdrawal by Subject|11|||
130834644|NCT03594747|471019796|FG000|Overall Study|Lost to Follow-up|4|||
130834645|NCT03594747|471019797|FG001|Overall Study|Lost to Follow-up|1|||
130834646|NCT03594747|471019798|FG002|Overall Study|Lost to Follow-up|1|||
130834647|NCT03594747|471019796|FG000|Overall Study|Physician Decision|0|||
130834648|NCT03594747|471019797|FG001|Overall Study|Physician Decision|1|||
130834649|NCT03594747|471019798|FG002|Overall Study|Physician Decision|0|||
130834650|NCT03594747|471019796|FG000|Overall Study|Sponsor decision|23|||
130834651|NCT03594747|471019797|FG001|Overall Study|Sponsor decision|17|||
130834652|NCT03594747|471019798|FG002|Overall Study|Sponsor decision|16|||
130834653|NCT03594747|471019796|FG000|Overall Study|Did not meet inclusion criteria|0|||
130834654|NCT03594747|471019797|FG001|Overall Study|Did not meet inclusion criteria|0|||
130834655|NCT03594747|471019798|FG002|Overall Study|Did not meet inclusion criteria|1|||
130834656|NCT03594747|471019796|FG000|Overall Study|Transfer to long term extension study|10|||
130834657|NCT03594747|471019797|FG001|Overall Study|Transfer to long term extension study|12|||
130834658|NCT03594747|471019798|FG002|Overall Study|Transfer to long term extension study|5|||
130834659|NCT03028415|471019799|FG000|Overall Study|Lost to Follow-up|6|||
130834660|NCT03028415|471019800|FG001|Overall Study|Lost to Follow-up|3|||
130834661|NCT03028415|471019799|FG000|Overall Study|Withdrawal by Subject|1|||
130834662|NCT03028415|471019800|FG001|Overall Study|Withdrawal by Subject|0|||
130834663|NCT03028415|471019799|FG000|Overall Study|Discontinued due to COVID-19|1|||
130834664|NCT03028415|471019800|FG001|Overall Study|Discontinued due to COVID-19|0|||
130834665|NCT02907216|471019801|FG000|Overall Study|No benefit to be obtained by continuing|0|||
130834666|NCT02907216|471019802|FG001|Overall Study|No benefit to be obtained by continuing|1|||
130834667|NCT02907216|471019801|FG000|Overall Study|Withdrawal by Subject|1|||
130834668|NCT02907216|471019802|FG001|Overall Study|Withdrawal by Subject|0|||
130834669|NCT02241733|471019803|FG000|Overall Study|Lost to Follow-up|9|||
130834670|NCT02241733|471019804|FG001|Overall Study|Lost to Follow-up|4|||
130834671|NCT02241733|471019803|FG000|Overall Study|Physician Decision|6|||
130834672|NCT02241733|471019804|FG001|Overall Study|Physician Decision|2|||
130834673|NCT02241733|471019803|FG000|Overall Study|Withdrawal by Subject|0|||
130834674|NCT02241733|471019804|FG001|Overall Study|Withdrawal by Subject|2|||
130834675|NCT02241733|471019803|FG000|Overall Study|Death|0|||
130834676|NCT02241733|471019804|FG001|Overall Study|Death|2|||
130834677|NCT02095873|471019811|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130834678|NCT02095873|471019812|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
130834679|NCT02095873|471019811|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
130834680|NCT02095873|471019812|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130834681|NCT02095873|471019811|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
130834682|NCT02095873|471019812|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
130834683|NCT00792740|471019814|FG000|Overall Study|Disease Worsening|3|||
130834684|NCT00792740|471019815|FG001|Overall Study|Disease Worsening|2|||
130834685|NCT00792740|471019814|FG000|Overall Study|Personal Reason|1|||
130834686|NCT00792740|471019815|FG001|Overall Study|Personal Reason|0|||
130834687|NCT00792740|471019814|FG000|Overall Study|Adverse Event|1|||
130834688|NCT00792740|471019815|FG001|Overall Study|Adverse Event|3|||
130834689|NCT00792740|471019814|FG000|Overall Study|Patient's withdrawal of consent|0|||
130834690|NCT00792740|471019815|FG001|Overall Study|Patient's withdrawal of consent|1|||
130834691|NCT00792740|471019814|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
130834692|NCT00792740|471019815|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
130834693|NCT00792740|471019814|FG000|Overall Study|Other reasons|0|||
130834694|NCT00792740|471019815|FG001|Overall Study|Other reasons|1|||
130834695|NCT00703846|471019816|FG000|Overall Study|Adverse Event|8|||
130834696|NCT00703846|471019816|FG000|Overall Study|Lost to Follow-up|55|||
130834697|NCT00703846|471019816|FG000|Overall Study|Lack of Efficacy|15|||
130834698|NCT00703846|471019816|FG000|Overall Study|Noncompliance with Study Treatment|2|||
130834699|NCT00703846|471019816|FG000|Overall Study|Withdrawal by Subject|40|||
130834700|NCT00703846|471019816|FG000|Overall Study|Death|1|||
130834701|NCT00703846|471019816|FG000|Overall Study|Other|14|||
130834702|NCT00703846|471019816|FG000|Overall Study|Did Not Receive Study Drug|2|||
130834703|NCT02485639|471019819|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
130834704|NCT02485639|471019819|FG000|Overall Study|Early termination|4|||
130834705|NCT02485639|471019819|FG000|Overall Study|Withdrawal by Subject|4|||
130834706|NCT02015481|471019820|FG000|Overall Study|Death|1|||
130834707|NCT02566785|471019827|FG000|Overall Study|Lost to Follow-up|0|||
130834708|NCT02566785|471019828|FG001|Overall Study|Lost to Follow-up|2|||
130834709|NCT02566785|471019827|FG000|Overall Study|Worsening condition|1|||
130834710|NCT02566785|471019828|FG001|Overall Study|Worsening condition|1|||
130834711|NCT01170273|471019832|FG000|Overall Study|Lost to Follow-up|6|||
130834712|NCT01170273|471019833|FG001|Overall Study|Lost to Follow-up|8|||
130834713|NCT01170273|471019832|FG000|Overall Study|Protocol Violation|1|||
130834714|NCT01170273|471019833|FG001|Overall Study|Protocol Violation|0|||
130834715|NCT01170273|471019832|FG000|Overall Study|Death|1|||
130834716|NCT01170273|471019833|FG001|Overall Study|Death|0|||
130834717|NCT01170273|471019832|FG000|Overall Study|Adverse Event|0|||
130834718|NCT01170273|471019833|FG001|Overall Study|Adverse Event|1|||
130834719|NCT00334737|471019834|FG000|Hospital Phase|Death|1|||
130834720|NCT00334737|471019835|FG001|Hospital Phase|Death|2|||
130834721|NCT00334737|471019836|FG002|Hospital Phase|Death|3|||
130834722|NCT00334737|471019834|FG000|Hospital Phase|Withdrawal by Subject|0|||
130834723|NCT00334737|471019835|FG001|Hospital Phase|Withdrawal by Subject|0|||
130834724|NCT00334737|471019836|FG002|Hospital Phase|Withdrawal by Subject|1|||
130834725|NCT00334737|471019834|FG000|Hospital Phase|Did not receive study drug|1|||
130834726|NCT00334737|471019835|FG001|Hospital Phase|Did not receive study drug|0|||
130834727|NCT00334737|471019836|FG002|Hospital Phase|Did not receive study drug|0|||
130834728|NCT00334737|471019834|FG000|Follow up Phase|Lost to Follow-up|5|||
130834729|NCT00334737|471019835|FG001|Follow up Phase|Lost to Follow-up|3|||
130834730|NCT00334737|471019836|FG002|Follow up Phase|Lost to Follow-up|6|||
130834731|NCT00583752|471019837|FG000|Overall Study|Lost to Follow-up|5|||
130834732|NCT00583752|471019838|FG001|Overall Study|Lost to Follow-up|5|||
130834733|NCT02316353|471019839|FG000|Overall Study|Pregnancy|1|||
130834734|NCT02316353|471019840|FG001|Overall Study|Pregnancy|3|||
130834735|NCT02316353|471019839|FG000|Overall Study|Adverse Event|1|||
130834736|NCT02316353|471019840|FG001|Overall Study|Adverse Event|3|||
130834737|NCT02316353|471019839|FG000|Overall Study|Withdrawal by Subject|6|||
130834738|NCT02316353|471019840|FG001|Overall Study|Withdrawal by Subject|2|||
130834739|NCT02147197|471019841|FG000|Overall Study|Adverse Event|1|||
130834740|NCT02147197|471019842|FG001|Overall Study|Adverse Event|0|||
130834741|NCT02147197|471019843|FG002|Overall Study|Adverse Event|0|||
130834742|NCT02147197|471019841|FG000|Overall Study|Withdrawal of Consent|4|||
130834743|NCT02147197|471019842|FG001|Overall Study|Withdrawal of Consent|3|||
130834744|NCT02147197|471019843|FG002|Overall Study|Withdrawal of Consent|2|||
130834745|NCT02147197|471019841|FG000|Overall Study|Lost to Follow-up|2|||
130834746|NCT02147197|471019842|FG001|Overall Study|Lost to Follow-up|3|||
130834747|NCT02147197|471019843|FG002|Overall Study|Lost to Follow-up|1|||
130834748|NCT02147197|471019841|FG000|Overall Study|Protocol Violation|1|||
130834749|NCT02147197|471019842|FG001|Overall Study|Protocol Violation|0|||
130834750|NCT02147197|471019843|FG002|Overall Study|Protocol Violation|3|||
130834751|NCT02147197|471019841|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130834752|NCT02147197|471019842|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130834753|NCT02147197|471019843|FG002|Overall Study|Other Miscellaneous Reasons|3|||
130834754|NCT02954406|471021503|FG000|Overall Study|Adverse Event|0|||
130834755|NCT02954406|471021504|FG001|Overall Study|Adverse Event|1|||
130834756|NCT02954406|471021505|FG002|Overall Study|Adverse Event|0|||
130834757|NCT02954406|471021506|FG003|Overall Study|Adverse Event|0|||
130834758|NCT02954406|471021507|FG004|Overall Study|Adverse Event|1|||
130834759|NCT02954406|471021508|FG005|Overall Study|Adverse Event|0|||
130834760|NCT02954406|471021509|FG006|Overall Study|Adverse Event|0|||
130834761|NCT02954406|471021510|FG007|Overall Study|Adverse Event|0|||
130834762|NCT02954406|471021511|FG008|Overall Study|Adverse Event|1|||
130834763|NCT02954406|471021512|FG009|Overall Study|Adverse Event|1|||
130834764|NCT02954406|471021513|FG010|Overall Study|Adverse Event|0|||
130834765|NCT02954406|471021503|FG000|Overall Study|Progressive Disease|3|||
130834766|NCT02954406|471021504|FG001|Overall Study|Progressive Disease|4|||
130834767|NCT02954406|471021505|FG002|Overall Study|Progressive Disease|3|||
130834768|NCT02954406|471021506|FG003|Overall Study|Progressive Disease|4|||
130834769|NCT02954406|471021507|FG004|Overall Study|Progressive Disease|3|||
130834770|NCT02954406|471021508|FG005|Overall Study|Progressive Disease|3|||
130834771|NCT02954406|471021509|FG006|Overall Study|Progressive Disease|2|||
130834772|NCT02954406|471021510|FG007|Overall Study|Progressive Disease|2|||
130834773|NCT02954406|471021511|FG008|Overall Study|Progressive Disease|1|||
130834774|NCT02954406|471021512|FG009|Overall Study|Progressive Disease|1|||
130834775|NCT02954406|471021513|FG010|Overall Study|Progressive Disease|0|||
130834776|NCT02954406|471021503|FG000|Overall Study|Symptomatic Deterioration|0|||
130834777|NCT02954406|471021504|FG001|Overall Study|Symptomatic Deterioration|1|||
130834778|NCT02954406|471021505|FG002|Overall Study|Symptomatic Deterioration|0|||
130834779|NCT02954406|471021506|FG003|Overall Study|Symptomatic Deterioration|0|||
130834780|NCT02954406|471021507|FG004|Overall Study|Symptomatic Deterioration|0|||
130834781|NCT02954406|471021508|FG005|Overall Study|Symptomatic Deterioration|0|||
130834782|NCT02954406|471021509|FG006|Overall Study|Symptomatic Deterioration|0|||
130834783|NCT02954406|471021510|FG007|Overall Study|Symptomatic Deterioration|0|||
130834784|NCT02954406|471021511|FG008|Overall Study|Symptomatic Deterioration|0|||
130834785|NCT02954406|471021512|FG009|Overall Study|Symptomatic Deterioration|0|||
130834786|NCT02954406|471021513|FG010|Overall Study|Symptomatic Deterioration|0|||
130834787|NCT02954406|471021503|FG000|Overall Study|Death|0|||
130834788|NCT02954406|471021504|FG001|Overall Study|Death|0|||
130834789|NCT02954406|471021505|FG002|Overall Study|Death|0|||
130834790|NCT02954406|471021506|FG003|Overall Study|Death|0|||
130834791|NCT02954406|471021507|FG004|Overall Study|Death|1|||
130834792|NCT02954406|471021508|FG005|Overall Study|Death|0|||
130834793|NCT02954406|471021509|FG006|Overall Study|Death|0|||
130834794|NCT02954406|471021510|FG007|Overall Study|Death|0|||
130834795|NCT02954406|471021511|FG008|Overall Study|Death|1|||
130834796|NCT02954406|471021512|FG009|Overall Study|Death|1|||
130834797|NCT02954406|471021513|FG010|Overall Study|Death|0|||
130834798|NCT02954406|471021503|FG000|Overall Study|Reason Not Specified|0|||
130834799|NCT02954406|471021504|FG001|Overall Study|Reason Not Specified|0|||
130834800|NCT02954406|471021505|FG002|Overall Study|Reason Not Specified|3|||
130834801|NCT02954406|471021506|FG003|Overall Study|Reason Not Specified|2|||
130834802|NCT02954406|471021507|FG004|Overall Study|Reason Not Specified|2|||
130834803|NCT02954406|471021508|FG005|Overall Study|Reason Not Specified|0|||
130834804|NCT02954406|471021509|FG006|Overall Study|Reason Not Specified|1|||
130834805|NCT02954406|471021510|FG007|Overall Study|Reason Not Specified|0|||
130834806|NCT02954406|471021511|FG008|Overall Study|Reason Not Specified|1|||
130834807|NCT02954406|471021512|FG009|Overall Study|Reason Not Specified|0|||
130834808|NCT02954406|471021513|FG010|Overall Study|Reason Not Specified|0|||
130834809|NCT00782171|471021514|FG000|Overall Study|Lost to Follow-up|2|||
130834810|NCT00782171|471021515|FG001|Overall Study|Lost to Follow-up|2|||
130834811|NCT00782171|471021514|FG000|Overall Study|Withdrawal by Subject|2|||
130834812|NCT00782171|471021515|FG001|Overall Study|Withdrawal by Subject|1|||
130834813|NCT00782171|471021514|FG000|Overall Study|complications|3|||
130834814|NCT00782171|471021515|FG001|Overall Study|complications|1|||
130834815|NCT00782171|471021514|FG000|Overall Study|others|7|||
130834816|NCT00782171|471021515|FG001|Overall Study|others|9|||
130834817|NCT00782171|471021514|FG000|Overall Study|not eligible|8|||
130834818|NCT00782171|471021515|FG001|Overall Study|not eligible|6|||
130834819|NCT02482428|471021524|FG000|Overall Study|Lost to Follow-up|4|||
130834820|NCT02482428|471021525|FG001|Overall Study|Lost to Follow-up|9|||
130834821|NCT02482428|471021526|FG002|Overall Study|Lost to Follow-up|1|||
130834822|NCT02482428|471021527|FG003|Overall Study|Lost to Follow-up|2|||
130834823|NCT02482428|471021528|FG004|Overall Study|Lost to Follow-up|4|||
130834824|NCT02482428|471021524|FG000|Overall Study|Physician Decision|0|||
130834825|NCT02482428|471021525|FG001|Overall Study|Physician Decision|0|||
130834826|NCT02482428|471021526|FG002|Overall Study|Physician Decision|0|||
130834827|NCT02482428|471021527|FG003|Overall Study|Physician Decision|0|||
130834828|NCT02482428|471021528|FG004|Overall Study|Physician Decision|1|||
130834829|NCT02482428|471021524|FG000|Overall Study|protocol deviation|1|||
130834830|NCT02482428|471021525|FG001|Overall Study|protocol deviation|1|||
130834831|NCT02482428|471021526|FG002|Overall Study|protocol deviation|0|||
130834832|NCT02482428|471021527|FG003|Overall Study|protocol deviation|0|||
130834833|NCT02482428|471021528|FG004|Overall Study|protocol deviation|0|||
130834834|NCT02482428|471021524|FG000|Overall Study|subject/guardian decision|4|||
130834835|NCT02482428|471021525|FG001|Overall Study|subject/guardian decision|2|||
130834836|NCT02482428|471021526|FG002|Overall Study|subject/guardian decision|0|||
130834837|NCT02482428|471021527|FG003|Overall Study|subject/guardian decision|0|||
130834838|NCT02482428|471021528|FG004|Overall Study|subject/guardian decision|2|||
130834839|NCT04308239|471021535|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
130834840|NCT04308239|471021536|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
130834841|NCT04308239|471021535|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
130834842|NCT04308239|471021536|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
130834843|NCT04308239|471021535|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
130834844|NCT04308239|471021536|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
130834845|NCT04308239|471021535|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
130834846|NCT04308239|471021536|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
130834847|NCT00559845|471021539|FG000|Overall Study|Withdrew Consent|1|||
130834848|NCT00559845|471021539|FG000|Overall Study|Disease Progression|1|||
130834849|NCT00559845|471021539|FG000|Overall Study|Adverse Event|3|||
130834850|NCT00559845|471021539|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
130834851|NCT00559845|471021539|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
130834852|NCT01406938|471021542|FG000|Induction Period|Subject/guardian decision|6|||
130834853|NCT01406938|471021543|FG001|Induction Period|Subject/guardian decision|8|||
130834854|NCT01406938|471021544|FG002|Induction Period|Subject/guardian decision|0|||
130834855|NCT01406938|471021545|FG003|Induction Period|Subject/guardian decision|0|||
130834856|NCT01406938|471021546|FG004|Induction Period|Subject/guardian decision|0|||
130834857|NCT01406938|471021547|FG005|Induction Period|Subject/guardian decision|0|||
130834858|NCT01406938|471021542|FG000|Induction Period|Protocol deviation|1|||
130834859|NCT01406938|471021543|FG001|Induction Period|Protocol deviation|0|||
130834860|NCT01406938|471021544|FG002|Induction Period|Protocol deviation|0|||
130834861|NCT01406938|471021545|FG003|Induction Period|Protocol deviation|0|||
130834862|NCT01406938|471021546|FG004|Induction Period|Protocol deviation|0|||
130834863|NCT01406938|471021547|FG005|Induction Period|Protocol deviation|0|||
130834864|NCT01406938|471021542|FG000|Induction Period|Adverse Event|8|||
130834865|NCT01406938|471021543|FG001|Induction Period|Adverse Event|9|||
130834866|NCT01406938|471021544|FG002|Induction Period|Adverse Event|0|||
130834867|NCT01406938|471021545|FG003|Induction Period|Adverse Event|0|||
130834868|NCT01406938|471021546|FG004|Induction Period|Adverse Event|0|||
130834869|NCT01406938|471021547|FG005|Induction Period|Adverse Event|0|||
130834870|NCT01406938|471021542|FG000|Induction Period|Lack of Efficacy|1|||
130834871|NCT01406938|471021543|FG001|Induction Period|Lack of Efficacy|0|||
130834872|NCT01406938|471021544|FG002|Induction Period|Lack of Efficacy|0|||
130834873|NCT01406938|471021545|FG003|Induction Period|Lack of Efficacy|0|||
130834874|NCT01406938|471021546|FG004|Induction Period|Lack of Efficacy|0|||
130834875|NCT01406938|471021547|FG005|Induction Period|Lack of Efficacy|0|||
130834876|NCT01406938|471021542|FG000|Induction Period|Lost to Follow-up|2|||
130834877|NCT01406938|471021543|FG001|Induction Period|Lost to Follow-up|3|||
130834878|NCT01406938|471021544|FG002|Induction Period|Lost to Follow-up|0|||
130834879|NCT01406938|471021545|FG003|Induction Period|Lost to Follow-up|0|||
130834880|NCT01406938|471021546|FG004|Induction Period|Lost to Follow-up|0|||
130834881|NCT01406938|471021547|FG005|Induction Period|Lost to Follow-up|0|||
130834882|NCT01406938|471021542|FG000|Maintenance Period|Adverse Event|0|||
130834883|NCT01406938|471021543|FG001|Maintenance Period|Adverse Event|0|||
130834884|NCT01406938|471021544|FG002|Maintenance Period|Adverse Event|2|||
130834885|NCT01406938|471021545|FG003|Maintenance Period|Adverse Event|8|||
130834886|NCT01406938|471021546|FG004|Maintenance Period|Adverse Event|4|||
130834887|NCT01406938|471021547|FG005|Maintenance Period|Adverse Event|2|||
130834888|NCT01406938|471021542|FG000|Maintenance Period|Death|0|||
130834889|NCT01406938|471021543|FG001|Maintenance Period|Death|0|||
130834890|NCT01406938|471021544|FG002|Maintenance Period|Death|0|||
130834891|NCT01406938|471021545|FG003|Maintenance Period|Death|0|||
130834892|NCT01406938|471021546|FG004|Maintenance Period|Death|1|||
130834893|NCT01406938|471021547|FG005|Maintenance Period|Death|0|||
130834894|NCT01406938|471021542|FG000|Maintenance Period|Subject/guardian decision|0|||
130834895|NCT01406938|471021543|FG001|Maintenance Period|Subject/guardian decision|0|||
130834896|NCT01406938|471021544|FG002|Maintenance Period|Subject/guardian decision|11|||
130834897|NCT01406938|471021545|FG003|Maintenance Period|Subject/guardian decision|7|||
130834898|NCT01406938|471021546|FG004|Maintenance Period|Subject/guardian decision|10|||
130834899|NCT01406938|471021547|FG005|Maintenance Period|Subject/guardian decision|7|||
130834900|NCT01406938|471021542|FG000|Maintenance Period|Protocol Violation|0|||
130834901|NCT01406938|471021543|FG001|Maintenance Period|Protocol Violation|0|||
130834902|NCT01406938|471021544|FG002|Maintenance Period|Protocol Violation|2|||
130834903|NCT01406938|471021545|FG003|Maintenance Period|Protocol Violation|2|||
130834904|NCT01406938|471021546|FG004|Maintenance Period|Protocol Violation|2|||
130834905|NCT01406938|471021547|FG005|Maintenance Period|Protocol Violation|2|||
130834906|NCT01406938|471021542|FG000|Maintenance Period|Pregnancy|0|||
130834907|NCT01406938|471021543|FG001|Maintenance Period|Pregnancy|0|||
130834908|NCT01406938|471021544|FG002|Maintenance Period|Pregnancy|0|||
130834909|NCT01406938|471021545|FG003|Maintenance Period|Pregnancy|0|||
130834910|NCT01406938|471021546|FG004|Maintenance Period|Pregnancy|1|||
130834911|NCT01406938|471021547|FG005|Maintenance Period|Pregnancy|0|||
130834912|NCT01406938|471021542|FG000|Maintenance Period|Lost to Follow-up|0|||
130834913|NCT01406938|471021543|FG001|Maintenance Period|Lost to Follow-up|0|||
130834914|NCT01406938|471021544|FG002|Maintenance Period|Lost to Follow-up|0|||
130834915|NCT01406938|471021545|FG003|Maintenance Period|Lost to Follow-up|0|||
130834916|NCT01406938|471021546|FG004|Maintenance Period|Lost to Follow-up|4|||
130834917|NCT01406938|471021547|FG005|Maintenance Period|Lost to Follow-up|0|||
130834918|NCT01406938|471021542|FG000|Maintenance Period|Lack of Efficacy|0|||
130834919|NCT01406938|471021543|FG001|Maintenance Period|Lack of Efficacy|0|||
130834920|NCT01406938|471021544|FG002|Maintenance Period|Lack of Efficacy|2|||
130834921|NCT01406938|471021545|FG003|Maintenance Period|Lack of Efficacy|1|||
130834922|NCT01406938|471021546|FG004|Maintenance Period|Lack of Efficacy|3|||
130834923|NCT01406938|471021547|FG005|Maintenance Period|Lack of Efficacy|5|||
130834924|NCT01406938|471021542|FG000|Follow up|Lack of Efficacy|3|||
130834925|NCT01406938|471021543|FG001|Follow up|Lack of Efficacy|2|||
130834926|NCT01406938|471021544|FG002|Follow up|Lack of Efficacy|1|||
130834927|NCT01406938|471021545|FG003|Follow up|Lack of Efficacy|0|||
130834928|NCT01406938|471021546|FG004|Follow up|Lack of Efficacy|0|||
130834929|NCT01406938|471021547|FG005|Follow up|Lack of Efficacy|0|||
130834930|NCT01406938|471021542|FG000|Follow up|Patient/guardian decision|4|||
130834931|NCT01406938|471021543|FG001|Follow up|Patient/guardian decision|2|||
130834932|NCT01406938|471021544|FG002|Follow up|Patient/guardian decision|4|||
130834933|NCT01406938|471021545|FG003|Follow up|Patient/guardian decision|2|||
130834934|NCT01406938|471021546|FG004|Follow up|Patient/guardian decision|4|||
130834935|NCT01406938|471021547|FG005|Follow up|Patient/guardian decision|1|||
130834936|NCT01406938|471021542|FG000|Follow up|Protocol Violation|0|||
130834937|NCT01406938|471021543|FG001|Follow up|Protocol Violation|0|||
130834938|NCT01406938|471021544|FG002|Follow up|Protocol Violation|1|||
130834939|NCT01406938|471021545|FG003|Follow up|Protocol Violation|0|||
130834940|NCT01406938|471021546|FG004|Follow up|Protocol Violation|0|||
130834941|NCT01406938|471021547|FG005|Follow up|Protocol Violation|0|||
130834942|NCT01406938|471021542|FG000|Follow up|Physician Decision|0|||
130834943|NCT01406938|471021543|FG001|Follow up|Physician Decision|0|||
130834944|NCT01406938|471021544|FG002|Follow up|Physician Decision|2|||
130834945|NCT01406938|471021545|FG003|Follow up|Physician Decision|0|||
130834946|NCT01406938|471021546|FG004|Follow up|Physician Decision|3|||
130834947|NCT01406938|471021547|FG005|Follow up|Physician Decision|1|||
130834948|NCT01406938|471021542|FG000|Follow up|Lost to Follow-up|1|||
130834949|NCT01406938|471021543|FG001|Follow up|Lost to Follow-up|1|||
130834950|NCT01406938|471021544|FG002|Follow up|Lost to Follow-up|0|||
130834951|NCT01406938|471021545|FG003|Follow up|Lost to Follow-up|1|||
130834952|NCT01406938|471021546|FG004|Follow up|Lost to Follow-up|2|||
130834953|NCT01406938|471021547|FG005|Follow up|Lost to Follow-up|1|||
130834954|NCT01951586|471021549|FG000|Overall Study|Death|61|||
130834955|NCT01951586|471021550|FG001|Overall Study|Death|120|||
130834956|NCT01951586|471021549|FG000|Overall Study|Withdrawal by Subject|8|||
130834957|NCT01951586|471021550|FG001|Overall Study|Withdrawal by Subject|17|||
130834958|NCT01951586|471021549|FG000|Overall Study|Lost to Follow-up|0|||
130834959|NCT01951586|471021550|FG001|Overall Study|Lost to Follow-up|1|||
130834960|NCT01951586|471021549|FG000|Overall Study|Sponsor Decision|9|||
130834961|NCT01951586|471021550|FG001|Overall Study|Sponsor Decision|10|||
130834962|NCT00878254|471021552|FG000|Overall Study|Physician Decision|1|||
130834963|NCT00878254|471021552|FG000|Overall Study|Death|1|||
130834964|NCT00878254|471021552|FG000|Overall Study|Withdrawal by Subject|1|||
130834965|NCT00194077|471021555|FG000|Overall Study|Lack of Efficacy|22|||
130834966|NCT00194077|471021556|FG001|Overall Study|Lack of Efficacy|29|||
130834967|NCT00194077|471021555|FG000|Overall Study|Study nonadherence|1|||
130834968|NCT00194077|471021556|FG001|Overall Study|Study nonadherence|0|||
130834969|NCT00194077|471021555|FG000|Overall Study|Withdrawal by Subject|1|||
130834970|NCT00194077|471021556|FG001|Overall Study|Withdrawal by Subject|1|||
130834971|NCT03286543|471021559|FG000|Consented|Screen failure before randomization|2|||
130834972|NCT03286543|471021560|FG001|Consented|Screen failure before randomization|0|||
130834973|NCT03286543|471021561|FG002|Consented|Screen failure before randomization|0|||
130834974|NCT03286543|471021559|FG000|Consented|Screen failure before enrollment|4|||
130834975|NCT03286543|471021560|FG001|Consented|Screen failure before enrollment|0|||
130834976|NCT03286543|471021561|FG002|Consented|Screen failure before enrollment|0|||
130834977|NCT03286543|471021559|FG000|Consented|TKA cancelled after enrollment|1|||
130834978|NCT03286543|471021560|FG001|Consented|TKA cancelled after enrollment|0|||
130834979|NCT03286543|471021561|FG002|Consented|TKA cancelled after enrollment|0|||
130834980|NCT03286543|471021559|FG000|Consented|Withdrawn from study|12|||
130834981|NCT03286543|471021560|FG001|Consented|Withdrawn from study|0|||
130834982|NCT03286543|471021561|FG002|Consented|Withdrawn from study|0|||
130834983|NCT03286543|471021559|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
130834984|NCT03286543|471021560|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
130834985|NCT03286543|471021561|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
130834986|NCT03286543|471021559|FG000|Study Enrollment|Withdrawn from study|0|||
130834987|NCT03286543|471021560|FG001|Study Enrollment|Withdrawn from study|6|||
130834988|NCT03286543|471021561|FG002|Study Enrollment|Withdrawn from study|6|||
130834989|NCT01822899|471021562|FG000|Overall Study|Adverse Event|6|||
130834990|NCT01822899|471021563|FG001|Overall Study|Adverse Event|5|||
130834991|NCT01822899|471021562|FG000|Overall Study|Lack of Efficacy|6|||
130834992|NCT01822899|471021563|FG001|Overall Study|Lack of Efficacy|3|||
130834993|NCT01822899|471021562|FG000|Overall Study|Protocol Violation|6|||
130834994|NCT01822899|471021563|FG001|Overall Study|Protocol Violation|3|||
130834995|NCT01822899|471021562|FG000|Overall Study|Lost to Follow-up|1|||
130834996|NCT01822899|471021563|FG001|Overall Study|Lost to Follow-up|0|||
130834997|NCT01822899|471021562|FG000|Overall Study|Withdrawal by Subject|5|||
130834998|NCT01822899|471021563|FG001|Overall Study|Withdrawal by Subject|7|||
130834999|NCT05332392|471021564|FG000|Overall Study|Did not meet inclusion criteria|25|||
130835000|NCT05332392|471021564|FG000|Overall Study|Principal Investigator's decision|17|||
130835001|NCT05332392|471021564|FG000|Overall Study|Adverse Event|1|||
130835002|NCT05332392|471021564|FG000|Overall Study|Subject's decision|1|||
130835003|NCT00759876|471021566|FG000|Overall Study|Sponsor terminated study early|36|||
130835004|NCT03636893|471021567|FG000|Overall Study|Death|0|||
130835005|NCT03636893|471021568|FG001|Overall Study|Death|1|||
130835006|NCT03636893|471021567|FG000|Overall Study|Protocol Violation|0|||
130835007|NCT03636893|471021568|FG001|Overall Study|Protocol Violation|3|||
130835008|NCT03636893|471021567|FG000|Overall Study|Withdrawal by Subject|1|||
130835009|NCT03636893|471021568|FG001|Overall Study|Withdrawal by Subject|2|||
130835010|NCT03636893|471021567|FG000|Overall Study|Refusal to surgery|4|||
130835011|NCT03636893|471021568|FG001|Overall Study|Refusal to surgery|3|||
130835012|NCT03636893|471021567|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
130835013|NCT03636893|471021568|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
130835014|NCT03636893|471021567|FG000|Overall Study|Adverse Event|1|||
130835015|NCT03636893|471021568|FG001|Overall Study|Adverse Event|1|||
130835016|NCT00758069|471021569|FG000|Overall Study|Lack of Efficacy|0|||
130835017|NCT00758069|471021570|FG001|Overall Study|Lack of Efficacy|0|||
130835018|NCT00758069|471021571|FG002|Overall Study|Lack of Efficacy|1|||
130835019|NCT00758069|471021569|FG000|Overall Study|Incorrect Study Drug|1|||
130835020|NCT00758069|471021570|FG001|Overall Study|Incorrect Study Drug|0|||
130835021|NCT00758069|471021571|FG002|Overall Study|Incorrect Study Drug|0|||
130835022|NCT02277691|471021572|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
130835023|NCT02277691|471021572|FG000|Overall Study|Voluntary Withdrawal|7|||
130835024|NCT02277691|471021572|FG000|Overall Study|Lack of Efficacy|5|||
130835025|NCT02277691|471021572|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
130835026|NCT03818607|471021573|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
130835027|NCT03818607|471021574|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
130835028|NCT03818607|471021573|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
130835029|NCT03818607|471021574|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
130835030|NCT03818607|471021573|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
130835031|NCT03818607|471021574|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
130835032|NCT00588237|471021576|FG000|Overall Study|Evaluable for toxicity only|3|||
130835033|NCT00588237|471021576|FG000|Overall Study|Patien not treated|1|||
130835034|NCT01164891|471021580|FG000|Overall Study|Disease Progression|5|||
130835035|NCT01164891|471021580|FG000|Overall Study|Adverse Event|1|||
130835036|NCT00441142|471021581|FG000|Overall Study|Adverse Event|2|||
130835037|NCT00441142|471021582|FG001|Overall Study|Adverse Event|3|||
130835038|NCT00441142|471021583|FG002|Overall Study|Adverse Event|3|||
130835039|NCT00441142|471021584|FG003|Overall Study|Adverse Event|22|||
130835040|NCT00441142|471021581|FG000|Overall Study|Lack of Efficacy|3|||
130835041|NCT00441142|471021582|FG001|Overall Study|Lack of Efficacy|3|||
130835042|NCT00441142|471021583|FG002|Overall Study|Lack of Efficacy|17|||
130835043|NCT00441142|471021584|FG003|Overall Study|Lack of Efficacy|32|||
130835044|NCT00441142|471021581|FG000|Overall Study|Withdrawal by Subject|0|||
130835045|NCT00441142|471021582|FG001|Overall Study|Withdrawal by Subject|0|||
130835046|NCT00441142|471021583|FG002|Overall Study|Withdrawal by Subject|2|||
130835047|NCT00441142|471021584|FG003|Overall Study|Withdrawal by Subject|10|||
130835048|NCT00441142|471021581|FG000|Overall Study|Patient still receiving active study tx|1|||
130835049|NCT00441142|471021582|FG001|Overall Study|Patient still receiving active study tx|0|||
130835050|NCT00441142|471021583|FG002|Overall Study|Patient still receiving active study tx|0|||
130835051|NCT00441142|471021584|FG003|Overall Study|Patient still receiving active study tx|2|||
130835052|NCT00441142|471021581|FG000|Overall Study|Physician Decision|0|||
130835053|NCT00441142|471021582|FG001|Overall Study|Physician Decision|1|||
130835054|NCT00441142|471021583|FG002|Overall Study|Physician Decision|0|||
130835055|NCT00441142|471021584|FG003|Overall Study|Physician Decision|1|||
130835056|NCT00441142|471021581|FG000|Overall Study|Death|0|||
130835057|NCT00441142|471021582|FG001|Overall Study|Death|0|||
130835058|NCT00441142|471021583|FG002|Overall Study|Death|0|||
130835059|NCT00441142|471021584|FG003|Overall Study|Death|1|||
130835060|NCT04952597|471021585|FG000|Overall Study|Death|12|||
130835061|NCT04952597|471021586|FG001|Overall Study|Death|13|||
130835062|NCT04952597|471021587|FG002|Overall Study|Death|14|||
130835063|NCT04952597|471021585|FG000|Overall Study|Withdrawal by Subject|1|||
130835064|NCT04952597|471021586|FG001|Overall Study|Withdrawal by Subject|0|||
130835065|NCT04952597|471021587|FG002|Overall Study|Withdrawal by Subject|3|||
130835066|NCT04952597|471021585|FG000|Overall Study|Lost to Follow-up|0|||
130835067|NCT04952597|471021586|FG001|Overall Study|Lost to Follow-up|1|||
130835068|NCT04952597|471021587|FG002|Overall Study|Lost to Follow-up|1|||
130835069|NCT04908865|471021588|FG000|Overall Study|Adverse Event|2|||
130835070|NCT04908865|471021588|FG000|Overall Study|Lack of Efficacy|5|||
130835071|NCT04908865|471021588|FG000|Overall Study|Lost to Follow-up|1|||
130835072|NCT05730335|471021589|FG000|Overall Study|Lost to Follow-up|8|||
130835073|NCT05730335|471021589|FG000|Overall Study|Withdrawal by Subject|6|||
130835074|NCT01296711|471021590|FG000|Overall Study|Adverse Event|3|||
130835075|NCT01296711|471021591|FG001|Overall Study|Adverse Event|1|||
130835076|NCT01296711|471021592|FG002|Overall Study|Adverse Event|4|||
130835077|NCT01296711|471021593|FG003|Overall Study|Adverse Event|3|||
130835078|NCT01296711|471021594|FG004|Overall Study|Adverse Event|1|||
130835079|NCT01296711|471021595|FG005|Overall Study|Adverse Event|6|||
130835080|NCT01296711|471021596|FG006|Overall Study|Adverse Event|11|||
130835081|NCT01296711|471021597|FG007|Overall Study|Adverse Event|3|||
130835082|NCT01296711|471021590|FG000|Overall Study|Lack of Efficacy|1|||
130835083|NCT01296711|471021591|FG001|Overall Study|Lack of Efficacy|4|||
130835084|NCT01296711|471021592|FG002|Overall Study|Lack of Efficacy|1|||
130835085|NCT01296711|471021593|FG003|Overall Study|Lack of Efficacy|1|||
130835086|NCT01296711|471021594|FG004|Overall Study|Lack of Efficacy|1|||
130835087|NCT01296711|471021595|FG005|Overall Study|Lack of Efficacy|0|||
130835088|NCT01296711|471021596|FG006|Overall Study|Lack of Efficacy|2|||
130835089|NCT01296711|471021597|FG007|Overall Study|Lack of Efficacy|3|||
130835090|NCT01296711|471021590|FG000|Overall Study|Lost to Follow-up|0|||
130835091|NCT01296711|471021591|FG001|Overall Study|Lost to Follow-up|0|||
130835092|NCT01296711|471021592|FG002|Overall Study|Lost to Follow-up|1|||
130835093|NCT01296711|471021593|FG003|Overall Study|Lost to Follow-up|1|||
130835094|NCT01296711|471021594|FG004|Overall Study|Lost to Follow-up|2|||
130835095|NCT01296711|471021595|FG005|Overall Study|Lost to Follow-up|0|||
130835096|NCT01296711|471021596|FG006|Overall Study|Lost to Follow-up|4|||
130835097|NCT01296711|471021597|FG007|Overall Study|Lost to Follow-up|2|||
130835098|NCT01296711|471021590|FG000|Overall Study|Protocol Violation|0|||
130835099|NCT01296711|471021591|FG001|Overall Study|Protocol Violation|0|||
130835100|NCT01296711|471021592|FG002|Overall Study|Protocol Violation|0|||
130835101|NCT01296711|471021593|FG003|Overall Study|Protocol Violation|1|||
130835102|NCT01296711|471021594|FG004|Overall Study|Protocol Violation|1|||
130835103|NCT01296711|471021595|FG005|Overall Study|Protocol Violation|0|||
130835104|NCT01296711|471021596|FG006|Overall Study|Protocol Violation|0|||
130835105|NCT01296711|471021597|FG007|Overall Study|Protocol Violation|0|||
130835106|NCT01296711|471021590|FG000|Overall Study|Withdrawal by Subject|4|||
130835107|NCT01296711|471021591|FG001|Overall Study|Withdrawal by Subject|2|||
130835108|NCT01296711|471021592|FG002|Overall Study|Withdrawal by Subject|2|||
130835109|NCT01296711|471021593|FG003|Overall Study|Withdrawal by Subject|1|||
130835110|NCT01296711|471021594|FG004|Overall Study|Withdrawal by Subject|1|||
130835111|NCT01296711|471021595|FG005|Overall Study|Withdrawal by Subject|1|||
130835112|NCT01296711|471021596|FG006|Overall Study|Withdrawal by Subject|2|||
130835113|NCT01296711|471021597|FG007|Overall Study|Withdrawal by Subject|1|||
130835114|NCT01296711|471021590|FG000|Overall Study|Study termination|8|||
130835115|NCT01296711|471021591|FG001|Overall Study|Study termination|1|||
130835116|NCT01296711|471021592|FG002|Overall Study|Study termination|5|||
130835117|NCT01296711|471021593|FG003|Overall Study|Study termination|4|||
130835118|NCT01296711|471021594|FG004|Overall Study|Study termination|4|||
130835119|NCT01296711|471021595|FG005|Overall Study|Study termination|4|||
130835120|NCT01296711|471021596|FG006|Overall Study|Study termination|8|||
130835121|NCT01296711|471021597|FG007|Overall Study|Study termination|10|||
130835122|NCT01296711|471021590|FG000|Overall Study|Continued elevated liver enzymes|0|||
130835123|NCT01296711|471021591|FG001|Overall Study|Continued elevated liver enzymes|0|||
130835124|NCT01296711|471021592|FG002|Overall Study|Continued elevated liver enzymes|0|||
130835125|NCT01296711|471021593|FG003|Overall Study|Continued elevated liver enzymes|1|||
130835126|NCT01296711|471021594|FG004|Overall Study|Continued elevated liver enzymes|0|||
130835127|NCT01296711|471021595|FG005|Overall Study|Continued elevated liver enzymes|0|||
130835128|NCT01296711|471021596|FG006|Overall Study|Continued elevated liver enzymes|0|||
130835129|NCT01296711|471021597|FG007|Overall Study|Continued elevated liver enzymes|0|||
130835130|NCT01296711|471021590|FG000|Overall Study|Methotrexate discontinued|0|||
130835131|NCT01296711|471021591|FG001|Overall Study|Methotrexate discontinued|0|||
130835132|NCT01296711|471021592|FG002|Overall Study|Methotrexate discontinued|0|||
130835133|NCT01296711|471021593|FG003|Overall Study|Methotrexate discontinued|1|||
130835134|NCT01296711|471021594|FG004|Overall Study|Methotrexate discontinued|0|||
130835135|NCT01296711|471021595|FG005|Overall Study|Methotrexate discontinued|0|||
130835136|NCT01296711|471021596|FG006|Overall Study|Methotrexate discontinued|0|||
130835137|NCT01296711|471021597|FG007|Overall Study|Methotrexate discontinued|0|||
130835138|NCT01296711|471021590|FG000|Overall Study|Investigator discretion|0|||
130835139|NCT01296711|471021591|FG001|Overall Study|Investigator discretion|0|||
130835140|NCT01296711|471021592|FG002|Overall Study|Investigator discretion|0|||
130835141|NCT01296711|471021593|FG003|Overall Study|Investigator discretion|0|||
130835142|NCT01296711|471021594|FG004|Overall Study|Investigator discretion|0|||
130835143|NCT01296711|471021595|FG005|Overall Study|Investigator discretion|0|||
130835144|NCT01296711|471021596|FG006|Overall Study|Investigator discretion|1|||
130835145|NCT01296711|471021597|FG007|Overall Study|Investigator discretion|0|||
130835146|NCT01296711|471021590|FG000|Overall Study|Other|0|||
130835147|NCT01296711|471021591|FG001|Overall Study|Other|0|||
130835148|NCT01296711|471021592|FG002|Overall Study|Other|0|||
130835149|NCT01296711|471021593|FG003|Overall Study|Other|0|||
130835150|NCT01296711|471021594|FG004|Overall Study|Other|0|||
130835151|NCT01296711|471021595|FG005|Overall Study|Other|0|||
130835152|NCT01296711|471021596|FG006|Overall Study|Other|1|||
130835153|NCT01296711|471021597|FG007|Overall Study|Other|0|||
130835154|NCT01296711|471021590|FG000|Overall Study|Required restricted steroid injections|0|||
130835155|NCT01296711|471021591|FG001|Overall Study|Required restricted steroid injections|0|||
130835156|NCT01296711|471021592|FG002|Overall Study|Required restricted steroid injections|0|||
130835157|NCT01296711|471021593|FG003|Overall Study|Required restricted steroid injections|0|||
130835158|NCT01296711|471021594|FG004|Overall Study|Required restricted steroid injections|0|||
130835159|NCT01296711|471021595|FG005|Overall Study|Required restricted steroid injections|0|||
130835160|NCT01296711|471021596|FG006|Overall Study|Required restricted steroid injections|1|||
130835161|NCT01296711|471021597|FG007|Overall Study|Required restricted steroid injections|0|||
130835162|NCT01296711|471021590|FG000|Overall Study|Ongoing missed appointments|0|||
130835163|NCT01296711|471021591|FG001|Overall Study|Ongoing missed appointments|0|||
130835164|NCT01296711|471021592|FG002|Overall Study|Ongoing missed appointments|0|||
130835165|NCT01296711|471021593|FG003|Overall Study|Ongoing missed appointments|0|||
130835166|NCT01296711|471021594|FG004|Overall Study|Ongoing missed appointments|0|||
130835167|NCT01296711|471021595|FG005|Overall Study|Ongoing missed appointments|0|||
130835168|NCT01296711|471021596|FG006|Overall Study|Ongoing missed appointments|1|||
130835169|NCT01296711|471021597|FG007|Overall Study|Ongoing missed appointments|0|||
130835170|NCT01296711|471021590|FG000|Overall Study|Failure to comply with visits|0|||
130835171|NCT01296711|471021591|FG001|Overall Study|Failure to comply with visits|0|||
130835172|NCT01296711|471021592|FG002|Overall Study|Failure to comply with visits|0|||
130835173|NCT01296711|471021593|FG003|Overall Study|Failure to comply with visits|0|||
130835174|NCT01296711|471021594|FG004|Overall Study|Failure to comply with visits|0|||
130835175|NCT01296711|471021595|FG005|Overall Study|Failure to comply with visits|0|||
130835176|NCT01296711|471021596|FG006|Overall Study|Failure to comply with visits|0|||
130835177|NCT01296711|471021597|FG007|Overall Study|Failure to comply with visits|1|||
130835178|NCT01296711|471021590|FG000|Overall Study|Patient decision due to transport|0|||
130835179|NCT01296711|471021591|FG001|Overall Study|Patient decision due to transport|0|||
130835180|NCT01296711|471021592|FG002|Overall Study|Patient decision due to transport|0|||
130835181|NCT01296711|471021593|FG003|Overall Study|Patient decision due to transport|0|||
130835182|NCT01296711|471021594|FG004|Overall Study|Patient decision due to transport|0|||
130835183|NCT01296711|471021595|FG005|Overall Study|Patient decision due to transport|0|||
130835184|NCT01296711|471021596|FG006|Overall Study|Patient decision due to transport|0|||
130835185|NCT01296711|471021597|FG007|Overall Study|Patient decision due to transport|1|||
130835186|NCT00606034|471021600|FG000|Overall Study|incarceration|1|||
130835187|NCT01126268|471021603|FG000|Overall Study|Adverse Event|1|||
130835188|NCT01864148|471021608|FG000|Overall Study|Other|2|||
130835189|NCT01864148|471021609|FG001|Overall Study|Other|1|||
130835190|NCT01864148|471021610|FG002|Overall Study|Other|1|||
130835191|NCT01864148|471021611|FG003|Overall Study|Other|3|||
130835192|NCT01864148|471021612|FG004|Overall Study|Other|1|||
130835193|NCT01864148|471021608|FG000|Overall Study|Death|0|||
130835194|NCT01864148|471021609|FG001|Overall Study|Death|0|||
130835195|NCT01864148|471021610|FG002|Overall Study|Death|0|||
130835196|NCT01864148|471021611|FG003|Overall Study|Death|1|||
130835197|NCT01864148|471021612|FG004|Overall Study|Death|0|||
130835198|NCT01864148|471021608|FG000|Overall Study|Investigator Decision|5|||
130835199|NCT01864148|471021609|FG001|Overall Study|Investigator Decision|0|||
130835200|NCT01864148|471021610|FG002|Overall Study|Investigator Decision|0|||
130835201|NCT01864148|471021611|FG003|Overall Study|Investigator Decision|4|||
130835202|NCT01864148|471021612|FG004|Overall Study|Investigator Decision|6|||
130835203|NCT01864148|471021608|FG000|Overall Study|Withdrawal by Subject|9|||
130835204|NCT01864148|471021609|FG001|Overall Study|Withdrawal by Subject|2|||
130835205|NCT01864148|471021610|FG002|Overall Study|Withdrawal by Subject|6|||
130835206|NCT01864148|471021611|FG003|Overall Study|Withdrawal by Subject|8|||
130835207|NCT01864148|471021612|FG004|Overall Study|Withdrawal by Subject|8|||
130835208|NCT01864148|471021608|FG000|Overall Study|Lost to Follow-up|0|||
130835209|NCT01864148|471021609|FG001|Overall Study|Lost to Follow-up|0|||
130835210|NCT01864148|471021610|FG002|Overall Study|Lost to Follow-up|0|||
130835211|NCT01864148|471021611|FG003|Overall Study|Lost to Follow-up|2|||
130835212|NCT01864148|471021612|FG004|Overall Study|Lost to Follow-up|1|||
130835213|NCT01864148|471021608|FG000|Overall Study|Adverse Event|4|||
130835214|NCT01864148|471021609|FG001|Overall Study|Adverse Event|2|||
130835215|NCT01864148|471021610|FG002|Overall Study|Adverse Event|4|||
130835216|NCT01864148|471021611|FG003|Overall Study|Adverse Event|7|||
130835217|NCT01864148|471021612|FG004|Overall Study|Adverse Event|7|||
130835218|NCT01864148|471021608|FG000|Overall Study|Not Dosed|0|||
130835219|NCT01864148|471021609|FG001|Overall Study|Not Dosed|0|||
130835220|NCT01864148|471021610|FG002|Overall Study|Not Dosed|0|||
130835221|NCT01864148|471021611|FG003|Overall Study|Not Dosed|1|||
130835222|NCT01864148|471021612|FG004|Overall Study|Not Dosed|0|||
130835223|NCT02466425|471021615|FG000|Overall Study|Adverse Event|3|||
130835224|NCT02466425|471021616|FG001|Overall Study|Adverse Event|11|||
130835225|NCT02466425|471021615|FG000|Overall Study|Lack of Efficacy|4|||
130835226|NCT02466425|471021616|FG001|Overall Study|Lack of Efficacy|1|||
130835227|NCT02466425|471021615|FG000|Overall Study|Lost to Follow-up|3|||
130835228|NCT02466425|471021616|FG001|Overall Study|Lost to Follow-up|0|||
130835229|NCT02466425|471021615|FG000|Overall Study|Protocol Violation|1|||
130835230|NCT02466425|471021616|FG001|Overall Study|Protocol Violation|0|||
130835231|NCT02466425|471021615|FG000|Overall Study|Withdrawal by Subject|0|||
130835232|NCT02466425|471021616|FG001|Overall Study|Withdrawal by Subject|1|||
130835233|NCT02466425|471021615|FG000|Overall Study|Other|1|||
130835234|NCT02466425|471021616|FG001|Overall Study|Other|3|||
130835235|NCT02466425|471021615|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130835236|NCT02466425|471021616|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130835237|NCT01721486|471021621|FG000|Overall Study|Protocol Violation|1|||
130835238|NCT01721486|471021622|FG001|Overall Study|Protocol Violation|0|||
130835239|NCT01721486|471021621|FG000|Overall Study|Physician Decision|0|||
130835240|NCT01721486|471021622|FG001|Overall Study|Physician Decision|1|||
130835241|NCT00582712|471021623|FG000|Overall Study|Adverse Event|1|||
130835242|NCT00582712|471021623|FG000|Overall Study|Lack of Efficacy|1|||
130835243|NCT00582712|471021623|FG000|Overall Study|Withdrawal by Subject|1|||
130835244|NCT00582712|471021623|FG000|Overall Study|Complicating disease requiring treatment|1|||
130835245|NCT01901289|471021625|FG000|Overall Study|Death|32|||
130835246|NCT01901289|471021625|FG000|Overall Study|Lost to Follow-up|16|||
130835247|NCT01901289|471021625|FG000|Overall Study|Withdrawal by Subject|35|||
130835248|NCT01901289|471021625|FG000|Overall Study|Other type of endpoint met|2|||
130835249|NCT01813058|471021626|FG000|Overall Study|Withdrawal by Subject|5|||
130835250|NCT01813058|471021627|FG001|Overall Study|Withdrawal by Subject|4|||
130835251|NCT00395486|471021628|FG000|Overall Study|Adverse Event|1|||
130835252|NCT00395486|471021629|FG001|Overall Study|Adverse Event|2|||
130835253|NCT00395486|471021628|FG000|Overall Study|Withdrawal by Subject|5|||
130835254|NCT00395486|471021629|FG001|Overall Study|Withdrawal by Subject|2|||
130835255|NCT00395486|471021628|FG000|Overall Study|Lost to Follow-up|0|||
130835256|NCT00395486|471021629|FG001|Overall Study|Lost to Follow-up|1|||
130835257|NCT00361231|471021630|FG000|Overall Study|Physician Decision|3|||
130835258|NCT00361231|471021630|FG000|Overall Study|Symptomatic deterioration|5|||
130835259|NCT00361231|471021630|FG000|Overall Study|Radiographic disease progression|16|||
130835260|NCT00361231|471021630|FG000|Overall Study|Withdrawal by Subject|4|||
130835261|NCT00361231|471021630|FG000|Overall Study|Adverse Event|6|||
130835262|NCT01814397|471021633|FG000|Overall Study|Adverse Event|7|||
130835263|NCT01814397|471021633|FG000|Overall Study|Withdrawal by Subject|7|||
130835264|NCT00313144|471021634|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
130835265|NCT00313144|471021634|FG000|Overall Study|Death|7|||
130835266|NCT00313144|471021634|FG000|Overall Study|Lost to Follow-up|5|||
130835267|NCT00313144|471021634|FG000|Overall Study|Withdrawal by Subject|4|||
130835268|NCT00313144|471021634|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
130835269|NCT00313144|471021634|FG000|Overall Study|Physician Decision|4|||
130835270|NCT00313144|471021634|FG000|Overall Study|Adverse event - transient|5|||
130835271|NCT00313144|471021634|FG000|Overall Study|Liver transplant|1|||
130835272|NCT00313144|471021634|FG000|Overall Study|Insurance (homecare provider) change|1|||
130835273|NCT00313144|471021634|FG000|Overall Study|Change to different product|1|||
130835274|NCT00313144|471021634|FG000|Overall Study|Due to termination of the study|66|||
130835275|NCT01917929|471021638|FG000|Overall Study|Death|8|||
130835276|NCT01917929|471021638|FG000|Overall Study|Lost to Follow-up|19|||
130835277|NCT01917929|471021638|FG000|Overall Study|Withdrawal by Subject|33|||
130835278|NCT01917929|471021638|FG000|Overall Study|Adverse Event|6|||
130835279|NCT01917929|471021638|FG000|Overall Study|Investigative Site Terminated|35|||
130835280|NCT01917929|471021638|FG000|Overall Study|Censored because study device not implanted|6|||
130835281|NCT01917929|471021638|FG000|Overall Study|Censored because surgery not performed|3|||
130835282|NCT01917929|471021638|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
130835283|NCT01917929|471021638|FG000|Overall Study|Sponsor terminated study|175|||
130835284|NCT01063062|471021644|FG000|Overall Study|Patient withdrew consent|0|||
130835285|NCT01063062|471021645|FG001|Overall Study|Patient withdrew consent|1|||
130835286|NCT01063062|471021644|FG000|Overall Study|Adverse Event|2|||
130835287|NCT01063062|471021645|FG001|Overall Study|Adverse Event|4|||
130835288|NCT01063062|471021644|FG000|Overall Study|Protocol Violation|5|||
130835289|NCT01063062|471021645|FG001|Overall Study|Protocol Violation|4|||
130835290|NCT01063062|471021644|FG000|Overall Study|Investigator's request|1|||
130835291|NCT01063062|471021645|FG001|Overall Study|Investigator's request|0|||
130835292|NCT01063062|471021644|FG000|Overall Study|Lost to Follow-up|0|||
130835293|NCT01063062|471021645|FG001|Overall Study|Lost to Follow-up|2|||
130835294|NCT01063062|471021644|FG000|Overall Study|Miscellaneous reason|0|||
130835295|NCT01063062|471021645|FG001|Overall Study|Miscellaneous reason|1|||
130835296|NCT02597452|471021648|FG000|Overall Study|testing incomplete|30|||
130835297|NCT04621240|471021649|FG000|Overall Study|Withdrawal by Subject|36|||
130835298|NCT03206918|471021650|FG000|Overall Study|Death|11|||
130835299|NCT03206918|471021650|FG000|Overall Study|Withdrawal by Subject|5|||
130835300|NCT03206918|471021650|FG000|Overall Study|Study terminated by sponsor|12|||
130835301|NCT03206918|471021650|FG000|Overall Study|Lost to Follow-up|3|||
130835302|NCT03206918|471021650|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
130835303|NCT04075292|471022843|FG000|Overall Study|Withdrawal by Subject|1|||
130835304|NCT04075292|471022844|FG001|Overall Study|Withdrawal by Subject|9|||
130835305|NCT04075292|471022843|FG000|Overall Study|Death|2|||
130835306|NCT04075292|471022844|FG001|Overall Study|Death|5|||
130835307|NCT04075292|471022843|FG000|Overall Study|Remained on study at time of DCO|74|||
130835308|NCT04075292|471022844|FG001|Overall Study|Remained on study at time of DCO|64|||
130835309|NCT01443364|471022845|FG000|Overall Study|Lack of Efficacy|14|||
130835310|NCT01443364|471022845|FG000|Overall Study|Lost to Follow-up|3|||
130835311|NCT01443364|471022845|FG000|Overall Study|Withdrawal by Subject|5|||
130835312|NCT01443364|471022845|FG000|Overall Study|Other Reason|4|||
130835313|NCT01443364|471022845|FG000|Overall Study|SAE, non-fatal|6|||
130835314|NCT01443364|471022845|FG000|Overall Study|AE, non-serious non-fatal|8|||
130835315|NCT01443364|471022845|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130835316|NCT03367403|471022846|FG000|Overall Study|Adverse Event|20|||
130835317|NCT03367403|471022847|FG001|Overall Study|Adverse Event|6|||
130835318|NCT03367403|471022848|FG002|Overall Study|Adverse Event|2|||
130835319|NCT03367403|471022846|FG000|Overall Study|Withdrawal by Subject|12|||
130835320|NCT03367403|471022847|FG001|Overall Study|Withdrawal by Subject|13|||
130835321|NCT03367403|471022848|FG002|Overall Study|Withdrawal by Subject|1|||
130835322|NCT03367403|471022846|FG000|Overall Study|Death|1|||
130835323|NCT03367403|471022847|FG001|Overall Study|Death|2|||
130835324|NCT03367403|471022848|FG002|Overall Study|Death|0|||
130835325|NCT03367403|471022846|FG000|Overall Study|Physician Decision|0|||
130835326|NCT03367403|471022847|FG001|Overall Study|Physician Decision|1|||
130835327|NCT03367403|471022848|FG002|Overall Study|Physician Decision|0|||
130835328|NCT03367403|471022846|FG000|Overall Study|Protocol Violation|1|||
130835329|NCT03367403|471022847|FG001|Overall Study|Protocol Violation|1|||
130835330|NCT03367403|471022848|FG002|Overall Study|Protocol Violation|0|||
130835331|NCT03367403|471022846|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
130835332|NCT03367403|471022847|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
130835333|NCT03367403|471022848|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
130835334|NCT03367403|471022846|FG000|Overall Study|COVID-19|3|||
130835335|NCT03367403|471022847|FG001|Overall Study|COVID-19|6|||
130835336|NCT03367403|471022848|FG002|Overall Study|COVID-19|0|||
130835337|NCT03367403|471022846|FG000|Overall Study|Abuse of Alcohol Intake|0|||
130835338|NCT03367403|471022847|FG001|Overall Study|Abuse of Alcohol Intake|1|||
130835339|NCT03367403|471022848|FG002|Overall Study|Abuse of Alcohol Intake|0|||
130835340|NCT03367403|471022846|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
130835341|NCT03367403|471022847|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
130835342|NCT03367403|471022848|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
130835343|NCT03470194|471022849|FG000|Overall Study|Lost to Follow-up|11|||
130835344|NCT03470194|471022850|FG001|Overall Study|Lost to Follow-up|17|||
130835345|NCT05059301|471022854|FG000|Overall Study|Adverse Event|0|||
130835346|NCT05059301|471022855|FG001|Overall Study|Adverse Event|2|||
130835347|NCT05059301|471022856|FG002|Overall Study|Adverse Event|2|||
130835348|NCT05059301|471022854|FG000|Overall Study|Lost to Follow-up|2|||
130835349|NCT05059301|471022855|FG001|Overall Study|Lost to Follow-up|3|||
130835350|NCT05059301|471022856|FG002|Overall Study|Lost to Follow-up|3|||
130835351|NCT01988662|471022857|FG000|Overall Study|Subject/guardian decision|1|||
130835352|NCT01988662|471022858|FG001|Overall Study|Subject/guardian decision|1|||
130835353|NCT01988662|471022857|FG000|Overall Study|Adverse Event|3|||
130835354|NCT01988662|471022858|FG001|Overall Study|Adverse Event|1|||
130835355|NCT00842153|471022859|FG000|Overall Study|Adverse Event|0|||
130835356|NCT00842153|471022860|FG001|Overall Study|Adverse Event|1|||
130835357|NCT00842153|471022859|FG000|Overall Study|Lost to Follow-up|1|||
130835358|NCT00842153|471022860|FG001|Overall Study|Lost to Follow-up|2|||
130835359|NCT00002540|471022861|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
130835360|NCT00002540|471022862|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
130835361|NCT00002540|471022861|FG000|Overall Study|Died Before Randomization|2|||
130835362|NCT00002540|471022862|FG001|Overall Study|Died Before Randomization|6|||
130835363|NCT00002540|471022861|FG000|Overall Study|Died Before ASU (Control)|202|||
130835364|NCT00002540|471022862|FG001|Overall Study|Died Before ASU (Control)|0|||
130835365|NCT00002540|471022861|FG000|Overall Study|Refused ASU (Control)|597|||
130835366|NCT00002540|471022862|FG001|Overall Study|Refused ASU (Control)|0|||
130835367|NCT00002540|471022861|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
130835368|NCT00002540|471022862|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
130835369|NCT05312697|471022863|FG000|Overall Study|Sponsor Terminated Trial|2|||
130835370|NCT04445519|471022864|FG000|Overall Study|Due to adaptive design|3|||
130835371|NCT04445519|471022865|FG001|Overall Study|Due to adaptive design|0|||
130835372|NCT04445519|471022866|FG002|Overall Study|Due to adaptive design|0|||
130835373|NCT04445519|471022864|FG000|Overall Study|Lost to Follow-up|0|||
130835374|NCT04445519|471022865|FG001|Overall Study|Lost to Follow-up|1|||
130835375|NCT04445519|471022866|FG002|Overall Study|Lost to Follow-up|4|||
130835376|NCT04445519|471022864|FG000|Overall Study|Sponsor or IRB Decision|0|||
130835377|NCT04445519|471022865|FG001|Overall Study|Sponsor or IRB Decision|1|||
130835378|NCT04445519|471022866|FG002|Overall Study|Sponsor or IRB Decision|2|||
130835379|NCT04445519|471022864|FG000|Overall Study|Withdrawal by Subject|0|||
130835380|NCT04445519|471022865|FG001|Overall Study|Withdrawal by Subject|3|||
130835381|NCT04445519|471022866|FG002|Overall Study|Withdrawal by Subject|3|||
130835382|NCT04445519|471022864|FG000|Overall Study|Adverse Event|0|||
130835383|NCT04445519|471022865|FG001|Overall Study|Adverse Event|8|||
130835384|NCT04445519|471022866|FG002|Overall Study|Adverse Event|6|||
130835385|NCT04445519|471022864|FG000|Overall Study|Other Reason|0|||
130835386|NCT04445519|471022865|FG001|Overall Study|Other Reason|1|||
130835387|NCT04445519|471022866|FG002|Overall Study|Other Reason|1|||
130835388|NCT04445519|471022864|FG000|Overall Study|Protocol Violation|0|||
130835389|NCT04445519|471022865|FG001|Overall Study|Protocol Violation|0|||
130835390|NCT04445519|471022866|FG002|Overall Study|Protocol Violation|1|||
130835391|NCT01345929|471022867|FG000|Overall Study|Withdrawal by Subject|9|||
130835392|NCT01345929|471022868|FG001|Overall Study|Withdrawal by Subject|8|||
130835393|NCT01345929|471022867|FG000|Overall Study|Lost to Follow-up|9|||
130835394|NCT01345929|471022868|FG001|Overall Study|Lost to Follow-up|9|||
130835395|NCT01345929|471022867|FG000|Overall Study|Adverse Event|0|||
130835396|NCT01345929|471022868|FG001|Overall Study|Adverse Event|1|||
130835397|NCT01345929|471022867|FG000|Overall Study|Didn't meet eligibility criteria|2|||
130835398|NCT01345929|471022868|FG001|Overall Study|Didn't meet eligibility criteria|0|||
130835399|NCT01345929|471022867|FG000|Overall Study|40,000 CFU/ML|1|||
130835400|NCT01345929|471022868|FG001|Overall Study|40,000 CFU/ML|0|||
130835401|NCT01345929|471022867|FG000|Overall Study|Patient withdrawal|0|||
130835402|NCT01345929|471022868|FG001|Overall Study|Patient withdrawal|1|||
130835403|NCT02151903|471022869|FG000|Overall Study|Withdrawal by Subject|1|||
130835404|NCT02151903|471022870|FG001|Overall Study|Withdrawal by Subject|0|||
130835405|NCT02151903|471022869|FG000|Overall Study|Progressive disease|2|||
130835406|NCT02151903|471022870|FG001|Overall Study|Progressive disease|1|||
130835407|NCT05319600|471022871|FG000|Overall Study|Withdrawal by Subject|1|||
130835408|NCT05319600|471022872|FG001|Overall Study|Withdrawal by Subject|0|||
130835409|NCT05319600|471022871|FG000|Overall Study|Lost to Follow-up|0|||
130835410|NCT05319600|471022872|FG001|Overall Study|Lost to Follow-up|4|||
130835411|NCT03768089|471022876|FG000|Part A|Lost to Follow-up|0|||
130835412|NCT03768089|471022877|FG001|Part A|Lost to Follow-up|0|||
130835413|NCT03768089|471022878|FG002|Part A|Lost to Follow-up|0|||
130835414|NCT03768089|471022879|FG003|Part A|Lost to Follow-up|0|||
130835415|NCT03768089|471022880|FG004|Part A|Lost to Follow-up|1|||
130835416|NCT03768089|471022881|FG005|Part A|Lost to Follow-up|0|||
130835417|NCT03768089|471022882|FG006|Part A|Lost to Follow-up|0|||
130835418|NCT03768089|471022883|FG007|Part A|Lost to Follow-up|0|||
130835419|NCT03768089|471022884|FG008|Part A|Lost to Follow-up|0|||
130835420|NCT03768089|471022885|FG009|Part A|Lost to Follow-up|0|||
130835421|NCT03768089|471022886|FG010|Part A|Lost to Follow-up|0|||
130835422|NCT03768089|471022887|FG011|Part A|Lost to Follow-up|0|||
130835423|NCT03768089|471022888|FG012|Part A|Lost to Follow-up|0|||
130835424|NCT03768089|471022889|FG013|Part A|Lost to Follow-up|0|||
130835425|NCT03768089|471022890|FG014|Part A|Lost to Follow-up|0|||
130835426|NCT03768089|471022891|FG015|Part A|Lost to Follow-up|0|||
130835427|NCT03768089|471022892|FG016|Part A|Lost to Follow-up|0|||
130835428|NCT03768089|471022893|FG017|Part A|Lost to Follow-up|0|||
130835429|NCT03768089|471022876|FG000|Part C|Randomized, Never Dosed|0|||
130835430|NCT03768089|471022877|FG001|Part C|Randomized, Never Dosed|0|||
130835431|NCT03768089|471022878|FG002|Part C|Randomized, Never Dosed|0|||
130835432|NCT03768089|471022879|FG003|Part C|Randomized, Never Dosed|0|||
130835433|NCT03768089|471022880|FG004|Part C|Randomized, Never Dosed|0|||
130835434|NCT03768089|471022881|FG005|Part C|Randomized, Never Dosed|0|||
130835435|NCT03768089|471022882|FG006|Part C|Randomized, Never Dosed|0|||
130835436|NCT03768089|471022883|FG007|Part C|Randomized, Never Dosed|0|||
130835437|NCT03768089|471022884|FG008|Part C|Randomized, Never Dosed|0|||
130835438|NCT03768089|471022885|FG009|Part C|Randomized, Never Dosed|0|||
130835439|NCT03768089|471022886|FG010|Part C|Randomized, Never Dosed|0|||
130835440|NCT03768089|471022887|FG011|Part C|Randomized, Never Dosed|0|||
130835441|NCT03768089|471022888|FG012|Part C|Randomized, Never Dosed|0|||
130835442|NCT03768089|471022889|FG013|Part C|Randomized, Never Dosed|0|||
130835443|NCT03768089|471022890|FG014|Part C|Randomized, Never Dosed|1|||
130835444|NCT03768089|471022891|FG015|Part C|Randomized, Never Dosed|0|||
130835445|NCT03768089|471022892|FG016|Part C|Randomized, Never Dosed|0|||
130835446|NCT03768089|471022893|FG017|Part C|Randomized, Never Dosed|0|||
130835447|NCT02120300|471022898|FG000|Overall Study|Enrolled but Never Treated|2|||
130835448|NCT02120300|471022899|FG001|Overall Study|Enrolled but Never Treated|0|||
130835449|NCT02120300|471022900|FG002|Overall Study|Enrolled but Never Treated|0|||
130835450|NCT02120300|471022901|FG003|Overall Study|Enrolled but Never Treated|0|||
130835451|NCT02120300|471022898|FG000|Overall Study|Lack of Efficacy|0|||
130835452|NCT02120300|471022899|FG001|Overall Study|Lack of Efficacy|0|||
130835453|NCT02120300|471022900|FG002|Overall Study|Lack of Efficacy|0|||
130835454|NCT02120300|471022901|FG003|Overall Study|Lack of Efficacy|1|||
130835455|NCT02120300|471022898|FG000|Overall Study|Lost to Follow-up|1|||
130835456|NCT02120300|471022899|FG001|Overall Study|Lost to Follow-up|0|||
130835457|NCT02120300|471022900|FG002|Overall Study|Lost to Follow-up|0|||
130835458|NCT02120300|471022901|FG003|Overall Study|Lost to Follow-up|0|||
130835459|NCT05141175|471022902|FG000|Overall Study|Withdrawal by Subject|1|||
130835460|NCT00177294|471022903|FG000|Overall Study|Withdrawal by Subject|7|||
130835461|NCT00177294|471022904|FG001|Overall Study|Withdrawal by Subject|5|||
130835462|NCT02443116|471022908|FG000|Part 1|Adverse Event|2|||
130835463|NCT02443116|471022909|FG001|Part 1|Adverse Event|3|||
130835464|NCT02443116|471022910|FG002|Part 1|Adverse Event|0|||
130835465|NCT02443116|471022911|FG003|Part 1|Adverse Event|0|||
130835466|NCT02443116|471022912|FG004|Part 1|Adverse Event|0|||
130835467|NCT02443116|471022913|FG005|Part 1|Adverse Event|0|||
130835468|NCT02443116|471022914|FG006|Part 1|Adverse Event|0|||
130835469|NCT02443116|471022915|FG007|Part 1|Adverse Event|0|||
130835470|NCT02443116|471022916|FG008|Part 1|Adverse Event|0|||
130835471|NCT02443116|471022908|FG000|Part 1|Withdrew informed consent|0|||
130835472|NCT02443116|471022909|FG001|Part 1|Withdrew informed consent|1|||
130835473|NCT02443116|471022910|FG002|Part 1|Withdrew informed consent|0|||
130835474|NCT02443116|471022911|FG003|Part 1|Withdrew informed consent|0|||
130835475|NCT02443116|471022912|FG004|Part 1|Withdrew informed consent|0|||
130835476|NCT02443116|471022913|FG005|Part 1|Withdrew informed consent|0|||
130835477|NCT02443116|471022914|FG006|Part 1|Withdrew informed consent|0|||
130835478|NCT02443116|471022915|FG007|Part 1|Withdrew informed consent|0|||
130835479|NCT02443116|471022916|FG008|Part 1|Withdrew informed consent|0|||
130835480|NCT02443116|471022908|FG000|Part 1|Lost to Follow-up|0|||
130835481|NCT02443116|471022909|FG001|Part 1|Lost to Follow-up|0|||
130835482|NCT02443116|471022910|FG002|Part 1|Lost to Follow-up|2|||
130835483|NCT02443116|471022911|FG003|Part 1|Lost to Follow-up|0|||
130835484|NCT02443116|471022912|FG004|Part 1|Lost to Follow-up|0|||
130835485|NCT02443116|471022913|FG005|Part 1|Lost to Follow-up|0|||
130835486|NCT02443116|471022914|FG006|Part 1|Lost to Follow-up|0|||
130835487|NCT02443116|471022915|FG007|Part 1|Lost to Follow-up|0|||
130835488|NCT02443116|471022916|FG008|Part 1|Lost to Follow-up|0|||
130835489|NCT02443116|471022908|FG000|Part 1|Participant moved out of state|0|||
130835490|NCT02443116|471022909|FG001|Part 1|Participant moved out of state|0|||
130835491|NCT02443116|471022910|FG002|Part 1|Participant moved out of state|1|||
130835492|NCT02443116|471022911|FG003|Part 1|Participant moved out of state|0|||
130835493|NCT02443116|471022912|FG004|Part 1|Participant moved out of state|0|||
130835494|NCT02443116|471022913|FG005|Part 1|Participant moved out of state|0|||
130835495|NCT02443116|471022914|FG006|Part 1|Participant moved out of state|0|||
130835496|NCT02443116|471022915|FG007|Part 1|Participant moved out of state|0|||
130835497|NCT02443116|471022916|FG008|Part 1|Participant moved out of state|0|||
130835498|NCT02443116|471022908|FG000|Part 1|Participant enrolled in another clinical trial|0|||
130835499|NCT02443116|471022909|FG001|Part 1|Participant enrolled in another clinical trial|0|||
130835500|NCT02443116|471022910|FG002|Part 1|Participant enrolled in another clinical trial|1|||
130835501|NCT02443116|471022911|FG003|Part 1|Participant enrolled in another clinical trial|0|||
130835502|NCT02443116|471022912|FG004|Part 1|Participant enrolled in another clinical trial|0|||
130835503|NCT02443116|471022913|FG005|Part 1|Participant enrolled in another clinical trial|0|||
130835504|NCT02443116|471022914|FG006|Part 1|Participant enrolled in another clinical trial|0|||
130835505|NCT02443116|471022915|FG007|Part 1|Participant enrolled in another clinical trial|0|||
130835506|NCT02443116|471022916|FG008|Part 1|Participant enrolled in another clinical trial|0|||
130835507|NCT02443116|471022908|FG000|Part 2|Adverse Event|0|||
130835508|NCT02443116|471022909|FG001|Part 2|Adverse Event|0|||
130835509|NCT02443116|471022910|FG002|Part 2|Adverse Event|0|||
130835510|NCT02443116|471022911|FG003|Part 2|Adverse Event|0|||
130835511|NCT02443116|471022912|FG004|Part 2|Adverse Event|1|||
130835512|NCT02443116|471022913|FG005|Part 2|Adverse Event|1|||
130835513|NCT02443116|471022914|FG006|Part 2|Adverse Event|2|||
130835514|NCT02443116|471022915|FG007|Part 2|Adverse Event|0|||
130835515|NCT02443116|471022916|FG008|Part 2|Adverse Event|0|||
130835516|NCT02443116|471022908|FG000|Part 2|Withdrew informed consent|0|||
130835517|NCT02443116|471022909|FG001|Part 2|Withdrew informed consent|0|||
130835518|NCT02443116|471022910|FG002|Part 2|Withdrew informed consent|0|||
130835519|NCT02443116|471022911|FG003|Part 2|Withdrew informed consent|0|||
130835520|NCT02443116|471022912|FG004|Part 2|Withdrew informed consent|0|||
130835521|NCT02443116|471022913|FG005|Part 2|Withdrew informed consent|1|||
130835522|NCT02443116|471022914|FG006|Part 2|Withdrew informed consent|1|||
130835523|NCT02443116|471022915|FG007|Part 2|Withdrew informed consent|0|||
130835524|NCT02443116|471022916|FG008|Part 2|Withdrew informed consent|0|||
130835525|NCT02443116|471022908|FG000|Part 2|Inability to comply with protocol|0|||
130835526|NCT02443116|471022909|FG001|Part 2|Inability to comply with protocol|0|||
130835527|NCT02443116|471022910|FG002|Part 2|Inability to comply with protocol|0|||
130835528|NCT02443116|471022911|FG003|Part 2|Inability to comply with protocol|1|||
130835529|NCT02443116|471022912|FG004|Part 2|Inability to comply with protocol|0|||
130835530|NCT02443116|471022913|FG005|Part 2|Inability to comply with protocol|0|||
130835531|NCT02443116|471022914|FG006|Part 2|Inability to comply with protocol|0|||
130835532|NCT02443116|471022915|FG007|Part 2|Inability to comply with protocol|0|||
130835533|NCT02443116|471022916|FG008|Part 2|Inability to comply with protocol|0|||
130835534|NCT02443116|471022908|FG000|Part 2|Lost to Follow-up|0|||
130835535|NCT02443116|471022909|FG001|Part 2|Lost to Follow-up|0|||
130835536|NCT02443116|471022910|FG002|Part 2|Lost to Follow-up|0|||
130835537|NCT02443116|471022911|FG003|Part 2|Lost to Follow-up|1|||
130835538|NCT02443116|471022912|FG004|Part 2|Lost to Follow-up|0|||
130835539|NCT02443116|471022913|FG005|Part 2|Lost to Follow-up|0|||
130835540|NCT02443116|471022914|FG006|Part 2|Lost to Follow-up|0|||
130835541|NCT02443116|471022915|FG007|Part 2|Lost to Follow-up|0|||
130835542|NCT02443116|471022916|FG008|Part 2|Lost to Follow-up|0|||
130835543|NCT02443116|471022908|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130835544|NCT02443116|471022909|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130835545|NCT02443116|471022910|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130835546|NCT02443116|471022911|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130835547|NCT02443116|471022912|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130835548|NCT02443116|471022913|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
130835549|NCT02443116|471022914|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130835550|NCT02443116|471022915|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130835551|NCT02443116|471022916|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130835552|NCT02443116|471022908|FG000|Part 3|Adverse Event|0|||
130835553|NCT02443116|471022909|FG001|Part 3|Adverse Event|0|||
130835554|NCT02443116|471022910|FG002|Part 3|Adverse Event|0|||
130835555|NCT02443116|471022911|FG003|Part 3|Adverse Event|0|||
130835556|NCT02443116|471022912|FG004|Part 3|Adverse Event|0|||
130835557|NCT02443116|471022913|FG005|Part 3|Adverse Event|0|||
130835558|NCT02443116|471022914|FG006|Part 3|Adverse Event|0|||
130835559|NCT02443116|471022915|FG007|Part 3|Adverse Event|0|||
130835560|NCT02443116|471022916|FG008|Part 3|Adverse Event|1|||
130835561|NCT02443116|471022908|FG000|Part 3|Withdrew informed consent|0|||
130835562|NCT02443116|471022909|FG001|Part 3|Withdrew informed consent|0|||
130835563|NCT02443116|471022910|FG002|Part 3|Withdrew informed consent|0|||
130835564|NCT02443116|471022911|FG003|Part 3|Withdrew informed consent|0|||
130835565|NCT02443116|471022912|FG004|Part 3|Withdrew informed consent|0|||
130835566|NCT02443116|471022913|FG005|Part 3|Withdrew informed consent|0|||
130835567|NCT02443116|471022914|FG006|Part 3|Withdrew informed consent|0|||
130835568|NCT02443116|471022915|FG007|Part 3|Withdrew informed consent|3|||
130835569|NCT02443116|471022916|FG008|Part 3|Withdrew informed consent|2|||
130835570|NCT02443116|471022908|FG000|Part 3|Lost to Follow-up|0|||
130835571|NCT02443116|471022909|FG001|Part 3|Lost to Follow-up|0|||
130835572|NCT02443116|471022910|FG002|Part 3|Lost to Follow-up|0|||
130835573|NCT02443116|471022911|FG003|Part 3|Lost to Follow-up|0|||
130835574|NCT02443116|471022912|FG004|Part 3|Lost to Follow-up|0|||
130835575|NCT02443116|471022913|FG005|Part 3|Lost to Follow-up|0|||
130835576|NCT02443116|471022914|FG006|Part 3|Lost to Follow-up|0|||
130835577|NCT02443116|471022915|FG007|Part 3|Lost to Follow-up|1|||
130835578|NCT02443116|471022916|FG008|Part 3|Lost to Follow-up|2|||
130835579|NCT02016716|471022921|FG000|Overall Study|Withdrawal by Subject|5|||
130835580|NCT02016716|471022922|FG001|Overall Study|Withdrawal by Subject|5|||
130835581|NCT02016716|471022923|FG002|Overall Study|Withdrawal by Subject|5|||
130835582|NCT02016716|471022921|FG000|Overall Study|Protocol-specified Criteria|0|||
130835583|NCT02016716|471022922|FG001|Overall Study|Protocol-specified Criteria|1|||
130835584|NCT02016716|471022923|FG002|Overall Study|Protocol-specified Criteria|0|||
130835585|NCT02016716|471022921|FG000|Overall Study|Lost to Follow-up|1|||
130835586|NCT02016716|471022922|FG001|Overall Study|Lost to Follow-up|2|||
130835587|NCT02016716|471022923|FG002|Overall Study|Lost to Follow-up|1|||
130835588|NCT02248649|471022924|FG000|Overall Study|Death|7|||
130835589|NCT02248649|471022925|FG001|Overall Study|Death|11|||
130835590|NCT02248649|471022924|FG000|Overall Study|Lost to Follow-up|14|||
130835591|NCT02248649|471022925|FG001|Overall Study|Lost to Follow-up|10|||
130835592|NCT01439971|471022926|FG000|Overall Study|Required number in cohort dosed|0|||
130835593|NCT01439971|471022927|FG001|Overall Study|Required number in cohort dosed|1|||
130835594|NCT01439971|471022928|FG002|Overall Study|Required number in cohort dosed|2|||
130835595|NCT01439971|471022929|FG003|Overall Study|Required number in cohort dosed|0|||
130835596|NCT01439971|471022930|FG004|Overall Study|Required number in cohort dosed|1|||
130835597|NCT03479541|471022935|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
130835598|NCT03479541|471022936|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
130835599|NCT03479541|471022937|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
130835600|NCT03479541|471022938|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
130835601|NCT03479541|471022935|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
130835602|NCT03479541|471022936|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
130835603|NCT03479541|471022937|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
130835604|NCT03479541|471022938|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
130835605|NCT03479541|471022935|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
130835606|NCT03479541|471022936|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
130835607|NCT03479541|471022937|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
130835608|NCT03479541|471022938|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
130835609|NCT03479541|471022935|FG000|Home Monitoring|Lost to Follow-up|0|||
130835610|NCT03479541|471022936|FG001|Home Monitoring|Lost to Follow-up|0|||
130835611|NCT03479541|471022937|FG002|Home Monitoring|Lost to Follow-up|8|||
130835612|NCT03479541|471022938|FG003|Home Monitoring|Lost to Follow-up|12|||
130835613|NCT03479541|471022935|FG000|Home Monitoring|Withdrawal by Subject|0|||
130835614|NCT03479541|471022936|FG001|Home Monitoring|Withdrawal by Subject|0|||
130835615|NCT03479541|471022937|FG002|Home Monitoring|Withdrawal by Subject|17|||
130835616|NCT03479541|471022938|FG003|Home Monitoring|Withdrawal by Subject|30|||
130835617|NCT03479541|471022935|FG000|Home Monitoring|Early Termination - PI Decision|0|||
130835618|NCT03479541|471022936|FG001|Home Monitoring|Early Termination - PI Decision|0|||
130835619|NCT03479541|471022937|FG002|Home Monitoring|Early Termination - PI Decision|4|||
130835620|NCT03479541|471022938|FG003|Home Monitoring|Early Termination - PI Decision|6|||
130835621|NCT01673854|471022939|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
130835622|NCT01673854|471022939|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
130835623|NCT01673854|471022939|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
130835624|NCT01673854|471022939|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
130835625|NCT01673854|471022939|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
130835626|NCT01673854|471022939|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
130835627|NCT01673854|471022939|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
130835628|NCT01673854|471022939|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
130835629|NCT01673854|471022939|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
130835630|NCT01673854|471022939|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
130835631|NCT01673854|471022939|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
130835632|NCT01673854|471022939|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
130835633|NCT00107900|471022943|FG000|Overall Study|Adverse Event|3|||
130835634|NCT00107900|471022944|FG001|Overall Study|Adverse Event|2|||
130835635|NCT00107900|471022945|FG002|Overall Study|Adverse Event|10|||
130835636|NCT00107900|471022946|FG003|Overall Study|Adverse Event|3|||
130835637|NCT00107900|471022947|FG004|Overall Study|Adverse Event|5|||
130835638|NCT00107900|471022948|FG005|Overall Study|Adverse Event|3|||
130835639|NCT00107900|471022943|FG000|Overall Study|Death|0|||
130835640|NCT00107900|471022944|FG001|Overall Study|Death|0|||
130835641|NCT00107900|471022945|FG002|Overall Study|Death|0|||
130835642|NCT00107900|471022946|FG003|Overall Study|Death|0|||
130835643|NCT00107900|471022947|FG004|Overall Study|Death|1|||
130835644|NCT00107900|471022948|FG005|Overall Study|Death|0|||
130835645|NCT00107900|471022943|FG000|Overall Study|Lost to Follow-up|4|||
130835646|NCT00107900|471022944|FG001|Overall Study|Lost to Follow-up|1|||
130835647|NCT00107900|471022945|FG002|Overall Study|Lost to Follow-up|3|||
130835648|NCT00107900|471022946|FG003|Overall Study|Lost to Follow-up|2|||
130835649|NCT00107900|471022947|FG004|Overall Study|Lost to Follow-up|5|||
130835650|NCT00107900|471022948|FG005|Overall Study|Lost to Follow-up|5|||
130835651|NCT00107900|471022943|FG000|Overall Study|Protocol Violation|1|||
130835652|NCT00107900|471022944|FG001|Overall Study|Protocol Violation|0|||
130835653|NCT00107900|471022945|FG002|Overall Study|Protocol Violation|5|||
130835654|NCT00107900|471022946|FG003|Overall Study|Protocol Violation|5|||
130835655|NCT00107900|471022947|FG004|Overall Study|Protocol Violation|7|||
130835656|NCT00107900|471022948|FG005|Overall Study|Protocol Violation|0|||
130835657|NCT00107900|471022943|FG000|Overall Study|Withdrawal by Subject|1|||
130835658|NCT00107900|471022944|FG001|Overall Study|Withdrawal by Subject|0|||
130835659|NCT00107900|471022945|FG002|Overall Study|Withdrawal by Subject|5|||
130835660|NCT00107900|471022946|FG003|Overall Study|Withdrawal by Subject|0|||
130835661|NCT00107900|471022947|FG004|Overall Study|Withdrawal by Subject|1|||
130835662|NCT00107900|471022948|FG005|Overall Study|Withdrawal by Subject|1|||
130835663|NCT00107900|471022943|FG000|Overall Study|Administrative Reasons|1|||
130835664|NCT00107900|471022944|FG001|Overall Study|Administrative Reasons|0|||
130835665|NCT00107900|471022945|FG002|Overall Study|Administrative Reasons|2|||
130835666|NCT00107900|471022946|FG003|Overall Study|Administrative Reasons|2|||
130835667|NCT00107900|471022947|FG004|Overall Study|Administrative Reasons|2|||
130835668|NCT00107900|471022948|FG005|Overall Study|Administrative Reasons|0|||
130835669|NCT00830375|471022952|FG000|Overall Study|Lost to Follow-up|1|||
130835670|NCT01700959|471022953|FG000|Overall Study|Adverse Event|0|||
130835671|NCT01700959|471022954|FG001|Overall Study|Adverse Event|1|||
130835672|NCT01700959|471022955|FG002|Overall Study|Adverse Event|1|||
130835673|NCT01700959|471022956|FG003|Overall Study|Adverse Event|2|||
130835674|NCT01700959|471022957|FG004|Overall Study|Adverse Event|0|||
130835675|NCT01700959|471022958|FG005|Overall Study|Adverse Event|2|||
130835676|NCT01700959|471022953|FG000|Overall Study|Withdrawal by Subject|15|||
130835677|NCT01700959|471022954|FG001|Overall Study|Withdrawal by Subject|9|||
130835678|NCT01700959|471022955|FG002|Overall Study|Withdrawal by Subject|12|||
130835679|NCT01700959|471022956|FG003|Overall Study|Withdrawal by Subject|11|||
130835680|NCT01700959|471022957|FG004|Overall Study|Withdrawal by Subject|8|||
130835681|NCT01700959|471022958|FG005|Overall Study|Withdrawal by Subject|12|||
130835682|NCT01700959|471022953|FG000|Overall Study|Ineligible|2|||
130835683|NCT01700959|471022954|FG001|Overall Study|Ineligible|1|||
130835684|NCT01700959|471022955|FG002|Overall Study|Ineligible|2|||
130835685|NCT01700959|471022956|FG003|Overall Study|Ineligible|0|||
130835686|NCT01700959|471022957|FG004|Overall Study|Ineligible|0|||
130835687|NCT01700959|471022958|FG005|Overall Study|Ineligible|1|||
130835688|NCT01700959|471022953|FG000|Overall Study|Noncompliant|9|||
130835689|NCT01700959|471022954|FG001|Overall Study|Noncompliant|9|||
130835690|NCT01700959|471022955|FG002|Overall Study|Noncompliant|17|||
130835691|NCT01700959|471022956|FG003|Overall Study|Noncompliant|18|||
130835692|NCT01700959|471022957|FG004|Overall Study|Noncompliant|15|||
130835693|NCT01700959|471022958|FG005|Overall Study|Noncompliant|9|||
130835694|NCT01700959|471022953|FG000|Overall Study|Side effects|1|||
130835695|NCT01700959|471022954|FG001|Overall Study|Side effects|4|||
130835696|NCT01700959|471022955|FG002|Overall Study|Side effects|8|||
130835697|NCT01700959|471022956|FG003|Overall Study|Side effects|4|||
130835698|NCT01700959|471022957|FG004|Overall Study|Side effects|4|||
130835699|NCT01700959|471022958|FG005|Overall Study|Side effects|1|||
130835700|NCT00875485|471026137|FG000|Challenge Dose Epoch|Pregnancy|1|||
130835701|NCT00875485|471026138|FG001|Challenge Dose Epoch|Pregnancy|0|||
130835702|NCT01271010|471026139|FG000|Overall Study|Reason not specified|11|||
130835703|NCT01271010|471026139|FG000|Overall Study|Start of new CLL therapy|1|||
130835704|NCT01271010|471026139|FG000|Overall Study|Protocol Violation|1|||
130835705|NCT01271010|471026139|FG000|Overall Study|Death|2|||
130835706|NCT01271010|471026139|FG000|Overall Study|Progression and relapse of disease|1|||
130835707|NCT01271010|471026139|FG000|Overall Study|Withdrawal by Subject|18|||
130835708|NCT01271010|471026139|FG000|Overall Study|Disease progression|27|||
130835709|NCT01631747|471026140|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
130835710|NCT01631747|471026141|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
130835711|NCT01631747|471026140|FG000|Live Birth|Pregnancy Termination|1|||
130835712|NCT01631747|471026141|FG001|Live Birth|Pregnancy Termination|0|||
130835713|NCT01631747|471026140|FG000|Live Birth|MIscarriage|2|||
130835714|NCT01631747|471026141|FG001|Live Birth|MIscarriage|0|||
130835715|NCT01631747|471026140|FG000|Live Birth|Stillbirth|1|||
130835716|NCT01631747|471026141|FG001|Live Birth|Stillbirth|1|||
130835717|NCT01631747|471026140|FG000|One Year Infant Outcomes|Patient Refused|13|||
130835718|NCT01631747|471026141|FG001|One Year Infant Outcomes|Patient Refused|9|||
130835719|NCT01456195|471026142|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130835720|NCT01456195|471026143|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
130835721|NCT01456195|471026144|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
130835722|NCT01456195|471026142|FG000|Overall Study|Lost to Follow-up|3|||
130835723|NCT01456195|471026143|FG001|Overall Study|Lost to Follow-up|1|||
130835724|NCT01456195|471026144|FG002|Overall Study|Lost to Follow-up|3|||
130835725|NCT01456195|471026142|FG000|Overall Study|Voluntary Withdrawal|5|||
130835726|NCT01456195|471026143|FG001|Overall Study|Voluntary Withdrawal|3|||
130835727|NCT01456195|471026144|FG002|Overall Study|Voluntary Withdrawal|7|||
130835728|NCT01456195|471026142|FG000|Overall Study|Lack of Efficacy|0|||
130835729|NCT01456195|471026143|FG001|Overall Study|Lack of Efficacy|1|||
130835730|NCT01456195|471026144|FG002|Overall Study|Lack of Efficacy|0|||
130835731|NCT01456195|471026142|FG000|Overall Study|Other Reasons|2|||
130835732|NCT01456195|471026143|FG001|Overall Study|Other Reasons|1|||
130835733|NCT01456195|471026144|FG002|Overall Study|Other Reasons|3|||
130835734|NCT03100539|471026153|FG000|Overall Study|Lost to Follow-up|60|||
130835735|NCT03100539|471026154|FG001|Overall Study|Lost to Follow-up|54|||
130835736|NCT03100539|471026155|FG002|Overall Study|Lost to Follow-up|17|||
130835737|NCT03100539|471026153|FG000|Overall Study|Uncollected|8|||
130835738|NCT03100539|471026154|FG001|Overall Study|Uncollected|8|||
130835739|NCT03100539|471026155|FG002|Overall Study|Uncollected|0|||
130835740|NCT03100539|471026153|FG000|Overall Study|Ally Health|0|||
130835741|NCT03100539|471026154|FG001|Overall Study|Ally Health|0|||
130835742|NCT03100539|471026155|FG002|Overall Study|Ally Health|3|||
130835743|NCT03100539|471026153|FG000|Overall Study|Disinterest|0|||
130835744|NCT03100539|471026154|FG001|Overall Study|Disinterest|0|||
130835745|NCT03100539|471026155|FG002|Overall Study|Disinterest|22|||
130835746|NCT03100539|471026153|FG000|Overall Study|Veteran Health|0|||
130835747|NCT03100539|471026154|FG001|Overall Study|Veteran Health|0|||
130835748|NCT03100539|471026155|FG002|Overall Study|Veteran Health|8|||
130835749|NCT03100539|471026153|FG000|Overall Study|Moved|0|||
130835750|NCT03100539|471026154|FG001|Overall Study|Moved|0|||
130835751|NCT03100539|471026155|FG002|Overall Study|Moved|1|||
130835752|NCT03100539|471026153|FG000|Overall Study|Scheduling Conflicts|0|||
130835753|NCT03100539|471026154|FG001|Overall Study|Scheduling Conflicts|0|||
130835754|NCT03100539|471026155|FG002|Overall Study|Scheduling Conflicts|12|||
130835755|NCT00809835|471026158|FG000|Overall Study|Lost to Follow-up|7|||
130835756|NCT00809835|471026159|FG001|Overall Study|Lost to Follow-up|6|||
130835757|NCT00809835|471026160|FG002|Overall Study|Lost to Follow-up|10|||
130835758|NCT00809835|471026161|FG003|Overall Study|Lost to Follow-up|2|||
130835759|NCT00809835|471026158|FG000|Overall Study|Withdrawal by Subject|1|||
130835760|NCT00809835|471026159|FG001|Overall Study|Withdrawal by Subject|1|||
130835761|NCT00809835|471026160|FG002|Overall Study|Withdrawal by Subject|1|||
130835762|NCT00809835|471026161|FG003|Overall Study|Withdrawal by Subject|0|||
130835763|NCT05659719|471026162|FG000|Overall Study|At sponsor's request|0|||
130835764|NCT05659719|471026163|FG001|Overall Study|At sponsor's request|0|||
130835765|NCT05659719|471026164|FG002|Overall Study|At sponsor's request|0|||
130835766|NCT05659719|471026165|FG003|Overall Study|At sponsor's request|95|||
130835767|NCT05659719|471026162|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
130835768|NCT05659719|471026163|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
130835769|NCT05659719|471026164|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
130835770|NCT05659719|471026165|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
130835771|NCT05659719|471026162|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
130835772|NCT05659719|471026163|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
130835773|NCT05659719|471026164|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
130835774|NCT05659719|471026165|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
130835775|NCT05659719|471026162|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
130835776|NCT05659719|471026163|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
130835777|NCT05659719|471026164|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
130835778|NCT05659719|471026165|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
130835779|NCT05659719|471026162|FG000|Overall Study|Lost to Follow-up|0|||
130835780|NCT05659719|471026163|FG001|Overall Study|Lost to Follow-up|0|||
130835781|NCT05659719|471026164|FG002|Overall Study|Lost to Follow-up|0|||
130835782|NCT05659719|471026165|FG003|Overall Study|Lost to Follow-up|2|||
130835783|NCT05659719|471026162|FG000|Overall Study|Moved to another observational study|0|||
130835784|NCT05659719|471026163|FG001|Overall Study|Moved to another observational study|0|||
130835785|NCT05659719|471026164|FG002|Overall Study|Moved to another observational study|0|||
130835786|NCT05659719|471026165|FG003|Overall Study|Moved to another observational study|1|||
130835787|NCT05659719|471026162|FG000|Overall Study|The child was enrolled in an interventional study|0|||
130835788|NCT05659719|471026163|FG001|Overall Study|The child was enrolled in an interventional study|0|||
130835789|NCT05659719|471026164|FG002|Overall Study|The child was enrolled in an interventional study|0|||
130835790|NCT05659719|471026165|FG003|Overall Study|The child was enrolled in an interventional study|55|||
130835791|NCT05659719|471026162|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
130835792|NCT05659719|471026163|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
130835793|NCT05659719|471026164|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
130835794|NCT05659719|471026165|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
130835795|NCT05659719|471026162|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
130835796|NCT05659719|471026163|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
130835797|NCT05659719|471026164|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
130835798|NCT05659719|471026165|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
130835799|NCT01681186|471026166|FG000|Washout Period From Second Intervention|Adverse Event|0|||
130835800|NCT01681186|471026167|FG001|Washout Period From Second Intervention|Adverse Event|0|||
130835801|NCT01681186|471026168|FG002|Washout Period From Second Intervention|Adverse Event|0|||
130835802|NCT01681186|471026169|FG003|Washout Period From Second Intervention|Adverse Event|0|||
130835803|NCT01681186|471026170|FG004|Washout Period From Second Intervention|Adverse Event|0|||
130835804|NCT01681186|471026171|FG005|Washout Period From Second Intervention|Adverse Event|0|||
130835805|NCT01681186|471026172|FG006|Washout Period From Second Intervention|Adverse Event|1|||
130835806|NCT01681186|471026173|FG007|Washout Period From Second Intervention|Adverse Event|0|||
130835807|NCT01681186|471026166|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
130835808|NCT01681186|471026167|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
130835809|NCT01681186|471026168|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
130835810|NCT01681186|471026169|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
130835811|NCT01681186|471026170|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
130835812|NCT01681186|471026171|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
130835813|NCT01681186|471026172|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
130835814|NCT01681186|471026173|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
130835815|NCT01681186|471026166|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
130835816|NCT01681186|471026167|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
130835817|NCT01681186|471026168|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
130835818|NCT01681186|471026169|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
130835819|NCT01681186|471026170|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
130835820|NCT01681186|471026171|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
130835821|NCT01681186|471026172|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
130835822|NCT01681186|471026173|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
130835823|NCT01681186|471026166|FG000|Fourth Intervention|Protocol Violation|0|||
130835824|NCT01681186|471026167|FG001|Fourth Intervention|Protocol Violation|0|||
130835825|NCT01681186|471026168|FG002|Fourth Intervention|Protocol Violation|0|||
130835826|NCT01681186|471026169|FG003|Fourth Intervention|Protocol Violation|0|||
130835827|NCT01681186|471026170|FG004|Fourth Intervention|Protocol Violation|0|||
130835828|NCT01681186|471026171|FG005|Fourth Intervention|Protocol Violation|0|||
130835829|NCT01681186|471026172|FG006|Fourth Intervention|Protocol Violation|0|||
130835830|NCT01681186|471026173|FG007|Fourth Intervention|Protocol Violation|1|||
130835831|NCT05160415|471026174|FG000|Overall Study|Withdrawal by Subject|3|||
130835832|NCT02582814|471026175|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130835833|NCT02582814|471026176|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130835834|NCT02582814|471026175|FG000|Overall Study|Withdrawal by Subject|4|||
130835835|NCT02582814|471026176|FG001|Overall Study|Withdrawal by Subject|3|||
130835836|NCT02582814|471026175|FG000|Overall Study|Adverse Event|4|||
130835837|NCT02582814|471026176|FG001|Overall Study|Adverse Event|4|||
130835838|NCT03530995|471026177|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
130835839|NCT03530995|471026178|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
130835840|NCT03530995|471026177|FG000|Part 1 Period 3|Protocol Violation|1|||
130835841|NCT03530995|471026178|FG001|Part 1 Period 3|Protocol Violation|0|||
130835842|NCT03530995|471026177|FG000|Part 1 Period 4|Physician Decision|1|||
130835843|NCT03530995|471026178|FG001|Part 1 Period 4|Physician Decision|0|||
130835844|NCT03530995|471026177|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
130835845|NCT03530995|471026178|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
130835846|NCT04848220|471026182|FG000|Overall Study|Unable to proceed to study procedure|0|||
130835847|NCT04848220|471026183|FG001|Overall Study|Unable to proceed to study procedure|1|||
130835848|NCT04848220|471026184|FG002|Overall Study|Unable to proceed to study procedure|0|||
130835849|NCT04848220|471026182|FG000|Overall Study|Fractional flow not significant|0|||
130835850|NCT04848220|471026183|FG001|Overall Study|Fractional flow not significant|1|||
130835851|NCT04848220|471026184|FG002|Overall Study|Fractional flow not significant|0|||
130835852|NCT01986231|471026185|FG000|Overall Study|Adverse Event|1|||
130835853|NCT02923830|471026186|FG000|Overall Study|Physician Decision|13|||
130835854|NCT02923830|471026187|FG001|Overall Study|Physician Decision|15|||
130835855|NCT00623233|471026188|FG000|Overall Study|Adverse Event|10|||
130835856|NCT00623233|471026188|FG000|Overall Study|Physician Decision|10|||
130835857|NCT00623233|471026188|FG000|Overall Study|Lost to Follow-up|1|||
130835858|NCT00623233|471026188|FG000|Overall Study|Withdrawal by Subject|3|||
130835859|NCT01751906|471026189|FG000|Overall Study|Lost to Follow-up|151|||
130835860|NCT01751906|471026190|FG001|Overall Study|Lost to Follow-up|68|||
130835861|NCT01751906|471026189|FG000|Overall Study|Withdrawal by Subject|22|||
130835862|NCT01751906|471026190|FG001|Overall Study|Withdrawal by Subject|18|||
130835863|NCT01751906|471026189|FG000|Overall Study|Physician Decision|5|||
130835864|NCT01751906|471026190|FG001|Overall Study|Physician Decision|2|||
130835865|NCT01751906|471026189|FG000|Overall Study|Death|84|||
130835866|NCT01751906|471026190|FG001|Overall Study|Death|43|||
130835867|NCT01751906|471026189|FG000|Overall Study|Denied on premises for follow-up by law|1|||
130835868|NCT01751906|471026190|FG001|Overall Study|Denied on premises for follow-up by law|0|||
130835869|NCT01110330|471026191|FG000|Overall Study|Adverse Event|0|||
130835870|NCT01110330|471026192|FG001|Overall Study|Adverse Event|4|||
130835871|NCT01110330|471026193|FG002|Overall Study|Adverse Event|3|||
130835872|NCT01110330|471026191|FG000|Overall Study|Lack of Efficacy|3|||
130835873|NCT01110330|471026192|FG001|Overall Study|Lack of Efficacy|1|||
130835874|NCT01110330|471026193|FG002|Overall Study|Lack of Efficacy|1|||
130835875|NCT01110330|471026191|FG000|Overall Study|Lost to Follow-up|9|||
130835876|NCT01110330|471026192|FG001|Overall Study|Lost to Follow-up|10|||
130835877|NCT01110330|471026193|FG002|Overall Study|Lost to Follow-up|15|||
130835878|NCT01110330|471026191|FG000|Overall Study|Physician Decision|0|||
130835879|NCT01110330|471026192|FG001|Overall Study|Physician Decision|1|||
130835880|NCT01110330|471026193|FG002|Overall Study|Physician Decision|0|||
130835881|NCT01110330|471026191|FG000|Overall Study|Protocol Violation|2|||
130835882|NCT01110330|471026192|FG001|Overall Study|Protocol Violation|0|||
130835883|NCT01110330|471026193|FG002|Overall Study|Protocol Violation|4|||
130835884|NCT01110330|471026191|FG000|Overall Study|Withdrawal by Subject|0|||
130835885|NCT01110330|471026192|FG001|Overall Study|Withdrawal by Subject|6|||
130835886|NCT01110330|471026193|FG002|Overall Study|Withdrawal by Subject|2|||
130835887|NCT01110330|471026191|FG000|Overall Study|Other|1|||
130835888|NCT01110330|471026192|FG001|Overall Study|Other|1|||
130835889|NCT01110330|471026193|FG002|Overall Study|Other|1|||
130835890|NCT02557100|471026194|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
130835891|NCT02557100|471026195|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
130835892|NCT02557100|471026196|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
130835893|NCT02557100|471026194|FG000|Single Blind Treatment Period|Death|0|||
130835894|NCT02557100|471026195|FG001|Single Blind Treatment Period|Death|1|||
130835895|NCT02557100|471026196|FG002|Single Blind Treatment Period|Death|0|||
130835896|NCT02557100|471026194|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
130835897|NCT02557100|471026195|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
130835898|NCT02557100|471026196|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
130835899|NCT02557100|471026194|FG000|Single Blind Treatment Period|Adverse Event|0|||
130835900|NCT02557100|471026195|FG001|Single Blind Treatment Period|Adverse Event|1|||
130835901|NCT02557100|471026196|FG002|Single Blind Treatment Period|Adverse Event|0|||
130835902|NCT02557100|471026194|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
130835903|NCT02557100|471026195|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
130835904|NCT02557100|471026196|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
130835905|NCT02557100|471026194|FG000|Cumulative Abatacept Period|Other Reasons|0|||
130835906|NCT02557100|471026195|FG001|Cumulative Abatacept Period|Other Reasons|0|||
130835907|NCT02557100|471026196|FG002|Cumulative Abatacept Period|Other Reasons|1|||
130835908|NCT02557100|471026194|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
130835909|NCT02557100|471026195|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
130835910|NCT02557100|471026196|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
130835911|NCT02557100|471026194|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
130835912|NCT02557100|471026195|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
130835913|NCT02557100|471026196|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
130835914|NCT00510718|471026197|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
130835915|NCT00510718|471026198|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
130835916|NCT00510718|471026197|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
130835917|NCT00510718|471026198|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
130835918|NCT00510718|471026197|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
130835919|NCT00510718|471026198|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
130835920|NCT00510718|471026197|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
130835921|NCT00510718|471026198|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
130835922|NCT00510718|471026197|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
130835923|NCT00510718|471026198|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
130835924|NCT00510718|471026197|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
130835925|NCT00510718|471026198|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
130835926|NCT02150057|471026208|FG000|Overall Study|Lost to Follow-up|6|||
130835927|NCT02150057|471026209|FG001|Overall Study|Lost to Follow-up|4|||
130835928|NCT00489424|471026210|FG000|Overall Study|Adverse Event|3|||
130835929|NCT00489424|471026211|FG001|Overall Study|Adverse Event|3|||
130835930|NCT00489424|471026212|FG002|Overall Study|Adverse Event|4|||
130835931|NCT00489424|471026210|FG000|Overall Study|Lack of Efficacy|1|||
130835932|NCT00489424|471026211|FG001|Overall Study|Lack of Efficacy|0|||
130835933|NCT00489424|471026212|FG002|Overall Study|Lack of Efficacy|0|||
130835934|NCT00489424|471026210|FG000|Overall Study|Administrative problems|0|||
130835935|NCT00489424|471026211|FG001|Overall Study|Administrative problems|2|||
130835936|NCT00489424|471026212|FG002|Overall Study|Administrative problems|1|||
130835937|NCT00394251|471026213|FG000|Overall Study|Adverse Event|7|||
130835938|NCT00394251|471026214|FG001|Overall Study|Adverse Event|5|||
130835939|NCT00394251|471026213|FG000|Overall Study|Unacceptable Toxicity|20|||
130835940|NCT00394251|471026214|FG001|Overall Study|Unacceptable Toxicity|18|||
130835941|NCT00394251|471026213|FG000|Overall Study|Physician Decision|1|||
130835942|NCT00394251|471026214|FG001|Overall Study|Physician Decision|1|||
130835943|NCT00394251|471026213|FG000|Overall Study|Protocol Violation|0|||
130835944|NCT00394251|471026214|FG001|Overall Study|Protocol Violation|1|||
130835945|NCT00394251|471026213|FG000|Overall Study|Withdrawal by Subject|7|||
130835946|NCT00394251|471026214|FG001|Overall Study|Withdrawal by Subject|11|||
130835947|NCT00394251|471026213|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
130835948|NCT00394251|471026214|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
130835949|NCT05791565|471026215|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
130835950|NCT05791565|471026216|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
130835951|NCT01558115|471026217|FG000|Overall Study|Withdrawal by Subject|3|||
130835952|NCT01558115|471026217|FG000|Overall Study|Study closed due to poor enrollment|4|||
130835953|NCT01696994|471026218|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
130835954|NCT01696994|471026219|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
130835955|NCT01696994|471026218|FG000|Overall Study|Died Before Randomization|1|||
130835956|NCT01696994|471026219|FG001|Overall Study|Died Before Randomization|2|||
130835957|NCT01696994|471026218|FG000|Overall Study|Died Before ASU (Control)|73|||
130835958|NCT01696994|471026219|FG001|Overall Study|Died Before ASU (Control)|0|||
130835959|NCT01696994|471026218|FG000|Overall Study|No Ovaries at Baseline|4807|||
130835960|NCT01696994|471026219|FG001|Overall Study|No Ovaries at Baseline|4851|||
130835961|NCT01696994|471026218|FG000|Overall Study|Refused ASU (Control)|311|||
130835962|NCT01696994|471026219|FG001|Overall Study|Refused ASU (Control)|0|||
130835963|NCT01696994|471026218|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
130835964|NCT01696994|471026219|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
130835965|NCT04644276|471026220|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
130835966|NCT04644276|471026221|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
130835967|NCT04644276|471026222|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
130835968|NCT02388165|471026223|FG000|Overall Study|Study terminated by sponsor|5|||
130835969|NCT02388165|471026224|FG001|Overall Study|Study terminated by sponsor|5|||
130835970|NCT02388165|471026223|FG000|Overall Study|Other|11|||
130835971|NCT02388165|471026224|FG001|Overall Study|Other|13|||
130835972|NCT02388165|471026223|FG000|Overall Study|No longer meet eligibility criteria|40|||
130835973|NCT02388165|471026224|FG001|Overall Study|No longer meet eligibility criteria|43|||
130835974|NCT02388165|471026223|FG000|Overall Study|Withdrawal of consent|31|||
130835975|NCT02388165|471026224|FG001|Overall Study|Withdrawal of consent|32|||
130835976|NCT02388165|471026223|FG000|Overall Study|Lost to Follow-up|19|||
130835977|NCT02388165|471026224|FG001|Overall Study|Lost to Follow-up|20|||
130835978|NCT02388165|471026223|FG000|Overall Study|Death|13|||
130835979|NCT02388165|471026224|FG001|Overall Study|Death|10|||
130835980|NCT02388165|471026223|FG000|Overall Study|Adverse Event|3|||
130835981|NCT02388165|471026224|FG001|Overall Study|Adverse Event|5|||
130835982|NCT02388165|471026223|FG000|Overall Study|Did not meet entrance criteria|5|||
130835983|NCT02388165|471026224|FG001|Overall Study|Did not meet entrance criteria|2|||
130835984|NCT00705250|471026225|FG000|Overall Study|Withdrawal by Subject|1|||
130835985|NCT00705250|471026225|FG000|Overall Study|Patient died in car accident|1|||
130835986|NCT00880269|471026226|FG000|Overall Study|Protocol Violation|1|||
130835987|NCT00880269|471026227|FG001|Overall Study|Protocol Violation|0|||
130835988|NCT00880269|471026226|FG000|Overall Study|Disease Progression|13|||
130835989|NCT00880269|471026227|FG001|Overall Study|Disease Progression|11|||
130835990|NCT00880269|471026226|FG000|Overall Study|New Cancer Therapy|1|||
130835991|NCT00880269|471026227|FG001|Overall Study|New Cancer Therapy|0|||
130835992|NCT00880269|471026226|FG000|Overall Study|Death|4|||
130835993|NCT00880269|471026227|FG001|Overall Study|Death|2|||
130835994|NCT00880269|471026226|FG000|Overall Study|Lost to Follow-up|0|||
130835995|NCT00880269|471026227|FG001|Overall Study|Lost to Follow-up|1|||
130835996|NCT00880269|471026226|FG000|Overall Study|Withdrawal by Subject|3|||
130835997|NCT00880269|471026227|FG001|Overall Study|Withdrawal by Subject|4|||
130835998|NCT00880269|471026226|FG000|Overall Study|Adverse Event|10|||
130835999|NCT00880269|471026227|FG001|Overall Study|Adverse Event|9|||
130836000|NCT01576146|471026228|FG000|Extension Period 1|Adverse Event|2|||
130836001|NCT01576146|471026228|FG000|Extension Period 1|Death|2|||
130836002|NCT01576146|471026228|FG000|Extension Period 1|Physician Decision|2|||
130836003|NCT01576146|471026228|FG000|Extension Period 1|Withdrawal by Subject|1|||
130836004|NCT01576146|471026228|FG000|Extension Period 1|Lost to Follow-up|1|||
130836005|NCT01576146|471026228|FG000|Extension Period 1|Parathyroidectomy|1|||
130836006|NCT01576146|471026228|FG000|Extension Period 1|Renal Transplant|1|||
130836007|NCT01576146|471026228|FG000|Extension Period 2|Sponsor Decision|13|||
130836008|NCT01576146|471026228|FG000|Extension Period 2|Death|1|||
130836009|NCT01576146|471026228|FG000|Extension Period 2|Adverse Event|1|||
130836010|NCT01576146|471026228|FG000|Extension Period 2|Renal Transplant|1|||
130836011|NCT01576146|471026228|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
130836012|NCT01667224|471026230|FG000|Overall Study|Withdrawal by Subject|3|||
130836013|NCT01667224|471026231|FG001|Overall Study|Withdrawal by Subject|1|||
130836014|NCT01667224|471026230|FG000|Overall Study|Protocol Violation|1|||
130836015|NCT01667224|471026231|FG001|Overall Study|Protocol Violation|1|||
130836016|NCT00316225|471026234|FG000|Overall Study|Adverse Event|2|||
130836017|NCT00316225|471026234|FG000|Overall Study|Physician Decision|3|||
130836018|NCT00316225|471026234|FG000|Overall Study|Progressive Disease|15|||
130836019|NCT00316225|471026234|FG000|Overall Study|Withdrawal by Subject|3|||
130836020|NCT00316225|471026234|FG000|Overall Study|Death|2|||
130836021|NCT01811485|471026235|FG000|Overall Study|Adverse Event|1|||
130836022|NCT01811485|471026236|FG001|Overall Study|Adverse Event|3|||
130836023|NCT01811485|471026237|FG002|Overall Study|Adverse Event|2|||
130836024|NCT01811485|471026235|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130836025|NCT01811485|471026236|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130836026|NCT01811485|471026237|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
130836027|NCT01811485|471026235|FG000|Overall Study|Administrative problems|1|||
130836028|NCT01811485|471026236|FG001|Overall Study|Administrative problems|0|||
130836029|NCT01811485|471026237|FG002|Overall Study|Administrative problems|0|||
130836030|NCT01811485|471026235|FG000|Overall Study|Protocol Deviation|0|||
130836031|NCT01811485|471026236|FG001|Overall Study|Protocol Deviation|1|||
130836032|NCT01811485|471026237|FG002|Overall Study|Protocol Deviation|0|||
130836033|NCT01545934|471026238|FG000|Overall Study|Withdrawal by Subject|4|||
130836034|NCT01545934|471026239|FG001|Overall Study|Withdrawal by Subject|3|||
130836035|NCT01545934|471026238|FG000|Overall Study|Lost to Follow-up|1|||
130836036|NCT01545934|471026239|FG001|Overall Study|Lost to Follow-up|0|||
130836037|NCT03654404|471026240|FG000|Overall Study|Death|1|||
130836038|NCT03654404|471026240|FG000|Overall Study|Lost to Follow-up|2|||
130836039|NCT03654404|471026240|FG000|Overall Study|Withdrawal by Subject|5|||
130836040|NCT03215758|471026245|FG000|Overall Study|Technical Problems|1|||
130836041|NCT03215758|471026246|FG001|Overall Study|Technical Problems|0|||
130836042|NCT03215758|471026245|FG000|Overall Study|Protocol deviation|0|||
130836043|NCT03215758|471026246|FG001|Overall Study|Protocol deviation|1|||
130836044|NCT03215758|471026245|FG000|Overall Study|Physician Decision|0|||
130836045|NCT03215758|471026246|FG001|Overall Study|Physician Decision|1|||
130836046|NCT03215758|471026245|FG000|Overall Study|Death|0|||
130836047|NCT03215758|471026246|FG001|Overall Study|Death|1|||
130836048|NCT03215758|471026245|FG000|Overall Study|Adverse Event|1|||
130836049|NCT03215758|471026246|FG001|Overall Study|Adverse Event|2|||
130836050|NCT03215758|471026245|FG000|Overall Study|Subject/Guardian Decision|3|||
130836051|NCT03215758|471026246|FG001|Overall Study|Subject/Guardian Decision|3|||
130836052|NCT02003638|471026252|FG000|Overall Study|Withdrawal by Subject|1|||
130836053|NCT02003638|471026253|FG001|Overall Study|Withdrawal by Subject|0|||
130836054|NCT04115748|471026254|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
130836055|NCT04115748|471026255|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
130836056|NCT04115748|471026256|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
130836057|NCT04115748|471026257|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
130836058|NCT04115748|471026258|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130836059|NCT04115748|471026259|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130836060|NCT04115748|471026260|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130836061|NCT04115748|471026261|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130836062|NCT04115748|471026262|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130836063|NCT04115748|471026263|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130836064|NCT04115748|471026254|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130836065|NCT04115748|471026255|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130836066|NCT04115748|471026256|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130836067|NCT04115748|471026257|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
130836068|NCT04115748|471026258|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130836069|NCT04115748|471026259|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130836070|NCT04115748|471026260|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130836071|NCT04115748|471026261|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130836072|NCT04115748|471026262|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130836073|NCT04115748|471026263|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130836074|NCT04115748|471026254|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130836075|NCT04115748|471026255|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130836076|NCT04115748|471026256|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130836077|NCT04115748|471026257|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130836078|NCT04115748|471026258|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
130836079|NCT04115748|471026259|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
130836080|NCT04115748|471026260|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
130836081|NCT04115748|471026261|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
130836082|NCT04115748|471026262|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
130836083|NCT04115748|471026263|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
130836084|NCT04115748|471026254|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130836085|NCT04115748|471026255|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130836086|NCT04115748|471026256|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130836087|NCT04115748|471026257|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130836088|NCT04115748|471026258|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130836089|NCT04115748|471026259|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130836090|NCT04115748|471026260|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130836091|NCT04115748|471026261|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130836092|NCT04115748|471026262|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
130836093|NCT04115748|471026263|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130836094|NCT00713349|471026264|FG000|Overall Study|Protocol Violation|1|||
130836095|NCT03764631|471026265|FG000|Overall Study|Personal Reasons|3|||
130836096|NCT03764631|471026266|FG001|Overall Study|Personal Reasons|2|||
130836097|NCT03764631|471026265|FG000|Overall Study|Switching Therapy|3|||
130836098|NCT03764631|471026266|FG001|Overall Study|Switching Therapy|3|||
130836099|NCT03764631|471026265|FG000|Overall Study|Adverse Event|0|||
130836100|NCT03764631|471026266|FG001|Overall Study|Adverse Event|1|||
130836101|NCT03764631|471026265|FG000|Overall Study|Lost to Follow-up|33|||
130836102|NCT03764631|471026266|FG001|Overall Study|Lost to Follow-up|41|||
130836103|NCT03764631|471026265|FG000|Overall Study|No data as study site was closed|2|||
130836104|NCT03764631|471026266|FG001|Overall Study|No data as study site was closed|6|||
130836105|NCT01200407|471026267|FG000|Overall Study|Lost to Follow-up|56|||
130836106|NCT01200407|471026267|FG000|Overall Study|Adverse Event|3|||
130836107|NCT01200407|471026267|FG000|Overall Study|Withdrawal by Subject|4|||
130836108|NCT01200407|471026267|FG000|Overall Study|Other|19|||
130836109|NCT03299881|471026268|FG000|Overall Study|Study Termination|17|||
130836110|NCT03299881|471026269|FG001|Overall Study|Study Termination|13|||
130836111|NCT02314156|471026273|FG000|Overall Study|Adverse Event|1|||
130836112|NCT02314156|471026274|FG001|Overall Study|Adverse Event|0|||
130836113|NCT02314156|471026273|FG000|Overall Study|Withdrawal by Subject|1|||
130836114|NCT02314156|471026274|FG001|Overall Study|Withdrawal by Subject|0|||
130836115|NCT02752633|471026275|FG000|Overall Study|Withdrawal by Subject|1|||
130836116|NCT02846389|471026276|FG000|Overall Study|Withdrawal by Subject|1|||
130836117|NCT02846389|471026277|FG001|Overall Study|Withdrawal by Subject|1|||
130836118|NCT01450696|471026278|FG000|Overall Study|Never Treated|1|||
130836119|NCT01450696|471026279|FG001|Overall Study|Never Treated|1|||
130836120|NCT01450696|471026278|FG000|Overall Study|Death|77|||
130836121|NCT01450696|471026279|FG001|Overall Study|Death|84|||
130836122|NCT01450696|471026278|FG000|Overall Study|Lost to Follow-up|3|||
130836123|NCT01450696|471026279|FG001|Overall Study|Lost to Follow-up|3|||
130836124|NCT01450696|471026278|FG000|Overall Study|Non-Compliance|1|||
130836125|NCT01450696|471026279|FG001|Overall Study|Non-Compliance|0|||
130836126|NCT01450696|471026278|FG000|Overall Study|Withdrawal by Subject|13|||
130836127|NCT01450696|471026279|FG001|Overall Study|Withdrawal by Subject|2|||
130836128|NCT01450696|471026278|FG000|Overall Study|Study Terminated by Sponsor|53|||
130836129|NCT01450696|471026279|FG001|Overall Study|Study Terminated by Sponsor|58|||
130836130|NCT01843673|471026280|FG000|Overall Study|Lack of Efficacy|2|||
130836131|NCT01843673|471026280|FG000|Overall Study|Withdrawal by Subject|4|||
130836132|NCT02321319|471026281|FG000|Overall Study|Product discontinued|5|||
130836133|NCT02249091|471026284|FG000|Overall Study|Lack of Efficacy|8|||
130836134|NCT02249091|471026285|FG001|Overall Study|Lack of Efficacy|3|||
130836135|NCT02249091|471026284|FG000|Overall Study|Physician Decision|4|||
130836136|NCT02249091|471026285|FG001|Overall Study|Physician Decision|1|||
130836137|NCT02249091|471026284|FG000|Overall Study|Withdrawal by Subject|2|||
130836138|NCT02249091|471026285|FG001|Overall Study|Withdrawal by Subject|2|||
130836139|NCT02249091|471026284|FG000|Overall Study|Death|3|||
130836140|NCT02249091|471026285|FG001|Overall Study|Death|4|||
130836141|NCT02249091|471026284|FG000|Overall Study|Adverse Event|1|||
130836142|NCT02249091|471026285|FG001|Overall Study|Adverse Event|0|||
130836143|NCT02249091|471026284|FG000|Overall Study|Stable disease with following SCT|0|||
130836144|NCT02249091|471026285|FG001|Overall Study|Stable disease with following SCT|1|||
130836145|NCT02249091|471026284|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
130836146|NCT02249091|471026285|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
130836147|NCT02249091|471026284|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
130836148|NCT02249091|471026285|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
130836149|NCT02249091|471026284|FG000|Overall Study|Refractory AML|1|||
130836150|NCT02249091|471026285|FG001|Overall Study|Refractory AML|1|||
130836151|NCT00433966|471026286|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
130836152|NCT00433966|471026287|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
130836153|NCT00433966|471026288|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
130836154|NCT00433966|471026289|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
130836155|NCT00433966|471026286|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
130836156|NCT00433966|471026287|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
130836157|NCT00433966|471026288|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
130836158|NCT00433966|471026289|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
130836159|NCT00433966|471026286|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
130836160|NCT00433966|471026287|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
130836161|NCT00433966|471026288|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
130836162|NCT00433966|471026289|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
130836163|NCT00433966|471026286|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
130836164|NCT00433966|471026287|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
130836165|NCT00433966|471026288|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
130836166|NCT00433966|471026289|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
130836167|NCT00433966|471026286|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
130836168|NCT00433966|471026287|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
130836169|NCT00433966|471026288|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
130836170|NCT00433966|471026289|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
130836171|NCT00853242|471026291|FG000|Overall Study|Adverse Event|0|||
130836172|NCT00853242|471026292|FG001|Overall Study|Adverse Event|1|||
130836173|NCT00853242|471026293|FG002|Overall Study|Adverse Event|1|||
130836174|NCT00853242|471026294|FG003|Overall Study|Adverse Event|0|||
130836175|NCT00853242|471026295|FG004|Overall Study|Adverse Event|3|||
130836176|NCT00853242|471026296|FG005|Overall Study|Adverse Event|1|||
130836177|NCT00853242|471026297|FG006|Overall Study|Adverse Event|1|||
130836178|NCT00853242|471026291|FG000|Overall Study|Noncompliant|0|||
130836179|NCT00853242|471026292|FG001|Overall Study|Noncompliant|0|||
130836180|NCT00853242|471026293|FG002|Overall Study|Noncompliant|0|||
130836181|NCT00853242|471026294|FG003|Overall Study|Noncompliant|0|||
130836182|NCT00853242|471026295|FG004|Overall Study|Noncompliant|1|||
130836183|NCT00853242|471026296|FG005|Overall Study|Noncompliant|0|||
130836184|NCT00853242|471026297|FG006|Overall Study|Noncompliant|0|||
130836185|NCT00853242|471026291|FG000|Overall Study|Withdrawal by Subject|1|||
130836186|NCT00853242|471026292|FG001|Overall Study|Withdrawal by Subject|2|||
130836187|NCT00853242|471026293|FG002|Overall Study|Withdrawal by Subject|0|||
130836188|NCT00853242|471026294|FG003|Overall Study|Withdrawal by Subject|4|||
130836189|NCT00853242|471026295|FG004|Overall Study|Withdrawal by Subject|0|||
130836190|NCT00853242|471026296|FG005|Overall Study|Withdrawal by Subject|0|||
130836191|NCT00853242|471026297|FG006|Overall Study|Withdrawal by Subject|2|||
130836192|NCT00853242|471026291|FG000|Overall Study|Other|2|||
130836193|NCT00853242|471026292|FG001|Overall Study|Other|0|||
130836194|NCT00853242|471026293|FG002|Overall Study|Other|2|||
130836195|NCT00853242|471026294|FG003|Overall Study|Other|0|||
130836196|NCT00853242|471026295|FG004|Overall Study|Other|0|||
130836197|NCT00853242|471026296|FG005|Overall Study|Other|1|||
130836198|NCT00853242|471026297|FG006|Overall Study|Other|2|||
130836199|NCT03497975|471026298|FG000|Overall Study|Withdrew Consent|34|||
130836200|NCT03497975|471026299|FG001|Overall Study|Withdrew Consent|35|||
130836201|NCT03497975|471026298|FG000|Overall Study|Lost to Follow-up|7|||
130836202|NCT03497975|471026299|FG001|Overall Study|Lost to Follow-up|7|||
130836203|NCT03497975|471026298|FG000|Overall Study|Physician Decision|4|||
130836204|NCT03497975|471026299|FG001|Overall Study|Physician Decision|5|||
130836205|NCT03497975|471026298|FG000|Overall Study|Discontinued|42|||
130836206|NCT03497975|471026299|FG001|Overall Study|Discontinued|39|||
130836207|NCT03497975|471026298|FG000|Overall Study|Reason Not Specified|15|||
130836208|NCT03497975|471026299|FG001|Overall Study|Reason Not Specified|14|||
130836209|NCT01257230|471026302|FG000|Overall Study|Not Treated|0|||
130836210|NCT01257230|471026303|FG001|Overall Study|Not Treated|0|||
130836211|NCT01257230|471026304|FG002|Overall Study|Not Treated|1|||
130836212|NCT01257230|471026302|FG000|Overall Study|Adverse Event|2|||
130836213|NCT01257230|471026303|FG001|Overall Study|Adverse Event|0|||
130836214|NCT01257230|471026304|FG002|Overall Study|Adverse Event|0|||
130836215|NCT01257230|471026302|FG000|Overall Study|Lack of Efficacy|0|||
130836216|NCT01257230|471026303|FG001|Overall Study|Lack of Efficacy|1|||
130836217|NCT01257230|471026304|FG002|Overall Study|Lack of Efficacy|0|||
130836218|NCT01257230|471026302|FG000|Overall Study|Protocol Violation|3|||
130836219|NCT01257230|471026303|FG001|Overall Study|Protocol Violation|0|||
130836220|NCT01257230|471026304|FG002|Overall Study|Protocol Violation|1|||
130836221|NCT01257230|471026302|FG000|Overall Study|Withdrawal by Subject|0|||
130836222|NCT01257230|471026303|FG001|Overall Study|Withdrawal by Subject|4|||
130836223|NCT01257230|471026304|FG002|Overall Study|Withdrawal by Subject|1|||
130836224|NCT01257230|471026302|FG000|Overall Study|Other reason not defined above|1|||
130836225|NCT01257230|471026303|FG001|Overall Study|Other reason not defined above|5|||
130836226|NCT01257230|471026304|FG002|Overall Study|Other reason not defined above|3|||
130836227|NCT01205061|471026307|FG000|Overall Study|Adverse Event|4|||
130836228|NCT01205061|471026307|FG000|Overall Study|Withdrawal by Subject|11|||
130836229|NCT01205061|471026307|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
130836230|NCT01205061|471026307|FG000|Overall Study|Lost to Follow-up|9|||
130836231|NCT01205061|471026307|FG000|Overall Study|Other|1|||
130836232|NCT00765037|471026308|FG000|Overall Study|Lost to Follow-up|5|||
130836233|NCT00765037|471026308|FG000|Overall Study|Adverse Event|1|||
130836234|NCT04026009|471026313|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130836235|NCT04026009|471026314|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130836236|NCT04026009|471026315|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130836237|NCT04026009|471026316|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130836238|NCT04026009|471026317|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130836239|NCT04026009|471026313|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
130836240|NCT04026009|471026314|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
130836241|NCT04026009|471026315|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
130836242|NCT04026009|471026316|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
130836243|NCT04026009|471026317|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
130836244|NCT01500252|471026321|FG000|Overall Study|Death|4|||
130836245|NCT01500252|471026322|FG001|Overall Study|Death|2|||
130836246|NCT01500252|471026321|FG000|Overall Study|Lost to Follow-up|5|||
130836247|NCT01500252|471026322|FG001|Overall Study|Lost to Follow-up|4|||
130836248|NCT02059499|471026326|FG000|Upto Week 20|Lost to Follow-up|2|||
130836249|NCT02059499|471026327|FG001|Upto Week 20|Lost to Follow-up|6|||
130836250|NCT02059499|471026328|FG002|Upto Week 20|Lost to Follow-up|0|||
130836251|NCT02059499|471026326|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
130836252|NCT02059499|471026327|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
130836253|NCT02059499|471026328|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
130836254|NCT02059499|471026326|FG000|Upto Week 20|Withdrawal by Subject|1|||
130836255|NCT02059499|471026327|FG001|Upto Week 20|Withdrawal by Subject|1|||
130836256|NCT02059499|471026328|FG002|Upto Week 20|Withdrawal by Subject|0|||
130836257|NCT02059499|471026326|FG000|Upto Week 20|No treatment per protocol criteria|0|||
130836258|NCT02059499|471026327|FG001|Upto Week 20|No treatment per protocol criteria|0|||
130836259|NCT02059499|471026328|FG002|Upto Week 20|No treatment per protocol criteria|5|||
130836260|NCT02059499|471026326|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
130836261|NCT02059499|471026327|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
130836262|NCT02059499|471026328|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
130836263|NCT02059499|471026326|FG000|Post-week 20|Lost to Follow-up|0|||
130836264|NCT02059499|471026327|FG001|Post-week 20|Lost to Follow-up|2|||
130836265|NCT02059499|471026328|FG002|Post-week 20|Lost to Follow-up|0|||
130836266|NCT02059499|471026326|FG000|Post-week 20|Withdrawal by Subject|0|||
130836267|NCT02059499|471026327|FG001|Post-week 20|Withdrawal by Subject|1|||
130836268|NCT02059499|471026328|FG002|Post-week 20|Withdrawal by Subject|0|||
130836269|NCT02059499|471026326|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
130836270|NCT02059499|471026327|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
130836271|NCT02059499|471026328|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
130836272|NCT03989349|471026329|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
130836273|NCT03989349|471026330|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130836274|NCT03989349|471026331|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130836275|NCT03989349|471026332|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130836276|NCT03989349|471026333|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130836277|NCT03989349|471026334|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130836278|NCT03989349|471026329|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
130836279|NCT03989349|471026330|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
130836280|NCT03989349|471026331|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130836281|NCT03989349|471026332|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130836282|NCT03989349|471026333|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130836283|NCT03989349|471026334|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130836284|NCT03989349|471026329|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
130836285|NCT03989349|471026330|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
130836286|NCT03989349|471026331|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130836287|NCT03989349|471026332|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130836288|NCT03989349|471026333|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130836289|NCT03989349|471026334|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130836290|NCT03989349|471026329|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
130836291|NCT03989349|471026330|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
130836292|NCT03989349|471026331|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130836293|NCT03989349|471026332|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130836294|NCT03989349|471026333|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130836295|NCT03989349|471026334|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130836296|NCT03989349|471026329|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
130836297|NCT03989349|471026330|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
130836298|NCT03989349|471026331|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130836299|NCT03989349|471026332|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130836300|NCT03989349|471026333|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130836301|NCT03989349|471026334|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130836302|NCT03989349|471026329|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
130836303|NCT03989349|471026330|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130836304|NCT03989349|471026331|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130836305|NCT03989349|471026332|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130836306|NCT03989349|471026333|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130836307|NCT03989349|471026334|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130836308|NCT03989349|471026329|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
130836309|NCT03989349|471026330|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
130836310|NCT03989349|471026331|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130836311|NCT03989349|471026332|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130836312|NCT03989349|471026333|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130836313|NCT03989349|471026334|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130836314|NCT03989349|471026329|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130836315|NCT03989349|471026330|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130836316|NCT03989349|471026331|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
130836317|NCT03989349|471026332|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
130836318|NCT03989349|471026333|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
130836319|NCT03989349|471026334|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
130836320|NCT03989349|471026329|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130836321|NCT03989349|471026330|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130836322|NCT03989349|471026331|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
130836323|NCT03989349|471026332|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
130836324|NCT03989349|471026333|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
130836325|NCT03989349|471026334|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
130836326|NCT03989349|471026329|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130836327|NCT03989349|471026330|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130836328|NCT03989349|471026331|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
130836329|NCT03989349|471026332|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
130836330|NCT03989349|471026333|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
130836331|NCT03989349|471026334|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
130836332|NCT03989349|471026329|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130836333|NCT03989349|471026330|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130836334|NCT03989349|471026331|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130836335|NCT03989349|471026332|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130836336|NCT03989349|471026333|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
130836337|NCT03989349|471026334|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130836338|NCT03989349|471026329|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130836339|NCT03989349|471026330|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130836340|NCT03989349|471026331|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130836341|NCT03989349|471026332|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130836342|NCT03989349|471026333|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130836343|NCT03989349|471026334|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130836344|NCT03989349|471026329|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
130836345|NCT03989349|471026330|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
130836346|NCT03989349|471026331|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
130836347|NCT03989349|471026332|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
130836348|NCT03989349|471026333|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
130836349|NCT03989349|471026334|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
130836350|NCT03989349|471026329|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
130836351|NCT03989349|471026330|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
130836352|NCT03989349|471026331|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
130836353|NCT03989349|471026332|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
130836354|NCT03989349|471026333|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
130836355|NCT03989349|471026334|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
130836356|NCT01352221|471026335|FG000|Double-blind Phase|Adverse Event|6|||
130836357|NCT01352221|471026336|FG001|Double-blind Phase|Adverse Event|4|||
130836358|NCT01352221|471026337|FG002|Double-blind Phase|Adverse Event|0|||
130836359|NCT01352221|471026338|FG003|Double-blind Phase|Adverse Event|0|||
130836360|NCT01352221|471026335|FG000|Double-blind Phase|Withdrawal by Subject|3|||
130836361|NCT01352221|471026336|FG001|Double-blind Phase|Withdrawal by Subject|5|||
130836362|NCT01352221|471026337|FG002|Double-blind Phase|Withdrawal by Subject|0|||
130836363|NCT01352221|471026338|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130836364|NCT01352221|471026335|FG000|Double-blind Phase|Lost to Follow-up|0|||
130836365|NCT01352221|471026336|FG001|Double-blind Phase|Lost to Follow-up|1|||
130836366|NCT01352221|471026337|FG002|Double-blind Phase|Lost to Follow-up|0|||
130836367|NCT01352221|471026338|FG003|Double-blind Phase|Lost to Follow-up|0|||
130836368|NCT01352221|471026335|FG000|Double-blind Phase|Protocol Violation|0|||
130836369|NCT01352221|471026336|FG001|Double-blind Phase|Protocol Violation|1|||
130836370|NCT01352221|471026337|FG002|Double-blind Phase|Protocol Violation|0|||
130836371|NCT01352221|471026338|FG003|Double-blind Phase|Protocol Violation|0|||
130836372|NCT01352221|471026335|FG000|Open-label Phase|Physician Decision|0|||
130836373|NCT01352221|471026336|FG001|Open-label Phase|Physician Decision|0|||
130836374|NCT01352221|471026337|FG002|Open-label Phase|Physician Decision|2|||
130836375|NCT01352221|471026338|FG003|Open-label Phase|Physician Decision|1|||
130836376|NCT01352221|471026335|FG000|Open-label Phase|Pregnancy|0|||
130836377|NCT01352221|471026336|FG001|Open-label Phase|Pregnancy|0|||
130836378|NCT01352221|471026337|FG002|Open-label Phase|Pregnancy|1|||
130836379|NCT01352221|471026338|FG003|Open-label Phase|Pregnancy|0|||
130836380|NCT01352221|471026335|FG000|Open-label Phase|Adverse Event|0|||
130836381|NCT01352221|471026336|FG001|Open-label Phase|Adverse Event|0|||
130836382|NCT01352221|471026337|FG002|Open-label Phase|Adverse Event|8|||
130836383|NCT01352221|471026338|FG003|Open-label Phase|Adverse Event|4|||
130836384|NCT01352221|471026335|FG000|Open-label Phase|Withdrawal by Subject|0|||
130836385|NCT01352221|471026336|FG001|Open-label Phase|Withdrawal by Subject|0|||
130836386|NCT01352221|471026337|FG002|Open-label Phase|Withdrawal by Subject|1|||
130836387|NCT01352221|471026338|FG003|Open-label Phase|Withdrawal by Subject|6|||
130836388|NCT01352221|471026335|FG000|Open-label Phase|Worsening of IBD|0|||
130836389|NCT01352221|471026336|FG001|Open-label Phase|Worsening of IBD|0|||
130836390|NCT01352221|471026337|FG002|Open-label Phase|Worsening of IBD|1|||
130836391|NCT01352221|471026338|FG003|Open-label Phase|Worsening of IBD|0|||
130836392|NCT01221623|471026339|FG000|Overall Study|Withdrawal by Subject|19|||
130836393|NCT01221623|471026340|FG001|Overall Study|Withdrawal by Subject|8|||
130836394|NCT01221623|471026339|FG000|Overall Study|Lost to Follow-up|7|||
130836395|NCT01221623|471026340|FG001|Overall Study|Lost to Follow-up|1|||
130836396|NCT01221623|471026339|FG000|Overall Study|Adverse Event|6|||
130836397|NCT01221623|471026340|FG001|Overall Study|Adverse Event|3|||
130836398|NCT01221623|471026339|FG000|Overall Study|Death|1|||
130836399|NCT01221623|471026340|FG001|Overall Study|Death|0|||
130836400|NCT01221623|471026339|FG000|Overall Study|Other|5|||
130836401|NCT01221623|471026340|FG001|Overall Study|Other|2|||
130836402|NCT00661726|471026341|FG000|Overall Study|Adverse Event|1|||
130836403|NCT02109432|471027987|FG000|Overall Study|Withdrawal by Subject|1|||
130836404|NCT02908685|471027988|FG000|Part 1 OLE|Withdrawal by Subject|0|||
130836405|NCT02908685|471027989|FG001|Part 1 OLE|Withdrawal by Subject|0|||
130836406|NCT02908685|471027990|FG002|Part 1 OLE|Withdrawal by Subject|0|||
130836407|NCT02908685|471027991|FG003|Part 1 OLE|Withdrawal by Subject|0|||
130836408|NCT02908685|471027992|FG004|Part 1 OLE|Withdrawal by Subject|0|||
130836409|NCT02908685|471027993|FG005|Part 1 OLE|Withdrawal by Subject|0|||
130836410|NCT02908685|471027994|FG006|Part 1 OLE|Withdrawal by Subject|0|||
130836411|NCT02908685|471027995|FG007|Part 1 OLE|Withdrawal by Subject|0|||
130836412|NCT02908685|471027996|FG008|Part 1 OLE|Withdrawal by Subject|0|||
130836413|NCT02908685|471027997|FG009|Part 1 OLE|Withdrawal by Subject|0|||
130836414|NCT02908685|471027998|FG010|Part 1 OLE|Withdrawal by Subject|2|||
130836415|NCT02908685|471027999|FG011|Part 1 OLE|Withdrawal by Subject|1|||
130836416|NCT02908685|471028000|FG012|Part 1 OLE|Withdrawal by Subject|0|||
130836417|NCT02908685|471028001|FG013|Part 1 OLE|Withdrawal by Subject|0|||
130836418|NCT02908685|471027988|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836419|NCT02908685|471027989|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836420|NCT02908685|471027990|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836421|NCT02908685|471027991|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836422|NCT02908685|471027992|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836423|NCT02908685|471027993|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836424|NCT02908685|471027994|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836425|NCT02908685|471027995|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836426|NCT02908685|471027996|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836427|NCT02908685|471027997|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836428|NCT02908685|471027998|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836429|NCT02908685|471027999|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130836430|NCT02908685|471028000|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
130836431|NCT02908685|471028001|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
130836432|NCT02908685|471027988|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836433|NCT02908685|471027989|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836434|NCT02908685|471027990|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836435|NCT02908685|471027991|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836436|NCT02908685|471027992|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836437|NCT02908685|471027993|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836438|NCT02908685|471027994|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836439|NCT02908685|471027995|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836440|NCT02908685|471027996|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836441|NCT02908685|471027997|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836442|NCT02908685|471027998|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836443|NCT02908685|471027999|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836444|NCT02908685|471028000|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
130836445|NCT02908685|471028001|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130836446|NCT02908685|471027988|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836447|NCT02908685|471027989|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836448|NCT02908685|471027990|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836449|NCT02908685|471027991|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836450|NCT02908685|471027992|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836451|NCT02908685|471027993|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836452|NCT02908685|471027994|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836453|NCT02908685|471027995|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836454|NCT02908685|471027996|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836455|NCT02908685|471027997|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836456|NCT02908685|471027998|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836457|NCT02908685|471027999|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836458|NCT02908685|471028000|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
130836459|NCT02908685|471028001|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130836460|NCT02908685|471027988|FG000|Part 2 OLE: > Month 24|Death|0|||
130836461|NCT02908685|471027989|FG001|Part 2 OLE: > Month 24|Death|0|||
130836462|NCT02908685|471027990|FG002|Part 2 OLE: > Month 24|Death|0|||
130836463|NCT02908685|471027991|FG003|Part 2 OLE: > Month 24|Death|0|||
130836464|NCT02908685|471027992|FG004|Part 2 OLE: > Month 24|Death|0|||
130836465|NCT02908685|471027993|FG005|Part 2 OLE: > Month 24|Death|0|||
130836466|NCT02908685|471027994|FG006|Part 2 OLE: > Month 24|Death|0|||
130836467|NCT02908685|471027995|FG007|Part 2 OLE: > Month 24|Death|0|||
130836468|NCT02908685|471027996|FG008|Part 2 OLE: > Month 24|Death|0|||
130836469|NCT02908685|471027997|FG009|Part 2 OLE: > Month 24|Death|0|||
130836470|NCT02908685|471027998|FG010|Part 2 OLE: > Month 24|Death|0|||
130836471|NCT02908685|471027999|FG011|Part 2 OLE: > Month 24|Death|0|||
130836472|NCT02908685|471028000|FG012|Part 2 OLE: > Month 24|Death|1|||
130836473|NCT02908685|471028001|FG013|Part 2 OLE: > Month 24|Death|0|||
130836474|NCT02908685|471027988|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
130836475|NCT02908685|471027989|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
130836476|NCT02908685|471027990|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
130836477|NCT02908685|471027991|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
130836478|NCT02908685|471027992|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
130836479|NCT02908685|471027993|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
130836480|NCT02908685|471027994|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
130836481|NCT02908685|471027995|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
130836482|NCT02908685|471027996|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
130836483|NCT02908685|471027997|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
130836484|NCT02908685|471027998|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
130836485|NCT02908685|471027999|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
130836486|NCT02908685|471028000|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
130836487|NCT02908685|471028001|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
130836488|NCT02908685|471027988|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836489|NCT02908685|471027989|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836490|NCT02908685|471027990|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836491|NCT02908685|471027991|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836492|NCT02908685|471027992|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836493|NCT02908685|471027993|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836494|NCT02908685|471027994|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836495|NCT02908685|471027995|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836496|NCT02908685|471027996|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836497|NCT02908685|471027997|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836498|NCT02908685|471027998|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836499|NCT02908685|471027999|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130836500|NCT02908685|471028000|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
130836501|NCT02908685|471028001|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
130836502|NCT02370537|471028003|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
130836503|NCT02370537|471028004|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
130836504|NCT02370537|471028005|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
130836505|NCT02370537|471028003|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
130836506|NCT02370537|471028004|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
130836507|NCT02370537|471028005|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
130836508|NCT02370537|471028003|FG000|Part B|Not randomised to receive treatment|1|||
130836509|NCT02370537|471028004|FG001|Part B|Not randomised to receive treatment|2|||
130836510|NCT02370537|471028005|FG002|Part B|Not randomised to receive treatment|259|||
130836511|NCT02370537|471028003|FG000|Part B|Withdrawal by Subject|0|||
130836512|NCT02370537|471028004|FG001|Part B|Withdrawal by Subject|1|||
130836513|NCT02370537|471028005|FG002|Part B|Withdrawal by Subject|0|||
130836514|NCT01691014|471028006|FG000|Overall Study|Premature Termination|1|||
130836515|NCT01691014|471028007|FG001|Overall Study|Premature Termination|6|||
130836516|NCT01691014|471028008|FG002|Overall Study|Premature Termination|0|||
130836517|NCT01691014|471028009|FG003|Overall Study|Premature Termination|3|||
130836518|NCT01691014|471028006|FG000|Overall Study|Other|0|||
130836519|NCT01691014|471028007|FG001|Overall Study|Other|0|||
130836520|NCT01691014|471028008|FG002|Overall Study|Other|2|||
130836521|NCT01691014|471028009|FG003|Overall Study|Other|0|||
130836522|NCT01691014|471028006|FG000|Overall Study|Withdrawal by Subject|0|||
130836523|NCT01691014|471028007|FG001|Overall Study|Withdrawal by Subject|1|||
130836524|NCT01691014|471028008|FG002|Overall Study|Withdrawal by Subject|1|||
130836525|NCT01691014|471028009|FG003|Overall Study|Withdrawal by Subject|1|||
130836526|NCT01691014|471028006|FG000|Overall Study|Adverse Event|0|||
130836527|NCT01691014|471028007|FG001|Overall Study|Adverse Event|5|||
130836528|NCT01691014|471028008|FG002|Overall Study|Adverse Event|1|||
130836529|NCT01691014|471028009|FG003|Overall Study|Adverse Event|1|||
130836530|NCT01691014|471028006|FG000|Overall Study|Lack of Efficacy|2|||
130836531|NCT01691014|471028007|FG001|Overall Study|Lack of Efficacy|3|||
130836532|NCT01691014|471028008|FG002|Overall Study|Lack of Efficacy|7|||
130836533|NCT01691014|471028009|FG003|Overall Study|Lack of Efficacy|0|||
130836534|NCT05897242|471028010|FG000|Overall Study|Lost to Follow-up|6|||
130836535|NCT05897242|471028011|FG001|Overall Study|Lost to Follow-up|1|||
130836536|NCT05897242|471028010|FG000|Overall Study|Incomplete|1|||
130836537|NCT05897242|471028011|FG001|Overall Study|Incomplete|0|||
130836538|NCT05897242|471028010|FG000|Overall Study|Withdrawal by Subject|1|||
130836539|NCT05897242|471028011|FG001|Overall Study|Withdrawal by Subject|0|||
130836540|NCT04439539|471028015|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
130836541|NCT04439539|471028016|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
130836542|NCT04439539|471028017|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
130836543|NCT04439539|471028015|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
130836544|NCT04439539|471028016|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
130836545|NCT04439539|471028017|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
130836546|NCT04439539|471028015|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
130836547|NCT04439539|471028016|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
130836548|NCT04439539|471028017|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
130836549|NCT02920528|471028018|FG000|Overall Study|Incomplete Data|1|||
130836550|NCT02920528|471028019|FG001|Overall Study|Incomplete Data|1|||
130836551|NCT02920528|471028020|FG002|Overall Study|Incomplete Data|1|||
130836552|NCT02920528|471028018|FG000|Overall Study|Adverse Event|0|||
130836553|NCT02920528|471028019|FG001|Overall Study|Adverse Event|0|||
130836554|NCT02920528|471028020|FG002|Overall Study|Adverse Event|3|||
130836555|NCT02920528|471028018|FG000|Overall Study|Did not meet inclusion criteria|2|||
130836556|NCT02920528|471028019|FG001|Overall Study|Did not meet inclusion criteria|0|||
130836557|NCT02920528|471028020|FG002|Overall Study|Did not meet inclusion criteria|1|||
130836558|NCT02547038|471028021|FG000|Overall Study|Lost to Follow-up|3|||
130836559|NCT02547038|471028022|FG001|Overall Study|Lost to Follow-up|2|||
130836560|NCT01340625|471028023|FG000|First Intervention|Adverse Event|1|||
130836561|NCT01340625|471028024|FG001|First Intervention|Adverse Event|0|||
130836562|NCT01340625|471028023|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
130836563|NCT01340625|471028024|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
130836564|NCT00066703|471028025|FG000|Overall Study|Adverse Event|80|||
130836565|NCT00066703|471028026|FG001|Overall Study|Adverse Event|111|||
130836566|NCT00066703|471028025|FG000|Overall Study|Death|3|||
130836567|NCT00066703|471028026|FG001|Overall Study|Death|0|||
130836568|NCT00066703|471028025|FG000|Overall Study|Lack of Efficacy|114|||
130836569|NCT00066703|471028026|FG001|Overall Study|Lack of Efficacy|69|||
130836570|NCT00066703|471028025|FG000|Overall Study|Lost to Follow-up|31|||
130836571|NCT00066703|471028026|FG001|Overall Study|Lost to Follow-up|28|||
130836572|NCT00066703|471028025|FG000|Overall Study|Withdrawal by Subject|38|||
130836573|NCT00066703|471028026|FG001|Overall Study|Withdrawal by Subject|63|||
130836574|NCT00066703|471028025|FG000|Overall Study|Treatment ongoing|346|||
130836575|NCT00066703|471028026|FG001|Overall Study|Treatment ongoing|311|||
130836576|NCT01696968|471028027|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
130836577|NCT01696968|471028028|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
130836578|NCT01696968|471028027|FG000|Overall Study|Died Before Randomization|3|||
130836579|NCT01696968|471028028|FG001|Overall Study|Died Before Randomization|8|||
130836580|NCT01696968|471028027|FG000|Overall Study|Died Before ASU (Control)|278|||
130836581|NCT01696968|471028028|FG001|Overall Study|Died Before ASU (Control)|0|||
130836582|NCT01696968|471028027|FG000|Overall Study|Refused ASU (Control)|920|||
130836583|NCT01696968|471028028|FG001|Overall Study|Refused ASU (Control)|0|||
130836584|NCT01696968|471028027|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
130836585|NCT01696968|471028028|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
130836586|NCT01519791|471028041|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
130836587|NCT01519791|471028042|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
130836588|NCT01519791|471028041|FG000|Overall Study|Protocol Violation|6|||
130836589|NCT01519791|471028042|FG001|Overall Study|Protocol Violation|19|||
130836590|NCT01519791|471028041|FG000|Overall Study|Other Reason|87|||
130836591|NCT01519791|471028042|FG001|Overall Study|Other Reason|222|||
130836592|NCT01519791|471028041|FG000|Overall Study|subjects randomized in error|2|||
130836593|NCT01519791|471028042|FG001|Overall Study|subjects randomized in error|0|||
130836594|NCT01519791|471028041|FG000|Overall Study|Lack of Efficacy|16|||
130836595|NCT01519791|471028042|FG001|Overall Study|Lack of Efficacy|20|||
130836596|NCT01519791|471028041|FG000|Overall Study|SAE, non-fatal|6|||
130836597|NCT01519791|471028042|FG001|Overall Study|SAE, non-fatal|22|||
130836598|NCT01519791|471028041|FG000|Overall Study|AE, serious fatal|0|||
130836599|NCT01519791|471028042|FG001|Overall Study|AE, serious fatal|1|||
130836600|NCT01519791|471028041|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
130836601|NCT01519791|471028042|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
130836602|NCT01519791|471028041|FG000|Overall Study|AE, non-serious non-fatal|12|||
130836603|NCT01519791|471028042|FG001|Overall Study|AE, non-serious non-fatal|31|||
130836604|NCT01519791|471028041|FG000|Overall Study|Withdrawal by Subject|15|||
130836605|NCT01519791|471028042|FG001|Overall Study|Withdrawal by Subject|37|||
130836606|NCT01519791|471028041|FG000|Overall Study|Lost to Follow-up|6|||
130836607|NCT01519791|471028042|FG001|Overall Study|Lost to Follow-up|14|||
130836608|NCT00632827|471028057|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
130836609|NCT00632827|471028057|FG000|Overall Study|Death|2|||
130836610|NCT00632827|471028057|FG000|Overall Study|Adverse Event|5|||
130836611|NCT00632827|471028057|FG000|Overall Study|Lost to Follow-up|1|||
130836612|NCT03425006|471028058|FG000|Overall Study|Withdrawal by Subject|1|||
130836613|NCT03425006|471028058|FG000|Overall Study|Physician Decision|1|||
130836614|NCT03425006|471028058|FG000|Overall Study|Death|1|||
130836615|NCT03070171|471028064|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
130836616|NCT03070171|471028065|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
130836617|NCT03070171|471028064|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
130836618|NCT03070171|471028065|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
130836619|NCT01471028|471028069|FG000|VTI-208|Adverse Event|39|||
130836620|NCT01471028|471028070|FG001|VTI-208|Adverse Event|41|||
130836621|NCT01471028|471028069|FG000|VTI-208|Withdrawal by Subject|0|||
130836622|NCT01471028|471028070|FG001|VTI-208|Withdrawal by Subject|2|||
130836623|NCT01471028|471028069|FG000|VTI-208|Lost to Follow-up|1|||
130836624|NCT01471028|471028070|FG001|VTI-208|Lost to Follow-up|1|||
130836625|NCT01471028|471028069|FG000|VTI-208E|Death|7|||
130836626|NCT01471028|471028070|FG001|VTI-208E|Death|10|||
130836627|NCT01471028|471028069|FG000|VTI-208E|Withdrawal by Subject|1|||
130836628|NCT01471028|471028070|FG001|VTI-208E|Withdrawal by Subject|0|||
130836629|NCT01471028|471028069|FG000|VTI-208E|Lost to Follow-up|0|||
130836630|NCT01471028|471028070|FG001|VTI-208E|Lost to Follow-up|2|||
130836631|NCT00610857|471028072|FG000|Overall Study|Not evaluable for response|2|||
130836632|NCT01626118|471028073|FG000|Overall Study|Lack of Efficacy|1|||
130836633|NCT01626118|471028074|FG001|Overall Study|Lack of Efficacy|0|||
130836634|NCT01626118|471028075|FG002|Overall Study|Lack of Efficacy|1|||
130836635|NCT01626118|471028076|FG003|Overall Study|Lack of Efficacy|3|||
130836636|NCT01626118|471028073|FG000|Overall Study|Lost to Follow-up|1|||
130836637|NCT01626118|471028074|FG001|Overall Study|Lost to Follow-up|0|||
130836638|NCT01626118|471028075|FG002|Overall Study|Lost to Follow-up|0|||
130836639|NCT01626118|471028076|FG003|Overall Study|Lost to Follow-up|0|||
130836640|NCT01626118|471028073|FG000|Overall Study|Adverse Event|0|||
130836641|NCT01626118|471028074|FG001|Overall Study|Adverse Event|1|||
130836642|NCT01626118|471028075|FG002|Overall Study|Adverse Event|1|||
130836643|NCT01626118|471028076|FG003|Overall Study|Adverse Event|0|||
130836644|NCT01626118|471028073|FG000|Overall Study|Investigator Decision|0|||
130836645|NCT01626118|471028074|FG001|Overall Study|Investigator Decision|1|||
130836646|NCT01626118|471028075|FG002|Overall Study|Investigator Decision|0|||
130836647|NCT01626118|471028076|FG003|Overall Study|Investigator Decision|0|||
130836648|NCT04826094|471028077|FG000|Overall Study|Lost to Follow-up|2|||
130836649|NCT04826094|471028078|FG001|Overall Study|Lost to Follow-up|1|||
130836650|NCT04826094|471028079|FG002|Overall Study|Lost to Follow-up|0|||
130836651|NCT04826094|471028080|FG003|Overall Study|Lost to Follow-up|0|||
130836652|NCT04826094|471028081|FG004|Overall Study|Lost to Follow-up|1|||
130836653|NCT04826094|471028082|FG005|Overall Study|Lost to Follow-up|3|||
130836654|NCT04826094|471028083|FG006|Overall Study|Lost to Follow-up|1|||
130836655|NCT04826094|471028084|FG007|Overall Study|Lost to Follow-up|1|||
130836656|NCT04826094|471028077|FG000|Overall Study|Participant withdrew consent|1|||
130836657|NCT04826094|471028078|FG001|Overall Study|Participant withdrew consent|0|||
130836658|NCT04826094|471028079|FG002|Overall Study|Participant withdrew consent|0|||
130836659|NCT04826094|471028080|FG003|Overall Study|Participant withdrew consent|1|||
130836660|NCT04826094|471028081|FG004|Overall Study|Participant withdrew consent|1|||
130836661|NCT04826094|471028082|FG005|Overall Study|Participant withdrew consent|1|||
130836662|NCT04826094|471028083|FG006|Overall Study|Participant withdrew consent|0|||
130836663|NCT04826094|471028084|FG007|Overall Study|Participant withdrew consent|1|||
130836664|NCT04826094|471028077|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
130836665|NCT04826094|471028078|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
130836666|NCT04826094|471028079|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
130836667|NCT04826094|471028080|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
130836668|NCT04826094|471028081|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
130836669|NCT04826094|471028082|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
130836670|NCT04826094|471028083|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
130836671|NCT04826094|471028084|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
130836672|NCT04826094|471028077|FG000|Overall Study|Withdrawn by Investigator|0|||
130836673|NCT04826094|471028078|FG001|Overall Study|Withdrawn by Investigator|0|||
130836674|NCT04826094|471028079|FG002|Overall Study|Withdrawn by Investigator|0|||
130836675|NCT04826094|471028080|FG003|Overall Study|Withdrawn by Investigator|0|||
130836676|NCT04826094|471028081|FG004|Overall Study|Withdrawn by Investigator|0|||
130836677|NCT04826094|471028082|FG005|Overall Study|Withdrawn by Investigator|1|||
130836678|NCT04826094|471028083|FG006|Overall Study|Withdrawn by Investigator|0|||
130836679|NCT04826094|471028084|FG007|Overall Study|Withdrawn by Investigator|1|||
130836680|NCT04826094|471028077|FG000|Overall Study|Other: Moved from area|1|||
130836681|NCT04826094|471028078|FG001|Overall Study|Other: Moved from area|1|||
130836682|NCT04826094|471028079|FG002|Overall Study|Other: Moved from area|1|||
130836683|NCT04826094|471028080|FG003|Overall Study|Other: Moved from area|0|||
130836684|NCT04826094|471028081|FG004|Overall Study|Other: Moved from area|0|||
130836685|NCT04826094|471028082|FG005|Overall Study|Other: Moved from area|0|||
130836686|NCT04826094|471028083|FG006|Overall Study|Other: Moved from area|0|||
130836687|NCT04826094|471028084|FG007|Overall Study|Other: Moved from area|0|||
130836688|NCT04826094|471028077|FG000|Overall Study|Other: Declined|0|||
130836689|NCT04826094|471028078|FG001|Overall Study|Other: Declined|0|||
130836690|NCT04826094|471028079|FG002|Overall Study|Other: Declined|0|||
130836691|NCT04826094|471028080|FG003|Overall Study|Other: Declined|0|||
130836692|NCT04826094|471028081|FG004|Overall Study|Other: Declined|1|||
130836693|NCT04826094|471028082|FG005|Overall Study|Other: Declined|0|||
130836694|NCT04826094|471028083|FG006|Overall Study|Other: Declined|0|||
130836695|NCT04826094|471028084|FG007|Overall Study|Other: Declined|0|||
130836696|NCT04826094|471028077|FG000|Overall Study|Other: Vaccine not administered|0|||
130836697|NCT04826094|471028078|FG001|Overall Study|Other: Vaccine not administered|0|||
130836698|NCT04826094|471028079|FG002|Overall Study|Other: Vaccine not administered|1|||
130836699|NCT04826094|471028080|FG003|Overall Study|Other: Vaccine not administered|0|||
130836700|NCT04826094|471028081|FG004|Overall Study|Other: Vaccine not administered|0|||
130836701|NCT04826094|471028082|FG005|Overall Study|Other: Vaccine not administered|1|||
130836702|NCT04826094|471028083|FG006|Overall Study|Other: Vaccine not administered|1|||
130836703|NCT04826094|471028084|FG007|Overall Study|Other: Vaccine not administered|3|||
130836704|NCT03931382|471028085|FG000|Overall Study|Equipment malfunction|2|||
130836705|NCT03931382|471028086|FG001|Overall Study|Equipment malfunction|0|||
130836706|NCT03931382|471028087|FG002|Overall Study|Equipment malfunction|2|||
130836707|NCT03931382|471028085|FG000|Overall Study|Withdrawal by Subject|0|||
130836708|NCT03931382|471028086|FG001|Overall Study|Withdrawal by Subject|1|||
130836709|NCT03931382|471028087|FG002|Overall Study|Withdrawal by Subject|0|||
130836710|NCT00675441|471028091|FG000|Overall Study|Withdrawal by Subject|2|||
130836711|NCT00675441|471028091|FG000|Overall Study|Death|1|||
130836712|NCT00700882|471028095|FG000|Overall Study|Never received treatment|6|||
130836713|NCT00700882|471028095|FG000|Overall Study|Ineligible|2|||
130836714|NCT00700882|471028095|FG000|Overall Study|No KIT mutation|51|||
130836715|NCT04154293|471028099|FG000|Overall Study|Withdrawal by Subject|2|||
130836716|NCT04154293|471028100|FG001|Overall Study|Withdrawal by Subject|3|||
130836717|NCT04154293|471028101|FG002|Overall Study|Withdrawal by Subject|1|||
130836718|NCT04154293|471028099|FG000|Overall Study|Physician Decision|0|||
130836719|NCT04154293|471028100|FG001|Overall Study|Physician Decision|0|||
130836720|NCT04154293|471028101|FG002|Overall Study|Physician Decision|1|||
130836721|NCT04731298|471028102|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
130836722|NCT04731298|471028103|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
130836723|NCT01208961|471028104|FG000|High-Fat Period III|Protocol Violation|1|||
130836724|NCT01208961|471028105|FG001|High-Fat Period III|Protocol Violation|0|||
130836725|NCT03403361|471028106|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
130836726|NCT02152371|471028108|FG000|Overall Study|Adverse Event|6|||
130836727|NCT02152371|471028109|FG001|Overall Study|Adverse Event|2|||
130836728|NCT02152371|471028108|FG000|Overall Study|Withdrawal by Subject|3|||
130836729|NCT02152371|471028109|FG001|Overall Study|Withdrawal by Subject|7|||
130836730|NCT02152371|471028108|FG000|Overall Study|Protocol Violation|2|||
130836731|NCT02152371|471028109|FG001|Overall Study|Protocol Violation|3|||
130836732|NCT02152371|471028108|FG000|Overall Study|Lost to Follow-up|1|||
130836733|NCT02152371|471028109|FG001|Overall Study|Lost to Follow-up|0|||
130836734|NCT02152371|471028108|FG000|Overall Study|Lack of Efficacy|0|||
130836735|NCT02152371|471028109|FG001|Overall Study|Lack of Efficacy|1|||
130836736|NCT02152371|471028108|FG000|Overall Study|Physician Decision|0|||
130836737|NCT02152371|471028109|FG001|Overall Study|Physician Decision|2|||
130836738|NCT02152371|471028108|FG000|Overall Study|Reason Not Given|0|||
130836739|NCT02152371|471028109|FG001|Overall Study|Reason Not Given|1|||
130836740|NCT04382586|471028114|FG000|Overall Study|Death|3|||
130836741|NCT04382586|471028115|FG001|Overall Study|Death|4|||
130836742|NCT04382586|471028114|FG000|Overall Study|Lost to Follow-up|11|||
130836743|NCT04382586|471028115|FG001|Overall Study|Lost to Follow-up|8|||
130836744|NCT04382586|471028114|FG000|Overall Study|Withdrawal by Subject|3|||
130836745|NCT04382586|471028115|FG001|Overall Study|Withdrawal by Subject|1|||
130836746|NCT04382586|471028114|FG000|Overall Study|Physician Decision|0|||
130836747|NCT04382586|471028115|FG001|Overall Study|Physician Decision|3|||
130836748|NCT06099223|471028121|FG000|Overall Study|Preoperative surveys missed|0|||
130836749|NCT06099223|471028122|FG001|Overall Study|Preoperative surveys missed|1|||
130836750|NCT00079391|471028123|FG000|Overall Study|Withdrawal by Subject|1|||
130836751|NCT02628600|471028127|FG000|Overall Study|Death|2|||
130836752|NCT02628600|471028128|FG001|Overall Study|Death|1|||
130836753|NCT02628600|471028127|FG000|Overall Study|Adverse Event|3|||
130836754|NCT02628600|471028128|FG001|Overall Study|Adverse Event|20|||
130836755|NCT02628600|471028127|FG000|Overall Study|Protocol Violation|0|||
130836756|NCT02628600|471028128|FG001|Overall Study|Protocol Violation|1|||
130836757|NCT02628600|471028127|FG000|Overall Study|Lack of Efficacy|2|||
130836758|NCT02628600|471028128|FG001|Overall Study|Lack of Efficacy|0|||
130836759|NCT02628600|471028127|FG000|Overall Study|Withdrawal by Subject|13|||
130836760|NCT02628600|471028128|FG001|Overall Study|Withdrawal by Subject|8|||
130836761|NCT02628600|471028127|FG000|Overall Study|Lost to Follow-up|1|||
130836762|NCT02628600|471028128|FG001|Overall Study|Lost to Follow-up|0|||
130836763|NCT02628600|471028127|FG000|Overall Study|Physician Decision|2|||
130836764|NCT02628600|471028128|FG001|Overall Study|Physician Decision|2|||
130836765|NCT02628600|471028127|FG000|Overall Study|Other not specified|1|||
130836766|NCT02628600|471028128|FG001|Overall Study|Other not specified|0|||
130836767|NCT02644096|471028129|FG000|Overall Study|Withdrawal by Subject|28|||
130836768|NCT02644096|471028130|FG001|Overall Study|Withdrawal by Subject|25|||
130836769|NCT02461290|471028131|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
130836770|NCT02461290|471028131|FG000|Overall Study|Lost to Follow-up|3|||
130836771|NCT00526656|471028132|FG000|Overall Study|Death|1|||
130836772|NCT00526656|471028132|FG000|Overall Study|Refused surgery|1|||
130836773|NCT03372551|471030135|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
130836774|NCT03372551|471030136|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
130836775|NCT03727646|471030137|FG000|Overall Study|Adverse Event|1|||
130836776|NCT03727646|471030138|FG001|Overall Study|Adverse Event|0|||
130836777|NCT01289353|471030144|FG000|Overall Study|Lost to Follow-up|2|||
130836778|NCT01549886|471030145|FG000|Overall Study|Sponsor's decision|2|||
130836779|NCT01549886|471030146|FG001|Overall Study|Sponsor's decision|3|||
130836780|NCT06004895|471030147|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
130836781|NCT06004895|471030147|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
130836782|NCT00967694|471030148|FG000|Overall Study|Withdrawal by Subject|6|||
130836783|NCT02957747|471030149|FG000|Overall Study|Withdrawal by Subject|0|||
130836784|NCT02957747|471030150|FG001|Overall Study|Withdrawal by Subject|3|||
130836785|NCT02957747|471030149|FG000|Overall Study|Lost to Follow-up|10|||
130836786|NCT02957747|471030150|FG001|Overall Study|Lost to Follow-up|5|||
130836787|NCT00888329|471030153|FG000|Overall Study|Physician Decision|6|||
130836788|NCT00888329|471030154|FG001|Overall Study|Physician Decision|9|||
130836789|NCT00778375|471030160|FG000|Overall Study|Ineligible|3|||
130836790|NCT00939029|471030161|FG000|Overall Study|Withdrawal by Subject|3|||
130836791|NCT00939029|471030162|FG001|Overall Study|Withdrawal by Subject|7|||
130836792|NCT00939029|471030161|FG000|Overall Study|Lost to Follow-up|3|||
130836793|NCT00939029|471030162|FG001|Overall Study|Lost to Follow-up|4|||
130836794|NCT00939029|471030161|FG000|Overall Study|Adverse Event|0|||
130836795|NCT00939029|471030162|FG001|Overall Study|Adverse Event|1|||
130836796|NCT01421303|471030163|FG000|Overall Study|Lost to Follow-up|13|||
130836797|NCT01421303|471030163|FG000|Overall Study|Non compliance with study procedure|1|||
130836798|NCT01421303|471030163|FG000|Overall Study|Other|7|||
130836799|NCT01421303|471030163|FG000|Overall Study|Withdrawal by Subject|1|||
130836800|NCT06003777|471030164|FG000|Period 1|Adverse Event|0|||
130836801|NCT06003777|471030165|FG001|Period 1|Adverse Event|0|||
130836802|NCT06003777|471030166|FG002|Period 1|Adverse Event|1|||
130836803|NCT06003777|471030167|FG003|Period 1|Adverse Event|0|||
130836804|NCT06003777|471030168|FG004|Period 1|Adverse Event|0|||
130836805|NCT06003777|471030169|FG005|Period 1|Adverse Event|0|||
130836806|NCT06003777|471030170|FG006|Period 1|Adverse Event|0|||
130836807|NCT06003777|471030171|FG007|Period 1|Adverse Event|0|||
130836808|NCT06003777|471030172|FG008|Period 1|Adverse Event|0|||
130836809|NCT06003777|471030173|FG009|Period 1|Adverse Event|0|||
130836810|NCT06003777|471030174|FG010|Period 1|Adverse Event|0|||
130836811|NCT06003777|471030175|FG011|Period 1|Adverse Event|0|||
130836812|NCT06003777|471030164|FG000|Period 1|Withdrawal by Subject|0|||
130836813|NCT06003777|471030165|FG001|Period 1|Withdrawal by Subject|0|||
130836814|NCT06003777|471030166|FG002|Period 1|Withdrawal by Subject|0|||
130836815|NCT06003777|471030167|FG003|Period 1|Withdrawal by Subject|0|||
130836816|NCT06003777|471030168|FG004|Period 1|Withdrawal by Subject|1|||
130836817|NCT06003777|471030169|FG005|Period 1|Withdrawal by Subject|0|||
130836818|NCT06003777|471030170|FG006|Period 1|Withdrawal by Subject|0|||
130836819|NCT06003777|471030171|FG007|Period 1|Withdrawal by Subject|0|||
130836820|NCT06003777|471030172|FG008|Period 1|Withdrawal by Subject|0|||
130836821|NCT06003777|471030173|FG009|Period 1|Withdrawal by Subject|0|||
130836822|NCT06003777|471030174|FG010|Period 1|Withdrawal by Subject|0|||
130836823|NCT06003777|471030175|FG011|Period 1|Withdrawal by Subject|0|||
130836824|NCT06003777|471030164|FG000|Period 2|Withdrawal by Subject|0|||
130836825|NCT06003777|471030165|FG001|Period 2|Withdrawal by Subject|0|||
130836826|NCT06003777|471030166|FG002|Period 2|Withdrawal by Subject|0|||
130836827|NCT06003777|471030167|FG003|Period 2|Withdrawal by Subject|0|||
130836828|NCT06003777|471030168|FG004|Period 2|Withdrawal by Subject|0|||
130836829|NCT06003777|471030169|FG005|Period 2|Withdrawal by Subject|0|||
130836830|NCT06003777|471030170|FG006|Period 2|Withdrawal by Subject|0|||
130836831|NCT06003777|471030171|FG007|Period 2|Withdrawal by Subject|0|||
130836832|NCT06003777|471030172|FG008|Period 2|Withdrawal by Subject|1|||
130836833|NCT06003777|471030173|FG009|Period 2|Withdrawal by Subject|0|||
130836834|NCT06003777|471030174|FG010|Period 2|Withdrawal by Subject|0|||
130836835|NCT06003777|471030175|FG011|Period 2|Withdrawal by Subject|0|||
130836836|NCT06003777|471030164|FG000|Period 3|Adverse Event|0|||
130836837|NCT06003777|471030165|FG001|Period 3|Adverse Event|0|||
130836838|NCT06003777|471030166|FG002|Period 3|Adverse Event|0|||
130836839|NCT06003777|471030167|FG003|Period 3|Adverse Event|0|||
130836840|NCT06003777|471030168|FG004|Period 3|Adverse Event|0|||
130836841|NCT06003777|471030169|FG005|Period 3|Adverse Event|0|||
130836842|NCT06003777|471030170|FG006|Period 3|Adverse Event|1|||
130836843|NCT06003777|471030171|FG007|Period 3|Adverse Event|0|||
130836844|NCT06003777|471030172|FG008|Period 3|Adverse Event|0|||
130836845|NCT06003777|471030173|FG009|Period 3|Adverse Event|0|||
130836846|NCT06003777|471030174|FG010|Period 3|Adverse Event|0|||
130836847|NCT06003777|471030175|FG011|Period 3|Adverse Event|0|||
130836848|NCT06003777|471030164|FG000|Period 4|No longer met eligibility criteria|0|||
130836849|NCT06003777|471030165|FG001|Period 4|No longer met eligibility criteria|0|||
130836850|NCT06003777|471030166|FG002|Period 4|No longer met eligibility criteria|1|||
130836851|NCT06003777|471030167|FG003|Period 4|No longer met eligibility criteria|0|||
130836852|NCT06003777|471030168|FG004|Period 4|No longer met eligibility criteria|0|||
130836853|NCT06003777|471030169|FG005|Period 4|No longer met eligibility criteria|0|||
130836854|NCT06003777|471030170|FG006|Period 4|No longer met eligibility criteria|0|||
130836855|NCT06003777|471030171|FG007|Period 4|No longer met eligibility criteria|0|||
130836856|NCT06003777|471030172|FG008|Period 4|No longer met eligibility criteria|0|||
130836857|NCT06003777|471030173|FG009|Period 4|No longer met eligibility criteria|0|||
130836858|NCT06003777|471030174|FG010|Period 4|No longer met eligibility criteria|0|||
130836859|NCT06003777|471030175|FG011|Period 4|No longer met eligibility criteria|0|||
130836860|NCT06003777|471030164|FG000|Period 4|Withdrawal by Subject|0|||
130836861|NCT06003777|471030165|FG001|Period 4|Withdrawal by Subject|1|||
130836862|NCT06003777|471030166|FG002|Period 4|Withdrawal by Subject|0|||
130836863|NCT06003777|471030167|FG003|Period 4|Withdrawal by Subject|0|||
130836864|NCT06003777|471030168|FG004|Period 4|Withdrawal by Subject|0|||
130836865|NCT06003777|471030169|FG005|Period 4|Withdrawal by Subject|0|||
130836866|NCT06003777|471030170|FG006|Period 4|Withdrawal by Subject|0|||
130836867|NCT06003777|471030171|FG007|Period 4|Withdrawal by Subject|0|||
130836868|NCT06003777|471030172|FG008|Period 4|Withdrawal by Subject|0|||
130836869|NCT06003777|471030173|FG009|Period 4|Withdrawal by Subject|0|||
130836870|NCT06003777|471030174|FG010|Period 4|Withdrawal by Subject|0|||
130836871|NCT06003777|471030175|FG011|Period 4|Withdrawal by Subject|0|||
130836872|NCT04154605|471030179|FG000|Overall Study|Procedure Canceled|1|||
130836873|NCT04154605|471030180|FG001|Overall Study|Procedure Canceled|1|||
130836874|NCT04154605|471030179|FG000|Overall Study|Missed follow up|1|||
130836875|NCT04154605|471030180|FG001|Overall Study|Missed follow up|1|||
130836876|NCT04154605|471030179|FG000|Overall Study|Withdrawal by Subject|1|||
130836877|NCT04154605|471030180|FG001|Overall Study|Withdrawal by Subject|0|||
130836878|NCT01581021|471030181|FG000|Overall Study|Lost to Follow-up|4|||
130836879|NCT01581021|471030182|FG001|Overall Study|Lost to Follow-up|6|||
130836880|NCT01581021|471030181|FG000|Overall Study|More than 2 hooks in thoracic|3|||
130836881|NCT01581021|471030182|FG001|Overall Study|More than 2 hooks in thoracic|0|||
130836882|NCT01581021|471030181|FG000|Overall Study|Neuromuscular|2|||
130836883|NCT01581021|471030182|FG001|Overall Study|Neuromuscular|1|||
130836884|NCT01581021|471030181|FG000|Overall Study|Not Randomized|1|||
130836885|NCT01581021|471030182|FG001|Overall Study|Not Randomized|2|||
130836886|NCT01581021|471030181|FG000|Overall Study|Lenke 6 Classification|0|||
130836887|NCT01581021|471030182|FG001|Overall Study|Lenke 6 Classification|1|||
130836888|NCT01581021|471030181|FG000|Overall Study|Lack of Efficacy|0|||
130836889|NCT01581021|471030182|FG001|Overall Study|Lack of Efficacy|1|||
130836890|NCT00054327|471030185|FG000|Overall Study|Engraftment failure|1|||
130836891|NCT00054327|471030186|FG001|Overall Study|Engraftment failure|0|||
130836892|NCT00054327|471030187|FG002|Overall Study|Engraftment failure|0|||
130836893|NCT00054327|471030188|FG003|Overall Study|Engraftment failure|0|||
130836894|NCT00054327|471030189|FG004|Overall Study|Engraftment failure|0|||
130836895|NCT00054327|471030190|FG005|Overall Study|Engraftment failure|0|||
130836896|NCT00344318|471030191|FG000|Overall Study|Adverse Event|0|||
130836897|NCT00344318|471030192|FG001|Overall Study|Adverse Event|3|||
130836898|NCT00344318|471030193|FG002|Overall Study|Adverse Event|0|||
130836899|NCT00344318|471030194|FG003|Overall Study|Adverse Event|1|||
130836900|NCT00344318|471030191|FG000|Overall Study|Withdrawal by Subject|2|||
130836901|NCT00344318|471030192|FG001|Overall Study|Withdrawal by Subject|2|||
130836902|NCT00344318|471030193|FG002|Overall Study|Withdrawal by Subject|0|||
130836903|NCT00344318|471030194|FG003|Overall Study|Withdrawal by Subject|2|||
130836904|NCT00344318|471030191|FG000|Overall Study|Lost to Follow-up|2|||
130836905|NCT00344318|471030192|FG001|Overall Study|Lost to Follow-up|0|||
130836906|NCT00344318|471030193|FG002|Overall Study|Lost to Follow-up|1|||
130836907|NCT00344318|471030194|FG003|Overall Study|Lost to Follow-up|0|||
130836908|NCT01923363|471030195|FG000|Overall Study|Protocol Violation|1|||
130836909|NCT00290771|471030202|FG000|Overall Study|Disease progression|95|||
130836910|NCT00290771|471030203|FG001|Overall Study|Disease progression|73|||
130836911|NCT00290771|471030202|FG000|Overall Study|Death|11|||
130836912|NCT00290771|471030203|FG001|Overall Study|Death|10|||
130836913|NCT00290771|471030202|FG000|Overall Study|Adverse Event|12|||
130836914|NCT00290771|471030203|FG001|Overall Study|Adverse Event|6|||
130836915|NCT00290771|471030202|FG000|Overall Study|Withdrawal by Subject|5|||
130836916|NCT00290771|471030203|FG001|Overall Study|Withdrawal by Subject|6|||
130836917|NCT00290771|471030202|FG000|Overall Study|Administrative problems|2|||
130836918|NCT00290771|471030203|FG001|Overall Study|Administrative problems|1|||
130836919|NCT00290771|471030202|FG000|Overall Study|Protocol Violation|2|||
130836920|NCT00290771|471030203|FG001|Overall Study|Protocol Violation|0|||
130836921|NCT00290771|471030202|FG000|Overall Study|Lost to Follow-up|0|||
130836922|NCT00290771|471030203|FG001|Overall Study|Lost to Follow-up|1|||
130836923|NCT00244933|471030206|FG000|Overall Study|Not response evaluable|2|||
130836924|NCT00656058|471030208|FG000|Overall Study|Withdrawal by Subject|2|||
130836925|NCT00656058|471030208|FG000|Overall Study|Withdrawal by Subject|4|||
130836926|NCT06359028|471030209|FG000|Overall Study|Adverse Event|1|||
130836927|NCT06359028|471030210|FG001|Overall Study|Adverse Event|0|||
130836928|NCT06359028|471030209|FG000|Overall Study|Withdrawal by Subject|1|||
130836929|NCT06359028|471030210|FG001|Overall Study|Withdrawal by Subject|0|||
130836930|NCT03515551|471030211|FG000|Overall Study|Death|4|||
130836931|NCT03515551|471030212|FG001|Overall Study|Death|1|||
130836932|NCT03515551|471030213|FG002|Overall Study|Death|2|||
130836933|NCT03515551|471030214|FG003|Overall Study|Death|2|||
130836934|NCT03515551|471030215|FG004|Overall Study|Death|2|||
130836935|NCT03515551|471030216|FG005|Overall Study|Death|4|||
130836936|NCT03515551|471030217|FG006|Overall Study|Death|1|||
130836937|NCT03515551|471030211|FG000|Overall Study|Lost to Follow-up|0|||
130836938|NCT03515551|471030212|FG001|Overall Study|Lost to Follow-up|0|||
130836939|NCT03515551|471030213|FG002|Overall Study|Lost to Follow-up|1|||
130836940|NCT03515551|471030214|FG003|Overall Study|Lost to Follow-up|0|||
130836941|NCT03515551|471030215|FG004|Overall Study|Lost to Follow-up|0|||
130836942|NCT03515551|471030216|FG005|Overall Study|Lost to Follow-up|0|||
130836943|NCT03515551|471030217|FG006|Overall Study|Lost to Follow-up|0|||
130836944|NCT03515551|471030211|FG000|Overall Study|Withdrawal by Subject|0|||
130836945|NCT03515551|471030212|FG001|Overall Study|Withdrawal by Subject|1|||
130836946|NCT03515551|471030213|FG002|Overall Study|Withdrawal by Subject|0|||
130836947|NCT03515551|471030214|FG003|Overall Study|Withdrawal by Subject|0|||
130836948|NCT03515551|471030215|FG004|Overall Study|Withdrawal by Subject|0|||
130836949|NCT03515551|471030216|FG005|Overall Study|Withdrawal by Subject|0|||
130836950|NCT03515551|471030217|FG006|Overall Study|Withdrawal by Subject|1|||
130836951|NCT03515551|471030211|FG000|Overall Study|Study ended by sponsor|0|||
130836952|NCT03515551|471030212|FG001|Overall Study|Study ended by sponsor|0|||
130836953|NCT03515551|471030213|FG002|Overall Study|Study ended by sponsor|2|||
130836954|NCT03515551|471030214|FG003|Overall Study|Study ended by sponsor|1|||
130836955|NCT03515551|471030215|FG004|Overall Study|Study ended by sponsor|3|||
130836956|NCT03515551|471030216|FG005|Overall Study|Study ended by sponsor|0|||
130836957|NCT03515551|471030217|FG006|Overall Study|Study ended by sponsor|3|||
130836958|NCT03515551|471030211|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130836959|NCT03515551|471030212|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
130836960|NCT03515551|471030213|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130836961|NCT03515551|471030214|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130836962|NCT03515551|471030215|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130836963|NCT03515551|471030216|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130836964|NCT03515551|471030217|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130836965|NCT00920387|471030224|FG000|Stage 1|Adverse Event|1|||
130836966|NCT00920387|471030225|FG001|Stage 1|Adverse Event|0|||
130836967|NCT00920387|471030226|FG002|Stage 1|Adverse Event|0|||
130836968|NCT02265536|471030237|FG000|Overall Study|Adverse Event|1|||
130836969|NCT02265536|471030238|FG001|Overall Study|Adverse Event|0|||
130836970|NCT02265536|471030239|FG002|Overall Study|Adverse Event|0|||
130836971|NCT02265536|471030240|FG003|Overall Study|Adverse Event|0|||
130836972|NCT02265536|471030241|FG004|Overall Study|Adverse Event|1|||
130836973|NCT02265536|471030242|FG005|Overall Study|Adverse Event|0|||
130836974|NCT02265536|471030237|FG000|Overall Study|Physician Decision|0|||
130836975|NCT02265536|471030238|FG001|Overall Study|Physician Decision|0|||
130836976|NCT02265536|471030239|FG002|Overall Study|Physician Decision|0|||
130836977|NCT02265536|471030240|FG003|Overall Study|Physician Decision|0|||
130836978|NCT02265536|471030241|FG004|Overall Study|Physician Decision|2|||
130836979|NCT02265536|471030242|FG005|Overall Study|Physician Decision|0|||
130836980|NCT02265536|471030237|FG000|Overall Study|Withdrawal by Subject|0|||
130836981|NCT02265536|471030238|FG001|Overall Study|Withdrawal by Subject|3|||
130836982|NCT02265536|471030239|FG002|Overall Study|Withdrawal by Subject|0|||
130836983|NCT02265536|471030240|FG003|Overall Study|Withdrawal by Subject|0|||
130836984|NCT02265536|471030241|FG004|Overall Study|Withdrawal by Subject|0|||
130836985|NCT02265536|471030242|FG005|Overall Study|Withdrawal by Subject|0|||
130836986|NCT02602275|471030243|FG000|Day 1|Physician Decision|0|||
130836987|NCT02602275|471030244|FG001|Day 1|Physician Decision|1|||
130836988|NCT01866111|471030245|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
130836989|NCT01866111|471030246|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
130836990|NCT01866111|471030247|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
130836991|NCT01866111|471030248|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
130836992|NCT01866111|471030245|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
130836993|NCT01866111|471030246|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
130836994|NCT01866111|471030247|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
130836995|NCT01866111|471030248|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
130836996|NCT01866111|471030245|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
130836997|NCT01866111|471030246|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
130836998|NCT01866111|471030247|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
130836999|NCT01866111|471030248|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
130837000|NCT01866111|471030245|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
130837001|NCT01866111|471030246|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
130837002|NCT01866111|471030247|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
130837003|NCT01866111|471030248|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
130837004|NCT01866111|471030245|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
130837005|NCT01866111|471030246|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
130837006|NCT01866111|471030247|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
130837007|NCT01866111|471030248|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
130837008|NCT01866111|471030245|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
130837009|NCT01866111|471030246|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
130837010|NCT01866111|471030247|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
130837011|NCT01866111|471030248|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
130837012|NCT01866111|471030245|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
130837013|NCT01866111|471030246|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
130837014|NCT01866111|471030247|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
130837015|NCT01866111|471030248|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
130837016|NCT01866111|471030245|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
130837017|NCT01866111|471030246|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
130837018|NCT01866111|471030247|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
130837019|NCT01866111|471030248|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
130837020|NCT01866111|471030245|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
130837021|NCT01866111|471030246|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
130837022|NCT01866111|471030247|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
130837023|NCT01866111|471030248|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
130837024|NCT01866111|471030245|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
130837025|NCT01866111|471030246|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
130837026|NCT01866111|471030247|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
130837027|NCT01866111|471030248|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
130837028|NCT01866111|471030245|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
130837029|NCT01866111|471030246|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
130837030|NCT01866111|471030247|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
130837031|NCT01866111|471030248|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
130837032|NCT01866111|471030245|FG000|Open-label Extension Study YKP3089C017|Death|1|||
130837033|NCT01866111|471030246|FG001|Open-label Extension Study YKP3089C017|Death|1|||
130837034|NCT01866111|471030247|FG002|Open-label Extension Study YKP3089C017|Death|3|||
130837035|NCT01866111|471030248|FG003|Open-label Extension Study YKP3089C017|Death|2|||
130837036|NCT01866111|471030245|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
130837037|NCT01866111|471030246|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
130837038|NCT01866111|471030247|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
130837039|NCT01866111|471030248|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
130837040|NCT01866111|471030245|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
130837041|NCT01866111|471030246|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
130837042|NCT01866111|471030247|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
130837043|NCT01866111|471030248|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
130837044|NCT01866111|471030245|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
130837045|NCT01866111|471030246|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
130837046|NCT01866111|471030247|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
130837047|NCT01866111|471030248|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
130837048|NCT05596734|471030249|FG000|Substudy A|Withdrawal by Subject|1|||
130837049|NCT05596734|471030250|FG001|Substudy A|Withdrawal by Subject|0|||
130837050|NCT05596734|471030251|FG002|Substudy A|Withdrawal by Subject|0|||
130837051|NCT05596734|471030252|FG003|Substudy A|Withdrawal by Subject|0|||
130837052|NCT05596734|471030253|FG004|Substudy A|Withdrawal by Subject|0|||
130837053|NCT05596734|471030254|FG005|Substudy A|Withdrawal by Subject|0|||
130837054|NCT05596734|471030255|FG006|Substudy A|Withdrawal by Subject|1|||
130837055|NCT05596734|471030256|FG007|Substudy A|Withdrawal by Subject|0|||
130837056|NCT05596734|471030257|FG008|Substudy A|Withdrawal by Subject|0|||
130837057|NCT05596734|471030258|FG009|Substudy A|Withdrawal by Subject|0|||
130837058|NCT05596734|471030259|FG010|Substudy A|Withdrawal by Subject|0|||
130837059|NCT05596734|471030260|FG011|Substudy A|Withdrawal by Subject|0|||
130837060|NCT05596734|471030261|FG012|Substudy A|Withdrawal by Subject|0|||
130837061|NCT05596734|471030262|FG013|Substudy A|Withdrawal by Subject|0|||
130837062|NCT05596734|471030263|FG014|Substudy A|Withdrawal by Subject|0|||
130837063|NCT05596734|471030264|FG015|Substudy A|Withdrawal by Subject|0|||
130837064|NCT05596734|471030265|FG016|Substudy A|Withdrawal by Subject|0|||
130837065|NCT05596734|471030266|FG017|Substudy A|Withdrawal by Subject|0|||
130837066|NCT05596734|471030267|FG018|Substudy A|Withdrawal by Subject|0|||
130837067|NCT05596734|471030268|FG019|Substudy A|Withdrawal by Subject|0|||
130837068|NCT05596734|471030269|FG020|Substudy A|Withdrawal by Subject|0|||
130837069|NCT05596734|471030270|FG021|Substudy A|Withdrawal by Subject|0|||
130837070|NCT05596734|471030271|FG022|Substudy A|Withdrawal by Subject|0|||
130837071|NCT05596734|471030272|FG023|Substudy A|Withdrawal by Subject|0|||
130837072|NCT05596734|471030249|FG000|Substudy A|Lost to Follow-up|1|||
130837073|NCT05596734|471030250|FG001|Substudy A|Lost to Follow-up|0|||
130837074|NCT05596734|471030251|FG002|Substudy A|Lost to Follow-up|1|||
130837075|NCT05596734|471030252|FG003|Substudy A|Lost to Follow-up|0|||
130837076|NCT05596734|471030253|FG004|Substudy A|Lost to Follow-up|0|||
130837077|NCT05596734|471030254|FG005|Substudy A|Lost to Follow-up|0|||
130837078|NCT05596734|471030255|FG006|Substudy A|Lost to Follow-up|0|||
130837079|NCT05596734|471030256|FG007|Substudy A|Lost to Follow-up|0|||
130837080|NCT05596734|471030257|FG008|Substudy A|Lost to Follow-up|0|||
130837081|NCT05596734|471030258|FG009|Substudy A|Lost to Follow-up|0|||
130837082|NCT05596734|471030259|FG010|Substudy A|Lost to Follow-up|0|||
130837083|NCT05596734|471030260|FG011|Substudy A|Lost to Follow-up|0|||
130837084|NCT05596734|471030261|FG012|Substudy A|Lost to Follow-up|0|||
130837085|NCT05596734|471030262|FG013|Substudy A|Lost to Follow-up|0|||
130837086|NCT05596734|471030263|FG014|Substudy A|Lost to Follow-up|0|||
130837087|NCT05596734|471030264|FG015|Substudy A|Lost to Follow-up|0|||
130837088|NCT05596734|471030265|FG016|Substudy A|Lost to Follow-up|0|||
130837089|NCT05596734|471030266|FG017|Substudy A|Lost to Follow-up|0|||
130837090|NCT05596734|471030267|FG018|Substudy A|Lost to Follow-up|0|||
130837091|NCT05596734|471030268|FG019|Substudy A|Lost to Follow-up|0|||
130837092|NCT05596734|471030269|FG020|Substudy A|Lost to Follow-up|0|||
130837093|NCT05596734|471030270|FG021|Substudy A|Lost to Follow-up|0|||
130837094|NCT05596734|471030271|FG022|Substudy A|Lost to Follow-up|0|||
130837095|NCT05596734|471030272|FG023|Substudy A|Lost to Follow-up|0|||
130837096|NCT05596734|471030249|FG000|Substudy B|Withdrawal by Subject|0|||
130837097|NCT05596734|471030250|FG001|Substudy B|Withdrawal by Subject|0|||
130837098|NCT05596734|471030251|FG002|Substudy B|Withdrawal by Subject|0|||
130837099|NCT05596734|471030252|FG003|Substudy B|Withdrawal by Subject|0|||
130837100|NCT05596734|471030253|FG004|Substudy B|Withdrawal by Subject|0|||
130837101|NCT05596734|471030254|FG005|Substudy B|Withdrawal by Subject|0|||
130837102|NCT05596734|471030255|FG006|Substudy B|Withdrawal by Subject|0|||
130837103|NCT05596734|471030256|FG007|Substudy B|Withdrawal by Subject|0|||
130837104|NCT05596734|471030257|FG008|Substudy B|Withdrawal by Subject|0|||
130837105|NCT05596734|471030258|FG009|Substudy B|Withdrawal by Subject|0|||
130837106|NCT05596734|471030259|FG010|Substudy B|Withdrawal by Subject|0|||
130837107|NCT05596734|471030260|FG011|Substudy B|Withdrawal by Subject|0|||
130837108|NCT05596734|471030261|FG012|Substudy B|Withdrawal by Subject|1|||
130837109|NCT05596734|471030262|FG013|Substudy B|Withdrawal by Subject|0|||
130837110|NCT05596734|471030263|FG014|Substudy B|Withdrawal by Subject|1|||
130837111|NCT05596734|471030264|FG015|Substudy B|Withdrawal by Subject|2|||
130837112|NCT05596734|471030265|FG016|Substudy B|Withdrawal by Subject|2|||
130837113|NCT05596734|471030266|FG017|Substudy B|Withdrawal by Subject|1|||
130837114|NCT05596734|471030267|FG018|Substudy B|Withdrawal by Subject|2|||
130837115|NCT05596734|471030268|FG019|Substudy B|Withdrawal by Subject|0|||
130837116|NCT05596734|471030269|FG020|Substudy B|Withdrawal by Subject|0|||
130837117|NCT05596734|471030270|FG021|Substudy B|Withdrawal by Subject|0|||
130837118|NCT05596734|471030271|FG022|Substudy B|Withdrawal by Subject|0|||
130837119|NCT05596734|471030272|FG023|Substudy B|Withdrawal by Subject|1|||
130837120|NCT05596734|471030249|FG000|Substudy B|Physician Decision|0|||
130837121|NCT05596734|471030250|FG001|Substudy B|Physician Decision|0|||
130837122|NCT05596734|471030251|FG002|Substudy B|Physician Decision|0|||
130837123|NCT05596734|471030252|FG003|Substudy B|Physician Decision|0|||
130837124|NCT05596734|471030253|FG004|Substudy B|Physician Decision|0|||
130837125|NCT05596734|471030254|FG005|Substudy B|Physician Decision|0|||
130837126|NCT05596734|471030255|FG006|Substudy B|Physician Decision|0|||
130837127|NCT05596734|471030256|FG007|Substudy B|Physician Decision|0|||
130837128|NCT05596734|471030257|FG008|Substudy B|Physician Decision|0|||
130837129|NCT05596734|471030258|FG009|Substudy B|Physician Decision|0|||
130837130|NCT05596734|471030259|FG010|Substudy B|Physician Decision|0|||
130837131|NCT05596734|471030260|FG011|Substudy B|Physician Decision|0|||
130837132|NCT05596734|471030261|FG012|Substudy B|Physician Decision|0|||
130837133|NCT05596734|471030262|FG013|Substudy B|Physician Decision|0|||
130837134|NCT05596734|471030263|FG014|Substudy B|Physician Decision|0|||
130837135|NCT05596734|471030264|FG015|Substudy B|Physician Decision|1|||
130837136|NCT05596734|471030265|FG016|Substudy B|Physician Decision|0|||
130837137|NCT05596734|471030266|FG017|Substudy B|Physician Decision|0|||
130837138|NCT05596734|471030267|FG018|Substudy B|Physician Decision|0|||
130837139|NCT05596734|471030268|FG019|Substudy B|Physician Decision|0|||
130837140|NCT05596734|471030269|FG020|Substudy B|Physician Decision|0|||
130837141|NCT05596734|471030270|FG021|Substudy B|Physician Decision|0|||
130837142|NCT05596734|471030271|FG022|Substudy B|Physician Decision|0|||
130837143|NCT05596734|471030272|FG023|Substudy B|Physician Decision|0|||
130837144|NCT05596734|471030249|FG000|Substudy B|Lost to Follow-up|0|||
130837145|NCT05596734|471030250|FG001|Substudy B|Lost to Follow-up|0|||
130837146|NCT05596734|471030251|FG002|Substudy B|Lost to Follow-up|0|||
130837147|NCT05596734|471030252|FG003|Substudy B|Lost to Follow-up|0|||
130837148|NCT05596734|471030253|FG004|Substudy B|Lost to Follow-up|0|||
130837149|NCT05596734|471030254|FG005|Substudy B|Lost to Follow-up|0|||
130837150|NCT05596734|471030255|FG006|Substudy B|Lost to Follow-up|0|||
130837151|NCT05596734|471030256|FG007|Substudy B|Lost to Follow-up|0|||
130837152|NCT05596734|471030257|FG008|Substudy B|Lost to Follow-up|0|||
130837153|NCT05596734|471030258|FG009|Substudy B|Lost to Follow-up|0|||
130837154|NCT05596734|471030259|FG010|Substudy B|Lost to Follow-up|0|||
130837155|NCT05596734|471030260|FG011|Substudy B|Lost to Follow-up|0|||
130837156|NCT05596734|471030261|FG012|Substudy B|Lost to Follow-up|1|||
130837157|NCT05596734|471030262|FG013|Substudy B|Lost to Follow-up|0|||
130837158|NCT05596734|471030263|FG014|Substudy B|Lost to Follow-up|1|||
130837159|NCT05596734|471030264|FG015|Substudy B|Lost to Follow-up|1|||
130837160|NCT05596734|471030265|FG016|Substudy B|Lost to Follow-up|0|||
130837161|NCT05596734|471030266|FG017|Substudy B|Lost to Follow-up|0|||
130837162|NCT05596734|471030267|FG018|Substudy B|Lost to Follow-up|0|||
130837163|NCT05596734|471030268|FG019|Substudy B|Lost to Follow-up|0|||
130837164|NCT05596734|471030269|FG020|Substudy B|Lost to Follow-up|0|||
130837165|NCT05596734|471030270|FG021|Substudy B|Lost to Follow-up|0|||
130837166|NCT05596734|471030271|FG022|Substudy B|Lost to Follow-up|0|||
130837167|NCT05596734|471030272|FG023|Substudy B|Lost to Follow-up|0|||
130837168|NCT04113018|471030275|FG000|Overall Study|Death|2|||
130837169|NCT04113018|471030275|FG000|Overall Study|Lost to Follow-up|1|||
130837170|NCT04113018|471030275|FG000|Overall Study|Still On Study (on study treatment)|24|||
130837171|NCT04113018|471030275|FG000|Overall Study|Still On Study (in follow up)|12|||
130837172|NCT01108731|471030276|FG000|Overall Study|Withdrawal by Subject|1|||
130837173|NCT01108731|471030277|FG001|Overall Study|Withdrawal by Subject|1|||
130837174|NCT01108731|471030276|FG000|Overall Study|Adverse Event|3|||
130837175|NCT01108731|471030277|FG001|Overall Study|Adverse Event|3|||
130837176|NCT03802630|471030278|FG000|Overall Study|Study terminated by sponsor|130|||
130837177|NCT03802630|471030279|FG001|Overall Study|Study terminated by sponsor|134|||
130837178|NCT03802630|471030278|FG000|Overall Study|Subject decision|16|||
130837179|NCT03802630|471030279|FG001|Overall Study|Subject decision|9|||
130837180|NCT03802630|471030278|FG000|Overall Study|Adverse Event|3|||
130837181|NCT03802630|471030279|FG001|Overall Study|Adverse Event|1|||
130837182|NCT03802630|471030278|FG000|Overall Study|Lost to Follow-up|2|||
130837183|NCT03802630|471030279|FG001|Overall Study|Lost to Follow-up|2|||
130837184|NCT03802630|471030278|FG000|Overall Study|Physician Decision|2|||
130837185|NCT03802630|471030279|FG001|Overall Study|Physician Decision|0|||
130837186|NCT03802630|471030278|FG000|Overall Study|Death|0|||
130837187|NCT03802630|471030279|FG001|Overall Study|Death|2|||
130837188|NCT00157196|471030280|FG000|Overall Study|Ongoing at data cut-off|9|||
130837189|NCT05005013|471030281|FG000|Overall Study|Withdrawal by Subject|5|||
130837190|NCT05005013|471030282|FG001|Overall Study|Withdrawal by Subject|1|||
130837191|NCT05005013|471030281|FG000|Overall Study|Lost to Follow-up|3|||
130837192|NCT05005013|471030282|FG001|Overall Study|Lost to Follow-up|1|||
130837193|NCT05005013|471030281|FG000|Overall Study|Ineligibility|1|||
130837194|NCT05005013|471030282|FG001|Overall Study|Ineligibility|1|||
130837195|NCT04210245|471030283|FG000|Overall Study|Adverse Event|0|||
130837196|NCT04210245|471030284|FG001|Overall Study|Adverse Event|3|||
130837197|NCT04210245|471030285|FG002|Overall Study|Adverse Event|6|||
130837198|NCT04210245|471030286|FG003|Overall Study|Adverse Event|0|||
130837199|NCT04210245|471030283|FG000|Overall Study|Withdrawal by Subject|0|||
130837200|NCT04210245|471030284|FG001|Overall Study|Withdrawal by Subject|1|||
130837201|NCT04210245|471030285|FG002|Overall Study|Withdrawal by Subject|4|||
130837202|NCT04210245|471030286|FG003|Overall Study|Withdrawal by Subject|4|||
130837203|NCT04210245|471030283|FG000|Overall Study|Lost to Follow-up|0|||
130837204|NCT04210245|471030284|FG001|Overall Study|Lost to Follow-up|1|||
130837205|NCT04210245|471030285|FG002|Overall Study|Lost to Follow-up|1|||
130837206|NCT04210245|471030286|FG003|Overall Study|Lost to Follow-up|1|||
130837207|NCT04210245|471030283|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
130837208|NCT04210245|471030284|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
130837209|NCT04210245|471030285|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
130837210|NCT04210245|471030286|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
130837211|NCT01802580|471030289|FG000|Overall Study|Physician Decision|1|||
130837212|NCT01802580|471030290|FG001|Overall Study|Physician Decision|0|||
130837213|NCT01802580|471030289|FG000|Overall Study|Protocol Violation|2|||
130837214|NCT01802580|471030290|FG001|Overall Study|Protocol Violation|0|||
130837215|NCT01802580|471030289|FG000|Overall Study|Withdrawal by Subject|5|||
130837216|NCT01802580|471030290|FG001|Overall Study|Withdrawal by Subject|6|||
130837217|NCT01802580|471030289|FG000|Overall Study|Other|1|||
130837218|NCT01802580|471030290|FG001|Overall Study|Other|3|||
130837219|NCT01802580|471030289|FG000|Overall Study|Lack of Efficacy|0|||
130837220|NCT01802580|471030290|FG001|Overall Study|Lack of Efficacy|2|||
130837221|NCT01252186|471030291|FG000|Overall Study|Adverse Event|9|||
130837222|NCT01252186|471030292|FG001|Overall Study|Adverse Event|6|||
130837223|NCT01252186|471030293|FG002|Overall Study|Adverse Event|8|||
130837224|NCT01252186|471030291|FG000|Overall Study|Withdrawal by Subject|2|||
130837225|NCT01252186|471030292|FG001|Overall Study|Withdrawal by Subject|5|||
130837226|NCT01252186|471030293|FG002|Overall Study|Withdrawal by Subject|2|||
130837227|NCT01252186|471030291|FG000|Overall Study|Physician Decision|0|||
130837228|NCT01252186|471030292|FG001|Overall Study|Physician Decision|0|||
130837229|NCT01252186|471030293|FG002|Overall Study|Physician Decision|1|||
130837230|NCT01252186|471030291|FG000|Overall Study|Non-compliance|0|||
130837231|NCT01252186|471030292|FG001|Overall Study|Non-compliance|3|||
130837232|NCT01252186|471030293|FG002|Overall Study|Non-compliance|4|||
130837233|NCT01252186|471030291|FG000|Overall Study|Protocol Violation|0|||
130837234|NCT01252186|471030292|FG001|Overall Study|Protocol Violation|0|||
130837235|NCT01252186|471030293|FG002|Overall Study|Protocol Violation|1|||
130837236|NCT01252186|471030291|FG000|Overall Study|Pregnancy|2|||
130837237|NCT01252186|471030292|FG001|Overall Study|Pregnancy|2|||
130837238|NCT01252186|471030293|FG002|Overall Study|Pregnancy|0|||
130837239|NCT01252186|471030291|FG000|Overall Study|Sponsor Request|2|||
130837240|NCT01252186|471030292|FG001|Overall Study|Sponsor Request|1|||
130837241|NCT01252186|471030293|FG002|Overall Study|Sponsor Request|0|||
130837242|NCT01252186|471030291|FG000|Overall Study|Lost to Follow-up|10|||
130837243|NCT01252186|471030292|FG001|Overall Study|Lost to Follow-up|10|||
130837244|NCT01252186|471030293|FG002|Overall Study|Lost to Follow-up|11|||
130837245|NCT01252186|471030291|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
130837246|NCT01252186|471030292|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
130837247|NCT01252186|471030293|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
130837248|NCT02791516|471030298|FG000|Overall Study|Withdrawal by Subject|1|||
130837249|NCT02791516|471030299|FG001|Overall Study|Withdrawal by Subject|1|||
130837250|NCT02524275|471030300|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
130837251|NCT04283994|471030302|FG000|Overall Study|Death|11|||
130837252|NCT04283994|471030303|FG001|Overall Study|Death|20|||
130837253|NCT04283994|471030304|FG002|Overall Study|Death|11|||
130837254|NCT04283994|471030305|FG003|Overall Study|Death|0|||
130837255|NCT04283994|471030306|FG004|Overall Study|Death|0|||
130837256|NCT04283994|471030307|FG005|Overall Study|Death|0|||
130837257|NCT04283994|471030308|FG006|Overall Study|Death|0|||
130837258|NCT04283994|471030302|FG000|Overall Study|Withdrawal by Subject|16|||
130837259|NCT04283994|471030303|FG001|Overall Study|Withdrawal by Subject|4|||
130837260|NCT04283994|471030304|FG002|Overall Study|Withdrawal by Subject|6|||
130837261|NCT04283994|471030305|FG003|Overall Study|Withdrawal by Subject|1|||
130837262|NCT04283994|471030306|FG004|Overall Study|Withdrawal by Subject|0|||
130837263|NCT04283994|471030307|FG005|Overall Study|Withdrawal by Subject|1|||
130837264|NCT04283994|471030308|FG006|Overall Study|Withdrawal by Subject|0|||
130837265|NCT03763656|471030309|FG000|Overall Study|Physician Decision|1|||
130837266|NCT03763656|471030309|FG000|Overall Study|Protocol Violation|1|||
130837267|NCT03763656|471030309|FG000|Overall Study|Withdrawal by Subject|7|||
130837268|NCT00211757|471030310|FG000|Overall Study|Withdrawal by Subject|1|||
130837269|NCT00211757|471030311|FG001|Overall Study|Withdrawal by Subject|1|||
130837270|NCT00211757|471030310|FG000|Overall Study|Lack of Efficacy|0|||
130837271|NCT00211757|471030311|FG001|Overall Study|Lack of Efficacy|1|||
130837272|NCT00322452|471030314|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130837273|NCT00322452|471030315|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130837274|NCT00322452|471030314|FG000|Overall Study|Lost to Follow-up|5|||
130837275|NCT00322452|471030315|FG001|Overall Study|Lost to Follow-up|2|||
130837276|NCT00322452|471030314|FG000|Overall Study|Withdrawal by Subject|19|||
130837277|NCT00322452|471030315|FG001|Overall Study|Withdrawal by Subject|46|||
130837278|NCT00322452|471030314|FG000|Overall Study|Death|223|||
130837279|NCT00322452|471030315|FG001|Overall Study|Death|227|||
130837280|NCT04091581|471030316|FG000|Overall Study|Lost to Follow-up|0|||
130837281|NCT04091581|471030317|FG001|Overall Study|Lost to Follow-up|1|||
130837282|NCT01795495|471030318|FG000|Overall Study|Protocol Violation|1|||
130837283|NCT01795495|471030319|FG001|Overall Study|Protocol Violation|0|||
130837284|NCT01795495|471030320|FG002|Overall Study|Protocol Violation|1|||
130837285|NCT01795495|471030318|FG000|Overall Study|Physician Decision|0|||
130837286|NCT01795495|471030319|FG001|Overall Study|Physician Decision|0|||
130837287|NCT01795495|471030320|FG002|Overall Study|Physician Decision|1|||
130837288|NCT01331837|471030321|FG000|Overall Study|Death|30|||
130837289|NCT01331837|471030322|FG001|Overall Study|Death|34|||
130837290|NCT01331837|471030321|FG000|Overall Study|Lost to Follow-up|3|||
130837291|NCT01331837|471030322|FG001|Overall Study|Lost to Follow-up|1|||
130837292|NCT01331837|471030321|FG000|Overall Study|Info not recorded|10|||
130837293|NCT01331837|471030322|FG001|Overall Study|Info not recorded|16|||
130837294|NCT01331837|471030321|FG000|Overall Study|Withdrawal by Subject|13|||
130837295|NCT01331837|471030322|FG001|Overall Study|Withdrawal by Subject|16|||
130837296|NCT00734604|471032036|FG000|Overall Study|Adverse Event|0|||
130837297|NCT00734604|471032037|FG001|Overall Study|Adverse Event|2|||
130837298|NCT00734604|471032038|FG002|Overall Study|Adverse Event|0|||
130837299|NCT00734604|471032039|FG003|Overall Study|Adverse Event|2|||
130837300|NCT00734604|471032040|FG004|Overall Study|Adverse Event|1|||
130837301|NCT00734604|471032041|FG005|Overall Study|Adverse Event|1|||
130837302|NCT00734604|471032036|FG000|Overall Study|Serious Adverse Event|1|||
130837303|NCT00734604|471032037|FG001|Overall Study|Serious Adverse Event|0|||
130837304|NCT00734604|471032038|FG002|Overall Study|Serious Adverse Event|1|||
130837305|NCT00734604|471032039|FG003|Overall Study|Serious Adverse Event|2|||
130837306|NCT00734604|471032040|FG004|Overall Study|Serious Adverse Event|0|||
130837307|NCT00734604|471032041|FG005|Overall Study|Serious Adverse Event|1|||
130837308|NCT00734604|471032036|FG000|Overall Study|Lost to Follow-up|1|||
130837309|NCT00734604|471032037|FG001|Overall Study|Lost to Follow-up|2|||
130837310|NCT00734604|471032038|FG002|Overall Study|Lost to Follow-up|2|||
130837311|NCT00734604|471032039|FG003|Overall Study|Lost to Follow-up|4|||
130837312|NCT00734604|471032040|FG004|Overall Study|Lost to Follow-up|2|||
130837313|NCT00734604|471032041|FG005|Overall Study|Lost to Follow-up|3|||
130837314|NCT00734604|471032036|FG000|Overall Study|Physician Decision|0|||
130837315|NCT00734604|471032037|FG001|Overall Study|Physician Decision|1|||
130837316|NCT00734604|471032038|FG002|Overall Study|Physician Decision|1|||
130837317|NCT00734604|471032039|FG003|Overall Study|Physician Decision|0|||
130837318|NCT00734604|471032040|FG004|Overall Study|Physician Decision|0|||
130837319|NCT00734604|471032041|FG005|Overall Study|Physician Decision|0|||
130837320|NCT00734604|471032036|FG000|Overall Study|Protocol Violation|0|||
130837321|NCT00734604|471032037|FG001|Overall Study|Protocol Violation|2|||
130837322|NCT00734604|471032038|FG002|Overall Study|Protocol Violation|0|||
130837323|NCT00734604|471032039|FG003|Overall Study|Protocol Violation|0|||
130837324|NCT00734604|471032040|FG004|Overall Study|Protocol Violation|1|||
130837325|NCT00734604|471032041|FG005|Overall Study|Protocol Violation|0|||
130837326|NCT00734604|471032036|FG000|Overall Study|Sponsor Decision|1|||
130837327|NCT00734604|471032037|FG001|Overall Study|Sponsor Decision|2|||
130837328|NCT00734604|471032038|FG002|Overall Study|Sponsor Decision|1|||
130837329|NCT00734604|471032039|FG003|Overall Study|Sponsor Decision|0|||
130837330|NCT00734604|471032040|FG004|Overall Study|Sponsor Decision|2|||
130837331|NCT00734604|471032041|FG005|Overall Study|Sponsor Decision|0|||
130837332|NCT00734604|471032036|FG000|Overall Study|Withdrawal by Subject|0|||
130837333|NCT00734604|471032037|FG001|Overall Study|Withdrawal by Subject|2|||
130837334|NCT00734604|471032038|FG002|Overall Study|Withdrawal by Subject|0|||
130837335|NCT00734604|471032039|FG003|Overall Study|Withdrawal by Subject|1|||
130837336|NCT00734604|471032040|FG004|Overall Study|Withdrawal by Subject|2|||
130837337|NCT00734604|471032041|FG005|Overall Study|Withdrawal by Subject|1|||
130837338|NCT00734604|471032036|FG000|Overall Study|Lack of Efficacy|0|||
130837339|NCT00734604|471032037|FG001|Overall Study|Lack of Efficacy|1|||
130837340|NCT00734604|471032038|FG002|Overall Study|Lack of Efficacy|1|||
130837341|NCT00734604|471032039|FG003|Overall Study|Lack of Efficacy|0|||
130837342|NCT00734604|471032040|FG004|Overall Study|Lack of Efficacy|0|||
130837343|NCT00734604|471032041|FG005|Overall Study|Lack of Efficacy|0|||
130837344|NCT00327015|471032042|FG000|Overall Study|Lack of Efficacy|18|||
130837345|NCT00327015|471032043|FG001|Overall Study|Lack of Efficacy|18|||
130837346|NCT00327015|471032044|FG002|Overall Study|Lack of Efficacy|35|||
130837347|NCT00327015|471032045|FG003|Overall Study|Lack of Efficacy|29|||
130837348|NCT00327015|471032042|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
130837349|NCT00327015|471032043|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
130837350|NCT00327015|471032044|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
130837351|NCT00327015|471032045|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
130837352|NCT00327015|471032042|FG000|Overall Study|Lost to Follow-up|22|||
130837353|NCT00327015|471032043|FG001|Overall Study|Lost to Follow-up|23|||
130837354|NCT00327015|471032044|FG002|Overall Study|Lost to Follow-up|29|||
130837355|NCT00327015|471032045|FG003|Overall Study|Lost to Follow-up|22|||
130837356|NCT00327015|471032042|FG000|Overall Study|Adverse Event|14|||
130837357|NCT00327015|471032043|FG001|Overall Study|Adverse Event|10|||
130837358|NCT00327015|471032044|FG002|Overall Study|Adverse Event|14|||
130837359|NCT00327015|471032045|FG003|Overall Study|Adverse Event|14|||
130837360|NCT00327015|471032042|FG000|Overall Study|Subject no longer meets study criteria|4|||
130837361|NCT00327015|471032043|FG001|Overall Study|Subject no longer meets study criteria|2|||
130837362|NCT00327015|471032044|FG002|Overall Study|Subject no longer meets study criteria|8|||
130837363|NCT00327015|471032045|FG003|Overall Study|Subject no longer meets study criteria|7|||
130837364|NCT00327015|471032042|FG000|Overall Study|Poor/Noncompliance|11|||
130837365|NCT00327015|471032043|FG001|Overall Study|Poor/Noncompliance|8|||
130837366|NCT00327015|471032044|FG002|Overall Study|Poor/Noncompliance|4|||
130837367|NCT00327015|471032045|FG003|Overall Study|Poor/Noncompliance|5|||
130837368|NCT00327015|471032042|FG000|Overall Study|Physician Decision|0|||
130837369|NCT00327015|471032043|FG001|Overall Study|Physician Decision|1|||
130837370|NCT00327015|471032044|FG002|Overall Study|Physician Decision|3|||
130837371|NCT00327015|471032045|FG003|Overall Study|Physician Decision|2|||
130837372|NCT00327015|471032042|FG000|Overall Study|Death|1|||
130837373|NCT00327015|471032043|FG001|Overall Study|Death|2|||
130837374|NCT00327015|471032044|FG002|Overall Study|Death|2|||
130837375|NCT00327015|471032045|FG003|Overall Study|Death|3|||
130837376|NCT00327015|471032042|FG000|Overall Study|Pregnancy|0|||
130837377|NCT00327015|471032043|FG001|Overall Study|Pregnancy|2|||
130837378|NCT00327015|471032044|FG002|Overall Study|Pregnancy|1|||
130837379|NCT00327015|471032045|FG003|Overall Study|Pregnancy|1|||
130837380|NCT00327015|471032042|FG000|Overall Study|Administrative Reason by Sponsor|1|||
130837381|NCT00327015|471032043|FG001|Overall Study|Administrative Reason by Sponsor|2|||
130837382|NCT00327015|471032044|FG002|Overall Study|Administrative Reason by Sponsor|2|||
130837383|NCT00327015|471032045|FG003|Overall Study|Administrative Reason by Sponsor|1|||
130837384|NCT00837265|471032046|FG000|Pilot Phase|Withdrawal by Subject|0|||
130837385|NCT00837265|471032047|FG001|Pilot Phase|Withdrawal by Subject|2|||
130837386|NCT00837265|471032048|FG002|Pilot Phase|Withdrawal by Subject|3|||
130837387|NCT00837265|471032049|FG003|Pilot Phase|Withdrawal by Subject|2|||
130837388|NCT00837265|471032050|FG004|Pilot Phase|Withdrawal by Subject|0|||
130837389|NCT00837265|471032051|FG005|Pilot Phase|Withdrawal by Subject|0|||
130837390|NCT00837265|471032052|FG006|Pilot Phase|Withdrawal by Subject|0|||
130837391|NCT00837265|471032046|FG000|Pilot Phase|Decision of the investigator|2|||
130837392|NCT00837265|471032047|FG001|Pilot Phase|Decision of the investigator|1|||
130837393|NCT00837265|471032048|FG002|Pilot Phase|Decision of the investigator|0|||
130837394|NCT00837265|471032049|FG003|Pilot Phase|Decision of the investigator|0|||
130837395|NCT00837265|471032050|FG004|Pilot Phase|Decision of the investigator|0|||
130837396|NCT00837265|471032051|FG005|Pilot Phase|Decision of the investigator|0|||
130837397|NCT00837265|471032052|FG006|Pilot Phase|Decision of the investigator|0|||
130837398|NCT00837265|471032046|FG000|Pilot Phase|Adverse Event|1|||
130837399|NCT00837265|471032047|FG001|Pilot Phase|Adverse Event|0|||
130837400|NCT00837265|471032048|FG002|Pilot Phase|Adverse Event|0|||
130837401|NCT00837265|471032049|FG003|Pilot Phase|Adverse Event|0|||
130837402|NCT00837265|471032050|FG004|Pilot Phase|Adverse Event|0|||
130837403|NCT00837265|471032051|FG005|Pilot Phase|Adverse Event|0|||
130837404|NCT00837265|471032052|FG006|Pilot Phase|Adverse Event|0|||
130837405|NCT00837265|471032046|FG000|Pilot Phase|Disease progression|0|||
130837406|NCT00837265|471032047|FG001|Pilot Phase|Disease progression|0|||
130837407|NCT00837265|471032048|FG002|Pilot Phase|Disease progression|0|||
130837408|NCT00837265|471032049|FG003|Pilot Phase|Disease progression|1|||
130837409|NCT00837265|471032050|FG004|Pilot Phase|Disease progression|0|||
130837410|NCT00837265|471032051|FG005|Pilot Phase|Disease progression|0|||
130837411|NCT00837265|471032052|FG006|Pilot Phase|Disease progression|0|||
130837412|NCT00837265|471032046|FG000|Pilot Phase|Participant left the city|0|||
130837413|NCT00837265|471032047|FG001|Pilot Phase|Participant left the city|0|||
130837414|NCT00837265|471032048|FG002|Pilot Phase|Participant left the city|0|||
130837415|NCT00837265|471032049|FG003|Pilot Phase|Participant left the city|1|||
130837416|NCT00837265|471032050|FG004|Pilot Phase|Participant left the city|0|||
130837417|NCT00837265|471032051|FG005|Pilot Phase|Participant left the city|0|||
130837418|NCT00837265|471032052|FG006|Pilot Phase|Participant left the city|0|||
130837419|NCT00837265|471032046|FG000|Main Phase|Withdrawal by Subject|0|||
130837420|NCT00837265|471032047|FG001|Main Phase|Withdrawal by Subject|0|||
130837421|NCT00837265|471032048|FG002|Main Phase|Withdrawal by Subject|0|||
130837422|NCT00837265|471032049|FG003|Main Phase|Withdrawal by Subject|0|||
130837423|NCT00837265|471032050|FG004|Main Phase|Withdrawal by Subject|4|||
130837424|NCT00837265|471032051|FG005|Main Phase|Withdrawal by Subject|2|||
130837425|NCT00837265|471032052|FG006|Main Phase|Withdrawal by Subject|1|||
130837426|NCT00837265|471032046|FG000|Main Phase|Decision of the investigator|0|||
130837427|NCT00837265|471032047|FG001|Main Phase|Decision of the investigator|0|||
130837428|NCT00837265|471032048|FG002|Main Phase|Decision of the investigator|0|||
130837429|NCT00837265|471032049|FG003|Main Phase|Decision of the investigator|0|||
130837430|NCT00837265|471032050|FG004|Main Phase|Decision of the investigator|0|||
130837431|NCT00837265|471032051|FG005|Main Phase|Decision of the investigator|2|||
130837432|NCT00837265|471032052|FG006|Main Phase|Decision of the investigator|1|||
130837433|NCT00837265|471032046|FG000|Main Phase|Adverse Event|0|||
130837434|NCT00837265|471032047|FG001|Main Phase|Adverse Event|0|||
130837435|NCT00837265|471032048|FG002|Main Phase|Adverse Event|0|||
130837436|NCT00837265|471032049|FG003|Main Phase|Adverse Event|0|||
130837437|NCT00837265|471032050|FG004|Main Phase|Adverse Event|0|||
130837438|NCT00837265|471032051|FG005|Main Phase|Adverse Event|1|||
130837439|NCT00837265|471032052|FG006|Main Phase|Adverse Event|0|||
130837440|NCT00837265|471032046|FG000|Main Phase|Death|0|||
130837441|NCT00837265|471032047|FG001|Main Phase|Death|0|||
130837442|NCT00837265|471032048|FG002|Main Phase|Death|0|||
130837443|NCT00837265|471032049|FG003|Main Phase|Death|0|||
130837444|NCT00837265|471032050|FG004|Main Phase|Death|2|||
130837445|NCT00837265|471032051|FG005|Main Phase|Death|0|||
130837446|NCT00837265|471032052|FG006|Main Phase|Death|1|||
130837447|NCT00837265|471032046|FG000|Main Phase|Lost to Follow-up|0|||
130837448|NCT00837265|471032047|FG001|Main Phase|Lost to Follow-up|0|||
130837449|NCT00837265|471032048|FG002|Main Phase|Lost to Follow-up|0|||
130837450|NCT00837265|471032049|FG003|Main Phase|Lost to Follow-up|0|||
130837451|NCT00837265|471032050|FG004|Main Phase|Lost to Follow-up|1|||
130837452|NCT00837265|471032051|FG005|Main Phase|Lost to Follow-up|0|||
130837453|NCT00837265|471032052|FG006|Main Phase|Lost to Follow-up|0|||
130837454|NCT00837265|471032046|FG000|Main Phase|Principal investigator resignation|0|||
130837455|NCT00837265|471032047|FG001|Main Phase|Principal investigator resignation|0|||
130837456|NCT00837265|471032048|FG002|Main Phase|Principal investigator resignation|0|||
130837457|NCT00837265|471032049|FG003|Main Phase|Principal investigator resignation|0|||
130837458|NCT00837265|471032050|FG004|Main Phase|Principal investigator resignation|2|||
130837459|NCT00837265|471032051|FG005|Main Phase|Principal investigator resignation|0|||
130837460|NCT00837265|471032052|FG006|Main Phase|Principal investigator resignation|0|||
130837461|NCT00837265|471032046|FG000|Main Phase|Participant's personal reason|0|||
130837462|NCT00837265|471032047|FG001|Main Phase|Participant's personal reason|0|||
130837463|NCT00837265|471032048|FG002|Main Phase|Participant's personal reason|0|||
130837464|NCT00837265|471032049|FG003|Main Phase|Participant's personal reason|0|||
130837465|NCT00837265|471032050|FG004|Main Phase|Participant's personal reason|1|||
130837466|NCT00837265|471032051|FG005|Main Phase|Participant's personal reason|0|||
130837467|NCT00837265|471032052|FG006|Main Phase|Participant's personal reason|0|||
130837468|NCT00473668|471032057|FG000|Overall Study|Withdrawal by Subject|0|||
130837469|NCT00473668|471032058|FG001|Overall Study|Withdrawal by Subject|2|||
130837470|NCT00473668|471032059|FG002|Overall Study|Withdrawal by Subject|0|||
130837471|NCT00473668|471032057|FG000|Overall Study|Migrated/moved from study area|3|||
130837472|NCT00473668|471032058|FG001|Overall Study|Migrated/moved from study area|2|||
130837473|NCT00473668|471032059|FG002|Overall Study|Migrated/moved from study area|0|||
130837474|NCT00473668|471032057|FG000|Overall Study|Lost to Follow-up|0|||
130837475|NCT00473668|471032058|FG001|Overall Study|Lost to Follow-up|4|||
130837476|NCT00473668|471032059|FG002|Overall Study|Lost to Follow-up|6|||
130837477|NCT00473668|471032057|FG000|Overall Study|Other|2|||
130837478|NCT00473668|471032058|FG001|Overall Study|Other|3|||
130837479|NCT00473668|471032059|FG002|Overall Study|Other|4|||
130837480|NCT02226562|471032060|FG000|Overall Study|Lost to Follow-up|0|||
130837481|NCT02226562|471032061|FG001|Overall Study|Lost to Follow-up|1|||
130837482|NCT01474772|471032063|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
130837483|NCT01474772|471032064|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
130837484|NCT01474772|471032063|FG000|Period 1|AE not Related to Study Drug|1|||
130837485|NCT01474772|471032064|FG001|Period 1|AE not Related to Study Drug|0|||
130837486|NCT01474772|471032063|FG000|Period 1|Withdrawal by Subject|3|||
130837487|NCT01474772|471032064|FG001|Period 1|Withdrawal by Subject|1|||
130837488|NCT01474772|471032063|FG000|Period 1|Lost to Follow-up|1|||
130837489|NCT01474772|471032064|FG001|Period 1|Lost to Follow-up|0|||
130837490|NCT01474772|471032063|FG000|Period 1|Reason not Specified|1|||
130837491|NCT01474772|471032064|FG001|Period 1|Reason not Specified|1|||
130837492|NCT01474772|471032063|FG000|Washout|AE not Related to Study Drug|2|||
130837493|NCT01474772|471032064|FG001|Washout|AE not Related to Study Drug|0|||
130837494|NCT01474772|471032063|FG000|Washout|Withdrawal by Subject|1|||
130837495|NCT01474772|471032064|FG001|Washout|Withdrawal by Subject|0|||
130837496|NCT01474772|471032063|FG000|Washout|Lost to Follow-up|0|||
130837497|NCT01474772|471032064|FG001|Washout|Lost to Follow-up|1|||
130837498|NCT01474772|471032063|FG000|Washout|Reason not Specified|0|||
130837499|NCT01474772|471032064|FG001|Washout|Reason not Specified|1|||
130837500|NCT01474772|471032063|FG000|Period 2|Death|0|||
130837501|NCT01474772|471032064|FG001|Period 2|Death|1|||
130837502|NCT01474772|471032063|FG000|Period 2|AE Related to Study Drug|0|||
130837503|NCT01474772|471032064|FG001|Period 2|AE Related to Study Drug|1|||
130837504|NCT01474772|471032063|FG000|Period 2|AE not Related to Study Drug|4|||
130837505|NCT01474772|471032064|FG001|Period 2|AE not Related to Study Drug|1|||
130837506|NCT01474772|471032063|FG000|Period 2|Lack of Efficacy|1|||
130837507|NCT01474772|471032064|FG001|Period 2|Lack of Efficacy|0|||
130837508|NCT01474772|471032063|FG000|Period 2|Withdrawal by Subject|3|||
130837509|NCT01474772|471032064|FG001|Period 2|Withdrawal by Subject|4|||
130837510|NCT01474772|471032063|FG000|Period 2|Lost to Follow-up|1|||
130837511|NCT01474772|471032064|FG001|Period 2|Lost to Follow-up|1|||
130837512|NCT01474772|471032063|FG000|Period 2|Reason not Specified|0|||
130837513|NCT01474772|471032064|FG001|Period 2|Reason not Specified|2|||
130837514|NCT01474772|471032063|FG000|Follow-up|AE not Related to Study Drug|0|||
130837515|NCT01474772|471032064|FG001|Follow-up|AE not Related to Study Drug|1|||
130837516|NCT00223808|471032065|FG000|Overall Study|<5 hrs therapy before discharge|3|||
130837517|NCT00223808|471032066|FG001|Overall Study|<5 hrs therapy before discharge|5|||
130837518|NCT00223808|471032067|FG002|Overall Study|<5 hrs therapy before discharge|5|||
130837519|NCT03195660|471032068|FG000|Overall Study|The study was terminated|2|||
130837520|NCT05260073|471032070|FG000|Overall Study|Physician Decision|1|||
130837521|NCT05260073|471032070|FG000|Overall Study|Withdrawal by Subject|6|||
130837522|NCT05260073|471032070|FG000|Overall Study|Lost to Follow-up|14|||
130837523|NCT03458910|471032071|FG000|Overall Study|Withdrawal by Subject|7|||
130837524|NCT03458910|471032072|FG001|Overall Study|Withdrawal by Subject|8|||
130837525|NCT03458910|471032073|FG002|Overall Study|Withdrawal by Subject|6|||
130837526|NCT03458910|471032074|FG003|Overall Study|Withdrawal by Subject|4|||
130837527|NCT03458910|471032071|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
130837528|NCT03458910|471032072|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
130837529|NCT03458910|471032073|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
130837530|NCT03458910|471032074|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
130837531|NCT04484649|471032075|FG000|Overall Study|Lost to Follow-up|2|||
130837532|NCT04484649|471032076|FG001|Overall Study|Lost to Follow-up|1|||
130837533|NCT04484649|471032075|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
130837534|NCT04484649|471032076|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
130837535|NCT01681069|471032077|FG000|Overall Study|Withdrawal by Subject|4|||
130837536|NCT01681069|471032078|FG001|Overall Study|Withdrawal by Subject|5|||
130837537|NCT01681069|471032077|FG000|Overall Study|Protocol Violation|1|||
130837538|NCT01681069|471032078|FG001|Overall Study|Protocol Violation|1|||
130837539|NCT01681069|471032077|FG000|Overall Study|Adverse Event|0|||
130837540|NCT01681069|471032078|FG001|Overall Study|Adverse Event|1|||
130837541|NCT00152477|471032083|FG000|Chemotherapy Period|Adverse Event|9|||
130837542|NCT00152477|471032084|FG001|Chemotherapy Period|Adverse Event|4|||
130837543|NCT00152477|471032085|FG002|Chemotherapy Period|Adverse Event|5|||
130837544|NCT00152477|471032083|FG000|Chemotherapy Period|Death|1|||
130837545|NCT00152477|471032084|FG001|Chemotherapy Period|Death|3|||
130837546|NCT00152477|471032085|FG002|Chemotherapy Period|Death|3|||
130837547|NCT00152477|471032083|FG000|Chemotherapy Period|Lack of Efficacy|4|||
130837548|NCT00152477|471032084|FG001|Chemotherapy Period|Lack of Efficacy|5|||
130837549|NCT00152477|471032085|FG002|Chemotherapy Period|Lack of Efficacy|6|||
130837550|NCT00152477|471032083|FG000|Chemotherapy Period|Lost to Follow-up|1|||
130837551|NCT00152477|471032084|FG001|Chemotherapy Period|Lost to Follow-up|0|||
130837552|NCT00152477|471032085|FG002|Chemotherapy Period|Lost to Follow-up|1|||
130837553|NCT00152477|471032083|FG000|Chemotherapy Period|Protocol Violation|1|||
130837554|NCT00152477|471032084|FG001|Chemotherapy Period|Protocol Violation|1|||
130837555|NCT00152477|471032085|FG002|Chemotherapy Period|Protocol Violation|0|||
130837556|NCT00152477|471032083|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
130837557|NCT00152477|471032084|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
130837558|NCT00152477|471032085|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
130837559|NCT00152477|471032083|FG000|Chemotherapy Period|Progression of Disease|6|||
130837560|NCT00152477|471032084|FG001|Chemotherapy Period|Progression of Disease|8|||
130837561|NCT00152477|471032085|FG002|Chemotherapy Period|Progression of Disease|4|||
130837562|NCT00152477|471032083|FG000|Chemotherapy Period|Investigator decision|0|||
130837563|NCT00152477|471032084|FG001|Chemotherapy Period|Investigator decision|0|||
130837564|NCT00152477|471032085|FG002|Chemotherapy Period|Investigator decision|1|||
130837565|NCT00152477|471032083|FG000|Chemotherapy Period|Patient condition worsened|1|||
130837566|NCT00152477|471032084|FG001|Chemotherapy Period|Patient condition worsened|0|||
130837567|NCT00152477|471032085|FG002|Chemotherapy Period|Patient condition worsened|0|||
130837568|NCT00152477|471032083|FG000|Monotherapy Period|Adverse Event|1|||
130837569|NCT00152477|471032084|FG001|Monotherapy Period|Adverse Event|0|||
130837570|NCT00152477|471032085|FG002|Monotherapy Period|Adverse Event|5|||
130837571|NCT00152477|471032083|FG000|Monotherapy Period|Death|2|||
130837572|NCT00152477|471032084|FG001|Monotherapy Period|Death|0|||
130837573|NCT00152477|471032085|FG002|Monotherapy Period|Death|1|||
130837574|NCT00152477|471032083|FG000|Monotherapy Period|Lack of Efficacy|7|||
130837575|NCT00152477|471032084|FG001|Monotherapy Period|Lack of Efficacy|16|||
130837576|NCT00152477|471032085|FG002|Monotherapy Period|Lack of Efficacy|10|||
130837577|NCT00152477|471032083|FG000|Monotherapy Period|Protocol Violation|0|||
130837578|NCT00152477|471032084|FG001|Monotherapy Period|Protocol Violation|1|||
130837579|NCT00152477|471032085|FG002|Monotherapy Period|Protocol Violation|0|||
130837580|NCT00152477|471032083|FG000|Monotherapy Period|Withdrawal by Subject|0|||
130837581|NCT00152477|471032084|FG001|Monotherapy Period|Withdrawal by Subject|0|||
130837582|NCT00152477|471032085|FG002|Monotherapy Period|Withdrawal by Subject|4|||
130837583|NCT00152477|471032083|FG000|Monotherapy Period|Progression of Disease|5|||
130837584|NCT00152477|471032084|FG001|Monotherapy Period|Progression of Disease|11|||
130837585|NCT00152477|471032085|FG002|Monotherapy Period|Progression of Disease|12|||
130837586|NCT00152477|471032083|FG000|Monotherapy Period|Patient decision|0|||
130837587|NCT00152477|471032084|FG001|Monotherapy Period|Patient decision|1|||
130837588|NCT00152477|471032085|FG002|Monotherapy Period|Patient decision|1|||
130837589|NCT00152477|471032083|FG000|Monotherapy Period|Study personel decision|0|||
130837590|NCT00152477|471032084|FG001|Monotherapy Period|Study personel decision|0|||
130837591|NCT00152477|471032085|FG002|Monotherapy Period|Study personel decision|1|||
130837592|NCT03275246|471032092|FG000|Overall Study|Protocol Violation|5|||
130837593|NCT03275246|471032092|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
130837594|NCT02570152|471032095|FG000|Overall Study|Protocol Violation|2|||
130837595|NCT02570152|471032095|FG000|Overall Study|Migrated/moved from study area|13|||
130837596|NCT00923975|471032099|FG000|Overall Study|Did not meet inclusion criteria|1|||
130837597|NCT01328535|471032100|FG000|Overall Study|Ineligible|1|||
130837598|NCT01005316|471032103|FG000|Overall Study|Adverse Event|0|||
130837599|NCT01005316|471032104|FG001|Overall Study|Adverse Event|0|||
130837600|NCT01005316|471032105|FG002|Overall Study|Adverse Event|0|||
130837601|NCT01005316|471032106|FG003|Overall Study|Adverse Event|1|||
130837602|NCT01005316|471032103|FG000|Overall Study|Death|20|||
130837603|NCT01005316|471032104|FG001|Overall Study|Death|5|||
130837604|NCT01005316|471032105|FG002|Overall Study|Death|1|||
130837605|NCT01005316|471032106|FG003|Overall Study|Death|15|||
130837606|NCT01005316|471032103|FG000|Overall Study|Study Termination|5|||
130837607|NCT01005316|471032104|FG001|Overall Study|Study Termination|63|||
130837608|NCT01005316|471032105|FG002|Overall Study|Study Termination|9|||
130837609|NCT01005316|471032106|FG003|Overall Study|Study Termination|85|||
130837610|NCT01005316|471032103|FG000|Overall Study|Lost to Follow-up|1|||
130837611|NCT01005316|471032104|FG001|Overall Study|Lost to Follow-up|3|||
130837612|NCT01005316|471032105|FG002|Overall Study|Lost to Follow-up|0|||
130837613|NCT01005316|471032106|FG003|Overall Study|Lost to Follow-up|2|||
130837614|NCT01005316|471032103|FG000|Overall Study|Physician Decision|6|||
130837615|NCT01005316|471032104|FG001|Overall Study|Physician Decision|0|||
130837616|NCT01005316|471032105|FG002|Overall Study|Physician Decision|0|||
130837617|NCT01005316|471032106|FG003|Overall Study|Physician Decision|0|||
130837618|NCT01005316|471032103|FG000|Overall Study|Sponsor Decision|6|||
130837619|NCT01005316|471032104|FG001|Overall Study|Sponsor Decision|3|||
130837620|NCT01005316|471032105|FG002|Overall Study|Sponsor Decision|0|||
130837621|NCT01005316|471032106|FG003|Overall Study|Sponsor Decision|0|||
130837622|NCT01005316|471032103|FG000|Overall Study|Withdrawal by Subject|1|||
130837623|NCT01005316|471032104|FG001|Overall Study|Withdrawal by Subject|1|||
130837624|NCT01005316|471032105|FG002|Overall Study|Withdrawal by Subject|0|||
130837625|NCT01005316|471032106|FG003|Overall Study|Withdrawal by Subject|2|||
130837626|NCT01005316|471032103|FG000|Overall Study|Consented to Another Study|2|||
130837627|NCT01005316|471032104|FG001|Overall Study|Consented to Another Study|0|||
130837628|NCT01005316|471032105|FG002|Overall Study|Consented to Another Study|0|||
130837629|NCT01005316|471032106|FG003|Overall Study|Consented to Another Study|0|||
130837630|NCT01005316|471032103|FG000|Overall Study|Delisted|8|||
130837631|NCT01005316|471032104|FG001|Overall Study|Delisted|0|||
130837632|NCT01005316|471032105|FG002|Overall Study|Delisted|0|||
130837633|NCT01005316|471032106|FG003|Overall Study|Delisted|0|||
130837634|NCT01005316|471032103|FG000|Overall Study|Transferred Care|1|||
130837635|NCT01005316|471032104|FG001|Overall Study|Transferred Care|0|||
130837636|NCT01005316|471032105|FG002|Overall Study|Transferred Care|1|||
130837637|NCT01005316|471032106|FG003|Overall Study|Transferred Care|3|||
130837638|NCT01005316|471032103|FG000|Overall Study|Retransplanted|0|||
130837639|NCT01005316|471032104|FG001|Overall Study|Retransplanted|1|||
130837640|NCT01005316|471032105|FG002|Overall Study|Retransplanted|0|||
130837641|NCT01005316|471032106|FG003|Overall Study|Retransplanted|0|||
130837642|NCT00960011|471032107|FG000|Overall Study|Death|5|||
130837643|NCT00960011|471032108|FG001|Overall Study|Death|0|||
130837644|NCT00960011|471032107|FG000|Overall Study|Lost to Follow-up|6|||
130837645|NCT00960011|471032108|FG001|Overall Study|Lost to Follow-up|2|||
130837646|NCT04417218|471032109|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
130837647|NCT04417218|471032110|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
130837648|NCT02516098|471032113|FG000|Period 1|Protocol Violation|1|||
130837649|NCT02516098|471032114|FG001|Period 1|Protocol Violation|0|||
130837650|NCT02516098|471032113|FG000|Washout After Period 1|Adverse Event|0|||
130837651|NCT02516098|471032114|FG001|Washout After Period 1|Adverse Event|1|||
130837652|NCT02516098|471032113|FG000|Period 2|Withdrawal by Subject|0|||
130837653|NCT02516098|471032114|FG001|Period 2|Withdrawal by Subject|1|||
130837654|NCT00873041|471032115|FG000|Core Study|Adverse Event|2|||
130837655|NCT00873041|471032116|FG001|Core Study|Adverse Event|3|||
130837656|NCT00873041|471032117|FG002|Core Study|Adverse Event|1|||
130837657|NCT00873041|471032115|FG000|Core Study|Withdrawal by Subject|1|||
130837658|NCT00873041|471032116|FG001|Core Study|Withdrawal by Subject|2|||
130837659|NCT00873041|471032117|FG002|Core Study|Withdrawal by Subject|2|||
130837660|NCT00873041|471032115|FG000|Core Study|Lost to Follow-up|3|||
130837661|NCT00873041|471032116|FG001|Core Study|Lost to Follow-up|1|||
130837662|NCT00873041|471032117|FG002|Core Study|Lost to Follow-up|0|||
130837663|NCT00873041|471032115|FG000|Core Study|Abnormal laboratory value|0|||
130837664|NCT00873041|471032116|FG001|Core Study|Abnormal laboratory value|0|||
130837665|NCT00873041|471032117|FG002|Core Study|Abnormal laboratory value|1|||
130837666|NCT00873041|471032115|FG000|Core Study|Protocol deviation|1|||
130837667|NCT00873041|471032116|FG001|Core Study|Protocol deviation|0|||
130837668|NCT00873041|471032117|FG002|Core Study|Protocol deviation|1|||
130837669|NCT00873041|471032115|FG000|Extension Study|Adverse Event|1|||
130837670|NCT00873041|471032116|FG001|Extension Study|Adverse Event|0|||
130837671|NCT00873041|471032117|FG002|Extension Study|Adverse Event|1|||
130837672|NCT00873041|471032115|FG000|Extension Study|Administrative reasons|0|||
130837673|NCT00873041|471032116|FG001|Extension Study|Administrative reasons|0|||
130837674|NCT00873041|471032117|FG002|Extension Study|Administrative reasons|1|||
130837675|NCT01734395|471032120|FG000|Overall Study|Other|65|||
130837676|NCT01734395|471032120|FG000|Overall Study|Lost to Follow-up|287|||
130837677|NCT01734395|471032120|FG000|Overall Study|Lack of Efficacy|5|||
130837678|NCT01734395|471032120|FG000|Overall Study|Adverse Event|40|||
130837679|NCT01734395|471032120|FG000|Overall Study|Withdrawal by Subject|10|||
130837680|NCT01734395|471032120|FG000|Overall Study|Missing the reasons for not completed|3|||
130837681|NCT01032291|471032121|FG000|Safety Lead-in|Adverse Event|1|||
130837682|NCT01032291|471032122|FG001|Safety Lead-in|Adverse Event|0|||
130837683|NCT01032291|471032123|FG002|Safety Lead-in|Adverse Event|0|||
130837684|NCT01032291|471032121|FG000|Safety Lead-in|Death|1|||
130837685|NCT01032291|471032122|FG001|Safety Lead-in|Death|0|||
130837686|NCT01032291|471032123|FG002|Safety Lead-in|Death|0|||
130837687|NCT01032291|471032121|FG000|Proof of Concept|Adverse Event|0|||
130837688|NCT01032291|471032122|FG001|Proof of Concept|Adverse Event|5|||
130837689|NCT01032291|471032123|FG002|Proof of Concept|Adverse Event|1|||
130837690|NCT01032291|471032121|FG000|Proof of Concept|Death|0|||
130837691|NCT01032291|471032122|FG001|Proof of Concept|Death|1|||
130837692|NCT01032291|471032123|FG002|Proof of Concept|Death|2|||
130837693|NCT01032291|471032121|FG000|Proof of Concept|Lack of Efficacy|0|||
130837694|NCT01032291|471032122|FG001|Proof of Concept|Lack of Efficacy|1|||
130837695|NCT01032291|471032123|FG002|Proof of Concept|Lack of Efficacy|0|||
130837696|NCT01032291|471032121|FG000|Proof of Concept|Never Received Study Drug|0|||
130837697|NCT01032291|471032122|FG001|Proof of Concept|Never Received Study Drug|1|||
130837698|NCT01032291|471032123|FG002|Proof of Concept|Never Received Study Drug|0|||
130837699|NCT00313313|471032124|FG000|Overall Study|Lack of Efficacy|14|||
130837700|NCT00313313|471032125|FG001|Overall Study|Lack of Efficacy|9|||
130837701|NCT00313313|471032126|FG002|Overall Study|Lack of Efficacy|20|||
130837702|NCT00313313|471032124|FG000|Overall Study|Withdrawal of consent by subject|18|||
130837703|NCT00313313|471032125|FG001|Overall Study|Withdrawal of consent by subject|17|||
130837704|NCT00313313|471032126|FG002|Overall Study|Withdrawal of consent by subject|31|||
130837705|NCT00313313|471032124|FG000|Overall Study|Lost to Follow-up|10|||
130837706|NCT00313313|471032125|FG001|Overall Study|Lost to Follow-up|7|||
130837707|NCT00313313|471032126|FG002|Overall Study|Lost to Follow-up|9|||
130837708|NCT00313313|471032124|FG000|Overall Study|Adverse Event|15|||
130837709|NCT00313313|471032125|FG001|Overall Study|Adverse Event|16|||
130837710|NCT00313313|471032126|FG002|Overall Study|Adverse Event|12|||
130837711|NCT00313313|471032124|FG000|Overall Study|Physician Decision|2|||
130837712|NCT00313313|471032125|FG001|Overall Study|Physician Decision|6|||
130837713|NCT00313313|471032126|FG002|Overall Study|Physician Decision|4|||
130837714|NCT00313313|471032124|FG000|Overall Study|Poor/Noncompliance|3|||
130837715|NCT00313313|471032125|FG001|Overall Study|Poor/Noncompliance|6|||
130837716|NCT00313313|471032126|FG002|Overall Study|Poor/Noncompliance|2|||
130837717|NCT00313313|471032124|FG000|Overall Study|Pregnancy|1|||
130837718|NCT00313313|471032125|FG001|Overall Study|Pregnancy|2|||
130837719|NCT00313313|471032126|FG002|Overall Study|Pregnancy|0|||
130837720|NCT00313313|471032124|FG000|Overall Study|Death|0|||
130837721|NCT00313313|471032125|FG001|Overall Study|Death|0|||
130837722|NCT00313313|471032126|FG002|Overall Study|Death|2|||
130837723|NCT00313313|471032124|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
130837724|NCT00313313|471032125|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
130837725|NCT00313313|471032126|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
130837726|NCT00758264|471032127|FG000|Active Phase|Withdrawal by Subject|0|||
130837727|NCT00758264|471032128|FG001|Active Phase|Withdrawal by Subject|0|||
130837728|NCT00758264|471032129|FG002|Active Phase|Withdrawal by Subject|1|||
130837729|NCT00758264|471032127|FG000|Active Phase|Lost to Follow-up|1|||
130837730|NCT00758264|471032128|FG001|Active Phase|Lost to Follow-up|0|||
130837731|NCT00758264|471032129|FG002|Active Phase|Lost to Follow-up|0|||
130837732|NCT00758264|471032127|FG000|Active Phase|Other|0|||
130837733|NCT00758264|471032128|FG001|Active Phase|Other|0|||
130837734|NCT00758264|471032129|FG002|Active Phase|Other|4|||
130837735|NCT01177553|471032130|FG000|Overall Study|babies not yet 6 months of age|1|||
130837736|NCT01177553|471032131|FG001|Overall Study|babies not yet 6 months of age|0|||
130837737|NCT03831191|471032133|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
130837738|NCT03831191|471032134|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
130837739|NCT03831191|471032135|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
130837740|NCT03831191|471032136|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
130837741|NCT03831191|471032137|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
130837742|NCT03831191|471032138|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
130837743|NCT03831191|471032139|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
130837744|NCT03831191|471032140|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
130837745|NCT03831191|471032141|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
130837746|NCT03831191|471032142|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
130837747|NCT03831191|471032143|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
130837748|NCT03831191|471032144|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
130837749|NCT03831191|471032145|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
130837750|NCT03831191|471032146|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
130837751|NCT03831191|471032147|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
130837752|NCT03831191|471032133|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
130837753|NCT03831191|471032134|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
130837754|NCT03831191|471032135|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837755|NCT03831191|471032136|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837756|NCT03831191|471032137|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837757|NCT03831191|471032138|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837758|NCT03831191|471032139|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837759|NCT03831191|471032140|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837760|NCT03831191|471032141|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837761|NCT03831191|471032142|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837762|NCT03831191|471032143|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837763|NCT03831191|471032144|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837764|NCT03831191|471032145|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837765|NCT03831191|471032146|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837766|NCT03831191|471032147|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130837767|NCT03831191|471032133|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
130837768|NCT03831191|471032134|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
130837769|NCT03831191|471032135|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
130837770|NCT03831191|471032136|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
130837771|NCT03831191|471032137|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
130837772|NCT03831191|471032138|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
130837773|NCT03831191|471032139|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
130837774|NCT03831191|471032140|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
130837775|NCT03831191|471032141|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
130837776|NCT03831191|471032142|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
130837777|NCT03831191|471032143|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
130837778|NCT03831191|471032144|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
130837779|NCT03831191|471032145|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
130837780|NCT03831191|471032146|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
130837781|NCT03831191|471032147|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
130837782|NCT03831191|471032133|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
130837783|NCT03831191|471032134|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
130837784|NCT03831191|471032135|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
130837785|NCT03831191|471032136|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
130837786|NCT03831191|471032137|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
130837787|NCT03831191|471032138|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
130837788|NCT03831191|471032139|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
130837789|NCT03831191|471032140|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
130837790|NCT03831191|471032141|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
130837791|NCT03831191|471032142|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
130837792|NCT03831191|471032143|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
130837793|NCT03831191|471032144|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
130837794|NCT03831191|471032145|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
130837795|NCT03831191|471032146|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
130837796|NCT03831191|471032147|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
130837797|NCT03831191|471032133|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
130837798|NCT03831191|471032134|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
130837799|NCT03831191|471032135|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
130837800|NCT03831191|471032136|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
130837801|NCT03831191|471032137|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837802|NCT03831191|471032138|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837803|NCT03831191|471032139|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837804|NCT03831191|471032140|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837805|NCT03831191|471032141|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837806|NCT03831191|471032142|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837807|NCT03831191|471032143|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837808|NCT03831191|471032144|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837809|NCT03831191|471032145|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837810|NCT03831191|471032146|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837811|NCT03831191|471032147|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130837812|NCT03831191|471032133|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
130837813|NCT03831191|471032134|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
130837814|NCT03831191|471032135|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
130837815|NCT03831191|471032136|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
130837816|NCT03831191|471032137|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837817|NCT03831191|471032138|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837818|NCT03831191|471032139|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837819|NCT03831191|471032140|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837820|NCT03831191|471032141|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837821|NCT03831191|471032142|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837822|NCT03831191|471032143|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837823|NCT03831191|471032144|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837824|NCT03831191|471032145|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837825|NCT03831191|471032146|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837826|NCT03831191|471032147|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130837827|NCT03831191|471032133|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837828|NCT03831191|471032134|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837829|NCT03831191|471032135|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837830|NCT03831191|471032136|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
130837831|NCT03831191|471032137|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837832|NCT03831191|471032138|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837833|NCT03831191|471032139|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837834|NCT03831191|471032140|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837835|NCT03831191|471032141|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837836|NCT03831191|471032142|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837837|NCT03831191|471032143|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837838|NCT03831191|471032144|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837839|NCT03831191|471032145|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837840|NCT03831191|471032146|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837841|NCT03831191|471032147|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
130837842|NCT03831191|471032133|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130837843|NCT03831191|471032134|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130837844|NCT03831191|471032135|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130837845|NCT03831191|471032136|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130837846|NCT03831191|471032137|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
130837847|NCT03831191|471032138|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
130837848|NCT03831191|471032139|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
130837849|NCT03831191|471032140|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
130837850|NCT03831191|471032141|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
130837851|NCT03831191|471032142|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
130837852|NCT03831191|471032143|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
130837853|NCT03831191|471032144|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
130837854|NCT03831191|471032145|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
130837855|NCT03831191|471032146|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
130837856|NCT03831191|471032147|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
130837857|NCT03831191|471032133|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837858|NCT03831191|471032134|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837859|NCT03831191|471032135|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837860|NCT03831191|471032136|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837861|NCT03831191|471032137|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837862|NCT03831191|471032138|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837863|NCT03831191|471032139|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837864|NCT03831191|471032140|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837865|NCT03831191|471032141|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837866|NCT03831191|471032142|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837867|NCT03831191|471032143|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837868|NCT03831191|471032144|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837869|NCT03831191|471032145|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837870|NCT03831191|471032146|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130837871|NCT03831191|471032147|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
130837872|NCT03831191|471032133|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837873|NCT03831191|471032134|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837874|NCT03831191|471032135|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837875|NCT03831191|471032136|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837876|NCT03831191|471032137|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837877|NCT03831191|471032138|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837878|NCT03831191|471032139|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837879|NCT03831191|471032140|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837880|NCT03831191|471032141|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837881|NCT03831191|471032142|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837882|NCT03831191|471032143|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837883|NCT03831191|471032144|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837884|NCT03831191|471032145|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837885|NCT03831191|471032146|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130837886|NCT03831191|471032147|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
130837887|NCT02300558|471032150|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
130837888|NCT02300558|471032150|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
130837889|NCT02300558|471032150|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
130837890|NCT02300558|471032150|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
130837891|NCT00695955|471032151|FG000|Cohort 1|Adverse Event|26|||
130837892|NCT00695955|471032151|FG000|Cohort 1|Protocol Violation|2|||
130837893|NCT00695955|471032151|FG000|Cohort 1|Lost to Follow-up|30|||
130837894|NCT00695955|471032151|FG000|Cohort 1|Withdrawal by Subject|25|||
130837895|NCT00695955|471032151|FG000|Cohort 1|Lack of Efficacy|3|||
130837896|NCT00695955|471032151|FG000|Cohort 1|Other|16|||
130837897|NCT00695955|471032151|FG000|Cohort 2|Adverse Event|24|||
130837898|NCT00695955|471032151|FG000|Cohort 2|Protocol Violation|5|||
130837899|NCT00695955|471032151|FG000|Cohort 2|Lost to Follow-up|38|||
130837900|NCT00695955|471032151|FG000|Cohort 2|Withdrawal by Subject|28|||
130837901|NCT00695955|471032151|FG000|Cohort 2|Lack of Efficacy|4|||
130837902|NCT00695955|471032151|FG000|Cohort 2|Other|5|||
130837903|NCT01054560|471032154|FG000|Overall Study|Death|10|||
130837904|NCT01054560|471032155|FG001|Overall Study|Death|21|||
130837905|NCT01054560|471032154|FG000|Overall Study|Lost to Follow-up|2|||
130837906|NCT01054560|471032155|FG001|Overall Study|Lost to Follow-up|5|||
130837907|NCT01054560|471032154|FG000|Overall Study|Withdrawal by Subject|0|||
130837908|NCT01054560|471032155|FG001|Overall Study|Withdrawal by Subject|2|||
130837909|NCT01054560|471032154|FG000|Overall Study|Physician Decision|1|||
130837910|NCT01054560|471032155|FG001|Overall Study|Physician Decision|0|||
130837911|NCT01106651|471032156|FG000|Overall Study|Adverse Event|17|||
130837912|NCT01106651|471032157|FG001|Overall Study|Adverse Event|9|||
130837913|NCT01106651|471032158|FG002|Overall Study|Adverse Event|23|||
130837914|NCT01106651|471032156|FG000|Overall Study|Lost to Follow-up|8|||
130837915|NCT01106651|471032157|FG001|Overall Study|Lost to Follow-up|2|||
130837916|NCT01106651|471032158|FG002|Overall Study|Lost to Follow-up|6|||
130837917|NCT01106651|471032156|FG000|Overall Study|Physician Decision|4|||
130837918|NCT01106651|471032157|FG001|Overall Study|Physician Decision|3|||
130837919|NCT01106651|471032158|FG002|Overall Study|Physician Decision|1|||
130837920|NCT01106651|471032156|FG000|Overall Study|Protocol Violation|1|||
130837921|NCT01106651|471032157|FG001|Overall Study|Protocol Violation|2|||
130837922|NCT01106651|471032158|FG002|Overall Study|Protocol Violation|1|||
130837923|NCT01106651|471032156|FG000|Overall Study|Withdrawal by Subject|14|||
130837924|NCT01106651|471032157|FG001|Overall Study|Withdrawal by Subject|7|||
130837925|NCT01106651|471032158|FG002|Overall Study|Withdrawal by Subject|4|||
130837926|NCT01106651|471032156|FG000|Overall Study|Noncompliance with study drug|1|||
130837927|NCT01106651|471032157|FG001|Overall Study|Noncompliance with study drug|0|||
130837928|NCT01106651|471032158|FG002|Overall Study|Noncompliance with study drug|2|||
130837929|NCT01106651|471032156|FG000|Overall Study|Other|34|||
130837930|NCT01106651|471032157|FG001|Overall Study|Other|31|||
130837931|NCT01106651|471032158|FG002|Overall Study|Other|21|||
130837932|NCT01106651|471032156|FG000|Overall Study|Death|0|||
130837933|NCT01106651|471032157|FG001|Overall Study|Death|3|||
130837934|NCT01106651|471032158|FG002|Overall Study|Death|0|||
130837935|NCT02135029|471032162|FG000|Overall Study|Adverse Event|2|||
130837936|NCT02135029|471032163|FG001|Overall Study|Adverse Event|2|||
130837937|NCT02135029|471032164|FG002|Overall Study|Adverse Event|2|||
130837938|NCT02135029|471032162|FG000|Overall Study|Lost to Follow-up|0|||
130837939|NCT02135029|471032163|FG001|Overall Study|Lost to Follow-up|1|||
130837940|NCT02135029|471032164|FG002|Overall Study|Lost to Follow-up|0|||
130837941|NCT02135029|471032162|FG000|Overall Study|Withdrawal by Subject|2|||
130837942|NCT02135029|471032163|FG001|Overall Study|Withdrawal by Subject|0|||
130837943|NCT02135029|471032164|FG002|Overall Study|Withdrawal by Subject|1|||
130837944|NCT02135029|471032162|FG000|Overall Study|Other|0|||
130837945|NCT02135029|471032163|FG001|Overall Study|Other|1|||
130837946|NCT02135029|471032164|FG002|Overall Study|Other|0|||
130837947|NCT02135029|471032162|FG000|Overall Study|Death|0|||
130837948|NCT02135029|471032163|FG001|Overall Study|Death|1|||
130837949|NCT02135029|471032164|FG002|Overall Study|Death|0|||
130837950|NCT00712725|471032165|FG000|Overall Study|Adverse Event|1|||
130837951|NCT00712725|471032166|FG001|Overall Study|Adverse Event|0|||
130837952|NCT00712725|471032167|FG002|Overall Study|Adverse Event|0|||
130837953|NCT00712725|471032168|FG003|Overall Study|Adverse Event|1|||
130837954|NCT00712725|471032169|FG004|Overall Study|Adverse Event|0|||
130837955|NCT00712725|471032170|FG005|Overall Study|Adverse Event|0|||
130837956|NCT00712725|471032171|FG006|Overall Study|Adverse Event|0|||
130837957|NCT00712725|471032172|FG007|Overall Study|Adverse Event|0|||
130837958|NCT00712725|471032165|FG000|Overall Study|Lost to Follow-up|3|||
130837959|NCT00712725|471032166|FG001|Overall Study|Lost to Follow-up|2|||
130837960|NCT00712725|471032167|FG002|Overall Study|Lost to Follow-up|1|||
130837961|NCT00712725|471032168|FG003|Overall Study|Lost to Follow-up|1|||
130837962|NCT00712725|471032169|FG004|Overall Study|Lost to Follow-up|2|||
130837963|NCT00712725|471032170|FG005|Overall Study|Lost to Follow-up|2|||
130837964|NCT00712725|471032171|FG006|Overall Study|Lost to Follow-up|3|||
130837965|NCT00712725|471032172|FG007|Overall Study|Lost to Follow-up|1|||
130837966|NCT00712725|471032165|FG000|Overall Study|Physician Decision|2|||
130837967|NCT00712725|471032166|FG001|Overall Study|Physician Decision|0|||
130837968|NCT00712725|471032167|FG002|Overall Study|Physician Decision|0|||
130837969|NCT00712725|471032168|FG003|Overall Study|Physician Decision|0|||
130837970|NCT00712725|471032169|FG004|Overall Study|Physician Decision|1|||
130837971|NCT00712725|471032170|FG005|Overall Study|Physician Decision|0|||
130837972|NCT00712725|471032171|FG006|Overall Study|Physician Decision|2|||
130837973|NCT00712725|471032172|FG007|Overall Study|Physician Decision|0|||
130837974|NCT00712725|471032165|FG000|Overall Study|Pregnancy|0|||
130837975|NCT00712725|471032166|FG001|Overall Study|Pregnancy|1|||
130837976|NCT00712725|471032167|FG002|Overall Study|Pregnancy|0|||
130837977|NCT00712725|471032168|FG003|Overall Study|Pregnancy|0|||
130837978|NCT00712725|471032169|FG004|Overall Study|Pregnancy|1|||
130837979|NCT00712725|471032170|FG005|Overall Study|Pregnancy|0|||
130837980|NCT00712725|471032171|FG006|Overall Study|Pregnancy|2|||
130837981|NCT00712725|471032172|FG007|Overall Study|Pregnancy|0|||
130837982|NCT00712725|471032165|FG000|Overall Study|Protocol Violation|2|||
130837983|NCT00712725|471032166|FG001|Overall Study|Protocol Violation|0|||
130837984|NCT00712725|471032167|FG002|Overall Study|Protocol Violation|1|||
130837985|NCT00712725|471032168|FG003|Overall Study|Protocol Violation|3|||
130837986|NCT00712725|471032169|FG004|Overall Study|Protocol Violation|2|||
130837987|NCT00712725|471032170|FG005|Overall Study|Protocol Violation|0|||
130837988|NCT00712725|471032171|FG006|Overall Study|Protocol Violation|1|||
130837989|NCT00712725|471032172|FG007|Overall Study|Protocol Violation|1|||
130837990|NCT00712725|471032165|FG000|Overall Study|Withdrawal by Subject|2|||
130837991|NCT00712725|471032166|FG001|Overall Study|Withdrawal by Subject|1|||
130837992|NCT00712725|471032167|FG002|Overall Study|Withdrawal by Subject|1|||
130837993|NCT00712725|471032168|FG003|Overall Study|Withdrawal by Subject|2|||
130837994|NCT00712725|471032169|FG004|Overall Study|Withdrawal by Subject|1|||
130837995|NCT00712725|471032170|FG005|Overall Study|Withdrawal by Subject|1|||
130837996|NCT00712725|471032171|FG006|Overall Study|Withdrawal by Subject|1|||
130837997|NCT00712725|471032172|FG007|Overall Study|Withdrawal by Subject|2|||
130837998|NCT00712725|471032165|FG000|Overall Study|Lack of Qualifying Event|16|||
130837999|NCT00712725|471032166|FG001|Overall Study|Lack of Qualifying Event|2|||
130838000|NCT00712725|471032167|FG002|Overall Study|Lack of Qualifying Event|6|||
130838001|NCT00712725|471032168|FG003|Overall Study|Lack of Qualifying Event|8|||
130838002|NCT00712725|471032169|FG004|Overall Study|Lack of Qualifying Event|11|||
130838003|NCT00712725|471032170|FG005|Overall Study|Lack of Qualifying Event|13|||
130838004|NCT00712725|471032171|FG006|Overall Study|Lack of Qualifying Event|11|||
130838005|NCT00712725|471032172|FG007|Overall Study|Lack of Qualifying Event|6|||
130838006|NCT00712725|471032165|FG000|Overall Study|Protocol Specified Criteria|3|||
130838007|NCT00712725|471032166|FG001|Overall Study|Protocol Specified Criteria|0|||
130838008|NCT00712725|471032167|FG002|Overall Study|Protocol Specified Criteria|1|||
130838009|NCT00712725|471032168|FG003|Overall Study|Protocol Specified Criteria|2|||
130838010|NCT00712725|471032169|FG004|Overall Study|Protocol Specified Criteria|1|||
130838011|NCT00712725|471032170|FG005|Overall Study|Protocol Specified Criteria|0|||
130838012|NCT00712725|471032171|FG006|Overall Study|Protocol Specified Criteria|2|||
130838013|NCT00712725|471032172|FG007|Overall Study|Protocol Specified Criteria|1|||
130838014|NCT03466099|471032173|FG000|Overall Study|Adverse Event|1|||
130838015|NCT03466099|471032174|FG001|Overall Study|Adverse Event|1|||
130838016|NCT03466099|471032175|FG002|Overall Study|Adverse Event|1|||
130838017|NCT03466099|471032173|FG000|Overall Study|Withdrawal by Subject|2|||
130838018|NCT03466099|471032174|FG001|Overall Study|Withdrawal by Subject|3|||
130838019|NCT03466099|471032175|FG002|Overall Study|Withdrawal by Subject|1|||
130838020|NCT03466099|471032173|FG000|Overall Study|Use of rescue medication|8|||
130838021|NCT03466099|471032174|FG001|Overall Study|Use of rescue medication|9|||
130838022|NCT03466099|471032175|FG002|Overall Study|Use of rescue medication|13|||
130838023|NCT03466099|471032173|FG000|Overall Study|Rescued without meeting criteria|4|||
130838024|NCT03466099|471032174|FG001|Overall Study|Rescued without meeting criteria|1|||
130838025|NCT03466099|471032175|FG002|Overall Study|Rescued without meeting criteria|1|||
130838026|NCT03466099|471032173|FG000|Overall Study|Subject compliance|2|||
130838027|NCT03466099|471032174|FG001|Overall Study|Subject compliance|0|||
130838028|NCT03466099|471032175|FG002|Overall Study|Subject compliance|0|||
130838029|NCT03466099|471032173|FG000|Overall Study|Worsening disease|0|||
130838030|NCT03466099|471032174|FG001|Overall Study|Worsening disease|0|||
130838031|NCT03466099|471032175|FG002|Overall Study|Worsening disease|1|||
130838032|NCT04590404|471032176|FG000|Overall Study|Death|16|||
130838033|NCT04590404|471032177|FG001|Overall Study|Death|17|||
130838034|NCT04590404|471032176|FG000|Overall Study|Withdrawal by Subject|7|||
130838035|NCT04590404|471032177|FG001|Overall Study|Withdrawal by Subject|2|||
130838036|NCT00613327|471032180|FG000|Overall Study|Adverse Event|38|||
130838037|NCT00613327|471032180|FG000|Overall Study|Lost to Follow-up|8|||
130838038|NCT00613327|471032180|FG000|Overall Study|Withdrawal by Subject|6|||
130838039|NCT00613327|471032180|FG000|Overall Study|Protocol Violation|2|||
130838040|NCT00613327|471032180|FG000|Overall Study|Other|47|||
130838041|NCT02487654|471032184|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
130838042|NCT02487654|471032185|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
130838043|NCT02487654|471032184|FG000|Overall Study|Withdrawal by Subject|3|||
130838044|NCT02487654|471032185|FG001|Overall Study|Withdrawal by Subject|7|||
130838045|NCT02247011|471032186|FG000|Overall Study|Poor quality of radiological results|125|||
130838046|NCT00616018|471032187|FG000|Overall Study|Protocol Violation|3|||
130838047|NCT03718884|471032188|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
130838048|NCT03718884|471032189|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
130838049|NCT03718884|471032188|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
130838050|NCT03718884|471032189|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
130838051|NCT00349921|471032190|FG000|First Spinal Injection|Physician Decision|1|||
130838052|NCT00349921|471032191|FG001|First Spinal Injection|Physician Decision|0|||
130838053|NCT00349921|471032192|FG002|First Spinal Injection|Physician Decision|0|||
130838054|NCT00349921|471032193|FG003|First Spinal Injection|Physician Decision|0|||
130838055|NCT00349921|471032190|FG000|First Spinal Injection|Adverse Event|0|||
130838056|NCT00349921|471032191|FG001|First Spinal Injection|Adverse Event|0|||
130838057|NCT00349921|471032192|FG002|First Spinal Injection|Adverse Event|1|||
130838058|NCT00349921|471032193|FG003|First Spinal Injection|Adverse Event|0|||
130838059|NCT04700540|471032194|FG000|Overall Study|Withdrawal by Subject|12|||
130838060|NCT04700540|471032195|FG001|Overall Study|Withdrawal by Subject|8|||
130838061|NCT04700540|471032194|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
130838062|NCT04700540|471032195|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
130838063|NCT00082368|471032198|FG000|Overall Study|Not treated-pt had poor IV access|1|||
130838064|NCT03319953|471032201|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
130838065|NCT03319953|471032202|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
130838066|NCT03319953|471032203|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
130838067|NCT03319953|471032204|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
130838068|NCT03319953|471032201|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
130838069|NCT03319953|471032202|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
130838070|NCT03319953|471032203|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
130838071|NCT03319953|471032204|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
130838072|NCT03724981|471034069|FG000|First Device|Protocol Violation|1|||
130838073|NCT03724981|471034070|FG001|First Device|Protocol Violation|1|||
130838074|NCT00197145|471034071|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
130838075|NCT00197145|471034072|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
130838076|NCT00197145|471034071|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
130838077|NCT00197145|471034072|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
130838078|NCT00197145|471034071|FG000|Period 1: Randomized Treatment Phase|Other|2|||
130838079|NCT00197145|471034072|FG001|Period 1: Randomized Treatment Phase|Other|2|||
130838080|NCT00197145|471034071|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
130838081|NCT00197145|471034072|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
130838082|NCT00197145|471034071|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
130838083|NCT00197145|471034072|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
130838084|NCT00197145|471034071|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
130838085|NCT00197145|471034072|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
130838086|NCT00197145|471034071|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
130838087|NCT00197145|471034072|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
130838088|NCT00197145|471034071|FG000|Period 2 : Open Label Phase|Other|1|||
130838089|NCT00197145|471034072|FG001|Period 2 : Open Label Phase|Other|0|||
130838090|NCT02578680|471034075|FG000|Overall Study|Death|329|||
130838091|NCT02578680|471034076|FG001|Overall Study|Death|181|||
130838092|NCT02578680|471034075|FG000|Overall Study|Lost to Follow-up|3|||
130838093|NCT02578680|471034076|FG001|Overall Study|Lost to Follow-up|1|||
130838094|NCT02578680|471034075|FG000|Overall Study|Physician Decision|0|||
130838095|NCT02578680|471034076|FG001|Overall Study|Physician Decision|1|||
130838096|NCT02578680|471034075|FG000|Overall Study|Protocol Violation|1|||
130838097|NCT02578680|471034076|FG001|Overall Study|Protocol Violation|1|||
130838098|NCT02578680|471034075|FG000|Overall Study|Sponsor Decision|64|||
130838099|NCT02578680|471034076|FG001|Overall Study|Sponsor Decision|13|||
130838100|NCT02578680|471034075|FG000|Overall Study|Withdrawal by Subject|13|||
130838101|NCT02578680|471034076|FG001|Overall Study|Withdrawal by Subject|9|||
130838102|NCT03596047|471034077|FG000|Overall Study|Withdrawal by Subject|7|||
130838103|NCT03596047|471034078|FG001|Overall Study|Withdrawal by Subject|4|||
130838104|NCT03596047|471034077|FG000|Overall Study|Lost to Follow-up|0|||
130838105|NCT03596047|471034078|FG001|Overall Study|Lost to Follow-up|2|||
130838106|NCT02290691|471034079|FG000|Overall Study|Noncompliance|0|||
130838107|NCT02290691|471034080|FG001|Overall Study|Noncompliance|1|||
130838108|NCT02290691|471034079|FG000|Overall Study|Withdrawal by Subject|1|||
130838109|NCT02290691|471034080|FG001|Overall Study|Withdrawal by Subject|1|||
130838110|NCT02290691|471034079|FG000|Overall Study|Lost to Follow-up|7|||
130838111|NCT02290691|471034080|FG001|Overall Study|Lost to Follow-up|7|||
130838112|NCT02589665|471034085|FG000|Induction Period|Did not receive drug|0|||
130838113|NCT02589665|471034086|FG001|Induction Period|Did not receive drug|0|||
130838114|NCT02589665|471034087|FG002|Induction Period|Did not receive drug|0|||
130838115|NCT02589665|471034088|FG003|Induction Period|Did not receive drug|1|||
130838116|NCT02589665|471034089|FG004|Induction Period|Did not receive drug|0|||
130838117|NCT02589665|471034090|FG005|Induction Period|Did not receive drug|0|||
130838118|NCT02589665|471034091|FG006|Induction Period|Did not receive drug|0|||
130838119|NCT02589665|471034092|FG007|Induction Period|Did not receive drug|0|||
130838120|NCT02589665|471034093|FG008|Induction Period|Did not receive drug|0|||
130838121|NCT02589665|471034094|FG009|Induction Period|Did not receive drug|0|||
130838122|NCT02589665|471034085|FG000|Induction Period|Adverse Event|3|||
130838123|NCT02589665|471034086|FG001|Induction Period|Adverse Event|0|||
130838124|NCT02589665|471034087|FG002|Induction Period|Adverse Event|2|||
130838125|NCT02589665|471034088|FG003|Induction Period|Adverse Event|2|||
130838126|NCT02589665|471034089|FG004|Induction Period|Adverse Event|0|||
130838127|NCT02589665|471034090|FG005|Induction Period|Adverse Event|0|||
130838128|NCT02589665|471034091|FG006|Induction Period|Adverse Event|0|||
130838129|NCT02589665|471034092|FG007|Induction Period|Adverse Event|0|||
130838130|NCT02589665|471034093|FG008|Induction Period|Adverse Event|0|||
130838131|NCT02589665|471034094|FG009|Induction Period|Adverse Event|0|||
130838132|NCT02589665|471034085|FG000|Induction Period|Withdrawal by Subject|0|||
130838133|NCT02589665|471034086|FG001|Induction Period|Withdrawal by Subject|1|||
130838134|NCT02589665|471034087|FG002|Induction Period|Withdrawal by Subject|0|||
130838135|NCT02589665|471034088|FG003|Induction Period|Withdrawal by Subject|1|||
130838136|NCT02589665|471034089|FG004|Induction Period|Withdrawal by Subject|0|||
130838137|NCT02589665|471034090|FG005|Induction Period|Withdrawal by Subject|0|||
130838138|NCT02589665|471034091|FG006|Induction Period|Withdrawal by Subject|0|||
130838139|NCT02589665|471034092|FG007|Induction Period|Withdrawal by Subject|0|||
130838140|NCT02589665|471034093|FG008|Induction Period|Withdrawal by Subject|0|||
130838141|NCT02589665|471034094|FG009|Induction Period|Withdrawal by Subject|0|||
130838142|NCT02589665|471034085|FG000|Induction Period|Protocol Violation|0|||
130838143|NCT02589665|471034086|FG001|Induction Period|Protocol Violation|1|||
130838144|NCT02589665|471034087|FG002|Induction Period|Protocol Violation|0|||
130838145|NCT02589665|471034088|FG003|Induction Period|Protocol Violation|0|||
130838146|NCT02589665|471034089|FG004|Induction Period|Protocol Violation|0|||
130838147|NCT02589665|471034090|FG005|Induction Period|Protocol Violation|0|||
130838148|NCT02589665|471034091|FG006|Induction Period|Protocol Violation|0|||
130838149|NCT02589665|471034092|FG007|Induction Period|Protocol Violation|0|||
130838150|NCT02589665|471034093|FG008|Induction Period|Protocol Violation|0|||
130838151|NCT02589665|471034094|FG009|Induction Period|Protocol Violation|0|||
130838152|NCT02589665|471034085|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838153|NCT02589665|471034086|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838154|NCT02589665|471034087|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838155|NCT02589665|471034088|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838156|NCT02589665|471034089|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
130838157|NCT02589665|471034090|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
130838158|NCT02589665|471034091|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
130838159|NCT02589665|471034092|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838160|NCT02589665|471034093|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838161|NCT02589665|471034094|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838162|NCT02589665|471034085|FG000|Maintenance Period|Withdrawal by Subject|0|||
130838163|NCT02589665|471034086|FG001|Maintenance Period|Withdrawal by Subject|0|||
130838164|NCT02589665|471034087|FG002|Maintenance Period|Withdrawal by Subject|0|||
130838165|NCT02589665|471034088|FG003|Maintenance Period|Withdrawal by Subject|0|||
130838166|NCT02589665|471034089|FG004|Maintenance Period|Withdrawal by Subject|4|||
130838167|NCT02589665|471034090|FG005|Maintenance Period|Withdrawal by Subject|2|||
130838168|NCT02589665|471034091|FG006|Maintenance Period|Withdrawal by Subject|4|||
130838169|NCT02589665|471034092|FG007|Maintenance Period|Withdrawal by Subject|0|||
130838170|NCT02589665|471034093|FG008|Maintenance Period|Withdrawal by Subject|0|||
130838171|NCT02589665|471034094|FG009|Maintenance Period|Withdrawal by Subject|0|||
130838172|NCT02589665|471034085|FG000|Maintenance Period|Lack of Efficacy|0|||
130838173|NCT02589665|471034086|FG001|Maintenance Period|Lack of Efficacy|0|||
130838174|NCT02589665|471034087|FG002|Maintenance Period|Lack of Efficacy|0|||
130838175|NCT02589665|471034088|FG003|Maintenance Period|Lack of Efficacy|0|||
130838176|NCT02589665|471034089|FG004|Maintenance Period|Lack of Efficacy|2|||
130838177|NCT02589665|471034090|FG005|Maintenance Period|Lack of Efficacy|1|||
130838178|NCT02589665|471034091|FG006|Maintenance Period|Lack of Efficacy|0|||
130838179|NCT02589665|471034092|FG007|Maintenance Period|Lack of Efficacy|0|||
130838180|NCT02589665|471034093|FG008|Maintenance Period|Lack of Efficacy|0|||
130838181|NCT02589665|471034094|FG009|Maintenance Period|Lack of Efficacy|0|||
130838182|NCT02589665|471034085|FG000|Maintenance Period|Adverse Event|0|||
130838183|NCT02589665|471034086|FG001|Maintenance Period|Adverse Event|0|||
130838184|NCT02589665|471034087|FG002|Maintenance Period|Adverse Event|0|||
130838185|NCT02589665|471034088|FG003|Maintenance Period|Adverse Event|0|||
130838186|NCT02589665|471034089|FG004|Maintenance Period|Adverse Event|0|||
130838187|NCT02589665|471034090|FG005|Maintenance Period|Adverse Event|0|||
130838188|NCT02589665|471034091|FG006|Maintenance Period|Adverse Event|2|||
130838189|NCT02589665|471034092|FG007|Maintenance Period|Adverse Event|0|||
130838190|NCT02589665|471034093|FG008|Maintenance Period|Adverse Event|0|||
130838191|NCT02589665|471034094|FG009|Maintenance Period|Adverse Event|0|||
130838192|NCT02589665|471034085|FG000|Maintenance Period|Lost to Follow-up|0|||
130838193|NCT02589665|471034086|FG001|Maintenance Period|Lost to Follow-up|0|||
130838194|NCT02589665|471034087|FG002|Maintenance Period|Lost to Follow-up|0|||
130838195|NCT02589665|471034088|FG003|Maintenance Period|Lost to Follow-up|0|||
130838196|NCT02589665|471034089|FG004|Maintenance Period|Lost to Follow-up|0|||
130838197|NCT02589665|471034090|FG005|Maintenance Period|Lost to Follow-up|1|||
130838198|NCT02589665|471034091|FG006|Maintenance Period|Lost to Follow-up|0|||
130838199|NCT02589665|471034092|FG007|Maintenance Period|Lost to Follow-up|0|||
130838200|NCT02589665|471034093|FG008|Maintenance Period|Lost to Follow-up|0|||
130838201|NCT02589665|471034094|FG009|Maintenance Period|Lost to Follow-up|0|||
130838202|NCT02589665|471034085|FG000|Maintenance Period|Physician Decision|0|||
130838203|NCT02589665|471034086|FG001|Maintenance Period|Physician Decision|0|||
130838204|NCT02589665|471034087|FG002|Maintenance Period|Physician Decision|0|||
130838205|NCT02589665|471034088|FG003|Maintenance Period|Physician Decision|0|||
130838206|NCT02589665|471034089|FG004|Maintenance Period|Physician Decision|0|||
130838207|NCT02589665|471034090|FG005|Maintenance Period|Physician Decision|1|||
130838208|NCT02589665|471034091|FG006|Maintenance Period|Physician Decision|0|||
130838209|NCT02589665|471034092|FG007|Maintenance Period|Physician Decision|0|||
130838210|NCT02589665|471034093|FG008|Maintenance Period|Physician Decision|0|||
130838211|NCT02589665|471034094|FG009|Maintenance Period|Physician Decision|0|||
130838212|NCT02589665|471034085|FG000|Maintenance Period|Reason Not Collected|0|||
130838213|NCT02589665|471034086|FG001|Maintenance Period|Reason Not Collected|0|||
130838214|NCT02589665|471034087|FG002|Maintenance Period|Reason Not Collected|0|||
130838215|NCT02589665|471034088|FG003|Maintenance Period|Reason Not Collected|0|||
130838216|NCT02589665|471034089|FG004|Maintenance Period|Reason Not Collected|0|||
130838217|NCT02589665|471034090|FG005|Maintenance Period|Reason Not Collected|1|||
130838218|NCT02589665|471034091|FG006|Maintenance Period|Reason Not Collected|1|||
130838219|NCT02589665|471034092|FG007|Maintenance Period|Reason Not Collected|0|||
130838220|NCT02589665|471034093|FG008|Maintenance Period|Reason Not Collected|0|||
130838221|NCT02589665|471034094|FG009|Maintenance Period|Reason Not Collected|0|||
130838222|NCT02589665|471034085|FG000|Induction Extension Period|Adverse Event|0|||
130838223|NCT02589665|471034086|FG001|Induction Extension Period|Adverse Event|0|||
130838224|NCT02589665|471034087|FG002|Induction Extension Period|Adverse Event|0|||
130838225|NCT02589665|471034088|FG003|Induction Extension Period|Adverse Event|0|||
130838226|NCT02589665|471034089|FG004|Induction Extension Period|Adverse Event|0|||
130838227|NCT02589665|471034090|FG005|Induction Extension Period|Adverse Event|0|||
130838228|NCT02589665|471034091|FG006|Induction Extension Period|Adverse Event|0|||
130838229|NCT02589665|471034092|FG007|Induction Extension Period|Adverse Event|0|||
130838230|NCT02589665|471034093|FG008|Induction Extension Period|Adverse Event|4|||
130838231|NCT02589665|471034094|FG009|Induction Extension Period|Adverse Event|0|||
130838232|NCT02589665|471034085|FG000|Induction Extension Period|Lack of Efficacy|0|||
130838233|NCT02589665|471034086|FG001|Induction Extension Period|Lack of Efficacy|0|||
130838234|NCT02589665|471034087|FG002|Induction Extension Period|Lack of Efficacy|0|||
130838235|NCT02589665|471034088|FG003|Induction Extension Period|Lack of Efficacy|0|||
130838236|NCT02589665|471034089|FG004|Induction Extension Period|Lack of Efficacy|0|||
130838237|NCT02589665|471034090|FG005|Induction Extension Period|Lack of Efficacy|0|||
130838238|NCT02589665|471034091|FG006|Induction Extension Period|Lack of Efficacy|0|||
130838239|NCT02589665|471034092|FG007|Induction Extension Period|Lack of Efficacy|0|||
130838240|NCT02589665|471034093|FG008|Induction Extension Period|Lack of Efficacy|3|||
130838241|NCT02589665|471034094|FG009|Induction Extension Period|Lack of Efficacy|0|||
130838242|NCT02589665|471034085|FG000|Induction Extension Period|Withdrawal by Subject|0|||
130838243|NCT02589665|471034086|FG001|Induction Extension Period|Withdrawal by Subject|0|||
130838244|NCT02589665|471034087|FG002|Induction Extension Period|Withdrawal by Subject|0|||
130838245|NCT02589665|471034088|FG003|Induction Extension Period|Withdrawal by Subject|0|||
130838246|NCT02589665|471034089|FG004|Induction Extension Period|Withdrawal by Subject|0|||
130838247|NCT02589665|471034090|FG005|Induction Extension Period|Withdrawal by Subject|0|||
130838248|NCT02589665|471034091|FG006|Induction Extension Period|Withdrawal by Subject|0|||
130838249|NCT02589665|471034092|FG007|Induction Extension Period|Withdrawal by Subject|2|||
130838250|NCT02589665|471034093|FG008|Induction Extension Period|Withdrawal by Subject|3|||
130838251|NCT02589665|471034094|FG009|Induction Extension Period|Withdrawal by Subject|0|||
130838252|NCT02589665|471034085|FG000|Induction Extension Period|Physician Decision|0|||
130838253|NCT02589665|471034086|FG001|Induction Extension Period|Physician Decision|0|||
130838254|NCT02589665|471034087|FG002|Induction Extension Period|Physician Decision|0|||
130838255|NCT02589665|471034088|FG003|Induction Extension Period|Physician Decision|0|||
130838256|NCT02589665|471034089|FG004|Induction Extension Period|Physician Decision|0|||
130838257|NCT02589665|471034090|FG005|Induction Extension Period|Physician Decision|0|||
130838258|NCT02589665|471034091|FG006|Induction Extension Period|Physician Decision|0|||
130838259|NCT02589665|471034092|FG007|Induction Extension Period|Physician Decision|0|||
130838260|NCT02589665|471034093|FG008|Induction Extension Period|Physician Decision|1|||
130838261|NCT02589665|471034094|FG009|Induction Extension Period|Physician Decision|0|||
130838262|NCT02589665|471034085|FG000|Induction Extension Period|Reason Not Collected|0|||
130838263|NCT02589665|471034086|FG001|Induction Extension Period|Reason Not Collected|0|||
130838264|NCT02589665|471034087|FG002|Induction Extension Period|Reason Not Collected|0|||
130838265|NCT02589665|471034088|FG003|Induction Extension Period|Reason Not Collected|0|||
130838266|NCT02589665|471034089|FG004|Induction Extension Period|Reason Not Collected|0|||
130838267|NCT02589665|471034090|FG005|Induction Extension Period|Reason Not Collected|0|||
130838268|NCT02589665|471034091|FG006|Induction Extension Period|Reason Not Collected|0|||
130838269|NCT02589665|471034092|FG007|Induction Extension Period|Reason Not Collected|0|||
130838270|NCT02589665|471034093|FG008|Induction Extension Period|Reason Not Collected|1|||
130838271|NCT02589665|471034094|FG009|Induction Extension Period|Reason Not Collected|0|||
130838272|NCT02589665|471034085|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838273|NCT02589665|471034086|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838274|NCT02589665|471034087|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838275|NCT02589665|471034088|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838276|NCT02589665|471034089|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838277|NCT02589665|471034090|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838278|NCT02589665|471034091|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838279|NCT02589665|471034092|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838280|NCT02589665|471034093|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130838281|NCT02589665|471034094|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
130838282|NCT02589665|471034085|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
130838283|NCT02589665|471034086|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
130838284|NCT02589665|471034087|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
130838285|NCT02589665|471034088|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
130838286|NCT02589665|471034089|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
130838287|NCT02589665|471034090|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
130838288|NCT02589665|471034091|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
130838289|NCT02589665|471034092|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
130838290|NCT02589665|471034093|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
130838291|NCT02589665|471034094|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
130838292|NCT02589665|471034085|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
130838293|NCT02589665|471034086|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
130838294|NCT02589665|471034087|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
130838295|NCT02589665|471034088|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
130838296|NCT02589665|471034089|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
130838297|NCT02589665|471034090|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
130838298|NCT02589665|471034091|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
130838299|NCT02589665|471034092|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
130838300|NCT02589665|471034093|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
130838301|NCT02589665|471034094|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
130838302|NCT02589665|471034085|FG000|Maintenance Extension Period|Adverse Event|0|||
130838303|NCT02589665|471034086|FG001|Maintenance Extension Period|Adverse Event|0|||
130838304|NCT02589665|471034087|FG002|Maintenance Extension Period|Adverse Event|0|||
130838305|NCT02589665|471034088|FG003|Maintenance Extension Period|Adverse Event|0|||
130838306|NCT02589665|471034089|FG004|Maintenance Extension Period|Adverse Event|0|||
130838307|NCT02589665|471034090|FG005|Maintenance Extension Period|Adverse Event|0|||
130838308|NCT02589665|471034091|FG006|Maintenance Extension Period|Adverse Event|0|||
130838309|NCT02589665|471034092|FG007|Maintenance Extension Period|Adverse Event|0|||
130838310|NCT02589665|471034093|FG008|Maintenance Extension Period|Adverse Event|0|||
130838311|NCT02589665|471034094|FG009|Maintenance Extension Period|Adverse Event|2|||
130838312|NCT02589665|471034085|FG000|Maintenance Extension Period|Non-responder|0|||
130838313|NCT02589665|471034086|FG001|Maintenance Extension Period|Non-responder|0|||
130838314|NCT02589665|471034087|FG002|Maintenance Extension Period|Non-responder|0|||
130838315|NCT02589665|471034088|FG003|Maintenance Extension Period|Non-responder|0|||
130838316|NCT02589665|471034089|FG004|Maintenance Extension Period|Non-responder|0|||
130838317|NCT02589665|471034090|FG005|Maintenance Extension Period|Non-responder|0|||
130838318|NCT02589665|471034091|FG006|Maintenance Extension Period|Non-responder|0|||
130838319|NCT02589665|471034092|FG007|Maintenance Extension Period|Non-responder|0|||
130838320|NCT02589665|471034093|FG008|Maintenance Extension Period|Non-responder|0|||
130838321|NCT02589665|471034094|FG009|Maintenance Extension Period|Non-responder|1|||
130838322|NCT00978380|471034095|FG000|Overall Study|Protocol Violation|2|||
130838323|NCT00978380|471034095|FG000|Overall Study|Withdrawal criteria|9|||
130838324|NCT00978380|471034095|FG000|Overall Study|Unclassified|8|||
130838325|NCT03350035|471034101|FG000|Overall Study|Lack of Efficacy|2|||
130838326|NCT03350035|471034102|FG001|Overall Study|Lack of Efficacy|0|||
130838327|NCT03350035|471034103|FG002|Overall Study|Lack of Efficacy|0|||
130838328|NCT03350035|471034101|FG000|Overall Study|Subject discharged to hospice|0|||
130838329|NCT03350035|471034102|FG001|Overall Study|Subject discharged to hospice|0|||
130838330|NCT03350035|471034103|FG002|Overall Study|Subject discharged to hospice|1|||
130838331|NCT01610557|471034104|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130838332|NCT01610557|471034105|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
130838333|NCT01610557|471034106|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130838334|NCT01610557|471034107|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130838335|NCT01610557|471034108|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130838336|NCT01610557|471034104|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130838337|NCT01610557|471034105|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130838338|NCT01610557|471034106|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130838339|NCT01610557|471034107|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130838340|NCT01610557|471034108|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
130838341|NCT02039219|471034109|FG000|Treatment|Withdrawal by Subject|1|||
130838342|NCT02039219|471034110|FG001|Treatment|Withdrawal by Subject|0|||
130838343|NCT02039219|471034109|FG000|Treatment|Adverse Event|0|||
130838344|NCT02039219|471034110|FG001|Treatment|Adverse Event|1|||
130838345|NCT02039219|471034109|FG000|Treatment|Physician Decision|1|||
130838346|NCT02039219|471034110|FG001|Treatment|Physician Decision|0|||
130838347|NCT02039219|471034109|FG000|Treatment|Lost to Follow-up|0|||
130838348|NCT02039219|471034110|FG001|Treatment|Lost to Follow-up|1|||
130838349|NCT02039219|471034109|FG000|Treatment|Protocol Violation|1|||
130838350|NCT02039219|471034110|FG001|Treatment|Protocol Violation|0|||
130838351|NCT02039219|471034109|FG000|Treatment|Death|1|||
130838352|NCT02039219|471034110|FG001|Treatment|Death|0|||
130838353|NCT02039219|471034109|FG000|Follow up|Adverse Event|0|||
130838354|NCT02039219|471034110|FG001|Follow up|Adverse Event|1|||
130838355|NCT02974855|471034111|FG000|Overall Study|Adverse Event|0|||
130838356|NCT02974855|471034112|FG001|Overall Study|Adverse Event|1|||
130838357|NCT02974855|471034113|FG002|Overall Study|Adverse Event|0|||
130838358|NCT02974855|471034114|FG003|Overall Study|Adverse Event|1|||
130838359|NCT03576066|471034115|FG000|Overall Study|Noncompliance with study drug|0|||
130838360|NCT03576066|471034116|FG001|Overall Study|Noncompliance with study drug|1|||
130838361|NCT00129701|471034117|FG000|Overall Study|Withdrawal by Subject|33|||
130838362|NCT02750345|471034118|FG000|Intervention 1|Adverse Event|0|||
130838363|NCT02750345|471034119|FG001|Intervention 1|Adverse Event|0|||
130838364|NCT02750345|471034120|FG002|Intervention 1|Adverse Event|0|||
130838365|NCT02750345|471034121|FG003|Intervention 1|Adverse Event|0|||
130838366|NCT02750345|471034122|FG004|Intervention 1|Adverse Event|1|||
130838367|NCT02750345|471034123|FG005|Intervention 1|Adverse Event|0|||
130838368|NCT00006164|471034124|FG000|Overall Study|Withdrew or lost to follow-up|70|||
130838369|NCT00006164|471034125|FG001|Overall Study|Withdrew or lost to follow-up|81|||
130838370|NCT00633074|471034128|FG000|Overall Study|Adverse Event|1|||
130838371|NCT00633074|471034129|FG001|Overall Study|Adverse Event|0|||
130838372|NCT00365105|471034130|FG000|Overall Study|Protocol Violation|5|||
130838373|NCT00365105|471034131|FG001|Overall Study|Protocol Violation|8|||
130838374|NCT00608023|471034132|FG000|Overall Study|Withdrawal by Subject|8|||
130838375|NCT00608023|471034133|FG001|Overall Study|Withdrawal by Subject|10|||
130838376|NCT00608023|471034134|FG002|Overall Study|Withdrawal by Subject|7|||
130838377|NCT00608023|471034132|FG000|Overall Study|Adverse Event|1|||
130838378|NCT00608023|471034133|FG001|Overall Study|Adverse Event|4|||
130838379|NCT00608023|471034134|FG002|Overall Study|Adverse Event|5|||
130838380|NCT00608023|471034132|FG000|Overall Study|Lost to Follow-up|2|||
130838381|NCT00608023|471034133|FG001|Overall Study|Lost to Follow-up|2|||
130838382|NCT00608023|471034134|FG002|Overall Study|Lost to Follow-up|1|||
130838383|NCT00608023|471034132|FG000|Overall Study|Protocol Violation|1|||
130838384|NCT00608023|471034133|FG001|Overall Study|Protocol Violation|3|||
130838385|NCT00608023|471034134|FG002|Overall Study|Protocol Violation|1|||
130838386|NCT00608023|471034132|FG000|Overall Study|Unknown reason|0|||
130838387|NCT00608023|471034133|FG001|Overall Study|Unknown reason|3|||
130838388|NCT00608023|471034134|FG002|Overall Study|Unknown reason|0|||
130838389|NCT06422364|471034135|FG000|Overall Study|Withdrawn due to study closure|0|||
130838390|NCT06422364|471034136|FG001|Overall Study|Withdrawn due to study closure|2|||
130838391|NCT01463696|471034141|FG000|Overall Study|Adverse Event|0|||
130838392|NCT01463696|471034142|FG001|Overall Study|Adverse Event|1|||
130838393|NCT01463696|471034143|FG002|Overall Study|Adverse Event|0|||
130838394|NCT01463696|471034144|FG003|Overall Study|Adverse Event|2|||
130838395|NCT01463696|471034145|FG004|Overall Study|Adverse Event|0|||
130838396|NCT01463696|471034146|FG005|Overall Study|Adverse Event|1|||
130838397|NCT01463696|471034147|FG006|Overall Study|Adverse Event|3|||
130838398|NCT01463696|471034148|FG007|Overall Study|Adverse Event|2|||
130838399|NCT01463696|471034141|FG000|Overall Study|Lost to Follow-up|0|||
130838400|NCT01463696|471034142|FG001|Overall Study|Lost to Follow-up|0|||
130838401|NCT01463696|471034143|FG002|Overall Study|Lost to Follow-up|1|||
130838402|NCT01463696|471034144|FG003|Overall Study|Lost to Follow-up|0|||
130838403|NCT01463696|471034145|FG004|Overall Study|Lost to Follow-up|0|||
130838404|NCT01463696|471034146|FG005|Overall Study|Lost to Follow-up|0|||
130838405|NCT01463696|471034147|FG006|Overall Study|Lost to Follow-up|0|||
130838406|NCT01463696|471034148|FG007|Overall Study|Lost to Follow-up|0|||
130838407|NCT01463696|471034141|FG000|Overall Study|Progressive Disease|0|||
130838408|NCT01463696|471034142|FG001|Overall Study|Progressive Disease|1|||
130838409|NCT01463696|471034143|FG002|Overall Study|Progressive Disease|0|||
130838410|NCT01463696|471034144|FG003|Overall Study|Progressive Disease|1|||
130838411|NCT01463696|471034145|FG004|Overall Study|Progressive Disease|0|||
130838412|NCT01463696|471034146|FG005|Overall Study|Progressive Disease|1|||
130838413|NCT01463696|471034147|FG006|Overall Study|Progressive Disease|4|||
130838414|NCT01463696|471034148|FG007|Overall Study|Progressive Disease|2|||
130838415|NCT01463696|471034141|FG000|Overall Study|Withdrawal by Subject|0|||
130838416|NCT01463696|471034142|FG001|Overall Study|Withdrawal by Subject|0|||
130838417|NCT01463696|471034143|FG002|Overall Study|Withdrawal by Subject|0|||
130838418|NCT01463696|471034144|FG003|Overall Study|Withdrawal by Subject|1|||
130838419|NCT01463696|471034145|FG004|Overall Study|Withdrawal by Subject|1|||
130838420|NCT01463696|471034146|FG005|Overall Study|Withdrawal by Subject|1|||
130838421|NCT01463696|471034147|FG006|Overall Study|Withdrawal by Subject|2|||
130838422|NCT01463696|471034148|FG007|Overall Study|Withdrawal by Subject|0|||
130838423|NCT01463696|471034141|FG000|Overall Study|Not Treated|0|||
130838424|NCT01463696|471034142|FG001|Overall Study|Not Treated|0|||
130838425|NCT01463696|471034143|FG002|Overall Study|Not Treated|0|||
130838426|NCT01463696|471034144|FG003|Overall Study|Not Treated|0|||
130838427|NCT01463696|471034145|FG004|Overall Study|Not Treated|0|||
130838428|NCT01463696|471034146|FG005|Overall Study|Not Treated|0|||
130838429|NCT01463696|471034147|FG006|Overall Study|Not Treated|1|||
130838430|NCT01463696|471034148|FG007|Overall Study|Not Treated|0|||
130838431|NCT03883165|471034149|FG000|Overall Study|Withdrawal by Subject|4|||
130838432|NCT03883165|471034150|FG001|Overall Study|Withdrawal by Subject|3|||
130838433|NCT00245050|471034154|FG000|Overall Study|Adverse Event|3|||
130838434|NCT00245050|471034155|FG001|Overall Study|Adverse Event|2|||
130838435|NCT00425698|471034156|FG000|Overall Study|Adverse Event|3|||
130838436|NCT00425698|471034157|FG001|Overall Study|Adverse Event|1|||
130838437|NCT00425698|471034156|FG000|Overall Study|Withdrawal by Subject|0|||
130838438|NCT00425698|471034157|FG001|Overall Study|Withdrawal by Subject|1|||
130838439|NCT03905265|471034159|FG000|Overall Study|Withdrawal by Subject|1|||
130838440|NCT03905265|471034160|FG001|Overall Study|Withdrawal by Subject|1|||
130838441|NCT03905265|471034161|FG002|Overall Study|Withdrawal by Subject|0|||
130838442|NCT03905265|471034162|FG003|Overall Study|Withdrawal by Subject|0|||
130838443|NCT03832322|471034165|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
130838444|NCT03832322|471034166|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
130838445|NCT00404755|471034167|FG000|Phase I (Bupropion)|Adverse Event|3|||
130838446|NCT00404755|471034167|FG000|Phase I (Bupropion)|Other|1|||
130838447|NCT00404755|471034167|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
130838448|NCT00350870|471034168|FG000|Overall Study|Withdrawal by Subject|21|||
130838449|NCT00350870|471034169|FG001|Overall Study|Withdrawal by Subject|17|||
130838450|NCT00350870|471034170|FG002|Overall Study|Withdrawal by Subject|15|||
130838451|NCT00350870|471034171|FG003|Overall Study|Withdrawal by Subject|14|||
130838452|NCT00350870|471034168|FG000|Overall Study|Physician Decision|1|||
130838453|NCT00350870|471034169|FG001|Overall Study|Physician Decision|0|||
130838454|NCT00350870|471034170|FG002|Overall Study|Physician Decision|1|||
130838455|NCT00350870|471034171|FG003|Overall Study|Physician Decision|1|||
130838456|NCT03194568|471034172|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
130838457|NCT01453205|471034173|FG000|Overall Study|Lost to Follow-up|3|||
130838458|NCT01453205|471034174|FG001|Overall Study|Lost to Follow-up|0|||
130838459|NCT01453205|471034175|FG002|Overall Study|Lost to Follow-up|1|||
130838460|NCT01453205|471034173|FG000|Overall Study|Withdrawal by Subject|8|||
130838461|NCT01453205|471034174|FG001|Overall Study|Withdrawal by Subject|3|||
130838462|NCT01453205|471034175|FG002|Overall Study|Withdrawal by Subject|0|||
130838463|NCT01453205|471034173|FG000|Overall Study|Death|24|||
130838464|NCT01453205|471034174|FG001|Overall Study|Death|22|||
130838465|NCT01453205|471034175|FG002|Overall Study|Death|18|||
130838466|NCT01453205|471034173|FG000|Overall Study|Other|45|||
130838467|NCT01453205|471034174|FG001|Overall Study|Other|27|||
130838468|NCT01453205|471034175|FG002|Overall Study|Other|35|||
130838469|NCT03268954|471034177|FG000|Overall Study|Ongoing|23|||
130838470|NCT03268954|471034178|FG001|Overall Study|Ongoing|31|||
130838471|NCT03268954|471034177|FG000|Overall Study|Adverse Event|53|||
130838472|NCT03268954|471034178|FG001|Overall Study|Adverse Event|62|||
130838473|NCT03268954|471034177|FG000|Overall Study|Withdrawal by Subject|25|||
130838474|NCT03268954|471034178|FG001|Overall Study|Withdrawal by Subject|16|||
130838475|NCT03268954|471034177|FG000|Overall Study|Progressive Disease|61|||
130838476|NCT03268954|471034178|FG001|Overall Study|Progressive Disease|48|||
130838477|NCT03268954|471034177|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
130838478|NCT03268954|471034178|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
130838479|NCT03268954|471034177|FG000|Overall Study|Reason not Specified|40|||
130838480|NCT03268954|471034178|FG001|Overall Study|Reason not Specified|40|||
130838481|NCT03255967|471034179|FG000|Overall Study|Adverse Event|26|||
130838482|NCT03255967|471034180|FG001|Overall Study|Adverse Event|30|||
130838483|NCT03255967|471034179|FG000|Overall Study|Withdrawal by Subject|6|||
130838484|NCT03255967|471034180|FG001|Overall Study|Withdrawal by Subject|6|||
130838485|NCT03255967|471034179|FG000|Overall Study|Schedule conflict|6|||
130838486|NCT03255967|471034180|FG001|Overall Study|Schedule conflict|4|||
130838487|NCT03255967|471034179|FG000|Overall Study|POA did not sign consent form|2|||
130838488|NCT03255967|471034180|FG001|Overall Study|POA did not sign consent form|0|||
130838489|NCT00778258|471034181|FG000|Overall Study|Adverse Event|1|||
130838490|NCT00778258|471034182|FG001|Overall Study|Adverse Event|0|||
130838491|NCT00778258|471034183|FG002|Overall Study|Adverse Event|0|||
130838492|NCT00778258|471034184|FG003|Overall Study|Adverse Event|0|||
130838493|NCT00778258|471034185|FG004|Overall Study|Adverse Event|0|||
130838494|NCT00778258|471034186|FG005|Overall Study|Adverse Event|1|||
130838495|NCT00778258|471034187|FG006|Overall Study|Adverse Event|0|||
130838496|NCT00778258|471034188|FG007|Overall Study|Adverse Event|0|||
130838497|NCT00778258|471034189|FG008|Overall Study|Adverse Event|0|||
130838498|NCT00778258|471034181|FG000|Overall Study|Lost to Follow-up|0|||
130838499|NCT00778258|471034182|FG001|Overall Study|Lost to Follow-up|0|||
130838500|NCT00778258|471034183|FG002|Overall Study|Lost to Follow-up|2|||
130838501|NCT00778258|471034184|FG003|Overall Study|Lost to Follow-up|0|||
130838502|NCT00778258|471034185|FG004|Overall Study|Lost to Follow-up|0|||
130838503|NCT00778258|471034186|FG005|Overall Study|Lost to Follow-up|3|||
130838504|NCT00778258|471034187|FG006|Overall Study|Lost to Follow-up|2|||
130838505|NCT00778258|471034188|FG007|Overall Study|Lost to Follow-up|2|||
130838506|NCT00778258|471034189|FG008|Overall Study|Lost to Follow-up|0|||
130838507|NCT00778258|471034181|FG000|Overall Study|Withdrawal by Subject|6|||
130838508|NCT00778258|471034182|FG001|Overall Study|Withdrawal by Subject|2|||
130838509|NCT00778258|471034183|FG002|Overall Study|Withdrawal by Subject|8|||
130838510|NCT00778258|471034184|FG003|Overall Study|Withdrawal by Subject|2|||
130838511|NCT00778258|471034185|FG004|Overall Study|Withdrawal by Subject|0|||
130838512|NCT00778258|471034186|FG005|Overall Study|Withdrawal by Subject|6|||
130838513|NCT00778258|471034187|FG006|Overall Study|Withdrawal by Subject|12|||
130838514|NCT00778258|471034188|FG007|Overall Study|Withdrawal by Subject|12|||
130838515|NCT00778258|471034189|FG008|Overall Study|Withdrawal by Subject|4|||
130838516|NCT00778258|471034181|FG000|Overall Study|New Contraindication|0|||
130838517|NCT00778258|471034182|FG001|Overall Study|New Contraindication|0|||
130838518|NCT00778258|471034183|FG002|Overall Study|New Contraindication|0|||
130838519|NCT00778258|471034184|FG003|Overall Study|New Contraindication|0|||
130838520|NCT00778258|471034185|FG004|Overall Study|New Contraindication|0|||
130838521|NCT00778258|471034186|FG005|Overall Study|New Contraindication|0|||
130838522|NCT00778258|471034187|FG006|Overall Study|New Contraindication|0|||
130838523|NCT00778258|471034188|FG007|Overall Study|New Contraindication|1|||
130838524|NCT00778258|471034189|FG008|Overall Study|New Contraindication|0|||
130838525|NCT00778258|471034181|FG000|Overall Study|Non-compliance|0|||
130838526|NCT00778258|471034182|FG001|Overall Study|Non-compliance|0|||
130838527|NCT00778258|471034183|FG002|Overall Study|Non-compliance|0|||
130838528|NCT00778258|471034184|FG003|Overall Study|Non-compliance|1|||
130838529|NCT00778258|471034185|FG004|Overall Study|Non-compliance|0|||
130838530|NCT00778258|471034186|FG005|Overall Study|Non-compliance|0|||
130838531|NCT00778258|471034187|FG006|Overall Study|Non-compliance|0|||
130838532|NCT00778258|471034188|FG007|Overall Study|Non-compliance|0|||
130838533|NCT00778258|471034189|FG008|Overall Study|Non-compliance|0|||
130838534|NCT00778258|471034181|FG000|Overall Study|Other|0|||
130838535|NCT00778258|471034182|FG001|Overall Study|Other|0|||
130838536|NCT00778258|471034183|FG002|Overall Study|Other|0|||
130838537|NCT00778258|471034184|FG003|Overall Study|Other|0|||
130838538|NCT00778258|471034185|FG004|Overall Study|Other|0|||
130838539|NCT00778258|471034186|FG005|Overall Study|Other|0|||
130838540|NCT00778258|471034187|FG006|Overall Study|Other|1|||
130838541|NCT00778258|471034188|FG007|Overall Study|Other|0|||
130838542|NCT00778258|471034189|FG008|Overall Study|Other|0|||
130838543|NCT01202188|471034193|FG000|Overall Study|Protocol deviation|14|||
130838544|NCT01202188|471034194|FG001|Overall Study|Protocol deviation|8|||
130838545|NCT01202188|471034195|FG002|Overall Study|Protocol deviation|12|||
130838546|NCT01202188|471034196|FG003|Overall Study|Protocol deviation|10|||
130838547|NCT01202188|471034197|FG004|Overall Study|Protocol deviation|11|||
130838548|NCT01202188|471034193|FG000|Overall Study|Subject withdrew consent|12|||
130838549|NCT01202188|471034194|FG001|Overall Study|Subject withdrew consent|13|||
130838550|NCT01202188|471034195|FG002|Overall Study|Subject withdrew consent|22|||
130838551|NCT01202188|471034196|FG003|Overall Study|Subject withdrew consent|11|||
130838552|NCT01202188|471034197|FG004|Overall Study|Subject withdrew consent|13|||
130838553|NCT01202188|471034193|FG000|Overall Study|Adverse Event|5|||
130838554|NCT01202188|471034194|FG001|Overall Study|Adverse Event|23|||
130838555|NCT01202188|471034195|FG002|Overall Study|Adverse Event|13|||
130838556|NCT01202188|471034196|FG003|Overall Study|Adverse Event|10|||
130838557|NCT01202188|471034197|FG004|Overall Study|Adverse Event|10|||
130838558|NCT01202188|471034193|FG000|Overall Study|Administrative problems|3|||
130838559|NCT01202188|471034194|FG001|Overall Study|Administrative problems|2|||
130838560|NCT01202188|471034195|FG002|Overall Study|Administrative problems|1|||
130838561|NCT01202188|471034196|FG003|Overall Study|Administrative problems|1|||
130838562|NCT01202188|471034197|FG004|Overall Study|Administrative problems|2|||
130838563|NCT01202188|471034193|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130838564|NCT01202188|471034194|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
130838565|NCT01202188|471034195|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130838566|NCT01202188|471034196|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
130838567|NCT01202188|471034197|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
130838568|NCT01202188|471034193|FG000|Overall Study|Lost to Follow-up|1|||
130838569|NCT01202188|471034194|FG001|Overall Study|Lost to Follow-up|1|||
130838570|NCT01202188|471034195|FG002|Overall Study|Lost to Follow-up|0|||
130838571|NCT01202188|471034196|FG003|Overall Study|Lost to Follow-up|4|||
130838572|NCT01202188|471034197|FG004|Overall Study|Lost to Follow-up|1|||
130838573|NCT01202188|471034193|FG000|Overall Study|Death|1|||
130838574|NCT01202188|471034194|FG001|Overall Study|Death|1|||
130838575|NCT01202188|471034195|FG002|Overall Study|Death|1|||
130838576|NCT01202188|471034196|FG003|Overall Study|Death|1|||
130838577|NCT01202188|471034197|FG004|Overall Study|Death|0|||
130838578|NCT01202188|471034193|FG000|Overall Study|Abnormal test procedure result (s)|0|||
130838579|NCT01202188|471034194|FG001|Overall Study|Abnormal test procedure result (s)|0|||
130838580|NCT01202188|471034195|FG002|Overall Study|Abnormal test procedure result (s)|2|||
130838581|NCT01202188|471034196|FG003|Overall Study|Abnormal test procedure result (s)|0|||
130838582|NCT01202188|471034197|FG004|Overall Study|Abnormal test procedure result (s)|0|||
130838583|NCT00487942|471034205|FG000|Overall Study|Adverse Event|1|||
130838584|NCT00487942|471034206|FG001|Overall Study|Adverse Event|1|||
130838585|NCT00487942|471034207|FG002|Overall Study|Adverse Event|1|||
130838586|NCT00487942|471034208|FG003|Overall Study|Adverse Event|1|||
130838587|NCT00487942|471034205|FG000|Overall Study|Lost to Follow-up|1|||
130838588|NCT00487942|471034206|FG001|Overall Study|Lost to Follow-up|0|||
130838589|NCT00487942|471034207|FG002|Overall Study|Lost to Follow-up|0|||
130838590|NCT00487942|471034208|FG003|Overall Study|Lost to Follow-up|1|||
130838591|NCT00487942|471034205|FG000|Overall Study|Protocol Violation|1|||
130838592|NCT00487942|471034206|FG001|Overall Study|Protocol Violation|1|||
130838593|NCT00487942|471034207|FG002|Overall Study|Protocol Violation|0|||
130838594|NCT00487942|471034208|FG003|Overall Study|Protocol Violation|0|||
130838595|NCT00487942|471034205|FG000|Overall Study|Withdrawal by Subject|0|||
130838596|NCT00487942|471034206|FG001|Overall Study|Withdrawal by Subject|1|||
130838597|NCT00487942|471034207|FG002|Overall Study|Withdrawal by Subject|2|||
130838598|NCT00487942|471034208|FG003|Overall Study|Withdrawal by Subject|0|||
130838599|NCT00780143|471034214|FG000|Overall Study|Progressive disease|1|||
130838600|NCT00780143|471034214|FG000|Overall Study|Toxicity|1|||
130838601|NCT00780143|471034214|FG000|Overall Study|Adverse Event|1|||
130838602|NCT02640625|471035731|FG000|Overall Study|Adverse Event|1|||
130838603|NCT00790868|471035732|FG000|Overall Study|Withdrawal by Subject|4|||
130838604|NCT00790868|471035733|FG001|Overall Study|Withdrawal by Subject|5|||
130838605|NCT00790868|471035732|FG000|Overall Study|Lost to Follow-up|2|||
130838606|NCT00790868|471035733|FG001|Overall Study|Lost to Follow-up|12|||
130838607|NCT01380535|471035734|FG000|Overall Study|Adverse Event|3|||
130838608|NCT01380535|471035735|FG001|Overall Study|Adverse Event|3|||
130838609|NCT01380535|471035734|FG000|Overall Study|Death|3|||
130838610|NCT01380535|471035735|FG001|Overall Study|Death|0|||
130838611|NCT01380535|471035734|FG000|Overall Study|Study site closed|0|||
130838612|NCT01380535|471035735|FG001|Overall Study|Study site closed|5|||
130838613|NCT01380535|471035734|FG000|Overall Study|Withdrawal by Subject|1|||
130838614|NCT01380535|471035735|FG001|Overall Study|Withdrawal by Subject|2|||
130838615|NCT01380535|471035734|FG000|Overall Study|Protocol Violation|0|||
130838616|NCT01380535|471035735|FG001|Overall Study|Protocol Violation|2|||
130838617|NCT01380535|471035734|FG000|Overall Study|Lack of Efficacy|0|||
130838618|NCT01380535|471035735|FG001|Overall Study|Lack of Efficacy|3|||
130838619|NCT04753658|471035741|FG000|Overall Study|Progressive disease|7|||
130838620|NCT04753658|471035741|FG000|Overall Study|Other|7|||
130838621|NCT04753658|471035741|FG000|Overall Study|Adverse Event|1|||
130838622|NCT00306293|471035742|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
130838623|NCT00306293|471035743|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
130838624|NCT00306293|471035742|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
130838625|NCT00306293|471035743|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
130838626|NCT00306293|471035742|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
130838627|NCT00306293|471035743|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
130838628|NCT00306293|471035742|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
130838629|NCT00306293|471035743|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
130838630|NCT00306293|471035742|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
130838631|NCT00306293|471035743|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
130838632|NCT00306293|471035742|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
130838633|NCT00306293|471035743|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
130838634|NCT00306293|471035742|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
130838635|NCT00306293|471035743|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
130838636|NCT00306293|471035742|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
130838637|NCT00306293|471035743|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
130838638|NCT00218634|471035744|FG000|Overall Study|Lost to Follow-up|8|||
130838639|NCT00218634|471035745|FG001|Overall Study|Lost to Follow-up|15|||
130838640|NCT05243745|471035746|FG000|Overall Study|Withdrawal by Subject|0|||
130838641|NCT05243745|471035747|FG001|Overall Study|Withdrawal by Subject|0|||
130838642|NCT05243745|471035748|FG002|Overall Study|Withdrawal by Subject|0|||
130838643|NCT05243745|471035749|FG003|Overall Study|Withdrawal by Subject|1|||
130838644|NCT05243745|471035746|FG000|Overall Study|Unable to Attend Visit 6|0|||
130838645|NCT05243745|471035747|FG001|Overall Study|Unable to Attend Visit 6|0|||
130838646|NCT05243745|471035748|FG002|Overall Study|Unable to Attend Visit 6|1|||
130838647|NCT05243745|471035749|FG003|Overall Study|Unable to Attend Visit 6|0|||
130838648|NCT00176488|471035752|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
130838649|NCT01044745|471035753|FG000|Overall Study|Ineiligible|2|||
130838650|NCT01159171|471035758|FG000|Overall Study|Adverse Event|11|||
130838651|NCT01159171|471035758|FG000|Overall Study|Progression of Disease|28|||
130838652|NCT01159171|471035758|FG000|Overall Study|Protocol Violation|1|||
130838653|NCT01159171|471035758|FG000|Overall Study|Need for Surgery|5|||
130838654|NCT01159171|471035758|FG000|Overall Study|Medical Decision|4|||
130838655|NCT01159171|471035758|FG000|Overall Study|Death|1|||
130838656|NCT02242435|471035772|FG000|Overall Study|Lost to Follow-up|3|||
130838657|NCT02242435|471035773|FG001|Overall Study|Lost to Follow-up|4|||
130838658|NCT02242435|471035772|FG000|Overall Study|Adverse Event|3|||
130838659|NCT02242435|471035773|FG001|Overall Study|Adverse Event|2|||
130838660|NCT02242435|471035772|FG000|Overall Study|Withdrawal by Subject|13|||
130838661|NCT02242435|471035773|FG001|Overall Study|Withdrawal by Subject|8|||
130838662|NCT02242435|471035772|FG000|Overall Study|Death|0|||
130838663|NCT02242435|471035773|FG001|Overall Study|Death|1|||
130838664|NCT02242435|471035772|FG000|Overall Study|Protocol Violation|1|||
130838665|NCT02242435|471035773|FG001|Overall Study|Protocol Violation|0|||
130838666|NCT02242435|471035772|FG000|Overall Study|Physician Decision|0|||
130838667|NCT02242435|471035773|FG001|Overall Study|Physician Decision|1|||
130838668|NCT03895086|471035774|FG000|Overall Study|Early termination study|1|||
130838669|NCT03895086|471035775|FG001|Overall Study|Early termination study|0|||
130838670|NCT01089413|471035782|FG000|Overall Study|Lost to Follow-up|1|||
130838671|NCT01089413|471035782|FG000|Overall Study|Progressive Disease|93|||
130838672|NCT01089413|471035782|FG000|Overall Study|Participant Withdrew Consent|1|||
130838673|NCT01089413|471035782|FG000|Overall Study|Unacceptable Toxicity|12|||
130838674|NCT01089413|471035782|FG000|Overall Study|Death|10|||
130838675|NCT01089413|471035782|FG000|Overall Study|Metastasectomy|13|||
130838676|NCT01089413|471035782|FG000|Overall Study|Other|71|||
130838677|NCT02513485|471035783|FG000|Overall Study|Adverse Event|1|||
130838678|NCT02513485|471035784|FG001|Overall Study|Adverse Event|0|||
130838679|NCT02526524|471035791|FG000|Overall Study|Withdrawal by Subject|3|||
130838680|NCT02526524|471035792|FG001|Overall Study|Withdrawal by Subject|3|||
130838681|NCT02526524|471035793|FG002|Overall Study|Withdrawal by Subject|6|||
130838682|NCT02526524|471035794|FG003|Overall Study|Withdrawal by Subject|1|||
130838683|NCT02526524|471035795|FG004|Overall Study|Withdrawal by Subject|9|||
130838684|NCT02526524|471035796|FG005|Overall Study|Withdrawal by Subject|5|||
130838685|NCT02526524|471035791|FG000|Overall Study|Adverse Event|3|||
130838686|NCT02526524|471035792|FG001|Overall Study|Adverse Event|2|||
130838687|NCT02526524|471035793|FG002|Overall Study|Adverse Event|4|||
130838688|NCT02526524|471035794|FG003|Overall Study|Adverse Event|2|||
130838689|NCT02526524|471035795|FG004|Overall Study|Adverse Event|6|||
130838690|NCT02526524|471035796|FG005|Overall Study|Adverse Event|8|||
130838691|NCT02526524|471035791|FG000|Overall Study|Lost to Follow-up|2|||
130838692|NCT02526524|471035792|FG001|Overall Study|Lost to Follow-up|3|||
130838693|NCT02526524|471035793|FG002|Overall Study|Lost to Follow-up|8|||
130838694|NCT02526524|471035794|FG003|Overall Study|Lost to Follow-up|1|||
130838695|NCT02526524|471035795|FG004|Overall Study|Lost to Follow-up|2|||
130838696|NCT02526524|471035796|FG005|Overall Study|Lost to Follow-up|5|||
130838697|NCT02526524|471035791|FG000|Overall Study|Protocol Violation|3|||
130838698|NCT02526524|471035792|FG001|Overall Study|Protocol Violation|1|||
130838699|NCT02526524|471035793|FG002|Overall Study|Protocol Violation|5|||
130838700|NCT02526524|471035794|FG003|Overall Study|Protocol Violation|3|||
130838701|NCT02526524|471035795|FG004|Overall Study|Protocol Violation|4|||
130838702|NCT02526524|471035796|FG005|Overall Study|Protocol Violation|3|||
130838703|NCT02526524|471035791|FG000|Overall Study|Loss of Glucose Control|0|||
130838704|NCT02526524|471035792|FG001|Overall Study|Loss of Glucose Control|0|||
130838705|NCT02526524|471035793|FG002|Overall Study|Loss of Glucose Control|3|||
130838706|NCT02526524|471035794|FG003|Overall Study|Loss of Glucose Control|0|||
130838707|NCT02526524|471035795|FG004|Overall Study|Loss of Glucose Control|2|||
130838708|NCT02526524|471035796|FG005|Overall Study|Loss of Glucose Control|0|||
130838709|NCT02526524|471035791|FG000|Overall Study|Physician Decision|0|||
130838710|NCT02526524|471035792|FG001|Overall Study|Physician Decision|0|||
130838711|NCT02526524|471035793|FG002|Overall Study|Physician Decision|0|||
130838712|NCT02526524|471035794|FG003|Overall Study|Physician Decision|0|||
130838713|NCT02526524|471035795|FG004|Overall Study|Physician Decision|1|||
130838714|NCT02526524|471035796|FG005|Overall Study|Physician Decision|0|||
130838715|NCT02526524|471035791|FG000|Overall Study|Sponsor Decision|1|||
130838716|NCT02526524|471035792|FG001|Overall Study|Sponsor Decision|0|||
130838717|NCT02526524|471035793|FG002|Overall Study|Sponsor Decision|0|||
130838718|NCT02526524|471035794|FG003|Overall Study|Sponsor Decision|0|||
130838719|NCT02526524|471035795|FG004|Overall Study|Sponsor Decision|0|||
130838720|NCT02526524|471035796|FG005|Overall Study|Sponsor Decision|0|||
130838721|NCT00420004|471035804|FG000|Overall Study|Adverse Event|4|||
130838722|NCT00420004|471035805|FG001|Overall Study|Adverse Event|1|||
130838723|NCT00420004|471035806|FG002|Overall Study|Adverse Event|1|||
130838724|NCT00420004|471035804|FG000|Overall Study|Lack of Efficacy|5|||
130838725|NCT00420004|471035805|FG001|Overall Study|Lack of Efficacy|4|||
130838726|NCT00420004|471035806|FG002|Overall Study|Lack of Efficacy|1|||
130838727|NCT00420004|471035804|FG000|Overall Study|Lost to Follow-up|31|||
130838728|NCT00420004|471035805|FG001|Overall Study|Lost to Follow-up|12|||
130838729|NCT00420004|471035806|FG002|Overall Study|Lost to Follow-up|10|||
130838730|NCT00420004|471035804|FG000|Overall Study|Entry Criteria Not Met|0|||
130838731|NCT00420004|471035805|FG001|Overall Study|Entry Criteria Not Met|1|||
130838732|NCT00420004|471035806|FG002|Overall Study|Entry Criteria Not Met|0|||
130838733|NCT00420004|471035804|FG000|Overall Study|Physician Decision|14|||
130838734|NCT00420004|471035805|FG001|Overall Study|Physician Decision|4|||
130838735|NCT00420004|471035806|FG002|Overall Study|Physician Decision|2|||
130838736|NCT00420004|471035804|FG000|Overall Study|Protocol Violation|5|||
130838737|NCT00420004|471035805|FG001|Overall Study|Protocol Violation|4|||
130838738|NCT00420004|471035806|FG002|Overall Study|Protocol Violation|3|||
130838739|NCT00420004|471035804|FG000|Overall Study|Withdrawal by Subject|67|||
130838740|NCT00420004|471035805|FG001|Overall Study|Withdrawal by Subject|42|||
130838741|NCT00420004|471035806|FG002|Overall Study|Withdrawal by Subject|14|||
130838742|NCT00420004|471035804|FG000|Overall Study|Sponsor Decision|3|||
130838743|NCT00420004|471035805|FG001|Overall Study|Sponsor Decision|3|||
130838744|NCT00420004|471035806|FG002|Overall Study|Sponsor Decision|1|||
130838745|NCT00591149|471035807|FG000|Overall Study|Adverse Event|4|||
130838746|NCT00591149|471035807|FG000|Overall Study|Withdrawal by Subject|1|||
130838747|NCT00470093|471035808|FG000|Overall Study|Adverse Event|2|||
130838748|NCT00664560|471035809|FG000|Overall Study|Adverse Event|19|||
130838749|NCT00664560|471035810|FG001|Overall Study|Adverse Event|16|||
130838750|NCT00664560|471035811|FG002|Overall Study|Adverse Event|7|||
130838751|NCT00664560|471035809|FG000|Overall Study|Withdrawal by Subject|9|||
130838752|NCT00664560|471035810|FG001|Overall Study|Withdrawal by Subject|13|||
130838753|NCT00664560|471035811|FG002|Overall Study|Withdrawal by Subject|7|||
130838754|NCT00664560|471035809|FG000|Overall Study|Lost to Follow-up|0|||
130838755|NCT00664560|471035810|FG001|Overall Study|Lost to Follow-up|2|||
130838756|NCT00664560|471035811|FG002|Overall Study|Lost to Follow-up|0|||
130838757|NCT00664560|471035809|FG000|Overall Study|Other|11|||
130838758|NCT00664560|471035810|FG001|Overall Study|Other|4|||
130838759|NCT00664560|471035811|FG002|Overall Study|Other|5|||
130838760|NCT02456636|471035812|FG000|Overall Study|Death|0|||
130838761|NCT02456636|471035813|FG001|Overall Study|Death|3|||
130838762|NCT02456636|471035814|FG002|Overall Study|Death|0|||
130838763|NCT02456636|471035812|FG000|Overall Study|Pregnancy|1|||
130838764|NCT02456636|471035813|FG001|Overall Study|Pregnancy|3|||
130838765|NCT02456636|471035814|FG002|Overall Study|Pregnancy|5|||
130838766|NCT02456636|471035812|FG000|Overall Study|Physician Decision|4|||
130838767|NCT02456636|471035813|FG001|Overall Study|Physician Decision|5|||
130838768|NCT02456636|471035814|FG002|Overall Study|Physician Decision|4|||
130838769|NCT02456636|471035812|FG000|Overall Study|Withdrawal by Subject|13|||
130838770|NCT02456636|471035813|FG001|Overall Study|Withdrawal by Subject|14|||
130838771|NCT02456636|471035814|FG002|Overall Study|Withdrawal by Subject|16|||
130838772|NCT02456636|471035812|FG000|Overall Study|Lost to Follow-up|50|||
130838773|NCT02456636|471035813|FG001|Overall Study|Lost to Follow-up|44|||
130838774|NCT02456636|471035814|FG002|Overall Study|Lost to Follow-up|50|||
130838775|NCT05312632|471035817|FG000|Overall Study|Adverse Event|12|||
130838776|NCT05312632|471035817|FG000|Overall Study|Withdrawal by Subject|10|||
130838777|NCT05312632|471035817|FG000|Overall Study|Lack of Efficacy|4|||
130838778|NCT05312632|471035817|FG000|Overall Study|Non-compliance with study procedures|9|||
130838779|NCT05312632|471035817|FG000|Overall Study|Other|4|||
130838780|NCT02379221|471035818|FG000|Overall Study|Lost to Follow-up|1|||
130838781|NCT00519376|471035819|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838782|NCT00519376|471035820|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838783|NCT00519376|471035821|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838784|NCT00519376|471035822|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838785|NCT00519376|471035823|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838786|NCT00519376|471035824|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838787|NCT00519376|471035825|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838788|NCT00519376|471035826|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838789|NCT00519376|471035827|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838790|NCT00519376|471035828|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838791|NCT00519376|471035829|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838792|NCT00519376|471035830|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838793|NCT00519376|471035831|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
130838794|NCT00519376|471035832|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838795|NCT00519376|471035833|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838796|NCT00519376|471035834|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130838797|NCT00519376|471035819|FG000|Treatment Period 4|Lost to Follow-up|0|||
130838798|NCT00519376|471035820|FG001|Treatment Period 4|Lost to Follow-up|0|||
130838799|NCT00519376|471035821|FG002|Treatment Period 4|Lost to Follow-up|1|||
130838800|NCT00519376|471035822|FG003|Treatment Period 4|Lost to Follow-up|0|||
130838801|NCT00519376|471035823|FG004|Treatment Period 4|Lost to Follow-up|0|||
130838802|NCT00519376|471035824|FG005|Treatment Period 4|Lost to Follow-up|0|||
130838803|NCT00519376|471035825|FG006|Treatment Period 4|Lost to Follow-up|0|||
130838804|NCT00519376|471035826|FG007|Treatment Period 4|Lost to Follow-up|0|||
130838805|NCT00519376|471035827|FG008|Treatment Period 4|Lost to Follow-up|0|||
130838806|NCT00519376|471035828|FG009|Treatment Period 4|Lost to Follow-up|0|||
130838807|NCT00519376|471035829|FG010|Treatment Period 4|Lost to Follow-up|0|||
130838808|NCT00519376|471035830|FG011|Treatment Period 4|Lost to Follow-up|0|||
130838809|NCT00519376|471035831|FG012|Treatment Period 4|Lost to Follow-up|0|||
130838810|NCT00519376|471035832|FG013|Treatment Period 4|Lost to Follow-up|0|||
130838811|NCT00519376|471035833|FG014|Treatment Period 4|Lost to Follow-up|0|||
130838812|NCT00519376|471035834|FG015|Treatment Period 4|Lost to Follow-up|0|||
130838813|NCT02650128|471035837|FG000|Overall Study|Death|2|||
130838814|NCT01801436|471035851|FG000|Overall Study|Withdrawal by Subject|3|||
130838815|NCT01801436|471035851|FG000|Overall Study|Adverse Event|2|||
130838816|NCT01801436|471035851|FG000|Overall Study|Progressive disease|4|||
130838817|NCT01885208|471035852|FG000|Overall Study|Unclassified|32|||
130838818|NCT01885208|471035853|FG001|Overall Study|Unclassified|38|||
130838819|NCT01973387|471035857|FG000|Overall Study|Adverse Event|14|||
130838820|NCT01973387|471035858|FG001|Overall Study|Adverse Event|4|||
130838821|NCT01973387|471035857|FG000|Overall Study|Withdrawal by Subject|7|||
130838822|NCT01973387|471035858|FG001|Overall Study|Withdrawal by Subject|4|||
130838823|NCT01973387|471035857|FG000|Overall Study|Study terminated by sponsor|63|||
130838824|NCT01973387|471035858|FG001|Overall Study|Study terminated by sponsor|0|||
130838825|NCT01973387|471035857|FG000|Overall Study|Progressive disease or relapse|16|||
130838826|NCT01973387|471035858|FG001|Overall Study|Progressive disease or relapse|5|||
130838827|NCT01973387|471035857|FG000|Overall Study|Death|4|||
130838828|NCT01973387|471035858|FG001|Overall Study|Death|3|||
130838829|NCT01973387|471035857|FG000|Overall Study|Randomized, not treated|2|||
130838830|NCT01973387|471035858|FG001|Overall Study|Randomized, not treated|2|||
130838831|NCT01498575|471035859|FG000|Overall Sample|Withdrawal by Subject|60|||
130838832|NCT01498575|471035860|FG001|Overall Sample|Withdrawal by Subject|14|||
130838833|NCT01498575|471035859|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
130838834|NCT01498575|471035860|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
130838835|NCT01498575|471035859|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
130838836|NCT01498575|471035860|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
130838837|NCT03888235|471035870|FG000|Overall Study|Lost to Follow-up|1|||
130838838|NCT03888235|471035871|FG001|Overall Study|Lost to Follow-up|1|||
130838839|NCT03888235|471035872|FG002|Overall Study|Lost to Follow-up|0|||
130838840|NCT03525600|471035877|FG000|Overall Study|Adverse Event|9|||
130838841|NCT03525600|471035878|FG001|Overall Study|Adverse Event|6|||
130838842|NCT03525600|471035879|FG002|Overall Study|Adverse Event|5|||
130838843|NCT03525600|471035880|FG003|Overall Study|Adverse Event|3|||
130838844|NCT03525600|471035877|FG000|Overall Study|Lost to Follow-up|2|||
130838845|NCT03525600|471035878|FG001|Overall Study|Lost to Follow-up|4|||
130838846|NCT03525600|471035879|FG002|Overall Study|Lost to Follow-up|4|||
130838847|NCT03525600|471035880|FG003|Overall Study|Lost to Follow-up|0|||
130838848|NCT03525600|471035877|FG000|Overall Study|Physician Decision|1|||
130838849|NCT03525600|471035878|FG001|Overall Study|Physician Decision|0|||
130838850|NCT03525600|471035879|FG002|Overall Study|Physician Decision|2|||
130838851|NCT03525600|471035880|FG003|Overall Study|Physician Decision|0|||
130838852|NCT03525600|471035877|FG000|Overall Study|Consent withdrawal|36|||
130838853|NCT03525600|471035878|FG001|Overall Study|Consent withdrawal|20|||
130838854|NCT03525600|471035879|FG002|Overall Study|Consent withdrawal|6|||
130838855|NCT03525600|471035880|FG003|Overall Study|Consent withdrawal|13|||
130838856|NCT03525600|471035877|FG000|Overall Study|Death|7|||
130838857|NCT03525600|471035878|FG001|Overall Study|Death|6|||
130838858|NCT03525600|471035879|FG002|Overall Study|Death|4|||
130838859|NCT03525600|471035880|FG003|Overall Study|Death|3|||
130838860|NCT03525600|471035877|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
130838861|NCT03525600|471035878|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
130838862|NCT03525600|471035879|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
130838863|NCT03525600|471035880|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
130838864|NCT03525600|471035877|FG000|Overall Study|Other|0|||
130838865|NCT03525600|471035878|FG001|Overall Study|Other|1|||
130838866|NCT03525600|471035879|FG002|Overall Study|Other|0|||
130838867|NCT03525600|471035880|FG003|Overall Study|Other|0|||
130838868|NCT03703817|471035890|FG000|Overall Study|Not meeting eligibility criteria|7|||
130838869|NCT03703817|471035891|FG001|Overall Study|Not meeting eligibility criteria|4|||
130838870|NCT05248997|471035895|FG000|Overall Study|Lost to Follow-up|1|||
130838871|NCT05248997|471035896|FG001|Overall Study|Lost to Follow-up|1|||
130838872|NCT05248997|471035895|FG000|Overall Study|Randomized but not treated|32|||
130838873|NCT05248997|471035896|FG001|Overall Study|Randomized but not treated|25|||
130838874|NCT04262882|471035898|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
130838875|NCT04262882|471035899|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
130838876|NCT04262882|471035898|FG000|Overall Study|Lost to Follow-up|1|||
130838877|NCT04262882|471035899|FG001|Overall Study|Lost to Follow-up|0|||
130838878|NCT01301066|471035900|FG000|Overall Study|Lost to Follow-up|5|||
130838879|NCT01301066|471035901|FG001|Overall Study|Lost to Follow-up|11|||
130838880|NCT01301066|471035900|FG000|Overall Study|Protocol Violation|8|||
130838881|NCT01301066|471035901|FG001|Overall Study|Protocol Violation|7|||
130838882|NCT01301066|471035900|FG000|Overall Study|Withdrawal by Subject|4|||
130838883|NCT01301066|471035901|FG001|Overall Study|Withdrawal by Subject|9|||
130838884|NCT01301066|471035900|FG000|Overall Study|Adverse Event|6|||
130838885|NCT01301066|471035901|FG001|Overall Study|Adverse Event|6|||
130838886|NCT01301066|471035900|FG000|Overall Study|Sponsor Decision|2|||
130838887|NCT01301066|471035901|FG001|Overall Study|Sponsor Decision|1|||
130838888|NCT01301066|471035900|FG000|Overall Study|Physician Decision|0|||
130838889|NCT01301066|471035901|FG001|Overall Study|Physician Decision|1|||
130838890|NCT01301066|471035900|FG000|Overall Study|Other|2|||
130838891|NCT01301066|471035901|FG001|Overall Study|Other|0|||
130838892|NCT02438384|471035906|FG000|Overall Study|Lost to Follow-up|8|||
130838893|NCT02438384|471035907|FG001|Overall Study|Lost to Follow-up|6|||
130838894|NCT02438384|471035908|FG002|Overall Study|Lost to Follow-up|4|||
130838895|NCT00511433|471038100|FG000|Overall Study|Adverse Event|5|||
130838896|NCT00511433|471038101|FG001|Overall Study|Adverse Event|0|||
130838897|NCT00511433|471038100|FG000|Overall Study|Other Reason|1|||
130838898|NCT00511433|471038101|FG001|Overall Study|Other Reason|1|||
130838899|NCT01740089|471038102|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
130838900|NCT01740089|471038103|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
130838901|NCT01740089|471038104|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
130838902|NCT01740089|471038102|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
130838903|NCT01740089|471038103|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
130838904|NCT01740089|471038104|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
130838905|NCT01740089|471038102|FG000|After 12 Weeks|Lack of Efficacy|3|||
130838906|NCT01740089|471038103|FG001|After 12 Weeks|Lack of Efficacy|1|||
130838907|NCT01740089|471038104|FG002|After 12 Weeks|Lack of Efficacy|4|||
130838908|NCT01740089|471038102|FG000|After 12 Weeks|Adverse Event|2|||
130838909|NCT01740089|471038103|FG001|After 12 Weeks|Adverse Event|0|||
130838910|NCT01740089|471038104|FG002|After 12 Weeks|Adverse Event|5|||
130838911|NCT01740089|471038102|FG000|After 12 Weeks|Protocol Violation|1|||
130838912|NCT01740089|471038103|FG001|After 12 Weeks|Protocol Violation|1|||
130838913|NCT01740089|471038104|FG002|After 12 Weeks|Protocol Violation|1|||
130838914|NCT01740089|471038102|FG000|After 12 Weeks|Withdrawal by Subject|1|||
130838915|NCT01740089|471038103|FG001|After 12 Weeks|Withdrawal by Subject|1|||
130838916|NCT01740089|471038104|FG002|After 12 Weeks|Withdrawal by Subject|1|||
130838917|NCT01579565|471038107|FG000|Randomized|Adverse Event|1|||
130838918|NCT01579565|471038108|FG001|Randomized|Adverse Event|3|||
130838919|NCT01579565|471038107|FG000|Randomized|Withdrawal by Subject|3|||
130838920|NCT01579565|471038108|FG001|Randomized|Withdrawal by Subject|0|||
130838921|NCT01579565|471038107|FG000|Randomized|inadequate preoperative pupil dilation|0|||
130838922|NCT01579565|471038108|FG001|Randomized|inadequate preoperative pupil dilation|1|||
130838923|NCT01579565|471038107|FG000|Randomized|prohibited preoperative eating|1|||
130838924|NCT01579565|471038108|FG001|Randomized|prohibited preoperative eating|0|||
130838925|NCT01579565|471038107|FG000|Randomized|prohibited preoperative medication|0|||
130838926|NCT01579565|471038108|FG001|Randomized|prohibited preoperative medication|1|||
130838927|NCT01579565|471038107|FG000|Treated|Physician Decision|0|||
130838928|NCT01579565|471038108|FG001|Treated|Physician Decision|1|||
130838929|NCT01579565|471038107|FG000|Treated|Lost to Follow-up|2|||
130838930|NCT01579565|471038108|FG001|Treated|Lost to Follow-up|1|||
130838931|NCT01579565|471038107|FG000|Treated|declined to return for final visit|0|||
130838932|NCT01579565|471038108|FG001|Treated|declined to return for final visit|1|||
130838933|NCT02867813|471038109|FG000|Overall Study|Withdrawal by Subject|57|||
130838934|NCT02867813|471038110|FG001|Overall Study|Withdrawal by Subject|56|||
130838935|NCT02867813|471038109|FG000|Overall Study|Decision by Sponsor|7|||
130838936|NCT02867813|471038110|FG001|Overall Study|Decision by Sponsor|7|||
130838937|NCT02867813|471038109|FG000|Overall Study|Lost to Follow-up|91|||
130838938|NCT02867813|471038110|FG001|Overall Study|Lost to Follow-up|78|||
130838939|NCT02867813|471038109|FG000|Overall Study|Missing|2|||
130838940|NCT02867813|471038110|FG001|Overall Study|Missing|1|||
130838941|NCT02867813|471038109|FG000|Overall Study|Death|294|||
130838942|NCT02867813|471038110|FG001|Overall Study|Death|268|||
130838943|NCT01952665|471038116|FG000|Overall Study|Physician Decision|3|||
130838944|NCT01952665|471038117|FG001|Overall Study|Physician Decision|2|||
130838945|NCT01952665|471038116|FG000|Overall Study|Lost to Follow-up|1|||
130838946|NCT01952665|471038117|FG001|Overall Study|Lost to Follow-up|2|||
130838947|NCT01952665|471038116|FG000|Overall Study|Adverse Event|2|||
130838948|NCT01952665|471038117|FG001|Overall Study|Adverse Event|1|||
130838949|NCT01952665|471038116|FG000|Overall Study|Protocol Violation|0|||
130838950|NCT01952665|471038117|FG001|Overall Study|Protocol Violation|1|||
130838951|NCT01537081|471038119|FG000|Overall Study|Adverse Event|5|||
130838952|NCT01537081|471038120|FG001|Overall Study|Adverse Event|2|||
130838953|NCT01537081|471038121|FG002|Overall Study|Adverse Event|2|||
130838954|NCT01537081|471038119|FG000|Overall Study|Lack of Efficacy|2|||
130838955|NCT01537081|471038120|FG001|Overall Study|Lack of Efficacy|1|||
130838956|NCT01537081|471038121|FG002|Overall Study|Lack of Efficacy|0|||
130838957|NCT01537081|471038119|FG000|Overall Study|Lost to Follow-up|17|||
130838958|NCT01537081|471038120|FG001|Overall Study|Lost to Follow-up|15|||
130838959|NCT01537081|471038121|FG002|Overall Study|Lost to Follow-up|9|||
130838960|NCT01537081|471038119|FG000|Overall Study|Protocol Violation|3|||
130838961|NCT01537081|471038120|FG001|Overall Study|Protocol Violation|2|||
130838962|NCT01537081|471038121|FG002|Overall Study|Protocol Violation|2|||
130838963|NCT01537081|471038119|FG000|Overall Study|Withdrawal by Subject|6|||
130838964|NCT01537081|471038120|FG001|Overall Study|Withdrawal by Subject|11|||
130838965|NCT01537081|471038121|FG002|Overall Study|Withdrawal by Subject|3|||
130838966|NCT01537081|471038119|FG000|Overall Study|Physician Decision|5|||
130838967|NCT01537081|471038120|FG001|Overall Study|Physician Decision|6|||
130838968|NCT01537081|471038121|FG002|Overall Study|Physician Decision|0|||
130838969|NCT01537081|471038119|FG000|Overall Study|Sponsor decision|0|||
130838970|NCT01537081|471038120|FG001|Overall Study|Sponsor decision|1|||
130838971|NCT01537081|471038121|FG002|Overall Study|Sponsor decision|0|||
130838972|NCT01537081|471038119|FG000|Overall Study|Assigned but never dosed|1|||
130838973|NCT01537081|471038120|FG001|Overall Study|Assigned but never dosed|0|||
130838974|NCT01537081|471038121|FG002|Overall Study|Assigned but never dosed|0|||
130838975|NCT01463111|471038124|FG000|Overall Study|Withdrawal by Subject|2|||
130838976|NCT01463111|471038124|FG000|Overall Study|Lost to Follow-up|5|||
130838977|NCT01463111|471038124|FG000|Overall Study|Physician Decision|2|||
130838978|NCT03285958|471038125|FG000|Overall Study|Lost to Follow-up|1|||
130838979|NCT03285958|471038126|FG001|Overall Study|Lost to Follow-up|1|||
130838980|NCT03285958|471038125|FG000|Overall Study|Withdrawal by Subject|1|||
130838981|NCT03285958|471038126|FG001|Overall Study|Withdrawal by Subject|0|||
130838982|NCT03285958|471038125|FG000|Overall Study|Not able to attend required orientation|3|||
130838983|NCT03285958|471038126|FG001|Overall Study|Not able to attend required orientation|0|||
130838984|NCT03116828|471038129|FG000|Overall Study|Adverse Event|1|||
130838985|NCT03116828|471038130|FG001|Overall Study|Adverse Event|10|||
130838986|NCT03116828|471038129|FG000|Overall Study|Withdrawal by Subject|4|||
130838987|NCT03116828|471038130|FG001|Overall Study|Withdrawal by Subject|8|||
130838988|NCT03116828|471038129|FG000|Overall Study|OTHER|3|||
130838989|NCT03116828|471038130|FG001|Overall Study|OTHER|3|||
130838990|NCT00882583|471038131|FG000|Overall Study|Physician Decision|1|||
130838991|NCT00882583|471038132|FG001|Overall Study|Physician Decision|0|||
130838992|NCT00882583|471038131|FG000|Overall Study|Adverse Event|0|||
130838993|NCT00882583|471038132|FG001|Overall Study|Adverse Event|1|||
130838994|NCT02596958|471038139|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
130838995|NCT02596958|471038139|FG000|Overall Study|Cancer Progression|441|||
130838996|NCT02596958|471038139|FG000|Overall Study|Death From Cancer|112|||
130838997|NCT02596958|471038139|FG000|Overall Study|Death From Other Cause|33|||
130838998|NCT02596958|471038139|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
130838999|NCT02596958|471038139|FG000|Overall Study|Administrative Reasons/Other|231|||
130839000|NCT02596958|471038139|FG000|Overall Study|Lost to Follow-up|33|||
130839001|NCT02596958|471038139|FG000|Overall Study|Missing|32|||
130839002|NCT02596958|471038139|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
130839003|NCT01559259|471038140|FG000|Overall Study|Withdrawal by Subject|0|||
130839004|NCT01559259|471038141|FG001|Overall Study|Withdrawal by Subject|0|||
130839005|NCT01559259|471038142|FG002|Overall Study|Withdrawal by Subject|0|||
130839006|NCT01559259|471038143|FG003|Overall Study|Withdrawal by Subject|1|||
130839007|NCT01559259|471038144|FG004|Overall Study|Withdrawal by Subject|0|||
130839008|NCT01559259|471038140|FG000|Overall Study|Adverse Event|0|||
130839009|NCT01559259|471038141|FG001|Overall Study|Adverse Event|1|||
130839010|NCT01559259|471038142|FG002|Overall Study|Adverse Event|1|||
130839011|NCT01559259|471038143|FG003|Overall Study|Adverse Event|0|||
130839012|NCT01559259|471038144|FG004|Overall Study|Adverse Event|0|||
130839013|NCT00185380|471038146|FG000|Overall Study|Adverse Event|41|||
130839014|NCT00185380|471038147|FG001|Overall Study|Adverse Event|43|||
130839015|NCT00185380|471038148|FG002|Overall Study|Adverse Event|48|||
130839016|NCT00185380|471038146|FG000|Overall Study|Lost to Follow-up|0|||
130839017|NCT00185380|471038147|FG001|Overall Study|Lost to Follow-up|4|||
130839018|NCT00185380|471038148|FG002|Overall Study|Lost to Follow-up|3|||
130839019|NCT00185380|471038146|FG000|Overall Study|Pregnancy|1|||
130839020|NCT00185380|471038147|FG001|Overall Study|Pregnancy|4|||
130839021|NCT00185380|471038148|FG002|Overall Study|Pregnancy|0|||
130839022|NCT00185380|471038146|FG000|Overall Study|Protocol Violation|2|||
130839023|NCT00185380|471038147|FG001|Overall Study|Protocol Violation|2|||
130839024|NCT00185380|471038148|FG002|Overall Study|Protocol Violation|1|||
130839025|NCT00185380|471038146|FG000|Overall Study|Withdrawal by Subject|1|||
130839026|NCT00185380|471038147|FG001|Overall Study|Withdrawal by Subject|2|||
130839027|NCT00185380|471038148|FG002|Overall Study|Withdrawal by Subject|0|||
130839028|NCT00185380|471038146|FG000|Overall Study|Failed insertion|1|||
130839029|NCT00185380|471038147|FG001|Overall Study|Failed insertion|1|||
130839030|NCT00185380|471038148|FG002|Overall Study|Failed insertion|2|||
130839031|NCT00185380|471038146|FG000|Overall Study|Planned pregnancy|9|||
130839032|NCT00185380|471038147|FG001|Overall Study|Planned pregnancy|12|||
130839033|NCT00185380|471038148|FG002|Overall Study|Planned pregnancy|12|||
130839034|NCT00185380|471038146|FG000|Overall Study|No need for contraception|3|||
130839035|NCT00185380|471038147|FG001|Overall Study|No need for contraception|3|||
130839036|NCT00185380|471038148|FG002|Overall Study|No need for contraception|3|||
130839037|NCT00185380|471038146|FG000|Overall Study|Could not attend visits|2|||
130839038|NCT00185380|471038147|FG001|Overall Study|Could not attend visits|0|||
130839039|NCT00185380|471038148|FG002|Overall Study|Could not attend visits|4|||
130839040|NCT00185380|471038146|FG000|Overall Study|personal reason|6|||
130839041|NCT00185380|471038147|FG001|Overall Study|personal reason|1|||
130839042|NCT00185380|471038148|FG002|Overall Study|personal reason|1|||
130839043|NCT02199314|471038159|FG000|Overall Study|Withdrawal by Subject|6|||
130839044|NCT02199314|471038159|FG000|Overall Study|Physician Decision|10|||
130839045|NCT03842969|471038160|FG000|Overall Study|Participant declined follow-up visit|0|||
130839046|NCT03842969|471038161|FG001|Overall Study|Participant declined follow-up visit|1|||
130839047|NCT03842969|471038162|FG002|Overall Study|Participant declined follow-up visit|0|||
130839048|NCT03842969|471038160|FG000|Overall Study|Sponsor's decision|12|||
130839049|NCT03842969|471038161|FG001|Overall Study|Sponsor's decision|99|||
130839050|NCT03842969|471038162|FG002|Overall Study|Sponsor's decision|61|||
130839051|NCT03842969|471038160|FG000|Overall Study|Pregnancy|0|||
130839052|NCT03842969|471038161|FG001|Overall Study|Pregnancy|0|||
130839053|NCT03842969|471038162|FG002|Overall Study|Pregnancy|1|||
130839054|NCT03842969|471038160|FG000|Overall Study|Death|1|||
130839055|NCT03842969|471038161|FG001|Overall Study|Death|0|||
130839056|NCT03842969|471038162|FG002|Overall Study|Death|1|||
130839057|NCT03842969|471038160|FG000|Overall Study|Withdrawal by Subject|3|||
130839058|NCT03842969|471038161|FG001|Overall Study|Withdrawal by Subject|30|||
130839059|NCT03842969|471038162|FG002|Overall Study|Withdrawal by Subject|18|||
130839060|NCT03842969|471038160|FG000|Overall Study|Protocol Violation|1|||
130839061|NCT03842969|471038161|FG001|Overall Study|Protocol Violation|1|||
130839062|NCT03842969|471038162|FG002|Overall Study|Protocol Violation|0|||
130839063|NCT03842969|471038160|FG000|Overall Study|Physician Decision|0|||
130839064|NCT03842969|471038161|FG001|Overall Study|Physician Decision|3|||
130839065|NCT03842969|471038162|FG002|Overall Study|Physician Decision|0|||
130839066|NCT03842969|471038160|FG000|Overall Study|Lost to Follow-up|0|||
130839067|NCT03842969|471038161|FG001|Overall Study|Lost to Follow-up|2|||
130839068|NCT03842969|471038162|FG002|Overall Study|Lost to Follow-up|0|||
130839069|NCT03842969|471038160|FG000|Overall Study|Adverse Event|0|||
130839070|NCT03842969|471038161|FG001|Overall Study|Adverse Event|2|||
130839071|NCT03842969|471038162|FG002|Overall Study|Adverse Event|0|||
130839072|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Adverse Event|76|||
130839073|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Adverse Event|0|||
130839074|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Adverse Event|0|||
130839075|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Death|3|||
130839076|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Death|0|||
130839077|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Death|0|||
130839078|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
130839079|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
130839080|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
130839081|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Physician Decision|9|||
130839082|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Physician Decision|0|||
130839083|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Physician Decision|0|||
130839084|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
130839085|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
130839086|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
130839087|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Disease progression|45|||
130839088|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Disease progression|0|||
130839089|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Disease progression|0|||
130839090|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
130839091|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
130839092|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
130839093|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
130839094|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
130839095|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
130839096|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
130839097|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
130839098|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
130839099|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
130839100|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
130839101|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
130839102|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
130839103|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
130839104|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
130839105|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
130839106|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
130839107|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
130839108|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
130839109|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
130839110|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
130839111|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
130839112|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
130839113|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
130839114|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
130839115|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
130839116|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
130839117|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Promotor request|1|||
130839118|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Promotor request|0|||
130839119|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Promotor request|0|||
130839120|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
130839121|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
130839122|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
130839123|NCT01461928|471038163|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
130839124|NCT01461928|471038164|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
130839125|NCT01461928|471038165|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
130839126|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Death|3|||
130839127|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Death|0|||
130839128|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Death|0|||
130839129|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
130839130|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
130839131|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
130839132|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
130839133|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
130839134|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
130839135|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Diseases progression|91|||
130839136|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Diseases progression|0|||
130839137|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Diseases progression|0|||
130839138|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Adverse Event|70|||
130839139|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Adverse Event|0|||
130839140|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Adverse Event|0|||
130839141|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Physician Decision|9|||
130839142|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Physician Decision|0|||
130839143|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Physician Decision|0|||
130839144|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
130839145|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
130839146|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
130839147|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
130839148|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
130839149|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
130839150|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
130839151|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
130839152|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
130839153|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Not compliant|1|||
130839154|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Not compliant|0|||
130839155|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Not compliant|0|||
130839156|NCT01461928|471038163|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
130839157|NCT01461928|471038164|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
130839158|NCT01461928|471038165|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
130839159|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Adverse Event|0|||
130839160|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Adverse Event|2|||
130839161|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Adverse Event|0|||
130839162|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Death|0|||
130839163|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Death|10|||
130839164|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Death|8|||
130839165|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Physician Decision|0|||
130839166|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Physician Decision|0|||
130839167|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Physician Decision|4|||
130839168|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
130839169|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
130839170|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
130839171|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Moved to another town|0|||
130839172|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Moved to another town|1|||
130839173|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Moved to another town|0|||
130839174|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Disease progression|0|||
130839175|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Disease progression|0|||
130839176|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Disease progression|3|||
130839177|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
130839178|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
130839179|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
130839180|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
130839181|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
130839182|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
130839183|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
130839184|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
130839185|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
130839186|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
130839187|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
130839188|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
130839189|NCT01461928|471038163|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
130839190|NCT01461928|471038164|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
130839191|NCT01461928|471038165|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
130839192|NCT01892436|471038166|FG000|Overall Study|Withdrawal by Subject|8|||
130839193|NCT01892436|471038167|FG001|Overall Study|Withdrawal by Subject|15|||
130839194|NCT01892436|471038168|FG002|Overall Study|Withdrawal by Subject|4|||
130839195|NCT01892436|471038169|FG003|Overall Study|Withdrawal by Subject|4|||
130839196|NCT01892436|471038166|FG000|Overall Study|Death|1|||
130839197|NCT01892436|471038167|FG001|Overall Study|Death|1|||
130839198|NCT01892436|471038168|FG002|Overall Study|Death|0|||
130839199|NCT01892436|471038169|FG003|Overall Study|Death|0|||
130839200|NCT01892436|471038166|FG000|Overall Study|Physician Decision|2|||
130839201|NCT01892436|471038167|FG001|Overall Study|Physician Decision|1|||
130839202|NCT01892436|471038168|FG002|Overall Study|Physician Decision|0|||
130839203|NCT01892436|471038169|FG003|Overall Study|Physician Decision|1|||
130839204|NCT01892436|471038166|FG000|Overall Study|Pregnancy|0|||
130839205|NCT01892436|471038167|FG001|Overall Study|Pregnancy|2|||
130839206|NCT01892436|471038168|FG002|Overall Study|Pregnancy|1|||
130839207|NCT01892436|471038169|FG003|Overall Study|Pregnancy|0|||
130839208|NCT01892436|471038166|FG000|Overall Study|Technical problems|2|||
130839209|NCT01892436|471038167|FG001|Overall Study|Technical problems|1|||
130839210|NCT01892436|471038168|FG002|Overall Study|Technical problems|1|||
130839211|NCT01892436|471038169|FG003|Overall Study|Technical problems|1|||
130839212|NCT01892436|471038166|FG000|Overall Study|Lack of Efficacy|1|||
130839213|NCT01892436|471038167|FG001|Overall Study|Lack of Efficacy|2|||
130839214|NCT01892436|471038168|FG002|Overall Study|Lack of Efficacy|2|||
130839215|NCT01892436|471038169|FG003|Overall Study|Lack of Efficacy|2|||
130839216|NCT01892436|471038166|FG000|Overall Study|Lost to Follow-up|1|||
130839217|NCT01892436|471038167|FG001|Overall Study|Lost to Follow-up|1|||
130839218|NCT01892436|471038168|FG002|Overall Study|Lost to Follow-up|1|||
130839219|NCT01892436|471038169|FG003|Overall Study|Lost to Follow-up|3|||
130839220|NCT01892436|471038166|FG000|Overall Study|non-compliance with treatment|1|||
130839221|NCT01892436|471038167|FG001|Overall Study|non-compliance with treatment|0|||
130839222|NCT01892436|471038168|FG002|Overall Study|non-compliance with treatment|0|||
130839223|NCT01892436|471038169|FG003|Overall Study|non-compliance with treatment|0|||
130839224|NCT01892436|471038166|FG000|Overall Study|Adverse Event|7|||
130839225|NCT01892436|471038167|FG001|Overall Study|Adverse Event|6|||
130839226|NCT01892436|471038168|FG002|Overall Study|Adverse Event|2|||
130839227|NCT01892436|471038169|FG003|Overall Study|Adverse Event|3|||
130839228|NCT00733291|471038171|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
130839229|NCT00733291|471038172|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
130839230|NCT00733291|471038173|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
130839231|NCT00733291|471038174|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
130839232|NCT02759107|471038176|FG000|Overall Study|Adverse Event|0|||
130839233|NCT02759107|471038177|FG001|Overall Study|Adverse Event|0|||
130839234|NCT02759107|471038178|FG002|Overall Study|Adverse Event|0|||
130839235|NCT02759107|471038179|FG003|Overall Study|Adverse Event|0|||
130839236|NCT02759107|471038180|FG004|Overall Study|Adverse Event|0|||
130839237|NCT02759107|471038181|FG005|Overall Study|Adverse Event|0|||
130839238|NCT02759107|471038182|FG006|Overall Study|Adverse Event|0|||
130839239|NCT02759107|471038183|FG007|Overall Study|Adverse Event|0|||
130839240|NCT02759107|471038184|FG008|Overall Study|Adverse Event|0|||
130839241|NCT02759107|471038185|FG009|Overall Study|Adverse Event|0|||
130839242|NCT02759107|471038186|FG010|Overall Study|Adverse Event|0|||
130839243|NCT02759107|471038187|FG011|Overall Study|Adverse Event|0|||
130839244|NCT02759107|471038188|FG012|Overall Study|Adverse Event|2|||
130839245|NCT02759107|471038189|FG013|Overall Study|Adverse Event|0|||
130839246|NCT02759107|471038190|FG014|Overall Study|Adverse Event|0|||
130839247|NCT02759107|471038191|FG015|Overall Study|Adverse Event|1|||
130839248|NCT02759107|471038192|FG016|Overall Study|Adverse Event|0|||
130839249|NCT02759107|471038193|FG017|Overall Study|Adverse Event|2|||
130839250|NCT02759107|471038176|FG000|Overall Study|Scheduling Conflict|0|||
130839251|NCT02759107|471038177|FG001|Overall Study|Scheduling Conflict|0|||
130839252|NCT02759107|471038178|FG002|Overall Study|Scheduling Conflict|0|||
130839253|NCT02759107|471038179|FG003|Overall Study|Scheduling Conflict|0|||
130839254|NCT02759107|471038180|FG004|Overall Study|Scheduling Conflict|0|||
130839255|NCT02759107|471038181|FG005|Overall Study|Scheduling Conflict|0|||
130839256|NCT02759107|471038182|FG006|Overall Study|Scheduling Conflict|0|||
130839257|NCT02759107|471038183|FG007|Overall Study|Scheduling Conflict|0|||
130839258|NCT02759107|471038184|FG008|Overall Study|Scheduling Conflict|0|||
130839259|NCT02759107|471038185|FG009|Overall Study|Scheduling Conflict|1|||
130839260|NCT02759107|471038186|FG010|Overall Study|Scheduling Conflict|0|||
130839261|NCT02759107|471038187|FG011|Overall Study|Scheduling Conflict|0|||
130839262|NCT02759107|471038188|FG012|Overall Study|Scheduling Conflict|0|||
130839263|NCT02759107|471038189|FG013|Overall Study|Scheduling Conflict|0|||
130839264|NCT02759107|471038190|FG014|Overall Study|Scheduling Conflict|0|||
130839265|NCT02759107|471038191|FG015|Overall Study|Scheduling Conflict|0|||
130839266|NCT02759107|471038192|FG016|Overall Study|Scheduling Conflict|0|||
130839267|NCT02759107|471038193|FG017|Overall Study|Scheduling Conflict|0|||
130839268|NCT02019108|471038196|FG000|Overall Study|Lost to Follow-up|5|||
130839269|NCT02019108|471038197|FG001|Overall Study|Lost to Follow-up|7|||
130839270|NCT04569136|471038203|FG000|Overall Study|Lost to Follow-up|2|||
130839271|NCT04569136|471038204|FG001|Overall Study|Lost to Follow-up|0|||
130839272|NCT04569136|471038205|FG002|Overall Study|Lost to Follow-up|1|||
130839273|NCT01466660|471038210|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
130839274|NCT01466660|471038211|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
130839275|NCT01466660|471038210|FG000|Overall Study|Worsening of underlying cancer disease|5|||
130839276|NCT01466660|471038211|FG001|Overall Study|Worsening of underlying cancer disease|2|||
130839277|NCT01466660|471038210|FG000|Overall Study|Other adverse event|19|||
130839278|NCT01466660|471038211|FG001|Overall Study|Other adverse event|18|||
130839279|NCT01466660|471038210|FG000|Overall Study|Protocol Violation|2|||
130839280|NCT01466660|471038211|FG001|Overall Study|Protocol Violation|1|||
130839281|NCT01466660|471038210|FG000|Overall Study|Refused continuation of trial medication|4|||
130839282|NCT01466660|471038211|FG001|Overall Study|Refused continuation of trial medication|3|||
130839283|NCT01466660|471038210|FG000|Overall Study|Other reason not defined above|10|||
130839284|NCT01466660|471038211|FG001|Overall Study|Other reason not defined above|8|||
130839285|NCT00191724|471038212|FG000|Overall Study|Adverse Event|0|||
130839286|NCT00191724|471038213|FG001|Overall Study|Adverse Event|0|||
130839287|NCT00191724|471038214|FG002|Overall Study|Adverse Event|1|||
130839288|NCT00191724|471038215|FG003|Overall Study|Adverse Event|0|||
130839289|NCT00191724|471038216|FG004|Overall Study|Adverse Event|0|||
130839290|NCT00191724|471038212|FG000|Overall Study|Lost to Follow-up|1|||
130839291|NCT00191724|471038213|FG001|Overall Study|Lost to Follow-up|1|||
130839292|NCT00191724|471038214|FG002|Overall Study|Lost to Follow-up|0|||
130839293|NCT00191724|471038215|FG003|Overall Study|Lost to Follow-up|2|||
130839294|NCT00191724|471038216|FG004|Overall Study|Lost to Follow-up|3|||
130839295|NCT00191724|471038212|FG000|Overall Study|Withdrawal by Subject|0|||
130839296|NCT00191724|471038213|FG001|Overall Study|Withdrawal by Subject|0|||
130839297|NCT00191724|471038214|FG002|Overall Study|Withdrawal by Subject|0|||
130839298|NCT00191724|471038215|FG003|Overall Study|Withdrawal by Subject|1|||
130839299|NCT00191724|471038216|FG004|Overall Study|Withdrawal by Subject|0|||
130839300|NCT02301546|471038219|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
130839301|NCT02301546|471038220|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
130839302|NCT02301546|471038219|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
130839303|NCT02301546|471038220|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
130839304|NCT02301546|471038219|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
130839305|NCT02301546|471038220|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
130839306|NCT02301546|471038219|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
130839307|NCT02301546|471038220|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
130839308|NCT02301546|471038219|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
130839309|NCT02301546|471038220|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
130839310|NCT02301546|471038219|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
130839311|NCT02301546|471038220|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
130839312|NCT02301546|471038219|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
130839313|NCT02301546|471038220|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
130839314|NCT04085458|471038225|FG000|Overall Study|Other|1|||
130839315|NCT04085458|471038225|FG000|Overall Study|Withdrawal by Subject|2|||
130839316|NCT04085458|471038225|FG000|Overall Study|Adverse Event|2|||
130839317|NCT02447250|471038226|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
130839318|NCT02447250|471038226|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
130839319|NCT02447250|471038226|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
130839320|NCT03632993|471038227|FG000|Overall Study|Withdrawal by Subject|1|||
130839321|NCT03632993|471038228|FG001|Overall Study|Withdrawal by Subject|0|||
130839322|NCT03632993|471038229|FG002|Overall Study|Withdrawal by Subject|0|||
130839323|NCT03632993|471038230|FG003|Overall Study|Withdrawal by Subject|0|||
130839324|NCT03632993|471038231|FG004|Overall Study|Withdrawal by Subject|0|||
130839325|NCT03632993|471038232|FG005|Overall Study|Withdrawal by Subject|0|||
130839326|NCT03632993|471038233|FG006|Overall Study|Withdrawal by Subject|0|||
130839327|NCT03632993|471038234|FG007|Overall Study|Withdrawal by Subject|0|||
130839328|NCT03632993|471038235|FG008|Overall Study|Withdrawal by Subject|0|||
130839329|NCT03632993|471038236|FG009|Overall Study|Withdrawal by Subject|1|||
130839330|NCT03632993|471038227|FG000|Overall Study|Protocol Non-compliance|0|||
130839331|NCT03632993|471038228|FG001|Overall Study|Protocol Non-compliance|1|||
130839332|NCT03632993|471038229|FG002|Overall Study|Protocol Non-compliance|0|||
130839333|NCT03632993|471038230|FG003|Overall Study|Protocol Non-compliance|0|||
130839334|NCT03632993|471038231|FG004|Overall Study|Protocol Non-compliance|0|||
130839335|NCT03632993|471038232|FG005|Overall Study|Protocol Non-compliance|0|||
130839336|NCT03632993|471038233|FG006|Overall Study|Protocol Non-compliance|0|||
130839337|NCT03632993|471038234|FG007|Overall Study|Protocol Non-compliance|0|||
130839338|NCT03632993|471038235|FG008|Overall Study|Protocol Non-compliance|0|||
130839339|NCT03632993|471038236|FG009|Overall Study|Protocol Non-compliance|0|||
130839340|NCT03632993|471038227|FG000|Overall Study|Lost to Follow-up|0|||
130839341|NCT03632993|471038228|FG001|Overall Study|Lost to Follow-up|0|||
130839342|NCT03632993|471038229|FG002|Overall Study|Lost to Follow-up|0|||
130839343|NCT03632993|471038230|FG003|Overall Study|Lost to Follow-up|0|||
130839344|NCT03632993|471038231|FG004|Overall Study|Lost to Follow-up|0|||
130839345|NCT03632993|471038232|FG005|Overall Study|Lost to Follow-up|1|||
130839346|NCT03632993|471038233|FG006|Overall Study|Lost to Follow-up|0|||
130839347|NCT03632993|471038234|FG007|Overall Study|Lost to Follow-up|1|||
130839348|NCT03632993|471038235|FG008|Overall Study|Lost to Follow-up|0|||
130839349|NCT03632993|471038236|FG009|Overall Study|Lost to Follow-up|0|||
130839350|NCT03632993|471038227|FG000|Overall Study|Adverse Event|0|||
130839351|NCT03632993|471038228|FG001|Overall Study|Adverse Event|0|||
130839352|NCT03632993|471038229|FG002|Overall Study|Adverse Event|0|||
130839353|NCT03632993|471038230|FG003|Overall Study|Adverse Event|0|||
130839354|NCT03632993|471038231|FG004|Overall Study|Adverse Event|0|||
130839355|NCT03632993|471038232|FG005|Overall Study|Adverse Event|1|||
130839356|NCT03632993|471038233|FG006|Overall Study|Adverse Event|0|||
130839357|NCT03632993|471038234|FG007|Overall Study|Adverse Event|1|||
130839358|NCT03632993|471038235|FG008|Overall Study|Adverse Event|0|||
130839359|NCT03632993|471038236|FG009|Overall Study|Adverse Event|0|||
130839360|NCT03224507|471038237|FG000|Overall Study|Death|3|||
130839361|NCT03224507|471038238|FG001|Overall Study|Death|0|||
130839362|NCT03224507|471038237|FG000|Overall Study|Lack of Efficacy|6|||
130839363|NCT03224507|471038238|FG001|Overall Study|Lack of Efficacy|0|||
130839364|NCT03224507|471038237|FG000|Overall Study|Withdrawal by Subject|6|||
130839365|NCT03224507|471038238|FG001|Overall Study|Withdrawal by Subject|0|||
130839366|NCT01126437|471038244|FG000|Overall Study|Not treated|11|||
130839367|NCT01126437|471038245|FG001|Overall Study|Not treated|18|||
130839368|NCT01126437|471038246|FG002|Overall Study|Not treated|19|||
130839369|NCT01126437|471038244|FG000|Overall Study|Sites with data irregularities/fraud|6|||
130839370|NCT01126437|471038245|FG001|Overall Study|Sites with data irregularities/fraud|6|||
130839371|NCT01126437|471038246|FG002|Overall Study|Sites with data irregularities/fraud|7|||
130839372|NCT01126437|471038244|FG000|Overall Study|Adverse Event|602|||
130839373|NCT01126437|471038245|FG001|Overall Study|Adverse Event|606|||
130839374|NCT01126437|471038246|FG002|Overall Study|Adverse Event|635|||
130839375|NCT01126437|471038244|FG000|Overall Study|Lack of Efficacy|65|||
130839376|NCT01126437|471038245|FG001|Overall Study|Lack of Efficacy|60|||
130839377|NCT01126437|471038246|FG002|Overall Study|Lack of Efficacy|59|||
130839378|NCT01126437|471038244|FG000|Overall Study|Protocol Violation|64|||
130839379|NCT01126437|471038245|FG001|Overall Study|Protocol Violation|66|||
130839380|NCT01126437|471038246|FG002|Overall Study|Protocol Violation|41|||
130839381|NCT01126437|471038244|FG000|Overall Study|Lost to Follow-up|52|||
130839382|NCT01126437|471038245|FG001|Overall Study|Lost to Follow-up|63|||
130839383|NCT01126437|471038246|FG002|Overall Study|Lost to Follow-up|55|||
130839384|NCT01126437|471038244|FG000|Overall Study|Withdrawal by Subject|331|||
130839385|NCT01126437|471038245|FG001|Overall Study|Withdrawal by Subject|335|||
130839386|NCT01126437|471038246|FG002|Overall Study|Withdrawal by Subject|319|||
130839387|NCT01126437|471038244|FG000|Overall Study|Other reason not specified|210|||
130839388|NCT01126437|471038245|FG001|Overall Study|Other reason not specified|176|||
130839389|NCT01126437|471038246|FG002|Overall Study|Other reason not specified|178|||
130839390|NCT01972308|471038253|FG000|Overall Study|Withdrawal by Subject|0|||
130839391|NCT01972308|471038254|FG001|Overall Study|Withdrawal by Subject|1|||
130839392|NCT01972308|471038253|FG000|Overall Study|Lost to Follow-up|4|||
130839393|NCT01972308|471038254|FG001|Overall Study|Lost to Follow-up|6|||
130839394|NCT01972308|471038253|FG000|Overall Study|Death|4|||
130839395|NCT01972308|471038254|FG001|Overall Study|Death|1|||
130839396|NCT01846663|471038255|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
130839397|NCT01846663|471038256|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
130839398|NCT01846663|471038255|FG000|Overall Study|Withdrawal by Subject|1|||
130839399|NCT01846663|471038256|FG001|Overall Study|Withdrawal by Subject|0|||
130839400|NCT01846663|471038255|FG000|Overall Study|Adverse Event|1|||
130839401|NCT01846663|471038256|FG001|Overall Study|Adverse Event|2|||
130839402|NCT01562314|471038261|FG000|Overall Study|Adverse Event|10|||
130839403|NCT01562314|471038262|FG001|Overall Study|Adverse Event|5|||
130839404|NCT01562314|471038261|FG000|Overall Study|Met Withdrawal Criteria|3|||
130839405|NCT01562314|471038262|FG001|Overall Study|Met Withdrawal Criteria|2|||
130839406|NCT01562314|471038261|FG000|Overall Study|Withdrawal by Subject|0|||
130839407|NCT01562314|471038262|FG001|Overall Study|Withdrawal by Subject|1|||
130839408|NCT02851797|471038263|FG000|Overall Study|Withdrawal by Subject|4|||
130839409|NCT02851797|471038264|FG001|Overall Study|Withdrawal by Subject|2|||
130839410|NCT02851797|471038263|FG000|Overall Study|Adverse Event|3|||
130839411|NCT02851797|471038264|FG001|Overall Study|Adverse Event|0|||
130839412|NCT03655054|471038265|FG000|Overall Study|Lost to Follow-up|1|||
130839413|NCT00813865|471038269|FG000|Overall Study|Failure to Respond|3|||
130839414|NCT00813865|471038269|FG000|Overall Study|Lost to Follow-up|3|||
130839415|NCT00813865|471038269|FG000|Overall Study|Withdrawal by Subject|1|||
130839416|NCT02256384|471038283|FG000|Overall Study|Withdrawal by Subject|12|||
130839417|NCT02256384|471038283|FG000|Overall Study|Equipment not capturing data|2|||
130839418|NCT00543803|471038286|FG000|Overall Study|Adverse Event|14|||
130839419|NCT00543803|471038286|FG000|Overall Study|Lack of Efficacy|22|||
130839420|NCT00543803|471038286|FG000|Overall Study|Lost to Follow-up|20|||
130839421|NCT00543803|471038286|FG000|Overall Study|Other|86|||
130839422|NCT04295681|471038288|FG000|Overall Study|Eligibility error|1|||
130839423|NCT04295681|471038289|FG001|Overall Study|Eligibility error|3|||
130839424|NCT00075946|471038297|FG000|Overall Study|Path ineligible: undetermined histology|0|||
130839425|NCT00075946|471038298|FG001|Overall Study|Path ineligible: undetermined histology|0|||
130839426|NCT00075946|471038299|FG002|Overall Study|Path ineligible: undetermined histology|0|||
130839427|NCT00075946|471038300|FG003|Overall Study|Path ineligible: undetermined histology|0|||
130839428|NCT00075946|471038301|FG004|Overall Study|Path ineligible: undetermined histology|6|||
130839429|NCT00075946|471038297|FG000|Overall Study|Did not achieve response after induction|0|||
130839430|NCT00075946|471038298|FG001|Overall Study|Did not achieve response after induction|0|||
130839431|NCT00075946|471038299|FG002|Overall Study|Did not achieve response after induction|0|||
130839432|NCT00075946|471038300|FG003|Overall Study|Did not achieve response after induction|0|||
130839433|NCT00075946|471038301|FG004|Overall Study|Did not achieve response after induction|182|||
130839434|NCT00075946|471038297|FG000|Overall Study|Incorrectly randomized (no response)|5|||
130839435|NCT00075946|471038298|FG001|Overall Study|Incorrectly randomized (no response)|5|||
130839436|NCT00075946|471038299|FG002|Overall Study|Incorrectly randomized (no response)|5|||
130839437|NCT00075946|471038300|FG003|Overall Study|Incorrectly randomized (no response)|1|||
130839438|NCT00075946|471038301|FG004|Overall Study|Incorrectly randomized (no response)|0|||
130839439|NCT00075946|471038297|FG000|Overall Study|Adverse Event|2|||
130839440|NCT00075946|471038298|FG001|Overall Study|Adverse Event|10|||
130839441|NCT00075946|471038299|FG002|Overall Study|Adverse Event|0|||
130839442|NCT00075946|471038300|FG003|Overall Study|Adverse Event|2|||
130839443|NCT00075946|471038301|FG004|Overall Study|Adverse Event|0|||
130839444|NCT00075946|471038297|FG000|Overall Study|Death|0|||
130839445|NCT00075946|471038298|FG001|Overall Study|Death|1|||
130839446|NCT00075946|471038299|FG002|Overall Study|Death|0|||
130839447|NCT00075946|471038300|FG003|Overall Study|Death|0|||
130839448|NCT00075946|471038301|FG004|Overall Study|Death|0|||
130839449|NCT00075946|471038297|FG000|Overall Study|Withdrawal by Subject|23|||
130839450|NCT00075946|471038298|FG001|Overall Study|Withdrawal by Subject|58|||
130839451|NCT00075946|471038299|FG002|Overall Study|Withdrawal by Subject|4|||
130839452|NCT00075946|471038300|FG003|Overall Study|Withdrawal by Subject|9|||
130839453|NCT00075946|471038301|FG004|Overall Study|Withdrawal by Subject|0|||
130839454|NCT00075946|471038297|FG000|Overall Study|Alternative therapy|16|||
130839455|NCT00075946|471038298|FG001|Overall Study|Alternative therapy|2|||
130839456|NCT00075946|471038299|FG002|Overall Study|Alternative therapy|5|||
130839457|NCT00075946|471038300|FG003|Overall Study|Alternative therapy|0|||
130839458|NCT00075946|471038301|FG004|Overall Study|Alternative therapy|0|||
130839459|NCT00075946|471038297|FG000|Overall Study|Other complicating disease|7|||
130839460|NCT00075946|471038298|FG001|Overall Study|Other complicating disease|13|||
130839461|NCT00075946|471038299|FG002|Overall Study|Other complicating disease|1|||
130839462|NCT00075946|471038300|FG003|Overall Study|Other complicating disease|4|||
130839463|NCT00075946|471038301|FG004|Overall Study|Other complicating disease|0|||
130839464|NCT00075946|471038297|FG000|Overall Study|No response to retreatment|23|||
130839465|NCT00075946|471038298|FG001|Overall Study|No response to retreatment|0|||
130839466|NCT00075946|471038299|FG002|Overall Study|No response to retreatment|2|||
130839467|NCT00075946|471038300|FG003|Overall Study|No response to retreatment|0|||
130839468|NCT00075946|471038301|FG004|Overall Study|No response to retreatment|0|||
130839469|NCT00075946|471038297|FG000|Overall Study|Time to progression less than 6 months|15|||
130839470|NCT00075946|471038298|FG001|Overall Study|Time to progression less than 6 months|30|||
130839471|NCT00075946|471038299|FG002|Overall Study|Time to progression less than 6 months|8|||
130839472|NCT00075946|471038300|FG003|Overall Study|Time to progression less than 6 months|3|||
130839473|NCT00075946|471038301|FG004|Overall Study|Time to progression less than 6 months|0|||
130839474|NCT00075946|471038297|FG000|Overall Study|Other|57|||
130839475|NCT00075946|471038298|FG001|Overall Study|Other|32|||
130839476|NCT00075946|471038299|FG002|Overall Study|Other|3|||
130839477|NCT00075946|471038300|FG003|Overall Study|Other|11|||
130839478|NCT00075946|471038301|FG004|Overall Study|Other|0|||
130839479|NCT01229254|471038303|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
130839480|NCT01229254|471038304|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
130839481|NCT01229254|471038305|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
130839482|NCT01229254|471038303|FG000|Overall Study|Adverse Event|4|||
130839483|NCT01229254|471038304|FG001|Overall Study|Adverse Event|5|||
130839484|NCT01229254|471038305|FG002|Overall Study|Adverse Event|3|||
130839485|NCT01229254|471038303|FG000|Overall Study|Lost to Follow-up|3|||
130839486|NCT01229254|471038304|FG001|Overall Study|Lost to Follow-up|0|||
130839487|NCT01229254|471038305|FG002|Overall Study|Lost to Follow-up|1|||
130839488|NCT01229254|471038303|FG000|Overall Study|Physician Decision|0|||
130839489|NCT01229254|471038304|FG001|Overall Study|Physician Decision|3|||
130839490|NCT01229254|471038305|FG002|Overall Study|Physician Decision|0|||
130839491|NCT01229254|471038303|FG000|Overall Study|Protocol Violation|4|||
130839492|NCT01229254|471038304|FG001|Overall Study|Protocol Violation|6|||
130839493|NCT01229254|471038305|FG002|Overall Study|Protocol Violation|5|||
130839494|NCT01229254|471038303|FG000|Overall Study|Withdrawal by Subject|1|||
130839495|NCT01229254|471038304|FG001|Overall Study|Withdrawal by Subject|0|||
130839496|NCT01229254|471038305|FG002|Overall Study|Withdrawal by Subject|1|||
130839497|NCT01229254|471038303|FG000|Overall Study|Non-compliance with Study Drug|0|||
130839498|NCT01229254|471038304|FG001|Overall Study|Non-compliance with Study Drug|1|||
130839499|NCT01229254|471038305|FG002|Overall Study|Non-compliance with Study Drug|1|||
130839500|NCT03070223|471038312|FG000|Overall Study|Lost to Follow-up|34|||
130839501|NCT03070223|471038313|FG001|Overall Study|Lost to Follow-up|27|||
130839502|NCT03070223|471038312|FG000|Overall Study|Withdrawal by Subject|12|||
130839503|NCT03070223|471038313|FG001|Overall Study|Withdrawal by Subject|22|||
130839504|NCT03070223|471038312|FG000|Overall Study|Protocol Violation|0|||
130839505|NCT03070223|471038313|FG001|Overall Study|Protocol Violation|1|||
130839506|NCT03219034|471038314|FG000|Overall Study|Lost to Follow-up|9|||
130839507|NCT03219034|471038315|FG001|Overall Study|Lost to Follow-up|13|||
130839508|NCT03219034|471038314|FG000|Overall Study|Additional dental work needed|1|||
130839509|NCT03219034|471038315|FG001|Overall Study|Additional dental work needed|0|||
130839510|NCT03219034|471038314|FG000|Overall Study|UPPP Surgery|1|||
130839511|NCT03219034|471038315|FG001|Overall Study|UPPP Surgery|0|||
130839512|NCT03219034|471038314|FG000|Overall Study|Dental sensitivity|0|||
130839513|NCT03219034|471038315|FG001|Overall Study|Dental sensitivity|1|||
130839514|NCT03219034|471038314|FG000|Overall Study|Death in family|0|||
130839515|NCT03219034|471038315|FG001|Overall Study|Death in family|1|||
130839516|NCT02438683|471038316|FG000|Overall Study|Adverse Event|1|||
130839517|NCT02438683|471038317|FG001|Overall Study|Adverse Event|0|||
130839518|NCT02438683|471038318|FG002|Overall Study|Adverse Event|0|||
130839519|NCT02438683|471038319|FG003|Overall Study|Adverse Event|0|||
130839520|NCT02438683|471038320|FG004|Overall Study|Adverse Event|0|||
130839521|NCT02438683|471038321|FG005|Overall Study|Adverse Event|0|||
130839522|NCT03315793|471038322|FG000|Overall Study|Adverse Event|4|||
130839523|NCT03315793|471038323|FG001|Overall Study|Adverse Event|2|||
130839524|NCT03315793|471038322|FG000|Overall Study|Protocol Deviation|1|||
130839525|NCT03315793|471038323|FG001|Overall Study|Protocol Deviation|0|||
130839526|NCT03315793|471038322|FG000|Overall Study|Difficult for regular visit|0|||
130839527|NCT03315793|471038323|FG001|Overall Study|Difficult for regular visit|1|||
130839528|NCT02013206|471040105|FG000|Overall Study|Progressive disease (PD)|14|||
130839529|NCT02013206|471040106|FG001|Overall Study|Progressive disease (PD)|17|||
130839530|NCT02013206|471040105|FG000|Overall Study|Symptomatic deterioration|3|||
130839531|NCT02013206|471040106|FG001|Overall Study|Symptomatic deterioration|1|||
130839532|NCT02013206|471040105|FG000|Overall Study|Adverse Event|1|||
130839533|NCT02013206|471040106|FG001|Overall Study|Adverse Event|0|||
130839534|NCT02013206|471040105|FG000|Overall Study|Patient refusal|2|||
130839535|NCT02013206|471040106|FG001|Overall Study|Patient refusal|0|||
130839536|NCT02013206|471040105|FG000|Overall Study|Patient non-compliance|1|||
130839537|NCT02013206|471040106|FG001|Overall Study|Patient non-compliance|0|||
130839538|NCT02013206|471040105|FG000|Overall Study|Death|1|||
130839539|NCT02013206|471040106|FG001|Overall Study|Death|2|||
130839540|NCT02013206|471040105|FG000|Overall Study|Other reasons off treatment|5|||
130839541|NCT02013206|471040106|FG001|Overall Study|Other reasons off treatment|2|||
130839542|NCT02791191|471040107|FG000|Overall Study|Adverse Event|2|||
130839543|NCT02791191|471040108|FG001|Overall Study|Adverse Event|4|||
130839544|NCT02791191|471040109|FG002|Overall Study|Adverse Event|5|||
130839545|NCT02791191|471040107|FG000|Overall Study|Lack of Efficacy|0|||
130839546|NCT02791191|471040108|FG001|Overall Study|Lack of Efficacy|1|||
130839547|NCT02791191|471040109|FG002|Overall Study|Lack of Efficacy|0|||
130839548|NCT02791191|471040107|FG000|Overall Study|Study Drug Non-Compliance|0|||
130839549|NCT02791191|471040108|FG001|Overall Study|Study Drug Non-Compliance|2|||
130839550|NCT02791191|471040109|FG002|Overall Study|Study Drug Non-Compliance|0|||
130839551|NCT02791191|471040107|FG000|Overall Study|Site Closed by Sponsor|1|||
130839552|NCT02791191|471040108|FG001|Overall Study|Site Closed by Sponsor|1|||
130839553|NCT02791191|471040109|FG002|Overall Study|Site Closed by Sponsor|3|||
130839554|NCT02791191|471040107|FG000|Overall Study|Progressive Disease|1|||
130839555|NCT02791191|471040108|FG001|Overall Study|Progressive Disease|0|||
130839556|NCT02791191|471040109|FG002|Overall Study|Progressive Disease|0|||
130839557|NCT02791191|471040107|FG000|Overall Study|Study Terminated by Sponsor|29|||
130839558|NCT02791191|471040108|FG001|Overall Study|Study Terminated by Sponsor|101|||
130839559|NCT02791191|471040109|FG002|Overall Study|Study Terminated by Sponsor|109|||
130839560|NCT02791191|471040107|FG000|Overall Study|Withdrawal by Subject|3|||
130839561|NCT02791191|471040108|FG001|Overall Study|Withdrawal by Subject|1|||
130839562|NCT02791191|471040109|FG002|Overall Study|Withdrawal by Subject|3|||
130839563|NCT02791191|471040107|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
130839564|NCT02791191|471040108|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
130839565|NCT02791191|471040109|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
130839566|NCT03077438|471040110|FG000|Overall Study|Protocol Violation|3|||
130839567|NCT03077438|471040111|FG001|Overall Study|Protocol Violation|5|||
130839568|NCT03077438|471040110|FG000|Overall Study|Withdrawal by Subject|3|||
130839569|NCT03077438|471040111|FG001|Overall Study|Withdrawal by Subject|6|||
130839570|NCT03077438|471040110|FG000|Overall Study|Lost to Follow-up|6|||
130839571|NCT03077438|471040111|FG001|Overall Study|Lost to Follow-up|3|||
130839572|NCT01190475|471040112|FG000|Overall Study|Withdrawal by Subject|0|||
130839573|NCT01190475|471040113|FG001|Overall Study|Withdrawal by Subject|0|||
130839574|NCT01190475|471040114|FG002|Overall Study|Withdrawal by Subject|1|||
130839575|NCT00624585|471040115|FG000|Overall Study|Death|3|||
130839576|NCT00624585|471040115|FG000|Overall Study|Disease Progression|6|||
130839577|NCT00624585|471040115|FG000|Overall Study|Adverse Event|3|||
130839578|NCT00676520|471040119|FG000|Overall Study|Withdrawal by Subject|163|||
130839579|NCT00676520|471040119|FG000|Overall Study|Lost to Follow-up|162|||
130839580|NCT00676520|471040119|FG000|Overall Study|Death|159|||
130839581|NCT00676520|471040119|FG000|Overall Study|Physician Decision|20|||
130839582|NCT00676520|471040119|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
130839583|NCT00676520|471040119|FG000|Overall Study|Other Reason|18|||
130839584|NCT01425359|471040120|FG000|Overall Study|Randomized but Not Treated|2|||
130839585|NCT01425359|471040121|FG001|Overall Study|Randomized but Not Treated|3|||
130839586|NCT01425359|471040120|FG000|Overall Study|Adverse Event|9|||
130839587|NCT01425359|471040121|FG001|Overall Study|Adverse Event|8|||
130839588|NCT01425359|471040120|FG000|Overall Study|Revascularization|0|||
130839589|NCT01425359|471040121|FG001|Overall Study|Revascularization|1|||
130839590|NCT01425359|471040120|FG000|Overall Study|Death|0|||
130839591|NCT01425359|471040121|FG001|Overall Study|Death|1|||
130839592|NCT01425359|471040120|FG000|Overall Study|Unsatisfactory Response|1|||
130839593|NCT01425359|471040121|FG001|Overall Study|Unsatisfactory Response|0|||
130839594|NCT01425359|471040120|FG000|Overall Study|Protocol Violation|1|||
130839595|NCT01425359|471040121|FG001|Overall Study|Protocol Violation|2|||
130839596|NCT01425359|471040120|FG000|Overall Study|Subject Withdrew Consent|1|||
130839597|NCT01425359|471040121|FG001|Overall Study|Subject Withdrew Consent|2|||
130839598|NCT01425359|471040120|FG000|Overall Study|Investigator's Discretion|2|||
130839599|NCT01425359|471040121|FG001|Overall Study|Investigator's Discretion|0|||
130839600|NCT01425359|471040120|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
130839601|NCT01425359|471040121|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
130839602|NCT03172325|471040132|FG000|Overall Study|Adverse Event|2|||
130839603|NCT03172325|471040133|FG001|Overall Study|Adverse Event|3|||
130839604|NCT03172325|471040132|FG000|Overall Study|Positive PPD|1|||
130839605|NCT03172325|471040133|FG001|Overall Study|Positive PPD|0|||
130839606|NCT03172325|471040132|FG000|Overall Study|Poor Compliance|1|||
130839607|NCT03172325|471040133|FG001|Overall Study|Poor Compliance|1|||
130839608|NCT03305419|471040139|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130839609|NCT03305419|471040140|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
130839610|NCT03305419|471040141|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130839611|NCT03305419|471040142|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130839612|NCT03305419|471040143|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130839613|NCT03305419|471040144|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130839614|NCT03305419|471040145|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130839615|NCT03305419|471040146|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130839616|NCT03305419|471040139|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
130839617|NCT03305419|471040140|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130839618|NCT03305419|471040141|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130839619|NCT03305419|471040142|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130839620|NCT03305419|471040143|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130839621|NCT03305419|471040144|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130839622|NCT03305419|471040145|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130839623|NCT03305419|471040146|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130839624|NCT03305419|471040139|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
130839625|NCT03305419|471040140|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130839626|NCT03305419|471040141|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130839627|NCT03305419|471040142|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130839628|NCT03305419|471040143|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130839629|NCT03305419|471040144|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130839630|NCT03305419|471040145|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130839631|NCT03305419|471040146|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130839632|NCT03305419|471040139|FG000|Part B (14 Days)|Adverse Event|0|||
130839633|NCT03305419|471040140|FG001|Part B (14 Days)|Adverse Event|0|||
130839634|NCT03305419|471040141|FG002|Part B (14 Days)|Adverse Event|0|||
130839635|NCT03305419|471040142|FG003|Part B (14 Days)|Adverse Event|0|||
130839636|NCT03305419|471040143|FG004|Part B (14 Days)|Adverse Event|1|||
130839637|NCT03305419|471040144|FG005|Part B (14 Days)|Adverse Event|2|||
130839638|NCT03305419|471040145|FG006|Part B (14 Days)|Adverse Event|4|||
130839639|NCT03305419|471040146|FG007|Part B (14 Days)|Adverse Event|0|||
130839640|NCT03305419|471040139|FG000|Part B (14 Days)|Physician Decision|0|||
130839641|NCT03305419|471040140|FG001|Part B (14 Days)|Physician Decision|0|||
130839642|NCT03305419|471040141|FG002|Part B (14 Days)|Physician Decision|0|||
130839643|NCT03305419|471040142|FG003|Part B (14 Days)|Physician Decision|0|||
130839644|NCT03305419|471040143|FG004|Part B (14 Days)|Physician Decision|2|||
130839645|NCT03305419|471040144|FG005|Part B (14 Days)|Physician Decision|8|||
130839646|NCT03305419|471040145|FG006|Part B (14 Days)|Physician Decision|1|||
130839647|NCT03305419|471040146|FG007|Part B (14 Days)|Physician Decision|0|||
130839648|NCT00889603|471040148|FG000|Overall Study|Adverse Event|7|||
130839649|NCT00889603|471040148|FG000|Overall Study|Death|3|||
130839650|NCT00889603|471040148|FG000|Overall Study|Lost to Follow-up|19|||
130839651|NCT00889603|471040148|FG000|Overall Study|No longer willing to participant in stud|4|||
130839652|NCT00889603|471040148|FG000|Overall Study|Other|4|||
130839653|NCT02231892|471040149|FG000|Overall Study|Lost to Follow-up|1|||
130839654|NCT02231892|471040150|FG001|Overall Study|Lost to Follow-up|0|||
130839655|NCT02231892|471040151|FG002|Overall Study|Lost to Follow-up|3|||
130839656|NCT02231892|471040149|FG000|Overall Study|Withdrawal by Subject|4|||
130839657|NCT02231892|471040150|FG001|Overall Study|Withdrawal by Subject|3|||
130839658|NCT02231892|471040151|FG002|Overall Study|Withdrawal by Subject|15|||
130839659|NCT02231892|471040149|FG000|Overall Study|Physician Decision|0|||
130839660|NCT02231892|471040150|FG001|Overall Study|Physician Decision|2|||
130839661|NCT02231892|471040151|FG002|Overall Study|Physician Decision|4|||
130839662|NCT02231892|471040149|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
130839663|NCT02231892|471040150|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
130839664|NCT02231892|471040151|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
130839665|NCT02231892|471040149|FG000|Overall Study|Participant motor threshold was >83%|0|||
130839666|NCT02231892|471040150|FG001|Overall Study|Participant motor threshold was >83%|0|||
130839667|NCT02231892|471040151|FG002|Overall Study|Participant motor threshold was >83%|9|||
130839668|NCT02231892|471040149|FG000|Overall Study|Could not find motor threshold|2|||
130839669|NCT02231892|471040150|FG001|Overall Study|Could not find motor threshold|0|||
130839670|NCT02231892|471040151|FG002|Overall Study|Could not find motor threshold|1|||
130839671|NCT02231892|471040149|FG000|Overall Study|Could not find reliable motor hotspot|0|||
130839672|NCT02231892|471040150|FG001|Overall Study|Could not find reliable motor hotspot|0|||
130839673|NCT02231892|471040151|FG002|Overall Study|Could not find reliable motor hotspot|1|||
130839674|NCT02680041|471040153|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
130839675|NCT02680041|471040153|FG000|Overall Study|Lost to Follow-up|2|||
130839676|NCT02186652|471040154|FG000|Overall Study|Lost to Follow-up|2|||
130839677|NCT02186652|471040155|FG001|Overall Study|Lost to Follow-up|0|||
130839678|NCT00744978|471040159|FG000|Period 1|Lost to Follow-up|1|||
130839679|NCT00744978|471040160|FG001|Period 1|Lost to Follow-up|0|||
130839680|NCT00744978|471040159|FG000|Period 1|Withdrawal by Subject|0|||
130839681|NCT00744978|471040160|FG001|Period 1|Withdrawal by Subject|2|||
130839682|NCT00744978|471040159|FG000|Period 1|Other|0|||
130839683|NCT00744978|471040160|FG001|Period 1|Other|2|||
130839684|NCT00744978|471040159|FG000|Period 1|Adverse Event|4|||
130839685|NCT00744978|471040160|FG001|Period 1|Adverse Event|0|||
130839686|NCT00744978|471040159|FG000|Period 1|Randomized but not Treated|1|||
130839687|NCT00744978|471040160|FG001|Period 1|Randomized but not Treated|1|||
130839688|NCT00744978|471040159|FG000|Period 2|Adverse Event|0|||
130839689|NCT00744978|471040160|FG001|Period 2|Adverse Event|1|||
130839690|NCT00515294|471040161|FG000|Overall Study|Lost to Follow-up|3|||
130839691|NCT00515294|471040162|FG001|Overall Study|Lost to Follow-up|2|||
130839692|NCT00515294|471040163|FG002|Overall Study|Lost to Follow-up|3|||
130839693|NCT00515294|471040164|FG003|Overall Study|Lost to Follow-up|1|||
130839694|NCT00515294|471040161|FG000|Overall Study|Driver simulator problems|1|||
130839695|NCT00515294|471040162|FG001|Overall Study|Driver simulator problems|1|||
130839696|NCT00515294|471040163|FG002|Overall Study|Driver simulator problems|1|||
130839697|NCT00515294|471040164|FG003|Overall Study|Driver simulator problems|3|||
130839698|NCT00515294|471040161|FG000|Overall Study|Caffeine amount inaccurate|5|||
130839699|NCT00515294|471040162|FG001|Overall Study|Caffeine amount inaccurate|0|||
130839700|NCT00515294|471040163|FG002|Overall Study|Caffeine amount inaccurate|7|||
130839701|NCT00515294|471040164|FG003|Overall Study|Caffeine amount inaccurate|0|||
130839702|NCT03943550|471040171|FG000|Overall Study|Adverse Event|0|||
130839703|NCT03943550|471040172|FG001|Overall Study|Adverse Event|0|||
130839704|NCT03943550|471040173|FG002|Overall Study|Adverse Event|1|||
130839705|NCT03943550|471040171|FG000|Overall Study|Lost to Follow-up|0|||
130839706|NCT03943550|471040172|FG001|Overall Study|Lost to Follow-up|0|||
130839707|NCT03943550|471040173|FG002|Overall Study|Lost to Follow-up|1|||
130839708|NCT03943550|471040171|FG000|Overall Study|Progressive Disease|0|||
130839709|NCT03943550|471040172|FG001|Overall Study|Progressive Disease|0|||
130839710|NCT03943550|471040173|FG002|Overall Study|Progressive Disease|2|||
130839711|NCT03943550|471040171|FG000|Overall Study|Participant Moved Out of the Country|0|||
130839712|NCT03943550|471040172|FG001|Overall Study|Participant Moved Out of the Country|1|||
130839713|NCT03943550|471040173|FG002|Overall Study|Participant Moved Out of the Country|0|||
130839714|NCT03359785|471040174|FG000|Overall Study|Protocol Violation|0|||
130839715|NCT03359785|471040175|FG001|Overall Study|Protocol Violation|1|||
130839716|NCT03359785|471040176|FG002|Overall Study|Protocol Violation|0|||
130839717|NCT03359785|471040177|FG003|Overall Study|Protocol Violation|0|||
130839718|NCT03359785|471040174|FG000|Overall Study|Early study termination due to study pause|0|||
130839719|NCT03359785|471040175|FG001|Overall Study|Early study termination due to study pause|0|||
130839720|NCT03359785|471040176|FG002|Overall Study|Early study termination due to study pause|2|||
130839721|NCT03359785|471040177|FG003|Overall Study|Early study termination due to study pause|0|||
130839722|NCT03359785|471040174|FG000|Overall Study|Withdrawal by Subject|2|||
130839723|NCT03359785|471040175|FG001|Overall Study|Withdrawal by Subject|2|||
130839724|NCT03359785|471040176|FG002|Overall Study|Withdrawal by Subject|0|||
130839725|NCT03359785|471040177|FG003|Overall Study|Withdrawal by Subject|0|||
130839726|NCT01895543|471040178|FG000|Overall Study|Withdrawal by Subject|43|||
130839727|NCT01895543|471040178|FG000|Overall Study|Lost to Follow-up|25|||
130839728|NCT01895543|471040178|FG000|Overall Study|Adverse Event|28|||
130839729|NCT01895543|471040178|FG000|Overall Study|Subject's substantial non-compliance|6|||
130839730|NCT01895543|471040178|FG000|Overall Study|Protocol Violation|1|||
130839731|NCT01895543|471040178|FG000|Overall Study|Physician Decision|2|||
130839732|NCT01895543|471040178|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
130839733|NCT04659174|471040183|FG000|Overall Study|Sponsor decision to discontinue study|0|||
130839734|NCT04659174|471040184|FG001|Overall Study|Sponsor decision to discontinue study|2|||
130839735|NCT04659174|471040183|FG000|Overall Study|Lost to Follow-up|9|||
130839736|NCT04659174|471040184|FG001|Overall Study|Lost to Follow-up|11|||
130839737|NCT04659174|471040183|FG000|Overall Study|Adverse Event|8|||
130839738|NCT04659174|471040184|FG001|Overall Study|Adverse Event|5|||
130839739|NCT04659174|471040183|FG000|Overall Study|Withdrawal by Subject|17|||
130839740|NCT04659174|471040184|FG001|Overall Study|Withdrawal by Subject|33|||
130839741|NCT04659174|471040183|FG000|Overall Study|Progressive disease|0|||
130839742|NCT04659174|471040184|FG001|Overall Study|Progressive disease|2|||
130839743|NCT04659174|471040183|FG000|Overall Study|Other reasons|0|||
130839744|NCT04659174|471040184|FG001|Overall Study|Other reasons|2|||
130839745|NCT04659174|471040183|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
130839746|NCT04659174|471040184|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
130839747|NCT04659174|471040183|FG000|Overall Study|Alcohol or illegal drug use|0|||
130839748|NCT04659174|471040184|FG001|Overall Study|Alcohol or illegal drug use|3|||
130839749|NCT04659174|471040183|FG000|Overall Study|Violation of entry criteria|1|||
130839750|NCT04659174|471040184|FG001|Overall Study|Violation of entry criteria|0|||
130839751|NCT04659174|471040183|FG000|Overall Study|Death|0|||
130839752|NCT04659174|471040184|FG001|Overall Study|Death|1|||
130839753|NCT05129449|471040187|FG000|Overall Study|Protocol Violation|1|||
130839754|NCT03650803|471040191|FG000|Overall Study|Lost to Follow-up|6|||
130839755|NCT02901054|471040192|FG000|Overall Study|Physician Decision|1|||
130839756|NCT02901054|471040192|FG000|Overall Study|Withdrawal by Subject|3|||
130839757|NCT01818258|471040194|FG000|Overall Study|Death|3|||
130839758|NCT01818258|471040195|FG001|Overall Study|Death|0|||
130839759|NCT01818258|471040194|FG000|Overall Study|Withdrawal by Subject|0|||
130839760|NCT01818258|471040195|FG001|Overall Study|Withdrawal by Subject|1|||
130839761|NCT01818258|471040194|FG000|Overall Study|Lost to Follow-up|0|||
130839762|NCT01818258|471040195|FG001|Overall Study|Lost to Follow-up|1|||
130839763|NCT01818258|471040194|FG000|Overall Study|Unable to Travel to Clinic|0|||
130839764|NCT01818258|471040195|FG001|Overall Study|Unable to Travel to Clinic|1|||
130839765|NCT02099344|471040198|FG000|Overall Study|Physician Decision|1|||
130839766|NCT02099344|471040199|FG001|Overall Study|Physician Decision|0|||
130839767|NCT02839720|471040202|FG000|Overall Study|Adverse Event|2|||
130839768|NCT02839720|471040202|FG000|Overall Study|Non-compliance|2|||
130839769|NCT02839720|471040202|FG000|Overall Study|Intercurrent Illness|1|||
130839770|NCT02839720|471040202|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
130839771|NCT02649218|471040203|FG000|Overall Study|Adverse Event|8|||
130839772|NCT02649218|471040203|FG000|Overall Study|Lack of Efficacy|8|||
130839773|NCT02649218|471040203|FG000|Overall Study|Pregnancy|3|||
130839774|NCT02649218|471040203|FG000|Overall Study|Protocol Violation|3|||
130839775|NCT02649218|471040203|FG000|Overall Study|Physician Decision|1|||
130839776|NCT02649218|471040203|FG000|Overall Study|Withdrawal by Subject|2|||
130839777|NCT05145322|471040206|FG000|Overall Study|Lost to Follow-up|4|||
130839778|NCT05145322|471040207|FG001|Overall Study|Lost to Follow-up|5|||
130839779|NCT01349322|471040208|FG000|Overall Study|Protocol Violation|45|||
130839780|NCT01349322|471040209|FG001|Overall Study|Protocol Violation|47|||
130839781|NCT00503581|471040210|FG000|Overall Study|Study closed|3|||
130839782|NCT00503581|471040211|FG001|Overall Study|Study closed|4|||
130839783|NCT00503581|471040212|FG002|Overall Study|Study closed|2|||
130839784|NCT06107803|471040214|FG000|Overall Study|Adverse Event|1|||
130839785|NCT06107803|471040214|FG000|Overall Study|Withdrawal by Subject|2|||
130839786|NCT06107803|471040214|FG000|Overall Study|Protocol Violation|1|||
130839787|NCT04730635|471040216|FG000|Overall Study|Lost to Follow-up|1|||
130839788|NCT04730635|471040217|FG001|Overall Study|Lost to Follow-up|0|||
130839789|NCT04730635|471040216|FG000|Overall Study|Withdrawal by Subject|0|||
130839790|NCT04730635|471040217|FG001|Overall Study|Withdrawal by Subject|1|||
130839791|NCT01096368|471040218|FG000|Overall Study|Death|0|||
130839792|NCT01096368|471040219|FG001|Overall Study|Death|1|||
130839793|NCT01096368|471040220|FG002|Overall Study|Death|0|||
130839794|NCT01096368|471040221|FG003|Overall Study|Death|0|||
130839795|NCT01096368|471040222|FG004|Overall Study|Death|0|||
130839796|NCT01096368|471040218|FG000|Overall Study|Physician Decision|0|||
130839797|NCT01096368|471040219|FG001|Overall Study|Physician Decision|13|||
130839798|NCT01096368|471040220|FG002|Overall Study|Physician Decision|2|||
130839799|NCT01096368|471040221|FG003|Overall Study|Physician Decision|4|||
130839800|NCT01096368|471040222|FG004|Overall Study|Physician Decision|6|||
130839801|NCT01096368|471040218|FG000|Overall Study|Withdrawal by Subject|0|||
130839802|NCT01096368|471040219|FG001|Overall Study|Withdrawal by Subject|52|||
130839803|NCT01096368|471040220|FG002|Overall Study|Withdrawal by Subject|0|||
130839804|NCT01096368|471040221|FG003|Overall Study|Withdrawal by Subject|10|||
130839805|NCT01096368|471040222|FG004|Overall Study|Withdrawal by Subject|14|||
130839806|NCT01096368|471040218|FG000|Overall Study|Ineligible|0|||
130839807|NCT01096368|471040219|FG001|Overall Study|Ineligible|3|||
130839808|NCT01096368|471040220|FG002|Overall Study|Ineligible|2|||
130839809|NCT01096368|471040221|FG003|Overall Study|Ineligible|0|||
130839810|NCT01096368|471040222|FG004|Overall Study|Ineligible|25|||
130839811|NCT01096368|471040218|FG000|Overall Study|Did not start treatment|0|||
130839812|NCT01096368|471040219|FG001|Overall Study|Did not start treatment|4|||
130839813|NCT01096368|471040220|FG002|Overall Study|Did not start treatment|4|||
130839814|NCT01096368|471040221|FG003|Overall Study|Did not start treatment|0|||
130839815|NCT01096368|471040222|FG004|Overall Study|Did not start treatment|0|||
130839816|NCT01096368|471040218|FG000|Overall Study|Progressive disease|0|||
130839817|NCT01096368|471040219|FG001|Overall Study|Progressive disease|6|||
130839818|NCT01096368|471040220|FG002|Overall Study|Progressive disease|0|||
130839819|NCT01096368|471040221|FG003|Overall Study|Progressive disease|10|||
130839820|NCT01096368|471040222|FG004|Overall Study|Progressive disease|3|||
130839821|NCT01096368|471040218|FG000|Overall Study|Other|0|||
130839822|NCT01096368|471040219|FG001|Overall Study|Other|0|||
130839823|NCT01096368|471040220|FG002|Overall Study|Other|1|||
130839824|NCT01096368|471040221|FG003|Overall Study|Other|0|||
130839825|NCT01096368|471040222|FG004|Overall Study|Other|0|||
130839826|NCT01096368|471040218|FG000|Overall Study|Treated with institutional review|0|||
130839827|NCT01096368|471040219|FG001|Overall Study|Treated with institutional review|0|||
130839828|NCT01096368|471040220|FG002|Overall Study|Treated with institutional review|0|||
130839829|NCT01096368|471040221|FG003|Overall Study|Treated with institutional review|0|||
130839830|NCT01096368|471040222|FG004|Overall Study|Treated with institutional review|1|||
130839831|NCT04934800|471040223|FG000|Overall Study|Other|1|||
130839832|NCT04934800|471040223|FG000|Overall Study|Withdrawal by Subject|5|||
130839833|NCT04934800|471040223|FG000|Overall Study|Lack of Efficacy|1|||
130839834|NCT04934800|471040223|FG000|Overall Study|Adverse Event|9|||
130839835|NCT04934800|471040223|FG000|Overall Study|Lost to Follow-up|5|||
130839836|NCT04934800|471040223|FG000|Overall Study|Enrolled but not treated|1|||
130839837|NCT00516906|471040224|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
130839838|NCT00516906|471040225|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
130839839|NCT01974206|471040228|FG000|Overall Study|Did Not Take Study Drug|0|||
130839840|NCT01974206|471040229|FG001|Overall Study|Did Not Take Study Drug|1|||
130839841|NCT01974206|471040228|FG000|Overall Study|Physician Decision|1|||
130839842|NCT01974206|471040229|FG001|Overall Study|Physician Decision|0|||
130839843|NCT01974206|471040228|FG000|Overall Study|Withdrawal by Subject|3|||
130839844|NCT01974206|471040229|FG001|Overall Study|Withdrawal by Subject|0|||
130839845|NCT01974206|471040228|FG000|Overall Study|Lost to Follow-up|1|||
130839846|NCT01974206|471040229|FG001|Overall Study|Lost to Follow-up|0|||
130839847|NCT01974206|471040228|FG000|Overall Study|Death|1|||
130839848|NCT01974206|471040229|FG001|Overall Study|Death|0|||
130839849|NCT02118766|471040234|FG000|Overall Study|Adverse Event|7|||
130839850|NCT02118766|471040235|FG001|Overall Study|Adverse Event|2|||
130839851|NCT02118766|471040234|FG000|Overall Study|Withdrawal by Subject|3|||
130839852|NCT02118766|471040235|FG001|Overall Study|Withdrawal by Subject|6|||
130839853|NCT02118766|471040234|FG000|Overall Study|Lost to Follow-up|5|||
130839854|NCT02118766|471040235|FG001|Overall Study|Lost to Follow-up|4|||
130839855|NCT02118766|471040234|FG000|Overall Study|Withdrawal by parent/guardian|12|||
130839856|NCT02118766|471040235|FG001|Overall Study|Withdrawal by parent/guardian|18|||
130839857|NCT02118766|471040234|FG000|Overall Study|Other|3|||
130839858|NCT02118766|471040235|FG001|Overall Study|Other|1|||
130839859|NCT04669262|471040253|FG000|Overall Study|Withdrawal by Subject|0|||
130839860|NCT04669262|471040254|FG001|Overall Study|Withdrawal by Subject|0|||
130839861|NCT04669262|471040255|FG002|Overall Study|Withdrawal by Subject|0|||
130839862|NCT04669262|471040256|FG003|Overall Study|Withdrawal by Subject|1|||
130839863|NCT04669262|471040253|FG000|Overall Study|Randomized but Not Treated|0|||
130839864|NCT04669262|471040254|FG001|Overall Study|Randomized but Not Treated|1|||
130839865|NCT04669262|471040255|FG002|Overall Study|Randomized but Not Treated|0|||
130839866|NCT04669262|471040256|FG003|Overall Study|Randomized but Not Treated|0|||
130839867|NCT01638013|471040257|FG000|Overall Study|Adverse Event|36|||
130839868|NCT01638013|471040258|FG001|Overall Study|Adverse Event|29|||
130839869|NCT01638013|471040259|FG002|Overall Study|Adverse Event|48|||
130839870|NCT01638013|471040257|FG000|Overall Study|Lack of Efficacy|39|||
130839871|NCT01638013|471040258|FG001|Overall Study|Lack of Efficacy|11|||
130839872|NCT01638013|471040259|FG002|Overall Study|Lack of Efficacy|14|||
130839873|NCT01638013|471040257|FG000|Overall Study|Protocol Violation|10|||
130839874|NCT01638013|471040258|FG001|Overall Study|Protocol Violation|7|||
130839875|NCT01638013|471040259|FG002|Overall Study|Protocol Violation|11|||
130839876|NCT01638013|471040257|FG000|Overall Study|Met discontinuation criteria|4|||
130839877|NCT01638013|471040258|FG001|Overall Study|Met discontinuation criteria|0|||
130839878|NCT01638013|471040259|FG002|Overall Study|Met discontinuation criteria|7|||
130839879|NCT01638013|471040257|FG000|Overall Study|Subject Lost to Follow up|1|||
130839880|NCT01638013|471040258|FG001|Overall Study|Subject Lost to Follow up|0|||
130839881|NCT01638013|471040259|FG002|Overall Study|Subject Lost to Follow up|1|||
130839882|NCT01638013|471040257|FG000|Overall Study|Miscellaneous|25|||
130839883|NCT01638013|471040258|FG001|Overall Study|Miscellaneous|19|||
130839884|NCT01638013|471040259|FG002|Overall Study|Miscellaneous|23|||
130839885|NCT01638013|471040257|FG000|Overall Study|Withdrawal of Consent|16|||
130839886|NCT01638013|471040258|FG001|Overall Study|Withdrawal of Consent|12|||
130839887|NCT01638013|471040259|FG002|Overall Study|Withdrawal of Consent|16|||
130839888|NCT01638013|471040257|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
130839889|NCT01638013|471040258|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
130839890|NCT01638013|471040259|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
130839891|NCT03559517|471040262|FG000|Overall Study|Withdrawal by Subject|1|||
130839892|NCT03559517|471040263|FG001|Overall Study|Withdrawal by Subject|0|||
130839893|NCT03559517|471040264|FG002|Overall Study|Withdrawal by Subject|0|||
130839894|NCT01846299|471040265|FG000|Overall Study|Physician Decision|4|||
130839895|NCT01846299|471040266|FG001|Overall Study|Physician Decision|2|||
130839896|NCT01846299|471040265|FG000|Overall Study|Protocol deviation|1|||
130839897|NCT01846299|471040266|FG001|Overall Study|Protocol deviation|0|||
130839898|NCT01846299|471040265|FG000|Overall Study|Death|1|||
130839899|NCT01846299|471040266|FG001|Overall Study|Death|2|||
130839900|NCT01846299|471040265|FG000|Overall Study|Lost to Follow-up|3|||
130839901|NCT01846299|471040266|FG001|Overall Study|Lost to Follow-up|0|||
130839902|NCT01846299|471040265|FG000|Overall Study|Withdrawal by Subject|1|||
130839903|NCT01846299|471040266|FG001|Overall Study|Withdrawal by Subject|6|||
130839904|NCT01846299|471040265|FG000|Overall Study|Adverse Event|2|||
130839905|NCT01846299|471040266|FG001|Overall Study|Adverse Event|0|||
130839906|NCT01330628|471040268|FG000|Overall Study|Death|2|||
130839907|NCT01330628|471040269|FG001|Overall Study|Death|3|||
130839908|NCT01330628|471040268|FG000|Overall Study|Lost to Follow-up|5|||
130839909|NCT01330628|471040269|FG001|Overall Study|Lost to Follow-up|6|||
130839910|NCT01330628|471040268|FG000|Overall Study|Adverse Event|44|||
130839911|NCT01330628|471040269|FG001|Overall Study|Adverse Event|25|||
130839912|NCT01330628|471040268|FG000|Overall Study|Withdrawn|18|||
130839913|NCT01330628|471040269|FG001|Overall Study|Withdrawn|6|||
130839914|NCT01330628|471040268|FG000|Overall Study|Didn't receive study treatment|1|||
130839915|NCT01330628|471040269|FG001|Overall Study|Didn't receive study treatment|0|||
130839916|NCT01357161|471040270|FG000|Part 1 (Open Label Run-in)|Death|5|||
130839917|NCT01357161|471040271|FG001|Part 1 (Open Label Run-in)|Death|0|||
130839918|NCT01357161|471040272|FG002|Part 1 (Open Label Run-in)|Death|0|||
130839919|NCT01357161|471040270|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
130839920|NCT01357161|471040271|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
130839921|NCT01357161|471040272|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
130839922|NCT01357161|471040270|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
130839923|NCT01357161|471040271|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
130839924|NCT01357161|471040272|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
130839925|NCT01357161|471040270|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
130839926|NCT01357161|471040271|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
130839927|NCT01357161|471040272|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
130839928|NCT01357161|471040270|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
130839929|NCT01357161|471040271|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
130839930|NCT01357161|471040272|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
130839931|NCT01357161|471040270|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
130839932|NCT01357161|471040271|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
130839933|NCT01357161|471040272|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
130839934|NCT01357161|471040270|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
130839935|NCT01357161|471040271|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
130839936|NCT01357161|471040272|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
130839937|NCT01357161|471040270|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
130839938|NCT01357161|471040271|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
130839939|NCT01357161|471040272|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
130839940|NCT01357161|471040270|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
130839941|NCT01357161|471040271|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
130839942|NCT01357161|471040272|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
130839943|NCT01357161|471040270|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
130839944|NCT01357161|471040271|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
130839945|NCT01357161|471040272|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
130839946|NCT01357161|471040270|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
130839947|NCT01357161|471040271|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
130839948|NCT01357161|471040272|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
130839949|NCT01448824|471042011|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130839950|NCT01448824|471042012|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130839951|NCT01448824|471042013|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130839952|NCT01448824|471042014|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130839953|NCT01448824|471042015|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130839954|NCT01448824|471042016|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130839955|NCT01448824|471042017|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
130839956|NCT01448824|471042018|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130839957|NCT01448824|471042011|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130839958|NCT01448824|471042012|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130839959|NCT01448824|471042013|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130839960|NCT01448824|471042014|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
130839961|NCT01448824|471042015|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
130839962|NCT01448824|471042016|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
130839963|NCT01448824|471042017|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130839964|NCT01448824|471042018|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130839965|NCT01448824|471042011|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130839966|NCT01448824|471042012|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130839967|NCT01448824|471042013|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130839968|NCT01448824|471042014|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130839969|NCT01448824|471042015|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130839970|NCT01448824|471042016|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
130839971|NCT01448824|471042017|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130839972|NCT01448824|471042018|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130839973|NCT01448824|471042011|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
130839974|NCT01448824|471042012|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
130839975|NCT01448824|471042013|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
130839976|NCT01448824|471042014|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
130839977|NCT01448824|471042015|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
130839978|NCT01448824|471042016|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
130839979|NCT01448824|471042017|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
130839980|NCT01448824|471042018|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
130839981|NCT01448824|471042011|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130839982|NCT01448824|471042012|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130839983|NCT01448824|471042013|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130839984|NCT01448824|471042014|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130839985|NCT01448824|471042015|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130839986|NCT01448824|471042016|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130839987|NCT01448824|471042017|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130839988|NCT01448824|471042018|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
130839989|NCT01448824|471042011|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130839990|NCT01448824|471042012|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130839991|NCT01448824|471042013|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130839992|NCT01448824|471042014|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130839993|NCT01448824|471042015|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130839994|NCT01448824|471042016|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130839995|NCT01448824|471042017|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130839996|NCT01448824|471042018|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
130839997|NCT01448824|471042011|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130839998|NCT01448824|471042012|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130839999|NCT01448824|471042013|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130840000|NCT01448824|471042014|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130840001|NCT01448824|471042015|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130840002|NCT01448824|471042016|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130840003|NCT01448824|471042017|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130840004|NCT01448824|471042018|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
130840005|NCT01448824|471042011|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130840006|NCT01448824|471042012|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130840007|NCT01448824|471042013|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130840008|NCT01448824|471042014|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130840009|NCT01448824|471042015|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130840010|NCT01448824|471042016|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130840011|NCT01448824|471042017|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130840012|NCT01448824|471042018|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
130840013|NCT01995669|471042021|FG000|Overall Study|Progression|2|||
130840014|NCT01995669|471042022|FG001|Overall Study|Progression|1|||
130840015|NCT01995669|471042023|FG002|Overall Study|Progression|1|||
130840016|NCT01995669|471042024|FG003|Overall Study|Progression|13|||
130840017|NCT01995669|471042021|FG000|Overall Study|Adverse Event|0|||
130840018|NCT01995669|471042022|FG001|Overall Study|Adverse Event|0|||
130840019|NCT01995669|471042023|FG002|Overall Study|Adverse Event|0|||
130840020|NCT01995669|471042024|FG003|Overall Study|Adverse Event|3|||
130840021|NCT01995669|471042021|FG000|Overall Study|Death|0|||
130840022|NCT01995669|471042022|FG001|Overall Study|Death|0|||
130840023|NCT01995669|471042023|FG002|Overall Study|Death|0|||
130840024|NCT01995669|471042024|FG003|Overall Study|Death|6|||
130840025|NCT01995669|471042021|FG000|Overall Study|Withdrawal by Subject|0|||
130840026|NCT01995669|471042022|FG001|Overall Study|Withdrawal by Subject|0|||
130840027|NCT01995669|471042023|FG002|Overall Study|Withdrawal by Subject|0|||
130840028|NCT01995669|471042024|FG003|Overall Study|Withdrawal by Subject|6|||
130840029|NCT01995669|471042021|FG000|Overall Study|Insurance Expired|0|||
130840030|NCT01995669|471042022|FG001|Overall Study|Insurance Expired|0|||
130840031|NCT01995669|471042023|FG002|Overall Study|Insurance Expired|0|||
130840032|NCT01995669|471042024|FG003|Overall Study|Insurance Expired|1|||
130840033|NCT05425732|471042025|FG000|Overall Study|Death|4|||
130840034|NCT05425732|471042026|FG001|Overall Study|Death|2|||
130840035|NCT05425732|471042027|FG002|Overall Study|Death|0|||
130840036|NCT05425732|471042028|FG003|Overall Study|Death|0|||
130840037|NCT05425732|471042025|FG000|Overall Study|Lost to Follow-up|10|||
130840038|NCT05425732|471042026|FG001|Overall Study|Lost to Follow-up|15|||
130840039|NCT05425732|471042027|FG002|Overall Study|Lost to Follow-up|5|||
130840040|NCT05425732|471042028|FG003|Overall Study|Lost to Follow-up|3|||
130840041|NCT05425732|471042025|FG000|Overall Study|Physician Decision|0|||
130840042|NCT05425732|471042026|FG001|Overall Study|Physician Decision|2|||
130840043|NCT05425732|471042027|FG002|Overall Study|Physician Decision|0|||
130840044|NCT05425732|471042028|FG003|Overall Study|Physician Decision|0|||
130840045|NCT05425732|471042025|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130840046|NCT05425732|471042026|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
130840047|NCT05425732|471042027|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130840048|NCT05425732|471042028|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130840049|NCT05425732|471042025|FG000|Overall Study|Withdrawal by Subject|4|||
130840050|NCT05425732|471042026|FG001|Overall Study|Withdrawal by Subject|8|||
130840051|NCT05425732|471042027|FG002|Overall Study|Withdrawal by Subject|1|||
130840052|NCT05425732|471042028|FG003|Overall Study|Withdrawal by Subject|1|||
130840053|NCT05425732|471042025|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
130840054|NCT05425732|471042026|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
130840055|NCT05425732|471042027|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
130840056|NCT05425732|471042028|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
130840057|NCT02998203|471042029|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
130840058|NCT02998203|471042030|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
130840059|NCT02998203|471042029|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
130840060|NCT02998203|471042030|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
130840061|NCT04187144|471042031|FG000|Overall Study|Lost to Follow-up|12|||
130840062|NCT04187144|471042032|FG001|Overall Study|Lost to Follow-up|11|||
130840063|NCT04187144|471042031|FG000|Overall Study|Withdrawal by Subject|20|||
130840064|NCT04187144|471042032|FG001|Overall Study|Withdrawal by Subject|18|||
130840065|NCT04187144|471042031|FG000|Overall Study|Adverse Event|19|||
130840066|NCT04187144|471042032|FG001|Overall Study|Adverse Event|4|||
130840067|NCT04187144|471042031|FG000|Overall Study|Physician Decision|5|||
130840068|NCT04187144|471042032|FG001|Overall Study|Physician Decision|3|||
130840069|NCT04187144|471042031|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
130840070|NCT04187144|471042032|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
130840071|NCT04187144|471042031|FG000|Overall Study|Protocol Deviation|1|||
130840072|NCT04187144|471042032|FG001|Overall Study|Protocol Deviation|4|||
130840073|NCT02650804|471042033|FG000|Overall Study|Adverse Event|3|||
130840074|NCT02650804|471042034|FG001|Overall Study|Adverse Event|2|||
130840075|NCT02650804|471042033|FG000|Overall Study|Death|1|||
130840076|NCT02650804|471042034|FG001|Overall Study|Death|2|||
130840077|NCT02650804|471042033|FG000|Overall Study|Progressive Disease|7|||
130840078|NCT02650804|471042034|FG001|Overall Study|Progressive Disease|10|||
130840079|NCT02650804|471042033|FG000|Overall Study|Physician Decision|0|||
130840080|NCT02650804|471042034|FG001|Overall Study|Physician Decision|2|||
130840081|NCT02650804|471042033|FG000|Overall Study|Withdrawal by Subject|1|||
130840082|NCT02650804|471042034|FG001|Overall Study|Withdrawal by Subject|4|||
130840083|NCT02650804|471042033|FG000|Overall Study|Symptomatic deterioration|5|||
130840084|NCT02650804|471042034|FG001|Overall Study|Symptomatic deterioration|7|||
130840085|NCT02650804|471042033|FG000|Overall Study|Protocol Violation|0|||
130840086|NCT02650804|471042034|FG001|Overall Study|Protocol Violation|1|||
130840087|NCT02743949|471042035|FG000|Overall Study|Adverse Event|0|||
130840088|NCT02743949|471042036|FG001|Overall Study|Adverse Event|0|||
130840089|NCT02743949|471042037|FG002|Overall Study|Adverse Event|2|||
130840090|NCT02743949|471042035|FG000|Overall Study|Significant Protocol Deviation|2|||
130840091|NCT02743949|471042036|FG001|Overall Study|Significant Protocol Deviation|0|||
130840092|NCT02743949|471042037|FG002|Overall Study|Significant Protocol Deviation|1|||
130840093|NCT02743949|471042035|FG000|Overall Study|Voluntary Withdrawal|2|||
130840094|NCT02743949|471042036|FG001|Overall Study|Voluntary Withdrawal|1|||
130840095|NCT02743949|471042037|FG002|Overall Study|Voluntary Withdrawal|0|||
130840096|NCT03389555|471042038|FG000|Overall Study|Protocol Violation|1|||
130840097|NCT03389555|471042039|FG001|Overall Study|Protocol Violation|3|||
130840098|NCT03389555|471042038|FG000|Overall Study|Death|1|||
130840099|NCT03389555|471042039|FG001|Overall Study|Death|0|||
130840100|NCT00920218|471042040|FG000|Overall Study|Serious Adverse Event|2|||
130840101|NCT00920218|471042041|FG001|Overall Study|Serious Adverse Event|0|||
130840102|NCT00920218|471042042|FG002|Overall Study|Serious Adverse Event|2|||
130840103|NCT00920218|471042043|FG003|Overall Study|Serious Adverse Event|1|||
130840104|NCT00920218|471042040|FG000|Overall Study|Withdrawal by Subject|0|||
130840105|NCT00920218|471042041|FG001|Overall Study|Withdrawal by Subject|3|||
130840106|NCT00920218|471042042|FG002|Overall Study|Withdrawal by Subject|2|||
130840107|NCT00920218|471042043|FG003|Overall Study|Withdrawal by Subject|0|||
130840108|NCT00920218|471042040|FG000|Overall Study|Migrated/moved from study area|0|||
130840109|NCT00920218|471042041|FG001|Overall Study|Migrated/moved from study area|0|||
130840110|NCT00920218|471042042|FG002|Overall Study|Migrated/moved from study area|1|||
130840111|NCT00920218|471042043|FG003|Overall Study|Migrated/moved from study area|0|||
130840112|NCT00920218|471042040|FG000|Overall Study|Lost to Follow-up|0|||
130840113|NCT00920218|471042041|FG001|Overall Study|Lost to Follow-up|1|||
130840114|NCT00920218|471042042|FG002|Overall Study|Lost to Follow-up|0|||
130840115|NCT00920218|471042043|FG003|Overall Study|Lost to Follow-up|3|||
130840116|NCT00920218|471042040|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
130840117|NCT00920218|471042041|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
130840118|NCT00920218|471042042|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
130840119|NCT00920218|471042043|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
130840120|NCT00920218|471042040|FG000|Overall Study|Other|0|||
130840121|NCT00920218|471042041|FG001|Overall Study|Other|0|||
130840122|NCT00920218|471042042|FG002|Overall Study|Other|1|||
130840123|NCT00920218|471042043|FG003|Overall Study|Other|0|||
130840124|NCT01007435|471042044|FG000|Overall Study|Adverse Event|16|||
130840125|NCT01007435|471042045|FG001|Overall Study|Adverse Event|25|||
130840126|NCT01007435|471042046|FG002|Overall Study|Adverse Event|47|||
130840127|NCT01007435|471042047|FG003|Overall Study|Adverse Event|31|||
130840128|NCT01007435|471042044|FG000|Overall Study|Death|2|||
130840129|NCT01007435|471042045|FG001|Overall Study|Death|4|||
130840130|NCT01007435|471042046|FG002|Overall Study|Death|2|||
130840131|NCT01007435|471042047|FG003|Overall Study|Death|1|||
130840132|NCT01007435|471042044|FG000|Overall Study|Insufficient Therapeutic Response|21|||
130840133|NCT01007435|471042045|FG001|Overall Study|Insufficient Therapeutic Response|7|||
130840134|NCT01007435|471042046|FG002|Overall Study|Insufficient Therapeutic Response|2|||
130840135|NCT01007435|471042047|FG003|Overall Study|Insufficient Therapeutic Response|9|||
130840136|NCT01007435|471042044|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
130840137|NCT01007435|471042045|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
130840138|NCT01007435|471042046|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
130840139|NCT01007435|471042047|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
130840140|NCT01007435|471042044|FG000|Overall Study|Other Protocol Violation|2|||
130840141|NCT01007435|471042045|FG001|Overall Study|Other Protocol Violation|0|||
130840142|NCT01007435|471042046|FG002|Overall Study|Other Protocol Violation|1|||
130840143|NCT01007435|471042047|FG003|Overall Study|Other Protocol Violation|0|||
130840144|NCT01007435|471042044|FG000|Overall Study|Refused Treatment|13|||
130840145|NCT01007435|471042045|FG001|Overall Study|Refused Treatment|13|||
130840146|NCT01007435|471042046|FG002|Overall Study|Refused Treatment|5|||
130840147|NCT01007435|471042047|FG003|Overall Study|Refused Treatment|8|||
130840148|NCT01007435|471042044|FG000|Overall Study|Failure to Return|5|||
130840149|NCT01007435|471042045|FG001|Overall Study|Failure to Return|4|||
130840150|NCT01007435|471042046|FG002|Overall Study|Failure to Return|3|||
130840151|NCT01007435|471042047|FG003|Overall Study|Failure to Return|6|||
130840152|NCT01007435|471042044|FG000|Overall Study|Reason not Specified|1|||
130840153|NCT01007435|471042045|FG001|Overall Study|Reason not Specified|1|||
130840154|NCT01007435|471042046|FG002|Overall Study|Reason not Specified|2|||
130840155|NCT01007435|471042047|FG003|Overall Study|Reason not Specified|1|||
130840156|NCT01345591|471042050|FG000|Overall Study|Lost to Follow-up|1|||
130840157|NCT02442310|471042051|FG000|Overall Study|Adverse Event|2|||
130840158|NCT02442310|471042051|FG000|Overall Study|Withdrawal by Subject|1|||
130840159|NCT00688324|471042052|FG000|Overall Study|Withdrawal by Subject|2|||
130840160|NCT00688324|471042052|FG000|Overall Study|Physician Decision|5|||
130840161|NCT00688324|471042052|FG000|Overall Study|Lost to Follow-up|1|||
130840162|NCT00006046|471042059|FG000|Overall Study|Adverse Event|3|||
130840163|NCT00006046|471042060|FG001|Overall Study|Adverse Event|0|||
130840164|NCT00006046|471042061|FG002|Overall Study|Adverse Event|0|||
130840165|NCT00006046|471042062|FG003|Overall Study|Adverse Event|0|||
130840166|NCT00006046|471042063|FG004|Overall Study|Adverse Event|0|||
130840167|NCT00006046|471042059|FG000|Overall Study|Disease Progression|2|||
130840168|NCT00006046|471042060|FG001|Overall Study|Disease Progression|0|||
130840169|NCT00006046|471042061|FG002|Overall Study|Disease Progression|0|||
130840170|NCT00006046|471042062|FG003|Overall Study|Disease Progression|0|||
130840171|NCT00006046|471042063|FG004|Overall Study|Disease Progression|0|||
130840172|NCT03176472|471042064|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
130840173|NCT03176472|471042065|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
130840174|NCT03176472|471042064|FG000|Double Blind Treatment Period|Adverse Event|0|||
130840175|NCT03176472|471042065|FG001|Double Blind Treatment Period|Adverse Event|5|||
130840176|NCT03176472|471042064|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
130840177|NCT03176472|471042065|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130840178|NCT03176472|471042064|FG000|Double Blind Treatment Period|Physician Decision|0|||
130840179|NCT03176472|471042065|FG001|Double Blind Treatment Period|Physician Decision|1|||
130840180|NCT03176472|471042064|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130840181|NCT03176472|471042065|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130840182|NCT03176472|471042064|FG000|Double Blind Treatment Period|Not Provided|1|||
130840183|NCT03176472|471042065|FG001|Double Blind Treatment Period|Not Provided|0|||
130840184|NCT03176472|471042064|FG000|Open Label Extension|Withdrawal by Subject|3|||
130840185|NCT03176472|471042065|FG001|Open Label Extension|Withdrawal by Subject|4|||
130840186|NCT03176472|471042064|FG000|Open Label Extension|Adverse Event|2|||
130840187|NCT03176472|471042065|FG001|Open Label Extension|Adverse Event|4|||
130840188|NCT03176472|471042064|FG000|Open Label Extension|Lost to Follow-up|1|||
130840189|NCT03176472|471042065|FG001|Open Label Extension|Lost to Follow-up|2|||
130840190|NCT03176472|471042064|FG000|Open Label Extension|Protocol Violation|0|||
130840191|NCT03176472|471042065|FG001|Open Label Extension|Protocol Violation|1|||
130840192|NCT03176472|471042064|FG000|Open Label Extension|Not Provided|2|||
130840193|NCT03176472|471042065|FG001|Open Label Extension|Not Provided|1|||
130840194|NCT00596154|471042066|FG000|Overall Study|Not Evaluable|2|||
130840195|NCT00642369|471042067|FG000|Overall Study|Adverse Event|2|||
130840196|NCT00642369|471042068|FG001|Overall Study|Adverse Event|3|||
130840197|NCT00642369|471042067|FG000|Overall Study|Withdrawal by Subject|1|||
130840198|NCT00642369|471042068|FG001|Overall Study|Withdrawal by Subject|0|||
130840199|NCT00642369|471042067|FG000|Overall Study|misdiagnosis|0|||
130840200|NCT00642369|471042068|FG001|Overall Study|misdiagnosis|1|||
130840201|NCT00642369|471042067|FG000|Overall Study|Lack of Efficacy|2|||
130840202|NCT00642369|471042068|FG001|Overall Study|Lack of Efficacy|2|||
130840203|NCT00847665|471042069|FG000|Overall Study|Withdrawal by Subject|1|||
130840204|NCT00847665|471042070|FG001|Overall Study|Withdrawal by Subject|0|||
130840205|NCT00585546|471042077|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
130840206|NCT00585546|471042077|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
130840207|NCT04154345|471042078|FG000|Overall Study|Covid-19 pandemic|4|||
130840208|NCT03622112|471042081|FG000|Overall Study|Withdrawal by Subject|6|||
130840209|NCT03622112|471042082|FG001|Overall Study|Withdrawal by Subject|2|||
130840210|NCT03622112|471042083|FG002|Overall Study|Withdrawal by Subject|4|||
130840211|NCT03622112|471042084|FG003|Overall Study|Withdrawal by Subject|2|||
130840212|NCT03622112|471042085|FG004|Overall Study|Withdrawal by Subject|1|||
130840213|NCT03622112|471042086|FG005|Overall Study|Withdrawal by Subject|2|||
130840214|NCT03622112|471042087|FG006|Overall Study|Withdrawal by Subject|2|||
130840215|NCT03622112|471042081|FG000|Overall Study|Death|0|||
130840216|NCT03622112|471042082|FG001|Overall Study|Death|0|||
130840217|NCT03622112|471042083|FG002|Overall Study|Death|0|||
130840218|NCT03622112|471042084|FG003|Overall Study|Death|1|||
130840219|NCT03622112|471042085|FG004|Overall Study|Death|0|||
130840220|NCT03622112|471042086|FG005|Overall Study|Death|0|||
130840221|NCT03622112|471042087|FG006|Overall Study|Death|0|||
130840222|NCT03622112|471042081|FG000|Overall Study|Lost to Follow-up|1|||
130840223|NCT03622112|471042082|FG001|Overall Study|Lost to Follow-up|1|||
130840224|NCT03622112|471042083|FG002|Overall Study|Lost to Follow-up|0|||
130840225|NCT03622112|471042084|FG003|Overall Study|Lost to Follow-up|0|||
130840226|NCT03622112|471042085|FG004|Overall Study|Lost to Follow-up|0|||
130840227|NCT03622112|471042086|FG005|Overall Study|Lost to Follow-up|0|||
130840228|NCT03622112|471042087|FG006|Overall Study|Lost to Follow-up|0|||
130840229|NCT03622112|471042081|FG000|Overall Study|Study-specific withdrawal criteria|10|||
130840230|NCT03622112|471042082|FG001|Overall Study|Study-specific withdrawal criteria|8|||
130840231|NCT03622112|471042083|FG002|Overall Study|Study-specific withdrawal criteria|7|||
130840232|NCT03622112|471042084|FG003|Overall Study|Study-specific withdrawal criteria|6|||
130840233|NCT03622112|471042085|FG004|Overall Study|Study-specific withdrawal criteria|4|||
130840234|NCT03622112|471042086|FG005|Overall Study|Study-specific withdrawal criteria|18|||
130840235|NCT03622112|471042087|FG006|Overall Study|Study-specific withdrawal criteria|4|||
130840236|NCT03622112|471042081|FG000|Overall Study|Protocol Violation|2|||
130840237|NCT03622112|471042082|FG001|Overall Study|Protocol Violation|0|||
130840238|NCT03622112|471042083|FG002|Overall Study|Protocol Violation|1|||
130840239|NCT03622112|471042084|FG003|Overall Study|Protocol Violation|1|||
130840240|NCT03622112|471042085|FG004|Overall Study|Protocol Violation|0|||
130840241|NCT03622112|471042086|FG005|Overall Study|Protocol Violation|0|||
130840242|NCT03622112|471042087|FG006|Overall Study|Protocol Violation|0|||
130840243|NCT03622112|471042081|FG000|Overall Study|Adverse Event|6|||
130840244|NCT03622112|471042082|FG001|Overall Study|Adverse Event|8|||
130840245|NCT03622112|471042083|FG002|Overall Study|Adverse Event|4|||
130840246|NCT03622112|471042084|FG003|Overall Study|Adverse Event|11|||
130840247|NCT03622112|471042085|FG004|Overall Study|Adverse Event|4|||
130840248|NCT03622112|471042086|FG005|Overall Study|Adverse Event|20|||
130840249|NCT03622112|471042087|FG006|Overall Study|Adverse Event|2|||
130840250|NCT03622112|471042081|FG000|Overall Study|Reason not specified|0|||
130840251|NCT03622112|471042082|FG001|Overall Study|Reason not specified|1|||
130840252|NCT03622112|471042083|FG002|Overall Study|Reason not specified|0|||
130840253|NCT03622112|471042084|FG003|Overall Study|Reason not specified|1|||
130840254|NCT03622112|471042085|FG004|Overall Study|Reason not specified|1|||
130840255|NCT03622112|471042086|FG005|Overall Study|Reason not specified|2|||
130840256|NCT03622112|471042087|FG006|Overall Study|Reason not specified|1|||
130840257|NCT02210689|471042088|FG000|Overall Study|Withdrawal by Subject|7|||
130840258|NCT02210689|471042089|FG001|Overall Study|Withdrawal by Subject|4|||
130840259|NCT02210689|471042090|FG002|Overall Study|Withdrawal by Subject|2|||
130840260|NCT02210689|471042088|FG000|Overall Study|Adverse Event|0|||
130840261|NCT02210689|471042089|FG001|Overall Study|Adverse Event|1|||
130840262|NCT02210689|471042090|FG002|Overall Study|Adverse Event|0|||
130840263|NCT02210689|471042088|FG000|Overall Study|Protocol Violation|1|||
130840264|NCT02210689|471042089|FG001|Overall Study|Protocol Violation|0|||
130840265|NCT02210689|471042090|FG002|Overall Study|Protocol Violation|0|||
130840266|NCT02210689|471042088|FG000|Overall Study|Lost to Follow-up|11|||
130840267|NCT02210689|471042089|FG001|Overall Study|Lost to Follow-up|9|||
130840268|NCT02210689|471042090|FG002|Overall Study|Lost to Follow-up|5|||
130840269|NCT02210689|471042088|FG000|Overall Study|Pregnancy|0|||
130840270|NCT02210689|471042089|FG001|Overall Study|Pregnancy|1|||
130840271|NCT02210689|471042090|FG002|Overall Study|Pregnancy|0|||
130840272|NCT02210689|471042088|FG000|Overall Study|Lack of Efficacy|0|||
130840273|NCT02210689|471042089|FG001|Overall Study|Lack of Efficacy|1|||
130840274|NCT02210689|471042090|FG002|Overall Study|Lack of Efficacy|5|||
130840275|NCT02210689|471042088|FG000|Overall Study|Prohibited medication|2|||
130840276|NCT02210689|471042089|FG001|Overall Study|Prohibited medication|8|||
130840277|NCT02210689|471042090|FG002|Overall Study|Prohibited medication|1|||
130840278|NCT02210689|471042088|FG000|Overall Study|Negative Nugent score at baseline|6|||
130840279|NCT02210689|471042089|FG001|Overall Study|Negative Nugent score at baseline|2|||
130840280|NCT02210689|471042090|FG002|Overall Study|Negative Nugent score at baseline|2|||
130840281|NCT02210689|471042088|FG000|Overall Study|Other|25|||
130840282|NCT02210689|471042089|FG001|Overall Study|Other|21|||
130840283|NCT02210689|471042090|FG002|Overall Study|Other|8|||
130840284|NCT00866047|471042091|FG000|Treatment Period|Progressive disease|13|||
130840285|NCT00866047|471042091|FG000|Treatment Period|Adverse Event|16|||
130840286|NCT00866047|471042091|FG000|Treatment Period|Physician Decision|14|||
130840287|NCT00866047|471042091|FG000|Treatment Period|Withdrawal by Subject|5|||
130840288|NCT00866047|471042091|FG000|Follow-up Period|Lost to Follow-up|5|||
130840289|NCT01610713|471042092|FG000|Overall Study|Adverse Event|3|||
130840290|NCT01610713|471042093|FG001|Overall Study|Adverse Event|0|||
130840291|NCT01610713|471042092|FG000|Overall Study|Lack of Efficacy|1|||
130840292|NCT01610713|471042093|FG001|Overall Study|Lack of Efficacy|0|||
130840293|NCT01610713|471042092|FG000|Overall Study|low mood and poor motivation|1|||
130840294|NCT01610713|471042093|FG001|Overall Study|low mood and poor motivation|0|||
130840295|NCT01610713|471042092|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
130840296|NCT01610713|471042093|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
130840297|NCT01610713|471042092|FG000|Overall Study|Lost to Follow-up|0|||
130840298|NCT01610713|471042093|FG001|Overall Study|Lost to Follow-up|1|||
130840299|NCT03770728|471042095|FG000|Overall Study|Adverse Event|1|||
130840300|NCT03770728|471042096|FG001|Overall Study|Adverse Event|0|||
130840301|NCT03770728|471042097|FG002|Overall Study|Adverse Event|1|||
130840302|NCT03770728|471042098|FG003|Overall Study|Adverse Event|0|||
130840303|NCT03770728|471042095|FG000|Overall Study|Poor compliance to protocol|0|||
130840304|NCT03770728|471042096|FG001|Overall Study|Poor compliance to protocol|0|||
130840305|NCT03770728|471042097|FG002|Overall Study|Poor compliance to protocol|1|||
130840306|NCT03770728|471042098|FG003|Overall Study|Poor compliance to protocol|0|||
130840307|NCT03770728|471042095|FG000|Overall Study|Withdrawal by Subject|13|||
130840308|NCT03770728|471042096|FG001|Overall Study|Withdrawal by Subject|8|||
130840309|NCT03770728|471042097|FG002|Overall Study|Withdrawal by Subject|9|||
130840310|NCT03770728|471042098|FG003|Overall Study|Withdrawal by Subject|13|||
130840311|NCT03770728|471042095|FG000|Overall Study|Other than specified|24|||
130840312|NCT03770728|471042096|FG001|Overall Study|Other than specified|23|||
130840313|NCT03770728|471042097|FG002|Overall Study|Other than specified|21|||
130840314|NCT03770728|471042098|FG003|Overall Study|Other than specified|22|||
130840315|NCT00503776|471042099|FG000|Overall Study|Withdrawal by Subject|1|||
130840316|NCT00503776|471042100|FG001|Overall Study|Withdrawal by Subject|0|||
130840317|NCT00503776|471042101|FG002|Overall Study|Withdrawal by Subject|1|||
130840318|NCT00503776|471042102|FG003|Overall Study|Withdrawal by Subject|1|||
130840319|NCT00503776|471042099|FG000|Overall Study|Physician Decision|0|||
130840320|NCT00503776|471042100|FG001|Overall Study|Physician Decision|0|||
130840321|NCT00503776|471042101|FG002|Overall Study|Physician Decision|1|||
130840322|NCT00503776|471042102|FG003|Overall Study|Physician Decision|1|||
130840323|NCT02778555|471042103|FG000|Overall Study|Withdrawal by Subject|55|||
130840324|NCT02778555|471042104|FG001|Overall Study|Withdrawal by Subject|32|||
130840325|NCT02778555|471042105|FG002|Overall Study|Withdrawal by Subject|107|||
130840326|NCT02379988|471042106|FG000|Overall Study|Not eligible|1|||
130840327|NCT00223977|471042107|FG000|Overall Study|Adverse Event|7|||
130840328|NCT00223977|471042108|FG001|Overall Study|Adverse Event|10|||
130840329|NCT00223977|471042109|FG002|Overall Study|Adverse Event|0|||
130840330|NCT00223977|471042107|FG000|Overall Study|Protocol Violation|0|||
130840331|NCT00223977|471042108|FG001|Overall Study|Protocol Violation|0|||
130840332|NCT00223977|471042109|FG002|Overall Study|Protocol Violation|1|||
130840333|NCT00223977|471042107|FG000|Overall Study|Withdrawal by Subject|1|||
130840334|NCT00223977|471042108|FG001|Overall Study|Withdrawal by Subject|1|||
130840335|NCT00223977|471042109|FG002|Overall Study|Withdrawal by Subject|2|||
130840336|NCT00223977|471042107|FG000|Overall Study|Other|1|||
130840337|NCT00223977|471042108|FG001|Overall Study|Other|0|||
130840338|NCT00223977|471042109|FG002|Overall Study|Other|0|||
130840339|NCT01534260|471042114|FG000|Overall Study|Adverse Event|1|||
130840340|NCT01534260|471042115|FG001|Overall Study|Adverse Event|8|||
130840341|NCT01534260|471042114|FG000|Overall Study|Death|2|||
130840342|NCT01534260|471042115|FG001|Overall Study|Death|0|||
130840343|NCT01534260|471042114|FG000|Overall Study|Lack of Efficacy|1|||
130840344|NCT01534260|471042115|FG001|Overall Study|Lack of Efficacy|1|||
130840345|NCT01534260|471042114|FG000|Overall Study|Withdrawal by Subject|1|||
130840346|NCT01534260|471042115|FG001|Overall Study|Withdrawal by Subject|3|||
130840347|NCT01534260|471042114|FG000|Overall Study|Disease Progression|8|||
130840348|NCT01534260|471042115|FG001|Overall Study|Disease Progression|6|||
130840349|NCT01534260|471042114|FG000|Overall Study|Physician Decision|3|||
130840350|NCT01534260|471042115|FG001|Overall Study|Physician Decision|1|||
130840351|NCT01534260|471042114|FG000|Overall Study|No treatment, per protocol|0|||
130840352|NCT01534260|471042115|FG001|Overall Study|No treatment, per protocol|1|||
130840353|NCT01639339|471042118|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
130840354|NCT01639339|471042119|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
130840355|NCT01639339|471042118|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
130840356|NCT01639339|471042119|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
130840357|NCT01639339|471042118|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
130840358|NCT01639339|471042119|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
130840359|NCT01639339|471042118|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
130840360|NCT01639339|471042119|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
130840361|NCT01639339|471042118|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
130840362|NCT01639339|471042119|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
130840363|NCT01639339|471042118|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
130840364|NCT01639339|471042119|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
130840365|NCT01639339|471042118|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
130840366|NCT01639339|471042119|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
130840367|NCT01639339|471042118|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
130840368|NCT01639339|471042119|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
130840369|NCT01639339|471042118|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
130840370|NCT01639339|471042119|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
130840371|NCT01639339|471042118|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
130840372|NCT01639339|471042119|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
130840373|NCT03022097|471042121|FG000|Overall Study|Adverse Event|3|||
130840374|NCT03022097|471042122|FG001|Overall Study|Adverse Event|4|||
130840375|NCT03022097|471042123|FG002|Overall Study|Adverse Event|1|||
130840376|NCT03022097|471042124|FG003|Overall Study|Adverse Event|3|||
130840377|NCT03022097|471042121|FG000|Overall Study|Progressive Disease|2|||
130840378|NCT03022097|471042122|FG001|Overall Study|Progressive Disease|0|||
130840379|NCT03022097|471042123|FG002|Overall Study|Progressive Disease|5|||
130840380|NCT03022097|471042124|FG003|Overall Study|Progressive Disease|2|||
130840381|NCT03022097|471042121|FG000|Overall Study|Lack of Efficacy|0|||
130840382|NCT03022097|471042122|FG001|Overall Study|Lack of Efficacy|0|||
130840383|NCT03022097|471042123|FG002|Overall Study|Lack of Efficacy|3|||
130840384|NCT03022097|471042124|FG003|Overall Study|Lack of Efficacy|3|||
130840385|NCT03022097|471042121|FG000|Overall Study|Protocol Violation|1|||
130840386|NCT03022097|471042122|FG001|Overall Study|Protocol Violation|0|||
130840387|NCT03022097|471042123|FG002|Overall Study|Protocol Violation|1|||
130840388|NCT03022097|471042124|FG003|Overall Study|Protocol Violation|0|||
130840389|NCT03022097|471042121|FG000|Overall Study|Withdrawal by Subject|11|||
130840390|NCT03022097|471042122|FG001|Overall Study|Withdrawal by Subject|13|||
130840391|NCT03022097|471042123|FG002|Overall Study|Withdrawal by Subject|15|||
130840392|NCT03022097|471042124|FG003|Overall Study|Withdrawal by Subject|21|||
130840393|NCT03022097|471042121|FG000|Overall Study|Lost to Follow-up|0|||
130840394|NCT03022097|471042122|FG001|Overall Study|Lost to Follow-up|0|||
130840395|NCT03022097|471042123|FG002|Overall Study|Lost to Follow-up|1|||
130840396|NCT03022097|471042124|FG003|Overall Study|Lost to Follow-up|1|||
130840397|NCT03022097|471042121|FG000|Overall Study|Other|4|||
130840398|NCT03022097|471042122|FG001|Overall Study|Other|1|||
130840399|NCT03022097|471042123|FG002|Overall Study|Other|6|||
130840400|NCT03022097|471042124|FG003|Overall Study|Other|4|||
130840401|NCT03022097|471042121|FG000|Overall Study|Due to COVID-19 pandemic|0|||
130840402|NCT03022097|471042122|FG001|Overall Study|Due to COVID-19 pandemic|1|||
130840403|NCT03022097|471042123|FG002|Overall Study|Due to COVID-19 pandemic|0|||
130840404|NCT03022097|471042124|FG003|Overall Study|Due to COVID-19 pandemic|0|||
130840405|NCT05593913|471042131|FG000|Overall Study|Insufficient image quality|39|||
130840406|NCT04470908|471042132|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
130840407|NCT04376684|471042133|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
130840408|NCT04376684|471042134|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
130840409|NCT04376684|471042135|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
130840410|NCT04376684|471042136|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
130840411|NCT04376684|471042133|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
130840412|NCT04376684|471042134|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
130840413|NCT04376684|471042135|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
130840414|NCT04376684|471042136|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
130840415|NCT04376684|471042133|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
130840416|NCT04376684|471042134|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
130840417|NCT04376684|471042135|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
130840418|NCT04376684|471042136|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
130840419|NCT04376684|471042133|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
130840420|NCT04376684|471042134|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
130840421|NCT04376684|471042135|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
130840422|NCT04376684|471042136|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
130840423|NCT04376684|471042133|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
130840424|NCT04376684|471042134|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
130840425|NCT04376684|471042135|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
130840426|NCT04376684|471042136|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
130840427|NCT04376684|471042133|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
130840428|NCT04376684|471042134|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
130840429|NCT04376684|471042135|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
130840430|NCT04376684|471042136|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
130840431|NCT04376684|471042133|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
130840432|NCT04376684|471042134|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
130840433|NCT04376684|471042135|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
130840434|NCT04376684|471042136|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
130840435|NCT02979093|471042139|FG000|First Scan Session|Scanning data problems|1|||
130840436|NCT02979093|471042140|FG001|First Scan Session|Scanning data problems|2|||
130840437|NCT02979093|471042141|FG002|First Scan Session|Scanning data problems|2|||
130840438|NCT02979093|471042142|FG003|First Scan Session|Scanning data problems|0|||
130840439|NCT02979093|471042139|FG000|Second Scan Session|Scanning data problems|3|||
130840440|NCT02979093|471042140|FG001|Second Scan Session|Scanning data problems|0|||
130840441|NCT02979093|471042141|FG002|Second Scan Session|Scanning data problems|1|||
130840442|NCT02979093|471042142|FG003|Second Scan Session|Scanning data problems|3|||
130840443|NCT02684058|471042145|FG000|Treatment Period|Progressive disease|4|||
130840444|NCT02684058|471042146|FG001|Treatment Period|Progressive disease|10|||
130840445|NCT02684058|471042147|FG002|Treatment Period|Progressive disease|19|||
130840446|NCT02684058|471042145|FG000|Treatment Period|Adverse Event|3|||
130840447|NCT02684058|471042146|FG001|Treatment Period|Adverse Event|8|||
130840448|NCT02684058|471042147|FG002|Treatment Period|Adverse Event|1|||
130840449|NCT02684058|471042145|FG000|Treatment Period|Physician Decision|5|||
130840450|NCT02684058|471042146|FG001|Treatment Period|Physician Decision|1|||
130840451|NCT02684058|471042147|FG002|Treatment Period|Physician Decision|2|||
130840452|NCT02684058|471042145|FG000|Treatment Period|New therapy for study indication|1|||
130840453|NCT02684058|471042146|FG001|Treatment Period|New therapy for study indication|0|||
130840454|NCT02684058|471042147|FG002|Treatment Period|New therapy for study indication|0|||
130840455|NCT02684058|471042145|FG000|Treatment Period|Protocol deviation|0|||
130840456|NCT02684058|471042146|FG001|Treatment Period|Protocol deviation|1|||
130840457|NCT02684058|471042147|FG002|Treatment Period|Protocol deviation|0|||
130840458|NCT02684058|471042145|FG000|Treatment Period|Subject/guardian decision|4|||
130840459|NCT02684058|471042146|FG001|Treatment Period|Subject/guardian decision|3|||
130840460|NCT02684058|471042147|FG002|Treatment Period|Subject/guardian decision|0|||
130840461|NCT02684058|471042145|FG000|Treatment Period|Death|0|||
130840462|NCT02684058|471042146|FG001|Treatment Period|Death|0|||
130840463|NCT02684058|471042147|FG002|Treatment Period|Death|2|||
130840464|NCT02684058|471042145|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130840465|NCT02684058|471042146|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
130840466|NCT02684058|471042147|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
130840467|NCT02684058|471042145|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
130840468|NCT02684058|471042146|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
130840469|NCT02684058|471042147|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
130840470|NCT02684058|471042145|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130840471|NCT02684058|471042146|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130840472|NCT02684058|471042147|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
130840473|NCT02684058|471042145|FG000|Post-treatment Efficacy Follow-up|Death|0|||
130840474|NCT02684058|471042146|FG001|Post-treatment Efficacy Follow-up|Death|0|||
130840475|NCT02684058|471042147|FG002|Post-treatment Efficacy Follow-up|Death|3|||
130840476|NCT02684058|471042145|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
130840477|NCT02684058|471042146|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
130840478|NCT02684058|471042147|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
130840479|NCT02684058|471042145|FG000|Post-treatment Survival Follow-up|Death|0|||
130840480|NCT02684058|471042146|FG001|Post-treatment Survival Follow-up|Death|0|||
130840481|NCT02684058|471042147|FG002|Post-treatment Survival Follow-up|Death|7|||
130840482|NCT02684058|471042145|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
130840483|NCT02684058|471042146|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
130840484|NCT02684058|471042147|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
130840485|NCT02684058|471042145|FG000|Crossover Treatment Period|Progressive disease|0|||
130840486|NCT02684058|471042146|FG001|Crossover Treatment Period|Progressive disease|1|||
130840487|NCT02684058|471042147|FG002|Crossover Treatment Period|Progressive disease|0|||
130840488|NCT02136680|471042149|FG000|Overall Study|No Longer Interested|1|||
130840489|NCT02136680|471042150|FG001|Overall Study|No Longer Interested|1|||
130840490|NCT02136680|471042149|FG000|Overall Study|No longer receiving care at clinic|3|||
130840491|NCT02136680|471042150|FG001|Overall Study|No longer receiving care at clinic|5|||
130840492|NCT02136680|471042149|FG000|Overall Study|Moved away|5|||
130840493|NCT02136680|471042150|FG001|Overall Study|Moved away|4|||
130840494|NCT02136680|471042149|FG000|Overall Study|Unable to schedule|17|||
130840495|NCT02136680|471042150|FG001|Overall Study|Unable to schedule|16|||
130840496|NCT02136680|471042149|FG000|Overall Study|Study ended before interview due|6|||
130840497|NCT02136680|471042150|FG001|Overall Study|Study ended before interview due|3|||
130840498|NCT05151445|471042151|FG000|Overall Study|Withdrawal by Subject|3|||
130840499|NCT01457014|471042152|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
130840500|NCT01457014|471042153|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
130840501|NCT01457014|471042154|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
130840502|NCT01457014|471042155|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
130840503|NCT01457014|471042152|FG000|First Night|Withdrawal by Subject|3|||
130840504|NCT01457014|471042153|FG001|First Night|Withdrawal by Subject|0|||
130840505|NCT01457014|471042154|FG002|First Night|Withdrawal by Subject|0|||
130840506|NCT01457014|471042155|FG003|First Night|Withdrawal by Subject|0|||
130840507|NCT05463744|471042156|FG000|Treatment Period|Withdrawal by Subject|19|||
130840508|NCT05463744|471042157|FG001|Treatment Period|Withdrawal by Subject|16|||
130840509|NCT05463744|471042156|FG000|Treatment Period|Adverse Event|4|||
130840510|NCT05463744|471042157|FG001|Treatment Period|Adverse Event|4|||
130840511|NCT05463744|471042156|FG000|Treatment Period|Pregnancy|0|||
130840512|NCT05463744|471042157|FG001|Treatment Period|Pregnancy|3|||
130840513|NCT05463744|471042156|FG000|Treatment Period|Lost to Follow-up|1|||
130840514|NCT05463744|471042157|FG001|Treatment Period|Lost to Follow-up|3|||
130840515|NCT05463744|471042156|FG000|Treatment Period|Inadvertent enrollment|2|||
130840516|NCT05463744|471042157|FG001|Treatment Period|Inadvertent enrollment|1|||
130840517|NCT05463744|471042156|FG000|Treatment Period|Death|0|||
130840518|NCT05463744|471042157|FG001|Treatment Period|Death|1|||
130840519|NCT05463744|471042156|FG000|Treatment Period|Non-compliance with Study Drug|1|||
130840520|NCT05463744|471042157|FG001|Treatment Period|Non-compliance with Study Drug|0|||
130840521|NCT05463744|471042156|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
130840522|NCT05463744|471042157|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
130840523|NCT05463744|471042156|FG000|Treatment Period|Physician Decision|0|||
130840524|NCT05463744|471042157|FG001|Treatment Period|Physician Decision|1|||
130840525|NCT05463744|471042156|FG000|Follow-Up Period|Withdrawal by Subject|3|||
130840526|NCT05463744|471042157|FG001|Follow-Up Period|Withdrawal by Subject|1|||
130840527|NCT05463744|471042156|FG000|Follow-Up Period|Lost to Follow-up|1|||
130840528|NCT05463744|471042157|FG001|Follow-Up Period|Lost to Follow-up|1|||
130840529|NCT02825420|471042160|FG000|Overall Study|Death|30|||
130840530|NCT02825420|471042161|FG001|Overall Study|Death|12|||
130840531|NCT02825420|471042160|FG000|Overall Study|Progressive disease|6|||
130840532|NCT02825420|471042161|FG001|Overall Study|Progressive disease|1|||
130840533|NCT02825420|471042160|FG000|Overall Study|Lost to Follow-up|2|||
130840534|NCT02825420|471042161|FG001|Overall Study|Lost to Follow-up|2|||
130840535|NCT02825420|471042160|FG000|Overall Study|Withdrawal by Subject|1|||
130840536|NCT02825420|471042161|FG001|Overall Study|Withdrawal by Subject|1|||
130840537|NCT02825420|471042160|FG000|Overall Study|Protocol amendment not signed|1|||
130840538|NCT02825420|471042161|FG001|Overall Study|Protocol amendment not signed|1|||
130840539|NCT02825420|471042160|FG000|Overall Study|Physician Decision|1|||
130840540|NCT02825420|471042161|FG001|Overall Study|Physician Decision|0|||
130840541|NCT02825420|471042160|FG000|Overall Study|Did not receive PLD|2|||
130840542|NCT02825420|471042161|FG001|Overall Study|Did not receive PLD|0|||
130840543|NCT04027049|471042162|FG000|Overall Study|Withdrawn by family|1|||
130840544|NCT04027049|471042163|FG001|Overall Study|Withdrawn by family|0|||
130840545|NCT04027049|471042162|FG000|Overall Study|Participant safety|1|||
130840546|NCT04027049|471042163|FG001|Overall Study|Participant safety|0|||
130840547|NCT02264665|471043873|FG000|Overall Study|Other|0|||
130840548|NCT02264665|471043874|FG001|Overall Study|Other|0|||
130840549|NCT02264665|471043875|FG002|Overall Study|Other|3|||
130840550|NCT02264665|471043876|FG003|Overall Study|Other|0|||
130840551|NCT02264665|471043877|FG004|Overall Study|Other|0|||
130840552|NCT02264665|471043878|FG005|Overall Study|Other|0|||
130840553|NCT02264665|471043879|FG006|Overall Study|Other|0|||
130840554|NCT02264665|471043873|FG000|Overall Study|Death|9|||
130840555|NCT02264665|471043874|FG001|Overall Study|Death|8|||
130840556|NCT02264665|471043875|FG002|Overall Study|Death|13|||
130840557|NCT02264665|471043876|FG003|Overall Study|Death|5|||
130840558|NCT02264665|471043877|FG004|Overall Study|Death|0|||
130840559|NCT02264665|471043878|FG005|Overall Study|Death|0|||
130840560|NCT02264665|471043879|FG006|Overall Study|Death|1|||
130840561|NCT02264665|471043873|FG000|Overall Study|Lost to Follow-up|1|||
130840562|NCT02264665|471043874|FG001|Overall Study|Lost to Follow-up|0|||
130840563|NCT02264665|471043875|FG002|Overall Study|Lost to Follow-up|2|||
130840564|NCT02264665|471043876|FG003|Overall Study|Lost to Follow-up|1|||
130840565|NCT02264665|471043877|FG004|Overall Study|Lost to Follow-up|0|||
130840566|NCT02264665|471043878|FG005|Overall Study|Lost to Follow-up|0|||
130840567|NCT02264665|471043879|FG006|Overall Study|Lost to Follow-up|0|||
130840568|NCT02264665|471043873|FG000|Overall Study|Participant decision|0|||
130840569|NCT02264665|471043874|FG001|Overall Study|Participant decision|0|||
130840570|NCT02264665|471043875|FG002|Overall Study|Participant decision|0|||
130840571|NCT02264665|471043876|FG003|Overall Study|Participant decision|1|||
130840572|NCT02264665|471043877|FG004|Overall Study|Participant decision|0|||
130840573|NCT02264665|471043878|FG005|Overall Study|Participant decision|0|||
130840574|NCT02264665|471043879|FG006|Overall Study|Participant decision|0|||
130840575|NCT02264665|471043873|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
130840576|NCT02264665|471043874|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
130840577|NCT02264665|471043875|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
130840578|NCT02264665|471043876|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
130840579|NCT02264665|471043877|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
130840580|NCT02264665|471043878|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
130840581|NCT02264665|471043879|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
130840582|NCT02264665|471043873|FG000|Overall Study|Data Missing|0|||
130840583|NCT02264665|471043874|FG001|Overall Study|Data Missing|0|||
130840584|NCT02264665|471043875|FG002|Overall Study|Data Missing|1|||
130840585|NCT02264665|471043876|FG003|Overall Study|Data Missing|0|||
130840586|NCT02264665|471043877|FG004|Overall Study|Data Missing|0|||
130840587|NCT02264665|471043878|FG005|Overall Study|Data Missing|0|||
130840588|NCT02264665|471043879|FG006|Overall Study|Data Missing|0|||
130840589|NCT00789581|471043885|FG000|AC Therapy|Adverse Event|2|||
130840590|NCT00789581|471043886|FG001|AC Therapy|Adverse Event|3|||
130840591|NCT00789581|471043885|FG000|AC Therapy|Withdrawal by Subject|4|||
130840592|NCT00789581|471043886|FG001|AC Therapy|Withdrawal by Subject|7|||
130840593|NCT00789581|471043885|FG000|AC Therapy|Disease recurrence|3|||
130840594|NCT00789581|471043886|FG001|AC Therapy|Disease recurrence|1|||
130840595|NCT00789581|471043885|FG000|AC Therapy|Intercurrent Illness|1|||
130840596|NCT00789581|471043886|FG001|AC Therapy|Intercurrent Illness|0|||
130840597|NCT00789581|471043885|FG000|AC Therapy|Never Treated|1|||
130840598|NCT00789581|471043886|FG001|AC Therapy|Never Treated|4|||
130840599|NCT00789581|471043885|FG000|AC Therapy|Other|0|||
130840600|NCT00789581|471043886|FG001|AC Therapy|Other|2|||
130840601|NCT00789581|471043885|FG000|Adjuvant Therapy|Never treated|2|||
130840602|NCT00789581|471043886|FG001|Adjuvant Therapy|Never treated|2|||
130840603|NCT00789581|471043885|FG000|Adjuvant Therapy|Adverse Event|20|||
130840604|NCT00789581|471043886|FG001|Adjuvant Therapy|Adverse Event|44|||
130840605|NCT00789581|471043885|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
130840606|NCT00789581|471043886|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
130840607|NCT00789581|471043885|FG000|Adjuvant Therapy|Disease recurrence|2|||
130840608|NCT00789581|471043886|FG001|Adjuvant Therapy|Disease recurrence|1|||
130840609|NCT00789581|471043885|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
130840610|NCT00789581|471043886|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
130840611|NCT00789581|471043885|FG000|Adjuvant Therapy|Protocol Violation|1|||
130840612|NCT00789581|471043886|FG001|Adjuvant Therapy|Protocol Violation|1|||
130840613|NCT00789581|471043885|FG000|Adjuvant Therapy|Other|0|||
130840614|NCT00789581|471043886|FG001|Adjuvant Therapy|Other|1|||
130840615|NCT01468207|471043887|FG000|Treatment Period 1|Adverse Event|1|||
130840616|NCT01468207|471043888|FG001|Treatment Period 1|Adverse Event|0|||
130840617|NCT01468207|471043889|FG002|Treatment Period 1|Adverse Event|0|||
130840618|NCT01468207|471043890|FG003|Treatment Period 1|Adverse Event|0|||
130840619|NCT01468207|471043891|FG004|Treatment Period 1|Adverse Event|0|||
130840620|NCT01468207|471043892|FG005|Treatment Period 1|Adverse Event|0|||
130840621|NCT01468207|471043887|FG000|Treatment Period 1|Protocol Violation|1|||
130840622|NCT01468207|471043888|FG001|Treatment Period 1|Protocol Violation|1|||
130840623|NCT01468207|471043889|FG002|Treatment Period 1|Protocol Violation|0|||
130840624|NCT01468207|471043890|FG003|Treatment Period 1|Protocol Violation|0|||
130840625|NCT01468207|471043891|FG004|Treatment Period 1|Protocol Violation|0|||
130840626|NCT01468207|471043892|FG005|Treatment Period 1|Protocol Violation|0|||
130840627|NCT01468207|471043887|FG000|Treatment Period 1|Withdrawal by Subject|5|||
130840628|NCT01468207|471043888|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130840629|NCT01468207|471043889|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130840630|NCT01468207|471043890|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130840631|NCT01468207|471043891|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130840632|NCT01468207|471043892|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130840633|NCT01468207|471043887|FG000|Treatment Period 1|Lost to Follow-up|2|||
130840634|NCT01468207|471043888|FG001|Treatment Period 1|Lost to Follow-up|1|||
130840635|NCT01468207|471043889|FG002|Treatment Period 1|Lost to Follow-up|0|||
130840636|NCT01468207|471043890|FG003|Treatment Period 1|Lost to Follow-up|0|||
130840637|NCT01468207|471043891|FG004|Treatment Period 1|Lost to Follow-up|0|||
130840638|NCT01468207|471043892|FG005|Treatment Period 1|Lost to Follow-up|0|||
130840639|NCT01468207|471043887|FG000|Treatment Period 1|Other|0|||
130840640|NCT01468207|471043888|FG001|Treatment Period 1|Other|2|||
130840641|NCT01468207|471043889|FG002|Treatment Period 1|Other|0|||
130840642|NCT01468207|471043890|FG003|Treatment Period 1|Other|0|||
130840643|NCT01468207|471043891|FG004|Treatment Period 1|Other|0|||
130840644|NCT01468207|471043892|FG005|Treatment Period 1|Other|0|||
130840645|NCT01468207|471043887|FG000|Treatment Period 2|Adverse Event|0|||
130840646|NCT01468207|471043888|FG001|Treatment Period 2|Adverse Event|0|||
130840647|NCT01468207|471043889|FG002|Treatment Period 2|Adverse Event|6|||
130840648|NCT01468207|471043890|FG003|Treatment Period 2|Adverse Event|1|||
130840649|NCT01468207|471043891|FG004|Treatment Period 2|Adverse Event|2|||
130840650|NCT01468207|471043892|FG005|Treatment Period 2|Adverse Event|1|||
130840651|NCT01468207|471043887|FG000|Treatment Period 2|Lack of Efficacy|0|||
130840652|NCT01468207|471043888|FG001|Treatment Period 2|Lack of Efficacy|0|||
130840653|NCT01468207|471043889|FG002|Treatment Period 2|Lack of Efficacy|1|||
130840654|NCT01468207|471043890|FG003|Treatment Period 2|Lack of Efficacy|1|||
130840655|NCT01468207|471043891|FG004|Treatment Period 2|Lack of Efficacy|0|||
130840656|NCT01468207|471043892|FG005|Treatment Period 2|Lack of Efficacy|2|||
130840657|NCT01468207|471043887|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130840658|NCT01468207|471043888|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130840659|NCT01468207|471043889|FG002|Treatment Period 2|Withdrawal by Subject|5|||
130840660|NCT01468207|471043890|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130840661|NCT01468207|471043891|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130840662|NCT01468207|471043892|FG005|Treatment Period 2|Withdrawal by Subject|2|||
130840663|NCT01468207|471043887|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
130840664|NCT01468207|471043888|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
130840665|NCT01468207|471043889|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
130840666|NCT01468207|471043890|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
130840667|NCT01468207|471043891|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
130840668|NCT01468207|471043892|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
130840669|NCT01468207|471043887|FG000|Treatment Period 2|Lost to Follow-up|0|||
130840670|NCT01468207|471043888|FG001|Treatment Period 2|Lost to Follow-up|0|||
130840671|NCT01468207|471043889|FG002|Treatment Period 2|Lost to Follow-up|5|||
130840672|NCT01468207|471043890|FG003|Treatment Period 2|Lost to Follow-up|1|||
130840673|NCT01468207|471043891|FG004|Treatment Period 2|Lost to Follow-up|0|||
130840674|NCT01468207|471043892|FG005|Treatment Period 2|Lost to Follow-up|0|||
130840675|NCT01468207|471043887|FG000|Treatment Period 2|Other|0|||
130840676|NCT01468207|471043888|FG001|Treatment Period 2|Other|0|||
130840677|NCT01468207|471043889|FG002|Treatment Period 2|Other|5|||
130840678|NCT01468207|471043890|FG003|Treatment Period 2|Other|1|||
130840679|NCT01468207|471043891|FG004|Treatment Period 2|Other|1|||
130840680|NCT01468207|471043892|FG005|Treatment Period 2|Other|2|||
130840681|NCT00539513|471043895|FG000|Overall Study|Withdrawal by Subject|2|||
130840682|NCT00539513|471043896|FG001|Overall Study|Withdrawal by Subject|1|||
130840683|NCT00539513|471043895|FG000|Overall Study|Lost to Follow-up|0|||
130840684|NCT00539513|471043896|FG001|Overall Study|Lost to Follow-up|1|||
130840685|NCT01328041|471043897|FG000|Overall Study|Adverse Event|7|||
130840686|NCT01328041|471043897|FG000|Overall Study|Lack of Efficacy|27|||
130840687|NCT01328041|471043897|FG000|Overall Study|Protocol Violation|7|||
130840688|NCT01328041|471043897|FG000|Overall Study|Lost to Follow-up|7|||
130840689|NCT01328041|471043897|FG000|Overall Study|Physician Decision|2|||
130840690|NCT01328041|471043897|FG000|Overall Study|Withdrawal by Subject|7|||
130840691|NCT02688088|471043901|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130840692|NCT02688088|471043902|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
130840693|NCT02688088|471043903|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130840694|NCT02688088|471043904|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130840695|NCT02688088|471043905|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130840696|NCT02688088|471043901|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130840697|NCT02688088|471043902|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
130840698|NCT02688088|471043903|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130840699|NCT02688088|471043904|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130840700|NCT02688088|471043905|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130840701|NCT02688088|471043901|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130840702|NCT02688088|471043902|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
130840703|NCT02688088|471043903|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130840704|NCT02688088|471043904|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130840705|NCT02688088|471043905|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130840706|NCT02688088|471043901|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130840707|NCT02688088|471043902|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
130840708|NCT02688088|471043903|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130840709|NCT02688088|471043904|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130840710|NCT02688088|471043905|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130840711|NCT02688088|471043901|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130840712|NCT02688088|471043902|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130840713|NCT02688088|471043903|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
130840714|NCT02688088|471043904|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130840715|NCT02688088|471043905|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130840716|NCT02688088|471043901|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130840717|NCT02688088|471043902|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130840718|NCT02688088|471043903|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
130840719|NCT02688088|471043904|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130840720|NCT02688088|471043905|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130840721|NCT02688088|471043901|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130840722|NCT02688088|471043902|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130840723|NCT02688088|471043903|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130840724|NCT02688088|471043904|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
130840725|NCT02688088|471043905|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130840726|NCT02688088|471043901|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130840727|NCT02688088|471043902|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130840728|NCT02688088|471043903|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130840729|NCT02688088|471043904|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
130840730|NCT02688088|471043905|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130840731|NCT02688088|471043901|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130840732|NCT02688088|471043902|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130840733|NCT02688088|471043903|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130840734|NCT02688088|471043904|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130840735|NCT02688088|471043905|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
130840736|NCT04021524|471043908|FG000|Overall Study|Change in surgical intervention|0|||
130840737|NCT04021524|471043909|FG001|Overall Study|Change in surgical intervention|1|||
130840738|NCT05275010|471043910|FG000|Overall Study|Reason Not Specified|4|||
130840739|NCT05275010|471043911|FG001|Overall Study|Reason Not Specified|1|||
130840740|NCT05275010|471043910|FG000|Overall Study|Withdrawal by Subject|1|||
130840741|NCT05275010|471043911|FG001|Overall Study|Withdrawal by Subject|0|||
130840742|NCT05275010|471043910|FG000|Overall Study|Lost to Follow-up|0|||
130840743|NCT05275010|471043911|FG001|Overall Study|Lost to Follow-up|1|||
130840744|NCT00730041|471043912|FG000|Overall Study|Lost to Follow-up|0|||
130840745|NCT00730041|471043913|FG001|Overall Study|Lost to Follow-up|2|||
130840746|NCT05526781|471043914|FG000|Overall Study|Lost to Follow-up|1|||
130840747|NCT01921218|471043915|FG000|Overall Study|Death|2|||
130840748|NCT01921218|471043916|FG001|Overall Study|Death|1|||
130840749|NCT01921218|471043915|FG000|Overall Study|Withdrawal by Subject|0|||
130840750|NCT01921218|471043916|FG001|Overall Study|Withdrawal by Subject|2|||
130840751|NCT01921218|471043915|FG000|Overall Study|Kidney transplant|1|||
130840752|NCT01921218|471043916|FG001|Overall Study|Kidney transplant|1|||
130840753|NCT02449889|471043917|FG000|Overall Study|Adverse Event|1|||
130840754|NCT02449889|471043918|FG001|Overall Study|Adverse Event|2|||
130840755|NCT02449889|471043919|FG002|Overall Study|Adverse Event|0|||
130840756|NCT02449889|471043917|FG000|Overall Study|Protocol Violation|0|||
130840757|NCT02449889|471043918|FG001|Overall Study|Protocol Violation|4|||
130840758|NCT02449889|471043919|FG002|Overall Study|Protocol Violation|1|||
130840759|NCT03327220|471043920|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
130840760|NCT03327220|471043921|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
130840761|NCT03327220|471043920|FG000|Overall Study|Investigator Decision|2|||
130840762|NCT03327220|471043921|FG001|Overall Study|Investigator Decision|0|||
130840763|NCT03327220|471043920|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
130840764|NCT03327220|471043921|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
130840765|NCT03327220|471043920|FG000|Overall Study|Fungal infection|1|||
130840766|NCT03327220|471043921|FG001|Overall Study|Fungal infection|0|||
130840767|NCT03327220|471043920|FG000|Overall Study|Discharged to Rehabilitation|0|||
130840768|NCT03327220|471043921|FG001|Overall Study|Discharged to Rehabilitation|1|||
130840769|NCT03327220|471043920|FG000|Overall Study|Missing|1|||
130840770|NCT03327220|471043921|FG001|Overall Study|Missing|0|||
130840771|NCT00368836|471043924|FG000|Phase II|Screen Failure|1|||
130840772|NCT00368836|471043924|FG000|Phase II|Withdrawal by Subject|1|||
130840773|NCT00368836|471043924|FG000|Phase II|unable to collect blood and/or breath|17|||
130840774|NCT00368836|471043924|FG000|Phase II|Protocol Violation|2|||
130840775|NCT00693017|471043925|FG000|Overall Study|Sponsor Decision|2|||
130840776|NCT00693017|471043926|FG001|Overall Study|Sponsor Decision|1|||
130840777|NCT00693017|471043925|FG000|Overall Study|Death|0|||
130840778|NCT00693017|471043926|FG001|Overall Study|Death|1|||
130840779|NCT01082874|471043928|FG000|Overall Study|Lost to Follow-up|10|||
130840780|NCT01082874|471043929|FG001|Overall Study|Lost to Follow-up|10|||
130840781|NCT01082874|471043930|FG002|Overall Study|Lost to Follow-up|6|||
130840782|NCT01082874|471043931|FG003|Overall Study|Lost to Follow-up|10|||
130840783|NCT01082874|471043928|FG000|Overall Study|Withdrawal by Subject|1|||
130840784|NCT01082874|471043929|FG001|Overall Study|Withdrawal by Subject|2|||
130840785|NCT01082874|471043930|FG002|Overall Study|Withdrawal by Subject|5|||
130840786|NCT01082874|471043931|FG003|Overall Study|Withdrawal by Subject|3|||
130840787|NCT00090142|471043932|FG000|Treatment Period I|Lost to Follow-up|1|||
130840788|NCT00090142|471043933|FG001|Treatment Period I|Lost to Follow-up|2|||
130840789|NCT00090142|471043932|FG000|Treatment Period I|Protocol Violation|2|||
130840790|NCT00090142|471043933|FG001|Treatment Period I|Protocol Violation|0|||
130840791|NCT00090142|471043932|FG000|Treatment Period I|Withdrawal by Subject|2|||
130840792|NCT00090142|471043933|FG001|Treatment Period I|Withdrawal by Subject|0|||
130840793|NCT00090142|471043932|FG000|Treatment Period I|Other|0|||
130840794|NCT00090142|471043933|FG001|Treatment Period I|Other|1|||
130840795|NCT00090142|471043932|FG000|Treatment Period II|Other|1|||
130840796|NCT00090142|471043933|FG001|Treatment Period II|Other|0|||
130840797|NCT00113399|471043945|FG000|Overall Study|Death|1|||
130840798|NCT00113399|471043946|FG001|Overall Study|Death|1|||
130840799|NCT00113399|471043945|FG000|Overall Study|Withdrawal by Subject|1|||
130840800|NCT00113399|471043946|FG001|Overall Study|Withdrawal by Subject|2|||
130840801|NCT00113399|471043945|FG000|Overall Study|Complete Response|0|||
130840802|NCT00113399|471043946|FG001|Overall Study|Complete Response|1|||
130840803|NCT00113399|471043945|FG000|Overall Study|Other|0|||
130840804|NCT00113399|471043946|FG001|Overall Study|Other|1|||
130840805|NCT01779856|471043948|FG000|Overall Study|Withdrawal by Subject|15|||
130840806|NCT01779856|471043948|FG000|Overall Study|Death|3|||
130840807|NCT01779856|471043948|FG000|Overall Study|Physician Decision|1|||
130840808|NCT01779856|471043948|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
130840809|NCT01779856|471043948|FG000|Overall Study|Delays in scheduling implant|1|||
130840810|NCT01779856|471043948|FG000|Overall Study|Subject ineligible for Implant|2|||
130840811|NCT01535599|471043949|FG000|Overall Study|Adverse Event|6|||
130840812|NCT01535599|471043950|FG001|Overall Study|Adverse Event|15|||
130840813|NCT01535599|471043949|FG000|Overall Study|Lost to Follow-up|3|||
130840814|NCT01535599|471043950|FG001|Overall Study|Lost to Follow-up|4|||
130840815|NCT01535599|471043949|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
130840816|NCT01535599|471043950|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
130840817|NCT01535599|471043949|FG000|Overall Study|Treatment Failure|33|||
130840818|NCT01535599|471043950|FG001|Overall Study|Treatment Failure|66|||
130840819|NCT01535599|471043949|FG000|Overall Study|BL Culture + for Group A Strep|0|||
130840820|NCT01535599|471043950|FG001|Overall Study|BL Culture + for Group A Strep|1|||
130840821|NCT01535599|471043949|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
130840822|NCT01535599|471043950|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
130840823|NCT01535599|471043949|FG000|Overall Study|Randomized in Error|2|||
130840824|NCT01535599|471043950|FG001|Overall Study|Randomized in Error|4|||
130840825|NCT01535599|471043949|FG000|Overall Study|Did not use product|1|||
130840826|NCT01535599|471043950|FG001|Overall Study|Did not use product|0|||
130840827|NCT01535599|471043949|FG000|Overall Study|Other|1|||
130840828|NCT01535599|471043950|FG001|Overall Study|Other|0|||
130840829|NCT01535599|471043949|FG000|Overall Study|Stopped medication|0|||
130840830|NCT01535599|471043950|FG001|Overall Study|Stopped medication|1|||
130840831|NCT01535599|471043949|FG000|Overall Study|Noncompliance|0|||
130840832|NCT01535599|471043950|FG001|Overall Study|Noncompliance|1|||
130840833|NCT04043234|471043951|FG000|Overall Study|Lost to Follow-up|1|||
130840834|NCT04043234|471043951|FG000|Overall Study|Withdrawal by Subject|1|||
130840835|NCT01694121|471043956|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
130840836|NCT01694121|471043957|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
130840837|NCT00521599|471043958|FG000|Overall Study|Adverse Event|5|||
130840838|NCT00521599|471043959|FG001|Overall Study|Adverse Event|7|||
130840839|NCT00521599|471043960|FG002|Overall Study|Adverse Event|6|||
130840840|NCT00521599|471043958|FG000|Overall Study|Treatment Failure|8|||
130840841|NCT00521599|471043959|FG001|Overall Study|Treatment Failure|9|||
130840842|NCT00521599|471043960|FG002|Overall Study|Treatment Failure|22|||
130840843|NCT00521599|471043958|FG000|Overall Study|Lost to Follow-up|2|||
130840844|NCT00521599|471043959|FG001|Overall Study|Lost to Follow-up|1|||
130840845|NCT00521599|471043960|FG002|Overall Study|Lost to Follow-up|2|||
130840846|NCT00521599|471043958|FG000|Overall Study|Withdrawal by Subject|3|||
130840847|NCT00521599|471043959|FG001|Overall Study|Withdrawal by Subject|5|||
130840848|NCT00521599|471043960|FG002|Overall Study|Withdrawal by Subject|1|||
130840849|NCT00521599|471043958|FG000|Overall Study|Withdrawal by subject treatment related|3|||
130840850|NCT00521599|471043959|FG001|Overall Study|Withdrawal by subject treatment related|1|||
130840851|NCT00521599|471043960|FG002|Overall Study|Withdrawal by subject treatment related|2|||
130840852|NCT00521599|471043958|FG000|Overall Study|Protocol Violation|2|||
130840853|NCT00521599|471043959|FG001|Overall Study|Protocol Violation|4|||
130840854|NCT00521599|471043960|FG002|Overall Study|Protocol Violation|2|||
130840855|NCT00521599|471043958|FG000|Overall Study|Did not meet protocol eligibility|2|||
130840856|NCT00521599|471043959|FG001|Overall Study|Did not meet protocol eligibility|2|||
130840857|NCT00521599|471043960|FG002|Overall Study|Did not meet protocol eligibility|1|||
130840858|NCT01778049|471043961|FG000|Open Label Treatment Period|Adverse Event|5|||
130840859|NCT01778049|471043962|FG001|Open Label Treatment Period|Adverse Event|15|||
130840860|NCT01778049|471043963|FG002|Open Label Treatment Period|Adverse Event|0|||
130840861|NCT01778049|471043964|FG003|Open Label Treatment Period|Adverse Event|0|||
130840862|NCT01778049|471043965|FG004|Open Label Treatment Period|Adverse Event|0|||
130840863|NCT01778049|471043966|FG005|Open Label Treatment Period|Adverse Event|0|||
130840864|NCT01778049|471043961|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
130840865|NCT01778049|471043962|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
130840866|NCT01778049|471043963|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
130840867|NCT01778049|471043964|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
130840868|NCT01778049|471043965|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
130840869|NCT01778049|471043966|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
130840870|NCT01778049|471043961|FG000|Open Label Treatment Period|Protocol Violation|5|||
130840871|NCT01778049|471043962|FG001|Open Label Treatment Period|Protocol Violation|5|||
130840872|NCT01778049|471043963|FG002|Open Label Treatment Period|Protocol Violation|0|||
130840873|NCT01778049|471043964|FG003|Open Label Treatment Period|Protocol Violation|0|||
130840874|NCT01778049|471043965|FG004|Open Label Treatment Period|Protocol Violation|0|||
130840875|NCT01778049|471043966|FG005|Open Label Treatment Period|Protocol Violation|0|||
130840876|NCT01778049|471043961|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
130840877|NCT01778049|471043962|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
130840878|NCT01778049|471043963|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
130840879|NCT01778049|471043964|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
130840880|NCT01778049|471043965|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
130840881|NCT01778049|471043966|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
130840882|NCT01778049|471043961|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
130840883|NCT01778049|471043962|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
130840884|NCT01778049|471043963|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
130840885|NCT01778049|471043964|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
130840886|NCT01778049|471043965|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
130840887|NCT01778049|471043966|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
130840888|NCT01778049|471043961|FG000|Open Label Treatment Period|Not treated|2|||
130840889|NCT01778049|471043962|FG001|Open Label Treatment Period|Not treated|1|||
130840890|NCT01778049|471043963|FG002|Open Label Treatment Period|Not treated|0|||
130840891|NCT01778049|471043964|FG003|Open Label Treatment Period|Not treated|0|||
130840892|NCT01778049|471043965|FG004|Open Label Treatment Period|Not treated|0|||
130840893|NCT01778049|471043966|FG005|Open Label Treatment Period|Not treated|0|||
130840894|NCT01778049|471043961|FG000|Open Label Treatment Period|Other reason not defined above|77|||
130840895|NCT01778049|471043962|FG001|Open Label Treatment Period|Other reason not defined above|94|||
130840896|NCT01778049|471043963|FG002|Open Label Treatment Period|Other reason not defined above|0|||
130840897|NCT01778049|471043964|FG003|Open Label Treatment Period|Other reason not defined above|0|||
130840898|NCT01778049|471043965|FG004|Open Label Treatment Period|Other reason not defined above|0|||
130840899|NCT01778049|471043966|FG005|Open Label Treatment Period|Other reason not defined above|0|||
130840900|NCT01778049|471043961|FG000|Double Blind Treatment Period|Adverse Event|0|||
130840901|NCT01778049|471043962|FG001|Double Blind Treatment Period|Adverse Event|0|||
130840902|NCT01778049|471043963|FG002|Double Blind Treatment Period|Adverse Event|4|||
130840903|NCT01778049|471043964|FG003|Double Blind Treatment Period|Adverse Event|5|||
130840904|NCT01778049|471043965|FG004|Double Blind Treatment Period|Adverse Event|3|||
130840905|NCT01778049|471043966|FG005|Double Blind Treatment Period|Adverse Event|2|||
130840906|NCT01778049|471043961|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
130840907|NCT01778049|471043962|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
130840908|NCT01778049|471043963|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
130840909|NCT01778049|471043964|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
130840910|NCT01778049|471043965|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
130840911|NCT01778049|471043966|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
130840912|NCT01778049|471043961|FG000|Double Blind Treatment Period|Protocol Violation|0|||
130840913|NCT01778049|471043962|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130840914|NCT01778049|471043963|FG002|Double Blind Treatment Period|Protocol Violation|2|||
130840915|NCT01778049|471043964|FG003|Double Blind Treatment Period|Protocol Violation|0|||
130840916|NCT01778049|471043965|FG004|Double Blind Treatment Period|Protocol Violation|0|||
130840917|NCT01778049|471043966|FG005|Double Blind Treatment Period|Protocol Violation|0|||
130840918|NCT01778049|471043961|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
130840919|NCT01778049|471043962|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130840920|NCT01778049|471043963|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
130840921|NCT01778049|471043964|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
130840922|NCT01778049|471043965|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
130840923|NCT01778049|471043966|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
130840924|NCT01778049|471043961|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
130840925|NCT01778049|471043962|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
130840926|NCT01778049|471043963|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
130840927|NCT01778049|471043964|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
130840928|NCT01778049|471043965|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
130840929|NCT01778049|471043966|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
130840930|NCT01778049|471043961|FG000|Double Blind Treatment Period|Not treated|0|||
130840931|NCT01778049|471043962|FG001|Double Blind Treatment Period|Not treated|0|||
130840932|NCT01778049|471043963|FG002|Double Blind Treatment Period|Not treated|0|||
130840933|NCT01778049|471043964|FG003|Double Blind Treatment Period|Not treated|2|||
130840934|NCT01778049|471043965|FG004|Double Blind Treatment Period|Not treated|2|||
130840935|NCT01778049|471043966|FG005|Double Blind Treatment Period|Not treated|0|||
130840936|NCT01778049|471043961|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
130840937|NCT01778049|471043962|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
130840938|NCT01778049|471043963|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
130840939|NCT01778049|471043964|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
130840940|NCT01778049|471043965|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
130840941|NCT01778049|471043966|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
130840942|NCT03773133|471043967|FG000|Overall Study|Screen Failure|8|||
130840943|NCT02928029|471043968|FG000|Overall Study|Withdrawal by Subject|0|||
130840944|NCT02928029|471043969|FG001|Overall Study|Withdrawal by Subject|1|||
130840945|NCT02928029|471043968|FG000|Overall Study|Radiological progression|1|||
130840946|NCT02928029|471043969|FG001|Overall Study|Radiological progression|0|||
130840947|NCT02928029|471043968|FG000|Overall Study|Clinical progression|1|||
130840948|NCT02928029|471043969|FG001|Overall Study|Clinical progression|2|||
130840949|NCT02928029|471043968|FG000|Overall Study|AE not related to clinical progression|1|||
130840950|NCT02928029|471043969|FG001|Overall Study|AE not related to clinical progression|1|||
130840951|NCT00107315|471043976|FG000|Overall Study|Disease Progression|9|||
130840952|NCT00107315|471043976|FG000|Overall Study|Adverse Event|4|||
130840953|NCT00107315|471043976|FG000|Overall Study|Withdrawal by Subject|2|||
130840954|NCT02509039|471043977|FG000|Overall Study|Adverse Event|0|||
130840955|NCT02509039|471043978|FG001|Overall Study|Adverse Event|1|||
130840956|NCT02509039|471043979|FG002|Overall Study|Adverse Event|1|||
130840957|NCT02509039|471043980|FG003|Overall Study|Adverse Event|1|||
130840958|NCT02509039|471043977|FG000|Overall Study|Withdrawal by Subject|0|||
130840959|NCT02509039|471043978|FG001|Overall Study|Withdrawal by Subject|0|||
130840960|NCT02509039|471043979|FG002|Overall Study|Withdrawal by Subject|1|||
130840961|NCT02509039|471043980|FG003|Overall Study|Withdrawal by Subject|0|||
130840962|NCT02509039|471043977|FG000|Overall Study|Progressive disease|2|||
130840963|NCT02509039|471043978|FG001|Overall Study|Progressive disease|2|||
130840964|NCT02509039|471043979|FG002|Overall Study|Progressive disease|1|||
130840965|NCT02509039|471043980|FG003|Overall Study|Progressive disease|5|||
130840966|NCT02509039|471043977|FG000|Overall Study|Study terminated by Sponsor|1|||
130840967|NCT02509039|471043978|FG001|Overall Study|Study terminated by Sponsor|0|||
130840968|NCT02509039|471043979|FG002|Overall Study|Study terminated by Sponsor|0|||
130840969|NCT02509039|471043980|FG003|Overall Study|Study terminated by Sponsor|0|||
130840970|NCT05427539|471043985|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130840971|NCT05427539|471043986|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130840972|NCT05427539|471043985|FG000|Period 1|Withdrawal by Subject|1|||
130840973|NCT05427539|471043986|FG001|Period 1|Withdrawal by Subject|0|||
130840974|NCT00543296|471043989|FG000|Overall Study|Physician Decision|7|||
130840975|NCT00934947|471043990|FG000|Overall Study|Adverse Event|0|||
130840976|NCT00934947|471043991|FG001|Overall Study|Adverse Event|2|||
130840977|NCT01703208|471043992|FG000|Overall Study|Death|61|||
130840978|NCT01703208|471043993|FG001|Overall Study|Death|48|||
130840979|NCT01703208|471043992|FG000|Overall Study|Lack of Efficacy|1|||
130840980|NCT01703208|471043993|FG001|Overall Study|Lack of Efficacy|2|||
130840981|NCT01703208|471043992|FG000|Overall Study|Lost to Follow-up|68|||
130840982|NCT01703208|471043993|FG001|Overall Study|Lost to Follow-up|62|||
130840983|NCT01703208|471043992|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130840984|NCT01703208|471043993|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130840985|NCT01703208|471043992|FG000|Overall Study|Excluded Medication|1|||
130840986|NCT01703208|471043993|FG001|Overall Study|Excluded Medication|2|||
130840987|NCT01703208|471043992|FG000|Overall Study|Site Discontinued Study Participation|23|||
130840988|NCT01703208|471043993|FG001|Overall Study|Site Discontinued Study Participation|27|||
130840989|NCT01703208|471043992|FG000|Overall Study|Physician Decision|11|||
130840990|NCT01703208|471043993|FG001|Overall Study|Physician Decision|13|||
130840991|NCT01703208|471043992|FG000|Overall Study|Progressive disease|2|||
130840992|NCT01703208|471043993|FG001|Overall Study|Progressive disease|2|||
130840993|NCT01703208|471043992|FG000|Overall Study|Protocol Violation|1|||
130840994|NCT01703208|471043993|FG001|Overall Study|Protocol Violation|1|||
130840995|NCT01703208|471043992|FG000|Overall Study|Study Terminated by Sponsor|1710|||
130840996|NCT01703208|471043993|FG001|Overall Study|Study Terminated by Sponsor|1716|||
130840997|NCT01703208|471043992|FG000|Overall Study|Withdrawal by Subject|205|||
130840998|NCT01703208|471043993|FG001|Overall Study|Withdrawal by Subject|209|||
130840999|NCT01703208|471043992|FG000|Overall Study|Adverse Event|14|||
130841000|NCT01703208|471043993|FG001|Overall Study|Adverse Event|19|||
130841001|NCT01703208|471043992|FG000|Overall Study|Technical Problems|0|||
130841002|NCT01703208|471043993|FG001|Overall Study|Technical Problems|1|||
130841003|NCT01703208|471043992|FG000|Overall Study|Protocol Deviation|2|||
130841004|NCT01703208|471043993|FG001|Overall Study|Protocol Deviation|0|||
130841005|NCT01451931|471043997|FG000|Overall Study|Lost to Follow-up|17|||
130841006|NCT01451931|471043998|FG001|Overall Study|Lost to Follow-up|36|||
130841007|NCT01451931|471043999|FG002|Overall Study|Lost to Follow-up|21|||
130841008|NCT01451931|471043997|FG000|Overall Study|Withdrawal by Subject|16|||
130841009|NCT01451931|471043998|FG001|Overall Study|Withdrawal by Subject|22|||
130841010|NCT01451931|471043999|FG002|Overall Study|Withdrawal by Subject|22|||
130841011|NCT04003207|471044005|FG000|Overall Study|Protocol Violation|1|||
130841012|NCT03099174|471044008|FG000|Overall Study|Withdrawal by Subject|0|||
130841013|NCT03099174|471044009|FG001|Overall Study|Withdrawal by Subject|0|||
130841014|NCT03099174|471044010|FG002|Overall Study|Withdrawal by Subject|1|||
130841015|NCT03099174|471044011|FG003|Overall Study|Withdrawal by Subject|0|||
130841016|NCT03099174|471044012|FG004|Overall Study|Withdrawal by Subject|2|||
130841017|NCT03099174|471044013|FG005|Overall Study|Withdrawal by Subject|2|||
130841018|NCT03099174|471044014|FG006|Overall Study|Withdrawal by Subject|1|||
130841019|NCT03099174|471044015|FG007|Overall Study|Withdrawal by Subject|4|||
130841020|NCT03099174|471044008|FG000|Overall Study|Adverse Event|0|||
130841021|NCT03099174|471044009|FG001|Overall Study|Adverse Event|1|||
130841022|NCT03099174|471044010|FG002|Overall Study|Adverse Event|1|||
130841023|NCT03099174|471044011|FG003|Overall Study|Adverse Event|2|||
130841024|NCT03099174|471044012|FG004|Overall Study|Adverse Event|5|||
130841025|NCT03099174|471044013|FG005|Overall Study|Adverse Event|3|||
130841026|NCT03099174|471044014|FG006|Overall Study|Adverse Event|6|||
130841027|NCT03099174|471044015|FG007|Overall Study|Adverse Event|4|||
130841028|NCT03099174|471044008|FG000|Overall Study|Other than listed|6|||
130841029|NCT03099174|471044009|FG001|Overall Study|Other than listed|6|||
130841030|NCT03099174|471044010|FG002|Overall Study|Other than listed|5|||
130841031|NCT03099174|471044011|FG003|Overall Study|Other than listed|6|||
130841032|NCT03099174|471044012|FG004|Overall Study|Other than listed|19|||
130841033|NCT03099174|471044013|FG005|Overall Study|Other than listed|10|||
130841034|NCT03099174|471044014|FG006|Overall Study|Other than listed|26|||
130841035|NCT03099174|471044015|FG007|Overall Study|Other than listed|23|||
130841036|NCT02378298|471044016|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
130841037|NCT02378298|471044017|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
130841038|NCT02378298|471044018|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
130841039|NCT02378298|471044016|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
130841040|NCT02378298|471044017|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
130841041|NCT02378298|471044018|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
130841042|NCT02378298|471044016|FG000|Surveillance (19-68 Weeks)|Death|1|||
130841043|NCT02378298|471044017|FG001|Surveillance (19-68 Weeks)|Death|0|||
130841044|NCT02378298|471044018|FG002|Surveillance (19-68 Weeks)|Death|0|||
130841045|NCT04173260|471044019|FG000|Overall Study|Early termination|4|||
130841046|NCT02308163|471044020|FG000|Overall Study|Not fulfill eligible criteria|1|||
130841047|NCT02308163|471044021|FG001|Overall Study|Not fulfill eligible criteria|2|||
130841048|NCT02308163|471044022|FG002|Overall Study|Not fulfill eligible criteria|0|||
130841049|NCT02308163|471044023|FG003|Overall Study|Not fulfill eligible criteria|1|||
130841050|NCT02308163|471044024|FG004|Overall Study|Not fulfill eligible criteria|1|||
130841051|NCT02308163|471044020|FG000|Overall Study|Adverse Event|9|||
130841052|NCT02308163|471044021|FG001|Overall Study|Adverse Event|5|||
130841053|NCT02308163|471044022|FG002|Overall Study|Adverse Event|2|||
130841054|NCT02308163|471044023|FG003|Overall Study|Adverse Event|2|||
130841055|NCT02308163|471044024|FG004|Overall Study|Adverse Event|11|||
130841056|NCT02308163|471044020|FG000|Overall Study|Lack of Efficacy|11|||
130841057|NCT02308163|471044021|FG001|Overall Study|Lack of Efficacy|3|||
130841058|NCT02308163|471044022|FG002|Overall Study|Lack of Efficacy|8|||
130841059|NCT02308163|471044023|FG003|Overall Study|Lack of Efficacy|4|||
130841060|NCT02308163|471044024|FG004|Overall Study|Lack of Efficacy|6|||
130841061|NCT02308163|471044020|FG000|Overall Study|Withdrawal of consent|2|||
130841062|NCT02308163|471044021|FG001|Overall Study|Withdrawal of consent|3|||
130841063|NCT02308163|471044022|FG002|Overall Study|Withdrawal of consent|0|||
130841064|NCT02308163|471044023|FG003|Overall Study|Withdrawal of consent|2|||
130841065|NCT02308163|471044024|FG004|Overall Study|Withdrawal of consent|6|||
130841066|NCT02308163|471044020|FG000|Overall Study|Protocol Violation|3|||
130841067|NCT02308163|471044021|FG001|Overall Study|Protocol Violation|3|||
130841068|NCT02308163|471044022|FG002|Overall Study|Protocol Violation|3|||
130841069|NCT02308163|471044023|FG003|Overall Study|Protocol Violation|2|||
130841070|NCT02308163|471044024|FG004|Overall Study|Protocol Violation|5|||
130841071|NCT02308163|471044020|FG000|Overall Study|Lab data met discontinuation criteria|3|||
130841072|NCT02308163|471044021|FG001|Overall Study|Lab data met discontinuation criteria|0|||
130841073|NCT02308163|471044022|FG002|Overall Study|Lab data met discontinuation criteria|0|||
130841074|NCT02308163|471044023|FG003|Overall Study|Lab data met discontinuation criteria|2|||
130841075|NCT02308163|471044024|FG004|Overall Study|Lab data met discontinuation criteria|0|||
130841076|NCT02308163|471044020|FG000|Overall Study|Miscellaneous|2|||
130841077|NCT02308163|471044021|FG001|Overall Study|Miscellaneous|2|||
130841078|NCT02308163|471044022|FG002|Overall Study|Miscellaneous|1|||
130841079|NCT02308163|471044023|FG003|Overall Study|Miscellaneous|0|||
130841080|NCT02308163|471044024|FG004|Overall Study|Miscellaneous|5|||
130841081|NCT03941964|471044026|FG000|Overall Study|Adverse Event|1|||
130841082|NCT03941964|471044027|FG001|Overall Study|Adverse Event|8|||
130841083|NCT03941964|471044026|FG000|Overall Study|Progressive disease|7|||
130841084|NCT03941964|471044027|FG001|Overall Study|Progressive disease|3|||
130841085|NCT03941964|471044026|FG000|Overall Study|Lack of Efficacy|0|||
130841086|NCT03941964|471044027|FG001|Overall Study|Lack of Efficacy|1|||
130841087|NCT03941964|471044026|FG000|Overall Study|Death|3|||
130841088|NCT03941964|471044027|FG001|Overall Study|Death|1|||
130841089|NCT03941964|471044026|FG000|Overall Study|Withdrew consent|1|||
130841090|NCT03941964|471044027|FG001|Overall Study|Withdrew consent|3|||
130841091|NCT03941964|471044026|FG000|Overall Study|Physician Decision|9|||
130841092|NCT03941964|471044027|FG001|Overall Study|Physician Decision|2|||
130841093|NCT03941964|471044026|FG000|Overall Study|Other, not specified|2|||
130841094|NCT03941964|471044027|FG001|Overall Study|Other, not specified|1|||
130841095|NCT02298179|471044028|FG000|Overall Study|Lost to Follow-up|0|||
130841096|NCT02298179|471044029|FG001|Overall Study|Lost to Follow-up|0|||
130841097|NCT02298179|471044030|FG002|Overall Study|Lost to Follow-up|1|||
130841098|NCT02298179|471044031|FG003|Overall Study|Lost to Follow-up|0|||
130841099|NCT02298179|471044032|FG004|Overall Study|Lost to Follow-up|0|||
130841100|NCT02298179|471044033|FG005|Overall Study|Lost to Follow-up|0|||
130841101|NCT02298179|471044034|FG006|Overall Study|Lost to Follow-up|0|||
130841102|NCT02298179|471044035|FG007|Overall Study|Lost to Follow-up|1|||
130841103|NCT02298179|471044036|FG008|Overall Study|Lost to Follow-up|0|||
130841104|NCT02298179|471044037|FG009|Overall Study|Lost to Follow-up|0|||
130841105|NCT02298179|471044038|FG010|Overall Study|Lost to Follow-up|0|||
130841106|NCT02298179|471044039|FG011|Overall Study|Lost to Follow-up|0|||
130841107|NCT00983515|471045675|FG000|Ritonavir Alone|liver panel out of range|6|||
130841108|NCT00983515|471045675|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
130841109|NCT01730339|471045676|FG000|Overall Study|Withdrawal by Subject|3|||
130841110|NCT01730339|471045677|FG001|Overall Study|Withdrawal by Subject|2|||
130841111|NCT01730339|471045676|FG000|Overall Study|Lost to Follow-up|1|||
130841112|NCT01730339|471045677|FG001|Overall Study|Lost to Follow-up|1|||
130841113|NCT01730339|471045676|FG000|Overall Study|Un-specified|1|||
130841114|NCT01730339|471045677|FG001|Overall Study|Un-specified|0|||
130841115|NCT03095027|471045678|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
130841116|NCT03095027|471045679|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
130841117|NCT04143217|471045680|FG000|Overall Study|Withdrawal by Subject|42|||
130841118|NCT04143217|471045680|FG000|Overall Study|Adverse Event|29|||
130841119|NCT04143217|471045680|FG000|Overall Study|Lost to Follow-up|29|||
130841120|NCT04143217|471045680|FG000|Overall Study|Lack of Efficacy|15|||
130841121|NCT04143217|471045680|FG000|Overall Study|Physician Decision|1|||
130841122|NCT04143217|471045680|FG000|Overall Study|Non-Compliance With Study Drug|6|||
130841123|NCT04143217|471045680|FG000|Overall Study|Other, Multiple Categories|11|||
130841124|NCT01962987|471045683|FG000|Overall Study|Adverse Event|4|||
130841125|NCT01962987|471045684|FG001|Overall Study|Adverse Event|4|||
130841126|NCT01962987|471045685|FG002|Overall Study|Adverse Event|0|||
130841127|NCT01962987|471045683|FG000|Overall Study|Lost to Follow-up|0|||
130841128|NCT01962987|471045684|FG001|Overall Study|Lost to Follow-up|0|||
130841129|NCT01962987|471045685|FG002|Overall Study|Lost to Follow-up|1|||
130841130|NCT01962987|471045683|FG000|Overall Study|Non compliance with dosing requirements|4|||
130841131|NCT01962987|471045684|FG001|Overall Study|Non compliance with dosing requirements|2|||
130841132|NCT01962987|471045685|FG002|Overall Study|Non compliance with dosing requirements|0|||
130841133|NCT01962987|471045683|FG000|Overall Study|Miscellaneous|1|||
130841134|NCT01962987|471045684|FG001|Overall Study|Miscellaneous|9|||
130841135|NCT01962987|471045685|FG002|Overall Study|Miscellaneous|2|||
130841136|NCT01962987|471045683|FG000|Overall Study|Restricted medication|5|||
130841137|NCT01962987|471045684|FG001|Overall Study|Restricted medication|1|||
130841138|NCT01962987|471045685|FG002|Overall Study|Restricted medication|1|||
130841139|NCT01962987|471045683|FG000|Overall Study|Serious Adverse Event|1|||
130841140|NCT01962987|471045684|FG001|Overall Study|Serious Adverse Event|0|||
130841141|NCT01962987|471045685|FG002|Overall Study|Serious Adverse Event|0|||
130841142|NCT01962987|471045683|FG000|Overall Study|Withdrawal by Subject|11|||
130841143|NCT01962987|471045684|FG001|Overall Study|Withdrawal by Subject|10|||
130841144|NCT01962987|471045685|FG002|Overall Study|Withdrawal by Subject|6|||
130841145|NCT01962987|471045683|FG000|Overall Study|Randomized in Error|4|||
130841146|NCT01962987|471045684|FG001|Overall Study|Randomized in Error|2|||
130841147|NCT01962987|471045685|FG002|Overall Study|Randomized in Error|2|||
130841148|NCT03392883|471045689|FG000|Overall Study|Lost to Follow-up|122|||
130841149|NCT03392883|471045690|FG001|Overall Study|Lost to Follow-up|13|||
130841150|NCT03392883|471045691|FG002|Overall Study|Lost to Follow-up|9|||
130841151|NCT03392883|471045689|FG000|Overall Study|Death|4|||
130841152|NCT03392883|471045690|FG001|Overall Study|Death|0|||
130841153|NCT03392883|471045691|FG002|Overall Study|Death|0|||
130841154|NCT03392883|471045689|FG000|Overall Study|Lack of Efficacy|29|||
130841155|NCT03392883|471045690|FG001|Overall Study|Lack of Efficacy|0|||
130841156|NCT03392883|471045691|FG002|Overall Study|Lack of Efficacy|0|||
130841157|NCT03392883|471045689|FG000|Overall Study|Withdrawal by Subject|180|||
130841158|NCT03392883|471045690|FG001|Overall Study|Withdrawal by Subject|0|||
130841159|NCT03392883|471045691|FG002|Overall Study|Withdrawal by Subject|0|||
130841160|NCT03392883|471045689|FG000|Overall Study|Adverse Event|1|||
130841161|NCT03392883|471045690|FG001|Overall Study|Adverse Event|0|||
130841162|NCT03392883|471045691|FG002|Overall Study|Adverse Event|0|||
130841163|NCT00347438|471045694|FG000|Overall Study|Withdrawal by Subject|1|||
130841164|NCT00347438|471045694|FG000|Overall Study|Physician Decision|1|||
130841165|NCT00322023|471045695|FG000|Overall Study|various|0|||
130841166|NCT00322023|471045696|FG001|Overall Study|various|2|||
130841167|NCT00322023|471045697|FG002|Overall Study|various|6|||
130841168|NCT00523705|471045698|FG000|Overall Study|No time for study.|0|||
130841169|NCT00523705|471045699|FG001|Overall Study|No time for study.|1|||
130841170|NCT00396136|471045700|FG000|Overall Study|Death|43|||
130841171|NCT00396136|471045700|FG000|Overall Study|Withdrawal by Subject|59|||
130841172|NCT00396136|471045700|FG000|Overall Study|Lost to Follow-up|15|||
130841173|NCT00396136|471045700|FG000|Overall Study|Study device explanted|8|||
130841174|NCT03960580|471045701|FG000|Overall Study|Adverse Event|2|||
130841175|NCT03960580|471045702|FG001|Overall Study|Adverse Event|1|||
130841176|NCT03960580|471045703|FG002|Overall Study|Adverse Event|1|||
130841177|NCT03960580|471045701|FG000|Overall Study|Lost to Follow-up|1|||
130841178|NCT03960580|471045702|FG001|Overall Study|Lost to Follow-up|0|||
130841179|NCT03960580|471045703|FG002|Overall Study|Lost to Follow-up|0|||
130841180|NCT03960580|471045701|FG000|Overall Study|Lack of Efficacy|2|||
130841181|NCT03960580|471045702|FG001|Overall Study|Lack of Efficacy|1|||
130841182|NCT03960580|471045703|FG002|Overall Study|Lack of Efficacy|0|||
130841183|NCT03960580|471045701|FG000|Overall Study|Protocol Violation|0|||
130841184|NCT03960580|471045702|FG001|Overall Study|Protocol Violation|0|||
130841185|NCT03960580|471045703|FG002|Overall Study|Protocol Violation|1|||
130841186|NCT03960580|471045701|FG000|Overall Study|Withdrawal by Subject|1|||
130841187|NCT03960580|471045702|FG001|Overall Study|Withdrawal by Subject|1|||
130841188|NCT03960580|471045703|FG002|Overall Study|Withdrawal by Subject|1|||
130841189|NCT03960580|471045701|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
130841190|NCT03960580|471045702|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
130841191|NCT03960580|471045703|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
130841192|NCT01165320|471045708|FG000|Overall Study|Clinical adverse experience|2|||
130841193|NCT01165320|471045709|FG001|Overall Study|Clinical adverse experience|1|||
130841194|NCT01165320|471045710|FG002|Overall Study|Clinical adverse experience|0|||
130841195|NCT01165320|471045708|FG000|Overall Study|Laboratory adverse experience|1|||
130841196|NCT01165320|471045709|FG001|Overall Study|Laboratory adverse experience|0|||
130841197|NCT01165320|471045710|FG002|Overall Study|Laboratory adverse experience|0|||
130841198|NCT01165320|471045708|FG000|Overall Study|Lack of Efficacy|0|||
130841199|NCT01165320|471045709|FG001|Overall Study|Lack of Efficacy|2|||
130841200|NCT01165320|471045710|FG002|Overall Study|Lack of Efficacy|0|||
130841201|NCT01165320|471045708|FG000|Overall Study|Reason unknown|0|||
130841202|NCT01165320|471045709|FG001|Overall Study|Reason unknown|1|||
130841203|NCT01165320|471045710|FG002|Overall Study|Reason unknown|0|||
130841204|NCT00385944|471045711|FG000|1st Maintenance Dose Period|Physician Decision|1|||
130841205|NCT00385944|471045712|FG001|1st Maintenance Dose Period|Physician Decision|0|||
130841206|NCT00385944|471045713|FG002|1st Maintenance Dose Period|Physician Decision|0|||
130841207|NCT00385944|471045711|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
130841208|NCT00385944|471045712|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
130841209|NCT00385944|471045713|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
130841210|NCT00385944|471045711|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
130841211|NCT00385944|471045712|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
130841212|NCT00385944|471045713|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
130841213|NCT00385944|471045711|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
130841214|NCT00385944|471045712|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
130841215|NCT00385944|471045713|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
130841216|NCT00590824|471045714|FG000|Overall Study|Disease could not be resected|0|||
130841217|NCT00590824|471045715|FG001|Overall Study|Disease could not be resected|2|||
130841218|NCT00590824|471045716|FG002|Overall Study|Disease could not be resected|1|||
130841219|NCT00590824|471045717|FG003|Overall Study|Disease could not be resected|0|||
130841220|NCT00590824|471045714|FG000|Overall Study|Adverse Event|0|||
130841221|NCT00590824|471045715|FG001|Overall Study|Adverse Event|0|||
130841222|NCT00590824|471045716|FG002|Overall Study|Adverse Event|0|||
130841223|NCT00590824|471045717|FG003|Overall Study|Adverse Event|1|||
130841224|NCT01155466|471045718|FG000|Overall Study|Adverse Event|13|||
130841225|NCT01155466|471045719|FG001|Overall Study|Adverse Event|15|||
130841226|NCT01155466|471045720|FG002|Overall Study|Adverse Event|6|||
130841227|NCT01155466|471045721|FG003|Overall Study|Adverse Event|17|||
130841228|NCT01155466|471045722|FG004|Overall Study|Adverse Event|18|||
130841229|NCT01155466|471045718|FG000|Overall Study|Lost to Follow-up|0|||
130841230|NCT01155466|471045719|FG001|Overall Study|Lost to Follow-up|0|||
130841231|NCT01155466|471045720|FG002|Overall Study|Lost to Follow-up|0|||
130841232|NCT01155466|471045721|FG003|Overall Study|Lost to Follow-up|0|||
130841233|NCT01155466|471045722|FG004|Overall Study|Lost to Follow-up|2|||
130841234|NCT01155466|471045718|FG000|Overall Study|Withdrawal by Subject|7|||
130841235|NCT01155466|471045719|FG001|Overall Study|Withdrawal by Subject|5|||
130841236|NCT01155466|471045720|FG002|Overall Study|Withdrawal by Subject|9|||
130841237|NCT01155466|471045721|FG003|Overall Study|Withdrawal by Subject|4|||
130841238|NCT01155466|471045722|FG004|Overall Study|Withdrawal by Subject|4|||
130841239|NCT01155466|471045718|FG000|Overall Study|Protocol Violation|0|||
130841240|NCT01155466|471045719|FG001|Overall Study|Protocol Violation|0|||
130841241|NCT01155466|471045720|FG002|Overall Study|Protocol Violation|2|||
130841242|NCT01155466|471045721|FG003|Overall Study|Protocol Violation|0|||
130841243|NCT01155466|471045722|FG004|Overall Study|Protocol Violation|1|||
130841244|NCT01155466|471045718|FG000|Overall Study|Administrative|0|||
130841245|NCT01155466|471045719|FG001|Overall Study|Administrative|3|||
130841246|NCT01155466|471045720|FG002|Overall Study|Administrative|0|||
130841247|NCT01155466|471045721|FG003|Overall Study|Administrative|0|||
130841248|NCT01155466|471045722|FG004|Overall Study|Administrative|0|||
130841249|NCT01155466|471045718|FG000|Overall Study|Randomized not treated|2|||
130841250|NCT01155466|471045719|FG001|Overall Study|Randomized not treated|2|||
130841251|NCT01155466|471045720|FG002|Overall Study|Randomized not treated|3|||
130841252|NCT01155466|471045721|FG003|Overall Study|Randomized not treated|0|||
130841253|NCT01155466|471045722|FG004|Overall Study|Randomized not treated|2|||
130841254|NCT00791479|471045728|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130841255|NCT00791479|471045729|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130841256|NCT00791479|471045730|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130841257|NCT00791479|471045731|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130841258|NCT00791479|471045732|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
130841259|NCT00791479|471045733|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130841260|NCT00791479|471045728|FG000|Overall Study|Adverse Event|0|||
130841261|NCT00791479|471045729|FG001|Overall Study|Adverse Event|1|||
130841262|NCT00791479|471045730|FG002|Overall Study|Adverse Event|0|||
130841263|NCT00791479|471045731|FG003|Overall Study|Adverse Event|2|||
130841264|NCT00791479|471045732|FG004|Overall Study|Adverse Event|0|||
130841265|NCT00791479|471045733|FG005|Overall Study|Adverse Event|1|||
130841266|NCT00791479|471045728|FG000|Overall Study|Lost to Follow-up|0|||
130841267|NCT00791479|471045729|FG001|Overall Study|Lost to Follow-up|1|||
130841268|NCT00791479|471045730|FG002|Overall Study|Lost to Follow-up|0|||
130841269|NCT00791479|471045731|FG003|Overall Study|Lost to Follow-up|0|||
130841270|NCT00791479|471045732|FG004|Overall Study|Lost to Follow-up|0|||
130841271|NCT00791479|471045733|FG005|Overall Study|Lost to Follow-up|1|||
130841272|NCT00791479|471045728|FG000|Overall Study|Protocol Violation|2|||
130841273|NCT00791479|471045729|FG001|Overall Study|Protocol Violation|1|||
130841274|NCT00791479|471045730|FG002|Overall Study|Protocol Violation|0|||
130841275|NCT00791479|471045731|FG003|Overall Study|Protocol Violation|1|||
130841276|NCT00791479|471045732|FG004|Overall Study|Protocol Violation|0|||
130841277|NCT00791479|471045733|FG005|Overall Study|Protocol Violation|0|||
130841278|NCT00791479|471045728|FG000|Overall Study|Withdrawal by Subject|0|||
130841279|NCT00791479|471045729|FG001|Overall Study|Withdrawal by Subject|0|||
130841280|NCT00791479|471045730|FG002|Overall Study|Withdrawal by Subject|0|||
130841281|NCT00791479|471045731|FG003|Overall Study|Withdrawal by Subject|1|||
130841282|NCT00791479|471045732|FG004|Overall Study|Withdrawal by Subject|0|||
130841283|NCT00791479|471045733|FG005|Overall Study|Withdrawal by Subject|1|||
130841284|NCT03136497|471045734|FG000|Overall Study|Screen Failure|1|||
130841285|NCT03136497|471045735|FG001|Overall Study|Screen Failure|0|||
130841286|NCT03136497|471045736|FG002|Overall Study|Screen Failure|0|||
130841287|NCT00557310|471045737|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
130841288|NCT00557310|471045737|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
130841289|NCT00557310|471045737|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
130841290|NCT00557310|471045737|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
130841291|NCT00557310|471045737|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
130841292|NCT00557310|471045737|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
130841293|NCT03276026|471045740|FG000|Overall Study|Protocol Violation|1|||
130841294|NCT03276026|471045741|FG001|Overall Study|Protocol Violation|0|||
130841295|NCT04049266|471045745|FG000|Overall Study|Adverse Event|16|||
130841296|NCT04049266|471045746|FG001|Overall Study|Adverse Event|9|||
130841297|NCT04049266|471045745|FG000|Overall Study|Non-compliance with study drug|0|||
130841298|NCT04049266|471045746|FG001|Overall Study|Non-compliance with study drug|3|||
130841299|NCT04049266|471045745|FG000|Overall Study|Withdrawal by Subject|6|||
130841300|NCT04049266|471045746|FG001|Overall Study|Withdrawal by Subject|10|||
130841301|NCT04049266|471045745|FG000|Overall Study|Lost to Follow-up|2|||
130841302|NCT04049266|471045746|FG001|Overall Study|Lost to Follow-up|2|||
130841303|NCT04049266|471045745|FG000|Overall Study|Progressive disease|11|||
130841304|NCT04049266|471045746|FG001|Overall Study|Progressive disease|2|||
130841305|NCT04049266|471045745|FG000|Overall Study|Physician Decision|1|||
130841306|NCT04049266|471045746|FG001|Overall Study|Physician Decision|0|||
130841307|NCT04049266|471045745|FG000|Overall Study|Patient moved out of state|1|||
130841308|NCT04049266|471045746|FG001|Overall Study|Patient moved out of state|0|||
130841309|NCT02359045|471045747|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
130841310|NCT02359045|471045748|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130841311|NCT02359045|471045747|FG000|Overall Study|Lost to Follow-up|1|||
130841312|NCT02359045|471045748|FG001|Overall Study|Lost to Follow-up|1|||
130841313|NCT02359045|471045747|FG000|Overall Study|Adverse Event|0|||
130841314|NCT02359045|471045748|FG001|Overall Study|Adverse Event|1|||
130841315|NCT00367744|471045754|FG000|Overall Study|Lost to Follow-up|4|||
130841316|NCT00367744|471045755|FG001|Overall Study|Lost to Follow-up|5|||
130841317|NCT01271712|471045760|FG000|Double Blind Treatment|Death|2|||
130841318|NCT01271712|471045761|FG001|Double Blind Treatment|Death|0|||
130841319|NCT01271712|471045760|FG000|Double Blind Treatment|Lack of Efficacy|1|||
130841320|NCT01271712|471045761|FG001|Double Blind Treatment|Lack of Efficacy|0|||
130841321|NCT01271712|471045760|FG000|Double Blind Treatment|Adverse Event|9|||
130841322|NCT01271712|471045761|FG001|Double Blind Treatment|Adverse Event|4|||
130841323|NCT01271712|471045760|FG000|Double Blind Treatment|Progressive disease|23|||
130841324|NCT01271712|471045761|FG001|Double Blind Treatment|Progressive disease|3|||
130841325|NCT01271712|471045760|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
130841326|NCT01271712|471045761|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
130841327|NCT01271712|471045760|FG000|Double Blind Treatment|Non compliance with study drug|2|||
130841328|NCT01271712|471045761|FG001|Double Blind Treatment|Non compliance with study drug|0|||
130841329|NCT01271712|471045760|FG000|Double Blind Treatment|receive no study drug|1|||
130841330|NCT01271712|471045761|FG001|Double Blind Treatment|receive no study drug|0|||
130841331|NCT01271712|471045760|FG000|Open Label Treatment|Death|6|||
130841332|NCT01271712|471045761|FG001|Open Label Treatment|Death|5|||
130841333|NCT01271712|471045760|FG000|Open Label Treatment|Withdrawal by Subject|6|||
130841334|NCT01271712|471045761|FG001|Open Label Treatment|Withdrawal by Subject|11|||
130841335|NCT01271712|471045760|FG000|Open Label Treatment|Physician Decision|2|||
130841336|NCT01271712|471045761|FG001|Open Label Treatment|Physician Decision|0|||
130841337|NCT01271712|471045760|FG000|Open Label Treatment|Adverse Event|14|||
130841338|NCT01271712|471045761|FG001|Open Label Treatment|Adverse Event|8|||
130841339|NCT01271712|471045760|FG000|Open Label Treatment|Progressive disease|59|||
130841340|NCT01271712|471045761|FG001|Open Label Treatment|Progressive disease|32|||
130841341|NCT01271712|471045760|FG000|Open Label Treatment|transferred to rollover study|1|||
130841342|NCT01271712|471045761|FG001|Open Label Treatment|transferred to rollover study|0|||
130841343|NCT01271712|471045760|FG000|Open Label Treatment|Non-compliance with study drug|1|||
130841344|NCT01271712|471045761|FG001|Open Label Treatment|Non-compliance with study drug|0|||
130841345|NCT01271712|471045760|FG000|Open Label Treatment|Protocol Violation|0|||
130841346|NCT01271712|471045761|FG001|Open Label Treatment|Protocol Violation|1|||
130841347|NCT01271712|471045760|FG000|Open Label Treatment|Switching to other therapy|2|||
130841348|NCT01271712|471045761|FG001|Open Label Treatment|Switching to other therapy|1|||
130841349|NCT01271712|471045760|FG000|Safety Follow-up|Death|11|||
130841350|NCT01271712|471045761|FG001|Safety Follow-up|Death|7|||
130841351|NCT01271712|471045760|FG000|Safety Follow-up|Withdrawal by Subject|4|||
130841352|NCT01271712|471045761|FG001|Safety Follow-up|Withdrawal by Subject|2|||
130841353|NCT01271712|471045760|FG000|Safety Follow-up|Protocol Violation|1|||
130841354|NCT01271712|471045761|FG001|Safety Follow-up|Protocol Violation|1|||
130841355|NCT01271712|471045760|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
130841356|NCT01271712|471045761|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
130841357|NCT01271712|471045760|FG000|Safety Follow-up|No follow-up|1|||
130841358|NCT01271712|471045761|FG001|Safety Follow-up|No follow-up|1|||
130841359|NCT01271712|471045760|FG000|Safety Follow-up|Progressive disease|1|||
130841360|NCT01271712|471045761|FG001|Safety Follow-up|Progressive disease|0|||
130841361|NCT01271712|471045760|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
130841362|NCT01271712|471045761|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
130841363|NCT00096226|471045764|FG000|Overall Study|Ineligible|2|||
130841364|NCT00096226|471045764|FG000|Overall Study|Protocol treatment not started|1|||
130841365|NCT01666119|471045765|FG000|Overall Study|Adverse Event|6|||
130841366|NCT01666119|471045765|FG000|Overall Study|Withdrawal by Subject|16|||
130841367|NCT01666119|471045765|FG000|Overall Study|Lost to Follow-up|7|||
130841368|NCT01666119|471045765|FG000|Overall Study|non compliance with study medication, pa|18|||
130841369|NCT01666119|471045765|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
130841370|NCT00118846|471045769|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
130841371|NCT00118846|471045770|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
130841372|NCT00118846|471045769|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
130841373|NCT00118846|471045770|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
130841374|NCT00118846|471045769|FG000|Overall Study|Physician Decision|1|||
130841375|NCT00118846|471045770|FG001|Overall Study|Physician Decision|0|||
130841376|NCT00118846|471045769|FG000|Overall Study|Medical condition|2|||
130841377|NCT00118846|471045770|FG001|Overall Study|Medical condition|2|||
130841378|NCT00118846|471045769|FG000|Overall Study|Lost to Follow-up|0|||
130841379|NCT00118846|471045770|FG001|Overall Study|Lost to Follow-up|2|||
130841380|NCT00118846|471045769|FG000|Overall Study|Personal reason|4|||
130841381|NCT00118846|471045770|FG001|Overall Study|Personal reason|5|||
130841382|NCT00443053|471045772|FG000|Overall Study|Adverse Event|2|||
130841383|NCT00443053|471045773|FG001|Overall Study|Adverse Event|1|||
130841384|NCT00443053|471045772|FG000|Overall Study|Withdrawal by Subject|9|||
130841385|NCT00443053|471045773|FG001|Overall Study|Withdrawal by Subject|18|||
130841386|NCT00443053|471045772|FG000|Overall Study|Lost to Follow-up|4|||
130841387|NCT00443053|471045773|FG001|Overall Study|Lost to Follow-up|5|||
130841388|NCT00443053|471045772|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
130841389|NCT00443053|471045773|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
130841390|NCT00443053|471045772|FG000|Overall Study|Noncompliance|2|||
130841391|NCT00443053|471045773|FG001|Overall Study|Noncompliance|1|||
130841392|NCT00443053|471045772|FG000|Overall Study|Other|3|||
130841393|NCT00443053|471045773|FG001|Overall Study|Other|4|||
130841394|NCT00443053|471045772|FG000|Overall Study|Physician Decision|0|||
130841395|NCT00443053|471045773|FG001|Overall Study|Physician Decision|4|||
130841396|NCT00541866|471045774|FG000|Overall Study|Adverse Event|3|||
130841397|NCT00541866|471045775|FG001|Overall Study|Adverse Event|0|||
130841398|NCT00541866|471045776|FG002|Overall Study|Adverse Event|0|||
130841399|NCT00541866|471045777|FG003|Overall Study|Adverse Event|0|||
130841400|NCT00541866|471045778|FG004|Overall Study|Adverse Event|0|||
130841401|NCT00541866|471045774|FG000|Overall Study|Death|1|||
130841402|NCT00541866|471045775|FG001|Overall Study|Death|0|||
130841403|NCT00541866|471045776|FG002|Overall Study|Death|0|||
130841404|NCT00541866|471045777|FG003|Overall Study|Death|0|||
130841405|NCT00541866|471045778|FG004|Overall Study|Death|0|||
130841406|NCT00541866|471045774|FG000|Overall Study|Lack of Efficacy|19|||
130841407|NCT00541866|471045775|FG001|Overall Study|Lack of Efficacy|15|||
130841408|NCT00541866|471045776|FG002|Overall Study|Lack of Efficacy|10|||
130841409|NCT00541866|471045777|FG003|Overall Study|Lack of Efficacy|12|||
130841410|NCT00541866|471045778|FG004|Overall Study|Lack of Efficacy|14|||
130841411|NCT00541866|471045774|FG000|Overall Study|Not Reported or Other|11|||
130841412|NCT00541866|471045775|FG001|Overall Study|Not Reported or Other|3|||
130841413|NCT00541866|471045776|FG002|Overall Study|Not Reported or Other|3|||
130841414|NCT00541866|471045777|FG003|Overall Study|Not Reported or Other|3|||
130841415|NCT00541866|471045778|FG004|Overall Study|Not Reported or Other|1|||
130841416|NCT00541866|471045774|FG000|Overall Study|Physician Decision|0|||
130841417|NCT00541866|471045775|FG001|Overall Study|Physician Decision|0|||
130841418|NCT00541866|471045776|FG002|Overall Study|Physician Decision|2|||
130841419|NCT00541866|471045777|FG003|Overall Study|Physician Decision|1|||
130841420|NCT00541866|471045778|FG004|Overall Study|Physician Decision|0|||
130841421|NCT01327053|471045779|FG000|Overall Study|Adverse Event|23|||
130841422|NCT01327053|471045780|FG001|Overall Study|Adverse Event|57|||
130841423|NCT01327053|471045779|FG000|Overall Study|Patient/guardian decision|11|||
130841424|NCT01327053|471045780|FG001|Overall Study|Patient/guardian decision|35|||
130841425|NCT01327053|471045779|FG000|Overall Study|Physician Decision|10|||
130841426|NCT01327053|471045780|FG001|Overall Study|Physician Decision|14|||
130841427|NCT01327053|471045779|FG000|Overall Study|Death|1|||
130841428|NCT01327053|471045780|FG001|Overall Study|Death|5|||
130841429|NCT01327053|471045779|FG000|Overall Study|Lost to Follow-up|2|||
130841430|NCT01327053|471045780|FG001|Overall Study|Lost to Follow-up|4|||
130841431|NCT01327053|471045779|FG000|Overall Study|Non-compliance with study treatment|0|||
130841432|NCT01327053|471045780|FG001|Overall Study|Non-compliance with study treatment|5|||
130841433|NCT01327053|471045779|FG000|Overall Study|Study terminated by Sponsor|1|||
130841434|NCT01327053|471045780|FG001|Overall Study|Study terminated by Sponsor|3|||
130841435|NCT01327053|471045779|FG000|Overall Study|Progressive disease|31|||
130841436|NCT01327053|471045780|FG001|Overall Study|Progressive disease|26|||
130841437|NCT01327053|471045779|FG000|Overall Study|Protocol Violation|0|||
130841438|NCT01327053|471045780|FG001|Overall Study|Protocol Violation|1|||
130841439|NCT01327053|471045779|FG000|Overall Study|Untreated|0|||
130841440|NCT01327053|471045780|FG001|Overall Study|Untreated|1|||
130841441|NCT01574157|471045781|FG000|Overall Study|Withdrawal by Subject|4|||
130841442|NCT01574157|471045782|FG001|Overall Study|Withdrawal by Subject|5|||
130841443|NCT01574157|471045781|FG000|Overall Study|Lost to Follow-up|0|||
130841444|NCT01574157|471045782|FG001|Overall Study|Lost to Follow-up|3|||
130841445|NCT00721578|471045783|FG000|Overall Study|Death|1|||
130841446|NCT00721578|471045784|FG001|Overall Study|Death|1|||
130841447|NCT00721578|471045783|FG000|Overall Study|Withdrawal by Subject|1|||
130841448|NCT00721578|471045784|FG001|Overall Study|Withdrawal by Subject|1|||
130841449|NCT01944098|471045785|FG000|Overall Study|Physician Decision|1|||
130841450|NCT01944098|471045786|FG001|Overall Study|Physician Decision|0|||
130841451|NCT05032690|471045787|FG000|Period 1|Adverse Event|0|||
130841452|NCT05032690|471045788|FG001|Period 1|Adverse Event|1|||
130841453|NCT05032690|471045789|FG002|Period 1|Adverse Event|0|||
130841454|NCT05032690|471045790|FG003|Period 1|Adverse Event|0|||
130841455|NCT05032690|471045787|FG000|Period 1|Withdrawal by Subject|1|||
130841456|NCT05032690|471045788|FG001|Period 1|Withdrawal by Subject|0|||
130841457|NCT05032690|471045789|FG002|Period 1|Withdrawal by Subject|0|||
130841458|NCT05032690|471045790|FG003|Period 1|Withdrawal by Subject|0|||
130841459|NCT05032690|471045787|FG000|Period 1|No longer meets eligibility criteria|0|||
130841460|NCT05032690|471045788|FG001|Period 1|No longer meets eligibility criteria|1|||
130841461|NCT05032690|471045789|FG002|Period 1|No longer meets eligibility criteria|0|||
130841462|NCT05032690|471045790|FG003|Period 1|No longer meets eligibility criteria|0|||
130841463|NCT05032690|471045787|FG000|Period 2|Adverse Event|1|||
130841464|NCT05032690|471045788|FG001|Period 2|Adverse Event|0|||
130841465|NCT05032690|471045789|FG002|Period 2|Adverse Event|0|||
130841466|NCT05032690|471045790|FG003|Period 2|Adverse Event|0|||
130841467|NCT05032690|471045787|FG000|Period 2|Withdrawal by Subject|0|||
130841468|NCT05032690|471045788|FG001|Period 2|Withdrawal by Subject|1|||
130841469|NCT05032690|471045789|FG002|Period 2|Withdrawal by Subject|0|||
130841470|NCT05032690|471045790|FG003|Period 2|Withdrawal by Subject|0|||
130841471|NCT05032690|471045787|FG000|Period 2|No longer meets eligibility criteria|0|||
130841472|NCT05032690|471045788|FG001|Period 2|No longer meets eligibility criteria|1|||
130841473|NCT05032690|471045789|FG002|Period 2|No longer meets eligibility criteria|0|||
130841474|NCT05032690|471045790|FG003|Period 2|No longer meets eligibility criteria|0|||
130841475|NCT05032690|471045787|FG000|Period 3|Adverse Event|0|||
130841476|NCT05032690|471045788|FG001|Period 3|Adverse Event|1|||
130841477|NCT05032690|471045789|FG002|Period 3|Adverse Event|0|||
130841478|NCT05032690|471045790|FG003|Period 3|Adverse Event|0|||
130841479|NCT00433160|471045797|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
130841480|NCT00433160|471045798|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
130841481|NCT00433160|471045797|FG000|52-Week Double-Blind (DB) Period|Death|0|||
130841482|NCT00433160|471045798|FG001|52-Week Double-Blind (DB) Period|Death|0|||
130841483|NCT00433160|471045797|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
130841484|NCT00433160|471045798|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
130841485|NCT00433160|471045797|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
130841486|NCT00433160|471045798|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
130841487|NCT00433160|471045797|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
130841488|NCT00433160|471045798|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
130841489|NCT00433160|471045797|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
130841490|NCT00433160|471045798|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
130841491|NCT00433160|471045797|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
130841492|NCT00433160|471045798|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
130841493|NCT00433160|471045797|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
130841494|NCT00433160|471045798|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
130841495|NCT00433160|471045797|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
130841496|NCT00433160|471045798|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
130841497|NCT00433160|471045797|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
130841498|NCT00433160|471045798|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
130841499|NCT00433160|471045797|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
130841500|NCT00433160|471045798|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
130841501|NCT00433160|471045797|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
130841502|NCT00433160|471045798|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
130841503|NCT00433160|471045797|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
130841504|NCT00433160|471045798|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
130841505|NCT00433160|471045797|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
130841506|NCT00433160|471045798|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
130841507|NCT00433160|471045797|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
130841508|NCT00433160|471045798|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
130841509|NCT00433160|471045797|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
130841510|NCT00433160|471045798|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
130841511|NCT02080481|471045799|FG000|Overall Study|Never received a block.|1|||
130841512|NCT02080481|471045800|FG001|Overall Study|Never received a block.|0|||
130841513|NCT02226198|471047284|FG000|Lead-in Phase|Protocol Violation|1|||
130841514|NCT02226198|471047285|FG001|Lead-in Phase|Protocol Violation|0|||
130841515|NCT02226198|471047286|FG002|Lead-in Phase|Protocol Violation|0|||
130841516|NCT02226198|471047284|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
130841517|NCT02226198|471047285|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
130841518|NCT02226198|471047286|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
130841519|NCT01440517|471047288|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
130841520|NCT01288612|471047290|FG000|Overall Study|Unable to contact|11|||
130841521|NCT01288612|471047291|FG001|Overall Study|Unable to contact|16|||
130841522|NCT01288612|471047292|FG002|Overall Study|Unable to contact|20|||
130841523|NCT01288612|471047290|FG000|Overall Study|Declined|78|||
130841524|NCT01288612|471047291|FG001|Overall Study|Declined|63|||
130841525|NCT01288612|471047292|FG002|Overall Study|Declined|62|||
130841526|NCT01288612|471047290|FG000|Overall Study|Unable to intubate|0|||
130841527|NCT01288612|471047291|FG001|Overall Study|Unable to intubate|3|||
130841528|NCT01288612|471047292|FG002|Overall Study|Unable to intubate|0|||
130841529|NCT00840060|471047293|FG000|Overall Study|Withdrawal by Subject|1|||
130841530|NCT00840060|471047294|FG001|Overall Study|Withdrawal by Subject|0|||
130841531|NCT00840060|471047293|FG000|Overall Study|Change in emotional/behavioral status|0|||
130841532|NCT00840060|471047294|FG001|Overall Study|Change in emotional/behavioral status|1|||
130841533|NCT00871923|471047295|FG000|Overall Study|Death|1|||
130841534|NCT00871923|471047295|FG000|Overall Study|Withdrawal by Subject|1|||
130841535|NCT05599451|471047300|FG000|Overall Study|Not randomized|11|||
130841536|NCT05599451|471047301|FG001|Overall Study|Not randomized|0|||
130841537|NCT05599451|471047302|FG002|Overall Study|Not randomized|0|||
130841538|NCT05599451|471047303|FG003|Overall Study|Not randomized|0|||
130841539|NCT05599451|471047304|FG004|Overall Study|Not randomized|0|||
130841540|NCT05599451|471047300|FG000|Overall Study|Physician Decision|0|||
130841541|NCT05599451|471047301|FG001|Overall Study|Physician Decision|0|||
130841542|NCT05599451|471047302|FG002|Overall Study|Physician Decision|0|||
130841543|NCT05599451|471047303|FG003|Overall Study|Physician Decision|1|||
130841544|NCT05599451|471047304|FG004|Overall Study|Physician Decision|0|||
130841545|NCT02723006|471047305|FG000|Overall Study|Withdrawal by Subject|0|||
130841546|NCT02723006|471047306|FG001|Overall Study|Withdrawal by Subject|1|||
130841547|NCT02723006|471047307|FG002|Overall Study|Withdrawal by Subject|1|||
130841548|NCT02723006|471047305|FG000|Overall Study|Study Terminated by Sponsor|1|||
130841549|NCT02723006|471047306|FG001|Overall Study|Study Terminated by Sponsor|6|||
130841550|NCT02723006|471047307|FG002|Overall Study|Study Terminated by Sponsor|6|||
130841551|NCT00496483|471047308|FG000|Overall Study|Not dosed|9|||
130841552|NCT00496483|471047308|FG000|Overall Study|Adverse Event|2|||
130841553|NCT00496483|471047308|FG000|Overall Study|Lack of Efficacy|1|||
130841554|NCT00303446|471047309|FG000|Overall Study|Withdrawal by Subject|2|||
130841555|NCT00303446|471047310|FG001|Overall Study|Withdrawal by Subject|2|||
130841556|NCT00303446|471047309|FG000|Overall Study|Death|0|||
130841557|NCT00303446|471047310|FG001|Overall Study|Death|1|||
130841558|NCT00303446|471047309|FG000|Overall Study|Physician Decision|0|||
130841559|NCT00303446|471047310|FG001|Overall Study|Physician Decision|1|||
130841560|NCT04258995|471047311|FG000|Overall Study|Lost to Follow-up|1|||
130841561|NCT04258995|471047312|FG001|Overall Study|Lost to Follow-up|1|||
130841562|NCT00642174|471047323|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
130841563|NCT00642174|471047324|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
130841564|NCT00896363|471047325|FG000|Overall Study|Adverse Event|3|||
130841565|NCT00896363|471047326|FG001|Overall Study|Adverse Event|4|||
130841566|NCT00896363|471047327|FG002|Overall Study|Adverse Event|2|||
130841567|NCT00896363|471047325|FG000|Overall Study|Lack of Efficacy|0|||
130841568|NCT00896363|471047326|FG001|Overall Study|Lack of Efficacy|2|||
130841569|NCT00896363|471047327|FG002|Overall Study|Lack of Efficacy|1|||
130841570|NCT00896363|471047325|FG000|Overall Study|Withdrawal by Subject|3|||
130841571|NCT00896363|471047326|FG001|Overall Study|Withdrawal by Subject|5|||
130841572|NCT00896363|471047327|FG002|Overall Study|Withdrawal by Subject|5|||
130841573|NCT01145352|471047332|FG000|Overall Study|Found to have been registered twice|6|||
130841574|NCT01145352|471047332|FG000|Overall Study|Treated before marketing approval|4|||
130841575|NCT01145352|471047332|FG000|Overall Study|Syringe formulation was used|1|||
130841576|NCT01967823|471047333|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
130841577|NCT00316693|471047334|FG000|Overall Study|Adverse Event|6|||
130841578|NCT00316693|471047335|FG001|Overall Study|Adverse Event|1|||
130841579|NCT00316693|471047334|FG000|Overall Study|Protocol Violation|1|||
130841580|NCT00316693|471047335|FG001|Overall Study|Protocol Violation|0|||
130841581|NCT00316693|471047334|FG000|Overall Study|Withdrawal by Subject|6|||
130841582|NCT00316693|471047335|FG001|Overall Study|Withdrawal by Subject|6|||
130841583|NCT00316693|471047334|FG000|Overall Study|Lost to Follow-up|26|||
130841584|NCT00316693|471047335|FG001|Overall Study|Lost to Follow-up|34|||
130841585|NCT00316693|471047334|FG000|Overall Study|Other|38|||
130841586|NCT00316693|471047335|FG001|Overall Study|Other|44|||
130841587|NCT03002818|471047339|FG000|Overall Study|Decision of the investigator|1|||
130841588|NCT00711113|471047343|FG000|Overall Study|Lost to Follow-up|9|||
130841589|NCT00711113|471047343|FG000|Overall Study|Implant lost|2|||
130841590|NCT01606787|471047350|FG000|Overall Study|Withdrawal by Subject|4|||
130841591|NCT01606787|471047351|FG001|Overall Study|Withdrawal by Subject|5|||
130841592|NCT01606787|471047350|FG000|Overall Study|Surgery canceled|0|||
130841593|NCT01606787|471047351|FG001|Overall Study|Surgery canceled|2|||
130841594|NCT05289271|471047352|FG000|Overall Study|Mistakenly allocated, untreated|1|||
130841595|NCT05289271|471047353|FG001|Overall Study|Mistakenly allocated, untreated|0|||
130841596|NCT01257568|471047354|FG000|Overall Study|Lost to Follow-up|2|||
130841597|NCT01257568|471047354|FG000|Overall Study|Withdrawal by Subject|6|||
130841598|NCT01257568|471047354|FG000|Overall Study|Terminated|1|||
130841599|NCT01257568|471047354|FG000|Overall Study|Component Revision|24|||
130841600|NCT00132691|471047361|FG000|Overall Study|Lost to Follow-up|5|||
130841601|NCT00132691|471047362|FG001|Overall Study|Lost to Follow-up|8|||
130841602|NCT00132691|471047361|FG000|Overall Study|Missed 2-year visit|4|||
130841603|NCT00132691|471047362|FG001|Overall Study|Missed 2-year visit|4|||
130841604|NCT00132691|471047361|FG000|Overall Study|Death|2|||
130841605|NCT00132691|471047362|FG001|Overall Study|Death|0|||
130841606|NCT01739933|471047366|FG000|Overall Study|Death|89|||
130841607|NCT01739933|471047367|FG001|Overall Study|Death|86|||
130841608|NCT01739933|471047366|FG000|Overall Study|Withdrawal by Subject|10|||
130841609|NCT01739933|471047367|FG001|Overall Study|Withdrawal by Subject|8|||
130841610|NCT01739933|471047366|FG000|Overall Study|Lost to Follow-up|3|||
130841611|NCT01739933|471047367|FG001|Overall Study|Lost to Follow-up|10|||
130841612|NCT01739933|471047366|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
130841613|NCT01739933|471047367|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
130841614|NCT04098367|471047368|FG000|Overall Study|Adverse Event|0|||
130841615|NCT04098367|471047369|FG001|Overall Study|Adverse Event|0|||
130841616|NCT04098367|471047370|FG002|Overall Study|Adverse Event|1|||
130841617|NCT04098367|471047368|FG000|Overall Study|Lost to Follow-up|1|||
130841618|NCT04098367|471047369|FG001|Overall Study|Lost to Follow-up|5|||
130841619|NCT04098367|471047370|FG002|Overall Study|Lost to Follow-up|2|||
130841620|NCT04098367|471047368|FG000|Overall Study|Withdrawal by Subject|0|||
130841621|NCT04098367|471047369|FG001|Overall Study|Withdrawal by Subject|0|||
130841622|NCT04098367|471047370|FG002|Overall Study|Withdrawal by Subject|1|||
130841623|NCT04098367|471047368|FG000|Overall Study|Sick . Could not attend visit|1|||
130841624|NCT04098367|471047369|FG001|Overall Study|Sick . Could not attend visit|0|||
130841625|NCT04098367|471047370|FG002|Overall Study|Sick . Could not attend visit|0|||
130841626|NCT01231321|471047376|FG000|Overall Study|Adverse Event|3|||
130841627|NCT01231321|471047376|FG000|Overall Study|Lack of Efficacy|2|||
130841628|NCT00908115|471047377|FG000|Overall Study|Other|14|||
130841629|NCT01728077|471047378|FG000|Overall Study|Lack of Efficacy|3|||
130841630|NCT01728077|471047379|FG001|Overall Study|Lack of Efficacy|1|||
130841631|NCT01728077|471047378|FG000|Overall Study|Lost to Follow-up|1|||
130841632|NCT01728077|471047379|FG001|Overall Study|Lost to Follow-up|0|||
130841633|NCT01728077|471047378|FG000|Overall Study|Subject choice|2|||
130841634|NCT01728077|471047379|FG001|Overall Study|Subject choice|3|||
130841635|NCT01728077|471047378|FG000|Overall Study|Death|0|||
130841636|NCT01728077|471047379|FG001|Overall Study|Death|1|||
130841637|NCT01728077|471047378|FG000|Overall Study|Patient moving|1|||
130841638|NCT01728077|471047379|FG001|Overall Study|Patient moving|0|||
130841639|NCT01728077|471047378|FG000|Overall Study|Non compliance|1|||
130841640|NCT01728077|471047379|FG001|Overall Study|Non compliance|0|||
130841641|NCT04686084|471047385|FG000|Overall Study|Lost to Follow-up|1|||
130841642|NCT05479097|471047388|FG000|Overall Study|Withdrawal by Subject|2|||
130841643|NCT03894969|471047391|FG000|Overall Study|Adverse Event|0|||
130841644|NCT03894969|471047392|FG001|Overall Study|Adverse Event|2|||
130841645|NCT03894969|471047393|FG002|Overall Study|Adverse Event|0|||
130841646|NCT03894969|471047394|FG003|Overall Study|Adverse Event|1|||
130841647|NCT03894969|471047395|FG004|Overall Study|Adverse Event|2|||
130841648|NCT03894969|471047391|FG000|Overall Study|Lost to Follow-up|3|||
130841649|NCT03894969|471047392|FG001|Overall Study|Lost to Follow-up|1|||
130841650|NCT03894969|471047393|FG002|Overall Study|Lost to Follow-up|1|||
130841651|NCT03894969|471047394|FG003|Overall Study|Lost to Follow-up|0|||
130841652|NCT03894969|471047395|FG004|Overall Study|Lost to Follow-up|0|||
130841653|NCT03894969|471047391|FG000|Overall Study|Withdrawal by Subject|2|||
130841654|NCT03894969|471047392|FG001|Overall Study|Withdrawal by Subject|1|||
130841655|NCT03894969|471047393|FG002|Overall Study|Withdrawal by Subject|3|||
130841656|NCT03894969|471047394|FG003|Overall Study|Withdrawal by Subject|4|||
130841657|NCT03894969|471047395|FG004|Overall Study|Withdrawal by Subject|8|||
130841658|NCT03894969|471047391|FG000|Overall Study|Other|0|||
130841659|NCT03894969|471047392|FG001|Overall Study|Other|0|||
130841660|NCT03894969|471047393|FG002|Overall Study|Other|0|||
130841661|NCT03894969|471047394|FG003|Overall Study|Other|0|||
130841662|NCT03894969|471047395|FG004|Overall Study|Other|3|||
130841663|NCT03894969|471047391|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
130841664|NCT03894969|471047392|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
130841665|NCT03894969|471047393|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
130841666|NCT03894969|471047394|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
130841667|NCT03894969|471047395|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
130841668|NCT03894969|471047391|FG000|Overall Study|Solicited Adverse Event|0|||
130841669|NCT03894969|471047392|FG001|Overall Study|Solicited Adverse Event|1|||
130841670|NCT03894969|471047393|FG002|Overall Study|Solicited Adverse Event|0|||
130841671|NCT03894969|471047394|FG003|Overall Study|Solicited Adverse Event|0|||
130841672|NCT03894969|471047395|FG004|Overall Study|Solicited Adverse Event|0|||
130841673|NCT00468676|471047397|FG000|Overall Study|Lost to Follow-up|14|||
130841674|NCT00468676|471047398|FG001|Overall Study|Lost to Follow-up|11|||
130841675|NCT00468676|471047397|FG000|Overall Study|Death|2|||
130841676|NCT00468676|471047398|FG001|Overall Study|Death|1|||
130841677|NCT00578877|471047403|FG000|Overall Study|Lost to Follow-up|8|||
130841678|NCT00578877|471047404|FG001|Overall Study|Lost to Follow-up|10|||
130841679|NCT00578877|471047403|FG000|Overall Study|early discontinue|61|||
130841680|NCT00578877|471047404|FG001|Overall Study|early discontinue|101|||
130841681|NCT00578877|471047403|FG000|Overall Study|did not provide follow-up data|12|||
130841682|NCT00578877|471047404|FG001|Overall Study|did not provide follow-up data|17|||
130841683|NCT02437409|471047409|FG000|Overall Study|Withdrawal by Subject|3|||
130841684|NCT02437409|471047409|FG000|Overall Study|Screening failure|12|||
130841685|NCT00737568|471047410|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
130841686|NCT00737568|471047411|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
130841687|NCT00737568|471047410|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
130841688|NCT00737568|471047411|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
130841689|NCT00737568|471047410|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
130841690|NCT00737568|471047411|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
130841691|NCT00737568|471047410|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
130841692|NCT00737568|471047411|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
130841693|NCT00737568|471047410|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
130841694|NCT00737568|471047411|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
130841695|NCT00737568|471047410|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
130841696|NCT00737568|471047411|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
130841697|NCT00737568|471047410|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
130841698|NCT00737568|471047411|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
130841699|NCT00737568|471047410|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
130841700|NCT00737568|471047411|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
130841701|NCT00737568|471047410|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
130841702|NCT00737568|471047411|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
130841703|NCT00350272|471047412|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
130841704|NCT00350272|471047413|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
130841705|NCT00350272|471047412|FG000|Blinded 12-Week Treatment|Death|1|||
130841706|NCT00350272|471047413|FG001|Blinded 12-Week Treatment|Death|0|||
130841707|NCT00350272|471047412|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
130841708|NCT00350272|471047413|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
130841709|NCT00350272|471047412|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
130841710|NCT00350272|471047413|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
130841711|NCT00350272|471047412|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
130841712|NCT00350272|471047413|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
130841713|NCT00350272|471047412|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
130841714|NCT00350272|471047413|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
130841715|NCT00350272|471047412|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
130841716|NCT00350272|471047413|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
130841717|NCT00350272|471047412|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
130841718|NCT00350272|471047413|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
130841719|NCT00350272|471047412|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
130841720|NCT00350272|471047413|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
130841721|NCT00350272|471047412|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
130841722|NCT00350272|471047413|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
130841723|NCT00350272|471047412|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
130841724|NCT00350272|471047413|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
130841725|NCT02910401|471047414|FG000|Overall Study|Study closure Study closure|0|||
130841726|NCT02910401|471047415|FG001|Overall Study|Study closure Study closure|0|||
130841727|NCT02910401|471047416|FG002|Overall Study|Study closure Study closure|2|||
130841728|NCT02910401|471047414|FG000|Overall Study|Physician Decision|1|||
130841729|NCT02910401|471047415|FG001|Overall Study|Physician Decision|0|||
130841730|NCT02910401|471047416|FG002|Overall Study|Physician Decision|0|||
130841731|NCT03300024|471047417|FG000|Overall Study|Physician Decision|4|||
130841732|NCT03300024|471047418|FG001|Overall Study|Physician Decision|6|||
130841733|NCT03222973|471047421|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
130841734|NCT03222973|471047422|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
130841735|NCT03222973|471047423|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
130841736|NCT03222973|471047424|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
130841737|NCT03222973|471047421|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
130841738|NCT03222973|471047422|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
130841739|NCT03222973|471047423|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
130841740|NCT03222973|471047424|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
130841741|NCT03222973|471047421|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
130841742|NCT03222973|471047422|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
130841743|NCT03222973|471047423|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
130841744|NCT03222973|471047424|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
130841745|NCT03222973|471047421|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
130841746|NCT03222973|471047422|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
130841747|NCT03222973|471047423|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
130841748|NCT03222973|471047424|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
130841749|NCT03222973|471047421|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
130841750|NCT03222973|471047422|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
130841751|NCT03222973|471047423|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
130841752|NCT03222973|471047424|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
130841753|NCT03222973|471047421|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
130841754|NCT03222973|471047422|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
130841755|NCT03222973|471047423|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
130841756|NCT03222973|471047424|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
130841757|NCT03222973|471047421|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
130841758|NCT03222973|471047422|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
130841759|NCT03222973|471047423|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
130841760|NCT03222973|471047424|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
130841761|NCT03222973|471047421|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
130841762|NCT03222973|471047422|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
130841763|NCT03222973|471047423|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
130841764|NCT03222973|471047424|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
130841765|NCT03222973|471047421|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
130841766|NCT03222973|471047422|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
130841767|NCT03222973|471047423|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
130841768|NCT03222973|471047424|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
130841769|NCT03222973|471047421|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
130841770|NCT03222973|471047422|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
130841771|NCT03222973|471047423|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
130841772|NCT03222973|471047424|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
130841773|NCT03222973|471047421|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
130841774|NCT03222973|471047422|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
130841775|NCT03222973|471047423|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
130841776|NCT03222973|471047424|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
130841777|NCT03222973|471047421|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
130841778|NCT03222973|471047422|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
130841779|NCT03222973|471047423|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
130841780|NCT03222973|471047424|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
130841781|NCT03551665|471047425|FG000|Overall Study|Lost to Follow-up|11|||
130841782|NCT03551665|471047426|FG001|Overall Study|Lost to Follow-up|2|||
130841783|NCT01263015|471049510|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
130841784|NCT01263015|471049511|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
130841785|NCT01263015|471049510|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
130841786|NCT01263015|471049511|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
130841787|NCT01263015|471049510|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
130841788|NCT01263015|471049511|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
130841789|NCT01263015|471049510|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
130841790|NCT01263015|471049511|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
130841791|NCT01263015|471049510|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
130841792|NCT01263015|471049511|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
130841793|NCT01263015|471049510|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
130841794|NCT01263015|471049511|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
130841795|NCT01263015|471049510|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
130841796|NCT01263015|471049511|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
130841797|NCT01263015|471049510|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
130841798|NCT01263015|471049511|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
130841799|NCT01263015|471049510|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
130841800|NCT01263015|471049511|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
130841801|NCT01263015|471049510|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
130841802|NCT01263015|471049511|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
130841803|NCT01263015|471049510|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
130841804|NCT01263015|471049511|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
130841805|NCT01263015|471049510|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
130841806|NCT01263015|471049511|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
130841807|NCT00413894|471049513|FG000|Overall Study|Withdrawal by Subject|10|||
130841808|NCT00413894|471049513|FG000|Overall Study|Administrative Reasons|1|||
130841809|NCT00413894|471049513|FG000|Overall Study|Hb <10 grams/deciliter|12|||
130841810|NCT00413894|471049513|FG000|Overall Study|Adverse Event|28|||
130841811|NCT00413894|471049513|FG000|Overall Study|Protocol Violation|11|||
130841812|NCT00413894|471049513|FG000|Overall Study|Other|18|||
130841813|NCT04225676|471049514|FG000|Overall Study|Physician Decision|1|||
130841814|NCT04225676|471049514|FG000|Overall Study|Lack of Efficacy|1|||
130841815|NCT04225676|471049514|FG000|Overall Study|Study terminated by sponsor|3|||
130841816|NCT03245736|471049515|FG000|Overall Study|Adverse Event|1|||
130841817|NCT03245736|471049515|FG000|Overall Study|Progressive Disease|4|||
130841818|NCT01942161|471049516|FG000|Overall Study|Adverse Event|1|||
130841819|NCT01942161|471049517|FG001|Overall Study|Adverse Event|2|||
130841820|NCT01942161|471049518|FG002|Overall Study|Adverse Event|5|||
130841821|NCT01942161|471049516|FG000|Overall Study|Physician Decision|3|||
130841822|NCT01942161|471049517|FG001|Overall Study|Physician Decision|1|||
130841823|NCT01942161|471049518|FG002|Overall Study|Physician Decision|0|||
130841824|NCT01942161|471049516|FG000|Overall Study|Protocol Violation|1|||
130841825|NCT01942161|471049517|FG001|Overall Study|Protocol Violation|0|||
130841826|NCT01942161|471049518|FG002|Overall Study|Protocol Violation|0|||
130841827|NCT01942161|471049516|FG000|Overall Study|Withdrawal by Subject|3|||
130841828|NCT01942161|471049517|FG001|Overall Study|Withdrawal by Subject|3|||
130841829|NCT01942161|471049518|FG002|Overall Study|Withdrawal by Subject|1|||
130841830|NCT02251717|471049522|FG000|Overall Study|Adverse Event|0|||
130841831|NCT02251717|471049523|FG001|Overall Study|Adverse Event|1|||
130841832|NCT02251717|471049522|FG000|Overall Study|Withdrew Consent|1|||
130841833|NCT02251717|471049523|FG001|Overall Study|Withdrew Consent|0|||
130841834|NCT03356977|471049524|FG000|Overall Study|Lost to Follow-up|3|||
130841835|NCT03356977|471049524|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130841836|NCT00354107|471049530|FG000|Overall Study|Adverse Event|2|||
130841837|NCT00354107|471049530|FG000|Overall Study|Physician Decision|2|||
130841838|NCT00354107|471049530|FG000|Overall Study|Withdrawal by Subject|1|||
130841839|NCT03575065|471049536|FG000|Overall Study|Death|31|||
130841840|NCT03575065|471049537|FG001|Overall Study|Death|12|||
130841841|NCT03575065|471049536|FG000|Overall Study|Sponsor's Decision|28|||
130841842|NCT03575065|471049537|FG001|Overall Study|Sponsor's Decision|13|||
130841843|NCT03575065|471049536|FG000|Overall Study|Withdrawal by Subject|2|||
130841844|NCT03575065|471049537|FG001|Overall Study|Withdrawal by Subject|1|||
130841845|NCT03575065|471049536|FG000|Overall Study|Lost to Follow-up|1|||
130841846|NCT03575065|471049537|FG001|Overall Study|Lost to Follow-up|0|||
130841847|NCT02323126|471049542|FG000|Overall Study|Patient / guardian decision|0|||
130841848|NCT02323126|471049543|FG001|Overall Study|Patient / guardian decision|1|||
130841849|NCT02323126|471049544|FG002|Overall Study|Patient / guardian decision|2|||
130841850|NCT02323126|471049542|FG000|Overall Study|Progressive disease|14|||
130841851|NCT02323126|471049543|FG001|Overall Study|Progressive disease|8|||
130841852|NCT02323126|471049544|FG002|Overall Study|Progressive disease|14|||
130841853|NCT02323126|471049542|FG000|Overall Study|Physician Decision|0|||
130841854|NCT02323126|471049543|FG001|Overall Study|Physician Decision|1|||
130841855|NCT02323126|471049544|FG002|Overall Study|Physician Decision|3|||
130841856|NCT02323126|471049542|FG000|Overall Study|Death|1|||
130841857|NCT02323126|471049543|FG001|Overall Study|Death|1|||
130841858|NCT02323126|471049544|FG002|Overall Study|Death|4|||
130841859|NCT02323126|471049542|FG000|Overall Study|Adverse Event|3|||
130841860|NCT02323126|471049543|FG001|Overall Study|Adverse Event|5|||
130841861|NCT02323126|471049544|FG002|Overall Study|Adverse Event|7|||
130841862|NCT01685801|471049545|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
130841863|NCT01685801|471049546|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
130841864|NCT01685801|471049547|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
130841865|NCT01685801|471049548|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
130841866|NCT01685801|471049545|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
130841867|NCT01685801|471049546|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
130841868|NCT01685801|471049547|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
130841869|NCT01685801|471049548|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
130841870|NCT03447314|471049552|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
130841871|NCT03447314|471049553|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
130841872|NCT03447314|471049554|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
130841873|NCT03447314|471049555|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
130841874|NCT03447314|471049556|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
130841875|NCT03447314|471049557|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
130841876|NCT03447314|471049558|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
130841877|NCT03447314|471049559|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130841878|NCT03447314|471049560|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130841879|NCT03447314|471049561|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130841880|NCT03447314|471049562|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
130841881|NCT03447314|471049563|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
130841882|NCT03447314|471049564|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130841883|NCT03447314|471049565|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130841884|NCT03447314|471049566|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130841885|NCT03447314|471049567|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130841886|NCT03447314|471049568|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130841887|NCT03447314|471049569|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130841888|NCT03447314|471049552|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130841889|NCT03447314|471049553|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841890|NCT03447314|471049554|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130841891|NCT03447314|471049555|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841892|NCT03447314|471049556|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841893|NCT03447314|471049557|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130841894|NCT03447314|471049558|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130841895|NCT03447314|471049559|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841896|NCT03447314|471049560|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841897|NCT03447314|471049561|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841898|NCT03447314|471049562|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841899|NCT03447314|471049563|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841900|NCT03447314|471049564|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841901|NCT03447314|471049565|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841902|NCT03447314|471049566|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841903|NCT03447314|471049567|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841904|NCT03447314|471049568|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841905|NCT03447314|471049569|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130841906|NCT03447314|471049552|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841907|NCT03447314|471049553|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841908|NCT03447314|471049554|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
130841909|NCT03447314|471049555|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841910|NCT03447314|471049556|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841911|NCT03447314|471049557|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841912|NCT03447314|471049558|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841913|NCT03447314|471049559|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841914|NCT03447314|471049560|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841915|NCT03447314|471049561|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841916|NCT03447314|471049562|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841917|NCT03447314|471049563|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841918|NCT03447314|471049564|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841919|NCT03447314|471049565|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841920|NCT03447314|471049566|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841921|NCT03447314|471049567|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841922|NCT03447314|471049568|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841923|NCT03447314|471049569|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130841924|NCT03447314|471049552|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841925|NCT03447314|471049553|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841926|NCT03447314|471049554|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
130841927|NCT03447314|471049555|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841928|NCT03447314|471049556|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841929|NCT03447314|471049557|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841930|NCT03447314|471049558|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841931|NCT03447314|471049559|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841932|NCT03447314|471049560|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841933|NCT03447314|471049561|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841934|NCT03447314|471049562|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841935|NCT03447314|471049563|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841936|NCT03447314|471049564|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841937|NCT03447314|471049565|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841938|NCT03447314|471049566|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841939|NCT03447314|471049567|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841940|NCT03447314|471049568|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841941|NCT03447314|471049569|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130841942|NCT03447314|471049552|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841943|NCT03447314|471049553|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841944|NCT03447314|471049554|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841945|NCT03447314|471049555|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841946|NCT03447314|471049556|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841947|NCT03447314|471049557|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841948|NCT03447314|471049558|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841949|NCT03447314|471049559|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841950|NCT03447314|471049560|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841951|NCT03447314|471049561|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841952|NCT03447314|471049562|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
130841953|NCT03447314|471049563|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841954|NCT03447314|471049564|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841955|NCT03447314|471049565|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841956|NCT03447314|471049566|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841957|NCT03447314|471049567|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841958|NCT03447314|471049568|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841959|NCT03447314|471049569|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130841960|NCT03447314|471049552|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841961|NCT03447314|471049553|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841962|NCT03447314|471049554|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841963|NCT03447314|471049555|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
130841964|NCT03447314|471049556|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841965|NCT03447314|471049557|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
130841966|NCT03447314|471049558|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841967|NCT03447314|471049559|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841968|NCT03447314|471049560|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841969|NCT03447314|471049561|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841970|NCT03447314|471049562|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841971|NCT03447314|471049563|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841972|NCT03447314|471049564|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841973|NCT03447314|471049565|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841974|NCT03447314|471049566|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841975|NCT03447314|471049567|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841976|NCT03447314|471049568|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841977|NCT03447314|471049569|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130841978|NCT04600076|471049570|FG000|Overall Study|Lost to Follow-up|3|||
130841979|NCT02891681|471049571|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
130841980|NCT02891681|471049572|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
130841981|NCT02891681|471049573|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
130841982|NCT02891681|471049571|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
130841983|NCT02891681|471049572|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
130841984|NCT02891681|471049573|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
130841985|NCT02891681|471049571|FG000|Overall Study|Taken off study after first imaging appointment|1|||
130841986|NCT02891681|471049572|FG001|Overall Study|Taken off study after first imaging appointment|0|||
130841987|NCT02891681|471049573|FG002|Overall Study|Taken off study after first imaging appointment|0|||
130841988|NCT03006458|471049579|FG000|First Intervention|Unsatisfied Vision|0|||
130841989|NCT03006458|471049580|FG001|First Intervention|Unsatisfied Vision|3|||
130841990|NCT00957944|471049581|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
130841991|NCT00957944|471049582|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
130841992|NCT00522418|471049588|FG000|Overall Study|Local IRB Consent Violation|5|||
130841993|NCT00522418|471049589|FG001|Overall Study|Local IRB Consent Violation|5|||
130841994|NCT00522418|471049588|FG000|Overall Study|Early Study Termination|46|||
130841995|NCT00522418|471049589|FG001|Overall Study|Early Study Termination|47|||
130841996|NCT00522418|471049588|FG000|Overall Study|Noncompliance|2|||
130841997|NCT00522418|471049589|FG001|Overall Study|Noncompliance|2|||
130841998|NCT00522418|471049588|FG000|Overall Study|Reason Not Specified|3|||
130841999|NCT00522418|471049589|FG001|Overall Study|Reason Not Specified|1|||
130842000|NCT00522418|471049588|FG000|Overall Study|Consent Withdraw|1|||
130842001|NCT00522418|471049589|FG001|Overall Study|Consent Withdraw|2|||
130842002|NCT00522418|471049588|FG000|Overall Study|Lack of Efficacy|0|||
130842003|NCT00522418|471049589|FG001|Overall Study|Lack of Efficacy|1|||
130842004|NCT01482169|471049590|FG000|Overall Study|Physician Decision|2|||
130842005|NCT01468233|471049591|FG000|Treatment Period 1|Adverse Event|5|||
130842006|NCT01468233|471049592|FG001|Treatment Period 1|Adverse Event|3|||
130842007|NCT01468233|471049593|FG002|Treatment Period 1|Adverse Event|0|||
130842008|NCT01468233|471049594|FG003|Treatment Period 1|Adverse Event|0|||
130842009|NCT01468233|471049595|FG004|Treatment Period 1|Adverse Event|0|||
130842010|NCT01468233|471049596|FG005|Treatment Period 1|Adverse Event|0|||
130842011|NCT01468233|471049591|FG000|Treatment Period 1|Withdrawal by Subject|3|||
130842012|NCT01468233|471049592|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130842013|NCT01468233|471049593|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130842014|NCT01468233|471049594|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130842015|NCT01468233|471049595|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130842016|NCT01468233|471049596|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130842017|NCT01468233|471049591|FG000|Treatment Period 1|Lost to Follow-up|3|||
130842018|NCT01468233|471049592|FG001|Treatment Period 1|Lost to Follow-up|0|||
130842019|NCT01468233|471049593|FG002|Treatment Period 1|Lost to Follow-up|0|||
130842020|NCT01468233|471049594|FG003|Treatment Period 1|Lost to Follow-up|0|||
130842021|NCT01468233|471049595|FG004|Treatment Period 1|Lost to Follow-up|0|||
130842022|NCT01468233|471049596|FG005|Treatment Period 1|Lost to Follow-up|0|||
130842023|NCT01468233|471049591|FG000|Treatment Period 1|Other|1|||
130842024|NCT01468233|471049592|FG001|Treatment Period 1|Other|1|||
130842025|NCT01468233|471049593|FG002|Treatment Period 1|Other|0|||
130842026|NCT01468233|471049594|FG003|Treatment Period 1|Other|0|||
130842027|NCT01468233|471049595|FG004|Treatment Period 1|Other|0|||
130842028|NCT01468233|471049596|FG005|Treatment Period 1|Other|0|||
130842029|NCT01468233|471049591|FG000|Treatment Period 2|Adverse Event|0|||
130842030|NCT01468233|471049592|FG001|Treatment Period 2|Adverse Event|0|||
130842031|NCT01468233|471049593|FG002|Treatment Period 2|Adverse Event|3|||
130842032|NCT01468233|471049594|FG003|Treatment Period 2|Adverse Event|0|||
130842033|NCT01468233|471049595|FG004|Treatment Period 2|Adverse Event|2|||
130842034|NCT01468233|471049596|FG005|Treatment Period 2|Adverse Event|1|||
130842035|NCT01468233|471049591|FG000|Treatment Period 2|Lack of Efficacy|0|||
130842036|NCT01468233|471049592|FG001|Treatment Period 2|Lack of Efficacy|0|||
130842037|NCT01468233|471049593|FG002|Treatment Period 2|Lack of Efficacy|9|||
130842038|NCT01468233|471049594|FG003|Treatment Period 2|Lack of Efficacy|2|||
130842039|NCT01468233|471049595|FG004|Treatment Period 2|Lack of Efficacy|0|||
130842040|NCT01468233|471049596|FG005|Treatment Period 2|Lack of Efficacy|1|||
130842041|NCT01468233|471049591|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130842042|NCT01468233|471049592|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130842043|NCT01468233|471049593|FG002|Treatment Period 2|Withdrawal by Subject|9|||
130842044|NCT01468233|471049594|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130842045|NCT01468233|471049595|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130842046|NCT01468233|471049596|FG005|Treatment Period 2|Withdrawal by Subject|1|||
130842047|NCT01468233|471049591|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
130842048|NCT01468233|471049592|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
130842049|NCT01468233|471049593|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
130842050|NCT01468233|471049594|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
130842051|NCT01468233|471049595|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
130842052|NCT01468233|471049596|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
130842053|NCT01468233|471049591|FG000|Treatment Period 2|Lost to Follow-up|0|||
130842054|NCT01468233|471049592|FG001|Treatment Period 2|Lost to Follow-up|0|||
130842055|NCT01468233|471049593|FG002|Treatment Period 2|Lost to Follow-up|3|||
130842056|NCT01468233|471049594|FG003|Treatment Period 2|Lost to Follow-up|0|||
130842057|NCT01468233|471049595|FG004|Treatment Period 2|Lost to Follow-up|2|||
130842058|NCT01468233|471049596|FG005|Treatment Period 2|Lost to Follow-up|0|||
130842059|NCT01468233|471049591|FG000|Treatment Period 2|Other|0|||
130842060|NCT01468233|471049592|FG001|Treatment Period 2|Other|0|||
130842061|NCT01468233|471049593|FG002|Treatment Period 2|Other|3|||
130842062|NCT01468233|471049594|FG003|Treatment Period 2|Other|0|||
130842063|NCT01468233|471049595|FG004|Treatment Period 2|Other|1|||
130842064|NCT01468233|471049596|FG005|Treatment Period 2|Other|0|||
130842065|NCT00457821|471049602|FG000|Part 2|Withdrawal by Subject|0|||
130842066|NCT00457821|471049603|FG001|Part 2|Withdrawal by Subject|0|||
130842067|NCT00457821|471049604|FG002|Part 2|Withdrawal by Subject|0|||
130842068|NCT00457821|471049605|FG003|Part 2|Withdrawal by Subject|0|||
130842069|NCT00457821|471049606|FG004|Part 2|Withdrawal by Subject|0|||
130842070|NCT00457821|471049607|FG005|Part 2|Withdrawal by Subject|0|||
130842071|NCT00457821|471049608|FG006|Part 2|Withdrawal by Subject|0|||
130842072|NCT00457821|471049609|FG007|Part 2|Withdrawal by Subject|1|||
130842073|NCT01632241|471049610|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
130842074|NCT01632241|471049611|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
130842075|NCT01632241|471049610|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
130842076|NCT01632241|471049611|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
130842077|NCT01632241|471049610|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
130842078|NCT01632241|471049611|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
130842079|NCT01632241|471049610|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
130842080|NCT01632241|471049611|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
130842081|NCT01632241|471049610|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
130842082|NCT01632241|471049611|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
130842083|NCT01632241|471049610|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
130842084|NCT01632241|471049611|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
130842085|NCT01632241|471049610|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
130842086|NCT01632241|471049611|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
130842087|NCT01632241|471049610|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
130842088|NCT01632241|471049611|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
130842089|NCT01632241|471049610|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
130842090|NCT01632241|471049611|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
130842091|NCT01632241|471049610|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
130842092|NCT01632241|471049611|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
130842093|NCT01632241|471049610|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
130842094|NCT01632241|471049611|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
130842095|NCT01632241|471049610|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
130842096|NCT01632241|471049611|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
130842097|NCT01632241|471049610|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
130842098|NCT01632241|471049611|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
130842099|NCT01632241|471049610|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
130842100|NCT01632241|471049611|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
130842101|NCT00855933|471049623|FG000|Overall Study|Withdrawal by Subject|0|||
130842102|NCT00855933|471049624|FG001|Overall Study|Withdrawal by Subject|1|||
130842103|NCT00951080|471049625|FG000|Overall Study|Adverse Event|3|||
130842104|NCT00951080|471049626|FG001|Overall Study|Adverse Event|3|||
130842105|NCT00951080|471049625|FG000|Overall Study|Lost to Follow-up|0|||
130842106|NCT00951080|471049626|FG001|Overall Study|Lost to Follow-up|1|||
130842107|NCT00951080|471049625|FG000|Overall Study|Physician Decision|4|||
130842108|NCT00951080|471049626|FG001|Overall Study|Physician Decision|1|||
130842109|NCT00951080|471049625|FG000|Overall Study|Other|19|||
130842110|NCT00951080|471049626|FG001|Overall Study|Other|22|||
130842111|NCT01960998|471049627|FG000|Overall Study|Lost to Follow-up|3|||
130842112|NCT01960998|471049628|FG001|Overall Study|Lost to Follow-up|7|||
130842113|NCT01960998|471049627|FG000|Overall Study|Death|0|||
130842114|NCT01960998|471049628|FG001|Overall Study|Death|1|||
130842115|NCT01960998|471049627|FG000|Overall Study|Withdrawal by Subject|8|||
130842116|NCT01960998|471049628|FG001|Overall Study|Withdrawal by Subject|2|||
130842117|NCT01960998|471049627|FG000|Overall Study|lost computer access|0|||
130842118|NCT01960998|471049628|FG001|Overall Study|lost computer access|1|||
130842119|NCT00759356|471049629|FG000|Overall Study|Adverse Event|0|||
130842120|NCT00759356|471049630|FG001|Overall Study|Adverse Event|1|||
130842121|NCT00759356|471049629|FG000|Overall Study|Withdrawal by Subject|0|||
130842122|NCT00759356|471049630|FG001|Overall Study|Withdrawal by Subject|2|||
130842123|NCT00759356|471049629|FG000|Overall Study|Subject was unable to return|1|||
130842124|NCT00759356|471049630|FG001|Overall Study|Subject was unable to return|0|||
130842125|NCT02851407|471049631|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130842126|NCT02851407|471049632|FG001|Overall Study|Withdrawal by parent/guardian|7|||
130842127|NCT02851407|471049631|FG000|Overall Study|Protocol deviation|0|||
130842128|NCT02851407|471049632|FG001|Overall Study|Protocol deviation|1|||
130842129|NCT02851407|471049631|FG000|Overall Study|Transferred to another hospital to continue|1|||
130842130|NCT02851407|471049632|FG001|Overall Study|Transferred to another hospital to continue|0|||
130842131|NCT02851407|471049631|FG000|Overall Study|Other Death|30|||
130842132|NCT02851407|471049632|FG001|Overall Study|Other Death|20|||
130842133|NCT02851407|471049631|FG000|Overall Study|Adverse event, serious fatal|6|||
130842134|NCT02851407|471049632|FG001|Overall Study|Adverse event, serious fatal|8|||
130842135|NCT02851407|471049631|FG000|Overall Study|Consent withdrawn by participant|5|||
130842136|NCT02851407|471049632|FG001|Overall Study|Consent withdrawn by participant|3|||
130842137|NCT02851407|471049631|FG000|Overall Study|Screen failure|2|||
130842138|NCT02851407|471049632|FG001|Overall Study|Screen failure|1|||
130842139|NCT02851407|471049631|FG000|Overall Study|Disease relapse|9|||
130842140|NCT02851407|471049632|FG001|Overall Study|Disease relapse|6|||
130842141|NCT02851407|471049631|FG000|Overall Study|Physician Decision|7|||
130842142|NCT02851407|471049632|FG001|Overall Study|Physician Decision|6|||
130842143|NCT02851407|471049631|FG000|Overall Study|Transferred to hospital closer to home|0|||
130842144|NCT02851407|471049632|FG001|Overall Study|Transferred to hospital closer to home|1|||
130842145|NCT02851407|471049631|FG000|Overall Study|Enrolled in an investigational study|0|||
130842146|NCT02851407|471049632|FG001|Overall Study|Enrolled in an investigational study|1|||
130842147|NCT02851407|471049631|FG000|Overall Study|Early recovery|1|||
130842148|NCT02851407|471049632|FG001|Overall Study|Early recovery|0|||
130842149|NCT02851407|471049631|FG000|Overall Study|Adverse event, non-fatal|7|||
130842150|NCT02851407|471049632|FG001|Overall Study|Adverse event, non-fatal|5|||
130842151|NCT02851407|471049631|FG000|Overall Study|Lost to Follow-up|0|||
130842152|NCT02851407|471049632|FG001|Overall Study|Lost to Follow-up|2|||
130842153|NCT01713283|471049636|FG000|Overall Study|Lack of Efficacy|10|||
130842154|NCT01713283|471049637|FG001|Overall Study|Lack of Efficacy|2|||
130842155|NCT01713283|471049636|FG000|Overall Study|Lost to Follow-up|1|||
130842156|NCT01713283|471049637|FG001|Overall Study|Lost to Follow-up|1|||
130842157|NCT02403635|471049638|FG000|Overall Study|Not eligible|9|||
130842158|NCT01904149|471049644|FG000|Overall Study|Adverse Event|3|||
130842159|NCT01904149|471049645|FG001|Overall Study|Adverse Event|4|||
130842160|NCT01904149|471049646|FG002|Overall Study|Adverse Event|0|||
130842161|NCT01904149|471049647|FG003|Overall Study|Adverse Event|1|||
130842162|NCT01904149|471049648|FG004|Overall Study|Adverse Event|1|||
130842163|NCT01904149|471049649|FG005|Overall Study|Adverse Event|2|||
130842164|NCT01904149|471049644|FG000|Overall Study|Lack of Efficacy|0|||
130842165|NCT01904149|471049645|FG001|Overall Study|Lack of Efficacy|3|||
130842166|NCT01904149|471049646|FG002|Overall Study|Lack of Efficacy|1|||
130842167|NCT01904149|471049647|FG003|Overall Study|Lack of Efficacy|3|||
130842168|NCT01904149|471049648|FG004|Overall Study|Lack of Efficacy|3|||
130842169|NCT01904149|471049649|FG005|Overall Study|Lack of Efficacy|1|||
130842170|NCT01904149|471049644|FG000|Overall Study|Withdrawal by Subject|1|||
130842171|NCT01904149|471049645|FG001|Overall Study|Withdrawal by Subject|3|||
130842172|NCT01904149|471049646|FG002|Overall Study|Withdrawal by Subject|1|||
130842173|NCT01904149|471049647|FG003|Overall Study|Withdrawal by Subject|0|||
130842174|NCT01904149|471049648|FG004|Overall Study|Withdrawal by Subject|1|||
130842175|NCT01904149|471049649|FG005|Overall Study|Withdrawal by Subject|0|||
130842176|NCT01904149|471049644|FG000|Overall Study|Protocol Violation|0|||
130842177|NCT01904149|471049645|FG001|Overall Study|Protocol Violation|1|||
130842178|NCT01904149|471049646|FG002|Overall Study|Protocol Violation|0|||
130842179|NCT01904149|471049647|FG003|Overall Study|Protocol Violation|0|||
130842180|NCT01904149|471049648|FG004|Overall Study|Protocol Violation|0|||
130842181|NCT01904149|471049649|FG005|Overall Study|Protocol Violation|0|||
130842182|NCT01904149|471049644|FG000|Overall Study|non compliance with study drug|1|||
130842183|NCT01904149|471049645|FG001|Overall Study|non compliance with study drug|0|||
130842184|NCT01904149|471049646|FG002|Overall Study|non compliance with study drug|0|||
130842185|NCT01904149|471049647|FG003|Overall Study|non compliance with study drug|0|||
130842186|NCT01904149|471049648|FG004|Overall Study|non compliance with study drug|0|||
130842187|NCT01904149|471049649|FG005|Overall Study|non compliance with study drug|0|||
130842188|NCT00835640|471049650|FG000|Second Intervention|Protocol Violation|1|||
130842189|NCT00835640|471049651|FG001|Second Intervention|Protocol Violation|0|||
130842190|NCT00812006|471049652|FG000|Overall Study|Lost to Follow-up|0|||
130842191|NCT00812006|471049653|FG001|Overall Study|Lost to Follow-up|0|||
130842192|NCT00812006|471049654|FG002|Overall Study|Lost to Follow-up|2|||
130842193|NCT00812006|471049652|FG000|Overall Study|Physician Decision|0|||
130842194|NCT00812006|471049653|FG001|Overall Study|Physician Decision|0|||
130842195|NCT00812006|471049654|FG002|Overall Study|Physician Decision|1|||
130842196|NCT00812006|471049652|FG000|Overall Study|Withdrawal by Subject|2|||
130842197|NCT00812006|471049653|FG001|Overall Study|Withdrawal by Subject|1|||
130842198|NCT00812006|471049654|FG002|Overall Study|Withdrawal by Subject|1|||
130842199|NCT00812006|471049652|FG000|Overall Study|Lack of Qualifying Event|4|||
130842200|NCT00812006|471049653|FG001|Overall Study|Lack of Qualifying Event|2|||
130842201|NCT00812006|471049654|FG002|Overall Study|Lack of Qualifying Event|2|||
130842202|NCT00068250|471049655|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
130842203|NCT00068250|471049656|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
130842204|NCT00068250|471049657|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
130842205|NCT00068250|471049658|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
130842206|NCT00235391|471049659|FG000|Overall Study|Adverse Event|4|||
130842207|NCT00235391|471049660|FG001|Overall Study|Adverse Event|5|||
130842208|NCT00235391|471049661|FG002|Overall Study|Adverse Event|10|||
130842209|NCT00235391|471049662|FG003|Overall Study|Adverse Event|72|||
130842210|NCT00235391|471049663|FG004|Overall Study|Adverse Event|5|||
130842211|NCT00235391|471049664|FG005|Overall Study|Adverse Event|2|||
130842212|NCT00235391|471049659|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130842213|NCT00235391|471049660|FG001|Overall Study|Abnormal laboratory value(s)|5|||
130842214|NCT00235391|471049661|FG002|Overall Study|Abnormal laboratory value(s)|4|||
130842215|NCT00235391|471049662|FG003|Overall Study|Abnormal laboratory value(s)|27|||
130842216|NCT00235391|471049663|FG004|Overall Study|Abnormal laboratory value(s)|1|||
130842217|NCT00235391|471049664|FG005|Overall Study|Abnormal laboratory value(s)|2|||
130842218|NCT00235391|471049659|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130842219|NCT00235391|471049660|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130842220|NCT00235391|471049661|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130842221|NCT00235391|471049662|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
130842222|NCT00235391|471049663|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
130842223|NCT00235391|471049664|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
130842224|NCT00235391|471049659|FG000|Overall Study|Condition no longer requires treatment|3|||
130842225|NCT00235391|471049660|FG001|Overall Study|Condition no longer requires treatment|0|||
130842226|NCT00235391|471049661|FG002|Overall Study|Condition no longer requires treatment|0|||
130842227|NCT00235391|471049662|FG003|Overall Study|Condition no longer requires treatment|11|||
130842228|NCT00235391|471049663|FG004|Overall Study|Condition no longer requires treatment|1|||
130842229|NCT00235391|471049664|FG005|Overall Study|Condition no longer requires treatment|0|||
130842230|NCT00235391|471049659|FG000|Overall Study|Protocol deviation|0|||
130842231|NCT00235391|471049660|FG001|Overall Study|Protocol deviation|0|||
130842232|NCT00235391|471049661|FG002|Overall Study|Protocol deviation|1|||
130842233|NCT00235391|471049662|FG003|Overall Study|Protocol deviation|11|||
130842234|NCT00235391|471049663|FG004|Overall Study|Protocol deviation|0|||
130842235|NCT00235391|471049664|FG005|Overall Study|Protocol deviation|0|||
130842236|NCT00235391|471049659|FG000|Overall Study|Withdrawal by Subject|2|||
130842237|NCT00235391|471049660|FG001|Overall Study|Withdrawal by Subject|3|||
130842238|NCT00235391|471049661|FG002|Overall Study|Withdrawal by Subject|3|||
130842239|NCT00235391|471049662|FG003|Overall Study|Withdrawal by Subject|61|||
130842240|NCT00235391|471049663|FG004|Overall Study|Withdrawal by Subject|5|||
130842241|NCT00235391|471049664|FG005|Overall Study|Withdrawal by Subject|0|||
130842242|NCT00235391|471049659|FG000|Overall Study|Lost to Follow-up|0|||
130842243|NCT00235391|471049660|FG001|Overall Study|Lost to Follow-up|3|||
130842244|NCT00235391|471049661|FG002|Overall Study|Lost to Follow-up|3|||
130842245|NCT00235391|471049662|FG003|Overall Study|Lost to Follow-up|16|||
130842246|NCT00235391|471049663|FG004|Overall Study|Lost to Follow-up|0|||
130842247|NCT00235391|471049664|FG005|Overall Study|Lost to Follow-up|0|||
130842248|NCT00235391|471049659|FG000|Overall Study|Administrative problems|0|||
130842249|NCT00235391|471049660|FG001|Overall Study|Administrative problems|0|||
130842250|NCT00235391|471049661|FG002|Overall Study|Administrative problems|0|||
130842251|NCT00235391|471049662|FG003|Overall Study|Administrative problems|1|||
130842252|NCT00235391|471049663|FG004|Overall Study|Administrative problems|0|||
130842253|NCT00235391|471049664|FG005|Overall Study|Administrative problems|0|||
130842254|NCT00235391|471049659|FG000|Overall Study|Death|0|||
130842255|NCT00235391|471049660|FG001|Overall Study|Death|0|||
130842256|NCT00235391|471049661|FG002|Overall Study|Death|1|||
130842257|NCT00235391|471049662|FG003|Overall Study|Death|4|||
130842258|NCT00235391|471049663|FG004|Overall Study|Death|0|||
130842259|NCT00235391|471049664|FG005|Overall Study|Death|0|||
130842260|NCT03349645|471049665|FG000|Overall Study|Sponsor Terminated Study|75|||
130842261|NCT03349645|471049665|FG000|Overall Study|Withdrawal by Subject|4|||
130842262|NCT03349645|471049665|FG000|Overall Study|Protocol Violation|1|||
130842263|NCT03349645|471049665|FG000|Overall Study|Other|2|||
130842264|NCT00580034|471049671|FG000|Overall Study|Toxicity|10|||
130842265|NCT00580034|471049672|FG001|Overall Study|Toxicity|0|||
130842266|NCT01939002|471049673|FG000|Overall Study|Adverse Event|13|||
130842267|NCT01939002|471049674|FG001|Overall Study|Adverse Event|13|||
130842268|NCT01939002|471049673|FG000|Overall Study|Withdrawal by Subject|5|||
130842269|NCT01939002|471049674|FG001|Overall Study|Withdrawal by Subject|3|||
130842270|NCT01939002|471049673|FG000|Overall Study|Other|1|||
130842271|NCT01939002|471049674|FG001|Overall Study|Other|2|||
130842272|NCT00098748|471049677|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
130842273|NCT00098748|471049678|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
130842274|NCT00098748|471049679|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
130842275|NCT00098748|471049677|FG000|Received Study Treatment|Death|2|||
130842276|NCT00098748|471049678|FG001|Received Study Treatment|Death|1|||
130842277|NCT00098748|471049679|FG002|Received Study Treatment|Death|2|||
130842278|NCT00098748|471049677|FG000|Received Study Treatment|Adverse Event|1|||
130842279|NCT00098748|471049678|FG001|Received Study Treatment|Adverse Event|2|||
130842280|NCT00098748|471049679|FG002|Received Study Treatment|Adverse Event|5|||
130842281|NCT00098748|471049677|FG000|Received Study Treatment|Lack of Efficacy|40|||
130842282|NCT00098748|471049678|FG001|Received Study Treatment|Lack of Efficacy|27|||
130842283|NCT00098748|471049679|FG002|Received Study Treatment|Lack of Efficacy|27|||
130842284|NCT00098748|471049677|FG000|Received Study Treatment|Other|2|||
130842285|NCT00098748|471049678|FG001|Received Study Treatment|Other|2|||
130842286|NCT00098748|471049679|FG002|Received Study Treatment|Other|6|||
130842287|NCT00098748|471049677|FG000|Received Study Treatment|Subject defaulted|3|||
130842288|NCT00098748|471049678|FG001|Received Study Treatment|Subject defaulted|4|||
130842289|NCT00098748|471049679|FG002|Received Study Treatment|Subject defaulted|4|||
130842290|NCT00098748|471049677|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
130842291|NCT00098748|471049678|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
130842292|NCT00098748|471049679|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
130842293|NCT00098748|471049677|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
130842294|NCT00098748|471049678|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
130842295|NCT00098748|471049679|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
130842296|NCT00098748|471049677|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
130842297|NCT00098748|471049678|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
130842298|NCT00098748|471049679|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
130842299|NCT00098748|471049677|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
130842300|NCT00098748|471049678|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
130842301|NCT00098748|471049679|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
130842302|NCT00098748|471049677|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
130842303|NCT00098748|471049678|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
130842304|NCT00098748|471049679|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
130842305|NCT00570037|471049680|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
130842306|NCT00570037|471049681|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
130842307|NCT01081301|471049682|FG000|Overall Study|Bereaved|3|||
130842308|NCT01081301|471049682|FG000|Overall Study|Too busy|5|||
130842309|NCT01081301|471049682|FG000|Overall Study|Patient too ill|2|||
130842310|NCT01081301|471049682|FG000|Overall Study|Lost to Follow-up|4|||
130842311|NCT00853125|471049685|FG000|Overall Study|Study participant's donor was CMV +|1|||
130842312|NCT03023826|471049687|FG000|Period 1|Withdrawal by Subject|0|||
130842313|NCT03023826|471049688|FG001|Period 1|Withdrawal by Subject|0|||
130842314|NCT03023826|471049689|FG002|Period 1|Withdrawal by Subject|0|||
130842315|NCT03023826|471049690|FG003|Period 1|Withdrawal by Subject|0|||
130842316|NCT03023826|471049691|FG004|Period 1|Withdrawal by Subject|1|||
130842317|NCT03023826|471049692|FG005|Period 1|Withdrawal by Subject|0|||
130842318|NCT00428220|471051504|FG000|Overall Study|Participant died|8|||
130842319|NCT00428220|471051504|FG000|Overall Study|Global deterioration of health status|7|||
130842320|NCT00428220|471051504|FG000|Overall Study|Lost to Follow-up|4|||
130842321|NCT00428220|471051504|FG000|Overall Study|Objective progression or relapse|123|||
130842322|NCT00428220|471051504|FG000|Overall Study|Participant refused continued treatment|7|||
130842323|NCT00428220|471051504|FG000|Overall Study|Adverse Event|51|||
130842324|NCT00428220|471051504|FG000|Overall Study|Other|23|||
130842325|NCT00549900|471051506|FG000|Overall Study|Adverse Event|1|||
130842326|NCT02982018|471051507|FG000|Overall Study|Incorrect Lens Dispensed|1|||
130842327|NCT02982018|471051508|FG001|Overall Study|Incorrect Lens Dispensed|0|||
130842328|NCT02982018|471051507|FG000|Overall Study|Protocol Violation|1|||
130842329|NCT02982018|471051508|FG001|Overall Study|Protocol Violation|1|||
130842330|NCT02982018|471051507|FG000|Overall Study|Adverse Event|1|||
130842331|NCT02982018|471051508|FG001|Overall Study|Adverse Event|1|||
130842332|NCT02982018|471051507|FG000|Overall Study|Lens Discomfort|2|||
130842333|NCT02982018|471051508|FG001|Overall Study|Lens Discomfort|0|||
130842334|NCT02982018|471051507|FG000|Overall Study|Withdrawal by Subject|0|||
130842335|NCT02982018|471051508|FG001|Overall Study|Withdrawal by Subject|1|||
130842336|NCT03283098|471051509|FG000|Overall Study|Withdrawal by Subject|0|||
130842337|NCT03283098|471051510|FG001|Overall Study|Withdrawal by Subject|1|||
130842338|NCT00445939|471051514|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
130842339|NCT00445939|471051515|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
130842340|NCT00445939|471051516|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
130842341|NCT00445939|471051517|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
130842342|NCT00445939|471051514|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
130842343|NCT00445939|471051515|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
130842344|NCT00445939|471051516|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
130842345|NCT00445939|471051517|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
130842346|NCT00798317|471051518|FG000|Overall Study|Physician Decision|0|||
130842347|NCT00798317|471051519|FG001|Overall Study|Physician Decision|1|||
130842348|NCT00798317|471051518|FG000|Overall Study|Withdrawal by Subject|5|||
130842349|NCT00798317|471051519|FG001|Overall Study|Withdrawal by Subject|4|||
130842350|NCT00798317|471051518|FG000|Overall Study|Lost to Follow-up|2|||
130842351|NCT00798317|471051519|FG001|Overall Study|Lost to Follow-up|2|||
130842352|NCT00798317|471051518|FG000|Overall Study|Adverse Event|2|||
130842353|NCT00798317|471051519|FG001|Overall Study|Adverse Event|0|||
130842354|NCT00798317|471051518|FG000|Overall Study|Death|1|||
130842355|NCT00798317|471051519|FG001|Overall Study|Death|0|||
130842356|NCT00378599|471051523|FG000|Overall Study|Adverse Event|38|||
130842357|NCT00378599|471051523|FG000|Overall Study|Protocol Violation|2|||
130842358|NCT00378599|471051523|FG000|Overall Study|Treatment failure|7|||
130842359|NCT00378599|471051523|FG000|Overall Study|Withdrawal by Subject|5|||
130842360|NCT00416715|471051524|FG000|Overall Study|Not evaluable for joint aches|7|||
130842361|NCT00416715|471051524|FG000|Overall Study|Vitamin D levels not evaluable|8|||
130842362|NCT00489736|471051528|FG000|Overall Study|Lack of Efficacy|53|||
130842363|NCT00489736|471051529|FG001|Overall Study|Lack of Efficacy|14|||
130842364|NCT00489736|471051528|FG000|Overall Study|Adverse Event|32|||
130842365|NCT00489736|471051529|FG001|Overall Study|Adverse Event|45|||
130842366|NCT00489736|471051528|FG000|Overall Study|Poor compliance|6|||
130842367|NCT00489736|471051529|FG001|Overall Study|Poor compliance|2|||
130842368|NCT00489736|471051528|FG000|Overall Study|Not coded/ Not pre-specified|5|||
130842369|NCT00489736|471051529|FG001|Overall Study|Not coded/ Not pre-specified|8|||
130842370|NCT03812185|471051530|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
130842371|NCT02576535|471051543|FG000|Overall Study|Withdrawal by Subject|2|||
130842372|NCT02545517|471051544|FG000|Overall Study|Death|2|||
130842373|NCT02545517|471051545|FG001|Overall Study|Death|2|||
130842374|NCT02545517|471051546|FG002|Overall Study|Death|1|||
130842375|NCT02545517|471051544|FG000|Overall Study|Lost to Follow-up|14|||
130842376|NCT02545517|471051545|FG001|Overall Study|Lost to Follow-up|13|||
130842377|NCT02545517|471051546|FG002|Overall Study|Lost to Follow-up|17|||
130842378|NCT02545517|471051544|FG000|Overall Study|Protocol Violation|0|||
130842379|NCT02545517|471051545|FG001|Overall Study|Protocol Violation|1|||
130842380|NCT02545517|471051546|FG002|Overall Study|Protocol Violation|1|||
130842381|NCT02545517|471051544|FG000|Overall Study|Withdrawal by Subject|5|||
130842382|NCT02545517|471051545|FG001|Overall Study|Withdrawal by Subject|8|||
130842383|NCT02545517|471051546|FG002|Overall Study|Withdrawal by Subject|9|||
130842384|NCT02545517|471051544|FG000|Overall Study|Administrative reason|5|||
130842385|NCT02545517|471051545|FG001|Overall Study|Administrative reason|6|||
130842386|NCT02545517|471051546|FG002|Overall Study|Administrative reason|10|||
130842387|NCT02545517|471051544|FG000|Overall Study|Other|2|||
130842388|NCT02545517|471051545|FG001|Overall Study|Other|4|||
130842389|NCT02545517|471051546|FG002|Overall Study|Other|3|||
130842390|NCT01529515|471051547|FG000|TRANSITION PHASE|Adverse Event|16|||
130842391|NCT01529515|471051548|FG001|TRANSITION PHASE|Adverse Event|0|||
130842392|NCT01529515|471051549|FG002|TRANSITION PHASE|Adverse Event|0|||
130842393|NCT01529515|471051550|FG003|TRANSITION PHASE|Adverse Event|0|||
130842394|NCT01529515|471051547|FG000|TRANSITION PHASE|Death|1|||
130842395|NCT01529515|471051548|FG001|TRANSITION PHASE|Death|0|||
130842396|NCT01529515|471051549|FG002|TRANSITION PHASE|Death|0|||
130842397|NCT01529515|471051550|FG003|TRANSITION PHASE|Death|0|||
130842398|NCT01529515|471051547|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
130842399|NCT01529515|471051548|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
130842400|NCT01529515|471051549|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
130842401|NCT01529515|471051550|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
130842402|NCT01529515|471051547|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
130842403|NCT01529515|471051548|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
130842404|NCT01529515|471051549|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
130842405|NCT01529515|471051550|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
130842406|NCT01529515|471051547|FG000|TRANSITION PHASE|Protocol Violation|4|||
130842407|NCT01529515|471051548|FG001|TRANSITION PHASE|Protocol Violation|0|||
130842408|NCT01529515|471051549|FG002|TRANSITION PHASE|Protocol Violation|0|||
130842409|NCT01529515|471051550|FG003|TRANSITION PHASE|Protocol Violation|0|||
130842410|NCT01529515|471051547|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
130842411|NCT01529515|471051548|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
130842412|NCT01529515|471051549|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
130842413|NCT01529515|471051550|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
130842414|NCT01529515|471051547|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
130842415|NCT01529515|471051548|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
130842416|NCT01529515|471051549|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
130842417|NCT01529515|471051550|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
130842418|NCT01529515|471051547|FG000|TRANSITION PHASE|Other|9|||
130842419|NCT01529515|471051548|FG001|TRANSITION PHASE|Other|0|||
130842420|NCT01529515|471051549|FG002|TRANSITION PHASE|Other|0|||
130842421|NCT01529515|471051550|FG003|TRANSITION PHASE|Other|0|||
130842422|NCT01529515|471051547|FG000|MAINTENANCE PHASE|Adverse Event|0|||
130842423|NCT01529515|471051548|FG001|MAINTENANCE PHASE|Adverse Event|10|||
130842424|NCT01529515|471051549|FG002|MAINTENANCE PHASE|Adverse Event|0|||
130842425|NCT01529515|471051550|FG003|MAINTENANCE PHASE|Adverse Event|0|||
130842426|NCT01529515|471051547|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
130842427|NCT01529515|471051548|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
130842428|NCT01529515|471051549|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
130842429|NCT01529515|471051550|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
130842430|NCT01529515|471051547|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
130842431|NCT01529515|471051548|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
130842432|NCT01529515|471051549|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
130842433|NCT01529515|471051550|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
130842434|NCT01529515|471051547|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
130842435|NCT01529515|471051548|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
130842436|NCT01529515|471051549|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
130842437|NCT01529515|471051550|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
130842438|NCT01529515|471051547|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
130842439|NCT01529515|471051548|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
130842440|NCT01529515|471051549|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
130842441|NCT01529515|471051550|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
130842442|NCT01529515|471051547|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
130842443|NCT01529515|471051548|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
130842444|NCT01529515|471051549|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
130842445|NCT01529515|471051550|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
130842446|NCT01529515|471051547|FG000|MAINTENANCE PHASE|Other|0|||
130842447|NCT01529515|471051548|FG001|MAINTENANCE PHASE|Other|10|||
130842448|NCT01529515|471051549|FG002|MAINTENANCE PHASE|Other|0|||
130842449|NCT01529515|471051550|FG003|MAINTENANCE PHASE|Other|0|||
130842450|NCT01529515|471051547|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
130842451|NCT01529515|471051548|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
130842452|NCT01529515|471051549|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
130842453|NCT01529515|471051550|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
130842454|NCT01529515|471051547|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
130842455|NCT01529515|471051548|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
130842456|NCT01529515|471051549|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
130842457|NCT01529515|471051550|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
130842458|NCT01529515|471051547|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
130842459|NCT01529515|471051548|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
130842460|NCT01529515|471051549|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
130842461|NCT01529515|471051550|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
130842462|NCT01529515|471051547|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
130842463|NCT01529515|471051548|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
130842464|NCT01529515|471051549|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
130842465|NCT01529515|471051550|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
130842466|NCT01529515|471051547|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
130842467|NCT01529515|471051548|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
130842468|NCT01529515|471051549|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
130842469|NCT01529515|471051550|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
130842470|NCT01529515|471051547|FG000|DOUBLE BLIND PHASE|Other|0|||
130842471|NCT01529515|471051548|FG001|DOUBLE BLIND PHASE|Other|0|||
130842472|NCT01529515|471051549|FG002|DOUBLE BLIND PHASE|Other|9|||
130842473|NCT01529515|471051550|FG003|DOUBLE BLIND PHASE|Other|2|||
130842474|NCT03334851|471051554|FG000|Overall Study|Other|0|||
130842475|NCT03334851|471051555|FG001|Overall Study|Other|0|||
130842476|NCT03334851|471051556|FG002|Overall Study|Other|0|||
130842477|NCT03334851|471051557|FG003|Overall Study|Other|0|||
130842478|NCT03334851|471051558|FG004|Overall Study|Other|0|||
130842479|NCT03334851|471051559|FG005|Overall Study|Other|0|||
130842480|NCT03334851|471051560|FG006|Overall Study|Other|0|||
130842481|NCT03334851|471051561|FG007|Overall Study|Other|1|||
130842482|NCT03334851|471051562|FG008|Overall Study|Other|0|||
130842483|NCT03334851|471051563|FG009|Overall Study|Other|0|||
130842484|NCT03334851|471051564|FG010|Overall Study|Other|0|||
130842485|NCT03334851|471051565|FG011|Overall Study|Other|0|||
130842486|NCT03334851|471051566|FG012|Overall Study|Other|0|||
130842487|NCT03334851|471051554|FG000|Overall Study|Adverse Event|0|||
130842488|NCT03334851|471051555|FG001|Overall Study|Adverse Event|0|||
130842489|NCT03334851|471051556|FG002|Overall Study|Adverse Event|0|||
130842490|NCT03334851|471051557|FG003|Overall Study|Adverse Event|0|||
130842491|NCT03334851|471051558|FG004|Overall Study|Adverse Event|0|||
130842492|NCT03334851|471051559|FG005|Overall Study|Adverse Event|0|||
130842493|NCT03334851|471051560|FG006|Overall Study|Adverse Event|0|||
130842494|NCT03334851|471051561|FG007|Overall Study|Adverse Event|1|||
130842495|NCT03334851|471051562|FG008|Overall Study|Adverse Event|0|||
130842496|NCT03334851|471051563|FG009|Overall Study|Adverse Event|0|||
130842497|NCT03334851|471051564|FG010|Overall Study|Adverse Event|0|||
130842498|NCT03334851|471051565|FG011|Overall Study|Adverse Event|0|||
130842499|NCT03334851|471051566|FG012|Overall Study|Adverse Event|0|||
130842500|NCT03334851|471051554|FG000|Overall Study|Withdrawal by Subject|0|||
130842501|NCT03334851|471051555|FG001|Overall Study|Withdrawal by Subject|0|||
130842502|NCT03334851|471051556|FG002|Overall Study|Withdrawal by Subject|0|||
130842503|NCT03334851|471051557|FG003|Overall Study|Withdrawal by Subject|0|||
130842504|NCT03334851|471051558|FG004|Overall Study|Withdrawal by Subject|0|||
130842505|NCT03334851|471051559|FG005|Overall Study|Withdrawal by Subject|0|||
130842506|NCT03334851|471051560|FG006|Overall Study|Withdrawal by Subject|0|||
130842507|NCT03334851|471051561|FG007|Overall Study|Withdrawal by Subject|0|||
130842508|NCT03334851|471051562|FG008|Overall Study|Withdrawal by Subject|0|||
130842509|NCT03334851|471051563|FG009|Overall Study|Withdrawal by Subject|0|||
130842510|NCT03334851|471051564|FG010|Overall Study|Withdrawal by Subject|1|||
130842511|NCT03334851|471051565|FG011|Overall Study|Withdrawal by Subject|0|||
130842512|NCT03334851|471051566|FG012|Overall Study|Withdrawal by Subject|1|||
130842513|NCT03334851|471051554|FG000|Overall Study|Lost to Follow-up|0|||
130842514|NCT03334851|471051555|FG001|Overall Study|Lost to Follow-up|0|||
130842515|NCT03334851|471051556|FG002|Overall Study|Lost to Follow-up|0|||
130842516|NCT03334851|471051557|FG003|Overall Study|Lost to Follow-up|0|||
130842517|NCT03334851|471051558|FG004|Overall Study|Lost to Follow-up|0|||
130842518|NCT03334851|471051559|FG005|Overall Study|Lost to Follow-up|0|||
130842519|NCT03334851|471051560|FG006|Overall Study|Lost to Follow-up|0|||
130842520|NCT03334851|471051561|FG007|Overall Study|Lost to Follow-up|0|||
130842521|NCT03334851|471051562|FG008|Overall Study|Lost to Follow-up|0|||
130842522|NCT03334851|471051563|FG009|Overall Study|Lost to Follow-up|0|||
130842523|NCT03334851|471051564|FG010|Overall Study|Lost to Follow-up|2|||
130842524|NCT03334851|471051565|FG011|Overall Study|Lost to Follow-up|1|||
130842525|NCT03334851|471051566|FG012|Overall Study|Lost to Follow-up|0|||
130842526|NCT03920293|471051567|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
130842527|NCT03920293|471051568|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
130842528|NCT03920293|471051567|FG000|Randomized-Controlled Period|Physician Decision|1|||
130842529|NCT03920293|471051568|FG001|Randomized-Controlled Period|Physician Decision|2|||
130842530|NCT03920293|471051567|FG000|Randomized-Controlled Period|Adverse Event|0|||
130842531|NCT03920293|471051568|FG001|Randomized-Controlled Period|Adverse Event|2|||
130842532|NCT03920293|471051567|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
130842533|NCT03920293|471051568|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
130842534|NCT03920293|471051567|FG000|Randomized-Controlled Period|Death|2|||
130842535|NCT03920293|471051568|FG001|Randomized-Controlled Period|Death|0|||
130842536|NCT03920293|471051567|FG000|Randomized-Controlled Period|Protocol Violation|1|||
130842537|NCT03920293|471051568|FG001|Randomized-Controlled Period|Protocol Violation|0|||
130842538|NCT03920293|471051567|FG000|Randomized-Controlled Period|Noncompliance|1|||
130842539|NCT03920293|471051568|FG001|Randomized-Controlled Period|Noncompliance|0|||
130875421|NCT03137992|471173816|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
130842540|NCT03920293|471051567|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
130842541|NCT03920293|471051568|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
130842542|NCT03920293|471051567|FG000|Open- Label Extension Period|Death|3|||
130842543|NCT03920293|471051568|FG001|Open- Label Extension Period|Death|3|||
130842544|NCT03920293|471051567|FG000|Open- Label Extension Period|Physician Decision|5|||
130842545|NCT03920293|471051568|FG001|Open- Label Extension Period|Physician Decision|3|||
130842546|NCT03920293|471051567|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
130842547|NCT03920293|471051568|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
130842548|NCT01069861|471051569|FG000|Overall Study|Death|1|||
130842549|NCT01069861|471051569|FG000|Overall Study|Adverse Event|1|||
130842550|NCT01069861|471051569|FG000|Overall Study|Did not meet entrance criteria|1|||
130842551|NCT01691885|471051571|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
130842552|NCT01691885|471051572|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
130842553|NCT01691885|471051571|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
130842554|NCT01691885|471051572|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
130842555|NCT03555981|471051573|FG000|Overall Study|Lost to Follow-up|0|||
130842556|NCT03555981|471051574|FG001|Overall Study|Lost to Follow-up|2|||
130842557|NCT03272828|471051577|FG000|Overall Study|Lost to Follow-up|7|||
130842558|NCT03272828|471051578|FG001|Overall Study|Lost to Follow-up|7|||
130842559|NCT03272828|471051577|FG000|Overall Study|Withdrawal by Subject|2|||
130842560|NCT03272828|471051578|FG001|Overall Study|Withdrawal by Subject|0|||
130842561|NCT03272828|471051577|FG000|Overall Study|Deceased|1|||
130842562|NCT03272828|471051578|FG001|Overall Study|Deceased|1|||
130842563|NCT03272828|471051577|FG000|Overall Study|Failed implant|1|||
130842564|NCT03272828|471051578|FG001|Overall Study|Failed implant|2|||
130842565|NCT00996281|471051579|FG000|Overall Study|Adverse Event|75|||
130842566|NCT00996281|471051580|FG001|Overall Study|Adverse Event|37|||
130842567|NCT00996281|471051579|FG000|Overall Study|Major Protocol Deviation|6|||
130842568|NCT00996281|471051580|FG001|Overall Study|Major Protocol Deviation|7|||
130842569|NCT00996281|471051579|FG000|Overall Study|Lost to Follow-up|14|||
130842570|NCT00996281|471051580|FG001|Overall Study|Lost to Follow-up|16|||
130842571|NCT00996281|471051579|FG000|Overall Study|Withdrawal by Subject|31|||
130842572|NCT00996281|471051580|FG001|Overall Study|Withdrawal by Subject|20|||
130842573|NCT00996281|471051579|FG000|Overall Study|Lack of Efficacy|0|||
130842574|NCT00996281|471051580|FG001|Overall Study|Lack of Efficacy|2|||
130842575|NCT00996281|471051579|FG000|Overall Study|Other|5|||
130842576|NCT00996281|471051580|FG001|Overall Study|Other|7|||
130842577|NCT03505788|471051581|FG000|Overall Study|Lost to Follow-up|2|||
130842578|NCT03505788|471051582|FG001|Overall Study|Lost to Follow-up|1|||
130842579|NCT03505788|471051581|FG000|Overall Study|Withdrawal by Subject|1|||
130842580|NCT03505788|471051582|FG001|Overall Study|Withdrawal by Subject|3|||
130842581|NCT03505788|471051581|FG000|Overall Study|Physician Decision|0|||
130842582|NCT03505788|471051582|FG001|Overall Study|Physician Decision|1|||
130842583|NCT03350256|471051583|FG000|Overall Study|Inclusion/exclusion violation|4|||
130842584|NCT03350256|471051583|FG000|Overall Study|Recommended for other therapies|2|||
130842585|NCT03350256|471051583|FG000|Overall Study|Protocol Violation|3|||
130842586|NCT03350256|471051583|FG000|Overall Study|Non compliance|2|||
130842587|NCT03350256|471051583|FG000|Overall Study|Denial by insurance|1|||
130842588|NCT03350256|471051583|FG000|Overall Study|Adverse Event|2|||
130842589|NCT03350256|471051583|FG000|Overall Study|Trial failure|12|||
130842590|NCT03350256|471051583|FG000|Overall Study|Did not proceed to permanent implant|3|||
130842591|NCT03350256|471051583|FG000|Overall Study|Withdrawal by Subject|3|||
130842592|NCT03350256|471051583|FG000|Overall Study|Subject moving out of state|1|||
130842593|NCT03350256|471051583|FG000|Overall Study|Lost to Follow-up|1|||
130842594|NCT03350256|471051583|FG000|Overall Study|Lack of Efficacy|2|||
130842595|NCT02324205|471051584|FG000|Overall Study|Withdrawal by Subject|37|||
130842596|NCT00613925|471051587|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
130842597|NCT00613925|471051588|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
130842598|NCT01920568|471051596|FG000|Overall Study|Adverse Event|27|||
130842599|NCT01920568|471051597|FG001|Overall Study|Adverse Event|8|||
130842600|NCT01920568|471051596|FG000|Overall Study|Protocol Violation|5|||
130842601|NCT01920568|471051597|FG001|Overall Study|Protocol Violation|3|||
130842602|NCT01920568|471051596|FG000|Overall Study|Lost to Follow-up|2|||
130842603|NCT01920568|471051597|FG001|Overall Study|Lost to Follow-up|2|||
130842604|NCT01920568|471051596|FG000|Overall Study|Physician Decision|13|||
130842605|NCT01920568|471051597|FG001|Overall Study|Physician Decision|4|||
130842606|NCT01920568|471051596|FG000|Overall Study|Withdrawal by Subject|79|||
130842607|NCT01920568|471051597|FG001|Overall Study|Withdrawal by Subject|55|||
130842608|NCT01920568|471051596|FG000|Overall Study|Death due to disease progression|25|||
130842609|NCT01920568|471051597|FG001|Overall Study|Death due to disease progression|12|||
130842610|NCT00252694|471051602|FG000|Overall Study|Withdrawal by Subject|83|||
130842611|NCT00252694|471051603|FG001|Overall Study|Withdrawal by Subject|91|||
130842612|NCT00252694|471051602|FG000|Overall Study|Death|36|||
130842613|NCT00252694|471051603|FG001|Overall Study|Death|34|||
130842614|NCT00252694|471051602|FG000|Overall Study|Mostly Lost to Follow Up|8|||
130842615|NCT00252694|471051603|FG001|Overall Study|Mostly Lost to Follow Up|13|||
130842616|NCT00252694|471051602|FG000|Overall Study|Patient Moving|17|||
130842617|NCT00252694|471051603|FG001|Overall Study|Patient Moving|16|||
130842618|NCT03664674|471051605|FG000|Overall Study|Adverse Event|1|||
130842619|NCT03664674|471051606|FG001|Overall Study|Adverse Event|1|||
130842620|NCT03664674|471051605|FG000|Overall Study|Physician Decision|0|||
130842621|NCT03664674|471051606|FG001|Overall Study|Physician Decision|1|||
130842622|NCT03664674|471051605|FG000|Overall Study|Withdrawal by Subject|2|||
130842623|NCT03664674|471051606|FG001|Overall Study|Withdrawal by Subject|0|||
130842624|NCT02174523|471051607|FG000|Overall Study|Withdrawal by Subject|1|||
130842625|NCT02174523|471051608|FG001|Overall Study|Withdrawal by Subject|0|||
130842626|NCT00856206|471051609|FG000|Overall Study|Protocol Violation|6|||
130842627|NCT00856206|471051610|FG001|Overall Study|Protocol Violation|18|||
130842628|NCT00856206|471051609|FG000|Overall Study|Adverse Event|10|||
130842629|NCT00856206|471051610|FG001|Overall Study|Adverse Event|46|||
130842630|NCT00856206|471051609|FG000|Overall Study|Lack of Efficacy|1|||
130842631|NCT00856206|471051610|FG001|Overall Study|Lack of Efficacy|2|||
130842632|NCT00856206|471051609|FG000|Overall Study|Withdrawal by Subject|15|||
130842633|NCT00856206|471051610|FG001|Overall Study|Withdrawal by Subject|36|||
130842634|NCT00856206|471051609|FG000|Overall Study|Lost to Follow-up|13|||
130842635|NCT00856206|471051610|FG001|Overall Study|Lost to Follow-up|39|||
130842636|NCT00856206|471051609|FG000|Overall Study|Death|2|||
130842637|NCT00856206|471051610|FG001|Overall Study|Death|2|||
130842638|NCT00856206|471051609|FG000|Overall Study|Decision by the Sponsor|4|||
130842639|NCT00856206|471051610|FG001|Overall Study|Decision by the Sponsor|8|||
130842640|NCT00856206|471051609|FG000|Overall Study|Other than specified above|3|||
130842641|NCT00856206|471051610|FG001|Overall Study|Other than specified above|10|||
130842642|NCT02780856|471051615|FG000|Overall Study|Lost to Follow-up|1|||
130842643|NCT00230282|471051617|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
130842644|NCT00230282|471051617|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
130842645|NCT00230282|471051617|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
130842646|NCT00230282|471051617|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
130842647|NCT03372460|471051621|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
130842648|NCT03372460|471051622|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
130842649|NCT02499900|471051623|FG000|Core Study Period|Other|1|||
130842650|NCT02499900|471051624|FG001|Core Study Period|Other|4|||
130842651|NCT02499900|471051623|FG000|Core Study Period|Lost to Follow-up|1|||
130842652|NCT02499900|471051624|FG001|Core Study Period|Lost to Follow-up|2|||
130842653|NCT02499900|471051623|FG000|Core Study Period|Per sponsor request|0|||
130842654|NCT02499900|471051624|FG001|Core Study Period|Per sponsor request|1|||
130842655|NCT02499900|471051623|FG000|Core Study Period|Pregnancy|1|||
130842656|NCT02499900|471051624|FG001|Core Study Period|Pregnancy|0|||
130842657|NCT02499900|471051623|FG000|Core Study Period|Protocol Violation|3|||
130842658|NCT02499900|471051624|FG001|Core Study Period|Protocol Violation|0|||
130842659|NCT02499900|471051623|FG000|Core Study Period|Withdrawal by Subject|11|||
130842660|NCT02499900|471051624|FG001|Core Study Period|Withdrawal by Subject|10|||
130842661|NCT02499900|471051623|FG000|Core Study Period|Adverse Event|18|||
130842662|NCT02499900|471051624|FG001|Core Study Period|Adverse Event|14|||
130842663|NCT02499900|471051623|FG000|Core Study Period|Death|0|||
130842664|NCT02499900|471051624|FG001|Core Study Period|Death|1|||
130842665|NCT02499900|471051623|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
130842666|NCT02499900|471051624|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
130842667|NCT02499900|471051623|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
130842668|NCT02499900|471051624|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
130842669|NCT02499900|471051623|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
130842670|NCT02499900|471051624|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
130842671|NCT02499900|471051623|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
130842672|NCT02499900|471051624|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
130842673|NCT02499900|471051623|FG000|Extension Study Period|Adverse Event|2|||
130842674|NCT02499900|471051624|FG001|Extension Study Period|Adverse Event|4|||
130842675|NCT02499900|471051623|FG000|Extension Study Period|Withdrawal by Subject|5|||
130842676|NCT02499900|471051624|FG001|Extension Study Period|Withdrawal by Subject|2|||
130842677|NCT02499900|471051623|FG000|Extension Study Period|Physician Decision|2|||
130842678|NCT02499900|471051624|FG001|Extension Study Period|Physician Decision|5|||
130842679|NCT02499900|471051623|FG000|Extension Study Period|Pregnancy|1|||
130842680|NCT02499900|471051624|FG001|Extension Study Period|Pregnancy|2|||
130842681|NCT02499900|471051623|FG000|Extension Study Period|Lost to Follow-up|2|||
130842682|NCT02499900|471051624|FG001|Extension Study Period|Lost to Follow-up|5|||
130842683|NCT02499900|471051623|FG000|Extension Study Period|Other|0|||
130842684|NCT02499900|471051624|FG001|Extension Study Period|Other|2|||
130842685|NCT03385265|471051625|FG000|Overall Study|Withdrawal by Subject|5|||
130842686|NCT03385265|471051626|FG001|Overall Study|Withdrawal by Subject|2|||
130842687|NCT03385265|471051627|FG002|Overall Study|Withdrawal by Subject|5|||
130842688|NCT03385265|471051628|FG003|Overall Study|Withdrawal by Subject|2|||
130842689|NCT02439450|471051630|FG000|Overall Study|Adverse Event|4|||
130842690|NCT02439450|471051631|FG001|Overall Study|Adverse Event|1|||
130842691|NCT02439450|471051632|FG002|Overall Study|Adverse Event|0|||
130842692|NCT02439450|471051633|FG003|Overall Study|Adverse Event|0|||
130842693|NCT02439450|471051630|FG000|Overall Study|Withdrawal by Subject|1|||
130842694|NCT02439450|471051631|FG001|Overall Study|Withdrawal by Subject|2|||
130842695|NCT02439450|471051632|FG002|Overall Study|Withdrawal by Subject|0|||
130842696|NCT02439450|471051633|FG003|Overall Study|Withdrawal by Subject|0|||
130842697|NCT02439450|471051630|FG000|Overall Study|Death|3|||
130842698|NCT02439450|471051631|FG001|Overall Study|Death|0|||
130842699|NCT02439450|471051632|FG002|Overall Study|Death|0|||
130842700|NCT02439450|471051633|FG003|Overall Study|Death|1|||
130842701|NCT02439450|471051630|FG000|Overall Study|Progressive Disease|18|||
130842702|NCT02439450|471051631|FG001|Overall Study|Progressive Disease|41|||
130842703|NCT02439450|471051632|FG002|Overall Study|Progressive Disease|2|||
130842704|NCT02439450|471051633|FG003|Overall Study|Progressive Disease|3|||
130842705|NCT01170065|471051638|FG000|Overall Study|Adverse Event|17|||
130842706|NCT01170065|471051639|FG001|Overall Study|Adverse Event|50|||
130842707|NCT01170065|471051640|FG002|Overall Study|Adverse Event|10|||
130842708|NCT01170065|471051638|FG000|Overall Study|Lost to Follow-up|1|||
130842709|NCT01170065|471051639|FG001|Overall Study|Lost to Follow-up|4|||
130842710|NCT01170065|471051640|FG002|Overall Study|Lost to Follow-up|1|||
130842711|NCT01170065|471051638|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
130842712|NCT01170065|471051639|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
130842713|NCT01170065|471051640|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
130842714|NCT01170065|471051638|FG000|Overall Study|Reason other than specified|3|||
130842715|NCT01170065|471051639|FG001|Overall Study|Reason other than specified|8|||
130842716|NCT01170065|471051640|FG002|Overall Study|Reason other than specified|3|||
130842717|NCT01170065|471051638|FG000|Overall Study|Ongoing after planned observation time|5|||
130842718|NCT01170065|471051639|FG001|Overall Study|Ongoing after planned observation time|26|||
130842719|NCT01170065|471051640|FG002|Overall Study|Ongoing after planned observation time|10|||
130842720|NCT02752958|471051643|FG000|Overall Study|Adverse Event|3|||
130842721|NCT02752958|471051643|FG000|Overall Study|Lost to Follow-up|1|||
130842722|NCT02752958|471051643|FG000|Overall Study|Protocol Violation|1|||
130842723|NCT02752958|471051643|FG000|Overall Study|Withdrawal by Subject|2|||
130842724|NCT02752958|471051643|FG000|Overall Study|Other (Reason not specified)|2|||
130842725|NCT02182440|471051644|FG000|Overall Study|Adverse Event|0|||
130842726|NCT02182440|471051645|FG001|Overall Study|Adverse Event|1|||
130842727|NCT02182440|471051646|FG002|Overall Study|Adverse Event|0|||
130842728|NCT02182440|471051647|FG003|Overall Study|Adverse Event|0|||
130842729|NCT02182440|471051644|FG000|Overall Study|Death|31|||
130842730|NCT02182440|471051645|FG001|Overall Study|Death|8|||
130842731|NCT02182440|471051646|FG002|Overall Study|Death|5|||
130842732|NCT02182440|471051647|FG003|Overall Study|Death|16|||
130842733|NCT02182440|471051644|FG000|Overall Study|Protocol Violation|0|||
130842734|NCT02182440|471051645|FG001|Overall Study|Protocol Violation|1|||
130842735|NCT02182440|471051646|FG002|Overall Study|Protocol Violation|0|||
130842736|NCT02182440|471051647|FG003|Overall Study|Protocol Violation|0|||
130842737|NCT02182440|471051644|FG000|Overall Study|Physician Decision|1|||
130842738|NCT02182440|471051645|FG001|Overall Study|Physician Decision|0|||
130842739|NCT02182440|471051646|FG002|Overall Study|Physician Decision|0|||
130842740|NCT02182440|471051647|FG003|Overall Study|Physician Decision|0|||
130842741|NCT02182440|471051644|FG000|Overall Study|Withdrawal by Subject|1|||
130842742|NCT02182440|471051645|FG001|Overall Study|Withdrawal by Subject|1|||
130842743|NCT02182440|471051646|FG002|Overall Study|Withdrawal by Subject|3|||
130842744|NCT02182440|471051647|FG003|Overall Study|Withdrawal by Subject|4|||
130842745|NCT02182440|471051644|FG000|Overall Study|different, e.g adm other hospital|12|||
130842746|NCT02182440|471051645|FG001|Overall Study|different, e.g adm other hospital|3|||
130842747|NCT02182440|471051646|FG002|Overall Study|different, e.g adm other hospital|3|||
130842748|NCT02182440|471051647|FG003|Overall Study|different, e.g adm other hospital|10|||
130842749|NCT01166958|471051648|FG000|Overall Study|Withdrawal by Subject|1|||
130842750|NCT01166958|471051649|FG001|Overall Study|Withdrawal by Subject|0|||
130842751|NCT01444027|471051657|FG000|Overall Study|Withdrawal by Subject|4|||
130842752|NCT01444027|471051658|FG001|Overall Study|Withdrawal by Subject|10|||
130842753|NCT01444027|471051659|FG002|Overall Study|Withdrawal by Subject|24|||
130842754|NCT01444027|471051657|FG000|Overall Study|Lost to Follow-up|26|||
130842755|NCT01444027|471051658|FG001|Overall Study|Lost to Follow-up|20|||
130842756|NCT01444027|471051659|FG002|Overall Study|Lost to Follow-up|14|||
130842757|NCT04035564|471053491|FG000|Overall Study|Protocol Violation|1|||
130842758|NCT04035564|471053492|FG001|Overall Study|Protocol Violation|2|||
130842759|NCT04035564|471053491|FG000|Overall Study|No laboratory available|2|||
130842760|NCT04035564|471053492|FG001|Overall Study|No laboratory available|2|||
130842761|NCT04035564|471053491|FG000|Overall Study|Guardian declined consent|1|||
130842762|NCT04035564|471053492|FG001|Overall Study|Guardian declined consent|2|||
130842763|NCT02754141|471053493|FG000|Overall Study|Disease progression|11|||
130842764|NCT02754141|471053494|FG001|Overall Study|Disease progression|7|||
130842765|NCT02754141|471053495|FG002|Overall Study|Disease progression|8|||
130842766|NCT02754141|471053496|FG003|Overall Study|Disease progression|5|||
130842767|NCT02754141|471053497|FG004|Overall Study|Disease progression|7|||
130842768|NCT02754141|471053498|FG005|Overall Study|Disease progression|7|||
130842769|NCT02754141|471053499|FG006|Overall Study|Disease progression|7|||
130842770|NCT02754141|471053500|FG007|Overall Study|Disease progression|6|||
130842771|NCT02754141|471053501|FG008|Overall Study|Disease progression|11|||
130842772|NCT02754141|471053502|FG009|Overall Study|Disease progression|16|||
130842773|NCT02754141|471053503|FG010|Overall Study|Disease progression|18|||
130842774|NCT02754141|471053504|FG011|Overall Study|Disease progression|13|||
130842775|NCT02754141|471053505|FG012|Overall Study|Disease progression|10|||
130842776|NCT02754141|471053506|FG013|Overall Study|Disease progression|12|||
130842777|NCT02754141|471053507|FG014|Overall Study|Disease progression|12|||
130842778|NCT02754141|471053508|FG015|Overall Study|Disease progression|14|||
130842779|NCT02754141|471053509|FG016|Overall Study|Disease progression|0|||
130842780|NCT02754141|471053510|FG017|Overall Study|Disease progression|1|||
130842781|NCT02754141|471053493|FG000|Overall Study|Study drug toxicity|1|||
130842782|NCT02754141|471053494|FG001|Overall Study|Study drug toxicity|1|||
130842783|NCT02754141|471053495|FG002|Overall Study|Study drug toxicity|0|||
130842784|NCT02754141|471053496|FG003|Overall Study|Study drug toxicity|0|||
130842785|NCT02754141|471053497|FG004|Overall Study|Study drug toxicity|0|||
130842786|NCT02754141|471053498|FG005|Overall Study|Study drug toxicity|0|||
130842787|NCT02754141|471053499|FG006|Overall Study|Study drug toxicity|0|||
130842788|NCT02754141|471053500|FG007|Overall Study|Study drug toxicity|0|||
130842789|NCT02754141|471053501|FG008|Overall Study|Study drug toxicity|0|||
130842790|NCT02754141|471053502|FG009|Overall Study|Study drug toxicity|0|||
130842791|NCT02754141|471053503|FG010|Overall Study|Study drug toxicity|2|||
130842792|NCT02754141|471053504|FG011|Overall Study|Study drug toxicity|1|||
130842793|NCT02754141|471053505|FG012|Overall Study|Study drug toxicity|1|||
130842794|NCT02754141|471053506|FG013|Overall Study|Study drug toxicity|0|||
130842795|NCT02754141|471053507|FG014|Overall Study|Study drug toxicity|0|||
130842796|NCT02754141|471053508|FG015|Overall Study|Study drug toxicity|0|||
130842797|NCT02754141|471053509|FG016|Overall Study|Study drug toxicity|0|||
130842798|NCT02754141|471053510|FG017|Overall Study|Study drug toxicity|0|||
130842799|NCT02754141|471053493|FG000|Overall Study|AE unrelated to study drug|1|||
130842800|NCT02754141|471053494|FG001|Overall Study|AE unrelated to study drug|1|||
130842801|NCT02754141|471053495|FG002|Overall Study|AE unrelated to study drug|0|||
130842802|NCT02754141|471053496|FG003|Overall Study|AE unrelated to study drug|1|||
130842803|NCT02754141|471053497|FG004|Overall Study|AE unrelated to study drug|3|||
130842804|NCT02754141|471053498|FG005|Overall Study|AE unrelated to study drug|2|||
130842805|NCT02754141|471053499|FG006|Overall Study|AE unrelated to study drug|1|||
130842806|NCT02754141|471053500|FG007|Overall Study|AE unrelated to study drug|0|||
130842807|NCT02754141|471053501|FG008|Overall Study|AE unrelated to study drug|0|||
130842808|NCT02754141|471053502|FG009|Overall Study|AE unrelated to study drug|0|||
130842809|NCT02754141|471053503|FG010|Overall Study|AE unrelated to study drug|0|||
130842810|NCT02754141|471053504|FG011|Overall Study|AE unrelated to study drug|0|||
130842811|NCT02754141|471053505|FG012|Overall Study|AE unrelated to study drug|0|||
130842812|NCT02754141|471053506|FG013|Overall Study|AE unrelated to study drug|0|||
130842813|NCT02754141|471053507|FG014|Overall Study|AE unrelated to study drug|0|||
130842814|NCT02754141|471053508|FG015|Overall Study|AE unrelated to study drug|0|||
130842815|NCT02754141|471053509|FG016|Overall Study|AE unrelated to study drug|0|||
130842816|NCT02754141|471053510|FG017|Overall Study|AE unrelated to study drug|0|||
130842817|NCT02754141|471053493|FG000|Overall Study|Request to discontinue|0|||
130842818|NCT02754141|471053494|FG001|Overall Study|Request to discontinue|0|||
130842819|NCT02754141|471053495|FG002|Overall Study|Request to discontinue|0|||
130842820|NCT02754141|471053496|FG003|Overall Study|Request to discontinue|0|||
130842821|NCT02754141|471053497|FG004|Overall Study|Request to discontinue|0|||
130842822|NCT02754141|471053498|FG005|Overall Study|Request to discontinue|0|||
130842823|NCT02754141|471053499|FG006|Overall Study|Request to discontinue|0|||
130842824|NCT02754141|471053500|FG007|Overall Study|Request to discontinue|0|||
130842825|NCT02754141|471053501|FG008|Overall Study|Request to discontinue|1|||
130842826|NCT02754141|471053502|FG009|Overall Study|Request to discontinue|0|||
130842827|NCT02754141|471053503|FG010|Overall Study|Request to discontinue|0|||
130842828|NCT02754141|471053504|FG011|Overall Study|Request to discontinue|0|||
130842829|NCT02754141|471053505|FG012|Overall Study|Request to discontinue|0|||
130842830|NCT02754141|471053506|FG013|Overall Study|Request to discontinue|1|||
130842831|NCT02754141|471053507|FG014|Overall Study|Request to discontinue|1|||
130842832|NCT02754141|471053508|FG015|Overall Study|Request to discontinue|0|||
130842833|NCT02754141|471053509|FG016|Overall Study|Request to discontinue|0|||
130842834|NCT02754141|471053510|FG017|Overall Study|Request to discontinue|0|||
130842835|NCT02754141|471053493|FG000|Overall Study|Withdrew consent|0|||
130842836|NCT02754141|471053494|FG001|Overall Study|Withdrew consent|0|||
130842837|NCT02754141|471053495|FG002|Overall Study|Withdrew consent|0|||
130842838|NCT02754141|471053496|FG003|Overall Study|Withdrew consent|0|||
130842839|NCT02754141|471053497|FG004|Overall Study|Withdrew consent|0|||
130842840|NCT02754141|471053498|FG005|Overall Study|Withdrew consent|0|||
130842841|NCT02754141|471053499|FG006|Overall Study|Withdrew consent|0|||
130842842|NCT02754141|471053500|FG007|Overall Study|Withdrew consent|0|||
130842843|NCT02754141|471053501|FG008|Overall Study|Withdrew consent|0|||
130842844|NCT02754141|471053502|FG009|Overall Study|Withdrew consent|1|||
130842845|NCT02754141|471053503|FG010|Overall Study|Withdrew consent|0|||
130842846|NCT02754141|471053504|FG011|Overall Study|Withdrew consent|0|||
130842847|NCT02754141|471053505|FG012|Overall Study|Withdrew consent|0|||
130842848|NCT02754141|471053506|FG013|Overall Study|Withdrew consent|0|||
130842849|NCT02754141|471053507|FG014|Overall Study|Withdrew consent|0|||
130842850|NCT02754141|471053508|FG015|Overall Study|Withdrew consent|0|||
130842851|NCT02754141|471053509|FG016|Overall Study|Withdrew consent|0|||
130842852|NCT02754141|471053510|FG017|Overall Study|Withdrew consent|0|||
130842853|NCT02754141|471053493|FG000|Overall Study|Maximum clinical benefit|0|||
130842854|NCT02754141|471053494|FG001|Overall Study|Maximum clinical benefit|0|||
130842855|NCT02754141|471053495|FG002|Overall Study|Maximum clinical benefit|0|||
130842856|NCT02754141|471053496|FG003|Overall Study|Maximum clinical benefit|1|||
130842857|NCT02754141|471053497|FG004|Overall Study|Maximum clinical benefit|0|||
130842858|NCT02754141|471053498|FG005|Overall Study|Maximum clinical benefit|0|||
130842859|NCT02754141|471053499|FG006|Overall Study|Maximum clinical benefit|0|||
130842860|NCT02754141|471053500|FG007|Overall Study|Maximum clinical benefit|0|||
130842861|NCT02754141|471053501|FG008|Overall Study|Maximum clinical benefit|0|||
130842862|NCT02754141|471053502|FG009|Overall Study|Maximum clinical benefit|0|||
130842863|NCT02754141|471053503|FG010|Overall Study|Maximum clinical benefit|0|||
130842864|NCT02754141|471053504|FG011|Overall Study|Maximum clinical benefit|0|||
130842865|NCT02754141|471053505|FG012|Overall Study|Maximum clinical benefit|0|||
130842866|NCT02754141|471053506|FG013|Overall Study|Maximum clinical benefit|0|||
130842867|NCT02754141|471053507|FG014|Overall Study|Maximum clinical benefit|0|||
130842868|NCT02754141|471053508|FG015|Overall Study|Maximum clinical benefit|0|||
130842869|NCT02754141|471053509|FG016|Overall Study|Maximum clinical benefit|0|||
130842870|NCT02754141|471053510|FG017|Overall Study|Maximum clinical benefit|0|||
130842871|NCT02754141|471053493|FG000|Overall Study|No longer meets study criteria|0|||
130842872|NCT02754141|471053494|FG001|Overall Study|No longer meets study criteria|0|||
130842873|NCT02754141|471053495|FG002|Overall Study|No longer meets study criteria|0|||
130842874|NCT02754141|471053496|FG003|Overall Study|No longer meets study criteria|1|||
130842875|NCT02754141|471053497|FG004|Overall Study|No longer meets study criteria|0|||
130842876|NCT02754141|471053498|FG005|Overall Study|No longer meets study criteria|0|||
130842877|NCT02754141|471053499|FG006|Overall Study|No longer meets study criteria|0|||
130842878|NCT02754141|471053500|FG007|Overall Study|No longer meets study criteria|0|||
130842879|NCT02754141|471053501|FG008|Overall Study|No longer meets study criteria|0|||
130842880|NCT02754141|471053502|FG009|Overall Study|No longer meets study criteria|0|||
130842881|NCT02754141|471053503|FG010|Overall Study|No longer meets study criteria|0|||
130842882|NCT02754141|471053504|FG011|Overall Study|No longer meets study criteria|0|||
130842883|NCT02754141|471053505|FG012|Overall Study|No longer meets study criteria|0|||
130842884|NCT02754141|471053506|FG013|Overall Study|No longer meets study criteria|0|||
130842885|NCT02754141|471053507|FG014|Overall Study|No longer meets study criteria|0|||
130842886|NCT02754141|471053508|FG015|Overall Study|No longer meets study criteria|0|||
130842887|NCT02754141|471053509|FG016|Overall Study|No longer meets study criteria|0|||
130842888|NCT02754141|471053510|FG017|Overall Study|No longer meets study criteria|0|||
130842889|NCT02754141|471053493|FG000|Overall Study|Other reasons|0|||
130842890|NCT02754141|471053494|FG001|Overall Study|Other reasons|0|||
130842891|NCT02754141|471053495|FG002|Overall Study|Other reasons|0|||
130842892|NCT02754141|471053496|FG003|Overall Study|Other reasons|0|||
130842893|NCT02754141|471053497|FG004|Overall Study|Other reasons|0|||
130842894|NCT02754141|471053498|FG005|Overall Study|Other reasons|0|||
130842895|NCT02754141|471053499|FG006|Overall Study|Other reasons|0|||
130842896|NCT02754141|471053500|FG007|Overall Study|Other reasons|1|||
130842897|NCT02754141|471053501|FG008|Overall Study|Other reasons|0|||
130842898|NCT02754141|471053502|FG009|Overall Study|Other reasons|0|||
130842899|NCT02754141|471053503|FG010|Overall Study|Other reasons|0|||
130842900|NCT02754141|471053504|FG011|Overall Study|Other reasons|0|||
130842901|NCT02754141|471053505|FG012|Overall Study|Other reasons|2|||
130842902|NCT02754141|471053506|FG013|Overall Study|Other reasons|0|||
130842903|NCT02754141|471053507|FG014|Overall Study|Other reasons|0|||
130842904|NCT02754141|471053508|FG015|Overall Study|Other reasons|0|||
130842905|NCT02754141|471053509|FG016|Overall Study|Other reasons|0|||
130842906|NCT02754141|471053510|FG017|Overall Study|Other reasons|0|||
130842907|NCT02754141|471053493|FG000|Overall Study|Completed treatment as per protocol|0|||
130842908|NCT02754141|471053494|FG001|Overall Study|Completed treatment as per protocol|1|||
130842909|NCT02754141|471053495|FG002|Overall Study|Completed treatment as per protocol|0|||
130842910|NCT02754141|471053496|FG003|Overall Study|Completed treatment as per protocol|0|||
130842911|NCT02754141|471053497|FG004|Overall Study|Completed treatment as per protocol|0|||
130842912|NCT02754141|471053498|FG005|Overall Study|Completed treatment as per protocol|0|||
130842913|NCT02754141|471053499|FG006|Overall Study|Completed treatment as per protocol|0|||
130842914|NCT02754141|471053500|FG007|Overall Study|Completed treatment as per protocol|0|||
130842915|NCT02754141|471053501|FG008|Overall Study|Completed treatment as per protocol|0|||
130842916|NCT02754141|471053502|FG009|Overall Study|Completed treatment as per protocol|0|||
130842917|NCT02754141|471053503|FG010|Overall Study|Completed treatment as per protocol|0|||
130842918|NCT02754141|471053504|FG011|Overall Study|Completed treatment as per protocol|0|||
130842919|NCT02754141|471053505|FG012|Overall Study|Completed treatment as per protocol|1|||
130842920|NCT02754141|471053506|FG013|Overall Study|Completed treatment as per protocol|0|||
130842921|NCT02754141|471053507|FG014|Overall Study|Completed treatment as per protocol|0|||
130842922|NCT02754141|471053508|FG015|Overall Study|Completed treatment as per protocol|0|||
130842923|NCT02754141|471053509|FG016|Overall Study|Completed treatment as per protocol|0|||
130842924|NCT02754141|471053510|FG017|Overall Study|Completed treatment as per protocol|0|||
130842925|NCT02754141|471053493|FG000|Overall Study|Not completing monotherapy|0|||
130842926|NCT02754141|471053494|FG001|Overall Study|Not completing monotherapy|0|||
130842927|NCT02754141|471053495|FG002|Overall Study|Not completing monotherapy|0|||
130842928|NCT02754141|471053496|FG003|Overall Study|Not completing monotherapy|0|||
130842929|NCT02754141|471053497|FG004|Overall Study|Not completing monotherapy|0|||
130842930|NCT02754141|471053498|FG005|Overall Study|Not completing monotherapy|0|||
130842931|NCT02754141|471053499|FG006|Overall Study|Not completing monotherapy|0|||
130842932|NCT02754141|471053500|FG007|Overall Study|Not completing monotherapy|0|||
130842933|NCT02754141|471053501|FG008|Overall Study|Not completing monotherapy|0|||
130842934|NCT02754141|471053502|FG009|Overall Study|Not completing monotherapy|0|||
130842935|NCT02754141|471053503|FG010|Overall Study|Not completing monotherapy|0|||
130842936|NCT02754141|471053504|FG011|Overall Study|Not completing monotherapy|0|||
130842937|NCT02754141|471053505|FG012|Overall Study|Not completing monotherapy|0|||
130842938|NCT02754141|471053506|FG013|Overall Study|Not completing monotherapy|1|||
130842939|NCT02754141|471053507|FG014|Overall Study|Not completing monotherapy|0|||
130842940|NCT02754141|471053508|FG015|Overall Study|Not completing monotherapy|0|||
130842941|NCT02754141|471053509|FG016|Overall Study|Not completing monotherapy|0|||
130842942|NCT02754141|471053510|FG017|Overall Study|Not completing monotherapy|0|||
130842943|NCT03361189|471053511|FG000|Overall Study|Received heart transplant|1|||
130842944|NCT03361189|471053512|FG001|Overall Study|Received heart transplant|0|||
130842945|NCT03361189|471053511|FG000|Overall Study|Pacemake replacement|0|||
130842946|NCT03361189|471053512|FG001|Overall Study|Pacemake replacement|1|||
130842947|NCT03344549|471053513|FG000|Overall Study|Withdrawal by Subject|3|||
130842948|NCT03344549|471053514|FG001|Overall Study|Withdrawal by Subject|2|||
130842949|NCT03344549|471053513|FG000|Overall Study|Dialysis|2|||
130842950|NCT03344549|471053514|FG001|Overall Study|Dialysis|0|||
130842951|NCT03344549|471053513|FG000|Overall Study|Cancer|1|||
130842952|NCT03344549|471053514|FG001|Overall Study|Cancer|0|||
130842953|NCT03344549|471053513|FG000|Overall Study|Lack of electronic device|1|||
130842954|NCT03344549|471053514|FG001|Overall Study|Lack of electronic device|0|||
130842955|NCT03344549|471053513|FG000|Overall Study|Transportation difficulty|0|||
130842956|NCT03344549|471053514|FG001|Overall Study|Transportation difficulty|13|||
130842957|NCT03333252|471053515|FG000|Overall Study|Adverse Event|10|||
130842958|NCT03333252|471053516|FG001|Overall Study|Adverse Event|6|||
130842959|NCT03333252|471053517|FG002|Overall Study|Adverse Event|5|||
130842960|NCT03333252|471053518|FG003|Overall Study|Adverse Event|2|||
130842961|NCT03333252|471053515|FG000|Overall Study|Death|1|||
130842962|NCT03333252|471053516|FG001|Overall Study|Death|3|||
130842963|NCT03333252|471053517|FG002|Overall Study|Death|0|||
130842964|NCT03333252|471053518|FG003|Overall Study|Death|0|||
130842965|NCT03333252|471053515|FG000|Overall Study|Lack of Efficacy|8|||
130842966|NCT03333252|471053516|FG001|Overall Study|Lack of Efficacy|4|||
130842967|NCT03333252|471053517|FG002|Overall Study|Lack of Efficacy|0|||
130842968|NCT03333252|471053518|FG003|Overall Study|Lack of Efficacy|7|||
130842969|NCT03333252|471053515|FG000|Overall Study|Lost to Follow-up|0|||
130842970|NCT03333252|471053516|FG001|Overall Study|Lost to Follow-up|5|||
130842971|NCT03333252|471053517|FG002|Overall Study|Lost to Follow-up|9|||
130842972|NCT03333252|471053518|FG003|Overall Study|Lost to Follow-up|3|||
130842973|NCT03333252|471053515|FG000|Overall Study|Withdrawal by Subject|14|||
130842974|NCT03333252|471053516|FG001|Overall Study|Withdrawal by Subject|24|||
130842975|NCT03333252|471053517|FG002|Overall Study|Withdrawal by Subject|11|||
130842976|NCT03333252|471053518|FG003|Overall Study|Withdrawal by Subject|17|||
130842977|NCT00666588|471053522|FG000|Overall Study|ineligible|2|||
130842978|NCT00666588|471053523|FG001|Overall Study|ineligible|0|||
130842979|NCT00666588|471053524|FG002|Overall Study|ineligible|0|||
130842980|NCT00666588|471053525|FG003|Overall Study|ineligible|2|||
130842981|NCT00666588|471053522|FG000|Overall Study|inevaluable|2|||
130842982|NCT00666588|471053523|FG001|Overall Study|inevaluable|0|||
130842983|NCT00666588|471053524|FG002|Overall Study|inevaluable|0|||
130842984|NCT00666588|471053525|FG003|Overall Study|inevaluable|0|||
130842985|NCT01007123|471053530|FG000|Overall Study|Adverse Event|3|||
130842986|NCT01007123|471053531|FG001|Overall Study|Adverse Event|4|||
130842987|NCT01007123|471053532|FG002|Overall Study|Adverse Event|7|||
130842988|NCT01007123|471053533|FG003|Overall Study|Adverse Event|1|||
130842989|NCT01007123|471053530|FG000|Overall Study|Lack of Efficacy|1|||
130842990|NCT01007123|471053531|FG001|Overall Study|Lack of Efficacy|0|||
130842991|NCT01007123|471053532|FG002|Overall Study|Lack of Efficacy|1|||
130842992|NCT01007123|471053533|FG003|Overall Study|Lack of Efficacy|4|||
130842993|NCT01007123|471053530|FG000|Overall Study|Protocol Violation|1|||
130842994|NCT01007123|471053531|FG001|Overall Study|Protocol Violation|1|||
130842995|NCT01007123|471053532|FG002|Overall Study|Protocol Violation|2|||
130842996|NCT01007123|471053533|FG003|Overall Study|Protocol Violation|1|||
130842997|NCT01007123|471053530|FG000|Overall Study|Withdrawal by Subject|1|||
130842998|NCT01007123|471053531|FG001|Overall Study|Withdrawal by Subject|0|||
130842999|NCT01007123|471053532|FG002|Overall Study|Withdrawal by Subject|1|||
130843000|NCT01007123|471053533|FG003|Overall Study|Withdrawal by Subject|0|||
130843001|NCT01007123|471053530|FG000|Overall Study|Lost to Follow-up|0|||
130843002|NCT01007123|471053531|FG001|Overall Study|Lost to Follow-up|1|||
130843003|NCT01007123|471053532|FG002|Overall Study|Lost to Follow-up|0|||
130843004|NCT01007123|471053533|FG003|Overall Study|Lost to Follow-up|0|||
130843005|NCT02075047|471053534|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
130843006|NCT02075047|471053535|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
130843007|NCT02075047|471053534|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
130843008|NCT02075047|471053535|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
130843009|NCT02075047|471053534|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
130843010|NCT02075047|471053535|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
130843011|NCT02075047|471053534|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
130843012|NCT02075047|471053535|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
130843013|NCT02075047|471053534|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
130843014|NCT02075047|471053535|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
130843015|NCT02075047|471053534|FG000|Treatment Phase (4 Weeks)|Other|1|||
130843016|NCT02075047|471053535|FG001|Treatment Phase (4 Weeks)|Other|1|||
130843017|NCT02075047|471053534|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
130843018|NCT02075047|471053535|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
130843019|NCT02075047|471053534|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
130843020|NCT02075047|471053535|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
130843021|NCT02075047|471053534|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
130843022|NCT02075047|471053535|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
130843023|NCT02075047|471053534|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
130843024|NCT02075047|471053535|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
130843025|NCT02075047|471053534|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
130843026|NCT02075047|471053535|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
130843027|NCT02075047|471053534|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
130843028|NCT02075047|471053535|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
130843029|NCT02075047|471053534|FG000|Follow up Phase (5 Weeks)|Other|1|||
130843030|NCT02075047|471053535|FG001|Follow up Phase (5 Weeks)|Other|2|||
130843031|NCT02075047|471053534|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
130843032|NCT02075047|471053535|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
130843033|NCT04195438|471053542|FG000|Overall Study|Withdrawal by Subject|1|||
130843034|NCT01774097|471053543|FG000|Overall Study|Withdrawal by Subject|1|||
130843035|NCT01774097|471053544|FG001|Overall Study|Withdrawal by Subject|1|||
130843036|NCT01774097|471053543|FG000|Overall Study|Adverse Event|1|||
130843037|NCT01774097|471053544|FG001|Overall Study|Adverse Event|1|||
130843038|NCT00794365|471053547|FG000|Overall Study|Lost to Follow-up|38|||
130843039|NCT00794365|471053547|FG000|Overall Study|Other|17|||
130843040|NCT00794365|471053547|FG000|Overall Study|Poor Compliance|11|||
130843041|NCT00794365|471053547|FG000|Overall Study|Adverse Event|10|||
130843042|NCT00794365|471053547|FG000|Overall Study|Lack of Efficacy|3|||
130843043|NCT03538444|471053558|FG000|Overall Study|opioid withdrawal|1|||
130843044|NCT03538444|471053559|FG001|Overall Study|opioid withdrawal|0|||
130843045|NCT04584346|471053560|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
130843046|NCT04584346|471053561|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
130843047|NCT03640052|471053562|FG000|Overall Study|Lost to Follow-up|0|||
130843048|NCT03640052|471053563|FG001|Overall Study|Lost to Follow-up|1|||
130843049|NCT03640052|471053564|FG002|Overall Study|Lost to Follow-up|0|||
130843050|NCT03640052|471053565|FG003|Overall Study|Lost to Follow-up|0|||
130843051|NCT03640052|471053566|FG004|Overall Study|Lost to Follow-up|0|||
130843052|NCT04422561|471053567|FG000|Overall Study|Lost to Follow-up|25|||
130843053|NCT04422561|471053568|FG001|Overall Study|Lost to Follow-up|11|||
130843054|NCT04239222|471053571|FG000|Baseline|Withdrawal by Subject|0|||
130843055|NCT04239222|471053572|FG001|Baseline|Withdrawal by Subject|0|||
130843056|NCT04239222|471053573|FG002|Baseline|Withdrawal by Subject|1|||
130843057|NCT04239222|471053574|FG003|Baseline|Withdrawal by Subject|1|||
130843058|NCT04239222|471053571|FG000|First Foot Assignment|Withdrawal by Subject|0|||
130843059|NCT04239222|471053572|FG001|First Foot Assignment|Withdrawal by Subject|0|||
130843060|NCT04239222|471053573|FG002|First Foot Assignment|Withdrawal by Subject|1|||
130843061|NCT04239222|471053574|FG003|First Foot Assignment|Withdrawal by Subject|0|||
130843062|NCT04239222|471053571|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
130843063|NCT04239222|471053572|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
130843064|NCT04239222|471053573|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
130843065|NCT04239222|471053574|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
130843066|NCT00790647|471053580|FG000|Overall Study|Adverse Event|1|||
130843069|NCT02701777|471053582|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
130843070|NCT02701777|471053583|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
130843071|NCT02701777|471053584|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
130843072|NCT02701777|471053585|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
130843073|NCT02701777|471053582|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
130843074|NCT02701777|471053583|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
130843075|NCT02701777|471053584|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
130843076|NCT02701777|471053585|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
130843077|NCT01774253|471053586|FG000|Overall Study|Lack of Efficacy|4|||
130843078|NCT01774253|471053586|FG000|Overall Study|Physician Decision|2|||
130843079|NCT01774253|471053586|FG000|Overall Study|Withdrawal by Subject|2|||
130843080|NCT01774253|471053586|FG000|Overall Study|Death|1|||
130843081|NCT00772369|471053587|FG000|Overall Study|Did not return record release form|1|||
130843082|NCT00554619|471053588|FG000|Overall Study|Adverse Event|1|||
130843083|NCT00554619|471053588|FG000|Overall Study|Physician Decision|1|||
130843084|NCT00554619|471053588|FG000|Overall Study|Liver Function Test Abnormality|1|||
130843085|NCT01571284|471053591|FG000|Overall Study|Participant's decision|84|||
130843086|NCT01571284|471053591|FG000|Overall Study|Lost to Follow-up|3|||
130843087|NCT01571284|471053591|FG000|Overall Study|Enrolled but not treated|2|||
130843088|NCT01571284|471053591|FG000|Overall Study|Other than specified above|80|||
130843089|NCT00075725|471053592|FG000|Overall Study|Adverse Event|6|||
130843090|NCT00075725|471053593|FG001|Overall Study|Adverse Event|6|||
130843091|NCT00075725|471053594|FG002|Overall Study|Adverse Event|20|||
130843092|NCT00075725|471053595|FG003|Overall Study|Adverse Event|8|||
130843093|NCT00075725|471053596|FG004|Overall Study|Adverse Event|4|||
130843094|NCT00075725|471053597|FG005|Overall Study|Adverse Event|38|||
130843095|NCT00075725|471053598|FG006|Overall Study|Adverse Event|3|||
130843096|NCT00075725|471053599|FG007|Overall Study|Adverse Event|51|||
130843097|NCT00075725|471053600|FG008|Overall Study|Adverse Event|15|||
130843098|NCT00075725|471053601|FG009|Overall Study|Adverse Event|4|||
130843099|NCT00075725|471053602|FG010|Overall Study|Adverse Event|2|||
130843100|NCT00075725|471053603|FG011|Overall Study|Adverse Event|2|||
130843101|NCT00075725|471053592|FG000|Overall Study|Death|3|||
130843102|NCT00075725|471053593|FG001|Overall Study|Death|5|||
130843103|NCT00075725|471053594|FG002|Overall Study|Death|10|||
130843104|NCT00075725|471053595|FG003|Overall Study|Death|2|||
130843105|NCT00075725|471053596|FG004|Overall Study|Death|3|||
130843106|NCT00075725|471053597|FG005|Overall Study|Death|25|||
130843107|NCT00075725|471053598|FG006|Overall Study|Death|4|||
130843108|NCT00075725|471053599|FG007|Overall Study|Death|22|||
130843109|NCT00075725|471053600|FG008|Overall Study|Death|14|||
130843110|NCT00075725|471053601|FG009|Overall Study|Death|4|||
130843111|NCT00075725|471053602|FG010|Overall Study|Death|3|||
130843112|NCT00075725|471053603|FG011|Overall Study|Death|0|||
130843113|NCT00075725|471053592|FG000|Overall Study|Lost to Follow-up|1|||
130843114|NCT00075725|471053593|FG001|Overall Study|Lost to Follow-up|1|||
130843115|NCT00075725|471053594|FG002|Overall Study|Lost to Follow-up|4|||
130843116|NCT00075725|471053595|FG003|Overall Study|Lost to Follow-up|1|||
130843117|NCT00075725|471053596|FG004|Overall Study|Lost to Follow-up|0|||
130843118|NCT00075725|471053597|FG005|Overall Study|Lost to Follow-up|13|||
130843119|NCT00075725|471053598|FG006|Overall Study|Lost to Follow-up|2|||
130843120|NCT00075725|471053599|FG007|Overall Study|Lost to Follow-up|4|||
130843121|NCT00075725|471053600|FG008|Overall Study|Lost to Follow-up|1|||
130843122|NCT00075725|471053601|FG009|Overall Study|Lost to Follow-up|0|||
130843123|NCT00075725|471053602|FG010|Overall Study|Lost to Follow-up|0|||
130843124|NCT00075725|471053603|FG011|Overall Study|Lost to Follow-up|0|||
130843125|NCT00075725|471053592|FG000|Overall Study|Physician Decision|2|||
130843126|NCT00075725|471053593|FG001|Overall Study|Physician Decision|6|||
130843127|NCT00075725|471053594|FG002|Overall Study|Physician Decision|5|||
130843128|NCT00075725|471053595|FG003|Overall Study|Physician Decision|8|||
130843129|NCT00075725|471053596|FG004|Overall Study|Physician Decision|4|||
130843130|NCT00075725|471053597|FG005|Overall Study|Physician Decision|19|||
130843131|NCT00075725|471053598|FG006|Overall Study|Physician Decision|3|||
130843132|NCT00075725|471053599|FG007|Overall Study|Physician Decision|17|||
130843133|NCT00075725|471053600|FG008|Overall Study|Physician Decision|5|||
130843134|NCT00075725|471053601|FG009|Overall Study|Physician Decision|0|||
130843135|NCT00075725|471053602|FG010|Overall Study|Physician Decision|1|||
130843136|NCT00075725|471053603|FG011|Overall Study|Physician Decision|0|||
130843137|NCT00075725|471053592|FG000|Overall Study|Pregnancy|0|||
130843138|NCT00075725|471053593|FG001|Overall Study|Pregnancy|0|||
130843139|NCT00075725|471053594|FG002|Overall Study|Pregnancy|0|||
130843140|NCT00075725|471053595|FG003|Overall Study|Pregnancy|0|||
130843141|NCT00075725|471053596|FG004|Overall Study|Pregnancy|0|||
130843142|NCT00075725|471053597|FG005|Overall Study|Pregnancy|1|||
130843143|NCT00075725|471053598|FG006|Overall Study|Pregnancy|0|||
130843144|NCT00075725|471053599|FG007|Overall Study|Pregnancy|1|||
130843145|NCT00075725|471053600|FG008|Overall Study|Pregnancy|0|||
130843146|NCT00075725|471053601|FG009|Overall Study|Pregnancy|0|||
130843147|NCT00075725|471053602|FG010|Overall Study|Pregnancy|0|||
130843148|NCT00075725|471053603|FG011|Overall Study|Pregnancy|0|||
130843149|NCT00075725|471053592|FG000|Overall Study|Protocol Violation|1|||
130843150|NCT00075725|471053593|FG001|Overall Study|Protocol Violation|1|||
130843151|NCT00075725|471053594|FG002|Overall Study|Protocol Violation|0|||
130843152|NCT00075725|471053595|FG003|Overall Study|Protocol Violation|3|||
130843153|NCT00075725|471053596|FG004|Overall Study|Protocol Violation|3|||
130843154|NCT00075725|471053597|FG005|Overall Study|Protocol Violation|2|||
130843155|NCT00075725|471053598|FG006|Overall Study|Protocol Violation|1|||
130843156|NCT00075725|471053599|FG007|Overall Study|Protocol Violation|2|||
130843157|NCT00075725|471053600|FG008|Overall Study|Protocol Violation|3|||
130843158|NCT00075725|471053601|FG009|Overall Study|Protocol Violation|0|||
130843159|NCT00075725|471053602|FG010|Overall Study|Protocol Violation|0|||
130843160|NCT00075725|471053603|FG011|Overall Study|Protocol Violation|1|||
130843161|NCT00075725|471053592|FG000|Overall Study|Withdrawal by Subject|12|||
130843162|NCT00075725|471053593|FG001|Overall Study|Withdrawal by Subject|3|||
130843163|NCT00075725|471053594|FG002|Overall Study|Withdrawal by Subject|6|||
130843164|NCT00075725|471053595|FG003|Overall Study|Withdrawal by Subject|10|||
130843165|NCT00075725|471053596|FG004|Overall Study|Withdrawal by Subject|6|||
130843166|NCT00075725|471053597|FG005|Overall Study|Withdrawal by Subject|27|||
130843167|NCT00075725|471053598|FG006|Overall Study|Withdrawal by Subject|7|||
130843168|NCT00075725|471053599|FG007|Overall Study|Withdrawal by Subject|31|||
130843169|NCT00075725|471053600|FG008|Overall Study|Withdrawal by Subject|10|||
130843170|NCT00075725|471053601|FG009|Overall Study|Withdrawal by Subject|2|||
130843171|NCT00075725|471053602|FG010|Overall Study|Withdrawal by Subject|0|||
130843172|NCT00075725|471053603|FG011|Overall Study|Withdrawal by Subject|0|||
130843173|NCT00075725|471053592|FG000|Overall Study|Disease Progression, all other reasons|17|||
130843174|NCT00075725|471053593|FG001|Overall Study|Disease Progression, all other reasons|5|||
130843175|NCT00075725|471053594|FG002|Overall Study|Disease Progression, all other reasons|33|||
130843176|NCT00075725|471053595|FG003|Overall Study|Disease Progression, all other reasons|6|||
130843177|NCT00075725|471053596|FG004|Overall Study|Disease Progression, all other reasons|21|||
130843178|NCT00075725|471053597|FG005|Overall Study|Disease Progression, all other reasons|59|||
130843179|NCT00075725|471053598|FG006|Overall Study|Disease Progression, all other reasons|20|||
130843180|NCT00075725|471053599|FG007|Overall Study|Disease Progression, all other reasons|46|||
130843181|NCT00075725|471053600|FG008|Overall Study|Disease Progression, all other reasons|21|||
130843182|NCT00075725|471053601|FG009|Overall Study|Disease Progression, all other reasons|4|||
130843183|NCT00075725|471053602|FG010|Overall Study|Disease Progression, all other reasons|0|||
130843184|NCT00075725|471053603|FG011|Overall Study|Disease Progression, all other reasons|5|||
130843185|NCT00075725|471053592|FG000|Overall Study|Patient off treatment|0|||
130843186|NCT00075725|471053593|FG001|Overall Study|Patient off treatment|0|||
130843187|NCT00075725|471053594|FG002|Overall Study|Patient off treatment|1|||
130843188|NCT00075725|471053595|FG003|Overall Study|Patient off treatment|2|||
130843189|NCT00075725|471053596|FG004|Overall Study|Patient off treatment|1|||
130843190|NCT00075725|471053597|FG005|Overall Study|Patient off treatment|0|||
130843191|NCT00075725|471053598|FG006|Overall Study|Patient off treatment|0|||
130843192|NCT00075725|471053599|FG007|Overall Study|Patient off treatment|2|||
130843193|NCT00075725|471053600|FG008|Overall Study|Patient off treatment|1|||
130843194|NCT00075725|471053601|FG009|Overall Study|Patient off treatment|0|||
130843195|NCT00075725|471053602|FG010|Overall Study|Patient off treatment|0|||
130843196|NCT00075725|471053603|FG011|Overall Study|Patient off treatment|0|||
130843197|NCT00075725|471053592|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
130843198|NCT00075725|471053593|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
130843199|NCT00075725|471053594|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
130843200|NCT00075725|471053595|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
130843201|NCT00075725|471053596|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
130843202|NCT00075725|471053597|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
130843203|NCT00075725|471053598|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
130843204|NCT00075725|471053599|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
130843205|NCT00075725|471053600|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
130843206|NCT00075725|471053601|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
130843207|NCT00075725|471053602|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
130843208|NCT00075725|471053603|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
130843209|NCT00075725|471053592|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
130843210|NCT00075725|471053593|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
130843211|NCT00075725|471053594|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
130843212|NCT00075725|471053595|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
130843213|NCT00075725|471053596|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
130843214|NCT00075725|471053597|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
130843215|NCT00075725|471053598|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
130843216|NCT00075725|471053599|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
130843217|NCT00075725|471053600|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
130843218|NCT00075725|471053601|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
130843219|NCT00075725|471053602|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
130843220|NCT00075725|471053603|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
130843221|NCT00075725|471053592|FG000|Overall Study|Pt non compliant with therapy|2|||
130843222|NCT00075725|471053593|FG001|Overall Study|Pt non compliant with therapy|1|||
130843223|NCT00075725|471053594|FG002|Overall Study|Pt non compliant with therapy|1|||
130843224|NCT00075725|471053595|FG003|Overall Study|Pt non compliant with therapy|0|||
130843225|NCT00075725|471053596|FG004|Overall Study|Pt non compliant with therapy|2|||
130843226|NCT00075725|471053597|FG005|Overall Study|Pt non compliant with therapy|14|||
130843227|NCT00075725|471053598|FG006|Overall Study|Pt non compliant with therapy|2|||
130843228|NCT00075725|471053599|FG007|Overall Study|Pt non compliant with therapy|5|||
130843229|NCT00075725|471053600|FG008|Overall Study|Pt non compliant with therapy|3|||
130843230|NCT00075725|471053601|FG009|Overall Study|Pt non compliant with therapy|0|||
130843231|NCT00075725|471053602|FG010|Overall Study|Pt non compliant with therapy|0|||
130843232|NCT00075725|471053603|FG011|Overall Study|Pt non compliant with therapy|0|||
130843233|NCT00075725|471053592|FG000|Overall Study|Pt age out of range for treatment|0|||
130843234|NCT00075725|471053593|FG001|Overall Study|Pt age out of range for treatment|1|||
130843235|NCT00075725|471053594|FG002|Overall Study|Pt age out of range for treatment|0|||
130843236|NCT00075725|471053595|FG003|Overall Study|Pt age out of range for treatment|0|||
130843237|NCT00075725|471053596|FG004|Overall Study|Pt age out of range for treatment|0|||
130843238|NCT00075725|471053597|FG005|Overall Study|Pt age out of range for treatment|1|||
130843239|NCT00075725|471053598|FG006|Overall Study|Pt age out of range for treatment|0|||
130843240|NCT00075725|471053599|FG007|Overall Study|Pt age out of range for treatment|1|||
130843241|NCT00075725|471053600|FG008|Overall Study|Pt age out of range for treatment|0|||
130843242|NCT00075725|471053601|FG009|Overall Study|Pt age out of range for treatment|0|||
130843243|NCT00075725|471053602|FG010|Overall Study|Pt age out of range for treatment|0|||
130843244|NCT00075725|471053603|FG011|Overall Study|Pt age out of range for treatment|0|||
130843245|NCT00075725|471053592|FG000|Overall Study|Insurance issues|0|||
130843246|NCT00075725|471053593|FG001|Overall Study|Insurance issues|1|||
130843247|NCT00075725|471053594|FG002|Overall Study|Insurance issues|0|||
130843248|NCT00075725|471053595|FG003|Overall Study|Insurance issues|1|||
130843249|NCT00075725|471053596|FG004|Overall Study|Insurance issues|1|||
130843250|NCT00075725|471053597|FG005|Overall Study|Insurance issues|1|||
130843251|NCT00075725|471053598|FG006|Overall Study|Insurance issues|0|||
130843252|NCT00075725|471053599|FG007|Overall Study|Insurance issues|1|||
130843253|NCT00075725|471053600|FG008|Overall Study|Insurance issues|0|||
130843254|NCT00075725|471053601|FG009|Overall Study|Insurance issues|0|||
130843255|NCT00075725|471053602|FG010|Overall Study|Insurance issues|0|||
130843256|NCT00075725|471053603|FG011|Overall Study|Insurance issues|0|||
130843257|NCT00075725|471053592|FG000|Overall Study|MRD positive after extended ind|0|||
130843258|NCT00075725|471053593|FG001|Overall Study|MRD positive after extended ind|1|||
130843259|NCT00075725|471053594|FG002|Overall Study|MRD positive after extended ind|1|||
130843260|NCT00075725|471053595|FG003|Overall Study|MRD positive after extended ind|0|||
130843261|NCT00075725|471053596|FG004|Overall Study|MRD positive after extended ind|1|||
130843262|NCT00075725|471053597|FG005|Overall Study|MRD positive after extended ind|2|||
130843263|NCT00075725|471053598|FG006|Overall Study|MRD positive after extended ind|0|||
130843264|NCT00075725|471053599|FG007|Overall Study|MRD positive after extended ind|1|||
130843265|NCT00075725|471053600|FG008|Overall Study|MRD positive after extended ind|0|||
130843266|NCT00075725|471053601|FG009|Overall Study|MRD positive after extended ind|0|||
130843267|NCT00075725|471053602|FG010|Overall Study|MRD positive after extended ind|0|||
130843268|NCT00075725|471053603|FG011|Overall Study|MRD positive after extended ind|0|||
130843269|NCT00075725|471053592|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
130843270|NCT00075725|471053593|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
130843271|NCT00075725|471053594|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
130843272|NCT00075725|471053595|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
130843273|NCT00075725|471053596|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
130843274|NCT00075725|471053597|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
130843275|NCT00075725|471053598|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
130843276|NCT00075725|471053599|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
130843277|NCT00075725|471053600|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
130843278|NCT00075725|471053601|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
130843279|NCT00075725|471053602|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
130843280|NCT00075725|471053603|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
130843281|NCT00075725|471053592|FG000|Overall Study|Inevaluable|1|||
130843282|NCT00075725|471053593|FG001|Overall Study|Inevaluable|1|||
130843283|NCT00075725|471053594|FG002|Overall Study|Inevaluable|4|||
130843284|NCT00075725|471053595|FG003|Overall Study|Inevaluable|2|||
130843285|NCT00075725|471053596|FG004|Overall Study|Inevaluable|2|||
130843286|NCT00075725|471053597|FG005|Overall Study|Inevaluable|9|||
130843287|NCT00075725|471053598|FG006|Overall Study|Inevaluable|1|||
130843288|NCT00075725|471053599|FG007|Overall Study|Inevaluable|11|||
130843289|NCT00075725|471053600|FG008|Overall Study|Inevaluable|2|||
130843290|NCT00075725|471053601|FG009|Overall Study|Inevaluable|0|||
130843291|NCT00075725|471053602|FG010|Overall Study|Inevaluable|1|||
130843292|NCT00075725|471053603|FG011|Overall Study|Inevaluable|0|||
130843293|NCT00075725|471053592|FG000|Overall Study|Other|4|||
130843294|NCT00075725|471053593|FG001|Overall Study|Other|2|||
130843295|NCT00075725|471053594|FG002|Overall Study|Other|1|||
130843296|NCT00075725|471053595|FG003|Overall Study|Other|1|||
130843297|NCT00075725|471053596|FG004|Overall Study|Other|1|||
130843298|NCT00075725|471053597|FG005|Overall Study|Other|4|||
130843299|NCT00075725|471053598|FG006|Overall Study|Other|2|||
130843300|NCT00075725|471053599|FG007|Overall Study|Other|9|||
130843301|NCT00075725|471053600|FG008|Overall Study|Other|2|||
130843302|NCT00075725|471053601|FG009|Overall Study|Other|1|||
130843303|NCT00075725|471053602|FG010|Overall Study|Other|0|||
130843304|NCT00075725|471053603|FG011|Overall Study|Other|3|||
130843305|NCT00075725|471053592|FG000|Overall Study|Pt trying to find a BM donor|0|||
130843306|NCT00075725|471053593|FG001|Overall Study|Pt trying to find a BM donor|1|||
130843307|NCT00075725|471053594|FG002|Overall Study|Pt trying to find a BM donor|0|||
130843308|NCT00075725|471053595|FG003|Overall Study|Pt trying to find a BM donor|0|||
130843309|NCT00075725|471053596|FG004|Overall Study|Pt trying to find a BM donor|0|||
130843310|NCT00075725|471053597|FG005|Overall Study|Pt trying to find a BM donor|0|||
130843311|NCT00075725|471053598|FG006|Overall Study|Pt trying to find a BM donor|0|||
130843312|NCT00075725|471053599|FG007|Overall Study|Pt trying to find a BM donor|0|||
130843313|NCT00075725|471053600|FG008|Overall Study|Pt trying to find a BM donor|0|||
130843314|NCT00075725|471053601|FG009|Overall Study|Pt trying to find a BM donor|0|||
130843315|NCT00075725|471053602|FG010|Overall Study|Pt trying to find a BM donor|0|||
130843316|NCT00075725|471053603|FG011|Overall Study|Pt trying to find a BM donor|0|||
130843317|NCT00075725|471053592|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
130843318|NCT00075725|471053593|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
130843319|NCT00075725|471053594|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
130843320|NCT00075725|471053595|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
130843321|NCT00075725|471053596|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
130843322|NCT00075725|471053597|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
130843323|NCT00075725|471053598|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
130843324|NCT00075725|471053599|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
130843325|NCT00075725|471053600|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
130843326|NCT00075725|471053601|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
130843327|NCT00075725|471053602|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
130843328|NCT00075725|471053603|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
130843329|NCT00075725|471053592|FG000|Overall Study|Unsuccessful institutional transfer|0|||
130843330|NCT00075725|471053593|FG001|Overall Study|Unsuccessful institutional transfer|0|||
130843331|NCT00075725|471053594|FG002|Overall Study|Unsuccessful institutional transfer|2|||
130843332|NCT00075725|471053595|FG003|Overall Study|Unsuccessful institutional transfer|0|||
130843333|NCT00075725|471053596|FG004|Overall Study|Unsuccessful institutional transfer|0|||
130843334|NCT00075725|471053597|FG005|Overall Study|Unsuccessful institutional transfer|0|||
130843335|NCT00075725|471053598|FG006|Overall Study|Unsuccessful institutional transfer|0|||
130843336|NCT00075725|471053599|FG007|Overall Study|Unsuccessful institutional transfer|0|||
130843337|NCT00075725|471053600|FG008|Overall Study|Unsuccessful institutional transfer|0|||
130843338|NCT00075725|471053601|FG009|Overall Study|Unsuccessful institutional transfer|1|||
130843339|NCT00075725|471053602|FG010|Overall Study|Unsuccessful institutional transfer|0|||
130843340|NCT00075725|471053603|FG011|Overall Study|Unsuccessful institutional transfer|0|||
130843341|NCT00075725|471053592|FG000|Overall Study|specimen(s) not submitted|0|||
130843342|NCT00075725|471053593|FG001|Overall Study|specimen(s) not submitted|0|||
130843343|NCT00075725|471053594|FG002|Overall Study|specimen(s) not submitted|2|||
130843344|NCT00075725|471053595|FG003|Overall Study|specimen(s) not submitted|0|||
130843345|NCT00075725|471053596|FG004|Overall Study|specimen(s) not submitted|0|||
130843346|NCT00075725|471053597|FG005|Overall Study|specimen(s) not submitted|0|||
130843347|NCT00075725|471053598|FG006|Overall Study|specimen(s) not submitted|0|||
130843348|NCT00075725|471053599|FG007|Overall Study|specimen(s) not submitted|0|||
130843349|NCT00075725|471053600|FG008|Overall Study|specimen(s) not submitted|0|||
130843350|NCT00075725|471053601|FG009|Overall Study|specimen(s) not submitted|0|||
130843351|NCT00075725|471053602|FG010|Overall Study|specimen(s) not submitted|0|||
130843352|NCT00075725|471053603|FG011|Overall Study|specimen(s) not submitted|0|||
130843353|NCT00075725|471053592|FG000|Overall Study|Pt went to transplant|0|||
130843354|NCT00075725|471053593|FG001|Overall Study|Pt went to transplant|0|||
130843355|NCT00075725|471053594|FG002|Overall Study|Pt went to transplant|0|||
130843356|NCT00075725|471053595|FG003|Overall Study|Pt went to transplant|1|||
130843357|NCT00075725|471053596|FG004|Overall Study|Pt went to transplant|0|||
130843358|NCT00075725|471053597|FG005|Overall Study|Pt went to transplant|1|||
130843359|NCT00075725|471053598|FG006|Overall Study|Pt went to transplant|0|||
130843360|NCT00075725|471053599|FG007|Overall Study|Pt went to transplant|0|||
130843361|NCT00075725|471053600|FG008|Overall Study|Pt went to transplant|0|||
130843362|NCT00075725|471053601|FG009|Overall Study|Pt went to transplant|0|||
130843363|NCT00075725|471053602|FG010|Overall Study|Pt went to transplant|0|||
130843364|NCT00075725|471053603|FG011|Overall Study|Pt went to transplant|0|||
130843365|NCT00075725|471053592|FG000|Overall Study|Pt received additional steroids|0|||
130843366|NCT00075725|471053593|FG001|Overall Study|Pt received additional steroids|0|||
130843367|NCT00075725|471053594|FG002|Overall Study|Pt received additional steroids|0|||
130843368|NCT00075725|471053595|FG003|Overall Study|Pt received additional steroids|1|||
130843369|NCT00075725|471053596|FG004|Overall Study|Pt received additional steroids|0|||
130843370|NCT00075725|471053597|FG005|Overall Study|Pt received additional steroids|0|||
130843371|NCT00075725|471053598|FG006|Overall Study|Pt received additional steroids|0|||
130843372|NCT00075725|471053599|FG007|Overall Study|Pt received additional steroids|0|||
130843373|NCT00075725|471053600|FG008|Overall Study|Pt received additional steroids|0|||
130843374|NCT00075725|471053601|FG009|Overall Study|Pt received additional steroids|0|||
130843375|NCT00075725|471053602|FG010|Overall Study|Pt received additional steroids|0|||
130843376|NCT00075725|471053603|FG011|Overall Study|Pt received additional steroids|0|||
130843377|NCT00075725|471053592|FG000|Overall Study|Pt relocated|0|||
130843378|NCT00075725|471053593|FG001|Overall Study|Pt relocated|0|||
130843379|NCT00075725|471053594|FG002|Overall Study|Pt relocated|0|||
130843380|NCT00075725|471053595|FG003|Overall Study|Pt relocated|2|||
130843381|NCT00075725|471053596|FG004|Overall Study|Pt relocated|0|||
130843382|NCT00075725|471053597|FG005|Overall Study|Pt relocated|1|||
130843383|NCT00075725|471053598|FG006|Overall Study|Pt relocated|1|||
130843384|NCT00075725|471053599|FG007|Overall Study|Pt relocated|2|||
130843385|NCT00075725|471053600|FG008|Overall Study|Pt relocated|1|||
130843386|NCT00075725|471053601|FG009|Overall Study|Pt relocated|0|||
130843387|NCT00075725|471053602|FG010|Overall Study|Pt relocated|0|||
130843388|NCT00075725|471053603|FG011|Overall Study|Pt relocated|0|||
130843389|NCT00075725|471053592|FG000|Overall Study|Institution Terminated|0|||
130843390|NCT00075725|471053593|FG001|Overall Study|Institution Terminated|0|||
130843391|NCT00075725|471053594|FG002|Overall Study|Institution Terminated|0|||
130843392|NCT00075725|471053595|FG003|Overall Study|Institution Terminated|0|||
130843393|NCT00075725|471053596|FG004|Overall Study|Institution Terminated|1|||
130843394|NCT00075725|471053597|FG005|Overall Study|Institution Terminated|0|||
130843395|NCT00075725|471053598|FG006|Overall Study|Institution Terminated|0|||
130843396|NCT00075725|471053599|FG007|Overall Study|Institution Terminated|3|||
130843397|NCT00075725|471053600|FG008|Overall Study|Institution Terminated|0|||
130843398|NCT00075725|471053601|FG009|Overall Study|Institution Terminated|0|||
130843399|NCT00075725|471053602|FG010|Overall Study|Institution Terminated|0|||
130843400|NCT00075725|471053603|FG011|Overall Study|Institution Terminated|0|||
130843401|NCT00075725|471053592|FG000|Overall Study|Study Closure|1|||
130843402|NCT00075725|471053593|FG001|Overall Study|Study Closure|0|||
130843403|NCT00075725|471053594|FG002|Overall Study|Study Closure|0|||
130843404|NCT00075725|471053595|FG003|Overall Study|Study Closure|0|||
130843405|NCT00075725|471053596|FG004|Overall Study|Study Closure|1|||
130843406|NCT00075725|471053597|FG005|Overall Study|Study Closure|3|||
130843407|NCT00075725|471053598|FG006|Overall Study|Study Closure|0|||
130843408|NCT00075725|471053599|FG007|Overall Study|Study Closure|1|||
130843409|NCT00075725|471053600|FG008|Overall Study|Study Closure|0|||
130843410|NCT00075725|471053601|FG009|Overall Study|Study Closure|0|||
130843411|NCT00075725|471053602|FG010|Overall Study|Study Closure|0|||
130843412|NCT00075725|471053603|FG011|Overall Study|Study Closure|0|||
130843413|NCT00075725|471053592|FG000|Overall Study|Other complications|0|||
130843414|NCT00075725|471053593|FG001|Overall Study|Other complications|0|||
130843415|NCT00075725|471053594|FG002|Overall Study|Other complications|0|||
130843416|NCT00075725|471053595|FG003|Overall Study|Other complications|0|||
130843417|NCT00075725|471053596|FG004|Overall Study|Other complications|0|||
130843418|NCT00075725|471053597|FG005|Overall Study|Other complications|1|||
130843419|NCT00075725|471053598|FG006|Overall Study|Other complications|0|||
130843420|NCT00075725|471053599|FG007|Overall Study|Other complications|0|||
130843421|NCT00075725|471053600|FG008|Overall Study|Other complications|0|||
130843422|NCT00075725|471053601|FG009|Overall Study|Other complications|0|||
130843423|NCT00075725|471053602|FG010|Overall Study|Other complications|0|||
130843424|NCT00075725|471053603|FG011|Overall Study|Other complications|0|||
130843425|NCT00075725|471053592|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
130843426|NCT00075725|471053593|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
130843427|NCT00075725|471053594|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
130843428|NCT00075725|471053595|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
130843429|NCT00075725|471053596|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
130843430|NCT00075725|471053597|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
130843431|NCT00075725|471053598|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
130843432|NCT00075725|471053599|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
130843433|NCT00075725|471053600|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
130843434|NCT00075725|471053601|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
130843435|NCT00075725|471053602|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
130843436|NCT00075725|471053603|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
130843437|NCT00075725|471053592|FG000|Overall Study|Pt incarcerated|0|||
130843438|NCT00075725|471053593|FG001|Overall Study|Pt incarcerated|0|||
130843439|NCT00075725|471053594|FG002|Overall Study|Pt incarcerated|0|||
130843440|NCT00075725|471053595|FG003|Overall Study|Pt incarcerated|0|||
130843441|NCT00075725|471053596|FG004|Overall Study|Pt incarcerated|0|||
130843442|NCT00075725|471053597|FG005|Overall Study|Pt incarcerated|0|||
130843443|NCT00075725|471053598|FG006|Overall Study|Pt incarcerated|0|||
130843444|NCT00075725|471053599|FG007|Overall Study|Pt incarcerated|1|||
130843445|NCT00075725|471053600|FG008|Overall Study|Pt incarcerated|0|||
130843446|NCT00075725|471053601|FG009|Overall Study|Pt incarcerated|0|||
130843447|NCT00075725|471053602|FG010|Overall Study|Pt incarcerated|0|||
130843448|NCT00075725|471053603|FG011|Overall Study|Pt incarcerated|0|||
130843449|NCT02240368|471053604|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
130843450|NCT02240368|471053605|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
130843451|NCT02240368|471053606|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
130843452|NCT02240368|471053604|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
130843453|NCT02240368|471053605|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
130843454|NCT02240368|471053606|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
130843455|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Death|1|||
130843456|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Death|1|||
130843457|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Death|0|||
130843458|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Death|0|||
130843459|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Death|1|||
130843460|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Death|0|||
130843461|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Death|0|||
130843462|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Death|0|||
130843463|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Death|0|||
130843464|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Death|0|||
130843465|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
130843466|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
130843467|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
130843468|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
130843469|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
130843470|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
130843471|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
130843472|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
130843473|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
130843474|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
130843475|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130843476|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130843477|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130843478|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130843479|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
130843480|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130843481|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130843482|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130843483|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130843484|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130843485|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
130843486|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130843487|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130843488|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130843489|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130843490|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130843491|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130843492|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130843493|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130843494|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130843495|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
130843496|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130843497|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130843498|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
130843499|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
130843500|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130843501|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130843502|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130843503|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130843504|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130843505|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
130843506|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130843507|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130843508|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
130843509|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130843510|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130843511|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130843512|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130843513|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130843514|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130843515|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
130843516|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
130843517|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
130843518|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
130843519|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
130843520|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130843521|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130843522|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130843523|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130843524|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130843525|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
130843526|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
130843527|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
130843528|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843529|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
130843530|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843531|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843532|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843533|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843534|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843535|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
130843536|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130843537|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130843538|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
130843539|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
130843540|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130843541|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130843542|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130843543|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130843544|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130843545|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130843546|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130843547|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843548|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130843549|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130843550|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843551|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843552|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843553|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843554|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843555|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843556|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843557|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
130843558|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843559|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
130843560|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843561|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843562|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843563|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843564|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843565|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
130843566|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
130843567|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
130843568|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
130843569|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
130843570|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130843571|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130843572|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130843573|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130843574|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130843575|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843576|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843577|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843578|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
130843579|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
130843580|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843581|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843582|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843583|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843584|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843585|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130843586|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843587|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130843588|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130843589|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130843590|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843591|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843592|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843593|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843594|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843595|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
130843596|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843597|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843598|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843599|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
130843600|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843601|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843602|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843603|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130843604|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130875422|NCT03137992|471173817|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
130843605|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843606|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843607|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843608|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843609|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
130843610|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843611|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843612|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843613|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843614|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843615|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130843616|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
130843617|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130843618|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130843619|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
130843620|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130843621|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130843622|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130843623|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130843624|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130843625|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
130843626|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130843627|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130843628|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130843629|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
130843630|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130843631|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130843632|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130843633|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130843634|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130843635|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
130843636|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130843637|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
130843638|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130843639|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
130843640|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130843641|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130843642|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130843643|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130843644|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130843645|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Other|5|||
130843646|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Other|1|||
130843647|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Other|0|||
130843648|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Other|3|||
130843649|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Other|0|||
130843650|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Other|0|||
130843651|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Other|0|||
130843652|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Other|0|||
130843653|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Other|0|||
130843654|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Other|0|||
130843655|NCT03352557|471053607|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
130843656|NCT03352557|471053608|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
130843657|NCT03352557|471053609|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
130843658|NCT03352557|471053610|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
130843659|NCT03352557|471053611|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
130843660|NCT03352557|471053612|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
130843661|NCT03352557|471053613|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
130843662|NCT03352557|471053614|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
130843663|NCT03352557|471053615|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
130843664|NCT03352557|471053616|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
130843665|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Death|0|||
130843666|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Death|0|||
130843667|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Death|0|||
130843668|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Death|0|||
130843669|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Death|0|||
130843670|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Death|1|||
130843671|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Death|0|||
130843672|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Death|1|||
130843673|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Death|1|||
130843674|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Death|1|||
130843675|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130843676|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130843677|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130843678|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130843679|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130843680|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
130843681|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130843682|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130843683|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130843684|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130843685|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130843686|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130843687|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130843688|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130843689|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130843690|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130843691|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130843692|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130843693|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
130843694|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130843695|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130843696|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130843697|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130843698|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130843699|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130843700|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
130843701|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
130843702|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
130843703|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
130843704|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
130843705|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843706|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843707|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843708|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843709|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843710|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
130843711|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130843712|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
130843713|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
130843714|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
130843715|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843716|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843717|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843718|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843719|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843720|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130843721|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843722|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130843723|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130843724|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130843725|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130843726|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130843727|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130843728|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130843729|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130843730|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
130843731|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130843732|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
130843733|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
130843734|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
130843735|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843736|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843737|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843738|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843739|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843740|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843741|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843742|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130843743|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
130843744|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
130843745|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843746|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843747|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843748|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843749|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843750|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843751|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843752|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130843753|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843754|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130843755|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130843756|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130843757|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130843758|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130843759|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130843760|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130843761|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130843762|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
130843763|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130843764|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130843765|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843766|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843767|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843768|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843769|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843770|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843771|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843772|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
130843773|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
130843774|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130843775|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130843776|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130843777|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130843778|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130843779|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130843780|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
130843781|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130843782|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130843783|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
130843784|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130843785|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130843786|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130843787|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130843788|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130843789|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130843790|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130843791|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130843792|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130843793|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130843794|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
130843795|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130843796|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130843797|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130843798|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130843799|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130843800|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130843801|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130843802|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130843803|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
130843804|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
130843805|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130843806|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130843807|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130843808|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130843809|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130843810|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130843811|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130843812|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
130843813|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
130843814|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130843815|NCT03352557|471053607|FG000|LTE Period: Week 80 to Week 173|Other|0|||
130843816|NCT03352557|471053608|FG001|LTE Period: Week 80 to Week 173|Other|0|||
130843817|NCT03352557|471053609|FG002|LTE Period: Week 80 to Week 173|Other|0|||
130843818|NCT03352557|471053610|FG003|LTE Period: Week 80 to Week 173|Other|0|||
130843819|NCT03352557|471053611|FG004|LTE Period: Week 80 to Week 173|Other|0|||
130843820|NCT03352557|471053612|FG005|LTE Period: Week 80 to Week 173|Other|0|||
130843821|NCT03352557|471053613|FG006|LTE Period: Week 80 to Week 173|Other|0|||
130843822|NCT03352557|471053614|FG007|LTE Period: Week 80 to Week 173|Other|1|||
130843823|NCT03352557|471053615|FG008|LTE Period: Week 80 to Week 173|Other|0|||
130843824|NCT03352557|471053616|FG009|LTE Period: Week 80 to Week 173|Other|0|||
130843825|NCT04065074|471053622|FG000|Overall Study|Adverse Event|1|||
130843826|NCT04065074|471053622|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
130843827|NCT00871117|471053623|FG000|Overall Study|Lost to Follow-up|5|||
130843828|NCT00871117|471053624|FG001|Overall Study|Lost to Follow-up|6|||
130843829|NCT00871117|471053623|FG000|Overall Study|Other|0|||
130843830|NCT00871117|471053624|FG001|Overall Study|Other|4|||
130843831|NCT00916058|471053625|FG000|Phase 1|Screen Failure|0|||
130843832|NCT00916058|471053626|FG001|Phase 1|Screen Failure|0|||
130843833|NCT00916058|471053627|FG002|Phase 1|Screen Failure|0|||
130843834|NCT00916058|471053628|FG003|Phase 1|Screen Failure|0|||
130843835|NCT00916058|471053629|FG004|Phase 1|Screen Failure|0|||
130843836|NCT00916058|471053630|FG005|Phase 1|Screen Failure|1|||
130843837|NCT00916058|471053631|FG006|Phase 1|Screen Failure|0|||
130843838|NCT00916058|471053625|FG000|Phase 2|Screen Failure|0|||
130843839|NCT00916058|471053626|FG001|Phase 2|Screen Failure|0|||
130843840|NCT00916058|471053627|FG002|Phase 2|Screen Failure|0|||
130843841|NCT00916058|471053628|FG003|Phase 2|Screen Failure|0|||
130843842|NCT00916058|471053629|FG004|Phase 2|Screen Failure|0|||
130843843|NCT00916058|471053630|FG005|Phase 2|Screen Failure|0|||
130843844|NCT00916058|471053631|FG006|Phase 2|Screen Failure|3|||
130843845|NCT03444766|471053632|FG000|Overall Study|Other Reasons|2|||
130843846|NCT03444766|471053632|FG000|Overall Study|Participant Withdrew Consent|5|||
130843847|NCT03444766|471053632|FG000|Overall Study|Lost to Follow-up|2|||
130843848|NCT03444766|471053632|FG000|Overall Study|Death|2|||
130843849|NCT03444766|471053632|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
130843850|NCT03444766|471053632|FG000|Overall Study|Disease Progression|49|||
130843851|NCT01767493|471053633|FG000|Overall Study|screen failures|3|||
130843852|NCT03746600|471053634|FG000|Overall Study|Withdrawal by Subject|3|||
130843853|NCT03746600|471053635|FG001|Overall Study|Withdrawal by Subject|3|||
130843854|NCT03746600|471053634|FG000|Overall Study|dismissed from study|1|||
130843855|NCT03746600|471053635|FG001|Overall Study|dismissed from study|0|||
130843856|NCT03746600|471053634|FG000|Overall Study|Lost to Follow-up|1|||
130843857|NCT03746600|471053635|FG001|Overall Study|Lost to Follow-up|0|||
130843858|NCT00717522|471053636|FG000|Overall Study|Disease Progression|5|||
130843859|NCT00717522|471053636|FG000|Overall Study|Adverse Event|1|||
130843860|NCT00717522|471053636|FG000|Overall Study|Death|1|||
130843861|NCT00072293|471053637|FG000|Overall Study|Lost to Follow-up|1|||
130843862|NCT00072293|471053638|FG001|Overall Study|Lost to Follow-up|1|||
130843863|NCT00072293|471053637|FG000|Overall Study|Withdrawal by Subject|0|||
130843864|NCT00072293|471053638|FG001|Overall Study|Withdrawal by Subject|1|||
130843865|NCT04209114|471053639|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
130843866|NCT04209114|471053640|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
130843867|NCT04209114|471053641|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
130843868|NCT04209114|471053639|FG000|Pre-Treatment Phase|Other reasons|0|||
130843869|NCT04209114|471053640|FG001|Pre-Treatment Phase|Other reasons|0|||
130843870|NCT04209114|471053641|FG002|Pre-Treatment Phase|Other reasons|1|||
130843871|NCT04209114|471053639|FG000|Pre-Treatment Phase|Death|0|||
130843872|NCT04209114|471053640|FG001|Pre-Treatment Phase|Death|0|||
130843873|NCT04209114|471053641|FG002|Pre-Treatment Phase|Death|1|||
130843874|NCT04209114|471053639|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
130843875|NCT04209114|471053640|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
130843876|NCT04209114|471053641|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
130843877|NCT04209114|471053639|FG000|Treatment Phase|Other reasons|5|||
130843878|NCT04209114|471053640|FG001|Treatment Phase|Other reasons|3|||
130843879|NCT04209114|471053641|FG002|Treatment Phase|Other reasons|0|||
130843880|NCT04209114|471053639|FG000|Treatment Phase|Lost to Follow-up|1|||
130843881|NCT04209114|471053640|FG001|Treatment Phase|Lost to Follow-up|0|||
130843882|NCT04209114|471053641|FG002|Treatment Phase|Lost to Follow-up|0|||
130843883|NCT04209114|471053639|FG000|Treatment Phase|Participant withdrew consent|1|||
130843884|NCT04209114|471053640|FG001|Treatment Phase|Participant withdrew consent|0|||
130843885|NCT04209114|471053641|FG002|Treatment Phase|Participant withdrew consent|0|||
130843886|NCT04209114|471053639|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
130843887|NCT04209114|471053640|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
130843888|NCT04209114|471053641|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
130843889|NCT04209114|471053639|FG000|Treatment Phase|Death|4|||
130843890|NCT04209114|471053640|FG001|Treatment Phase|Death|1|||
130843891|NCT04209114|471053641|FG002|Treatment Phase|Death|0|||
130843892|NCT04209114|471053639|FG000|Treatment Phase|Study drug toxicity|4|||
130843893|NCT04209114|471053640|FG001|Treatment Phase|Study drug toxicity|6|||
130843894|NCT04209114|471053641|FG002|Treatment Phase|Study drug toxicity|0|||
130843895|NCT04209114|471053639|FG000|Treatment Phase|Disease progression|6|||
130843896|NCT04209114|471053640|FG001|Treatment Phase|Disease progression|9|||
130843897|NCT04209114|471053641|FG002|Treatment Phase|Disease progression|0|||
130843898|NCT00405964|471053644|FG000|Overall Study|Treatment Failure|17|||
130843899|NCT00405964|471053645|FG001|Overall Study|Treatment Failure|45|||
130843900|NCT00405964|471053644|FG000|Overall Study|Adverse Event|7|||
130843901|NCT00405964|471053645|FG001|Overall Study|Adverse Event|16|||
130843902|NCT00405964|471053644|FG000|Overall Study|Lost to Follow-up|5|||
130843903|NCT00405964|471053645|FG001|Overall Study|Lost to Follow-up|5|||
130843904|NCT00405964|471053644|FG000|Overall Study|Withdrawal by Subject|19|||
130843905|NCT00405964|471053645|FG001|Overall Study|Withdrawal by Subject|23|||
130843906|NCT00405964|471053644|FG000|Overall Study|Protocol Violation|11|||
130843907|NCT00405964|471053645|FG001|Overall Study|Protocol Violation|6|||
130843908|NCT02981407|471053651|FG000|Overall Study|Withdrawal by Subject|2|||
130843909|NCT02981407|471053652|FG001|Overall Study|Withdrawal by Subject|0|||
130843910|NCT01416441|471053653|FG000|Overall Study|Lost to Follow-up|5|||
130843911|NCT01416441|471053653|FG000|Overall Study|Adverse Event|6|||
130843912|NCT01416441|471053653|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
130843913|NCT01416441|471053653|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
130843914|NCT01416441|471053653|FG000|Overall Study|Investigator Withdrew Subject|2|||
130843915|NCT01416441|471053653|FG000|Overall Study|Subject Withdrew Consent|12|||
130843916|NCT01416441|471053653|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
130843917|NCT02653495|471053654|FG000|Overall Study|Lost to Follow-up|2|||
130843918|NCT02653495|471053655|FG001|Overall Study|Lost to Follow-up|0|||
130843919|NCT02653495|471053654|FG000|Overall Study|Screening Failure|10|||
130843920|NCT02653495|471053655|FG001|Overall Study|Screening Failure|0|||
130843921|NCT00953680|471053656|FG000|Period 1|Withdrawal by Subject|0|||
130843922|NCT00953680|471053657|FG001|Period 1|Withdrawal by Subject|1|||
130843923|NCT01360398|471053658|FG000|Overall Study|Withdrawal by Subject|14|||
130843924|NCT01360398|471053658|FG000|Overall Study|Other|7|||
130843925|NCT01360398|471053658|FG000|Overall Study|Migrated/moved from study area|1|||
130843926|NCT00737711|471053659|FG000|Overall Study|Adverse Event|2|||
130843927|NCT00737711|471053659|FG000|Overall Study|Death|8|||
130843928|NCT00737711|471053659|FG000|Overall Study|Failure to return|4|||
130843929|NCT00737711|471053659|FG000|Overall Study|Protocol Violation|1|||
130843930|NCT00737711|471053659|FG000|Overall Study|Withdrawal by Subject|5|||
130843931|NCT00737711|471053659|FG000|Overall Study|Blood transfusion|6|||
130843932|NCT00737711|471053659|FG000|Overall Study|Other|5|||
130843933|NCT00624780|471053663|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
130843934|NCT00624780|471053664|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
130843935|NCT00624780|471053665|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
130843936|NCT00624780|471053666|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
130843937|NCT00624780|471053667|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
130843938|NCT00624780|471053668|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
130843939|NCT00624780|471053663|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
130843940|NCT00624780|471053664|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
130843941|NCT00624780|471053665|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
130843942|NCT00624780|471053666|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
130843943|NCT00624780|471053667|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
130843944|NCT00624780|471053668|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
130843945|NCT00624780|471053663|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
130843946|NCT00624780|471053664|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
130843947|NCT00624780|471053665|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
130843948|NCT00624780|471053666|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
130843949|NCT00624780|471053667|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
130843950|NCT00624780|471053668|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
130843951|NCT00624780|471053663|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
130843952|NCT00624780|471053664|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
130843953|NCT00624780|471053665|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
130843954|NCT00624780|471053666|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
130843955|NCT00624780|471053667|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
130843956|NCT00624780|471053668|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
130843957|NCT00624780|471053663|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
130843958|NCT00624780|471053664|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
130843959|NCT00624780|471053665|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
130843960|NCT00624780|471053666|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
130843961|NCT00624780|471053667|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
130843962|NCT00624780|471053668|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
130843963|NCT00624780|471053663|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
130843964|NCT00624780|471053664|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
130843965|NCT00624780|471053665|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
130843966|NCT00624780|471053666|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
130843967|NCT00624780|471053667|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
130843968|NCT00624780|471053668|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
130843969|NCT00624780|471053663|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
130843970|NCT00624780|471053664|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
130843971|NCT00624780|471053665|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
130843972|NCT00624780|471053666|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
130843973|NCT00624780|471053667|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
130843974|NCT00624780|471053668|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
130843975|NCT00624780|471053663|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130843976|NCT00624780|471053664|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
130843977|NCT00624780|471053665|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130843978|NCT00624780|471053666|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
130843979|NCT00624780|471053667|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130843980|NCT00624780|471053668|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130843981|NCT00624780|471053663|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
130843982|NCT00624780|471053664|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
130843983|NCT00624780|471053665|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
130843984|NCT00624780|471053666|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
130843985|NCT00624780|471053667|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
130843986|NCT00624780|471053668|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
130843987|NCT00624780|471053663|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
130843988|NCT00624780|471053664|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
130843989|NCT00624780|471053665|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
130843990|NCT00624780|471053666|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
130843991|NCT00624780|471053667|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
130843992|NCT00624780|471053668|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
130843993|NCT00624780|471053663|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
130843994|NCT00624780|471053664|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
130843995|NCT00624780|471053665|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
130843996|NCT00624780|471053666|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
130843997|NCT00624780|471053667|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
130843998|NCT00624780|471053668|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
130843999|NCT00624780|471053663|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
130844000|NCT00624780|471053664|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130844001|NCT00624780|471053665|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130844002|NCT00624780|471053666|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130844003|NCT00624780|471053667|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130844004|NCT00624780|471053668|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130844005|NCT00624780|471053663|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130844006|NCT00624780|471053664|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130844007|NCT00624780|471053665|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
130844008|NCT00624780|471053666|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130844009|NCT00624780|471053667|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130844010|NCT00624780|471053668|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130844011|NCT00624780|471053663|FG000|Follow-up (Week 26)|Death|0|||
130844012|NCT00624780|471053664|FG001|Follow-up (Week 26)|Death|0|||
130844013|NCT00624780|471053665|FG002|Follow-up (Week 26)|Death|1|||
130844014|NCT00624780|471053666|FG003|Follow-up (Week 26)|Death|0|||
130844015|NCT00624780|471053667|FG004|Follow-up (Week 26)|Death|0|||
130844016|NCT00624780|471053668|FG005|Follow-up (Week 26)|Death|0|||
130844017|NCT00624780|471053663|FG000|Follow-up (Week 26)|Adverse Event|0|||
130844018|NCT00624780|471053664|FG001|Follow-up (Week 26)|Adverse Event|0|||
130844019|NCT00624780|471053665|FG002|Follow-up (Week 26)|Adverse Event|0|||
130844020|NCT00624780|471053666|FG003|Follow-up (Week 26)|Adverse Event|0|||
130844021|NCT00624780|471053667|FG004|Follow-up (Week 26)|Adverse Event|1|||
130844022|NCT00624780|471053668|FG005|Follow-up (Week 26)|Adverse Event|0|||
130844023|NCT00624780|471053663|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
130844024|NCT00624780|471053664|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
130844025|NCT00624780|471053665|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
130844026|NCT00624780|471053666|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
130844027|NCT00624780|471053667|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
130844028|NCT00624780|471053668|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
130844029|NCT00624780|471053663|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
130844030|NCT00624780|471053664|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
130844031|NCT00624780|471053665|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
130844032|NCT00624780|471053666|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
130844033|NCT00624780|471053667|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
130844034|NCT00624780|471053668|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
130844035|NCT00624780|471053663|FG000|Follow-up (Week 26)|Other|1|||
130844036|NCT00624780|471053664|FG001|Follow-up (Week 26)|Other|1|||
130844037|NCT00624780|471053665|FG002|Follow-up (Week 26)|Other|0|||
130844038|NCT00624780|471053666|FG003|Follow-up (Week 26)|Other|0|||
130844039|NCT00624780|471053667|FG004|Follow-up (Week 26)|Other|0|||
130844040|NCT00624780|471053668|FG005|Follow-up (Week 26)|Other|0|||
130844041|NCT01514240|471055644|FG000|Overall Study|Adverse Event|4|||
130844042|NCT01514240|471055645|FG001|Overall Study|Adverse Event|4|||
130844043|NCT01514240|471055644|FG000|Overall Study|Subject Decision|2|||
130844044|NCT01514240|471055645|FG001|Overall Study|Subject Decision|7|||
130844045|NCT01103063|471055646|FG000|Overall Study|Adverse Event|3|||
130844046|NCT01103063|471055647|FG001|Overall Study|Adverse Event|1|||
130844047|NCT01103063|471055646|FG000|Overall Study|Lost to Follow-up|68|||
130844048|NCT01103063|471055647|FG001|Overall Study|Lost to Follow-up|51|||
130844049|NCT01103063|471055646|FG000|Overall Study|Withdrawal by Subject|60|||
130844050|NCT01103063|471055647|FG001|Overall Study|Withdrawal by Subject|15|||
130844051|NCT01103063|471055646|FG000|Overall Study|Other|16|||
130844052|NCT01103063|471055647|FG001|Overall Study|Other|11|||
130844053|NCT01103063|471055646|FG000|Overall Study|Protocol Violation|1|||
130844054|NCT01103063|471055647|FG001|Overall Study|Protocol Violation|0|||
130844055|NCT01103063|471055646|FG000|Overall Study|Study terminated by Sponsor|326|||
130844056|NCT01103063|471055647|FG001|Overall Study|Study terminated by Sponsor|342|||
130844057|NCT01103063|471055646|FG000|Overall Study|Death|3|||
130844058|NCT01103063|471055647|FG001|Overall Study|Death|1|||
130844059|NCT01187446|471055650|FG000|Overall Study|Patient started non-protocol therapy|0|||
130844060|NCT01187446|471055651|FG001|Overall Study|Patient started non-protocol therapy|1|||
130844061|NCT00149994|471055652|FG000|Overall Study|Administrative problems:|1|||
130844062|NCT00149994|471055653|FG001|Overall Study|Administrative problems:|0|||
130844063|NCT00149994|471055652|FG000|Overall Study|Protocol Violation|0|||
130844064|NCT00149994|471055653|FG001|Overall Study|Protocol Violation|1|||
130844065|NCT01342965|471055654|FG000|Overall Study|Death|58|||
130844066|NCT01342965|471055655|FG001|Overall Study|Death|57|||
130844067|NCT01342965|471055654|FG000|Overall Study|Lost to Follow-up|5|||
130844068|NCT01342965|471055655|FG001|Overall Study|Lost to Follow-up|3|||
130844069|NCT01342965|471055654|FG000|Overall Study|Other Reasons- Unspecified|44|||
130844070|NCT01342965|471055655|FG001|Overall Study|Other Reasons- Unspecified|38|||
130844071|NCT01342965|471055654|FG000|Overall Study|Withdrawal by Subject|2|||
130844072|NCT01342965|471055655|FG001|Overall Study|Withdrawal by Subject|9|||
130844073|NCT03549871|471055662|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
130844074|NCT03549871|471055663|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
130844075|NCT03549871|471055662|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
130844076|NCT03549871|471055663|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
130844077|NCT03549871|471055662|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
130844078|NCT03549871|471055663|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
130844079|NCT03549871|471055662|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
130844080|NCT03549871|471055663|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
130844081|NCT03549871|471055662|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
130844082|NCT03549871|471055663|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
130844083|NCT03549871|471055662|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
130844084|NCT03549871|471055663|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
130844085|NCT03549871|471055662|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
130844086|NCT03549871|471055663|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
130844087|NCT03549871|471055662|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
130844088|NCT03549871|471055663|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
130844089|NCT03549871|471055662|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
130844090|NCT03549871|471055663|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
130844091|NCT03549871|471055662|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
130844092|NCT03549871|471055663|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
130844093|NCT03549871|471055662|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
130844094|NCT03549871|471055663|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
130844095|NCT01133626|471055665|FG000|Overall Study|Adverse Event|0|||
130844096|NCT01133626|471055666|FG001|Overall Study|Adverse Event|1|||
130844097|NCT01133626|471055667|FG002|Overall Study|Adverse Event|0|||
130844098|NCT01133626|471055665|FG000|Overall Study|Withdrawal by Subject|1|||
130844099|NCT01133626|471055666|FG001|Overall Study|Withdrawal by Subject|2|||
130844100|NCT01133626|471055667|FG002|Overall Study|Withdrawal by Subject|2|||
130844101|NCT01133626|471055665|FG000|Overall Study|Other|0|||
130844102|NCT01133626|471055666|FG001|Overall Study|Other|2|||
130844103|NCT01133626|471055667|FG002|Overall Study|Other|0|||
130844104|NCT03298984|471055670|FG000|Overall Study|Physician Decision|1|||
130844105|NCT03298984|471055671|FG001|Overall Study|Physician Decision|0|||
130844106|NCT03298984|471055672|FG002|Overall Study|Physician Decision|0|||
130844107|NCT03298984|471055673|FG003|Overall Study|Physician Decision|6|||
130844108|NCT03298984|471055670|FG000|Overall Study|Lack of Efficacy|0|||
130844109|NCT03298984|471055671|FG001|Overall Study|Lack of Efficacy|1|||
130844110|NCT03298984|471055672|FG002|Overall Study|Lack of Efficacy|1|||
130844111|NCT03298984|471055673|FG003|Overall Study|Lack of Efficacy|4|||
130844112|NCT03298984|471055670|FG000|Overall Study|Relapsed disease (following remission)|0|||
130844113|NCT03298984|471055671|FG001|Overall Study|Relapsed disease (following remission)|0|||
130844114|NCT03298984|471055672|FG002|Overall Study|Relapsed disease (following remission)|1|||
130844115|NCT03298984|471055673|FG003|Overall Study|Relapsed disease (following remission)|1|||
130844116|NCT03298984|471055670|FG000|Overall Study|Adverse Event|0|||
130844117|NCT03298984|471055671|FG001|Overall Study|Adverse Event|0|||
130844118|NCT03298984|471055672|FG002|Overall Study|Adverse Event|0|||
130844119|NCT03298984|471055673|FG003|Overall Study|Adverse Event|1|||
130844120|NCT03298984|471055670|FG000|Overall Study|Death|0|||
130844121|NCT03298984|471055671|FG001|Overall Study|Death|0|||
130844122|NCT03298984|471055672|FG002|Overall Study|Death|0|||
130844123|NCT03298984|471055673|FG003|Overall Study|Death|2|||
130844124|NCT03298984|471055670|FG000|Overall Study|Insurance Company Decision|0|||
130844125|NCT03298984|471055671|FG001|Overall Study|Insurance Company Decision|0|||
130844126|NCT03298984|471055672|FG002|Overall Study|Insurance Company Decision|0|||
130844127|NCT03298984|471055673|FG003|Overall Study|Insurance Company Decision|1|||
130844128|NCT00294645|471055674|FG000|Overall Study|Death|10|||
130844129|NCT00294645|471055675|FG001|Overall Study|Death|18|||
130844130|NCT00294645|471055674|FG000|Overall Study|Lost to Follow-up|1|||
130844131|NCT00294645|471055675|FG001|Overall Study|Lost to Follow-up|10|||
130844132|NCT00294645|471055674|FG000|Overall Study|Withdrawal by Subject|18|||
130844133|NCT00294645|471055675|FG001|Overall Study|Withdrawal by Subject|34|||
130844134|NCT00294645|471055674|FG000|Overall Study|Physician Decision|15|||
130844135|NCT00294645|471055675|FG001|Overall Study|Physician Decision|20|||
130844136|NCT00294645|471055674|FG000|Overall Study|Other|4|||
130844137|NCT00294645|471055675|FG001|Overall Study|Other|10|||
130844138|NCT03263923|471055676|FG000|Overall Study|Withdrawal by Subject|10|||
130844139|NCT03263923|471055677|FG001|Overall Study|Withdrawal by Subject|8|||
130844140|NCT03263923|471055676|FG000|Overall Study|Lost to Follow-up|15|||
130844141|NCT03263923|471055677|FG001|Overall Study|Lost to Follow-up|13|||
130844142|NCT03305081|471055684|FG000|Overall Study|Lost to Follow-up|10|||
130844143|NCT03305081|471055685|FG001|Overall Study|Lost to Follow-up|15|||
130844144|NCT02437305|471055693|FG000|Overall Study|Lost to Follow-up|18|||
130844145|NCT02437305|471055694|FG001|Overall Study|Lost to Follow-up|12|||
130844146|NCT01560637|471055695|FG000|Overall Study|Adverse Event|63|||
130844147|NCT01560637|471055695|FG000|Overall Study|Death|69|||
130844148|NCT01560637|471055695|FG000|Overall Study|Lost to Follow-up|8|||
130844149|NCT01560637|471055695|FG000|Overall Study|Protocol Violation|8|||
130844150|NCT01560637|471055695|FG000|Overall Study|Withdrawal by Subject|24|||
130844151|NCT01560637|471055695|FG000|Overall Study|Progressive Disease|20|||
130844152|NCT01560637|471055695|FG000|Overall Study|Other Reason Not Specified|6|||
130844153|NCT01185964|471055698|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
130844154|NCT01185964|471055699|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
130844155|NCT01185964|471055700|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
130844156|NCT01185964|471055701|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
130844157|NCT01185964|471055698|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
130844158|NCT01185964|471055699|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
130844159|NCT01185964|471055700|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
130844160|NCT01185964|471055701|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
130844161|NCT01185964|471055698|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
130844162|NCT01185964|471055699|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
130844163|NCT01185964|471055700|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
130844164|NCT01185964|471055701|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
130844165|NCT01185964|471055698|FG000|Phase 1b and Phase 2|Adverse Event|1|||
130844166|NCT01185964|471055699|FG001|Phase 1b and Phase 2|Adverse Event|0|||
130844167|NCT01185964|471055700|FG002|Phase 1b and Phase 2|Adverse Event|2|||
130844168|NCT01185964|471055701|FG003|Phase 1b and Phase 2|Adverse Event|0|||
130844169|NCT01185964|471055698|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
130844170|NCT01185964|471055699|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
130844171|NCT01185964|471055700|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
130844172|NCT01185964|471055701|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
130844173|NCT01185964|471055698|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
130844174|NCT01185964|471055699|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
130844175|NCT01185964|471055700|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
130844176|NCT01185964|471055701|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
130844177|NCT01185964|471055698|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
130844178|NCT01185964|471055699|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
130844179|NCT01185964|471055700|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
130844180|NCT01185964|471055701|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
130844181|NCT01185964|471055698|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
130844182|NCT01185964|471055699|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
130844183|NCT01185964|471055700|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
130844184|NCT01185964|471055701|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
130844185|NCT01920893|471055702|FG000|Overall Study|Adverse Event|5|||
130844186|NCT01920893|471055703|FG001|Overall Study|Adverse Event|2|||
130844187|NCT01920893|471055702|FG000|Overall Study|Lack of Efficacy|2|||
130844188|NCT01920893|471055703|FG001|Overall Study|Lack of Efficacy|0|||
130844189|NCT03762616|471055704|FG000|Overall Study|Protocol Violation|2|||
130844190|NCT04465877|471055705|FG000|Overall Study|Noncompliant with study requirements|0|||
130844191|NCT04465877|471055706|FG001|Overall Study|Noncompliant with study requirements|0|||
130844192|NCT04465877|471055707|FG002|Overall Study|Noncompliant with study requirements|1|||
130844193|NCT04465877|471055708|FG003|Overall Study|Noncompliant with study requirements|0|||
130844194|NCT02323204|471055717|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
130844195|NCT02323204|471055718|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
130844196|NCT02323204|471055719|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
130844197|NCT02323204|471055720|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
130844198|NCT02323204|471055717|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
130844199|NCT02323204|471055718|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
130844200|NCT02323204|471055719|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
130844201|NCT02323204|471055720|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
130844202|NCT02323204|471055717|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
130844203|NCT02323204|471055718|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
130844204|NCT02323204|471055719|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
130844205|NCT02323204|471055720|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
130844206|NCT02323204|471055717|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
130844207|NCT02323204|471055718|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
130844208|NCT02323204|471055719|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
130844209|NCT02323204|471055720|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
130844210|NCT02323204|471055717|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
130844211|NCT02323204|471055718|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
130844212|NCT02323204|471055719|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
130844213|NCT02323204|471055720|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
130844214|NCT02323204|471055717|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
130844215|NCT02323204|471055718|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
130844216|NCT02323204|471055719|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
130844217|NCT02323204|471055720|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
130844218|NCT02323204|471055717|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130844219|NCT02323204|471055718|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
130844220|NCT02323204|471055719|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130844221|NCT02323204|471055720|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
130844222|NCT02323204|471055717|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
130844223|NCT02323204|471055718|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
130844224|NCT02323204|471055719|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
130844225|NCT02323204|471055720|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
130844226|NCT02323204|471055717|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130844227|NCT02323204|471055718|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130844228|NCT02323204|471055719|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
130844229|NCT02323204|471055720|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
130844230|NCT03440918|471055721|FG000|Overall Study|Protocol Violation|0|||
130844231|NCT03440918|471055722|FG001|Overall Study|Protocol Violation|16|||
130844232|NCT01396265|471055734|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
130844233|NCT03576755|471055735|FG000|Overall Study|Withdrawal by Subject|1|||
130844234|NCT03576755|471055736|FG001|Overall Study|Withdrawal by Subject|0|||
130844235|NCT03576755|471055737|FG002|Overall Study|Withdrawal by Subject|0|||
130844236|NCT03576755|471055738|FG003|Overall Study|Withdrawal by Subject|0|||
130844237|NCT04962230|471055739|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
130844238|NCT04962230|471055739|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
130844239|NCT03958656|471055740|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
130844240|NCT03958656|471055741|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
130844241|NCT03958656|471055742|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
130844242|NCT03958656|471055743|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
130844243|NCT03958656|471055740|FG000|Overall Study|No longer meets eligibility criteria|0|||
130844244|NCT03958656|471055741|FG001|Overall Study|No longer meets eligibility criteria|0|||
130844245|NCT03958656|471055742|FG002|Overall Study|No longer meets eligibility criteria|1|||
130844246|NCT03958656|471055743|FG003|Overall Study|No longer meets eligibility criteria|0|||
130844247|NCT03958656|471055740|FG000|Overall Study|Started anti-cancer treatment|0|||
130844248|NCT03958656|471055741|FG001|Overall Study|Started anti-cancer treatment|0|||
130844249|NCT03958656|471055742|FG002|Overall Study|Started anti-cancer treatment|1|||
130844250|NCT03958656|471055743|FG003|Overall Study|Started anti-cancer treatment|0|||
130844251|NCT03831880|471055744|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
130844252|NCT03831880|471055745|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
130844253|NCT03831880|471055744|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
130844254|NCT03831880|471055745|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
130844255|NCT01598753|471055750|FG000|Overall Study|Adverse Event|1|||
130844256|NCT01598753|471055751|FG001|Overall Study|Adverse Event|9|||
130844257|NCT01598753|471055752|FG002|Overall Study|Adverse Event|1|||
130844258|NCT01598753|471055753|FG003|Overall Study|Adverse Event|7|||
130844259|NCT01598753|471055750|FG000|Overall Study|Lost to Follow-up|4|||
130844260|NCT01598753|471055751|FG001|Overall Study|Lost to Follow-up|3|||
130844261|NCT01598753|471055752|FG002|Overall Study|Lost to Follow-up|7|||
130844262|NCT01598753|471055753|FG003|Overall Study|Lost to Follow-up|5|||
130844263|NCT01598753|471055750|FG000|Overall Study|Physician Decision|0|||
130844264|NCT01598753|471055751|FG001|Overall Study|Physician Decision|1|||
130844265|NCT01598753|471055752|FG002|Overall Study|Physician Decision|0|||
130844266|NCT01598753|471055753|FG003|Overall Study|Physician Decision|2|||
130844267|NCT01598753|471055750|FG000|Overall Study|Withdrawal by Subject|7|||
130844268|NCT01598753|471055751|FG001|Overall Study|Withdrawal by Subject|2|||
130844269|NCT01598753|471055752|FG002|Overall Study|Withdrawal by Subject|0|||
130844270|NCT01598753|471055753|FG003|Overall Study|Withdrawal by Subject|1|||
130844271|NCT04346108|471055754|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
130844272|NCT04346108|471055755|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
130844273|NCT04346108|471055756|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
130844274|NCT04346108|471055754|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
130844275|NCT04346108|471055755|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
130844276|NCT04346108|471055756|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
130844277|NCT02788201|471055757|FG000|Overall Study|Death|1|||
130844278|NCT02788201|471055758|FG001|Overall Study|Death|1|||
130844279|NCT02788201|471055759|FG002|Overall Study|Death|1|||
130844280|NCT02788201|471055760|FG003|Overall Study|Death|1|||
130844281|NCT02788201|471055761|FG004|Overall Study|Death|0|||
130844282|NCT02788201|471055762|FG005|Overall Study|Death|1|||
130844283|NCT02788201|471055757|FG000|Overall Study|Ineligible|0|||
130844284|NCT02788201|471055758|FG001|Overall Study|Ineligible|0|||
130844285|NCT02788201|471055759|FG002|Overall Study|Ineligible|0|||
130844286|NCT02788201|471055760|FG003|Overall Study|Ineligible|0|||
130844287|NCT02788201|471055761|FG004|Overall Study|Ineligible|0|||
130844288|NCT02788201|471055762|FG005|Overall Study|Ineligible|1|||
130844289|NCT02788201|471055757|FG000|Overall Study|Withdrawal by Subject|0|||
130844290|NCT02788201|471055758|FG001|Overall Study|Withdrawal by Subject|0|||
130844291|NCT02788201|471055759|FG002|Overall Study|Withdrawal by Subject|0|||
130844292|NCT02788201|471055760|FG003|Overall Study|Withdrawal by Subject|0|||
130844293|NCT02788201|471055761|FG004|Overall Study|Withdrawal by Subject|0|||
130844294|NCT02788201|471055762|FG005|Overall Study|Withdrawal by Subject|1|||
130844295|NCT01852825|471055763|FG000|Overall Study|Withdrawal by Subject|2|||
130844296|NCT01852825|471055764|FG001|Overall Study|Withdrawal by Subject|0|||
130844297|NCT01852825|471055765|FG002|Overall Study|Withdrawal by Subject|0|||
130844298|NCT02275117|471055766|FG000|Overall Study|Adverse Event|0|||
130844299|NCT02275117|471055767|FG001|Overall Study|Adverse Event|0|||
130844300|NCT02275117|471055768|FG002|Overall Study|Adverse Event|0|||
130844301|NCT02275117|471055769|FG003|Overall Study|Adverse Event|0|||
130844302|NCT02275117|471055770|FG004|Overall Study|Adverse Event|1|||
130844303|NCT02275117|471055766|FG000|Overall Study|Lack of Efficacy|6|||
130844304|NCT02275117|471055767|FG001|Overall Study|Lack of Efficacy|7|||
130844305|NCT02275117|471055768|FG002|Overall Study|Lack of Efficacy|5|||
130844306|NCT02275117|471055769|FG003|Overall Study|Lack of Efficacy|2|||
130844307|NCT02275117|471055770|FG004|Overall Study|Lack of Efficacy|10|||
130844308|NCT02275117|471055766|FG000|Overall Study|Lost to Follow-up|11|||
130844309|NCT02275117|471055767|FG001|Overall Study|Lost to Follow-up|16|||
130844310|NCT02275117|471055768|FG002|Overall Study|Lost to Follow-up|15|||
130844311|NCT02275117|471055769|FG003|Overall Study|Lost to Follow-up|16|||
130844312|NCT02275117|471055770|FG004|Overall Study|Lost to Follow-up|8|||
130844313|NCT02275117|471055766|FG000|Overall Study|Physician Decision|0|||
130844314|NCT02275117|471055767|FG001|Overall Study|Physician Decision|1|||
130844315|NCT02275117|471055768|FG002|Overall Study|Physician Decision|1|||
130844316|NCT02275117|471055769|FG003|Overall Study|Physician Decision|0|||
130844317|NCT02275117|471055770|FG004|Overall Study|Physician Decision|1|||
130844318|NCT02275117|471055766|FG000|Overall Study|Protocol Violation|1|||
130844319|NCT02275117|471055767|FG001|Overall Study|Protocol Violation|0|||
130844320|NCT02275117|471055768|FG002|Overall Study|Protocol Violation|1|||
130844321|NCT02275117|471055769|FG003|Overall Study|Protocol Violation|1|||
130844322|NCT02275117|471055770|FG004|Overall Study|Protocol Violation|0|||
130844323|NCT02275117|471055766|FG000|Overall Study|Withdrawal by Subject|6|||
130844324|NCT02275117|471055767|FG001|Overall Study|Withdrawal by Subject|4|||
130844325|NCT02275117|471055768|FG002|Overall Study|Withdrawal by Subject|7|||
130844326|NCT02275117|471055769|FG003|Overall Study|Withdrawal by Subject|3|||
130844327|NCT02275117|471055770|FG004|Overall Study|Withdrawal by Subject|3|||
130844328|NCT02275117|471055766|FG000|Overall Study|Terminated by Sponsor|4|||
130844329|NCT02275117|471055767|FG001|Overall Study|Terminated by Sponsor|4|||
130844330|NCT02275117|471055768|FG002|Overall Study|Terminated by Sponsor|4|||
130844331|NCT02275117|471055769|FG003|Overall Study|Terminated by Sponsor|6|||
130844332|NCT02275117|471055770|FG004|Overall Study|Terminated by Sponsor|4|||
130844333|NCT02275117|471055766|FG000|Overall Study|Worsening of Study Indication|0|||
130844334|NCT02275117|471055767|FG001|Overall Study|Worsening of Study Indication|1|||
130844335|NCT02275117|471055768|FG002|Overall Study|Worsening of Study Indication|2|||
130844336|NCT02275117|471055769|FG003|Overall Study|Worsening of Study Indication|0|||
130844337|NCT02275117|471055770|FG004|Overall Study|Worsening of Study Indication|0|||
130844338|NCT02275117|471055766|FG000|Overall Study|Study Burden|5|||
130844339|NCT02275117|471055767|FG001|Overall Study|Study Burden|4|||
130844340|NCT02275117|471055768|FG002|Overall Study|Study Burden|7|||
130844341|NCT02275117|471055769|FG003|Overall Study|Study Burden|5|||
130844342|NCT02275117|471055770|FG004|Overall Study|Study Burden|7|||
130844343|NCT02275117|471055766|FG000|Overall Study|Other|1|||
130844344|NCT02275117|471055767|FG001|Overall Study|Other|0|||
130844345|NCT02275117|471055768|FG002|Overall Study|Other|0|||
130844346|NCT02275117|471055769|FG003|Overall Study|Other|0|||
130844347|NCT02275117|471055770|FG004|Overall Study|Other|2|||
130844348|NCT04508751|471055776|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
130844349|NCT04508751|471055777|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
130844350|NCT04508751|471055778|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
130844351|NCT00724854|471055779|FG000|Overall Study|Lack of Efficacy|187|||
130844352|NCT00724854|471055780|FG001|Overall Study|Lack of Efficacy|13|||
130844353|NCT00724854|471055779|FG000|Overall Study|Lost to Follow-up|87|||
130844354|NCT00724854|471055780|FG001|Overall Study|Lost to Follow-up|10|||
130844355|NCT00724854|471055779|FG000|Overall Study|Adverse Event|62|||
130844356|NCT00724854|471055780|FG001|Overall Study|Adverse Event|4|||
130844357|NCT00724854|471055779|FG000|Overall Study|Other|42|||
130844358|NCT00724854|471055780|FG001|Overall Study|Other|3|||
130844359|NCT00724854|471055779|FG000|Overall Study|Death|11|||
130844360|NCT00724854|471055780|FG001|Overall Study|Death|0|||
130844361|NCT00724854|471055779|FG000|Overall Study|Change of treatment|7|||
130844362|NCT00724854|471055780|FG001|Overall Study|Change of treatment|0|||
130844363|NCT00724854|471055779|FG000|Overall Study|Withdrawal by Subject|5|||
130844364|NCT00724854|471055780|FG001|Overall Study|Withdrawal by Subject|0|||
130844365|NCT00724854|471055779|FG000|Overall Study|Adverse event + lack of efficacy|2|||
130844366|NCT00724854|471055780|FG001|Overall Study|Adverse event + lack of efficacy|1|||
130844367|NCT01865812|471055781|FG000|Primary Treatment Phase|Adverse Event|2|||
130844368|NCT01865812|471055782|FG001|Primary Treatment Phase|Adverse Event|0|||
130844369|NCT01865812|471055781|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
130844370|NCT01865812|471055782|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
130844371|NCT01865812|471055781|FG000|Long-term Safety Extension Phase|Pruritus|0|||
130844372|NCT01865812|471055782|FG001|Long-term Safety Extension Phase|Pruritus|3|||
130844373|NCT01865812|471055781|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
130844374|NCT01865812|471055782|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
130844375|NCT01865812|471055781|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
130844376|NCT01865812|471055782|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
130844377|NCT00977938|471055787|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
130844378|NCT00977938|471055788|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
130844379|NCT00977938|471055789|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
130844380|NCT00977938|471055790|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
130844381|NCT00977938|471055787|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
130844382|NCT00977938|471055788|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
130844383|NCT00977938|471055789|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
130844384|NCT00977938|471055790|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
130844385|NCT00977938|471055787|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
130844386|NCT00977938|471055788|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
130844387|NCT00977938|471055789|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
130844388|NCT00977938|471055790|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
130844389|NCT00977938|471055787|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
130844390|NCT00977938|471055788|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
130844391|NCT00977938|471055789|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
130844392|NCT00977938|471055790|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
130844393|NCT00977938|471055787|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
130844394|NCT00977938|471055788|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
130844395|NCT00977938|471055789|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
130844396|NCT00977938|471055790|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
130844397|NCT00977938|471055787|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
130844398|NCT00977938|471055788|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
130844399|NCT00977938|471055789|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
130844400|NCT00977938|471055790|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
130844401|NCT02142283|471055793|FG000|Overall Study|Death|20|||
130844402|NCT02142283|471055794|FG001|Overall Study|Death|18|||
130844403|NCT02142283|471055793|FG000|Overall Study|Withdrawal by Subject|1|||
130844404|NCT02142283|471055794|FG001|Overall Study|Withdrawal by Subject|3|||
130844405|NCT02460783|471055795|FG000|Overall Study|Withdrawal by Subject|1|||
130844406|NCT02460783|471055796|FG001|Overall Study|Withdrawal by Subject|3|||
130844407|NCT02460783|471055795|FG000|Overall Study|Lost to Follow-up|1|||
130844408|NCT02460783|471055796|FG001|Overall Study|Lost to Follow-up|1|||
130844409|NCT01646645|471055797|FG000|Overall Study|No Treated|1|||
130844410|NCT01646645|471055797|FG000|Overall Study|Inevaluable Donor|29|||
130844411|NCT02374814|471055803|FG000|Overall Study|Lost to Follow-up|1|||
130844412|NCT02374814|471055804|FG001|Overall Study|Lost to Follow-up|1|||
130844413|NCT02374814|471055805|FG002|Overall Study|Lost to Follow-up|0|||
130844414|NCT02374814|471055806|FG003|Overall Study|Lost to Follow-up|1|||
130844415|NCT02374814|471055807|FG004|Overall Study|Lost to Follow-up|0|||
130844416|NCT02374814|471055808|FG005|Overall Study|Lost to Follow-up|0|||
130844417|NCT02374814|471055803|FG000|Overall Study|Withdrawal by Subject|0|||
130844418|NCT02374814|471055804|FG001|Overall Study|Withdrawal by Subject|0|||
130844419|NCT02374814|471055805|FG002|Overall Study|Withdrawal by Subject|1|||
130844420|NCT02374814|471055806|FG003|Overall Study|Withdrawal by Subject|1|||
130844421|NCT02374814|471055807|FG004|Overall Study|Withdrawal by Subject|0|||
130844422|NCT02374814|471055808|FG005|Overall Study|Withdrawal by Subject|0|||
130844423|NCT00884039|471055812|FG000|Overall Study|Withdrawal by Subject|0|||
130844424|NCT00884039|471055813|FG001|Overall Study|Withdrawal by Subject|1|||
130844425|NCT00884039|471055812|FG000|Overall Study|Lack of Efficacy|2|||
130844426|NCT00884039|471055813|FG001|Overall Study|Lack of Efficacy|0|||
130844427|NCT00624819|471055816|FG000|Follow-up Period: Year 4|Parents decision|0|||
130844428|NCT00624819|471055817|FG001|Follow-up Period: Year 4|Parents decision|0|||
130844429|NCT00624819|471055818|FG002|Follow-up Period: Year 4|Parents decision|1|||
130844430|NCT00624819|471055819|FG003|Follow-up Period: Year 4|Parents decision|0|||
130844431|NCT00624819|471055816|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
130844432|NCT00624819|471055817|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
130844433|NCT00624819|471055818|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
130844434|NCT00624819|471055819|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
130844435|NCT00509093|471058405|FG000|Overall Study|Adverse Event|10|||
130844436|NCT00509093|471058405|FG000|Overall Study|Disease Progression|9|||
130844437|NCT00509093|471058405|FG000|Overall Study|Transformed into MDS|1|||
130844438|NCT00509093|471058405|FG000|Overall Study|Withdrawal by Subject|3|||
130844439|NCT00509093|471058405|FG000|Overall Study|Physician Decision|1|||
130844440|NCT03187834|471058406|FG000|Overall Study|Lost to Follow-up|0|||
130844441|NCT03187834|471058407|FG001|Overall Study|Lost to Follow-up|1|||
130844442|NCT03187834|471058408|FG002|Overall Study|Lost to Follow-up|2|||
130844443|NCT03187834|471058409|FG003|Overall Study|Lost to Follow-up|2|||
130844444|NCT03187834|471058406|FG000|Overall Study|Had invalid anthropometric measurements|5|||
130844445|NCT03187834|471058407|FG001|Overall Study|Had invalid anthropometric measurements|3|||
130844446|NCT03187834|471058408|FG002|Overall Study|Had invalid anthropometric measurements|4|||
130844447|NCT03187834|471058409|FG003|Overall Study|Had invalid anthropometric measurements|2|||
130844448|NCT00823212|471058413|FG000|Overall Study|Death|8|||
130844449|NCT00823212|471058414|FG001|Overall Study|Death|10|||
130844450|NCT00823212|471058413|FG000|Overall Study|Withdrawal by Subject|6|||
130844451|NCT00823212|471058414|FG001|Overall Study|Withdrawal by Subject|1|||
130844452|NCT00823212|471058413|FG000|Overall Study|Incarcerated|0|||
130844453|NCT00823212|471058414|FG001|Overall Study|Incarcerated|1|||
130844454|NCT00823212|471058413|FG000|Overall Study|Missed 12-month visit|21|||
130844455|NCT00823212|471058414|FG001|Overall Study|Missed 12-month visit|21|||
130844456|NCT00496197|471058415|FG000|Overall Study|Discontinued study due to death|43|||
130844457|NCT00496197|471058415|FG000|Overall Study|Adverse Event|13|||
130844458|NCT00496197|471058415|FG000|Overall Study|Does not meet entrance criteria|5|||
130844459|NCT00496197|471058415|FG000|Overall Study|Insufficient clinical response|3|||
130844460|NCT00496197|471058415|FG000|Overall Study|Insufficient bacteriological response|10|||
130844461|NCT00496197|471058415|FG000|Overall Study|Lost to Follow-up|11|||
130844462|NCT00496197|471058415|FG000|Overall Study|Withdrawal by Subject|11|||
130844463|NCT00496197|471058415|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
130844464|NCT00496197|471058415|FG000|Overall Study|Other|14|||
130844465|NCT00496197|471058415|FG000|Overall Study|Protocol Violation|8|||
130844466|NCT01344538|471058416|FG000|Overall Study|Adverse Event|1|||
130844467|NCT01344538|471058417|FG001|Overall Study|Adverse Event|1|||
130844468|NCT01344538|471058416|FG000|Overall Study|Lost to Follow-up|1|||
130844469|NCT01344538|471058417|FG001|Overall Study|Lost to Follow-up|0|||
130844470|NCT01655381|471058418|FG000|Overall Study|Investigator Decision|1|||
130844471|NCT01655381|471058418|FG000|Overall Study|Moved to Another City|1|||
130844472|NCT01655381|471058418|FG000|Overall Study|Insufficient Treatment Response|1|||
130844473|NCT04979897|471058420|FG000|Overall Study|Death|1|||
130844474|NCT04979897|471058421|FG001|Overall Study|Death|8|||
130844475|NCT04979897|471058420|FG000|Overall Study|Lost to Follow-up|111|||
130844476|NCT04979897|471058421|FG001|Overall Study|Lost to Follow-up|56|||
130844477|NCT04979897|471058420|FG000|Overall Study|Withdrawal by Subject|7|||
130844478|NCT04979897|471058421|FG001|Overall Study|Withdrawal by Subject|2|||
130844479|NCT03405935|471058422|FG000|Overall Study|Adverse Event|3|||
130844480|NCT03405935|471058422|FG000|Overall Study|Death|2|||
130844481|NCT03405935|471058422|FG000|Overall Study|Withdrawal by Subject|1|||
130844482|NCT03405935|471058422|FG000|Overall Study|Lost to Follow-up|2|||
130844483|NCT00683917|471058423|FG000|Overall Study|Study prematurely terminated|10|||
130844484|NCT01170598|471058430|FG000|Overall Study|Withdrawal by Subject|1|||
130844485|NCT01170598|471058430|FG000|Overall Study|Death|3|||
130844486|NCT01170598|471058430|FG000|Overall Study|Lost to Follow-up|1|||
130844487|NCT01170598|471058430|FG000|Overall Study|Refused|1|||
130844488|NCT01779869|471058431|FG000|Overall Study|Physician Decision|2|||
130844489|NCT00445848|471058432|FG000|Overall Study|Adverse Event|14|||
130844490|NCT00445848|471058432|FG000|Overall Study|Withdrawal by Subject|4|||
130844491|NCT00445848|471058432|FG000|Overall Study|Progression|62|||
130844492|NCT00445848|471058432|FG000|Overall Study|Other-Not protocol specified|5|||
130844493|NCT00027378|471058433|FG000|Overall Study|Physician Decision|0|||
130844494|NCT00027378|471058434|FG001|Overall Study|Physician Decision|3|||
130844495|NCT05605691|471058435|FG000|Overall Study|Lost to Follow-up|1|||
130844496|NCT04706273|471058436|FG000|Overall Study|Withdrawal by Subject|27|||
130844497|NCT04706273|471058436|FG000|Overall Study|Physician Decision|1|||
130844498|NCT04706273|471058436|FG000|Overall Study|Lost to Follow-up|42|||
130844499|NCT04706273|471058436|FG000|Overall Study|Death|85|||
130844500|NCT04706273|471058436|FG000|Overall Study|Amputation that removes study device|2|||
130844501|NCT04706273|471058436|FG000|Overall Study|Surgical bypass|3|||
130844502|NCT04706273|471058436|FG000|Overall Study|Changing hospital|23|||
130844503|NCT04706273|471058436|FG000|Overall Study|Unable to attend hospital|2|||
130844504|NCT03199053|471058439|FG000|ST Period|Withdrawal by Subject|2|||
130844505|NCT03199053|471058440|FG001|ST Period|Withdrawal by Subject|4|||
130844506|NCT03199053|471058441|FG002|ST Period|Withdrawal by Subject|6|||
130844507|NCT03199053|471058439|FG000|ST Period|Withdrawal by parent/guardian|1|||
130844508|NCT03199053|471058440|FG001|ST Period|Withdrawal by parent/guardian|1|||
130844509|NCT03199053|471058441|FG002|ST Period|Withdrawal by parent/guardian|1|||
130844510|NCT03199053|471058439|FG000|ST Period|Lost to Follow-up|2|||
130844511|NCT03199053|471058440|FG001|ST Period|Lost to Follow-up|0|||
130844512|NCT03199053|471058441|FG002|ST Period|Lost to Follow-up|1|||
130844513|NCT03199053|471058439|FG000|LT Period|Withdrawal by Subject|1|||
130844514|NCT03199053|471058440|FG001|LT Period|Withdrawal by Subject|3|||
130844515|NCT03199053|471058441|FG002|LT Period|Withdrawal by Subject|3|||
130844516|NCT03199053|471058439|FG000|LT Period|Withdrawal by parent/guardian|0|||
130844517|NCT03199053|471058440|FG001|LT Period|Withdrawal by parent/guardian|0|||
130844518|NCT03199053|471058441|FG002|LT Period|Withdrawal by parent/guardian|1|||
130844519|NCT03199053|471058439|FG000|LT Period|Lost to Follow-up|0|||
130844520|NCT03199053|471058440|FG001|LT Period|Lost to Follow-up|1|||
130844521|NCT03199053|471058441|FG002|LT Period|Lost to Follow-up|1|||
130844522|NCT03199053|471058439|FG000|LT Period|Miscellaneous|0|||
130844523|NCT03199053|471058440|FG001|LT Period|Miscellaneous|0|||
130844524|NCT03199053|471058441|FG002|LT Period|Miscellaneous|2|||
130844525|NCT03199053|471058439|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
130844526|NCT03199053|471058440|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
130844527|NCT03199053|471058441|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
130844528|NCT03199053|471058439|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
130844529|NCT03199053|471058440|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
130844530|NCT03199053|471058441|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
130844531|NCT03199053|471058439|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
130844532|NCT03199053|471058440|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
130844533|NCT03199053|471058441|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
130844534|NCT03199053|471058439|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
130844535|NCT03199053|471058440|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
130844536|NCT03199053|471058441|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
130844537|NCT02509052|471058444|FG000|Overall Study|Non compliance|0|||
130844538|NCT02509052|471058445|FG001|Overall Study|Non compliance|0|||
130844539|NCT02509052|471058446|FG002|Overall Study|Non compliance|1|||
130844540|NCT01824823|471058447|FG000|Overall Study|Lack of Efficacy|1|||
130844541|NCT01824823|471058448|FG001|Overall Study|Lack of Efficacy|1|||
130844542|NCT01824823|471058447|FG000|Overall Study|Off-treatment reason not submitted|1|||
130844543|NCT01824823|471058448|FG001|Overall Study|Off-treatment reason not submitted|0|||
130844544|NCT02098369|471058451|FG000|Overall Study|Withdrawal by Subject|1|||
130844545|NCT02098369|471058452|FG001|Overall Study|Withdrawal by Subject|5|||
130844546|NCT02098369|471058453|FG002|Overall Study|Withdrawal by Subject|0|||
130844547|NCT02098369|471058451|FG000|Overall Study|Lost to Follow-up|5|||
130844548|NCT02098369|471058452|FG001|Overall Study|Lost to Follow-up|1|||
130844549|NCT02098369|471058453|FG002|Overall Study|Lost to Follow-up|3|||
130844550|NCT02098369|471058451|FG000|Overall Study|Death|1|||
130844551|NCT02098369|471058452|FG001|Overall Study|Death|1|||
130844552|NCT02098369|471058453|FG002|Overall Study|Death|1|||
130844553|NCT02098369|471058451|FG000|Overall Study|Other|0|||
130844554|NCT02098369|471058452|FG001|Overall Study|Other|2|||
130844555|NCT02098369|471058453|FG002|Overall Study|Other|1|||
130844556|NCT03362931|471058454|FG000|Overall Study|Adverse Event|1|||
130844557|NCT03362931|471058454|FG000|Overall Study|Death|2|||
130844558|NCT02927925|471058470|FG000|Overall Study|Death|16|||
130844559|NCT02927925|471058470|FG000|Overall Study|Physician Decision|1|||
130844560|NCT02927925|471058470|FG000|Overall Study|Withdrawal by Subject|11|||
130844561|NCT02927925|471058470|FG000|Overall Study|Other|3|||
130844562|NCT02927925|471058470|FG000|Overall Study|Disease progression at clinical cutoff|1|||
130844563|NCT02229214|471058471|FG000|Overall Study|Adverse Event|2|||
130844564|NCT02229214|471058472|FG001|Overall Study|Adverse Event|0|||
130844565|NCT02229214|471058471|FG000|Overall Study|Withdrawal by Subject|4|||
130844566|NCT02229214|471058472|FG001|Overall Study|Withdrawal by Subject|0|||
130844567|NCT01080768|471058473|FG000|Overall Study|Protocol Deviation|2|||
130844568|NCT01080768|471058474|FG001|Overall Study|Protocol Deviation|1|||
130844569|NCT00246025|471058479|FG000|Overall Study|Adverse Event|7|||
130844570|NCT00246025|471058480|FG001|Overall Study|Adverse Event|9|||
130844571|NCT00246025|471058481|FG002|Overall Study|Adverse Event|9|||
130844572|NCT00246025|471058482|FG003|Overall Study|Adverse Event|10|||
130844573|NCT00246025|471058479|FG000|Overall Study|Withdrawal by Subject|3|||
130844574|NCT00246025|471058480|FG001|Overall Study|Withdrawal by Subject|0|||
130844575|NCT00246025|471058481|FG002|Overall Study|Withdrawal by Subject|1|||
130844576|NCT00246025|471058482|FG003|Overall Study|Withdrawal by Subject|2|||
130844577|NCT00246025|471058479|FG000|Overall Study|unsuitable medical history was found|0|||
130844578|NCT00246025|471058480|FG001|Overall Study|unsuitable medical history was found|0|||
130844579|NCT00246025|471058481|FG002|Overall Study|unsuitable medical history was found|0|||
130844580|NCT00246025|471058482|FG003|Overall Study|unsuitable medical history was found|1|||
130844581|NCT01643850|471058485|FG000|Overall Study|Withdrawal by Subject|0|||
130844582|NCT01643850|471058486|FG001|Overall Study|Withdrawal by Subject|0|||
130844583|NCT01643850|471058487|FG002|Overall Study|Withdrawal by Subject|0|||
130844584|NCT01643850|471058488|FG003|Overall Study|Withdrawal by Subject|0|||
130844585|NCT01643850|471058489|FG004|Overall Study|Withdrawal by Subject|1|||
130844586|NCT01643850|471058490|FG005|Overall Study|Withdrawal by Subject|0|||
130844587|NCT01643850|471058491|FG006|Overall Study|Withdrawal by Subject|0|||
130844588|NCT01643850|471058492|FG007|Overall Study|Withdrawal by Subject|0|||
130844589|NCT01643850|471058493|FG008|Overall Study|Withdrawal by Subject|0|||
130844590|NCT01643850|471058485|FG000|Overall Study|Lost to Follow-up|0|||
130844591|NCT01643850|471058486|FG001|Overall Study|Lost to Follow-up|0|||
130844592|NCT01643850|471058487|FG002|Overall Study|Lost to Follow-up|0|||
130844593|NCT01643850|471058488|FG003|Overall Study|Lost to Follow-up|0|||
130844594|NCT01643850|471058489|FG004|Overall Study|Lost to Follow-up|0|||
130844595|NCT01643850|471058490|FG005|Overall Study|Lost to Follow-up|0|||
130844596|NCT01643850|471058491|FG006|Overall Study|Lost to Follow-up|1|||
130844597|NCT01643850|471058492|FG007|Overall Study|Lost to Follow-up|0|||
130844598|NCT01643850|471058493|FG008|Overall Study|Lost to Follow-up|1|||
130844599|NCT01643850|471058485|FG000|Overall Study|Adverse Event|0|||
130844600|NCT01643850|471058486|FG001|Overall Study|Adverse Event|0|||
130844601|NCT01643850|471058487|FG002|Overall Study|Adverse Event|0|||
130844602|NCT01643850|471058488|FG003|Overall Study|Adverse Event|0|||
130844603|NCT01643850|471058489|FG004|Overall Study|Adverse Event|1|||
130844604|NCT01643850|471058490|FG005|Overall Study|Adverse Event|0|||
130844605|NCT01643850|471058491|FG006|Overall Study|Adverse Event|0|||
130844606|NCT01643850|471058492|FG007|Overall Study|Adverse Event|0|||
130844607|NCT01643850|471058493|FG008|Overall Study|Adverse Event|0|||
130844608|NCT01643850|471058485|FG000|Overall Study|Administrative Problems|0|||
130844609|NCT01643850|471058486|FG001|Overall Study|Administrative Problems|0|||
130844610|NCT01643850|471058487|FG002|Overall Study|Administrative Problems|1|||
130844611|NCT01643850|471058488|FG003|Overall Study|Administrative Problems|0|||
130844612|NCT01643850|471058489|FG004|Overall Study|Administrative Problems|1|||
130844613|NCT01643850|471058490|FG005|Overall Study|Administrative Problems|0|||
130844614|NCT01643850|471058491|FG006|Overall Study|Administrative Problems|0|||
130844615|NCT01643850|471058492|FG007|Overall Study|Administrative Problems|0|||
130844616|NCT01643850|471058493|FG008|Overall Study|Administrative Problems|0|||
130844617|NCT03054350|471058496|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
130844618|NCT03054350|471058497|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
130844619|NCT03054350|471058498|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
130844620|NCT03054350|471058499|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
130844621|NCT03054350|471058500|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
130844622|NCT03054350|471058501|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
130844623|NCT03054350|471058496|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130844624|NCT03054350|471058497|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130844625|NCT03054350|471058498|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
130844626|NCT03054350|471058499|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130844627|NCT03054350|471058500|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130844628|NCT03054350|471058501|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130844629|NCT03054350|471058496|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
130844630|NCT03054350|471058497|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130844631|NCT03054350|471058498|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130844632|NCT03054350|471058499|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
130844633|NCT03054350|471058500|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130844634|NCT03054350|471058501|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130844635|NCT03054350|471058496|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130844636|NCT03054350|471058497|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130844637|NCT03054350|471058498|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
130844638|NCT03054350|471058499|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130844639|NCT03054350|471058500|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130844640|NCT03054350|471058501|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130844641|NCT00931723|471058502|FG000|Overall Study|Withdrawal by Subject|11|||
130844642|NCT00931723|471058503|FG001|Overall Study|Withdrawal by Subject|13|||
130844643|NCT00931723|471058502|FG000|Overall Study|Adverse Event|6|||
130844644|NCT00931723|471058503|FG001|Overall Study|Adverse Event|13|||
130844645|NCT00931723|471058502|FG000|Overall Study|Lithium found in blood|0|||
130844646|NCT00931723|471058503|FG001|Overall Study|Lithium found in blood|1|||
130844647|NCT00931723|471058502|FG000|Overall Study|Condition under investigation worsened|1|||
130844648|NCT00931723|471058503|FG001|Overall Study|Condition under investigation worsened|2|||
130844649|NCT00931723|471058502|FG000|Overall Study|Lost to Follow-up|1|||
130844650|NCT00931723|471058503|FG001|Overall Study|Lost to Follow-up|2|||
130844651|NCT00931723|471058502|FG000|Overall Study|Study-specific discontinuation criteria|1|||
130844652|NCT00931723|471058503|FG001|Overall Study|Study-specific discontinuation criteria|1|||
130844653|NCT00931723|471058502|FG000|Overall Study|Severe non-compliance to protocol|2|||
130844654|NCT00931723|471058503|FG001|Overall Study|Severe non-compliance to protocol|0|||
130844655|NCT00931723|471058502|FG000|Overall Study|Safety reasons|0|||
130844656|NCT00931723|471058503|FG001|Overall Study|Safety reasons|1|||
130844657|NCT00931723|471058502|FG000|Overall Study|Took prohibited concomitant medication|0|||
130844658|NCT00931723|471058503|FG001|Overall Study|Took prohibited concomitant medication|1|||
130844659|NCT00931723|471058502|FG000|Overall Study|Lack or insufficient theraputic response|2|||
130844660|NCT00931723|471058503|FG001|Overall Study|Lack or insufficient theraputic response|5|||
130844661|NCT00931723|471058502|FG000|Overall Study|Sponsor decision|1|||
130844662|NCT00931723|471058503|FG001|Overall Study|Sponsor decision|0|||
130844663|NCT00931723|471058502|FG000|Overall Study|Late hospital discharge|1|||
130844664|NCT00931723|471058503|FG001|Overall Study|Late hospital discharge|0|||
130844665|NCT01133405|471058505|FG000|Period 1|Withdrawal by Subject|0|||
130844666|NCT01133405|471058506|FG001|Period 1|Withdrawal by Subject|1|||
130844667|NCT01133405|471058507|FG002|Period 1|Withdrawal by Subject|0|||
130844668|NCT01133405|471058508|FG003|Period 1|Withdrawal by Subject|1|||
130844669|NCT01133405|471058509|FG004|Period 1|Withdrawal by Subject|0|||
130844670|NCT01133405|471058510|FG005|Period 1|Withdrawal by Subject|1|||
130844671|NCT01133405|471058511|FG006|Period 1|Withdrawal by Subject|0|||
130844672|NCT01133405|471058512|FG007|Period 1|Withdrawal by Subject|0|||
130844673|NCT01133405|471058513|FG008|Period 1|Withdrawal by Subject|0|||
130844674|NCT01133405|471058514|FG009|Period 1|Withdrawal by Subject|0|||
130844675|NCT01133405|471058505|FG000|Period 1|Physician Decision|0|||
130844676|NCT01133405|471058506|FG001|Period 1|Physician Decision|0|||
130844677|NCT01133405|471058507|FG002|Period 1|Physician Decision|0|||
130844678|NCT01133405|471058508|FG003|Period 1|Physician Decision|1|||
130844679|NCT01133405|471058509|FG004|Period 1|Physician Decision|0|||
130844680|NCT01133405|471058510|FG005|Period 1|Physician Decision|0|||
130844681|NCT01133405|471058511|FG006|Period 1|Physician Decision|0|||
130844682|NCT01133405|471058512|FG007|Period 1|Physician Decision|0|||
130844683|NCT01133405|471058513|FG008|Period 1|Physician Decision|0|||
130844684|NCT01133405|471058514|FG009|Period 1|Physician Decision|0|||
130844685|NCT01133405|471058505|FG000|Period 1|Discontinued after randomization|1|||
130844686|NCT01133405|471058506|FG001|Period 1|Discontinued after randomization|0|||
130844687|NCT01133405|471058507|FG002|Period 1|Discontinued after randomization|0|||
130844688|NCT01133405|471058508|FG003|Period 1|Discontinued after randomization|0|||
130844689|NCT01133405|471058509|FG004|Period 1|Discontinued after randomization|0|||
130844690|NCT01133405|471058510|FG005|Period 1|Discontinued after randomization|0|||
130844691|NCT01133405|471058511|FG006|Period 1|Discontinued after randomization|1|||
130844692|NCT01133405|471058512|FG007|Period 1|Discontinued after randomization|0|||
130844693|NCT01133405|471058513|FG008|Period 1|Discontinued after randomization|0|||
130844694|NCT01133405|471058514|FG009|Period 1|Discontinued after randomization|0|||
130844695|NCT01133405|471058505|FG000|Period 1|Received drug only in period 2|0|||
130844696|NCT01133405|471058506|FG001|Period 1|Received drug only in period 2|1|||
130844697|NCT01133405|471058507|FG002|Period 1|Received drug only in period 2|0|||
130844698|NCT01133405|471058508|FG003|Period 1|Received drug only in period 2|2|||
130844699|NCT01133405|471058509|FG004|Period 1|Received drug only in period 2|0|||
130844700|NCT01133405|471058510|FG005|Period 1|Received drug only in period 2|1|||
130844701|NCT01133405|471058511|FG006|Period 1|Received drug only in period 2|0|||
130844702|NCT01133405|471058512|FG007|Period 1|Received drug only in period 2|0|||
130844703|NCT01133405|471058513|FG008|Period 1|Received drug only in period 2|0|||
130844704|NCT01133405|471058514|FG009|Period 1|Received drug only in period 2|0|||
130844705|NCT01133405|471058505|FG000|Period 1|Received drug only in period 3|0|||
130844706|NCT01133405|471058506|FG001|Period 1|Received drug only in period 3|1|||
130844707|NCT01133405|471058507|FG002|Period 1|Received drug only in period 3|1|||
130844708|NCT01133405|471058508|FG003|Period 1|Received drug only in period 3|0|||
130844709|NCT01133405|471058509|FG004|Period 1|Received drug only in period 3|0|||
130844710|NCT01133405|471058510|FG005|Period 1|Received drug only in period 3|0|||
130844711|NCT01133405|471058511|FG006|Period 1|Received drug only in period 3|0|||
130844712|NCT01133405|471058512|FG007|Period 1|Received drug only in period 3|0|||
130844713|NCT01133405|471058513|FG008|Period 1|Received drug only in period 3|0|||
130844714|NCT01133405|471058514|FG009|Period 1|Received drug only in period 3|0|||
130844715|NCT01133405|471058505|FG000|Period 2|Adverse Event|0|||
130844716|NCT01133405|471058506|FG001|Period 2|Adverse Event|0|||
130844717|NCT01133405|471058507|FG002|Period 2|Adverse Event|1|||
130844718|NCT01133405|471058508|FG003|Period 2|Adverse Event|0|||
130844719|NCT01133405|471058509|FG004|Period 2|Adverse Event|0|||
130844720|NCT01133405|471058510|FG005|Period 2|Adverse Event|0|||
130844721|NCT01133405|471058511|FG006|Period 2|Adverse Event|0|||
130844722|NCT01133405|471058512|FG007|Period 2|Adverse Event|0|||
130844723|NCT01133405|471058513|FG008|Period 2|Adverse Event|0|||
130844724|NCT01133405|471058514|FG009|Period 2|Adverse Event|0|||
130844725|NCT01133405|471058505|FG000|Period 2|Withdrawal by Subject|0|||
130844726|NCT01133405|471058506|FG001|Period 2|Withdrawal by Subject|0|||
130844727|NCT01133405|471058507|FG002|Period 2|Withdrawal by Subject|0|||
130844728|NCT01133405|471058508|FG003|Period 2|Withdrawal by Subject|1|||
130844729|NCT01133405|471058509|FG004|Period 2|Withdrawal by Subject|0|||
130844730|NCT01133405|471058510|FG005|Period 2|Withdrawal by Subject|1|||
130844731|NCT01133405|471058511|FG006|Period 2|Withdrawal by Subject|0|||
130844732|NCT01133405|471058512|FG007|Period 2|Withdrawal by Subject|0|||
130844733|NCT01133405|471058513|FG008|Period 2|Withdrawal by Subject|0|||
130844734|NCT01133405|471058514|FG009|Period 2|Withdrawal by Subject|0|||
130844735|NCT01133405|471058505|FG000|Period 2|Entry Criteria Not Met|0|||
130844736|NCT01133405|471058506|FG001|Period 2|Entry Criteria Not Met|1|||
130844737|NCT01133405|471058507|FG002|Period 2|Entry Criteria Not Met|0|||
130844738|NCT01133405|471058508|FG003|Period 2|Entry Criteria Not Met|0|||
130844739|NCT01133405|471058509|FG004|Period 2|Entry Criteria Not Met|0|||
130844740|NCT01133405|471058510|FG005|Period 2|Entry Criteria Not Met|0|||
130844741|NCT01133405|471058511|FG006|Period 2|Entry Criteria Not Met|0|||
130844742|NCT01133405|471058512|FG007|Period 2|Entry Criteria Not Met|0|||
130844743|NCT01133405|471058513|FG008|Period 2|Entry Criteria Not Met|0|||
130844744|NCT01133405|471058514|FG009|Period 2|Entry Criteria Not Met|0|||
130844745|NCT01133405|471058505|FG000|Period 2|Physician Decision|0|||
130844746|NCT01133405|471058506|FG001|Period 2|Physician Decision|0|||
130844747|NCT01133405|471058507|FG002|Period 2|Physician Decision|0|||
130844748|NCT01133405|471058508|FG003|Period 2|Physician Decision|0|||
130844749|NCT01133405|471058509|FG004|Period 2|Physician Decision|0|||
130844750|NCT01133405|471058510|FG005|Period 2|Physician Decision|1|||
130844751|NCT01133405|471058511|FG006|Period 2|Physician Decision|0|||
130844752|NCT01133405|471058512|FG007|Period 2|Physician Decision|0|||
130844753|NCT01133405|471058513|FG008|Period 2|Physician Decision|0|||
130844754|NCT01133405|471058514|FG009|Period 2|Physician Decision|0|||
130844755|NCT01238835|471058515|FG000|Overall Study|Death|124|||
130844756|NCT01238835|471058515|FG000|Overall Study|Withdrawal by Subject|9|||
130844757|NCT01238835|471058515|FG000|Overall Study|Lost to Follow-up|1|||
130844758|NCT01238835|471058515|FG000|Overall Study|Site early discontinuation|2|||
130844759|NCT00907803|471058517|FG000|Overall Study|Withdrawal of consent - long commute|1|||
130844760|NCT00907803|471058518|FG001|Overall Study|Withdrawal of consent - long commute|0|||
130844761|NCT00907803|471058519|FG002|Overall Study|Withdrawal of consent - long commute|0|||
130844762|NCT00907803|471058517|FG000|Overall Study|Adverse Event|2|||
130844763|NCT00907803|471058518|FG001|Overall Study|Adverse Event|0|||
130844764|NCT00907803|471058519|FG002|Overall Study|Adverse Event|0|||
130844765|NCT00907803|471058517|FG000|Overall Study|Withdrawal by Subject|0|||
130844766|NCT00907803|471058518|FG001|Overall Study|Withdrawal by Subject|1|||
130844767|NCT00907803|471058519|FG002|Overall Study|Withdrawal by Subject|0|||
130844768|NCT00907803|471058517|FG000|Overall Study|Lost to Follow-up|0|||
130844769|NCT00907803|471058518|FG001|Overall Study|Lost to Follow-up|1|||
130844770|NCT00907803|471058519|FG002|Overall Study|Lost to Follow-up|0|||
130844771|NCT00907803|471058517|FG000|Overall Study|Protocol Violation|0|||
130844772|NCT00907803|471058518|FG001|Overall Study|Protocol Violation|1|||
130844773|NCT00907803|471058519|FG002|Overall Study|Protocol Violation|0|||
130844774|NCT03510468|471058520|FG000|Overall Study|Lost to Follow-up|1|||
130844775|NCT03510468|471058520|FG000|Overall Study|Adverse Event|5|||
130844776|NCT03510468|471058520|FG000|Overall Study|Physician Decision|1|||
130844777|NCT03510468|471058520|FG000|Overall Study|non-compliant with treatment|2|||
130844778|NCT03510468|471058520|FG000|Overall Study|Missed visit|1|||
130844779|NCT04612842|471058521|FG000|Overall Study|Lost to Follow-up|20|||
130844780|NCT04612842|471058522|FG001|Overall Study|Lost to Follow-up|11|||
130844781|NCT04612842|471058521|FG000|Overall Study|Withdrawal by Subject|26|||
130844782|NCT04612842|471058522|FG001|Overall Study|Withdrawal by Subject|15|||
130844783|NCT04612842|471058521|FG000|Overall Study|Death|2|||
130844784|NCT04612842|471058522|FG001|Overall Study|Death|2|||
130844785|NCT05426031|471058523|FG000|Overall Study|Circulatory Arrest|3|||
130844786|NCT05426031|471058524|FG001|Overall Study|Circulatory Arrest|2|||
130844787|NCT02419131|471058525|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
130844788|NCT02419131|471058526|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
130844789|NCT02419131|471058527|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
130844790|NCT02419131|471058525|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
130844791|NCT02419131|471058526|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
130844792|NCT02419131|471058527|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
130844793|NCT04677660|471058528|FG000|Overall Study|Lost to Follow-up|0|||
130844794|NCT04677660|471058529|FG001|Overall Study|Lost to Follow-up|2|||
130844795|NCT04677660|471058528|FG000|Overall Study|Withdrawal by Subject|0|||
130844796|NCT04677660|471058529|FG001|Overall Study|Withdrawal by Subject|1|||
130844797|NCT04677660|471058528|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
130844798|NCT04677660|471058529|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
130844799|NCT00413920|471058548|FG000|Overall Study|Adverse Event|9|||
130844800|NCT00413920|471058549|FG001|Overall Study|Adverse Event|11|||
130844801|NCT00413920|471058548|FG000|Overall Study|Lack of Efficacy|11|||
130844802|NCT00413920|471058549|FG001|Overall Study|Lack of Efficacy|9|||
130844803|NCT00413920|471058548|FG000|Overall Study|Death|3|||
130844804|NCT00413920|471058549|FG001|Overall Study|Death|5|||
130844805|NCT00413920|471058548|FG000|Overall Study|Graft Loss|5|||
130844806|NCT00413920|471058549|FG001|Overall Study|Graft Loss|3|||
130844807|NCT01071200|471058550|FG000|Overall Study|Lack of ovarian response|1|||
130844808|NCT01071200|471058551|FG001|Overall Study|Lack of ovarian response|1|||
130844809|NCT01071200|471058550|FG000|Overall Study|No fertilization|4|||
130844810|NCT01071200|471058551|FG001|Overall Study|No fertilization|0|||
130844811|NCT01071200|471058550|FG000|Overall Study|No oocytes retrieved|1|||
130844812|NCT01071200|471058551|FG001|Overall Study|No oocytes retrieved|1|||
130844813|NCT01071200|471058550|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
130844814|NCT01071200|471058551|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
130844815|NCT01071200|471058550|FG000|Overall Study|No viable embryos|0|||
130844816|NCT01071200|471058551|FG001|Overall Study|No viable embryos|1|||
130844817|NCT03730961|471058552|FG000|Overall Study|Adverse Event|0|||
130844818|NCT03730961|471058553|FG001|Overall Study|Adverse Event|1|||
130844819|NCT03158012|471058557|FG000|Overall Study|Withdrawal by Subject|0|||
130844820|NCT03158012|471058558|FG001|Overall Study|Withdrawal by Subject|1|||
130844821|NCT01338610|471058559|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
130844822|NCT01338610|471058560|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
130844823|NCT01338610|471058561|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
130844824|NCT01338610|471058559|FG000|Overall Study|Protocol Violation|1|||
130844825|NCT01338610|471058560|FG001|Overall Study|Protocol Violation|0|||
130844826|NCT01338610|471058561|FG002|Overall Study|Protocol Violation|1|||
130844827|NCT01338610|471058559|FG000|Overall Study|Adverse Event|3|||
130844828|NCT01338610|471058560|FG001|Overall Study|Adverse Event|0|||
130844829|NCT01338610|471058561|FG002|Overall Study|Adverse Event|0|||
130844830|NCT01095653|471058562|FG000|Overall Study|Lack of Efficacy|3|||
130844831|NCT01095653|471058563|FG001|Overall Study|Lack of Efficacy|0|||
130844832|NCT01095653|471058564|FG002|Overall Study|Lack of Efficacy|0|||
130844833|NCT01095653|471058562|FG000|Overall Study|Adverse Event|1|||
130844834|NCT01095653|471058563|FG001|Overall Study|Adverse Event|4|||
130844835|NCT01095653|471058564|FG002|Overall Study|Adverse Event|4|||
130844836|NCT01095653|471058562|FG000|Overall Study|Lost to Follow-up|1|||
130844837|NCT01095653|471058563|FG001|Overall Study|Lost to Follow-up|0|||
130844838|NCT01095653|471058564|FG002|Overall Study|Lost to Follow-up|4|||
130844839|NCT01095653|471058562|FG000|Overall Study|Withdrawal by Subject|4|||
130844840|NCT01095653|471058563|FG001|Overall Study|Withdrawal by Subject|5|||
130844841|NCT01095653|471058564|FG002|Overall Study|Withdrawal by Subject|3|||
130844842|NCT01095653|471058562|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
130844843|NCT01095653|471058563|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
130844844|NCT01095653|471058564|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
130844845|NCT02046226|471058565|FG000|Overall Study|Lost to Follow-up|7|||
130844846|NCT02692040|471058566|FG000|Overall Study|Protocol Violation|0|||
130844847|NCT02692040|471058567|FG001|Overall Study|Protocol Violation|0|||
130844848|NCT02692040|471058568|FG002|Overall Study|Protocol Violation|0|||
130844849|NCT02692040|471058569|FG003|Overall Study|Protocol Violation|0|||
130844850|NCT02692040|471058570|FG004|Overall Study|Protocol Violation|0|||
130844851|NCT02692040|471058571|FG005|Overall Study|Protocol Violation|0|||
130844852|NCT02692040|471058572|FG006|Overall Study|Protocol Violation|0|||
130844853|NCT02692040|471058573|FG007|Overall Study|Protocol Violation|0|||
130844854|NCT02692040|471058574|FG008|Overall Study|Protocol Violation|0|||
130844855|NCT02692040|471058575|FG009|Overall Study|Protocol Violation|0|||
130844856|NCT02692040|471058576|FG010|Overall Study|Protocol Violation|0|||
130844857|NCT02692040|471058577|FG011|Overall Study|Protocol Violation|0|||
130844858|NCT02692040|471058578|FG012|Overall Study|Protocol Violation|1|||
130844859|NCT02692040|471058579|FG013|Overall Study|Protocol Violation|0|||
130844860|NCT02692040|471058580|FG014|Overall Study|Protocol Violation|0|||
130844861|NCT02692040|471058581|FG015|Overall Study|Protocol Violation|0|||
130844862|NCT02692040|471058582|FG016|Overall Study|Protocol Violation|0|||
130844863|NCT02692040|471058566|FG000|Overall Study|Adverse Event|0|||
130844864|NCT02692040|471058567|FG001|Overall Study|Adverse Event|0|||
130844865|NCT02692040|471058568|FG002|Overall Study|Adverse Event|0|||
130844866|NCT02692040|471058569|FG003|Overall Study|Adverse Event|0|||
130844867|NCT02692040|471058570|FG004|Overall Study|Adverse Event|0|||
130844868|NCT02692040|471058571|FG005|Overall Study|Adverse Event|0|||
130844869|NCT02692040|471058572|FG006|Overall Study|Adverse Event|0|||
130844870|NCT02692040|471058573|FG007|Overall Study|Adverse Event|0|||
130844871|NCT02692040|471058574|FG008|Overall Study|Adverse Event|0|||
130844872|NCT02692040|471058575|FG009|Overall Study|Adverse Event|0|||
130844873|NCT02692040|471058576|FG010|Overall Study|Adverse Event|0|||
130844874|NCT02692040|471058577|FG011|Overall Study|Adverse Event|0|||
130844875|NCT02692040|471058578|FG012|Overall Study|Adverse Event|0|||
130844876|NCT02692040|471058579|FG013|Overall Study|Adverse Event|3|||
130844877|NCT02692040|471058580|FG014|Overall Study|Adverse Event|1|||
130844878|NCT02692040|471058581|FG015|Overall Study|Adverse Event|1|||
130844879|NCT02692040|471058582|FG016|Overall Study|Adverse Event|0|||
130844880|NCT00171925|471058583|FG000|Overall Study|Adverse Event|10|||
130844881|NCT00171925|471058584|FG001|Overall Study|Adverse Event|6|||
130844882|NCT00171925|471058583|FG000|Overall Study|Protocol Violation|1|||
130844883|NCT00171925|471058584|FG001|Overall Study|Protocol Violation|1|||
130844884|NCT00171925|471058583|FG000|Overall Study|Withdrawal by Subject|6|||
130844885|NCT00171925|471058584|FG001|Overall Study|Withdrawal by Subject|9|||
130844886|NCT00171925|471058583|FG000|Overall Study|Lost to Follow-up|2|||
130844887|NCT00171925|471058584|FG001|Overall Study|Lost to Follow-up|2|||
130844888|NCT00171925|471058583|FG000|Overall Study|Administrative problems|10|||
130844889|NCT00171925|471058584|FG001|Overall Study|Administrative problems|11|||
130844890|NCT00171925|471058583|FG000|Overall Study|Death|1|||
130844891|NCT00171925|471058584|FG001|Overall Study|Death|2|||
130844892|NCT02826421|471058592|FG000|Overall Study|Adverse Event|1|||
130844893|NCT02826421|471058593|FG001|Overall Study|Adverse Event|0|||
130844894|NCT02826421|471058594|FG002|Overall Study|Adverse Event|0|||
130844895|NCT02826421|471058595|FG003|Overall Study|Adverse Event|1|||
130844896|NCT02826421|471058592|FG000|Overall Study|Withdrawal by Subject|1|||
130844897|NCT02826421|471058593|FG001|Overall Study|Withdrawal by Subject|3|||
130844898|NCT02826421|471058594|FG002|Overall Study|Withdrawal by Subject|1|||
130844899|NCT02826421|471058595|FG003|Overall Study|Withdrawal by Subject|1|||
130844900|NCT02826421|471058592|FG000|Overall Study|Reason not given|1|||
130844901|NCT02826421|471058593|FG001|Overall Study|Reason not given|0|||
130844902|NCT02826421|471058594|FG002|Overall Study|Reason not given|1|||
130844903|NCT02826421|471058595|FG003|Overall Study|Reason not given|0|||
130844904|NCT02210221|471058600|FG000|Overall Study|Lack of Efficacy|7|||
130844905|NCT02210221|471058600|FG000|Overall Study|Withdrawal by Subject|43|||
130844906|NCT02141490|471058601|FG000|Overall Study|Screening failures|4|||
130844907|NCT02141490|471058602|FG001|Overall Study|Screening failures|0|||
130844908|NCT02141490|471058603|FG002|Overall Study|Screening failures|0|||
130844909|NCT00355342|471058608|FG000|Overall Study|Adverse Event|13|||
130844910|NCT00355342|471058609|FG001|Overall Study|Adverse Event|15|||
130844911|NCT00355342|471058608|FG000|Overall Study|Lost to Follow-up|4|||
130844912|NCT00355342|471058609|FG001|Overall Study|Lost to Follow-up|2|||
130844913|NCT00355342|471058608|FG000|Overall Study|Withdrawal by Subject|14|||
130844914|NCT00355342|471058609|FG001|Overall Study|Withdrawal by Subject|11|||
130844915|NCT00355342|471058608|FG000|Overall Study|Sponsor terminated study|2|||
130844916|NCT00355342|471058609|FG001|Overall Study|Sponsor terminated study|2|||
130844917|NCT00355342|471058608|FG000|Overall Study|Overcompliant-PI discretion|1|||
130844918|NCT00355342|471058609|FG001|Overall Study|Overcompliant-PI discretion|0|||
130844919|NCT00355342|471058608|FG000|Overall Study|Use of prohibited medication|1|||
130844920|NCT00355342|471058609|FG001|Overall Study|Use of prohibited medication|0|||
130844921|NCT00355342|471058608|FG000|Overall Study|COPD exacerbation|1|||
130844922|NCT00355342|471058609|FG001|Overall Study|COPD exacerbation|1|||
130844923|NCT00355342|471058608|FG000|Overall Study|Dispensed wrong study drug kit|1|||
130844924|NCT00355342|471058609|FG001|Overall Study|Dispensed wrong study drug kit|0|||
130844925|NCT00355342|471058608|FG000|Overall Study|Non-compliance with Dexa scans|1|||
130844926|NCT00355342|471058609|FG001|Overall Study|Non-compliance with Dexa scans|0|||
130844927|NCT00355342|471058608|FG000|Overall Study|Withdrawal by participant and physician|1|||
130844928|NCT00355342|471058609|FG001|Overall Study|Withdrawal by participant and physician|0|||
130844929|NCT00355342|471058608|FG000|Overall Study|Participant relocated|0|||
130844930|NCT00355342|471058609|FG001|Overall Study|Participant relocated|1|||
130844931|NCT00355342|471058608|FG000|Overall Study|Participant discontinued study drug|0|||
130844932|NCT00355342|471058609|FG001|Overall Study|Participant discontinued study drug|1|||
130844933|NCT00355342|471058608|FG000|Overall Study|Study management|0|||
130844934|NCT00355342|471058609|FG001|Overall Study|Study management|1|||
130844935|NCT00355342|471058608|FG000|Overall Study|Protocol Violation|0|||
130844936|NCT00355342|471058609|FG001|Overall Study|Protocol Violation|1|||
130844937|NCT00355342|471058608|FG000|Overall Study|Use of protocol excluded medication|0|||
130844938|NCT00355342|471058609|FG001|Overall Study|Use of protocol excluded medication|1|||
130844939|NCT00434759|471058610|FG000|Overall Study|Lack of Efficacy|5|||
130844940|NCT00434759|471058611|FG001|Overall Study|Lack of Efficacy|4|||
130844941|NCT00434759|471058610|FG000|Overall Study|Withdrawal by Subject|17|||
130844942|NCT00434759|471058611|FG001|Overall Study|Withdrawal by Subject|1|||
130844943|NCT00434759|471058610|FG000|Overall Study|family affairs|2|||
130844944|NCT00434759|471058611|FG001|Overall Study|family affairs|0|||
130844945|NCT00432744|471058612|FG000|Months 0-6|Withdrawal by Subject|4|||
130844946|NCT00432744|471058613|FG001|Months 0-6|Withdrawal by Subject|4|||
130844947|NCT00432744|471058612|FG000|Months 0-6|Too disabled to score|1|||
130844948|NCT00432744|471058613|FG001|Months 0-6|Too disabled to score|0|||
130844949|NCT00432744|471058612|FG000|Months 7 - 12|Withdrawal by Subject|1|||
130844950|NCT00432744|471058613|FG001|Months 7 - 12|Withdrawal by Subject|0|||
130844951|NCT00432744|471058612|FG000|Months 7 - 12|Too disabled to score|0|||
130844952|NCT00432744|471058613|FG001|Months 7 - 12|Too disabled to score|1|||
130844953|NCT01319721|471058614|FG000|Overall Study|Lost to Follow-up|1|||
130844954|NCT01319721|471058615|FG001|Overall Study|Lost to Follow-up|6|||
130844955|NCT00461305|471058617|FG000|Treatment|Adverse Event|26|||
130844956|NCT00461305|471058618|FG001|Treatment|Adverse Event|3|||
130844957|NCT00461305|471058617|FG000|Treatment|Lost to Follow-up|4|||
130844958|NCT00461305|471058618|FG001|Treatment|Lost to Follow-up|2|||
130844959|NCT00461305|471058617|FG000|Treatment|Protocol Violation|13|||
130844960|NCT00461305|471058618|FG001|Treatment|Protocol Violation|2|||
130844961|NCT00461305|471058617|FG000|Treatment|Withdrawal by Subject|48|||
130844962|NCT00461305|471058618|FG001|Treatment|Withdrawal by Subject|2|||
130844963|NCT00461305|471058617|FG000|Treatment|Never dispensed|5|||
130844964|NCT00461305|471058618|FG001|Treatment|Never dispensed|0|||
130844965|NCT00461305|471058617|FG000|Treatment|Study drug not taken|1|||
130844966|NCT00461305|471058618|FG001|Treatment|Study drug not taken|0|||
130844967|NCT00461305|471058617|FG000|Treatment|Partially missing diary|2|||
130844968|NCT00461305|471058618|FG001|Treatment|Partially missing diary|0|||
130844969|NCT00461305|471058617|FG000|Treatment|Other (missing drug etc)|2|||
130844970|NCT00461305|471058618|FG001|Treatment|Other (missing drug etc)|0|||
130844971|NCT00461305|471058617|FG000|Continued Treatment|Adverse Event|26|||
130844972|NCT00461305|471058618|FG001|Continued Treatment|Adverse Event|0|||
130844973|NCT00461305|471058617|FG000|Continued Treatment|Lost to Follow-up|4|||
130844974|NCT00461305|471058618|FG001|Continued Treatment|Lost to Follow-up|0|||
130844975|NCT00461305|471058617|FG000|Continued Treatment|Protocol Violation|13|||
130844976|NCT00461305|471058618|FG001|Continued Treatment|Protocol Violation|0|||
130844977|NCT00461305|471058617|FG000|Continued Treatment|Withdrawal by Subject|48|||
130844978|NCT00461305|471058618|FG001|Continued Treatment|Withdrawal by Subject|0|||
130844979|NCT00461305|471058617|FG000|Continued Treatment|Partially missing diary|2|||
130844980|NCT00461305|471058618|FG001|Continued Treatment|Partially missing diary|0|||
130844981|NCT00461305|471058617|FG000|Continued Treatment|Other (missing drug etc)|2|||
130844982|NCT00461305|471058618|FG001|Continued Treatment|Other (missing drug etc)|0|||
130844983|NCT00787930|471058623|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
130844984|NCT01896271|471058624|FG000|Overall Study|Physician Decision|10|||
130844985|NCT00969761|471058628|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130844986|NCT00969761|471058629|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130844987|NCT00969761|471058630|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130844988|NCT00969761|471058631|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130844989|NCT00969761|471058632|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130844990|NCT00969761|471058633|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130844991|NCT00969761|471058634|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130844992|NCT00969761|471058635|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130844993|NCT00969761|471058636|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130844994|NCT00969761|471058637|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130844995|NCT00969761|471058638|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130844996|NCT00969761|471058639|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130844997|NCT00969761|471058628|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130844998|NCT00969761|471058629|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130844999|NCT00969761|471058630|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
130845000|NCT00969761|471058631|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130845001|NCT00969761|471058632|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130845002|NCT00969761|471058633|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130845003|NCT00969761|471058634|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130845004|NCT00969761|471058635|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130845005|NCT00969761|471058636|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130845006|NCT00969761|471058637|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130845007|NCT00969761|471058638|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130845008|NCT00969761|471058639|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130845009|NCT00969761|471058628|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845010|NCT00969761|471058629|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845011|NCT00969761|471058630|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
130845012|NCT00969761|471058631|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845013|NCT00969761|471058632|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845014|NCT00969761|471058633|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845015|NCT00969761|471058634|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845016|NCT00969761|471058635|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845017|NCT00969761|471058636|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845018|NCT00969761|471058637|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845019|NCT00969761|471058638|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845020|NCT00969761|471058639|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130845021|NCT00969761|471058628|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845022|NCT00969761|471058629|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845023|NCT00969761|471058630|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845024|NCT00969761|471058631|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845025|NCT00969761|471058632|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845026|NCT00969761|471058633|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845027|NCT00969761|471058634|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845028|NCT00969761|471058635|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845029|NCT00969761|471058636|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
130845030|NCT00969761|471058637|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845031|NCT00969761|471058638|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845032|NCT00969761|471058639|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130845033|NCT00969761|471058628|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
130845034|NCT00969761|471058629|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130845035|NCT00969761|471058630|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
130845036|NCT00969761|471058631|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130845037|NCT00969761|471058632|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
130845038|NCT00969761|471058633|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130845039|NCT00969761|471058634|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130845040|NCT00969761|471058635|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
130845041|NCT00969761|471058636|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
130845042|NCT00969761|471058637|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
130845043|NCT00969761|471058638|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130845044|NCT00969761|471058639|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130845045|NCT00969761|471058628|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130845046|NCT00969761|471058629|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130845047|NCT00969761|471058630|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130845048|NCT00969761|471058631|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
130845049|NCT00969761|471058632|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
130845050|NCT00969761|471058633|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130845051|NCT00969761|471058634|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130845052|NCT00969761|471058635|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130845053|NCT00969761|471058636|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
130845054|NCT00969761|471058637|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130845055|NCT00969761|471058638|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130845056|NCT00969761|471058639|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130845057|NCT04030247|471061173|FG000|Overall Study|Withdrawal by Subject|4|||
130845058|NCT04030247|471061173|FG000|Overall Study|Lost to Follow-up|13|||
130845059|NCT00320255|471061174|FG000|Overall Study|Lack of Efficacy|1|||
130845060|NCT00320255|471061175|FG001|Overall Study|Lack of Efficacy|0|||
130845061|NCT00320255|471061176|FG002|Overall Study|Lack of Efficacy|0|||
130845062|NCT00320255|471061177|FG003|Overall Study|Lack of Efficacy|0|||
130845063|NCT00320255|471061178|FG004|Overall Study|Lack of Efficacy|0|||
130845064|NCT00320255|471061179|FG005|Overall Study|Lack of Efficacy|0|||
130845065|NCT00320255|471061174|FG000|Overall Study|Adverse Event|5|||
130845066|NCT00320255|471061175|FG001|Overall Study|Adverse Event|2|||
130845067|NCT00320255|471061176|FG002|Overall Study|Adverse Event|3|||
130845068|NCT00320255|471061177|FG003|Overall Study|Adverse Event|2|||
130845069|NCT00320255|471061178|FG004|Overall Study|Adverse Event|0|||
130845070|NCT00320255|471061179|FG005|Overall Study|Adverse Event|0|||
130845071|NCT00320255|471061174|FG000|Overall Study|Withdrawal by Subject|1|||
130845072|NCT00320255|471061175|FG001|Overall Study|Withdrawal by Subject|2|||
130845073|NCT00320255|471061176|FG002|Overall Study|Withdrawal by Subject|2|||
130845074|NCT00320255|471061177|FG003|Overall Study|Withdrawal by Subject|4|||
130845075|NCT00320255|471061178|FG004|Overall Study|Withdrawal by Subject|0|||
130845076|NCT00320255|471061179|FG005|Overall Study|Withdrawal by Subject|0|||
130845077|NCT00320255|471061174|FG000|Overall Study|Poor compliance/noncompliance|1|||
130845078|NCT00320255|471061175|FG001|Overall Study|Poor compliance/noncompliance|1|||
130845079|NCT00320255|471061176|FG002|Overall Study|Poor compliance/noncompliance|0|||
130845080|NCT00320255|471061177|FG003|Overall Study|Poor compliance/noncompliance|1|||
130845081|NCT00320255|471061178|FG004|Overall Study|Poor compliance/noncompliance|0|||
130845082|NCT00320255|471061179|FG005|Overall Study|Poor compliance/noncompliance|0|||
130845083|NCT00320255|471061174|FG000|Overall Study|No longer meets study criteria|0|||
130845084|NCT00320255|471061175|FG001|Overall Study|No longer meets study criteria|0|||
130845085|NCT00320255|471061176|FG002|Overall Study|No longer meets study criteria|0|||
130845086|NCT00320255|471061177|FG003|Overall Study|No longer meets study criteria|1|||
130845087|NCT00320255|471061178|FG004|Overall Study|No longer meets study criteria|0|||
130845088|NCT00320255|471061179|FG005|Overall Study|No longer meets study criteria|0|||
130845089|NCT00320255|471061174|FG000|Overall Study|Other|3|||
130845090|NCT00320255|471061175|FG001|Overall Study|Other|2|||
130845091|NCT00320255|471061176|FG002|Overall Study|Other|1|||
130845092|NCT00320255|471061177|FG003|Overall Study|Other|0|||
130845093|NCT00320255|471061178|FG004|Overall Study|Other|0|||
130845094|NCT00320255|471061179|FG005|Overall Study|Other|0|||
130845095|NCT03383783|471061184|FG000|Overall Study|Withdrawal by Subject|2|||
130845096|NCT02781792|471061187|FG000|Overall Study|Adverse Event|1|||
130845097|NCT02781792|471061188|FG001|Overall Study|Adverse Event|2|||
130845098|NCT02781792|471061187|FG000|Overall Study|Withdrawal by Subject|3|||
130845099|NCT02781792|471061188|FG001|Overall Study|Withdrawal by Subject|1|||
130845100|NCT02781792|471061187|FG000|Overall Study|Lack of Efficacy|1|||
130845101|NCT02781792|471061188|FG001|Overall Study|Lack of Efficacy|1|||
130845102|NCT02781792|471061187|FG000|Overall Study|Hospice|0|||
130845103|NCT02781792|471061188|FG001|Overall Study|Hospice|1|||
130845104|NCT01703117|471061189|FG000|Overall Study|Adverse Event|4|||
130845105|NCT01703117|471061190|FG001|Overall Study|Adverse Event|3|||
130845106|NCT01703117|471061189|FG000|Overall Study|Withdrawal by Subject|0|||
130845107|NCT01703117|471061190|FG001|Overall Study|Withdrawal by Subject|1|||
130845108|NCT00937404|471061202|FG000|Overall Study|Protocol Violation|1|||
130845109|NCT00937404|471061202|FG000|Overall Study|Withdrawal by Subject|1|||
130845110|NCT04644237|471061203|FG000|Overall Study|Death|3|||
130845111|NCT04644237|471061204|FG001|Overall Study|Death|2|||
130845112|NCT04644237|471061203|FG000|Overall Study|Adverse Event|15|||
130845113|NCT04644237|471061204|FG001|Overall Study|Adverse Event|12|||
130845114|NCT04644237|471061203|FG000|Overall Study|Progressive Disease|47|||
130845115|NCT04644237|471061204|FG001|Overall Study|Progressive Disease|19|||
130845116|NCT04644237|471061203|FG000|Overall Study|Clinical Progression|4|||
130845117|NCT04644237|471061204|FG001|Overall Study|Clinical Progression|1|||
130845118|NCT04644237|471061203|FG000|Overall Study|Withdrawal by Subject|1|||
130845119|NCT04644237|471061204|FG001|Overall Study|Withdrawal by Subject|2|||
130845120|NCT04644237|471061203|FG000|Overall Study|Physician Decision|3|||
130845121|NCT04644237|471061204|FG001|Overall Study|Physician Decision|0|||
130845122|NCT04644237|471061203|FG000|Overall Study|Other|1|||
130845123|NCT04644237|471061204|FG001|Overall Study|Other|0|||
130845124|NCT04644237|471061203|FG000|Overall Study|Randomized but not Treated|1|||
130845125|NCT04644237|471061204|FG001|Overall Study|Randomized but not Treated|0|||
130845126|NCT00090233|471061205|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
130845127|NCT00090233|471061206|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
130845128|NCT00090233|471061205|FG000|Overall Study|Adverse Event|214|||
130845129|NCT00090233|471061206|FG001|Overall Study|Adverse Event|198|||
130845130|NCT00090233|471061205|FG000|Overall Study|Lost to Follow-up|68|||
130845131|NCT00090233|471061206|FG001|Overall Study|Lost to Follow-up|95|||
130845132|NCT00090233|471061205|FG000|Overall Study|Protocol Violation|960|||
130845133|NCT00090233|471061206|FG001|Overall Study|Protocol Violation|1022|||
130845134|NCT00090233|471061205|FG000|Overall Study|Withdrawal by Subject|182|||
130845135|NCT00090233|471061206|FG001|Overall Study|Withdrawal by Subject|211|||
130845136|NCT00090233|471061205|FG000|Overall Study|Moved|203|||
130845137|NCT00090233|471061206|FG001|Overall Study|Moved|189|||
130845138|NCT00090233|471061205|FG000|Overall Study|Other|1211|||
130845139|NCT00090233|471061206|FG001|Overall Study|Other|1160|||
130845140|NCT00090233|471061205|FG000|Overall Study|Data not available at data cut-off point|1552|||
130845141|NCT00090233|471061206|FG001|Overall Study|Data not available at data cut-off point|1563|||
130845142|NCT04863248|471061207|FG000|Overall Study|Sponsor Terminated|4|||
130845143|NCT04863248|471061208|FG001|Overall Study|Sponsor Terminated|1|||
130845144|NCT04863248|471061207|FG000|Overall Study|Death|0|||
130845145|NCT04863248|471061208|FG001|Overall Study|Death|1|||
130845146|NCT04863248|471061207|FG000|Overall Study|Withdrawal by Subject|0|||
130845147|NCT04863248|471061208|FG001|Overall Study|Withdrawal by Subject|1|||
130845148|NCT02536300|471061209|FG000|Overall Study|Investigator's Discretion|17|||
130845149|NCT02536300|471061210|FG001|Overall Study|Investigator's Discretion|11|||
130845150|NCT02536300|471061211|FG002|Overall Study|Investigator's Discretion|2|||
130845151|NCT02536300|471061209|FG000|Overall Study|Progressive Disease|11|||
130845152|NCT02536300|471061210|FG001|Overall Study|Progressive Disease|7|||
130845153|NCT02536300|471061211|FG002|Overall Study|Progressive Disease|6|||
130845154|NCT02536300|471061209|FG000|Overall Study|Study Terminated by Sponsor|6|||
130845155|NCT02536300|471061210|FG001|Overall Study|Study Terminated by Sponsor|4|||
130845156|NCT02536300|471061211|FG002|Overall Study|Study Terminated by Sponsor|7|||
130845157|NCT02536300|471061209|FG000|Overall Study|Death|7|||
130845158|NCT02536300|471061210|FG001|Overall Study|Death|0|||
130845159|NCT02536300|471061211|FG002|Overall Study|Death|5|||
130845160|NCT02536300|471061209|FG000|Overall Study|Withdrew Consent|4|||
130845161|NCT02536300|471061210|FG001|Overall Study|Withdrew Consent|2|||
130845162|NCT02536300|471061211|FG002|Overall Study|Withdrew Consent|0|||
130845163|NCT02536300|471061209|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
130845164|NCT02536300|471061210|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
130845165|NCT02536300|471061211|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
130845166|NCT02536300|471061209|FG000|Overall Study|Enrolled but Never Treated|0|||
130845167|NCT02536300|471061210|FG001|Overall Study|Enrolled but Never Treated|0|||
130845168|NCT02536300|471061211|FG002|Overall Study|Enrolled but Never Treated|1|||
130845169|NCT02536300|471061209|FG000|Overall Study|Non-compliance With Study Drug|1|||
130845170|NCT02536300|471061210|FG001|Overall Study|Non-compliance With Study Drug|0|||
130845171|NCT02536300|471061211|FG002|Overall Study|Non-compliance With Study Drug|0|||
130845172|NCT02536300|471061209|FG000|Overall Study|Protocol Violation|0|||
130845173|NCT02536300|471061210|FG001|Overall Study|Protocol Violation|1|||
130845174|NCT02536300|471061211|FG002|Overall Study|Protocol Violation|0|||
130845175|NCT01691105|471061218|FG000|1 Month Follow-up|Lost to Follow-up|41|||
130845176|NCT01691105|471061219|FG001|1 Month Follow-up|Lost to Follow-up|38|||
130845177|NCT01691105|471061218|FG000|1 Month Follow-up|Death|2|||
130845178|NCT01691105|471061219|FG001|1 Month Follow-up|Death|3|||
130845179|NCT01691105|471061218|FG000|6 Month Follow-up|Lost to Follow-up|39|||
130845180|NCT01691105|471061219|FG001|6 Month Follow-up|Lost to Follow-up|58|||
130845181|NCT01691105|471061218|FG000|6 Month Follow-up|Death|13|||
130845182|NCT01691105|471061219|FG001|6 Month Follow-up|Death|13|||
130845183|NCT01691105|471061218|FG000|12 Month Follow-up|Lost to Follow-up|50|||
130845184|NCT01691105|471061219|FG001|12 Month Follow-up|Lost to Follow-up|71|||
130845185|NCT01691105|471061218|FG000|12 Month Follow-up|Death|22|||
130845186|NCT01691105|471061219|FG001|12 Month Follow-up|Death|30|||
130845187|NCT01691105|471061218|FG000|12 Month Biochemical Verification|Death|22|||
130845188|NCT01691105|471061219|FG001|12 Month Biochemical Verification|Death|30|||
130845189|NCT01691105|471061218|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
130845190|NCT01691105|471061219|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
130845191|NCT01691105|471061218|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
130845192|NCT01691105|471061219|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
130845193|NCT02233738|471061220|FG000|Overall Study|Lost to Follow-up|5|||
130845194|NCT02233738|471061221|FG001|Overall Study|Lost to Follow-up|12|||
130845195|NCT02233738|471061220|FG000|Overall Study|Death|0|||
130845196|NCT02233738|471061221|FG001|Overall Study|Death|1|||
130845197|NCT02233738|471061220|FG000|Overall Study|Withdrawal by Subject|0|||
130845198|NCT02233738|471061221|FG001|Overall Study|Withdrawal by Subject|1|||
130845199|NCT02233738|471061220|FG000|Overall Study|Did not return after Baseline|3|||
130845200|NCT02233738|471061221|FG001|Overall Study|Did not return after Baseline|2|||
130845201|NCT00096174|471061222|FG000|Overall Study|Lack of Efficacy|9|||
130845202|NCT00096174|471061222|FG000|Overall Study|Adverse Event|15|||
130845203|NCT00096174|471061222|FG000|Overall Study|Death|6|||
130845204|NCT00096174|471061222|FG000|Overall Study|Withdrawal by Subject|15|||
130845205|NCT00096174|471061222|FG000|Overall Study|Not started protocol therapy|3|||
130845206|NCT00096174|471061222|FG000|Overall Study|Ineligible|6|||
130845207|NCT00096174|471061222|FG000|Overall Study|other reason|8|||
130845208|NCT02279719|471061226|FG000|Overall Study|Patients randomized but never treated|0|||
130845209|NCT02279719|471061227|FG001|Overall Study|Patients randomized but never treated|0|||
130845210|NCT02279719|471061228|FG002|Overall Study|Patients randomized but never treated|0|||
130845211|NCT02279719|471061229|FG003|Overall Study|Patients randomized but never treated|0|||
130845212|NCT02279719|471061230|FG004|Overall Study|Patients randomized but never treated|3|||
130845213|NCT02279719|471061231|FG005|Overall Study|Patients randomized but never treated|0|||
130845214|NCT02279719|471061232|FG006|Overall Study|Patients randomized but never treated|3|||
130845215|NCT03541187|471061233|FG000|Overall Study|Lost to Follow-up|2|||
130845216|NCT03541187|471061234|FG001|Overall Study|Lost to Follow-up|6|||
130845217|NCT03541187|471061233|FG000|Overall Study|Pregnancy|0|||
130845218|NCT03541187|471061234|FG001|Overall Study|Pregnancy|1|||
130845219|NCT03541187|471061233|FG000|Overall Study|Withdrawal by Subject|6|||
130845220|NCT03541187|471061234|FG001|Overall Study|Withdrawal by Subject|2|||
130845221|NCT03541187|471061233|FG000|Overall Study|Moved out of town|1|||
130845222|NCT03541187|471061234|FG001|Overall Study|Moved out of town|0|||
130845223|NCT03541187|471061233|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
130845224|NCT03541187|471061234|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
130845225|NCT03541187|471061233|FG000|Overall Study|Did not meet randomization criteria|1|||
130845226|NCT03541187|471061234|FG001|Overall Study|Did not meet randomization criteria|1|||
130845227|NCT03541187|471061233|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
130845228|NCT03541187|471061234|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
130845229|NCT03541187|471061233|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
130845230|NCT03541187|471061234|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
130845231|NCT01369680|471061235|FG000|Overall Study|Lost to Follow-up|0|||
130845232|NCT01369680|471061236|FG001|Overall Study|Lost to Follow-up|0|||
130845233|NCT01369680|471061237|FG002|Overall Study|Lost to Follow-up|1|||
130845234|NCT01369680|471061238|FG003|Overall Study|Lost to Follow-up|2|||
130845235|NCT00585221|471061241|FG000|Overall Study|Protocol Violation|8|||
130845236|NCT01323270|471061243|FG000|Overall Study|Withdrawal by Subject|19|||
130845237|NCT01323270|471061244|FG001|Overall Study|Withdrawal by Subject|10|||
130845238|NCT01323270|471061243|FG000|Overall Study|Protocol Violation|9|||
130845239|NCT01323270|471061244|FG001|Overall Study|Protocol Violation|7|||
130845240|NCT01323270|471061243|FG000|Overall Study|Lost to Follow-up|4|||
130845241|NCT01323270|471061244|FG001|Overall Study|Lost to Follow-up|6|||
130845242|NCT01323270|471061243|FG000|Overall Study|Adverse Event|8|||
130845243|NCT01323270|471061244|FG001|Overall Study|Adverse Event|0|||
130845244|NCT01323270|471061243|FG000|Overall Study|Other|0|||
130845245|NCT01323270|471061244|FG001|Overall Study|Other|3|||
130845246|NCT01323270|471061243|FG000|Overall Study|Physician Decision|0|||
130845247|NCT01323270|471061244|FG001|Overall Study|Physician Decision|2|||
130845248|NCT01323270|471061243|FG000|Overall Study|Not eligible|1|||
130845249|NCT01323270|471061244|FG001|Overall Study|Not eligible|1|||
130845250|NCT01323270|471061243|FG000|Overall Study|Death|1|||
130845251|NCT01323270|471061244|FG001|Overall Study|Death|0|||
130845252|NCT01323270|471061243|FG000|Overall Study|Randomized, but not vaccinated|1|||
130845253|NCT01323270|471061244|FG001|Overall Study|Randomized, but not vaccinated|0|||
130845254|NCT03761394|471061245|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
130845255|NCT03761394|471061246|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
130845256|NCT03761394|471061247|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
130845257|NCT03761394|471061248|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
130845258|NCT03761394|471061245|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
130845259|NCT03761394|471061246|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
130845260|NCT03761394|471061247|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
130845261|NCT03761394|471061248|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
130845262|NCT03761394|471061245|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
130845263|NCT03761394|471061246|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
130845264|NCT03761394|471061247|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
130845265|NCT03761394|471061248|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
130845266|NCT03761394|471061245|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
130845267|NCT03761394|471061246|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
130845268|NCT03761394|471061247|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
130845269|NCT03761394|471061248|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
130845270|NCT03242772|471061256|FG000|Overall Study|Lost to Follow-up|2|||
130845271|NCT03242772|471061257|FG001|Overall Study|Lost to Follow-up|0|||
130845272|NCT03242772|471061256|FG000|Overall Study|Physician Decision|0|||
130845273|NCT03242772|471061257|FG001|Overall Study|Physician Decision|1|||
130845274|NCT03242772|471061256|FG000|Overall Study|Withdrawal by Subject|1|||
130845275|NCT03242772|471061257|FG001|Overall Study|Withdrawal by Subject|0|||
130845276|NCT00089986|471061258|FG000|Overall Study|Adverse Event|6|||
130845277|NCT00089986|471061259|FG001|Overall Study|Adverse Event|9|||
130845278|NCT00089986|471061260|FG002|Overall Study|Adverse Event|6|||
130845279|NCT00089986|471061258|FG000|Overall Study|Lost to Follow-up|3|||
130845280|NCT00089986|471061259|FG001|Overall Study|Lost to Follow-up|1|||
130845281|NCT00089986|471061260|FG002|Overall Study|Lost to Follow-up|1|||
130845282|NCT00089986|471061258|FG000|Overall Study|Protocol Violation|0|||
130845283|NCT00089986|471061259|FG001|Overall Study|Protocol Violation|1|||
130845284|NCT00089986|471061260|FG002|Overall Study|Protocol Violation|0|||
130845285|NCT00089986|471061258|FG000|Overall Study|Patient transferred to another hospital|2|||
130845286|NCT00089986|471061259|FG001|Overall Study|Patient transferred to another hospital|1|||
130845287|NCT00089986|471061260|FG002|Overall Study|Patient transferred to another hospital|0|||
130845288|NCT00089986|471061258|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
130845289|NCT00089986|471061259|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
130845290|NCT00089986|471061260|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
130845291|NCT00089986|471061258|FG000|Overall Study|Hemohlobin stopping rule|0|||
130845292|NCT00089986|471061259|FG001|Overall Study|Hemohlobin stopping rule|1|||
130845293|NCT00089986|471061260|FG002|Overall Study|Hemohlobin stopping rule|0|||
130845294|NCT00089986|471061258|FG000|Overall Study|Investigator decision to withdrew|0|||
130845295|NCT00089986|471061259|FG001|Overall Study|Investigator decision to withdrew|1|||
130845296|NCT00089986|471061260|FG002|Overall Study|Investigator decision to withdrew|0|||
130845297|NCT00089986|471061258|FG000|Overall Study|Enrollment in another study|0|||
130845298|NCT00089986|471061259|FG001|Overall Study|Enrollment in another study|1|||
130845299|NCT00089986|471061260|FG002|Overall Study|Enrollment in another study|0|||
130845300|NCT00089986|471061258|FG000|Overall Study|Family decision|0|||
130845301|NCT00089986|471061259|FG001|Overall Study|Family decision|1|||
130845302|NCT00089986|471061260|FG002|Overall Study|Family decision|0|||
130845303|NCT00089986|471061258|FG000|Overall Study|Do not resuscitate (DNR)|0|||
130845304|NCT00089986|471061259|FG001|Overall Study|Do not resuscitate (DNR)|0|||
130845305|NCT00089986|471061260|FG002|Overall Study|Do not resuscitate (DNR)|1|||
130845306|NCT00089986|471061258|FG000|Overall Study|Withdrawal by Subject|3|||
130845307|NCT00089986|471061259|FG001|Overall Study|Withdrawal by Subject|6|||
130845308|NCT00089986|471061260|FG002|Overall Study|Withdrawal by Subject|2|||
130845309|NCT02334683|471061270|FG000|First 12 Week Period|Lost to Follow-up|1|||
130845310|NCT02334683|471061271|FG001|First 12 Week Period|Lost to Follow-up|0|||
130845311|NCT02334683|471061270|FG000|Second 12 Week Period|Adverse Event|0|||
130845312|NCT02334683|471061271|FG001|Second 12 Week Period|Adverse Event|1|||
130845313|NCT01062841|471061272|FG000|Overall Study|Indwelling Device Removed|41|||
130845314|NCT01062841|471061273|FG001|Overall Study|Indwelling Device Removed|48|||
130845315|NCT01062841|471061272|FG000|Overall Study|Death|3|||
130845316|NCT01062841|471061273|FG001|Overall Study|Death|5|||
130845317|NCT01062841|471061272|FG000|Overall Study|Withdrawal by Subject|2|||
130845318|NCT01062841|471061273|FG001|Overall Study|Withdrawal by Subject|0|||
130845319|NCT01062841|471061272|FG000|Overall Study|Withdrawal by Study|3|||
130845320|NCT01062841|471061273|FG001|Overall Study|Withdrawal by Study|0|||
130845321|NCT01218100|471061274|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
130845322|NCT01218100|471061275|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
130845323|NCT01218100|471061276|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
130845324|NCT01218100|471061277|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
130845325|NCT01218100|471061274|FG000|Overall Study|Adverse Event|4|||
130845326|NCT01218100|471061275|FG001|Overall Study|Adverse Event|6|||
130845327|NCT01218100|471061276|FG002|Overall Study|Adverse Event|6|||
130845328|NCT01218100|471061277|FG003|Overall Study|Adverse Event|7|||
130845329|NCT01218100|471061274|FG000|Overall Study|Lack of Efficacy|9|||
130845330|NCT01218100|471061275|FG001|Overall Study|Lack of Efficacy|6|||
130845331|NCT01218100|471061276|FG002|Overall Study|Lack of Efficacy|5|||
130845332|NCT01218100|471061277|FG003|Overall Study|Lack of Efficacy|12|||
130845333|NCT01218100|471061274|FG000|Overall Study|Protocol Violation|0|||
130845334|NCT01218100|471061275|FG001|Overall Study|Protocol Violation|0|||
130845335|NCT01218100|471061276|FG002|Overall Study|Protocol Violation|1|||
130845336|NCT01218100|471061277|FG003|Overall Study|Protocol Violation|1|||
130845337|NCT01218100|471061274|FG000|Overall Study|Withdrawal by Subject|5|||
130845338|NCT01218100|471061275|FG001|Overall Study|Withdrawal by Subject|2|||
130845339|NCT01218100|471061276|FG002|Overall Study|Withdrawal by Subject|6|||
130845340|NCT01218100|471061277|FG003|Overall Study|Withdrawal by Subject|7|||
130845341|NCT01218100|471061274|FG000|Overall Study|Lost to Follow-up|3|||
130845342|NCT01218100|471061275|FG001|Overall Study|Lost to Follow-up|8|||
130845343|NCT01218100|471061276|FG002|Overall Study|Lost to Follow-up|2|||
130845344|NCT01218100|471061277|FG003|Overall Study|Lost to Follow-up|1|||
130845345|NCT01218100|471061274|FG000|Overall Study|Other Reason|2|||
130845346|NCT01218100|471061275|FG001|Overall Study|Other Reason|2|||
130845347|NCT01218100|471061276|FG002|Overall Study|Other Reason|6|||
130845348|NCT01218100|471061277|FG003|Overall Study|Other Reason|4|||
130845349|NCT01118520|471061278|FG000|Overall Study|AAA repair|9|||
130845350|NCT01118520|471061279|FG001|Overall Study|AAA repair|7|||
130845351|NCT01118520|471061280|FG002|Overall Study|AAA repair|9|||
130845352|NCT01118520|471061278|FG000|Overall Study|Adverse Event|3|||
130845353|NCT01118520|471061279|FG001|Overall Study|Adverse Event|3|||
130845354|NCT01118520|471061280|FG002|Overall Study|Adverse Event|3|||
130845355|NCT01118520|471061278|FG000|Overall Study|Withdrawal by Subject|8|||
130845356|NCT01118520|471061279|FG001|Overall Study|Withdrawal by Subject|13|||
130845357|NCT01118520|471061280|FG002|Overall Study|Withdrawal by Subject|8|||
130845358|NCT01089023|471061287|FG000|Overall Study|Lost to Follow-up|3|||
130845359|NCT01089023|471061287|FG000|Overall Study|Adverse Event|1|||
130845360|NCT01089023|471061287|FG000|Overall Study|Withdrawal by Subject|1|||
130845361|NCT01089023|471061287|FG000|Overall Study|Protocol Violation|1|||
130845362|NCT01089023|471061287|FG000|Overall Study|Lack of Efficacy|1|||
130845363|NCT02434354|471061290|FG000|Overall Study|screen fail|3|||
130845364|NCT02446418|471061291|FG000|Overall Study|Adverse Event|4|||
130845365|NCT02446418|471061292|FG001|Overall Study|Adverse Event|8|||
130845366|NCT02446418|471061291|FG000|Overall Study|Physician Decision|5|||
130845367|NCT02446418|471061292|FG001|Overall Study|Physician Decision|1|||
130845368|NCT02446418|471061291|FG000|Overall Study|Withdrawal by Subject|3|||
130845369|NCT02446418|471061292|FG001|Overall Study|Withdrawal by Subject|3|||
130845370|NCT02446418|471061291|FG000|Overall Study|Lost to Follow-up|2|||
130845371|NCT02446418|471061292|FG001|Overall Study|Lost to Follow-up|2|||
130845372|NCT02446418|471061291|FG000|Overall Study|Protocol Violation|1|||
130845373|NCT02446418|471061292|FG001|Overall Study|Protocol Violation|2|||
130845374|NCT02446418|471061291|FG000|Overall Study|Lack of Efficacy|2|||
130845375|NCT02446418|471061292|FG001|Overall Study|Lack of Efficacy|0|||
130845376|NCT02446418|471061291|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
130845377|NCT02446418|471061292|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
130845378|NCT02014480|471061295|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130845379|NCT02014480|471061296|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130845380|NCT02014480|471061297|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
130845381|NCT02014480|471061298|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130845382|NCT02014480|471061299|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130845383|NCT02014480|471061300|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130845384|NCT02014480|471061295|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130845385|NCT02014480|471061296|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130845386|NCT02014480|471061297|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130845387|NCT02014480|471061298|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
130845388|NCT02014480|471061299|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130845389|NCT02014480|471061300|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130845390|NCT02014480|471061295|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130845391|NCT02014480|471061296|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130845392|NCT02014480|471061297|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
130845393|NCT02014480|471061298|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130845394|NCT02014480|471061299|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130845395|NCT02014480|471061300|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130845396|NCT02014480|471061295|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130845397|NCT02014480|471061296|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130845398|NCT02014480|471061297|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
130845399|NCT02014480|471061298|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130845400|NCT02014480|471061299|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130845401|NCT02014480|471061300|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130845402|NCT02014480|471061295|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130845403|NCT02014480|471061296|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
130845404|NCT02014480|471061297|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130845405|NCT02014480|471061298|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130845406|NCT02014480|471061299|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130845407|NCT02014480|471061300|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130845408|NCT02014480|471061295|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
130845409|NCT02014480|471061296|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
130845410|NCT02014480|471061297|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
130845411|NCT02014480|471061298|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
130845412|NCT02014480|471061299|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
130845413|NCT02014480|471061300|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
130845414|NCT02014480|471061295|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130845415|NCT02014480|471061296|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130845416|NCT02014480|471061297|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130845417|NCT02014480|471061298|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130845418|NCT02014480|471061299|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130845419|NCT02014480|471061300|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
130845420|NCT01414205|471061301|FG000|Overall Study|Death|5|||
130845421|NCT01414205|471061302|FG001|Overall Study|Death|1|||
130845422|NCT01414205|471061301|FG000|Overall Study|Lost to Follow-up|1|||
130845423|NCT01414205|471061302|FG001|Overall Study|Lost to Follow-up|4|||
130845424|NCT01414205|471061301|FG000|Overall Study|Physician Decision|0|||
130845425|NCT01414205|471061302|FG001|Overall Study|Physician Decision|1|||
130845426|NCT01414205|471061301|FG000|Overall Study|Randomized but not Treated|1|||
130845427|NCT01414205|471061302|FG001|Overall Study|Randomized but not Treated|1|||
130845428|NCT03421743|471061308|FG000|Overall Study|Lack of Efficacy|1|||
130845429|NCT03421743|471061309|FG001|Overall Study|Lack of Efficacy|0|||
130845430|NCT03421743|471061308|FG000|Overall Study|Adverse Event|2|||
130845431|NCT03421743|471061309|FG001|Overall Study|Adverse Event|1|||
130845432|NCT03421743|471061308|FG000|Overall Study|Withdrawal by Subject|0|||
130845433|NCT03421743|471061309|FG001|Overall Study|Withdrawal by Subject|1|||
130845434|NCT01166373|471061310|FG000|Overall Study|Lost to Follow-up|3|||
130845435|NCT01166373|471061311|FG001|Overall Study|Lost to Follow-up|2|||
130845436|NCT01166373|471061312|FG002|Overall Study|Lost to Follow-up|2|||
130845437|NCT01166373|471061313|FG003|Overall Study|Lost to Follow-up|2|||
130845438|NCT01166373|471061310|FG000|Overall Study|Withdrawal by Subject|1|||
130845439|NCT01166373|471061311|FG001|Overall Study|Withdrawal by Subject|2|||
130845440|NCT01166373|471061312|FG002|Overall Study|Withdrawal by Subject|2|||
130845441|NCT01166373|471061313|FG003|Overall Study|Withdrawal by Subject|3|||
130845442|NCT01166373|471061310|FG000|Overall Study|Physician Decision|1|||
130845443|NCT01166373|471061311|FG001|Overall Study|Physician Decision|0|||
130845444|NCT01166373|471061312|FG002|Overall Study|Physician Decision|0|||
130845445|NCT01166373|471061313|FG003|Overall Study|Physician Decision|0|||
130845446|NCT01819129|471061314|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
130845447|NCT01819129|471061315|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
130845448|NCT01819129|471061314|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
130845449|NCT01819129|471061315|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
130845450|NCT01819129|471061314|FG000|Overall Study|Other, Subject moved out of the country|0|||
130845451|NCT01819129|471061315|FG001|Overall Study|Other, Subject moved out of the country|1|||
130845452|NCT01819129|471061314|FG000|Overall Study|Withdrawal by Subject|15|||
130845453|NCT01819129|471061315|FG001|Overall Study|Withdrawal by Subject|15|||
130845454|NCT01819129|471061314|FG000|Overall Study|Lost to Follow-up|5|||
130845455|NCT01819129|471061315|FG001|Overall Study|Lost to Follow-up|2|||
130845456|NCT01819129|471061314|FG000|Overall Study|Lack of Efficacy|0|||
130845457|NCT01819129|471061315|FG001|Overall Study|Lack of Efficacy|1|||
130845458|NCT01819129|471061314|FG000|Overall Study|Adverse Event|1|||
130845459|NCT01819129|471061315|FG001|Overall Study|Adverse Event|4|||
130845460|NCT01819129|471061314|FG000|Overall Study|Death|1|||
130845461|NCT01819129|471061315|FG001|Overall Study|Death|1|||
130845462|NCT01819129|471061314|FG000|Overall Study|Withdrawal Criteria|20|||
130845463|NCT01819129|471061315|FG001|Overall Study|Withdrawal Criteria|15|||
130845464|NCT02836873|471061319|FG000|Overall Study|Protocol Violation|0|||
130845465|NCT02836873|471061320|FG001|Overall Study|Protocol Violation|1|||
130845466|NCT02836873|471061319|FG000|Overall Study|Adverse Event|1|||
130845467|NCT02836873|471061320|FG001|Overall Study|Adverse Event|4|||
130845468|NCT02836873|471061319|FG000|Overall Study|Withdrawal by Subject|2|||
130845469|NCT02836873|471061320|FG001|Overall Study|Withdrawal by Subject|2|||
130845470|NCT02836873|471061319|FG000|Overall Study|Lost to Follow-up|1|||
130845471|NCT02836873|471061320|FG001|Overall Study|Lost to Follow-up|3|||
130845472|NCT02836873|471061319|FG000|Overall Study|Physician Decision|0|||
130845473|NCT02836873|471061320|FG001|Overall Study|Physician Decision|1|||
130845474|NCT02836873|471061319|FG000|Overall Study|Other|1|||
130845475|NCT02836873|471061320|FG001|Overall Study|Other|0|||
130845476|NCT00694096|471061327|FG000|Overall Study|Withdrawal by Subject|5|||
130845477|NCT02914548|471061330|FG000|Overall Study|Adverse Event|15|||
130845478|NCT02914548|471061331|FG001|Overall Study|Adverse Event|7|||
130845479|NCT02914548|471061332|FG002|Overall Study|Adverse Event|15|||
130845480|NCT02914548|471061330|FG000|Overall Study|Physician Decision|2|||
130845481|NCT02914548|471061331|FG001|Overall Study|Physician Decision|2|||
130845482|NCT02914548|471061332|FG002|Overall Study|Physician Decision|0|||
130845483|NCT02914548|471061330|FG000|Overall Study|Protocol Violation|1|||
130845484|NCT02914548|471061331|FG001|Overall Study|Protocol Violation|0|||
130845485|NCT02914548|471061332|FG002|Overall Study|Protocol Violation|0|||
130845486|NCT02914548|471061330|FG000|Overall Study|Withdrawal by Subject|3|||
130845487|NCT02914548|471061331|FG001|Overall Study|Withdrawal by Subject|4|||
130845488|NCT02914548|471061332|FG002|Overall Study|Withdrawal by Subject|4|||
130845489|NCT02914548|471061330|FG000|Overall Study|>40% of body surface area|0|||
130845490|NCT02914548|471061331|FG001|Overall Study|>40% of body surface area|1|||
130845491|NCT02914548|471061332|FG002|Overall Study|>40% of body surface area|1|||
130845492|NCT02847858|471061333|FG000|Overall Study|Lost to Follow-up|401|||
130845493|NCT02847858|471061334|FG001|Overall Study|Lost to Follow-up|269|||
130845494|NCT02305849|471061337|FG000|Overall Study|Adverse Event|10|||
130845495|NCT02305849|471061338|FG001|Overall Study|Adverse Event|12|||
130845496|NCT02305849|471061339|FG002|Overall Study|Adverse Event|7|||
130845497|NCT02305849|471061340|FG003|Overall Study|Adverse Event|3|||
130845498|NCT02305849|471061337|FG000|Overall Study|Lack of Efficacy|10|||
130845499|NCT02305849|471061338|FG001|Overall Study|Lack of Efficacy|6|||
130845500|NCT02305849|471061339|FG002|Overall Study|Lack of Efficacy|3|||
130845501|NCT02305849|471061340|FG003|Overall Study|Lack of Efficacy|9|||
130845502|NCT02305849|471061337|FG000|Overall Study|Withdrawal by Subject|2|||
130845503|NCT02305849|471061338|FG001|Overall Study|Withdrawal by Subject|2|||
130845504|NCT02305849|471061339|FG002|Overall Study|Withdrawal by Subject|1|||
130845505|NCT02305849|471061340|FG003|Overall Study|Withdrawal by Subject|4|||
130845506|NCT02305849|471061337|FG000|Overall Study|Lost to Follow-up|0|||
130845507|NCT02305849|471061338|FG001|Overall Study|Lost to Follow-up|2|||
130845508|NCT02305849|471061339|FG002|Overall Study|Lost to Follow-up|0|||
130845509|NCT02305849|471061340|FG003|Overall Study|Lost to Follow-up|0|||
130845510|NCT02305849|471061337|FG000|Overall Study|Protocol Violation|3|||
130845511|NCT02305849|471061338|FG001|Overall Study|Protocol Violation|2|||
130845512|NCT02305849|471061339|FG002|Overall Study|Protocol Violation|1|||
130845513|NCT02305849|471061340|FG003|Overall Study|Protocol Violation|1|||
130845514|NCT02305849|471061337|FG000|Overall Study|Lab data met discontinuation criteria|0|||
130845515|NCT02305849|471061338|FG001|Overall Study|Lab data met discontinuation criteria|1|||
130845516|NCT02305849|471061339|FG002|Overall Study|Lab data met discontinuation criteria|2|||
130845517|NCT02305849|471061340|FG003|Overall Study|Lab data met discontinuation criteria|1|||
130845518|NCT02305849|471061337|FG000|Overall Study|Miscellaneous|1|||
130845519|NCT02305849|471061338|FG001|Overall Study|Miscellaneous|2|||
130845520|NCT02305849|471061339|FG002|Overall Study|Miscellaneous|4|||
130845521|NCT02305849|471061340|FG003|Overall Study|Miscellaneous|1|||
130845522|NCT02305849|471061337|FG000|Overall Study|Not fulfill eligibility criteria|1|||
130845523|NCT02305849|471061338|FG001|Overall Study|Not fulfill eligibility criteria|1|||
130845524|NCT02305849|471061339|FG002|Overall Study|Not fulfill eligibility criteria|0|||
130845525|NCT02305849|471061340|FG003|Overall Study|Not fulfill eligibility criteria|0|||
130845526|NCT00495521|471061346|FG000|Overall Study|Physician Decision|0|||
130845527|NCT00495521|471061347|FG001|Overall Study|Physician Decision|1|||
130845528|NCT01300819|471061348|FG000|Overall Study|Adverse Event|9|||
130845529|NCT01300819|471061349|FG001|Overall Study|Adverse Event|27|||
130845530|NCT01300819|471061348|FG000|Overall Study|Lack of Efficacy|2|||
130845531|NCT01300819|471061349|FG001|Overall Study|Lack of Efficacy|1|||
130845532|NCT01300819|471061348|FG000|Overall Study|Withdrawal by Subject|10|||
130845533|NCT01300819|471061349|FG001|Overall Study|Withdrawal by Subject|12|||
130845534|NCT01300819|471061348|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
130845535|NCT01300819|471061349|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
130845536|NCT01300819|471061348|FG000|Overall Study|Refusal to down titrate study drug|0|||
130845537|NCT01300819|471061349|FG001|Overall Study|Refusal to down titrate study drug|1|||
130845538|NCT01300819|471061348|FG000|Overall Study|Administrative reason|0|||
130845539|NCT01300819|471061349|FG001|Overall Study|Administrative reason|1|||
130845540|NCT01300819|471061348|FG000|Overall Study|Safety follow up not done by mistake|0|||
130845541|NCT01300819|471061349|FG001|Overall Study|Safety follow up not done by mistake|1|||
130845542|NCT01300819|471061348|FG000|Overall Study|Follow up call was not done|1|||
130845543|NCT01300819|471061349|FG001|Overall Study|Follow up call was not done|0|||
130845544|NCT02818036|471061352|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
130845545|NCT02818036|471061353|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
130845546|NCT02818036|471061352|FG000|Overall Study|Withdrawal by Subject|1|||
130845547|NCT02818036|471061353|FG001|Overall Study|Withdrawal by Subject|0|||
130845548|NCT01038713|471061357|FG000|Overall Study|Patient to hospice|1|||
130845549|NCT01038713|471061358|FG001|Overall Study|Patient to hospice|1|||
130845550|NCT01038713|471061359|FG002|Overall Study|Patient to hospice|1|||
130845551|NCT01038713|471061357|FG000|Overall Study|Lost to Follow-up|3|||
130845552|NCT01038713|471061358|FG001|Overall Study|Lost to Follow-up|0|||
130845553|NCT01038713|471061359|FG002|Overall Study|Lost to Follow-up|0|||
130845554|NCT01038713|471061357|FG000|Overall Study|Neuroendocrine Tumor|0|||
130845555|NCT01038713|471061358|FG001|Overall Study|Neuroendocrine Tumor|1|||
130845556|NCT01038713|471061359|FG002|Overall Study|Neuroendocrine Tumor|0|||
130845557|NCT01038713|471061357|FG000|Overall Study|died from PEP|0|||
130845558|NCT01038713|471061358|FG001|Overall Study|died from PEP|1|||
130845559|NCT01038713|471061359|FG002|Overall Study|died from PEP|0|||
130845560|NCT01038713|471061357|FG000|Overall Study|Autoimmune Pancreatitis|1|||
130845561|NCT01038713|471061358|FG001|Overall Study|Autoimmune Pancreatitis|0|||
130845562|NCT01038713|471061359|FG002|Overall Study|Autoimmune Pancreatitis|0|||
130845563|NCT01154283|471061360|FG000|0-6 Weeks|Withdrawal by Subject|7|||
130845564|NCT01154283|471061361|FG001|0-6 Weeks|Withdrawal by Subject|2|||
130845565|NCT01154283|471061360|FG000|0-6 Weeks|Death|0|||
130845566|NCT01154283|471061361|FG001|0-6 Weeks|Death|1|||
130845567|NCT01154283|471061360|FG000|7-12 Weeks|Death|1|||
130845568|NCT01154283|471061361|FG001|7-12 Weeks|Death|0|||
130845569|NCT01154283|471061360|FG000|7-12 Weeks|Withdrawal by Subject|0|||
130845570|NCT01154283|471061361|FG001|7-12 Weeks|Withdrawal by Subject|1|||
130845571|NCT03777917|471061362|FG000|Overall Study|Withdrawal by Subject|1|||
130845572|NCT03777917|471061363|FG001|Overall Study|Withdrawal by Subject|0|||
130845573|NCT03777917|471061362|FG000|Overall Study|Physician Decision|1|||
130845574|NCT03777917|471061363|FG001|Overall Study|Physician Decision|0|||
130845575|NCT03777917|471061362|FG000|Overall Study|Lost to Follow-up|6|||
130845576|NCT03777917|471061363|FG001|Overall Study|Lost to Follow-up|2|||
130845577|NCT03777917|471061362|FG000|Overall Study|Other|1|||
130845578|NCT03777917|471061363|FG001|Overall Study|Other|0|||
130845579|NCT00042432|471061364|FG000|Overall Study|Adverse Event|4|||
130845580|NCT00042432|471061365|FG001|Overall Study|Adverse Event|1|||
130845581|NCT00042432|471061364|FG000|Overall Study|Withdrawal by Subject|1|||
130845582|NCT00042432|471061365|FG001|Overall Study|Withdrawal by Subject|3|||
130845583|NCT00042432|471061364|FG000|Overall Study|Death|0|||
130845584|NCT00042432|471061365|FG001|Overall Study|Death|2|||
130845585|NCT00042432|471061364|FG000|Overall Study|Ineligibility determined|1|||
130845586|NCT00042432|471061365|FG001|Overall Study|Ineligibility determined|0|||
130845587|NCT00042432|471061364|FG000|Overall Study|Initiation of maintenance dialysis|1|||
130845588|NCT00042432|471061365|FG001|Overall Study|Initiation of maintenance dialysis|1|||
130845589|NCT00042432|471061364|FG000|Overall Study|Other|2|||
130845590|NCT00042432|471061365|FG001|Overall Study|Other|0|||
130845591|NCT02966795|471061366|FG000|Overall Study|Patient Left the Country|0|||
130845592|NCT02966795|471061367|FG001|Overall Study|Patient Left the Country|1|||
130845593|NCT00468845|471061370|FG000|Overall Study|Adverse Event|9|||
130845594|NCT00468845|471061371|FG001|Overall Study|Adverse Event|14|||
130845595|NCT00468845|471061372|FG002|Overall Study|Adverse Event|11|||
130845596|NCT00468845|471061370|FG000|Overall Study|Lost to Follow-up|2|||
130845597|NCT00468845|471061371|FG001|Overall Study|Lost to Follow-up|1|||
130845598|NCT00468845|471061372|FG002|Overall Study|Lost to Follow-up|2|||
130845599|NCT00468845|471061370|FG000|Overall Study|Other|4|||
130845600|NCT00468845|471061371|FG001|Overall Study|Other|9|||
130845601|NCT00468845|471061372|FG002|Overall Study|Other|5|||
130845602|NCT00468845|471061370|FG000|Overall Study|No longer willing to participate|5|||
130845603|NCT00468845|471061371|FG001|Overall Study|No longer willing to participate|6|||
130845604|NCT00468845|471061372|FG002|Overall Study|No longer willing to participate|10|||
130845605|NCT00468845|471061370|FG000|Overall Study|Randomized, not treated|1|||
130845606|NCT00468845|471061371|FG001|Overall Study|Randomized, not treated|4|||
130845607|NCT00468845|471061372|FG002|Overall Study|Randomized, not treated|2|||
130845608|NCT02761694|471061377|FG000|Overall Study|Lack of Efficacy|0|||
130845609|NCT02761694|471061378|FG001|Overall Study|Lack of Efficacy|0|||
130845610|NCT02761694|471061379|FG002|Overall Study|Lack of Efficacy|0|||
130845611|NCT02761694|471061380|FG003|Overall Study|Lack of Efficacy|0|||
130845612|NCT02761694|471061381|FG004|Overall Study|Lack of Efficacy|0|||
130845613|NCT02761694|471061382|FG005|Overall Study|Lack of Efficacy|0|||
130845614|NCT02761694|471061383|FG006|Overall Study|Lack of Efficacy|6|||
130845615|NCT02761694|471061384|FG007|Overall Study|Lack of Efficacy|0|||
130845616|NCT02761694|471061385|FG008|Overall Study|Lack of Efficacy|0|||
130845617|NCT02761694|471061386|FG009|Overall Study|Lack of Efficacy|1|||
130845618|NCT02761694|471061387|FG010|Overall Study|Lack of Efficacy|1|||
130845619|NCT02761694|471061388|FG011|Overall Study|Lack of Efficacy|4|||
130845620|NCT02761694|471061377|FG000|Overall Study|Death|0|||
130845621|NCT02761694|471061378|FG001|Overall Study|Death|0|||
130845622|NCT02761694|471061379|FG002|Overall Study|Death|0|||
130845623|NCT02761694|471061380|FG003|Overall Study|Death|0|||
130845624|NCT02761694|471061381|FG004|Overall Study|Death|0|||
130845625|NCT02761694|471061382|FG005|Overall Study|Death|0|||
130845626|NCT02761694|471061383|FG006|Overall Study|Death|2|||
130845627|NCT02761694|471061384|FG007|Overall Study|Death|0|||
130845628|NCT02761694|471061385|FG008|Overall Study|Death|2|||
130845629|NCT02761694|471061386|FG009|Overall Study|Death|2|||
130845630|NCT02761694|471061387|FG010|Overall Study|Death|1|||
130845631|NCT02761694|471061388|FG011|Overall Study|Death|0|||
130845632|NCT02761694|471061377|FG000|Overall Study|Physician Decision|0|||
130845633|NCT02761694|471061378|FG001|Overall Study|Physician Decision|0|||
130845634|NCT02761694|471061379|FG002|Overall Study|Physician Decision|0|||
130845635|NCT02761694|471061380|FG003|Overall Study|Physician Decision|0|||
130845636|NCT02761694|471061381|FG004|Overall Study|Physician Decision|0|||
130845637|NCT02761694|471061382|FG005|Overall Study|Physician Decision|0|||
130845638|NCT02761694|471061383|FG006|Overall Study|Physician Decision|1|||
130845639|NCT02761694|471061384|FG007|Overall Study|Physician Decision|0|||
130845640|NCT02761694|471061385|FG008|Overall Study|Physician Decision|0|||
130845641|NCT02761694|471061386|FG009|Overall Study|Physician Decision|0|||
130845642|NCT02761694|471061387|FG010|Overall Study|Physician Decision|0|||
130845643|NCT02761694|471061388|FG011|Overall Study|Physician Decision|0|||
130845644|NCT02761694|471061377|FG000|Overall Study|Withdrawal by Subject|0|||
130845645|NCT02761694|471061378|FG001|Overall Study|Withdrawal by Subject|0|||
130845646|NCT02761694|471061379|FG002|Overall Study|Withdrawal by Subject|0|||
130845647|NCT02761694|471061380|FG003|Overall Study|Withdrawal by Subject|1|||
130845648|NCT02761694|471061381|FG004|Overall Study|Withdrawal by Subject|0|||
130845649|NCT02761694|471061382|FG005|Overall Study|Withdrawal by Subject|0|||
130845650|NCT02761694|471061383|FG006|Overall Study|Withdrawal by Subject|4|||
130845651|NCT02761694|471061384|FG007|Overall Study|Withdrawal by Subject|0|||
130845652|NCT02761694|471061385|FG008|Overall Study|Withdrawal by Subject|2|||
130845653|NCT02761694|471061386|FG009|Overall Study|Withdrawal by Subject|1|||
130845654|NCT02761694|471061387|FG010|Overall Study|Withdrawal by Subject|0|||
130845655|NCT02761694|471061388|FG011|Overall Study|Withdrawal by Subject|0|||
130845656|NCT02761694|471061377|FG000|Overall Study|Lost to Follow-up|0|||
130845657|NCT02761694|471061378|FG001|Overall Study|Lost to Follow-up|0|||
130845658|NCT02761694|471061379|FG002|Overall Study|Lost to Follow-up|0|||
130845659|NCT02761694|471061380|FG003|Overall Study|Lost to Follow-up|0|||
130845660|NCT02761694|471061381|FG004|Overall Study|Lost to Follow-up|0|||
130845661|NCT02761694|471061382|FG005|Overall Study|Lost to Follow-up|0|||
130845662|NCT02761694|471061383|FG006|Overall Study|Lost to Follow-up|1|||
130845663|NCT02761694|471061384|FG007|Overall Study|Lost to Follow-up|0|||
130845664|NCT02761694|471061385|FG008|Overall Study|Lost to Follow-up|0|||
130845665|NCT02761694|471061386|FG009|Overall Study|Lost to Follow-up|0|||
130845666|NCT02761694|471061387|FG010|Overall Study|Lost to Follow-up|0|||
130845667|NCT02761694|471061388|FG011|Overall Study|Lost to Follow-up|1|||
130845668|NCT02761694|471061377|FG000|Overall Study|Adverse Event|0|||
130845669|NCT02761694|471061378|FG001|Overall Study|Adverse Event|0|||
130845670|NCT02761694|471061379|FG002|Overall Study|Adverse Event|0|||
130845671|NCT02761694|471061380|FG003|Overall Study|Adverse Event|0|||
130845672|NCT02761694|471061381|FG004|Overall Study|Adverse Event|0|||
130845673|NCT02761694|471061382|FG005|Overall Study|Adverse Event|0|||
130845674|NCT02761694|471061383|FG006|Overall Study|Adverse Event|1|||
130845675|NCT02761694|471061384|FG007|Overall Study|Adverse Event|0|||
130845676|NCT02761694|471061385|FG008|Overall Study|Adverse Event|1|||
130845677|NCT02761694|471061386|FG009|Overall Study|Adverse Event|0|||
130845678|NCT02761694|471061387|FG010|Overall Study|Adverse Event|0|||
130845679|NCT02761694|471061388|FG011|Overall Study|Adverse Event|1|||
130845680|NCT02761694|471061377|FG000|Overall Study|Other|4|||
130845681|NCT02761694|471061378|FG001|Overall Study|Other|4|||
130845682|NCT02761694|471061379|FG002|Overall Study|Other|1|||
130845683|NCT02761694|471061380|FG003|Overall Study|Other|2|||
130845684|NCT02761694|471061381|FG004|Overall Study|Other|3|||
130845685|NCT02761694|471061382|FG005|Overall Study|Other|3|||
130845686|NCT02761694|471061383|FG006|Overall Study|Other|18|||
130845687|NCT02761694|471061384|FG007|Overall Study|Other|8|||
130845688|NCT02761694|471061385|FG008|Overall Study|Other|0|||
130845689|NCT02761694|471061386|FG009|Overall Study|Other|1|||
130845690|NCT02761694|471061387|FG010|Overall Study|Other|1|||
130845691|NCT02761694|471061388|FG011|Overall Study|Other|0|||
130845692|NCT02395055|471061389|FG000|Overall Study|Withdrawal by Subject|7|||
130845693|NCT02395055|471061390|FG001|Overall Study|Withdrawal by Subject|3|||
130845694|NCT00526110|471061395|FG000|Overall Study|Adverse Event|2|||
130845695|NCT00526110|471061396|FG001|Overall Study|Adverse Event|9|||
130845696|NCT00526110|471061395|FG000|Overall Study|Disease Progression|0|||
130845697|NCT00526110|471061396|FG001|Overall Study|Disease Progression|19|||
130845698|NCT00526110|471061395|FG000|Overall Study|Maximal Response|0|||
130845699|NCT00526110|471061396|FG001|Overall Study|Maximal Response|6|||
130845700|NCT00526110|471061395|FG000|Overall Study|Withdrawal by Subject|0|||
130845701|NCT00526110|471061396|FG001|Overall Study|Withdrawal by Subject|2|||
130845702|NCT00526110|471061395|FG000|Overall Study|Poor Tolerance|0|||
130845703|NCT00526110|471061396|FG001|Overall Study|Poor Tolerance|5|||
130845704|NCT02091284|471063477|FG000|Overall Study|Withdrawal by Subject|2|||
130845705|NCT02091284|471063478|FG001|Overall Study|Withdrawal by Subject|1|||
130845706|NCT02091284|471063477|FG000|Overall Study|unreliable data|1|||
130845707|NCT02091284|471063478|FG001|Overall Study|unreliable data|0|||
130845708|NCT02534935|471063479|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
130845709|NCT02534935|471063480|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
130845710|NCT02534935|471063481|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
130845711|NCT02534935|471063479|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
130845712|NCT02534935|471063480|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
130845713|NCT02534935|471063481|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
130845714|NCT02534935|471063479|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
130845715|NCT02534935|471063480|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
130845716|NCT02534935|471063481|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
130845717|NCT02534935|471063479|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
130845718|NCT02534935|471063480|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
130845719|NCT02534935|471063481|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
130845720|NCT02534935|471063479|FG000|Stage 1: 24 Months|Adverse Event|0|||
130845721|NCT02534935|471063480|FG001|Stage 1: 24 Months|Adverse Event|2|||
130845722|NCT02534935|471063481|FG002|Stage 1: 24 Months|Adverse Event|0|||
130845723|NCT02534935|471063479|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
130845724|NCT02534935|471063480|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
130845725|NCT02534935|471063481|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
130845726|NCT02534935|471063479|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
130845727|NCT02534935|471063480|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
130845728|NCT02534935|471063481|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
130845729|NCT01460719|471063482|FG000|Overall Study|Adverse Event|1|||
130845730|NCT01460719|471063482|FG000|Overall Study|Withdrawal by Subject|1|||
130845731|NCT02838901|471063486|FG000|Overall Study|Withdrawal by Subject|1|||
130845732|NCT02838901|471063487|FG001|Overall Study|Withdrawal by Subject|1|||
130845733|NCT02838901|471063486|FG000|Overall Study|Lost to Follow-up|1|||
130845734|NCT02838901|471063487|FG001|Overall Study|Lost to Follow-up|1|||
130845735|NCT00076336|471063488|FG000|Overall Study|Death|13|||
130845736|NCT00076336|471063489|FG001|Overall Study|Death|17|||
130845737|NCT00076336|471063488|FG000|Overall Study|Adverse Event|4|||
130845738|NCT00076336|471063489|FG001|Overall Study|Adverse Event|4|||
130845739|NCT00076336|471063488|FG000|Overall Study|Lost to Follow-up|4|||
130845740|NCT00076336|471063489|FG001|Overall Study|Lost to Follow-up|4|||
130845741|NCT00076336|471063488|FG000|Overall Study|Non-Compliance|2|||
130845742|NCT00076336|471063489|FG001|Overall Study|Non-Compliance|0|||
130845743|NCT00076336|471063488|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
130845744|NCT00076336|471063489|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
130845745|NCT00076336|471063488|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
130845746|NCT00076336|471063489|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
130845747|NCT00076336|471063488|FG000|Overall Study|Liver Transplantation|3|||
130845748|NCT00076336|471063489|FG001|Overall Study|Liver Transplantation|3|||
130845749|NCT00076336|471063488|FG000|Overall Study|Virologic Breakthrough|14|||
130845750|NCT00076336|471063489|FG001|Overall Study|Virologic Breakthrough|16|||
130845751|NCT00076336|471063488|FG000|Overall Study|Treatment failure|4|||
130845752|NCT00076336|471063489|FG001|Overall Study|Treatment failure|5|||
130845753|NCT01224821|471063494|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
130845754|NCT01224821|471063494|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
130845755|NCT01224821|471063494|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
130845756|NCT01224821|471063494|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
130845757|NCT01224821|471063494|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
130845758|NCT01224821|471063494|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
130845759|NCT01224821|471063494|FG000|Long-Term Follow-Up|Death|2|||
130845760|NCT01224821|471063494|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
130845761|NCT01340937|471063495|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
130845762|NCT01340937|471063496|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
130845763|NCT01340937|471063497|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
130845764|NCT01340937|471063498|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
130845765|NCT01340937|471063495|FG000|Period 1: Infant Series|Adverse Event|0|||
130845766|NCT01340937|471063496|FG001|Period 1: Infant Series|Adverse Event|1|||
130845767|NCT01340937|471063497|FG002|Period 1: Infant Series|Adverse Event|4|||
130845768|NCT01340937|471063498|FG003|Period 1: Infant Series|Adverse Event|0|||
130845769|NCT01340937|471063495|FG000|Period 1: Infant Series|Death|2|||
130845770|NCT01340937|471063496|FG001|Period 1: Infant Series|Death|0|||
130845771|NCT01340937|471063497|FG002|Period 1: Infant Series|Death|2|||
130845772|NCT01340937|471063498|FG003|Period 1: Infant Series|Death|0|||
130845773|NCT01340937|471063495|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
130845774|NCT01340937|471063496|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
130845775|NCT01340937|471063497|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
130845776|NCT01340937|471063498|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
130845777|NCT01340937|471063495|FG000|Period 1: Infant Series|Physician Decision|2|||
130845778|NCT01340937|471063496|FG001|Period 1: Infant Series|Physician Decision|3|||
130845779|NCT01340937|471063497|FG002|Period 1: Infant Series|Physician Decision|1|||
130845780|NCT01340937|471063498|FG003|Period 1: Infant Series|Physician Decision|0|||
130845781|NCT01340937|471063495|FG000|Period 1: Infant Series|Protocol Violation|1|||
130845782|NCT01340937|471063496|FG001|Period 1: Infant Series|Protocol Violation|4|||
130845783|NCT01340937|471063497|FG002|Period 1: Infant Series|Protocol Violation|4|||
130845784|NCT01340937|471063498|FG003|Period 1: Infant Series|Protocol Violation|3|||
130845785|NCT01340937|471063495|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
130845786|NCT01340937|471063496|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
130845787|NCT01340937|471063497|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
130845788|NCT01340937|471063498|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
130845789|NCT01340937|471063495|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
130845790|NCT01340937|471063496|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
130845791|NCT01340937|471063497|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
130845792|NCT01340937|471063498|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
130845793|NCT01340937|471063495|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
130845794|NCT01340937|471063496|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
130845795|NCT01340937|471063497|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
130845796|NCT01340937|471063498|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
130845797|NCT01340937|471063495|FG000|Period 2: Interim Period|Adverse Event|1|||
130845798|NCT01340937|471063496|FG001|Period 2: Interim Period|Adverse Event|0|||
130845799|NCT01340937|471063497|FG002|Period 2: Interim Period|Adverse Event|1|||
130845800|NCT01340937|471063498|FG003|Period 2: Interim Period|Adverse Event|0|||
130845801|NCT01340937|471063495|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
130845802|NCT01340937|471063496|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
130845803|NCT01340937|471063497|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
130845804|NCT01340937|471063498|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
130845805|NCT01340937|471063495|FG000|Period 2: Interim Period|Physician Decision|0|||
130845806|NCT01340937|471063496|FG001|Period 2: Interim Period|Physician Decision|1|||
130845807|NCT01340937|471063497|FG002|Period 2: Interim Period|Physician Decision|1|||
130845808|NCT01340937|471063498|FG003|Period 2: Interim Period|Physician Decision|0|||
130845809|NCT01340937|471063495|FG000|Period 2: Interim Period|Protocol Violation|5|||
130845810|NCT01340937|471063496|FG001|Period 2: Interim Period|Protocol Violation|3|||
130845811|NCT01340937|471063497|FG002|Period 2: Interim Period|Protocol Violation|6|||
130845812|NCT01340937|471063498|FG003|Period 2: Interim Period|Protocol Violation|3|||
130845813|NCT01340937|471063495|FG000|Period 2: Interim Period|Technical problems|4|||
130845814|NCT01340937|471063496|FG001|Period 2: Interim Period|Technical problems|4|||
130845815|NCT01340937|471063497|FG002|Period 2: Interim Period|Technical problems|6|||
130845816|NCT01340937|471063498|FG003|Period 2: Interim Period|Technical problems|3|||
130845817|NCT01340937|471063495|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
130845818|NCT01340937|471063496|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
130845819|NCT01340937|471063497|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
130845820|NCT01340937|471063498|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
130845821|NCT01340937|471063495|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
130845822|NCT01340937|471063496|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
130845823|NCT01340937|471063497|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
130845824|NCT01340937|471063498|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
130845825|NCT01340937|471063495|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
130845826|NCT01340937|471063496|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
130845827|NCT01340937|471063497|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
130845828|NCT01340937|471063498|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
130845829|NCT01340937|471063495|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
130845830|NCT01340937|471063496|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
130845831|NCT01340937|471063497|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
130845832|NCT01340937|471063498|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
130845833|NCT02469415|471063499|FG000|Overall Study|Withdrawal by Subject|1|||
130845834|NCT02469415|471063499|FG000|Overall Study|Investigational agent placed on hold|2|||
130845835|NCT02119156|471063500|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
130845836|NCT02119156|471063501|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
130845837|NCT02119156|471063502|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
130845838|NCT02119156|471063500|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
130845839|NCT02119156|471063501|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
130845840|NCT02119156|471063502|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
130845841|NCT02119156|471063500|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
130845842|NCT02119156|471063501|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
130845843|NCT02119156|471063502|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
130845844|NCT02119156|471063500|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
130845845|NCT02119156|471063501|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
130845846|NCT02119156|471063502|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
130845847|NCT02119156|471063500|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
130845848|NCT02119156|471063501|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
130845849|NCT02119156|471063502|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
130845850|NCT00350623|471063505|FG000|Overall Study|Lost to Follow-up|8|||
130845851|NCT00350623|471063506|FG001|Overall Study|Lost to Follow-up|3|||
130845852|NCT00350623|471063507|FG002|Overall Study|Lost to Follow-up|4|||
130845853|NCT00350623|471063505|FG000|Overall Study|Withdrawal by Subject|0|||
130845854|NCT00350623|471063506|FG001|Overall Study|Withdrawal by Subject|1|||
130845855|NCT00350623|471063507|FG002|Overall Study|Withdrawal by Subject|1|||
130845856|NCT00350623|471063505|FG000|Overall Study|patient traveling outside the country|0|||
130845857|NCT00350623|471063506|FG001|Overall Study|patient traveling outside the country|0|||
130845858|NCT00350623|471063507|FG002|Overall Study|patient traveling outside the country|1|||
130845859|NCT00623545|471063508|FG000|Overall Study|Adverse Event|6|||
130845860|NCT00623545|471063508|FG000|Overall Study|Withdrawal by Subject|4|||
130845861|NCT02685748|471063509|FG000|Overall Study|Withdrawal by Subject|3|||
130845862|NCT02685748|471063510|FG001|Overall Study|Withdrawal by Subject|2|||
130845863|NCT04126564|471063511|FG000|Overall Study|Withdrawal by Subject|0|||
130845864|NCT04126564|471063512|FG001|Overall Study|Withdrawal by Subject|2|||
130845865|NCT04126564|471063511|FG000|Overall Study|Lost to Follow-up|0|||
130845866|NCT04126564|471063512|FG001|Overall Study|Lost to Follow-up|1|||
130845867|NCT03500172|471063513|FG000|Period 1: Baseline Randomization|Death|0|||
130845868|NCT03500172|471063514|FG001|Period 1: Baseline Randomization|Death|0|||
130845869|NCT03500172|471063515|FG002|Period 1: Baseline Randomization|Death|0|||
130845870|NCT03500172|471063516|FG003|Period 1: Baseline Randomization|Death|0|||
130845871|NCT03500172|471063517|FG004|Period 1: Baseline Randomization|Death|0|||
130845872|NCT03500172|471063518|FG005|Period 1: Baseline Randomization|Death|0|||
130845873|NCT03500172|471063519|FG006|Period 1: Baseline Randomization|Death|0|||
130845874|NCT03500172|471063520|FG007|Period 1: Baseline Randomization|Death|0|||
130845875|NCT03500172|471063521|FG008|Period 1: Baseline Randomization|Death|0|||
130845876|NCT03500172|471063522|FG009|Period 1: Baseline Randomization|Death|2|||
130845877|NCT03500172|471063523|FG010|Period 1: Baseline Randomization|Death|0|||
130845878|NCT03500172|471063513|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
130845879|NCT03500172|471063514|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
130845880|NCT03500172|471063515|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
130845881|NCT03500172|471063516|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
130845882|NCT03500172|471063517|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
130845883|NCT03500172|471063518|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
130845884|NCT03500172|471063519|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
130845885|NCT03500172|471063520|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
130845886|NCT03500172|471063521|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
130845887|NCT03500172|471063522|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
130845888|NCT03500172|471063523|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
130845889|NCT03500172|471063513|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
130845890|NCT03500172|471063514|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
130845891|NCT03500172|471063515|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
130845892|NCT03500172|471063516|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
130845893|NCT03500172|471063517|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
130845894|NCT03500172|471063518|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
130845895|NCT03500172|471063519|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
130845896|NCT03500172|471063520|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
130845897|NCT03500172|471063521|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
130845898|NCT03500172|471063522|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
130845899|NCT03500172|471063523|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
130845900|NCT03500172|471063513|FG000|Period 2: Re-Randomization|Death|0|||
130845901|NCT03500172|471063514|FG001|Period 2: Re-Randomization|Death|0|||
130845902|NCT03500172|471063515|FG002|Period 2: Re-Randomization|Death|0|||
130845903|NCT03500172|471063516|FG003|Period 2: Re-Randomization|Death|4|||
130845904|NCT03500172|471063517|FG004|Period 2: Re-Randomization|Death|2|||
130845905|NCT03500172|471063518|FG005|Period 2: Re-Randomization|Death|0|||
130845906|NCT03500172|471063519|FG006|Period 2: Re-Randomization|Death|5|||
130845907|NCT03500172|471063520|FG007|Period 2: Re-Randomization|Death|2|||
130845908|NCT03500172|471063521|FG008|Period 2: Re-Randomization|Death|0|||
130845909|NCT03500172|471063522|FG009|Period 2: Re-Randomization|Death|0|||
130845910|NCT03500172|471063523|FG010|Period 2: Re-Randomization|Death|0|||
130845911|NCT01974752|471063526|FG000|Overall Study|Death|33|||
130845912|NCT01974752|471063527|FG001|Overall Study|Death|11|||
130845913|NCT01974752|471063526|FG000|Overall Study|Lost to Follow-up|2|||
130845914|NCT01974752|471063527|FG001|Overall Study|Lost to Follow-up|0|||
130845915|NCT01974752|471063526|FG000|Overall Study|Withdrawal by Subject|2|||
130845916|NCT01974752|471063527|FG001|Overall Study|Withdrawal by Subject|3|||
130845917|NCT01974752|471063526|FG000|Overall Study|Other Eligibility Criteria|0|||
130845918|NCT01974752|471063527|FG001|Overall Study|Other Eligibility Criteria|1|||
130845919|NCT02435680|471063529|FG000|Overall Study|Physician Decision|3|||
130845920|NCT02435680|471063530|FG001|Overall Study|Physician Decision|0|||
130845921|NCT02435680|471063531|FG002|Overall Study|Physician Decision|0|||
130845922|NCT02435680|471063529|FG000|Overall Study|subject / guardian decision|0|||
130845923|NCT02435680|471063530|FG001|Overall Study|subject / guardian decision|3|||
130845924|NCT02435680|471063531|FG002|Overall Study|subject / guardian decision|2|||
130845925|NCT02435680|471063529|FG000|Overall Study|Adverse Event|8|||
130845926|NCT02435680|471063530|FG001|Overall Study|Adverse Event|3|||
130845927|NCT02435680|471063531|FG002|Overall Study|Adverse Event|2|||
130845928|NCT02435680|471063529|FG000|Overall Study|progressive disease|10|||
130845929|NCT02435680|471063530|FG001|Overall Study|progressive disease|7|||
130845930|NCT02435680|471063531|FG002|Overall Study|progressive disease|11|||
130845931|NCT02435680|471063529|FG000|Overall Study|not treated|0|||
130845932|NCT02435680|471063530|FG001|Overall Study|not treated|0|||
130845933|NCT02435680|471063531|FG002|Overall Study|not treated|1|||
130845934|NCT00330928|471063534|FG000|Overall Study|Lost to Follow-up|6|||
130845935|NCT00330928|471063534|FG000|Overall Study|Physician Decision|9|||
130845936|NCT00330928|471063534|FG000|Overall Study|Death|1|||
130845937|NCT00330928|471063534|FG000|Overall Study|IVUS could not be performed.|1|||
130845938|NCT03028480|471063535|FG000|Overall Study|No revisit after the first prescription date|2|||
130845939|NCT03028480|471063535|FG000|Overall Study|Did not use the drug|1|||
130845940|NCT03028480|471063535|FG000|Overall Study|Violation of the enrollment deadline|10|||
130845941|NCT03028480|471063535|FG000|Overall Study|Case report forms were not collected|21|||
130845942|NCT02585830|471063540|FG000|Overall Study|Withdrawal by Subject|3|||
130845943|NCT00919867|471063543|FG000|First Intervention|Withdrawal by Subject|0|||
130845944|NCT00919867|471063544|FG001|First Intervention|Withdrawal by Subject|0|||
130845945|NCT00919867|471063545|FG002|First Intervention|Withdrawal by Subject|1|||
130845946|NCT00919867|471063546|FG003|First Intervention|Withdrawal by Subject|0|||
130845947|NCT00919867|471063547|FG004|First Intervention|Withdrawal by Subject|0|||
130845948|NCT00919867|471063548|FG005|First Intervention|Withdrawal by Subject|0|||
130845949|NCT00919867|471063543|FG000|First Intervention|Physician Decision|0|||
130845950|NCT00919867|471063544|FG001|First Intervention|Physician Decision|0|||
130845951|NCT00919867|471063545|FG002|First Intervention|Physician Decision|0|||
130845952|NCT00919867|471063546|FG003|First Intervention|Physician Decision|0|||
130845953|NCT00919867|471063547|FG004|First Intervention|Physician Decision|0|||
130845954|NCT00919867|471063548|FG005|First Intervention|Physician Decision|1|||
130845955|NCT00435162|471063549|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
130845956|NCT00435162|471063550|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
130845957|NCT00435162|471063551|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
130845958|NCT00435162|471063552|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
130845959|NCT00435162|471063553|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
130845960|NCT00435162|471063554|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
130845961|NCT01765426|471063557|FG000|Overall Study|Lost to Follow-up|0|||
130845962|NCT01765426|471063558|FG001|Overall Study|Lost to Follow-up|1|||
130845963|NCT01765426|471063559|FG002|Overall Study|Lost to Follow-up|0|||
130845964|NCT01765426|471063560|FG003|Overall Study|Lost to Follow-up|0|||
130845965|NCT01510184|471063561|FG000|Overall Study|Sponsor discretion|28|||
130845966|NCT01510184|471063562|FG001|Overall Study|Sponsor discretion|28|||
130845967|NCT01510184|471063561|FG000|Overall Study|Death|1|||
130845968|NCT01510184|471063562|FG001|Overall Study|Death|2|||
130845969|NCT01510184|471063561|FG000|Overall Study|Withdrawal by Subject|1|||
130845970|NCT01510184|471063562|FG001|Overall Study|Withdrawal by Subject|4|||
130845971|NCT01510184|471063561|FG000|Overall Study|Other|0|||
130845972|NCT01510184|471063562|FG001|Overall Study|Other|1|||
130845973|NCT01484834|471063573|FG000|Overall Study|Lost to Follow-up|5|||
130845974|NCT01484834|471063574|FG001|Overall Study|Lost to Follow-up|8|||
130845975|NCT01484834|471063575|FG002|Overall Study|Lost to Follow-up|1|||
130845976|NCT01484834|471063576|FG003|Overall Study|Lost to Follow-up|4|||
130845977|NCT00747344|471063577|FG000|Controlled Period|Adverse Event|3|||
130845978|NCT00747344|471063578|FG001|Controlled Period|Adverse Event|0|||
130845979|NCT00747344|471063579|FG002|Controlled Period|Adverse Event|0|||
130845980|NCT00747344|471063580|FG003|Controlled Period|Adverse Event|0|||
130845981|NCT00747344|471063577|FG000|Controlled Period|Lack of Efficacy|2|||
130845982|NCT00747344|471063578|FG001|Controlled Period|Lack of Efficacy|1|||
130845983|NCT00747344|471063579|FG002|Controlled Period|Lack of Efficacy|0|||
130845984|NCT00747344|471063580|FG003|Controlled Period|Lack of Efficacy|0|||
130845985|NCT00747344|471063577|FG000|Controlled Period|Other|0|||
130845986|NCT00747344|471063578|FG001|Controlled Period|Other|3|||
130845987|NCT00747344|471063579|FG002|Controlled Period|Other|0|||
130845988|NCT00747344|471063580|FG003|Controlled Period|Other|0|||
130845989|NCT00747344|471063577|FG000|After Controlled Period|Adverse Event|0|||
130845990|NCT00747344|471063578|FG001|After Controlled Period|Adverse Event|0|||
130845991|NCT00747344|471063579|FG002|After Controlled Period|Adverse Event|0|||
130845992|NCT00747344|471063580|FG003|After Controlled Period|Adverse Event|1|||
130845993|NCT00765882|471063581|FG000|Overall Study|Adverse Event|10|||
130845994|NCT00765882|471063582|FG001|Overall Study|Adverse Event|21|||
130845995|NCT00765882|471063583|FG002|Overall Study|Adverse Event|20|||
130845996|NCT00765882|471063581|FG000|Overall Study|Lack of Efficacy|4|||
130845997|NCT00765882|471063582|FG001|Overall Study|Lack of Efficacy|0|||
130845998|NCT00765882|471063583|FG002|Overall Study|Lack of Efficacy|1|||
130845999|NCT00765882|471063581|FG000|Overall Study|Protocol Violation|4|||
130846000|NCT00765882|471063582|FG001|Overall Study|Protocol Violation|3|||
130846001|NCT00765882|471063583|FG002|Overall Study|Protocol Violation|1|||
130846002|NCT00765882|471063581|FG000|Overall Study|Withdrawal by Subject|2|||
130846003|NCT00765882|471063582|FG001|Overall Study|Withdrawal by Subject|6|||
130846004|NCT00765882|471063583|FG002|Overall Study|Withdrawal by Subject|6|||
130846005|NCT00765882|471063581|FG000|Overall Study|Lost to Follow-up|1|||
130846006|NCT00765882|471063582|FG001|Overall Study|Lost to Follow-up|9|||
130846007|NCT00765882|471063583|FG002|Overall Study|Lost to Follow-up|6|||
130846008|NCT00765882|471063581|FG000|Overall Study|Other Reason|3|||
130846009|NCT00765882|471063582|FG001|Overall Study|Other Reason|1|||
130846010|NCT00765882|471063583|FG002|Overall Study|Other Reason|2|||
130846011|NCT02231762|471063584|FG000|Combination Phase|Adverse Event|10|||
130846012|NCT02231762|471063585|FG001|Combination Phase|Adverse Event|0|||
130846013|NCT02231762|471063586|FG002|Combination Phase|Adverse Event|0|||
130846014|NCT02231762|471063587|FG003|Combination Phase|Adverse Event|0|||
130846015|NCT02231762|471063584|FG000|Combination Phase|Withdrawal by Subject|2|||
130846016|NCT02231762|471063585|FG001|Combination Phase|Withdrawal by Subject|0|||
130846017|NCT02231762|471063586|FG002|Combination Phase|Withdrawal by Subject|0|||
130846018|NCT02231762|471063587|FG003|Combination Phase|Withdrawal by Subject|0|||
130846019|NCT02231762|471063584|FG000|Combination Phase|Disease Progression|6|||
130846020|NCT02231762|471063585|FG001|Combination Phase|Disease Progression|0|||
130846021|NCT02231762|471063586|FG002|Combination Phase|Disease Progression|0|||
130846022|NCT02231762|471063587|FG003|Combination Phase|Disease Progression|0|||
130846023|NCT02231762|471063584|FG000|Combination Phase|Did not meet inclusion criteria|1|||
130846024|NCT02231762|471063585|FG001|Combination Phase|Did not meet inclusion criteria|0|||
130846025|NCT02231762|471063586|FG002|Combination Phase|Did not meet inclusion criteria|0|||
130846026|NCT02231762|471063587|FG003|Combination Phase|Did not meet inclusion criteria|0|||
130846027|NCT02231762|471063584|FG000|Combination Phase|Protocol Violation|1|||
130846028|NCT02231762|471063585|FG001|Combination Phase|Protocol Violation|0|||
130846029|NCT02231762|471063586|FG002|Combination Phase|Protocol Violation|0|||
130846030|NCT02231762|471063587|FG003|Combination Phase|Protocol Violation|0|||
130846031|NCT02231762|471063584|FG000|Maintenance Phase|Disease progression|0|||
130846032|NCT02231762|471063585|FG001|Maintenance Phase|Disease progression|3|||
130846033|NCT02231762|471063586|FG002|Maintenance Phase|Disease progression|4|||
130846034|NCT02231762|471063587|FG003|Maintenance Phase|Disease progression|3|||
130846035|NCT02231762|471063584|FG000|Maintenance Phase|Adverse Event|0|||
130846036|NCT02231762|471063585|FG001|Maintenance Phase|Adverse Event|0|||
130846037|NCT02231762|471063586|FG002|Maintenance Phase|Adverse Event|1|||
130846038|NCT02231762|471063587|FG003|Maintenance Phase|Adverse Event|2|||
130846039|NCT02214225|471063588|FG000|Overall Study|Lost to Follow-up|46|||
130846040|NCT02214225|471063589|FG001|Overall Study|Lost to Follow-up|18|||
130846041|NCT02214225|471063590|FG002|Overall Study|Lost to Follow-up|18|||
130846042|NCT02214225|471063588|FG000|Overall Study|Withdrawal by Subject|2|||
130846043|NCT02214225|471063589|FG001|Overall Study|Withdrawal by Subject|0|||
130846044|NCT02214225|471063590|FG002|Overall Study|Withdrawal by Subject|2|||
130846045|NCT02214225|471063588|FG000|Overall Study|Death|5|||
130846046|NCT02214225|471063589|FG001|Overall Study|Death|0|||
130846047|NCT02214225|471063590|FG002|Overall Study|Death|1|||
130846048|NCT02214225|471063588|FG000|Overall Study|randomized in error, not vaccinated|2|||
130846049|NCT02214225|471063589|FG001|Overall Study|randomized in error, not vaccinated|1|||
130846050|NCT02214225|471063590|FG002|Overall Study|randomized in error, not vaccinated|1|||
130846051|NCT03754582|471063591|FG000|Treatment Phase|Adverse Event|0|||
130846052|NCT03754582|471063592|FG001|Treatment Phase|Adverse Event|1|||
130846053|NCT03754582|471063593|FG002|Treatment Phase|Adverse Event|0|||
130846054|NCT03754582|471063591|FG000|Follow-up Phase|Other|0|||
130846055|NCT03754582|471063592|FG001|Follow-up Phase|Other|0|||
130846056|NCT03754582|471063593|FG002|Follow-up Phase|Other|1|||
130846057|NCT02680574|471063594|FG000|Overall Study|Death|137|||
130846058|NCT02680574|471063595|FG001|Overall Study|Death|137|||
130846059|NCT02680574|471063594|FG000|Overall Study|Withdrawal by Subject|17|||
130846060|NCT02680574|471063595|FG001|Overall Study|Withdrawal by Subject|9|||
130846061|NCT02680574|471063594|FG000|Overall Study|Lost to Follow-up|4|||
130846062|NCT02680574|471063595|FG001|Overall Study|Lost to Follow-up|6|||
130846063|NCT00681564|471063596|FG000|Overall Study|Lost to Follow-up|6|||
130846064|NCT00681564|471063597|FG001|Overall Study|Lost to Follow-up|6|||
130846065|NCT00681564|471063596|FG000|Overall Study|Withdrawal by Subject|0|||
130846066|NCT00681564|471063597|FG001|Overall Study|Withdrawal by Subject|1|||
130846067|NCT00681564|471063596|FG000|Overall Study|Death|0|||
130846068|NCT00681564|471063597|FG001|Overall Study|Death|1|||
130846069|NCT01009346|471063600|FG000|Overall Study|Adverse Event|4|||
130846070|NCT01253265|471063602|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
130846071|NCT01253265|471063603|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
130846072|NCT01253265|471063604|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
130846073|NCT01253265|471063605|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
130846074|NCT01253265|471063606|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
130846075|NCT01253265|471063602|FG000|Overall Study|Withdrawal by Subject|0|||
130846076|NCT01253265|471063603|FG001|Overall Study|Withdrawal by Subject|0|||
130846077|NCT01253265|471063604|FG002|Overall Study|Withdrawal by Subject|0|||
130846078|NCT01253265|471063605|FG003|Overall Study|Withdrawal by Subject|0|||
130846079|NCT01253265|471063606|FG004|Overall Study|Withdrawal by Subject|1|||
130846080|NCT00541099|471063607|FG000|Overall Study|Ineligible|3|||
130846081|NCT00066469|471063609|FG000|Overall Study|Death|3|||
130846082|NCT00066469|471063609|FG000|Overall Study|Lack of Efficacy|9|||
130846083|NCT00066469|471063609|FG000|Overall Study|Lost to Follow-up|1|||
130846084|NCT00066469|471063609|FG000|Overall Study|Physician Decision|1|||
130846085|NCT00066469|471063609|FG000|Overall Study|Withdrawal by Subject|1|||
130846086|NCT00066469|471063609|FG000|Overall Study|ineligible|1|||
130846087|NCT03271047|471063610|FG000|Phase 1b: Dose Finding Period|Death|8|||
130846088|NCT03271047|471063611|FG001|Phase 1b: Dose Finding Period|Death|8|||
130846089|NCT03271047|471063612|FG002|Phase 1b: Dose Finding Period|Death|0|||
130846090|NCT03271047|471063613|FG003|Phase 1b: Dose Finding Period|Death|0|||
130846091|NCT03271047|471063610|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
130846092|NCT03271047|471063611|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
130846093|NCT03271047|471063612|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
130846094|NCT03271047|471063613|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
130846095|NCT03271047|471063610|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
130846096|NCT03271047|471063611|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
130846097|NCT03271047|471063612|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
130846098|NCT03271047|471063613|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
130846099|NCT03271047|471063610|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
130846100|NCT03271047|471063611|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
130846101|NCT03271047|471063612|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
130846102|NCT03271047|471063613|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
130846103|NCT03271047|471063610|FG000|Randomized Phase 2 Period|Other|0|||
130846104|NCT03271047|471063611|FG001|Randomized Phase 2 Period|Other|0|||
130846105|NCT03271047|471063612|FG002|Randomized Phase 2 Period|Other|0|||
130846106|NCT03271047|471063613|FG003|Randomized Phase 2 Period|Other|1|||
130846107|NCT03271047|471063610|FG000|Randomized Phase 2 Period|Death|0|||
130846108|NCT03271047|471063611|FG001|Randomized Phase 2 Period|Death|0|||
130846109|NCT03271047|471063612|FG002|Randomized Phase 2 Period|Death|20|||
130846110|NCT03271047|471063613|FG003|Randomized Phase 2 Period|Death|21|||
130846111|NCT03271047|471063610|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
130846112|NCT03271047|471063611|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
130846113|NCT03271047|471063612|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
130846114|NCT03271047|471063613|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
130846115|NCT03271047|471063610|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
130846116|NCT03271047|471063611|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
130846117|NCT03271047|471063612|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
130846118|NCT03271047|471063613|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
130846119|NCT03271047|471063610|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
130846120|NCT03271047|471063611|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
130846121|NCT03271047|471063612|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
130846122|NCT03271047|471063613|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
130846123|NCT00711802|471063614|FG000|Overall Study|Not treated (no further detail)|2|||
130846124|NCT00711802|471063615|FG001|Overall Study|Not treated (no further detail)|1|||
130846125|NCT00711802|471063616|FG002|Overall Study|Not treated (no further detail)|2|||
130846126|NCT00711802|471063617|FG003|Overall Study|Not treated (no further detail)|0|||
130846127|NCT00711802|471063618|FG004|Overall Study|Not treated (no further detail)|2|||
130846128|NCT00711802|471063619|FG005|Overall Study|Not treated (no further detail)|0|||
130846129|NCT00711802|471063620|FG006|Overall Study|Not treated (no further detail)|0|||
130846130|NCT00711802|471063621|FG007|Overall Study|Not treated (no further detail)|0|||
130846131|NCT00711802|471063614|FG000|Overall Study|Adverse Event|0|||
130846132|NCT00711802|471063615|FG001|Overall Study|Adverse Event|0|||
130846133|NCT00711802|471063616|FG002|Overall Study|Adverse Event|0|||
130846134|NCT00711802|471063617|FG003|Overall Study|Adverse Event|0|||
130846135|NCT00711802|471063618|FG004|Overall Study|Adverse Event|1|||
130846136|NCT00711802|471063619|FG005|Overall Study|Adverse Event|1|||
130846137|NCT00711802|471063620|FG006|Overall Study|Adverse Event|0|||
130846138|NCT00711802|471063621|FG007|Overall Study|Adverse Event|0|||
130846139|NCT00711802|471063614|FG000|Overall Study|Microbiological failure|0|||
130846140|NCT00711802|471063615|FG001|Overall Study|Microbiological failure|1|||
130846141|NCT00711802|471063616|FG002|Overall Study|Microbiological failure|0|||
130846142|NCT00711802|471063617|FG003|Overall Study|Microbiological failure|0|||
130846143|NCT00711802|471063618|FG004|Overall Study|Microbiological failure|0|||
130846144|NCT00711802|471063619|FG005|Overall Study|Microbiological failure|1|||
130846145|NCT00711802|471063620|FG006|Overall Study|Microbiological failure|0|||
130846146|NCT00711802|471063621|FG007|Overall Study|Microbiological failure|0|||
130846147|NCT00711802|471063614|FG000|Overall Study|Protocol Violation|0|||
130846148|NCT00711802|471063615|FG001|Overall Study|Protocol Violation|0|||
130846149|NCT00711802|471063616|FG002|Overall Study|Protocol Violation|0|||
130846150|NCT00711802|471063617|FG003|Overall Study|Protocol Violation|1|||
130846151|NCT00711802|471063618|FG004|Overall Study|Protocol Violation|0|||
130846152|NCT00711802|471063619|FG005|Overall Study|Protocol Violation|0|||
130846153|NCT00711802|471063620|FG006|Overall Study|Protocol Violation|0|||
130846154|NCT00711802|471063621|FG007|Overall Study|Protocol Violation|0|||
130846155|NCT00711802|471063614|FG000|Overall Study|Physician Decision|0|||
130846156|NCT00711802|471063615|FG001|Overall Study|Physician Decision|2|||
130846157|NCT00711802|471063616|FG002|Overall Study|Physician Decision|0|||
130846158|NCT00711802|471063617|FG003|Overall Study|Physician Decision|0|||
130846159|NCT00711802|471063618|FG004|Overall Study|Physician Decision|0|||
130846160|NCT00711802|471063619|FG005|Overall Study|Physician Decision|0|||
130846161|NCT00711802|471063620|FG006|Overall Study|Physician Decision|0|||
130846162|NCT00711802|471063621|FG007|Overall Study|Physician Decision|0|||
130846163|NCT00711802|471063614|FG000|Overall Study|Withdrawal by Subject|0|||
130846164|NCT00711802|471063615|FG001|Overall Study|Withdrawal by Subject|1|||
130846165|NCT00711802|471063616|FG002|Overall Study|Withdrawal by Subject|0|||
130846166|NCT00711802|471063617|FG003|Overall Study|Withdrawal by Subject|1|||
130846167|NCT00711802|471063618|FG004|Overall Study|Withdrawal by Subject|0|||
130846168|NCT00711802|471063619|FG005|Overall Study|Withdrawal by Subject|0|||
130846169|NCT00711802|471063620|FG006|Overall Study|Withdrawal by Subject|0|||
130846170|NCT00711802|471063621|FG007|Overall Study|Withdrawal by Subject|0|||
130846171|NCT00711802|471063614|FG000|Overall Study|Lost to Follow-up|0|||
130846172|NCT00711802|471063615|FG001|Overall Study|Lost to Follow-up|0|||
130846173|NCT00711802|471063616|FG002|Overall Study|Lost to Follow-up|3|||
130846174|NCT00711802|471063617|FG003|Overall Study|Lost to Follow-up|1|||
130846175|NCT00711802|471063618|FG004|Overall Study|Lost to Follow-up|10|||
130846176|NCT00711802|471063619|FG005|Overall Study|Lost to Follow-up|6|||
130846177|NCT00711802|471063620|FG006|Overall Study|Lost to Follow-up|4|||
130846178|NCT00711802|471063621|FG007|Overall Study|Lost to Follow-up|2|||
130846179|NCT00711802|471063614|FG000|Overall Study|Reason not reported|0|||
130846180|NCT00711802|471063615|FG001|Overall Study|Reason not reported|1|||
130846181|NCT00711802|471063616|FG002|Overall Study|Reason not reported|1|||
130846182|NCT00711802|471063617|FG003|Overall Study|Reason not reported|0|||
130846183|NCT00711802|471063618|FG004|Overall Study|Reason not reported|1|||
130846184|NCT00711802|471063619|FG005|Overall Study|Reason not reported|0|||
130846185|NCT00711802|471063620|FG006|Overall Study|Reason not reported|1|||
130846186|NCT00711802|471063621|FG007|Overall Study|Reason not reported|0|||
130846187|NCT02410824|471063622|FG000|First Intervention (One Week)|Headache|0|||
130846188|NCT02410824|471063623|FG001|First Intervention (One Week)|Headache|1|||
130846189|NCT00392808|471063624|FG000|Overall Study|Lost to Follow-up|3|||
130846190|NCT00392808|471063625|FG001|Overall Study|Lost to Follow-up|2|||
130846191|NCT00392808|471063626|FG002|Overall Study|Lost to Follow-up|1|||
130846192|NCT00392808|471063627|FG003|Overall Study|Lost to Follow-up|2|||
130846193|NCT00392808|471063624|FG000|Overall Study|Unable to withdraw blood|3|||
130846194|NCT00392808|471063625|FG001|Overall Study|Unable to withdraw blood|1|||
130846195|NCT00392808|471063626|FG002|Overall Study|Unable to withdraw blood|1|||
130846196|NCT00392808|471063627|FG003|Overall Study|Unable to withdraw blood|2|||
130846197|NCT02436408|471063628|FG000|Overall Study|Death|1|||
130846198|NCT02649855|471063629|FG000|Overall Study|Refused further treatment|2|||
130846199|NCT02649855|471063630|FG001|Overall Study|Refused further treatment|1|||
130846200|NCT02649855|471063631|FG002|Overall Study|Refused further treatment|1|||
130846201|NCT02649855|471063629|FG000|Overall Study|Withdrew consent|0|||
130846202|NCT02649855|471063630|FG001|Overall Study|Withdrew consent|1|||
130846203|NCT02649855|471063631|FG002|Overall Study|Withdrew consent|0|||
130846204|NCT02649855|471063629|FG000|Overall Study|Switched to alternative treatment|0|||
130846205|NCT02649855|471063630|FG001|Overall Study|Switched to alternative treatment|1|||
130846206|NCT02649855|471063631|FG002|Overall Study|Switched to alternative treatment|1|||
130846207|NCT02649855|471063629|FG000|Overall Study|Principal investigator discretion|0|||
130846208|NCT02649855|471063630|FG001|Overall Study|Principal investigator discretion|1|||
130846209|NCT02649855|471063631|FG002|Overall Study|Principal investigator discretion|1|||
130846210|NCT02649855|471063629|FG000|Overall Study|No treatment, per protocol|1|||
130846211|NCT02649855|471063630|FG001|Overall Study|No treatment, per protocol|0|||
130846212|NCT02649855|471063631|FG002|Overall Study|No treatment, per protocol|0|||
130846213|NCT02649855|471063629|FG000|Overall Study|Initiate new treatment|1|||
130846214|NCT02649855|471063630|FG001|Overall Study|Initiate new treatment|0|||
130846215|NCT02649855|471063631|FG002|Overall Study|Initiate new treatment|0|||
130846216|NCT02782325|471063632|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
130846217|NCT02782325|471063633|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
130846218|NCT02782325|471063634|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
130846219|NCT02782325|471063632|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
130846220|NCT02782325|471063633|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
130846221|NCT02782325|471063634|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
130846222|NCT00657150|471063635|FG000|Overall Study|Adverse Event|19|||
130846223|NCT00657150|471063636|FG001|Overall Study|Adverse Event|10|||
130846224|NCT00657150|471063635|FG000|Overall Study|Non-compliant with protocol|5|||
130846225|NCT00657150|471063636|FG001|Overall Study|Non-compliant with protocol|9|||
130846226|NCT00657150|471063635|FG000|Overall Study|Lost to Follow-up|2|||
130846227|NCT00657150|471063636|FG001|Overall Study|Lost to Follow-up|0|||
130846228|NCT00657150|471063635|FG000|Overall Study|Withdrawal by Subject|51|||
130846229|NCT00657150|471063636|FG001|Overall Study|Withdrawal by Subject|36|||
130846230|NCT00657150|471063635|FG000|Overall Study|Other|38|||
130846231|NCT00657150|471063636|FG001|Overall Study|Other|38|||
130846232|NCT00657150|471063635|FG000|Treatment|Adverse Event|60|||
130846233|NCT00657150|471063636|FG001|Treatment|Adverse Event|53|||
130846234|NCT00657150|471063635|FG000|Treatment|Non-compliant with protocol|10|||
130846235|NCT00657150|471063636|FG001|Treatment|Non-compliant with protocol|9|||
130846236|NCT00657150|471063635|FG000|Treatment|Lost to Follow-up|1|||
130846237|NCT00657150|471063636|FG001|Treatment|Lost to Follow-up|0|||
130846238|NCT00657150|471063635|FG000|Treatment|Withdrawal by Subject|23|||
130846239|NCT00657150|471063636|FG001|Treatment|Withdrawal by Subject|20|||
130846240|NCT00657150|471063635|FG000|Treatment|Other|13|||
130846241|NCT00657150|471063636|FG001|Treatment|Other|15|||
130846242|NCT02513823|471063647|FG000|Overall Study|Lost to Follow-up|4|||
130846243|NCT02513823|471063647|FG000|Overall Study|Physician Decision|1|||
130846244|NCT02743780|471063652|FG000|Part 3 (7 Days)|Adverse Event|0|||
130846245|NCT02743780|471063653|FG001|Part 3 (7 Days)|Adverse Event|0|||
130846246|NCT02743780|471063654|FG002|Part 3 (7 Days)|Adverse Event|1|||
130846247|NCT02743780|471063655|FG003|Part 3 (7 Days)|Adverse Event|0|||
130846248|NCT02743780|471063656|FG004|Part 3 (7 Days)|Adverse Event|0|||
130846249|NCT01294462|471063657|FG000|Overall Study|Lost to Follow-up|1|||
130846250|NCT01294462|471063658|FG001|Overall Study|Lost to Follow-up|0|||
130846251|NCT01294462|471063657|FG000|Overall Study|Withdrawal by Subject|65|||
130846252|NCT01294462|471063658|FG001|Overall Study|Withdrawal by Subject|63|||
130846253|NCT04342689|471063666|FG000|Overall Study|Withdrawal by Subject|32|||
130846254|NCT04342689|471063667|FG001|Overall Study|Withdrawal by Subject|33|||
130846255|NCT04342689|471063666|FG000|Overall Study|Lost to Follow-up|10|||
130846256|NCT04342689|471063667|FG001|Overall Study|Lost to Follow-up|12|||
130846257|NCT01460407|471063670|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
130846258|NCT01460407|471063671|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
130846259|NCT04070326|471063674|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
130846260|NCT04070326|471063675|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
130846261|NCT01367704|471063676|FG000|Overall Study|Lost to Follow-up|47|||
130846262|NCT01367704|471063677|FG001|Overall Study|Lost to Follow-up|161|||
130846263|NCT01400243|471063679|FG000|Overall Study|Protocol Violation|8|||
130846264|NCT01400243|471063680|FG001|Overall Study|Protocol Violation|11|||
130846265|NCT02193087|471063681|FG000|Overall Study|Adverse Event|2|||
130846266|NCT02193087|471063682|FG001|Overall Study|Adverse Event|0|||
130846267|NCT02193087|471063683|FG002|Overall Study|Adverse Event|0|||
130846268|NCT02193087|471063684|FG003|Overall Study|Adverse Event|11|||
130846269|NCT02193087|471063681|FG000|Overall Study|Lost to Follow-up|14|||
130846270|NCT02193087|471063682|FG001|Overall Study|Lost to Follow-up|6|||
130846271|NCT02193087|471063683|FG002|Overall Study|Lost to Follow-up|4|||
130846272|NCT02193087|471063684|FG003|Overall Study|Lost to Follow-up|37|||
130846273|NCT02193087|471063681|FG000|Overall Study|Protocol Violation|2|||
130846274|NCT02193087|471063682|FG001|Overall Study|Protocol Violation|0|||
130846275|NCT02193087|471063683|FG002|Overall Study|Protocol Violation|1|||
130846276|NCT02193087|471063684|FG003|Overall Study|Protocol Violation|2|||
130846277|NCT02193087|471063681|FG000|Overall Study|Withdrawal by Subject|10|||
130846278|NCT02193087|471063682|FG001|Overall Study|Withdrawal by Subject|3|||
130846279|NCT02193087|471063683|FG002|Overall Study|Withdrawal by Subject|1|||
130846280|NCT02193087|471063684|FG003|Overall Study|Withdrawal by Subject|19|||
130846281|NCT02193087|471063681|FG000|Overall Study|Other Reason Not Specified|7|||
130846282|NCT02193087|471063682|FG001|Overall Study|Other Reason Not Specified|2|||
130846283|NCT02193087|471063683|FG002|Overall Study|Other Reason Not Specified|1|||
130846284|NCT02193087|471063684|FG003|Overall Study|Other Reason Not Specified|9|||
130846285|NCT02193087|471063681|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
130846286|NCT02193087|471063682|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
130846287|NCT02193087|471063683|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
130846288|NCT02193087|471063684|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
130846289|NCT04096820|471063685|FG000|Overall Study|Did not return for intervention|2|||
130846290|NCT04096820|471063685|FG000|Overall Study|Death|1|||
130846291|NCT00475865|471063686|FG000|Overall Study|Adverse Event|0|||
130846292|NCT00475865|471063687|FG001|Overall Study|Adverse Event|3|||
130846293|NCT00475865|471063688|FG002|Overall Study|Adverse Event|4|||
130846294|NCT00475865|471063686|FG000|Overall Study|Lack of Efficacy|1|||
130846295|NCT00475865|471063687|FG001|Overall Study|Lack of Efficacy|0|||
130846296|NCT00475865|471063688|FG002|Overall Study|Lack of Efficacy|0|||
130846297|NCT00475865|471063686|FG000|Overall Study|Progressive disease|0|||
130846298|NCT00475865|471063687|FG001|Overall Study|Progressive disease|1|||
130846299|NCT00475865|471063688|FG002|Overall Study|Progressive disease|2|||
130846300|NCT00475865|471063686|FG000|Overall Study|Participant did not wish to continue|1|||
130846301|NCT00475865|471063687|FG001|Overall Study|Participant did not wish to continue|0|||
130846302|NCT00475865|471063688|FG002|Overall Study|Participant did not wish to continue|0|||
130846303|NCT00475865|471063686|FG000|Overall Study|Other than above|0|||
130846304|NCT00475865|471063687|FG001|Overall Study|Other than above|1|||
130846305|NCT00475865|471063688|FG002|Overall Study|Other than above|0|||
130846306|NCT03959982|471065268|FG000|Overall Study|Withdrawal by Subject|1|||
130846307|NCT03959982|471065269|FG001|Overall Study|Withdrawal by Subject|0|||
130846308|NCT03959982|471065268|FG000|Overall Study|Physician Decision|2|||
130846309|NCT03959982|471065269|FG001|Overall Study|Physician Decision|0|||
130846310|NCT03959982|471065268|FG000|Overall Study|Lost to Follow-up|1|||
130846311|NCT03959982|471065269|FG001|Overall Study|Lost to Follow-up|0|||
130846312|NCT00758589|471065270|FG000|Overall Study|Adverse Event|3|||
130846313|NCT00758589|471065271|FG001|Overall Study|Adverse Event|2|||
130846314|NCT00758589|471065272|FG002|Overall Study|Adverse Event|5|||
130846315|NCT00758589|471065273|FG003|Overall Study|Adverse Event|4|||
130846316|NCT00758589|471065270|FG000|Overall Study|Withdrawal by Subject|0|||
130846317|NCT00758589|471065271|FG001|Overall Study|Withdrawal by Subject|1|||
130846318|NCT00758589|471065272|FG002|Overall Study|Withdrawal by Subject|1|||
130846319|NCT00758589|471065273|FG003|Overall Study|Withdrawal by Subject|1|||
130846320|NCT00758589|471065270|FG000|Overall Study|Palm stopped to work|0|||
130846321|NCT00758589|471065271|FG001|Overall Study|Palm stopped to work|0|||
130846322|NCT00758589|471065272|FG002|Overall Study|Palm stopped to work|0|||
130846323|NCT00758589|471065273|FG003|Overall Study|Palm stopped to work|1|||
130846324|NCT05320393|471065274|FG000|Overall Study|Withdrawal by Subject|1|||
130846325|NCT05320393|471065275|FG001|Overall Study|Withdrawal by Subject|0|||
130846326|NCT05320393|471065276|FG002|Overall Study|Withdrawal by Subject|2|||
130846327|NCT05320393|471065274|FG000|Overall Study|Lost to Follow-up|1|||
130846328|NCT05320393|471065275|FG001|Overall Study|Lost to Follow-up|2|||
130846329|NCT05320393|471065276|FG002|Overall Study|Lost to Follow-up|1|||
130846330|NCT05320393|471065274|FG000|Overall Study|Moved; too much driving|0|||
130846331|NCT05320393|471065275|FG001|Overall Study|Moved; too much driving|0|||
130846332|NCT05320393|471065276|FG002|Overall Study|Moved; too much driving|2|||
130846333|NCT05320393|471065274|FG000|Overall Study|Did not receive treatment|0|||
130846334|NCT05320393|471065275|FG001|Overall Study|Did not receive treatment|0|||
130846335|NCT05320393|471065276|FG002|Overall Study|Did not receive treatment|1|||
130846336|NCT03559699|471065280|FG000|Overall Study|Withdrawal by Subject|6|||
130846337|NCT03559699|471065280|FG000|Overall Study|Lost to Follow-up|1|||
130846338|NCT05438602|471065285|FG000|Treatment (15 Days)|Adverse Event|2|||
130846339|NCT05438602|471065286|FG001|Treatment (15 Days)|Adverse Event|1|||
130846340|NCT05438602|471065287|FG002|Treatment (15 Days)|Adverse Event|3|||
130846341|NCT05438602|471065285|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
130846342|NCT05438602|471065286|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
130846343|NCT05438602|471065287|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
130846344|NCT05438602|471065285|FG000|Treatment (15 Days)|Other|0|||
130846345|NCT05438602|471065286|FG001|Treatment (15 Days)|Other|0|||
130846346|NCT05438602|471065287|FG002|Treatment (15 Days)|Other|1|||
130846347|NCT05438602|471065285|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
130846348|NCT05438602|471065286|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
130846349|NCT05438602|471065287|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
130846350|NCT05438602|471065285|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
130846351|NCT05438602|471065286|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
130846352|NCT05438602|471065287|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
130846353|NCT05438602|471065285|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
130846354|NCT05438602|471065286|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
130846355|NCT05438602|471065287|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
130846356|NCT05438602|471065285|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
130846357|NCT05438602|471065286|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
130846358|NCT05438602|471065287|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
130846359|NCT05438602|471065285|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
130846360|NCT05438602|471065286|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
130846361|NCT05438602|471065287|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
130846362|NCT05438602|471065285|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
130846363|NCT05438602|471065286|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
130846364|NCT05438602|471065287|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
130846365|NCT05438602|471065285|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
130846366|NCT05438602|471065286|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
130846367|NCT05438602|471065287|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
130846368|NCT01930890|471065288|FG000|Overall Study|Study Termination|14|||
130846369|NCT01930890|471065289|FG001|Overall Study|Study Termination|28|||
130846370|NCT01930890|471065290|FG002|Overall Study|Study Termination|13|||
130846371|NCT01930890|471065291|FG003|Overall Study|Study Termination|25|||
130846372|NCT01930890|471065288|FG000|Overall Study|Death|0|||
130846373|NCT01930890|471065289|FG001|Overall Study|Death|0|||
130846374|NCT01930890|471065290|FG002|Overall Study|Death|0|||
130846375|NCT01930890|471065291|FG003|Overall Study|Death|1|||
130846376|NCT01930890|471065288|FG000|Overall Study|Investigator Decision|0|||
130846377|NCT01930890|471065289|FG001|Overall Study|Investigator Decision|1|||
130846378|NCT01930890|471065290|FG002|Overall Study|Investigator Decision|0|||
130846379|NCT01930890|471065291|FG003|Overall Study|Investigator Decision|0|||
130846380|NCT01930890|471065288|FG000|Overall Study|Consent Withdrawn|0|||
130846381|NCT01930890|471065289|FG001|Overall Study|Consent Withdrawn|3|||
130846382|NCT01930890|471065290|FG002|Overall Study|Consent Withdrawn|0|||
130846383|NCT01930890|471065291|FG003|Overall Study|Consent Withdrawn|1|||
130846384|NCT01930890|471065288|FG000|Overall Study|Adverse Event|0|||
130846385|NCT01930890|471065289|FG001|Overall Study|Adverse Event|1|||
130846386|NCT01930890|471065290|FG002|Overall Study|Adverse Event|0|||
130846387|NCT01930890|471065291|FG003|Overall Study|Adverse Event|0|||
130846388|NCT01278407|471065292|FG000|Confirmatory Phase|Adverse Event|5|||
130846389|NCT01278407|471065293|FG001|Confirmatory Phase|Adverse Event|10|||
130846390|NCT01278407|471065294|FG002|Confirmatory Phase|Adverse Event|1|||
130846391|NCT01278407|471065295|FG003|Confirmatory Phase|Adverse Event|0|||
130846392|NCT01278407|471065296|FG004|Confirmatory Phase|Adverse Event|0|||
130846393|NCT01278407|471065292|FG000|Confirmatory Phase|Participant's Choice|3|||
130846394|NCT01278407|471065293|FG001|Confirmatory Phase|Participant's Choice|5|||
130846395|NCT01278407|471065294|FG002|Confirmatory Phase|Participant's Choice|3|||
130846396|NCT01278407|471065295|FG003|Confirmatory Phase|Participant's Choice|0|||
130846397|NCT01278407|471065296|FG004|Confirmatory Phase|Participant's Choice|0|||
130846398|NCT01278407|471065292|FG000|Confirmatory Phase|Other|1|||
130846399|NCT01278407|471065293|FG001|Confirmatory Phase|Other|1|||
130846400|NCT01278407|471065294|FG002|Confirmatory Phase|Other|2|||
130846401|NCT01278407|471065295|FG003|Confirmatory Phase|Other|0|||
130846402|NCT01278407|471065296|FG004|Confirmatory Phase|Other|0|||
130846403|NCT01278407|471065292|FG000|Extension Phase|Adverse Event|0|||
130846404|NCT01278407|471065293|FG001|Extension Phase|Adverse Event|0|||
130846405|NCT01278407|471065294|FG002|Extension Phase|Adverse Event|0|||
130846406|NCT01278407|471065295|FG003|Extension Phase|Adverse Event|7|||
130846407|NCT01278407|471065296|FG004|Extension Phase|Adverse Event|16|||
130846408|NCT01278407|471065292|FG000|Extension Phase|Participant's Choice|0|||
130846409|NCT01278407|471065293|FG001|Extension Phase|Participant's Choice|0|||
130846410|NCT01278407|471065294|FG002|Extension Phase|Participant's Choice|0|||
130846411|NCT01278407|471065295|FG003|Extension Phase|Participant's Choice|4|||
130846412|NCT01278407|471065296|FG004|Extension Phase|Participant's Choice|11|||
130846413|NCT01278407|471065292|FG000|Extension Phase|Other|0|||
130846414|NCT01278407|471065293|FG001|Extension Phase|Other|0|||
130846415|NCT01278407|471065294|FG002|Extension Phase|Other|0|||
130846416|NCT01278407|471065295|FG003|Extension Phase|Other|1|||
130846417|NCT01278407|471065296|FG004|Extension Phase|Other|3|||
130846418|NCT04431713|471065305|FG000|Overall Study|Withdrawal by Subject|2|||
130846419|NCT04431713|471065306|FG001|Overall Study|Withdrawal by Subject|0|||
130846420|NCT04431713|471065305|FG000|Overall Study|Death|2|||
130846421|NCT04431713|471065306|FG001|Overall Study|Death|2|||
130846422|NCT02285114|471065308|FG000|Main Phase|Investigator's Discretion|0|||
130846423|NCT02285114|471065309|FG001|Main Phase|Investigator's Discretion|2|||
130846424|NCT02285114|471065310|FG002|Main Phase|Investigator's Discretion|0|||
130846425|NCT02285114|471065311|FG003|Main Phase|Investigator's Discretion|0|||
130846426|NCT02285114|471065312|FG004|Main Phase|Investigator's Discretion|0|||
130846427|NCT02285114|471065313|FG005|Main Phase|Investigator's Discretion|0|||
130846428|NCT02285114|471065308|FG000|Main Phase|Enrolled but Never Treated|1|||
130846429|NCT02285114|471065309|FG001|Main Phase|Enrolled but Never Treated|0|||
130846430|NCT02285114|471065310|FG002|Main Phase|Enrolled but Never Treated|0|||
130846431|NCT02285114|471065311|FG003|Main Phase|Enrolled but Never Treated|0|||
130846432|NCT02285114|471065312|FG004|Main Phase|Enrolled but Never Treated|0|||
130846433|NCT02285114|471065313|FG005|Main Phase|Enrolled but Never Treated|0|||
130846434|NCT02285114|471065308|FG000|Main Phase|Withdrew Consent|0|||
130846435|NCT02285114|471065309|FG001|Main Phase|Withdrew Consent|0|||
130846436|NCT02285114|471065310|FG002|Main Phase|Withdrew Consent|1|||
130846437|NCT02285114|471065311|FG003|Main Phase|Withdrew Consent|0|||
130846438|NCT02285114|471065312|FG004|Main Phase|Withdrew Consent|0|||
130846439|NCT02285114|471065313|FG005|Main Phase|Withdrew Consent|0|||
130846440|NCT02285114|471065308|FG000|Extension Phase|Investigator's Discretion|0|||
130846441|NCT02285114|471065309|FG001|Extension Phase|Investigator's Discretion|0|||
130846442|NCT02285114|471065310|FG002|Extension Phase|Investigator's Discretion|0|||
130846443|NCT02285114|471065311|FG003|Extension Phase|Investigator's Discretion|14|||
130846444|NCT02285114|471065312|FG004|Extension Phase|Investigator's Discretion|1|||
130846445|NCT02285114|471065313|FG005|Extension Phase|Investigator's Discretion|0|||
130846446|NCT02285114|471065308|FG000|Extension Phase|Lost to Follow-up|0|||
130846447|NCT02285114|471065309|FG001|Extension Phase|Lost to Follow-up|0|||
130846448|NCT02285114|471065310|FG002|Extension Phase|Lost to Follow-up|0|||
130846449|NCT02285114|471065311|FG003|Extension Phase|Lost to Follow-up|1|||
130846450|NCT02285114|471065312|FG004|Extension Phase|Lost to Follow-up|1|||
130846451|NCT02285114|471065313|FG005|Extension Phase|Lost to Follow-up|0|||
130846452|NCT02285114|471065308|FG000|Extension Phase|Non-compliance with Study Drug|0|||
130846453|NCT02285114|471065309|FG001|Extension Phase|Non-compliance with Study Drug|0|||
130846454|NCT02285114|471065310|FG002|Extension Phase|Non-compliance with Study Drug|0|||
130846455|NCT02285114|471065311|FG003|Extension Phase|Non-compliance with Study Drug|2|||
130846456|NCT02285114|471065312|FG004|Extension Phase|Non-compliance with Study Drug|0|||
130846457|NCT02285114|471065313|FG005|Extension Phase|Non-compliance with Study Drug|0|||
130846458|NCT02285114|471065308|FG000|Extension Phase|Pregnancy|0|||
130846459|NCT02285114|471065309|FG001|Extension Phase|Pregnancy|0|||
130846460|NCT02285114|471065310|FG002|Extension Phase|Pregnancy|0|||
130846461|NCT02285114|471065311|FG003|Extension Phase|Pregnancy|1|||
130846462|NCT02285114|471065312|FG004|Extension Phase|Pregnancy|0|||
130846463|NCT02285114|471065313|FG005|Extension Phase|Pregnancy|0|||
130846464|NCT01156389|471065319|FG000|Overall Study|Elevated liver enzymes|4|||
130846465|NCT01156389|471065320|FG001|Overall Study|Elevated liver enzymes|0|||
130846466|NCT01156389|471065319|FG000|Overall Study|Vomiting|0|||
130846467|NCT01156389|471065320|FG001|Overall Study|Vomiting|1|||
130846468|NCT04599166|471065328|FG000|Overall Study|Technological failure connecting to study app|80|||
130846469|NCT01777542|471065329|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
130846470|NCT01777542|471065330|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
130846471|NCT00953524|471065332|FG000|Overall Study|Adverse Event|2|||
130846472|NCT00953524|471065333|FG001|Overall Study|Adverse Event|0|||
130846473|NCT00953524|471065334|FG002|Overall Study|Adverse Event|1|||
130846474|NCT00953524|471065335|FG003|Overall Study|Adverse Event|2|||
130846475|NCT00953524|471065332|FG000|Overall Study|Protocol Violation|18|||
130846476|NCT00953524|471065333|FG001|Overall Study|Protocol Violation|10|||
130846477|NCT00953524|471065334|FG002|Overall Study|Protocol Violation|11|||
130846478|NCT00953524|471065335|FG003|Overall Study|Protocol Violation|6|||
130846479|NCT00953524|471065332|FG000|Overall Study|Lost to Follow-up|0|||
130846480|NCT00953524|471065333|FG001|Overall Study|Lost to Follow-up|1|||
130846481|NCT00953524|471065334|FG002|Overall Study|Lost to Follow-up|1|||
130846482|NCT00953524|471065335|FG003|Overall Study|Lost to Follow-up|0|||
130846483|NCT00953524|471065332|FG000|Overall Study|Withdrawal by Subject|2|||
130846484|NCT00953524|471065333|FG001|Overall Study|Withdrawal by Subject|4|||
130846485|NCT00953524|471065334|FG002|Overall Study|Withdrawal by Subject|1|||
130846486|NCT00953524|471065335|FG003|Overall Study|Withdrawal by Subject|0|||
130846487|NCT00869050|471065343|FG000|Overall Study|Screen Failure|3|||
130846488|NCT03554772|471065353|FG000|Overall Study|Lost to Follow-up|0|||
130846489|NCT03554772|471065354|FG001|Overall Study|Lost to Follow-up|0|||
130846490|NCT03554772|471065355|FG002|Overall Study|Lost to Follow-up|0|||
130846491|NCT03554772|471065356|FG003|Overall Study|Lost to Follow-up|2|||
130846492|NCT03276052|471065358|FG000|Overall Study|Withdrawal by Subject|5|||
130846493|NCT03276052|471065358|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
130846494|NCT01145053|471065359|FG000|Overall Study|Adverse Event|22|||
130846495|NCT01145053|471065359|FG000|Overall Study|Lost to Follow-up|28|||
130846496|NCT01145053|471065359|FG000|Overall Study|Withdrawal by Subject|25|||
130846497|NCT01145053|471065359|FG000|Overall Study|Other|18|||
130846498|NCT01994863|471065360|FG000|Period 1|Adverse Event|4|||
130846499|NCT01994863|471065361|FG001|Period 1|Adverse Event|0|||
130846500|NCT01994863|471065360|FG000|Period 1|Withdrawal by Subject|1|||
130846501|NCT01994863|471065361|FG001|Period 1|Withdrawal by Subject|0|||
130846502|NCT01994863|471065360|FG000|Period 1|Trial stopped by sponsor|1|||
130846503|NCT01994863|471065361|FG001|Period 1|Trial stopped by sponsor|3|||
130846504|NCT01994863|471065360|FG000|Period 1|Lack of Efficacy|1|||
130846505|NCT01994863|471065361|FG001|Period 1|Lack of Efficacy|0|||
130846506|NCT01994863|471065360|FG000|Period 2|Adverse Event|0|||
130846507|NCT01994863|471065361|FG001|Period 2|Adverse Event|1|||
130846508|NCT01994863|471065360|FG000|Period 2|Lack of Efficacy|0|||
130846509|NCT01994863|471065361|FG001|Period 2|Lack of Efficacy|2|||
130846510|NCT01994863|471065360|FG000|Period 2|Withdrawal by Subject|1|||
130846511|NCT01994863|471065361|FG001|Period 2|Withdrawal by Subject|1|||
130846512|NCT05136898|471065362|FG000|Overall Study|Adverse Event|2|||
130846513|NCT03060512|471065363|FG000|Overall Study|Adverse Event|4|||
130846514|NCT03060512|471065364|FG001|Overall Study|Adverse Event|6|||
130846515|NCT03060512|471065363|FG000|Overall Study|Lost to Follow-up|1|||
130846516|NCT03060512|471065364|FG001|Overall Study|Lost to Follow-up|1|||
130846517|NCT03060512|471065363|FG000|Overall Study|Withdrawal by Subject|1|||
130846518|NCT03060512|471065364|FG001|Overall Study|Withdrawal by Subject|0|||
130846519|NCT03060512|471065363|FG000|Overall Study|Non-compliance with study medication|1|||
130846520|NCT03060512|471065364|FG001|Overall Study|Non-compliance with study medication|2|||
130846521|NCT03946124|471065365|FG000|Overall Study|Withdrawal by Subject|19|||
130846522|NCT00241631|471065367|FG000|Run in (2 Weeks)|Physician Decision|3|||
130846523|NCT00241631|471065368|FG001|Run in (2 Weeks)|Physician Decision|3|||
130846524|NCT00241631|471065367|FG000|Phase 1 (4 Weeks)|sore throat|1|||
130846525|NCT00241631|471065368|FG001|Phase 1 (4 Weeks)|sore throat|0|||
130846526|NCT00241631|471065367|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
130846527|NCT00241631|471065368|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
130846528|NCT00241631|471065367|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
130846529|NCT00241631|471065368|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
130846530|NCT00241631|471065367|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
130846531|NCT00241631|471065368|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
130846532|NCT03220581|471065370|FG000|Overall Study|Withdrawal by Subject|0|||
130846533|NCT03220581|471065371|FG001|Overall Study|Withdrawal by Subject|1|||
130846534|NCT03220581|471065370|FG000|Overall Study|Lost to Follow-up|3|||
130846535|NCT03220581|471065371|FG001|Overall Study|Lost to Follow-up|6|||
130846536|NCT01799239|471065373|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
130846537|NCT01799239|471065374|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
130846538|NCT01799239|471065373|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
130846539|NCT01799239|471065374|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
130846540|NCT01799239|471065373|FG000|Period 1 (7 Days)|Protocol Violation|0|||
130846541|NCT01799239|471065374|FG001|Period 1 (7 Days)|Protocol Violation|1|||
130846542|NCT01799239|471065373|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
130846543|NCT01799239|471065374|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
130846544|NCT01799239|471065373|FG000|Period 2 (7 Days)|Protocol Violation|1|||
130846545|NCT01799239|471065374|FG001|Period 2 (7 Days)|Protocol Violation|0|||
130846546|NCT01286987|471065378|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
130846547|NCT01286987|471065379|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
130846548|NCT01286987|471065380|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
130846549|NCT01286987|471065381|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
130846550|NCT01286987|471065382|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
130846551|NCT01286987|471065383|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
130846552|NCT01286987|471065384|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
130846553|NCT01286987|471065385|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
130846554|NCT01286987|471065386|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
130846555|NCT01286987|471065387|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
130846556|NCT01286987|471065388|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
130846557|NCT01286987|471065389|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
130846558|NCT01286987|471065390|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
130846559|NCT01286987|471065391|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
130846560|NCT01286987|471065392|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
130846561|NCT01286987|471065378|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
130846562|NCT01286987|471065379|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
130846563|NCT01286987|471065380|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
130846564|NCT01286987|471065381|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
130846565|NCT01286987|471065382|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
130846566|NCT01286987|471065383|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
130846567|NCT01286987|471065384|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
130846568|NCT01286987|471065385|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
130846569|NCT01286987|471065386|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
130846570|NCT01286987|471065387|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
130846571|NCT01286987|471065388|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
130846572|NCT01286987|471065389|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
130846573|NCT01286987|471065390|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
130846574|NCT01286987|471065391|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
130846575|NCT01286987|471065392|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
130846576|NCT01286987|471065378|FG000|Part 1: Dose Escalation|Physician Decision|0|||
130846577|NCT01286987|471065379|FG001|Part 1: Dose Escalation|Physician Decision|0|||
130846578|NCT01286987|471065380|FG002|Part 1: Dose Escalation|Physician Decision|0|||
130846579|NCT01286987|471065381|FG003|Part 1: Dose Escalation|Physician Decision|0|||
130846580|NCT01286987|471065382|FG004|Part 1: Dose Escalation|Physician Decision|1|||
130846581|NCT01286987|471065383|FG005|Part 1: Dose Escalation|Physician Decision|0|||
130846582|NCT01286987|471065384|FG006|Part 1: Dose Escalation|Physician Decision|0|||
130846583|NCT01286987|471065385|FG007|Part 1: Dose Escalation|Physician Decision|0|||
130846584|NCT01286987|471065386|FG008|Part 1: Dose Escalation|Physician Decision|0|||
130846585|NCT01286987|471065387|FG009|Part 1: Dose Escalation|Physician Decision|0|||
130846586|NCT01286987|471065388|FG010|Part 1: Dose Escalation|Physician Decision|0|||
130846587|NCT01286987|471065389|FG011|Part 1: Dose Escalation|Physician Decision|0|||
130846588|NCT01286987|471065390|FG012|Part 1: Dose Escalation|Physician Decision|0|||
130846589|NCT01286987|471065391|FG013|Part 1: Dose Escalation|Physician Decision|0|||
130846590|NCT01286987|471065392|FG014|Part 1: Dose Escalation|Physician Decision|0|||
130846591|NCT01286987|471065378|FG000|Part 2: Dose Expansion|Death|0|||
130846592|NCT01286987|471065379|FG001|Part 2: Dose Expansion|Death|0|||
130846593|NCT01286987|471065380|FG002|Part 2: Dose Expansion|Death|0|||
130846594|NCT01286987|471065381|FG003|Part 2: Dose Expansion|Death|0|||
130846595|NCT01286987|471065382|FG004|Part 2: Dose Expansion|Death|0|||
130846596|NCT01286987|471065383|FG005|Part 2: Dose Expansion|Death|0|||
130846597|NCT01286987|471065384|FG006|Part 2: Dose Expansion|Death|0|||
130846598|NCT01286987|471065385|FG007|Part 2: Dose Expansion|Death|0|||
130846599|NCT01286987|471065386|FG008|Part 2: Dose Expansion|Death|0|||
130846600|NCT01286987|471065387|FG009|Part 2: Dose Expansion|Death|0|||
130846601|NCT01286987|471065388|FG010|Part 2: Dose Expansion|Death|0|||
130846602|NCT01286987|471065389|FG011|Part 2: Dose Expansion|Death|0|||
130846603|NCT01286987|471065390|FG012|Part 2: Dose Expansion|Death|1|||
130846604|NCT01286987|471065391|FG013|Part 2: Dose Expansion|Death|1|||
130846605|NCT01286987|471065392|FG014|Part 2: Dose Expansion|Death|0|||
130846606|NCT01286987|471065378|FG000|Part 2: Dose Expansion|Physician Decision|0|||
130846607|NCT01286987|471065379|FG001|Part 2: Dose Expansion|Physician Decision|0|||
130846608|NCT01286987|471065380|FG002|Part 2: Dose Expansion|Physician Decision|0|||
130846609|NCT01286987|471065381|FG003|Part 2: Dose Expansion|Physician Decision|0|||
130846610|NCT01286987|471065382|FG004|Part 2: Dose Expansion|Physician Decision|0|||
130846611|NCT01286987|471065383|FG005|Part 2: Dose Expansion|Physician Decision|0|||
130846612|NCT01286987|471065384|FG006|Part 2: Dose Expansion|Physician Decision|0|||
130846613|NCT01286987|471065385|FG007|Part 2: Dose Expansion|Physician Decision|0|||
130846614|NCT01286987|471065386|FG008|Part 2: Dose Expansion|Physician Decision|0|||
130846615|NCT01286987|471065387|FG009|Part 2: Dose Expansion|Physician Decision|0|||
130846616|NCT01286987|471065388|FG010|Part 2: Dose Expansion|Physician Decision|1|||
130846617|NCT01286987|471065389|FG011|Part 2: Dose Expansion|Physician Decision|1|||
130846618|NCT01286987|471065390|FG012|Part 2: Dose Expansion|Physician Decision|0|||
130846619|NCT01286987|471065391|FG013|Part 2: Dose Expansion|Physician Decision|1|||
130846620|NCT01286987|471065392|FG014|Part 2: Dose Expansion|Physician Decision|0|||
130846621|NCT01286987|471065378|FG000|Part 2: Dose Expansion|Other|0|||
130846622|NCT01286987|471065379|FG001|Part 2: Dose Expansion|Other|0|||
130846623|NCT01286987|471065380|FG002|Part 2: Dose Expansion|Other|0|||
130846624|NCT01286987|471065381|FG003|Part 2: Dose Expansion|Other|0|||
130846625|NCT01286987|471065382|FG004|Part 2: Dose Expansion|Other|0|||
130846626|NCT01286987|471065383|FG005|Part 2: Dose Expansion|Other|0|||
130846627|NCT01286987|471065384|FG006|Part 2: Dose Expansion|Other|0|||
130846628|NCT01286987|471065385|FG007|Part 2: Dose Expansion|Other|0|||
130846629|NCT01286987|471065386|FG008|Part 2: Dose Expansion|Other|0|||
130846630|NCT01286987|471065387|FG009|Part 2: Dose Expansion|Other|0|||
130846631|NCT01286987|471065388|FG010|Part 2: Dose Expansion|Other|0|||
130846632|NCT01286987|471065389|FG011|Part 2: Dose Expansion|Other|0|||
130846633|NCT01286987|471065390|FG012|Part 2: Dose Expansion|Other|0|||
130846634|NCT01286987|471065391|FG013|Part 2: Dose Expansion|Other|1|||
130846635|NCT01286987|471065392|FG014|Part 2: Dose Expansion|Other|0|||
130846636|NCT01286987|471065378|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
130846637|NCT01286987|471065379|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
130846638|NCT01286987|471065380|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
130846639|NCT01286987|471065381|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
130846640|NCT01286987|471065382|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
130846641|NCT01286987|471065383|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
130846642|NCT01286987|471065384|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
130846643|NCT01286987|471065385|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
130846644|NCT01286987|471065386|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
130846645|NCT01286987|471065387|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
130846646|NCT01286987|471065388|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
130846647|NCT01286987|471065389|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
130846648|NCT01286987|471065390|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
130846649|NCT01286987|471065391|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
130846650|NCT01286987|471065392|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
130846651|NCT01286987|471065378|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
130846652|NCT01286987|471065379|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
130846653|NCT01286987|471065380|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
130846654|NCT01286987|471065381|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
130846655|NCT01286987|471065382|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
130846656|NCT01286987|471065383|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
130846657|NCT01286987|471065384|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
130846658|NCT01286987|471065385|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
130846659|NCT01286987|471065386|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
130846660|NCT01286987|471065387|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
130846661|NCT01286987|471065388|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
130846662|NCT01286987|471065389|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
130846663|NCT01286987|471065390|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
130846664|NCT01286987|471065391|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
130846665|NCT01286987|471065392|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
130846666|NCT01286987|471065378|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846667|NCT01286987|471065379|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846668|NCT01286987|471065380|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846669|NCT01286987|471065381|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846670|NCT01286987|471065382|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846671|NCT01286987|471065383|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846672|NCT01286987|471065384|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846673|NCT01286987|471065385|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846674|NCT01286987|471065386|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846675|NCT01286987|471065387|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846676|NCT01286987|471065388|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
130846677|NCT01286987|471065389|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846678|NCT01286987|471065390|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846679|NCT01286987|471065391|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846680|NCT01286987|471065392|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130846681|NCT02594098|471065393|FG000|Overall Study|Lack of Efficacy|17|||
130846682|NCT02594098|471065394|FG001|Overall Study|Lack of Efficacy|6|||
130846683|NCT02594098|471065393|FG000|Overall Study|Withdrawal by Subject|1|||
130846684|NCT02594098|471065394|FG001|Overall Study|Withdrawal by Subject|3|||
130846685|NCT02594098|471065393|FG000|Overall Study|Terminated participation|6|||
130846686|NCT02594098|471065394|FG001|Overall Study|Terminated participation|2|||
130846687|NCT02594098|471065393|FG000|Overall Study|Seek alternative treatment|2|||
130846688|NCT02594098|471065394|FG001|Overall Study|Seek alternative treatment|1|||
130846689|NCT02594098|471065393|FG000|Overall Study|Other|0|||
130846690|NCT02594098|471065394|FG001|Overall Study|Other|1|||
130846691|NCT00033540|471065395|FG000|Overall Study|Adverse Event|14|||
130846692|NCT00033540|471065395|FG000|Overall Study|Death|1|||
130846693|NCT00033540|471065395|FG000|Overall Study|Progression|26|||
130846694|NCT00033540|471065395|FG000|Overall Study|Withdrawal by Subject|6|||
130846695|NCT00033540|471065395|FG000|Overall Study|Other|5|||
130846696|NCT00033540|471065395|FG000|Overall Study|Ineligible|3|||
130846697|NCT00033540|471065395|FG000|Overall Study|Never received treatment|2|||
130846698|NCT03366103|471065396|FG000|Overall Study|Disease Progression|3|||
130846699|NCT03366103|471065397|FG001|Overall Study|Disease Progression|1|||
130846700|NCT03366103|471065398|FG002|Overall Study|Disease Progression|0|||
130846701|NCT03366103|471065396|FG000|Overall Study|Adverse Event|0|||
130846702|NCT03366103|471065397|FG001|Overall Study|Adverse Event|1|||
130846703|NCT03366103|471065398|FG002|Overall Study|Adverse Event|0|||
130846704|NCT01036529|471065399|FG000|Overall Study|Adverse Event|0|||
130846705|NCT01036529|471065400|FG001|Overall Study|Adverse Event|1|||
130846706|NCT01036529|471065399|FG000|Overall Study|Lost to Follow-up|0|||
130846707|NCT01036529|471065400|FG001|Overall Study|Lost to Follow-up|1|||
130846708|NCT01036529|471065399|FG000|Overall Study|Physician Decision|1|||
130846709|NCT01036529|471065400|FG001|Overall Study|Physician Decision|0|||
130846710|NCT01036529|471065399|FG000|Overall Study|Withdrawal by Subject|1|||
130846711|NCT01036529|471065400|FG001|Overall Study|Withdrawal by Subject|1|||
130846712|NCT01036529|471065399|FG000|Overall Study|Sponsor study termination|11|||
130846713|NCT01036529|471065400|FG001|Overall Study|Sponsor study termination|12|||
130846714|NCT01853072|471065401|FG000|Overall Study|Adverse event prior to treatment|0|||
130846715|NCT01853072|471065402|FG001|Overall Study|Adverse event prior to treatment|1|||
130846716|NCT01853072|471065401|FG000|Overall Study|Adverse Event|0|||
130846717|NCT01853072|471065402|FG001|Overall Study|Adverse Event|3|||
130846718|NCT01853072|471065401|FG000|Overall Study|Death|1|||
130846719|NCT01853072|471065402|FG001|Overall Study|Death|4|||
130846720|NCT01853072|471065401|FG000|Overall Study|Lost to Follow-up|0|||
130846721|NCT01853072|471065402|FG001|Overall Study|Lost to Follow-up|3|||
130846722|NCT01853072|471065401|FG000|Overall Study|Non-compliance with study drug|0|||
130846723|NCT01853072|471065402|FG001|Overall Study|Non-compliance with study drug|1|||
130846724|NCT01853072|471065401|FG000|Overall Study|Physician Decision|1|||
130846725|NCT01853072|471065402|FG001|Overall Study|Physician Decision|1|||
130846726|NCT01853072|471065401|FG000|Overall Study|Withdrawal by Subject|1|||
130846727|NCT01853072|471065402|FG001|Overall Study|Withdrawal by Subject|2|||
130846728|NCT01853072|471065401|FG000|Overall Study|Reason not specified|9|||
130846729|NCT01853072|471065402|FG001|Overall Study|Reason not specified|6|||
130846730|NCT01816906|471065403|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
130846731|NCT01816906|471065404|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
130846732|NCT01816906|471065403|FG000|Six Months|Lost to Follow-up|14|||
130846733|NCT01816906|471065404|FG001|Six Months|Lost to Follow-up|16|||
130846734|NCT01816906|471065403|FG000|12 Months|Adverse Event|2|||
130846735|NCT01816906|471065404|FG001|12 Months|Adverse Event|2|||
130846736|NCT01816906|471065403|FG000|12 Months|Death|0|||
130846737|NCT01816906|471065404|FG001|12 Months|Death|2|||
130846738|NCT01816906|471065403|FG000|12 Months|Lost to Follow-up|2|||
130846739|NCT01816906|471065404|FG001|12 Months|Lost to Follow-up|1|||
130846740|NCT00746733|471065405|FG000|Second Intervention|Adverse Event|1|||
130846741|NCT00746733|471065406|FG001|Second Intervention|Adverse Event|0|||
130846742|NCT00746733|471065405|FG000|Third Intervention|Withdrawal by Subject|1|||
130846743|NCT00746733|471065406|FG001|Third Intervention|Withdrawal by Subject|1|||
130846744|NCT01527383|471065407|FG000|Overall Study|Adverse Event|5|||
130846745|NCT01527383|471065408|FG001|Overall Study|Adverse Event|0|||
130846746|NCT01527383|471065407|FG000|Overall Study|Lost to Follow-up|3|||
130846747|NCT01527383|471065408|FG001|Overall Study|Lost to Follow-up|0|||
130846748|NCT01527383|471065407|FG000|Overall Study|Physician Decision|2|||
130846749|NCT01527383|471065408|FG001|Overall Study|Physician Decision|0|||
130846750|NCT01527383|471065407|FG000|Overall Study|Pregnancy|1|||
130846751|NCT01527383|471065408|FG001|Overall Study|Pregnancy|0|||
130846752|NCT01527383|471065407|FG000|Overall Study|Protocol Violation|1|||
130846753|NCT01527383|471065408|FG001|Overall Study|Protocol Violation|0|||
130846754|NCT01527383|471065407|FG000|Overall Study|Screen failure|1|||
130846755|NCT01527383|471065408|FG001|Overall Study|Screen failure|0|||
130846756|NCT01527383|471065407|FG000|Overall Study|Participant moved|0|||
130846757|NCT01527383|471065408|FG001|Overall Study|Participant moved|1|||
130846758|NCT01527383|471065407|FG000|Overall Study|Withdrawal by Subject|2|||
130846759|NCT01527383|471065408|FG001|Overall Study|Withdrawal by Subject|3|||
130846760|NCT03412604|471065409|FG000|Overall Study|Withdrawal by Subject|1|||
130846761|NCT01287221|471065411|FG000|Overall Study|Lack of Perceived Benefit|1|||
130846762|NCT01287221|471065412|FG001|Overall Study|Lack of Perceived Benefit|1|||
130846763|NCT01287221|471065411|FG000|Overall Study|Adverse Event|3|||
130846764|NCT01287221|471065412|FG001|Overall Study|Adverse Event|3|||
130846765|NCT01287221|471065411|FG000|Overall Study|Withdrawal by Subject|0|||
130846766|NCT01287221|471065412|FG001|Overall Study|Withdrawal by Subject|1|||
130846767|NCT00930969|471065413|FG000|Overall Study|Death|5|||
130846768|NCT00930969|471065413|FG000|Overall Study|Lost to Follow-up|1|||
130846769|NCT00930969|471065413|FG000|Overall Study|Physician Decision|13|||
130846770|NCT00930969|471065413|FG000|Overall Study|Withdrawal by Subject|19|||
130846771|NCT00787137|471065415|FG000|Overall Study|Study Termination|0|||
130846772|NCT00787137|471065416|FG001|Overall Study|Study Termination|0|||
130846773|NCT00787137|471065417|FG002|Overall Study|Study Termination|1|||
130846774|NCT00946322|471065418|FG000|Pre-treatment|participant failure to follow up|1|||
130846775|NCT00946322|471065418|FG000|Post-treatment|participant failure to follow up|2|||
130846776|NCT01453946|471065420|FG000|Overall Study|Did not receive drug for the taper phase|1|||
130846777|NCT01453946|471065420|FG000|Overall Study|Protocol Violation|2|||
130846778|NCT01453946|471065420|FG000|Overall Study|Lack of Efficacy|3|||
130846779|NCT01453946|471065420|FG000|Overall Study|Adverse Event|3|||
130846780|NCT00846040|471065421|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
130846781|NCT00846040|471065422|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
130846782|NCT00846040|471065423|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
130846783|NCT00846040|471065421|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
130846784|NCT00846040|471065422|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
130846785|NCT00846040|471065423|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
130846786|NCT01822535|471065426|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
130846787|NCT01822535|471065427|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
130846788|NCT01822535|471065426|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
130846789|NCT01822535|471065427|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
130846790|NCT01822535|471065426|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
130846791|NCT01822535|471065427|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
130846792|NCT02278614|471065428|FG000|Overall Study|Withdrawal by Subject|3|||
130846793|NCT02278614|471065429|FG001|Overall Study|Withdrawal by Subject|5|||
130846794|NCT02278614|471065428|FG000|Overall Study|Adverse Event|1|||
130846795|NCT02278614|471065429|FG001|Overall Study|Adverse Event|0|||
130846796|NCT02278614|471065428|FG000|Overall Study|left eye was not eligible|1|||
130846797|NCT02278614|471065429|FG001|Overall Study|left eye was not eligible|0|||
130846798|NCT02279498|471065432|FG000|Overall Study|Adverse Event|3|||
130846799|NCT02279498|471065433|FG001|Overall Study|Adverse Event|0|||
130846800|NCT02279498|471065432|FG000|Overall Study|Lack of Efficacy|4|||
130846801|NCT02279498|471065433|FG001|Overall Study|Lack of Efficacy|0|||
130846802|NCT02279498|471065432|FG000|Overall Study|Lost to Follow-up|0|||
130846803|NCT02279498|471065433|FG001|Overall Study|Lost to Follow-up|1|||
130846804|NCT02279498|471065432|FG000|Overall Study|Withdrawal by Subject|9|||
130846805|NCT02279498|471065433|FG001|Overall Study|Withdrawal by Subject|2|||
130846806|NCT02279498|471065432|FG000|Overall Study|Undefined|2|||
130846807|NCT02279498|471065433|FG001|Overall Study|Undefined|1|||
130846808|NCT01048866|471065434|FG000|Overall Study|Adverse Event|1|||
130846809|NCT01048866|471065435|FG001|Overall Study|Adverse Event|0|||
130846810|NCT01048866|471065434|FG000|Overall Study|Protocol Violation|1|||
130846811|NCT01048866|471065435|FG001|Overall Study|Protocol Violation|0|||
130846812|NCT01048866|471065434|FG000|Overall Study|Physician Decision|1|||
130846813|NCT01048866|471065435|FG001|Overall Study|Physician Decision|0|||
130846814|NCT01048866|471065434|FG000|Overall Study|Withdrawal by Subject|0|||
130846815|NCT01048866|471065435|FG001|Overall Study|Withdrawal by Subject|2|||
130846816|NCT01048866|471065434|FG000|Overall Study|Lost to Follow-up|0|||
130846817|NCT01048866|471065435|FG001|Overall Study|Lost to Follow-up|2|||
130846818|NCT01048866|471065434|FG000|Overall Study|Other|1|||
130846819|NCT01048866|471065435|FG001|Overall Study|Other|1|||
130846820|NCT03582813|471065436|FG000|Overall Study|Lost to Follow-up|18|||
130846821|NCT03582813|471065437|FG001|Overall Study|Lost to Follow-up|21|||
130846822|NCT03582813|471065436|FG000|Overall Study|Withdrawal by Subject|1|||
130846823|NCT03582813|471065437|FG001|Overall Study|Withdrawal by Subject|0|||
130846824|NCT02230683|471065440|FG000|Overall Study|Adverse Event|1|||
130846825|NCT00260065|471065441|FG000|Overall Study|Progressive Disease|22|||
130846826|NCT00260065|471065441|FG000|Overall Study|Adverse Event|17|||
130846827|NCT00260065|471065441|FG000|Overall Study|Death|13|||
130846828|NCT00260065|471065441|FG000|Overall Study|Withdrawal by Subject|13|||
130846829|NCT00260065|471065441|FG000|Overall Study|Physician Decision|19|||
130846830|NCT00260065|471065441|FG000|Overall Study|Not otherwise specified|8|||
130846831|NCT00260065|471065441|FG000|Overall Study|Medication Noncompliance|1|||
130846832|NCT04068519|471065442|FG000|Dose Verification|Death|15|||
130846833|NCT04068519|471065442|FG000|Dose Verification|Withdrawal by Subject|1|||
130846834|NCT04068519|471065442|FG000|Pharmacokinetic Sub-study|Death|35|||
130846835|NCT04068519|471065442|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
130846836|NCT04068519|471065442|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
130846837|NCT04068519|471065442|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
130846838|NCT04068519|471065442|FG000|Indication Expansion|Death|152|||
130846839|NCT04068519|471065442|FG000|Indication Expansion|Withdrawal by Subject|10|||
130846840|NCT04068519|471065442|FG000|Indication Expansion|Lost to Follow-up|7|||
130846844|NCT01998893|471066936|FG000|Overall Study|Adverse Event|2|||
130846845|NCT01998893|471066936|FG000|Overall Study|Death|1|||
130846846|NCT01998893|471066936|FG000|Overall Study|Lost to Follow-up|8|||
130846847|NCT01998893|471066936|FG000|Overall Study|Physician Decision|2|||
130846848|NCT01998893|471066936|FG000|Overall Study|Protocol Violation|2|||
130846849|NCT01998893|471066936|FG000|Overall Study|Withdrawal by Subject|1|||
130846850|NCT01998893|471066936|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
130846851|NCT03784846|471066937|FG000|Pre-COVID Study|Lost to Follow-up|3|||
130846852|NCT03784846|471066938|FG001|Pre-COVID Study|Lost to Follow-up|3|||
130846853|NCT03784846|471066939|FG002|Pre-COVID Study|Lost to Follow-up|2|||
130846854|NCT03784846|471066937|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
130846855|NCT03784846|471066938|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
130846856|NCT03784846|471066939|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
130846857|NCT03784846|471066937|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
130846858|NCT03784846|471066938|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
130846859|NCT03784846|471066939|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
130846860|NCT03784846|471066937|FG000|Post-COVID Study|Lost to Follow-up|3|||
130846861|NCT03784846|471066938|FG001|Post-COVID Study|Lost to Follow-up|5|||
130846862|NCT03784846|471066939|FG002|Post-COVID Study|Lost to Follow-up|1|||
130846863|NCT03784846|471066937|FG000|Post-COVID Study|Withdrawal by Subject|1|||
130846864|NCT03784846|471066938|FG001|Post-COVID Study|Withdrawal by Subject|2|||
130846865|NCT03784846|471066939|FG002|Post-COVID Study|Withdrawal by Subject|0|||
130846866|NCT00867087|471066940|FG000|Overall Study|Other|1|||
130846867|NCT00867087|471066940|FG000|Overall Study|Withdrawal by Subject|4|||
130846868|NCT00867087|471066940|FG000|Overall Study|Death|37|||
130846869|NCT03883113|471066942|FG000|Overall Study|Physician Decision|4|||
130846870|NCT03883113|471066943|FG001|Overall Study|Physician Decision|2|||
130846871|NCT03883113|471066942|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
130846872|NCT03883113|471066943|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
130846873|NCT03883113|471066942|FG000|Overall Study|Pregnancy|1|||
130846874|NCT03883113|471066943|FG001|Overall Study|Pregnancy|0|||
130846875|NCT03883113|471066942|FG000|Overall Study|Adverse Event|0|||
130846876|NCT03883113|471066943|FG001|Overall Study|Adverse Event|1|||
130846877|NCT03883113|471066942|FG000|Overall Study|Withdrawal by Subject|1|||
130846878|NCT03883113|471066943|FG001|Overall Study|Withdrawal by Subject|2|||
130846879|NCT03883113|471066942|FG000|Overall Study|Lost to Follow-up|1|||
130846880|NCT03883113|471066943|FG001|Overall Study|Lost to Follow-up|0|||
130846881|NCT01457950|471066944|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
130846882|NCT01457950|471066945|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
130846883|NCT01457950|471066946|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
130846884|NCT01457950|471066947|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
130846885|NCT01457950|471066944|FG000|Double-Blind Phase|Protocol Violation|2|||
130846886|NCT01457950|471066945|FG001|Double-Blind Phase|Protocol Violation|1|||
130846887|NCT01457950|471066946|FG002|Double-Blind Phase|Protocol Violation|0|||
130846888|NCT01457950|471066947|FG003|Double-Blind Phase|Protocol Violation|0|||
130846889|NCT01457950|471066944|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
130846890|NCT01457950|471066945|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
130846891|NCT01457950|471066946|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130846892|NCT01457950|471066947|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130846893|NCT01457950|471066944|FG000|Open-Label Phase|Adverse Event|0|||
130846894|NCT01457950|471066945|FG001|Open-Label Phase|Adverse Event|0|||
130846895|NCT01457950|471066946|FG002|Open-Label Phase|Adverse Event|0|||
130846896|NCT01457950|471066947|FG003|Open-Label Phase|Adverse Event|1|||
130846897|NCT01457950|471066944|FG000|Open-Label Phase|Protocol Violation|0|||
130846898|NCT01457950|471066945|FG001|Open-Label Phase|Protocol Violation|0|||
130846899|NCT01457950|471066946|FG002|Open-Label Phase|Protocol Violation|0|||
130846900|NCT01457950|471066947|FG003|Open-Label Phase|Protocol Violation|1|||
130846901|NCT01457950|471066944|FG000|Open-Label Phase|Withdrawal by Subject|0|||
130846902|NCT01457950|471066945|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130846903|NCT01457950|471066946|FG002|Open-Label Phase|Withdrawal by Subject|2|||
130846904|NCT01457950|471066947|FG003|Open-Label Phase|Withdrawal by Subject|0|||
130846905|NCT00054691|471066948|FG000|Overall Study|Unmeasurable Disease|2|||
130846906|NCT00054691|471066948|FG000|Overall Study|Noncompliant|1|||
130846907|NCT02498067|471066949|FG000|Overall Study|Lost to Follow-up|22|||
130846908|NCT02498067|471066949|FG000|Overall Study|Did not meet inclusion criteria|11|||
130846909|NCT03351114|471066950|FG000|Overall Study|Withdrawal by Subject|1|||
130846910|NCT01371643|471066958|FG000|Overall Study|Withdrawal by Subject|3|||
130846911|NCT01371643|471066959|FG001|Overall Study|Withdrawal by Subject|0|||
130846912|NCT03987932|471066963|FG000|Overall Study|Lost to Follow-up|2|||
130846913|NCT03987932|471066964|FG001|Overall Study|Lost to Follow-up|1|||
130846914|NCT03987932|471066965|FG002|Overall Study|Lost to Follow-up|1|||
130846915|NCT03987932|471066963|FG000|Overall Study|Non-study related elective surgery|0|||
130846916|NCT03987932|471066964|FG001|Overall Study|Non-study related elective surgery|0|||
130846917|NCT03987932|471066965|FG002|Overall Study|Non-study related elective surgery|1|||
130846918|NCT01561755|471066970|FG000|Overall Study|Lost to Follow-up|0|||
130846919|NCT01561755|471066971|FG001|Overall Study|Lost to Follow-up|1|||
130846920|NCT02813668|471066973|FG000|Overall Study|Death|4|||
130846921|NCT02813668|471066973|FG000|Overall Study|Lost to Follow-up|509|||
130846922|NCT02813668|471066973|FG000|Overall Study|Withdrawal by Subject|148|||
130846923|NCT02813668|471066973|FG000|Overall Study|No longer at worksite|85|||
130846924|NCT02813668|471066973|FG000|Overall Study|Medical reasons not related to the study|4|||
130846925|NCT04662073|471066974|FG000|Overall Study|Withdrawal by Subject|1|||
130846926|NCT04662073|471066975|FG001|Overall Study|Withdrawal by Subject|0|||
130846927|NCT02185014|471066976|FG000|Overall Study|Adverse Event|18|||
130846928|NCT02185014|471066976|FG000|Overall Study|Withdrew Consent|8|||
130846929|NCT02185014|471066976|FG000|Overall Study|Lost to Follow-up|4|||
130846930|NCT02185014|471066976|FG000|Overall Study|Lack of Efficacy|14|||
130846931|NCT02185014|471066976|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
130846932|NCT02185014|471066976|FG000|Overall Study|Subject Noncompliance|1|||
130846933|NCT02185014|471066976|FG000|Overall Study|Other|4|||
130846934|NCT02370641|471066981|FG000|Overall Study|dropped study|4|||
130846935|NCT02370641|471066982|FG001|Overall Study|dropped study|2|||
130846936|NCT02133664|471066986|FG000|Overall Study|Lost to Follow-up|2|||
130846937|NCT02133664|471066987|FG001|Overall Study|Lost to Follow-up|1|||
130846938|NCT02133664|471066986|FG000|Overall Study|Adverse Event|3|||
130846939|NCT02133664|471066987|FG001|Overall Study|Adverse Event|6|||
130846940|NCT00810901|471066988|FG000|Overall Study|Lost to Follow-up|88|||
130846941|NCT00810901|471066989|FG001|Overall Study|Lost to Follow-up|58|||
130846942|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
130846943|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
130846944|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
130846945|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
130846946|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
130846947|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
130846948|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
130846949|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
130846950|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
130846951|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
130846952|NCT03906656|471066992|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
130846953|NCT03906656|471066993|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
130846954|NCT03906656|471066992|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
130846955|NCT03906656|471066993|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
130846956|NCT03906656|471066992|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
130846957|NCT03906656|471066993|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
130846958|NCT03906656|471066992|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
130846959|NCT03906656|471066993|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
130846960|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
130846961|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
130846962|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
130846963|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
130846964|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
130846965|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
130846966|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
130846967|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
130846968|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
130846969|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
130846970|NCT03906656|471066992|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
130846971|NCT03906656|471066993|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
130846972|NCT03906656|471066992|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
130846973|NCT03906656|471066993|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
130846974|NCT03906656|471066992|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
130846975|NCT03906656|471066993|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
130846976|NCT03906656|471066992|FG000|Home Use 2 (3 Months)|Death|2|||
130846977|NCT03906656|471066993|FG001|Home Use 2 (3 Months)|Death|0|||
130846978|NCT03906656|471066992|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
130846979|NCT03906656|471066993|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
130846980|NCT03906656|471066992|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
130846981|NCT03906656|471066993|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
130846982|NCT01945775|471067000|FG000|Overall Study|Death|214|||
130846983|NCT01945775|471067001|FG001|Overall Study|Death|98|||
130846984|NCT01945775|471067000|FG000|Overall Study|Lost to Follow-up|12|||
130846985|NCT01945775|471067001|FG001|Overall Study|Lost to Follow-up|7|||
130846986|NCT01945775|471067000|FG000|Overall Study|Withdrawal by Subject|11|||
130846987|NCT01945775|471067001|FG001|Overall Study|Withdrawal by Subject|21|||
130846988|NCT01945775|471067000|FG000|Overall Study|Other|50|||
130846989|NCT01945775|471067001|FG001|Overall Study|Other|18|||
130846990|NCT02876328|471067002|FG000|Overall Study|Death|2|||
130846991|NCT02876328|471067003|FG001|Overall Study|Death|1|||
130846992|NCT02876328|471067004|FG002|Overall Study|Death|3|||
130846993|NCT02876328|471067005|FG003|Overall Study|Death|0|||
130846994|NCT02876328|471067006|FG004|Overall Study|Death|0|||
130846995|NCT02876328|471067007|FG005|Overall Study|Death|0|||
130846996|NCT02876328|471067008|FG006|Overall Study|Death|1|||
130846997|NCT02876328|471067009|FG007|Overall Study|Death|3|||
130846998|NCT02876328|471067010|FG008|Overall Study|Death|0|||
130846999|NCT02876328|471067011|FG009|Overall Study|Death|1|||
130847000|NCT02876328|471067012|FG010|Overall Study|Death|1|||
130847001|NCT02876328|471067013|FG011|Overall Study|Death|0|||
130847002|NCT02876328|471067014|FG012|Overall Study|Death|0|||
130847003|NCT02876328|471067015|FG013|Overall Study|Death|0|||
130847004|NCT02876328|471067016|FG014|Overall Study|Death|0|||
130847005|NCT02876328|471067017|FG015|Overall Study|Death|0|||
130847006|NCT02876328|471067018|FG016|Overall Study|Death|1|||
130847007|NCT02876328|471067019|FG017|Overall Study|Death|1|||
130847008|NCT02876328|471067020|FG018|Overall Study|Death|0|||
130847009|NCT02876328|471067021|FG019|Overall Study|Death|0|||
130847010|NCT02876328|471067022|FG020|Overall Study|Death|0|||
130847011|NCT02876328|471067023|FG021|Overall Study|Death|1|||
130847012|NCT02876328|471067024|FG022|Overall Study|Death|0|||
130847013|NCT02876328|471067025|FG023|Overall Study|Death|0|||
130847014|NCT02876328|471067002|FG000|Overall Study|Withdrawal by Subject|0|||
130847015|NCT02876328|471067003|FG001|Overall Study|Withdrawal by Subject|2|||
130847016|NCT02876328|471067004|FG002|Overall Study|Withdrawal by Subject|3|||
130847017|NCT02876328|471067005|FG003|Overall Study|Withdrawal by Subject|3|||
130847018|NCT02876328|471067006|FG004|Overall Study|Withdrawal by Subject|0|||
130847019|NCT02876328|471067007|FG005|Overall Study|Withdrawal by Subject|1|||
130847020|NCT02876328|471067008|FG006|Overall Study|Withdrawal by Subject|0|||
130847021|NCT02876328|471067009|FG007|Overall Study|Withdrawal by Subject|1|||
130847022|NCT02876328|471067010|FG008|Overall Study|Withdrawal by Subject|1|||
130847023|NCT02876328|471067011|FG009|Overall Study|Withdrawal by Subject|2|||
130847024|NCT02876328|471067012|FG010|Overall Study|Withdrawal by Subject|0|||
130847025|NCT02876328|471067013|FG011|Overall Study|Withdrawal by Subject|0|||
130847026|NCT02876328|471067014|FG012|Overall Study|Withdrawal by Subject|0|||
130847027|NCT02876328|471067015|FG013|Overall Study|Withdrawal by Subject|0|||
130847028|NCT02876328|471067016|FG014|Overall Study|Withdrawal by Subject|0|||
130847029|NCT02876328|471067017|FG015|Overall Study|Withdrawal by Subject|0|||
130847030|NCT02876328|471067018|FG016|Overall Study|Withdrawal by Subject|1|||
130847031|NCT02876328|471067019|FG017|Overall Study|Withdrawal by Subject|3|||
130847032|NCT02876328|471067020|FG018|Overall Study|Withdrawal by Subject|0|||
130847033|NCT02876328|471067021|FG019|Overall Study|Withdrawal by Subject|0|||
130847034|NCT02876328|471067022|FG020|Overall Study|Withdrawal by Subject|1|||
130847035|NCT02876328|471067023|FG021|Overall Study|Withdrawal by Subject|0|||
130847036|NCT02876328|471067024|FG022|Overall Study|Withdrawal by Subject|0|||
130847037|NCT02876328|471067025|FG023|Overall Study|Withdrawal by Subject|0|||
130847038|NCT02876328|471067002|FG000|Overall Study|Missed 12 Month Visit|15|||
130847039|NCT02876328|471067003|FG001|Overall Study|Missed 12 Month Visit|10|||
130847040|NCT02876328|471067004|FG002|Overall Study|Missed 12 Month Visit|11|||
130847041|NCT02876328|471067005|FG003|Overall Study|Missed 12 Month Visit|6|||
130847042|NCT02876328|471067006|FG004|Overall Study|Missed 12 Month Visit|10|||
130847043|NCT02876328|471067007|FG005|Overall Study|Missed 12 Month Visit|14|||
130847044|NCT02876328|471067008|FG006|Overall Study|Missed 12 Month Visit|3|||
130847045|NCT02876328|471067009|FG007|Overall Study|Missed 12 Month Visit|8|||
130847046|NCT02876328|471067010|FG008|Overall Study|Missed 12 Month Visit|9|||
130847047|NCT02876328|471067011|FG009|Overall Study|Missed 12 Month Visit|5|||
130847048|NCT02876328|471067012|FG010|Overall Study|Missed 12 Month Visit|4|||
130847049|NCT02876328|471067013|FG011|Overall Study|Missed 12 Month Visit|1|||
130847050|NCT02876328|471067014|FG012|Overall Study|Missed 12 Month Visit|5|||
130847051|NCT02876328|471067015|FG013|Overall Study|Missed 12 Month Visit|4|||
130847052|NCT02876328|471067016|FG014|Overall Study|Missed 12 Month Visit|4|||
130847053|NCT02876328|471067017|FG015|Overall Study|Missed 12 Month Visit|4|||
130847054|NCT02876328|471067018|FG016|Overall Study|Missed 12 Month Visit|3|||
130847055|NCT02876328|471067019|FG017|Overall Study|Missed 12 Month Visit|6|||
130847056|NCT02876328|471067020|FG018|Overall Study|Missed 12 Month Visit|2|||
130847057|NCT02876328|471067021|FG019|Overall Study|Missed 12 Month Visit|2|||
130847058|NCT02876328|471067022|FG020|Overall Study|Missed 12 Month Visit|11|||
130847059|NCT02876328|471067023|FG021|Overall Study|Missed 12 Month Visit|7|||
130847060|NCT02876328|471067024|FG022|Overall Study|Missed 12 Month Visit|1|||
130847061|NCT02876328|471067025|FG023|Overall Study|Missed 12 Month Visit|0|||
130847062|NCT03515941|471067030|FG000|Overall Study|Adverse Event|1|||
130847063|NCT03515941|471067031|FG001|Overall Study|Adverse Event|0|||
130847064|NCT00334282|471067032|FG000|Overall Study|Lost to Follow-up|11|||
130847065|NCT00334282|471067033|FG001|Overall Study|Lost to Follow-up|5|||
130847066|NCT00334282|471067032|FG000|Overall Study|Withdrawal by Subject|17|||
130847067|NCT00334282|471067033|FG001|Overall Study|Withdrawal by Subject|3|||
130847068|NCT00334282|471067032|FG000|Overall Study|Death|194|||
130847069|NCT00334282|471067033|FG001|Overall Study|Death|100|||
130847070|NCT02759315|471067034|FG000|Overall Study|Adverse Event|0|||
130847071|NCT02759315|471067035|FG001|Overall Study|Adverse Event|0|||
130847072|NCT02759315|471067036|FG002|Overall Study|Adverse Event|0|||
130847073|NCT02759315|471067037|FG003|Overall Study|Adverse Event|1|||
130847074|NCT02759315|471067038|FG004|Overall Study|Adverse Event|0|||
130847075|NCT02759315|471067034|FG000|Overall Study|Death|0|||
130847076|NCT02759315|471067035|FG001|Overall Study|Death|0|||
130847077|NCT02759315|471067036|FG002|Overall Study|Death|1|||
130847078|NCT02759315|471067037|FG003|Overall Study|Death|0|||
130847079|NCT02759315|471067038|FG004|Overall Study|Death|0|||
130847080|NCT02759315|471067034|FG000|Overall Study|Lost to Follow-up|2|||
130847081|NCT02759315|471067035|FG001|Overall Study|Lost to Follow-up|0|||
130847082|NCT02759315|471067036|FG002|Overall Study|Lost to Follow-up|4|||
130847083|NCT02759315|471067037|FG003|Overall Study|Lost to Follow-up|0|||
130847084|NCT02759315|471067038|FG004|Overall Study|Lost to Follow-up|0|||
130847085|NCT02759315|471067034|FG000|Overall Study|Protocol Violation|0|||
130847086|NCT02759315|471067035|FG001|Overall Study|Protocol Violation|1|||
130847087|NCT02759315|471067036|FG002|Overall Study|Protocol Violation|0|||
130847088|NCT02759315|471067037|FG003|Overall Study|Protocol Violation|0|||
130847089|NCT02759315|471067038|FG004|Overall Study|Protocol Violation|0|||
130847090|NCT02759315|471067034|FG000|Overall Study|Study terminated prior to completion|2|||
130847091|NCT02759315|471067035|FG001|Overall Study|Study terminated prior to completion|0|||
130847092|NCT02759315|471067036|FG002|Overall Study|Study terminated prior to completion|5|||
130847093|NCT02759315|471067037|FG003|Overall Study|Study terminated prior to completion|0|||
130847094|NCT02759315|471067038|FG004|Overall Study|Study terminated prior to completion|1|||
130847095|NCT03464422|471067048|FG000|Overall Study|Lost to Follow-up|2|||
130847096|NCT03464422|471067048|FG000|Overall Study|Withdrawal by Subject|2|||
130847097|NCT01628367|471067053|FG000|Overall Study|Adverse Event|1|||
130847098|NCT01628367|471067054|FG001|Overall Study|Adverse Event|0|||
130847099|NCT03353922|471067055|FG000|Overall Study|Withdrawal by Subject|1|||
130847100|NCT03353922|471067056|FG001|Overall Study|Withdrawal by Subject|0|||
130847101|NCT03353922|471067057|FG002|Overall Study|Withdrawal by Subject|1|||
130847102|NCT03353922|471067058|FG003|Overall Study|Withdrawal by Subject|1|||
130847103|NCT03353922|471067059|FG004|Overall Study|Withdrawal by Subject|0|||
130847104|NCT03353922|471067060|FG005|Overall Study|Withdrawal by Subject|0|||
130847105|NCT03353922|471067055|FG000|Overall Study|Adverse Event|0|||
130847106|NCT03353922|471067056|FG001|Overall Study|Adverse Event|1|||
130847107|NCT03353922|471067057|FG002|Overall Study|Adverse Event|0|||
130847108|NCT03353922|471067058|FG003|Overall Study|Adverse Event|0|||
130847109|NCT03353922|471067059|FG004|Overall Study|Adverse Event|0|||
130847110|NCT03353922|471067060|FG005|Overall Study|Adverse Event|0|||
130847111|NCT00740714|471067061|FG000|Overall Study|Withdrawal by Subject|17|||
130847112|NCT00740714|471067062|FG001|Overall Study|Withdrawal by Subject|19|||
130847113|NCT00740714|471067063|FG002|Overall Study|Withdrawal by Subject|29|||
130847114|NCT03688555|471067064|FG000|Treatment Period|Adverse Event|0|||
130847115|NCT03688555|471067065|FG001|Treatment Period|Adverse Event|0|||
130847116|NCT03688555|471067066|FG002|Treatment Period|Adverse Event|1|||
130847117|NCT00886119|471067067|FG000|Period 1|Did not meet inclusion criteria|1|||
130847118|NCT00886119|471067068|FG001|Period 1|Did not meet inclusion criteria|0|||
130847119|NCT01352741|471067073|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
130847120|NCT01352741|471067074|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
130847121|NCT01352741|471067073|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
130847122|NCT01352741|471067074|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
130847123|NCT01352741|471067073|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
130847124|NCT01352741|471067074|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
130847125|NCT01352741|471067073|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
130847126|NCT01352741|471067074|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
130847127|NCT01352741|471067073|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
130847128|NCT01352741|471067074|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
130847129|NCT01352741|471067073|FG000|Open-label Tapentadol Titration Period|Other|4|||
130847130|NCT01352741|471067074|FG001|Open-label Tapentadol Titration Period|Other|0|||
130847131|NCT01352741|471067073|FG000|Double-blind Comparative Period|Protocol Violation|2|||
130847132|NCT01352741|471067074|FG001|Double-blind Comparative Period|Protocol Violation|0|||
130847133|NCT01352741|471067073|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
130847134|NCT01352741|471067074|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
130847135|NCT01352741|471067073|FG000|Double-blind Comparative Period|Adverse Event|16|||
130847136|NCT01352741|471067074|FG001|Double-blind Comparative Period|Adverse Event|17|||
130847137|NCT01352741|471067073|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
130847138|NCT01352741|471067074|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
130847139|NCT01352741|471067073|FG000|Double-blind Comparative Period|Death|0|||
130847140|NCT01352741|471067074|FG001|Double-blind Comparative Period|Death|1|||
130847141|NCT01352741|471067073|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
130847142|NCT01352741|471067074|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
130847143|NCT01352741|471067073|FG000|Double-blind Comparative Period|Other|1|||
130847144|NCT01352741|471067074|FG001|Double-blind Comparative Period|Other|2|||
130847145|NCT01352741|471067073|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
130847146|NCT01352741|471067074|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
130847147|NCT01352741|471067073|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
130847148|NCT01352741|471067074|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
130847149|NCT01352741|471067073|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
130847150|NCT01352741|471067074|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
130847151|NCT01352741|471067073|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
130847152|NCT01352741|471067074|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
130847153|NCT00259298|471067075|FG000|Overall Study|Withdrawal by Subject|1|||
130847154|NCT00259298|471067075|FG000|Overall Study|Physician Decision|2|||
130847155|NCT00645528|471067076|FG000|Overall Study|Did not show up for Visit 2|7|||
130847156|NCT01886690|471067077|FG000|Overall Study|Protocol Violation|0|||
130847157|NCT01886690|471067078|FG001|Overall Study|Protocol Violation|1|||
130847158|NCT01886690|471067077|FG000|Overall Study|Personal Reasons|0|||
130847159|NCT01886690|471067078|FG001|Overall Study|Personal Reasons|1|||
130847160|NCT01140568|471067079|FG000|Overall Study|disease progression|31|||
130847161|NCT01140568|471067079|FG000|Overall Study|Withdrawal by Subject|1|||
130847162|NCT01140568|471067079|FG000|Overall Study|Screen Fail|4|||
130847163|NCT03618628|471067080|FG000|Overall Study|Death|1|||
130847164|NCT03618628|471067080|FG000|Overall Study|Lost to Follow-up|1|||
130847165|NCT01741532|471067082|FG000|Overall Study|Adverse Event|4|||
130847166|NCT01741532|471067083|FG001|Overall Study|Adverse Event|0|||
130847167|NCT01741532|471067082|FG000|Overall Study|Withdrawal by Subject|1|||
130847168|NCT01741532|471067083|FG001|Overall Study|Withdrawal by Subject|1|||
130847169|NCT01741532|471067082|FG000|Overall Study|Protocol Violation|0|||
130847170|NCT01741532|471067083|FG001|Overall Study|Protocol Violation|1|||
130847171|NCT01741532|471067082|FG000|Overall Study|Worsening of the disease|3|||
130847172|NCT01741532|471067083|FG001|Overall Study|Worsening of the disease|1|||
130847173|NCT01741532|471067082|FG000|Overall Study|Sponsor decision|1|||
130847174|NCT01741532|471067083|FG001|Overall Study|Sponsor decision|0|||
130847175|NCT01741532|471067082|FG000|Overall Study|Medical event|1|||
130847176|NCT01741532|471067083|FG001|Overall Study|Medical event|0|||
130847177|NCT01510145|471067084|FG000|Overall Study|Adverse Event|6|||
130847178|NCT01510145|471067084|FG000|Overall Study|Lost to Follow-up|5|||
130847179|NCT01510145|471067084|FG000|Overall Study|Withdrawal by Subject|6|||
130847180|NCT01510145|471067084|FG000|Overall Study|Relative reported subject withdrew|1|||
130847181|NCT02153346|471067087|FG000|Overall Study|Lost to Follow-up|11|||
130847182|NCT03158272|471067089|FG000|Overall Study|Disease progression|3|||
130847183|NCT03158272|471067090|FG001|Overall Study|Disease progression|3|||
130847184|NCT03158272|471067091|FG002|Overall Study|Disease progression|4|||
130847185|NCT03158272|471067092|FG003|Overall Study|Disease progression|6|||
130847186|NCT03158272|471067089|FG000|Overall Study|Death|0|||
130847187|NCT03158272|471067090|FG001|Overall Study|Death|0|||
130847188|NCT03158272|471067091|FG002|Overall Study|Death|1|||
130847189|NCT03158272|471067092|FG003|Overall Study|Death|0|||
130847190|NCT03158272|471067089|FG000|Overall Study|Other reasons|0|||
130847191|NCT03158272|471067090|FG001|Overall Study|Other reasons|0|||
130847192|NCT03158272|471067091|FG002|Overall Study|Other reasons|1|||
130847193|NCT03158272|471067092|FG003|Overall Study|Other reasons|0|||
130847194|NCT03158272|471067089|FG000|Overall Study|Adverse event unrelated to the drug|0|||
130847195|NCT03158272|471067090|FG001|Overall Study|Adverse event unrelated to the drug|1|||
130847196|NCT03158272|471067091|FG002|Overall Study|Adverse event unrelated to the drug|0|||
130847197|NCT03158272|471067092|FG003|Overall Study|Adverse event unrelated to the drug|0|||
130847198|NCT02366767|471067095|FG000|Overall Study|left for home after 1 day at camp|1|||
130847199|NCT02366767|471067096|FG001|Overall Study|left for home after 1 day at camp|0|||
130847200|NCT02558400|471067099|FG000|Overall Study|Adverse Event|47|||
130847201|NCT02558400|471067100|FG001|Overall Study|Adverse Event|53|||
130847202|NCT02558400|471067101|FG002|Overall Study|Adverse Event|4|||
130847203|NCT02558400|471067099|FG000|Overall Study|Withdrawal by Subject|13|||
130847204|NCT02558400|471067100|FG001|Overall Study|Withdrawal by Subject|9|||
130847205|NCT02558400|471067101|FG002|Overall Study|Withdrawal by Subject|8|||
130847206|NCT02558400|471067099|FG000|Overall Study|Non-Compliant|0|||
130847207|NCT02558400|471067100|FG001|Overall Study|Non-Compliant|1|||
130847208|NCT02558400|471067101|FG002|Overall Study|Non-Compliant|3|||
130847209|NCT02558400|471067099|FG000|Overall Study|Lost to Follow-up|5|||
130847210|NCT02558400|471067100|FG001|Overall Study|Lost to Follow-up|5|||
130847211|NCT02558400|471067101|FG002|Overall Study|Lost to Follow-up|4|||
130847212|NCT02558400|471067099|FG000|Overall Study|Lack of Efficacy|0|||
130847213|NCT02558400|471067100|FG001|Overall Study|Lack of Efficacy|13|||
130847214|NCT02558400|471067101|FG002|Overall Study|Lack of Efficacy|1|||
130847215|NCT02558400|471067099|FG000|Overall Study|Disallowed Concurrent Medication|6|||
130847216|NCT02558400|471067100|FG001|Overall Study|Disallowed Concurrent Medication|7|||
130847217|NCT02558400|471067101|FG002|Overall Study|Disallowed Concurrent Medication|5|||
130847218|NCT02558400|471067099|FG000|Overall Study|Physician Decision|2|||
130847219|NCT02558400|471067100|FG001|Overall Study|Physician Decision|2|||
130847220|NCT02558400|471067101|FG002|Overall Study|Physician Decision|0|||
130847221|NCT02558400|471067099|FG000|Overall Study|Protocol Violation|6|||
130847222|NCT02558400|471067100|FG001|Overall Study|Protocol Violation|3|||
130847223|NCT02558400|471067101|FG002|Overall Study|Protocol Violation|8|||
130847224|NCT02558400|471067099|FG000|Overall Study|Death|0|||
130847225|NCT02558400|471067100|FG001|Overall Study|Death|1|||
130847226|NCT02558400|471067101|FG002|Overall Study|Death|0|||
130847227|NCT02558400|471067099|FG000|Overall Study|Ineligible for the study|0|||
130847228|NCT02558400|471067100|FG001|Overall Study|Ineligible for the study|2|||
130847229|NCT02558400|471067101|FG002|Overall Study|Ineligible for the study|0|||
130847230|NCT03081858|471068811|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
130847231|NCT03081858|471068812|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
130847232|NCT03081858|471068813|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
130847233|NCT03081858|471068814|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
130847234|NCT00262847|471068817|FG000|Overall Study|Disease Progression|309|||
130847235|NCT00262847|471068818|FG001|Overall Study|Disease Progression|274|||
130847236|NCT00262847|471068819|FG002|Overall Study|Disease Progression|195|||
130847237|NCT00262847|471068817|FG000|Overall Study|Patient Refusal|41|||
130847238|NCT00262847|471068818|FG001|Overall Study|Patient Refusal|52|||
130847239|NCT00262847|471068819|FG002|Overall Study|Patient Refusal|47|||
130847240|NCT00262847|471068817|FG000|Overall Study|Adverse Event|74|||
130847241|NCT00262847|471068818|FG001|Overall Study|Adverse Event|88|||
130847242|NCT00262847|471068819|FG002|Overall Study|Adverse Event|108|||
130847243|NCT00262847|471068817|FG000|Overall Study|Death|8|||
130847244|NCT00262847|471068818|FG001|Overall Study|Death|8|||
130847245|NCT00262847|471068819|FG002|Overall Study|Death|11|||
130847246|NCT00262847|471068817|FG000|Overall Study|Concomitant disease|3|||
130847247|NCT00262847|471068818|FG001|Overall Study|Concomitant disease|2|||
130847248|NCT00262847|471068819|FG002|Overall Study|Concomitant disease|4|||
130847249|NCT00262847|471068817|FG000|Overall Study|Other Reasons|79|||
130847250|NCT00262847|471068818|FG001|Overall Study|Other Reasons|88|||
130847251|NCT00262847|471068819|FG002|Overall Study|Other Reasons|27|||
130847252|NCT00262847|471068817|FG000|Overall Study|Did not receive study treatment|4|||
130847253|NCT00262847|471068818|FG001|Overall Study|Did not receive study treatment|1|||
130847254|NCT00262847|471068819|FG002|Overall Study|Did not receive study treatment|4|||
130847255|NCT03966885|471068820|FG000|Overall Study|Death|1|||
130847256|NCT03966885|471068821|FG001|Overall Study|Death|0|||
130847257|NCT03966885|471068820|FG000|Overall Study|Lost to Follow-up|1|||
130847258|NCT03966885|471068821|FG001|Overall Study|Lost to Follow-up|2|||
130847259|NCT03966885|471068820|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
130847260|NCT03966885|471068821|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
130847261|NCT03966885|471068820|FG000|Overall Study|Moved from study area.|0|||
130847262|NCT03966885|471068821|FG001|Overall Study|Moved from study area.|2|||
130847263|NCT05013424|471068840|FG000|Overall Study|Lost to Follow-up|1|||
130847264|NCT05013424|471068841|FG001|Overall Study|Lost to Follow-up|1|||
130847265|NCT05013424|471068842|FG002|Overall Study|Lost to Follow-up|1|||
130847266|NCT05013424|471068840|FG000|Overall Study|Withdrawal by Subject|0|||
130847267|NCT05013424|471068841|FG001|Overall Study|Withdrawal by Subject|1|||
130847268|NCT05013424|471068842|FG002|Overall Study|Withdrawal by Subject|0|||
130847269|NCT03654885|471068843|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
130847270|NCT03654885|471068844|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
130847271|NCT03654885|471068843|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
130847272|NCT03654885|471068844|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
130847273|NCT03654885|471068843|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
130847274|NCT03654885|471068844|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
130847275|NCT03654885|471068843|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
130847276|NCT03654885|471068844|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
130847277|NCT03654885|471068843|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
130847278|NCT03654885|471068844|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
130847279|NCT03654885|471068843|FG000|Overall Study|Adverse Event in Study Eye|3|||
130847280|NCT03654885|471068844|FG001|Overall Study|Adverse Event in Study Eye|0|||
130847281|NCT03654885|471068843|FG000|Overall Study|Consent Withdrawn|1|||
130847282|NCT03654885|471068844|FG001|Overall Study|Consent Withdrawn|0|||
130847283|NCT03654885|471068843|FG000|Overall Study|Death|3|||
130847284|NCT03654885|471068844|FG001|Overall Study|Death|1|||
130847285|NCT03654885|471068843|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
130847286|NCT03654885|471068844|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
130847287|NCT03654885|471068843|FG000|Overall Study|Lost to Follow-up|3|||
130847288|NCT03654885|471068844|FG001|Overall Study|Lost to Follow-up|3|||
130847289|NCT05275582|471068845|FG000|Overall Study|Lost to Follow-up|1|||
130847290|NCT05275582|471068846|FG001|Overall Study|Lost to Follow-up|0|||
130847291|NCT05275582|471068845|FG000|Overall Study|Withdrawal by Subject|0|||
130847292|NCT05275582|471068846|FG001|Overall Study|Withdrawal by Subject|2|||
130847293|NCT05275582|471068845|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
130847294|NCT05275582|471068846|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
130847295|NCT05275582|471068845|FG000|Overall Study|Death|1|||
130847296|NCT05275582|471068846|FG001|Overall Study|Death|0|||
130847297|NCT05275582|471068845|FG000|Overall Study|Protocol Violation|1|||
130847298|NCT05275582|471068846|FG001|Overall Study|Protocol Violation|0|||
130847299|NCT03899064|471068847|FG000|Overall Study|Lost to Follow-up|1|||
130847300|NCT03899064|471068847|FG000|Overall Study|Protocol Violation|2|||
130847301|NCT03899064|471068847|FG000|Overall Study|Withdrawal by Subject|2|||
130847302|NCT03899064|471068847|FG000|Overall Study|Other|2|||
130847303|NCT00031460|471068850|FG000|Overall Study|Lost to Follow-up|0|||
130847304|NCT00031460|471068851|FG001|Overall Study|Lost to Follow-up|1|||
130847305|NCT00031460|471068850|FG000|Overall Study|Withdrawal by Subject|1|||
130847306|NCT00031460|471068851|FG001|Overall Study|Withdrawal by Subject|1|||
130847307|NCT00031460|471068850|FG000|Overall Study|Non-Compliant|1|||
130847308|NCT00031460|471068851|FG001|Overall Study|Non-Compliant|1|||
130847309|NCT00031460|471068850|FG000|Overall Study|Death|0|||
130847310|NCT00031460|471068851|FG001|Overall Study|Death|1|||
130847311|NCT00031460|471068850|FG000|Overall Study|Reactivation of Disease|5|||
130847312|NCT00031460|471068851|FG001|Overall Study|Reactivation of Disease|9|||
130847313|NCT00031460|471068850|FG000|Overall Study|Disruption of blinded drug supply|2|||
130847314|NCT00031460|471068851|FG001|Overall Study|Disruption of blinded drug supply|0|||
130847315|NCT00031460|471068850|FG000|Overall Study|Confirmed unevaluable|0|||
130847316|NCT00031460|471068851|FG001|Overall Study|Confirmed unevaluable|1|||
130847317|NCT02210832|471068852|FG000|Overall Study|Pregnancy termination .|3|||
130847318|NCT02210832|471068853|FG001|Overall Study|Pregnancy termination .|4|||
130847319|NCT02210832|471068854|FG002|Overall Study|Pregnancy termination .|1|||
130847320|NCT02210832|471068852|FG000|Overall Study|Lost to Follow-up|26|||
130847321|NCT02210832|471068853|FG001|Overall Study|Lost to Follow-up|32|||
130847322|NCT02210832|471068854|FG002|Overall Study|Lost to Follow-up|17|||
130847323|NCT02080260|471068858|FG000|Overall Study|Death|18|||
130847324|NCT02080260|471068858|FG000|Overall Study|Withdrawal by Subject|1|||
130847325|NCT00471887|471068862|FG000|Overall Study|Adverse Event|9|||
130847326|NCT03710876|471068863|FG000|Overall Study|Death|0|||
130847327|NCT03710876|471068864|FG001|Overall Study|Death|2|||
130847328|NCT03710876|471068863|FG000|Overall Study|Withdrawal by Subject|0|||
130847329|NCT03710876|471068864|FG001|Overall Study|Withdrawal by Subject|2|||
130847330|NCT03602885|471068873|FG000|Overall Study|Lost to Follow-up|3|||
130847331|NCT03602885|471068874|FG001|Overall Study|Lost to Follow-up|0|||
130847332|NCT01030874|471068876|FG000|Overall Study|Withdrawal by Subject|1|||
130847333|NCT01030874|471068877|FG001|Overall Study|Withdrawal by Subject|0|||
130847334|NCT01030874|471068876|FG000|Overall Study|Discharged in first 2 weeks|17|||
130847335|NCT01030874|471068877|FG001|Overall Study|Discharged in first 2 weeks|16|||
130847336|NCT03106415|471068878|FG000|Phase 1|Withdrawal by Subject|1|||
130847337|NCT03106415|471068879|FG001|Phase 1|Withdrawal by Subject|0|||
130847338|NCT03106415|471068880|FG002|Phase 1|Withdrawal by Subject|0|||
130847339|NCT03106415|471068878|FG000|Phase 1|Adverse Event|1|||
130847340|NCT03106415|471068879|FG001|Phase 1|Adverse Event|1|||
130847341|NCT03106415|471068880|FG002|Phase 1|Adverse Event|0|||
130847342|NCT03106415|471068878|FG000|Phase 1|Protocol Violation|0|||
130847343|NCT03106415|471068879|FG001|Phase 1|Protocol Violation|1|||
130847344|NCT03106415|471068880|FG002|Phase 1|Protocol Violation|0|||
130847345|NCT02046174|471068881|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
130847346|NCT02046174|471068882|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
130847347|NCT02118597|471068883|FG000|Overall Study|Sponsor terminated the study|14|||
130847348|NCT02118597|471068883|FG000|Overall Study|Serious Adverse Event|1|||
130847349|NCT02118597|471068883|FG000|Overall Study|Investigator's decision|1|||
130847350|NCT01891344|471068884|FG000|Overall Study|Ongoing|6|||
130847351|NCT01891344|471068885|FG001|Overall Study|Ongoing|2|||
130847352|NCT01891344|471068886|FG002|Overall Study|Ongoing|0|||
130847353|NCT01891344|471068887|FG003|Overall Study|Ongoing|1|||
130847354|NCT01891344|471068888|FG004|Overall Study|Ongoing|4|||
130847355|NCT01891344|471068889|FG005|Overall Study|Ongoing|1|||
130847356|NCT01891344|471068890|FG006|Overall Study|Ongoing|0|||
130847357|NCT01891344|471068891|FG007|Overall Study|Ongoing|0|||
130847358|NCT03294135|471068892|FG000|Overall Study|Serious Adverse Event|1|||
130847359|NCT03294135|471068893|FG001|Overall Study|Serious Adverse Event|0|||
130847360|NCT03294135|471068894|FG002|Overall Study|Serious Adverse Event|0|||
130847361|NCT03294135|471068892|FG000|Overall Study|Lost to Follow-up|1|||
130847362|NCT03294135|471068893|FG001|Overall Study|Lost to Follow-up|0|||
130847363|NCT03294135|471068894|FG002|Overall Study|Lost to Follow-up|1|||
130847364|NCT03294135|471068892|FG000|Overall Study|Withdrawal by Subject|0|||
130847365|NCT03294135|471068893|FG001|Overall Study|Withdrawal by Subject|0|||
130847366|NCT03294135|471068894|FG002|Overall Study|Withdrawal by Subject|1|||
130847367|NCT03294135|471068892|FG000|Overall Study|Other|2|||
130847368|NCT03294135|471068893|FG001|Overall Study|Other|0|||
130847369|NCT03294135|471068894|FG002|Overall Study|Other|0|||
130847370|NCT00186537|471068895|FG000|Overall Study|Withdrawal by Subject|4|||
130847371|NCT00186537|471068896|FG001|Overall Study|Withdrawal by Subject|0|||
130847372|NCT00186537|471068897|FG002|Overall Study|Withdrawal by Subject|3|||
130847373|NCT00186537|471068895|FG000|Overall Study|ALT > 1.5 x ULN|3|||
130847374|NCT00186537|471068896|FG001|Overall Study|ALT > 1.5 x ULN|0|||
130847375|NCT00186537|471068897|FG002|Overall Study|ALT > 1.5 x ULN|0|||
130847376|NCT02763254|471068898|FG000|Overall Study|Adverse Event|1|||
130847377|NCT03684304|471068899|FG000|Overall Study|Lost to Follow-up|19|||
130847378|NCT03684304|471068900|FG001|Overall Study|Lost to Follow-up|17|||
130847379|NCT01143051|471068901|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
130847380|NCT01143051|471068902|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
130847381|NCT01143051|471068903|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
130847382|NCT01143051|471068904|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
130847383|NCT01143051|471068905|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
130847384|NCT01143051|471068906|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
130847385|NCT01143051|471068901|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
130847386|NCT01143051|471068902|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
130847387|NCT01143051|471068903|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
130847388|NCT01143051|471068904|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
130847389|NCT01143051|471068905|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
130847390|NCT01143051|471068906|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
130847391|NCT01665430|471068907|FG000|Overall Study|Adverse Event|1|||
130847392|NCT01665430|471068907|FG000|Overall Study|Withdrawal by Subject|6|||
130847393|NCT01665430|471068907|FG000|Overall Study|Other Unspecified|2|||
130847394|NCT02310230|471068908|FG000|Overall Study|Physician Decision|1|||
130847395|NCT02310230|471068909|FG001|Overall Study|Physician Decision|3|||
130847396|NCT02310230|471068908|FG000|Overall Study|monitor baseline taken after induction|2|||
130847397|NCT02310230|471068909|FG001|Overall Study|monitor baseline taken after induction|7|||
130847398|NCT02310230|471068908|FG000|Overall Study|Poor signal quality|5|||
130847399|NCT02310230|471068909|FG001|Overall Study|Poor signal quality|8|||
130847400|NCT02310230|471068908|FG000|Overall Study|Case cancelled|1|||
130847401|NCT02310230|471068909|FG001|Overall Study|Case cancelled|0|||
130847402|NCT03249935|471068910|FG000|Overall Study|Discharged from facility early|36|||
130847403|NCT03249935|471068910|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
130847404|NCT03249935|471068910|FG000|Overall Study|Protocol Violation|5|||
130847405|NCT03593681|471068911|FG000|Overall Study|Inadequate sample collected|12|||
130847406|NCT03593681|471068911|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
130847407|NCT03593681|471068911|FG000|Overall Study|Protocol Violation|3|||
130847408|NCT03593681|471068911|FG000|Overall Study|Withdrawal by Subject|3|||
130847409|NCT03593681|471068911|FG000|Overall Study|Procedure not attempted|3|||
130847410|NCT03593681|471068911|FG000|Overall Study|Adverse Event|2|||
130847411|NCT03593681|471068911|FG000|Overall Study|Physician Decision|1|||
130847412|NCT01669421|471068915|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
130847413|NCT01669421|471068915|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
130847414|NCT01605227|471068919|FG000|Overall Study|Did not receive study treatment|2|||
130847415|NCT01605227|471068920|FG001|Overall Study|Did not receive study treatment|3|||
130847416|NCT01605227|471068919|FG000|Overall Study|Adverse Event|228|||
130847417|NCT01605227|471068920|FG001|Overall Study|Adverse Event|42|||
130847418|NCT01605227|471068919|FG000|Overall Study|Progressive Disease|132|||
130847419|NCT01605227|471068920|FG001|Overall Study|Progressive Disease|128|||
130847420|NCT01605227|471068919|FG000|Overall Study|Clinical Deterioration|227|||
130847421|NCT01605227|471068920|FG001|Overall Study|Clinical Deterioration|133|||
130847422|NCT01605227|471068919|FG000|Overall Study|Lost to Follow-up|1|||
130847423|NCT01605227|471068920|FG001|Overall Study|Lost to Follow-up|0|||
130847424|NCT01605227|471068919|FG000|Overall Study|Protocol Violation|1|||
130847425|NCT01605227|471068920|FG001|Overall Study|Protocol Violation|0|||
130847426|NCT01605227|471068919|FG000|Overall Study|Physician Decision|9|||
130847427|NCT01605227|471068920|FG001|Overall Study|Physician Decision|7|||
130847428|NCT01605227|471068919|FG000|Overall Study|Withdrawal by Subject|18|||
130847429|NCT01605227|471068920|FG001|Overall Study|Withdrawal by Subject|14|||
130847430|NCT01605227|471068919|FG000|Overall Study|Sponsor Decision|2|||
130847431|NCT01605227|471068920|FG001|Overall Study|Sponsor Decision|0|||
130847432|NCT01605227|471068919|FG000|Overall Study|Started New Therapy|1|||
130847433|NCT01605227|471068920|FG001|Overall Study|Started New Therapy|0|||
130847434|NCT01605227|471068919|FG000|Overall Study|Subject Decision|0|||
130847435|NCT01605227|471068920|FG001|Overall Study|Subject Decision|1|||
130847436|NCT01605227|471068919|FG000|Overall Study|Dose Held >6 weeks|0|||
130847437|NCT01605227|471068920|FG001|Overall Study|Dose Held >6 weeks|1|||
130847438|NCT02961790|471068921|FG000|Overall Study|Canceled|4|||
130847439|NCT02961790|471068922|FG001|Overall Study|Canceled|5|||
130847440|NCT02961790|471068923|FG002|Overall Study|Canceled|1|||
130847441|NCT02961790|471068924|FG003|Overall Study|Canceled|4|||
130847442|NCT02961790|471068921|FG000|Overall Study|without baseline data|4|||
130847443|NCT02961790|471068922|FG001|Overall Study|without baseline data|0|||
130847444|NCT02961790|471068923|FG002|Overall Study|without baseline data|1|||
130847445|NCT02961790|471068924|FG003|Overall Study|without baseline data|0|||
130847446|NCT02961790|471068921|FG000|Overall Study|without post baseline data|7|||
130847447|NCT02961790|471068922|FG001|Overall Study|without post baseline data|6|||
130847448|NCT02961790|471068923|FG002|Overall Study|without post baseline data|4|||
130847449|NCT02961790|471068924|FG003|Overall Study|without post baseline data|1|||
130847450|NCT02078102|471068925|FG000|Overall Study|Adverse Event|1|||
130847451|NCT02078102|471068926|FG001|Overall Study|Adverse Event|0|||
130847452|NCT02078102|471068925|FG000|Overall Study|Withdrawal by Subject|1|||
130847453|NCT02078102|471068926|FG001|Overall Study|Withdrawal by Subject|0|||
130847454|NCT02078102|471068925|FG000|Overall Study|Physician Decision|0|||
130847455|NCT02078102|471068926|FG001|Overall Study|Physician Decision|1|||
130847456|NCT03093974|471068929|FG000|Overall Study|Withdrawal by Subject|32|||
130847457|NCT03093974|471068930|FG001|Overall Study|Withdrawal by Subject|27|||
130847458|NCT03093974|471068929|FG000|Overall Study|Adverse Event|17|||
130847459|NCT03093974|471068930|FG001|Overall Study|Adverse Event|24|||
130847460|NCT03093974|471068929|FG000|Overall Study|Death|0|||
130847461|NCT03093974|471068930|FG001|Overall Study|Death|1|||
130847462|NCT03093974|471068929|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130847463|NCT03093974|471068930|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130847464|NCT03093974|471068929|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
130847465|NCT03093974|471068930|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
130847466|NCT03093974|471068929|FG000|Overall Study|Lost to Follow-up|0|||
130847467|NCT03093974|471068930|FG001|Overall Study|Lost to Follow-up|1|||
130847468|NCT03093974|471068929|FG000|Overall Study|Other|1|||
130847469|NCT03093974|471068930|FG001|Overall Study|Other|2|||
130847470|NCT01813721|471068933|FG000|Overall Study|Ineligibility determined|63|||
130847471|NCT01813721|471068933|FG000|Overall Study|Withdrawal by Subject|1|||
130847472|NCT01866423|471068934|FG000|Overall Study|Lack of Efficacy|3|||
130847473|NCT01866423|471068934|FG000|Overall Study|Sponsor Decision|1|||
130847474|NCT02387164|471068935|FG000|Overall Study|Lost to Follow-up|2|||
130847475|NCT02387164|471068936|FG001|Overall Study|Lost to Follow-up|0|||
130847476|NCT02387164|471068935|FG000|Overall Study|Diagnosed|1|||
130847477|NCT02387164|471068936|FG001|Overall Study|Diagnosed|2|||
130847478|NCT00343915|471068937|FG000|Primary Study|Withdrawal by Subject|1|||
130847479|NCT00343915|471068938|FG001|Primary Study|Withdrawal by Subject|0|||
130847480|NCT00343915|471068937|FG000|Primary Study|Lost to Follow-up|2|||
130847481|NCT00343915|471068938|FG001|Primary Study|Lost to Follow-up|3|||
130847482|NCT00343915|471068937|FG000|Primary Study|Other|1|||
130847483|NCT00343915|471068938|FG001|Primary Study|Other|0|||
130847484|NCT00882908|471068939|FG000|Overall Study|Adverse Event|0|||
130847485|NCT00882908|471068940|FG001|Overall Study|Adverse Event|0|||
130847486|NCT00882908|471068941|FG002|Overall Study|Adverse Event|1|||
130847487|NCT00882908|471068942|FG003|Overall Study|Adverse Event|0|||
130847488|NCT00882908|471068943|FG004|Overall Study|Adverse Event|1|||
130847489|NCT00882908|471068939|FG000|Overall Study|Lost to Follow-up|3|||
130847490|NCT00882908|471068940|FG001|Overall Study|Lost to Follow-up|5|||
130847491|NCT00882908|471068941|FG002|Overall Study|Lost to Follow-up|3|||
130847492|NCT00882908|471068942|FG003|Overall Study|Lost to Follow-up|1|||
130847493|NCT00882908|471068943|FG004|Overall Study|Lost to Follow-up|2|||
130847494|NCT00882908|471068939|FG000|Overall Study|Protocol Violation|0|||
130847495|NCT00882908|471068940|FG001|Overall Study|Protocol Violation|1|||
130847496|NCT00882908|471068941|FG002|Overall Study|Protocol Violation|0|||
130847497|NCT00882908|471068942|FG003|Overall Study|Protocol Violation|0|||
130847498|NCT00882908|471068943|FG004|Overall Study|Protocol Violation|0|||
130847499|NCT00882908|471068939|FG000|Overall Study|Withdrawal by Subject|0|||
130847500|NCT00882908|471068940|FG001|Overall Study|Withdrawal by Subject|0|||
130847501|NCT00882908|471068941|FG002|Overall Study|Withdrawal by Subject|3|||
130847502|NCT00882908|471068942|FG003|Overall Study|Withdrawal by Subject|5|||
130847503|NCT00882908|471068943|FG004|Overall Study|Withdrawal by Subject|2|||
130847504|NCT00882908|471068939|FG000|Overall Study|Subject reached a virologic endpoint|0|||
130847505|NCT00882908|471068940|FG001|Overall Study|Subject reached a virologic endpoint|0|||
130847506|NCT00882908|471068941|FG002|Overall Study|Subject reached a virologic endpoint|0|||
130847507|NCT00882908|471068942|FG003|Overall Study|Subject reached a virologic endpoint|0|||
130847508|NCT00882908|471068943|FG004|Overall Study|Subject reached a virologic endpoint|1|||
130847509|NCT00882908|471068939|FG000|Overall Study|Study terminated in error|0|||
130847510|NCT00882908|471068940|FG001|Overall Study|Study terminated in error|0|||
130847511|NCT00882908|471068941|FG002|Overall Study|Study terminated in error|0|||
130847512|NCT00882908|471068942|FG003|Overall Study|Study terminated in error|1|||
130847513|NCT00882908|471068943|FG004|Overall Study|Study terminated in error|0|||
130847514|NCT05291936|471068944|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130847515|NCT05291936|471068945|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
130847516|NCT05291936|471068944|FG000|Period 1|Withdrew Consent during study|1|||
130847517|NCT05291936|471068945|FG001|Period 1|Withdrew Consent during study|0|||
130847518|NCT05291936|471068944|FG000|Period 2|Adverse Event|0|||
130847519|NCT05291936|471068945|FG001|Period 2|Adverse Event|1|||
130847520|NCT05291936|471068944|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
130847521|NCT05291936|471068945|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130847522|NCT00581828|471068946|FG000|Overall Study|Protocol Violation|1|||
130847523|NCT02370095|471068947|FG000|Overall Study|Withdrawal by Subject|0|||
130847524|NCT02370095|471068948|FG001|Overall Study|Withdrawal by Subject|1|||
130847525|NCT01667562|471068952|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
130847526|NCT01667562|471068953|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
130847527|NCT01667562|471068952|FG000|Erlotinib Phase|Lost to Follow-up|0|||
130847528|NCT01667562|471068953|FG001|Erlotinib Phase|Lost to Follow-up|1|||
130847529|NCT01667562|471068952|FG000|Erlotinib Phase|Adverse Event|0|||
130847530|NCT01667562|471068953|FG001|Erlotinib Phase|Adverse Event|1|||
130847531|NCT01667562|471068952|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
130847532|NCT01667562|471068953|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
130847533|NCT01129882|471068954|FG000|Overall Study|Adverse Event|39|||
130847534|NCT01129882|471068954|FG000|Overall Study|Death|6|||
130847535|NCT01129882|471068954|FG000|Overall Study|Lack of Efficacy|5|||
130847536|NCT01129882|471068954|FG000|Overall Study|Lost to Follow-up|13|||
130847537|NCT01129882|471068954|FG000|Overall Study|Physician Decision|27|||
130847538|NCT01129882|471068954|FG000|Overall Study|Protocol Deviation|3|||
130847539|NCT01129882|471068954|FG000|Overall Study|Withdrawal Criteria Met|19|||
130847540|NCT01129882|471068954|FG000|Overall Study|Trial Termination by Sponsor|6|||
130847541|NCT01129882|471068954|FG000|Overall Study|Withdrawal by Subject|160|||
130847542|NCT02130986|471068955|FG000|Overall Study|Withdrawal by Subject|4|||
130847543|NCT02130986|471068956|FG001|Overall Study|Withdrawal by Subject|4|||
130847544|NCT02130986|471068955|FG000|Overall Study|Lost to Follow-up|151|||
130847545|NCT02130986|471068956|FG001|Overall Study|Lost to Follow-up|160|||
130847546|NCT05590000|471068957|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
130847547|NCT00762996|471068958|FG000|Period One|Protocol Violation|0|||
130847548|NCT00762996|471068959|FG001|Period One|Protocol Violation|0|||
130847549|NCT00762996|471068960|FG002|Period One|Protocol Violation|1|||
130847550|NCT00762996|471068961|FG003|Period One|Protocol Violation|0|||
130847551|NCT00762996|471068958|FG000|Period One|ineligible|0|||
130847552|NCT00762996|471068959|FG001|Period One|ineligible|0|||
130847553|NCT00762996|471068960|FG002|Period One|ineligible|1|||
130847554|NCT00762996|471068961|FG003|Period One|ineligible|1|||
130847555|NCT00762996|471068958|FG000|Period One|Adverse Event|0|||
130847556|NCT00762996|471068959|FG001|Period One|Adverse Event|0|||
130847557|NCT00762996|471068960|FG002|Period One|Adverse Event|1|||
130847558|NCT00762996|471068961|FG003|Period One|Adverse Event|0|||
130847559|NCT00762996|471068958|FG000|Period One|Withdrawal by Subject|0|||
130847560|NCT00762996|471068959|FG001|Period One|Withdrawal by Subject|0|||
130847561|NCT00762996|471068960|FG002|Period One|Withdrawal by Subject|1|||
130847562|NCT00762996|471068961|FG003|Period One|Withdrawal by Subject|0|||
130847563|NCT00536874|471068962|FG000|Overall Study|Adverse Event|1|||
130847564|NCT00536874|471068962|FG000|Overall Study|Death|2|||
130847565|NCT00536874|471068962|FG000|Overall Study|Withdrawal by Subject|1|||
130847566|NCT02689076|471068964|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
130847567|NCT02689076|471068965|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
130847568|NCT02689076|471068966|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
130847569|NCT02689076|471068964|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
130847570|NCT02689076|471068965|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
130847571|NCT02689076|471068966|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
130847572|NCT02689076|471068964|FG000|Overall Study|Did not have an HIE match|2|||
130847573|NCT02689076|471068965|FG001|Overall Study|Did not have an HIE match|0|||
130847574|NCT02689076|471068966|FG002|Overall Study|Did not have an HIE match|0|||
130847575|NCT02689076|471068964|FG000|Overall Study|Death during non-VA encounter|2|||
130847576|NCT02689076|471068965|FG001|Overall Study|Death during non-VA encounter|5|||
130847577|NCT02689076|471068966|FG002|Overall Study|Death during non-VA encounter|0|||
130847578|NCT02689076|471068964|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
130847579|NCT02689076|471068965|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
130847580|NCT02689076|471068966|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
130847581|NCT02689076|471068964|FG000|Overall Study|Participant no longer active in VA system|1|||
130847582|NCT02689076|471068965|FG001|Overall Study|Participant no longer active in VA system|0|||
130847583|NCT02689076|471068966|FG002|Overall Study|Participant no longer active in VA system|0|||
130847584|NCT02689076|471068964|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
130847585|NCT02689076|471068965|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
130847586|NCT02689076|471068966|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
130847587|NCT02084238|471068967|FG000|Overall Study|Lost to Follow-up|2|||
130847588|NCT01304329|471068968|FG000|Third Intervention (3 Days)|Adverse Event|0|||
130847589|NCT01304329|471068969|FG001|Third Intervention (3 Days)|Adverse Event|1|||
130847590|NCT01304329|471068970|FG002|Third Intervention (3 Days)|Adverse Event|0|||
130847591|NCT01304329|471068971|FG003|Third Intervention (3 Days)|Adverse Event|0|||
130847592|NCT01304329|471068972|FG004|Third Intervention (3 Days)|Adverse Event|0|||
130847593|NCT01304329|471068973|FG005|Third Intervention (3 Days)|Adverse Event|0|||
130847594|NCT00993499|471068980|FG000|Run-in Period (8 Days)|Adverse Event|0|||
130847595|NCT00993499|471068981|FG001|Run-in Period (8 Days)|Adverse Event|1|||
130847596|NCT00993499|471068982|FG002|Run-in Period (8 Days)|Adverse Event|0|||
130847597|NCT00993499|471068983|FG003|Run-in Period (8 Days)|Adverse Event|0|||
130847598|NCT00993499|471068984|FG004|Run-in Period (8 Days)|Adverse Event|0|||
130847599|NCT00993499|471068985|FG005|Run-in Period (8 Days)|Adverse Event|0|||
130847600|NCT00993499|471068980|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
130847601|NCT00993499|471068981|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130847602|NCT00993499|471068982|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130847603|NCT00993499|471068983|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130847604|NCT00993499|471068984|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130847605|NCT00993499|471068985|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130847606|NCT00993499|471068980|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
130847607|NCT00993499|471068981|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
130847608|NCT00993499|471068982|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
130847609|NCT00993499|471068983|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
130847610|NCT00993499|471068984|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
130847611|NCT00993499|471068985|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
130847612|NCT00993499|471068980|FG000|Run-in Period (8 Days)|Progressive disease|0|||
130847613|NCT00993499|471068981|FG001|Run-in Period (8 Days)|Progressive disease|1|||
130847614|NCT00993499|471068982|FG002|Run-in Period (8 Days)|Progressive disease|1|||
130847615|NCT00993499|471068983|FG003|Run-in Period (8 Days)|Progressive disease|0|||
130847616|NCT00993499|471068984|FG004|Run-in Period (8 Days)|Progressive disease|0|||
130847617|NCT00993499|471068985|FG005|Run-in Period (8 Days)|Progressive disease|0|||
130847618|NCT00993499|471068980|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
130847619|NCT00993499|471068981|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
130847620|NCT00993499|471068982|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
130847621|NCT00993499|471068983|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
130847622|NCT00993499|471068984|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
130847623|NCT00993499|471068985|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
130847624|NCT00993499|471068980|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
130847625|NCT00993499|471068981|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
130847626|NCT00993499|471068982|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130847627|NCT00993499|471068983|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130847628|NCT00993499|471068984|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130847629|NCT00993499|471068985|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130847630|NCT00993499|471068980|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130847631|NCT00993499|471068981|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130847632|NCT00993499|471068982|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
130847633|NCT00993499|471068983|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
130847634|NCT00993499|471068984|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130847635|NCT00993499|471068985|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130847636|NCT00993499|471068980|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130847637|NCT00993499|471068981|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130847638|NCT00993499|471068982|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
130847639|NCT00993499|471068983|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130847640|NCT00993499|471068984|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130847641|NCT00993499|471068985|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130847642|NCT00993499|471068980|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130847643|NCT00993499|471068981|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
130847644|NCT00993499|471068982|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130847645|NCT00993499|471068983|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130847646|NCT00993499|471068984|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130847647|NCT00993499|471068985|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130847648|NCT00993499|471068980|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
130847649|NCT00993499|471068981|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
130847650|NCT00993499|471068982|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
130847651|NCT00993499|471068983|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
130847652|NCT00993499|471068984|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
130847653|NCT00993499|471068985|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
130847654|NCT00993499|471068980|FG000|Discontinued After Starting Course 3|DLT|1|||
130847655|NCT00993499|471068981|FG001|Discontinued After Starting Course 3|DLT|0|||
130847656|NCT00993499|471068982|FG002|Discontinued After Starting Course 3|DLT|2|||
130847657|NCT00993499|471068983|FG003|Discontinued After Starting Course 3|DLT|1|||
130847658|NCT00993499|471068984|FG004|Discontinued After Starting Course 3|DLT|0|||
130847659|NCT00993499|471068985|FG005|Discontinued After Starting Course 3|DLT|0|||
130847660|NCT00993499|471068980|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
130847661|NCT00993499|471068981|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
130847662|NCT00993499|471068982|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
130847663|NCT00993499|471068983|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
130847664|NCT00993499|471068984|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
130847665|NCT00993499|471068985|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
130847666|NCT01406015|471068994|FG000|Overall Study|Withdrawal by Subject|3|||
130847667|NCT01406015|471068995|FG001|Overall Study|Withdrawal by Subject|3|||
130847668|NCT00844805|471068996|FG000|Treatment Phase|Adverse Event|5|||
130847669|NCT00844805|471068997|FG001|Treatment Phase|Adverse Event|1|||
130847670|NCT00844805|471068998|FG002|Treatment Phase|Adverse Event|0|||
130847671|NCT00844805|471068999|FG003|Treatment Phase|Adverse Event|0|||
130847672|NCT00844805|471068996|FG000|Treatment Phase|Withdrawal by Subject|3|||
130847673|NCT00844805|471068997|FG001|Treatment Phase|Withdrawal by Subject|4|||
130847674|NCT00844805|471068998|FG002|Treatment Phase|Withdrawal by Subject|0|||
130847675|NCT00844805|471068999|FG003|Treatment Phase|Withdrawal by Subject|0|||
130847676|NCT00844805|471068996|FG000|Treatment Phase|Noncompliance With Protocol|1|||
130847677|NCT00844805|471068997|FG001|Treatment Phase|Noncompliance With Protocol|0|||
130847678|NCT00844805|471068998|FG002|Treatment Phase|Noncompliance With Protocol|0|||
130847679|NCT00844805|471068999|FG003|Treatment Phase|Noncompliance With Protocol|0|||
130847680|NCT00844805|471068996|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
130847681|NCT00844805|471068997|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
130847682|NCT00844805|471068998|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
130847683|NCT00844805|471068999|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
130847684|NCT00844805|471068996|FG000|Follow-Up Phase|Adverse Event|0|||
130847685|NCT00844805|471068997|FG001|Follow-Up Phase|Adverse Event|0|||
130847686|NCT00844805|471068998|FG002|Follow-Up Phase|Adverse Event|1|||
130847687|NCT00844805|471068999|FG003|Follow-Up Phase|Adverse Event|0|||
130847688|NCT00844805|471068996|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
130847689|NCT00844805|471068997|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
130847690|NCT00844805|471068998|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
130847691|NCT00844805|471068999|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
130847692|NCT00844805|471068996|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
130847693|NCT00844805|471068997|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
130847694|NCT00844805|471068998|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
130847695|NCT00844805|471068999|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
130847696|NCT00844805|471068996|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
130847697|NCT00844805|471068997|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
130847698|NCT00844805|471068998|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
130847699|NCT00844805|471068999|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
130847700|NCT00844805|471068996|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
130847701|NCT00844805|471068997|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
130847702|NCT00844805|471068998|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
130847703|NCT00844805|471068999|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
130847704|NCT00387647|471070706|FG000|Overall Study|Death|18|||
130847705|NCT01309269|471070709|FG000|Overall Study|Adverse Event|56|||
130847706|NCT01309269|471070709|FG000|Overall Study|Withdrawal by Subject|25|||
130847707|NCT01309269|471070709|FG000|Overall Study|Lack of Acceptance|15|||
130847708|NCT01309269|471070709|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
130847709|NCT01309269|471070709|FG000|Overall Study|Kidney Transplant|25|||
130847710|NCT01309269|471070709|FG000|Overall Study|Administrative Problems|141|||
130847711|NCT01309269|471070709|FG000|Overall Study|Other|256|||
130847712|NCT01309269|471070709|FG000|Overall Study|Other|1|||
130847713|NCT01309269|471070709|FG000|Overall Study|Study Completion Data Not Recorded|95|||
130847714|NCT01309269|471070709|FG000|Overall Study|Enrolled but not Treated|107|||
130847715|NCT03131596|471070712|FG000|Overall Study|Protocol Violation|3|||
130847716|NCT03131596|471070713|FG001|Overall Study|Protocol Violation|3|||
130847717|NCT03131596|471070712|FG000|Overall Study|Lost to Follow-up|3|||
130847718|NCT03131596|471070713|FG001|Overall Study|Lost to Follow-up|0|||
130847719|NCT04411420|471070714|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
130847720|NCT04411420|471070715|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
130847721|NCT04411420|471070714|FG000|Survey Subset|Lost to Follow-up|134|||
130847722|NCT04411420|471070715|FG001|Survey Subset|Lost to Follow-up|120|||
130847723|NCT03769311|471070718|FG000|Overall Study|Withdrawal by Subject|1|||
130847724|NCT01596335|471070719|FG000|Overall Study|exacerbation of primary disease|5|||
130847725|NCT01596335|471070720|FG001|Overall Study|exacerbation of primary disease|9|||
130847726|NCT03627065|471070721|FG000|Overall Study|Study Terminated by sponsor|1|||
130847727|NCT03627065|471070721|FG000|Overall Study|Withdrawal by Subject|2|||
130847728|NCT04524455|471070722|FG000|Overall Study|Death|3|||
130847729|NCT04524455|471070723|FG001|Overall Study|Death|3|||
130847730|NCT04524455|471070722|FG000|Overall Study|Decision by Sponsor|0|||
130847731|NCT04524455|471070723|FG001|Overall Study|Decision by Sponsor|2|||
130847732|NCT04524455|471070722|FG000|Overall Study|Withdrawal of Consent From Study|1|||
130847733|NCT04524455|471070723|FG001|Overall Study|Withdrawal of Consent From Study|0|||
130847734|NCT04524455|471070722|FG000|Overall Study|Lost to Follow-up|0|||
130847735|NCT04524455|471070723|FG001|Overall Study|Lost to Follow-up|1|||
130847736|NCT00289198|471070728|FG000|Overall Study|Adverse Event|0|||
130847737|NCT00289198|471070729|FG001|Overall Study|Adverse Event|2|||
130847738|NCT00289198|471070728|FG000|Overall Study|Protocol Violation|2|||
130847739|NCT00289198|471070729|FG001|Overall Study|Protocol Violation|1|||
130847740|NCT00289198|471070728|FG000|Overall Study|Withdrawal by Subject|4|||
130847741|NCT00289198|471070729|FG001|Overall Study|Withdrawal by Subject|1|||
130847742|NCT00289198|471070728|FG000|Overall Study|Lack of Efficacy|2|||
130847743|NCT00289198|471070729|FG001|Overall Study|Lack of Efficacy|0|||
130847744|NCT00289198|471070728|FG000|Overall Study|Other: Low compliance|0|||
130847745|NCT00289198|471070729|FG001|Overall Study|Other: Low compliance|1|||
130847746|NCT00289198|471070728|FG000|Overall Study|Other: Physician's decision|0|||
130847747|NCT00289198|471070729|FG001|Overall Study|Other: Physician's decision|1|||
130847748|NCT00289198|471070728|FG000|Overall Study|Other: Unable to attend on schedule|2|||
130847749|NCT00289198|471070729|FG001|Overall Study|Other: Unable to attend on schedule|1|||
130847750|NCT00289198|471070728|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
130847751|NCT00289198|471070729|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
130847752|NCT00289198|471070728|FG000|Overall Study|Other: Impossible to come on visit|0|||
130847753|NCT00289198|471070729|FG001|Overall Study|Other: Impossible to come on visit|1|||
130847754|NCT01176565|471070730|FG000|Overall Study|Lost to Follow-up|12|||
130847755|NCT01176565|471070731|FG001|Overall Study|Lost to Follow-up|16|||
130847756|NCT01176565|471070730|FG000|Overall Study|Withdrawal by Subject|7|||
130847757|NCT01176565|471070731|FG001|Overall Study|Withdrawal by Subject|1|||
130847758|NCT01176565|471070730|FG000|Overall Study|Not Analyzed (any other reason)|1|||
130847759|NCT01176565|471070731|FG001|Overall Study|Not Analyzed (any other reason)|2|||
130847760|NCT01062061|471070734|FG000|Overall Study|Enrolled more than once|2|||
130847761|NCT01062061|471070734|FG000|Overall Study|Investigated before study start|13|||
130847762|NCT01062061|471070734|FG000|Overall Study|Outside chief indications|10|||
130847763|NCT01062061|471070734|FG000|Overall Study|Failed to meet inclusion criteria|2|||
130847764|NCT00524589|471070735|FG000|Overall Study|Withdrawal by Subject|2|||
130847765|NCT00524589|471070735|FG000|Overall Study|Disease Progression|16|||
130847766|NCT00098722|471070738|FG000|Double Blind Phase|Adverse Event|7|||
130847767|NCT00098722|471070739|FG001|Double Blind Phase|Adverse Event|7|||
130847768|NCT00098722|471070740|FG002|Double Blind Phase|Adverse Event|3|||
130847769|NCT00098722|471070741|FG003|Double Blind Phase|Adverse Event|0|||
130847770|NCT00098722|471070742|FG004|Double Blind Phase|Adverse Event|0|||
130847771|NCT00098722|471070743|FG005|Double Blind Phase|Adverse Event|0|||
130847772|NCT00098722|471070744|FG006|Double Blind Phase|Adverse Event|0|||
130847773|NCT00098722|471070738|FG000|Double Blind Phase|Death|2|||
130847774|NCT00098722|471070739|FG001|Double Blind Phase|Death|5|||
130847775|NCT00098722|471070740|FG002|Double Blind Phase|Death|0|||
130847776|NCT00098722|471070741|FG003|Double Blind Phase|Death|0|||
130847777|NCT00098722|471070742|FG004|Double Blind Phase|Death|0|||
130847778|NCT00098722|471070743|FG005|Double Blind Phase|Death|0|||
130847779|NCT00098722|471070744|FG006|Double Blind Phase|Death|0|||
130847780|NCT00098722|471070738|FG000|Double Blind Phase|Lack of Efficacy|21|||
130847781|NCT00098722|471070739|FG001|Double Blind Phase|Lack of Efficacy|23|||
130847782|NCT00098722|471070740|FG002|Double Blind Phase|Lack of Efficacy|15|||
130847783|NCT00098722|471070741|FG003|Double Blind Phase|Lack of Efficacy|0|||
130847784|NCT00098722|471070742|FG004|Double Blind Phase|Lack of Efficacy|0|||
130847785|NCT00098722|471070743|FG005|Double Blind Phase|Lack of Efficacy|0|||
130847786|NCT00098722|471070744|FG006|Double Blind Phase|Lack of Efficacy|0|||
130847787|NCT00098722|471070738|FG000|Double Blind Phase|Participant defaulted|16|||
130847788|NCT00098722|471070739|FG001|Double Blind Phase|Participant defaulted|11|||
130847789|NCT00098722|471070740|FG002|Double Blind Phase|Participant defaulted|9|||
130847790|NCT00098722|471070741|FG003|Double Blind Phase|Participant defaulted|0|||
130847791|NCT00098722|471070742|FG004|Double Blind Phase|Participant defaulted|0|||
130847792|NCT00098722|471070743|FG005|Double Blind Phase|Participant defaulted|0|||
130847793|NCT00098722|471070744|FG006|Double Blind Phase|Participant defaulted|0|||
130847794|NCT00098722|471070738|FG000|Double Blind Phase|Pregnancy|1|||
130847795|NCT00098722|471070739|FG001|Double Blind Phase|Pregnancy|0|||
130847796|NCT00098722|471070740|FG002|Double Blind Phase|Pregnancy|0|||
130847797|NCT00098722|471070741|FG003|Double Blind Phase|Pregnancy|0|||
130847798|NCT00098722|471070742|FG004|Double Blind Phase|Pregnancy|0|||
130847799|NCT00098722|471070743|FG005|Double Blind Phase|Pregnancy|0|||
130847800|NCT00098722|471070744|FG006|Double Blind Phase|Pregnancy|0|||
130847801|NCT00098722|471070738|FG000|Double Blind Phase|Randomized, not treated|4|||
130847802|NCT00098722|471070739|FG001|Double Blind Phase|Randomized, not treated|3|||
130847803|NCT00098722|471070740|FG002|Double Blind Phase|Randomized, not treated|3|||
130847804|NCT00098722|471070741|FG003|Double Blind Phase|Randomized, not treated|0|||
130847805|NCT00098722|471070742|FG004|Double Blind Phase|Randomized, not treated|0|||
130847806|NCT00098722|471070743|FG005|Double Blind Phase|Randomized, not treated|0|||
130847807|NCT00098722|471070744|FG006|Double Blind Phase|Randomized, not treated|0|||
130847808|NCT00098722|471070738|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
130847809|NCT00098722|471070739|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
130847810|NCT00098722|471070740|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
130847811|NCT00098722|471070741|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
130847812|NCT00098722|471070742|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
130847813|NCT00098722|471070743|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
130847814|NCT00098722|471070744|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
130847815|NCT00098722|471070738|FG000|Double Blind Phase|Other|7|||
130847816|NCT00098722|471070739|FG001|Double Blind Phase|Other|8|||
130847817|NCT00098722|471070740|FG002|Double Blind Phase|Other|7|||
130847818|NCT00098722|471070741|FG003|Double Blind Phase|Other|0|||
130847819|NCT00098722|471070742|FG004|Double Blind Phase|Other|0|||
130847820|NCT00098722|471070743|FG005|Double Blind Phase|Other|0|||
130847821|NCT00098722|471070744|FG006|Double Blind Phase|Other|0|||
130847822|NCT00098722|471070738|FG000|Open Label Phase|Adverse Event|0|||
130847823|NCT00098722|471070739|FG001|Open Label Phase|Adverse Event|0|||
130847824|NCT00098722|471070740|FG002|Open Label Phase|Adverse Event|0|||
130847825|NCT00098722|471070741|FG003|Open Label Phase|Adverse Event|5|||
130847826|NCT00098722|471070742|FG004|Open Label Phase|Adverse Event|0|||
130847827|NCT00098722|471070743|FG005|Open Label Phase|Adverse Event|0|||
130847828|NCT00098722|471070744|FG006|Open Label Phase|Adverse Event|0|||
130847829|NCT00098722|471070738|FG000|Open Label Phase|Death|0|||
130847830|NCT00098722|471070739|FG001|Open Label Phase|Death|0|||
130847831|NCT00098722|471070740|FG002|Open Label Phase|Death|0|||
130847832|NCT00098722|471070741|FG003|Open Label Phase|Death|2|||
130847833|NCT00098722|471070742|FG004|Open Label Phase|Death|0|||
130847834|NCT00098722|471070743|FG005|Open Label Phase|Death|0|||
130847835|NCT00098722|471070744|FG006|Open Label Phase|Death|0|||
130847836|NCT00098722|471070738|FG000|Open Label Phase|Lack of Efficacy|0|||
130847837|NCT00098722|471070739|FG001|Open Label Phase|Lack of Efficacy|0|||
130847838|NCT00098722|471070740|FG002|Open Label Phase|Lack of Efficacy|0|||
130847839|NCT00098722|471070741|FG003|Open Label Phase|Lack of Efficacy|8|||
130847840|NCT00098722|471070742|FG004|Open Label Phase|Lack of Efficacy|0|||
130847841|NCT00098722|471070743|FG005|Open Label Phase|Lack of Efficacy|0|||
130847842|NCT00098722|471070744|FG006|Open Label Phase|Lack of Efficacy|0|||
130847843|NCT00098722|471070738|FG000|Open Label Phase|Pregnancy|0|||
130847844|NCT00098722|471070739|FG001|Open Label Phase|Pregnancy|0|||
130847845|NCT00098722|471070740|FG002|Open Label Phase|Pregnancy|0|||
130847846|NCT00098722|471070741|FG003|Open Label Phase|Pregnancy|1|||
130847847|NCT00098722|471070742|FG004|Open Label Phase|Pregnancy|0|||
130847848|NCT00098722|471070743|FG005|Open Label Phase|Pregnancy|0|||
130847849|NCT00098722|471070744|FG006|Open Label Phase|Pregnancy|0|||
130847850|NCT00098722|471070738|FG000|Open Label Phase|Participant defaulted|0|||
130847851|NCT00098722|471070739|FG001|Open Label Phase|Participant defaulted|0|||
130847852|NCT00098722|471070740|FG002|Open Label Phase|Participant defaulted|0|||
130847853|NCT00098722|471070741|FG003|Open Label Phase|Participant defaulted|18|||
130847854|NCT00098722|471070742|FG004|Open Label Phase|Participant defaulted|0|||
130847855|NCT00098722|471070743|FG005|Open Label Phase|Participant defaulted|0|||
130847856|NCT00098722|471070744|FG006|Open Label Phase|Participant defaulted|0|||
130847857|NCT00098722|471070738|FG000|Open Label Phase|Ongoing at cut-off date|0|||
130847858|NCT00098722|471070739|FG001|Open Label Phase|Ongoing at cut-off date|0|||
130847859|NCT00098722|471070740|FG002|Open Label Phase|Ongoing at cut-off date|0|||
130847860|NCT00098722|471070741|FG003|Open Label Phase|Ongoing at cut-off date|220|||
130847861|NCT00098722|471070742|FG004|Open Label Phase|Ongoing at cut-off date|50|||
130847862|NCT00098722|471070743|FG005|Open Label Phase|Ongoing at cut-off date|0|||
130847863|NCT00098722|471070744|FG006|Open Label Phase|Ongoing at cut-off date|0|||
130847864|NCT00098722|471070738|FG000|Open Label Phase|Other|0|||
130847865|NCT00098722|471070739|FG001|Open Label Phase|Other|0|||
130847866|NCT00098722|471070740|FG002|Open Label Phase|Other|0|||
130847867|NCT00098722|471070741|FG003|Open Label Phase|Other|18|||
130847868|NCT00098722|471070742|FG004|Open Label Phase|Other|0|||
130847869|NCT00098722|471070743|FG005|Open Label Phase|Other|0|||
130847870|NCT00098722|471070744|FG006|Open Label Phase|Other|0|||
130847871|NCT00098722|471070738|FG000|Observation Phase|Death|0|||
130847872|NCT00098722|471070739|FG001|Observation Phase|Death|0|||
130847873|NCT00098722|471070740|FG002|Observation Phase|Death|0|||
130847874|NCT00098722|471070741|FG003|Observation Phase|Death|0|||
130847875|NCT00098722|471070742|FG004|Observation Phase|Death|0|||
130847876|NCT00098722|471070743|FG005|Observation Phase|Death|5|||
130847877|NCT00098722|471070744|FG006|Observation Phase|Death|3|||
130847878|NCT00098722|471070738|FG000|Observation Phase|Lack of Efficacy|0|||
130847879|NCT00098722|471070739|FG001|Observation Phase|Lack of Efficacy|0|||
130847880|NCT00098722|471070740|FG002|Observation Phase|Lack of Efficacy|0|||
130847881|NCT00098722|471070741|FG003|Observation Phase|Lack of Efficacy|0|||
130847882|NCT00098722|471070742|FG004|Observation Phase|Lack of Efficacy|0|||
130847883|NCT00098722|471070743|FG005|Observation Phase|Lack of Efficacy|2|||
130847884|NCT00098722|471070744|FG006|Observation Phase|Lack of Efficacy|0|||
130847885|NCT00098722|471070738|FG000|Observation Phase|Participant defaulted|0|||
130847886|NCT00098722|471070739|FG001|Observation Phase|Participant defaulted|0|||
130847887|NCT00098722|471070740|FG002|Observation Phase|Participant defaulted|0|||
130847888|NCT00098722|471070741|FG003|Observation Phase|Participant defaulted|0|||
130847889|NCT00098722|471070742|FG004|Observation Phase|Participant defaulted|0|||
130847890|NCT00098722|471070743|FG005|Observation Phase|Participant defaulted|17|||
130847891|NCT00098722|471070744|FG006|Observation Phase|Participant defaulted|4|||
130847892|NCT00098722|471070738|FG000|Observation Phase|Other|0|||
130847893|NCT00098722|471070739|FG001|Observation Phase|Other|0|||
130847894|NCT00098722|471070740|FG002|Observation Phase|Other|0|||
130847895|NCT00098722|471070741|FG003|Observation Phase|Other|0|||
130847896|NCT00098722|471070742|FG004|Observation Phase|Other|0|||
130847897|NCT00098722|471070743|FG005|Observation Phase|Other|21|||
130847898|NCT00098722|471070744|FG006|Observation Phase|Other|10|||
130847899|NCT02351349|471070745|FG000|Overall Study|Withdrawal by Subject|2|||
130847900|NCT02351349|471070746|FG001|Overall Study|Withdrawal by Subject|3|||
130847901|NCT00440310|471070747|FG000|Overall Study|Lost to Follow-up|4|||
130847902|NCT00440310|471070748|FG001|Overall Study|Lost to Follow-up|5|||
130847903|NCT00440310|471070747|FG000|Overall Study|Protocol Violation|0|||
130847904|NCT00440310|471070748|FG001|Overall Study|Protocol Violation|1|||
130847905|NCT00440310|471070747|FG000|Overall Study|Withdrawal by Subject|15|||
130847906|NCT00440310|471070748|FG001|Overall Study|Withdrawal by Subject|14|||
130847907|NCT00440310|471070747|FG000|Overall Study|No Reply at EOS|7|||
130847908|NCT00440310|471070748|FG001|Overall Study|No Reply at EOS|7|||
130847909|NCT00440310|471070747|FG000|Overall Study|Other|1|||
130847910|NCT00440310|471070748|FG001|Overall Study|Other|0|||
130847911|NCT00440310|471070747|FG000|Overall Study|Status Unknown|1|||
130847912|NCT00440310|471070748|FG001|Overall Study|Status Unknown|3|||
130847913|NCT01519674|471070755|FG000|Overall Study|Adverse Event|3|||
130847914|NCT01519674|471070756|FG001|Overall Study|Adverse Event|3|||
130847915|NCT01519674|471070757|FG002|Overall Study|Adverse Event|0|||
130847916|NCT01519674|471070755|FG000|Overall Study|Lack of Efficacy|1|||
130847917|NCT01519674|471070756|FG001|Overall Study|Lack of Efficacy|1|||
130847918|NCT01519674|471070757|FG002|Overall Study|Lack of Efficacy|1|||
130847919|NCT01519674|471070755|FG000|Overall Study|Protocol Violation|0|||
130847920|NCT01519674|471070756|FG001|Overall Study|Protocol Violation|3|||
130847921|NCT01519674|471070757|FG002|Overall Study|Protocol Violation|1|||
130847922|NCT01519674|471070755|FG000|Overall Study|Withdrawal Criteria|7|||
130847923|NCT01519674|471070756|FG001|Overall Study|Withdrawal Criteria|2|||
130847924|NCT01519674|471070757|FG002|Overall Study|Withdrawal Criteria|7|||
130847925|NCT01519674|471070755|FG000|Overall Study|Unsclassified|10|||
130847926|NCT01519674|471070756|FG001|Overall Study|Unsclassified|4|||
130847927|NCT01519674|471070757|FG002|Overall Study|Unsclassified|3|||
130847928|NCT01610596|471070758|FG000|Overall Study|Lost to Follow-up|0|||
130847929|NCT01610596|471070759|FG001|Overall Study|Lost to Follow-up|1|||
130847930|NCT00799591|471070760|FG000|Overall Study|De-escalation of doses|20|||
130847931|NCT00799591|471070760|FG000|Overall Study|Death|14|||
130847932|NCT00799591|471070760|FG000|Overall Study|Technical failure|12|||
130847933|NCT00799591|471070760|FG000|Overall Study|Resistant germ|11|||
130847934|NCT00799591|471070760|FG000|Overall Study|New infection|4|||
130847935|NCT00799591|471070760|FG000|Overall Study|Resistance germ and technical failure|2|||
130847936|NCT00799591|471070760|FG000|Overall Study|Persistance of fever undetermined origin|1|||
130847937|NCT00799591|471070760|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
130847938|NCT00799591|471070760|FG000|Overall Study|Infectious origin not probable|1|||
130847939|NCT02317809|471070761|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
130847940|NCT02317809|471070762|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
130847941|NCT02317809|471070761|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
130847942|NCT02317809|471070762|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
130847943|NCT00293709|471070765|FG000|Overall Study|Other|47|||
130847944|NCT02088073|471070766|FG000|Acute Phase|Withdrawal by Subject|5|||
130847945|NCT02088073|471070767|FG001|Acute Phase|Withdrawal by Subject|0|||
130847946|NCT02088073|471070768|FG002|Acute Phase|Withdrawal by Subject|0|||
130847947|NCT02088073|471070769|FG003|Acute Phase|Withdrawal by Subject|0|||
130847948|NCT02088073|471070770|FG004|Acute Phase|Withdrawal by Subject|0|||
130847949|NCT02088073|471070766|FG000|Acute Phase|Hyperkalemia|2|||
130847950|NCT02088073|471070767|FG001|Acute Phase|Hyperkalemia|0|||
130847951|NCT02088073|471070768|FG002|Acute Phase|Hyperkalemia|0|||
130847952|NCT02088073|471070769|FG003|Acute Phase|Hyperkalemia|0|||
130847953|NCT02088073|471070770|FG004|Acute Phase|Hyperkalemia|0|||
130847954|NCT02088073|471070766|FG000|Maintanance Phase|Withdrawal by Subject|0|||
130847955|NCT02088073|471070767|FG001|Maintanance Phase|Withdrawal by Subject|2|||
130847956|NCT02088073|471070768|FG002|Maintanance Phase|Withdrawal by Subject|0|||
130847957|NCT02088073|471070769|FG003|Maintanance Phase|Withdrawal by Subject|0|||
130847958|NCT02088073|471070770|FG004|Maintanance Phase|Withdrawal by Subject|0|||
130847959|NCT02088073|471070766|FG000|Maintanance Phase|Adverse Event|0|||
130847960|NCT02088073|471070767|FG001|Maintanance Phase|Adverse Event|0|||
130847961|NCT02088073|471070768|FG002|Maintanance Phase|Adverse Event|3|||
130847962|NCT02088073|471070769|FG003|Maintanance Phase|Adverse Event|0|||
130847963|NCT02088073|471070770|FG004|Maintanance Phase|Adverse Event|1|||
130847964|NCT02088073|471070766|FG000|Maintanance Phase|Physician Decision|0|||
130847965|NCT02088073|471070767|FG001|Maintanance Phase|Physician Decision|0|||
130847966|NCT02088073|471070768|FG002|Maintanance Phase|Physician Decision|0|||
130847967|NCT02088073|471070769|FG003|Maintanance Phase|Physician Decision|0|||
130847968|NCT02088073|471070770|FG004|Maintanance Phase|Physician Decision|1|||
130847969|NCT02088073|471070766|FG000|Maintanance Phase|Sponsor's decision|0|||
130847970|NCT02088073|471070767|FG001|Maintanance Phase|Sponsor's decision|2|||
130847971|NCT02088073|471070768|FG002|Maintanance Phase|Sponsor's decision|0|||
130847972|NCT02088073|471070769|FG003|Maintanance Phase|Sponsor's decision|2|||
130847973|NCT02088073|471070770|FG004|Maintanance Phase|Sponsor's decision|1|||
130847974|NCT02088073|471070766|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
130847975|NCT02088073|471070767|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
130847976|NCT02088073|471070768|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
130847977|NCT02088073|471070769|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
130847978|NCT02088073|471070770|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
130847979|NCT02088073|471070766|FG000|Maintanance Phase|Miscellaneous|0|||
130847980|NCT02088073|471070767|FG001|Maintanance Phase|Miscellaneous|2|||
130847981|NCT02088073|471070768|FG002|Maintanance Phase|Miscellaneous|1|||
130847982|NCT02088073|471070769|FG003|Maintanance Phase|Miscellaneous|2|||
130847983|NCT02088073|471070770|FG004|Maintanance Phase|Miscellaneous|1|||
130847984|NCT02088073|471070766|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
130847985|NCT02088073|471070767|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
130847986|NCT02088073|471070768|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
130847987|NCT02088073|471070769|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
130847988|NCT02088073|471070770|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
130847989|NCT02088073|471070766|FG000|Maintanance Phase|Subject compliance|0|||
130847990|NCT02088073|471070767|FG001|Maintanance Phase|Subject compliance|1|||
130847991|NCT02088073|471070768|FG002|Maintanance Phase|Subject compliance|0|||
130847992|NCT02088073|471070769|FG003|Maintanance Phase|Subject compliance|0|||
130847993|NCT02088073|471070770|FG004|Maintanance Phase|Subject compliance|0|||
130847994|NCT01804582|471070771|FG000|Overall Study|Lost to Follow-up|47|||
130847995|NCT01804582|471070772|FG001|Overall Study|Lost to Follow-up|56|||
130847996|NCT01804582|471070771|FG000|Overall Study|Physician Decision|2|||
130847997|NCT01804582|471070772|FG001|Overall Study|Physician Decision|0|||
130847998|NCT02969590|471070776|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
130847999|NCT02969590|471070777|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
130848000|NCT02969590|471070778|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
130848001|NCT02590562|471070783|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
130848002|NCT00598078|471070789|FG000|Period 2 (Day 2)|Adverse Event|1|||
130848003|NCT00598078|471070790|FG001|Period 2 (Day 2)|Adverse Event|0|||
130848004|NCT01479595|471070793|FG000|Overall Study|Protocol deviation|0|||
130848005|NCT01479595|471070794|FG001|Overall Study|Protocol deviation|1|||
130848006|NCT01479595|471070793|FG000|Overall Study|Adverse Event|2|||
130848007|NCT01479595|471070794|FG001|Overall Study|Adverse Event|1|||
130848008|NCT02255565|471070796|FG000|Overall Study|Withdrawal by Subject|0|||
130848009|NCT02255565|471070797|FG001|Overall Study|Withdrawal by Subject|1|||
130848010|NCT02255565|471070798|FG002|Overall Study|Withdrawal by Subject|0|||
130848011|NCT02120365|471070799|FG000|Overall Study|Withdrawal by Subject|0|||
130848012|NCT02120365|471070800|FG001|Overall Study|Withdrawal by Subject|0|||
130848013|NCT02120365|471070801|FG002|Overall Study|Withdrawal by Subject|2|||
130848014|NCT02120365|471070802|FG003|Overall Study|Withdrawal by Subject|4|||
130848015|NCT02120365|471070803|FG004|Overall Study|Withdrawal by Subject|0|||
130848016|NCT02120365|471070804|FG005|Overall Study|Withdrawal by Subject|2|||
130848017|NCT01719003|471070807|FG000|Overall Study|Non compliant with protocol|1|||
130848018|NCT01719003|471070808|FG001|Overall Study|Non compliant with protocol|1|||
130848019|NCT01719003|471070809|FG002|Overall Study|Non compliant with protocol|0|||
130848020|NCT01719003|471070810|FG003|Overall Study|Non compliant with protocol|1|||
130848021|NCT01719003|471070811|FG004|Overall Study|Non compliant with protocol|2|||
130848022|NCT01719003|471070812|FG005|Overall Study|Non compliant with protocol|1|||
130848023|NCT01719003|471070813|FG006|Overall Study|Non compliant with protocol|2|||
130848024|NCT01719003|471070814|FG007|Overall Study|Non compliant with protocol|3|||
130848025|NCT01719003|471070815|FG008|Overall Study|Non compliant with protocol|0|||
130848026|NCT01719003|471070807|FG000|Overall Study|Adverse Event|6|||
130848027|NCT01719003|471070808|FG001|Overall Study|Adverse Event|5|||
130848028|NCT01719003|471070809|FG002|Overall Study|Adverse Event|4|||
130848029|NCT01719003|471070810|FG003|Overall Study|Adverse Event|3|||
130848030|NCT01719003|471070811|FG004|Overall Study|Adverse Event|4|||
130848031|NCT01719003|471070812|FG005|Overall Study|Adverse Event|3|||
130848032|NCT01719003|471070813|FG006|Overall Study|Adverse Event|6|||
130848033|NCT01719003|471070814|FG007|Overall Study|Adverse Event|5|||
130848034|NCT01719003|471070815|FG008|Overall Study|Adverse Event|0|||
130848035|NCT01719003|471070807|FG000|Overall Study|Lost to Follow-up|0|||
130848036|NCT01719003|471070808|FG001|Overall Study|Lost to Follow-up|6|||
130848037|NCT01719003|471070809|FG002|Overall Study|Lost to Follow-up|7|||
130848038|NCT01719003|471070810|FG003|Overall Study|Lost to Follow-up|2|||
130848039|NCT01719003|471070811|FG004|Overall Study|Lost to Follow-up|3|||
130848040|NCT01719003|471070812|FG005|Overall Study|Lost to Follow-up|4|||
130848041|NCT01719003|471070813|FG006|Overall Study|Lost to Follow-up|3|||
130848042|NCT01719003|471070814|FG007|Overall Study|Lost to Follow-up|2|||
130848043|NCT01719003|471070815|FG008|Overall Study|Lost to Follow-up|2|||
130848044|NCT01719003|471070807|FG000|Overall Study|Refusal to continue, not due to AE|2|||
130848045|NCT01719003|471070808|FG001|Overall Study|Refusal to continue, not due to AE|5|||
130848046|NCT01719003|471070809|FG002|Overall Study|Refusal to continue, not due to AE|4|||
130848047|NCT01719003|471070810|FG003|Overall Study|Refusal to continue, not due to AE|4|||
130848048|NCT01719003|471070811|FG004|Overall Study|Refusal to continue, not due to AE|4|||
130848049|NCT01719003|471070812|FG005|Overall Study|Refusal to continue, not due to AE|3|||
130848050|NCT01719003|471070813|FG006|Overall Study|Refusal to continue, not due to AE|8|||
130848051|NCT01719003|471070814|FG007|Overall Study|Refusal to continue, not due to AE|7|||
130848052|NCT01719003|471070815|FG008|Overall Study|Refusal to continue, not due to AE|1|||
130848053|NCT01719003|471070807|FG000|Overall Study|Reason other than those specified|0|||
130848054|NCT01719003|471070808|FG001|Overall Study|Reason other than those specified|0|||
130848055|NCT01719003|471070809|FG002|Overall Study|Reason other than those specified|2|||
130848056|NCT01719003|471070810|FG003|Overall Study|Reason other than those specified|3|||
130848057|NCT01719003|471070811|FG004|Overall Study|Reason other than those specified|4|||
130848058|NCT01719003|471070812|FG005|Overall Study|Reason other than those specified|1|||
130848059|NCT01719003|471070813|FG006|Overall Study|Reason other than those specified|0|||
130848060|NCT01719003|471070814|FG007|Overall Study|Reason other than those specified|3|||
130848061|NCT01719003|471070815|FG008|Overall Study|Reason other than those specified|1|||
130848062|NCT01719003|471070807|FG000|Overall Study|Lack of Efficacy|0|||
130848063|NCT01719003|471070808|FG001|Overall Study|Lack of Efficacy|0|||
130848064|NCT01719003|471070809|FG002|Overall Study|Lack of Efficacy|0|||
130848065|NCT01719003|471070810|FG003|Overall Study|Lack of Efficacy|0|||
130848066|NCT01719003|471070811|FG004|Overall Study|Lack of Efficacy|0|||
130848067|NCT01719003|471070812|FG005|Overall Study|Lack of Efficacy|0|||
130848068|NCT01719003|471070813|FG006|Overall Study|Lack of Efficacy|1|||
130848069|NCT01719003|471070814|FG007|Overall Study|Lack of Efficacy|0|||
130848070|NCT01719003|471070815|FG008|Overall Study|Lack of Efficacy|0|||
130848071|NCT00900146|471070816|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
130848072|NCT00900146|471070817|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
130848073|NCT00900146|471070818|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
130848074|NCT00900146|471070819|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
130848075|NCT00900146|471070820|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
130848076|NCT00900146|471070816|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
130848077|NCT00900146|471070817|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
130848078|NCT00900146|471070818|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
130848079|NCT00900146|471070819|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
130848080|NCT00900146|471070820|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
130848081|NCT00900146|471070816|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
130848082|NCT00900146|471070817|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130848083|NCT00900146|471070818|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130848084|NCT00900146|471070819|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130848085|NCT00900146|471070820|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130848086|NCT00900146|471070816|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
130848087|NCT00900146|471070817|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
130848088|NCT00900146|471070818|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
130848089|NCT00900146|471070819|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
130848090|NCT00900146|471070820|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
130848091|NCT00900146|471070816|FG000|Intermediate: Period III|Lost to Follow-up|2|||
130848092|NCT00900146|471070817|FG001|Intermediate: Period III|Lost to Follow-up|0|||
130848093|NCT00900146|471070818|FG002|Intermediate: Period III|Lost to Follow-up|0|||
130848094|NCT00900146|471070819|FG003|Intermediate: Period III|Lost to Follow-up|0|||
130848095|NCT00900146|471070820|FG004|Intermediate: Period III|Lost to Follow-up|1|||
130848096|NCT00900146|471070816|FG000|Intermediate: Period III|Administrative problems|85|||
130848097|NCT00900146|471070817|FG001|Intermediate: Period III|Administrative problems|92|||
130848098|NCT00900146|471070818|FG002|Intermediate: Period III|Administrative problems|84|||
130848099|NCT00900146|471070819|FG003|Intermediate: Period III|Administrative problems|90|||
130848100|NCT00900146|471070820|FG004|Intermediate: Period III|Administrative problems|163|||
130848101|NCT01028716|471070825|FG000|Overall Study|Physician Decision|1|||
130848102|NCT01143896|471070830|FG000|Overall Study|Did not complete Baseline Interview|5|||
130848103|NCT01143896|471070831|FG001|Overall Study|Did not complete Baseline Interview|4|||
130848104|NCT01143896|471070830|FG000|Overall Study|Lost to Follow-up|18|||
130848105|NCT01143896|471070831|FG001|Overall Study|Lost to Follow-up|13|||
130848106|NCT01143896|471070830|FG000|Overall Study|Withdrawal by Subject|13|||
130848107|NCT01143896|471070831|FG001|Overall Study|Withdrawal by Subject|5|||
130848108|NCT01143896|471070830|FG000|Overall Study|Death|6|||
130848109|NCT01143896|471070831|FG001|Overall Study|Death|3|||
130848110|NCT00320372|471070832|FG000|Overall Study|Physician Decision|4|||
130848111|NCT00320372|471070833|FG001|Overall Study|Physician Decision|7|||
130848112|NCT00320372|471070832|FG000|Overall Study|Death|7|||
130848113|NCT00320372|471070833|FG001|Overall Study|Death|8|||
130848114|NCT00320372|471070832|FG000|Overall Study|Withdrawal by Subject|55|||
130848115|NCT00320372|471070833|FG001|Overall Study|Withdrawal by Subject|37|||
130848116|NCT00320372|471070832|FG000|Overall Study|Non-Compliance|40|||
130848117|NCT00320372|471070833|FG001|Overall Study|Non-Compliance|39|||
130848118|NCT00320372|471070832|FG000|Overall Study|Did not Meet (I/E)|3|||
130848119|NCT00320372|471070833|FG001|Overall Study|Did not Meet (I/E)|1|||
130848120|NCT00320372|471070832|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
130848121|NCT00320372|471070833|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
130848122|NCT02068118|471070835|FG000|18-month Comparative Study Period|Death|90|||
130848123|NCT02068118|471070836|FG001|18-month Comparative Study Period|Death|97|||
130848124|NCT02068118|471070835|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
130848125|NCT02068118|471070836|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
130848126|NCT02068118|471070835|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
130848127|NCT02068118|471070836|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
130848128|NCT02068118|471070835|FG000|18-month Comparative Study Period|Heart transplant|9|||
130848129|NCT02068118|471070836|FG001|18-month Comparative Study Period|Heart transplant|15|||
130848130|NCT02068118|471070835|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
130848131|NCT02068118|471070836|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
130848132|NCT02068118|471070835|FG000|18-month Comparative Study Period|Hemiplegia|0|||
130848133|NCT02068118|471070836|FG001|18-month Comparative Study Period|Hemiplegia|1|||
130848134|NCT02068118|471070835|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
130848135|NCT02068118|471070836|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
130848136|NCT02068118|471070835|FG000|18-month Comparative Study Period|Move|0|||
130848137|NCT02068118|471070836|FG001|18-month Comparative Study Period|Move|1|||
130848138|NCT02068118|471070835|FG000|18-month Comparative Study Period|Hearing loss|0|||
130848139|NCT02068118|471070836|FG001|18-month Comparative Study Period|Hearing loss|1|||
130848140|NCT02068118|471070835|FG000|Extension Period|Death|0|||
130848141|NCT02068118|471070836|FG001|Extension Period|Death|2|||
130848142|NCT02068118|471070835|FG000|Extension Period|Withdrawal by Subject|1|||
130848143|NCT02068118|471070836|FG001|Extension Period|Withdrawal by Subject|0|||
130848144|NCT02068118|471070835|FG000|Extension Period|Heart transplant|1|||
130848145|NCT02068118|471070836|FG001|Extension Period|Heart transplant|0|||
130848146|NCT02068118|471070835|FG000|Extension Period|Wrong device use|0|||
130848147|NCT02068118|471070836|FG001|Extension Period|Wrong device use|1|||
130848148|NCT00283868|471070837|FG000|Overall Study|Lost to Follow-up|7|||
130848149|NCT00283868|471070838|FG001|Overall Study|Lost to Follow-up|8|||
130848150|NCT01996592|471070840|FG000|Overall Study|no response to text/no diary entry|32|||
130848151|NCT01996592|471070840|FG000|Overall Study|change in surgical date|4|||
130848152|NCT01996592|471070840|FG000|Overall Study|Withdrawal by Subject|5|||
130848153|NCT01996592|471070840|FG000|Overall Study|change in mode of delivery|4|||
130848154|NCT00394901|471070841|FG000|Baseline Phase|Protocol Violation|0|||
130848155|NCT00394901|471070842|FG001|Baseline Phase|Protocol Violation|0|||
130848156|NCT00394901|471070843|FG002|Baseline Phase|Protocol Violation|1|||
130848157|NCT00394901|471070844|FG003|Baseline Phase|Protocol Violation|0|||
130848158|NCT00394901|471070841|FG000|Double-blind Phase|Adverse Event|5|||
130848159|NCT00394901|471070842|FG001|Double-blind Phase|Adverse Event|7|||
130848160|NCT00394901|471070843|FG002|Double-blind Phase|Adverse Event|16|||
130848161|NCT00394901|471070844|FG003|Double-blind Phase|Adverse Event|20|||
130848162|NCT00394901|471070841|FG000|Double-blind Phase|Lack of Efficacy|6|||
130848163|NCT00394901|471070842|FG001|Double-blind Phase|Lack of Efficacy|4|||
130848164|NCT00394901|471070843|FG002|Double-blind Phase|Lack of Efficacy|1|||
130848165|NCT00394901|471070844|FG003|Double-blind Phase|Lack of Efficacy|3|||
130848166|NCT00394901|471070841|FG000|Double-blind Phase|Withdrawal by Subject|2|||
130848167|NCT00394901|471070842|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130848168|NCT00394901|471070843|FG002|Double-blind Phase|Withdrawal by Subject|0|||
130848169|NCT00394901|471070844|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130848170|NCT00394901|471070841|FG000|Double-blind Phase|Lost to Follow-up|0|||
130848171|NCT00394901|471070842|FG001|Double-blind Phase|Lost to Follow-up|0|||
130848172|NCT00394901|471070843|FG002|Double-blind Phase|Lost to Follow-up|0|||
130848173|NCT00394901|471070844|FG003|Double-blind Phase|Lost to Follow-up|1|||
130848174|NCT00394901|471070841|FG000|Double-blind Phase|Protocol Violation|0|||
130848175|NCT00394901|471070842|FG001|Double-blind Phase|Protocol Violation|0|||
130848176|NCT00394901|471070843|FG002|Double-blind Phase|Protocol Violation|0|||
130848177|NCT00394901|471070844|FG003|Double-blind Phase|Protocol Violation|1|||
130848178|NCT00394901|471070841|FG000|Double-blind Phase|Death|1|||
130848179|NCT00394901|471070842|FG001|Double-blind Phase|Death|0|||
130848180|NCT00394901|471070843|FG002|Double-blind Phase|Death|0|||
130848181|NCT00394901|471070844|FG003|Double-blind Phase|Death|0|||
130848182|NCT00394901|471070841|FG000|Double-blind Phase|Subject's Personal Reason|1|||
130848183|NCT00394901|471070842|FG001|Double-blind Phase|Subject's Personal Reason|0|||
130848184|NCT00394901|471070843|FG002|Double-blind Phase|Subject's Personal Reason|0|||
130848185|NCT00394901|471070844|FG003|Double-blind Phase|Subject's Personal Reason|1|||
130848186|NCT00394901|471070841|FG000|Double-blind Phase|Lack of Compliance|0|||
130848187|NCT00394901|471070842|FG001|Double-blind Phase|Lack of Compliance|3|||
130848188|NCT00394901|471070843|FG002|Double-blind Phase|Lack of Compliance|0|||
130848189|NCT00394901|471070844|FG003|Double-blind Phase|Lack of Compliance|0|||
130848190|NCT00394901|471070841|FG000|Double-blind Phase|Entry into another study was found|0|||
130848191|NCT00394901|471070842|FG001|Double-blind Phase|Entry into another study was found|0|||
130848192|NCT00394901|471070843|FG002|Double-blind Phase|Entry into another study was found|1|||
130848193|NCT00394901|471070844|FG003|Double-blind Phase|Entry into another study was found|0|||
130848194|NCT00394901|471070841|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
130848195|NCT00394901|471070842|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
130848196|NCT00394901|471070843|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
130848197|NCT00394901|471070844|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
130848198|NCT05028517|471070845|FG000|Overall Study|Lost to Follow-up|13|||
130848199|NCT05028517|471070846|FG001|Overall Study|Lost to Follow-up|20|||
130848200|NCT05028517|471070847|FG002|Overall Study|Lost to Follow-up|12|||
130848201|NCT05028517|471070845|FG000|Overall Study|Withdrawal by Subject|0|||
130848202|NCT05028517|471070846|FG001|Overall Study|Withdrawal by Subject|0|||
130848203|NCT05028517|471070847|FG002|Overall Study|Withdrawal by Subject|1|||
130848204|NCT02256267|471070848|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
130848205|NCT02256267|471070848|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
130848206|NCT01066780|471070852|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
130848207|NCT01066780|471070853|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
130848208|NCT02360293|471070854|FG000|Overall Study|Lost to Follow-up|73|||
130848209|NCT02360293|471070855|FG001|Overall Study|Lost to Follow-up|95|||
130848210|NCT02360293|471070854|FG000|Overall Study|Withdrawal by Subject|2|||
130848211|NCT02360293|471070855|FG001|Overall Study|Withdrawal by Subject|1|||
130848212|NCT02360293|471070854|FG000|Overall Study|Excluded|1|||
130848213|NCT02360293|471070855|FG001|Overall Study|Excluded|0|||
130848214|NCT04316741|471070856|FG000|Baseline Enrollment|Lost to Follow-up|1|||
130848215|NCT04316741|471070857|FG001|Baseline Enrollment|Lost to Follow-up|1|||
130848216|NCT04316741|471070856|FG000|Immediate Post-Test|Lost to Follow-up|5|||
130848217|NCT04316741|471070857|FG001|Immediate Post-Test|Lost to Follow-up|1|||
130848218|NCT04316741|471070856|FG000|1-month Post-test|Lost to Follow-up|7|||
130848219|NCT04316741|471070857|FG001|1-month Post-test|Lost to Follow-up|2|||
130848220|NCT04316741|471070856|FG000|3-month Follow-up|Lost to Follow-up|10|||
130848221|NCT04316741|471070857|FG001|3-month Follow-up|Lost to Follow-up|2|||
130848222|NCT01498185|471070859|FG000|Overall Study|Adverse Event|0|||
130848223|NCT01498185|471070860|FG001|Overall Study|Adverse Event|0|||
130848224|NCT01498185|471070861|FG002|Overall Study|Adverse Event|0|||
130848225|NCT01498185|471070862|FG003|Overall Study|Adverse Event|1|||
130848226|NCT01498185|471070863|FG004|Overall Study|Adverse Event|0|||
130848227|NCT01498185|471070859|FG000|Overall Study|Withdrawal by Subject|1|||
130848228|NCT01498185|471070860|FG001|Overall Study|Withdrawal by Subject|1|||
130848229|NCT01498185|471070861|FG002|Overall Study|Withdrawal by Subject|0|||
130848230|NCT01498185|471070862|FG003|Overall Study|Withdrawal by Subject|2|||
130848231|NCT01498185|471070863|FG004|Overall Study|Withdrawal by Subject|1|||
130848232|NCT01498185|471070859|FG000|Overall Study|No longer met criteria, etc|0|||
130848233|NCT01498185|471070860|FG001|Overall Study|No longer met criteria, etc|0|||
130848234|NCT01498185|471070861|FG002|Overall Study|No longer met criteria, etc|0|||
130848235|NCT01498185|471070862|FG003|Overall Study|No longer met criteria, etc|0|||
130848236|NCT01498185|471070863|FG004|Overall Study|No longer met criteria, etc|2|||
130848237|NCT01827332|471070864|FG000|Overall Study|Lost to Follow-up|2|||
130848238|NCT01827332|471070865|FG001|Overall Study|Lost to Follow-up|1|||
130848239|NCT02725593|471070866|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
130848240|NCT02725593|471070867|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
130848241|NCT02725593|471070866|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
130848242|NCT02725593|471070867|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
130848243|NCT02725593|471070866|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
130848244|NCT02725593|471070867|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
130848245|NCT02725593|471070866|FG000|Long Term Extension|Withdrawal by Subject|1|||
130848246|NCT02725593|471070867|FG001|Long Term Extension|Withdrawal by Subject|3|||
130848247|NCT00664326|471072396|FG000|Overall Study|Adverse Event|14|||
130848248|NCT00664326|471072396|FG000|Overall Study|Noncompliance with study medication|3|||
130848249|NCT00664326|471072396|FG000|Overall Study|Withdrawal by Subject|1|||
130848250|NCT00664326|471072396|FG000|Overall Study|Physician Decision|1|||
130848251|NCT00664326|471072396|FG000|Overall Study|Other Reasons|3|||
130848252|NCT00664326|471072396|FG000|Overall Study|Death|2|||
130848253|NCT00664326|471072396|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
130848254|NCT01266317|471072397|FG000|Overall Study|Withdrawal by Subject|2|||
130848255|NCT00490776|471072398|FG000|Overall Study|Withdrawal by Subject|1|||
130848256|NCT00490776|471072398|FG000|Overall Study|Administrative Problems|1|||
130848257|NCT00490776|471072398|FG000|Overall Study|Death|1|||
130848258|NCT00490776|471072398|FG000|Overall Study|New Cancer Therapy|1|||
130848259|NCT00490776|471072398|FG000|Overall Study|Disease Progression|5|||
130848260|NCT00046930|471072406|FG000|Overall Study|Ineligible|12|||
130848261|NCT00046930|471072407|FG001|Overall Study|Ineligible|4|||
130848262|NCT04912895|471072408|FG000|Overall Study|Unable to provide specimen|2|||
130848263|NCT04912895|471072409|FG001|Overall Study|Unable to provide specimen|0|||
130848264|NCT04912895|471072410|FG002|Overall Study|Unable to provide specimen|0|||
130848265|NCT00520013|471072411|FG000|Overall Study|Withdrawal by Subject|0|||
130848266|NCT00520013|471072412|FG001|Overall Study|Withdrawal by Subject|0|||
130848267|NCT00520013|471072413|FG002|Overall Study|Withdrawal by Subject|1|||
130848268|NCT00520013|471072411|FG000|Overall Study|Adverse Event|2|||
130848269|NCT00520013|471072412|FG001|Overall Study|Adverse Event|10|||
130848270|NCT00520013|471072413|FG002|Overall Study|Adverse Event|7|||
130848271|NCT00520013|471072411|FG000|Overall Study|Progressive Disease|7|||
130848272|NCT00520013|471072412|FG001|Overall Study|Progressive Disease|3|||
130848273|NCT00520013|471072413|FG002|Overall Study|Progressive Disease|0|||
130848274|NCT00520013|471072411|FG000|Overall Study|Clinical Progression|3|||
130848275|NCT00520013|471072412|FG001|Overall Study|Clinical Progression|1|||
130848276|NCT00520013|471072413|FG002|Overall Study|Clinical Progression|0|||
130848277|NCT00520013|471072411|FG000|Overall Study|Death|0|||
130848278|NCT00520013|471072412|FG001|Overall Study|Death|1|||
130848279|NCT00520013|471072413|FG002|Overall Study|Death|0|||
130848280|NCT00520013|471072411|FG000|Overall Study|Physician Decision|0|||
130848281|NCT00520013|471072412|FG001|Overall Study|Physician Decision|0|||
130848282|NCT00520013|471072413|FG002|Overall Study|Physician Decision|3|||
130848283|NCT02677844|471072414|FG000|Period 3|Withdrawal by Subject|0|||
130848284|NCT02677844|471072415|FG001|Period 3|Withdrawal by Subject|0|||
130848285|NCT02677844|471072416|FG002|Period 3|Withdrawal by Subject|0|||
130848286|NCT02677844|471072417|FG003|Period 3|Withdrawal by Subject|1|||
130848287|NCT02677844|471072418|FG004|Period 3|Withdrawal by Subject|0|||
130848288|NCT02677844|471072419|FG005|Period 3|Withdrawal by Subject|0|||
130848289|NCT02677844|471072420|FG006|Period 3|Withdrawal by Subject|0|||
130848290|NCT01149486|471072421|FG000|First Intervention|Adverse Event|0|||
130848291|NCT01149486|471072422|FG001|First Intervention|Adverse Event|1|||
130848292|NCT01135914|471072423|FG000|Overall Study|Withdrawal by Subject|1|||
130848293|NCT01135914|471072424|FG001|Overall Study|Withdrawal by Subject|3|||
130848294|NCT01135914|471072425|FG002|Overall Study|Withdrawal by Subject|6|||
130848295|NCT01135914|471072423|FG000|Overall Study|Lost to Follow-up|1|||
130848296|NCT01135914|471072424|FG001|Overall Study|Lost to Follow-up|0|||
130848297|NCT01135914|471072425|FG002|Overall Study|Lost to Follow-up|1|||
130848298|NCT01135914|471072423|FG000|Overall Study|Protocol Violation|0|||
130848299|NCT01135914|471072424|FG001|Overall Study|Protocol Violation|0|||
130848300|NCT01135914|471072425|FG002|Overall Study|Protocol Violation|3|||
130848301|NCT01135914|471072423|FG000|Overall Study|Lack of Efficacy|2|||
130848302|NCT01135914|471072424|FG001|Overall Study|Lack of Efficacy|1|||
130848303|NCT01135914|471072425|FG002|Overall Study|Lack of Efficacy|10|||
130848304|NCT01135914|471072423|FG000|Overall Study|Adverse Event|0|||
130848305|NCT01135914|471072424|FG001|Overall Study|Adverse Event|1|||
130848306|NCT01135914|471072425|FG002|Overall Study|Adverse Event|2|||
130848307|NCT03532932|471072432|FG000|Overall Study|Protocol Deviation|33|||
130848308|NCT03532932|471072433|FG001|Overall Study|Protocol Deviation|31|||
130848309|NCT03532932|471072432|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
130848310|NCT03532932|471072433|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
130848311|NCT03532932|471072432|FG000|Overall Study|Withdrawal by Subject|2|||
130848312|NCT03532932|471072433|FG001|Overall Study|Withdrawal by Subject|0|||
130848313|NCT03532932|471072432|FG000|Overall Study|Lost to Follow-up|15|||
130848314|NCT03532932|471072433|FG001|Overall Study|Lost to Follow-up|9|||
130848315|NCT03532932|471072432|FG000|Overall Study|Adverse Event|4|||
130848316|NCT03532932|471072433|FG001|Overall Study|Adverse Event|3|||
130848317|NCT03532932|471072432|FG000|Overall Study|Death|0|||
130848318|NCT03532932|471072433|FG001|Overall Study|Death|2|||
130848319|NCT03532932|471072432|FG000|Overall Study|Other|11|||
130848320|NCT03532932|471072433|FG001|Overall Study|Other|16|||
130848321|NCT02699450|471072434|FG000|Overall Study|Death|2|||
130848322|NCT02699450|471072435|FG001|Overall Study|Death|1|||
130848323|NCT02699450|471072436|FG002|Overall Study|Death|2|||
130848324|NCT02699450|471072434|FG000|Overall Study|Met Criteria for Study Exit|0|||
130848325|NCT02699450|471072435|FG001|Overall Study|Met Criteria for Study Exit|0|||
130848326|NCT02699450|471072436|FG002|Overall Study|Met Criteria for Study Exit|1|||
130848327|NCT02699450|471072434|FG000|Overall Study|Protocol Violation|4|||
130848328|NCT02699450|471072435|FG001|Overall Study|Protocol Violation|3|||
130848329|NCT02699450|471072436|FG002|Overall Study|Protocol Violation|5|||
130848330|NCT02699450|471072434|FG000|Overall Study|Lost to Follow-up|3|||
130848331|NCT02699450|471072435|FG001|Overall Study|Lost to Follow-up|0|||
130848332|NCT02699450|471072436|FG002|Overall Study|Lost to Follow-up|5|||
130848333|NCT02699450|471072434|FG000|Overall Study|Physician Decision|2|||
130848334|NCT02699450|471072435|FG001|Overall Study|Physician Decision|0|||
130848335|NCT02699450|471072436|FG002|Overall Study|Physician Decision|0|||
130848336|NCT02699450|471072434|FG000|Overall Study|Withdrawal by Subject|3|||
130848337|NCT02699450|471072435|FG001|Overall Study|Withdrawal by Subject|1|||
130848338|NCT02699450|471072436|FG002|Overall Study|Withdrawal by Subject|2|||
130848339|NCT02699450|471072434|FG000|Overall Study|Adverse Event|1|||
130848340|NCT02699450|471072435|FG001|Overall Study|Adverse Event|0|||
130848341|NCT02699450|471072436|FG002|Overall Study|Adverse Event|0|||
130848342|NCT01344629|471072443|FG000|Crossover Period 2|Withdrawal by Subject|0|||
130848343|NCT01344629|471072444|FG001|Crossover Period 2|Withdrawal by Subject|1|||
130848344|NCT01133275|471072445|FG000|Overall Study|Withdrawal by Subject|1|||
130848345|NCT01133275|471072445|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
130848346|NCT00700102|471072446|FG000|Overall Study|Died|394|||
130848347|NCT00700102|471072447|FG001|Overall Study|Died|385|||
130848348|NCT00700102|471072446|FG000|Overall Study|Lost to Follow-up|8|||
130848349|NCT00700102|471072447|FG001|Overall Study|Lost to Follow-up|10|||
130848350|NCT02525939|471072448|FG000|Overall Study|Lost to Follow-up|27|||
130848351|NCT02525939|471072449|FG001|Overall Study|Lost to Follow-up|24|||
130848352|NCT02525939|471072448|FG000|Overall Study|Physician Decision|0|||
130848353|NCT02525939|471072449|FG001|Overall Study|Physician Decision|1|||
130848354|NCT02525939|471072448|FG000|Overall Study|Withdrawal by Subject|24|||
130848355|NCT02525939|471072449|FG001|Overall Study|Withdrawal by Subject|39|||
130848356|NCT02525939|471072448|FG000|Overall Study|Death|180|||
130848357|NCT02525939|471072449|FG001|Overall Study|Death|179|||
130848358|NCT01635764|471072450|FG000|Overall Study|Adverse Event|46|||
130848359|NCT01635764|471072450|FG000|Overall Study|Lack of Efficacy|76|||
130848360|NCT01635764|471072450|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
130848361|NCT01635764|471072450|FG000|Overall Study|Protocol Deviation|1|||
130848362|NCT01635764|471072450|FG000|Overall Study|Withdrew Consent|67|||
130848363|NCT01635764|471072450|FG000|Overall Study|Lost to Follow-up|53|||
130848364|NCT01635764|471072450|FG000|Overall Study|Other|28|||
130848365|NCT01174004|471072451|FG000|Overall Study|Adverse Event|2|||
130848366|NCT01174004|471072452|FG001|Overall Study|Adverse Event|10|||
130848367|NCT01174004|471072451|FG000|Overall Study|Withdrawal by Subject|2|||
130848368|NCT01174004|471072452|FG001|Overall Study|Withdrawal by Subject|3|||
130848369|NCT01174004|471072451|FG000|Overall Study|At Discretion of Sponsor|2|||
130848370|NCT01174004|471072452|FG001|Overall Study|At Discretion of Sponsor|2|||
130848371|NCT01174004|471072451|FG000|Overall Study|Protocol Violation|0|||
130848372|NCT01174004|471072452|FG001|Overall Study|Protocol Violation|1|||
130848373|NCT01174004|471072451|FG000|Overall Study|Physician Decision|1|||
130848374|NCT01174004|471072452|FG001|Overall Study|Physician Decision|0|||
130848375|NCT00391391|471072454|FG000|Overall Study|Adverse Event|0|||
130848376|NCT00391391|471072455|FG001|Overall Study|Adverse Event|0|||
130848377|NCT00391391|471072456|FG002|Overall Study|Adverse Event|0|||
130848378|NCT00391391|471072457|FG003|Overall Study|Adverse Event|1|||
130848379|NCT00391391|471072454|FG000|Overall Study|Lost to Follow-up|1|||
130848380|NCT00391391|471072455|FG001|Overall Study|Lost to Follow-up|3|||
130848381|NCT00391391|471072456|FG002|Overall Study|Lost to Follow-up|7|||
130848382|NCT00391391|471072457|FG003|Overall Study|Lost to Follow-up|4|||
130848383|NCT00391391|471072454|FG000|Overall Study|Protocol Violation|2|||
130848384|NCT00391391|471072455|FG001|Overall Study|Protocol Violation|3|||
130848385|NCT00391391|471072456|FG002|Overall Study|Protocol Violation|6|||
130848386|NCT00391391|471072457|FG003|Overall Study|Protocol Violation|7|||
130848387|NCT00391391|471072454|FG000|Overall Study|Withdrawal by Subject|6|||
130848388|NCT00391391|471072455|FG001|Overall Study|Withdrawal by Subject|4|||
130848389|NCT00391391|471072456|FG002|Overall Study|Withdrawal by Subject|10|||
130848390|NCT00391391|471072457|FG003|Overall Study|Withdrawal by Subject|7|||
130848391|NCT00693472|471072458|FG000|Part 1|Adverse Event|1|||
130848392|NCT00693472|471072459|FG001|Part 1|Adverse Event|1|||
130848393|NCT00693472|471072460|FG002|Part 1|Adverse Event|0|||
130848394|NCT00693472|471072461|FG003|Part 1|Adverse Event|0|||
130848395|NCT00693472|471072458|FG000|Part 1|Lost to Follow-up|0|||
130848396|NCT00693472|471072459|FG001|Part 1|Lost to Follow-up|1|||
130848397|NCT00693472|471072460|FG002|Part 1|Lost to Follow-up|0|||
130848398|NCT00693472|471072461|FG003|Part 1|Lost to Follow-up|0|||
130848399|NCT00693472|471072458|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
130848400|NCT00693472|471072459|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
130848401|NCT00693472|471072460|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
130848402|NCT00693472|471072461|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
130848403|NCT00693472|471072458|FG000|Part 2|Adverse Event|0|||
130848404|NCT00693472|471072459|FG001|Part 2|Adverse Event|0|||
130848405|NCT00693472|471072460|FG002|Part 2|Adverse Event|1|||
130848406|NCT00693472|471072461|FG003|Part 2|Adverse Event|0|||
130848407|NCT00693472|471072458|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
130848408|NCT00693472|471072459|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
130848409|NCT00693472|471072460|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
130848410|NCT00693472|471072461|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
130848411|NCT04063787|471072464|FG000|Overall Study|Inadequate Doppler data|4|||
130848412|NCT04063787|471072464|FG000|Overall Study|Lost to Follow-up|2|||
130848413|NCT04063787|471072464|FG000|Overall Study|Death|3|||
130848414|NCT00849875|471072465|FG000|Overall Study|Death|28|||
130848415|NCT00849875|471072465|FG000|Overall Study|Ongoing (unknown completion status)|11|||
130848416|NCT00849875|471072465|FG000|Overall Study|Others|6|||
130848417|NCT00849875|471072465|FG000|Overall Study|Lost to Follow-up|2|||
130848418|NCT00086502|471072466|FG000|Overall Study|Adverse Event|11|||
130848419|NCT00086502|471072467|FG001|Overall Study|Adverse Event|2|||
130848420|NCT00086502|471072466|FG000|Overall Study|Lack of Efficacy|0|||
130848421|NCT00086502|471072467|FG001|Overall Study|Lack of Efficacy|2|||
130848422|NCT00086502|471072466|FG000|Overall Study|Lost to Follow-up|3|||
130848423|NCT00086502|471072467|FG001|Overall Study|Lost to Follow-up|1|||
130848424|NCT00086502|471072466|FG000|Overall Study|Physician Decision|1|||
130848425|NCT00086502|471072467|FG001|Overall Study|Physician Decision|1|||
130848426|NCT00086502|471072466|FG000|Overall Study|Pregnancy|0|||
130848427|NCT00086502|471072467|FG001|Overall Study|Pregnancy|1|||
130848428|NCT00086502|471072466|FG000|Overall Study|Protocol Violation|3|||
130848429|NCT00086502|471072467|FG001|Overall Study|Protocol Violation|3|||
130848430|NCT00086502|471072466|FG000|Overall Study|Withdrawal by Subject|5|||
130848431|NCT00086502|471072467|FG001|Overall Study|Withdrawal by Subject|6|||
130848432|NCT00086502|471072466|FG000|Overall Study|Patient Moved|1|||
130848433|NCT00086502|471072467|FG001|Overall Study|Patient Moved|1|||
130848434|NCT00086502|471072466|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
130848435|NCT00086502|471072467|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
130848436|NCT00086502|471072466|FG000|Overall Study|Patient Accidentally Unblinded|1|||
130848437|NCT00086502|471072467|FG001|Overall Study|Patient Accidentally Unblinded|0|||
130848438|NCT01515475|471072473|FG000|Overall Study|Lost to Follow-up|20|||
130848439|NCT01515475|471072474|FG001|Overall Study|Lost to Follow-up|15|||
130848440|NCT01515475|471072475|FG002|Overall Study|Lost to Follow-up|12|||
130848441|NCT01515475|471072476|FG003|Overall Study|Lost to Follow-up|12|||
130848442|NCT01420627|471072477|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
130848443|NCT00837876|471072478|FG000|Overall Study|Death|2|||
130848444|NCT00837876|471072478|FG000|Overall Study|Adverse Event|7|||
130848445|NCT00837876|471072478|FG000|Overall Study|Physician Decision|1|||
130848446|NCT00837876|471072478|FG000|Overall Study|Withdrawal by Subject|3|||
130848447|NCT00837876|471072478|FG000|Overall Study|disease progression|24|||
130848448|NCT00453973|471072479|FG000|Overall Study|Adverse Event|4|||
130848449|NCT00453973|471072480|FG001|Overall Study|Adverse Event|9|||
130848450|NCT00453973|471072479|FG000|Overall Study|Withdrawal by Subject|7|||
130848451|NCT00453973|471072480|FG001|Overall Study|Withdrawal by Subject|6|||
130848452|NCT00453973|471072479|FG000|Overall Study|PI Decision|0|||
130848453|NCT00453973|471072480|FG001|Overall Study|PI Decision|2|||
130848454|NCT00453973|471072479|FG000|Overall Study|Relocation|1|||
130848455|NCT00453973|471072480|FG001|Overall Study|Relocation|0|||
130848456|NCT00453973|471072479|FG000|Overall Study|Renal transplant|1|||
130848457|NCT00453973|471072480|FG001|Overall Study|Renal transplant|1|||
130848458|NCT00453973|471072479|FG000|Overall Study|Site closed by sponsor|3|||
130848459|NCT00453973|471072480|FG001|Overall Study|Site closed by sponsor|0|||
130848460|NCT00453973|471072479|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
130848461|NCT00453973|471072480|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
130848462|NCT00276094|471072481|FG000|Overall Study|Adverse Event|15|||
130848463|NCT00276094|471072482|FG001|Overall Study|Adverse Event|13|||
130848464|NCT00276094|471072483|FG002|Overall Study|Adverse Event|11|||
130848465|NCT00276094|471072481|FG000|Overall Study|Withdrawal by Subject|14|||
130848466|NCT00276094|471072482|FG001|Overall Study|Withdrawal by Subject|14|||
130848467|NCT00276094|471072483|FG002|Overall Study|Withdrawal by Subject|12|||
130848468|NCT00276094|471072481|FG000|Overall Study|Protocol Violation|16|||
130848469|NCT00276094|471072482|FG001|Overall Study|Protocol Violation|7|||
130848470|NCT00276094|471072483|FG002|Overall Study|Protocol Violation|10|||
130848471|NCT00276094|471072481|FG000|Overall Study|Lost to Follow-up|8|||
130848472|NCT00276094|471072482|FG001|Overall Study|Lost to Follow-up|6|||
130848473|NCT00276094|471072483|FG002|Overall Study|Lost to Follow-up|4|||
130848474|NCT00276094|471072481|FG000|Overall Study|Other-Subject moved out of country|1|||
130848475|NCT00276094|471072482|FG001|Overall Study|Other-Subject moved out of country|0|||
130848476|NCT00276094|471072483|FG002|Overall Study|Other-Subject moved out of country|0|||
130848477|NCT00276094|471072481|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
130848478|NCT00276094|471072482|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
130848479|NCT00276094|471072483|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
130848480|NCT00276094|471072481|FG000|Overall Study|Other-Lack of efficacy|1|||
130848481|NCT00276094|471072482|FG001|Overall Study|Other-Lack of efficacy|0|||
130848482|NCT00276094|471072483|FG002|Overall Study|Other-Lack of efficacy|0|||
130848483|NCT00276094|471072481|FG000|Overall Study|Other-Refused follow-up visit|1|||
130848484|NCT00276094|471072482|FG001|Overall Study|Other-Refused follow-up visit|0|||
130848485|NCT00276094|471072483|FG002|Overall Study|Other-Refused follow-up visit|0|||
130848486|NCT00276094|471072481|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
130848487|NCT00276094|471072482|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
130848488|NCT00276094|471072483|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
130848489|NCT00276094|471072481|FG000|Overall Study|Other-Relocation|0|||
130848490|NCT00276094|471072482|FG001|Overall Study|Other-Relocation|1|||
130848491|NCT00276094|471072483|FG002|Overall Study|Other-Relocation|0|||
130848492|NCT00276094|471072481|FG000|Overall Study|Other-Study medication lost|0|||
130848493|NCT00276094|471072482|FG001|Overall Study|Other-Study medication lost|0|||
130848494|NCT00276094|471072483|FG002|Overall Study|Other-Study medication lost|1|||
130848495|NCT02075632|471072488|FG000|Overall Study|Adverse Event|1|||
130848496|NCT02075632|471072489|FG001|Overall Study|Adverse Event|1|||
130848497|NCT02075632|471072488|FG000|Overall Study|Lost to Follow-up|0|||
130848498|NCT02075632|471072489|FG001|Overall Study|Lost to Follow-up|3|||
130848499|NCT02075632|471072488|FG000|Overall Study|Withdrawal by Subject|0|||
130848500|NCT02075632|471072489|FG001|Overall Study|Withdrawal by Subject|1|||
130848501|NCT01969500|471072498|FG000|Overall Study|Death|0|||
130848502|NCT01969500|471072499|FG001|Overall Study|Death|1|||
130848503|NCT01969500|471072498|FG000|Overall Study|extended hospitalization|1|||
130848504|NCT01969500|471072499|FG001|Overall Study|extended hospitalization|1|||
130848505|NCT01873729|471072500|FG000|Overall Study|Withdrawal by Subject|1|||
130848506|NCT02463032|471072501|FG000|Overall Study|Lack of Efficacy|61|||
130848507|NCT02463032|471072502|FG001|Overall Study|Lack of Efficacy|50|||
130848508|NCT02463032|471072501|FG000|Overall Study|Death|8|||
130848509|NCT02463032|471072502|FG001|Overall Study|Death|8|||
130848510|NCT02463032|471072501|FG000|Overall Study|Adverse Event|2|||
130848511|NCT02463032|471072502|FG001|Overall Study|Adverse Event|6|||
130848512|NCT00613080|471072503|FG000|Overall Study|Ineligible / no protocol treatment|11|||
130848513|NCT03757130|471072504|FG000|Overall Study|Lost to Follow-up|0|||
130848514|NCT03757130|471072505|FG001|Overall Study|Lost to Follow-up|0|||
130848515|NCT03757130|471072506|FG002|Overall Study|Lost to Follow-up|0|||
130848516|NCT03757130|471072507|FG003|Overall Study|Lost to Follow-up|1|||
130848517|NCT03757130|471072508|FG004|Overall Study|Lost to Follow-up|0|||
130848518|NCT03757130|471072509|FG005|Overall Study|Lost to Follow-up|0|||
130848519|NCT03757130|471072510|FG006|Overall Study|Lost to Follow-up|0|||
130848520|NCT03757130|471072511|FG007|Overall Study|Lost to Follow-up|1|||
130848521|NCT03757130|471072504|FG000|Overall Study|Withdrawal by Subject|0|||
130848522|NCT03757130|471072505|FG001|Overall Study|Withdrawal by Subject|0|||
130848523|NCT03757130|471072506|FG002|Overall Study|Withdrawal by Subject|0|||
130848524|NCT03757130|471072507|FG003|Overall Study|Withdrawal by Subject|0|||
130848525|NCT03757130|471072508|FG004|Overall Study|Withdrawal by Subject|0|||
130848526|NCT03757130|471072509|FG005|Overall Study|Withdrawal by Subject|0|||
130848527|NCT03757130|471072510|FG006|Overall Study|Withdrawal by Subject|1|||
130848528|NCT03757130|471072511|FG007|Overall Study|Withdrawal by Subject|0|||
130848529|NCT02226549|471072512|FG000|Overall Study|Randomized but Never Treated|1|||
130848530|NCT02226549|471072513|FG001|Overall Study|Randomized but Never Treated|0|||
130848531|NCT02226549|471072512|FG000|Overall Study|Lost to Follow-up|0|||
130848532|NCT02226549|471072513|FG001|Overall Study|Lost to Follow-up|1|||
130848533|NCT02726880|471072515|FG000|Overall Study|Withdrawal by Subject|2|||
130848534|NCT02726880|471072516|FG001|Overall Study|Withdrawal by Subject|0|||
130848535|NCT02726880|471072515|FG000|Overall Study|Lost to Follow-up|1|||
130848536|NCT02726880|471072516|FG001|Overall Study|Lost to Follow-up|3|||
130848537|NCT02312219|471072517|FG000|Overall Study|Withdrawal by Subject|1|||
130848538|NCT02312219|471072518|FG001|Overall Study|Withdrawal by Subject|2|||
130848539|NCT02312219|471072517|FG000|Overall Study|could not schedule imaging in time|0|||
130848540|NCT02312219|471072518|FG001|Overall Study|could not schedule imaging in time|2|||
130848541|NCT02312219|471072517|FG000|Overall Study|Other|0|||
130848542|NCT02312219|471072518|FG001|Overall Study|Other|1|||
130848543|NCT02312219|471072517|FG000|Overall Study|Not randomized. Ineligible|0|||
130848544|NCT02312219|471072518|FG001|Overall Study|Not randomized. Ineligible|1|||
130848545|NCT01269385|471072519|FG000|Overall Study|Adverse Event|1|||
130848546|NCT01269385|471072520|FG001|Overall Study|Adverse Event|1|||
130848547|NCT01269385|471072521|FG002|Overall Study|Adverse Event|0|||
130848548|NCT01269385|471072522|FG003|Overall Study|Adverse Event|0|||
130848549|NCT00546260|471072523|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
130848550|NCT00546260|471072524|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
130848551|NCT03759041|471072525|FG000|Overall Study|Withdrawal by Subject|4|||
130848552|NCT03759041|471072526|FG001|Overall Study|Withdrawal by Subject|10|||
130848553|NCT03759041|471072527|FG002|Overall Study|Withdrawal by Subject|10|||
130848554|NCT03759041|471072525|FG000|Overall Study|Adverse Event|1|||
130848555|NCT03759041|471072526|FG001|Overall Study|Adverse Event|3|||
130848556|NCT03759041|471072527|FG002|Overall Study|Adverse Event|4|||
130848557|NCT03759041|471072525|FG000|Overall Study|Lack of Efficacy|0|||
130848558|NCT03759041|471072526|FG001|Overall Study|Lack of Efficacy|0|||
130848559|NCT03759041|471072527|FG002|Overall Study|Lack of Efficacy|1|||
130848560|NCT03759041|471072525|FG000|Overall Study|Study Terminated by Sponsor|15|||
130848561|NCT03759041|471072526|FG001|Overall Study|Study Terminated by Sponsor|16|||
130848562|NCT03759041|471072527|FG002|Overall Study|Study Terminated by Sponsor|10|||
130848563|NCT03759041|471072525|FG000|Overall Study|Other reason for discontinuation|0|||
130848564|NCT03759041|471072526|FG001|Overall Study|Other reason for discontinuation|2|||
130848565|NCT03759041|471072527|FG002|Overall Study|Other reason for discontinuation|1|||
130848566|NCT03759041|471072525|FG000|Overall Study|Lost to Follow-up|7|||
130848567|NCT03759041|471072526|FG001|Overall Study|Lost to Follow-up|2|||
130848568|NCT03759041|471072527|FG002|Overall Study|Lost to Follow-up|2|||
130848569|NCT03759041|471072525|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
130848570|NCT03759041|471072526|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
130848571|NCT03759041|471072527|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
130848572|NCT04384107|471072528|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
130848573|NCT04384107|471072529|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
130848574|NCT04384107|471072528|FG000|Overall Study|Lost to Follow-up|1|||
130848575|NCT04384107|471072529|FG001|Overall Study|Lost to Follow-up|0|||
130848576|NCT00276614|471072530|FG000|Overall Study|Progression of disease under study|3|||
130848577|NCT01522404|471072533|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
130848578|NCT01522404|471072534|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
130848579|NCT01522404|471072533|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
130848580|NCT01522404|471072534|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
130848581|NCT01522404|471072533|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
130848582|NCT01522404|471072534|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
130848583|NCT01591863|471072539|FG000|Overall Study|Adverse Event|3|||
130848584|NCT01591863|471072539|FG000|Overall Study|Withdrawal by Subject|1|||
130848585|NCT01591863|471072539|FG000|Overall Study|recurrence|9|||
130848586|NCT01591863|471072539|FG000|Overall Study|Lack of Efficacy|1|||
130848587|NCT02032407|471073931|FG000|Overall Study|Lost to Follow-up|2|||
130848588|NCT02032407|471073931|FG000|Overall Study|Pregnancy|1|||
130848589|NCT02032407|471073931|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130848590|NCT02191605|471073932|FG000|Overall Study|Lost to Follow-up|9|||
130848591|NCT02191605|471073933|FG001|Overall Study|Lost to Follow-up|4|||
130848592|NCT02191605|471073934|FG002|Overall Study|Lost to Follow-up|7|||
130848593|NCT02191605|471073935|FG003|Overall Study|Lost to Follow-up|3|||
130848594|NCT02191605|471073936|FG004|Overall Study|Lost to Follow-up|4|||
130848595|NCT00734071|471073937|FG000|Overall Study|Adverse Event|4|||
130848596|NCT00734071|471073938|FG001|Overall Study|Adverse Event|3|||
130848597|NCT00734071|471073937|FG000|Overall Study|Lack of Efficacy|3|||
130848598|NCT00734071|471073938|FG001|Overall Study|Lack of Efficacy|1|||
130848599|NCT00734071|471073937|FG000|Overall Study|Noncompliance|2|||
130848600|NCT00734071|471073938|FG001|Overall Study|Noncompliance|2|||
130848601|NCT00734071|471073937|FG000|Overall Study|Protocol Deviations|3|||
130848602|NCT00734071|471073938|FG001|Overall Study|Protocol Deviations|4|||
130848603|NCT00734071|471073937|FG000|Overall Study|Voluntary Withdrawal|9|||
130848604|NCT00734071|471073938|FG001|Overall Study|Voluntary Withdrawal|7|||
130848605|NCT00734071|471073937|FG000|Overall Study|Lost to Follow-up|16|||
130848606|NCT00734071|471073938|FG001|Overall Study|Lost to Follow-up|8|||
130848607|NCT00734071|471073937|FG000|Overall Study|Other|1|||
130848608|NCT00734071|471073938|FG001|Overall Study|Other|2|||
130848609|NCT00240110|471073942|FG000|Overall Study|Lost to Follow-up|6|||
130848610|NCT00240110|471073943|FG001|Overall Study|Lost to Follow-up|7|||
130848611|NCT00583791|471073944|FG000|Overall Study|Other|67|||
130848612|NCT00583791|471073944|FG000|Overall Study|Death|6|||
130848613|NCT03323736|471073945|FG000|Overall Study|Screen Failure|14|||
130848614|NCT03323736|471073946|FG001|Overall Study|Screen Failure|9|||
130848615|NCT03323736|471073947|FG002|Overall Study|Screen Failure|1|||
130848616|NCT03323736|471073945|FG000|Overall Study|Withdrawal Before Treatment|3|||
130848617|NCT03323736|471073946|FG001|Overall Study|Withdrawal Before Treatment|1|||
130848618|NCT03323736|471073947|FG002|Overall Study|Withdrawal Before Treatment|1|||
130848619|NCT03323736|471073945|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
130848620|NCT03323736|471073946|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
130848621|NCT03323736|471073947|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
130848622|NCT02654236|471073951|FG000|Overall Study|Withdrawal by Subject|0|||
130848623|NCT02654236|471073952|FG001|Overall Study|Withdrawal by Subject|0|||
130848624|NCT02654236|471073953|FG002|Overall Study|Withdrawal by Subject|2|||
130848625|NCT03204890|471073954|FG000|Overall Study|Withdrawal by Subject|1|||
130848626|NCT01549873|471073955|FG000|Overall Study|Physician Decision|0|||
130848627|NCT01549873|471073956|FG001|Overall Study|Physician Decision|1|||
130848628|NCT05545644|471073957|FG000|Overall Study|Lost to Follow-up|4|||
130848629|NCT05545644|471073958|FG001|Overall Study|Lost to Follow-up|3|||
130848630|NCT00554099|471073961|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
130848631|NCT00554099|471073962|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
130848632|NCT00554099|471073963|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
130848633|NCT00554099|471073961|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
130848634|NCT00554099|471073962|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
130848635|NCT00554099|471073963|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
130848636|NCT00554099|471073961|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130848637|NCT00554099|471073962|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130848638|NCT00554099|471073963|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
130848639|NCT00554099|471073961|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
130848640|NCT00554099|471073962|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
130848641|NCT00554099|471073963|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
130848642|NCT00554099|471073961|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
130848643|NCT00554099|471073962|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
130848644|NCT00554099|471073963|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
130848645|NCT00554099|471073961|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130848646|NCT00554099|471073962|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130848647|NCT00554099|471073963|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130848648|NCT00554099|471073961|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
130848649|NCT00554099|471073962|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
130848650|NCT00554099|471073963|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
130848651|NCT00554099|471073961|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
130848652|NCT00554099|471073962|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
130848653|NCT00554099|471073963|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
130848654|NCT00554099|471073961|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
130848655|NCT00554099|471073962|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
130848656|NCT00554099|471073963|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
130848657|NCT03002623|471073964|FG000|Overall Study|Lost to Follow-up|1|||
130848658|NCT03002623|471073965|FG001|Overall Study|Lost to Follow-up|0|||
130848659|NCT03002623|471073964|FG000|Overall Study|Physician Decision|1|||
130848660|NCT03002623|471073965|FG001|Overall Study|Physician Decision|1|||
130848661|NCT01011933|471073966|FG000|Overall Study|Wrong cell type|1|||
130848662|NCT01011933|471073966|FG000|Overall Study|Improper pre-protocol Rx|1|||
130848663|NCT01011933|471073966|FG000|Overall Study|Inadequate pathology|1|||
130848664|NCT01011933|471073966|FG000|Overall Study|Never treated|1|||
130848665|NCT01439074|471073968|FG000|Overall Study|Lost to Follow-up|3|||
130848666|NCT01439074|471073969|FG001|Overall Study|Lost to Follow-up|4|||
130848667|NCT01439074|471073968|FG000|Overall Study|Subject shedding|1|||
130848668|NCT01439074|471073969|FG001|Overall Study|Subject shedding|0|||
130848669|NCT01439074|471073968|FG000|Overall Study|Withdrawal by Subject|1|||
130848670|NCT01439074|471073969|FG001|Overall Study|Withdrawal by Subject|5|||
130848671|NCT01439074|471073968|FG000|Overall Study|Other|4|||
130848672|NCT01439074|471073969|FG001|Overall Study|Other|4|||
130848673|NCT02639338|471073970|FG000|Overall Study|Lost to Follow-up|2|||
130848674|NCT02639338|471073971|FG001|Overall Study|Lost to Follow-up|2|||
130848675|NCT02639338|471073970|FG000|Overall Study|Withdrew Consent|1|||
130848676|NCT02639338|471073971|FG001|Overall Study|Withdrew Consent|2|||
130848677|NCT02639338|471073970|FG000|Overall Study|Death|1|||
130848678|NCT02639338|471073971|FG001|Overall Study|Death|0|||
130848679|NCT02639338|471073970|FG000|Overall Study|Randomized but Not Treated|0|||
130848680|NCT02639338|471073971|FG001|Overall Study|Randomized but Not Treated|1|||
130848681|NCT00493636|471073972|FG000|Overall Study|Withdrawal by Subject|1|||
130848682|NCT00493636|471073973|FG001|Overall Study|Withdrawal by Subject|0|||
130848683|NCT00493636|471073972|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
130848684|NCT00493636|471073973|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
130848685|NCT00493636|471073972|FG000|Overall Study|Mis-randomization|1|||
130848686|NCT00493636|471073973|FG001|Overall Study|Mis-randomization|1|||
130848687|NCT02012686|471073980|FG000|Overall Study|muscle contraction|0|||
130848688|NCT02012686|471073981|FG001|Overall Study|muscle contraction|1|||
130848689|NCT02012686|471073980|FG000|Overall Study|electrocardiography monitoring noise|0|||
130848690|NCT02012686|471073981|FG001|Overall Study|electrocardiography monitoring noise|1|||
130848691|NCT00612508|471073982|FG000|Overall Study|Withdrawal by Subject|3|||
130848692|NCT00612508|471073983|FG001|Overall Study|Withdrawal by Subject|4|||
130848693|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
130848694|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
130848695|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
130848696|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
130848697|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
130848698|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
130848699|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
130848700|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
130848701|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
130848702|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
130848703|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
130848704|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
130848705|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
130848706|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
130848707|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
130848708|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
130848709|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
130848710|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
130848711|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
130848712|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
130848713|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
130848714|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
130848715|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
130848716|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
130848717|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
130848718|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
130848719|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
130848720|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
130848721|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
130848722|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
130848723|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
130848724|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
130848725|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
130848726|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
130848727|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
130848728|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
130848729|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
130848730|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
130848731|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
130848732|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
130848733|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
130848734|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
130848735|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
130848736|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
130848737|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
130848738|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
130848739|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
130848740|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
130848741|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
130848742|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
130848743|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
130848744|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
130848745|NCT02008357|471073984|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
130848746|NCT02008357|471073985|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
130848747|NCT02008357|471073984|FG000|Open-label Extension Period|Adverse Event|8|||
130848748|NCT02008357|471073985|FG001|Open-label Extension Period|Adverse Event|7|||
130848749|NCT02008357|471073984|FG000|Open-label Extension Period|Death|7|||
130848750|NCT02008357|471073985|FG001|Open-label Extension Period|Death|4|||
130848751|NCT02008357|471073984|FG000|Open-label Extension Period|Lack of Efficacy|9|||
130848752|NCT02008357|471073985|FG001|Open-label Extension Period|Lack of Efficacy|5|||
130848753|NCT02008357|471073984|FG000|Open-label Extension Period|Lost to Follow-up|2|||
130848754|NCT02008357|471073985|FG001|Open-label Extension Period|Lost to Follow-up|2|||
130848755|NCT02008357|471073984|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
130848756|NCT02008357|471073985|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
130848757|NCT02008357|471073984|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
130848758|NCT02008357|471073985|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
130848759|NCT02008357|471073984|FG000|Open-label Extension Period|Safety Risk|2|||
130848760|NCT02008357|471073985|FG001|Open-label Extension Period|Safety Risk|1|||
130848761|NCT02008357|471073984|FG000|Open-label Extension Period|Non-Compliance|0|||
130848762|NCT02008357|471073985|FG001|Open-label Extension Period|Non-Compliance|1|||
130848763|NCT02008357|471073984|FG000|Open-label Extension Period|Investigator Recommendation|0|||
130848764|NCT02008357|471073985|FG001|Open-label Extension Period|Investigator Recommendation|1|||
130848765|NCT02008357|471073984|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
130848766|NCT02008357|471073985|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
130848767|NCT02008357|471073984|FG000|Open-label Extension Period|Coordinating Center Request|2|||
130848768|NCT02008357|471073985|FG001|Open-label Extension Period|Coordinating Center Request|4|||
130848769|NCT02008357|471073984|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
130848770|NCT02008357|471073985|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
130848771|NCT02008357|471073984|FG000|Open-label Extension Period|Study Ended|20|||
130848772|NCT02008357|471073985|FG001|Open-label Extension Period|Study Ended|25|||
130848773|NCT02008357|471073984|FG000|Open-label Extension Period|Personal Reasons|0|||
130848774|NCT02008357|471073985|FG001|Open-label Extension Period|Personal Reasons|1|||
130848775|NCT02008357|471073984|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
130848776|NCT02008357|471073985|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
130848777|NCT02008357|471073984|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
130848778|NCT02008357|471073985|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
130848779|NCT02008357|471073984|FG000|Open-label Extension Period|Other|2|||
130848780|NCT02008357|471073985|FG001|Open-label Extension Period|Other|0|||
130848781|NCT00787202|471073986|FG000|Overall Study|Adverse Event|3|||
130848782|NCT00787202|471073987|FG001|Overall Study|Adverse Event|2|||
130848783|NCT00787202|471073988|FG002|Overall Study|Adverse Event|0|||
130848784|NCT00787202|471073989|FG003|Overall Study|Adverse Event|0|||
130848785|NCT00787202|471073990|FG004|Overall Study|Adverse Event|2|||
130848786|NCT00787202|471073986|FG000|Overall Study|Lack of Efficacy|5|||
130848787|NCT00787202|471073987|FG001|Overall Study|Lack of Efficacy|6|||
130848788|NCT00787202|471073988|FG002|Overall Study|Lack of Efficacy|5|||
130848789|NCT00787202|471073989|FG003|Overall Study|Lack of Efficacy|2|||
130848790|NCT00787202|471073990|FG004|Overall Study|Lack of Efficacy|1|||
130848791|NCT00787202|471073986|FG000|Overall Study|Lost to Follow-up|1|||
130848792|NCT00787202|471073987|FG001|Overall Study|Lost to Follow-up|0|||
130848793|NCT00787202|471073988|FG002|Overall Study|Lost to Follow-up|0|||
130848794|NCT00787202|471073989|FG003|Overall Study|Lost to Follow-up|0|||
130848795|NCT00787202|471073990|FG004|Overall Study|Lost to Follow-up|0|||
130848796|NCT00787202|471073986|FG000|Overall Study|Withdrawal by Subject|2|||
130848797|NCT00787202|471073987|FG001|Overall Study|Withdrawal by Subject|2|||
130848798|NCT00787202|471073988|FG002|Overall Study|Withdrawal by Subject|2|||
130848799|NCT00787202|471073989|FG003|Overall Study|Withdrawal by Subject|0|||
130848800|NCT00787202|471073990|FG004|Overall Study|Withdrawal by Subject|0|||
130848801|NCT00787202|471073986|FG000|Overall Study|Protocol Violation|2|||
130848802|NCT00787202|471073987|FG001|Overall Study|Protocol Violation|1|||
130848803|NCT00787202|471073988|FG002|Overall Study|Protocol Violation|0|||
130848804|NCT00787202|471073989|FG003|Overall Study|Protocol Violation|0|||
130848805|NCT00787202|471073990|FG004|Overall Study|Protocol Violation|1|||
130848806|NCT00787202|471073986|FG000|Overall Study|Randomized, not treated|1|||
130848807|NCT00787202|471073987|FG001|Overall Study|Randomized, not treated|0|||
130848808|NCT00787202|471073988|FG002|Overall Study|Randomized, not treated|0|||
130848809|NCT00787202|471073989|FG003|Overall Study|Randomized, not treated|0|||
130848810|NCT00787202|471073990|FG004|Overall Study|Randomized, not treated|0|||
130848811|NCT01442064|471073991|FG000|Overall Study|Adverse Event|2|||
130848812|NCT01442064|471073992|FG001|Overall Study|Adverse Event|2|||
130848813|NCT01442064|471073993|FG002|Overall Study|Adverse Event|2|||
130848814|NCT01442064|471073994|FG003|Overall Study|Adverse Event|1|||
130848815|NCT01442064|471073995|FG004|Overall Study|Adverse Event|2|||
130848816|NCT01442064|471073996|FG005|Overall Study|Adverse Event|0|||
130848817|NCT01442064|471073991|FG000|Overall Study|Death|0|||
130848818|NCT01442064|471073992|FG001|Overall Study|Death|1|||
130848819|NCT01442064|471073993|FG002|Overall Study|Death|3|||
130848820|NCT01442064|471073994|FG003|Overall Study|Death|3|||
130848821|NCT01442064|471073995|FG004|Overall Study|Death|1|||
130848822|NCT01442064|471073996|FG005|Overall Study|Death|3|||
130848823|NCT01442064|471073991|FG000|Overall Study|Lost to Follow-up|5|||
130848824|NCT01442064|471073992|FG001|Overall Study|Lost to Follow-up|5|||
130848825|NCT01442064|471073993|FG002|Overall Study|Lost to Follow-up|1|||
130848826|NCT01442064|471073994|FG003|Overall Study|Lost to Follow-up|1|||
130848827|NCT01442064|471073995|FG004|Overall Study|Lost to Follow-up|3|||
130848828|NCT01442064|471073996|FG005|Overall Study|Lost to Follow-up|3|||
130848829|NCT01442064|471073991|FG000|Overall Study|Physician Decision|1|||
130848830|NCT01442064|471073992|FG001|Overall Study|Physician Decision|1|||
130848831|NCT01442064|471073993|FG002|Overall Study|Physician Decision|2|||
130848832|NCT01442064|471073994|FG003|Overall Study|Physician Decision|3|||
130848833|NCT01442064|471073995|FG004|Overall Study|Physician Decision|3|||
130848834|NCT01442064|471073996|FG005|Overall Study|Physician Decision|1|||
130848835|NCT01442064|471073991|FG000|Overall Study|Withdrawal by Subject|6|||
130848836|NCT01442064|471073992|FG001|Overall Study|Withdrawal by Subject|3|||
130848837|NCT01442064|471073993|FG002|Overall Study|Withdrawal by Subject|2|||
130848838|NCT01442064|471073994|FG003|Overall Study|Withdrawal by Subject|2|||
130848839|NCT01442064|471073995|FG004|Overall Study|Withdrawal by Subject|2|||
130848840|NCT01442064|471073996|FG005|Overall Study|Withdrawal by Subject|1|||
130848841|NCT01442064|471073991|FG000|Overall Study|Sponsor decision|82|||
130848842|NCT01442064|471073992|FG001|Overall Study|Sponsor decision|88|||
130848843|NCT01442064|471073993|FG002|Overall Study|Sponsor decision|92|||
130848844|NCT01442064|471073994|FG003|Overall Study|Sponsor decision|88|||
130848845|NCT01442064|471073995|FG004|Overall Study|Sponsor decision|95|||
130848846|NCT01442064|471073996|FG005|Overall Study|Sponsor decision|87|||
130848847|NCT01442064|471073991|FG000|Overall Study|Subject non-compliance|0|||
130848848|NCT01442064|471073992|FG001|Overall Study|Subject non-compliance|0|||
130848849|NCT01442064|471073993|FG002|Overall Study|Subject non-compliance|0|||
130848850|NCT01442064|471073994|FG003|Overall Study|Subject non-compliance|0|||
130848851|NCT01442064|471073995|FG004|Overall Study|Subject non-compliance|0|||
130848852|NCT01442064|471073996|FG005|Overall Study|Subject non-compliance|2|||
130848853|NCT01442064|471073991|FG000|Overall Study|Condition mandated other intervention|1|||
130848854|NCT01442064|471073992|FG001|Overall Study|Condition mandated other intervention|1|||
130848855|NCT01442064|471073993|FG002|Overall Study|Condition mandated other intervention|2|||
130848856|NCT01442064|471073994|FG003|Overall Study|Condition mandated other intervention|0|||
130848857|NCT01442064|471073995|FG004|Overall Study|Condition mandated other intervention|0|||
130848858|NCT01442064|471073996|FG005|Overall Study|Condition mandated other intervention|2|||
130848859|NCT03553498|471073999|FG000|Overall Study|Missing primary outcome|1|||
130848860|NCT03553498|471074000|FG001|Overall Study|Missing primary outcome|2|||
130848861|NCT04941807|471074001|FG000|Overall Study|Lost to Follow-up|1|||
130848862|NCT04941807|471074002|FG001|Overall Study|Lost to Follow-up|1|||
130848863|NCT02741570|471074003|FG000|Pre-Treatment Period|Other reasons|0|||
130848864|NCT02741570|471074004|FG001|Pre-Treatment Period|Other reasons|3|||
130848865|NCT02741570|471074003|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
130848866|NCT02741570|471074004|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
130848867|NCT02741570|471074003|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
130848868|NCT02741570|471074004|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
130848869|NCT02741570|471074003|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
130848870|NCT02741570|471074004|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
130848871|NCT02741570|471074003|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
130848872|NCT02741570|471074004|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
130848873|NCT02741570|471074003|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130848874|NCT02741570|471074004|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
130848875|NCT02741570|471074003|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
130848876|NCT02741570|471074004|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130848877|NCT02741570|471074003|FG000|Pre-Treatment Period|Death|0|||
130848878|NCT02741570|471074004|FG001|Pre-Treatment Period|Death|1|||
130848879|NCT02741570|471074003|FG000|Pre-Treatment Period|Disease progression|0|||
130848880|NCT02741570|471074004|FG001|Pre-Treatment Period|Disease progression|1|||
130848881|NCT02741570|471074003|FG000|Treatment Period|Other reasons|47|||
130848882|NCT02741570|471074004|FG001|Treatment Period|Other reasons|12|||
130848883|NCT02741570|471074003|FG000|Treatment Period|Poor/non-compliance|0|||
130848884|NCT02741570|471074004|FG001|Treatment Period|Poor/non-compliance|2|||
130848885|NCT02741570|471074003|FG000|Treatment Period|Maximum clinical benefit|4|||
130848886|NCT02741570|471074004|FG001|Treatment Period|Maximum clinical benefit|6|||
130848887|NCT02741570|471074003|FG000|Treatment Period|Lost to Follow-up|1|||
130848888|NCT02741570|471074004|FG001|Treatment Period|Lost to Follow-up|3|||
130848889|NCT02741570|471074003|FG000|Treatment Period|Participant withdrew consent|9|||
130848890|NCT02741570|471074004|FG001|Treatment Period|Participant withdrew consent|13|||
130848891|NCT02741570|471074003|FG000|Treatment Period|Participant request to discontinue treatment|8|||
130848892|NCT02741570|471074004|FG001|Treatment Period|Participant request to discontinue treatment|23|||
130848893|NCT02741570|471074003|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
130848894|NCT02741570|471074004|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
130848895|NCT02741570|471074003|FG000|Treatment Period|Death|9|||
130848896|NCT02741570|471074004|FG001|Treatment Period|Death|7|||
130848897|NCT02741570|471074003|FG000|Treatment Period|Study drug toxicity|55|||
130848898|NCT02741570|471074004|FG001|Treatment Period|Study drug toxicity|47|||
130848899|NCT02741570|471074003|FG000|Treatment Period|Disease progression|294|||
130848900|NCT02741570|471074004|FG001|Treatment Period|Disease progression|301|||
130848901|NCT02741570|471074003|FG000|Treatment Period|Administrative reason by sponsor|0|||
130848902|NCT02741570|471074004|FG001|Treatment Period|Administrative reason by sponsor|1|||
130848903|NCT01100567|471074005|FG000|Overall Study|Withdrawal by Subject|5|||
130848904|NCT01100567|471074006|FG001|Overall Study|Withdrawal by Subject|8|||
130848905|NCT01100567|471074005|FG000|Overall Study|Early Hospital Discharge|6|||
130848906|NCT01100567|471074006|FG001|Overall Study|Early Hospital Discharge|4|||
130848907|NCT01100567|471074005|FG000|Overall Study|Lost to Follow-up|1|||
130848908|NCT01100567|471074006|FG001|Overall Study|Lost to Follow-up|2|||
130848909|NCT01100567|471074005|FG000|Overall Study|Physician Decision|0|||
130848910|NCT01100567|471074006|FG001|Overall Study|Physician Decision|1|||
130848911|NCT01100567|471074005|FG000|Overall Study|Deemed ineligible after consent|0|||
130848912|NCT01100567|471074006|FG001|Overall Study|Deemed ineligible after consent|1|||
130848913|NCT00160199|471074009|FG000|Overall Study|Adverse Event|5|||
130848914|NCT00160199|471074010|FG001|Overall Study|Adverse Event|14|||
130848915|NCT00160199|471074009|FG000|Overall Study|Lack of Efficacy|0|||
130848916|NCT00160199|471074010|FG001|Overall Study|Lack of Efficacy|1|||
130848917|NCT00160199|471074009|FG000|Overall Study|Lost to Follow-up|7|||
130848918|NCT00160199|471074010|FG001|Overall Study|Lost to Follow-up|7|||
130848919|NCT00160199|471074009|FG000|Overall Study|Withdrawal by Subject|4|||
130848920|NCT00160199|471074010|FG001|Overall Study|Withdrawal by Subject|6|||
130848921|NCT00160199|471074009|FG000|Overall Study|Administrative|0|||
130848922|NCT00160199|471074010|FG001|Overall Study|Administrative|1|||
130848923|NCT00160199|471074009|FG000|Overall Study|Protocol Violation|8|||
130848924|NCT00160199|471074010|FG001|Overall Study|Protocol Violation|8|||
130848925|NCT03352453|471074013|FG000|Overall Study|Miscellaneous Reasons|1|||
130848926|NCT03352453|471074014|FG001|Overall Study|Miscellaneous Reasons|2|||
130848927|NCT03352453|471074013|FG000|Overall Study|Lack of Efficacy|1|||
130848928|NCT03352453|471074014|FG001|Overall Study|Lack of Efficacy|0|||
130848929|NCT03352453|471074013|FG000|Overall Study|Withdrawal by Subject|8|||
130848930|NCT03352453|471074014|FG001|Overall Study|Withdrawal by Subject|14|||
130848931|NCT03352453|471074013|FG000|Overall Study|Study Terminated by Sponsor|2|||
130848932|NCT03352453|471074014|FG001|Overall Study|Study Terminated by Sponsor|1|||
130848933|NCT03352453|471074013|FG000|Overall Study|Protocol Deviation|1|||
130848934|NCT03352453|471074014|FG001|Overall Study|Protocol Deviation|0|||
130848935|NCT03352453|471074013|FG000|Overall Study|Lost to Follow-up|7|||
130848936|NCT03352453|471074014|FG001|Overall Study|Lost to Follow-up|6|||
130848937|NCT03352453|471074013|FG000|Overall Study|Adverse Event|2|||
130848938|NCT03352453|471074014|FG001|Overall Study|Adverse Event|9|||
130848939|NCT01241760|471074017|FG000|Overall Study|Adverse Event|1|||
130848940|NCT01241760|471074018|FG001|Overall Study|Adverse Event|0|||
130848941|NCT01241760|471074017|FG000|Overall Study|Lost to Follow-up|18|||
130848942|NCT01241760|471074018|FG001|Overall Study|Lost to Follow-up|22|||
130848943|NCT01241760|471074017|FG000|Overall Study|Withdrawal by Subject|13|||
130848944|NCT01241760|471074018|FG001|Overall Study|Withdrawal by Subject|13|||
130848945|NCT01241760|471074017|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
130848946|NCT01241760|471074018|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
130848947|NCT01241760|471074017|FG000|Overall Study|Other|1|||
130848948|NCT01241760|471074018|FG001|Overall Study|Other|1|||
130848949|NCT00514020|471074019|FG000|Overall Study|Adverse Event|6|||
130848950|NCT00514020|471074019|FG000|Overall Study|Withdrawal by Subject|3|||
130848951|NCT00514020|471074019|FG000|Overall Study|Physician Decision|1|||
130848952|NCT00514020|471074019|FG000|Overall Study|disease progression|9|||
130848953|NCT00514020|471074019|FG000|Overall Study|other complicating disease|2|||
130848954|NCT00514020|471074019|FG000|Overall Study|patient went to radiation treatment|1|||
130848955|NCT00514020|471074019|FG000|Overall Study|"patients moved to the no tx group"|6|||
130848956|NCT03089944|471074020|FG000|Overall Study|Lost to Follow-up|8|||
130848957|NCT03089944|471074020|FG000|Overall Study|Withdrew Consent|2|||
130848958|NCT03089944|471074020|FG000|Overall Study|Adverse Event|1|||
130848959|NCT03089944|471074020|FG000|Overall Study|Other|1|||
130848960|NCT03780959|471074021|FG000|Part 1|Adverse Event|1|||
130848961|NCT03780959|471074022|FG001|Part 1|Adverse Event|0|||
130848962|NCT03780959|471074023|FG002|Part 1|Adverse Event|0|||
130848963|NCT03780959|471074021|FG000|Part 1|Withdrawal by Subject|1|||
130848964|NCT03780959|471074022|FG001|Part 1|Withdrawal by Subject|0|||
130848965|NCT03780959|471074023|FG002|Part 1|Withdrawal by Subject|0|||
130848966|NCT03780959|471074021|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
130848967|NCT03780959|471074022|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
130848968|NCT03780959|471074023|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
130848969|NCT03780959|471074021|FG000|Part 1|Response Status|2|||
130848970|NCT03780959|471074022|FG001|Part 1|Response Status|0|||
130848971|NCT03780959|471074023|FG002|Part 1|Response Status|0|||
130848972|NCT03780959|471074021|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
130848973|NCT03780959|471074022|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
130848974|NCT03780959|471074023|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
130848975|NCT03780959|471074021|FG000|Part 2|Response Status|0|||
130848976|NCT03780959|471074022|FG001|Part 2|Response Status|18|||
130848977|NCT03780959|471074023|FG002|Part 2|Response Status|6|||
130848978|NCT01636713|471074025|FG000|Overall Study|Adverse Event|16|||
130848979|NCT01636713|471074026|FG001|Overall Study|Adverse Event|16|||
130848980|NCT01636713|471074027|FG002|Overall Study|Adverse Event|7|||
130848981|NCT01636713|471074025|FG000|Overall Study|Lack of Efficacy|6|||
130848982|NCT01636713|471074026|FG001|Overall Study|Lack of Efficacy|6|||
130848983|NCT01636713|471074027|FG002|Overall Study|Lack of Efficacy|2|||
130848984|NCT01636713|471074025|FG000|Overall Study|Protocol Violation|3|||
130848985|NCT01636713|471074026|FG001|Overall Study|Protocol Violation|0|||
130848986|NCT01636713|471074027|FG002|Overall Study|Protocol Violation|1|||
130848987|NCT01636713|471074025|FG000|Overall Study|Lost to Follow-up|0|||
130848988|NCT01636713|471074026|FG001|Overall Study|Lost to Follow-up|0|||
130848989|NCT01636713|471074027|FG002|Overall Study|Lost to Follow-up|1|||
130848990|NCT01636713|471074025|FG000|Overall Study|Withdrawal by Subject|5|||
130848991|NCT01636713|471074026|FG001|Overall Study|Withdrawal by Subject|4|||
130848992|NCT01636713|471074027|FG002|Overall Study|Withdrawal by Subject|8|||
130848993|NCT01636713|471074025|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
130848994|NCT01636713|471074026|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
130848995|NCT01636713|471074027|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
130848996|NCT03689244|471074031|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
130848997|NCT03689244|471074032|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
130848998|NCT03689244|471074033|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
130848999|NCT03689244|471074034|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
130849000|NCT03689244|471074031|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
130849001|NCT03689244|471074032|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
130849002|NCT03689244|471074033|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
130849003|NCT03689244|471074034|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
130849004|NCT03689244|471074031|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
130849005|NCT03689244|471074032|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
130849006|NCT03689244|471074033|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
130849007|NCT03689244|471074034|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
130849008|NCT03689244|471074031|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
130849009|NCT03689244|471074032|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
130849010|NCT03689244|471074033|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
130849011|NCT03689244|471074034|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
130849012|NCT03689244|471074031|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
130849013|NCT03689244|471074032|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
130849014|NCT03689244|471074033|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
130849015|NCT03689244|471074034|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
130849016|NCT03689244|471074031|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
130849017|NCT03689244|471074032|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
130849018|NCT03689244|471074033|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
130849019|NCT03689244|471074034|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
130849020|NCT03689244|471074031|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
130849021|NCT03689244|471074032|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
130849022|NCT03689244|471074033|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
130849023|NCT03689244|471074034|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
130849024|NCT03689244|471074031|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
130849025|NCT03689244|471074032|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
130849026|NCT03689244|471074033|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
130849027|NCT03689244|471074034|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
130849028|NCT03697993|471074045|FG000|Overall Study|Became Ineligible after Enrollment|1|||
130849029|NCT03697993|471074046|FG001|Overall Study|Became Ineligible after Enrollment|3|||
130849030|NCT03697993|471074045|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
130849031|NCT03697993|471074046|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
130849032|NCT03697993|471074045|FG000|Overall Study|Lost to Follow-up|3|||
130849033|NCT03697993|471074046|FG001|Overall Study|Lost to Follow-up|0|||
130849034|NCT03697993|471074045|FG000|Overall Study|Physician Decision|4|||
130849035|NCT03697993|471074046|FG001|Overall Study|Physician Decision|0|||
130849036|NCT03697993|471074045|FG000|Overall Study|Initial Urine Culture Negative|0|||
130849037|NCT03697993|471074046|FG001|Overall Study|Initial Urine Culture Negative|1|||
130849038|NCT01565564|471074049|FG000|Overall Study|Lost to Follow-up|5|||
130849039|NCT01565564|471074050|FG001|Overall Study|Lost to Follow-up|1|||
130849040|NCT02698371|471074055|FG000|All Participants Flow|Lost to Follow-up|3|||
130849041|NCT02698371|471074055|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
130849042|NCT02698371|471074055|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
130849043|NCT02698371|471074055|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
130849044|NCT02698371|471074055|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
130849045|NCT02698371|471074055|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
130849046|NCT02698371|471074055|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
130849047|NCT02525094|471074056|FG000|Overall Study|Lost to Follow-up|2|||
130849048|NCT02525094|471074057|FG001|Overall Study|Lost to Follow-up|1|||
130849049|NCT02525094|471074056|FG000|Overall Study|Withdrawal by Subject|5|||
130849050|NCT02525094|471074057|FG001|Overall Study|Withdrawal by Subject|6|||
130849051|NCT02525094|471074056|FG000|Overall Study|Not Treated|1|||
130849052|NCT02525094|471074057|FG001|Overall Study|Not Treated|1|||
130849053|NCT01751776|471074063|FG000|Overall Study|Adverse Event|0|||
130849054|NCT01751776|471074064|FG001|Overall Study|Adverse Event|0|||
130849055|NCT01751776|471074065|FG002|Overall Study|Adverse Event|0|||
130849056|NCT01751776|471074066|FG003|Overall Study|Adverse Event|0|||
130849057|NCT01751776|471074067|FG004|Overall Study|Adverse Event|0|||
130849058|NCT01751776|471074068|FG005|Overall Study|Adverse Event|0|||
130849059|NCT01751776|471074069|FG006|Overall Study|Adverse Event|4|||
130849060|NCT01751776|471074070|FG007|Overall Study|Adverse Event|2|||
130849061|NCT01751776|471074063|FG000|Overall Study|Consent withdrawn|0|||
130849062|NCT01751776|471074064|FG001|Overall Study|Consent withdrawn|0|||
130849063|NCT01751776|471074065|FG002|Overall Study|Consent withdrawn|0|||
130849064|NCT01751776|471074066|FG003|Overall Study|Consent withdrawn|0|||
130849065|NCT01751776|471074067|FG004|Overall Study|Consent withdrawn|0|||
130849066|NCT01751776|471074068|FG005|Overall Study|Consent withdrawn|0|||
130849067|NCT01751776|471074069|FG006|Overall Study|Consent withdrawn|0|||
130849068|NCT01751776|471074070|FG007|Overall Study|Consent withdrawn|1|||
130849069|NCT01751776|471074063|FG000|Overall Study|Other reason not specified above|0|||
130849070|NCT01751776|471074064|FG001|Overall Study|Other reason not specified above|0|||
130849071|NCT01751776|471074065|FG002|Overall Study|Other reason not specified above|0|||
130849072|NCT01751776|471074066|FG003|Overall Study|Other reason not specified above|0|||
130849073|NCT01751776|471074067|FG004|Overall Study|Other reason not specified above|0|||
130849074|NCT01751776|471074068|FG005|Overall Study|Other reason not specified above|0|||
130849075|NCT01751776|471074069|FG006|Overall Study|Other reason not specified above|0|||
130849076|NCT01751776|471074070|FG007|Overall Study|Other reason not specified above|1|||
130849077|NCT00831701|471074075|FG000|Overall Study|Withdrawal by Subject|2|||
130849078|NCT00831701|471074076|FG001|Overall Study|Withdrawal by Subject|0|||
130849079|NCT00831701|471074075|FG000|Overall Study|Stone expulsion before first medication|2|||
130849080|NCT00831701|471074076|FG001|Overall Study|Stone expulsion before first medication|2|||
130849081|NCT00831701|471074075|FG000|Overall Study|Lost to Follow-up|1|||
130849082|NCT00831701|471074076|FG001|Overall Study|Lost to Follow-up|3|||
130849083|NCT02210091|471074077|FG000|Overall Study|Physician Decision|0|||
130849084|NCT02210091|471074078|FG001|Overall Study|Physician Decision|1|||
130849085|NCT02210091|471074077|FG000|Overall Study|Withdrawal by Sponsor|0|||
130849086|NCT02210091|471074078|FG001|Overall Study|Withdrawal by Sponsor|1|||
130849087|NCT02290938|471074082|FG000|Overall Study|Lost to Follow-up|14|||
130849088|NCT02290938|471074083|FG001|Overall Study|Lost to Follow-up|43|||
130849089|NCT00459537|471074084|FG000|Overall Study|Adverse Event|1|||
130849090|NCT00459537|471074085|FG001|Overall Study|Adverse Event|6|||
130849091|NCT00459537|471074084|FG000|Overall Study|Lack of Efficacy|10|||
130849092|NCT00459537|471074085|FG001|Overall Study|Lack of Efficacy|11|||
130849093|NCT00459537|471074084|FG000|Overall Study|Withdrawal by Subject|20|||
130849094|NCT00459537|471074085|FG001|Overall Study|Withdrawal by Subject|26|||
130849095|NCT00459537|471074084|FG000|Overall Study|Lost to Follow-up|27|||
130849096|NCT00459537|471074085|FG001|Overall Study|Lost to Follow-up|30|||
130849097|NCT00459537|471074084|FG000|Overall Study|Administrative problems|3|||
130849098|NCT00459537|471074085|FG001|Overall Study|Administrative problems|0|||
130849099|NCT00459537|471074084|FG000|Overall Study|Protocol Violation|4|||
130849100|NCT00459537|471074085|FG001|Overall Study|Protocol Violation|3|||
130849101|NCT00459537|471074084|FG000|Overall Study|Missing|1|||
130849102|NCT00459537|471074085|FG001|Overall Study|Missing|0|||
130849103|NCT03159104|471074086|FG000|Overall Study|Violation of inclusion criteria|1|||
130849104|NCT03159104|471074087|FG001|Overall Study|Violation of inclusion criteria|2|||
130849105|NCT00456599|471074088|FG000|Overall Study|Non-compliance|1|||
130849106|NCT00456599|471074088|FG000|Overall Study|Withdrawal by Subject|2|||
130849107|NCT01999218|471074089|FG000|Overall Study|Hyperglycemia|18|||
130849108|NCT01999218|471074090|FG001|Overall Study|Hyperglycemia|17|||
130849109|NCT01999218|471074091|FG002|Overall Study|Hyperglycemia|17|||
130849110|NCT01999218|471074089|FG000|Overall Study|Lack of Efficacy|1|||
130849111|NCT01999218|471074090|FG001|Overall Study|Lack of Efficacy|0|||
130849112|NCT01999218|471074091|FG002|Overall Study|Lack of Efficacy|1|||
130849113|NCT01999218|471074089|FG000|Overall Study|Lost to Follow-up|22|||
130849114|NCT01999218|471074090|FG001|Overall Study|Lost to Follow-up|17|||
130849115|NCT01999218|471074091|FG002|Overall Study|Lost to Follow-up|18|||
130849116|NCT01999218|471074089|FG000|Overall Study|Non-Compliance With Study Drug|6|||
130849117|NCT01999218|471074090|FG001|Overall Study|Non-Compliance With Study Drug|4|||
130849118|NCT01999218|471074091|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130849119|NCT01999218|471074089|FG000|Overall Study|Physician Decision|1|||
130849120|NCT01999218|471074090|FG001|Overall Study|Physician Decision|4|||
130849121|NCT01999218|471074091|FG002|Overall Study|Physician Decision|6|||
130849122|NCT01999218|471074089|FG000|Overall Study|Protocol Violation|4|||
130849123|NCT01999218|471074090|FG001|Overall Study|Protocol Violation|5|||
130849124|NCT01999218|471074091|FG002|Overall Study|Protocol Violation|4|||
130849125|NCT01999218|471074089|FG000|Overall Study|Screen failure|0|||
130849126|NCT01999218|471074090|FG001|Overall Study|Screen failure|1|||
130849127|NCT01999218|471074091|FG002|Overall Study|Screen failure|0|||
130849128|NCT01999218|471074089|FG000|Overall Study|Study Terminated By Sponsor|7|||
130849129|NCT01999218|471074090|FG001|Overall Study|Study Terminated By Sponsor|5|||
130849130|NCT01999218|471074091|FG002|Overall Study|Study Terminated By Sponsor|12|||
130849131|NCT01999218|471074089|FG000|Overall Study|Participant moves|2|||
130849132|NCT01999218|471074090|FG001|Overall Study|Participant moves|5|||
130849133|NCT01999218|471074091|FG002|Overall Study|Participant moves|3|||
130849134|NCT01999218|471074089|FG000|Overall Study|Withdrawal by Subject|28|||
130849135|NCT01999218|471074090|FG001|Overall Study|Withdrawal by Subject|29|||
130849136|NCT01999218|471074091|FG002|Overall Study|Withdrawal by Subject|34|||
130849137|NCT01999218|471074089|FG000|Overall Study|Creatinine/eGFR|0|||
130849138|NCT01999218|471074090|FG001|Overall Study|Creatinine/eGFR|0|||
130849139|NCT01999218|471074091|FG002|Overall Study|Creatinine/eGFR|1|||
130849140|NCT01999218|471074089|FG000|Overall Study|Death|7|||
130849141|NCT01999218|471074090|FG001|Overall Study|Death|1|||
130849142|NCT01999218|471074091|FG002|Overall Study|Death|2|||
130849143|NCT01999218|471074089|FG000|Overall Study|Excluded Medication|1|||
130849144|NCT01999218|471074090|FG001|Overall Study|Excluded Medication|1|||
130849145|NCT01999218|471074091|FG002|Overall Study|Excluded Medication|2|||
130849146|NCT01999218|471074089|FG000|Overall Study|Adverse Event|9|||
130849147|NCT01999218|471074090|FG001|Overall Study|Adverse Event|7|||
130849148|NCT01999218|471074091|FG002|Overall Study|Adverse Event|7|||
130849149|NCT01999218|471074089|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
130849150|NCT01999218|471074090|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
130849151|NCT01999218|471074091|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
130875423|NCT03137992|471173818|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
130875424|NCT03137992|471173819|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
130875425|NCT03137992|471173820|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
130875426|NCT03137992|471173821|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
130875427|NCT03137992|471173816|FG000|Period 2 (Visit 3)|Adverse Event|0|||
130875428|NCT03137992|471173817|FG001|Period 2 (Visit 3)|Adverse Event|1|||
130875429|NCT03137992|471173818|FG002|Period 2 (Visit 3)|Adverse Event|0|||
130875430|NCT03137992|471173819|FG003|Period 2 (Visit 3)|Adverse Event|0|||
130875431|NCT03137992|471173820|FG004|Period 2 (Visit 3)|Adverse Event|0|||
130875432|NCT03137992|471173821|FG005|Period 2 (Visit 3)|Adverse Event|0|||
130875433|NCT03137992|471173816|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
130875434|NCT03137992|471173817|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
130875435|NCT03137992|471173818|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
130875436|NCT03137992|471173819|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
130875437|NCT03137992|471173820|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
130875438|NCT03137992|471173821|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
130875439|NCT03137992|471173816|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130875440|NCT03137992|471173817|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
130875441|NCT03137992|471173818|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130875442|NCT03137992|471173819|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130875443|NCT03137992|471173820|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
130875444|NCT03137992|471173821|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130875445|NCT03137992|471173816|FG000|Washout Period 2|COPD Exacerbation|1|||
130875446|NCT03137992|471173817|FG001|Washout Period 2|COPD Exacerbation|1|||
130875447|NCT03137992|471173818|FG002|Washout Period 2|COPD Exacerbation|0|||
130875448|NCT03137992|471173819|FG003|Washout Period 2|COPD Exacerbation|0|||
130875449|NCT03137992|471173820|FG004|Washout Period 2|COPD Exacerbation|1|||
130875450|NCT03137992|471173821|FG005|Washout Period 2|COPD Exacerbation|0|||
130875451|NCT03137992|471173816|FG000|Washout Period 2|Subject Non-compliance|0|||
130875452|NCT03137992|471173817|FG001|Washout Period 2|Subject Non-compliance|1|||
130875453|NCT03137992|471173818|FG002|Washout Period 2|Subject Non-compliance|0|||
130875454|NCT03137992|471173819|FG003|Washout Period 2|Subject Non-compliance|0|||
130875455|NCT03137992|471173820|FG004|Washout Period 2|Subject Non-compliance|0|||
130875456|NCT03137992|471173821|FG005|Washout Period 2|Subject Non-compliance|0|||
130875457|NCT03137992|471173816|FG000|Washout Period 2|Adverse Event|0|||
130875458|NCT03137992|471173817|FG001|Washout Period 2|Adverse Event|0|||
130875459|NCT03137992|471173818|FG002|Washout Period 2|Adverse Event|0|||
130875460|NCT03137992|471173819|FG003|Washout Period 2|Adverse Event|1|||
130875461|NCT03137992|471173820|FG004|Washout Period 2|Adverse Event|1|||
130875462|NCT03137992|471173821|FG005|Washout Period 2|Adverse Event|0|||
130875463|NCT03137992|471173816|FG000|Washout Period 2|Withdrawal by Subject|1|||
130875464|NCT03137992|471173817|FG001|Washout Period 2|Withdrawal by Subject|0|||
130875465|NCT03137992|471173818|FG002|Washout Period 2|Withdrawal by Subject|0|||
130875466|NCT03137992|471173819|FG003|Washout Period 2|Withdrawal by Subject|0|||
130875467|NCT03137992|471173820|FG004|Washout Period 2|Withdrawal by Subject|1|||
130875468|NCT03137992|471173821|FG005|Washout Period 2|Withdrawal by Subject|0|||
130875469|NCT03137992|471173816|FG000|Washout Period 2|Sponsor Decision|0|||
130875470|NCT03137992|471173817|FG001|Washout Period 2|Sponsor Decision|0|||
130875471|NCT03137992|471173818|FG002|Washout Period 2|Sponsor Decision|0|||
130875472|NCT03137992|471173819|FG003|Washout Period 2|Sponsor Decision|0|||
130875473|NCT03137992|471173820|FG004|Washout Period 2|Sponsor Decision|0|||
130875474|NCT03137992|471173821|FG005|Washout Period 2|Sponsor Decision|1|||
130875475|NCT03137992|471173816|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
130875476|NCT03137992|471173817|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
130875477|NCT03137992|471173818|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
130875478|NCT03137992|471173819|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
130875479|NCT03137992|471173820|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
130875480|NCT03137992|471173821|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
130875481|NCT03137992|471173816|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
130875482|NCT03137992|471173817|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
130875483|NCT03137992|471173818|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
130875484|NCT03137992|471173819|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
130875485|NCT03137992|471173820|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
130875486|NCT03137992|471173821|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
130875487|NCT03137992|471173816|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
130875488|NCT03137992|471173817|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130849152|NCT03647267|471075927|FG000|Overall Study|Lost to Follow-up|1|||
130849153|NCT03647267|471075928|FG001|Overall Study|Lost to Follow-up|0|||
130849154|NCT01350115|471075929|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
130849155|NCT01350115|471075930|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
130849156|NCT01350115|471075929|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
130849157|NCT01350115|471075930|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
130849158|NCT01350115|471075929|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
130849159|NCT01350115|471075930|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
130849160|NCT05079477|471075931|FG000|Overall Study|Lost to Follow-up|2|||
130849161|NCT05079477|471075932|FG001|Overall Study|Lost to Follow-up|0|||
130849162|NCT05079477|471075931|FG000|Overall Study|Withdrawal by Subject|1|||
130849163|NCT05079477|471075932|FG001|Overall Study|Withdrawal by Subject|0|||
130849164|NCT05079477|471075931|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
130849165|NCT05079477|471075932|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
130849166|NCT05079477|471075931|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
130849167|NCT05079477|471075932|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
130849168|NCT01688739|471075936|FG000|Overall Study|Administrative Decision|1|||
130849169|NCT01688739|471075937|FG001|Overall Study|Administrative Decision|0|||
130849170|NCT01688739|471075938|FG002|Overall Study|Administrative Decision|0|||
130849171|NCT01688739|471075939|FG003|Overall Study|Administrative Decision|0|||
130849172|NCT01688739|471075940|FG004|Overall Study|Administrative Decision|0|||
130849173|NCT01688739|471075941|FG005|Overall Study|Administrative Decision|0|||
130849174|NCT01688739|471075942|FG006|Overall Study|Administrative Decision|0|||
130849175|NCT01688739|471075943|FG007|Overall Study|Administrative Decision|0|||
130849176|NCT01688739|471075944|FG008|Overall Study|Administrative Decision|0|||
130849177|NCT01688739|471075945|FG009|Overall Study|Administrative Decision|0|||
130849178|NCT02559414|471075947|FG000|Overall Study|Lost to Follow-up|0|||
130849179|NCT02559414|471075948|FG001|Overall Study|Lost to Follow-up|1|||
130849180|NCT02559414|471075949|FG002|Overall Study|Lost to Follow-up|0|||
130849181|NCT02559414|471075947|FG000|Overall Study|Withdrawal by Subject|1|||
130849182|NCT02559414|471075948|FG001|Overall Study|Withdrawal by Subject|0|||
130849183|NCT02559414|471075949|FG002|Overall Study|Withdrawal by Subject|1|||
130849184|NCT02559414|471075947|FG000|Overall Study|Other|0|||
130849185|NCT02559414|471075948|FG001|Overall Study|Other|1|||
130849186|NCT02559414|471075949|FG002|Overall Study|Other|1|||
130849187|NCT03369431|471075950|FG000|Overall Study|Lost to Follow-up|1|||
130849188|NCT03369431|471075951|FG001|Overall Study|Lost to Follow-up|3|||
130849189|NCT03369431|471075950|FG000|Overall Study|Withdrawal by Subject|2|||
130849190|NCT03369431|471075951|FG001|Overall Study|Withdrawal by Subject|3|||
130849191|NCT03369431|471075950|FG000|Overall Study|Protocol Violation|1|||
130849192|NCT03369431|471075951|FG001|Overall Study|Protocol Violation|1|||
130849193|NCT01113580|471075956|FG000|Overall Study|Protocol Violation|1|||
130849194|NCT01113580|471075957|FG001|Overall Study|Protocol Violation|0|||
130849195|NCT02785458|471075965|FG000|1 Month|Withdrawal by Subject|2|||
130849196|NCT02785458|471075966|FG001|1 Month|Withdrawal by Subject|1|||
130849197|NCT02785458|471075965|FG000|1 Month|Lost to Follow-up|38|||
130849198|NCT02785458|471075966|FG001|1 Month|Lost to Follow-up|31|||
130849199|NCT02785458|471075965|FG000|1 Month|Deemed Ineligible|1|||
130849200|NCT02785458|471075966|FG001|1 Month|Deemed Ineligible|0|||
130849201|NCT02785458|471075965|FG000|1 Month|Completed Evaluation by Baseline|42|||
130849202|NCT02785458|471075966|FG001|1 Month|Completed Evaluation by Baseline|39|||
130849203|NCT02785458|471075965|FG000|1 Month|Partial Interview|0|||
130849204|NCT02785458|471075966|FG001|1 Month|Partial Interview|4|||
130849205|NCT02785458|471075965|FG000|3 Months|Withdrawal by Subject|3|||
130849206|NCT02785458|471075966|FG001|3 Months|Withdrawal by Subject|1|||
130849207|NCT02785458|471075965|FG000|3 Months|Lost to Follow-up|25|||
130849208|NCT02785458|471075966|FG001|3 Months|Lost to Follow-up|21|||
130849209|NCT02785458|471075965|FG000|3 Months|Completed Evaluation at 1 Month|100|||
130849210|NCT02785458|471075966|FG001|3 Months|Completed Evaluation at 1 Month|89|||
130849211|NCT00824005|471075968|FG000|Overall Study|Death|0|||
130849212|NCT00824005|471075969|FG001|Overall Study|Death|1|||
130849213|NCT00824005|471075968|FG000|Overall Study|Lost to Follow-up|0|||
130849214|NCT00824005|471075969|FG001|Overall Study|Lost to Follow-up|1|||
130849215|NCT03458702|471075970|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
130849216|NCT03458702|471075971|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
130849217|NCT03458702|471075970|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
130849218|NCT03458702|471075971|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
130849219|NCT01390779|471075972|FG000|Overall Study|Physician Decision|1|||
130849220|NCT01874275|471075973|FG000|Overall Study|Lost to Follow-up|1|||
130849221|NCT01874275|471075974|FG001|Overall Study|Lost to Follow-up|0|||
130849222|NCT01697462|471075977|FG000|Overall Study|Disease Progression|1|||
130849223|NCT01697462|471075977|FG000|Overall Study|Adverse Event|6|||
130849224|NCT01697462|471075977|FG000|Overall Study|Lost to Follow-up|21|||
130849225|NCT01697462|471075977|FG000|Overall Study|Withdrawal by Subject|12|||
130849226|NCT01697462|471075977|FG000|Overall Study|Investigator Decision|21|||
130849227|NCT01697462|471075977|FG000|Overall Study|Death|1|||
130849228|NCT01697462|471075977|FG000|Overall Study|Other|10|||
130849229|NCT01697462|471075977|FG000|Overall Study|Missing|5|||
130849230|NCT00168103|471075978|FG000|Overall Study|Withdrawal by Subject|1|||
130849231|NCT00168103|471075979|FG001|Overall Study|Withdrawal by Subject|2|||
130849232|NCT00168103|471075980|FG002|Overall Study|Withdrawal by Subject|1|||
130849233|NCT00168103|471075981|FG003|Overall Study|Withdrawal by Subject|0|||
130849234|NCT00168103|471075978|FG000|Overall Study|Lost to Follow-up|1|||
130849235|NCT00168103|471075979|FG001|Overall Study|Lost to Follow-up|3|||
130849236|NCT00168103|471075980|FG002|Overall Study|Lost to Follow-up|0|||
130849237|NCT00168103|471075981|FG003|Overall Study|Lost to Follow-up|0|||
130849238|NCT00989235|471075982|FG000|Overall Study|Death|0|||
130849239|NCT00989235|471075983|FG001|Overall Study|Death|1|||
130849240|NCT00989235|471075982|FG000|Overall Study|Adverse Event|0|||
130849241|NCT00989235|471075983|FG001|Overall Study|Adverse Event|1|||
130849242|NCT00989235|471075982|FG000|Overall Study|Lack of Efficacy|1|||
130849243|NCT00989235|471075983|FG001|Overall Study|Lack of Efficacy|0|||
130849244|NCT00989235|471075982|FG000|Overall Study|Withdrawal of Consent|1|||
130849245|NCT00989235|471075983|FG001|Overall Study|Withdrawal of Consent|1|||
130849246|NCT00989235|471075982|FG000|Overall Study|Desire to Become Pregnant|1|||
130849247|NCT00989235|471075983|FG001|Overall Study|Desire to Become Pregnant|0|||
130849248|NCT00989235|471075982|FG000|Overall Study|Randomized by Mistake|0|||
130849249|NCT00989235|471075983|FG001|Overall Study|Randomized by Mistake|2|||
130849250|NCT00989235|471075982|FG000|Overall Study|Lost to Follow-up|0|||
130849251|NCT00989235|471075983|FG001|Overall Study|Lost to Follow-up|1|||
130849252|NCT00545532|471075984|FG000|Overall Study|Withdrawal by Subject|1|||
130849253|NCT00545532|471075985|FG001|Overall Study|Withdrawal by Subject|3|||
130849254|NCT00545532|471075984|FG000|Overall Study|Lost to Follow-up|5|||
130849255|NCT00545532|471075985|FG001|Overall Study|Lost to Follow-up|6|||
130849256|NCT00545532|471075984|FG000|Overall Study|Death|0|||
130849257|NCT00545532|471075985|FG001|Overall Study|Death|1|||
130849258|NCT03630302|471075988|FG000|Surgery|hardware issue prevented LFP recordings|1|||
130849259|NCT03630302|471075988|FG000|3 Month Visit|Adverse Event|2|||
130849260|NCT03630302|471075988|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
130849261|NCT00931801|471075991|FG000|Overall Study|Adverse Event|0|||
130849262|NCT00931801|471075992|FG001|Overall Study|Adverse Event|0|||
130849263|NCT00931801|471075993|FG002|Overall Study|Adverse Event|1|||
130849264|NCT00931801|471075991|FG000|Overall Study|Lost to Follow-up|0|||
130849265|NCT00931801|471075992|FG001|Overall Study|Lost to Follow-up|1|||
130849266|NCT00931801|471075993|FG002|Overall Study|Lost to Follow-up|0|||
130849267|NCT00931801|471075991|FG000|Overall Study|Withdrawal by Subject|1|||
130849268|NCT00931801|471075992|FG001|Overall Study|Withdrawal by Subject|0|||
130849269|NCT00931801|471075993|FG002|Overall Study|Withdrawal by Subject|0|||
130849270|NCT00931801|471075991|FG000|Overall Study|Confirmed Virologic Failure|0|||
130849271|NCT00931801|471075992|FG001|Overall Study|Confirmed Virologic Failure|0|||
130849272|NCT00931801|471075993|FG002|Overall Study|Confirmed Virologic Failure|3|||
130849273|NCT00933244|471075994|FG000|Overall Study|Withdrawal by Subject|5|||
130849274|NCT00933244|471075995|FG001|Overall Study|Withdrawal by Subject|1|||
130849275|NCT00933244|471075996|FG002|Overall Study|Withdrawal by Subject|3|||
130849276|NCT02266875|471075997|FG000|Overall Study|Withdrawal by Subject|9|||
130849277|NCT02266875|471075998|FG001|Overall Study|Withdrawal by Subject|0|||
130849278|NCT02266875|471075997|FG000|Overall Study|Lost to Follow-up|2|||
130849279|NCT02266875|471075998|FG001|Overall Study|Lost to Follow-up|0|||
130849280|NCT00875056|471076002|FG000|Overall Study|Adverse Event|6|||
130849281|NCT00875056|471076003|FG001|Overall Study|Adverse Event|1|||
130849282|NCT00875056|471076004|FG002|Overall Study|Adverse Event|2|||
130849283|NCT00875056|471076002|FG000|Overall Study|Progressive Disease|14|||
130849284|NCT00875056|471076003|FG001|Overall Study|Progressive Disease|8|||
130849285|NCT00875056|471076004|FG002|Overall Study|Progressive Disease|3|||
130849286|NCT00875056|471076002|FG000|Overall Study|Withdrawal by Subject|3|||
130849287|NCT00875056|471076003|FG001|Overall Study|Withdrawal by Subject|0|||
130849288|NCT00875056|471076004|FG002|Overall Study|Withdrawal by Subject|1|||
130849289|NCT02956850|471076005|FG000|Overall Study|Withdrawal by Subject|0|||
130849290|NCT02956850|471076006|FG001|Overall Study|Withdrawal by Subject|0|||
130849291|NCT02956850|471076007|FG002|Overall Study|Withdrawal by Subject|0|||
130849292|NCT02956850|471076008|FG003|Overall Study|Withdrawal by Subject|0|||
130849293|NCT02956850|471076009|FG004|Overall Study|Withdrawal by Subject|0|||
130849294|NCT02956850|471076010|FG005|Overall Study|Withdrawal by Subject|0|||
130849295|NCT02956850|471076011|FG006|Overall Study|Withdrawal by Subject|0|||
130849296|NCT02956850|471076012|FG007|Overall Study|Withdrawal by Subject|0|||
130849297|NCT02956850|471076013|FG008|Overall Study|Withdrawal by Subject|0|||
130849298|NCT02956850|471076014|FG009|Overall Study|Withdrawal by Subject|0|||
130849299|NCT02956850|471076015|FG010|Overall Study|Withdrawal by Subject|0|||
130849300|NCT02956850|471076016|FG011|Overall Study|Withdrawal by Subject|0|||
130849301|NCT02956850|471076017|FG012|Overall Study|Withdrawal by Subject|0|||
130849302|NCT02956850|471076018|FG013|Overall Study|Withdrawal by Subject|0|||
130849303|NCT02956850|471076019|FG014|Overall Study|Withdrawal by Subject|0|||
130849304|NCT02956850|471076020|FG015|Overall Study|Withdrawal by Subject|0|||
130849305|NCT02956850|471076021|FG016|Overall Study|Withdrawal by Subject|0|||
130849306|NCT02956850|471076022|FG017|Overall Study|Withdrawal by Subject|1|||
130849307|NCT01920152|471076027|FG000|Overall Study|Withdrawal by Subject|1|||
130849308|NCT01920152|471076028|FG001|Overall Study|Withdrawal by Subject|2|||
130849309|NCT04375397|471076029|FG000|Overall Study|Death|1|||
130849310|NCT04375397|471076030|FG001|Overall Study|Death|1|||
130849311|NCT04375397|471076029|FG000|Overall Study|Withdrew consent|2|||
130849312|NCT04375397|471076030|FG001|Overall Study|Withdrew consent|0|||
130849313|NCT04375397|471076029|FG000|Overall Study|Lost to Follow-up|6|||
130849314|NCT04375397|471076030|FG001|Overall Study|Lost to Follow-up|4|||
130849315|NCT04375397|471076029|FG000|Overall Study|Other, not specified|0|||
130849316|NCT04375397|471076030|FG001|Overall Study|Other, not specified|1|||
130849317|NCT00610441|471076034|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
130849318|NCT00610441|471076035|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
130849319|NCT00610441|471076036|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
130849320|NCT00610441|471076037|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
130849321|NCT00610441|471076034|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
130849322|NCT00610441|471076035|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
130849323|NCT00610441|471076036|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
130849324|NCT00610441|471076037|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
130849325|NCT00610441|471076034|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
130849326|NCT00610441|471076035|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
130849327|NCT00610441|471076036|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
130849328|NCT00610441|471076037|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
130849329|NCT00610441|471076034|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
130849330|NCT00610441|471076035|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
130849331|NCT00610441|471076036|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
130849332|NCT00610441|471076037|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
130849333|NCT00610441|471076034|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
130849334|NCT00610441|471076035|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
130849335|NCT00610441|471076036|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
130849336|NCT00610441|471076037|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
130849337|NCT00610441|471076034|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
130849338|NCT00610441|471076035|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
130849339|NCT00610441|471076036|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
130849340|NCT00610441|471076037|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
130849341|NCT00610441|471076034|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
130849342|NCT00610441|471076035|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
130849343|NCT00610441|471076036|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
130849344|NCT00610441|471076037|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
130849345|NCT00610441|471076034|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
130849346|NCT00610441|471076035|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
130849347|NCT00610441|471076036|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
130849348|NCT00610441|471076037|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
130849349|NCT00610441|471076034|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
130849350|NCT00610441|471076035|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
130849351|NCT00610441|471076036|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
130849352|NCT00610441|471076037|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
130849353|NCT01995552|471076040|FG000|Overall Study|Protocol Violation|1|||
130849354|NCT01995552|471076040|FG000|Overall Study|Lack of Efficacy|15|||
130849355|NCT01995552|471076040|FG000|Overall Study|Death|1|||
130849356|NCT00870194|471076044|FG000|Overall Study|Adverse Event|10|||
130849357|NCT00870194|471076045|FG001|Overall Study|Adverse Event|5|||
130849358|NCT00870194|471076044|FG000|Overall Study|Lack of Efficacy|0|||
130849359|NCT00870194|471076045|FG001|Overall Study|Lack of Efficacy|1|||
130849360|NCT00870194|471076044|FG000|Overall Study|Lost to Follow-up|2|||
130849361|NCT00870194|471076045|FG001|Overall Study|Lost to Follow-up|0|||
130849362|NCT00870194|471076044|FG000|Overall Study|Physician Decision|3|||
130849363|NCT00870194|471076045|FG001|Overall Study|Physician Decision|1|||
130849364|NCT00870194|471076044|FG000|Overall Study|Protocol Violation|3|||
130849365|NCT00870194|471076045|FG001|Overall Study|Protocol Violation|3|||
130849366|NCT00870194|471076044|FG000|Overall Study|Entry Criteria Not Met|1|||
130849367|NCT00870194|471076045|FG001|Overall Study|Entry Criteria Not Met|2|||
130849368|NCT00870194|471076044|FG000|Overall Study|Subject Decision|7|||
130849369|NCT00870194|471076045|FG001|Overall Study|Subject Decision|2|||
130849370|NCT02322190|471076046|FG000|Overall Study|Death on study|1|||
130849371|NCT02322190|471076047|FG001|Overall Study|Death on study|0|||
130849372|NCT00973102|471076056|FG000|Overall Study|Protocol Violation|1|||
130849373|NCT00973102|471076057|FG001|Overall Study|Protocol Violation|0|||
130849374|NCT00973102|471076056|FG000|Overall Study|Prisoner|0|||
130849375|NCT00973102|471076057|FG001|Overall Study|Prisoner|1|||
130849376|NCT00966719|471076060|FG000|Overall Study|Lost to Follow-up|6|||
130849377|NCT00966719|471076061|FG001|Overall Study|Lost to Follow-up|11|||
130849378|NCT01710527|471076062|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
130875566|NCT00880620|471173837|FG003|Overall Study|Other|2|||
130849379|NCT01710527|471076063|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
130849380|NCT02635347|471076064|FG000|Overall Study|Failed screening|20|||
130849381|NCT02635347|471076065|FG001|Overall Study|Failed screening|7|||
130849382|NCT02124772|471076069|FG000|Overall Study|Lack of Efficacy|2|||
130849383|NCT02124772|471076070|FG001|Overall Study|Lack of Efficacy|0|||
130849384|NCT02124772|471076071|FG002|Overall Study|Lack of Efficacy|0|||
130849385|NCT02124772|471076072|FG003|Overall Study|Lack of Efficacy|1|||
130849386|NCT02124772|471076073|FG004|Overall Study|Lack of Efficacy|2|||
130849387|NCT02124772|471076074|FG005|Overall Study|Lack of Efficacy|3|||
130849388|NCT02124772|471076075|FG006|Overall Study|Lack of Efficacy|0|||
130849389|NCT02124772|471076076|FG007|Overall Study|Lack of Efficacy|2|||
130849390|NCT02124772|471076077|FG008|Overall Study|Lack of Efficacy|0|||
130849391|NCT02124772|471076078|FG009|Overall Study|Lack of Efficacy|1|||
130849392|NCT02124772|471076079|FG010|Overall Study|Lack of Efficacy|0|||
130849393|NCT02124772|471076080|FG011|Overall Study|Lack of Efficacy|0|||
130849394|NCT02124772|471076081|FG012|Overall Study|Lack of Efficacy|1|||
130849395|NCT02124772|471076069|FG000|Overall Study|Adverse Event|1|||
130849396|NCT02124772|471076070|FG001|Overall Study|Adverse Event|4|||
130849397|NCT02124772|471076071|FG002|Overall Study|Adverse Event|1|||
130849398|NCT02124772|471076072|FG003|Overall Study|Adverse Event|5|||
130849399|NCT02124772|471076073|FG004|Overall Study|Adverse Event|2|||
130849400|NCT02124772|471076074|FG005|Overall Study|Adverse Event|1|||
130849401|NCT02124772|471076075|FG006|Overall Study|Adverse Event|1|||
130849402|NCT02124772|471076076|FG007|Overall Study|Adverse Event|5|||
130849403|NCT02124772|471076077|FG008|Overall Study|Adverse Event|0|||
130849404|NCT02124772|471076078|FG009|Overall Study|Adverse Event|3|||
130849405|NCT02124772|471076079|FG010|Overall Study|Adverse Event|1|||
130849406|NCT02124772|471076080|FG011|Overall Study|Adverse Event|3|||
130849407|NCT02124772|471076081|FG012|Overall Study|Adverse Event|1|||
130849408|NCT02124772|471076069|FG000|Overall Study|Withdrawal consent|0|||
130849409|NCT02124772|471076070|FG001|Overall Study|Withdrawal consent|1|||
130849410|NCT02124772|471076071|FG002|Overall Study|Withdrawal consent|1|||
130849411|NCT02124772|471076072|FG003|Overall Study|Withdrawal consent|1|||
130849412|NCT02124772|471076073|FG004|Overall Study|Withdrawal consent|0|||
130849413|NCT02124772|471076074|FG005|Overall Study|Withdrawal consent|1|||
130849414|NCT02124772|471076075|FG006|Overall Study|Withdrawal consent|1|||
130849415|NCT02124772|471076076|FG007|Overall Study|Withdrawal consent|0|||
130849416|NCT02124772|471076077|FG008|Overall Study|Withdrawal consent|0|||
130849417|NCT02124772|471076078|FG009|Overall Study|Withdrawal consent|1|||
130849418|NCT02124772|471076079|FG010|Overall Study|Withdrawal consent|0|||
130849419|NCT02124772|471076080|FG011|Overall Study|Withdrawal consent|1|||
130849420|NCT02124772|471076081|FG012|Overall Study|Withdrawal consent|0|||
130849421|NCT02124772|471076069|FG000|Overall Study|Investigator discretion|0|||
130849422|NCT02124772|471076070|FG001|Overall Study|Investigator discretion|2|||
130849423|NCT02124772|471076071|FG002|Overall Study|Investigator discretion|2|||
130849424|NCT02124772|471076072|FG003|Overall Study|Investigator discretion|1|||
130849425|NCT02124772|471076073|FG004|Overall Study|Investigator discretion|1|||
130849426|NCT02124772|471076074|FG005|Overall Study|Investigator discretion|0|||
130849427|NCT02124772|471076075|FG006|Overall Study|Investigator discretion|1|||
130849428|NCT02124772|471076076|FG007|Overall Study|Investigator discretion|0|||
130849429|NCT02124772|471076077|FG008|Overall Study|Investigator discretion|0|||
130849430|NCT02124772|471076078|FG009|Overall Study|Investigator discretion|1|||
130849431|NCT02124772|471076079|FG010|Overall Study|Investigator discretion|0|||
130849432|NCT02124772|471076080|FG011|Overall Study|Investigator discretion|1|||
130849433|NCT02124772|471076081|FG012|Overall Study|Investigator discretion|0|||
130849434|NCT02124772|471076069|FG000|Overall Study|Progressive disease|0|||
130849435|NCT02124772|471076070|FG001|Overall Study|Progressive disease|0|||
130849436|NCT02124772|471076071|FG002|Overall Study|Progressive disease|0|||
130849437|NCT02124772|471076072|FG003|Overall Study|Progressive disease|0|||
130849438|NCT02124772|471076073|FG004|Overall Study|Progressive disease|0|||
130849439|NCT02124772|471076074|FG005|Overall Study|Progressive disease|0|||
130849440|NCT02124772|471076075|FG006|Overall Study|Progressive disease|1|||
130849441|NCT02124772|471076076|FG007|Overall Study|Progressive disease|1|||
130849442|NCT02124772|471076077|FG008|Overall Study|Progressive disease|0|||
130849443|NCT02124772|471076078|FG009|Overall Study|Progressive disease|0|||
130849444|NCT02124772|471076079|FG010|Overall Study|Progressive disease|0|||
130849445|NCT02124772|471076080|FG011|Overall Study|Progressive disease|0|||
130849446|NCT02124772|471076081|FG012|Overall Study|Progressive disease|0|||
130849447|NCT02124772|471076069|FG000|Overall Study|Other|0|||
130849448|NCT02124772|471076070|FG001|Overall Study|Other|7|||
130849449|NCT02124772|471076071|FG002|Overall Study|Other|2|||
130849450|NCT02124772|471076072|FG003|Overall Study|Other|5|||
130849451|NCT02124772|471076073|FG004|Overall Study|Other|4|||
130849452|NCT02124772|471076074|FG005|Overall Study|Other|3|||
130849453|NCT02124772|471076075|FG006|Overall Study|Other|4|||
130849454|NCT02124772|471076076|FG007|Overall Study|Other|1|||
130849455|NCT02124772|471076077|FG008|Overall Study|Other|1|||
130849456|NCT02124772|471076078|FG009|Overall Study|Other|1|||
130849457|NCT02124772|471076079|FG010|Overall Study|Other|1|||
130849458|NCT02124772|471076080|FG011|Overall Study|Other|1|||
130849459|NCT02124772|471076081|FG012|Overall Study|Other|0|||
130849460|NCT00780273|471076082|FG000|Overall Study|Death|1|||
130849461|NCT00780273|471076082|FG000|Overall Study|Lost to Follow-up|1|||
130849462|NCT01688921|471076083|FG000|Overall Study|Lost to Follow-up|7|||
130849463|NCT01688921|471076084|FG001|Overall Study|Lost to Follow-up|13|||
130849464|NCT01688921|471076083|FG000|Overall Study|Physician Decision|6|||
130849465|NCT01688921|471076084|FG001|Overall Study|Physician Decision|1|||
130849466|NCT01688921|471076083|FG000|Overall Study|Protocol Violation|0|||
130849467|NCT01688921|471076084|FG001|Overall Study|Protocol Violation|1|||
130849468|NCT01688921|471076083|FG000|Overall Study|informed consent|3|||
130849469|NCT01688921|471076084|FG001|Overall Study|informed consent|0|||
130849470|NCT02358044|471076085|FG000|Overall Study|Adverse Event|0|||
130849471|NCT02358044|471076086|FG001|Overall Study|Adverse Event|1|||
130849472|NCT02358044|471076085|FG000|Overall Study|Lost to Follow-up|2|||
130849473|NCT02358044|471076086|FG001|Overall Study|Lost to Follow-up|1|||
130849474|NCT02358044|471076085|FG000|Overall Study|Physician Decision|0|||
130849475|NCT02358044|471076086|FG001|Overall Study|Physician Decision|1|||
130849476|NCT02358044|471076085|FG000|Overall Study|Withdrawal by Subject|0|||
130849477|NCT02358044|471076086|FG001|Overall Study|Withdrawal by Subject|4|||
130849478|NCT01739803|471076089|FG000|Overall Study|Lost to Follow-up|9|||
130849479|NCT01739803|471076090|FG001|Overall Study|Lost to Follow-up|6|||
130849480|NCT00969436|471076092|FG000|Overall Study|Protocol Violation|1|||
130849481|NCT00969436|471076093|FG001|Overall Study|Protocol Violation|3|||
130849482|NCT00969436|471076094|FG002|Overall Study|Protocol Violation|0|||
130849483|NCT00969436|471076092|FG000|Overall Study|Migrated/moved from study area|12|||
130849484|NCT00969436|471076093|FG001|Overall Study|Migrated/moved from study area|10|||
130849485|NCT00969436|471076094|FG002|Overall Study|Migrated/moved from study area|2|||
130849486|NCT00969436|471076092|FG000|Overall Study|Father - serious health problem|0|||
130849487|NCT00969436|471076093|FG001|Overall Study|Father - serious health problem|0|||
130849488|NCT00969436|471076094|FG002|Overall Study|Father - serious health problem|1|||
130849489|NCT00969436|471076092|FG000|Overall Study|Parents personal problem|0|||
130849490|NCT00969436|471076093|FG001|Overall Study|Parents personal problem|0|||
130849491|NCT00969436|471076094|FG002|Overall Study|Parents personal problem|1|||
130849492|NCT00969436|471076092|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
130849493|NCT00969436|471076093|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
130849494|NCT00969436|471076094|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
130849495|NCT00969436|471076092|FG000|Overall Study|Withdrawal by Subject|3|||
130849496|NCT00969436|471076093|FG001|Overall Study|Withdrawal by Subject|0|||
130849497|NCT00969436|471076094|FG002|Overall Study|Withdrawal by Subject|2|||
130849498|NCT00969436|471076092|FG000|Overall Study|Lost to Follow-up|8|||
130849499|NCT00969436|471076093|FG001|Overall Study|Lost to Follow-up|8|||
130849500|NCT00969436|471076094|FG002|Overall Study|Lost to Follow-up|5|||
130849501|NCT00151372|471077513|FG000|Overall Study|Death|12|||
130849502|NCT00151372|471077514|FG001|Overall Study|Death|11|||
130849503|NCT00151372|471077513|FG000|Overall Study|Lost to Follow-up|5|||
130849504|NCT00151372|471077514|FG001|Overall Study|Lost to Follow-up|5|||
130849505|NCT00151372|471077513|FG000|Overall Study|Too sick medically to continue|5|||
130849506|NCT00151372|471077514|FG001|Overall Study|Too sick medically to continue|6|||
130849507|NCT00151372|471077513|FG000|Overall Study|Withdrawal by Subject|7|||
130849508|NCT00151372|471077514|FG001|Overall Study|Withdrawal by Subject|7|||
130849509|NCT00541346|471077515|FG000|Follow-up|Adverse Event|1|||
130849510|NCT04732949|471077516|FG000|Overall Study|Withdrawal by Subject|23|||
130849511|NCT04732949|471077517|FG001|Overall Study|Withdrawal by Subject|27|||
130849512|NCT04732949|471077516|FG000|Overall Study|Protocol Violation|0|||
130849513|NCT04732949|471077517|FG001|Overall Study|Protocol Violation|1|||
130849514|NCT04732949|471077516|FG000|Overall Study|Non-compliance|0|||
130849515|NCT04732949|471077517|FG001|Overall Study|Non-compliance|2|||
130849516|NCT04732949|471077516|FG000|Overall Study|Physician Decision|2|||
130849517|NCT04732949|471077517|FG001|Overall Study|Physician Decision|1|||
130849518|NCT04732949|471077516|FG000|Overall Study|Serious adverse event (Fatal)|16|||
130849519|NCT04732949|471077517|FG001|Overall Study|Serious adverse event (Fatal)|18|||
130849520|NCT04732949|471077516|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
130849521|NCT04732949|471077517|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
130849522|NCT04732949|471077516|FG000|Overall Study|Non-serious adverse event|1|||
130849523|NCT04732949|471077517|FG001|Overall Study|Non-serious adverse event|3|||
130849524|NCT04732949|471077516|FG000|Overall Study|Lost to Follow-up|26|||
130849525|NCT04732949|471077517|FG001|Overall Study|Lost to Follow-up|27|||
130849526|NCT04732949|471077516|FG000|Overall Study|Other|6|||
130849527|NCT04732949|471077517|FG001|Overall Study|Other|3|||
130849528|NCT05160766|471077520|FG000|Overall Study|Adverse Event|0|||
130849529|NCT05160766|471077521|FG001|Overall Study|Adverse Event|1|||
130849530|NCT05160766|471077522|FG002|Overall Study|Adverse Event|0|||
130849531|NCT05160766|471077523|FG003|Overall Study|Adverse Event|0|||
130849532|NCT05160766|471077520|FG000|Overall Study|COVID-19 infection|0|||
130849533|NCT05160766|471077521|FG001|Overall Study|COVID-19 infection|1|||
130849534|NCT05160766|471077522|FG002|Overall Study|COVID-19 infection|0|||
130849535|NCT05160766|471077523|FG003|Overall Study|COVID-19 infection|0|||
130849536|NCT05160766|471077520|FG000|Overall Study|travel time|1|||
130849537|NCT05160766|471077521|FG001|Overall Study|travel time|0|||
130849538|NCT05160766|471077522|FG002|Overall Study|travel time|0|||
130849539|NCT05160766|471077523|FG003|Overall Study|travel time|1|||
130849540|NCT05160766|471077520|FG000|Overall Study|Withdrawal by Subject|3|||
130849541|NCT05160766|471077521|FG001|Overall Study|Withdrawal by Subject|5|||
130849542|NCT05160766|471077522|FG002|Overall Study|Withdrawal by Subject|4|||
130849543|NCT05160766|471077523|FG003|Overall Study|Withdrawal by Subject|2|||
130849544|NCT05160766|471077520|FG000|Overall Study|Death|0|||
130849545|NCT05160766|471077521|FG001|Overall Study|Death|0|||
130849546|NCT05160766|471077522|FG002|Overall Study|Death|2|||
130849547|NCT05160766|471077523|FG003|Overall Study|Death|5|||
130849548|NCT05160766|471077520|FG000|Overall Study|Lost to Follow-up|0|||
130849549|NCT05160766|471077521|FG001|Overall Study|Lost to Follow-up|0|||
130849550|NCT05160766|471077522|FG002|Overall Study|Lost to Follow-up|1|||
130849551|NCT05160766|471077523|FG003|Overall Study|Lost to Follow-up|2|||
130849552|NCT05160766|471077520|FG000|Overall Study|No show|0|||
130849553|NCT05160766|471077521|FG001|Overall Study|No show|0|||
130849554|NCT05160766|471077522|FG002|Overall Study|No show|1|||
130849555|NCT05160766|471077523|FG003|Overall Study|No show|1|||
130849556|NCT05160766|471077520|FG000|Overall Study|Physician Decision|0|||
130849557|NCT05160766|471077521|FG001|Overall Study|Physician Decision|0|||
130849558|NCT05160766|471077522|FG002|Overall Study|Physician Decision|0|||
130849559|NCT05160766|471077523|FG003|Overall Study|Physician Decision|1|||
130849560|NCT05160766|471077520|FG000|Overall Study|Protocol Violation|0|||
130849561|NCT05160766|471077521|FG001|Overall Study|Protocol Violation|0|||
130849562|NCT05160766|471077522|FG002|Overall Study|Protocol Violation|1|||
130849563|NCT05160766|471077523|FG003|Overall Study|Protocol Violation|0|||
130849564|NCT02853435|471077524|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130849565|NCT02853435|471077525|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130849566|NCT02853435|471077526|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130849567|NCT02853435|471077527|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130849568|NCT02853435|471077528|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
130849569|NCT02853435|471077529|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130849570|NCT03747120|471077530|FG000|Overall Study|treatment related toxicity|3|||
130849571|NCT03747120|471077531|FG001|Overall Study|treatment related toxicity|0|||
130849572|NCT03747120|471077532|FG002|Overall Study|treatment related toxicity|0|||
130849573|NCT03747120|471077530|FG000|Overall Study|Withdrawal by Subject|0|||
130849574|NCT03747120|471077531|FG001|Overall Study|Withdrawal by Subject|1|||
130849575|NCT03747120|471077532|FG002|Overall Study|Withdrawal by Subject|2|||
130849576|NCT00996801|471077533|FG000|Overall Study|Adverse Event|6|||
130849577|NCT00996801|471077534|FG001|Overall Study|Adverse Event|4|||
130849578|NCT00996801|471077535|FG002|Overall Study|Adverse Event|12|||
130849579|NCT00996801|471077536|FG003|Overall Study|Adverse Event|17|||
130849580|NCT00996801|471077537|FG004|Overall Study|Adverse Event|31|||
130849581|NCT00996801|471077538|FG005|Overall Study|Adverse Event|3|||
130849582|NCT00996801|471077533|FG000|Overall Study|Lack of Efficacy|3|||
130849583|NCT00996801|471077534|FG001|Overall Study|Lack of Efficacy|0|||
130849584|NCT00996801|471077535|FG002|Overall Study|Lack of Efficacy|1|||
130849585|NCT00996801|471077536|FG003|Overall Study|Lack of Efficacy|3|||
130849586|NCT00996801|471077537|FG004|Overall Study|Lack of Efficacy|0|||
130849587|NCT00996801|471077538|FG005|Overall Study|Lack of Efficacy|1|||
130849588|NCT00996801|471077533|FG000|Overall Study|Lost to Follow-up|0|||
130849589|NCT00996801|471077534|FG001|Overall Study|Lost to Follow-up|0|||
130849590|NCT00996801|471077535|FG002|Overall Study|Lost to Follow-up|0|||
130849591|NCT00996801|471077536|FG003|Overall Study|Lost to Follow-up|3|||
130849592|NCT00996801|471077537|FG004|Overall Study|Lost to Follow-up|3|||
130849593|NCT00996801|471077538|FG005|Overall Study|Lost to Follow-up|2|||
130849594|NCT00996801|471077533|FG000|Overall Study|Physician Decision|0|||
130849595|NCT00996801|471077534|FG001|Overall Study|Physician Decision|0|||
130849596|NCT00996801|471077535|FG002|Overall Study|Physician Decision|0|||
130849597|NCT00996801|471077536|FG003|Overall Study|Physician Decision|1|||
130849598|NCT00996801|471077537|FG004|Overall Study|Physician Decision|0|||
130849599|NCT00996801|471077538|FG005|Overall Study|Physician Decision|0|||
130849600|NCT00996801|471077533|FG000|Overall Study|Progressive Disease|0|||
130849601|NCT00996801|471077534|FG001|Overall Study|Progressive Disease|1|||
130849602|NCT00996801|471077535|FG002|Overall Study|Progressive Disease|0|||
130849603|NCT00996801|471077536|FG003|Overall Study|Progressive Disease|0|||
130849604|NCT00996801|471077537|FG004|Overall Study|Progressive Disease|0|||
130849605|NCT00996801|471077538|FG005|Overall Study|Progressive Disease|0|||
130849606|NCT00996801|471077533|FG000|Overall Study|Protocol Violation|3|||
130849607|NCT00996801|471077534|FG001|Overall Study|Protocol Violation|4|||
130849608|NCT00996801|471077535|FG002|Overall Study|Protocol Violation|1|||
130849609|NCT00996801|471077536|FG003|Overall Study|Protocol Violation|2|||
130849610|NCT00996801|471077537|FG004|Overall Study|Protocol Violation|3|||
130849611|NCT00996801|471077538|FG005|Overall Study|Protocol Violation|4|||
130849612|NCT00996801|471077533|FG000|Overall Study|Study Terminated by Sponsor|0|||
130849613|NCT00996801|471077534|FG001|Overall Study|Study Terminated by Sponsor|1|||
130849614|NCT00996801|471077535|FG002|Overall Study|Study Terminated by Sponsor|0|||
130849615|NCT00996801|471077536|FG003|Overall Study|Study Terminated by Sponsor|0|||
130849616|NCT00996801|471077537|FG004|Overall Study|Study Terminated by Sponsor|46|||
130849617|NCT00996801|471077538|FG005|Overall Study|Study Terminated by Sponsor|0|||
130849618|NCT00996801|471077533|FG000|Overall Study|Withdrawal by Subject|8|||
130849619|NCT00996801|471077534|FG001|Overall Study|Withdrawal by Subject|6|||
130849620|NCT00996801|471077535|FG002|Overall Study|Withdrawal by Subject|9|||
130849621|NCT00996801|471077536|FG003|Overall Study|Withdrawal by Subject|5|||
130849622|NCT00996801|471077537|FG004|Overall Study|Withdrawal by Subject|5|||
130849623|NCT00996801|471077538|FG005|Overall Study|Withdrawal by Subject|9|||
130849624|NCT02804750|471077539|FG000|Period 1|Adverse Event|0|||
130849625|NCT02804750|471077540|FG001|Period 1|Adverse Event|2|||
130849626|NCT02804750|471077539|FG000|Period 1|Withdrawal by Subject|0|||
130849627|NCT02804750|471077540|FG001|Period 1|Withdrawal by Subject|1|||
130849628|NCT02804750|471077539|FG000|Period 2|Adverse Event|1|||
130849629|NCT02804750|471077540|FG001|Period 2|Adverse Event|0|||
130849630|NCT02804750|471077539|FG000|Period 3|Adverse Event|0|||
130849631|NCT02804750|471077540|FG001|Period 3|Adverse Event|2|||
130849632|NCT02804750|471077539|FG000|Period 4|Adverse Event|0|||
130849633|NCT02804750|471077540|FG001|Period 4|Adverse Event|5|||
130849634|NCT01657760|471077544|FG000|Overall Study|Withdrawal by Subject|0|||
130849635|NCT01657760|471077545|FG001|Overall Study|Withdrawal by Subject|0|||
130849636|NCT01657760|471077546|FG002|Overall Study|Withdrawal by Subject|0|||
130849637|NCT01657760|471077547|FG003|Overall Study|Withdrawal by Subject|1|||
130849638|NCT01657760|471077544|FG000|Overall Study|Physician Decision|1|||
130849639|NCT01657760|471077545|FG001|Overall Study|Physician Decision|1|||
130849640|NCT01657760|471077546|FG002|Overall Study|Physician Decision|1|||
130849641|NCT01657760|471077547|FG003|Overall Study|Physician Decision|2|||
130849642|NCT00940485|471077557|FG000|Overall Study|HBeAb positive at Baseline|3|||
130849643|NCT00940485|471077558|FG001|Overall Study|HBeAb positive at Baseline|2|||
130849644|NCT00940485|471077557|FG000|Overall Study|Lost to Follow-up|2|||
130849645|NCT00940485|471077558|FG001|Overall Study|Lost to Follow-up|3|||
130849646|NCT00940485|471077557|FG000|Overall Study|Adverse Event|8|||
130849647|NCT00940485|471077558|FG001|Overall Study|Adverse Event|0|||
130849648|NCT00940485|471077557|FG000|Overall Study|Withdrawal by Subject|1|||
130849649|NCT00940485|471077558|FG001|Overall Study|Withdrawal by Subject|1|||
130849650|NCT00940485|471077557|FG000|Overall Study|Others|1|||
130849651|NCT00940485|471077558|FG001|Overall Study|Others|1|||
130849652|NCT04271475|471077562|FG000|DB Period: Day 1 up to EODBT|Death|1|||
130849653|NCT04271475|471077563|FG001|DB Period: Day 1 up to EODBT|Death|0|||
130849654|NCT04271475|471077564|FG002|DB Period: Day 1 up to EODBT|Death|0|||
130849655|NCT04271475|471077565|FG003|DB Period: Day 1 up to EODBT|Death|0|||
130849656|NCT04271475|471077562|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
130849657|NCT04271475|471077563|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
130849658|NCT04271475|471077564|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
130849659|NCT04271475|471077565|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
130849660|NCT04271475|471077562|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
130849661|NCT04271475|471077563|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
130849662|NCT04271475|471077564|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
130849663|NCT04271475|471077565|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
130849664|NCT04271475|471077562|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
130849665|NCT04271475|471077563|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
130849666|NCT04271475|471077564|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
130849667|NCT04271475|471077565|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
130849668|NCT04271475|471077562|FG000|DB Period: Day 1 up to EODBT|Other|8|||
130849669|NCT04271475|471077563|FG001|DB Period: Day 1 up to EODBT|Other|5|||
130849670|NCT04271475|471077564|FG002|DB Period: Day 1 up to EODBT|Other|0|||
130849671|NCT04271475|471077565|FG003|DB Period: Day 1 up to EODBT|Other|0|||
130849672|NCT04271475|471077562|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
130849673|NCT04271475|471077563|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
130849674|NCT04271475|471077564|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
130849675|NCT04271475|471077565|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
130849676|NCT04271475|471077562|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
130849677|NCT04271475|471077563|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
130849678|NCT04271475|471077564|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
130849679|NCT04271475|471077565|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
130849680|NCT06250738|471077568|FG000|Overall Study|Lost to Follow-up|1|||
130849681|NCT02936284|471077570|FG000|Overall Study|Withdrawal by Subject|3|||
130849682|NCT02936284|471077571|FG001|Overall Study|Withdrawal by Subject|1|||
130849683|NCT02936284|471077570|FG000|Overall Study|Lost to Follow-up|7|||
130849684|NCT02936284|471077571|FG001|Overall Study|Lost to Follow-up|8|||
130849685|NCT01068249|471077574|FG000|Overall Study|Death|1|||
130849686|NCT01068249|471077574|FG000|Overall Study|Withdrawal by Subject|3|||
130849687|NCT03921554|471077578|FG000|Overall Study|Adverse Event|2|||
130849688|NCT03921554|471077578|FG000|Overall Study|Withdrawal by Subject|1|||
130849689|NCT03921554|471077578|FG000|Overall Study|Death|3|||
130849690|NCT00159913|471077583|FG000|Overall Study|Adverse Event|1|||
130849691|NCT00159913|471077584|FG001|Overall Study|Adverse Event|0|||
130849692|NCT00159913|471077585|FG002|Overall Study|Adverse Event|1|||
130849693|NCT00159913|471077586|FG003|Overall Study|Adverse Event|0|||
130849694|NCT00159913|471077583|FG000|Overall Study|Withdrawal by Subject|0|||
130849695|NCT00159913|471077584|FG001|Overall Study|Withdrawal by Subject|0|||
130849696|NCT00159913|471077585|FG002|Overall Study|Withdrawal by Subject|0|||
130849697|NCT00159913|471077586|FG003|Overall Study|Withdrawal by Subject|1|||
130849698|NCT00159913|471077583|FG000|Overall Study|Lost to Follow-up|0|||
130849699|NCT00159913|471077584|FG001|Overall Study|Lost to Follow-up|0|||
130849700|NCT00159913|471077585|FG002|Overall Study|Lost to Follow-up|0|||
130849701|NCT00159913|471077586|FG003|Overall Study|Lost to Follow-up|1|||
130849702|NCT00159913|471077583|FG000|Overall Study|Protocol Violation|1|||
130849703|NCT00159913|471077584|FG001|Overall Study|Protocol Violation|0|||
130849704|NCT00159913|471077585|FG002|Overall Study|Protocol Violation|1|||
130849705|NCT00159913|471077586|FG003|Overall Study|Protocol Violation|0|||
130849706|NCT01318070|471077587|FG000|Overall Study|Adverse Event|1|||
130849707|NCT01318070|471077588|FG001|Overall Study|Adverse Event|1|||
130849708|NCT01318070|471077589|FG002|Overall Study|Adverse Event|5|||
130849709|NCT01318070|471077587|FG000|Overall Study|Withdrawal by Subject|0|||
130849710|NCT01318070|471077588|FG001|Overall Study|Withdrawal by Subject|1|||
130849711|NCT01318070|471077589|FG002|Overall Study|Withdrawal by Subject|1|||
130849712|NCT01318070|471077587|FG000|Overall Study|Lack of Efficacy|0|||
130849713|NCT01318070|471077588|FG001|Overall Study|Lack of Efficacy|0|||
130849714|NCT01318070|471077589|FG002|Overall Study|Lack of Efficacy|1|||
130849715|NCT01318070|471077587|FG000|Overall Study|Principal Investigator Discretion|1|||
130849716|NCT01318070|471077588|FG001|Overall Study|Principal Investigator Discretion|0|||
130849717|NCT01318070|471077589|FG002|Overall Study|Principal Investigator Discretion|0|||
130849718|NCT01287195|471077592|FG000|Overall Study|Withdrawal by Subject|2|||
130849719|NCT01685983|471077594|FG000|Overall Study|Adverse Event|7|||
130849720|NCT01685983|471077594|FG000|Overall Study|Death|1|||
130849721|NCT01685983|471077594|FG000|Overall Study|Withdrawal by Subject|19|||
130849722|NCT01685983|471077594|FG000|Overall Study|Protocol Violation|2|||
130849723|NCT01685983|471077594|FG000|Overall Study|Physician Decision|13|||
130849724|NCT01685983|471077594|FG000|Overall Study|Other|7|||
130849725|NCT01685983|471077594|FG000|Overall Study|Progressive Disease|32|||
130849726|NCT01685983|471077594|FG000|Overall Study|Noncompliance with Study Drug|1|||
130849727|NCT01443130|471077596|FG000|Overall Study|Lost to Follow-up|44|||
130849728|NCT01443130|471077597|FG001|Overall Study|Lost to Follow-up|42|||
130849729|NCT01443130|471077598|FG002|Overall Study|Lost to Follow-up|50|||
130849730|NCT01443130|471077599|FG003|Overall Study|Lost to Follow-up|23|||
130849731|NCT01443130|471077600|FG004|Overall Study|Lost to Follow-up|25|||
130849732|NCT01443130|471077601|FG005|Overall Study|Lost to Follow-up|21|||
130849733|NCT01443130|471077596|FG000|Overall Study|Death|0|||
130849734|NCT01443130|471077597|FG001|Overall Study|Death|1|||
130849735|NCT01443130|471077598|FG002|Overall Study|Death|0|||
130849736|NCT01443130|471077599|FG003|Overall Study|Death|7|||
130849737|NCT01443130|471077600|FG004|Overall Study|Death|10|||
130849738|NCT01443130|471077601|FG005|Overall Study|Death|8|||
130849739|NCT01443130|471077596|FG000|Overall Study|Adverse Event|2|||
130849740|NCT01443130|471077597|FG001|Overall Study|Adverse Event|1|||
130849741|NCT01443130|471077598|FG002|Overall Study|Adverse Event|1|||
130849742|NCT01443130|471077599|FG003|Overall Study|Adverse Event|0|||
130849743|NCT01443130|471077600|FG004|Overall Study|Adverse Event|0|||
130849744|NCT01443130|471077601|FG005|Overall Study|Adverse Event|0|||
130849745|NCT01443130|471077596|FG000|Overall Study|Protocol Violation|2|||
130849746|NCT01443130|471077597|FG001|Overall Study|Protocol Violation|1|||
130849747|NCT01443130|471077598|FG002|Overall Study|Protocol Violation|3|||
130849748|NCT01443130|471077599|FG003|Overall Study|Protocol Violation|2|||
130849749|NCT01443130|471077600|FG004|Overall Study|Protocol Violation|2|||
130849750|NCT01443130|471077601|FG005|Overall Study|Protocol Violation|3|||
130849751|NCT01443130|471077596|FG000|Overall Study|Withdrawal by Subject|15|||
130849752|NCT01443130|471077597|FG001|Overall Study|Withdrawal by Subject|14|||
130849753|NCT01443130|471077598|FG002|Overall Study|Withdrawal by Subject|12|||
130849754|NCT01443130|471077599|FG003|Overall Study|Withdrawal by Subject|7|||
130849755|NCT01443130|471077600|FG004|Overall Study|Withdrawal by Subject|7|||
130849756|NCT01443130|471077601|FG005|Overall Study|Withdrawal by Subject|2|||
130849757|NCT01443130|471077596|FG000|Overall Study|Death of Subject's Infant|5|||
130849758|NCT01443130|471077597|FG001|Overall Study|Death of Subject's Infant|10|||
130849759|NCT01443130|471077598|FG002|Overall Study|Death of Subject's Infant|11|||
130849760|NCT01443130|471077599|FG003|Overall Study|Death of Subject's Infant|0|||
130849761|NCT01443130|471077600|FG004|Overall Study|Death of Subject's Infant|0|||
130849762|NCT01443130|471077601|FG005|Overall Study|Death of Subject's Infant|0|||
130849763|NCT01167907|471077602|FG000|Overall Study|Protocol Violation|1|||
130849764|NCT01167907|471077603|FG001|Overall Study|Protocol Violation|0|||
130849765|NCT01167907|471077602|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
130849766|NCT01167907|471077603|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
130849767|NCT03077698|471077604|FG000|Progestin Monotherapy|Stable Disease|8|||
130849768|NCT03077698|471077605|FG001|Progestin Monotherapy|Stable Disease|0|||
130849769|NCT03077698|471077604|FG000|Progestin Monotherapy|Adverse Event|1|||
130849770|NCT03077698|471077605|FG001|Progestin Monotherapy|Adverse Event|0|||
130849771|NCT03077698|471077604|FG000|Progestin Monotherapy|Death|1|||
130849772|NCT03077698|471077605|FG001|Progestin Monotherapy|Death|0|||
130849773|NCT03077698|471077604|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
130849774|NCT03077698|471077605|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
130849775|NCT03077698|471077604|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
130849776|NCT03077698|471077605|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
130849777|NCT03077698|471077604|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
130849778|NCT03077698|471077605|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
130849779|NCT03077698|471077604|FG000|Safety Follow Up|Withdrawal by Subject|2|||
130849780|NCT03077698|471077605|FG001|Safety Follow Up|Withdrawal by Subject|1|||
130849781|NCT03077698|471077604|FG000|Safety Follow Up|Transfer of care to hospice|1|||
130849782|NCT03077698|471077605|FG001|Safety Follow Up|Transfer of care to hospice|0|||
130849783|NCT03461406|471077606|FG000|Overall Study|Death|1|||
130849784|NCT03461406|471077607|FG001|Overall Study|Death|2|||
130849785|NCT03461406|471077606|FG000|Overall Study|Consent Withdrawn by Participant|0|||
130849786|NCT03461406|471077607|FG001|Overall Study|Consent Withdrawn by Participant|1|||
130849787|NCT03461406|471077606|FG000|Overall Study|Screen Failure|3|||
130849788|NCT03461406|471077607|FG001|Overall Study|Screen Failure|1|||
130849789|NCT03461406|471077606|FG000|Overall Study|Reason not Specified|1|||
130849790|NCT03461406|471077607|FG001|Overall Study|Reason not Specified|3|||
130849791|NCT03461406|471077606|FG000|Overall Study|Lost to Follow-up|3|||
130849792|NCT03461406|471077607|FG001|Overall Study|Lost to Follow-up|0|||
130849793|NCT03474081|471077612|FG000|Overall Study|Adverse Event|6|||
130849794|NCT03474081|471077613|FG001|Overall Study|Adverse Event|3|||
130849795|NCT03474081|471077612|FG000|Overall Study|Lost to Follow-up|2|||
130849796|NCT03474081|471077613|FG001|Overall Study|Lost to Follow-up|1|||
130849797|NCT03474081|471077612|FG000|Overall Study|Physician Decision|3|||
130849798|NCT03474081|471077613|FG001|Overall Study|Physician Decision|2|||
130849799|NCT03474081|471077612|FG000|Overall Study|Withdrawal by Subject|5|||
130849800|NCT03474081|471077613|FG001|Overall Study|Withdrawal by Subject|7|||
130849801|NCT03474081|471077612|FG000|Overall Study|Investigator site closed|1|||
130849802|NCT03474081|471077613|FG001|Overall Study|Investigator site closed|0|||
130849803|NCT01831817|471077614|FG000|Overall Study|Lost to Follow-up|1|||
130849804|NCT01831817|471077615|FG001|Overall Study|Lost to Follow-up|0|||
130849805|NCT01831817|471077616|FG002|Overall Study|Lost to Follow-up|0|||
130849806|NCT01831817|471077617|FG003|Overall Study|Lost to Follow-up|0|||
130849807|NCT01831817|471077614|FG000|Overall Study|Withdrawl of Consent|3|||
130849808|NCT01831817|471077615|FG001|Overall Study|Withdrawl of Consent|0|||
130849809|NCT01831817|471077616|FG002|Overall Study|Withdrawl of Consent|0|||
130849810|NCT01831817|471077617|FG003|Overall Study|Withdrawl of Consent|0|||
130849811|NCT02198235|471077619|FG000|Overall Study|Lost to Follow-up|3|||
130849812|NCT02198235|471077620|FG001|Overall Study|Lost to Follow-up|2|||
130849813|NCT02198235|471077621|FG002|Overall Study|Lost to Follow-up|2|||
130849814|NCT04573881|471077624|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
130849815|NCT01825941|471079232|FG000|Overall Study|Lost to Follow-up|4|||
130849816|NCT01825941|471079233|FG001|Overall Study|Lost to Follow-up|1|||
130849817|NCT00203021|471079234|FG000|Overall Study|Death|4|||
130849818|NCT00203021|471079235|FG001|Overall Study|Death|1|||
130849819|NCT00203021|471079234|FG000|Overall Study|Adverse Event|10|||
130849820|NCT00203021|471079235|FG001|Overall Study|Adverse Event|5|||
130849821|NCT00203021|471079234|FG000|Overall Study|Withdrawal by Subject|45|||
130849822|NCT00203021|471079235|FG001|Overall Study|Withdrawal by Subject|48|||
130849823|NCT00203021|471079234|FG000|Overall Study|Lost to Follow-up|9|||
130849824|NCT00203021|471079235|FG001|Overall Study|Lost to Follow-up|7|||
130849825|NCT00203021|471079234|FG000|Overall Study|Other than specified|11|||
130849826|NCT00203021|471079235|FG001|Overall Study|Other than specified|16|||
130849827|NCT01146652|471079245|FG000|Overall Study|Adverse Event|506|||
130849828|NCT01146652|471079246|FG001|Overall Study|Adverse Event|15|||
130849829|NCT01146652|471079245|FG000|Overall Study|Lack of Efficacy|91|||
130849830|NCT01146652|471079246|FG001|Overall Study|Lack of Efficacy|7|||
130849831|NCT01146652|471079245|FG000|Overall Study|Poor compliance to protocol|38|||
130849832|NCT01146652|471079246|FG001|Overall Study|Poor compliance to protocol|1|||
130849833|NCT01146652|471079245|FG000|Overall Study|Other unspecified reasons|314|||
130849834|NCT01146652|471079246|FG001|Overall Study|Other unspecified reasons|22|||
130849835|NCT01146652|471079245|FG000|Overall Study|Enrolled but not treated|2|||
130849836|NCT01146652|471079246|FG001|Overall Study|Enrolled but not treated|0|||
130849837|NCT01146288|471079250|FG000|First Intervention(1 Day)|Adverse Event|0|||
130849838|NCT01146288|471079251|FG001|First Intervention(1 Day)|Adverse Event|1|||
130849839|NCT00385723|471079252|FG000|Overall Study|Lost to Follow-up|1|||
130849840|NCT00385723|471079253|FG001|Overall Study|Lost to Follow-up|1|||
130849841|NCT00385723|471079254|FG002|Overall Study|Lost to Follow-up|0|||
130849842|NCT00385723|471079252|FG000|Overall Study|Withdrawal by Subject|1|||
130849843|NCT00385723|471079253|FG001|Overall Study|Withdrawal by Subject|0|||
130849844|NCT00385723|471079254|FG002|Overall Study|Withdrawal by Subject|2|||
130849845|NCT03455829|471079255|FG000|Overall Study|Death|2|||
130849846|NCT03455829|471079256|FG001|Overall Study|Death|3|||
130849847|NCT03455829|471079257|FG002|Overall Study|Death|2|||
130849848|NCT03455829|471079258|FG003|Overall Study|Death|4|||
130849849|NCT03455829|471079259|FG004|Overall Study|Death|2|||
130849850|NCT03455829|471079255|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
130849851|NCT03455829|471079256|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
130849852|NCT03455829|471079257|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
130849853|NCT03455829|471079258|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
130849854|NCT03455829|471079259|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
130849855|NCT03455829|471079255|FG000|Overall Study|Disease progression|0|||
130849856|NCT03455829|471079256|FG001|Overall Study|Disease progression|0|||
130849857|NCT03455829|471079257|FG002|Overall Study|Disease progression|0|||
130849858|NCT03455829|471079258|FG003|Overall Study|Disease progression|1|||
130849859|NCT03455829|471079259|FG004|Overall Study|Disease progression|1|||
130849860|NCT00096018|471079267|FG000|Overall Study|Became Ineligible (not treated)|0|||
130849861|NCT00096018|471079268|FG001|Overall Study|Became Ineligible (not treated)|3|||
130849862|NCT00096018|471079267|FG000|Overall Study|Miscellaneous (not treated)|0|||
130849863|NCT00096018|471079268|FG001|Overall Study|Miscellaneous (not treated)|2|||
130849864|NCT00096018|471079267|FG000|Overall Study|Adverse Event|0|||
130849865|NCT00096018|471079268|FG001|Overall Study|Adverse Event|5|||
130849866|NCT00096018|471079267|FG000|Overall Study|Death|0|||
130849867|NCT00096018|471079268|FG001|Overall Study|Death|1|||
130849868|NCT00096018|471079267|FG000|Overall Study|Withdrawal by Subject|0|||
130849869|NCT00096018|471079268|FG001|Overall Study|Withdrawal by Subject|2|||
130849870|NCT00096018|471079267|FG000|Overall Study|Miscellaneous|2|||
130849871|NCT00096018|471079268|FG001|Overall Study|Miscellaneous|1|||
130849872|NCT03689712|471079269|FG000|Overall Study|Adverse Event|1|||
130849873|NCT03689712|471079270|FG001|Overall Study|Adverse Event|0|||
130849874|NCT03689712|471079269|FG000|Overall Study|Death|20|||
130849875|NCT03689712|471079270|FG001|Overall Study|Death|10|||
130849876|NCT03689712|471079269|FG000|Overall Study|Lost to Follow-up|6|||
130849877|NCT03689712|471079270|FG001|Overall Study|Lost to Follow-up|6|||
130849878|NCT03689712|471079269|FG000|Overall Study|Other|1|||
130849879|NCT03689712|471079270|FG001|Overall Study|Other|0|||
130849880|NCT03689712|471079269|FG000|Overall Study|Patient Non-Compliance|0|||
130849881|NCT03689712|471079270|FG001|Overall Study|Patient Non-Compliance|1|||
130849882|NCT03689712|471079269|FG000|Overall Study|Withdrawal by Subject|20|||
130849883|NCT03689712|471079270|FG001|Overall Study|Withdrawal by Subject|4|||
130849884|NCT03689712|471079269|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
130849885|NCT03689712|471079270|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
130849886|NCT03689712|471079269|FG000|Overall Study|Randomized but not Treated|13|||
130849887|NCT03689712|471079270|FG001|Overall Study|Randomized but not Treated|7|||
130849888|NCT03689712|471079269|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
130849889|NCT03689712|471079270|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
130849890|NCT00689793|471079271|FG000|Overall Study|Lost to Follow-up|4|||
130849891|NCT00689793|471079272|FG001|Overall Study|Lost to Follow-up|5|||
130849892|NCT03968159|471079275|FG000|Overall Study|Adverse Event|4|||
130849893|NCT03968159|471079276|FG001|Overall Study|Adverse Event|4|||
130849894|NCT03968159|471079275|FG000|Overall Study|Lost to Follow-up|1|||
130849895|NCT03968159|471079276|FG001|Overall Study|Lost to Follow-up|1|||
130849896|NCT03968159|471079275|FG000|Overall Study|Use of prohibited medication|0|||
130849897|NCT03968159|471079276|FG001|Overall Study|Use of prohibited medication|1|||
130849898|NCT03968159|471079275|FG000|Overall Study|Protocol Violation|2|||
130849899|NCT03968159|471079276|FG001|Overall Study|Protocol Violation|2|||
130849900|NCT03968159|471079275|FG000|Overall Study|Withdrawal by Subject|4|||
130849901|NCT03968159|471079276|FG001|Overall Study|Withdrawal by Subject|6|||
130849902|NCT03968159|471079275|FG000|Overall Study|Lack of Efficacy|0|||
130849903|NCT03968159|471079276|FG001|Overall Study|Lack of Efficacy|1|||
130849904|NCT03968159|471079275|FG000|Overall Study|Not further specified|2|||
130849905|NCT03968159|471079276|FG001|Overall Study|Not further specified|0|||
130849906|NCT03283150|471079279|FG000|Overall Study|Withdrawal by Subject|6|||
130849907|NCT03283150|471079280|FG001|Overall Study|Withdrawal by Subject|0|||
130849908|NCT03283150|471079281|FG002|Overall Study|Withdrawal by Subject|0|||
130849909|NCT01299571|471079282|FG000|Overall Study|Protocol Violation|107|||
130849910|NCT00864851|471079283|FG000|Overall Study|Withdrawal by Subject|0|||
130849911|NCT00864851|471079284|FG001|Overall Study|Withdrawal by Subject|1|||
130849912|NCT00864851|471079285|FG002|Overall Study|Withdrawal by Subject|0|||
130849913|NCT00864851|471079283|FG000|Overall Study|Physician Decision|1|||
130849914|NCT00864851|471079284|FG001|Overall Study|Physician Decision|0|||
130849915|NCT00864851|471079285|FG002|Overall Study|Physician Decision|0|||
130849916|NCT00864851|471079283|FG000|Overall Study|Death|1|||
130849917|NCT00864851|471079284|FG001|Overall Study|Death|0|||
130849918|NCT00864851|471079285|FG002|Overall Study|Death|0|||
130849919|NCT00864851|471079283|FG000|Overall Study|Patient uncooperative|1|||
130849920|NCT00864851|471079284|FG001|Overall Study|Patient uncooperative|0|||
130849921|NCT00864851|471079285|FG002|Overall Study|Patient uncooperative|0|||
130849922|NCT00708734|471079288|FG000|Overall Study|scheduling conflict|2|||
130849923|NCT00708734|471079288|FG000|Overall Study|moved|1|||
130849924|NCT00708734|471079288|FG000|Overall Study|leg injury|1|||
130849925|NCT00708734|471079288|FG000|Overall Study|knee replacement|1|||
130849926|NCT00708734|471079288|FG000|Overall Study|vertigo|1|||
130849927|NCT00708734|471079288|FG000|Overall Study|leg fracture|1|||
130849928|NCT01842581|471079292|FG000|Overall Study|Adverse Event|6|||
130849929|NCT01842581|471079293|FG001|Overall Study|Adverse Event|4|||
130849930|NCT01842581|471079292|FG000|Overall Study|HE breakthrough|26|||
130849931|NCT01842581|471079293|FG001|Overall Study|HE breakthrough|13|||
130849932|NCT01842581|471079292|FG000|Overall Study|Liver transplant|2|||
130849933|NCT01842581|471079293|FG001|Overall Study|Liver transplant|0|||
130849934|NCT01842581|471079292|FG000|Overall Study|Lost to Follow-up|2|||
130849935|NCT01842581|471079293|FG001|Overall Study|Lost to Follow-up|5|||
130849936|NCT01842581|471079292|FG000|Overall Study|Withdrawal by Subject|5|||
130849937|NCT01842581|471079293|FG001|Overall Study|Withdrawal by Subject|7|||
130849938|NCT01842581|471079292|FG000|Overall Study|Other than specified|3|||
130849939|NCT01842581|471079293|FG001|Overall Study|Other than specified|1|||
130849940|NCT00353873|471079294|FG000|Overall Study|Protocol Violation|1|||
130849941|NCT00353873|471079295|FG001|Overall Study|Protocol Violation|2|||
130849942|NCT00353873|471079294|FG000|Overall Study|Exacerbation|1|||
130849943|NCT00353873|471079295|FG001|Overall Study|Exacerbation|0|||
130849944|NCT00353873|471079294|FG000|Overall Study|Adverse Event|1|||
130849945|NCT00353873|471079295|FG001|Overall Study|Adverse Event|0|||
130849946|NCT00353873|471079294|FG000|Overall Study|Physician Decision|2|||
130849947|NCT00353873|471079295|FG001|Overall Study|Physician Decision|0|||
130849948|NCT00353873|471079294|FG000|Overall Study|Withdrawal by Subject|1|||
130849949|NCT00353873|471079295|FG001|Overall Study|Withdrawal by Subject|1|||
130849950|NCT02717130|471079296|FG000|Overall Study|Withdrawal by Subject|1|||
130849951|NCT02717130|471079296|FG000|Overall Study|Adverse Event|1|||
130849952|NCT02717130|471079296|FG000|Overall Study|Physician Decision|1|||
130849953|NCT02717130|471079296|FG000|Overall Study|Study Closure|4|||
130849954|NCT00106691|471079297|FG000|Overall Study|Adverse Event|60|||
130849955|NCT00106691|471079298|FG001|Overall Study|Adverse Event|64|||
130849956|NCT00106691|471079297|FG000|Overall Study|Lost to Follow-up|23|||
130849957|NCT00106691|471079298|FG001|Overall Study|Lost to Follow-up|18|||
130849958|NCT00106691|471079297|FG000|Overall Study|Physician Decision|18|||
130849959|NCT00106691|471079298|FG001|Overall Study|Physician Decision|21|||
130849960|NCT00106691|471079297|FG000|Overall Study|Protocol Violation|13|||
130849961|NCT00106691|471079298|FG001|Overall Study|Protocol Violation|18|||
130849962|NCT00106691|471079297|FG000|Overall Study|Withdrawal by Subject|75|||
130849963|NCT00106691|471079298|FG001|Overall Study|Withdrawal by Subject|70|||
130849964|NCT00106691|471079297|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
130849965|NCT00106691|471079298|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
130849966|NCT00106691|471079297|FG000|Overall Study|QTc>480|3|||
130849967|NCT00106691|471079298|FG001|Overall Study|QTc>480|1|||
130849968|NCT00106691|471079297|FG000|Overall Study|mililtary deployment|2|||
130849969|NCT00106691|471079298|FG001|Overall Study|mililtary deployment|0|||
130849970|NCT00106691|471079297|FG000|Overall Study|Study Site Closing/PI Moved|1|||
130849971|NCT00106691|471079298|FG001|Overall Study|Study Site Closing/PI Moved|2|||
130849972|NCT00106691|471079297|FG000|Overall Study|Cardiologist recommendation|1|||
130849973|NCT00106691|471079298|FG001|Overall Study|Cardiologist recommendation|0|||
130849974|NCT00106691|471079297|FG000|Overall Study|Pt. moved to another state|1|||
130849975|NCT00106691|471079298|FG001|Overall Study|Pt. moved to another state|0|||
130849976|NCT00106691|471079297|FG000|Overall Study|Taking exclusionary avodart|1|||
130849977|NCT00106691|471079298|FG001|Overall Study|Taking exclusionary avodart|0|||
130849978|NCT00106691|471079297|FG000|Overall Study|Not able to discontinue plavix|0|||
130849979|NCT00106691|471079298|FG001|Overall Study|Not able to discontinue plavix|1|||
130849980|NCT00530920|471079299|FG000|Overall Study|Randomized but not treated|0|||
130849981|NCT00530920|471079300|FG001|Overall Study|Randomized but not treated|2|||
130849982|NCT00530920|471079301|FG002|Overall Study|Randomized but not treated|0|||
130849983|NCT00530920|471079299|FG000|Overall Study|Adverse Event|0|||
130849984|NCT00530920|471079300|FG001|Overall Study|Adverse Event|0|||
130849985|NCT00530920|471079301|FG002|Overall Study|Adverse Event|3|||
130849986|NCT00530920|471079299|FG000|Overall Study|Withdrawal by Subject|0|||
130849987|NCT00530920|471079300|FG001|Overall Study|Withdrawal by Subject|0|||
130849988|NCT00530920|471079301|FG002|Overall Study|Withdrawal by Subject|1|||
130849989|NCT04957758|471079303|FG000|Overall Study|Adverse Event|1|||
130849990|NCT04957758|471079304|FG001|Overall Study|Adverse Event|0|||
130849991|NCT04957758|471079303|FG000|Overall Study|Lost to Follow-up|0|||
130849992|NCT04957758|471079304|FG001|Overall Study|Lost to Follow-up|2|||
130849993|NCT04957758|471079303|FG000|Overall Study|Withdrawal by Subject|4|||
130849994|NCT04957758|471079304|FG001|Overall Study|Withdrawal by Subject|2|||
130849995|NCT04957758|471079303|FG000|Overall Study|Protocol Violation|0|||
130849996|NCT04957758|471079304|FG001|Overall Study|Protocol Violation|1|||
130849997|NCT00707746|471079305|FG000|Treatment Period|Adverse Event|2|||
130849998|NCT00707746|471079306|FG001|Treatment Period|Adverse Event|4|||
130849999|NCT00707746|471079305|FG000|Treatment Period|Ineligibility|0|||
130850000|NCT00707746|471079306|FG001|Treatment Period|Ineligibility|1|||
130850001|NCT00685373|471079309|FG000|Overall Study|Adverse Event|3|||
130850002|NCT00685373|471079309|FG000|Overall Study|Withdrawal by Subject|5|||
130850003|NCT00685373|471079309|FG000|Overall Study|Lack of Efficacy|3|||
130850004|NCT00685373|471079309|FG000|Overall Study|Condition no longer requires study drug|1|||
130850005|NCT00685373|471079309|FG000|Overall Study|Lost to Follow-up|2|||
130850006|NCT00685373|471079309|FG000|Overall Study|Protocol Violation|1|||
130850007|NCT02642965|471079311|FG000|Overall Study|Lack of Efficacy|4|||
130850008|NCT02642965|471079311|FG000|Overall Study|Physician Decision|9|||
130850009|NCT03099148|471079314|FG000|Wash-out|scheduling conflict|0|||
130850010|NCT03099148|471079315|FG001|Wash-out|scheduling conflict|1|||
130850011|NCT03099148|471079316|FG002|Wash-out|scheduling conflict|0|||
130850012|NCT03099148|471079317|FG003|Wash-out|scheduling conflict|0|||
130850013|NCT03099148|471079314|FG000|Wash-out|Adverse Event|0|||
130850014|NCT03099148|471079315|FG001|Wash-out|Adverse Event|1|||
130850015|NCT03099148|471079316|FG002|Wash-out|Adverse Event|0|||
130850016|NCT03099148|471079317|FG003|Wash-out|Adverse Event|0|||
130850017|NCT01703065|471079318|FG000|Overall Study|Lack of Efficacy|1|||
130850018|NCT01703065|471079319|FG001|Overall Study|Lack of Efficacy|0|||
130850019|NCT01439126|471079320|FG000|Overall Study|Adverse Event|2|||
130850020|NCT01439126|471079321|FG001|Overall Study|Adverse Event|0|||
130850021|NCT01439126|471079320|FG000|Overall Study|Withdrawal by Subject|5|||
130850022|NCT01439126|471079321|FG001|Overall Study|Withdrawal by Subject|21|||
130850023|NCT01439126|471079320|FG000|Overall Study|Protocol Violation|6|||
130850024|NCT01439126|471079321|FG001|Overall Study|Protocol Violation|4|||
130850025|NCT01439126|471079320|FG000|Overall Study|Lost to Follow-up|6|||
130850026|NCT01439126|471079321|FG001|Overall Study|Lost to Follow-up|3|||
130850027|NCT01439126|471079320|FG000|Overall Study|Other-Use of prohibited treatment|0|||
130850028|NCT01439126|471079321|FG001|Overall Study|Other-Use of prohibited treatment|2|||
130850029|NCT01439126|471079320|FG000|Overall Study|Other-Miscellaneous|12|||
130850030|NCT01439126|471079321|FG001|Overall Study|Other-Miscellaneous|12|||
130850031|NCT01617447|471079322|FG000|Overall Study|Adverse Event|0|||
130850032|NCT01617447|471079323|FG001|Overall Study|Adverse Event|1|||
130850033|NCT01617447|471079322|FG000|Overall Study|Physician Decision|0|||
130850034|NCT01617447|471079323|FG001|Overall Study|Physician Decision|2|||
130850035|NCT02713529|471079325|FG000|Overall Study|Withdrawal by Subject|3|||
130850036|NCT02713529|471079326|FG001|Overall Study|Withdrawal by Subject|1|||
130850037|NCT02713529|471079327|FG002|Overall Study|Withdrawal by Subject|4|||
130850038|NCT02713529|471079328|FG003|Overall Study|Withdrawal by Subject|2|||
130850039|NCT02713529|471079329|FG004|Overall Study|Withdrawal by Subject|0|||
130850040|NCT02713529|471079330|FG005|Overall Study|Withdrawal by Subject|1|||
130850041|NCT02713529|471079331|FG006|Overall Study|Withdrawal by Subject|1|||
130850042|NCT02713529|471079325|FG000|Overall Study|Lost to Follow-up|1|||
130850043|NCT02713529|471079326|FG001|Overall Study|Lost to Follow-up|0|||
130850044|NCT02713529|471079327|FG002|Overall Study|Lost to Follow-up|1|||
130850045|NCT02713529|471079328|FG003|Overall Study|Lost to Follow-up|0|||
130850046|NCT02713529|471079329|FG004|Overall Study|Lost to Follow-up|0|||
130850047|NCT02713529|471079330|FG005|Overall Study|Lost to Follow-up|0|||
130850048|NCT02713529|471079331|FG006|Overall Study|Lost to Follow-up|0|||
130850049|NCT02713529|471079325|FG000|Overall Study|Death|3|||
130850050|NCT02713529|471079326|FG001|Overall Study|Death|3|||
130850051|NCT02713529|471079327|FG002|Overall Study|Death|26|||
130850052|NCT02713529|471079328|FG003|Overall Study|Death|27|||
130850053|NCT02713529|471079329|FG004|Overall Study|Death|3|||
130850054|NCT02713529|471079330|FG005|Overall Study|Death|13|||
130850055|NCT02713529|471079331|FG006|Overall Study|Death|3|||
130850056|NCT02827500|471079332|FG000|Overall Study|Death|7|||
130850057|NCT02827500|471079333|FG001|Overall Study|Death|3|||
130850058|NCT02827500|471079332|FG000|Overall Study|Lost to Follow-up|1|||
130850059|NCT02827500|471079333|FG001|Overall Study|Lost to Follow-up|1|||
130850060|NCT02827500|471079332|FG000|Overall Study|Withdrawal by Subject|3|||
130850061|NCT02827500|471079333|FG001|Overall Study|Withdrawal by Subject|1|||
130850062|NCT02827500|471079332|FG000|Overall Study|Missing primary endpoint data|3|||
130850063|NCT02827500|471079333|FG001|Overall Study|Missing primary endpoint data|1|||
130850064|NCT02827500|471079332|FG000|Overall Study|Other|5|||
130850065|NCT02827500|471079333|FG001|Overall Study|Other|1|||
130850066|NCT02308488|471079334|FG000|Overall Study|Withdrawal by Subject|2|||
130850067|NCT02356887|471079336|FG000|Overall Study|poor compliance|2|||
130850068|NCT01490294|471079337|FG000|Overall Study|Prematurely discontinuation|4|||
130850069|NCT01490294|471079338|FG001|Overall Study|Prematurely discontinuation|0|||
130850070|NCT01490294|471079339|FG002|Overall Study|Prematurely discontinuation|1|||
130850071|NCT01490294|471079340|FG003|Overall Study|Prematurely discontinuation|1|||
130850072|NCT01490294|471079337|FG000|Overall Study|Adverse Event|1|||
130850073|NCT01490294|471079338|FG001|Overall Study|Adverse Event|0|||
130850074|NCT01490294|471079339|FG002|Overall Study|Adverse Event|0|||
130850075|NCT01490294|471079340|FG003|Overall Study|Adverse Event|0|||
130850076|NCT00160654|471079347|FG000|Overall Study|Adverse Event|14|||
130850077|NCT00160654|471079347|FG000|Overall Study|Lack of Efficacy|4|||
130850078|NCT00160654|471079347|FG000|Overall Study|Lost to Follow-up|2|||
130850079|NCT00160654|471079347|FG000|Overall Study|Intake of expired drug|7|||
130850080|NCT00160654|471079347|FG000|Overall Study|Psychological trauma|1|||
130850081|NCT00160654|471079347|FG000|Overall Study|Sponsor decision|1|||
130850082|NCT00160654|471079347|FG000|Overall Study|Patient met exclusion criteria|1|||
130850083|NCT00160654|471079347|FG000|Overall Study|Patient decision|1|||
130850084|NCT00160654|471079347|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
130850085|NCT00160654|471079347|FG000|Overall Study|Met exclusion criteria|1|||
130850086|NCT02404649|471079348|FG000|Overall Study|Adverse Event|1|||
130850087|NCT02404649|471079349|FG001|Overall Study|Adverse Event|2|||
130850088|NCT01839656|471079353|FG000|Overall Study|Withdrawal by Subject|1|||
130850089|NCT01839656|471079354|FG001|Overall Study|Withdrawal by Subject|1|||
130850090|NCT01839656|471079353|FG000|Overall Study|Adverse event, serious fatal|1|||
130850091|NCT01839656|471079354|FG001|Overall Study|Adverse event, serious fatal|4|||
130850092|NCT01839656|471079353|FG000|Overall Study|Early study closure|0|||
130850093|NCT01839656|471079354|FG001|Overall Study|Early study closure|11|||
130850094|NCT01839656|471079353|FG000|Overall Study|Adverse Event|1|||
130850095|NCT01839656|471079354|FG001|Overall Study|Adverse Event|0|||
130850096|NCT02242981|471079364|FG000|Overall Study|Withdrawal by Subject|1|||
130850097|NCT02535416|471079365|FG000|Overall Study|Family bereavement overseas|1|||
130850098|NCT02535416|471079366|FG001|Overall Study|Family bereavement overseas|0|||
130850099|NCT02535416|471079367|FG002|Overall Study|Family bereavement overseas|0|||
130850100|NCT02535416|471079368|FG003|Overall Study|Family bereavement overseas|0|||
130850101|NCT02535416|471079369|FG004|Overall Study|Family bereavement overseas|0|||
130850102|NCT02535416|471079370|FG005|Overall Study|Family bereavement overseas|0|||
130850103|NCT02535416|471079371|FG006|Overall Study|Family bereavement overseas|0|||
130850104|NCT02535416|471079372|FG007|Overall Study|Family bereavement overseas|0|||
130850105|NCT02535416|471079373|FG008|Overall Study|Family bereavement overseas|0|||
130850106|NCT02644356|471079381|FG000|Overall Study|Withdrawal by Subject|2|||
130850107|NCT02739321|471079383|FG000|Overall Study|Lack of Efficacy|1|||
130850108|NCT02739321|471079384|FG001|Overall Study|Lack of Efficacy|1|||
130850109|NCT02739321|471079383|FG000|Overall Study|Lost to Follow-up|1|||
130850110|NCT02739321|471079384|FG001|Overall Study|Lost to Follow-up|1|||
130850111|NCT02739321|471079383|FG000|Overall Study|Withdrawal by Subject|1|||
130850112|NCT02739321|471079384|FG001|Overall Study|Withdrawal by Subject|2|||
130850113|NCT01711866|471079385|FG000|Overall Study|Noncompliant|3|||
130850114|NCT01711866|471079385|FG000|Overall Study|Withdrawal by Subject|3|||
130850115|NCT01711866|471079385|FG000|Overall Study|Adverse Event|2|||
130850116|NCT00897390|471079386|FG000|Overall Study|Adverse Event|2|||
130850117|NCT00897390|471079386|FG000|Overall Study|No Longer Met Study Criteria|1|||
130850118|NCT00897390|471079386|FG000|Overall Study|Personal Reasons|1|||
130850119|NCT00897390|471079386|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
130850120|NCT00958217|471079390|FG000|Overall Study|Death|2|||
130850121|NCT00958217|471079391|FG001|Overall Study|Death|1|||
130850122|NCT00958217|471079390|FG000|Overall Study|Withdrawal by Subject|4|||
130850123|NCT00958217|471079391|FG001|Overall Study|Withdrawal by Subject|3|||
130850124|NCT00958217|471079390|FG000|Overall Study|Lost to Follow-up|17|||
130850125|NCT00958217|471079391|FG001|Overall Study|Lost to Follow-up|19|||
130850126|NCT00958217|471079390|FG000|Overall Study|Moved out of area|1|||
130850127|NCT00958217|471079391|FG001|Overall Study|Moved out of area|1|||
130850128|NCT00958217|471079390|FG000|Overall Study|Inpatient hospitalization|0|||
130850129|NCT00958217|471079391|FG001|Overall Study|Inpatient hospitalization|1|||
130850130|NCT02564978|471079394|FG000|Overall Study|Adverse Event|8|||
130850131|NCT02564978|471079394|FG000|Overall Study|Death|1|||
130850132|NCT02564978|471079394|FG000|Overall Study|Lost to Follow-up|1|||
130850133|NCT02564978|471079394|FG000|Overall Study|Withdrawal by Subject|15|||
130850134|NCT02564978|471079394|FG000|Overall Study|Early Study Closure|2|||
130850135|NCT02564978|471079394|FG000|Overall Study|Other Reason|5|||
130850136|NCT00528996|471080878|FG000|Overall Study|Other reasons than listing|6|||
130850137|NCT00528996|471080879|FG001|Overall Study|Other reasons than listing|7|||
130850138|NCT00528996|471080880|FG002|Overall Study|Other reasons than listing|14|||
130850139|NCT00528996|471080881|FG003|Overall Study|Other reasons than listing|11|||
130850140|NCT00528996|471080882|FG004|Overall Study|Other reasons than listing|5|||
130850141|NCT00528996|471080878|FG000|Overall Study|Refused continue medication|16|||
130850142|NCT00528996|471080879|FG001|Overall Study|Refused continue medication|0|||
130850143|NCT00528996|471080880|FG002|Overall Study|Refused continue medication|3|||
130850144|NCT00528996|471080881|FG003|Overall Study|Refused continue medication|3|||
130850145|NCT00528996|471080882|FG004|Overall Study|Refused continue medication|6|||
130850146|NCT00528996|471080878|FG000|Overall Study|Lost to Follow-up|2|||
130850147|NCT00528996|471080879|FG001|Overall Study|Lost to Follow-up|0|||
130850148|NCT00528996|471080880|FG002|Overall Study|Lost to Follow-up|4|||
130850149|NCT00528996|471080881|FG003|Overall Study|Lost to Follow-up|1|||
130850150|NCT00528996|471080882|FG004|Overall Study|Lost to Follow-up|3|||
130850151|NCT00528996|471080878|FG000|Overall Study|Protocol Violation|1|||
130850152|NCT00528996|471080879|FG001|Overall Study|Protocol Violation|2|||
130850153|NCT00528996|471080880|FG002|Overall Study|Protocol Violation|3|||
130850154|NCT00528996|471080881|FG003|Overall Study|Protocol Violation|3|||
130850155|NCT00528996|471080882|FG004|Overall Study|Protocol Violation|2|||
130850156|NCT00528996|471080878|FG000|Overall Study|Lack of Efficacy|7|||
130850157|NCT00528996|471080879|FG001|Overall Study|Lack of Efficacy|2|||
130850158|NCT00528996|471080880|FG002|Overall Study|Lack of Efficacy|1|||
130850159|NCT00528996|471080881|FG003|Overall Study|Lack of Efficacy|3|||
130850160|NCT00528996|471080882|FG004|Overall Study|Lack of Efficacy|3|||
130850161|NCT00528996|471080878|FG000|Overall Study|Adverse Event|32|||
130850162|NCT00528996|471080879|FG001|Overall Study|Adverse Event|13|||
130850163|NCT00528996|471080880|FG002|Overall Study|Adverse Event|18|||
130850164|NCT00528996|471080881|FG003|Overall Study|Adverse Event|29|||
130850165|NCT00528996|471080882|FG004|Overall Study|Adverse Event|18|||
130850166|NCT05565937|471080884|FG000|Overall Study|Adverse Event|0|||
130850167|NCT05565937|471080885|FG001|Overall Study|Adverse Event|1|||
130850168|NCT05565937|471080884|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
130850169|NCT05565937|471080885|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
130850170|NCT05565937|471080884|FG000|Overall Study|Lost to Follow-up|2|||
130850171|NCT05565937|471080885|FG001|Overall Study|Lost to Follow-up|0|||
130850172|NCT05565937|471080884|FG000|Overall Study|Pregnancy|0|||
130850173|NCT05565937|471080885|FG001|Overall Study|Pregnancy|2|||
130850174|NCT05565937|471080884|FG000|Overall Study|Anisometropia|0|||
130850175|NCT05565937|471080885|FG001|Overall Study|Anisometropia|1|||
130850176|NCT04544683|471080886|FG000|Overall Study|Lost to Follow-up|2|||
130850177|NCT04544683|471080886|FG000|Overall Study|Underwent cervical spine surgery|6|||
130850178|NCT04938037|471080889|FG000|Overall Study|Lost to Follow-up|4|||
130850179|NCT04938037|471080890|FG001|Overall Study|Lost to Follow-up|3|||
130850180|NCT01806064|471080891|FG000|Overall Study|Randomized Not Enrolled|0|||
130850181|NCT01806064|471080892|FG001|Overall Study|Randomized Not Enrolled|0|||
130850182|NCT01806064|471080893|FG002|Overall Study|Randomized Not Enrolled|0|||
130850183|NCT01806064|471080894|FG003|Overall Study|Randomized Not Enrolled|1|||
130850184|NCT01806064|471080895|FG004|Overall Study|Randomized Not Enrolled|2|||
130850185|NCT01282294|471080899|FG000|Overall Study|Lost to Follow-up|14|||
130850186|NCT01282294|471080899|FG000|Overall Study|Screening failure|1|||
130850187|NCT01282294|471080899|FG000|Overall Study|Adverse Event|1|||
130850188|NCT01282294|471080899|FG000|Overall Study|Patient non-compliance|2|||
130850189|NCT01282294|471080899|FG000|Overall Study|Physician Decision|1|||
130850190|NCT02943915|471080900|FG000|Overall Study|Withdrawal by Subject|2|||
130850191|NCT02943915|471080901|FG001|Overall Study|Withdrawal by Subject|1|||
130850192|NCT02943915|471080902|FG002|Overall Study|Withdrawal by Subject|0|||
130850193|NCT02943915|471080903|FG003|Overall Study|Withdrawal by Subject|0|||
130850194|NCT02943915|471080900|FG000|Overall Study|Lost to Follow-up|3|||
130850195|NCT02943915|471080901|FG001|Overall Study|Lost to Follow-up|1|||
130850196|NCT02943915|471080902|FG002|Overall Study|Lost to Follow-up|0|||
130850197|NCT02943915|471080903|FG003|Overall Study|Lost to Follow-up|0|||
130850198|NCT02943915|471080900|FG000|Overall Study|excluded|0|||
130850199|NCT02943915|471080901|FG001|Overall Study|excluded|1|||
130850200|NCT02943915|471080902|FG002|Overall Study|excluded|0|||
130850201|NCT02943915|471080903|FG003|Overall Study|excluded|0|||
130850202|NCT00004445|471080906|FG000|Overall Study|Physician Decision|2|||
130850203|NCT00004445|471080906|FG000|Overall Study|Withdrawal by Subject|1|||
130850204|NCT02753127|471080916|FG000|Overall Study|Lost to Follow-up|13|||
130850205|NCT02753127|471080917|FG001|Overall Study|Lost to Follow-up|11|||
130850206|NCT02753127|471080916|FG000|Overall Study|Withdrawal by Subject|37|||
130850207|NCT02753127|471080917|FG001|Overall Study|Withdrawal by Subject|47|||
130850208|NCT02753127|471080916|FG000|Overall Study|Other|3|||
130850209|NCT02753127|471080917|FG001|Overall Study|Other|8|||
130850210|NCT02753127|471080916|FG000|Overall Study|Hospice|0|||
130850211|NCT02753127|471080917|FG001|Overall Study|Hospice|2|||
130850212|NCT01818284|471080921|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
130850213|NCT01818284|471080922|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
130850214|NCT01818284|471080921|FG000|Overall Study|Death|0|||
130850215|NCT01818284|471080922|FG001|Overall Study|Death|2|||
130850216|NCT03681678|471080923|FG000|Overall Study|Lost to Follow-up|20|||
130850217|NCT04619004|471080924|FG000|Overall Study|Death|114|||
130850218|NCT04619004|471080925|FG001|Overall Study|Death|28|||
130850219|NCT04619004|471080924|FG000|Overall Study|Lost to Follow-up|1|||
130850220|NCT04619004|471080925|FG001|Overall Study|Lost to Follow-up|1|||
130850221|NCT04619004|471080924|FG000|Overall Study|Withdrawal by Subject|24|||
130850222|NCT04619004|471080925|FG001|Overall Study|Withdrawal by Subject|7|||
130850223|NCT04619004|471080924|FG000|Overall Study|Other - Not specified|0|||
130850224|NCT04619004|471080925|FG001|Overall Study|Other - Not specified|1|||
130850225|NCT01114360|471080927|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
130850226|NCT01114360|471080928|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
130850227|NCT03007745|471080929|FG000|Overall Study|Sleep test negative for OSA|53|||
130850228|NCT03007745|471080930|FG001|Overall Study|Sleep test negative for OSA|49|||
130850229|NCT03007745|471080929|FG000|Overall Study|Physician Decision|6|||
130850230|NCT03007745|471080930|FG001|Overall Study|Physician Decision|9|||
130850231|NCT03007745|471080929|FG000|Overall Study|Withdrawal by Subject|38|||
130850232|NCT03007745|471080930|FG001|Overall Study|Withdrawal by Subject|16|||
130850233|NCT03007745|471080929|FG000|Overall Study|Lost to Follow-up|19|||
130850234|NCT03007745|471080930|FG001|Overall Study|Lost to Follow-up|25|||
130850235|NCT03007745|471080929|FG000|Overall Study|Unable to login to website|17|||
130850236|NCT03007745|471080930|FG001|Overall Study|Unable to login to website|4|||
130850237|NCT04284813|471080931|FG000|Overall Study|Withdrawal by Subject|1|||
130850238|NCT00431951|471080932|FG000|Overall Study|Inability to follow study procedures|1|||
130875567|NCT00301808|471173839|FG000|Overall Study|Adverse Event|5|||
130850239|NCT00431951|471080933|FG001|Overall Study|Inability to follow study procedures|0|||
130850240|NCT00431951|471080934|FG002|Overall Study|Inability to follow study procedures|1|||
130850241|NCT00431951|471080935|FG003|Overall Study|Inability to follow study procedures|2|||
130850242|NCT00431951|471080932|FG000|Overall Study|Lost to Follow-up|0|||
130850243|NCT00431951|471080933|FG001|Overall Study|Lost to Follow-up|1|||
130850244|NCT00431951|471080934|FG002|Overall Study|Lost to Follow-up|0|||
130850245|NCT00431951|471080935|FG003|Overall Study|Lost to Follow-up|0|||
130850246|NCT00431951|471080932|FG000|Overall Study|Withdrawal by Subject|0|||
130850247|NCT00431951|471080933|FG001|Overall Study|Withdrawal by Subject|1|||
130850248|NCT00431951|471080934|FG002|Overall Study|Withdrawal by Subject|0|||
130850249|NCT00431951|471080935|FG003|Overall Study|Withdrawal by Subject|0|||
130850250|NCT00431951|471080932|FG000|Overall Study|Adverse Event|0|||
130850251|NCT00431951|471080933|FG001|Overall Study|Adverse Event|0|||
130850252|NCT00431951|471080934|FG002|Overall Study|Adverse Event|1|||
130850253|NCT00431951|471080935|FG003|Overall Study|Adverse Event|0|||
130850254|NCT01100528|471080936|FG000|Overall Study|Death|1|||
130850255|NCT01100528|471080936|FG000|Overall Study|Withdrawal by Subject|2|||
130850256|NCT02006069|471080940|FG000|Overall Study|MPP other programming|239|||
130850257|NCT02006069|471080941|FG001|Overall Study|MPP other programming|0|||
130850258|NCT02006069|471080940|FG000|Overall Study|RV only pacing|0|||
130850259|NCT02006069|471080941|FG001|Overall Study|RV only pacing|3|||
130850260|NCT02066129|471080942|FG000|Overall Study|Lost to Follow-up|13|||
130850261|NCT02066129|471080943|FG001|Overall Study|Lost to Follow-up|12|||
130850262|NCT02066129|471080942|FG000|Overall Study|Withdrawal by Subject|7|||
130850263|NCT02066129|471080943|FG001|Overall Study|Withdrawal by Subject|10|||
130850264|NCT02066129|471080942|FG000|Overall Study|Lack of Efficacy|8|||
130850265|NCT02066129|471080943|FG001|Overall Study|Lack of Efficacy|10|||
130850266|NCT02066129|471080942|FG000|Overall Study|Physician Decision|1|||
130850267|NCT02066129|471080943|FG001|Overall Study|Physician Decision|1|||
130850268|NCT00357656|471080944|FG000|Overall Study|Other, No surgery performed|0|||
130850269|NCT00357656|471080945|FG001|Overall Study|Other, No surgery performed|3|||
130850270|NCT02573246|471080946|FG000|Overall Study|Lost to Follow-up|2|||
130850271|NCT02573246|471080947|FG001|Overall Study|Lost to Follow-up|0|||
130850272|NCT02573246|471080948|FG002|Overall Study|Lost to Follow-up|0|||
130850273|NCT02573246|471080949|FG003|Overall Study|Lost to Follow-up|0|||
130850274|NCT02573246|471080950|FG004|Overall Study|Lost to Follow-up|1|||
130850275|NCT02573246|471080946|FG000|Overall Study|Withdrawal by Subject|0|||
130850276|NCT02573246|471080947|FG001|Overall Study|Withdrawal by Subject|0|||
130850277|NCT02573246|471080948|FG002|Overall Study|Withdrawal by Subject|0|||
130850278|NCT02573246|471080949|FG003|Overall Study|Withdrawal by Subject|0|||
130850279|NCT02573246|471080950|FG004|Overall Study|Withdrawal by Subject|1|||
130850280|NCT02573246|471080946|FG000|Overall Study|Physician Decision|1|||
130850281|NCT02573246|471080947|FG001|Overall Study|Physician Decision|1|||
130850282|NCT02573246|471080948|FG002|Overall Study|Physician Decision|3|||
130850283|NCT02573246|471080949|FG003|Overall Study|Physician Decision|2|||
130850284|NCT02573246|471080950|FG004|Overall Study|Physician Decision|2|||
130850285|NCT01219933|471080951|FG000|Overall Study|Adverse Event|8|||
130850286|NCT01219933|471080951|FG000|Overall Study|No LDA reached|5|||
130850287|NCT01219933|471080951|FG000|Overall Study|No LDA maintained|7|||
130850288|NCT01219933|471080951|FG000|Overall Study|Lost to Follow-up|3|||
130850289|NCT01219933|471080951|FG000|Overall Study|GC free|1|||
130850290|NCT01219933|471080951|FG000|Overall Study|Withdrawal by Subject|5|||
130850291|NCT01219933|471080951|FG000|Overall Study|Protocol Violation|8|||
130850292|NCT01219933|471080951|FG000|Overall Study|Lack of Efficacy|1|||
130850293|NCT00316888|471080955|FG000|Overall Study|Adverse Event|4|||
130850294|NCT00316888|471080956|FG001|Overall Study|Adverse Event|5|||
130850295|NCT00316888|471080955|FG000|Overall Study|Withdrawal by Subject|2|||
130850296|NCT00316888|471080956|FG001|Overall Study|Withdrawal by Subject|2|||
130850297|NCT00316888|471080955|FG000|Overall Study|Not start protocol therapy|0|||
130850298|NCT00316888|471080956|FG001|Overall Study|Not start protocol therapy|1|||
130850299|NCT03149003|471080957|FG000|Overall Study|Randomized but not treated|0|||
130850300|NCT03149003|471080958|FG001|Overall Study|Randomized but not treated|1|||
130850301|NCT03149003|471080959|FG002|Overall Study|Randomized but not treated|18|||
130850302|NCT00857948|471080960|FG000|Overall Study|Withdrawal by Subject|2|||
130850303|NCT00857948|471080961|FG001|Overall Study|Withdrawal by Subject|0|||
130850304|NCT00857948|471080962|FG002|Overall Study|Withdrawal by Subject|0|||
130850305|NCT00857948|471080963|FG003|Overall Study|Withdrawal by Subject|0|||
130850306|NCT00857948|471080960|FG000|Overall Study|Protocol Violation|1|||
130850307|NCT00857948|471080961|FG001|Overall Study|Protocol Violation|0|||
130850308|NCT00857948|471080962|FG002|Overall Study|Protocol Violation|1|||
130850309|NCT00857948|471080963|FG003|Overall Study|Protocol Violation|0|||
130850310|NCT00815191|471080965|FG000|Overall Study|Protocol Violation|1|||
130850311|NCT00815191|471080966|FG001|Overall Study|Protocol Violation|1|||
130850312|NCT01814670|471080969|FG000|Overall Study|Protocol Violation|12|||
130850313|NCT03443427|471080970|FG000|Overall Study|Adverse Event|2|||
130850314|NCT03443427|471080971|FG001|Overall Study|Adverse Event|3|||
130850315|NCT03443427|471080970|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
130850316|NCT03443427|471080971|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
130850317|NCT03443427|471080970|FG000|Overall Study|Other|4|||
130850318|NCT03443427|471080971|FG001|Overall Study|Other|6|||
130850319|NCT02576860|471080972|FG000|Overall Study|Adverse Event|6|||
130850320|NCT02576860|471080973|FG001|Overall Study|Adverse Event|6|||
130850321|NCT02576860|471080972|FG000|Overall Study|Lost to Follow-up|5|||
130850322|NCT02576860|471080973|FG001|Overall Study|Lost to Follow-up|7|||
130850323|NCT02576860|471080972|FG000|Overall Study|Physician Decision|0|||
130850324|NCT02576860|471080973|FG001|Overall Study|Physician Decision|1|||
130850325|NCT02576860|471080972|FG000|Overall Study|Protocol Violation|0|||
130850326|NCT02576860|471080973|FG001|Overall Study|Protocol Violation|2|||
130850327|NCT02576860|471080972|FG000|Overall Study|Withdrawal by Subject|13|||
130850328|NCT02576860|471080973|FG001|Overall Study|Withdrawal by Subject|8|||
130850329|NCT02576860|471080972|FG000|Overall Study|Disallowed medication|1|||
130850330|NCT02576860|471080973|FG001|Overall Study|Disallowed medication|0|||
130850331|NCT01541917|471080974|FG000|Overall Study|Lost to Follow-up|2|||
130850332|NCT01541917|471080975|FG001|Overall Study|Lost to Follow-up|2|||
130850333|NCT01541917|471080974|FG000|Overall Study|Withdrawal by Subject|13|||
130850334|NCT01541917|471080975|FG001|Overall Study|Withdrawal by Subject|7|||
130850335|NCT00121641|471080976|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
130850336|NCT00121641|471080977|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
130850337|NCT00121641|471080978|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
130850338|NCT00121641|471080979|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
130850339|NCT00121641|471080980|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
130850340|NCT00121641|471080976|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
130850341|NCT00121641|471080977|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
130850342|NCT00121641|471080978|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
130850343|NCT00121641|471080979|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
130850344|NCT00121641|471080980|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
130850345|NCT00121641|471080976|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
130850346|NCT00121641|471080977|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
130850347|NCT00121641|471080978|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
130850348|NCT00121641|471080979|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
130850349|NCT00121641|471080980|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
130850350|NCT00121641|471080976|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
130850351|NCT00121641|471080977|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
130850352|NCT00121641|471080978|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
130850353|NCT00121641|471080979|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
130850354|NCT00121641|471080980|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
130850355|NCT00121641|471080976|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
130850356|NCT00121641|471080977|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
130850357|NCT00121641|471080978|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
130850358|NCT00121641|471080979|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
130850359|NCT00121641|471080980|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
130850360|NCT00121641|471080976|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
130850361|NCT00121641|471080977|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
130850362|NCT00121641|471080978|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
130850363|NCT00121641|471080979|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
130850364|NCT00121641|471080980|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
130850365|NCT00121641|471080976|FG000|24-week Short-term Treatment Period|Other Reason|1|||
130850366|NCT00121641|471080977|FG001|24-week Short-term Treatment Period|Other Reason|0|||
130850367|NCT00121641|471080978|FG002|24-week Short-term Treatment Period|Other Reason|0|||
130850368|NCT00121641|471080979|FG003|24-week Short-term Treatment Period|Other Reason|0|||
130850369|NCT00121641|471080980|FG004|24-week Short-term Treatment Period|Other Reason|0|||
130850370|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
130850371|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
130850372|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
130850373|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
130850374|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
130850375|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
130850376|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
130850377|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
130850378|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
130850379|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
130850380|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
130850381|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
130850382|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
130850383|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
130850384|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
130850385|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
130850386|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
130850387|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
130850388|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
130850389|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
130850390|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
130850391|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
130850392|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
130850393|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
130850394|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
130850395|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
130850396|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
130850397|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
130850398|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
130850399|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
130850400|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
130850401|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
130850402|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
130850403|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
130850404|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
130850405|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
130850406|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
130850407|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
130850408|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
130850409|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
130850410|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Death|0|||
130850411|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Death|0|||
130850412|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Death|0|||
130850413|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Death|1|||
130850414|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Death|0|||
130850415|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Missing|0|||
130850416|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Missing|0|||
130850417|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Missing|1|||
130850418|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Missing|0|||
130850419|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Missing|0|||
130850420|NCT00121641|471080976|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
130850421|NCT00121641|471080977|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
130850422|NCT00121641|471080978|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
130850423|NCT00121641|471080979|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
130850424|NCT00121641|471080980|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
130850425|NCT00094107|471080991|FG000|Overall Study|Lack of Efficacy|23|||
130850426|NCT00094107|471080991|FG000|Overall Study|Death|5|||
130850427|NCT00094107|471080991|FG000|Overall Study|Adverse Event|3|||
130850428|NCT00094107|471080991|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
130850429|NCT00525824|471080994|FG000|Overall Study|Adverse Event|7|||
130850430|NCT00525824|471080995|FG001|Overall Study|Adverse Event|11|||
130850431|NCT00525824|471080996|FG002|Overall Study|Adverse Event|6|||
130850432|NCT00525824|471080997|FG003|Overall Study|Adverse Event|7|||
130850433|NCT00525824|471080994|FG000|Overall Study|Withdrawal by Subject|5|||
130850434|NCT00525824|471080995|FG001|Overall Study|Withdrawal by Subject|9|||
130850435|NCT00525824|471080996|FG002|Overall Study|Withdrawal by Subject|3|||
130850436|NCT00525824|471080997|FG003|Overall Study|Withdrawal by Subject|4|||
130850437|NCT00525824|471080994|FG000|Overall Study|Lost to Follow-up|4|||
130850438|NCT00525824|471080995|FG001|Overall Study|Lost to Follow-up|2|||
130850439|NCT00525824|471080996|FG002|Overall Study|Lost to Follow-up|4|||
130850440|NCT00525824|471080997|FG003|Overall Study|Lost to Follow-up|0|||
130850441|NCT00525824|471080994|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
130850442|NCT00525824|471080995|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
130850443|NCT00525824|471080996|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
130850444|NCT00525824|471080997|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
130850445|NCT00525824|471080994|FG000|Overall Study|Severe non-compliance|0|||
130850446|NCT00525824|471080995|FG001|Overall Study|Severe non-compliance|1|||
130850447|NCT00525824|471080996|FG002|Overall Study|Severe non-compliance|1|||
130850448|NCT00525824|471080997|FG003|Overall Study|Severe non-compliance|1|||
130850449|NCT00525824|471080994|FG000|Overall Study|Safety reasons|1|||
130850450|NCT00525824|471080995|FG001|Overall Study|Safety reasons|0|||
130850451|NCT00525824|471080996|FG002|Overall Study|Safety reasons|1|||
130850452|NCT00525824|471080997|FG003|Overall Study|Safety reasons|0|||
130850453|NCT00525824|471080994|FG000|Overall Study|Other|1|||
130850454|NCT00525824|471080995|FG001|Overall Study|Other|3|||
130850455|NCT00525824|471080996|FG002|Overall Study|Other|3|||
130850456|NCT00525824|471080997|FG003|Overall Study|Other|1|||
130850457|NCT00806442|471081001|FG000|Overall Study|Lost to Follow-up|3|||
130850458|NCT00806442|471081002|FG001|Overall Study|Lost to Follow-up|2|||
130850459|NCT00806442|471081001|FG000|Overall Study|Withdrawal by Subject|1|||
130850460|NCT00806442|471081002|FG001|Overall Study|Withdrawal by Subject|5|||
130850461|NCT01264770|471081018|FG000|Overall Study|Not reported|0|||
130850462|NCT01264770|471081019|FG001|Overall Study|Not reported|0|||
130850463|NCT01264770|471081020|FG002|Overall Study|Not reported|1|||
130850464|NCT01264770|471081021|FG003|Overall Study|Not reported|0|||
130850465|NCT01264770|471081022|FG004|Overall Study|Not reported|0|||
130850466|NCT01264770|471081023|FG005|Overall Study|Not reported|0|||
130850467|NCT01264770|471081018|FG000|Overall Study|e.g., change in circumstances|8|||
130850468|NCT01264770|471081019|FG001|Overall Study|e.g., change in circumstances|3|||
130850469|NCT01264770|471081020|FG002|Overall Study|e.g., change in circumstances|3|||
130850470|NCT01264770|471081021|FG003|Overall Study|e.g., change in circumstances|3|||
130850471|NCT01264770|471081022|FG004|Overall Study|e.g., change in circumstances|4|||
130850472|NCT01264770|471081023|FG005|Overall Study|e.g., change in circumstances|4|||
130850473|NCT01264770|471081018|FG000|Overall Study|Severe non-compliance to protocol|0|||
130850474|NCT01264770|471081019|FG001|Overall Study|Severe non-compliance to protocol|0|||
130850475|NCT01264770|471081020|FG002|Overall Study|Severe non-compliance to protocol|1|||
130850476|NCT01264770|471081021|FG003|Overall Study|Severe non-compliance to protocol|1|||
130850477|NCT01264770|471081022|FG004|Overall Study|Severe non-compliance to protocol|0|||
130850478|NCT01264770|471081023|FG005|Overall Study|Severe non-compliance to protocol|0|||
130850479|NCT01264770|471081018|FG000|Overall Study|Lack of therapeutic response|1|||
130850480|NCT01264770|471081019|FG001|Overall Study|Lack of therapeutic response|0|||
130850481|NCT01264770|471081020|FG002|Overall Study|Lack of therapeutic response|2|||
130850482|NCT01264770|471081021|FG003|Overall Study|Lack of therapeutic response|1|||
130850483|NCT01264770|471081022|FG004|Overall Study|Lack of therapeutic response|1|||
130850484|NCT01264770|471081023|FG005|Overall Study|Lack of therapeutic response|0|||
130850485|NCT01264770|471081018|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
130850486|NCT01264770|471081019|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
130850487|NCT01264770|471081020|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
130850488|NCT01264770|471081021|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
130850489|NCT01264770|471081022|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
130850490|NCT01264770|471081023|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
130850491|NCT01264770|471081018|FG000|Overall Study|Lost to Follow-up|0|||
130850492|NCT01264770|471081019|FG001|Overall Study|Lost to Follow-up|0|||
130850493|NCT01264770|471081020|FG002|Overall Study|Lost to Follow-up|1|||
130850494|NCT01264770|471081021|FG003|Overall Study|Lost to Follow-up|1|||
130850495|NCT01264770|471081022|FG004|Overall Study|Lost to Follow-up|0|||
130850496|NCT01264770|471081023|FG005|Overall Study|Lost to Follow-up|0|||
130850497|NCT01264770|471081018|FG000|Overall Study|Adverse Event|7|||
130850498|NCT01264770|471081019|FG001|Overall Study|Adverse Event|7|||
130850499|NCT01264770|471081020|FG002|Overall Study|Adverse Event|8|||
130850500|NCT01264770|471081021|FG003|Overall Study|Adverse Event|0|||
130850501|NCT01264770|471081022|FG004|Overall Study|Adverse Event|2|||
130850502|NCT01264770|471081023|FG005|Overall Study|Adverse Event|1|||
130850503|NCT00330668|471081026|FG000|BID Dosing Period|Adverse Event|1|||
130850504|NCT00330668|471081026|FG000|BID Dosing Period|Lost to Follow-up|7|||
130850505|NCT00330668|471081026|FG000|BID Dosing Period|Non-Compliance|5|||
130850506|NCT00330668|471081026|FG000|BID Dosing Period|Withdrawal by Subject|19|||
130850507|NCT00330668|471081026|FG000|BID Dosing Period|Sponsor's decision|1|||
130850508|NCT00330668|471081026|FG000|BID Dosing Period|Other|3|||
130850509|NCT00330668|471081026|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
130850510|NCT00330668|471081026|FG000|QD Dosing Period|Other|1|||
130850511|NCT00330668|471081026|FG000|QD Dosing Period|Withdrawal by Subject|1|||
130850512|NCT00330668|471081026|FG000|QD Dosing Period|Lost to Follow-up|2|||
130850513|NCT01595581|471081027|FG000|Overall Study|Withdrawal by Subject|1|||
130850514|NCT01595581|471081028|FG001|Overall Study|Withdrawal by Subject|0|||
130850515|NCT04030962|471082538|FG000|Stage 2|Adverse Event|0|||
130850516|NCT04030962|471082539|FG001|Stage 2|Adverse Event|0|||
130850517|NCT04030962|471082540|FG002|Stage 2|Adverse Event|0|||
130850518|NCT04030962|471082541|FG003|Stage 2|Adverse Event|0|||
130850519|NCT04030962|471082542|FG004|Stage 2|Adverse Event|0|||
130850520|NCT04030962|471082543|FG005|Stage 2|Adverse Event|0|||
130850521|NCT04030962|471082544|FG006|Stage 2|Adverse Event|0|||
130850522|NCT04030962|471082545|FG007|Stage 2|Adverse Event|0|||
130850523|NCT04030962|471082546|FG008|Stage 2|Adverse Event|1|||
130850524|NCT04030962|471082547|FG009|Stage 2|Adverse Event|0|||
130850525|NCT04030962|471082548|FG010|Stage 2|Adverse Event|1|||
130850526|NCT04030962|471082549|FG011|Stage 2|Adverse Event|1|||
130850527|NCT04030962|471082550|FG012|Stage 2|Adverse Event|1|||
130850528|NCT04030962|471082538|FG000|Stage 2|Withdrawal by Subject|0|||
130850529|NCT04030962|471082539|FG001|Stage 2|Withdrawal by Subject|0|||
130850530|NCT04030962|471082540|FG002|Stage 2|Withdrawal by Subject|0|||
130850531|NCT04030962|471082541|FG003|Stage 2|Withdrawal by Subject|0|||
130850532|NCT04030962|471082542|FG004|Stage 2|Withdrawal by Subject|0|||
130850533|NCT04030962|471082543|FG005|Stage 2|Withdrawal by Subject|0|||
130850534|NCT04030962|471082544|FG006|Stage 2|Withdrawal by Subject|0|||
130850535|NCT04030962|471082545|FG007|Stage 2|Withdrawal by Subject|0|||
130850536|NCT04030962|471082546|FG008|Stage 2|Withdrawal by Subject|1|||
130850537|NCT04030962|471082547|FG009|Stage 2|Withdrawal by Subject|0|||
130850538|NCT04030962|471082548|FG010|Stage 2|Withdrawal by Subject|0|||
130850539|NCT04030962|471082549|FG011|Stage 2|Withdrawal by Subject|2|||
130850540|NCT04030962|471082550|FG012|Stage 2|Withdrawal by Subject|1|||
130850541|NCT04030962|471082538|FG000|Stage 2|Lost to Follow-up|0|||
130850542|NCT04030962|471082539|FG001|Stage 2|Lost to Follow-up|0|||
130850543|NCT04030962|471082540|FG002|Stage 2|Lost to Follow-up|0|||
130850544|NCT04030962|471082541|FG003|Stage 2|Lost to Follow-up|0|||
130850545|NCT04030962|471082542|FG004|Stage 2|Lost to Follow-up|0|||
130850546|NCT04030962|471082543|FG005|Stage 2|Lost to Follow-up|0|||
130850547|NCT04030962|471082544|FG006|Stage 2|Lost to Follow-up|0|||
130850548|NCT04030962|471082545|FG007|Stage 2|Lost to Follow-up|0|||
130850549|NCT04030962|471082546|FG008|Stage 2|Lost to Follow-up|1|||
130850550|NCT04030962|471082547|FG009|Stage 2|Lost to Follow-up|0|||
130850551|NCT04030962|471082548|FG010|Stage 2|Lost to Follow-up|0|||
130850552|NCT04030962|471082549|FG011|Stage 2|Lost to Follow-up|0|||
130850553|NCT04030962|471082550|FG012|Stage 2|Lost to Follow-up|0|||
130850554|NCT04030962|471082538|FG000|Stage 2|Technical Problems|0|||
130850555|NCT04030962|471082539|FG001|Stage 2|Technical Problems|0|||
130850556|NCT04030962|471082540|FG002|Stage 2|Technical Problems|0|||
130850557|NCT04030962|471082541|FG003|Stage 2|Technical Problems|0|||
130850558|NCT04030962|471082542|FG004|Stage 2|Technical Problems|0|||
130850559|NCT04030962|471082543|FG005|Stage 2|Technical Problems|0|||
130850560|NCT04030962|471082544|FG006|Stage 2|Technical Problems|0|||
130850561|NCT04030962|471082545|FG007|Stage 2|Technical Problems|0|||
130850562|NCT04030962|471082546|FG008|Stage 2|Technical Problems|0|||
130850563|NCT04030962|471082547|FG009|Stage 2|Technical Problems|0|||
130850564|NCT04030962|471082548|FG010|Stage 2|Technical Problems|0|||
130850565|NCT04030962|471082549|FG011|Stage 2|Technical Problems|1|||
130850566|NCT04030962|471082550|FG012|Stage 2|Technical Problems|0|||
130850567|NCT02981524|471082554|FG000|Overall Study|Progressive Disease|14|||
130850568|NCT02981524|471082554|FG000|Overall Study|Death (unrelated)|1|||
130850569|NCT02981524|471082554|FG000|Overall Study|Treatment Related Toxicity|1|||
130850570|NCT02981524|471082554|FG000|Overall Study|Withdrawal by Subject|1|||
130850571|NCT01300351|471082555|FG000|Overall Study|Did not receive treatment|2|||
130850572|NCT01300351|471082556|FG001|Overall Study|Did not receive treatment|0|||
130850573|NCT01300351|471082555|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
130850574|NCT01300351|471082556|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
130850575|NCT01300351|471082555|FG000|Overall Study|Lost to Follow-up|0|||
130850576|NCT01300351|471082556|FG001|Overall Study|Lost to Follow-up|1|||
130850577|NCT01300351|471082555|FG000|Overall Study|Adverse Event|0|||
130850578|NCT01300351|471082556|FG001|Overall Study|Adverse Event|4|||
130850579|NCT01300351|471082555|FG000|Overall Study|Withdrawal by Subject|7|||
130850580|NCT01300351|471082556|FG001|Overall Study|Withdrawal by Subject|10|||
130850581|NCT05824936|471082560|FG000|Overall Study|Lost to Follow-up|1|||
130850582|NCT00673881|471082561|FG000|Overall Study|Withdrawal by Subject|1|||
130850583|NCT00413010|471082564|FG000|Overall Study|Adverse Event|8|||
130850584|NCT00413010|471082565|FG001|Overall Study|Adverse Event|4|||
130850585|NCT00413010|471082564|FG000|Overall Study|Laboratory abnormality|0|||
130850586|NCT00413010|471082565|FG001|Overall Study|Laboratory abnormality|2|||
130850587|NCT00413010|471082564|FG000|Overall Study|Lack of Efficacy|0|||
130850588|NCT00413010|471082565|FG001|Overall Study|Lack of Efficacy|3|||
130850589|NCT00413010|471082564|FG000|Overall Study|Lost to Follow-up|3|||
130850590|NCT00413010|471082565|FG001|Overall Study|Lost to Follow-up|0|||
130850591|NCT00413010|471082564|FG000|Overall Study|Withdrawal by Subject|7|||
130850592|NCT00413010|471082565|FG001|Overall Study|Withdrawal by Subject|2|||
130850593|NCT00413010|471082564|FG000|Overall Study|Due to termination of the study|54|||
130850594|NCT00413010|471082565|FG001|Overall Study|Due to termination of the study|52|||
130850595|NCT01533922|471082566|FG000|Overall Study|Adverse Event|5|||
130850596|NCT01533922|471082567|FG001|Overall Study|Adverse Event|8|||
130850597|NCT01533922|471082568|FG002|Overall Study|Adverse Event|6|||
130850598|NCT01533922|471082569|FG003|Overall Study|Adverse Event|3|||
130850599|NCT01533922|471082570|FG004|Overall Study|Adverse Event|4|||
130850600|NCT01533922|471082566|FG000|Overall Study|Lack of Efficacy|0|||
130850601|NCT01533922|471082567|FG001|Overall Study|Lack of Efficacy|0|||
130850602|NCT01533922|471082568|FG002|Overall Study|Lack of Efficacy|1|||
130850603|NCT01533922|471082569|FG003|Overall Study|Lack of Efficacy|0|||
130850604|NCT01533922|471082570|FG004|Overall Study|Lack of Efficacy|0|||
130850605|NCT01533922|471082566|FG000|Overall Study|Protocol Violation|0|||
130850606|NCT01533922|471082567|FG001|Overall Study|Protocol Violation|3|||
130850607|NCT01533922|471082568|FG002|Overall Study|Protocol Violation|0|||
130850608|NCT01533922|471082569|FG003|Overall Study|Protocol Violation|0|||
130850609|NCT01533922|471082570|FG004|Overall Study|Protocol Violation|1|||
130850610|NCT01533922|471082566|FG000|Overall Study|Withdrawal by Subject|3|||
130850611|NCT01533922|471082567|FG001|Overall Study|Withdrawal by Subject|1|||
130850612|NCT01533922|471082568|FG002|Overall Study|Withdrawal by Subject|2|||
130850613|NCT01533922|471082569|FG003|Overall Study|Withdrawal by Subject|2|||
130850614|NCT01533922|471082570|FG004|Overall Study|Withdrawal by Subject|1|||
130850615|NCT01533922|471082566|FG000|Overall Study|Other reason not defined above|2|||
130850616|NCT01533922|471082567|FG001|Overall Study|Other reason not defined above|0|||
130850617|NCT01533922|471082568|FG002|Overall Study|Other reason not defined above|1|||
130850618|NCT01533922|471082569|FG003|Overall Study|Other reason not defined above|0|||
130850619|NCT01533922|471082570|FG004|Overall Study|Other reason not defined above|0|||
130850620|NCT02634606|471082573|FG000|Overall Study|unable to obtain the drug at start|13|||
130850621|NCT01267175|471082574|FG000|Overall Study|Withdrawal by Subject|1|||
130850622|NCT01267175|471082574|FG000|Overall Study|Lost to Follow-up|1|||
130850623|NCT00895661|471082576|FG000|Overall Study|Death|1|||
130850624|NCT00895661|471082576|FG000|Overall Study|reason unknown|2|||
130850625|NCT00286221|471082579|FG000|Overall Study|Protocol Violation|2|||
130850626|NCT00286221|471082580|FG001|Overall Study|Protocol Violation|1|||
130850627|NCT00286221|471082581|FG002|Overall Study|Protocol Violation|6|||
130850628|NCT00286221|471082582|FG003|Overall Study|Protocol Violation|4|||
130850629|NCT00286221|471082579|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
130850630|NCT00286221|471082580|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
130850631|NCT00286221|471082581|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
130850632|NCT00286221|471082582|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
130850633|NCT00286221|471082579|FG000|Overall Study|Inability to trigger PCA|2|||
130850634|NCT00286221|471082580|FG001|Overall Study|Inability to trigger PCA|0|||
130850635|NCT00286221|471082581|FG002|Overall Study|Inability to trigger PCA|0|||
130850636|NCT00286221|471082582|FG003|Overall Study|Inability to trigger PCA|0|||
130850637|NCT00286221|471082579|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
130850638|NCT00286221|471082580|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
130850639|NCT00286221|471082581|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
130850640|NCT00286221|471082582|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
130850641|NCT02553538|471082584|FG000|Overall Study|Could Not Reach by Telephone|133|||
130850642|NCT02553538|471082585|FG001|Overall Study|Could Not Reach by Telephone|0|||
130850643|NCT02553538|471082584|FG000|Overall Study|Died or Left Network|54|||
130850644|NCT02553538|471082585|FG001|Overall Study|Died or Left Network|56|||
130850645|NCT04094584|471082586|FG000|Overall Study|No interest in study|88|||
130850646|NCT04094584|471082586|FG000|Overall Study|Unwilling to undergo screening tests|36|||
130850647|NCT04094584|471082586|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
130850648|NCT04094584|471082586|FG000|Overall Study|Opioid use|7|||
130850649|NCT04094584|471082586|FG000|Overall Study|Need for major surgery in study period|4|||
130850650|NCT04094584|471082586|FG000|Overall Study|eligible but declined enrollment|4|||
130850651|NCT04094584|471082586|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
130850652|NCT04094584|471082586|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
130850653|NCT04094584|471082586|FG000|Overall Study|Lost to Follow-up|3|||
130850654|NCT04094584|471082586|FG000|Overall Study|Withdrawal by Subject|2|||
130850655|NCT02690649|471082587|FG000|Overall Study|Withdrawal by Subject|1|||
130850656|NCT02690649|471082588|FG001|Overall Study|Withdrawal by Subject|1|||
130850657|NCT02690649|471082587|FG000|Overall Study|Protocol Violation|0|||
130850658|NCT02690649|471082588|FG001|Overall Study|Protocol Violation|3|||
130850659|NCT02276547|471082589|FG000|Overall Study|Death|2|||
130850660|NCT02276547|471082589|FG000|Overall Study|Explant|2|||
130850661|NCT01754194|471082590|FG000|Overall Study|Lost to Follow-up|39|||
130850662|NCT01754194|471082591|FG001|Overall Study|Lost to Follow-up|14|||
130850663|NCT01754194|471082590|FG000|Overall Study|Withdrawal by Subject|4|||
130850664|NCT01754194|471082591|FG001|Overall Study|Withdrawal by Subject|5|||
130850665|NCT01754194|471082590|FG000|Overall Study|Other|9|||
130850666|NCT01754194|471082591|FG001|Overall Study|Other|8|||
130850667|NCT00907296|471082592|FG000|Overall Study|Ineligibility Determined|1|||
130850668|NCT00907296|471082593|FG001|Overall Study|Ineligibility Determined|0|||
130850669|NCT00907296|471082594|FG002|Overall Study|Ineligibility Determined|0|||
130850670|NCT00907296|471082595|FG003|Overall Study|Ineligibility Determined|1|||
130850671|NCT00907296|471082596|FG004|Overall Study|Ineligibility Determined|0|||
130850672|NCT00907296|471082597|FG005|Overall Study|Ineligibility Determined|0|||
130850673|NCT00907296|471082598|FG006|Overall Study|Ineligibility Determined|0|||
130850674|NCT00907296|471082599|FG007|Overall Study|Ineligibility Determined|1|||
130850675|NCT00907296|471082600|FG008|Overall Study|Ineligibility Determined|0|||
130850676|NCT00907296|471082601|FG009|Overall Study|Ineligibility Determined|0|||
130850677|NCT00907296|471082592|FG000|Overall Study|Protocol Deviation|0|||
130850678|NCT00907296|471082593|FG001|Overall Study|Protocol Deviation|1|||
130850679|NCT00907296|471082594|FG002|Overall Study|Protocol Deviation|0|||
130850680|NCT00907296|471082595|FG003|Overall Study|Protocol Deviation|0|||
130850681|NCT00907296|471082596|FG004|Overall Study|Protocol Deviation|0|||
130850682|NCT00907296|471082597|FG005|Overall Study|Protocol Deviation|0|||
130850683|NCT00907296|471082598|FG006|Overall Study|Protocol Deviation|0|||
130850684|NCT00907296|471082599|FG007|Overall Study|Protocol Deviation|0|||
130850685|NCT00907296|471082600|FG008|Overall Study|Protocol Deviation|0|||
130850686|NCT00907296|471082601|FG009|Overall Study|Protocol Deviation|0|||
130850687|NCT00907296|471082592|FG000|Overall Study|Noncompliance|1|||
130850688|NCT00907296|471082593|FG001|Overall Study|Noncompliance|1|||
130850689|NCT00907296|471082594|FG002|Overall Study|Noncompliance|1|||
130850690|NCT00907296|471082595|FG003|Overall Study|Noncompliance|0|||
130850691|NCT00907296|471082596|FG004|Overall Study|Noncompliance|0|||
130850692|NCT00907296|471082597|FG005|Overall Study|Noncompliance|1|||
130850693|NCT00907296|471082598|FG006|Overall Study|Noncompliance|0|||
130850694|NCT00907296|471082599|FG007|Overall Study|Noncompliance|2|||
130850695|NCT00907296|471082600|FG008|Overall Study|Noncompliance|0|||
130850696|NCT00907296|471082601|FG009|Overall Study|Noncompliance|0|||
130850697|NCT00907296|471082592|FG000|Overall Study|Adverse Event|2|||
130850698|NCT00907296|471082593|FG001|Overall Study|Adverse Event|0|||
130850699|NCT00907296|471082594|FG002|Overall Study|Adverse Event|0|||
130850700|NCT00907296|471082595|FG003|Overall Study|Adverse Event|0|||
130850701|NCT00907296|471082596|FG004|Overall Study|Adverse Event|0|||
130850702|NCT00907296|471082597|FG005|Overall Study|Adverse Event|0|||
130850703|NCT00907296|471082598|FG006|Overall Study|Adverse Event|1|||
130850704|NCT00907296|471082599|FG007|Overall Study|Adverse Event|0|||
130850705|NCT00907296|471082600|FG008|Overall Study|Adverse Event|0|||
130850706|NCT00907296|471082601|FG009|Overall Study|Adverse Event|1|||
130850707|NCT00907296|471082592|FG000|Overall Study|Withdrawal by Subject|7|||
130850708|NCT00907296|471082593|FG001|Overall Study|Withdrawal by Subject|2|||
130850709|NCT00907296|471082594|FG002|Overall Study|Withdrawal by Subject|1|||
130850710|NCT00907296|471082595|FG003|Overall Study|Withdrawal by Subject|1|||
130850711|NCT00907296|471082596|FG004|Overall Study|Withdrawal by Subject|1|||
130850712|NCT00907296|471082597|FG005|Overall Study|Withdrawal by Subject|5|||
130850713|NCT00907296|471082598|FG006|Overall Study|Withdrawal by Subject|3|||
130850714|NCT00907296|471082599|FG007|Overall Study|Withdrawal by Subject|2|||
130850715|NCT00907296|471082600|FG008|Overall Study|Withdrawal by Subject|4|||
130850716|NCT00907296|471082601|FG009|Overall Study|Withdrawal by Subject|2|||
130850717|NCT00907296|471082592|FG000|Overall Study|Lost to Follow-up|9|||
130850718|NCT00907296|471082593|FG001|Overall Study|Lost to Follow-up|1|||
130850719|NCT00907296|471082594|FG002|Overall Study|Lost to Follow-up|0|||
130850720|NCT00907296|471082595|FG003|Overall Study|Lost to Follow-up|2|||
130850721|NCT00907296|471082596|FG004|Overall Study|Lost to Follow-up|0|||
130850722|NCT00907296|471082597|FG005|Overall Study|Lost to Follow-up|3|||
130850723|NCT00907296|471082598|FG006|Overall Study|Lost to Follow-up|2|||
130850724|NCT00907296|471082599|FG007|Overall Study|Lost to Follow-up|2|||
130850725|NCT00907296|471082600|FG008|Overall Study|Lost to Follow-up|0|||
130850726|NCT00907296|471082601|FG009|Overall Study|Lost to Follow-up|4|||
130850727|NCT02900170|471082605|FG000|Overall Study|Lost to Follow-up|8|||
130850728|NCT01565941|471082606|FG000|Overall Study|Withdrawn by parent/guardian|3|||
130850729|NCT01565941|471082607|FG001|Overall Study|Withdrawn by parent/guardian|2|||
130850730|NCT01565941|471082606|FG000|Overall Study|Randomized; did not receive intevention|8|||
130850731|NCT01565941|471082607|FG001|Overall Study|Randomized; did not receive intevention|2|||
130850732|NCT02365285|471082608|FG000|Overall Study|Physician Decision|0|||
130850733|NCT02365285|471082609|FG001|Overall Study|Physician Decision|1|||
130850734|NCT02365285|471082610|FG002|Overall Study|Physician Decision|1|||
130850735|NCT02365285|471082611|FG003|Overall Study|Physician Decision|0|||
130850736|NCT02365285|471082608|FG000|Overall Study|Adverse Event|0|||
130850737|NCT02365285|471082609|FG001|Overall Study|Adverse Event|0|||
130850738|NCT02365285|471082610|FG002|Overall Study|Adverse Event|0|||
130850739|NCT02365285|471082611|FG003|Overall Study|Adverse Event|2|||
130850740|NCT03262116|471082612|FG000|Overall Study|Physician Decision|0|||
130850741|NCT03262116|471082613|FG001|Overall Study|Physician Decision|2|||
130850742|NCT03262116|471082614|FG002|Overall Study|Physician Decision|1|||
130850743|NCT03262116|471082615|FG003|Overall Study|Physician Decision|1|||
130850744|NCT03262116|471082616|FG004|Overall Study|Physician Decision|1|||
130850745|NCT03262116|471082617|FG005|Overall Study|Physician Decision|2|||
130850746|NCT02608450|471082620|FG000|Overall Study|Lost to Follow-up|39|||
130850747|NCT02608450|471082621|FG001|Overall Study|Lost to Follow-up|32|||
130850748|NCT02608450|471082620|FG000|Overall Study|Withdrawal by Subject|21|||
130850749|NCT02608450|471082621|FG001|Overall Study|Withdrawal by Subject|15|||
130850750|NCT02608450|471082620|FG000|Overall Study|Adverse Event|3|||
130850751|NCT02608450|471082621|FG001|Overall Study|Adverse Event|6|||
130850752|NCT02608450|471082620|FG000|Overall Study|Withdrawal by parent|2|||
130850753|NCT02608450|471082621|FG001|Overall Study|Withdrawal by parent|3|||
130850754|NCT02608450|471082620|FG000|Overall Study|Lack of Efficacy|0|||
130850755|NCT02608450|471082621|FG001|Overall Study|Lack of Efficacy|3|||
130850756|NCT02608450|471082620|FG000|Overall Study|Noncompliance with study drug|0|||
130850757|NCT02608450|471082621|FG001|Overall Study|Noncompliance with study drug|2|||
130850758|NCT02608450|471082620|FG000|Overall Study|Physician Decision|0|||
130850759|NCT02608450|471082621|FG001|Overall Study|Physician Decision|1|||
130850760|NCT02608450|471082620|FG000|Overall Study|Pregnancy|0|||
130850761|NCT02608450|471082621|FG001|Overall Study|Pregnancy|1|||
130850762|NCT02608450|471082620|FG000|Overall Study|Progressive disease|1|||
130850763|NCT02608450|471082621|FG001|Overall Study|Progressive disease|0|||
130850764|NCT02608450|471082620|FG000|Overall Study|Multiple reasons|0|||
130850765|NCT02608450|471082621|FG001|Overall Study|Multiple reasons|2|||
130850766|NCT02636946|471082622|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
130850767|NCT02636946|471082623|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
130850768|NCT02636946|471082622|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
130850769|NCT02636946|471082623|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
130850770|NCT02636946|471082622|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
130850771|NCT02636946|471082623|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
130850772|NCT02636946|471082622|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
130850773|NCT02636946|471082623|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
130850774|NCT02636946|471082622|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
130850775|NCT02636946|471082623|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
130850776|NCT02636946|471082622|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
130850777|NCT02636946|471082623|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
130850778|NCT00249613|471082633|FG000|12 Month Follow-up|Death|1|||
130850779|NCT00249613|471082634|FG001|12 Month Follow-up|Death|1|||
130850780|NCT00249613|471082633|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
130850781|NCT00249613|471082634|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
130850782|NCT00249613|471082633|FG000|12 Month Follow-up|Lost to Follow-up|10|||
130850783|NCT00249613|471082634|FG001|12 Month Follow-up|Lost to Follow-up|8|||
130850784|NCT00424190|471082663|FG000|Overall Study|Withdrew consent|3|||
130850785|NCT00424190|471082664|FG001|Overall Study|Withdrew consent|4|||
130850786|NCT00424190|471082663|FG000|Overall Study|Death|3|||
130850787|NCT00424190|471082664|FG001|Overall Study|Death|0|||
130850788|NCT00424190|471082663|FG000|Overall Study|Noncompliance|1|||
130850789|NCT00424190|471082664|FG001|Overall Study|Noncompliance|2|||
130850790|NCT00424190|471082663|FG000|Overall Study|Request of sponsor or investigator|0|||
130850791|NCT00424190|471082664|FG001|Overall Study|Request of sponsor or investigator|2|||
130850792|NCT00424190|471082663|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
130850793|NCT00424190|471082664|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
130850794|NCT00424190|471082663|FG000|Overall Study|Other|15|||
130850795|NCT00424190|471082664|FG001|Overall Study|Other|21|||
130850796|NCT00351273|471082665|FG000|Overall Study|Lost to Follow-up|1|||
130850797|NCT00351273|471082666|FG001|Overall Study|Lost to Follow-up|2|||
130850798|NCT00351273|471082667|FG002|Overall Study|Lost to Follow-up|5|||
130850799|NCT01672866|471082668|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
130850800|NCT01672866|471082669|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
130850801|NCT01672866|471082670|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
130850802|NCT01672866|471082668|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
130850803|NCT01672866|471082669|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
130850804|NCT01672866|471082670|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
130850805|NCT01672866|471082668|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
130850806|NCT01672866|471082669|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
130850807|NCT01672866|471082670|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
130850808|NCT01672866|471082668|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
130850809|NCT01672866|471082669|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
130850810|NCT01672866|471082670|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
130850811|NCT01672866|471082668|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
130850812|NCT01672866|471082669|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
130850813|NCT01672866|471082670|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
130850814|NCT01672866|471082668|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
130850815|NCT01672866|471082669|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
130850816|NCT01672866|471082670|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
130850817|NCT01672866|471082668|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
130850818|NCT01672866|471082669|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
130850819|NCT01672866|471082670|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
130850820|NCT01672866|471082668|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
130850821|NCT01672866|471082669|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
130850822|NCT01672866|471082670|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
130850823|NCT01672866|471082668|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
130850824|NCT01672866|471082669|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
130850825|NCT01672866|471082670|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
130850826|NCT01672866|471082668|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
130850827|NCT01672866|471082669|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
130850828|NCT01672866|471082670|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
130850829|NCT01672866|471082668|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
130850830|NCT01672866|471082669|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
130850831|NCT01672866|471082670|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
130850832|NCT01672866|471082668|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
130850833|NCT01672866|471082669|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
130850834|NCT01672866|471082670|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
130850835|NCT01672866|471082668|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
130850836|NCT01672866|471082669|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
130850837|NCT01672866|471082670|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
130850838|NCT01378429|471082673|FG000|Overall Study|Noncompliance with study drug|1|||
130850839|NCT01378429|471082674|FG001|Overall Study|Noncompliance with study drug|0|||
130850840|NCT02241187|471082675|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
130850841|NCT00199888|471082676|FG000|Overall Study|Lost to Follow-up|1|||
130850842|NCT05219669|471082677|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
130850843|NCT05219669|471082678|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
130850844|NCT05219669|471082679|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
130850845|NCT05219669|471082680|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
130850846|NCT05219669|471082681|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
130850847|NCT05219669|471082682|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
130850848|NCT02544373|471082684|FG000|Overall Study|Lost to Follow-up|5|||
130850849|NCT02544373|471082685|FG001|Overall Study|Lost to Follow-up|3|||
130850850|NCT02544373|471082684|FG000|Overall Study|Withdrawal by Subject|8|||
130850851|NCT02544373|471082685|FG001|Overall Study|Withdrawal by Subject|2|||
130850852|NCT02621073|471082686|FG000|Overall Study|Lost to Follow-up|0|||
130850853|NCT02621073|471082687|FG001|Overall Study|Lost to Follow-up|1|||
130850854|NCT02621073|471082686|FG000|Overall Study|Physician Decision|3|||
130850855|NCT02621073|471082687|FG001|Overall Study|Physician Decision|2|||
130850856|NCT01440881|471082688|FG000|Overall Study|Death|0|||
130850857|NCT01440881|471082689|FG001|Overall Study|Death|1|||
130850858|NCT02383433|471082692|FG000|Overall Study|Disease progression|2|||
130850859|NCT01977690|471082693|FG000|Overall Study|Withdrawal by Subject|0|||
130850860|NCT01977690|471082694|FG001|Overall Study|Withdrawal by Subject|4|||
130850861|NCT02920957|471082695|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
130850862|NCT02920957|471082696|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
130850863|NCT02920957|471082695|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
130850864|NCT02920957|471082696|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
130850865|NCT02920957|471082695|FG000|First Intervention : 1 Month|Adverse Event|1|||
130850866|NCT02920957|471082696|FG001|First Intervention : 1 Month|Adverse Event|0|||
130850867|NCT02920957|471082695|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
130850868|NCT02920957|471082696|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
130850869|NCT01345682|471082702|FG000|Overall Study|Progressive disease per RECIST|226|||
130850870|NCT01345682|471082703|FG001|Overall Study|Progressive disease per RECIST|93|||
130850871|NCT01345682|471082702|FG000|Overall Study|Worsening of underlying cancer disease|23|||
130850872|NCT01345682|471082703|FG001|Overall Study|Worsening of underlying cancer disease|12|||
130850873|NCT01345682|471082702|FG000|Overall Study|Adverse Event|51|||
130850874|NCT01345682|471082703|FG001|Overall Study|Adverse Event|41|||
130850875|NCT01345682|471082702|FG000|Overall Study|Non-compliance with protocol|0|||
130850876|NCT01345682|471082703|FG001|Overall Study|Non-compliance with protocol|1|||
130850877|NCT01345682|471082702|FG000|Overall Study|Lost to Follow-up|0|||
130850878|NCT01345682|471082703|FG001|Overall Study|Lost to Follow-up|1|||
130850879|NCT01345682|471082702|FG000|Overall Study|Refused to continue trial medication|16|||
130850880|NCT01345682|471082703|FG001|Overall Study|Refused to continue trial medication|9|||
130850881|NCT01345682|471082702|FG000|Overall Study|Not treated|2|||
130850882|NCT01345682|471082703|FG001|Overall Study|Not treated|1|||
130850883|NCT01345682|471082702|FG000|Overall Study|Reason other than those specified above|4|||
130850884|NCT01345682|471082703|FG001|Overall Study|Reason other than those specified above|3|||
130850885|NCT01075984|471082708|FG000|Treatment Phase|Adverse Event|0|||
130850886|NCT01075984|471082709|FG001|Treatment Phase|Adverse Event|1|||
130850887|NCT01075984|471082710|FG002|Treatment Phase|Adverse Event|3|||
130850888|NCT01075984|471082711|FG003|Treatment Phase|Adverse Event|7|||
130850889|NCT01075984|471082712|FG004|Treatment Phase|Adverse Event|35|||
130850890|NCT01075984|471082708|FG000|Treatment Phase|Protocol Violation|0|||
130850891|NCT01075984|471082709|FG001|Treatment Phase|Protocol Violation|0|||
130850892|NCT01075984|471082710|FG002|Treatment Phase|Protocol Violation|1|||
130850893|NCT01075984|471082711|FG003|Treatment Phase|Protocol Violation|0|||
130850894|NCT01075984|471082712|FG004|Treatment Phase|Protocol Violation|3|||
130850895|NCT01075984|471082708|FG000|Treatment Phase|Withdrawal by Subject|0|||
130850896|NCT01075984|471082709|FG001|Treatment Phase|Withdrawal by Subject|0|||
130850897|NCT01075984|471082710|FG002|Treatment Phase|Withdrawal by Subject|2|||
130850898|NCT01075984|471082711|FG003|Treatment Phase|Withdrawal by Subject|0|||
130850899|NCT01075984|471082712|FG004|Treatment Phase|Withdrawal by Subject|15|||
130850900|NCT01075984|471082708|FG000|Treatment Phase|Treatment Failure|0|||
130850901|NCT01075984|471082709|FG001|Treatment Phase|Treatment Failure|0|||
130850902|NCT01075984|471082710|FG002|Treatment Phase|Treatment Failure|1|||
130850903|NCT01075984|471082711|FG003|Treatment Phase|Treatment Failure|0|||
130850904|NCT01075984|471082712|FG004|Treatment Phase|Treatment Failure|5|||
130850905|NCT01075984|471082708|FG000|Treatment Phase|Progression of disease|0|||
130850906|NCT01075984|471082709|FG001|Treatment Phase|Progression of disease|0|||
130850907|NCT01075984|471082710|FG002|Treatment Phase|Progression of disease|0|||
130850908|NCT01075984|471082711|FG003|Treatment Phase|Progression of disease|0|||
130850909|NCT01075984|471082712|FG004|Treatment Phase|Progression of disease|2|||
130850910|NCT01075984|471082708|FG000|Follow-up Phase|Protocol Violation|0|||
130850911|NCT01075984|471082709|FG001|Follow-up Phase|Protocol Violation|0|||
130850912|NCT01075984|471082710|FG002|Follow-up Phase|Protocol Violation|1|||
130850913|NCT01075984|471082711|FG003|Follow-up Phase|Protocol Violation|0|||
130850914|NCT01075984|471082712|FG004|Follow-up Phase|Protocol Violation|3|||
130850915|NCT01075984|471082708|FG000|Follow-up Phase|Adverse Event|0|||
130850916|NCT01075984|471082709|FG001|Follow-up Phase|Adverse Event|0|||
130850917|NCT01075984|471082710|FG002|Follow-up Phase|Adverse Event|0|||
130850918|NCT01075984|471082711|FG003|Follow-up Phase|Adverse Event|2|||
130850919|NCT01075984|471082712|FG004|Follow-up Phase|Adverse Event|27|||
130850920|NCT01075984|471082708|FG000|Follow-up Phase|Administrative|0|||
130850921|NCT01075984|471082709|FG001|Follow-up Phase|Administrative|0|||
130850922|NCT01075984|471082710|FG002|Follow-up Phase|Administrative|0|||
130850923|NCT01075984|471082711|FG003|Follow-up Phase|Administrative|0|||
130850924|NCT01075984|471082712|FG004|Follow-up Phase|Administrative|1|||
130850925|NCT01075984|471082708|FG000|Follow-up Phase|Withdrawal by Subject|0|||
130850926|NCT01075984|471082709|FG001|Follow-up Phase|Withdrawal by Subject|0|||
130850927|NCT01075984|471082710|FG002|Follow-up Phase|Withdrawal by Subject|0|||
130850928|NCT01075984|471082711|FG003|Follow-up Phase|Withdrawal by Subject|0|||
130850929|NCT01075984|471082712|FG004|Follow-up Phase|Withdrawal by Subject|10|||
130850930|NCT01075984|471082708|FG000|Follow-up Phase|Progression of disease|0|||
130850931|NCT01075984|471082709|FG001|Follow-up Phase|Progression of disease|0|||
130850932|NCT01075984|471082710|FG002|Follow-up Phase|Progression of disease|0|||
130850933|NCT01075984|471082711|FG003|Follow-up Phase|Progression of disease|0|||
130850934|NCT01075984|471082712|FG004|Follow-up Phase|Progression of disease|2|||
130850935|NCT01075984|471082708|FG000|Follow-up Phase|Treatment failure|0|||
130850936|NCT01075984|471082709|FG001|Follow-up Phase|Treatment failure|0|||
130850937|NCT01075984|471082710|FG002|Follow-up Phase|Treatment failure|0|||
130850938|NCT01075984|471082711|FG003|Follow-up Phase|Treatment failure|0|||
130850939|NCT01075984|471082712|FG004|Follow-up Phase|Treatment failure|4|||
130850940|NCT03442296|471082718|FG000|3 Month Follow-up|Death|3|||
130850941|NCT03442296|471082719|FG001|3 Month Follow-up|Death|1|||
130850942|NCT03442296|471082718|FG000|3 Month Follow-up|Lost to Follow-up|1|||
130850943|NCT03442296|471082719|FG001|3 Month Follow-up|Lost to Follow-up|1|||
130850944|NCT03442296|471082718|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
130850945|NCT03442296|471082719|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
130850946|NCT03442296|471082718|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
130850947|NCT03442296|471082719|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
130850948|NCT03442296|471082718|FG000|12 Month Follow-up|Incomplete measurement|1|||
130850949|NCT03442296|471082719|FG001|12 Month Follow-up|Incomplete measurement|1|||
130850950|NCT02440789|471082720|FG000|Overall Study|Withdrawal by Subject|3|||
130850951|NCT02440789|471082720|FG000|Overall Study|Not willing to adhere to reqs|1|||
130850952|NCT03684694|471082723|FG000|Phase 1|Withdrawal by Subject|1|||
130850953|NCT03684694|471082724|FG001|Phase 1|Withdrawal by Subject|0|||
130850954|NCT03684694|471082725|FG002|Phase 1|Withdrawal by Subject|0|||
130850955|NCT03684694|471082726|FG003|Phase 1|Withdrawal by Subject|0|||
130850956|NCT03684694|471082727|FG004|Phase 1|Withdrawal by Subject|0|||
130850957|NCT03684694|471082728|FG005|Phase 1|Withdrawal by Subject|0|||
130850958|NCT03684694|471082723|FG000|Phase 1|Investigator/Sponsor Decision|12|||
130850959|NCT03684694|471082724|FG001|Phase 1|Investigator/Sponsor Decision|2|||
130850960|NCT03684694|471082725|FG002|Phase 1|Investigator/Sponsor Decision|1|||
130850961|NCT03684694|471082726|FG003|Phase 1|Investigator/Sponsor Decision|0|||
130850962|NCT03684694|471082727|FG004|Phase 1|Investigator/Sponsor Decision|0|||
130850963|NCT03684694|471082728|FG005|Phase 1|Investigator/Sponsor Decision|0|||
130850964|NCT03684694|471082723|FG000|Phase 1|Death|24|||
130850965|NCT03684694|471082724|FG001|Phase 1|Death|0|||
130850966|NCT03684694|471082725|FG002|Phase 1|Death|3|||
130850967|NCT03684694|471082726|FG003|Phase 1|Death|0|||
130850968|NCT03684694|471082727|FG004|Phase 1|Death|0|||
130850969|NCT03684694|471082728|FG005|Phase 1|Death|0|||
130850970|NCT03684694|471082723|FG000|Phase 1|Lost to Follow-up|0|||
130850971|NCT03684694|471082724|FG001|Phase 1|Lost to Follow-up|0|||
130850972|NCT03684694|471082725|FG002|Phase 1|Lost to Follow-up|1|||
130850973|NCT03684694|471082726|FG003|Phase 1|Lost to Follow-up|0|||
130850974|NCT03684694|471082727|FG004|Phase 1|Lost to Follow-up|0|||
130850975|NCT03684694|471082728|FG005|Phase 1|Lost to Follow-up|0|||
130850976|NCT03684694|471082723|FG000|Phase 1|Miscellaneous|0|||
130850977|NCT03684694|471082724|FG001|Phase 1|Miscellaneous|1|||
130850978|NCT03684694|471082725|FG002|Phase 1|Miscellaneous|0|||
130850979|NCT03684694|471082726|FG003|Phase 1|Miscellaneous|0|||
130850980|NCT03684694|471082727|FG004|Phase 1|Miscellaneous|0|||
130850981|NCT03684694|471082728|FG005|Phase 1|Miscellaneous|0|||
130850982|NCT03684694|471082723|FG000|Phase 2|Withdrawal by Subject|0|||
130850983|NCT03684694|471082724|FG001|Phase 2|Withdrawal by Subject|0|||
130850984|NCT03684694|471082725|FG002|Phase 2|Withdrawal by Subject|0|||
130850985|NCT03684694|471082726|FG003|Phase 2|Withdrawal by Subject|0|||
130850986|NCT03684694|471082727|FG004|Phase 2|Withdrawal by Subject|0|||
130850987|NCT03684694|471082728|FG005|Phase 2|Withdrawal by Subject|1|||
130850988|NCT03684694|471082723|FG000|Phase 2|Investigator/Sponsor Decision|0|||
130850989|NCT03684694|471082724|FG001|Phase 2|Investigator/Sponsor Decision|0|||
130850990|NCT03684694|471082725|FG002|Phase 2|Investigator/Sponsor Decision|0|||
130875568|NCT00301808|471173839|FG000|Overall Study|Death|3|||
130850991|NCT03684694|471082726|FG003|Phase 2|Investigator/Sponsor Decision|17|||
130850992|NCT03684694|471082727|FG004|Phase 2|Investigator/Sponsor Decision|16|||
130850993|NCT03684694|471082728|FG005|Phase 2|Investigator/Sponsor Decision|6|||
130850994|NCT03684694|471082723|FG000|Phase 2|Death|0|||
130850995|NCT03684694|471082724|FG001|Phase 2|Death|0|||
130850996|NCT03684694|471082725|FG002|Phase 2|Death|0|||
130850997|NCT03684694|471082726|FG003|Phase 2|Death|28|||
130850998|NCT03684694|471082727|FG004|Phase 2|Death|14|||
130850999|NCT03684694|471082728|FG005|Phase 2|Death|3|||
130851000|NCT03684694|471082723|FG000|Phase 2|Lost to Follow-up|0|||
130851001|NCT03684694|471082724|FG001|Phase 2|Lost to Follow-up|0|||
130851002|NCT03684694|471082725|FG002|Phase 2|Lost to Follow-up|0|||
130851003|NCT03684694|471082726|FG003|Phase 2|Lost to Follow-up|1|||
130851004|NCT03684694|471082727|FG004|Phase 2|Lost to Follow-up|0|||
130851005|NCT03684694|471082728|FG005|Phase 2|Lost to Follow-up|0|||
130851006|NCT03684694|471082723|FG000|Phase 2|Miscellaneous|0|||
130851007|NCT03684694|471082724|FG001|Phase 2|Miscellaneous|0|||
130851008|NCT03684694|471082725|FG002|Phase 2|Miscellaneous|0|||
130851009|NCT03684694|471082726|FG003|Phase 2|Miscellaneous|3|||
130851010|NCT03684694|471082727|FG004|Phase 2|Miscellaneous|0|||
130851011|NCT03684694|471082728|FG005|Phase 2|Miscellaneous|0|||
130851012|NCT03172130|471084143|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
130851013|NCT03172130|471084144|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
130851014|NCT02831933|471084148|FG000|Overall Study|Physician Decision|11|||
130851015|NCT05065190|471084154|FG000|Overall Study|Other than listed|2|||
130851016|NCT05065190|471084155|FG001|Overall Study|Other than listed|12|||
130851017|NCT05065190|471084154|FG000|Overall Study|Lack of Efficacy|4|||
130851018|NCT05065190|471084155|FG001|Overall Study|Lack of Efficacy|0|||
130851019|NCT05065190|471084154|FG000|Overall Study|Adverse Event|1|||
130851020|NCT05065190|471084155|FG001|Overall Study|Adverse Event|10|||
130851021|NCT02769962|471084162|FG000|Overall Study|Physician Decision|0|||
130851022|NCT02769962|471084163|FG001|Overall Study|Physician Decision|0|||
130851023|NCT02769962|471084164|FG002|Overall Study|Physician Decision|0|||
130851024|NCT02769962|471084165|FG003|Overall Study|Physician Decision|0|||
130851025|NCT02769962|471084166|FG004|Overall Study|Physician Decision|0|||
130851026|NCT02769962|471084167|FG005|Overall Study|Physician Decision|1|||
130851027|NCT02769962|471084168|FG006|Overall Study|Physician Decision|0|||
130851028|NCT02769962|471084169|FG007|Overall Study|Physician Decision|1|||
130851029|NCT02769962|471084162|FG000|Overall Study|Refused further treatment|0|||
130851030|NCT02769962|471084163|FG001|Overall Study|Refused further treatment|0|||
130851031|NCT02769962|471084164|FG002|Overall Study|Refused further treatment|0|||
130851032|NCT02769962|471084165|FG003|Overall Study|Refused further treatment|0|||
130851033|NCT02769962|471084166|FG004|Overall Study|Refused further treatment|0|||
130851034|NCT02769962|471084167|FG005|Overall Study|Refused further treatment|1|||
130851035|NCT02769962|471084168|FG006|Overall Study|Refused further treatment|1|||
130851036|NCT02769962|471084169|FG007|Overall Study|Refused further treatment|0|||
130851037|NCT01073930|471084171|FG000|Overall Study|Withdrawal by Subject|3|||
130851038|NCT01073930|471084172|FG001|Overall Study|Withdrawal by Subject|2|||
130851039|NCT01073930|471084171|FG000|Overall Study|Lost to Follow-up|0|||
130851040|NCT01073930|471084172|FG001|Overall Study|Lost to Follow-up|1|||
130851041|NCT01073930|471084171|FG000|Overall Study|Adverse Event|0|||
130851042|NCT01073930|471084172|FG001|Overall Study|Adverse Event|1|||
130851043|NCT01073930|471084171|FG000|Overall Study|Noncompliance with study drug|0|||
130851044|NCT01073930|471084172|FG001|Overall Study|Noncompliance with study drug|1|||
130851045|NCT01073930|471084171|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
130851046|NCT01073930|471084172|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
130851047|NCT01022424|471084173|FG000|Overall Study|Adverse Event|1|||
130851048|NCT01022424|471084173|FG000|Overall Study|Physician Decision|1|||
130851049|NCT01022424|471084173|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
130851050|NCT01266590|471084174|FG000|Overall Study|Adverse Event|3|||
130851051|NCT01266590|471084174|FG000|Overall Study|Lost to Follow-up|1|||
130851052|NCT01266590|471084174|FG000|Overall Study|Withdrawal by Subject|1|||
130851053|NCT01266590|471084174|FG000|Overall Study|Physician Decision|1|||
130851054|NCT02783170|471084179|FG000|Overall Study|Randomized but not Vaccinated|1|||
130851055|NCT02783170|471084180|FG001|Overall Study|Randomized but not Vaccinated|0|||
130851056|NCT03320330|471084181|FG000|Overall Study|Lack of Efficacy|5|||
130851057|NCT03320330|471084182|FG001|Overall Study|Lack of Efficacy|5|||
130851058|NCT03320330|471084183|FG002|Overall Study|Lack of Efficacy|14|||
130851059|NCT03320330|471084181|FG000|Overall Study|Physician Decision|1|||
130851060|NCT03320330|471084182|FG001|Overall Study|Physician Decision|0|||
130851061|NCT03320330|471084183|FG002|Overall Study|Physician Decision|0|||
130851062|NCT04692077|471084185|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
130851063|NCT05149313|471084186|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
130851064|NCT05149313|471084187|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
130851065|NCT05149313|471084188|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
130851066|NCT05149313|471084189|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
130851067|NCT05149313|471084186|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
130851068|NCT05149313|471084187|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
130851069|NCT05149313|471084188|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
130851070|NCT05149313|471084189|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
130851071|NCT05149313|471084186|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
130851072|NCT05149313|471084187|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
130851073|NCT05149313|471084188|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
130851074|NCT05149313|471084189|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
130851075|NCT05149313|471084186|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
130851076|NCT05149313|471084187|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
130851077|NCT05149313|471084188|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
130851078|NCT05149313|471084189|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
130851079|NCT05149313|471084186|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
130851080|NCT05149313|471084187|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
130851081|NCT05149313|471084188|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
130851082|NCT05149313|471084189|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
130851083|NCT05149313|471084186|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
130851084|NCT05149313|471084187|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
130851085|NCT05149313|471084188|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
130851086|NCT05149313|471084189|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
130851087|NCT05149313|471084186|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
130851088|NCT05149313|471084187|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
130851089|NCT05149313|471084188|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
130851090|NCT05149313|471084189|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
130851091|NCT05149313|471084186|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130851092|NCT05149313|471084187|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130851093|NCT05149313|471084188|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
130851094|NCT05149313|471084189|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
130851095|NCT05149313|471084186|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
130851096|NCT05149313|471084187|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
130851097|NCT05149313|471084188|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
130851098|NCT05149313|471084189|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
130851099|NCT05149313|471084186|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130851100|NCT05149313|471084187|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130851101|NCT05149313|471084188|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
130851102|NCT05149313|471084189|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130851103|NCT05149313|471084186|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
130851104|NCT05149313|471084187|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
130851105|NCT05149313|471084188|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
130851106|NCT05149313|471084189|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
130851107|NCT03199391|471084194|FG000|Overall Study|Death|1|||
130851108|NCT03199391|471084194|FG000|Overall Study|Lost to Follow-up|3|||
130851109|NCT03199391|471084194|FG000|Overall Study|Adverse Event|2|||
130851110|NCT03199391|471084194|FG000|Overall Study|Withdrawal by Subject|10|||
130851111|NCT01867086|471084195|FG000|Overall Study|Disease Progression|1|||
130851112|NCT03826342|471084196|FG000|Overall Study|Withdrawal by Subject|8|||
130851113|NCT03826342|471084197|FG001|Overall Study|Withdrawal by Subject|1|||
130851114|NCT03826342|471084196|FG000|Overall Study|Lost to Follow-up|7|||
130851115|NCT03826342|471084197|FG001|Overall Study|Lost to Follow-up|7|||
130851116|NCT03826342|471084196|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
130851117|NCT03826342|471084197|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
130851118|NCT02046070|471084201|FG000|Overall Study|Progressive Disease|18|||
130851119|NCT02046070|471084202|FG001|Overall Study|Progressive Disease|11|||
130851120|NCT02046070|471084203|FG002|Overall Study|Progressive Disease|40|||
130851121|NCT02046070|471084201|FG000|Overall Study|Adverse Event|8|||
130851122|NCT02046070|471084202|FG001|Overall Study|Adverse Event|10|||
130851123|NCT02046070|471084203|FG002|Overall Study|Adverse Event|17|||
130851124|NCT02046070|471084201|FG000|Overall Study|Withdrawal by Subject|1|||
130851125|NCT02046070|471084202|FG001|Overall Study|Withdrawal by Subject|2|||
130851126|NCT02046070|471084203|FG002|Overall Study|Withdrawal by Subject|6|||
130851127|NCT02046070|471084201|FG000|Overall Study|Study Terminated by Sponsor|1|||
130851128|NCT02046070|471084202|FG001|Overall Study|Study Terminated by Sponsor|1|||
130851129|NCT02046070|471084203|FG002|Overall Study|Study Terminated by Sponsor|1|||
130851130|NCT02046070|471084201|FG000|Overall Study|Reason not Specified|4|||
130851131|NCT02046070|471084202|FG001|Overall Study|Reason not Specified|4|||
130851132|NCT02046070|471084203|FG002|Overall Study|Reason not Specified|6|||
130851133|NCT05601102|471084204|FG000|Overall Study|Death|1|||
130851134|NCT05601102|471084205|FG001|Overall Study|Death|2|||
130851135|NCT05601102|471084204|FG000|Overall Study|Withdrawal by Subject|1|||
130851136|NCT05601102|471084205|FG001|Overall Study|Withdrawal by Subject|1|||
130851137|NCT05601102|471084204|FG000|Overall Study|Lost to Follow-up|0|||
130851138|NCT05601102|471084205|FG001|Overall Study|Lost to Follow-up|2|||
130851139|NCT05288166|471084206|FG000|Overall Study|Adverse Event|1|||
130851140|NCT05288166|471084207|FG001|Overall Study|Adverse Event|0|||
130851141|NCT05288166|471084206|FG000|Overall Study|Lost to Follow-up|2|||
130851142|NCT05288166|471084207|FG001|Overall Study|Lost to Follow-up|0|||
130851143|NCT05288166|471084206|FG000|Overall Study|Physician Decision|0|||
130851144|NCT05288166|471084207|FG001|Overall Study|Physician Decision|2|||
130851145|NCT05288166|471084206|FG000|Overall Study|Screen Failure|1|||
130851146|NCT05288166|471084207|FG001|Overall Study|Screen Failure|1|||
130851147|NCT05288166|471084206|FG000|Overall Study|Withdrawal by Subject|4|||
130851148|NCT05288166|471084207|FG001|Overall Study|Withdrawal by Subject|2|||
130851149|NCT05288166|471084206|FG000|Overall Study|On Study Treatment|408|||
130851150|NCT05288166|471084207|FG001|Overall Study|On Study Treatment|418|||
130851151|NCT00483041|471084209|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
130851152|NCT00483041|471084210|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
130851153|NCT02258529|471084212|FG000|Overall Study|Study Terminated by Sponsor|9|||
130851154|NCT02258529|471084212|FG000|Overall Study|Adverse Event|1|||
130851155|NCT00443781|471084213|FG000|Overall Study|Lost to Follow-up|10|||
130851156|NCT00443781|471084213|FG000|Overall Study|Physician Decision|2|||
130851157|NCT00443781|471084213|FG000|Overall Study|Protocol Violation|1|||
130851158|NCT00443781|471084213|FG000|Overall Study|Withdrawal by Subject|6|||
130851159|NCT00443781|471084213|FG000|Overall Study|Unable to comply with study follow up|2|||
130851160|NCT00443781|471084213|FG000|Overall Study|Investigator terminated participation|1|||
130851161|NCT00443781|471084213|FG000|Overall Study|Insurance not covered|2|||
130851162|NCT00443781|471084213|FG000|Overall Study|PD/FAD not done|1|||
130851163|NCT02066415|471084214|FG000|Overall Study|Decision by Sponsor|5|||
130851164|NCT02066415|471084215|FG001|Overall Study|Decision by Sponsor|4|||
130851165|NCT02066415|471084216|FG002|Overall Study|Decision by Sponsor|2|||
130851166|NCT02066415|471084214|FG000|Overall Study|Withdrawal by Subject|9|||
130851167|NCT02066415|471084215|FG001|Overall Study|Withdrawal by Subject|1|||
130851168|NCT02066415|471084216|FG002|Overall Study|Withdrawal by Subject|4|||
130851169|NCT02066415|471084214|FG000|Overall Study|Lost to Follow-up|7|||
130851170|NCT02066415|471084215|FG001|Overall Study|Lost to Follow-up|2|||
130851171|NCT02066415|471084216|FG002|Overall Study|Lost to Follow-up|2|||
130851172|NCT05432167|471084220|FG000|Overall Study|Adverse Event|0|||
130851173|NCT05432167|471084221|FG001|Overall Study|Adverse Event|2|||
130851174|NCT05432167|471084222|FG002|Overall Study|Adverse Event|1|||
130851175|NCT05432167|471084220|FG000|Overall Study|Lost to Follow-up|3|||
130851176|NCT05432167|471084221|FG001|Overall Study|Lost to Follow-up|3|||
130851177|NCT05432167|471084222|FG002|Overall Study|Lost to Follow-up|2|||
130851178|NCT05432167|471084220|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
130851179|NCT05432167|471084221|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
130851180|NCT05432167|471084222|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
130851181|NCT05432167|471084220|FG000|Overall Study|Physician Decision|1|||
130851182|NCT05432167|471084221|FG001|Overall Study|Physician Decision|0|||
130851183|NCT05432167|471084222|FG002|Overall Study|Physician Decision|0|||
130851184|NCT05432167|471084220|FG000|Overall Study|Withdrawal by Subject|7|||
130851185|NCT05432167|471084221|FG001|Overall Study|Withdrawal by Subject|4|||
130851186|NCT05432167|471084222|FG002|Overall Study|Withdrawal by Subject|11|||
130851187|NCT05432167|471084220|FG000|Overall Study|Other|0|||
130851188|NCT05432167|471084221|FG001|Overall Study|Other|0|||
130851189|NCT05432167|471084222|FG002|Overall Study|Other|1|||
130851190|NCT00791557|471084227|FG000|Overall Study|Adverse Event|1|||
130851191|NCT03344640|471084228|FG000|Overall Study|Adverse Event|1|||
130851192|NCT03344640|471084229|FG001|Overall Study|Adverse Event|0|||
130851193|NCT03344640|471084228|FG000|Overall Study|Physician Decision|1|||
130851194|NCT03344640|471084229|FG001|Overall Study|Physician Decision|1|||
130851195|NCT03344640|471084228|FG000|Overall Study|Withdrawal by Subject|1|||
130851196|NCT03344640|471084229|FG001|Overall Study|Withdrawal by Subject|2|||
130851197|NCT03344640|471084228|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
130851198|NCT03344640|471084229|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
130851199|NCT01902888|471084230|FG000|Overall Study|Study Terminated|3|||
130851200|NCT02616393|471084234|FG000|Overall Study|Death|5|||
130851201|NCT02616393|471084235|FG001|Overall Study|Death|12|||
130851202|NCT02616393|471084236|FG002|Overall Study|Death|1|||
130851203|NCT02616393|471084234|FG000|Overall Study|Termination by Sponsor|4|||
130851204|NCT02616393|471084235|FG001|Overall Study|Termination by Sponsor|5|||
130851205|NCT02616393|471084236|FG002|Overall Study|Termination by Sponsor|2|||
130851206|NCT02616393|471084234|FG000|Overall Study|Other|3|||
130851207|NCT02616393|471084235|FG001|Overall Study|Other|0|||
130851208|NCT02616393|471084236|FG002|Overall Study|Other|0|||
130851209|NCT02616393|471084234|FG000|Overall Study|Withdrawal by Subject|1|||
130851210|NCT02616393|471084235|FG001|Overall Study|Withdrawal by Subject|1|||
130851211|NCT02616393|471084236|FG002|Overall Study|Withdrawal by Subject|0|||
130851212|NCT02616393|471084234|FG000|Overall Study|Lost to Follow-up|0|||
130851213|NCT02616393|471084235|FG001|Overall Study|Lost to Follow-up|2|||
130851214|NCT02616393|471084236|FG002|Overall Study|Lost to Follow-up|0|||
130851215|NCT00582738|471084238|FG000|Overall Study|Administrative Problems|7|||
130851216|NCT00582738|471084239|FG001|Overall Study|Administrative Problems|8|||
130851217|NCT00582738|471084238|FG000|Overall Study|Adverse Event|0|||
130851218|NCT00582738|471084239|FG001|Overall Study|Adverse Event|5|||
130851219|NCT00582738|471084238|FG000|Overall Study|Graft Lost|0|||
130851220|NCT00582738|471084239|FG001|Overall Study|Graft Lost|1|||
130851221|NCT00582738|471084238|FG000|Overall Study|Other|1|||
130851222|NCT00582738|471084239|FG001|Overall Study|Other|0|||
130851223|NCT00582738|471084238|FG000|Overall Study|Protocol Violation|1|||
130851224|NCT00582738|471084239|FG001|Overall Study|Protocol Violation|1|||
130851225|NCT00582738|471084238|FG000|Overall Study|Withdrawal by Subject|0|||
130851226|NCT00582738|471084239|FG001|Overall Study|Withdrawal by Subject|3|||
130851227|NCT02758301|471084240|FG000|Overall Study|Death|12|||
130851228|NCT02758301|471084241|FG001|Overall Study|Death|0|||
130851229|NCT02758301|471084240|FG000|Overall Study|Physician Decision|10|||
130851230|NCT02758301|471084241|FG001|Overall Study|Physician Decision|1|||
130851231|NCT02758301|471084240|FG000|Overall Study|Withdrawal by Subject|5|||
130851232|NCT02758301|471084241|FG001|Overall Study|Withdrawal by Subject|6|||
130851233|NCT02758301|471084240|FG000|Overall Study|Lost to Follow-up|7|||
130851234|NCT02758301|471084241|FG001|Overall Study|Lost to Follow-up|0|||
130851235|NCT02758301|471084240|FG000|Overall Study|Protocol Violation|0|||
130851236|NCT02758301|471084241|FG001|Overall Study|Protocol Violation|1|||
130851237|NCT00364533|471084242|FG000|Overall Study|Adverse Event|8|||
130851238|NCT00364533|471084243|FG001|Overall Study|Adverse Event|7|||
130851239|NCT00364533|471084244|FG002|Overall Study|Adverse Event|15|||
130851240|NCT00364533|471084245|FG003|Overall Study|Adverse Event|5|||
130851241|NCT00364533|471084246|FG004|Overall Study|Adverse Event|2|||
130851242|NCT00364533|471084242|FG000|Overall Study|Withdrawal by Subject|4|||
130851243|NCT00364533|471084243|FG001|Overall Study|Withdrawal by Subject|8|||
130851244|NCT00364533|471084244|FG002|Overall Study|Withdrawal by Subject|6|||
130851245|NCT00364533|471084245|FG003|Overall Study|Withdrawal by Subject|6|||
130851246|NCT00364533|471084246|FG004|Overall Study|Withdrawal by Subject|6|||
130851247|NCT00364533|471084242|FG000|Overall Study|Lack of Efficacy|22|||
130851248|NCT00364533|471084243|FG001|Overall Study|Lack of Efficacy|22|||
130851249|NCT00364533|471084244|FG002|Overall Study|Lack of Efficacy|21|||
130851250|NCT00364533|471084245|FG003|Overall Study|Lack of Efficacy|17|||
130851251|NCT00364533|471084246|FG004|Overall Study|Lack of Efficacy|42|||
130851252|NCT00364533|471084242|FG000|Overall Study|Subject discharged from hospital|4|||
130851253|NCT00364533|471084243|FG001|Overall Study|Subject discharged from hospital|1|||
130851254|NCT00364533|471084244|FG002|Overall Study|Subject discharged from hospital|2|||
130851255|NCT00364533|471084245|FG003|Overall Study|Subject discharged from hospital|3|||
130851256|NCT00364533|471084246|FG004|Overall Study|Subject discharged from hospital|1|||
130851257|NCT00364533|471084242|FG000|Overall Study|Variations in drug compliance|2|||
130851258|NCT00364533|471084243|FG001|Overall Study|Variations in drug compliance|1|||
130851259|NCT00364533|471084244|FG002|Overall Study|Variations in drug compliance|1|||
130851260|NCT00364533|471084245|FG003|Overall Study|Variations in drug compliance|0|||
130851261|NCT00364533|471084246|FG004|Overall Study|Variations in drug compliance|0|||
130851262|NCT00364533|471084242|FG000|Overall Study|Non-compliance|1|||
130851263|NCT00364533|471084243|FG001|Overall Study|Non-compliance|0|||
130851264|NCT00364533|471084244|FG002|Overall Study|Non-compliance|0|||
130851265|NCT00364533|471084245|FG003|Overall Study|Non-compliance|0|||
130851266|NCT00364533|471084246|FG004|Overall Study|Non-compliance|0|||
130851267|NCT00364533|471084242|FG000|Overall Study|Protocol Violation|1|||
130851268|NCT00364533|471084243|FG001|Overall Study|Protocol Violation|1|||
130851269|NCT00364533|471084244|FG002|Overall Study|Protocol Violation|0|||
130851270|NCT00364533|471084245|FG003|Overall Study|Protocol Violation|0|||
130851271|NCT00364533|471084246|FG004|Overall Study|Protocol Violation|0|||
130851272|NCT00652899|471084247|FG000|Overall Study|Death|1|||
130851273|NCT00652899|471084247|FG000|Overall Study|Treating physician decision|1|||
130851274|NCT04135859|471084249|FG000|Overall Study|Withdrawal by Subject|1|||
130851275|NCT04135859|471084250|FG001|Overall Study|Withdrawal by Subject|0|||
130851276|NCT04135859|471084249|FG000|Overall Study|Withdrawal due to screening failure|1|||
130851277|NCT04135859|471084250|FG001|Overall Study|Withdrawal due to screening failure|2|||
130851278|NCT04135859|471084249|FG000|Overall Study|Did not complete stress test|3|||
130851279|NCT04135859|471084250|FG001|Overall Study|Did not complete stress test|3|||
130851280|NCT04135859|471084249|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
130851281|NCT04135859|471084250|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
130851282|NCT00551291|471084251|FG000|Overall Study|Physician Decision|1|||
130851283|NCT01943552|471084252|FG000|Overall Study|Adverse Event|3|||
130851284|NCT01943552|471084253|FG001|Overall Study|Adverse Event|2|||
130851285|NCT01943552|471084252|FG000|Overall Study|Withdrawal by Subject|6|||
130851286|NCT01943552|471084253|FG001|Overall Study|Withdrawal by Subject|6|||
130851287|NCT01943552|471084252|FG000|Overall Study|Other Reasons|16|||
130851288|NCT01943552|471084253|FG001|Overall Study|Other Reasons|17|||
130851289|NCT01600053|471084254|FG000|Overall Study|Adverse Event|2|||
130851290|NCT01600053|471084254|FG000|Overall Study|trial will not meet the interim endpoint|9|||
130851291|NCT04047420|471084255|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
130851292|NCT04047420|471084255|FG000|Washout Period|Refused Participation|2|||
130851293|NCT00477269|471084257|FG000|Core Study|Adverse Event|6|||
130851294|NCT00477269|471084258|FG001|Core Study|Adverse Event|4|||
130851295|NCT00477269|471084259|FG002|Core Study|Adverse Event|0|||
130851296|NCT00477269|471084257|FG000|Core Study|Death|3|||
130851297|NCT00477269|471084258|FG001|Core Study|Death|3|||
130851298|NCT00477269|471084259|FG002|Core Study|Death|0|||
130851299|NCT00477269|471084257|FG000|Core Study|Withdrawn Consent|0|||
130851300|NCT00477269|471084258|FG001|Core Study|Withdrawn Consent|1|||
130851301|NCT00477269|471084259|FG002|Core Study|Withdrawn Consent|0|||
130851302|NCT00477269|471084257|FG000|Open Label Extension|Adverse Event|0|||
130851303|NCT00477269|471084258|FG001|Open Label Extension|Adverse Event|0|||
130851304|NCT00477269|471084259|FG002|Open Label Extension|Adverse Event|4|||
130851305|NCT00477269|471084257|FG000|Open Label Extension|Abnormal laboratory values|0|||
130851306|NCT00477269|471084258|FG001|Open Label Extension|Abnormal laboratory values|0|||
130851307|NCT00477269|471084259|FG002|Open Label Extension|Abnormal laboratory values|1|||
130851308|NCT00477269|471084257|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
130851309|NCT00477269|471084258|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
130851310|NCT00477269|471084259|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
130851311|NCT00477269|471084257|FG000|Open Label Extension|Adminiatrative problems|0|||
130851312|NCT00477269|471084258|FG001|Open Label Extension|Adminiatrative problems|0|||
130851313|NCT00477269|471084259|FG002|Open Label Extension|Adminiatrative problems|2|||
130851314|NCT00477269|471084257|FG000|Open Label Extension|Death|0|||
130851315|NCT00477269|471084258|FG001|Open Label Extension|Death|0|||
130851316|NCT00477269|471084259|FG002|Open Label Extension|Death|4|||
130851317|NCT01792518|471084260|FG000|Overall Study|Adverse Event|3|||
130851318|NCT01792518|471084261|FG001|Overall Study|Adverse Event|4|||
130851319|NCT01792518|471084260|FG000|Overall Study|Protocol Violation|0|||
130851320|NCT01792518|471084261|FG001|Overall Study|Protocol Violation|1|||
130851321|NCT01792518|471084260|FG000|Overall Study|Lost to Follow-up|3|||
130851322|NCT01792518|471084261|FG001|Overall Study|Lost to Follow-up|1|||
130851323|NCT01792518|471084260|FG000|Overall Study|Withdrawal by Subject|2|||
130851324|NCT01792518|471084261|FG001|Overall Study|Withdrawal by Subject|0|||
130851325|NCT01792518|471084260|FG000|Overall Study|Other Reason|0|||
130851326|NCT01792518|471084261|FG001|Overall Study|Other Reason|1|||
130851327|NCT02449018|471084262|FG000|Overall Study|Abnormal laboratory value|0|||
130851328|NCT02449018|471084263|FG001|Overall Study|Abnormal laboratory value|1|||
130851329|NCT02449018|471084262|FG000|Overall Study|Administrative problems|1|||
130851330|NCT02449018|471084263|FG001|Overall Study|Administrative problems|0|||
130851331|NCT02449018|471084262|FG000|Overall Study|Adverse Event|5|||
130851332|NCT02449018|471084263|FG001|Overall Study|Adverse Event|1|||
130851333|NCT02449018|471084262|FG000|Overall Study|Protocol deviation|4|||
130851334|NCT02449018|471084263|FG001|Overall Study|Protocol deviation|0|||
130851335|NCT02449018|471084262|FG000|Overall Study|Patient decision|2|||
130851336|NCT02449018|471084263|FG001|Overall Study|Patient decision|0|||
130851337|NCT03995355|471084264|FG000|Overall Study|Adverse Event|1|||
130851338|NCT03995355|471084265|FG001|Overall Study|Adverse Event|0|||
130851339|NCT03995355|471084264|FG000|Overall Study|Withdrawal by Subject|1|||
130851340|NCT03995355|471084265|FG001|Overall Study|Withdrawal by Subject|0|||
130851341|NCT03995355|471084264|FG000|Overall Study|Scheduling Issues|0|||
130851342|NCT03995355|471084265|FG001|Overall Study|Scheduling Issues|1|||
130851343|NCT03426631|471084266|FG000|Overall Study|Lost to Follow-up|0|||
130851344|NCT03426631|471084267|FG001|Overall Study|Lost to Follow-up|1|||
130851345|NCT00267150|471084274|FG000|Overall Study|Adverse Event|1|||
130851346|NCT03134183|471084275|FG000|Overall Study|Withdrawal by Subject|1|||
130851347|NCT03134183|471084276|FG001|Overall Study|Withdrawal by Subject|1|||
130851348|NCT01969721|471084277|FG000|Overall Study|Adverse Event|3|||
130851349|NCT01969721|471084278|FG001|Overall Study|Adverse Event|8|||
130851350|NCT01969721|471084279|FG002|Overall Study|Adverse Event|3|||
130851351|NCT01969721|471084280|FG003|Overall Study|Adverse Event|2|||
130851352|NCT01969721|471084277|FG000|Overall Study|Lack of Efficacy|0|||
130851353|NCT01969721|471084278|FG001|Overall Study|Lack of Efficacy|0|||
130851354|NCT01969721|471084279|FG002|Overall Study|Lack of Efficacy|1|||
130851355|NCT01969721|471084280|FG003|Overall Study|Lack of Efficacy|0|||
130851356|NCT01969721|471084277|FG000|Overall Study|Non compliant with protocol|1|||
130851357|NCT01969721|471084278|FG001|Overall Study|Non compliant with protocol|1|||
130851358|NCT01969721|471084279|FG002|Overall Study|Non compliant with protocol|0|||
130851359|NCT01969721|471084280|FG003|Overall Study|Non compliant with protocol|2|||
130851360|NCT01969721|471084277|FG000|Overall Study|Other not defined above|0|||
130851361|NCT01969721|471084278|FG001|Overall Study|Other not defined above|2|||
130851362|NCT01969721|471084279|FG002|Overall Study|Other not defined above|0|||
130851363|NCT01969721|471084280|FG003|Overall Study|Other not defined above|0|||
130851364|NCT01969721|471084277|FG000|Overall Study|Discontinued during washout periods.|0|||
130851365|NCT01969721|471084278|FG001|Overall Study|Discontinued during washout periods.|1|||
130851366|NCT01969721|471084279|FG002|Overall Study|Discontinued during washout periods.|1|||
130851367|NCT01969721|471084280|FG003|Overall Study|Discontinued during washout periods.|2|||
130851368|NCT02117349|471084281|FG000|Overall Study|Withdrawal by Subject|1|||
130851369|NCT02117349|471084282|FG001|Overall Study|Withdrawal by Subject|0|||
130851370|NCT02117349|471084281|FG000|Overall Study|Lost to Follow-up|1|||
130851371|NCT02117349|471084282|FG001|Overall Study|Lost to Follow-up|1|||
130851372|NCT02117349|471084281|FG000|Overall Study|Death|1|||
130851373|NCT02117349|471084282|FG001|Overall Study|Death|0|||
130851374|NCT00495755|471084283|FG000|Overall Study|Adverse Event|3|||
130851375|NCT01012323|471084284|FG000|Overall Study|Investigator Judgment|1|||
130851376|NCT02265796|471084285|FG000|Overall Study|Death|1|||
130851377|NCT02265796|471084286|FG001|Overall Study|Death|0|||
130851378|NCT02265796|471084285|FG000|Overall Study|started on excluded medication|1|||
130851379|NCT02265796|471084286|FG001|Overall Study|started on excluded medication|0|||
130851380|NCT02265796|471084285|FG000|Overall Study|Withdrawal by Subject|1|||
130851381|NCT02265796|471084286|FG001|Overall Study|Withdrawal by Subject|1|||
130851382|NCT00447122|471084288|FG000|Overall Study|worsening medical condition -came off|0|||
130851383|NCT00447122|471084289|FG001|Overall Study|worsening medical condition -came off|1|||
130851384|NCT00447122|471084290|FG002|Overall Study|worsening medical condition -came off|0|||
130851385|NCT00447122|471084291|FG003|Overall Study|worsening medical condition -came off|0|||
130851386|NCT01174173|471084294|FG000|Overall Study|drug-drug interaction|1|||
130851387|NCT00720343|471085436|FG000|Overall Study|Lost to Follow-up|1|||
130851388|NCT00720343|471085437|FG001|Overall Study|Lost to Follow-up|0|||
130851389|NCT00720343|471085436|FG000|Overall Study|Protocol Violation|0|||
130851390|NCT00720343|471085437|FG001|Overall Study|Protocol Violation|2|||
130851391|NCT02008773|471085438|FG000|Overall Study|Adverse Event|3|||
130851392|NCT02008773|471085439|FG001|Overall Study|Adverse Event|3|||
130851393|NCT02008773|471085440|FG002|Overall Study|Adverse Event|1|||
130851394|NCT02008773|471085441|FG003|Overall Study|Adverse Event|2|||
130851395|NCT02008773|471085438|FG000|Overall Study|Medication Non-compliance|2|||
130851396|NCT02008773|471085439|FG001|Overall Study|Medication Non-compliance|1|||
130851397|NCT02008773|471085440|FG002|Overall Study|Medication Non-compliance|3|||
130851398|NCT02008773|471085441|FG003|Overall Study|Medication Non-compliance|2|||
130851399|NCT02008773|471085438|FG000|Overall Study|Withdrawal by Subject|8|||
130851400|NCT02008773|471085439|FG001|Overall Study|Withdrawal by Subject|4|||
130851401|NCT02008773|471085440|FG002|Overall Study|Withdrawal by Subject|7|||
130851402|NCT02008773|471085441|FG003|Overall Study|Withdrawal by Subject|6|||
130851403|NCT02008773|471085438|FG000|Overall Study|Lost to Follow-up|0|||
130851404|NCT02008773|471085439|FG001|Overall Study|Lost to Follow-up|1|||
130851405|NCT02008773|471085440|FG002|Overall Study|Lost to Follow-up|3|||
130851406|NCT02008773|471085441|FG003|Overall Study|Lost to Follow-up|2|||
130851407|NCT02198794|471085442|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
130851408|NCT02198794|471085443|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
130851409|NCT02198794|471085444|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
130851410|NCT02198794|471085445|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
130851411|NCT02198794|471085442|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
130851412|NCT02198794|471085443|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
130851413|NCT02198794|471085444|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
130851414|NCT02198794|471085445|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
130851415|NCT02198794|471085442|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
130851416|NCT02198794|471085443|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
130851417|NCT02198794|471085444|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
130851418|NCT02198794|471085445|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
130851419|NCT02198794|471085442|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
130851420|NCT02198794|471085443|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
130851421|NCT02198794|471085444|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
130851422|NCT02198794|471085445|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
130851423|NCT02198794|471085442|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
130851424|NCT02198794|471085443|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
130851425|NCT02198794|471085444|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
130851426|NCT02198794|471085445|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
130851427|NCT02198794|471085442|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
130851428|NCT02198794|471085443|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
130851429|NCT02198794|471085444|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
130851430|NCT02198794|471085445|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
130851431|NCT02198794|471085442|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
130851432|NCT02198794|471085443|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
130851433|NCT02198794|471085444|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
130851434|NCT02198794|471085445|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
130851435|NCT02198794|471085442|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
130851436|NCT02198794|471085443|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
130851437|NCT02198794|471085444|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
130851438|NCT02198794|471085445|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
130851439|NCT02198794|471085442|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
130851440|NCT02198794|471085443|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
130851441|NCT02198794|471085444|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
130851442|NCT02198794|471085445|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
130875569|NCT00301808|471173839|FG000|Overall Study|Lack of Efficacy|4|||
130851443|NCT02198794|471085442|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
130851444|NCT02198794|471085443|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
130851445|NCT02198794|471085444|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
130851446|NCT02198794|471085445|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
130851447|NCT02198794|471085442|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
130851448|NCT02198794|471085443|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
130851449|NCT02198794|471085444|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
130851450|NCT02198794|471085445|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
130851451|NCT02198794|471085442|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
130851452|NCT02198794|471085443|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
130851453|NCT02198794|471085444|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
130851454|NCT02198794|471085445|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
130851455|NCT02198794|471085442|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
130851456|NCT02198794|471085443|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
130851457|NCT02198794|471085444|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
130851458|NCT02198794|471085445|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
130851459|NCT02198794|471085442|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
130851460|NCT02198794|471085443|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
130851461|NCT02198794|471085444|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
130851462|NCT02198794|471085445|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
130851463|NCT02198794|471085442|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
130851464|NCT02198794|471085443|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
130851465|NCT02198794|471085444|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
130851466|NCT02198794|471085445|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
130851467|NCT01918332|471085446|FG000|Overall Study|Adverse Event|0|||
130851468|NCT01918332|471085447|FG001|Overall Study|Adverse Event|0|||
130851469|NCT01918332|471085448|FG002|Overall Study|Adverse Event|0|||
130851470|NCT01918332|471085449|FG003|Overall Study|Adverse Event|1|||
130851471|NCT01918332|471085446|FG000|Overall Study|Withdrawal by Subject|2|||
130851472|NCT01918332|471085447|FG001|Overall Study|Withdrawal by Subject|3|||
130851473|NCT01918332|471085448|FG002|Overall Study|Withdrawal by Subject|2|||
130851474|NCT01918332|471085449|FG003|Overall Study|Withdrawal by Subject|3|||
130851475|NCT01918332|471085446|FG000|Overall Study|Protocol Violation|6|||
130851476|NCT01918332|471085447|FG001|Overall Study|Protocol Violation|2|||
130851477|NCT01918332|471085448|FG002|Overall Study|Protocol Violation|6|||
130851478|NCT01918332|471085449|FG003|Overall Study|Protocol Violation|3|||
130851479|NCT01918332|471085446|FG000|Overall Study|lipid result by central lab did not meet|0|||
130851480|NCT01918332|471085447|FG001|Overall Study|lipid result by central lab did not meet|0|||
130851481|NCT01918332|471085448|FG002|Overall Study|lipid result by central lab did not meet|1|||
130851482|NCT01918332|471085449|FG003|Overall Study|lipid result by central lab did not meet|0|||
130851483|NCT02408523|471085450|FG000|Overall Study|Adverse Event|4|||
130851484|NCT02408523|471085451|FG001|Overall Study|Adverse Event|10|||
130851485|NCT02408523|471085450|FG000|Overall Study|Lack of Efficacy|0|||
130851486|NCT02408523|471085451|FG001|Overall Study|Lack of Efficacy|1|||
130851487|NCT02408523|471085450|FG000|Overall Study|Protocol Violation|1|||
130851488|NCT02408523|471085451|FG001|Overall Study|Protocol Violation|2|||
130851489|NCT02408523|471085450|FG000|Overall Study|Lost to Follow-up|2|||
130851490|NCT02408523|471085451|FG001|Overall Study|Lost to Follow-up|3|||
130851491|NCT02408523|471085450|FG000|Overall Study|Withdrawal by Subject|3|||
130851492|NCT02408523|471085451|FG001|Overall Study|Withdrawal by Subject|1|||
130851493|NCT02408523|471085450|FG000|Overall Study|Sponsor request|1|||
130851494|NCT02408523|471085451|FG001|Overall Study|Sponsor request|0|||
130851495|NCT02408523|471085450|FG000|Overall Study|Did not satisfy extension conditions|0|||
130851496|NCT02408523|471085451|FG001|Overall Study|Did not satisfy extension conditions|1|||
130851497|NCT00701805|471085452|FG000|Overall Study|Withdrawal by Subject|3|||
130851498|NCT00701805|471085453|FG001|Overall Study|Withdrawal by Subject|1|||
130851499|NCT00701805|471085454|FG002|Overall Study|Withdrawal by Subject|4|||
130851500|NCT00701805|471085455|FG003|Overall Study|Withdrawal by Subject|3|||
130851501|NCT00701805|471085452|FG000|Overall Study|Adverse Event|0|||
130851502|NCT00701805|471085453|FG001|Overall Study|Adverse Event|1|||
130851503|NCT00701805|471085454|FG002|Overall Study|Adverse Event|1|||
130851504|NCT00701805|471085455|FG003|Overall Study|Adverse Event|0|||
130851505|NCT00701805|471085452|FG000|Overall Study|Missed 7 consecutive doses|0|||
130851506|NCT00701805|471085453|FG001|Overall Study|Missed 7 consecutive doses|1|||
130851507|NCT00701805|471085454|FG002|Overall Study|Missed 7 consecutive doses|0|||
130851508|NCT00701805|471085455|FG003|Overall Study|Missed 7 consecutive doses|0|||
130851509|NCT00701805|471085452|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
130851510|NCT00701805|471085453|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
130851511|NCT00701805|471085454|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
130851512|NCT00701805|471085455|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
130851513|NCT00701805|471085452|FG000|Overall Study|Physician decision, change of therapy|0|||
130851514|NCT00701805|471085453|FG001|Overall Study|Physician decision, change of therapy|0|||
130851515|NCT00701805|471085454|FG002|Overall Study|Physician decision, change of therapy|0|||
130851516|NCT00701805|471085455|FG003|Overall Study|Physician decision, change of therapy|1|||
130851517|NCT00701805|471085452|FG000|Overall Study|Difficult to travel to dialysis site|0|||
130851518|NCT00701805|471085453|FG001|Overall Study|Difficult to travel to dialysis site|0|||
130851519|NCT00701805|471085454|FG002|Overall Study|Difficult to travel to dialysis site|1|||
130851520|NCT00701805|471085455|FG003|Overall Study|Difficult to travel to dialysis site|0|||
130851521|NCT00701805|471085452|FG000|Overall Study|Resumption criteria were not met|0|||
130851522|NCT00701805|471085453|FG001|Overall Study|Resumption criteria were not met|1|||
130851523|NCT00701805|471085454|FG002|Overall Study|Resumption criteria were not met|0|||
130851524|NCT00701805|471085455|FG003|Overall Study|Resumption criteria were not met|0|||
130851525|NCT02252965|471085459|FG000|Overall Study|Adverse Event|9|||
130851526|NCT02252965|471085460|FG001|Overall Study|Adverse Event|14|||
130851527|NCT02252965|471085459|FG000|Overall Study|Lost to Follow-up|16|||
130851528|NCT02252965|471085460|FG001|Overall Study|Lost to Follow-up|8|||
130851529|NCT02252965|471085459|FG000|Overall Study|Protocol Violation|4|||
130851530|NCT02252965|471085460|FG001|Overall Study|Protocol Violation|5|||
130851531|NCT02252965|471085459|FG000|Overall Study|Lack of Efficacy|0|||
130851532|NCT02252965|471085460|FG001|Overall Study|Lack of Efficacy|2|||
130851533|NCT02252965|471085459|FG000|Overall Study|Withdrawal by Subject|7|||
130851534|NCT02252965|471085460|FG001|Overall Study|Withdrawal by Subject|9|||
130851535|NCT02252965|471085459|FG000|Overall Study|Other|4|||
130851536|NCT02252965|471085460|FG001|Overall Study|Other|5|||
130851537|NCT04256512|471085461|FG000|Overall Study|Withdrawal by Subject|1|||
130851538|NCT04435600|471085469|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130851539|NCT04435600|471085470|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130851540|NCT04435600|471085471|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
130851541|NCT04435600|471085472|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130851542|NCT04435600|471085473|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130851543|NCT04435600|471085474|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130851544|NCT04435600|471085475|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130851545|NCT04435600|471085476|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130851546|NCT04435600|471085477|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130851547|NCT04435600|471085478|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130851548|NCT04435600|471085469|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130851549|NCT04435600|471085470|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130851550|NCT04435600|471085471|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130851551|NCT04435600|471085472|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130851552|NCT04435600|471085473|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130851553|NCT04435600|471085474|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130851554|NCT04435600|471085475|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130851555|NCT04435600|471085476|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130851556|NCT04435600|471085477|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130851557|NCT04435600|471085478|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
130851558|NCT04435600|471085469|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130851559|NCT04435600|471085470|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130851560|NCT04435600|471085471|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130851561|NCT04435600|471085472|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130851562|NCT04435600|471085473|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130851563|NCT04435600|471085474|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130851564|NCT04435600|471085475|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130851565|NCT04435600|471085476|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130851566|NCT04435600|471085477|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130851567|NCT04435600|471085478|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
130851568|NCT04435600|471085469|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
130851569|NCT04435600|471085470|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
130851570|NCT04435600|471085471|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
130851571|NCT04435600|471085472|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
130851572|NCT04435600|471085473|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
130851573|NCT04435600|471085474|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
130851574|NCT04435600|471085475|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
130851575|NCT04435600|471085476|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
130851576|NCT04435600|471085477|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
130851577|NCT04435600|471085478|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
130851578|NCT02797184|471085480|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
130851579|NCT02797184|471085481|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
130851580|NCT02212678|471085482|FG000|Overall Study|Adverse Event|1|||
130851581|NCT02337634|471085483|FG000|Overall Study|Protocol Violation|3|||
130851582|NCT02337634|471085484|FG001|Overall Study|Protocol Violation|1|||
130851583|NCT02337634|471085483|FG000|Overall Study|Lost to Follow-up|1|||
130851584|NCT02337634|471085484|FG001|Overall Study|Lost to Follow-up|0|||
130851585|NCT04068610|471085485|FG000|Overall Study|Death|4|||
130851586|NCT04068610|471085486|FG001|Overall Study|Death|8|||
130851587|NCT04068610|471085487|FG002|Overall Study|Death|13|||
130851588|NCT04068610|471085485|FG000|Overall Study|Lost to Follow-up|0|||
130851589|NCT04068610|471085486|FG001|Overall Study|Lost to Follow-up|2|||
130851590|NCT04068610|471085487|FG002|Overall Study|Lost to Follow-up|0|||
130851591|NCT04068610|471085485|FG000|Overall Study|Withdrawal by Subject|0|||
130851592|NCT04068610|471085486|FG001|Overall Study|Withdrawal by Subject|4|||
130851593|NCT04068610|471085487|FG002|Overall Study|Withdrawal by Subject|2|||
130851594|NCT04068610|471085485|FG000|Overall Study|Other|3|||
130851595|NCT04068610|471085486|FG001|Overall Study|Other|12|||
130851596|NCT04068610|471085487|FG002|Overall Study|Other|11|||
130851597|NCT02428205|471085488|FG000|Overall Study|Lack of Efficacy|1|||
130851598|NCT02428205|471085489|FG001|Overall Study|Lack of Efficacy|0|||
130851599|NCT02428205|471085488|FG000|Overall Study|Lost to Follow-up|1|||
130851600|NCT02428205|471085489|FG001|Overall Study|Lost to Follow-up|1|||
130851601|NCT02428205|471085488|FG000|Overall Study|Worse behavior|0|||
130851602|NCT02428205|471085489|FG001|Overall Study|Worse behavior|1|||
130851603|NCT00527319|471085490|FG000|Overall Study|Withdrawal by Subject|5|||
130851604|NCT00527319|471085491|FG001|Overall Study|Withdrawal by Subject|0|||
130851605|NCT00527319|471085492|FG002|Overall Study|Withdrawal by Subject|1|||
130851606|NCT00527319|471085490|FG000|Overall Study|Lost to Follow-up|1|||
130851607|NCT00527319|471085491|FG001|Overall Study|Lost to Follow-up|0|||
130851608|NCT00527319|471085492|FG002|Overall Study|Lost to Follow-up|0|||
130851609|NCT00527319|471085490|FG000|Overall Study|Death|0|||
130851610|NCT00527319|471085491|FG001|Overall Study|Death|3|||
130851611|NCT00527319|471085492|FG002|Overall Study|Death|1|||
130851612|NCT00527319|471085490|FG000|Overall Study|Intercurrent Medical Illness|0|||
130851613|NCT00527319|471085491|FG001|Overall Study|Intercurrent Medical Illness|1|||
130851614|NCT00527319|471085492|FG002|Overall Study|Intercurrent Medical Illness|3|||
130851615|NCT00527319|471085490|FG000|Overall Study|Adverse Event|0|||
130851616|NCT00527319|471085491|FG001|Overall Study|Adverse Event|0|||
130851617|NCT00527319|471085492|FG002|Overall Study|Adverse Event|1|||
130851618|NCT03344172|471085495|FG000|Overall Study|Received <1 dose of treatment|1|||
130851619|NCT03344172|471085496|FG001|Overall Study|Received <1 dose of treatment|0|||
130851620|NCT00680368|471085499|FG000|Overall Study|not supervised, not eligible|15|||
130851621|NCT00430937|471085500|FG000|Overall Study|Adverse Event|3|||
130851622|NCT00430937|471085501|FG001|Overall Study|Adverse Event|8|||
130851623|NCT00430937|471085500|FG000|Overall Study|Death|0|||
130851624|NCT00430937|471085501|FG001|Overall Study|Death|1|||
130851625|NCT00430937|471085500|FG000|Overall Study|Lost to Follow-up|6|||
130851626|NCT00430937|471085501|FG001|Overall Study|Lost to Follow-up|6|||
130851627|NCT00430937|471085500|FG000|Overall Study|Withdrawal by Subject|5|||
130851628|NCT00430937|471085501|FG001|Overall Study|Withdrawal by Subject|2|||
130851629|NCT00430937|471085500|FG000|Overall Study|Protocol Violation|3|||
130851630|NCT00430937|471085501|FG001|Overall Study|Protocol Violation|2|||
130851631|NCT00430937|471085500|FG000|Overall Study|Lack of Efficacy|6|||
130851632|NCT00430937|471085501|FG001|Overall Study|Lack of Efficacy|5|||
130851633|NCT00430937|471085500|FG000|Overall Study|Inappropriate enrollment|2|||
130851634|NCT00430937|471085501|FG001|Overall Study|Inappropriate enrollment|1|||
130851635|NCT00430937|471085500|FG000|Overall Study|Administrative reasons|1|||
130851636|NCT00430937|471085501|FG001|Overall Study|Administrative reasons|0|||
130851637|NCT00430937|471085500|FG000|Overall Study|Protocol discontinuation criteria met|1|||
130851638|NCT00430937|471085501|FG001|Overall Study|Protocol discontinuation criteria met|2|||
130851639|NCT00430937|471085500|FG000|Overall Study|Unable to classify|0|||
130851640|NCT00430937|471085501|FG001|Overall Study|Unable to classify|1|||
130851641|NCT02392403|471085502|FG000|Overall Study|Adverse Event|1|||
130851642|NCT02392403|471085502|FG000|Overall Study|Death|1|||
130851643|NCT02392403|471085502|FG000|Overall Study|Withdrawal by Subject|1|||
130851644|NCT00657371|471085506|FG000|Overall Study|Poor bowel preparation|15|||
130851645|NCT00657371|471085506|FG000|Overall Study|Unable to intubate the cecum|5|||
130851646|NCT00657371|471085506|FG000|Overall Study|Protocol Violation|2|||
130851647|NCT00657371|471085506|FG000|Overall Study|Device- related reasons|13|||
130851648|NCT00657371|471085506|FG000|Overall Study|Pre-existing medical condition|4|||
130851649|NCT02445573|471085507|FG000|Overall Study|Withdrawal by Subject|1|||
130851650|NCT02445573|471085508|FG001|Overall Study|Withdrawal by Subject|1|||
130851651|NCT02445573|471085507|FG000|Overall Study|Lost to Follow-up|0|||
130851652|NCT02445573|471085508|FG001|Overall Study|Lost to Follow-up|1|||
130851653|NCT02855944|471085509|FG000|Period 1: Treatment|Ongoing|14|||
130851654|NCT02855944|471085510|FG001|Period 1: Treatment|Ongoing|0|||
130851655|NCT02855944|471085509|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
130851656|NCT02855944|471085510|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
130851657|NCT02855944|471085509|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
130851658|NCT02855944|471085510|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
130851659|NCT03242018|471085519|FG000|Overall Study|Adverse Event|7|||
130851660|NCT03242018|471085520|FG001|Overall Study|Adverse Event|7|||
130851661|NCT03242018|471085521|FG002|Overall Study|Adverse Event|6|||
130851662|NCT03242018|471085519|FG000|Overall Study|Lost to Follow-up|2|||
130851663|NCT03242018|471085520|FG001|Overall Study|Lost to Follow-up|2|||
130851664|NCT03242018|471085521|FG002|Overall Study|Lost to Follow-up|2|||
130851665|NCT03242018|471085519|FG000|Overall Study|At the Participant's Own Request|5|||
130851666|NCT03242018|471085520|FG001|Overall Study|At the Participant's Own Request|1|||
130851667|NCT03242018|471085521|FG002|Overall Study|At the Participant's Own Request|4|||
130851668|NCT03242018|471085519|FG000|Overall Study|Reason Not Specified|3|||
130851669|NCT03242018|471085520|FG001|Overall Study|Reason Not Specified|4|||
130851670|NCT03242018|471085521|FG002|Overall Study|Reason Not Specified|1|||
130851671|NCT03242018|471085519|FG000|Overall Study|Study Terminated by Sponsor|1|||
130851672|NCT03242018|471085520|FG001|Overall Study|Study Terminated by Sponsor|0|||
130851673|NCT03242018|471085521|FG002|Overall Study|Study Terminated by Sponsor|1|||
130851674|NCT01283542|471085523|FG000|Main Phase|Acute or progressive vision loss|1|||
130851675|NCT01283542|471085523|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
130851676|NCT01283542|471085523|FG000|Main Phase|abnormal laboratory values|5|||
130851677|NCT01283542|471085523|FG000|Extension Phase|Physician Decision|1|||
130851678|NCT01283542|471085523|FG000|Extension Phase|Adverse Event|1|||
130851679|NCT01283542|471085523|FG000|Extension Phase|Administrative problems|1|||
130851680|NCT00903331|471085524|FG000|Overall Study|Death|4|||
130851681|NCT00903331|471085525|FG001|Overall Study|Death|8|||
130851682|NCT00903331|471085524|FG000|Overall Study|Withdrawal of consent|1|||
130851683|NCT00903331|471085525|FG001|Overall Study|Withdrawal of consent|8|||
130851684|NCT00903331|471085524|FG000|Overall Study|Lung transplant|0|||
130851685|NCT00903331|471085525|FG001|Overall Study|Lung transplant|2|||
130851686|NCT00257660|471085526|FG000|Overall Study|Lack of Efficacy|5|||
130851687|NCT00257660|471085527|FG001|Overall Study|Lack of Efficacy|23|||
130851688|NCT00257660|471085526|FG000|Overall Study|Withdrawal by Subject|2|||
130851689|NCT00257660|471085527|FG001|Overall Study|Withdrawal by Subject|0|||
130851690|NCT00257660|471085526|FG000|Overall Study|Lost to Follow-up|1|||
130851691|NCT00257660|471085527|FG001|Overall Study|Lost to Follow-up|0|||
130851692|NCT00257660|471085526|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
130851693|NCT00257660|471085527|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
130851694|NCT00257660|471085526|FG000|Overall Study|No longer wanted to do blood draws|1|||
130851695|NCT00257660|471085527|FG001|Overall Study|No longer wanted to do blood draws|0|||
130851696|NCT00654004|471085532|FG000|Overall Study|Lost to Follow-up|1|||
130851697|NCT00654004|471085533|FG001|Overall Study|Lost to Follow-up|0|||
130851698|NCT00162266|471085534|FG000|Double-Blind Period|Adverse Event|5|||
130851699|NCT00162266|471085535|FG001|Double-Blind Period|Adverse Event|9|||
130851700|NCT00162266|471085536|FG002|Double-Blind Period|Adverse Event|11|||
130851701|NCT00162266|471085537|FG003|Double-Blind Period|Adverse Event|0|||
130851702|NCT00162266|471085534|FG000|Double-Blind Period|Death|0|||
130851703|NCT00162266|471085535|FG001|Double-Blind Period|Death|1|||
130851704|NCT00162266|471085536|FG002|Double-Blind Period|Death|0|||
130851705|NCT00162266|471085537|FG003|Double-Blind Period|Death|0|||
130851706|NCT00162266|471085534|FG000|Double-Blind Period|Lost to Follow-up|1|||
130851707|NCT00162266|471085535|FG001|Double-Blind Period|Lost to Follow-up|2|||
130851708|NCT00162266|471085536|FG002|Double-Blind Period|Lost to Follow-up|0|||
130851709|NCT00162266|471085537|FG003|Double-Blind Period|Lost to Follow-up|0|||
130851710|NCT00162266|471085534|FG000|Double-Blind Period|Other Reason|1|||
130851711|NCT00162266|471085535|FG001|Double-Blind Period|Other Reason|0|||
130851712|NCT00162266|471085536|FG002|Double-Blind Period|Other Reason|1|||
130851713|NCT00162266|471085537|FG003|Double-Blind Period|Other Reason|0|||
130851714|NCT00162266|471085534|FG000|Double-Blind Period|Lack of Efficacy|13|||
130851715|NCT00162266|471085535|FG001|Double-Blind Period|Lack of Efficacy|17|||
130851716|NCT00162266|471085536|FG002|Double-Blind Period|Lack of Efficacy|30|||
130851717|NCT00162266|471085537|FG003|Double-Blind Period|Lack of Efficacy|0|||
130851718|NCT00162266|471085534|FG000|Double-Blind Period|Withdrawal by Subject|5|||
130851719|NCT00162266|471085535|FG001|Double-Blind Period|Withdrawal by Subject|2|||
130851720|NCT00162266|471085536|FG002|Double-Blind Period|Withdrawal by Subject|6|||
130851721|NCT00162266|471085537|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130851722|NCT00162266|471085534|FG000|Open-Label Period|Death|0|||
130851723|NCT00162266|471085535|FG001|Open-Label Period|Death|0|||
130851724|NCT00162266|471085536|FG002|Open-Label Period|Death|0|||
130851725|NCT00162266|471085537|FG003|Open-Label Period|Death|7|||
130851726|NCT00162266|471085534|FG000|Open-Label Period|Adverse Event|0|||
130851727|NCT00162266|471085535|FG001|Open-Label Period|Adverse Event|0|||
130851728|NCT00162266|471085536|FG002|Open-Label Period|Adverse Event|0|||
130851729|NCT00162266|471085537|FG003|Open-Label Period|Adverse Event|46|||
130851730|NCT00162266|471085534|FG000|Open-Label Period|Lack of Efficacy|0|||
130851731|NCT00162266|471085535|FG001|Open-Label Period|Lack of Efficacy|0|||
130851732|NCT00162266|471085536|FG002|Open-Label Period|Lack of Efficacy|0|||
130851733|NCT00162266|471085537|FG003|Open-Label Period|Lack of Efficacy|26|||
130851734|NCT00162266|471085534|FG000|Open-Label Period|Lost to Follow-up|0|||
130851735|NCT00162266|471085535|FG001|Open-Label Period|Lost to Follow-up|0|||
130851736|NCT00162266|471085536|FG002|Open-Label Period|Lost to Follow-up|0|||
130851737|NCT00162266|471085537|FG003|Open-Label Period|Lost to Follow-up|3|||
130851738|NCT00162266|471085534|FG000|Open-Label Period|Withdrawal by Subject|0|||
130851739|NCT00162266|471085535|FG001|Open-Label Period|Withdrawal by Subject|0|||
130851740|NCT00162266|471085536|FG002|Open-Label Period|Withdrawal by Subject|0|||
130851741|NCT00162266|471085537|FG003|Open-Label Period|Withdrawal by Subject|31|||
130851742|NCT00162266|471085534|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
130851743|NCT00162266|471085535|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
130851744|NCT00162266|471085536|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
130851745|NCT00162266|471085537|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
130851746|NCT00162266|471085534|FG000|Open-Label Period|Other Reasons|0|||
130851747|NCT00162266|471085535|FG001|Open-Label Period|Other Reasons|0|||
130851748|NCT00162266|471085536|FG002|Open-Label Period|Other Reasons|0|||
130851749|NCT00162266|471085537|FG003|Open-Label Period|Other Reasons|15|||
130851750|NCT02299076|471085538|FG000|Overall Study|Fraudulent Entries|20|||
130851751|NCT02299076|471085539|FG001|Overall Study|Fraudulent Entries|14|||
130851752|NCT04208087|471085540|FG000|Overall Study|Adverse Event|1|||
130851753|NCT04208087|471085541|FG001|Overall Study|Adverse Event|0|||
130851754|NCT04208087|471085542|FG002|Overall Study|Adverse Event|0|||
130851755|NCT04208087|471085543|FG003|Overall Study|Adverse Event|0|||
130851756|NCT04208087|471085544|FG004|Overall Study|Adverse Event|0|||
130851757|NCT04208087|471085540|FG000|Overall Study|Withdrawal by Subject|0|||
130851758|NCT04208087|471085541|FG001|Overall Study|Withdrawal by Subject|0|||
130851759|NCT04208087|471085542|FG002|Overall Study|Withdrawal by Subject|1|||
130851760|NCT04208087|471085543|FG003|Overall Study|Withdrawal by Subject|0|||
130851761|NCT04208087|471085544|FG004|Overall Study|Withdrawal by Subject|0|||
130851762|NCT04208087|471085540|FG000|Overall Study|Other|0|||
130851763|NCT04208087|471085541|FG001|Overall Study|Other|0|||
130851764|NCT04208087|471085542|FG002|Overall Study|Other|0|||
130851765|NCT04208087|471085543|FG003|Overall Study|Other|0|||
130851766|NCT04208087|471085544|FG004|Overall Study|Other|1|||
130851767|NCT02477553|471085546|FG000|Overall Study|Screening up-to-date|12|||
130851768|NCT02477553|471085547|FG001|Overall Study|Screening up-to-date|13|||
130851769|NCT02477553|471085546|FG000|Overall Study|No MD visit|1|||
130851770|NCT02477553|471085547|FG001|Overall Study|No MD visit|1|||
130851771|NCT02477553|471085546|FG000|Overall Study|Workup consistent w/CRC|1|||
130851772|NCT02477553|471085547|FG001|Overall Study|Workup consistent w/CRC|1|||
130851773|NCT02477553|471085546|FG000|Overall Study|Technical issues with intervention|2|||
130851774|NCT02477553|471085547|FG001|Overall Study|Technical issues with intervention|0|||
130851775|NCT02477553|471085546|FG000|Overall Study|Elevated risk for CRC|2|||
130851776|NCT02477553|471085547|FG001|Overall Study|Elevated risk for CRC|2|||
130851777|NCT02477553|471085546|FG000|Overall Study|MD advised against screening|1|||
130851778|NCT02477553|471085547|FG001|Overall Study|MD advised against screening|3|||
130851779|NCT02477553|471085546|FG000|Overall Study|patient deceased|1|||
130851780|NCT02477553|471085547|FG001|Overall Study|patient deceased|0|||
130851781|NCT00637572|471085549|FG000|Overall Study|Adverse Event|1|||
130851782|NCT00637572|471085550|FG001|Overall Study|Adverse Event|2|||
130851783|NCT00637572|471085549|FG000|Overall Study|Death|0|||
130851784|NCT00637572|471085550|FG001|Overall Study|Death|1|||
130851785|NCT00637572|471085549|FG000|Overall Study|Lost to Follow-up|0|||
130851786|NCT00637572|471085550|FG001|Overall Study|Lost to Follow-up|1|||
130851787|NCT00637572|471085549|FG000|Overall Study|Physician Decision|1|||
130851788|NCT00637572|471085550|FG001|Overall Study|Physician Decision|1|||
130851789|NCT00637572|471085549|FG000|Overall Study|Withdrawal by Subject|0|||
130851790|NCT00637572|471085550|FG001|Overall Study|Withdrawal by Subject|2|||
130851791|NCT00637572|471085549|FG000|Overall Study|Illicit Drug Use|1|||
130851792|NCT00637572|471085550|FG001|Overall Study|Illicit Drug Use|0|||
130851793|NCT00896649|471085551|FG000|Overall Study|Physician Decision|1|||
130851794|NCT00896649|471085551|FG000|Overall Study|Pregnancy|1|||
130851795|NCT00896649|471085551|FG000|Overall Study|missing documentation|1|||
130851796|NCT00896649|471085551|FG000|Overall Study|technical difficulties|2|||
130851797|NCT00483002|471085556|FG000|Overall Study|Adverse Event|68|||
130851798|NCT00483002|471085556|FG000|Overall Study|Lack of Efficacy|555|||
130851799|NCT00483002|471085556|FG000|Overall Study|Lost to Follow-up|962|||
130851800|NCT00483002|471085556|FG000|Overall Study|Other|2|||
130851801|NCT00483002|471085556|FG000|Overall Study|Other|967|||
130851802|NCT04576897|471085557|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
130851803|NCT02666105|471085558|FG000|Overall Study|Death|1|||
130851804|NCT03938324|471087001|FG000|Overall Study|Lost to Follow-up|42|||
130851805|NCT03938324|471087002|FG001|Overall Study|Lost to Follow-up|21|||
130851806|NCT03938324|471087001|FG000|Overall Study|Withdrawal by Subject|6|||
130851807|NCT03938324|471087002|FG001|Overall Study|Withdrawal by Subject|1|||
130851808|NCT00837759|471087003|FG000|Overall Study|Protocol Violation|3|||
130851809|NCT00837759|471087003|FG000|Overall Study|Lost to Follow-up|1|||
130851810|NCT02100969|471087004|FG000|Overall Study|Did not pass screening phase|1|||
130851811|NCT02081599|471087005|FG000|Period 1：Double-blind Period|Adverse Event|3|||
130851812|NCT02081599|471087006|FG001|Period 1：Double-blind Period|Adverse Event|0|||
130851813|NCT02081599|471087005|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
130851814|NCT02081599|471087006|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
130851815|NCT02081599|471087005|FG000|Period 1：Double-blind Period|Physician Decision|1|||
130851816|NCT02081599|471087006|FG001|Period 1：Double-blind Period|Physician Decision|0|||
130875570|NCT05893862|471173846|FG000|Overall Study|Physician Decision|0|||
130851817|NCT02081599|471087005|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
130851818|NCT02081599|471087006|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
130851819|NCT02081599|471087005|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
130851820|NCT02081599|471087006|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
130851821|NCT02081599|471087005|FG000|Period 1：Double-blind Period|stopping criteria|1|||
130851822|NCT02081599|471087006|FG001|Period 1：Double-blind Period|stopping criteria|0|||
130851823|NCT02081599|471087005|FG000|Period 2：Open-label Period|Adverse Event|1|||
130851824|NCT02081599|471087006|FG001|Period 2：Open-label Period|Adverse Event|0|||
130851825|NCT02081599|471087005|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
130851826|NCT02081599|471087006|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
130851827|NCT02081599|471087005|FG000|Period 2：Open-label Period|Physician Decision|1|||
130851828|NCT02081599|471087006|FG001|Period 2：Open-label Period|Physician Decision|0|||
130851829|NCT02081599|471087005|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
130851830|NCT02081599|471087006|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
130851831|NCT01629953|471087007|FG000|Overall Study|Death|3|||
130851832|NCT01629953|471087008|FG001|Overall Study|Death|1|||
130851833|NCT01629953|471087007|FG000|Overall Study|Lost to Follow-up|10|||
130851834|NCT01629953|471087008|FG001|Overall Study|Lost to Follow-up|14|||
130851835|NCT01286077|471087009|FG000|Overall Study|Adverse Event|2|||
130851836|NCT01286077|471087010|FG001|Overall Study|Adverse Event|0|||
130851837|NCT01286077|471087009|FG000|Overall Study|Death|1|||
130851838|NCT01286077|471087010|FG001|Overall Study|Death|0|||
130851839|NCT01286077|471087009|FG000|Overall Study|Protocol Violation|1|||
130851840|NCT01286077|471087010|FG001|Overall Study|Protocol Violation|1|||
130851841|NCT01286077|471087009|FG000|Overall Study|Withdrawal by Subject|0|||
130851842|NCT01286077|471087010|FG001|Overall Study|Withdrawal by Subject|2|||
130851843|NCT01286077|471087009|FG000|Overall Study|Intercurrent illness|1|||
130851844|NCT01286077|471087010|FG001|Overall Study|Intercurrent illness|0|||
130851845|NCT01286077|471087009|FG000|Overall Study|Non-compliance|1|||
130851846|NCT01286077|471087010|FG001|Overall Study|Non-compliance|0|||
130851847|NCT01286077|471087009|FG000|Overall Study|The subject starts with alternative MMY|0|||
130851848|NCT01286077|471087010|FG001|Overall Study|The subject starts with alternative MMY|3|||
130851849|NCT01286077|471087009|FG000|Overall Study|Patient's decision to stop treatment|3|||
130851850|NCT01286077|471087010|FG001|Overall Study|Patient's decision to stop treatment|0|||
130851851|NCT01286077|471087009|FG000|Overall Study|Progression of disease|0|||
130851852|NCT01286077|471087010|FG001|Overall Study|Progression of disease|1|||
130851853|NCT01286077|471087009|FG000|Overall Study|refill medication not received in time|1|||
130851854|NCT01286077|471087010|FG001|Overall Study|refill medication not received in time|0|||
130851855|NCT05063539|471087011|FG000|Overall Study|Adverse Event|1|||
130851856|NCT05063539|471087012|FG001|Overall Study|Adverse Event|2|||
130851857|NCT05063539|471087013|FG002|Overall Study|Adverse Event|1|||
130851858|NCT05063539|471087011|FG000|Overall Study|Death|0|||
130851859|NCT05063539|471087012|FG001|Overall Study|Death|1|||
130851860|NCT05063539|471087013|FG002|Overall Study|Death|1|||
130851861|NCT05063539|471087011|FG000|Overall Study|Lost to Follow-up|0|||
130851862|NCT05063539|471087012|FG001|Overall Study|Lost to Follow-up|1|||
130851863|NCT05063539|471087013|FG002|Overall Study|Lost to Follow-up|0|||
130851864|NCT05063539|471087011|FG000|Overall Study|Physician Decision|4|||
130851865|NCT05063539|471087012|FG001|Overall Study|Physician Decision|3|||
130851866|NCT05063539|471087013|FG002|Overall Study|Physician Decision|1|||
130851867|NCT05063539|471087011|FG000|Overall Study|Progressive Disease|0|||
130851868|NCT05063539|471087012|FG001|Overall Study|Progressive Disease|2|||
130851869|NCT05063539|471087013|FG002|Overall Study|Progressive Disease|0|||
130851870|NCT05063539|471087011|FG000|Overall Study|Withdrawal by Subject|17|||
130851871|NCT05063539|471087012|FG001|Overall Study|Withdrawal by Subject|26|||
130851872|NCT05063539|471087013|FG002|Overall Study|Withdrawal by Subject|14|||
130851873|NCT05063539|471087011|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
130851874|NCT05063539|471087012|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
130851875|NCT05063539|471087013|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
130851876|NCT05063539|471087011|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
130851877|NCT05063539|471087012|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
130851878|NCT05063539|471087013|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
130851879|NCT05063539|471087011|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
130851880|NCT05063539|471087012|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
130851881|NCT05063539|471087013|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
130851882|NCT05063539|471087011|FG000|Overall Study|Discontinued due to Common Close Design|0|||
130851883|NCT05063539|471087012|FG001|Overall Study|Discontinued due to Common Close Design|1|||
130851884|NCT05063539|471087013|FG002|Overall Study|Discontinued due to Common Close Design|0|||
130851885|NCT05063539|471087011|FG000|Overall Study|Participant not co-operative|0|||
130851886|NCT05063539|471087012|FG001|Overall Study|Participant not co-operative|1|||
130851887|NCT05063539|471087013|FG002|Overall Study|Participant not co-operative|0|||
130875571|NCT05893862|471173847|FG001|Overall Study|Physician Decision|1|||
130851888|NCT05063539|471087011|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
130851889|NCT05063539|471087012|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
130851890|NCT05063539|471087013|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
130851891|NCT05063539|471087011|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
130851892|NCT05063539|471087012|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
130851893|NCT05063539|471087013|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
130851894|NCT01751139|471087014|FG000|Overall Study|Other|135|||
130851895|NCT01751139|471087014|FG000|Overall Study|Sponsor study termination|1609|||
130851896|NCT01751139|471087014|FG000|Overall Study|Lost to Follow-up|240|||
130851897|NCT01751139|471087014|FG000|Overall Study|Withdrawal by Subject|251|||
130851898|NCT01751139|471087014|FG000|Overall Study|Adverse Event|1|||
130851899|NCT01751139|471087014|FG000|Overall Study|Death|31|||
130851900|NCT04736628|471087015|FG000|Overall Study|Not treated|0|||
130851901|NCT04736628|471087016|FG001|Overall Study|Not treated|0|||
130851902|NCT04736628|471087017|FG002|Overall Study|Not treated|0|||
130851903|NCT04736628|471087018|FG003|Overall Study|Not treated|2|||
130851904|NCT04736628|471087015|FG000|Overall Study|Other reason than listed|1|||
130851905|NCT04736628|471087016|FG001|Overall Study|Other reason than listed|2|||
130851906|NCT04736628|471087017|FG002|Overall Study|Other reason than listed|2|||
130851907|NCT04736628|471087018|FG003|Overall Study|Other reason than listed|3|||
130851908|NCT04736628|471087015|FG000|Overall Study|Protocol deviation|0|||
130851909|NCT04736628|471087016|FG001|Overall Study|Protocol deviation|0|||
130851910|NCT04736628|471087017|FG002|Overall Study|Protocol deviation|0|||
130851911|NCT04736628|471087018|FG003|Overall Study|Protocol deviation|1|||
130851912|NCT04736628|471087015|FG000|Overall Study|Burden of study procedures|1|||
130851913|NCT04736628|471087016|FG001|Overall Study|Burden of study procedures|0|||
130851914|NCT04736628|471087017|FG002|Overall Study|Burden of study procedures|0|||
130851915|NCT04736628|471087018|FG003|Overall Study|Burden of study procedures|1|||
130851916|NCT04736628|471087015|FG000|Overall Study|Change of residence|0|||
130851917|NCT04736628|471087016|FG001|Overall Study|Change of residence|1|||
130851918|NCT04736628|471087017|FG002|Overall Study|Change of residence|0|||
130851919|NCT04736628|471087018|FG003|Overall Study|Change of residence|0|||
130851920|NCT04736628|471087015|FG000|Overall Study|Perceived lack of efficacy|1|||
130851921|NCT04736628|471087016|FG001|Overall Study|Perceived lack of efficacy|0|||
130851922|NCT04736628|471087017|FG002|Overall Study|Perceived lack of efficacy|0|||
130851923|NCT04736628|471087018|FG003|Overall Study|Perceived lack of efficacy|1|||
130851924|NCT04736628|471087015|FG000|Overall Study|Adverse Event|3|||
130851925|NCT04736628|471087016|FG001|Overall Study|Adverse Event|2|||
130851926|NCT04736628|471087017|FG002|Overall Study|Adverse Event|4|||
130851927|NCT04736628|471087018|FG003|Overall Study|Adverse Event|3|||
130851928|NCT04279613|471087019|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130851929|NCT04279613|471087020|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130851930|NCT04279613|471087021|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130851931|NCT04279613|471087022|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130851932|NCT04279613|471087023|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
130851933|NCT04279613|471087019|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130851934|NCT04279613|471087020|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
130851935|NCT04279613|471087021|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130851936|NCT04279613|471087022|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130851937|NCT04279613|471087023|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130851938|NCT04279613|471087019|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130851939|NCT04279613|471087020|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130851940|NCT04279613|471087021|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
130851941|NCT04279613|471087022|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130851942|NCT04279613|471087023|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130851943|NCT04279613|471087019|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130851944|NCT04279613|471087020|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130851945|NCT04279613|471087021|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130851946|NCT04279613|471087022|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130851947|NCT04279613|471087023|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
130851948|NCT04279613|471087019|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130851949|NCT04279613|471087020|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130851950|NCT04279613|471087021|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130851951|NCT04279613|471087022|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
130851952|NCT04279613|471087023|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130851953|NCT02704689|471087024|FG000|Overall Study|Physician Decision|1|||
130851954|NCT02704689|471087024|FG000|Overall Study|Study device not implanted|2|||
130851955|NCT01646203|471087027|FG000|Overall Study|Adverse Event|2|||
130851956|NCT01646203|471087028|FG001|Overall Study|Adverse Event|0|||
130851957|NCT01646203|471087029|FG002|Overall Study|Adverse Event|1|||
130851958|NCT01646203|471087027|FG000|Overall Study|Withdrawal by Subject|0|||
130851959|NCT01646203|471087028|FG001|Overall Study|Withdrawal by Subject|1|||
130851960|NCT01646203|471087029|FG002|Overall Study|Withdrawal by Subject|0|||
130851961|NCT01646203|471087027|FG000|Overall Study|Physician's Decision|0|||
130851962|NCT01646203|471087028|FG001|Overall Study|Physician's Decision|1|||
130851963|NCT01646203|471087029|FG002|Overall Study|Physician's Decision|0|||
130851964|NCT03242252|471087034|FG000|Overall Study|At the Participant's own Request|18|||
130851965|NCT03242252|471087035|FG001|Overall Study|At the Participant's own Request|10|||
130851966|NCT03242252|471087036|FG002|Overall Study|At the Participant's own Request|15|||
130851967|NCT03242252|471087034|FG000|Overall Study|Adverse Event|8|||
130851968|NCT03242252|471087035|FG001|Overall Study|Adverse Event|6|||
130851969|NCT03242252|471087036|FG002|Overall Study|Adverse Event|9|||
130851970|NCT03242252|471087034|FG000|Overall Study|Poor Compliance to Protocol|0|||
130851971|NCT03242252|471087035|FG001|Overall Study|Poor Compliance to Protocol|2|||
130851972|NCT03242252|471087036|FG002|Overall Study|Poor Compliance to Protocol|3|||
130851973|NCT03242252|471087034|FG000|Overall Study|Study Terminated by Sponsor|1|||
130851974|NCT03242252|471087035|FG001|Overall Study|Study Terminated by Sponsor|0|||
130851975|NCT03242252|471087036|FG002|Overall Study|Study Terminated by Sponsor|0|||
130851976|NCT03242252|471087034|FG000|Overall Study|Reason not Specified|4|||
130851977|NCT03242252|471087035|FG001|Overall Study|Reason not Specified|4|||
130851978|NCT03242252|471087036|FG002|Overall Study|Reason not Specified|1|||
130851979|NCT03242252|471087034|FG000|Overall Study|Lost to Follow-up|5|||
130851980|NCT03242252|471087035|FG001|Overall Study|Lost to Follow-up|1|||
130851981|NCT03242252|471087036|FG002|Overall Study|Lost to Follow-up|4|||
130851982|NCT01659255|471087037|FG000|Overall Study|Adverse Event|0|||
130851983|NCT01659255|471087038|FG001|Overall Study|Adverse Event|0|||
130851984|NCT01659255|471087039|FG002|Overall Study|Adverse Event|0|||
130851985|NCT01659255|471087040|FG003|Overall Study|Adverse Event|0|||
130851986|NCT01659255|471087041|FG004|Overall Study|Adverse Event|0|||
130851987|NCT01659255|471087042|FG005|Overall Study|Adverse Event|1|||
130851988|NCT01659255|471087043|FG006|Overall Study|Adverse Event|1|||
130851989|NCT01659255|471087044|FG007|Overall Study|Adverse Event|0|||
130851990|NCT01659255|471087045|FG008|Overall Study|Adverse Event|0|||
130851991|NCT01659255|471087046|FG009|Overall Study|Adverse Event|1|||
130851992|NCT01659255|471087047|FG010|Overall Study|Adverse Event|0|||
130851993|NCT01659255|471087048|FG011|Overall Study|Adverse Event|1|||
130851994|NCT01659255|471087049|FG012|Overall Study|Adverse Event|0|||
130851995|NCT01659255|471087050|FG013|Overall Study|Adverse Event|2|||
130851996|NCT01659255|471087051|FG014|Overall Study|Adverse Event|0|||
130851997|NCT01659255|471087052|FG015|Overall Study|Adverse Event|1|||
130851998|NCT01659255|471087053|FG016|Overall Study|Adverse Event|0|||
130851999|NCT01659255|471087037|FG000|Overall Study|Death|0|||
130852000|NCT01659255|471087038|FG001|Overall Study|Death|1|||
130852001|NCT01659255|471087039|FG002|Overall Study|Death|0|||
130852002|NCT01659255|471087040|FG003|Overall Study|Death|0|||
130852003|NCT01659255|471087041|FG004|Overall Study|Death|0|||
130852004|NCT01659255|471087042|FG005|Overall Study|Death|0|||
130852005|NCT01659255|471087043|FG006|Overall Study|Death|0|||
130852006|NCT01659255|471087044|FG007|Overall Study|Death|1|||
130852007|NCT01659255|471087045|FG008|Overall Study|Death|1|||
130852008|NCT01659255|471087046|FG009|Overall Study|Death|0|||
130852009|NCT01659255|471087047|FG010|Overall Study|Death|0|||
130852010|NCT01659255|471087048|FG011|Overall Study|Death|0|||
130852011|NCT01659255|471087049|FG012|Overall Study|Death|1|||
130852012|NCT01659255|471087050|FG013|Overall Study|Death|1|||
130852013|NCT01659255|471087051|FG014|Overall Study|Death|2|||
130852014|NCT01659255|471087052|FG015|Overall Study|Death|1|||
130852015|NCT01659255|471087053|FG016|Overall Study|Death|0|||
130852016|NCT01659255|471087037|FG000|Overall Study|Progressive Disease|2|||
130852017|NCT01659255|471087038|FG001|Overall Study|Progressive Disease|0|||
130852018|NCT01659255|471087039|FG002|Overall Study|Progressive Disease|0|||
130852019|NCT01659255|471087040|FG003|Overall Study|Progressive Disease|0|||
130852020|NCT01659255|471087041|FG004|Overall Study|Progressive Disease|0|||
130852021|NCT01659255|471087042|FG005|Overall Study|Progressive Disease|0|||
130852022|NCT01659255|471087043|FG006|Overall Study|Progressive Disease|0|||
130852023|NCT01659255|471087044|FG007|Overall Study|Progressive Disease|1|||
130852024|NCT01659255|471087045|FG008|Overall Study|Progressive Disease|0|||
130852025|NCT01659255|471087046|FG009|Overall Study|Progressive Disease|2|||
130852026|NCT01659255|471087047|FG010|Overall Study|Progressive Disease|2|||
130852027|NCT01659255|471087048|FG011|Overall Study|Progressive Disease|3|||
130852028|NCT01659255|471087049|FG012|Overall Study|Progressive Disease|5|||
130852029|NCT01659255|471087050|FG013|Overall Study|Progressive Disease|13|||
130852030|NCT01659255|471087051|FG014|Overall Study|Progressive Disease|6|||
130852031|NCT01659255|471087052|FG015|Overall Study|Progressive Disease|2|||
130852032|NCT01659255|471087053|FG016|Overall Study|Progressive Disease|3|||
130852033|NCT01659255|471087037|FG000|Overall Study|Withdrew Consent|0|||
130852034|NCT01659255|471087038|FG001|Overall Study|Withdrew Consent|0|||
130852035|NCT01659255|471087039|FG002|Overall Study|Withdrew Consent|0|||
130852036|NCT01659255|471087040|FG003|Overall Study|Withdrew Consent|0|||
130852037|NCT01659255|471087041|FG004|Overall Study|Withdrew Consent|0|||
130852038|NCT01659255|471087042|FG005|Overall Study|Withdrew Consent|0|||
130852039|NCT01659255|471087043|FG006|Overall Study|Withdrew Consent|0|||
130852040|NCT01659255|471087044|FG007|Overall Study|Withdrew Consent|0|||
130852041|NCT01659255|471087045|FG008|Overall Study|Withdrew Consent|0|||
130852042|NCT01659255|471087046|FG009|Overall Study|Withdrew Consent|0|||
130852043|NCT01659255|471087047|FG010|Overall Study|Withdrew Consent|1|||
130852044|NCT01659255|471087048|FG011|Overall Study|Withdrew Consent|0|||
130852045|NCT01659255|471087049|FG012|Overall Study|Withdrew Consent|0|||
130852046|NCT01659255|471087050|FG013|Overall Study|Withdrew Consent|1|||
130852047|NCT01659255|471087051|FG014|Overall Study|Withdrew Consent|0|||
130852048|NCT01659255|471087052|FG015|Overall Study|Withdrew Consent|0|||
130852049|NCT01659255|471087053|FG016|Overall Study|Withdrew Consent|0|||
130852050|NCT01659255|471087037|FG000|Overall Study|Investigator Decision|0|||
130852051|NCT01659255|471087038|FG001|Overall Study|Investigator Decision|0|||
130852052|NCT01659255|471087039|FG002|Overall Study|Investigator Decision|0|||
130852053|NCT01659255|471087040|FG003|Overall Study|Investigator Decision|0|||
130852054|NCT01659255|471087041|FG004|Overall Study|Investigator Decision|0|||
130852055|NCT01659255|471087042|FG005|Overall Study|Investigator Decision|0|||
130852056|NCT01659255|471087043|FG006|Overall Study|Investigator Decision|0|||
130852057|NCT01659255|471087044|FG007|Overall Study|Investigator Decision|0|||
130852058|NCT01659255|471087045|FG008|Overall Study|Investigator Decision|0|||
130852059|NCT01659255|471087046|FG009|Overall Study|Investigator Decision|0|||
130852060|NCT01659255|471087047|FG010|Overall Study|Investigator Decision|0|||
130852061|NCT01659255|471087048|FG011|Overall Study|Investigator Decision|0|||
130852062|NCT01659255|471087049|FG012|Overall Study|Investigator Decision|1|||
130852063|NCT01659255|471087050|FG013|Overall Study|Investigator Decision|1|||
130852064|NCT01659255|471087051|FG014|Overall Study|Investigator Decision|0|||
130852065|NCT01659255|471087052|FG015|Overall Study|Investigator Decision|0|||
130852066|NCT01659255|471087053|FG016|Overall Study|Investigator Decision|0|||
130852067|NCT01659255|471087037|FG000|Overall Study|Sponsor's Decision|0|||
130852068|NCT01659255|471087038|FG001|Overall Study|Sponsor's Decision|0|||
130852069|NCT01659255|471087039|FG002|Overall Study|Sponsor's Decision|0|||
130852070|NCT01659255|471087040|FG003|Overall Study|Sponsor's Decision|0|||
130852071|NCT01659255|471087041|FG004|Overall Study|Sponsor's Decision|0|||
130852072|NCT01659255|471087042|FG005|Overall Study|Sponsor's Decision|0|||
130852073|NCT01659255|471087043|FG006|Overall Study|Sponsor's Decision|1|||
130852074|NCT01659255|471087044|FG007|Overall Study|Sponsor's Decision|0|||
130852075|NCT01659255|471087045|FG008|Overall Study|Sponsor's Decision|0|||
130852076|NCT01659255|471087046|FG009|Overall Study|Sponsor's Decision|0|||
130852077|NCT01659255|471087047|FG010|Overall Study|Sponsor's Decision|0|||
130852078|NCT01659255|471087048|FG011|Overall Study|Sponsor's Decision|0|||
130852079|NCT01659255|471087049|FG012|Overall Study|Sponsor's Decision|0|||
130852080|NCT01659255|471087050|FG013|Overall Study|Sponsor's Decision|0|||
130852081|NCT01659255|471087051|FG014|Overall Study|Sponsor's Decision|0|||
130852082|NCT01659255|471087052|FG015|Overall Study|Sponsor's Decision|0|||
130852083|NCT01659255|471087053|FG016|Overall Study|Sponsor's Decision|0|||
130852084|NCT01659255|471087037|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852085|NCT01659255|471087038|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852086|NCT01659255|471087039|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852087|NCT01659255|471087040|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852088|NCT01659255|471087041|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852089|NCT01659255|471087042|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852090|NCT01659255|471087043|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852091|NCT01659255|471087044|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852092|NCT01659255|471087045|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852093|NCT01659255|471087046|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852094|NCT01659255|471087047|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852095|NCT01659255|471087048|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852096|NCT01659255|471087049|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852097|NCT01659255|471087050|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852098|NCT01659255|471087051|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852099|NCT01659255|471087052|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
130852100|NCT01659255|471087053|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130852101|NCT01659255|471087037|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
130852102|NCT01659255|471087038|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
130852103|NCT01659255|471087039|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
130852104|NCT01659255|471087040|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
130852105|NCT01659255|471087041|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
130852106|NCT01659255|471087042|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
130852107|NCT01659255|471087043|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
130852108|NCT01659255|471087044|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
130852109|NCT01659255|471087045|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
130852110|NCT01659255|471087046|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
130852111|NCT01659255|471087047|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
130852112|NCT01659255|471087048|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
130875572|NCT05893862|471173848|FG002|Overall Study|Physician Decision|0|||
130852113|NCT01659255|471087049|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
130852114|NCT01659255|471087050|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
130852115|NCT01659255|471087051|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
130852116|NCT01659255|471087052|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
130852117|NCT01659255|471087053|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
130852118|NCT01116427|471087056|FG000|Core Phase|Adverse Event|0|||
130852119|NCT01116427|471087057|FG001|Core Phase|Adverse Event|1|||
130852120|NCT01116427|471087056|FG000|Core Phase|Lost to Follow-up|1|||
130852121|NCT01116427|471087057|FG001|Core Phase|Lost to Follow-up|0|||
130852122|NCT01116427|471087056|FG000|Core Phase|Withdrawal by Subject|3|||
130852123|NCT01116427|471087057|FG001|Core Phase|Withdrawal by Subject|0|||
130852124|NCT01116427|471087056|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
130852125|NCT01116427|471087057|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
130852126|NCT01116427|471087056|FG000|Extension Phase|Adverse Event|1|||
130852127|NCT01116427|471087057|FG001|Extension Phase|Adverse Event|1|||
130852128|NCT01116427|471087056|FG000|Extension Phase|Lost to Follow-up|2|||
130852129|NCT01116427|471087057|FG001|Extension Phase|Lost to Follow-up|0|||
130852130|NCT01116427|471087056|FG000|Extension Phase|Withdrawal by Subject|5|||
130852131|NCT01116427|471087057|FG001|Extension Phase|Withdrawal by Subject|1|||
130852132|NCT01116427|471087056|FG000|Extension Phase|Not using appropriate birth control|1|||
130852133|NCT01116427|471087057|FG001|Extension Phase|Not using appropriate birth control|0|||
130852134|NCT02989805|471087058|FG000|Overall Study|invalid consent|6|||
130852135|NCT02989805|471087059|FG001|Overall Study|invalid consent|4|||
130852136|NCT02211313|471087060|FG000|Overall Study|Treatment Failure|5|||
130852137|NCT02211313|471087061|FG001|Overall Study|Treatment Failure|2|||
130852138|NCT02211313|471087060|FG000|Overall Study|No Follow up Questionnaires|1|||
130852139|NCT02211313|471087061|FG001|Overall Study|No Follow up Questionnaires|1|||
130852140|NCT03743064|471087062|FG000|Overall Study|Adverse Event|7|||
130852141|NCT03743064|471087063|FG001|Overall Study|Adverse Event|9|||
130852142|NCT03743064|471087062|FG000|Overall Study|Death|25|||
130852143|NCT03743064|471087063|FG001|Overall Study|Death|28|||
130852144|NCT03743064|471087062|FG000|Overall Study|Lost to Follow-up|3|||
130852145|NCT03743064|471087063|FG001|Overall Study|Lost to Follow-up|6|||
130852146|NCT03743064|471087062|FG000|Overall Study|Withdrawal by Subject|28|||
130852147|NCT03743064|471087063|FG001|Overall Study|Withdrawal by Subject|25|||
130852148|NCT03743064|471087062|FG000|Overall Study|Physician Decision|2|||
130852149|NCT03743064|471087063|FG001|Overall Study|Physician Decision|4|||
130852150|NCT03743064|471087062|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
130852151|NCT03743064|471087063|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
130852152|NCT02771626|471087064|FG000|Overall Study|Adverse Event|1|||
130852153|NCT02771626|471087065|FG001|Overall Study|Adverse Event|5|||
130852154|NCT02771626|471087066|FG002|Overall Study|Adverse Event|3|||
130852155|NCT02771626|471087067|FG003|Overall Study|Adverse Event|0|||
130852156|NCT02771626|471087068|FG004|Overall Study|Adverse Event|1|||
130852157|NCT02771626|471087069|FG005|Overall Study|Adverse Event|1|||
130852158|NCT02771626|471087064|FG000|Overall Study|Radiologic Disease Progression|6|||
130852159|NCT02771626|471087065|FG001|Overall Study|Radiologic Disease Progression|13|||
130852160|NCT02771626|471087066|FG002|Overall Study|Radiologic Disease Progression|10|||
130852161|NCT02771626|471087067|FG003|Overall Study|Radiologic Disease Progression|7|||
130852162|NCT02771626|471087068|FG004|Overall Study|Radiologic Disease Progression|28|||
130852163|NCT02771626|471087069|FG005|Overall Study|Radiologic Disease Progression|15|||
130852164|NCT02771626|471087064|FG000|Overall Study|Symptomatic Deterioration|0|||
130852165|NCT02771626|471087065|FG001|Overall Study|Symptomatic Deterioration|4|||
130852166|NCT02771626|471087066|FG002|Overall Study|Symptomatic Deterioration|2|||
130852167|NCT02771626|471087067|FG003|Overall Study|Symptomatic Deterioration|0|||
130852168|NCT02771626|471087068|FG004|Overall Study|Symptomatic Deterioration|5|||
130852169|NCT02771626|471087069|FG005|Overall Study|Symptomatic Deterioration|2|||
130852170|NCT02771626|471087064|FG000|Overall Study|Participant Request|0|||
130852171|NCT02771626|471087065|FG001|Overall Study|Participant Request|1|||
130852172|NCT02771626|471087066|FG002|Overall Study|Participant Request|0|||
130852173|NCT02771626|471087067|FG003|Overall Study|Participant Request|2|||
130852174|NCT02771626|471087068|FG004|Overall Study|Participant Request|0|||
130852175|NCT02771626|471087069|FG005|Overall Study|Participant Request|1|||
130852176|NCT02771626|471087064|FG000|Overall Study|Investigator Decision|0|||
130852177|NCT02771626|471087065|FG001|Overall Study|Investigator Decision|1|||
130852178|NCT02771626|471087066|FG002|Overall Study|Investigator Decision|0|||
130852179|NCT02771626|471087067|FG003|Overall Study|Investigator Decision|0|||
130852180|NCT02771626|471087068|FG004|Overall Study|Investigator Decision|1|||
130852181|NCT02771626|471087069|FG005|Overall Study|Investigator Decision|0|||
130852182|NCT02771626|471087064|FG000|Overall Study|Study Termination by Sponsor|0|||
130852183|NCT02771626|471087065|FG001|Overall Study|Study Termination by Sponsor|2|||
130852184|NCT02771626|471087066|FG002|Overall Study|Study Termination by Sponsor|1|||
130852185|NCT02771626|471087067|FG003|Overall Study|Study Termination by Sponsor|0|||
130852186|NCT02771626|471087068|FG004|Overall Study|Study Termination by Sponsor|1|||
130852187|NCT02771626|471087069|FG005|Overall Study|Study Termination by Sponsor|0|||
130852188|NCT02771626|471087064|FG000|Overall Study|Informed Consent Withdrawn|0|||
130852189|NCT02771626|471087065|FG001|Overall Study|Informed Consent Withdrawn|0|||
130852190|NCT02771626|471087066|FG002|Overall Study|Informed Consent Withdrawn|1|||
130852191|NCT02771626|471087067|FG003|Overall Study|Informed Consent Withdrawn|0|||
130852192|NCT02771626|471087068|FG004|Overall Study|Informed Consent Withdrawn|1|||
130852193|NCT02771626|471087069|FG005|Overall Study|Informed Consent Withdrawn|1|||
130852194|NCT02771626|471087064|FG000|Overall Study|Other, Not Specified|1|||
130852195|NCT02771626|471087065|FG001|Overall Study|Other, Not Specified|0|||
130852196|NCT02771626|471087066|FG002|Overall Study|Other, Not Specified|0|||
130852197|NCT02771626|471087067|FG003|Overall Study|Other, Not Specified|0|||
130852198|NCT02771626|471087068|FG004|Overall Study|Other, Not Specified|0|||
130852199|NCT02771626|471087069|FG005|Overall Study|Other, Not Specified|1|||
130852200|NCT02648217|471087072|FG000|Overall Study|Adverse Event|0|||
130852201|NCT02648217|471087073|FG001|Overall Study|Adverse Event|1|||
130852202|NCT02648217|471087072|FG000|Overall Study|Lost to Follow-up|1|||
130852203|NCT02648217|471087073|FG001|Overall Study|Lost to Follow-up|1|||
130852204|NCT02648217|471087072|FG000|Overall Study|Withdrawal by Subject|4|||
130852205|NCT02648217|471087073|FG001|Overall Study|Withdrawal by Subject|3|||
130852206|NCT02648217|471087072|FG000|Overall Study|Unclassified|5|||
130852207|NCT02648217|471087073|FG001|Overall Study|Unclassified|0|||
130852208|NCT03316950|471087074|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
130852209|NCT03316950|471087075|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
130852210|NCT03316950|471087076|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
130852211|NCT03316950|471087077|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
130852212|NCT03316950|471087074|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
130852213|NCT03316950|471087075|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
130852214|NCT03316950|471087076|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
130852215|NCT03316950|471087077|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
130852216|NCT03316950|471087074|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
130852217|NCT03316950|471087075|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
130852218|NCT03316950|471087076|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
130852219|NCT03316950|471087077|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
130852220|NCT02335424|471087078|FG000|Overall Study|Withdrawal by Subject|19|||
130852221|NCT02335424|471087078|FG000|Overall Study|Adverse Event|25|||
130852222|NCT02335424|471087078|FG000|Overall Study|Death|273|||
130852223|NCT02335424|471087078|FG000|Overall Study|Lost to Follow-up|3|||
130852224|NCT02335424|471087078|FG000|Overall Study|Physician Decision|13|||
130852225|NCT02335424|471087078|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
130852226|NCT02335424|471087078|FG000|Overall Study|Protocol Violation|1|||
130852227|NCT02335424|471087078|FG000|Overall Study|Screen failure|1|||
130852228|NCT02776033|471087081|FG000|Overall Study|Withdrawal by Subject|0|||
130852229|NCT02776033|471087082|FG001|Overall Study|Withdrawal by Subject|0|||
130852230|NCT02776033|471087083|FG002|Overall Study|Withdrawal by Subject|2|||
130852231|NCT02776033|471087081|FG000|Overall Study|Physician Decision|2|||
130852232|NCT02776033|471087082|FG001|Overall Study|Physician Decision|0|||
130852233|NCT02776033|471087083|FG002|Overall Study|Physician Decision|0|||
130852234|NCT02776033|471087081|FG000|Overall Study|Lost to Follow-up|1|||
130852235|NCT02776033|471087082|FG001|Overall Study|Lost to Follow-up|0|||
130852236|NCT02776033|471087083|FG002|Overall Study|Lost to Follow-up|0|||
130852237|NCT02776033|471087081|FG000|Overall Study|Adverse Event|1|||
130852238|NCT02776033|471087082|FG001|Overall Study|Adverse Event|2|||
130852239|NCT02776033|471087083|FG002|Overall Study|Adverse Event|0|||
130852240|NCT02712424|471087084|FG000|Overall Study|Lost to Follow-up|34|||
130852241|NCT02712424|471087085|FG001|Overall Study|Lost to Follow-up|32|||
130852242|NCT01302054|471087091|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
130852243|NCT01302054|471087092|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
130852244|NCT01302054|471087093|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
130852245|NCT01302054|471087091|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
130852246|NCT01302054|471087092|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
130852247|NCT01302054|471087093|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
130852248|NCT01302054|471087091|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
130852249|NCT01302054|471087092|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
130852250|NCT01302054|471087093|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
130852251|NCT01302054|471087091|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
130852252|NCT01302054|471087092|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
130852253|NCT01302054|471087093|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
130852254|NCT01302054|471087091|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
130852255|NCT01302054|471087092|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
130852256|NCT01302054|471087093|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
130852257|NCT01302054|471087091|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
130852258|NCT01302054|471087092|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
130852259|NCT01302054|471087093|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
130852260|NCT01302054|471087091|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
130852261|NCT01302054|471087092|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
130852262|NCT01302054|471087093|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
130852263|NCT01302054|471087091|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
130852264|NCT01302054|471087092|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
130852265|NCT01302054|471087093|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
130852266|NCT01302054|471087091|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130852267|NCT01302054|471087092|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
130852268|NCT01302054|471087093|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
130852269|NCT01302054|471087091|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130852270|NCT01302054|471087092|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
130852271|NCT01302054|471087093|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130852272|NCT01302054|471087091|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130852273|NCT01302054|471087092|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
130852274|NCT01302054|471087093|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
130852275|NCT01302054|471087091|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
130852276|NCT01302054|471087092|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
130852277|NCT01302054|471087093|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
130852278|NCT01302054|471087091|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130852279|NCT01302054|471087092|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
130852280|NCT01302054|471087093|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
130852281|NCT01302054|471087091|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
130852282|NCT01302054|471087092|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
130852283|NCT01302054|471087093|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
130852284|NCT01302054|471087091|FG000|Double-Blind Treatment Phase|Other|0|||
130852285|NCT01302054|471087092|FG001|Double-Blind Treatment Phase|Other|4|||
130852286|NCT01302054|471087093|FG002|Double-Blind Treatment Phase|Other|9|||
130852287|NCT02713867|471087094|FG000|Randomization|Other Reason|2|||
130852288|NCT02713867|471087095|FG001|Randomization|Other Reason|1|||
130852289|NCT02713867|471087094|FG000|Randomization|Participant Withdrew consent|0|||
130852290|NCT02713867|471087095|FG001|Randomization|Participant Withdrew consent|2|||
130852291|NCT02713867|471087094|FG000|Treatment Period|Other Reasons|22|||
130852292|NCT02713867|471087095|FG001|Treatment Period|Other Reasons|28|||
130852293|NCT02713867|471087094|FG000|Treatment Period|Administrative reason by sponsor|21|||
130852294|NCT02713867|471087095|FG001|Treatment Period|Administrative reason by sponsor|16|||
130852295|NCT02713867|471087094|FG000|Treatment Period|No longer meets study criteria|2|||
130852296|NCT02713867|471087095|FG001|Treatment Period|No longer meets study criteria|1|||
130852297|NCT02713867|471087094|FG000|Treatment Period|Poor/Non Compliance|1|||
130852298|NCT02713867|471087095|FG001|Treatment Period|Poor/Non Compliance|0|||
130852299|NCT02713867|471087094|FG000|Treatment Period|Maximum Clinical Benefit|5|||
130852300|NCT02713867|471087095|FG001|Treatment Period|Maximum Clinical Benefit|6|||
130852301|NCT02713867|471087094|FG000|Treatment Period|Withdrew consent|3|||
130852302|NCT02713867|471087095|FG001|Treatment Period|Withdrew consent|6|||
130852303|NCT02713867|471087094|FG000|Treatment Period|Requested to Discontinue|8|||
130852304|NCT02713867|471087095|FG001|Treatment Period|Requested to Discontinue|8|||
130852305|NCT02713867|471087094|FG000|Treatment Period|AE unrelated to Study Drug|11|||
130852306|NCT02713867|471087095|FG001|Treatment Period|AE unrelated to Study Drug|10|||
130852307|NCT02713867|471087094|FG000|Treatment Period|Death|7|||
130852308|NCT02713867|471087095|FG001|Treatment Period|Death|3|||
130852309|NCT02713867|471087094|FG000|Treatment Period|Study Drug Toxicity|16|||
130852310|NCT02713867|471087095|FG001|Treatment Period|Study Drug Toxicity|19|||
130852311|NCT02713867|471087094|FG000|Treatment Period|Disease Progression|82|||
130852312|NCT02713867|471087095|FG001|Treatment Period|Disease Progression|83|||
130852313|NCT01177969|471087096|FG000|Overall Study|Protocol Violation|2|||
130852314|NCT01177969|471087097|FG001|Overall Study|Protocol Violation|1|||
130852315|NCT01177969|471087096|FG000|Overall Study|Withdrawal by Subject|1|||
130852316|NCT01177969|471087097|FG001|Overall Study|Withdrawal by Subject|2|||
130852317|NCT01639755|471087098|FG000|Overall Study|Study Ongoing|15|||
130852318|NCT01639755|471087098|FG000|Overall Study|Patient had device explantation|4|||
130852319|NCT03629912|471087099|FG000|Overall Study|Lost to Follow-up|19|||
130852320|NCT03629912|471087100|FG001|Overall Study|Lost to Follow-up|7|||
130852321|NCT03629912|471087101|FG002|Overall Study|Lost to Follow-up|5|||
130852322|NCT03629912|471087102|FG003|Overall Study|Lost to Follow-up|1|||
130852323|NCT03629912|471087099|FG000|Overall Study|Withdrawal by Subject|6|||
130852324|NCT03629912|471087100|FG001|Overall Study|Withdrawal by Subject|0|||
130852325|NCT03629912|471087101|FG002|Overall Study|Withdrawal by Subject|1|||
130852326|NCT03629912|471087102|FG003|Overall Study|Withdrawal by Subject|2|||
130852327|NCT03629912|471087099|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
130852328|NCT03629912|471087100|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
130852329|NCT03629912|471087101|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
130852330|NCT03629912|471087102|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
130852331|NCT03629912|471087099|FG000|Overall Study|Death|1|||
130852332|NCT03629912|471087100|FG001|Overall Study|Death|0|||
130852333|NCT03629912|471087101|FG002|Overall Study|Death|0|||
130852334|NCT03629912|471087102|FG003|Overall Study|Death|0|||
130852335|NCT01475162|471087103|FG000|Overall Study|Physician Decision|1|||
130852336|NCT01475162|471087103|FG000|Overall Study|Death|10|||
130852337|NCT01475162|471087103|FG000|Overall Study|Study closed for safety|3|||
130852338|NCT00490022|471087104|FG000|Overall Study|Adverse Event|0|||
130852339|NCT00490022|471087105|FG001|Overall Study|Adverse Event|2|||
130852340|NCT00490022|471087104|FG000|Overall Study|Withdrawal by Subject|1|||
130852341|NCT00490022|471087105|FG001|Overall Study|Withdrawal by Subject|0|||
130852342|NCT00490022|471087104|FG000|Overall Study|Subject failed to disclose concommitant|0|||
130852343|NCT00490022|471087105|FG001|Overall Study|Subject failed to disclose concommitant|1|||
130852344|NCT00635089|471087106|FG000|Overall Study|Adverse Event|7|||
130852345|NCT00635089|471087106|FG000|Overall Study|Lack of Efficacy|28|||
130852346|NCT00635089|471087106|FG000|Overall Study|Protocol Deviation|4|||
130852347|NCT00635089|471087106|FG000|Overall Study|Lost to Follow-up|8|||
130852348|NCT00635089|471087106|FG000|Overall Study|Other|31|||
130852349|NCT05059977|471087108|FG000|Overall Study|Withdrawal by Subject|0|||
130852350|NCT05059977|471087109|FG001|Overall Study|Withdrawal by Subject|0|||
130852351|NCT05059977|471087110|FG002|Overall Study|Withdrawal by Subject|1|||
130852352|NCT04405245|471087111|FG000|Overall Study|Adverse Event|0|||
130852353|NCT04405245|471087112|FG001|Overall Study|Adverse Event|1|||
130852354|NCT04405245|471087113|FG002|Overall Study|Adverse Event|0|||
130852355|NCT00576472|471087117|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852356|NCT00576472|471087118|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852357|NCT00576472|471087119|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852358|NCT00576472|471087120|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
130852359|NCT00576472|471087121|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852360|NCT00576472|471087122|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852361|NCT00576472|471087123|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852362|NCT00576472|471087124|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852363|NCT00576472|471087125|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852364|NCT00576472|471087126|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852365|NCT00576472|471087127|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852366|NCT00576472|471087128|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852367|NCT00576472|471087129|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852368|NCT00576472|471087130|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852369|NCT00576472|471087131|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
130852370|NCT00576472|471087117|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
130852371|NCT00576472|471087118|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
130852372|NCT00576472|471087119|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
130852373|NCT00576472|471087120|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
130852374|NCT00576472|471087121|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
130852375|NCT00576472|471087122|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
130852376|NCT00576472|471087123|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
130852377|NCT00576472|471087124|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
130852378|NCT00576472|471087125|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
130852379|NCT00576472|471087126|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
130852380|NCT00576472|471087127|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
130852381|NCT00576472|471087128|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
130852382|NCT00576472|471087129|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
130852383|NCT00576472|471087130|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
130852384|NCT00576472|471087131|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
130852385|NCT00576472|471087117|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852386|NCT00576472|471087118|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852387|NCT00576472|471087119|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852388|NCT00576472|471087120|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
130852389|NCT00576472|471087121|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852390|NCT00576472|471087122|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852391|NCT00576472|471087123|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852392|NCT00576472|471087124|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852393|NCT00576472|471087125|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852394|NCT00576472|471087126|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852395|NCT00576472|471087127|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852396|NCT00576472|471087128|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852397|NCT00576472|471087129|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852398|NCT00576472|471087130|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852399|NCT00576472|471087131|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130852400|NCT00576472|471087117|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
130852401|NCT00576472|471087118|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
130852402|NCT00576472|471087119|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
130852403|NCT00576472|471087120|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
130875573|NCT05893862|471173849|FG003|Overall Study|Physician Decision|0|||
130852404|NCT00576472|471087121|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
130852405|NCT00576472|471087122|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
130852406|NCT00576472|471087123|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
130852407|NCT00576472|471087124|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
130852408|NCT00576472|471087125|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
130852409|NCT00576472|471087126|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
130852410|NCT00576472|471087127|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
130852411|NCT00576472|471087128|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
130852412|NCT00576472|471087129|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
130852413|NCT00576472|471087130|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
130852414|NCT00576472|471087131|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
130852415|NCT00576472|471087117|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852416|NCT00576472|471087118|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852417|NCT00576472|471087119|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852418|NCT00576472|471087120|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
130852419|NCT00576472|471087121|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852420|NCT00576472|471087122|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852421|NCT00576472|471087123|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852422|NCT00576472|471087124|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852423|NCT00576472|471087125|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852424|NCT00576472|471087126|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852425|NCT00576472|471087127|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852426|NCT00576472|471087128|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852427|NCT00576472|471087129|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852428|NCT00576472|471087130|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852429|NCT00576472|471087131|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
130852430|NCT00576472|471087117|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852431|NCT00576472|471087118|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852432|NCT00576472|471087119|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852433|NCT00576472|471087120|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852434|NCT00576472|471087121|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852435|NCT00576472|471087122|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852436|NCT00576472|471087123|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
130852437|NCT00576472|471087124|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852438|NCT00576472|471087125|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852439|NCT00576472|471087126|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852440|NCT00576472|471087127|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852441|NCT00576472|471087128|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852442|NCT00576472|471087129|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852443|NCT00576472|471087130|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852444|NCT00576472|471087131|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
130852445|NCT00576472|471087117|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
130852446|NCT00576472|471087118|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
130852447|NCT00576472|471087119|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
130852448|NCT00576472|471087120|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
130852449|NCT00576472|471087121|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
130852450|NCT00576472|471087122|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
130852451|NCT00576472|471087123|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
130852452|NCT00576472|471087124|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
130852453|NCT00576472|471087125|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
130852454|NCT00576472|471087126|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
130852455|NCT00576472|471087127|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
130852456|NCT00576472|471087128|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
130852457|NCT00576472|471087129|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
130852458|NCT00576472|471087130|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
130852459|NCT00576472|471087131|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
130852460|NCT00576472|471087117|FG000|MPH Cross Over Phase|Physician Decision|0|||
130852461|NCT00576472|471087118|FG001|MPH Cross Over Phase|Physician Decision|0|||
130852462|NCT00576472|471087119|FG002|MPH Cross Over Phase|Physician Decision|0|||
130852463|NCT00576472|471087120|FG003|MPH Cross Over Phase|Physician Decision|0|||
130852464|NCT00576472|471087121|FG004|MPH Cross Over Phase|Physician Decision|0|||
130852465|NCT00576472|471087122|FG005|MPH Cross Over Phase|Physician Decision|0|||
130852466|NCT00576472|471087123|FG006|MPH Cross Over Phase|Physician Decision|4|||
130852467|NCT00576472|471087124|FG007|MPH Cross Over Phase|Physician Decision|0|||
130852468|NCT00576472|471087125|FG008|MPH Cross Over Phase|Physician Decision|0|||
130852469|NCT00576472|471087126|FG009|MPH Cross Over Phase|Physician Decision|0|||
130852470|NCT00576472|471087127|FG010|MPH Cross Over Phase|Physician Decision|0|||
130852471|NCT00576472|471087128|FG011|MPH Cross Over Phase|Physician Decision|0|||
130852472|NCT00576472|471087129|FG012|MPH Cross Over Phase|Physician Decision|0|||
130852473|NCT00576472|471087130|FG013|MPH Cross Over Phase|Physician Decision|0|||
130852474|NCT00576472|471087131|FG014|MPH Cross Over Phase|Physician Decision|0|||
130852475|NCT00576472|471087117|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852476|NCT00576472|471087118|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852477|NCT00576472|471087119|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852478|NCT00576472|471087120|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852479|NCT00576472|471087121|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852480|NCT00576472|471087122|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852481|NCT00576472|471087123|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852482|NCT00576472|471087124|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852483|NCT00576472|471087125|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
130852484|NCT00576472|471087126|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852485|NCT00576472|471087127|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
130852486|NCT00576472|471087128|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
130852487|NCT00576472|471087129|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852488|NCT00576472|471087130|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852489|NCT00576472|471087131|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
130852490|NCT00576472|471087117|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852491|NCT00576472|471087118|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852492|NCT00576472|471087119|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852493|NCT00576472|471087120|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852494|NCT00576472|471087121|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852495|NCT00576472|471087122|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852496|NCT00576472|471087123|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852497|NCT00576472|471087124|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852498|NCT00576472|471087125|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852499|NCT00576472|471087126|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852500|NCT00576472|471087127|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852501|NCT00576472|471087128|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852502|NCT00576472|471087129|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852503|NCT00576472|471087130|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
130852504|NCT00576472|471087131|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130852505|NCT00576472|471087117|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
130852506|NCT00576472|471087118|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
130852507|NCT00576472|471087119|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
130852508|NCT00576472|471087120|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
130852509|NCT00576472|471087121|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
130852510|NCT00576472|471087122|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
130852511|NCT00576472|471087123|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
130852512|NCT00576472|471087124|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
130852513|NCT00576472|471087125|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
130852514|NCT00576472|471087126|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
130852515|NCT00576472|471087127|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
130852516|NCT00576472|471087128|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
130852517|NCT00576472|471087129|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
130852518|NCT00576472|471087130|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
130852519|NCT00576472|471087131|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
130852520|NCT00576472|471087117|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
130852521|NCT00576472|471087118|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
130852522|NCT00576472|471087119|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
130852523|NCT00576472|471087120|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
130852524|NCT00576472|471087121|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
130852525|NCT00576472|471087122|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
130852526|NCT00576472|471087123|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
130852527|NCT00576472|471087124|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
130852528|NCT00576472|471087125|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
130852529|NCT00576472|471087126|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
130852530|NCT00576472|471087127|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
130852531|NCT00576472|471087128|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
130852532|NCT00576472|471087129|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
130852533|NCT00576472|471087130|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
130852534|NCT00576472|471087131|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
130852535|NCT00576472|471087117|FG000|MPH Home Maintenance Phase|Side effects|0|||
130852536|NCT00576472|471087118|FG001|MPH Home Maintenance Phase|Side effects|0|||
130852537|NCT00576472|471087119|FG002|MPH Home Maintenance Phase|Side effects|0|||
130852538|NCT00576472|471087120|FG003|MPH Home Maintenance Phase|Side effects|0|||
130852539|NCT00576472|471087121|FG004|MPH Home Maintenance Phase|Side effects|0|||
130852540|NCT00576472|471087122|FG005|MPH Home Maintenance Phase|Side effects|0|||
130852541|NCT00576472|471087123|FG006|MPH Home Maintenance Phase|Side effects|0|||
130852542|NCT00576472|471087124|FG007|MPH Home Maintenance Phase|Side effects|0|||
130852543|NCT00576472|471087125|FG008|MPH Home Maintenance Phase|Side effects|0|||
130852544|NCT00576472|471087126|FG009|MPH Home Maintenance Phase|Side effects|0|||
130852545|NCT00576472|471087127|FG010|MPH Home Maintenance Phase|Side effects|0|||
130852546|NCT00576472|471087128|FG011|MPH Home Maintenance Phase|Side effects|0|||
130852547|NCT00576472|471087129|FG012|MPH Home Maintenance Phase|Side effects|0|||
130852548|NCT00576472|471087130|FG013|MPH Home Maintenance Phase|Side effects|0|||
130852549|NCT00576472|471087131|FG014|MPH Home Maintenance Phase|Side effects|8|||
130852550|NCT00576472|471087117|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852551|NCT00576472|471087118|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852552|NCT00576472|471087119|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852553|NCT00576472|471087120|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852554|NCT00576472|471087121|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852555|NCT00576472|471087122|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852556|NCT00576472|471087123|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852557|NCT00576472|471087124|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852558|NCT00576472|471087125|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852559|NCT00576472|471087126|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852560|NCT00576472|471087127|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852561|NCT00576472|471087128|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852562|NCT00576472|471087129|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852563|NCT00576472|471087130|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130852564|NCT00576472|471087131|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
130852565|NCT00576472|471087117|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
130852566|NCT00576472|471087118|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
130852567|NCT00576472|471087119|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
130852568|NCT00576472|471087120|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
130852569|NCT00576472|471087121|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
130852570|NCT00576472|471087122|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
130852571|NCT00576472|471087123|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
130852572|NCT00576472|471087124|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
130852573|NCT00576472|471087125|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
130852574|NCT00576472|471087126|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
130852575|NCT00576472|471087127|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
130852576|NCT00576472|471087128|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
130852577|NCT00576472|471087129|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
130852578|NCT00576472|471087130|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
130852579|NCT00576472|471087131|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
130852580|NCT00576472|471087117|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852581|NCT00576472|471087118|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852582|NCT00576472|471087119|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852583|NCT00576472|471087120|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852584|NCT00576472|471087121|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852585|NCT00576472|471087122|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852586|NCT00576472|471087123|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852587|NCT00576472|471087124|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852588|NCT00576472|471087125|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852589|NCT00576472|471087126|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852590|NCT00576472|471087127|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852591|NCT00576472|471087128|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852592|NCT00576472|471087129|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852593|NCT00576472|471087130|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130852594|NCT00576472|471087131|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
130852595|NCT02391961|471087134|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
130852596|NCT02391961|471087135|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
130852597|NCT02391961|471087134|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
130852598|NCT02391961|471087135|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
130852599|NCT02391961|471087134|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130852600|NCT02391961|471087135|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130852601|NCT03263780|471087138|FG000|Overall Study|Withdrawal by Subject|3|||
130852602|NCT03263780|471087138|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
130852603|NCT01504204|471087139|FG000|Overall Study|Lost to Follow-up|1|||
130852604|NCT01504204|471087140|FG001|Overall Study|Lost to Follow-up|1|||
130852605|NCT02723175|471087141|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
130852606|NCT02723175|471087142|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
130852607|NCT02723175|471087141|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
130852608|NCT02723175|471087142|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
130852609|NCT03691779|471087146|FG000|Part B (24 Weeks)|Adverse Event|0|||
130852610|NCT03691779|471087147|FG001|Part B (24 Weeks)|Adverse Event|1|||
130852611|NCT03691779|471087146|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
130852612|NCT03691779|471087147|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
130852613|NCT01561963|471087148|FG000|Overall Study|Adverse Event|1|||
130852614|NCT00952614|471087151|FG000|Overall Study|Death|3|||
130852615|NCT00952614|471087151|FG000|Overall Study|Lost to Follow-up|3|||
130852616|NCT00952614|471087151|FG000|Overall Study|other reason|1|||
130852617|NCT04023682|471087152|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
130852618|NCT03652675|471087153|FG000|Overall Study|Lost to Follow-up|4|||
130852619|NCT03652675|471087154|FG001|Overall Study|Lost to Follow-up|4|||
130852620|NCT01638559|471087155|FG000|Overall Study|Lost to Follow-up|1|||
130852621|NCT01638559|471087155|FG000|Overall Study|Withdrawal by Subject|1|||
130852622|NCT01638559|471087155|FG000|Overall Study|Subject declined to travel for biopsy|1|||
130852623|NCT01403116|471087156|FG000|Overall Study|Adverse Event|7|||
130852624|NCT01403116|471087157|FG001|Overall Study|Adverse Event|4|||
130852625|NCT01403116|471087156|FG000|Overall Study|Lost to Follow-up|7|||
130852626|NCT01403116|471087157|FG001|Overall Study|Lost to Follow-up|5|||
130852627|NCT01403116|471087156|FG000|Overall Study|Withdrawal by Subject|12|||
130852628|NCT01403116|471087157|FG001|Overall Study|Withdrawal by Subject|15|||
130852629|NCT01403116|471087156|FG000|Overall Study|Non-compliance of study drug|3|||
130852630|NCT01403116|471087157|FG001|Overall Study|Non-compliance of study drug|0|||
130852631|NCT01403116|471087156|FG000|Overall Study|Protocol Violation|0|||
130852632|NCT01403116|471087157|FG001|Overall Study|Protocol Violation|1|||
130852633|NCT01403116|471087156|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
130852634|NCT01403116|471087157|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
130852635|NCT01403116|471087156|FG000|Overall Study|Hct >54%|2|||
130852636|NCT01403116|471087157|FG001|Overall Study|Hct >54%|0|||
130852637|NCT01403116|471087156|FG000|Overall Study|unable to keep appointments|0|||
130852638|NCT01403116|471087157|FG001|Overall Study|unable to keep appointments|2|||
130852639|NCT01895309|471087158|FG000|Overall Study|Adverse Event|13|||
130852640|NCT01895309|471087159|FG001|Overall Study|Adverse Event|17|||
130852641|NCT01895309|471087158|FG000|Overall Study|Protocol Violation|1|||
130852642|NCT01895309|471087159|FG001|Overall Study|Protocol Violation|0|||
130852643|NCT01895309|471087158|FG000|Overall Study|Lack of Efficacy|1|||
130852644|NCT01895309|471087159|FG001|Overall Study|Lack of Efficacy|3|||
130852645|NCT01895309|471087158|FG000|Overall Study|Lost to Follow-up|1|||
130852646|NCT01895309|471087159|FG001|Overall Study|Lost to Follow-up|3|||
130852647|NCT01895309|471087158|FG000|Overall Study|Physician Decision|15|||
130852648|NCT01895309|471087159|FG001|Overall Study|Physician Decision|10|||
130852649|NCT01895309|471087158|FG000|Overall Study|Withdrawal by Subject|9|||
130852650|NCT01895309|471087159|FG001|Overall Study|Withdrawal by Subject|18|||
130852651|NCT04268745|471087160|FG000|Overall Study|Lost to Follow-up|2|||
130852652|NCT04268745|471087161|FG001|Overall Study|Lost to Follow-up|3|||
130852653|NCT04268745|471087160|FG000|Overall Study|Withdrawal by Subject|4|||
130852654|NCT04268745|471087161|FG001|Overall Study|Withdrawal by Subject|2|||
130852655|NCT04268745|471087160|FG000|Overall Study|Death in the family|1|||
130852656|NCT04268745|471087161|FG001|Overall Study|Death in the family|0|||
130852657|NCT04046250|471087164|FG000|Overall Study|Death|0|||
130852658|NCT04046250|471087165|FG001|Overall Study|Death|1|||
130852659|NCT04046250|471087164|FG000|Overall Study|Withdrawal by Subject|3|||
130852660|NCT04046250|471087165|FG001|Overall Study|Withdrawal by Subject|3|||
130852661|NCT00527332|471087168|FG000|Overall Study|Protocol Violation|4|||
130852662|NCT00527332|471087169|FG001|Overall Study|Protocol Violation|8|||
130852663|NCT00527332|471087168|FG000|Overall Study|Withdrew consent|5|||
130852664|NCT00527332|471087169|FG001|Overall Study|Withdrew consent|1|||
130852665|NCT00707954|471088960|FG000|Overall Study|Physician Decision|0|||
130852666|NCT00707954|471088961|FG001|Overall Study|Physician Decision|0|||
130852667|NCT00707954|471088962|FG002|Overall Study|Physician Decision|0|||
130852668|NCT00707954|471088963|FG003|Overall Study|Physician Decision|0|||
130852669|NCT00707954|471088964|FG004|Overall Study|Physician Decision|1|||
130852670|NCT04037254|471088965|FG000|Overall Study|Protocol Violation|1|||
130852671|NCT04037254|471088966|FG001|Overall Study|Protocol Violation|0|||
130852672|NCT04037254|471088967|FG002|Overall Study|Protocol Violation|0|||
130852673|NCT04037254|471088968|FG003|Overall Study|Protocol Violation|0|||
130852674|NCT04037254|471088969|FG004|Overall Study|Protocol Violation|0|||
130852675|NCT04037254|471088965|FG000|Overall Study|Withdrawal by Subject|0|||
130852676|NCT04037254|471088966|FG001|Overall Study|Withdrawal by Subject|0|||
130852677|NCT04037254|471088967|FG002|Overall Study|Withdrawal by Subject|1|||
130852678|NCT04037254|471088968|FG003|Overall Study|Withdrawal by Subject|0|||
130852679|NCT04037254|471088969|FG004|Overall Study|Withdrawal by Subject|0|||
130852680|NCT04037254|471088965|FG000|Overall Study|Delayed or incomplete treatment|0|||
130852681|NCT04037254|471088966|FG001|Overall Study|Delayed or incomplete treatment|2|||
130852682|NCT04037254|471088967|FG002|Overall Study|Delayed or incomplete treatment|1|||
130852683|NCT04037254|471088968|FG003|Overall Study|Delayed or incomplete treatment|0|||
130852684|NCT04037254|471088969|FG004|Overall Study|Delayed or incomplete treatment|0|||
130852685|NCT00448747|471088971|FG000|Overall Study|collapsed veins|1|||
130852686|NCT00448747|471088972|FG001|Overall Study|collapsed veins|0|||
130852687|NCT01424566|471088973|FG000|Single-blind Treatment|Adverse Event|71|||
130852688|NCT01424566|471088974|FG001|Single-blind Treatment|Adverse Event|0|||
130852689|NCT01424566|471088975|FG002|Single-blind Treatment|Adverse Event|0|||
130852690|NCT01424566|471088973|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
130852691|NCT01424566|471088974|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
130852692|NCT01424566|471088975|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
130852693|NCT01424566|471088973|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
130852694|NCT01424566|471088974|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
130852695|NCT01424566|471088975|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
130852696|NCT01424566|471088973|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
130852697|NCT01424566|471088974|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
130852698|NCT01424566|471088975|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
130852699|NCT01424566|471088973|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
130852700|NCT01424566|471088974|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
130852701|NCT01424566|471088975|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
130852702|NCT01424566|471088973|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
130852703|NCT01424566|471088974|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
130852704|NCT01424566|471088975|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
130852705|NCT01424566|471088973|FG000|Double-blind Treatment|Adverse Event|0|||
130852706|NCT01424566|471088974|FG001|Double-blind Treatment|Adverse Event|21|||
130852707|NCT01424566|471088975|FG002|Double-blind Treatment|Adverse Event|13|||
130852708|NCT01424566|471088973|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
130852709|NCT01424566|471088974|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
130852710|NCT01424566|471088975|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
130852711|NCT01424566|471088973|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
130852712|NCT01424566|471088974|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
130852713|NCT01424566|471088975|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
130852714|NCT01424566|471088973|FG000|Double-blind Treatment|Lack of Efficacy|0|||
130852715|NCT01424566|471088974|FG001|Double-blind Treatment|Lack of Efficacy|1|||
130852716|NCT01424566|471088975|FG002|Double-blind Treatment|Lack of Efficacy|1|||
130852717|NCT02715726|471088979|FG000|Overall Study|Adverse Event|2|||
130852718|NCT02715726|471088980|FG001|Overall Study|Adverse Event|6|||
130852719|NCT02715726|471088979|FG000|Overall Study|Protocol Violation|1|||
130852720|NCT02715726|471088980|FG001|Overall Study|Protocol Violation|0|||
130852721|NCT02715726|471088979|FG000|Overall Study|Death|2|||
130852722|NCT02715726|471088980|FG001|Overall Study|Death|1|||
130852723|NCT02715726|471088979|FG000|Overall Study|Participant moved|1|||
130852724|NCT02715726|471088980|FG001|Overall Study|Participant moved|3|||
130852725|NCT02715726|471088979|FG000|Overall Study|Other than specified above|11|||
130852726|NCT02715726|471088980|FG001|Overall Study|Other than specified above|15|||
130852727|NCT02715726|471088979|FG000|Overall Study|Randomized but not treated|1|||
130852728|NCT02715726|471088980|FG001|Overall Study|Randomized but not treated|2|||
130852729|NCT03230292|471088981|FG000|Overall Study|Adverse Event|1|||
130852730|NCT03230292|471088981|FG000|Overall Study|Protocol Violation|1|||
130852731|NCT03230292|471088981|FG000|Overall Study|Lost to Follow-up|1|||
130852732|NCT03230292|471088981|FG000|Overall Study|Withdrawal by Subject|3|||
130852733|NCT02565810|471088983|FG000|Overall Study|Withdrawal by Subject|1|||
130852734|NCT04109976|471088986|FG000|Overall Study|Withdrawal by Subject|1|||
130852735|NCT04109976|471088987|FG001|Overall Study|Withdrawal by Subject|0|||
130852736|NCT00491608|471088988|FG000|Overall Study|Death|2|||
130852737|NCT00491608|471088988|FG000|Overall Study|Withdrawal by Subject|1|||
130852738|NCT00413374|471088989|FG000|Overall Study|Ineligible due to screening criteria.|3|||
130852739|NCT00413374|471088990|FG001|Overall Study|Ineligible due to screening criteria.|0|||
130852740|NCT00413374|471088989|FG000|Overall Study|Adverse Event|1|||
130852741|NCT00413374|471088990|FG001|Overall Study|Adverse Event|0|||
130852742|NCT00413374|471088989|FG000|Overall Study|Lost to Follow-up|1|||
130852743|NCT00413374|471088990|FG001|Overall Study|Lost to Follow-up|0|||
130852744|NCT00413374|471088989|FG000|Overall Study|Surgery|1|||
130852745|NCT00413374|471088990|FG001|Overall Study|Surgery|0|||
130852746|NCT02613169|471088992|FG000|Overall Study|Withdrawal by Subject|4|||
130852747|NCT02613169|471088993|FG001|Overall Study|Withdrawal by Subject|1|||
130852748|NCT02613169|471088992|FG000|Overall Study|Lost to Follow-up|0|||
130852749|NCT02613169|471088993|FG001|Overall Study|Lost to Follow-up|5|||
130852750|NCT02613169|471088992|FG000|Overall Study|HIV|0|||
130852751|NCT02613169|471088993|FG001|Overall Study|HIV|2|||
130852752|NCT02613169|471088992|FG000|Overall Study|No TB infection endpoint|14|||
130852753|NCT02613169|471088993|FG001|Overall Study|No TB infection endpoint|9|||
130852754|NCT00343382|471088994|FG000|Overall Study|Adverse Event|2|||
130852755|NCT00343382|471088995|FG001|Overall Study|Adverse Event|10|||
130852756|NCT00343382|471088996|FG002|Overall Study|Adverse Event|7|||
130852757|NCT00343382|471088994|FG000|Overall Study|Withdrawal by Subject|1|||
130852758|NCT00343382|471088995|FG001|Overall Study|Withdrawal by Subject|2|||
130852759|NCT00343382|471088996|FG002|Overall Study|Withdrawal by Subject|6|||
130852760|NCT00343382|471088994|FG000|Overall Study|Other Reason Not Specified|1|||
130852761|NCT00343382|471088995|FG001|Overall Study|Other Reason Not Specified|2|||
130852762|NCT00343382|471088996|FG002|Overall Study|Other Reason Not Specified|4|||
130852763|NCT02914561|471089001|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
130852764|NCT02914561|471089002|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
130852765|NCT02914561|471089003|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
130852766|NCT02914561|471089004|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
130852767|NCT02914561|471089005|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
130852768|NCT02914561|471089006|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
130852769|NCT02914561|471089007|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130852770|NCT02914561|471089008|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130852771|NCT02914561|471089009|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130852772|NCT02914561|471089010|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130852773|NCT02914561|471089011|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130852774|NCT02914561|471089001|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
130852775|NCT02914561|471089002|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
130852776|NCT02914561|471089003|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
130852777|NCT02914561|471089004|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130852778|NCT02914561|471089005|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
130852779|NCT02914561|471089006|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
130852780|NCT02914561|471089007|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130852781|NCT02914561|471089008|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130852782|NCT02914561|471089009|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130852783|NCT02914561|471089010|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130852784|NCT02914561|471089011|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130852785|NCT02914561|471089001|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130852786|NCT02914561|471089002|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
130852787|NCT02914561|471089003|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
130852788|NCT02914561|471089004|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
130852789|NCT02914561|471089005|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
130852790|NCT02914561|471089006|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
130852791|NCT02914561|471089007|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130852792|NCT02914561|471089008|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130852793|NCT02914561|471089009|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130852794|NCT02914561|471089010|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130852795|NCT02914561|471089011|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130852796|NCT02914561|471089001|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
130852797|NCT02914561|471089002|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
130852798|NCT02914561|471089003|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
130852799|NCT02914561|471089004|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130852800|NCT02914561|471089005|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
130852801|NCT02914561|471089006|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
130852802|NCT02914561|471089007|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130852803|NCT02914561|471089008|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130852804|NCT02914561|471089009|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130852805|NCT02914561|471089010|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130852806|NCT02914561|471089011|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130852807|NCT02914561|471089001|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130852808|NCT02914561|471089002|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130852809|NCT02914561|471089003|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
130852810|NCT02914561|471089004|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130852811|NCT02914561|471089005|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130852812|NCT02914561|471089006|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
130852813|NCT02914561|471089007|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130852814|NCT02914561|471089008|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130852815|NCT02914561|471089009|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130852816|NCT02914561|471089010|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130852817|NCT02914561|471089011|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130852818|NCT02914561|471089001|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
130852819|NCT02914561|471089002|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130852820|NCT02914561|471089003|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130852821|NCT02914561|471089004|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130852822|NCT02914561|471089005|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130852823|NCT02914561|471089006|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130852824|NCT02914561|471089007|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130852825|NCT02914561|471089008|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130852826|NCT02914561|471089009|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130852827|NCT02914561|471089010|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130852828|NCT02914561|471089011|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130852829|NCT02914561|471089001|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130852830|NCT02914561|471089002|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130852831|NCT02914561|471089003|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
130852832|NCT02914561|471089004|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130852833|NCT02914561|471089005|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130852834|NCT02914561|471089006|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130852835|NCT02914561|471089007|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130852836|NCT02914561|471089008|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130852837|NCT02914561|471089009|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130852838|NCT02914561|471089010|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130852839|NCT02914561|471089011|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130852840|NCT02914561|471089001|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
130852841|NCT02914561|471089002|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130852842|NCT02914561|471089003|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130852843|NCT02914561|471089004|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130852844|NCT02914561|471089005|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130852845|NCT02914561|471089006|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130852846|NCT02914561|471089007|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130852847|NCT02914561|471089008|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130852848|NCT02914561|471089009|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130852849|NCT02914561|471089010|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130852850|NCT02914561|471089011|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130852851|NCT02914561|471089001|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130852852|NCT02914561|471089002|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130852853|NCT02914561|471089003|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130852854|NCT02914561|471089004|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130852855|NCT02914561|471089005|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130852856|NCT02914561|471089006|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130852857|NCT02914561|471089007|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
130852858|NCT02914561|471089008|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
130852859|NCT02914561|471089009|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
130852860|NCT02914561|471089010|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
130852861|NCT02914561|471089011|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
130852862|NCT02914561|471089001|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130852863|NCT02914561|471089002|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130852864|NCT02914561|471089003|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130852865|NCT02914561|471089004|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130852866|NCT02914561|471089005|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130852867|NCT02914561|471089006|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130852868|NCT02914561|471089007|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
130852869|NCT02914561|471089008|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
130852870|NCT02914561|471089009|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
130852871|NCT02914561|471089010|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
130852872|NCT02914561|471089011|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
130852873|NCT02914561|471089001|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130852874|NCT02914561|471089002|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130852875|NCT02914561|471089003|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130852876|NCT02914561|471089004|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130852877|NCT02914561|471089005|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130852878|NCT02914561|471089006|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130852879|NCT02914561|471089007|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
130852880|NCT02914561|471089008|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
130852881|NCT02914561|471089009|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
130852882|NCT02914561|471089010|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
130852883|NCT02914561|471089011|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
130852884|NCT02914561|471089001|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130852885|NCT02914561|471089002|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130852886|NCT02914561|471089003|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130852887|NCT02914561|471089004|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130852888|NCT02914561|471089005|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130852889|NCT02914561|471089006|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130852890|NCT02914561|471089007|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
130852891|NCT02914561|471089008|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130852892|NCT02914561|471089009|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
130852893|NCT02914561|471089010|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130852894|NCT02914561|471089011|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
130852895|NCT02914561|471089001|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130852896|NCT02914561|471089002|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130852897|NCT02914561|471089003|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130852898|NCT02914561|471089004|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130852899|NCT02914561|471089005|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130852900|NCT02914561|471089006|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130852901|NCT02914561|471089007|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
130852902|NCT02914561|471089008|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130852903|NCT02914561|471089009|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
130852904|NCT02914561|471089010|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
130852905|NCT02914561|471089011|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
130852906|NCT02914561|471089001|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130852907|NCT02914561|471089002|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130852908|NCT02914561|471089003|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130852909|NCT02914561|471089004|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130852910|NCT02914561|471089005|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130852911|NCT02914561|471089006|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130852912|NCT02914561|471089007|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
130852913|NCT02914561|471089008|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130852914|NCT02914561|471089009|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
130852915|NCT02914561|471089010|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130852916|NCT02914561|471089011|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130852917|NCT02914561|471089001|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130852918|NCT02914561|471089002|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130852919|NCT02914561|471089003|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130852920|NCT02914561|471089004|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130852921|NCT02914561|471089005|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130852922|NCT02914561|471089006|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130852923|NCT02914561|471089007|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130852924|NCT02914561|471089008|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130852925|NCT02914561|471089009|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
130852926|NCT02914561|471089010|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130852927|NCT02914561|471089011|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130852928|NCT02914561|471089001|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130852929|NCT02914561|471089002|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130852930|NCT02914561|471089003|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130852931|NCT02914561|471089004|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130852932|NCT02914561|471089005|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130852933|NCT02914561|471089006|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130852934|NCT02914561|471089007|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
130852935|NCT02914561|471089008|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130852936|NCT02914561|471089009|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130852937|NCT02914561|471089010|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130852938|NCT02914561|471089011|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130852939|NCT02914561|471089001|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130852940|NCT02914561|471089002|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130852941|NCT02914561|471089003|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130852942|NCT02914561|471089004|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130852943|NCT02914561|471089005|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130852944|NCT02914561|471089006|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130852945|NCT02914561|471089007|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130852946|NCT02914561|471089008|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130852947|NCT02914561|471089009|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
130852948|NCT02914561|471089010|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
130852949|NCT02914561|471089011|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
130852950|NCT01455220|471089014|FG000|Overall Study|screen fail|30|||
130852951|NCT00521222|471089016|FG000|Overall Study|Lost to Follow-up|0|||
130852952|NCT00521222|471089017|FG001|Overall Study|Lost to Follow-up|0|||
130852953|NCT00521222|471089018|FG002|Overall Study|Lost to Follow-up|1|||
130852954|NCT00521222|471089019|FG003|Overall Study|Lost to Follow-up|1|||
130852955|NCT00521222|471089016|FG000|Overall Study|Withdrawal by Subject|0|||
130852956|NCT00521222|471089017|FG001|Overall Study|Withdrawal by Subject|0|||
130852957|NCT00521222|471089018|FG002|Overall Study|Withdrawal by Subject|2|||
130852958|NCT00521222|471089019|FG003|Overall Study|Withdrawal by Subject|0|||
130852959|NCT00521222|471089016|FG000|Overall Study|Physician Decision|0|||
130852960|NCT00521222|471089017|FG001|Overall Study|Physician Decision|1|||
130852961|NCT00521222|471089018|FG002|Overall Study|Physician Decision|0|||
130852962|NCT00521222|471089019|FG003|Overall Study|Physician Decision|1|||
130852963|NCT03332160|471089020|FG000|Overall Study|Withdrawal by Subject|1|||
130852964|NCT03332160|471089021|FG001|Overall Study|Withdrawal by Subject|1|||
130852965|NCT03332160|471089020|FG000|Overall Study|Adverse Event|0|||
130852966|NCT03332160|471089021|FG001|Overall Study|Adverse Event|1|||
130852967|NCT03332160|471089020|FG000|Overall Study|Developed Exclusion Criteria|0|||
130852968|NCT03332160|471089021|FG001|Overall Study|Developed Exclusion Criteria|1|||
130852969|NCT03332160|471089020|FG000|Overall Study|Non-adherence to treatment|0|||
130852970|NCT03332160|471089021|FG001|Overall Study|Non-adherence to treatment|2|||
130852971|NCT03869333|471089025|FG000|Overall Study|Lost to Follow-up|1|||
130852972|NCT03869333|471089026|FG001|Overall Study|Lost to Follow-up|0|||
130852973|NCT03869333|471089027|FG002|Overall Study|Lost to Follow-up|0|||
130852974|NCT03869333|471089028|FG003|Overall Study|Lost to Follow-up|0|||
130852975|NCT03869333|471089025|FG000|Overall Study|Pregnancy|1|||
130852976|NCT03869333|471089026|FG001|Overall Study|Pregnancy|0|||
130852977|NCT03869333|471089027|FG002|Overall Study|Pregnancy|0|||
130852978|NCT03869333|471089028|FG003|Overall Study|Pregnancy|0|||
130852979|NCT03869333|471089025|FG000|Overall Study|Physician Decision|0|||
130852980|NCT03869333|471089026|FG001|Overall Study|Physician Decision|1|||
130852981|NCT03869333|471089027|FG002|Overall Study|Physician Decision|0|||
130852982|NCT03869333|471089028|FG003|Overall Study|Physician Decision|0|||
130852983|NCT01927055|471089029|FG000|Open-label|Adverse Event|6|||
130852984|NCT01927055|471089030|FG001|Open-label|Adverse Event|0|||
130852985|NCT01927055|471089031|FG002|Open-label|Adverse Event|0|||
130852986|NCT01927055|471089029|FG000|Open-label|Withdrawal by Subject|1|||
130852987|NCT01927055|471089030|FG001|Open-label|Withdrawal by Subject|0|||
130852988|NCT01927055|471089031|FG002|Open-label|Withdrawal by Subject|0|||
130852989|NCT01927055|471089029|FG000|Open-label|Study Stopped|4|||
130852990|NCT01927055|471089030|FG001|Open-label|Study Stopped|0|||
130852991|NCT01927055|471089031|FG002|Open-label|Study Stopped|0|||
130852992|NCT01927055|471089029|FG000|Open-label|Supine Hypertension|4|||
130852993|NCT01927055|471089030|FG001|Open-label|Supine Hypertension|0|||
130852994|NCT01927055|471089031|FG002|Open-label|Supine Hypertension|0|||
130852995|NCT01927055|471089029|FG000|Open-label|Difficulty attending study visits|1|||
130852996|NCT01927055|471089030|FG001|Open-label|Difficulty attending study visits|0|||
130852997|NCT01927055|471089031|FG002|Open-label|Difficulty attending study visits|0|||
130852998|NCT01927055|471089029|FG000|Double-Blind|Adverse Event|0|||
130852999|NCT01927055|471089030|FG001|Double-Blind|Adverse Event|1|||
130853000|NCT01927055|471089031|FG002|Double-Blind|Adverse Event|1|||
130853001|NCT01927055|471089029|FG000|Double-Blind|Protocol Violation|0|||
130853002|NCT01927055|471089030|FG001|Double-Blind|Protocol Violation|0|||
130853003|NCT01927055|471089031|FG002|Double-Blind|Protocol Violation|1|||
130853004|NCT01927055|471089029|FG000|Double-Blind|Withdrawal by Subject|0|||
130853005|NCT01927055|471089030|FG001|Double-Blind|Withdrawal by Subject|2|||
130853006|NCT01927055|471089031|FG002|Double-Blind|Withdrawal by Subject|3|||
130853007|NCT01927055|471089029|FG000|Double-Blind|Study Stopped|0|||
130853008|NCT01927055|471089030|FG001|Double-Blind|Study Stopped|7|||
130853009|NCT01927055|471089031|FG002|Double-Blind|Study Stopped|7|||
130853010|NCT01927055|471089029|FG000|Double-Blind|Supine Hypertension|0|||
130853011|NCT01927055|471089030|FG001|Double-Blind|Supine Hypertension|0|||
130853012|NCT01927055|471089031|FG002|Double-Blind|Supine Hypertension|1|||
130853013|NCT01927055|471089029|FG000|Double-Blind|Extended Vacation|0|||
130853014|NCT01927055|471089030|FG001|Double-Blind|Extended Vacation|1|||
130853015|NCT01927055|471089031|FG002|Double-Blind|Extended Vacation|0|||
130853016|NCT02598128|471089032|FG000|Period A: Days -7 to -1|Adverse Event|1|||
130853017|NCT02598128|471089033|FG001|Period A: Days -7 to -1|Adverse Event|0|||
130853018|NCT02598128|471089034|FG002|Period A: Days -7 to -1|Adverse Event|0|||
130853019|NCT02598128|471089035|FG003|Period A: Days -7 to -1|Adverse Event|0|||
130853020|NCT01459913|471089037|FG000|Overall Study|Adverse Event|0|||
130853021|NCT01459913|471089038|FG001|Overall Study|Adverse Event|0|||
130853022|NCT01459913|471089039|FG002|Overall Study|Adverse Event|0|||
130853023|NCT01459913|471089040|FG003|Overall Study|Adverse Event|3|||
130853024|NCT01459913|471089037|FG000|Overall Study|Withdrawal by Subject|4|||
130853025|NCT01459913|471089038|FG001|Overall Study|Withdrawal by Subject|0|||
130853026|NCT01459913|471089039|FG002|Overall Study|Withdrawal by Subject|0|||
130853027|NCT01459913|471089040|FG003|Overall Study|Withdrawal by Subject|5|||
130853028|NCT01459913|471089037|FG000|Overall Study|Lost to Follow-up|7|||
130853029|NCT01459913|471089038|FG001|Overall Study|Lost to Follow-up|4|||
130853030|NCT01459913|471089039|FG002|Overall Study|Lost to Follow-up|1|||
130853031|NCT01459913|471089040|FG003|Overall Study|Lost to Follow-up|8|||
130853032|NCT01459913|471089037|FG000|Overall Study|Death|0|||
130853033|NCT01459913|471089038|FG001|Overall Study|Death|0|||
130853034|NCT01459913|471089039|FG002|Overall Study|Death|0|||
130853035|NCT01459913|471089040|FG003|Overall Study|Death|1|||
130853036|NCT01459913|471089037|FG000|Overall Study|Non- Compliance|0|||
130853037|NCT01459913|471089038|FG001|Overall Study|Non- Compliance|0|||
130853038|NCT01459913|471089039|FG002|Overall Study|Non- Compliance|0|||
130853039|NCT01459913|471089040|FG003|Overall Study|Non- Compliance|3|||
130853040|NCT01459913|471089037|FG000|Overall Study|Physician Decision|0|||
130853041|NCT01459913|471089038|FG001|Overall Study|Physician Decision|1|||
130853042|NCT01459913|471089039|FG002|Overall Study|Physician Decision|0|||
130853043|NCT01459913|471089040|FG003|Overall Study|Physician Decision|0|||
130853044|NCT01459913|471089037|FG000|Overall Study|Study Terminated by Sponsor|30|||
130853045|NCT01459913|471089038|FG001|Overall Study|Study Terminated by Sponsor|15|||
130853046|NCT01459913|471089039|FG002|Overall Study|Study Terminated by Sponsor|9|||
130853047|NCT01459913|471089040|FG003|Overall Study|Study Terminated by Sponsor|11|||
130853048|NCT01459913|471089037|FG000|Overall Study|Other|0|||
130853049|NCT01459913|471089038|FG001|Overall Study|Other|0|||
130853050|NCT01459913|471089039|FG002|Overall Study|Other|3|||
130853051|NCT01459913|471089040|FG003|Overall Study|Other|1|||
130853052|NCT01459913|471089037|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
130853053|NCT01459913|471089038|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
130853054|NCT01459913|471089039|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
130853055|NCT01459913|471089040|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
130853056|NCT01064687|471089044|FG000|Overall Study|Adverse Event|9|||
130853057|NCT01064687|471089045|FG001|Overall Study|Adverse Event|4|||
130853058|NCT01064687|471089046|FG002|Overall Study|Adverse Event|10|||
130853059|NCT01064687|471089047|FG003|Overall Study|Adverse Event|3|||
130853060|NCT01064687|471089044|FG000|Overall Study|Death|1|||
130853061|NCT01064687|471089045|FG001|Overall Study|Death|1|||
130853062|NCT01064687|471089046|FG002|Overall Study|Death|0|||
130853063|NCT01064687|471089047|FG003|Overall Study|Death|0|||
130853064|NCT01064687|471089044|FG000|Overall Study|Entry Criteria Not Met|3|||
130853065|NCT01064687|471089045|FG001|Overall Study|Entry Criteria Not Met|0|||
130853066|NCT01064687|471089046|FG002|Overall Study|Entry Criteria Not Met|0|||
130853067|NCT01064687|471089047|FG003|Overall Study|Entry Criteria Not Met|0|||
130853068|NCT01064687|471089044|FG000|Overall Study|Lack of Efficacy|1|||
130853069|NCT01064687|471089045|FG001|Overall Study|Lack of Efficacy|0|||
130853070|NCT01064687|471089046|FG002|Overall Study|Lack of Efficacy|2|||
130853071|NCT01064687|471089047|FG003|Overall Study|Lack of Efficacy|3|||
130853072|NCT01064687|471089044|FG000|Overall Study|Lost to Follow-up|7|||
130853073|NCT01064687|471089045|FG001|Overall Study|Lost to Follow-up|10|||
130853074|NCT01064687|471089046|FG002|Overall Study|Lost to Follow-up|13|||
130853075|NCT01064687|471089047|FG003|Overall Study|Lost to Follow-up|5|||
130853076|NCT01064687|471089044|FG000|Overall Study|Physician Decision|2|||
130853077|NCT01064687|471089045|FG001|Overall Study|Physician Decision|2|||
130853078|NCT01064687|471089046|FG002|Overall Study|Physician Decision|0|||
130853079|NCT01064687|471089047|FG003|Overall Study|Physician Decision|0|||
130853080|NCT01064687|471089044|FG000|Overall Study|Protocol Violation|1|||
130853081|NCT01064687|471089045|FG001|Overall Study|Protocol Violation|1|||
130853082|NCT01064687|471089046|FG002|Overall Study|Protocol Violation|0|||
130853083|NCT01064687|471089047|FG003|Overall Study|Protocol Violation|1|||
130853084|NCT01064687|471089044|FG000|Overall Study|Sponsor Decision|0|||
130853085|NCT01064687|471089045|FG001|Overall Study|Sponsor Decision|0|||
130853086|NCT01064687|471089046|FG002|Overall Study|Sponsor Decision|3|||
130853087|NCT01064687|471089047|FG003|Overall Study|Sponsor Decision|0|||
130853088|NCT01064687|471089044|FG000|Overall Study|Withdrawal by Subject|9|||
130853089|NCT01064687|471089045|FG001|Overall Study|Withdrawal by Subject|7|||
130853090|NCT01064687|471089046|FG002|Overall Study|Withdrawal by Subject|12|||
130853091|NCT01064687|471089047|FG003|Overall Study|Withdrawal by Subject|5|||
130853092|NCT01064687|471089044|FG000|Overall Study|Treatment Noncompliance|1|||
130853093|NCT01064687|471089045|FG001|Overall Study|Treatment Noncompliance|1|||
130853094|NCT01064687|471089046|FG002|Overall Study|Treatment Noncompliance|1|||
130853095|NCT01064687|471089047|FG003|Overall Study|Treatment Noncompliance|0|||
130853096|NCT00619489|471089048|FG000|Overall Study|Adverse Event|0|||
130853097|NCT00619489|471089049|FG001|Overall Study|Adverse Event|7|||
130853098|NCT00619489|471089048|FG000|Overall Study|Withdrawal by Subject|1|||
130853099|NCT00619489|471089049|FG001|Overall Study|Withdrawal by Subject|1|||
130853100|NCT00619489|471089048|FG000|Overall Study|Lack of Efficacy|0|||
130853101|NCT00619489|471089049|FG001|Overall Study|Lack of Efficacy|11|||
130853102|NCT00619489|471089048|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
130853103|NCT00619489|471089049|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
130853104|NCT02966015|471089050|FG000|Inclusion Visit|did not answer questionnaire|8|||
130853105|NCT02966015|471089051|FG001|Inclusion Visit|did not answer questionnaire|3|||
130853106|NCT03040986|471089058|FG000|Overall Study|Hospice|1|||
130853107|NCT03040986|471089059|FG001|Overall Study|Hospice|0|||
130853108|NCT03040986|471089058|FG000|Overall Study|Adverse Event|2|||
130853109|NCT03040986|471089059|FG001|Overall Study|Adverse Event|1|||
130853110|NCT03040986|471089058|FG000|Overall Study|Disease progression on study|3|||
130853111|NCT03040986|471089059|FG001|Overall Study|Disease progression on study|1|||
130853112|NCT00845065|471089064|FG000|Overall Study|Adverse Event|3|||
130853113|NCT00845065|471089065|FG001|Overall Study|Adverse Event|23|||
130853114|NCT00845065|471089064|FG000|Overall Study|Lack of Efficacy|43|||
130853115|NCT00845065|471089065|FG001|Overall Study|Lack of Efficacy|21|||
130853116|NCT00845065|471089064|FG000|Overall Study|Non-Medical Reasons|1|||
130853117|NCT00845065|471089065|FG001|Overall Study|Non-Medical Reasons|11|||
130853118|NCT01183468|471089066|FG000|Overall Study|Lost to Follow-up|2|||
130853119|NCT01183468|471089067|FG001|Overall Study|Lost to Follow-up|1|||
130853120|NCT01183468|471089068|FG002|Overall Study|Lost to Follow-up|0|||
130853121|NCT01183468|471089069|FG003|Overall Study|Lost to Follow-up|0|||
130853122|NCT01183468|471089066|FG000|Overall Study|Physician Decision|1|||
130853123|NCT01183468|471089067|FG001|Overall Study|Physician Decision|0|||
130853124|NCT01183468|471089068|FG002|Overall Study|Physician Decision|0|||
130853125|NCT01183468|471089069|FG003|Overall Study|Physician Decision|0|||
130853126|NCT01183468|471089066|FG000|Overall Study|Withdrawal by Subject|0|||
130853127|NCT01183468|471089067|FG001|Overall Study|Withdrawal by Subject|1|||
130853128|NCT01183468|471089068|FG002|Overall Study|Withdrawal by Subject|0|||
130853129|NCT01183468|471089069|FG003|Overall Study|Withdrawal by Subject|0|||
130853130|NCT01198509|471089070|FG000|Overall Study|Withdrawal by Subject|1|||
130853131|NCT01198509|471089071|FG001|Overall Study|Withdrawal by Subject|0|||
130853132|NCT01198509|471089072|FG002|Overall Study|Withdrawal by Subject|0|||
130853133|NCT01198509|471089073|FG003|Overall Study|Withdrawal by Subject|0|||
130853134|NCT01198509|471089074|FG004|Overall Study|Withdrawal by Subject|0|||
130853135|NCT01198509|471089075|FG005|Overall Study|Withdrawal by Subject|0|||
130853136|NCT00499746|471089076|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
130853137|NCT00499746|471089076|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
130853138|NCT00499746|471089076|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
130853139|NCT00499746|471089076|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
130853140|NCT02273960|471089077|FG000|Short Term Period|Lost to Follow-up|1|||
130853141|NCT02273960|471089078|FG001|Short Term Period|Lost to Follow-up|0|||
130853142|NCT02273960|471089079|FG002|Short Term Period|Lost to Follow-up|0|||
130853143|NCT02273960|471089080|FG003|Short Term Period|Lost to Follow-up|0|||
130853144|NCT02273960|471089077|FG000|Short Term Period|Lack of Efficacy|0|||
130853145|NCT02273960|471089078|FG001|Short Term Period|Lack of Efficacy|0|||
130853146|NCT02273960|471089079|FG002|Short Term Period|Lack of Efficacy|0|||
130853147|NCT02273960|471089080|FG003|Short Term Period|Lack of Efficacy|1|||
130853148|NCT02273960|471089077|FG000|Short Term Period|ST complete, not entering LTE|4|||
130853149|NCT02273960|471089078|FG001|Short Term Period|ST complete, not entering LTE|6|||
130853150|NCT02273960|471089079|FG002|Short Term Period|ST complete, not entering LTE|4|||
130853151|NCT02273960|471089080|FG003|Short Term Period|ST complete, not entering LTE|5|||
130853152|NCT02273960|471089077|FG000|Long Term Extension|Death|0|||
130853153|NCT02273960|471089078|FG001|Long Term Extension|Death|0|||
130853154|NCT02273960|471089079|FG002|Long Term Extension|Death|0|||
130853155|NCT02273960|471089080|FG003|Long Term Extension|Death|1|||
130853156|NCT00558272|471089081|FG000|Overall Study|Adverse Event|10|||
130853157|NCT00558272|471089082|FG001|Overall Study|Adverse Event|0|||
130853158|NCT00558272|471089081|FG000|Overall Study|Death|1|||
130853159|NCT00558272|471089082|FG001|Overall Study|Death|0|||
130853160|NCT00558272|471089081|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
130853161|NCT00558272|471089082|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
130853162|NCT00558272|471089081|FG000|Overall Study|AZ study team decision|0|||
130853163|NCT00558272|471089082|FG001|Overall Study|AZ study team decision|1|||
130853164|NCT00558272|471089081|FG000|Overall Study|Incorrectly enrolled|1|||
130853165|NCT00558272|471089082|FG001|Overall Study|Incorrectly enrolled|0|||
130853166|NCT00558272|471089081|FG000|Overall Study|Withdrawal by Subject|0|||
130853167|NCT00558272|471089082|FG001|Overall Study|Withdrawal by Subject|1|||
130853168|NCT02745535|471089084|FG000|Overall Study|Death|1|||
130853169|NCT02745535|471089084|FG000|Overall Study|Adverse Event|3|||
130853170|NCT02745535|471089084|FG000|Overall Study|Lost to Follow-up|2|||
130853171|NCT01291277|471089085|FG000|Overall Study|Death|2|||
130853172|NCT01291277|471089086|FG001|Overall Study|Death|2|||
130853173|NCT01291277|471089085|FG000|Overall Study|Lost to Follow-up|3|||
130853174|NCT01291277|471089086|FG001|Overall Study|Lost to Follow-up|1|||
130853175|NCT00849108|471089087|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
130853176|NCT00849108|471089088|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
130853177|NCT00849108|471089087|FG000|Cohort 2 Efficacy|Adverse Event|0|||
130853178|NCT00849108|471089088|FG001|Cohort 2 Efficacy|Adverse Event|1|||
130853179|NCT00849108|471089087|FG000|Cohort 2 Efficacy|Other|0|||
130853180|NCT00849108|471089088|FG001|Cohort 2 Efficacy|Other|9|||
130853181|NCT02963701|471089089|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
130853182|NCT02963701|471089090|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
130853183|NCT03480009|471089091|FG000|Overall Study|Lost to Follow-up|4|||
130853184|NCT03480009|471089092|FG001|Overall Study|Lost to Follow-up|5|||
130853185|NCT03480009|471089093|FG002|Overall Study|Lost to Follow-up|4|||
130853186|NCT03480009|471089094|FG003|Overall Study|Lost to Follow-up|0|||
130853187|NCT01563172|471089097|FG000|Overall Study|Adverse Event|5|||
130853188|NCT01563172|471089097|FG000|Overall Study|Lost to Follow-up|2|||
130853189|NCT01563172|471089097|FG000|Overall Study|Other (Protocol deviation)|5|||
130853190|NCT01563172|471089097|FG000|Overall Study|Other (Not specified)|1|||
130853191|NCT01105377|471089098|FG000|Overall Study|Withdrawal by Subject|0|||
130853192|NCT01105377|471089099|FG001|Overall Study|Withdrawal by Subject|1|||
130853193|NCT02014584|471089107|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130853194|NCT02014584|471089108|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
130853195|NCT02014584|471089109|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130853196|NCT02014584|471089110|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130853197|NCT02014584|471089111|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130853198|NCT02014584|471089112|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130875574|NCT05893862|471173850|FG004|Overall Study|Physician Decision|1|||
130853199|NCT02014584|471089107|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
130853200|NCT02014584|471089108|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
130853201|NCT02014584|471089109|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130853202|NCT02014584|471089110|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130853203|NCT02014584|471089111|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130853204|NCT02014584|471089112|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130853205|NCT02014584|471089107|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130853206|NCT02014584|471089108|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130853207|NCT02014584|471089109|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
130853208|NCT02014584|471089110|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130853209|NCT02014584|471089111|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130853210|NCT02014584|471089112|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130853211|NCT02014584|471089107|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130853212|NCT02014584|471089108|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130853213|NCT02014584|471089109|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
130853214|NCT02014584|471089110|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
130853215|NCT02014584|471089111|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130853216|NCT02014584|471089112|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130853217|NCT02014584|471089107|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130853218|NCT02014584|471089108|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130853219|NCT02014584|471089109|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130853220|NCT02014584|471089110|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130853221|NCT02014584|471089111|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
130853222|NCT02014584|471089112|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130853223|NCT01624090|471089113|FG000|Overall Study|DLT, taken off therapy|0|||
130853224|NCT01624090|471089114|FG001|Overall Study|DLT, taken off therapy|1|||
130853225|NCT01624090|471089115|FG002|Overall Study|DLT, taken off therapy|0|||
130853226|NCT01624090|471089116|FG003|Overall Study|DLT, taken off therapy|0|||
130853227|NCT01624090|471089113|FG000|Overall Study|Withdrew prior to treatment|0|||
130853228|NCT01624090|471089114|FG001|Overall Study|Withdrew prior to treatment|1|||
130853229|NCT01624090|471089115|FG002|Overall Study|Withdrew prior to treatment|0|||
130853230|NCT01624090|471089116|FG003|Overall Study|Withdrew prior to treatment|0|||
130853231|NCT01624090|471089113|FG000|Overall Study|Died on study|0|||
130853232|NCT01624090|471089114|FG001|Overall Study|Died on study|0|||
130853233|NCT01624090|471089115|FG002|Overall Study|Died on study|2|||
130853234|NCT01624090|471089116|FG003|Overall Study|Died on study|0|||
130853235|NCT01624090|471089113|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
130853236|NCT01624090|471089114|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
130853237|NCT01624090|471089115|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
130853238|NCT01624090|471089116|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
130853239|NCT01624090|471089113|FG000|Overall Study|Dose escalated|0|||
130853240|NCT01624090|471089114|FG001|Overall Study|Dose escalated|0|||
130853241|NCT01624090|471089115|FG002|Overall Study|Dose escalated|3|||
130853242|NCT01624090|471089116|FG003|Overall Study|Dose escalated|0|||
130853243|NCT00772109|471089117|FG000|Overall Study|Serious adverse event|1|||
130853244|NCT00772109|471089118|FG001|Overall Study|Serious adverse event|0|||
130853245|NCT00772109|471089119|FG002|Overall Study|Serious adverse event|1|||
130853246|NCT00772109|471089120|FG003|Overall Study|Serious adverse event|0|||
130853247|NCT00772109|471089117|FG000|Overall Study|Protocol Violation|5|||
130853248|NCT00772109|471089118|FG001|Overall Study|Protocol Violation|8|||
130853249|NCT00772109|471089119|FG002|Overall Study|Protocol Violation|7|||
130853250|NCT00772109|471089120|FG003|Overall Study|Protocol Violation|6|||
130853251|NCT00772109|471089117|FG000|Overall Study|Lost to Follow-up|7|||
130853252|NCT00772109|471089118|FG001|Overall Study|Lost to Follow-up|3|||
130853253|NCT00772109|471089119|FG002|Overall Study|Lost to Follow-up|5|||
130853254|NCT00772109|471089120|FG003|Overall Study|Lost to Follow-up|9|||
130853255|NCT00772109|471089117|FG000|Overall Study|Withdrawal by Subject|8|||
130853256|NCT00772109|471089118|FG001|Overall Study|Withdrawal by Subject|8|||
130853257|NCT00772109|471089119|FG002|Overall Study|Withdrawal by Subject|6|||
130853258|NCT00772109|471089120|FG003|Overall Study|Withdrawal by Subject|16|||
130853259|NCT00752726|471089121|FG000|Overall Study|Lost to Follow-up|2|||
130853260|NCT00752726|471089122|FG001|Overall Study|Lost to Follow-up|1|||
130853261|NCT00752726|471089121|FG000|Overall Study|Adverse Event|3|||
130853262|NCT00752726|471089122|FG001|Overall Study|Adverse Event|0|||
130853263|NCT00752726|471089121|FG000|Overall Study|Withdrawal by Subject|5|||
130853264|NCT00752726|471089122|FG001|Overall Study|Withdrawal by Subject|10|||
130853265|NCT00752726|471089121|FG000|Overall Study|Other Reason|1|||
130853266|NCT00752726|471089122|FG001|Overall Study|Other Reason|2|||
130853267|NCT00042666|471089123|FG000|Overall Study|Adverse Event|2|||
130853268|NCT00042666|471089123|FG000|Overall Study|Death|4|||
130853269|NCT00042666|471089123|FG000|Overall Study|Protocol Violation|1|||
130853270|NCT00042666|471089123|FG000|Overall Study|Participant/Physician Perception|1|||
130853271|NCT00042666|471089123|FG000|Overall Study|Progressive Disease|41|||
130853272|NCT00042666|471089123|FG000|Overall Study|Other|1|||
130853273|NCT00042666|471089123|FG000|Overall Study|Other|4|||
130853274|NCT04232215|471089124|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
130853275|NCT04232215|471089125|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130853276|NCT01555125|471089128|FG000|Induction Period|Lost to Follow-up|0|||
130853277|NCT01555125|471089129|FG001|Induction Period|Lost to Follow-up|2|||
130853278|NCT01555125|471089130|FG002|Induction Period|Lost to Follow-up|0|||
130853279|NCT01555125|471089131|FG003|Induction Period|Lost to Follow-up|0|||
130853280|NCT01555125|471089132|FG004|Induction Period|Lost to Follow-up|0|||
130853281|NCT01555125|471089128|FG000|Induction Period|Adverse Event|0|||
130853282|NCT01555125|471089129|FG001|Induction Period|Adverse Event|1|||
130853283|NCT01555125|471089130|FG002|Induction Period|Adverse Event|0|||
130853284|NCT01555125|471089131|FG003|Induction Period|Adverse Event|0|||
130853285|NCT01555125|471089132|FG004|Induction Period|Adverse Event|1|||
130853286|NCT01555125|471089128|FG000|Induction Period|Subject / guardian decision|0|||
130853287|NCT01555125|471089129|FG001|Induction Period|Subject / guardian decision|0|||
130853288|NCT01555125|471089130|FG002|Induction Period|Subject / guardian decision|0|||
130853289|NCT01555125|471089131|FG003|Induction Period|Subject / guardian decision|0|||
130853290|NCT01555125|471089132|FG004|Induction Period|Subject / guardian decision|2|||
130853291|NCT01555125|471089128|FG000|Induction Period|Death|1|||
130853292|NCT01555125|471089129|FG001|Induction Period|Death|0|||
130853293|NCT01555125|471089130|FG002|Induction Period|Death|0|||
130853294|NCT01555125|471089131|FG003|Induction Period|Death|0|||
130853295|NCT01555125|471089132|FG004|Induction Period|Death|0|||
130853296|NCT01555125|471089128|FG000|Maintenance Period|Adverse Event|1|||
130853297|NCT01555125|471089129|FG001|Maintenance Period|Adverse Event|1|||
130853298|NCT01555125|471089130|FG002|Maintenance Period|Adverse Event|0|||
130853299|NCT01555125|471089131|FG003|Maintenance Period|Adverse Event|0|||
130853300|NCT01555125|471089132|FG004|Maintenance Period|Adverse Event|0|||
130853301|NCT01555125|471089128|FG000|Maintenance Period|Subject / guardian decision|1|||
130853302|NCT01555125|471089129|FG001|Maintenance Period|Subject / guardian decision|2|||
130853303|NCT01555125|471089130|FG002|Maintenance Period|Subject / guardian decision|0|||
130853304|NCT01555125|471089131|FG003|Maintenance Period|Subject / guardian decision|0|||
130853305|NCT01555125|471089132|FG004|Maintenance Period|Subject / guardian decision|0|||
130853306|NCT01555125|471089128|FG000|Maintenance Period|Lost to Follow-up|2|||
130853307|NCT01555125|471089129|FG001|Maintenance Period|Lost to Follow-up|0|||
130853308|NCT01555125|471089130|FG002|Maintenance Period|Lost to Follow-up|0|||
130853309|NCT01555125|471089131|FG003|Maintenance Period|Lost to Follow-up|1|||
130853310|NCT01555125|471089132|FG004|Maintenance Period|Lost to Follow-up|0|||
130853311|NCT01555125|471089128|FG000|Maintenance Period|Lack of Efficacy|6|||
130853312|NCT01555125|471089129|FG001|Maintenance Period|Lack of Efficacy|1|||
130853313|NCT01555125|471089130|FG002|Maintenance Period|Lack of Efficacy|3|||
130853314|NCT01555125|471089131|FG003|Maintenance Period|Lack of Efficacy|0|||
130853315|NCT01555125|471089132|FG004|Maintenance Period|Lack of Efficacy|0|||
130853316|NCT01555125|471089128|FG000|Maintenance Period|Physician Decision|0|||
130853317|NCT01555125|471089129|FG001|Maintenance Period|Physician Decision|0|||
130853318|NCT01555125|471089130|FG002|Maintenance Period|Physician Decision|1|||
130853319|NCT01555125|471089131|FG003|Maintenance Period|Physician Decision|0|||
130853320|NCT01555125|471089132|FG004|Maintenance Period|Physician Decision|0|||
130853321|NCT01555125|471089128|FG000|Maintenance Period|Death|0|||
130853322|NCT01555125|471089129|FG001|Maintenance Period|Death|0|||
130853323|NCT01555125|471089130|FG002|Maintenance Period|Death|0|||
130853324|NCT01555125|471089131|FG003|Maintenance Period|Death|1|||
130853325|NCT01555125|471089132|FG004|Maintenance Period|Death|0|||
130853326|NCT01555125|471089128|FG000|Extension|Adverse Event|1|||
130853327|NCT01555125|471089129|FG001|Extension|Adverse Event|2|||
130853328|NCT01555125|471089130|FG002|Extension|Adverse Event|1|||
130853329|NCT01555125|471089131|FG003|Extension|Adverse Event|1|||
130853330|NCT01555125|471089132|FG004|Extension|Adverse Event|0|||
130853331|NCT01555125|471089128|FG000|Extension|Protocol deviation|1|||
130853332|NCT01555125|471089129|FG001|Extension|Protocol deviation|0|||
130853333|NCT01555125|471089130|FG002|Extension|Protocol deviation|0|||
130853334|NCT01555125|471089131|FG003|Extension|Protocol deviation|0|||
130853335|NCT01555125|471089132|FG004|Extension|Protocol deviation|0|||
130853336|NCT01555125|471089128|FG000|Extension|Lack of Efficacy|7|||
130853337|NCT01555125|471089129|FG001|Extension|Lack of Efficacy|6|||
130853338|NCT01555125|471089130|FG002|Extension|Lack of Efficacy|3|||
130853339|NCT01555125|471089131|FG003|Extension|Lack of Efficacy|0|||
130853340|NCT01555125|471089132|FG004|Extension|Lack of Efficacy|0|||
130853341|NCT01555125|471089128|FG000|Extension|Lost to Follow-up|2|||
130853342|NCT01555125|471089129|FG001|Extension|Lost to Follow-up|1|||
130853343|NCT01555125|471089130|FG002|Extension|Lost to Follow-up|2|||
130853344|NCT01555125|471089131|FG003|Extension|Lost to Follow-up|0|||
130853345|NCT01555125|471089132|FG004|Extension|Lost to Follow-up|0|||
130853346|NCT01555125|471089128|FG000|Extension|Study terminated by sponsor|32|||
130853347|NCT01555125|471089129|FG001|Extension|Study terminated by sponsor|33|||
130853348|NCT01555125|471089130|FG002|Extension|Study terminated by sponsor|16|||
130853349|NCT01555125|471089131|FG003|Extension|Study terminated by sponsor|20|||
130875575|NCT05893862|471173851|FG005|Overall Study|Physician Decision|0|||
130853350|NCT01555125|471089132|FG004|Extension|Study terminated by sponsor|0|||
130853351|NCT01555125|471089128|FG000|Extension|Subject/guardian decision|1|||
130853352|NCT01555125|471089129|FG001|Extension|Subject/guardian decision|9|||
130853353|NCT01555125|471089130|FG002|Extension|Subject/guardian decision|1|||
130853354|NCT01555125|471089131|FG003|Extension|Subject/guardian decision|0|||
130853355|NCT01555125|471089132|FG004|Extension|Subject/guardian decision|0|||
130853356|NCT01555125|471089128|FG000|Extension|Technical Problems|1|||
130853357|NCT01555125|471089129|FG001|Extension|Technical Problems|0|||
130853358|NCT01555125|471089130|FG002|Extension|Technical Problems|0|||
130853359|NCT01555125|471089131|FG003|Extension|Technical Problems|1|||
130853360|NCT01555125|471089132|FG004|Extension|Technical Problems|0|||
130853361|NCT01555125|471089128|FG000|Follow-Up Period|Lost to Follow-up|1|||
130853362|NCT01555125|471089129|FG001|Follow-Up Period|Lost to Follow-up|0|||
130853363|NCT01555125|471089130|FG002|Follow-Up Period|Lost to Follow-up|0|||
130853364|NCT01555125|471089131|FG003|Follow-Up Period|Lost to Follow-up|0|||
130853365|NCT01555125|471089132|FG004|Follow-Up Period|Lost to Follow-up|0|||
130853366|NCT01555125|471089128|FG000|Follow-Up Period|Subject / guardian decision|3|||
130853367|NCT01555125|471089129|FG001|Follow-Up Period|Subject / guardian decision|1|||
130853368|NCT01555125|471089130|FG002|Follow-Up Period|Subject / guardian decision|1|||
130853369|NCT01555125|471089131|FG003|Follow-Up Period|Subject / guardian decision|1|||
130853370|NCT01555125|471089132|FG004|Follow-Up Period|Subject / guardian decision|0|||
130853371|NCT02651220|471089133|FG000|Overall Study|Adverse Event|1|||
130853372|NCT02651220|471089134|FG001|Overall Study|Adverse Event|5|||
130853373|NCT02651220|471089135|FG002|Overall Study|Adverse Event|1|||
130853374|NCT02651220|471089133|FG000|Overall Study|Lost to Follow-up|8|||
130853375|NCT02651220|471089134|FG001|Overall Study|Lost to Follow-up|14|||
130853376|NCT02651220|471089135|FG002|Overall Study|Lost to Follow-up|14|||
130853377|NCT02651220|471089133|FG000|Overall Study|Non-Compliance with Study Drug|4|||
130853378|NCT02651220|471089134|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130853379|NCT02651220|471089135|FG002|Overall Study|Non-Compliance with Study Drug|1|||
130853380|NCT02651220|471089133|FG000|Overall Study|Pregnancy|1|||
130853381|NCT02651220|471089134|FG001|Overall Study|Pregnancy|0|||
130853382|NCT02651220|471089135|FG002|Overall Study|Pregnancy|1|||
130853383|NCT02651220|471089133|FG000|Overall Study|Protocol Violation|0|||
130853384|NCT02651220|471089134|FG001|Overall Study|Protocol Violation|0|||
130853385|NCT02651220|471089135|FG002|Overall Study|Protocol Violation|1|||
130853386|NCT02651220|471089133|FG000|Overall Study|Withdrawal by Subject|5|||
130853387|NCT02651220|471089134|FG001|Overall Study|Withdrawal by Subject|6|||
130853388|NCT02651220|471089135|FG002|Overall Study|Withdrawal by Subject|8|||
130853389|NCT02651220|471089133|FG000|Overall Study|Miscellaneous|4|||
130853390|NCT02651220|471089134|FG001|Overall Study|Miscellaneous|1|||
130853391|NCT02651220|471089135|FG002|Overall Study|Miscellaneous|2|||
130853392|NCT02651220|471089133|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130853393|NCT02651220|471089134|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130853394|NCT02651220|471089135|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
130853395|NCT02540291|471089136|FG000|Overall Study|Death|7|||
130853396|NCT02540291|471089137|FG001|Overall Study|Death|7|||
130853397|NCT02540291|471089138|FG002|Overall Study|Death|5|||
130853398|NCT02540291|471089139|FG003|Overall Study|Death|7|||
130853399|NCT02540291|471089136|FG000|Overall Study|Lost to Follow-up|0|||
130853400|NCT02540291|471089137|FG001|Overall Study|Lost to Follow-up|0|||
130853401|NCT02540291|471089138|FG002|Overall Study|Lost to Follow-up|1|||
130853402|NCT02540291|471089139|FG003|Overall Study|Lost to Follow-up|0|||
130853403|NCT02540291|471089136|FG000|Overall Study|Withdrawal Of Consent|0|||
130853404|NCT02540291|471089137|FG001|Overall Study|Withdrawal Of Consent|1|||
130853405|NCT02540291|471089138|FG002|Overall Study|Withdrawal Of Consent|0|||
130853406|NCT02540291|471089139|FG003|Overall Study|Withdrawal Of Consent|0|||
130853407|NCT02540291|471089136|FG000|Overall Study|Study Terminated By Sponsor|1|||
130853408|NCT02540291|471089137|FG001|Overall Study|Study Terminated By Sponsor|0|||
130853409|NCT02540291|471089138|FG002|Overall Study|Study Terminated By Sponsor|0|||
130853410|NCT02540291|471089139|FG003|Overall Study|Study Terminated By Sponsor|0|||
130853411|NCT02540291|471089136|FG000|Overall Study|Other|0|||
130853412|NCT02540291|471089137|FG001|Overall Study|Other|0|||
130853413|NCT02540291|471089138|FG002|Overall Study|Other|1|||
130853414|NCT02540291|471089139|FG003|Overall Study|Other|0|||
130853415|NCT01306656|471090711|FG000|Overall Study|Lost to Follow-up|1|||
130853416|NCT01306656|471090712|FG001|Overall Study|Lost to Follow-up|0|||
130853417|NCT00477152|471090713|FG000|Overall Study|Parent withdrew consent|2|||
130853418|NCT00477152|471090713|FG000|Overall Study|Adverse Event|1|||
130853419|NCT02504580|471090714|FG000|Overall Study|Other|1|||
130853420|NCT02504580|471090715|FG001|Overall Study|Other|0|||
130853421|NCT02504580|471090716|FG002|Overall Study|Other|0|||
130853422|NCT02504580|471090717|FG003|Overall Study|Other|2|||
130853423|NCT02504580|471090718|FG004|Overall Study|Other|1|||
130853424|NCT02504580|471090719|FG005|Overall Study|Other|1|||
130853425|NCT02504580|471090720|FG006|Overall Study|Other|1|||
130853426|NCT02504580|471090721|FG007|Overall Study|Other|2|||
130853427|NCT02504580|471090722|FG008|Overall Study|Other|0|||
130853428|NCT02504580|471090723|FG009|Overall Study|Other|0|||
130853429|NCT02504580|471090724|FG010|Overall Study|Other|0|||
130853430|NCT02504580|471090725|FG011|Overall Study|Other|2|||
130853431|NCT02504580|471090714|FG000|Overall Study|Subject refusal to continue|0|||
130853432|NCT02504580|471090715|FG001|Overall Study|Subject refusal to continue|1|||
130853433|NCT02504580|471090716|FG002|Overall Study|Subject refusal to continue|0|||
130853434|NCT02504580|471090717|FG003|Overall Study|Subject refusal to continue|0|||
130853435|NCT02504580|471090718|FG004|Overall Study|Subject refusal to continue|0|||
130853436|NCT02504580|471090719|FG005|Overall Study|Subject refusal to continue|0|||
130853437|NCT02504580|471090720|FG006|Overall Study|Subject refusal to continue|0|||
130853438|NCT02504580|471090721|FG007|Overall Study|Subject refusal to continue|0|||
130853439|NCT02504580|471090722|FG008|Overall Study|Subject refusal to continue|0|||
130853440|NCT02504580|471090723|FG009|Overall Study|Subject refusal to continue|0|||
130853441|NCT02504580|471090724|FG010|Overall Study|Subject refusal to continue|0|||
130853442|NCT02504580|471090725|FG011|Overall Study|Subject refusal to continue|0|||
130853443|NCT04051827|471090731|FG000|Overall Study|Death|1|||
130853444|NCT04051827|471090731|FG000|Overall Study|Withdrawal by Subject|4|||
130853445|NCT04051827|471090731|FG000|Overall Study|Progressive disease|16|||
130853446|NCT04051827|471090731|FG000|Overall Study|Physician Decision|1|||
130853447|NCT04051827|471090731|FG000|Overall Study|Other|4|||
130853448|NCT04676867|471090736|FG000|Overall Study|Screen failure|0|||
130853449|NCT04676867|471090737|FG001|Overall Study|Screen failure|0|||
130853450|NCT04676867|471090738|FG002|Overall Study|Screen failure|6|||
130853451|NCT04676867|471090739|FG003|Overall Study|Screen failure|2|||
130853452|NCT04676867|471090736|FG000|Overall Study|Death|0|||
130853453|NCT04676867|471090737|FG001|Overall Study|Death|0|||
130853454|NCT04676867|471090738|FG002|Overall Study|Death|1|||
130853455|NCT04676867|471090739|FG003|Overall Study|Death|0|||
130853456|NCT04676867|471090736|FG000|Overall Study|Withdrawal by Subject|2|||
130853457|NCT04676867|471090737|FG001|Overall Study|Withdrawal by Subject|2|||
130853458|NCT04676867|471090738|FG002|Overall Study|Withdrawal by Subject|4|||
130853459|NCT04676867|471090739|FG003|Overall Study|Withdrawal by Subject|4|||
130853460|NCT04676867|471090736|FG000|Overall Study|Lost to Follow-up|1|||
130853461|NCT04676867|471090737|FG001|Overall Study|Lost to Follow-up|0|||
130853462|NCT04676867|471090738|FG002|Overall Study|Lost to Follow-up|0|||
130853463|NCT04676867|471090739|FG003|Overall Study|Lost to Follow-up|0|||
130853464|NCT03779503|471090740|FG000|First Intervention|Adverse Event|0|||
130853465|NCT03779503|471090741|FG001|First Intervention|Adverse Event|1|||
130853466|NCT03779503|471090740|FG000|First Intervention|Withdrawal by Subject|1|||
130853467|NCT03779503|471090741|FG001|First Intervention|Withdrawal by Subject|0|||
130853468|NCT00549770|471090746|FG000|Overall Study|Protocol deviation|1|||
130853469|NCT00549770|471090747|FG001|Overall Study|Protocol deviation|1|||
130853470|NCT00549770|471090748|FG002|Overall Study|Protocol deviation|1|||
130853471|NCT00549770|471090749|FG003|Overall Study|Protocol deviation|2|||
130853472|NCT00549770|471090750|FG004|Overall Study|Protocol deviation|2|||
130853473|NCT00549770|471090751|FG005|Overall Study|Protocol deviation|2|||
130853474|NCT00549770|471090752|FG006|Overall Study|Protocol deviation|1|||
130853475|NCT00549770|471090753|FG007|Overall Study|Protocol deviation|2|||
130853476|NCT00549770|471090746|FG000|Overall Study|Administrative problems|0|||
130853477|NCT00549770|471090747|FG001|Overall Study|Administrative problems|1|||
130853478|NCT00549770|471090748|FG002|Overall Study|Administrative problems|0|||
130853479|NCT00549770|471090749|FG003|Overall Study|Administrative problems|0|||
130853480|NCT00549770|471090750|FG004|Overall Study|Administrative problems|0|||
130853481|NCT00549770|471090751|FG005|Overall Study|Administrative problems|0|||
130853482|NCT00549770|471090752|FG006|Overall Study|Administrative problems|0|||
130853483|NCT00549770|471090753|FG007|Overall Study|Administrative problems|1|||
130853484|NCT00549770|471090746|FG000|Overall Study|Lost to Follow-up|0|||
130853485|NCT00549770|471090747|FG001|Overall Study|Lost to Follow-up|0|||
130853486|NCT00549770|471090748|FG002|Overall Study|Lost to Follow-up|2|||
130853487|NCT00549770|471090749|FG003|Overall Study|Lost to Follow-up|2|||
130853488|NCT00549770|471090750|FG004|Overall Study|Lost to Follow-up|3|||
130853489|NCT00549770|471090751|FG005|Overall Study|Lost to Follow-up|2|||
130853490|NCT00549770|471090752|FG006|Overall Study|Lost to Follow-up|0|||
130853491|NCT00549770|471090753|FG007|Overall Study|Lost to Follow-up|0|||
130853492|NCT00549770|471090746|FG000|Overall Study|Withdrawal by Subject|4|||
130853493|NCT00549770|471090747|FG001|Overall Study|Withdrawal by Subject|6|||
130853494|NCT00549770|471090748|FG002|Overall Study|Withdrawal by Subject|4|||
130853495|NCT00549770|471090749|FG003|Overall Study|Withdrawal by Subject|5|||
130853496|NCT00549770|471090750|FG004|Overall Study|Withdrawal by Subject|6|||
130853497|NCT00549770|471090751|FG005|Overall Study|Withdrawal by Subject|6|||
130853498|NCT00549770|471090752|FG006|Overall Study|Withdrawal by Subject|4|||
130853499|NCT00549770|471090753|FG007|Overall Study|Withdrawal by Subject|9|||
130853500|NCT00549770|471090746|FG000|Overall Study|Lack of Efficacy|1|||
130853501|NCT00549770|471090747|FG001|Overall Study|Lack of Efficacy|0|||
130853502|NCT00549770|471090748|FG002|Overall Study|Lack of Efficacy|2|||
130853503|NCT00549770|471090749|FG003|Overall Study|Lack of Efficacy|3|||
130853504|NCT00549770|471090750|FG004|Overall Study|Lack of Efficacy|5|||
130853505|NCT00549770|471090751|FG005|Overall Study|Lack of Efficacy|1|||
130853506|NCT00549770|471090752|FG006|Overall Study|Lack of Efficacy|3|||
130853507|NCT00549770|471090753|FG007|Overall Study|Lack of Efficacy|8|||
130853508|NCT00549770|471090746|FG000|Overall Study|Abnormal test procedure results|0|||
130853509|NCT00549770|471090747|FG001|Overall Study|Abnormal test procedure results|0|||
130853510|NCT00549770|471090748|FG002|Overall Study|Abnormal test procedure results|0|||
130853511|NCT00549770|471090749|FG003|Overall Study|Abnormal test procedure results|2|||
130853512|NCT00549770|471090750|FG004|Overall Study|Abnormal test procedure results|0|||
130853513|NCT00549770|471090751|FG005|Overall Study|Abnormal test procedure results|1|||
130853514|NCT00549770|471090752|FG006|Overall Study|Abnormal test procedure results|1|||
130853515|NCT00549770|471090753|FG007|Overall Study|Abnormal test procedure results|1|||
130853516|NCT00549770|471090746|FG000|Overall Study|Abnormal laboratory values|0|||
130853517|NCT00549770|471090747|FG001|Overall Study|Abnormal laboratory values|0|||
130853518|NCT00549770|471090748|FG002|Overall Study|Abnormal laboratory values|0|||
130853519|NCT00549770|471090749|FG003|Overall Study|Abnormal laboratory values|0|||
130853520|NCT00549770|471090750|FG004|Overall Study|Abnormal laboratory values|0|||
130853521|NCT00549770|471090751|FG005|Overall Study|Abnormal laboratory values|1|||
130853522|NCT00549770|471090752|FG006|Overall Study|Abnormal laboratory values|0|||
130853523|NCT00549770|471090753|FG007|Overall Study|Abnormal laboratory values|0|||
130853524|NCT00549770|471090746|FG000|Overall Study|Adverse Event|1|||
130853525|NCT00549770|471090747|FG001|Overall Study|Adverse Event|3|||
130853526|NCT00549770|471090748|FG002|Overall Study|Adverse Event|1|||
130853527|NCT00549770|471090749|FG003|Overall Study|Adverse Event|2|||
130853528|NCT00549770|471090750|FG004|Overall Study|Adverse Event|1|||
130853529|NCT00549770|471090751|FG005|Overall Study|Adverse Event|0|||
130853530|NCT00549770|471090752|FG006|Overall Study|Adverse Event|5|||
130853531|NCT00549770|471090753|FG007|Overall Study|Adverse Event|4|||
130853532|NCT01079936|471090754|FG000|Phase I: MTD|First Remission Status|2|||
130853533|NCT01079936|471090755|FG001|Phase I: MTD|First Remission Status|0|||
130853534|NCT01079936|471090756|FG002|Phase I: MTD|First Remission Status|0|||
130853535|NCT01079936|471090757|FG003|Phase I: MTD|First Remission Status|0|||
130853536|NCT01079936|471090758|FG004|Phase I: MTD|First Remission Status|0|||
130853537|NCT01079936|471090754|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
130853538|NCT01079936|471090755|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
130853539|NCT01079936|471090756|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
130853540|NCT01079936|471090757|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
130853541|NCT01079936|471090758|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
130853542|NCT01079936|471090754|FG000|Phase II|Adverse Event|0|||
130853543|NCT01079936|471090755|FG001|Phase II|Adverse Event|0|||
130853544|NCT01079936|471090756|FG002|Phase II|Adverse Event|1|||
130853545|NCT01079936|471090757|FG003|Phase II|Adverse Event|0|||
130853546|NCT01079936|471090758|FG004|Phase II|Adverse Event|0|||
130853547|NCT01079936|471090754|FG000|Phase II|Insurance Issue|0|||
130853548|NCT01079936|471090755|FG001|Phase II|Insurance Issue|0|||
130853549|NCT01079936|471090756|FG002|Phase II|Insurance Issue|0|||
130853550|NCT01079936|471090757|FG003|Phase II|Insurance Issue|0|||
130853551|NCT01079936|471090758|FG004|Phase II|Insurance Issue|1|||
130853552|NCT00548717|471090759|FG000|Overall Study|Death|5|||
130853553|NCT00548717|471090760|FG001|Overall Study|Death|2|||
130853554|NCT00548717|471090759|FG000|Overall Study|Relapse|3|||
130853555|NCT00548717|471090760|FG001|Overall Study|Relapse|0|||
130853556|NCT00548717|471090759|FG000|Overall Study|Alternative treatment for GVHD|1|||
130853557|NCT00548717|471090760|FG001|Overall Study|Alternative treatment for GVHD|0|||
130853558|NCT02809053|471090762|FG000|Overall Study|Death|0|||
130853559|NCT02809053|471090763|FG001|Overall Study|Death|1|||
130853560|NCT02809053|471090762|FG000|Overall Study|Lost to Follow-up|3|||
130853561|NCT02809053|471090763|FG001|Overall Study|Lost to Follow-up|1|||
130853562|NCT02809053|471090762|FG000|Overall Study|Withdrawal by Subject|2|||
130853563|NCT02809053|471090763|FG001|Overall Study|Withdrawal by Subject|3|||
130853564|NCT02809053|471090762|FG000|Overall Study|Disease Progression|2|||
130853565|NCT02809053|471090763|FG001|Overall Study|Disease Progression|1|||
130853566|NCT00687609|471090766|FG000|Overall Study|Physician Decision|1|||
130853567|NCT00687609|471090766|FG000|Overall Study|Withdrawal by Subject|2|||
130853568|NCT00908037|471090767|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130853569|NCT00908037|471090768|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130853570|NCT00908037|471090769|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130853571|NCT00908037|471090770|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130853572|NCT00908037|471090771|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
130853573|NCT00908037|471090772|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130853574|NCT00908037|471090773|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
130853575|NCT00908037|471090774|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130853576|NCT00908037|471090775|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
130853577|NCT00908037|471090776|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130853578|NCT00908037|471090777|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130853579|NCT00908037|471090778|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130853580|NCT00908037|471090767|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130853581|NCT00908037|471090768|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130853582|NCT00908037|471090769|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130853583|NCT00908037|471090770|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130853584|NCT00908037|471090771|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
130853585|NCT00908037|471090772|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130853586|NCT00908037|471090773|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130853587|NCT00908037|471090774|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130853588|NCT00908037|471090775|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
130853589|NCT00908037|471090776|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130853590|NCT00908037|471090777|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130853591|NCT00908037|471090778|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130853592|NCT00908037|471090767|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130853593|NCT00908037|471090768|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130853594|NCT00908037|471090769|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130853595|NCT00908037|471090770|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
130853596|NCT00908037|471090771|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130853597|NCT00908037|471090772|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130853598|NCT00908037|471090773|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
130853599|NCT00908037|471090774|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130853600|NCT00908037|471090775|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130853601|NCT00908037|471090776|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130853602|NCT00908037|471090777|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130853603|NCT00908037|471090778|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130853604|NCT00908037|471090767|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853605|NCT00908037|471090768|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853606|NCT00908037|471090769|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853607|NCT00908037|471090770|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853608|NCT00908037|471090771|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853609|NCT00908037|471090772|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853610|NCT00908037|471090773|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853611|NCT00908037|471090774|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853612|NCT00908037|471090775|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853613|NCT00908037|471090776|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853614|NCT00908037|471090777|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130853615|NCT00908037|471090778|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
130853616|NCT00908037|471090767|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130853617|NCT00908037|471090768|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130853618|NCT00908037|471090769|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130853619|NCT00908037|471090770|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130853620|NCT00908037|471090771|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130853621|NCT00908037|471090772|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130853622|NCT00908037|471090773|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130853623|NCT00908037|471090774|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130853624|NCT00908037|471090775|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130853625|NCT00908037|471090776|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
130853626|NCT00908037|471090777|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130853627|NCT00908037|471090778|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
130853628|NCT00908037|471090767|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853629|NCT00908037|471090768|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853630|NCT00908037|471090769|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853631|NCT00908037|471090770|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853632|NCT00908037|471090771|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853633|NCT00908037|471090772|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853634|NCT00908037|471090773|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853635|NCT00908037|471090774|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853636|NCT00908037|471090775|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853637|NCT00908037|471090776|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
130853638|NCT00908037|471090777|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853639|NCT00908037|471090778|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130853640|NCT00908037|471090767|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853641|NCT00908037|471090768|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853642|NCT00908037|471090769|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853643|NCT00908037|471090770|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853644|NCT00908037|471090771|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853645|NCT00908037|471090772|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853646|NCT00908037|471090773|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853647|NCT00908037|471090774|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853648|NCT00908037|471090775|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853649|NCT00908037|471090776|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853650|NCT00908037|471090777|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
130853651|NCT00908037|471090778|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130853652|NCT00908037|471090767|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853653|NCT00908037|471090768|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853654|NCT00908037|471090769|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853655|NCT00908037|471090770|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853656|NCT00908037|471090771|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853657|NCT00908037|471090772|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853658|NCT00908037|471090773|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853659|NCT00908037|471090774|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853660|NCT00908037|471090775|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853661|NCT00908037|471090776|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
130853662|NCT00908037|471090777|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853663|NCT00908037|471090778|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130853664|NCT00908037|471090767|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853665|NCT00908037|471090768|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853666|NCT00908037|471090769|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853667|NCT00908037|471090770|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853668|NCT00908037|471090771|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853669|NCT00908037|471090772|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853670|NCT00908037|471090773|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853671|NCT00908037|471090774|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853672|NCT00908037|471090775|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853673|NCT00908037|471090776|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853674|NCT00908037|471090777|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
130853675|NCT00908037|471090778|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130853676|NCT00869401|471090784|FG000|Overall Study|Withdrawal by Subject|0|||
130853677|NCT00869401|471090785|FG001|Overall Study|Withdrawal by Subject|0|||
130853678|NCT00869401|471090786|FG002|Overall Study|Withdrawal by Subject|0|||
130853679|NCT00869401|471090787|FG003|Overall Study|Withdrawal by Subject|5|||
130853680|NCT00869401|471090788|FG004|Overall Study|Withdrawal by Subject|3|||
130853681|NCT01147900|471090789|FG000|At Year 10|Lost to Follow-up|0|||
130853682|NCT01147900|471090790|FG001|At Year 10|Lost to Follow-up|1|||
130853683|NCT01147900|471090791|FG002|At Year 10|Lost to Follow-up|0|||
130853684|NCT00581360|471090792|FG000|Overall Study|Withdrawal by Subject|1|||
130853685|NCT01953913|471090793|FG000|Overall Study|Disease Progression|349|||
130853686|NCT01953913|471090793|FG000|Overall Study|Worsening of underlying cancer|22|||
130853687|NCT01953913|471090793|FG000|Overall Study|Adverse Event|20|||
130853688|NCT01953913|471090793|FG000|Overall Study|Protocol Violation|6|||
130853689|NCT01953913|471090793|FG000|Overall Study|Lost to Follow-up|4|||
130853690|NCT01953913|471090793|FG000|Overall Study|Withdrawal by Subject|32|||
130853691|NCT01953913|471090793|FG000|Overall Study|Other than listed|108|||
130853692|NCT01953913|471090793|FG000|Overall Study|Not Treated|1|||
130853693|NCT00552760|471090794|FG000|Overall Study|Adverse Event|3|||
130853694|NCT00552760|471090795|FG001|Overall Study|Adverse Event|5|||
130853695|NCT00552760|471090794|FG000|Overall Study|Relapsed- Depressed Event|10|||
130853696|NCT00552760|471090795|FG001|Overall Study|Relapsed- Depressed Event|16|||
130853697|NCT00552760|471090794|FG000|Overall Study|Relapse- Manic Event|3|||
130853698|NCT00552760|471090795|FG001|Overall Study|Relapse- Manic Event|3|||
130853699|NCT00552760|471090794|FG000|Overall Study|Relapsed- Mixed Event|3|||
130853700|NCT00552760|471090795|FG001|Overall Study|Relapsed- Mixed Event|5|||
130853701|NCT00552760|471090794|FG000|Overall Study|Protocol Violation|0|||
130853702|NCT00552760|471090795|FG001|Overall Study|Protocol Violation|1|||
130853703|NCT00552760|471090794|FG000|Overall Study|Lost to Follow-up|1|||
130853704|NCT00552760|471090795|FG001|Overall Study|Lost to Follow-up|1|||
130853705|NCT00552760|471090794|FG000|Overall Study|Non-compliance|1|||
130853706|NCT00552760|471090795|FG001|Overall Study|Non-compliance|1|||
130853707|NCT00552760|471090794|FG000|Overall Study|Medical Condition|1|||
130853708|NCT00552760|471090795|FG001|Overall Study|Medical Condition|1|||
130853709|NCT00552760|471090794|FG000|Overall Study|Withdrawal by Subject|3|||
130853710|NCT00552760|471090795|FG001|Overall Study|Withdrawal by Subject|0|||
130853711|NCT00552760|471090794|FG000|Overall Study|Medication Change|1|||
130853712|NCT00552760|471090795|FG001|Overall Study|Medication Change|0|||
130853713|NCT00924404|471090798|FG000|Overall Study|Lost to Follow-up|6|||
130853714|NCT00924404|471090799|FG001|Overall Study|Lost to Follow-up|4|||
130853715|NCT03831945|471090800|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
130853716|NCT03831945|471090801|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
130853717|NCT03831945|471090800|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
130853718|NCT03831945|471090801|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
130853719|NCT03831945|471090800|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
130853720|NCT03831945|471090801|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
130853721|NCT00710385|471090803|FG000|Overall Study|Did not qualify|1|||
130853722|NCT00710385|471090803|FG000|Overall Study|Withdrawal by Subject|1|||
130853723|NCT00710385|471090803|FG000|Overall Study|Undisclosed back pain|1|||
130853724|NCT00710385|471090803|FG000|Overall Study|Physician Decision|1|||
130853725|NCT00710385|471090803|FG000|Overall Study|Undisclosed excessive methadone use|1|||
130853726|NCT02976103|471090804|FG000|Overall Study|Withdrawal by Subject|1|||
130853727|NCT02976103|471090805|FG001|Overall Study|Withdrawal by Subject|0|||
130853728|NCT02976103|471090804|FG000|Overall Study|Lost to Follow-up|12|||
130853729|NCT02976103|471090805|FG001|Overall Study|Lost to Follow-up|8|||
130853730|NCT01985360|471090806|FG000|Overall Study|Withdrawal by Subject|4|||
130853731|NCT01985360|471090807|FG001|Overall Study|Withdrawal by Subject|0|||
130853732|NCT01985360|471090806|FG000|Overall Study|Lost to Follow-up|5|||
130853733|NCT01985360|471090807|FG001|Overall Study|Lost to Follow-up|3|||
130853734|NCT02438813|471090810|FG000|Overall Study|Patient Decision|59|||
130853735|NCT02438813|471090810|FG000|Overall Study|Patient Lost to Follow-Up|137|||
130853736|NCT02438813|471090810|FG000|Overall Study|Study Ended by Sponsor|80|||
130853737|NCT02438813|471090810|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
130853738|NCT04881747|471090811|FG000|Period 2 Washout|Adverse Event|1|||
130853739|NCT04881747|471090812|FG001|Period 2 Washout|Adverse Event|0|||
130853740|NCT04881747|471090813|FG002|Period 2 Washout|Adverse Event|0|||
130853741|NCT04881747|471090814|FG003|Period 2 Washout|Adverse Event|0|||
130853742|NCT04881747|471090815|FG004|Period 2 Washout|Adverse Event|1|||
130853743|NCT04881747|471090816|FG005|Period 2 Washout|Adverse Event|0|||
130853744|NCT04881747|471090811|FG000|Period 2 Washout|Withdrawal by Subject|1|||
130853745|NCT04881747|471090812|FG001|Period 2 Washout|Withdrawal by Subject|0|||
130853746|NCT04881747|471090813|FG002|Period 2 Washout|Withdrawal by Subject|0|||
130853747|NCT04881747|471090814|FG003|Period 2 Washout|Withdrawal by Subject|1|||
130853748|NCT04881747|471090815|FG004|Period 2 Washout|Withdrawal by Subject|0|||
130853749|NCT04881747|471090816|FG005|Period 2 Washout|Withdrawal by Subject|0|||
130853750|NCT04598269|471090819|FG000|Overall Study|Adverse Event|0|||
130853751|NCT04598269|471090820|FG001|Overall Study|Adverse Event|3|||
130853752|NCT04598269|471090819|FG000|Overall Study|Withdrawal by Subject|1|||
130853753|NCT04598269|471090820|FG001|Overall Study|Withdrawal by Subject|4|||
130853754|NCT04598269|471090819|FG000|Overall Study|Lost to Follow-up|1|||
130853755|NCT04598269|471090820|FG001|Overall Study|Lost to Follow-up|0|||
130853756|NCT04598269|471090819|FG000|Overall Study|Not Treated|2|||
130853757|NCT04598269|471090820|FG001|Overall Study|Not Treated|0|||
130853758|NCT02228096|471090827|FG000|Overall Study|Study terminated by Sponsor|24|||
130853759|NCT02228096|471090827|FG000|Overall Study|Lack of Efficacy|18|||
130853760|NCT02228096|471090827|FG000|Overall Study|Death|12|||
130853761|NCT02228096|471090827|FG000|Overall Study|Physician Decision|3|||
130853762|NCT02228096|471090827|FG000|Overall Study|Subject/guardian decision|2|||
130853763|NCT02228096|471090827|FG000|Overall Study|New therapy for study indication|1|||
130853764|NCT02228096|471090827|FG000|Overall Study|Enrolled, not infused|11|||
130853765|NCT01789606|471090828|FG000|Overall Study|Participant not Purchased the Product|0|||
130853766|NCT01789606|471090829|FG001|Overall Study|Participant not Purchased the Product|20|||
130853767|NCT01789606|471090828|FG000|Overall Study|Withdrawal by Subject|0|||
130853768|NCT01789606|471090829|FG001|Overall Study|Withdrawal by Subject|1|||
130853769|NCT01789606|471090828|FG000|Overall Study|Ineligible|6|||
130853770|NCT01789606|471090829|FG001|Overall Study|Ineligible|2|||
130853771|NCT01789606|471090828|FG000|Overall Study|Administrative Reasons|17|||
130853772|NCT01789606|471090829|FG001|Overall Study|Administrative Reasons|6|||
130853773|NCT01789606|471090828|FG000|Overall Study|No Study Medication Taken|0|||
130853774|NCT01789606|471090829|FG001|Overall Study|No Study Medication Taken|1|||
130853775|NCT01789606|471090828|FG000|Overall Study|Protocol Violation|0|||
130853776|NCT01789606|471090829|FG001|Overall Study|Protocol Violation|55|||
130853777|NCT01789606|471090828|FG000|Overall Study|Adverse Event|0|||
130853778|NCT01789606|471090829|FG001|Overall Study|Adverse Event|3|||
130853779|NCT01789606|471090828|FG000|Overall Study|Lost to Follow-up|0|||
130853780|NCT01789606|471090829|FG001|Overall Study|Lost to Follow-up|14|||
130853781|NCT01789606|471090828|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
130853782|NCT01789606|471090829|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
130853783|NCT05327361|471090843|FG000|Overall Study|Lost to Follow-up|4|||
130853784|NCT01439373|471090849|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
130853785|NCT01439373|471090850|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
130853786|NCT01439373|471090849|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
130853787|NCT01439373|471090850|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
130853788|NCT00626405|471090851|FG000|Overall Study|Deemed Ineligible|1|||
130853789|NCT00626405|471090852|FG001|Overall Study|Deemed Ineligible|0|||
130853790|NCT00626405|471090851|FG000|Overall Study|Withdrawal by Subject|0|||
130853791|NCT00626405|471090852|FG001|Overall Study|Withdrawal by Subject|1|||
130853792|NCT03834220|471090857|FG000|Overall Study|Adverse Event|1|||
130853793|NCT03834220|471090858|FG001|Overall Study|Adverse Event|0|||
130853794|NCT03834220|471090859|FG002|Overall Study|Adverse Event|0|||
130853795|NCT03834220|471090857|FG000|Overall Study|Death|8|||
130853796|NCT03834220|471090858|FG001|Overall Study|Death|1|||
130853797|NCT03834220|471090859|FG002|Overall Study|Death|17|||
130853798|NCT03834220|471090857|FG000|Overall Study|Reason not Specified|9|||
130853799|NCT03834220|471090858|FG001|Overall Study|Reason not Specified|0|||
130853800|NCT03834220|471090859|FG002|Overall Study|Reason not Specified|6|||
130853801|NCT03834220|471090857|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
130853802|NCT03834220|471090858|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
130853803|NCT03834220|471090859|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
130853804|NCT03834220|471090857|FG000|Overall Study|Withdrawal of Consent|2|||
130853805|NCT03834220|471090858|FG001|Overall Study|Withdrawal of Consent|2|||
130853806|NCT03834220|471090859|FG002|Overall Study|Withdrawal of Consent|2|||
130853807|NCT02593318|471090860|FG000|Overall Study|Withdrawal by Subject|1|||
130853808|NCT02593318|471090861|FG001|Overall Study|Withdrawal by Subject|1|||
130853809|NCT01078168|471090866|FG000|Overall Study|Physician Decision|0|||
130853810|NCT01078168|471090867|FG001|Overall Study|Physician Decision|1|||
130853811|NCT01264419|471090871|FG000|Overall Study|Lost to Follow-up|3|||
130853812|NCT02905006|471093332|FG000|Overall Study|Adverse Event|1|||
130853813|NCT02905006|471093333|FG001|Overall Study|Adverse Event|1|||
130853814|NCT02905006|471093334|FG002|Overall Study|Adverse Event|1|||
130853815|NCT02905006|471093335|FG003|Overall Study|Adverse Event|1|||
130853816|NCT02905006|471093336|FG004|Overall Study|Adverse Event|0|||
130853817|NCT02905006|471093337|FG005|Overall Study|Adverse Event|1|||
130853818|NCT02905006|471093332|FG000|Overall Study|Lack of Efficacy|1|||
130853819|NCT02905006|471093333|FG001|Overall Study|Lack of Efficacy|0|||
130853820|NCT02905006|471093334|FG002|Overall Study|Lack of Efficacy|0|||
130853821|NCT02905006|471093335|FG003|Overall Study|Lack of Efficacy|0|||
130853822|NCT02905006|471093336|FG004|Overall Study|Lack of Efficacy|0|||
130853823|NCT02905006|471093337|FG005|Overall Study|Lack of Efficacy|0|||
130853824|NCT02905006|471093332|FG000|Overall Study|Protocol Violation|2|||
130853825|NCT02905006|471093333|FG001|Overall Study|Protocol Violation|0|||
130853826|NCT02905006|471093334|FG002|Overall Study|Protocol Violation|0|||
130853827|NCT02905006|471093335|FG003|Overall Study|Protocol Violation|0|||
130853828|NCT02905006|471093336|FG004|Overall Study|Protocol Violation|0|||
130853829|NCT02905006|471093337|FG005|Overall Study|Protocol Violation|0|||
130853830|NCT02905006|471093332|FG000|Overall Study|Lost to Follow-up|0|||
130853831|NCT02905006|471093333|FG001|Overall Study|Lost to Follow-up|0|||
130853832|NCT02905006|471093334|FG002|Overall Study|Lost to Follow-up|0|||
130853833|NCT02905006|471093335|FG003|Overall Study|Lost to Follow-up|1|||
130853834|NCT02905006|471093336|FG004|Overall Study|Lost to Follow-up|1|||
130853835|NCT02905006|471093337|FG005|Overall Study|Lost to Follow-up|0|||
130853836|NCT02905006|471093332|FG000|Overall Study|Withdrawal by Subject|0|||
130853837|NCT02905006|471093333|FG001|Overall Study|Withdrawal by Subject|0|||
130853838|NCT02905006|471093334|FG002|Overall Study|Withdrawal by Subject|1|||
130853839|NCT02905006|471093335|FG003|Overall Study|Withdrawal by Subject|1|||
130853840|NCT02905006|471093336|FG004|Overall Study|Withdrawal by Subject|0|||
130853841|NCT02905006|471093337|FG005|Overall Study|Withdrawal by Subject|1|||
130853842|NCT02905006|471093332|FG000|Overall Study|Screening exclusion criteria met|1|||
130853843|NCT02905006|471093333|FG001|Overall Study|Screening exclusion criteria met|0|||
130853844|NCT02905006|471093334|FG002|Overall Study|Screening exclusion criteria met|0|||
130853845|NCT02905006|471093335|FG003|Overall Study|Screening exclusion criteria met|0|||
130853846|NCT02905006|471093336|FG004|Overall Study|Screening exclusion criteria met|0|||
130853847|NCT02905006|471093337|FG005|Overall Study|Screening exclusion criteria met|0|||
130853848|NCT02905006|471093332|FG000|Overall Study|Lab withdrawal criterion met|0|||
130853849|NCT02905006|471093333|FG001|Overall Study|Lab withdrawal criterion met|1|||
130853850|NCT02905006|471093334|FG002|Overall Study|Lab withdrawal criterion met|2|||
130853851|NCT02905006|471093335|FG003|Overall Study|Lab withdrawal criterion met|2|||
130853852|NCT02905006|471093336|FG004|Overall Study|Lab withdrawal criterion met|2|||
130853853|NCT02905006|471093337|FG005|Overall Study|Lab withdrawal criterion met|1|||
130853854|NCT02905006|471093332|FG000|Overall Study|Positive for Tuberculosis|0|||
130853855|NCT02905006|471093333|FG001|Overall Study|Positive for Tuberculosis|1|||
130853856|NCT02905006|471093334|FG002|Overall Study|Positive for Tuberculosis|0|||
130853857|NCT02905006|471093335|FG003|Overall Study|Positive for Tuberculosis|0|||
130853858|NCT02905006|471093336|FG004|Overall Study|Positive for Tuberculosis|0|||
130853859|NCT02905006|471093337|FG005|Overall Study|Positive for Tuberculosis|0|||
130853860|NCT02905006|471093332|FG000|Overall Study|Subject positive for Hep B|0|||
130853861|NCT02905006|471093333|FG001|Overall Study|Subject positive for Hep B|0|||
130853862|NCT02905006|471093334|FG002|Overall Study|Subject positive for Hep B|1|||
130853863|NCT02905006|471093335|FG003|Overall Study|Subject positive for Hep B|0|||
130853864|NCT02905006|471093336|FG004|Overall Study|Subject positive for Hep B|0|||
130853865|NCT02905006|471093337|FG005|Overall Study|Subject positive for Hep B|0|||
130853866|NCT02905006|471093332|FG000|Overall Study|Patient moved abroad|0|||
130853867|NCT02905006|471093333|FG001|Overall Study|Patient moved abroad|0|||
130853868|NCT02905006|471093334|FG002|Overall Study|Patient moved abroad|0|||
130853869|NCT02905006|471093335|FG003|Overall Study|Patient moved abroad|1|||
130853870|NCT02905006|471093336|FG004|Overall Study|Patient moved abroad|0|||
130853871|NCT02905006|471093337|FG005|Overall Study|Patient moved abroad|0|||
130853872|NCT02905006|471093332|FG000|Overall Study|Patient randomized by mistake|0|||
130853873|NCT02905006|471093333|FG001|Overall Study|Patient randomized by mistake|0|||
130853874|NCT02905006|471093334|FG002|Overall Study|Patient randomized by mistake|0|||
130853875|NCT02905006|471093335|FG003|Overall Study|Patient randomized by mistake|0|||
130853876|NCT02905006|471093336|FG004|Overall Study|Patient randomized by mistake|0|||
130853877|NCT02905006|471093337|FG005|Overall Study|Patient randomized by mistake|1|||
130853878|NCT02429791|471093339|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
130853879|NCT02429791|471093340|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
130853880|NCT02429791|471093339|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
130853881|NCT02429791|471093340|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
130853882|NCT02429791|471093339|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
130853883|NCT02429791|471093340|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
130853884|NCT02429791|471093339|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
130853885|NCT02429791|471093340|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
130853886|NCT02429791|471093339|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
130853887|NCT02429791|471093340|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
130853888|NCT02429791|471093339|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
130853889|NCT02429791|471093340|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
130853890|NCT02429791|471093339|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
130853891|NCT02429791|471093340|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
130853892|NCT02429791|471093339|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
130853893|NCT02429791|471093340|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
130853894|NCT02429791|471093339|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
130853895|NCT02429791|471093340|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
130853896|NCT02429791|471093339|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
130853897|NCT02429791|471093340|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
130853898|NCT02429791|471093339|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
130853899|NCT02429791|471093340|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
130853900|NCT02429791|471093339|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
130853901|NCT02429791|471093340|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
130853902|NCT02429791|471093339|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
130853903|NCT02429791|471093340|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
130853904|NCT02429791|471093339|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
130853905|NCT02429791|471093340|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
130853906|NCT02429791|471093339|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
130853907|NCT02429791|471093340|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
130853908|NCT02429791|471093339|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
130853909|NCT02429791|471093340|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
130853910|NCT02429791|471093339|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
130853911|NCT02429791|471093340|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
130853912|NCT02429791|471093339|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
130853913|NCT02429791|471093340|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
130853914|NCT04201093|471093341|FG000|Overall Study|Adverse Event|6|||
130853915|NCT04201093|471093342|FG001|Overall Study|Adverse Event|29|||
130853916|NCT04201093|471093343|FG002|Overall Study|Adverse Event|35|||
130853917|NCT04201093|471093341|FG000|Overall Study|Death|2|||
130853918|NCT04201093|471093342|FG001|Overall Study|Death|1|||
130853919|NCT04201093|471093343|FG002|Overall Study|Death|0|||
130853920|NCT04201093|471093341|FG000|Overall Study|Lack of Efficacy|5|||
130853921|NCT04201093|471093342|FG001|Overall Study|Lack of Efficacy|1|||
130853922|NCT04201093|471093343|FG002|Overall Study|Lack of Efficacy|2|||
130853923|NCT04201093|471093341|FG000|Overall Study|Lost to Follow-up|0|||
130853924|NCT04201093|471093342|FG001|Overall Study|Lost to Follow-up|0|||
130853925|NCT04201093|471093343|FG002|Overall Study|Lost to Follow-up|1|||
130853926|NCT04201093|471093341|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
130853927|NCT04201093|471093342|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
130853928|NCT04201093|471093343|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
130853929|NCT04201093|471093341|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
130853930|NCT04201093|471093342|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
130853931|NCT04201093|471093343|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
130853932|NCT04201093|471093341|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
130853933|NCT04201093|471093342|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
130853934|NCT04201093|471093343|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
130853935|NCT04201093|471093341|FG000|Overall Study|Physician Decision|1|||
130853936|NCT04201093|471093342|FG001|Overall Study|Physician Decision|0|||
130853937|NCT04201093|471093343|FG002|Overall Study|Physician Decision|0|||
130853938|NCT04201093|471093341|FG000|Overall Study|Protocol Deviation|1|||
130853939|NCT04201093|471093342|FG001|Overall Study|Protocol Deviation|0|||
130853940|NCT04201093|471093343|FG002|Overall Study|Protocol Deviation|0|||
130853941|NCT04201093|471093341|FG000|Overall Study|Site Terminated by Sponsor|5|||
130853942|NCT04201093|471093342|FG001|Overall Study|Site Terminated by Sponsor|3|||
130853943|NCT04201093|471093343|FG002|Overall Study|Site Terminated by Sponsor|1|||
130853944|NCT04201093|471093341|FG000|Overall Study|Withdrawal by Subject|7|||
130853945|NCT04201093|471093342|FG001|Overall Study|Withdrawal by Subject|8|||
130853946|NCT04201093|471093343|FG002|Overall Study|Withdrawal by Subject|15|||
130853947|NCT04201093|471093341|FG000|Overall Study|Other|0|||
130853948|NCT04201093|471093342|FG001|Overall Study|Other|1|||
130853949|NCT04201093|471093343|FG002|Overall Study|Other|2|||
130853950|NCT00007020|471093344|FG000|Overall Study|Death|16|||
130853951|NCT00007020|471093344|FG000|Overall Study|Lost to Follow-up|13|||
130853952|NCT00007020|471093344|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
130853953|NCT00007020|471093344|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
130853954|NCT00007020|471093344|FG000|Overall Study|Pt cared for by outside physician|4|||
130853955|NCT00007020|471093344|FG000|Overall Study|No evidence of treatment|6|||
130853956|NCT00881504|471093345|FG000|Overall Study|Withdrawal by Subject|1|||
130853957|NCT01276223|471093346|FG000|Overall Study|Adverse Event|7|||
130853958|NCT01276223|471093347|FG001|Overall Study|Adverse Event|4|||
130853959|NCT01276223|471093348|FG002|Overall Study|Adverse Event|1|||
130853960|NCT01276223|471093346|FG000|Overall Study|Lost to Follow-up|0|||
130853961|NCT01276223|471093347|FG001|Overall Study|Lost to Follow-up|0|||
130853962|NCT01276223|471093348|FG002|Overall Study|Lost to Follow-up|1|||
130853963|NCT01276223|471093346|FG000|Overall Study|Other|0|||
130853964|NCT01276223|471093347|FG001|Overall Study|Other|0|||
130853965|NCT01276223|471093348|FG002|Overall Study|Other|1|||
130853966|NCT01276223|471093346|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
130853967|NCT01276223|471093347|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
130853968|NCT01276223|471093348|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
130853969|NCT01276223|471093346|FG000|Overall Study|Protocol Violation|1|||
130853970|NCT01276223|471093347|FG001|Overall Study|Protocol Violation|0|||
130853971|NCT01276223|471093348|FG002|Overall Study|Protocol Violation|0|||
130853972|NCT02017522|471093349|FG000|Overall Study|Withdrawal by Subject|1|||
130853973|NCT02166463|471093350|FG000|Overall Study|Lost to Follow-up|0|||
130853974|NCT02166463|471093351|FG001|Overall Study|Lost to Follow-up|1|||
130853975|NCT02166463|471093350|FG000|Overall Study|Physician Decision|10|||
130853976|NCT02166463|471093351|FG001|Overall Study|Physician Decision|10|||
130853977|NCT02166463|471093350|FG000|Overall Study|Ineligible|11|||
130853978|NCT02166463|471093351|FG001|Overall Study|Ineligible|2|||
130853979|NCT02166463|471093350|FG000|Overall Study|Progressive Disease|9|||
130853980|NCT02166463|471093351|FG001|Overall Study|Progressive Disease|6|||
130853981|NCT02166463|471093350|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
130853982|NCT02166463|471093351|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
130853983|NCT02166463|471093350|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
130853984|NCT02166463|471093351|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
130853985|NCT02166463|471093350|FG000|Overall Study|Refusal of further protocol therapy|5|||
130853986|NCT02166463|471093351|FG001|Overall Study|Refusal of further protocol therapy|6|||
130853987|NCT05856227|471093352|FG000|Overall Study|Adverse Event|0|||
130853988|NCT05856227|471093353|FG001|Overall Study|Adverse Event|1|||
130853989|NCT05856227|471093352|FG000|Overall Study|Due to Investigator absence|1|||
130853990|NCT05856227|471093353|FG001|Overall Study|Due to Investigator absence|0|||
130853991|NCT05856227|471093352|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
130853992|NCT05856227|471093353|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
130853993|NCT01571232|471093355|FG000|Overall Study|Lost to Follow-up|0|||
130853994|NCT01571232|471093356|FG001|Overall Study|Lost to Follow-up|1|||
130853995|NCT01571232|471093355|FG000|Overall Study|Withdrawal by Subject|1|||
130853996|NCT01571232|471093356|FG001|Overall Study|Withdrawal by Subject|0|||
130853997|NCT00771615|471093357|FG000|Overall Study|Withdrawal by Subject|0|||
130853998|NCT00771615|471093358|FG001|Overall Study|Withdrawal by Subject|1|||
130853999|NCT00771615|471093359|FG002|Overall Study|Withdrawal by Subject|0|||
130854000|NCT00771615|471093360|FG003|Overall Study|Withdrawal by Subject|0|||
130854001|NCT00771615|471093361|FG004|Overall Study|Withdrawal by Subject|0|||
130854002|NCT00771615|471093362|FG005|Overall Study|Withdrawal by Subject|0|||
130854003|NCT00771615|471093363|FG006|Overall Study|Withdrawal by Subject|0|||
130854004|NCT00771615|471093364|FG007|Overall Study|Withdrawal by Subject|1|||
130854005|NCT00771615|471093365|FG008|Overall Study|Withdrawal by Subject|0|||
130854006|NCT00771615|471093357|FG000|Overall Study|Lost to Follow-up|1|||
130854007|NCT00771615|471093358|FG001|Overall Study|Lost to Follow-up|1|||
130854008|NCT00771615|471093359|FG002|Overall Study|Lost to Follow-up|1|||
130854009|NCT00771615|471093360|FG003|Overall Study|Lost to Follow-up|1|||
130854010|NCT00771615|471093361|FG004|Overall Study|Lost to Follow-up|0|||
130854011|NCT00771615|471093362|FG005|Overall Study|Lost to Follow-up|1|||
130854012|NCT00771615|471093363|FG006|Overall Study|Lost to Follow-up|1|||
130854013|NCT00771615|471093364|FG007|Overall Study|Lost to Follow-up|0|||
130854014|NCT00771615|471093365|FG008|Overall Study|Lost to Follow-up|0|||
130854015|NCT02455076|471093366|FG000|Inpatient|Withdrawal by Subject|1|||
130854016|NCT02455076|471093367|FG001|Inpatient|Withdrawal by Subject|0|||
130854017|NCT02455076|471093368|FG002|Inpatient|Withdrawal by Subject|0|||
130854018|NCT02455076|471093369|FG003|Inpatient|Withdrawal by Subject|0|||
130854019|NCT02455076|471093370|FG004|Inpatient|Withdrawal by Subject|0|||
130854020|NCT02455076|471093366|FG000|Inpatient|Discharged <24 h after admission|0|||
130854021|NCT02455076|471093367|FG001|Inpatient|Discharged <24 h after admission|1|||
130854022|NCT02455076|471093368|FG002|Inpatient|Discharged <24 h after admission|0|||
130854023|NCT02455076|471093369|FG003|Inpatient|Discharged <24 h after admission|0|||
130854024|NCT02455076|471093370|FG004|Inpatient|Discharged <24 h after admission|0|||
130854025|NCT02455076|471093366|FG000|Inpatient|Adverse Event|3|||
130854026|NCT02455076|471093367|FG001|Inpatient|Adverse Event|0|||
130854027|NCT02455076|471093368|FG002|Inpatient|Adverse Event|0|||
130854028|NCT02455076|471093369|FG003|Inpatient|Adverse Event|0|||
130854029|NCT02455076|471093370|FG004|Inpatient|Adverse Event|0|||
130854030|NCT02455076|471093366|FG000|Outpatient|Adverse Event|0|||
130854031|NCT02455076|471093367|FG001|Outpatient|Adverse Event|0|||
130854032|NCT02455076|471093368|FG002|Outpatient|Adverse Event|0|||
130854033|NCT02455076|471093369|FG003|Outpatient|Adverse Event|5|||
130854034|NCT02455076|471093370|FG004|Outpatient|Adverse Event|0|||
130854035|NCT02455076|471093366|FG000|Outpatient|Lost to Follow-up|0|||
130854036|NCT02455076|471093367|FG001|Outpatient|Lost to Follow-up|0|||
130854037|NCT02455076|471093368|FG002|Outpatient|Lost to Follow-up|0|||
130854038|NCT02455076|471093369|FG003|Outpatient|Lost to Follow-up|1|||
130854039|NCT02455076|471093370|FG004|Outpatient|Lost to Follow-up|12|||
130854040|NCT00859937|471093371|FG000|Overall Study|Protocol Violation|1|||
130854041|NCT00859937|471093372|FG001|Overall Study|Protocol Violation|0|||
130854068|NCT02478164|471093375|FG000|Overall Study|Lack of Efficacy|13|||
130854069|NCT02478164|471093375|FG000|Overall Study|Adverse Event|1|||
130854070|NCT02478164|471093375|FG000|Overall Study|Withdrawal by Subject|1|||
130854071|NCT05194267|471093376|FG000|Overall Study|Withdrawal by Subject|2|||
130854072|NCT00802893|471093377|FG000|Overall Study|study terminated|3|||
130854073|NCT06151288|471093378|FG000|Overall Study|Lost to Follow-up|4|||
130854074|NCT06151288|471093379|FG001|Overall Study|Lost to Follow-up|2|||
130854075|NCT06151288|471093380|FG002|Overall Study|Lost to Follow-up|4|||
130854076|NCT06151288|471093381|FG003|Overall Study|Lost to Follow-up|3|||
130854077|NCT06151288|471093378|FG000|Overall Study|Withdrawal by Subject|4|||
130854078|NCT06151288|471093379|FG001|Overall Study|Withdrawal by Subject|5|||
130854079|NCT06151288|471093380|FG002|Overall Study|Withdrawal by Subject|1|||
130854080|NCT06151288|471093381|FG003|Overall Study|Withdrawal by Subject|1|||
130854081|NCT04588389|471093382|FG000|Overall Study|Issues with anesthesia during surgery|2|||
130854082|NCT04588389|471093383|FG001|Overall Study|Issues with anesthesia during surgery|0|||
130854083|NCT04588389|471093384|FG002|Overall Study|Issues with anesthesia during surgery|0|||
130854084|NCT02911142|471093389|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
130854085|NCT02911142|471093389|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
130854086|NCT02911142|471093389|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
130854087|NCT02911142|471093389|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
130854088|NCT05779007|471093390|FG000|Overall Study|not meeting eligibility criteria|3517|||
130854089|NCT05779007|471093391|FG001|Overall Study|not meeting eligibility criteria|2009|||
130854090|NCT00026312|471093392|FG000|Overall Study|Adverse Event|0|||
130854091|NCT00026312|471093393|FG001|Overall Study|Adverse Event|32|||
130854092|NCT00026312|471093392|FG000|Overall Study|Death|1|||
130854093|NCT00026312|471093393|FG001|Overall Study|Death|7|||
130854094|NCT00026312|471093392|FG000|Overall Study|Lack of Efficacy|19|||
130854095|NCT00026312|471093393|FG001|Overall Study|Lack of Efficacy|114|||
130854096|NCT00026312|471093392|FG000|Overall Study|Lost to Follow-up|0|||
130854097|NCT00026312|471093393|FG001|Overall Study|Lost to Follow-up|5|||
130854098|NCT00026312|471093392|FG000|Overall Study|Physician Decision|1|||
130854099|NCT00026312|471093393|FG001|Overall Study|Physician Decision|37|||
130854100|NCT00026312|471093392|FG000|Overall Study|Protocol Violation|0|||
130854101|NCT00026312|471093393|FG001|Overall Study|Protocol Violation|3|||
130854102|NCT00026312|471093392|FG000|Overall Study|Withdrawal by Subject|1|||
130854103|NCT00026312|471093393|FG001|Overall Study|Withdrawal by Subject|6|||
130854104|NCT00026312|471093392|FG000|Overall Study|Ineligible|4|||
130854105|NCT00026312|471093393|FG001|Overall Study|Ineligible|5|||
130854106|NCT00026312|471093392|FG000|Overall Study|Entry onto another COG study|0|||
130854107|NCT00026312|471093393|FG001|Overall Study|Entry onto another COG study|1|||
130854108|NCT00026312|471093392|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
130854109|NCT00026312|471093393|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
130854110|NCT05147662|471093408|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130854111|NCT05147662|471093408|FG000|Overall Study|Assigned to treatment but never treated|1|||
130854112|NCT02294734|471093409|FG000|Overall Study|Adverse Event|5|||
130854113|NCT02294734|471093410|FG001|Overall Study|Adverse Event|5|||
130854114|NCT02294734|471093409|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
130854115|NCT02294734|471093410|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
130854116|NCT02294734|471093409|FG000|Overall Study|Lost to Follow-up|2|||
130854117|NCT02294734|471093410|FG001|Overall Study|Lost to Follow-up|0|||
130854118|NCT02294734|471093409|FG000|Overall Study|Physician Decision|2|||
130854119|NCT02294734|471093410|FG001|Overall Study|Physician Decision|1|||
130854120|NCT02294734|471093409|FG000|Overall Study|Withdrawal by Subject|4|||
130854121|NCT02294734|471093410|FG001|Overall Study|Withdrawal by Subject|2|||
130854122|NCT03157583|471093411|FG000|Overall Study|Other (did not meet study criteria)|1|||
130854123|NCT00847015|471093414|FG000|Overall Study|Withdrawal by Subject|1|||
130854124|NCT00847015|471093414|FG000|Overall Study|declined any surgery|1|||
130854125|NCT00847015|471093414|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
130854126|NCT01141478|471093415|FG000|Overall Study|Withdrawal by Subject|1|||
130854127|NCT01141478|471093416|FG001|Overall Study|Withdrawal by Subject|1|||
130854128|NCT03847909|471093426|FG000|Overall Study|Withdrawal by Subject|1|||
130854129|NCT03847909|471093427|FG001|Overall Study|Withdrawal by Subject|1|||
130854130|NCT00975143|471093428|FG000|Overall Study|Adverse Event|19|||
130854131|NCT00975143|471093429|FG001|Overall Study|Adverse Event|15|||
130854132|NCT00975143|471093428|FG000|Overall Study|Withdrawal by Subject|15|||
130854133|NCT00975143|471093429|FG001|Overall Study|Withdrawal by Subject|15|||
130854134|NCT00975143|471093428|FG000|Overall Study|Lost to Follow-up|20|||
130854135|NCT00975143|471093429|FG001|Overall Study|Lost to Follow-up|16|||
130854136|NCT00975143|471093428|FG000|Overall Study|Non-compliance|5|||
130854137|NCT00975143|471093429|FG001|Overall Study|Non-compliance|8|||
130854138|NCT00975143|471093428|FG000|Overall Study|Physician Decision|1|||
130854139|NCT00975143|471093429|FG001|Overall Study|Physician Decision|2|||
130854140|NCT00975143|471093428|FG000|Overall Study|Details not available|10|||
130854141|NCT00975143|471093429|FG001|Overall Study|Details not available|4|||
130854142|NCT01375608|471093430|FG000|Overall Study|Withdrawal by Subject|2|||
130854143|NCT01732913|471093433|FG000|Overall Study|Study Terminated by Sponsor|105|||
130854144|NCT01732913|471093434|FG001|Overall Study|Study Terminated by Sponsor|55|||
130854145|NCT01732913|471093433|FG000|Overall Study|Withdrawal by Subject|27|||
130854146|NCT01732913|471093434|FG001|Overall Study|Withdrawal by Subject|4|||
130854147|NCT01732913|471093433|FG000|Overall Study|Physician Decision|14|||
130854148|NCT01732913|471093434|FG001|Overall Study|Physician Decision|7|||
130854149|NCT01732913|471093433|FG000|Overall Study|Other|7|||
130854150|NCT01732913|471093434|FG001|Overall Study|Other|1|||
130854151|NCT01732913|471093433|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
130854152|NCT01732913|471093434|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
130854153|NCT00082381|471093435|FG000|Overall Study|Adverse Event|27|||
130854154|NCT00082381|471093436|FG001|Overall Study|Adverse Event|2|||
130854155|NCT00082381|471093435|FG000|Overall Study|Lost to Follow-up|5|||
130854156|NCT00082381|471093436|FG001|Overall Study|Lost to Follow-up|7|||
130854157|NCT00082381|471093435|FG000|Overall Study|Patient Decision|8|||
130854158|NCT00082381|471093436|FG001|Overall Study|Patient Decision|4|||
130854159|NCT00082381|471093435|FG000|Overall Study|Physician Decision|1|||
130854160|NCT00082381|471093436|FG001|Overall Study|Physician Decision|2|||
130854161|NCT00082381|471093435|FG000|Overall Study|Protocol Violation|10|||
130854162|NCT00082381|471093436|FG001|Overall Study|Protocol Violation|11|||
130854163|NCT00082381|471093435|FG000|Overall Study|Loss of Glucose Control|4|||
130854164|NCT00082381|471093436|FG001|Overall Study|Loss of Glucose Control|0|||
130854165|NCT02049138|471093437|FG000|Overall Study|Adverse Event|46|||
130854166|NCT02049138|471093438|FG001|Overall Study|Adverse Event|25|||
130854167|NCT02049138|471093439|FG002|Overall Study|Adverse Event|1|||
130854168|NCT02049138|471093437|FG000|Overall Study|Withdrawal by Subject|57|||
130854169|NCT02049138|471093438|FG001|Overall Study|Withdrawal by Subject|21|||
130854170|NCT02049138|471093439|FG002|Overall Study|Withdrawal by Subject|5|||
130854171|NCT02049138|471093437|FG000|Overall Study|Lost to Follow-up|18|||
130854172|NCT02049138|471093438|FG001|Overall Study|Lost to Follow-up|5|||
130854173|NCT02049138|471093439|FG002|Overall Study|Lost to Follow-up|1|||
130854174|NCT02049138|471093437|FG000|Overall Study|Lack of Efficacy|10|||
130854175|NCT02049138|471093438|FG001|Overall Study|Lack of Efficacy|26|||
130854176|NCT02049138|471093439|FG002|Overall Study|Lack of Efficacy|1|||
130854177|NCT02049138|471093437|FG000|Overall Study|Non-Compliance|15|||
130854178|NCT02049138|471093438|FG001|Overall Study|Non-Compliance|6|||
130854179|NCT02049138|471093439|FG002|Overall Study|Non-Compliance|0|||
130854180|NCT02049138|471093437|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
130854181|NCT02049138|471093438|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
130854182|NCT02049138|471093439|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
130854183|NCT02049138|471093437|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
130854184|NCT02049138|471093438|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130854185|NCT02049138|471093439|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130854186|NCT02049138|471093437|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
130854187|NCT02049138|471093438|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
130854188|NCT02049138|471093439|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
130854189|NCT02049138|471093437|FG000|Overall Study|Other|15|||
130854190|NCT02049138|471093438|FG001|Overall Study|Other|13|||
130854191|NCT02049138|471093439|FG002|Overall Study|Other|0|||
130854192|NCT02049138|471093437|FG000|Overall Study|Missing|0|||
130854193|NCT02049138|471093438|FG001|Overall Study|Missing|1|||
130854194|NCT02049138|471093439|FG002|Overall Study|Missing|0|||
130854195|NCT02925741|471093440|FG000|Overall Study|Withdrawal by Subject|11|||
130854196|NCT02925741|471093441|FG001|Overall Study|Withdrawal by Subject|0|||
130854197|NCT00025155|471093442|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
130854198|NCT00025155|471093442|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
130854199|NCT05086510|471093443|FG000|Overall Study|Lost to Follow-up|0|||
130854200|NCT05086510|471093444|FG001|Overall Study|Lost to Follow-up|2|||
130854201|NCT05086510|471093443|FG000|Overall Study|Death|0|||
130854202|NCT05086510|471093444|FG001|Overall Study|Death|2|||
130854203|NCT03022981|471093445|FG000|Overall Study|Adverse Event|0|||
130854204|NCT03022981|471093446|FG001|Overall Study|Adverse Event|1|||
130854205|NCT03022981|471093447|FG002|Overall Study|Adverse Event|0|||
130854206|NCT03022981|471093445|FG000|Overall Study|Investigator's Discretion|0|||
130854207|NCT03022981|471093446|FG001|Overall Study|Investigator's Discretion|1|||
130854208|NCT03022981|471093447|FG002|Overall Study|Investigator's Discretion|2|||
130854209|NCT03022981|471093445|FG000|Overall Study|Lost to Follow-up|6|||
130854210|NCT03022981|471093446|FG001|Overall Study|Lost to Follow-up|2|||
130854211|NCT03022981|471093447|FG002|Overall Study|Lost to Follow-up|1|||
130854212|NCT03022981|471093445|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130854213|NCT03022981|471093446|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130854214|NCT03022981|471093447|FG002|Overall Study|Non-Compliance With Study Drug|2|||
130854215|NCT03022981|471093445|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
130854216|NCT03022981|471093446|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
130854217|NCT03022981|471093447|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
130854218|NCT00295932|471093448|FG000|Overall Study|Not Treated|0|||
130854219|NCT00295932|471093449|FG001|Overall Study|Not Treated|0|||
130854220|NCT00295932|471093450|FG002|Overall Study|Not Treated|0|||
130854221|NCT00295932|471093451|FG003|Overall Study|Not Treated|0|||
130854222|NCT00295932|471093452|FG004|Overall Study|Not Treated|0|||
130854223|NCT00295932|471093453|FG005|Overall Study|Not Treated|0|||
130854224|NCT00295932|471093454|FG006|Overall Study|Not Treated|0|||
130854225|NCT00295932|471093455|FG007|Overall Study|Not Treated|0|||
130854226|NCT00295932|471093456|FG008|Overall Study|Not Treated|0|||
130854227|NCT00295932|471093457|FG009|Overall Study|Not Treated|0|||
130854228|NCT00295932|471093458|FG010|Overall Study|Not Treated|1|||
130854229|NCT00109577|471093459|FG000|Overall Study|Withdrawal by Subject|3|||
130854230|NCT00109577|471093460|FG001|Overall Study|Withdrawal by Subject|3|||
130854231|NCT00884832|471093461|FG000|Overall Study|Withdrawal by Subject|0|||
130854232|NCT00884832|471093462|FG001|Overall Study|Withdrawal by Subject|1|||
130854233|NCT00444067|471093463|FG000|Overall Study|Lost to Follow-up|0|||
130854234|NCT00444067|471093464|FG001|Overall Study|Lost to Follow-up|1|||
130854235|NCT03178669|471093465|FG000|Overall Study|Adverse Event|4|||
130854236|NCT03178669|471093466|FG001|Overall Study|Adverse Event|1|||
130854237|NCT03178669|471093467|FG002|Overall Study|Adverse Event|4|||
130854238|NCT03178669|471093468|FG003|Overall Study|Adverse Event|2|||
130854239|NCT03178669|471093469|FG004|Overall Study|Adverse Event|2|||
130854240|NCT03178669|471093465|FG000|Overall Study|Lack of Efficacy|0|||
130854241|NCT03178669|471093466|FG001|Overall Study|Lack of Efficacy|0|||
130854242|NCT03178669|471093467|FG002|Overall Study|Lack of Efficacy|2|||
130854243|NCT03178669|471093468|FG003|Overall Study|Lack of Efficacy|0|||
130854244|NCT03178669|471093469|FG004|Overall Study|Lack of Efficacy|1|||
130854245|NCT03178669|471093465|FG000|Overall Study|Physician Decision|0|||
130854246|NCT03178669|471093466|FG001|Overall Study|Physician Decision|0|||
130854247|NCT03178669|471093467|FG002|Overall Study|Physician Decision|0|||
130854248|NCT03178669|471093468|FG003|Overall Study|Physician Decision|0|||
130854249|NCT03178669|471093469|FG004|Overall Study|Physician Decision|1|||
130854250|NCT03178669|471093465|FG000|Overall Study|Withdrawal by Subject|1|||
130854251|NCT03178669|471093466|FG001|Overall Study|Withdrawal by Subject|0|||
130854252|NCT03178669|471093467|FG002|Overall Study|Withdrawal by Subject|1|||
130854253|NCT03178669|471093468|FG003|Overall Study|Withdrawal by Subject|1|||
130854254|NCT03178669|471093469|FG004|Overall Study|Withdrawal by Subject|0|||
130854255|NCT03178669|471093465|FG000|Overall Study|Lost to Follow-up|0|||
130854256|NCT03178669|471093466|FG001|Overall Study|Lost to Follow-up|0|||
130854257|NCT03178669|471093467|FG002|Overall Study|Lost to Follow-up|0|||
130854258|NCT03178669|471093468|FG003|Overall Study|Lost to Follow-up|1|||
130854259|NCT03178669|471093469|FG004|Overall Study|Lost to Follow-up|0|||
130854260|NCT01600092|471093470|FG000|Overall Study|Adverse Event|2|||
130854261|NCT01600092|471093471|FG001|Overall Study|Adverse Event|0|||
130854262|NCT01600092|471093470|FG000|Overall Study|Lost to Follow-up|4|||
130854263|NCT01600092|471093471|FG001|Overall Study|Lost to Follow-up|6|||
130854264|NCT01600092|471093470|FG000|Overall Study|Withdrawal by parent/guardian|8|||
130854265|NCT01600092|471093471|FG001|Overall Study|Withdrawal by parent/guardian|6|||
130854266|NCT01600092|471093470|FG000|Overall Study|Physician Decision|1|||
130854267|NCT01600092|471093471|FG001|Overall Study|Physician Decision|1|||
130854268|NCT01600092|471093470|FG000|Overall Study|Randomized but not vaccinated|3|||
130854269|NCT01600092|471093471|FG001|Overall Study|Randomized but not vaccinated|3|||
130854270|NCT00079677|471093472|FG000|Overall Study|Adverse Event|5|||
130854271|NCT00079677|471093473|FG001|Overall Study|Adverse Event|6|||
130854272|NCT00079677|471093472|FG000|Overall Study|Lack of Efficacy|1|||
130854273|NCT00079677|471093473|FG001|Overall Study|Lack of Efficacy|0|||
130854274|NCT00079677|471093472|FG000|Overall Study|Lost to Follow-up|2|||
130854275|NCT00079677|471093473|FG001|Overall Study|Lost to Follow-up|2|||
130854276|NCT00079677|471093472|FG000|Overall Study|Physician Decision|3|||
130854277|NCT00079677|471093473|FG001|Overall Study|Physician Decision|0|||
130854278|NCT00079677|471093472|FG000|Overall Study|Protocol Violation|2|||
130854279|NCT00079677|471093473|FG001|Overall Study|Protocol Violation|3|||
130854280|NCT00079677|471093472|FG000|Overall Study|Withdrawal by Subject|5|||
130854281|NCT00079677|471093473|FG001|Overall Study|Withdrawal by Subject|3|||
130854282|NCT00079677|471093472|FG000|Overall Study|Miscellaneous|2|||
130854283|NCT00079677|471093473|FG001|Overall Study|Miscellaneous|0|||
130854284|NCT01300455|471093474|FG000|Washout|Withdrawal by Subject|1|||
130854285|NCT01300455|471093475|FG001|Washout|Withdrawal by Subject|0|||
130854286|NCT00084487|471093476|FG000|Overall Study|Death|1|||
130854287|NCT00565136|471093477|FG000|Overall Study|Lost to Follow-up|1|||
130854288|NCT00565136|471093477|FG000|Overall Study|Withdrawal by Subject|1|||
130854289|NCT00565136|471093477|FG000|Overall Study|Protocol Violation|1|||
130854290|NCT02528357|471093478|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854291|NCT02528357|471093479|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
130854292|NCT02528357|471093480|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854293|NCT02528357|471093481|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854294|NCT02528357|471093482|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854295|NCT02528357|471093483|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854296|NCT02528357|471093484|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854297|NCT02528357|471093485|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854298|NCT02528357|471093486|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854299|NCT02528357|471093487|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854300|NCT02528357|471093488|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854301|NCT02528357|471093489|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854302|NCT02528357|471093490|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854303|NCT02528357|471093491|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854304|NCT02528357|471093492|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854305|NCT02528357|471093493|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854306|NCT02528357|471093494|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854307|NCT02528357|471093495|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854308|NCT02528357|471093496|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130854309|NCT02528357|471093478|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854310|NCT02528357|471093479|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854311|NCT02528357|471093480|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854312|NCT02528357|471093481|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
130854313|NCT02528357|471093482|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854314|NCT02528357|471093483|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
130854315|NCT02528357|471093484|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854316|NCT02528357|471093485|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
130854317|NCT02528357|471093486|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854318|NCT02528357|471093487|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854319|NCT02528357|471093488|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854320|NCT02528357|471093489|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854321|NCT02528357|471093490|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854322|NCT02528357|471093491|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854323|NCT02528357|471093492|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854324|NCT02528357|471093493|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854325|NCT02528357|471093494|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854326|NCT02528357|471093495|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854327|NCT02528357|471093496|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130854328|NCT02528357|471093478|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854329|NCT02528357|471093479|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854330|NCT02528357|471093480|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
130854331|NCT02528357|471093481|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854332|NCT02528357|471093482|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
130854333|NCT02528357|471093483|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854334|NCT02528357|471093484|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
130854335|NCT02528357|471093485|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
130854336|NCT02528357|471093486|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854337|NCT02528357|471093487|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854338|NCT02528357|471093488|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854339|NCT02528357|471093489|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854340|NCT02528357|471093490|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854341|NCT02528357|471093491|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854342|NCT02528357|471093492|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854343|NCT02528357|471093493|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854344|NCT02528357|471093494|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854345|NCT02528357|471093495|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854346|NCT02528357|471093496|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130854347|NCT02528357|471093478|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854348|NCT02528357|471093479|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854349|NCT02528357|471093480|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854350|NCT02528357|471093481|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854351|NCT02528357|471093482|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130854352|NCT02528357|471093483|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854353|NCT02528357|471093484|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854354|NCT02528357|471093485|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854355|NCT02528357|471093486|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854356|NCT02528357|471093487|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854357|NCT02528357|471093488|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854358|NCT02528357|471093489|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854359|NCT02528357|471093490|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854360|NCT02528357|471093491|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854361|NCT02528357|471093492|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854362|NCT02528357|471093493|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854363|NCT02528357|471093494|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854364|NCT02528357|471093495|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854365|NCT02528357|471093496|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854366|NCT02528357|471093478|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854367|NCT02528357|471093479|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854368|NCT02528357|471093480|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854369|NCT02528357|471093481|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854370|NCT02528357|471093482|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854371|NCT02528357|471093483|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854372|NCT02528357|471093484|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854373|NCT02528357|471093485|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854374|NCT02528357|471093486|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854375|NCT02528357|471093487|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854376|NCT02528357|471093488|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854377|NCT02528357|471093489|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854378|NCT02528357|471093490|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854379|NCT02528357|471093491|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
130854380|NCT02528357|471093492|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
130854381|NCT02528357|471093493|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854382|NCT02528357|471093494|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854383|NCT02528357|471093495|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854384|NCT02528357|471093496|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130854385|NCT02528357|471093478|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854386|NCT02528357|471093479|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854387|NCT02528357|471093480|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854388|NCT02528357|471093481|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854389|NCT02528357|471093482|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854390|NCT02528357|471093483|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854391|NCT02528357|471093484|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854392|NCT02528357|471093485|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854393|NCT02528357|471093486|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854394|NCT02528357|471093487|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854395|NCT02528357|471093488|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854396|NCT02528357|471093489|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854397|NCT02528357|471093490|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854398|NCT02528357|471093491|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
130854399|NCT02528357|471093492|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854400|NCT02528357|471093493|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854401|NCT02528357|471093494|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854402|NCT02528357|471093495|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854403|NCT02528357|471093496|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130854404|NCT02528357|471093478|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854405|NCT02528357|471093479|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854406|NCT02528357|471093480|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854407|NCT02528357|471093481|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854408|NCT02528357|471093482|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854409|NCT02528357|471093483|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854410|NCT02528357|471093484|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854411|NCT02528357|471093485|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854412|NCT02528357|471093486|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854413|NCT02528357|471093487|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854414|NCT02528357|471093488|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
130854415|NCT02528357|471093489|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854416|NCT02528357|471093490|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
130854417|NCT02528357|471093491|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
130854418|NCT02528357|471093492|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
130854419|NCT02528357|471093493|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854420|NCT02528357|471093494|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854421|NCT02528357|471093495|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854422|NCT02528357|471093496|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130854423|NCT02528357|471093478|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854424|NCT02528357|471093479|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854425|NCT02528357|471093480|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854426|NCT02528357|471093481|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854427|NCT02528357|471093482|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854428|NCT02528357|471093483|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854429|NCT02528357|471093484|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854430|NCT02528357|471093485|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854431|NCT02528357|471093486|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130854432|NCT02528357|471093487|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130854433|NCT02528357|471093488|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854434|NCT02528357|471093489|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
130854435|NCT02528357|471093490|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
130854436|NCT02528357|471093491|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130854437|NCT02528357|471093492|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130854438|NCT02528357|471093493|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854439|NCT02528357|471093494|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854440|NCT02528357|471093495|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854441|NCT02528357|471093496|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854442|NCT02528357|471093478|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854443|NCT02528357|471093479|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854444|NCT02528357|471093480|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854445|NCT02528357|471093481|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854446|NCT02528357|471093482|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854447|NCT02528357|471093483|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854448|NCT02528357|471093484|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854449|NCT02528357|471093485|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854450|NCT02528357|471093486|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854451|NCT02528357|471093487|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854452|NCT02528357|471093488|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854453|NCT02528357|471093489|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854454|NCT02528357|471093490|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854455|NCT02528357|471093491|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854456|NCT02528357|471093492|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854457|NCT02528357|471093493|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854458|NCT02528357|471093494|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
130854459|NCT02528357|471093495|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854460|NCT02528357|471093496|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130854461|NCT02528357|471093478|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854462|NCT02528357|471093479|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854463|NCT02528357|471093480|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854464|NCT02528357|471093481|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854465|NCT02528357|471093482|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854466|NCT02528357|471093483|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854467|NCT02528357|471093484|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854468|NCT02528357|471093485|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854469|NCT02528357|471093486|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854470|NCT02528357|471093487|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854471|NCT02528357|471093488|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854472|NCT02528357|471093489|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854473|NCT02528357|471093490|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854474|NCT02528357|471093491|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854475|NCT02528357|471093492|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854476|NCT02528357|471093493|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130854477|NCT02528357|471093494|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130854478|NCT02528357|471093495|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
130854479|NCT02528357|471093496|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
130854480|NCT00454649|471093507|FG000|Overall Study|Lack of Efficacy|2|||
130854481|NCT00454649|471093508|FG001|Overall Study|Lack of Efficacy|2|||
130854482|NCT00454649|471093509|FG002|Overall Study|Lack of Efficacy|10|||
130854483|NCT00454649|471093510|FG003|Overall Study|Lack of Efficacy|3|||
130854484|NCT00454649|471093511|FG004|Overall Study|Lack of Efficacy|0|||
130854485|NCT00454649|471093512|FG005|Overall Study|Lack of Efficacy|4|||
130854486|NCT00454649|471093513|FG006|Overall Study|Lack of Efficacy|5|||
130854487|NCT00454649|471093514|FG007|Overall Study|Lack of Efficacy|13|||
130854488|NCT00454649|471093515|FG008|Overall Study|Lack of Efficacy|10|||
130854489|NCT00454649|471093516|FG009|Overall Study|Lack of Efficacy|2|||
130854490|NCT00454649|471093507|FG000|Overall Study|Adverse Event|0|||
130854491|NCT00454649|471093508|FG001|Overall Study|Adverse Event|1|||
130854492|NCT00454649|471093509|FG002|Overall Study|Adverse Event|3|||
130854493|NCT00454649|471093510|FG003|Overall Study|Adverse Event|0|||
130854494|NCT00454649|471093511|FG004|Overall Study|Adverse Event|1|||
130854495|NCT00454649|471093512|FG005|Overall Study|Adverse Event|2|||
130854496|NCT00454649|471093513|FG006|Overall Study|Adverse Event|3|||
130854497|NCT00454649|471093514|FG007|Overall Study|Adverse Event|4|||
130854498|NCT00454649|471093515|FG008|Overall Study|Adverse Event|6|||
130854499|NCT00454649|471093516|FG009|Overall Study|Adverse Event|2|||
130854500|NCT00454649|471093507|FG000|Overall Study|Lost to Follow-up|0|||
130854501|NCT00454649|471093508|FG001|Overall Study|Lost to Follow-up|0|||
130854502|NCT00454649|471093509|FG002|Overall Study|Lost to Follow-up|1|||
130854503|NCT00454649|471093510|FG003|Overall Study|Lost to Follow-up|0|||
130854504|NCT00454649|471093511|FG004|Overall Study|Lost to Follow-up|0|||
130854505|NCT00454649|471093512|FG005|Overall Study|Lost to Follow-up|0|||
130854506|NCT00454649|471093513|FG006|Overall Study|Lost to Follow-up|1|||
130854507|NCT00454649|471093514|FG007|Overall Study|Lost to Follow-up|0|||
130854508|NCT00454649|471093515|FG008|Overall Study|Lost to Follow-up|0|||
130854509|NCT00454649|471093516|FG009|Overall Study|Lost to Follow-up|0|||
130854510|NCT00454649|471093507|FG000|Overall Study|Other|1|||
130854511|NCT00454649|471093508|FG001|Overall Study|Other|1|||
130854512|NCT00454649|471093509|FG002|Overall Study|Other|5|||
130854513|NCT00454649|471093510|FG003|Overall Study|Other|3|||
130854514|NCT00454649|471093511|FG004|Overall Study|Other|0|||
130854515|NCT00454649|471093512|FG005|Overall Study|Other|0|||
130854516|NCT00454649|471093513|FG006|Overall Study|Other|0|||
130854517|NCT00454649|471093514|FG007|Overall Study|Other|0|||
130854518|NCT00454649|471093515|FG008|Overall Study|Other|3|||
130854519|NCT00454649|471093516|FG009|Overall Study|Other|1|||
130854520|NCT00454649|471093507|FG000|Overall Study|Withdrawal by Subject|0|||
130854521|NCT00454649|471093508|FG001|Overall Study|Withdrawal by Subject|0|||
130854522|NCT00454649|471093509|FG002|Overall Study|Withdrawal by Subject|0|||
130854523|NCT00454649|471093510|FG003|Overall Study|Withdrawal by Subject|0|||
130854524|NCT00454649|471093511|FG004|Overall Study|Withdrawal by Subject|0|||
130854525|NCT00454649|471093512|FG005|Overall Study|Withdrawal by Subject|1|||
130854526|NCT00454649|471093513|FG006|Overall Study|Withdrawal by Subject|0|||
130854527|NCT00454649|471093514|FG007|Overall Study|Withdrawal by Subject|2|||
130854528|NCT00454649|471093515|FG008|Overall Study|Withdrawal by Subject|1|||
130854529|NCT00454649|471093516|FG009|Overall Study|Withdrawal by Subject|0|||
130854530|NCT03281304|471093521|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
130854531|NCT03281304|471093522|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
130854532|NCT03281304|471093521|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
130854533|NCT03281304|471093522|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
130854534|NCT03281304|471093521|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
130854535|NCT03281304|471093522|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
130854536|NCT03281304|471093521|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
130854537|NCT03281304|471093522|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
130854538|NCT03281304|471093521|FG000|Treatment Phase (up to 42 Months)|Death|0|||
130854539|NCT03281304|471093522|FG001|Treatment Phase (up to 42 Months)|Death|1|||
130854540|NCT03281304|471093521|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
130854541|NCT03281304|471093522|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
130854542|NCT03281304|471093521|FG000|Treatment Phase (up to 42 Months)|Other|0|||
130854543|NCT03281304|471093522|FG001|Treatment Phase (up to 42 Months)|Other|2|||
130854544|NCT03281304|471093521|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
130854545|NCT03281304|471093522|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
130854546|NCT02720692|471095393|FG000|Overall Study|Withdrawal by Subject|3|||
130854547|NCT02720692|471095394|FG001|Overall Study|Withdrawal by Subject|0|||
130854548|NCT02720692|471095393|FG000|Overall Study|Physician Decision|1|||
130854549|NCT02720692|471095394|FG001|Overall Study|Physician Decision|0|||
130854550|NCT02720692|471095393|FG000|Overall Study|Lost to Follow-up|8|||
130854551|NCT02720692|471095394|FG001|Overall Study|Lost to Follow-up|3|||
130854552|NCT02720692|471095393|FG000|Overall Study|Subject unable to return for visit|1|||
130854553|NCT02720692|471095394|FG001|Overall Study|Subject unable to return for visit|0|||
130854554|NCT05011513|471095395|FG000|Overall Study|Death|0|||
130854555|NCT05011513|471095396|FG001|Overall Study|Death|1|||
130854556|NCT05011513|471095395|FG000|Overall Study|Lost to Follow-up|4|||
130854557|NCT05011513|471095396|FG001|Overall Study|Lost to Follow-up|0|||
130854558|NCT05011513|471095395|FG000|Overall Study|Withdrawal by Subject|18|||
130854559|NCT05011513|471095396|FG001|Overall Study|Withdrawal by Subject|17|||
130854560|NCT05011513|471095395|FG000|Overall Study|Other|4|||
130854561|NCT05011513|471095396|FG001|Overall Study|Other|2|||
130854562|NCT03878758|471095397|FG000|Overall Study|Withdrawal by Subject|1|||
130854563|NCT03878758|471095397|FG000|Overall Study|Protocol defined|2|||
130854564|NCT03878758|471095397|FG000|Overall Study|Improper consent documentation|1|||
130854565|NCT02315560|471095398|FG000|Overall Study|noncompliance by subjects|3|||
130854566|NCT03495102|471095399|FG000|Overall Study|Adverse Event|5|||
130854567|NCT03495102|471095400|FG001|Overall Study|Adverse Event|7|||
130854568|NCT03495102|471095401|FG002|Overall Study|Adverse Event|10|||
130854569|NCT03495102|471095399|FG000|Overall Study|Death|3|||
130854570|NCT03495102|471095400|FG001|Overall Study|Death|4|||
130854571|NCT03495102|471095401|FG002|Overall Study|Death|4|||
130854572|NCT03495102|471095399|FG000|Overall Study|Lost to Follow-up|15|||
130854573|NCT03495102|471095400|FG001|Overall Study|Lost to Follow-up|16|||
130854574|NCT03495102|471095401|FG002|Overall Study|Lost to Follow-up|17|||
130854575|NCT03495102|471095399|FG000|Overall Study|Physician Decision|2|||
130854576|NCT03495102|471095400|FG001|Overall Study|Physician Decision|0|||
130854577|NCT03495102|471095401|FG002|Overall Study|Physician Decision|2|||
130854578|NCT03495102|471095399|FG000|Overall Study|Withdrawal by Subject|25|||
130854579|NCT03495102|471095400|FG001|Overall Study|Withdrawal by Subject|36|||
130854580|NCT03495102|471095401|FG002|Overall Study|Withdrawal by Subject|18|||
130854581|NCT03495102|471095399|FG000|Overall Study|Protocol Violation|1|||
130854582|NCT03495102|471095400|FG001|Overall Study|Protocol Violation|1|||
130854583|NCT03495102|471095401|FG002|Overall Study|Protocol Violation|0|||
130854584|NCT03495102|471095399|FG000|Overall Study|Site Closure|3|||
130854585|NCT03495102|471095400|FG001|Overall Study|Site Closure|1|||
130854586|NCT03495102|471095401|FG002|Overall Study|Site Closure|2|||
130854587|NCT03495102|471095399|FG000|Overall Study|Non-compliance|1|||
130854588|NCT03495102|471095400|FG001|Overall Study|Non-compliance|0|||
130854589|NCT03495102|471095401|FG002|Overall Study|Non-compliance|0|||
130854590|NCT03495102|471095399|FG000|Overall Study|Participant Duplicated at Another Site|0|||
130854591|NCT03495102|471095400|FG001|Overall Study|Participant Duplicated at Another Site|0|||
130854592|NCT03495102|471095401|FG002|Overall Study|Participant Duplicated at Another Site|1|||
130854593|NCT03495102|471095399|FG000|Overall Study|Primary Care Physician Recommendation|0|||
130854594|NCT03495102|471095400|FG001|Overall Study|Primary Care Physician Recommendation|1|||
130854595|NCT03495102|471095401|FG002|Overall Study|Primary Care Physician Recommendation|0|||
130854596|NCT03495102|471095399|FG000|Overall Study|Relocated to Another Country|0|||
130854597|NCT03495102|471095400|FG001|Overall Study|Relocated to Another Country|1|||
130854598|NCT03495102|471095401|FG002|Overall Study|Relocated to Another Country|0|||
130854599|NCT03495102|471095399|FG000|Overall Study|Participant was in Rehabilitation|1|||
130854600|NCT03495102|471095400|FG001|Overall Study|Participant was in Rehabilitation|0|||
130854601|NCT03495102|471095401|FG002|Overall Study|Participant was in Rehabilitation|0|||
130854602|NCT01161537|471095404|FG000|Part B|Withdrawal by Subject|2|||
130854603|NCT00358436|471095407|FG000|Overall Study|Adverse Event|29|||
130854604|NCT00358436|471095408|FG001|Overall Study|Adverse Event|13|||
130854605|NCT00358436|471095407|FG000|Overall Study|Lack of Efficacy|34|||
130854606|NCT00358436|471095408|FG001|Overall Study|Lack of Efficacy|36|||
130854607|NCT00358436|471095407|FG000|Overall Study|Lost to Follow-up|11|||
130854608|NCT00358436|471095408|FG001|Overall Study|Lost to Follow-up|6|||
130854609|NCT00358436|471095407|FG000|Overall Study|Protocol Violation|8|||
130854610|NCT00358436|471095408|FG001|Overall Study|Protocol Violation|3|||
130854611|NCT00358436|471095407|FG000|Overall Study|Withdrawal by Subject|40|||
130854612|NCT00358436|471095408|FG001|Overall Study|Withdrawal by Subject|17|||
130854613|NCT00358436|471095407|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
130854614|NCT00358436|471095408|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
130854615|NCT00358436|471095407|FG000|Overall Study|COPD exacerbation|22|||
130854616|NCT00358436|471095408|FG001|Overall Study|COPD exacerbation|10|||
130854617|NCT00358436|471095407|FG000|Overall Study|Other|6|||
130854618|NCT00358436|471095408|FG001|Overall Study|Other|1|||
130854619|NCT00321464|471095409|FG000|Overall Study|Death|169|||
130854620|NCT00321464|471095410|FG001|Overall Study|Death|174|||
130854621|NCT00321464|471095409|FG000|Overall Study|Disease progression|124|||
130854622|NCT00321464|471095410|FG001|Overall Study|Disease progression|124|||
130854623|NCT00321464|471095409|FG000|Overall Study|Withdrawal by Subject|117|||
130854624|NCT00321464|471095410|FG001|Overall Study|Withdrawal by Subject|118|||
130854625|NCT00321464|471095409|FG000|Overall Study|Participant request|57|||
130854626|NCT00321464|471095410|FG001|Overall Study|Participant request|61|||
130854627|NCT00321464|471095409|FG000|Overall Study|Adverse Event|43|||
130854628|NCT00321464|471095410|FG001|Overall Study|Adverse Event|28|||
130854629|NCT00321464|471095409|FG000|Overall Study|Physician Decision|15|||
130854630|NCT00321464|471095410|FG001|Overall Study|Physician Decision|14|||
130854631|NCT00321464|471095409|FG000|Overall Study|Noncompliance|4|||
130854632|NCT00321464|471095410|FG001|Overall Study|Noncompliance|10|||
130854633|NCT00321464|471095409|FG000|Overall Study|Lost to Follow-up|7|||
130854634|NCT00321464|471095410|FG001|Overall Study|Lost to Follow-up|8|||
130854635|NCT00321464|471095409|FG000|Overall Study|Protocol deviation|0|||
130854636|NCT00321464|471095410|FG001|Overall Study|Protocol deviation|2|||
130854637|NCT00321464|471095409|FG000|Overall Study|Ineligibility determined|2|||
130854638|NCT00321464|471095410|FG001|Overall Study|Ineligibility determined|1|||
130854639|NCT00321464|471095409|FG000|Overall Study|Other|21|||
130854640|NCT00321464|471095410|FG001|Overall Study|Other|18|||
130854641|NCT04327024|471095411|FG000|Overall Study|Death|1|||
130854642|NCT04327024|471095412|FG001|Overall Study|Death|2|||
130854643|NCT04327024|471095413|FG002|Overall Study|Death|1|||
130854644|NCT04327024|471095411|FG000|Overall Study|Non-compliance with study drug|0|||
130854645|NCT04327024|471095412|FG001|Overall Study|Non-compliance with study drug|1|||
130854646|NCT04327024|471095413|FG002|Overall Study|Non-compliance with study drug|0|||
130854647|NCT04327024|471095411|FG000|Overall Study|Withdrawal by Subject|1|||
130854648|NCT04327024|471095412|FG001|Overall Study|Withdrawal by Subject|1|||
130854649|NCT04327024|471095413|FG002|Overall Study|Withdrawal by Subject|2|||
130854650|NCT01192568|471095417|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
130854651|NCT01192568|471095418|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
130854652|NCT01192568|471095419|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
130854653|NCT01192568|471095420|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
130854654|NCT01192568|471095417|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
130854655|NCT01192568|471095418|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
130854656|NCT01192568|471095419|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
130854657|NCT01192568|471095420|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
130854658|NCT00652951|471095421|FG000|Booster Phase|Adverse event, non-fatal|0|||
130854659|NCT00652951|471095422|FG001|Booster Phase|Adverse event, non-fatal|1|||
130854660|NCT00652951|471095423|FG002|Booster Phase|Adverse event, non-fatal|0|||
130854661|NCT00652951|471095421|FG000|Booster Phase|Other|1|||
130854662|NCT00652951|471095422|FG001|Booster Phase|Other|0|||
130854663|NCT00652951|471095423|FG002|Booster Phase|Other|0|||
130854664|NCT01206582|471095424|FG000|Overall Study|Withdrew prior to study|1|||
130854665|NCT01206582|471095425|FG001|Overall Study|Withdrew prior to study|0|||
130854666|NCT01206582|471095424|FG000|Overall Study|Discontinued intervention before week 8|1|||
130854667|NCT01206582|471095425|FG001|Overall Study|Discontinued intervention before week 8|2|||
130854668|NCT02522325|471095426|FG000|Overall Study|Adverse Event|0|||
130854669|NCT02522325|471095427|FG001|Overall Study|Adverse Event|1|||
130854670|NCT01209078|471095428|FG000|Overall Study|Adverse Event|5|||
130854671|NCT01209078|471095429|FG001|Overall Study|Adverse Event|0|||
130854672|NCT01209078|471095428|FG000|Overall Study|Lost to Follow-up|4|||
130854673|NCT01209078|471095429|FG001|Overall Study|Lost to Follow-up|0|||
130854674|NCT01209078|471095428|FG000|Overall Study|Physician Decision|5|||
130854675|NCT01209078|471095429|FG001|Overall Study|Physician Decision|2|||
130854676|NCT01209078|471095428|FG000|Overall Study|Withdrawal by Subject|2|||
130854677|NCT01209078|471095429|FG001|Overall Study|Withdrawal by Subject|1|||
130854678|NCT00924508|471095432|FG000|Overall Study|Withdrawal by Subject|3|||
130854679|NCT06359080|471095433|FG000|Overall Study|Withdrawal by Subject|3|||
130854680|NCT00511134|471095434|FG000|Overall Study|Withdrawal by Subject|0|||
130854681|NCT00511134|471095435|FG001|Overall Study|Withdrawal by Subject|2|||
130854682|NCT01949090|471095436|FG000|Overall Study|Serious Adverse Event|0|||
130854683|NCT01949090|471095437|FG001|Overall Study|Serious Adverse Event|1|||
130854684|NCT01949090|471095438|FG002|Overall Study|Serious Adverse Event|2|||
130854685|NCT01949090|471095439|FG003|Overall Study|Serious Adverse Event|0|||
130854686|NCT01949090|471095440|FG004|Overall Study|Serious Adverse Event|1|||
130854687|NCT01949090|471095436|FG000|Overall Study|Withdrawal by Subject|2|||
130854688|NCT01949090|471095437|FG001|Overall Study|Withdrawal by Subject|0|||
130854689|NCT01949090|471095438|FG002|Overall Study|Withdrawal by Subject|0|||
130854690|NCT01949090|471095439|FG003|Overall Study|Withdrawal by Subject|0|||
130854691|NCT01949090|471095440|FG004|Overall Study|Withdrawal by Subject|1|||
130854692|NCT01949090|471095436|FG000|Overall Study|Protocol non-compliance|0|||
130854693|NCT01949090|471095437|FG001|Overall Study|Protocol non-compliance|0|||
130854694|NCT01949090|471095438|FG002|Overall Study|Protocol non-compliance|0|||
130854695|NCT01949090|471095439|FG003|Overall Study|Protocol non-compliance|0|||
130854696|NCT01949090|471095440|FG004|Overall Study|Protocol non-compliance|1|||
130854697|NCT01949090|471095436|FG000|Overall Study|Lost to Follow-up|2|||
130854698|NCT01949090|471095437|FG001|Overall Study|Lost to Follow-up|1|||
130854699|NCT01949090|471095438|FG002|Overall Study|Lost to Follow-up|0|||
130854700|NCT01949090|471095439|FG003|Overall Study|Lost to Follow-up|1|||
130854701|NCT01949090|471095440|FG004|Overall Study|Lost to Follow-up|1|||
130854702|NCT03459365|471095443|FG000|Overall Study|Withdrawal by Subject|6|||
130854703|NCT03459365|471095443|FG000|Overall Study|Protocol Violation|8|||
130854704|NCT00306527|471095447|FG000|Overall Study|Lost to Follow-up|3|||
130854705|NCT00306527|471095448|FG001|Overall Study|Lost to Follow-up|4|||
130854706|NCT00306527|471095449|FG002|Overall Study|Lost to Follow-up|3|||
130854707|NCT00306527|471095450|FG003|Overall Study|Lost to Follow-up|0|||
130854708|NCT00306527|471095447|FG000|Overall Study|Withdrawal by Subject|2|||
130854709|NCT00306527|471095448|FG001|Overall Study|Withdrawal by Subject|3|||
130854710|NCT00306527|471095449|FG002|Overall Study|Withdrawal by Subject|0|||
130854711|NCT00306527|471095450|FG003|Overall Study|Withdrawal by Subject|3|||
130854712|NCT00306527|471095447|FG000|Overall Study|Adverse Event|0|||
130854713|NCT00306527|471095448|FG001|Overall Study|Adverse Event|0|||
130854714|NCT00306527|471095449|FG002|Overall Study|Adverse Event|1|||
130854715|NCT00306527|471095450|FG003|Overall Study|Adverse Event|1|||
130854716|NCT00306527|471095447|FG000|Overall Study|Death|1|||
130854717|NCT00306527|471095448|FG001|Overall Study|Death|0|||
130854718|NCT00306527|471095449|FG002|Overall Study|Death|1|||
130854719|NCT00306527|471095450|FG003|Overall Study|Death|2|||
130854720|NCT00785980|471095451|FG000|7 Day Washout Period|Protocol Violation|3|||
130854721|NCT03055013|471095452|FG000|Overall Study|Adverse Event|78|||
130854722|NCT03055013|471095453|FG001|Overall Study|Adverse Event|0|||
130854723|NCT03055013|471095452|FG000|Overall Study|Death|6|||
130854724|NCT03055013|471095453|FG001|Overall Study|Death|0|||
130854725|NCT03055013|471095452|FG000|Overall Study|Disease relapse|33|||
130854726|NCT03055013|471095453|FG001|Overall Study|Disease relapse|0|||
130854727|NCT03055013|471095452|FG000|Overall Study|Withdrawal by Subject|28|||
130854728|NCT03055013|471095453|FG001|Overall Study|Withdrawal by Subject|0|||
130854729|NCT03055013|471095452|FG000|Overall Study|Other complicating disease|5|||
130854730|NCT03055013|471095453|FG001|Overall Study|Other complicating disease|0|||
130854731|NCT03055013|471095452|FG000|Overall Study|Physician Decision|1|||
130854732|NCT03055013|471095453|FG001|Overall Study|Physician Decision|0|||
130854733|NCT03055013|471095452|FG000|Overall Study|Benign mass/non-RCC|4|||
130854734|NCT03055013|471095453|FG001|Overall Study|Benign mass/non-RCC|0|||
130854735|NCT03055013|471095452|FG000|Overall Study|Enrolled in another trial|1|||
130854736|NCT03055013|471095453|FG001|Overall Study|Enrolled in another trial|0|||
130854737|NCT03055013|471095452|FG000|Overall Study|Non-protocol therapy|1|||
130854738|NCT03055013|471095453|FG001|Overall Study|Non-protocol therapy|0|||
130854739|NCT03055013|471095452|FG000|Overall Study|Incompliance|1|||
130854740|NCT03055013|471095453|FG001|Overall Study|Incompliance|0|||
130854741|NCT03055013|471095452|FG000|Overall Study|Insurance issues|1|||
130854742|NCT03055013|471095453|FG001|Overall Study|Insurance issues|0|||
130854743|NCT03055013|471095452|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
130854744|NCT03055013|471095453|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
130854745|NCT03055013|471095452|FG000|Overall Study|Did not receive nivolumab|10|||
130854746|NCT03055013|471095453|FG001|Overall Study|Did not receive nivolumab|0|||
130854747|NCT03055013|471095452|FG000|Overall Study|Did not receive surgery|0|||
130854748|NCT03055013|471095453|FG001|Overall Study|Did not receive surgery|28|||
130854749|NCT00528801|471095454|FG000|Overall Study|Withdrawal by Subject|1|||
130854750|NCT00528801|471095455|FG001|Overall Study|Withdrawal by Subject|1|||
130854751|NCT00528801|471095454|FG000|Overall Study|Protocol Violation|11|||
130854752|NCT00528801|471095455|FG001|Overall Study|Protocol Violation|5|||
130854753|NCT00528801|471095454|FG000|Overall Study|Lost to Follow-up|15|||
130854754|NCT00528801|471095455|FG001|Overall Study|Lost to Follow-up|4|||
130854755|NCT00528801|471095454|FG000|Overall Study|Administrative Reasons|0|||
130854756|NCT00528801|471095455|FG001|Overall Study|Administrative Reasons|1|||
130854757|NCT00344500|471095456|FG000|Overall Study|Adverse Event|6|||
130854758|NCT00344500|471095457|FG001|Overall Study|Adverse Event|2|||
130854759|NCT00344500|471095458|FG002|Overall Study|Adverse Event|0|||
130854760|NCT00344500|471095456|FG000|Overall Study|Lost to Follow-up|5|||
130854761|NCT00344500|471095457|FG001|Overall Study|Lost to Follow-up|13|||
130854762|NCT00344500|471095458|FG002|Overall Study|Lost to Follow-up|1|||
130854763|NCT00344500|471095456|FG000|Overall Study|Withdrawal by Subject|7|||
130854764|NCT00344500|471095457|FG001|Overall Study|Withdrawal by Subject|10|||
130854765|NCT00344500|471095458|FG002|Overall Study|Withdrawal by Subject|0|||
130854766|NCT00344500|471095456|FG000|Overall Study|Protocol Violation|4|||
130854767|NCT00344500|471095457|FG001|Overall Study|Protocol Violation|7|||
130854768|NCT00344500|471095458|FG002|Overall Study|Protocol Violation|1|||
130854769|NCT00344500|471095456|FG000|Overall Study|Not Noted|1|||
130854770|NCT00344500|471095457|FG001|Overall Study|Not Noted|3|||
130854771|NCT00344500|471095458|FG002|Overall Study|Not Noted|0|||
130854772|NCT02207491|471095459|FG000|Overall Study|Adverse Event|20|||
130854773|NCT02207491|471095460|FG001|Overall Study|Adverse Event|4|||
130854774|NCT02207491|471095459|FG000|Overall Study|Withdrawal by Subject|3|||
130854775|NCT02207491|471095460|FG001|Overall Study|Withdrawal by Subject|2|||
130854776|NCT02207491|471095459|FG000|Overall Study|Non-compliant|0|||
130854777|NCT02207491|471095460|FG001|Overall Study|Non-compliant|1|||
130854778|NCT02207491|471095459|FG000|Overall Study|Lost to Follow-up|0|||
130854779|NCT02207491|471095460|FG001|Overall Study|Lost to Follow-up|1|||
130854780|NCT02207491|471095459|FG000|Overall Study|Lack of Efficacy|3|||
130854781|NCT02207491|471095460|FG001|Overall Study|Lack of Efficacy|0|||
130854782|NCT02207491|471095459|FG000|Overall Study|Physician Decision|2|||
130854783|NCT02207491|471095460|FG001|Overall Study|Physician Decision|0|||
130854784|NCT02207491|471095459|FG000|Overall Study|Protocol Violation|3|||
130854785|NCT02207491|471095460|FG001|Overall Study|Protocol Violation|5|||
130854786|NCT00599755|471095461|FG000|Overall Study|Adverse Event|11|||
130854787|NCT00599755|471095461|FG000|Overall Study|Withdrawal by Subject|2|||
130854788|NCT00599755|471095461|FG000|Overall Study|Progression of Disease|3|||
130854789|NCT00599755|471095461|FG000|Overall Study|Other Reason|2|||
130854790|NCT00599755|471095461|FG000|Overall Study|No data available|1|||
130854791|NCT00417963|471095465|FG000|Overall Study|Lost to Follow-up|3|||
130854792|NCT00417963|471095465|FG000|Overall Study|Withdrawal by Subject|18|||
130854793|NCT00417963|471095465|FG000|Overall Study|Death|17|||
130854794|NCT00417963|471095465|FG000|Overall Study|Study device could not be deployed|3|||
130854795|NCT01023672|471095479|FG000|Overall Study|Worsening disease|2|||
130854796|NCT01023672|471095479|FG000|Overall Study|Death|1|||
130854797|NCT00387725|471095480|FG000|Overall Study|Adverse Event|0|||
130854798|NCT00387725|471095481|FG001|Overall Study|Adverse Event|0|||
130854799|NCT00387725|471095482|FG002|Overall Study|Adverse Event|0|||
130854800|NCT00387725|471095483|FG003|Overall Study|Adverse Event|1|||
130854801|NCT00387725|471095480|FG000|Overall Study|Protocol Violation|0|||
130854802|NCT00387725|471095481|FG001|Overall Study|Protocol Violation|1|||
130854803|NCT00387725|471095482|FG002|Overall Study|Protocol Violation|0|||
130854804|NCT00387725|471095483|FG003|Overall Study|Protocol Violation|0|||
130854805|NCT00387725|471095480|FG000|Overall Study|Withdrawal by Subject|1|||
130854806|NCT00387725|471095481|FG001|Overall Study|Withdrawal by Subject|0|||
130854807|NCT00387725|471095482|FG002|Overall Study|Withdrawal by Subject|1|||
130854808|NCT00387725|471095483|FG003|Overall Study|Withdrawal by Subject|0|||
130854809|NCT00387725|471095480|FG000|Overall Study|Parent/legal guardian request|0|||
130854810|NCT00387725|471095481|FG001|Overall Study|Parent/legal guardian request|0|||
130854811|NCT00387725|471095482|FG002|Overall Study|Parent/legal guardian request|1|||
130854812|NCT00387725|471095483|FG003|Overall Study|Parent/legal guardian request|1|||
130854813|NCT00231413|471095484|FG000|Overall Study|Non-serious AE|0|||
130854814|NCT00231413|471095485|FG001|Overall Study|Non-serious AE|0|||
130854815|NCT00231413|471095486|FG002|Overall Study|Non-serious AE|1|||
130854816|NCT00231413|471095487|FG003|Overall Study|Non-serious AE|0|||
130854817|NCT00231413|471095488|FG004|Overall Study|Non-serious AE|0|||
130854818|NCT00231413|471095489|FG005|Overall Study|Non-serious AE|0|||
130854819|NCT00231413|471095490|FG006|Overall Study|Non-serious AE|1|||
130854820|NCT00231413|471095484|FG000|Overall Study|Withdrawal by Subject|3|||
130854821|NCT00231413|471095485|FG001|Overall Study|Withdrawal by Subject|1|||
130854822|NCT00231413|471095486|FG002|Overall Study|Withdrawal by Subject|4|||
130854823|NCT00231413|471095487|FG003|Overall Study|Withdrawal by Subject|2|||
130854824|NCT00231413|471095488|FG004|Overall Study|Withdrawal by Subject|2|||
130854825|NCT00231413|471095489|FG005|Overall Study|Withdrawal by Subject|0|||
130854826|NCT00231413|471095490|FG006|Overall Study|Withdrawal by Subject|3|||
130854827|NCT00231413|471095484|FG000|Overall Study|Migrated/moved from study area|0|||
130854828|NCT00231413|471095485|FG001|Overall Study|Migrated/moved from study area|0|||
130854829|NCT00231413|471095486|FG002|Overall Study|Migrated/moved from study area|1|||
130854830|NCT00231413|471095487|FG003|Overall Study|Migrated/moved from study area|0|||
130854831|NCT00231413|471095488|FG004|Overall Study|Migrated/moved from study area|0|||
130854832|NCT00231413|471095489|FG005|Overall Study|Migrated/moved from study area|1|||
130854833|NCT00231413|471095490|FG006|Overall Study|Migrated/moved from study area|0|||
130854834|NCT00231413|471095484|FG000|Overall Study|Lost to Follow-up|4|||
130854835|NCT00231413|471095485|FG001|Overall Study|Lost to Follow-up|4|||
130854836|NCT00231413|471095486|FG002|Overall Study|Lost to Follow-up|1|||
130854837|NCT00231413|471095487|FG003|Overall Study|Lost to Follow-up|1|||
130854838|NCT00231413|471095488|FG004|Overall Study|Lost to Follow-up|1|||
130854839|NCT00231413|471095489|FG005|Overall Study|Lost to Follow-up|4|||
130854840|NCT00231413|471095490|FG006|Overall Study|Lost to Follow-up|0|||
130854841|NCT00231413|471095484|FG000|Overall Study|Pregnancy|1|||
130854842|NCT00231413|471095485|FG001|Overall Study|Pregnancy|0|||
130854843|NCT00231413|471095486|FG002|Overall Study|Pregnancy|0|||
130854844|NCT00231413|471095487|FG003|Overall Study|Pregnancy|0|||
130854845|NCT00231413|471095488|FG004|Overall Study|Pregnancy|0|||
130854846|NCT00231413|471095489|FG005|Overall Study|Pregnancy|0|||
130854847|NCT00231413|471095490|FG006|Overall Study|Pregnancy|0|||
130854848|NCT02337725|471095491|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
130854849|NCT02337725|471095492|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
130854850|NCT02337725|471095491|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
130854851|NCT02337725|471095492|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
130854852|NCT02337725|471095491|FG000|Overall Study|Major Protocol Deviation|0|||
130854853|NCT02337725|471095492|FG001|Overall Study|Major Protocol Deviation|1|||
130854854|NCT02337725|471095491|FG000|Overall Study|Voluntary Withdrawal|14|||
130854855|NCT02337725|471095492|FG001|Overall Study|Voluntary Withdrawal|3|||
130854856|NCT02337725|471095491|FG000|Overall Study|Lack of Efficacy|4|||
130854857|NCT02337725|471095492|FG001|Overall Study|Lack of Efficacy|0|||
130854858|NCT03322423|471095493|FG000|Period 1|Subject no longer eligible|0|||
130854859|NCT03322423|471095494|FG001|Period 1|Subject no longer eligible|1|||
130854860|NCT03322423|471095493|FG000|Period 1|Withdrawal by Subject|0|||
130854861|NCT03322423|471095494|FG001|Period 1|Withdrawal by Subject|1|||
130854862|NCT03322423|471095493|FG000|Period 1|Incorrect Lens Dispensed|1|||
130854863|NCT03322423|471095494|FG001|Period 1|Incorrect Lens Dispensed|0|||
130854864|NCT03322423|471095493|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
130854865|NCT03322423|471095494|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
130854866|NCT03322423|471095493|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
130854867|NCT03322423|471095494|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
130854868|NCT03322423|471095493|FG000|Period 2|Protocol Violation|1|||
130854869|NCT03322423|471095494|FG001|Period 2|Protocol Violation|0|||
130854870|NCT03322423|471095493|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
130854871|NCT03322423|471095494|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
130854872|NCT02096263|471095495|FG000|Overall Study|Adverse Event|1|||
130854873|NCT02096263|471095496|FG001|Overall Study|Adverse Event|0|||
130854874|NCT02096263|471095497|FG002|Overall Study|Adverse Event|1|||
130854875|NCT02096263|471095495|FG000|Overall Study|Lost to Follow-up|14|||
130854876|NCT02096263|471095496|FG001|Overall Study|Lost to Follow-up|18|||
130854877|NCT02096263|471095497|FG002|Overall Study|Lost to Follow-up|15|||
130854878|NCT02096263|471095495|FG000|Overall Study|Other|7|||
130854879|NCT02096263|471095496|FG001|Overall Study|Other|9|||
130854880|NCT02096263|471095497|FG002|Overall Study|Other|6|||
130854881|NCT02096263|471095495|FG000|Overall Study|Sponsor study termination|0|||
130854882|NCT02096263|471095496|FG001|Overall Study|Sponsor study termination|0|||
130854883|NCT02096263|471095497|FG002|Overall Study|Sponsor study termination|1|||
130854884|NCT02096263|471095495|FG000|Overall Study|Protocol Violation|7|||
130854885|NCT02096263|471095496|FG001|Overall Study|Protocol Violation|2|||
130854886|NCT02096263|471095497|FG002|Overall Study|Protocol Violation|8|||
130854887|NCT02096263|471095495|FG000|Overall Study|Withdrawal by Subject|5|||
130854888|NCT02096263|471095496|FG001|Overall Study|Withdrawal by Subject|7|||
130854889|NCT02096263|471095497|FG002|Overall Study|Withdrawal by Subject|8|||
130854890|NCT00500760|471095504|FG000|Overall Study|Death|32|||
130854891|NCT00500760|471095505|FG001|Overall Study|Death|15|||
130854892|NCT00500760|471095504|FG000|Overall Study|Withdrawal by Subject|5|||
130854893|NCT00500760|471095505|FG001|Overall Study|Withdrawal by Subject|7|||
130854894|NCT00500760|471095504|FG000|Overall Study|Administrative decision|2|||
130854895|NCT00500760|471095505|FG001|Overall Study|Administrative decision|0|||
130854896|NCT00500760|471095504|FG000|Overall Study|Lost to Follow-up|3|||
130854897|NCT00500760|471095505|FG001|Overall Study|Lost to Follow-up|0|||
130854898|NCT00500760|471095504|FG000|Overall Study|Other|1|||
130854899|NCT00500760|471095505|FG001|Overall Study|Other|2|||
130854900|NCT04284774|471095507|FG000|Overall Study|Progressive disease|5|||
130854901|NCT02879578|471095508|FG000|Overall Study|Adverse Event|1|||
130854902|NCT02879578|471095509|FG001|Overall Study|Adverse Event|2|||
130854903|NCT02879578|471095510|FG002|Overall Study|Adverse Event|14|||
130854904|NCT02879578|471095508|FG000|Overall Study|Protocol Violation|0|||
130854905|NCT02879578|471095509|FG001|Overall Study|Protocol Violation|1|||
130854906|NCT02879578|471095510|FG002|Overall Study|Protocol Violation|1|||
130854907|NCT02879578|471095508|FG000|Overall Study|Withdrawal by Subject|8|||
130854908|NCT02879578|471095509|FG001|Overall Study|Withdrawal by Subject|6|||
130854909|NCT02879578|471095510|FG002|Overall Study|Withdrawal by Subject|9|||
130854910|NCT02879578|471095508|FG000|Overall Study|Lost to Follow-up|1|||
130854911|NCT02879578|471095509|FG001|Overall Study|Lost to Follow-up|0|||
130854912|NCT02879578|471095510|FG002|Overall Study|Lost to Follow-up|4|||
130854913|NCT02879578|471095508|FG000|Overall Study|Physician Decision|0|||
130854914|NCT02879578|471095509|FG001|Overall Study|Physician Decision|0|||
130854915|NCT02879578|471095510|FG002|Overall Study|Physician Decision|4|||
130854916|NCT02925728|471095519|FG000|Overall Study|Death|3|||
130854917|NCT02925728|471095520|FG001|Overall Study|Death|5|||
130854918|NCT02925728|471095519|FG000|Overall Study|Physician Decision|1|||
130854919|NCT02925728|471095520|FG001|Overall Study|Physician Decision|0|||
130854920|NCT02925728|471095519|FG000|Overall Study|Withdrawal by Subject|1|||
130854921|NCT02925728|471095520|FG001|Overall Study|Withdrawal by Subject|0|||
130854922|NCT05098509|471095521|FG000|Overall Study|Withdrawal by Subject|0|||
130854923|NCT05098509|471095522|FG001|Overall Study|Withdrawal by Subject|0|||
130854924|NCT05098509|471095523|FG002|Overall Study|Withdrawal by Subject|1|||
130854925|NCT05098509|471095524|FG003|Overall Study|Withdrawal by Subject|0|||
130854926|NCT05098509|471095521|FG000|Overall Study|Early study termination|1|||
130854927|NCT05098509|471095522|FG001|Overall Study|Early study termination|1|||
130854928|NCT05098509|471095523|FG002|Overall Study|Early study termination|1|||
130854929|NCT05098509|471095524|FG003|Overall Study|Early study termination|0|||
130854930|NCT04033068|471095525|FG000|Overall Study|Withdrawal by Subject|0|||
130854931|NCT04033068|471095526|FG001|Overall Study|Withdrawal by Subject|0|||
130854932|NCT04033068|471095527|FG002|Overall Study|Withdrawal by Subject|1|||
130854933|NCT04033068|471095528|FG003|Overall Study|Withdrawal by Subject|0|||
130854934|NCT04033068|471095525|FG000|Overall Study|Lost to Follow-up|0|||
130854935|NCT04033068|471095526|FG001|Overall Study|Lost to Follow-up|1|||
130854936|NCT04033068|471095527|FG002|Overall Study|Lost to Follow-up|0|||
130854937|NCT04033068|471095528|FG003|Overall Study|Lost to Follow-up|0|||
130854938|NCT04033068|471095525|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
130854939|NCT04033068|471095526|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
130854940|NCT04033068|471095527|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
130854941|NCT04033068|471095528|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
130854942|NCT02986854|471095530|FG000|Overall Study|Withdrawal by Subject|0|||
130854943|NCT02986854|471095531|FG001|Overall Study|Withdrawal by Subject|1|||
130854944|NCT02986854|471095532|FG002|Overall Study|Withdrawal by Subject|1|||
130854945|NCT02986854|471095530|FG000|Overall Study|Lost to Follow-up|3|||
130854946|NCT02986854|471095531|FG001|Overall Study|Lost to Follow-up|11|||
130854947|NCT02986854|471095532|FG002|Overall Study|Lost to Follow-up|2|||
130854948|NCT00324233|471095533|FG000|First Period|unable to insert catheter|1|||
130854949|NCT00324233|471095534|FG001|First Period|unable to insert catheter|0|||
130854950|NCT00324233|471095533|FG000|Second Period|unable to insert catheter|1|||
130854951|NCT00324233|471095534|FG001|Second Period|unable to insert catheter|1|||
130854952|NCT00324233|471095533|FG000|Second Period|Protocol Violation|4|||
130854953|NCT00324233|471095534|FG001|Second Period|Protocol Violation|6|||
130854954|NCT01972789|471095539|FG000|Overall Study|Adverse Event|11|||
130854955|NCT01972789|471095540|FG001|Overall Study|Adverse Event|4|||
130854956|NCT01972789|471095539|FG000|Overall Study|Subject withdrew consent|14|||
130854957|NCT01972789|471095540|FG001|Overall Study|Subject withdrew consent|12|||
130854958|NCT01972789|471095539|FG000|Overall Study|Lost to Follow-up|4|||
130854959|NCT01972789|471095540|FG001|Overall Study|Lost to Follow-up|7|||
130854960|NCT01972789|471095539|FG000|Overall Study|Death|7|||
130854961|NCT01972789|471095540|FG001|Overall Study|Death|5|||
130854962|NCT01972789|471095539|FG000|Overall Study|Protocol deviation|1|||
130854963|NCT01972789|471095540|FG001|Overall Study|Protocol deviation|0|||
130854964|NCT01972789|471095539|FG000|Overall Study|Physician Decision|3|||
130854965|NCT01972789|471095540|FG001|Overall Study|Physician Decision|2|||
130854966|NCT00086411|471095548|FG000|Overall Study|Lost to Follow-up|11|||
130854967|NCT00086411|471095549|FG001|Overall Study|Lost to Follow-up|11|||
130854968|NCT00086411|471095550|FG002|Overall Study|Lost to Follow-up|13|||
130854969|NCT00086411|471095551|FG003|Overall Study|Lost to Follow-up|12|||
130854970|NCT02409342|471095552|FG000|Overall Study|Death|211|||
130854971|NCT02409342|471095553|FG001|Overall Study|Death|201|||
130854972|NCT02409342|471095552|FG000|Overall Study|Withdrawal by Subject|24|||
130854973|NCT02409342|471095553|FG001|Overall Study|Withdrawal by Subject|17|||
130854974|NCT02409342|471095552|FG000|Overall Study|Study Terminated By Sponsor|48|||
130854975|NCT02409342|471095553|FG001|Overall Study|Study Terminated By Sponsor|59|||
130854976|NCT02409342|471095552|FG000|Overall Study|Lost to Follow-up|3|||
130854977|NCT02409342|471095553|FG001|Overall Study|Lost to Follow-up|5|||
130854978|NCT02409342|471095552|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
130854979|NCT02409342|471095553|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
130854980|NCT02409342|471095552|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
130854981|NCT02409342|471095553|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
130854982|NCT02409342|471095552|FG000|Overall Study|Sponsor Decision|1|||
130854983|NCT02409342|471095553|FG001|Overall Study|Sponsor Decision|0|||
130854984|NCT00279812|471095554|FG000|Overall Study|Protocol Violation|1|||
130854985|NCT00279812|471095555|FG001|Overall Study|Protocol Violation|1|||
130854986|NCT00279812|471095556|FG002|Overall Study|Protocol Violation|0|||
130854987|NCT00279812|471095557|FG003|Overall Study|Protocol Violation|0|||
130854988|NCT00279812|471095558|FG004|Overall Study|Protocol Violation|1|||
130854989|NCT00279812|471095559|FG005|Overall Study|Protocol Violation|0|||
130854990|NCT00279812|471095554|FG000|Overall Study|Withdrawal by Subject|0|||
130854991|NCT00279812|471095555|FG001|Overall Study|Withdrawal by Subject|4|||
130854992|NCT00279812|471095556|FG002|Overall Study|Withdrawal by Subject|2|||
130854993|NCT00279812|471095557|FG003|Overall Study|Withdrawal by Subject|0|||
130854994|NCT00279812|471095558|FG004|Overall Study|Withdrawal by Subject|0|||
130854995|NCT00279812|471095559|FG005|Overall Study|Withdrawal by Subject|0|||
130854996|NCT00279812|471095554|FG000|Overall Study|Adverse Event|0|||
130854997|NCT00279812|471095555|FG001|Overall Study|Adverse Event|1|||
130854998|NCT00279812|471095556|FG002|Overall Study|Adverse Event|1|||
130854999|NCT00279812|471095557|FG003|Overall Study|Adverse Event|0|||
130855000|NCT00279812|471095558|FG004|Overall Study|Adverse Event|2|||
130855001|NCT00279812|471095559|FG005|Overall Study|Adverse Event|1|||
130855002|NCT01274429|471095560|FG000|Overall Study|Study closed do to lack of funding|5|||
130855003|NCT01879072|471095562|FG000|Overall Study|Withdrawal by Subject|121|||
130855004|NCT01879072|471095562|FG000|Overall Study|Not Transplanted|30|||
130855005|NCT03268941|471097379|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130855006|NCT03268941|471097380|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130855007|NCT03268941|471097381|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130855008|NCT03268941|471097382|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
130855009|NCT03268941|471097383|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130855010|NCT03268941|471097384|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130855011|NCT03268941|471097385|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130855012|NCT03268941|471097379|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
130855013|NCT03268941|471097380|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
130855014|NCT03268941|471097381|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
130855015|NCT03268941|471097382|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
130855016|NCT03268941|471097383|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
130855017|NCT03268941|471097384|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
130855018|NCT03268941|471097385|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
130855019|NCT03268941|471097379|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
130855020|NCT03268941|471097380|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130855021|NCT03268941|471097381|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130855022|NCT03268941|471097382|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130855023|NCT03268941|471097383|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130855024|NCT03268941|471097384|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130855025|NCT03268941|471097385|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130855026|NCT03268941|471097379|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
130855027|NCT03268941|471097380|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
130855028|NCT03268941|471097381|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
130855029|NCT03268941|471097382|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
130855030|NCT03268941|471097383|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
130855031|NCT03268941|471097384|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
130855032|NCT03268941|471097385|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
130855033|NCT03268941|471097379|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130855034|NCT03268941|471097380|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130855035|NCT03268941|471097381|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130855036|NCT03268941|471097382|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130855037|NCT03268941|471097383|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130855038|NCT03268941|471097384|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130855039|NCT03268941|471097385|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
130855040|NCT01216683|471097390|FG000|Induction|Never started treatment|0|||
130855041|NCT01216683|471097391|FG001|Induction|Never started treatment|6|||
130855042|NCT01216683|471097392|FG002|Induction|Never started treatment|3|||
130855043|NCT01216683|471097390|FG000|Induction|Lack of Efficacy|4|||
130855044|NCT01216683|471097391|FG001|Induction|Lack of Efficacy|3|||
130855045|NCT01216683|471097392|FG002|Induction|Lack of Efficacy|7|||
130855046|NCT01216683|471097390|FG000|Induction|Adverse Event|0|||
130855047|NCT01216683|471097391|FG001|Induction|Adverse Event|5|||
130855048|NCT01216683|471097392|FG002|Induction|Adverse Event|5|||
130855049|NCT01216683|471097390|FG000|Induction|Death|0|||
130855050|NCT01216683|471097391|FG001|Induction|Death|0|||
130855051|NCT01216683|471097392|FG002|Induction|Death|2|||
130855052|NCT01216683|471097390|FG000|Induction|Withdrawal by Subject|0|||
130855053|NCT01216683|471097391|FG001|Induction|Withdrawal by Subject|4|||
130855054|NCT01216683|471097392|FG002|Induction|Withdrawal by Subject|2|||
130855055|NCT01216683|471097390|FG000|Induction|Other disease|0|||
130855056|NCT01216683|471097391|FG001|Induction|Other disease|1|||
130855057|NCT01216683|471097392|FG002|Induction|Other disease|2|||
130855058|NCT01216683|471097390|FG000|Continuation|Lack of Efficacy|3|||
130855059|NCT01216683|471097391|FG001|Continuation|Lack of Efficacy|2|||
130855060|NCT01216683|471097392|FG002|Continuation|Lack of Efficacy|7|||
130855061|NCT01216683|471097390|FG000|Continuation|Adverse Event|5|||
130855062|NCT01216683|471097391|FG001|Continuation|Adverse Event|3|||
130855063|NCT01216683|471097392|FG002|Continuation|Adverse Event|16|||
130855064|NCT01216683|471097390|FG000|Continuation|Death|1|||
130855065|NCT01216683|471097391|FG001|Continuation|Death|0|||
130855066|NCT01216683|471097392|FG002|Continuation|Death|2|||
130855067|NCT01216683|471097390|FG000|Continuation|Withdrawal by Subject|4|||
130855068|NCT01216683|471097391|FG001|Continuation|Withdrawal by Subject|5|||
130855069|NCT01216683|471097392|FG002|Continuation|Withdrawal by Subject|9|||
130855070|NCT01216683|471097390|FG000|Continuation|Other diseases|0|||
130855071|NCT01216683|471097391|FG001|Continuation|Other diseases|2|||
130855072|NCT01216683|471097392|FG002|Continuation|Other diseases|1|||
130855073|NCT01216683|471097390|FG000|Continuation|Physician Decision|1|||
130855074|NCT01216683|471097391|FG001|Continuation|Physician Decision|0|||
130855075|NCT01216683|471097392|FG002|Continuation|Physician Decision|1|||
130855076|NCT01216683|471097390|FG000|Continuation|Non-compliance|1|||
130855077|NCT01216683|471097391|FG001|Continuation|Non-compliance|0|||
130855078|NCT01216683|471097392|FG002|Continuation|Non-compliance|1|||
130855079|NCT01216683|471097390|FG000|Continuation|Insurance change|0|||
130855080|NCT01216683|471097391|FG001|Continuation|Insurance change|1|||
130855081|NCT01216683|471097392|FG002|Continuation|Insurance change|0|||
130855082|NCT01216683|471097390|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
130855083|NCT01216683|471097391|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
130855084|NCT01216683|471097392|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
130855085|NCT01216683|471097390|FG000|Continuation|Not reported|0|||
130855086|NCT01216683|471097391|FG001|Continuation|Not reported|0|||
130855087|NCT01216683|471097392|FG002|Continuation|Not reported|1|||
130855088|NCT01216683|471097390|FG000|Continuation|Never started treatment|0|||
130855089|NCT01216683|471097391|FG001|Continuation|Never started treatment|1|||
130855090|NCT01216683|471097392|FG002|Continuation|Never started treatment|5|||
130855091|NCT02503501|471097394|FG000|Overall Study|Physician Decision|1|||
130855092|NCT02503501|471097395|FG001|Overall Study|Physician Decision|0|||
130855093|NCT02503501|471097394|FG000|Overall Study|Protocol Violation|0|||
130855094|NCT02503501|471097395|FG001|Overall Study|Protocol Violation|1|||
130855095|NCT02503501|471097394|FG000|Overall Study|Withdrawal by Subject|0|||
130855096|NCT02503501|471097395|FG001|Overall Study|Withdrawal by Subject|2|||
130855097|NCT01740401|471097396|FG000|Overall Study|Progression of disease|6|||
130855098|NCT01740401|471097396|FG000|Overall Study|Adverse Event|2|||
130855099|NCT01740401|471097396|FG000|Overall Study|Did not reach primary endpoint|2|||
130855100|NCT02806960|471097397|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130855101|NCT02806960|471097398|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130855102|NCT02806960|471097399|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130855103|NCT02806960|471097400|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130855104|NCT03667690|471097401|FG000|Overall Study|Adverse Event|0|||
130855105|NCT03667690|471097402|FG001|Overall Study|Adverse Event|3|||
130855106|NCT03667690|471097401|FG000|Overall Study|Death|22|||
130855107|NCT03667690|471097402|FG001|Overall Study|Death|21|||
130855108|NCT03667690|471097401|FG000|Overall Study|Lost to Follow-up|4|||
130855109|NCT03667690|471097402|FG001|Overall Study|Lost to Follow-up|5|||
130855110|NCT03667690|471097401|FG000|Overall Study|Withdrawal by Subject|7|||
130855111|NCT03667690|471097402|FG001|Overall Study|Withdrawal by Subject|8|||
130855112|NCT03667690|471097401|FG000|Overall Study|Subject could not return for additional investigational product|1|||
130855113|NCT03667690|471097402|FG001|Overall Study|Subject could not return for additional investigational product|0|||
130855114|NCT03667690|471097401|FG000|Overall Study|Subject discharged to hospice care|2|||
130855115|NCT03667690|471097402|FG001|Overall Study|Subject discharged to hospice care|0|||
130855116|NCT03667690|471097401|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
130855117|NCT03667690|471097402|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
130855118|NCT03667690|471097401|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
130855119|NCT03667690|471097402|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
130855120|NCT03667690|471097401|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
130855121|NCT03667690|471097402|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
130855122|NCT03667690|471097401|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
130855123|NCT03667690|471097402|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
130855124|NCT03667690|471097401|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
130855125|NCT03667690|471097402|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
130855126|NCT00765063|471097408|FG000|Overall Study|Lack of Efficacy|5|||
130855127|NCT00765063|471097408|FG000|Overall Study|Withdrawal by Subject|1|||
130855128|NCT00765063|471097408|FG000|Overall Study|Other|16|||
130855129|NCT00765063|471097408|FG000|Overall Study|Protocol Violation|6|||
130855130|NCT00765063|471097408|FG000|Overall Study|Adverse Event|4|||
130855131|NCT03614325|471097411|FG000|Overall Study|Withdrawal by Subject|0|||
130855132|NCT03614325|471097412|FG001|Overall Study|Withdrawal by Subject|2|||
130855133|NCT03614325|471097411|FG000|Overall Study|Surgery Cancelled|2|||
130855134|NCT03614325|471097412|FG001|Overall Study|Surgery Cancelled|1|||
130855135|NCT03614325|471097411|FG000|Overall Study|Lost to Follow-up|2|||
130855136|NCT03614325|471097412|FG001|Overall Study|Lost to Follow-up|1|||
130855137|NCT03614325|471097411|FG000|Overall Study|Surgery never scheduled|1|||
130855138|NCT03614325|471097412|FG001|Overall Study|Surgery never scheduled|0|||
130855139|NCT01041287|471097413|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
130855140|NCT01041287|471097414|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
130855141|NCT01041287|471097413|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
130855142|NCT01041287|471097414|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
130855143|NCT02814175|471097415|FG000|Part 1|Adverse Event|2|||
130855144|NCT02814175|471097416|FG001|Part 1|Adverse Event|3|||
130855145|NCT02814175|471097417|FG002|Part 1|Adverse Event|0|||
130855146|NCT02814175|471097418|FG003|Part 1|Adverse Event|0|||
130855147|NCT02814175|471097419|FG004|Part 1|Adverse Event|0|||
130855148|NCT02814175|471097420|FG005|Part 1|Adverse Event|0|||
130855149|NCT02814175|471097415|FG000|Part 1|Withdrawal Consent|8|||
130855150|NCT02814175|471097416|FG001|Part 1|Withdrawal Consent|1|||
130855151|NCT02814175|471097417|FG002|Part 1|Withdrawal Consent|0|||
130855152|NCT02814175|471097418|FG003|Part 1|Withdrawal Consent|0|||
130855153|NCT02814175|471097419|FG004|Part 1|Withdrawal Consent|0|||
130855154|NCT02814175|471097420|FG005|Part 1|Withdrawal Consent|0|||
130855155|NCT02814175|471097415|FG000|Part 1|Lost to Follow-up|1|||
130855156|NCT02814175|471097416|FG001|Part 1|Lost to Follow-up|0|||
130855157|NCT02814175|471097417|FG002|Part 1|Lost to Follow-up|0|||
130855158|NCT02814175|471097418|FG003|Part 1|Lost to Follow-up|0|||
130855159|NCT02814175|471097419|FG004|Part 1|Lost to Follow-up|0|||
130855160|NCT02814175|471097420|FG005|Part 1|Lost to Follow-up|0|||
130855161|NCT02814175|471097415|FG000|Part 1|Lack of Efficacy|1|||
130855162|NCT02814175|471097416|FG001|Part 1|Lack of Efficacy|2|||
130855163|NCT02814175|471097417|FG002|Part 1|Lack of Efficacy|0|||
130855164|NCT02814175|471097418|FG003|Part 1|Lack of Efficacy|0|||
130855165|NCT02814175|471097419|FG004|Part 1|Lack of Efficacy|0|||
130855166|NCT02814175|471097420|FG005|Part 1|Lack of Efficacy|0|||
130855167|NCT02814175|471097415|FG000|Part 2|Adverse Event|0|||
130855168|NCT02814175|471097416|FG001|Part 2|Adverse Event|0|||
130855169|NCT02814175|471097417|FG002|Part 2|Adverse Event|0|||
130855170|NCT02814175|471097418|FG003|Part 2|Adverse Event|1|||
130855171|NCT02814175|471097419|FG004|Part 2|Adverse Event|1|||
130855172|NCT02814175|471097420|FG005|Part 2|Adverse Event|2|||
130855173|NCT02814175|471097415|FG000|Part 2|Withdrawal Consent|0|||
130855174|NCT02814175|471097416|FG001|Part 2|Withdrawal Consent|0|||
130855175|NCT02814175|471097417|FG002|Part 2|Withdrawal Consent|0|||
130855176|NCT02814175|471097418|FG003|Part 2|Withdrawal Consent|2|||
130855177|NCT02814175|471097419|FG004|Part 2|Withdrawal Consent|1|||
130855178|NCT02814175|471097420|FG005|Part 2|Withdrawal Consent|1|||
130855179|NCT02814175|471097415|FG000|Part 2|Lost to Follow-up|0|||
130855180|NCT02814175|471097416|FG001|Part 2|Lost to Follow-up|0|||
130855181|NCT02814175|471097417|FG002|Part 2|Lost to Follow-up|0|||
130855182|NCT02814175|471097418|FG003|Part 2|Lost to Follow-up|1|||
130855183|NCT02814175|471097419|FG004|Part 2|Lost to Follow-up|0|||
130855184|NCT02814175|471097420|FG005|Part 2|Lost to Follow-up|0|||
130855185|NCT02814175|471097415|FG000|Part 2|Lack of Efficacy|0|||
130855186|NCT02814175|471097416|FG001|Part 2|Lack of Efficacy|0|||
130855187|NCT02814175|471097417|FG002|Part 2|Lack of Efficacy|0|||
130855188|NCT02814175|471097418|FG003|Part 2|Lack of Efficacy|0|||
130855189|NCT02814175|471097419|FG004|Part 2|Lack of Efficacy|0|||
130855190|NCT02814175|471097420|FG005|Part 2|Lack of Efficacy|3|||
130855191|NCT01673620|471097426|FG000|Overall Study|Adverse Event|1|||
130855192|NCT01673620|471097427|FG001|Overall Study|Adverse Event|0|||
130855193|NCT01597635|471097428|FG000|Part A|Adverse Event|3|||
130855194|NCT01597635|471097429|FG001|Part A|Adverse Event|0|||
130855195|NCT01597635|471097430|FG002|Part A|Adverse Event|0|||
130855196|NCT01597635|471097428|FG000|Part B|Adverse Event|0|||
130855197|NCT01597635|471097429|FG001|Part B|Adverse Event|0|||
130855198|NCT01597635|471097430|FG002|Part B|Adverse Event|1|||
130855199|NCT01597635|471097428|FG000|Part B|Protocol Violation|0|||
130855200|NCT01597635|471097429|FG001|Part B|Protocol Violation|1|||
130855201|NCT01597635|471097430|FG002|Part B|Protocol Violation|0|||
130855202|NCT01597635|471097428|FG000|Part B|Protocol-defined stopping criteria|0|||
130855203|NCT01597635|471097429|FG001|Part B|Protocol-defined stopping criteria|4|||
130855204|NCT01597635|471097430|FG002|Part B|Protocol-defined stopping criteria|3|||
130855205|NCT01597635|471097428|FG000|Part B|Withdrawal by Subject|0|||
130855206|NCT01597635|471097429|FG001|Part B|Withdrawal by Subject|1|||
130855207|NCT01597635|471097430|FG002|Part B|Withdrawal by Subject|0|||
130855208|NCT02593825|471097431|FG000|Intervention|Lost to Follow-up|10|||
130855209|NCT02593825|471097432|FG001|Intervention|Lost to Follow-up|12|||
130855210|NCT00495625|471097433|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
130855211|NCT01912339|471097434|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
130855212|NCT01912339|471097435|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
130855213|NCT01912339|471097436|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
130855214|NCT01912339|471097434|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
130855215|NCT01912339|471097435|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
130855216|NCT01912339|471097436|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
130855217|NCT01912339|471097434|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
130855218|NCT01912339|471097435|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
130855219|NCT01912339|471097436|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
130855220|NCT01912339|471097434|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
130855221|NCT01912339|471097435|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
130855222|NCT01912339|471097436|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
130855223|NCT01912339|471097434|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
130855224|NCT01912339|471097435|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
130855225|NCT01912339|471097436|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
130855226|NCT01912339|471097434|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
130855227|NCT01912339|471097435|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
130855228|NCT01912339|471097436|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
130855229|NCT01912339|471097434|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
130855230|NCT01912339|471097435|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
130855231|NCT01912339|471097436|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
130855232|NCT01912339|471097434|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
130855233|NCT01912339|471097435|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
130855234|NCT01912339|471097436|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
130855235|NCT01912339|471097434|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
130855236|NCT01912339|471097435|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
130855237|NCT01912339|471097436|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
130855238|NCT01912339|471097434|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
130855239|NCT01912339|471097435|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
130855240|NCT01912339|471097436|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
130855241|NCT01912339|471097434|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
130855242|NCT01912339|471097435|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
130855243|NCT01912339|471097436|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
130855244|NCT01912339|471097434|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
130855245|NCT01912339|471097435|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
130855246|NCT01912339|471097436|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
130855247|NCT01912339|471097434|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
130855248|NCT01912339|471097435|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
130855249|NCT01912339|471097436|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
130855250|NCT03464019|471097438|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
130855251|NCT03464019|471097439|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
130855252|NCT03464019|471097440|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
130855253|NCT03464019|471097438|FG000|NODE-301 Part 1|Ablation|0|||
130855254|NCT03464019|471097439|FG001|NODE-301 Part 1|Ablation|0|||
130855255|NCT03464019|471097440|FG002|NODE-301 Part 1|Ablation|16|||
130855256|NCT03464019|471097438|FG000|NODE-301 Part 1|Test Dose Failure|0|||
130855257|NCT03464019|471097439|FG001|NODE-301 Part 1|Test Dose Failure|0|||
130855258|NCT03464019|471097440|FG002|NODE-301 Part 1|Test Dose Failure|8|||
130855259|NCT03464019|471097438|FG000|NODE-301 Part 1|Adverse Event|0|||
130855260|NCT03464019|471097439|FG001|NODE-301 Part 1|Adverse Event|0|||
130855261|NCT03464019|471097440|FG002|NODE-301 Part 1|Adverse Event|5|||
130855262|NCT03464019|471097438|FG000|NODE-301 Part 1|Physician Decision|0|||
130855263|NCT03464019|471097439|FG001|NODE-301 Part 1|Physician Decision|0|||
130855264|NCT03464019|471097440|FG002|NODE-301 Part 1|Physician Decision|4|||
130855265|NCT03464019|471097438|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
130855266|NCT03464019|471097439|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
130855267|NCT03464019|471097440|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
130855268|NCT03464019|471097438|FG000|NODE-301 Part 1|Protocol Violation|0|||
130855269|NCT03464019|471097439|FG001|NODE-301 Part 1|Protocol Violation|0|||
130855270|NCT03464019|471097440|FG002|NODE-301 Part 1|Protocol Violation|2|||
130855271|NCT03464019|471097438|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
130855272|NCT03464019|471097439|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
130855273|NCT03464019|471097440|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
130855274|NCT03464019|471097438|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
130855275|NCT03464019|471097439|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
130855276|NCT03464019|471097440|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
130855277|NCT03464019|471097438|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
130855278|NCT03464019|471097439|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
130855279|NCT03464019|471097440|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
130855280|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
130855281|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
130855282|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
130855283|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
130855284|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
130855285|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
130855286|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
130855287|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
130855288|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
130855289|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
130855290|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
130855291|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
130855292|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
130855293|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
130855294|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
130855295|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
130855296|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
130855297|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
130855298|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
130855299|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
130855300|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
130855301|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
130855302|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
130855303|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
130855304|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
130855305|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
130855306|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
130855307|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
130855308|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
130855309|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
130855310|NCT03464019|471097438|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
130855311|NCT03464019|471097439|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
130855312|NCT03464019|471097440|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
130855313|NCT04680975|471097441|FG000|Overall Study|Adverse Event|3|||
130855314|NCT04680975|471097441|FG000|Overall Study|Death|1|||
130855315|NCT04680975|471097441|FG000|Overall Study|Progressive Disease|1|||
130855316|NCT04680975|471097441|FG000|Overall Study|Withdrawal by Subject|1|||
130855317|NCT03909152|471097442|FG000|Overall Study|Adverse Event|14|||
130855318|NCT03909152|471097443|FG001|Overall Study|Adverse Event|5|||
130855319|NCT03909152|471097444|FG002|Overall Study|Adverse Event|1|||
130855320|NCT03909152|471097445|FG003|Overall Study|Adverse Event|14|||
130855321|NCT02615691|471097446|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
130855322|NCT02615691|471097446|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
130855323|NCT02615691|471097446|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
130855324|NCT02615691|471097446|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
130855325|NCT02702414|471097447|FG000|Overall Study|Death|96|||
130855326|NCT02702414|471097448|FG001|Overall Study|Death|42|||
130855327|NCT02702414|471097447|FG000|Overall Study|Lost to Follow-up|0|||
130855328|NCT02702414|471097448|FG001|Overall Study|Lost to Follow-up|1|||
130855329|NCT02702414|471097447|FG000|Overall Study|Withdrawal by Subject|0|||
130855330|NCT02702414|471097448|FG001|Overall Study|Withdrawal by Subject|1|||
130855331|NCT02702414|471097447|FG000|Overall Study|Protocol Violation|1|||
130855332|NCT02702414|471097448|FG001|Overall Study|Protocol Violation|0|||
130855333|NCT02702414|471097447|FG000|Overall Study|Sponsor Decision|8|||
130855334|NCT02702414|471097448|FG001|Overall Study|Sponsor Decision|7|||
130855335|NCT02596230|471097449|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
130855336|NCT02596230|471097450|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
130855337|NCT02596230|471097451|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
130855338|NCT02596230|471097452|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
130855339|NCT02596230|471097453|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
130855340|NCT02596230|471097449|FG000|Objective 2, One Year|Lost to Follow-up|0|||
130855341|NCT02596230|471097450|FG001|Objective 2, One Year|Lost to Follow-up|41|||
130855342|NCT02596230|471097451|FG002|Objective 2, One Year|Lost to Follow-up|41|||
130855343|NCT02596230|471097452|FG003|Objective 2, One Year|Lost to Follow-up|32|||
130855344|NCT02596230|471097453|FG004|Objective 2, One Year|Lost to Follow-up|46|||
130855345|NCT02596230|471097449|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
130855346|NCT02596230|471097450|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
130855347|NCT02596230|471097451|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
130855348|NCT02596230|471097452|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
130855349|NCT02596230|471097453|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
130855350|NCT02596230|471097449|FG000|Objective 2, One Year|Adverse drug reaction|0|||
130855351|NCT02596230|471097450|FG001|Objective 2, One Year|Adverse drug reaction|1|||
130855352|NCT02596230|471097451|FG002|Objective 2, One Year|Adverse drug reaction|0|||
130855353|NCT02596230|471097452|FG003|Objective 2, One Year|Adverse drug reaction|0|||
130855354|NCT02596230|471097453|FG004|Objective 2, One Year|Adverse drug reaction|0|||
130855355|NCT02596230|471097449|FG000|Objective 2, One Year|Death|0|||
130855356|NCT02596230|471097450|FG001|Objective 2, One Year|Death|12|||
130855357|NCT02596230|471097451|FG002|Objective 2, One Year|Death|41|||
130855358|NCT02596230|471097452|FG003|Objective 2, One Year|Death|21|||
130855359|NCT02596230|471097453|FG004|Objective 2, One Year|Death|30|||
130855360|NCT02596230|471097449|FG000|Objective 2, One Year|Other|0|||
130855361|NCT02596230|471097450|FG001|Objective 2, One Year|Other|3|||
130855362|NCT02596230|471097451|FG002|Objective 2, One Year|Other|2|||
130855363|NCT02596230|471097452|FG003|Objective 2, One Year|Other|0|||
130855364|NCT02596230|471097453|FG004|Objective 2, One Year|Other|0|||
130855365|NCT01272869|471097454|FG000|Period 2 (14 Days)|Adverse Event|1|||
130855366|NCT01272869|471097455|FG001|Period 2 (14 Days)|Adverse Event|0|||
130855367|NCT03908476|471097457|FG000|Overall Study|Death|3|||
130855368|NCT03908476|471097458|FG001|Overall Study|Death|0|||
130855369|NCT03908476|471097457|FG000|Overall Study|Lost to Follow-up|3|||
130855370|NCT03908476|471097458|FG001|Overall Study|Lost to Follow-up|1|||
130855371|NCT03908476|471097457|FG000|Overall Study|Withdrawal by Subject|7|||
130855372|NCT03908476|471097458|FG001|Overall Study|Withdrawal by Subject|1|||
130855373|NCT03908476|471097457|FG000|Overall Study|Physician Decision|2|||
130855374|NCT03908476|471097458|FG001|Overall Study|Physician Decision|0|||
130855375|NCT03908476|471097457|FG000|Overall Study|System Explanted and not Replaced|4|||
130855376|NCT03908476|471097458|FG001|Overall Study|System Explanted and not Replaced|0|||
130855377|NCT03908476|471097457|FG000|Overall Study|Intrathecal Pump|1|||
130855378|NCT03908476|471097458|FG001|Overall Study|Intrathecal Pump|0|||
130855379|NCT03908476|471097457|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
130855380|NCT03908476|471097458|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
130855381|NCT02868229|471097459|FG000|Overall Study|Adverse Event|1|||
130855382|NCT02868229|471097460|FG001|Overall Study|Adverse Event|0|||
130855383|NCT02868229|471097461|FG002|Overall Study|Adverse Event|0|||
130855384|NCT02868229|471097462|FG003|Overall Study|Adverse Event|1|||
130855385|NCT02868229|471097459|FG000|Overall Study|Death|0|||
130855386|NCT02868229|471097460|FG001|Overall Study|Death|0|||
130855387|NCT02868229|471097461|FG002|Overall Study|Death|1|||
130855388|NCT02868229|471097462|FG003|Overall Study|Death|1|||
130855389|NCT02868229|471097459|FG000|Overall Study|Missed dose|0|||
130855390|NCT02868229|471097460|FG001|Overall Study|Missed dose|0|||
130855391|NCT02868229|471097461|FG002|Overall Study|Missed dose|0|||
130855392|NCT02868229|471097462|FG003|Overall Study|Missed dose|3|||
130855393|NCT03194438|471097463|FG000|Overall Study|Withdrawal by Subject|2|||
130855394|NCT02250664|471097464|FG000|Overall Study|Lost to Follow-up|18|||
130855395|NCT02250664|471097465|FG001|Overall Study|Lost to Follow-up|28|||
130855396|NCT02250664|471097466|FG002|Overall Study|Lost to Follow-up|33|||
130855397|NCT02250664|471097464|FG000|Overall Study|Personal Reasons|7|||
130855398|NCT02250664|471097465|FG001|Overall Study|Personal Reasons|8|||
130855399|NCT02250664|471097466|FG002|Overall Study|Personal Reasons|14|||
130855400|NCT02250664|471097464|FG000|Overall Study|Adverse Event|6|||
130855401|NCT02250664|471097465|FG001|Overall Study|Adverse Event|3|||
130855402|NCT02250664|471097466|FG002|Overall Study|Adverse Event|8|||
130855403|NCT02250664|471097464|FG000|Overall Study|Incarcerated|2|||
130855404|NCT02250664|471097465|FG001|Overall Study|Incarcerated|1|||
130855405|NCT02250664|471097466|FG002|Overall Study|Incarcerated|2|||
130855406|NCT02250664|471097464|FG000|Overall Study|Withdrawal by Subject|0|||
130855407|NCT02250664|471097465|FG001|Overall Study|Withdrawal by Subject|1|||
130855408|NCT02250664|471097466|FG002|Overall Study|Withdrawal by Subject|2|||
130855409|NCT02250664|471097464|FG000|Overall Study|Death|0|||
130855410|NCT02250664|471097465|FG001|Overall Study|Death|1|||
130855411|NCT02250664|471097466|FG002|Overall Study|Death|1|||
130855412|NCT02250664|471097464|FG000|Overall Study|Physician Decision|1|||
130855413|NCT02250664|471097465|FG001|Overall Study|Physician Decision|3|||
130855414|NCT02250664|471097466|FG002|Overall Study|Physician Decision|1|||
130855415|NCT02250664|471097464|FG000|Overall Study|Protocol Violation|1|||
130855416|NCT02250664|471097465|FG001|Overall Study|Protocol Violation|0|||
130855417|NCT02250664|471097466|FG002|Overall Study|Protocol Violation|1|||
130855418|NCT02250664|471097464|FG000|Overall Study|Reason unknown|1|||
130855419|NCT02250664|471097465|FG001|Overall Study|Reason unknown|0|||
130855420|NCT02250664|471097466|FG002|Overall Study|Reason unknown|0|||
130855421|NCT00117793|471097467|FG000|Overall Study|Withdrawal by Subject|12|||
130855422|NCT04268173|471097468|FG000|Overall Study|Lost to Follow-up|75|||
130855423|NCT04268173|471097469|FG001|Overall Study|Lost to Follow-up|108|||
130855424|NCT00545103|471097470|FG000|Overall Study|Lack of Efficacy|48|||
130855425|NCT00545103|471097471|FG001|Overall Study|Lack of Efficacy|45|||
130855426|NCT00545103|471097472|FG002|Overall Study|Lack of Efficacy|31|||
130855427|NCT00545103|471097473|FG003|Overall Study|Lack of Efficacy|27|||
130855428|NCT00545103|471097470|FG000|Overall Study|Withdrawal by Subject|6|||
130855429|NCT00545103|471097471|FG001|Overall Study|Withdrawal by Subject|10|||
130855430|NCT00545103|471097472|FG002|Overall Study|Withdrawal by Subject|18|||
130855431|NCT00545103|471097473|FG003|Overall Study|Withdrawal by Subject|22|||
130855432|NCT00545103|471097470|FG000|Overall Study|Adverse Event|11|||
130855433|NCT00545103|471097471|FG001|Overall Study|Adverse Event|12|||
130855434|NCT00545103|471097472|FG002|Overall Study|Adverse Event|17|||
130855435|NCT00545103|471097473|FG003|Overall Study|Adverse Event|10|||
130855436|NCT00545103|471097470|FG000|Overall Study|Lost to Follow-up|4|||
130855437|NCT00545103|471097471|FG001|Overall Study|Lost to Follow-up|6|||
130855438|NCT00545103|471097472|FG002|Overall Study|Lost to Follow-up|3|||
130855439|NCT00545103|471097473|FG003|Overall Study|Lost to Follow-up|4|||
130855440|NCT00545103|471097470|FG000|Overall Study|Protocol Violation|1|||
130855441|NCT00545103|471097471|FG001|Overall Study|Protocol Violation|2|||
130855442|NCT00545103|471097472|FG002|Overall Study|Protocol Violation|3|||
130855443|NCT00545103|471097473|FG003|Overall Study|Protocol Violation|0|||
130855444|NCT00545103|471097470|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
130855445|NCT00545103|471097471|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
130855446|NCT00545103|471097472|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
130855447|NCT00545103|471097473|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
130855448|NCT00545103|471097470|FG000|Overall Study|Difficult to open package|0|||
130855449|NCT00545103|471097471|FG001|Overall Study|Difficult to open package|0|||
130855450|NCT00545103|471097472|FG002|Overall Study|Difficult to open package|0|||
130855451|NCT00545103|471097473|FG003|Overall Study|Difficult to open package|1|||
130855452|NCT00545103|471097470|FG000|Overall Study|Investigational product not taken|1|||
130855453|NCT00545103|471097471|FG001|Overall Study|Investigational product not taken|0|||
130855454|NCT00545103|471097472|FG002|Overall Study|Investigational product not taken|0|||
130855455|NCT00545103|471097473|FG003|Overall Study|Investigational product not taken|1|||
130855456|NCT00545103|471097470|FG000|Overall Study|Wish to start a family|0|||
130855457|NCT00545103|471097471|FG001|Overall Study|Wish to start a family|0|||
130855458|NCT00545103|471097472|FG002|Overall Study|Wish to start a family|0|||
130855459|NCT00545103|471097473|FG003|Overall Study|Wish to start a family|1|||
130855460|NCT00545103|471097470|FG000|Overall Study|Diverticulitis crisis|0|||
130855461|NCT00545103|471097471|FG001|Overall Study|Diverticulitis crisis|0|||
130855462|NCT00545103|471097472|FG002|Overall Study|Diverticulitis crisis|0|||
130855463|NCT00545103|471097473|FG003|Overall Study|Diverticulitis crisis|1|||
130855464|NCT00545103|471097470|FG000|Overall Study|Personal reasons|1|||
130855465|NCT00545103|471097471|FG001|Overall Study|Personal reasons|0|||
130855466|NCT00545103|471097472|FG002|Overall Study|Personal reasons|0|||
130855467|NCT00545103|471097473|FG003|Overall Study|Personal reasons|0|||
130855468|NCT00545103|471097470|FG000|Overall Study|Subject's decision|1|||
130855469|NCT00545103|471097471|FG001|Overall Study|Subject's decision|0|||
130855470|NCT00545103|471097472|FG002|Overall Study|Subject's decision|0|||
130855471|NCT00545103|471097473|FG003|Overall Study|Subject's decision|0|||
130855472|NCT00545103|471097470|FG000|Overall Study|Noncompliance|0|||
130855473|NCT00545103|471097471|FG001|Overall Study|Noncompliance|1|||
130855474|NCT00545103|471097472|FG002|Overall Study|Noncompliance|0|||
130855475|NCT00545103|471097473|FG003|Overall Study|Noncompliance|0|||
130855476|NCT00545103|471097470|FG000|Overall Study|Investigator decision|0|||
130855477|NCT00545103|471097471|FG001|Overall Study|Investigator decision|0|||
130855478|NCT00545103|471097472|FG002|Overall Study|Investigator decision|1|||
130855479|NCT00545103|471097473|FG003|Overall Study|Investigator decision|0|||
130855480|NCT00545103|471097470|FG000|Overall Study|Subject moved|0|||
130855481|NCT00545103|471097471|FG001|Overall Study|Subject moved|1|||
130855482|NCT00545103|471097472|FG002|Overall Study|Subject moved|0|||
130855483|NCT00545103|471097473|FG003|Overall Study|Subject moved|0|||
130855484|NCT00545103|471097470|FG000|Overall Study|Use of prohibited medication|0|||
130855485|NCT00545103|471097471|FG001|Overall Study|Use of prohibited medication|0|||
130855486|NCT00545103|471097472|FG002|Overall Study|Use of prohibited medication|1|||
130855487|NCT00545103|471097473|FG003|Overall Study|Use of prohibited medication|0|||
130855488|NCT00545103|471097470|FG000|Overall Study|Does not want to take study drug anymore|1|||
130855489|NCT00545103|471097471|FG001|Overall Study|Does not want to take study drug anymore|0|||
130855490|NCT00545103|471097472|FG002|Overall Study|Does not want to take study drug anymore|1|||
130855491|NCT00545103|471097473|FG003|Overall Study|Does not want to take study drug anymore|0|||
130855492|NCT00545103|471097470|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
130855493|NCT00545103|471097471|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
130855494|NCT00545103|471097472|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
130855495|NCT00545103|471097473|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
130855496|NCT00545103|471097470|FG000|Overall Study|Death|0|||
130855497|NCT00545103|471097471|FG001|Overall Study|Death|1|||
130855498|NCT00545103|471097472|FG002|Overall Study|Death|0|||
130855499|NCT00545103|471097473|FG003|Overall Study|Death|0|||
130855500|NCT03615066|471097474|FG000|Main Study|Withdrew Consent|0|||
130855501|NCT03615066|471097475|FG001|Main Study|Withdrew Consent|1|||
130855502|NCT03615066|471097476|FG002|Main Study|Withdrew Consent|1|||
130855503|NCT03615066|471097474|FG000|Main Study|Lost to Follow-up|0|||
130855504|NCT03615066|471097475|FG001|Main Study|Lost to Follow-up|0|||
130855505|NCT03615066|471097476|FG002|Main Study|Lost to Follow-up|1|||
130855506|NCT03615066|471097474|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
130855507|NCT03615066|471097475|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
130855508|NCT03615066|471097476|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
130855509|NCT03615066|471097474|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
130855510|NCT03615066|471097475|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
130855511|NCT03615066|471097476|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
130855512|NCT03615066|471097474|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
130855513|NCT03615066|471097475|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
130855514|NCT03615066|471097476|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
130855515|NCT04891107|471097477|FG000|Overall Study|Physician Decision|1|||
130855516|NCT04891107|471097477|FG000|Overall Study|Withdrawal by Subject|1|||
130855517|NCT04891107|471097477|FG000|Overall Study|Screen failure after consent|1|||
130855518|NCT01571453|471097478|FG000|Overall Study|Adverse Event|14|||
130855519|NCT01571453|471097479|FG001|Overall Study|Adverse Event|32|||
130855520|NCT01571453|471097478|FG000|Overall Study|Lack of Efficacy|8|||
130855521|NCT01571453|471097479|FG001|Overall Study|Lack of Efficacy|3|||
130855522|NCT01571453|471097478|FG000|Overall Study|Non-compliance|2|||
130855523|NCT01571453|471097479|FG001|Overall Study|Non-compliance|4|||
130855524|NCT01571453|471097478|FG000|Overall Study|Protocol Violation|1|||
130855525|NCT01571453|471097479|FG001|Overall Study|Protocol Violation|5|||
130855526|NCT01571453|471097478|FG000|Overall Study|Withdrawal of consent|5|||
130855527|NCT01571453|471097479|FG001|Overall Study|Withdrawal of consent|13|||
130855528|NCT01571453|471097478|FG000|Overall Study|Lost to Follow-up|4|||
130855529|NCT01571453|471097479|FG001|Overall Study|Lost to Follow-up|2|||
130855530|NCT01571453|471097478|FG000|Overall Study|Administrative or other reason(s)|4|||
130855531|NCT01571453|471097479|FG001|Overall Study|Administrative or other reason(s)|3|||
130855532|NCT02453555|471097480|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
130855533|NCT02453555|471097481|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
130855534|NCT02453555|471097482|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
130855535|NCT02453555|471097483|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
130855536|NCT02453555|471097484|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
130855537|NCT02453555|471097485|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
130855538|NCT02453555|471097480|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
130855539|NCT02453555|471097481|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130855540|NCT02453555|471097482|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130855541|NCT02453555|471097483|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130855542|NCT02453555|471097484|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130855543|NCT02453555|471097485|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130855544|NCT02453555|471097480|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
130855545|NCT02453555|471097481|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
130855546|NCT02453555|471097482|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130855547|NCT02453555|471097483|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130855548|NCT02453555|471097484|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130855549|NCT02453555|471097485|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130855550|NCT02453555|471097480|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
130855551|NCT02453555|471097481|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
130855552|NCT02453555|471097482|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
130855553|NCT02453555|471097483|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
130855554|NCT02453555|471097484|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
130855555|NCT02453555|471097485|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
130855556|NCT02453555|471097480|FG000|Extension Period|Adverse Event|0|||
130855557|NCT02453555|471097481|FG001|Extension Period|Adverse Event|0|||
130855558|NCT02453555|471097482|FG002|Extension Period|Adverse Event|1|||
130855559|NCT02453555|471097483|FG003|Extension Period|Adverse Event|2|||
130855560|NCT02453555|471097484|FG004|Extension Period|Adverse Event|1|||
130855561|NCT02453555|471097485|FG005|Extension Period|Adverse Event|1|||
130855562|NCT02453555|471097480|FG000|Extension Period|Protocol Violation|0|||
130855563|NCT02453555|471097481|FG001|Extension Period|Protocol Violation|0|||
130855564|NCT02453555|471097482|FG002|Extension Period|Protocol Violation|1|||
130855565|NCT02453555|471097483|FG003|Extension Period|Protocol Violation|0|||
130855566|NCT02453555|471097484|FG004|Extension Period|Protocol Violation|0|||
130855567|NCT02453555|471097485|FG005|Extension Period|Protocol Violation|0|||
130855568|NCT02453555|471097480|FG000|Extension Period|Withdrawal by Subject|0|||
130855569|NCT02453555|471097481|FG001|Extension Period|Withdrawal by Subject|0|||
130855570|NCT02453555|471097482|FG002|Extension Period|Withdrawal by Subject|1|||
130855571|NCT02453555|471097483|FG003|Extension Period|Withdrawal by Subject|0|||
130855572|NCT02453555|471097484|FG004|Extension Period|Withdrawal by Subject|0|||
130855573|NCT02453555|471097485|FG005|Extension Period|Withdrawal by Subject|0|||
130855574|NCT00129961|471097486|FG000|Overall Study|Adverse Event|1|||
130855575|NCT00129961|471097487|FG001|Overall Study|Adverse Event|0|||
130855576|NCT00129961|471097486|FG000|Overall Study|Death|1|||
130855577|NCT00129961|471097487|FG001|Overall Study|Death|1|||
130855578|NCT00129961|471097486|FG000|Overall Study|Withdrawal by Sponsor|14|||
130855579|NCT00129961|471097487|FG001|Overall Study|Withdrawal by Sponsor|20|||
130855580|NCT00129961|471097486|FG000|Overall Study|Physician Decision|1|||
130855581|NCT00129961|471097487|FG001|Overall Study|Physician Decision|0|||
130855582|NCT00129961|471097486|FG000|Overall Study|Withdrawal by Subject|2|||
130855583|NCT00129961|471097487|FG001|Overall Study|Withdrawal by Subject|1|||
130855584|NCT00129961|471097486|FG000|Overall Study|Missing Record|0|||
130855585|NCT00129961|471097487|FG001|Overall Study|Missing Record|1|||
130855586|NCT00694304|471097491|FG000|Overall Study|Adverse Event|42|||
130855587|NCT00694304|471097491|FG000|Overall Study|Lack of Efficacy|35|||
130855588|NCT00694304|471097491|FG000|Overall Study|Non-compliance With Study Product|16|||
130855589|NCT00694304|471097491|FG000|Overall Study|Protocol Violation|6|||
130855590|NCT00694304|471097491|FG000|Overall Study|Withdrawal of Consent|61|||
130855591|NCT00694304|471097491|FG000|Overall Study|Lost to Follow-up|15|||
130855592|NCT00694304|471097491|FG000|Overall Study|Administrative or Other Reasons|32|||
130855593|NCT01270256|471097492|FG000|Overall Study|Withdrawal by Subject|1|||
130855594|NCT01270256|471097493|FG001|Overall Study|Withdrawal by Subject|0|||
130855595|NCT03203291|471097494|FG000|Overall Study|Withdrawal by Subject|1|||
130855596|NCT02039856|471097498|FG000|Overall Study|Death|5|||
130855597|NCT02039856|471097499|FG001|Overall Study|Death|3|||
130855598|NCT02039856|471097498|FG000|Overall Study|Partial survey completion|61|||
130855599|NCT02039856|471097499|FG001|Overall Study|Partial survey completion|26|||
130855600|NCT02039856|471097498|FG000|Overall Study|Lost to Follow-up|388|||
130855601|NCT02039856|471097499|FG001|Overall Study|Lost to Follow-up|206|||
130855602|NCT02039856|471097498|FG000|Overall Study|Withdrawal by Subject|1573|||
130855603|NCT02039856|471097499|FG001|Overall Study|Withdrawal by Subject|618|||
130855604|NCT04407234|471097504|FG000|Overall Study|Adverse Event|3|||
130855605|NCT04407234|471097505|FG001|Overall Study|Adverse Event|3|||
130855606|NCT03908970|471097506|FG000|Overall Study|Adverse Event|7|||
130855607|NCT03908970|471097507|FG001|Overall Study|Adverse Event|21|||
130855608|NCT03908970|471097506|FG000|Overall Study|Physician Decision|1|||
130855609|NCT03908970|471097507|FG001|Overall Study|Physician Decision|4|||
130855610|NCT03908970|471097506|FG000|Overall Study|Withdrawal by Subject|9|||
130855611|NCT03908970|471097507|FG001|Overall Study|Withdrawal by Subject|22|||
130855612|NCT00126776|471099382|FG000|Overall Study|follow up complete on all patients|0|||
130855613|NCT00126776|471099383|FG001|Overall Study|follow up complete on all patients|0|||
130855614|NCT03626545|471099387|FG000|Overall Study|Progressive disease|3|||
130855615|NCT03626545|471099388|FG001|Overall Study|Progressive disease|82|||
130855616|NCT03626545|471099389|FG002|Overall Study|Progressive disease|85|||
130855617|NCT03626545|471099387|FG000|Overall Study|Adverse Event|3|||
130855618|NCT03626545|471099388|FG001|Overall Study|Adverse Event|13|||
130855619|NCT03626545|471099389|FG002|Overall Study|Adverse Event|10|||
130855620|NCT03626545|471099387|FG000|Overall Study|Physician Decision|1|||
130855621|NCT03626545|471099388|FG001|Overall Study|Physician Decision|18|||
130855622|NCT03626545|471099389|FG002|Overall Study|Physician Decision|14|||
130855623|NCT03626545|471099387|FG000|Overall Study|Subject Decision|0|||
130855624|NCT03626545|471099388|FG001|Overall Study|Subject Decision|5|||
130855625|NCT03626545|471099389|FG002|Overall Study|Subject Decision|5|||
130855626|NCT03626545|471099387|FG000|Overall Study|Death|1|||
130855627|NCT03626545|471099388|FG001|Overall Study|Death|1|||
130855628|NCT03626545|471099389|FG002|Overall Study|Death|1|||
130855629|NCT03626545|471099387|FG000|Overall Study|Protocol Deviation|0|||
130855630|NCT03626545|471099388|FG001|Overall Study|Protocol Deviation|1|||
130855631|NCT03626545|471099389|FG002|Overall Study|Protocol Deviation|1|||
130855632|NCT03626545|471099387|FG000|Overall Study|Guardian Decision|0|||
130855633|NCT03626545|471099388|FG001|Overall Study|Guardian Decision|0|||
130855634|NCT03626545|471099389|FG002|Overall Study|Guardian Decision|1|||
130855635|NCT01939366|471099392|FG000|Overall Study|Adverse Event|8|||
130855636|NCT01939366|471099393|FG001|Overall Study|Adverse Event|17|||
130855637|NCT01939366|471099394|FG002|Overall Study|Adverse Event|30|||
130855638|NCT01939366|471099395|FG003|Overall Study|Adverse Event|8|||
130855639|NCT01939366|471099396|FG004|Overall Study|Adverse Event|5|||
130855640|NCT01939366|471099392|FG000|Overall Study|Lack of Efficacy|2|||
130855641|NCT01939366|471099393|FG001|Overall Study|Lack of Efficacy|1|||
130855642|NCT01939366|471099394|FG002|Overall Study|Lack of Efficacy|1|||
130855643|NCT01939366|471099395|FG003|Overall Study|Lack of Efficacy|1|||
130855644|NCT01939366|471099396|FG004|Overall Study|Lack of Efficacy|3|||
130855645|NCT01939366|471099392|FG000|Overall Study|Lost to Follow-up|1|||
130855646|NCT01939366|471099393|FG001|Overall Study|Lost to Follow-up|1|||
130855647|NCT01939366|471099394|FG002|Overall Study|Lost to Follow-up|0|||
130855648|NCT01939366|471099395|FG003|Overall Study|Lost to Follow-up|0|||
130855649|NCT01939366|471099396|FG004|Overall Study|Lost to Follow-up|0|||
130855650|NCT01939366|471099392|FG000|Overall Study|Withdrawal by Subject|1|||
130855651|NCT01939366|471099393|FG001|Overall Study|Withdrawal by Subject|0|||
130855652|NCT01939366|471099394|FG002|Overall Study|Withdrawal by Subject|2|||
130855653|NCT01939366|471099395|FG003|Overall Study|Withdrawal by Subject|2|||
130855654|NCT01939366|471099396|FG004|Overall Study|Withdrawal by Subject|3|||
130855655|NCT01939366|471099392|FG000|Overall Study|Inclusion criteria not met|0|||
130855656|NCT01939366|471099393|FG001|Overall Study|Inclusion criteria not met|1|||
130855657|NCT01939366|471099394|FG002|Overall Study|Inclusion criteria not met|1|||
130855658|NCT01939366|471099395|FG003|Overall Study|Inclusion criteria not met|0|||
130855659|NCT01939366|471099396|FG004|Overall Study|Inclusion criteria not met|1|||
130855660|NCT01939366|471099392|FG000|Overall Study|Other|0|||
130855661|NCT01939366|471099393|FG001|Overall Study|Other|0|||
130855662|NCT01939366|471099394|FG002|Overall Study|Other|2|||
130855663|NCT01939366|471099395|FG003|Overall Study|Other|2|||
130855664|NCT01939366|471099396|FG004|Overall Study|Other|1|||
130855665|NCT01939366|471099392|FG000|Overall Study|Protocol Violation|0|||
130855666|NCT01939366|471099393|FG001|Overall Study|Protocol Violation|0|||
130855667|NCT01939366|471099394|FG002|Overall Study|Protocol Violation|0|||
130855668|NCT01939366|471099395|FG003|Overall Study|Protocol Violation|1|||
130855669|NCT01939366|471099396|FG004|Overall Study|Protocol Violation|0|||
130855670|NCT01939366|471099392|FG000|Overall Study|Sponsor decision|0|||
130855671|NCT01939366|471099393|FG001|Overall Study|Sponsor decision|0|||
130855672|NCT01939366|471099394|FG002|Overall Study|Sponsor decision|0|||
130855673|NCT01939366|471099395|FG003|Overall Study|Sponsor decision|0|||
130855674|NCT01939366|471099396|FG004|Overall Study|Sponsor decision|2|||
130855675|NCT01939366|471099392|FG000|Overall Study|GCP non-compliance at site|2|||
130855676|NCT01939366|471099393|FG001|Overall Study|GCP non-compliance at site|3|||
130855677|NCT01939366|471099394|FG002|Overall Study|GCP non-compliance at site|2|||
130855678|NCT01939366|471099395|FG003|Overall Study|GCP non-compliance at site|3|||
130855679|NCT01939366|471099396|FG004|Overall Study|GCP non-compliance at site|3|||
130855680|NCT02271945|471099401|FG000|Overall Study|Death|3|||
130855681|NCT02271945|471099402|FG001|Overall Study|Death|3|||
130855682|NCT02271945|471099401|FG000|Overall Study|Withdrawal by Subject|1|||
130855683|NCT02271945|471099402|FG001|Overall Study|Withdrawal by Subject|1|||
130855684|NCT02271945|471099401|FG000|Overall Study|Other|1|||
130855685|NCT02271945|471099402|FG001|Overall Study|Other|1|||
130855686|NCT00615030|471099403|FG000|Period I|Administrative problem|0|||
130855687|NCT00615030|471099404|FG001|Period I|Administrative problem|0|||
130855688|NCT00615030|471099405|FG002|Period I|Administrative problem|0|||
130855689|NCT00615030|471099406|FG003|Period I|Administrative problem|0|||
130855690|NCT00615030|471099407|FG004|Period I|Administrative problem|1|||
130855691|NCT00615030|471099408|FG005|Period I|Administrative problem|0|||
130855692|NCT00615030|471099409|FG006|Period I|Administrative problem|0|||
130855693|NCT00615030|471099410|FG007|Period I|Administrative problem|0|||
130855694|NCT00615030|471099411|FG008|Period I|Administrative problem|0|||
130855695|NCT00615030|471099412|FG009|Period I|Administrative problem|0|||
130855696|NCT00615030|471099413|FG010|Period I|Administrative problem|0|||
130855697|NCT00615030|471099414|FG011|Period I|Administrative problem|0|||
130855698|NCT00615030|471099403|FG000|Period I|Protocol deviation|1|||
130855699|NCT00615030|471099404|FG001|Period I|Protocol deviation|0|||
130855700|NCT00615030|471099405|FG002|Period I|Protocol deviation|0|||
130855701|NCT00615030|471099406|FG003|Period I|Protocol deviation|0|||
130855702|NCT00615030|471099407|FG004|Period I|Protocol deviation|0|||
130855703|NCT00615030|471099408|FG005|Period I|Protocol deviation|0|||
130855704|NCT00615030|471099409|FG006|Period I|Protocol deviation|0|||
130855705|NCT00615030|471099410|FG007|Period I|Protocol deviation|0|||
130855706|NCT00615030|471099411|FG008|Period I|Protocol deviation|0|||
130855707|NCT00615030|471099412|FG009|Period I|Protocol deviation|0|||
130855708|NCT00615030|471099413|FG010|Period I|Protocol deviation|0|||
130855709|NCT00615030|471099414|FG011|Period I|Protocol deviation|0|||
130855710|NCT00615030|471099403|FG000|Period I|Subject withdrew consent|0|||
130855711|NCT00615030|471099404|FG001|Period I|Subject withdrew consent|0|||
130855712|NCT00615030|471099405|FG002|Period I|Subject withdrew consent|0|||
130855713|NCT00615030|471099406|FG003|Period I|Subject withdrew consent|0|||
130855714|NCT00615030|471099407|FG004|Period I|Subject withdrew consent|0|||
130855715|NCT00615030|471099408|FG005|Period I|Subject withdrew consent|0|||
130855716|NCT00615030|471099409|FG006|Period I|Subject withdrew consent|0|||
130855717|NCT00615030|471099410|FG007|Period I|Subject withdrew consent|0|||
130855718|NCT00615030|471099411|FG008|Period I|Subject withdrew consent|1|||
130855719|NCT00615030|471099412|FG009|Period I|Subject withdrew consent|0|||
130855720|NCT00615030|471099413|FG010|Period I|Subject withdrew consent|1|||
130855721|NCT00615030|471099414|FG011|Period I|Subject withdrew consent|1|||
130855722|NCT00615030|471099403|FG000|Period I|Abnormal laboratory value(s)|0|||
130855723|NCT00615030|471099404|FG001|Period I|Abnormal laboratory value(s)|0|||
130855724|NCT00615030|471099405|FG002|Period I|Abnormal laboratory value(s)|0|||
130855725|NCT00615030|471099406|FG003|Period I|Abnormal laboratory value(s)|0|||
130855726|NCT00615030|471099407|FG004|Period I|Abnormal laboratory value(s)|0|||
130855727|NCT00615030|471099408|FG005|Period I|Abnormal laboratory value(s)|1|||
130855728|NCT00615030|471099409|FG006|Period I|Abnormal laboratory value(s)|0|||
130855729|NCT00615030|471099410|FG007|Period I|Abnormal laboratory value(s)|0|||
130855730|NCT00615030|471099411|FG008|Period I|Abnormal laboratory value(s)|0|||
130855731|NCT00615030|471099412|FG009|Period I|Abnormal laboratory value(s)|0|||
130855732|NCT00615030|471099413|FG010|Period I|Abnormal laboratory value(s)|0|||
130855733|NCT00615030|471099414|FG011|Period I|Abnormal laboratory value(s)|0|||
130855734|NCT00615030|471099403|FG000|Period II|Adverse Event|0|||
130855735|NCT00615030|471099404|FG001|Period II|Adverse Event|0|||
130855736|NCT00615030|471099405|FG002|Period II|Adverse Event|1|||
130855737|NCT00615030|471099406|FG003|Period II|Adverse Event|0|||
130855738|NCT00615030|471099407|FG004|Period II|Adverse Event|0|||
130855739|NCT00615030|471099408|FG005|Period II|Adverse Event|0|||
130855740|NCT00615030|471099409|FG006|Period II|Adverse Event|0|||
130855741|NCT00615030|471099410|FG007|Period II|Adverse Event|0|||
130855742|NCT00615030|471099411|FG008|Period II|Adverse Event|1|||
130855743|NCT00615030|471099412|FG009|Period II|Adverse Event|0|||
130855744|NCT00615030|471099413|FG010|Period II|Adverse Event|0|||
130855745|NCT00615030|471099414|FG011|Period II|Adverse Event|0|||
130855746|NCT00615030|471099403|FG000|Period II|Subject withdrew consent|0|||
130855747|NCT00615030|471099404|FG001|Period II|Subject withdrew consent|0|||
130855748|NCT00615030|471099405|FG002|Period II|Subject withdrew consent|0|||
130855749|NCT00615030|471099406|FG003|Period II|Subject withdrew consent|1|||
130855750|NCT00615030|471099407|FG004|Period II|Subject withdrew consent|0|||
130855751|NCT00615030|471099408|FG005|Period II|Subject withdrew consent|0|||
130855752|NCT00615030|471099409|FG006|Period II|Subject withdrew consent|1|||
130855753|NCT00615030|471099410|FG007|Period II|Subject withdrew consent|0|||
130855754|NCT00615030|471099411|FG008|Period II|Subject withdrew consent|0|||
130855755|NCT00615030|471099412|FG009|Period II|Subject withdrew consent|0|||
130855756|NCT00615030|471099413|FG010|Period II|Subject withdrew consent|0|||
130855757|NCT00615030|471099414|FG011|Period II|Subject withdrew consent|0|||
130855758|NCT00615030|471099403|FG000|Period III|Administrative problems|1|||
130855759|NCT00615030|471099404|FG001|Period III|Administrative problems|0|||
130855760|NCT00615030|471099405|FG002|Period III|Administrative problems|0|||
130855761|NCT00615030|471099406|FG003|Period III|Administrative problems|1|||
130855762|NCT00615030|471099407|FG004|Period III|Administrative problems|0|||
130855763|NCT00615030|471099408|FG005|Period III|Administrative problems|0|||
130855764|NCT00615030|471099409|FG006|Period III|Administrative problems|0|||
130855765|NCT00615030|471099410|FG007|Period III|Administrative problems|0|||
130855766|NCT00615030|471099411|FG008|Period III|Administrative problems|0|||
130855767|NCT00615030|471099412|FG009|Period III|Administrative problems|0|||
130855768|NCT00615030|471099413|FG010|Period III|Administrative problems|0|||
130855769|NCT00615030|471099414|FG011|Period III|Administrative problems|0|||
130855770|NCT00151476|471099415|FG000|FAP Identified Subjects|Protocol Violation|0|||
130855771|NCT00151476|471099416|FG001|FAP Identified Subjects|Protocol Violation|1|||
130855772|NCT00151476|471099415|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
130855773|NCT00151476|471099416|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
130855774|NCT00151476|471099415|FG000|FAP Analyzed Subjects|Other study participation|0|||
130855775|NCT00151476|471099416|FG001|FAP Analyzed Subjects|Other study participation|1|||
130855776|NCT03446456|471099417|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
130855777|NCT03446456|471099418|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
130855778|NCT03446456|471099417|FG000|Overall Study|Lost to Follow-up|1|||
130855779|NCT03446456|471099418|FG001|Overall Study|Lost to Follow-up|3|||
130855780|NCT03446456|471099417|FG000|Overall Study|Participant failed the toxicology test|1|||
130855781|NCT03446456|471099418|FG001|Overall Study|Participant failed the toxicology test|0|||
130855782|NCT03446456|471099417|FG000|Overall Study|Break down of the experimental equipment|1|||
130855783|NCT03446456|471099418|FG001|Overall Study|Break down of the experimental equipment|0|||
130855784|NCT04099511|471099425|FG000|Overall Study|Lost to Follow-up|2|||
130855785|NCT04099511|471099426|FG001|Overall Study|Lost to Follow-up|2|||
130855786|NCT04099511|471099425|FG000|Overall Study|Withdrawal by Subject|8|||
130855787|NCT04099511|471099426|FG001|Overall Study|Withdrawal by Subject|4|||
130855788|NCT03002311|471099431|FG000|Overall Study|Lost to Follow-up|13|||
130855789|NCT03002311|471099432|FG001|Overall Study|Lost to Follow-up|26|||
130855790|NCT03002311|471099431|FG000|Overall Study|Referral provider called to schedule app|3|||
130855791|NCT03002311|471099432|FG001|Overall Study|Referral provider called to schedule app|3|||
130855792|NCT03002311|471099431|FG000|Overall Study|Physician Decision|3|||
130855793|NCT03002311|471099432|FG001|Overall Study|Physician Decision|1|||
130855794|NCT00320424|471099433|FG000|Overall Study|Adverse Event|3|||
130855795|NCT00320424|471099433|FG000|Overall Study|Other|3|||
130855796|NCT02649894|471099439|FG000|Overall Study|Adverse Event|1|||
130855797|NCT02649894|471099440|FG001|Overall Study|Adverse Event|0|||
130855798|NCT02649894|471099439|FG000|Overall Study|Physician Decision|0|||
130855799|NCT02649894|471099440|FG001|Overall Study|Physician Decision|1|||
130855800|NCT02649894|471099439|FG000|Overall Study|Withdrawal by Subject|5|||
130855801|NCT02649894|471099440|FG001|Overall Study|Withdrawal by Subject|2|||
130855802|NCT02649894|471099439|FG000|Overall Study|Lost to Follow-up|2|||
130855803|NCT02649894|471099440|FG001|Overall Study|Lost to Follow-up|1|||
130855804|NCT02649894|471099439|FG000|Overall Study|Death|30|||
130855805|NCT02649894|471099440|FG001|Overall Study|Death|7|||
130855806|NCT02649894|471099439|FG000|Overall Study|Other, not specified|6|||
130855807|NCT02649894|471099440|FG001|Overall Study|Other, not specified|0|||
130855808|NCT00719680|471099441|FG000|Overall Study|Adverse Event|1|||
130855809|NCT00719680|471099441|FG000|Overall Study|Lost to Follow-up|1|||
130855810|NCT00719680|471099441|FG000|Overall Study|Withdrawal by Subject|3|||
130855811|NCT00658814|471099442|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
130855812|NCT00658814|471099443|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
130855813|NCT00658814|471099442|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
130855814|NCT00658814|471099443|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
130855815|NCT00658814|471099442|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
130855816|NCT00658814|471099443|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
130855817|NCT00658814|471099442|FG000|Remission Induction Chemotherapy|Death|1|||
130855818|NCT00658814|471099443|FG001|Remission Induction Chemotherapy|Death|4|||
130855819|NCT00658814|471099442|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
130855820|NCT00658814|471099443|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
130855821|NCT00658814|471099442|FG000|Remission Induction Chemotherapy|Not eligible|1|||
130855822|NCT00658814|471099443|FG001|Remission Induction Chemotherapy|Not eligible|2|||
130855823|NCT00658814|471099442|FG000|Consolidation Therapy|Not protocol specified|0|||
130855824|NCT00658814|471099443|FG001|Consolidation Therapy|Not protocol specified|1|||
130855825|NCT00658814|471099442|FG000|Consolidation Therapy|Not eligible|2|||
130855826|NCT00658814|471099443|FG001|Consolidation Therapy|Not eligible|2|||
130855827|NCT00658814|471099442|FG000|Maintenance Therapy|Adverse Event|1|||
130855828|NCT00658814|471099443|FG001|Maintenance Therapy|Adverse Event|1|||
130855829|NCT00658814|471099442|FG000|Maintenance Therapy|Not protocol specified|1|||
130855830|NCT00658814|471099443|FG001|Maintenance Therapy|Not protocol specified|0|||
130855831|NCT00658814|471099442|FG000|Maintenance Therapy|Not eligible|1|||
130855832|NCT00658814|471099443|FG001|Maintenance Therapy|Not eligible|0|||
130855833|NCT03270891|471099444|FG000|Overall Study|Lost to Follow-up|3|||
130855834|NCT03270891|471099445|FG001|Overall Study|Lost to Follow-up|6|||
130855835|NCT03270891|471099446|FG002|Overall Study|Lost to Follow-up|0|||
130855836|NCT03270891|471099444|FG000|Overall Study|Withdrawal by Subject|1|||
130855837|NCT03270891|471099445|FG001|Overall Study|Withdrawal by Subject|0|||
130855838|NCT03270891|471099446|FG002|Overall Study|Withdrawal by Subject|0|||
130855839|NCT03270891|471099444|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
130855840|NCT03270891|471099445|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
130855841|NCT03270891|471099446|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
130855842|NCT02540668|471099447|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
130855843|NCT02540668|471099448|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
130855844|NCT04071158|471099450|FG000|Overall Study|Lost to Follow-up|1|||
130855845|NCT04071158|471099451|FG001|Overall Study|Lost to Follow-up|2|||
130855846|NCT04071158|471099452|FG002|Overall Study|Lost to Follow-up|3|||
130855847|NCT04071158|471099453|FG003|Overall Study|Lost to Follow-up|3|||
130855848|NCT04071158|471099454|FG004|Overall Study|Lost to Follow-up|5|||
130855849|NCT04071158|471099450|FG000|Overall Study|Randomized but not treated|2|||
130855850|NCT04071158|471099451|FG001|Overall Study|Randomized but not treated|2|||
130855851|NCT04071158|471099452|FG002|Overall Study|Randomized but not treated|0|||
130855852|NCT04071158|471099453|FG003|Overall Study|Randomized but not treated|0|||
130855853|NCT04071158|471099454|FG004|Overall Study|Randomized but not treated|0|||
130855856|NCT02888743|471099457|FG000|Overall Study|Withdrawal by Subject|1|||
130855857|NCT02888743|471099458|FG001|Overall Study|Withdrawal by Subject|2|||
130855858|NCT02888743|471099459|FG002|Overall Study|Withdrawal by Subject|2|||
130855859|NCT02888743|471099460|FG003|Overall Study|Withdrawal by Subject|0|||
130855860|NCT02888743|471099461|FG004|Overall Study|Withdrawal by Subject|1|||
130855861|NCT02888743|471099457|FG000|Overall Study|Disease progression before treatment|2|||
130855862|NCT02888743|471099458|FG001|Overall Study|Disease progression before treatment|0|||
130855863|NCT02888743|471099459|FG002|Overall Study|Disease progression before treatment|2|||
130855864|NCT02888743|471099460|FG003|Overall Study|Disease progression before treatment|0|||
130855865|NCT02888743|471099461|FG004|Overall Study|Disease progression before treatment|0|||
130855866|NCT02888743|471099457|FG000|Overall Study|Patient ineligible|1|||
130855867|NCT02888743|471099458|FG001|Overall Study|Patient ineligible|2|||
130855868|NCT02888743|471099459|FG002|Overall Study|Patient ineligible|0|||
130855869|NCT02888743|471099460|FG003|Overall Study|Patient ineligible|0|||
130855870|NCT02888743|471099461|FG004|Overall Study|Patient ineligible|0|||
130855871|NCT04816721|471099466|FG000|Overall Study|Withdrawal by Subject|0|||
130855872|NCT04816721|471099467|FG001|Overall Study|Withdrawal by Subject|2|||
130855873|NCT04816721|471099468|FG002|Overall Study|Withdrawal by Subject|0|||
130855874|NCT04816721|471099469|FG003|Overall Study|Withdrawal by Subject|1|||
130855875|NCT04816721|471099470|FG004|Overall Study|Withdrawal by Subject|1|||
130855876|NCT04816721|471099471|FG005|Overall Study|Withdrawal by Subject|0|||
130855877|NCT04816721|471099472|FG006|Overall Study|Withdrawal by Subject|0|||
130855878|NCT04816721|471099473|FG007|Overall Study|Withdrawal by Subject|0|||
130855879|NCT04816721|471099466|FG000|Overall Study|Miscellaneous|0|||
130855880|NCT04816721|471099467|FG001|Overall Study|Miscellaneous|0|||
130855881|NCT04816721|471099468|FG002|Overall Study|Miscellaneous|0|||
130855882|NCT04816721|471099469|FG003|Overall Study|Miscellaneous|0|||
130855883|NCT04816721|471099470|FG004|Overall Study|Miscellaneous|0|||
130855884|NCT04816721|471099471|FG005|Overall Study|Miscellaneous|1|||
130855885|NCT04816721|471099472|FG006|Overall Study|Miscellaneous|0|||
130855886|NCT04816721|471099473|FG007|Overall Study|Miscellaneous|0|||
130855887|NCT04816721|471099466|FG000|Overall Study|Lost to Follow-up|0|||
130855888|NCT04816721|471099467|FG001|Overall Study|Lost to Follow-up|0|||
130855889|NCT04816721|471099468|FG002|Overall Study|Lost to Follow-up|0|||
130855890|NCT04816721|471099469|FG003|Overall Study|Lost to Follow-up|1|||
130855891|NCT04816721|471099470|FG004|Overall Study|Lost to Follow-up|0|||
130855892|NCT04816721|471099471|FG005|Overall Study|Lost to Follow-up|0|||
130855893|NCT04816721|471099472|FG006|Overall Study|Lost to Follow-up|0|||
130855894|NCT04816721|471099473|FG007|Overall Study|Lost to Follow-up|0|||
130855895|NCT01286740|471099474|FG000|Overall Study|Enrolled but not treated|1|||
130855896|NCT01286740|471099474|FG000|Overall Study|Protocol Violation|1|||
130855897|NCT02708485|471099476|FG000|Overall Study|Withdrawal by Subject|3|||
130855898|NCT02708485|471099477|FG001|Overall Study|Withdrawal by Subject|2|||
130855899|NCT03266172|471099478|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
130855900|NCT03266172|471099479|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
130855901|NCT03266172|471099480|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
130855902|NCT03266172|471099478|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
130855903|NCT03266172|471099479|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
130855904|NCT03266172|471099480|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
130855905|NCT03266172|471099478|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
130855906|NCT03266172|471099479|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
130855907|NCT03266172|471099480|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
130855908|NCT03266172|471099478|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
130855909|NCT03266172|471099479|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
130855910|NCT03266172|471099480|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
130855911|NCT03266172|471099478|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130855912|NCT03266172|471099479|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130855913|NCT03266172|471099480|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
130855914|NCT03266172|471099478|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130855915|NCT03266172|471099479|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130855916|NCT03266172|471099480|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
130855917|NCT01554514|471099483|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
130855918|NCT01554514|471099483|FG000|Overall Study|Physician Decision|1|||
130855919|NCT00300365|471099484|FG000|Overall Study|Lost to Follow-up|1|||
130855920|NCT00300365|471099485|FG001|Overall Study|Lost to Follow-up|0|||
130855921|NCT00300365|471099484|FG000|Overall Study|Physician Decision|2|||
130855922|NCT00300365|471099485|FG001|Overall Study|Physician Decision|0|||
130855923|NCT00300365|471099484|FG000|Overall Study|Withdrawal by Subject|1|||
130855924|NCT00300365|471099485|FG001|Overall Study|Withdrawal by Subject|0|||
130855925|NCT00300365|471099484|FG000|Overall Study|Adverse Event|0|||
130855926|NCT00300365|471099485|FG001|Overall Study|Adverse Event|2|||
130855927|NCT00290498|471099486|FG000|Overall Study|Death|2|||
130855928|NCT00290498|471099487|FG001|Overall Study|Death|0|||
130855929|NCT00290498|471099486|FG000|Overall Study|Physician Decision|1|||
130855930|NCT00290498|471099487|FG001|Overall Study|Physician Decision|0|||
130855931|NCT00290498|471099486|FG000|Overall Study|Withdrawal by Subject|1|||
130855932|NCT00290498|471099487|FG001|Overall Study|Withdrawal by Subject|0|||
130855933|NCT00290498|471099486|FG000|Overall Study|Ineligible|3|||
130855934|NCT00290498|471099487|FG001|Overall Study|Ineligible|0|||
130855935|NCT00290498|471099486|FG000|Overall Study|Non-Compliance|1|||
130855936|NCT00290498|471099487|FG001|Overall Study|Non-Compliance|0|||
130855937|NCT01716104|471099489|FG000|Overall Study|Do not meet inclusion criteria|6|||
130855938|NCT01716104|471099490|FG001|Overall Study|Do not meet inclusion criteria|7|||
130855939|NCT01753401|471099491|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
130855940|NCT01753401|471099492|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
130855941|NCT01753401|471099493|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
130855942|NCT01753401|471099494|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
130855943|NCT01753401|471099491|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
130855944|NCT01753401|471099492|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
130855945|NCT01753401|471099493|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
130855946|NCT01753401|471099494|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
130855947|NCT01753401|471099491|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
130855948|NCT01753401|471099492|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
130855949|NCT01753401|471099493|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
130855950|NCT01753401|471099494|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
130855951|NCT01753401|471099491|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
130855952|NCT01753401|471099492|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
130855953|NCT01753401|471099493|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
130855954|NCT01753401|471099494|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
130855955|NCT01753401|471099491|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
130855956|NCT01753401|471099492|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
130855957|NCT01753401|471099493|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
130855958|NCT01753401|471099494|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
130855959|NCT01753401|471099491|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
130855960|NCT01753401|471099492|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
130855961|NCT01753401|471099493|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
130855962|NCT01753401|471099494|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
130855963|NCT01753401|471099491|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
130855964|NCT01753401|471099492|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
130855965|NCT01753401|471099493|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
130855966|NCT01753401|471099494|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
130855967|NCT05026853|471099495|FG000|Overall Study|Cancelled appointment|1|||
130855968|NCT05026853|471099496|FG001|Overall Study|Cancelled appointment|0|||
130855969|NCT05026853|471099495|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
130855970|NCT05026853|471099496|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
130855971|NCT05026853|471099495|FG000|Overall Study|Did not complete 12-week survey|16|||
130855972|NCT05026853|471099496|FG001|Overall Study|Did not complete 12-week survey|16|||
130855973|NCT01353911|471099497|FG000|Overall Study|Lost to Follow-up|2|||
130855974|NCT01353911|471099498|FG001|Overall Study|Lost to Follow-up|6|||
130855975|NCT01353911|471099499|FG002|Overall Study|Lost to Follow-up|4|||
130855976|NCT01353911|471099500|FG003|Overall Study|Lost to Follow-up|0|||
130855977|NCT01353911|471099501|FG004|Overall Study|Lost to Follow-up|4|||
130855978|NCT01353911|471099502|FG005|Overall Study|Lost to Follow-up|4|||
130855979|NCT01353911|471099503|FG006|Overall Study|Lost to Follow-up|3|||
130855980|NCT01353911|471099504|FG007|Overall Study|Lost to Follow-up|6|||
130855981|NCT01353911|471099497|FG000|Overall Study|Withdrawal by Subject|2|||
130855982|NCT01353911|471099498|FG001|Overall Study|Withdrawal by Subject|3|||
130855983|NCT01353911|471099499|FG002|Overall Study|Withdrawal by Subject|4|||
130855984|NCT01353911|471099500|FG003|Overall Study|Withdrawal by Subject|2|||
130855985|NCT01353911|471099501|FG004|Overall Study|Withdrawal by Subject|2|||
130855986|NCT01353911|471099502|FG005|Overall Study|Withdrawal by Subject|3|||
130855987|NCT01353911|471099503|FG006|Overall Study|Withdrawal by Subject|3|||
130855988|NCT01353911|471099504|FG007|Overall Study|Withdrawal by Subject|9|||
130855989|NCT01353911|471099497|FG000|Overall Study|Status Not Recorded|4|||
130855990|NCT01353911|471099498|FG001|Overall Study|Status Not Recorded|0|||
130855991|NCT01353911|471099499|FG002|Overall Study|Status Not Recorded|1|||
130855992|NCT01353911|471099500|FG003|Overall Study|Status Not Recorded|0|||
130855993|NCT01353911|471099501|FG004|Overall Study|Status Not Recorded|0|||
130855994|NCT01353911|471099502|FG005|Overall Study|Status Not Recorded|0|||
130855995|NCT01353911|471099503|FG006|Overall Study|Status Not Recorded|0|||
130855996|NCT01353911|471099504|FG007|Overall Study|Status Not Recorded|0|||
130855997|NCT00462748|471099509|FG000|Overall Study|Adverse Event|7|||
130855998|NCT00462748|471099510|FG001|Overall Study|Adverse Event|5|||
130855999|NCT00462748|471099511|FG002|Overall Study|Adverse Event|9|||
130856000|NCT00462748|471099509|FG000|Overall Study|Protocol Violation|0|||
130856001|NCT00462748|471099510|FG001|Overall Study|Protocol Violation|2|||
130856002|NCT00462748|471099511|FG002|Overall Study|Protocol Violation|1|||
130856003|NCT00462748|471099509|FG000|Overall Study|Withdrew consent|3|||
130856004|NCT00462748|471099510|FG001|Overall Study|Withdrew consent|3|||
130856005|NCT00462748|471099511|FG002|Overall Study|Withdrew consent|0|||
130856006|NCT00462748|471099509|FG000|Overall Study|Lost to Follow-up|1|||
130856007|NCT00462748|471099510|FG001|Overall Study|Lost to Follow-up|1|||
130856008|NCT00462748|471099511|FG002|Overall Study|Lost to Follow-up|1|||
130856009|NCT00462748|471099509|FG000|Overall Study|Discontinued after 41 days Rx|1|||
130856010|NCT00462748|471099510|FG001|Overall Study|Discontinued after 41 days Rx|0|||
130856011|NCT00462748|471099511|FG002|Overall Study|Discontinued after 41 days Rx|0|||
130856012|NCT00587847|471099512|FG000|Overall Study|Lack of Efficacy|5|||
130856013|NCT00587847|471099512|FG000|Overall Study|Adverse Event|2|||
130856014|NCT03729245|471099513|FG000|Overall Study|Lost to Follow-up|5|||
130856015|NCT03729245|471099514|FG001|Overall Study|Lost to Follow-up|6|||
130856016|NCT03729245|471099513|FG000|Overall Study|Withdrawal by Subject|16|||
130856017|NCT03729245|471099514|FG001|Overall Study|Withdrawal by Subject|19|||
130856018|NCT03729245|471099513|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
130856019|NCT03729245|471099514|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
130856020|NCT04032080|471099515|FG000|Overall Study|Death|6|||
130856021|NCT00989781|471099522|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
130856022|NCT00989781|471099523|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
130856023|NCT00576576|471099526|FG000|Overall Study|Lost to Follow-up|6|||
130856024|NCT00576576|471099526|FG000|Overall Study|Protocol Violation|1|||
130856025|NCT01805037|471099532|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
130856026|NCT01805037|471099533|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
130856027|NCT01805037|471099532|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
130856028|NCT01805037|471099533|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
130856029|NCT01805037|471099532|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
130856030|NCT01805037|471099533|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
130856031|NCT01805037|471099532|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
130856032|NCT01805037|471099533|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
130856033|NCT01805037|471099532|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
130856034|NCT01805037|471099533|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
130856035|NCT01805037|471099532|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
130856036|NCT01805037|471099533|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
130856037|NCT01805037|471099532|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
130856038|NCT01805037|471099533|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
130856039|NCT01805037|471099532|FG000|Follow Up (up to 3 Years)|Death|0|||
130856040|NCT01805037|471099533|FG001|Follow Up (up to 3 Years)|Death|2|||
130856041|NCT01805037|471099532|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
130856042|NCT01805037|471099533|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
130856043|NCT01805037|471099532|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
130856044|NCT01805037|471099533|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
130856045|NCT02540265|471099536|FG000|Overall Study|Lost to Follow-up|0|||
130856046|NCT02540265|471099537|FG001|Overall Study|Lost to Follow-up|0|||
130856047|NCT02540265|471099538|FG002|Overall Study|Lost to Follow-up|1|||
130856048|NCT02102399|471099544|FG000|Overall Study|Withdrawal by Subject|6|||
130856049|NCT02102399|471099545|FG001|Overall Study|Withdrawal by Subject|4|||
130856050|NCT03101085|471099546|FG000|Overall Study|Lost to Follow-up|0|||
130856051|NCT03101085|471099547|FG001|Overall Study|Lost to Follow-up|1|||
130856052|NCT00718770|471099548|FG000|Overall Study|Adverse Event|1|||
130856053|NCT00718770|471099548|FG000|Overall Study|Lack of Efficacy|1|||
130856054|NCT00718770|471099548|FG000|Overall Study|Lack of Efficacy|1|||
130856055|NCT00718770|471099548|FG000|Overall Study|Adverse Event|1|||
130856056|NCT00718770|471099548|FG000|Overall Study|Lack of Efficacy|1|||
130856057|NCT00718770|471099548|FG000|Overall Study|Adverse Event|1|||
130856058|NCT00718770|471099548|FG000|Overall Study|Lack of Efficacy|1|||
130856059|NCT00718770|471099548|FG000|Overall Study|Adverse Event|1|||
130856060|NCT00695864|471099551|FG000|Placebo|Withdrawal by Subject|1|||
130856061|NCT00695864|471099551|FG000|Placebo|Physician Decision|4|||
130856062|NCT01704456|471099552|FG000|Overall Study|Lost to Follow-up|8|||
130856063|NCT01704456|471099553|FG001|Overall Study|Lost to Follow-up|14|||
130856064|NCT00498355|471099554|FG000|Overall Study|Lost to Follow-up|1|||
130856065|NCT04583956|471099555|FG000|Overall Study|Death|9|||
130856066|NCT04583956|471099556|FG001|Overall Study|Death|11|||
130856067|NCT04583956|471099555|FG000|Overall Study|Lost to Follow-up|7|||
130856068|NCT04583956|471099556|FG001|Overall Study|Lost to Follow-up|9|||
130856069|NCT04583956|471099555|FG000|Overall Study|Protocol Violation|2|||
130856070|NCT04583956|471099556|FG001|Overall Study|Protocol Violation|0|||
130856071|NCT04583956|471099555|FG000|Overall Study|Withdrawal by Subject|0|||
130856072|NCT04583956|471099556|FG001|Overall Study|Withdrawal by Subject|2|||
130856073|NCT04583956|471099555|FG000|Overall Study|Randomized but not dosed|2|||
130856074|NCT04583956|471099556|FG001|Overall Study|Randomized but not dosed|3|||
130856075|NCT04583956|471099555|FG000|Overall Study|Withdrawal of consent before product administration|1|||
130856076|NCT04583956|471099556|FG001|Overall Study|Withdrawal of consent before product administration|0|||
130856077|NCT00727558|471099559|FG000|Overall Study|Lens issue|0|||
130856078|NCT00727558|471099560|FG001|Overall Study|Lens issue|1|||
130856079|NCT00727558|471099559|FG000|Overall Study|Adverse Event|0|||
130856080|NCT00727558|471099560|FG001|Overall Study|Adverse Event|1|||
130856081|NCT00727558|471099559|FG000|Overall Study|Subject unable to return for follow-up|1|||
130856082|NCT00727558|471099560|FG001|Overall Study|Subject unable to return for follow-up|1|||
130856083|NCT00727558|471099559|FG000|Overall Study|Lost to Follow-up|1|||
130856084|NCT00727558|471099560|FG001|Overall Study|Lost to Follow-up|0|||
130856085|NCT01754493|471101230|FG000|Overall Study|Adverse Event|1|||
130856086|NCT01754493|471101230|FG000|Overall Study|Lost to Follow-up|3|||
130856087|NCT01754493|471101230|FG000|Overall Study|Withdrawal by Subject|1|||
130856088|NCT01754493|471101230|FG000|Overall Study|Moved out of town|1|||
130856089|NCT01754493|471101230|FG000|Overall Study|Scheduling conflict|1|||
130856090|NCT01543776|471101231|FG000|Overall Study|Withdrawal by Subject|2|||
130856091|NCT01543776|471101232|FG001|Overall Study|Withdrawal by Subject|2|||
130856092|NCT00568126|471101233|FG000|Overall Study|Adverse Event|3|||
130856093|NCT00568126|471101234|FG001|Overall Study|Adverse Event|0|||
130856094|NCT00568126|471101233|FG000|Overall Study|Withdrawal by Subject|2|||
130856095|NCT00568126|471101234|FG001|Overall Study|Withdrawal by Subject|3|||
130856096|NCT00568126|471101233|FG000|Overall Study|Lost to Follow-up|4|||
130856097|NCT00568126|471101234|FG001|Overall Study|Lost to Follow-up|3|||
130856098|NCT00568126|471101233|FG000|Overall Study|Lack of Efficacy|0|||
130856099|NCT00568126|471101234|FG001|Overall Study|Lack of Efficacy|1|||
130856100|NCT00568126|471101233|FG000|Overall Study|Physician Decision|2|||
130856101|NCT00568126|471101234|FG001|Overall Study|Physician Decision|2|||
130856102|NCT04395690|471101235|FG000|Overall Study|Lost to Follow-up|1|||
130856103|NCT04395690|471101236|FG001|Overall Study|Lost to Follow-up|1|||
130856104|NCT03387020|471101238|FG000|Overall Study|Adverse Event|0|||
130856105|NCT03387020|471101239|FG001|Overall Study|Adverse Event|2|||
130856106|NCT03387020|471101240|FG002|Overall Study|Adverse Event|0|||
130856107|NCT03387020|471101238|FG000|Overall Study|Withdrawal by Subject|2|||
130856108|NCT03387020|471101239|FG001|Overall Study|Withdrawal by Subject|0|||
130856109|NCT03387020|471101240|FG002|Overall Study|Withdrawal by Subject|0|||
130856110|NCT00434642|471101241|FG000|Blinded Treatment Phase|Adverse Event|12|||
130856111|NCT00434642|471101242|FG001|Blinded Treatment Phase|Adverse Event|58|||
130856112|NCT00434642|471101241|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
130856113|NCT00434642|471101242|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
130856114|NCT00434642|471101241|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
130856115|NCT00434642|471101242|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
130856116|NCT00434642|471101241|FG000|Blinded Treatment Phase|Physician Decision|19|||
130856117|NCT00434642|471101242|FG001|Blinded Treatment Phase|Physician Decision|27|||
130856118|NCT00434642|471101241|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
130856119|NCT00434642|471101242|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
130856120|NCT00434642|471101241|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
130856121|NCT00434642|471101242|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
130856122|NCT00434642|471101241|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
130856123|NCT00434642|471101242|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
130856124|NCT00434642|471101241|FG000|Open-label Treatment Phase|Adverse Event|0|||
130856125|NCT00434642|471101242|FG001|Open-label Treatment Phase|Adverse Event|5|||
130856126|NCT00434642|471101241|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
130856127|NCT00434642|471101242|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
130856128|NCT04512976|471101247|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130856129|NCT04512976|471101248|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130856130|NCT04512976|471101249|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130856131|NCT04512976|471101250|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130856132|NCT04512976|471101251|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130856133|NCT04512976|471101252|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
130856134|NCT00527982|471101253|FG000|Overall Study|Physician Decision|1|||
130856135|NCT00527982|471101254|FG001|Overall Study|Physician Decision|0|||
130856136|NCT00753454|471101261|FG000|Overall Study|Adverse Event|4|||
130856137|NCT00753454|471101261|FG000|Overall Study|Lack of Efficacy|1|||
130856138|NCT00753454|471101261|FG000|Overall Study|Lost to Follow-up|3|||
130856139|NCT00753454|471101261|FG000|Overall Study|Withdrawal by Subject|5|||
130856140|NCT00753454|471101261|FG000|Overall Study|Investigator Decision|1|||
130856141|NCT03927144|471101262|FG000|Core Phase|Adverse Event|9|||
130856142|NCT03927144|471101263|FG001|Core Phase|Adverse Event|5|||
130856143|NCT03927144|471101262|FG000|Core Phase|Lost to Follow-up|3|||
130856144|NCT03927144|471101263|FG001|Core Phase|Lost to Follow-up|2|||
130856145|NCT03927144|471101262|FG000|Core Phase|New Therapy for Study Indication|0|||
130856146|NCT03927144|471101263|FG001|Core Phase|New Therapy for Study Indication|1|||
130856147|NCT03927144|471101262|FG000|Core Phase|No Longer Clinically Benefiting|4|||
130856148|NCT03927144|471101263|FG001|Core Phase|No Longer Clinically Benefiting|4|||
130856149|NCT03927144|471101262|FG000|Core Phase|Physician Decision|2|||
130856150|NCT03927144|471101263|FG001|Core Phase|Physician Decision|8|||
130856151|NCT03927144|471101262|FG000|Core Phase|Protocol Violation|2|||
130856152|NCT03927144|471101263|FG001|Core Phase|Protocol Violation|2|||
130856153|NCT03927144|471101262|FG000|Core Phase|Withdrawal by Subject|16|||
130856154|NCT03927144|471101263|FG001|Core Phase|Withdrawal by Subject|40|||
130856155|NCT03927144|471101262|FG000|Extension Phase|Adverse Event|2|||
130856156|NCT03927144|471101263|FG001|Extension Phase|Adverse Event|1|||
130856157|NCT03927144|471101262|FG000|Extension Phase|No longer clinically benefiting|4|||
130856158|NCT03927144|471101263|FG001|Extension Phase|No longer clinically benefiting|5|||
130856159|NCT03927144|471101262|FG000|Extension Phase|Pregnancy|1|||
130856160|NCT03927144|471101263|FG001|Extension Phase|Pregnancy|0|||
130856161|NCT03927144|471101262|FG000|Extension Phase|Protocol Violation|0|||
130856162|NCT03927144|471101263|FG001|Extension Phase|Protocol Violation|1|||
130856163|NCT03927144|471101262|FG000|Extension Phase|Withdrawal by Subject|8|||
130856164|NCT03927144|471101263|FG001|Extension Phase|Withdrawal by Subject|3|||
130856165|NCT04541628|471101266|FG000|Overall Study|Study Terminated|1|||
130856166|NCT04541628|471101267|FG001|Overall Study|Study Terminated|1|||
130856167|NCT04541628|471101268|FG002|Overall Study|Study Terminated|1|||
130856168|NCT05011058|471101272|FG000|Overall Study|Sponsor Decision|2|||
130856169|NCT05011058|471101273|FG001|Overall Study|Sponsor Decision|0|||
130856170|NCT05011058|471101274|FG002|Overall Study|Sponsor Decision|14|||
130856171|NCT05011058|471101275|FG003|Overall Study|Sponsor Decision|0|||
130856172|NCT05011058|471101276|FG004|Overall Study|Sponsor Decision|0|||
130856173|NCT05011058|471101277|FG005|Overall Study|Sponsor Decision|1|||
130856174|NCT05011058|471101278|FG006|Overall Study|Sponsor Decision|0|||
130856175|NCT05011058|471101279|FG007|Overall Study|Sponsor Decision|5|||
130856176|NCT01452919|471101280|FG000|Open-Label Treatment|Adverse Event|5|||
130856177|NCT01452919|471101281|FG001|Open-Label Treatment|Adverse Event|0|||
130856178|NCT01452919|471101282|FG002|Open-Label Treatment|Adverse Event|0|||
130856179|NCT01452919|471101280|FG000|Open-Label Treatment|Lost to Follow-up|4|||
130856180|NCT01452919|471101281|FG001|Open-Label Treatment|Lost to Follow-up|0|||
130856181|NCT01452919|471101282|FG002|Open-Label Treatment|Lost to Follow-up|0|||
130856182|NCT01452919|471101280|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
130856183|NCT01452919|471101281|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
130856184|NCT01452919|471101282|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
130856185|NCT01452919|471101280|FG000|Open-Label Treatment|Protocol Violation|4|||
130856186|NCT01452919|471101281|FG001|Open-Label Treatment|Protocol Violation|0|||
130856187|NCT01452919|471101282|FG002|Open-Label Treatment|Protocol Violation|0|||
130856188|NCT01452919|471101280|FG000|Open-Label Treatment|Sponsor Decision|1|||
130856189|NCT01452919|471101281|FG001|Open-Label Treatment|Sponsor Decision|0|||
130856190|NCT01452919|471101282|FG002|Open-Label Treatment|Sponsor Decision|0|||
130856191|NCT01452919|471101280|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
130856192|NCT01452919|471101281|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
130856193|NCT01452919|471101282|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
130856194|NCT01452919|471101280|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
130856195|NCT01452919|471101281|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
130856196|NCT01452919|471101282|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
130856197|NCT01452919|471101280|FG000|Randomization Treatment|Adverse Event|0|||
130856198|NCT01452919|471101281|FG001|Randomization Treatment|Adverse Event|0|||
130856199|NCT01452919|471101282|FG002|Randomization Treatment|Adverse Event|2|||
130856200|NCT01452919|471101280|FG000|Randomization Treatment|Sponsor Decision|0|||
130856201|NCT01452919|471101281|FG001|Randomization Treatment|Sponsor Decision|1|||
130856202|NCT01452919|471101282|FG002|Randomization Treatment|Sponsor Decision|0|||
130856203|NCT01452919|471101280|FG000|Randomization Treatment|Withdrawal by Subject|0|||
130856204|NCT01452919|471101281|FG001|Randomization Treatment|Withdrawal by Subject|1|||
130856205|NCT01452919|471101282|FG002|Randomization Treatment|Withdrawal by Subject|0|||
130856206|NCT01452919|471101280|FG000|Randomization Treatment|Subject is moving or has moved|0|||
130856207|NCT01452919|471101281|FG001|Randomization Treatment|Subject is moving or has moved|1|||
130856208|NCT01452919|471101282|FG002|Randomization Treatment|Subject is moving or has moved|0|||
130856209|NCT01192412|471101283|FG000|Overall Study|Lost to Follow-up|2|||
130856210|NCT01192412|471101284|FG001|Overall Study|Lost to Follow-up|1|||
130856211|NCT01192412|471101283|FG000|Overall Study|Withdrawal by Subject|2|||
130856212|NCT01192412|471101284|FG001|Overall Study|Withdrawal by Subject|1|||
130856213|NCT02421588|471101285|FG000|Overall Study|Non-treatment-related AE|8|||
130856214|NCT02421588|471101286|FG001|Overall Study|Non-treatment-related AE|8|||
130856215|NCT02421588|471101285|FG000|Overall Study|Progressive disease|152|||
130856216|NCT02421588|471101286|FG001|Overall Study|Progressive disease|135|||
130856217|NCT02421588|471101285|FG000|Overall Study|Death|11|||
130856218|NCT02421588|471101286|FG001|Overall Study|Death|3|||
130856219|NCT02421588|471101285|FG000|Overall Study|Physician Decision|8|||
130856220|NCT02421588|471101286|FG001|Overall Study|Physician Decision|17|||
130856221|NCT02421588|471101285|FG000|Overall Study|Other reason not specified|3|||
130856222|NCT02421588|471101286|FG001|Overall Study|Other reason not specified|1|||
130856223|NCT02421588|471101285|FG000|Overall Study|Symptomatic deterioration|13|||
130856224|NCT02421588|471101286|FG001|Overall Study|Symptomatic deterioration|19|||
130856225|NCT02421588|471101285|FG000|Overall Study|Treatment-related AE|10|||
130856226|NCT02421588|471101286|FG001|Overall Study|Treatment-related AE|14|||
130856227|NCT02421588|471101285|FG000|Overall Study|Withdrawal by Subject|14|||
130856228|NCT02421588|471101286|FG001|Overall Study|Withdrawal by Subject|16|||
130856229|NCT02421588|471101285|FG000|Overall Study|Not treated|2|||
130856230|NCT02421588|471101286|FG001|Overall Study|Not treated|8|||
130856231|NCT01359943|471101289|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
130856232|NCT01359943|471101290|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
130856233|NCT01359943|471101291|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
130856234|NCT01359943|471101289|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
130856235|NCT01359943|471101290|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
130856236|NCT01359943|471101291|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
130856237|NCT01359943|471101289|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
130856238|NCT01359943|471101290|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
130856239|NCT01359943|471101291|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
130856240|NCT01359943|471101289|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
130856241|NCT01359943|471101290|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
130856242|NCT01359943|471101291|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
130856243|NCT01359943|471101289|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
130856244|NCT01359943|471101290|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
130856245|NCT01359943|471101291|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
130856246|NCT01359943|471101289|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
130856247|NCT01359943|471101290|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
130856248|NCT01359943|471101291|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
130856249|NCT01359943|471101289|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
130856250|NCT01359943|471101290|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
130856251|NCT01359943|471101291|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
130856252|NCT01359943|471101289|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
130856253|NCT01359943|471101290|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
130856254|NCT01359943|471101291|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
130856255|NCT01359943|471101289|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
130856256|NCT01359943|471101290|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
130856257|NCT01359943|471101291|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
130856258|NCT01359943|471101289|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
130856259|NCT01359943|471101290|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
130856260|NCT01359943|471101291|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
130856261|NCT01359943|471101289|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
130856262|NCT01359943|471101290|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
130856263|NCT01359943|471101291|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
130856264|NCT01359943|471101289|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
130856265|NCT01359943|471101290|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
130856266|NCT01359943|471101291|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
130856267|NCT01359943|471101289|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
130856268|NCT01359943|471101290|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
130856269|NCT01359943|471101291|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
130856270|NCT01359943|471101289|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
130856271|NCT01359943|471101290|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
130856272|NCT01359943|471101291|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
130856273|NCT01359943|471101289|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
130856274|NCT01359943|471101290|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
130856275|NCT01359943|471101291|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
130856276|NCT00308074|471101295|FG000|Overall Study|Withdrawal by Subject|1|||
130856277|NCT01529034|471101302|FG000|Overall Study|Discontinued prior to study treatment|14|||
130856278|NCT01529034|471101302|FG000|Overall Study|Site closure|62|||
130856279|NCT01529034|471101302|FG000|Overall Study|Study termination|29|||
130856280|NCT01529034|471101302|FG000|Overall Study|Withdrawal by Subject|25|||
130856281|NCT01529034|471101302|FG000|Overall Study|No treated SCs within protocol window|13|||
130856282|NCT01529034|471101302|FG000|Overall Study|Noncompliance|8|||
130856283|NCT01529034|471101302|FG000|Overall Study|Caregiver no longer available|7|||
130856284|NCT01529034|471101302|FG000|Overall Study|Adverse Event|4|||
130856285|NCT01529034|471101302|FG000|Overall Study|Protocol Violation|4|||
130856286|NCT01529034|471101302|FG000|Overall Study|Lack of Efficacy|4|||
130856287|NCT01529034|471101302|FG000|Overall Study|Investigator no longer available|2|||
130856288|NCT01529034|471101302|FG000|Overall Study|Study drug not available|2|||
130856289|NCT03194646|471101305|FG000|Overall Study|Adverse Event|24|||
130856290|NCT03194646|471101306|FG001|Overall Study|Adverse Event|25|||
130856291|NCT03194646|471101307|FG002|Overall Study|Adverse Event|14|||
130856292|NCT03194646|471101308|FG003|Overall Study|Adverse Event|17|||
130856293|NCT03194646|471101305|FG000|Overall Study|Lack of Efficacy|4|||
130856294|NCT03194646|471101306|FG001|Overall Study|Lack of Efficacy|2|||
130856295|NCT03194646|471101307|FG002|Overall Study|Lack of Efficacy|2|||
130856296|NCT03194646|471101308|FG003|Overall Study|Lack of Efficacy|12|||
130856297|NCT03194646|471101305|FG000|Overall Study|Lost to Follow-up|30|||
130856298|NCT03194646|471101306|FG001|Overall Study|Lost to Follow-up|22|||
130856299|NCT03194646|471101307|FG002|Overall Study|Lost to Follow-up|12|||
130856300|NCT03194646|471101308|FG003|Overall Study|Lost to Follow-up|35|||
130856301|NCT03194646|471101305|FG000|Overall Study|Non-compliance with study drug|4|||
130856302|NCT03194646|471101306|FG001|Overall Study|Non-compliance with study drug|0|||
130856303|NCT03194646|471101307|FG002|Overall Study|Non-compliance with study drug|1|||
130856304|NCT03194646|471101308|FG003|Overall Study|Non-compliance with study drug|1|||
130856305|NCT03194646|471101305|FG000|Overall Study|Other|89|||
130856306|NCT03194646|471101306|FG001|Overall Study|Other|68|||
130856307|NCT03194646|471101307|FG002|Overall Study|Other|34|||
130856308|NCT03194646|471101308|FG003|Overall Study|Other|31|||
130856309|NCT03194646|471101305|FG000|Overall Study|Physician Decision|7|||
130856310|NCT03194646|471101306|FG001|Overall Study|Physician Decision|9|||
130856311|NCT03194646|471101307|FG002|Overall Study|Physician Decision|5|||
130856312|NCT03194646|471101308|FG003|Overall Study|Physician Decision|4|||
130856313|NCT03194646|471101305|FG000|Overall Study|Pregnancy|4|||
130856314|NCT03194646|471101306|FG001|Overall Study|Pregnancy|5|||
130856315|NCT03194646|471101307|FG002|Overall Study|Pregnancy|1|||
130856316|NCT03194646|471101308|FG003|Overall Study|Pregnancy|2|||
130856317|NCT03194646|471101305|FG000|Overall Study|Protocol Violation|4|||
130856318|NCT03194646|471101306|FG001|Overall Study|Protocol Violation|2|||
130856319|NCT03194646|471101307|FG002|Overall Study|Protocol Violation|1|||
130856320|NCT03194646|471101308|FG003|Overall Study|Protocol Violation|1|||
130856321|NCT03194646|471101305|FG000|Overall Study|Site terminated by sponsor|0|||
130856322|NCT03194646|471101306|FG001|Overall Study|Site terminated by sponsor|0|||
130856323|NCT03194646|471101307|FG002|Overall Study|Site terminated by sponsor|2|||
130856324|NCT03194646|471101308|FG003|Overall Study|Site terminated by sponsor|0|||
130856325|NCT03194646|471101305|FG000|Overall Study|Study terminated by sponsor|62|||
130856326|NCT03194646|471101306|FG001|Overall Study|Study terminated by sponsor|61|||
130856327|NCT03194646|471101307|FG002|Overall Study|Study terminated by sponsor|30|||
130856328|NCT03194646|471101308|FG003|Overall Study|Study terminated by sponsor|34|||
130856329|NCT03194646|471101305|FG000|Overall Study|Withdrawal by Subject|75|||
130856330|NCT03194646|471101306|FG001|Overall Study|Withdrawal by Subject|74|||
130856331|NCT03194646|471101307|FG002|Overall Study|Withdrawal by Subject|36|||
130856332|NCT03194646|471101308|FG003|Overall Study|Withdrawal by Subject|131|||
130856333|NCT03194646|471101305|FG000|Overall Study|Missing|1|||
130856334|NCT03194646|471101306|FG001|Overall Study|Missing|0|||
130856335|NCT03194646|471101307|FG002|Overall Study|Missing|1|||
130856336|NCT03194646|471101308|FG003|Overall Study|Missing|12|||
130856337|NCT02141360|471101310|FG000|Overall Study|Withdrawal by Subject|6|||
130856338|NCT02141360|471101311|FG001|Overall Study|Withdrawal by Subject|0|||
130856339|NCT02141360|471101312|FG002|Overall Study|Withdrawal by Subject|0|||
130856340|NCT02141360|471101310|FG000|Overall Study|Study Terminated before Visit|1|||
130856341|NCT02141360|471101311|FG001|Overall Study|Study Terminated before Visit|0|||
130856342|NCT02141360|471101312|FG002|Overall Study|Study Terminated before Visit|0|||
130856343|NCT01178099|471101313|FG000|Overall Study|Physician Decision|0|||
130856344|NCT01178099|471101314|FG001|Overall Study|Physician Decision|1|||
130856345|NCT02516592|471101317|FG000|Overall Study|Patient withdrew consent|5|||
130856346|NCT02516592|471101318|FG001|Overall Study|Patient withdrew consent|2|||
130856347|NCT02516592|471101317|FG000|Overall Study|Protocol deviation|4|||
130856348|NCT02516592|471101318|FG001|Overall Study|Protocol deviation|4|||
130856349|NCT02516592|471101317|FG000|Overall Study|Lost to Follow-up|2|||
130856350|NCT02516592|471101318|FG001|Overall Study|Lost to Follow-up|3|||
130856351|NCT02516592|471101317|FG000|Overall Study|Patient/guardian decision|2|||
130856352|NCT02516592|471101318|FG001|Overall Study|Patient/guardian decision|1|||
130856353|NCT02516592|471101317|FG000|Overall Study|Adverse Event|1|||
130856354|NCT02516592|471101318|FG001|Overall Study|Adverse Event|2|||
130856355|NCT02516592|471101317|FG000|Overall Study|Abnormal test procedure result|1|||
130856356|NCT02516592|471101318|FG001|Overall Study|Abnormal test procedure result|0|||
130856357|NCT02516592|471101317|FG000|Overall Study|Death|1|||
130856358|NCT02516592|471101318|FG001|Overall Study|Death|1|||
130856359|NCT02473367|471101319|FG000|Wait 1|Withdrawal by Subject|1|||
130856360|NCT02473367|471101319|FG000|Period 4|Lost to Follow-up|1|||
130856361|NCT01110382|471101320|FG000|Overall Study|Withdrawal by Subject|0|||
130856362|NCT01110382|471101321|FG001|Overall Study|Withdrawal by Subject|1|||
130856363|NCT01110382|471101320|FG000|Overall Study|Protocol Violation|0|||
130856364|NCT01110382|471101321|FG001|Overall Study|Protocol Violation|1|||
130856365|NCT05222555|471101322|FG000|Overall Study|Ongoing|2|||
130856366|NCT05222555|471101323|FG001|Overall Study|Ongoing|18|||
130856367|NCT05222555|471101322|FG000|Overall Study|Adverse Event|1|||
130856368|NCT05222555|471101323|FG001|Overall Study|Adverse Event|1|||
130856369|NCT05222555|471101322|FG000|Overall Study|Death|0|||
130856370|NCT05222555|471101323|FG001|Overall Study|Death|6|||
130856371|NCT05222555|471101322|FG000|Overall Study|Withdrawal by Subject|0|||
130856372|NCT05222555|471101323|FG001|Overall Study|Withdrawal by Subject|11|||
130856373|NCT01422824|471101324|FG000|Overall Study|Case record form not evaluated|1|||
130856374|NCT01422824|471101324|FG000|Overall Study|Lost to Follow-up|37|||
130856375|NCT00902174|471101325|FG000|Overall Study|Adverse Event|27|||
130856376|NCT00902174|471101326|FG001|Overall Study|Adverse Event|7|||
130856377|NCT00902174|471101325|FG000|Overall Study|Lack of Efficacy|1|||
130856378|NCT00902174|471101326|FG001|Overall Study|Lack of Efficacy|5|||
130856379|NCT00902174|471101325|FG000|Overall Study|Death|2|||
130856380|NCT00902174|471101326|FG001|Overall Study|Death|2|||
130856381|NCT00902174|471101325|FG000|Overall Study|Withdrawal by Subject|2|||
130856382|NCT00902174|471101326|FG001|Overall Study|Withdrawal by Subject|1|||
130856383|NCT00902174|471101325|FG000|Overall Study|Abnormal labs|1|||
130856384|NCT00902174|471101326|FG001|Overall Study|Abnormal labs|1|||
130856385|NCT00902174|471101325|FG000|Overall Study|Protocol Violation|1|||
130856386|NCT00902174|471101326|FG001|Overall Study|Protocol Violation|1|||
130856387|NCT00902174|471101325|FG000|Overall Study|Administration problem|0|||
130856388|NCT00902174|471101326|FG001|Overall Study|Administration problem|1|||
130856389|NCT01581619|471101327|FG000|Overall Study|Withdrawal by Subject|1|||
130856390|NCT01581619|471101327|FG000|Overall Study|Lost to Follow-up|1|||
130856391|NCT03129360|471101330|FG000|Overall Study|Did not meet entry criteria|0|||
130856392|NCT03129360|471101331|FG001|Overall Study|Did not meet entry criteria|2|||
130856393|NCT03129360|471101332|FG002|Overall Study|Did not meet entry criteria|1|||
130856394|NCT03129360|471101330|FG000|Overall Study|Excluded due to motion in scanner|1|||
130856395|NCT03129360|471101331|FG001|Overall Study|Excluded due to motion in scanner|0|||
130856396|NCT03129360|471101332|FG002|Overall Study|Excluded due to motion in scanner|0|||
130856397|NCT03006887|471101333|FG000|Overall Study|Adverse Event|1|||
130856398|NCT03836677|471101334|FG000|Period 1|Adverse Event|0|||
130856399|NCT03836677|471101335|FG001|Period 1|Adverse Event|1|||
130856400|NCT03836677|471101334|FG000|Period 2|Severe non-compliance to protocol|1|||
130856401|NCT03836677|471101335|FG001|Period 2|Severe non-compliance to protocol|0|||
130856402|NCT03233438|471101336|FG000|Overall Study|Lost to Follow-up|4|||
130856403|NCT03233438|471101337|FG001|Overall Study|Lost to Follow-up|9|||
130856404|NCT03233438|471101336|FG000|Overall Study|Withdrawal by Subject|2|||
130856405|NCT03233438|471101337|FG001|Overall Study|Withdrawal by Subject|1|||
130856406|NCT03233438|471101336|FG000|Overall Study|No recording of dalbavancin|0|||
130856407|NCT03233438|471101337|FG001|Overall Study|No recording of dalbavancin|1|||
130856408|NCT03429543|471101338|FG000|Overall Study|Adverse Event|1|||
130856409|NCT03429543|471101339|FG001|Overall Study|Adverse Event|1|||
130856410|NCT03429543|471101340|FG002|Overall Study|Adverse Event|0|||
130856411|NCT03429543|471101341|FG003|Overall Study|Adverse Event|0|||
130856412|NCT03429543|471101342|FG004|Overall Study|Adverse Event|0|||
130856413|NCT03429543|471101343|FG005|Overall Study|Adverse Event|2|||
130856414|NCT03429543|471101344|FG006|Overall Study|Adverse Event|0|||
130856415|NCT03429543|471101338|FG000|Overall Study|Lost to Follow-up|1|||
130856416|NCT03429543|471101339|FG001|Overall Study|Lost to Follow-up|0|||
130856417|NCT03429543|471101340|FG002|Overall Study|Lost to Follow-up|0|||
130856418|NCT03429543|471101341|FG003|Overall Study|Lost to Follow-up|0|||
130856419|NCT03429543|471101342|FG004|Overall Study|Lost to Follow-up|1|||
130856420|NCT03429543|471101343|FG005|Overall Study|Lost to Follow-up|0|||
130856421|NCT03429543|471101344|FG006|Overall Study|Lost to Follow-up|0|||
130856422|NCT03429543|471101338|FG000|Overall Study|Withdrawal by Subject|5|||
130856423|NCT03429543|471101339|FG001|Overall Study|Withdrawal by Subject|0|||
130856424|NCT03429543|471101340|FG002|Overall Study|Withdrawal by Subject|1|||
130856425|NCT03429543|471101341|FG003|Overall Study|Withdrawal by Subject|2|||
130856426|NCT03429543|471101342|FG004|Overall Study|Withdrawal by Subject|6|||
130856427|NCT03429543|471101343|FG005|Overall Study|Withdrawal by Subject|3|||
130856428|NCT03429543|471101344|FG006|Overall Study|Withdrawal by Subject|1|||
130856429|NCT03429543|471101338|FG000|Overall Study|Other reason than listed|0|||
130856430|NCT03429543|471101339|FG001|Overall Study|Other reason than listed|1|||
130856431|NCT03429543|471101340|FG002|Overall Study|Other reason than listed|0|||
130856432|NCT03429543|471101341|FG003|Overall Study|Other reason than listed|0|||
130856433|NCT03429543|471101342|FG004|Overall Study|Other reason than listed|4|||
130856434|NCT03429543|471101343|FG005|Overall Study|Other reason than listed|4|||
130856435|NCT03429543|471101344|FG006|Overall Study|Other reason than listed|0|||
130856436|NCT03429543|471101338|FG000|Overall Study|Not treated|0|||
130856437|NCT03429543|471101339|FG001|Overall Study|Not treated|0|||
130856438|NCT03429543|471101340|FG002|Overall Study|Not treated|0|||
130856439|NCT03429543|471101341|FG003|Overall Study|Not treated|0|||
130856440|NCT03429543|471101342|FG004|Overall Study|Not treated|1|||
130856441|NCT03429543|471101343|FG005|Overall Study|Not treated|0|||
130856442|NCT03429543|471101344|FG006|Overall Study|Not treated|0|||
130856443|NCT01818492|471101345|FG000|Overall Study|Adverse Event|2|||
130856444|NCT01818492|471101345|FG000|Overall Study|Death|3|||
130856445|NCT01818492|471101345|FG000|Overall Study|Withdrawal by Subject|1|||
130856446|NCT01818492|471101345|FG000|Overall Study|Additional therapy when not allowed PP|4|||
130856447|NCT01729208|471101346|FG000|Baseline|Physician Decision|5|||
130856448|NCT01729208|471101347|FG001|Baseline|Physician Decision|4|||
130856449|NCT01729208|471101346|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
130856450|NCT01729208|471101347|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
130856451|NCT01729208|471101346|FG000|12 Months Follow-up|Lost to Follow-up|3|||
130856452|NCT01729208|471101347|FG001|12 Months Follow-up|Lost to Follow-up|3|||
130856453|NCT01729208|471101346|FG000|24 Months Follow-up|Lost to Follow-up|3|||
130856454|NCT01729208|471101347|FG001|24 Months Follow-up|Lost to Follow-up|0|||
130856455|NCT01729208|471101346|FG000|36 Months Follow-up|Physician Decision|1|||
130856456|NCT01729208|471101347|FG001|36 Months Follow-up|Physician Decision|0|||
130856457|NCT01729208|471101346|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
130856458|NCT01729208|471101347|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
130856459|NCT02428413|471101348|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
130856460|NCT02428413|471101349|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
130856461|NCT02428413|471101348|FG000|Overall Study|Protocol Violation|1|||
130856462|NCT02428413|471101349|FG001|Overall Study|Protocol Violation|2|||
130856463|NCT02428413|471101348|FG000|Overall Study|Case Cancelled|2|||
130856464|NCT02428413|471101349|FG001|Overall Study|Case Cancelled|0|||
130856465|NCT02428413|471101348|FG000|Overall Study|Missed Cases|1|||
130856466|NCT02428413|471101349|FG001|Overall Study|Missed Cases|2|||
130856467|NCT02428413|471101348|FG000|Overall Study|Nurse Refusal|1|||
130856468|NCT02428413|471101349|FG001|Overall Study|Nurse Refusal|0|||
130856469|NCT03688100|471101355|FG000|Overall Study|Lost to Follow-up|21|||
130856470|NCT03688100|471101356|FG001|Overall Study|Lost to Follow-up|15|||
130856471|NCT03688100|471101357|FG002|Overall Study|Lost to Follow-up|15|||
130856472|NCT03688100|471101358|FG003|Overall Study|Lost to Follow-up|18|||
130856473|NCT03688100|471101355|FG000|Overall Study|Withdrawal by Subject|19|||
130856474|NCT03688100|471101356|FG001|Overall Study|Withdrawal by Subject|16|||
130856475|NCT03688100|471101357|FG002|Overall Study|Withdrawal by Subject|0|||
130856476|NCT03688100|471101358|FG003|Overall Study|Withdrawal by Subject|0|||
130856477|NCT03688100|471101355|FG000|Overall Study|Death|36|||
130856478|NCT03688100|471101356|FG001|Overall Study|Death|27|||
130856479|NCT03688100|471101357|FG002|Overall Study|Death|0|||
130856480|NCT03688100|471101358|FG003|Overall Study|Death|0|||
130856481|NCT02345330|471101359|FG000|Overall Study|Death|1|||
130856482|NCT02345330|471101359|FG000|Overall Study|Progressive Disease|2|||
130856483|NCT00494507|471101360|FG000|Double-Blind Phase|Adverse Event|2|||
130856484|NCT00494507|471101361|FG001|Double-Blind Phase|Adverse Event|0|||
130856485|NCT00494507|471101362|FG002|Double-Blind Phase|Adverse Event|1|||
130856486|NCT00494507|471101363|FG003|Double-Blind Phase|Adverse Event|0|||
130856487|NCT00494507|471101360|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
130856488|NCT00494507|471101361|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
130856489|NCT00494507|471101362|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130856490|NCT00494507|471101363|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130856491|NCT00494507|471101360|FG000|Double-Blind Phase|Subject Non-compliance|0|||
130856492|NCT00494507|471101361|FG001|Double-Blind Phase|Subject Non-compliance|0|||
130856493|NCT00494507|471101362|FG002|Double-Blind Phase|Subject Non-compliance|1|||
130856494|NCT00494507|471101363|FG003|Double-Blind Phase|Subject Non-compliance|0|||
130856495|NCT00494507|471101360|FG000|Double-Blind Phase|Negative DNA test|0|||
130856496|NCT00494507|471101361|FG001|Double-Blind Phase|Negative DNA test|0|||
130856497|NCT00494507|471101362|FG002|Double-Blind Phase|Negative DNA test|0|||
130856498|NCT00494507|471101363|FG003|Double-Blind Phase|Negative DNA test|1|||
130856499|NCT00494507|471101360|FG000|Open-Label Phase|Adverse Event|0|||
130856500|NCT00494507|471101361|FG001|Open-Label Phase|Adverse Event|1|||
130856501|NCT00494507|471101362|FG002|Open-Label Phase|Adverse Event|5|||
130856502|NCT00494507|471101363|FG003|Open-Label Phase|Adverse Event|3|||
130856503|NCT00494507|471101360|FG000|Open-Label Phase|Worsening Disease|0|||
130856504|NCT00494507|471101361|FG001|Open-Label Phase|Worsening Disease|0|||
130856505|NCT00494507|471101362|FG002|Open-Label Phase|Worsening Disease|0|||
130856506|NCT00494507|471101363|FG003|Open-Label Phase|Worsening Disease|2|||
130856507|NCT02437084|471101365|FG000|Overall Study|Withdrawal by Subject|2|||
130856508|NCT02437084|471101365|FG000|Overall Study|Physician Decision|1|||
130856509|NCT02177838|471101367|FG000|Overall Study|Withdrawal by Subject|1|||
130856510|NCT02177838|471101367|FG000|Overall Study|Physician Decision|1|||
130856511|NCT02177838|471101367|FG000|Overall Study|Death|1|||
130856512|NCT03517566|471101368|FG000|Overall Study|Adverse Event|5|||
130856513|NCT03517566|471101369|FG001|Overall Study|Adverse Event|2|||
130856514|NCT03517566|471101370|FG002|Overall Study|Adverse Event|2|||
130856515|NCT03517566|471101371|FG003|Overall Study|Adverse Event|8|||
130856516|NCT03517566|471101372|FG004|Overall Study|Adverse Event|7|||
130856517|NCT03517566|471101368|FG000|Overall Study|Lack of Efficacy|3|||
130856518|NCT03517566|471101369|FG001|Overall Study|Lack of Efficacy|2|||
130856519|NCT03517566|471101370|FG002|Overall Study|Lack of Efficacy|1|||
130856520|NCT03517566|471101371|FG003|Overall Study|Lack of Efficacy|1|||
130856521|NCT03517566|471101372|FG004|Overall Study|Lack of Efficacy|4|||
130856522|NCT03517566|471101368|FG000|Overall Study|Lost to Follow-up|3|||
130856523|NCT03517566|471101369|FG001|Overall Study|Lost to Follow-up|1|||
130856524|NCT03517566|471101370|FG002|Overall Study|Lost to Follow-up|1|||
130856525|NCT03517566|471101371|FG003|Overall Study|Lost to Follow-up|1|||
130856526|NCT03517566|471101372|FG004|Overall Study|Lost to Follow-up|0|||
130856527|NCT03517566|471101368|FG000|Overall Study|Physician Decision|1|||
130856528|NCT03517566|471101369|FG001|Overall Study|Physician Decision|1|||
130856529|NCT03517566|471101370|FG002|Overall Study|Physician Decision|0|||
130856530|NCT03517566|471101371|FG003|Overall Study|Physician Decision|1|||
130856531|NCT03517566|471101372|FG004|Overall Study|Physician Decision|0|||
130856532|NCT03517566|471101368|FG000|Overall Study|Pregnancy|0|||
130856533|NCT03517566|471101369|FG001|Overall Study|Pregnancy|1|||
130856534|NCT03517566|471101370|FG002|Overall Study|Pregnancy|0|||
130856535|NCT03517566|471101371|FG003|Overall Study|Pregnancy|0|||
130856536|NCT03517566|471101372|FG004|Overall Study|Pregnancy|0|||
130856537|NCT03517566|471101368|FG000|Overall Study|Protocol Deviation|0|||
130856538|NCT03517566|471101369|FG001|Overall Study|Protocol Deviation|1|||
130856539|NCT03517566|471101370|FG002|Overall Study|Protocol Deviation|0|||
130856540|NCT03517566|471101371|FG003|Overall Study|Protocol Deviation|1|||
130856541|NCT03517566|471101372|FG004|Overall Study|Protocol Deviation|1|||
130856542|NCT03517566|471101368|FG000|Overall Study|Study terminated by Sponsor|11|||
130856543|NCT03517566|471101369|FG001|Overall Study|Study terminated by Sponsor|5|||
130856544|NCT03517566|471101370|FG002|Overall Study|Study terminated by Sponsor|6|||
130856545|NCT03517566|471101371|FG003|Overall Study|Study terminated by Sponsor|14|||
130856546|NCT03517566|471101372|FG004|Overall Study|Study terminated by Sponsor|12|||
130856547|NCT03517566|471101368|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
130856548|NCT03517566|471101369|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
130856549|NCT03517566|471101370|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
130856550|NCT03517566|471101371|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
130856551|NCT03517566|471101372|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
130856552|NCT04566692|471101374|FG000|Overall Study|Adverse Event|2|||
130856553|NCT04566692|471101375|FG001|Overall Study|Adverse Event|0|||
130856554|NCT04566692|471101374|FG000|Overall Study|Withdrawal by Subject|1|||
130856555|NCT04566692|471101375|FG001|Overall Study|Withdrawal by Subject|1|||
130856556|NCT04311463|471101378|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
130856557|NCT04311463|471101379|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
130856558|NCT04311463|471101378|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
130856559|NCT04311463|471101379|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
130856560|NCT04311463|471101378|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
130856561|NCT04311463|471101379|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
130856562|NCT00737633|471101381|FG000|Overall Study|Study terminated by sponsor|44|||
130856563|NCT00737633|471101382|FG001|Overall Study|Study terminated by sponsor|55|||
130856564|NCT00737633|471101381|FG000|Overall Study|Lost to Follow-up|0|||
130856565|NCT00737633|471101382|FG001|Overall Study|Lost to Follow-up|1|||
130856566|NCT00737633|471101381|FG000|Overall Study|protocol non-compliance|0|||
130856567|NCT00737633|471101382|FG001|Overall Study|protocol non-compliance|1|||
130856568|NCT01300260|471101387|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
130856569|NCT01300260|471101388|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
130856570|NCT01300260|471101387|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
130856571|NCT01300260|471101388|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
130856572|NCT01300260|471101387|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
130856573|NCT01300260|471101388|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
130856574|NCT00293020|471101394|FG000|Overall Study|Withdrawal by Subject|34|||
130856575|NCT00293020|471101394|FG000|Overall Study|Adverse Event|30|||
130856576|NCT00293020|471101394|FG000|Overall Study|Death|32|||
130856577|NCT00293020|471101394|FG000|Overall Study|Lack of Efficacy|12|||
130856578|NCT00293020|471101394|FG000|Overall Study|Lost to Follow-up|4|||
130856579|NCT00293020|471101394|FG000|Overall Study|Protocol Violation|6|||
130856580|NCT00293020|471101394|FG000|Overall Study|Physician Decision|21|||
130856581|NCT00293020|471101394|FG000|Overall Study|Other Reason|22|||
130856582|NCT00293020|471101394|FG000|Overall Study|No dose taken|1|||
130856583|NCT01147848|471101395|FG000|Run-in Period|Screen Failure|623|||
130856584|NCT01147848|471101396|FG001|Run-in Period|Screen Failure|0|||
130856585|NCT01147848|471101397|FG002|Run-in Period|Screen Failure|0|||
130856586|NCT01147848|471101395|FG000|Run-in Period|Run-in Failure|135|||
130856587|NCT01147848|471101396|FG001|Run-in Period|Run-in Failure|0|||
130856588|NCT01147848|471101397|FG002|Run-in Period|Run-in Failure|0|||
130856589|NCT01147848|471101395|FG000|Randomized Phase|Adverse Event|0|||
130856590|NCT01147848|471101396|FG001|Randomized Phase|Adverse Event|6|||
130856591|NCT01147848|471101397|FG002|Randomized Phase|Adverse Event|8|||
130856592|NCT01147848|471101395|FG000|Randomized Phase|Lack of Efficacy|0|||
130856593|NCT01147848|471101396|FG001|Randomized Phase|Lack of Efficacy|20|||
130856594|NCT01147848|471101397|FG002|Randomized Phase|Lack of Efficacy|11|||
130856595|NCT01147848|471101395|FG000|Randomized Phase|Protocol Violation|0|||
130856596|NCT01147848|471101396|FG001|Randomized Phase|Protocol Violation|7|||
130856597|NCT01147848|471101397|FG002|Randomized Phase|Protocol Violation|10|||
130856598|NCT01147848|471101395|FG000|Randomized Phase|Lost to Follow-up|0|||
130856599|NCT01147848|471101396|FG001|Randomized Phase|Lost to Follow-up|5|||
130856600|NCT01147848|471101397|FG002|Randomized Phase|Lost to Follow-up|7|||
130856601|NCT01147848|471101395|FG000|Randomized Phase|Physician Decision|0|||
130856602|NCT01147848|471101396|FG001|Randomized Phase|Physician Decision|0|||
130856603|NCT01147848|471101397|FG002|Randomized Phase|Physician Decision|1|||
130856604|NCT01147848|471101395|FG000|Randomized Phase|Withdrawal by Subject|0|||
130856605|NCT01147848|471101396|FG001|Randomized Phase|Withdrawal by Subject|7|||
130856606|NCT01147848|471101397|FG002|Randomized Phase|Withdrawal by Subject|9|||
130856607|NCT03157037|471101399|FG000|Overall Study|Death|1|||
130856608|NCT02100475|471103139|FG000|Overall Study|Unclassified|1|||
130856609|NCT02100475|471103140|FG001|Overall Study|Unclassified|2|||
130856610|NCT02100475|471103139|FG000|Overall Study|Withdrawal criteria|1|||
130856611|NCT02100475|471103140|FG001|Overall Study|Withdrawal criteria|0|||
130856612|NCT00649428|471103141|FG000|Overall Study|Adverse Event|2|||
130856613|NCT00649428|471103142|FG001|Overall Study|Adverse Event|2|||
130856614|NCT00649428|471103141|FG000|Overall Study|Withdrawal by Subject|6|||
130856615|NCT00649428|471103142|FG001|Overall Study|Withdrawal by Subject|6|||
130856616|NCT00649428|471103141|FG000|Overall Study|Lost to Follow-up|1|||
130856617|NCT00649428|471103142|FG001|Overall Study|Lost to Follow-up|3|||
130856618|NCT00649428|471103141|FG000|Overall Study|Insufficient manufacturing yield|5|||
130856619|NCT00649428|471103142|FG001|Overall Study|Insufficient manufacturing yield|1|||
130856620|NCT00649428|471103141|FG000|Overall Study|Protocol Violation|6|||
130856621|NCT00649428|471103142|FG001|Overall Study|Protocol Violation|2|||
130856622|NCT00649428|471103141|FG000|Overall Study|Physician Decision|0|||
130856623|NCT00649428|471103142|FG001|Overall Study|Physician Decision|1|||
130856624|NCT04599465|471103145|FG000|Overall Study|Physician Decision|1|||
130856625|NCT04599465|471103145|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
130856626|NCT00742417|471103146|FG000|Randomized|Withdrawal by legal representative|0|||
130856627|NCT00742417|471103147|FG001|Randomized|Withdrawal by legal representative|1|||
130856628|NCT00742417|471103146|FG000|Randomized|Withdrawal by Subject|1|||
130856629|NCT00742417|471103147|FG001|Randomized|Withdrawal by Subject|0|||
130856630|NCT00742417|471103146|FG000|Randomized|Physician Decision|1|||
130856631|NCT00742417|471103147|FG001|Randomized|Physician Decision|0|||
130856632|NCT00742417|471103146|FG000|Intensive Period|Withdrawal by Subject|1|||
130856633|NCT00742417|471103147|FG001|Intensive Period|Withdrawal by Subject|1|||
130856634|NCT00742417|471103146|FG000|Intensive Period|Adverse Event|2|||
130856635|NCT00742417|471103147|FG001|Intensive Period|Adverse Event|0|||
130856636|NCT04566601|471103148|FG000|Overall Study|Other than listed|13|||
130856637|NCT04566601|471103149|FG001|Overall Study|Other than listed|4|||
130856638|NCT04566601|471103150|FG002|Overall Study|Other than listed|2|||
130856639|NCT04566601|471103151|FG003|Overall Study|Other than listed|1|||
130856640|NCT04566601|471103152|FG004|Overall Study|Other than listed|4|||
130856641|NCT04566601|471103148|FG000|Overall Study|Protocol deviation|3|||
130856642|NCT04566601|471103149|FG001|Overall Study|Protocol deviation|0|||
130856643|NCT04566601|471103150|FG002|Overall Study|Protocol deviation|1|||
130856644|NCT04566601|471103151|FG003|Overall Study|Protocol deviation|1|||
130856645|NCT04566601|471103152|FG004|Overall Study|Protocol deviation|1|||
130856646|NCT04566601|471103148|FG000|Overall Study|Technical problems|0|||
130856647|NCT04566601|471103149|FG001|Overall Study|Technical problems|0|||
130856648|NCT04566601|471103150|FG002|Overall Study|Technical problems|1|||
130856649|NCT04566601|471103151|FG003|Overall Study|Technical problems|0|||
130856650|NCT04566601|471103152|FG004|Overall Study|Technical problems|0|||
130856651|NCT04566601|471103148|FG000|Overall Study|No reason available|3|||
130856652|NCT04566601|471103149|FG001|Overall Study|No reason available|2|||
130856653|NCT04566601|471103150|FG002|Overall Study|No reason available|7|||
130856654|NCT04566601|471103151|FG003|Overall Study|No reason available|1|||
130856655|NCT04566601|471103152|FG004|Overall Study|No reason available|5|||
130856656|NCT04566601|471103148|FG000|Overall Study|Burden of study procedures|3|||
130856657|NCT04566601|471103149|FG001|Overall Study|Burden of study procedures|0|||
130856658|NCT04566601|471103150|FG002|Overall Study|Burden of study procedures|0|||
130856659|NCT04566601|471103151|FG003|Overall Study|Burden of study procedures|3|||
130856660|NCT04566601|471103152|FG004|Overall Study|Burden of study procedures|1|||
130856661|NCT04566601|471103148|FG000|Overall Study|Change of residence|2|||
130856662|NCT04566601|471103149|FG001|Overall Study|Change of residence|2|||
130856663|NCT04566601|471103150|FG002|Overall Study|Change of residence|0|||
130856664|NCT04566601|471103151|FG003|Overall Study|Change of residence|1|||
130856665|NCT04566601|471103152|FG004|Overall Study|Change of residence|2|||
130856666|NCT04566601|471103148|FG000|Overall Study|Perceived lack of efficacy|2|||
130856667|NCT04566601|471103149|FG001|Overall Study|Perceived lack of efficacy|0|||
130856668|NCT04566601|471103150|FG002|Overall Study|Perceived lack of efficacy|1|||
130856669|NCT04566601|471103151|FG003|Overall Study|Perceived lack of efficacy|1|||
130856670|NCT04566601|471103152|FG004|Overall Study|Perceived lack of efficacy|2|||
130856671|NCT04566601|471103148|FG000|Overall Study|Adverse Event|7|||
130856672|NCT04566601|471103149|FG001|Overall Study|Adverse Event|4|||
130856673|NCT04566601|471103150|FG002|Overall Study|Adverse Event|6|||
130856674|NCT04566601|471103151|FG003|Overall Study|Adverse Event|5|||
130856675|NCT04566601|471103152|FG004|Overall Study|Adverse Event|12|||
130856676|NCT01363661|471103154|FG000|Overall Study|Adverse Event|9|||
130856677|NCT01363661|471103155|FG001|Overall Study|Adverse Event|2|||
130856678|NCT01363661|471103154|FG000|Overall Study|Withdrawal by Subject|1|||
130856679|NCT01363661|471103155|FG001|Overall Study|Withdrawal by Subject|1|||
130856680|NCT01363661|471103154|FG000|Overall Study|Protocol Violation|1|||
130856681|NCT01363661|471103155|FG001|Overall Study|Protocol Violation|0|||
130856682|NCT01363661|471103154|FG000|Overall Study|Lost to Follow-up|3|||
130856683|NCT01363661|471103155|FG001|Overall Study|Lost to Follow-up|1|||
130856684|NCT01971008|471103156|FG000|Overall Study|Protocol Violation|2|||
130856685|NCT01971008|471103157|FG001|Overall Study|Protocol Violation|1|||
130856686|NCT03416127|471103158|FG000|Overall Study|Withdrawal by Subject|0|||
130856687|NCT03416127|471103159|FG001|Overall Study|Withdrawal by Subject|1|||
130856688|NCT03416127|471103160|FG002|Overall Study|Withdrawal by Subject|1|||
130856689|NCT03775512|471103161|FG000|Overall Study|Death|1|||
130856690|NCT03775512|471103162|FG001|Overall Study|Death|1|||
130856691|NCT03775512|471103161|FG000|Overall Study|Withdrawal by Subject|7|||
130856692|NCT03775512|471103162|FG001|Overall Study|Withdrawal by Subject|4|||
130856693|NCT03775512|471103161|FG000|Overall Study|Lost to Follow-up|5|||
130856694|NCT03775512|471103162|FG001|Overall Study|Lost to Follow-up|5|||
130856695|NCT03775512|471103161|FG000|Overall Study|Excluded before Catheter insertion|14|||
130856696|NCT03775512|471103162|FG001|Overall Study|Excluded before Catheter insertion|5|||
130856697|NCT03775512|471103161|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
130856698|NCT03775512|471103162|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
130856699|NCT03775512|471103161|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
130856700|NCT03775512|471103162|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
130856701|NCT01378325|471103165|FG000|Overall Study|Protocol Violation|0|||
130856702|NCT01378325|471103166|FG001|Overall Study|Protocol Violation|1|||
130856703|NCT00767806|471103169|FG000|Overall Study|Adverse Event|30|||
130856704|NCT00767806|471103170|FG001|Overall Study|Adverse Event|11|||
130856705|NCT00767806|471103169|FG000|Overall Study|Withdrawal by Subject|8|||
130856706|NCT00767806|471103170|FG001|Overall Study|Withdrawal by Subject|13|||
130856707|NCT00767806|471103169|FG000|Overall Study|Protocol Violation|6|||
130856708|NCT00767806|471103170|FG001|Overall Study|Protocol Violation|5|||
130856709|NCT00767806|471103169|FG000|Overall Study|Lack of Efficacy|1|||
130856710|NCT00767806|471103170|FG001|Overall Study|Lack of Efficacy|9|||
130856711|NCT00767806|471103169|FG000|Overall Study|Physician Decision|4|||
130856712|NCT00767806|471103170|FG001|Overall Study|Physician Decision|3|||
130856713|NCT00767806|471103169|FG000|Overall Study|Lost to Follow-up|1|||
130856714|NCT00767806|471103170|FG001|Overall Study|Lost to Follow-up|4|||
130856715|NCT00767806|471103169|FG000|Overall Study|Entry Criteria Not Met|1|||
130856716|NCT00767806|471103170|FG001|Overall Study|Entry Criteria Not Met|1|||
130856717|NCT00767806|471103169|FG000|Overall Study|Sponsor Decision|0|||
130856718|NCT00767806|471103170|FG001|Overall Study|Sponsor Decision|1|||
130856719|NCT02489942|471103171|FG000|Overall Study|Request by patient|602|||
130856720|NCT02489942|471103171|FG000|Overall Study|Improvement/remission|157|||
130856721|NCT02489942|471103171|FG000|Overall Study|No change/Progressive disease|263|||
130856722|NCT02489942|471103171|FG000|Overall Study|Adverse Event|522|||
130856723|NCT02489942|471103171|FG000|Overall Study|Other personal reasons|1218|||
130856724|NCT02489942|471103171|FG000|Overall Study|Lost to Follow-up|456|||
130856725|NCT02489942|471103171|FG000|Overall Study|Not continuously investigated|7|||
130856726|NCT02489942|471103171|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
130856727|NCT02489942|471103171|FG000|Overall Study|Multiple registration|1|||
130856728|NCT02489942|471103171|FG000|Overall Study|No patient visit after entry|100|||
130856729|NCT02489942|471103171|FG000|Overall Study|No treatment with Jardiance|2|||
130856730|NCT02489942|471103171|FG000|Overall Study|Patient received Jardiance before registration|1|||
130856731|NCT02489942|471103171|FG000|Overall Study|No CRF collected|86|||
130856732|NCT00858208|471103172|FG000|Overall Study|Adverse Event|3|||
130856733|NCT00858208|471103172|FG000|Overall Study|Lost to Follow-up|26|||
130856734|NCT00858208|471103172|FG000|Overall Study|Participant refused|40|||
130856735|NCT00858208|471103172|FG000|Overall Study|Other|10|||
130856736|NCT01272635|471103173|FG000|Overall Study|Lost to Follow-up|31|||
130856737|NCT01272635|471103174|FG001|Overall Study|Lost to Follow-up|20|||
130856738|NCT01272635|471103175|FG002|Overall Study|Lost to Follow-up|31|||
130856739|NCT01272635|471103176|FG003|Overall Study|Lost to Follow-up|23|||
130856740|NCT02702180|471103179|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130856741|NCT02702180|471103180|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
130856742|NCT02702180|471103181|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130856743|NCT02702180|471103179|FG000|Double-blind Treatment Period|Adverse Event|0|||
130856744|NCT02702180|471103180|FG001|Double-blind Treatment Period|Adverse Event|0|||
130856745|NCT02702180|471103181|FG002|Double-blind Treatment Period|Adverse Event|1|||
130856746|NCT02702180|471103179|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130856747|NCT02702180|471103180|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
130856748|NCT02702180|471103181|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
130856749|NCT02702180|471103179|FG000|Double-blind Treatment Period|Protocol Violation|0|||
130856750|NCT02702180|471103180|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130856751|NCT02702180|471103181|FG002|Double-blind Treatment Period|Protocol Violation|2|||
130856752|NCT02702180|471103179|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
130856753|NCT02702180|471103180|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
130856754|NCT02702180|471103181|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
130856755|NCT02702180|471103179|FG000|Open-label Treatment Period|Withdrawn in error|0|||
130856756|NCT02702180|471103180|FG001|Open-label Treatment Period|Withdrawn in error|0|||
130856757|NCT02702180|471103181|FG002|Open-label Treatment Period|Withdrawn in error|1|||
130856758|NCT00567359|471103182|FG000|Overall Study|Withdrawal by Subject|1|||
130856759|NCT02397057|471103183|FG000|Overall Study|Withdrawal by Subject|6|||
130856760|NCT02397057|471103184|FG001|Overall Study|Withdrawal by Subject|7|||
130856761|NCT02397057|471103183|FG000|Overall Study|Lost to Follow-up|4|||
130856762|NCT02397057|471103184|FG001|Overall Study|Lost to Follow-up|3|||
130856763|NCT02397057|471103183|FG000|Overall Study|Death|1|||
130856764|NCT02397057|471103184|FG001|Overall Study|Death|0|||
130856765|NCT02397057|471103183|FG000|Overall Study|Adverse Event|0|||
130856766|NCT02397057|471103184|FG001|Overall Study|Adverse Event|1|||
130856767|NCT02397057|471103183|FG000|Overall Study|Physician Decision|0|||
130856768|NCT02397057|471103184|FG001|Overall Study|Physician Decision|1|||
130856769|NCT02397057|471103183|FG000|Overall Study|Subject did not receive study drug|0|||
130856770|NCT02397057|471103184|FG001|Overall Study|Subject did not receive study drug|1|||
130856771|NCT01393639|471103185|FG000|Overall Study|Protocol Violation|0|||
130856772|NCT01393639|471103186|FG001|Overall Study|Protocol Violation|0|||
130856773|NCT01393639|471103187|FG002|Overall Study|Protocol Violation|0|||
130856774|NCT01393639|471103188|FG003|Overall Study|Protocol Violation|1|||
130856775|NCT01393639|471103189|FG004|Overall Study|Protocol Violation|0|||
130856776|NCT01393639|471103190|FG005|Overall Study|Protocol Violation|0|||
130856777|NCT01393639|471103191|FG006|Overall Study|Protocol Violation|0|||
130856778|NCT01393639|471103185|FG000|Overall Study|Other|0|||
130856779|NCT01393639|471103186|FG001|Overall Study|Other|2|||
130856780|NCT01393639|471103187|FG002|Overall Study|Other|0|||
130856781|NCT01393639|471103188|FG003|Overall Study|Other|2|||
130856782|NCT01393639|471103189|FG004|Overall Study|Other|1|||
130856783|NCT01393639|471103190|FG005|Overall Study|Other|0|||
130856784|NCT01393639|471103191|FG006|Overall Study|Other|1|||
130856785|NCT01393639|471103185|FG000|Overall Study|Withdrawal by Subject|1|||
130856786|NCT01393639|471103186|FG001|Overall Study|Withdrawal by Subject|1|||
130856787|NCT01393639|471103187|FG002|Overall Study|Withdrawal by Subject|0|||
130856788|NCT01393639|471103188|FG003|Overall Study|Withdrawal by Subject|0|||
130856789|NCT01393639|471103189|FG004|Overall Study|Withdrawal by Subject|0|||
130856790|NCT01393639|471103190|FG005|Overall Study|Withdrawal by Subject|0|||
130856791|NCT01393639|471103191|FG006|Overall Study|Withdrawal by Subject|1|||
130856792|NCT01393639|471103185|FG000|Overall Study|Medication error without associated AE|0|||
130856793|NCT01393639|471103186|FG001|Overall Study|Medication error without associated AE|0|||
130856794|NCT01393639|471103187|FG002|Overall Study|Medication error without associated AE|0|||
130856795|NCT01393639|471103188|FG003|Overall Study|Medication error without associated AE|0|||
130856796|NCT01393639|471103189|FG004|Overall Study|Medication error without associated AE|0|||
130856797|NCT01393639|471103190|FG005|Overall Study|Medication error without associated AE|0|||
130856798|NCT01393639|471103191|FG006|Overall Study|Medication error without associated AE|1|||
130856799|NCT01393639|471103185|FG000|Overall Study|Lost to Follow-up|0|||
130856800|NCT01393639|471103186|FG001|Overall Study|Lost to Follow-up|1|||
130856801|NCT01393639|471103187|FG002|Overall Study|Lost to Follow-up|0|||
130856802|NCT01393639|471103188|FG003|Overall Study|Lost to Follow-up|0|||
130856803|NCT01393639|471103189|FG004|Overall Study|Lost to Follow-up|0|||
130856804|NCT01393639|471103190|FG005|Overall Study|Lost to Follow-up|0|||
130856805|NCT01393639|471103191|FG006|Overall Study|Lost to Follow-up|1|||
130856806|NCT01393639|471103185|FG000|Overall Study|Lack of Efficacy|0|||
130856807|NCT01393639|471103186|FG001|Overall Study|Lack of Efficacy|0|||
130856808|NCT01393639|471103187|FG002|Overall Study|Lack of Efficacy|0|||
130856809|NCT01393639|471103188|FG003|Overall Study|Lack of Efficacy|0|||
130856810|NCT01393639|471103189|FG004|Overall Study|Lack of Efficacy|0|||
130856811|NCT01393639|471103190|FG005|Overall Study|Lack of Efficacy|0|||
130856812|NCT01393639|471103191|FG006|Overall Study|Lack of Efficacy|1|||
130856813|NCT01393639|471103185|FG000|Overall Study|Adverse Event|2|||
130856814|NCT01393639|471103186|FG001|Overall Study|Adverse Event|3|||
130856815|NCT01393639|471103187|FG002|Overall Study|Adverse Event|1|||
130856816|NCT01393639|471103188|FG003|Overall Study|Adverse Event|2|||
130856817|NCT01393639|471103189|FG004|Overall Study|Adverse Event|0|||
130856818|NCT01393639|471103190|FG005|Overall Study|Adverse Event|2|||
130856819|NCT01393639|471103191|FG006|Overall Study|Adverse Event|3|||
130856820|NCT00679172|471103192|FG000|Overall Study|Non-compliance|1|||
130856821|NCT00679172|471103193|FG001|Overall Study|Non-compliance|1|||
130856822|NCT00679172|471103194|FG002|Overall Study|Non-compliance|0|||
130856823|NCT00679172|471103195|FG003|Overall Study|Non-compliance|1|||
130856824|NCT00679172|471103196|FG004|Overall Study|Non-compliance|0|||
130856825|NCT00679172|471103192|FG000|Overall Study|Other not specified|0|||
130856826|NCT00679172|471103193|FG001|Overall Study|Other not specified|0|||
130856827|NCT00679172|471103194|FG002|Overall Study|Other not specified|1|||
130856828|NCT00679172|471103195|FG003|Overall Study|Other not specified|0|||
130856829|NCT00679172|471103196|FG004|Overall Study|Other not specified|0|||
130856830|NCT00793325|471103197|FG000|Overall Study|Protocol Violation|18|||
130856831|NCT00793325|471103197|FG000|Overall Study|Lost to Follow-up|1|||
130856832|NCT00372697|471103198|FG000|Overall Study|Protocol Violation|1|||
130856833|NCT00372697|471103199|FG001|Overall Study|Protocol Violation|1|||
130856834|NCT01815840|471103200|FG000|Overall Study|Missing|1|||
130856835|NCT01815840|471103201|FG001|Overall Study|Missing|0|||
130856836|NCT01815840|471103200|FG000|Overall Study|Withdrew Consent|31|||
130856837|NCT01815840|471103201|FG001|Overall Study|Withdrew Consent|30|||
130856838|NCT01815840|471103200|FG000|Overall Study|Administrative/Other|1|||
130856839|NCT01815840|471103201|FG001|Overall Study|Administrative/Other|3|||
130856840|NCT01815840|471103200|FG000|Overall Study|Adverse Event|10|||
130856841|NCT01815840|471103201|FG001|Overall Study|Adverse Event|16|||
130856842|NCT01815840|471103200|FG000|Overall Study|Death|2|||
130856843|NCT01815840|471103201|FG001|Overall Study|Death|2|||
130856844|NCT01815840|471103200|FG000|Overall Study|Disease progression|3|||
130856845|NCT01815840|471103201|FG001|Overall Study|Disease progression|2|||
130856846|NCT01815840|471103200|FG000|Overall Study|Investigators Decision|2|||
130856847|NCT01815840|471103201|FG001|Overall Study|Investigators Decision|3|||
130856848|NCT01815840|471103200|FG000|Overall Study|Lost to Follow-up|3|||
130856849|NCT01815840|471103201|FG001|Overall Study|Lost to Follow-up|6|||
130856850|NCT01815840|471103200|FG000|Overall Study|Refused Treatment|5|||
130856851|NCT01815840|471103201|FG001|Overall Study|Refused Treatment|1|||
130856852|NCT01815840|471103200|FG000|Overall Study|Sponsor Termination Treatment|1|||
130856853|NCT01815840|471103201|FG001|Overall Study|Sponsor Termination Treatment|0|||
130856854|NCT03221842|471103202|FG000|Period 1 (Open-label)|Adverse Event|4|||
130856855|NCT03221842|471103203|FG001|Period 1 (Open-label)|Adverse Event|0|||
130856856|NCT03221842|471103202|FG000|Period 1 (Open-label)|Physician Decision|2|||
130856857|NCT03221842|471103203|FG001|Period 1 (Open-label)|Physician Decision|0|||
130856858|NCT03221842|471103202|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
130856859|NCT03221842|471103203|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
130856860|NCT03221842|471103202|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
130856861|NCT03221842|471103203|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
130856862|NCT03221842|471103202|FG000|Period 1 (Open-label)|Other|2|||
130856863|NCT03221842|471103203|FG001|Period 1 (Open-label)|Other|0|||
130856864|NCT03221842|471103202|FG000|Period 2 (Randomized, Blinded)|Death|0|||
130856865|NCT03221842|471103203|FG001|Period 2 (Randomized, Blinded)|Death|1|||
130856866|NCT03221842|471103202|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
130856867|NCT03221842|471103203|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
130856868|NCT00704288|471103205|FG000|Overall Treatment Period|Adverse Event|11|||
130856869|NCT00704288|471103206|FG001|Overall Treatment Period|Adverse Event|8|||
130856870|NCT00704288|471103207|FG002|Overall Treatment Period|Adverse Event|22|||
130856871|NCT00704288|471103205|FG000|Overall Treatment Period|Death|0|||
130856872|NCT00704288|471103206|FG001|Overall Treatment Period|Death|0|||
130856873|NCT00704288|471103207|FG002|Overall Treatment Period|Death|1|||
130856874|NCT00704288|471103205|FG000|Overall Treatment Period|Physician Decision|0|||
130856875|NCT00704288|471103206|FG001|Overall Treatment Period|Physician Decision|2|||
130856876|NCT00704288|471103207|FG002|Overall Treatment Period|Physician Decision|0|||
130856877|NCT00704288|471103205|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
130856878|NCT00704288|471103206|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
130856879|NCT00704288|471103207|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
130856880|NCT00704288|471103205|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
130856881|NCT00704288|471103206|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
130856882|NCT00704288|471103207|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
130856883|NCT00704288|471103205|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
130856884|NCT00704288|471103206|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
130856885|NCT00704288|471103207|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
130856886|NCT00704288|471103205|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
130856887|NCT00704288|471103206|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
130856888|NCT00704288|471103207|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
130856889|NCT00704288|471103205|FG000|Overall Treatment Period|Roll-over to another study|1|||
130856890|NCT00704288|471103206|FG001|Overall Treatment Period|Roll-over to another study|0|||
130856891|NCT00704288|471103207|FG002|Overall Treatment Period|Roll-over to another study|4|||
130856892|NCT00704288|471103205|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
130856893|NCT00704288|471103206|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
130856894|NCT00704288|471103207|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
130856895|NCT00704288|471103205|FG000|Extended Post Treatment Follow Up Period|Death|41|||
130856896|NCT00704288|471103206|FG001|Extended Post Treatment Follow Up Period|Death|50|||
130856897|NCT00704288|471103207|FG002|Extended Post Treatment Follow Up Period|Death|93|||
130856898|NCT00704288|471103205|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
130856899|NCT00704288|471103206|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
130856900|NCT00704288|471103207|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
130856901|NCT00704288|471103205|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
130856902|NCT00704288|471103206|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
130856903|NCT00704288|471103207|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
130856904|NCT00704288|471103205|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
130856905|NCT00704288|471103206|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
130856906|NCT00704288|471103207|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
130856907|NCT02241343|471103210|FG000|Overall Study|Adverse Event|1|||
130856908|NCT01329939|471103213|FG000|Overall Study|Lost to Follow-up|3|||
130856909|NCT01329939|471103214|FG001|Overall Study|Lost to Follow-up|0|||
130856910|NCT01329939|471103215|FG002|Overall Study|Lost to Follow-up|1|||
130856911|NCT01329939|471103216|FG003|Overall Study|Lost to Follow-up|2|||
130856912|NCT01329939|471103213|FG000|Overall Study|Withdrawal by Subject|0|||
130856913|NCT01329939|471103214|FG001|Overall Study|Withdrawal by Subject|1|||
130856914|NCT01329939|471103215|FG002|Overall Study|Withdrawal by Subject|0|||
130856915|NCT01329939|471103216|FG003|Overall Study|Withdrawal by Subject|0|||
130856916|NCT01329939|471103213|FG000|Overall Study|Adverse Event|0|||
130856917|NCT01329939|471103214|FG001|Overall Study|Adverse Event|0|||
130856918|NCT01329939|471103215|FG002|Overall Study|Adverse Event|0|||
130856919|NCT01329939|471103216|FG003|Overall Study|Adverse Event|3|||
130856920|NCT03722524|471103217|FG000|Overall Study|Protocol Violation|86|||
130856921|NCT03722524|471103217|FG000|Overall Study|Adverse Event|7|||
130856922|NCT03722524|471103217|FG000|Overall Study|Lost to Follow-up|1|||
130856923|NCT03722524|471103217|FG000|Overall Study|Reason is not stated|1|||
130856924|NCT03722524|471103217|FG000|Overall Study|Physician Decision|1|||
130856925|NCT03722524|471103217|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
130856926|NCT02942485|471103218|FG000|Overall Study|Lost to Follow-up|1|||
130856927|NCT02942485|471103219|FG001|Overall Study|Lost to Follow-up|0|||
130856928|NCT04369950|471103221|FG000|Overall Study|Protocol Violation|2|||
130856929|NCT04369950|471103222|FG001|Overall Study|Protocol Violation|2|||
130856930|NCT00989963|471103223|FG000|Overall Study|Adverse Event|1|||
130856931|NCT00989963|471103224|FG001|Overall Study|Adverse Event|1|||
130856932|NCT00989963|471103225|FG002|Overall Study|Adverse Event|1|||
130856933|NCT01240200|471103226|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
130856934|NCT01240200|471103227|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
130856935|NCT00646399|471103230|FG000|Overall Study|Death|63|||
130856936|NCT00646399|471103231|FG001|Overall Study|Death|53|||
130856937|NCT00646399|471103230|FG000|Overall Study|Withdrawal by Subject|9|||
130856938|NCT00646399|471103231|FG001|Overall Study|Withdrawal by Subject|10|||
130856939|NCT00646399|471103230|FG000|Overall Study|Other Reason|11|||
130856940|NCT00646399|471103231|FG001|Overall Study|Other Reason|11|||
130856941|NCT00455143|471103235|FG000|Overall Study|Physician Decision|1|||
130856942|NCT00455143|471103235|FG000|Overall Study|Withdrawal by Subject|1|||
130856943|NCT00455143|471103235|FG000|Overall Study|Staff was not avail to follow patient|2|||
130856944|NCT00455143|471103235|FG000|Overall Study|No longer met Inclusion Criteria|1|||
130856945|NCT00455143|471103235|FG000|Overall Study|Surgical time, staff not available|1|||
130856946|NCT00454584|471103237|FG000|Controlled Period|Adverse Event|5|||
130856947|NCT00454584|471103238|FG001|Controlled Period|Adverse Event|2|||
130856948|NCT00454584|471103239|FG002|Controlled Period|Adverse Event|1|||
130856949|NCT00454584|471103240|FG003|Controlled Period|Adverse Event|0|||
130856950|NCT00454584|471103241|FG004|Controlled Period|Adverse Event|0|||
130856951|NCT00454584|471103242|FG005|Controlled Period|Adverse Event|0|||
130856952|NCT00454584|471103237|FG000|Controlled Period|Lost to Follow-up|1|||
130856953|NCT00454584|471103238|FG001|Controlled Period|Lost to Follow-up|2|||
130856954|NCT00454584|471103239|FG002|Controlled Period|Lost to Follow-up|2|||
130856955|NCT00454584|471103240|FG003|Controlled Period|Lost to Follow-up|0|||
130856956|NCT00454584|471103241|FG004|Controlled Period|Lost to Follow-up|0|||
130856957|NCT00454584|471103242|FG005|Controlled Period|Lost to Follow-up|0|||
130856958|NCT00454584|471103237|FG000|Controlled Period|Other|5|||
130856959|NCT00454584|471103238|FG001|Controlled Period|Other|4|||
130856960|NCT00454584|471103239|FG002|Controlled Period|Other|2|||
130856961|NCT00454584|471103240|FG003|Controlled Period|Other|0|||
130856962|NCT00454584|471103241|FG004|Controlled Period|Other|0|||
130856963|NCT00454584|471103242|FG005|Controlled Period|Other|0|||
130856964|NCT00454584|471103237|FG000|After Controlled Period|Adverse Event|0|||
130856965|NCT00454584|471103238|FG001|After Controlled Period|Adverse Event|0|||
130856966|NCT00454584|471103239|FG002|After Controlled Period|Adverse Event|0|||
130856967|NCT00454584|471103240|FG003|After Controlled Period|Adverse Event|9|||
130856968|NCT00454584|471103241|FG004|After Controlled Period|Adverse Event|3|||
130856969|NCT00454584|471103242|FG005|After Controlled Period|Adverse Event|9|||
130856970|NCT00454584|471103237|FG000|After Controlled Period|Lack of Efficacy|0|||
130856971|NCT00454584|471103238|FG001|After Controlled Period|Lack of Efficacy|0|||
130856972|NCT00454584|471103239|FG002|After Controlled Period|Lack of Efficacy|0|||
130856973|NCT00454584|471103240|FG003|After Controlled Period|Lack of Efficacy|1|||
130856974|NCT00454584|471103241|FG004|After Controlled Period|Lack of Efficacy|0|||
130856975|NCT00454584|471103242|FG005|After Controlled Period|Lack of Efficacy|0|||
130856976|NCT00454584|471103237|FG000|After Controlled Period|Lost to Follow-up|0|||
130856977|NCT00454584|471103238|FG001|After Controlled Period|Lost to Follow-up|0|||
130856978|NCT00454584|471103239|FG002|After Controlled Period|Lost to Follow-up|0|||
130856979|NCT00454584|471103240|FG003|After Controlled Period|Lost to Follow-up|2|||
130856980|NCT00454584|471103241|FG004|After Controlled Period|Lost to Follow-up|4|||
130856981|NCT00454584|471103242|FG005|After Controlled Period|Lost to Follow-up|6|||
130856982|NCT00454584|471103237|FG000|After Controlled Period|Other|0|||
130856983|NCT00454584|471103238|FG001|After Controlled Period|Other|0|||
130856984|NCT00454584|471103239|FG002|After Controlled Period|Other|0|||
130856985|NCT00454584|471103240|FG003|After Controlled Period|Other|1|||
130856986|NCT00454584|471103241|FG004|After Controlled Period|Other|0|||
130856987|NCT00454584|471103242|FG005|After Controlled Period|Other|0|||
130856988|NCT00454584|471103237|FG000|After Controlled Period|Other|0|||
130856989|NCT00454584|471103238|FG001|After Controlled Period|Other|0|||
130856990|NCT00454584|471103239|FG002|After Controlled Period|Other|0|||
130856991|NCT00454584|471103240|FG003|After Controlled Period|Other|13|||
130856992|NCT00454584|471103241|FG004|After Controlled Period|Other|5|||
130856993|NCT00454584|471103242|FG005|After Controlled Period|Other|17|||
130856994|NCT00470418|471103243|FG000|Overall Study|Withdrawal by Subject|1|||
130856995|NCT00470418|471103244|FG001|Overall Study|Withdrawal by Subject|0|||
130856996|NCT00454181|471103246|FG000|Overall Study|Adverse Event|1|||
130856997|NCT00454181|471103247|FG001|Overall Study|Adverse Event|1|||
130856998|NCT00454181|471103246|FG000|Overall Study|Lost to Follow-up|11|||
130856999|NCT00454181|471103247|FG001|Overall Study|Lost to Follow-up|1|||
130857000|NCT00454181|471103246|FG000|Overall Study|Protocol Violation|1|||
130857001|NCT00454181|471103247|FG001|Overall Study|Protocol Violation|1|||
130857002|NCT00454181|471103246|FG000|Overall Study|Withdrawal by Subject|2|||
130857003|NCT00454181|471103247|FG001|Overall Study|Withdrawal by Subject|0|||
130857004|NCT03689855|471103259|FG000|Overall Study|Adverse Event|3|||
130857005|NCT03689855|471103259|FG000|Overall Study|Withdrawal by Subject|1|||
130857006|NCT02409719|471103260|FG000|Overall Study|Lost to Follow-up|3|||
130857007|NCT02409719|471103261|FG001|Overall Study|Lost to Follow-up|3|||
130857008|NCT02479139|471103262|FG000|Overall Study|Lost to Follow-up|2|||
130857009|NCT02479139|471103263|FG001|Overall Study|Lost to Follow-up|4|||
130857010|NCT02479139|471103264|FG002|Overall Study|Lost to Follow-up|4|||
130857011|NCT02479139|471103265|FG003|Overall Study|Lost to Follow-up|2|||
130857012|NCT02479139|471103266|FG004|Overall Study|Lost to Follow-up|3|||
130857013|NCT02479139|471103267|FG005|Overall Study|Lost to Follow-up|5|||
130857014|NCT02479139|471103262|FG000|Overall Study|Withdrew Consent|5|||
130857015|NCT02479139|471103263|FG001|Overall Study|Withdrew Consent|6|||
130857016|NCT02479139|471103264|FG002|Overall Study|Withdrew Consent|1|||
130857017|NCT02479139|471103265|FG003|Overall Study|Withdrew Consent|4|||
130857018|NCT02479139|471103266|FG004|Overall Study|Withdrew Consent|1|||
130857019|NCT02479139|471103267|FG005|Overall Study|Withdrew Consent|1|||
130857020|NCT02479139|471103262|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130857021|NCT02479139|471103263|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130857022|NCT02479139|471103264|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
130857023|NCT02479139|471103265|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130857024|NCT02479139|471103266|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130857025|NCT02479139|471103267|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130857026|NCT02479139|471103262|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130857027|NCT02479139|471103263|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130857028|NCT02479139|471103264|FG002|Overall Study|Other Miscellaneous Reasons|1|||
130857029|NCT02479139|471103265|FG003|Overall Study|Other Miscellaneous Reasons|1|||
130857030|NCT02479139|471103266|FG004|Overall Study|Other Miscellaneous Reasons|1|||
130857031|NCT02479139|471103267|FG005|Overall Study|Other Miscellaneous Reasons|0|||
130857032|NCT00764673|471103268|FG000|Overall Study|Death|1|||
130857033|NCT00764673|471103268|FG000|Overall Study|Lost to Follow-up|3|||
130857034|NCT00764673|471103268|FG000|Overall Study|Withdrawal by Subject|6|||
130857035|NCT00764673|471103268|FG000|Overall Study|Revision of Device|2|||
130857036|NCT01438177|471103269|FG000|Overall Study|Withdrawal by Subject|1|||
130857037|NCT01438177|471103269|FG000|Overall Study|Initiation of new therapy|1|||
130857038|NCT01727336|471103270|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130857039|NCT01727336|471103271|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
130857040|NCT01727336|471103272|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
130857041|NCT01727336|471103273|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130857042|NCT01727336|471103274|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130857043|NCT01727336|471103275|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130857044|NCT01727336|471103270|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
130857045|NCT01727336|471103271|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
130857046|NCT01727336|471103272|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
130857047|NCT01727336|471103273|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
130857048|NCT01727336|471103274|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
130857049|NCT01727336|471103275|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
130857050|NCT01727336|471103270|FG000|Part 2 Blinded|Death|0|||
130857051|NCT01727336|471103271|FG001|Part 2 Blinded|Death|0|||
130857052|NCT01727336|471103272|FG002|Part 2 Blinded|Death|0|||
130857053|NCT01727336|471103273|FG003|Part 2 Blinded|Death|0|||
130857054|NCT01727336|471103274|FG004|Part 2 Blinded|Death|20|||
130857055|NCT01727336|471103275|FG005|Part 2 Blinded|Death|16|||
130857056|NCT01727336|471103270|FG000|Part 2 Blinded|Lack of Efficacy|0|||
130857057|NCT01727336|471103271|FG001|Part 2 Blinded|Lack of Efficacy|0|||
130857058|NCT01727336|471103272|FG002|Part 2 Blinded|Lack of Efficacy|0|||
130857059|NCT01727336|471103273|FG003|Part 2 Blinded|Lack of Efficacy|0|||
130857060|NCT01727336|471103274|FG004|Part 2 Blinded|Lack of Efficacy|42|||
130857061|NCT01727336|471103275|FG005|Part 2 Blinded|Lack of Efficacy|44|||
130857062|NCT01727336|471103270|FG000|Part 2 Blinded|Lost to Follow-up|0|||
130857063|NCT01727336|471103271|FG001|Part 2 Blinded|Lost to Follow-up|0|||
130857064|NCT01727336|471103272|FG002|Part 2 Blinded|Lost to Follow-up|0|||
130857065|NCT01727336|471103273|FG003|Part 2 Blinded|Lost to Follow-up|0|||
130857066|NCT01727336|471103274|FG004|Part 2 Blinded|Lost to Follow-up|0|||
130857067|NCT01727336|471103275|FG005|Part 2 Blinded|Lost to Follow-up|1|||
130857068|NCT01727336|471103270|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
130857069|NCT01727336|471103271|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
130857070|NCT01727336|471103272|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
130857071|NCT01727336|471103273|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
130857072|NCT01727336|471103274|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
130857073|NCT01727336|471103275|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
130857074|NCT01727336|471103270|FG000|Part 2 Blinded|use of prohibited medications|0|||
130857075|NCT01727336|471103271|FG001|Part 2 Blinded|use of prohibited medications|0|||
130857076|NCT01727336|471103272|FG002|Part 2 Blinded|use of prohibited medications|0|||
130857077|NCT01727336|471103273|FG003|Part 2 Blinded|use of prohibited medications|0|||
130857078|NCT01727336|471103274|FG004|Part 2 Blinded|use of prohibited medications|1|||
130857079|NCT01727336|471103275|FG005|Part 2 Blinded|use of prohibited medications|3|||
130857080|NCT00619099|471103278|FG000|Overall Study|Progressive Disease|7|||
130857081|NCT00619099|471103279|FG001|Overall Study|Progressive Disease|5|||
130857082|NCT00619099|471103278|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
130857083|NCT00619099|471103279|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
130857084|NCT00619099|471103278|FG000|Overall Study|Adverse Event|4|||
130857085|NCT00619099|471103279|FG001|Overall Study|Adverse Event|3|||
130857086|NCT00619099|471103278|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
130857087|NCT00619099|471103279|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
130857088|NCT00619099|471103278|FG000|Overall Study|Withdrawal by Subject|10|||
130857089|NCT00619099|471103279|FG001|Overall Study|Withdrawal by Subject|2|||
130857090|NCT00619099|471103278|FG000|Overall Study|Physician Decision|9|||
130857091|NCT00619099|471103279|FG001|Overall Study|Physician Decision|6|||
130857092|NCT00885482|471103280|FG000|Overall Study|Pregnancy|1|||
130857093|NCT00885482|471103280|FG000|Overall Study|Lack of Efficacy|1|||
130857094|NCT00885482|471103280|FG000|Overall Study|Death|1|||
130857095|NCT00885482|471103280|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
130857096|NCT00129467|471103281|FG000|Received Intervention|Death|1|||
130857097|NCT00129467|471103282|FG001|Received Intervention|Death|1|||
130857098|NCT00129467|471103281|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
130857099|NCT00129467|471103282|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
130857100|NCT00129467|471103281|FG000|Received Intervention|Delirium|2|||
130857101|NCT00129467|471103282|FG001|Received Intervention|Delirium|0|||
130857102|NCT00129467|471103281|FG000|Received Intervention|Withdrawal by Subject|1|||
130857103|NCT00129467|471103282|FG001|Received Intervention|Withdrawal by Subject|0|||
130857104|NCT00129467|471103281|FG000|Received Intervention|Nausea|1|||
130857105|NCT00129467|471103282|FG001|Received Intervention|Nausea|0|||
130857106|NCT00129467|471103281|FG000|Received Intervention|Intolerance to citalopram|0|||
130857107|NCT00129467|471103282|FG001|Received Intervention|Intolerance to citalopram|1|||
130857108|NCT00129467|471103281|FG000|Received Intervention|Dizzyness, fatigue|0|||
130857109|NCT00129467|471103282|FG001|Received Intervention|Dizzyness, fatigue|1|||
130857110|NCT00129467|471103281|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
130857111|NCT00129467|471103282|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
130857112|NCT00129467|471103281|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
130857113|NCT00129467|471103282|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
130857114|NCT01424228|471103288|FG000|Overall Study|Withdrawal by Subject|27|||
130857115|NCT01424228|471103289|FG001|Overall Study|Withdrawal by Subject|11|||
130857116|NCT01424228|471103288|FG000|Overall Study|Adverse Event|10|||
130857117|NCT01424228|471103289|FG001|Overall Study|Adverse Event|14|||
130857118|NCT01424228|471103288|FG000|Overall Study|Sponsor's decision|9|||
130857119|NCT01424228|471103289|FG001|Overall Study|Sponsor's decision|12|||
130857120|NCT01424228|471103288|FG000|Overall Study|Lack of Efficacy|5|||
130857121|NCT01424228|471103289|FG001|Overall Study|Lack of Efficacy|7|||
130857122|NCT01424228|471103288|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
130857123|NCT01424228|471103289|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
130857124|NCT01424228|471103288|FG000|Overall Study|Non-compliance|2|||
130857125|NCT01424228|471103289|FG001|Overall Study|Non-compliance|0|||
130857126|NCT01424228|471103288|FG000|Overall Study|Worsening of symptoms|1|||
130857127|NCT01424228|471103289|FG001|Overall Study|Worsening of symptoms|0|||
130857128|NCT01424228|471103288|FG000|Overall Study|Unplanned journey|0|||
130857129|NCT01424228|471103289|FG001|Overall Study|Unplanned journey|1|||
130857130|NCT00671437|471103292|FG000|Overall Study|Progressive disease before C1 week 8|8|||
130857131|NCT00671437|471103292|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
130857132|NCT00671437|471103292|FG000|Overall Study|Adverse Event|3|||
130857133|NCT00671437|471103292|FG000|Overall Study|Ineligible post-hoc|1|||
130857134|NCT03927404|471103294|FG000|Overall Study|Withdrawal by Subject|1|||
130857135|NCT01229449|471103295|FG000|Overall Study|Withdrawal by Subject|0|||
130857136|NCT01229449|471103296|FG001|Overall Study|Withdrawal by Subject|3|||
130857137|NCT01229449|471103297|FG002|Overall Study|Withdrawal by Subject|0|||
130857138|NCT01229449|471103298|FG003|Overall Study|Withdrawal by Subject|1|||
130857139|NCT01229449|471103299|FG004|Overall Study|Withdrawal by Subject|1|||
130857140|NCT01229449|471103295|FG000|Overall Study|Lost to Follow-up|1|||
130857141|NCT01229449|471103296|FG001|Overall Study|Lost to Follow-up|1|||
130857142|NCT01229449|471103297|FG002|Overall Study|Lost to Follow-up|1|||
130857143|NCT01229449|471103298|FG003|Overall Study|Lost to Follow-up|0|||
130857144|NCT01229449|471103299|FG004|Overall Study|Lost to Follow-up|0|||
130857145|NCT01229449|471103295|FG000|Overall Study|Physician Decision|0|||
130857146|NCT01229449|471103296|FG001|Overall Study|Physician Decision|0|||
130857147|NCT01229449|471103297|FG002|Overall Study|Physician Decision|1|||
130857148|NCT01229449|471103298|FG003|Overall Study|Physician Decision|0|||
130857149|NCT01229449|471103299|FG004|Overall Study|Physician Decision|0|||
130857150|NCT00377364|471103300|FG000|Overall Study|Lost to Follow-up|1|||
130857151|NCT00377364|471103301|FG001|Overall Study|Lost to Follow-up|0|||
130857152|NCT00377364|471103300|FG000|Overall Study|Withdrawal by Subject|1|||
130857153|NCT00377364|471103301|FG001|Overall Study|Withdrawal by Subject|0|||
130857154|NCT03180307|471103305|FG000|Overall Study|Lost to Follow-up|2|||
130857155|NCT03180307|471103306|FG001|Overall Study|Lost to Follow-up|0|||
130857156|NCT03180307|471103305|FG000|Overall Study|Death|1|||
130857157|NCT03180307|471103306|FG001|Overall Study|Death|0|||
130857158|NCT03180307|471103305|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
130857159|NCT03180307|471103306|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
130857160|NCT03596450|471103307|FG000|Overall Study|Death|9|||
130857161|NCT03596450|471103308|FG001|Overall Study|Death|9|||
130857162|NCT03596450|471103307|FG000|Overall Study|Protocol Violation|18|||
130857163|NCT03596450|471103308|FG001|Overall Study|Protocol Violation|26|||
130857164|NCT03596450|471103307|FG000|Overall Study|Lost to Follow-up|50|||
130857165|NCT03596450|471103308|FG001|Overall Study|Lost to Follow-up|56|||
130857166|NCT03596450|471103307|FG000|Overall Study|Adverse Event|14|||
130857167|NCT03596450|471103308|FG001|Overall Study|Adverse Event|7|||
130857168|NCT03596450|471103307|FG000|Overall Study|Withdrawal by Subject|38|||
130857169|NCT03596450|471103308|FG001|Overall Study|Withdrawal by Subject|36|||
130857170|NCT03596450|471103307|FG000|Overall Study|Accidentally Randomized|2|||
130857171|NCT03596450|471103308|FG001|Overall Study|Accidentally Randomized|0|||
130857172|NCT03596450|471103307|FG000|Overall Study|Other reasons|48|||
130857173|NCT03596450|471103308|FG001|Overall Study|Other reasons|53|||
130857174|NCT03596450|471103307|FG000|Overall Study|Pregnancy|2|||
130857175|NCT03596450|471103308|FG001|Overall Study|Pregnancy|0|||
130857176|NCT00410605|471103312|FG000|Overall Study|Adverse Event|12|||
130857177|NCT00410605|471103312|FG000|Overall Study|Physician Decision|3|||
130857178|NCT00410605|471103312|FG000|Overall Study|Withdrawal by Subject|5|||
130857179|NCT00410605|471103312|FG000|Overall Study|Started Non-Protocol Therapy|3|||
130857180|NCT00410605|471103312|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
130857181|NCT00410605|471103312|FG000|Overall Study|Transferred to another Institution|1|||
130857182|NCT05066165|471105871|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
130857183|NCT05066165|471105872|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
130857184|NCT05066165|471105871|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
130857185|NCT05066165|471105872|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
130857186|NCT03738618|471105873|FG000|Overall Study|Protocol deviation|23|||
130857187|NCT03738618|471105874|FG001|Overall Study|Protocol deviation|0|||
130857188|NCT03738618|471105873|FG000|Overall Study|Adverse Event|4|||
130857189|NCT03738618|471105874|FG001|Overall Study|Adverse Event|0|||
130857190|NCT03738618|471105873|FG000|Overall Study|Lost to Follow-up|2|||
130857191|NCT03738618|471105874|FG001|Overall Study|Lost to Follow-up|0|||
130857192|NCT03738618|471105873|FG000|Overall Study|Randomization failure|1|||
130857193|NCT03738618|471105874|FG001|Overall Study|Randomization failure|0|||
130857194|NCT03738618|471105873|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
130857195|NCT03738618|471105874|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
130857196|NCT03738618|471105873|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
130857197|NCT03738618|471105874|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
130857198|NCT01769196|471105875|FG000|Overall Study|Adverse Event|24|||
130857199|NCT01769196|471105876|FG001|Overall Study|Adverse Event|20|||
130857200|NCT01769196|471105875|FG000|Overall Study|Death|21|||
130857201|NCT01769196|471105876|FG001|Overall Study|Death|26|||
130857202|NCT01769196|471105875|FG000|Overall Study|Investigator Discretion|7|||
130857203|NCT01769196|471105876|FG001|Overall Study|Investigator Discretion|3|||
130857204|NCT01769196|471105875|FG000|Overall Study|Lack of Efficacy|3|||
130857205|NCT01769196|471105876|FG001|Overall Study|Lack of Efficacy|2|||
130857206|NCT01769196|471105875|FG000|Overall Study|Progressive disease|11|||
130857207|NCT01769196|471105876|FG001|Overall Study|Progressive disease|6|||
130857208|NCT01769196|471105875|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
130857209|NCT01769196|471105876|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
130857210|NCT01769196|471105875|FG000|Overall Study|Protocol Violation|0|||
130857211|NCT01769196|471105876|FG001|Overall Study|Protocol Violation|3|||
130857212|NCT01769196|471105875|FG000|Overall Study|Study terminated by sponsor|160|||
130857213|NCT01769196|471105876|FG001|Overall Study|Study terminated by sponsor|161|||
130857214|NCT01769196|471105875|FG000|Overall Study|Participant never dosed with study drug|1|||
130857215|NCT01769196|471105876|FG001|Overall Study|Participant never dosed with study drug|0|||
130857216|NCT01769196|471105875|FG000|Overall Study|Withdrew consent|36|||
130857217|NCT01769196|471105876|FG001|Overall Study|Withdrew consent|40|||
130857218|NCT01450098|471105883|FG000|Period 3|Protocol Violation|0|||
130857219|NCT01450098|471105884|FG001|Period 3|Protocol Violation|1|||
130857220|NCT01450098|471105883|FG000|Period 3|Withdrawal by Subject|0|||
130857221|NCT01450098|471105884|FG001|Period 3|Withdrawal by Subject|2|||
130857222|NCT00655629|471105885|FG000|Overall Study|Adverse Event|4|||
130857223|NCT00655629|471105886|FG001|Overall Study|Adverse Event|1|||
130857224|NCT00655629|471105885|FG000|Overall Study|Lack of Efficacy|2|||
130857225|NCT00655629|471105886|FG001|Overall Study|Lack of Efficacy|12|||
130857226|NCT00655629|471105885|FG000|Overall Study|Lost to Follow-up|4|||
130857227|NCT00655629|471105886|FG001|Overall Study|Lost to Follow-up|3|||
130857228|NCT00655629|471105885|FG000|Overall Study|Protocol Violation|5|||
130857229|NCT00655629|471105886|FG001|Overall Study|Protocol Violation|3|||
130857230|NCT00655629|471105885|FG000|Overall Study|consent withdrawn|6|||
130857231|NCT00655629|471105886|FG001|Overall Study|consent withdrawn|4|||
130857232|NCT00705367|471105887|FG000|Long-term Extension Period|Adverse Event|2|||
130857233|NCT00705367|471105888|FG001|Long-term Extension Period|Adverse Event|0|||
130857234|NCT00705367|471105887|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
130857235|NCT00705367|471105888|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
130857236|NCT00705367|471105887|FG000|Long-term Extension Period|Lack of Efficacy|1|||
130857237|NCT00705367|471105888|FG001|Long-term Extension Period|Lack of Efficacy|0|||
130857238|NCT00705367|471105887|FG000|Long-term Extension Period|No longer met study criteria|1|||
130857239|NCT00705367|471105888|FG001|Long-term Extension Period|No longer met study criteria|0|||
130857240|NCT00705367|471105887|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
130857241|NCT00705367|471105888|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
130857242|NCT01832155|471105889|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
130857243|NCT01832155|471105890|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
130857244|NCT01832155|471105889|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
130857245|NCT01832155|471105890|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
130857246|NCT01055314|471105891|FG000|Overall Study|Adverse Event|7|||
130857247|NCT01055314|471105892|FG001|Overall Study|Adverse Event|4|||
130857248|NCT01055314|471105891|FG000|Overall Study|Death|2|||
130857249|NCT01055314|471105892|FG001|Overall Study|Death|1|||
130857250|NCT01055314|471105891|FG000|Overall Study|Lack of Efficacy|11|||
130857251|NCT01055314|471105892|FG001|Overall Study|Lack of Efficacy|19|||
130857252|NCT01055314|471105891|FG000|Overall Study|Physician Decision|10|||
130857253|NCT01055314|471105892|FG001|Overall Study|Physician Decision|5|||
130857254|NCT01055314|471105891|FG000|Overall Study|Withdrawal by Subject|1|||
130857255|NCT01055314|471105892|FG001|Overall Study|Withdrawal by Subject|0|||
130857256|NCT01055314|471105891|FG000|Overall Study|Ineligible|3|||
130857257|NCT01055314|471105892|FG001|Overall Study|Ineligible|5|||
130857258|NCT01055314|471105891|FG000|Overall Study|Refusal of further protocol therapy|10|||
130857259|NCT01055314|471105892|FG001|Overall Study|Refusal of further protocol therapy|4|||
130857260|NCT01055314|471105891|FG000|Overall Study|No treatment|1|||
130857261|NCT01055314|471105892|FG001|Overall Study|No treatment|0|||
130857262|NCT01279616|471105893|FG000|Overall Study|donor could not be located|5|||
130857263|NCT01279616|471105893|FG000|Overall Study|no signs of sickle cell disease|2|||
130857264|NCT02462720|471105894|FG000|Part 2|Withdrawal by Subject|1|||
130857265|NCT02462720|471105895|FG001|Part 2|Withdrawal by Subject|0|||
130857266|NCT02462720|471105894|FG000|Part 2|Protocol Violation|0|||
130857267|NCT02462720|471105895|FG001|Part 2|Protocol Violation|1|||
130857268|NCT00183625|471105898|FG000|Overall Study|Withdrawal by Subject|18|||
130857269|NCT00183625|471105899|FG001|Overall Study|Withdrawal by Subject|18|||
130857270|NCT00183625|471105900|FG002|Overall Study|Withdrawal by Subject|19|||
130857271|NCT00183625|471105901|FG003|Overall Study|Withdrawal by Subject|14|||
130857272|NCT05249569|471105904|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
130857273|NCT02678923|471105905|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
130857274|NCT02678923|471105906|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
130857275|NCT02678923|471105905|FG000|Overall Study|Withdrawal by Subject|3|||
130857276|NCT02678923|471105906|FG001|Overall Study|Withdrawal by Subject|2|||
130857277|NCT02678923|471105905|FG000|Overall Study|Lost to Follow-up|1|||
130857278|NCT02678923|471105906|FG001|Overall Study|Lost to Follow-up|0|||
130857279|NCT02678923|471105905|FG000|Overall Study|Did Not Return for Study Visits|1|||
130857280|NCT02678923|471105906|FG001|Overall Study|Did Not Return for Study Visits|0|||
130857281|NCT00098306|471105909|FG000|Double Blind|Randomized, not treated|9|||
130857282|NCT00098306|471105910|FG001|Double Blind|Randomized, not treated|5|||
130857283|NCT00098306|471105911|FG002|Double Blind|Randomized, not treated|2|||
130857284|NCT00098306|471105912|FG003|Double Blind|Randomized, not treated|0|||
130857285|NCT00098306|471105913|FG004|Double Blind|Randomized, not treated|0|||
130857286|NCT00098306|471105914|FG005|Double Blind|Randomized, not treated|0|||
130857287|NCT00098306|471105915|FG006|Double Blind|Randomized, not treated|0|||
130857288|NCT00098306|471105909|FG000|Double Blind|Ongoing at cut-off date|151|||
130857289|NCT00098306|471105910|FG001|Double Blind|Ongoing at cut-off date|166|||
130857290|NCT00098306|471105911|FG002|Double Blind|Ongoing at cut-off date|72|||
130857291|NCT00098306|471105912|FG003|Double Blind|Ongoing at cut-off date|0|||
130857292|NCT00098306|471105913|FG004|Double Blind|Ongoing at cut-off date|0|||
130857293|NCT00098306|471105914|FG005|Double Blind|Ongoing at cut-off date|0|||
130857294|NCT00098306|471105915|FG006|Double Blind|Ongoing at cut-off date|0|||
130857295|NCT00098306|471105909|FG000|Double Blind|Adverse Event|11|||
130857296|NCT00098306|471105910|FG001|Double Blind|Adverse Event|10|||
130857297|NCT00098306|471105911|FG002|Double Blind|Adverse Event|6|||
130857298|NCT00098306|471105912|FG003|Double Blind|Adverse Event|0|||
130857299|NCT00098306|471105913|FG004|Double Blind|Adverse Event|0|||
130857300|NCT00098306|471105914|FG005|Double Blind|Adverse Event|0|||
130857301|NCT00098306|471105915|FG006|Double Blind|Adverse Event|0|||
130857302|NCT00098306|471105909|FG000|Double Blind|Lack of Efficacy|43|||
130857303|NCT00098306|471105910|FG001|Double Blind|Lack of Efficacy|34|||
130857304|NCT00098306|471105911|FG002|Double Blind|Lack of Efficacy|17|||
130857305|NCT00098306|471105912|FG003|Double Blind|Lack of Efficacy|0|||
130857306|NCT00098306|471105913|FG004|Double Blind|Lack of Efficacy|0|||
130857307|NCT00098306|471105914|FG005|Double Blind|Lack of Efficacy|0|||
130857308|NCT00098306|471105915|FG006|Double Blind|Lack of Efficacy|0|||
130857309|NCT00098306|471105909|FG000|Double Blind|Death|1|||
130857310|NCT00098306|471105910|FG001|Double Blind|Death|4|||
130857311|NCT00098306|471105911|FG002|Double Blind|Death|1|||
130857312|NCT00098306|471105912|FG003|Double Blind|Death|0|||
130857313|NCT00098306|471105913|FG004|Double Blind|Death|0|||
130857314|NCT00098306|471105914|FG005|Double Blind|Death|0|||
130857315|NCT00098306|471105915|FG006|Double Blind|Death|0|||
130857316|NCT00098306|471105909|FG000|Double Blind|Participant defaulted|19|||
130857317|NCT00098306|471105910|FG001|Double Blind|Participant defaulted|18|||
130857318|NCT00098306|471105911|FG002|Double Blind|Participant defaulted|11|||
130857319|NCT00098306|471105912|FG003|Double Blind|Participant defaulted|0|||
130857320|NCT00098306|471105913|FG004|Double Blind|Participant defaulted|0|||
130857321|NCT00098306|471105914|FG005|Double Blind|Participant defaulted|0|||
130857322|NCT00098306|471105915|FG006|Double Blind|Participant defaulted|0|||
130857323|NCT00098306|471105909|FG000|Double Blind|Un-specified|7|||
130857324|NCT00098306|471105910|FG001|Double Blind|Un-specified|3|||
130857325|NCT00098306|471105911|FG002|Double Blind|Un-specified|11|||
130857326|NCT00098306|471105912|FG003|Double Blind|Un-specified|0|||
130857327|NCT00098306|471105913|FG004|Double Blind|Un-specified|0|||
130857328|NCT00098306|471105914|FG005|Double Blind|Un-specified|0|||
130857329|NCT00098306|471105915|FG006|Double Blind|Un-specified|0|||
130857330|NCT00098306|471105909|FG000|Open Label|Lack of Efficacy|0|||
130857331|NCT00098306|471105910|FG001|Open Label|Lack of Efficacy|0|||
130857332|NCT00098306|471105911|FG002|Open Label|Lack of Efficacy|0|||
130857333|NCT00098306|471105912|FG003|Open Label|Lack of Efficacy|13|||
130857334|NCT00098306|471105913|FG004|Open Label|Lack of Efficacy|0|||
130857335|NCT00098306|471105914|FG005|Open Label|Lack of Efficacy|0|||
130857336|NCT00098306|471105915|FG006|Open Label|Lack of Efficacy|0|||
130857337|NCT00098306|471105909|FG000|Open Label|Adverse Event|0|||
130857338|NCT00098306|471105910|FG001|Open Label|Adverse Event|0|||
130857339|NCT00098306|471105911|FG002|Open Label|Adverse Event|0|||
130857340|NCT00098306|471105912|FG003|Open Label|Adverse Event|2|||
130857341|NCT00098306|471105913|FG004|Open Label|Adverse Event|0|||
130857342|NCT00098306|471105914|FG005|Open Label|Adverse Event|0|||
130857343|NCT00098306|471105915|FG006|Open Label|Adverse Event|0|||
130857344|NCT00098306|471105909|FG000|Open Label|Death|0|||
130857345|NCT00098306|471105910|FG001|Open Label|Death|0|||
130857346|NCT00098306|471105911|FG002|Open Label|Death|0|||
130857347|NCT00098306|471105912|FG003|Open Label|Death|4|||
130857348|NCT00098306|471105913|FG004|Open Label|Death|0|||
130857349|NCT00098306|471105914|FG005|Open Label|Death|0|||
130857350|NCT00098306|471105915|FG006|Open Label|Death|0|||
130857351|NCT00098306|471105909|FG000|Open Label|Participant defaulted|0|||
130857352|NCT00098306|471105910|FG001|Open Label|Participant defaulted|0|||
130857353|NCT00098306|471105911|FG002|Open Label|Participant defaulted|0|||
130857354|NCT00098306|471105912|FG003|Open Label|Participant defaulted|24|||
130857355|NCT00098306|471105913|FG004|Open Label|Participant defaulted|0|||
130857356|NCT00098306|471105914|FG005|Open Label|Participant defaulted|0|||
130857357|NCT00098306|471105915|FG006|Open Label|Participant defaulted|0|||
130857358|NCT00098306|471105909|FG000|Open Label|Un-specified|0|||
130857359|NCT00098306|471105910|FG001|Open Label|Un-specified|0|||
130857360|NCT00098306|471105911|FG002|Open Label|Un-specified|0|||
130857361|NCT00098306|471105912|FG003|Open Label|Un-specified|15|||
130857362|NCT00098306|471105913|FG004|Open Label|Un-specified|0|||
130857363|NCT00098306|471105914|FG005|Open Label|Un-specified|0|||
130857364|NCT00098306|471105915|FG006|Open Label|Un-specified|0|||
130857365|NCT00098306|471105909|FG000|Open Label|Ongoing at cut-off date|0|||
130857366|NCT00098306|471105910|FG001|Open Label|Ongoing at cut-off date|0|||
130857367|NCT00098306|471105911|FG002|Open Label|Ongoing at cut-off date|0|||
130857368|NCT00098306|471105912|FG003|Open Label|Ongoing at cut-off date|269|||
130857369|NCT00098306|471105913|FG004|Open Label|Ongoing at cut-off date|62|||
130857370|NCT00098306|471105914|FG005|Open Label|Ongoing at cut-off date|0|||
130857371|NCT00098306|471105915|FG006|Open Label|Ongoing at cut-off date|0|||
130857372|NCT00098306|471105909|FG000|Observational Phase|Death|0|||
130857373|NCT00098306|471105910|FG001|Observational Phase|Death|0|||
130857374|NCT00098306|471105911|FG002|Observational Phase|Death|0|||
130857375|NCT00098306|471105912|FG003|Observational Phase|Death|0|||
130857376|NCT00098306|471105913|FG004|Observational Phase|Death|0|||
130857377|NCT00098306|471105914|FG005|Observational Phase|Death|5|||
130857378|NCT00098306|471105915|FG006|Observational Phase|Death|4|||
130857379|NCT00098306|471105909|FG000|Observational Phase|Participant defaulted|0|||
130857380|NCT00098306|471105910|FG001|Observational Phase|Participant defaulted|0|||
130857381|NCT00098306|471105911|FG002|Observational Phase|Participant defaulted|0|||
130857382|NCT00098306|471105912|FG003|Observational Phase|Participant defaulted|0|||
130857383|NCT00098306|471105913|FG004|Observational Phase|Participant defaulted|0|||
130857384|NCT00098306|471105914|FG005|Observational Phase|Participant defaulted|34|||
130857385|NCT00098306|471105915|FG006|Observational Phase|Participant defaulted|18|||
130857386|NCT00098306|471105909|FG000|Observational Phase|Un-specified|0|||
130857387|NCT00098306|471105910|FG001|Observational Phase|Un-specified|0|||
130857388|NCT00098306|471105911|FG002|Observational Phase|Un-specified|0|||
130857389|NCT00098306|471105912|FG003|Observational Phase|Un-specified|0|||
130857390|NCT00098306|471105913|FG004|Observational Phase|Un-specified|0|||
130857391|NCT00098306|471105914|FG005|Observational Phase|Un-specified|7|||
130857392|NCT00098306|471105915|FG006|Observational Phase|Un-specified|4|||
130857393|NCT01423916|471105916|FG000|Overall Study|Adverse Event|5|||
130857394|NCT01423916|471105917|FG001|Overall Study|Adverse Event|9|||
130857395|NCT01423916|471105918|FG002|Overall Study|Adverse Event|2|||
130857396|NCT01423916|471105916|FG000|Overall Study|Met Withdrawal Criteria|1|||
130857397|NCT01423916|471105917|FG001|Overall Study|Met Withdrawal Criteria|1|||
130857398|NCT01423916|471105918|FG002|Overall Study|Met Withdrawal Criteria|1|||
130857399|NCT01423916|471105916|FG000|Overall Study|Physician Decision|1|||
130857400|NCT01423916|471105917|FG001|Overall Study|Physician Decision|0|||
130857401|NCT01423916|471105918|FG002|Overall Study|Physician Decision|1|||
130857402|NCT01423916|471105916|FG000|Overall Study|Withdrawal by Subject|3|||
130857403|NCT01423916|471105917|FG001|Overall Study|Withdrawal by Subject|10|||
130857404|NCT01423916|471105918|FG002|Overall Study|Withdrawal by Subject|3|||
130857405|NCT01423916|471105916|FG000|Overall Study|Protocol Deviation|1|||
130857406|NCT01423916|471105917|FG001|Overall Study|Protocol Deviation|0|||
130857407|NCT01423916|471105918|FG002|Overall Study|Protocol Deviation|0|||
130857408|NCT01966445|471105921|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130857409|NCT01966445|471105922|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130857410|NCT01966445|471105923|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130857411|NCT01966445|471105924|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
130857412|NCT01966445|471105925|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130857413|NCT01966445|471105926|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
130857414|NCT01966445|471105927|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130857415|NCT01966445|471105921|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130857416|NCT01966445|471105922|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
130857417|NCT01966445|471105923|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130857418|NCT01966445|471105924|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
130857419|NCT01966445|471105925|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
130857420|NCT01966445|471105926|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130857421|NCT01966445|471105927|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130857422|NCT01966445|471105921|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130857423|NCT01966445|471105922|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
130857424|NCT01966445|471105923|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
130857425|NCT01966445|471105924|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130857426|NCT01966445|471105925|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
130857427|NCT01966445|471105926|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130857428|NCT01966445|471105927|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130857429|NCT01966445|471105921|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130857430|NCT01966445|471105922|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130857431|NCT01966445|471105923|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130857432|NCT01966445|471105924|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130857433|NCT01966445|471105925|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130857434|NCT01966445|471105926|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130857435|NCT01966445|471105927|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
130857436|NCT01966445|471105921|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130857437|NCT01966445|471105922|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130857438|NCT01966445|471105923|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130857439|NCT01966445|471105924|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130857440|NCT01966445|471105925|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130857441|NCT01966445|471105926|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130857442|NCT01966445|471105927|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
130857443|NCT01374178|471105930|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
130857444|NCT01374178|471105931|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
130857445|NCT01374178|471105930|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
130857446|NCT01374178|471105931|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
130857447|NCT04856904|471105934|FG000|Overall Study|Physician Decision|1|||
130857448|NCT04856904|471105935|FG001|Overall Study|Physician Decision|1|||
130857449|NCT04856904|471105934|FG000|Overall Study|Withdrawal by Subject|13|||
130857450|NCT04856904|471105935|FG001|Overall Study|Withdrawal by Subject|13|||
130857451|NCT04856904|471105934|FG000|Overall Study|Adverse Event|1|||
130857452|NCT04856904|471105935|FG001|Overall Study|Adverse Event|1|||
130857453|NCT04856904|471105934|FG000|Overall Study|Non-compliance with study drug|1|||
130857454|NCT04856904|471105935|FG001|Overall Study|Non-compliance with study drug|1|||
130857455|NCT04856904|471105934|FG000|Overall Study|Lost to Follow-up|4|||
130857456|NCT04856904|471105935|FG001|Overall Study|Lost to Follow-up|4|||
130857457|NCT04856904|471105934|FG000|Overall Study|Withdrawal by Subject|1|||
130857458|NCT04856904|471105935|FG001|Overall Study|Withdrawal by Subject|1|||
130857459|NCT04856904|471105934|FG000|Overall Study|Protocol Violation|1|||
130857460|NCT04856904|471105935|FG001|Overall Study|Protocol Violation|1|||
130857461|NCT00077649|471105936|FG000|Overall Study|Adverse Event|5|||
130857462|NCT00077649|471105937|FG001|Overall Study|Adverse Event|1|||
130857463|NCT00077649|471105938|FG002|Overall Study|Adverse Event|7|||
130857464|NCT00077649|471105939|FG003|Overall Study|Adverse Event|9|||
130857465|NCT00077649|471105936|FG000|Overall Study|Lack of Efficacy|5|||
130857466|NCT00077649|471105937|FG001|Overall Study|Lack of Efficacy|3|||
130857467|NCT00077649|471105938|FG002|Overall Study|Lack of Efficacy|3|||
130857468|NCT00077649|471105939|FG003|Overall Study|Lack of Efficacy|2|||
130857469|NCT00077649|471105936|FG000|Overall Study|Withdrawal by Subject|0|||
130857470|NCT00077649|471105937|FG001|Overall Study|Withdrawal by Subject|1|||
130857471|NCT00077649|471105938|FG002|Overall Study|Withdrawal by Subject|1|||
130857472|NCT00077649|471105939|FG003|Overall Study|Withdrawal by Subject|2|||
130857473|NCT00077649|471105936|FG000|Overall Study|Lost to Follow-up|2|||
130857474|NCT00077649|471105937|FG001|Overall Study|Lost to Follow-up|2|||
130857475|NCT00077649|471105938|FG002|Overall Study|Lost to Follow-up|3|||
130857476|NCT00077649|471105939|FG003|Overall Study|Lost to Follow-up|2|||
130857477|NCT00077649|471105936|FG000|Overall Study|Abnormality of Laboratory Test|1|||
130857478|NCT00077649|471105937|FG001|Overall Study|Abnormality of Laboratory Test|2|||
130857479|NCT00077649|471105938|FG002|Overall Study|Abnormality of Laboratory Test|1|||
130857480|NCT00077649|471105939|FG003|Overall Study|Abnormality of Laboratory Test|2|||
130857481|NCT00077649|471105936|FG000|Overall Study|Randomized but never dosed|1|||
130857482|NCT00077649|471105937|FG001|Overall Study|Randomized but never dosed|0|||
130857483|NCT00077649|471105938|FG002|Overall Study|Randomized but never dosed|0|||
130857484|NCT00077649|471105939|FG003|Overall Study|Randomized but never dosed|0|||
130857485|NCT01641822|471105940|FG000|Run-in Phase|Noncompliance with study drug|1|||
130857486|NCT01641822|471105941|FG001|Run-in Phase|Noncompliance with study drug|0|||
130857487|NCT01641822|471105942|FG002|Run-in Phase|Noncompliance with study drug|0|||
130857488|NCT01641822|471105940|FG000|Run-in Phase|Adverse Event|3|||
130857489|NCT01641822|471105941|FG001|Run-in Phase|Adverse Event|0|||
130857490|NCT01641822|471105942|FG002|Run-in Phase|Adverse Event|0|||
130857491|NCT01641822|471105940|FG000|Run-in Phase|Withdrew consent|1|||
130857492|NCT01641822|471105941|FG001|Run-in Phase|Withdrew consent|0|||
130857493|NCT01641822|471105942|FG002|Run-in Phase|Withdrew consent|0|||
130857494|NCT01641822|471105940|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
130857495|NCT01641822|471105941|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
130857496|NCT01641822|471105942|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
130857497|NCT01641822|471105940|FG000|Comparative Phase|Noncompliance with study drug|0|||
130857498|NCT01641822|471105941|FG001|Comparative Phase|Noncompliance with study drug|1|||
130857499|NCT01641822|471105942|FG002|Comparative Phase|Noncompliance with study drug|0|||
130857500|NCT01641822|471105940|FG000|Comparative Phase|Investigator's discretion|0|||
130857501|NCT01641822|471105941|FG001|Comparative Phase|Investigator's discretion|0|||
130857502|NCT01641822|471105942|FG002|Comparative Phase|Investigator's discretion|1|||
130857503|NCT01641822|471105940|FG000|Comparative Phase|Pregnancy|0|||
130857504|NCT01641822|471105941|FG001|Comparative Phase|Pregnancy|0|||
130857505|NCT01641822|471105942|FG002|Comparative Phase|Pregnancy|1|||
130857506|NCT01641822|471105940|FG000|Comparative Phase|Adverse event, serious fatal|0|||
130857507|NCT01641822|471105941|FG001|Comparative Phase|Adverse event, serious fatal|1|||
130857508|NCT01641822|471105942|FG002|Comparative Phase|Adverse event, serious fatal|0|||
130857509|NCT01641822|471105940|FG000|Comparative Phase|Withdrew consent|0|||
130857510|NCT01641822|471105941|FG001|Comparative Phase|Withdrew consent|3|||
130857511|NCT01641822|471105942|FG002|Comparative Phase|Withdrew consent|7|||
130857512|NCT01641822|471105940|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
130857513|NCT01641822|471105941|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
130857514|NCT01641822|471105942|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
130857515|NCT02421601|471105943|FG000|Overall Study|Adverse Event|4|||
130857516|NCT02421601|471105943|FG000|Overall Study|Lack of Efficacy|5|||
130857517|NCT02421601|471105943|FG000|Overall Study|Physician Decision|1|||
130857518|NCT02421601|471105943|FG000|Overall Study|Withdrawal by Subject|31|||
130857519|NCT02421601|471105943|FG000|Overall Study|Others|41|||
130857520|NCT00599638|471105944|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
130857521|NCT00599638|471105945|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
130857522|NCT00599638|471105946|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
130857523|NCT00599638|471105947|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
130857524|NCT00599638|471105944|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
130857525|NCT00599638|471105945|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
130857526|NCT00599638|471105946|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
130857527|NCT00599638|471105947|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
130857528|NCT00599638|471105944|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
130857529|NCT00599638|471105945|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
130857530|NCT00599638|471105946|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
130857531|NCT00599638|471105947|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
130857532|NCT00599638|471105944|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
130857533|NCT00599638|471105945|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
130857534|NCT00599638|471105946|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
130857535|NCT00599638|471105947|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
130857536|NCT00599638|471105944|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
130857537|NCT00599638|471105945|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
130857538|NCT00599638|471105946|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
130857539|NCT00599638|471105947|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
130857540|NCT00599638|471105944|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
130857541|NCT00599638|471105945|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
130857542|NCT00599638|471105946|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
130857543|NCT00599638|471105947|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
130857544|NCT00599638|471105944|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
130857545|NCT00599638|471105945|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
130857546|NCT00599638|471105946|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
130857547|NCT00599638|471105947|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
130857548|NCT00599638|471105944|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
130857549|NCT00599638|471105945|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
130857550|NCT00599638|471105946|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
130857551|NCT00599638|471105947|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
130857552|NCT00599638|471105944|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
130857553|NCT00599638|471105945|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
130857554|NCT00599638|471105946|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
130857555|NCT00599638|471105947|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
130857556|NCT02895945|471105950|FG000|Overall Study|Physician Decision|2|||
130857557|NCT02895945|471105951|FG001|Overall Study|Physician Decision|1|||
130857558|NCT00084656|471105955|FG000|Overall Study|Other reasons|0|||
130857559|NCT00084656|471105956|FG001|Overall Study|Other reasons|12|||
130857560|NCT00084656|471105957|FG002|Overall Study|Other reasons|11|||
130857561|NCT00084656|471105955|FG000|Overall Study|Withdrawal by Subject|15|||
130857562|NCT00084656|471105956|FG001|Overall Study|Withdrawal by Subject|4|||
130857563|NCT00084656|471105957|FG002|Overall Study|Withdrawal by Subject|4|||
130857564|NCT00084656|471105955|FG000|Overall Study|Disease relapse|0|||
130857565|NCT00084656|471105956|FG001|Overall Study|Disease relapse|9|||
130857566|NCT00084656|471105957|FG002|Overall Study|Disease relapse|10|||
130857567|NCT00084656|471105955|FG000|Overall Study|Disease progression|9|||
130857568|NCT00084656|471105956|FG001|Overall Study|Disease progression|0|||
130857569|NCT00084656|471105957|FG002|Overall Study|Disease progression|0|||
130857570|NCT00084656|471105955|FG000|Overall Study|Lost to Follow-up|1|||
130857571|NCT00084656|471105956|FG001|Overall Study|Lost to Follow-up|0|||
130857572|NCT00084656|471105957|FG002|Overall Study|Lost to Follow-up|1|||
130857573|NCT02772978|471105958|FG000|Overall Study|Withdrawal by Subject|1|||
130857574|NCT02772978|471105959|FG001|Overall Study|Withdrawal by Subject|1|||
130857575|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
130857576|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
130857577|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
130857578|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
130857579|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
130857580|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
130857581|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
130857582|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
130857583|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
130857584|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
130857585|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
130857586|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
130857587|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
130857588|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
130857589|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
130857590|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
130857591|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
130857592|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
130857593|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
130857594|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
130857595|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
130857596|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
130857597|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
130857598|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
130857599|NCT01532869|471105960|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
130857600|NCT01532869|471105961|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
130857601|NCT01532869|471105960|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
130857602|NCT01532869|471105961|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
130857603|NCT01532869|471105960|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
130857604|NCT01532869|471105961|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
130857605|NCT01532869|471105960|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
130857606|NCT01532869|471105961|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
130857607|NCT01532869|471105960|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
130857608|NCT01532869|471105961|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
130857609|NCT01331291|471105962|FG000|Overall Study|Lack of Efficacy|2|||
130857610|NCT01331291|471105963|FG001|Overall Study|Lack of Efficacy|8|||
130857611|NCT01331291|471105962|FG000|Overall Study|Death|0|||
130857612|NCT01331291|471105963|FG001|Overall Study|Death|1|||
130857613|NCT01026220|471105964|FG000|Induction|Death|1|||
130857614|NCT01026220|471105965|FG001|Induction|Death|0|||
130857615|NCT01026220|471105966|FG002|Induction|Death|0|||
130857616|NCT01026220|471105964|FG000|Induction|Lack of Efficacy|2|||
130857617|NCT01026220|471105965|FG001|Induction|Lack of Efficacy|0|||
130857618|NCT01026220|471105966|FG002|Induction|Lack of Efficacy|0|||
130857619|NCT01026220|471105964|FG000|Induction|Physician Decision|12|||
130857620|NCT01026220|471105965|FG001|Induction|Physician Decision|0|||
130857621|NCT01026220|471105966|FG002|Induction|Physician Decision|0|||
130857622|NCT01026220|471105964|FG000|Induction|Withdrawal by Subject|9|||
130857623|NCT01026220|471105965|FG001|Induction|Withdrawal by Subject|0|||
130857624|NCT01026220|471105966|FG002|Induction|Withdrawal by Subject|0|||
130857625|NCT01026220|471105964|FG000|Induction|Ineligible|1|||
130857626|NCT01026220|471105965|FG001|Induction|Ineligible|0|||
130857627|NCT01026220|471105966|FG002|Induction|Ineligible|0|||
130857628|NCT01026220|471105964|FG000|Consolidation Maintenance|Death|0|||
130857629|NCT01026220|471105965|FG001|Consolidation Maintenance|Death|1|||
130857630|NCT01026220|471105966|FG002|Consolidation Maintenance|Death|0|||
130857631|NCT01026220|471105964|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
130857632|NCT01026220|471105965|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
130857633|NCT01026220|471105966|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
130857634|NCT01026220|471105964|FG000|Consolidation Maintenance|Physician Decision|0|||
130857635|NCT01026220|471105965|FG001|Consolidation Maintenance|Physician Decision|2|||
130857636|NCT01026220|471105966|FG002|Consolidation Maintenance|Physician Decision|7|||
130857637|NCT01026220|471105964|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
130857638|NCT01026220|471105965|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
130857639|NCT01026220|471105966|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
130857640|NCT00778895|471105967|FG000|Active Phase|Adverse Event|3|||
130857641|NCT00778895|471105968|FG001|Active Phase|Adverse Event|1|||
130857642|NCT00778895|471105969|FG002|Active Phase|Adverse Event|0|||
130857643|NCT00778895|471105967|FG000|Active Phase|Withdrawal by Subject|1|||
130857644|NCT00778895|471105968|FG001|Active Phase|Withdrawal by Subject|4|||
130857645|NCT00778895|471105969|FG002|Active Phase|Withdrawal by Subject|0|||
130857646|NCT00778895|471105967|FG000|Active Phase|Lost to Follow-up|1|||
130857647|NCT00778895|471105968|FG001|Active Phase|Lost to Follow-up|1|||
130857648|NCT00778895|471105969|FG002|Active Phase|Lost to Follow-up|0|||
130857649|NCT00778895|471105967|FG000|Active Phase|Other|2|||
130857650|NCT00778895|471105968|FG001|Active Phase|Other|0|||
130857651|NCT00778895|471105969|FG002|Active Phase|Other|0|||
130857652|NCT00778895|471105967|FG000|ESFU Phase|Adverse Event|2|||
130857653|NCT00778895|471105968|FG001|ESFU Phase|Adverse Event|1|||
130857654|NCT00778895|471105969|FG002|ESFU Phase|Adverse Event|0|||
130857655|NCT00778895|471105967|FG000|ESFU Phase|Withdrawal by Subject|1|||
130857656|NCT00778895|471105968|FG001|ESFU Phase|Withdrawal by Subject|4|||
130857657|NCT00778895|471105969|FG002|ESFU Phase|Withdrawal by Subject|0|||
130857658|NCT00778895|471105967|FG000|ESFU Phase|Lost to Follow-up|6|||
130857659|NCT00778895|471105968|FG001|ESFU Phase|Lost to Follow-up|7|||
130857660|NCT00778895|471105969|FG002|ESFU Phase|Lost to Follow-up|2|||
130857661|NCT00778895|471105967|FG000|ESFU Phase|Other|2|||
130857662|NCT00778895|471105968|FG001|ESFU Phase|Other|0|||
130857663|NCT00778895|471105969|FG002|ESFU Phase|Other|0|||
130857664|NCT02540993|471105971|FG000|Overall Study|Lost to Follow-up|5|||
130857665|NCT02540993|471105972|FG001|Overall Study|Lost to Follow-up|3|||
130857666|NCT02540993|471105971|FG000|Overall Study|Withdrawal by Subject|4|||
130857667|NCT02540993|471105972|FG001|Overall Study|Withdrawal by Subject|6|||
130857668|NCT02540993|471105971|FG000|Overall Study|GCP violations|33|||
130857669|NCT02540993|471105972|FG001|Overall Study|GCP violations|27|||
130857670|NCT00409344|471105973|FG000|Overall Study|no enrollment|0|||
130857671|NCT00409344|471105974|FG001|Overall Study|no enrollment|0|||
130857672|NCT03550404|471105975|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
130857673|NCT03550404|471105976|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
130857674|NCT03550404|471105977|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
130857675|NCT03550404|471105975|FG000|Phase 2|Vacated position|1|||
130857676|NCT03550404|471105976|FG001|Phase 2|Vacated position|0|||
130857677|NCT03550404|471105977|FG002|Phase 2|Vacated position|0|||
130857678|NCT01009086|471105979|FG000|Overall Study|Lack of Efficacy|16|||
130857679|NCT01009086|471105980|FG001|Overall Study|Lack of Efficacy|15|||
130857680|NCT01009086|471105981|FG002|Overall Study|Lack of Efficacy|9|||
130857681|NCT01009086|471105979|FG000|Overall Study|Lost to Follow-up|4|||
130857682|NCT01009086|471105980|FG001|Overall Study|Lost to Follow-up|5|||
130857683|NCT01009086|471105981|FG002|Overall Study|Lost to Follow-up|3|||
130857684|NCT01009086|471105979|FG000|Overall Study|Adverse Event|12|||
130857685|NCT01009086|471105980|FG001|Overall Study|Adverse Event|11|||
130857686|NCT01009086|471105981|FG002|Overall Study|Adverse Event|8|||
130857687|NCT01009086|471105979|FG000|Overall Study|Withdrawal by Subject|9|||
130857688|NCT01009086|471105980|FG001|Overall Study|Withdrawal by Subject|11|||
130857689|NCT01009086|471105981|FG002|Overall Study|Withdrawal by Subject|13|||
130857690|NCT01009086|471105979|FG000|Overall Study|Other|3|||
130857691|NCT01009086|471105980|FG001|Overall Study|Other|5|||
130857692|NCT01009086|471105981|FG002|Overall Study|Other|1|||
130857693|NCT01389323|471105982|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
130857694|NCT01389323|471105982|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
130857695|NCT01389323|471105982|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
130857696|NCT01389323|471105982|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
130857697|NCT01389323|471105982|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
130857698|NCT01389323|471105982|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
130857699|NCT01389323|471105982|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
130857700|NCT01389323|471105982|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
130857701|NCT01389323|471105982|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
130857702|NCT01389323|471105982|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
130857703|NCT01389323|471105982|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
130857704|NCT05096312|471105983|FG000|Overall Study|Lost to Follow-up|2|||
130857705|NCT05096312|471105984|FG001|Overall Study|Lost to Follow-up|4|||
130857706|NCT05096312|471105983|FG000|Overall Study|Adverse Event|1|||
130857707|NCT05096312|471105984|FG001|Overall Study|Adverse Event|0|||
130857708|NCT03135210|471105985|FG000|Overall Study|Death|0|||
130857709|NCT03135210|471105986|FG001|Overall Study|Death|1|||
130857710|NCT00590577|471105988|FG000|Overall Study|Lack of Efficacy|31|||
130857711|NCT00590577|471105989|FG001|Overall Study|Lack of Efficacy|28|||
130857712|NCT00590577|471105990|FG002|Overall Study|Lack of Efficacy|23|||
130857713|NCT00590577|471105991|FG003|Overall Study|Lack of Efficacy|45|||
130857714|NCT00590577|471105988|FG000|Overall Study|Withdrawal by Subject|23|||
130857715|NCT00590577|471105989|FG001|Overall Study|Withdrawal by Subject|28|||
130857716|NCT00590577|471105990|FG002|Overall Study|Withdrawal by Subject|30|||
130857717|NCT00590577|471105991|FG003|Overall Study|Withdrawal by Subject|26|||
130857718|NCT00590577|471105988|FG000|Overall Study|Adverse Event|10|||
130857719|NCT00590577|471105989|FG001|Overall Study|Adverse Event|10|||
130857720|NCT00590577|471105990|FG002|Overall Study|Adverse Event|13|||
130857721|NCT00590577|471105991|FG003|Overall Study|Adverse Event|11|||
130857722|NCT00590577|471105988|FG000|Overall Study|Lost to Follow-up|12|||
130857723|NCT00590577|471105989|FG001|Overall Study|Lost to Follow-up|6|||
130857724|NCT00590577|471105990|FG002|Overall Study|Lost to Follow-up|6|||
130857725|NCT00590577|471105991|FG003|Overall Study|Lost to Follow-up|9|||
130857726|NCT00590577|471105988|FG000|Overall Study|Pregnancy|0|||
130857727|NCT00590577|471105989|FG001|Overall Study|Pregnancy|1|||
130857728|NCT00590577|471105990|FG002|Overall Study|Pregnancy|0|||
130857729|NCT00590577|471105991|FG003|Overall Study|Pregnancy|0|||
130857730|NCT00590577|471105988|FG000|Overall Study|Various reasons|1|||
130857731|NCT00590577|471105989|FG001|Overall Study|Various reasons|3|||
130857732|NCT00590577|471105990|FG002|Overall Study|Various reasons|1|||
130857733|NCT00590577|471105991|FG003|Overall Study|Various reasons|2|||
130857734|NCT04349033|471105992|FG000|Overall Study|Lost to Follow-up|3|||
130857735|NCT04349033|471105993|FG001|Overall Study|Lost to Follow-up|1|||
130857736|NCT04349033|471105994|FG002|Overall Study|Lost to Follow-up|1|||
130857737|NCT04058886|471105998|FG000|Overall Study|Withdrawal by Subject|4|||
130857738|NCT04058886|471105998|FG000|Overall Study|Inadequate deafness interpreter service|1|||
130857739|NCT02332291|471105999|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
130857740|NCT02332291|471106000|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
130857741|NCT02332291|471105999|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
130857742|NCT02332291|471106000|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
130857743|NCT02332291|471105999|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
130857744|NCT02332291|471106000|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
130857745|NCT02332291|471105999|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
130857746|NCT02332291|471106000|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
130857747|NCT02332291|471105999|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
130857748|NCT02332291|471106000|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
130857749|NCT02332291|471105999|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
130857750|NCT02332291|471106000|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
130857751|NCT02220712|471106004|FG000|Overall Study|Adverse Event|1|||
130857752|NCT02220712|471106004|FG000|Overall Study|Withdrawal by Subject|2|||
130857753|NCT02220712|471106004|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
130857754|NCT00760838|471106005|FG000|Overall Study|Adverse Event|1|||
130857755|NCT00760838|471106006|FG001|Overall Study|Adverse Event|1|||
130857756|NCT00760838|471106005|FG000|Overall Study|Lack of Efficacy|1|||
130857757|NCT00760838|471106006|FG001|Overall Study|Lack of Efficacy|0|||
130857758|NCT00760838|471106005|FG000|Overall Study|Lost to Follow-up|2|||
130857759|NCT00760838|471106006|FG001|Overall Study|Lost to Follow-up|0|||
130857760|NCT00760838|471106005|FG000|Overall Study|Withdrawal by Subject|1|||
130857761|NCT00760838|471106006|FG001|Overall Study|Withdrawal by Subject|1|||
130857762|NCT03624127|471106007|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
130857763|NCT03624127|471106008|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
130857764|NCT03624127|471106009|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
130857765|NCT03624127|471106007|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
130857766|NCT03624127|471106008|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
130857767|NCT03624127|471106009|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
130857768|NCT03624127|471106007|FG000|Treatment Week 0 - Week 16|Death|0|||
130857769|NCT03624127|471106008|FG001|Treatment Week 0 - Week 16|Death|1|||
130857770|NCT03624127|471106009|FG002|Treatment Week 0 - Week 16|Death|0|||
130857771|NCT03624127|471106007|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
130857772|NCT03624127|471106008|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
130857773|NCT03624127|471106009|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
130857774|NCT03624127|471106007|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
130857775|NCT03624127|471106008|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
130857776|NCT03624127|471106009|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
130857777|NCT03624127|471106007|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
130857778|NCT03624127|471106008|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
130857779|NCT03624127|471106009|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
130857780|NCT03624127|471106007|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
130857781|NCT03624127|471106008|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
130857782|NCT03624127|471106009|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
130857783|NCT03624127|471106007|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
130857784|NCT03624127|471106008|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
130857785|NCT03624127|471106009|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
130857786|NCT03624127|471106007|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
130857787|NCT03624127|471106008|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
130857788|NCT03624127|471106009|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
130857789|NCT03624127|471106007|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
130857790|NCT03624127|471106008|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
130857791|NCT03624127|471106009|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
130857792|NCT03624127|471106007|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
130857793|NCT03624127|471106008|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
130857794|NCT03624127|471106009|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
130857795|NCT03624127|471106007|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
130857796|NCT03624127|471106008|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
130857797|NCT03624127|471106009|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
130857798|NCT03624127|471106007|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
130857799|NCT03624127|471106008|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
130857800|NCT03624127|471106009|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
130857801|NCT03624127|471106007|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
130857802|NCT03624127|471106008|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
130857803|NCT03624127|471106009|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
130857804|NCT03624127|471106007|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
130857805|NCT03624127|471106008|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
130857806|NCT03624127|471106009|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
130857807|NCT03624127|471106007|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
130857808|NCT03624127|471106008|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
130857809|NCT03624127|471106009|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
130857810|NCT03624127|471106007|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
130857811|NCT03624127|471106008|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
130857812|NCT03624127|471106009|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
130857813|NCT03624127|471106007|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
130857814|NCT03624127|471106008|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
130857815|NCT03624127|471106009|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
130857816|NCT03624127|471106007|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
130857817|NCT03624127|471106008|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
130857818|NCT03624127|471106009|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
130857819|NCT03624127|471106007|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
130857820|NCT03624127|471106008|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
130857821|NCT03624127|471106009|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
130857822|NCT03624127|471106007|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
130857823|NCT03624127|471106008|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
130857824|NCT03624127|471106009|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
130857825|NCT02607228|471106010|FG000|Overall Study|Progressive Disease|4|||
130857826|NCT02607228|471106011|FG001|Overall Study|Progressive Disease|3|||
130857827|NCT02607228|471106012|FG002|Overall Study|Progressive Disease|1|||
130857828|NCT02607228|471106013|FG003|Overall Study|Progressive Disease|5|||
130857829|NCT02607228|471106014|FG004|Overall Study|Progressive Disease|4|||
130857830|NCT02607228|471106015|FG005|Overall Study|Progressive Disease|3|||
130857831|NCT02607228|471106016|FG006|Overall Study|Progressive Disease|1|||
130857832|NCT02607228|471106010|FG000|Overall Study|Adverse Event|1|||
130857833|NCT02607228|471106011|FG001|Overall Study|Adverse Event|0|||
130857834|NCT02607228|471106012|FG002|Overall Study|Adverse Event|1|||
130857835|NCT02607228|471106013|FG003|Overall Study|Adverse Event|0|||
130857836|NCT02607228|471106014|FG004|Overall Study|Adverse Event|1|||
130857837|NCT02607228|471106015|FG005|Overall Study|Adverse Event|1|||
130857838|NCT02607228|471106016|FG006|Overall Study|Adverse Event|1|||
130857839|NCT02607228|471106010|FG000|Overall Study|Investigator's Discretion|0|||
130857840|NCT02607228|471106011|FG001|Overall Study|Investigator's Discretion|0|||
130857841|NCT02607228|471106012|FG002|Overall Study|Investigator's Discretion|1|||
130857842|NCT02607228|471106013|FG003|Overall Study|Investigator's Discretion|0|||
130857843|NCT02607228|471106014|FG004|Overall Study|Investigator's Discretion|0|||
130857844|NCT02607228|471106015|FG005|Overall Study|Investigator's Discretion|1|||
130857845|NCT02607228|471106016|FG006|Overall Study|Investigator's Discretion|0|||
130857846|NCT02607228|471106010|FG000|Overall Study|Withdrew Consent|0|||
130857847|NCT02607228|471106011|FG001|Overall Study|Withdrew Consent|1|||
130857848|NCT02607228|471106012|FG002|Overall Study|Withdrew Consent|0|||
130857849|NCT02607228|471106013|FG003|Overall Study|Withdrew Consent|0|||
130857850|NCT02607228|471106014|FG004|Overall Study|Withdrew Consent|0|||
130857851|NCT02607228|471106015|FG005|Overall Study|Withdrew Consent|1|||
130857852|NCT02607228|471106016|FG006|Overall Study|Withdrew Consent|0|||
130857853|NCT02607228|471106010|FG000|Overall Study|Study Terminated by Sponsor|0|||
130857854|NCT02607228|471106011|FG001|Overall Study|Study Terminated by Sponsor|0|||
130857855|NCT02607228|471106012|FG002|Overall Study|Study Terminated by Sponsor|0|||
130857856|NCT02607228|471106013|FG003|Overall Study|Study Terminated by Sponsor|1|||
130857857|NCT02607228|471106014|FG004|Overall Study|Study Terminated by Sponsor|0|||
130857858|NCT02607228|471106015|FG005|Overall Study|Study Terminated by Sponsor|0|||
130857859|NCT02607228|471106016|FG006|Overall Study|Study Terminated by Sponsor|0|||
130857860|NCT03576716|471106019|FG000|Overall Study|Withdrawal by Subject|0|||
130857861|NCT03576716|471106020|FG001|Overall Study|Withdrawal by Subject|1|||
130857862|NCT00559988|471106021|FG000|Overall Study|Death|147|||
130857863|NCT00559988|471106022|FG001|Overall Study|Death|140|||
130857864|NCT00559988|471106021|FG000|Overall Study|Withdrawal by Subject|152|||
130857865|NCT00559988|471106022|FG001|Overall Study|Withdrawal by Subject|139|||
130857866|NCT00559988|471106021|FG000|Overall Study|Lost to Follow-up|42|||
130857867|NCT00559988|471106022|FG001|Overall Study|Lost to Follow-up|56|||
130857868|NCT00559988|471106021|FG000|Overall Study|ICD device explanted|10|||
130857869|NCT00559988|471106022|FG001|Overall Study|ICD device explanted|17|||
130857870|NCT02249182|471106023|FG000|Treatment Phase|Lost to Follow-up|4|||
130857871|NCT02249182|471106024|FG001|Treatment Phase|Lost to Follow-up|0|||
130857872|NCT02249182|471106025|FG002|Treatment Phase|Lost to Follow-up|0|||
130857873|NCT02249182|471106026|FG003|Treatment Phase|Lost to Follow-up|0|||
130857874|NCT02249182|471106027|FG004|Treatment Phase|Lost to Follow-up|0|||
130857875|NCT01455194|471106028|FG000|Overall Study|Screen Failure|20|||
130857876|NCT01455194|471106029|FG001|Overall Study|Screen Failure|0|||
130857877|NCT01455194|471106030|FG002|Overall Study|Screen Failure|0|||
130857878|NCT01455194|471106031|FG003|Overall Study|Screen Failure|0|||
130857879|NCT01455194|471106028|FG000|Overall Study|Randomisation Failure|90|||
130857880|NCT01455194|471106029|FG001|Overall Study|Randomisation Failure|0|||
130857881|NCT01455194|471106030|FG002|Overall Study|Randomisation Failure|0|||
130857882|NCT01455194|471106031|FG003|Overall Study|Randomisation Failure|0|||
130857883|NCT01455194|471106028|FG000|Overall Study|Deterioration in asthma|12|||
130857884|NCT01455194|471106029|FG001|Overall Study|Deterioration in asthma|6|||
130857885|NCT01455194|471106030|FG002|Overall Study|Deterioration in asthma|14|||
130857886|NCT01455194|471106031|FG003|Overall Study|Deterioration in asthma|9|||
130857887|NCT01455194|471106028|FG000|Overall Study|Adverse Event|1|||
130857888|NCT01455194|471106029|FG001|Overall Study|Adverse Event|1|||
130857889|NCT01455194|471106030|FG002|Overall Study|Adverse Event|1|||
130857890|NCT01455194|471106031|FG003|Overall Study|Adverse Event|3|||
130857891|NCT01455194|471106028|FG000|Overall Study|Withdrawal by Subject|21|||
130857892|NCT01455194|471106029|FG001|Overall Study|Withdrawal by Subject|16|||
130857893|NCT01455194|471106030|FG002|Overall Study|Withdrawal by Subject|12|||
130857894|NCT01455194|471106031|FG003|Overall Study|Withdrawal by Subject|9|||
130857895|NCT01455194|471106028|FG000|Overall Study|Lost to Follow-up|2|||
130857896|NCT01455194|471106029|FG001|Overall Study|Lost to Follow-up|0|||
130857897|NCT01455194|471106030|FG002|Overall Study|Lost to Follow-up|1|||
130857898|NCT01455194|471106031|FG003|Overall Study|Lost to Follow-up|1|||
130857899|NCT01455194|471106028|FG000|Overall Study|Pregnancy|0|||
130857900|NCT01455194|471106029|FG001|Overall Study|Pregnancy|1|||
130857901|NCT01455194|471106030|FG002|Overall Study|Pregnancy|1|||
130857902|NCT01455194|471106031|FG003|Overall Study|Pregnancy|0|||
130857903|NCT01455194|471106028|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
130857904|NCT01455194|471106029|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
130857905|NCT01455194|471106030|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
130857906|NCT01455194|471106031|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
130857907|NCT01455194|471106028|FG000|Overall Study|Miscellaneous|4|||
130857908|NCT01455194|471106029|FG001|Overall Study|Miscellaneous|5|||
130857909|NCT01455194|471106030|FG002|Overall Study|Miscellaneous|1|||
130857910|NCT01455194|471106031|FG003|Overall Study|Miscellaneous|4|||
130857911|NCT04356040|471106034|FG000|Overall Study|Death|2|||
130857912|NCT04356040|471106035|FG001|Overall Study|Death|0|||
130857913|NCT04356040|471106034|FG000|Overall Study|Lost to Follow-up|1|||
130857914|NCT04356040|471106035|FG001|Overall Study|Lost to Follow-up|0|||
130857915|NCT04356040|471106034|FG000|Overall Study|Physician Decision|0|||
130857916|NCT04356040|471106035|FG001|Overall Study|Physician Decision|1|||
130857917|NCT04356040|471106034|FG000|Overall Study|Withdrawal by Subject|13|||
130857918|NCT04356040|471106035|FG001|Overall Study|Withdrawal by Subject|1|||
130857919|NCT04356040|471106034|FG000|Overall Study|Enrollment Pause|10|||
130857920|NCT04356040|471106035|FG001|Overall Study|Enrollment Pause|0|||
130857921|NCT04356040|471106034|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
130857922|NCT04356040|471106035|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
130857923|NCT04356040|471106034|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
130857924|NCT04356040|471106035|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
130857925|NCT04356040|471106034|FG000|Overall Study|PI left institution|3|||
130857926|NCT04356040|471106035|FG001|Overall Study|PI left institution|0|||
130857927|NCT00788710|471106036|FG000|Overall Study|Adverse Event|1|||
130857928|NCT00788710|471106037|FG001|Overall Study|Adverse Event|3|||
130857929|NCT00788710|471106038|FG002|Overall Study|Adverse Event|4|||
130857930|NCT00788710|471106036|FG000|Overall Study|Lack of Efficacy|0|||
130857931|NCT00788710|471106037|FG001|Overall Study|Lack of Efficacy|0|||
130857932|NCT00788710|471106038|FG002|Overall Study|Lack of Efficacy|1|||
130857933|NCT00788710|471106036|FG000|Overall Study|Lost to Follow-up|0|||
130857934|NCT00788710|471106037|FG001|Overall Study|Lost to Follow-up|1|||
130857935|NCT00788710|471106038|FG002|Overall Study|Lost to Follow-up|0|||
130857936|NCT00788710|471106036|FG000|Overall Study|Physician Decision|2|||
130857937|NCT00788710|471106037|FG001|Overall Study|Physician Decision|1|||
130857938|NCT00788710|471106038|FG002|Overall Study|Physician Decision|0|||
130857939|NCT00788710|471106036|FG000|Overall Study|Protocol Violation|0|||
130857940|NCT00788710|471106037|FG001|Overall Study|Protocol Violation|1|||
130857941|NCT00788710|471106038|FG002|Overall Study|Protocol Violation|1|||
130857942|NCT00788710|471106036|FG000|Overall Study|Withdrawal by Subject|2|||
130857943|NCT00788710|471106037|FG001|Overall Study|Withdrawal by Subject|2|||
130857944|NCT00788710|471106038|FG002|Overall Study|Withdrawal by Subject|0|||
130857945|NCT01990859|471106039|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
130857946|NCT01990859|471106039|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
130857947|NCT01717326|471106040|FG000|Overall Study|Death|0|||
130857948|NCT01717326|471106041|FG001|Overall Study|Death|0|||
130857949|NCT01717326|471106042|FG002|Overall Study|Death|0|||
130857950|NCT01717326|471106043|FG003|Overall Study|Death|0|||
130857951|NCT01717326|471106044|FG004|Overall Study|Death|0|||
130857952|NCT01717326|471106045|FG005|Overall Study|Death|0|||
130857953|NCT01717326|471106046|FG006|Overall Study|Death|0|||
130857954|NCT01717326|471106047|FG007|Overall Study|Death|0|||
130857955|NCT01717326|471106048|FG008|Overall Study|Death|0|||
130857956|NCT01717326|471106049|FG009|Overall Study|Death|0|||
130857957|NCT01717326|471106050|FG010|Overall Study|Death|1|||
130857958|NCT01717326|471106051|FG011|Overall Study|Death|0|||
130857959|NCT01717326|471106052|FG012|Overall Study|Death|0|||
130857960|NCT01717326|471106053|FG013|Overall Study|Death|0|||
130857961|NCT01717326|471106054|FG014|Overall Study|Death|0|||
130857962|NCT01717326|471106055|FG015|Overall Study|Death|0|||
130857963|NCT01717326|471106056|FG016|Overall Study|Death|0|||
130857964|NCT01717326|471106057|FG017|Overall Study|Death|0|||
130857965|NCT01717326|471106058|FG018|Overall Study|Death|0|||
130857966|NCT01717326|471106059|FG019|Overall Study|Death|0|||
130857967|NCT01717326|471106040|FG000|Overall Study|Lost to Follow-up|3|||
130857968|NCT01717326|471106041|FG001|Overall Study|Lost to Follow-up|0|||
130857969|NCT01717326|471106042|FG002|Overall Study|Lost to Follow-up|0|||
130857970|NCT01717326|471106043|FG003|Overall Study|Lost to Follow-up|2|||
130857971|NCT01717326|471106044|FG004|Overall Study|Lost to Follow-up|1|||
130857972|NCT01717326|471106045|FG005|Overall Study|Lost to Follow-up|0|||
130857973|NCT01717326|471106046|FG006|Overall Study|Lost to Follow-up|1|||
130857974|NCT01717326|471106047|FG007|Overall Study|Lost to Follow-up|0|||
130857975|NCT01717326|471106048|FG008|Overall Study|Lost to Follow-up|0|||
130857976|NCT01717326|471106049|FG009|Overall Study|Lost to Follow-up|0|||
130857977|NCT01717326|471106050|FG010|Overall Study|Lost to Follow-up|1|||
130857978|NCT01717326|471106051|FG011|Overall Study|Lost to Follow-up|0|||
130857979|NCT01717326|471106052|FG012|Overall Study|Lost to Follow-up|0|||
130857980|NCT01717326|471106053|FG013|Overall Study|Lost to Follow-up|0|||
130857981|NCT01717326|471106054|FG014|Overall Study|Lost to Follow-up|0|||
130857982|NCT01717326|471106055|FG015|Overall Study|Lost to Follow-up|2|||
130857983|NCT01717326|471106056|FG016|Overall Study|Lost to Follow-up|1|||
130857984|NCT01717326|471106057|FG017|Overall Study|Lost to Follow-up|0|||
130857985|NCT01717326|471106058|FG018|Overall Study|Lost to Follow-up|2|||
130857986|NCT01717326|471106059|FG019|Overall Study|Lost to Follow-up|3|||
130857987|NCT01717326|471106040|FG000|Overall Study|Physician Decision|0|||
130857988|NCT01717326|471106041|FG001|Overall Study|Physician Decision|0|||
130857989|NCT01717326|471106042|FG002|Overall Study|Physician Decision|0|||
130857990|NCT01717326|471106043|FG003|Overall Study|Physician Decision|0|||
130857991|NCT01717326|471106044|FG004|Overall Study|Physician Decision|0|||
130857992|NCT01717326|471106045|FG005|Overall Study|Physician Decision|0|||
130857993|NCT01717326|471106046|FG006|Overall Study|Physician Decision|0|||
130857994|NCT01717326|471106047|FG007|Overall Study|Physician Decision|0|||
130857995|NCT01717326|471106048|FG008|Overall Study|Physician Decision|0|||
130857996|NCT01717326|471106049|FG009|Overall Study|Physician Decision|1|||
130857997|NCT01717326|471106050|FG010|Overall Study|Physician Decision|0|||
130857998|NCT01717326|471106051|FG011|Overall Study|Physician Decision|0|||
130857999|NCT01717326|471106052|FG012|Overall Study|Physician Decision|0|||
130858000|NCT01717326|471106053|FG013|Overall Study|Physician Decision|0|||
130858001|NCT01717326|471106054|FG014|Overall Study|Physician Decision|0|||
130858002|NCT01717326|471106055|FG015|Overall Study|Physician Decision|0|||
130858003|NCT01717326|471106056|FG016|Overall Study|Physician Decision|0|||
130858004|NCT01717326|471106057|FG017|Overall Study|Physician Decision|0|||
130858005|NCT01717326|471106058|FG018|Overall Study|Physician Decision|0|||
130858006|NCT01717326|471106059|FG019|Overall Study|Physician Decision|0|||
130858007|NCT01717326|471106040|FG000|Overall Study|Protocol Violation|0|||
130858008|NCT01717326|471106041|FG001|Overall Study|Protocol Violation|0|||
130858009|NCT01717326|471106042|FG002|Overall Study|Protocol Violation|0|||
130858010|NCT01717326|471106043|FG003|Overall Study|Protocol Violation|0|||
130858011|NCT01717326|471106044|FG004|Overall Study|Protocol Violation|1|||
130858012|NCT01717326|471106045|FG005|Overall Study|Protocol Violation|0|||
130858013|NCT01717326|471106046|FG006|Overall Study|Protocol Violation|0|||
130858014|NCT01717326|471106047|FG007|Overall Study|Protocol Violation|0|||
130858015|NCT01717326|471106048|FG008|Overall Study|Protocol Violation|0|||
130858016|NCT01717326|471106049|FG009|Overall Study|Protocol Violation|0|||
130858017|NCT01717326|471106050|FG010|Overall Study|Protocol Violation|0|||
130858018|NCT01717326|471106051|FG011|Overall Study|Protocol Violation|0|||
130858019|NCT01717326|471106052|FG012|Overall Study|Protocol Violation|0|||
130858020|NCT01717326|471106053|FG013|Overall Study|Protocol Violation|0|||
130858021|NCT01717326|471106054|FG014|Overall Study|Protocol Violation|0|||
130858022|NCT01717326|471106055|FG015|Overall Study|Protocol Violation|0|||
130858023|NCT01717326|471106056|FG016|Overall Study|Protocol Violation|0|||
130858024|NCT01717326|471106057|FG017|Overall Study|Protocol Violation|0|||
130858025|NCT01717326|471106058|FG018|Overall Study|Protocol Violation|0|||
130858026|NCT01717326|471106059|FG019|Overall Study|Protocol Violation|0|||
130858027|NCT01717326|471106040|FG000|Overall Study|Withdrawal by Subject|0|||
130858028|NCT01717326|471106041|FG001|Overall Study|Withdrawal by Subject|1|||
130858029|NCT01717326|471106042|FG002|Overall Study|Withdrawal by Subject|0|||
130858030|NCT01717326|471106043|FG003|Overall Study|Withdrawal by Subject|0|||
130858031|NCT01717326|471106044|FG004|Overall Study|Withdrawal by Subject|0|||
130858032|NCT01717326|471106045|FG005|Overall Study|Withdrawal by Subject|0|||
130858033|NCT01717326|471106046|FG006|Overall Study|Withdrawal by Subject|0|||
130858034|NCT01717326|471106047|FG007|Overall Study|Withdrawal by Subject|0|||
130858035|NCT01717326|471106048|FG008|Overall Study|Withdrawal by Subject|0|||
130858036|NCT01717326|471106049|FG009|Overall Study|Withdrawal by Subject|1|||
130858037|NCT01717326|471106050|FG010|Overall Study|Withdrawal by Subject|0|||
130858038|NCT01717326|471106051|FG011|Overall Study|Withdrawal by Subject|0|||
130858039|NCT01717326|471106052|FG012|Overall Study|Withdrawal by Subject|1|||
130858040|NCT01717326|471106053|FG013|Overall Study|Withdrawal by Subject|0|||
130858041|NCT01717326|471106054|FG014|Overall Study|Withdrawal by Subject|0|||
130858042|NCT01717326|471106055|FG015|Overall Study|Withdrawal by Subject|1|||
130858043|NCT01717326|471106056|FG016|Overall Study|Withdrawal by Subject|0|||
130858044|NCT01717326|471106057|FG017|Overall Study|Withdrawal by Subject|0|||
130858045|NCT01717326|471106058|FG018|Overall Study|Withdrawal by Subject|2|||
130858046|NCT01717326|471106059|FG019|Overall Study|Withdrawal by Subject|3|||
130858047|NCT02262754|471106061|FG000|Overall Study|Adverse Event|3|||
130858048|NCT02262754|471106062|FG001|Overall Study|Adverse Event|4|||
130858049|NCT02262754|471106063|FG002|Overall Study|Adverse Event|0|||
130858050|NCT02262754|471106061|FG000|Overall Study|Lack of Efficacy|2|||
130858051|NCT02262754|471106062|FG001|Overall Study|Lack of Efficacy|0|||
130858052|NCT02262754|471106063|FG002|Overall Study|Lack of Efficacy|1|||
130858053|NCT02262754|471106061|FG000|Overall Study|Lost to Follow-up|0|||
130858054|NCT02262754|471106062|FG001|Overall Study|Lost to Follow-up|0|||
130858055|NCT02262754|471106063|FG002|Overall Study|Lost to Follow-up|1|||
130858056|NCT02262754|471106061|FG000|Overall Study|No longer meets eligibility criteria|0|||
130858057|NCT02262754|471106062|FG001|Overall Study|No longer meets eligibility criteria|1|||
130858058|NCT02262754|471106063|FG002|Overall Study|No longer meets eligibility criteria|0|||
130858059|NCT02262754|471106061|FG000|Overall Study|Study terminated by sponsor|5|||
130858060|NCT02262754|471106062|FG001|Overall Study|Study terminated by sponsor|4|||
130858061|NCT02262754|471106063|FG002|Overall Study|Study terminated by sponsor|4|||
130858062|NCT02262754|471106061|FG000|Overall Study|Protocol Violation|1|||
130858063|NCT02262754|471106062|FG001|Overall Study|Protocol Violation|0|||
130858064|NCT02262754|471106063|FG002|Overall Study|Protocol Violation|0|||
130858065|NCT02262754|471106061|FG000|Overall Study|Withdrawal by Subject|1|||
130858066|NCT02262754|471106062|FG001|Overall Study|Withdrawal by Subject|0|||
130858067|NCT02262754|471106063|FG002|Overall Study|Withdrawal by Subject|1|||
130858068|NCT02262754|471106061|FG000|Overall Study|Other|4|||
130858069|NCT02262754|471106062|FG001|Overall Study|Other|0|||
130858070|NCT02262754|471106063|FG002|Overall Study|Other|2|||
130858071|NCT03208088|471106068|FG000|Period 2|Withdrawal by Subject|0|||
130858072|NCT03208088|471106069|FG001|Period 2|Withdrawal by Subject|0|||
130858073|NCT03208088|471106070|FG002|Period 2|Withdrawal by Subject|0|||
130858074|NCT03208088|471106071|FG003|Period 2|Withdrawal by Subject|0|||
130858075|NCT03208088|471106072|FG004|Period 2|Withdrawal by Subject|0|||
130858076|NCT03208088|471106073|FG005|Period 2|Withdrawal by Subject|0|||
130858077|NCT03208088|471106074|FG006|Period 2|Withdrawal by Subject|0|||
130858078|NCT03208088|471106075|FG007|Period 2|Withdrawal by Subject|0|||
130858079|NCT03208088|471106076|FG008|Period 2|Withdrawal by Subject|1|||
130858080|NCT03208088|471106077|FG009|Period 2|Withdrawal by Subject|0|||
130858081|NCT03208088|471106068|FG000|Period 3|Unsatisfactory Test Article|0|||
130858082|NCT03208088|471106069|FG001|Period 3|Unsatisfactory Test Article|0|||
130858083|NCT03208088|471106070|FG002|Period 3|Unsatisfactory Test Article|0|||
130858084|NCT03208088|471106071|FG003|Period 3|Unsatisfactory Test Article|1|||
130858085|NCT03208088|471106072|FG004|Period 3|Unsatisfactory Test Article|0|||
130858086|NCT03208088|471106073|FG005|Period 3|Unsatisfactory Test Article|0|||
130858087|NCT03208088|471106074|FG006|Period 3|Unsatisfactory Test Article|0|||
130858088|NCT03208088|471106075|FG007|Period 3|Unsatisfactory Test Article|0|||
130858089|NCT03208088|471106076|FG008|Period 3|Unsatisfactory Test Article|0|||
130858090|NCT03208088|471106077|FG009|Period 3|Unsatisfactory Test Article|0|||
130858091|NCT03208088|471106068|FG000|Period 4|Unsatisfactory Test Article|0|||
130858092|NCT03208088|471106069|FG001|Period 4|Unsatisfactory Test Article|0|||
130858093|NCT03208088|471106070|FG002|Period 4|Unsatisfactory Test Article|0|||
130858094|NCT03208088|471106071|FG003|Period 4|Unsatisfactory Test Article|1|||
130858095|NCT03208088|471106072|FG004|Period 4|Unsatisfactory Test Article|0|||
130858096|NCT03208088|471106073|FG005|Period 4|Unsatisfactory Test Article|0|||
130858097|NCT03208088|471106074|FG006|Period 4|Unsatisfactory Test Article|0|||
130858098|NCT03208088|471106075|FG007|Period 4|Unsatisfactory Test Article|0|||
130858099|NCT03208088|471106076|FG008|Period 4|Unsatisfactory Test Article|0|||
130858100|NCT03208088|471106077|FG009|Period 4|Unsatisfactory Test Article|0|||
130858101|NCT02577016|471106078|FG000|Overall Study|Adverse Event|2|||
130858102|NCT02577016|471106079|FG001|Overall Study|Adverse Event|1|||
130858103|NCT02577016|471106078|FG000|Overall Study|Physician Decision|0|||
130858104|NCT02577016|471106079|FG001|Overall Study|Physician Decision|1|||
130858105|NCT02126839|471106080|FG000|Overall Study|Adverse Event|0|||
130858106|NCT02126839|471106081|FG001|Overall Study|Adverse Event|1|||
130858107|NCT02126839|471106080|FG000|Overall Study|Withdrawal by Subject|1|||
130858108|NCT02126839|471106081|FG001|Overall Study|Withdrawal by Subject|0|||
130858109|NCT02126839|471106080|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130858110|NCT02126839|471106081|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130858111|NCT02126839|471106080|FG000|Overall Study|Protocol Violation|2|||
130858112|NCT02126839|471106081|FG001|Overall Study|Protocol Violation|3|||
130858113|NCT02126839|471106080|FG000|Overall Study|Sponsor request|0|||
130858114|NCT02126839|471106081|FG001|Overall Study|Sponsor request|1|||
130858115|NCT02126839|471106080|FG000|Overall Study|Lost to Follow-up|1|||
130858116|NCT02126839|471106081|FG001|Overall Study|Lost to Follow-up|4|||
130858117|NCT02126839|471106080|FG000|Overall Study|Other|5|||
130858118|NCT02126839|471106081|FG001|Overall Study|Other|5|||
130858119|NCT00812565|471106084|FG000|Overall Study|Did Not Receive Study Medication|1|||
130858120|NCT00812565|471106085|FG001|Overall Study|Did Not Receive Study Medication|1|||
130858121|NCT00812565|471106086|FG002|Overall Study|Did Not Receive Study Medication|0|||
130858122|NCT00812565|471106087|FG003|Overall Study|Did Not Receive Study Medication|0|||
130858123|NCT00812565|471106088|FG004|Overall Study|Did Not Receive Study Medication|0|||
130858124|NCT00812565|471106089|FG005|Overall Study|Did Not Receive Study Medication|0|||
130858125|NCT00812565|471106090|FG006|Overall Study|Did Not Receive Study Medication|0|||
130858126|NCT00812565|471106091|FG007|Overall Study|Did Not Receive Study Medication|0|||
130858127|NCT00812565|471106084|FG000|Overall Study|Adverse Event|0|||
130858128|NCT00812565|471106085|FG001|Overall Study|Adverse Event|0|||
130858129|NCT00812565|471106086|FG002|Overall Study|Adverse Event|0|||
130858130|NCT00812565|471106087|FG003|Overall Study|Adverse Event|2|||
130858131|NCT00812565|471106088|FG004|Overall Study|Adverse Event|0|||
130858132|NCT00812565|471106089|FG005|Overall Study|Adverse Event|0|||
130858133|NCT00812565|471106090|FG006|Overall Study|Adverse Event|0|||
130858134|NCT00812565|471106091|FG007|Overall Study|Adverse Event|1|||
130858135|NCT00812565|471106084|FG000|Overall Study|Did Not Come to Study Visit|1|||
130858136|NCT00812565|471106085|FG001|Overall Study|Did Not Come to Study Visit|0|||
130858137|NCT00812565|471106086|FG002|Overall Study|Did Not Come to Study Visit|0|||
130858138|NCT00812565|471106087|FG003|Overall Study|Did Not Come to Study Visit|0|||
130858139|NCT00812565|471106088|FG004|Overall Study|Did Not Come to Study Visit|0|||
130858140|NCT00812565|471106089|FG005|Overall Study|Did Not Come to Study Visit|0|||
130858141|NCT00812565|471106090|FG006|Overall Study|Did Not Come to Study Visit|0|||
130858142|NCT00812565|471106091|FG007|Overall Study|Did Not Come to Study Visit|0|||
130858143|NCT00812565|471106084|FG000|Overall Study|Withdrawal of Consent|1|||
130858144|NCT00812565|471106085|FG001|Overall Study|Withdrawal of Consent|0|||
130858145|NCT00812565|471106086|FG002|Overall Study|Withdrawal of Consent|0|||
130858146|NCT00812565|471106087|FG003|Overall Study|Withdrawal of Consent|0|||
130858147|NCT00812565|471106088|FG004|Overall Study|Withdrawal of Consent|1|||
130858148|NCT00812565|471106089|FG005|Overall Study|Withdrawal of Consent|0|||
130858149|NCT00812565|471106090|FG006|Overall Study|Withdrawal of Consent|0|||
130858150|NCT00812565|471106091|FG007|Overall Study|Withdrawal of Consent|0|||
130858151|NCT00812565|471106084|FG000|Overall Study|Reason Not Specified|0|||
130858152|NCT00812565|471106085|FG001|Overall Study|Reason Not Specified|0|||
130858153|NCT00812565|471106086|FG002|Overall Study|Reason Not Specified|0|||
130858154|NCT00812565|471106087|FG003|Overall Study|Reason Not Specified|0|||
130858155|NCT00812565|471106088|FG004|Overall Study|Reason Not Specified|0|||
130858156|NCT00812565|471106089|FG005|Overall Study|Reason Not Specified|1|||
130858157|NCT00812565|471106090|FG006|Overall Study|Reason Not Specified|0|||
130858158|NCT00812565|471106091|FG007|Overall Study|Reason Not Specified|0|||
130858159|NCT02596945|471106092|FG000|Overall Study|No documentation of study drug dosing|3|||
130858160|NCT02596945|471106092|FG000|Overall Study|Other|32|||
130858161|NCT02596945|471106092|FG000|Overall Study|Change to hemodialysis|15|||
130858162|NCT02596945|471106092|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
130858163|NCT02596945|471106092|FG000|Overall Study|Withdrawal by Subject|1|||
130858164|NCT02596945|471106092|FG000|Overall Study|Missing|1|||
130858165|NCT00422383|471106093|FG000|Overall Study|Adverse Event|5|||
130858166|NCT00422383|471106094|FG001|Overall Study|Adverse Event|3|||
130858167|NCT00422383|471106095|FG002|Overall Study|Adverse Event|1|||
130858168|NCT00422383|471106096|FG003|Overall Study|Adverse Event|1|||
130858169|NCT00422383|471106097|FG004|Overall Study|Adverse Event|0|||
130858170|NCT00422383|471106093|FG000|Overall Study|Lack of Efficacy|4|||
130858171|NCT00422383|471106094|FG001|Overall Study|Lack of Efficacy|4|||
130858172|NCT00422383|471106095|FG002|Overall Study|Lack of Efficacy|2|||
130858173|NCT00422383|471106096|FG003|Overall Study|Lack of Efficacy|1|||
130858174|NCT00422383|471106097|FG004|Overall Study|Lack of Efficacy|1|||
130858175|NCT00422383|471106093|FG000|Overall Study|Lost to Follow-up|0|||
130858176|NCT00422383|471106094|FG001|Overall Study|Lost to Follow-up|1|||
130858177|NCT00422383|471106095|FG002|Overall Study|Lost to Follow-up|0|||
130858178|NCT00422383|471106096|FG003|Overall Study|Lost to Follow-up|0|||
130858179|NCT00422383|471106097|FG004|Overall Study|Lost to Follow-up|1|||
130858180|NCT00422383|471106093|FG000|Overall Study|Protocol Violation|1|||
130858181|NCT00422383|471106094|FG001|Overall Study|Protocol Violation|1|||
130858182|NCT00422383|471106095|FG002|Overall Study|Protocol Violation|1|||
130858183|NCT00422383|471106096|FG003|Overall Study|Protocol Violation|0|||
130858184|NCT00422383|471106097|FG004|Overall Study|Protocol Violation|0|||
130858185|NCT00422383|471106093|FG000|Overall Study|Withdrawal by Subject|5|||
130858186|NCT00422383|471106094|FG001|Overall Study|Withdrawal by Subject|5|||
130858187|NCT00422383|471106095|FG002|Overall Study|Withdrawal by Subject|0|||
130858188|NCT00422383|471106096|FG003|Overall Study|Withdrawal by Subject|0|||
130858189|NCT00422383|471106097|FG004|Overall Study|Withdrawal by Subject|1|||
130858190|NCT00842543|471108301|FG000|Overall Study|Withdrawal by Subject|2|||
130858191|NCT00842543|471108302|FG001|Overall Study|Withdrawal by Subject|0|||
130858192|NCT00842543|471108303|FG002|Overall Study|Withdrawal by Subject|3|||
130858193|NCT00842543|471108304|FG003|Overall Study|Withdrawal by Subject|4|||
130858194|NCT01483183|471108309|FG000|Overall Study|Physician Decision|0|||
130858195|NCT01483183|471108310|FG001|Overall Study|Physician Decision|0|||
130858196|NCT01483183|471108311|FG002|Overall Study|Physician Decision|0|||
130858197|NCT01483183|471108312|FG003|Overall Study|Physician Decision|0|||
130858198|NCT01483183|471108313|FG004|Overall Study|Physician Decision|0|||
130858199|NCT01483183|471108314|FG005|Overall Study|Physician Decision|0|||
130858200|NCT01483183|471108315|FG006|Overall Study|Physician Decision|2|||
130858201|NCT01483183|471108316|FG007|Overall Study|Physician Decision|0|||
130858202|NCT01483183|471108317|FG008|Overall Study|Physician Decision|0|||
130858203|NCT01483183|471108318|FG009|Overall Study|Physician Decision|0|||
130858204|NCT01483183|471108309|FG000|Overall Study|Withdrawal by Subject|0|||
130858205|NCT01483183|471108310|FG001|Overall Study|Withdrawal by Subject|0|||
130858206|NCT01483183|471108311|FG002|Overall Study|Withdrawal by Subject|0|||
130858207|NCT01483183|471108312|FG003|Overall Study|Withdrawal by Subject|0|||
130858208|NCT01483183|471108313|FG004|Overall Study|Withdrawal by Subject|0|||
130858209|NCT01483183|471108314|FG005|Overall Study|Withdrawal by Subject|0|||
130858210|NCT01483183|471108315|FG006|Overall Study|Withdrawal by Subject|0|||
130858211|NCT01483183|471108316|FG007|Overall Study|Withdrawal by Subject|0|||
130858212|NCT01483183|471108317|FG008|Overall Study|Withdrawal by Subject|0|||
130858213|NCT01483183|471108318|FG009|Overall Study|Withdrawal by Subject|1|||
130858214|NCT00239928|471108319|FG000|Overall Study|Lack of Efficacy|1|||
130858215|NCT00239928|471108319|FG000|Overall Study|Adverse Event|4|||
130858216|NCT00239928|471108319|FG000|Overall Study|Not need to continue study|3|||
130858217|NCT00239928|471108319|FG000|Overall Study|Withdrawal by Subject|2|||
130858218|NCT03100058|471108321|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130858219|NCT03100058|471108322|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130858220|NCT03100058|471108323|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
130858221|NCT03100058|471108324|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
130858222|NCT03100058|471108325|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
130858223|NCT03100058|471108326|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130858224|NCT03100058|471108327|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
130858225|NCT03100058|471108328|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
130858226|NCT03100058|471108329|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
130858227|NCT03100058|471108330|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130858228|NCT03100058|471108331|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130858229|NCT03100058|471108332|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130858230|NCT03100058|471108333|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130858231|NCT03100058|471108321|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
130858232|NCT03100058|471108322|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
130858233|NCT03100058|471108323|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
130858234|NCT03100058|471108324|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
130858235|NCT03100058|471108325|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
130858236|NCT03100058|471108326|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
130858237|NCT03100058|471108327|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
130858238|NCT03100058|471108328|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
130858239|NCT03100058|471108329|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
130858240|NCT03100058|471108330|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130858241|NCT03100058|471108331|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130858242|NCT03100058|471108332|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130858243|NCT03100058|471108333|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130858244|NCT03100058|471108321|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130858245|NCT03100058|471108322|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130858246|NCT03100058|471108323|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130858247|NCT03100058|471108324|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130858248|NCT03100058|471108325|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130858249|NCT03100058|471108326|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130858250|NCT03100058|471108327|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130858251|NCT03100058|471108328|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130858252|NCT03100058|471108329|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130858253|NCT03100058|471108330|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130858254|NCT03100058|471108331|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130858255|NCT03100058|471108332|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130858256|NCT03100058|471108333|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130858257|NCT03100058|471108321|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130858258|NCT03100058|471108322|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130858259|NCT03100058|471108323|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130858260|NCT03100058|471108324|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130858261|NCT03100058|471108325|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130858262|NCT03100058|471108326|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130858263|NCT03100058|471108327|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130858264|NCT03100058|471108328|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130858265|NCT03100058|471108329|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130858266|NCT03100058|471108330|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130858267|NCT03100058|471108331|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130858268|NCT03100058|471108332|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130858269|NCT03100058|471108333|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130858270|NCT03100058|471108321|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858271|NCT03100058|471108322|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858272|NCT03100058|471108323|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858273|NCT03100058|471108324|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
130858274|NCT03100058|471108325|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858275|NCT03100058|471108326|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858276|NCT03100058|471108327|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858277|NCT03100058|471108328|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
130858278|NCT03100058|471108329|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858279|NCT03100058|471108330|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858280|NCT03100058|471108331|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858281|NCT03100058|471108332|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858282|NCT03100058|471108333|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130858283|NCT03100058|471108321|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858284|NCT03100058|471108322|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858285|NCT03100058|471108323|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858286|NCT03100058|471108324|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
130858287|NCT03100058|471108325|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858288|NCT03100058|471108326|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858289|NCT03100058|471108327|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
130858290|NCT03100058|471108328|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858291|NCT03100058|471108329|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858292|NCT03100058|471108330|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858293|NCT03100058|471108331|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858294|NCT03100058|471108332|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858295|NCT03100058|471108333|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130858296|NCT03100058|471108321|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858297|NCT03100058|471108322|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
130858298|NCT03100058|471108323|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858299|NCT03100058|471108324|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858300|NCT03100058|471108325|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858301|NCT03100058|471108326|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858302|NCT03100058|471108327|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858303|NCT03100058|471108328|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858304|NCT03100058|471108329|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858305|NCT03100058|471108330|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858306|NCT03100058|471108331|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858307|NCT03100058|471108332|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858308|NCT03100058|471108333|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130858309|NCT03100058|471108321|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
130858310|NCT03100058|471108322|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858311|NCT03100058|471108323|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858312|NCT03100058|471108324|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858313|NCT03100058|471108325|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858314|NCT03100058|471108326|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858315|NCT03100058|471108327|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858316|NCT03100058|471108328|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858317|NCT03100058|471108329|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858318|NCT03100058|471108330|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858319|NCT03100058|471108331|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858320|NCT03100058|471108332|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858321|NCT03100058|471108333|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130858322|NCT03100058|471108321|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858323|NCT03100058|471108322|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858324|NCT03100058|471108323|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858325|NCT03100058|471108324|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858326|NCT03100058|471108325|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858327|NCT03100058|471108326|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858328|NCT03100058|471108327|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
130858329|NCT03100058|471108328|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858330|NCT03100058|471108329|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858331|NCT03100058|471108330|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858332|NCT03100058|471108331|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858333|NCT03100058|471108332|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858334|NCT03100058|471108333|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130858335|NCT03100058|471108321|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130858336|NCT03100058|471108322|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130858337|NCT03100058|471108323|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130858338|NCT03100058|471108324|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130858339|NCT03100058|471108325|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130858340|NCT03100058|471108326|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130858341|NCT03100058|471108327|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130858342|NCT03100058|471108328|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130858343|NCT03100058|471108329|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130858344|NCT03100058|471108330|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130858345|NCT03100058|471108331|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
130858346|NCT03100058|471108332|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
130858347|NCT03100058|471108333|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
130858348|NCT03100058|471108321|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858349|NCT03100058|471108322|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858350|NCT03100058|471108323|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858351|NCT03100058|471108324|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858352|NCT03100058|471108325|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858353|NCT03100058|471108326|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858354|NCT03100058|471108327|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858355|NCT03100058|471108328|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858356|NCT03100058|471108329|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858357|NCT03100058|471108330|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858358|NCT03100058|471108331|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
130858359|NCT03100058|471108332|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
130858360|NCT03100058|471108333|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130858361|NCT03100058|471108321|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130858362|NCT03100058|471108322|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130858363|NCT03100058|471108323|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130858364|NCT03100058|471108324|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130858365|NCT03100058|471108325|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130858366|NCT03100058|471108326|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130858367|NCT03100058|471108327|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130858368|NCT03100058|471108328|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130858369|NCT03100058|471108329|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130858370|NCT03100058|471108330|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
130858371|NCT03100058|471108331|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
130858372|NCT03100058|471108332|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130858373|NCT03100058|471108333|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
130858374|NCT03100058|471108321|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858375|NCT03100058|471108322|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858376|NCT03100058|471108323|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858377|NCT03100058|471108324|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858378|NCT03100058|471108325|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858379|NCT03100058|471108326|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858380|NCT03100058|471108327|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858381|NCT03100058|471108328|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858382|NCT03100058|471108329|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858383|NCT03100058|471108330|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858384|NCT03100058|471108331|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
130858385|NCT03100058|471108332|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858386|NCT03100058|471108333|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130858387|NCT03100058|471108321|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858388|NCT03100058|471108322|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858389|NCT03100058|471108323|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858390|NCT03100058|471108324|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858391|NCT03100058|471108325|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858392|NCT03100058|471108326|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858393|NCT03100058|471108327|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858394|NCT03100058|471108328|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858395|NCT03100058|471108329|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858396|NCT03100058|471108330|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858397|NCT03100058|471108331|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858398|NCT03100058|471108332|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130858399|NCT03100058|471108333|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
130858400|NCT03100058|471108321|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858401|NCT03100058|471108322|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858402|NCT03100058|471108323|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858403|NCT03100058|471108324|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858404|NCT03100058|471108325|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858405|NCT03100058|471108326|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858406|NCT03100058|471108327|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858407|NCT03100058|471108328|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858408|NCT03100058|471108329|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858409|NCT03100058|471108330|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
130858410|NCT03100058|471108331|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858411|NCT03100058|471108332|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858412|NCT03100058|471108333|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130858413|NCT00844558|471108336|FG000|Overall Study|Withdrawal by Subject|9|||
130858414|NCT00844558|471108337|FG001|Overall Study|Withdrawal by Subject|2|||
130858415|NCT00844558|471108336|FG000|Overall Study|Death|1|||
130858416|NCT00844558|471108337|FG001|Overall Study|Death|0|||
130858417|NCT00844558|471108336|FG000|Overall Study|Protocol Violation|1|||
130858418|NCT00844558|471108337|FG001|Overall Study|Protocol Violation|1|||
130858419|NCT00844558|471108336|FG000|Overall Study|Lost to Follow-up|0|||
130858420|NCT00844558|471108337|FG001|Overall Study|Lost to Follow-up|1|||
130858421|NCT00844558|471108336|FG000|Overall Study|Physician Decision|1|||
130858422|NCT00844558|471108337|FG001|Overall Study|Physician Decision|0|||
130858423|NCT01894022|471108353|FG000|Overall Study|Death|1|||
130858424|NCT01894022|471108354|FG001|Overall Study|Death|0|||
130858425|NCT01894022|471108353|FG000|Overall Study|Adverse Event, non-fatal|1|||
130858426|NCT01894022|471108354|FG001|Overall Study|Adverse Event, non-fatal|0|||
130858427|NCT01894022|471108353|FG000|Overall Study|Study Closed/terminated|7|||
130858428|NCT01894022|471108354|FG001|Overall Study|Study Closed/terminated|10|||
130858429|NCT05392803|471108363|FG000|Overall Study|Lost to Follow-up|0|||
130858430|NCT05392803|471108364|FG001|Overall Study|Lost to Follow-up|2|||
130858431|NCT04294147|471108365|FG000|Overall Study|Protocol Violation|2|||
130858432|NCT04294147|471108366|FG001|Overall Study|Protocol Violation|0|||
130858433|NCT01887353|471108369|FG000|Overall Study|Study stopped early|4|||
130858434|NCT01887353|471108370|FG001|Overall Study|Study stopped early|3|||
130858435|NCT00699335|471108371|FG000|Overall Study|Combination of multiple reasons|176|||
130858436|NCT00699335|471108371|FG000|Overall Study|Missing data|52|||
130858437|NCT01069705|471108372|FG000|Overall Study|Adverse Event|1|||
130858438|NCT01069705|471108372|FG000|Overall Study|Withdrawal by Subject|2|||
130858439|NCT02999633|471108373|FG000|Overall Study|Adverse Event|2|||
130858440|NCT02999633|471108373|FG000|Overall Study|Progressive disease|12|||
130858441|NCT01545050|471108374|FG000|Overall Study|Lack of Efficacy|0|||
130858442|NCT01545050|471108375|FG001|Overall Study|Lack of Efficacy|0|||
130858443|NCT01545050|471108376|FG002|Overall Study|Lack of Efficacy|0|||
130858444|NCT01545050|471108377|FG003|Overall Study|Lack of Efficacy|3|||
130858445|NCT01545050|471108378|FG004|Overall Study|Lack of Efficacy|2|||
130858446|NCT01545050|471108374|FG000|Overall Study|Adverse Event|1|||
130858447|NCT01545050|471108375|FG001|Overall Study|Adverse Event|1|||
130858448|NCT01545050|471108376|FG002|Overall Study|Adverse Event|2|||
130858449|NCT01545050|471108377|FG003|Overall Study|Adverse Event|2|||
130858450|NCT01545050|471108378|FG004|Overall Study|Adverse Event|0|||
130858451|NCT01545050|471108374|FG000|Overall Study|Discontinued study treatment|1|||
130858452|NCT01545050|471108375|FG001|Overall Study|Discontinued study treatment|0|||
130858453|NCT01545050|471108376|FG002|Overall Study|Discontinued study treatment|0|||
130858454|NCT01545050|471108377|FG003|Overall Study|Discontinued study treatment|0|||
130858455|NCT01545050|471108378|FG004|Overall Study|Discontinued study treatment|0|||
130858456|NCT01545050|471108374|FG000|Overall Study|Withdrawal by Subject|1|||
130858457|NCT01545050|471108375|FG001|Overall Study|Withdrawal by Subject|0|||
130858458|NCT01545050|471108376|FG002|Overall Study|Withdrawal by Subject|0|||
130858459|NCT01545050|471108377|FG003|Overall Study|Withdrawal by Subject|2|||
130858460|NCT01545050|471108378|FG004|Overall Study|Withdrawal by Subject|1|||
130858461|NCT01545050|471108374|FG000|Overall Study|Participant no longer meets study criteria|0|||
130858462|NCT01545050|471108375|FG001|Overall Study|Participant no longer meets study criteria|2|||
130858463|NCT01545050|471108376|FG002|Overall Study|Participant no longer meets study criteria|0|||
130858464|NCT01545050|471108377|FG003|Overall Study|Participant no longer meets study criteria|0|||
130858465|NCT01545050|471108378|FG004|Overall Study|Participant no longer meets study criteria|1|||
130858466|NCT01545050|471108374|FG000|Overall Study|Administrative reason by sponsor|4|||
130858467|NCT01545050|471108375|FG001|Overall Study|Administrative reason by sponsor|2|||
130858468|NCT01545050|471108376|FG002|Overall Study|Administrative reason by sponsor|3|||
130858469|NCT01545050|471108377|FG003|Overall Study|Administrative reason by sponsor|5|||
130858470|NCT01545050|471108378|FG004|Overall Study|Administrative reason by sponsor|5|||
130858471|NCT03262441|471108379|FG000|Overall Study|Withdrawal by Subject|1|||
130858472|NCT03235089|471108380|FG000|Overall Study|Lost to Follow-up|1|||
130858473|NCT03235089|471108381|FG001|Overall Study|Lost to Follow-up|1|||
130858474|NCT03235089|471108380|FG000|Overall Study|Physician Decision|2|||
130858475|NCT03235089|471108381|FG001|Overall Study|Physician Decision|2|||
130858476|NCT03238924|471108383|FG000|Overall Study|Withdrawal by Subject|2|||
130858477|NCT03238924|471108384|FG001|Overall Study|Withdrawal by Subject|2|||
130858478|NCT02516228|471108385|FG000|Overall Study|Lost to Follow-up|1|||
130858479|NCT02516228|471108385|FG000|Overall Study|Withdrawal by Subject|1|||
130858480|NCT02516228|471108385|FG000|Overall Study|Physician Decision|1|||
130858481|NCT03916484|471108388|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130858482|NCT03916484|471108389|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
130858483|NCT03916484|471108390|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130858484|NCT03916484|471108391|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130858485|NCT03916484|471108388|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
130858486|NCT03916484|471108389|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
130858487|NCT03916484|471108390|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
130858488|NCT03916484|471108391|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
130858489|NCT05090852|471108398|FG000|Overall Study|Physician Decision|5|||
130858490|NCT00504894|471108399|FG000|Overall Study|fMRI technical problems|1|||
130858491|NCT00504894|471108400|FG001|Overall Study|fMRI technical problems|1|||
130858492|NCT00504894|471108401|FG002|Overall Study|fMRI technical problems|0|||
130858493|NCT00504894|471108399|FG000|Overall Study|Withdrawal by Subject|0|||
130858494|NCT00504894|471108400|FG001|Overall Study|Withdrawal by Subject|1|||
130858495|NCT00504894|471108401|FG002|Overall Study|Withdrawal by Subject|0|||
130858496|NCT00504894|471108399|FG000|Overall Study|Infusion technical problems|0|||
130858497|NCT00504894|471108400|FG001|Overall Study|Infusion technical problems|1|||
130858498|NCT00504894|471108401|FG002|Overall Study|Infusion technical problems|0|||
130858499|NCT00504894|471108399|FG000|Overall Study|poor subject data|2|||
130858500|NCT00504894|471108400|FG001|Overall Study|poor subject data|0|||
130858501|NCT00504894|471108401|FG002|Overall Study|poor subject data|0|||
130858502|NCT01196416|471108404|FG000|Overall Study|Withdrawal by Subject|2|||
130858503|NCT00148941|471108406|FG000|Overall Study|Lost to Follow-up|17|||
130858504|NCT00148941|471108407|FG001|Overall Study|Lost to Follow-up|24|||
130858505|NCT00148941|471108408|FG002|Overall Study|Lost to Follow-up|18|||
130858506|NCT00148941|471108409|FG003|Overall Study|Lost to Follow-up|22|||
130858507|NCT00148941|471108406|FG000|Overall Study|Withdrawal by Subject|1|||
130858508|NCT00148941|471108407|FG001|Overall Study|Withdrawal by Subject|0|||
130858509|NCT00148941|471108408|FG002|Overall Study|Withdrawal by Subject|1|||
130858510|NCT00148941|471108409|FG003|Overall Study|Withdrawal by Subject|0|||
130858511|NCT00148941|471108406|FG000|Overall Study|Other|0|||
130858512|NCT00148941|471108407|FG001|Overall Study|Other|0|||
130858513|NCT00148941|471108408|FG002|Overall Study|Other|1|||
130858514|NCT00148941|471108409|FG003|Overall Study|Other|2|||
130858515|NCT02673684|471108410|FG000|Overall Study|Study not completed d/t loss of funding|9|||
130858516|NCT02673684|471108411|FG001|Overall Study|Study not completed d/t loss of funding|8|||
130858517|NCT01092663|471108412|FG000|Overall Study|Withdrawal by Subject|3|||
130858518|NCT01092663|471108413|FG001|Overall Study|Withdrawal by Subject|2|||
130858519|NCT01092663|471108412|FG000|Overall Study|Glucose >300mg/dL|1|||
130858520|NCT01092663|471108413|FG001|Overall Study|Glucose >300mg/dL|0|||
130858521|NCT01092663|471108412|FG000|Overall Study|High fasting triglyceride|2|||
130858522|NCT01092663|471108413|FG001|Overall Study|High fasting triglyceride|0|||
130858523|NCT01092663|471108412|FG000|Overall Study|Adverse Event|1|||
130858524|NCT01092663|471108413|FG001|Overall Study|Adverse Event|1|||
130858525|NCT01092663|471108412|FG000|Overall Study|Protocol Violation|0|||
130858526|NCT01092663|471108413|FG001|Overall Study|Protocol Violation|1|||
130858527|NCT03688620|471108414|FG000|Overall Study|Other|0|||
130858528|NCT03688620|471108415|FG001|Overall Study|Other|0|||
130858529|NCT03688620|471108416|FG002|Overall Study|Other|1|||
130858530|NCT03688620|471108414|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
130858531|NCT03688620|471108415|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
130858532|NCT03688620|471108416|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
130858533|NCT03688620|471108414|FG000|Overall Study|Lost to Follow-up|16|||
130858534|NCT03688620|471108415|FG001|Overall Study|Lost to Follow-up|0|||
130858535|NCT03688620|471108416|FG002|Overall Study|Lost to Follow-up|1|||
130858536|NCT03688620|471108414|FG000|Overall Study|Withdrawal by Subject|0|||
130858537|NCT03688620|471108415|FG001|Overall Study|Withdrawal by Subject|0|||
130858538|NCT03688620|471108416|FG002|Overall Study|Withdrawal by Subject|6|||
130858539|NCT01008904|471108417|FG000|Overall Study|Lost to Follow-up|1|||
130858540|NCT01008904|471108417|FG000|Overall Study|Adverse Event|2|||
130858541|NCT01008904|471108417|FG000|Overall Study|unexpected unrelated surgery|1|||
130858542|NCT01183065|471108418|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
130858543|NCT02456857|471108419|FG000|Overall Study|Disease Progression|4|||
130858544|NCT00781859|471108420|FG000|Overall Study|Adverse Event|2|||
130858545|NCT00781859|471108421|FG001|Overall Study|Adverse Event|2|||
130858546|NCT00781859|471108420|FG000|Overall Study|Withdrawal by Subject|8|||
130858547|NCT00781859|471108421|FG001|Overall Study|Withdrawal by Subject|4|||
130858548|NCT00781859|471108420|FG000|Overall Study|Lost to Follow-up|6|||
130858549|NCT00781859|471108421|FG001|Overall Study|Lost to Follow-up|3|||
130858550|NCT00781859|471108420|FG000|Overall Study|Death|3|||
130858551|NCT00781859|471108421|FG001|Overall Study|Death|0|||
130858552|NCT01983774|471108425|FG000|Overall Study|Lung Transplant|0|||
130858553|NCT01983774|471108426|FG001|Overall Study|Lung Transplant|1|||
130858554|NCT01983774|471108425|FG000|Overall Study|Lost to Follow-up|1|||
130858555|NCT01983774|471108426|FG001|Overall Study|Lost to Follow-up|0|||
130858556|NCT01008449|471108427|FG000|Overall Study|Lost to Follow-up|29|||
130858557|NCT01008449|471108428|FG001|Overall Study|Lost to Follow-up|19|||
130858558|NCT01220180|471108429|FG000|Overall Study|Lost to Follow-up|76|||
130858559|NCT01220180|471108429|FG000|Overall Study|Other|72|||
130858560|NCT01220180|471108429|FG000|Overall Study|Adverse Event|35|||
130858561|NCT01220180|471108429|FG000|Overall Study|Lack of Efficacy|22|||
130858562|NCT01220180|471108429|FG000|Overall Study|Death|1|||
130858563|NCT01220180|471108429|FG000|Overall Study|Randomized but not treated|1|||
130858564|NCT01067469|471108435|FG000|Overall Study|Withdrawal by Subject|0|||
130858565|NCT01067469|471108436|FG001|Overall Study|Withdrawal by Subject|1|||
130858566|NCT01067469|471108435|FG000|Overall Study|Disease Progression|0|||
130858567|NCT01067469|471108436|FG001|Overall Study|Disease Progression|1|||
130858568|NCT01299116|471108438|FG000|Overall Study|Lost to Follow-up|65|||
130858569|NCT01299116|471108439|FG001|Overall Study|Lost to Follow-up|9|||
130858570|NCT01299116|471108440|FG002|Overall Study|Lost to Follow-up|11|||
130858571|NCT01620944|471108442|FG000|Overall Study|Early termination of Study|2|||
130858572|NCT01620944|471108443|FG001|Overall Study|Early termination of Study|1|||
130858573|NCT01123707|471108444|FG000|Overall Study|Lost to Follow-up|3|||
130858574|NCT01123707|471108445|FG001|Overall Study|Lost to Follow-up|1|||
130858575|NCT01123707|471108446|FG002|Overall Study|Lost to Follow-up|3|||
130858576|NCT01123707|471108447|FG003|Overall Study|Lost to Follow-up|2|||
130858577|NCT01123707|471108444|FG000|Overall Study|Adverse Event|5|||
130858578|NCT01123707|471108445|FG001|Overall Study|Adverse Event|7|||
130858579|NCT01123707|471108446|FG002|Overall Study|Adverse Event|5|||
130858580|NCT01123707|471108447|FG003|Overall Study|Adverse Event|3|||
130858581|NCT01123707|471108444|FG000|Overall Study|Sponsor Discontinued Study|30|||
130858582|NCT01123707|471108445|FG001|Overall Study|Sponsor Discontinued Study|24|||
130858583|NCT01123707|471108446|FG002|Overall Study|Sponsor Discontinued Study|25|||
130858584|NCT01123707|471108447|FG003|Overall Study|Sponsor Discontinued Study|40|||
130858585|NCT01123707|471108444|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
130858586|NCT01123707|471108445|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
130858587|NCT01123707|471108446|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
130858588|NCT01123707|471108447|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
130858589|NCT01123707|471108444|FG000|Overall Study|Investigator Withdrew Participant|0|||
130858590|NCT01123707|471108445|FG001|Overall Study|Investigator Withdrew Participant|1|||
130858591|NCT01123707|471108446|FG002|Overall Study|Investigator Withdrew Participant|1|||
130858592|NCT01123707|471108447|FG003|Overall Study|Investigator Withdrew Participant|1|||
130858593|NCT01123707|471108444|FG000|Overall Study|Subject Withdrew Consent|4|||
130858594|NCT01123707|471108445|FG001|Overall Study|Subject Withdrew Consent|5|||
130858595|NCT01123707|471108446|FG002|Overall Study|Subject Withdrew Consent|1|||
130858596|NCT01123707|471108447|FG003|Overall Study|Subject Withdrew Consent|2|||
130858597|NCT01123707|471108444|FG000|Overall Study|Lack of Efficacy|1|||
130858598|NCT01123707|471108445|FG001|Overall Study|Lack of Efficacy|2|||
130858599|NCT01123707|471108446|FG002|Overall Study|Lack of Efficacy|1|||
130858600|NCT01123707|471108447|FG003|Overall Study|Lack of Efficacy|0|||
130858601|NCT01123707|471108444|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
130858602|NCT01123707|471108445|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
130858603|NCT01123707|471108446|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
130858604|NCT01123707|471108447|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
130858605|NCT04378114|471108448|FG000|Overall Study|Withdrawal by Subject|5|||
130858606|NCT01959243|471108451|FG000|Overall Study|Investigator Decision|3|||
130858607|NCT01959243|471108452|FG001|Overall Study|Investigator Decision|0|||
130858608|NCT01959243|471108451|FG000|Overall Study|Adverse Event|5|||
130858609|NCT01959243|471108452|FG001|Overall Study|Adverse Event|2|||
130858610|NCT01959243|471108451|FG000|Overall Study|Administrative reasons|2|||
130858611|NCT01959243|471108452|FG001|Overall Study|Administrative reasons|1|||
130858612|NCT01959243|471108451|FG000|Overall Study|Lost to Follow-up|3|||
130858613|NCT01959243|471108452|FG001|Overall Study|Lost to Follow-up|1|||
130858614|NCT00629798|471108455|FG000|Overall Study|Not Treated|4|||
130858615|NCT04667104|471108457|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
130858616|NCT04667104|471108458|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
130858617|NCT04667104|471108459|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
130858618|NCT02188849|471108460|FG000|Overall Study|Lost to Follow-up|3|||
130858619|NCT02188849|471108461|FG001|Overall Study|Lost to Follow-up|8|||
130858620|NCT01630889|471108462|FG000|Overall Study|Death|2|||
130858621|NCT01630889|471108462|FG000|Overall Study|Withdrawal by Subject|1|||
130858622|NCT01630889|471108462|FG000|Overall Study|Other than Specified|2|||
130858623|NCT01630889|471108462|FG000|Overall Study|Lost to Follow-up|4|||
130858624|NCT01630889|471108462|FG000|Overall Study|Other|1|||
130858625|NCT00605345|471108463|FG000|Overall Study|Withdrawal by Subject|1|||
130858626|NCT00605345|471108464|FG001|Overall Study|Withdrawal by Subject|0|||
130858627|NCT00605345|471108463|FG000|Overall Study|Adverse Event|0|||
130858628|NCT00605345|471108464|FG001|Overall Study|Adverse Event|1|||
130858629|NCT00605345|471108463|FG000|Overall Study|Protocol Violation|0|||
130858630|NCT00605345|471108464|FG001|Overall Study|Protocol Violation|2|||
130858631|NCT00566254|471108465|FG000|Overall Study|Adverse Event|3|||
130858632|NCT00566254|471108466|FG001|Overall Study|Adverse Event|1|||
130858633|NCT00566254|471108465|FG000|Overall Study|Protocol Violation|1|||
130858634|NCT00566254|471108466|FG001|Overall Study|Protocol Violation|3|||
130858635|NCT00566254|471108465|FG000|Overall Study|Withdrawal by Subject|1|||
130858636|NCT00566254|471108466|FG001|Overall Study|Withdrawal by Subject|2|||
130858637|NCT00566254|471108465|FG000|Overall Study|Lack of Efficacy|5|||
130858638|NCT00566254|471108466|FG001|Overall Study|Lack of Efficacy|6|||
130858639|NCT00566254|471108465|FG000|Overall Study|Other|0|||
130858640|NCT00566254|471108466|FG001|Overall Study|Other|2|||
130858641|NCT00238238|471108467|FG000|Overall Study|Withdrawal by Subject|0|||
130858642|NCT00238238|471108468|FG001|Overall Study|Withdrawal by Subject|3|||
130858643|NCT00238238|471108469|FG002|Overall Study|Withdrawal by Subject|0|||
130858644|NCT01345669|471108470|FG000|Overall Study|Primary tumour recurrence|53|||
130858645|NCT01345669|471108471|FG001|Overall Study|Primary tumour recurrence|32|||
130858646|NCT01345669|471108470|FG000|Overall Study|Second primary tumour|4|||
130858647|NCT01345669|471108471|FG001|Overall Study|Second primary tumour|3|||
130858648|NCT01345669|471108470|FG000|Overall Study|Adverse Event|63|||
130858649|NCT01345669|471108471|FG001|Overall Study|Adverse Event|9|||
130858650|NCT01345669|471108470|FG000|Overall Study|Protocol Violation|3|||
130858651|NCT01345669|471108471|FG001|Overall Study|Protocol Violation|1|||
130858652|NCT01345669|471108470|FG000|Overall Study|Lost to Follow-up|1|||
130858653|NCT01345669|471108471|FG001|Overall Study|Lost to Follow-up|1|||
130858654|NCT01345669|471108470|FG000|Overall Study|Withdrawal by Subject|52|||
130858655|NCT01345669|471108471|FG001|Overall Study|Withdrawal by Subject|13|||
130858656|NCT01345669|471108470|FG000|Overall Study|Other Reasons|111|||
130858657|NCT01345669|471108471|FG001|Overall Study|Other Reasons|60|||
130858658|NCT01793883|471108472|FG000|Overall Study|Withdrawal by Subject|3|||
130858659|NCT01793883|471108473|FG001|Overall Study|Withdrawal by Subject|7|||
130858660|NCT01793883|471108474|FG002|Overall Study|Withdrawal by Subject|3|||
130858661|NCT01793883|471108472|FG000|Overall Study|Subject noncompliance|0|||
130858662|NCT01793883|471108473|FG001|Overall Study|Subject noncompliance|1|||
130858663|NCT01793883|471108474|FG002|Overall Study|Subject noncompliance|1|||
130858664|NCT01793883|471108472|FG000|Overall Study|Lost to Follow-up|5|||
130858665|NCT01793883|471108473|FG001|Overall Study|Lost to Follow-up|1|||
130858666|NCT01793883|471108474|FG002|Overall Study|Lost to Follow-up|3|||
130858667|NCT01793883|471108472|FG000|Overall Study|Randomized in error|1|||
130858668|NCT01793883|471108473|FG001|Overall Study|Randomized in error|0|||
130858669|NCT01793883|471108474|FG002|Overall Study|Randomized in error|0|||
130858670|NCT01793883|471108472|FG000|Overall Study|Unable to complete spriometry|1|||
130858671|NCT01793883|471108473|FG001|Overall Study|Unable to complete spriometry|0|||
130858672|NCT01793883|471108474|FG002|Overall Study|Unable to complete spriometry|0|||
130858673|NCT01793883|471108472|FG000|Overall Study|Unable to complete measurements|1|||
130858674|NCT01793883|471108473|FG001|Overall Study|Unable to complete measurements|0|||
130858675|NCT01793883|471108474|FG002|Overall Study|Unable to complete measurements|0|||
130858676|NCT01793883|471108472|FG000|Overall Study|Met exclusion criteria|1|||
130858677|NCT01793883|471108473|FG001|Overall Study|Met exclusion criteria|0|||
130858678|NCT01793883|471108474|FG002|Overall Study|Met exclusion criteria|0|||
130858679|NCT01793883|471108472|FG000|Overall Study|Dosing error|0|||
130858680|NCT01793883|471108473|FG001|Overall Study|Dosing error|1|||
130858681|NCT01793883|471108474|FG002|Overall Study|Dosing error|0|||
130858682|NCT01793883|471108472|FG000|Overall Study|Respiratory distress during spirometry|0|||
130858683|NCT01793883|471108473|FG001|Overall Study|Respiratory distress during spirometry|0|||
130858684|NCT01793883|471108474|FG002|Overall Study|Respiratory distress during spirometry|1|||
130858685|NCT02478255|471108475|FG000|Overall Study|Physician Decision|6|||
130858686|NCT02478255|471108476|FG001|Overall Study|Physician Decision|0|||
130858687|NCT02478255|471108475|FG000|Overall Study|Withdrawal by Subject|2|||
130858688|NCT02478255|471108476|FG001|Overall Study|Withdrawal by Subject|0|||
130858689|NCT01730586|471108477|FG000|Overall Study|Progressive Disease|2|||
130858690|NCT01730586|471108477|FG000|Overall Study|Inadequate Trial|8|||
130858691|NCT01730586|471108477|FG000|Overall Study|Adverse Event|2|||
130858692|NCT01730586|471108477|FG000|Overall Study|Hospice|1|||
130858693|NCT00061633|471108478|FG000|Overall Study|Adverse Event|1|||
130858694|NCT00061633|471108479|FG001|Overall Study|Adverse Event|2|||
130858695|NCT00061633|471108478|FG000|Overall Study|Withdrawal by Subject|2|||
130858696|NCT00061633|471108479|FG001|Overall Study|Withdrawal by Subject|2|||
130858697|NCT00061633|471108478|FG000|Overall Study|Lost to Follow-up|1|||
130858698|NCT00061633|471108479|FG001|Overall Study|Lost to Follow-up|4|||
130858699|NCT00061633|471108478|FG000|Overall Study|Other|1|||
130858700|NCT00061633|471108479|FG001|Overall Study|Other|1|||
130858701|NCT00061633|471108478|FG000|Overall Study|Never received study treatment|0|||
130858702|NCT00061633|471108479|FG001|Overall Study|Never received study treatment|2|||
130858703|NCT03210961|471110268|FG000|Overall Study|Adverse Event|0|||
130858704|NCT03210961|471110269|FG001|Overall Study|Adverse Event|0|||
130858705|NCT03210961|471110270|FG002|Overall Study|Adverse Event|0|||
130858706|NCT03210961|471110271|FG003|Overall Study|Adverse Event|0|||
130858707|NCT03210961|471110272|FG004|Overall Study|Adverse Event|0|||
130858708|NCT03210961|471110273|FG005|Overall Study|Adverse Event|0|||
130858709|NCT03210961|471110274|FG006|Overall Study|Adverse Event|0|||
130858710|NCT03210961|471110275|FG007|Overall Study|Adverse Event|0|||
130858711|NCT03210961|471110276|FG008|Overall Study|Adverse Event|0|||
130858712|NCT03210961|471110277|FG009|Overall Study|Adverse Event|0|||
130858713|NCT03210961|471110278|FG010|Overall Study|Adverse Event|0|||
130858714|NCT03210961|471110279|FG011|Overall Study|Adverse Event|0|||
130858715|NCT03210961|471110280|FG012|Overall Study|Adverse Event|0|||
130858716|NCT03210961|471110281|FG013|Overall Study|Adverse Event|1|||
130858717|NCT03210961|471110282|FG014|Overall Study|Adverse Event|0|||
130858718|NCT03210961|471110268|FG000|Overall Study|Lost to Follow-up|0|||
130858719|NCT03210961|471110269|FG001|Overall Study|Lost to Follow-up|0|||
130858720|NCT03210961|471110270|FG002|Overall Study|Lost to Follow-up|0|||
130858721|NCT03210961|471110271|FG003|Overall Study|Lost to Follow-up|0|||
130858722|NCT03210961|471110272|FG004|Overall Study|Lost to Follow-up|0|||
130858723|NCT03210961|471110273|FG005|Overall Study|Lost to Follow-up|0|||
130858724|NCT03210961|471110274|FG006|Overall Study|Lost to Follow-up|0|||
130858725|NCT03210961|471110275|FG007|Overall Study|Lost to Follow-up|0|||
130858726|NCT03210961|471110276|FG008|Overall Study|Lost to Follow-up|0|||
130858727|NCT03210961|471110277|FG009|Overall Study|Lost to Follow-up|0|||
130858728|NCT03210961|471110278|FG010|Overall Study|Lost to Follow-up|0|||
130858729|NCT03210961|471110279|FG011|Overall Study|Lost to Follow-up|0|||
130858730|NCT03210961|471110280|FG012|Overall Study|Lost to Follow-up|0|||
130858731|NCT03210961|471110281|FG013|Overall Study|Lost to Follow-up|0|||
130858732|NCT03210961|471110282|FG014|Overall Study|Lost to Follow-up|1|||
130858733|NCT03210961|471110268|FG000|Overall Study|Withdrawal by Subject|0|||
130858734|NCT03210961|471110269|FG001|Overall Study|Withdrawal by Subject|0|||
130858735|NCT03210961|471110270|FG002|Overall Study|Withdrawal by Subject|0|||
130858736|NCT03210961|471110271|FG003|Overall Study|Withdrawal by Subject|0|||
130858737|NCT03210961|471110272|FG004|Overall Study|Withdrawal by Subject|0|||
130858738|NCT03210961|471110273|FG005|Overall Study|Withdrawal by Subject|0|||
130858739|NCT03210961|471110274|FG006|Overall Study|Withdrawal by Subject|0|||
130858740|NCT03210961|471110275|FG007|Overall Study|Withdrawal by Subject|0|||
130858741|NCT03210961|471110276|FG008|Overall Study|Withdrawal by Subject|0|||
130858742|NCT03210961|471110277|FG009|Overall Study|Withdrawal by Subject|0|||
130858743|NCT03210961|471110278|FG010|Overall Study|Withdrawal by Subject|0|||
130858744|NCT03210961|471110279|FG011|Overall Study|Withdrawal by Subject|0|||
130858745|NCT03210961|471110280|FG012|Overall Study|Withdrawal by Subject|0|||
130858746|NCT03210961|471110281|FG013|Overall Study|Withdrawal by Subject|0|||
130858747|NCT03210961|471110282|FG014|Overall Study|Withdrawal by Subject|1|||
130858748|NCT03210961|471110268|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858749|NCT03210961|471110269|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858750|NCT03210961|471110270|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858751|NCT03210961|471110271|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858752|NCT03210961|471110272|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858753|NCT03210961|471110273|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858754|NCT03210961|471110274|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858755|NCT03210961|471110275|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858756|NCT03210961|471110276|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858757|NCT03210961|471110277|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858758|NCT03210961|471110278|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858759|NCT03210961|471110279|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858760|NCT03210961|471110280|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858761|NCT03210961|471110281|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
130858762|NCT03210961|471110282|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
130858763|NCT03210961|471110268|FG000|Overall Study|Other|0|||
130858764|NCT03210961|471110269|FG001|Overall Study|Other|0|||
130858765|NCT03210961|471110270|FG002|Overall Study|Other|0|||
130858766|NCT03210961|471110271|FG003|Overall Study|Other|1|||
130858767|NCT03210961|471110272|FG004|Overall Study|Other|0|||
130858768|NCT03210961|471110273|FG005|Overall Study|Other|0|||
130858769|NCT03210961|471110274|FG006|Overall Study|Other|1|||
130858770|NCT03210961|471110275|FG007|Overall Study|Other|0|||
130858771|NCT03210961|471110276|FG008|Overall Study|Other|0|||
130858772|NCT03210961|471110277|FG009|Overall Study|Other|0|||
130858773|NCT03210961|471110278|FG010|Overall Study|Other|1|||
130858774|NCT03210961|471110279|FG011|Overall Study|Other|0|||
130858775|NCT03210961|471110280|FG012|Overall Study|Other|2|||
130858776|NCT03210961|471110281|FG013|Overall Study|Other|2|||
130858777|NCT03210961|471110282|FG014|Overall Study|Other|0|||
130858778|NCT00602420|471110283|FG000|Overall Study|Death|1|||
130858779|NCT00602420|471110284|FG001|Overall Study|Death|4|||
130858780|NCT00602420|471110283|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
130858781|NCT00602420|471110284|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
130858782|NCT00602420|471110283|FG000|Overall Study|Withdrawal by Subject|18|||
130858783|NCT00602420|471110284|FG001|Overall Study|Withdrawal by Subject|17|||
130858784|NCT00602420|471110283|FG000|Overall Study|Adverse Event|1|||
130858785|NCT00602420|471110284|FG001|Overall Study|Adverse Event|0|||
130858786|NCT00703924|471110293|FG000|Overall Study|Withdrawal by Subject|1|||
130858787|NCT00703924|471110294|FG001|Overall Study|Withdrawal by Subject|1|||
130858788|NCT03077919|471110295|FG000|Overall Study|Lost to Follow-up|4|||
130858789|NCT03077919|471110296|FG001|Overall Study|Lost to Follow-up|1|||
130858790|NCT03592368|471110297|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
130858791|NCT03592368|471110298|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
130858792|NCT03592368|471110299|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
130858793|NCT03592368|471110300|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
130858794|NCT03592368|471110297|FG000|Overall Study|Adverse Event|0|||
130858795|NCT03592368|471110298|FG001|Overall Study|Adverse Event|0|||
130858796|NCT03592368|471110299|FG002|Overall Study|Adverse Event|0|||
130858797|NCT03592368|471110300|FG003|Overall Study|Adverse Event|1|||
130858798|NCT03592368|471110297|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
130858799|NCT03592368|471110298|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
130858800|NCT03592368|471110299|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
130858801|NCT03592368|471110300|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
130858802|NCT03499314|471110301|FG000|Overall Study|Time Commitment|1|||
130858803|NCT03499314|471110302|FG001|Overall Study|Time Commitment|2|||
130858804|NCT03499314|471110301|FG000|Overall Study|Medical issue unrelated to research study|1|||
130858805|NCT03499314|471110302|FG001|Overall Study|Medical issue unrelated to research study|1|||
130858806|NCT01618695|471110304|FG000|Core Phase|Adverse Event|4|||
130858807|NCT01618695|471110305|FG001|Core Phase|Adverse Event|5|||
130858808|NCT01618695|471110306|FG002|Core Phase|Adverse Event|15|||
130858809|NCT01618695|471110307|FG003|Core Phase|Adverse Event|20|||
130858810|NCT01618695|471110304|FG000|Core Phase|Lost to Follow-up|0|||
130858811|NCT01618695|471110305|FG001|Core Phase|Lost to Follow-up|0|||
130858812|NCT01618695|471110306|FG002|Core Phase|Lost to Follow-up|1|||
130858813|NCT01618695|471110307|FG003|Core Phase|Lost to Follow-up|0|||
130858814|NCT01618695|471110304|FG000|Core Phase|Withdrawal by Subject|16|||
130858815|NCT01618695|471110305|FG001|Core Phase|Withdrawal by Subject|11|||
130858816|NCT01618695|471110306|FG002|Core Phase|Withdrawal by Subject|9|||
130858817|NCT01618695|471110307|FG003|Core Phase|Withdrawal by Subject|13|||
130858818|NCT01618695|471110304|FG000|Core Phase|Pregnancy|2|||
130858819|NCT01618695|471110305|FG001|Core Phase|Pregnancy|0|||
130858820|NCT01618695|471110306|FG002|Core Phase|Pregnancy|0|||
130858821|NCT01618695|471110307|FG003|Core Phase|Pregnancy|0|||
130858822|NCT01618695|471110304|FG000|Core Phase|Lack of Efficacy|1|||
130858823|NCT01618695|471110305|FG001|Core Phase|Lack of Efficacy|2|||
130858824|NCT01618695|471110306|FG002|Core Phase|Lack of Efficacy|1|||
130858825|NCT01618695|471110307|FG003|Core Phase|Lack of Efficacy|1|||
130858826|NCT01618695|471110304|FG000|Core Phase|Other than specified|1|||
130858827|NCT01618695|471110305|FG001|Core Phase|Other than specified|2|||
130858828|NCT01618695|471110306|FG002|Core Phase|Other than specified|2|||
130858829|NCT01618695|471110307|FG003|Core Phase|Other than specified|2|||
130858830|NCT01618695|471110304|FG000|Core Phase|Not treated|1|||
130858831|NCT01618695|471110305|FG001|Core Phase|Not treated|0|||
130858832|NCT01618695|471110306|FG002|Core Phase|Not treated|2|||
130858833|NCT01618695|471110307|FG003|Core Phase|Not treated|0|||
130858834|NCT01618695|471110304|FG000|Extension Phase|Lack of Efficacy|17|||
130858835|NCT01618695|471110305|FG001|Extension Phase|Lack of Efficacy|33|||
130858836|NCT01618695|471110306|FG002|Extension Phase|Lack of Efficacy|26|||
130858837|NCT01618695|471110307|FG003|Extension Phase|Lack of Efficacy|24|||
130858838|NCT01618695|471110304|FG000|Extension Phase|Pregnancy|2|||
130858839|NCT01618695|471110305|FG001|Extension Phase|Pregnancy|0|||
130858840|NCT01618695|471110306|FG002|Extension Phase|Pregnancy|1|||
130858841|NCT01618695|471110307|FG003|Extension Phase|Pregnancy|1|||
130858842|NCT01618695|471110304|FG000|Extension Phase|Withdrawal by Subject|43|||
130858843|NCT01618695|471110305|FG001|Extension Phase|Withdrawal by Subject|48|||
130858844|NCT01618695|471110306|FG002|Extension Phase|Withdrawal by Subject|42|||
130858845|NCT01618695|471110307|FG003|Extension Phase|Withdrawal by Subject|33|||
130858846|NCT01618695|471110304|FG000|Extension Phase|Adverse Event|18|||
130858847|NCT01618695|471110305|FG001|Extension Phase|Adverse Event|16|||
130858848|NCT01618695|471110306|FG002|Extension Phase|Adverse Event|9|||
130858849|NCT01618695|471110307|FG003|Extension Phase|Adverse Event|20|||
130858850|NCT01618695|471110304|FG000|Extension Phase|Lost to Follow-up|2|||
130858851|NCT01618695|471110305|FG001|Extension Phase|Lost to Follow-up|1|||
130858852|NCT01618695|471110306|FG002|Extension Phase|Lost to Follow-up|1|||
130858853|NCT01618695|471110307|FG003|Extension Phase|Lost to Follow-up|1|||
130858854|NCT01618695|471110304|FG000|Extension Phase|Other than specified|13|||
130858855|NCT01618695|471110305|FG001|Extension Phase|Other than specified|18|||
130858856|NCT01618695|471110306|FG002|Extension Phase|Other than specified|13|||
130858857|NCT01618695|471110307|FG003|Extension Phase|Other than specified|18|||
130858858|NCT02454478|471110310|FG000|Overall Study|Incomplete DLT Evaluation|1|||
130858859|NCT02352753|471110314|FG000|6-Month Dosing Period|Decision by sponsor|2|||
130858860|NCT02352753|471110314|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
130858861|NCT02352753|471110314|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
130858862|NCT02352753|471110314|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
130858863|NCT02352753|471110314|FG000|3-Month Dosing Period|Decision by sponsor|14|||
130858864|NCT02352753|471110314|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
130858865|NCT00539305|471110315|FG000|Overall Study|Adverse Event|1|||
130858866|NCT00539305|471110316|FG001|Overall Study|Adverse Event|0|||
130858867|NCT00539305|471110315|FG000|Overall Study|Substance Use|0|||
130858868|NCT00539305|471110316|FG001|Overall Study|Substance Use|1|||
130858869|NCT00539305|471110315|FG000|Overall Study|Withdrawal by Subject|0|||
130858870|NCT00539305|471110316|FG001|Overall Study|Withdrawal by Subject|1|||
130858871|NCT00413036|471110322|FG000|Overall Study|Adverse Event|44|||
130858872|NCT00413036|471110322|FG000|Overall Study|Lack of Efficacy|129|||
130858873|NCT00413036|471110322|FG000|Overall Study|Withdrawal by Subject|7|||
130858874|NCT00413036|471110322|FG000|Overall Study|Death|9|||
130858875|NCT00413036|471110322|FG000|Overall Study|Other|26|||
130858876|NCT00413036|471110322|FG000|Overall Study|Missing|2|||
130858877|NCT01369641|471110323|FG000|Overall Study|Withdrawal by Subject|1|||
130858878|NCT00774800|471110326|FG000|Intervention 4|Withdrawal by Subject|1|||
130858879|NCT01331109|471110331|FG000|Overall Study|Adverse Event|6|||
130858880|NCT01331109|471110331|FG000|Overall Study|Lack of Efficacy|2|||
130858881|NCT01331109|471110331|FG000|Overall Study|Protocol Violation|3|||
130858882|NCT01331109|471110331|FG000|Overall Study|Withdrawal by Subject|7|||
130858883|NCT01331109|471110331|FG000|Overall Study|Lost to Follow-up|1|||
130858884|NCT01331109|471110331|FG000|Overall Study|Study Terminated by Sponsor|38|||
130858885|NCT00479856|471110332|FG000|Overall Study|Adverse Event|1|||
130858886|NCT00479856|471110332|FG000|Overall Study|Withdrawal by Subject|1|||
130858887|NCT00479856|471110332|FG000|Overall Study|Physician Decision|1|||
130858888|NCT00661622|471110335|FG000|Overall Study|Protocol Violation|1|||
130858889|NCT00661622|471110336|FG001|Overall Study|Protocol Violation|0|||
130858890|NCT03068754|471110340|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
130858891|NCT03068754|471110341|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
130858892|NCT03068754|471110342|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
130858893|NCT03068754|471110343|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
130858894|NCT03068754|471110340|FG000|Randomized Treatment Period (RTP)|Death|2|||
130858895|NCT03068754|471110341|FG001|Randomized Treatment Period (RTP)|Death|2|||
130858896|NCT03068754|471110342|FG002|Randomized Treatment Period (RTP)|Death|0|||
130858897|NCT03068754|471110343|FG003|Randomized Treatment Period (RTP)|Death|0|||
130858898|NCT03068754|471110340|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
130858899|NCT03068754|471110341|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
130858900|NCT03068754|471110342|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
130858901|NCT03068754|471110343|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
130858902|NCT03068754|471110340|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
130858903|NCT03068754|471110341|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
130858904|NCT03068754|471110342|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
130858905|NCT03068754|471110343|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
130858906|NCT03068754|471110340|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
130858907|NCT03068754|471110341|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
130858908|NCT03068754|471110342|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
130858909|NCT03068754|471110343|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
130858910|NCT03068754|471110340|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
130858911|NCT03068754|471110341|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
130858912|NCT03068754|471110342|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
130858913|NCT03068754|471110343|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
130858914|NCT03068754|471110340|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
130858915|NCT03068754|471110341|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
130858916|NCT03068754|471110342|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
130858917|NCT03068754|471110343|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
130858918|NCT03068754|471110340|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
130858919|NCT03068754|471110341|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
130858920|NCT03068754|471110342|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
130858921|NCT03068754|471110343|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
130858922|NCT03068754|471110340|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
130858923|NCT03068754|471110341|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
130858924|NCT03068754|471110342|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
130858925|NCT03068754|471110343|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
130858926|NCT03068754|471110340|FG000|Open Label Extension Period (OLE)|Death|0|||
130858927|NCT03068754|471110341|FG001|Open Label Extension Period (OLE)|Death|0|||
130858928|NCT03068754|471110342|FG002|Open Label Extension Period (OLE)|Death|0|||
130858929|NCT03068754|471110343|FG003|Open Label Extension Period (OLE)|Death|1|||
130858930|NCT03068754|471110340|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
130858931|NCT03068754|471110341|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
130858932|NCT03068754|471110342|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
130858933|NCT03068754|471110343|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
130858934|NCT03068754|471110340|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
130858935|NCT03068754|471110341|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
130858936|NCT03068754|471110342|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
130858937|NCT03068754|471110343|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
130858938|NCT03068754|471110340|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
130858939|NCT03068754|471110341|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
130858940|NCT03068754|471110342|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
130858941|NCT03068754|471110343|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
130858942|NCT03068754|471110340|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
130858943|NCT03068754|471110341|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
130858944|NCT03068754|471110342|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
130858945|NCT03068754|471110343|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
130858946|NCT02760810|471110345|FG000|Overall Study|Protocol Violation|1|||
130858947|NCT00820222|471110346|FG000|Overall Study|Lost to Follow-up|10|||
130858948|NCT00820222|471110347|FG001|Overall Study|Lost to Follow-up|9|||
130858949|NCT00820222|471110346|FG000|Overall Study|Withdrawal by Subject|19|||
130858950|NCT00820222|471110347|FG001|Overall Study|Withdrawal by Subject|21|||
130858951|NCT00820222|471110346|FG000|Overall Study|Physician Decision|93|||
130858952|NCT00820222|471110347|FG001|Overall Study|Physician Decision|88|||
130858953|NCT00820222|471110346|FG000|Overall Study|Sponsor Terminated Study|43|||
130858954|NCT00820222|471110347|FG001|Overall Study|Sponsor Terminated Study|65|||
130858955|NCT00820222|471110346|FG000|Overall Study|Unkown|11|||
130858956|NCT00820222|471110347|FG001|Overall Study|Unkown|7|||
130858957|NCT00932165|471110348|FG000|Overall Study|Lost to Follow-up|1|||
130858958|NCT00588094|471110349|FG000|Overall Study|Adverse Event|3|||
130858959|NCT00588094|471110349|FG000|Overall Study|Progression of Disease|2|||
130858960|NCT01336023|471110350|FG000|Week 0 to Week 26|Adverse Event|8|||
130858961|NCT01336023|471110351|FG001|Week 0 to Week 26|Adverse Event|10|||
130858962|NCT01336023|471110352|FG002|Week 0 to Week 26|Adverse Event|24|||
130858963|NCT01336023|471110350|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
130858964|NCT01336023|471110351|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
130858965|NCT01336023|471110352|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
130858966|NCT01336023|471110350|FG000|Week 0 to Week 26|Protocol Violation|1|||
130858967|NCT01336023|471110351|FG001|Week 0 to Week 26|Protocol Violation|2|||
130858968|NCT01336023|471110352|FG002|Week 0 to Week 26|Protocol Violation|0|||
130858969|NCT01336023|471110350|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
130858970|NCT01336023|471110351|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
130858971|NCT01336023|471110352|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
130858972|NCT01336023|471110350|FG000|Week 0 to Week 26|Unclassified|5|||
130858973|NCT01336023|471110351|FG001|Week 0 to Week 26|Unclassified|16|||
130858974|NCT01336023|471110352|FG002|Week 0 to Week 26|Unclassified|9|||
130858975|NCT01336023|471110350|FG000|Week 27 to 52|Adverse Event|1|||
130858976|NCT01336023|471110351|FG001|Week 27 to 52|Adverse Event|5|||
130858977|NCT01336023|471110352|FG002|Week 27 to 52|Adverse Event|2|||
130858978|NCT01336023|471110350|FG000|Week 27 to 52|Protocol Violation|0|||
130858979|NCT01336023|471110351|FG001|Week 27 to 52|Protocol Violation|2|||
130858980|NCT01336023|471110352|FG002|Week 27 to 52|Protocol Violation|1|||
130858981|NCT01336023|471110350|FG000|Week 27 to 52|Withdrawal Criteria|14|||
130858982|NCT01336023|471110351|FG001|Week 27 to 52|Withdrawal Criteria|19|||
130858983|NCT01336023|471110352|FG002|Week 27 to 52|Withdrawal Criteria|16|||
130858984|NCT01336023|471110350|FG000|Week 27 to 52|Unclassified|13|||
130858985|NCT01336023|471110351|FG001|Week 27 to 52|Unclassified|18|||
130858986|NCT01336023|471110352|FG002|Week 27 to 52|Unclassified|9|||
130858987|NCT04496453|471110361|FG000|Overall Study|Lost to Follow-up|6|||
130858988|NCT03997825|471110362|FG000|Overall Study|Death|3|||
130858989|NCT03997825|471110362|FG000|Overall Study|Lost to Follow-up|10|||
130858990|NCT03997825|471110362|FG000|Overall Study|Withdrawal by Subject|3|||
130858991|NCT03997825|471110362|FG000|Overall Study|Refused participation|1|||
130858992|NCT00383162|471110363|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
130858993|NCT00383162|471110364|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
130858994|NCT00383162|471110363|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
130858995|NCT00383162|471110364|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
130858996|NCT00383162|471110363|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
130858997|NCT00383162|471110364|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
130858998|NCT00383162|471110363|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
130858999|NCT00383162|471110364|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
130859000|NCT00383162|471110363|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
130859001|NCT00383162|471110364|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
130859002|NCT00383162|471110363|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
130859003|NCT00383162|471110364|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
130859004|NCT00383162|471110363|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
130859005|NCT00383162|471110364|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
130859006|NCT00383162|471110363|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
130859007|NCT00383162|471110364|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
130859008|NCT00383162|471110363|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
130859009|NCT00383162|471110364|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
130859010|NCT00767819|471110365|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
130859011|NCT00767819|471110366|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
130859012|NCT00767819|471110367|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130859013|NCT00767819|471110365|FG000|Overall Study|Withdrawal by Subject|1|||
130859014|NCT00767819|471110366|FG001|Overall Study|Withdrawal by Subject|1|||
130859015|NCT00767819|471110367|FG002|Overall Study|Withdrawal by Subject|0|||
130859016|NCT00767819|471110365|FG000|Overall Study|Administrative problems|0|||
130859017|NCT00767819|471110366|FG001|Overall Study|Administrative problems|1|||
130859018|NCT00767819|471110367|FG002|Overall Study|Administrative problems|0|||
130859019|NCT00767819|471110365|FG000|Overall Study|Death|2|||
130859020|NCT00767819|471110366|FG001|Overall Study|Death|3|||
130859021|NCT00767819|471110367|FG002|Overall Study|Death|0|||
130859022|NCT00767819|471110365|FG000|Overall Study|Adverse Event|2|||
130859023|NCT00767819|471110366|FG001|Overall Study|Adverse Event|0|||
130859024|NCT00767819|471110367|FG002|Overall Study|Adverse Event|0|||
130859025|NCT00767819|471110365|FG000|Overall Study|Abnormal lab values|1|||
130859026|NCT00767819|471110366|FG001|Overall Study|Abnormal lab values|0|||
130859027|NCT00767819|471110367|FG002|Overall Study|Abnormal lab values|0|||
130859028|NCT00767819|471110365|FG000|Overall Study|Lost to Follow-up|1|||
130859029|NCT00767819|471110366|FG001|Overall Study|Lost to Follow-up|0|||
130859030|NCT00767819|471110367|FG002|Overall Study|Lost to Follow-up|0|||
130859031|NCT02726022|471110369|FG000|Overall Study|Adverse Event|14|||
130859032|NCT02726022|471110369|FG000|Overall Study|Treatment Failure|8|||
130859033|NCT02726022|471110369|FG000|Overall Study|Poor Compliance|13|||
130859034|NCT02726022|471110369|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
130859035|NCT00915551|471110370|FG000|Overall Study|Withdrawal by Subject|0|||
130859036|NCT00915551|471110371|FG001|Overall Study|Withdrawal by Subject|1|||
130859037|NCT00235716|471110372|FG000|Overall Study|Death|26|||
130859038|NCT00235716|471110373|FG001|Overall Study|Death|39|||
130859039|NCT00235716|471110374|FG002|Overall Study|Death|32|||
130859040|NCT00235716|471110375|FG003|Overall Study|Death|31|||
130859041|NCT00235716|471110372|FG000|Overall Study|Withdrawal by Subject|23|||
130859042|NCT00235716|471110373|FG001|Overall Study|Withdrawal by Subject|19|||
130859043|NCT00235716|471110374|FG002|Overall Study|Withdrawal by Subject|17|||
130859044|NCT00235716|471110375|FG003|Overall Study|Withdrawal by Subject|18|||
130859045|NCT00235716|471110372|FG000|Overall Study|Lost to Follow-up|12|||
130859046|NCT00235716|471110373|FG001|Overall Study|Lost to Follow-up|7|||
130859047|NCT00235716|471110374|FG002|Overall Study|Lost to Follow-up|14|||
130859048|NCT00235716|471110375|FG003|Overall Study|Lost to Follow-up|10|||
130859049|NCT00235716|471110372|FG000|Overall Study|Adverse Event|1|||
130859050|NCT00235716|471110373|FG001|Overall Study|Adverse Event|1|||
130859051|NCT00235716|471110374|FG002|Overall Study|Adverse Event|1|||
130859052|NCT00235716|471110375|FG003|Overall Study|Adverse Event|0|||
130859053|NCT00235716|471110372|FG000|Overall Study|Physician Decision|0|||
130859054|NCT00235716|471110373|FG001|Overall Study|Physician Decision|1|||
130859055|NCT00235716|471110374|FG002|Overall Study|Physician Decision|1|||
130859056|NCT00235716|471110375|FG003|Overall Study|Physician Decision|3|||
130859057|NCT04390841|471110376|FG000|Overall Study|Withdrawal by Subject|2|||
130859058|NCT02891382|471110389|FG000|Overall Study|Lost to Follow-up|3|||
130859059|NCT02891382|471110390|FG001|Overall Study|Lost to Follow-up|4|||
130859060|NCT02891382|471110391|FG002|Overall Study|Lost to Follow-up|5|||
130859061|NCT02891382|471110392|FG003|Overall Study|Lost to Follow-up|3|||
130859062|NCT02891382|471110393|FG004|Overall Study|Lost to Follow-up|4|||
130859063|NCT02554981|471110396|FG000|Overall Study|Adverse Event|1|||
130859064|NCT02554981|471110396|FG000|Overall Study|Administrative Reasons|1|||
130859065|NCT02554981|471110396|FG000|Overall Study|Other Miscellaneous Reasons|3|||
130859066|NCT01114438|471110397|FG000|Overall Study|Adverse Event|10|||
130859067|NCT01114438|471110397|FG000|Overall Study|concomitant medication|1|||
130859068|NCT01114438|471110397|FG000|Overall Study|Physician Decision|1|||
130859069|NCT01114438|471110397|FG000|Overall Study|Withdrawal by Subject|2|||
130859070|NCT00428844|471110400|FG000|Completed Study Drug Treatment|Adverse Event|2|||
130859071|NCT00428844|471110401|FG001|Completed Study Drug Treatment|Adverse Event|4|||
130859072|NCT00428844|471110402|FG002|Completed Study Drug Treatment|Adverse Event|4|||
130859073|NCT00428844|471110400|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
130859074|NCT00428844|471110401|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
130859075|NCT00428844|471110402|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
130859076|NCT00428844|471110400|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
130859077|NCT00428844|471110401|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
130859078|NCT00428844|471110402|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
130859079|NCT00428844|471110400|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
130859080|NCT00428844|471110401|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
130859081|NCT00428844|471110402|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
130859082|NCT00428844|471110400|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
130859083|NCT00428844|471110401|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
130859084|NCT00428844|471110402|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
130859085|NCT00428844|471110400|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
130859086|NCT00428844|471110401|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
130859087|NCT00428844|471110402|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
130859088|NCT00428844|471110400|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
130859089|NCT00428844|471110401|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
130859090|NCT00428844|471110402|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
130859091|NCT00428844|471110400|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
130859092|NCT00428844|471110401|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
130859093|NCT00428844|471110402|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
130859094|NCT00428844|471110400|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
130859095|NCT00428844|471110401|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
130859096|NCT00428844|471110402|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
130859097|NCT00488826|471110405|FG000|Overall Study|Withdrawal by Subject|40|||
130859098|NCT00488826|471110406|FG001|Overall Study|Withdrawal by Subject|35|||
130859099|NCT00488826|471110407|FG002|Overall Study|Withdrawal by Subject|19|||
130859100|NCT00488826|471110405|FG000|Overall Study|Protocol Violation|0|||
130859101|NCT00488826|471110406|FG001|Overall Study|Protocol Violation|0|||
130859102|NCT00488826|471110407|FG002|Overall Study|Protocol Violation|2|||
130859103|NCT00488826|471110405|FG000|Overall Study|Adverse Event|9|||
130859104|NCT00488826|471110406|FG001|Overall Study|Adverse Event|15|||
130859105|NCT00488826|471110407|FG002|Overall Study|Adverse Event|4|||
130859106|NCT00488826|471110405|FG000|Overall Study|Lost to Follow-up|5|||
130859107|NCT00488826|471110406|FG001|Overall Study|Lost to Follow-up|1|||
130859108|NCT00488826|471110407|FG002|Overall Study|Lost to Follow-up|0|||
130859109|NCT00488826|471110405|FG000|Overall Study|Protocol Deviations|2|||
130859110|NCT00488826|471110406|FG001|Overall Study|Protocol Deviations|1|||
130859111|NCT00488826|471110407|FG002|Overall Study|Protocol Deviations|1|||
130859112|NCT02292706|471110408|FG000|Overall Study|Lost to Follow-up|20|||
130859113|NCT02292706|471110409|FG001|Overall Study|Lost to Follow-up|44|||
130859114|NCT02292706|471110410|FG002|Overall Study|Lost to Follow-up|24|||
130859115|NCT02292706|471110411|FG003|Overall Study|Lost to Follow-up|61|||
130859116|NCT02292706|471110412|FG004|Overall Study|Lost to Follow-up|21|||
130859117|NCT02292706|471110413|FG005|Overall Study|Lost to Follow-up|52|||
130859118|NCT02292706|471110414|FG006|Overall Study|Lost to Follow-up|25|||
130859119|NCT02292706|471110415|FG007|Overall Study|Lost to Follow-up|0|||
130859120|NCT02292706|471110408|FG000|Overall Study|Withdrew consent|15|||
130859121|NCT02292706|471110409|FG001|Overall Study|Withdrew consent|56|||
130859122|NCT02292706|471110410|FG002|Overall Study|Withdrew consent|43|||
130859123|NCT02292706|471110411|FG003|Overall Study|Withdrew consent|36|||
130859124|NCT02292706|471110412|FG004|Overall Study|Withdrew consent|13|||
130859125|NCT02292706|471110413|FG005|Overall Study|Withdrew consent|51|||
130859126|NCT02292706|471110414|FG006|Overall Study|Withdrew consent|20|||
130859127|NCT02292706|471110415|FG007|Overall Study|Withdrew consent|0|||
130859128|NCT02292706|471110408|FG000|Overall Study|Death|3|||
130859129|NCT02292706|471110409|FG001|Overall Study|Death|11|||
130859130|NCT02292706|471110410|FG002|Overall Study|Death|16|||
130859131|NCT02292706|471110411|FG003|Overall Study|Death|22|||
130859132|NCT02292706|471110412|FG004|Overall Study|Death|8|||
130859133|NCT02292706|471110413|FG005|Overall Study|Death|17|||
130859134|NCT02292706|471110414|FG006|Overall Study|Death|3|||
130859135|NCT02292706|471110415|FG007|Overall Study|Death|0|||
130859136|NCT02292706|471110408|FG000|Overall Study|Study terminated by sponsor|0|||
130859137|NCT02292706|471110409|FG001|Overall Study|Study terminated by sponsor|9|||
130859138|NCT02292706|471110410|FG002|Overall Study|Study terminated by sponsor|4|||
130859139|NCT02292706|471110411|FG003|Overall Study|Study terminated by sponsor|21|||
130859140|NCT02292706|471110412|FG004|Overall Study|Study terminated by sponsor|11|||
130859141|NCT02292706|471110413|FG005|Overall Study|Study terminated by sponsor|13|||
130859142|NCT02292706|471110414|FG006|Overall Study|Study terminated by sponsor|3|||
130859143|NCT02292706|471110415|FG007|Overall Study|Study terminated by sponsor|0|||
130859144|NCT02292706|471110408|FG000|Overall Study|Investigator's discretion|4|||
130859145|NCT02292706|471110409|FG001|Overall Study|Investigator's discretion|9|||
130859146|NCT02292706|471110410|FG002|Overall Study|Investigator's discretion|7|||
130859147|NCT02292706|471110411|FG003|Overall Study|Investigator's discretion|11|||
130859148|NCT02292706|471110412|FG004|Overall Study|Investigator's discretion|4|||
130859149|NCT02292706|471110413|FG005|Overall Study|Investigator's discretion|10|||
130859150|NCT02292706|471110414|FG006|Overall Study|Investigator's discretion|1|||
130859151|NCT02292706|471110415|FG007|Overall Study|Investigator's discretion|0|||
130859152|NCT02292706|471110408|FG000|Overall Study|Liver transplant|1|||
130859153|NCT02292706|471110409|FG001|Overall Study|Liver transplant|1|||
130859154|NCT02292706|471110410|FG002|Overall Study|Liver transplant|11|||
130859155|NCT02292706|471110411|FG003|Overall Study|Liver transplant|16|||
130859156|NCT02292706|471110412|FG004|Overall Study|Liver transplant|5|||
130859157|NCT02292706|471110413|FG005|Overall Study|Liver transplant|6|||
130859158|NCT02292706|471110414|FG006|Overall Study|Liver transplant|5|||
130859159|NCT02292706|471110415|FG007|Overall Study|Liver transplant|0|||
130859160|NCT02292706|471110408|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
130859161|NCT02292706|471110409|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
130859162|NCT02292706|471110410|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
130859163|NCT02292706|471110411|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
130859164|NCT02292706|471110412|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
130859165|NCT02292706|471110413|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
130859166|NCT02292706|471110414|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
130859167|NCT02292706|471110415|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
130859168|NCT02292706|471110408|FG000|Overall Study|Subject terminated by sponsor|1|||
130859169|NCT02292706|471110409|FG001|Overall Study|Subject terminated by sponsor|0|||
130859170|NCT02292706|471110410|FG002|Overall Study|Subject terminated by sponsor|0|||
130859171|NCT02292706|471110411|FG003|Overall Study|Subject terminated by sponsor|2|||
130859172|NCT02292706|471110412|FG004|Overall Study|Subject terminated by sponsor|1|||
130859173|NCT02292706|471110413|FG005|Overall Study|Subject terminated by sponsor|0|||
130859174|NCT02292706|471110414|FG006|Overall Study|Subject terminated by sponsor|0|||
130859175|NCT02292706|471110415|FG007|Overall Study|Subject terminated by sponsor|0|||
130859176|NCT02292706|471110408|FG000|Overall Study|Missing|0|||
130859177|NCT02292706|471110409|FG001|Overall Study|Missing|0|||
130859178|NCT02292706|471110410|FG002|Overall Study|Missing|1|||
130859179|NCT02292706|471110411|FG003|Overall Study|Missing|1|||
130859180|NCT02292706|471110412|FG004|Overall Study|Missing|0|||
130859181|NCT02292706|471110413|FG005|Overall Study|Missing|1|||
130859182|NCT02292706|471110414|FG006|Overall Study|Missing|0|||
130859183|NCT02292706|471110415|FG007|Overall Study|Missing|0|||
130859184|NCT02292706|471110408|FG000|Overall Study|Virologic relapse or reinfection|1|||
130859185|NCT02292706|471110409|FG001|Overall Study|Virologic relapse or reinfection|0|||
130859186|NCT02292706|471110410|FG002|Overall Study|Virologic relapse or reinfection|0|||
130859187|NCT02292706|471110411|FG003|Overall Study|Virologic relapse or reinfection|1|||
130859188|NCT02292706|471110412|FG004|Overall Study|Virologic relapse or reinfection|0|||
130859189|NCT02292706|471110413|FG005|Overall Study|Virologic relapse or reinfection|1|||
130859190|NCT02292706|471110414|FG006|Overall Study|Virologic relapse or reinfection|0|||
130859191|NCT02292706|471110415|FG007|Overall Study|Virologic relapse or reinfection|0|||
130859192|NCT02725866|471110418|FG000|Overall Study|Failure to return|6|||
130859193|NCT02725866|471110418|FG000|Overall Study|Withdrew consent|3|||
130859194|NCT02725866|471110418|FG000|Overall Study|Insufficient virological response|1|||
130859195|NCT02725866|471110418|FG000|Overall Study|Other, not specified|4|||
130859196|NCT03043651|471110424|FG000|Overall Study|Death|1|||
130859197|NCT03043651|471110424|FG000|Overall Study|Progressive Disease|2|||
130859198|NCT03043651|471110424|FG000|Overall Study|Adverse Event|2|||
130859199|NCT03043651|471110424|FG000|Overall Study|Withdrawal by Subject|4|||
130859200|NCT03043651|471110424|FG000|Overall Study|Study Terminated by Sponsor|39|||
130859201|NCT03597061|471110432|FG000|Overall Study|Lost to Follow-up|1|||
130859202|NCT03597061|471110433|FG001|Overall Study|Lost to Follow-up|0|||
130859203|NCT03597061|471110432|FG000|Overall Study|Protocol Violation|0|||
130859204|NCT03597061|471110433|FG001|Overall Study|Protocol Violation|1|||
130859205|NCT00411632|471110434|FG000|Overall Study|Death|1|||
130859206|NCT00761527|471110435|FG000|Overall Study|Adverse Event|3|||
130859207|NCT00761527|471110435|FG000|Overall Study|Poor Compliance|8|||
130859208|NCT00761527|471110435|FG000|Overall Study|Lost to Follow-up|9|||
130859209|NCT00761527|471110435|FG000|Overall Study|Unknown reason|2|||
130859210|NCT01431963|471110436|FG000|Overall Study|Adverse Event|18|||
130859211|NCT01431963|471110436|FG000|Overall Study|Lack of Efficacy|7|||
130859212|NCT01431963|471110436|FG000|Overall Study|Protocol Violation|1|||
130859213|NCT01431963|471110436|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
130859214|NCT01431963|471110436|FG000|Overall Study|Physician Decision|4|||
130859215|NCT01431963|471110436|FG000|Overall Study|Withdrawal by Subject|3|||
130859216|NCT02921087|471110439|FG000|Overall Study|Withdrawal by Subject|0|||
130859217|NCT02921087|471110440|FG001|Overall Study|Withdrawal by Subject|1|||
130859218|NCT00687531|471110441|FG000|Overall Study|Did not meet protocol eligibility|104|||
130859219|NCT00687531|471110441|FG000|Overall Study|Adverse Event|5|||
130859220|NCT00687531|471110441|FG000|Overall Study|Lost to Follow-up|26|||
130859221|NCT00619307|471110442|FG000|Overall Study|Adverse Event|0|||
130859222|NCT00619307|471110443|FG001|Overall Study|Adverse Event|1|||
130859223|NCT00619307|471110442|FG000|Overall Study|Lost to Follow-up|0|||
130859224|NCT00619307|471110443|FG001|Overall Study|Lost to Follow-up|1|||
130859225|NCT00619307|471110442|FG000|Overall Study|Protocol Violation|3|||
130859226|NCT00619307|471110443|FG001|Overall Study|Protocol Violation|0|||
130859227|NCT00619307|471110442|FG000|Overall Study|Withdrew consent|1|||
130859228|NCT00619307|471110443|FG001|Overall Study|Withdrew consent|0|||
130859229|NCT00619307|471110442|FG000|Overall Study|Severe migraine|0|||
130859230|NCT00619307|471110443|FG001|Overall Study|Severe migraine|1|||
130859231|NCT00619307|471110442|FG000|Overall Study|MS attack plus steroids|0|||
130859232|NCT00619307|471110443|FG001|Overall Study|MS attack plus steroids|1|||
130859233|NCT03109184|471112081|FG000|Overall Study|Lost to Follow-up|6|||
130859234|NCT03109184|471112082|FG001|Overall Study|Lost to Follow-up|6|||
130859235|NCT03109184|471112081|FG000|Overall Study|Withdrawal by Subject|1|||
130859236|NCT03109184|471112082|FG001|Overall Study|Withdrawal by Subject|1|||
130859237|NCT01031979|471112085|FG000|Overall Study|Lost to Follow-up|5|||
130859238|NCT01031979|471112086|FG001|Overall Study|Lost to Follow-up|4|||
130859239|NCT03831100|471112088|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
130859240|NCT03831100|471112089|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
130859241|NCT02008227|471112093|FG000|Overall Study|Lost to Follow-up|7|||
130859242|NCT02008227|471112094|FG001|Overall Study|Lost to Follow-up|9|||
130859243|NCT02008227|471112093|FG000|Overall Study|Death|494|||
130859244|NCT02008227|471112094|FG001|Overall Study|Death|485|||
130859245|NCT02008227|471112093|FG000|Overall Study|Withdrawal by Subject|67|||
130859246|NCT02008227|471112094|FG001|Overall Study|Withdrawal by Subject|36|||
130859247|NCT02008227|471112093|FG000|Overall Study|Study Terminated By Sponsor|44|||
130859248|NCT02008227|471112094|FG001|Overall Study|Study Terminated By Sponsor|83|||
130859249|NCT01487265|471112097|FG000|Overall Study|Adverse Event|8|||
130859250|NCT01487265|471112097|FG000|Overall Study|Withdrawal by Subject|5|||
130859251|NCT01487265|471112097|FG000|Overall Study|Disease Progression|21|||
130859252|NCT01487265|471112097|FG000|Overall Study|Death|2|||
130859253|NCT01487265|471112097|FG000|Overall Study|Still on Treatment|1|||
130859254|NCT00965575|471112098|FG000|Overall Study|subject unwillingness to swallow study c|1|||
130859255|NCT00965575|471112099|FG001|Overall Study|subject unwillingness to swallow study c|0|||
130859256|NCT01959841|471112100|FG000|Overall Study|Adverse Event|1|||
130859257|NCT01959841|471112101|FG001|Overall Study|Adverse Event|3|||
130859258|NCT01959841|471112102|FG002|Overall Study|Adverse Event|2|||
130859259|NCT01959841|471112100|FG000|Overall Study|Lack of Efficacy|5|||
130859260|NCT01959841|471112101|FG001|Overall Study|Lack of Efficacy|0|||
130859261|NCT01959841|471112102|FG002|Overall Study|Lack of Efficacy|0|||
130859262|NCT01959841|471112100|FG000|Overall Study|Lost to Follow-up|1|||
130859263|NCT01959841|471112101|FG001|Overall Study|Lost to Follow-up|1|||
130859264|NCT01959841|471112102|FG002|Overall Study|Lost to Follow-up|0|||
130859265|NCT01959841|471112100|FG000|Overall Study|Physician Decision|0|||
130859266|NCT01959841|471112101|FG001|Overall Study|Physician Decision|2|||
130859267|NCT01959841|471112102|FG002|Overall Study|Physician Decision|3|||
130859268|NCT01959841|471112100|FG000|Overall Study|Protocol Violation|16|||
130859269|NCT01959841|471112101|FG001|Overall Study|Protocol Violation|23|||
130859270|NCT01959841|471112102|FG002|Overall Study|Protocol Violation|16|||
130859271|NCT01959841|471112100|FG000|Overall Study|Withdrawal by Subject|7|||
130859272|NCT01959841|471112101|FG001|Overall Study|Withdrawal by Subject|7|||
130859273|NCT01959841|471112102|FG002|Overall Study|Withdrawal by Subject|5|||
130859274|NCT01959841|471112100|FG000|Overall Study|Clinical laboratory value|2|||
130859275|NCT01959841|471112101|FG001|Overall Study|Clinical laboratory value|6|||
130859276|NCT01959841|471112102|FG002|Overall Study|Clinical laboratory value|6|||
130859277|NCT01959841|471112100|FG000|Overall Study|Platelet count below on day1 or 4|11|||
130859278|NCT01959841|471112101|FG001|Overall Study|Platelet count below on day1 or 4|15|||
130859279|NCT01959841|471112102|FG002|Overall Study|Platelet count below on day1 or 4|11|||
130859280|NCT00780416|471112103|FG000|Overall Study|Physician Decision|3|||
130859281|NCT00780416|471112104|FG001|Overall Study|Physician Decision|3|||
130859282|NCT00780416|471112103|FG000|Overall Study|Protocol Violation|1|||
130859283|NCT00780416|471112104|FG001|Overall Study|Protocol Violation|0|||
130859284|NCT00780416|471112103|FG000|Overall Study|Withdrawal by Subject|8|||
130859285|NCT00780416|471112104|FG001|Overall Study|Withdrawal by Subject|6|||
130859286|NCT00666224|471112105|FG000|Double-Blind|Adverse Event|15|||
130859287|NCT00666224|471112106|FG001|Double-Blind|Adverse Event|5|||
130859288|NCT00666224|471112105|FG000|Double-Blind|Lost to Follow-up|2|||
130859289|NCT00666224|471112106|FG001|Double-Blind|Lost to Follow-up|2|||
130859290|NCT00666224|471112105|FG000|Double-Blind|Withdrawal by Subject|18|||
130859291|NCT00666224|471112106|FG001|Double-Blind|Withdrawal by Subject|14|||
130859292|NCT00666224|471112105|FG000|Double-Blind|Physician Decision|0|||
130859293|NCT00666224|471112106|FG001|Double-Blind|Physician Decision|3|||
130859294|NCT00666224|471112105|FG000|Double-Blind|Sponsor decision|1|||
130859295|NCT00666224|471112106|FG001|Double-Blind|Sponsor decision|0|||
130859296|NCT00666224|471112105|FG000|Double-Blind|Pregnancy|3|||
130859297|NCT00666224|471112106|FG001|Double-Blind|Pregnancy|2|||
130859298|NCT00666224|471112105|FG000|Double-Blind|Noncompliance|1|||
130859299|NCT00666224|471112106|FG001|Double-Blind|Noncompliance|0|||
130859300|NCT00666224|471112105|FG000|Double-Blind|Death|1|||
130859301|NCT00666224|471112106|FG001|Double-Blind|Death|0|||
130859302|NCT00666224|471112105|FG000|Double-Blind|Undefined/Unknown|4|||
130859303|NCT00666224|471112106|FG001|Double-Blind|Undefined/Unknown|1|||
130859304|NCT00666224|471112105|FG000|Open-Label|Adverse Event|8|||
130859305|NCT00666224|471112106|FG001|Open-Label|Adverse Event|43|||
130859306|NCT00666224|471112105|FG000|Open-Label|Lost to Follow-up|4|||
130859307|NCT00666224|471112106|FG001|Open-Label|Lost to Follow-up|5|||
130859308|NCT00666224|471112105|FG000|Open-Label|Withdrawal by Subject|12|||
130859309|NCT00666224|471112106|FG001|Open-Label|Withdrawal by Subject|25|||
130859310|NCT00666224|471112105|FG000|Open-Label|Physician Decision|7|||
130859311|NCT00666224|471112106|FG001|Open-Label|Physician Decision|5|||
130859312|NCT00666224|471112105|FG000|Open-Label|Pregnancy|1|||
130859313|NCT00666224|471112106|FG001|Open-Label|Pregnancy|5|||
130859314|NCT00666224|471112105|FG000|Open-Label|Noncompliance|2|||
130859315|NCT00666224|471112106|FG001|Open-Label|Noncompliance|1|||
130859316|NCT00666224|471112105|FG000|Open-Label|Undefined/Unknown|1|||
130859317|NCT00666224|471112106|FG001|Open-Label|Undefined/Unknown|1|||
130859318|NCT03521141|471112110|FG000|Overall Study|Death|1|||
130859319|NCT03521141|471112111|FG001|Overall Study|Death|0|||
130859320|NCT03521141|471112112|FG002|Overall Study|Death|1|||
130859321|NCT01271725|471112119|FG000|Part A|Progressive disease according to RECIST|8|||
130859322|NCT01271725|471112120|FG001|Part A|Progressive disease according to RECIST|0|||
130859323|NCT01271725|471112119|FG000|Part A|Clinical signs/symptoms of progression|2|||
130859324|NCT01271725|471112120|FG001|Part A|Clinical signs/symptoms of progression|0|||
130859325|NCT01271725|471112119|FG000|Part A|Other Adverse Event|8|||
130859326|NCT01271725|471112120|FG001|Part A|Other Adverse Event|0|||
130859327|NCT01271725|471112119|FG000|Part A|Lost to Follow-up|1|||
130859328|NCT01271725|471112120|FG001|Part A|Lost to Follow-up|0|||
130859329|NCT01271725|471112119|FG000|Part A|Withdrawal by Subject|12|||
130859330|NCT01271725|471112120|FG001|Part A|Withdrawal by Subject|0|||
130859331|NCT01271725|471112119|FG000|Part A|Other than specified|3|||
130859332|NCT01271725|471112120|FG001|Part A|Other than specified|0|||
130859333|NCT01271725|471112119|FG000|Part A|Protocol Violation|1|||
130859334|NCT01271725|471112120|FG001|Part A|Protocol Violation|0|||
130859335|NCT01271725|471112119|FG000|Part B|Other than specified|0|||
130859336|NCT01271725|471112120|FG001|Part B|Other than specified|2|||
130859337|NCT01271725|471112119|FG000|Part B|Clinical signs/symptoms of progression|0|||
130859338|NCT01271725|471112120|FG001|Part B|Clinical signs/symptoms of progression|2|||
130859339|NCT01271725|471112119|FG000|Part B|Other Adverse Event|0|||
130859340|NCT01271725|471112120|FG001|Part B|Other Adverse Event|1|||
130859341|NCT01271725|471112119|FG000|Part B|Protocol Violation|0|||
130859342|NCT01271725|471112120|FG001|Part B|Protocol Violation|1|||
130859343|NCT01271725|471112119|FG000|Part B|Withdrawal by Subject|0|||
130859344|NCT01271725|471112120|FG001|Part B|Withdrawal by Subject|6|||
130859345|NCT01702025|471112121|FG000|Overall Study|Equipment failure|1|||
130859346|NCT01702025|471112122|FG001|Overall Study|Equipment failure|0|||
130859347|NCT01702025|471112123|FG002|Overall Study|Equipment failure|0|||
130859348|NCT01702025|471112124|FG003|Overall Study|Equipment failure|0|||
130859349|NCT01702025|471112121|FG000|Overall Study|Adverse Event|1|||
130859350|NCT01702025|471112122|FG001|Overall Study|Adverse Event|1|||
130859351|NCT01702025|471112123|FG002|Overall Study|Adverse Event|1|||
130859352|NCT01702025|471112124|FG003|Overall Study|Adverse Event|0|||
130859353|NCT03354273|471112125|FG000|Overall Study|Adverse Event|5|||
130859354|NCT03354273|471112125|FG000|Overall Study|Screen Failure|21|||
130859355|NCT03354273|471112125|FG000|Overall Study|Withdrawal by Subject|34|||
130859356|NCT03354273|471112125|FG000|Overall Study|Technical Problems|30|||
130859357|NCT03354273|471112125|FG000|Overall Study|Lost to Follow-up|4|||
130859358|NCT03354273|471112125|FG000|Overall Study|Investigator Decision|3|||
130859359|NCT03354273|471112125|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
130859360|NCT03354273|471112125|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
130859361|NCT03354273|471112125|FG000|Overall Study|COVID-19 Restrictions|9|||
130859362|NCT03354273|471112125|FG000|Overall Study|Other|5|||
130859363|NCT03229109|471112131|FG000|Overall Study|Withdrawal by Subject|0|||
130859364|NCT03229109|471112132|FG001|Overall Study|Withdrawal by Subject|0|||
130859365|NCT03229109|471112133|FG002|Overall Study|Withdrawal by Subject|0|||
130859366|NCT03229109|471112134|FG003|Overall Study|Withdrawal by Subject|1|||
130859367|NCT04207749|471112135|FG000|Overall Study|Lost to Follow-up|0|||
130859368|NCT04207749|471112136|FG001|Overall Study|Lost to Follow-up|2|||
130859369|NCT04207749|471112135|FG000|Overall Study|Protocol Violation|0|||
130859370|NCT04207749|471112136|FG001|Overall Study|Protocol Violation|1|||
130859371|NCT04207749|471112135|FG000|Overall Study|Withdrawal by Subject|3|||
130859372|NCT04207749|471112136|FG001|Overall Study|Withdrawal by Subject|0|||
130859373|NCT04207749|471112135|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
130859374|NCT04207749|471112136|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
130859375|NCT01835223|471112139|FG000|Overall Study|Adverse Event|1|||
130859376|NCT01835223|471112140|FG001|Overall Study|Adverse Event|0|||
130859377|NCT01835223|471112139|FG000|Overall Study|Withdrawal by Subject|2|||
130859378|NCT01835223|471112140|FG001|Overall Study|Withdrawal by Subject|0|||
130859379|NCT01835223|471112139|FG000|Overall Study|Disease progression|2|||
130859380|NCT01835223|471112140|FG001|Overall Study|Disease progression|1|||
130859381|NCT01835223|471112139|FG000|Overall Study|Became Inelligible|4|||
130859382|NCT01835223|471112140|FG001|Overall Study|Became Inelligible|0|||
130859383|NCT01504841|471112144|FG000|Overall Study|Withdrawal by Subject|1|||
130859384|NCT01504841|471112145|FG001|Overall Study|Withdrawal by Subject|1|||
130859385|NCT01504841|471112146|FG002|Overall Study|Withdrawal by Subject|0|||
130859386|NCT03149055|471112151|FG000|Overall Study|Not treated|4|||
130859387|NCT04440813|471112152|FG000|Overall Study|Lost to Follow-up|5|||
130859388|NCT04440813|471112153|FG001|Overall Study|Lost to Follow-up|5|||
130859389|NCT01610336|471112154|FG000|Overall Study|Progressive Disease|4|||
130859390|NCT01610336|471112155|FG001|Overall Study|Progressive Disease|6|||
130859391|NCT01610336|471112156|FG002|Overall Study|Progressive Disease|6|||
130859392|NCT01610336|471112157|FG003|Overall Study|Progressive Disease|5|||
130859393|NCT01610336|471112158|FG004|Overall Study|Progressive Disease|3|||
130859394|NCT01610336|471112159|FG005|Overall Study|Progressive Disease|10|||
130859395|NCT01610336|471112160|FG006|Overall Study|Progressive Disease|1|||
130859396|NCT01610336|471112161|FG007|Overall Study|Progressive Disease|6|||
130859397|NCT01610336|471112162|FG008|Overall Study|Progressive Disease|6|||
130859398|NCT01610336|471112163|FG009|Overall Study|Progressive Disease|40|||
130859399|NCT01610336|471112164|FG010|Overall Study|Progressive Disease|36|||
130859400|NCT01610336|471112154|FG000|Overall Study|Adverse Event|0|||
130859401|NCT01610336|471112155|FG001|Overall Study|Adverse Event|0|||
130859402|NCT01610336|471112156|FG002|Overall Study|Adverse Event|0|||
130859403|NCT01610336|471112157|FG003|Overall Study|Adverse Event|1|||
130859404|NCT01610336|471112158|FG004|Overall Study|Adverse Event|1|||
130859405|NCT01610336|471112159|FG005|Overall Study|Adverse Event|1|||
130859406|NCT01610336|471112160|FG006|Overall Study|Adverse Event|0|||
130859407|NCT01610336|471112161|FG007|Overall Study|Adverse Event|0|||
130859408|NCT01610336|471112162|FG008|Overall Study|Adverse Event|2|||
130859409|NCT01610336|471112163|FG009|Overall Study|Adverse Event|8|||
130859410|NCT01610336|471112164|FG010|Overall Study|Adverse Event|6|||
130859411|NCT01610336|471112154|FG000|Overall Study|Subject/Guardian decision|1|||
130859412|NCT01610336|471112155|FG001|Overall Study|Subject/Guardian decision|1|||
130859413|NCT01610336|471112156|FG002|Overall Study|Subject/Guardian decision|0|||
130859414|NCT01610336|471112157|FG003|Overall Study|Subject/Guardian decision|1|||
130859415|NCT01610336|471112158|FG004|Overall Study|Subject/Guardian decision|0|||
130859416|NCT01610336|471112159|FG005|Overall Study|Subject/Guardian decision|0|||
130859417|NCT01610336|471112160|FG006|Overall Study|Subject/Guardian decision|0|||
130859418|NCT01610336|471112161|FG007|Overall Study|Subject/Guardian decision|1|||
130859419|NCT01610336|471112162|FG008|Overall Study|Subject/Guardian decision|0|||
130859420|NCT01610336|471112163|FG009|Overall Study|Subject/Guardian decision|2|||
130859421|NCT01610336|471112164|FG010|Overall Study|Subject/Guardian decision|2|||
130859422|NCT01610336|471112154|FG000|Overall Study|Death|0|||
130859423|NCT01610336|471112155|FG001|Overall Study|Death|0|||
130859424|NCT01610336|471112156|FG002|Overall Study|Death|0|||
130859425|NCT01610336|471112157|FG003|Overall Study|Death|0|||
130859426|NCT01610336|471112158|FG004|Overall Study|Death|0|||
130859427|NCT01610336|471112159|FG005|Overall Study|Death|1|||
130859428|NCT01610336|471112160|FG006|Overall Study|Death|3|||
130859429|NCT01610336|471112161|FG007|Overall Study|Death|0|||
130859430|NCT01610336|471112162|FG008|Overall Study|Death|0|||
130859431|NCT01610336|471112163|FG009|Overall Study|Death|1|||
130859432|NCT01610336|471112164|FG010|Overall Study|Death|2|||
130859433|NCT01610336|471112154|FG000|Overall Study|Non-Compliance with study treatment|0|||
130859434|NCT01610336|471112155|FG001|Overall Study|Non-Compliance with study treatment|0|||
130859435|NCT01610336|471112156|FG002|Overall Study|Non-Compliance with study treatment|0|||
130859436|NCT01610336|471112157|FG003|Overall Study|Non-Compliance with study treatment|0|||
130859437|NCT01610336|471112158|FG004|Overall Study|Non-Compliance with study treatment|0|||
130859438|NCT01610336|471112159|FG005|Overall Study|Non-Compliance with study treatment|0|||
130859439|NCT01610336|471112160|FG006|Overall Study|Non-Compliance with study treatment|0|||
130859440|NCT01610336|471112161|FG007|Overall Study|Non-Compliance with study treatment|0|||
130859441|NCT01610336|471112162|FG008|Overall Study|Non-Compliance with study treatment|0|||
130859442|NCT01610336|471112163|FG009|Overall Study|Non-Compliance with study treatment|1|||
130859443|NCT01610336|471112164|FG010|Overall Study|Non-Compliance with study treatment|0|||
130859444|NCT01610336|471112154|FG000|Overall Study|Physician Decision|0|||
130859445|NCT01610336|471112155|FG001|Overall Study|Physician Decision|0|||
130859446|NCT01610336|471112156|FG002|Overall Study|Physician Decision|0|||
130859447|NCT01610336|471112157|FG003|Overall Study|Physician Decision|0|||
130859448|NCT01610336|471112158|FG004|Overall Study|Physician Decision|0|||
130859449|NCT01610336|471112159|FG005|Overall Study|Physician Decision|0|||
130859450|NCT01610336|471112160|FG006|Overall Study|Physician Decision|1|||
130859451|NCT01610336|471112161|FG007|Overall Study|Physician Decision|0|||
130859452|NCT01610336|471112162|FG008|Overall Study|Physician Decision|0|||
130859453|NCT01610336|471112163|FG009|Overall Study|Physician Decision|0|||
130859454|NCT01610336|471112164|FG010|Overall Study|Physician Decision|0|||
130859455|NCT01610336|471112154|FG000|Overall Study|Protocol Deviation|0|||
130859456|NCT01610336|471112155|FG001|Overall Study|Protocol Deviation|0|||
130859457|NCT01610336|471112156|FG002|Overall Study|Protocol Deviation|0|||
130859458|NCT01610336|471112157|FG003|Overall Study|Protocol Deviation|0|||
130859459|NCT01610336|471112158|FG004|Overall Study|Protocol Deviation|0|||
130859460|NCT01610336|471112159|FG005|Overall Study|Protocol Deviation|0|||
130859461|NCT01610336|471112160|FG006|Overall Study|Protocol Deviation|0|||
130859462|NCT01610336|471112161|FG007|Overall Study|Protocol Deviation|0|||
130859463|NCT01610336|471112162|FG008|Overall Study|Protocol Deviation|0|||
130859464|NCT01610336|471112163|FG009|Overall Study|Protocol Deviation|1|||
130859465|NCT01610336|471112164|FG010|Overall Study|Protocol Deviation|0|||
130859466|NCT01610336|471112154|FG000|Overall Study|Transfer to another trial|0|||
130859467|NCT01610336|471112155|FG001|Overall Study|Transfer to another trial|0|||
130859468|NCT01610336|471112156|FG002|Overall Study|Transfer to another trial|0|||
130859469|NCT01610336|471112157|FG003|Overall Study|Transfer to another trial|0|||
130859470|NCT01610336|471112158|FG004|Overall Study|Transfer to another trial|0|||
130859471|NCT01610336|471112159|FG005|Overall Study|Transfer to another trial|0|||
130859472|NCT01610336|471112160|FG006|Overall Study|Transfer to another trial|0|||
130859473|NCT01610336|471112161|FG007|Overall Study|Transfer to another trial|0|||
130859474|NCT01610336|471112162|FG008|Overall Study|Transfer to another trial|0|||
130859475|NCT01610336|471112163|FG009|Overall Study|Transfer to another trial|0|||
130859476|NCT01610336|471112164|FG010|Overall Study|Transfer to another trial|1|||
130859477|NCT03679624|471112165|FG000|Overall Study|Adverse Event|1|||
130859478|NCT03679624|471112166|FG001|Overall Study|Adverse Event|0|||
130859479|NCT02629822|471112167|FG000|Base Study|Lost to Follow-up|2|||
130859480|NCT02629822|471112167|FG000|Base Study|Non-Compliance With Study Drug|1|||
130859481|NCT02629822|471112167|FG000|Extension Study|Adverse Event|1|||
130859482|NCT02629822|471112167|FG000|Extension Study|Lost to Follow-up|1|||
130859483|NCT00741013|471112168|FG000|Overall Study|Adverse Event|1|||
130859484|NCT00741013|471112169|FG001|Overall Study|Adverse Event|0|||
130859485|NCT00741013|471112170|FG002|Overall Study|Adverse Event|0|||
130859486|NCT00741013|471112168|FG000|Overall Study|Withdrawal by Subject|0|||
130859487|NCT00741013|471112169|FG001|Overall Study|Withdrawal by Subject|0|||
130859488|NCT00741013|471112170|FG002|Overall Study|Withdrawal by Subject|1|||
130859489|NCT00741013|471112168|FG000|Overall Study|Discovered failed screen after enrolled|0|||
130859490|NCT00741013|471112169|FG001|Overall Study|Discovered failed screen after enrolled|2|||
130859491|NCT00741013|471112170|FG002|Overall Study|Discovered failed screen after enrolled|0|||
130859492|NCT01559675|471112174|FG000|Overall Study|Protocol Violation|1|||
130859493|NCT01559675|471112175|FG001|Overall Study|Protocol Violation|2|||
130859494|NCT01559675|471112174|FG000|Overall Study|2nd operation on same patient excluded|14|||
130859495|NCT01559675|471112175|FG001|Overall Study|2nd operation on same patient excluded|12|||
130859496|NCT00291018|471112176|FG000|Overall Study|Not Consented or Declined PAS|12|||
130859497|NCT00291018|471112177|FG001|Overall Study|Not Consented or Declined PAS|15|||
130859498|NCT00291018|471112178|FG002|Overall Study|Not Consented or Declined PAS|15|||
130859499|NCT00291018|471112176|FG000|Overall Study|Death|3|||
130859500|NCT00291018|471112177|FG001|Overall Study|Death|3|||
130859501|NCT00291018|471112178|FG002|Overall Study|Death|4|||
130859502|NCT00291018|471112176|FG000|Overall Study|Withdrawal by Subject|2|||
130859503|NCT00291018|471112177|FG001|Overall Study|Withdrawal by Subject|8|||
130859504|NCT00291018|471112178|FG002|Overall Study|Withdrawal by Subject|1|||
130859505|NCT00291018|471112176|FG000|Overall Study|Failures|5|||
130859506|NCT00291018|471112177|FG001|Overall Study|Failures|12|||
130859507|NCT00291018|471112178|FG002|Overall Study|Failures|5|||
130859508|NCT00291018|471112176|FG000|Overall Study|Lost to Follow-up|3|||
130859509|NCT00291018|471112177|FG001|Overall Study|Lost to Follow-up|4|||
130859510|NCT00291018|471112178|FG002|Overall Study|Lost to Follow-up|18|||
130859511|NCT01496469|471112179|FG000|Overall Study|Adverse Event|1|||
130859512|NCT01496469|471112180|FG001|Overall Study|Adverse Event|0|||
130859513|NCT01496469|471112179|FG000|Overall Study|Protocol Violation|2|||
130859514|NCT01496469|471112180|FG001|Overall Study|Protocol Violation|0|||
130859515|NCT01496469|471112179|FG000|Overall Study|Lost to Follow-up|1|||
130859516|NCT01496469|471112180|FG001|Overall Study|Lost to Follow-up|1|||
130859517|NCT01496469|471112179|FG000|Overall Study|Withdrawal by Subject|4|||
130859518|NCT01496469|471112180|FG001|Overall Study|Withdrawal by Subject|4|||
130859519|NCT01496469|471112179|FG000|Overall Study|BP exceeds protocol limits|1|||
130859520|NCT01496469|471112180|FG001|Overall Study|BP exceeds protocol limits|2|||
130859521|NCT01496469|471112179|FG000|Overall Study|Other|1|||
130859522|NCT01496469|471112180|FG001|Overall Study|Other|1|||
130859523|NCT00193180|471112181|FG000|Overall Study|Lack of Efficacy|1|||
130859524|NCT00193180|471112181|FG000|Overall Study|Adverse Event|8|||
130859525|NCT00193180|471112181|FG000|Overall Study|Protocol Violation|1|||
130859526|NCT01357551|471112182|FG000|Overall Study|Withdrawal by Subject|6|||
130859527|NCT01357551|471112183|FG001|Overall Study|Withdrawal by Subject|4|||
130859528|NCT01357551|471112182|FG000|Overall Study|Death|0|||
130859529|NCT01357551|471112183|FG001|Overall Study|Death|1|||
130859530|NCT01357551|471112182|FG000|Overall Study|Lost to Follow-up|16|||
130859531|NCT01357551|471112183|FG001|Overall Study|Lost to Follow-up|6|||
130859532|NCT05362058|471112184|FG000|Treatment Period|Adverse Event|3|||
130859533|NCT05362058|471112185|FG001|Treatment Period|Adverse Event|3|||
130859534|NCT05362058|471112184|FG000|Treatment Period|Assigned treatment by mistake|3|||
130859535|NCT05362058|471112185|FG001|Treatment Period|Assigned treatment by mistake|4|||
130859536|NCT05362058|471112184|FG000|Treatment Period|Death|1|||
130859537|NCT05362058|471112185|FG001|Treatment Period|Death|1|||
130859538|NCT05362058|471112184|FG000|Treatment Period|Lost to Follow-up|6|||
130859539|NCT05362058|471112185|FG001|Treatment Period|Lost to Follow-up|3|||
130859540|NCT05362058|471112184|FG000|Treatment Period|Non-compliance with study drug|0|||
130859541|NCT05362058|471112185|FG001|Treatment Period|Non-compliance with study drug|1|||
130859542|NCT05362058|471112184|FG000|Treatment Period|Physician Decision|1|||
130859543|NCT05362058|471112185|FG001|Treatment Period|Physician Decision|0|||
130859544|NCT05362058|471112184|FG000|Treatment Period|Protocol deviation|1|||
130859545|NCT05362058|471112185|FG001|Treatment Period|Protocol deviation|0|||
130859546|NCT05362058|471112184|FG000|Treatment Period|Withdrawal by Subject|10|||
130859547|NCT05362058|471112185|FG001|Treatment Period|Withdrawal by Subject|11|||
130859548|NCT05362058|471112184|FG000|Follow-Up Period|Death|1|||
130859549|NCT05362058|471112185|FG001|Follow-Up Period|Death|0|||
130859550|NCT05362058|471112184|FG000|Follow-Up Period|Lost to Follow-up|2|||
130859551|NCT05362058|471112185|FG001|Follow-Up Period|Lost to Follow-up|1|||
130859552|NCT05362058|471112184|FG000|Follow-Up Period|Protocol deviation|1|||
130859553|NCT05362058|471112185|FG001|Follow-Up Period|Protocol deviation|1|||
130859554|NCT05362058|471112184|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130859555|NCT05362058|471112185|FG001|Follow-Up Period|Withdrawal by Subject|3|||
130859556|NCT01235234|471112186|FG000|Overall Study|Adverse Event|2|||
130859557|NCT01235234|471112187|FG001|Overall Study|Adverse Event|2|||
130859558|NCT01235234|471112188|FG002|Overall Study|Adverse Event|1|||
130859559|NCT00666965|471112191|FG000|Overall Study|Adverse Event|0|||
130859560|NCT00666965|471112192|FG001|Overall Study|Adverse Event|2|||
130859561|NCT00666965|471112193|FG002|Overall Study|Adverse Event|1|||
130859562|NCT00666965|471112194|FG003|Overall Study|Adverse Event|9|||
130859563|NCT00666965|471112191|FG000|Overall Study|Lack of Efficacy|1|||
130859564|NCT00666965|471112192|FG001|Overall Study|Lack of Efficacy|1|||
130859565|NCT00666965|471112193|FG002|Overall Study|Lack of Efficacy|0|||
130859566|NCT00666965|471112194|FG003|Overall Study|Lack of Efficacy|0|||
130859567|NCT00666965|471112191|FG000|Overall Study|Protocol Violation|0|||
130859568|NCT00666965|471112192|FG001|Overall Study|Protocol Violation|0|||
130859569|NCT00666965|471112193|FG002|Overall Study|Protocol Violation|0|||
130859570|NCT00666965|471112194|FG003|Overall Study|Protocol Violation|2|||
130859571|NCT00666965|471112191|FG000|Overall Study|Discontinuation criteria|2|||
130859572|NCT00666965|471112192|FG001|Overall Study|Discontinuation criteria|1|||
130859573|NCT00666965|471112193|FG002|Overall Study|Discontinuation criteria|1|||
130859574|NCT00666965|471112194|FG003|Overall Study|Discontinuation criteria|2|||
130859575|NCT00666965|471112191|FG000|Overall Study|Withdrawal by Subject|0|||
130859576|NCT00666965|471112192|FG001|Overall Study|Withdrawal by Subject|0|||
130859577|NCT00666965|471112193|FG002|Overall Study|Withdrawal by Subject|0|||
130859578|NCT00666965|471112194|FG003|Overall Study|Withdrawal by Subject|2|||
130859579|NCT01853878|471112198|FG000|Overall Study|Recurrence|2|||
130859580|NCT01853878|471112199|FG001|Overall Study|Recurrence|0|||
130859581|NCT01853878|471112198|FG000|Overall Study|Adverse Event|2|||
130859582|NCT01853878|471112199|FG001|Overall Study|Adverse Event|0|||
130859583|NCT01853878|471112198|FG000|Overall Study|Withdrawal by Subject|3|||
130859584|NCT01853878|471112199|FG001|Overall Study|Withdrawal by Subject|1|||
130859585|NCT01853878|471112198|FG000|Overall Study|Migrated/moved from the study area|1|||
130859586|NCT01853878|471112199|FG001|Overall Study|Migrated/moved from the study area|0|||
130859587|NCT01853878|471112198|FG000|Overall Study|Other|55|||
130859588|NCT01853878|471112199|FG001|Overall Study|Other|43|||
130859589|NCT01361178|471112200|FG000|Overall Study|Death|13|||
130859590|NCT01361178|471112201|FG001|Overall Study|Death|0|||
130859591|NCT00391625|471112202|FG000|Month 14|Withdrawal by Subject|1|||
130859592|NCT00391625|471112202|FG000|Month 50|Physician Decision|1|||
130859593|NCT03916081|471112205|FG000|Overall Study|Adverse Event|1|||
130859594|NCT03916081|471112206|FG001|Overall Study|Adverse Event|0|||
130859595|NCT03916081|471112207|FG002|Overall Study|Adverse Event|0|||
130859596|NCT03916081|471112205|FG000|Overall Study|Physician Decision|0|||
130859597|NCT03916081|471112206|FG001|Overall Study|Physician Decision|0|||
130859598|NCT03916081|471112207|FG002|Overall Study|Physician Decision|1|||
130859599|NCT03916081|471112205|FG000|Overall Study|Lost to Follow-up|0|||
130859600|NCT03916081|471112206|FG001|Overall Study|Lost to Follow-up|1|||
130859601|NCT03916081|471112207|FG002|Overall Study|Lost to Follow-up|0|||
130859602|NCT03916081|471112205|FG000|Overall Study|Withdrawal by Subject|3|||
130859603|NCT03916081|471112206|FG001|Overall Study|Withdrawal by Subject|0|||
130859604|NCT03916081|471112207|FG002|Overall Study|Withdrawal by Subject|1|||
130859605|NCT03916081|471112205|FG000|Overall Study|Worsening of AD|0|||
130859606|NCT03916081|471112206|FG001|Overall Study|Worsening of AD|0|||
130859607|NCT03916081|471112207|FG002|Overall Study|Worsening of AD|1|||
130859608|NCT03244826|471112208|FG000|Overall Study|Withdrawal by Subject|2|||
130859609|NCT03244826|471112209|FG001|Overall Study|Withdrawal by Subject|0|||
130859610|NCT03244826|471112208|FG000|Overall Study|Transplant delayed or withdrawn|12|||
130859611|NCT03244826|471112209|FG001|Overall Study|Transplant delayed or withdrawn|10|||
130859612|NCT00416455|471112214|FG000|Overall Study|PET / CT not done|3|||
130859613|NCT00416455|471112215|FG001|Overall Study|PET / CT not done|5|||
130859614|NCT00416455|471112214|FG000|Overall Study|PET / CT poor quality|2|||
130859615|NCT00416455|471112215|FG001|Overall Study|PET / CT poor quality|1|||
130859616|NCT00416455|471112214|FG000|Overall Study|Inadequate pathology|11|||
130859617|NCT00416455|471112215|FG001|Overall Study|Inadequate pathology|2|||
130859618|NCT00348309|471112216|FG000|Overall Study|Adverse Event|56|||
130859619|NCT00348309|471112217|FG001|Overall Study|Adverse Event|28|||
130859620|NCT00348309|471112218|FG002|Overall Study|Adverse Event|63|||
130859621|NCT00348309|471112216|FG000|Overall Study|Lost to Follow-up|6|||
130859622|NCT00348309|471112217|FG001|Overall Study|Lost to Follow-up|7|||
130859623|NCT00348309|471112218|FG002|Overall Study|Lost to Follow-up|4|||
130859624|NCT00348309|471112216|FG000|Overall Study|Protocol Violation|7|||
130859625|NCT00348309|471112217|FG001|Overall Study|Protocol Violation|12|||
130859626|NCT00348309|471112218|FG002|Overall Study|Protocol Violation|7|||
130859627|NCT00348309|471112216|FG000|Overall Study|Withdrawal by Subject|33|||
130859628|NCT00348309|471112217|FG001|Overall Study|Withdrawal by Subject|37|||
130859629|NCT00348309|471112218|FG002|Overall Study|Withdrawal by Subject|40|||
130859630|NCT00348309|471112216|FG000|Overall Study|Non-compliance|8|||
130859631|NCT00348309|471112217|FG001|Overall Study|Non-compliance|6|||
130859632|NCT00348309|471112218|FG002|Overall Study|Non-compliance|8|||
130859633|NCT00348309|471112216|FG000|Overall Study|Death of caregiver|1|||
130859634|NCT00348309|471112217|FG001|Overall Study|Death of caregiver|0|||
130859635|NCT00348309|471112218|FG002|Overall Study|Death of caregiver|1|||
130859636|NCT00348309|471112216|FG000|Overall Study|Lack of insight, dementia|1|||
130859637|NCT00348309|471112217|FG001|Overall Study|Lack of insight, dementia|0|||
130859638|NCT00348309|471112218|FG002|Overall Study|Lack of insight, dementia|0|||
130859639|NCT00348309|471112216|FG000|Overall Study|Wrong bottle allocated|1|||
130859640|NCT00348309|471112217|FG001|Overall Study|Wrong bottle allocated|0|||
130859641|NCT00348309|471112218|FG002|Overall Study|Wrong bottle allocated|0|||
130859642|NCT00348309|471112216|FG000|Overall Study|Caregiver sick|1|||
130859643|NCT00348309|471112217|FG001|Overall Study|Caregiver sick|0|||
130859644|NCT00348309|471112218|FG002|Overall Study|Caregiver sick|0|||
130859645|NCT00348309|471112216|FG000|Overall Study|Use of prohibited medication|5|||
130859646|NCT00348309|471112217|FG001|Overall Study|Use of prohibited medication|2|||
130859647|NCT00348309|471112218|FG002|Overall Study|Use of prohibited medication|2|||
130859648|NCT00348309|471112216|FG000|Overall Study|Caregiver withdrawal|3|||
130859649|NCT00348309|471112217|FG001|Overall Study|Caregiver withdrawal|0|||
130859650|NCT00348309|471112218|FG002|Overall Study|Caregiver withdrawal|7|||
130859651|NCT00348309|471112216|FG000|Overall Study|Unable to complete ET visit|1|||
130859652|NCT00348309|471112217|FG001|Overall Study|Unable to complete ET visit|0|||
130859653|NCT00348309|471112218|FG002|Overall Study|Unable to complete ET visit|0|||
130859654|NCT00348309|471112216|FG000|Overall Study|PI closing medical practice|1|||
130859655|NCT00348309|471112217|FG001|Overall Study|PI closing medical practice|0|||
130859656|NCT00348309|471112218|FG002|Overall Study|PI closing medical practice|0|||
130859657|NCT00348309|471112216|FG000|Overall Study|Principal investigator's decision|1|||
130859658|NCT00348309|471112217|FG001|Overall Study|Principal investigator's decision|0|||
130859659|NCT00348309|471112218|FG002|Overall Study|Principal investigator's decision|0|||
130859660|NCT00348309|471112216|FG000|Overall Study|No disponibility of medication|1|||
130859661|NCT00348309|471112217|FG001|Overall Study|No disponibility of medication|0|||
130859662|NCT00348309|471112218|FG002|Overall Study|No disponibility of medication|0|||
130859663|NCT00348309|471112216|FG000|Overall Study|Worsened neurodegenerative disease|1|||
130859664|NCT00348309|471112217|FG001|Overall Study|Worsened neurodegenerative disease|0|||
130859665|NCT00348309|471112218|FG002|Overall Study|Worsened neurodegenerative disease|0|||
130859666|NCT00348309|471112216|FG000|Overall Study|Cognitive and behaviour worsening|2|||
130859667|NCT00348309|471112217|FG001|Overall Study|Cognitive and behaviour worsening|0|||
130859668|NCT00348309|471112218|FG002|Overall Study|Cognitive and behaviour worsening|0|||
130859669|NCT00348309|471112216|FG000|Overall Study|Worsening of alzheimer|1|||
130859670|NCT00348309|471112217|FG001|Overall Study|Worsening of alzheimer|0|||
130859671|NCT00348309|471112218|FG002|Overall Study|Worsening of alzheimer|1|||
130859672|NCT00348309|471112216|FG000|Overall Study|Did not appear in time for Visit 3|1|||
130859673|NCT00348309|471112217|FG001|Overall Study|Did not appear in time for Visit 3|0|||
130859674|NCT00348309|471112218|FG002|Overall Study|Did not appear in time for Visit 3|0|||
130859675|NCT00348309|471112216|FG000|Overall Study|Participant died|2|||
130859676|NCT00348309|471112217|FG001|Overall Study|Participant died|1|||
130859677|NCT00348309|471112218|FG002|Overall Study|Participant died|1|||
130859678|NCT00348309|471112216|FG000|Overall Study|Decision of sponsor|1|||
130859679|NCT00348309|471112217|FG001|Overall Study|Decision of sponsor|0|||
130859680|NCT00348309|471112218|FG002|Overall Study|Decision of sponsor|0|||
130859681|NCT00348309|471112216|FG000|Overall Study|Ineffectiveness of treatment|0|||
130859682|NCT00348309|471112217|FG001|Overall Study|Ineffectiveness of treatment|1|||
130859683|NCT00348309|471112218|FG002|Overall Study|Ineffectiveness of treatment|0|||
130859684|NCT00348309|471112216|FG000|Overall Study|A foul of exclusion criteria|0|||
130859685|NCT00348309|471112217|FG001|Overall Study|A foul of exclusion criteria|1|||
130859686|NCT00348309|471112218|FG002|Overall Study|A foul of exclusion criteria|0|||
130859687|NCT00348309|471112216|FG000|Overall Study|Participant was hospitalized|0|||
130859688|NCT00348309|471112217|FG001|Overall Study|Participant was hospitalized|1|||
130859689|NCT00348309|471112218|FG002|Overall Study|Participant was hospitalized|0|||
130859690|NCT00348309|471112216|FG000|Overall Study|Sponsor refuseal|0|||
130859691|NCT00348309|471112217|FG001|Overall Study|Sponsor refuseal|1|||
130859692|NCT00348309|471112218|FG002|Overall Study|Sponsor refuseal|1|||
130859693|NCT00348309|471112216|FG000|Overall Study|Forgot often medication|0|||
130859694|NCT00348309|471112217|FG001|Overall Study|Forgot often medication|1|||
130859695|NCT00348309|471112218|FG002|Overall Study|Forgot often medication|0|||
130859696|NCT00348309|471112216|FG000|Overall Study|Medical Monitor decision|0|||
130859697|NCT00348309|471112217|FG001|Overall Study|Medical Monitor decision|0|||
130859698|NCT00348309|471112218|FG002|Overall Study|Medical Monitor decision|1|||
130859699|NCT00348309|471112216|FG000|Overall Study|Increased dose of Aricept|0|||
130859700|NCT00348309|471112217|FG001|Overall Study|Increased dose of Aricept|0|||
130859701|NCT00348309|471112218|FG002|Overall Study|Increased dose of Aricept|1|||
130859702|NCT00348309|471112216|FG000|Overall Study|Site closure|0|||
130859703|NCT00348309|471112217|FG001|Overall Study|Site closure|0|||
130859704|NCT00348309|471112218|FG002|Overall Study|Site closure|1|||
130859705|NCT00348309|471112216|FG000|Overall Study|Adverse event not attended|0|||
130859706|NCT00348309|471112217|FG001|Overall Study|Adverse event not attended|0|||
130859707|NCT00348309|471112218|FG002|Overall Study|Adverse event not attended|1|||
130859708|NCT00348309|471112216|FG000|Overall Study|ECG abnormal|0|||
130859709|NCT00348309|471112217|FG001|Overall Study|ECG abnormal|0|||
130859710|NCT00348309|471112218|FG002|Overall Study|ECG abnormal|2|||
130859711|NCT00348309|471112216|FG000|Overall Study|Cardiologist recommendations|0|||
130859712|NCT00348309|471112217|FG001|Overall Study|Cardiologist recommendations|0|||
130859713|NCT00348309|471112218|FG002|Overall Study|Cardiologist recommendations|1|||
130859714|NCT00348309|471112216|FG000|Overall Study|HCV career|0|||
130859715|NCT00348309|471112217|FG001|Overall Study|HCV career|0|||
130859716|NCT00348309|471112218|FG002|Overall Study|HCV career|1|||
130859717|NCT00622388|471112219|FG000|Overall Study|Disease Progression|47|||
130859718|NCT00622388|471112219|FG000|Overall Study|Adverse Event|6|||
130859719|NCT00622388|471112219|FG000|Overall Study|Protocol Violation|3|||
130859720|NCT00622388|471112219|FG000|Overall Study|Participant Refusal|1|||
130859721|NCT00622388|471112219|FG000|Overall Study|Death|3|||
130859722|NCT00622388|471112219|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
130859723|NCT00622388|471112219|FG000|Overall Study|Took Prohibited Medication|2|||
130859724|NCT00622388|471112219|FG000|Overall Study|Withdrew Consent|1|||
130859725|NCT00622388|471112219|FG000|Overall Study|Insurance Expired|1|||
130859726|NCT00828750|471112220|FG000|Overall Study|Lack of Efficacy|3|||
130859727|NCT00828750|471112220|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
130859728|NCT04079114|471112221|FG000|Overall Study|Study prematuely terminated.|166|||
130859729|NCT01364389|471112222|FG000|Overall Study|Withdrawal by Subject|0|||
130859730|NCT01364389|471112223|FG001|Overall Study|Withdrawal by Subject|1|||
130859731|NCT01364389|471112224|FG002|Overall Study|Withdrawal by Subject|0|||
130859732|NCT01364389|471112222|FG000|Overall Study|Protocol deviation|0|||
130859733|NCT01364389|471112223|FG001|Overall Study|Protocol deviation|0|||
130859734|NCT01364389|471112224|FG002|Overall Study|Protocol deviation|1|||
130859735|NCT01364389|471112222|FG000|Overall Study|Administrative problems|1|||
130859736|NCT01364389|471112223|FG001|Overall Study|Administrative problems|0|||
130859737|NCT01364389|471112224|FG002|Overall Study|Administrative problems|0|||
130859738|NCT01364389|471112222|FG000|Overall Study|Adverse Event|1|||
130859739|NCT01364389|471112223|FG001|Overall Study|Adverse Event|0|||
130859740|NCT01364389|471112224|FG002|Overall Study|Adverse Event|0|||
130859741|NCT01068158|471112225|FG000|Overall Study|Withdrawal by Subject|1|||
130859742|NCT01068158|471112226|FG001|Overall Study|Withdrawal by Subject|2|||
130859743|NCT01068158|471112225|FG000|Overall Study|Lost to Follow-up|7|||
130859744|NCT01068158|471112226|FG001|Overall Study|Lost to Follow-up|0|||
130859745|NCT01068158|471112225|FG000|Overall Study|Protocol Violation|0|||
130859746|NCT01068158|471112226|FG001|Overall Study|Protocol Violation|2|||
130859747|NCT00991406|471112227|FG000|Overall Study|One participant did not respond to FES.|1|||
130859748|NCT01300572|471112228|FG000|Overall Study|HAMA + post dosimetry|1|||
130859749|NCT02160145|471112230|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
130859750|NCT02160145|471112231|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
130859751|NCT02160145|471112232|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
130859752|NCT02160145|471112230|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
130859753|NCT02160145|471112231|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
130859754|NCT02160145|471112232|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
130859755|NCT02160145|471112230|FG000|Randomized Double-blind Period|Subject decision|0|||
130859756|NCT02160145|471112231|FG001|Randomized Double-blind Period|Subject decision|21|||
130859757|NCT02160145|471112232|FG002|Randomized Double-blind Period|Subject decision|20|||
130859758|NCT02160145|471112230|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
130859759|NCT02160145|471112231|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
130859760|NCT02160145|471112232|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
130859761|NCT02160145|471112230|FG000|Randomized Double-blind Period|Physician Decision|0|||
130859762|NCT02160145|471112231|FG001|Randomized Double-blind Period|Physician Decision|7|||
130859763|NCT02160145|471112232|FG002|Randomized Double-blind Period|Physician Decision|5|||
130859764|NCT00375518|471112233|FG000|Overall Study|Withdrawal by Subject|2|||
130859765|NCT00375518|471112234|FG001|Overall Study|Withdrawal by Subject|10|||
130859766|NCT00375518|471112233|FG000|Overall Study|Patient Not Treated|6|||
130859767|NCT00375518|471112234|FG001|Overall Study|Patient Not Treated|6|||
130859768|NCT00375518|471112233|FG000|Overall Study|Death|0|||
130859769|NCT00375518|471112234|FG001|Overall Study|Death|1|||
130859770|NCT01108523|471112235|FG000|Overall Study|Protocol Violation|4|||
130859771|NCT03848949|471112245|FG000|Overall Study|Lost to Follow-up|5|||
130859772|NCT03848949|471112246|FG001|Overall Study|Lost to Follow-up|7|||
130859773|NCT02353728|471112247|FG000|Overall Study|Subject non-compliance|1|||
130859774|NCT02301624|471112250|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
130859775|NCT02301624|471112251|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
130859776|NCT02301624|471112250|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
130859777|NCT02301624|471112251|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
130859778|NCT02301624|471112250|FG000|Open-label Maintenance Phase|Adverse Event|2|||
130859779|NCT02301624|471112251|FG001|Open-label Maintenance Phase|Adverse Event|5|||
130859780|NCT02301624|471112250|FG000|Open-label Maintenance Phase|Physician Decision|3|||
130859781|NCT02301624|471112251|FG001|Open-label Maintenance Phase|Physician Decision|3|||
130859782|NCT02301624|471112250|FG000|Open-label Maintenance Phase|Death|2|||
130859783|NCT02301624|471112251|FG001|Open-label Maintenance Phase|Death|1|||
130859784|NCT02301624|471112250|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
130859785|NCT02301624|471112251|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
130859786|NCT00895310|471112252|FG000|Overall Study|Withdrawal by Subject|1|||
130859787|NCT00659230|471112253|FG000|Overall Study|Lost to Follow-up|2|||
130859788|NCT00659230|471112254|FG001|Overall Study|Lost to Follow-up|5|||
130859789|NCT00659230|471112253|FG000|Overall Study|Lost source documentation|5|||
130859790|NCT00659230|471112254|FG001|Overall Study|Lost source documentation|4|||
130859791|NCT00659230|471112253|FG000|Overall Study|Did not return post-randomization|2|||
130859792|NCT00659230|471112254|FG001|Overall Study|Did not return post-randomization|3|||
130859793|NCT00547521|471112255|FG000|Short Term Study (4 Months)|Adverse Event|1|||
130859794|NCT00547521|471112256|FG001|Short Term Study (4 Months)|Adverse Event|0|||
130859795|NCT00547521|471112255|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
130859796|NCT00547521|471112256|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
130859797|NCT00547521|471112255|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
130859798|NCT00547521|471112256|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
130859799|NCT00547521|471112255|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
130859800|NCT00547521|471112256|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
130859801|NCT00547521|471112255|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
130859802|NCT00547521|471112256|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
130859803|NCT00547521|471112255|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
130859804|NCT00547521|471112256|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
130859805|NCT00547521|471112255|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
130859806|NCT00547521|471112256|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
130859807|NCT00547521|471112255|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
130859808|NCT00547521|471112256|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
130859809|NCT00547521|471112255|FG000|Long Term Extension (LTE) Study|Other|0|||
130859810|NCT00547521|471112256|FG001|Long Term Extension (LTE) Study|Other|2|||
130859811|NCT00547521|471112255|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
130859812|NCT00547521|471112256|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
130859813|NCT02467582|471114718|FG000|Allocation|Withdrawal by Subject|1|||
130859814|NCT02467582|471114719|FG001|Allocation|Withdrawal by Subject|0|||
130859815|NCT02467582|471114718|FG000|Follow-up|Death|5|||
130859816|NCT02467582|471114719|FG001|Follow-up|Death|4|||
130859817|NCT02467582|471114718|FG000|Follow-up|Lost to Follow-up|6|||
130859818|NCT02467582|471114719|FG001|Follow-up|Lost to Follow-up|5|||
130859819|NCT02291419|471114720|FG000|Overall Study|Early study termination|1|||
130859820|NCT02291419|471114721|FG001|Overall Study|Early study termination|5|||
130859821|NCT03047031|471114733|FG000|Overall Study|Other than listed|1|||
130859822|NCT03047031|471114734|FG001|Overall Study|Other than listed|0|||
130859823|NCT03047031|471114735|FG002|Overall Study|Other than listed|0|||
130859824|NCT03047031|471114733|FG000|Overall Study|Lost to Follow-up|4|||
130859825|NCT03047031|471114734|FG001|Overall Study|Lost to Follow-up|0|||
130859826|NCT03047031|471114735|FG002|Overall Study|Lost to Follow-up|0|||
130859827|NCT03047031|471114733|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
130859828|NCT03047031|471114734|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
130859829|NCT03047031|471114735|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
130859830|NCT03047031|471114733|FG000|Overall Study|Adverse Event|1|||
130859831|NCT03047031|471114734|FG001|Overall Study|Adverse Event|0|||
130859832|NCT03047031|471114735|FG002|Overall Study|Adverse Event|0|||
130859833|NCT03047031|471114733|FG000|Overall Study|Withdrawal by Subject|2|||
130859834|NCT03047031|471114734|FG001|Overall Study|Withdrawal by Subject|0|||
130859835|NCT03047031|471114735|FG002|Overall Study|Withdrawal by Subject|0|||
130859836|NCT03047031|471114733|FG000|Overall Study|Change to other medication|2|||
130859837|NCT03047031|471114734|FG001|Overall Study|Change to other medication|0|||
130859838|NCT03047031|471114735|FG002|Overall Study|Change to other medication|0|||
130859839|NCT03047031|471114733|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
130859840|NCT03047031|471114734|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
130859841|NCT03047031|471114735|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
130859842|NCT01959139|471114746|FG000|Phase II|Disease progression|0|||
130859843|NCT01959139|471114747|FG001|Phase II|Disease progression|0|||
130859844|NCT01959139|471114748|FG002|Phase II|Disease progression|26|||
130859845|NCT01959139|471114749|FG003|Phase II|Disease progression|34|||
130859846|NCT01959139|471114746|FG000|Phase II|Adverse Event|0|||
130859847|NCT01959139|471114747|FG001|Phase II|Adverse Event|0|||
130859848|NCT01959139|471114748|FG002|Phase II|Adverse Event|10|||
130859849|NCT01959139|471114749|FG003|Phase II|Adverse Event|11|||
130859850|NCT01959139|471114746|FG000|Phase II|Patient Refusal|0|||
130859851|NCT01959139|471114747|FG001|Phase II|Patient Refusal|0|||
130859852|NCT01959139|471114748|FG002|Phase II|Patient Refusal|5|||
130859853|NCT01959139|471114749|FG003|Phase II|Patient Refusal|4|||
130859854|NCT01959139|471114746|FG000|Phase II|Death|0|||
130859855|NCT01959139|471114747|FG001|Phase II|Death|0|||
130859856|NCT01959139|471114748|FG002|Phase II|Death|3|||
130859857|NCT01959139|471114749|FG003|Phase II|Death|1|||
130859858|NCT01959139|471114746|FG000|Phase II|Other/Unknown|0|||
130859859|NCT01959139|471114747|FG001|Phase II|Other/Unknown|0|||
130859860|NCT01959139|471114748|FG002|Phase II|Other/Unknown|8|||
130859861|NCT01959139|471114749|FG003|Phase II|Other/Unknown|5|||
130859862|NCT01959139|471114746|FG000|Phase II|On treatment|0|||
130859863|NCT01959139|471114747|FG001|Phase II|On treatment|0|||
130859864|NCT01959139|471114748|FG002|Phase II|On treatment|4|||
130859865|NCT01959139|471114749|FG003|Phase II|On treatment|0|||
130859866|NCT00630344|471114752|FG000|Overall Study|Adverse Event|5|||
130859867|NCT00630344|471114752|FG000|Overall Study|Progressive Disease|19|||
130859868|NCT00630344|471114752|FG000|Overall Study|Physician Decision|9|||
130859869|NCT00630344|471114752|FG000|Overall Study|Withdrawal by Subject|1|||
130859870|NCT00630344|471114752|FG000|Overall Study|Intercurrent Illness|1|||
130859871|NCT00630344|471114752|FG000|Overall Study|Other|1|||
130859872|NCT00930553|471114755|FG000|Overall Study|Adverse Event|1|||
130859873|NCT00930553|471114755|FG000|Overall Study|Lack of Efficacy|7|||
130859874|NCT00930553|471114755|FG000|Overall Study|Physician Decision|39|||
130859875|NCT00930553|471114755|FG000|Overall Study|Protocol Violation|1|||
130859876|NCT00930553|471114755|FG000|Overall Study|Pregnancy|1|||
130859877|NCT00930553|471114755|FG000|Overall Study|Withdrawal by Subject|88|||
130859878|NCT00930553|471114755|FG000|Overall Study|Lost to Follow-up|25|||
130859879|NCT00930553|471114755|FG000|Overall Study|Death|9|||
130859880|NCT00930553|471114755|FG000|Overall Study|Study terminated by sponsor|24|||
130859881|NCT00930553|471114755|FG000|Overall Study|Other than specified above|28|||
130859882|NCT00286494|471114760|FG000|Overall Study|Hyperglycemic rescue|12|||
130859883|NCT00286494|471114761|FG001|Overall Study|Hyperglycemic rescue|19|||
130859884|NCT00286494|471114762|FG002|Overall Study|Hyperglycemic rescue|18|||
130859885|NCT00286494|471114760|FG000|Overall Study|Withdrawal by Subject|2|||
130859886|NCT00286494|471114761|FG001|Overall Study|Withdrawal by Subject|10|||
130859887|NCT00286494|471114762|FG002|Overall Study|Withdrawal by Subject|9|||
130859888|NCT00286494|471114760|FG000|Overall Study|Adverse Event|3|||
130859889|NCT00286494|471114761|FG001|Overall Study|Adverse Event|8|||
130859890|NCT00286494|471114762|FG002|Overall Study|Adverse Event|6|||
130859891|NCT00286494|471114760|FG000|Overall Study|Physician Decision|5|||
130859892|NCT00286494|471114761|FG001|Overall Study|Physician Decision|5|||
130859893|NCT00286494|471114762|FG002|Overall Study|Physician Decision|1|||
130859894|NCT00286494|471114760|FG000|Overall Study|Lost to Follow-up|3|||
130859895|NCT00286494|471114761|FG001|Overall Study|Lost to Follow-up|1|||
130859896|NCT00286494|471114762|FG002|Overall Study|Lost to Follow-up|3|||
130859897|NCT00286494|471114760|FG000|Overall Study|Protocol Violation|1|||
130859898|NCT00286494|471114761|FG001|Overall Study|Protocol Violation|1|||
130859899|NCT00286494|471114762|FG002|Overall Study|Protocol Violation|2|||
130859900|NCT04776317|471114763|FG000|Overall Study|Physician Decision|0|||
130859901|NCT04776317|471114764|FG001|Overall Study|Physician Decision|1|||
130859902|NCT04776317|471114765|FG002|Overall Study|Physician Decision|0|||
130859903|NCT04776317|471114766|FG003|Overall Study|Physician Decision|0|||
130859904|NCT04776317|471114767|FG004|Overall Study|Physician Decision|0|||
130859905|NCT04776317|471114768|FG005|Overall Study|Physician Decision|0|||
130859906|NCT04776317|471114769|FG006|Overall Study|Physician Decision|0|||
130859907|NCT04776317|471114770|FG007|Overall Study|Physician Decision|0|||
130859908|NCT04776317|471114771|FG008|Overall Study|Physician Decision|0|||
130859909|NCT04776317|471114772|FG009|Overall Study|Physician Decision|0|||
130859910|NCT04776317|471114773|FG010|Overall Study|Physician Decision|0|||
130859911|NCT04776317|471114774|FG011|Overall Study|Physician Decision|0|||
130859912|NCT04776317|471114775|FG012|Overall Study|Physician Decision|0|||
130859913|NCT04776317|471114776|FG013|Overall Study|Physician Decision|0|||
130859914|NCT04776317|471114777|FG014|Overall Study|Physician Decision|0|||
130859915|NCT04776317|471114763|FG000|Overall Study|Protocol Violation|0|||
130859916|NCT04776317|471114764|FG001|Overall Study|Protocol Violation|0|||
130859917|NCT04776317|471114765|FG002|Overall Study|Protocol Violation|1|||
130859918|NCT04776317|471114766|FG003|Overall Study|Protocol Violation|0|||
130859919|NCT04776317|471114767|FG004|Overall Study|Protocol Violation|0|||
130859920|NCT04776317|471114768|FG005|Overall Study|Protocol Violation|0|||
130859921|NCT04776317|471114769|FG006|Overall Study|Protocol Violation|0|||
130859922|NCT04776317|471114770|FG007|Overall Study|Protocol Violation|0|||
130859923|NCT04776317|471114771|FG008|Overall Study|Protocol Violation|0|||
130859924|NCT04776317|471114772|FG009|Overall Study|Protocol Violation|0|||
130859925|NCT04776317|471114773|FG010|Overall Study|Protocol Violation|0|||
130859926|NCT04776317|471114774|FG011|Overall Study|Protocol Violation|0|||
130859927|NCT04776317|471114775|FG012|Overall Study|Protocol Violation|0|||
130859928|NCT04776317|471114776|FG013|Overall Study|Protocol Violation|0|||
130859929|NCT04776317|471114777|FG014|Overall Study|Protocol Violation|0|||
130859930|NCT04776317|471114763|FG000|Overall Study|Withdrawal by Subject|0|||
130859931|NCT04776317|471114764|FG001|Overall Study|Withdrawal by Subject|0|||
130859932|NCT04776317|471114765|FG002|Overall Study|Withdrawal by Subject|0|||
130859933|NCT04776317|471114766|FG003|Overall Study|Withdrawal by Subject|0|||
130859934|NCT04776317|471114767|FG004|Overall Study|Withdrawal by Subject|1|||
130859935|NCT04776317|471114768|FG005|Overall Study|Withdrawal by Subject|0|||
130859936|NCT04776317|471114769|FG006|Overall Study|Withdrawal by Subject|0|||
130859937|NCT04776317|471114770|FG007|Overall Study|Withdrawal by Subject|0|||
130859938|NCT04776317|471114771|FG008|Overall Study|Withdrawal by Subject|0|||
130859939|NCT04776317|471114772|FG009|Overall Study|Withdrawal by Subject|0|||
130859940|NCT04776317|471114773|FG010|Overall Study|Withdrawal by Subject|0|||
130859941|NCT04776317|471114774|FG011|Overall Study|Withdrawal by Subject|0|||
130859942|NCT04776317|471114775|FG012|Overall Study|Withdrawal by Subject|0|||
130859943|NCT04776317|471114776|FG013|Overall Study|Withdrawal by Subject|0|||
130859944|NCT04776317|471114777|FG014|Overall Study|Withdrawal by Subject|0|||
130859945|NCT04207060|471114778|FG000|Overall Study|Lost to Follow-up|2|||
130859946|NCT04207060|471114779|FG001|Overall Study|Lost to Follow-up|0|||
130859947|NCT02524158|471114780|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
130859948|NCT02524158|471114781|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
130859949|NCT02524158|471114780|FG000|12-weeks Assessment|Lost to Follow-up|18|||
130859950|NCT02524158|471114781|FG001|12-weeks Assessment|Lost to Follow-up|12|||
130859951|NCT02524158|471114780|FG000|6-month Assessment|Withdrawal by Subject|1|||
130859952|NCT02524158|471114781|FG001|6-month Assessment|Withdrawal by Subject|1|||
130859953|NCT02524158|471114780|FG000|6-month Assessment|Lost to Follow-up|21|||
130859954|NCT02524158|471114781|FG001|6-month Assessment|Lost to Follow-up|20|||
130859955|NCT03671304|471114782|FG000|Overall Study|study terminated|7|||
130859956|NCT02718716|471114783|FG000|Overall Study|Lack of Efficacy|1|||
130859957|NCT02718716|471114784|FG001|Overall Study|Lack of Efficacy|0|||
130859958|NCT02718716|471114785|FG002|Overall Study|Lack of Efficacy|0|||
130859959|NCT02718716|471114786|FG003|Overall Study|Lack of Efficacy|0|||
130859960|NCT02718716|471114787|FG004|Overall Study|Lack of Efficacy|0|||
130859961|NCT04869358|471114791|FG000|Overall Study|Wish to have children.|1|||
130859962|NCT04869358|471114792|FG001|Overall Study|Wish to have children.|0|||
130859963|NCT04869358|471114793|FG002|Overall Study|Wish to have children.|0|||
130859964|NCT04869358|471114794|FG003|Overall Study|Wish to have children.|0|||
130859965|NCT04164732|471114795|FG000|Treatment run-in Period|Adverse Event|4|||
130859966|NCT04164732|471114796|FG001|Treatment run-in Period|Adverse Event|0|||
130859967|NCT04164732|471114797|FG002|Treatment run-in Period|Adverse Event|0|||
130859968|NCT04164732|471114795|FG000|Treatment run-in Period|Physician Decision|1|||
130859969|NCT04164732|471114796|FG001|Treatment run-in Period|Physician Decision|0|||
130859970|NCT04164732|471114797|FG002|Treatment run-in Period|Physician Decision|0|||
130859971|NCT04164732|471114795|FG000|Treatment run-in Period|Screen Failure|1|||
130859972|NCT04164732|471114796|FG001|Treatment run-in Period|Screen Failure|0|||
130859973|NCT04164732|471114797|FG002|Treatment run-in Period|Screen Failure|0|||
130859974|NCT04164732|471114795|FG000|Randomized Treatment Period|Adverse Event|0|||
130859975|NCT04164732|471114796|FG001|Randomized Treatment Period|Adverse Event|1|||
130859976|NCT04164732|471114797|FG002|Randomized Treatment Period|Adverse Event|0|||
130859977|NCT04164732|471114795|FG000|Randomized Treatment Period|Protocol Deviation|0|||
130859978|NCT04164732|471114796|FG001|Randomized Treatment Period|Protocol Deviation|1|||
130859979|NCT04164732|471114797|FG002|Randomized Treatment Period|Protocol Deviation|1|||
130859980|NCT04164732|471114795|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
130859981|NCT04164732|471114796|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
130859982|NCT04164732|471114797|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
130859983|NCT04302545|471114798|FG000|Overall Study|Lost to Follow-up|3|||
130859984|NCT04302545|471114799|FG001|Overall Study|Lost to Follow-up|4|||
130859985|NCT02690714|471114803|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
130859986|NCT02690714|471114803|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
130859987|NCT02202538|471114804|FG000|Overall Study|Withdrawal by Subject|5|||
130859988|NCT02202538|471114804|FG000|Overall Study|Did not meet all inclusion criteria|2|||
130859989|NCT02202538|471114804|FG000|Overall Study|Investigator Decision|1|||
130859990|NCT01457846|471114805|FG000|Overall Study|Death before treatment|1|||
130859991|NCT01457846|471114806|FG001|Overall Study|Death before treatment|2|||
130859992|NCT01457846|471114805|FG000|Overall Study|Did not receive treatment|0|||
130859993|NCT01457846|471114806|FG001|Overall Study|Did not receive treatment|1|||
130859994|NCT01457846|471114805|FG000|Overall Study|Death|27|||
130859995|NCT01457846|471114806|FG001|Overall Study|Death|16|||
130859996|NCT01457846|471114805|FG000|Overall Study|Unclassified reason for not completed|11|||
130859997|NCT01457846|471114806|FG001|Overall Study|Unclassified reason for not completed|10|||
130859998|NCT01457846|471114805|FG000|Overall Study|Withdrawal by Subject|1|||
130859999|NCT01457846|471114806|FG001|Overall Study|Withdrawal by Subject|1|||
130860000|NCT01457846|471114805|FG000|Overall Study|Lost to Follow-up|1|||
130860001|NCT01457846|471114806|FG001|Overall Study|Lost to Follow-up|0|||
130860002|NCT02161757|471114807|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
130860003|NCT02161757|471114808|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
130860004|NCT02161757|471114809|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
130860005|NCT02161757|471114807|FG000|Treatment Through Study Completion|Adverse Event|1|||
130860006|NCT02161757|471114808|FG001|Treatment Through Study Completion|Adverse Event|1|||
130860007|NCT02161757|471114809|FG002|Treatment Through Study Completion|Adverse Event|0|||
130860008|NCT02161757|471114807|FG000|Treatment Through Study Completion|Protocol Violation|0|||
130860009|NCT02161757|471114808|FG001|Treatment Through Study Completion|Protocol Violation|1|||
130860010|NCT02161757|471114809|FG002|Treatment Through Study Completion|Protocol Violation|2|||
130860011|NCT02161757|471114807|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
130860012|NCT02161757|471114808|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
130860013|NCT02161757|471114809|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
130860014|NCT02161757|471114807|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
130860015|NCT02161757|471114808|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
130860016|NCT02161757|471114809|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
130860017|NCT02161757|471114807|FG000|Treatment Through Study Completion|Other|20|||
130860018|NCT02161757|471114808|FG001|Treatment Through Study Completion|Other|19|||
130860019|NCT02161757|471114809|FG002|Treatment Through Study Completion|Other|12|||
130860020|NCT02161757|471114807|FG000|Treatment Through Study Completion|Death|2|||
130860021|NCT02161757|471114808|FG001|Treatment Through Study Completion|Death|1|||
130860022|NCT02161757|471114809|FG002|Treatment Through Study Completion|Death|1|||
130860023|NCT00465647|471114814|FG000|Overall Study|Administrative|2|||
130860024|NCT00465647|471114815|FG001|Overall Study|Administrative|2|||
130860025|NCT00465647|471114816|FG002|Overall Study|Administrative|3|||
130860026|NCT00465647|471114817|FG003|Overall Study|Administrative|2|||
130860027|NCT00465647|471114814|FG000|Overall Study|Adverse Event|2|||
130860028|NCT00465647|471114815|FG001|Overall Study|Adverse Event|0|||
130860029|NCT00465647|471114816|FG002|Overall Study|Adverse Event|3|||
130860030|NCT00465647|471114817|FG003|Overall Study|Adverse Event|2|||
130860031|NCT00465647|471114814|FG000|Overall Study|Withdrawal by Subject|1|||
130860032|NCT00465647|471114815|FG001|Overall Study|Withdrawal by Subject|2|||
130860033|NCT00465647|471114816|FG002|Overall Study|Withdrawal by Subject|2|||
130860034|NCT00465647|471114817|FG003|Overall Study|Withdrawal by Subject|7|||
130860035|NCT00465647|471114814|FG000|Overall Study|"The other reasons included loss of IV"|8|||
130860036|NCT00465647|471114815|FG001|Overall Study|"The other reasons included loss of IV"|4|||
130860037|NCT00465647|471114816|FG002|Overall Study|"The other reasons included loss of IV"|3|||
130860038|NCT00465647|471114817|FG003|Overall Study|"The other reasons included loss of IV"|2|||
130860039|NCT01240135|471114818|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
130860040|NCT01240135|471114819|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
130860041|NCT01240135|471114818|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
130860042|NCT01240135|471114819|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
130860043|NCT01371305|471114820|FG000|Overall Study|Adverse Event|0|||
130860044|NCT01371305|471114821|FG001|Overall Study|Adverse Event|0|||
130860045|NCT01371305|471114822|FG002|Overall Study|Adverse Event|0|||
130860046|NCT01371305|471114823|FG003|Overall Study|Adverse Event|2|||
130860047|NCT01371305|471114824|FG004|Overall Study|Adverse Event|1|||
130860048|NCT01371305|471114825|FG005|Overall Study|Adverse Event|0|||
130860049|NCT01371305|471114820|FG000|Overall Study|Study terminated by sponsor|0|||
130860050|NCT01371305|471114821|FG001|Overall Study|Study terminated by sponsor|0|||
130860051|NCT01371305|471114822|FG002|Overall Study|Study terminated by sponsor|0|||
130860052|NCT01371305|471114823|FG003|Overall Study|Study terminated by sponsor|0|||
130860053|NCT01371305|471114824|FG004|Overall Study|Study terminated by sponsor|3|||
130860054|NCT01371305|471114825|FG005|Overall Study|Study terminated by sponsor|1|||
130860055|NCT01371305|471114820|FG000|Overall Study|Subject request|0|||
130860056|NCT01371305|471114821|FG001|Overall Study|Subject request|0|||
130860057|NCT01371305|471114822|FG002|Overall Study|Subject request|0|||
130860058|NCT01371305|471114823|FG003|Overall Study|Subject request|0|||
130860059|NCT01371305|471114824|FG004|Overall Study|Subject request|0|||
130860060|NCT01371305|471114825|FG005|Overall Study|Subject request|1|||
130860061|NCT02828020|471114828|FG000|Treatment Period|Adverse Event|3|||
130860062|NCT02828020|471114829|FG001|Treatment Period|Adverse Event|1|||
130860063|NCT02828020|471114830|FG002|Treatment Period|Adverse Event|1|||
130860064|NCT02828020|471114828|FG000|Treatment Period|Withdrawal of Consent|10|||
130860065|NCT02828020|471114829|FG001|Treatment Period|Withdrawal of Consent|14|||
130860066|NCT02828020|471114830|FG002|Treatment Period|Withdrawal of Consent|9|||
130860067|NCT02828020|471114828|FG000|Treatment Period|Lost to Follow-up|21|||
130860068|NCT02828020|471114829|FG001|Treatment Period|Lost to Follow-up|24|||
130860069|NCT02828020|471114830|FG002|Treatment Period|Lost to Follow-up|18|||
130860070|NCT02828020|471114828|FG000|Treatment Period|Lack of Qualifying Event|44|||
130860071|NCT02828020|471114829|FG001|Treatment Period|Lack of Qualifying Event|53|||
130860072|NCT02828020|471114830|FG002|Treatment Period|Lack of Qualifying Event|43|||
130860073|NCT02828020|471114828|FG000|Treatment Period|Pregnancy|0|||
130860074|NCT02828020|471114829|FG001|Treatment Period|Pregnancy|2|||
130860075|NCT02828020|471114830|FG002|Treatment Period|Pregnancy|0|||
130860076|NCT02828020|471114828|FG000|Treatment Period|Protocol Violation|2|||
130860077|NCT02828020|471114829|FG001|Treatment Period|Protocol Violation|4|||
130860078|NCT02828020|471114830|FG002|Treatment Period|Protocol Violation|7|||
130860079|NCT02828020|471114828|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
130860080|NCT02828020|471114829|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
130860081|NCT02828020|471114830|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
130860082|NCT02828020|471114828|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
130860083|NCT02828020|471114829|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
130860084|NCT02828020|471114830|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
130860085|NCT02828020|471114828|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
130860086|NCT02828020|471114829|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
130860087|NCT02828020|471114830|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
130860088|NCT02828020|471114828|FG000|Safety Follow-up Period|Protocol Violation|0|||
130860089|NCT02828020|471114829|FG001|Safety Follow-up Period|Protocol Violation|2|||
130860090|NCT02828020|471114830|FG002|Safety Follow-up Period|Protocol Violation|1|||
130860091|NCT02828020|471114828|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
130860092|NCT02828020|471114829|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
130860093|NCT02828020|471114830|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
130860094|NCT01138501|471114831|FG000|Overall Study|Protocol Violation|2|||
130860095|NCT01138501|471114831|FG000|Overall Study|Withdrawal by Subject|3|||
130860096|NCT01339897|471114832|FG000|Overall Study|Adverse Event|1|||
130860097|NCT01339897|471114833|FG001|Overall Study|Adverse Event|0|||
130860098|NCT01339897|471114834|FG002|Overall Study|Adverse Event|0|||
130860099|NCT01339897|471114835|FG003|Overall Study|Adverse Event|1|||
130860100|NCT00847197|471114839|FG000|Overall Study|Adverse Event|21|||
130860101|NCT00847197|471114840|FG001|Overall Study|Adverse Event|3|||
130860102|NCT00847197|471114839|FG000|Overall Study|Protocol Violation|0|||
130860103|NCT00847197|471114840|FG001|Overall Study|Protocol Violation|1|||
130860104|NCT00847197|471114839|FG000|Overall Study|Withdrawal by Subject|3|||
130860105|NCT00847197|471114840|FG001|Overall Study|Withdrawal by Subject|1|||
130860106|NCT01743040|471114841|FG000|Overall Study|Death|1|||
130860107|NCT01743040|471114841|FG000|Overall Study|Lost to Follow-up|66|||
130860108|NCT01743040|471114841|FG000|Overall Study|Physician Decision|40|||
130860109|NCT01743040|471114841|FG000|Overall Study|Protocol Violation|1|||
130860110|NCT01743040|471114841|FG000|Overall Study|Withdrawal by Subject|121|||
130860111|NCT01894243|471114842|FG000|Overall Study|Adverse Event|0|||
130860112|NCT01894243|471114843|FG001|Overall Study|Adverse Event|1|||
130860113|NCT01894243|471114844|FG002|Overall Study|Adverse Event|2|||
130860114|NCT01894243|471114842|FG000|Overall Study|Death|0|||
130860115|NCT01894243|471114843|FG001|Overall Study|Death|0|||
130860116|NCT01894243|471114844|FG002|Overall Study|Death|3|||
130860117|NCT01894243|471114842|FG000|Overall Study|Lack of Efficacy|3|||
130860118|NCT01894243|471114843|FG001|Overall Study|Lack of Efficacy|3|||
130860119|NCT01894243|471114844|FG002|Overall Study|Lack of Efficacy|1|||
130860120|NCT01894243|471114842|FG000|Overall Study|Condition under investigation worsened|8|||
130860121|NCT01894243|471114843|FG001|Overall Study|Condition under investigation worsened|6|||
130860122|NCT01894243|471114844|FG002|Overall Study|Condition under investigation worsened|2|||
130860123|NCT01894243|471114842|FG000|Overall Study|Subject decision|1|||
130860124|NCT01894243|471114843|FG001|Overall Study|Subject decision|0|||
130860125|NCT01894243|471114844|FG002|Overall Study|Subject decision|0|||
130860126|NCT01894243|471114842|FG000|Overall Study|Other|1|||
130860127|NCT01894243|471114843|FG001|Overall Study|Other|0|||
130860128|NCT01894243|471114844|FG002|Overall Study|Other|0|||
130860129|NCT00830180|471114848|FG000|Overall Study|Adverse Event|6|||
130860130|NCT00830180|471114848|FG000|Overall Study|Death|11|||
130860131|NCT00830180|471114848|FG000|Overall Study|Insufficient clinical response|1|||
130860132|NCT00830180|471114848|FG000|Overall Study|Withdrawal by Subject|5|||
130860133|NCT00830180|471114848|FG000|Overall Study|Progressive disease|2|||
130860134|NCT00830180|471114848|FG000|Overall Study|Other - Unspecified|1|||
130860135|NCT01832532|471114849|FG000|Overall Study|Withdrawal by Subject|5|||
130860136|NCT01832532|471114850|FG001|Overall Study|Withdrawal by Subject|2|||
130860137|NCT02687581|471114852|FG000|Overall Study|Withdrawal by Subject|1|||
130860138|NCT02687581|471114853|FG001|Overall Study|Withdrawal by Subject|0|||
130860139|NCT02687581|471114854|FG002|Overall Study|Withdrawal by Subject|0|||
130860140|NCT02687581|471114855|FG003|Overall Study|Withdrawal by Subject|1|||
130860141|NCT02687581|471114852|FG000|Overall Study|Lost to Follow-up|2|||
130860142|NCT02687581|471114853|FG001|Overall Study|Lost to Follow-up|2|||
130860143|NCT02687581|471114854|FG002|Overall Study|Lost to Follow-up|0|||
130860144|NCT02687581|471114855|FG003|Overall Study|Lost to Follow-up|0|||
130860145|NCT02687581|471114852|FG000|Overall Study|the device is too small for the patient.|1|||
130860146|NCT02687581|471114853|FG001|Overall Study|the device is too small for the patient.|0|||
130860147|NCT02687581|471114854|FG002|Overall Study|the device is too small for the patient.|0|||
130860148|NCT02687581|471114855|FG003|Overall Study|the device is too small for the patient.|0|||
130860149|NCT01990612|471114858|FG000|Overall Study|Lost to Follow-up|2|||
130860150|NCT01990612|471114859|FG001|Overall Study|Lost to Follow-up|1|||
130860151|NCT01990612|471114858|FG000|Overall Study|Withdrawal by Subject|5|||
130860152|NCT01990612|471114859|FG001|Overall Study|Withdrawal by Subject|2|||
130860153|NCT02974842|471114860|FG000|Overall Study|Withdrawal by Subject|4|||
130860154|NCT02974842|471114860|FG000|Overall Study|Screen failures|4|||
130860155|NCT03824587|471114873|FG000|Run-in Period|Screen Failure|0|||
130860156|NCT03824587|471114874|FG001|Run-in Period|Screen Failure|275|||
130860157|NCT03824587|471114873|FG000|Treatment Period|Adverse Event|4|||
130860158|NCT03824587|471114874|FG001|Treatment Period|Adverse Event|1|||
130860159|NCT03824587|471114873|FG000|Treatment Period|Withdrawal by Subject|0|||
130860160|NCT03824587|471114874|FG001|Treatment Period|Withdrawal by Subject|1|||
130860161|NCT03824587|471114873|FG000|Treatment Period|Kidney Transplant|1|||
130860162|NCT03824587|471114874|FG001|Treatment Period|Kidney Transplant|1|||
130860163|NCT00986362|471114875|FG000|Overall Study|Death|2|||
130860164|NCT00986362|471114876|FG001|Overall Study|Death|0|||
130860165|NCT00986362|471114875|FG000|Overall Study|Lost to Follow-up|0|||
130860166|NCT00986362|471114876|FG001|Overall Study|Lost to Follow-up|1|||
130860167|NCT02006979|471114877|FG000|Overall Study|Withdrawal by Subject|1|||
130860168|NCT02006979|471114878|FG001|Overall Study|Withdrawal by Subject|1|||
130860169|NCT02006979|471114877|FG000|Overall Study|Protocol Violation|0|||
130860170|NCT02006979|471114878|FG001|Overall Study|Protocol Violation|1|||
130860171|NCT03170193|471114879|FG000|Overall Study|Withdrawal by Subject|0|||
130860172|NCT03170193|471114880|FG001|Overall Study|Withdrawal by Subject|0|||
130860173|NCT03170193|471114881|FG002|Overall Study|Withdrawal by Subject|0|||
130860174|NCT03170193|471114882|FG003|Overall Study|Withdrawal by Subject|1|||
130860175|NCT03170193|471114883|FG004|Overall Study|Withdrawal by Subject|0|||
130860176|NCT03170193|471114884|FG005|Overall Study|Withdrawal by Subject|0|||
130860177|NCT03170193|471114885|FG006|Overall Study|Withdrawal by Subject|0|||
130860178|NCT03170193|471114879|FG000|Overall Study|Lost to Follow-up|1|||
130860179|NCT03170193|471114880|FG001|Overall Study|Lost to Follow-up|1|||
130860180|NCT03170193|471114881|FG002|Overall Study|Lost to Follow-up|0|||
130860181|NCT03170193|471114882|FG003|Overall Study|Lost to Follow-up|0|||
130860182|NCT03170193|471114883|FG004|Overall Study|Lost to Follow-up|0|||
130860183|NCT03170193|471114884|FG005|Overall Study|Lost to Follow-up|0|||
130860184|NCT03170193|471114885|FG006|Overall Study|Lost to Follow-up|0|||
130860185|NCT01368081|471114886|FG000|Overall Study|Adverse Event|4|||
130860186|NCT01368081|471114887|FG001|Overall Study|Adverse Event|4|||
130860187|NCT01368081|471114888|FG002|Overall Study|Adverse Event|3|||
130860188|NCT01368081|471114889|FG003|Overall Study|Adverse Event|2|||
130860189|NCT01368081|471114890|FG004|Overall Study|Adverse Event|2|||
130860190|NCT01368081|471114891|FG005|Overall Study|Adverse Event|5|||
130860191|NCT01368081|471114892|FG006|Overall Study|Adverse Event|6|||
130860192|NCT01368081|471114893|FG007|Overall Study|Adverse Event|2|||
130860193|NCT01368081|471114894|FG008|Overall Study|Adverse Event|3|||
130860194|NCT01368081|471114895|FG009|Overall Study|Adverse Event|5|||
130860195|NCT01368081|471114896|FG010|Overall Study|Adverse Event|6|||
130860196|NCT01368081|471114897|FG011|Overall Study|Adverse Event|1|||
130860197|NCT01368081|471114898|FG012|Overall Study|Adverse Event|3|||
130860198|NCT01368081|471114886|FG000|Overall Study|Lack of Efficacy|0|||
130860199|NCT01368081|471114887|FG001|Overall Study|Lack of Efficacy|1|||
130860200|NCT01368081|471114888|FG002|Overall Study|Lack of Efficacy|0|||
130860201|NCT01368081|471114889|FG003|Overall Study|Lack of Efficacy|1|||
130860202|NCT01368081|471114890|FG004|Overall Study|Lack of Efficacy|0|||
130860203|NCT01368081|471114891|FG005|Overall Study|Lack of Efficacy|0|||
130860204|NCT01368081|471114892|FG006|Overall Study|Lack of Efficacy|0|||
130860205|NCT01368081|471114893|FG007|Overall Study|Lack of Efficacy|2|||
130860206|NCT01368081|471114894|FG008|Overall Study|Lack of Efficacy|0|||
130860207|NCT01368081|471114895|FG009|Overall Study|Lack of Efficacy|0|||
130860208|NCT01368081|471114896|FG010|Overall Study|Lack of Efficacy|0|||
130860209|NCT01368081|471114897|FG011|Overall Study|Lack of Efficacy|0|||
130860210|NCT01368081|471114898|FG012|Overall Study|Lack of Efficacy|0|||
130860211|NCT01368081|471114886|FG000|Overall Study|Protocol Violation|0|||
130860212|NCT01368081|471114887|FG001|Overall Study|Protocol Violation|0|||
130860213|NCT01368081|471114888|FG002|Overall Study|Protocol Violation|0|||
130860214|NCT01368081|471114889|FG003|Overall Study|Protocol Violation|0|||
130860215|NCT01368081|471114890|FG004|Overall Study|Protocol Violation|0|||
130860216|NCT01368081|471114891|FG005|Overall Study|Protocol Violation|1|||
130860217|NCT01368081|471114892|FG006|Overall Study|Protocol Violation|0|||
130860218|NCT01368081|471114893|FG007|Overall Study|Protocol Violation|1|||
130860219|NCT01368081|471114894|FG008|Overall Study|Protocol Violation|0|||
130860220|NCT01368081|471114895|FG009|Overall Study|Protocol Violation|0|||
130860221|NCT01368081|471114896|FG010|Overall Study|Protocol Violation|0|||
130860222|NCT01368081|471114897|FG011|Overall Study|Protocol Violation|0|||
130860223|NCT01368081|471114898|FG012|Overall Study|Protocol Violation|0|||
130860224|NCT01368081|471114886|FG000|Overall Study|Lost to Follow-up|0|||
130860225|NCT01368081|471114887|FG001|Overall Study|Lost to Follow-up|0|||
130860226|NCT01368081|471114888|FG002|Overall Study|Lost to Follow-up|0|||
130860227|NCT01368081|471114889|FG003|Overall Study|Lost to Follow-up|0|||
130860228|NCT01368081|471114890|FG004|Overall Study|Lost to Follow-up|0|||
130860229|NCT01368081|471114891|FG005|Overall Study|Lost to Follow-up|0|||
130860230|NCT01368081|471114892|FG006|Overall Study|Lost to Follow-up|0|||
130860231|NCT01368081|471114893|FG007|Overall Study|Lost to Follow-up|0|||
130860232|NCT01368081|471114894|FG008|Overall Study|Lost to Follow-up|0|||
130860233|NCT01368081|471114895|FG009|Overall Study|Lost to Follow-up|0|||
130860234|NCT01368081|471114896|FG010|Overall Study|Lost to Follow-up|0|||
130860235|NCT01368081|471114897|FG011|Overall Study|Lost to Follow-up|0|||
130860236|NCT01368081|471114898|FG012|Overall Study|Lost to Follow-up|1|||
130860237|NCT01368081|471114886|FG000|Overall Study|Withdrawal by Subject|4|||
130860238|NCT01368081|471114887|FG001|Overall Study|Withdrawal by Subject|4|||
130860239|NCT01368081|471114888|FG002|Overall Study|Withdrawal by Subject|1|||
130860240|NCT01368081|471114889|FG003|Overall Study|Withdrawal by Subject|1|||
130860241|NCT01368081|471114890|FG004|Overall Study|Withdrawal by Subject|0|||
130860242|NCT01368081|471114891|FG005|Overall Study|Withdrawal by Subject|3|||
130860243|NCT01368081|471114892|FG006|Overall Study|Withdrawal by Subject|4|||
130860244|NCT01368081|471114893|FG007|Overall Study|Withdrawal by Subject|2|||
130860245|NCT01368081|471114894|FG008|Overall Study|Withdrawal by Subject|5|||
130860246|NCT01368081|471114895|FG009|Overall Study|Withdrawal by Subject|4|||
130860247|NCT01368081|471114896|FG010|Overall Study|Withdrawal by Subject|3|||
130860248|NCT01368081|471114897|FG011|Overall Study|Withdrawal by Subject|2|||
130860249|NCT01368081|471114898|FG012|Overall Study|Withdrawal by Subject|0|||
130860250|NCT01368081|471114886|FG000|Overall Study|Other reason not defined above|2|||
130860251|NCT01368081|471114887|FG001|Overall Study|Other reason not defined above|0|||
130860252|NCT01368081|471114888|FG002|Overall Study|Other reason not defined above|0|||
130860253|NCT01368081|471114889|FG003|Overall Study|Other reason not defined above|1|||
130860254|NCT01368081|471114890|FG004|Overall Study|Other reason not defined above|0|||
130860255|NCT01368081|471114891|FG005|Overall Study|Other reason not defined above|1|||
130860256|NCT01368081|471114892|FG006|Overall Study|Other reason not defined above|2|||
130860257|NCT01368081|471114893|FG007|Overall Study|Other reason not defined above|0|||
130860258|NCT01368081|471114894|FG008|Overall Study|Other reason not defined above|0|||
130860259|NCT01368081|471114895|FG009|Overall Study|Other reason not defined above|1|||
130860260|NCT01368081|471114896|FG010|Overall Study|Other reason not defined above|0|||
130860261|NCT01368081|471114897|FG011|Overall Study|Other reason not defined above|0|||
130860262|NCT01368081|471114898|FG012|Overall Study|Other reason not defined above|3|||
130860263|NCT02277119|471114899|FG000|Overall Study|Lack of Efficacy|1|||
130860264|NCT02277119|471114900|FG001|Overall Study|Lack of Efficacy|1|||
130860265|NCT02277119|471114901|FG002|Overall Study|Lack of Efficacy|1|||
130860266|NCT02277119|471114899|FG000|Overall Study|Protocol Violation|2|||
130860267|NCT02277119|471114900|FG001|Overall Study|Protocol Violation|3|||
130860268|NCT02277119|471114901|FG002|Overall Study|Protocol Violation|7|||
130860269|NCT04699461|471114902|FG000|Overall Study|Withdrawal by Subject|1|||
130860270|NCT04699461|471114903|FG001|Overall Study|Withdrawal by Subject|0|||
130860271|NCT04699461|471114902|FG000|Overall Study|Study termination by sponsor|2|||
130860272|NCT04699461|471114903|FG001|Overall Study|Study termination by sponsor|1|||
130860273|NCT04699461|471114902|FG000|Overall Study|Death|1|||
130860274|NCT04699461|471114903|FG001|Overall Study|Death|0|||
130860275|NCT04699461|471114902|FG000|Overall Study|Radiographic progression|0|||
130860276|NCT04699461|471114903|FG001|Overall Study|Radiographic progression|1|||
130860277|NCT03068767|471114904|FG000|Overall Study|Lost to Follow-up|7|||
130860278|NCT03068767|471114905|FG001|Overall Study|Lost to Follow-up|3|||
130860279|NCT03068767|471114904|FG000|Overall Study|Protocol Violation|3|||
130860280|NCT03068767|471114905|FG001|Overall Study|Protocol Violation|0|||
130860281|NCT04167137|471114906|FG000|Overall Study|Disease progression|1|||
130860282|NCT04167137|471114907|FG001|Overall Study|Disease progression|1|||
130860283|NCT04167137|471114908|FG002|Overall Study|Disease progression|3|||
130860284|NCT04167137|471114909|FG003|Overall Study|Disease progression|3|||
130860285|NCT04167137|471114910|FG004|Overall Study|Disease progression|2|||
130860286|NCT04167137|471114911|FG005|Overall Study|Disease progression|3|||
130860287|NCT04167137|471114912|FG006|Overall Study|Disease progression|2|||
130860288|NCT04167137|471114913|FG007|Overall Study|Disease progression|2|||
130860289|NCT04167137|471114906|FG000|Overall Study|Withdrawal by Subject|1|||
130860290|NCT04167137|471114907|FG001|Overall Study|Withdrawal by Subject|0|||
130860291|NCT04167137|471114908|FG002|Overall Study|Withdrawal by Subject|0|||
130860292|NCT04167137|471114909|FG003|Overall Study|Withdrawal by Subject|1|||
130860293|NCT04167137|471114910|FG004|Overall Study|Withdrawal by Subject|0|||
130860294|NCT04167137|471114911|FG005|Overall Study|Withdrawal by Subject|2|||
130860295|NCT04167137|471114912|FG006|Overall Study|Withdrawal by Subject|1|||
130860296|NCT04167137|471114913|FG007|Overall Study|Withdrawal by Subject|0|||
130860297|NCT04167137|471114906|FG000|Overall Study|Adverse Event|0|||
130860298|NCT04167137|471114907|FG001|Overall Study|Adverse Event|0|||
130860299|NCT04167137|471114908|FG002|Overall Study|Adverse Event|0|||
130860300|NCT04167137|471114909|FG003|Overall Study|Adverse Event|0|||
130860301|NCT04167137|471114910|FG004|Overall Study|Adverse Event|0|||
130860302|NCT04167137|471114911|FG005|Overall Study|Adverse Event|1|||
130860303|NCT04167137|471114912|FG006|Overall Study|Adverse Event|0|||
130860304|NCT04167137|471114913|FG007|Overall Study|Adverse Event|1|||
130860305|NCT04167137|471114906|FG000|Overall Study|Physician Decision|0|||
130860306|NCT04167137|471114907|FG001|Overall Study|Physician Decision|0|||
130860307|NCT04167137|471114908|FG002|Overall Study|Physician Decision|0|||
130860308|NCT04167137|471114909|FG003|Overall Study|Physician Decision|1|||
130860309|NCT04167137|471114910|FG004|Overall Study|Physician Decision|0|||
130860310|NCT04167137|471114911|FG005|Overall Study|Physician Decision|0|||
130860311|NCT04167137|471114912|FG006|Overall Study|Physician Decision|1|||
130860312|NCT04167137|471114913|FG007|Overall Study|Physician Decision|0|||
130860313|NCT04167137|471114906|FG000|Overall Study|Death|0|||
130860314|NCT04167137|471114907|FG001|Overall Study|Death|1|||
130860315|NCT04167137|471114908|FG002|Overall Study|Death|0|||
130860316|NCT04167137|471114909|FG003|Overall Study|Death|0|||
130860317|NCT04167137|471114910|FG004|Overall Study|Death|0|||
130860318|NCT04167137|471114911|FG005|Overall Study|Death|0|||
130860319|NCT04167137|471114912|FG006|Overall Study|Death|0|||
130860320|NCT04167137|471114913|FG007|Overall Study|Death|0|||
130860321|NCT04167137|471114906|FG000|Overall Study|Study terminated by Sponsor|0|||
130860322|NCT04167137|471114907|FG001|Overall Study|Study terminated by Sponsor|0|||
130860323|NCT04167137|471114908|FG002|Overall Study|Study terminated by Sponsor|0|||
130860324|NCT04167137|471114909|FG003|Overall Study|Study terminated by Sponsor|0|||
130860325|NCT04167137|471114910|FG004|Overall Study|Study terminated by Sponsor|0|||
130860326|NCT04167137|471114911|FG005|Overall Study|Study terminated by Sponsor|0|||
130860327|NCT04167137|471114912|FG006|Overall Study|Study terminated by Sponsor|0|||
130860328|NCT04167137|471114913|FG007|Overall Study|Study terminated by Sponsor|1|||
130860329|NCT01748825|471114916|FG000|Dose Escalation|Refused further treatment|2|||
130860330|NCT01748825|471114917|FG001|Dose Escalation|Refused further treatment|2|||
130860331|NCT01748825|471114918|FG002|Dose Escalation|Refused further treatment|0|||
130860332|NCT01748825|471114919|FG003|Dose Escalation|Refused further treatment|0|||
130860333|NCT01748825|471114920|FG004|Dose Escalation|Refused further treatment|1|||
130860334|NCT01748825|471114921|FG005|Dose Escalation|Refused further treatment|2|||
130860335|NCT01748825|471114922|FG006|Dose Escalation|Refused further treatment|0|||
130860336|NCT01748825|471114923|FG007|Dose Escalation|Refused further treatment|0|||
130860337|NCT01748825|471114924|FG008|Dose Escalation|Refused further treatment|0|||
130860338|NCT01748825|471114925|FG009|Dose Escalation|Refused further treatment|0|||
130860339|NCT01748825|471114916|FG000|Dose Escalation|Switched to alternative treatment|0|||
130860340|NCT01748825|471114917|FG001|Dose Escalation|Switched to alternative treatment|0|||
130860341|NCT01748825|471114918|FG002|Dose Escalation|Switched to alternative treatment|0|||
130860342|NCT01748825|471114919|FG003|Dose Escalation|Switched to alternative treatment|1|||
130860343|NCT01748825|471114920|FG004|Dose Escalation|Switched to alternative treatment|0|||
130860344|NCT01748825|471114921|FG005|Dose Escalation|Switched to alternative treatment|0|||
130860345|NCT01748825|471114922|FG006|Dose Escalation|Switched to alternative treatment|0|||
130860346|NCT01748825|471114923|FG007|Dose Escalation|Switched to alternative treatment|0|||
130860347|NCT01748825|471114924|FG008|Dose Escalation|Switched to alternative treatment|0|||
130860348|NCT01748825|471114925|FG009|Dose Escalation|Switched to alternative treatment|0|||
130860349|NCT01748825|471114916|FG000|Dose Escalation|Adverse Event|0|||
130860350|NCT01748825|471114917|FG001|Dose Escalation|Adverse Event|0|||
130860351|NCT01748825|471114918|FG002|Dose Escalation|Adverse Event|0|||
130860352|NCT01748825|471114919|FG003|Dose Escalation|Adverse Event|0|||
130860353|NCT01748825|471114920|FG004|Dose Escalation|Adverse Event|0|||
130860354|NCT01748825|471114921|FG005|Dose Escalation|Adverse Event|0|||
130860355|NCT01748825|471114922|FG006|Dose Escalation|Adverse Event|1|||
130860356|NCT01748825|471114923|FG007|Dose Escalation|Adverse Event|0|||
130860357|NCT01748825|471114924|FG008|Dose Escalation|Adverse Event|0|||
130860358|NCT01748825|471114925|FG009|Dose Escalation|Adverse Event|0|||
130860359|NCT01748825|471114916|FG000|Dose Expansion|Refused further treatment|0|||
130860360|NCT01748825|471114917|FG001|Dose Expansion|Refused further treatment|0|||
130860361|NCT01748825|471114918|FG002|Dose Expansion|Refused further treatment|0|||
130860362|NCT01748825|471114919|FG003|Dose Expansion|Refused further treatment|0|||
130860363|NCT01748825|471114920|FG004|Dose Expansion|Refused further treatment|0|||
130860364|NCT01748825|471114921|FG005|Dose Expansion|Refused further treatment|0|||
130860365|NCT01748825|471114922|FG006|Dose Expansion|Refused further treatment|0|||
130860366|NCT01748825|471114923|FG007|Dose Expansion|Refused further treatment|0|||
130860367|NCT01748825|471114924|FG008|Dose Expansion|Refused further treatment|1|||
130860368|NCT01748825|471114925|FG009|Dose Expansion|Refused further treatment|1|||
130860369|NCT01748825|471114916|FG000|Dose Expansion|Switched to alternative treatment|0|||
130860370|NCT01748825|471114917|FG001|Dose Expansion|Switched to alternative treatment|0|||
130860371|NCT01748825|471114918|FG002|Dose Expansion|Switched to alternative treatment|0|||
130860372|NCT01748825|471114919|FG003|Dose Expansion|Switched to alternative treatment|0|||
130860373|NCT01748825|471114920|FG004|Dose Expansion|Switched to alternative treatment|0|||
130860374|NCT01748825|471114921|FG005|Dose Expansion|Switched to alternative treatment|0|||
130860375|NCT01748825|471114922|FG006|Dose Expansion|Switched to alternative treatment|0|||
130860376|NCT01748825|471114923|FG007|Dose Expansion|Switched to alternative treatment|0|||
130860377|NCT01748825|471114924|FG008|Dose Expansion|Switched to alternative treatment|0|||
130860378|NCT01748825|471114925|FG009|Dose Expansion|Switched to alternative treatment|1|||
130860379|NCT01748825|471114916|FG000|Dose Expansion|Adverse Event|0|||
130860380|NCT01748825|471114917|FG001|Dose Expansion|Adverse Event|0|||
130860381|NCT01748825|471114918|FG002|Dose Expansion|Adverse Event|0|||
130860382|NCT01748825|471114919|FG003|Dose Expansion|Adverse Event|0|||
130860383|NCT01748825|471114920|FG004|Dose Expansion|Adverse Event|0|||
130860384|NCT01748825|471114921|FG005|Dose Expansion|Adverse Event|0|||
130860385|NCT01748825|471114922|FG006|Dose Expansion|Adverse Event|0|||
130860386|NCT01748825|471114923|FG007|Dose Expansion|Adverse Event|0|||
130860387|NCT01748825|471114924|FG008|Dose Expansion|Adverse Event|0|||
130860388|NCT01748825|471114925|FG009|Dose Expansion|Adverse Event|3|||
130860389|NCT01748825|471114916|FG000|Dose Expansion|Physician Decision|0|||
130860390|NCT01748825|471114917|FG001|Dose Expansion|Physician Decision|0|||
130860391|NCT01748825|471114918|FG002|Dose Expansion|Physician Decision|0|||
130860392|NCT01748825|471114919|FG003|Dose Expansion|Physician Decision|0|||
130860393|NCT01748825|471114920|FG004|Dose Expansion|Physician Decision|0|||
130860394|NCT01748825|471114921|FG005|Dose Expansion|Physician Decision|0|||
130860395|NCT01748825|471114922|FG006|Dose Expansion|Physician Decision|0|||
130860396|NCT01748825|471114923|FG007|Dose Expansion|Physician Decision|0|||
130860397|NCT01748825|471114924|FG008|Dose Expansion|Physician Decision|1|||
130860398|NCT01748825|471114925|FG009|Dose Expansion|Physician Decision|0|||
130860399|NCT01370265|471116783|FG000|First Intervention|Adverse Event|1|||
130860400|NCT01370265|471116784|FG001|First Intervention|Adverse Event|1|||
130860401|NCT01732770|471116786|FG000|Overall Study|Lost to Follow-up|2|||
130860402|NCT01732770|471116787|FG001|Overall Study|Lost to Follow-up|3|||
130860403|NCT01732770|471116786|FG000|Overall Study|Withdrawal by Subject|5|||
130860404|NCT01732770|471116787|FG001|Overall Study|Withdrawal by Subject|3|||
130860405|NCT01732770|471116786|FG000|Overall Study|Decision by Sponsor|2|||
130860406|NCT01732770|471116787|FG001|Overall Study|Decision by Sponsor|2|||
130860407|NCT01732770|471116786|FG000|Overall Study|Death|1|||
130860408|NCT01732770|471116787|FG001|Overall Study|Death|0|||
130860409|NCT00871338|471116790|FG000|Prior to Booster|Withdrawal by Subject|1|||
130860410|NCT00871338|471116791|FG001|Prior to Booster|Withdrawal by Subject|3|||
130860411|NCT00871338|471116790|FG000|Prior to Booster|Lost to Follow-up|1|||
130860412|NCT00871338|471116791|FG001|Prior to Booster|Lost to Follow-up|0|||
130860413|NCT02391363|471116792|FG000|Overall Study|Lost to Follow-up|5|||
130860414|NCT02391363|471116793|FG001|Overall Study|Lost to Follow-up|5|||
130860415|NCT02391363|471116792|FG000|Overall Study|Withdrawal by Subject|6|||
130860416|NCT02391363|471116793|FG001|Overall Study|Withdrawal by Subject|3|||
130860417|NCT04794270|471116794|FG000|Period 1|Non Compliance|1|||
130860418|NCT04794270|471116795|FG001|Period 1|Non Compliance|0|||
130860419|NCT04794270|471116794|FG000|Period 1|Adverse Event|1|||
130860420|NCT04794270|471116795|FG001|Period 1|Adverse Event|0|||
130860421|NCT04794270|471116794|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
130860422|NCT04794270|471116795|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
130860423|NCT00265317|471116798|FG000|Lead-In|Objective progression or relapse|6|||
130860424|NCT00265317|471116799|FG001|Lead-In|Objective progression or relapse|11|||
130860425|NCT00265317|471116800|FG002|Lead-In|Objective progression or relapse|0|||
130860426|NCT00265317|471116801|FG003|Lead-In|Objective progression or relapse|0|||
130860427|NCT00265317|471116798|FG000|Lead-In|Adverse Event|2|||
130860428|NCT00265317|471116799|FG001|Lead-In|Adverse Event|1|||
130860429|NCT00265317|471116800|FG002|Lead-In|Adverse Event|0|||
130860430|NCT00265317|471116801|FG003|Lead-In|Adverse Event|0|||
130860431|NCT00265317|471116798|FG000|Lead-In|Death|3|||
130860432|NCT00265317|471116799|FG001|Lead-In|Death|5|||
130860433|NCT00265317|471116800|FG002|Lead-In|Death|0|||
130860434|NCT00265317|471116801|FG003|Lead-In|Death|0|||
130860435|NCT00265317|471116798|FG000|Lead-In|Withdrawal/other than adverse event|1|||
130860436|NCT00265317|471116799|FG001|Lead-In|Withdrawal/other than adverse event|0|||
130860437|NCT00265317|471116800|FG002|Lead-In|Withdrawal/other than adverse event|0|||
130860438|NCT00265317|471116801|FG003|Lead-In|Withdrawal/other than adverse event|0|||
130860439|NCT00265317|471116798|FG000|Phase 2|Objective progression or relapse|0|||
130860440|NCT00265317|471116799|FG001|Phase 2|Objective progression or relapse|0|||
130860441|NCT00265317|471116800|FG002|Phase 2|Objective progression or relapse|37|||
130860442|NCT00265317|471116801|FG003|Phase 2|Objective progression or relapse|38|||
130860443|NCT00265317|471116798|FG000|Phase 2|Global deterioration of health status|0|||
130860444|NCT00265317|471116799|FG001|Phase 2|Global deterioration of health status|0|||
130860445|NCT00265317|471116800|FG002|Phase 2|Global deterioration of health status|3|||
130860446|NCT00265317|471116801|FG003|Phase 2|Global deterioration of health status|0|||
130860447|NCT00265317|471116798|FG000|Phase 2|Adverse Event|0|||
130860448|NCT00265317|471116799|FG001|Phase 2|Adverse Event|0|||
130860449|NCT00265317|471116800|FG002|Phase 2|Adverse Event|7|||
130860450|NCT00265317|471116801|FG003|Phase 2|Adverse Event|5|||
130860451|NCT00265317|471116798|FG000|Phase 2|Death|0|||
130860452|NCT00265317|471116799|FG001|Phase 2|Death|0|||
130860453|NCT00265317|471116800|FG002|Phase 2|Death|12|||
130860454|NCT00265317|471116801|FG003|Phase 2|Death|15|||
130860455|NCT00265317|471116798|FG000|Phase 2|Protocol Violation|0|||
130860456|NCT00265317|471116799|FG001|Phase 2|Protocol Violation|0|||
130860457|NCT00265317|471116800|FG002|Phase 2|Protocol Violation|1|||
130860458|NCT00265317|471116801|FG003|Phase 2|Protocol Violation|4|||
130860459|NCT00265317|471116798|FG000|Phase 2|Lost to Follow-up|0|||
130860460|NCT00265317|471116799|FG001|Phase 2|Lost to Follow-up|0|||
130860461|NCT00265317|471116800|FG002|Phase 2|Lost to Follow-up|0|||
130860462|NCT00265317|471116801|FG003|Phase 2|Lost to Follow-up|1|||
130860463|NCT00265317|471116798|FG000|Phase 2|Withdrawal/other than adverse event|0|||
130860464|NCT00265317|471116799|FG001|Phase 2|Withdrawal/other than adverse event|0|||
130860465|NCT00265317|471116800|FG002|Phase 2|Withdrawal/other than adverse event|2|||
130860466|NCT00265317|471116801|FG003|Phase 2|Withdrawal/other than adverse event|1|||
130860467|NCT00265317|471116798|FG000|Phase 2|Study terminated by sponsor|0|||
130860468|NCT00265317|471116799|FG001|Phase 2|Study terminated by sponsor|0|||
130860469|NCT00265317|471116800|FG002|Phase 2|Study terminated by sponsor|1|||
130860470|NCT00265317|471116801|FG003|Phase 2|Study terminated by sponsor|0|||
130860471|NCT00265317|471116798|FG000|Phase 2|Other|0|||
130860472|NCT00265317|471116799|FG001|Phase 2|Other|0|||
130860473|NCT00265317|471116800|FG002|Phase 2|Other|1|||
130860474|NCT00265317|471116801|FG003|Phase 2|Other|1|||
130860475|NCT02510001|471116802|FG000|Overall Study|Early disease progression|0|||
130860476|NCT02510001|471116803|FG001|Overall Study|Early disease progression|0|||
130860477|NCT02510001|471116804|FG002|Overall Study|Early disease progression|0|||
130860478|NCT02510001|471116805|FG003|Overall Study|Early disease progression|1|||
130860479|NCT02510001|471116806|FG004|Overall Study|Early disease progression|1|||
130860480|NCT02510001|471116807|FG005|Overall Study|Early disease progression|1|||
130860481|NCT02510001|471116808|FG006|Overall Study|Early disease progression|0|||
130860482|NCT02510001|471116809|FG007|Overall Study|Early disease progression|0|||
130860483|NCT02510001|471116802|FG000|Overall Study|Adverse Event|0|||
130860484|NCT02510001|471116803|FG001|Overall Study|Adverse Event|0|||
130860485|NCT02510001|471116804|FG002|Overall Study|Adverse Event|0|||
130860486|NCT02510001|471116805|FG003|Overall Study|Adverse Event|1|||
130860487|NCT02510001|471116806|FG004|Overall Study|Adverse Event|2|||
130860488|NCT02510001|471116807|FG005|Overall Study|Adverse Event|1|||
130860489|NCT02510001|471116808|FG006|Overall Study|Adverse Event|2|||
130860490|NCT02510001|471116809|FG007|Overall Study|Adverse Event|5|||
130860491|NCT02510001|471116802|FG000|Overall Study|Physician Decision|0|||
130860492|NCT02510001|471116803|FG001|Overall Study|Physician Decision|0|||
130860493|NCT02510001|471116804|FG002|Overall Study|Physician Decision|0|||
130860494|NCT02510001|471116805|FG003|Overall Study|Physician Decision|0|||
130860495|NCT02510001|471116806|FG004|Overall Study|Physician Decision|1|||
130860496|NCT02510001|471116807|FG005|Overall Study|Physician Decision|0|||
130860497|NCT02510001|471116808|FG006|Overall Study|Physician Decision|0|||
130860498|NCT02510001|471116809|FG007|Overall Study|Physician Decision|0|||
130860499|NCT02510001|471116802|FG000|Overall Study|Withdrawal by Subject|0|||
130860500|NCT02510001|471116803|FG001|Overall Study|Withdrawal by Subject|0|||
130860501|NCT02510001|471116804|FG002|Overall Study|Withdrawal by Subject|0|||
130860502|NCT02510001|471116805|FG003|Overall Study|Withdrawal by Subject|0|||
130860503|NCT02510001|471116806|FG004|Overall Study|Withdrawal by Subject|0|||
130860504|NCT02510001|471116807|FG005|Overall Study|Withdrawal by Subject|0|||
130860505|NCT02510001|471116808|FG006|Overall Study|Withdrawal by Subject|0|||
130860506|NCT02510001|471116809|FG007|Overall Study|Withdrawal by Subject|2|||
130860507|NCT02950480|471116814|FG000|Overall Study|Withdrawal by Subject|1|||
130860508|NCT02950480|471116815|FG001|Overall Study|Withdrawal by Subject|0|||
130860509|NCT01964963|471116816|FG000|Overall Study|Case Report Forms Uncollected|888|||
130860510|NCT01964963|471116816|FG000|Overall Study|Protocol Deviation|50|||
130860511|NCT01964963|471116816|FG000|Overall Study|Data Reliability was not Assured|5|||
130860512|NCT00711971|471116819|FG000|Overall Study|Lost to Follow-up|3|||
130860513|NCT00711971|471116820|FG001|Overall Study|Lost to Follow-up|4|||
130860514|NCT00711971|471116821|FG002|Overall Study|Lost to Follow-up|1|||
130860515|NCT02644343|471116822|FG000|Overall Study|Withdrawal by Subject|1|||
130860516|NCT03704688|471116831|FG000|Overall Study|Adverse Event|0|||
130860517|NCT03704688|471116832|FG001|Overall Study|Adverse Event|0|||
130860518|NCT03704688|471116833|FG002|Overall Study|Adverse Event|0|||
130860519|NCT03704688|471116834|FG003|Overall Study|Adverse Event|4|||
130860520|NCT03704688|471116835|FG004|Overall Study|Adverse Event|1|||
130860521|NCT03704688|471116836|FG005|Overall Study|Adverse Event|0|||
130860522|NCT03704688|471116831|FG000|Overall Study|Disease Progression|0|||
130860523|NCT03704688|471116832|FG001|Overall Study|Disease Progression|0|||
130860524|NCT03704688|471116833|FG002|Overall Study|Disease Progression|0|||
130860525|NCT03704688|471116834|FG003|Overall Study|Disease Progression|3|||
130860526|NCT03704688|471116835|FG004|Overall Study|Disease Progression|1|||
130860527|NCT03704688|471116836|FG005|Overall Study|Disease Progression|0|||
130860528|NCT03704688|471116831|FG000|Overall Study|Death|0|||
130860529|NCT03704688|471116832|FG001|Overall Study|Death|0|||
130860530|NCT03704688|471116833|FG002|Overall Study|Death|0|||
130860531|NCT03704688|471116834|FG003|Overall Study|Death|0|||
130860532|NCT03704688|471116835|FG004|Overall Study|Death|3|||
130860533|NCT03704688|471116836|FG005|Overall Study|Death|0|||
130860534|NCT01440816|471116842|FG000|Overall Study|Disease Progression|0|||
130860535|NCT01440816|471116843|FG001|Overall Study|Disease Progression|9|||
130860536|NCT01440816|471116842|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
130860537|NCT01440816|471116843|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
130860538|NCT00856544|471116844|FG000|Overall Study|Randomized but not treated|3|||
130860539|NCT00856544|471116845|FG001|Overall Study|Randomized but not treated|0|||
130860540|NCT00856544|471116846|FG002|Overall Study|Randomized but not treated|0|||
130860541|NCT00856544|471116847|FG003|Overall Study|Randomized but not treated|0|||
130860542|NCT00856544|471116844|FG000|Overall Study|Death|0|||
130860543|NCT00856544|471116845|FG001|Overall Study|Death|2|||
130860544|NCT00856544|471116846|FG002|Overall Study|Death|0|||
130860545|NCT00856544|471116847|FG003|Overall Study|Death|0|||
130860546|NCT00856544|471116844|FG000|Overall Study|Adverse Event|20|||
130860547|NCT00856544|471116845|FG001|Overall Study|Adverse Event|29|||
130860548|NCT00856544|471116846|FG002|Overall Study|Adverse Event|2|||
130860549|NCT00856544|471116847|FG003|Overall Study|Adverse Event|3|||
130860550|NCT00856544|471116844|FG000|Overall Study|Lack of Efficacy|16|||
130860551|NCT00856544|471116845|FG001|Overall Study|Lack of Efficacy|12|||
130860552|NCT00856544|471116846|FG002|Overall Study|Lack of Efficacy|3|||
130860553|NCT00856544|471116847|FG003|Overall Study|Lack of Efficacy|3|||
130860554|NCT00856544|471116844|FG000|Overall Study|Other|9|||
130860555|NCT00856544|471116845|FG001|Overall Study|Other|16|||
130860556|NCT00856544|471116846|FG002|Overall Study|Other|1|||
130860557|NCT00856544|471116847|FG003|Overall Study|Other|6|||
130860558|NCT00856544|471116844|FG000|Overall Study|Lost to Follow-up|1|||
130860559|NCT00856544|471116845|FG001|Overall Study|Lost to Follow-up|2|||
130860560|NCT00856544|471116846|FG002|Overall Study|Lost to Follow-up|2|||
130860561|NCT00856544|471116847|FG003|Overall Study|Lost to Follow-up|0|||
130860562|NCT00856544|471116844|FG000|Overall Study|Withdrawal by Subject|8|||
130860563|NCT00856544|471116845|FG001|Overall Study|Withdrawal by Subject|5|||
130860564|NCT00856544|471116846|FG002|Overall Study|Withdrawal by Subject|0|||
130860565|NCT00856544|471116847|FG003|Overall Study|Withdrawal by Subject|1|||
130860566|NCT00787189|471116848|FG000|Overall Study|Lost to Follow-up|2|||
130860567|NCT00787189|471116849|FG001|Overall Study|Lost to Follow-up|2|||
130860568|NCT00847886|471116850|FG000|Overall Study|Adverse Event|0|||
130860569|NCT00847886|471116851|FG001|Overall Study|Adverse Event|1|||
130860570|NCT01687101|471116852|FG000|Overall Study|Lost to Follow-up|7|||
130860571|NCT03920254|471116854|FG000|Overall Study|Adverse Event|1|||
130860572|NCT03920254|471116855|FG001|Overall Study|Adverse Event|0|||
130860573|NCT03920254|471116856|FG002|Overall Study|Adverse Event|0|||
130860574|NCT03920254|471116854|FG000|Overall Study|Physician Decision|0|||
130860575|NCT03920254|471116855|FG001|Overall Study|Physician Decision|1|||
130860576|NCT03920254|471116856|FG002|Overall Study|Physician Decision|2|||
130860577|NCT03920254|471116854|FG000|Overall Study|Study Terminated By Sponsor|12|||
130860578|NCT03920254|471116855|FG001|Overall Study|Study Terminated By Sponsor|17|||
130860579|NCT03920254|471116856|FG002|Overall Study|Study Terminated By Sponsor|12|||
130860580|NCT03920254|471116854|FG000|Overall Study|Withdrawal by Subject|0|||
130860581|NCT03920254|471116855|FG001|Overall Study|Withdrawal by Subject|0|||
130860582|NCT03920254|471116856|FG002|Overall Study|Withdrawal by Subject|1|||
130860583|NCT03250182|471116857|FG000|Overall Study|Withdrawal by Subject|1|||
130860584|NCT05274269|471116858|FG000|Overall Study|Adverse Event|0|||
130860585|NCT05274269|471116859|FG001|Overall Study|Adverse Event|3|||
130860586|NCT05274269|471116858|FG000|Overall Study|Death|0|||
130860587|NCT05274269|471116859|FG001|Overall Study|Death|1|||
130860588|NCT05274269|471116858|FG000|Overall Study|Other|0|||
130860589|NCT05274269|471116859|FG001|Overall Study|Other|2|||
130860590|NCT05274269|471116858|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
130860591|NCT05274269|471116859|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
130860592|NCT01858740|471116863|FG000|Overall Study|Death|4|||
130860593|NCT01068769|471116864|FG000|Overall Study|Ineligible|1|||
130860594|NCT00709618|471116865|FG000|Overall Study|Withdrawal by Subject|4|||
130860595|NCT00709618|471116865|FG000|Overall Study|Lost to Follow-up|1|||
130860596|NCT00709618|471116865|FG000|Overall Study|Study Closed/Terminated|25|||
130860597|NCT04042909|471116866|FG000|Overall Study|Withdrawal by Subject|1|||
130860598|NCT04042909|471116867|FG001|Overall Study|Withdrawal by Subject|0|||
130860599|NCT04042909|471116868|FG002|Overall Study|Withdrawal by Subject|0|||
130860600|NCT04042909|471116866|FG000|Overall Study|duplicate cases|2|||
130860601|NCT04042909|471116867|FG001|Overall Study|duplicate cases|0|||
130860602|NCT04042909|471116868|FG002|Overall Study|duplicate cases|0|||
130860603|NCT04042909|471116866|FG000|Overall Study|technical problem|0|||
130860604|NCT04042909|471116867|FG001|Overall Study|technical problem|1|||
130860605|NCT04042909|471116868|FG002|Overall Study|technical problem|0|||
130860606|NCT00296140|471116869|FG000|Overall Study|Lost to Follow-up|1|||
130860607|NCT00296140|471116870|FG001|Overall Study|Lost to Follow-up|0|||
130860608|NCT00296140|471116869|FG000|Overall Study|Withdrawal by Subject|1|||
130860609|NCT00296140|471116870|FG001|Overall Study|Withdrawal by Subject|0|||
130860610|NCT00296140|471116869|FG000|Overall Study|Discharge to Nursing Home|1|||
130860611|NCT00296140|471116870|FG001|Overall Study|Discharge to Nursing Home|0|||
130860612|NCT01856582|471116871|FG000|Overall Study|Died prior to Boost infusion|1|||
130860613|NCT00596830|471116872|FG000|Overall Study|Death|258|||
130860614|NCT00596830|471116873|FG001|Overall Study|Death|247|||
130860615|NCT00596830|471116872|FG000|Overall Study|Lost to Follow-up|7|||
130860616|NCT00596830|471116873|FG001|Overall Study|Lost to Follow-up|11|||
130860617|NCT00596830|471116872|FG000|Overall Study|Withdrawal by Subject|22|||
130860618|NCT00596830|471116873|FG001|Overall Study|Withdrawal by Subject|12|||
130860619|NCT00596830|471116872|FG000|Overall Study|Study terminated by sponsor|51|||
130860620|NCT00596830|471116873|FG001|Overall Study|Study terminated by sponsor|62|||
130860621|NCT00596830|471116872|FG000|Overall Study|Follow-up was discontinued|1|||
130860622|NCT00596830|471116873|FG001|Overall Study|Follow-up was discontinued|0|||
130860623|NCT00596830|471116872|FG000|Overall Study|Randomized but not treated|3|||
130860624|NCT00596830|471116873|FG001|Overall Study|Randomized but not treated|7|||
130860625|NCT00887926|471116874|FG000|Overall Study|Withdrawal by Subject|0|||
130860626|NCT00887926|471116875|FG001|Overall Study|Withdrawal by Subject|1|||
130860627|NCT00887926|471116876|FG002|Overall Study|Withdrawal by Subject|0|||
130860628|NCT00887926|471116877|FG003|Overall Study|Withdrawal by Subject|0|||
130860629|NCT00880191|471116878|FG000|Overall Study|Refused further treatment|4|||
130860630|NCT00880191|471116879|FG001|Overall Study|Refused further treatment|1|||
130860631|NCT00880191|471116878|FG000|Overall Study|Adverse Event|8|||
130860632|NCT00880191|471116879|FG001|Overall Study|Adverse Event|6|||
130860633|NCT00880191|471116878|FG000|Overall Study|Hospitalization/efficacy|1|||
130860634|NCT00880191|471116879|FG001|Overall Study|Hospitalization/efficacy|1|||
130860635|NCT02097030|471116880|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
130860636|NCT02097030|471116881|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
130860637|NCT02097030|471116880|FG000|First Intervention (3 Days)|Visual Acuity|0|||
130860638|NCT02097030|471116881|FG001|First Intervention (3 Days)|Visual Acuity|1|||
130860639|NCT01919801|471116882|FG000|Overall Study|Withdrawal by Subject|1|||
130860640|NCT01919801|471116883|FG001|Overall Study|Withdrawal by Subject|0|||
130860641|NCT01919801|471116882|FG000|Overall Study|Physician Decision|0|||
130860642|NCT01919801|471116883|FG001|Overall Study|Physician Decision|1|||
130860643|NCT01919801|471116882|FG000|Overall Study|Lost to Follow-up|0|||
130860644|NCT01919801|471116883|FG001|Overall Study|Lost to Follow-up|1|||
130860645|NCT01919801|471116882|FG000|Overall Study|Other|0|||
130860646|NCT01919801|471116883|FG001|Overall Study|Other|1|||
130860647|NCT01843062|471116884|FG000|Overall Study|Protocol Violation|1|||
130860648|NCT01843062|471116885|FG001|Overall Study|Protocol Violation|0|||
130860649|NCT01843062|471116884|FG000|Overall Study|New treatment following progression|2|||
130860650|NCT01843062|471116885|FG001|Overall Study|New treatment following progression|0|||
130860651|NCT01843062|471116884|FG000|Overall Study|Pregnancy|1|||
130860652|NCT01843062|471116885|FG001|Overall Study|Pregnancy|0|||
130860653|NCT01843062|471116884|FG000|Overall Study|Adverse Event|2|||
130860654|NCT01843062|471116885|FG001|Overall Study|Adverse Event|0|||
130860655|NCT01843062|471116884|FG000|Overall Study|Incorrect randomisation|1|||
130860656|NCT01843062|471116885|FG001|Overall Study|Incorrect randomisation|0|||
130860657|NCT01843062|471116884|FG000|Overall Study|Withdrawal by Subject|12|||
130860658|NCT01843062|471116885|FG001|Overall Study|Withdrawal by Subject|3|||
130860659|NCT01843062|471116884|FG000|Overall Study|Death|1|||
130860660|NCT01843062|471116885|FG001|Overall Study|Death|2|||
130860661|NCT01843062|471116884|FG000|Overall Study|Lost to Follow-up|2|||
130860662|NCT01843062|471116885|FG001|Overall Study|Lost to Follow-up|4|||
130860663|NCT01677858|471116886|FG000|Overall Study|Adverse Event|0|||
130860664|NCT01677858|471116887|FG001|Overall Study|Adverse Event|0|||
130860665|NCT01677858|471116888|FG002|Overall Study|Adverse Event|2|||
130860666|NCT01677858|471116889|FG003|Overall Study|Adverse Event|3|||
130860667|NCT01677858|471116890|FG004|Overall Study|Adverse Event|13|||
130860668|NCT01677858|471116886|FG000|Overall Study|Death|0|||
130860669|NCT01677858|471116887|FG001|Overall Study|Death|0|||
130860670|NCT01677858|471116888|FG002|Overall Study|Death|0|||
130860671|NCT01677858|471116889|FG003|Overall Study|Death|0|||
130860672|NCT01677858|471116890|FG004|Overall Study|Death|1|||
130860673|NCT01677858|471116886|FG000|Overall Study|Physician Decision|1|||
130860674|NCT01677858|471116887|FG001|Overall Study|Physician Decision|0|||
130860675|NCT01677858|471116888|FG002|Overall Study|Physician Decision|2|||
130860676|NCT01677858|471116889|FG003|Overall Study|Physician Decision|0|||
130860677|NCT01677858|471116890|FG004|Overall Study|Physician Decision|12|||
130860678|NCT01677858|471116886|FG000|Overall Study|Progressive Disease|2|||
130860679|NCT01677858|471116887|FG001|Overall Study|Progressive Disease|1|||
130860680|NCT01677858|471116888|FG002|Overall Study|Progressive Disease|9|||
130860681|NCT01677858|471116889|FG003|Overall Study|Progressive Disease|3|||
130860682|NCT01677858|471116890|FG004|Overall Study|Progressive Disease|43|||
130860683|NCT01677858|471116886|FG000|Overall Study|Withdrawal by Subject|0|||
130860684|NCT01677858|471116887|FG001|Overall Study|Withdrawal by Subject|1|||
130860685|NCT01677858|471116888|FG002|Overall Study|Withdrawal by Subject|1|||
130860686|NCT01677858|471116889|FG003|Overall Study|Withdrawal by Subject|0|||
130860687|NCT01677858|471116890|FG004|Overall Study|Withdrawal by Subject|15|||
130860688|NCT01677858|471116886|FG000|Overall Study|Lost to Follow-up|0|||
130860689|NCT01677858|471116887|FG001|Overall Study|Lost to Follow-up|0|||
130860690|NCT01677858|471116888|FG002|Overall Study|Lost to Follow-up|0|||
130860691|NCT01677858|471116889|FG003|Overall Study|Lost to Follow-up|0|||
130860692|NCT01677858|471116890|FG004|Overall Study|Lost to Follow-up|1|||
130860693|NCT00773747|471116891|FG000|Overall Study|Lack of Efficacy|112|||
130860694|NCT00773747|471116892|FG001|Overall Study|Lack of Efficacy|144|||
130860695|NCT00773747|471116891|FG000|Overall Study|Physician Decision|26|||
130860696|NCT00773747|471116892|FG001|Overall Study|Physician Decision|18|||
130860697|NCT00773747|471116891|FG000|Overall Study|Lost to Follow-up|0|||
130860698|NCT00773747|471116892|FG001|Overall Study|Lost to Follow-up|1|||
130860699|NCT00773747|471116891|FG000|Overall Study|Protocol Violation|2|||
130860700|NCT00773747|471116892|FG001|Overall Study|Protocol Violation|2|||
130860701|NCT00773747|471116891|FG000|Overall Study|Withdrawal by Subject|89|||
130860702|NCT00773747|471116892|FG001|Overall Study|Withdrawal by Subject|61|||
130860703|NCT00773747|471116891|FG000|Overall Study|Adverse Event|61|||
130860704|NCT00773747|471116892|FG001|Overall Study|Adverse Event|62|||
130860705|NCT00773747|471116891|FG000|Overall Study|Death|5|||
130860706|NCT00773747|471116892|FG001|Overall Study|Death|8|||
130860707|NCT00773747|471116891|FG000|Overall Study|Not Treated|2|||
130860708|NCT00773747|471116892|FG001|Overall Study|Not Treated|0|||
130860709|NCT02669212|471116895|FG000|Overall Study|Lost to Follow-up|1|||
130860710|NCT02669212|471116896|FG001|Overall Study|Lost to Follow-up|0|||
130860711|NCT02669212|471116895|FG000|Overall Study|Medical Condition|3|||
130860712|NCT02669212|471116896|FG001|Overall Study|Medical Condition|4|||
130860713|NCT02669212|471116895|FG000|Overall Study|Withdrawal by Subject|0|||
130860714|NCT02669212|471116896|FG001|Overall Study|Withdrawal by Subject|2|||
130860715|NCT02669212|471116895|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
130860716|NCT02669212|471116896|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
130860717|NCT03549104|471116897|FG000|Overall Study|Withdrawal by Subject|5|||
130860718|NCT03549104|471116898|FG001|Overall Study|Withdrawal by Subject|2|||
130860719|NCT03549104|471116897|FG000|Overall Study|Covid shelter in place|1|||
130860720|NCT03549104|471116898|FG001|Overall Study|Covid shelter in place|2|||
130860721|NCT03078855|471116899|FG000|Overall Study|Lack of Efficacy|62|||
130860722|NCT03078855|471116900|FG001|Overall Study|Lack of Efficacy|31|||
130860723|NCT03078855|471116899|FG000|Overall Study|Death|1|||
130860724|NCT03078855|471116900|FG001|Overall Study|Death|0|||
130860725|NCT03078855|471116899|FG000|Overall Study|Withdrawal by Subject|12|||
130860726|NCT03078855|471116900|FG001|Overall Study|Withdrawal by Subject|6|||
130860727|NCT03078855|471116899|FG000|Overall Study|Physician Decision|3|||
130860728|NCT03078855|471116900|FG001|Overall Study|Physician Decision|2|||
130860729|NCT03078855|471116899|FG000|Overall Study|Second Malignancy|4|||
130860730|NCT03078855|471116900|FG001|Overall Study|Second Malignancy|0|||
130860731|NCT03078855|471116899|FG000|Overall Study|Ineligible|2|||
130860732|NCT03078855|471116900|FG001|Overall Study|Ineligible|0|||
130860733|NCT03078855|471116899|FG000|Overall Study|Withdrew before day 1 treatment|2|||
130860734|NCT03078855|471116900|FG001|Overall Study|Withdrew before day 1 treatment|1|||
130860735|NCT00391027|471116901|FG000|Overall Study|Adverse Event|8|||
130860736|NCT00391027|471116902|FG001|Overall Study|Adverse Event|8|||
130860737|NCT00391027|471116901|FG000|Overall Study|Lack of Efficacy|3|||
130860738|NCT00391027|471116902|FG001|Overall Study|Lack of Efficacy|0|||
130860739|NCT00391027|471116901|FG000|Overall Study|Withdrawal by Subject|10|||
130860740|NCT00391027|471116902|FG001|Overall Study|Withdrawal by Subject|1|||
130860741|NCT00391027|471116901|FG000|Overall Study|Other|4|||
130860742|NCT00391027|471116902|FG001|Overall Study|Other|3|||
130860743|NCT01846741|471116910|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
130860744|NCT01628965|471116911|FG000|Overall Study|Adverse Event|30|||
130860745|NCT01628965|471116911|FG000|Overall Study|Lack of Efficacy|7|||
130860746|NCT01628965|471116911|FG000|Overall Study|Withdrawal by Subject|3|||
130860747|NCT01628965|471116911|FG000|Overall Study|Lost to Follow-up|1|||
130860748|NCT01628965|471116911|FG000|Overall Study|Discontinuation criteria|8|||
130860749|NCT00360568|471116913|FG000|Overall Study|Adverse Event|1|||
130860750|NCT00360568|471116914|FG001|Overall Study|Adverse Event|2|||
130860751|NCT00360568|471116913|FG000|Overall Study|Lack of Efficacy|1|||
130860752|NCT00360568|471116914|FG001|Overall Study|Lack of Efficacy|0|||
130860753|NCT00360568|471116913|FG000|Overall Study|Withdrawal by Subject|0|||
130860754|NCT00360568|471116914|FG001|Overall Study|Withdrawal by Subject|3|||
130860755|NCT04006392|471116915|FG000|Overall Study|Lost to Follow-up|0|||
130860756|NCT04006392|471116916|FG001|Overall Study|Lost to Follow-up|1|||
130860757|NCT03755661|471116919|FG000|Overall Study|Lost to Follow-up|1|||
130860758|NCT03755661|471116920|FG001|Overall Study|Lost to Follow-up|0|||
130860759|NCT04412707|471116923|FG000|Cycle 1|Death|0|||
130860760|NCT04412707|471116924|FG001|Cycle 1|Death|3|||
130860761|NCT04412707|471116923|FG000|Cycle 1|Disease progression|1|||
130860762|NCT04412707|471116924|FG001|Cycle 1|Disease progression|2|||
130860763|NCT04412707|471116923|FG000|Cycle 2|Death|0|||
130860764|NCT04412707|471116924|FG001|Cycle 2|Death|1|||
130860765|NCT04412707|471116923|FG000|Cycle 2|Disease progression|3|||
130860766|NCT04412707|471116924|FG001|Cycle 2|Disease progression|0|||
130860767|NCT04412707|471116923|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
130860768|NCT04412707|471116924|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
130860769|NCT04412707|471116923|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
130860770|NCT04412707|471116924|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
130860771|NCT04412707|471116923|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
130860772|NCT04412707|471116924|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
130860773|NCT04412707|471116923|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
130860774|NCT04412707|471116924|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
130860775|NCT02611817|471118708|FG000|Open-label Induction Phase|Reason not Specified|9|||
130860776|NCT02611817|471118709|FG001|Open-label Induction Phase|Reason not Specified|0|||
130860777|NCT02611817|471118710|FG002|Open-label Induction Phase|Reason not Specified|0|||
130860778|NCT02611817|471118708|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
130860779|NCT02611817|471118709|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
130860780|NCT02611817|471118710|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
130860781|NCT02611817|471118708|FG000|Open-label Induction Phase|Pregnancy|1|||
130860782|NCT02611817|471118709|FG001|Open-label Induction Phase|Pregnancy|0|||
130860783|NCT02611817|471118710|FG002|Open-label Induction Phase|Pregnancy|0|||
130860784|NCT02611817|471118708|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
130860785|NCT02611817|471118709|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
130860786|NCT02611817|471118710|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
130860787|NCT02611817|471118708|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
130860788|NCT02611817|471118709|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
130860789|NCT02611817|471118710|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
130860790|NCT02611817|471118708|FG000|Open-label Induction Phase|Protocol Violation|5|||
130860791|NCT02611817|471118709|FG001|Open-label Induction Phase|Protocol Violation|0|||
130860792|NCT02611817|471118710|FG002|Open-label Induction Phase|Protocol Violation|0|||
130860793|NCT02611817|471118708|FG000|Open-label Induction Phase|Adverse Event|16|||
130860794|NCT02611817|471118709|FG001|Open-label Induction Phase|Adverse Event|0|||
130860795|NCT02611817|471118710|FG002|Open-label Induction Phase|Adverse Event|0|||
130860796|NCT02611817|471118708|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
130860797|NCT02611817|471118709|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
130860798|NCT02611817|471118710|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
130860799|NCT02611817|471118708|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
130860800|NCT02611817|471118709|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
130860801|NCT02611817|471118710|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
130860802|NCT02611817|471118708|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
130860803|NCT02611817|471118709|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
130860804|NCT02611817|471118710|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
130860805|NCT02611817|471118708|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
130860806|NCT02611817|471118709|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
130860807|NCT02611817|471118710|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
130860808|NCT02611817|471118708|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
130860809|NCT02611817|471118709|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
130860810|NCT02611817|471118710|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
130860811|NCT02611817|471118708|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
130860812|NCT02611817|471118709|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
130860813|NCT02611817|471118710|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
130860814|NCT02611817|471118708|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
130860815|NCT02611817|471118709|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
130860816|NCT02611817|471118710|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
130860817|NCT00931606|471118711|FG000|Overall Study|Death|1|||
130860818|NCT00931606|471118712|FG001|Overall Study|Death|3|||
130860819|NCT00931606|471118713|FG002|Overall Study|Death|2|||
130860820|NCT00931606|471118714|FG003|Overall Study|Death|0|||
130860821|NCT00931606|471118711|FG000|Overall Study|Lost to Follow-up|0|||
130860822|NCT00931606|471118712|FG001|Overall Study|Lost to Follow-up|1|||
130860823|NCT00931606|471118713|FG002|Overall Study|Lost to Follow-up|0|||
130860824|NCT00931606|471118714|FG003|Overall Study|Lost to Follow-up|0|||
130860825|NCT00931606|471118711|FG000|Overall Study|Physician Decision|0|||
130860826|NCT00931606|471118712|FG001|Overall Study|Physician Decision|0|||
130860827|NCT00931606|471118713|FG002|Overall Study|Physician Decision|3|||
130860828|NCT00931606|471118714|FG003|Overall Study|Physician Decision|0|||
130860829|NCT00931606|471118711|FG000|Overall Study|Sponsor Decision|1|||
130860830|NCT00931606|471118712|FG001|Overall Study|Sponsor Decision|4|||
130860831|NCT00931606|471118713|FG002|Overall Study|Sponsor Decision|0|||
130860832|NCT00931606|471118714|FG003|Overall Study|Sponsor Decision|2|||
130860833|NCT00931606|471118711|FG000|Overall Study|Withdrawal by Subject|3|||
130860834|NCT00931606|471118712|FG001|Overall Study|Withdrawal by Subject|1|||
130860835|NCT00931606|471118713|FG002|Overall Study|Withdrawal by Subject|1|||
130860836|NCT00931606|471118714|FG003|Overall Study|Withdrawal by Subject|1|||
130860837|NCT03412812|471118721|FG000|Level 1|Death|3|||
130860838|NCT03412812|471118722|FG001|Level 1|Death|0|||
130860839|NCT03412812|471118721|FG000|Level 1|Adverse Event|0|||
130860840|NCT03412812|471118722|FG001|Level 1|Adverse Event|1|||
130860841|NCT03828617|471118726|FG000|Overall Study|Lost to Follow-up|22|||
130860842|NCT03828617|471118727|FG001|Overall Study|Lost to Follow-up|12|||
130860843|NCT03828617|471118728|FG002|Overall Study|Lost to Follow-up|23|||
130860844|NCT03828617|471118729|FG003|Overall Study|Lost to Follow-up|7|||
130860845|NCT03828617|471118726|FG000|Overall Study|No longer met eligibility criteria|0|||
130860846|NCT03828617|471118727|FG001|Overall Study|No longer met eligibility criteria|1|||
130860847|NCT03828617|471118728|FG002|Overall Study|No longer met eligibility criteria|1|||
130860848|NCT03828617|471118729|FG003|Overall Study|No longer met eligibility criteria|3|||
130860849|NCT03828617|471118726|FG000|Overall Study|Protocol Violation|0|||
130860850|NCT03828617|471118727|FG001|Overall Study|Protocol Violation|2|||
130860851|NCT03828617|471118728|FG002|Overall Study|Protocol Violation|0|||
130860852|NCT03828617|471118729|FG003|Overall Study|Protocol Violation|0|||
130860853|NCT03828617|471118726|FG000|Overall Study|Withdrawal by Subject|2|||
130860854|NCT03828617|471118727|FG001|Overall Study|Withdrawal by Subject|0|||
130860855|NCT03828617|471118728|FG002|Overall Study|Withdrawal by Subject|2|||
130860856|NCT03828617|471118729|FG003|Overall Study|Withdrawal by Subject|0|||
130860857|NCT03826186|471118730|FG000|Overall Study|Protocol Violation|2|||
130860858|NCT03826186|471118731|FG001|Overall Study|Protocol Violation|0|||
130860859|NCT03826186|471118730|FG000|Overall Study|Withdrawal by Subject|1|||
130860860|NCT03826186|471118731|FG001|Overall Study|Withdrawal by Subject|0|||
130860861|NCT00082407|471118734|FG000|Overall Study|Adverse Event|20|||
130860862|NCT00082407|471118735|FG001|Overall Study|Adverse Event|0|||
130860863|NCT00082407|471118734|FG000|Overall Study|Protocol Violation|14|||
130860864|NCT00082407|471118735|FG001|Overall Study|Protocol Violation|12|||
130860865|NCT00082407|471118734|FG000|Overall Study|Patient Decision|13|||
130860866|NCT00082407|471118735|FG001|Overall Study|Patient Decision|6|||
130860867|NCT00082407|471118734|FG000|Overall Study|Physician Decision|5|||
130860868|NCT00082407|471118735|FG001|Overall Study|Physician Decision|3|||
130860869|NCT00082407|471118734|FG000|Overall Study|Loss of Glucose Control|2|||
130860870|NCT00082407|471118735|FG001|Overall Study|Loss of Glucose Control|2|||
130860871|NCT00082407|471118734|FG000|Overall Study|Death|2|||
130860872|NCT00082407|471118735|FG001|Overall Study|Death|1|||
130860873|NCT00082407|471118734|FG000|Overall Study|Lost to Follow-up|0|||
130860874|NCT00082407|471118735|FG001|Overall Study|Lost to Follow-up|3|||
130860875|NCT00891228|471118737|FG000|Overall Study|Adverse Event|0|||
130860876|NCT00891228|471118738|FG001|Overall Study|Adverse Event|2|||
130860877|NCT00891228|471118739|FG002|Overall Study|Adverse Event|3|||
130860878|NCT00891228|471118737|FG000|Overall Study|Withdrawal by Subject|2|||
130860879|NCT00891228|471118738|FG001|Overall Study|Withdrawal by Subject|4|||
130860880|NCT00891228|471118739|FG002|Overall Study|Withdrawal by Subject|5|||
130860881|NCT00891228|471118737|FG000|Overall Study|Protocol Violation|3|||
130860882|NCT00891228|471118738|FG001|Overall Study|Protocol Violation|1|||
130860883|NCT00891228|471118739|FG002|Overall Study|Protocol Violation|2|||
130860884|NCT00891228|471118737|FG000|Overall Study|Physician Decision|2|||
130860885|NCT00891228|471118738|FG001|Overall Study|Physician Decision|1|||
130860886|NCT00891228|471118739|FG002|Overall Study|Physician Decision|0|||
130860887|NCT00891228|471118737|FG000|Overall Study|Lost to Follow-up|4|||
130860888|NCT00891228|471118738|FG001|Overall Study|Lost to Follow-up|4|||
130860889|NCT00891228|471118739|FG002|Overall Study|Lost to Follow-up|5|||
130860890|NCT00891228|471118737|FG000|Overall Study|Pregnancy|0|||
130860891|NCT00891228|471118738|FG001|Overall Study|Pregnancy|1|||
130860892|NCT00891228|471118739|FG002|Overall Study|Pregnancy|0|||
130860893|NCT02688985|471118742|FG000|Overall Study|Adverse Event|1|||
130860894|NCT02688985|471118743|FG001|Overall Study|Adverse Event|2|||
130860895|NCT02688985|471118744|FG002|Overall Study|Adverse Event|2|||
130860896|NCT02688985|471118745|FG003|Overall Study|Adverse Event|0|||
130860897|NCT02688985|471118746|FG004|Overall Study|Adverse Event|0|||
130860898|NCT02688985|471118742|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
130860899|NCT02688985|471118743|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
130860900|NCT02688985|471118744|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
130860901|NCT02688985|471118745|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
130860902|NCT02688985|471118746|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
130860903|NCT02688985|471118742|FG000|Overall Study|Death|0|||
130860904|NCT02688985|471118743|FG001|Overall Study|Death|0|||
130860905|NCT02688985|471118744|FG002|Overall Study|Death|0|||
130860906|NCT02688985|471118745|FG003|Overall Study|Death|0|||
130860907|NCT02688985|471118746|FG004|Overall Study|Death|1|||
130860908|NCT02688985|471118742|FG000|Overall Study|Lack of Efficacy|0|||
130860909|NCT02688985|471118743|FG001|Overall Study|Lack of Efficacy|0|||
130860910|NCT02688985|471118744|FG002|Overall Study|Lack of Efficacy|0|||
130860911|NCT02688985|471118745|FG003|Overall Study|Lack of Efficacy|0|||
130860912|NCT02688985|471118746|FG004|Overall Study|Lack of Efficacy|1|||
130860913|NCT02688985|471118742|FG000|Overall Study|Lost to Follow-up|2|||
130860914|NCT02688985|471118743|FG001|Overall Study|Lost to Follow-up|0|||
130860915|NCT02688985|471118744|FG002|Overall Study|Lost to Follow-up|1|||
130860916|NCT02688985|471118745|FG003|Overall Study|Lost to Follow-up|1|||
130860917|NCT02688985|471118746|FG004|Overall Study|Lost to Follow-up|1|||
130860918|NCT02688985|471118742|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130860919|NCT02688985|471118743|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130860920|NCT02688985|471118744|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130860921|NCT02688985|471118745|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130860922|NCT02688985|471118746|FG004|Overall Study|Non-Compliance With Study Drug|1|||
130860923|NCT02688985|471118742|FG000|Overall Study|Other|3|||
130860924|NCT02688985|471118743|FG001|Overall Study|Other|4|||
130860925|NCT02688985|471118744|FG002|Overall Study|Other|1|||
130860926|NCT02688985|471118745|FG003|Overall Study|Other|0|||
130860927|NCT02688985|471118746|FG004|Overall Study|Other|0|||
130860928|NCT02688985|471118742|FG000|Overall Study|Physician Decision|2|||
130860929|NCT02688985|471118743|FG001|Overall Study|Physician Decision|2|||
130860930|NCT02688985|471118744|FG002|Overall Study|Physician Decision|0|||
130860931|NCT02688985|471118745|FG003|Overall Study|Physician Decision|0|||
130860932|NCT02688985|471118746|FG004|Overall Study|Physician Decision|1|||
130860933|NCT02688985|471118742|FG000|Overall Study|Pregnancy|0|||
130860934|NCT02688985|471118743|FG001|Overall Study|Pregnancy|0|||
130860935|NCT02688985|471118744|FG002|Overall Study|Pregnancy|2|||
130860936|NCT02688985|471118745|FG003|Overall Study|Pregnancy|1|||
130860937|NCT02688985|471118746|FG004|Overall Study|Pregnancy|0|||
130860938|NCT02688985|471118742|FG000|Overall Study|Study Terminated By Sponsor|0|||
130860939|NCT02688985|471118743|FG001|Overall Study|Study Terminated By Sponsor|0|||
130860940|NCT02688985|471118744|FG002|Overall Study|Study Terminated By Sponsor|0|||
130860941|NCT02688985|471118745|FG003|Overall Study|Study Terminated By Sponsor|1|||
130860942|NCT02688985|471118746|FG004|Overall Study|Study Terminated By Sponsor|0|||
130860943|NCT02688985|471118742|FG000|Overall Study|Withdrawal by Subject|2|||
130860944|NCT02688985|471118743|FG001|Overall Study|Withdrawal by Subject|8|||
130860945|NCT02688985|471118744|FG002|Overall Study|Withdrawal by Subject|7|||
130860946|NCT02688985|471118745|FG003|Overall Study|Withdrawal by Subject|1|||
130860947|NCT02688985|471118746|FG004|Overall Study|Withdrawal by Subject|4|||
130860948|NCT03437577|471118749|FG000|Pre-Randomization|Withdrawal by Subject|0|||
130860949|NCT03437577|471118750|FG001|Pre-Randomization|Withdrawal by Subject|0|||
130860950|NCT03437577|471118751|FG002|Pre-Randomization|Withdrawal by Subject|10|||
130860951|NCT03437577|471118749|FG000|Post-Randomization|Physician Decision|0|||
130860952|NCT03437577|471118750|FG001|Post-Randomization|Physician Decision|2|||
130860953|NCT03437577|471118751|FG002|Post-Randomization|Physician Decision|0|||
130860954|NCT00894361|471118760|FG000|Overall Study|deaths and less than 2 years followup|24|||
130860955|NCT00894361|471118761|FG001|Overall Study|deaths and less than 2 years followup|64|||
130860956|NCT00988091|471118770|FG000|Double-blind Period|Withdrawal by Subject|15|||
130860957|NCT00988091|471118771|FG001|Double-blind Period|Withdrawal by Subject|13|||
130860958|NCT00988091|471118770|FG000|Double-blind Period|Lost to Follow-up|12|||
130860959|NCT00988091|471118771|FG001|Double-blind Period|Lost to Follow-up|14|||
130860960|NCT00988091|471118770|FG000|Double-blind Period|Other|8|||
130860961|NCT00988091|471118771|FG001|Double-blind Period|Other|8|||
130860962|NCT00988091|471118770|FG000|Double-blind Period|Adverse Event|6|||
130860963|NCT00988091|471118771|FG001|Double-blind Period|Adverse Event|9|||
130860964|NCT00988091|471118770|FG000|Double-blind Period|Use of exclusionary medication|2|||
130860965|NCT00988091|471118771|FG001|Double-blind Period|Use of exclusionary medication|3|||
130860966|NCT00988091|471118770|FG000|Open-label Period|Adverse Event|4|||
130860967|NCT00988091|471118771|FG001|Open-label Period|Adverse Event|7|||
130860968|NCT00988091|471118770|FG000|Open-label Period|Use of exclusionary medication|1|||
130860969|NCT00988091|471118771|FG001|Open-label Period|Use of exclusionary medication|1|||
130860970|NCT00988091|471118770|FG000|Open-label Period|Protocol Violation|1|||
130860971|NCT00988091|471118771|FG001|Open-label Period|Protocol Violation|1|||
130860972|NCT00988091|471118770|FG000|Open-label Period|Withdrawal by Subject|10|||
130860973|NCT00988091|471118771|FG001|Open-label Period|Withdrawal by Subject|16|||
130860974|NCT00988091|471118770|FG000|Open-label Period|Lost to Follow-up|3|||
130860975|NCT00988091|471118771|FG001|Open-label Period|Lost to Follow-up|5|||
130860976|NCT00988091|471118770|FG000|Open-label Period|Other|2|||
130860977|NCT00988091|471118771|FG001|Open-label Period|Other|3|||
130860978|NCT04124705|471118775|FG000|Titration Period|Adverse Event|9|||
130860979|NCT04124705|471118776|FG001|Titration Period|Adverse Event|5|||
130860980|NCT04124705|471118775|FG000|Titration Period|Withdrawal by Subject|6|||
130860981|NCT04124705|471118776|FG001|Titration Period|Withdrawal by Subject|3|||
130860982|NCT04124705|471118775|FG000|Titration Period|Lost to Follow-up|0|||
130860983|NCT04124705|471118776|FG001|Titration Period|Lost to Follow-up|1|||
130860984|NCT04124705|471118775|FG000|Titration Period|Death|1|||
130860985|NCT04124705|471118776|FG001|Titration Period|Death|1|||
130860986|NCT04124705|471118775|FG000|Titration Period|Lack of Efficacy|2|||
130860987|NCT04124705|471118776|FG001|Titration Period|Lack of Efficacy|0|||
130860988|NCT04124705|471118775|FG000|Titration Period|Physician Decision|2|||
130860989|NCT04124705|471118776|FG001|Titration Period|Physician Decision|0|||
130860990|NCT04124705|471118775|FG000|Titration Period|Non-compliance with Study Drug|2|||
130860991|NCT04124705|471118776|FG001|Titration Period|Non-compliance with Study Drug|0|||
130860992|NCT04124705|471118775|FG000|Titration Period|Other|4|||
130860993|NCT04124705|471118776|FG001|Titration Period|Other|9|||
130860994|NCT04124705|471118775|FG000|Stabilization Period|Adverse Event|4|||
130860995|NCT04124705|471118776|FG001|Stabilization Period|Adverse Event|2|||
130860996|NCT04124705|471118775|FG000|Stabilization Period|Withdrawal by Subject|1|||
130860997|NCT04124705|471118776|FG001|Stabilization Period|Withdrawal by Subject|1|||
130860998|NCT04124705|471118775|FG000|Stabilization Period|Lost to Follow-up|0|||
130860999|NCT04124705|471118776|FG001|Stabilization Period|Lost to Follow-up|1|||
130861000|NCT04124705|471118775|FG000|Stabilization Period|Lack of Efficacy|4|||
130861001|NCT04124705|471118776|FG001|Stabilization Period|Lack of Efficacy|2|||
130861002|NCT04124705|471118775|FG000|Stabilization Period|Protocol Deviation|0|||
130861003|NCT04124705|471118776|FG001|Stabilization Period|Protocol Deviation|2|||
130861004|NCT04124705|471118775|FG000|Stabilization Period|Other|2|||
130861005|NCT04124705|471118776|FG001|Stabilization Period|Other|2|||
130861006|NCT01973998|471118777|FG000|Overall Study|Death|2|||
130861007|NCT01973998|471118778|FG001|Overall Study|Death|2|||
130861008|NCT01636986|471118781|FG000|Overall Study|Withdrawal by Subject|0|||
130861009|NCT01636986|471118782|FG001|Overall Study|Withdrawal by Subject|1|||
130861010|NCT01636986|471118781|FG000|Overall Study|Corneal Staining|0|||
130861011|NCT01636986|471118782|FG001|Overall Study|Corneal Staining|1|||
130861012|NCT01844778|471118789|FG000|Overall Study|Protocol deviation|0|||
130861013|NCT01844778|471118790|FG001|Overall Study|Protocol deviation|1|||
130861014|NCT01844778|471118791|FG002|Overall Study|Protocol deviation|2|||
130861015|NCT01844778|471118789|FG000|Overall Study|Withdrawal by Subject|2|||
130861016|NCT01844778|471118790|FG001|Overall Study|Withdrawal by Subject|0|||
130861017|NCT01844778|471118791|FG002|Overall Study|Withdrawal by Subject|0|||
130861018|NCT01844778|471118789|FG000|Overall Study|Adverse Event|0|||
130861019|NCT01844778|471118790|FG001|Overall Study|Adverse Event|2|||
130861020|NCT01844778|471118791|FG002|Overall Study|Adverse Event|2|||
130861021|NCT02951429|471118793|FG000|Overall Study|Adverse Event|3|||
130861022|NCT02951429|471118794|FG001|Overall Study|Adverse Event|7|||
130861023|NCT02951429|471118793|FG000|Overall Study|Death|28|||
130861024|NCT02951429|471118794|FG001|Overall Study|Death|36|||
130861025|NCT02951429|471118793|FG000|Overall Study|Lack of Efficacy|0|||
130861026|NCT02951429|471118794|FG001|Overall Study|Lack of Efficacy|1|||
130861027|NCT02951429|471118793|FG000|Overall Study|Lost to Follow-up|0|||
130861028|NCT02951429|471118794|FG001|Overall Study|Lost to Follow-up|1|||
130861029|NCT02951429|471118793|FG000|Overall Study|Lung Transplantation|9|||
130861030|NCT02951429|471118794|FG001|Overall Study|Lung Transplantation|6|||
130861031|NCT02951429|471118793|FG000|Overall Study|Other|1|||
130861032|NCT02951429|471118794|FG001|Overall Study|Other|3|||
130861033|NCT02951429|471118793|FG000|Overall Study|Progressive Disease|1|||
130861034|NCT02951429|471118794|FG001|Overall Study|Progressive Disease|1|||
130861035|NCT02951429|471118793|FG000|Overall Study|Withdrawal by Subject|7|||
130861036|NCT02951429|471118794|FG001|Overall Study|Withdrawal by Subject|11|||
130861037|NCT02951429|471118793|FG000|Overall Study|Participant ongoing in the study|23|||
130861038|NCT02951429|471118794|FG001|Overall Study|Participant ongoing in the study|17|||
130861039|NCT01620528|471118795|FG000|Treatment Period|Did Not Receive Study Drug|0|||
130861040|NCT01620528|471118796|FG001|Treatment Period|Did Not Receive Study Drug|0|||
130861041|NCT01620528|471118797|FG002|Treatment Period|Did Not Receive Study Drug|1|||
130861042|NCT01620528|471118795|FG000|Treatment Period|Withdrawal by Subject|35|||
130861043|NCT01620528|471118796|FG001|Treatment Period|Withdrawal by Subject|21|||
130861044|NCT01620528|471118797|FG002|Treatment Period|Withdrawal by Subject|16|||
130861045|NCT01620528|471118795|FG000|Treatment Period|Adverse Event|17|||
130861046|NCT01620528|471118796|FG001|Treatment Period|Adverse Event|13|||
130861047|NCT01620528|471118797|FG002|Treatment Period|Adverse Event|21|||
130861048|NCT01620528|471118795|FG000|Treatment Period|Lost to Follow-up|16|||
130861049|NCT01620528|471118796|FG001|Treatment Period|Lost to Follow-up|8|||
130861050|NCT01620528|471118797|FG002|Treatment Period|Lost to Follow-up|14|||
130861051|NCT01620528|471118795|FG000|Treatment Period|Other|9|||
130861052|NCT01620528|471118796|FG001|Treatment Period|Other|5|||
130861053|NCT01620528|471118797|FG002|Treatment Period|Other|7|||
130861054|NCT01620528|471118795|FG000|Treatment Period|Subject Noncompliant|11|||
130861055|NCT01620528|471118796|FG001|Treatment Period|Subject Noncompliant|2|||
130861056|NCT01620528|471118797|FG002|Treatment Period|Subject Noncompliant|2|||
130861057|NCT01620528|471118795|FG000|Treatment Period|Pregnancy|7|||
130861058|NCT01620528|471118796|FG001|Treatment Period|Pregnancy|2|||
130861059|NCT01620528|471118797|FG002|Treatment Period|Pregnancy|2|||
130861060|NCT01620528|471118795|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
130861061|NCT01620528|471118796|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
130861062|NCT01620528|471118797|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
130861063|NCT01620528|471118795|FG000|Treatment Period|Exclusionary Medication Received|0|||
130861064|NCT01620528|471118796|FG001|Treatment Period|Exclusionary Medication Received|1|||
130861065|NCT01620528|471118797|FG002|Treatment Period|Exclusionary Medication Received|0|||
130861066|NCT01620528|471118795|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
130861067|NCT01620528|471118796|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
130861068|NCT01620528|471118797|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
130861069|NCT01620528|471118795|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130861070|NCT01620528|471118796|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130861071|NCT01620528|471118797|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
130861072|NCT01620528|471118795|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
130861073|NCT01620528|471118796|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
130861074|NCT01620528|471118797|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
130861075|NCT01620528|471118795|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
130861076|NCT01620528|471118796|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
130861077|NCT01620528|471118797|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
130861078|NCT01620528|471118795|FG000|Post-Treatment Follow-Up Period|Other|6|||
130861079|NCT01620528|471118796|FG001|Post-Treatment Follow-Up Period|Other|4|||
130861080|NCT01620528|471118797|FG002|Post-Treatment Follow-Up Period|Other|2|||
130861081|NCT03664765|471118798|FG000|Overall Study|Withdrawal by Subject|4|||
130861082|NCT03664765|471118799|FG001|Overall Study|Withdrawal by Subject|1|||
130861083|NCT03664765|471118798|FG000|Overall Study|Lost to Follow-up|0|||
130861084|NCT03664765|471118799|FG001|Overall Study|Lost to Follow-up|1|||
130861085|NCT01153698|471118800|FG000|Overall Study|Adverse Event|12|||
130861086|NCT01153698|471118800|FG000|Overall Study|Lost to Follow-up|4|||
130861087|NCT01153698|471118800|FG000|Overall Study|Withdrawal by Subject|2|||
130861088|NCT01153698|471118800|FG000|Overall Study|Switch to other anticoagulants|4|||
130861089|NCT01153698|471118800|FG000|Overall Study|Other|2|||
130861090|NCT01153698|471118800|FG000|Overall Study|Not treated with Pradaxa|5|||
130861091|NCT02106403|471118802|FG000|Follow-Up Visit 3|Other Reason|0|||
130861092|NCT02106403|471118803|FG001|Follow-Up Visit 3|Other Reason|0|||
130861093|NCT02106403|471118804|FG002|Follow-Up Visit 3|Other Reason|0|||
130861094|NCT02106403|471118805|FG003|Follow-Up Visit 3|Other Reason|0|||
130861095|NCT02106403|471118806|FG004|Follow-Up Visit 3|Other Reason|0|||
130861096|NCT02106403|471118807|FG005|Follow-Up Visit 3|Other Reason|1|||
130861097|NCT04038567|471118809|FG000|Overall Study|Lost to Follow-up|6|||
130861098|NCT04038567|471118810|FG001|Overall Study|Lost to Follow-up|4|||
130861099|NCT04038567|471118811|FG002|Overall Study|Lost to Follow-up|5|||
130861100|NCT04038567|471118812|FG003|Overall Study|Lost to Follow-up|4|||
130861101|NCT04038567|471118813|FG004|Overall Study|Lost to Follow-up|6|||
130861102|NCT04038567|471118814|FG005|Overall Study|Lost to Follow-up|4|||
130861103|NCT04038567|471118815|FG006|Overall Study|Lost to Follow-up|4|||
130861104|NCT04038567|471118816|FG007|Overall Study|Lost to Follow-up|1|||
130861105|NCT04038567|471118809|FG000|Overall Study|Withdrawal by Subject|2|||
130861106|NCT04038567|471118810|FG001|Overall Study|Withdrawal by Subject|1|||
130861107|NCT04038567|471118811|FG002|Overall Study|Withdrawal by Subject|1|||
130861108|NCT04038567|471118812|FG003|Overall Study|Withdrawal by Subject|1|||
130861109|NCT04038567|471118813|FG004|Overall Study|Withdrawal by Subject|4|||
130861110|NCT04038567|471118814|FG005|Overall Study|Withdrawal by Subject|1|||
130861111|NCT04038567|471118815|FG006|Overall Study|Withdrawal by Subject|1|||
130861112|NCT04038567|471118816|FG007|Overall Study|Withdrawal by Subject|1|||
130861113|NCT04038567|471118809|FG000|Overall Study|missed survey window|1|||
130861114|NCT04038567|471118810|FG001|Overall Study|missed survey window|2|||
130861115|NCT04038567|471118811|FG002|Overall Study|missed survey window|0|||
130861116|NCT04038567|471118812|FG003|Overall Study|missed survey window|0|||
130861117|NCT04038567|471118813|FG004|Overall Study|missed survey window|1|||
130861118|NCT04038567|471118814|FG005|Overall Study|missed survey window|1|||
130861119|NCT04038567|471118815|FG006|Overall Study|missed survey window|2|||
130861120|NCT04038567|471118816|FG007|Overall Study|missed survey window|2|||
130861121|NCT04038567|471118809|FG000|Overall Study|technical issues|0|||
130861122|NCT04038567|471118810|FG001|Overall Study|technical issues|0|||
130861123|NCT04038567|471118811|FG002|Overall Study|technical issues|0|||
130861124|NCT04038567|471118812|FG003|Overall Study|technical issues|0|||
130861125|NCT04038567|471118813|FG004|Overall Study|technical issues|0|||
130861126|NCT04038567|471118814|FG005|Overall Study|technical issues|0|||
130861127|NCT04038567|471118815|FG006|Overall Study|technical issues|1|||
130861128|NCT04038567|471118816|FG007|Overall Study|technical issues|0|||
130861129|NCT04038567|471118809|FG000|Overall Study|Medical issues (i.e., illness)|0|||
130861130|NCT04038567|471118810|FG001|Overall Study|Medical issues (i.e., illness)|1|||
130861131|NCT04038567|471118811|FG002|Overall Study|Medical issues (i.e., illness)|2|||
130861132|NCT04038567|471118812|FG003|Overall Study|Medical issues (i.e., illness)|1|||
130861133|NCT04038567|471118813|FG004|Overall Study|Medical issues (i.e., illness)|1|||
130861134|NCT04038567|471118814|FG005|Overall Study|Medical issues (i.e., illness)|1|||
130861135|NCT04038567|471118815|FG006|Overall Study|Medical issues (i.e., illness)|0|||
130861136|NCT04038567|471118816|FG007|Overall Study|Medical issues (i.e., illness)|0|||
130861137|NCT04038567|471118809|FG000|Overall Study|Death|0|||
130861138|NCT04038567|471118810|FG001|Overall Study|Death|0|||
130861139|NCT04038567|471118811|FG002|Overall Study|Death|0|||
130861140|NCT04038567|471118812|FG003|Overall Study|Death|1|||
130861141|NCT04038567|471118813|FG004|Overall Study|Death|1|||
130861142|NCT04038567|471118814|FG005|Overall Study|Death|0|||
130861143|NCT04038567|471118815|FG006|Overall Study|Death|0|||
130861144|NCT04038567|471118816|FG007|Overall Study|Death|1|||
130861145|NCT01496846|471118820|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
130861146|NCT01496846|471118821|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
130861147|NCT01496846|471118822|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130861148|NCT01496846|471118823|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130861149|NCT01496846|471118824|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130861150|NCT01496846|471118825|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130861151|NCT01817959|471118828|FG000|Overall Study|Graft loss|1|||
130861152|NCT01817959|471118829|FG001|Overall Study|Graft loss|1|||
130861153|NCT01817959|471118828|FG000|Overall Study|forbidden medication|1|||
130861154|NCT01817959|471118829|FG001|Overall Study|forbidden medication|1|||
130861155|NCT01817959|471118828|FG000|Overall Study|Adverse Event|1|||
130861156|NCT01817959|471118829|FG001|Overall Study|Adverse Event|0|||
130861157|NCT01817959|471118828|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
130861158|NCT01817959|471118829|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
130861159|NCT01772576|471118830|FG000|Overall Study|Death|15|||
130861160|NCT01772576|471118830|FG000|Overall Study|Protocol Violation|1|||
130861161|NCT01772576|471118830|FG000|Overall Study|Lost to Follow-up|3|||
130861162|NCT01772576|471118830|FG000|Overall Study|Study device not used|3|||
130861163|NCT01772576|471118830|FG000|Overall Study|Adverse Event|6|||
130861164|NCT01772576|471118830|FG000|Overall Study|Withdrawal by Subject|6|||
130861165|NCT04356352|471118838|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
130861166|NCT04356352|471118839|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
130861167|NCT04356352|471118840|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
130861168|NCT04356352|471118838|FG000|Overall Study|Protocol Violation|0|||
130861169|NCT04356352|471118839|FG001|Overall Study|Protocol Violation|3|||
130861170|NCT04356352|471118840|FG002|Overall Study|Protocol Violation|1|||
130861171|NCT00379912|471118845|FG000|Overall Study|Lack of Efficacy|1|||
130861172|NCT00379912|471118846|FG001|Overall Study|Lack of Efficacy|0|||
130861173|NCT01371734|471118847|FG000|Overall Study|Other|2|||
130861174|NCT01371734|471118848|FG001|Overall Study|Other|1|||
130861175|NCT01371734|471118849|FG002|Overall Study|Other|2|||
130861176|NCT01371734|471118847|FG000|Overall Study|Withdrawal by Subject|3|||
130861177|NCT01371734|471118848|FG001|Overall Study|Withdrawal by Subject|4|||
130861178|NCT01371734|471118849|FG002|Overall Study|Withdrawal by Subject|9|||
130861179|NCT01371734|471118847|FG000|Overall Study|Lost to Follow-up|5|||
130861180|NCT01371734|471118848|FG001|Overall Study|Lost to Follow-up|3|||
130861181|NCT01371734|471118849|FG002|Overall Study|Lost to Follow-up|1|||
130861182|NCT01371734|471118847|FG000|Overall Study|Protocol Violation|3|||
130861183|NCT01371734|471118848|FG001|Overall Study|Protocol Violation|1|||
130861184|NCT01371734|471118849|FG002|Overall Study|Protocol Violation|2|||
130861185|NCT01371734|471118847|FG000|Overall Study|Adverse Event|8|||
130861186|NCT01371734|471118848|FG001|Overall Study|Adverse Event|8|||
130861187|NCT01371734|471118849|FG002|Overall Study|Adverse Event|3|||
130861188|NCT01371734|471118847|FG000|Overall Study|Lack of Efficacy|2|||
130861189|NCT01371734|471118848|FG001|Overall Study|Lack of Efficacy|2|||
130861190|NCT01371734|471118849|FG002|Overall Study|Lack of Efficacy|0|||
130861191|NCT00621140|471118850|FG000|Overall Study|Adverse Event|4|||
130861192|NCT00621140|471118851|FG001|Overall Study|Adverse Event|5|||
130861193|NCT00621140|471118850|FG000|Overall Study|Lost to Follow-up|1|||
130861194|NCT00621140|471118851|FG001|Overall Study|Lost to Follow-up|2|||
130861195|NCT00621140|471118850|FG000|Overall Study|Withdrawal by Subject|4|||
130861196|NCT00621140|471118851|FG001|Overall Study|Withdrawal by Subject|6|||
130861197|NCT00621140|471118850|FG000|Overall Study|Other incl. lack of efficacy|6|||
130861198|NCT00621140|471118851|FG001|Overall Study|Other incl. lack of efficacy|5|||
130861199|NCT02873338|471118855|FG000|Overall Study|Adverse Event|0|||
130861200|NCT02873338|471118856|FG001|Overall Study|Adverse Event|2|||
130861201|NCT02873338|471118857|FG002|Overall Study|Adverse Event|1|||
130861202|NCT02873338|471118855|FG000|Overall Study|Death|2|||
130861203|NCT02873338|471118856|FG001|Overall Study|Death|1|||
130861204|NCT02873338|471118857|FG002|Overall Study|Death|1|||
130861205|NCT02873338|471118855|FG000|Overall Study|Withdrawal by Subject|2|||
130861206|NCT02873338|471118856|FG001|Overall Study|Withdrawal by Subject|1|||
130861207|NCT02873338|471118857|FG002|Overall Study|Withdrawal by Subject|3|||
130861208|NCT02873338|471118855|FG000|Overall Study|Lack of Efficacy|0|||
130861209|NCT02873338|471118856|FG001|Overall Study|Lack of Efficacy|2|||
130861210|NCT02873338|471118857|FG002|Overall Study|Lack of Efficacy|0|||
130861211|NCT02873338|471118855|FG000|Overall Study|Other or Missing|14|||
130861212|NCT02873338|471118856|FG001|Overall Study|Other or Missing|15|||
130861213|NCT02873338|471118857|FG002|Overall Study|Other or Missing|13|||
130861214|NCT03657095|471118858|FG000|Overall Study|Withdrawal by Subject|1|||
130861215|NCT03657095|471118859|FG001|Overall Study|Withdrawal by Subject|1|||
130861216|NCT03657095|471118858|FG000|Overall Study|Adverse Event|0|||
130861217|NCT03657095|471118859|FG001|Overall Study|Adverse Event|3|||
130861218|NCT03657095|471118858|FG000|Overall Study|Study Terminated by Sponsor|58|||
130861219|NCT03657095|471118859|FG001|Overall Study|Study Terminated by Sponsor|49|||
130861220|NCT01140061|471118860|FG000|Part I|Adverse Event|1|||
130861221|NCT01140061|471118861|FG001|Part I|Adverse Event|0|||
130861222|NCT01140061|471118862|FG002|Part I|Adverse Event|0|||
130861223|NCT01140061|471118863|FG003|Part I|Adverse Event|0|||
130861224|NCT01140061|471118864|FG004|Part I|Adverse Event|0|||
130861225|NCT01140061|471118865|FG005|Part I|Adverse Event|0|||
130861226|NCT01140061|471118866|FG006|Part I|Adverse Event|0|||
130861227|NCT01140061|471118867|FG007|Part I|Adverse Event|0|||
130861228|NCT01140061|471118868|FG008|Part I|Adverse Event|0|||
130861229|NCT01140061|471118869|FG009|Part I|Adverse Event|0|||
130861230|NCT01140061|471118860|FG000|Extension|Laboratory Adverse Event|0|||
130861231|NCT01140061|471118861|FG001|Extension|Laboratory Adverse Event|0|||
130861232|NCT01140061|471118862|FG002|Extension|Laboratory Adverse Event|0|||
130861233|NCT01140061|471118863|FG003|Extension|Laboratory Adverse Event|0|||
130861234|NCT01140061|471118864|FG004|Extension|Laboratory Adverse Event|0|||
130861235|NCT01140061|471118865|FG005|Extension|Laboratory Adverse Event|0|||
130861236|NCT01140061|471118866|FG006|Extension|Laboratory Adverse Event|0|||
130861237|NCT01140061|471118867|FG007|Extension|Laboratory Adverse Event|0|||
130861238|NCT01140061|471118868|FG008|Extension|Laboratory Adverse Event|0|||
130861239|NCT01140061|471118869|FG009|Extension|Laboratory Adverse Event|1|||
130861240|NCT00835341|471118870|FG000|Overall Study|Lost to Follow-up|3|||
130861241|NCT00835341|471118871|FG001|Overall Study|Lost to Follow-up|12|||
130861242|NCT00392990|471118874|FG000|Treatment on Study|Adverse Event|3|||
130861243|NCT00392990|471118875|FG001|Treatment on Study|Adverse Event|1|||
130861244|NCT00392990|471118874|FG000|Follow up for 2 Years|Death|4|||
130861245|NCT00392990|471118875|FG001|Follow up for 2 Years|Death|0|||
130861246|NCT02980133|471118878|FG000|Overall Study|Other than specified|1|||
130861247|NCT02980133|471118879|FG001|Overall Study|Other than specified|1|||
130861248|NCT02980133|471118880|FG002|Overall Study|Other than specified|2|||
130861249|NCT02980133|471118881|FG003|Overall Study|Other than specified|2|||
130861250|NCT02980133|471118878|FG000|Overall Study|Lost to Follow-up|0|||
130861251|NCT02980133|471118879|FG001|Overall Study|Lost to Follow-up|0|||
130861252|NCT02980133|471118880|FG002|Overall Study|Lost to Follow-up|1|||
130861253|NCT02980133|471118881|FG003|Overall Study|Lost to Follow-up|3|||
130861254|NCT02980133|471118878|FG000|Overall Study|Protocol Violation|0|||
130861255|NCT02980133|471118879|FG001|Overall Study|Protocol Violation|1|||
130861256|NCT02980133|471118880|FG002|Overall Study|Protocol Violation|0|||
130861257|NCT02980133|471118881|FG003|Overall Study|Protocol Violation|0|||
130861258|NCT02980133|471118878|FG000|Overall Study|Withdrawal by parent/guardian|6|||
130861259|NCT02980133|471118879|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130861260|NCT02980133|471118880|FG002|Overall Study|Withdrawal by parent/guardian|3|||
130861261|NCT02980133|471118881|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130861262|NCT02980133|471118878|FG000|Overall Study|Withdrawal by Subject|0|||
130861263|NCT02980133|471118879|FG001|Overall Study|Withdrawal by Subject|0|||
130861264|NCT02980133|471118880|FG002|Overall Study|Withdrawal by Subject|1|||
130861265|NCT02980133|471118881|FG003|Overall Study|Withdrawal by Subject|0|||
130861266|NCT00384332|471118882|FG000|Overall Study|Lost to Follow-up|4|||
130861267|NCT00384332|471118883|FG001|Overall Study|Lost to Follow-up|0|||
130861268|NCT02560012|471118884|FG000|Overall Study|Study Terminated|2|||
130861269|NCT01007838|471118885|FG000|Overall Study|Withdrawal by Subject|1|||
130861270|NCT01007838|471118886|FG001|Overall Study|Withdrawal by Subject|0|||
130861271|NCT01007838|471118887|FG002|Overall Study|Withdrawal by Subject|0|||
130861272|NCT01007838|471118888|FG003|Overall Study|Withdrawal by Subject|0|||
130861273|NCT01007838|471118885|FG000|Overall Study|Physician Decision|1|||
130861274|NCT01007838|471118886|FG001|Overall Study|Physician Decision|0|||
130861275|NCT01007838|471118887|FG002|Overall Study|Physician Decision|0|||
130861276|NCT01007838|471118888|FG003|Overall Study|Physician Decision|0|||
130861277|NCT01007838|471118885|FG000|Overall Study|Started home haemodialysis|1|||
130861278|NCT01007838|471118886|FG001|Overall Study|Started home haemodialysis|0|||
130861279|NCT01007838|471118887|FG002|Overall Study|Started home haemodialysis|0|||
130861280|NCT01007838|471118888|FG003|Overall Study|Started home haemodialysis|0|||
130861281|NCT03052816|471118889|FG000|Overall Study|Withdrawal by Subject|1|||
130861282|NCT03052816|471118890|FG001|Overall Study|Withdrawal by Subject|0|||
130861283|NCT03052816|471118889|FG000|Overall Study|Desired opioids|2|||
130861284|NCT03052816|471118890|FG001|Overall Study|Desired opioids|0|||
130861285|NCT00852241|471118891|FG000|Overall Study|Physician Decision|18|||
130861286|NCT00118430|471118893|FG000|Overall Study|Withdrawal by Subject|6|||
130861287|NCT00118430|471118894|FG001|Overall Study|Withdrawal by Subject|2|||
130861288|NCT00118430|471118895|FG002|Overall Study|Withdrawal by Subject|0|||
130861289|NCT00118430|471118893|FG000|Overall Study|Lost to Follow-up|15|||
130861290|NCT00118430|471118894|FG001|Overall Study|Lost to Follow-up|22|||
130861291|NCT00118430|471118895|FG002|Overall Study|Lost to Follow-up|28|||
130861292|NCT02147288|471118896|FG000|Overall Study|post-operative hematoma|1|||
130861293|NCT02147288|471118897|FG001|Overall Study|post-operative hematoma|1|||
130861294|NCT02147288|471118898|FG002|Overall Study|post-operative hematoma|0|||
130861295|NCT02147288|471118899|FG003|Overall Study|post-operative hematoma|0|||
130861296|NCT02147288|471118900|FG004|Overall Study|post-operative hematoma|0|||
130861297|NCT02147288|471118901|FG005|Overall Study|post-operative hematoma|0|||
130861298|NCT02147288|471118902|FG006|Overall Study|post-operative hematoma|0|||
130861299|NCT02147288|471118903|FG007|Overall Study|post-operative hematoma|0|||
130861300|NCT02147288|471118904|FG008|Overall Study|post-operative hematoma|0|||
130861301|NCT02147288|471118905|FG009|Overall Study|post-operative hematoma|0|||
130861302|NCT02147288|471118896|FG000|Overall Study|complications from concurrent hernia rep|0|||
130861303|NCT02147288|471118897|FG001|Overall Study|complications from concurrent hernia rep|1|||
130861304|NCT02147288|471118898|FG002|Overall Study|complications from concurrent hernia rep|0|||
130861305|NCT02147288|471118899|FG003|Overall Study|complications from concurrent hernia rep|0|||
130861306|NCT02147288|471118900|FG004|Overall Study|complications from concurrent hernia rep|0|||
130861307|NCT02147288|471118901|FG005|Overall Study|complications from concurrent hernia rep|0|||
130861308|NCT02147288|471118902|FG006|Overall Study|complications from concurrent hernia rep|0|||
130861309|NCT02147288|471118903|FG007|Overall Study|complications from concurrent hernia rep|0|||
130861310|NCT02147288|471118904|FG008|Overall Study|complications from concurrent hernia rep|0|||
130861311|NCT02147288|471118905|FG009|Overall Study|complications from concurrent hernia rep|0|||
130861312|NCT02069392|471118908|FG000|Overall Study|Withdrawal by Subject|4|||
130861313|NCT02069392|471118909|FG001|Overall Study|Withdrawal by Subject|2|||
130861314|NCT00269633|471118910|FG000|Overall Study|Withdrawal by Subject|1|||
130861315|NCT00269633|471118911|FG001|Overall Study|Withdrawal by Subject|0|||
130861316|NCT02927938|471118912|FG000|Overall Study|Death|0|||
130861317|NCT02927938|471118913|FG001|Overall Study|Death|1|||
130861318|NCT02927938|471118914|FG002|Overall Study|Death|0|||
130861319|NCT02927938|471118915|FG003|Overall Study|Death|4|||
130861320|NCT02927938|471118912|FG000|Overall Study|Early Study Termination|1|||
130861321|NCT02927938|471118913|FG001|Overall Study|Early Study Termination|5|||
130861322|NCT02927938|471118914|FG002|Overall Study|Early Study Termination|4|||
130861323|NCT02927938|471118915|FG003|Overall Study|Early Study Termination|3|||
130861324|NCT02476006|471118916|FG000|Overall Study|Death|4|||
130861325|NCT02476006|471118916|FG000|Overall Study|Lack of treatment efficacy|2|||
130861326|NCT02476006|471118916|FG000|Overall Study|Pregnancy|1|||
130861327|NCT02476006|471118916|FG000|Overall Study|Participant did not wish to continue|39|||
130861328|NCT02476006|471118916|FG000|Overall Study|Adverse Event|41|||
130861329|NCT02476006|471118916|FG000|Overall Study|Poor compliance to study protocol|3|||
130861330|NCT02476006|471118916|FG000|Overall Study|Sponsor decision|6|||
130861331|NCT02476006|471118916|FG000|Overall Study|Lost to Follow-up|5|||
130861332|NCT02476006|471118916|FG000|Overall Study|Physician Decision|5|||
130861333|NCT02476006|471118916|FG000|Overall Study|Study ended treatment not available|4|||
130861334|NCT02476006|471118916|FG000|Overall Study|Switched to commercial drug|4|||
130861335|NCT02476006|471118916|FG000|Overall Study|Excluded from study|1|||
130861336|NCT02476006|471118916|FG000|Overall Study|Protocol Violation|1|||
130861337|NCT02476006|471118916|FG000|Overall Study|Enrolled but not treated|4|||
130861338|NCT00303485|471120576|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
130861339|NCT00303485|471120577|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
130861340|NCT00303485|471120576|FG000|Overall Study|Failure to return|0|||
130861341|NCT00303485|471120577|FG001|Overall Study|Failure to return|1|||
130861342|NCT00303485|471120576|FG000|Overall Study|Withdrawal by Subject|1|||
130861343|NCT00303485|471120577|FG001|Overall Study|Withdrawal by Subject|0|||
130861344|NCT02219334|471120583|FG000|Overall Study|Withdrawal by Subject|1|||
130861345|NCT02219334|471120584|FG001|Overall Study|Withdrawal by Subject|0|||
130861346|NCT02219334|471120583|FG000|Overall Study|Protocol Violation|7|||
130861347|NCT02219334|471120584|FG001|Overall Study|Protocol Violation|3|||
130861348|NCT01726582|471120585|FG000|Overall Study|Physician Decision|99|||
130861349|NCT01726582|471120585|FG000|Overall Study|Death|85|||
130861350|NCT01363908|471120586|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
130861351|NCT01363908|471120587|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
130861352|NCT01363908|471120586|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
130861353|NCT01363908|471120587|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
130861354|NCT01363908|471120586|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
130861355|NCT01363908|471120587|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
130861356|NCT01363908|471120586|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
130861357|NCT01363908|471120587|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
130861358|NCT00536471|471120588|FG000|Overall Study|Lost to Follow-up|48|||
130861359|NCT00536471|471120589|FG001|Overall Study|Lost to Follow-up|23|||
130861360|NCT00536471|471120590|FG002|Overall Study|Lost to Follow-up|48|||
130861361|NCT00536471|471120591|FG003|Overall Study|Lost to Follow-up|22|||
130861362|NCT00536471|471120588|FG000|Overall Study|Adverse Event|32|||
130861363|NCT00536471|471120589|FG001|Overall Study|Adverse Event|16|||
130861364|NCT00536471|471120590|FG002|Overall Study|Adverse Event|28|||
130861365|NCT00536471|471120591|FG003|Overall Study|Adverse Event|13|||
130861366|NCT00536471|471120588|FG000|Overall Study|Withdrawal by Subject|40|||
130861367|NCT00536471|471120589|FG001|Overall Study|Withdrawal by Subject|24|||
130861368|NCT00536471|471120590|FG002|Overall Study|Withdrawal by Subject|43|||
130861369|NCT00536471|471120591|FG003|Overall Study|Withdrawal by Subject|21|||
130861370|NCT00536471|471120588|FG000|Overall Study|Lack of Efficacy|17|||
130861371|NCT00536471|471120589|FG001|Overall Study|Lack of Efficacy|18|||
130861372|NCT00536471|471120590|FG002|Overall Study|Lack of Efficacy|11|||
130861373|NCT00536471|471120591|FG003|Overall Study|Lack of Efficacy|9|||
130861374|NCT00536471|471120588|FG000|Overall Study|Protocol Violation|8|||
130861375|NCT00536471|471120589|FG001|Overall Study|Protocol Violation|1|||
130861376|NCT00536471|471120590|FG002|Overall Study|Protocol Violation|2|||
130861377|NCT00536471|471120591|FG003|Overall Study|Protocol Violation|3|||
130861378|NCT00536471|471120588|FG000|Overall Study|Physician Decision|11|||
130861379|NCT00536471|471120589|FG001|Overall Study|Physician Decision|1|||
130861380|NCT00536471|471120590|FG002|Overall Study|Physician Decision|3|||
130861381|NCT00536471|471120591|FG003|Overall Study|Physician Decision|2|||
130861382|NCT00536471|471120588|FG000|Overall Study|Death|0|||
130861383|NCT00536471|471120589|FG001|Overall Study|Death|0|||
130861384|NCT00536471|471120590|FG002|Overall Study|Death|1|||
130861385|NCT00536471|471120591|FG003|Overall Study|Death|2|||
130861386|NCT00536471|471120588|FG000|Overall Study|Sponsor Decision|0|||
130861387|NCT00536471|471120589|FG001|Overall Study|Sponsor Decision|1|||
130861388|NCT00536471|471120590|FG002|Overall Study|Sponsor Decision|3|||
130861389|NCT00536471|471120591|FG003|Overall Study|Sponsor Decision|2|||
130861390|NCT00994422|471120595|FG000|Overall Study|Lost to Follow-up|7|||
130861391|NCT00994422|471120596|FG001|Overall Study|Lost to Follow-up|1|||
130861392|NCT00836186|471120598|FG000|Overall Study|Blood could not be drawn|1|||
130861393|NCT00532298|471120599|FG000|Overall Study|Adverse Event|1|||
130861394|NCT00532298|471120600|FG001|Overall Study|Adverse Event|0|||
130861395|NCT00532298|471120601|FG002|Overall Study|Adverse Event|0|||
130861396|NCT00532298|471120602|FG003|Overall Study|Adverse Event|0|||
130861397|NCT00532298|471120603|FG004|Overall Study|Adverse Event|1|||
130861398|NCT00532298|471120604|FG005|Overall Study|Adverse Event|1|||
130861399|NCT00532298|471120599|FG000|Overall Study|Lost to Follow-up|1|||
130861400|NCT00532298|471120600|FG001|Overall Study|Lost to Follow-up|1|||
130861401|NCT00532298|471120601|FG002|Overall Study|Lost to Follow-up|1|||
130861402|NCT00532298|471120602|FG003|Overall Study|Lost to Follow-up|0|||
130861403|NCT00532298|471120603|FG004|Overall Study|Lost to Follow-up|0|||
130861404|NCT00532298|471120604|FG005|Overall Study|Lost to Follow-up|1|||
130861405|NCT00395850|471120611|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
130861406|NCT00395850|471120612|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
130861407|NCT00395850|471120613|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
130861408|NCT00395850|471120614|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
130861409|NCT00395850|471120611|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
130861410|NCT00395850|471120612|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
130861411|NCT00395850|471120613|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
130861412|NCT00395850|471120614|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
130861413|NCT00395850|471120611|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
130861414|NCT00395850|471120612|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
130861415|NCT00395850|471120613|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
130861416|NCT00395850|471120614|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
130861417|NCT00395850|471120611|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
130861418|NCT00395850|471120612|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
130861419|NCT00395850|471120613|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
130861420|NCT00395850|471120614|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
130861421|NCT00395850|471120611|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
130861422|NCT00395850|471120612|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
130861423|NCT00395850|471120613|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
130861424|NCT00395850|471120614|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
130861425|NCT00395850|471120611|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
130861426|NCT00395850|471120612|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
130861427|NCT00395850|471120613|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
130861428|NCT00395850|471120614|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
130861429|NCT00395850|471120611|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
130861430|NCT00395850|471120612|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
130861431|NCT00395850|471120613|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
130861432|NCT00395850|471120614|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
130861433|NCT01620762|471120617|FG000|Overall Study|Protocol Violation|1|||
130861434|NCT01620762|471120618|FG001|Overall Study|Protocol Violation|1|||
130861435|NCT01620762|471120619|FG002|Overall Study|Protocol Violation|1|||
130861436|NCT01620762|471120617|FG000|Overall Study|Adverse Event|9|||
130861437|NCT01620762|471120618|FG001|Overall Study|Adverse Event|5|||
130861438|NCT01620762|471120619|FG002|Overall Study|Adverse Event|2|||
130861439|NCT01620762|471120617|FG000|Overall Study|Withdrawal by Subject|23|||
130861440|NCT01620762|471120618|FG001|Overall Study|Withdrawal by Subject|26|||
130861441|NCT01620762|471120619|FG002|Overall Study|Withdrawal by Subject|27|||
130861442|NCT01620762|471120617|FG000|Overall Study|Lost to Follow-up|11|||
130861443|NCT01620762|471120618|FG001|Overall Study|Lost to Follow-up|17|||
130861444|NCT01620762|471120619|FG002|Overall Study|Lost to Follow-up|10|||
130861445|NCT01620762|471120617|FG000|Overall Study|Protocol deviation|1|||
130861446|NCT01620762|471120618|FG001|Overall Study|Protocol deviation|1|||
130861447|NCT01620762|471120619|FG002|Overall Study|Protocol deviation|6|||
130861448|NCT01620762|471120617|FG000|Overall Study|Subject deterioration|0|||
130861449|NCT01620762|471120618|FG001|Overall Study|Subject deterioration|1|||
130861450|NCT01620762|471120619|FG002|Overall Study|Subject deterioration|1|||
130861451|NCT01620762|471120617|FG000|Overall Study|Non-specified|3|||
130861452|NCT01620762|471120618|FG001|Overall Study|Non-specified|6|||
130861453|NCT01620762|471120619|FG002|Overall Study|Non-specified|5|||
130861454|NCT01620762|471120617|FG000|Overall Study|Use of prohibted therapies|0|||
130861455|NCT01620762|471120618|FG001|Overall Study|Use of prohibted therapies|1|||
130861456|NCT01620762|471120619|FG002|Overall Study|Use of prohibted therapies|1|||
130861457|NCT00705146|471120624|FG000|Overall Study|Lost to Follow-up|1|||
130861458|NCT00705146|471120625|FG001|Overall Study|Lost to Follow-up|1|||
130861459|NCT00095173|471120628|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
130861460|NCT00095173|471120629|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130861461|NCT00095173|471120630|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130861462|NCT00095173|471120631|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130861463|NCT00095173|471120632|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130861464|NCT00095173|471120633|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130861465|NCT00095173|471120628|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
130861466|NCT00095173|471120629|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130861467|NCT00095173|471120630|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130861468|NCT00095173|471120631|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130861469|NCT00095173|471120632|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130861470|NCT00095173|471120633|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130861471|NCT00095173|471120628|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
130861472|NCT00095173|471120629|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130861473|NCT00095173|471120630|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130861474|NCT00095173|471120631|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130861475|NCT00095173|471120632|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130861476|NCT00095173|471120633|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130861477|NCT00095173|471120628|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
130861478|NCT00095173|471120629|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
130861479|NCT00095173|471120630|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
130861480|NCT00095173|471120631|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
130861481|NCT00095173|471120632|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
130861482|NCT00095173|471120633|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
130861483|NCT00095173|471120628|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130861484|NCT00095173|471120629|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
130861485|NCT00095173|471120630|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
130861486|NCT00095173|471120631|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130861487|NCT00095173|471120632|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130861488|NCT00095173|471120633|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130861489|NCT00095173|471120628|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130861490|NCT00095173|471120629|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
130861491|NCT00095173|471120630|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130861492|NCT00095173|471120631|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130861493|NCT00095173|471120632|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130861494|NCT00095173|471120633|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130861495|NCT00095173|471120628|FG000|Open-Label Extension Phase (Period C)|Death|0|||
130861496|NCT00095173|471120629|FG001|Open-Label Extension Phase (Period C)|Death|0|||
130861497|NCT00095173|471120630|FG002|Open-Label Extension Phase (Period C)|Death|0|||
130861498|NCT00095173|471120631|FG003|Open-Label Extension Phase (Period C)|Death|0|||
130861499|NCT00095173|471120632|FG004|Open-Label Extension Phase (Period C)|Death|0|||
130861500|NCT00095173|471120633|FG005|Open-Label Extension Phase (Period C)|Death|1|||
130861501|NCT00095173|471120628|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
130861502|NCT00095173|471120629|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
130861503|NCT00095173|471120630|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
130861504|NCT00095173|471120631|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
130861505|NCT00095173|471120632|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
130861506|NCT00095173|471120633|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
130861507|NCT00095173|471120628|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
130861508|NCT00095173|471120629|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
130861509|NCT00095173|471120630|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
130861510|NCT00095173|471120631|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
130861511|NCT00095173|471120632|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
130861512|NCT00095173|471120633|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
130861513|NCT00095173|471120628|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
130861514|NCT00095173|471120629|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
130861515|NCT00095173|471120630|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
130861516|NCT00095173|471120631|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
130861517|NCT00095173|471120632|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
130861518|NCT00095173|471120633|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
130861519|NCT00095173|471120628|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130861520|NCT00095173|471120629|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130861521|NCT00095173|471120630|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130861522|NCT00095173|471120631|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
130861523|NCT00095173|471120632|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
130861524|NCT00095173|471120633|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130861525|NCT00095173|471120628|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130861526|NCT00095173|471120629|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130861527|NCT00095173|471120630|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130861528|NCT00095173|471120631|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130861529|NCT00095173|471120632|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
130861530|NCT00095173|471120633|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
130861531|NCT00095173|471120628|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130861532|NCT00095173|471120629|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130861533|NCT00095173|471120630|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130861534|NCT00095173|471120631|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130861535|NCT00095173|471120632|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
130861536|NCT00095173|471120633|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
130861537|NCT00095173|471120628|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
130861538|NCT00095173|471120629|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
130861539|NCT00095173|471120630|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
130861540|NCT00095173|471120631|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
130861541|NCT00095173|471120632|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
130861542|NCT00095173|471120633|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
130861543|NCT00095173|471120628|FG000|Open-Label Extension Phase (Period C)|Other|0|||
130861544|NCT00095173|471120629|FG001|Open-Label Extension Phase (Period C)|Other|0|||
130861545|NCT00095173|471120630|FG002|Open-Label Extension Phase (Period C)|Other|0|||
130861546|NCT00095173|471120631|FG003|Open-Label Extension Phase (Period C)|Other|4|||
130861547|NCT00095173|471120632|FG004|Open-Label Extension Phase (Period C)|Other|6|||
130861548|NCT00095173|471120633|FG005|Open-Label Extension Phase (Period C)|Other|8|||
130861549|NCT01090063|471120640|FG000|Screen|Screen Failed|4|||
130861550|NCT01090063|471120640|FG000|Treatment|Withdrawal by Subject|4|||
130861551|NCT00923845|471120645|FG000|Induction Therapy|Poor performance status|0|||
130861552|NCT00923845|471120646|FG001|Induction Therapy|Poor performance status|2|||
130861553|NCT00330681|471120650|FG000|Overall Study|Adverse Event|3|||
130861554|NCT00330681|471120651|FG001|Overall Study|Adverse Event|6|||
130861555|NCT00330681|471120650|FG000|Overall Study|Protocol Violation|0|||
130861556|NCT00330681|471120651|FG001|Overall Study|Protocol Violation|1|||
130861557|NCT00330681|471120650|FG000|Overall Study|Withdrawal by Subject|5|||
130861558|NCT00330681|471120651|FG001|Overall Study|Withdrawal by Subject|5|||
130861559|NCT00330681|471120650|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
130861560|NCT00330681|471120651|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
130861561|NCT04698993|471120652|FG000|Overall Study|PCR results not accessible|2|||
130861562|NCT04698993|471120653|FG001|Overall Study|PCR results not accessible|7|||
130861563|NCT04698993|471120652|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
130861564|NCT04698993|471120653|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
130861565|NCT01128946|471120654|FG000|Period I|Protocol Violation|0|||
130861566|NCT01128946|471120655|FG001|Period I|Protocol Violation|1|||
130861567|NCT01128946|471120656|FG002|Period I|Protocol Violation|0|||
130861568|NCT01128946|471120657|FG003|Period I|Protocol Violation|0|||
130861569|NCT01128946|471120654|FG000|Period I|Withdrawal by Subject|0|||
130861570|NCT01128946|471120655|FG001|Period I|Withdrawal by Subject|0|||
130861571|NCT01128946|471120656|FG002|Period I|Withdrawal by Subject|1|||
130861572|NCT01128946|471120657|FG003|Period I|Withdrawal by Subject|1|||
130861573|NCT01128946|471120654|FG000|Period II|Protocol Violation|0|||
130861574|NCT01128946|471120655|FG001|Period II|Protocol Violation|1|||
130861575|NCT01128946|471120656|FG002|Period II|Protocol Violation|0|||
130861576|NCT01128946|471120657|FG003|Period II|Protocol Violation|0|||
130861577|NCT01128946|471120654|FG000|Period II|Withdrawal by Subject|0|||
130861578|NCT01128946|471120655|FG001|Period II|Withdrawal by Subject|0|||
130861579|NCT01128946|471120656|FG002|Period II|Withdrawal by Subject|0|||
130861580|NCT01128946|471120657|FG003|Period II|Withdrawal by Subject|1|||
130861581|NCT01128946|471120654|FG000|Period III|Protocol Violation|1|||
130861582|NCT01128946|471120655|FG001|Period III|Protocol Violation|0|||
130861583|NCT01128946|471120656|FG002|Period III|Protocol Violation|0|||
130861584|NCT01128946|471120657|FG003|Period III|Protocol Violation|0|||
130861585|NCT02578186|471120658|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
130861586|NCT02578186|471120659|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
130861587|NCT02578186|471120658|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
130861588|NCT02578186|471120659|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
130861589|NCT00527904|471120660|FG000|Overall Study|Adverse Event|45|||
130861590|NCT00527904|471120660|FG000|Overall Study|Withdrawal by Subject|21|||
130861591|NCT00527904|471120660|FG000|Overall Study|Lost to Follow-up|8|||
130861592|NCT00527904|471120660|FG000|Overall Study|misc|22|||
130861593|NCT03565237|471120661|FG000|Overall Study|Non-compliance of Investigational Product|1|||
130861594|NCT03565237|471120661|FG000|Overall Study|Physician Decision|1|||
130861595|NCT00428389|471120662|FG000|Core Phase|Adverse Event|6|||
130861596|NCT00428389|471120663|FG001|Core Phase|Adverse Event|4|||
130861597|NCT00428389|471120662|FG000|Core Phase|Lack of Efficacy|2|||
130861598|NCT00428389|471120663|FG001|Core Phase|Lack of Efficacy|0|||
130861599|NCT00428389|471120662|FG000|Core Phase|Abnormal test procedure result(s)|0|||
130861600|NCT00428389|471120663|FG001|Core Phase|Abnormal test procedure result(s)|1|||
130861601|NCT00428389|471120662|FG000|Core Phase|Withdrawal by Subject|3|||
130861602|NCT00428389|471120663|FG001|Core Phase|Withdrawal by Subject|4|||
130861603|NCT00428389|471120662|FG000|Core Phase|Protocol deviation|0|||
130861604|NCT00428389|471120663|FG001|Core Phase|Protocol deviation|2|||
130861605|NCT00428389|471120662|FG000|Extension Phase|Adverse Event|17|||
130861606|NCT00428389|471120663|FG001|Extension Phase|Adverse Event|11|||
130861607|NCT00428389|471120662|FG000|Extension Phase|Lack of Efficacy|4|||
130861608|NCT00428389|471120663|FG001|Extension Phase|Lack of Efficacy|3|||
130861609|NCT00428389|471120662|FG000|Extension Phase|Withdrawal by Subject|6|||
130861610|NCT00428389|471120663|FG001|Extension Phase|Withdrawal by Subject|6|||
130861611|NCT00428389|471120662|FG000|Extension Phase|Lost to Follow-up|0|||
130861612|NCT00428389|471120663|FG001|Extension Phase|Lost to Follow-up|3|||
130861613|NCT00428389|471120662|FG000|Extension Phase|Death|1|||
130861614|NCT00428389|471120663|FG001|Extension Phase|Death|0|||
130861615|NCT00428389|471120662|FG000|Extension Phase|Protocol Violation|3|||
130861616|NCT00428389|471120663|FG001|Extension Phase|Protocol Violation|2|||
130861617|NCT00428389|471120662|FG000|Extension Phase|Administrative problems|1|||
130861618|NCT00428389|471120663|FG001|Extension Phase|Administrative problems|1|||
130861619|NCT01534195|471120664|FG000|Overall Study|Withdrawal by Subject|1|||
130861620|NCT01534195|471120665|FG001|Overall Study|Withdrawal by Subject|1|||
130861621|NCT02669121|471120666|FG000|Overall Study|Adverse Event|4|||
130861622|NCT02669121|471120667|FG001|Overall Study|Adverse Event|5|||
130861623|NCT02669121|471120666|FG000|Overall Study|Lost to Follow-up|15|||
130861624|NCT02669121|471120667|FG001|Overall Study|Lost to Follow-up|27|||
130861625|NCT02669121|471120666|FG000|Overall Study|Withdrawal by Subject|132|||
130861626|NCT02669121|471120667|FG001|Overall Study|Withdrawal by Subject|140|||
130861627|NCT02669121|471120666|FG000|Overall Study|Pregnancy|0|||
130861628|NCT02669121|471120667|FG001|Overall Study|Pregnancy|1|||
130861629|NCT02669121|471120666|FG000|Overall Study|Discharged from US Military Active Service|117|||
130861630|NCT02669121|471120667|FG001|Overall Study|Discharged from US Military Active Service|91|||
130861631|NCT02669121|471120666|FG000|Overall Study|Reason not Specified|22|||
130861632|NCT02669121|471120667|FG001|Overall Study|Reason not Specified|18|||
130861633|NCT02708355|471120668|FG000|Overall Study|Adverse Event|1|||
130861634|NCT02708355|471120669|FG001|Overall Study|Adverse Event|0|||
130861635|NCT02708355|471120670|FG002|Overall Study|Adverse Event|0|||
130861636|NCT04384523|471120671|FG000|Overall Study|Lost to Follow-up|0|||
130861637|NCT04384523|471120672|FG001|Overall Study|Lost to Follow-up|0|||
130861638|NCT04384523|471120673|FG002|Overall Study|Lost to Follow-up|0|||
130861639|NCT04384523|471120674|FG003|Overall Study|Lost to Follow-up|0|||
130861640|NCT04384523|471120675|FG004|Overall Study|Lost to Follow-up|0|||
130861641|NCT04384523|471120676|FG005|Overall Study|Lost to Follow-up|1|||
130861642|NCT04384523|471120671|FG000|Overall Study|Protocol Violation|0|||
130861643|NCT04384523|471120672|FG001|Overall Study|Protocol Violation|1|||
130861644|NCT04384523|471120673|FG002|Overall Study|Protocol Violation|0|||
130861645|NCT04384523|471120674|FG003|Overall Study|Protocol Violation|0|||
130861646|NCT04384523|471120675|FG004|Overall Study|Protocol Violation|0|||
130861647|NCT04384523|471120676|FG005|Overall Study|Protocol Violation|0|||
130861648|NCT04384523|471120671|FG000|Overall Study|Withdrawal by Subject|1|||
130861649|NCT04384523|471120672|FG001|Overall Study|Withdrawal by Subject|0|||
130861650|NCT04384523|471120673|FG002|Overall Study|Withdrawal by Subject|0|||
130861651|NCT04384523|471120674|FG003|Overall Study|Withdrawal by Subject|0|||
130861652|NCT04384523|471120675|FG004|Overall Study|Withdrawal by Subject|0|||
130861653|NCT04384523|471120676|FG005|Overall Study|Withdrawal by Subject|0|||
130861654|NCT03216746|471120677|FG000|Overall Study|Lost to Follow-up|6|||
130861655|NCT03216746|471120678|FG001|Overall Study|Lost to Follow-up|8|||
130861656|NCT03216746|471120679|FG002|Overall Study|Lost to Follow-up|5|||
130861657|NCT03216746|471120680|FG003|Overall Study|Lost to Follow-up|6|||
130861658|NCT00635882|471120681|FG000|Overall Study|Protocol Violation|1|||
130861659|NCT00635882|471120682|FG001|Overall Study|Protocol Violation|0|||
130861660|NCT00635882|471120683|FG002|Overall Study|Protocol Violation|0|||
130861661|NCT00635882|471120684|FG003|Overall Study|Protocol Violation|0|||
130861662|NCT00635882|471120685|FG004|Overall Study|Protocol Violation|0|||
130861663|NCT00635882|471120686|FG005|Overall Study|Protocol Violation|0|||
130861664|NCT01320202|471120687|FG000|Overall Study|Adverse Event|5|||
130861665|NCT01320202|471120688|FG001|Overall Study|Adverse Event|5|||
130861666|NCT01320202|471120687|FG000|Overall Study|Death|5|||
130861667|NCT01320202|471120688|FG001|Overall Study|Death|3|||
130861668|NCT01320202|471120687|FG000|Overall Study|Lost to Follow-up|1|||
130861669|NCT01320202|471120688|FG001|Overall Study|Lost to Follow-up|0|||
130861670|NCT01320202|471120687|FG000|Overall Study|Physician Decision|3|||
130861671|NCT01320202|471120688|FG001|Overall Study|Physician Decision|1|||
130861672|NCT01320202|471120687|FG000|Overall Study|Protocol Violation|2|||
130861673|NCT01320202|471120688|FG001|Overall Study|Protocol Violation|1|||
130861674|NCT01320202|471120687|FG000|Overall Study|Withdrawal by Subject|10|||
130861675|NCT01320202|471120688|FG001|Overall Study|Withdrawal by Subject|3|||
130861676|NCT01320202|471120687|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
130861677|NCT01320202|471120688|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
130861678|NCT01320202|471120687|FG000|Overall Study|kidney transplant|1|||
130861679|NCT01320202|471120688|FG001|Overall Study|kidney transplant|2|||
130861680|NCT01320202|471120687|FG000|Overall Study|blood transfusion|1|||
130861681|NCT01320202|471120688|FG001|Overall Study|blood transfusion|7|||
130861682|NCT01320202|471120687|FG000|Overall Study|moved/changed dialysis|5|||
130861683|NCT01320202|471120688|FG001|Overall Study|moved/changed dialysis|2|||
130861684|NCT01320202|471120687|FG000|Overall Study|sponsor request|2|||
130861685|NCT01320202|471120688|FG001|Overall Study|sponsor request|0|||
130861686|NCT01320202|471120687|FG000|Overall Study|ineligible|3|||
130861687|NCT01320202|471120688|FG001|Overall Study|ineligible|0|||
130861688|NCT01320202|471120687|FG000|Overall Study|regained renal function|1|||
130861689|NCT01320202|471120688|FG001|Overall Study|regained renal function|0|||
130861690|NCT04405076|471120690|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
130861691|NCT04405076|471120691|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
130861692|NCT04405076|471120692|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
130861693|NCT04405076|471120693|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
130861694|NCT04405076|471120694|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
130861695|NCT04405076|471120695|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
130861696|NCT04405076|471120696|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
130861697|NCT04405076|471120697|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
130861698|NCT04405076|471120698|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
130861699|NCT04405076|471120690|FG000|Part A (Blinded Phase)|Physician Decision|1|||
130861700|NCT04405076|471120691|FG001|Part A (Blinded Phase)|Physician Decision|2|||
130861701|NCT04405076|471120692|FG002|Part A (Blinded Phase)|Physician Decision|0|||
130861702|NCT04405076|471120693|FG003|Part A (Blinded Phase)|Physician Decision|0|||
130861703|NCT04405076|471120694|FG004|Part A (Blinded Phase)|Physician Decision|0|||
130861704|NCT04405076|471120695|FG005|Part A (Blinded Phase)|Physician Decision|0|||
130861705|NCT04405076|471120696|FG006|Part A (Blinded Phase)|Physician Decision|0|||
130861706|NCT04405076|471120697|FG007|Part A (Blinded Phase)|Physician Decision|0|||
130861707|NCT04405076|471120698|FG008|Part A (Blinded Phase)|Physician Decision|0|||
130861708|NCT04405076|471120690|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
130861709|NCT04405076|471120691|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
130861710|NCT04405076|471120692|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
130861711|NCT04405076|471120693|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
130861712|NCT04405076|471120694|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
130861713|NCT04405076|471120695|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
130861714|NCT04405076|471120696|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
130861715|NCT04405076|471120697|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
130861716|NCT04405076|471120698|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
130861717|NCT04405076|471120690|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
130861718|NCT04405076|471120691|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130861719|NCT04405076|471120692|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130861720|NCT04405076|471120693|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130861721|NCT04405076|471120694|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130861722|NCT04405076|471120695|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130861723|NCT04405076|471120696|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130861724|NCT04405076|471120697|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130861725|NCT04405076|471120698|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130861726|NCT04405076|471120690|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
130861727|NCT04405076|471120691|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
130861728|NCT04405076|471120692|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130861729|NCT04405076|471120693|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130861730|NCT04405076|471120694|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130861731|NCT04405076|471120695|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130861732|NCT04405076|471120696|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130861733|NCT04405076|471120697|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130861734|NCT04405076|471120698|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130861735|NCT04405076|471120690|FG000|Part A (Blinded Phase)|Other than Specified|0|||
130861736|NCT04405076|471120691|FG001|Part A (Blinded Phase)|Other than Specified|0|||
130861737|NCT04405076|471120692|FG002|Part A (Blinded Phase)|Other than Specified|3|||
130861738|NCT04405076|471120693|FG003|Part A (Blinded Phase)|Other than Specified|0|||
130861739|NCT04405076|471120694|FG004|Part A (Blinded Phase)|Other than Specified|0|||
130861740|NCT04405076|471120695|FG005|Part A (Blinded Phase)|Other than Specified|0|||
130861741|NCT04405076|471120696|FG006|Part A (Blinded Phase)|Other than Specified|0|||
130861742|NCT04405076|471120697|FG007|Part A (Blinded Phase)|Other than Specified|0|||
130861743|NCT04405076|471120698|FG008|Part A (Blinded Phase)|Other than Specified|0|||
130861744|NCT04405076|471120690|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130861745|NCT04405076|471120691|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130861746|NCT04405076|471120692|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130861747|NCT04405076|471120693|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
130861748|NCT04405076|471120694|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
130861749|NCT04405076|471120695|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
130861750|NCT04405076|471120696|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130861751|NCT04405076|471120697|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130861752|NCT04405076|471120698|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130861753|NCT04405076|471120690|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130861754|NCT04405076|471120691|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130861755|NCT04405076|471120692|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130861756|NCT04405076|471120693|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130861757|NCT04405076|471120694|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
130861758|NCT04405076|471120695|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130861759|NCT04405076|471120696|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130861760|NCT04405076|471120697|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130861761|NCT04405076|471120698|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130861762|NCT04405076|471120690|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130861763|NCT04405076|471120691|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130861764|NCT04405076|471120692|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130861765|NCT04405076|471120693|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
130861766|NCT04405076|471120694|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
130861767|NCT04405076|471120695|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
130861768|NCT04405076|471120696|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130861769|NCT04405076|471120697|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130861770|NCT04405076|471120698|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130861771|NCT04405076|471120690|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130861772|NCT04405076|471120691|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130861773|NCT04405076|471120692|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130861774|NCT04405076|471120693|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130861775|NCT04405076|471120694|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130861776|NCT04405076|471120695|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130861777|NCT04405076|471120696|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130861778|NCT04405076|471120697|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
130861779|NCT04405076|471120698|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
130861780|NCT04405076|471120690|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130861781|NCT04405076|471120691|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130861782|NCT04405076|471120692|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130861783|NCT04405076|471120693|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130861784|NCT04405076|471120694|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130861785|NCT04405076|471120695|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130861786|NCT04405076|471120696|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
130861787|NCT04405076|471120697|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130861788|NCT04405076|471120698|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130861789|NCT00825812|471120699|FG000|Overall Study|Never entered follow up|0|||
130861790|NCT00825812|471120700|FG001|Overall Study|Never entered follow up|0|||
130861791|NCT00825812|471120701|FG002|Overall Study|Never entered follow up|0|||
130861792|NCT00825812|471120702|FG003|Overall Study|Never entered follow up|1|||
130861793|NCT00825812|471120699|FG000|Overall Study|Adverse Event|0|||
130861794|NCT00825812|471120700|FG001|Overall Study|Adverse Event|0|||
130861795|NCT00825812|471120701|FG002|Overall Study|Adverse Event|0|||
130861796|NCT00825812|471120702|FG003|Overall Study|Adverse Event|1|||
130861797|NCT00825812|471120699|FG000|Overall Study|Subject withdrew consent|0|||
130861798|NCT00825812|471120700|FG001|Overall Study|Subject withdrew consent|0|||
130861799|NCT00825812|471120701|FG002|Overall Study|Subject withdrew consent|3|||
130861800|NCT00825812|471120702|FG003|Overall Study|Subject withdrew consent|2|||
130861801|NCT00825812|471120699|FG000|Overall Study|Non-compliance with protocol|0|||
130861802|NCT00825812|471120700|FG001|Overall Study|Non-compliance with protocol|0|||
130861803|NCT00825812|471120701|FG002|Overall Study|Non-compliance with protocol|0|||
130861804|NCT00825812|471120702|FG003|Overall Study|Non-compliance with protocol|1|||
130861805|NCT00825812|471120699|FG000|Overall Study|Administrative|0|||
130861806|NCT00825812|471120700|FG001|Overall Study|Administrative|1|||
130861807|NCT00825812|471120701|FG002|Overall Study|Administrative|3|||
130861808|NCT00825812|471120702|FG003|Overall Study|Administrative|5|||
130861809|NCT00408434|471120705|FG000|Overall Study|Adverse Event|0|||
130861810|NCT00408434|471120706|FG001|Overall Study|Adverse Event|0|||
130861811|NCT00408434|471120707|FG002|Overall Study|Adverse Event|1|||
130861812|NCT00408434|471120708|FG003|Overall Study|Adverse Event|0|||
130861813|NCT00408434|471120709|FG004|Overall Study|Adverse Event|0|||
130861814|NCT00408434|471120710|FG005|Overall Study|Adverse Event|0|||
130861815|NCT00408434|471120711|FG006|Overall Study|Adverse Event|0|||
130861816|NCT00408434|471120705|FG000|Overall Study|Progressive disease|6|||
130861817|NCT00408434|471120706|FG001|Overall Study|Progressive disease|3|||
130861818|NCT00408434|471120707|FG002|Overall Study|Progressive disease|4|||
130861819|NCT00408434|471120708|FG003|Overall Study|Progressive disease|3|||
130861820|NCT00408434|471120709|FG004|Overall Study|Progressive disease|3|||
130861821|NCT00408434|471120710|FG005|Overall Study|Progressive disease|1|||
130861822|NCT00408434|471120711|FG006|Overall Study|Progressive disease|4|||
130861823|NCT00408434|471120705|FG000|Overall Study|Other|0|||
130861824|NCT00408434|471120706|FG001|Overall Study|Other|0|||
130861825|NCT00408434|471120707|FG002|Overall Study|Other|1|||
130861826|NCT00408434|471120708|FG003|Overall Study|Other|0|||
130861827|NCT00408434|471120709|FG004|Overall Study|Other|2|||
130861828|NCT00408434|471120710|FG005|Overall Study|Other|1|||
130861829|NCT00408434|471120711|FG006|Overall Study|Other|0|||
130861830|NCT00408434|471120705|FG000|Overall Study|Terminated by Investigator|0|||
130861831|NCT00408434|471120706|FG001|Overall Study|Terminated by Investigator|0|||
130861832|NCT00408434|471120707|FG002|Overall Study|Terminated by Investigator|0|||
130861833|NCT00408434|471120708|FG003|Overall Study|Terminated by Investigator|0|||
130861834|NCT00408434|471120709|FG004|Overall Study|Terminated by Investigator|1|||
130861835|NCT00408434|471120710|FG005|Overall Study|Terminated by Investigator|1|||
130861836|NCT00408434|471120711|FG006|Overall Study|Terminated by Investigator|0|||
130861837|NCT01278797|471120712|FG000|Period 1|Adverse Event|0|||
130861838|NCT01278797|471120713|FG001|Period 1|Adverse Event|1|||
130861839|NCT01278797|471120712|FG000|Period 1|Protocol Violation|1|||
130861840|NCT01278797|471120713|FG001|Period 1|Protocol Violation|0|||
130861841|NCT00588354|471120714|FG000|Baseline to 2 Weeks|Adverse Event|1|||
130861842|NCT00588354|471120715|FG001|Baseline to 2 Weeks|Adverse Event|0|||
130861843|NCT00588354|471120714|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
130861844|NCT00588354|471120715|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
130861845|NCT00588354|471120714|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
130861846|NCT00588354|471120715|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
130861847|NCT04000581|471120716|FG000|Overall Study|Withdrawal by Subject|0|||
130861848|NCT04000581|471120717|FG001|Overall Study|Withdrawal by Subject|1|||
130861849|NCT00895453|471120718|FG000|Overall Study|Lost to Follow-up|25|||
130861850|NCT00895453|471120719|FG001|Overall Study|Lost to Follow-up|25|||
130861851|NCT00895453|471120720|FG002|Overall Study|Lost to Follow-up|23|||
130861852|NCT01736618|471120727|FG000|Overall Study|Death|294|||
130861853|NCT01736618|471120727|FG000|Overall Study|Lost to Follow-up|193|||
130861854|NCT01736618|471120727|FG000|Overall Study|Withdrawal by Subject|54|||
130861855|NCT01736618|471120727|FG000|Overall Study|Subject unable to be followed at study location|223|||
130861856|NCT01736618|471120727|FG000|Overall Study|Physician Decision|33|||
130861857|NCT01736618|471120727|FG000|Overall Study|Transplant or removal of target organ|19|||
130861858|NCT01736618|471120727|FG000|Overall Study|Change in indication or condition|78|||
130861859|NCT01736618|471120727|FG000|Overall Study|Study device explant|103|||
130861860|NCT01736618|471120727|FG000|Overall Study|Unable to complete implant|2|||
130861861|NCT00400569|471120732|FG000|Overall Study|Death|1|||
130861862|NCT00620113|471120735|FG000|Overall Study|Adverse Event|3|||
130861863|NCT00620113|471120736|FG001|Overall Study|Adverse Event|2|||
130861864|NCT00620113|471120737|FG002|Overall Study|Adverse Event|2|||
130861865|NCT00620113|471120738|FG003|Overall Study|Adverse Event|1|||
130861866|NCT00620113|471120735|FG000|Overall Study|Lack of Efficacy|2|||
130861867|NCT00620113|471120736|FG001|Overall Study|Lack of Efficacy|3|||
130861868|NCT00620113|471120737|FG002|Overall Study|Lack of Efficacy|0|||
130861869|NCT00620113|471120738|FG003|Overall Study|Lack of Efficacy|2|||
130861870|NCT00620113|471120735|FG000|Overall Study|Physician Decision|1|||
130861871|NCT00620113|471120736|FG001|Overall Study|Physician Decision|0|||
130861872|NCT00620113|471120737|FG002|Overall Study|Physician Decision|0|||
130861873|NCT00620113|471120738|FG003|Overall Study|Physician Decision|2|||
130861874|NCT00620113|471120735|FG000|Overall Study|Protocol Violation|2|||
130861875|NCT00620113|471120736|FG001|Overall Study|Protocol Violation|1|||
130861876|NCT00620113|471120737|FG002|Overall Study|Protocol Violation|0|||
130861877|NCT00620113|471120738|FG003|Overall Study|Protocol Violation|0|||
130861878|NCT00620113|471120735|FG000|Overall Study|Withdrawal by Subject|5|||
130861879|NCT00620113|471120736|FG001|Overall Study|Withdrawal by Subject|1|||
130861880|NCT00620113|471120737|FG002|Overall Study|Withdrawal by Subject|3|||
130861881|NCT00620113|471120738|FG003|Overall Study|Withdrawal by Subject|5|||
130861882|NCT02461745|471120741|FG000|Overall Study|Lack of Efficacy|9|||
130861883|NCT02461745|471120742|FG001|Overall Study|Lack of Efficacy|1|||
130861884|NCT02461745|471120741|FG000|Overall Study|Lost to Follow-up|2|||
130861885|NCT02461745|471120742|FG001|Overall Study|Lost to Follow-up|2|||
130861886|NCT02461745|471120741|FG000|Overall Study|Withdrawal by Subject|3|||
130861887|NCT02461745|471120742|FG001|Overall Study|Withdrawal by Subject|1|||
130861888|NCT00211887|471120745|FG000|Overall Study|Adverse Event|8|||
130861889|NCT00211887|471120746|FG001|Overall Study|Adverse Event|4|||
130861890|NCT00211887|471120747|FG002|Overall Study|Adverse Event|6|||
130861891|NCT00211887|471120745|FG000|Overall Study|Death|1|||
130861892|NCT00211887|471120746|FG001|Overall Study|Death|1|||
130861893|NCT00211887|471120747|FG002|Overall Study|Death|1|||
130861894|NCT00211887|471120745|FG000|Overall Study|Lost to Follow-up|28|||
130861895|NCT00211887|471120746|FG001|Overall Study|Lost to Follow-up|13|||
130861896|NCT00211887|471120747|FG002|Overall Study|Lost to Follow-up|9|||
130861897|NCT00211887|471120745|FG000|Overall Study|Non-medical reason|31|||
130861898|NCT00211887|471120746|FG001|Overall Study|Non-medical reason|14|||
130861899|NCT00211887|471120747|FG002|Overall Study|Non-medical reason|8|||
130861900|NCT00211887|471120745|FG000|Overall Study|Other medical reason|15|||
130861901|NCT00211887|471120746|FG001|Overall Study|Other medical reason|11|||
130861902|NCT00211887|471120747|FG002|Overall Study|Other medical reason|7|||
130861903|NCT00211887|471120745|FG000|Overall Study|Side effects|19|||
130861904|NCT00211887|471120746|FG001|Overall Study|Side effects|13|||
130861905|NCT00211887|471120747|FG002|Overall Study|Side effects|5|||
130861906|NCT00965419|471120751|FG000|Open Label Treatment for Responders|Adverse Event|33|||
130861907|NCT00965419|471120751|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
130861908|NCT00965419|471120751|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
130861909|NCT00965419|471120751|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
130861910|NCT00965419|471120751|FG000|Open Label Treatment for Responders|Physician Decision|6|||
130861911|NCT00965419|471120751|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
130861912|NCT00965419|471120751|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
130861913|NCT00965419|471120751|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
130861914|NCT00965419|471120751|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
130861915|NCT00965419|471120751|FG000|Follow-up Phase|Adverse Event|9|||
130861916|NCT00965419|471120751|FG000|Follow-up Phase|Protocol Violation|4|||
130861917|NCT00965419|471120751|FG000|Follow-up Phase|Withdrawal by Subject|8|||
130861918|NCT00965419|471120751|FG000|Follow-up Phase|Physician Decision|4|||
130861919|NCT00965419|471120751|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
130861920|NCT00965419|471120751|FG000|Follow-up Phase|Lack of Efficacy|28|||
130861921|NCT00826618|471122943|FG000|Overall Study|Withdrawal by Subject|1|||
130861922|NCT03712787|471122944|FG000|Overall Study|Adverse Event|2|||
130861923|NCT03712787|471122945|FG001|Overall Study|Adverse Event|3|||
130861924|NCT03712787|471122946|FG002|Overall Study|Adverse Event|0|||
130861925|NCT03712787|471122947|FG003|Overall Study|Adverse Event|4|||
130861926|NCT03712787|471122944|FG000|Overall Study|Withdrawal by Subject|4|||
130861927|NCT03712787|471122945|FG001|Overall Study|Withdrawal by Subject|14|||
130861928|NCT03712787|471122946|FG002|Overall Study|Withdrawal by Subject|12|||
130861929|NCT03712787|471122947|FG003|Overall Study|Withdrawal by Subject|8|||
130861930|NCT03712787|471122944|FG000|Overall Study|Lost to Follow-up|1|||
130861931|NCT03712787|471122945|FG001|Overall Study|Lost to Follow-up|1|||
130861932|NCT03712787|471122946|FG002|Overall Study|Lost to Follow-up|2|||
130861933|NCT03712787|471122947|FG003|Overall Study|Lost to Follow-up|1|||
130861934|NCT03712787|471122944|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
130861935|NCT03712787|471122945|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
130861936|NCT03712787|471122946|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
130861937|NCT03712787|471122947|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
130861938|NCT03712787|471122944|FG000|Overall Study|COVID-19 Infection|0|||
130861939|NCT03712787|471122945|FG001|Overall Study|COVID-19 Infection|1|||
130861940|NCT03712787|471122946|FG002|Overall Study|COVID-19 Infection|0|||
130861941|NCT03712787|471122947|FG003|Overall Study|COVID-19 Infection|0|||
130861942|NCT03712787|471122944|FG000|Overall Study|Other, Not Specified|79|||
130861943|NCT03712787|471122945|FG001|Overall Study|Other, Not Specified|77|||
130861944|NCT03712787|471122946|FG002|Overall Study|Other, Not Specified|74|||
130861945|NCT03712787|471122947|FG003|Overall Study|Other, Not Specified|78|||
130861946|NCT05128578|471122948|FG000|Overall Study|Withdrawal by Subject|9|||
130861947|NCT05128578|471122948|FG000|Overall Study|Lost to Follow-up|5|||
130861948|NCT00872599|471122951|FG000|Second Washout Period|Adverse Event|1|||
130861949|NCT00872599|471122952|FG001|Second Washout Period|Adverse Event|1|||
130861950|NCT00801229|471122955|FG000|Signed Consent|Withdrawal by Subject|2|||
130861951|NCT00801229|471122956|FG001|Signed Consent|Withdrawal by Subject|2|||
130861952|NCT00801229|471122955|FG000|Signed Consent|Found Ineligible|1|||
130861953|NCT00801229|471122956|FG001|Signed Consent|Found Ineligible|1|||
130861954|NCT00801229|471122955|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
130861955|NCT00801229|471122956|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
130861956|NCT00801229|471122955|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
130861957|NCT00801229|471122956|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
130861958|NCT00801229|471122955|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
130861959|NCT00801229|471122956|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
130861960|NCT00801229|471122955|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
130861961|NCT00801229|471122956|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
130861962|NCT00801229|471122955|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
130861963|NCT00801229|471122956|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
130861964|NCT00801229|471122955|FG000|Received Study Drug/Placebo|Adverse Event|1|||
130861965|NCT00801229|471122956|FG001|Received Study Drug/Placebo|Adverse Event|1|||
130861966|NCT02610777|471122957|FG000|Overall Study|Lost to Follow-up|1|||
130861967|NCT02610777|471122958|FG001|Overall Study|Lost to Follow-up|0|||
130861968|NCT02610777|471122957|FG000|Overall Study|Site Terminated by Sponsor|9|||
130861969|NCT02610777|471122958|FG001|Overall Study|Site Terminated by Sponsor|8|||
130861970|NCT02610777|471122957|FG000|Overall Study|Withdrawal by Subject|2|||
130861971|NCT02610777|471122958|FG001|Overall Study|Withdrawal by Subject|2|||
130861972|NCT02610777|471122957|FG000|Overall Study|Reason not Specified|0|||
130861973|NCT02610777|471122958|FG001|Overall Study|Reason not Specified|1|||
130861974|NCT02610777|471122957|FG000|Overall Study|Death|50|||
130861975|NCT02610777|471122958|FG001|Overall Study|Death|47|||
130861976|NCT00732875|471122959|FG000|Overall Study|Adverse Event|16|||
130861977|NCT00732875|471122959|FG000|Overall Study|Withdrawal by Subject|6|||
130861978|NCT00732875|471122959|FG000|Overall Study|Lack of Efficacy|13|||
130861979|NCT02300259|471122962|FG000|Period 1|Adverse Event|0|||
130861980|NCT02300259|471122963|FG001|Period 1|Adverse Event|0|||
130861981|NCT02300259|471122964|FG002|Period 1|Adverse Event|1|||
130861982|NCT02300259|471122962|FG000|Period 1|Withdrawal by Subject|0|||
130861983|NCT02300259|471122963|FG001|Period 1|Withdrawal by Subject|0|||
130861984|NCT02300259|471122964|FG002|Period 1|Withdrawal by Subject|1|||
130861985|NCT02300259|471122962|FG000|Period 2|Adverse Event|1|||
130861986|NCT02300259|471122963|FG001|Period 2|Adverse Event|0|||
130861987|NCT02300259|471122964|FG002|Period 2|Adverse Event|0|||
130861988|NCT02300259|471122962|FG000|Period 2|Withdrawal by Subject|0|||
130861989|NCT02300259|471122963|FG001|Period 2|Withdrawal by Subject|0|||
130861990|NCT02300259|471122964|FG002|Period 2|Withdrawal by Subject|1|||
130861991|NCT02737475|471122965|FG000|Overall Study|Other reasons|0|||
130861992|NCT02737475|471122966|FG001|Overall Study|Other reasons|0|||
130861993|NCT02737475|471122967|FG002|Overall Study|Other reasons|0|||
130861994|NCT02737475|471122968|FG003|Overall Study|Other reasons|0|||
130861995|NCT02737475|471122969|FG004|Overall Study|Other reasons|1|||
130861996|NCT02737475|471122970|FG005|Overall Study|Other reasons|1|||
130861997|NCT02737475|471122971|FG006|Overall Study|Other reasons|0|||
130861998|NCT02737475|471122972|FG007|Overall Study|Other reasons|0|||
130861999|NCT02737475|471122973|FG008|Overall Study|Other reasons|1|||
130862000|NCT02737475|471122974|FG009|Overall Study|Other reasons|0|||
130862001|NCT02737475|471122975|FG010|Overall Study|Other reasons|1|||
130862002|NCT02737475|471122976|FG011|Overall Study|Other reasons|0|||
130862003|NCT02737475|471122977|FG012|Overall Study|Other reasons|0|||
130862004|NCT02737475|471122978|FG013|Overall Study|Other reasons|0|||
130862005|NCT02737475|471122979|FG014|Overall Study|Other reasons|0|||
130862006|NCT02737475|471122980|FG015|Overall Study|Other reasons|0|||
130862007|NCT02737475|471122981|FG016|Overall Study|Other reasons|0|||
130862008|NCT02737475|471122982|FG017|Overall Study|Other reasons|0|||
130862009|NCT02737475|471122983|FG018|Overall Study|Other reasons|0|||
130862010|NCT02737475|471122984|FG019|Overall Study|Other reasons|0|||
130862011|NCT02737475|471122985|FG020|Overall Study|Other reasons|0|||
130862012|NCT02737475|471122986|FG021|Overall Study|Other reasons|1|||
130862013|NCT02737475|471122987|FG022|Overall Study|Other reasons|0|||
130862014|NCT02737475|471122988|FG023|Overall Study|Other reasons|1|||
130862015|NCT02737475|471122989|FG024|Overall Study|Other reasons|1|||
130862016|NCT02737475|471122990|FG025|Overall Study|Other reasons|1|||
130862017|NCT02737475|471122991|FG026|Overall Study|Other reasons|0|||
130862018|NCT02737475|471122965|FG000|Overall Study|Death|1|||
130862019|NCT02737475|471122966|FG001|Overall Study|Death|0|||
130862020|NCT02737475|471122967|FG002|Overall Study|Death|0|||
130862021|NCT02737475|471122968|FG003|Overall Study|Death|1|||
130862022|NCT02737475|471122969|FG004|Overall Study|Death|0|||
130862023|NCT02737475|471122970|FG005|Overall Study|Death|0|||
130862024|NCT02737475|471122971|FG006|Overall Study|Death|0|||
130862025|NCT02737475|471122972|FG007|Overall Study|Death|2|||
130862026|NCT02737475|471122973|FG008|Overall Study|Death|0|||
130862027|NCT02737475|471122974|FG009|Overall Study|Death|0|||
130862028|NCT02737475|471122975|FG010|Overall Study|Death|0|||
130862029|NCT02737475|471122976|FG011|Overall Study|Death|4|||
130862030|NCT02737475|471122977|FG012|Overall Study|Death|2|||
130862031|NCT02737475|471122978|FG013|Overall Study|Death|2|||
130862032|NCT02737475|471122979|FG014|Overall Study|Death|0|||
130862033|NCT02737475|471122980|FG015|Overall Study|Death|2|||
130862034|NCT02737475|471122981|FG016|Overall Study|Death|2|||
130862035|NCT02737475|471122982|FG017|Overall Study|Death|2|||
130862036|NCT02737475|471122983|FG018|Overall Study|Death|1|||
130862037|NCT02737475|471122984|FG019|Overall Study|Death|0|||
130862038|NCT02737475|471122985|FG020|Overall Study|Death|0|||
130862039|NCT02737475|471122986|FG021|Overall Study|Death|0|||
130862040|NCT02737475|471122987|FG022|Overall Study|Death|0|||
130862041|NCT02737475|471122988|FG023|Overall Study|Death|0|||
130862042|NCT02737475|471122989|FG024|Overall Study|Death|0|||
130862043|NCT02737475|471122990|FG025|Overall Study|Death|0|||
130862044|NCT02737475|471122991|FG026|Overall Study|Death|0|||
130862045|NCT02737475|471122965|FG000|Overall Study|Participant withdrew consent|0|||
130862046|NCT02737475|471122966|FG001|Overall Study|Participant withdrew consent|0|||
130862047|NCT02737475|471122967|FG002|Overall Study|Participant withdrew consent|0|||
130862048|NCT02737475|471122968|FG003|Overall Study|Participant withdrew consent|0|||
130862049|NCT02737475|471122969|FG004|Overall Study|Participant withdrew consent|0|||
130862050|NCT02737475|471122970|FG005|Overall Study|Participant withdrew consent|2|||
130862051|NCT02737475|471122971|FG006|Overall Study|Participant withdrew consent|0|||
130862052|NCT02737475|471122972|FG007|Overall Study|Participant withdrew consent|0|||
130862053|NCT02737475|471122973|FG008|Overall Study|Participant withdrew consent|0|||
130862054|NCT02737475|471122974|FG009|Overall Study|Participant withdrew consent|0|||
130862055|NCT02737475|471122975|FG010|Overall Study|Participant withdrew consent|0|||
130862056|NCT02737475|471122976|FG011|Overall Study|Participant withdrew consent|0|||
130862057|NCT02737475|471122977|FG012|Overall Study|Participant withdrew consent|0|||
130862058|NCT02737475|471122978|FG013|Overall Study|Participant withdrew consent|0|||
130862059|NCT02737475|471122979|FG014|Overall Study|Participant withdrew consent|1|||
130862060|NCT02737475|471122980|FG015|Overall Study|Participant withdrew consent|0|||
130862061|NCT02737475|471122981|FG016|Overall Study|Participant withdrew consent|0|||
130862062|NCT02737475|471122982|FG017|Overall Study|Participant withdrew consent|2|||
130862063|NCT02737475|471122983|FG018|Overall Study|Participant withdrew consent|1|||
130862064|NCT02737475|471122984|FG019|Overall Study|Participant withdrew consent|0|||
130862065|NCT02737475|471122985|FG020|Overall Study|Participant withdrew consent|2|||
130862066|NCT02737475|471122986|FG021|Overall Study|Participant withdrew consent|0|||
130862067|NCT02737475|471122987|FG022|Overall Study|Participant withdrew consent|0|||
130862068|NCT02737475|471122988|FG023|Overall Study|Participant withdrew consent|0|||
130862069|NCT02737475|471122989|FG024|Overall Study|Participant withdrew consent|0|||
130862070|NCT02737475|471122990|FG025|Overall Study|Participant withdrew consent|0|||
130862071|NCT02737475|471122991|FG026|Overall Study|Participant withdrew consent|0|||
130862072|NCT02737475|471122965|FG000|Overall Study|Lost to Follow-up|0|||
130862073|NCT02737475|471122966|FG001|Overall Study|Lost to Follow-up|0|||
130862074|NCT02737475|471122967|FG002|Overall Study|Lost to Follow-up|0|||
130862075|NCT02737475|471122968|FG003|Overall Study|Lost to Follow-up|0|||
130862076|NCT02737475|471122969|FG004|Overall Study|Lost to Follow-up|0|||
130862077|NCT02737475|471122970|FG005|Overall Study|Lost to Follow-up|0|||
130862078|NCT02737475|471122971|FG006|Overall Study|Lost to Follow-up|0|||
130862079|NCT02737475|471122972|FG007|Overall Study|Lost to Follow-up|0|||
130862080|NCT02737475|471122973|FG008|Overall Study|Lost to Follow-up|0|||
130862081|NCT02737475|471122974|FG009|Overall Study|Lost to Follow-up|0|||
130862082|NCT02737475|471122975|FG010|Overall Study|Lost to Follow-up|0|||
130862083|NCT02737475|471122976|FG011|Overall Study|Lost to Follow-up|0|||
130862084|NCT02737475|471122977|FG012|Overall Study|Lost to Follow-up|0|||
130862085|NCT02737475|471122978|FG013|Overall Study|Lost to Follow-up|0|||
130862086|NCT02737475|471122979|FG014|Overall Study|Lost to Follow-up|0|||
130862087|NCT02737475|471122980|FG015|Overall Study|Lost to Follow-up|1|||
130862088|NCT02737475|471122981|FG016|Overall Study|Lost to Follow-up|0|||
130862089|NCT02737475|471122982|FG017|Overall Study|Lost to Follow-up|0|||
130862090|NCT02737475|471122983|FG018|Overall Study|Lost to Follow-up|0|||
130862091|NCT02737475|471122984|FG019|Overall Study|Lost to Follow-up|0|||
130862092|NCT02737475|471122985|FG020|Overall Study|Lost to Follow-up|0|||
130862093|NCT02737475|471122986|FG021|Overall Study|Lost to Follow-up|0|||
130862094|NCT02737475|471122987|FG022|Overall Study|Lost to Follow-up|0|||
130862095|NCT02737475|471122988|FG023|Overall Study|Lost to Follow-up|0|||
130862096|NCT02737475|471122989|FG024|Overall Study|Lost to Follow-up|0|||
130862097|NCT02737475|471122990|FG025|Overall Study|Lost to Follow-up|0|||
130862098|NCT02737475|471122991|FG026|Overall Study|Lost to Follow-up|0|||
130862099|NCT02737475|471122965|FG000|Overall Study|Disease Progression|0|||
130862100|NCT02737475|471122966|FG001|Overall Study|Disease Progression|0|||
130862101|NCT02737475|471122967|FG002|Overall Study|Disease Progression|0|||
130862102|NCT02737475|471122968|FG003|Overall Study|Disease Progression|0|||
130862103|NCT02737475|471122969|FG004|Overall Study|Disease Progression|0|||
130862104|NCT02737475|471122970|FG005|Overall Study|Disease Progression|0|||
130862105|NCT02737475|471122971|FG006|Overall Study|Disease Progression|0|||
130862106|NCT02737475|471122972|FG007|Overall Study|Disease Progression|0|||
130862107|NCT02737475|471122973|FG008|Overall Study|Disease Progression|0|||
130862108|NCT02737475|471122974|FG009|Overall Study|Disease Progression|0|||
130862109|NCT02737475|471122975|FG010|Overall Study|Disease Progression|0|||
130862110|NCT02737475|471122976|FG011|Overall Study|Disease Progression|0|||
130862111|NCT02737475|471122977|FG012|Overall Study|Disease Progression|0|||
130862112|NCT02737475|471122978|FG013|Overall Study|Disease Progression|0|||
130862113|NCT02737475|471122979|FG014|Overall Study|Disease Progression|0|||
130862114|NCT02737475|471122980|FG015|Overall Study|Disease Progression|0|||
130862115|NCT02737475|471122981|FG016|Overall Study|Disease Progression|0|||
130862116|NCT02737475|471122982|FG017|Overall Study|Disease Progression|0|||
130862117|NCT02737475|471122983|FG018|Overall Study|Disease Progression|0|||
130862118|NCT02737475|471122984|FG019|Overall Study|Disease Progression|0|||
130862119|NCT02737475|471122985|FG020|Overall Study|Disease Progression|0|||
130862120|NCT02737475|471122986|FG021|Overall Study|Disease Progression|0|||
130862121|NCT02737475|471122987|FG022|Overall Study|Disease Progression|0|||
130862122|NCT02737475|471122988|FG023|Overall Study|Disease Progression|0|||
130862123|NCT02737475|471122989|FG024|Overall Study|Disease Progression|0|||
130862124|NCT02737475|471122990|FG025|Overall Study|Disease Progression|0|||
130862125|NCT02737475|471122991|FG026|Overall Study|Disease Progression|1|||
130862126|NCT03688074|471122992|FG000|Overall Study|Adverse Event|0|||
130862127|NCT03688074|471122993|FG001|Overall Study|Adverse Event|1|||
130862128|NCT03688074|471122992|FG000|Overall Study|Other|1|||
130862129|NCT03688074|471122993|FG001|Overall Study|Other|0|||
130862130|NCT00660179|471122995|FG000|Overall Study|Death|44|||
130862131|NCT00660179|471122996|FG001|Overall Study|Death|47|||
130862132|NCT00660179|471122997|FG002|Overall Study|Death|34|||
130862133|NCT00660179|471122995|FG000|Overall Study|Withdrawal of consent|4|||
130862134|NCT00660179|471122996|FG001|Overall Study|Withdrawal of consent|6|||
130862135|NCT00660179|471122997|FG002|Overall Study|Withdrawal of consent|4|||
130862136|NCT00660179|471122995|FG000|Overall Study|Lost to Follow-up|7|||
130862137|NCT00660179|471122996|FG001|Overall Study|Lost to Follow-up|5|||
130862138|NCT00660179|471122997|FG002|Overall Study|Lost to Follow-up|2|||
130862139|NCT00660179|471122995|FG000|Overall Study|Administrative reason|0|||
130862140|NCT00660179|471122996|FG001|Overall Study|Administrative reason|0|||
130862141|NCT00660179|471122997|FG002|Overall Study|Administrative reason|1|||
130862142|NCT00660179|471122995|FG000|Overall Study|Incorrect randomization|1|||
130862143|NCT00660179|471122996|FG001|Overall Study|Incorrect randomization|0|||
130862144|NCT00660179|471122997|FG002|Overall Study|Incorrect randomization|0|||
130862145|NCT02255461|471122998|FG000|Overall Study|Adverse Event|0|||
130862146|NCT02255461|471122999|FG001|Overall Study|Adverse Event|1|||
130862147|NCT02255461|471123000|FG002|Overall Study|Adverse Event|0|||
130862148|NCT02255461|471123001|FG003|Overall Study|Adverse Event|0|||
130862149|NCT02255461|471123002|FG004|Overall Study|Adverse Event|1|||
130862150|NCT02255461|471122998|FG000|Overall Study|Withdrawal by Subject|0|||
130862151|NCT02255461|471122999|FG001|Overall Study|Withdrawal by Subject|0|||
130862152|NCT02255461|471123000|FG002|Overall Study|Withdrawal by Subject|1|||
130862153|NCT02255461|471123001|FG003|Overall Study|Withdrawal by Subject|0|||
130862154|NCT02255461|471123002|FG004|Overall Study|Withdrawal by Subject|1|||
130862155|NCT02255461|471122998|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
130862156|NCT02255461|471122999|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
130862157|NCT02255461|471123000|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
130862158|NCT02255461|471123001|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
130862159|NCT02255461|471123002|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
130862160|NCT03056339|471123007|FG000|Overall Study|Failed Requirements|0|||
130862161|NCT03056339|471123008|FG001|Overall Study|Failed Requirements|2|||
130862162|NCT03056339|471123009|FG002|Overall Study|Failed Requirements|7|||
130862163|NCT03056339|471123010|FG003|Overall Study|Failed Requirements|1|||
130862164|NCT04809285|471123017|FG000|Phase 1|Lost to Follow-up|6|||
130862165|NCT04809285|471123017|FG000|Phase 1|Protocol Violation|2|||
130862166|NCT04809285|471123017|FG000|Phase 1|Physician Decision|3|||
130862167|NCT04809285|471123017|FG000|Phase 1|Withdrawal by Subject|29|||
130862168|NCT04809285|471123017|FG000|Phase 2|Protocol Violation|3|||
130862169|NCT04809285|471123017|FG000|Phase 2|Withdrawal by Subject|4|||
130862170|NCT02630472|471123019|FG000|Overall Study|Physician Decision|10|||
130862171|NCT02630472|471123020|FG001|Overall Study|Physician Decision|0|||
130862172|NCT04878211|471123023|FG000|Overall Study|Lost to Follow-up|0|||
130862173|NCT04878211|471123024|FG001|Overall Study|Lost to Follow-up|0|||
130862174|NCT04878211|471123025|FG002|Overall Study|Lost to Follow-up|0|||
130862175|NCT04878211|471123026|FG003|Overall Study|Lost to Follow-up|1|||
130862176|NCT04878211|471123027|FG004|Overall Study|Lost to Follow-up|0|||
130862177|NCT04878211|471123028|FG005|Overall Study|Lost to Follow-up|1|||
130862178|NCT04878211|471123023|FG000|Overall Study|Protocol deviation|1|||
130862179|NCT04878211|471123024|FG001|Overall Study|Protocol deviation|0|||
130862180|NCT04878211|471123025|FG002|Overall Study|Protocol deviation|0|||
130862181|NCT04878211|471123026|FG003|Overall Study|Protocol deviation|0|||
130862182|NCT04878211|471123027|FG004|Overall Study|Protocol deviation|0|||
130862183|NCT04878211|471123028|FG005|Overall Study|Protocol deviation|0|||
130862184|NCT04878211|471123023|FG000|Overall Study|Study terminated by sponsor|0|||
130862185|NCT04878211|471123024|FG001|Overall Study|Study terminated by sponsor|0|||
130862186|NCT04878211|471123025|FG002|Overall Study|Study terminated by sponsor|0|||
130862187|NCT04878211|471123026|FG003|Overall Study|Study terminated by sponsor|0|||
130862188|NCT04878211|471123027|FG004|Overall Study|Study terminated by sponsor|9|||
130862189|NCT04878211|471123028|FG005|Overall Study|Study terminated by sponsor|4|||
130862190|NCT04878211|471123023|FG000|Overall Study|Subject decision|0|||
130862191|NCT04878211|471123024|FG001|Overall Study|Subject decision|0|||
130862192|NCT04878211|471123025|FG002|Overall Study|Subject decision|0|||
130862193|NCT04878211|471123026|FG003|Overall Study|Subject decision|0|||
130862194|NCT04878211|471123027|FG004|Overall Study|Subject decision|1|||
130862195|NCT04878211|471123028|FG005|Overall Study|Subject decision|0|||
130862196|NCT04774926|471123029|FG000|Overall Study|Adverse Event|15|||
130862197|NCT04774926|471123029|FG000|Overall Study|Lost to Follow-up|3|||
130862198|NCT04774926|471123029|FG000|Overall Study|Physician Decision|6|||
130862199|NCT04774926|471123029|FG000|Overall Study|Withdrawal by Subject|3|||
130862200|NCT04774926|471123029|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
130862201|NCT02783599|471123030|FG000|Overall Study|Progressive disease|23|||
130862202|NCT02783599|471123030|FG000|Overall Study|Surgical Resection|10|||
130862203|NCT02783599|471123030|FG000|Overall Study|Adverse Event|4|||
130862204|NCT02783599|471123030|FG000|Overall Study|Physician Decision|2|||
130862205|NCT02783599|471123030|FG000|Overall Study|Death|1|||
130862206|NCT03040674|471123034|FG000|Overall Study|Lost to Follow-up|225|||
130862207|NCT03040674|471123034|FG000|Overall Study|Death|23|||
130862208|NCT02206035|471123035|FG000|Overall Study|Physician Decision|10|||
130862209|NCT02206035|471123036|FG001|Overall Study|Physician Decision|0|||
130862210|NCT02206035|471123037|FG002|Overall Study|Physician Decision|175|||
130862211|NCT01934010|471123038|FG000|Overall Study|Adverse Event|1|||
130862212|NCT01934010|471123039|FG001|Overall Study|Adverse Event|1|||
130862213|NCT01934010|471123040|FG002|Overall Study|Adverse Event|0|||
130862214|NCT01934010|471123038|FG000|Overall Study|Withdrawal by Subject|15|||
130862215|NCT01934010|471123039|FG001|Overall Study|Withdrawal by Subject|6|||
130862216|NCT01934010|471123040|FG002|Overall Study|Withdrawal by Subject|2|||
130862217|NCT01934010|471123038|FG000|Overall Study|Lost to Follow-up|7|||
130862218|NCT01934010|471123039|FG001|Overall Study|Lost to Follow-up|4|||
130862219|NCT01934010|471123040|FG002|Overall Study|Lost to Follow-up|0|||
130862220|NCT05173012|471123041|FG000|Overall Study|Adverse Event|2|||
130862221|NCT05173012|471123042|FG001|Overall Study|Adverse Event|3|||
130862222|NCT05173012|471123043|FG002|Overall Study|Adverse Event|4|||
130862223|NCT05173012|471123044|FG003|Overall Study|Adverse Event|13|||
130862224|NCT05173012|471123045|FG004|Overall Study|Adverse Event|0|||
130862225|NCT05173012|471123046|FG005|Overall Study|Adverse Event|0|||
130862226|NCT05173012|471123047|FG006|Overall Study|Adverse Event|2|||
130862227|NCT05173012|471123048|FG007|Overall Study|Adverse Event|4|||
130862228|NCT05173012|471123041|FG000|Overall Study|Lost to Follow-up|0|||
130862229|NCT05173012|471123042|FG001|Overall Study|Lost to Follow-up|0|||
130862230|NCT05173012|471123043|FG002|Overall Study|Lost to Follow-up|0|||
130862231|NCT05173012|471123044|FG003|Overall Study|Lost to Follow-up|1|||
130862232|NCT05173012|471123045|FG004|Overall Study|Lost to Follow-up|0|||
130862233|NCT05173012|471123046|FG005|Overall Study|Lost to Follow-up|0|||
130862234|NCT05173012|471123047|FG006|Overall Study|Lost to Follow-up|0|||
130862235|NCT05173012|471123048|FG007|Overall Study|Lost to Follow-up|0|||
130862236|NCT05173012|471123041|FG000|Overall Study|Withdrawal by Subject|1|||
130862237|NCT05173012|471123042|FG001|Overall Study|Withdrawal by Subject|0|||
130862238|NCT05173012|471123043|FG002|Overall Study|Withdrawal by Subject|1|||
130862239|NCT05173012|471123044|FG003|Overall Study|Withdrawal by Subject|3|||
130862240|NCT05173012|471123045|FG004|Overall Study|Withdrawal by Subject|1|||
130862241|NCT05173012|471123046|FG005|Overall Study|Withdrawal by Subject|0|||
130862242|NCT05173012|471123047|FG006|Overall Study|Withdrawal by Subject|1|||
130862243|NCT05173012|471123048|FG007|Overall Study|Withdrawal by Subject|0|||
130862244|NCT05173012|471123041|FG000|Overall Study|Protocol Deviation|0|||
130862245|NCT05173012|471123042|FG001|Overall Study|Protocol Deviation|0|||
130862246|NCT05173012|471123043|FG002|Overall Study|Protocol Deviation|0|||
130862247|NCT05173012|471123044|FG003|Overall Study|Protocol Deviation|1|||
130862248|NCT05173012|471123045|FG004|Overall Study|Protocol Deviation|0|||
130862249|NCT05173012|471123046|FG005|Overall Study|Protocol Deviation|0|||
130862250|NCT05173012|471123047|FG006|Overall Study|Protocol Deviation|0|||
130862251|NCT05173012|471123048|FG007|Overall Study|Protocol Deviation|0|||
130862252|NCT05173012|471123041|FG000|Overall Study|Other|0|||
130862253|NCT05173012|471123042|FG001|Overall Study|Other|0|||
130862254|NCT05173012|471123043|FG002|Overall Study|Other|0|||
130862255|NCT05173012|471123044|FG003|Overall Study|Other|2|||
130862256|NCT05173012|471123045|FG004|Overall Study|Other|0|||
130862257|NCT05173012|471123046|FG005|Overall Study|Other|0|||
130862258|NCT05173012|471123047|FG006|Overall Study|Other|0|||
130862259|NCT05173012|471123048|FG007|Overall Study|Other|0|||
130862260|NCT02936843|471123049|FG000|Overall Study|Lost to Follow-up|3|||
130862261|NCT02936843|471123050|FG001|Overall Study|Lost to Follow-up|1|||
130862262|NCT02936843|471123049|FG000|Overall Study|Withdrawal by Subject|1|||
130862263|NCT02936843|471123050|FG001|Overall Study|Withdrawal by Subject|1|||
130862264|NCT03668613|471123051|FG000|Overall Study|Adverse Event|1|||
130862265|NCT03668613|471123052|FG001|Overall Study|Adverse Event|2|||
130862266|NCT03668613|471123051|FG000|Overall Study|Lack of Efficacy|5|||
130862267|NCT03668613|471123052|FG001|Overall Study|Lack of Efficacy|1|||
130862268|NCT03668613|471123051|FG000|Overall Study|Pregnancy|0|||
130862269|NCT03668613|471123052|FG001|Overall Study|Pregnancy|2|||
130862270|NCT03668613|471123051|FG000|Overall Study|Protocol Violation|1|||
130862271|NCT03668613|471123052|FG001|Overall Study|Protocol Violation|0|||
130862272|NCT03668613|471123051|FG000|Overall Study|Physician Decision|1|||
130862273|NCT03668613|471123052|FG001|Overall Study|Physician Decision|0|||
130862274|NCT03668613|471123051|FG000|Overall Study|Withdrawal by Subject|2|||
130862275|NCT03668613|471123052|FG001|Overall Study|Withdrawal by Subject|1|||
130862276|NCT03668613|471123051|FG000|Overall Study|Guardian decision|1|||
130862277|NCT03668613|471123052|FG001|Overall Study|Guardian decision|0|||
130862278|NCT01393821|471123053|FG000|Overall Study|Cancel|1|||
130862279|NCT01393821|471123054|FG001|Overall Study|Cancel|1|||
130862280|NCT01393821|471123053|FG000|Overall Study|not evaluable for primary endpoint|4|||
130862281|NCT01393821|471123054|FG001|Overall Study|not evaluable for primary endpoint|2|||
130862282|NCT03386487|471123055|FG000|Overall Study|Lost to Follow-up|5|||
130862283|NCT03386487|471123056|FG001|Overall Study|Lost to Follow-up|6|||
130862284|NCT03386487|471123055|FG000|Overall Study|Withdrawal by Subject|11|||
130862285|NCT03386487|471123056|FG001|Overall Study|Withdrawal by Subject|7|||
130862286|NCT03386487|471123055|FG000|Overall Study|Physician Decision|11|||
130862287|NCT03386487|471123056|FG001|Overall Study|Physician Decision|8|||
130862288|NCT02703324|471123057|FG000|Period Two|Withdrawal by Subject|0|||
130862289|NCT02703324|471123058|FG001|Period Two|Withdrawal by Subject|0|||
130862290|NCT02703324|471123059|FG002|Period Two|Withdrawal by Subject|1|||
130862291|NCT02703324|471123060|FG003|Period Two|Withdrawal by Subject|0|||
130862292|NCT02703324|471123061|FG004|Period Two|Withdrawal by Subject|0|||
130862293|NCT02703324|471123062|FG005|Period Two|Withdrawal by Subject|0|||
130862294|NCT06312592|471123063|FG000|Overall Study|Lost to Follow-up|29|||
130862295|NCT06312592|471123064|FG001|Overall Study|Lost to Follow-up|13|||
130862296|NCT01948063|471123067|FG000|Overall Study|Boston MCI halted research protocol|0|||
130862297|NCT01948063|471123068|FG001|Overall Study|Boston MCI halted research protocol|1|||
130862298|NCT01948063|471123067|FG000|Overall Study|Discovered an enrollment in other study|0|||
130862299|NCT01948063|471123068|FG001|Overall Study|Discovered an enrollment in other study|1|||
130862300|NCT01948063|471123067|FG000|Overall Study|Blood samples were accidentally thawed|1|||
130862301|NCT01948063|471123068|FG001|Overall Study|Blood samples were accidentally thawed|0|||
130862302|NCT01858766|471123069|FG000|Overall Study|Randomized but Never Treated|0|||
130862303|NCT01858766|471123070|FG001|Overall Study|Randomized but Never Treated|0|||
130862304|NCT01858766|471123071|FG002|Overall Study|Randomized but Never Treated|0|||
130862305|NCT01858766|471123072|FG003|Overall Study|Randomized but Never Treated|0|||
130862306|NCT01858766|471123073|FG004|Overall Study|Randomized but Never Treated|0|||
130862307|NCT01858766|471123074|FG005|Overall Study|Randomized but Never Treated|1|||
130862308|NCT01858766|471123075|FG006|Overall Study|Randomized but Never Treated|0|||
130862309|NCT01858766|471123076|FG007|Overall Study|Randomized but Never Treated|0|||
130862310|NCT01858766|471123077|FG008|Overall Study|Randomized but Never Treated|0|||
130862311|NCT01858766|471123078|FG009|Overall Study|Randomized but Never Treated|0|||
130862312|NCT01858766|471123079|FG010|Overall Study|Randomized but Never Treated|0|||
130862313|NCT01858766|471123080|FG011|Overall Study|Randomized but Never Treated|0|||
130862314|NCT01858766|471123081|FG012|Overall Study|Randomized but Never Treated|0|||
130862315|NCT01858766|471123082|FG013|Overall Study|Randomized but Never Treated|0|||
130862316|NCT01858766|471123083|FG014|Overall Study|Randomized but Never Treated|0|||
130862317|NCT01858766|471123084|FG015|Overall Study|Randomized but Never Treated|0|||
130862318|NCT01858766|471123085|FG016|Overall Study|Randomized but Never Treated|0|||
130862319|NCT01858766|471123086|FG017|Overall Study|Randomized but Never Treated|1|||
130862320|NCT01858766|471123087|FG018|Overall Study|Randomized but Never Treated|0|||
130862321|NCT01858766|471123069|FG000|Overall Study|Death|0|||
130862322|NCT01858766|471123070|FG001|Overall Study|Death|0|||
130862323|NCT01858766|471123071|FG002|Overall Study|Death|1|||
130862324|NCT01858766|471123072|FG003|Overall Study|Death|0|||
130862325|NCT01858766|471123073|FG004|Overall Study|Death|0|||
130862326|NCT01858766|471123074|FG005|Overall Study|Death|0|||
130862327|NCT01858766|471123075|FG006|Overall Study|Death|0|||
130862328|NCT01858766|471123076|FG007|Overall Study|Death|0|||
130862329|NCT01858766|471123077|FG008|Overall Study|Death|0|||
130862330|NCT01858766|471123078|FG009|Overall Study|Death|0|||
130862331|NCT01858766|471123079|FG010|Overall Study|Death|0|||
130862332|NCT01858766|471123080|FG011|Overall Study|Death|0|||
130862333|NCT01858766|471123081|FG012|Overall Study|Death|0|||
130862334|NCT01858766|471123082|FG013|Overall Study|Death|0|||
130862335|NCT01858766|471123083|FG014|Overall Study|Death|0|||
130862336|NCT01858766|471123084|FG015|Overall Study|Death|0|||
130862337|NCT01858766|471123085|FG016|Overall Study|Death|0|||
130862338|NCT01858766|471123086|FG017|Overall Study|Death|0|||
130862339|NCT01858766|471123087|FG018|Overall Study|Death|0|||
130862340|NCT01858766|471123069|FG000|Overall Study|Lack of Efficacy|1|||
130862341|NCT01858766|471123070|FG001|Overall Study|Lack of Efficacy|0|||
130862342|NCT01858766|471123071|FG002|Overall Study|Lack of Efficacy|0|||
130862343|NCT01858766|471123072|FG003|Overall Study|Lack of Efficacy|0|||
130862344|NCT01858766|471123073|FG004|Overall Study|Lack of Efficacy|1|||
130862345|NCT01858766|471123074|FG005|Overall Study|Lack of Efficacy|2|||
130862346|NCT01858766|471123075|FG006|Overall Study|Lack of Efficacy|0|||
130862347|NCT01858766|471123076|FG007|Overall Study|Lack of Efficacy|0|||
130862348|NCT01858766|471123077|FG008|Overall Study|Lack of Efficacy|0|||
130862349|NCT01858766|471123078|FG009|Overall Study|Lack of Efficacy|0|||
130862350|NCT01858766|471123079|FG010|Overall Study|Lack of Efficacy|0|||
130862351|NCT01858766|471123080|FG011|Overall Study|Lack of Efficacy|3|||
130862352|NCT01858766|471123081|FG012|Overall Study|Lack of Efficacy|5|||
130862353|NCT01858766|471123082|FG013|Overall Study|Lack of Efficacy|3|||
130862354|NCT01858766|471123083|FG014|Overall Study|Lack of Efficacy|5|||
130862355|NCT01858766|471123084|FG015|Overall Study|Lack of Efficacy|5|||
130862356|NCT01858766|471123085|FG016|Overall Study|Lack of Efficacy|2|||
130862357|NCT01858766|471123086|FG017|Overall Study|Lack of Efficacy|3|||
130862358|NCT01858766|471123087|FG018|Overall Study|Lack of Efficacy|3|||
130862359|NCT01858766|471123069|FG000|Overall Study|Lost to Follow-up|0|||
130862360|NCT01858766|471123070|FG001|Overall Study|Lost to Follow-up|0|||
130862361|NCT01858766|471123071|FG002|Overall Study|Lost to Follow-up|0|||
130862362|NCT01858766|471123072|FG003|Overall Study|Lost to Follow-up|0|||
130862363|NCT01858766|471123073|FG004|Overall Study|Lost to Follow-up|0|||
130862364|NCT01858766|471123074|FG005|Overall Study|Lost to Follow-up|1|||
130862365|NCT01858766|471123075|FG006|Overall Study|Lost to Follow-up|0|||
130862366|NCT01858766|471123076|FG007|Overall Study|Lost to Follow-up|2|||
130862367|NCT01858766|471123077|FG008|Overall Study|Lost to Follow-up|0|||
130862368|NCT01858766|471123078|FG009|Overall Study|Lost to Follow-up|0|||
130862369|NCT01858766|471123079|FG010|Overall Study|Lost to Follow-up|0|||
130862370|NCT01858766|471123080|FG011|Overall Study|Lost to Follow-up|1|||
130862371|NCT01858766|471123081|FG012|Overall Study|Lost to Follow-up|0|||
130862372|NCT01858766|471123082|FG013|Overall Study|Lost to Follow-up|0|||
130862373|NCT01858766|471123083|FG014|Overall Study|Lost to Follow-up|3|||
130862374|NCT01858766|471123084|FG015|Overall Study|Lost to Follow-up|1|||
130862375|NCT01858766|471123085|FG016|Overall Study|Lost to Follow-up|1|||
130862376|NCT01858766|471123086|FG017|Overall Study|Lost to Follow-up|0|||
130862377|NCT01858766|471123087|FG018|Overall Study|Lost to Follow-up|1|||
130862378|NCT01858766|471123069|FG000|Overall Study|Withdrew Consent|0|||
130862379|NCT01858766|471123070|FG001|Overall Study|Withdrew Consent|0|||
130862380|NCT01858766|471123071|FG002|Overall Study|Withdrew Consent|0|||
130862381|NCT01858766|471123072|FG003|Overall Study|Withdrew Consent|0|||
130862382|NCT01858766|471123073|FG004|Overall Study|Withdrew Consent|0|||
130862383|NCT01858766|471123074|FG005|Overall Study|Withdrew Consent|0|||
130862384|NCT01858766|471123075|FG006|Overall Study|Withdrew Consent|0|||
130862385|NCT01858766|471123076|FG007|Overall Study|Withdrew Consent|0|||
130862386|NCT01858766|471123077|FG008|Overall Study|Withdrew Consent|0|||
130862387|NCT01858766|471123078|FG009|Overall Study|Withdrew Consent|0|||
130862388|NCT01858766|471123079|FG010|Overall Study|Withdrew Consent|0|||
130862389|NCT01858766|471123080|FG011|Overall Study|Withdrew Consent|1|||
130862390|NCT01858766|471123081|FG012|Overall Study|Withdrew Consent|0|||
130862391|NCT01858766|471123082|FG013|Overall Study|Withdrew Consent|0|||
130862392|NCT01858766|471123083|FG014|Overall Study|Withdrew Consent|0|||
130862393|NCT01858766|471123084|FG015|Overall Study|Withdrew Consent|0|||
130862394|NCT01858766|471123085|FG016|Overall Study|Withdrew Consent|0|||
130862395|NCT01858766|471123086|FG017|Overall Study|Withdrew Consent|0|||
130862396|NCT01858766|471123087|FG018|Overall Study|Withdrew Consent|0|||
130862397|NCT03517228|471123090|FG000|Overall Study|Withdrawal by Subject|2|||
130862398|NCT03517228|471123090|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
130862399|NCT03517228|471123090|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
130862400|NCT03517228|471123090|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
130862401|NCT03517228|471123090|FG000|Overall Study|Canceled due to device being updated|1|||
130862402|NCT03517228|471123090|FG000|Overall Study|No V Cares in stock|1|||
130862403|NCT03517228|471123090|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
130862404|NCT03781414|471123101|FG000|Overall Study|Study terminated by sponsor|39|||
130862405|NCT03781414|471123102|FG001|Overall Study|Study terminated by sponsor|34|||
130862406|NCT03781414|471123103|FG002|Overall Study|Study terminated by sponsor|25|||
130862407|NCT03781414|471123101|FG000|Overall Study|Adverse Event|3|||
130862408|NCT03781414|471123102|FG001|Overall Study|Adverse Event|6|||
130862409|NCT03781414|471123103|FG002|Overall Study|Adverse Event|3|||
130862410|NCT03781414|471123101|FG000|Overall Study|Physician Decision|2|||
130862411|NCT03781414|471123102|FG001|Overall Study|Physician Decision|0|||
130862412|NCT03781414|471123103|FG002|Overall Study|Physician Decision|1|||
130862413|NCT03781414|471123101|FG000|Overall Study|Withdrawal by Subject|2|||
130862414|NCT03781414|471123102|FG001|Overall Study|Withdrawal by Subject|3|||
130862415|NCT03781414|471123103|FG002|Overall Study|Withdrawal by Subject|3|||
130862416|NCT03781414|471123101|FG000|Overall Study|Death|1|||
130862417|NCT03781414|471123102|FG001|Overall Study|Death|4|||
130862418|NCT03781414|471123103|FG002|Overall Study|Death|0|||
130862419|NCT03781414|471123101|FG000|Overall Study|Lost to Follow-up|1|||
130862420|NCT03781414|471123102|FG001|Overall Study|Lost to Follow-up|1|||
130862421|NCT03781414|471123103|FG002|Overall Study|Lost to Follow-up|0|||
130862422|NCT04752358|471123107|FG000|Overall Study|Death|2|||
130862423|NCT04752358|471123108|FG001|Overall Study|Death|1|||
130862424|NCT00719355|471123111|FG000|Overall Study|Death|0|||
130862425|NCT00719355|471123112|FG001|Overall Study|Death|1|||
130862426|NCT00719355|471123111|FG000|Overall Study|Medical|14|||
130862427|NCT00719355|471123112|FG001|Overall Study|Medical|5|||
130862428|NCT00719355|471123111|FG000|Overall Study|Compliance|4|||
130862429|NCT00719355|471123112|FG001|Overall Study|Compliance|6|||
130862430|NCT00719355|471123111|FG000|Overall Study|Moved|0|||
130862431|NCT00719355|471123112|FG001|Overall Study|Moved|1|||
130862432|NCT01835158|471123113|FG000|Overall Study|Withdrawal by Subject|1|||
130862433|NCT01835158|471123114|FG001|Overall Study|Withdrawal by Subject|6|||
130862434|NCT03364738|471123116|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
130862435|NCT03364738|471123116|FG000|Overall Study|Withdrawal by Subject|1|||
130862436|NCT03364738|471123116|FG000|Overall Study|Adverse Event|1|||
130862437|NCT03245398|471123120|FG000|Overall Study|Travelled to another island|1|||
130862438|NCT03245398|471123121|FG001|Overall Study|Travelled to another island|0|||
130862439|NCT03422536|471123128|FG000|Randomized|Physician Decision|1|||
130862440|NCT03422536|471123129|FG001|Randomized|Physician Decision|1|||
130862441|NCT03422536|471123128|FG000|Allocation - Received Intervention|Disease progression|19|||
130862442|NCT03422536|471123129|FG001|Allocation - Received Intervention|Disease progression|25|||
130862443|NCT03422536|471123128|FG000|Allocation - Received Intervention|Death|1|||
130862444|NCT03422536|471123129|FG001|Allocation - Received Intervention|Death|3|||
130862445|NCT03422536|471123128|FG000|Allocation - Received Intervention|Adverse Event|1|||
130862446|NCT03422536|471123129|FG001|Allocation - Received Intervention|Adverse Event|0|||
130862447|NCT03422536|471123128|FG000|Allocation - Received Intervention|Physician Decision|1|||
130862448|NCT03422536|471123129|FG001|Allocation - Received Intervention|Physician Decision|1|||
130862449|NCT03422536|471123128|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
130862450|NCT03422536|471123129|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
130862451|NCT03422536|471123128|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
130862452|NCT03422536|471123129|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
130862453|NCT04531241|471123130|FG000|Period 1|Withdrawal by Subject|2|||
130862454|NCT04531241|471123131|FG001|Period 1|Withdrawal by Subject|0|||
130862455|NCT04531241|471123130|FG000|Period 1|Dispesed incorrect lens power|1|||
130862456|NCT04531241|471123131|FG001|Period 1|Dispesed incorrect lens power|0|||
130862457|NCT04531241|471123130|FG000|Period 1|Protocol Violation|1|||
130862458|NCT04531241|471123131|FG001|Period 1|Protocol Violation|0|||
130862459|NCT04531241|471123130|FG000|Period 1|No longer eligible|0|||
130862460|NCT04531241|471123131|FG001|Period 1|No longer eligible|1|||
130862461|NCT04531241|471123130|FG000|Period 1|Lens Discomfort|0|||
130862462|NCT04531241|471123131|FG001|Period 1|Lens Discomfort|1|||
130862463|NCT04531241|471123130|FG000|Period 2|Covid-19 Related|1|||
130862464|NCT04531241|471123131|FG001|Period 2|Covid-19 Related|1|||
130862465|NCT02023996|471123132|FG000|Overall Study|Protocol Violation|6|||
130862466|NCT04929249|471123133|FG000|Overall Study|Adverse Event|2|||
130862467|NCT04929249|471123134|FG001|Overall Study|Adverse Event|1|||
130862468|NCT04929249|471123133|FG000|Overall Study|Death|2|||
130862469|NCT04929249|471123134|FG001|Overall Study|Death|1|||
130862470|NCT04929249|471123133|FG000|Overall Study|Lost to Follow-up|3|||
130862471|NCT04929249|471123134|FG001|Overall Study|Lost to Follow-up|11|||
130862472|NCT04929249|471123133|FG000|Overall Study|Technical problems|0|||
130862473|NCT04929249|471123134|FG001|Overall Study|Technical problems|1|||
130862474|NCT04929249|471123133|FG000|Overall Study|Subject decision|6|||
130862475|NCT04929249|471123134|FG001|Overall Study|Subject decision|8|||
130862476|NCT04929249|471123133|FG000|Overall Study|Withdrew consent|0|||
130862477|NCT04929249|471123134|FG001|Overall Study|Withdrew consent|8|||
130862478|NCT01088399|471123135|FG000|Overall Study|Adverse Event|211|||
130862479|NCT01088399|471123136|FG001|Overall Study|Adverse Event|16|||
130862480|NCT01088399|471123137|FG002|Overall Study|Adverse Event|0|||
130862481|NCT01088399|471123135|FG000|Overall Study|Death|204|||
130862482|NCT01088399|471123136|FG001|Overall Study|Death|45|||
130862483|NCT01088399|471123137|FG002|Overall Study|Death|0|||
130862484|NCT01088399|471123135|FG000|Overall Study|Lack of Efficacy|298|||
130862485|NCT01088399|471123136|FG001|Overall Study|Lack of Efficacy|7|||
130862486|NCT01088399|471123137|FG002|Overall Study|Lack of Efficacy|5|||
130862487|NCT01088399|471123135|FG000|Overall Study|Lost to Follow-up|1070|||
130862488|NCT01088399|471123136|FG001|Overall Study|Lost to Follow-up|278|||
130862489|NCT01088399|471123137|FG002|Overall Study|Lost to Follow-up|58|||
130862490|NCT01088399|471123135|FG000|Overall Study|Physician Decision|531|||
130862491|NCT01088399|471123136|FG001|Overall Study|Physician Decision|88|||
130862492|NCT01088399|471123137|FG002|Overall Study|Physician Decision|16|||
130862493|NCT01088399|471123135|FG000|Overall Study|Withdrawal by Subject|544|||
130862494|NCT01088399|471123136|FG001|Overall Study|Withdrawal by Subject|195|||
130862495|NCT01088399|471123137|FG002|Overall Study|Withdrawal by Subject|33|||
130862496|NCT01088399|471123135|FG000|Overall Study|Change to or start of somatropin therapy|234|||
130862497|NCT01088399|471123136|FG001|Overall Study|Change to or start of somatropin therapy|17|||
130862498|NCT01088399|471123137|FG002|Overall Study|Change to or start of somatropin therapy|12|||
130862499|NCT01088399|471123135|FG000|Overall Study|Sponsor decision|1573|||
130862500|NCT01088399|471123136|FG001|Overall Study|Sponsor decision|298|||
130862501|NCT01088399|471123137|FG002|Overall Study|Sponsor decision|7|||
130862502|NCT01088399|471123135|FG000|Overall Study|Protocol Violation|10|||
130862503|NCT01088399|471123136|FG001|Overall Study|Protocol Violation|1|||
130862504|NCT01088399|471123137|FG002|Overall Study|Protocol Violation|0|||
130862505|NCT01088399|471123135|FG000|Overall Study|Enrollment criteria not met|48|||
130862506|NCT01088399|471123136|FG001|Overall Study|Enrollment criteria not met|119|||
130862507|NCT01088399|471123137|FG002|Overall Study|Enrollment criteria not met|70|||
130862508|NCT01088399|471123135|FG000|Overall Study|Study summary visit not completed|2398|||
130862509|NCT01088399|471123136|FG001|Overall Study|Study summary visit not completed|283|||
130862510|NCT01088399|471123137|FG002|Overall Study|Study summary visit not completed|80|||
130862511|NCT00782483|471123138|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
130862512|NCT03343626|471125093|FG000|Overall Study|Lost to Follow-up|4|||
130862513|NCT03343626|471125094|FG001|Overall Study|Lost to Follow-up|3|||
130862514|NCT03343626|471125095|FG002|Overall Study|Lost to Follow-up|2|||
130862515|NCT03343626|471125096|FG003|Overall Study|Lost to Follow-up|5|||
130862516|NCT03343626|471125097|FG004|Overall Study|Lost to Follow-up|4|||
130862517|NCT03343626|471125098|FG005|Overall Study|Lost to Follow-up|4|||
130862518|NCT03343626|471125099|FG006|Overall Study|Lost to Follow-up|4|||
130862519|NCT03343626|471125100|FG007|Overall Study|Lost to Follow-up|7|||
130862520|NCT03343626|471125093|FG000|Overall Study|Withdrawal of Consent|2|||
130862521|NCT03343626|471125094|FG001|Overall Study|Withdrawal of Consent|1|||
130862522|NCT03343626|471125095|FG002|Overall Study|Withdrawal of Consent|0|||
130862523|NCT03343626|471125096|FG003|Overall Study|Withdrawal of Consent|3|||
130862524|NCT03343626|471125097|FG004|Overall Study|Withdrawal of Consent|3|||
130862525|NCT03343626|471125098|FG005|Overall Study|Withdrawal of Consent|1|||
130862526|NCT03343626|471125099|FG006|Overall Study|Withdrawal of Consent|1|||
130862527|NCT03343626|471125100|FG007|Overall Study|Withdrawal of Consent|2|||
130862528|NCT03343626|471125093|FG000|Overall Study|Reason not Specified|0|||
130862529|NCT03343626|471125094|FG001|Overall Study|Reason not Specified|1|||
130862530|NCT03343626|471125095|FG002|Overall Study|Reason not Specified|0|||
130862531|NCT03343626|471125096|FG003|Overall Study|Reason not Specified|0|||
130862532|NCT03343626|471125097|FG004|Overall Study|Reason not Specified|0|||
130862533|NCT03343626|471125098|FG005|Overall Study|Reason not Specified|0|||
130862534|NCT03343626|471125099|FG006|Overall Study|Reason not Specified|0|||
130862535|NCT03343626|471125100|FG007|Overall Study|Reason not Specified|1|||
130862536|NCT03343626|471125093|FG000|Overall Study|Data Entry Error|0|||
130862537|NCT03343626|471125094|FG001|Overall Study|Data Entry Error|0|||
130862538|NCT03343626|471125095|FG002|Overall Study|Data Entry Error|0|||
130862539|NCT03343626|471125096|FG003|Overall Study|Data Entry Error|0|||
130862540|NCT03343626|471125097|FG004|Overall Study|Data Entry Error|0|||
130862541|NCT03343626|471125098|FG005|Overall Study|Data Entry Error|0|||
130862542|NCT03343626|471125099|FG006|Overall Study|Data Entry Error|0|||
130862543|NCT03343626|471125100|FG007|Overall Study|Data Entry Error|1|||
130862544|NCT02475278|471125103|FG000|Overall Study|Lost to Follow-up|1|||
130862545|NCT02475278|471125103|FG000|Overall Study|Reason Not Specified|1|||
130862546|NCT01865448|471125104|FG000|Overall Study|Adverse Event|1|||
130862547|NCT01865448|471125105|FG001|Overall Study|Adverse Event|1|||
130862548|NCT01865448|471125104|FG000|Overall Study|Pregnancy|0|||
130862549|NCT01865448|471125105|FG001|Overall Study|Pregnancy|1|||
130862550|NCT01865448|471125104|FG000|Overall Study|dropout unrelated to study|1|||
130862551|NCT01865448|471125105|FG001|Overall Study|dropout unrelated to study|1|||
130862552|NCT05111249|471125109|FG000|Overall Study|Lost to Follow-up|0|||
130862553|NCT05111249|471125110|FG001|Overall Study|Lost to Follow-up|2|||
130862554|NCT05111249|471125109|FG000|Overall Study|Physician Decision|0|||
130862555|NCT05111249|471125110|FG001|Overall Study|Physician Decision|1|||
130862556|NCT05111249|471125109|FG000|Overall Study|Participant decision|1|||
130862557|NCT05111249|471125110|FG001|Overall Study|Participant decision|5|||
130862558|NCT02451917|471125113|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
130862559|NCT02451917|471125114|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
130862560|NCT02451917|471125113|FG000|First Intervention (24 Weeks)|Death|0|||
130862561|NCT02451917|471125114|FG001|First Intervention (24 Weeks)|Death|1|||
130862562|NCT02451917|471125113|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
130862563|NCT02451917|471125114|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
130862564|NCT04737278|471125117|FG000|Overall Study|Lost to Follow-up|1|||
130862565|NCT04737278|471125118|FG001|Overall Study|Lost to Follow-up|1|||
130862566|NCT04737278|471125117|FG000|Overall Study|Withdrawal by Subject|1|||
130862567|NCT04737278|471125118|FG001|Overall Study|Withdrawal by Subject|0|||
130862568|NCT04737278|471125117|FG000|Overall Study|Protocol Violation|1|||
130862569|NCT04737278|471125118|FG001|Overall Study|Protocol Violation|1|||
130862570|NCT04737278|471125117|FG000|Overall Study|failure to complete questionnaire|1|||
130862571|NCT04737278|471125118|FG001|Overall Study|failure to complete questionnaire|1|||
130862572|NCT00546000|471125119|FG000|Overall Study|Adverse Event|1|||
130862573|NCT00546000|471125119|FG000|Overall Study|Lost to Follow-up|1|||
130862574|NCT00546000|471125119|FG000|Overall Study|Baseline HPA Axis Supression|2|||
130862575|NCT01504412|471125121|FG000|Overall Study|Adverse Event|1|||
130862576|NCT01504412|471125122|FG001|Overall Study|Adverse Event|8|||
130862577|NCT01504412|471125123|FG002|Overall Study|Adverse Event|1|||
130862578|NCT01504412|471125124|FG003|Overall Study|Adverse Event|7|||
130862579|NCT01504412|471125125|FG004|Overall Study|Adverse Event|10|||
130862580|NCT01504412|471125121|FG000|Overall Study|Withdrawal by Subject|2|||
130862581|NCT01504412|471125122|FG001|Overall Study|Withdrawal by Subject|1|||
130862582|NCT01504412|471125123|FG002|Overall Study|Withdrawal by Subject|1|||
130862583|NCT01504412|471125124|FG003|Overall Study|Withdrawal by Subject|5|||
130862584|NCT01504412|471125125|FG004|Overall Study|Withdrawal by Subject|1|||
130862585|NCT01504412|471125121|FG000|Overall Study|Other|2|||
130862586|NCT01504412|471125122|FG001|Overall Study|Other|1|||
130862587|NCT01504412|471125123|FG002|Overall Study|Other|1|||
130862588|NCT01504412|471125124|FG003|Overall Study|Other|6|||
130862589|NCT01504412|471125125|FG004|Overall Study|Other|1|||
130862590|NCT01504412|471125121|FG000|Overall Study|Lost to Follow-up|0|||
130862591|NCT01504412|471125122|FG001|Overall Study|Lost to Follow-up|2|||
130862592|NCT01504412|471125123|FG002|Overall Study|Lost to Follow-up|0|||
130862593|NCT01504412|471125124|FG003|Overall Study|Lost to Follow-up|0|||
130862594|NCT01504412|471125125|FG004|Overall Study|Lost to Follow-up|0|||
130862595|NCT01504412|471125121|FG000|Overall Study|Lack of Efficacy|0|||
130862596|NCT01504412|471125122|FG001|Overall Study|Lack of Efficacy|0|||
130862597|NCT01504412|471125123|FG002|Overall Study|Lack of Efficacy|1|||
130862598|NCT01504412|471125124|FG003|Overall Study|Lack of Efficacy|0|||
130862599|NCT01504412|471125125|FG004|Overall Study|Lack of Efficacy|1|||
130862600|NCT01504412|471125121|FG000|Overall Study|Death|0|||
130862601|NCT01504412|471125122|FG001|Overall Study|Death|0|||
130862602|NCT01504412|471125123|FG002|Overall Study|Death|0|||
130862603|NCT01504412|471125124|FG003|Overall Study|Death|1|||
130862604|NCT01504412|471125125|FG004|Overall Study|Death|0|||
130862605|NCT01128244|471125126|FG000|Overall Study|Adverse Event|1|||
130862606|NCT01128244|471125126|FG000|Overall Study|Scheduling conflict|2|||
130862607|NCT04171219|471125129|FG000|Overall Study|Adverse Event|1|||
130862608|NCT04171219|471125130|FG001|Overall Study|Adverse Event|0|||
130862609|NCT04171219|471125129|FG000|Overall Study|Death|0|||
130862610|NCT04171219|471125130|FG001|Overall Study|Death|1|||
130862611|NCT04171219|471125129|FG000|Overall Study|Lack of Efficacy|9|||
130862612|NCT04171219|471125130|FG001|Overall Study|Lack of Efficacy|13|||
130862613|NCT04171219|471125129|FG000|Overall Study|Withdrawal by Subject|1|||
130862614|NCT04171219|471125130|FG001|Overall Study|Withdrawal by Subject|2|||
130862615|NCT04171219|471125129|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
130862616|NCT04171219|471125130|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
130862617|NCT04171219|471125129|FG000|Overall Study|Clinical PD/Patient choice|1|||
130862618|NCT04171219|471125130|FG001|Overall Study|Clinical PD/Patient choice|0|||
130862619|NCT04171219|471125129|FG000|Overall Study|Toxicity/ Patient choice|1|||
130862620|NCT04171219|471125130|FG001|Overall Study|Toxicity/ Patient choice|0|||
130862621|NCT02974257|471125131|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
130862622|NCT02974257|471125132|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
130862623|NCT02974257|471125131|FG000|Overall Study|Clinical indication for thiamine|1|||
130862624|NCT02974257|471125132|FG001|Overall Study|Clinical indication for thiamine|0|||
130862625|NCT02974257|471125131|FG000|Overall Study|Already on thiamine|1|||
130862626|NCT02974257|471125132|FG001|Overall Study|Already on thiamine|0|||
130862627|NCT02974257|471125131|FG000|Overall Study|Extubated prior to study drug|0|||
130862628|NCT02974257|471125132|FG001|Overall Study|Extubated prior to study drug|1|||
130862629|NCT02974257|471125131|FG000|Overall Study|Death|0|||
130862630|NCT02974257|471125132|FG001|Overall Study|Death|1|||
130862631|NCT00398567|471125137|FG000|Overall Study|Disease Progression|3|||
130862632|NCT00398567|471125138|FG001|Overall Study|Disease Progression|4|||
130862633|NCT00398567|471125139|FG002|Overall Study|Disease Progression|27|||
130862634|NCT00398567|471125137|FG000|Overall Study|Withdrawal by Subject|1|||
130862635|NCT00398567|471125138|FG001|Overall Study|Withdrawal by Subject|0|||
130862636|NCT00398567|471125139|FG002|Overall Study|Withdrawal by Subject|4|||
130862637|NCT00398567|471125137|FG000|Overall Study|Adverse Event|0|||
130862638|NCT00398567|471125138|FG001|Overall Study|Adverse Event|0|||
130862639|NCT00398567|471125139|FG002|Overall Study|Adverse Event|2|||
130862640|NCT00398567|471125137|FG000|Overall Study|Protocol Violation|0|||
130862641|NCT00398567|471125138|FG001|Overall Study|Protocol Violation|0|||
130862642|NCT00398567|471125139|FG002|Overall Study|Protocol Violation|1|||
130862643|NCT04303572|471125140|FG000|Overall Study|Study closed due to poor enrollment|1|||
130862644|NCT05438576|471125141|FG000|Overall Study|Death|1|||
130862645|NCT05438576|471125142|FG001|Overall Study|Death|1|||
130862646|NCT05438576|471125141|FG000|Overall Study|Withdrawal by Subject|4|||
130862647|NCT05438576|471125142|FG001|Overall Study|Withdrawal by Subject|2|||
130862648|NCT05438576|471125141|FG000|Overall Study|Not Eligible|2|||
130862649|NCT05438576|471125142|FG001|Overall Study|Not Eligible|1|||
130862650|NCT05438576|471125141|FG000|Overall Study|Did not complete baseline testing|22|||
130862651|NCT05438576|471125142|FG001|Overall Study|Did not complete baseline testing|4|||
130862652|NCT01067144|471125148|FG000|Treatment|Did not receive allocated intervention|4|||
130862653|NCT01067144|471125149|FG001|Treatment|Did not receive allocated intervention|7|||
130862654|NCT01067144|471125148|FG000|Follow-up|Lost to Follow-up|22|||
130862655|NCT01067144|471125149|FG001|Follow-up|Lost to Follow-up|12|||
130862656|NCT01067144|471125148|FG000|Follow-up|Censored owing to second surgery|19|||
130862657|NCT01067144|471125149|FG001|Follow-up|Censored owing to second surgery|28|||
130862658|NCT01067144|471125148|FG000|Follow-up|Withdrawal by Subject|18|||
130862659|NCT01067144|471125149|FG001|Follow-up|Withdrawal by Subject|14|||
130862660|NCT01067144|471125148|FG000|Follow-up|Surgery cancelled|0|||
130862661|NCT01067144|471125149|FG001|Follow-up|Surgery cancelled|1|||
130862662|NCT01067144|471125148|FG000|Follow-up|Death|0|||
130862663|NCT01067144|471125149|FG001|Follow-up|Death|1|||
130862664|NCT00475709|471125150|FG000|Overall Study|Did not meet eligibility criteria|8|||
130862665|NCT00475709|471125150|FG000|Overall Study|Death|41|||
130862666|NCT00475709|471125150|FG000|Overall Study|Device Explant|6|||
130862667|NCT00475709|471125150|FG000|Overall Study|Lost to Follow-up|21|||
130862668|NCT00555672|471125151|FG000|Overall Study|Death|0|||
130862669|NCT00555672|471125152|FG001|Overall Study|Death|2|||
130862670|NCT00555672|471125151|FG000|Overall Study|Adverse Event|8|||
130862671|NCT00555672|471125152|FG001|Overall Study|Adverse Event|2|||
130862672|NCT00555672|471125151|FG000|Overall Study|Objective progression or relapse|11|||
130862673|NCT00555672|471125152|FG001|Overall Study|Objective progression or relapse|5|||
130862674|NCT00555672|471125151|FG000|Overall Study|Other|3|||
130862675|NCT00555672|471125152|FG001|Overall Study|Other|1|||
130862676|NCT00555672|471125151|FG000|Overall Study|Participant refused|2|||
130862677|NCT00555672|471125152|FG001|Overall Study|Participant refused|0|||
130862678|NCT01415401|471125157|FG000|Overall Study|Adverse Event|5|||
130862679|NCT01415401|471125157|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
130862680|NCT01415401|471125157|FG000|Overall Study|Terminated by Sponsor|1|||
130862681|NCT00172042|471125169|FG000|Overall Study|Adverse Event|27|||
130862682|NCT00172042|471125170|FG001|Overall Study|Adverse Event|13|||
130862683|NCT00172042|471125169|FG000|Overall Study|Abnormal laboratory value(s)|5|||
130862684|NCT00172042|471125170|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130862685|NCT00172042|471125169|FG000|Overall Study|Abnormal test procedure(s)|0|||
130862686|NCT00172042|471125170|FG001|Overall Study|Abnormal test procedure(s)|3|||
130862687|NCT00172042|471125169|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
130862688|NCT00172042|471125170|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
130862689|NCT00172042|471125169|FG000|Overall Study|Patient no longer requires study drug|10|||
130862690|NCT00172042|471125170|FG001|Overall Study|Patient no longer requires study drug|8|||
130862691|NCT00172042|471125169|FG000|Overall Study|Protocol Violation|8|||
130862692|NCT00172042|471125170|FG001|Overall Study|Protocol Violation|7|||
130862693|NCT00172042|471125169|FG000|Overall Study|Withdrawal by Subject|37|||
130862694|NCT00172042|471125170|FG001|Overall Study|Withdrawal by Subject|25|||
130862695|NCT00172042|471125169|FG000|Overall Study|Lost to Follow-up|3|||
130862696|NCT00172042|471125170|FG001|Overall Study|Lost to Follow-up|5|||
130862697|NCT00172042|471125169|FG000|Overall Study|Administrative problems|13|||
130862698|NCT00172042|471125170|FG001|Overall Study|Administrative problems|10|||
130862699|NCT00172042|471125169|FG000|Overall Study|Death|42|||
130862700|NCT00172042|471125170|FG001|Overall Study|Death|42|||
130862701|NCT01771250|471125171|FG000|Period 1|Met exclusion criteria|1|||
130862702|NCT01771250|471125172|FG001|Period 1|Met exclusion criteria|0|||
130862703|NCT00483938|471125173|FG000|Overall Study|Protocol Violation|0|||
130862704|NCT00483938|471125174|FG001|Overall Study|Protocol Violation|0|||
130862705|NCT00483938|471125175|FG002|Overall Study|Protocol Violation|0|||
130862706|NCT00483938|471125176|FG003|Overall Study|Protocol Violation|0|||
130862707|NCT00483938|471125177|FG004|Overall Study|Protocol Violation|0|||
130862708|NCT00483938|471125178|FG005|Overall Study|Protocol Violation|0|||
130862709|NCT00483938|471125179|FG006|Overall Study|Protocol Violation|3|||
130862710|NCT00483938|471125173|FG000|Overall Study|Withdrawal by Subject|1|||
130862711|NCT00483938|471125174|FG001|Overall Study|Withdrawal by Subject|6|||
130862712|NCT00483938|471125175|FG002|Overall Study|Withdrawal by Subject|0|||
130862713|NCT00483938|471125176|FG003|Overall Study|Withdrawal by Subject|0|||
130862714|NCT00483938|471125177|FG004|Overall Study|Withdrawal by Subject|1|||
130862715|NCT00483938|471125178|FG005|Overall Study|Withdrawal by Subject|3|||
130862716|NCT00483938|471125179|FG006|Overall Study|Withdrawal by Subject|2|||
130862717|NCT00483938|471125173|FG000|Overall Study|Lost to Follow-up|1|||
130862718|NCT00483938|471125174|FG001|Overall Study|Lost to Follow-up|2|||
130862719|NCT00483938|471125175|FG002|Overall Study|Lost to Follow-up|0|||
130862720|NCT00483938|471125176|FG003|Overall Study|Lost to Follow-up|2|||
130862721|NCT00483938|471125177|FG004|Overall Study|Lost to Follow-up|1|||
130862722|NCT00483938|471125178|FG005|Overall Study|Lost to Follow-up|1|||
130862723|NCT00483938|471125179|FG006|Overall Study|Lost to Follow-up|3|||
130862724|NCT00483938|471125173|FG000|Overall Study|Death|0|||
130862725|NCT00483938|471125174|FG001|Overall Study|Death|2|||
130862726|NCT00483938|471125175|FG002|Overall Study|Death|0|||
130862727|NCT00483938|471125176|FG003|Overall Study|Death|0|||
130862728|NCT00483938|471125177|FG004|Overall Study|Death|0|||
130862729|NCT00483938|471125178|FG005|Overall Study|Death|0|||
130862730|NCT00483938|471125179|FG006|Overall Study|Death|0|||
130862731|NCT00483938|471125173|FG000|Overall Study|Other|3|||
130862732|NCT00483938|471125174|FG001|Overall Study|Other|9|||
130862733|NCT00483938|471125175|FG002|Overall Study|Other|0|||
130862734|NCT00483938|471125176|FG003|Overall Study|Other|4|||
130862735|NCT00483938|471125177|FG004|Overall Study|Other|0|||
130862736|NCT00483938|471125178|FG005|Overall Study|Other|4|||
130862737|NCT00483938|471125179|FG006|Overall Study|Other|32|||
130862738|NCT02218008|471125180|FG000|Stage 1 (S1)|Adverse Event|6|||
130862739|NCT02218008|471125181|FG001|Stage 1 (S1)|Adverse Event|5|||
130862740|NCT02218008|471125182|FG002|Stage 1 (S1)|Adverse Event|11|||
130862741|NCT02218008|471125183|FG003|Stage 1 (S1)|Adverse Event|0|||
130862742|NCT02218008|471125184|FG004|Stage 1 (S1)|Adverse Event|0|||
130862743|NCT02218008|471125185|FG005|Stage 1 (S1)|Adverse Event|0|||
130862744|NCT02218008|471125180|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
130862745|NCT02218008|471125181|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
130862746|NCT02218008|471125182|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
130862747|NCT02218008|471125183|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
130862748|NCT02218008|471125184|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
130862749|NCT02218008|471125185|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
130862750|NCT02218008|471125180|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
130862751|NCT02218008|471125181|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
130862752|NCT02218008|471125182|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
130862753|NCT02218008|471125183|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
130862754|NCT02218008|471125184|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
130862755|NCT02218008|471125185|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
130862756|NCT02218008|471125180|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
130862757|NCT02218008|471125181|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
130862758|NCT02218008|471125182|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
130862759|NCT02218008|471125183|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
130862760|NCT02218008|471125184|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
130862761|NCT02218008|471125185|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
130862762|NCT02218008|471125180|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
130862763|NCT02218008|471125181|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
130862764|NCT02218008|471125182|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130862765|NCT02218008|471125183|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130862766|NCT02218008|471125184|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130862767|NCT02218008|471125185|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130862768|NCT02218008|471125180|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
130862769|NCT02218008|471125181|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
130862770|NCT02218008|471125182|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
130862771|NCT02218008|471125183|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
130862772|NCT02218008|471125184|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
130862773|NCT02218008|471125185|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
130862774|NCT02218008|471125180|FG000|Stage 1 (S1)|Pregnancy|0|||
130862775|NCT02218008|471125181|FG001|Stage 1 (S1)|Pregnancy|0|||
130862776|NCT02218008|471125182|FG002|Stage 1 (S1)|Pregnancy|1|||
130862777|NCT02218008|471125183|FG003|Stage 1 (S1)|Pregnancy|0|||
130862778|NCT02218008|471125184|FG004|Stage 1 (S1)|Pregnancy|0|||
130862779|NCT02218008|471125185|FG005|Stage 1 (S1)|Pregnancy|0|||
130862780|NCT02218008|471125180|FG000|Stage 1 (S1)|Protocol Violation|0|||
130862781|NCT02218008|471125181|FG001|Stage 1 (S1)|Protocol Violation|0|||
130862782|NCT02218008|471125182|FG002|Stage 1 (S1)|Protocol Violation|1|||
130862783|NCT02218008|471125183|FG003|Stage 1 (S1)|Protocol Violation|0|||
130862784|NCT02218008|471125184|FG004|Stage 1 (S1)|Protocol Violation|0|||
130862785|NCT02218008|471125185|FG005|Stage 1 (S1)|Protocol Violation|0|||
130862786|NCT02218008|471125180|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
130862787|NCT02218008|471125181|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130862788|NCT02218008|471125182|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130862789|NCT02218008|471125183|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130862790|NCT02218008|471125184|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130862791|NCT02218008|471125185|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130862792|NCT02218008|471125180|FG000|Stage 2 (S2)|Adverse Event|0|||
130862793|NCT02218008|471125181|FG001|Stage 2 (S2)|Adverse Event|0|||
130862794|NCT02218008|471125182|FG002|Stage 2 (S2)|Adverse Event|0|||
130862795|NCT02218008|471125183|FG003|Stage 2 (S2)|Adverse Event|2|||
130862796|NCT02218008|471125184|FG004|Stage 2 (S2)|Adverse Event|3|||
130862797|NCT02218008|471125185|FG005|Stage 2 (S2)|Adverse Event|3|||
130862798|NCT02218008|471125180|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
130862799|NCT02218008|471125181|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
130862800|NCT02218008|471125182|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
130862801|NCT02218008|471125183|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
130862802|NCT02218008|471125184|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
130862803|NCT02218008|471125185|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
130862804|NCT02218008|471125180|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
130862805|NCT02218008|471125181|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
130862806|NCT02218008|471125182|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
130862807|NCT02218008|471125183|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
130862808|NCT02218008|471125184|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
130862809|NCT02218008|471125185|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
130862810|NCT02218008|471125180|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130862811|NCT02218008|471125181|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130862812|NCT02218008|471125182|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130862813|NCT02218008|471125183|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
130862814|NCT02218008|471125184|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130862815|NCT02218008|471125185|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130862816|NCT02218008|471125180|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
130862817|NCT02218008|471125181|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
130862818|NCT02218008|471125182|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
130862819|NCT02218008|471125183|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
130862820|NCT02218008|471125184|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
130862821|NCT02218008|471125185|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
130862822|NCT00106353|471125186|FG000|Part 1|Disease progression|3|||
130862823|NCT00106353|471125187|FG001|Part 1|Disease progression|4|||
130862824|NCT00106353|471125188|FG002|Part 1|Disease progression|1|||
130862825|NCT00106353|471125189|FG003|Part 1|Disease progression|3|||
130862826|NCT00106353|471125190|FG004|Part 1|Disease progression|0|||
130862827|NCT00106353|471125191|FG005|Part 1|Disease progression|0|||
130862828|NCT00106353|471125192|FG006|Part 1|Disease progression|0|||
130862829|NCT00106353|471125186|FG000|Part 1|Withdrawal by Subject|0|||
130862830|NCT00106353|471125187|FG001|Part 1|Withdrawal by Subject|0|||
130862831|NCT00106353|471125188|FG002|Part 1|Withdrawal by Subject|1|||
130862832|NCT00106353|471125189|FG003|Part 1|Withdrawal by Subject|2|||
130862833|NCT00106353|471125190|FG004|Part 1|Withdrawal by Subject|0|||
130862834|NCT00106353|471125191|FG005|Part 1|Withdrawal by Subject|0|||
130862835|NCT00106353|471125192|FG006|Part 1|Withdrawal by Subject|0|||
130862836|NCT00106353|471125186|FG000|Part 1|Symptomatic deterioration|0|||
130862837|NCT00106353|471125187|FG001|Part 1|Symptomatic deterioration|0|||
130862838|NCT00106353|471125188|FG002|Part 1|Symptomatic deterioration|1|||
130862839|NCT00106353|471125189|FG003|Part 1|Symptomatic deterioration|0|||
130862840|NCT00106353|471125190|FG004|Part 1|Symptomatic deterioration|0|||
130862841|NCT00106353|471125191|FG005|Part 1|Symptomatic deterioration|0|||
130862842|NCT00106353|471125192|FG006|Part 1|Symptomatic deterioration|0|||
130862843|NCT00106353|471125186|FG000|Part 1|Entered follow-up phase|1|||
130862844|NCT00106353|471125187|FG001|Part 1|Entered follow-up phase|1|||
130862845|NCT00106353|471125188|FG002|Part 1|Entered follow-up phase|0|||
130862846|NCT00106353|471125189|FG003|Part 1|Entered follow-up phase|1|||
130862847|NCT00106353|471125190|FG004|Part 1|Entered follow-up phase|0|||
130862848|NCT00106353|471125191|FG005|Part 1|Entered follow-up phase|0|||
130862849|NCT00106353|471125192|FG006|Part 1|Entered follow-up phase|0|||
130862850|NCT00106353|471125186|FG000|Part 1|Adverse Event|0|||
130862851|NCT00106353|471125187|FG001|Part 1|Adverse Event|0|||
130862852|NCT00106353|471125188|FG002|Part 1|Adverse Event|0|||
130862853|NCT00106353|471125189|FG003|Part 1|Adverse Event|1|||
130862854|NCT00106353|471125190|FG004|Part 1|Adverse Event|0|||
130862855|NCT00106353|471125191|FG005|Part 1|Adverse Event|0|||
130862856|NCT00106353|471125192|FG006|Part 1|Adverse Event|0|||
130862857|NCT00106353|471125186|FG000|Part 2|Disease progression|0|||
130862858|NCT00106353|471125187|FG001|Part 2|Disease progression|0|||
130862859|NCT00106353|471125188|FG002|Part 2|Disease progression|0|||
130862860|NCT00106353|471125189|FG003|Part 2|Disease progression|0|||
130862861|NCT00106353|471125190|FG004|Part 2|Disease progression|8|||
130862862|NCT00106353|471125191|FG005|Part 2|Disease progression|14|||
130862863|NCT00106353|471125192|FG006|Part 2|Disease progression|13|||
130862864|NCT00106353|471125186|FG000|Part 2|Death|0|||
130862865|NCT00106353|471125187|FG001|Part 2|Death|0|||
130862866|NCT00106353|471125188|FG002|Part 2|Death|0|||
130862867|NCT00106353|471125189|FG003|Part 2|Death|0|||
130862868|NCT00106353|471125190|FG004|Part 2|Death|3|||
130862869|NCT00106353|471125191|FG005|Part 2|Death|0|||
130862870|NCT00106353|471125192|FG006|Part 2|Death|1|||
130862871|NCT00106353|471125186|FG000|Part 2|Symptomatic deterioration|0|||
130862872|NCT00106353|471125187|FG001|Part 2|Symptomatic deterioration|0|||
130862873|NCT00106353|471125188|FG002|Part 2|Symptomatic deterioration|0|||
130862874|NCT00106353|471125189|FG003|Part 2|Symptomatic deterioration|0|||
130862875|NCT00106353|471125190|FG004|Part 2|Symptomatic deterioration|3|||
130862876|NCT00106353|471125191|FG005|Part 2|Symptomatic deterioration|0|||
130862877|NCT00106353|471125192|FG006|Part 2|Symptomatic deterioration|0|||
130862878|NCT00106353|471125186|FG000|Part 2|Adverse Event|0|||
130862879|NCT00106353|471125187|FG001|Part 2|Adverse Event|0|||
130862880|NCT00106353|471125188|FG002|Part 2|Adverse Event|0|||
130862881|NCT00106353|471125189|FG003|Part 2|Adverse Event|0|||
130862882|NCT00106353|471125190|FG004|Part 2|Adverse Event|0|||
130862883|NCT00106353|471125191|FG005|Part 2|Adverse Event|2|||
130862884|NCT00106353|471125192|FG006|Part 2|Adverse Event|1|||
130862885|NCT00106353|471125186|FG000|Part 2|Other|0|||
130862886|NCT00106353|471125187|FG001|Part 2|Other|0|||
130862887|NCT00106353|471125188|FG002|Part 2|Other|0|||
130862888|NCT00106353|471125189|FG003|Part 2|Other|0|||
130862889|NCT00106353|471125190|FG004|Part 2|Other|1|||
130862890|NCT00106353|471125191|FG005|Part 2|Other|1|||
130862891|NCT00106353|471125192|FG006|Part 2|Other|1|||
130862892|NCT00106353|471125186|FG000|Part 2|Withdrawal by Subject|0|||
130862893|NCT00106353|471125187|FG001|Part 2|Withdrawal by Subject|0|||
130862894|NCT00106353|471125188|FG002|Part 2|Withdrawal by Subject|0|||
130862895|NCT00106353|471125189|FG003|Part 2|Withdrawal by Subject|0|||
130862896|NCT00106353|471125190|FG004|Part 2|Withdrawal by Subject|1|||
130862897|NCT00106353|471125191|FG005|Part 2|Withdrawal by Subject|0|||
130862898|NCT00106353|471125192|FG006|Part 2|Withdrawal by Subject|0|||
130862899|NCT00106353|471125186|FG000|Part 2|Physician Decision|0|||
130862900|NCT00106353|471125187|FG001|Part 2|Physician Decision|0|||
130862901|NCT00106353|471125188|FG002|Part 2|Physician Decision|0|||
130862902|NCT00106353|471125189|FG003|Part 2|Physician Decision|0|||
130862903|NCT00106353|471125190|FG004|Part 2|Physician Decision|0|||
130862904|NCT00106353|471125191|FG005|Part 2|Physician Decision|1|||
130862905|NCT00106353|471125192|FG006|Part 2|Physician Decision|0|||
130862906|NCT02038075|471125193|FG000|Overall Study|Withdrawal by Subject|3|||
130862907|NCT02038075|471125194|FG001|Overall Study|Withdrawal by Subject|0|||
130862908|NCT03477838|471125198|FG000|Overall Study|Lost to Follow-up|14|||
130862909|NCT02519595|471125199|FG000|Overall Study|Protocol Violation|8|||
130862910|NCT02519595|471125200|FG001|Overall Study|Protocol Violation|22|||
130862911|NCT02519595|471125201|FG002|Overall Study|Protocol Violation|16|||
130862912|NCT00850538|471125202|FG000|Overall Study|unable/unwilling to complete MRI|13|||
130862913|NCT00850538|471125202|FG000|Overall Study|specimen missed due to scheduling error|14|||
130862914|NCT00850538|471125202|FG000|Overall Study|specimen unusable|7|||
130862915|NCT00850538|471125202|FG000|Overall Study|Withdrawal by Subject|3|||
130862916|NCT00850538|471125202|FG000|Overall Study|radiology error|2|||
130862917|NCT00850538|471125202|FG000|Overall Study|Protocol Violation|2|||
130862918|NCT03188510|471125210|FG000|Overall Study|Inappropriate behavior with site staff|0|||
130862919|NCT03188510|471125211|FG001|Overall Study|Inappropriate behavior with site staff|1|||
130862920|NCT03188510|471125212|FG002|Overall Study|Inappropriate behavior with site staff|0|||
130862921|NCT03052049|471125214|FG000|Overall Study|Withdrawal by Subject|2|||
130862922|NCT02328027|471125215|FG000|Overall Study|Withdrawal by Subject|0|||
130862923|NCT02328027|471125216|FG001|Overall Study|Withdrawal by Subject|1|||
130862924|NCT00999518|471125220|FG000|Overall Study|Adverse Event|1|||
130862925|NCT00999518|471125221|FG001|Overall Study|Adverse Event|6|||
130862926|NCT00999518|471125222|FG002|Overall Study|Adverse Event|3|||
130862927|NCT00999518|471125223|FG003|Overall Study|Adverse Event|1|||
130862928|NCT00999518|471125224|FG004|Overall Study|Adverse Event|2|||
130862929|NCT00999518|471125220|FG000|Overall Study|Lack of Efficacy|2|||
130862930|NCT00999518|471125221|FG001|Overall Study|Lack of Efficacy|0|||
130862931|NCT00999518|471125222|FG002|Overall Study|Lack of Efficacy|0|||
130862932|NCT00999518|471125223|FG003|Overall Study|Lack of Efficacy|2|||
130862933|NCT00999518|471125224|FG004|Overall Study|Lack of Efficacy|2|||
130862934|NCT00999518|471125220|FG000|Overall Study|Lost to Follow-up|0|||
130862935|NCT00999518|471125221|FG001|Overall Study|Lost to Follow-up|0|||
130862936|NCT00999518|471125222|FG002|Overall Study|Lost to Follow-up|0|||
130862937|NCT00999518|471125223|FG003|Overall Study|Lost to Follow-up|4|||
130862938|NCT00999518|471125224|FG004|Overall Study|Lost to Follow-up|1|||
130862939|NCT00999518|471125220|FG000|Overall Study|Did not meet entrance criteria|0|||
130862940|NCT00999518|471125221|FG001|Overall Study|Did not meet entrance criteria|0|||
130862941|NCT00999518|471125222|FG002|Overall Study|Did not meet entrance criteria|0|||
130862942|NCT00999518|471125223|FG003|Overall Study|Did not meet entrance criteria|0|||
130862943|NCT00999518|471125224|FG004|Overall Study|Did not meet entrance criteria|1|||
130862944|NCT00999518|471125220|FG000|Overall Study|Study terminated by sponsor|10|||
130862945|NCT00999518|471125221|FG001|Overall Study|Study terminated by sponsor|6|||
130862946|NCT00999518|471125222|FG002|Overall Study|Study terminated by sponsor|5|||
130862947|NCT00999518|471125223|FG003|Overall Study|Study terminated by sponsor|5|||
130862948|NCT00999518|471125224|FG004|Overall Study|Study terminated by sponsor|9|||
130862949|NCT00999518|471125220|FG000|Overall Study|Pregnancy|0|||
130862950|NCT00999518|471125221|FG001|Overall Study|Pregnancy|0|||
130862951|NCT00999518|471125222|FG002|Overall Study|Pregnancy|1|||
130862952|NCT00999518|471125223|FG003|Overall Study|Pregnancy|0|||
130862953|NCT00999518|471125224|FG004|Overall Study|Pregnancy|0|||
130862954|NCT00999518|471125220|FG000|Overall Study|Protocol Violation|0|||
130862955|NCT00999518|471125221|FG001|Overall Study|Protocol Violation|1|||
130862956|NCT00999518|471125222|FG002|Overall Study|Protocol Violation|0|||
130862957|NCT00999518|471125223|FG003|Overall Study|Protocol Violation|0|||
130862958|NCT00999518|471125224|FG004|Overall Study|Protocol Violation|2|||
130862959|NCT00999518|471125220|FG000|Overall Study|Withdrawal by Subject|5|||
130862960|NCT00999518|471125221|FG001|Overall Study|Withdrawal by Subject|4|||
130862961|NCT00999518|471125222|FG002|Overall Study|Withdrawal by Subject|10|||
130862962|NCT00999518|471125223|FG003|Overall Study|Withdrawal by Subject|6|||
130862963|NCT00999518|471125224|FG004|Overall Study|Withdrawal by Subject|1|||
130862964|NCT00999518|471125220|FG000|Overall Study|Other|5|||
130862965|NCT00999518|471125221|FG001|Overall Study|Other|7|||
130862966|NCT00999518|471125222|FG002|Overall Study|Other|1|||
130862967|NCT00999518|471125223|FG003|Overall Study|Other|4|||
130862968|NCT00999518|471125224|FG004|Overall Study|Other|5|||
130862969|NCT00999518|471125220|FG000|Overall Study|Randomized but not Treated|1|||
130862970|NCT00999518|471125221|FG001|Overall Study|Randomized but not Treated|1|||
130862971|NCT00999518|471125222|FG002|Overall Study|Randomized but not Treated|2|||
130862972|NCT00999518|471125223|FG003|Overall Study|Randomized but not Treated|0|||
130862973|NCT00999518|471125224|FG004|Overall Study|Randomized but not Treated|1|||
130862974|NCT03304873|471125225|FG000|Overall Study|Lost to Follow-up|1|||
130862975|NCT03304873|471125226|FG001|Overall Study|Lost to Follow-up|8|||
130862976|NCT03319212|471125227|FG000|Overall Study|Discontinued as moving out of local area|0|||
130862977|NCT03319212|471125228|FG001|Overall Study|Discontinued as moving out of local area|1|||
130862978|NCT03319212|471125227|FG000|Overall Study|Adverse Event|2|||
130862979|NCT03319212|471125228|FG001|Overall Study|Adverse Event|2|||
130862980|NCT03319212|471125227|FG000|Overall Study|Withdrawal by Subject|0|||
130862981|NCT03319212|471125228|FG001|Overall Study|Withdrawal by Subject|1|||
130862982|NCT03319212|471125227|FG000|Overall Study|Lost to Follow-up|0|||
130862983|NCT03319212|471125228|FG001|Overall Study|Lost to Follow-up|1|||
130862984|NCT03319212|471125227|FG000|Overall Study|Physician Decision|1|||
130862985|NCT03319212|471125228|FG001|Overall Study|Physician Decision|0|||
130862986|NCT00250276|471125229|FG000|Overall Study|Serious Adverse Event|0|||
130862987|NCT00250276|471125230|FG001|Overall Study|Serious Adverse Event|0|||
130862988|NCT00250276|471125231|FG002|Overall Study|Serious Adverse Event|1|||
130862989|NCT00250276|471125232|FG003|Overall Study|Serious Adverse Event|0|||
130862990|NCT00250276|471125229|FG000|Overall Study|Non-serious Adverse Event|2|||
130862991|NCT00250276|471125230|FG001|Overall Study|Non-serious Adverse Event|0|||
130862992|NCT00250276|471125231|FG002|Overall Study|Non-serious Adverse Event|0|||
130862993|NCT00250276|471125232|FG003|Overall Study|Non-serious Adverse Event|2|||
130862994|NCT00250276|471125229|FG000|Overall Study|Protocol Violation|0|||
130862995|NCT00250276|471125230|FG001|Overall Study|Protocol Violation|1|||
130862996|NCT00250276|471125231|FG002|Overall Study|Protocol Violation|0|||
130862997|NCT00250276|471125232|FG003|Overall Study|Protocol Violation|0|||
130862998|NCT00250276|471125229|FG000|Overall Study|Withdrawal by Subject|1|||
130862999|NCT00250276|471125230|FG001|Overall Study|Withdrawal by Subject|2|||
130863000|NCT00250276|471125231|FG002|Overall Study|Withdrawal by Subject|3|||
130863001|NCT00250276|471125232|FG003|Overall Study|Withdrawal by Subject|2|||
130863002|NCT00250276|471125229|FG000|Overall Study|Migrated/moved from study area|3|||
130863003|NCT00250276|471125230|FG001|Overall Study|Migrated/moved from study area|0|||
130863004|NCT00250276|471125231|FG002|Overall Study|Migrated/moved from study area|2|||
130863005|NCT00250276|471125232|FG003|Overall Study|Migrated/moved from study area|7|||
130863006|NCT00250276|471125229|FG000|Overall Study|Lost to Follow-up|11|||
130863007|NCT00250276|471125230|FG001|Overall Study|Lost to Follow-up|18|||
130863008|NCT00250276|471125231|FG002|Overall Study|Lost to Follow-up|13|||
130863009|NCT00250276|471125232|FG003|Overall Study|Lost to Follow-up|8|||
130863010|NCT01546688|471125233|FG000|Overall Study|Adverse Event|0|||
130863011|NCT01546688|471125234|FG001|Overall Study|Adverse Event|4|||
130863012|NCT01546688|471125233|FG000|Overall Study|Withdrawal by Subject|2|||
130863013|NCT01546688|471125234|FG001|Overall Study|Withdrawal by Subject|1|||
130863014|NCT01546688|471125233|FG000|Overall Study|Lack of Efficacy|1|||
130863015|NCT01546688|471125234|FG001|Overall Study|Lack of Efficacy|0|||
130863016|NCT01811186|471125235|FG000|Overall Study|Adverse Event|54|||
130863017|NCT01811186|471125236|FG001|Overall Study|Adverse Event|38|||
130863018|NCT01811186|471125235|FG000|Overall Study|Protocol Violation|5|||
130863019|NCT01811186|471125236|FG001|Overall Study|Protocol Violation|6|||
130863020|NCT01811186|471125235|FG000|Overall Study|Withdrawal by Subject|5|||
130863021|NCT01811186|471125236|FG001|Overall Study|Withdrawal by Subject|10|||
130863022|NCT01811186|471125235|FG000|Overall Study|Lack of Efficacy|3|||
130863023|NCT01811186|471125236|FG001|Overall Study|Lack of Efficacy|6|||
130863024|NCT01811186|471125235|FG000|Overall Study|Lost to Follow-up|4|||
130863025|NCT01811186|471125236|FG001|Overall Study|Lost to Follow-up|2|||
130863026|NCT03369236|471125239|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
130863027|NCT03369236|471125240|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
130863028|NCT03369236|471125239|FG000|Open-label Extension Period|Lack of Efficacy|2|||
130863029|NCT03369236|471125240|FG001|Open-label Extension Period|Lack of Efficacy|1|||
130863030|NCT03369236|471125239|FG000|Open-label Extension Period|Adverse Event|0|||
130863031|NCT03369236|471125240|FG001|Open-label Extension Period|Adverse Event|1|||
130863032|NCT03369236|471125239|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
130863033|NCT03369236|471125240|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
130863034|NCT01153724|471125245|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130863035|NCT01153724|471125245|FG000|Treatment Period 2|Adverse Event|1|||
130863036|NCT01153724|471125245|FG000|Treatment Period 2|Other reason not defined above|1|||
130863037|NCT01946152|471126800|FG000|Overall Study|Adverse Event|1|||
130863038|NCT01946152|471126801|FG001|Overall Study|Adverse Event|0|||
130863039|NCT01946152|471126802|FG002|Overall Study|Adverse Event|0|||
130863040|NCT01946152|471126803|FG003|Overall Study|Adverse Event|0|||
130863041|NCT01946152|471126800|FG000|Overall Study|Withdrawal by Subject|0|||
130863042|NCT01946152|471126801|FG001|Overall Study|Withdrawal by Subject|2|||
130863043|NCT01946152|471126802|FG002|Overall Study|Withdrawal by Subject|0|||
130863044|NCT01946152|471126803|FG003|Overall Study|Withdrawal by Subject|0|||
130863045|NCT01946152|471126800|FG000|Overall Study|Progression|0|||
130863046|NCT01946152|471126801|FG001|Overall Study|Progression|1|||
130863047|NCT01946152|471126802|FG002|Overall Study|Progression|4|||
130863048|NCT01946152|471126803|FG003|Overall Study|Progression|7|||
130863049|NCT01946152|471126800|FG000|Overall Study|Physician Decision|0|||
130863050|NCT01946152|471126801|FG001|Overall Study|Physician Decision|0|||
130863051|NCT01946152|471126802|FG002|Overall Study|Physician Decision|1|||
130863052|NCT01946152|471126803|FG003|Overall Study|Physician Decision|0|||
130863053|NCT01946152|471126800|FG000|Overall Study|Second malignancy|0|||
130863054|NCT01946152|471126801|FG001|Overall Study|Second malignancy|0|||
130863055|NCT01946152|471126802|FG002|Overall Study|Second malignancy|1|||
130863056|NCT01946152|471126803|FG003|Overall Study|Second malignancy|0|||
130863057|NCT01946152|471126800|FG000|Overall Study|Adverse Event|0|||
130863058|NCT01946152|471126801|FG001|Overall Study|Adverse Event|0|||
130863059|NCT01946152|471126802|FG002|Overall Study|Adverse Event|0|||
130863060|NCT01946152|471126803|FG003|Overall Study|Adverse Event|1|||
130863061|NCT00799266|471126810|FG000|Overall Study|Adverse Event|0|||
130863062|NCT00799266|471126811|FG001|Overall Study|Adverse Event|1|||
130863063|NCT00799266|471126810|FG000|Overall Study|Subject withdrew consent|3|||
130863064|NCT00799266|471126811|FG001|Overall Study|Subject withdrew consent|0|||
130863065|NCT01016600|471126813|FG000|Overall Study|Did not start treatment|1|||
130863066|NCT01016600|471126814|FG001|Overall Study|Did not start treatment|0|||
130863067|NCT01016600|471126815|FG002|Overall Study|Did not start treatment|0|||
130863068|NCT01016600|471126816|FG003|Overall Study|Did not start treatment|0|||
130863069|NCT02679755|471126818|FG000|Overall Study|Death|0|||
130863070|NCT02679755|471126819|FG001|Overall Study|Death|3|||
130863071|NCT02679755|471126818|FG000|Overall Study|Global deterioration of health status|1|||
130863072|NCT02679755|471126819|FG001|Overall Study|Global deterioration of health status|8|||
130863073|NCT02679755|471126818|FG000|Overall Study|Lost to Follow-up|1|||
130863074|NCT02679755|471126819|FG001|Overall Study|Lost to Follow-up|0|||
130863075|NCT02679755|471126818|FG000|Overall Study|Objective progression or relapse|24|||
130863076|NCT02679755|471126819|FG001|Overall Study|Objective progression or relapse|83|||
130863077|NCT02679755|471126818|FG000|Overall Study|Not defined|0|||
130863078|NCT02679755|471126819|FG001|Overall Study|Not defined|2|||
130863079|NCT02679755|471126818|FG000|Overall Study|Withdrawal by participant|6|||
130863080|NCT02679755|471126819|FG001|Overall Study|Withdrawal by participant|3|||
130863081|NCT02679755|471126818|FG000|Overall Study|Adverse Event|1|||
130863082|NCT02679755|471126819|FG001|Overall Study|Adverse Event|4|||
130863083|NCT02679755|471126818|FG000|Overall Study|Adverse events not related to study drug|1|||
130863084|NCT02679755|471126819|FG001|Overall Study|Adverse events not related to study drug|2|||
130863085|NCT01061359|471126820|FG000|Overall Study|Death|32|||
130863086|NCT01061359|471126820|FG000|Overall Study|Lost to Follow-up|1072|||
130863087|NCT01061359|471126820|FG000|Overall Study|Relapse|187|||
130863088|NCT01061359|471126820|FG000|Overall Study|Secondary neoplasm|11|||
130863089|NCT01449006|471126827|FG000|Overall Study|Lost to Follow-up|1|||
130863090|NCT01449006|471126828|FG001|Overall Study|Lost to Follow-up|0|||
130863091|NCT01449006|471126827|FG000|Overall Study|Withdrawal by Subject|1|||
130863092|NCT01449006|471126828|FG001|Overall Study|Withdrawal by Subject|0|||
130863093|NCT01449006|471126827|FG000|Overall Study|Protocol Violation|1|||
130863094|NCT01449006|471126828|FG001|Overall Study|Protocol Violation|0|||
130863095|NCT03350815|471126829|FG000|Period 1|Adverse Event|10|||
130863096|NCT03350815|471126830|FG001|Period 1|Adverse Event|0|||
130863097|NCT03350815|471126831|FG002|Period 1|Adverse Event|0|||
130863098|NCT03350815|471126832|FG003|Period 1|Adverse Event|0|||
130863099|NCT03350815|471126829|FG000|Period 1|Technical problems|1|||
130863100|NCT03350815|471126830|FG001|Period 1|Technical problems|0|||
130863101|NCT03350815|471126831|FG002|Period 1|Technical problems|0|||
130863102|NCT03350815|471126832|FG003|Period 1|Technical problems|0|||
130863103|NCT03350815|471126829|FG000|Period 1|Lost to Follow-up|3|||
130863104|NCT03350815|471126830|FG001|Period 1|Lost to Follow-up|0|||
130863105|NCT03350815|471126831|FG002|Period 1|Lost to Follow-up|0|||
130863106|NCT03350815|471126832|FG003|Period 1|Lost to Follow-up|0|||
130863107|NCT03350815|471126829|FG000|Period 1|Physician Decision|1|||
130863108|NCT03350815|471126830|FG001|Period 1|Physician Decision|0|||
130863109|NCT03350815|471126831|FG002|Period 1|Physician Decision|0|||
130863110|NCT03350815|471126832|FG003|Period 1|Physician Decision|0|||
130863111|NCT03350815|471126829|FG000|Period 1|Withdrawal by Subject|8|||
130863112|NCT03350815|471126830|FG001|Period 1|Withdrawal by Subject|0|||
130863113|NCT03350815|471126831|FG002|Period 1|Withdrawal by Subject|0|||
130863114|NCT03350815|471126832|FG003|Period 1|Withdrawal by Subject|0|||
130863115|NCT03350815|471126829|FG000|Period 1|Lack of Efficacy|15|||
130863116|NCT03350815|471126830|FG001|Period 1|Lack of Efficacy|0|||
130863117|NCT03350815|471126831|FG002|Period 1|Lack of Efficacy|0|||
130863118|NCT03350815|471126832|FG003|Period 1|Lack of Efficacy|0|||
130863119|NCT03350815|471126829|FG000|Period 1|Non-compliance with study treatment|2|||
130863120|NCT03350815|471126830|FG001|Period 1|Non-compliance with study treatment|0|||
130863121|NCT03350815|471126831|FG002|Period 1|Non-compliance with study treatment|0|||
130863122|NCT03350815|471126832|FG003|Period 1|Non-compliance with study treatment|0|||
130863123|NCT03350815|471126829|FG000|Period 1|Protocol Violation|3|||
130863124|NCT03350815|471126830|FG001|Period 1|Protocol Violation|0|||
130863125|NCT03350815|471126831|FG002|Period 1|Protocol Violation|0|||
130863126|NCT03350815|471126832|FG003|Period 1|Protocol Violation|0|||
130863127|NCT03350815|471126829|FG000|Period 2|Adverse Event|0|||
130863128|NCT03350815|471126830|FG001|Period 2|Adverse Event|3|||
130863129|NCT03350815|471126831|FG002|Period 2|Adverse Event|5|||
130863130|NCT03350815|471126832|FG003|Period 2|Adverse Event|0|||
130863131|NCT03350815|471126829|FG000|Period 2|Technical problem|0|||
130863132|NCT03350815|471126830|FG001|Period 2|Technical problem|1|||
130863133|NCT03350815|471126831|FG002|Period 2|Technical problem|0|||
130863134|NCT03350815|471126832|FG003|Period 2|Technical problem|0|||
130863135|NCT03350815|471126829|FG000|Period 2|Lost to Follow-up|0|||
130863136|NCT03350815|471126830|FG001|Period 2|Lost to Follow-up|3|||
130863137|NCT03350815|471126831|FG002|Period 2|Lost to Follow-up|3|||
130863138|NCT03350815|471126832|FG003|Period 2|Lost to Follow-up|0|||
130863139|NCT03350815|471126829|FG000|Period 2|Physician Decision|0|||
130863140|NCT03350815|471126830|FG001|Period 2|Physician Decision|0|||
130863141|NCT03350815|471126831|FG002|Period 2|Physician Decision|1|||
130863142|NCT03350815|471126832|FG003|Period 2|Physician Decision|0|||
130863143|NCT03350815|471126829|FG000|Period 2|Withdrawal by Subject|0|||
130863144|NCT03350815|471126830|FG001|Period 2|Withdrawal by Subject|3|||
130863145|NCT03350815|471126831|FG002|Period 2|Withdrawal by Subject|4|||
130863146|NCT03350815|471126832|FG003|Period 2|Withdrawal by Subject|0|||
130863147|NCT03350815|471126829|FG000|Period 2|Lack of Efficacy|0|||
130863148|NCT03350815|471126830|FG001|Period 2|Lack of Efficacy|6|||
130863149|NCT03350815|471126831|FG002|Period 2|Lack of Efficacy|2|||
130863150|NCT03350815|471126832|FG003|Period 2|Lack of Efficacy|0|||
130863151|NCT03350815|471126829|FG000|Period 2|Protocol Violation|0|||
130863152|NCT03350815|471126830|FG001|Period 2|Protocol Violation|0|||
130863153|NCT03350815|471126831|FG002|Period 2|Protocol Violation|1|||
130863154|NCT03350815|471126832|FG003|Period 2|Protocol Violation|0|||
130863155|NCT03350815|471126829|FG000|Period 2|New therapy for study indication|0|||
130863156|NCT03350815|471126830|FG001|Period 2|New therapy for study indication|0|||
130863157|NCT03350815|471126831|FG002|Period 2|New therapy for study indication|1|||
130863158|NCT03350815|471126832|FG003|Period 2|New therapy for study indication|0|||
130863159|NCT02837029|471126835|FG000|Screening|Failed to meet screening requirements.|7|||
130863160|NCT02837029|471126836|FG001|Screening|Failed to meet screening requirements.|3|||
130863161|NCT02837029|471126837|FG002|Screening|Failed to meet screening requirements.|0|||
130863162|NCT02837029|471126835|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
130863163|NCT02837029|471126836|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
130863164|NCT02837029|471126837|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
130863165|NCT02837029|471126835|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
130863166|NCT02837029|471126836|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
130863167|NCT02837029|471126837|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
130863168|NCT02837029|471126835|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
130863169|NCT02837029|471126836|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
130863170|NCT02837029|471126837|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
130863171|NCT02837029|471126835|FG000|Cycle 2 and Beyond|Adverse Event|1|||
130863172|NCT02837029|471126836|FG001|Cycle 2 and Beyond|Adverse Event|0|||
130863173|NCT02837029|471126837|FG002|Cycle 2 and Beyond|Adverse Event|0|||
130863174|NCT02837029|471126835|FG000|2 Year Follow-up|Death|6|||
130863175|NCT02837029|471126836|FG001|2 Year Follow-up|Death|7|||
130863176|NCT02837029|471126837|FG002|2 Year Follow-up|Death|0|||
130863177|NCT02034877|471126838|FG000|Overall Study|Lost to Follow-up|0|||
130863178|NCT02034877|471126839|FG001|Overall Study|Lost to Follow-up|3|||
130863179|NCT02034877|471126838|FG000|Overall Study|No Longer Willing to Participate|0|||
130863180|NCT02034877|471126839|FG001|Overall Study|No Longer Willing to Participate|3|||
130863181|NCT04273893|471126842|FG000|Overall Study|Withdrawal by Subject|0|||
130863182|NCT04273893|471126843|FG001|Overall Study|Withdrawal by Subject|2|||
130863183|NCT04273893|471126842|FG000|Overall Study|Treatment of Disease Progression|0|||
130863184|NCT04273893|471126843|FG001|Overall Study|Treatment of Disease Progression|2|||
130863185|NCT04273893|471126842|FG000|Overall Study|Death|1|||
130863186|NCT04273893|471126843|FG001|Overall Study|Death|2|||
130863187|NCT04273893|471126842|FG000|Overall Study|Lost to Follow-up|0|||
130863188|NCT04273893|471126843|FG001|Overall Study|Lost to Follow-up|2|||
130863189|NCT04273893|471126842|FG000|Overall Study|Physician Decision|1|||
130863190|NCT04273893|471126843|FG001|Overall Study|Physician Decision|0|||
130863191|NCT03906071|471126844|FG000|Overall Study|Death|180|||
130863192|NCT03906071|471126845|FG001|Overall Study|Death|185|||
130863193|NCT03906071|471126844|FG000|Overall Study|Lost to Follow-up|3|||
130863194|NCT03906071|471126845|FG001|Overall Study|Lost to Follow-up|3|||
130863195|NCT03906071|471126844|FG000|Overall Study|Withdrawal by Subject|15|||
130863196|NCT03906071|471126845|FG001|Overall Study|Withdrawal by Subject|27|||
130863197|NCT03906071|471126844|FG000|Overall Study|Other|2|||
130863198|NCT03906071|471126845|FG001|Overall Study|Other|1|||
130863199|NCT01564732|471126858|FG000|Overall Study|Early termination by the study sponsor|6|||
130863200|NCT01564732|471126859|FG001|Overall Study|Early termination by the study sponsor|5|||
130863201|NCT01036321|471126862|FG000|Overall Study|Ineligible after randomization|0|||
130863202|NCT01036321|471126863|FG001|Overall Study|Ineligible after randomization|1|||
130863203|NCT01036321|471126862|FG000|Overall Study|Withdrawal by Subject|3|||
130863204|NCT01036321|471126863|FG001|Overall Study|Withdrawal by Subject|2|||
130863205|NCT01036321|471126862|FG000|Overall Study|Adverse Event|2|||
130863206|NCT01036321|471126863|FG001|Overall Study|Adverse Event|1|||
130863207|NCT00381693|471126866|FG000|Overall Study|Death|1|||
130863208|NCT00381693|471126866|FG000|Overall Study|Adverse Event|4|||
130863209|NCT00381693|471126866|FG000|Overall Study|Patient Choice|1|||
130863210|NCT00381693|471126866|FG000|Overall Study|Progression|2|||
130863211|NCT02598297|471126867|FG000|Overall Study|Study terminated by Sponsor|21|||
130863212|NCT02598297|471126868|FG001|Overall Study|Study terminated by Sponsor|23|||
130863213|NCT02598297|471126867|FG000|Overall Study|Adverse Event|1|||
130863214|NCT02598297|471126868|FG001|Overall Study|Adverse Event|1|||
130863215|NCT02598297|471126867|FG000|Overall Study|Physician Decision|1|||
130863216|NCT02598297|471126868|FG001|Overall Study|Physician Decision|0|||
130863217|NCT02598297|471126867|FG000|Overall Study|Subject/guardian decision|1|||
130863218|NCT02598297|471126868|FG001|Overall Study|Subject/guardian decision|0|||
130863219|NCT02598297|471126867|FG000|Overall Study|Followed for survival|1|||
130863220|NCT02598297|471126868|FG001|Overall Study|Followed for survival|0|||
130863221|NCT00394706|471126879|FG000|Overall Study|Withdrawal by Subject|2|||
130863222|NCT00394706|471126880|FG001|Overall Study|Withdrawal by Subject|0|||
130863223|NCT00394706|471126881|FG002|Overall Study|Withdrawal by Subject|1|||
130863224|NCT00394706|471126882|FG003|Overall Study|Withdrawal by Subject|0|||
130863225|NCT00394706|471126883|FG004|Overall Study|Withdrawal by Subject|0|||
130863226|NCT00394706|471126884|FG005|Overall Study|Withdrawal by Subject|2|||
130863227|NCT00394706|471126885|FG006|Overall Study|Withdrawal by Subject|1|||
130863228|NCT00394706|471126886|FG007|Overall Study|Withdrawal by Subject|0|||
130863229|NCT00394706|471126879|FG000|Overall Study|Lost to Follow-up|2|||
130863230|NCT00394706|471126880|FG001|Overall Study|Lost to Follow-up|2|||
130863231|NCT00394706|471126881|FG002|Overall Study|Lost to Follow-up|8|||
130863232|NCT00394706|471126882|FG003|Overall Study|Lost to Follow-up|1|||
130863233|NCT00394706|471126883|FG004|Overall Study|Lost to Follow-up|2|||
130863234|NCT00394706|471126884|FG005|Overall Study|Lost to Follow-up|5|||
130863235|NCT00394706|471126885|FG006|Overall Study|Lost to Follow-up|2|||
130863236|NCT00394706|471126886|FG007|Overall Study|Lost to Follow-up|0|||
130863237|NCT02003534|471126890|FG000|Overall Study|Lost to Follow-up|47|||
130863238|NCT02506192|471126893|FG000|Overall Study|Withdrawal by Subject|1|||
130863239|NCT02506192|471126894|FG001|Overall Study|Withdrawal by Subject|1|||
130863240|NCT05292131|471126897|FG000|Overall Study|Lost to Follow-up|1|||
130863241|NCT05292131|471126898|FG001|Overall Study|Lost to Follow-up|1|||
130863242|NCT05292131|471126897|FG000|Overall Study|Withdrawal by Subject|0|||
130863243|NCT05292131|471126898|FG001|Overall Study|Withdrawal by Subject|1|||
130863244|NCT06136897|471126899|FG000|Overall Study|Ineligible|3|||
130863245|NCT06136897|471126899|FG000|Overall Study|Mutation status not confirmed|7|||
130863246|NCT06136897|471126899|FG000|Overall Study|Adverse Event|2|||
130863247|NCT06136897|471126899|FG000|Overall Study|Death|1|||
130863248|NCT06136897|471126899|FG000|Overall Study|Disease progression|18|||
130863249|NCT06136897|471126899|FG000|Overall Study|Other complicating disease|1|||
130863250|NCT06136897|471126899|FG000|Overall Study|Withdrawal by Subject|1|||
130863251|NCT06136897|471126899|FG000|Overall Study|Still on treatment|1|||
130863252|NCT06136897|471126899|FG000|Overall Study|Lost to Follow-up|1|||
130863253|NCT03785405|471126900|FG000|Overall Study|Adverse Event|16|||
130863254|NCT03785405|471126901|FG001|Overall Study|Adverse Event|1|||
130863255|NCT03785405|471126900|FG000|Overall Study|Death|6|||
130863256|NCT03785405|471126901|FG001|Overall Study|Death|4|||
130863257|NCT03785405|471126900|FG000|Overall Study|Guardian decision|4|||
130863258|NCT03785405|471126901|FG001|Overall Study|Guardian decision|1|||
130863259|NCT03785405|471126900|FG000|Overall Study|Lost to Follow-up|1|||
130863260|NCT03785405|471126901|FG001|Overall Study|Lost to Follow-up|0|||
130863261|NCT03785405|471126900|FG000|Overall Study|Physician Decision|8|||
130863262|NCT03785405|471126901|FG001|Overall Study|Physician Decision|5|||
130863263|NCT03785405|471126900|FG000|Overall Study|Participant decision|2|||
130863264|NCT03785405|471126901|FG001|Overall Study|Participant decision|0|||
130863265|NCT03785405|471126900|FG000|Overall Study|Other|1|||
130863266|NCT03785405|471126901|FG001|Overall Study|Other|0|||
130863267|NCT03785405|471126900|FG000|Overall Study|No treatment was received|0|||
130863268|NCT03785405|471126901|FG001|Overall Study|No treatment was received|1|||
130863269|NCT03705559|471126902|FG000|Overall Study|COVID Shut down|1|||
130863270|NCT01979952|471126905|FG000|Overall Study|Adverse Event|4|||
130863271|NCT01979952|471126906|FG001|Overall Study|Adverse Event|5|||
130863272|NCT01979952|471126905|FG000|Overall Study|Protocol Violation|1|||
130863273|NCT01979952|471126906|FG001|Overall Study|Protocol Violation|0|||
130863274|NCT01979952|471126905|FG000|Overall Study|Withdrawal by Subject|2|||
130863275|NCT01979952|471126906|FG001|Overall Study|Withdrawal by Subject|1|||
130863276|NCT01979952|471126905|FG000|Overall Study|Other than specified above|1|||
130863277|NCT01979952|471126906|FG001|Overall Study|Other than specified above|0|||
130863278|NCT02881762|471126907|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130863279|NCT02881762|471126908|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130863280|NCT00203424|471126912|FG000|Treatment Period|Withdrawal by Subject|4|||
130863281|NCT00203424|471126912|FG000|Treatment Period|Adverse Event|5|||
130863282|NCT00203424|471126912|FG000|Treatment Period|progressive disease|2|||
130863283|NCT00203424|471126912|FG000|Follow-up Period|Withdrawal by Subject|1|||
130863284|NCT00203424|471126912|FG000|Follow-up Period|progressive disease|4|||
130863285|NCT00203424|471126912|FG000|Follow-up Period|Lost to Follow-up|1|||
130863286|NCT01053988|471126913|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
130863287|NCT01053988|471126914|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130863288|NCT01053988|471126915|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130863289|NCT01053988|471126916|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130863290|NCT01053988|471126917|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130863291|NCT01053988|471126918|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130863292|NCT01053988|471126913|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
130863293|NCT01053988|471126914|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130863294|NCT01053988|471126915|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130863295|NCT01053988|471126916|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130863296|NCT01053988|471126917|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130863297|NCT01053988|471126918|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130863298|NCT01053988|471126913|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
130863299|NCT01053988|471126914|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130863300|NCT01053988|471126915|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130863301|NCT01053988|471126916|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130863302|NCT01053988|471126917|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130863303|NCT01053988|471126918|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130863304|NCT01053988|471126913|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
130863305|NCT01053988|471126914|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
130863306|NCT01053988|471126915|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
130863307|NCT01053988|471126916|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
130863308|NCT01053988|471126917|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
130863309|NCT01053988|471126918|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
130863310|NCT01053988|471126913|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
130863311|NCT01053988|471126914|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
130863312|NCT01053988|471126915|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
130863313|NCT01053988|471126916|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
130863314|NCT01053988|471126917|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
130863315|NCT01053988|471126918|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
130863316|NCT01053988|471126913|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
130863317|NCT01053988|471126914|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130863318|NCT01053988|471126915|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130863319|NCT01053988|471126916|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130863320|NCT01053988|471126917|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130863321|NCT01053988|471126918|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130863322|NCT01053988|471126913|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
130863323|NCT01053988|471126914|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
130863324|NCT01053988|471126915|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
130863325|NCT01053988|471126916|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
130863326|NCT01053988|471126917|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
130863327|NCT01053988|471126918|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
130863328|NCT01053988|471126913|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130863329|NCT01053988|471126914|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
130863330|NCT01053988|471126915|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
130863331|NCT01053988|471126916|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
130863332|NCT01053988|471126917|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
130863333|NCT01053988|471126918|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130863334|NCT01053988|471126913|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
130863335|NCT01053988|471126914|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
130863336|NCT01053988|471126915|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
130863337|NCT01053988|471126916|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
130863338|NCT01053988|471126917|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
130863339|NCT01053988|471126918|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
130863340|NCT01053988|471126913|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130863341|NCT01053988|471126914|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
130863342|NCT01053988|471126915|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130863343|NCT01053988|471126916|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
130863344|NCT01053988|471126917|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
130863345|NCT01053988|471126918|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130863346|NCT01053988|471126913|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130863347|NCT01053988|471126914|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
130863348|NCT01053988|471126915|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
130863349|NCT01053988|471126916|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
130863350|NCT01053988|471126917|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
130863351|NCT01053988|471126918|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
130863352|NCT01053988|471126913|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130863353|NCT01053988|471126914|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
130863354|NCT01053988|471126915|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130863355|NCT01053988|471126916|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130863356|NCT01053988|471126917|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
130863357|NCT01053988|471126918|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
130863358|NCT01053988|471126913|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
130863359|NCT01053988|471126914|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
130863360|NCT01053988|471126915|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
130863361|NCT01053988|471126916|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
130863362|NCT01053988|471126917|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
130863363|NCT01053988|471126918|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
130863364|NCT01053988|471126913|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130863365|NCT01053988|471126914|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
130863366|NCT01053988|471126915|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130863367|NCT01053988|471126916|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
130863368|NCT01053988|471126917|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
130863369|NCT01053988|471126918|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130863370|NCT01922271|471126919|FG000|WASHOUT Period|Withdrawal by Subject|1|||
130863371|NCT01922271|471126920|FG001|WASHOUT Period|Withdrawal by Subject|0|||
130863372|NCT01824355|471126921|FG000|Overall Study|Adverse Event|2|||
130863373|NCT01824355|471126921|FG000|Overall Study|unevaluable reference method results per|1|||
130863374|NCT04765202|471126935|FG000|Overall Study|Lost to Follow-up|1|||
130863375|NCT04765202|471126936|FG001|Overall Study|Lost to Follow-up|1|||
130863376|NCT04765202|471126937|FG002|Overall Study|Lost to Follow-up|2|||
130863377|NCT04765202|471126938|FG003|Overall Study|Lost to Follow-up|2|||
130863378|NCT04765202|471126935|FG000|Overall Study|Physician Decision|0|||
130863379|NCT04765202|471126936|FG001|Overall Study|Physician Decision|0|||
130863380|NCT04765202|471126937|FG002|Overall Study|Physician Decision|1|||
130863381|NCT04765202|471126938|FG003|Overall Study|Physician Decision|1|||
130863382|NCT02305238|471126940|FG000|Overall Study|Death|2|||
130863383|NCT02305238|471126941|FG001|Overall Study|Death|1|||
130863384|NCT02305238|471126942|FG002|Overall Study|Death|0|||
130863385|NCT02305238|471126940|FG000|Overall Study|Progressive disease|4|||
130863386|NCT02305238|471126941|FG001|Overall Study|Progressive disease|4|||
130863387|NCT02305238|471126942|FG002|Overall Study|Progressive disease|0|||
130863388|NCT02305238|471126940|FG000|Overall Study|Logistical difficulties|1|||
130863389|NCT02305238|471126941|FG001|Overall Study|Logistical difficulties|3|||
130863390|NCT02305238|471126942|FG002|Overall Study|Logistical difficulties|0|||
130863391|NCT02305238|471126940|FG000|Overall Study|Protocol Violation|0|||
130863392|NCT02305238|471126941|FG001|Overall Study|Protocol Violation|3|||
130863393|NCT02305238|471126942|FG002|Overall Study|Protocol Violation|0|||
130863394|NCT02305238|471126940|FG000|Overall Study|Physician Decision|2|||
130863395|NCT02305238|471126941|FG001|Overall Study|Physician Decision|1|||
130863396|NCT02305238|471126942|FG002|Overall Study|Physician Decision|0|||
130863397|NCT02305238|471126940|FG000|Overall Study|Adverse Event|4|||
130863398|NCT02305238|471126941|FG001|Overall Study|Adverse Event|2|||
130863399|NCT02305238|471126942|FG002|Overall Study|Adverse Event|0|||
130863400|NCT02305238|471126940|FG000|Overall Study|Withdrawal by Subject|3|||
130863401|NCT02305238|471126941|FG001|Overall Study|Withdrawal by Subject|4|||
130863402|NCT02305238|471126942|FG002|Overall Study|Withdrawal by Subject|0|||
130863403|NCT02305238|471126940|FG000|Overall Study|Randomized failure|0|||
130863404|NCT02305238|471126941|FG001|Overall Study|Randomized failure|0|||
130863405|NCT02305238|471126942|FG002|Overall Study|Randomized failure|8|||
130863406|NCT02305238|471126940|FG000|Overall Study|Required procedure failed|0|||
130863407|NCT02305238|471126941|FG001|Overall Study|Required procedure failed|1|||
130863408|NCT02305238|471126942|FG002|Overall Study|Required procedure failed|0|||
130863409|NCT01019369|471126943|FG000|Overall Study|Lost to Follow-up|10|||
130863410|NCT01019369|471126944|FG001|Overall Study|Lost to Follow-up|6|||
130863411|NCT01019369|471126943|FG000|Overall Study|Withdrawal by Subject|0|||
130863412|NCT01019369|471126944|FG001|Overall Study|Withdrawal by Subject|1|||
130863413|NCT02513472|471126945|FG000|Overall Study|Radiological Disease Progression|45|||
130863414|NCT02513472|471126946|FG001|Overall Study|Radiological Disease Progression|57|||
130863415|NCT02513472|471126945|FG000|Overall Study|Clinical Disease Progression|5|||
130863416|NCT02513472|471126946|FG001|Overall Study|Clinical Disease Progression|13|||
130863417|NCT02513472|471126945|FG000|Overall Study|Adverse Event|8|||
130863418|NCT02513472|471126946|FG001|Overall Study|Adverse Event|11|||
130863419|NCT02513472|471126945|FG000|Overall Study|Withdrawal by Subject|0|||
130863420|NCT02513472|471126946|FG001|Overall Study|Withdrawal by Subject|4|||
130863421|NCT02513472|471126945|FG000|Overall Study|Subject Choice|2|||
130863422|NCT02513472|471126946|FG001|Overall Study|Subject Choice|7|||
130863423|NCT02513472|471126945|FG000|Overall Study|Treatment Completed as per Protocol|3|||
130863424|NCT02513472|471126946|FG001|Overall Study|Treatment Completed as per Protocol|3|||
130863425|NCT02513472|471126945|FG000|Overall Study|Other|3|||
130863426|NCT02513472|471126946|FG001|Overall Study|Other|6|||
130863427|NCT01380834|471126947|FG000|Overall Study|Physician Decision|1|||
130863428|NCT01380834|471126948|FG001|Overall Study|Physician Decision|0|||
130863429|NCT04310566|471126949|FG000|Period 1|Study Termination due to COVID-19|15|||
130863430|NCT04310566|471126950|FG001|Period 1|Study Termination due to COVID-19|17|||
130863431|NCT04310566|471126949|FG000|Period 1|Protocol Violation|0|||
130863432|NCT04310566|471126950|FG001|Period 1|Protocol Violation|1|||
130863433|NCT04310566|471126949|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
130863434|NCT04310566|471126950|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
130863435|NCT04310566|471126949|FG000|Period 1|Lost to Follow-up|1|||
130863436|NCT04310566|471126950|FG001|Period 1|Lost to Follow-up|0|||
130863437|NCT04310566|471126949|FG000|Period 1|Withdrawal by Subject|0|||
130863438|NCT04310566|471126950|FG001|Period 1|Withdrawal by Subject|1|||
130863439|NCT04310566|471126949|FG000|Period 2|Study Termination|7|||
130863440|NCT04310566|471126950|FG001|Period 2|Study Termination|5|||
130863441|NCT04565951|471126951|FG000|Overall Study|Lost to Follow-up|66|||
130863442|NCT04565951|471126952|FG001|Overall Study|Lost to Follow-up|38|||
130863443|NCT04565951|471126951|FG000|Overall Study|Withdrawal by Subject|14|||
130863444|NCT04565951|471126952|FG001|Overall Study|Withdrawal by Subject|7|||
130863445|NCT04565951|471126951|FG000|Overall Study|Death|0|||
130863446|NCT04565951|471126952|FG001|Overall Study|Death|1|||
130863447|NCT00429169|471126961|FG000|Overall Study|Lost to Follow-up|0|||
130863448|NCT00429169|471126962|FG001|Overall Study|Lost to Follow-up|1|||
130863449|NCT00429169|471126961|FG000|Overall Study|Ineligibility discovered after entry|2|||
130863450|NCT00429169|471126962|FG001|Overall Study|Ineligibility discovered after entry|1|||
130863451|NCT01711645|471126963|FG000|Overall Study|Withdrawal by Subject|8|||
130863452|NCT01711645|471126963|FG000|Overall Study|Lost to Follow-up|6|||
130863453|NCT01711645|471126963|FG000|Overall Study|Physician Decision|5|||
130863454|NCT01746173|471126969|FG000|Overall Study|Disease Progression|2|||
130863455|NCT01371552|471126973|FG000|Part 1, First 3 Days|Inconvenience|0|||
130863456|NCT01371552|471126974|FG001|Part 1, First 3 Days|Inconvenience|0|||
130863457|NCT01371552|471126975|FG002|Part 1, First 3 Days|Inconvenience|1|||
130863458|NCT01371552|471126976|FG003|Part 1, First 3 Days|Inconvenience|0|||
130863459|NCT01371552|471126977|FG004|Part 1, First 3 Days|Inconvenience|0|||
130863460|NCT01371552|471126978|FG005|Part 1, First 3 Days|Inconvenience|0|||
130863461|NCT02508428|471126981|FG000|Overall Study|Death|32|||
130863462|NCT02508428|471126982|FG001|Overall Study|Death|33|||
130863463|NCT02508428|471126981|FG000|Overall Study|Liner revised|3|||
130863464|NCT02508428|471126982|FG001|Overall Study|Liner revised|19|||
130863465|NCT02508428|471126981|FG000|Overall Study|Incomplete follow-up|17|||
130863466|NCT02508428|471126982|FG001|Overall Study|Incomplete follow-up|15|||
130863467|NCT00534976|471126987|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
130863468|NCT00534976|471126988|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
130863469|NCT00534976|471126987|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
130863470|NCT00534976|471126988|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
130863471|NCT00534976|471126987|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
130863472|NCT00534976|471126988|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
130863473|NCT02123576|471126989|FG000|Overall Study|Adverse Event|1|||
130863474|NCT02123576|471126990|FG001|Overall Study|Adverse Event|0|||
130863475|NCT00934128|471126991|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
130863476|NCT00934128|471126992|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
130863477|NCT00934128|471126991|FG000|First Intervention (2 Hours)|Adverse Event|4|||
130863478|NCT00934128|471126992|FG001|First Intervention (2 Hours)|Adverse Event|1|||
130863479|NCT00934128|471126991|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
130863480|NCT00934128|471126992|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
130863481|NCT00934128|471126991|FG000|Washout Period (1 Hour)|Patient preference|1|||
130863482|NCT00934128|471126992|FG001|Washout Period (1 Hour)|Patient preference|3|||
130863483|NCT00934128|471126991|FG000|Washout Period (1 Hour)|Pain|1|||
130863484|NCT00934128|471126992|FG001|Washout Period (1 Hour)|Pain|0|||
130863485|NCT00934128|471126991|FG000|Washout Period (1 Hour)|Too tired|1|||
130863486|NCT00934128|471126992|FG001|Washout Period (1 Hour)|Too tired|0|||
130863487|NCT00934128|471126991|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
130863488|NCT00934128|471126992|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
130863489|NCT00934128|471126991|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
130863490|NCT00934128|471126992|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
130863491|NCT02834247|471126993|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
130863492|NCT02834247|471126994|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
130863493|NCT02834247|471126995|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
130863494|NCT02834247|471126996|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
130863495|NCT02834247|471126993|FG000|Dose Escalation Phase|Death|5|||
130863496|NCT02834247|471126994|FG001|Dose Escalation Phase|Death|6|||
130863497|NCT02834247|471126995|FG002|Dose Escalation Phase|Death|5|||
130863498|NCT02834247|471126996|FG003|Dose Escalation Phase|Death|0|||
130863499|NCT02834247|471126993|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
130863500|NCT02834247|471126994|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
130863501|NCT02834247|471126995|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
130863502|NCT02834247|471126996|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
130863503|NCT02834247|471126993|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
130863504|NCT02834247|471126994|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
130863505|NCT02834247|471126995|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
130863506|NCT02834247|471126996|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130863507|NCT02834247|471126993|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
130863508|NCT02834247|471126994|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
130863509|NCT02834247|471126995|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
130863510|NCT02834247|471126996|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
130863511|NCT02834247|471126993|FG000|Dose Expansion Phase|Death|0|||
130863512|NCT02834247|471126994|FG001|Dose Expansion Phase|Death|0|||
130863513|NCT02834247|471126995|FG002|Dose Expansion Phase|Death|0|||
130863514|NCT02834247|471126996|FG003|Dose Expansion Phase|Death|8|||
130863515|NCT02834247|471126993|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
130863516|NCT02834247|471126994|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
130863517|NCT02834247|471126995|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
130863518|NCT02834247|471126996|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
130863519|NCT02834247|471126993|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
130863520|NCT02834247|471126994|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
130863521|NCT02834247|471126995|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
130863522|NCT02834247|471126996|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
130863523|NCT02221674|471128879|FG000|Overall Study|Lost to Follow-up|1|||
130863524|NCT02221674|471128880|FG001|Overall Study|Lost to Follow-up|0|||
130863525|NCT02221674|471128881|FG002|Overall Study|Lost to Follow-up|0|||
130863526|NCT02557542|471128883|FG000|Overall Study|Poor recruitment|3|||
130863527|NCT02557542|471128884|FG001|Overall Study|Poor recruitment|0|||
130863528|NCT04390880|471128885|FG000|Overall Study|Withdrawal by Subject|1|||
130863529|NCT00245037|471128886|FG000|Overall Study|Death|17|||
130863530|NCT02576795|471128891|FG000|Overall Study|Lost to Follow-up|0|||
130863531|NCT02576795|471128892|FG001|Overall Study|Lost to Follow-up|0|||
130863532|NCT02576795|471128893|FG002|Overall Study|Lost to Follow-up|1|||
130863533|NCT02576795|471128894|FG003|Overall Study|Lost to Follow-up|0|||
130863534|NCT03724890|471128895|FG000|Overall Study|Death|2|||
130863535|NCT03724890|471128896|FG001|Overall Study|Death|6|||
130863536|NCT03724890|471128897|FG002|Overall Study|Death|3|||
130863537|NCT03724890|471128898|FG003|Overall Study|Death|5|||
130863538|NCT03724890|471128899|FG004|Overall Study|Death|2|||
130863539|NCT03724890|471128900|FG005|Overall Study|Death|0|||
130863540|NCT03724890|471128901|FG006|Overall Study|Death|2|||
130863541|NCT03724890|471128902|FG007|Overall Study|Death|3|||
130863542|NCT03724890|471128903|FG008|Overall Study|Death|4|||
130863543|NCT03724890|471128904|FG009|Overall Study|Death|2|||
130863544|NCT03724890|471128905|FG010|Overall Study|Death|2|||
130863545|NCT03724890|471128895|FG000|Overall Study|Lost to Follow-up|0|||
130863546|NCT03724890|471128896|FG001|Overall Study|Lost to Follow-up|3|||
130863547|NCT03724890|471128897|FG002|Overall Study|Lost to Follow-up|0|||
130863548|NCT03724890|471128898|FG003|Overall Study|Lost to Follow-up|1|||
130863549|NCT03724890|471128899|FG004|Overall Study|Lost to Follow-up|2|||
130863550|NCT03724890|471128900|FG005|Overall Study|Lost to Follow-up|2|||
130863551|NCT03724890|471128901|FG006|Overall Study|Lost to Follow-up|1|||
130863552|NCT03724890|471128902|FG007|Overall Study|Lost to Follow-up|0|||
130863553|NCT03724890|471128903|FG008|Overall Study|Lost to Follow-up|2|||
130863554|NCT03724890|471128904|FG009|Overall Study|Lost to Follow-up|0|||
130863555|NCT03724890|471128905|FG010|Overall Study|Lost to Follow-up|0|||
130863556|NCT03724890|471128895|FG000|Overall Study|Withdrawal by Subject|1|||
130863557|NCT03724890|471128896|FG001|Overall Study|Withdrawal by Subject|2|||
130863558|NCT03724890|471128897|FG002|Overall Study|Withdrawal by Subject|1|||
130863559|NCT03724890|471128898|FG003|Overall Study|Withdrawal by Subject|0|||
130863560|NCT03724890|471128899|FG004|Overall Study|Withdrawal by Subject|0|||
130863561|NCT03724890|471128900|FG005|Overall Study|Withdrawal by Subject|1|||
130863562|NCT03724890|471128901|FG006|Overall Study|Withdrawal by Subject|0|||
130863563|NCT03724890|471128902|FG007|Overall Study|Withdrawal by Subject|0|||
130863564|NCT03724890|471128903|FG008|Overall Study|Withdrawal by Subject|2|||
130863565|NCT03724890|471128904|FG009|Overall Study|Withdrawal by Subject|2|||
130863566|NCT03724890|471128905|FG010|Overall Study|Withdrawal by Subject|1|||
130863567|NCT03724890|471128895|FG000|Overall Study|Other|1|||
130863568|NCT03724890|471128896|FG001|Overall Study|Other|0|||
130863569|NCT03724890|471128897|FG002|Overall Study|Other|0|||
130863570|NCT03724890|471128898|FG003|Overall Study|Other|0|||
130863571|NCT03724890|471128899|FG004|Overall Study|Other|0|||
130863572|NCT03724890|471128900|FG005|Overall Study|Other|0|||
130863573|NCT03724890|471128901|FG006|Overall Study|Other|0|||
130863574|NCT03724890|471128902|FG007|Overall Study|Other|1|||
130863575|NCT03724890|471128903|FG008|Overall Study|Other|1|||
130863576|NCT03724890|471128904|FG009|Overall Study|Other|0|||
130863577|NCT03724890|471128905|FG010|Overall Study|Other|2|||
130863578|NCT04427072|471128909|FG000|Randomized Treatment Phase|Progressive disease|9|||
130863579|NCT04427072|471128910|FG001|Randomized Treatment Phase|Progressive disease|4|||
130863580|NCT04427072|471128909|FG000|Randomized Treatment Phase|Adverse Event|3|||
130863581|NCT04427072|471128910|FG001|Randomized Treatment Phase|Adverse Event|1|||
130863582|NCT04427072|471128909|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
130863583|NCT04427072|471128910|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
130863584|NCT04427072|471128909|FG000|Randomized Treatment Phase|Death|0|||
130863585|NCT04427072|471128910|FG001|Randomized Treatment Phase|Death|1|||
130863586|NCT04427072|471128909|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
130863587|NCT04427072|471128910|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
130863588|NCT04427072|471128909|FG000|Extension Treatment Phase|Progressive disease|0|||
130863589|NCT04427072|471128910|FG001|Extension Treatment Phase|Progressive disease|5|||
130863590|NCT05232864|471128911|FG000|Overall Study|Adverse Event|0|||
130863591|NCT05232864|471128912|FG001|Overall Study|Adverse Event|1|||
130863592|NCT05232864|471128911|FG000|Overall Study|Study terminated by sponsor|16|||
130863593|NCT05232864|471128912|FG001|Overall Study|Study terminated by sponsor|14|||
130863594|NCT00465452|471128919|FG000|Overall Study|Adverse Event|1|||
130863595|NCT01635855|471128924|FG000|Overall Study|Withdrawal by Subject|4|||
130863596|NCT05870865|471128927|FG000|Randomized|Did not receive study treatment|2|||
130863597|NCT05870865|471128928|FG001|Randomized|Did not receive study treatment|4|||
130863598|NCT05870865|471128929|FG002|Randomized|Did not receive study treatment|4|||
130863599|NCT05870865|471128930|FG003|Randomized|Did not receive study treatment|3|||
130863600|NCT05870865|471128927|FG000|Treatment Period|Adverse Event|1|||
130863601|NCT05870865|471128928|FG001|Treatment Period|Adverse Event|1|||
130863602|NCT05870865|471128929|FG002|Treatment Period|Adverse Event|1|||
130863603|NCT05870865|471128930|FG003|Treatment Period|Adverse Event|1|||
130863604|NCT05870865|471128927|FG000|Treatment Period|Lost to Follow-up|0|||
130863605|NCT05870865|471128928|FG001|Treatment Period|Lost to Follow-up|1|||
130863606|NCT05870865|471128929|FG002|Treatment Period|Lost to Follow-up|2|||
130863607|NCT05870865|471128930|FG003|Treatment Period|Lost to Follow-up|0|||
130863608|NCT05870865|471128927|FG000|Treatment Period|Protocol Violation|0|||
130863609|NCT05870865|471128928|FG001|Treatment Period|Protocol Violation|0|||
130863610|NCT05870865|471128929|FG002|Treatment Period|Protocol Violation|0|||
130863611|NCT05870865|471128930|FG003|Treatment Period|Protocol Violation|1|||
130863612|NCT05870865|471128927|FG000|Treatment Period|Withdrawal by Subject|0|||
130863613|NCT05870865|471128928|FG001|Treatment Period|Withdrawal by Subject|1|||
130863614|NCT05870865|471128929|FG002|Treatment Period|Withdrawal by Subject|1|||
130863615|NCT05870865|471128930|FG003|Treatment Period|Withdrawal by Subject|1|||
130863616|NCT02104947|471128932|FG000|Overall Study|Withdrawal by Subject|10|||
130863617|NCT02104947|471128933|FG001|Overall Study|Withdrawal by Subject|3|||
130863618|NCT02104947|471128932|FG000|Overall Study|Lost to Follow-up|4|||
130863619|NCT02104947|471128933|FG001|Overall Study|Lost to Follow-up|4|||
130863620|NCT02104947|471128932|FG000|Overall Study|Protocol Violation|6|||
130863621|NCT02104947|471128933|FG001|Overall Study|Protocol Violation|8|||
130863622|NCT02104947|471128932|FG000|Overall Study|Adverse Event|57|||
130863623|NCT02104947|471128933|FG001|Overall Study|Adverse Event|38|||
130863624|NCT02104947|471128932|FG000|Overall Study|Other than stated above|2|||
130863625|NCT02104947|471128933|FG001|Overall Study|Other than stated above|3|||
130863626|NCT00206440|471128934|FG000|Overall Study|Protocol Violation|1|||
130863627|NCT00206440|471128935|FG001|Overall Study|Protocol Violation|2|||
130863628|NCT00206440|471128934|FG000|Overall Study|Adverse Event|4|||
130863629|NCT00206440|471128935|FG001|Overall Study|Adverse Event|2|||
130863630|NCT00145574|471128936|FG000|Double Blind|Adverse Event|0|||
130863631|NCT00145574|471128937|FG001|Double Blind|Adverse Event|3|||
130863632|NCT00145574|471128938|FG002|Double Blind|Adverse Event|1|||
130863633|NCT00145574|471128936|FG000|Double Blind|Withdrawal by Subject|1|||
130863634|NCT00145574|471128937|FG001|Double Blind|Withdrawal by Subject|1|||
130863635|NCT00145574|471128938|FG002|Double Blind|Withdrawal by Subject|1|||
130863636|NCT00145574|471128936|FG000|Double Blind|required restricted medicine|0|||
130863637|NCT00145574|471128937|FG001|Double Blind|required restricted medicine|1|||
130863638|NCT00145574|471128938|FG002|Double Blind|required restricted medicine|0|||
130863639|NCT00145574|471128936|FG000|Open Label Long-term Extension|Adverse Event|0|||
130863640|NCT00145574|471128937|FG001|Open Label Long-term Extension|Adverse Event|0|||
130863641|NCT00145574|471128938|FG002|Open Label Long-term Extension|Adverse Event|5|||
130863642|NCT00145574|471128936|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
130863643|NCT00145574|471128937|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
130863644|NCT00145574|471128938|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
130863645|NCT00145574|471128936|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
130863646|NCT00145574|471128937|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
130863647|NCT00145574|471128938|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
130863648|NCT00145574|471128936|FG000|Open Label Long-term Extension|required restricted medicine|0|||
130863649|NCT00145574|471128937|FG001|Open Label Long-term Extension|required restricted medicine|0|||
130863650|NCT00145574|471128938|FG002|Open Label Long-term Extension|required restricted medicine|1|||
130863651|NCT04090242|471128943|FG000|Overall Study|Withdrawal by Subject|1|||
130863652|NCT04090242|471128944|FG001|Overall Study|Withdrawal by Subject|0|||
130863653|NCT00858637|471128945|FG000|Active Comparison Phase|Adverse Event|14|||
130863654|NCT00858637|471128946|FG001|Active Comparison Phase|Adverse Event|0|||
130863655|NCT00858637|471128947|FG002|Active Comparison Phase|Adverse Event|0|||
130863656|NCT00858637|471128948|FG003|Active Comparison Phase|Adverse Event|9|||
130863657|NCT00858637|471128949|FG004|Active Comparison Phase|Adverse Event|0|||
130863658|NCT00858637|471128950|FG005|Active Comparison Phase|Adverse Event|0|||
130863659|NCT00858637|471128945|FG000|Active Comparison Phase|Death|1|||
130863660|NCT00858637|471128946|FG001|Active Comparison Phase|Death|0|||
130863661|NCT00858637|471128947|FG002|Active Comparison Phase|Death|0|||
130863662|NCT00858637|471128948|FG003|Active Comparison Phase|Death|1|||
130863663|NCT00858637|471128949|FG004|Active Comparison Phase|Death|0|||
130863664|NCT00858637|471128950|FG005|Active Comparison Phase|Death|0|||
130863665|NCT00858637|471128945|FG000|Active Comparison Phase|Physician Decision|1|||
130863666|NCT00858637|471128946|FG001|Active Comparison Phase|Physician Decision|0|||
130863667|NCT00858637|471128947|FG002|Active Comparison Phase|Physician Decision|0|||
130863668|NCT00858637|471128948|FG003|Active Comparison Phase|Physician Decision|1|||
130863669|NCT00858637|471128949|FG004|Active Comparison Phase|Physician Decision|0|||
130863670|NCT00858637|471128950|FG005|Active Comparison Phase|Physician Decision|0|||
130863671|NCT00858637|471128945|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
130863672|NCT00858637|471128946|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
130863673|NCT00858637|471128947|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
130863674|NCT00858637|471128948|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
130863675|NCT00858637|471128949|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
130863676|NCT00858637|471128950|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
130863677|NCT00858637|471128945|FG000|Active Comparison Phase|Other Reasons|1|||
130863678|NCT00858637|471128946|FG001|Active Comparison Phase|Other Reasons|0|||
130863679|NCT00858637|471128947|FG002|Active Comparison Phase|Other Reasons|0|||
130863680|NCT00858637|471128948|FG003|Active Comparison Phase|Other Reasons|1|||
130863681|NCT00858637|471128949|FG004|Active Comparison Phase|Other Reasons|0|||
130863682|NCT00858637|471128950|FG005|Active Comparison Phase|Other Reasons|0|||
130863683|NCT00858637|471128945|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
130863684|NCT00858637|471128946|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
130863685|NCT00858637|471128947|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
130863686|NCT00858637|471128948|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
130863687|NCT00858637|471128949|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
130863688|NCT00858637|471128950|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
130863689|NCT00858637|471128945|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130863690|NCT00858637|471128946|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130863691|NCT00858637|471128947|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130863692|NCT00858637|471128948|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130863693|NCT00858637|471128949|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130863694|NCT00858637|471128950|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
130863695|NCT00195663|471128951|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
130863696|NCT00195663|471128952|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
130863697|NCT00195663|471128953|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
130863698|NCT00195663|471128951|FG000|2-year Double-blind Treatment Period|Death|0|||
130863699|NCT00195663|471128952|FG001|2-year Double-blind Treatment Period|Death|2|||
130863700|NCT00195663|471128953|FG002|2-year Double-blind Treatment Period|Death|0|||
130863701|NCT00195663|471128951|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
130863702|NCT00195663|471128952|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
130863703|NCT00195663|471128953|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
130863704|NCT00195663|471128951|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
130863705|NCT00195663|471128952|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
130863706|NCT00195663|471128953|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
130863707|NCT00195663|471128951|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
130863708|NCT00195663|471128952|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
130863709|NCT00195663|471128953|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
130863710|NCT00195663|471128951|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
130863711|NCT00195663|471128952|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
130863712|NCT00195663|471128953|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
130863713|NCT00195663|471128951|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
130863714|NCT00195663|471128952|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
130863715|NCT00195663|471128953|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
130863716|NCT00195663|471128951|FG000|2-year Double-blind Treatment Period|Recovery|1|||
130863717|NCT00195663|471128952|FG001|2-year Double-blind Treatment Period|Recovery|0|||
130863718|NCT00195663|471128953|FG002|2-year Double-blind Treatment Period|Recovery|1|||
130863719|NCT00195663|471128951|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
130863720|NCT00195663|471128952|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
130863721|NCT00195663|471128953|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
130863722|NCT00195663|471128951|FG000|Open-Label Extension Period|Adverse Event|21|||
130863723|NCT00195663|471128952|FG001|Open-Label Extension Period|Adverse Event|32|||
130863724|NCT00195663|471128953|FG002|Open-Label Extension Period|Adverse Event|36|||
130863725|NCT00195663|471128951|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
130863726|NCT00195663|471128952|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
130863727|NCT00195663|471128953|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
130863728|NCT00195663|471128951|FG000|Open-Label Extension Period|Recovery|0|||
130863729|NCT00195663|471128952|FG001|Open-Label Extension Period|Recovery|2|||
130863730|NCT00195663|471128953|FG002|Open-Label Extension Period|Recovery|2|||
130863731|NCT00195663|471128951|FG000|Open-Label Extension Period|Protocol Violation|3|||
130863732|NCT00195663|471128952|FG001|Open-Label Extension Period|Protocol Violation|4|||
130863733|NCT00195663|471128953|FG002|Open-Label Extension Period|Protocol Violation|4|||
130863734|NCT00195663|471128951|FG000|Open-Label Extension Period|Death|2|||
130863735|NCT00195663|471128952|FG001|Open-Label Extension Period|Death|2|||
130863736|NCT00195663|471128953|FG002|Open-Label Extension Period|Death|2|||
130863737|NCT00195663|471128951|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
130863738|NCT00195663|471128952|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
130863739|NCT00195663|471128953|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
130863740|NCT00195663|471128951|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
130863741|NCT00195663|471128952|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
130863742|NCT00195663|471128953|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
130863743|NCT00195663|471128951|FG000|Open-Label Extension Period|Administrative reasons|11|||
130863744|NCT00195663|471128952|FG001|Open-Label Extension Period|Administrative reasons|11|||
130863745|NCT00195663|471128953|FG002|Open-Label Extension Period|Administrative reasons|13|||
130863746|NCT03214406|471128954|FG000|Overall Study|did not meet enrollment criteria|9|||
130863747|NCT03214406|471128955|FG001|Overall Study|did not meet enrollment criteria|13|||
130863748|NCT03214406|471128954|FG000|Overall Study|Withdrawal by Subject|1|||
130863749|NCT03214406|471128955|FG001|Overall Study|Withdrawal by Subject|0|||
130863750|NCT03214406|471128954|FG000|Overall Study|Lost to Follow-up|0|||
130863751|NCT03214406|471128955|FG001|Overall Study|Lost to Follow-up|2|||
130863752|NCT00604695|471128956|FG000|Overall Study|Did not receive first bolus.|0|||
130863753|NCT00604695|471128957|FG001|Overall Study|Did not receive first bolus.|4|||
130863754|NCT01098305|471128961|FG000|Overall Study|Lost to Follow-up|31|||
130863755|NCT01098305|471128962|FG001|Overall Study|Lost to Follow-up|33|||
130863756|NCT04677504|471128967|FG000|Overall Study|Death|51|||
130863757|NCT04677504|471128968|FG001|Overall Study|Death|49|||
130863758|NCT04677504|471128967|FG000|Overall Study|Progressive Disease|1|||
130863759|NCT04677504|471128968|FG001|Overall Study|Progressive Disease|0|||
130863760|NCT04677504|471128967|FG000|Overall Study|Symptomatic Deterioration|1|||
130863761|NCT04677504|471128968|FG001|Overall Study|Symptomatic Deterioration|0|||
130863762|NCT04677504|471128967|FG000|Overall Study|Withdrawal by Subject|2|||
130863763|NCT04677504|471128968|FG001|Overall Study|Withdrawal by Subject|5|||
130863764|NCT04677504|471128967|FG000|Overall Study|Study Terminated By Sponsor|28|||
130863765|NCT04677504|471128968|FG001|Overall Study|Study Terminated By Sponsor|24|||
130863766|NCT04677504|471128967|FG000|Overall Study|Adverse Event|0|||
130863767|NCT04677504|471128968|FG001|Overall Study|Adverse Event|1|||
130863768|NCT03182907|471128969|FG000|Overall Study|Death|3|||
130863769|NCT03182907|471128970|FG001|Overall Study|Death|0|||
130863770|NCT03182907|471128969|FG000|Overall Study|Protocol Violation|4|||
130863771|NCT03182907|471128970|FG001|Overall Study|Protocol Violation|0|||
130863772|NCT03182907|471128969|FG000|Overall Study|Lost to Follow-up|1|||
130863773|NCT03182907|471128970|FG001|Overall Study|Lost to Follow-up|0|||
130863774|NCT03182907|471128969|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130863775|NCT03182907|471128970|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130863776|NCT01180296|471128977|FG000|Overall Study|Protocol Violation|1|||
130863777|NCT01180296|471128978|FG001|Overall Study|Protocol Violation|2|||
130863778|NCT01052077|471128980|FG000|Phase A|Lost to Follow-up|22|||
130863779|NCT01052077|471128981|FG001|Phase A|Lost to Follow-up|0|||
130863780|NCT01052077|471128982|FG002|Phase A|Lost to Follow-up|0|||
130863781|NCT01052077|471128983|FG003|Phase A|Lost to Follow-up|0|||
130863782|NCT01052077|471128980|FG000|Phase A|Adverse Event|32|||
130863783|NCT01052077|471128981|FG001|Phase A|Adverse Event|0|||
130863784|NCT01052077|471128982|FG002|Phase A|Adverse Event|0|||
130863785|NCT01052077|471128983|FG003|Phase A|Adverse Event|0|||
130863786|NCT01052077|471128980|FG000|Phase A|Met Withdrawal Criteria|26|||
130863787|NCT01052077|471128981|FG001|Phase A|Met Withdrawal Criteria|0|||
130863788|NCT01052077|471128982|FG002|Phase A|Met Withdrawal Criteria|0|||
130863789|NCT01052077|471128983|FG003|Phase A|Met Withdrawal Criteria|0|||
130863790|NCT01052077|471128980|FG000|Phase A|Physician Decision|10|||
130863791|NCT01052077|471128981|FG001|Phase A|Physician Decision|0|||
130863792|NCT01052077|471128982|FG002|Phase A|Physician Decision|0|||
130863793|NCT01052077|471128983|FG003|Phase A|Physician Decision|0|||
130863794|NCT01052077|471128980|FG000|Phase A|Withdrawal by Subject|29|||
130863795|NCT01052077|471128981|FG001|Phase A|Withdrawal by Subject|0|||
130863796|NCT01052077|471128982|FG002|Phase A|Withdrawal by Subject|0|||
130863797|NCT01052077|471128983|FG003|Phase A|Withdrawal by Subject|0|||
130863798|NCT01052077|471128980|FG000|Phase A|Protocol Deviation|27|||
130863799|NCT01052077|471128981|FG001|Phase A|Protocol Deviation|0|||
130863800|NCT01052077|471128982|FG002|Phase A|Protocol Deviation|0|||
130863801|NCT01052077|471128983|FG003|Phase A|Protocol Deviation|0|||
130863802|NCT01052077|471128980|FG000|Phase B|Lost to Follow-up|0|||
130863803|NCT01052077|471128981|FG001|Phase B|Lost to Follow-up|2|||
130863804|NCT01052077|471128982|FG002|Phase B|Lost to Follow-up|3|||
130863805|NCT01052077|471128983|FG003|Phase B|Lost to Follow-up|0|||
130863806|NCT01052077|471128980|FG000|Phase B|Adverse Event|0|||
130863807|NCT01052077|471128981|FG001|Phase B|Adverse Event|9|||
130863808|NCT01052077|471128982|FG002|Phase B|Adverse Event|2|||
130863809|NCT01052077|471128983|FG003|Phase B|Adverse Event|0|||
130863810|NCT01052077|471128980|FG000|Phase B|Met Withdrawal Criteria|0|||
130863811|NCT01052077|471128981|FG001|Phase B|Met Withdrawal Criteria|2|||
130863812|NCT01052077|471128982|FG002|Phase B|Met Withdrawal Criteria|1|||
130863813|NCT01052077|471128983|FG003|Phase B|Met Withdrawal Criteria|0|||
130863814|NCT01052077|471128980|FG000|Phase B|Physician Decision|0|||
130863815|NCT01052077|471128981|FG001|Phase B|Physician Decision|1|||
130863816|NCT01052077|471128982|FG002|Phase B|Physician Decision|1|||
130863817|NCT01052077|471128983|FG003|Phase B|Physician Decision|0|||
130863818|NCT01052077|471128980|FG000|Phase B|Withdrawal by Subject|0|||
130863819|NCT01052077|471128981|FG001|Phase B|Withdrawal by Subject|0|||
130863820|NCT01052077|471128982|FG002|Phase B|Withdrawal by Subject|5|||
130863821|NCT01052077|471128983|FG003|Phase B|Withdrawal by Subject|0|||
130863822|NCT01052077|471128980|FG000|Phase B|Protocol Deviation|0|||
130863823|NCT01052077|471128981|FG001|Phase B|Protocol Deviation|3|||
130863824|NCT01052077|471128982|FG002|Phase B|Protocol Deviation|4|||
130863825|NCT01052077|471128983|FG003|Phase B|Protocol Deviation|0|||
130863826|NCT01052077|471128980|FG000|Phase B|Lack of Efficacy|0|||
130863827|NCT01052077|471128981|FG001|Phase B|Lack of Efficacy|1|||
130863828|NCT01052077|471128982|FG002|Phase B|Lack of Efficacy|0|||
130863829|NCT01052077|471128983|FG003|Phase B|Lack of Efficacy|0|||
130863830|NCT01052077|471128980|FG000|Phase A+|Lost to Follow-up|0|||
130863831|NCT01052077|471128981|FG001|Phase A+|Lost to Follow-up|0|||
130863832|NCT01052077|471128982|FG002|Phase A+|Lost to Follow-up|0|||
130863833|NCT01052077|471128983|FG003|Phase A+|Lost to Follow-up|8|||
130863834|NCT01052077|471128980|FG000|Phase A+|Adverse Event|0|||
130863835|NCT01052077|471128981|FG001|Phase A+|Adverse Event|0|||
130863836|NCT01052077|471128982|FG002|Phase A+|Adverse Event|0|||
130863837|NCT01052077|471128983|FG003|Phase A+|Adverse Event|4|||
130863838|NCT01052077|471128980|FG000|Phase A+|Met Withdrawal Criteria|0|||
130863839|NCT01052077|471128981|FG001|Phase A+|Met Withdrawal Criteria|0|||
130863840|NCT01052077|471128982|FG002|Phase A+|Met Withdrawal Criteria|0|||
130863841|NCT01052077|471128983|FG003|Phase A+|Met Withdrawal Criteria|2|||
130863842|NCT01052077|471128980|FG000|Phase A+|Withdrawal by Subject|0|||
130863843|NCT01052077|471128981|FG001|Phase A+|Withdrawal by Subject|0|||
130863844|NCT01052077|471128982|FG002|Phase A+|Withdrawal by Subject|0|||
130863845|NCT01052077|471128983|FG003|Phase A+|Withdrawal by Subject|7|||
130863846|NCT04230213|471128989|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
130863847|NCT04230213|471128990|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
130863848|NCT04230213|471128991|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
130863849|NCT04230213|471128989|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
130863850|NCT04230213|471128990|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
130863851|NCT04230213|471128991|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
130863852|NCT04230213|471128989|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
130863853|NCT04230213|471128990|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
130863854|NCT04230213|471128991|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
130863855|NCT04230213|471128989|FG000|TP2: Week 10 to Week 16|Other|0|||
130863856|NCT04230213|471128990|FG001|TP2: Week 10 to Week 16|Other|2|||
130863857|NCT04230213|471128991|FG002|TP2: Week 10 to Week 16|Other|1|||
130863858|NCT04230213|471128989|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
130863859|NCT04230213|471128990|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
130863860|NCT04230213|471128991|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
130863861|NCT04230213|471128989|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
130863862|NCT04230213|471128990|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
130863863|NCT04230213|471128991|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
130863864|NCT04230213|471128989|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
130863865|NCT04230213|471128990|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
130863866|NCT04230213|471128991|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
130863867|NCT04230213|471128989|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
130863868|NCT04230213|471128990|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
130863869|NCT04230213|471128991|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
130863870|NCT04230213|471128989|FG000|TP3: Week 16 to Week 22|Other|0|||
130863871|NCT04230213|471128990|FG001|TP3: Week 16 to Week 22|Other|1|||
130863872|NCT04230213|471128991|FG002|TP3: Week 16 to Week 22|Other|3|||
130863873|NCT04230213|471128989|FG000|TP4: Week 22 to Week 32|Other|0|||
130863874|NCT04230213|471128990|FG001|TP4: Week 22 to Week 32|Other|5|||
130863875|NCT04230213|471128991|FG002|TP4: Week 22 to Week 32|Other|5|||
130863876|NCT04230213|471128989|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
130863877|NCT04230213|471128990|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
130863878|NCT04230213|471128991|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
130863879|NCT04230213|471128989|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
130863880|NCT04230213|471128990|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
130863881|NCT04230213|471128991|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
130863882|NCT04230213|471128989|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
130863883|NCT04230213|471128990|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
130863884|NCT04230213|471128991|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
130863885|NCT04230213|471128989|FG000|Follow up: Week 32 to Week 36|Other|0|||
130863886|NCT04230213|471128990|FG001|Follow up: Week 32 to Week 36|Other|1|||
130863887|NCT04230213|471128991|FG002|Follow up: Week 32 to Week 36|Other|1|||
130863888|NCT04371666|471128993|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
130863889|NCT04371666|471128994|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
130863890|NCT04371666|471128993|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
130863891|NCT04371666|471128994|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
130863892|NCT04371666|471128993|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
130863893|NCT04371666|471128994|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
130863894|NCT04371666|471128993|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
130863895|NCT04371666|471128994|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
130863896|NCT04371666|471128993|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
130863897|NCT04371666|471128994|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
130863898|NCT04371666|471128993|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
130863899|NCT04371666|471128994|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
130863900|NCT00861471|471129007|FG000|Overall Study|Withdrawal by Subject|1|||
130863901|NCT00861471|471129007|FG000|Overall Study|Adverse Event|2|||
130863902|NCT00861471|471129007|FG000|Overall Study|Lack of Efficacy|3|||
130863903|NCT00861471|471129007|FG000|Overall Study|treatment for lumbar laminectomy|1|||
130863904|NCT00861471|471129007|FG000|Overall Study|Physician Decision|2|||
130863905|NCT01445080|471129008|FG000|Overall Study|Adverse Event|5|||
130863906|NCT01445080|471129009|FG001|Overall Study|Adverse Event|3|||
130863907|NCT01445080|471129010|FG002|Overall Study|Adverse Event|11|||
130863908|NCT01445080|471129011|FG003|Overall Study|Adverse Event|6|||
130863909|NCT01445080|471129012|FG004|Overall Study|Adverse Event|2|||
130863910|NCT01445080|471129013|FG005|Overall Study|Adverse Event|3|||
130863911|NCT01445080|471129014|FG006|Overall Study|Adverse Event|0|||
130863912|NCT01445080|471129015|FG007|Overall Study|Adverse Event|3|||
130863913|NCT01445080|471129016|FG008|Overall Study|Adverse Event|10|||
130863914|NCT01445080|471129008|FG000|Overall Study|Physician Decision|0|||
130863915|NCT01445080|471129009|FG001|Overall Study|Physician Decision|0|||
130863916|NCT01445080|471129010|FG002|Overall Study|Physician Decision|1|||
130863917|NCT01445080|471129011|FG003|Overall Study|Physician Decision|0|||
130863918|NCT01445080|471129012|FG004|Overall Study|Physician Decision|0|||
130863919|NCT01445080|471129013|FG005|Overall Study|Physician Decision|3|||
130863920|NCT01445080|471129014|FG006|Overall Study|Physician Decision|2|||
130863921|NCT01445080|471129015|FG007|Overall Study|Physician Decision|2|||
130863922|NCT01445080|471129016|FG008|Overall Study|Physician Decision|0|||
130863923|NCT01445080|471129008|FG000|Overall Study|Withdrawal by Subject|1|||
130863924|NCT01445080|471129009|FG001|Overall Study|Withdrawal by Subject|0|||
130863925|NCT01445080|471129010|FG002|Overall Study|Withdrawal by Subject|0|||
130863926|NCT01445080|471129011|FG003|Overall Study|Withdrawal by Subject|1|||
130863927|NCT01445080|471129012|FG004|Overall Study|Withdrawal by Subject|0|||
130863928|NCT01445080|471129013|FG005|Overall Study|Withdrawal by Subject|0|||
130863929|NCT01445080|471129014|FG006|Overall Study|Withdrawal by Subject|0|||
130863930|NCT01445080|471129015|FG007|Overall Study|Withdrawal by Subject|0|||
130863931|NCT01445080|471129016|FG008|Overall Study|Withdrawal by Subject|2|||
130863932|NCT01445080|471129008|FG000|Overall Study|Ineligible/Inevaluable|1|||
130863933|NCT01445080|471129009|FG001|Overall Study|Ineligible/Inevaluable|2|||
130863934|NCT01445080|471129010|FG002|Overall Study|Ineligible/Inevaluable|0|||
130863935|NCT01445080|471129011|FG003|Overall Study|Ineligible/Inevaluable|1|||
130863936|NCT01445080|471129012|FG004|Overall Study|Ineligible/Inevaluable|2|||
130863937|NCT01445080|471129013|FG005|Overall Study|Ineligible/Inevaluable|3|||
130863938|NCT01445080|471129014|FG006|Overall Study|Ineligible/Inevaluable|0|||
130863939|NCT01445080|471129015|FG007|Overall Study|Ineligible/Inevaluable|0|||
130863940|NCT01445080|471129016|FG008|Overall Study|Ineligible/Inevaluable|6|||
130863941|NCT00445770|471129017|FG000|Overall Study|Adverse Event|9|||
130863942|NCT00445770|471129018|FG001|Overall Study|Adverse Event|15|||
130863943|NCT00445770|471129019|FG002|Overall Study|Adverse Event|19|||
130863944|NCT00445770|471129017|FG000|Overall Study|Lack of Efficacy|38|||
130863945|NCT00445770|471129018|FG001|Overall Study|Lack of Efficacy|13|||
130863946|NCT00445770|471129019|FG002|Overall Study|Lack of Efficacy|6|||
130863947|NCT00445770|471129017|FG000|Overall Study|Lost to Follow-up|0|||
130863948|NCT00445770|471129018|FG001|Overall Study|Lost to Follow-up|2|||
130863949|NCT00445770|471129019|FG002|Overall Study|Lost to Follow-up|0|||
130863950|NCT00445770|471129017|FG000|Overall Study|Other|6|||
130863951|NCT00445770|471129018|FG001|Overall Study|Other|5|||
130863952|NCT00445770|471129019|FG002|Overall Study|Other|6|||
130863953|NCT03857542|471129020|FG000|Overall Study|Adverse Event|1|||
130863954|NCT03857542|471129021|FG001|Overall Study|Adverse Event|3|||
130863955|NCT03857542|471129020|FG000|Overall Study|Withdrawal by Subject|2|||
130863956|NCT03857542|471129021|FG001|Overall Study|Withdrawal by Subject|1|||
130863957|NCT03857542|471129020|FG000|Overall Study|Lost to Follow-up|2|||
130863958|NCT03857542|471129021|FG001|Overall Study|Lost to Follow-up|1|||
130863959|NCT03857542|471129020|FG000|Overall Study|Reason not Specified|1|||
130863960|NCT03857542|471129021|FG001|Overall Study|Reason not Specified|0|||
130863961|NCT03058692|471130895|FG000|Overall Study|Lost to Follow-up|2|||
130863962|NCT03058692|471130896|FG001|Overall Study|Lost to Follow-up|1|||
130863963|NCT03058692|471130895|FG000|Overall Study|Withdrawal by Subject|1|||
130863964|NCT03058692|471130896|FG001|Overall Study|Withdrawal by Subject|1|||
130863965|NCT01698814|471130899|FG000|Overall Study|Adverse Event|0|||
130863966|NCT01698814|471130900|FG001|Overall Study|Adverse Event|2|||
130863967|NCT01698814|471130899|FG000|Overall Study|Lost to Follow-up|0|||
130863968|NCT01698814|471130900|FG001|Overall Study|Lost to Follow-up|1|||
130863969|NCT01698814|471130899|FG000|Overall Study|Pregnancy|1|||
130863970|NCT01698814|471130900|FG001|Overall Study|Pregnancy|0|||
130863971|NCT01698814|471130899|FG000|Overall Study|Randomized in error|1|||
130863972|NCT01698814|471130900|FG001|Overall Study|Randomized in error|0|||
130863973|NCT04014062|471130901|FG000|Period I: Dosing|Medical Grounds|4|||
130863974|NCT04014062|471130902|FG001|Period I: Dosing|Medical Grounds|5|||
130863975|NCT04014062|471130901|FG000|Period I: Dosing|Withdrawal by Subject|3|||
130863976|NCT04014062|471130902|FG001|Period I: Dosing|Withdrawal by Subject|1|||
130863977|NCT03038126|471130904|FG000|Overall Study|Death|1|||
130863978|NCT03038126|471130905|FG001|Overall Study|Death|1|||
130863979|NCT03038126|471130904|FG000|Overall Study|Withdrawal by Subject|5|||
130863980|NCT03038126|471130905|FG001|Overall Study|Withdrawal by Subject|0|||
130863981|NCT03038126|471130904|FG000|Overall Study|Lost to Follow-up|0|||
130863982|NCT03038126|471130905|FG001|Overall Study|Lost to Follow-up|1|||
130863983|NCT03038126|471130904|FG000|Overall Study|Long Term Hospitalization|2|||
130863984|NCT03038126|471130905|FG001|Overall Study|Long Term Hospitalization|0|||
130863985|NCT03038126|471130904|FG000|Overall Study|Too Ill to Participate|1|||
130863986|NCT03038126|471130905|FG001|Overall Study|Too Ill to Participate|2|||
130863987|NCT01724866|471130906|FG000|Overall Study|Adverse Event|0|||
130863988|NCT01724866|471130907|FG001|Overall Study|Adverse Event|0|||
130863989|NCT01724866|471130908|FG002|Overall Study|Adverse Event|1|||
130863990|NCT01724866|471130909|FG003|Overall Study|Adverse Event|1|||
130863991|NCT01724866|471130906|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
130863992|NCT01724866|471130907|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
130863993|NCT01724866|471130908|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
130863994|NCT01724866|471130909|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
130863995|NCT01724866|471130906|FG000|Overall Study|Investigator's Discretion|0|||
130863996|NCT01724866|471130907|FG001|Overall Study|Investigator's Discretion|1|||
130863997|NCT01724866|471130908|FG002|Overall Study|Investigator's Discretion|1|||
130863998|NCT01724866|471130909|FG003|Overall Study|Investigator's Discretion|0|||
130863999|NCT01724866|471130906|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
130864000|NCT01724866|471130907|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
130864001|NCT01724866|471130908|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
130864002|NCT01724866|471130909|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
130864003|NCT01724866|471130906|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
130864004|NCT01724866|471130907|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
130864005|NCT01724866|471130908|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
130864006|NCT01724866|471130909|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
130864007|NCT01424501|471130910|FG000|Overall Study|Withdrawal by Subject|1|||
130864008|NCT01424501|471130911|FG001|Overall Study|Withdrawal by Subject|0|||
130864009|NCT01424501|471130912|FG002|Overall Study|Withdrawal by Subject|1|||
130864010|NCT01424501|471130913|FG003|Overall Study|Withdrawal by Subject|0|||
130864011|NCT01424501|471130914|FG004|Overall Study|Withdrawal by Subject|0|||
130864012|NCT01424501|471130915|FG005|Overall Study|Withdrawal by Subject|0|||
130864013|NCT01424501|471130910|FG000|Overall Study|Lost to Follow-up|0|||
130864014|NCT01424501|471130911|FG001|Overall Study|Lost to Follow-up|1|||
130864015|NCT01424501|471130912|FG002|Overall Study|Lost to Follow-up|1|||
130864016|NCT01424501|471130913|FG003|Overall Study|Lost to Follow-up|0|||
130864017|NCT01424501|471130914|FG004|Overall Study|Lost to Follow-up|0|||
130864018|NCT01424501|471130915|FG005|Overall Study|Lost to Follow-up|0|||
130864019|NCT01980095|471130916|FG000|Overall Study|Lost to Follow-up|6|||
130864020|NCT01980095|471130917|FG001|Overall Study|Lost to Follow-up|7|||
130864021|NCT01980095|471130916|FG000|Overall Study|Withdrawal by Subject|2|||
130864022|NCT01980095|471130917|FG001|Overall Study|Withdrawal by Subject|3|||
130864023|NCT01980095|471130916|FG000|Overall Study|Poor compliance|5|||
130864024|NCT01980095|471130917|FG001|Overall Study|Poor compliance|0|||
130864025|NCT01980095|471130916|FG000|Overall Study|Safety issue|0|||
130864026|NCT01980095|471130917|FG001|Overall Study|Safety issue|1|||
130864027|NCT01980095|471130916|FG000|Overall Study|Study drug discontinued|1|||
130864028|NCT01980095|471130917|FG001|Overall Study|Study drug discontinued|0|||
130864029|NCT01980095|471130916|FG000|Overall Study|Randomized by mistake|1|||
130864030|NCT01980095|471130917|FG001|Overall Study|Randomized by mistake|0|||
130864031|NCT04426318|471130918|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
130864032|NCT04426318|471130919|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
130864033|NCT03574779|471130920|FG000|Overall Study|Screening failure|13|||
130864034|NCT03574779|471130921|FG001|Overall Study|Screening failure|83|||
130864035|NCT02588261|471130922|FG000|Overall Study|Study Terminated by Sponsor|157|||
130864036|NCT02588261|471130923|FG001|Overall Study|Study Terminated by Sponsor|142|||
130864037|NCT02588261|471130922|FG000|Overall Study|Protocol Deviation|1|||
130864038|NCT02588261|471130923|FG001|Overall Study|Protocol Deviation|0|||
130864039|NCT02588261|471130922|FG000|Overall Study|Death|1|||
130864040|NCT02588261|471130923|FG001|Overall Study|Death|2|||
130864041|NCT02588261|471130922|FG000|Overall Study|Withdrawal by Subject|12|||
130864042|NCT02588261|471130923|FG001|Overall Study|Withdrawal by Subject|8|||
130864043|NCT02588261|471130922|FG000|Overall Study|Noncompliance with Study Drug|0|||
130864044|NCT02588261|471130923|FG001|Overall Study|Noncompliance with Study Drug|1|||
130864045|NCT02588261|471130922|FG000|Overall Study|Miscellaneous|5|||
130864046|NCT02588261|471130923|FG001|Overall Study|Miscellaneous|4|||
130864047|NCT02588261|471130922|FG000|Overall Study|Progressive Disease|61|||
130864048|NCT02588261|471130923|FG001|Overall Study|Progressive Disease|82|||
130864049|NCT02588261|471130922|FG000|Overall Study|Adverse Event|29|||
130864050|NCT02588261|471130923|FG001|Overall Study|Adverse Event|24|||
130864051|NCT02588261|471130922|FG000|Overall Study|Lost to Follow-up|1|||
130864052|NCT02588261|471130923|FG001|Overall Study|Lost to Follow-up|0|||
130864053|NCT03781778|471130925|FG000|Overall Study|Withdrawal by Subject|2|||
130864054|NCT03781778|471130926|FG001|Overall Study|Withdrawal by Subject|2|||
130864055|NCT02287467|471130927|FG000|Overall Study|Protocol Violation|12|||
130864056|NCT02287467|471130928|FG001|Overall Study|Protocol Violation|9|||
130864057|NCT01957202|471130929|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864058|NCT01957202|471130930|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
130864059|NCT01957202|471130931|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864060|NCT01957202|471130932|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864061|NCT01957202|471130933|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864062|NCT01957202|471130934|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864063|NCT01957202|471130935|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864064|NCT01957202|471130936|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864065|NCT01957202|471130937|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864066|NCT01957202|471130938|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864067|NCT01957202|471130939|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864068|NCT01957202|471130940|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864069|NCT01957202|471130941|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864070|NCT01957202|471130942|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864071|NCT01957202|471130943|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864072|NCT01957202|471130944|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864073|NCT01957202|471130945|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
130864074|NCT01957202|471130946|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130864075|NCT01957202|471130929|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864076|NCT01957202|471130930|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864077|NCT01957202|471130931|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864078|NCT01957202|471130932|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864079|NCT01957202|471130933|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864080|NCT01957202|471130934|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864081|NCT01957202|471130935|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864082|NCT01957202|471130936|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864083|NCT01957202|471130937|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864084|NCT01957202|471130938|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864085|NCT01957202|471130939|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864086|NCT01957202|471130940|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864087|NCT01957202|471130941|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864088|NCT01957202|471130942|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864089|NCT01957202|471130943|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864090|NCT01957202|471130944|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864091|NCT01957202|471130945|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
130864092|NCT01957202|471130946|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
130864093|NCT01456169|471130947|FG000|Overall Study|Adverse Event|1|||
130864094|NCT01456169|471130948|FG001|Overall Study|Adverse Event|2|||
130864095|NCT01456169|471130949|FG002|Overall Study|Adverse Event|7|||
130864096|NCT01456169|471130947|FG000|Overall Study|Major Protocol Deviation|3|||
130864097|NCT01456169|471130948|FG001|Overall Study|Major Protocol Deviation|2|||
130864098|NCT01456169|471130949|FG002|Overall Study|Major Protocol Deviation|3|||
130864099|NCT01456169|471130947|FG000|Overall Study|Voluntary Withdrawal|3|||
130864100|NCT01456169|471130948|FG001|Overall Study|Voluntary Withdrawal|0|||
130864101|NCT01456169|471130949|FG002|Overall Study|Voluntary Withdrawal|2|||
130864102|NCT01456169|471130947|FG000|Overall Study|Lack of Efficacy|2|||
130864103|NCT01456169|471130948|FG001|Overall Study|Lack of Efficacy|0|||
130864104|NCT01456169|471130949|FG002|Overall Study|Lack of Efficacy|0|||
130864105|NCT01456169|471130947|FG000|Overall Study|Other|1|||
130864106|NCT01456169|471130948|FG001|Overall Study|Other|1|||
130864107|NCT01456169|471130949|FG002|Overall Study|Other|0|||
130864108|NCT02652156|471130954|FG000|Overall Study|Physician Decision|1|||
130864109|NCT02652156|471130955|FG001|Overall Study|Physician Decision|0|||
130864110|NCT02652156|471130956|FG002|Overall Study|Physician Decision|0|||
130864111|NCT02342223|471130957|FG000|Overall Study|Lost to Follow-up|1|||
130864112|NCT01200368|471130962|FG000|Infant Series|Adverse Event|2|||
130864113|NCT01200368|471130963|FG001|Infant Series|Adverse Event|2|||
130864114|NCT01200368|471130964|FG002|Infant Series|Adverse Event|3|||
130864115|NCT01200368|471130962|FG000|Infant Series|Withdrawal by Subject|0|||
130864116|NCT01200368|471130963|FG001|Infant Series|Withdrawal by Subject|2|||
130864117|NCT01200368|471130964|FG002|Infant Series|Withdrawal by Subject|2|||
130864118|NCT01200368|471130962|FG000|Infant Series|Did not meet entrance criteria|0|||
130864119|NCT01200368|471130963|FG001|Infant Series|Did not meet entrance criteria|1|||
130864120|NCT01200368|471130964|FG002|Infant Series|Did not meet entrance criteria|0|||
130864121|NCT01200368|471130962|FG000|Infant Series|Randomized, not vaccinated|0|||
130864122|NCT01200368|471130963|FG001|Infant Series|Randomized, not vaccinated|1|||
130864123|NCT01200368|471130964|FG002|Infant Series|Randomized, not vaccinated|1|||
130864124|NCT01200368|471130962|FG000|Infant Series|Other|1|||
130864125|NCT01200368|471130963|FG001|Infant Series|Other|0|||
130864126|NCT01200368|471130964|FG002|Infant Series|Other|0|||
130864127|NCT01200368|471130962|FG000|After Infant Series|Adverse Event|6|||
130864128|NCT01200368|471130963|FG001|After Infant Series|Adverse Event|6|||
130864129|NCT01200368|471130964|FG002|After Infant Series|Adverse Event|3|||
130864130|NCT01200368|471130962|FG000|After Infant Series|Withdrawal by Subject|10|||
130864131|NCT01200368|471130963|FG001|After Infant Series|Withdrawal by Subject|8|||
130864132|NCT01200368|471130964|FG002|After Infant Series|Withdrawal by Subject|4|||
130864133|NCT01200368|471130962|FG000|After Infant Series|Lost to Follow-up|1|||
130864134|NCT01200368|471130963|FG001|After Infant Series|Lost to Follow-up|0|||
130864135|NCT01200368|471130964|FG002|After Infant Series|Lost to Follow-up|0|||
130864136|NCT01200368|471130962|FG000|After Infant Series|Other|1|||
130864137|NCT01200368|471130963|FG001|After Infant Series|Other|2|||
130864138|NCT01200368|471130964|FG002|After Infant Series|Other|2|||
130864139|NCT01200368|471130962|FG000|Toddler Dose|Adverse Event|0|||
130864140|NCT01200368|471130963|FG001|Toddler Dose|Adverse Event|3|||
130864141|NCT01200368|471130964|FG002|Toddler Dose|Adverse Event|1|||
130864142|NCT00108862|471130965|FG000|Overall Study|Death|31|||
130864143|NCT00108862|471130966|FG001|Overall Study|Death|37|||
130864144|NCT00108862|471130965|FG000|Overall Study|Withdrawal by Subject|10|||
130864145|NCT00108862|471130966|FG001|Overall Study|Withdrawal by Subject|6|||
130864146|NCT00108862|471130965|FG000|Overall Study|Lost to Follow-up|27|||
130864147|NCT00108862|471130966|FG001|Overall Study|Lost to Follow-up|19|||
130864148|NCT03534141|471130967|FG000|Overall Study|Enrolled in other clinical trial|1|||
130864149|NCT03534141|471130968|FG001|Overall Study|Enrolled in other clinical trial|0|||
130864150|NCT03534141|471130967|FG000|Overall Study|Liver transplant aborted after randomization|0|||
130864151|NCT03534141|471130968|FG001|Overall Study|Liver transplant aborted after randomization|2|||
130864152|NCT03534141|471130967|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
130864153|NCT03534141|471130968|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
130864154|NCT00517361|471130969|FG000|Overall Study|Death|6|||
130864155|NCT00517361|471130969|FG000|Overall Study|The study was terminated|5|||
130864156|NCT01685697|471130970|FG000|Overall Study|Protocol Violation|3|||
130864157|NCT01685697|471130971|FG001|Overall Study|Protocol Violation|3|||
130864158|NCT00726232|471130973|FG000|Initial Phase (Dose-finding)|Death|0|||
130864159|NCT00726232|471130974|FG001|Initial Phase (Dose-finding)|Death|0|||
130864160|NCT00726232|471130975|FG002|Initial Phase (Dose-finding)|Death|0|||
130864161|NCT00726232|471130976|FG003|Initial Phase (Dose-finding)|Death|0|||
130864162|NCT00726232|471130977|FG004|Initial Phase (Dose-finding)|Death|1|||
130864163|NCT00726232|471130978|FG005|Initial Phase (Dose-finding)|Death|0|||
130864164|NCT00726232|471130979|FG006|Initial Phase (Dose-finding)|Death|0|||
130864165|NCT00726232|471130980|FG007|Initial Phase (Dose-finding)|Death|0|||
130864166|NCT00726232|471130973|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
130864167|NCT00726232|471130974|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
130864168|NCT00726232|471130975|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
130864169|NCT00726232|471130976|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
130864170|NCT00726232|471130977|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
130864171|NCT00726232|471130978|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
130864172|NCT00726232|471130979|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
130864173|NCT00726232|471130980|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
130864174|NCT00726232|471130973|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
130864175|NCT00726232|471130974|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130864176|NCT00726232|471130975|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130864177|NCT00726232|471130976|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
130864178|NCT00726232|471130977|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130864179|NCT00726232|471130978|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
130864180|NCT00726232|471130979|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130864181|NCT00726232|471130980|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130864182|NCT00726232|471130973|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
130864183|NCT00726232|471130974|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
130864184|NCT00726232|471130975|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
130864185|NCT00726232|471130976|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
130864186|NCT00726232|471130977|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
130864187|NCT00726232|471130978|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
130864188|NCT00726232|471130979|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
130864189|NCT00726232|471130980|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
130864190|NCT00726232|471130973|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
130864191|NCT00726232|471130974|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
130864192|NCT00726232|471130975|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
130864193|NCT00726232|471130976|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
130864194|NCT00726232|471130977|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
130864195|NCT00726232|471130978|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
130864196|NCT00726232|471130979|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
130864197|NCT00726232|471130980|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
130864198|NCT00726232|471130973|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
130864199|NCT00726232|471130974|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130864200|NCT00726232|471130975|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130864201|NCT00726232|471130976|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
130864202|NCT00726232|471130977|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
130864203|NCT00726232|471130978|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
130864204|NCT00726232|471130979|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130864205|NCT00726232|471130980|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130864206|NCT00726232|471130973|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
130864207|NCT00726232|471130974|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
130864208|NCT00726232|471130975|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
130864209|NCT00726232|471130976|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
130864210|NCT00726232|471130977|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
130864211|NCT00726232|471130978|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
130864212|NCT00726232|471130979|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
130864213|NCT00726232|471130980|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
130864214|NCT00726232|471130973|FG000|Expansion Phase|Death|0|||
130864215|NCT00726232|471130974|FG001|Expansion Phase|Death|0|||
130864216|NCT00726232|471130975|FG002|Expansion Phase|Death|0|||
130864217|NCT00726232|471130976|FG003|Expansion Phase|Death|0|||
130864218|NCT00726232|471130977|FG004|Expansion Phase|Death|0|||
130864219|NCT00726232|471130978|FG005|Expansion Phase|Death|0|||
130864220|NCT00726232|471130979|FG006|Expansion Phase|Death|0|||
130864221|NCT00726232|471130980|FG007|Expansion Phase|Death|1|||
130864222|NCT00726232|471130973|FG000|Expansion Phase|Adverse Event|0|||
130864223|NCT00726232|471130974|FG001|Expansion Phase|Adverse Event|0|||
130864224|NCT00726232|471130975|FG002|Expansion Phase|Adverse Event|0|||
130864225|NCT00726232|471130976|FG003|Expansion Phase|Adverse Event|0|||
130864226|NCT00726232|471130977|FG004|Expansion Phase|Adverse Event|0|||
130864227|NCT00726232|471130978|FG005|Expansion Phase|Adverse Event|0|||
130864228|NCT00726232|471130979|FG006|Expansion Phase|Adverse Event|6|||
130864229|NCT00726232|471130980|FG007|Expansion Phase|Adverse Event|11|||
130864230|NCT00726232|471130973|FG000|Expansion Phase|Withdrawal by Subject|0|||
130864231|NCT00726232|471130974|FG001|Expansion Phase|Withdrawal by Subject|0|||
130864232|NCT00726232|471130975|FG002|Expansion Phase|Withdrawal by Subject|0|||
130864233|NCT00726232|471130976|FG003|Expansion Phase|Withdrawal by Subject|0|||
130864234|NCT00726232|471130977|FG004|Expansion Phase|Withdrawal by Subject|0|||
130864235|NCT00726232|471130978|FG005|Expansion Phase|Withdrawal by Subject|0|||
130864236|NCT00726232|471130979|FG006|Expansion Phase|Withdrawal by Subject|2|||
130864237|NCT00726232|471130980|FG007|Expansion Phase|Withdrawal by Subject|3|||
130864238|NCT00726232|471130973|FG000|Expansion Phase|Disease progression|0|||
130864239|NCT00726232|471130974|FG001|Expansion Phase|Disease progression|0|||
130864240|NCT00726232|471130975|FG002|Expansion Phase|Disease progression|0|||
130864241|NCT00726232|471130976|FG003|Expansion Phase|Disease progression|0|||
130864242|NCT00726232|471130977|FG004|Expansion Phase|Disease progression|0|||
130864243|NCT00726232|471130978|FG005|Expansion Phase|Disease progression|0|||
130864244|NCT00726232|471130979|FG006|Expansion Phase|Disease progression|4|||
130864245|NCT00726232|471130980|FG007|Expansion Phase|Disease progression|0|||
130864246|NCT00726232|471130973|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
130864247|NCT00726232|471130974|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
130864248|NCT00726232|471130975|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
130864249|NCT00726232|471130976|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
130864250|NCT00726232|471130977|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
130864251|NCT00726232|471130978|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
130864252|NCT00726232|471130979|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
130864253|NCT00726232|471130980|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
130864254|NCT00726232|471130973|FG000|Expansion Phase|Per Investigator: lack of response|0|||
130864255|NCT00726232|471130974|FG001|Expansion Phase|Per Investigator: lack of response|0|||
130864256|NCT00726232|471130975|FG002|Expansion Phase|Per Investigator: lack of response|0|||
130864257|NCT00726232|471130976|FG003|Expansion Phase|Per Investigator: lack of response|0|||
130864258|NCT00726232|471130977|FG004|Expansion Phase|Per Investigator: lack of response|0|||
130864259|NCT00726232|471130978|FG005|Expansion Phase|Per Investigator: lack of response|0|||
130864260|NCT00726232|471130979|FG006|Expansion Phase|Per Investigator: lack of response|1|||
130864261|NCT00726232|471130980|FG007|Expansion Phase|Per Investigator: lack of response|7|||
130864262|NCT00726232|471130973|FG000|Expansion Phase|Unspecified reason|0|||
130864263|NCT00726232|471130974|FG001|Expansion Phase|Unspecified reason|0|||
130864264|NCT00726232|471130975|FG002|Expansion Phase|Unspecified reason|0|||
130864265|NCT00726232|471130976|FG003|Expansion Phase|Unspecified reason|0|||
130864266|NCT00726232|471130977|FG004|Expansion Phase|Unspecified reason|0|||
130864267|NCT00726232|471130978|FG005|Expansion Phase|Unspecified reason|0|||
130864268|NCT00726232|471130979|FG006|Expansion Phase|Unspecified reason|1|||
130864269|NCT00726232|471130980|FG007|Expansion Phase|Unspecified reason|0|||
130864270|NCT04526145|471130981|FG000|Overall Study|Withdrawal by Subject|5|||
130864271|NCT00566852|471130984|FG000|Overall Study|Protocol Violation|22|||
130864272|NCT00566852|471130985|FG001|Overall Study|Protocol Violation|24|||
130864273|NCT00566852|471130984|FG000|Overall Study|Death|95|||
130864274|NCT00566852|471130985|FG001|Overall Study|Death|78|||
130864275|NCT00566852|471130984|FG000|Overall Study|Withdrawal by Subject|30|||
130864276|NCT00566852|471130985|FG001|Overall Study|Withdrawal by Subject|25|||
130864277|NCT00566852|471130984|FG000|Overall Study|Patient refusal|37|||
130864278|NCT00566852|471130985|FG001|Overall Study|Patient refusal|37|||
130864279|NCT00566852|471130984|FG000|Overall Study|Not tested due to disability|6|||
130864280|NCT00566852|471130985|FG001|Overall Study|Not tested due to disability|12|||
130864281|NCT00566852|471130984|FG000|Overall Study|Missing reason not specified|1|||
130864282|NCT00566852|471130985|FG001|Overall Study|Missing reason not specified|2|||
130864283|NCT00566852|471130984|FG000|Overall Study|Missing reason not reported|16|||
130864284|NCT00566852|471130985|FG001|Overall Study|Missing reason not reported|20|||
130864285|NCT04079816|471130986|FG000|Overall Study|Request of Subject|2|||
130864286|NCT04079816|471130986|FG000|Overall Study|Unable to draw samples|1|||
130864287|NCT04137731|471130987|FG000|Overall Study|Surgery Cancellation|1|||
130864288|NCT04137731|471130988|FG001|Overall Study|Surgery Cancellation|2|||
130864289|NCT04137731|471130987|FG000|Overall Study|Withdrawal by Subject|2|||
130864290|NCT04137731|471130988|FG001|Overall Study|Withdrawal by Subject|0|||
130864291|NCT04137731|471130987|FG000|Overall Study|Protocol Violation|0|||
130864292|NCT04137731|471130988|FG001|Overall Study|Protocol Violation|1|||
130864293|NCT00310817|471130989|FG000|Overall Study|AE or Death|3|||
130864294|NCT00310817|471130990|FG001|Overall Study|AE or Death|1|||
130864295|NCT00310817|471130991|FG002|Overall Study|AE or Death|0|||
130864296|NCT00310817|471130992|FG003|Overall Study|AE or Death|0|||
130864297|NCT00310817|471130989|FG000|Overall Study|Withdrawal by Subject|1|||
130864298|NCT00310817|471130990|FG001|Overall Study|Withdrawal by Subject|4|||
130864299|NCT00310817|471130991|FG002|Overall Study|Withdrawal by Subject|6|||
130864300|NCT00310817|471130992|FG003|Overall Study|Withdrawal by Subject|7|||
130864301|NCT00310817|471130989|FG000|Overall Study|Lost to Follow-up|2|||
130864302|NCT00310817|471130990|FG001|Overall Study|Lost to Follow-up|1|||
130864303|NCT00310817|471130991|FG002|Overall Study|Lost to Follow-up|0|||
130864304|NCT00310817|471130992|FG003|Overall Study|Lost to Follow-up|0|||
130864305|NCT00310817|471130989|FG000|Overall Study|Inappropriate Enrollment|1|||
130864306|NCT00310817|471130990|FG001|Overall Study|Inappropriate Enrollment|0|||
130864307|NCT00310817|471130991|FG002|Overall Study|Inappropriate Enrollment|1|||
130864308|NCT00310817|471130992|FG003|Overall Study|Inappropriate Enrollment|0|||
130864309|NCT00310817|471130989|FG000|Overall Study|Protocol Violation|1|||
130864310|NCT00310817|471130990|FG001|Overall Study|Protocol Violation|1|||
130864311|NCT00310817|471130991|FG002|Overall Study|Protocol Violation|1|||
130864312|NCT00310817|471130992|FG003|Overall Study|Protocol Violation|1|||
130864313|NCT00310817|471130989|FG000|Overall Study|Unable to classify|3|||
130864314|NCT00310817|471130990|FG001|Overall Study|Unable to classify|1|||
130864315|NCT00310817|471130991|FG002|Overall Study|Unable to classify|0|||
130864316|NCT00310817|471130992|FG003|Overall Study|Unable to classify|0|||
130864317|NCT01702246|471130993|FG000|Overall Study|Lost to Follow-up|2|||
130864318|NCT01702246|471130993|FG000|Overall Study|Withdrawal by Subject|2|||
130864319|NCT01702246|471130993|FG000|Overall Study|Physician Decision|1|||
130864320|NCT02123823|471130994|FG000|Overall Study|Lack of Efficacy|0|||
130864321|NCT02123823|471130995|FG001|Overall Study|Lack of Efficacy|2|||
130864322|NCT02123823|471130996|FG002|Overall Study|Lack of Efficacy|8|||
130864323|NCT02123823|471130997|FG003|Overall Study|Lack of Efficacy|10|||
130864324|NCT02123823|471130994|FG000|Overall Study|Progressive disease|3|||
130864325|NCT02123823|471130995|FG001|Overall Study|Progressive disease|19|||
130864326|NCT02123823|471130996|FG002|Overall Study|Progressive disease|52|||
130864327|NCT02123823|471130997|FG003|Overall Study|Progressive disease|53|||
130864328|NCT02123823|471130994|FG000|Overall Study|Withdrawal by Subject|0|||
130864329|NCT02123823|471130995|FG001|Overall Study|Withdrawal by Subject|0|||
130864330|NCT02123823|471130996|FG002|Overall Study|Withdrawal by Subject|7|||
130864331|NCT02123823|471130997|FG003|Overall Study|Withdrawal by Subject|2|||
130864332|NCT02123823|471130994|FG000|Overall Study|Adverse Event|0|||
130864333|NCT02123823|471130995|FG001|Overall Study|Adverse Event|0|||
130864334|NCT02123823|471130996|FG002|Overall Study|Adverse Event|3|||
130864335|NCT02123823|471130997|FG003|Overall Study|Adverse Event|5|||
130864336|NCT03828019|471131002|FG000|Overall Study|Withdrawal by Subject|3|||
130864337|NCT03828019|471131003|FG001|Overall Study|Withdrawal by Subject|8|||
130864338|NCT03828019|471131002|FG000|Overall Study|Lost to Follow-up|1|||
130864339|NCT03828019|471131003|FG001|Overall Study|Lost to Follow-up|6|||
130864340|NCT03828019|471131002|FG000|Overall Study|Incarcerated|1|||
130864341|NCT03828019|471131003|FG001|Overall Study|Incarcerated|0|||
130864342|NCT03828019|471131002|FG000|Overall Study|Adverse Event|0|||
130864343|NCT03828019|471131003|FG001|Overall Study|Adverse Event|1|||
130864344|NCT05715242|471131004|FG000|Overall Study|Lost to Follow-up|0|||
130864345|NCT05715242|471131005|FG001|Overall Study|Lost to Follow-up|0|||
130864346|NCT05715242|471131006|FG002|Overall Study|Lost to Follow-up|1|||
130864347|NCT05715242|471131007|FG003|Overall Study|Lost to Follow-up|0|||
130864348|NCT05715242|471131008|FG004|Overall Study|Lost to Follow-up|0|||
130864349|NCT05715242|471131009|FG005|Overall Study|Lost to Follow-up|1|||
130864350|NCT05715242|471131010|FG006|Overall Study|Lost to Follow-up|0|||
130864351|NCT05715242|471131011|FG007|Overall Study|Lost to Follow-up|0|||
130864352|NCT05715242|471131012|FG008|Overall Study|Lost to Follow-up|0|||
130864353|NCT05715242|471131013|FG009|Overall Study|Lost to Follow-up|0|||
130864354|NCT05715242|471131014|FG010|Overall Study|Lost to Follow-up|0|||
130864355|NCT05715242|471131015|FG011|Overall Study|Lost to Follow-up|0|||
130864356|NCT05715242|471131016|FG012|Overall Study|Lost to Follow-up|0|||
130864357|NCT05715242|471131017|FG013|Overall Study|Lost to Follow-up|0|||
130864358|NCT05715242|471131018|FG014|Overall Study|Lost to Follow-up|0|||
130864359|NCT05715242|471131019|FG015|Overall Study|Lost to Follow-up|0|||
130864360|NCT03400176|471131020|FG000|Dose Escalation|Progressive disease|1|||
130864361|NCT03400176|471131021|FG001|Dose Escalation|Progressive disease|1|||
130864362|NCT03400176|471131022|FG002|Dose Escalation|Progressive disease|0|||
130864363|NCT03400176|471131023|FG003|Dose Escalation|Progressive disease|0|||
130864364|NCT03400176|471131024|FG004|Dose Escalation|Progressive disease|1|||
130864365|NCT03400176|471131020|FG000|Dose Escalation|Patient decision|0|||
130864366|NCT03400176|471131021|FG001|Dose Escalation|Patient decision|0|||
130864367|NCT03400176|471131022|FG002|Dose Escalation|Patient decision|0|||
130864368|NCT03400176|471131023|FG003|Dose Escalation|Patient decision|0|||
130864369|NCT03400176|471131024|FG004|Dose Escalation|Patient decision|1|||
130864370|NCT03400176|471131020|FG000|Dose Expansion|Patient decision|0|||
130864371|NCT03400176|471131021|FG001|Dose Expansion|Patient decision|0|||
130864372|NCT03400176|471131022|FG002|Dose Expansion|Patient decision|0|||
130864373|NCT03400176|471131023|FG003|Dose Expansion|Patient decision|1|||
130864374|NCT03400176|471131024|FG004|Dose Expansion|Patient decision|0|||
130864375|NCT03400176|471131020|FG000|Dose Expansion|Adverse Event|0|||
130864376|NCT03400176|471131021|FG001|Dose Expansion|Adverse Event|0|||
130864377|NCT03400176|471131022|FG002|Dose Expansion|Adverse Event|0|||
130864378|NCT03400176|471131023|FG003|Dose Expansion|Adverse Event|1|||
130864379|NCT03400176|471131024|FG004|Dose Expansion|Adverse Event|0|||
130864380|NCT03400176|471131020|FG000|Dose Expansion|Physician Decision|0|||
130864381|NCT03400176|471131021|FG001|Dose Expansion|Physician Decision|0|||
130864382|NCT03400176|471131022|FG002|Dose Expansion|Physician Decision|0|||
130864383|NCT03400176|471131023|FG003|Dose Expansion|Physician Decision|1|||
130864384|NCT03400176|471131024|FG004|Dose Expansion|Physician Decision|0|||
130864385|NCT03400176|471131020|FG000|Dose Expansion|Progressive disease|0|||
130864386|NCT03400176|471131021|FG001|Dose Expansion|Progressive disease|0|||
130864387|NCT03400176|471131022|FG002|Dose Expansion|Progressive disease|1|||
130864388|NCT03400176|471131023|FG003|Dose Expansion|Progressive disease|1|||
130864389|NCT03400176|471131024|FG004|Dose Expansion|Progressive disease|0|||
130864390|NCT02343406|471131027|FG000|Overall Study|Progressive disease|72|||
130864391|NCT02343406|471131028|FG001|Overall Study|Progressive disease|70|||
130864392|NCT02343406|471131029|FG002|Overall Study|Progressive disease|43|||
130864393|NCT02343406|471131030|FG003|Overall Study|Progressive disease|15|||
130864394|NCT02343406|471131031|FG004|Overall Study|Progressive disease|5|||
130864395|NCT02343406|471131027|FG000|Overall Study|Adverse Event|6|||
130864396|NCT02343406|471131028|FG001|Overall Study|Adverse Event|8|||
130864397|NCT02343406|471131029|FG002|Overall Study|Adverse Event|6|||
130864398|NCT02343406|471131030|FG003|Overall Study|Adverse Event|3|||
130864399|NCT02343406|471131031|FG004|Overall Study|Adverse Event|0|||
130864400|NCT02343406|471131027|FG000|Overall Study|Withdrawal by Subject|6|||
130864401|NCT02343406|471131028|FG001|Overall Study|Withdrawal by Subject|4|||
130864402|NCT02343406|471131029|FG002|Overall Study|Withdrawal by Subject|8|||
130864403|NCT02343406|471131030|FG003|Overall Study|Withdrawal by Subject|3|||
130864404|NCT02343406|471131031|FG004|Overall Study|Withdrawal by Subject|0|||
130864405|NCT02343406|471131027|FG000|Overall Study|Death|2|||
130864406|NCT02343406|471131028|FG001|Overall Study|Death|1|||
130864407|NCT02343406|471131029|FG002|Overall Study|Death|0|||
130864408|NCT02343406|471131030|FG003|Overall Study|Death|0|||
130864409|NCT02343406|471131031|FG004|Overall Study|Death|0|||
130864410|NCT02343406|471131027|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
130864411|NCT02343406|471131028|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
130864412|NCT02343406|471131029|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
130864413|NCT02343406|471131030|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
130864414|NCT02343406|471131031|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
130864415|NCT02343406|471131027|FG000|Overall Study|Other primary malignancy|0|||
130864416|NCT02343406|471131028|FG001|Overall Study|Other primary malignancy|1|||
130864417|NCT02343406|471131029|FG002|Overall Study|Other primary malignancy|0|||
130864418|NCT02343406|471131030|FG003|Overall Study|Other primary malignancy|0|||
130864419|NCT02343406|471131031|FG004|Overall Study|Other primary malignancy|0|||
130864420|NCT02343406|471131027|FG000|Overall Study|Other, not specified|2|||
130864421|NCT02343406|471131028|FG001|Overall Study|Other, not specified|1|||
130864422|NCT02343406|471131029|FG002|Overall Study|Other, not specified|1|||
130864423|NCT02343406|471131030|FG003|Overall Study|Other, not specified|4|||
130864424|NCT02343406|471131031|FG004|Overall Study|Other, not specified|0|||
130864425|NCT00958165|471131032|FG000|Overall Study|Lost to Follow-up|5|||
130864426|NCT00958165|471131032|FG000|Overall Study|Not eligible|9|||
130864427|NCT01298765|471131033|FG000|Titration Period|Adverse Event|26|||
130864428|NCT01298765|471131033|FG000|Titration Period|Death|1|||
130864429|NCT01298765|471131033|FG000|Titration Period|Lack of Efficacy|21|||
130864430|NCT01298765|471131033|FG000|Titration Period|Lost to Follow-up|9|||
130864431|NCT01298765|471131033|FG000|Titration Period|Physician Decision|1|||
130864432|NCT01298765|471131033|FG000|Titration Period|Withdrawal by Subject|10|||
130864433|NCT01298765|471131033|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
130864434|NCT01298765|471131033|FG000|Long-Term Treatment Period|Adverse Event|19|||
130864435|NCT01298765|471131033|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
130864436|NCT01298765|471131033|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
130864437|NCT01298765|471131033|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
130864438|NCT01298765|471131033|FG000|Long-Term Treatment Period|Physician Decision|1|||
130864439|NCT01298765|471131033|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
130864440|NCT00766051|471131034|FG000|Overall Study|Withdrawal by Subject|2|||
130864441|NCT00766051|471131035|FG001|Overall Study|Withdrawal by Subject|0|||
130864442|NCT03302247|471131038|FG000|Overall Study|the study has closed prematurely|2|||
130864443|NCT03302247|471131038|FG000|Overall Study|Death|1|||
130864444|NCT00166439|471131042|FG000|Overall Study|Ineligible|5|||
130864445|NCT03364309|471131045|FG000|Induction Period|Adverse Event|4|||
130864446|NCT03364309|471131046|FG001|Induction Period|Adverse Event|0|||
130864447|NCT03364309|471131047|FG002|Induction Period|Adverse Event|1|||
130864448|NCT03364309|471131048|FG003|Induction Period|Adverse Event|0|||
130864449|NCT03364309|471131049|FG004|Induction Period|Adverse Event|0|||
130864450|NCT03364309|471131050|FG005|Induction Period|Adverse Event|0|||
130864451|NCT03364309|471131051|FG006|Induction Period|Adverse Event|0|||
130864452|NCT03364309|471131052|FG007|Induction Period|Adverse Event|0|||
130864453|NCT03364309|471131053|FG008|Induction Period|Adverse Event|0|||
130864454|NCT03364309|471131054|FG009|Induction Period|Adverse Event|0|||
130864455|NCT03364309|471131055|FG010|Induction Period|Adverse Event|0|||
130864456|NCT03364309|471131056|FG011|Induction Period|Adverse Event|0|||
130864457|NCT03364309|471131057|FG012|Induction Period|Adverse Event|0|||
130864458|NCT03364309|471131058|FG013|Induction Period|Adverse Event|0|||
130864459|NCT03364309|471131059|FG014|Induction Period|Adverse Event|0|||
130864460|NCT03364309|471131060|FG015|Induction Period|Adverse Event|0|||
130864461|NCT03364309|471131061|FG016|Induction Period|Adverse Event|0|||
130864462|NCT03364309|471131062|FG017|Induction Period|Adverse Event|0|||
130864463|NCT03364309|471131063|FG018|Induction Period|Adverse Event|0|||
130864464|NCT03364309|471131045|FG000|Induction Period|Withdrawal by Subject|1|||
130864465|NCT03364309|471131046|FG001|Induction Period|Withdrawal by Subject|3|||
130864466|NCT03364309|471131047|FG002|Induction Period|Withdrawal by Subject|0|||
130864467|NCT03364309|471131048|FG003|Induction Period|Withdrawal by Subject|0|||
130864468|NCT03364309|471131049|FG004|Induction Period|Withdrawal by Subject|0|||
130864469|NCT03364309|471131050|FG005|Induction Period|Withdrawal by Subject|0|||
130864470|NCT03364309|471131051|FG006|Induction Period|Withdrawal by Subject|0|||
130864471|NCT03364309|471131052|FG007|Induction Period|Withdrawal by Subject|0|||
130864472|NCT03364309|471131053|FG008|Induction Period|Withdrawal by Subject|0|||
130864473|NCT03364309|471131054|FG009|Induction Period|Withdrawal by Subject|0|||
130864474|NCT03364309|471131055|FG010|Induction Period|Withdrawal by Subject|0|||
130864475|NCT03364309|471131056|FG011|Induction Period|Withdrawal by Subject|0|||
130864476|NCT03364309|471131057|FG012|Induction Period|Withdrawal by Subject|0|||
130864477|NCT03364309|471131058|FG013|Induction Period|Withdrawal by Subject|0|||
130864478|NCT03364309|471131059|FG014|Induction Period|Withdrawal by Subject|0|||
130864479|NCT03364309|471131060|FG015|Induction Period|Withdrawal by Subject|0|||
130864480|NCT03364309|471131061|FG016|Induction Period|Withdrawal by Subject|0|||
130864481|NCT03364309|471131062|FG017|Induction Period|Withdrawal by Subject|0|||
130864482|NCT03364309|471131063|FG018|Induction Period|Withdrawal by Subject|0|||
130864483|NCT03364309|471131045|FG000|Induction Period|Lost to Follow-up|1|||
130864484|NCT03364309|471131046|FG001|Induction Period|Lost to Follow-up|0|||
130864485|NCT03364309|471131047|FG002|Induction Period|Lost to Follow-up|0|||
130864486|NCT03364309|471131048|FG003|Induction Period|Lost to Follow-up|0|||
130864487|NCT03364309|471131049|FG004|Induction Period|Lost to Follow-up|0|||
130864488|NCT03364309|471131050|FG005|Induction Period|Lost to Follow-up|0|||
130864489|NCT03364309|471131051|FG006|Induction Period|Lost to Follow-up|0|||
130864490|NCT03364309|471131052|FG007|Induction Period|Lost to Follow-up|0|||
130864491|NCT03364309|471131053|FG008|Induction Period|Lost to Follow-up|0|||
130864492|NCT03364309|471131054|FG009|Induction Period|Lost to Follow-up|0|||
130864493|NCT03364309|471131055|FG010|Induction Period|Lost to Follow-up|0|||
130864494|NCT03364309|471131056|FG011|Induction Period|Lost to Follow-up|0|||
130864495|NCT03364309|471131057|FG012|Induction Period|Lost to Follow-up|0|||
130864496|NCT03364309|471131058|FG013|Induction Period|Lost to Follow-up|0|||
130864497|NCT03364309|471131059|FG014|Induction Period|Lost to Follow-up|0|||
130864498|NCT03364309|471131060|FG015|Induction Period|Lost to Follow-up|0|||
130864499|NCT03364309|471131061|FG016|Induction Period|Lost to Follow-up|0|||
130864500|NCT03364309|471131062|FG017|Induction Period|Lost to Follow-up|0|||
130864501|NCT03364309|471131063|FG018|Induction Period|Lost to Follow-up|0|||
130864502|NCT03364309|471131045|FG000|Induction Period|Physician Decision|0|||
130864503|NCT03364309|471131046|FG001|Induction Period|Physician Decision|1|||
130864504|NCT03364309|471131047|FG002|Induction Period|Physician Decision|0|||
130864505|NCT03364309|471131048|FG003|Induction Period|Physician Decision|0|||
130864506|NCT03364309|471131049|FG004|Induction Period|Physician Decision|0|||
130864507|NCT03364309|471131050|FG005|Induction Period|Physician Decision|0|||
130864508|NCT03364309|471131051|FG006|Induction Period|Physician Decision|0|||
130864509|NCT03364309|471131052|FG007|Induction Period|Physician Decision|0|||
130864510|NCT03364309|471131053|FG008|Induction Period|Physician Decision|0|||
130864511|NCT03364309|471131054|FG009|Induction Period|Physician Decision|0|||
130864512|NCT03364309|471131055|FG010|Induction Period|Physician Decision|0|||
130864513|NCT03364309|471131056|FG011|Induction Period|Physician Decision|0|||
130864514|NCT03364309|471131057|FG012|Induction Period|Physician Decision|0|||
130864515|NCT03364309|471131058|FG013|Induction Period|Physician Decision|0|||
130864516|NCT03364309|471131059|FG014|Induction Period|Physician Decision|0|||
130864517|NCT03364309|471131060|FG015|Induction Period|Physician Decision|0|||
130864518|NCT03364309|471131061|FG016|Induction Period|Physician Decision|0|||
130864519|NCT03364309|471131062|FG017|Induction Period|Physician Decision|0|||
130864520|NCT03364309|471131063|FG018|Induction Period|Physician Decision|0|||
130864521|NCT03364309|471131045|FG000|Maintenance Period|Withdrawal by Subject|0|||
130864522|NCT03364309|471131046|FG001|Maintenance Period|Withdrawal by Subject|0|||
130864523|NCT03364309|471131047|FG002|Maintenance Period|Withdrawal by Subject|0|||
130864524|NCT03364309|471131048|FG003|Maintenance Period|Withdrawal by Subject|1|||
130864525|NCT03364309|471131049|FG004|Maintenance Period|Withdrawal by Subject|3|||
130864526|NCT03364309|471131050|FG005|Maintenance Period|Withdrawal by Subject|1|||
130864527|NCT03364309|471131051|FG006|Maintenance Period|Withdrawal by Subject|3|||
130864528|NCT03364309|471131052|FG007|Maintenance Period|Withdrawal by Subject|0|||
130864529|NCT03364309|471131053|FG008|Maintenance Period|Withdrawal by Subject|1|||
130864530|NCT03364309|471131054|FG009|Maintenance Period|Withdrawal by Subject|1|||
130864531|NCT03364309|471131055|FG010|Maintenance Period|Withdrawal by Subject|2|||
130864532|NCT03364309|471131056|FG011|Maintenance Period|Withdrawal by Subject|0|||
130864533|NCT03364309|471131057|FG012|Maintenance Period|Withdrawal by Subject|0|||
130864534|NCT03364309|471131058|FG013|Maintenance Period|Withdrawal by Subject|0|||
130864535|NCT03364309|471131059|FG014|Maintenance Period|Withdrawal by Subject|0|||
130864536|NCT03364309|471131060|FG015|Maintenance Period|Withdrawal by Subject|0|||
130864537|NCT03364309|471131061|FG016|Maintenance Period|Withdrawal by Subject|0|||
130864538|NCT03364309|471131062|FG017|Maintenance Period|Withdrawal by Subject|0|||
130864539|NCT03364309|471131063|FG018|Maintenance Period|Withdrawal by Subject|0|||
130864540|NCT03364309|471131045|FG000|Maintenance Period|Adverse Event|0|||
130864541|NCT03364309|471131046|FG001|Maintenance Period|Adverse Event|0|||
130864542|NCT03364309|471131047|FG002|Maintenance Period|Adverse Event|0|||
130864543|NCT03364309|471131048|FG003|Maintenance Period|Adverse Event|0|||
130864544|NCT03364309|471131049|FG004|Maintenance Period|Adverse Event|2|||
130864545|NCT03364309|471131050|FG005|Maintenance Period|Adverse Event|0|||
130864546|NCT03364309|471131051|FG006|Maintenance Period|Adverse Event|3|||
130864547|NCT03364309|471131052|FG007|Maintenance Period|Adverse Event|0|||
130864548|NCT03364309|471131053|FG008|Maintenance Period|Adverse Event|1|||
130864549|NCT03364309|471131054|FG009|Maintenance Period|Adverse Event|0|||
130864550|NCT03364309|471131055|FG010|Maintenance Period|Adverse Event|2|||
130864551|NCT03364309|471131056|FG011|Maintenance Period|Adverse Event|0|||
130864552|NCT03364309|471131057|FG012|Maintenance Period|Adverse Event|0|||
130864553|NCT03364309|471131058|FG013|Maintenance Period|Adverse Event|0|||
130864554|NCT03364309|471131059|FG014|Maintenance Period|Adverse Event|0|||
130864555|NCT03364309|471131060|FG015|Maintenance Period|Adverse Event|0|||
130864556|NCT03364309|471131061|FG016|Maintenance Period|Adverse Event|0|||
130864557|NCT03364309|471131062|FG017|Maintenance Period|Adverse Event|0|||
130864558|NCT03364309|471131063|FG018|Maintenance Period|Adverse Event|0|||
130864559|NCT03364309|471131045|FG000|Maintenance Period|Relapsed|0|||
130864560|NCT03364309|471131046|FG001|Maintenance Period|Relapsed|0|||
130864561|NCT03364309|471131047|FG002|Maintenance Period|Relapsed|0|||
130864562|NCT03364309|471131048|FG003|Maintenance Period|Relapsed|43|||
130864563|NCT03364309|471131049|FG004|Maintenance Period|Relapsed|7|||
130864564|NCT03364309|471131050|FG005|Maintenance Period|Relapsed|45|||
130864565|NCT03364309|471131051|FG006|Maintenance Period|Relapsed|10|||
130864566|NCT03364309|471131052|FG007|Maintenance Period|Relapsed|2|||
130864567|NCT03364309|471131053|FG008|Maintenance Period|Relapsed|0|||
130864568|NCT03364309|471131054|FG009|Maintenance Period|Relapsed|0|||
130864569|NCT03364309|471131055|FG010|Maintenance Period|Relapsed|0|||
130864570|NCT03364309|471131056|FG011|Maintenance Period|Relapsed|0|||
130864571|NCT03364309|471131057|FG012|Maintenance Period|Relapsed|0|||
130864572|NCT03364309|471131058|FG013|Maintenance Period|Relapsed|0|||
130864573|NCT03364309|471131059|FG014|Maintenance Period|Relapsed|0|||
130864574|NCT03364309|471131060|FG015|Maintenance Period|Relapsed|0|||
130864575|NCT03364309|471131061|FG016|Maintenance Period|Relapsed|0|||
130864576|NCT03364309|471131062|FG017|Maintenance Period|Relapsed|0|||
130864577|NCT03364309|471131063|FG018|Maintenance Period|Relapsed|0|||
130864578|NCT03364309|471131045|FG000|Maintenance Period|Lack of Efficacy|0|||
130864579|NCT03364309|471131046|FG001|Maintenance Period|Lack of Efficacy|0|||
130864580|NCT03364309|471131047|FG002|Maintenance Period|Lack of Efficacy|0|||
130864581|NCT03364309|471131048|FG003|Maintenance Period|Lack of Efficacy|0|||
130864582|NCT03364309|471131049|FG004|Maintenance Period|Lack of Efficacy|0|||
130864583|NCT03364309|471131050|FG005|Maintenance Period|Lack of Efficacy|0|||
130864584|NCT03364309|471131051|FG006|Maintenance Period|Lack of Efficacy|0|||
130864585|NCT03364309|471131052|FG007|Maintenance Period|Lack of Efficacy|0|||
130864586|NCT03364309|471131053|FG008|Maintenance Period|Lack of Efficacy|1|||
130864587|NCT03364309|471131054|FG009|Maintenance Period|Lack of Efficacy|3|||
130864588|NCT03364309|471131055|FG010|Maintenance Period|Lack of Efficacy|2|||
130864589|NCT03364309|471131056|FG011|Maintenance Period|Lack of Efficacy|0|||
130864590|NCT03364309|471131057|FG012|Maintenance Period|Lack of Efficacy|0|||
130864591|NCT03364309|471131058|FG013|Maintenance Period|Lack of Efficacy|0|||
130864592|NCT03364309|471131059|FG014|Maintenance Period|Lack of Efficacy|0|||
130864593|NCT03364309|471131060|FG015|Maintenance Period|Lack of Efficacy|0|||
130864594|NCT03364309|471131061|FG016|Maintenance Period|Lack of Efficacy|0|||
130864595|NCT03364309|471131062|FG017|Maintenance Period|Lack of Efficacy|0|||
130864596|NCT03364309|471131063|FG018|Maintenance Period|Lack of Efficacy|0|||
130864597|NCT03364309|471131045|FG000|Maintenance Period|Death|0|||
130864598|NCT03364309|471131046|FG001|Maintenance Period|Death|0|||
130864599|NCT03364309|471131047|FG002|Maintenance Period|Death|0|||
130864600|NCT03364309|471131048|FG003|Maintenance Period|Death|0|||
130864601|NCT03364309|471131049|FG004|Maintenance Period|Death|0|||
130864602|NCT03364309|471131050|FG005|Maintenance Period|Death|0|||
130864603|NCT03364309|471131051|FG006|Maintenance Period|Death|0|||
130864604|NCT03364309|471131052|FG007|Maintenance Period|Death|0|||
130864605|NCT03364309|471131053|FG008|Maintenance Period|Death|1|||
130864606|NCT03364309|471131054|FG009|Maintenance Period|Death|0|||
130864607|NCT03364309|471131055|FG010|Maintenance Period|Death|0|||
130864608|NCT03364309|471131056|FG011|Maintenance Period|Death|0|||
130864609|NCT03364309|471131057|FG012|Maintenance Period|Death|0|||
130864610|NCT03364309|471131058|FG013|Maintenance Period|Death|0|||
130864611|NCT03364309|471131059|FG014|Maintenance Period|Death|0|||
130864612|NCT03364309|471131060|FG015|Maintenance Period|Death|0|||
130864613|NCT03364309|471131061|FG016|Maintenance Period|Death|0|||
130864614|NCT03364309|471131062|FG017|Maintenance Period|Death|0|||
130864615|NCT03364309|471131063|FG018|Maintenance Period|Death|0|||
130864616|NCT03364309|471131045|FG000|Maintenance Period|Lost to Follow-up|0|||
130864617|NCT03364309|471131046|FG001|Maintenance Period|Lost to Follow-up|0|||
130864618|NCT03364309|471131047|FG002|Maintenance Period|Lost to Follow-up|0|||
130864619|NCT03364309|471131048|FG003|Maintenance Period|Lost to Follow-up|0|||
130864620|NCT03364309|471131049|FG004|Maintenance Period|Lost to Follow-up|0|||
130864621|NCT03364309|471131050|FG005|Maintenance Period|Lost to Follow-up|0|||
130864622|NCT03364309|471131051|FG006|Maintenance Period|Lost to Follow-up|0|||
130864623|NCT03364309|471131052|FG007|Maintenance Period|Lost to Follow-up|0|||
130864624|NCT03364309|471131053|FG008|Maintenance Period|Lost to Follow-up|1|||
130864625|NCT03364309|471131054|FG009|Maintenance Period|Lost to Follow-up|0|||
130864626|NCT03364309|471131055|FG010|Maintenance Period|Lost to Follow-up|0|||
130864627|NCT03364309|471131056|FG011|Maintenance Period|Lost to Follow-up|0|||
130864628|NCT03364309|471131057|FG012|Maintenance Period|Lost to Follow-up|0|||
130864629|NCT03364309|471131058|FG013|Maintenance Period|Lost to Follow-up|0|||
130864630|NCT03364309|471131059|FG014|Maintenance Period|Lost to Follow-up|0|||
130864631|NCT03364309|471131060|FG015|Maintenance Period|Lost to Follow-up|0|||
130864632|NCT03364309|471131061|FG016|Maintenance Period|Lost to Follow-up|0|||
130864633|NCT03364309|471131062|FG017|Maintenance Period|Lost to Follow-up|0|||
130864634|NCT03364309|471131063|FG018|Maintenance Period|Lost to Follow-up|0|||
130864635|NCT03364309|471131045|FG000|Maintenance Period|Miscellaneous|0|||
130864636|NCT03364309|471131046|FG001|Maintenance Period|Miscellaneous|0|||
130864637|NCT03364309|471131047|FG002|Maintenance Period|Miscellaneous|0|||
130864638|NCT03364309|471131048|FG003|Maintenance Period|Miscellaneous|0|||
130864639|NCT03364309|471131049|FG004|Maintenance Period|Miscellaneous|0|||
130864640|NCT03364309|471131050|FG005|Maintenance Period|Miscellaneous|0|||
130864641|NCT03364309|471131051|FG006|Maintenance Period|Miscellaneous|0|||
130864642|NCT03364309|471131052|FG007|Maintenance Period|Miscellaneous|0|||
130864643|NCT03364309|471131053|FG008|Maintenance Period|Miscellaneous|1|||
130864644|NCT03364309|471131054|FG009|Maintenance Period|Miscellaneous|0|||
130864645|NCT03364309|471131055|FG010|Maintenance Period|Miscellaneous|0|||
130864646|NCT03364309|471131056|FG011|Maintenance Period|Miscellaneous|0|||
130864647|NCT03364309|471131057|FG012|Maintenance Period|Miscellaneous|0|||
130864648|NCT03364309|471131058|FG013|Maintenance Period|Miscellaneous|0|||
130864649|NCT03364309|471131059|FG014|Maintenance Period|Miscellaneous|0|||
130864650|NCT03364309|471131060|FG015|Maintenance Period|Miscellaneous|0|||
130864651|NCT03364309|471131061|FG016|Maintenance Period|Miscellaneous|0|||
130864652|NCT03364309|471131062|FG017|Maintenance Period|Miscellaneous|0|||
130864653|NCT03364309|471131063|FG018|Maintenance Period|Miscellaneous|0|||
130864654|NCT03364309|471131045|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864655|NCT03364309|471131046|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864656|NCT03364309|471131047|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864657|NCT03364309|471131048|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864658|NCT03364309|471131049|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864659|NCT03364309|471131050|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864660|NCT03364309|471131051|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864661|NCT03364309|471131052|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864662|NCT03364309|471131053|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864663|NCT03364309|471131054|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864664|NCT03364309|471131055|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864665|NCT03364309|471131056|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864666|NCT03364309|471131057|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864667|NCT03364309|471131058|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
130864668|NCT03364309|471131059|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
130864669|NCT03364309|471131060|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
130864670|NCT03364309|471131061|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864671|NCT03364309|471131062|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864672|NCT03364309|471131063|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130864673|NCT03364309|471131045|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864674|NCT03364309|471131046|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864675|NCT03364309|471131047|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864676|NCT03364309|471131048|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864677|NCT03364309|471131049|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864678|NCT03364309|471131050|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864679|NCT03364309|471131051|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864680|NCT03364309|471131052|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864681|NCT03364309|471131053|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864682|NCT03364309|471131054|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864683|NCT03364309|471131055|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864684|NCT03364309|471131056|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864685|NCT03364309|471131057|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864686|NCT03364309|471131058|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864687|NCT03364309|471131059|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
130864688|NCT03364309|471131060|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864689|NCT03364309|471131061|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864690|NCT03364309|471131062|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864691|NCT03364309|471131063|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
130864692|NCT03364309|471131045|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
130864693|NCT03364309|471131046|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
130864694|NCT03364309|471131047|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
130864695|NCT03364309|471131048|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
130864696|NCT03364309|471131049|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
130864697|NCT03364309|471131050|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
130864698|NCT03364309|471131051|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
130864699|NCT03364309|471131052|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
130864700|NCT03364309|471131053|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
130864701|NCT03364309|471131054|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
130864702|NCT03364309|471131055|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
130864703|NCT03364309|471131056|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
130864704|NCT03364309|471131057|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
130864705|NCT03364309|471131058|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
130864706|NCT03364309|471131059|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
130864707|NCT03364309|471131060|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
130864708|NCT03364309|471131061|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
130864709|NCT03364309|471131062|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
130864710|NCT03364309|471131063|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
130864711|NCT03364309|471131045|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864712|NCT03364309|471131046|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864713|NCT03364309|471131047|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864714|NCT03364309|471131048|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864715|NCT03364309|471131049|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864716|NCT03364309|471131050|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864717|NCT03364309|471131051|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864718|NCT03364309|471131052|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864719|NCT03364309|471131053|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864720|NCT03364309|471131054|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864721|NCT03364309|471131055|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864722|NCT03364309|471131056|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864723|NCT03364309|471131057|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864724|NCT03364309|471131058|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864725|NCT03364309|471131059|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864726|NCT03364309|471131060|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130864727|NCT03364309|471131061|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
130864728|NCT03364309|471131062|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
130864729|NCT03364309|471131063|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
130864730|NCT03364309|471131045|FG000|Post-Treatment Followup Period|Adverse Event|0|||
130864731|NCT03364309|471131046|FG001|Post-Treatment Followup Period|Adverse Event|0|||
130864732|NCT03364309|471131047|FG002|Post-Treatment Followup Period|Adverse Event|0|||
130864733|NCT03364309|471131048|FG003|Post-Treatment Followup Period|Adverse Event|0|||
130864734|NCT03364309|471131049|FG004|Post-Treatment Followup Period|Adverse Event|0|||
130864735|NCT03364309|471131050|FG005|Post-Treatment Followup Period|Adverse Event|0|||
130864736|NCT03364309|471131051|FG006|Post-Treatment Followup Period|Adverse Event|0|||
130864737|NCT03364309|471131052|FG007|Post-Treatment Followup Period|Adverse Event|0|||
130864738|NCT03364309|471131053|FG008|Post-Treatment Followup Period|Adverse Event|0|||
130864739|NCT03364309|471131054|FG009|Post-Treatment Followup Period|Adverse Event|0|||
130864740|NCT03364309|471131055|FG010|Post-Treatment Followup Period|Adverse Event|0|||
130864741|NCT03364309|471131056|FG011|Post-Treatment Followup Period|Adverse Event|0|||
130864742|NCT03364309|471131057|FG012|Post-Treatment Followup Period|Adverse Event|0|||
130864743|NCT03364309|471131058|FG013|Post-Treatment Followup Period|Adverse Event|0|||
130864744|NCT03364309|471131059|FG014|Post-Treatment Followup Period|Adverse Event|0|||
130864745|NCT03364309|471131060|FG015|Post-Treatment Followup Period|Adverse Event|0|||
130864746|NCT03364309|471131061|FG016|Post-Treatment Followup Period|Adverse Event|2|||
130864747|NCT03364309|471131062|FG017|Post-Treatment Followup Period|Adverse Event|6|||
130864748|NCT03364309|471131063|FG018|Post-Treatment Followup Period|Adverse Event|1|||
130864749|NCT03364309|471131045|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864750|NCT03364309|471131046|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864751|NCT03364309|471131047|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864752|NCT03364309|471131048|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864753|NCT03364309|471131049|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864754|NCT03364309|471131050|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864755|NCT03364309|471131051|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864756|NCT03364309|471131052|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864757|NCT03364309|471131053|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864758|NCT03364309|471131054|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864759|NCT03364309|471131055|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864760|NCT03364309|471131056|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864761|NCT03364309|471131057|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864762|NCT03364309|471131058|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864763|NCT03364309|471131059|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864764|NCT03364309|471131060|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864765|NCT03364309|471131061|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864766|NCT03364309|471131062|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
130864767|NCT03364309|471131063|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
130864768|NCT03364309|471131045|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
130864769|NCT03364309|471131046|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
130864770|NCT03364309|471131047|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
130864771|NCT03364309|471131048|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
130864772|NCT03364309|471131049|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
130864773|NCT03364309|471131050|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
130864774|NCT03364309|471131051|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
130864775|NCT03364309|471131052|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
130864776|NCT03364309|471131053|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
130864777|NCT03364309|471131054|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
130864778|NCT03364309|471131055|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
130864779|NCT03364309|471131056|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
130864780|NCT03364309|471131057|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
130864781|NCT03364309|471131058|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
130864782|NCT03364309|471131059|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
130864783|NCT03364309|471131060|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
130864784|NCT03364309|471131061|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
130864785|NCT03364309|471131062|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
130864786|NCT03364309|471131063|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
130864787|NCT00615992|471131064|FG000|Overall Study|Protocol Violation|67|||
130864788|NCT00167310|471131065|FG000|Overall Study|Protocol Violation|5|||
130864789|NCT00167310|471131066|FG001|Overall Study|Protocol Violation|3|||
130864790|NCT00167310|471131065|FG000|Overall Study|Withdrawal by Subject|3|||
130864791|NCT00167310|471131066|FG001|Overall Study|Withdrawal by Subject|7|||
130864792|NCT03543137|471131069|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
130864793|NCT03543137|471131070|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
130864794|NCT03543137|471131069|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
130864795|NCT03543137|471131070|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
130864796|NCT03543137|471131069|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
130864797|NCT03543137|471131070|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
130864798|NCT02465203|471131071|FG000|Overall Study|Protocol Violation|1|||
130864799|NCT02465203|471131072|FG001|Overall Study|Protocol Violation|1|||
130864800|NCT02465203|471131073|FG002|Overall Study|Protocol Violation|1|||
130864801|NCT02465203|471131071|FG000|Overall Study|Study terminated by sponsor|50|||
130864802|NCT02465203|471131072|FG001|Overall Study|Study terminated by sponsor|34|||
130864803|NCT02465203|471131073|FG002|Overall Study|Study terminated by sponsor|11|||
130864804|NCT02465203|471131071|FG000|Overall Study|New therapy for study indication|4|||
130864805|NCT02465203|471131072|FG001|Overall Study|New therapy for study indication|0|||
130864806|NCT02465203|471131073|FG002|Overall Study|New therapy for study indication|0|||
130864807|NCT02465203|471131071|FG000|Overall Study|Patient/guardian decision|1|||
130864808|NCT02465203|471131072|FG001|Overall Study|Patient/guardian decision|1|||
130864809|NCT02465203|471131073|FG002|Overall Study|Patient/guardian decision|1|||
130864810|NCT00042991|471131074|FG000|Overall Study|Adverse Event|1|||
130864811|NCT00042991|471131075|FG001|Overall Study|Adverse Event|4|||
130864812|NCT00042991|471131076|FG002|Overall Study|Adverse Event|2|||
130864813|NCT00042991|471131077|FG003|Overall Study|Adverse Event|0|||
130864814|NCT00042991|471131078|FG004|Overall Study|Adverse Event|0|||
130864815|NCT00042991|471131079|FG005|Overall Study|Adverse Event|1|||
130864816|NCT00042991|471131080|FG006|Overall Study|Adverse Event|0|||
130864817|NCT00042991|471131074|FG000|Overall Study|Withdrawal by Subject|0|||
130864818|NCT00042991|471131075|FG001|Overall Study|Withdrawal by Subject|7|||
130864819|NCT00042991|471131076|FG002|Overall Study|Withdrawal by Subject|2|||
130864820|NCT00042991|471131077|FG003|Overall Study|Withdrawal by Subject|0|||
130864821|NCT00042991|471131078|FG004|Overall Study|Withdrawal by Subject|1|||
130864822|NCT00042991|471131079|FG005|Overall Study|Withdrawal by Subject|0|||
130864823|NCT00042991|471131080|FG006|Overall Study|Withdrawal by Subject|0|||
130864824|NCT00042991|471131074|FG000|Overall Study|Disease Progression|5|||
130864825|NCT00042991|471131075|FG001|Overall Study|Disease Progression|29|||
130864826|NCT00042991|471131076|FG002|Overall Study|Disease Progression|2|||
130864827|NCT00042991|471131077|FG003|Overall Study|Disease Progression|2|||
130864828|NCT00042991|471131078|FG004|Overall Study|Disease Progression|1|||
130864829|NCT00042991|471131079|FG005|Overall Study|Disease Progression|4|||
130864830|NCT00042991|471131080|FG006|Overall Study|Disease Progression|2|||
130864831|NCT00042991|471131074|FG000|Overall Study|Alternative Therapy|0|||
130864832|NCT00042991|471131075|FG001|Overall Study|Alternative Therapy|0|||
130864833|NCT00042991|471131076|FG002|Overall Study|Alternative Therapy|0|||
130864834|NCT00042991|471131077|FG003|Overall Study|Alternative Therapy|0|||
130864835|NCT00042991|471131078|FG004|Overall Study|Alternative Therapy|1|||
130864836|NCT00042991|471131079|FG005|Overall Study|Alternative Therapy|0|||
130864837|NCT00042991|471131080|FG006|Overall Study|Alternative Therapy|0|||
130864838|NCT04072887|471131085|FG000|Overall Study|Withdrawal by Subject|3|||
130864839|NCT04072887|471131086|FG001|Overall Study|Withdrawal by Subject|8|||
130864840|NCT04072887|471131087|FG002|Overall Study|Withdrawal by Subject|1|||
130864841|NCT04072887|471131088|FG003|Overall Study|Withdrawal by Subject|3|||
130864842|NCT04072887|471131089|FG004|Overall Study|Withdrawal by Subject|3|||
130864843|NCT04072887|471131090|FG005|Overall Study|Withdrawal by Subject|13|||
130864844|NCT04072887|471131085|FG000|Overall Study|Adverse Event|2|||
130864845|NCT04072887|471131086|FG001|Overall Study|Adverse Event|4|||
130864846|NCT04072887|471131087|FG002|Overall Study|Adverse Event|1|||
130864847|NCT04072887|471131088|FG003|Overall Study|Adverse Event|4|||
130864848|NCT04072887|471131089|FG004|Overall Study|Adverse Event|0|||
130864849|NCT04072887|471131090|FG005|Overall Study|Adverse Event|1|||
130864850|NCT04072887|471131085|FG000|Overall Study|Physician Decision|2|||
130864851|NCT04072887|471131086|FG001|Overall Study|Physician Decision|0|||
130864852|NCT04072887|471131087|FG002|Overall Study|Physician Decision|0|||
130864853|NCT04072887|471131088|FG003|Overall Study|Physician Decision|0|||
130864854|NCT04072887|471131089|FG004|Overall Study|Physician Decision|0|||
130864855|NCT04072887|471131090|FG005|Overall Study|Physician Decision|1|||
130864856|NCT04072887|471131085|FG000|Overall Study|Lost to Follow-up|1|||
130864857|NCT04072887|471131086|FG001|Overall Study|Lost to Follow-up|3|||
130864858|NCT04072887|471131087|FG002|Overall Study|Lost to Follow-up|0|||
130864859|NCT04072887|471131088|FG003|Overall Study|Lost to Follow-up|0|||
130864860|NCT04072887|471131089|FG004|Overall Study|Lost to Follow-up|0|||
130864861|NCT04072887|471131090|FG005|Overall Study|Lost to Follow-up|0|||
130864862|NCT04072887|471131085|FG000|Overall Study|Death|0|||
130864863|NCT04072887|471131086|FG001|Overall Study|Death|2|||
130864864|NCT04072887|471131087|FG002|Overall Study|Death|0|||
130864865|NCT04072887|471131088|FG003|Overall Study|Death|2|||
130864866|NCT04072887|471131089|FG004|Overall Study|Death|3|||
130864867|NCT04072887|471131090|FG005|Overall Study|Death|0|||
130864868|NCT03193736|471131091|FG000|Overall Study|Death|2|||
130864869|NCT03193736|471131091|FG000|Overall Study|Withdrawal by Subject|1|||
130864870|NCT03193736|471131091|FG000|Overall Study|Lost to Follow-up|1|||
130864871|NCT03193736|471131091|FG000|Overall Study|implant not received|1|||
130864872|NCT00856297|471131092|FG000|Overall Study|Unable to classify|2|||
130864873|NCT00856297|471131093|FG001|Overall Study|Unable to classify|0|||
130864874|NCT00856297|471131094|FG002|Overall Study|Unable to classify|0|||
130864875|NCT00856297|471131095|FG003|Overall Study|Unable to classify|0|||
130864876|NCT00856297|471131096|FG004|Overall Study|Unable to classify|0|||
130864877|NCT00423449|471131097|FG000|Overall Study|Clinical Adverse Event|1|||
130864878|NCT00423449|471131098|FG001|Overall Study|Clinical Adverse Event|0|||
130864879|NCT00423449|471131099|FG002|Overall Study|Clinical Adverse Event|1|||
130864880|NCT00423449|471131100|FG003|Overall Study|Clinical Adverse Event|8|||
130864881|NCT00423449|471131101|FG004|Overall Study|Clinical Adverse Event|2|||
130864882|NCT00423449|471131097|FG000|Overall Study|Death|1|||
130864883|NCT00423449|471131098|FG001|Overall Study|Death|0|||
130864884|NCT00423449|471131099|FG002|Overall Study|Death|2|||
130864885|NCT00423449|471131100|FG003|Overall Study|Death|1|||
130864886|NCT00423449|471131101|FG004|Overall Study|Death|1|||
130864887|NCT00423449|471131097|FG000|Overall Study|Progressive Disease|1|||
130864888|NCT00423449|471131098|FG001|Overall Study|Progressive Disease|3|||
130864889|NCT00423449|471131099|FG002|Overall Study|Progressive Disease|8|||
130864890|NCT00423449|471131100|FG003|Overall Study|Progressive Disease|11|||
130864891|NCT00423449|471131101|FG004|Overall Study|Progressive Disease|4|||
130864892|NCT00423449|471131097|FG000|Overall Study|Laboratory Adverse Event|0|||
130864893|NCT00423449|471131098|FG001|Overall Study|Laboratory Adverse Event|1|||
130864894|NCT00423449|471131099|FG002|Overall Study|Laboratory Adverse Event|2|||
130864895|NCT00423449|471131100|FG003|Overall Study|Laboratory Adverse Event|0|||
130864896|NCT00423449|471131101|FG004|Overall Study|Laboratory Adverse Event|0|||
130864897|NCT00423449|471131097|FG000|Overall Study|Other|0|||
130864898|NCT00423449|471131098|FG001|Overall Study|Other|0|||
130864899|NCT00423449|471131099|FG002|Overall Study|Other|0|||
130864900|NCT00423449|471131100|FG003|Overall Study|Other|1|||
130864901|NCT00423449|471131101|FG004|Overall Study|Other|0|||
130864902|NCT00423449|471131097|FG000|Overall Study|Protocol Violation|0|||
130864903|NCT00423449|471131098|FG001|Overall Study|Protocol Violation|0|||
130864904|NCT00423449|471131099|FG002|Overall Study|Protocol Violation|2|||
130864905|NCT00423449|471131100|FG003|Overall Study|Protocol Violation|1|||
130864906|NCT00423449|471131101|FG004|Overall Study|Protocol Violation|0|||
130864907|NCT02697435|471131102|FG000|Overall Study|Withdrawal by Subject|1|||
130864908|NCT02697435|471131103|FG001|Overall Study|Withdrawal by Subject|0|||
130864909|NCT02697435|471131102|FG000|Overall Study|Physician Decision|0|||
130864910|NCT02697435|471131103|FG001|Overall Study|Physician Decision|4|||
130864911|NCT00855959|471132831|FG000|Overall Study|Adverse Event|2|||
130864912|NCT00855959|471132831|FG000|Overall Study|Lost to Follow-up|2|||
130864913|NCT00855959|471132831|FG000|Overall Study|Withdrawal by Subject|3|||
130864914|NCT00855959|471132831|FG000|Overall Study|Pregnancy|1|||
130864915|NCT00855959|471132831|FG000|Overall Study|Incorrect enrolment|1|||
130864916|NCT02813889|471132832|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
130864917|NCT02813889|471132833|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
130864918|NCT00368641|471132834|FG000|Overall Study|Adverse Event|2|||
130864919|NCT00368641|471132835|FG001|Overall Study|Adverse Event|1|||
130864920|NCT00368641|471132834|FG000|Overall Study|Death|1|||
130864921|NCT00368641|471132835|FG001|Overall Study|Death|0|||
130864922|NCT00368641|471132834|FG000|Overall Study|Withdrawal by Subject|1|||
130864923|NCT00368641|471132835|FG001|Overall Study|Withdrawal by Subject|0|||
130864924|NCT00368641|471132834|FG000|Overall Study|Sponsor decision to terminate study|2|||
130864925|NCT00368641|471132835|FG001|Overall Study|Sponsor decision to terminate study|5|||
130864926|NCT01362608|471132848|FG000|Overall Study|Protocol Violation|0|||
130864927|NCT01362608|471132849|FG001|Overall Study|Protocol Violation|1|||
130864928|NCT01362608|471132848|FG000|Overall Study|Lost to Follow-up|3|||
130864929|NCT01362608|471132849|FG001|Overall Study|Lost to Follow-up|1|||
130864930|NCT01362608|471132848|FG000|Overall Study|Withdrawal by Subject|1|||
130864931|NCT01362608|471132849|FG001|Overall Study|Withdrawal by Subject|2|||
130864932|NCT01362608|471132848|FG000|Overall Study|Lack of Efficacy|0|||
130864933|NCT01362608|471132849|FG001|Overall Study|Lack of Efficacy|2|||
130864934|NCT01362608|471132848|FG000|Overall Study|Adverse Event|0|||
130864935|NCT01362608|471132849|FG001|Overall Study|Adverse Event|2|||
130864936|NCT04506502|471132855|FG000|Overall Study|Withdrawal by Subject|1|||
130864937|NCT04506502|471132855|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
130864938|NCT03526146|471132856|FG000|Overall Study|Lost to Follow-up|5|||
130864939|NCT03526146|471132856|FG000|Overall Study|Withdrawal by Subject|6|||
130864940|NCT03526146|471132856|FG000|Overall Study|class canceled due to COVID-19|4|||
130864941|NCT02517541|471132859|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
130864942|NCT02517541|471132859|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
130864943|NCT02517541|471132859|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
130864944|NCT02517541|471132859|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
130864945|NCT02517541|471132859|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
130864946|NCT02517541|471132859|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
130864947|NCT00699608|471132860|FG000|First Intervention|Withdrawal by Subject|0|||
130864948|NCT00699608|471132861|FG001|First Intervention|Withdrawal by Subject|0|||
130864949|NCT00699608|471132862|FG002|First Intervention|Withdrawal by Subject|1|||
130864950|NCT00699608|471132863|FG003|First Intervention|Withdrawal by Subject|0|||
130864951|NCT00699608|471132864|FG004|First Intervention|Withdrawal by Subject|0|||
130864952|NCT00699608|471132865|FG005|First Intervention|Withdrawal by Subject|0|||
130864953|NCT00699608|471132860|FG000|First Intervention|Protocol Violation|0|||
130864954|NCT00699608|471132861|FG001|First Intervention|Protocol Violation|0|||
130864955|NCT00699608|471132862|FG002|First Intervention|Protocol Violation|0|||
130864956|NCT00699608|471132863|FG003|First Intervention|Protocol Violation|0|||
130864957|NCT00699608|471132864|FG004|First Intervention|Protocol Violation|1|||
130864958|NCT00699608|471132865|FG005|First Intervention|Protocol Violation|0|||
130864959|NCT00699608|471132860|FG000|Second Intervention|Adverse Event|0|||
130864960|NCT00699608|471132861|FG001|Second Intervention|Adverse Event|0|||
130864961|NCT00699608|471132862|FG002|Second Intervention|Adverse Event|1|||
130864962|NCT00699608|471132863|FG003|Second Intervention|Adverse Event|0|||
130864963|NCT00699608|471132864|FG004|Second Intervention|Adverse Event|0|||
130864964|NCT00699608|471132865|FG005|Second Intervention|Adverse Event|0|||
130864965|NCT00699608|471132860|FG000|Second Intervention|Withdrawal by Subject|0|||
130864966|NCT00699608|471132861|FG001|Second Intervention|Withdrawal by Subject|0|||
130864967|NCT00699608|471132862|FG002|Second Intervention|Withdrawal by Subject|0|||
130864968|NCT00699608|471132863|FG003|Second Intervention|Withdrawal by Subject|1|||
130864969|NCT00699608|471132864|FG004|Second Intervention|Withdrawal by Subject|0|||
130864970|NCT00699608|471132865|FG005|Second Intervention|Withdrawal by Subject|0|||
130864971|NCT01136408|471132866|FG000|Overall Study|Adverse Event|4|||
130864972|NCT01136408|471132867|FG001|Overall Study|Adverse Event|8|||
130864973|NCT01136408|471132868|FG002|Overall Study|Adverse Event|4|||
130864974|NCT01136408|471132866|FG000|Overall Study|Protocol Violation|1|||
130864975|NCT01136408|471132867|FG001|Overall Study|Protocol Violation|1|||
130864976|NCT01136408|471132868|FG002|Overall Study|Protocol Violation|1|||
130864977|NCT02828436|471132869|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
130864978|NCT02828436|471132870|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
130864979|NCT02828436|471132869|FG000|Period 1|Lost to Follow-up|0|||
130864980|NCT02828436|471132870|FG001|Period 1|Lost to Follow-up|1|||
130864981|NCT02828436|471132869|FG000|Period 2|Withdrawal by Subject|4|||
130864982|NCT02828436|471132870|FG001|Period 2|Withdrawal by Subject|0|||
130864983|NCT02828436|471132869|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
130864984|NCT02828436|471132870|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
130864985|NCT02828436|471132869|FG000|Period 2|Lost to Follow-up|1|||
130864986|NCT02828436|471132870|FG001|Period 2|Lost to Follow-up|0|||
130864987|NCT03078556|471132875|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
130864988|NCT03078556|471132876|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
130864989|NCT03078556|471132877|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
130864990|NCT03078556|471132878|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
130864991|NCT03078556|471132875|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
130864992|NCT03078556|471132876|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
130864993|NCT03078556|471132877|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
130864994|NCT03078556|471132878|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
130864995|NCT03078556|471132875|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
130864996|NCT03078556|471132876|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
130864997|NCT03078556|471132877|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
130864998|NCT03078556|471132878|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
130864999|NCT03078556|471132875|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
130865000|NCT03078556|471132876|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
130865001|NCT03078556|471132877|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
130865002|NCT03078556|471132878|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
130865003|NCT04421482|471132879|FG000|Overall Study|Physician Decision|1|||
130865004|NCT03010319|471132882|FG000|Overall Study|Adverse Event|15|||
130865005|NCT03010319|471132883|FG001|Overall Study|Adverse Event|9|||
130865006|NCT03010319|471132882|FG000|Overall Study|Withdrawal by Subject|1|||
130865007|NCT03010319|471132883|FG001|Overall Study|Withdrawal by Subject|6|||
130865008|NCT03010319|471132882|FG000|Overall Study|Physician Decision|2|||
130865009|NCT03010319|471132883|FG001|Overall Study|Physician Decision|4|||
130865010|NCT03010319|471132882|FG000|Overall Study|Sponsor requested withdrawal|2|||
130865011|NCT03010319|471132883|FG001|Overall Study|Sponsor requested withdrawal|2|||
130865012|NCT03010319|471132882|FG000|Overall Study|Death|1|||
130865013|NCT03010319|471132883|FG001|Overall Study|Death|0|||
130865014|NCT03010319|471132882|FG000|Overall Study|Lost to Follow-up|0|||
130865015|NCT03010319|471132883|FG001|Overall Study|Lost to Follow-up|1|||
130865016|NCT03010319|471132882|FG000|Overall Study|Other Reason|5|||
130865017|NCT03010319|471132883|FG001|Overall Study|Other Reason|7|||
130865018|NCT02128724|471132884|FG000|Overall Study|Death|1|||
130865019|NCT02128724|471132885|FG001|Overall Study|Death|0|||
130865020|NCT02128724|471132886|FG002|Overall Study|Death|0|||
130865021|NCT02128724|471132887|FG003|Overall Study|Death|0|||
130865022|NCT02128724|471132884|FG000|Overall Study|Adverse Event|0|||
130865023|NCT02128724|471132885|FG001|Overall Study|Adverse Event|1|||
130865024|NCT02128724|471132886|FG002|Overall Study|Adverse Event|0|||
130865025|NCT02128724|471132887|FG003|Overall Study|Adverse Event|0|||
130865026|NCT02128724|471132884|FG000|Overall Study|Physician Decision|0|||
130865027|NCT02128724|471132885|FG001|Overall Study|Physician Decision|0|||
130865028|NCT02128724|471132886|FG002|Overall Study|Physician Decision|0|||
130865029|NCT02128724|471132887|FG003|Overall Study|Physician Decision|2|||
130865030|NCT02128724|471132884|FG000|Overall Study|Withdrawal by Subject|0|||
130865031|NCT02128724|471132885|FG001|Overall Study|Withdrawal by Subject|0|||
130865032|NCT02128724|471132886|FG002|Overall Study|Withdrawal by Subject|0|||
130865033|NCT02128724|471132887|FG003|Overall Study|Withdrawal by Subject|1|||
130865034|NCT03329092|471132888|FG000|Overall Study|Other|2|||
130865035|NCT03329092|471132889|FG001|Overall Study|Other|2|||
130865036|NCT03329092|471132888|FG000|Overall Study|Withdrawal by Subject|16|||
130865037|NCT03329092|471132889|FG001|Overall Study|Withdrawal by Subject|3|||
130865038|NCT03329092|471132888|FG000|Overall Study|Physician Decision|1|||
130865039|NCT03329092|471132889|FG001|Overall Study|Physician Decision|0|||
130865040|NCT03329092|471132888|FG000|Overall Study|Death|17|||
130865041|NCT03329092|471132889|FG001|Overall Study|Death|11|||
130865042|NCT03329092|471132888|FG000|Overall Study|Adverse Event|3|||
130865043|NCT03329092|471132889|FG001|Overall Study|Adverse Event|1|||
130865044|NCT03329092|471132888|FG000|Overall Study|Lost to Follow-up|1|||
130865045|NCT03329092|471132889|FG001|Overall Study|Lost to Follow-up|1|||
130865046|NCT05786508|471132890|FG000|Overall Study|Withdrawal by Subject|2|||
130865047|NCT05786508|471132891|FG001|Overall Study|Withdrawal by Subject|0|||
130865048|NCT03472950|471132895|FG000|Overall Study|Lost to Follow-up|0|||
130865049|NCT03472950|471132896|FG001|Overall Study|Lost to Follow-up|1|||
130865050|NCT03472950|471132895|FG000|Overall Study|Adverse Event|0|||
130865051|NCT03472950|471132896|FG001|Overall Study|Adverse Event|3|||
130865052|NCT00377858|471132902|FG000|Overall Study|Withdrawal by Subject|12|||
130865053|NCT00377858|471132903|FG001|Overall Study|Withdrawal by Subject|11|||
130865054|NCT00377858|471132902|FG000|Overall Study|Lost to Follow-up|6|||
130865055|NCT00377858|471132903|FG001|Overall Study|Lost to Follow-up|1|||
130865056|NCT00377858|471132902|FG000|Overall Study|Physician Decision|5|||
130865057|NCT00377858|471132903|FG001|Overall Study|Physician Decision|5|||
130865058|NCT00377858|471132902|FG000|Overall Study|Protocol Violation|3|||
130865059|NCT00377858|471132903|FG001|Overall Study|Protocol Violation|4|||
130865060|NCT00377858|471132902|FG000|Overall Study|Adverse Event|2|||
130865061|NCT00377858|471132903|FG001|Overall Study|Adverse Event|1|||
130865062|NCT00377858|471132902|FG000|Overall Study|Entry Criteria Not Met|2|||
130865063|NCT00377858|471132903|FG001|Overall Study|Entry Criteria Not Met|0|||
130865064|NCT00377858|471132902|FG000|Overall Study|Sponsor Decision|1|||
130865065|NCT00377858|471132903|FG001|Overall Study|Sponsor Decision|2|||
130865066|NCT00377858|471132902|FG000|Overall Study|Death|0|||
130865067|NCT00377858|471132903|FG001|Overall Study|Death|3|||
130865068|NCT00195091|471132904|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
130865069|NCT04034004|471132909|FG000|Overall Study|Withdrawal by Subject|1|||
130865070|NCT04034004|471132910|FG001|Overall Study|Withdrawal by Subject|2|||
130865071|NCT04034004|471132911|FG002|Overall Study|Withdrawal by Subject|2|||
130865072|NCT04034004|471132912|FG003|Overall Study|Withdrawal by Subject|3|||
130865073|NCT04034004|471132909|FG000|Overall Study|could not find vein to administer IV|2|||
130865074|NCT04034004|471132910|FG001|Overall Study|could not find vein to administer IV|1|||
130865075|NCT04034004|471132911|FG002|Overall Study|could not find vein to administer IV|0|||
130865076|NCT04034004|471132912|FG003|Overall Study|could not find vein to administer IV|0|||
130865077|NCT04034004|471132909|FG000|Overall Study|nurse accidentally unblinded subject|0|||
130865078|NCT04034004|471132910|FG001|Overall Study|nurse accidentally unblinded subject|0|||
130865079|NCT04034004|471132911|FG002|Overall Study|nurse accidentally unblinded subject|0|||
130865080|NCT04034004|471132912|FG003|Overall Study|nurse accidentally unblinded subject|1|||
130865081|NCT01502228|471132922|FG000|Overall Study|Death|1|||
130865082|NCT06964165|471132927|FG000|Overall Study|Withdrawal by Subject|0|||
130865083|NCT06964165|471132928|FG001|Overall Study|Withdrawal by Subject|1|||
130865084|NCT06964165|471132927|FG000|Overall Study|Ongoing at the time of analysis|15|||
130865085|NCT06964165|471132928|FG001|Overall Study|Ongoing at the time of analysis|14|||
130865086|NCT06964165|471132927|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
130865087|NCT06964165|471132928|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
130865088|NCT06964165|471132927|FG000|Overall Study|Participant removed due to non-compliance|0|||
130865089|NCT06964165|471132928|FG001|Overall Study|Participant removed due to non-compliance|1|||
130865090|NCT01587040|471132931|FG000|Overall Study|Protocol Violation|0|||
130865091|NCT01587040|471132932|FG001|Overall Study|Protocol Violation|0|||
130865092|NCT01587040|471132933|FG002|Overall Study|Protocol Violation|1|||
130865093|NCT01587040|471132934|FG003|Overall Study|Protocol Violation|0|||
130865094|NCT01587040|471132931|FG000|Overall Study|Adverse Event|0|||
130865095|NCT01587040|471132932|FG001|Overall Study|Adverse Event|1|||
130865096|NCT01587040|471132933|FG002|Overall Study|Adverse Event|10|||
130865097|NCT01587040|471132934|FG003|Overall Study|Adverse Event|0|||
130865098|NCT01587040|471132931|FG000|Overall Study|Disease progression|12|||
130865099|NCT01587040|471132932|FG001|Overall Study|Disease progression|1|||
130865100|NCT01587040|471132933|FG002|Overall Study|Disease progression|15|||
130865101|NCT01587040|471132934|FG003|Overall Study|Disease progression|3|||
130865102|NCT01587040|471132931|FG000|Overall Study|Other than specified|5|||
130865103|NCT01587040|471132932|FG001|Overall Study|Other than specified|1|||
130865104|NCT01587040|471132933|FG002|Overall Study|Other than specified|11|||
130865105|NCT01587040|471132934|FG003|Overall Study|Other than specified|1|||
130865106|NCT01518374|471132937|FG000|Overall Study|Withdrawal by Subject|2|||
130865107|NCT01518374|471132937|FG000|Overall Study|Protocol Violation|3|||
130865108|NCT01518374|471132937|FG000|Overall Study|Lost to Follow-up|2|||
130865109|NCT04607837|471132940|FG000|Overall Study|Adverse Event|8|||
130865110|NCT04607837|471132941|FG001|Overall Study|Adverse Event|2|||
130865111|NCT04607837|471132940|FG000|Overall Study|Withdrawal by Subject|8|||
130865112|NCT04607837|471132941|FG001|Overall Study|Withdrawal by Subject|7|||
130865113|NCT04607837|471132940|FG000|Overall Study|Physician Decision|2|||
130865114|NCT04607837|471132941|FG001|Overall Study|Physician Decision|0|||
130865115|NCT04607837|471132940|FG000|Overall Study|Lack of Efficacy|2|||
130865116|NCT04607837|471132941|FG001|Overall Study|Lack of Efficacy|0|||
130865117|NCT04607837|471132940|FG000|Overall Study|Participant terminated by sponsor|1|||
130865118|NCT04607837|471132941|FG001|Overall Study|Participant terminated by sponsor|0|||
130865119|NCT04607837|471132940|FG000|Overall Study|Disease worsening|36|||
130865120|NCT04607837|471132941|FG001|Overall Study|Disease worsening|36|||
130865121|NCT04607837|471132940|FG000|Overall Study|Other|1|||
130865122|NCT04607837|471132941|FG001|Overall Study|Other|0|||
130865123|NCT04346654|471132942|FG000|Overall Study|Adverse Event|2|||
130865124|NCT04346654|471132943|FG001|Overall Study|Adverse Event|0|||
130865125|NCT04346654|471132942|FG000|Overall Study|Non-response|1|||
130865126|NCT04346654|471132943|FG001|Overall Study|Non-response|1|||
130865127|NCT04346654|471132942|FG000|Overall Study|Withdrawal by Subject|2|||
130865128|NCT04346654|471132943|FG001|Overall Study|Withdrawal by Subject|0|||
130865129|NCT04346654|471132942|FG000|Overall Study|Lost to Follow-up|0|||
130865130|NCT04346654|471132943|FG001|Overall Study|Lost to Follow-up|1|||
130865131|NCT04346654|471132942|FG000|Overall Study|Pregnancy|0|||
130865132|NCT04346654|471132943|FG001|Overall Study|Pregnancy|1|||
130865133|NCT04752332|471132944|FG000|Overall Study|Adverse Event|3|||
130865134|NCT04752332|471132945|FG001|Overall Study|Adverse Event|1|||
130865135|NCT04752332|471132944|FG000|Overall Study|Disease Relapse|1|||
130865136|NCT04752332|471132945|FG001|Overall Study|Disease Relapse|0|||
130865137|NCT04752332|471132944|FG000|Overall Study|Non-compliance With Study Drug|2|||
130865138|NCT04752332|471132945|FG001|Overall Study|Non-compliance With Study Drug|0|||
130865139|NCT04752332|471132944|FG000|Overall Study|Physician Decision|2|||
130865140|NCT04752332|471132945|FG001|Overall Study|Physician Decision|1|||
130865141|NCT04752332|471132944|FG000|Overall Study|Protocol Violation|1|||
130865142|NCT04752332|471132945|FG001|Overall Study|Protocol Violation|1|||
130865143|NCT04752332|471132944|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
130865144|NCT04752332|471132945|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
130865145|NCT04752332|471132944|FG000|Overall Study|Study Terminated by Sponsor|10|||
130865146|NCT04752332|471132945|FG001|Overall Study|Study Terminated by Sponsor|48|||
130865147|NCT04752332|471132944|FG000|Overall Study|Withdrawal by Subject|11|||
130865148|NCT04752332|471132945|FG001|Overall Study|Withdrawal by Subject|3|||
130865149|NCT02915978|471132946|FG000|Overall Study|Adverse Event|2|||
130865150|NCT02915978|471132947|FG001|Overall Study|Adverse Event|1|||
130865151|NCT02915978|471132948|FG002|Overall Study|Adverse Event|0|||
130865152|NCT00048347|471132952|FG000|Overall Study|Screen failure|2|||
130865153|NCT02451124|471132953|FG000|Overall Study|Withdrawal by Subject|1|||
130865154|NCT02058563|471132954|FG000|Overall Study|Lost to Follow-up|26|||
130865155|NCT02058563|471132955|FG001|Overall Study|Lost to Follow-up|22|||
130865156|NCT02058563|471132954|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
130865157|NCT02058563|471132955|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
130865158|NCT02058563|471132954|FG000|Overall Study|Consent Withdrawal|1|||
130865159|NCT02058563|471132955|FG001|Overall Study|Consent Withdrawal|1|||
130865160|NCT02058563|471132954|FG000|Overall Study|Other (patient incarcerated)|0|||
130865161|NCT02058563|471132955|FG001|Overall Study|Other (patient incarcerated)|1|||
130865162|NCT04039217|471132956|FG000|Overall Study|Lost to Follow-up|1|||
130865163|NCT04522141|471132957|FG000|Overall Study|Withdrawal by Subject|1|||
130865164|NCT04522141|471132958|FG001|Overall Study|Withdrawal by Subject|0|||
130865165|NCT03508609|471132959|FG000|Overall Study|Withdrawal by Subject|1|||
130865166|NCT00555217|471132960|FG000|Overall Study|Withdrawal by Subject|35|||
130865167|NCT00555217|471132961|FG001|Overall Study|Withdrawal by Subject|31|||
130865168|NCT00555217|471132960|FG000|Overall Study|Lost to Follow-up|19|||
130865169|NCT00555217|471132961|FG001|Overall Study|Lost to Follow-up|20|||
130865170|NCT00555217|471132960|FG000|Overall Study|close out sites|21|||
130865171|NCT00555217|471132961|FG001|Overall Study|close out sites|17|||
130865172|NCT01868477|471132962|FG000|Overall Study|Adverse Event|2|||
130865173|NCT01868477|471132963|FG001|Overall Study|Adverse Event|4|||
130865174|NCT01868477|471132962|FG000|Overall Study|Disease progression|1|||
130865175|NCT01868477|471132963|FG001|Overall Study|Disease progression|1|||
130865176|NCT01868477|471132962|FG000|Overall Study|Withdrawal by Subject|1|||
130865177|NCT01868477|471132963|FG001|Overall Study|Withdrawal by Subject|0|||
130865178|NCT00367835|471132966|FG000|Overall Study|Adverse Event|14|||
130865179|NCT00367835|471132967|FG001|Overall Study|Adverse Event|1|||
130865180|NCT00367835|471132966|FG000|Overall Study|Protocol Violation|1|||
130865181|NCT00367835|471132967|FG001|Overall Study|Protocol Violation|7|||
130865182|NCT00367835|471132966|FG000|Overall Study|Withdrawal by Subject|7|||
130865183|NCT00367835|471132967|FG001|Overall Study|Withdrawal by Subject|6|||
130865184|NCT00367835|471132966|FG000|Overall Study|Lost to Follow-up|1|||
130865185|NCT00367835|471132967|FG001|Overall Study|Lost to Follow-up|4|||
130865186|NCT00367835|471132966|FG000|Overall Study|Lack of Efficacy|3|||
130865187|NCT00367835|471132967|FG001|Overall Study|Lack of Efficacy|12|||
130865188|NCT00367835|471132966|FG000|Overall Study|Subject in juvenile detention center|1|||
130865189|NCT00367835|471132967|FG001|Overall Study|Subject in juvenile detention center|0|||
130865190|NCT00367835|471132966|FG000|Overall Study|refused blood collection|1|||
130865191|NCT00367835|471132967|FG001|Overall Study|refused blood collection|0|||
130865192|NCT00367835|471132966|FG000|Overall Study|Did not respond to calls|1|||
130865193|NCT00367835|471132967|FG001|Overall Study|Did not respond to calls|0|||
130865194|NCT00367835|471132966|FG000|Overall Study|History of lead poisoning|0|||
130865195|NCT00367835|471132967|FG001|Overall Study|History of lead poisoning|1|||
130865196|NCT03761810|471132969|FG000|Overall Study|Adverse Event|12|||
130865197|NCT03761810|471132970|FG001|Overall Study|Adverse Event|0|||
130865198|NCT03761810|471132969|FG000|Overall Study|Lost to Follow-up|15|||
130865199|NCT03761810|471132970|FG001|Overall Study|Lost to Follow-up|7|||
130865200|NCT03761810|471132969|FG000|Overall Study|Pregnancy|1|||
130865201|NCT03761810|471132970|FG001|Overall Study|Pregnancy|0|||
130865202|NCT03761810|471132969|FG000|Overall Study|Withdrawal by Subject|14|||
130865203|NCT03761810|471132970|FG001|Overall Study|Withdrawal by Subject|5|||
130865204|NCT03761810|471132969|FG000|Overall Study|Physician Decision|1|||
130865205|NCT03761810|471132970|FG001|Overall Study|Physician Decision|0|||
130865206|NCT03761810|471132969|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
130865207|NCT03761810|471132970|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130865208|NCT03761810|471132969|FG000|Overall Study|Other Than Specified|1|||
130865209|NCT03761810|471132970|FG001|Overall Study|Other Than Specified|0|||
130865210|NCT01574651|471132971|FG000|Overall Study|Lost to Follow-up|2|||
130865211|NCT01574651|471132972|FG001|Overall Study|Lost to Follow-up|4|||
130865212|NCT01574651|471132971|FG000|Overall Study|Administrative problems|0|||
130865213|NCT01574651|471132972|FG001|Overall Study|Administrative problems|1|||
130865214|NCT01574651|471132971|FG000|Overall Study|Death|3|||
130865215|NCT01574651|471132972|FG001|Overall Study|Death|3|||
130865216|NCT01574651|471132971|FG000|Overall Study|Patient's inability to use the device|0|||
130865217|NCT01574651|471132972|FG001|Overall Study|Patient's inability to use the device|1|||
130865218|NCT01574651|471132971|FG000|Overall Study|Adverse Event|36|||
130865219|NCT01574651|471132972|FG001|Overall Study|Adverse Event|27|||
130865220|NCT01574651|471132971|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130865221|NCT01574651|471132972|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130865222|NCT01574651|471132971|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130865223|NCT01574651|471132972|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130865224|NCT01574651|471132971|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130865225|NCT01574651|471132972|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130865226|NCT01574651|471132971|FG000|Overall Study|Protocol Violation|3|||
130865227|NCT01574651|471132972|FG001|Overall Study|Protocol Violation|5|||
130865228|NCT01574651|471132971|FG000|Overall Study|Withdrawal by Subject|9|||
130865229|NCT01574651|471132972|FG001|Overall Study|Withdrawal by Subject|10|||
130865230|NCT01807299|471132974|FG000|Overall Study|Protocol Violation|3|||
130865231|NCT01807299|471132975|FG001|Overall Study|Protocol Violation|1|||
130865232|NCT01807299|471132976|FG002|Overall Study|Protocol Violation|0|||
130865233|NCT01807299|471132977|FG003|Overall Study|Protocol Violation|2|||
130865234|NCT00811174|471132978|FG000|Overall Study|Protocol Violation|2|||
130865235|NCT00811174|471132978|FG000|Overall Study|Sponsors Decision|1|||
130865236|NCT01392547|471134195|FG000|Overall Study|Adverse Event|2|||
130865237|NCT01392547|471134195|FG000|Overall Study|Non-compliance|2|||
130865238|NCT01392547|471134195|FG000|Overall Study|Withdrawal criteria|3|||
130865239|NCT01392547|471134195|FG000|Overall Study|Unclassified|1|||
130865240|NCT00615017|471134196|FG000|Overall Study|Adverse Event|0|||
130865241|NCT00615017|471134197|FG001|Overall Study|Adverse Event|1|||
130865242|NCT00615017|471134198|FG002|Overall Study|Adverse Event|2|||
130865243|NCT00615017|471134199|FG003|Overall Study|Adverse Event|0|||
130865244|NCT00615017|471134200|FG004|Overall Study|Adverse Event|0|||
130865245|NCT00615017|471134201|FG005|Overall Study|Adverse Event|1|||
130865246|NCT00615017|471134196|FG000|Overall Study|Death|0|||
130865247|NCT00615017|471134197|FG001|Overall Study|Death|0|||
130865248|NCT00615017|471134198|FG002|Overall Study|Death|2|||
130865249|NCT00615017|471134199|FG003|Overall Study|Death|0|||
130865250|NCT00615017|471134200|FG004|Overall Study|Death|1|||
130865251|NCT00615017|471134201|FG005|Overall Study|Death|1|||
130865252|NCT00615017|471134196|FG000|Overall Study|Sepsis resolved|0|||
130865253|NCT00615017|471134197|FG001|Overall Study|Sepsis resolved|0|||
130865254|NCT00615017|471134198|FG002|Overall Study|Sepsis resolved|1|||
130865255|NCT00615017|471134199|FG003|Overall Study|Sepsis resolved|0|||
130865256|NCT00615017|471134200|FG004|Overall Study|Sepsis resolved|0|||
130865257|NCT00615017|471134201|FG005|Overall Study|Sepsis resolved|0|||
130865258|NCT00615017|471134196|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
130865259|NCT00615017|471134197|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
130865260|NCT00615017|471134198|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
130865261|NCT00615017|471134199|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
130865262|NCT00615017|471134200|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
130865263|NCT00615017|471134201|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
130865264|NCT00615017|471134196|FG000|Overall Study|Physician discontinued drug|0|||
130865265|NCT00615017|471134197|FG001|Overall Study|Physician discontinued drug|0|||
130865266|NCT00615017|471134198|FG002|Overall Study|Physician discontinued drug|0|||
130865267|NCT00615017|471134199|FG003|Overall Study|Physician discontinued drug|0|||
130865268|NCT00615017|471134200|FG004|Overall Study|Physician discontinued drug|0|||
130865269|NCT00615017|471134201|FG005|Overall Study|Physician discontinued drug|1|||
130865270|NCT00806988|471134202|FG000|Overall Study|Death|15|||
130865271|NCT00806988|471134203|FG001|Overall Study|Death|16|||
130865272|NCT00806988|471134202|FG000|Overall Study|Withdrawal by Subject|8|||
130865273|NCT00806988|471134203|FG001|Overall Study|Withdrawal by Subject|8|||
130865274|NCT00806988|471134202|FG000|Overall Study|Lost to Follow-up|4|||
130865275|NCT00806988|471134203|FG001|Overall Study|Lost to Follow-up|19|||
130865276|NCT04775953|471134204|FG000|Overall Study|Lost to Follow-up|6|||
130865277|NCT04775953|471134205|FG001|Overall Study|Lost to Follow-up|11|||
130865278|NCT04775953|471134204|FG000|Overall Study|Death|5|||
130865279|NCT04775953|471134205|FG001|Overall Study|Death|4|||
130865280|NCT04775953|471134204|FG000|Overall Study|Withdrawal by Subject|3|||
130865281|NCT04775953|471134205|FG001|Overall Study|Withdrawal by Subject|3|||
130865282|NCT04775953|471134204|FG000|Overall Study|Protocol Violation|2|||
130865283|NCT04775953|471134205|FG001|Overall Study|Protocol Violation|0|||
130865284|NCT04775953|471134204|FG000|Overall Study|Participant non-compliance|0|||
130865285|NCT04775953|471134205|FG001|Overall Study|Participant non-compliance|1|||
130865286|NCT01442714|471134207|FG000|Overall Study|Death|11|||
130865287|NCT01442714|471134207|FG000|Overall Study|Withdrawal by Subject|1|||
130865288|NCT04306510|471134208|FG000|Overall Study|Voluntarily withdrawal|1|||
130865289|NCT04306510|471134208|FG000|Overall Study|Enrolled but Not Treated|1|||
130865290|NCT04720417|471134209|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
130865291|NCT03314987|471134210|FG000|Overall Study|Lost to Follow-up|13|||
130865292|NCT03314987|471134211|FG001|Overall Study|Lost to Follow-up|13|||
130865293|NCT02751580|471134212|FG000|Overall Study|Lost to Follow-up|4|||
130865294|NCT02751580|471134212|FG000|Overall Study|Death|2|||
130865295|NCT04829916|471134218|FG000|Overall Study|Withdrawal by Subject|1|||
130865296|NCT04829916|471134219|FG001|Overall Study|Withdrawal by Subject|0|||
130865297|NCT02152761|471134226|FG000|Epoch: Treatment Epoch|Technical problems|0|||
130865298|NCT02152761|471134227|FG001|Epoch: Treatment Epoch|Technical problems|0|||
130865299|NCT02152761|471134228|FG002|Epoch: Treatment Epoch|Technical problems|0|||
130865300|NCT02152761|471134229|FG003|Epoch: Treatment Epoch|Technical problems|1|||
130865301|NCT02152761|471134226|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
130865302|NCT02152761|471134227|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
130865303|NCT02152761|471134228|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
130865304|NCT02152761|471134229|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
130865305|NCT02152761|471134226|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
130865306|NCT02152761|471134227|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
130865307|NCT02152761|471134228|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
130865308|NCT02152761|471134229|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
130865309|NCT02152761|471134226|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
130865310|NCT02152761|471134227|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
130865311|NCT02152761|471134228|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
130865312|NCT02152761|471134229|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
130865313|NCT02152761|471134226|FG000|Epoch: Treatment Epoch|Death|0|||
130865314|NCT02152761|471134227|FG001|Epoch: Treatment Epoch|Death|3|||
130865315|NCT02152761|471134228|FG002|Epoch: Treatment Epoch|Death|1|||
130865316|NCT02152761|471134229|FG003|Epoch: Treatment Epoch|Death|0|||
130865317|NCT02152761|471134226|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
130865318|NCT02152761|471134227|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
130865319|NCT02152761|471134228|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
130865320|NCT02152761|471134229|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
130865321|NCT02152761|471134226|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
130865322|NCT02152761|471134227|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
130865323|NCT02152761|471134228|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
130865324|NCT02152761|471134229|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
130865325|NCT02152761|471134226|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
130865326|NCT02152761|471134227|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
130865327|NCT02152761|471134228|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
130865328|NCT02152761|471134229|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
130865329|NCT02152761|471134226|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
130865330|NCT02152761|471134227|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
130865331|NCT02152761|471134228|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
130865332|NCT02152761|471134229|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
130865333|NCT02152761|471134226|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
130865334|NCT02152761|471134227|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
130865335|NCT02152761|471134228|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
130865336|NCT02152761|471134229|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
130865337|NCT04343755|471134230|FG000|Overall Study|Death|11|||
130865338|NCT04343755|471134230|FG000|Overall Study|Screen Failure|1|||
130865339|NCT03755882|471134231|FG000|Period 1|Protocol Violation|1|||
130865340|NCT03755882|471134232|FG001|Period 1|Protocol Violation|0|||
130865341|NCT03755882|471134231|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
130865342|NCT03755882|471134232|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
130865343|NCT02292446|471134233|FG000|Overall Study|Adverse Event|12|||
130865344|NCT02292446|471134233|FG000|Overall Study|Death|1|||
130865345|NCT02292446|471134233|FG000|Overall Study|Disease progression|2|||
130865346|NCT02292446|471134233|FG000|Overall Study|Subject/guardian decision|2|||
130865347|NCT02292446|471134233|FG000|Overall Study|Withdrawal by Subject|3|||
130865348|NCT00496080|471134239|FG000|Overall Study|Lost to Follow-up|9|||
130865349|NCT00496080|471134239|FG000|Overall Study|Surgical re-intervention|7|||
130865350|NCT00496080|471134239|FG000|Overall Study|Withdrawal by Subject|5|||
130865351|NCT00496080|471134239|FG000|Overall Study|Physician Decision|6|||
130865352|NCT00570310|471134240|FG000|Overall Study|Adverse Event|1|||
130865353|NCT00570310|471134241|FG001|Overall Study|Adverse Event|2|||
130865354|NCT00570310|471134240|FG000|Overall Study|Lack of Efficacy|1|||
130865355|NCT00570310|471134241|FG001|Overall Study|Lack of Efficacy|4|||
130865356|NCT00887549|471134242|FG000|Induction Therapy|Adverse Event|8|||
130865357|NCT00887549|471134242|FG000|Induction Therapy|Physician Decision|1|||
130865358|NCT00887549|471134242|FG000|Induction Therapy|Progressive Disease|13|||
130865359|NCT00887549|471134242|FG000|Induction Therapy|Death due to Study Disease|4|||
130865360|NCT00887549|471134242|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
130865361|NCT00887549|471134242|FG000|Maintenance Therapy|Adverse Event|16|||
130865362|NCT00887549|471134242|FG000|Maintenance Therapy|Physician Decision|1|||
130865363|NCT00887549|471134242|FG000|Maintenance Therapy|Progressive Disease|25|||
130865364|NCT00887549|471134242|FG000|Maintenance Therapy|Death due to adverse event|1|||
130865365|NCT04112303|471134243|FG000|Overall Study|Death|1|||
130865366|NCT05636852|471134251|FG000|Overall Study|Withdrawal by Subject|1|||
130865367|NCT05636852|471134251|FG000|Overall Study|Other than specified|1|||
130865368|NCT01076036|471134252|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
130865369|NCT03088917|471134253|FG000|Overall Study|In care/cured elsewhere|15|||
130865370|NCT03088917|471134253|FG000|Overall Study|Refuse re-evaluation|13|||
130865371|NCT03088917|471134253|FG000|Overall Study|Contact not established|13|||
130865372|NCT03088917|471134253|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
130865373|NCT03088917|471134253|FG000|Overall Study|Moved outside study region|50|||
130865374|NCT01514201|471134268|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
130865375|NCT01514201|471134269|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130865376|NCT01514201|471134270|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130865377|NCT01514201|471134271|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130865378|NCT01514201|471134268|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130865379|NCT01514201|471134269|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
130865380|NCT01514201|471134270|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
130865381|NCT01514201|471134271|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130865382|NCT01514201|471134268|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
130865383|NCT01514201|471134269|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
130865384|NCT01514201|471134270|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
130865385|NCT01514201|471134271|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130865386|NCT01514201|471134268|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
130865387|NCT01514201|471134269|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
130865388|NCT01514201|471134270|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130865389|NCT01514201|471134271|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130865390|NCT01514201|471134268|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
130865391|NCT01514201|471134269|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
130865392|NCT01514201|471134270|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
130865393|NCT01514201|471134271|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
130865394|NCT01514201|471134268|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
130865395|NCT01514201|471134269|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
130865396|NCT01514201|471134270|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
130865397|NCT01514201|471134271|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
130865398|NCT01514201|471134268|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
130865399|NCT01514201|471134269|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
130865400|NCT01514201|471134270|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
130865401|NCT01514201|471134271|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
130865402|NCT01514201|471134268|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130865403|NCT01514201|471134269|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130865404|NCT01514201|471134270|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130865405|NCT01514201|471134271|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
130865406|NCT01514201|471134268|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
130865407|NCT01514201|471134269|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
130865408|NCT01514201|471134270|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
130865409|NCT01514201|471134271|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
130865410|NCT01514201|471134268|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130865411|NCT01514201|471134269|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130865412|NCT01514201|471134270|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130865413|NCT01514201|471134271|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
130865414|NCT01514201|471134268|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130865415|NCT01514201|471134269|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130865416|NCT01514201|471134270|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130865417|NCT01514201|471134271|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
130865418|NCT01514201|471134268|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130865419|NCT01514201|471134269|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130865420|NCT01514201|471134270|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130865421|NCT01514201|471134271|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
130865422|NCT05888181|471134273|FG000|Overall Study|Lost to Follow-up|1|||
130865423|NCT05888181|471134274|FG001|Overall Study|Lost to Follow-up|1|||
130865424|NCT05888181|471134275|FG002|Overall Study|Lost to Follow-up|0|||
130865425|NCT02534909|471134282|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
130865426|NCT01625000|471134285|FG000|Overall Study|Physician Decision|15|||
130865427|NCT01625000|471134286|FG001|Overall Study|Physician Decision|7|||
130865428|NCT01625000|471134287|FG002|Overall Study|Physician Decision|7|||
130865429|NCT01625000|471134288|FG003|Overall Study|Physician Decision|2|||
130865430|NCT01625000|471134289|FG004|Overall Study|Physician Decision|15|||
130865431|NCT01625000|471134285|FG000|Overall Study|Protocol Violation|3|||
130865432|NCT01625000|471134286|FG001|Overall Study|Protocol Violation|10|||
130865433|NCT01625000|471134287|FG002|Overall Study|Protocol Violation|4|||
130865434|NCT01625000|471134288|FG003|Overall Study|Protocol Violation|1|||
130865435|NCT01625000|471134289|FG004|Overall Study|Protocol Violation|2|||
130865436|NCT01625000|471134285|FG000|Overall Study|Withdrawal by Subject|19|||
130865437|NCT01625000|471134286|FG001|Overall Study|Withdrawal by Subject|16|||
130865438|NCT01625000|471134287|FG002|Overall Study|Withdrawal by Subject|11|||
130865439|NCT01625000|471134288|FG003|Overall Study|Withdrawal by Subject|9|||
130865440|NCT01625000|471134289|FG004|Overall Study|Withdrawal by Subject|17|||
130865441|NCT01625000|471134285|FG000|Overall Study|Adverse Event (including Death)|15|||
130865442|NCT01625000|471134286|FG001|Overall Study|Adverse Event (including Death)|19|||
130865443|NCT01625000|471134287|FG002|Overall Study|Adverse Event (including Death)|11|||
130865444|NCT01625000|471134288|FG003|Overall Study|Adverse Event (including Death)|7|||
130865445|NCT01625000|471134289|FG004|Overall Study|Adverse Event (including Death)|21|||
130865446|NCT00577824|471134292|FG000|Overall Study|Adverse Event|6|||
130865447|NCT00577824|471134293|FG001|Overall Study|Adverse Event|18|||
130865448|NCT00577824|471134294|FG002|Overall Study|Adverse Event|1|||
130865449|NCT00577824|471134292|FG000|Overall Study|Patient decision|0|||
130865450|NCT00577824|471134293|FG001|Overall Study|Patient decision|1|||
130865451|NCT00577824|471134294|FG002|Overall Study|Patient decision|1|||
130865452|NCT00577824|471134292|FG000|Overall Study|Protocol Violation|1|||
130865453|NCT00577824|471134293|FG001|Overall Study|Protocol Violation|1|||
130865454|NCT00577824|471134294|FG002|Overall Study|Protocol Violation|0|||
130865455|NCT00362648|471134298|FG000|Overall Study|Adverse Event|12|||
130865456|NCT00362648|471134299|FG001|Overall Study|Adverse Event|21|||
130865457|NCT00362648|471134300|FG002|Overall Study|Adverse Event|1|||
130865458|NCT00362648|471134301|FG003|Overall Study|Adverse Event|0|||
130865459|NCT00362648|471134298|FG000|Overall Study|Lost to Follow-up|62|||
130865460|NCT00362648|471134299|FG001|Overall Study|Lost to Follow-up|69|||
130865461|NCT00362648|471134300|FG002|Overall Study|Lost to Follow-up|4|||
130865462|NCT00362648|471134301|FG003|Overall Study|Lost to Follow-up|3|||
130865463|NCT00362648|471134298|FG000|Overall Study|Protocol Violation|4|||
130865464|NCT00362648|471134299|FG001|Overall Study|Protocol Violation|2|||
130865465|NCT00362648|471134300|FG002|Overall Study|Protocol Violation|2|||
130865466|NCT00362648|471134301|FG003|Overall Study|Protocol Violation|2|||
130865467|NCT00362648|471134298|FG000|Overall Study|Withdrawal by Subject|48|||
130865468|NCT00362648|471134299|FG001|Overall Study|Withdrawal by Subject|42|||
130865469|NCT00362648|471134300|FG002|Overall Study|Withdrawal by Subject|2|||
130865470|NCT00362648|471134301|FG003|Overall Study|Withdrawal by Subject|6|||
130865471|NCT02204072|471134302|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
130865472|NCT02204072|471134303|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
130865473|NCT02204072|471134304|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
130865474|NCT02204072|471134305|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
130865475|NCT02204072|471134306|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
130865476|NCT02204072|471134302|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
130865477|NCT02204072|471134303|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
130865478|NCT02204072|471134304|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
130865479|NCT02204072|471134305|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
130865480|NCT02204072|471134306|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
130865481|NCT02204072|471134302|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
130865482|NCT02204072|471134303|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
130865483|NCT02204072|471134304|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
130865484|NCT02204072|471134305|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
130865485|NCT02204072|471134306|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
130865486|NCT02204072|471134302|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130865487|NCT02204072|471134303|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130865488|NCT02204072|471134304|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
130865489|NCT02204072|471134305|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130865490|NCT02204072|471134306|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130865491|NCT03983304|471134307|FG000|Overall Study|Withdrawal by Subject|5|||
130865492|NCT03983304|471134307|FG000|Overall Study|Lost to Follow-up|2|||
130865493|NCT04300309|471134311|FG000|Overall Study|Lost to Follow-up|1|||
130865494|NCT04300309|471134312|FG001|Overall Study|Lost to Follow-up|0|||
130865495|NCT02362464|471134313|FG000|Overall Study|Switched to alternative therapy|1|||
130865496|NCT02362464|471134313|FG000|Overall Study|Refused further treatment|1|||
130865497|NCT02362464|471134313|FG000|Overall Study|Physician Decision|4|||
130865498|NCT04209205|471134314|FG000|Overall Study|Adverse Event|2|||
130865499|NCT04209205|471134315|FG001|Overall Study|Adverse Event|3|||
130865500|NCT04209205|471134314|FG000|Overall Study|Lost to Follow-up|3|||
130865501|NCT04209205|471134315|FG001|Overall Study|Lost to Follow-up|1|||
130865502|NCT04209205|471134314|FG000|Overall Study|Physician Decision|1|||
130865503|NCT04209205|471134315|FG001|Overall Study|Physician Decision|1|||
130865504|NCT04209205|471134314|FG000|Overall Study|Subject decision|10|||
130865505|NCT04209205|471134315|FG001|Overall Study|Subject decision|10|||
130865506|NCT04209205|471134314|FG000|Overall Study|Progressive disease|1|||
130865507|NCT04209205|471134315|FG001|Overall Study|Progressive disease|0|||
130865508|NCT04209205|471134314|FG000|Overall Study|Protocol deviation|0|||
130865509|NCT04209205|471134315|FG001|Overall Study|Protocol deviation|1|||
130865510|NCT04209205|471134314|FG000|Overall Study|New therapy for study indication|1|||
130865511|NCT04209205|471134315|FG001|Overall Study|New therapy for study indication|0|||
130865512|NCT04209205|471134314|FG000|Overall Study|Adverse event - placebo not switched|0|||
130865513|NCT04209205|471134315|FG001|Overall Study|Adverse event - placebo not switched|1|||
130865514|NCT04209205|471134314|FG000|Overall Study|Subject decision - placebo not switched|0|||
130865515|NCT04209205|471134315|FG001|Overall Study|Subject decision - placebo not switched|5|||
130865516|NCT04209205|471134314|FG000|Overall Study|Death - placebo not switched|0|||
130865517|NCT04209205|471134315|FG001|Overall Study|Death - placebo not switched|1|||
130865518|NCT03197376|471134316|FG000|Primary and Booster Phase|Adverse Event|0|||
130865519|NCT03197376|471134317|FG001|Primary and Booster Phase|Adverse Event|0|||
130865520|NCT03197376|471134318|FG002|Primary and Booster Phase|Adverse Event|0|||
130865521|NCT03197376|471134319|FG003|Primary and Booster Phase|Adverse Event|1|||
130865522|NCT03197376|471134316|FG000|Primary and Booster Phase|Death|1|||
130865523|NCT03197376|471134317|FG001|Primary and Booster Phase|Death|0|||
130865524|NCT03197376|471134318|FG002|Primary and Booster Phase|Death|0|||
130865525|NCT03197376|471134319|FG003|Primary and Booster Phase|Death|2|||
130865526|NCT03197376|471134316|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
130865527|NCT03197376|471134317|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
130865528|NCT03197376|471134318|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
130865529|NCT03197376|471134319|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
130865530|NCT03197376|471134316|FG000|Primary and Booster Phase|Physician Decision|1|||
130865531|NCT03197376|471134317|FG001|Primary and Booster Phase|Physician Decision|0|||
130865532|NCT03197376|471134318|FG002|Primary and Booster Phase|Physician Decision|1|||
130865533|NCT03197376|471134319|FG003|Primary and Booster Phase|Physician Decision|3|||
130865534|NCT03197376|471134316|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
130865535|NCT03197376|471134317|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
130865536|NCT03197376|471134318|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
130865537|NCT03197376|471134319|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
130865538|NCT03197376|471134316|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
130865539|NCT03197376|471134317|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
130865540|NCT03197376|471134318|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
130865541|NCT03197376|471134319|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
130865542|NCT03197376|471134316|FG000|Primary and Booster Phase|Not vaccine related|1|||
130865543|NCT03197376|471134317|FG001|Primary and Booster Phase|Not vaccine related|2|||
130865544|NCT03197376|471134318|FG002|Primary and Booster Phase|Not vaccine related|0|||
130865545|NCT03197376|471134319|FG003|Primary and Booster Phase|Not vaccine related|6|||
130865546|NCT03197376|471134316|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
130865547|NCT03197376|471134317|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
130865548|NCT03197376|471134318|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
130865549|NCT03197376|471134319|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
130865550|NCT03197376|471134316|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
130865551|NCT03197376|471134317|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
130865552|NCT03197376|471134318|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
130865553|NCT03197376|471134319|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
130865554|NCT03197376|471134316|FG000|Immune Persistence Phase|Not vaccine related|1|||
130865555|NCT03197376|471134317|FG001|Immune Persistence Phase|Not vaccine related|0|||
130865556|NCT03197376|471134318|FG002|Immune Persistence Phase|Not vaccine related|1|||
130865557|NCT03197376|471134319|FG003|Immune Persistence Phase|Not vaccine related|1|||
130865558|NCT01123395|471134320|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
130865559|NCT01123395|471134321|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
130865560|NCT03691571|471134322|FG000|Overall Study|Withdrawal by Subject|9|||
130865561|NCT03691571|471134323|FG001|Overall Study|Withdrawal by Subject|2|||
130865562|NCT03887221|471134324|FG000|Overall Study|Protocol Violation|1|||
130865563|NCT03887221|471134325|FG001|Overall Study|Protocol Violation|0|||
130865564|NCT02092025|471134326|FG000|Overall Study|Case Report Forms Uncollected|44|||
130865565|NCT02092025|471134326|FG000|Overall Study|Protocol Deviation|24|||
130865566|NCT03228212|471134327|FG000|Period 1|Adverse Event|1|||
130865567|NCT03228212|471134328|FG001|Period 1|Adverse Event|0|||
130865568|NCT03228212|471134327|FG000|Period 1|no longer meets eligibility criteria|0|||
130865569|NCT03228212|471134328|FG001|Period 1|no longer meets eligibility criteria|1|||
130865570|NCT03228212|471134327|FG000|Period 2|Lost to Follow-up|1|||
130865571|NCT03228212|471134328|FG001|Period 2|Lost to Follow-up|0|||
130865572|NCT02936635|471135603|FG000|Overall Study|Adverse Event|43|||
130865573|NCT02936635|471135604|FG001|Overall Study|Adverse Event|25|||
130865574|NCT02936635|471135603|FG000|Overall Study|Progressive Disease|10|||
130865575|NCT02936635|471135604|FG001|Overall Study|Progressive Disease|18|||
130865576|NCT02936635|471135603|FG000|Overall Study|Sponsor Discretion|10|||
130865577|NCT02936635|471135604|FG001|Overall Study|Sponsor Discretion|16|||
130865578|NCT02936635|471135603|FG000|Overall Study|Death|9|||
130865579|NCT02936635|471135604|FG001|Overall Study|Death|15|||
130865580|NCT02936635|471135603|FG000|Overall Study|Withdrawal by Subject|8|||
130865581|NCT02936635|471135604|FG001|Overall Study|Withdrawal by Subject|15|||
130865582|NCT02936635|471135603|FG000|Overall Study|Physician Decision|2|||
130865583|NCT02936635|471135604|FG001|Overall Study|Physician Decision|9|||
130865584|NCT02936635|471135603|FG000|Overall Study|Lost to Follow-up|1|||
130865585|NCT02936635|471135604|FG001|Overall Study|Lost to Follow-up|2|||
130865586|NCT02936635|471135603|FG000|Overall Study|Protocol Violation|1|||
130865587|NCT02936635|471135604|FG001|Overall Study|Protocol Violation|0|||
130865588|NCT02936635|471135603|FG000|Overall Study|Lack of effect/Entry into other study|31|||
130865589|NCT02936635|471135604|FG001|Overall Study|Lack of effect/Entry into other study|65|||
130865590|NCT02407223|471135605|FG000|Overall Study|Adverse Event|1|||
130865591|NCT02407223|471135606|FG001|Overall Study|Adverse Event|0|||
130865592|NCT02407223|471135607|FG002|Overall Study|Adverse Event|1|||
130865593|NCT02407223|471135605|FG000|Overall Study|Lack of Efficacy|6|||
130865594|NCT02407223|471135606|FG001|Overall Study|Lack of Efficacy|6|||
130865595|NCT02407223|471135607|FG002|Overall Study|Lack of Efficacy|4|||
130865596|NCT02407223|471135605|FG000|Overall Study|Lost to Follow-up|1|||
130865597|NCT02407223|471135606|FG001|Overall Study|Lost to Follow-up|0|||
130865598|NCT02407223|471135607|FG002|Overall Study|Lost to Follow-up|2|||
130865599|NCT02407223|471135605|FG000|Overall Study|Withdrawal by Subject|2|||
130865600|NCT02407223|471135606|FG001|Overall Study|Withdrawal by Subject|4|||
130865601|NCT02407223|471135607|FG002|Overall Study|Withdrawal by Subject|4|||
130865602|NCT02407223|471135605|FG000|Overall Study|Study Terminated by Sponsor|77|||
130865603|NCT02407223|471135606|FG001|Overall Study|Study Terminated by Sponsor|80|||
130865604|NCT02407223|471135607|FG002|Overall Study|Study Terminated by Sponsor|86|||
130865605|NCT02407223|471135605|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
130865606|NCT02407223|471135606|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
130865607|NCT02407223|471135607|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
130865608|NCT02407223|471135605|FG000|Overall Study|Other|29|||
130865609|NCT02407223|471135606|FG001|Overall Study|Other|27|||
130865610|NCT02407223|471135607|FG002|Overall Study|Other|25|||
130865611|NCT02451943|471135613|FG000|Overall Study|Withdrawal by Subject|13|||
130865612|NCT02451943|471135614|FG001|Overall Study|Withdrawal by Subject|16|||
130865613|NCT02451943|471135613|FG000|Overall Study|Lost to Follow-up|3|||
130865614|NCT02451943|471135614|FG001|Overall Study|Lost to Follow-up|4|||
130865615|NCT02451943|471135613|FG000|Overall Study|Sponsor Decision|0|||
130865616|NCT02451943|471135614|FG001|Overall Study|Sponsor Decision|4|||
130865617|NCT01101035|471135616|FG000|Overall Study|Adverse Event|191|||
130865618|NCT01101035|471135617|FG001|Overall Study|Adverse Event|172|||
130865619|NCT01101035|471135616|FG000|Overall Study|Major Protocol Deviation|52|||
130865620|NCT01101035|471135617|FG001|Overall Study|Major Protocol Deviation|46|||
130865621|NCT01101035|471135616|FG000|Overall Study|Lost to Follow-up|226|||
130865622|NCT01101035|471135617|FG001|Overall Study|Lost to Follow-up|223|||
130865623|NCT01101035|471135616|FG000|Overall Study|Voluntary Withdrawal|595|||
130865624|NCT01101035|471135617|FG001|Overall Study|Voluntary Withdrawal|587|||
130865625|NCT01101035|471135616|FG000|Overall Study|Reason not Specified|333|||
130865626|NCT01101035|471135617|FG001|Overall Study|Reason not Specified|363|||
130865627|NCT00681629|471135618|FG000|Overall Study|Study termination|4|||
130865628|NCT00681629|471135619|FG001|Overall Study|Study termination|2|||
130865629|NCT00681629|471135618|FG000|Overall Study|Adverse Event|1|||
130865630|NCT00681629|471135619|FG001|Overall Study|Adverse Event|0|||
130865631|NCT03951077|471135622|FG000|Overall Study|Adverse Event|1|||
130865632|NCT03951077|471135623|FG001|Overall Study|Adverse Event|0|||
130865633|NCT03951077|471135624|FG002|Overall Study|Adverse Event|0|||
130865634|NCT03951077|471135625|FG003|Overall Study|Adverse Event|0|||
130865635|NCT03951077|471135626|FG004|Overall Study|Adverse Event|0|||
130865636|NCT03951077|471135627|FG005|Overall Study|Adverse Event|0|||
130865637|NCT03951077|471135622|FG000|Overall Study|Withdrawal by Subject|3|||
130865638|NCT03951077|471135623|FG001|Overall Study|Withdrawal by Subject|3|||
130865639|NCT03951077|471135624|FG002|Overall Study|Withdrawal by Subject|0|||
130865640|NCT03951077|471135625|FG003|Overall Study|Withdrawal by Subject|3|||
130865641|NCT03951077|471135626|FG004|Overall Study|Withdrawal by Subject|3|||
130865642|NCT03951077|471135627|FG005|Overall Study|Withdrawal by Subject|2|||
130865643|NCT03951077|471135622|FG000|Overall Study|Lost to Follow-up|1|||
130865644|NCT03951077|471135623|FG001|Overall Study|Lost to Follow-up|1|||
130865645|NCT03951077|471135624|FG002|Overall Study|Lost to Follow-up|2|||
130865646|NCT03951077|471135625|FG003|Overall Study|Lost to Follow-up|3|||
130865647|NCT03951077|471135626|FG004|Overall Study|Lost to Follow-up|2|||
130865648|NCT03951077|471135627|FG005|Overall Study|Lost to Follow-up|3|||
130865649|NCT03951077|471135622|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
130865650|NCT03951077|471135623|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
130865651|NCT03951077|471135624|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
130865652|NCT03951077|471135625|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
130865653|NCT03951077|471135626|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
130865654|NCT03951077|471135627|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
130865655|NCT03951077|471135622|FG000|Overall Study|Other, Not Specified|12|||
130865656|NCT03951077|471135623|FG001|Overall Study|Other, Not Specified|10|||
130865657|NCT03951077|471135624|FG002|Overall Study|Other, Not Specified|10|||
130865658|NCT03951077|471135625|FG003|Overall Study|Other, Not Specified|5|||
130865659|NCT03951077|471135626|FG004|Overall Study|Other, Not Specified|9|||
130865660|NCT03951077|471135627|FG005|Overall Study|Other, Not Specified|6|||
130865661|NCT03951077|471135622|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
130865662|NCT03951077|471135623|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
130865663|NCT03951077|471135624|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
130865664|NCT03951077|471135625|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
130865665|NCT03951077|471135626|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
130865666|NCT03951077|471135627|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
130865667|NCT00713544|471135629|FG000|Overall Study|Adverse Event|5|||
130865668|NCT00713544|471135630|FG001|Overall Study|Adverse Event|3|||
130865669|NCT00713544|471135631|FG002|Overall Study|Adverse Event|7|||
130865670|NCT00713544|471135632|FG003|Overall Study|Adverse Event|7|||
130865671|NCT00713544|471135633|FG004|Overall Study|Adverse Event|3|||
130865672|NCT00713544|471135634|FG005|Overall Study|Adverse Event|5|||
130865673|NCT00713544|471135629|FG000|Overall Study|Withdrawal by Subject|2|||
130865674|NCT00713544|471135630|FG001|Overall Study|Withdrawal by Subject|0|||
130865675|NCT00713544|471135631|FG002|Overall Study|Withdrawal by Subject|3|||
130865676|NCT00713544|471135632|FG003|Overall Study|Withdrawal by Subject|2|||
130865677|NCT00713544|471135633|FG004|Overall Study|Withdrawal by Subject|3|||
130865678|NCT00713544|471135634|FG005|Overall Study|Withdrawal by Subject|1|||
130865679|NCT00713544|471135629|FG000|Overall Study|Protocol Violation|0|||
130865680|NCT00713544|471135630|FG001|Overall Study|Protocol Violation|0|||
130865681|NCT00713544|471135631|FG002|Overall Study|Protocol Violation|0|||
130865682|NCT00713544|471135632|FG003|Overall Study|Protocol Violation|0|||
130865683|NCT00713544|471135633|FG004|Overall Study|Protocol Violation|0|||
130865684|NCT00713544|471135634|FG005|Overall Study|Protocol Violation|1|||
130865685|NCT00713544|471135629|FG000|Overall Study|Physician Decision|0|||
130865686|NCT00713544|471135630|FG001|Overall Study|Physician Decision|0|||
130865687|NCT00713544|471135631|FG002|Overall Study|Physician Decision|0|||
130865688|NCT00713544|471135632|FG003|Overall Study|Physician Decision|0|||
130865689|NCT00713544|471135633|FG004|Overall Study|Physician Decision|0|||
130865690|NCT00713544|471135634|FG005|Overall Study|Physician Decision|2|||
130865691|NCT00713544|471135629|FG000|Overall Study|Lack of Efficacy|0|||
130865692|NCT00713544|471135630|FG001|Overall Study|Lack of Efficacy|1|||
130865693|NCT00713544|471135631|FG002|Overall Study|Lack of Efficacy|0|||
130865694|NCT00713544|471135632|FG003|Overall Study|Lack of Efficacy|1|||
130865695|NCT00713544|471135633|FG004|Overall Study|Lack of Efficacy|1|||
130865696|NCT00713544|471135634|FG005|Overall Study|Lack of Efficacy|0|||
130865697|NCT00713544|471135629|FG000|Overall Study|Lost to Follow-up|0|||
130865698|NCT00713544|471135630|FG001|Overall Study|Lost to Follow-up|0|||
130865699|NCT00713544|471135631|FG002|Overall Study|Lost to Follow-up|1|||
130865700|NCT00713544|471135632|FG003|Overall Study|Lost to Follow-up|0|||
130865701|NCT00713544|471135633|FG004|Overall Study|Lost to Follow-up|0|||
130865702|NCT00713544|471135634|FG005|Overall Study|Lost to Follow-up|0|||
130865703|NCT00713544|471135629|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130865704|NCT00713544|471135630|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
130865705|NCT00713544|471135631|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130865706|NCT00713544|471135632|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130865707|NCT00713544|471135633|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130865708|NCT00713544|471135634|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130865709|NCT00713544|471135629|FG000|Overall Study|Incorrect enrollment|0|||
130865710|NCT00713544|471135630|FG001|Overall Study|Incorrect enrollment|1|||
130865711|NCT00713544|471135631|FG002|Overall Study|Incorrect enrollment|0|||
130865712|NCT00713544|471135632|FG003|Overall Study|Incorrect enrollment|0|||
130865713|NCT00713544|471135633|FG004|Overall Study|Incorrect enrollment|0|||
130865714|NCT00713544|471135634|FG005|Overall Study|Incorrect enrollment|0|||
130865715|NCT00713544|471135629|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
130865716|NCT00713544|471135630|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
130865717|NCT00713544|471135631|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
130865718|NCT00713544|471135632|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
130865719|NCT00713544|471135633|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
130865720|NCT00713544|471135634|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
130865721|NCT00950846|471135635|FG000|Overall Study|Death|6|||
130865722|NCT00950846|471135635|FG000|Overall Study|Lost to Follow-up|3|||
130865723|NCT00950846|471135635|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
130865724|NCT01510158|471135640|FG000|Overall Study|Adverse Event|7|||
130865725|NCT01510158|471135641|FG001|Overall Study|Adverse Event|8|||
130865726|NCT01510158|471135642|FG002|Overall Study|Adverse Event|5|||
130865727|NCT01510158|471135640|FG000|Overall Study|Gout flare|1|||
130865728|NCT01510158|471135641|FG001|Overall Study|Gout flare|0|||
130865729|NCT01510158|471135642|FG002|Overall Study|Gout flare|0|||
130865730|NCT01510158|471135640|FG000|Overall Study|Protocol Violation|17|||
130865731|NCT01510158|471135641|FG001|Overall Study|Protocol Violation|16|||
130865732|NCT01510158|471135642|FG002|Overall Study|Protocol Violation|24|||
130865733|NCT01510158|471135640|FG000|Overall Study|Sponsor terminated study.|2|||
130865734|NCT01510158|471135641|FG001|Overall Study|Sponsor terminated study.|0|||
130865735|NCT01510158|471135642|FG002|Overall Study|Sponsor terminated study.|2|||
130865736|NCT01510158|471135640|FG000|Overall Study|Lost to Follow-up|13|||
130865737|NCT01510158|471135641|FG001|Overall Study|Lost to Follow-up|16|||
130865738|NCT01510158|471135642|FG002|Overall Study|Lost to Follow-up|9|||
130865739|NCT01510158|471135640|FG000|Overall Study|Withdrawal by Subject|10|||
130865740|NCT01510158|471135641|FG001|Overall Study|Withdrawal by Subject|13|||
130865741|NCT01510158|471135642|FG002|Overall Study|Withdrawal by Subject|10|||
130865742|NCT01510158|471135640|FG000|Overall Study|Death|1|||
130865743|NCT01510158|471135641|FG001|Overall Study|Death|0|||
130865744|NCT01510158|471135642|FG002|Overall Study|Death|0|||
130865745|NCT05258149|471135643|FG000|Period 1|Protocol Deviation|1|||
130865746|NCT05258149|471135644|FG001|Period 1|Protocol Deviation|0|||
130865747|NCT05258149|471135643|FG000|Period 1|Adverse Event|0|||
130865748|NCT05258149|471135644|FG001|Period 1|Adverse Event|1|||
130865749|NCT05258149|471135643|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
130865750|NCT05258149|471135644|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130865751|NCT05258149|471135643|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
130865752|NCT05258149|471135644|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
130865753|NCT05258149|471135643|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
130865754|NCT05258149|471135644|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
130865755|NCT01290757|471135653|FG000|Overall Study|Adverse Event|1|||
130865756|NCT01290757|471135654|FG001|Overall Study|Adverse Event|0|||
130865757|NCT01290757|471135653|FG000|Overall Study|Protocol Violation|1|||
130865758|NCT01290757|471135654|FG001|Overall Study|Protocol Violation|1|||
130865759|NCT01290757|471135653|FG000|Overall Study|Other|0|||
130865760|NCT01290757|471135654|FG001|Overall Study|Other|1|||
130865761|NCT00479336|471135656|FG000|Overall Study|Adverse Event|1|||
130865762|NCT00479336|471135657|FG001|Overall Study|Adverse Event|1|||
130865763|NCT00479336|471135658|FG002|Overall Study|Adverse Event|1|||
130865764|NCT00479336|471135659|FG003|Overall Study|Adverse Event|3|||
130865765|NCT00479336|471135656|FG000|Overall Study|Lack of Efficacy|1|||
130865766|NCT00479336|471135657|FG001|Overall Study|Lack of Efficacy|0|||
130865767|NCT00479336|471135658|FG002|Overall Study|Lack of Efficacy|0|||
130865768|NCT00479336|471135659|FG003|Overall Study|Lack of Efficacy|0|||
130865769|NCT00479336|471135656|FG000|Overall Study|Protocol Violation|0|||
130865770|NCT00479336|471135657|FG001|Overall Study|Protocol Violation|1|||
130865771|NCT00479336|471135658|FG002|Overall Study|Protocol Violation|0|||
130865772|NCT00479336|471135659|FG003|Overall Study|Protocol Violation|0|||
130865773|NCT00479336|471135656|FG000|Overall Study|Withdrawal by Subject|1|||
130865774|NCT00479336|471135657|FG001|Overall Study|Withdrawal by Subject|2|||
130865775|NCT00479336|471135658|FG002|Overall Study|Withdrawal by Subject|0|||
130865776|NCT00479336|471135659|FG003|Overall Study|Withdrawal by Subject|0|||
130865777|NCT00479336|471135656|FG000|Overall Study|Physician Decision|0|||
130865778|NCT00479336|471135657|FG001|Overall Study|Physician Decision|1|||
130865779|NCT00479336|471135658|FG002|Overall Study|Physician Decision|0|||
130865780|NCT00479336|471135659|FG003|Overall Study|Physician Decision|2|||
130865781|NCT00479336|471135656|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
130865782|NCT00479336|471135657|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
130865783|NCT00479336|471135658|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
130865784|NCT00479336|471135659|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
130865785|NCT03329846|471135660|FG000|Overall Study|Disease progression|4|||
130865786|NCT03329846|471135661|FG001|Overall Study|Disease progression|6|||
130865787|NCT03329846|471135660|FG000|Overall Study|Study drug toxicity|1|||
130865788|NCT03329846|471135661|FG001|Overall Study|Study drug toxicity|0|||
130865789|NCT03329846|471135660|FG000|Overall Study|Participant request to discontinue treatment|0|||
130865790|NCT03329846|471135661|FG001|Overall Study|Participant request to discontinue treatment|1|||
130865791|NCT03329846|471135660|FG000|Overall Study|Participant withdrew consent|1|||
130865792|NCT03329846|471135661|FG001|Overall Study|Participant withdrew consent|0|||
130865793|NCT03329846|471135660|FG000|Overall Study|Other reasons|2|||
130865794|NCT03329846|471135661|FG001|Overall Study|Other reasons|2|||
130865795|NCT03066193|471135662|FG000|Overall Study|Withdrawal by Subject|1|||
130865796|NCT02021643|471135663|FG000|Overall Study|Enrolled but Never Treated|1|||
130865797|NCT02021643|471135664|FG001|Overall Study|Enrolled but Never Treated|0|||
130865798|NCT02021643|471135665|FG002|Overall Study|Enrolled but Never Treated|0|||
130865799|NCT02021643|471135666|FG003|Overall Study|Enrolled but Never Treated|0|||
130865800|NCT02021643|471135663|FG000|Overall Study|Adverse Event|0|||
130865801|NCT02021643|471135664|FG001|Overall Study|Adverse Event|1|||
130865802|NCT02021643|471135665|FG002|Overall Study|Adverse Event|0|||
130865803|NCT02021643|471135666|FG003|Overall Study|Adverse Event|0|||
130865804|NCT02021643|471135663|FG000|Overall Study|Death|0|||
130865805|NCT02021643|471135664|FG001|Overall Study|Death|1|||
130865806|NCT02021643|471135665|FG002|Overall Study|Death|0|||
130865807|NCT02021643|471135666|FG003|Overall Study|Death|0|||
130865808|NCT02021643|471135663|FG000|Overall Study|Investigator's Discretion|1|||
130865809|NCT02021643|471135664|FG001|Overall Study|Investigator's Discretion|0|||
130865810|NCT02021643|471135665|FG002|Overall Study|Investigator's Discretion|0|||
130865811|NCT02021643|471135666|FG003|Overall Study|Investigator's Discretion|0|||
130865812|NCT02021643|471135663|FG000|Overall Study|Lack of Efficacy|7|||
130865813|NCT02021643|471135664|FG001|Overall Study|Lack of Efficacy|6|||
130865814|NCT02021643|471135665|FG002|Overall Study|Lack of Efficacy|0|||
130865815|NCT02021643|471135666|FG003|Overall Study|Lack of Efficacy|12|||
130865816|NCT02021643|471135663|FG000|Overall Study|Lost to Follow-up|0|||
130865817|NCT02021643|471135664|FG001|Overall Study|Lost to Follow-up|1|||
130865818|NCT02021643|471135665|FG002|Overall Study|Lost to Follow-up|0|||
130865819|NCT02021643|471135666|FG003|Overall Study|Lost to Follow-up|0|||
130865820|NCT02021643|471135663|FG000|Overall Study|Withdrew Consent|0|||
130865821|NCT02021643|471135664|FG001|Overall Study|Withdrew Consent|1|||
130865822|NCT02021643|471135665|FG002|Overall Study|Withdrew Consent|0|||
130865823|NCT02021643|471135666|FG003|Overall Study|Withdrew Consent|0|||
130865824|NCT04854551|471135667|FG000|Overall Study|Withdrawal by Subject|1|||
130865825|NCT04854551|471135668|FG001|Overall Study|Withdrawal by Subject|1|||
130865826|NCT02631551|471135669|FG000|Overall Study|Adverse Event|1|||
130865827|NCT02631551|471135670|FG001|Overall Study|Adverse Event|2|||
130865828|NCT02631551|471135671|FG002|Overall Study|Adverse Event|4|||
130865829|NCT02631551|471135672|FG003|Overall Study|Adverse Event|0|||
130865830|NCT02631551|471135669|FG000|Overall Study|Lack of Efficacy|0|||
130865831|NCT02631551|471135670|FG001|Overall Study|Lack of Efficacy|0|||
130865832|NCT02631551|471135671|FG002|Overall Study|Lack of Efficacy|1|||
130865833|NCT02631551|471135672|FG003|Overall Study|Lack of Efficacy|0|||
130865834|NCT02631551|471135669|FG000|Overall Study|Lost to Follow-up|1|||
130865835|NCT02631551|471135670|FG001|Overall Study|Lost to Follow-up|2|||
130865836|NCT02631551|471135671|FG002|Overall Study|Lost to Follow-up|0|||
130865837|NCT02631551|471135672|FG003|Overall Study|Lost to Follow-up|3|||
130865838|NCT02631551|471135669|FG000|Overall Study|Withdrawal by Subject|2|||
130865839|NCT02631551|471135670|FG001|Overall Study|Withdrawal by Subject|2|||
130865840|NCT02631551|471135671|FG002|Overall Study|Withdrawal by Subject|0|||
130865841|NCT02631551|471135672|FG003|Overall Study|Withdrawal by Subject|5|||
130865842|NCT02631551|471135669|FG000|Overall Study|Protocol deviation|3|||
130865843|NCT02631551|471135670|FG001|Overall Study|Protocol deviation|6|||
130865844|NCT02631551|471135671|FG002|Overall Study|Protocol deviation|3|||
130865845|NCT02631551|471135672|FG003|Overall Study|Protocol deviation|0|||
130865846|NCT02631551|471135669|FG000|Overall Study|Non-compliance with study procedures|0|||
130865847|NCT02631551|471135670|FG001|Overall Study|Non-compliance with study procedures|0|||
130865848|NCT02631551|471135671|FG002|Overall Study|Non-compliance with study procedures|1|||
130865849|NCT02631551|471135672|FG003|Overall Study|Non-compliance with study procedures|1|||
130865850|NCT02631551|471135669|FG000|Overall Study|Non-compliance with study drug|1|||
130865851|NCT02631551|471135670|FG001|Overall Study|Non-compliance with study drug|0|||
130865852|NCT02631551|471135671|FG002|Overall Study|Non-compliance with study drug|0|||
130865853|NCT02631551|471135672|FG003|Overall Study|Non-compliance with study drug|0|||
130865854|NCT02631551|471135669|FG000|Overall Study|Other, specific reasons not collected|5|||
130865855|NCT02631551|471135670|FG001|Overall Study|Other, specific reasons not collected|7|||
130865856|NCT02631551|471135671|FG002|Overall Study|Other, specific reasons not collected|2|||
130865857|NCT02631551|471135672|FG003|Overall Study|Other, specific reasons not collected|2|||
130865858|NCT00100789|471135673|FG000|Overall Study|Adverse Event|10|||
130865859|NCT00100789|471135673|FG000|Overall Study|Withdrawal by Subject|1|||
130865860|NCT00100789|471135673|FG000|Overall Study|Progression/relapse|42|||
130865861|NCT00100789|471135673|FG000|Overall Study|Death|2|||
130865862|NCT00100789|471135673|FG000|Overall Study|Not protocol specified|5|||
130865863|NCT00100789|471135673|FG000|Overall Study|Ineligible|3|||
130865864|NCT00100789|471135673|FG000|Overall Study|Never received treatment|1|||
130865865|NCT01746368|471135674|FG000|Overall Study|Lost to Follow-up|2|||
130865866|NCT01746368|471135675|FG001|Overall Study|Lost to Follow-up|0|||
130865867|NCT01746368|471135674|FG000|Overall Study|Withdrawal by Subject|0|||
130865868|NCT01746368|471135675|FG001|Overall Study|Withdrawal by Subject|1|||
130865869|NCT05280717|471135676|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
130865870|NCT05280717|471135677|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
130865871|NCT05280717|471135678|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
130865872|NCT05280717|471135679|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130865873|NCT05280717|471135680|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130865874|NCT05280717|471135681|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130865875|NCT05280717|471135682|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130865876|NCT05280717|471135676|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
130865877|NCT05280717|471135677|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130865878|NCT05280717|471135678|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130865879|NCT05280717|471135679|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130865880|NCT05280717|471135680|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130865881|NCT05280717|471135681|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130865882|NCT05280717|471135682|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130865883|NCT05280717|471135676|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130865884|NCT05280717|471135677|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
130865885|NCT05280717|471135678|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130865886|NCT05280717|471135679|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130865887|NCT05280717|471135680|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130865888|NCT05280717|471135681|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130865889|NCT05280717|471135682|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130865890|NCT05280717|471135676|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130865891|NCT05280717|471135677|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130865892|NCT05280717|471135678|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
130865893|NCT05280717|471135679|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130865894|NCT05280717|471135680|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130865895|NCT05280717|471135681|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130865896|NCT05280717|471135682|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130865897|NCT05280717|471135676|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130865898|NCT05280717|471135677|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130865899|NCT05280717|471135678|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130865900|NCT05280717|471135679|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130865901|NCT05280717|471135680|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130865902|NCT05280717|471135681|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
130865903|NCT05280717|471135682|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130865904|NCT05280717|471135676|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130865905|NCT05280717|471135677|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130865906|NCT05280717|471135678|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130865907|NCT05280717|471135679|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130865908|NCT05280717|471135680|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130865909|NCT05280717|471135681|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
130865910|NCT05280717|471135682|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130865911|NCT00080301|471135683|FG000|Overall Study|Randomized but Never Treated|5|||
130865912|NCT00080301|471135684|FG001|Overall Study|Randomized but Never Treated|10|||
130865913|NCT00080301|471135683|FG000|Overall Study|Still on Treatment as of CSR date|0|||
130865914|NCT00080301|471135684|FG001|Overall Study|Still on Treatment as of CSR date|1|||
130865915|NCT02518971|471135685|FG000|Overall Study|Lost to Follow-up|0|||
130865916|NCT02518971|471135686|FG001|Overall Study|Lost to Follow-up|1|||
130865917|NCT02518971|471135685|FG000|Overall Study|Physician Decision|6|||
130865918|NCT02518971|471135686|FG001|Overall Study|Physician Decision|6|||
130865919|NCT02518971|471135685|FG000|Overall Study|Protocol Violation|6|||
130865920|NCT02518971|471135686|FG001|Overall Study|Protocol Violation|4|||
130865921|NCT02518971|471135685|FG000|Overall Study|Withdrawal by Subject|4|||
130865922|NCT02518971|471135686|FG001|Overall Study|Withdrawal by Subject|5|||
130865923|NCT02518971|471135685|FG000|Overall Study|Side effects|1|||
130865924|NCT02518971|471135686|FG001|Overall Study|Side effects|0|||
130865925|NCT02518971|471135685|FG000|Overall Study|medication lost in mail|0|||
130865926|NCT02518971|471135686|FG001|Overall Study|medication lost in mail|1|||
130865927|NCT02518971|471135685|FG000|Overall Study|eligibility criteria no longer met|6|||
130865928|NCT02518971|471135686|FG001|Overall Study|eligibility criteria no longer met|3|||
130865929|NCT02524171|471135687|FG000|6-month Follow-up|Lost to Follow-up|53|||
130865930|NCT02524171|471135688|FG001|6-month Follow-up|Lost to Follow-up|45|||
130865931|NCT02524171|471135687|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
130865932|NCT02524171|471135688|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
130865933|NCT00757237|471135691|FG000|Overall Study|Lost to Follow-up|0|||
130865934|NCT00757237|471135692|FG001|Overall Study|Lost to Follow-up|1|||
130865935|NCT00757237|471135691|FG000|Overall Study|Protocol Violation|0|||
130865936|NCT00757237|471135692|FG001|Overall Study|Protocol Violation|2|||
130865937|NCT00757237|471135691|FG000|Overall Study|Physician Decision|2|||
130865938|NCT00757237|471135692|FG001|Overall Study|Physician Decision|3|||
130865939|NCT00757237|471135691|FG000|Overall Study|Withdrawal by Subject|8|||
130865940|NCT00757237|471135692|FG001|Overall Study|Withdrawal by Subject|12|||
130865941|NCT00757237|471135691|FG000|Overall Study|Safety or Tolerability|3|||
130865942|NCT00757237|471135692|FG001|Overall Study|Safety or Tolerability|5|||
130865943|NCT00757237|471135691|FG000|Overall Study|Other|0|||
130865944|NCT00757237|471135692|FG001|Overall Study|Other|2|||
130865945|NCT01345188|471135693|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
130865946|NCT01345188|471135693|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
130865947|NCT05150990|471135694|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
130865948|NCT05150990|471135695|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
130865949|NCT05150990|471135694|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
130865950|NCT05150990|471135695|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
130865951|NCT05150990|471135694|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
130865952|NCT05150990|471135695|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
130865953|NCT05150990|471135694|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
130865954|NCT05150990|471135695|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
130865955|NCT05150990|471135694|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
130865956|NCT05150990|471135695|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
130865957|NCT05150990|471135694|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
130865958|NCT05150990|471135695|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
130865959|NCT05150990|471135694|FG000|Overall Study|Death (unrelated to the intervention)|1|||
130865960|NCT05150990|471135695|FG001|Overall Study|Death (unrelated to the intervention)|2|||
130865961|NCT00466921|471135696|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
130865962|NCT00466921|471135696|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
130865963|NCT00466921|471135696|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
130865964|NCT00466921|471135696|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
130865965|NCT00466921|471135696|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
130865966|NCT00466921|471135696|FG000|Follow up for a Minimum of 1 Year|Death|6|||
130865967|NCT01397461|471135698|FG000|Overall Study|Withdrawal by Subject|2|||
130865968|NCT01397461|471135699|FG001|Overall Study|Withdrawal by Subject|1|||
130865969|NCT01397461|471135700|FG002|Overall Study|Withdrawal by Subject|0|||
130865970|NCT01397461|471135698|FG000|Overall Study|Lost to Follow-up|0|||
130865971|NCT01397461|471135699|FG001|Overall Study|Lost to Follow-up|2|||
130865972|NCT01397461|471135700|FG002|Overall Study|Lost to Follow-up|1|||
130865973|NCT01397461|471135698|FG000|Overall Study|Lack of Efficacy|0|||
130865974|NCT01397461|471135699|FG001|Overall Study|Lack of Efficacy|3|||
130865975|NCT01397461|471135700|FG002|Overall Study|Lack of Efficacy|0|||
130865976|NCT01397461|471135698|FG000|Overall Study|Not treated|0|||
130865977|NCT01397461|471135699|FG001|Overall Study|Not treated|0|||
130865978|NCT01397461|471135700|FG002|Overall Study|Not treated|1|||
130865979|NCT05729568|471135717|FG000|Overall Study|Still on Study|52|||
130865980|NCT05729568|471135718|FG001|Overall Study|Still on Study|26|||
130865981|NCT05729568|471135717|FG000|Overall Study|Randomized but Never Treated|3|||
130865982|NCT05729568|471135718|FG001|Overall Study|Randomized but Never Treated|0|||
130865983|NCT05729568|471135717|FG000|Overall Study|Adverse Event|0|||
130865984|NCT05729568|471135718|FG001|Overall Study|Adverse Event|1|||
130865985|NCT05729568|471135717|FG000|Overall Study|Investigator's Discretion|1|||
130865986|NCT05729568|471135718|FG001|Overall Study|Investigator's Discretion|0|||
130865987|NCT04181762|471135719|FG000|Overall Study|Adverse Event|1|||
130865988|NCT04181762|471135720|FG001|Overall Study|Adverse Event|3|||
130865989|NCT04181762|471135719|FG000|Overall Study|Lost to Follow-up|1|||
130865990|NCT04181762|471135720|FG001|Overall Study|Lost to Follow-up|1|||
130865991|NCT04181762|471135719|FG000|Overall Study|Physician Decision|1|||
130865992|NCT04181762|471135720|FG001|Overall Study|Physician Decision|3|||
130865993|NCT04181762|471135719|FG000|Overall Study|Pregnancy|0|||
130865994|NCT04181762|471135720|FG001|Overall Study|Pregnancy|1|||
130865995|NCT04181762|471135719|FG000|Overall Study|Lack of Efficacy|2|||
130865996|NCT04181762|471135720|FG001|Overall Study|Lack of Efficacy|2|||
130865997|NCT04181762|471135719|FG000|Overall Study|Study terminated by sponsor|95|||
130865998|NCT04181762|471135720|FG001|Overall Study|Study terminated by sponsor|97|||
130865999|NCT04181762|471135719|FG000|Overall Study|Subject decision|11|||
130866000|NCT04181762|471135720|FG001|Overall Study|Subject decision|4|||
130866001|NCT04181762|471135719|FG000|Overall Study|Death|1|||
130866002|NCT04181762|471135720|FG001|Overall Study|Death|1|||
130866003|NCT04181762|471135719|FG000|Overall Study|Protocol deviation|1|||
130866004|NCT04181762|471135720|FG001|Overall Study|Protocol deviation|0|||
130866005|NCT04181762|471135719|FG000|Overall Study|Withdrawal of informed consent|1|||
130866006|NCT04181762|471135720|FG001|Overall Study|Withdrawal of informed consent|3|||
130866007|NCT06041919|471135721|FG000|Overall Study|Lost to Follow-up|1|||
130866008|NCT06041919|471135722|FG001|Overall Study|Lost to Follow-up|0|||
130866009|NCT06041919|471135723|FG002|Overall Study|Lost to Follow-up|0|||
130866010|NCT06041919|471135724|FG003|Overall Study|Lost to Follow-up|0|||
130866011|NCT06041919|471135725|FG004|Overall Study|Lost to Follow-up|0|||
130866012|NCT06041919|471135721|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
130866013|NCT06041919|471135722|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
130866014|NCT06041919|471135723|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
130866015|NCT06041919|471135724|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
130866016|NCT06041919|471135725|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
130866017|NCT01221350|471135728|FG000|Overall Study|Discontinued intervention (GERD)|1|||
130866018|NCT01221350|471135729|FG001|Overall Study|Discontinued intervention (GERD)|0|||
130866019|NCT01221350|471135728|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
130866020|NCT01221350|471135729|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
130866021|NCT01221350|471135728|FG000|Overall Study|Withdrawal by Subject|4|||
130866022|NCT01221350|471135729|FG001|Overall Study|Withdrawal by Subject|2|||
130866023|NCT02735343|471135733|FG000|Overall Study|screen fail|0|||
130866024|NCT02735343|471135734|FG001|Overall Study|screen fail|2|||
130866025|NCT00637416|471135735|FG000|Overall Study|Lost to Follow-up|1|||
130866026|NCT00637416|471135736|FG001|Overall Study|Lost to Follow-up|1|||
130866027|NCT00637416|471135735|FG000|Overall Study|Unable to take study drug|0|||
130866028|NCT00637416|471135736|FG001|Overall Study|Unable to take study drug|1|||
130866029|NCT01147055|471135737|FG000|First Intervention Period|Lost to Follow-up|1|||
130866030|NCT01147055|471135738|FG001|First Intervention Period|Lost to Follow-up|0|||
130866031|NCT05236257|471135739|FG000|Overall Study|Ongoing with study treatment|29|||
130866032|NCT05236257|471135740|FG001|Overall Study|Ongoing with study treatment|1|||
130866033|NCT05236257|471135739|FG000|Overall Study|Discontinued study treatment|22|||
130866034|NCT05236257|471135740|FG001|Overall Study|Discontinued study treatment|41|||
130866035|NCT00874848|471135742|FG000|Overall Study|Adverse Event|13|||
130866036|NCT00874848|471135743|FG001|Overall Study|Adverse Event|2|||
130866037|NCT00874848|471135742|FG000|Overall Study|Progressive neoplastic disease|38|||
130866038|NCT00874848|471135743|FG001|Overall Study|Progressive neoplastic disease|18|||
130866039|NCT00874848|471135742|FG000|Overall Study|Withdrawal by Subject|7|||
130866040|NCT00874848|471135743|FG001|Overall Study|Withdrawal by Subject|4|||
130866041|NCT00874848|471135742|FG000|Overall Study|Noncompliance|1|||
130866042|NCT00874848|471135743|FG001|Overall Study|Noncompliance|1|||
130866043|NCT00874848|471135742|FG000|Overall Study|Failure to comply with protocol|0|||
130866044|NCT00874848|471135743|FG001|Overall Study|Failure to comply with protocol|1|||
130866045|NCT00874848|471135742|FG000|Overall Study|Physician Decision|0|||
130866046|NCT00874848|471135743|FG001|Overall Study|Physician Decision|2|||
130866047|NCT02713828|471135744|FG000|Overall Study|Death|2|||
130866048|NCT02713828|471135745|FG001|Overall Study|Death|0|||
130866049|NCT02713828|471135744|FG000|Overall Study|Withdrawal by Subject|1|||
130866050|NCT02713828|471135745|FG001|Overall Study|Withdrawal by Subject|0|||
130866051|NCT02713828|471135744|FG000|Overall Study|study terminated but patient allowed to|2|||
130866052|NCT02713828|471135745|FG001|Overall Study|study terminated but patient allowed to|0|||
130866053|NCT00186901|471135748|FG000|Overall Study|Pregnancy|6|||
130866054|NCT00186901|471135749|FG001|Overall Study|Pregnancy|3|||
130866055|NCT00186901|471135750|FG002|Overall Study|Pregnancy|0|||
130866056|NCT00186901|471135748|FG000|Overall Study|Lost to Follow-up|6|||
130866057|NCT00186901|471135749|FG001|Overall Study|Lost to Follow-up|3|||
130866058|NCT00186901|471135750|FG002|Overall Study|Lost to Follow-up|0|||
130866059|NCT00186901|471135748|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
130866060|NCT00186901|471135749|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
130866061|NCT00186901|471135750|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
130866062|NCT00186901|471135748|FG000|Overall Study|ALL relapse or second malignancy|1|||
130866063|NCT00186901|471135749|FG001|Overall Study|ALL relapse or second malignancy|2|||
130866064|NCT00186901|471135750|FG002|Overall Study|ALL relapse or second malignancy|0|||
130866065|NCT00186901|471135748|FG000|Overall Study|Withdrawal by Subject|4|||
130866066|NCT00186901|471135749|FG001|Overall Study|Withdrawal by Subject|5|||
130866067|NCT00186901|471135750|FG002|Overall Study|Withdrawal by Subject|0|||
130866068|NCT00186901|471135748|FG000|Overall Study|Open label|3|||
130866069|NCT00186901|471135749|FG001|Overall Study|Open label|2|||
130866070|NCT00186901|471135750|FG002|Overall Study|Open label|0|||
130866071|NCT00186901|471135748|FG000|Overall Study|Limited adherence to study requirements|20|||
130866072|NCT00186901|471135749|FG001|Overall Study|Limited adherence to study requirements|23|||
130866073|NCT00186901|471135750|FG002|Overall Study|Limited adherence to study requirements|0|||
130866074|NCT00186901|471135748|FG000|Overall Study|Bone Mineral Density > 0|0|||
130866075|NCT00186901|471135749|FG001|Overall Study|Bone Mineral Density > 0|0|||
130866076|NCT00186901|471135750|FG002|Overall Study|Bone Mineral Density > 0|149|||
130866077|NCT00291486|471135756|FG000|Overall Study|Adverse Event|0|||
130866078|NCT00291486|471135757|FG001|Overall Study|Adverse Event|3|||
130866079|NCT00291486|471135758|FG002|Overall Study|Adverse Event|0|||
130866080|NCT00291486|471135759|FG003|Overall Study|Adverse Event|1|||
130866081|NCT00291486|471135760|FG004|Overall Study|Adverse Event|0|||
130866082|NCT00291486|471135756|FG000|Overall Study|Withdrawal by Subject|0|||
130866083|NCT00291486|471135757|FG001|Overall Study|Withdrawal by Subject|0|||
130866084|NCT00291486|471135758|FG002|Overall Study|Withdrawal by Subject|0|||
130866085|NCT00291486|471135759|FG003|Overall Study|Withdrawal by Subject|0|||
130866086|NCT00291486|471135760|FG004|Overall Study|Withdrawal by Subject|1|||
130866087|NCT00291486|471135756|FG000|Overall Study|Disease progression|1|||
130866088|NCT00291486|471135757|FG001|Overall Study|Disease progression|0|||
130866089|NCT00291486|471135758|FG002|Overall Study|Disease progression|1|||
130866090|NCT00291486|471135759|FG003|Overall Study|Disease progression|0|||
130866091|NCT00291486|471135760|FG004|Overall Study|Disease progression|0|||
130866092|NCT01099397|471135761|FG000|Overall Study|Lost to Follow-up|4|||
130866093|NCT01099397|471135761|FG000|Overall Study|Protocol Violation|4|||
130866094|NCT01099397|471135761|FG000|Overall Study|Withdrawal by Subject|5|||
130866095|NCT02487030|471135769|FG000|Overall Study|Lack of Efficacy|2|||
130866096|NCT02487030|471135770|FG001|Overall Study|Lack of Efficacy|4|||
130866097|NCT02487030|471135771|FG002|Overall Study|Lack of Efficacy|1|||
130866098|NCT02487030|471135772|FG003|Overall Study|Lack of Efficacy|0|||
130866099|NCT02487030|471135773|FG004|Overall Study|Lack of Efficacy|1|||
130866100|NCT02487030|471135774|FG005|Overall Study|Lack of Efficacy|0|||
130866101|NCT02487030|471135775|FG006|Overall Study|Lack of Efficacy|0|||
130866102|NCT02487030|471135769|FG000|Overall Study|Lost to Follow-up|0|||
130866103|NCT02487030|471135770|FG001|Overall Study|Lost to Follow-up|0|||
130866104|NCT02487030|471135771|FG002|Overall Study|Lost to Follow-up|1|||
130866105|NCT02487030|471135772|FG003|Overall Study|Lost to Follow-up|1|||
130866106|NCT02487030|471135773|FG004|Overall Study|Lost to Follow-up|0|||
130866107|NCT02487030|471135774|FG005|Overall Study|Lost to Follow-up|1|||
130866108|NCT02487030|471135775|FG006|Overall Study|Lost to Follow-up|0|||
130866109|NCT02487030|471135769|FG000|Overall Study|Adverse Event|0|||
130866110|NCT02487030|471135770|FG001|Overall Study|Adverse Event|0|||
130866111|NCT02487030|471135771|FG002|Overall Study|Adverse Event|0|||
130866112|NCT02487030|471135772|FG003|Overall Study|Adverse Event|1|||
130866113|NCT02487030|471135773|FG004|Overall Study|Adverse Event|0|||
130866114|NCT02487030|471135774|FG005|Overall Study|Adverse Event|0|||
130866115|NCT02487030|471135775|FG006|Overall Study|Adverse Event|0|||
130866116|NCT02487030|471135769|FG000|Overall Study|Death|0|||
130866117|NCT02487030|471135770|FG001|Overall Study|Death|0|||
130866118|NCT02487030|471135771|FG002|Overall Study|Death|0|||
130866119|NCT02487030|471135772|FG003|Overall Study|Death|0|||
130866120|NCT02487030|471135773|FG004|Overall Study|Death|1|||
130866121|NCT02487030|471135774|FG005|Overall Study|Death|0|||
130866122|NCT02487030|471135775|FG006|Overall Study|Death|0|||
130866123|NCT00264537|471135776|FG000|Overall Study|Death|0|||
130866124|NCT00264537|471135777|FG001|Overall Study|Death|3|||
130866125|NCT00264537|471135778|FG002|Overall Study|Death|3|||
130866126|NCT00264537|471135779|FG003|Overall Study|Death|2|||
130866127|NCT00264537|471135776|FG000|Overall Study|Lost to Follow-up|3|||
130866128|NCT00264537|471135777|FG001|Overall Study|Lost to Follow-up|4|||
130866129|NCT00264537|471135778|FG002|Overall Study|Lost to Follow-up|7|||
130866130|NCT00264537|471135779|FG003|Overall Study|Lost to Follow-up|6|||
130866131|NCT00264537|471135776|FG000|Overall Study|Adverse Event|21|||
130866132|NCT00264537|471135777|FG001|Overall Study|Adverse Event|32|||
130866133|NCT00264537|471135778|FG002|Overall Study|Adverse Event|24|||
130866134|NCT00264537|471135779|FG003|Overall Study|Adverse Event|34|||
130866135|NCT00264537|471135776|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130866136|NCT00264537|471135777|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130866137|NCT00264537|471135778|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
130866138|NCT00264537|471135779|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
130866139|NCT00264537|471135776|FG000|Overall Study|Other|21|||
130866140|NCT00264537|471135777|FG001|Overall Study|Other|11|||
130866141|NCT00264537|471135778|FG002|Overall Study|Other|10|||
130866142|NCT00264537|471135779|FG003|Overall Study|Other|11|||
130866143|NCT00264537|471135776|FG000|Overall Study|Not treated|0|||
130866144|NCT00264537|471135777|FG001|Overall Study|Not treated|2|||
130866145|NCT00264537|471135778|FG002|Overall Study|Not treated|1|||
130866146|NCT00264537|471135779|FG003|Overall Study|Not treated|0|||
130866147|NCT00999544|471137390|FG000|Overall Study|Withdrawal by Subject|1|||
130866148|NCT03553758|471137395|FG000|Overall Study|Lost to Follow-up|1|||
130866149|NCT04864639|471137396|FG000|Overall Study|Death|1|||
130866150|NCT04864639|471137396|FG000|Overall Study|Lost to Follow-up|1|||
130866151|NCT00447226|471137397|FG000|12-Week Open-label Phase|Adverse Event|0|||
130866152|NCT00447226|471137398|FG001|12-Week Open-label Phase|Adverse Event|3|||
130866153|NCT00447226|471137397|FG000|12-Week Open-label Phase|Protocol Violation|0|||
130866154|NCT00447226|471137398|FG001|12-Week Open-label Phase|Protocol Violation|1|||
130866155|NCT00447226|471137397|FG000|12-Week Open-label Phase|Disease Progression|0|||
130866156|NCT00447226|471137398|FG001|12-Week Open-label Phase|Disease Progression|20|||
130866157|NCT00447226|471137397|FG000|12-Week Open-label Phase|Physician Decision|0|||
130866158|NCT00447226|471137398|FG001|12-Week Open-label Phase|Physician Decision|1|||
130866159|NCT00447226|471137397|FG000|Double-blind Phase|Disease Progression|4|||
130866160|NCT00447226|471137398|FG001|Double-blind Phase|Disease Progression|3|||
130866161|NCT01478971|471137407|FG000|Standard of Care Period|Adverse Event|1|||
130866162|NCT01478971|471137407|FG000|Standard of Care Period|Withdrawal by Subject|3|||
130866163|NCT01478971|471137407|FG000|Standard of Care Period|Death|8|||
130866164|NCT01478971|471137407|FG000|Standard of Care Period|Lost to Follow-up|9|||
130866165|NCT01478971|471137407|FG000|Standard of Care Period|Other|4|||
130866166|NCT01478971|471137407|FG000|Peginesatide Treatment Period|Adverse Event|1|||
130866167|NCT01478971|471137407|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
130866168|NCT01478971|471137407|FG000|Peginesatide Treatment Period|Death|4|||
130866169|NCT01478971|471137407|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
130866170|NCT01478971|471137407|FG000|Peginesatide Treatment Period|Other|4|||
130866171|NCT00584012|471137408|FG000|Overall Study|Withdrawal by Subject|1|||
130866172|NCT01525615|471137409|FG000|Overall Study|Adverse Event|11|||
130866173|NCT01525615|471137410|FG001|Overall Study|Adverse Event|7|||
130866174|NCT01525615|471137411|FG002|Overall Study|Adverse Event|5|||
130866175|NCT01525615|471137409|FG000|Overall Study|Lost to Follow-up|1|||
130866176|NCT01525615|471137410|FG001|Overall Study|Lost to Follow-up|0|||
130866177|NCT01525615|471137411|FG002|Overall Study|Lost to Follow-up|0|||
130866178|NCT01525615|471137409|FG000|Overall Study|Withdrawal by Subject|1|||
130866179|NCT01525615|471137410|FG001|Overall Study|Withdrawal by Subject|0|||
130866180|NCT01525615|471137411|FG002|Overall Study|Withdrawal by Subject|0|||
130866181|NCT01525615|471137409|FG000|Overall Study|Other reason not described above|1|||
130866182|NCT01525615|471137410|FG001|Overall Study|Other reason not described above|0|||
130866183|NCT01525615|471137411|FG002|Overall Study|Other reason not described above|1|||
130866184|NCT04050618|471137412|FG000|First Intervention|Withdrawal by Subject|2|||
130866185|NCT04050618|471137413|FG001|First Intervention|Withdrawal by Subject|0|||
130866186|NCT04050618|471137412|FG000|Second Intervention|Withdrawal by Subject|1|||
130866187|NCT04050618|471137413|FG001|Second Intervention|Withdrawal by Subject|0|||
130866188|NCT04404556|471137414|FG000|Intervention|Withdrawal by Subject|15|||
130866189|NCT04404556|471137415|FG001|Intervention|Withdrawal by Subject|3|||
130866190|NCT04404556|471137414|FG000|Intervention|Did not complete all intervention sessions|2|||
130866191|NCT04404556|471137415|FG001|Intervention|Did not complete all intervention sessions|1|||
130866192|NCT04404556|471137414|FG000|Post-Intervention|Missing Data|1|||
130866193|NCT04404556|471137415|FG001|Post-Intervention|Missing Data|2|||
130866194|NCT04404556|471137414|FG000|Follow-up 1|Withdrawal by Subject|5|||
130866195|NCT04404556|471137415|FG001|Follow-up 1|Withdrawal by Subject|1|||
130866196|NCT04404556|471137414|FG000|Follow-up 1|Missing Data|4|||
130866197|NCT04404556|471137415|FG001|Follow-up 1|Missing Data|7|||
130866198|NCT04404556|471137414|FG000|Follow-up 2|Withdrawal by Subject|1|||
130866199|NCT04404556|471137415|FG001|Follow-up 2|Withdrawal by Subject|1|||
130866200|NCT04404556|471137414|FG000|Follow-up 2|Missing Data|6|||
130866201|NCT04404556|471137415|FG001|Follow-up 2|Missing Data|5|||
130866202|NCT03777059|471137416|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
130866203|NCT03777059|471137417|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
130866204|NCT03777059|471137418|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
130866205|NCT03777059|471137419|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
130866206|NCT03777059|471137416|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
130866207|NCT03777059|471137417|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
130866208|NCT03777059|471137418|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
130866209|NCT03777059|471137419|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
130866210|NCT03777059|471137416|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
130866211|NCT03777059|471137417|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
130866212|NCT03777059|471137418|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
130866213|NCT03777059|471137419|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
130866214|NCT03777059|471137416|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
130866215|NCT03777059|471137417|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
130866216|NCT03777059|471137418|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
130866217|NCT03777059|471137419|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
130866218|NCT03777059|471137416|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
130866219|NCT03777059|471137417|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
130866220|NCT03777059|471137418|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
130866221|NCT03777059|471137419|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
130866222|NCT03777059|471137416|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
130866223|NCT03777059|471137417|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
130866224|NCT03777059|471137418|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
130866225|NCT03777059|471137419|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
130866226|NCT03777059|471137416|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
130866227|NCT03777059|471137417|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
130866228|NCT03777059|471137418|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
130866229|NCT03777059|471137419|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
130866230|NCT03777059|471137416|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
130866231|NCT03777059|471137417|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
130866232|NCT03777059|471137418|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
130866233|NCT03777059|471137419|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
130866234|NCT03777059|471137416|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
130866235|NCT03777059|471137417|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
130866236|NCT03777059|471137418|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
130866237|NCT03777059|471137419|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
130866238|NCT03777059|471137416|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
130866239|NCT03777059|471137417|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
130866240|NCT03777059|471137418|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
130866241|NCT03777059|471137419|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
130866242|NCT03777059|471137416|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
130866243|NCT03777059|471137417|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
130866244|NCT03777059|471137418|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
130866245|NCT03777059|471137419|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
130866246|NCT00763386|471137424|FG000|Overall Study|Adverse Event|43|||
130866247|NCT00763386|471137425|FG001|Overall Study|Adverse Event|33|||
130866248|NCT00763386|471137424|FG000|Overall Study|Death|1|||
130866249|NCT00763386|471137425|FG001|Overall Study|Death|2|||
130866250|NCT00763386|471137424|FG000|Overall Study|Lost to Follow-up|3|||
130866251|NCT00763386|471137425|FG001|Overall Study|Lost to Follow-up|3|||
130866252|NCT00763386|471137424|FG000|Overall Study|Withdrawal by Subject|0|||
130866253|NCT00763386|471137425|FG001|Overall Study|Withdrawal by Subject|1|||
130866254|NCT00763386|471137424|FG000|Overall Study|CRF missing|0|||
130866255|NCT00763386|471137425|FG001|Overall Study|CRF missing|1|||
130866256|NCT00763386|471137424|FG000|Overall Study|Study Prosthesis Removed|1|||
130866257|NCT00763386|471137425|FG001|Overall Study|Study Prosthesis Removed|0|||
130866258|NCT00502671|471137426|FG000|Overall Study|Disease Progression|13|||
130866259|NCT00502671|471137426|FG000|Overall Study|Personal Reasons|22|||
130866260|NCT00502671|471137426|FG000|Overall Study|Lost to Follow-up|7|||
130866261|NCT00502671|471137426|FG000|Overall Study|Protocol Violation|16|||
130866262|NCT00502671|471137426|FG000|Overall Study|Adverse Event|19|||
130866263|NCT00411671|471137429|FG000|Overall Study|Adverse Event|15|||
130866264|NCT00411671|471137429|FG000|Overall Study|Death|2|||
130866265|NCT00411671|471137429|FG000|Overall Study|Lost to Follow-up|3|||
130866266|NCT01173601|471137431|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
130866267|NCT01173601|471137432|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130866268|NCT01173601|471137433|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130866269|NCT01173601|471137434|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130866270|NCT01173601|471137435|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130866271|NCT01173601|471137431|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
130866272|NCT01173601|471137432|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130866273|NCT01173601|471137433|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130866274|NCT01173601|471137434|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130866275|NCT01173601|471137435|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130866276|NCT01173601|471137431|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
130866277|NCT01173601|471137432|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130866278|NCT01173601|471137433|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130866279|NCT01173601|471137434|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130866280|NCT01173601|471137435|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130866281|NCT01173601|471137431|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
130866282|NCT01173601|471137432|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130866283|NCT01173601|471137433|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130866284|NCT01173601|471137434|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130866285|NCT01173601|471137435|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130866286|NCT01173601|471137431|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
130866287|NCT01173601|471137432|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130866288|NCT01173601|471137433|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130866289|NCT01173601|471137434|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130866290|NCT01173601|471137435|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130866291|NCT01173601|471137431|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
130866292|NCT01173601|471137432|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130866293|NCT01173601|471137433|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130866294|NCT01173601|471137434|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130866295|NCT01173601|471137435|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130866296|NCT01173601|471137431|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
130866297|NCT01173601|471137432|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130866298|NCT01173601|471137433|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130866299|NCT01173601|471137434|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130866300|NCT01173601|471137435|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130866301|NCT01173601|471137431|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
130866302|NCT01173601|471137432|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
130866303|NCT01173601|471137433|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
130866304|NCT01173601|471137434|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
130866305|NCT01173601|471137435|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
130866306|NCT01173601|471137431|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
130866307|NCT01173601|471137432|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
130866308|NCT01173601|471137433|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
130866309|NCT01173601|471137434|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
130866310|NCT01173601|471137435|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
130866311|NCT01173601|471137431|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
130866312|NCT01173601|471137432|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
130866313|NCT01173601|471137433|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
130866314|NCT01173601|471137434|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
130866315|NCT01173601|471137435|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
130866316|NCT01173601|471137431|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130866317|NCT01173601|471137432|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
130866318|NCT01173601|471137433|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130866319|NCT01173601|471137434|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
130866320|NCT01173601|471137435|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
130866321|NCT01173601|471137431|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
130866322|NCT01173601|471137432|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
130866323|NCT01173601|471137433|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
130866324|NCT01173601|471137434|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
130866325|NCT01173601|471137435|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
130866326|NCT01173601|471137431|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
130866327|NCT01173601|471137432|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
130866328|NCT01173601|471137433|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
130866329|NCT01173601|471137434|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
130866330|NCT01173601|471137435|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
130866331|NCT01173601|471137431|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130866332|NCT01173601|471137432|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130866333|NCT01173601|471137433|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130866334|NCT01173601|471137434|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
130866335|NCT01173601|471137435|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
130866336|NCT00412893|471137436|FG000|Overall Study|Adverse Event|31|||
130866337|NCT00412893|471137437|FG001|Overall Study|Adverse Event|53|||
130866338|NCT00412893|471137436|FG000|Overall Study|Death|17|||
130866339|NCT00412893|471137437|FG001|Overall Study|Death|21|||
130866340|NCT00412893|471137436|FG000|Overall Study|Insufficient Therapeutic Response|39|||
130866341|NCT00412893|471137437|FG001|Overall Study|Insufficient Therapeutic Response|23|||
130866342|NCT00412893|471137436|FG000|Overall Study|Lost to Follow-up|2|||
130866343|NCT00412893|471137437|FG001|Overall Study|Lost to Follow-up|1|||
130866344|NCT00412893|471137436|FG000|Overall Study|Violation of Selection at Entry|17|||
130866345|NCT00412893|471137437|FG001|Overall Study|Violation of Selection at Entry|10|||
130866346|NCT00412893|471137436|FG000|Overall Study|Other Protocol Violation|10|||
130866347|NCT00412893|471137437|FG001|Overall Study|Other Protocol Violation|6|||
130866348|NCT00412893|471137436|FG000|Overall Study|Did Not Cooperate|12|||
130866349|NCT00412893|471137437|FG001|Overall Study|Did Not Cooperate|9|||
130866350|NCT00412893|471137436|FG000|Overall Study|Administrative Reason|12|||
130866351|NCT00412893|471137437|FG001|Overall Study|Administrative Reason|15|||
130866352|NCT00412893|471137436|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
130866353|NCT00412893|471137437|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
130866354|NCT01395901|471137440|FG000|Overall Study|Lost to Follow-up|4|||
130866355|NCT01395901|471137441|FG001|Overall Study|Lost to Follow-up|0|||
130866356|NCT01395901|471137440|FG000|Overall Study|Randomized but not received study drug|5|||
130866357|NCT01395901|471137441|FG001|Overall Study|Randomized but not received study drug|4|||
130866358|NCT01395901|471137440|FG000|Overall Study|Adverse Event|0|||
130866359|NCT01395901|471137441|FG001|Overall Study|Adverse Event|1|||
130866360|NCT01395901|471137440|FG000|Overall Study|Withdrawal of consent|1|||
130866361|NCT01395901|471137441|FG001|Overall Study|Withdrawal of consent|0|||
130866362|NCT02380287|471137447|FG000|Overall Study|Adverse Event|0|||
130866363|NCT02380287|471137448|FG001|Overall Study|Adverse Event|0|||
130866364|NCT02380287|471137449|FG002|Overall Study|Adverse Event|1|||
130866365|NCT02380287|471137450|FG003|Overall Study|Adverse Event|0|||
130866366|NCT02380287|471137451|FG004|Overall Study|Adverse Event|0|||
130866367|NCT02380287|471137452|FG005|Overall Study|Adverse Event|0|||
130866368|NCT02380287|471137453|FG006|Overall Study|Adverse Event|0|||
130866369|NCT02380287|471137454|FG007|Overall Study|Adverse Event|0|||
130866370|NCT01641601|471137455|FG000|Overall Study|Study discontinued.|3|||
130866371|NCT01641601|471137456|FG001|Overall Study|Study discontinued.|5|||
130866372|NCT01799226|471137462|FG000|Overall Study|Withdrawal by Subject|1|||
130866373|NCT01799226|471137463|FG001|Overall Study|Withdrawal by Subject|0|||
130866374|NCT01799226|471137462|FG000|Overall Study|Disqualified at Day 14|1|||
130866375|NCT01799226|471137463|FG001|Overall Study|Disqualified at Day 14|0|||
130866376|NCT02178995|471137464|FG000|Double Blind|Adverse Event|0|||
130866377|NCT02178995|471137465|FG001|Double Blind|Adverse Event|0|||
130866378|NCT02178995|471137466|FG002|Double Blind|Adverse Event|0|||
130866379|NCT02178995|471137467|FG003|Double Blind|Adverse Event|0|||
130866380|NCT02178995|471137468|FG004|Double Blind|Adverse Event|0|||
130866381|NCT02178995|471137469|FG005|Double Blind|Adverse Event|1|||
130866382|NCT02178995|471137470|FG006|Double Blind|Adverse Event|0|||
130866383|NCT02178995|471137471|FG007|Double Blind|Adverse Event|1|||
130866384|NCT02178995|471137472|FG008|Double Blind|Adverse Event|1|||
130866385|NCT02178995|471137464|FG000|Double Blind|Lost to Follow-up|0|||
130866386|NCT02178995|471137465|FG001|Double Blind|Lost to Follow-up|1|||
130866387|NCT02178995|471137466|FG002|Double Blind|Lost to Follow-up|0|||
130866388|NCT02178995|471137467|FG003|Double Blind|Lost to Follow-up|0|||
130866389|NCT02178995|471137468|FG004|Double Blind|Lost to Follow-up|0|||
130866390|NCT02178995|471137469|FG005|Double Blind|Lost to Follow-up|0|||
130866391|NCT02178995|471137470|FG006|Double Blind|Lost to Follow-up|0|||
130866392|NCT02178995|471137471|FG007|Double Blind|Lost to Follow-up|1|||
130866393|NCT02178995|471137472|FG008|Double Blind|Lost to Follow-up|0|||
130866394|NCT02178995|471137464|FG000|Open Label|Adverse Event|2|||
130866395|NCT02178995|471137465|FG001|Open Label|Adverse Event|0|||
130866396|NCT02178995|471137466|FG002|Open Label|Adverse Event|0|||
130866397|NCT02178995|471137467|FG003|Open Label|Adverse Event|0|||
130866398|NCT02178995|471137468|FG004|Open Label|Adverse Event|0|||
130866399|NCT02178995|471137469|FG005|Open Label|Adverse Event|0|||
130866400|NCT02178995|471137470|FG006|Open Label|Adverse Event|0|||
130866401|NCT02178995|471137471|FG007|Open Label|Adverse Event|0|||
130866402|NCT02178995|471137472|FG008|Open Label|Adverse Event|0|||
130866403|NCT00587158|471137473|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
130866404|NCT00587158|471137474|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
130866405|NCT00587158|471137473|FG000|Overall Study|Physician Decision|0|||
130866406|NCT00587158|471137474|FG001|Overall Study|Physician Decision|1|||
130866407|NCT00587158|471137473|FG000|Overall Study|Lost to Follow-up|1|||
130866408|NCT00587158|471137474|FG001|Overall Study|Lost to Follow-up|2|||
130866409|NCT00587158|471137473|FG000|Overall Study|Death|0|||
130866410|NCT00587158|471137474|FG001|Overall Study|Death|1|||
130866411|NCT00587158|471137473|FG000|Overall Study|Subject did not want to take study med|0|||
130866412|NCT00587158|471137474|FG001|Overall Study|Subject did not want to take study med|1|||
130866413|NCT02274792|471137475|FG000|Overall Study|Withdrawal by Subject|13|||
130866414|NCT02274792|471137475|FG000|Overall Study|Lost to Follow-up|8|||
130866415|NCT02274792|471137475|FG000|Overall Study|Protocol Specified Criteria|2|||
130866416|NCT02274792|471137475|FG000|Overall Study|Sponsor Decision|2|||
130866417|NCT00832416|471137476|FG000|Overall Study|Lack of Efficacy|17|||
130866418|NCT00832416|471137477|FG001|Overall Study|Lack of Efficacy|15|||
130866419|NCT00832416|471137478|FG002|Overall Study|Lack of Efficacy|13|||
130866420|NCT00832416|471137479|FG003|Overall Study|Lack of Efficacy|52|||
130866421|NCT00832416|471137476|FG000|Overall Study|Withdrawal by Subject|5|||
130866422|NCT00832416|471137477|FG001|Overall Study|Withdrawal by Subject|7|||
130866423|NCT00832416|471137478|FG002|Overall Study|Withdrawal by Subject|2|||
130866424|NCT00832416|471137479|FG003|Overall Study|Withdrawal by Subject|10|||
130866425|NCT00832416|471137476|FG000|Overall Study|Physician Decision|2|||
130866426|NCT00832416|471137477|FG001|Overall Study|Physician Decision|12|||
130866427|NCT00832416|471137478|FG002|Overall Study|Physician Decision|5|||
130866428|NCT00832416|471137479|FG003|Overall Study|Physician Decision|10|||
130866429|NCT00832416|471137476|FG000|Overall Study|Administrative|0|||
130866430|NCT00832416|471137477|FG001|Overall Study|Administrative|0|||
130866431|NCT00832416|471137478|FG002|Overall Study|Administrative|0|||
130866432|NCT00832416|471137479|FG003|Overall Study|Administrative|1|||
130866433|NCT00832416|471137476|FG000|Overall Study|Adverse Event|21|||
130866434|NCT00832416|471137477|FG001|Overall Study|Adverse Event|19|||
130866435|NCT00832416|471137478|FG002|Overall Study|Adverse Event|41|||
130866436|NCT00832416|471137479|FG003|Overall Study|Adverse Event|10|||
130866437|NCT00832416|471137476|FG000|Overall Study|Death|1|||
130866438|NCT00832416|471137477|FG001|Overall Study|Death|0|||
130866439|NCT00832416|471137478|FG002|Overall Study|Death|0|||
130866440|NCT00832416|471137479|FG003|Overall Study|Death|0|||
130866441|NCT02741596|471137486|FG000|Overall Study|Adverse Event|1|||
130866442|NCT02741596|471137487|FG001|Overall Study|Adverse Event|5|||
130866443|NCT02741596|471137486|FG000|Overall Study|Lost to Follow-up|1|||
130866444|NCT02741596|471137487|FG001|Overall Study|Lost to Follow-up|1|||
130866445|NCT02741596|471137486|FG000|Overall Study|Physician Decision|2|||
130866446|NCT02741596|471137487|FG001|Overall Study|Physician Decision|1|||
130866447|NCT02741596|471137486|FG000|Overall Study|Pregnancy|3|||
130866448|NCT02741596|471137487|FG001|Overall Study|Pregnancy|1|||
130866449|NCT02741596|471137486|FG000|Overall Study|Other (Unspecified)|0|||
130866450|NCT02741596|471137487|FG001|Overall Study|Other (Unspecified)|3|||
130866451|NCT02741596|471137486|FG000|Overall Study|Subject withdrawn-Other|17|||
130866452|NCT02741596|471137487|FG001|Overall Study|Subject withdrawn-Other|4|||
130866453|NCT02741596|471137486|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
130866454|NCT02741596|471137487|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
130866455|NCT02859246|471137490|FG000|Overall Study|Screen fails|3|||
130866456|NCT02859246|471137490|FG000|Overall Study|Adverse Event|1|||
130866457|NCT02859246|471137490|FG000|Overall Study|Withdrawal by Subject|1|||
130866458|NCT02336230|471137491|FG000|Overall Study|Adverse Event|1|||
130866459|NCT02336230|471137491|FG000|Overall Study|Withdrawal of consent|1|||
130866460|NCT02336230|471137491|FG000|Overall Study|Death|9|||
130866461|NCT02336230|471137491|FG000|Overall Study|Dose not received due to shipping delay|1|||
130866462|NCT02336230|471137491|FG000|Overall Study|Discontinuation of MSC infusion|1|||
130866463|NCT05447663|471137492|FG000|Overall Study|Study terminated by Sponsor|5|||
130866464|NCT05447663|471137492|FG000|Overall Study|Death|2|||
130866465|NCT05447663|471137492|FG000|Overall Study|Withdrawal by Subject|1|||
130866466|NCT02864901|471137493|FG000|Overall Study|Withdrawal by Subject|1|||
130866467|NCT02864901|471137494|FG001|Overall Study|Withdrawal by Subject|0|||
130866468|NCT01219985|471137495|FG000|Overall Study|Physician Decision|20|||
130866469|NCT04797780|471137496|FG000|Overall Study|Lost to Follow-up|1|||
130866470|NCT04797780|471137497|FG001|Overall Study|Lost to Follow-up|1|||
130866471|NCT04797780|471137496|FG000|Overall Study|Withdrawal by Subject|14|||
130866472|NCT04797780|471137497|FG001|Overall Study|Withdrawal by Subject|9|||
130866473|NCT04797780|471137496|FG000|Overall Study|Death|49|||
130866474|NCT04797780|471137497|FG001|Overall Study|Death|20|||
130866475|NCT05973006|471137498|FG000|Overall Study|Early termination|3|||
130866476|NCT05973006|471137499|FG001|Overall Study|Early termination|9|||
130866477|NCT00132808|471137507|FG000|Stratum I|Adverse Event|2|||
130866478|NCT00132808|471137508|FG001|Stratum I|Adverse Event|1|||
130866479|NCT00132808|471137509|FG002|Stratum I|Adverse Event|0|||
130866480|NCT00132808|471137507|FG000|Stratum I|Lost to Follow-up|3|||
130866481|NCT00132808|471137508|FG001|Stratum I|Lost to Follow-up|4|||
130866482|NCT00132808|471137509|FG002|Stratum I|Lost to Follow-up|1|||
130866483|NCT00132808|471137507|FG000|Stratum I|Withdrawal by Subject|4|||
130866484|NCT00132808|471137508|FG001|Stratum I|Withdrawal by Subject|7|||
130866485|NCT00132808|471137509|FG002|Stratum I|Withdrawal by Subject|3|||
130866486|NCT00132808|471137507|FG000|Stratum I|Abnormal test procedure result (s)|0|||
130866487|NCT00132808|471137508|FG001|Stratum I|Abnormal test procedure result (s)|0|||
130866488|NCT00132808|471137509|FG002|Stratum I|Abnormal test procedure result (s)|1|||
130866489|NCT00132808|471137507|FG000|Stratum II|Adverse Event|1|||
130866490|NCT00132808|471137508|FG001|Stratum II|Adverse Event|2|||
130866491|NCT00132808|471137509|FG002|Stratum II|Adverse Event|1|||
130866492|NCT00132808|471137507|FG000|Stratum II|Death|1|||
130866493|NCT00132808|471137508|FG001|Stratum II|Death|0|||
130866494|NCT00132808|471137509|FG002|Stratum II|Death|0|||
130866495|NCT00132808|471137507|FG000|Stratum II|Lost to Follow-up|2|||
130866496|NCT00132808|471137508|FG001|Stratum II|Lost to Follow-up|2|||
130866497|NCT00132808|471137509|FG002|Stratum II|Lost to Follow-up|1|||
130866498|NCT00132808|471137507|FG000|Stratum II|Protocol Violation|0|||
130866499|NCT00132808|471137508|FG001|Stratum II|Protocol Violation|2|||
130866500|NCT00132808|471137509|FG002|Stratum II|Protocol Violation|1|||
130866501|NCT00132808|471137507|FG000|Stratum II|Withdrawal by Subject|4|||
130866502|NCT00132808|471137508|FG001|Stratum II|Withdrawal by Subject|9|||
130866503|NCT00132808|471137509|FG002|Stratum II|Withdrawal by Subject|6|||
130866504|NCT00003199|471137552|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
130866505|NCT00003199|471137552|FG000|Overall Study|Lack of insurance clearance|2|||
130866506|NCT00003199|471137552|FG000|Overall Study|Screen fail|15|||
130866507|NCT00947115|471137553|FG000|Overall Study|Missed reporting interval|3|||
130866508|NCT00947115|471137554|FG001|Overall Study|Missed reporting interval|4|||
130866509|NCT00947115|471137555|FG002|Overall Study|Missed reporting interval|2|||
130866510|NCT00947115|471137553|FG000|Overall Study|Physician Decision|0|||
130866511|NCT00947115|471137554|FG001|Overall Study|Physician Decision|2|||
130866512|NCT00947115|471137555|FG002|Overall Study|Physician Decision|0|||
130866513|NCT00947115|471137553|FG000|Overall Study|Death|0|||
130866514|NCT00947115|471137554|FG001|Overall Study|Death|1|||
130866515|NCT00947115|471137555|FG002|Overall Study|Death|1|||
130866516|NCT00947115|471137553|FG000|Overall Study|Migrated from study area|2|||
130866517|NCT00947115|471137554|FG001|Overall Study|Migrated from study area|0|||
130866518|NCT00947115|471137555|FG002|Overall Study|Migrated from study area|0|||
130866519|NCT00947115|471137553|FG000|Overall Study|Withdrawal by Subject|1|||
130866520|NCT00947115|471137554|FG001|Overall Study|Withdrawal by Subject|3|||
130866521|NCT00947115|471137555|FG002|Overall Study|Withdrawal by Subject|4|||
130866522|NCT00947115|471137553|FG000|Overall Study|Lost to Follow-up|11|||
130866523|NCT00947115|471137554|FG001|Overall Study|Lost to Follow-up|12|||
130866524|NCT00947115|471137555|FG002|Overall Study|Lost to Follow-up|8|||
130866525|NCT01223183|471137557|FG000|Imaging Day 1|Physician Decision|0|||
130866526|NCT01223183|471137558|FG001|Imaging Day 1|Physician Decision|1|||
130866527|NCT01223183|471137557|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
130866528|NCT01223183|471137558|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
130866529|NCT01223183|471137557|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
130866530|NCT01223183|471137558|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
130866531|NCT00900029|471137561|FG000|Overall Study|Lost to Follow-up|0|||
130866532|NCT00900029|471137562|FG001|Overall Study|Lost to Follow-up|2|||
130866533|NCT00900029|471137563|FG002|Overall Study|Lost to Follow-up|1|||
130866534|NCT00900029|471137564|FG003|Overall Study|Lost to Follow-up|4|||
130866535|NCT00900029|471137565|FG004|Overall Study|Lost to Follow-up|4|||
130866536|NCT00900029|471137561|FG000|Overall Study|Withdrawal by Subject|2|||
130866537|NCT00900029|471137562|FG001|Overall Study|Withdrawal by Subject|2|||
130866538|NCT00900029|471137563|FG002|Overall Study|Withdrawal by Subject|1|||
130866539|NCT00900029|471137564|FG003|Overall Study|Withdrawal by Subject|1|||
130866540|NCT00900029|471137565|FG004|Overall Study|Withdrawal by Subject|1|||
130866541|NCT00900029|471137561|FG000|Overall Study|Adverse Event|0|||
130866542|NCT00900029|471137562|FG001|Overall Study|Adverse Event|0|||
130866543|NCT00900029|471137563|FG002|Overall Study|Adverse Event|1|||
130866544|NCT00900029|471137564|FG003|Overall Study|Adverse Event|1|||
130866545|NCT00900029|471137565|FG004|Overall Study|Adverse Event|1|||
130866546|NCT00900029|471137561|FG000|Overall Study|Death|1|||
130866547|NCT00900029|471137562|FG001|Overall Study|Death|0|||
130866548|NCT00900029|471137563|FG002|Overall Study|Death|0|||
130866549|NCT00900029|471137564|FG003|Overall Study|Death|1|||
130866550|NCT00900029|471137565|FG004|Overall Study|Death|0|||
130866551|NCT00511238|471137568|FG000|Overall Study|Adverse Event|13|||
130866552|NCT00511238|471137569|FG001|Overall Study|Adverse Event|33|||
130866553|NCT00511238|471137568|FG000|Overall Study|Withdrawal by Subject|2|||
130866554|NCT00511238|471137569|FG001|Overall Study|Withdrawal by Subject|22|||
130866555|NCT00511238|471137568|FG000|Overall Study|Progressive Disease|23|||
130866556|NCT00511238|471137569|FG001|Overall Study|Progressive Disease|157|||
130866557|NCT00511238|471137568|FG000|Overall Study|various reasons|4|||
130866558|NCT00511238|471137569|FG001|Overall Study|various reasons|14|||
130866559|NCT00163020|471137570|FG000|Overall Study|Lost to Follow-up|0|||
130866560|NCT00163020|471137571|FG001|Overall Study|Lost to Follow-up|2|||
130866561|NCT03772665|471137572|FG000|Overall Study|Protocol Violation|1|||
130866562|NCT03772665|471137573|FG001|Overall Study|Protocol Violation|0|||
130866563|NCT00922623|471140469|FG000|Overall Study|Other|4|||
130866564|NCT00922623|471140469|FG000|Overall Study|Lost to Follow-up|1|||
130866565|NCT02871635|471140470|FG000|Overall Study|Primary lack of efficacy|4|||
130866566|NCT02871635|471140471|FG001|Overall Study|Primary lack of efficacy|4|||
130866567|NCT02871635|471140470|FG000|Overall Study|Protocol Violation|3|||
130866568|NCT02871635|471140471|FG001|Overall Study|Protocol Violation|1|||
130866569|NCT02871635|471140470|FG000|Overall Study|Lost to Follow-up|1|||
130866570|NCT02871635|471140471|FG001|Overall Study|Lost to Follow-up|2|||
130866571|NCT02871635|471140470|FG000|Overall Study|Pregnancy|0|||
130866572|NCT02871635|471140471|FG001|Overall Study|Pregnancy|2|||
130866573|NCT02871635|471140470|FG000|Overall Study|Physician Decision|1|||
130866574|NCT02871635|471140471|FG001|Overall Study|Physician Decision|1|||
130866575|NCT02871635|471140470|FG000|Overall Study|Withdrawal by Subject|3|||
130866576|NCT02871635|471140471|FG001|Overall Study|Withdrawal by Subject|4|||
130866577|NCT02871635|471140470|FG000|Overall Study|Adverse Event|4|||
130866578|NCT02871635|471140471|FG001|Overall Study|Adverse Event|4|||
130866579|NCT02871635|471140470|FG000|Overall Study|Secondary lack of efficacy|2|||
130866580|NCT02871635|471140471|FG001|Overall Study|Secondary lack of efficacy|1|||
130866581|NCT02420379|471140472|FG000|Overall Study|Withdrawal by Subject|0|||
130866582|NCT02420379|471140473|FG001|Overall Study|Withdrawal by Subject|3|||
130866583|NCT02420379|471140472|FG000|Overall Study|Unable to complete due to schooling|0|||
130866584|NCT02420379|471140473|FG001|Overall Study|Unable to complete due to schooling|1|||
130866585|NCT02420379|471140472|FG000|Overall Study|Transitioned to commercial drug|1|||
130866586|NCT02420379|471140473|FG001|Overall Study|Transitioned to commercial drug|0|||
130866587|NCT01402817|471140474|FG000|Overall Study|Withdrawal by Subject|3|||
130866588|NCT01402817|471140474|FG000|Overall Study|Study Suspended by FDA|8|||
130866589|NCT01473732|471140476|FG000|Overall Study|Adverse Event|1|||
130866590|NCT01473732|471140477|FG001|Overall Study|Adverse Event|0|||
130866591|NCT01473732|471140476|FG000|Overall Study|Death|1|||
130866592|NCT01473732|471140477|FG001|Overall Study|Death|0|||
130866593|NCT01217944|471140481|FG000|Overall Study|Protocol Violation|1|||
130866594|NCT01217944|471140482|FG001|Overall Study|Protocol Violation|1|||
130866595|NCT01217944|471140483|FG002|Overall Study|Protocol Violation|0|||
130866596|NCT01217944|471140481|FG000|Overall Study|Lost to Follow-up|3|||
130866597|NCT01217944|471140482|FG001|Overall Study|Lost to Follow-up|1|||
130866598|NCT01217944|471140483|FG002|Overall Study|Lost to Follow-up|0|||
130866599|NCT01217944|471140481|FG000|Overall Study|Withdrawal by Subject|1|||
130866600|NCT01217944|471140482|FG001|Overall Study|Withdrawal by Subject|2|||
130866601|NCT01217944|471140483|FG002|Overall Study|Withdrawal by Subject|0|||
130866602|NCT01217944|471140481|FG000|Overall Study|Lack of Efficacy|1|||
130866603|NCT01217944|471140482|FG001|Overall Study|Lack of Efficacy|0|||
130866604|NCT01217944|471140483|FG002|Overall Study|Lack of Efficacy|0|||
130866605|NCT04473963|471140484|FG000|Overall Study|Withdrawal by Subject|1|||
130866606|NCT04473963|471140485|FG001|Overall Study|Withdrawal by Subject|1|||
130866607|NCT04473963|471140486|FG002|Overall Study|Withdrawal by Subject|0|||
130866608|NCT04473963|471140484|FG000|Overall Study|Not inducible in AF|0|||
130866609|NCT04473963|471140485|FG001|Overall Study|Not inducible in AF|0|||
130866610|NCT04473963|471140486|FG002|Overall Study|Not inducible in AF|2|||
130866611|NCT02114606|471140487|FG000|Overall Study|Unable to swallow Cytosponge|6|||
130866612|NCT00981461|471140488|FG000|Overall Study|Lost to Follow-up|5|||
130866613|NCT00981461|471140489|FG001|Overall Study|Lost to Follow-up|2|||
130866614|NCT03361293|471140498|FG000|Overall Study|Lost to Follow-up|0|||
130866615|NCT03361293|471140499|FG001|Overall Study|Lost to Follow-up|2|||
130866616|NCT03361293|471140498|FG000|Overall Study|Withdrawal by Subject|1|||
130866617|NCT03361293|471140499|FG001|Overall Study|Withdrawal by Subject|3|||
130866618|NCT01910402|471140500|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
130866619|NCT01910402|471140501|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
130866620|NCT01910402|471140502|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
130866621|NCT01910402|471140500|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
130866622|NCT01910402|471140501|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
130866623|NCT01910402|471140502|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
130866624|NCT01910402|471140500|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
130866625|NCT01910402|471140501|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
130866626|NCT01910402|471140502|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
130866627|NCT01910402|471140500|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
130866628|NCT01910402|471140501|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
130866629|NCT01910402|471140502|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
130866630|NCT01910402|471140500|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
130866631|NCT01910402|471140501|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
130866632|NCT01910402|471140502|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
130866633|NCT01910402|471140500|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
130866634|NCT01910402|471140501|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
130866635|NCT01910402|471140502|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
130866636|NCT01910402|471140500|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
130866637|NCT01910402|471140501|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
130866638|NCT01910402|471140502|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
130866639|NCT01910402|471140500|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
130866640|NCT01910402|471140501|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
130866641|NCT01910402|471140502|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
130866642|NCT01910402|471140500|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
130866643|NCT01910402|471140501|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
130866644|NCT01910402|471140502|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
130866645|NCT01910402|471140500|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
130866646|NCT01910402|471140501|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
130866647|NCT01910402|471140502|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
130866648|NCT01910402|471140500|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
130866649|NCT01910402|471140501|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
130866650|NCT01910402|471140502|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
130866651|NCT01910402|471140500|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
130866652|NCT01910402|471140501|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
130866653|NCT01910402|471140502|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
130866654|NCT01910402|471140500|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
130866655|NCT01910402|471140501|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
130866656|NCT01910402|471140502|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
130866657|NCT00483405|471140505|FG000|Overall Study|Adverse Event|8|||
130866658|NCT00483405|471140505|FG000|Overall Study|Lack of Efficacy|14|||
130866659|NCT00483405|471140505|FG000|Overall Study|Death|3|||
130866660|NCT00483405|471140505|FG000|Overall Study|Withdrawal by Subject|2|||
130866661|NCT00483405|471140505|FG000|Overall Study|Other complicating disease|1|||
130866662|NCT00571038|471140506|FG000|Overall Study|Lost to Follow-up|1|||
130866663|NCT00571038|471140507|FG001|Overall Study|Lost to Follow-up|4|||
130866664|NCT00571038|471140506|FG000|Overall Study|Death|7|||
130866665|NCT00571038|471140507|FG001|Overall Study|Death|5|||
130866666|NCT00571038|471140506|FG000|Overall Study|Withdrawal by Subject|1|||
130866667|NCT00571038|471140507|FG001|Overall Study|Withdrawal by Subject|3|||
130866668|NCT00571038|471140506|FG000|Overall Study|Moved out of state|2|||
130866669|NCT00571038|471140507|FG001|Overall Study|Moved out of state|2|||
130866670|NCT01550757|471140508|FG000|Overall Study|Lost to Follow-up|21|||
130866671|NCT01550757|471140509|FG001|Overall Study|Lost to Follow-up|14|||
130866672|NCT01550757|471140510|FG002|Overall Study|Lost to Follow-up|42|||
130866673|NCT01550757|471140511|FG003|Overall Study|Lost to Follow-up|53|||
130866674|NCT01550757|471140508|FG000|Overall Study|Withdrawal by Subject|2|||
130866675|NCT01550757|471140509|FG001|Overall Study|Withdrawal by Subject|0|||
130866676|NCT01550757|471140510|FG002|Overall Study|Withdrawal by Subject|3|||
130866677|NCT01550757|471140511|FG003|Overall Study|Withdrawal by Subject|1|||
130866678|NCT04098809|471140513|FG000|Overall Study|Withdrawal by Subject|1|||
130866679|NCT04098809|471140514|FG001|Overall Study|Withdrawal by Subject|3|||
130866680|NCT04098809|471140513|FG000|Overall Study|Physician Decision|2|||
130866681|NCT04098809|471140514|FG001|Overall Study|Physician Decision|1|||
130866682|NCT00193206|471140515|FG000|Preoperative Therapy|Lack of Efficacy|2|||
130866683|NCT00193206|471140515|FG000|Preoperative Therapy|Adverse Event|2|||
130866684|NCT00193206|471140515|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
130866685|NCT00193206|471140515|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
130866686|NCT00193206|471140515|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
130866687|NCT00193206|471140515|FG000|Postoperative Therapy|Physician Decision|3|||
130866688|NCT00193206|471140515|FG000|Postoperative Therapy|Intercurrent Illness|2|||
130866689|NCT00193206|471140515|FG000|Postoperative Therapy|Lack of Efficacy|1|||
130866690|NCT00193206|471140515|FG000|Postoperative Therapy|Protocol Violation|1|||
130866691|NCT01426958|471140516|FG000|Overall Study|Adverse Event|2|||
130866692|NCT00991939|471140519|FG000|Overall Study|Lost to Follow-up|0|||
130866693|NCT00991939|471140520|FG001|Overall Study|Lost to Follow-up|1|||
130866694|NCT00991939|471140519|FG000|Overall Study|Withdrawal by Subject|1|||
130866695|NCT00991939|471140520|FG001|Overall Study|Withdrawal by Subject|0|||
130866696|NCT00991939|471140519|FG000|Overall Study|Entire study terminated|4|||
130866697|NCT00991939|471140520|FG001|Overall Study|Entire study terminated|1|||
130866698|NCT00740584|471140521|FG000|Overall Study|Withdrawal by Subject|1|||
130866699|NCT02073682|471140526|FG000|Overall Study|Low Creatinine Clearance|1|||
130866700|NCT02073682|471140527|FG001|Overall Study|Low Creatinine Clearance|2|||
130866701|NCT02073682|471140526|FG000|Overall Study|Death|86|||
130866702|NCT02073682|471140527|FG001|Overall Study|Death|100|||
130866703|NCT02073682|471140526|FG000|Overall Study|Cancer Cured|10|||
130866704|NCT02073682|471140527|FG001|Overall Study|Cancer Cured|15|||
130866705|NCT02073682|471140526|FG000|Overall Study|ID: Patient Noncompliance|1|||
130866706|NCT02073682|471140527|FG001|Overall Study|ID: Patient Noncompliance|2|||
130866707|NCT02073682|471140526|FG000|Overall Study|ID: Palliative Treatment Only|10|||
130866708|NCT02073682|471140527|FG001|Overall Study|ID: Palliative Treatment Only|7|||
130866709|NCT02073682|471140526|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
130866710|NCT02073682|471140527|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
130866711|NCT02073682|471140526|FG000|Overall Study|Platelet Count <50,000/mL|1|||
130866712|NCT02073682|471140527|FG001|Overall Study|Platelet Count <50,000/mL|2|||
130866713|NCT02073682|471140526|FG000|Overall Study|Surgery/Medical Procedure|3|||
130866714|NCT02073682|471140527|FG001|Overall Study|Surgery/Medical Procedure|1|||
130866715|NCT02073682|471140526|FG000|Overall Study|Withdrawal by Subject|6|||
130866716|NCT02073682|471140527|FG001|Overall Study|Withdrawal by Subject|8|||
130866717|NCT02073682|471140526|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
130866718|NCT02073682|471140527|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
130866719|NCT02073682|471140526|FG000|Overall Study|Cancer Progression|53|||
130866720|NCT02073682|471140527|FG001|Overall Study|Cancer Progression|33|||
130866721|NCT02073682|471140526|FG000|Overall Study|Protocol Violation|1|||
130866722|NCT02073682|471140527|FG001|Overall Study|Protocol Violation|0|||
130866723|NCT02073682|471140526|FG000|Overall Study|Adverse Event|79|||
130866724|NCT02073682|471140527|FG001|Overall Study|Adverse Event|62|||
130866725|NCT02073682|471140526|FG000|Overall Study|No reason provided|11|||
130866726|NCT02073682|471140527|FG001|Overall Study|No reason provided|9|||
130866727|NCT02073682|471140526|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
130866728|NCT02073682|471140527|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
130866729|NCT02073682|471140526|FG000|Overall Study|Lost to Follow-up|1|||
130866730|NCT02073682|471140527|FG001|Overall Study|Lost to Follow-up|1|||
130866731|NCT02073682|471140526|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
130866732|NCT02073682|471140527|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
130866733|NCT00181766|471140528|FG000|Overall Study|Lost to Follow-up|6|||
130866734|NCT00181766|471140528|FG000|Overall Study|Adverse Event|4|||
130866735|NCT00181766|471140528|FG000|Overall Study|non-compliance|2|||
130866736|NCT00413218|471140530|FG000|Overall Study|Randomized but didn't receive study drug|2|||
130866737|NCT00413218|471140531|FG001|Overall Study|Randomized but didn't receive study drug|8|||
130866738|NCT00413218|471140530|FG000|Overall Study|Death|57|||
130866739|NCT00413218|471140531|FG001|Overall Study|Death|56|||
130866740|NCT00413218|471140530|FG000|Overall Study|Lost to Follow-up|14|||
130866741|NCT00413218|471140531|FG001|Overall Study|Lost to Follow-up|17|||
130866742|NCT00413218|471140530|FG000|Overall Study|Admin|20|||
130866743|NCT00413218|471140531|FG001|Overall Study|Admin|14|||
130866744|NCT00413218|471140530|FG000|Overall Study|Missing|1|||
130866745|NCT00413218|471140531|FG001|Overall Study|Missing|0|||
130866746|NCT00413218|471140530|FG000|Overall Study|Withdrawal by Subject|9|||
130866747|NCT00413218|471140531|FG001|Overall Study|Withdrawal by Subject|1|||
130866748|NCT01196026|471140533|FG000|Overall Study|Withdrawal by Subject|1|||
130866749|NCT01196026|471140534|FG001|Overall Study|Withdrawal by Subject|4|||
130866750|NCT01196026|471140535|FG002|Overall Study|Withdrawal by Subject|0|||
130866751|NCT01196026|471140536|FG003|Overall Study|Withdrawal by Subject|0|||
130866752|NCT01196026|471140537|FG004|Overall Study|Withdrawal by Subject|0|||
130866753|NCT01196026|471140538|FG005|Overall Study|Withdrawal by Subject|0|||
130866754|NCT01196026|471140533|FG000|Overall Study|Lost to Follow-up|0|||
130866755|NCT01196026|471140534|FG001|Overall Study|Lost to Follow-up|3|||
130866756|NCT01196026|471140535|FG002|Overall Study|Lost to Follow-up|0|||
130866757|NCT01196026|471140536|FG003|Overall Study|Lost to Follow-up|0|||
130866758|NCT01196026|471140537|FG004|Overall Study|Lost to Follow-up|1|||
130866759|NCT01196026|471140538|FG005|Overall Study|Lost to Follow-up|0|||
130866760|NCT01196026|471140533|FG000|Overall Study|Other|0|||
130866761|NCT01196026|471140534|FG001|Overall Study|Other|1|||
130866762|NCT01196026|471140535|FG002|Overall Study|Other|0|||
130866763|NCT01196026|471140536|FG003|Overall Study|Other|0|||
130866764|NCT01196026|471140537|FG004|Overall Study|Other|0|||
130866765|NCT01196026|471140538|FG005|Overall Study|Other|0|||
130866766|NCT01687296|471140539|FG000|Overall Study|Lack of Efficacy|1|||
130866767|NCT01687296|471140540|FG001|Overall Study|Lack of Efficacy|1|||
130866768|NCT01687296|471140539|FG000|Overall Study|Protocol Violation|0|||
130866769|NCT01687296|471140540|FG001|Overall Study|Protocol Violation|1|||
130866770|NCT01687296|471140539|FG000|Overall Study|Withdrawal by Subject|6|||
130866771|NCT01687296|471140540|FG001|Overall Study|Withdrawal by Subject|3|||
130866772|NCT03672292|471140544|FG000|Overall Study|Adverse Event|3|||
130866773|NCT03672292|471140545|FG001|Overall Study|Adverse Event|1|||
130866774|NCT03672292|471140544|FG000|Overall Study|Physician Decision|0|||
130866775|NCT03672292|471140545|FG001|Overall Study|Physician Decision|1|||
130866776|NCT03672292|471140544|FG000|Overall Study|Withdrawal by Subject|1|||
130866777|NCT03672292|471140545|FG001|Overall Study|Withdrawal by Subject|2|||
130866778|NCT00556998|471140550|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
130866779|NCT00556998|471140550|FG000|Voriconazole Intravenous (IV)|Other|4|||
130866780|NCT00556998|471140550|FG000|Voriconazole Oral|Adverse Event|1|||
130866781|NCT00556998|471140550|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
130866782|NCT00216671|471140553|FG000|Overall Study|Adverse Event|4|||
130866783|NCT00216671|471140554|FG001|Overall Study|Adverse Event|9|||
130866784|NCT00216671|471140553|FG000|Overall Study|Pregnancy|0|||
130866785|NCT00216671|471140554|FG001|Overall Study|Pregnancy|1|||
130866786|NCT00216671|471140553|FG000|Overall Study|Withdrawal by Subject|4|||
130866787|NCT00216671|471140554|FG001|Overall Study|Withdrawal by Subject|2|||
130866788|NCT00216671|471140553|FG000|Overall Study|Refused Injections|3|||
130866789|NCT00216671|471140554|FG001|Overall Study|Refused Injections|13|||
130866790|NCT00216671|471140553|FG000|Overall Study|No Need to Continue Medication|1|||
130866791|NCT00216671|471140554|FG001|Overall Study|No Need to Continue Medication|1|||
130866792|NCT00216671|471140553|FG000|Overall Study|Insufficient Response|9|||
130866793|NCT00216671|471140554|FG001|Overall Study|Insufficient Response|4|||
130866794|NCT00216671|471140553|FG000|Overall Study|Lost to Follow-up|3|||
130866795|NCT00216671|471140554|FG001|Overall Study|Lost to Follow-up|5|||
130866796|NCT00216671|471140553|FG000|Overall Study|Non compliant|2|||
130866797|NCT00216671|471140554|FG001|Overall Study|Non compliant|2|||
130866798|NCT00216671|471140553|FG000|Overall Study|Ineligible|0|||
130866799|NCT00216671|471140554|FG001|Overall Study|Ineligible|2|||
130866800|NCT00216671|471140553|FG000|Overall Study|Physician Decision|1|||
130866801|NCT00216671|471140554|FG001|Overall Study|Physician Decision|1|||
130866802|NCT00216671|471140553|FG000|Overall Study|Protocol Violation|3|||
130866803|NCT00216671|471140554|FG001|Overall Study|Protocol Violation|5|||
130866804|NCT00216671|471140553|FG000|Overall Study|Relapse|1|||
130866805|NCT00216671|471140554|FG001|Overall Study|Relapse|0|||
130866806|NCT00216671|471140553|FG000|Overall Study|Investigator Illness|0|||
130866807|NCT00216671|471140554|FG001|Overall Study|Investigator Illness|1|||
130866808|NCT00216671|471140553|FG000|Overall Study|Patient Moved|0|||
130866809|NCT00216671|471140554|FG001|Overall Study|Patient Moved|1|||
130866810|NCT00216671|471140553|FG000|Overall Study|Ineligible, no efficacy data|2|||
130866811|NCT00216671|471140554|FG001|Overall Study|Ineligible, no efficacy data|2|||
130866812|NCT00216671|471140553|FG000|Overall Study|Insufficient Response Adverse Event|2|||
130866813|NCT00216671|471140554|FG001|Overall Study|Insufficient Response Adverse Event|1|||
130866814|NCT04961541|471140555|FG000|Overall Study|Adverse Event|0|||
130866815|NCT04961541|471140556|FG001|Overall Study|Adverse Event|0|||
130866816|NCT04961541|471140557|FG002|Overall Study|Adverse Event|0|||
130866817|NCT04961541|471140558|FG003|Overall Study|Adverse Event|0|||
130866818|NCT04961541|471140559|FG004|Overall Study|Adverse Event|0|||
130866819|NCT04961541|471140560|FG005|Overall Study|Adverse Event|1|||
130866820|NCT04961541|471140561|FG006|Overall Study|Adverse Event|0|||
130866821|NCT04961541|471140562|FG007|Overall Study|Adverse Event|0|||
130866822|NCT04961541|471140563|FG008|Overall Study|Adverse Event|0|||
130866823|NCT04961541|471140564|FG009|Overall Study|Adverse Event|0|||
130866824|NCT04961541|471140565|FG010|Overall Study|Adverse Event|0|||
130866825|NCT04961541|471140566|FG011|Overall Study|Adverse Event|0|||
130866826|NCT04961541|471140567|FG012|Overall Study|Adverse Event|0|||
130866827|NCT04961541|471140568|FG013|Overall Study|Adverse Event|0|||
130866828|NCT04961541|471140555|FG000|Overall Study|Lost to Follow-up|0|||
130866829|NCT04961541|471140556|FG001|Overall Study|Lost to Follow-up|0|||
130866830|NCT04961541|471140557|FG002|Overall Study|Lost to Follow-up|3|||
130866831|NCT04961541|471140558|FG003|Overall Study|Lost to Follow-up|0|||
130866832|NCT04961541|471140559|FG004|Overall Study|Lost to Follow-up|0|||
130866833|NCT04961541|471140560|FG005|Overall Study|Lost to Follow-up|0|||
130866834|NCT04961541|471140561|FG006|Overall Study|Lost to Follow-up|1|||
130866835|NCT04961541|471140562|FG007|Overall Study|Lost to Follow-up|1|||
130866836|NCT04961541|471140563|FG008|Overall Study|Lost to Follow-up|0|||
130866837|NCT04961541|471140564|FG009|Overall Study|Lost to Follow-up|1|||
130866838|NCT04961541|471140565|FG010|Overall Study|Lost to Follow-up|0|||
130866839|NCT04961541|471140566|FG011|Overall Study|Lost to Follow-up|0|||
130866840|NCT04961541|471140567|FG012|Overall Study|Lost to Follow-up|1|||
130866841|NCT04961541|471140568|FG013|Overall Study|Lost to Follow-up|0|||
130866842|NCT04961541|471140555|FG000|Overall Study|Withdrawal by Subject|0|||
130866843|NCT04961541|471140556|FG001|Overall Study|Withdrawal by Subject|0|||
130866844|NCT04961541|471140557|FG002|Overall Study|Withdrawal by Subject|1|||
130866845|NCT04961541|471140558|FG003|Overall Study|Withdrawal by Subject|1|||
130866846|NCT04961541|471140559|FG004|Overall Study|Withdrawal by Subject|0|||
130866847|NCT04961541|471140560|FG005|Overall Study|Withdrawal by Subject|0|||
130866848|NCT04961541|471140561|FG006|Overall Study|Withdrawal by Subject|0|||
130866849|NCT04961541|471140562|FG007|Overall Study|Withdrawal by Subject|0|||
130866850|NCT04961541|471140563|FG008|Overall Study|Withdrawal by Subject|0|||
130866851|NCT04961541|471140564|FG009|Overall Study|Withdrawal by Subject|1|||
130866852|NCT04961541|471140565|FG010|Overall Study|Withdrawal by Subject|0|||
130866853|NCT04961541|471140566|FG011|Overall Study|Withdrawal by Subject|0|||
130866854|NCT04961541|471140567|FG012|Overall Study|Withdrawal by Subject|0|||
130866855|NCT04961541|471140568|FG013|Overall Study|Withdrawal by Subject|0|||
130866856|NCT03539601|471140569|FG000|Overall Study|Withdraw by parent/guardian|1|||
130866857|NCT03539601|471140570|FG001|Overall Study|Withdraw by parent/guardian|0|||
130866858|NCT03539601|471140571|FG002|Overall Study|Withdraw by parent/guardian|1|||
130866859|NCT03539601|471140572|FG003|Overall Study|Withdraw by parent/guardian|0|||
130866860|NCT03539601|471140569|FG000|Overall Study|Adverse Event|0|||
130866861|NCT03539601|471140570|FG001|Overall Study|Adverse Event|2|||
130866862|NCT03539601|471140571|FG002|Overall Study|Adverse Event|0|||
130866863|NCT03539601|471140572|FG003|Overall Study|Adverse Event|0|||
130866864|NCT03539601|471140569|FG000|Overall Study|Lost to Follow-up|2|||
130866865|NCT03539601|471140570|FG001|Overall Study|Lost to Follow-up|4|||
130866866|NCT03539601|471140571|FG002|Overall Study|Lost to Follow-up|5|||
130866867|NCT03539601|471140572|FG003|Overall Study|Lost to Follow-up|0|||
130866868|NCT03539601|471140569|FG000|Overall Study|Withdrawal by Subject|2|||
130866869|NCT03539601|471140570|FG001|Overall Study|Withdrawal by Subject|0|||
130866870|NCT03539601|471140571|FG002|Overall Study|Withdrawal by Subject|0|||
130866871|NCT03539601|471140572|FG003|Overall Study|Withdrawal by Subject|1|||
130866872|NCT03539601|471140569|FG000|Overall Study|Randomized but not treated|1|||
130866873|NCT03539601|471140570|FG001|Overall Study|Randomized but not treated|1|||
130866874|NCT03539601|471140571|FG002|Overall Study|Randomized but not treated|0|||
130866875|NCT03539601|471140572|FG003|Overall Study|Randomized but not treated|0|||
130866876|NCT03081884|471140573|FG000|Overall Study|deferred prostate cancer treatment|1|||
130866877|NCT03081884|471140573|FG000|Overall Study|metastasis managed with systemic therapy|3|||
130866878|NCT03948334|471140575|FG000|Overall Study|Adverse Event|1|||
130866879|NCT03948334|471140576|FG001|Overall Study|Adverse Event|4|||
130866880|NCT03948334|471140575|FG000|Overall Study|Lack of Efficacy|2|||
130866881|NCT03948334|471140576|FG001|Overall Study|Lack of Efficacy|0|||
130866882|NCT03948334|471140575|FG000|Overall Study|Lost to Follow-up|1|||
130866883|NCT03948334|471140576|FG001|Overall Study|Lost to Follow-up|0|||
130866884|NCT03948334|471140575|FG000|Overall Study|Physician Decision|1|||
130866885|NCT03948334|471140576|FG001|Overall Study|Physician Decision|0|||
130866886|NCT03948334|471140575|FG000|Overall Study|Pregnancy|0|||
130866887|NCT03948334|471140576|FG001|Overall Study|Pregnancy|1|||
130866888|NCT03948334|471140575|FG000|Overall Study|Protocol Deviation|1|||
130866889|NCT03948334|471140576|FG001|Overall Study|Protocol Deviation|0|||
130866890|NCT03948334|471140575|FG000|Overall Study|Study terminated by Sponsor|50|||
130866891|NCT03948334|471140576|FG001|Overall Study|Study terminated by Sponsor|51|||
130866892|NCT03948334|471140575|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
130866893|NCT03948334|471140576|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
130866894|NCT01100320|471140578|FG000|Period 1|Withdrawal by Subject|2|||
130866895|NCT01100320|471140579|FG001|Period 1|Withdrawal by Subject|4|||
130866896|NCT01100320|471140578|FG000|Period 1|Positive Drug Screen|1|||
130866897|NCT01100320|471140579|FG001|Period 1|Positive Drug Screen|1|||
130866898|NCT01100320|471140578|FG000|Period 1|Adverse Event|2|||
130866899|NCT01100320|471140579|FG001|Period 1|Adverse Event|2|||
130866900|NCT01100320|471140578|FG000|Period 2|Withdrawal by Subject|1|||
130866901|NCT01100320|471140579|FG001|Period 2|Withdrawal by Subject|1|||
130866902|NCT00550953|471140580|FG000|Overall Study|Adverse Event|4|||
130866903|NCT00550953|471140581|FG001|Overall Study|Adverse Event|3|||
130866904|NCT00550953|471140580|FG000|Overall Study|Not able to visit the site|2|||
130866905|NCT00550953|471140581|FG001|Overall Study|Not able to visit the site|3|||
130866906|NCT03797586|471140582|FG000|Overall Study|Lost to Follow-up|3|||
130866907|NCT03797586|471140583|FG001|Overall Study|Lost to Follow-up|6|||
130866908|NCT03797586|471140582|FG000|Overall Study|Death|1|||
130866909|NCT03797586|471140583|FG001|Overall Study|Death|1|||
130866910|NCT03797586|471140582|FG000|Overall Study|Adverse Event|0|||
130866911|NCT03797586|471140583|FG001|Overall Study|Adverse Event|2|||
130866912|NCT05730387|471140584|FG000|Overall Study|Stillbirth|0|||
130866913|NCT05730387|471140585|FG001|Overall Study|Stillbirth|262|||
130866914|NCT05730387|471140584|FG000|Overall Study|Died during or after delivery|2|||
130866915|NCT05730387|471140585|FG001|Overall Study|Died during or after delivery|85|||
130866916|NCT05730387|471140584|FG000|Overall Study|Died after being admitted|0|||
130866917|NCT05730387|471140585|FG001|Overall Study|Died after being admitted|44|||
130866918|NCT05730387|471140584|FG000|Overall Study|Lost to Follow-up|69|||
130866919|NCT05730387|471140585|FG001|Overall Study|Lost to Follow-up|77|||
130866920|NCT00924443|471140586|FG000|Overall Study|Physician Decision|2|||
130866921|NCT00924443|471140586|FG000|Overall Study|Protocol Violation|1|||
130866922|NCT00595478|471140592|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
130866923|NCT00595478|471140593|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
130866924|NCT00595478|471140592|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
130866925|NCT00595478|471140593|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
130866926|NCT03405818|471140596|FG000|Overall Study|Withdrawal by Subject|4|||
130866927|NCT03405818|471140596|FG000|Overall Study|Lost to Follow-up|4|||
130866928|NCT02978833|471140599|FG000|Overall Study|Study terminated|1|||
130866929|NCT02978833|471140600|FG001|Overall Study|Study terminated|1|||
130866930|NCT00103740|471140601|FG000|Period 1 - Core|Adverse Event|1|||
130866931|NCT00103740|471140602|FG001|Period 1 - Core|Adverse Event|0|||
130866932|NCT00103740|471140601|FG000|Period 1 - Core|Protocol Violation|3|||
130866933|NCT00103740|471140602|FG001|Period 1 - Core|Protocol Violation|2|||
130866934|NCT00103740|471140601|FG000|Period 1 - Core|Patient withdrew consent|3|||
130866935|NCT00103740|471140602|FG001|Period 1 - Core|Patient withdrew consent|2|||
130866936|NCT00103740|471140601|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
130866937|NCT00103740|471140602|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
130866938|NCT00103740|471140601|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
130866939|NCT00103740|471140602|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
130866940|NCT00103740|471140601|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
130866941|NCT00103740|471140602|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
130866942|NCT00103740|471140601|FG000|Period 2 - Extended Observation Period|Death|6|||
130866943|NCT00103740|471140602|FG001|Period 2 - Extended Observation Period|Death|2|||
130866944|NCT00103740|471140601|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
130866945|NCT00103740|471140602|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
130866946|NCT02363959|471140606|FG000|Overall Study|Medical instability|1|||
130866947|NCT02363959|471140607|FG001|Overall Study|Medical instability|0|||
130866948|NCT00950248|471140610|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
130866949|NCT00950248|471140611|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
130866950|NCT00950248|471140612|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
130866951|NCT00950248|471140610|FG000|Year 1: Baseline|worsening of symptoms|2|||
130866952|NCT00950248|471140611|FG001|Year 1: Baseline|worsening of symptoms|0|||
130866953|NCT00950248|471140612|FG002|Year 1: Baseline|worsening of symptoms|0|||
130866954|NCT00950248|471140610|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
130866955|NCT00950248|471140611|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
130866956|NCT00950248|471140612|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
130866957|NCT00950248|471140610|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
130866958|NCT00950248|471140611|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
130866959|NCT00950248|471140612|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
130866960|NCT00950248|471140610|FG000|Year 2&3 Treatment Randomization|Death|0|||
130866961|NCT00950248|471140611|FG001|Year 2&3 Treatment Randomization|Death|0|||
130866962|NCT00950248|471140612|FG002|Year 2&3 Treatment Randomization|Death|1|||
130866963|NCT00950248|471140610|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
130866964|NCT00950248|471140611|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
130866965|NCT00950248|471140612|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
130866966|NCT01900652|471140614|FG000|Overall Study|Progressive Disease|1|||
130866967|NCT01900652|471140615|FG001|Overall Study|Progressive Disease|0|||
130866968|NCT01900652|471140614|FG000|Overall Study|Consent withdrawn by subject|1|||
130866969|NCT01900652|471140615|FG001|Overall Study|Consent withdrawn by subject|1|||
130866970|NCT01900652|471140614|FG000|Overall Study|Death|3|||
130866971|NCT01900652|471140615|FG001|Overall Study|Death|0|||
130866972|NCT01900652|471140614|FG000|Overall Study|Adverse Event|2|||
130866973|NCT01900652|471140615|FG001|Overall Study|Adverse Event|1|||
130866974|NCT01900652|471140614|FG000|Overall Study|Physician Decision|1|||
130866975|NCT01900652|471140615|FG001|Overall Study|Physician Decision|1|||
130866976|NCT00869518|471140618|FG000|Overall Study|Lost to Follow-up|1|||
130866977|NCT00869518|471140619|FG001|Overall Study|Lost to Follow-up|1|||
130866978|NCT02663622|471140622|FG000|Overall Study|Death|3|||
130866979|NCT02663622|471140623|FG001|Overall Study|Death|1|||
130866980|NCT02663622|471140624|FG002|Overall Study|Death|1|||
130866981|NCT02663622|471140625|FG003|Overall Study|Death|8|||
130866982|NCT02663622|471140622|FG000|Overall Study|Protocol Violation|0|||
130866983|NCT02663622|471140623|FG001|Overall Study|Protocol Violation|0|||
130866984|NCT02663622|471140624|FG002|Overall Study|Protocol Violation|0|||
130866985|NCT02663622|471140625|FG003|Overall Study|Protocol Violation|1|||
130866986|NCT02587819|471140626|FG000|Overall Study|Adverse Event|1|||
130866987|NCT02587819|471140626|FG000|Overall Study|Lost to Follow-up|1|||
130866988|NCT01594931|471142430|FG000|Overall Study|Adverse Event|3|||
130866989|NCT01594931|471142431|FG001|Overall Study|Adverse Event|1|||
130866990|NCT01594931|471142432|FG002|Overall Study|Adverse Event|1|||
130866991|NCT01594931|471142430|FG000|Overall Study|Withdrawal by Subject|2|||
130866992|NCT01594931|471142431|FG001|Overall Study|Withdrawal by Subject|1|||
130866993|NCT01594931|471142432|FG002|Overall Study|Withdrawal by Subject|1|||
130866994|NCT01594931|471142430|FG000|Overall Study|Lack of Efficacy|7|||
130866995|NCT01594931|471142431|FG001|Overall Study|Lack of Efficacy|2|||
130866996|NCT01594931|471142432|FG002|Overall Study|Lack of Efficacy|2|||
130866997|NCT01594931|471142430|FG000|Overall Study|Lost to Follow-up|4|||
130866998|NCT01594931|471142431|FG001|Overall Study|Lost to Follow-up|3|||
130866999|NCT01594931|471142432|FG002|Overall Study|Lost to Follow-up|3|||
130867000|NCT01594931|471142430|FG000|Overall Study|Protocol Violation|2|||
130867001|NCT01594931|471142431|FG001|Overall Study|Protocol Violation|1|||
130867002|NCT01594931|471142432|FG002|Overall Study|Protocol Violation|0|||
130867003|NCT01594931|471142430|FG000|Overall Study|No defiined|11|||
130867004|NCT01594931|471142431|FG001|Overall Study|No defiined|4|||
130867005|NCT01594931|471142432|FG002|Overall Study|No defiined|7|||
130867006|NCT01467505|471142436|FG000|Overall Study|Adverse Event|1|||
130867007|NCT01467505|471142437|FG001|Overall Study|Adverse Event|0|||
130867008|NCT01467505|471142436|FG000|Overall Study|Withdrawal by Subject|4|||
130867009|NCT01467505|471142437|FG001|Overall Study|Withdrawal by Subject|0|||
130867010|NCT01467505|471142436|FG000|Overall Study|Study Terminated by Sponsor|28|||
130867011|NCT01467505|471142437|FG001|Overall Study|Study Terminated by Sponsor|3|||
130867012|NCT03449758|471142440|FG000|Overall Study|Major protocol deviation|1|||
130867013|NCT03449758|471142440|FG000|Overall Study|Treatment inefficacy|5|||
130867014|NCT03449758|471142440|FG000|Overall Study|Adverse Event|9|||
130867015|NCT03449758|471142440|FG000|Overall Study|Consent withdrawal|1|||
130867016|NCT03449758|471142440|FG000|Overall Study|Other unspecified reason|3|||
130867017|NCT00269919|471142451|FG000|Overall Study|Other|26|||
130867018|NCT00269919|471142451|FG000|Overall Study|Started but not treated|1|||
130867019|NCT02471014|471142454|FG000|Overall Study|Lost to Follow-up|2|||
130867020|NCT02471014|471142455|FG001|Overall Study|Lost to Follow-up|2|||
130867021|NCT01751984|471142456|FG000|Overall Study|Adverse Event|5|||
130867022|NCT01751984|471142457|FG001|Overall Study|Adverse Event|3|||
130867023|NCT01751984|471142456|FG000|Overall Study|Withdrawal by Subject|0|||
130867024|NCT01751984|471142457|FG001|Overall Study|Withdrawal by Subject|1|||
130867025|NCT01751984|471142456|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
130867026|NCT01751984|471142457|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130867027|NCT01388907|471142458|FG000|Overall Study|Adverse Event|2|||
130867028|NCT01388907|471142459|FG001|Overall Study|Adverse Event|0|||
130867029|NCT03187132|471142460|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
130867030|NCT03187132|471142461|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
130867031|NCT03187132|471142460|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
130867032|NCT03187132|471142461|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
130867033|NCT03187132|471142460|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
130867034|NCT03187132|471142461|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
130867035|NCT03187132|471142460|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
130867036|NCT03187132|471142461|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
130867037|NCT03187132|471142460|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
130867038|NCT03187132|471142461|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
130867039|NCT03187132|471142460|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
130867040|NCT03187132|471142461|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
130867041|NCT03187132|471142460|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
130867042|NCT03187132|471142461|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
130867043|NCT03187132|471142460|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
130867044|NCT03187132|471142461|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
130867045|NCT03187132|471142460|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
130867046|NCT03187132|471142461|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
130867047|NCT03187132|471142460|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
130867048|NCT03187132|471142461|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
130867049|NCT03187132|471142460|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
130867050|NCT03187132|471142461|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
130867051|NCT02045095|471142462|FG000|Overall Study|Other|0|||
130867052|NCT02045095|471142463|FG001|Overall Study|Other|0|||
130867053|NCT02045095|471142464|FG002|Overall Study|Other|1|||
130867054|NCT02045095|471142465|FG003|Overall Study|Other|0|||
130867055|NCT02045095|471142466|FG004|Overall Study|Other|0|||
130867056|NCT02045095|471142467|FG005|Overall Study|Other|2|||
130867057|NCT02045095|471142468|FG006|Overall Study|Other|0|||
130867058|NCT02045095|471142462|FG000|Overall Study|Progressive Disease|3|||
130867059|NCT02045095|471142463|FG001|Overall Study|Progressive Disease|3|||
130867060|NCT02045095|471142464|FG002|Overall Study|Progressive Disease|2|||
130867061|NCT02045095|471142465|FG003|Overall Study|Progressive Disease|4|||
130867062|NCT02045095|471142466|FG004|Overall Study|Progressive Disease|2|||
130867063|NCT02045095|471142467|FG005|Overall Study|Progressive Disease|4|||
130867064|NCT02045095|471142468|FG006|Overall Study|Progressive Disease|1|||
130867065|NCT02045095|471142462|FG000|Overall Study|Withdrawal by Subject|0|||
130867066|NCT02045095|471142463|FG001|Overall Study|Withdrawal by Subject|0|||
130867067|NCT02045095|471142464|FG002|Overall Study|Withdrawal by Subject|0|||
130867068|NCT02045095|471142465|FG003|Overall Study|Withdrawal by Subject|0|||
130867069|NCT02045095|471142466|FG004|Overall Study|Withdrawal by Subject|3|||
130867070|NCT02045095|471142467|FG005|Overall Study|Withdrawal by Subject|0|||
130867071|NCT02045095|471142468|FG006|Overall Study|Withdrawal by Subject|0|||
130867072|NCT02045095|471142462|FG000|Overall Study|Adverse Event|0|||
130867073|NCT02045095|471142463|FG001|Overall Study|Adverse Event|1|||
130867074|NCT02045095|471142464|FG002|Overall Study|Adverse Event|1|||
130867075|NCT02045095|471142465|FG003|Overall Study|Adverse Event|0|||
130867076|NCT02045095|471142466|FG004|Overall Study|Adverse Event|0|||
130867077|NCT02045095|471142467|FG005|Overall Study|Adverse Event|2|||
130867078|NCT02045095|471142468|FG006|Overall Study|Adverse Event|0|||
130867079|NCT03594773|471142469|FG000|Overall Study|Withdrawal by Subject|3|||
130867080|NCT03594773|471142470|FG001|Overall Study|Withdrawal by Subject|2|||
130867081|NCT03594773|471142469|FG000|Overall Study|Lost to Follow-up|3|||
130867082|NCT03594773|471142470|FG001|Overall Study|Lost to Follow-up|4|||
130867083|NCT00714415|471142472|FG000|Overall Study|Lack of Efficacy|1|||
130867084|NCT00714415|471142473|FG001|Overall Study|Lack of Efficacy|0|||
130867085|NCT00714415|471142472|FG000|Overall Study|Death|1|||
130867086|NCT00714415|471142473|FG001|Overall Study|Death|0|||
130867087|NCT01461707|471142476|FG000|Overall Study|Withdrawal by Subject|1|||
130867088|NCT01461707|471142477|FG001|Overall Study|Withdrawal by Subject|0|||
130867089|NCT00855816|471142483|FG000|Overall Study|Withdrawal by Subject|22|||
130867090|NCT00855816|471142484|FG001|Overall Study|Withdrawal by Subject|15|||
130867091|NCT00855816|471142483|FG000|Overall Study|Lost to Follow-up|3|||
130867092|NCT00855816|471142484|FG001|Overall Study|Lost to Follow-up|5|||
130867093|NCT00855816|471142483|FG000|Overall Study|Death|1|||
130867094|NCT00855816|471142484|FG001|Overall Study|Death|0|||
130867095|NCT00855816|471142483|FG000|Overall Study|Became ineligible|0|||
130867096|NCT00855816|471142484|FG001|Overall Study|Became ineligible|1|||
130867097|NCT01965704|471142488|FG000|Overall Study|Withdrawal by Subject|2|||
130867098|NCT01965704|471142489|FG001|Overall Study|Withdrawal by Subject|2|||
130867099|NCT01965704|471142490|FG002|Overall Study|Withdrawal by Subject|1|||
130867100|NCT01965704|471142491|FG003|Overall Study|Withdrawal by Subject|1|||
130867101|NCT01965704|471142488|FG000|Overall Study|Delivered at home|1|||
130867102|NCT01965704|471142489|FG001|Overall Study|Delivered at home|1|||
130867103|NCT01965704|471142490|FG002|Overall Study|Delivered at home|0|||
130867104|NCT01965704|471142491|FG003|Overall Study|Delivered at home|0|||
130867105|NCT01965704|471142488|FG000|Overall Study|Experienced complications|0|||
130867106|NCT01965704|471142489|FG001|Overall Study|Experienced complications|0|||
130867107|NCT01965704|471142490|FG002|Overall Study|Experienced complications|2|||
130867108|NCT01965704|471142491|FG003|Overall Study|Experienced complications|2|||
130867109|NCT01965704|471142488|FG000|Overall Study|Adverse Event|0|||
130867110|NCT01965704|471142489|FG001|Overall Study|Adverse Event|0|||
130867111|NCT01965704|471142490|FG002|Overall Study|Adverse Event|1|||
130867112|NCT01965704|471142491|FG003|Overall Study|Adverse Event|1|||
130867113|NCT01965704|471142488|FG000|Overall Study|Did not meet inclusion criteria|0|||
130867114|NCT01965704|471142489|FG001|Overall Study|Did not meet inclusion criteria|0|||
130867115|NCT01965704|471142490|FG002|Overall Study|Did not meet inclusion criteria|1|||
130867116|NCT01965704|471142491|FG003|Overall Study|Did not meet inclusion criteria|1|||
130867117|NCT00687804|471142499|FG000|Core Study|Adverse Event|5|||
130867118|NCT00687804|471142500|FG001|Core Study|Adverse Event|3|||
130867119|NCT00687804|471142501|FG002|Core Study|Adverse Event|3|||
130867120|NCT00687804|471142499|FG000|Core Study|Abnormal laboratory value(s)|1|||
130867121|NCT00687804|471142500|FG001|Core Study|Abnormal laboratory value(s)|0|||
130867122|NCT00687804|471142501|FG002|Core Study|Abnormal laboratory value(s)|0|||
130867123|NCT00687804|471142499|FG000|Core Study|Lack of Efficacy|1|||
130867124|NCT00687804|471142500|FG001|Core Study|Lack of Efficacy|1|||
130867125|NCT00687804|471142501|FG002|Core Study|Lack of Efficacy|1|||
130867126|NCT00687804|471142499|FG000|Core Study|Withdrawal by Subject|4|||
130867127|NCT00687804|471142500|FG001|Core Study|Withdrawal by Subject|7|||
130867128|NCT00687804|471142501|FG002|Core Study|Withdrawal by Subject|7|||
130867129|NCT00687804|471142499|FG000|Core Study|Lost to Follow-up|0|||
130867130|NCT00687804|471142500|FG001|Core Study|Lost to Follow-up|1|||
130867131|NCT00687804|471142501|FG002|Core Study|Lost to Follow-up|0|||
130867132|NCT00687804|471142499|FG000|Core Study|Death|2|||
130867133|NCT00687804|471142500|FG001|Core Study|Death|2|||
130867134|NCT00687804|471142501|FG002|Core Study|Death|2|||
130867135|NCT00687804|471142499|FG000|Core Study|Protocol Violation|1|||
130867136|NCT00687804|471142500|FG001|Core Study|Protocol Violation|1|||
130867137|NCT00687804|471142501|FG002|Core Study|Protocol Violation|0|||
130867138|NCT00687804|471142499|FG000|Open-Label Extension Study|Adverse Event|2|||
130867139|NCT00687804|471142500|FG001|Open-Label Extension Study|Adverse Event|2|||
130867140|NCT00687804|471142501|FG002|Open-Label Extension Study|Adverse Event|2|||
130867141|NCT00687804|471142499|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
130867142|NCT00687804|471142500|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
130867143|NCT00687804|471142501|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
130867144|NCT00687804|471142499|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
130867145|NCT00687804|471142500|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
130867146|NCT00687804|471142501|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
130867147|NCT00687804|471142499|FG000|Open-Label Extension Study|Administrative problems|1|||
130867148|NCT00687804|471142500|FG001|Open-Label Extension Study|Administrative problems|1|||
130867149|NCT00687804|471142501|FG002|Open-Label Extension Study|Administrative problems|0|||
130867150|NCT00687804|471142499|FG000|Open-Label Extension Study|Death|2|||
130867151|NCT00687804|471142500|FG001|Open-Label Extension Study|Death|3|||
130867152|NCT00687804|471142501|FG002|Open-Label Extension Study|Death|3|||
130867153|NCT04390243|471142502|FG000|Overall Study|Death|1|||
130867154|NCT04390243|471142502|FG000|Overall Study|Disease Progression|4|||
130867155|NCT04390243|471142502|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
130867156|NCT00799903|471142505|FG000|Overall Study|Investigator Site Closed|25|||
130867157|NCT00799903|471142506|FG001|Overall Study|Investigator Site Closed|23|||
130867158|NCT00799903|471142505|FG000|Overall Study|Withdrawal by Subject|179|||
130867159|NCT00799903|471142506|FG001|Overall Study|Withdrawal by Subject|175|||
130867160|NCT00799903|471142505|FG000|Overall Study|Lost to Follow-up|69|||
130867161|NCT00799903|471142506|FG001|Overall Study|Lost to Follow-up|80|||
130867162|NCT01970306|471142514|FG000|Overall Study|Not eligible|3|||
130867163|NCT01970306|471142514|FG000|Overall Study|Not able to be treated|9|||
130867164|NCT00226811|471142515|FG000|Overall Study|Death|8|||
130867165|NCT00226811|471142515|FG000|Overall Study|Adverse Event|11|||
130867166|NCT00226811|471142515|FG000|Overall Study|Lack of Efficacy|55|||
130867167|NCT00226811|471142515|FG000|Overall Study|Withdrawal by Subject|2|||
130867168|NCT03472326|471142516|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
130867169|NCT03472326|471142517|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
130867170|NCT03472326|471142518|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
130867171|NCT03472326|471142519|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
130867172|NCT03472326|471142516|FG000|Part 2: Combination Therapy|Pregnancy|0|||
130867173|NCT03472326|471142517|FG001|Part 2: Combination Therapy|Pregnancy|0|||
130867174|NCT03472326|471142518|FG002|Part 2: Combination Therapy|Pregnancy|0|||
130867175|NCT03472326|471142519|FG003|Part 2: Combination Therapy|Pregnancy|1|||
130867176|NCT00700713|471142521|FG000|Overall Study|Protocol Violation|1|||
130867177|NCT00700713|471142522|FG001|Overall Study|Protocol Violation|0|||
130867178|NCT00700713|471142523|FG002|Overall Study|Protocol Violation|1|||
130867179|NCT00700713|471142521|FG000|Overall Study|Withdrawal by Subject|0|||
130867180|NCT00700713|471142522|FG001|Overall Study|Withdrawal by Subject|0|||
130867181|NCT00700713|471142523|FG002|Overall Study|Withdrawal by Subject|1|||
130867182|NCT04980612|471142524|FG000|Overall Study|Withdrawal by Subject|7|||
130867183|NCT04980612|471142525|FG001|Overall Study|Withdrawal by Subject|5|||
130867184|NCT02446717|471142526|FG000|Overall Study|Adverse Event|0|||
130867185|NCT02446717|471142527|FG001|Overall Study|Adverse Event|0|||
130867186|NCT02446717|471142528|FG002|Overall Study|Adverse Event|1|||
130867187|NCT02446717|471142529|FG003|Overall Study|Adverse Event|0|||
130867188|NCT02446717|471142530|FG004|Overall Study|Adverse Event|0|||
130867189|NCT02446717|471142526|FG000|Overall Study|Lost to Follow-up|0|||
130867190|NCT02446717|471142527|FG001|Overall Study|Lost to Follow-up|1|||
130867191|NCT02446717|471142528|FG002|Overall Study|Lost to Follow-up|1|||
130867192|NCT02446717|471142529|FG003|Overall Study|Lost to Follow-up|0|||
130867193|NCT02446717|471142530|FG004|Overall Study|Lost to Follow-up|1|||
130867194|NCT02446717|471142526|FG000|Overall Study|Withdrew consent|0|||
130867195|NCT02446717|471142527|FG001|Overall Study|Withdrew consent|0|||
130867196|NCT02446717|471142528|FG002|Overall Study|Withdrew consent|0|||
130867197|NCT02446717|471142529|FG003|Overall Study|Withdrew consent|1|||
130867198|NCT02446717|471142530|FG004|Overall Study|Withdrew consent|0|||
130867199|NCT02680665|471142531|FG000|Overall Study|No visit after the first prescription|5|||
130867200|NCT00596752|471142532|FG000|Overall Study|Other Reason|44|||
130867201|NCT00596752|471142533|FG001|Overall Study|Other Reason|49|||
130867202|NCT00596752|471142532|FG000|Overall Study|Adverse Event|34|||
130867203|NCT00596752|471142533|FG001|Overall Study|Adverse Event|34|||
130867204|NCT00596752|471142532|FG000|Overall Study|Lost to Follow-up|22|||
130867205|NCT00596752|471142533|FG001|Overall Study|Lost to Follow-up|38|||
130867206|NCT00596752|471142532|FG000|Overall Study|Withdrawal by Subject|12|||
130867207|NCT00596752|471142533|FG001|Overall Study|Withdrawal by Subject|9|||
130867208|NCT00596752|471142532|FG000|Overall Study|Unsatisfactory Compliance|9|||
130867209|NCT00596752|471142533|FG001|Overall Study|Unsatisfactory Compliance|6|||
130867210|NCT00596752|471142532|FG000|Overall Study|Lack of Efficacy|4|||
130867211|NCT00596752|471142533|FG001|Overall Study|Lack of Efficacy|7|||
130867212|NCT00596752|471142532|FG000|Overall Study|Protocol Violation|1|||
130867213|NCT00596752|471142533|FG001|Overall Study|Protocol Violation|0|||
130867214|NCT04669301|471142534|FG000|Overall Study|Lost to Follow-up|0|||
130867215|NCT04669301|471142535|FG001|Overall Study|Lost to Follow-up|1|||
130867216|NCT04669301|471142536|FG002|Overall Study|Lost to Follow-up|0|||
130867217|NCT04669301|471142534|FG000|Overall Study|Withdrawal by Subject|3|||
130867218|NCT04669301|471142535|FG001|Overall Study|Withdrawal by Subject|2|||
130867219|NCT04669301|471142536|FG002|Overall Study|Withdrawal by Subject|0|||
130867220|NCT02940496|471142537|FG000|Overall Study|Adverse Event|1|||
130867221|NCT02940496|471142538|FG001|Overall Study|Adverse Event|0|||
130867222|NCT02940496|471142537|FG000|Overall Study|Death|2|||
130867223|NCT02940496|471142538|FG001|Overall Study|Death|0|||
130867224|NCT02940496|471142537|FG000|Overall Study|Hospice Care|1|||
130867225|NCT02940496|471142538|FG001|Overall Study|Hospice Care|0|||
130867226|NCT02940496|471142537|FG000|Overall Study|No MRE Done|1|||
130867227|NCT02940496|471142538|FG001|Overall Study|No MRE Done|0|||
130867228|NCT02940496|471142537|FG000|Overall Study|MRE Failure|1|||
130867229|NCT02940496|471142538|FG001|Overall Study|MRE Failure|0|||
130867230|NCT02715609|471142540|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
130867231|NCT02715609|471142541|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
130867232|NCT02715609|471142542|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
130867233|NCT02715609|471142540|FG000|Overall Study|Withdrawal by Subject|0|||
130867234|NCT02715609|471142541|FG001|Overall Study|Withdrawal by Subject|0|||
130867235|NCT02715609|471142542|FG002|Overall Study|Withdrawal by Subject|1|||
130867236|NCT05907395|471142545|FG000|Period 1|No longer met eligibility criteria|0|||
130867237|NCT05907395|471142546|FG001|Period 1|No longer met eligibility criteria|1|||
130867238|NCT05907395|471142547|FG002|Period 1|No longer met eligibility criteria|0|||
130867239|NCT05907395|471142548|FG003|Period 1|No longer met eligibility criteria|0|||
130867240|NCT05907395|471142549|FG004|Period 1|No longer met eligibility criteria|0|||
130867241|NCT05907395|471142550|FG005|Period 1|No longer met eligibility criteria|1|||
130867242|NCT05907395|471142551|FG006|Period 1|No longer met eligibility criteria|1|||
130867243|NCT05907395|471142552|FG007|Period 1|No longer met eligibility criteria|0|||
130867244|NCT05907395|471142553|FG008|Period 1|No longer met eligibility criteria|0|||
130867245|NCT05907395|471142554|FG009|Period 1|No longer met eligibility criteria|0|||
130867246|NCT05907395|471142555|FG010|Period 1|No longer met eligibility criteria|0|||
130867247|NCT05907395|471142556|FG011|Period 1|No longer met eligibility criteria|0|||
130867248|NCT05907395|471142545|FG000|Period 2|Adverse Event|0|||
130867249|NCT05907395|471142546|FG001|Period 2|Adverse Event|0|||
130867250|NCT05907395|471142547|FG002|Period 2|Adverse Event|0|||
130867251|NCT05907395|471142548|FG003|Period 2|Adverse Event|1|||
130867252|NCT05907395|471142549|FG004|Period 2|Adverse Event|0|||
130867253|NCT05907395|471142550|FG005|Period 2|Adverse Event|0|||
130867254|NCT05907395|471142551|FG006|Period 2|Adverse Event|0|||
130867255|NCT05907395|471142552|FG007|Period 2|Adverse Event|1|||
130867256|NCT05907395|471142553|FG008|Period 2|Adverse Event|0|||
130867257|NCT05907395|471142554|FG009|Period 2|Adverse Event|0|||
130867258|NCT05907395|471142555|FG010|Period 2|Adverse Event|0|||
130867259|NCT05907395|471142556|FG011|Period 2|Adverse Event|0|||
130867260|NCT05907395|471142545|FG000|Period 2|Personal reason|0|||
130867261|NCT05907395|471142546|FG001|Period 2|Personal reason|0|||
130867262|NCT05907395|471142547|FG002|Period 2|Personal reason|0|||
130867263|NCT05907395|471142548|FG003|Period 2|Personal reason|0|||
130867264|NCT05907395|471142549|FG004|Period 2|Personal reason|0|||
130867265|NCT05907395|471142550|FG005|Period 2|Personal reason|0|||
130867266|NCT05907395|471142551|FG006|Period 2|Personal reason|0|||
130867267|NCT05907395|471142552|FG007|Period 2|Personal reason|0|||
130867268|NCT05907395|471142553|FG008|Period 2|Personal reason|0|||
130867269|NCT05907395|471142554|FG009|Period 2|Personal reason|1|||
130867270|NCT05907395|471142555|FG010|Period 2|Personal reason|0|||
130867271|NCT05907395|471142556|FG011|Period 2|Personal reason|0|||
130867272|NCT05907395|471142545|FG000|Period 3|Adverse Event|0|||
130867273|NCT05907395|471142546|FG001|Period 3|Adverse Event|0|||
130867274|NCT05907395|471142547|FG002|Period 3|Adverse Event|0|||
130867275|NCT05907395|471142548|FG003|Period 3|Adverse Event|0|||
130867276|NCT05907395|471142549|FG004|Period 3|Adverse Event|1|||
130867277|NCT05907395|471142550|FG005|Period 3|Adverse Event|0|||
130867278|NCT05907395|471142551|FG006|Period 3|Adverse Event|0|||
130867279|NCT05907395|471142552|FG007|Period 3|Adverse Event|0|||
130867280|NCT05907395|471142553|FG008|Period 3|Adverse Event|0|||
130867281|NCT05907395|471142554|FG009|Period 3|Adverse Event|0|||
130867282|NCT05907395|471142555|FG010|Period 3|Adverse Event|0|||
130867283|NCT05907395|471142556|FG011|Period 3|Adverse Event|0|||
130867284|NCT04544956|471142557|FG000|Overall Study|Withdrawal by Subject|1|||
130867285|NCT00548145|471142562|FG000|Overall Study|Death|0|||
130867286|NCT00548145|471142563|FG001|Overall Study|Death|1|||
130867287|NCT00548145|471142562|FG000|Overall Study|Withdrawal by Subject|0|||
130867288|NCT00548145|471142563|FG001|Overall Study|Withdrawal by Subject|2|||
130867289|NCT00548145|471142562|FG000|Overall Study|Physician Decision|1|||
130867290|NCT00548145|471142563|FG001|Overall Study|Physician Decision|1|||
130867291|NCT02119663|471142565|FG000|Overall Study|Disease progression|26|||
130867292|NCT02119663|471142566|FG001|Overall Study|Disease progression|27|||
130867293|NCT02119663|471142565|FG000|Overall Study|Adverse Event|5|||
130867294|NCT02119663|471142566|FG001|Overall Study|Adverse Event|5|||
130867295|NCT02119663|471142565|FG000|Overall Study|Death|3|||
130867296|NCT02119663|471142566|FG001|Overall Study|Death|2|||
130867297|NCT02119663|471142565|FG000|Overall Study|Physician Decision|1|||
130867298|NCT02119663|471142566|FG001|Overall Study|Physician Decision|2|||
130867299|NCT02119663|471142565|FG000|Overall Study|Other unspecified|2|||
130867300|NCT02119663|471142566|FG001|Overall Study|Other unspecified|0|||
130867301|NCT02119663|471142565|FG000|Overall Study|Subject decision|0|||
130867302|NCT02119663|471142566|FG001|Overall Study|Subject decision|1|||
130867303|NCT02119663|471142565|FG000|Overall Study|Study Terminated by the Sponsor|3|||
130867304|NCT02119663|471142566|FG001|Overall Study|Study Terminated by the Sponsor|4|||
130867305|NCT02863328|471142567|FG000|Overall Study|Lost to Follow-up|4|||
130867306|NCT02863328|471142568|FG001|Overall Study|Lost to Follow-up|10|||
130867307|NCT02863328|471142567|FG000|Overall Study|Withdrawal by Subject|7|||
130867308|NCT02863328|471142568|FG001|Overall Study|Withdrawal by Subject|12|||
130867309|NCT02863328|471142567|FG000|Overall Study|Died|0|||
130867310|NCT02863328|471142568|FG001|Overall Study|Died|1|||
130867311|NCT00892775|471142569|FG000|Overall Study|Protocol Violation|1|||
130867312|NCT00892775|471142570|FG001|Overall Study|Protocol Violation|0|||
130867313|NCT00892775|471142569|FG000|Overall Study|Subject difficulties with blood drawing|1|||
130867314|NCT00892775|471142570|FG001|Overall Study|Subject difficulties with blood drawing|0|||
130867315|NCT00892775|471142569|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
130867316|NCT00892775|471142570|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
130867317|NCT00892775|471142569|FG000|Overall Study|Migrated/ moved from study area|1|||
130867318|NCT00892775|471142570|FG001|Overall Study|Migrated/ moved from study area|0|||
130867319|NCT00892775|471142569|FG000|Overall Study|Withdrawal by Subject|0|||
130867320|NCT00892775|471142570|FG001|Overall Study|Withdrawal by Subject|1|||
130867321|NCT00892775|471142569|FG000|Overall Study|Lost to Follow-up|1|||
130867322|NCT00892775|471142570|FG001|Overall Study|Lost to Follow-up|0|||
130867323|NCT00699660|471142571|FG000|Overall Study|Lost to Follow-up|4|||
130867324|NCT00699660|471142572|FG001|Overall Study|Lost to Follow-up|2|||
130867325|NCT00699660|471142571|FG000|Overall Study|missing reports and recording failures|10|||
130867326|NCT00699660|471142572|FG001|Overall Study|missing reports and recording failures|6|||
130867327|NCT00398320|471142573|FG000|Overall Study|Death|1|||
130867328|NCT00398320|471142573|FG000|Overall Study|Adverse Event|4|||
130867329|NCT00398320|471142573|FG000|Overall Study|Physician Decision|1|||
130867330|NCT00064792|471142574|FG000|Overall Study|Withdrawal by Subject|2|||
130867331|NCT00064792|471142575|FG001|Overall Study|Withdrawal by Subject|0|||
130867332|NCT00064792|471142574|FG000|Overall Study|Adverse Event|3|||
130867333|NCT00064792|471142575|FG001|Overall Study|Adverse Event|0|||
130867334|NCT01870726|471142576|FG000|Overall Study|Withdrawal of informed consent|0|||
130867335|NCT01870726|471142577|FG001|Overall Study|Withdrawal of informed consent|0|||
130867336|NCT01870726|471142578|FG002|Overall Study|Withdrawal of informed consent|0|||
130867337|NCT01870726|471142579|FG003|Overall Study|Withdrawal of informed consent|1|||
130867338|NCT01870726|471142580|FG004|Overall Study|Withdrawal of informed consent|0|||
130867339|NCT01870726|471142581|FG005|Overall Study|Withdrawal of informed consent|0|||
130867340|NCT01870726|471142582|FG006|Overall Study|Withdrawal of informed consent|0|||
130867341|NCT01870726|471142576|FG000|Overall Study|Withdrawal by Subject|0|||
130867342|NCT01870726|471142577|FG001|Overall Study|Withdrawal by Subject|1|||
130867343|NCT01870726|471142578|FG002|Overall Study|Withdrawal by Subject|0|||
130867344|NCT01870726|471142579|FG003|Overall Study|Withdrawal by Subject|0|||
130867345|NCT01870726|471142580|FG004|Overall Study|Withdrawal by Subject|0|||
130867346|NCT01870726|471142581|FG005|Overall Study|Withdrawal by Subject|0|||
130867347|NCT01870726|471142582|FG006|Overall Study|Withdrawal by Subject|0|||
130867348|NCT01870726|471142576|FG000|Overall Study|Adverse Event|0|||
130867349|NCT01870726|471142577|FG001|Overall Study|Adverse Event|0|||
130867350|NCT01870726|471142578|FG002|Overall Study|Adverse Event|0|||
130867351|NCT01870726|471142579|FG003|Overall Study|Adverse Event|0|||
130867352|NCT01870726|471142580|FG004|Overall Study|Adverse Event|1|||
130867353|NCT01870726|471142581|FG005|Overall Study|Adverse Event|1|||
130867354|NCT01870726|471142582|FG006|Overall Study|Adverse Event|0|||
130867355|NCT01870726|471142576|FG000|Overall Study|Progressive disease|5|||
130867356|NCT01870726|471142577|FG001|Overall Study|Progressive disease|5|||
130867357|NCT01870726|471142578|FG002|Overall Study|Progressive disease|4|||
130867358|NCT01870726|471142579|FG003|Overall Study|Progressive disease|5|||
130867359|NCT01870726|471142580|FG004|Overall Study|Progressive disease|6|||
130867360|NCT01870726|471142581|FG005|Overall Study|Progressive disease|4|||
130867361|NCT01870726|471142582|FG006|Overall Study|Progressive disease|10|||
130867362|NCT03301350|471142583|FG000|Overall Study|Withdrawal by Subject|4|||
130867363|NCT03301350|471142583|FG000|Overall Study|Adverse Event|1|||
130867364|NCT03301350|471142583|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
130867365|NCT03301350|471142583|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
130867366|NCT03301350|471142583|FG000|Overall Study|no detail provided|1|||
130867367|NCT01248949|471142586|FG000|Overall Study|Lost to Follow-up|2|||
130867368|NCT01248949|471142587|FG001|Overall Study|Lost to Follow-up|2|||
130867369|NCT01248949|471142588|FG002|Overall Study|Lost to Follow-up|2|||
130867370|NCT01248949|471142589|FG003|Overall Study|Lost to Follow-up|1|||
130867371|NCT01248949|471142590|FG004|Overall Study|Lost to Follow-up|0|||
130867372|NCT01248949|471142586|FG000|Overall Study|Withdrawal by Subject|5|||
130867373|NCT01248949|471142587|FG001|Overall Study|Withdrawal by Subject|3|||
130867374|NCT01248949|471142588|FG002|Overall Study|Withdrawal by Subject|11|||
130867375|NCT01248949|471142589|FG003|Overall Study|Withdrawal by Subject|3|||
130867376|NCT01248949|471142590|FG004|Overall Study|Withdrawal by Subject|1|||
130867377|NCT01248949|471142586|FG000|Overall Study|Death|22|||
130867378|NCT01248949|471142587|FG001|Overall Study|Death|7|||
130867379|NCT01248949|471142588|FG002|Overall Study|Death|21|||
130867380|NCT01248949|471142589|FG003|Overall Study|Death|6|||
130867381|NCT01248949|471142590|FG004|Overall Study|Death|2|||
130867382|NCT01248949|471142586|FG000|Overall Study|Alternative Therapy|1|||
130867383|NCT01248949|471142587|FG001|Overall Study|Alternative Therapy|0|||
130867384|NCT01248949|471142588|FG002|Overall Study|Alternative Therapy|0|||
130867385|NCT01248949|471142589|FG003|Overall Study|Alternative Therapy|0|||
130867386|NCT01248949|471142590|FG004|Overall Study|Alternative Therapy|0|||
130867387|NCT01248949|471142586|FG000|Overall Study|Alternative Therapy.|1|||
130867388|NCT01248949|471142587|FG001|Overall Study|Alternative Therapy.|0|||
130867389|NCT01248949|471142588|FG002|Overall Study|Alternative Therapy.|0|||
130867390|NCT01248949|471142589|FG003|Overall Study|Alternative Therapy.|0|||
130867391|NCT01248949|471142590|FG004|Overall Study|Alternative Therapy.|0|||
130867392|NCT01248949|471142586|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
130867393|NCT01248949|471142587|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
130867394|NCT01248949|471142588|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
130867395|NCT01248949|471142589|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
130867396|NCT01248949|471142590|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
130867397|NCT01248949|471142586|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
130867398|NCT01248949|471142587|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
130867399|NCT01248949|471142588|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
130867400|NCT01248949|471142589|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
130867401|NCT01248949|471142590|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
130867402|NCT01248949|471142586|FG000|Overall Study|Participant Went To Hospice|0|||
130867403|NCT01248949|471142587|FG001|Overall Study|Participant Went To Hospice|0|||
130867404|NCT01248949|471142588|FG002|Overall Study|Participant Went To Hospice|1|||
130867405|NCT01248949|471142589|FG003|Overall Study|Participant Went To Hospice|0|||
130867406|NCT01248949|471142590|FG004|Overall Study|Participant Went To Hospice|0|||
130867407|NCT01248949|471142586|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
130867408|NCT01248949|471142587|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130867409|NCT01248949|471142588|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130867410|NCT01248949|471142589|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130867411|NCT01248949|471142590|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130867412|NCT01248949|471142586|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
130867413|NCT01248949|471142587|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
130867414|NCT01248949|471142588|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
130867415|NCT01248949|471142589|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
130867416|NCT01248949|471142590|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
130867417|NCT01248949|471142586|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130867418|NCT01248949|471142587|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
130867419|NCT01248949|471142588|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130867420|NCT01248949|471142589|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130867421|NCT01248949|471142590|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130867422|NCT01248949|471142586|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130867423|NCT01248949|471142587|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130867424|NCT01248949|471142588|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
130867425|NCT01248949|471142589|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130867426|NCT01248949|471142590|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130867427|NCT00286429|471142591|FG000|Overall Study|Adverse Event|4|||
130867428|NCT00286429|471142592|FG001|Overall Study|Adverse Event|1|||
130867429|NCT00286429|471142593|FG002|Overall Study|Adverse Event|6|||
130867430|NCT00286429|471142591|FG000|Overall Study|Lack of Efficacy|52|||
130867431|NCT00286429|471142592|FG001|Overall Study|Lack of Efficacy|27|||
130867432|NCT00286429|471142593|FG002|Overall Study|Lack of Efficacy|25|||
130867433|NCT00286429|471142591|FG000|Overall Study|Lost to Follow-up|2|||
130867434|NCT00286429|471142592|FG001|Overall Study|Lost to Follow-up|4|||
130867435|NCT00286429|471142593|FG002|Overall Study|Lost to Follow-up|3|||
130867436|NCT00286429|471142591|FG000|Overall Study|Physician Decision|10|||
130867437|NCT00286429|471142592|FG001|Overall Study|Physician Decision|7|||
130867438|NCT00286429|471142593|FG002|Overall Study|Physician Decision|7|||
130867439|NCT00286429|471142591|FG000|Overall Study|Protocol Violation|3|||
130867440|NCT00286429|471142592|FG001|Overall Study|Protocol Violation|5|||
130867441|NCT00286429|471142593|FG002|Overall Study|Protocol Violation|4|||
130867442|NCT00286429|471142591|FG000|Overall Study|Withdrawal by Subject|3|||
130867443|NCT00286429|471142592|FG001|Overall Study|Withdrawal by Subject|2|||
130867444|NCT00286429|471142593|FG002|Overall Study|Withdrawal by Subject|6|||
130867445|NCT00286429|471142591|FG000|Overall Study|Administrative Error|1|||
130867446|NCT00286429|471142592|FG001|Overall Study|Administrative Error|1|||
130867447|NCT00286429|471142593|FG002|Overall Study|Administrative Error|1|||
130867448|NCT00286429|471142591|FG000|Overall Study|Administrative Decision|0|||
130867449|NCT00286429|471142592|FG001|Overall Study|Administrative Decision|1|||
130867450|NCT00286429|471142593|FG002|Overall Study|Administrative Decision|0|||
130867451|NCT01746225|471142596|FG000|Overall Study|Death|1|||
130867452|NCT01746225|471142597|FG001|Overall Study|Death|0|||
130867453|NCT01746225|471142598|FG002|Overall Study|Death|1|||
130867454|NCT01746225|471142596|FG000|Overall Study|Withdrawal by Subject|5|||
130867455|NCT01746225|471142597|FG001|Overall Study|Withdrawal by Subject|15|||
130867456|NCT01746225|471142598|FG002|Overall Study|Withdrawal by Subject|19|||
130867457|NCT01746225|471142596|FG000|Overall Study|Physician Decision|14|||
130867458|NCT01746225|471142597|FG001|Overall Study|Physician Decision|11|||
130867459|NCT01746225|471142598|FG002|Overall Study|Physician Decision|3|||
130867460|NCT01746225|471142596|FG000|Overall Study|Adverse Event|15|||
130867461|NCT01746225|471142597|FG001|Overall Study|Adverse Event|12|||
130867462|NCT01746225|471142598|FG002|Overall Study|Adverse Event|17|||
130867463|NCT01746225|471142596|FG000|Overall Study|Continuing Treatment|5|||
130867464|NCT01746225|471142597|FG001|Overall Study|Continuing Treatment|8|||
130867465|NCT01746225|471142598|FG002|Overall Study|Continuing Treatment|3|||
130867466|NCT03915470|471142599|FG000|Overall Study|Death|3|||
130867467|NCT03915470|471142600|FG001|Overall Study|Death|1|||
130867468|NCT03915470|471142599|FG000|Overall Study|Adverse Event|1|||
130867469|NCT03915470|471142600|FG001|Overall Study|Adverse Event|0|||
130867470|NCT03915470|471142599|FG000|Overall Study|Physician Decision|1|||
130867471|NCT03915470|471142600|FG001|Overall Study|Physician Decision|0|||
130867472|NCT03915470|471142599|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
130867473|NCT03915470|471142600|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
130867474|NCT03160898|471142601|FG000|Overall Study|Adverse Event|4|||
130867475|NCT03160898|471142602|FG001|Overall Study|Adverse Event|8|||
130867476|NCT03160898|471142603|FG002|Overall Study|Adverse Event|7|||
130867477|NCT03160898|471142604|FG003|Overall Study|Adverse Event|10|||
130867478|NCT03160898|471142601|FG000|Overall Study|Death|1|||
130867479|NCT03160898|471142602|FG001|Overall Study|Death|0|||
130867480|NCT03160898|471142603|FG002|Overall Study|Death|0|||
130867481|NCT03160898|471142604|FG003|Overall Study|Death|1|||
130867482|NCT03160898|471142601|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
130867483|NCT03160898|471142602|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
130867484|NCT03160898|471142603|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
130867485|NCT03160898|471142604|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
130867486|NCT03160898|471142601|FG000|Overall Study|Lost to Follow-up|1|||
130867487|NCT03160898|471142602|FG001|Overall Study|Lost to Follow-up|1|||
130867488|NCT03160898|471142603|FG002|Overall Study|Lost to Follow-up|1|||
130867489|NCT03160898|471142604|FG003|Overall Study|Lost to Follow-up|2|||
130867490|NCT03160898|471142601|FG000|Overall Study|Physician Decision|1|||
130867491|NCT03160898|471142602|FG001|Overall Study|Physician Decision|0|||
130867492|NCT03160898|471142603|FG002|Overall Study|Physician Decision|0|||
130867493|NCT03160898|471142604|FG003|Overall Study|Physician Decision|1|||
130867494|NCT03160898|471142601|FG000|Overall Study|Progressive Disease|4|||
130867495|NCT03160898|471142602|FG001|Overall Study|Progressive Disease|1|||
130867496|NCT03160898|471142603|FG002|Overall Study|Progressive Disease|2|||
130867497|NCT03160898|471142604|FG003|Overall Study|Progressive Disease|1|||
130867498|NCT03160898|471142601|FG000|Overall Study|Protocol Violation|1|||
130867499|NCT03160898|471142602|FG001|Overall Study|Protocol Violation|0|||
130867500|NCT03160898|471142603|FG002|Overall Study|Protocol Violation|2|||
130867501|NCT03160898|471142604|FG003|Overall Study|Protocol Violation|0|||
130867502|NCT03160898|471142601|FG000|Overall Study|Sponsor Discretion|2|||
130867503|NCT03160898|471142602|FG001|Overall Study|Sponsor Discretion|0|||
130867504|NCT03160898|471142603|FG002|Overall Study|Sponsor Discretion|0|||
130867505|NCT03160898|471142604|FG003|Overall Study|Sponsor Discretion|0|||
130867506|NCT03160898|471142601|FG000|Overall Study|Withdrawal by Subject|1|||
130867507|NCT03160898|471142602|FG001|Overall Study|Withdrawal by Subject|3|||
130867508|NCT03160898|471142603|FG002|Overall Study|Withdrawal by Subject|2|||
130867509|NCT03160898|471142604|FG003|Overall Study|Withdrawal by Subject|1|||
130867510|NCT03160898|471142601|FG000|Overall Study|Other|2|||
130867511|NCT03160898|471142602|FG001|Overall Study|Other|0|||
130867512|NCT03160898|471142603|FG002|Overall Study|Other|2|||
130867513|NCT03160898|471142604|FG003|Overall Study|Other|2|||
130867514|NCT03245775|471142605|FG000|Overall Study|Lost to Follow-up|25|||
130867515|NCT03245775|471142606|FG001|Overall Study|Lost to Follow-up|26|||
130867516|NCT03245775|471142607|FG002|Overall Study|Lost to Follow-up|16|||
130867517|NCT03245775|471142608|FG003|Overall Study|Lost to Follow-up|16|||
130867518|NCT00086047|471144292|FG000|Overall Study|Lost to Follow-up|7|||
130867519|NCT00086047|471144293|FG001|Overall Study|Lost to Follow-up|6|||
130867520|NCT00086047|471144292|FG000|Overall Study|Physician Decision|0|||
130867521|NCT00086047|471144293|FG001|Overall Study|Physician Decision|1|||
130867522|NCT03579940|471144297|FG000|Period 2|Withdrawal by Subject|0|||
130867523|NCT03579940|471144298|FG001|Period 2|Withdrawal by Subject|0|||
130867524|NCT03579940|471144299|FG002|Period 2|Withdrawal by Subject|1|||
130867525|NCT03579940|471144300|FG003|Period 2|Withdrawal by Subject|0|||
130867526|NCT03579940|471144301|FG004|Period 2|Withdrawal by Subject|0|||
130867527|NCT03579940|471144302|FG005|Period 2|Withdrawal by Subject|0|||
130867528|NCT03579940|471144303|FG006|Period 2|Withdrawal by Subject|0|||
130867529|NCT03579940|471144304|FG007|Period 2|Withdrawal by Subject|0|||
130867530|NCT03579940|471144305|FG008|Period 2|Withdrawal by Subject|0|||
130867531|NCT03579940|471144306|FG009|Period 2|Withdrawal by Subject|0|||
130867532|NCT03579940|471144307|FG010|Period 2|Withdrawal by Subject|0|||
130867533|NCT00671034|471144308|FG000|Overall Study|Adverse Event|5|||
130867534|NCT00671034|471144309|FG001|Overall Study|Adverse Event|7|||
130867535|NCT00671034|471144310|FG002|Overall Study|Adverse Event|1|||
130867536|NCT00671034|471144308|FG000|Overall Study|Death|3|||
130867537|NCT00671034|471144309|FG001|Overall Study|Death|2|||
130867538|NCT00671034|471144310|FG002|Overall Study|Death|1|||
130867539|NCT00671034|471144308|FG000|Overall Study|Physician Decision|12|||
130867540|NCT00671034|471144309|FG001|Overall Study|Physician Decision|4|||
130867541|NCT00671034|471144310|FG002|Overall Study|Physician Decision|5|||
130867542|NCT00671034|471144308|FG000|Overall Study|VHR ALL feature|8|||
130867543|NCT00671034|471144309|FG001|Overall Study|VHR ALL feature|3|||
130867544|NCT00671034|471144310|FG002|Overall Study|VHR ALL feature|5|||
130867545|NCT00671034|471144308|FG000|Overall Study|Refusal|5|||
130867546|NCT00671034|471144309|FG001|Overall Study|Refusal|3|||
130867547|NCT00671034|471144310|FG002|Overall Study|Refusal|5|||
130867548|NCT00671034|471144308|FG000|Overall Study|includes Alternative therapy, etc.|6|||
130867549|NCT00671034|471144309|FG001|Overall Study|includes Alternative therapy, etc.|1|||
130867550|NCT00671034|471144310|FG002|Overall Study|includes Alternative therapy, etc.|7|||
130867551|NCT00853151|471144311|FG000|Overall Study|Adverse Event|1|||
130867552|NCT00853151|471144312|FG001|Overall Study|Adverse Event|4|||
130867553|NCT00853151|471144313|FG002|Overall Study|Adverse Event|2|||
130867554|NCT00853151|471144314|FG003|Overall Study|Adverse Event|0|||
130867555|NCT00853151|471144311|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130867556|NCT00853151|471144312|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130867557|NCT00853151|471144313|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130867558|NCT00853151|471144314|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130867559|NCT00853151|471144311|FG000|Overall Study|Lost to Follow-up|2|||
130867560|NCT00853151|471144312|FG001|Overall Study|Lost to Follow-up|0|||
130867561|NCT00853151|471144313|FG002|Overall Study|Lost to Follow-up|3|||
130867562|NCT00853151|471144314|FG003|Overall Study|Lost to Follow-up|0|||
130867563|NCT00853151|471144311|FG000|Overall Study|Death|1|||
130867564|NCT00853151|471144312|FG001|Overall Study|Death|0|||
130867565|NCT00853151|471144313|FG002|Overall Study|Death|0|||
130867566|NCT00853151|471144314|FG003|Overall Study|Death|1|||
130867567|NCT00853151|471144311|FG000|Overall Study|Protocol Violation|0|||
130867568|NCT00853151|471144312|FG001|Overall Study|Protocol Violation|0|||
130867569|NCT00853151|471144313|FG002|Overall Study|Protocol Violation|0|||
130867570|NCT00853151|471144314|FG003|Overall Study|Protocol Violation|1|||
130867571|NCT00853151|471144311|FG000|Overall Study|Withdrawal by Subject|5|||
130867572|NCT00853151|471144312|FG001|Overall Study|Withdrawal by Subject|4|||
130867573|NCT00853151|471144313|FG002|Overall Study|Withdrawal by Subject|2|||
130867574|NCT00853151|471144314|FG003|Overall Study|Withdrawal by Subject|1|||
130867575|NCT00853151|471144311|FG000|Overall Study|Physician Decision|0|||
130867576|NCT00853151|471144312|FG001|Overall Study|Physician Decision|2|||
130867577|NCT00853151|471144313|FG002|Overall Study|Physician Decision|1|||
130867578|NCT00853151|471144314|FG003|Overall Study|Physician Decision|0|||
130867579|NCT00853151|471144311|FG000|Overall Study|Sponsor Decision|0|||
130867580|NCT00853151|471144312|FG001|Overall Study|Sponsor Decision|3|||
130867581|NCT00853151|471144313|FG002|Overall Study|Sponsor Decision|0|||
130867582|NCT00853151|471144314|FG003|Overall Study|Sponsor Decision|0|||
130867583|NCT01797263|471144315|FG000|Overall Study|Withdrawal by Subject|21|||
130867584|NCT01797263|471144316|FG001|Overall Study|Withdrawal by Subject|25|||
130867585|NCT01797263|471144315|FG000|Overall Study|Death|1|||
130867586|NCT01797263|471144316|FG001|Overall Study|Death|0|||
130867587|NCT01797263|471144315|FG000|Overall Study|Lost to Follow-up|15|||
130867588|NCT01797263|471144316|FG001|Overall Study|Lost to Follow-up|15|||
130867589|NCT01172535|471144317|FG000|Overall Study|Death|3|||
130867590|NCT01172535|471144317|FG000|Overall Study|Withdrawal by Subject|2|||
130867591|NCT01172535|471144317|FG000|Overall Study|Lost to Follow-up|1|||
130867592|NCT01172535|471144317|FG000|Overall Study|Ineligible at study entry|1|||
130867593|NCT01172535|471144317|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
130867594|NCT00988598|471144318|FG000|Overall Study|Withdrawal by Subject|2|||
130867595|NCT00988598|471144319|FG001|Overall Study|Withdrawal by Subject|0|||
130867596|NCT01450761|471144324|FG000|Randomization|Subject no longer meets study criteria|1|||
130867597|NCT01450761|471144325|FG001|Randomization|Subject no longer meets study criteria|2|||
130867598|NCT01450761|471144324|FG000|Randomization|Withdrawal by Subject|2|||
130867599|NCT01450761|471144325|FG001|Randomization|Withdrawal by Subject|0|||
130867600|NCT01450761|471144324|FG000|Randomization|Disease progression|0|||
130867601|NCT01450761|471144325|FG001|Randomization|Disease progression|2|||
130867602|NCT01450761|471144324|FG000|Randomization|Adverse Event unrelated to study drug|1|||
130867603|NCT01450761|471144325|FG001|Randomization|Adverse Event unrelated to study drug|0|||
130867604|NCT01450761|471144324|FG000|Randomization|Other|0|||
130867605|NCT01450761|471144325|FG001|Randomization|Other|1|||
130867606|NCT01450761|471144324|FG000|Lead-in Chemotherapy|Disease progression|33|||
130867607|NCT01450761|471144325|FG001|Lead-in Chemotherapy|Disease progression|32|||
130867608|NCT01450761|471144324|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
130867609|NCT01450761|471144325|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
130867610|NCT01450761|471144324|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
130867611|NCT01450761|471144325|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
130867612|NCT01450761|471144324|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
130867613|NCT01450761|471144325|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
130867614|NCT01450761|471144324|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
130867615|NCT01450761|471144325|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
130867616|NCT01450761|471144324|FG000|Lead-in Chemotherapy|Death|3|||
130867617|NCT01450761|471144325|FG001|Lead-in Chemotherapy|Death|3|||
130867618|NCT01450761|471144324|FG000|Lead-in Chemotherapy|Other|2|||
130867619|NCT01450761|471144325|FG001|Lead-in Chemotherapy|Other|2|||
130867620|NCT01450761|471144324|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
130867621|NCT01450761|471144325|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
130867622|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
130867623|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
130867624|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
130867625|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
130867626|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
130867627|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
130867628|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
130867629|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
130867630|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
130867631|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
130867632|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Death|5|||
130867633|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Death|6|||
130867634|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
130867635|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
130867636|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
130867637|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
130867638|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
130867639|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
130867640|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
130867641|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
130867642|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
130867643|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
130867644|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
130867645|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
130867646|NCT01450761|471144324|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
130867647|NCT01450761|471144325|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
130867648|NCT01818596|471144334|FG000|Overall Study|Enrolled but Not Treated|4|||
130867649|NCT01818596|471144335|FG001|Overall Study|Enrolled but Not Treated|0|||
130867650|NCT01818596|471144334|FG000|Overall Study|Adverse Event|7|||
130867651|NCT01818596|471144335|FG001|Overall Study|Adverse Event|0|||
130867652|NCT01818596|471144334|FG000|Overall Study|Death|3|||
130867653|NCT01818596|471144335|FG001|Overall Study|Death|0|||
130867654|NCT01818596|471144334|FG000|Overall Study|Investigator's Discretion|4|||
130867655|NCT01818596|471144335|FG001|Overall Study|Investigator's Discretion|0|||
130867656|NCT01818596|471144334|FG000|Overall Study|Protocol Violation|1|||
130867657|NCT01818596|471144335|FG001|Overall Study|Protocol Violation|0|||
130867658|NCT01818596|471144334|FG000|Overall Study|Withdrew Consent|5|||
130867659|NCT01818596|471144335|FG001|Overall Study|Withdrew Consent|0|||
130867660|NCT01818596|471144334|FG000|Overall Study|Lost to Follow-up|7|||
130867661|NCT01818596|471144335|FG001|Overall Study|Lost to Follow-up|0|||
130867662|NCT03461146|471144340|FG000|Overall Study|Adverse Event|2|||
130867663|NCT03461146|471144340|FG000|Overall Study|Physician Decision|1|||
130867664|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
130867665|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
130867666|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
130867667|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
130867668|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
130867669|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
130867670|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
130867671|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
130867672|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
130867673|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
130867674|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
130867675|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
130867676|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
130867677|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
130867678|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
130867679|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
130867680|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
130867681|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
130867682|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
130867683|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
130867684|NCT03573323|471144341|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
130867685|NCT03573323|471144342|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
130867686|NCT03573323|471144341|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
130867687|NCT03573323|471144342|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
130867688|NCT03573323|471144341|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
130867689|NCT03573323|471144342|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
130867690|NCT03573323|471144341|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
130867691|NCT03573323|471144342|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
130867692|NCT03573323|471144341|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
130867693|NCT03573323|471144342|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
130867694|NCT03573323|471144341|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
130867695|NCT03573323|471144342|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
130867696|NCT03573323|471144341|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
130867697|NCT03573323|471144342|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
130867698|NCT03573323|471144341|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
130867699|NCT03573323|471144342|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
130867700|NCT03573323|471144341|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
130867701|NCT03573323|471144342|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
130867702|NCT00837213|471144352|FG000|Overall Study|Lost to Follow-up|3|||
130867703|NCT00837213|471144353|FG001|Overall Study|Lost to Follow-up|2|||
130867704|NCT00837213|471144352|FG000|Overall Study|Withdrawal by Subject|2|||
130867705|NCT00837213|471144353|FG001|Overall Study|Withdrawal by Subject|2|||
130867706|NCT00837213|471144352|FG000|Overall Study|not stated|1|||
130867707|NCT00837213|471144353|FG001|Overall Study|not stated|1|||
130867708|NCT02698826|471144355|FG000|Overall Study|Death|13|||
130867709|NCT02698826|471144355|FG000|Overall Study|Adverse Event|1|||
130867710|NCT02915263|471144358|FG000|Overall Study|Covid|3|||
130867711|NCT02915263|471144359|FG001|Overall Study|Covid|2|||
130867712|NCT01879683|471144363|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
130867713|NCT04317040|471144366|FG000|Overall Study|Lost to Follow-up|2|||
130867714|NCT04317040|471144367|FG001|Overall Study|Lost to Follow-up|0|||
130867715|NCT04317040|471144366|FG000|Overall Study|Death|16|||
130867716|NCT04317040|471144367|FG001|Overall Study|Death|18|||
130867717|NCT04317040|471144366|FG000|Overall Study|Withdrawal by Subject|0|||
130867718|NCT04317040|471144367|FG001|Overall Study|Withdrawal by Subject|1|||
130867719|NCT04317040|471144366|FG000|Overall Study|Incomplete assessments|0|||
130867720|NCT04317040|471144367|FG001|Overall Study|Incomplete assessments|1|||
130867721|NCT01338818|471144371|FG000|Overall Study|Adverse Event|8|||
130867722|NCT01338818|471144371|FG000|Overall Study|Lack of Efficacy|5|||
130867723|NCT01338818|471144371|FG000|Overall Study|no longer require study drug|1|||
130867724|NCT01338818|471144371|FG000|Overall Study|Withdrawal by Subject|11|||
130867725|NCT01338818|471144371|FG000|Overall Study|Lost to Follow-up|4|||
130867726|NCT01338818|471144371|FG000|Overall Study|Administrative problems|3|||
130867727|NCT01338818|471144371|FG000|Overall Study|Protocol Deviation|4|||
130867728|NCT02868554|471144372|FG000|Overall Study|Lost to Follow-up|3|||
130867729|NCT02868554|471144373|FG001|Overall Study|Lost to Follow-up|0|||
130867730|NCT02868554|471144374|FG002|Overall Study|Lost to Follow-up|1|||
130867731|NCT02714569|471144375|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
130867732|NCT02714569|471144376|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
130867733|NCT02714569|471144377|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
130867734|NCT02714569|471144378|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
130867735|NCT02714569|471144379|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
130867736|NCT02714569|471144380|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
130867737|NCT02714569|471144381|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
130867738|NCT02714569|471144382|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
130867739|NCT02714569|471144383|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
130867740|NCT02714569|471144384|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
130867741|NCT02714569|471144385|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
130867742|NCT02714569|471144375|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130867743|NCT02714569|471144376|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130867744|NCT02714569|471144377|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130867745|NCT02714569|471144378|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
130867746|NCT02714569|471144379|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130867747|NCT02714569|471144380|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130867748|NCT02714569|471144381|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130867749|NCT02714569|471144382|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130867750|NCT02714569|471144383|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130867751|NCT02714569|471144384|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130867752|NCT02714569|471144385|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130867753|NCT02714569|471144375|FG000|Part A Third Intervention|Adverse Event|0|||
130867754|NCT02714569|471144376|FG001|Part A Third Intervention|Adverse Event|0|||
130867755|NCT02714569|471144377|FG002|Part A Third Intervention|Adverse Event|1|||
130867756|NCT02714569|471144378|FG003|Part A Third Intervention|Adverse Event|0|||
130867757|NCT02714569|471144379|FG004|Part A Third Intervention|Adverse Event|0|||
130867758|NCT02714569|471144380|FG005|Part A Third Intervention|Adverse Event|0|||
130867759|NCT02714569|471144381|FG006|Part A Third Intervention|Adverse Event|0|||
130867760|NCT02714569|471144382|FG007|Part A Third Intervention|Adverse Event|0|||
130867761|NCT02714569|471144383|FG008|Part A Third Intervention|Adverse Event|0|||
130867762|NCT02714569|471144384|FG009|Part A Third Intervention|Adverse Event|0|||
130867763|NCT02714569|471144385|FG010|Part A Third Intervention|Adverse Event|0|||
130867764|NCT02714569|471144375|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
130867765|NCT02714569|471144376|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130867766|NCT02714569|471144377|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130867767|NCT02714569|471144378|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130867768|NCT02714569|471144379|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130867769|NCT02714569|471144380|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
130867770|NCT02714569|471144381|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130867771|NCT02714569|471144382|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130867772|NCT02714569|471144383|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130867773|NCT02714569|471144384|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130867774|NCT02714569|471144385|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130867775|NCT02714569|471144375|FG000|Part B (Overall)|Lost to Follow-up|0|||
130867776|NCT02714569|471144376|FG001|Part B (Overall)|Lost to Follow-up|0|||
130867777|NCT02714569|471144377|FG002|Part B (Overall)|Lost to Follow-up|0|||
130867778|NCT02714569|471144378|FG003|Part B (Overall)|Lost to Follow-up|0|||
130867779|NCT02714569|471144379|FG004|Part B (Overall)|Lost to Follow-up|0|||
130867780|NCT02714569|471144380|FG005|Part B (Overall)|Lost to Follow-up|0|||
130867781|NCT02714569|471144381|FG006|Part B (Overall)|Lost to Follow-up|1|||
130867782|NCT02714569|471144382|FG007|Part B (Overall)|Lost to Follow-up|0|||
130867783|NCT02714569|471144383|FG008|Part B (Overall)|Lost to Follow-up|0|||
130867784|NCT02714569|471144384|FG009|Part B (Overall)|Lost to Follow-up|0|||
130867785|NCT02714569|471144385|FG010|Part B (Overall)|Lost to Follow-up|0|||
130867786|NCT02714569|471144375|FG000|Part B (Overall)|Withdrawal by Subject|0|||
130867787|NCT02714569|471144376|FG001|Part B (Overall)|Withdrawal by Subject|0|||
130867788|NCT02714569|471144377|FG002|Part B (Overall)|Withdrawal by Subject|0|||
130867789|NCT02714569|471144378|FG003|Part B (Overall)|Withdrawal by Subject|0|||
130867790|NCT02714569|471144379|FG004|Part B (Overall)|Withdrawal by Subject|0|||
130867791|NCT02714569|471144380|FG005|Part B (Overall)|Withdrawal by Subject|0|||
130867792|NCT02714569|471144381|FG006|Part B (Overall)|Withdrawal by Subject|0|||
130867793|NCT02714569|471144382|FG007|Part B (Overall)|Withdrawal by Subject|1|||
130867794|NCT02714569|471144383|FG008|Part B (Overall)|Withdrawal by Subject|0|||
130867795|NCT02714569|471144384|FG009|Part B (Overall)|Withdrawal by Subject|1|||
130867796|NCT02714569|471144385|FG010|Part B (Overall)|Withdrawal by Subject|0|||
130867797|NCT02714569|471144375|FG000|Part B (Overall)|Adverse Event|0|||
130867798|NCT02714569|471144376|FG001|Part B (Overall)|Adverse Event|0|||
130867799|NCT02714569|471144377|FG002|Part B (Overall)|Adverse Event|0|||
130867800|NCT02714569|471144378|FG003|Part B (Overall)|Adverse Event|0|||
130867801|NCT02714569|471144379|FG004|Part B (Overall)|Adverse Event|0|||
130867802|NCT02714569|471144380|FG005|Part B (Overall)|Adverse Event|0|||
130867803|NCT02714569|471144381|FG006|Part B (Overall)|Adverse Event|0|||
130867804|NCT02714569|471144382|FG007|Part B (Overall)|Adverse Event|0|||
130867805|NCT02714569|471144383|FG008|Part B (Overall)|Adverse Event|0|||
130867806|NCT02714569|471144384|FG009|Part B (Overall)|Adverse Event|1|||
130867807|NCT02714569|471144385|FG010|Part B (Overall)|Adverse Event|0|||
130867808|NCT00191308|471144386|FG000|Overall Study|Adverse Event|1|||
130867809|NCT01843023|471144387|FG000|Overall Study|Death|1|||
130867810|NCT01843023|471144388|FG001|Overall Study|Death|0|||
130867811|NCT01843023|471144387|FG000|Overall Study|Lost to Follow-up|24|||
130867812|NCT01843023|471144388|FG001|Overall Study|Lost to Follow-up|29|||
130867813|NCT01843023|471144387|FG000|Overall Study|Withdrawal by Subject|8|||
130867814|NCT01843023|471144388|FG001|Overall Study|Withdrawal by Subject|6|||
130867815|NCT00779025|471144389|FG000|Overall Study|Withdrawal by Subject|1|||
130867816|NCT03305770|471144390|FG000|Overall Study|Physician Decision - prior to dispense|0|||
130867817|NCT03305770|471144391|FG001|Overall Study|Physician Decision - prior to dispense|1|||
130867818|NCT03305770|471144390|FG000|Overall Study|Subject moved|1|||
130867819|NCT03305770|471144391|FG001|Overall Study|Subject moved|0|||
130867820|NCT01369784|471144397|FG000|Overall Study|Protocol Violation|12|||
130867821|NCT00782717|471144398|FG000|Overall Study|Adverse Event|2|||
130867822|NCT00782717|471144399|FG001|Overall Study|Adverse Event|5|||
130867823|NCT00782717|471144398|FG000|Overall Study|Patient decision unrelated to AE|6|||
130867824|NCT00782717|471144399|FG001|Overall Study|Patient decision unrelated to AE|3|||
130867825|NCT00782717|471144398|FG000|Overall Study|Noncompliance|2|||
130867826|NCT00782717|471144399|FG001|Overall Study|Noncompliance|1|||
130867827|NCT00782717|471144398|FG000|Overall Study|Treatment failure|3|||
130867828|NCT00782717|471144399|FG001|Overall Study|Treatment failure|14|||
130867829|NCT00782717|471144398|FG000|Overall Study|Enrollment close prior to surgery|1|||
130867830|NCT00782717|471144399|FG001|Overall Study|Enrollment close prior to surgery|0|||
130867831|NCT00782717|471144398|FG000|Overall Study|Did not meet entrance criteria|1|||
130867832|NCT00782717|471144399|FG001|Overall Study|Did not meet entrance criteria|3|||
130867833|NCT00782717|471144398|FG000|Overall Study|Exited in error|0|||
130867834|NCT00782717|471144399|FG001|Overall Study|Exited in error|2|||
130867835|NCT02905266|471144400|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
130867836|NCT02905266|471144401|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
130867837|NCT02905266|471144400|FG000|Treatment Phase Part 1|Disease Progression|6|||
130867838|NCT02905266|471144401|FG001|Treatment Phase Part 1|Disease Progression|7|||
130867839|NCT02905266|471144400|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
130867840|NCT02905266|471144401|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
130867841|NCT02905266|471144400|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
130867842|NCT02905266|471144401|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
130867843|NCT02905266|471144400|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
130867844|NCT02905266|471144401|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
130867845|NCT02905266|471144400|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
130867846|NCT02905266|471144401|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
130867847|NCT02905266|471144400|FG000|Transition From Part 1 to Part 2|Death|0|||
130867848|NCT02905266|471144401|FG001|Transition From Part 1 to Part 2|Death|1|||
130867849|NCT02905266|471144400|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
130867850|NCT02905266|471144401|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
130867851|NCT02905266|471144400|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
130867852|NCT02905266|471144401|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
130867853|NCT02905266|471144400|FG000|Maintenance Phase Part 2|Disease Progression|9|||
130867854|NCT02905266|471144401|FG001|Maintenance Phase Part 2|Disease Progression|2|||
130867855|NCT02905266|471144400|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
130867856|NCT02905266|471144401|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
130867857|NCT02905266|471144400|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
130867858|NCT02905266|471144401|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
130867859|NCT02292719|471144407|FG000|Overall Study|Withdrawal by Subject|0|||
130867860|NCT02292719|471144408|FG001|Overall Study|Withdrawal by Subject|0|||
130867861|NCT02292719|471144409|FG002|Overall Study|Withdrawal by Subject|0|||
130867862|NCT02292719|471144410|FG003|Overall Study|Withdrawal by Subject|1|||
130867863|NCT02292719|471144411|FG004|Overall Study|Withdrawal by Subject|1|||
130867864|NCT02292719|471144412|FG005|Overall Study|Withdrawal by Subject|0|||
130867865|NCT02292719|471144407|FG000|Overall Study|Subject enrolled in new study.|0|||
130867866|NCT02292719|471144408|FG001|Overall Study|Subject enrolled in new study.|0|||
130867867|NCT02292719|471144409|FG002|Overall Study|Subject enrolled in new study.|1|||
130867868|NCT02292719|471144410|FG003|Overall Study|Subject enrolled in new study.|0|||
130867869|NCT02292719|471144411|FG004|Overall Study|Subject enrolled in new study.|0|||
130867870|NCT02292719|471144412|FG005|Overall Study|Subject enrolled in new study.|0|||
130867871|NCT02586727|471144418|FG000|Overall Study|Lost to Follow-up|1|||
130867872|NCT02586727|471144419|FG001|Overall Study|Lost to Follow-up|0|||
130867873|NCT04378270|471144421|FG000|Overall Study|Lack of Efficacy|1|||
130867874|NCT04378270|471144421|FG000|Overall Study|Withdrawal by Subject|1|||
130867875|NCT04378270|471144421|FG000|Overall Study|Screen Failure|1|||
130867876|NCT04378270|471144421|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
130867877|NCT01327599|471144422|FG000|Overall Study|Adverse Event|1|||
130867878|NCT01327599|471144422|FG000|Overall Study|Could Not Attend Visit|1|||
130867879|NCT01327599|471144422|FG000|Overall Study|Withdrawal of Consent|1|||
130867880|NCT01132313|471144423|FG000|Overall Study|Lack of Efficacy|1|||
130867881|NCT01132313|471144424|FG001|Overall Study|Lack of Efficacy|0|||
130867882|NCT01132313|471144425|FG002|Overall Study|Lack of Efficacy|0|||
130867883|NCT01132313|471144426|FG003|Overall Study|Lack of Efficacy|0|||
130867884|NCT01132313|471144427|FG004|Overall Study|Lack of Efficacy|0|||
130867885|NCT01132313|471144428|FG005|Overall Study|Lack of Efficacy|0|||
130867886|NCT01132313|471144429|FG006|Overall Study|Lack of Efficacy|0|||
130867887|NCT01132313|471144430|FG007|Overall Study|Lack of Efficacy|3|||
130867888|NCT01132313|471144431|FG008|Overall Study|Lack of Efficacy|14|||
130867889|NCT01132313|471144432|FG009|Overall Study|Lack of Efficacy|16|||
130867890|NCT01132313|471144433|FG010|Overall Study|Lack of Efficacy|0|||
130867891|NCT01132313|471144434|FG011|Overall Study|Lack of Efficacy|0|||
130867892|NCT01132313|471144423|FG000|Overall Study|Not treated|2|||
130867893|NCT01132313|471144424|FG001|Overall Study|Not treated|0|||
130867894|NCT01132313|471144425|FG002|Overall Study|Not treated|0|||
130867895|NCT01132313|471144426|FG003|Overall Study|Not treated|0|||
130867896|NCT01132313|471144427|FG004|Overall Study|Not treated|2|||
130867897|NCT01132313|471144428|FG005|Overall Study|Not treated|1|||
130867898|NCT01132313|471144429|FG006|Overall Study|Not treated|3|||
130867899|NCT01132313|471144430|FG007|Overall Study|Not treated|0|||
130867900|NCT01132313|471144431|FG008|Overall Study|Not treated|0|||
130867901|NCT01132313|471144432|FG009|Overall Study|Not treated|0|||
130867902|NCT01132313|471144433|FG010|Overall Study|Not treated|0|||
130867903|NCT01132313|471144434|FG011|Overall Study|Not treated|0|||
130867904|NCT01132313|471144423|FG000|Overall Study|Adverse Event|0|||
130867905|NCT01132313|471144424|FG001|Overall Study|Adverse Event|0|||
130867906|NCT01132313|471144425|FG002|Overall Study|Adverse Event|4|||
130867907|NCT01132313|471144426|FG003|Overall Study|Adverse Event|10|||
130867908|NCT01132313|471144427|FG004|Overall Study|Adverse Event|19|||
130867909|NCT01132313|471144428|FG005|Overall Study|Adverse Event|6|||
130867910|NCT01132313|471144429|FG006|Overall Study|Adverse Event|5|||
130867911|NCT01132313|471144430|FG007|Overall Study|Adverse Event|3|||
130867912|NCT01132313|471144431|FG008|Overall Study|Adverse Event|7|||
130867913|NCT01132313|471144432|FG009|Overall Study|Adverse Event|2|||
130867914|NCT01132313|471144433|FG010|Overall Study|Adverse Event|0|||
130867915|NCT01132313|471144434|FG011|Overall Study|Adverse Event|0|||
130867916|NCT01132313|471144423|FG000|Overall Study|Protocol Violation|0|||
130867917|NCT01132313|471144424|FG001|Overall Study|Protocol Violation|0|||
130867918|NCT01132313|471144425|FG002|Overall Study|Protocol Violation|0|||
130867919|NCT01132313|471144426|FG003|Overall Study|Protocol Violation|1|||
130867920|NCT01132313|471144427|FG004|Overall Study|Protocol Violation|0|||
130867921|NCT01132313|471144428|FG005|Overall Study|Protocol Violation|0|||
130867922|NCT01132313|471144429|FG006|Overall Study|Protocol Violation|0|||
130867923|NCT01132313|471144430|FG007|Overall Study|Protocol Violation|0|||
130867924|NCT01132313|471144431|FG008|Overall Study|Protocol Violation|0|||
130867925|NCT01132313|471144432|FG009|Overall Study|Protocol Violation|0|||
130867926|NCT01132313|471144433|FG010|Overall Study|Protocol Violation|0|||
130867927|NCT01132313|471144434|FG011|Overall Study|Protocol Violation|0|||
130867928|NCT01132313|471144423|FG000|Overall Study|Lost to Follow-up|0|||
130867929|NCT01132313|471144424|FG001|Overall Study|Lost to Follow-up|0|||
130867930|NCT01132313|471144425|FG002|Overall Study|Lost to Follow-up|1|||
130867931|NCT01132313|471144426|FG003|Overall Study|Lost to Follow-up|0|||
130867932|NCT01132313|471144427|FG004|Overall Study|Lost to Follow-up|0|||
130867933|NCT01132313|471144428|FG005|Overall Study|Lost to Follow-up|0|||
130867934|NCT01132313|471144429|FG006|Overall Study|Lost to Follow-up|0|||
130867935|NCT01132313|471144430|FG007|Overall Study|Lost to Follow-up|1|||
130867936|NCT01132313|471144431|FG008|Overall Study|Lost to Follow-up|0|||
130867937|NCT01132313|471144432|FG009|Overall Study|Lost to Follow-up|0|||
130867938|NCT01132313|471144433|FG010|Overall Study|Lost to Follow-up|0|||
130867939|NCT01132313|471144434|FG011|Overall Study|Lost to Follow-up|0|||
130867940|NCT01132313|471144423|FG000|Overall Study|Withdrawal by Subject|0|||
130867941|NCT01132313|471144424|FG001|Overall Study|Withdrawal by Subject|0|||
130867942|NCT01132313|471144425|FG002|Overall Study|Withdrawal by Subject|3|||
130867943|NCT01132313|471144426|FG003|Overall Study|Withdrawal by Subject|3|||
130867944|NCT01132313|471144427|FG004|Overall Study|Withdrawal by Subject|6|||
130867945|NCT01132313|471144428|FG005|Overall Study|Withdrawal by Subject|0|||
130867946|NCT01132313|471144429|FG006|Overall Study|Withdrawal by Subject|1|||
130867947|NCT01132313|471144430|FG007|Overall Study|Withdrawal by Subject|0|||
130867948|NCT01132313|471144431|FG008|Overall Study|Withdrawal by Subject|0|||
130867949|NCT01132313|471144432|FG009|Overall Study|Withdrawal by Subject|2|||
130867950|NCT01132313|471144433|FG010|Overall Study|Withdrawal by Subject|0|||
130867951|NCT01132313|471144434|FG011|Overall Study|Withdrawal by Subject|0|||
130867952|NCT01132313|471144423|FG000|Overall Study|Lack of antiviral response|0|||
130867953|NCT01132313|471144424|FG001|Overall Study|Lack of antiviral response|0|||
130867954|NCT01132313|471144425|FG002|Overall Study|Lack of antiviral response|12|||
130867955|NCT01132313|471144426|FG003|Overall Study|Lack of antiviral response|18|||
130867956|NCT01132313|471144427|FG004|Overall Study|Lack of antiviral response|18|||
130867957|NCT01132313|471144428|FG005|Overall Study|Lack of antiviral response|18|||
130867958|NCT01132313|471144429|FG006|Overall Study|Lack of antiviral response|21|||
130867959|NCT01132313|471144430|FG007|Overall Study|Lack of antiviral response|0|||
130867960|NCT01132313|471144431|FG008|Overall Study|Lack of antiviral response|0|||
130867961|NCT01132313|471144432|FG009|Overall Study|Lack of antiviral response|0|||
130867962|NCT01132313|471144433|FG010|Overall Study|Lack of antiviral response|1|||
130867963|NCT01132313|471144434|FG011|Overall Study|Lack of antiviral response|0|||
130867964|NCT01132313|471144423|FG000|Overall Study|Other reason not defined above|0|||
130867965|NCT01132313|471144424|FG001|Overall Study|Other reason not defined above|0|||
130867966|NCT01132313|471144425|FG002|Overall Study|Other reason not defined above|0|||
130867967|NCT01132313|471144426|FG003|Overall Study|Other reason not defined above|0|||
130867968|NCT01132313|471144427|FG004|Overall Study|Other reason not defined above|0|||
130867969|NCT01132313|471144428|FG005|Overall Study|Other reason not defined above|0|||
130867970|NCT01132313|471144429|FG006|Overall Study|Other reason not defined above|0|||
130867971|NCT01132313|471144430|FG007|Overall Study|Other reason not defined above|1|||
130867972|NCT01132313|471144431|FG008|Overall Study|Other reason not defined above|0|||
130867973|NCT01132313|471144432|FG009|Overall Study|Other reason not defined above|0|||
130867974|NCT01132313|471144433|FG010|Overall Study|Other reason not defined above|0|||
130867975|NCT01132313|471144434|FG011|Overall Study|Other reason not defined above|0|||
130867976|NCT03201419|471144435|FG000|Overall Study|Adverse Event|3|||
130867977|NCT03201419|471144436|FG001|Overall Study|Adverse Event|1|||
130867978|NCT03201419|471144437|FG002|Overall Study|Adverse Event|0|||
130867979|NCT03201419|471144438|FG003|Overall Study|Adverse Event|0|||
130867980|NCT03201419|471144439|FG004|Overall Study|Adverse Event|1|||
130867981|NCT03201419|471144440|FG005|Overall Study|Adverse Event|1|||
130867982|NCT03201419|471144441|FG006|Overall Study|Adverse Event|5|||
130867983|NCT03201419|471144442|FG007|Overall Study|Adverse Event|0|||
130867984|NCT03201419|471144443|FG008|Overall Study|Adverse Event|0|||
130867985|NCT03201419|471144435|FG000|Overall Study|Lost to Follow-up|1|||
130867986|NCT03201419|471144436|FG001|Overall Study|Lost to Follow-up|0|||
130867987|NCT03201419|471144437|FG002|Overall Study|Lost to Follow-up|0|||
130867988|NCT03201419|471144438|FG003|Overall Study|Lost to Follow-up|0|||
130867989|NCT03201419|471144439|FG004|Overall Study|Lost to Follow-up|0|||
130867990|NCT03201419|471144440|FG005|Overall Study|Lost to Follow-up|0|||
130867991|NCT03201419|471144441|FG006|Overall Study|Lost to Follow-up|0|||
130867992|NCT03201419|471144442|FG007|Overall Study|Lost to Follow-up|0|||
130867993|NCT03201419|471144443|FG008|Overall Study|Lost to Follow-up|0|||
130867994|NCT03201419|471144435|FG000|Overall Study|Protocol Deviation|0|||
130867995|NCT03201419|471144436|FG001|Overall Study|Protocol Deviation|0|||
130867996|NCT03201419|471144437|FG002|Overall Study|Protocol Deviation|0|||
130867997|NCT03201419|471144438|FG003|Overall Study|Protocol Deviation|0|||
130867998|NCT03201419|471144439|FG004|Overall Study|Protocol Deviation|0|||
130867999|NCT03201419|471144440|FG005|Overall Study|Protocol Deviation|0|||
130868000|NCT03201419|471144441|FG006|Overall Study|Protocol Deviation|1|||
130868001|NCT03201419|471144442|FG007|Overall Study|Protocol Deviation|0|||
130868002|NCT03201419|471144443|FG008|Overall Study|Protocol Deviation|0|||
130868003|NCT03201419|471144435|FG000|Overall Study|Withdrawal by Subject|4|||
130868004|NCT03201419|471144436|FG001|Overall Study|Withdrawal by Subject|2|||
130868005|NCT03201419|471144437|FG002|Overall Study|Withdrawal by Subject|1|||
130868006|NCT03201419|471144438|FG003|Overall Study|Withdrawal by Subject|0|||
130868007|NCT03201419|471144439|FG004|Overall Study|Withdrawal by Subject|0|||
130868008|NCT03201419|471144440|FG005|Overall Study|Withdrawal by Subject|0|||
130868009|NCT03201419|471144441|FG006|Overall Study|Withdrawal by Subject|0|||
130868010|NCT03201419|471144442|FG007|Overall Study|Withdrawal by Subject|1|||
130868011|NCT03201419|471144443|FG008|Overall Study|Withdrawal by Subject|2|||
130868012|NCT03201419|471144435|FG000|Overall Study|Other|0|||
130868013|NCT03201419|471144436|FG001|Overall Study|Other|0|||
130868014|NCT03201419|471144437|FG002|Overall Study|Other|1|||
130868015|NCT03201419|471144438|FG003|Overall Study|Other|0|||
130868016|NCT03201419|471144439|FG004|Overall Study|Other|0|||
130868017|NCT03201419|471144440|FG005|Overall Study|Other|0|||
130868018|NCT03201419|471144441|FG006|Overall Study|Other|0|||
130868019|NCT03201419|471144442|FG007|Overall Study|Other|0|||
130868020|NCT03201419|471144443|FG008|Overall Study|Other|0|||
130868021|NCT00434109|471144444|FG000|Overall Study|Physician Decision|9|||
130868022|NCT00434109|471144444|FG000|Overall Study|Adverse Event|5|||
130868023|NCT00434109|471144444|FG000|Overall Study|Protocol Violation|1|||
130868024|NCT00434109|471144444|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
130868025|NCT00859547|471146598|FG000|Overall Study|Lost to Follow-up|1|||
130868026|NCT00859547|471146598|FG000|Overall Study|Parent withdrew consent|1|||
130868027|NCT03310723|471146599|FG000|Overall Study|Withdrawal by Subject|0|||
130868028|NCT03310723|471146600|FG001|Overall Study|Withdrawal by Subject|1|||
130868029|NCT03310723|471146599|FG000|Overall Study|Protocol Violation|0|||
130868030|NCT03310723|471146600|FG001|Overall Study|Protocol Violation|2|||
130868031|NCT02098746|471146601|FG000|Overall Study|Changes of Investigator|2|||
130868032|NCT02098746|471146601|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130868033|NCT02098746|471146601|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
130868034|NCT02098746|471146601|FG000|Overall Study|Data Not Available After Treatment|1|||
130868035|NCT01367834|471146602|FG000|Overall Study|Withdrawal by Subject|2|||
130868036|NCT01367834|471146603|FG001|Overall Study|Withdrawal by Subject|2|||
130868037|NCT01367834|471146602|FG000|Overall Study|Study was ended.|0|||
130868038|NCT01367834|471146603|FG001|Overall Study|Study was ended.|1|||
130868039|NCT03801174|471146611|FG000|Overall Study|Withdrawal by Subject|14|||
130868040|NCT03801174|471146612|FG001|Overall Study|Withdrawal by Subject|15|||
130868041|NCT03801174|471146611|FG000|Overall Study|Death|1|||
130868042|NCT03801174|471146612|FG001|Overall Study|Death|0|||
130868043|NCT03801174|471146611|FG000|Overall Study|Pregnancy|2|||
130868044|NCT03801174|471146612|FG001|Overall Study|Pregnancy|2|||
130868045|NCT03801174|471146611|FG000|Overall Study|Lost to Follow-up|19|||
130868046|NCT03801174|471146612|FG001|Overall Study|Lost to Follow-up|10|||
130868047|NCT03801174|471146611|FG000|Overall Study|Other|4|||
130868048|NCT03801174|471146612|FG001|Overall Study|Other|3|||
130868049|NCT03801174|471146611|FG000|Overall Study|Lack of Efficacy|4|||
130868050|NCT03801174|471146612|FG001|Overall Study|Lack of Efficacy|0|||
130868051|NCT03801174|471146611|FG000|Overall Study|Unwilling to complete activities|5|||
130868052|NCT03801174|471146612|FG001|Overall Study|Unwilling to complete activities|6|||
130868053|NCT03801174|471146611|FG000|Overall Study|Moved out of area|3|||
130868054|NCT03801174|471146612|FG001|Overall Study|Moved out of area|0|||
130868055|NCT00337207|471146617|FG000|Overall Study|Withdrawal by Subject|3|||
130868056|NCT01618669|471146618|FG000|Overall Study|Lost to Follow-up|1|||
130868057|NCT01618669|471146619|FG001|Overall Study|Lost to Follow-up|1|||
130868058|NCT01618669|471146618|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
130868059|NCT01618669|471146619|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
130868060|NCT01618669|471146618|FG000|Overall Study|Adverse Event|16|||
130868061|NCT01618669|471146619|FG001|Overall Study|Adverse Event|7|||
130868062|NCT01618669|471146618|FG000|Overall Study|Protocol Violation|5|||
130868063|NCT01618669|471146619|FG001|Overall Study|Protocol Violation|3|||
130868064|NCT01618669|471146618|FG000|Overall Study|Withdrawal by Subject|9|||
130868065|NCT01618669|471146619|FG001|Overall Study|Withdrawal by Subject|9|||
130868066|NCT01618669|471146618|FG000|Overall Study|Miscellaneous Reason|0|||
130868067|NCT01618669|471146619|FG001|Overall Study|Miscellaneous Reason|1|||
130868068|NCT01177007|471146620|FG000|Overall Study|Lost to Follow-up|2|||
130868069|NCT01177007|471146620|FG000|Overall Study|Death|4|||
130868070|NCT01177007|471146620|FG000|Overall Study|Entered hospice care|5|||
130868071|NCT01177007|471146620|FG000|Overall Study|Required additional Y90 treatment|6|||
130868072|NCT01177007|471146620|FG000|Overall Study|Change in treatment modality|21|||
130868073|NCT01702558|471146624|FG000|Overall Study|Withdrawal by Subject|0|||
130868074|NCT01702558|471146625|FG001|Overall Study|Withdrawal by Subject|0|||
130868075|NCT01702558|471146626|FG002|Overall Study|Withdrawal by Subject|0|||
130868076|NCT01702558|471146627|FG003|Overall Study|Withdrawal by Subject|12|||
130868077|NCT01702558|471146628|FG004|Overall Study|Withdrawal by Subject|4|||
130868078|NCT01702558|471146624|FG000|Overall Study|Lost to Follow-up|0|||
130868079|NCT01702558|471146625|FG001|Overall Study|Lost to Follow-up|0|||
130868080|NCT01702558|471146626|FG002|Overall Study|Lost to Follow-up|0|||
130868081|NCT01702558|471146627|FG003|Overall Study|Lost to Follow-up|3|||
130868082|NCT01702558|471146628|FG004|Overall Study|Lost to Follow-up|0|||
130868083|NCT01702558|471146624|FG000|Overall Study|Death|4|||
130868084|NCT01702558|471146625|FG001|Overall Study|Death|3|||
130868085|NCT01702558|471146626|FG002|Overall Study|Death|3|||
130868086|NCT01702558|471146627|FG003|Overall Study|Death|16|||
130868087|NCT01702558|471146628|FG004|Overall Study|Death|20|||
130868088|NCT01702558|471146624|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
130868089|NCT01702558|471146625|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
130868090|NCT01702558|471146626|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
130868091|NCT01702558|471146627|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
130868092|NCT01702558|471146628|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
130868093|NCT01702558|471146624|FG000|Overall Study|Study Terminated by Sponsor|0|||
130868094|NCT01702558|471146625|FG001|Overall Study|Study Terminated by Sponsor|1|||
130868095|NCT01702558|471146626|FG002|Overall Study|Study Terminated by Sponsor|0|||
130868096|NCT01702558|471146627|FG003|Overall Study|Study Terminated by Sponsor|0|||
130868097|NCT01702558|471146628|FG004|Overall Study|Study Terminated by Sponsor|1|||
130868098|NCT01702558|471146624|FG000|Overall Study|Other|0|||
130868099|NCT01702558|471146625|FG001|Overall Study|Other|0|||
130868100|NCT01702558|471146626|FG002|Overall Study|Other|0|||
130868101|NCT01702558|471146627|FG003|Overall Study|Other|16|||
130868102|NCT01702558|471146628|FG004|Overall Study|Other|17|||
130868103|NCT03259087|471146633|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130868104|NCT03259087|471146634|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130868105|NCT03259087|471146635|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130868106|NCT03259087|471146636|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130868107|NCT03259087|471146637|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
130868108|NCT03259087|471146633|FG000|Period 2 of Part 2|Adverse Event|0|||
130868109|NCT03259087|471146634|FG001|Period 2 of Part 2|Adverse Event|0|||
130868110|NCT03259087|471146635|FG002|Period 2 of Part 2|Adverse Event|0|||
130868111|NCT03259087|471146636|FG003|Period 2 of Part 2|Adverse Event|0|||
130868112|NCT03259087|471146637|FG004|Period 2 of Part 2|Adverse Event|1|||
130868113|NCT04950465|471146638|FG000|Overall Study|Lost to Follow-up|1|||
130868114|NCT04950465|471146639|FG001|Overall Study|Lost to Follow-up|0|||
130868115|NCT04950465|471146640|FG002|Overall Study|Lost to Follow-up|0|||
130868116|NCT02366195|471146644|FG000|Overall Study|Protocol-specified criteria|3|||
130868117|NCT02366195|471146644|FG000|Overall Study|Withdrawal by Subject|9|||
130868118|NCT02366195|471146644|FG000|Overall Study|Lost to Follow-up|1|||
130868119|NCT02366195|471146644|FG000|Overall Study|Death|41|||
130868120|NCT01788566|471146645|FG000|Overall Study|Death|4|||
130868121|NCT01788566|471146645|FG000|Overall Study|Adverse Event|1|||
130868122|NCT01788566|471146645|FG000|Overall Study|Clinical Progressive Disease|3|||
130868123|NCT01620086|471146648|FG000|Overall Study|Withdrawal by Subject|3|||
130868124|NCT01620086|471146649|FG001|Overall Study|Withdrawal by Subject|3|||
130868125|NCT01620086|471146650|FG002|Overall Study|Withdrawal by Subject|0|||
130868126|NCT01620086|471146648|FG000|Overall Study|failed study criteria|1|||
130868127|NCT01620086|471146649|FG001|Overall Study|failed study criteria|4|||
130868128|NCT01620086|471146650|FG002|Overall Study|failed study criteria|0|||
130868129|NCT01620086|471146648|FG000|Overall Study|Physician Decision|1|||
130868130|NCT01620086|471146649|FG001|Overall Study|Physician Decision|0|||
130868131|NCT01620086|471146650|FG002|Overall Study|Physician Decision|0|||
130868132|NCT01695135|471146651|FG000|Double-blind Treatment Phase|Progressive disease|50|||
130868133|NCT01695135|471146652|FG001|Double-blind Treatment Phase|Progressive disease|110|||
130868134|NCT01695135|471146653|FG002|Double-blind Treatment Phase|Progressive disease|0|||
130868135|NCT01695135|471146654|FG003|Double-blind Treatment Phase|Progressive disease|0|||
130868136|NCT01695135|471146651|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
130868137|NCT01695135|471146652|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
130868138|NCT01695135|471146653|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130868139|NCT01695135|471146654|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130868140|NCT01695135|471146651|FG000|Double-blind Treatment Phase|Adverse Event|7|||
130868141|NCT01695135|471146652|FG001|Double-blind Treatment Phase|Adverse Event|7|||
130868142|NCT01695135|471146653|FG002|Double-blind Treatment Phase|Adverse Event|0|||
130868143|NCT01695135|471146654|FG003|Double-blind Treatment Phase|Adverse Event|0|||
130868144|NCT01695135|471146651|FG000|Double-blind Treatment Phase|Other|1|||
130868145|NCT01695135|471146652|FG001|Double-blind Treatment Phase|Other|3|||
130868146|NCT01695135|471146653|FG002|Double-blind Treatment Phase|Other|0|||
130868147|NCT01695135|471146654|FG003|Double-blind Treatment Phase|Other|0|||
130868148|NCT01695135|471146651|FG000|Double-blind Treatment Phase|Physician Decision|6|||
130868149|NCT01695135|471146652|FG001|Double-blind Treatment Phase|Physician Decision|3|||
130868150|NCT01695135|471146653|FG002|Double-blind Treatment Phase|Physician Decision|0|||
130868151|NCT01695135|471146654|FG003|Double-blind Treatment Phase|Physician Decision|0|||
130868152|NCT01695135|471146651|FG000|Double-blind Treatment Phase|Death|1|||
130868153|NCT01695135|471146652|FG001|Double-blind Treatment Phase|Death|1|||
130868154|NCT01695135|471146653|FG002|Double-blind Treatment Phase|Death|0|||
130868155|NCT01695135|471146654|FG003|Double-blind Treatment Phase|Death|0|||
130868156|NCT01695135|471146651|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
130868157|NCT01695135|471146652|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
130868158|NCT01695135|471146653|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
130868159|NCT01695135|471146654|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
130868160|NCT01695135|471146651|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
130868161|NCT01695135|471146652|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
130868162|NCT01695135|471146653|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
130868163|NCT01695135|471146654|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
130868164|NCT01695135|471146651|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
130868165|NCT01695135|471146652|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
130868166|NCT01695135|471146653|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
130868167|NCT01695135|471146654|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
130868168|NCT01695135|471146651|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
130868169|NCT01695135|471146652|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
130868170|NCT01695135|471146653|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
130868171|NCT01695135|471146654|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
130868172|NCT01695135|471146651|FG000|Open Label Extension Treatment Phase|Other|0|||
130868173|NCT01695135|471146652|FG001|Open Label Extension Treatment Phase|Other|0|||
130868174|NCT01695135|471146653|FG002|Open Label Extension Treatment Phase|Other|4|||
130868175|NCT01695135|471146654|FG003|Open Label Extension Treatment Phase|Other|7|||
130868176|NCT01695135|471146651|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
130868177|NCT01695135|471146652|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
130868178|NCT01695135|471146653|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
130868179|NCT01695135|471146654|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
130868180|NCT01695135|471146651|FG000|Open Label Extension Treatment Phase|Death|0|||
130868181|NCT01695135|471146652|FG001|Open Label Extension Treatment Phase|Death|0|||
130868182|NCT01695135|471146653|FG002|Open Label Extension Treatment Phase|Death|2|||
130868183|NCT01695135|471146654|FG003|Open Label Extension Treatment Phase|Death|7|||
130868184|NCT01695135|471146651|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
130868185|NCT01695135|471146652|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
130868186|NCT01695135|471146653|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
130868187|NCT01695135|471146654|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
130868188|NCT02562716|471146655|FG000|Overall Study|Adverse Event|7|||
130868189|NCT02562716|471146656|FG001|Overall Study|Adverse Event|14|||
130868190|NCT02562716|471146655|FG000|Overall Study|Withdrawal unrelated to AE|7|||
130868191|NCT02562716|471146656|FG001|Overall Study|Withdrawal unrelated to AE|1|||
130868192|NCT02562716|471146655|FG000|Overall Study|Progression|8|||
130868193|NCT02562716|471146656|FG001|Overall Study|Progression|10|||
130868194|NCT02562716|471146655|FG000|Overall Study|Death|2|||
130868195|NCT02562716|471146656|FG001|Overall Study|Death|1|||
130868196|NCT02562716|471146655|FG000|Overall Study|Not protocol specified|4|||
130868197|NCT02562716|471146656|FG001|Overall Study|Not protocol specified|2|||
130868198|NCT00684996|471146657|FG000|Overall Study|Adverse Event|1|||
130868199|NCT00684996|471146657|FG000|Overall Study|Refusal unrelated to adverse event|1|||
130868200|NCT00684996|471146657|FG000|Overall Study|Progression/relapse|2|||
130868201|NCT00684996|471146657|FG000|Overall Study|Other reasons not protocol specified|1|||
130868202|NCT03030417|471146660|FG000|Dose Expansion|Disease progression before treatment|0|||
130868203|NCT03030417|471146661|FG001|Dose Expansion|Disease progression before treatment|0|||
130868204|NCT03030417|471146662|FG002|Dose Expansion|Disease progression before treatment|0|||
130868205|NCT03030417|471146663|FG003|Dose Expansion|Disease progression before treatment|0|||
130868206|NCT03030417|471146664|FG004|Dose Expansion|Disease progression before treatment|0|||
130868207|NCT03030417|471146665|FG005|Dose Expansion|Disease progression before treatment|0|||
130868208|NCT03030417|471146666|FG006|Dose Expansion|Disease progression before treatment|0|||
130868209|NCT03030417|471146667|FG007|Dose Expansion|Disease progression before treatment|0|||
130868210|NCT03030417|471146668|FG008|Dose Expansion|Disease progression before treatment|0|||
130868211|NCT03030417|471146669|FG009|Dose Expansion|Disease progression before treatment|0|||
130868212|NCT03030417|471146670|FG010|Dose Expansion|Disease progression before treatment|0|||
130868213|NCT03030417|471146671|FG011|Dose Expansion|Disease progression before treatment|0|||
130868214|NCT03030417|471146672|FG012|Dose Expansion|Disease progression before treatment|1|||
130868215|NCT01539759|471146673|FG000|Overall Study|Lost to Follow-up|6|||
130868216|NCT01539759|471146674|FG001|Overall Study|Lost to Follow-up|8|||
130868217|NCT01076959|471146675|FG000|Overall Study|Adverse Event|767|||
130868218|NCT01076959|471146675|FG000|Overall Study|Lack of Efficacy|849|||
130868219|NCT01076959|471146675|FG000|Overall Study|Non-compliance|274|||
130868220|NCT01076959|471146675|FG000|Overall Study|Lost to Follow-up|241|||
130868221|NCT01076959|471146675|FG000|Overall Study|Other|119|||
130868222|NCT01078441|471146676|FG000|Overall Study|Withdrawal by Subject|1|||
130868223|NCT01425801|471146677|FG000|Period 1|Withdrawal by Subject|0|||
130868224|NCT01425801|471146678|FG001|Period 1|Withdrawal by Subject|0|||
130868225|NCT01425801|471146679|FG002|Period 1|Withdrawal by Subject|0|||
130868226|NCT01425801|471146680|FG003|Period 1|Withdrawal by Subject|0|||
130868227|NCT01425801|471146681|FG004|Period 1|Withdrawal by Subject|1|||
130868228|NCT01425801|471146682|FG005|Period 1|Withdrawal by Subject|0|||
130868229|NCT01425801|471146677|FG000|Period 2|Withdrawal by Subject|0|||
130868230|NCT01425801|471146678|FG001|Period 2|Withdrawal by Subject|0|||
130868231|NCT01425801|471146679|FG002|Period 2|Withdrawal by Subject|0|||
130868232|NCT01425801|471146680|FG003|Period 2|Withdrawal by Subject|0|||
130868233|NCT01425801|471146681|FG004|Period 2|Withdrawal by Subject|1|||
130868234|NCT01425801|471146682|FG005|Period 2|Withdrawal by Subject|0|||
130868235|NCT01425801|471146677|FG000|Period 3|Stability criteria not fullfilled|0|||
130868236|NCT01425801|471146678|FG001|Period 3|Stability criteria not fullfilled|0|||
130868237|NCT01425801|471146679|FG002|Period 3|Stability criteria not fullfilled|1|||
130868238|NCT01425801|471146680|FG003|Period 3|Stability criteria not fullfilled|0|||
130868239|NCT01425801|471146681|FG004|Period 3|Stability criteria not fullfilled|0|||
130868240|NCT01425801|471146682|FG005|Period 3|Stability criteria not fullfilled|0|||
130868241|NCT01425801|471146677|FG000|Period 4|Not able to maintain visit schedule|0|||
130868242|NCT01425801|471146678|FG001|Period 4|Not able to maintain visit schedule|0|||
130868243|NCT01425801|471146679|FG002|Period 4|Not able to maintain visit schedule|1|||
130868244|NCT01425801|471146680|FG003|Period 4|Not able to maintain visit schedule|0|||
130868245|NCT01425801|471146681|FG004|Period 4|Not able to maintain visit schedule|0|||
130868246|NCT01425801|471146682|FG005|Period 4|Not able to maintain visit schedule|0|||
130868247|NCT02175017|471146683|FG000|Overall Study|Did not receive the investigational product|1|||
130868248|NCT02175017|471146684|FG001|Overall Study|Did not receive the investigational product|2|||
130868249|NCT02175017|471146683|FG000|Overall Study|Withdrawal by Subject|6|||
130868250|NCT02175017|471146684|FG001|Overall Study|Withdrawal by Subject|3|||
130868251|NCT02175017|471146683|FG000|Overall Study|Met an exclusion criteria|0|||
130868252|NCT02175017|471146684|FG001|Overall Study|Met an exclusion criteria|1|||
130868253|NCT02175017|471146683|FG000|Overall Study|Adverse Event|3|||
130868254|NCT02175017|471146684|FG001|Overall Study|Adverse Event|10|||
130868255|NCT02175017|471146683|FG000|Overall Study|Disease progression|20|||
130868256|NCT02175017|471146684|FG001|Overall Study|Disease progression|27|||
130868257|NCT02175017|471146683|FG000|Overall Study|Other than above reasons|3|||
130868258|NCT02175017|471146684|FG001|Overall Study|Other than above reasons|0|||
130868259|NCT02491983|471146685|FG000|Overall Study|Physician Decision|1|||
130868260|NCT02491983|471146686|FG001|Overall Study|Physician Decision|0|||
130868261|NCT02491983|471146685|FG000|Overall Study|Not meet selection criteria|1|||
130868262|NCT02491983|471146686|FG001|Overall Study|Not meet selection criteria|0|||
130868263|NCT02491983|471146685|FG000|Overall Study|Withdrawal by Subject|0|||
130868264|NCT02491983|471146686|FG001|Overall Study|Withdrawal by Subject|1|||
130868265|NCT04915729|471146687|FG000|Overall Study|Lost to Follow-up|20|||
130868266|NCT04915729|471146688|FG001|Overall Study|Lost to Follow-up|10|||
130868267|NCT04915729|471146687|FG000|Overall Study|Withdrawal by Subject|12|||
130868268|NCT04915729|471146688|FG001|Overall Study|Withdrawal by Subject|5|||
130868269|NCT04915729|471146687|FG000|Overall Study|Death|34|||
130868270|NCT04915729|471146688|FG001|Overall Study|Death|44|||
130868271|NCT04915729|471146687|FG000|Overall Study|not treated|3|||
130868272|NCT04915729|471146688|FG001|Overall Study|not treated|6|||
130868273|NCT04915729|471146687|FG000|Overall Study|Investigator removed subject|1|||
130868274|NCT04915729|471146688|FG001|Overall Study|Investigator removed subject|2|||
130868275|NCT04915729|471146687|FG000|Overall Study|questionnaire result not evaluated|1|||
130868276|NCT04915729|471146688|FG001|Overall Study|questionnaire result not evaluated|0|||
130868277|NCT04915729|471146687|FG000|Overall Study|refuse of hospital visit|1|||
130868278|NCT04915729|471146688|FG001|Overall Study|refuse of hospital visit|3|||
130868279|NCT04915729|471146687|FG000|Overall Study|Subject withdrew|1|||
130868280|NCT04915729|471146688|FG001|Overall Study|Subject withdrew|0|||
130868281|NCT01684202|471146689|FG000|Dose-escalation Period|Adverse Event|0|||
130868282|NCT01684202|471146690|FG001|Dose-escalation Period|Adverse Event|1|||
130868283|NCT01684202|471146691|FG002|Dose-escalation Period|Adverse Event|0|||
130868284|NCT01684202|471146692|FG003|Dose-escalation Period|Adverse Event|0|||
130868285|NCT01684202|471146689|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
130868286|NCT01684202|471146690|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
130868287|NCT01684202|471146691|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
130868288|NCT01684202|471146692|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
130868289|NCT01684202|471146689|FG000|Maintenance Period|Adverse Event|1|||
130868290|NCT01684202|471146690|FG001|Maintenance Period|Adverse Event|1|||
130868291|NCT01684202|471146691|FG002|Maintenance Period|Adverse Event|1|||
130868292|NCT01684202|471146692|FG003|Maintenance Period|Adverse Event|1|||
130868293|NCT01684202|471146689|FG000|Maintenance Period|Physician Decision|0|||
130868294|NCT01684202|471146690|FG001|Maintenance Period|Physician Decision|1|||
130868295|NCT01684202|471146691|FG002|Maintenance Period|Physician Decision|0|||
130868296|NCT01684202|471146692|FG003|Maintenance Period|Physician Decision|0|||
130868297|NCT01684202|471146689|FG000|Maintenance Period|Withdrawal by Subject|0|||
130868298|NCT01684202|471146690|FG001|Maintenance Period|Withdrawal by Subject|1|||
130868299|NCT01684202|471146691|FG002|Maintenance Period|Withdrawal by Subject|0|||
130868300|NCT01684202|471146692|FG003|Maintenance Period|Withdrawal by Subject|0|||
130868301|NCT03710642|471146696|FG000|Overall Study|Adverse Event|5|||
130868302|NCT03710642|471146697|FG001|Overall Study|Adverse Event|1|||
130868303|NCT03710642|471146696|FG000|Overall Study|non-site physician recommendation|1|||
130868304|NCT03710642|471146697|FG001|Overall Study|non-site physician recommendation|0|||
130868305|NCT03710642|471146696|FG000|Overall Study|Participant unwilling or unable to participate|1|||
130868306|NCT03710642|471146697|FG001|Overall Study|Participant unwilling or unable to participate|1|||
130868307|NCT03710642|471146696|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
130868308|NCT03710642|471146697|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
130868309|NCT03710642|471146696|FG000|Overall Study|NA-no code provided|1|||
130868310|NCT03710642|471146697|FG001|Overall Study|NA-no code provided|0|||
130868311|NCT03710642|471146696|FG000|Overall Study|Withdrawal by Subject|1|||
130868312|NCT03710642|471146697|FG001|Overall Study|Withdrawal by Subject|0|||
130868313|NCT02741635|471146700|FG000|Overall Study|Withdrawal by Subject|1|||
130868314|NCT01427933|471146704|FG000|Overall Study|Withdrawal by Subject|5|||
130868315|NCT01427933|471146705|FG001|Overall Study|Withdrawal by Subject|8|||
130868316|NCT01427933|471146704|FG000|Overall Study|Lost to Follow-up|1|||
130868317|NCT01427933|471146705|FG001|Overall Study|Lost to Follow-up|5|||
130868318|NCT01427933|471146704|FG000|Overall Study|Other|1|||
130868319|NCT01427933|471146705|FG001|Overall Study|Other|0|||
130868320|NCT01427933|471146704|FG000|Overall Study|Investigator's Decision|1|||
130868321|NCT01427933|471146705|FG001|Overall Study|Investigator's Decision|0|||
130868322|NCT01633541|471146706|FG000|Overall Study|Death|1|||
130868323|NCT01633541|471146707|FG001|Overall Study|Death|0|||
130868324|NCT01010971|471146708|FG000|Overall Study|Adverse Event|2|||
130868325|NCT01010971|471146709|FG001|Overall Study|Adverse Event|4|||
130868326|NCT01010971|471146710|FG002|Overall Study|Adverse Event|3|||
130868327|NCT01010971|471146708|FG000|Overall Study|Withdrawal by Subject|0|||
130868328|NCT01010971|471146709|FG001|Overall Study|Withdrawal by Subject|2|||
130868329|NCT01010971|471146710|FG002|Overall Study|Withdrawal by Subject|5|||
130868330|NCT01010971|471146708|FG000|Overall Study|Lost to Follow-up|0|||
130868331|NCT01010971|471146709|FG001|Overall Study|Lost to Follow-up|2|||
130868332|NCT01010971|471146710|FG002|Overall Study|Lost to Follow-up|3|||
130868333|NCT01010971|471146708|FG000|Overall Study|Other|1|||
130868334|NCT01010971|471146709|FG001|Overall Study|Other|0|||
130868335|NCT01010971|471146710|FG002|Overall Study|Other|2|||
130868336|NCT03386721|471146711|FG000|Overall Study|Death|12|||
130868337|NCT03386721|471146712|FG001|Overall Study|Death|21|||
130868338|NCT03386721|471146713|FG002|Overall Study|Death|2|||
130868339|NCT03386721|471146714|FG003|Overall Study|Death|5|||
130868340|NCT03386721|471146715|FG004|Overall Study|Death|1|||
130868341|NCT03386721|471146716|FG005|Overall Study|Death|12|||
130868342|NCT03386721|471146717|FG006|Overall Study|Death|1|||
130868343|NCT03386721|471146718|FG007|Overall Study|Death|1|||
130868344|NCT03386721|471146719|FG008|Overall Study|Death|12|||
130868345|NCT03386721|471146720|FG009|Overall Study|Death|20|||
130868346|NCT03386721|471146721|FG010|Overall Study|Death|21|||
130868347|NCT03386721|471146722|FG011|Overall Study|Death|21|||
130868348|NCT03386721|471146723|FG012|Overall Study|Death|14|||
130868349|NCT03386721|471146724|FG013|Overall Study|Death|2|||
130868350|NCT03386721|471146725|FG014|Overall Study|Death|1|||
130868351|NCT03386721|471146711|FG000|Overall Study|Lost to Follow-up|1|||
130868352|NCT03386721|471146712|FG001|Overall Study|Lost to Follow-up|3|||
130868353|NCT03386721|471146713|FG002|Overall Study|Lost to Follow-up|0|||
130868354|NCT03386721|471146714|FG003|Overall Study|Lost to Follow-up|0|||
130868355|NCT03386721|471146715|FG004|Overall Study|Lost to Follow-up|0|||
130868356|NCT03386721|471146716|FG005|Overall Study|Lost to Follow-up|2|||
130868357|NCT03386721|471146717|FG006|Overall Study|Lost to Follow-up|1|||
130868358|NCT03386721|471146718|FG007|Overall Study|Lost to Follow-up|0|||
130868359|NCT03386721|471146719|FG008|Overall Study|Lost to Follow-up|1|||
130868360|NCT03386721|471146720|FG009|Overall Study|Lost to Follow-up|2|||
130868361|NCT03386721|471146721|FG010|Overall Study|Lost to Follow-up|1|||
130868362|NCT03386721|471146722|FG011|Overall Study|Lost to Follow-up|0|||
130868363|NCT03386721|471146723|FG012|Overall Study|Lost to Follow-up|0|||
130868364|NCT03386721|471146724|FG013|Overall Study|Lost to Follow-up|0|||
130868365|NCT03386721|471146725|FG014|Overall Study|Lost to Follow-up|0|||
130868366|NCT03386721|471146711|FG000|Overall Study|Reason not specified|3|||
130868367|NCT03386721|471146712|FG001|Overall Study|Reason not specified|0|||
130868368|NCT03386721|471146713|FG002|Overall Study|Reason not specified|0|||
130868369|NCT03386721|471146714|FG003|Overall Study|Reason not specified|0|||
130868370|NCT03386721|471146715|FG004|Overall Study|Reason not specified|0|||
130868371|NCT03386721|471146716|FG005|Overall Study|Reason not specified|3|||
130868372|NCT03386721|471146717|FG006|Overall Study|Reason not specified|1|||
130868373|NCT03386721|471146718|FG007|Overall Study|Reason not specified|0|||
130868374|NCT03386721|471146719|FG008|Overall Study|Reason not specified|0|||
130868375|NCT03386721|471146720|FG009|Overall Study|Reason not specified|1|||
130868376|NCT03386721|471146721|FG010|Overall Study|Reason not specified|2|||
130868377|NCT03386721|471146722|FG011|Overall Study|Reason not specified|6|||
130868378|NCT03386721|471146723|FG012|Overall Study|Reason not specified|1|||
130868379|NCT03386721|471146724|FG013|Overall Study|Reason not specified|0|||
130868380|NCT03386721|471146725|FG014|Overall Study|Reason not specified|0|||
130868381|NCT03386721|471146711|FG000|Overall Study|Progressive Disease|0|||
130868382|NCT03386721|471146712|FG001|Overall Study|Progressive Disease|0|||
130868383|NCT03386721|471146713|FG002|Overall Study|Progressive Disease|1|||
130868384|NCT03386721|471146714|FG003|Overall Study|Progressive Disease|0|||
130868385|NCT03386721|471146715|FG004|Overall Study|Progressive Disease|0|||
130868386|NCT03386721|471146716|FG005|Overall Study|Progressive Disease|1|||
130868387|NCT03386721|471146717|FG006|Overall Study|Progressive Disease|0|||
130868388|NCT03386721|471146718|FG007|Overall Study|Progressive Disease|0|||
130868389|NCT03386721|471146719|FG008|Overall Study|Progressive Disease|2|||
130868390|NCT03386721|471146720|FG009|Overall Study|Progressive Disease|1|||
130868391|NCT03386721|471146721|FG010|Overall Study|Progressive Disease|1|||
130868392|NCT03386721|471146722|FG011|Overall Study|Progressive Disease|0|||
130868393|NCT03386721|471146723|FG012|Overall Study|Progressive Disease|1|||
130868394|NCT03386721|471146724|FG013|Overall Study|Progressive Disease|0|||
130868395|NCT03386721|471146725|FG014|Overall Study|Progressive Disease|0|||
130868396|NCT03386721|471146711|FG000|Overall Study|Site Terminated by Sponsor|5|||
130868397|NCT03386721|471146712|FG001|Overall Study|Site Terminated by Sponsor|5|||
130868398|NCT03386721|471146713|FG002|Overall Study|Site Terminated by Sponsor|0|||
130868399|NCT03386721|471146714|FG003|Overall Study|Site Terminated by Sponsor|0|||
130868400|NCT03386721|471146715|FG004|Overall Study|Site Terminated by Sponsor|1|||
130868401|NCT03386721|471146716|FG005|Overall Study|Site Terminated by Sponsor|3|||
130868402|NCT03386721|471146717|FG006|Overall Study|Site Terminated by Sponsor|0|||
130868403|NCT03386721|471146718|FG007|Overall Study|Site Terminated by Sponsor|1|||
130868404|NCT03386721|471146719|FG008|Overall Study|Site Terminated by Sponsor|4|||
130868405|NCT03386721|471146720|FG009|Overall Study|Site Terminated by Sponsor|5|||
130868406|NCT03386721|471146721|FG010|Overall Study|Site Terminated by Sponsor|3|||
130868407|NCT03386721|471146722|FG011|Overall Study|Site Terminated by Sponsor|11|||
130868408|NCT03386721|471146723|FG012|Overall Study|Site Terminated by Sponsor|6|||
130868409|NCT03386721|471146724|FG013|Overall Study|Site Terminated by Sponsor|0|||
130868410|NCT03386721|471146725|FG014|Overall Study|Site Terminated by Sponsor|0|||
130868411|NCT03386721|471146711|FG000|Overall Study|Symptomatic Deterioration|0|||
130868412|NCT03386721|471146712|FG001|Overall Study|Symptomatic Deterioration|0|||
130868413|NCT03386721|471146713|FG002|Overall Study|Symptomatic Deterioration|0|||
130868414|NCT03386721|471146714|FG003|Overall Study|Symptomatic Deterioration|0|||
130868415|NCT03386721|471146715|FG004|Overall Study|Symptomatic Deterioration|0|||
130868416|NCT03386721|471146716|FG005|Overall Study|Symptomatic Deterioration|0|||
130868417|NCT03386721|471146717|FG006|Overall Study|Symptomatic Deterioration|0|||
130868418|NCT03386721|471146718|FG007|Overall Study|Symptomatic Deterioration|0|||
130868419|NCT03386721|471146719|FG008|Overall Study|Symptomatic Deterioration|1|||
130868420|NCT03386721|471146720|FG009|Overall Study|Symptomatic Deterioration|0|||
130868421|NCT03386721|471146721|FG010|Overall Study|Symptomatic Deterioration|0|||
130868422|NCT03386721|471146722|FG011|Overall Study|Symptomatic Deterioration|1|||
130868423|NCT03386721|471146723|FG012|Overall Study|Symptomatic Deterioration|0|||
130868424|NCT03386721|471146724|FG013|Overall Study|Symptomatic Deterioration|0|||
130868425|NCT03386721|471146725|FG014|Overall Study|Symptomatic Deterioration|0|||
130868426|NCT03386721|471146711|FG000|Overall Study|Withdrawal by Subject|1|||
130868427|NCT03386721|471146712|FG001|Overall Study|Withdrawal by Subject|2|||
130868428|NCT03386721|471146713|FG002|Overall Study|Withdrawal by Subject|0|||
130868429|NCT03386721|471146714|FG003|Overall Study|Withdrawal by Subject|0|||
130868430|NCT03386721|471146715|FG004|Overall Study|Withdrawal by Subject|0|||
130868431|NCT03386721|471146716|FG005|Overall Study|Withdrawal by Subject|0|||
130868432|NCT03386721|471146717|FG006|Overall Study|Withdrawal by Subject|0|||
130868433|NCT03386721|471146718|FG007|Overall Study|Withdrawal by Subject|0|||
130868434|NCT03386721|471146719|FG008|Overall Study|Withdrawal by Subject|2|||
130868435|NCT03386721|471146720|FG009|Overall Study|Withdrawal by Subject|1|||
130868436|NCT03386721|471146721|FG010|Overall Study|Withdrawal by Subject|3|||
130868437|NCT03386721|471146722|FG011|Overall Study|Withdrawal by Subject|2|||
130868438|NCT03386721|471146723|FG012|Overall Study|Withdrawal by Subject|3|||
130868439|NCT03386721|471146724|FG013|Overall Study|Withdrawal by Subject|0|||
130868440|NCT03386721|471146725|FG014|Overall Study|Withdrawal by Subject|0|||
130868441|NCT05114473|471146726|FG000|Overall Study|Lost to Follow-up|2|||
130868442|NCT05114473|471146727|FG001|Overall Study|Lost to Follow-up|2|||
130868443|NCT05114473|471146728|FG002|Overall Study|Lost to Follow-up|0|||
130868444|NCT02330055|471146729|FG000|Overall Study|technical issues|2|||
130868445|NCT02330055|471146730|FG001|Overall Study|technical issues|0|||
130868446|NCT02330055|471146729|FG000|Overall Study|participant forgot to wear device|5|||
130868447|NCT02330055|471146730|FG001|Overall Study|participant forgot to wear device|5|||
130868448|NCT02330055|471146729|FG000|Overall Study|data for less than 60 minutes|3|||
130868449|NCT02330055|471146730|FG001|Overall Study|data for less than 60 minutes|3|||
130868450|NCT02330055|471146729|FG000|Overall Study|participant did not sleep|0|||
130868451|NCT02330055|471146730|FG001|Overall Study|participant did not sleep|1|||
130868452|NCT02728089|471146731|FG000|Overall Study|Physician Decision|2|||
130868453|NCT02728089|471146731|FG000|Overall Study|Withdrawal by Subject|1|||
130868454|NCT00731679|471146732|FG000|Overall Study|Adverse Event|7|||
130868455|NCT00731679|471146733|FG001|Overall Study|Adverse Event|8|||
130868456|NCT00731679|471146732|FG000|Overall Study|Withdrawal by Subject|8|||
130868457|NCT00731679|471146733|FG001|Overall Study|Withdrawal by Subject|8|||
130868458|NCT00731679|471146732|FG000|Overall Study|Lost to Follow-up|7|||
130868459|NCT00731679|471146733|FG001|Overall Study|Lost to Follow-up|8|||
130868460|NCT00731679|471146732|FG000|Overall Study|Noncompliance|0|||
130868461|NCT00731679|471146733|FG001|Overall Study|Noncompliance|1|||
130868462|NCT00731679|471146732|FG000|Overall Study|Pregnancy|0|||
130868463|NCT00731679|471146733|FG001|Overall Study|Pregnancy|1|||
130868464|NCT02488005|471146736|FG000|Overall Study|Lost to Follow-up|2|||
130868465|NCT02326597|471146743|FG000|Overall Study|Lost to Follow-up|42|||
130868466|NCT02326597|471146744|FG001|Overall Study|Lost to Follow-up|32|||
130868467|NCT04089761|471146747|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
130868468|NCT04089761|471146747|FG000|"Run In Phase"|Lost to Follow-up|1|||
130868469|NCT04089761|471146747|FG000|"Treatment Phase"|No evaluable data|5|||
130868470|NCT04089761|471146747|FG000|"Treatment Phase"|Lost to Follow-up|1|||
130868471|NCT04739436|471146748|FG000|Overall Study|Lost to Follow-up|21|||
130868472|NCT04739436|471146749|FG001|Overall Study|Lost to Follow-up|23|||
130868473|NCT04739436|471146748|FG000|Overall Study|Withdrawal by Subject|4|||
130868474|NCT04739436|471146749|FG001|Overall Study|Withdrawal by Subject|6|||
130868475|NCT04739436|471146748|FG000|Overall Study|not randomized properly|1|||
130868476|NCT04739436|471146749|FG001|Overall Study|not randomized properly|0|||
130868477|NCT04628780|471146750|FG000|Overall Study|Death|0|||
130868478|NCT04628780|471146751|FG001|Overall Study|Death|1|||
130868479|NCT04628780|471146752|FG002|Overall Study|Death|0|||
130868480|NCT04628780|471146753|FG003|Overall Study|Death|0|||
130868481|NCT04628780|471146754|FG004|Overall Study|Death|1|||
130868482|NCT04628780|471146755|FG005|Overall Study|Death|0|||
130868483|NCT04628780|471146750|FG000|Overall Study|Physician Decision|2|||
130868484|NCT04628780|471146751|FG001|Overall Study|Physician Decision|0|||
130868485|NCT04628780|471146752|FG002|Overall Study|Physician Decision|0|||
130868486|NCT04628780|471146753|FG003|Overall Study|Physician Decision|0|||
130868487|NCT04628780|471146754|FG004|Overall Study|Physician Decision|2|||
130868488|NCT04628780|471146755|FG005|Overall Study|Physician Decision|0|||
130868489|NCT04628780|471146750|FG000|Overall Study|Progressive disease|2|||
130868490|NCT04628780|471146751|FG001|Overall Study|Progressive disease|2|||
130868491|NCT04628780|471146752|FG002|Overall Study|Progressive disease|2|||
130868492|NCT04628780|471146753|FG003|Overall Study|Progressive disease|3|||
130868493|NCT04628780|471146754|FG004|Overall Study|Progressive disease|9|||
130868494|NCT04628780|471146755|FG005|Overall Study|Progressive disease|4|||
130868495|NCT04628780|471146750|FG000|Overall Study|Withdrawal by Subject|0|||
130868496|NCT04628780|471146751|FG001|Overall Study|Withdrawal by Subject|1|||
130868497|NCT04628780|471146752|FG002|Overall Study|Withdrawal by Subject|2|||
130868498|NCT04628780|471146753|FG003|Overall Study|Withdrawal by Subject|0|||
130868499|NCT04628780|471146754|FG004|Overall Study|Withdrawal by Subject|3|||
130868500|NCT04628780|471146755|FG005|Overall Study|Withdrawal by Subject|1|||
130868501|NCT04628780|471146750|FG000|Overall Study|Global deterioration of health status|0|||
130868502|NCT04628780|471146751|FG001|Overall Study|Global deterioration of health status|0|||
130868503|NCT04628780|471146752|FG002|Overall Study|Global deterioration of health status|0|||
130868504|NCT04628780|471146753|FG003|Overall Study|Global deterioration of health status|0|||
130868505|NCT04628780|471146754|FG004|Overall Study|Global deterioration of health status|1|||
130868506|NCT04628780|471146755|FG005|Overall Study|Global deterioration of health status|1|||
130868507|NCT03622814|471146757|FG000|Overall Study|Lost to Follow-up|8|||
130868508|NCT03622814|471146758|FG001|Overall Study|Lost to Follow-up|14|||
130868509|NCT01657292|471146760|FG000|Overall Study|Adverse Event|6|||
130868510|NCT01657292|471146760|FG000|Overall Study|Withdrawal by Subject|2|||
130868511|NCT01657292|471146760|FG000|Overall Study|Violation of eligibility criteria|1|||
130868512|NCT01657292|471146760|FG000|Overall Study|Change of therapy|1|||
130868513|NCT00650845|471146761|FG000|Overall Study|Withdrawal by Subject|5|||
130868514|NCT00650845|471146762|FG001|Overall Study|Withdrawal by Subject|0|||
130868515|NCT00650845|471146761|FG000|Overall Study|Protocol Violation|0|||
130868516|NCT00650845|471146762|FG001|Overall Study|Protocol Violation|13|||
130868517|NCT04178720|471146763|FG000|Overall Study|Withdrawal by Subject|2|||
130868518|NCT04178720|471146764|FG001|Overall Study|Withdrawal by Subject|0|||
130868519|NCT04178720|471146763|FG000|Overall Study|Relocation|0|||
130868520|NCT04178720|471146764|FG001|Overall Study|Relocation|1|||
130868521|NCT01301833|471146765|FG000|Overall Study|Adverse Event|7|||
130868522|NCT01301833|471146766|FG001|Overall Study|Adverse Event|5|||
130868523|NCT01301833|471146767|FG002|Overall Study|Adverse Event|5|||
130868524|NCT01301833|471146768|FG003|Overall Study|Adverse Event|5|||
130868525|NCT01301833|471146765|FG000|Overall Study|Lack of Efficacy|1|||
130868526|NCT01301833|471146766|FG001|Overall Study|Lack of Efficacy|1|||
130868527|NCT01301833|471146767|FG002|Overall Study|Lack of Efficacy|0|||
130868528|NCT01301833|471146768|FG003|Overall Study|Lack of Efficacy|0|||
130868529|NCT01301833|471146765|FG000|Overall Study|Physician Decision|3|||
130868530|NCT01301833|471146766|FG001|Overall Study|Physician Decision|1|||
130868531|NCT01301833|471146767|FG002|Overall Study|Physician Decision|1|||
130868532|NCT01301833|471146768|FG003|Overall Study|Physician Decision|0|||
130868533|NCT01301833|471146765|FG000|Overall Study|Withdrawal by Subject|3|||
130868534|NCT01301833|471146766|FG001|Overall Study|Withdrawal by Subject|1|||
130868535|NCT01301833|471146767|FG002|Overall Study|Withdrawal by Subject|1|||
130868536|NCT01301833|471146768|FG003|Overall Study|Withdrawal by Subject|2|||
130868537|NCT01301833|471146765|FG000|Overall Study|Personal matter|1|||
130868538|NCT01301833|471146766|FG001|Overall Study|Personal matter|0|||
130868539|NCT01301833|471146767|FG002|Overall Study|Personal matter|0|||
130868540|NCT01301833|471146768|FG003|Overall Study|Personal matter|0|||
130868541|NCT03922620|471146769|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
130868542|NCT03922620|471146770|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
130868543|NCT04177212|471146771|FG000|Overall Study|Withdrawal by Subject|9|||
130868544|NCT04177212|471146772|FG001|Overall Study|Withdrawal by Subject|7|||
130868545|NCT04177212|471146771|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
130868546|NCT04177212|471146772|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
130868547|NCT04177212|471146771|FG000|Overall Study|Physician Decision|1|||
130868548|NCT04177212|471146772|FG001|Overall Study|Physician Decision|0|||
130868549|NCT04177212|471146771|FG000|Overall Study|Lost to Follow-up|0|||
130868550|NCT04177212|471146772|FG001|Overall Study|Lost to Follow-up|3|||
130868551|NCT04177212|471146771|FG000|Overall Study|Adverse Event|0|||
130868552|NCT04177212|471146772|FG001|Overall Study|Adverse Event|1|||
130868553|NCT04177212|471146771|FG000|Overall Study|Other|1|||
130868554|NCT04177212|471146772|FG001|Overall Study|Other|2|||
130868555|NCT04725500|471146773|FG000|Screening|Screen Failure|26|||
130868556|NCT04725500|471146773|FG000|Screening|Withdrawal by Subject|1|||
130868557|NCT04725500|471146773|FG000|2 Week Take Home|Screen Fail|5|||
130868558|NCT01792115|471146774|FG000|Overall Study|Lost to Follow-up|0|||
130868559|NCT01792115|471146775|FG001|Overall Study|Lost to Follow-up|1|||
130868560|NCT01792115|471146776|FG002|Overall Study|Lost to Follow-up|0|||
130868561|NCT04618744|471146778|FG000|Overall Study|Adverse Event|0|||
130868562|NCT04618744|471146779|FG001|Overall Study|Adverse Event|1|||
130868563|NCT04618744|471146778|FG000|Overall Study|Withdrawal by Subject|0|||
130868564|NCT04618744|471146779|FG001|Overall Study|Withdrawal by Subject|1|||
130868565|NCT00930930|471146780|FG000|Overall Study|Death|1|||
130868566|NCT00930930|471146781|FG001|Overall Study|Death|0|||
130868567|NCT00930930|471146780|FG000|Overall Study|Physician Decision|1|||
130868568|NCT00930930|471146781|FG001|Overall Study|Physician Decision|0|||
130868569|NCT00930930|471146780|FG000|Overall Study|Adverse Event|13|||
130868570|NCT00930930|471146781|FG001|Overall Study|Adverse Event|3|||
130868571|NCT00930930|471146780|FG000|Overall Study|Withdrawal by Subject|3|||
130868572|NCT00930930|471146781|FG001|Overall Study|Withdrawal by Subject|1|||
130868573|NCT00930930|471146780|FG000|Overall Study|Disease progression|2|||
130868574|NCT00930930|471146781|FG001|Overall Study|Disease progression|3|||
130868575|NCT00930930|471146780|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
130868576|NCT00930930|471146781|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
130868577|NCT00930930|471146780|FG000|Overall Study|patients not compliant|1|||
130868578|NCT00930930|471146781|FG001|Overall Study|patients not compliant|1|||
130868579|NCT02709330|471146782|FG000|Overall Study|Death|5|||
130868580|NCT02709330|471146783|FG001|Overall Study|Death|0|||
130868581|NCT02709330|471146782|FG000|Overall Study|Lost to Follow-up|2|||
130868582|NCT02709330|471146783|FG001|Overall Study|Lost to Follow-up|0|||
130868583|NCT02709330|471146782|FG000|Overall Study|Physician Decision|2|||
130868584|NCT02709330|471146783|FG001|Overall Study|Physician Decision|0|||
130868585|NCT02709330|471146782|FG000|Overall Study|Withdrawal by Subject|4|||
130868586|NCT02709330|471146783|FG001|Overall Study|Withdrawal by Subject|0|||
130868587|NCT01279681|471146784|FG000|Overall Study|Disease Progression|9|||
130868588|NCT01279681|471146785|FG001|Overall Study|Disease Progression|6|||
130868589|NCT01279681|471146784|FG000|Overall Study|Withdrawal by Subject|3|||
130868590|NCT01279681|471146785|FG001|Overall Study|Withdrawal by Subject|4|||
130868591|NCT01279681|471146784|FG000|Overall Study|Adverse Event|2|||
130868592|NCT01279681|471146785|FG001|Overall Study|Adverse Event|3|||
130868593|NCT01279681|471146784|FG000|Overall Study|Death|0|||
130868594|NCT01279681|471146785|FG001|Overall Study|Death|1|||
130868595|NCT01279681|471146784|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
130868596|NCT01279681|471146785|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
130868597|NCT01279681|471146784|FG000|Overall Study|Physician Decision|1|||
130868598|NCT01279681|471146785|FG001|Overall Study|Physician Decision|0|||
130868599|NCT01279681|471146784|FG000|Overall Study|Other Reason|0|||
130868600|NCT01279681|471146785|FG001|Overall Study|Other Reason|2|||
130868601|NCT01633788|471148596|FG000|Overall Study|Adverse Event|1|||
130868602|NCT01633788|471148597|FG001|Overall Study|Adverse Event|3|||
130868603|NCT01633788|471148598|FG002|Overall Study|Adverse Event|3|||
130868604|NCT01633788|471148599|FG003|Overall Study|Adverse Event|3|||
130868605|NCT01633788|471148596|FG000|Overall Study|Lost to Follow-up|2|||
130868606|NCT01633788|471148597|FG001|Overall Study|Lost to Follow-up|2|||
130868607|NCT01633788|471148598|FG002|Overall Study|Lost to Follow-up|2|||
130868608|NCT01633788|471148599|FG003|Overall Study|Lost to Follow-up|0|||
130868609|NCT01633788|471148596|FG000|Overall Study|Personal Reasons|3|||
130868610|NCT01633788|471148597|FG001|Overall Study|Personal Reasons|1|||
130868611|NCT01633788|471148598|FG002|Overall Study|Personal Reasons|1|||
130868612|NCT01633788|471148599|FG003|Overall Study|Personal Reasons|3|||
130868613|NCT01633788|471148596|FG000|Overall Study|Protocol Violation|1|||
130868614|NCT01633788|471148597|FG001|Overall Study|Protocol Violation|0|||
130868615|NCT01633788|471148598|FG002|Overall Study|Protocol Violation|1|||
130868616|NCT01633788|471148599|FG003|Overall Study|Protocol Violation|0|||
130868617|NCT01633788|471148596|FG000|Overall Study|Other Reasons|0|||
130868618|NCT01633788|471148597|FG001|Overall Study|Other Reasons|2|||
130868619|NCT01633788|471148598|FG002|Overall Study|Other Reasons|3|||
130868620|NCT01633788|471148599|FG003|Overall Study|Other Reasons|7|||
130868621|NCT01929226|471148600|FG000|Overall Study|Lost to Follow-up|4|||
130868622|NCT01929226|471148601|FG001|Overall Study|Lost to Follow-up|0|||
130868623|NCT01929226|471148600|FG000|Overall Study|Withdrawal by Subject|1|||
130868624|NCT01929226|471148601|FG001|Overall Study|Withdrawal by Subject|1|||
130868625|NCT02807623|471148602|FG000|Overall Study|Lost to Follow-up|23|||
130868626|NCT02807623|471148603|FG001|Overall Study|Lost to Follow-up|18|||
130868627|NCT02807623|471148604|FG002|Overall Study|Lost to Follow-up|22|||
130868628|NCT02807623|471148602|FG000|Overall Study|Drug intolerance|0|||
130868629|NCT02807623|471148603|FG001|Overall Study|Drug intolerance|1|||
130868630|NCT02807623|471148604|FG002|Overall Study|Drug intolerance|0|||
130868631|NCT02807623|471148602|FG000|Overall Study|incomplete blood draw|0|||
130868632|NCT02807623|471148603|FG001|Overall Study|incomplete blood draw|2|||
130868633|NCT02807623|471148604|FG002|Overall Study|incomplete blood draw|1|||
130868634|NCT01410890|471148606|FG000|Overall Study|Withdrawal by Subject|0|||
130868635|NCT01410890|471148607|FG001|Overall Study|Withdrawal by Subject|1|||
130868636|NCT00217425|471148610|FG000|Overall Study|Never started treatment|2|||
130868637|NCT00217425|471148610|FG000|Overall Study|Patient ineligible|5|||
130868638|NCT00217425|471148610|FG000|Overall Study|Lack of Efficacy|13|||
130868639|NCT00217425|471148610|FG000|Overall Study|Adverse Event|8|||
130868640|NCT00217425|471148610|FG000|Overall Study|Withdrawal by Subject|4|||
130868641|NCT00217425|471148610|FG000|Overall Study|Other complicating disease|1|||
130868642|NCT00217425|471148610|FG000|Overall Study|Other|4|||
130868643|NCT01121146|471148611|FG000|Overall Study|Death|17|||
130868644|NCT01121146|471148612|FG001|Overall Study|Death|15|||
130868645|NCT01121146|471148611|FG000|Overall Study|Adverse Event|2|||
130868646|NCT01121146|471148612|FG001|Overall Study|Adverse Event|11|||
130868647|NCT01121146|471148611|FG000|Overall Study|Lost to Follow-up|7|||
130868648|NCT01121146|471148612|FG001|Overall Study|Lost to Follow-up|16|||
130868649|NCT00330759|471148615|FG000|Overall Study|Death|316|||
130868650|NCT00330759|471148616|FG001|Overall Study|Death|310|||
130868651|NCT00330759|471148615|FG000|Overall Study|Disease progression|104|||
130868652|NCT00330759|471148616|FG001|Overall Study|Disease progression|126|||
130868653|NCT00330759|471148615|FG000|Overall Study|Withdrawal by Subject|143|||
130868654|NCT00330759|471148616|FG001|Overall Study|Withdrawal by Subject|124|||
130868655|NCT00330759|471148615|FG000|Overall Study|Adverse Event|48|||
130868656|NCT00330759|471148616|FG001|Overall Study|Adverse Event|36|||
130868657|NCT00330759|471148615|FG000|Overall Study|Participant request|31|||
130868658|NCT00330759|471148616|FG001|Overall Study|Participant request|22|||
130868659|NCT00330759|471148615|FG000|Overall Study|Lost to Follow-up|16|||
130868660|NCT00330759|471148616|FG001|Overall Study|Lost to Follow-up|22|||
130868661|NCT00330759|471148615|FG000|Overall Study|Noncompliance|15|||
130868662|NCT00330759|471148616|FG001|Overall Study|Noncompliance|17|||
130868663|NCT00330759|471148615|FG000|Overall Study|Physician Decision|1|||
130868664|NCT00330759|471148616|FG001|Overall Study|Physician Decision|2|||
130868665|NCT00330759|471148615|FG000|Overall Study|Protocol deviation|0|||
130868666|NCT00330759|471148616|FG001|Overall Study|Protocol deviation|2|||
130868667|NCT00330759|471148615|FG000|Overall Study|Ineligibility determined|2|||
130868668|NCT00330759|471148616|FG001|Overall Study|Ineligibility determined|1|||
130868669|NCT00330759|471148615|FG000|Overall Study|Other|36|||
130868670|NCT00330759|471148616|FG001|Overall Study|Other|44|||
130868671|NCT00997035|471148617|FG000|3-week Followup Visit|Lost to Follow-up|9|||
130868672|NCT00997035|471148618|FG001|3-week Followup Visit|Lost to Follow-up|6|||
130868673|NCT00997035|471148617|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
130868674|NCT00997035|471148618|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
130868675|NCT01380769|471148623|FG000|Overall Study|Withdrawal by Subject|7|||
130868676|NCT01380769|471148624|FG001|Overall Study|Withdrawal by Subject|11|||
130868677|NCT01380769|471148623|FG000|Overall Study|Physician Decision|1|||
130868678|NCT01380769|471148624|FG001|Overall Study|Physician Decision|1|||
130868679|NCT01380769|471148623|FG000|Overall Study|Adverse Event|1|||
130868680|NCT01380769|471148624|FG001|Overall Study|Adverse Event|1|||
130868681|NCT01380769|471148623|FG000|Overall Study|Protocol Violation|0|||
130868682|NCT01380769|471148624|FG001|Overall Study|Protocol Violation|1|||
130868683|NCT03654690|471148625|FG000|Overall Study|Withdrawal by Subject|1|||
130868684|NCT03654690|471148626|FG001|Overall Study|Withdrawal by Subject|0|||
130868685|NCT03654690|471148627|FG002|Overall Study|Withdrawal by Subject|0|||
130868686|NCT00742183|471148630|FG000|Overall Study|Adverse Event|2|||
130868687|NCT00742183|471148631|FG001|Overall Study|Adverse Event|2|||
130868688|NCT00742183|471148630|FG000|Overall Study|Death|1|||
130868689|NCT00742183|471148631|FG001|Overall Study|Death|0|||
130868690|NCT00742183|471148630|FG000|Overall Study|Physician Decision|0|||
130868691|NCT00742183|471148631|FG001|Overall Study|Physician Decision|2|||
130868692|NCT00742183|471148630|FG000|Overall Study|Lost to Follow-up|4|||
130868693|NCT00742183|471148631|FG001|Overall Study|Lost to Follow-up|4|||
130868694|NCT00742183|471148630|FG000|Overall Study|Required skin-graft|1|||
130868695|NCT00742183|471148631|FG001|Overall Study|Required skin-graft|1|||
130868696|NCT00742183|471148630|FG000|Overall Study|Withdrawal by Subject|1|||
130868697|NCT00742183|471148631|FG001|Overall Study|Withdrawal by Subject|0|||
130868698|NCT00742183|471148630|FG000|Overall Study|Lack of Efficacy|0|||
130868699|NCT00742183|471148631|FG001|Overall Study|Lack of Efficacy|3|||
130868700|NCT00786799|471148635|FG000|Overall Study|Lost to Follow-up|1|||
130868701|NCT00786799|471148636|FG001|Overall Study|Lost to Follow-up|1|||
130868702|NCT02544503|471148637|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
130868703|NCT02544503|471148638|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
130868704|NCT02544503|471148637|FG000|Overall Study|Lost to Follow-up|9|||
130868705|NCT02544503|471148638|FG001|Overall Study|Lost to Follow-up|0|||
130868706|NCT02544503|471148637|FG000|Overall Study|Withdrawal by Subject|1|||
130868707|NCT02544503|471148638|FG001|Overall Study|Withdrawal by Subject|0|||
130868708|NCT01080807|471148642|FG000|Overall Study|Adverse Event|9|||
130868709|NCT01080807|471148643|FG001|Overall Study|Adverse Event|1|||
130868710|NCT01080807|471148642|FG000|Overall Study|Lack of Efficacy|0|||
130868711|NCT01080807|471148643|FG001|Overall Study|Lack of Efficacy|1|||
130868712|NCT01080807|471148642|FG000|Overall Study|Withdrawal by Subject|7|||
130868713|NCT01080807|471148643|FG001|Overall Study|Withdrawal by Subject|2|||
130868714|NCT01080807|471148642|FG000|Overall Study|Protocol Violation|7|||
130868715|NCT01080807|471148643|FG001|Overall Study|Protocol Violation|6|||
130868716|NCT01080807|471148642|FG000|Overall Study|Lost to Follow-up|6|||
130868717|NCT01080807|471148643|FG001|Overall Study|Lost to Follow-up|4|||
130868718|NCT01080807|471148642|FG000|Overall Study|Noncompliance with drug administration|1|||
130868719|NCT01080807|471148643|FG001|Overall Study|Noncompliance with drug administration|1|||
130868720|NCT01080807|471148642|FG000|Overall Study|Noncompliance to study procedures|1|||
130868721|NCT01080807|471148643|FG001|Overall Study|Noncompliance to study procedures|1|||
130868722|NCT01080807|471148642|FG000|Overall Study|Began working day shift|0|||
130868723|NCT01080807|471148643|FG001|Overall Study|Began working day shift|2|||
130868724|NCT01080807|471148642|FG000|Overall Study|Laid off or terminated from job|1|||
130868725|NCT01080807|471148643|FG001|Overall Study|Laid off or terminated from job|2|||
130868726|NCT01080807|471148642|FG000|Overall Study|Stopped working consistent night shifts|0|||
130868727|NCT01080807|471148643|FG001|Overall Study|Stopped working consistent night shifts|1|||
130868728|NCT01080807|471148642|FG000|Overall Study|Work schedule changing|1|||
130868729|NCT01080807|471148643|FG001|Overall Study|Work schedule changing|1|||
130868730|NCT01080807|471148642|FG000|Overall Study|Work schedule and travel|0|||
130868731|NCT01080807|471148643|FG001|Overall Study|Work schedule and travel|1|||
130868732|NCT01080807|471148642|FG000|Overall Study|Switched to first shift|1|||
130868733|NCT01080807|471148643|FG001|Overall Study|Switched to first shift|0|||
130868734|NCT01080807|471148642|FG000|Overall Study|Moved away without notifying center|1|||
130868735|NCT01080807|471148643|FG001|Overall Study|Moved away without notifying center|0|||
130868736|NCT03922581|471148649|FG000|Overall Study|Lost to Follow-up|20|||
130868737|NCT03922581|471148650|FG001|Overall Study|Lost to Follow-up|9|||
130868738|NCT03922581|471148649|FG000|Overall Study|Physician Decision|1|||
130868739|NCT03922581|471148650|FG001|Overall Study|Physician Decision|1|||
130868740|NCT03922581|471148649|FG000|Overall Study|Withdrawal by Subject|1|||
130868741|NCT03922581|471148650|FG001|Overall Study|Withdrawal by Subject|0|||
130868742|NCT04685798|471148653|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
130868743|NCT04640311|471148654|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
130868744|NCT04640311|471148655|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868745|NCT04640311|471148656|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868746|NCT04640311|471148657|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868747|NCT04640311|471148658|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868748|NCT04640311|471148659|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868749|NCT04640311|471148660|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868750|NCT04640311|471148661|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868751|NCT04640311|471148662|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868752|NCT04640311|471148663|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868753|NCT04640311|471148664|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868754|NCT04640311|471148665|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868755|NCT04640311|471148666|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868756|NCT04640311|471148654|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868757|NCT04640311|471148655|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
130868758|NCT04640311|471148656|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868759|NCT04640311|471148657|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868760|NCT04640311|471148658|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868761|NCT04640311|471148659|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868762|NCT04640311|471148660|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868763|NCT04640311|471148661|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868764|NCT04640311|471148662|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868765|NCT04640311|471148663|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868766|NCT04640311|471148664|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868767|NCT04640311|471148665|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868768|NCT04640311|471148666|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130868769|NCT04640311|471148654|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868770|NCT04640311|471148655|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
130868771|NCT04640311|471148656|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868772|NCT04640311|471148657|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868773|NCT04640311|471148658|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868774|NCT04640311|471148659|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868775|NCT04640311|471148660|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868776|NCT04640311|471148661|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868777|NCT04640311|471148662|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868778|NCT04640311|471148663|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868779|NCT04640311|471148664|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868780|NCT04640311|471148665|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868781|NCT04640311|471148666|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868782|NCT04640311|471148654|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
130868783|NCT04640311|471148655|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
130868784|NCT04640311|471148656|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
130868785|NCT04640311|471148657|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868786|NCT04640311|471148658|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868787|NCT04640311|471148659|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868788|NCT04640311|471148660|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868789|NCT04640311|471148661|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868790|NCT04640311|471148662|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868791|NCT04640311|471148663|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868792|NCT04640311|471148664|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868793|NCT04640311|471148665|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868794|NCT04640311|471148666|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130868795|NCT04640311|471148654|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868796|NCT04640311|471148655|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868797|NCT04640311|471148656|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
130868798|NCT04640311|471148657|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868799|NCT04640311|471148658|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868800|NCT04640311|471148659|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868801|NCT04640311|471148660|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868802|NCT04640311|471148661|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868803|NCT04640311|471148662|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868804|NCT04640311|471148663|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868805|NCT04640311|471148664|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868806|NCT04640311|471148665|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868807|NCT04640311|471148666|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130868808|NCT04640311|471148654|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868809|NCT04640311|471148655|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868810|NCT04640311|471148656|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868811|NCT04640311|471148657|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
130868812|NCT04640311|471148658|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868813|NCT04640311|471148659|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868814|NCT04640311|471148660|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
130868815|NCT04640311|471148661|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868816|NCT04640311|471148662|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868817|NCT04640311|471148663|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868818|NCT04640311|471148664|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868819|NCT04640311|471148665|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868820|NCT04640311|471148666|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130868821|NCT04640311|471148654|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868822|NCT04640311|471148655|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868823|NCT04640311|471148656|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868824|NCT04640311|471148657|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868825|NCT04640311|471148658|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868826|NCT04640311|471148659|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
130868827|NCT04640311|471148660|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868828|NCT04640311|471148661|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868829|NCT04640311|471148662|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
130868830|NCT04640311|471148663|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868831|NCT04640311|471148664|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868832|NCT04640311|471148665|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868833|NCT04640311|471148666|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130868834|NCT04640311|471148654|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868835|NCT04640311|471148655|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868836|NCT04640311|471148656|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868837|NCT04640311|471148657|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868838|NCT04640311|471148658|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868839|NCT04640311|471148659|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868840|NCT04640311|471148660|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
130868841|NCT04640311|471148661|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868842|NCT04640311|471148662|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868843|NCT04640311|471148663|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868844|NCT04640311|471148664|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
130868845|NCT04640311|471148665|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868846|NCT04640311|471148666|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130868847|NCT04640311|471148654|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868848|NCT04640311|471148655|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868849|NCT04640311|471148656|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868850|NCT04640311|471148657|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868851|NCT04640311|471148658|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868852|NCT04640311|471148659|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868853|NCT04640311|471148660|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868854|NCT04640311|471148661|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868855|NCT04640311|471148662|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868856|NCT04640311|471148663|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868857|NCT04640311|471148664|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868858|NCT04640311|471148665|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
130868859|NCT04640311|471148666|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130868860|NCT02223715|471148667|FG000|Overall Study|Death|31|||
130868861|NCT02223715|471148667|FG000|Overall Study|Lost to Follow-up|73|||
130868862|NCT03956550|471148668|FG000|Overall Study|Sponsor decision|65|||
130868863|NCT03956550|471148669|FG001|Overall Study|Sponsor decision|66|||
130868864|NCT03956550|471148670|FG002|Overall Study|Sponsor decision|64|||
130868865|NCT03956550|471148668|FG000|Overall Study|Adverse Event|0|||
130868866|NCT03956550|471148669|FG001|Overall Study|Adverse Event|1|||
130868867|NCT03956550|471148670|FG002|Overall Study|Adverse Event|0|||
130868868|NCT03956550|471148668|FG000|Overall Study|Withdrawal by Subject|5|||
130868869|NCT03956550|471148669|FG001|Overall Study|Withdrawal by Subject|5|||
130868870|NCT03956550|471148670|FG002|Overall Study|Withdrawal by Subject|6|||
130868871|NCT01745367|471148673|FG000|Overall Study|Death|1|||
130868872|NCT01745367|471148674|FG001|Overall Study|Death|0|||
130868873|NCT01745367|471148673|FG000|Overall Study|Withdrawal by Subject|1|||
130868874|NCT01745367|471148674|FG001|Overall Study|Withdrawal by Subject|2|||
130868875|NCT01745367|471148673|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
130868876|NCT01745367|471148674|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
130868877|NCT01745367|471148673|FG000|Overall Study|Other Reasons Unspecified|0|||
130868878|NCT01745367|471148674|FG001|Overall Study|Other Reasons Unspecified|2|||
130868879|NCT00592904|471148676|FG000|Overall Study|Adverse Event|15|||
130868880|NCT00592904|471148677|FG001|Overall Study|Adverse Event|25|||
130868881|NCT00592904|471148678|FG002|Overall Study|Adverse Event|13|||
130868882|NCT00592904|471148679|FG003|Overall Study|Adverse Event|5|||
130868883|NCT00592904|471148676|FG000|Overall Study|Protocol Violation|1|||
130868884|NCT00592904|471148677|FG001|Overall Study|Protocol Violation|1|||
130868885|NCT00592904|471148678|FG002|Overall Study|Protocol Violation|0|||
130868886|NCT00592904|471148679|FG003|Overall Study|Protocol Violation|1|||
130868887|NCT00592904|471148676|FG000|Overall Study|Withdrawal by Subject|4|||
130868888|NCT00592904|471148677|FG001|Overall Study|Withdrawal by Subject|16|||
130868889|NCT00592904|471148678|FG002|Overall Study|Withdrawal by Subject|1|||
130868890|NCT00592904|471148679|FG003|Overall Study|Withdrawal by Subject|2|||
130868891|NCT00592904|471148676|FG000|Overall Study|Lack of Efficacy|2|||
130868892|NCT00592904|471148677|FG001|Overall Study|Lack of Efficacy|7|||
130868893|NCT00592904|471148678|FG002|Overall Study|Lack of Efficacy|2|||
130868894|NCT00592904|471148679|FG003|Overall Study|Lack of Efficacy|3|||
130868895|NCT00592904|471148676|FG000|Overall Study|Physician Decision|0|||
130868896|NCT00592904|471148677|FG001|Overall Study|Physician Decision|3|||
130868897|NCT00592904|471148678|FG002|Overall Study|Physician Decision|1|||
130868898|NCT00592904|471148679|FG003|Overall Study|Physician Decision|0|||
130868899|NCT00592904|471148676|FG000|Overall Study|Other|3|||
130868900|NCT00592904|471148677|FG001|Overall Study|Other|3|||
130868901|NCT00592904|471148678|FG002|Overall Study|Other|0|||
130868902|NCT00592904|471148679|FG003|Overall Study|Other|0|||
130868903|NCT01359904|471148680|FG000|Overall Study|Withdrawal by Subject|1|||
130868904|NCT01359904|471148681|FG001|Overall Study|Withdrawal by Subject|0|||
130868905|NCT03191630|471148683|FG000|Overall Study|Lost to Follow-up|7|||
130868906|NCT03191630|471148684|FG001|Overall Study|Lost to Follow-up|7|||
130868907|NCT02640547|471148687|FG000|Overall Study|Failure to Return|1|||
130868908|NCT02640547|471148687|FG000|Overall Study|Withdrawal by Subject|1|||
130868909|NCT02640547|471148687|FG000|Overall Study|Death|6|||
130868910|NCT02640547|471148687|FG000|Overall Study|Miscellaneous|3|||
130868911|NCT02525588|471148688|FG000|Overall Study|Death|3|||
130868912|NCT02525588|471148689|FG001|Overall Study|Death|1|||
130868913|NCT02525588|471148688|FG000|Overall Study|Lost to Follow-up|2|||
130868914|NCT02525588|471148689|FG001|Overall Study|Lost to Follow-up|0|||
130868915|NCT02525588|471148688|FG000|Overall Study|Withdrawal by Subject|1|||
130868916|NCT02525588|471148689|FG001|Overall Study|Withdrawal by Subject|1|||
130868917|NCT02525588|471148688|FG000|Overall Study|Adverse Event|0|||
130868918|NCT02525588|471148689|FG001|Overall Study|Adverse Event|1|||
130868919|NCT03018691|471148693|FG000|Overall Study|Adverse Event|1|||
130868920|NCT03018691|471148694|FG001|Overall Study|Adverse Event|1|||
130868921|NCT03018691|471148695|FG002|Overall Study|Adverse Event|4|||
130868922|NCT03018691|471148693|FG000|Overall Study|Lack of Efficacy|0|||
130868923|NCT03018691|471148694|FG001|Overall Study|Lack of Efficacy|0|||
130868924|NCT03018691|471148695|FG002|Overall Study|Lack of Efficacy|1|||
130868925|NCT03018691|471148693|FG000|Overall Study|Withdrawal by Subject|0|||
130868926|NCT03018691|471148694|FG001|Overall Study|Withdrawal by Subject|0|||
130868927|NCT03018691|471148695|FG002|Overall Study|Withdrawal by Subject|1|||
130868928|NCT03018691|471148693|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130868929|NCT03018691|471148694|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130868930|NCT03018691|471148695|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130868931|NCT03369418|471148697|FG000|Overall Study|Withdrawal by Subject|3|||
130868932|NCT03369418|471148698|FG001|Overall Study|Withdrawal by Subject|3|||
130868933|NCT01485094|471148699|FG000|Overall Study|Adverse Event|1|||
130868934|NCT01485094|471148700|FG001|Overall Study|Adverse Event|1|||
130868935|NCT01485094|471148701|FG002|Overall Study|Adverse Event|1|||
130868936|NCT01485094|471148699|FG000|Overall Study|Lost to Follow-up|1|||
130868937|NCT01485094|471148700|FG001|Overall Study|Lost to Follow-up|0|||
130868938|NCT01485094|471148701|FG002|Overall Study|Lost to Follow-up|0|||
130868939|NCT01485094|471148699|FG000|Overall Study|Withdrawal by Subject|1|||
130868940|NCT01485094|471148700|FG001|Overall Study|Withdrawal by Subject|1|||
130868941|NCT01485094|471148701|FG002|Overall Study|Withdrawal by Subject|0|||
130868942|NCT01020786|471148709|FG000|Induction Period|Entry Criteria Not Met|2|||
130868943|NCT01020786|471148709|FG000|Induction Period|Adverse Event|10|||
130868944|NCT01020786|471148709|FG000|Induction Period|Progressive Disease|31|||
130868945|NCT01020786|471148709|FG000|Induction Period|Investigator Decision|3|||
130868946|NCT01020786|471148709|FG000|Induction Period|Withdrawal by Subject|3|||
130868947|NCT01020786|471148709|FG000|Maintenance Period|Adverse Event|8|||
130868948|NCT01020786|471148709|FG000|Maintenance Period|Progressive Disease|43|||
130868949|NCT01020786|471148709|FG000|Maintenance Period|Withdrawal by Subject|8|||
130868950|NCT01020786|471148709|FG000|Maintenance Period|Sponsor Decision|1|||
130868951|NCT02717494|471148711|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
130868952|NCT02717494|471148712|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
130868953|NCT02717494|471148713|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
130868954|NCT02717494|471148711|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
130868955|NCT02717494|471148712|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
130868956|NCT02717494|471148713|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
130868957|NCT02717494|471148711|FG000|First Intervention (Step 1)|Death|0|||
130868958|NCT02717494|471148712|FG001|First Intervention (Step 1)|Death|0|||
130868959|NCT02717494|471148713|FG002|First Intervention (Step 1)|Death|1|||
130868960|NCT02717494|471148711|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
130868961|NCT02717494|471148712|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
130868962|NCT02717494|471148713|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
130868963|NCT00770601|471148714|FG000|Overall Study|Withdrawal by Subject|1|||
130868964|NCT00428948|471148717|FG000|Overall Study|Lost to Follow-up|15|||
130868965|NCT00428948|471148718|FG001|Overall Study|Lost to Follow-up|8|||
130868966|NCT00428948|471148717|FG000|Overall Study|Adverse Event|148|||
130868967|NCT00428948|471148718|FG001|Overall Study|Adverse Event|24|||
130868968|NCT00428948|471148717|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
130868969|NCT00428948|471148718|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
130868970|NCT00428948|471148717|FG000|Overall Study|Investigator Withdrew Subject|3|||
130868971|NCT00428948|471148718|FG001|Overall Study|Investigator Withdrew Subject|4|||
130868972|NCT00428948|471148717|FG000|Overall Study|Subject Withdrew Consent|50|||
130868973|NCT00428948|471148718|FG001|Overall Study|Subject Withdrew Consent|30|||
130868974|NCT00428948|471148717|FG000|Overall Study|Protocol Deviation|1|||
130868975|NCT00428948|471148718|FG001|Overall Study|Protocol Deviation|1|||
130868976|NCT04417361|471148720|FG000|Overall Study|Withdrawal by Subject|1|||
130868977|NCT04417361|471148721|FG001|Overall Study|Withdrawal by Subject|0|||
130868978|NCT04417361|471148720|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
130868979|NCT04417361|471148721|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
130868980|NCT01288989|471148724|FG000|Overall Study|Death|0|||
130868981|NCT01288989|471148725|FG001|Overall Study|Death|0|||
130868982|NCT01288989|471148726|FG002|Overall Study|Death|0|||
130868983|NCT01288989|471148727|FG003|Overall Study|Death|1|||
130868984|NCT01288989|471148728|FG004|Overall Study|Death|0|||
130868985|NCT01288989|471148724|FG000|Overall Study|Dose limiting toxicity|1|||
130868986|NCT01288989|471148725|FG001|Overall Study|Dose limiting toxicity|0|||
130868987|NCT01288989|471148726|FG002|Overall Study|Dose limiting toxicity|0|||
130868988|NCT01288989|471148727|FG003|Overall Study|Dose limiting toxicity|0|||
130868989|NCT01288989|471148728|FG004|Overall Study|Dose limiting toxicity|0|||
130868990|NCT01288989|471148724|FG000|Overall Study|Adverse Event|0|||
130868991|NCT01288989|471148725|FG001|Overall Study|Adverse Event|0|||
130868992|NCT01288989|471148726|FG002|Overall Study|Adverse Event|0|||
130868993|NCT01288989|471148727|FG003|Overall Study|Adverse Event|0|||
130868994|NCT01288989|471148728|FG004|Overall Study|Adverse Event|2|||
130868995|NCT01288989|471148724|FG000|Overall Study|Physician Decision|0|||
130868996|NCT01288989|471148725|FG001|Overall Study|Physician Decision|0|||
130868997|NCT01288989|471148726|FG002|Overall Study|Physician Decision|0|||
130868998|NCT01288989|471148727|FG003|Overall Study|Physician Decision|0|||
130868999|NCT01288989|471148728|FG004|Overall Study|Physician Decision|1|||
130869000|NCT01288989|471148724|FG000|Overall Study|Withdrawal by Subject|0|||
130869001|NCT01288989|471148725|FG001|Overall Study|Withdrawal by Subject|0|||
130869002|NCT01288989|471148726|FG002|Overall Study|Withdrawal by Subject|0|||
130869003|NCT01288989|471148727|FG003|Overall Study|Withdrawal by Subject|0|||
130869004|NCT01288989|471148728|FG004|Overall Study|Withdrawal by Subject|3|||
130869005|NCT01156714|471148729|FG000|Overall Study|Withdrawal by Subject|9|||
130869006|NCT01156714|471148730|FG001|Overall Study|Withdrawal by Subject|4|||
130869007|NCT01156714|471148731|FG002|Overall Study|Withdrawal by Subject|3|||
130869008|NCT00165672|471148736|FG000|Overall Study|Adverse Event|0|||
130869009|NCT00165672|471148737|FG001|Overall Study|Adverse Event|1|||
130869010|NCT04965688|471148745|FG000|Overall Study|Withdrawal by Subject|2|||
130869011|NCT05864586|471148746|FG000|Overall Study|Ineligible|4|||
130869012|NCT05864586|471148747|FG001|Overall Study|Ineligible|12|||
130869013|NCT05864586|471148746|FG000|Overall Study|Pregnancy|0|||
130869014|NCT05864586|471148747|FG001|Overall Study|Pregnancy|1|||
130869015|NCT05864586|471148746|FG000|Overall Study|Withdrawal by Subject|0|||
130869016|NCT05864586|471148747|FG001|Overall Study|Withdrawal by Subject|1|||
130869017|NCT04896593|471148748|FG000|Overall Study|Withdrawal by Subject|2|||
130869018|NCT04896593|471148748|FG000|Overall Study|Lost to Follow-up|1|||
130869019|NCT04896593|471148748|FG000|Overall Study|Did not complete onboarding|2|||
130869020|NCT02777827|471148749|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
130869021|NCT02777827|471148750|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
130869022|NCT02777827|471148751|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
130869023|NCT02777827|471148752|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
130869024|NCT02777827|471148753|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
130869025|NCT02777827|471148754|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
130869026|NCT00369577|471148755|FG000|Overall Study|Withdrawal by Subject|0|||
130869027|NCT00369577|471148756|FG001|Overall Study|Withdrawal by Subject|0|||
130869028|NCT00369577|471148757|FG002|Overall Study|Withdrawal by Subject|1|||
130869029|NCT00176462|471148766|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
130869030|NCT00176462|471148767|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
130869031|NCT00176462|471148766|FG000|Induction (4 Weeks)|Death|1|||
130869032|NCT00176462|471148767|FG001|Induction (4 Weeks)|Death|2|||
130869033|NCT00176462|471148766|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
130869034|NCT00176462|471148767|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
130869035|NCT00176462|471148766|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
130869036|NCT00176462|471148767|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
130869037|NCT00176462|471148766|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
130869038|NCT00176462|471148767|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
130869039|NCT00176462|471148766|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
130869040|NCT00176462|471148767|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
130869041|NCT00176462|471148766|FG000|Consolidation (12 Weeks)|Not documented|0|||
130869042|NCT00176462|471148767|FG001|Consolidation (12 Weeks)|Not documented|1|||
130869043|NCT00176462|471148766|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
130869044|NCT00176462|471148767|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
130869045|NCT00176462|471148766|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
130869046|NCT00176462|471148767|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
130869047|NCT01408459|471148768|FG000|Overall Study|Withdrawal by Subject|1|||
130869048|NCT01408459|471148769|FG001|Overall Study|Withdrawal by Subject|1|||
130869049|NCT00824473|471150248|FG000|Overall Study|Adverse Event|4|||
130869050|NCT00824473|471150249|FG001|Overall Study|Adverse Event|5|||
130869051|NCT00824473|471150248|FG000|Overall Study|Lack of Efficacy|2|||
130869052|NCT00824473|471150249|FG001|Overall Study|Lack of Efficacy|2|||
130869053|NCT00824473|471150248|FG000|Overall Study|Protocol Violation|2|||
130869054|NCT00824473|471150249|FG001|Overall Study|Protocol Violation|0|||
130869055|NCT00824473|471150248|FG000|Overall Study|Non-Compliance|4|||
130869056|NCT00824473|471150249|FG001|Overall Study|Non-Compliance|2|||
130869057|NCT00824473|471150248|FG000|Overall Study|Withdrawal by Subject|2|||
130869058|NCT00824473|471150249|FG001|Overall Study|Withdrawal by Subject|3|||
130869059|NCT00824473|471150248|FG000|Overall Study|Other|1|||
130869060|NCT00824473|471150249|FG001|Overall Study|Other|1|||
130869061|NCT01521507|471150259|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
130869062|NCT01521507|471150260|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
130869063|NCT01521507|471150259|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
130869064|NCT01521507|471150260|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
130869065|NCT01521507|471150259|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
130869066|NCT01521507|471150260|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
130869067|NCT01521507|471150259|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
130869068|NCT01521507|471150260|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
130869069|NCT01521507|471150259|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
130869070|NCT01521507|471150260|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
130869071|NCT01521507|471150259|FG000|Stage 2: Observational Design|Physician Decision|1|||
130869072|NCT01521507|471150260|FG001|Stage 2: Observational Design|Physician Decision|0|||
130869073|NCT02478463|471150263|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
130869074|NCT02478463|471150263|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
130869075|NCT02478463|471150263|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
130869076|NCT01358825|471150266|FG000|Overall Study|Blood sample not drawn|0|||
130869077|NCT01358825|471150267|FG001|Overall Study|Blood sample not drawn|1|||
130869078|NCT01479868|471150268|FG000|Overall Study|Adverse Event|1|||
130869079|NCT01479868|471150268|FG000|Overall Study|Lost to Follow-up|4|||
130869080|NCT01479868|471150268|FG000|Overall Study|Protocol Violation|1|||
130869081|NCT01479868|471150268|FG000|Overall Study|Withdrawal by Subject|1|||
130869082|NCT01479868|471150268|FG000|Overall Study|Sponsor's Decision|1|||
130869083|NCT01479868|471150268|FG000|Overall Study|Initiation of new HCV Therapy|1|||
130869084|NCT01508169|471150269|FG000|Overall Study|Adverse Event|1|||
130869085|NCT01508169|471150270|FG001|Overall Study|Adverse Event|0|||
130869086|NCT01508169|471150269|FG000|Overall Study|Withdrawal by Subject|1|||
130869087|NCT01508169|471150270|FG001|Overall Study|Withdrawal by Subject|0|||
130869088|NCT01508169|471150269|FG000|Overall Study|Lost to Follow-up|1|||
130869089|NCT01508169|471150270|FG001|Overall Study|Lost to Follow-up|2|||
130869090|NCT01814527|471150275|FG000|Overall Study|RTP greater than 30 days|6|||
130869091|NCT01814527|471150276|FG001|Overall Study|RTP greater than 30 days|1|||
130869092|NCT04524858|471150279|FG000|Overall Study|Adverse Event|1|||
130869093|NCT01363700|471150282|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130869094|NCT01363700|471150283|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
130869095|NCT01363700|471150284|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130869096|NCT01363700|471150285|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130869097|NCT01363700|471150286|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130869098|NCT00113841|471150292|FG000|Overall Study|Disease progression|0|||
130869099|NCT00113841|471150293|FG001|Overall Study|Disease progression|2|||
130869100|NCT00113841|471150292|FG000|Overall Study|Non-compliant|1|||
130869101|NCT00113841|471150293|FG001|Overall Study|Non-compliant|0|||
130869102|NCT00580723|471150301|FG000|Overall Study|Did not want to participate in extension|3|||
130869103|NCT00580723|471150301|FG000|Overall Study|Lost to Follow-up|5|||
130869104|NCT00148759|471150302|FG000|Overall Study|Withdrawal by Subject|1|||
130869105|NCT00148759|471150303|FG001|Overall Study|Withdrawal by Subject|1|||
130869106|NCT00148759|471150302|FG000|Overall Study|Lost to Follow-up|1|||
130869107|NCT00148759|471150303|FG001|Overall Study|Lost to Follow-up|0|||
130869108|NCT05202418|471150304|FG000|Overall Study|Withdrawal by Subject|2|||
130869109|NCT05202418|471150305|FG001|Overall Study|Withdrawal by Subject|1|||
130869110|NCT05202418|471150304|FG000|Overall Study|Lost to Follow-up|1|||
130869111|NCT05202418|471150305|FG001|Overall Study|Lost to Follow-up|1|||
130869112|NCT02753946|471150306|FG000|Overall Study|Adverse Event|7|||
130869113|NCT02753946|471150307|FG001|Overall Study|Adverse Event|6|||
130869114|NCT02753946|471150306|FG000|Overall Study|Withdrawal by Subject|6|||
130869115|NCT02753946|471150307|FG001|Overall Study|Withdrawal by Subject|1|||
130869116|NCT02753946|471150306|FG000|Overall Study|Lack of Efficacy|1|||
130869117|NCT02753946|471150307|FG001|Overall Study|Lack of Efficacy|0|||
130869118|NCT02753946|471150306|FG000|Overall Study|Physician Decision|0|||
130869119|NCT02753946|471150307|FG001|Overall Study|Physician Decision|2|||
130869120|NCT02519439|471150308|FG000|Overall Study|Study Termination|19|||
130869121|NCT02519439|471150308|FG000|Overall Study|Withdrawal by Subject|1|||
130869122|NCT02519439|471150308|FG000|Overall Study|Adverse Event|1|||
130869123|NCT02721875|471150309|FG000|Overall Study|Progressive disease/relapse|1|||
130869124|NCT02721875|471150310|FG001|Overall Study|Progressive disease/relapse|0|||
130869125|NCT03901144|471150316|FG000|Overall Study|Lost to Follow-up|1|||
130869126|NCT03901144|471150317|FG001|Overall Study|Lost to Follow-up|1|||
130869127|NCT03901144|471150318|FG002|Overall Study|Lost to Follow-up|1|||
130869128|NCT03901144|471150319|FG003|Overall Study|Lost to Follow-up|1|||
130869129|NCT00104650|471150322|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
130869130|NCT00104650|471150323|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
130869131|NCT00104650|471150324|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
130869132|NCT00104650|471150322|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
130869133|NCT00104650|471150323|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
130869134|NCT00104650|471150324|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
130869135|NCT00104650|471150322|FG000|Treatment Period (25 Weeks)|Death|7|||
130869136|NCT00104650|471150323|FG001|Treatment Period (25 Weeks)|Death|5|||
130869137|NCT00104650|471150324|FG002|Treatment Period (25 Weeks)|Death|6|||
130869138|NCT00104650|471150322|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
130869139|NCT00104650|471150323|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
130869140|NCT00104650|471150324|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
130869141|NCT00104650|471150322|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
130869142|NCT00104650|471150323|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
130869143|NCT00104650|471150324|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
130869144|NCT00104650|471150322|FG000|Treatment Period (25 Weeks)|Other|1|||
130869145|NCT00104650|471150323|FG001|Treatment Period (25 Weeks)|Other|0|||
130869146|NCT00104650|471150324|FG002|Treatment Period (25 Weeks)|Other|0|||
130869147|NCT00104650|471150322|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
130869148|NCT00104650|471150323|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
130869149|NCT00104650|471150324|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
130869150|NCT00104650|471150322|FG000|Follow-up Period|Physician Decision|1|||
130869151|NCT00104650|471150323|FG001|Follow-up Period|Physician Decision|1|||
130869152|NCT00104650|471150324|FG002|Follow-up Period|Physician Decision|0|||
130869153|NCT00104650|471150322|FG000|Follow-up Period|Adverse Event|1|||
130869154|NCT00104650|471150323|FG001|Follow-up Period|Adverse Event|0|||
130869155|NCT00104650|471150324|FG002|Follow-up Period|Adverse Event|1|||
130869156|NCT00104650|471150322|FG000|Follow-up Period|Withdrawal by Subject|0|||
130869157|NCT00104650|471150323|FG001|Follow-up Period|Withdrawal by Subject|3|||
130869158|NCT00104650|471150324|FG002|Follow-up Period|Withdrawal by Subject|3|||
130869159|NCT00104650|471150322|FG000|Follow-up Period|Death|6|||
130869160|NCT00104650|471150323|FG001|Follow-up Period|Death|6|||
130869161|NCT00104650|471150324|FG002|Follow-up Period|Death|4|||
130869162|NCT00104650|471150322|FG000|Follow-up Period|Disease progression|3|||
130869163|NCT00104650|471150323|FG001|Follow-up Period|Disease progression|1|||
130869164|NCT00104650|471150324|FG002|Follow-up Period|Disease progression|0|||
130869165|NCT00104650|471150322|FG000|Follow-up Period|Lost to Follow-up|0|||
130869166|NCT00104650|471150323|FG001|Follow-up Period|Lost to Follow-up|1|||
130869167|NCT00104650|471150324|FG002|Follow-up Period|Lost to Follow-up|2|||
130869168|NCT00104650|471150322|FG000|Follow-up Period|Other|0|||
130869169|NCT00104650|471150323|FG001|Follow-up Period|Other|1|||
130869170|NCT00104650|471150324|FG002|Follow-up Period|Other|0|||
130869171|NCT02294058|471150325|FG000|Overall Study|Adverse Event|16|||
130869172|NCT02294058|471150326|FG001|Overall Study|Adverse Event|7|||
130869173|NCT02294058|471150327|FG002|Overall Study|Adverse Event|13|||
130869174|NCT02294058|471150325|FG000|Overall Study|Lack of Efficacy|3|||
130869175|NCT02294058|471150326|FG001|Overall Study|Lack of Efficacy|3|||
130869176|NCT02294058|471150327|FG002|Overall Study|Lack of Efficacy|0|||
130869177|NCT02294058|471150325|FG000|Overall Study|Lost to Follow-up|1|||
130869178|NCT02294058|471150326|FG001|Overall Study|Lost to Follow-up|0|||
130869179|NCT02294058|471150327|FG002|Overall Study|Lost to Follow-up|2|||
130869180|NCT02294058|471150325|FG000|Overall Study|Withdrawal by Subject|10|||
130869181|NCT02294058|471150326|FG001|Overall Study|Withdrawal by Subject|14|||
130869182|NCT02294058|471150327|FG002|Overall Study|Withdrawal by Subject|13|||
130869183|NCT02294058|471150325|FG000|Overall Study|Physician Decision|2|||
130869184|NCT02294058|471150326|FG001|Overall Study|Physician Decision|1|||
130869185|NCT02294058|471150327|FG002|Overall Study|Physician Decision|0|||
130869186|NCT02294058|471150325|FG000|Overall Study|Miscellaneous|4|||
130869187|NCT02294058|471150326|FG001|Overall Study|Miscellaneous|1|||
130869188|NCT02294058|471150327|FG002|Overall Study|Miscellaneous|1|||
130869189|NCT03575403|471150328|FG000|Overall Study|Adverse Event|1|||
130869190|NCT03575403|471150329|FG001|Overall Study|Adverse Event|0|||
130869191|NCT03575403|471150330|FG002|Overall Study|Adverse Event|0|||
130869192|NCT03575403|471150328|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
130869193|NCT03575403|471150329|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
130869194|NCT03575403|471150330|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
130869195|NCT00773513|471150331|FG000|Overall Study|Renal Transplant|254|||
130869196|NCT00773513|471150332|FG001|Overall Study|Renal Transplant|263|||
130869197|NCT00773513|471150331|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
130869198|NCT00773513|471150332|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
130869199|NCT00773513|471150331|FG000|Overall Study|Withdrew Consent|68|||
130869200|NCT00773513|471150332|FG001|Overall Study|Withdrew Consent|69|||
130869201|NCT00773513|471150331|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
130869202|NCT00773513|471150332|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
130869203|NCT00773513|471150331|FG000|Overall Study|Failure to Return|22|||
130869204|NCT00773513|471150332|FG001|Overall Study|Failure to Return|8|||
130869205|NCT00773513|471150331|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130869206|NCT00773513|471150332|FG001|Overall Study|Insufficient Therapeutic Response|18|||
130869207|NCT00773513|471150331|FG000|Overall Study|Reason Not Specified|159|||
130869208|NCT00773513|471150332|FG001|Overall Study|Reason Not Specified|126|||
130869209|NCT00773513|471150331|FG000|Overall Study|Death|531|||
130869210|NCT00773513|471150332|FG001|Overall Study|Death|545|||
130869211|NCT03359174|471150335|FG000|Overall Study|Adverse Event|1|||
130869212|NCT01332994|471150339|FG000|Overall Study|Adverse Event|34|||
130869213|NCT01332994|471150339|FG000|Overall Study|Death|1|||
130869214|NCT01332994|471150339|FG000|Overall Study|Lack of Efficacy|1|||
130869215|NCT01332994|471150339|FG000|Overall Study|Lost to Follow-up|4|||
130869216|NCT01332994|471150339|FG000|Overall Study|Protocol Violation|6|||
130869217|NCT01332994|471150339|FG000|Overall Study|Withdrawal by Subject|15|||
130869218|NCT01332994|471150339|FG000|Overall Study|Administrative Problem|2|||
130869219|NCT01332994|471150339|FG000|Overall Study|Other|8|||
130869220|NCT02800863|471150340|FG000|Overall Study|Adverse Event|14|||
130869221|NCT02800863|471150340|FG000|Overall Study|Another Device Implanted|1|||
130869222|NCT02800863|471150340|FG000|Overall Study|Device Explanted|1|||
130869223|NCT02800863|471150340|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
130869224|NCT02800863|471150340|FG000|Overall Study|Health Issues|1|||
130869225|NCT02800863|471150340|FG000|Overall Study|Insurance Denial|8|||
130869226|NCT02800863|471150340|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
130869227|NCT02800863|471150340|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
130869228|NCT02800863|471150340|FG000|Overall Study|Screen Failure|1|||
130869229|NCT02800863|471150340|FG000|Overall Study|Sponsor Request|6|||
130869230|NCT02800863|471150340|FG000|Overall Study|Death|3|||
130869231|NCT02800863|471150340|FG000|Overall Study|Subject Implant at Another Facility|1|||
130869232|NCT02800863|471150340|FG000|Overall Study|Lost to Follow-up|26|||
130869233|NCT02800863|471150340|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
130869234|NCT02800863|471150340|FG000|Overall Study|Subject and/or Family Request|64|||
130869235|NCT02800863|471150340|FG000|Overall Study|Trial Failure|81|||
130869236|NCT02800863|471150340|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
130869237|NCT00279916|471150341|FG000|Overall Study|Withdrawal by Subject|4|||
130869238|NCT00279916|471150342|FG001|Overall Study|Withdrawal by Subject|3|||
130869239|NCT00279916|471150341|FG000|Overall Study|Lost to Follow-up|3|||
130869240|NCT00279916|471150342|FG001|Overall Study|Lost to Follow-up|2|||
130869241|NCT01807598|471150343|FG000|Overall Study|Withdrawal by Subject|4|||
130869242|NCT01807598|471150343|FG000|Overall Study|Adverse Event|1|||
130869243|NCT01807598|471150343|FG000|Overall Study|Other Physician Decision|1|||
130869244|NCT00452790|471150347|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
130869245|NCT00452790|471150348|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
130869246|NCT00452790|471150347|FG000|Infant Series|Parent/legal guardian request|8|||
130869247|NCT00452790|471150348|FG001|Infant Series|Parent/legal guardian request|6|||
130869248|NCT00452790|471150347|FG000|Infant Series|Failed to return|4|||
130869249|NCT00452790|471150348|FG001|Infant Series|Failed to return|1|||
130869250|NCT00452790|471150347|FG000|Infant Series|Protocol Violation|1|||
130869251|NCT00452790|471150348|FG001|Infant Series|Protocol Violation|3|||
130869252|NCT00452790|471150347|FG000|Infant Series|Lost to Follow-up|2|||
130869253|NCT00452790|471150348|FG001|Infant Series|Lost to Follow-up|2|||
130869254|NCT00452790|471150347|FG000|Infant Series|Adverse Event|1|||
130869255|NCT00452790|471150348|FG001|Infant Series|Adverse Event|2|||
130869256|NCT00452790|471150347|FG000|Infant Series|Other reasons|1|||
130869257|NCT00452790|471150348|FG001|Infant Series|Other reasons|2|||
130869258|NCT00452790|471150347|FG000|Infant Series|Investigator request|0|||
130869259|NCT00452790|471150348|FG001|Infant Series|Investigator request|1|||
130869260|NCT00452790|471150347|FG000|Infant Series|Death|0|||
130869261|NCT00452790|471150348|FG001|Infant Series|Death|1|||
130869262|NCT00452790|471150347|FG000|After Infant Series|Investigator request|10|||
130869263|NCT00452790|471150348|FG001|After Infant Series|Investigator request|10|||
130869264|NCT00452790|471150347|FG000|After Infant Series|Adverse Event|4|||
130869265|NCT00452790|471150348|FG001|After Infant Series|Adverse Event|1|||
130869266|NCT00452790|471150347|FG000|After Infant Series|Parent/legal guardian request|1|||
130869267|NCT00452790|471150348|FG001|After Infant Series|Parent/legal guardian request|3|||
130869268|NCT00452790|471150347|FG000|After Infant Series|Lost to Follow-up|4|||
130869269|NCT00452790|471150348|FG001|After Infant Series|Lost to Follow-up|0|||
130869270|NCT00452790|471150347|FG000|After Infant Series|Failed to return|1|||
130869271|NCT00452790|471150348|FG001|After Infant Series|Failed to return|0|||
130869272|NCT00452790|471150347|FG000|After Infant Series|Other reasons|1|||
130869273|NCT00452790|471150348|FG001|After Infant Series|Other reasons|0|||
130869274|NCT00452790|471150347|FG000|Toddler Dose|Failed to return|0|||
130869275|NCT00452790|471150348|FG001|Toddler Dose|Failed to return|1|||
130869276|NCT00452790|471150347|FG000|Toddler Dose|Parent/legal guardian request|0|||
130869277|NCT00452790|471150348|FG001|Toddler Dose|Parent/legal guardian request|1|||
130869278|NCT00319254|471150351|FG000|Overall Study|Withdrawal by Subject|4|||
130869279|NCT00319254|471150351|FG000|Overall Study|Death|46|||
130869280|NCT00319254|471150351|FG000|Overall Study|Lost to Follow-up|2|||
130869281|NCT00319254|471150351|FG000|Overall Study|Enrolled, Not Treated|2|||
130869282|NCT01505374|471150352|FG000|Overall Study|Lost to Follow-up|1|||
130869283|NCT01505374|471150353|FG001|Overall Study|Lost to Follow-up|0|||
130869284|NCT02360228|471150354|FG000|Overall Study|Withdrawal by Subject|1|||
130869285|NCT02360228|471150355|FG001|Overall Study|Withdrawal by Subject|0|||
130869286|NCT02360228|471150356|FG002|Overall Study|Withdrawal by Subject|0|||
130869287|NCT02360228|471150354|FG000|Overall Study|Self-discontinued medication|0|||
130869288|NCT02360228|471150355|FG001|Overall Study|Self-discontinued medication|1|||
130869289|NCT02360228|471150356|FG002|Overall Study|Self-discontinued medication|0|||
130869290|NCT02360228|471150354|FG000|Overall Study|Unstable symptoms during screening|0|||
130869291|NCT02360228|471150355|FG001|Overall Study|Unstable symptoms during screening|0|||
130869292|NCT02360228|471150356|FG002|Overall Study|Unstable symptoms during screening|1|||
130869293|NCT02452424|471150357|FG000|Overall Study|Death|2|||
130869294|NCT02452424|471150358|FG001|Overall Study|Death|2|||
130869295|NCT02452424|471150359|FG002|Overall Study|Death|2|||
130869296|NCT02452424|471150360|FG003|Overall Study|Death|6|||
130869297|NCT02452424|471150361|FG004|Overall Study|Death|2|||
130869298|NCT02452424|471150362|FG005|Overall Study|Death|0|||
130869299|NCT02452424|471150363|FG006|Overall Study|Death|5|||
130869300|NCT02452424|471150364|FG007|Overall Study|Death|1|||
130869301|NCT02452424|471150365|FG008|Overall Study|Death|3|||
130869302|NCT02452424|471150366|FG009|Overall Study|Death|1|||
130869303|NCT02452424|471150367|FG010|Overall Study|Death|0|||
130869304|NCT02452424|471150357|FG000|Overall Study|Lost to Follow-up|0|||
130869305|NCT02452424|471150358|FG001|Overall Study|Lost to Follow-up|1|||
130869306|NCT02452424|471150359|FG002|Overall Study|Lost to Follow-up|1|||
130869307|NCT02452424|471150360|FG003|Overall Study|Lost to Follow-up|0|||
130869308|NCT02452424|471150361|FG004|Overall Study|Lost to Follow-up|0|||
130869309|NCT02452424|471150362|FG005|Overall Study|Lost to Follow-up|0|||
130869310|NCT02452424|471150363|FG006|Overall Study|Lost to Follow-up|0|||
130869311|NCT02452424|471150364|FG007|Overall Study|Lost to Follow-up|0|||
130869312|NCT02452424|471150365|FG008|Overall Study|Lost to Follow-up|0|||
130869313|NCT02452424|471150366|FG009|Overall Study|Lost to Follow-up|0|||
130869314|NCT02452424|471150367|FG010|Overall Study|Lost to Follow-up|0|||
130869315|NCT02452424|471150357|FG000|Overall Study|Withdrawal by Subject|0|||
130869316|NCT02452424|471150358|FG001|Overall Study|Withdrawal by Subject|0|||
130869317|NCT02452424|471150359|FG002|Overall Study|Withdrawal by Subject|3|||
130869318|NCT02452424|471150360|FG003|Overall Study|Withdrawal by Subject|2|||
130869319|NCT02452424|471150361|FG004|Overall Study|Withdrawal by Subject|0|||
130869320|NCT02452424|471150362|FG005|Overall Study|Withdrawal by Subject|0|||
130869321|NCT02452424|471150363|FG006|Overall Study|Withdrawal by Subject|1|||
130869322|NCT02452424|471150364|FG007|Overall Study|Withdrawal by Subject|0|||
130869323|NCT02452424|471150365|FG008|Overall Study|Withdrawal by Subject|1|||
130869324|NCT02452424|471150366|FG009|Overall Study|Withdrawal by Subject|1|||
130869325|NCT02452424|471150367|FG010|Overall Study|Withdrawal by Subject|0|||
130869326|NCT02452424|471150357|FG000|Overall Study|Other|0|||
130869327|NCT02452424|471150358|FG001|Overall Study|Other|0|||
130869328|NCT02452424|471150359|FG002|Overall Study|Other|1|||
130869329|NCT02452424|471150360|FG003|Overall Study|Other|0|||
130869330|NCT02452424|471150361|FG004|Overall Study|Other|0|||
130869331|NCT02452424|471150362|FG005|Overall Study|Other|1|||
130869332|NCT02452424|471150363|FG006|Overall Study|Other|4|||
130869333|NCT02452424|471150364|FG007|Overall Study|Other|3|||
130869334|NCT02452424|471150365|FG008|Overall Study|Other|0|||
130869335|NCT02452424|471150366|FG009|Overall Study|Other|0|||
130869336|NCT02452424|471150367|FG010|Overall Study|Other|1|||
130869337|NCT02452424|471150357|FG000|Overall Study|Progressive disease (per RECIST)|0|||
130869338|NCT02452424|471150358|FG001|Overall Study|Progressive disease (per RECIST)|0|||
130869339|NCT02452424|471150359|FG002|Overall Study|Progressive disease (per RECIST)|0|||
130869340|NCT02452424|471150360|FG003|Overall Study|Progressive disease (per RECIST)|0|||
130869341|NCT02452424|471150361|FG004|Overall Study|Progressive disease (per RECIST)|0|||
130869342|NCT02452424|471150362|FG005|Overall Study|Progressive disease (per RECIST)|0|||
130869343|NCT02452424|471150363|FG006|Overall Study|Progressive disease (per RECIST)|0|||
130869344|NCT02452424|471150364|FG007|Overall Study|Progressive disease (per RECIST)|0|||
130869345|NCT02452424|471150365|FG008|Overall Study|Progressive disease (per RECIST)|2|||
130869346|NCT02452424|471150366|FG009|Overall Study|Progressive disease (per RECIST)|0|||
130869347|NCT02452424|471150367|FG010|Overall Study|Progressive disease (per RECIST)|0|||
130869348|NCT02452424|471150357|FG000|Overall Study|Adverse Event|0|||
130869349|NCT02452424|471150358|FG001|Overall Study|Adverse Event|0|||
130869350|NCT02452424|471150359|FG002|Overall Study|Adverse Event|0|||
130869351|NCT02452424|471150360|FG003|Overall Study|Adverse Event|0|||
130869352|NCT02452424|471150361|FG004|Overall Study|Adverse Event|0|||
130869353|NCT02452424|471150362|FG005|Overall Study|Adverse Event|0|||
130869354|NCT02452424|471150363|FG006|Overall Study|Adverse Event|0|||
130869355|NCT02452424|471150364|FG007|Overall Study|Adverse Event|0|||
130869356|NCT02452424|471150365|FG008|Overall Study|Adverse Event|0|||
130869357|NCT02452424|471150366|FG009|Overall Study|Adverse Event|0|||
130869358|NCT02452424|471150367|FG010|Overall Study|Adverse Event|1|||
130869359|NCT01463306|471150368|FG000|Overall Study|Adverse Event|6|||
130869360|NCT01463306|471150369|FG001|Overall Study|Adverse Event|9|||
130869361|NCT01463306|471150370|FG002|Overall Study|Adverse Event|3|||
130869362|NCT01463306|471150368|FG000|Overall Study|Death|3|||
130869363|NCT01463306|471150369|FG001|Overall Study|Death|3|||
130869364|NCT01463306|471150370|FG002|Overall Study|Death|0|||
130869365|NCT01463306|471150368|FG000|Overall Study|Lack of Efficacy|22|||
130869366|NCT01463306|471150369|FG001|Overall Study|Lack of Efficacy|16|||
130869367|NCT01463306|471150370|FG002|Overall Study|Lack of Efficacy|1|||
130869368|NCT01463306|471150368|FG000|Overall Study|Lost to Follow-up|5|||
130869369|NCT01463306|471150369|FG001|Overall Study|Lost to Follow-up|2|||
130869370|NCT01463306|471150370|FG002|Overall Study|Lost to Follow-up|0|||
130869371|NCT01463306|471150368|FG000|Overall Study|Protocol Violation|4|||
130869372|NCT01463306|471150369|FG001|Overall Study|Protocol Violation|0|||
130869373|NCT01463306|471150370|FG002|Overall Study|Protocol Violation|0|||
130869374|NCT01463306|471150368|FG000|Overall Study|Withdrawal by Subject|19|||
130869375|NCT01463306|471150369|FG001|Overall Study|Withdrawal by Subject|9|||
130869376|NCT01463306|471150370|FG002|Overall Study|Withdrawal by Subject|1|||
130869377|NCT01463306|471150368|FG000|Overall Study|Other|26|||
130869378|NCT01463306|471150369|FG001|Overall Study|Other|13|||
130869379|NCT01463306|471150370|FG002|Overall Study|Other|0|||
130869380|NCT01463306|471150368|FG000|Overall Study|Approval expiry at site|1|||
130869381|NCT01463306|471150369|FG001|Overall Study|Approval expiry at site|0|||
130869382|NCT01463306|471150370|FG002|Overall Study|Approval expiry at site|0|||
130869383|NCT01059318|471150373|FG000|Core Study (26 Week)|Adverse Event|3|||
130869384|NCT01059318|471150373|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
130869385|NCT01059318|471150373|FG000|Extension (36 Week)|Adverse Event|3|||
130869386|NCT03790917|471150374|FG000|Overall Study|Death|1|||
130869387|NCT02679287|471150379|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
130869388|NCT02679287|471150380|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
130869389|NCT02679287|471150379|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
130869390|NCT02679287|471150380|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
130869391|NCT02679287|471150379|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
130869392|NCT02679287|471150380|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
130869393|NCT02679287|471150379|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
130869394|NCT02679287|471150380|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
130869395|NCT02679287|471150379|FG000|Period 2|Work/Scheduling Conflict|1|||
130869396|NCT02679287|471150380|FG001|Period 2|Work/Scheduling Conflict|0|||
130869397|NCT02679287|471150379|FG000|Period 2|Disliked Mobile System|2|||
130869398|NCT02679287|471150380|FG001|Period 2|Disliked Mobile System|0|||
130869399|NCT02679287|471150379|FG000|Period 3|Work/Scheduling Conflict|0|||
130869400|NCT02679287|471150380|FG001|Period 3|Work/Scheduling Conflict|1|||
130869401|NCT01045694|471150382|FG000|Overall Study|Withdrawal by Subject|2|||
130869402|NCT01150097|471150390|FG000|Months 24 to 36 Post-transplantation|Death|2|||
130869403|NCT01150097|471150391|FG001|Months 24 to 36 Post-transplantation|Death|0|||
130869404|NCT01150097|471150392|FG002|Months 24 to 36 Post-transplantation|Death|0|||
130869405|NCT01150097|471150390|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
130869406|NCT01150097|471150391|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
130869407|NCT01150097|471150392|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
130869408|NCT01150097|471150390|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
130869409|NCT01150097|471150391|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
130869410|NCT01150097|471150392|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
130869411|NCT01150097|471150390|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
130869412|NCT01150097|471150391|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
130869413|NCT01150097|471150392|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
130869414|NCT01150097|471150390|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
130869415|NCT01150097|471150391|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
130869416|NCT01150097|471150392|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
130869417|NCT01150097|471150390|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
130869418|NCT01150097|471150391|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
130869419|NCT01150097|471150392|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
130869420|NCT01150097|471150390|FG000|Months 24 to 48 Post-transplantation|Death|2|||
130869421|NCT01150097|471150391|FG001|Months 24 to 48 Post-transplantation|Death|0|||
130869422|NCT01150097|471150392|FG002|Months 24 to 48 Post-transplantation|Death|0|||
130869423|NCT00992459|471150393|FG000|Overall Study|Withdrawal by Subject|0|||
130869424|NCT00992459|471150394|FG001|Overall Study|Withdrawal by Subject|1|||
130869425|NCT00992459|471150393|FG000|Overall Study|Adverse Event|1|||
130869426|NCT00992459|471150394|FG001|Overall Study|Adverse Event|0|||
130869427|NCT00983385|471150397|FG000|Observation Period|Not eligible to be dosed|20|||
130869428|NCT00983385|471150397|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
130869429|NCT00227721|471151855|FG000|Overall Study|On study, but never treated.|1|||
130869430|NCT00961181|471151860|FG000|Overall Study|Death|2|||
130869431|NCT00961181|471151860|FG000|Overall Study|Withdrawal by Subject|2|||
130869432|NCT00961181|471151860|FG000|Overall Study|Lost to Follow-up|1|||
130869433|NCT00280917|471151861|FG000|Overall Study|Adverse Event|1|||
130869434|NCT00280917|471151862|FG001|Overall Study|Adverse Event|1|||
130869435|NCT00280917|471151863|FG002|Overall Study|Adverse Event|4|||
130869436|NCT00280917|471151864|FG003|Overall Study|Adverse Event|1|||
130869437|NCT00280917|471151861|FG000|Overall Study|Change Therapy|1|||
130869438|NCT00280917|471151862|FG001|Overall Study|Change Therapy|2|||
130869439|NCT00280917|471151863|FG002|Overall Study|Change Therapy|0|||
130869440|NCT00280917|471151864|FG003|Overall Study|Change Therapy|0|||
130869441|NCT00280917|471151861|FG000|Overall Study|Withdrawal by Subject|0|||
130869442|NCT00280917|471151862|FG001|Overall Study|Withdrawal by Subject|2|||
130869443|NCT00280917|471151863|FG002|Overall Study|Withdrawal by Subject|0|||
130869444|NCT00280917|471151864|FG003|Overall Study|Withdrawal by Subject|1|||
130869445|NCT00280917|471151861|FG000|Overall Study|Noncompliance|0|||
130869446|NCT00280917|471151862|FG001|Overall Study|Noncompliance|1|||
130869447|NCT00280917|471151863|FG002|Overall Study|Noncompliance|2|||
130869448|NCT00280917|471151864|FG003|Overall Study|Noncompliance|0|||
130869449|NCT01276639|471151877|FG000|Week 0 to 16|Death|1|||
130869450|NCT01276639|471151878|FG001|Week 0 to 16|Death|0|||
130869451|NCT01276639|471151879|FG002|Week 0 to 16|Death|0|||
130869452|NCT01276639|471151880|FG003|Week 0 to 16|Death|0|||
130869453|NCT01276639|471151881|FG004|Week 0 to 16|Death|0|||
130869454|NCT01276639|471151877|FG000|Week 0 to 16|Adverse Event|11|||
130869455|NCT01276639|471151878|FG001|Week 0 to 16|Adverse Event|8|||
130869456|NCT01276639|471151879|FG002|Week 0 to 16|Adverse Event|11|||
130869457|NCT01276639|471151880|FG003|Week 0 to 16|Adverse Event|0|||
130869458|NCT01276639|471151881|FG004|Week 0 to 16|Adverse Event|0|||
130869459|NCT01276639|471151877|FG000|Week 0 to 16|Lack of Efficacy|20|||
130869460|NCT01276639|471151878|FG001|Week 0 to 16|Lack of Efficacy|15|||
130869461|NCT01276639|471151879|FG002|Week 0 to 16|Lack of Efficacy|25|||
130869462|NCT01276639|471151880|FG003|Week 0 to 16|Lack of Efficacy|0|||
130869463|NCT01276639|471151881|FG004|Week 0 to 16|Lack of Efficacy|0|||
130869464|NCT01276639|471151877|FG000|Week 0 to 16|Lost to Follow-up|3|||
130869465|NCT01276639|471151878|FG001|Week 0 to 16|Lost to Follow-up|5|||
130869466|NCT01276639|471151879|FG002|Week 0 to 16|Lost to Follow-up|3|||
130869467|NCT01276639|471151880|FG003|Week 0 to 16|Lost to Follow-up|0|||
130869468|NCT01276639|471151881|FG004|Week 0 to 16|Lost to Follow-up|0|||
130869469|NCT01276639|471151877|FG000|Week 0 to 16|Withdrawal by Subject|8|||
130869470|NCT01276639|471151878|FG001|Week 0 to 16|Withdrawal by Subject|5|||
130869471|NCT01276639|471151879|FG002|Week 0 to 16|Withdrawal by Subject|4|||
130869472|NCT01276639|471151880|FG003|Week 0 to 16|Withdrawal by Subject|0|||
130869473|NCT01276639|471151881|FG004|Week 0 to 16|Withdrawal by Subject|0|||
130869474|NCT01276639|471151877|FG000|Week 0 to 16|Other|7|||
130869475|NCT01276639|471151878|FG001|Week 0 to 16|Other|7|||
130869476|NCT01276639|471151879|FG002|Week 0 to 16|Other|2|||
130869477|NCT01276639|471151880|FG003|Week 0 to 16|Other|0|||
130869478|NCT01276639|471151881|FG004|Week 0 to 16|Other|0|||
130869479|NCT01276639|471151877|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
130869480|NCT01276639|471151878|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
130869481|NCT01276639|471151879|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
130869482|NCT01276639|471151880|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
130869483|NCT01276639|471151881|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
130869484|NCT01276639|471151877|FG000|Week 16 to 52|Death|1|||
130869485|NCT01276639|471151878|FG001|Week 16 to 52|Death|0|||
130869486|NCT01276639|471151879|FG002|Week 16 to 52|Death|0|||
130869487|NCT01276639|471151880|FG003|Week 16 to 52|Death|0|||
130869488|NCT01276639|471151881|FG004|Week 16 to 52|Death|0|||
130869489|NCT01276639|471151877|FG000|Week 16 to 52|Adverse Event|10|||
130869490|NCT01276639|471151878|FG001|Week 16 to 52|Adverse Event|13|||
130869491|NCT01276639|471151879|FG002|Week 16 to 52|Adverse Event|0|||
130869492|NCT01276639|471151880|FG003|Week 16 to 52|Adverse Event|1|||
130869493|NCT01276639|471151881|FG004|Week 16 to 52|Adverse Event|3|||
130869494|NCT01276639|471151877|FG000|Week 16 to 52|Lack of Efficacy|99|||
130869495|NCT01276639|471151878|FG001|Week 16 to 52|Lack of Efficacy|71|||
130869496|NCT01276639|471151879|FG002|Week 16 to 52|Lack of Efficacy|0|||
130869497|NCT01276639|471151880|FG003|Week 16 to 52|Lack of Efficacy|14|||
130869498|NCT01276639|471151881|FG004|Week 16 to 52|Lack of Efficacy|13|||
130869499|NCT01276639|471151877|FG000|Week 16 to 52|Lost to Follow-up|3|||
130869500|NCT01276639|471151878|FG001|Week 16 to 52|Lost to Follow-up|1|||
130869501|NCT01276639|471151879|FG002|Week 16 to 52|Lost to Follow-up|0|||
130869502|NCT01276639|471151880|FG003|Week 16 to 52|Lost to Follow-up|0|||
130869503|NCT01276639|471151881|FG004|Week 16 to 52|Lost to Follow-up|1|||
130869504|NCT01276639|471151877|FG000|Week 16 to 52|Withdrawal by Subject|4|||
130869505|NCT01276639|471151878|FG001|Week 16 to 52|Withdrawal by Subject|4|||
130869506|NCT01276639|471151879|FG002|Week 16 to 52|Withdrawal by Subject|0|||
130869507|NCT01276639|471151880|FG003|Week 16 to 52|Withdrawal by Subject|0|||
130869508|NCT01276639|471151881|FG004|Week 16 to 52|Withdrawal by Subject|1|||
130869509|NCT01276639|471151877|FG000|Week 16 to 52|Other|10|||
130869510|NCT01276639|471151878|FG001|Week 16 to 52|Other|12|||
130869511|NCT01276639|471151879|FG002|Week 16 to 52|Other|0|||
130869512|NCT01276639|471151880|FG003|Week 16 to 52|Other|1|||
130869513|NCT01276639|471151881|FG004|Week 16 to 52|Other|3|||
130869514|NCT00466440|471151884|FG000|Overall Study|Adverse Event|0|||
130869515|NCT00466440|471151885|FG001|Overall Study|Adverse Event|3|||
130869516|NCT00466440|471151886|FG002|Overall Study|Adverse Event|1|||
130869517|NCT00466440|471151884|FG000|Overall Study|Death|1|||
130869518|NCT00466440|471151885|FG001|Overall Study|Death|1|||
130869519|NCT00466440|471151886|FG002|Overall Study|Death|0|||
130869520|NCT00466440|471151884|FG000|Overall Study|Progressive disease|13|||
130869521|NCT00466440|471151885|FG001|Overall Study|Progressive disease|5|||
130869522|NCT00466440|471151886|FG002|Overall Study|Progressive disease|4|||
130869523|NCT00466440|471151884|FG000|Overall Study|Lost to Follow-up|0|||
130869524|NCT00466440|471151885|FG001|Overall Study|Lost to Follow-up|1|||
130869525|NCT00466440|471151886|FG002|Overall Study|Lost to Follow-up|0|||
130869526|NCT00466440|471151884|FG000|Overall Study|Physician Decision|0|||
130869527|NCT00466440|471151885|FG001|Overall Study|Physician Decision|1|||
130869528|NCT00466440|471151886|FG002|Overall Study|Physician Decision|2|||
130869529|NCT00466440|471151884|FG000|Overall Study|Protocol entry criteria not met|0|||
130869530|NCT00466440|471151885|FG001|Overall Study|Protocol entry criteria not met|0|||
130869531|NCT00466440|471151886|FG002|Overall Study|Protocol entry criteria not met|4|||
130869532|NCT00466440|471151884|FG000|Overall Study|Withdrawal by Subject|0|||
130869533|NCT00466440|471151885|FG001|Overall Study|Withdrawal by Subject|1|||
130869534|NCT00466440|471151886|FG002|Overall Study|Withdrawal by Subject|0|||
130869535|NCT00466440|471151884|FG000|Overall Study|Sponsor decision|0|||
130869536|NCT00466440|471151885|FG001|Overall Study|Sponsor decision|0|||
130869537|NCT00466440|471151886|FG002|Overall Study|Sponsor decision|1|||
130869538|NCT00965081|471151887|FG000|Overall Study|Adverse Event|14|||
130869539|NCT00965081|471151888|FG001|Overall Study|Adverse Event|9|||
130869540|NCT00965081|471151887|FG000|Overall Study|Lack of Efficacy|2|||
130869541|NCT00965081|471151888|FG001|Overall Study|Lack of Efficacy|5|||
130869542|NCT00965081|471151887|FG000|Overall Study|Lost to Follow-up|4|||
130869543|NCT00965081|471151888|FG001|Overall Study|Lost to Follow-up|5|||
130869544|NCT00965081|471151887|FG000|Overall Study|Physician Decision|2|||
130869545|NCT00965081|471151888|FG001|Overall Study|Physician Decision|0|||
130869546|NCT00965081|471151887|FG000|Overall Study|Protocol Violation|2|||
130869547|NCT00965081|471151888|FG001|Overall Study|Protocol Violation|5|||
130869548|NCT00965081|471151887|FG000|Overall Study|Sponsor Decision|1|||
130869549|NCT00965081|471151888|FG001|Overall Study|Sponsor Decision|0|||
130869550|NCT00965081|471151887|FG000|Overall Study|Withdrawal by Subject|4|||
130869551|NCT00965081|471151888|FG001|Overall Study|Withdrawal by Subject|7|||
130869552|NCT00965081|471151887|FG000|Overall Study|Switched to Rescue Arm|5|||
130869553|NCT00965081|471151888|FG001|Overall Study|Switched to Rescue Arm|12|||
130869554|NCT00796666|471151891|FG000|Overall Study|Death|2|||
130869555|NCT00796666|471151892|FG001|Overall Study|Death|4|||
130869556|NCT00796666|471151891|FG000|Overall Study|Withdrawal by Subject|2|||
130869557|NCT00796666|471151892|FG001|Overall Study|Withdrawal by Subject|0|||
130869558|NCT00796666|471151891|FG000|Overall Study|Adverse Event|7|||
130869559|NCT00796666|471151892|FG001|Overall Study|Adverse Event|5|||
130869560|NCT00796666|471151891|FG000|Overall Study|Protocol Violation|1|||
130869561|NCT00796666|471151892|FG001|Overall Study|Protocol Violation|0|||
130869562|NCT00796666|471151891|FG000|Overall Study|Other|1|||
130869563|NCT00796666|471151892|FG001|Overall Study|Other|0|||
130869564|NCT00796666|471151891|FG000|Overall Study|Terminated by sponsor|53|||
130869565|NCT00796666|471151892|FG001|Overall Study|Terminated by sponsor|55|||
130869566|NCT00796666|471151891|FG000|Overall Study|Randomized and not treated|1|||
130869567|NCT00796666|471151892|FG001|Overall Study|Randomized and not treated|0|||
130869568|NCT00256724|471151895|FG000|Overall Study|Physician Decision|2|||
130869569|NCT00256724|471151896|FG001|Overall Study|Physician Decision|5|||
130869570|NCT00256724|471151895|FG000|Overall Study|Protocol Violation|3|||
130869571|NCT00256724|471151896|FG001|Overall Study|Protocol Violation|3|||
130869572|NCT01217463|471151897|FG000|Overall Study|Adverse Event|8|||
130869573|NCT01217463|471151898|FG001|Overall Study|Adverse Event|5|||
130869574|NCT01217463|471151897|FG000|Overall Study|Physician Decision|0|||
130869575|NCT01217463|471151898|FG001|Overall Study|Physician Decision|1|||
130869576|NCT01217463|471151897|FG000|Overall Study|Withdrawal by Subject|3|||
130869577|NCT01217463|471151898|FG001|Overall Study|Withdrawal by Subject|0|||
130869578|NCT01217463|471151897|FG000|Overall Study|Surgery on the Target Limb|0|||
130869579|NCT01217463|471151898|FG001|Overall Study|Surgery on the Target Limb|1|||
130869580|NCT01217463|471151897|FG000|Overall Study|Patient Non-compliant|1|||
130869581|NCT01217463|471151898|FG001|Overall Study|Patient Non-compliant|0|||
130869582|NCT01217463|471151897|FG000|Overall Study|Other|1|||
130869583|NCT01217463|471151898|FG001|Overall Study|Other|1|||
130869584|NCT02090426|471151902|FG000|Overall Study|Lost to Follow-up|12|||
130869585|NCT02090426|471151903|FG001|Overall Study|Lost to Follow-up|6|||
130869586|NCT01141712|471151904|FG000|Overall Study|Disease progression|3|||
130869587|NCT01012258|471151910|FG000|Overall Study|Death|14|||
130869588|NCT01012258|471151910|FG000|Overall Study|Lost to Follow-up|1|||
130869589|NCT01012258|471151910|FG000|Overall Study|Adverse Event|1|||
130869590|NCT01012258|471151910|FG000|Overall Study|Progressive Disease (PD)|18|||
130869591|NCT01012258|471151910|FG000|Overall Study|Symptomatic Deterioration|1|||
130869592|NCT01012258|471151910|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
130869593|NCT01012258|471151910|FG000|Overall Study|Another Tumor Discovered|1|||
130869594|NCT01012258|471151910|FG000|Overall Study|Ongoing|29|||
130869595|NCT03600740|471151911|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
130869596|NCT03571204|471151912|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
130869597|NCT03571204|471151913|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
130869598|NCT03571204|471151914|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
130869599|NCT03571204|471151912|FG000|Overall Study|Physician Decision|0|||
130869600|NCT03571204|471151913|FG001|Overall Study|Physician Decision|1|||
130869601|NCT03571204|471151914|FG002|Overall Study|Physician Decision|0|||
130869602|NCT02396212|471151915|FG000|Overall Study|Adverse Event|1|||
130869603|NCT02396212|471151915|FG000|Overall Study|Lack of Efficacy|2|||
130869604|NCT01623115|471151916|FG000|Overall Study|Randomized but not treated|0|||
130869605|NCT01623115|471151917|FG001|Overall Study|Randomized but not treated|1|||
130869606|NCT01623115|471151916|FG000|Overall Study|Physician Decision|1|||
130869607|NCT01623115|471151917|FG001|Overall Study|Physician Decision|0|||
130869608|NCT01623115|471151916|FG000|Overall Study|Participants moved|1|||
130869609|NCT01623115|471151917|FG001|Overall Study|Participants moved|5|||
130869610|NCT01623115|471151916|FG000|Overall Study|Adverse Event|10|||
130869611|NCT01623115|471151917|FG001|Overall Study|Adverse Event|13|||
130869612|NCT01623115|471151916|FG000|Overall Study|Poor compliance to protocol|4|||
130869613|NCT01623115|471151917|FG001|Overall Study|Poor compliance to protocol|10|||
130869614|NCT01623115|471151916|FG000|Overall Study|Consent withdrawn by participant|2|||
130869615|NCT01623115|471151917|FG001|Overall Study|Consent withdrawn by participant|6|||
130869616|NCT01623115|471151916|FG000|Overall Study|Related to study drug administration|0|||
130869617|NCT01623115|471151917|FG001|Overall Study|Related to study drug administration|2|||
130869618|NCT01623115|471151916|FG000|Overall Study|Last visit outside protocol visit window|14|||
130869619|NCT01623115|471151917|FG001|Overall Study|Last visit outside protocol visit window|26|||
130869620|NCT01623115|471151916|FG000|Overall Study|Site closure|1|||
130869621|NCT01623115|471151917|FG001|Overall Study|Site closure|7|||
130869622|NCT01623115|471151916|FG000|Overall Study|Death|0|||
130869623|NCT01623115|471151917|FG001|Overall Study|Death|4|||
130869624|NCT01623115|471151916|FG000|Overall Study|Other than specified above|0|||
130869625|NCT01623115|471151917|FG001|Overall Study|Other than specified above|3|||
130869626|NCT03384940|471151925|FG000|Overall Study|Progressive disease|36|||
130869627|NCT03384940|471151926|FG001|Overall Study|Progressive disease|11|||
130869628|NCT03384940|471151927|FG002|Overall Study|Progressive disease|13|||
130869629|NCT03384940|471151925|FG000|Overall Study|Clinical progression|4|||
130869630|NCT03384940|471151926|FG001|Overall Study|Clinical progression|0|||
130869631|NCT03384940|471151927|FG002|Overall Study|Clinical progression|3|||
130869632|NCT03384940|471151925|FG000|Overall Study|Adverse Event|7|||
130869633|NCT03384940|471151926|FG001|Overall Study|Adverse Event|1|||
130869634|NCT03384940|471151927|FG002|Overall Study|Adverse Event|1|||
130869635|NCT03384940|471151925|FG000|Overall Study|Withdrawal by Subject|3|||
130869636|NCT03384940|471151926|FG001|Overall Study|Withdrawal by Subject|1|||
130869637|NCT03384940|471151927|FG002|Overall Study|Withdrawal by Subject|0|||
130869638|NCT03384940|471151925|FG000|Overall Study|Physician Decision|1|||
130869639|NCT03384940|471151926|FG001|Overall Study|Physician Decision|1|||
130869640|NCT03384940|471151927|FG002|Overall Study|Physician Decision|0|||
130869641|NCT03384940|471151925|FG000|Overall Study|Death|2|||
130869642|NCT03384940|471151926|FG001|Overall Study|Death|1|||
130869643|NCT03384940|471151927|FG002|Overall Study|Death|0|||
130869644|NCT03384940|471151925|FG000|Overall Study|Other|0|||
130869645|NCT03384940|471151926|FG001|Overall Study|Other|0|||
130869646|NCT03384940|471151927|FG002|Overall Study|Other|1|||
130869647|NCT03089580|471151933|FG000|Overall Study|Lost to Follow-up|2|||
130869648|NCT03087513|471151934|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
130869649|NCT04170543|471151935|FG000|Overall Study|Death|1|||
130869650|NCT04170543|471151936|FG001|Overall Study|Death|1|||
130869651|NCT04170543|471151937|FG002|Overall Study|Death|1|||
130869652|NCT04170543|471151938|FG003|Overall Study|Death|1|||
130869653|NCT04170543|471151939|FG004|Overall Study|Death|1|||
130869654|NCT04170543|471151935|FG000|Overall Study|Lost to Follow-up|3|||
130869655|NCT04170543|471151936|FG001|Overall Study|Lost to Follow-up|3|||
130869656|NCT04170543|471151937|FG002|Overall Study|Lost to Follow-up|0|||
130869657|NCT04170543|471151938|FG003|Overall Study|Lost to Follow-up|3|||
130869658|NCT04170543|471151939|FG004|Overall Study|Lost to Follow-up|1|||
130869659|NCT04170543|471151935|FG000|Overall Study|Withdrawal by Subject|13|||
130869660|NCT04170543|471151936|FG001|Overall Study|Withdrawal by Subject|6|||
130869661|NCT04170543|471151937|FG002|Overall Study|Withdrawal by Subject|5|||
130869662|NCT04170543|471151938|FG003|Overall Study|Withdrawal by Subject|4|||
130869663|NCT04170543|471151939|FG004|Overall Study|Withdrawal by Subject|9|||
130869664|NCT04170543|471151935|FG000|Overall Study|Not able to transition to phase 2b|8|||
130869665|NCT04170543|471151936|FG001|Overall Study|Not able to transition to phase 2b|0|||
130869666|NCT04170543|471151937|FG002|Overall Study|Not able to transition to phase 2b|10|||
130869667|NCT04170543|471151938|FG003|Overall Study|Not able to transition to phase 2b|0|||
130869668|NCT04170543|471151939|FG004|Overall Study|Not able to transition to phase 2b|6|||
130869669|NCT04170543|471151935|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
130869670|NCT04170543|471151936|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
130869671|NCT04170543|471151937|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
130869672|NCT04170543|471151938|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
130869673|NCT04170543|471151939|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
130869674|NCT04170543|471151935|FG000|Overall Study|Not Treated|0|||
130869675|NCT04170543|471151936|FG001|Overall Study|Not Treated|0|||
130869676|NCT04170543|471151937|FG002|Overall Study|Not Treated|0|||
130869677|NCT04170543|471151938|FG003|Overall Study|Not Treated|0|||
130869678|NCT04170543|471151939|FG004|Overall Study|Not Treated|2|||
130869679|NCT04170543|471151935|FG000|Overall Study|(CRF)|16|||
130869680|NCT04170543|471151936|FG001|Overall Study|(CRF)|15|||
130869681|NCT04170543|471151937|FG002|Overall Study|(CRF)|12|||
130869682|NCT04170543|471151938|FG003|Overall Study|(CRF)|17|||
130869683|NCT04170543|471151939|FG004|Overall Study|(CRF)|17|||
130869684|NCT04170543|471151935|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
130869685|NCT04170543|471151936|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
130869686|NCT04170543|471151937|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
130869687|NCT04170543|471151938|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
130869688|NCT04170543|471151939|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
130869689|NCT00801216|471151940|FG000|Overall Study|Screening Failure|2|||
130869690|NCT05481359|471151941|FG000|Overall Study|Lost to Follow-up|3|||
130869691|NCT05481359|471151941|FG000|Overall Study|Withdrawal by Subject|1|||
130869692|NCT01712204|471151960|FG000|Overall Study|Adverse Event|3|||
130869693|NCT01712204|471151961|FG001|Overall Study|Adverse Event|1|||
130869694|NCT01712204|471151960|FG000|Overall Study|Withdrawal by Subject|3|||
130869695|NCT01712204|471151961|FG001|Overall Study|Withdrawal by Subject|3|||
130869696|NCT01712204|471151960|FG000|Overall Study|Lost to Follow-up|1|||
130869697|NCT01712204|471151961|FG001|Overall Study|Lost to Follow-up|0|||
130869698|NCT01712204|471151960|FG000|Overall Study|Protocol Violation|1|||
130869699|NCT01712204|471151961|FG001|Overall Study|Protocol Violation|1|||
130869700|NCT04186871|471151964|FG000|Overall Study|Lack of Efficacy|0|||
130869701|NCT04186871|471151965|FG001|Overall Study|Lack of Efficacy|1|||
130869702|NCT04186871|471151966|FG002|Overall Study|Lack of Efficacy|0|||
130869703|NCT04186871|471151967|FG003|Overall Study|Lack of Efficacy|0|||
130869704|NCT04186871|471151968|FG004|Overall Study|Lack of Efficacy|1|||
130869705|NCT04186871|471151969|FG005|Overall Study|Lack of Efficacy|1|||
130869706|NCT04186871|471151964|FG000|Overall Study|Adverse Event|1|||
130869707|NCT04186871|471151965|FG001|Overall Study|Adverse Event|1|||
130869708|NCT04186871|471151966|FG002|Overall Study|Adverse Event|0|||
130869709|NCT04186871|471151967|FG003|Overall Study|Adverse Event|0|||
130869710|NCT04186871|471151968|FG004|Overall Study|Adverse Event|0|||
130869711|NCT04186871|471151969|FG005|Overall Study|Adverse Event|2|||
130869712|NCT04186871|471151964|FG000|Overall Study|Study terminated by sponsor|1|||
130869713|NCT04186871|471151965|FG001|Overall Study|Study terminated by sponsor|2|||
130869714|NCT04186871|471151966|FG002|Overall Study|Study terminated by sponsor|0|||
130869715|NCT04186871|471151967|FG003|Overall Study|Study terminated by sponsor|1|||
130869716|NCT04186871|471151968|FG004|Overall Study|Study terminated by sponsor|0|||
130869717|NCT04186871|471151969|FG005|Overall Study|Study terminated by sponsor|0|||
130869718|NCT04186871|471151964|FG000|Overall Study|Other reasons|0|||
130869719|NCT04186871|471151965|FG001|Overall Study|Other reasons|0|||
130869720|NCT04186871|471151966|FG002|Overall Study|Other reasons|0|||
130869721|NCT04186871|471151967|FG003|Overall Study|Other reasons|0|||
130869722|NCT04186871|471151968|FG004|Overall Study|Other reasons|0|||
130869723|NCT04186871|471151969|FG005|Overall Study|Other reasons|1|||
130869724|NCT04186871|471151964|FG000|Overall Study|Withdrawal by Subject|0|||
130869725|NCT04186871|471151965|FG001|Overall Study|Withdrawal by Subject|0|||
130869726|NCT04186871|471151966|FG002|Overall Study|Withdrawal by Subject|0|||
130869727|NCT04186871|471151967|FG003|Overall Study|Withdrawal by Subject|0|||
130869728|NCT04186871|471151968|FG004|Overall Study|Withdrawal by Subject|0|||
130869729|NCT04186871|471151969|FG005|Overall Study|Withdrawal by Subject|1|||
130869730|NCT04186871|471151964|FG000|Overall Study|Lost to Follow-up|0|||
130869731|NCT04186871|471151965|FG001|Overall Study|Lost to Follow-up|0|||
130869732|NCT04186871|471151966|FG002|Overall Study|Lost to Follow-up|0|||
130869733|NCT04186871|471151967|FG003|Overall Study|Lost to Follow-up|0|||
130869734|NCT04186871|471151968|FG004|Overall Study|Lost to Follow-up|0|||
130869735|NCT04186871|471151969|FG005|Overall Study|Lost to Follow-up|1|||
130869736|NCT02464410|471151970|FG000|Overall Study|Death|3|||
130869737|NCT02464410|471151971|FG001|Overall Study|Death|4|||
130869738|NCT02464410|471151970|FG000|Overall Study|Lost to Follow-up|7|||
130869739|NCT02464410|471151971|FG001|Overall Study|Lost to Follow-up|9|||
130869740|NCT02464410|471151970|FG000|Overall Study|Withdrawal by Subject|12|||
130869741|NCT02464410|471151971|FG001|Overall Study|Withdrawal by Subject|3|||
130869742|NCT00543387|471151978|FG000|Panel 1 + Panel 2|Adverse Event|0|||
130869743|NCT00543387|471151979|FG001|Panel 1 + Panel 2|Adverse Event|1|||
130869744|NCT00543387|471151980|FG002|Panel 1 + Panel 2|Adverse Event|0|||
130869745|NCT00543387|471151981|FG003|Panel 1 + Panel 2|Adverse Event|0|||
130869746|NCT00543387|471151982|FG004|Panel 1 + Panel 2|Adverse Event|0|||
130869747|NCT00543387|471151983|FG005|Panel 1 + Panel 2|Adverse Event|0|||
130869748|NCT00543387|471151984|FG006|Panel 1 + Panel 2|Adverse Event|0|||
130869749|NCT00543387|471151985|FG007|Panel 1 + Panel 2|Adverse Event|1|||
130869750|NCT00543387|471151986|FG008|Panel 1 + Panel 2|Adverse Event|1|||
130869751|NCT00543387|471151987|FG009|Panel 1 + Panel 2|Adverse Event|0|||
130869752|NCT00543387|471151988|FG010|Panel 1 + Panel 2|Adverse Event|0|||
130869753|NCT00543387|471151978|FG000|Panel 1 + Panel 2|Physician Decision|0|||
130869754|NCT00543387|471151979|FG001|Panel 1 + Panel 2|Physician Decision|0|||
130869755|NCT00543387|471151980|FG002|Panel 1 + Panel 2|Physician Decision|1|||
130869756|NCT00543387|471151981|FG003|Panel 1 + Panel 2|Physician Decision|0|||
130869757|NCT00543387|471151982|FG004|Panel 1 + Panel 2|Physician Decision|0|||
130869758|NCT00543387|471151983|FG005|Panel 1 + Panel 2|Physician Decision|0|||
130869759|NCT00543387|471151984|FG006|Panel 1 + Panel 2|Physician Decision|0|||
130869760|NCT00543387|471151985|FG007|Panel 1 + Panel 2|Physician Decision|1|||
130869761|NCT00543387|471151986|FG008|Panel 1 + Panel 2|Physician Decision|0|||
130869762|NCT00543387|471151987|FG009|Panel 1 + Panel 2|Physician Decision|0|||
130869763|NCT00543387|471151988|FG010|Panel 1 + Panel 2|Physician Decision|0|||
130869764|NCT00543387|471151978|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130869765|NCT00543387|471151979|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
130869766|NCT00543387|471151980|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
130869767|NCT00543387|471151981|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130869768|NCT00543387|471151982|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130869769|NCT00543387|471151983|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130869770|NCT00543387|471151984|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
130869771|NCT00543387|471151985|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
130869772|NCT00543387|471151986|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
130869773|NCT00543387|471151987|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
130869774|NCT00543387|471151988|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
130869775|NCT00543387|471151978|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130869776|NCT00543387|471151979|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130869777|NCT00543387|471151980|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130869778|NCT00543387|471151981|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130869779|NCT00543387|471151982|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130869780|NCT00543387|471151983|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130869781|NCT00543387|471151984|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
130869782|NCT00543387|471151985|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130869783|NCT00543387|471151986|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130869784|NCT00543387|471151987|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130869785|NCT00543387|471151988|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130869786|NCT00543387|471151978|FG000|Crossover Participants|Progressive Disease|0|||
130869787|NCT00543387|471151979|FG001|Crossover Participants|Progressive Disease|0|||
130869788|NCT00543387|471151980|FG002|Crossover Participants|Progressive Disease|0|||
130869789|NCT00543387|471151981|FG003|Crossover Participants|Progressive Disease|0|||
130869790|NCT00543387|471151982|FG004|Crossover Participants|Progressive Disease|0|||
130869791|NCT00543387|471151983|FG005|Crossover Participants|Progressive Disease|0|||
130869792|NCT00543387|471151984|FG006|Crossover Participants|Progressive Disease|0|||
130869793|NCT00543387|471151985|FG007|Crossover Participants|Progressive Disease|0|||
130869794|NCT00543387|471151986|FG008|Crossover Participants|Progressive Disease|0|||
130869795|NCT00543387|471151987|FG009|Crossover Participants|Progressive Disease|1|||
130869796|NCT00543387|471151988|FG010|Crossover Participants|Progressive Disease|2|||
130869797|NCT00543387|471151978|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
130869798|NCT00543387|471151979|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
130869799|NCT00543387|471151980|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
130869800|NCT00543387|471151981|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
130869801|NCT00543387|471151982|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
130869802|NCT00543387|471151983|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
130869803|NCT00543387|471151984|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
130869804|NCT00543387|471151985|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
130869805|NCT00543387|471151986|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
130869806|NCT00543387|471151987|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
130869807|NCT00543387|471151988|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
130869808|NCT01114828|471151989|FG000|Overall Study|Adverse Event|1|||
130869809|NCT01114828|471151990|FG001|Overall Study|Adverse Event|1|||
130869810|NCT01114828|471151989|FG000|Overall Study|Lack of Efficacy|0|||
130869811|NCT01114828|471151990|FG001|Overall Study|Lack of Efficacy|2|||
130869812|NCT01114828|471151989|FG000|Overall Study|Protocol Violation|2|||
130869813|NCT01114828|471151990|FG001|Overall Study|Protocol Violation|0|||
130869814|NCT01114828|471151989|FG000|Overall Study|Withdrawal by Subject|0|||
130869815|NCT01114828|471151990|FG001|Overall Study|Withdrawal by Subject|1|||
130869816|NCT00940498|471151991|FG000|Overall Study|Death|2|||
130869817|NCT00940498|471151992|FG001|Overall Study|Death|0|||
130869818|NCT00940498|471151993|FG002|Overall Study|Death|0|||
130869819|NCT00940498|471151994|FG003|Overall Study|Death|1|||
130869820|NCT00940498|471151995|FG004|Overall Study|Death|5|||
130869821|NCT00940498|471151996|FG005|Overall Study|Death|0|||
130869822|NCT00940498|471151997|FG006|Overall Study|Death|1|||
130869823|NCT00940498|471151998|FG007|Overall Study|Death|0|||
130869824|NCT00940498|471151991|FG000|Overall Study|Lost to Follow-up|1|||
130869825|NCT00940498|471151992|FG001|Overall Study|Lost to Follow-up|1|||
130869826|NCT00940498|471151993|FG002|Overall Study|Lost to Follow-up|2|||
130869827|NCT00940498|471151994|FG003|Overall Study|Lost to Follow-up|0|||
130869828|NCT00940498|471151995|FG004|Overall Study|Lost to Follow-up|1|||
130869829|NCT00940498|471151996|FG005|Overall Study|Lost to Follow-up|0|||
130869830|NCT00940498|471151997|FG006|Overall Study|Lost to Follow-up|0|||
130869831|NCT00940498|471151998|FG007|Overall Study|Lost to Follow-up|1|||
130869832|NCT00940498|471151991|FG000|Overall Study|Disease Progression|0|||
130869833|NCT00940498|471151992|FG001|Overall Study|Disease Progression|0|||
130869834|NCT00940498|471151993|FG002|Overall Study|Disease Progression|1|||
130869835|NCT00940498|471151994|FG003|Overall Study|Disease Progression|1|||
130869836|NCT00940498|471151995|FG004|Overall Study|Disease Progression|0|||
130869837|NCT00940498|471151996|FG005|Overall Study|Disease Progression|1|||
130869838|NCT00940498|471151997|FG006|Overall Study|Disease Progression|0|||
130869839|NCT00940498|471151998|FG007|Overall Study|Disease Progression|0|||
130869840|NCT00940498|471151991|FG000|Overall Study|Physician Decision|0|||
130869841|NCT00940498|471151992|FG001|Overall Study|Physician Decision|0|||
130869842|NCT00940498|471151993|FG002|Overall Study|Physician Decision|0|||
130869843|NCT00940498|471151994|FG003|Overall Study|Physician Decision|0|||
130869844|NCT00940498|471151995|FG004|Overall Study|Physician Decision|2|||
130869845|NCT00940498|471151996|FG005|Overall Study|Physician Decision|0|||
130869846|NCT00940498|471151997|FG006|Overall Study|Physician Decision|0|||
130869847|NCT00940498|471151998|FG007|Overall Study|Physician Decision|0|||
130869848|NCT00940498|471151991|FG000|Overall Study|Not treated due to disease related pain|0|||
130869849|NCT00940498|471151992|FG001|Overall Study|Not treated due to disease related pain|0|||
130869850|NCT00940498|471151993|FG002|Overall Study|Not treated due to disease related pain|0|||
130869851|NCT00940498|471151994|FG003|Overall Study|Not treated due to disease related pain|0|||
130869852|NCT00940498|471151995|FG004|Overall Study|Not treated due to disease related pain|1|||
130869853|NCT00940498|471151996|FG005|Overall Study|Not treated due to disease related pain|0|||
130869854|NCT00940498|471151997|FG006|Overall Study|Not treated due to disease related pain|0|||
130869855|NCT00940498|471151998|FG007|Overall Study|Not treated due to disease related pain|0|||
130869856|NCT00549445|471151999|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
130869857|NCT00549445|471152000|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
130869858|NCT03932760|471152001|FG000|Overall Study|Became Ineligible|2|||
130869859|NCT03932760|471152002|FG001|Overall Study|Became Ineligible|5|||
130869860|NCT03932760|471152001|FG000|Overall Study|Withdrawal by Subject|6|||
130869861|NCT03932760|471152002|FG001|Overall Study|Withdrawal by Subject|6|||
130869862|NCT03566082|471152003|FG000|Overall Study|Death|7|||
130869863|NCT03566082|471152003|FG000|Overall Study|Failures (revision required)|2|||
130869864|NCT03566082|471152003|FG000|Overall Study|Lost to Follow-up|8|||
130869865|NCT01389882|471153172|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
130869866|NCT01389882|471153173|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
130869867|NCT01389882|471153172|FG000|Overall Study|Withdrawal by Subject|0|||
130869868|NCT01389882|471153173|FG001|Overall Study|Withdrawal by Subject|1|||
130869869|NCT03790111|471153174|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
130869870|NCT02796677|471153181|FG000|Overall Study|Adverse Event|11|||
130869871|NCT02796677|471153182|FG001|Overall Study|Adverse Event|22|||
130869872|NCT02796677|471153183|FG002|Overall Study|Adverse Event|14|||
130869873|NCT02796677|471153184|FG003|Overall Study|Adverse Event|14|||
130869874|NCT02796677|471153181|FG000|Overall Study|Protocol Violation|7|||
130869875|NCT02796677|471153182|FG001|Overall Study|Protocol Violation|5|||
130869876|NCT02796677|471153183|FG002|Overall Study|Protocol Violation|4|||
130869877|NCT02796677|471153184|FG003|Overall Study|Protocol Violation|8|||
130869878|NCT02796677|471153181|FG000|Overall Study|Lost to Follow-up|1|||
130869879|NCT02796677|471153182|FG001|Overall Study|Lost to Follow-up|5|||
130869880|NCT02796677|471153183|FG002|Overall Study|Lost to Follow-up|2|||
130869881|NCT02796677|471153184|FG003|Overall Study|Lost to Follow-up|2|||
130869882|NCT02796677|471153181|FG000|Overall Study|Lack of Efficacy|7|||
130869883|NCT02796677|471153182|FG001|Overall Study|Lack of Efficacy|9|||
130869884|NCT02796677|471153183|FG002|Overall Study|Lack of Efficacy|14|||
130869885|NCT02796677|471153184|FG003|Overall Study|Lack of Efficacy|20|||
130869886|NCT02796677|471153181|FG000|Overall Study|Withdrawal by Subject|4|||
130869887|NCT02796677|471153182|FG001|Overall Study|Withdrawal by Subject|14|||
130869888|NCT02796677|471153183|FG002|Overall Study|Withdrawal by Subject|6|||
130869889|NCT02796677|471153184|FG003|Overall Study|Withdrawal by Subject|7|||
130869890|NCT02796677|471153181|FG000|Overall Study|Progressive disease|6|||
130869891|NCT02796677|471153182|FG001|Overall Study|Progressive disease|15|||
130869892|NCT02796677|471153183|FG002|Overall Study|Progressive disease|13|||
130869893|NCT02796677|471153184|FG003|Overall Study|Progressive disease|18|||
130869894|NCT02796677|471153181|FG000|Overall Study|Reason not mentioned|2|||
130869895|NCT02796677|471153182|FG001|Overall Study|Reason not mentioned|3|||
130869896|NCT02796677|471153183|FG002|Overall Study|Reason not mentioned|0|||
130869897|NCT02796677|471153184|FG003|Overall Study|Reason not mentioned|5|||
130869898|NCT03811340|471153187|FG000|Overall Study|subjects did not complete the survey.|90|||
130869899|NCT01045967|471153188|FG000|Second Intervention|Protocol Violation|0|||
130869900|NCT01045967|471153189|FG001|Second Intervention|Protocol Violation|1|||
130869901|NCT01777308|471153190|FG000|Overall Study|Withdrawal by Subject|5|||
130869902|NCT01777308|471153191|FG001|Overall Study|Withdrawal by Subject|1|||
130869903|NCT01777308|471153190|FG000|Overall Study|Migrated/moved from study area|1|||
130869904|NCT01777308|471153191|FG001|Overall Study|Migrated/moved from study area|0|||
130869905|NCT01777308|471153190|FG000|Overall Study|Lost to Follow-up|7|||
130869906|NCT01777308|471153191|FG001|Overall Study|Lost to Follow-up|2|||
130869907|NCT01777308|471153190|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
130869908|NCT01777308|471153191|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
130869909|NCT03212326|471153192|FG000|Overall Study|Physician Decision|4|||
130869910|NCT02219464|471153194|FG000|Overall Study|Withdrawal by Subject|1|||
130869911|NCT02219464|471153195|FG001|Overall Study|Withdrawal by Subject|0|||
130869912|NCT02219464|471153194|FG000|Overall Study|case cancelled|1|||
130869913|NCT02219464|471153195|FG001|Overall Study|case cancelled|0|||
130869914|NCT02219464|471153194|FG000|Overall Study|catheter malfunction|1|||
130869915|NCT02219464|471153195|FG001|Overall Study|catheter malfunction|0|||
130869916|NCT01544920|471153212|FG000|Overall Study|Adverse Event|0|||
130869917|NCT01544920|471153213|FG001|Overall Study|Adverse Event|3|||
130869918|NCT01544920|471153212|FG000|Overall Study|Death|0|||
130869919|NCT01544920|471153213|FG001|Overall Study|Death|1|||
130869920|NCT01544920|471153212|FG000|Overall Study|Lost to Follow-up|11|||
130869921|NCT01544920|471153213|FG001|Overall Study|Lost to Follow-up|12|||
130869922|NCT01544920|471153212|FG000|Overall Study|Protocol Violation|0|||
130869923|NCT01544920|471153213|FG001|Overall Study|Protocol Violation|2|||
130869924|NCT01544920|471153212|FG000|Overall Study|Physician Decision|4|||
130869925|NCT01544920|471153213|FG001|Overall Study|Physician Decision|1|||
130869926|NCT01544920|471153212|FG000|Overall Study|Withdrawal by Subject|4|||
130869927|NCT01544920|471153213|FG001|Overall Study|Withdrawal by Subject|4|||
130869928|NCT00474955|471153216|FG000|Overall Study|Adverse Event|2|||
130869929|NCT00474955|471153216|FG000|Overall Study|Drug unavailability|1|||
130869930|NCT00474955|471153216|FG000|Overall Study|Personal reasons|5|||
130869931|NCT02576639|471153217|FG000|Overall Study|Withdrawal by Subject|1|||
130869932|NCT02576639|471153218|FG001|Overall Study|Withdrawal by Subject|2|||
130869933|NCT02576639|471153219|FG002|Overall Study|Withdrawal by Subject|1|||
130869934|NCT02576639|471153220|FG003|Overall Study|Withdrawal by Subject|0|||
130869935|NCT02576639|471153221|FG004|Overall Study|Withdrawal by Subject|1|||
130869936|NCT02576639|471153217|FG000|Overall Study|Adverse Event|1|||
130869937|NCT02576639|471153218|FG001|Overall Study|Adverse Event|0|||
130869938|NCT02576639|471153219|FG002|Overall Study|Adverse Event|1|||
130869939|NCT02576639|471153220|FG003|Overall Study|Adverse Event|1|||
130869940|NCT02576639|471153221|FG004|Overall Study|Adverse Event|2|||
130869941|NCT02576639|471153217|FG000|Overall Study|Physician Decision|0|||
130869942|NCT02576639|471153218|FG001|Overall Study|Physician Decision|0|||
130869943|NCT02576639|471153219|FG002|Overall Study|Physician Decision|0|||
130869944|NCT02576639|471153220|FG003|Overall Study|Physician Decision|0|||
130869945|NCT02576639|471153221|FG004|Overall Study|Physician Decision|1|||
130869946|NCT01135134|471153222|FG000|Overall Study|Adverse Event|1|||
130869947|NCT01135134|471153223|FG001|Overall Study|Adverse Event|1|||
130869948|NCT01135134|471153222|FG000|Overall Study|Did not meet protocol eligibility|1|||
130869949|NCT01135134|471153223|FG001|Overall Study|Did not meet protocol eligibility|0|||
130869950|NCT00255190|471153224|FG000|Overall Study|Adverse Event|17|||
130869951|NCT00255190|471153225|FG001|Overall Study|Adverse Event|36|||
130869952|NCT00255190|471153224|FG000|Overall Study|Protocol Violation|2|||
130869953|NCT00255190|471153225|FG001|Overall Study|Protocol Violation|2|||
130869954|NCT00255190|471153224|FG000|Overall Study|Lost to Follow-up|10|||
130869955|NCT00255190|471153225|FG001|Overall Study|Lost to Follow-up|27|||
130869956|NCT00255190|471153224|FG000|Overall Study|Withdrew Consent|17|||
130869957|NCT00255190|471153225|FG001|Overall Study|Withdrew Consent|48|||
130869958|NCT00255190|471153224|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
130869959|NCT00255190|471153225|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
130869960|NCT00255190|471153224|FG000|Overall Study|Erosive esophagitis not healed|0|||
130869961|NCT00255190|471153225|FG001|Overall Study|Erosive esophagitis not healed|20|||
130869962|NCT00255190|471153224|FG000|Overall Study|Various|4|||
130869963|NCT00255190|471153225|FG001|Overall Study|Various|23|||
130869964|NCT01569841|471153228|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
130869965|NCT01569841|471153229|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
130869966|NCT00764361|471153230|FG000|Overall Study|Withdrawal by Subject|2|||
130869967|NCT00764361|471153231|FG001|Overall Study|Withdrawal by Subject|3|||
130869968|NCT00764361|471153230|FG000|Overall Study|Adverse Event|0|||
130869969|NCT00764361|471153231|FG001|Overall Study|Adverse Event|1|||
130869970|NCT01454596|471153232|FG000|Overall Study|Death|0|||
130869971|NCT01454596|471153233|FG001|Overall Study|Death|0|||
130869972|NCT01454596|471153234|FG002|Overall Study|Death|0|||
130869973|NCT01454596|471153235|FG003|Overall Study|Death|0|||
130869974|NCT01454596|471153236|FG004|Overall Study|Death|0|||
130869975|NCT01454596|471153237|FG005|Overall Study|Death|0|||
130869976|NCT01454596|471153238|FG006|Overall Study|Death|0|||
130869977|NCT01454596|471153239|FG007|Overall Study|Death|0|||
130869978|NCT01454596|471153240|FG008|Overall Study|Death|0|||
130869979|NCT01454596|471153241|FG009|Overall Study|Death|1|||
130869980|NCT01454596|471153242|FG010|Overall Study|Death|1|||
130869981|NCT01454596|471153243|FG011|Overall Study|Death|0|||
130869982|NCT00857285|471153245|FG000|Overall Study|Adverse Event|4|||
130869983|NCT00857285|471153246|FG001|Overall Study|Adverse Event|2|||
130869984|NCT00857285|471153245|FG000|Overall Study|Lack of Efficacy|0|||
130869985|NCT00857285|471153246|FG001|Overall Study|Lack of Efficacy|2|||
130869986|NCT00857285|471153245|FG000|Overall Study|Protocol Violation|3|||
130869987|NCT00857285|471153246|FG001|Overall Study|Protocol Violation|1|||
130869988|NCT00857285|471153245|FG000|Overall Study|Withdrawal by Subject|4|||
130869989|NCT00857285|471153246|FG001|Overall Study|Withdrawal by Subject|0|||
130869990|NCT00857285|471153245|FG000|Overall Study|Randomization criteria not met|1|||
130869991|NCT00857285|471153246|FG001|Overall Study|Randomization criteria not met|1|||
130869992|NCT00430716|471153247|FG000|Double Blind Phase|Death|1|||
130869993|NCT00430716|471153248|FG001|Double Blind Phase|Death|0|||
130869994|NCT00430716|471153249|FG002|Double Blind Phase|Death|0|||
130869995|NCT00430716|471153247|FG000|Double Blind Phase|No longer willing to participate|2|||
130869996|NCT00430716|471153248|FG001|Double Blind Phase|No longer willing to participate|1|||
130869997|NCT00430716|471153249|FG002|Double Blind Phase|No longer willing to participate|1|||
130869998|NCT00430716|471153247|FG000|Double Blind Phase|Other|0|||
130869999|NCT00430716|471153248|FG001|Double Blind Phase|Other|2|||
130870000|NCT00430716|471153249|FG002|Double Blind Phase|Other|0|||
130870001|NCT00430716|471153247|FG000|Double Blind Phase|Study terminated by sponsor|1|||
130870002|NCT00430716|471153248|FG001|Double Blind Phase|Study terminated by sponsor|1|||
130870003|NCT00430716|471153249|FG002|Double Blind Phase|Study terminated by sponsor|2|||
130870004|NCT00430716|471153247|FG000|Double Blind Phase|Adverse Event|1|||
130870005|NCT00430716|471153248|FG001|Double Blind Phase|Adverse Event|1|||
130870006|NCT00430716|471153249|FG002|Double Blind Phase|Adverse Event|3|||
130870007|NCT00430716|471153247|FG000|Double Blind Phase|Not treated|1|||
130870008|NCT00430716|471153248|FG001|Double Blind Phase|Not treated|0|||
130870009|NCT00430716|471153249|FG002|Double Blind Phase|Not treated|0|||
130870010|NCT00430716|471153247|FG000|Open Label Phase|Lost to Follow-up|1|||
130870011|NCT00430716|471153248|FG001|Open Label Phase|Lost to Follow-up|0|||
130870012|NCT00430716|471153249|FG002|Open Label Phase|Lost to Follow-up|1|||
130870013|NCT00430716|471153247|FG000|Open Label Phase|No longer willing to participate|0|||
130870014|NCT00430716|471153248|FG001|Open Label Phase|No longer willing to participate|1|||
130870015|NCT00430716|471153249|FG002|Open Label Phase|No longer willing to participate|1|||
130870016|NCT00430716|471153247|FG000|Open Label Phase|Other|3|||
130870017|NCT00430716|471153248|FG001|Open Label Phase|Other|1|||
130870018|NCT00430716|471153249|FG002|Open Label Phase|Other|1|||
130870019|NCT00430716|471153247|FG000|Open Label Phase|Protocol Violation|1|||
130870020|NCT00430716|471153248|FG001|Open Label Phase|Protocol Violation|0|||
130870021|NCT00430716|471153249|FG002|Open Label Phase|Protocol Violation|0|||
130870022|NCT00430716|471153247|FG000|Open Label Phase|Study terminated by sponsor|4|||
130870023|NCT00430716|471153248|FG001|Open Label Phase|Study terminated by sponsor|5|||
130870024|NCT00430716|471153249|FG002|Open Label Phase|Study terminated by sponsor|4|||
130870025|NCT01329978|471153253|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
130870026|NCT01329978|471153254|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
130870027|NCT01329978|471153255|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
130870028|NCT01329978|471153256|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
130870029|NCT01329978|471153257|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
130870030|NCT01329978|471153253|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
130870031|NCT01329978|471153254|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
130870032|NCT01329978|471153255|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
130870033|NCT01329978|471153256|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
130870034|NCT01329978|471153257|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
130870035|NCT01329978|471153253|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
130870036|NCT01329978|471153254|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
130870037|NCT01329978|471153255|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
130870038|NCT01329978|471153256|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
130870039|NCT01329978|471153257|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
130870040|NCT01329978|471153253|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130870041|NCT01329978|471153254|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
130870042|NCT01329978|471153255|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130870043|NCT01329978|471153256|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130870044|NCT01329978|471153257|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130870045|NCT01329978|471153253|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130870046|NCT01329978|471153254|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
130870047|NCT01329978|471153255|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130870048|NCT01329978|471153256|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130870049|NCT01329978|471153257|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130870050|NCT01329978|471153253|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
130870051|NCT01329978|471153254|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
130870052|NCT01329978|471153255|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
130870053|NCT01329978|471153256|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
130870054|NCT01329978|471153257|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
130870055|NCT01329978|471153253|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130870056|NCT01329978|471153254|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130870057|NCT01329978|471153255|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130870058|NCT01329978|471153256|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130870059|NCT01329978|471153257|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
130870060|NCT04303559|471153262|FG000|Overall Study|Study closed due to poor enrollment.|1|||
130870061|NCT01987102|471153263|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
130870062|NCT01987102|471153264|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
130870063|NCT01987102|471153263|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
130870064|NCT01987102|471153264|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
130870065|NCT01987102|471153263|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
130870066|NCT01987102|471153264|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
130870067|NCT01987102|471153263|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
130870068|NCT01987102|471153264|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
130870069|NCT01987102|471153263|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
130870070|NCT01987102|471153264|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
130870071|NCT01987102|471153263|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
130870072|NCT01987102|471153264|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
130870073|NCT01236521|471153267|FG000|Overall Study|Withdrawal by Subject|12|||
130870074|NCT01236521|471153268|FG001|Overall Study|Withdrawal by Subject|17|||
130870075|NCT01236521|471153267|FG000|Overall Study|Death|2|||
130870076|NCT01236521|471153268|FG001|Overall Study|Death|1|||
130870077|NCT01236521|471153267|FG000|Overall Study|Lost to Follow-up|9|||
130870078|NCT01236521|471153268|FG001|Overall Study|Lost to Follow-up|7|||
130870079|NCT03116685|471153273|FG000|Overall Study|Physician Decision|0|||
130870080|NCT03116685|471153274|FG001|Overall Study|Physician Decision|1|||
130870081|NCT04491136|471153279|FG000|Overall Study|Patient withdraw informed consent|9|||
130870082|NCT04491136|471153279|FG000|Overall Study|Adverse Event|2|||
130870083|NCT04491136|471153279|FG000|Overall Study|Death|3|||
130870084|NCT04491136|471153279|FG000|Overall Study|Lost to Follow-up|3|||
130870085|NCT04491136|471153279|FG000|Overall Study|Physician Decision|45|||
130870086|NCT04491136|471153279|FG000|Overall Study|sponsor terminated the study early|16|||
130870087|NCT04491136|471153279|FG000|Overall Study|Patient/guardian's decision|1|||
130870088|NCT01611194|471153280|FG000|Overall Study|Lost to Follow-up|0|||
130870089|NCT01611194|471153281|FG001|Overall Study|Lost to Follow-up|1|||
130870090|NCT01611194|471153280|FG000|Overall Study|Withdrawal by Subject|0|||
130870091|NCT01611194|471153281|FG001|Overall Study|Withdrawal by Subject|1|||
130870092|NCT01611194|471153280|FG000|Overall Study|drug use|0|||
130870093|NCT01611194|471153281|FG001|Overall Study|drug use|1|||
130870094|NCT00348673|471153282|FG000|Stage 1|Randomized but not Treated|0|||
130870095|NCT00348673|471153283|FG001|Stage 1|Randomized but not Treated|0|||
130870096|NCT00348673|471153284|FG002|Stage 1|Randomized but not Treated|1|||
130870097|NCT00348673|471153285|FG003|Stage 1|Randomized but not Treated|0|||
130870098|NCT00348673|471153286|FG004|Stage 1|Randomized but not Treated|0|||
130870099|NCT00348673|471153287|FG005|Stage 1|Randomized but not Treated|0|||
130870100|NCT00348673|471153288|FG006|Stage 1|Randomized but not Treated|0|||
130870101|NCT00348673|471153289|FG007|Stage 1|Randomized but not Treated|0|||
130870102|NCT00348673|471153290|FG008|Stage 1|Randomized but not Treated|0|||
130870103|NCT01943591|471153294|FG000|Overall Study|Lost to Follow-up|3|||
130870104|NCT01943591|471153295|FG001|Overall Study|Lost to Follow-up|4|||
130870105|NCT01943591|471153294|FG000|Overall Study|Death|2|||
130870106|NCT01943591|471153295|FG001|Overall Study|Death|7|||
130870107|NCT02719171|471155039|FG000|Overall Study|Adverse Event|1|||
130870108|NCT02719171|471155040|FG001|Overall Study|Adverse Event|2|||
130870109|NCT02719171|471155041|FG002|Overall Study|Adverse Event|0|||
130870110|NCT02719171|471155042|FG003|Overall Study|Adverse Event|0|||
130870111|NCT02719171|471155043|FG004|Overall Study|Adverse Event|2|||
130870112|NCT02719171|471155039|FG000|Overall Study|Lost to Follow-up|0|||
130870113|NCT02719171|471155040|FG001|Overall Study|Lost to Follow-up|0|||
130870114|NCT02719171|471155041|FG002|Overall Study|Lost to Follow-up|1|||
130870115|NCT02719171|471155042|FG003|Overall Study|Lost to Follow-up|0|||
130870116|NCT02719171|471155043|FG004|Overall Study|Lost to Follow-up|0|||
130870117|NCT02719171|471155039|FG000|Overall Study|Subject Withdrawal|0|||
130870118|NCT02719171|471155040|FG001|Overall Study|Subject Withdrawal|2|||
130870119|NCT02719171|471155041|FG002|Overall Study|Subject Withdrawal|2|||
130870120|NCT02719171|471155042|FG003|Overall Study|Subject Withdrawal|1|||
130870121|NCT02719171|471155043|FG004|Overall Study|Subject Withdrawal|0|||
130870122|NCT02719171|471155039|FG000|Overall Study|Other|0|||
130870123|NCT02719171|471155040|FG001|Overall Study|Other|0|||
130870124|NCT02719171|471155041|FG002|Overall Study|Other|0|||
130870125|NCT02719171|471155042|FG003|Overall Study|Other|1|||
130870126|NCT02719171|471155043|FG004|Overall Study|Other|0|||
130870127|NCT02614729|471155044|FG000|Overall Study|Withdrawal by Subject|1|||
130870128|NCT02614729|471155045|FG001|Overall Study|Withdrawal by Subject|0|||
130870129|NCT02539797|471155048|FG000|Overall Study|Lost to Follow-up|0|||
130870130|NCT02539797|471155049|FG001|Overall Study|Lost to Follow-up|1|||
130870131|NCT02539797|471155050|FG002|Overall Study|Lost to Follow-up|0|||
130870132|NCT03798717|471155052|FG000|Overall Study|Failed Screening|0|||
130870133|NCT03798717|471155053|FG001|Overall Study|Failed Screening|0|||
130870134|NCT03798717|471155054|FG002|Overall Study|Failed Screening|0|||
130870135|NCT03798717|471155055|FG003|Overall Study|Failed Screening|0|||
130870136|NCT03798717|471155056|FG004|Overall Study|Failed Screening|0|||
130870137|NCT03798717|471155057|FG005|Overall Study|Failed Screening|1|||
130870138|NCT03798717|471155052|FG000|Overall Study|Physician Decision|1|||
130870139|NCT03798717|471155053|FG001|Overall Study|Physician Decision|0|||
130870140|NCT03798717|471155054|FG002|Overall Study|Physician Decision|1|||
130870141|NCT03798717|471155055|FG003|Overall Study|Physician Decision|0|||
130870142|NCT03798717|471155056|FG004|Overall Study|Physician Decision|0|||
130870143|NCT03798717|471155057|FG005|Overall Study|Physician Decision|0|||
130870144|NCT03798717|471155052|FG000|Overall Study|Withdrawal by Subject|0|||
130870145|NCT03798717|471155053|FG001|Overall Study|Withdrawal by Subject|0|||
130870146|NCT03798717|471155054|FG002|Overall Study|Withdrawal by Subject|0|||
130870147|NCT03798717|471155055|FG003|Overall Study|Withdrawal by Subject|1|||
130870148|NCT03798717|471155056|FG004|Overall Study|Withdrawal by Subject|0|||
130870149|NCT03798717|471155057|FG005|Overall Study|Withdrawal by Subject|0|||
130870150|NCT03798717|471155052|FG000|Overall Study|Lost to Follow-up|1|||
130870151|NCT03798717|471155053|FG001|Overall Study|Lost to Follow-up|0|||
130870152|NCT03798717|471155054|FG002|Overall Study|Lost to Follow-up|0|||
130870153|NCT03798717|471155055|FG003|Overall Study|Lost to Follow-up|1|||
130870154|NCT03798717|471155056|FG004|Overall Study|Lost to Follow-up|0|||
130870155|NCT03798717|471155057|FG005|Overall Study|Lost to Follow-up|0|||
130870156|NCT03798717|471155052|FG000|Overall Study|Adverse Event|0|||
130870157|NCT03798717|471155053|FG001|Overall Study|Adverse Event|1|||
130870158|NCT03798717|471155054|FG002|Overall Study|Adverse Event|0|||
130870159|NCT03798717|471155055|FG003|Overall Study|Adverse Event|0|||
130870160|NCT03798717|471155056|FG004|Overall Study|Adverse Event|0|||
130870161|NCT03798717|471155057|FG005|Overall Study|Adverse Event|0|||
130870162|NCT03798717|471155052|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130870163|NCT03798717|471155053|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130870164|NCT03798717|471155054|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130870165|NCT03798717|471155055|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130870166|NCT03798717|471155056|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
130870167|NCT03798717|471155057|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130870168|NCT04002960|471155059|FG000|Overall Study|Withdrawn prior to Completion|2|||
130870169|NCT00383786|471155074|FG000|Overall Study|Protocol Violation|2|||
130870170|NCT00383786|471155075|FG001|Overall Study|Protocol Violation|6|||
130870171|NCT00383786|471155074|FG000|Overall Study|Withdrawal by Subject|2|||
130870172|NCT00383786|471155075|FG001|Overall Study|Withdrawal by Subject|5|||
130870173|NCT00383786|471155074|FG000|Overall Study|Physician Decision|0|||
130870174|NCT00383786|471155075|FG001|Overall Study|Physician Decision|1|||
130870175|NCT00985673|471155076|FG000|Overall Study|Lost to Follow-up|6|||
130870176|NCT00985673|471155077|FG001|Overall Study|Lost to Follow-up|7|||
130870177|NCT00985673|471155078|FG002|Overall Study|Lost to Follow-up|6|||
130870178|NCT00985673|471155079|FG003|Overall Study|Lost to Follow-up|10|||
130870179|NCT00985673|471155080|FG004|Overall Study|Lost to Follow-up|5|||
130870180|NCT00985673|471155081|FG005|Overall Study|Lost to Follow-up|3|||
130870181|NCT00985673|471155076|FG000|Overall Study|Withdrawal by Subject|0|||
130870182|NCT00985673|471155077|FG001|Overall Study|Withdrawal by Subject|4|||
130870183|NCT00985673|471155078|FG002|Overall Study|Withdrawal by Subject|5|||
130870184|NCT00985673|471155079|FG003|Overall Study|Withdrawal by Subject|2|||
130870185|NCT00985673|471155080|FG004|Overall Study|Withdrawal by Subject|2|||
130870186|NCT00985673|471155081|FG005|Overall Study|Withdrawal by Subject|3|||
130870187|NCT00985673|471155076|FG000|Overall Study|Other|1|||
130870188|NCT00985673|471155077|FG001|Overall Study|Other|0|||
130870189|NCT00985673|471155078|FG002|Overall Study|Other|1|||
130870190|NCT00985673|471155079|FG003|Overall Study|Other|0|||
130870191|NCT00985673|471155080|FG004|Overall Study|Other|1|||
130870192|NCT00985673|471155081|FG005|Overall Study|Other|0|||
130870193|NCT02252146|471155082|FG000|Overall Study|Lack of Efficacy|4|||
130870194|NCT02252146|471155082|FG000|Overall Study|Entered hospice care|1|||
130870195|NCT02252146|471155082|FG000|Overall Study|Inability to travel to study site|1|||
130870196|NCT00531284|471155085|FG000|Overall Study|Progressive Disease|1|||
130870197|NCT00531284|471155086|FG001|Overall Study|Progressive Disease|3|||
130870198|NCT00531284|471155087|FG002|Overall Study|Progressive Disease|5|||
130870199|NCT00531284|471155088|FG003|Overall Study|Progressive Disease|42|||
130870200|NCT00531284|471155089|FG004|Overall Study|Progressive Disease|4|||
130870201|NCT00531284|471155090|FG005|Overall Study|Progressive Disease|4|||
130870202|NCT00531284|471155091|FG006|Overall Study|Progressive Disease|3|||
130870203|NCT00531284|471155092|FG007|Overall Study|Progressive Disease|8|||
130870204|NCT00531284|471155093|FG008|Overall Study|Progressive Disease|6|||
130870205|NCT00531284|471155094|FG009|Overall Study|Progressive Disease|3|||
130870206|NCT00531284|471155095|FG010|Overall Study|Progressive Disease|3|||
130870207|NCT00531284|471155096|FG011|Overall Study|Progressive Disease|14|||
130870208|NCT00531284|471155097|FG012|Overall Study|Progressive Disease|2|||
130870209|NCT00531284|471155098|FG013|Overall Study|Progressive Disease|1|||
130870210|NCT00531284|471155099|FG014|Overall Study|Progressive Disease|2|||
130870211|NCT00531284|471155100|FG015|Overall Study|Progressive Disease|11|||
130870212|NCT00531284|471155101|FG016|Overall Study|Progressive Disease|5|||
130870213|NCT00531284|471155085|FG000|Overall Study|Adverse Event|0|||
130870214|NCT00531284|471155086|FG001|Overall Study|Adverse Event|1|||
130870215|NCT00531284|471155087|FG002|Overall Study|Adverse Event|1|||
130870216|NCT00531284|471155088|FG003|Overall Study|Adverse Event|7|||
130870217|NCT00531284|471155089|FG004|Overall Study|Adverse Event|0|||
130870218|NCT00531284|471155090|FG005|Overall Study|Adverse Event|2|||
130870219|NCT00531284|471155091|FG006|Overall Study|Adverse Event|3|||
130870220|NCT00531284|471155092|FG007|Overall Study|Adverse Event|2|||
130870221|NCT00531284|471155093|FG008|Overall Study|Adverse Event|3|||
130870222|NCT00531284|471155094|FG009|Overall Study|Adverse Event|0|||
130870223|NCT00531284|471155095|FG010|Overall Study|Adverse Event|0|||
130870224|NCT00531284|471155096|FG011|Overall Study|Adverse Event|5|||
130870225|NCT00531284|471155097|FG012|Overall Study|Adverse Event|0|||
130870226|NCT00531284|471155098|FG013|Overall Study|Adverse Event|1|||
130870227|NCT00531284|471155099|FG014|Overall Study|Adverse Event|1|||
130870228|NCT00531284|471155100|FG015|Overall Study|Adverse Event|0|||
130870229|NCT00531284|471155101|FG016|Overall Study|Adverse Event|2|||
130870230|NCT00531284|471155085|FG000|Overall Study|Withdrawal by Subject|1|||
130870231|NCT00531284|471155086|FG001|Overall Study|Withdrawal by Subject|0|||
130870232|NCT00531284|471155087|FG002|Overall Study|Withdrawal by Subject|0|||
130870233|NCT00531284|471155088|FG003|Overall Study|Withdrawal by Subject|4|||
130870234|NCT00531284|471155089|FG004|Overall Study|Withdrawal by Subject|0|||
130870235|NCT00531284|471155090|FG005|Overall Study|Withdrawal by Subject|0|||
130870236|NCT00531284|471155091|FG006|Overall Study|Withdrawal by Subject|0|||
130870237|NCT00531284|471155092|FG007|Overall Study|Withdrawal by Subject|0|||
130870238|NCT00531284|471155093|FG008|Overall Study|Withdrawal by Subject|0|||
130870239|NCT00531284|471155094|FG009|Overall Study|Withdrawal by Subject|0|||
130870240|NCT00531284|471155095|FG010|Overall Study|Withdrawal by Subject|0|||
130870241|NCT00531284|471155096|FG011|Overall Study|Withdrawal by Subject|3|||
130870242|NCT00531284|471155097|FG012|Overall Study|Withdrawal by Subject|0|||
130870243|NCT00531284|471155098|FG013|Overall Study|Withdrawal by Subject|1|||
130870244|NCT00531284|471155099|FG014|Overall Study|Withdrawal by Subject|0|||
130870245|NCT00531284|471155100|FG015|Overall Study|Withdrawal by Subject|1|||
130870246|NCT00531284|471155101|FG016|Overall Study|Withdrawal by Subject|1|||
130870247|NCT00531284|471155085|FG000|Overall Study|Other|1|||
130870248|NCT00531284|471155086|FG001|Overall Study|Other|0|||
130870249|NCT00531284|471155087|FG002|Overall Study|Other|0|||
130870250|NCT00531284|471155088|FG003|Overall Study|Other|10|||
130870251|NCT00531284|471155089|FG004|Overall Study|Other|2|||
130870252|NCT00531284|471155090|FG005|Overall Study|Other|1|||
130870253|NCT00531284|471155091|FG006|Overall Study|Other|0|||
130870254|NCT00531284|471155092|FG007|Overall Study|Other|0|||
130870255|NCT00531284|471155093|FG008|Overall Study|Other|2|||
130870256|NCT00531284|471155094|FG009|Overall Study|Other|1|||
130870257|NCT00531284|471155095|FG010|Overall Study|Other|0|||
130870258|NCT00531284|471155096|FG011|Overall Study|Other|2|||
130870259|NCT00531284|471155097|FG012|Overall Study|Other|0|||
130870260|NCT00531284|471155098|FG013|Overall Study|Other|0|||
130870261|NCT00531284|471155099|FG014|Overall Study|Other|1|||
130870262|NCT00531284|471155100|FG015|Overall Study|Other|0|||
130870263|NCT00531284|471155101|FG016|Overall Study|Other|0|||
130870264|NCT00984256|471155102|FG000|Overall Study|Withdrawal by Subject|0|||
130870265|NCT00984256|471155103|FG001|Overall Study|Withdrawal by Subject|1|||
130870266|NCT03057496|471155104|FG000|Overall Study|Withdrawal by Subject|8|||
130870267|NCT03057496|471155104|FG000|Overall Study|Lost to Follow-up|5|||
130870268|NCT03057496|471155104|FG000|Overall Study|Did not use device during home trial|3|||
130870269|NCT03057496|471155104|FG000|Overall Study|Device failure|2|||
130870270|NCT02723773|471155112|FG000|Overall Study|Adverse Event|934|||
130870271|NCT02723773|471155113|FG001|Overall Study|Adverse Event|3|||
130870272|NCT02723773|471155114|FG002|Overall Study|Adverse Event|1|||
130870273|NCT02723773|471155115|FG003|Overall Study|Adverse Event|9|||
130870274|NCT02723773|471155112|FG000|Overall Study|Protocol Violation|1|||
130870275|NCT02723773|471155113|FG001|Overall Study|Protocol Violation|0|||
130870276|NCT02723773|471155114|FG002|Overall Study|Protocol Violation|0|||
130870277|NCT02723773|471155115|FG003|Overall Study|Protocol Violation|0|||
130870278|NCT02723773|471155112|FG000|Overall Study|Withdrawal by Subject|360|||
130870279|NCT02723773|471155113|FG001|Overall Study|Withdrawal by Subject|5|||
130870280|NCT02723773|471155114|FG002|Overall Study|Withdrawal by Subject|6|||
130870281|NCT02723773|471155115|FG003|Overall Study|Withdrawal by Subject|10|||
130870282|NCT02723773|471155112|FG000|Overall Study|Migrated/moved from study area|37|||
130870283|NCT02723773|471155113|FG001|Overall Study|Migrated/moved from study area|0|||
130870284|NCT02723773|471155114|FG002|Overall Study|Migrated/moved from study area|0|||
130870285|NCT02723773|471155115|FG003|Overall Study|Migrated/moved from study area|1|||
130870286|NCT02723773|471155112|FG000|Overall Study|Lost to Follow-up|198|||
130870287|NCT02723773|471155113|FG001|Overall Study|Lost to Follow-up|0|||
130870288|NCT02723773|471155114|FG002|Overall Study|Lost to Follow-up|0|||
130870289|NCT02723773|471155115|FG003|Overall Study|Lost to Follow-up|0|||
130870290|NCT02723773|471155112|FG000|Overall Study|Other|189|||
130870291|NCT02723773|471155113|FG001|Overall Study|Other|1|||
130870292|NCT02723773|471155114|FG002|Overall Study|Other|2|||
130870293|NCT02723773|471155115|FG003|Overall Study|Other|2|||
130870294|NCT01132807|471155116|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
130870295|NCT01132807|471155117|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
130870296|NCT01132807|471155118|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
130870297|NCT01132807|471155116|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
130870298|NCT01132807|471155117|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
130870299|NCT01132807|471155118|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
130870300|NCT00354679|471155123|FG000|Overall Study|Patient Not Treated|1|||
130870301|NCT02420093|471155124|FG000|Overall Study|Withdrawal by Subject|1|||
130870302|NCT02420093|471155125|FG001|Overall Study|Withdrawal by Subject|1|||
130870303|NCT01859923|471155126|FG000|Overall Study|Adverse Event|0|||
130870304|NCT01859923|471155127|FG001|Overall Study|Adverse Event|0|||
130870305|NCT01859923|471155128|FG002|Overall Study|Adverse Event|1|||
130870306|NCT01859923|471155129|FG003|Overall Study|Adverse Event|1|||
130870307|NCT00057863|471155133|FG000|Overall Study|Death|1|||
130870308|NCT00057863|471155133|FG000|Overall Study|Withdrawal by Subject|2|||
130870309|NCT02079038|471155137|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
130870310|NCT02079038|471155138|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
130870311|NCT02079038|471155137|FG000|Modified Intent to Treat Population|Death|1|||
130870312|NCT02079038|471155138|FG001|Modified Intent to Treat Population|Death|0|||
130870313|NCT02079038|471155137|FG000|Completed 6 Months|Lost to Follow-up|2|||
130870314|NCT02079038|471155138|FG001|Completed 6 Months|Lost to Follow-up|1|||
130870315|NCT01308736|471155139|FG000|Overall Study|Did not attend a single session|6|||
130870316|NCT01308736|471155140|FG001|Overall Study|Did not attend a single session|5|||
130870317|NCT03634085|471155141|FG000|Overall Study|Adverse Event|1|||
130870318|NCT03634085|471155142|FG001|Overall Study|Adverse Event|0|||
130870319|NCT03634085|471155141|FG000|Overall Study|Withdrawal by Subject|0|||
130870320|NCT03634085|471155142|FG001|Overall Study|Withdrawal by Subject|2|||
130870321|NCT00985465|471155145|FG000|Overall Study|Withdrawal by Subject|1|||
130870322|NCT00985465|471155146|FG001|Overall Study|Withdrawal by Subject|2|||
130870323|NCT00985465|471155145|FG000|Overall Study|Considered to be part of the other group|0|||
130870324|NCT00985465|471155146|FG001|Overall Study|Considered to be part of the other group|1|||
130870325|NCT04701333|471155147|FG000|Overall Study|Lost to Follow-up|3|||
130870326|NCT04701333|471155148|FG001|Overall Study|Lost to Follow-up|7|||
130870327|NCT04701333|471155147|FG000|Overall Study|Withdrawal by Subject|0|||
130870328|NCT04701333|471155148|FG001|Overall Study|Withdrawal by Subject|1|||
130870329|NCT01292187|471155149|FG000|Overall Study|Adverse Event|10|||
130870330|NCT01292187|471155150|FG001|Overall Study|Adverse Event|5|||
130870331|NCT01292187|471155149|FG000|Overall Study|Withdrawal by Subject|6|||
130870332|NCT01292187|471155150|FG001|Overall Study|Withdrawal by Subject|5|||
130870333|NCT01292187|471155149|FG000|Overall Study|All other reasons|1|||
130870334|NCT01292187|471155150|FG001|Overall Study|All other reasons|3|||
130870335|NCT01721161|471155154|FG000|Overall Study|Adverse Event|2|||
130870336|NCT01721161|471155155|FG001|Overall Study|Adverse Event|3|||
130870337|NCT01721161|471155154|FG000|Overall Study|Lost to Follow-up|1|||
130870338|NCT01721161|471155155|FG001|Overall Study|Lost to Follow-up|2|||
130870339|NCT01721161|471155154|FG000|Overall Study|Withdrawal by Subject|1|||
130870340|NCT01721161|471155155|FG001|Overall Study|Withdrawal by Subject|1|||
130870341|NCT01721161|471155154|FG000|Overall Study|Other|0|||
130870342|NCT01721161|471155155|FG001|Overall Study|Other|1|||
130870343|NCT01216202|471155156|FG000|Overall Study|Withdrawal by Subject|8|||
130870344|NCT01216202|471155157|FG001|Overall Study|Withdrawal by Subject|0|||
130870345|NCT01216202|471155156|FG000|Overall Study|Death|0|||
130870346|NCT01216202|471155157|FG001|Overall Study|Death|2|||
130870347|NCT01216202|471155156|FG000|Overall Study|Lost to Follow-up|14|||
130870348|NCT01216202|471155157|FG001|Overall Study|Lost to Follow-up|0|||
130870349|NCT02888106|471155168|FG000|Overall Study|Withdrawal by Subject|1|||
130870350|NCT02888106|471155169|FG001|Overall Study|Withdrawal by Subject|2|||
130870351|NCT02888106|471155170|FG002|Overall Study|Withdrawal by Subject|0|||
130870352|NCT02888106|471155171|FG003|Overall Study|Withdrawal by Subject|1|||
130870353|NCT02888106|471155172|FG004|Overall Study|Withdrawal by Subject|0|||
130870354|NCT02888106|471155173|FG005|Overall Study|Withdrawal by Subject|0|||
130870355|NCT02888106|471155168|FG000|Overall Study|Lost to Follow-up|1|||
130870356|NCT02888106|471155169|FG001|Overall Study|Lost to Follow-up|0|||
130870357|NCT02888106|471155170|FG002|Overall Study|Lost to Follow-up|0|||
130870358|NCT02888106|471155171|FG003|Overall Study|Lost to Follow-up|1|||
130870359|NCT02888106|471155172|FG004|Overall Study|Lost to Follow-up|0|||
130870360|NCT02888106|471155173|FG005|Overall Study|Lost to Follow-up|1|||
130870361|NCT02888106|471155168|FG000|Overall Study|Adverse Event|2|||
130870362|NCT02888106|471155169|FG001|Overall Study|Adverse Event|0|||
130870363|NCT02888106|471155170|FG002|Overall Study|Adverse Event|0|||
130870364|NCT02888106|471155171|FG003|Overall Study|Adverse Event|0|||
130870365|NCT02888106|471155172|FG004|Overall Study|Adverse Event|0|||
130870366|NCT02888106|471155173|FG005|Overall Study|Adverse Event|0|||
130870367|NCT02888106|471155168|FG000|Overall Study|Withdrawal of consent|0|||
130870368|NCT02888106|471155169|FG001|Overall Study|Withdrawal of consent|0|||
130870369|NCT02888106|471155170|FG002|Overall Study|Withdrawal of consent|0|||
130870370|NCT02888106|471155171|FG003|Overall Study|Withdrawal of consent|0|||
130870371|NCT02888106|471155172|FG004|Overall Study|Withdrawal of consent|1|||
130870372|NCT02888106|471155173|FG005|Overall Study|Withdrawal of consent|0|||
130870373|NCT02888106|471155168|FG000|Overall Study|Pregnancy|1|||
130870374|NCT02888106|471155169|FG001|Overall Study|Pregnancy|0|||
130870375|NCT02888106|471155170|FG002|Overall Study|Pregnancy|0|||
130870376|NCT02888106|471155171|FG003|Overall Study|Pregnancy|0|||
130870377|NCT02888106|471155172|FG004|Overall Study|Pregnancy|0|||
130870378|NCT02888106|471155173|FG005|Overall Study|Pregnancy|0|||
130870379|NCT01188772|471155176|FG000|Overall Study|Randomized but Not Treated|0|||
130870380|NCT01188772|471155177|FG001|Overall Study|Randomized but Not Treated|1|||
130870381|NCT01188772|471155178|FG002|Overall Study|Randomized but Not Treated|0|||
130870382|NCT01188772|471155179|FG003|Overall Study|Randomized but Not Treated|0|||
130870383|NCT01188772|471155176|FG000|Overall Study|Adverse Event|0|||
130870384|NCT01188772|471155177|FG001|Overall Study|Adverse Event|1|||
130870385|NCT01188772|471155178|FG002|Overall Study|Adverse Event|2|||
130870386|NCT01188772|471155179|FG003|Overall Study|Adverse Event|0|||
130870387|NCT01188772|471155176|FG000|Overall Study|Lost to Follow-up|4|||
130870388|NCT01188772|471155177|FG001|Overall Study|Lost to Follow-up|1|||
130870389|NCT01188772|471155178|FG002|Overall Study|Lost to Follow-up|1|||
130870390|NCT01188772|471155179|FG003|Overall Study|Lost to Follow-up|1|||
130870391|NCT01188772|471155176|FG000|Overall Study|Non-responder|0|||
130870392|NCT01188772|471155177|FG001|Overall Study|Non-responder|0|||
130870393|NCT01188772|471155178|FG002|Overall Study|Non-responder|3|||
130870394|NCT01188772|471155179|FG003|Overall Study|Non-responder|0|||
130870395|NCT01188772|471155176|FG000|Overall Study|Physician Decision|0|||
130870396|NCT01188772|471155177|FG001|Overall Study|Physician Decision|0|||
130870397|NCT01188772|471155178|FG002|Overall Study|Physician Decision|1|||
130870398|NCT01188772|471155179|FG003|Overall Study|Physician Decision|0|||
130870399|NCT01188772|471155176|FG000|Overall Study|Terminated by Sponsor|0|||
130870400|NCT01188772|471155177|FG001|Overall Study|Terminated by Sponsor|0|||
130870401|NCT01188772|471155178|FG002|Overall Study|Terminated by Sponsor|1|||
130870402|NCT01188772|471155179|FG003|Overall Study|Terminated by Sponsor|0|||
130870403|NCT01188772|471155176|FG000|Overall Study|Treatment Failure|0|||
130870404|NCT01188772|471155177|FG001|Overall Study|Treatment Failure|0|||
130870405|NCT01188772|471155178|FG002|Overall Study|Treatment Failure|1|||
130870406|NCT01188772|471155179|FG003|Overall Study|Treatment Failure|0|||
130870407|NCT01188772|471155176|FG000|Overall Study|Virologic Failure|1|||
130870408|NCT01188772|471155177|FG001|Overall Study|Virologic Failure|0|||
130870409|NCT01188772|471155178|FG002|Overall Study|Virologic Failure|0|||
130870410|NCT01188772|471155179|FG003|Overall Study|Virologic Failure|0|||
130870411|NCT01188772|471155176|FG000|Overall Study|Withdrawal by Subject|0|||
130870412|NCT01188772|471155177|FG001|Overall Study|Withdrawal by Subject|0|||
130870413|NCT01188772|471155178|FG002|Overall Study|Withdrawal by Subject|2|||
130870414|NCT01188772|471155179|FG003|Overall Study|Withdrawal by Subject|0|||
130870415|NCT01433172|471155180|FG000|Overall Study|Withdrawal by Subject|0|||
130870416|NCT01433172|471155181|FG001|Overall Study|Withdrawal by Subject|1|||
130870417|NCT01433172|471155182|FG002|Overall Study|Withdrawal by Subject|0|||
130870418|NCT01433172|471155180|FG000|Overall Study|Disease Progression|0|||
130870419|NCT01433172|471155181|FG001|Overall Study|Disease Progression|0|||
130870420|NCT01433172|471155182|FG002|Overall Study|Disease Progression|1|||
130870421|NCT01433172|471155180|FG000|Overall Study|Death|0|||
130870422|NCT01433172|471155181|FG001|Overall Study|Death|2|||
130870423|NCT01433172|471155182|FG002|Overall Study|Death|0|||
130870424|NCT01894607|471155186|FG000|Overall Study|Ineligible|1|||
130870425|NCT04393493|471155201|FG000|First 4 Days of Intervention|Early improvement|5|||
130870426|NCT04393493|471155202|FG001|First 4 Days of Intervention|Early improvement|7|||
130870427|NCT01572480|471155203|FG000|Participants Enrolled|Withdrawal by Subject|1|||
130870428|NCT01572480|471155203|FG000|Drug Administration|Discontinued drug/Off Study|1|||
130870429|NCT01572480|471155203|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
130870430|NCT01572480|471155203|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
130870431|NCT04037891|471155204|FG000|Open-label Period|Withdrawal by Subject|1|||
130870432|NCT04037891|471155205|FG001|Open-label Period|Withdrawal by Subject|0|||
130870433|NCT04037891|471155206|FG002|Open-label Period|Withdrawal by Subject|0|||
130870434|NCT04037891|471155204|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
130870435|NCT04037891|471155205|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
130870436|NCT04037891|471155206|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
130870437|NCT03446313|471155207|FG000|Overall Study|Lost to Follow-up|1|||
130870438|NCT03446313|471155208|FG001|Overall Study|Lost to Follow-up|2|||
130870439|NCT03446313|471155207|FG000|Overall Study|Failed primary screening|3|||
130870440|NCT03446313|471155208|FG001|Overall Study|Failed primary screening|0|||
130870441|NCT03446313|471155207|FG000|Overall Study|Diagnosed with terminal cancer|1|||
130870442|NCT03446313|471155208|FG001|Overall Study|Diagnosed with terminal cancer|0|||
130870443|NCT03446313|471155207|FG000|Overall Study|Excluded from analysis|1|||
130870444|NCT03446313|471155208|FG001|Overall Study|Excluded from analysis|1|||
130870445|NCT01232868|471157520|FG000|Overall Study|Lost to Follow-up|2|||
130870446|NCT01232868|471157521|FG001|Overall Study|Lost to Follow-up|4|||
130870447|NCT04481243|471157522|FG000|Overall Study|Withdrawal by Subject|4|||
130870448|NCT02544321|471157527|FG000|Overall Study|Withdrawal by Subject|1|||
130870449|NCT02544321|471157528|FG001|Overall Study|Withdrawal by Subject|2|||
130870450|NCT02544321|471157527|FG000|Overall Study|Adverse Event|1|||
130870451|NCT02544321|471157528|FG001|Overall Study|Adverse Event|1|||
130870452|NCT02544321|471157527|FG000|Overall Study|Protocol Violation|0|||
130870453|NCT02544321|471157528|FG001|Overall Study|Protocol Violation|1|||
130870454|NCT01517750|471157529|FG000|Overall Study|Lost to Follow-up|1|||
130870455|NCT01517750|471157530|FG001|Overall Study|Lost to Follow-up|2|||
130870456|NCT01517750|471157531|FG002|Overall Study|Lost to Follow-up|4|||
130870457|NCT01517750|471157532|FG003|Overall Study|Lost to Follow-up|1|||
130870458|NCT01584232|471157533|FG000|Overall Study|Adverse Event|3|||
130870459|NCT01584232|471157534|FG001|Overall Study|Adverse Event|1|||
130870460|NCT01584232|471157533|FG000|Overall Study|Withdrawal by Subject|2|||
130870461|NCT01584232|471157534|FG001|Overall Study|Withdrawal by Subject|1|||
130870462|NCT01584232|471157533|FG000|Overall Study|Physician Decision|2|||
130870463|NCT01584232|471157534|FG001|Overall Study|Physician Decision|1|||
130870464|NCT01584232|471157533|FG000|Overall Study|Lost to Follow-up|1|||
130870465|NCT01584232|471157534|FG001|Overall Study|Lost to Follow-up|0|||
130870466|NCT01307319|471157535|FG000|Overall Study|Adverse Event|2|||
130870467|NCT01307319|471157536|FG001|Overall Study|Adverse Event|2|||
130870468|NCT01307319|471157537|FG002|Overall Study|Adverse Event|1|||
130870469|NCT01307319|471157535|FG000|Overall Study|Lost to Follow-up|1|||
130870470|NCT01307319|471157536|FG001|Overall Study|Lost to Follow-up|0|||
130870471|NCT01307319|471157537|FG002|Overall Study|Lost to Follow-up|1|||
130870472|NCT01307319|471157535|FG000|Overall Study|Protocol Violation|1|||
130870473|NCT01307319|471157536|FG001|Overall Study|Protocol Violation|1|||
130870474|NCT01307319|471157537|FG002|Overall Study|Protocol Violation|0|||
130870475|NCT01307319|471157535|FG000|Overall Study|Withdrawal by Subject|0|||
130870476|NCT01307319|471157536|FG001|Overall Study|Withdrawal by Subject|1|||
130870477|NCT01307319|471157537|FG002|Overall Study|Withdrawal by Subject|2|||
130870478|NCT01307319|471157535|FG000|Overall Study|Other|0|||
130870479|NCT01307319|471157536|FG001|Overall Study|Other|4|||
130870480|NCT01307319|471157537|FG002|Overall Study|Other|3|||
130870481|NCT03629886|471157539|FG000|Overall Study|Migrated / moved from the study area|0|||
130870482|NCT03629886|471157540|FG001|Overall Study|Migrated / moved from the study area|55|||
130870483|NCT03629886|471157539|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
130870484|NCT03629886|471157540|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
130870485|NCT03629886|471157539|FG000|Overall Study|Study vaccine not administrated|0|||
130870486|NCT03629886|471157540|FG001|Overall Study|Study vaccine not administrated|3|||
130870487|NCT03629886|471157539|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
130870488|NCT03629886|471157540|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
130870489|NCT03629886|471157539|FG000|Overall Study|Refused vaccination step of the study|0|||
130870490|NCT03629886|471157540|FG001|Overall Study|Refused vaccination step of the study|44|||
130870491|NCT03347123|471157541|FG000|Overall Study|Death|1|||
130870492|NCT03347123|471157542|FG001|Overall Study|Death|2|||
130870493|NCT03347123|471157543|FG002|Overall Study|Death|0|||
130870494|NCT03347123|471157544|FG003|Overall Study|Death|0|||
130870495|NCT03347123|471157545|FG004|Overall Study|Death|0|||
130870496|NCT03347123|471157546|FG005|Overall Study|Death|0|||
130870497|NCT03347123|471157547|FG006|Overall Study|Death|0|||
130870498|NCT03347123|471157541|FG000|Overall Study|Withdrawal by Subject|1|||
130870499|NCT03347123|471157542|FG001|Overall Study|Withdrawal by Subject|0|||
130870500|NCT03347123|471157543|FG002|Overall Study|Withdrawal by Subject|0|||
130870501|NCT03347123|471157544|FG003|Overall Study|Withdrawal by Subject|0|||
130870502|NCT03347123|471157545|FG004|Overall Study|Withdrawal by Subject|0|||
130870503|NCT03347123|471157546|FG005|Overall Study|Withdrawal by Subject|0|||
130870504|NCT03347123|471157547|FG006|Overall Study|Withdrawal by Subject|0|||
130870505|NCT03347123|471157541|FG000|Overall Study|Reason not Specified|3|||
130870506|NCT03347123|471157542|FG001|Overall Study|Reason not Specified|4|||
130870507|NCT03347123|471157543|FG002|Overall Study|Reason not Specified|0|||
130870508|NCT03347123|471157544|FG003|Overall Study|Reason not Specified|0|||
130870509|NCT03347123|471157545|FG004|Overall Study|Reason not Specified|0|||
130870510|NCT03347123|471157546|FG005|Overall Study|Reason not Specified|0|||
130870511|NCT03347123|471157547|FG006|Overall Study|Reason not Specified|0|||
130870512|NCT01731912|471157552|FG000|Overall Study|noncompliance|2|||
130870513|NCT02222558|471157553|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
130870514|NCT02222558|471157554|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
130870515|NCT02222558|471157555|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
130870516|NCT02222558|471157556|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
130870517|NCT02222558|471157557|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
130870518|NCT02222558|471157558|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
130870519|NCT02222558|471157553|FG000|Period 3|Withdrawal by Subject|0|||
130870520|NCT02222558|471157554|FG001|Period 3|Withdrawal by Subject|0|||
130870521|NCT02222558|471157555|FG002|Period 3|Withdrawal by Subject|0|||
130870522|NCT02222558|471157556|FG003|Period 3|Withdrawal by Subject|0|||
130870523|NCT02222558|471157557|FG004|Period 3|Withdrawal by Subject|0|||
130870524|NCT02222558|471157558|FG005|Period 3|Withdrawal by Subject|1|||
130870525|NCT02322281|471157559|FG000|Overall Study|Progressive Disease|42|||
130870526|NCT02322281|471157560|FG001|Overall Study|Progressive Disease|14|||
130870527|NCT02322281|471157561|FG002|Overall Study|Progressive Disease|49|||
130870528|NCT02322281|471157559|FG000|Overall Study|Adverse Event|3|||
130870529|NCT02322281|471157560|FG001|Overall Study|Adverse Event|4|||
130870530|NCT02322281|471157561|FG002|Overall Study|Adverse Event|6|||
130870531|NCT02322281|471157559|FG000|Overall Study|Death|3|||
130870532|NCT02322281|471157560|FG001|Overall Study|Death|3|||
130870533|NCT02322281|471157561|FG002|Overall Study|Death|3|||
130870534|NCT02322281|471157559|FG000|Overall Study|Withdrawal by Subject|1|||
130870535|NCT02322281|471157560|FG001|Overall Study|Withdrawal by Subject|1|||
130870536|NCT02322281|471157561|FG002|Overall Study|Withdrawal by Subject|6|||
130870537|NCT02322281|471157559|FG000|Overall Study|Physician Decision|2|||
130870538|NCT02322281|471157560|FG001|Overall Study|Physician Decision|0|||
130870539|NCT02322281|471157561|FG002|Overall Study|Physician Decision|5|||
130870540|NCT02322281|471157559|FG000|Overall Study|Study Terminated by Sponsor|2|||
130870541|NCT02322281|471157560|FG001|Overall Study|Study Terminated by Sponsor|0|||
130870542|NCT02322281|471157561|FG002|Overall Study|Study Terminated by Sponsor|0|||
130870543|NCT02322281|471157559|FG000|Overall Study|Missing|0|||
130870544|NCT02322281|471157560|FG001|Overall Study|Missing|0|||
130870545|NCT02322281|471157561|FG002|Overall Study|Missing|1|||
130870546|NCT02322281|471157559|FG000|Overall Study|Miscellaneous|0|||
130870547|NCT02322281|471157560|FG001|Overall Study|Miscellaneous|0|||
130870548|NCT02322281|471157561|FG002|Overall Study|Miscellaneous|4|||
130870549|NCT01285401|471157562|FG000|Overall Study|Prematurely withdrawn from the study|17|||
130870550|NCT01285401|471157563|FG001|Overall Study|Prematurely withdrawn from the study|29|||
130870551|NCT00936702|471157572|FG000|Overall Study|Disease progression|34|||
130870552|NCT00936702|471157572|FG000|Overall Study|Adverse Event|8|||
130870553|NCT00936702|471157572|FG000|Overall Study|Withdrawal by Subject|2|||
130870554|NCT00936702|471157572|FG000|Overall Study|Alternative Treatment|1|||
130870555|NCT00936702|471157572|FG000|Overall Study|Other|1|||
130870556|NCT02366312|471157573|FG000|Overall Study|Lost to Follow-up|0|||
130870557|NCT02366312|471157574|FG001|Overall Study|Lost to Follow-up|1|||
130870558|NCT02532465|471157575|FG000|Overall Study|Protocol Violation|1|||
130870559|NCT02532465|471157576|FG001|Overall Study|Protocol Violation|0|||
130870560|NCT02532465|471157575|FG000|Overall Study|Lack of Efficacy|0|||
130870561|NCT02532465|471157576|FG001|Overall Study|Lack of Efficacy|1|||
130870562|NCT03719131|471157581|FG000|Overall Study|Death|1|||
130870563|NCT03719131|471157582|FG001|Overall Study|Death|2|||
130870564|NCT00622505|471157583|FG000|Overall Study|Adverse Event|9|||
130870565|NCT00622505|471157584|FG001|Overall Study|Adverse Event|7|||
130870566|NCT00622505|471157583|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
130870567|NCT00622505|471157584|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
130870568|NCT00622505|471157583|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130870569|NCT00622505|471157584|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130870570|NCT00622505|471157583|FG000|Overall Study|Withdrawal by Subject|12|||
130870571|NCT00622505|471157584|FG001|Overall Study|Withdrawal by Subject|5|||
130870572|NCT00622505|471157583|FG000|Overall Study|Administrative Problems|2|||
130870573|NCT00622505|471157584|FG001|Overall Study|Administrative Problems|4|||
130870574|NCT00622505|471157583|FG000|Overall Study|Death|2|||
130870575|NCT00622505|471157584|FG001|Overall Study|Death|2|||
130870576|NCT00619515|471157585|FG000|Overall Study|Study Termination by IRB|73|||
130870577|NCT03294590|471157588|FG000|Overall Study|Lost to Follow-up|105|||
130870578|NCT03294590|471157589|FG001|Overall Study|Lost to Follow-up|107|||
130870579|NCT04862065|471157594|FG000|Screening|Protocol Violation|54|||
130870580|NCT04862065|471157595|FG001|Screening|Protocol Violation|0|||
130870581|NCT04862065|471157596|FG002|Screening|Protocol Violation|0|||
130870582|NCT04862065|471157594|FG000|Screening|Insufficient Sample|1|||
130870583|NCT04862065|471157595|FG001|Screening|Insufficient Sample|0|||
130870584|NCT04862065|471157596|FG002|Screening|Insufficient Sample|0|||
130870585|NCT04862065|471157594|FG000|Follow-Up|Lost to Follow-up|3|||
130870586|NCT04862065|471157595|FG001|Follow-Up|Lost to Follow-up|0|||
130870587|NCT04862065|471157596|FG002|Follow-Up|Lost to Follow-up|0|||
130870588|NCT03244917|471157600|FG000|Overall Study|Lost to Follow-up|2|||
130870589|NCT03244917|471157601|FG001|Overall Study|Lost to Follow-up|2|||
130870590|NCT01272232|471157604|FG000|Weeks 0-56|Adverse Event|39|||
130870591|NCT01272232|471157605|FG001|Weeks 0-56|Adverse Event|18|||
130870592|NCT01272232|471157606|FG002|Weeks 0-56|Adverse Event|7|||
130870593|NCT01272232|471157604|FG000|Weeks 0-56|Lack of Efficacy|0|||
130870594|NCT01272232|471157605|FG001|Weeks 0-56|Lack of Efficacy|0|||
130870595|NCT01272232|471157606|FG002|Weeks 0-56|Lack of Efficacy|3|||
130870596|NCT01272232|471157604|FG000|Weeks 0-56|Protocol Violation|12|||
130870597|NCT01272232|471157605|FG001|Weeks 0-56|Protocol Violation|8|||
130870598|NCT01272232|471157606|FG002|Weeks 0-56|Protocol Violation|13|||
130870599|NCT01272232|471157604|FG000|Weeks 0-56|Withdrawal criteria|32|||
130870600|NCT01272232|471157605|FG001|Weeks 0-56|Withdrawal criteria|14|||
130870601|NCT01272232|471157606|FG002|Weeks 0-56|Withdrawal criteria|37|||
130870602|NCT01272232|471157604|FG000|Weeks 0-56|Unclassified|16|||
130870603|NCT01272232|471157605|FG001|Weeks 0-56|Unclassified|7|||
130870604|NCT01272232|471157606|FG002|Weeks 0-56|Unclassified|12|||
130870605|NCT01272232|471157604|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
130870606|NCT01272232|471157605|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
130870607|NCT01272232|471157606|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
130870608|NCT01272232|471157604|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
130870609|NCT01272232|471157605|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
130870610|NCT01272232|471157606|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
130870611|NCT01272232|471157604|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
130870612|NCT01272232|471157605|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
130870613|NCT01272232|471157606|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
130870614|NCT01272232|471157604|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
130870615|NCT01272232|471157605|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
130870616|NCT01272232|471157606|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
130870617|NCT01272232|471157604|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
130870618|NCT01272232|471157605|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
130870619|NCT01272232|471157606|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
130870620|NCT01147666|471157607|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130870621|NCT01147666|471157608|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130870622|NCT01147666|471157609|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130870623|NCT01147666|471157610|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870624|NCT01147666|471157611|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870625|NCT01147666|471157612|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870626|NCT01147666|471157613|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870627|NCT01147666|471157614|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870628|NCT01147666|471157615|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870629|NCT01147666|471157616|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870630|NCT01147666|471157617|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870631|NCT01147666|471157618|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870632|NCT01147666|471157619|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130870633|NCT01147666|471157620|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870634|NCT01147666|471157621|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130870635|NCT01147666|471157607|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130870636|NCT01147666|471157608|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130870637|NCT01147666|471157609|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130870638|NCT01147666|471157610|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130870639|NCT01147666|471157611|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
130870640|NCT01147666|471157612|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130870641|NCT01147666|471157613|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
130870642|NCT01147666|471157614|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
130870643|NCT01147666|471157615|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130870644|NCT01147666|471157616|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130870645|NCT01147666|471157617|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130870646|NCT01147666|471157618|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130870647|NCT01147666|471157619|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130870648|NCT01147666|471157620|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130870649|NCT01147666|471157621|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
130870650|NCT01147666|471157607|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
130870651|NCT01147666|471157608|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
130870652|NCT01147666|471157609|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
130870653|NCT01147666|471157610|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
130870654|NCT01147666|471157611|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
130870655|NCT01147666|471157612|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
130870656|NCT01147666|471157613|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
130870657|NCT01147666|471157614|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
130870658|NCT01147666|471157615|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
130870659|NCT01147666|471157616|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
130870660|NCT01147666|471157617|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
130870661|NCT01147666|471157618|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
130870662|NCT01147666|471157619|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
130870663|NCT01147666|471157620|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
130870664|NCT01147666|471157621|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
130870665|NCT01147666|471157607|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
130870666|NCT01147666|471157608|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870667|NCT01147666|471157609|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870668|NCT01147666|471157610|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
130870669|NCT01147666|471157611|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870670|NCT01147666|471157612|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870671|NCT01147666|471157613|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870672|NCT01147666|471157614|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870673|NCT01147666|471157615|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870674|NCT01147666|471157616|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870675|NCT01147666|471157617|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
130870676|NCT01147666|471157618|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870677|NCT01147666|471157619|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870678|NCT01147666|471157620|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870679|NCT01147666|471157621|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130870680|NCT01147666|471157607|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130870681|NCT01147666|471157608|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130870682|NCT01147666|471157609|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130870683|NCT01147666|471157610|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130870684|NCT01147666|471157611|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130870685|NCT01147666|471157612|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130870686|NCT01147666|471157613|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130870687|NCT01147666|471157614|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130870688|NCT01147666|471157615|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130870689|NCT01147666|471157616|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130870690|NCT01147666|471157617|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130870691|NCT01147666|471157618|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130870692|NCT01147666|471157619|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130870693|NCT01147666|471157620|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130870694|NCT01147666|471157621|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130870695|NCT01147666|471157607|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870696|NCT01147666|471157608|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870697|NCT01147666|471157609|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870698|NCT01147666|471157610|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
130870699|NCT01147666|471157611|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870700|NCT01147666|471157612|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870701|NCT01147666|471157613|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870702|NCT01147666|471157614|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870703|NCT01147666|471157615|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870704|NCT01147666|471157616|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870705|NCT01147666|471157617|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
130870706|NCT01147666|471157618|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870707|NCT01147666|471157619|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870708|NCT01147666|471157620|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870709|NCT01147666|471157621|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130870710|NCT01147666|471157607|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870711|NCT01147666|471157608|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870712|NCT01147666|471157609|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870713|NCT01147666|471157610|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870714|NCT01147666|471157611|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870715|NCT01147666|471157612|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870716|NCT01147666|471157613|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870717|NCT01147666|471157614|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870718|NCT01147666|471157615|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870719|NCT01147666|471157616|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870720|NCT01147666|471157617|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870721|NCT01147666|471157618|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
130870722|NCT01147666|471157619|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
130870723|NCT01147666|471157620|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130870724|NCT01147666|471157621|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
130870725|NCT01147666|471157607|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
130870726|NCT01147666|471157608|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
130870727|NCT01147666|471157609|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
130870728|NCT01147666|471157610|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
130870729|NCT01147666|471157611|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
130870730|NCT01147666|471157612|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
130870731|NCT01147666|471157613|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
130870732|NCT01147666|471157614|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
130870733|NCT01147666|471157615|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
130870734|NCT01147666|471157616|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
130870735|NCT01147666|471157617|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
130870736|NCT01147666|471157618|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
130870737|NCT01147666|471157619|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
130870738|NCT01147666|471157620|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
130870739|NCT01147666|471157621|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
130870740|NCT01147666|471157607|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130870741|NCT01147666|471157608|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130870742|NCT01147666|471157609|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130870743|NCT01147666|471157610|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130870744|NCT01147666|471157611|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
130870745|NCT01147666|471157612|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
130870746|NCT01147666|471157613|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
130870747|NCT01147666|471157614|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
130870748|NCT01147666|471157615|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130870749|NCT01147666|471157616|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
130870750|NCT01147666|471157617|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130870751|NCT01147666|471157618|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130870752|NCT01147666|471157619|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
130870753|NCT01147666|471157620|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130870754|NCT01147666|471157621|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
130870755|NCT01147666|471157607|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870756|NCT01147666|471157608|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870757|NCT01147666|471157609|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870758|NCT01147666|471157610|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
130870759|NCT01147666|471157611|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870760|NCT01147666|471157612|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870761|NCT01147666|471157613|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870762|NCT01147666|471157614|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870763|NCT01147666|471157615|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870764|NCT01147666|471157616|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870765|NCT01147666|471157617|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870766|NCT01147666|471157618|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870767|NCT01147666|471157619|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870768|NCT01147666|471157620|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870769|NCT01147666|471157621|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130870770|NCT01147666|471157607|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130870771|NCT01147666|471157608|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130870772|NCT01147666|471157609|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130870773|NCT01147666|471157610|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130870774|NCT01147666|471157611|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130870775|NCT01147666|471157612|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130870776|NCT01147666|471157613|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130870777|NCT01147666|471157614|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130870778|NCT01147666|471157615|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130870779|NCT01147666|471157616|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130870780|NCT01147666|471157617|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130870781|NCT01147666|471157618|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130870782|NCT01147666|471157619|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130870783|NCT01147666|471157620|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130870784|NCT01147666|471157621|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130870785|NCT01147666|471157607|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870786|NCT01147666|471157608|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870787|NCT01147666|471157609|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870788|NCT01147666|471157610|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
130870789|NCT01147666|471157611|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870790|NCT01147666|471157612|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870791|NCT01147666|471157613|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870792|NCT01147666|471157614|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870793|NCT01147666|471157615|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870794|NCT01147666|471157616|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870795|NCT01147666|471157617|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
130870796|NCT01147666|471157618|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870797|NCT01147666|471157619|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870798|NCT01147666|471157620|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870799|NCT01147666|471157621|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130870800|NCT01147666|471157607|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870801|NCT01147666|471157608|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870802|NCT01147666|471157609|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870803|NCT01147666|471157610|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870804|NCT01147666|471157611|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870805|NCT01147666|471157612|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870806|NCT01147666|471157613|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870807|NCT01147666|471157614|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870808|NCT01147666|471157615|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870809|NCT01147666|471157616|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870810|NCT01147666|471157617|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870811|NCT01147666|471157618|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870812|NCT01147666|471157619|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
130870813|NCT01147666|471157620|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870814|NCT01147666|471157621|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130870815|NCT01147666|471157607|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870816|NCT01147666|471157608|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870817|NCT01147666|471157609|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870818|NCT01147666|471157610|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870819|NCT01147666|471157611|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870820|NCT01147666|471157612|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870821|NCT01147666|471157613|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870822|NCT01147666|471157614|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870823|NCT01147666|471157615|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870824|NCT01147666|471157616|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870825|NCT01147666|471157617|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870826|NCT01147666|471157618|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870827|NCT01147666|471157619|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
130870828|NCT01147666|471157620|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130870829|NCT01147666|471157621|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
130870830|NCT02159066|471157622|FG000|Part I|Adverse Event|7|||
130870831|NCT02159066|471157623|FG001|Part I|Adverse Event|5|||
130870832|NCT02159066|471157624|FG002|Part I|Adverse Event|0|||
130870833|NCT02159066|471157625|FG003|Part I|Adverse Event|0|||
130870834|NCT02159066|471157626|FG004|Part I|Adverse Event|0|||
130870835|NCT02159066|471157627|FG005|Part I|Adverse Event|0|||
130870836|NCT02159066|471157622|FG000|Part I|Death|11|||
130870837|NCT02159066|471157623|FG001|Part I|Death|9|||
130870838|NCT02159066|471157624|FG002|Part I|Death|0|||
130870839|NCT02159066|471157625|FG003|Part I|Death|0|||
130870840|NCT02159066|471157626|FG004|Part I|Death|0|||
130870841|NCT02159066|471157627|FG005|Part I|Death|0|||
130870842|NCT02159066|471157622|FG000|Part I|Progressive Disease|37|||
130870843|NCT02159066|471157623|FG001|Part I|Progressive Disease|46|||
130870844|NCT02159066|471157624|FG002|Part I|Progressive Disease|0|||
130870845|NCT02159066|471157625|FG003|Part I|Progressive Disease|0|||
130870846|NCT02159066|471157626|FG004|Part I|Progressive Disease|0|||
130870847|NCT02159066|471157627|FG005|Part I|Progressive Disease|0|||
130870848|NCT02159066|471157622|FG000|Part I|New Therapy for Study Indication|5|||
130870849|NCT02159066|471157623|FG001|Part I|New Therapy for Study Indication|4|||
130870850|NCT02159066|471157624|FG002|Part I|New Therapy for Study Indication|0|||
130870851|NCT02159066|471157625|FG003|Part I|New Therapy for Study Indication|0|||
130870852|NCT02159066|471157626|FG004|Part I|New Therapy for Study Indication|0|||
130870853|NCT02159066|471157627|FG005|Part I|New Therapy for Study Indication|0|||
130870854|NCT02159066|471157622|FG000|Part I|Termination of participants from the study|3|||
130870855|NCT02159066|471157623|FG001|Part I|Termination of participants from the study|3|||
130870856|NCT02159066|471157624|FG002|Part I|Termination of participants from the study|0|||
130870857|NCT02159066|471157625|FG003|Part I|Termination of participants from the study|0|||
130870858|NCT02159066|471157626|FG004|Part I|Termination of participants from the study|0|||
130870859|NCT02159066|471157627|FG005|Part I|Termination of participants from the study|0|||
130870860|NCT02159066|471157622|FG000|Part I|Physician Decision|2|||
130870861|NCT02159066|471157623|FG001|Part I|Physician Decision|9|||
130870862|NCT02159066|471157624|FG002|Part I|Physician Decision|0|||
130870863|NCT02159066|471157625|FG003|Part I|Physician Decision|0|||
130870864|NCT02159066|471157626|FG004|Part I|Physician Decision|0|||
130870865|NCT02159066|471157627|FG005|Part I|Physician Decision|0|||
130870866|NCT02159066|471157622|FG000|Part I|Participant/Guardian Decision|9|||
130870867|NCT02159066|471157623|FG001|Part I|Participant/Guardian Decision|3|||
130870868|NCT02159066|471157624|FG002|Part I|Participant/Guardian Decision|0|||
130870869|NCT02159066|471157625|FG003|Part I|Participant/Guardian Decision|0|||
130870870|NCT02159066|471157626|FG004|Part I|Participant/Guardian Decision|0|||
130870871|NCT02159066|471157627|FG005|Part I|Participant/Guardian Decision|0|||
130870872|NCT02159066|471157622|FG000|Part I|Missing Data|1|||
130870873|NCT02159066|471157623|FG001|Part I|Missing Data|0|||
130870874|NCT02159066|471157624|FG002|Part I|Missing Data|0|||
130870875|NCT02159066|471157625|FG003|Part I|Missing Data|0|||
130870876|NCT02159066|471157626|FG004|Part I|Missing Data|0|||
130870877|NCT02159066|471157627|FG005|Part I|Missing Data|0|||
130870878|NCT02159066|471157622|FG000|Part II|Adverse Event|0|||
130870879|NCT02159066|471157623|FG001|Part II|Adverse Event|0|||
130870880|NCT02159066|471157624|FG002|Part II|Adverse Event|1|||
130870881|NCT02159066|471157625|FG003|Part II|Adverse Event|0|||
130870882|NCT02159066|471157626|FG004|Part II|Adverse Event|1|||
130870883|NCT02159066|471157627|FG005|Part II|Adverse Event|1|||
130870884|NCT02159066|471157622|FG000|Part II|Death|0|||
130870885|NCT02159066|471157623|FG001|Part II|Death|0|||
130870886|NCT02159066|471157624|FG002|Part II|Death|1|||
130870887|NCT02159066|471157625|FG003|Part II|Death|0|||
130870888|NCT02159066|471157626|FG004|Part II|Death|2|||
130870889|NCT02159066|471157627|FG005|Part II|Death|1|||
130870890|NCT02159066|471157622|FG000|Part II|Progressive Disease|0|||
130870891|NCT02159066|471157623|FG001|Part II|Progressive Disease|0|||
130870892|NCT02159066|471157624|FG002|Part II|Progressive Disease|35|||
130870893|NCT02159066|471157625|FG003|Part II|Progressive Disease|1|||
130870894|NCT02159066|471157626|FG004|Part II|Progressive Disease|7|||
130870895|NCT02159066|471157627|FG005|Part II|Progressive Disease|4|||
130870896|NCT02159066|471157622|FG000|Part II|New Therapy for Study Indication|0|||
130870897|NCT02159066|471157623|FG001|Part II|New Therapy for Study Indication|0|||
130870898|NCT02159066|471157624|FG002|Part II|New Therapy for Study Indication|0|||
130870899|NCT02159066|471157625|FG003|Part II|New Therapy for Study Indication|0|||
130870900|NCT02159066|471157626|FG004|Part II|New Therapy for Study Indication|1|||
130870901|NCT02159066|471157627|FG005|Part II|New Therapy for Study Indication|0|||
130870902|NCT02159066|471157622|FG000|Part II|Physician Decision|0|||
130870903|NCT02159066|471157623|FG001|Part II|Physician Decision|0|||
130870904|NCT02159066|471157624|FG002|Part II|Physician Decision|1|||
130870905|NCT02159066|471157625|FG003|Part II|Physician Decision|0|||
130870906|NCT02159066|471157626|FG004|Part II|Physician Decision|0|||
130870907|NCT02159066|471157627|FG005|Part II|Physician Decision|0|||
130870908|NCT02159066|471157622|FG000|Part II|Participant/Guardian Decision|0|||
130870909|NCT02159066|471157623|FG001|Part II|Participant/Guardian Decision|0|||
130870910|NCT02159066|471157624|FG002|Part II|Participant/Guardian Decision|0|||
130870911|NCT02159066|471157625|FG003|Part II|Participant/Guardian Decision|0|||
130870912|NCT02159066|471157626|FG004|Part II|Participant/Guardian Decision|2|||
130870913|NCT02159066|471157627|FG005|Part II|Participant/Guardian Decision|0|||
130870914|NCT00628030|471157634|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
130870915|NCT00628030|471157635|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
130870916|NCT00628030|471157634|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
130870917|NCT00628030|471157635|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
130870918|NCT00628030|471157634|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
130870919|NCT00628030|471157635|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
130870920|NCT01156480|471157637|FG000|Overall Study|change in diagnosis|0|||
130870921|NCT01156480|471157638|FG001|Overall Study|change in diagnosis|1|||
130870922|NCT03367858|471157639|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
130870923|NCT03367858|471157640|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
130870924|NCT03367858|471157639|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
130870925|NCT03367858|471157640|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
130870926|NCT03367858|471157639|FG000|3 Month Follow Up|Lost to Follow-up|8|||
130870927|NCT03367858|471157640|FG001|3 Month Follow Up|Lost to Follow-up|3|||
130870928|NCT03367858|471157639|FG000|3 Month Follow Up|Moved out of study area|2|||
130870929|NCT03367858|471157640|FG001|3 Month Follow Up|Moved out of study area|6|||
130870930|NCT03367858|471157639|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
130870931|NCT03367858|471157640|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
130870932|NCT03367858|471157639|FG000|3 Month Follow Up|MRI contraindication|2|||
130870933|NCT03367858|471157640|FG001|3 Month Follow Up|MRI contraindication|1|||
130870934|NCT03367858|471157639|FG000|3 Month Follow Up|Incarcerated|0|||
130870935|NCT03367858|471157640|FG001|3 Month Follow Up|Incarcerated|1|||
130870936|NCT03367858|471157639|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
130870937|NCT03367858|471157640|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
130870938|NCT03367858|471157639|FG000|6 Month Follow Up|Lost to Follow-up|5|||
130870939|NCT03367858|471157640|FG001|6 Month Follow Up|Lost to Follow-up|2|||
130870940|NCT03367858|471157639|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
130870941|NCT03367858|471157640|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
130870942|NCT03367858|471157639|FG000|12 Month Follow Up|Lost to Follow-up|3|||
130870943|NCT03367858|471157640|FG001|12 Month Follow Up|Lost to Follow-up|3|||
130870944|NCT03367858|471157639|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
130870945|NCT03367858|471157640|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
130870946|NCT04276233|471157651|FG000|Overall Study|Adverse Event|1|||
130870947|NCT04276233|471157651|FG000|Overall Study|Lost to Follow-up|3|||
130870948|NCT04276233|471157651|FG000|Overall Study|Physician Decision|4|||
130870949|NCT04276233|471157651|FG000|Overall Study|Withdrawal by Subject|2|||
130870950|NCT01946139|471157652|FG000|Overall Study|Withdrawal by Subject|8|||
130870951|NCT01946139|471157652|FG000|Overall Study|ineligible|8|||
130870952|NCT01946139|471157652|FG000|Overall Study|Specimens not available|4|||
130870953|NCT00296816|471157659|FG000|Overall Study|Disease Progression|37|||
130870954|NCT00296816|471157659|FG000|Overall Study|Adverse Event|18|||
130870955|NCT00296816|471157659|FG000|Overall Study|Investigator/Participant request|5|||
130870956|NCT00296816|471157659|FG000|Overall Study|Non-compliance|1|||
130870957|NCT00296816|471157659|FG000|Overall Study|Missing for end of treatment|4|||
130870958|NCT00296816|471157659|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
130870959|NCT00296816|471157659|FG000|Overall Study|Poor performance status|1|||
130870960|NCT00296816|471157659|FG000|Overall Study|Relocation to Florida|1|||
130870961|NCT00296816|471157659|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
130870962|NCT00296816|471157659|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
130870963|NCT00296816|471157659|FG000|Overall Study|Neuropathy/patient preference|1|||
130870964|NCT00296816|471157659|FG000|Overall Study|Proteinuria|1|||
130870965|NCT00296816|471157659|FG000|Overall Study|ineligibility due to radiation treatment|1|||
130870966|NCT03275740|471157660|FG000|Overall Study|Adverse Event|0|||
130870967|NCT03275740|471157661|FG001|Overall Study|Adverse Event|0|||
130870968|NCT03275740|471157662|FG002|Overall Study|Adverse Event|0|||
130870969|NCT03275740|471157663|FG003|Overall Study|Adverse Event|0|||
130870970|NCT03275740|471157664|FG004|Overall Study|Adverse Event|1|||
130870971|NCT03275740|471157665|FG005|Overall Study|Adverse Event|0|||
130870972|NCT03275740|471157666|FG006|Overall Study|Adverse Event|0|||
130870973|NCT03275740|471157667|FG007|Overall Study|Adverse Event|0|||
130870974|NCT03275740|471157668|FG008|Overall Study|Adverse Event|0|||
130870975|NCT03275740|471157669|FG009|Overall Study|Adverse Event|0|||
130870976|NCT03275740|471157670|FG010|Overall Study|Adverse Event|0|||
130870977|NCT03275740|471157671|FG011|Overall Study|Adverse Event|0|||
130870978|NCT03275740|471157660|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870979|NCT03275740|471157661|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870980|NCT03275740|471157662|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870981|NCT03275740|471157663|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870982|NCT03275740|471157664|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870983|NCT03275740|471157665|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
130870984|NCT03275740|471157666|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870985|NCT03275740|471157667|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870986|NCT03275740|471157668|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870987|NCT03275740|471157669|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870988|NCT03275740|471157670|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870989|NCT03275740|471157671|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130870990|NCT03275740|471157660|FG000|Overall Study|Withdrawal by Subject|0|||
130870991|NCT03275740|471157661|FG001|Overall Study|Withdrawal by Subject|0|||
130870992|NCT03275740|471157662|FG002|Overall Study|Withdrawal by Subject|0|||
130870993|NCT03275740|471157663|FG003|Overall Study|Withdrawal by Subject|0|||
130870994|NCT03275740|471157664|FG004|Overall Study|Withdrawal by Subject|0|||
130870995|NCT03275740|471157665|FG005|Overall Study|Withdrawal by Subject|0|||
130870996|NCT03275740|471157666|FG006|Overall Study|Withdrawal by Subject|0|||
130870997|NCT03275740|471157667|FG007|Overall Study|Withdrawal by Subject|0|||
130870998|NCT03275740|471157668|FG008|Overall Study|Withdrawal by Subject|1|||
130870999|NCT03275740|471157669|FG009|Overall Study|Withdrawal by Subject|1|||
130871000|NCT03275740|471157670|FG010|Overall Study|Withdrawal by Subject|0|||
130871001|NCT03275740|471157671|FG011|Overall Study|Withdrawal by Subject|0|||
130871002|NCT03827655|471157673|FG000|Overall Study|Death|0|||
130871003|NCT03827655|471157674|FG001|Overall Study|Death|0|||
130871004|NCT03827655|471157675|FG002|Overall Study|Death|0|||
130871005|NCT03827655|471157676|FG003|Overall Study|Death|0|||
130871006|NCT03827655|471157677|FG004|Overall Study|Death|1|||
130871007|NCT03827655|471157673|FG000|Overall Study|Protocol Deviation|1|||
130871008|NCT03827655|471157674|FG001|Overall Study|Protocol Deviation|0|||
130871009|NCT03827655|471157675|FG002|Overall Study|Protocol Deviation|1|||
130871010|NCT03827655|471157676|FG003|Overall Study|Protocol Deviation|1|||
130871011|NCT03827655|471157677|FG004|Overall Study|Protocol Deviation|0|||
130871012|NCT03827655|471157673|FG000|Overall Study|Withdrawal by Subject|3|||
130871013|NCT03827655|471157674|FG001|Overall Study|Withdrawal by Subject|2|||
130871014|NCT03827655|471157675|FG002|Overall Study|Withdrawal by Subject|2|||
130871015|NCT03827655|471157676|FG003|Overall Study|Withdrawal by Subject|0|||
130871016|NCT03827655|471157677|FG004|Overall Study|Withdrawal by Subject|1|||
130871017|NCT03827655|471157673|FG000|Overall Study|Reason not Specified|3|||
130871018|NCT03827655|471157674|FG001|Overall Study|Reason not Specified|1|||
130871019|NCT03827655|471157675|FG002|Overall Study|Reason not Specified|1|||
130871020|NCT03827655|471157676|FG003|Overall Study|Reason not Specified|1|||
130871021|NCT03827655|471157677|FG004|Overall Study|Reason not Specified|1|||
130871022|NCT02336607|471157678|FG000|Overall Study|Physician Decision|1|||
130871023|NCT02336607|471157679|FG001|Overall Study|Physician Decision|4|||
130871024|NCT02336607|471157680|FG002|Overall Study|Physician Decision|3|||
130871025|NCT02336607|471157681|FG003|Overall Study|Physician Decision|15|||
130871026|NCT02336607|471157678|FG000|Overall Study|Lack of Efficacy|1|||
130871027|NCT02336607|471157679|FG001|Overall Study|Lack of Efficacy|0|||
130871028|NCT02336607|471157680|FG002|Overall Study|Lack of Efficacy|0|||
130871029|NCT02336607|471157681|FG003|Overall Study|Lack of Efficacy|2|||
130871030|NCT02336607|471157678|FG000|Overall Study|Lost to Follow-up|2|||
130871031|NCT02336607|471157679|FG001|Overall Study|Lost to Follow-up|1|||
130871032|NCT02336607|471157680|FG002|Overall Study|Lost to Follow-up|0|||
130871033|NCT02336607|471157681|FG003|Overall Study|Lost to Follow-up|21|||
130871034|NCT02336607|471157678|FG000|Overall Study|Protocol Violation|0|||
130871035|NCT02336607|471157679|FG001|Overall Study|Protocol Violation|1|||
130871036|NCT02336607|471157680|FG002|Overall Study|Protocol Violation|1|||
130871037|NCT02336607|471157681|FG003|Overall Study|Protocol Violation|3|||
130871038|NCT02336607|471157678|FG000|Overall Study|Adverse Event|0|||
130871039|NCT02336607|471157679|FG001|Overall Study|Adverse Event|2|||
130871040|NCT02336607|471157680|FG002|Overall Study|Adverse Event|2|||
130871041|NCT02336607|471157681|FG003|Overall Study|Adverse Event|26|||
130871042|NCT02336607|471157678|FG000|Overall Study|Withdrawal by Subject|0|||
130871043|NCT02336607|471157679|FG001|Overall Study|Withdrawal by Subject|2|||
130871044|NCT02336607|471157680|FG002|Overall Study|Withdrawal by Subject|0|||
130871045|NCT02336607|471157681|FG003|Overall Study|Withdrawal by Subject|20|||
130871046|NCT02552966|471157682|FG000|Overall Study|Lost to Follow-up|2|||
130871047|NCT02552966|471157682|FG000|Overall Study|Withdrawal by Subject|3|||
130871048|NCT03259555|471157685|FG000|Overall Study|Adverse Event|6|||
130871049|NCT03259555|471157686|FG001|Overall Study|Adverse Event|4|||
130871050|NCT03259555|471157685|FG000|Overall Study|Lack of Efficacy|6|||
130871051|NCT03259555|471157686|FG001|Overall Study|Lack of Efficacy|4|||
130871052|NCT03259555|471157685|FG000|Overall Study|Lost to Follow-up|0|||
130871053|NCT03259555|471157686|FG001|Overall Study|Lost to Follow-up|2|||
130871054|NCT03259555|471157685|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130871055|NCT03259555|471157686|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130871056|NCT03259555|471157685|FG000|Overall Study|Progressive Disease|0|||
130871057|NCT03259555|471157686|FG001|Overall Study|Progressive Disease|2|||
130871058|NCT03259555|471157685|FG000|Overall Study|Withdrawal by Subject|19|||
130871059|NCT03259555|471157686|FG001|Overall Study|Withdrawal by Subject|16|||
130871060|NCT03259555|471157685|FG000|Overall Study|Physician Decision|1|||
130871061|NCT03259555|471157686|FG001|Overall Study|Physician Decision|2|||
130871062|NCT03259555|471157685|FG000|Overall Study|Other|1|||
130871063|NCT03259555|471157686|FG001|Overall Study|Other|0|||
130871064|NCT01125800|471157688|FG000|Phase I|Protocol Violation|0|||
130871065|NCT01125800|471157689|FG001|Phase I|Protocol Violation|3|||
130871066|NCT01125800|471157690|FG002|Phase I|Protocol Violation|1|||
130871067|NCT01125800|471157691|FG003|Phase I|Protocol Violation|1|||
130871068|NCT01125800|471157692|FG004|Phase I|Protocol Violation|0|||
130871069|NCT01125800|471157688|FG000|Phase I|Adverse Event|2|||
130871070|NCT01125800|471157689|FG001|Phase I|Adverse Event|2|||
130871071|NCT01125800|471157690|FG002|Phase I|Adverse Event|1|||
130871072|NCT01125800|471157691|FG003|Phase I|Adverse Event|7|||
130871073|NCT01125800|471157692|FG004|Phase I|Adverse Event|0|||
130871074|NCT01125800|471157688|FG000|Phase I|Administrative problems|1|||
130871075|NCT01125800|471157689|FG001|Phase I|Administrative problems|0|||
130871076|NCT01125800|471157690|FG002|Phase I|Administrative problems|0|||
130871077|NCT01125800|471157691|FG003|Phase I|Administrative problems|0|||
130871078|NCT01125800|471157692|FG004|Phase I|Administrative problems|0|||
130871079|NCT01125800|471157688|FG000|Phase I|Withdrawal by Subject|0|||
130871080|NCT01125800|471157689|FG001|Phase I|Withdrawal by Subject|0|||
130871081|NCT01125800|471157690|FG002|Phase I|Withdrawal by Subject|1|||
130871082|NCT01125800|471157691|FG003|Phase I|Withdrawal by Subject|0|||
130871083|NCT01125800|471157692|FG004|Phase I|Withdrawal by Subject|0|||
130871084|NCT01125800|471157688|FG000|Phase I|Disease progression|5|||
130871085|NCT01125800|471157689|FG001|Phase I|Disease progression|4|||
130871086|NCT01125800|471157690|FG002|Phase I|Disease progression|1|||
130871087|NCT01125800|471157691|FG003|Phase I|Disease progression|3|||
130871088|NCT01125800|471157692|FG004|Phase I|Disease progression|0|||
130871089|NCT01125800|471157688|FG000|Phase II|Protocol Violation|0|||
130871090|NCT01125800|471157689|FG001|Phase II|Protocol Violation|0|||
130871091|NCT01125800|471157690|FG002|Phase II|Protocol Violation|0|||
130871092|NCT01125800|471157691|FG003|Phase II|Protocol Violation|0|||
130871093|NCT01125800|471157692|FG004|Phase II|Protocol Violation|1|||
130871094|NCT01125800|471157688|FG000|Phase II|Adverse Event|0|||
130871095|NCT01125800|471157689|FG001|Phase II|Adverse Event|0|||
130871096|NCT01125800|471157690|FG002|Phase II|Adverse Event|0|||
130871097|NCT01125800|471157691|FG003|Phase II|Adverse Event|0|||
130871098|NCT01125800|471157692|FG004|Phase II|Adverse Event|2|||
130871099|NCT01125800|471157688|FG000|Phase II|Disease progression|0|||
130871100|NCT01125800|471157689|FG001|Phase II|Disease progression|0|||
130871101|NCT01125800|471157690|FG002|Phase II|Disease progression|0|||
130871102|NCT01125800|471157691|FG003|Phase II|Disease progression|1|||
130871103|NCT01125800|471157692|FG004|Phase II|Disease progression|8|||
130871104|NCT03370718|471157697|FG000|Overall Study|Withdrawal by Subject|1|||
130871111|NCT06172348|471157704|FG000|Treatment Period 2|Adverse Event|0|||
130871112|NCT06172348|471157705|FG001|Treatment Period 2|Adverse Event|0|||
130871113|NCT06172348|471157706|FG002|Treatment Period 2|Adverse Event|1|||
130871114|NCT06172348|471157707|FG003|Treatment Period 2|Adverse Event|0|||
130871115|NCT06172348|471157708|FG004|Treatment Period 2|Adverse Event|0|||
130871116|NCT06172348|471157709|FG005|Treatment Period 2|Adverse Event|0|||
130871117|NCT05579977|471157717|FG000|Treatment Phase|Other|0|||
130871118|NCT05579977|471157718|FG001|Treatment Phase|Other|0|||
130871119|NCT05579977|471157719|FG002|Treatment Phase|Other|0|||
130871120|NCT05579977|471157720|FG003|Treatment Phase|Other|2|||
130871121|NCT05579977|471157721|FG004|Treatment Phase|Other|1|||
130871122|NCT05579977|471157722|FG005|Treatment Phase|Other|2|||
130871123|NCT05579977|471157723|FG006|Treatment Phase|Other|1|||
130871124|NCT05579977|471157724|FG007|Treatment Phase|Other|2|||
130871125|NCT05579977|471157725|FG008|Treatment Phase|Other|2|||
130871126|NCT05579977|471157726|FG009|Treatment Phase|Other|1|||
130871127|NCT05579977|471157727|FG010|Treatment Phase|Other|0|||
130871128|NCT05579977|471157728|FG011|Treatment Phase|Other|0|||
130871129|NCT05579977|471157729|FG012|Treatment Phase|Other|3|||
130871130|NCT05579977|471157717|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
130871131|NCT05579977|471157718|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
130871132|NCT05579977|471157719|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
130871133|NCT05579977|471157720|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
130871134|NCT05579977|471157721|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
130871135|NCT05579977|471157722|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
130871136|NCT05579977|471157723|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
130871137|NCT05579977|471157724|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
130871138|NCT05579977|471157725|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
130871139|NCT05579977|471157726|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
130871140|NCT05579977|471157727|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
130871141|NCT05579977|471157728|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
130871142|NCT05579977|471157729|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
130871143|NCT05579977|471157717|FG000|Treatment Phase|Withdrawal by Subject|2|||
130871144|NCT05579977|471157718|FG001|Treatment Phase|Withdrawal by Subject|0|||
130871145|NCT05579977|471157719|FG002|Treatment Phase|Withdrawal by Subject|0|||
130871146|NCT05579977|471157720|FG003|Treatment Phase|Withdrawal by Subject|1|||
130871147|NCT05579977|471157721|FG004|Treatment Phase|Withdrawal by Subject|2|||
130871148|NCT05579977|471157722|FG005|Treatment Phase|Withdrawal by Subject|0|||
130871149|NCT05579977|471157723|FG006|Treatment Phase|Withdrawal by Subject|1|||
130871150|NCT05579977|471157724|FG007|Treatment Phase|Withdrawal by Subject|8|||
130871151|NCT05579977|471157725|FG008|Treatment Phase|Withdrawal by Subject|3|||
130871152|NCT05579977|471157726|FG009|Treatment Phase|Withdrawal by Subject|3|||
130871153|NCT05579977|471157727|FG010|Treatment Phase|Withdrawal by Subject|5|||
130871154|NCT05579977|471157728|FG011|Treatment Phase|Withdrawal by Subject|1|||
130871155|NCT05579977|471157729|FG012|Treatment Phase|Withdrawal by Subject|3|||
130871156|NCT05579977|471157717|FG000|Treatment Phase|Study terminated by sponsor|70|||
130871157|NCT05579977|471157718|FG001|Treatment Phase|Study terminated by sponsor|70|||
130871158|NCT05579977|471157719|FG002|Treatment Phase|Study terminated by sponsor|61|||
130871159|NCT05579977|471157720|FG003|Treatment Phase|Study terminated by sponsor|59|||
130871160|NCT05579977|471157721|FG004|Treatment Phase|Study terminated by sponsor|63|||
130871161|NCT05579977|471157722|FG005|Treatment Phase|Study terminated by sponsor|53|||
130871162|NCT05579977|471157723|FG006|Treatment Phase|Study terminated by sponsor|66|||
130871163|NCT05579977|471157724|FG007|Treatment Phase|Study terminated by sponsor|48|||
130871164|NCT05579977|471157725|FG008|Treatment Phase|Study terminated by sponsor|47|||
130871165|NCT05579977|471157726|FG009|Treatment Phase|Study terminated by sponsor|37|||
130871166|NCT05579977|471157727|FG010|Treatment Phase|Study terminated by sponsor|44|||
130871167|NCT05579977|471157728|FG011|Treatment Phase|Study terminated by sponsor|36|||
130871168|NCT05579977|471157729|FG012|Treatment Phase|Study terminated by sponsor|32|||
130871169|NCT05579977|471157717|FG000|Treatment Phase|Pregnancy|0|||
130871170|NCT05579977|471157718|FG001|Treatment Phase|Pregnancy|0|||
130871171|NCT05579977|471157719|FG002|Treatment Phase|Pregnancy|0|||
130871172|NCT05579977|471157720|FG003|Treatment Phase|Pregnancy|0|||
130871173|NCT05579977|471157721|FG004|Treatment Phase|Pregnancy|0|||
130871174|NCT05579977|471157722|FG005|Treatment Phase|Pregnancy|0|||
130871175|NCT05579977|471157723|FG006|Treatment Phase|Pregnancy|0|||
130871176|NCT05579977|471157724|FG007|Treatment Phase|Pregnancy|0|||
130871177|NCT05579977|471157725|FG008|Treatment Phase|Pregnancy|0|||
130871178|NCT05579977|471157726|FG009|Treatment Phase|Pregnancy|1|||
130871179|NCT05579977|471157727|FG010|Treatment Phase|Pregnancy|0|||
130871180|NCT05579977|471157728|FG011|Treatment Phase|Pregnancy|0|||
130871181|NCT05579977|471157729|FG012|Treatment Phase|Pregnancy|0|||
130871182|NCT05579977|471157717|FG000|Treatment Phase|Physician Decision|0|||
130871183|NCT05579977|471157718|FG001|Treatment Phase|Physician Decision|0|||
130871184|NCT05579977|471157719|FG002|Treatment Phase|Physician Decision|0|||
130871185|NCT05579977|471157720|FG003|Treatment Phase|Physician Decision|0|||
130871186|NCT05579977|471157721|FG004|Treatment Phase|Physician Decision|0|||
130871187|NCT05579977|471157722|FG005|Treatment Phase|Physician Decision|0|||
130871188|NCT05579977|471157723|FG006|Treatment Phase|Physician Decision|0|||
130871189|NCT05579977|471157724|FG007|Treatment Phase|Physician Decision|0|||
130871190|NCT05579977|471157725|FG008|Treatment Phase|Physician Decision|0|||
130871191|NCT05579977|471157726|FG009|Treatment Phase|Physician Decision|0|||
130871192|NCT05579977|471157727|FG010|Treatment Phase|Physician Decision|0|||
130871193|NCT05579977|471157728|FG011|Treatment Phase|Physician Decision|1|||
130871194|NCT05579977|471157729|FG012|Treatment Phase|Physician Decision|0|||
130871195|NCT05579977|471157717|FG000|Treatment Phase|Lost to Follow-up|0|||
130871196|NCT05579977|471157718|FG001|Treatment Phase|Lost to Follow-up|0|||
130871197|NCT05579977|471157719|FG002|Treatment Phase|Lost to Follow-up|0|||
130871198|NCT05579977|471157720|FG003|Treatment Phase|Lost to Follow-up|1|||
130871199|NCT05579977|471157721|FG004|Treatment Phase|Lost to Follow-up|1|||
130871200|NCT05579977|471157722|FG005|Treatment Phase|Lost to Follow-up|1|||
130871201|NCT05579977|471157723|FG006|Treatment Phase|Lost to Follow-up|0|||
130871202|NCT05579977|471157724|FG007|Treatment Phase|Lost to Follow-up|1|||
130871203|NCT05579977|471157725|FG008|Treatment Phase|Lost to Follow-up|2|||
130871204|NCT05579977|471157726|FG009|Treatment Phase|Lost to Follow-up|2|||
130871205|NCT05579977|471157727|FG010|Treatment Phase|Lost to Follow-up|1|||
130871206|NCT05579977|471157728|FG011|Treatment Phase|Lost to Follow-up|4|||
130871207|NCT05579977|471157729|FG012|Treatment Phase|Lost to Follow-up|3|||
130871208|NCT05579977|471157717|FG000|Treatment Phase|Death|1|||
130871209|NCT05579977|471157718|FG001|Treatment Phase|Death|0|||
130871210|NCT05579977|471157719|FG002|Treatment Phase|Death|0|||
130871211|NCT05579977|471157720|FG003|Treatment Phase|Death|0|||
130871212|NCT05579977|471157721|FG004|Treatment Phase|Death|0|||
130871213|NCT05579977|471157722|FG005|Treatment Phase|Death|0|||
130871214|NCT05579977|471157723|FG006|Treatment Phase|Death|0|||
130871215|NCT05579977|471157724|FG007|Treatment Phase|Death|0|||
130871216|NCT05579977|471157725|FG008|Treatment Phase|Death|0|||
130871217|NCT05579977|471157726|FG009|Treatment Phase|Death|0|||
130871218|NCT05579977|471157727|FG010|Treatment Phase|Death|0|||
130871219|NCT05579977|471157728|FG011|Treatment Phase|Death|0|||
130871220|NCT05579977|471157729|FG012|Treatment Phase|Death|0|||
130871221|NCT05579977|471157717|FG000|Treatment Phase|Adverse Event|0|||
130871222|NCT05579977|471157718|FG001|Treatment Phase|Adverse Event|3|||
130871223|NCT05579977|471157719|FG002|Treatment Phase|Adverse Event|11|||
130871224|NCT05579977|471157720|FG003|Treatment Phase|Adverse Event|10|||
130871225|NCT05579977|471157721|FG004|Treatment Phase|Adverse Event|5|||
130871226|NCT05579977|471157722|FG005|Treatment Phase|Adverse Event|17|||
130871227|NCT05579977|471157723|FG006|Treatment Phase|Adverse Event|5|||
130871228|NCT05579977|471157724|FG007|Treatment Phase|Adverse Event|5|||
130871229|NCT05579977|471157725|FG008|Treatment Phase|Adverse Event|12|||
130871230|NCT05579977|471157726|FG009|Treatment Phase|Adverse Event|20|||
130871231|NCT05579977|471157727|FG010|Treatment Phase|Adverse Event|15|||
130871232|NCT05579977|471157728|FG011|Treatment Phase|Adverse Event|24|||
130871233|NCT05579977|471157729|FG012|Treatment Phase|Adverse Event|23|||
130871234|NCT05579977|471157717|FG000|Treatment Phase|Randomized not treated|0|||
130871235|NCT05579977|471157718|FG001|Treatment Phase|Randomized not treated|0|||
130871236|NCT05579977|471157719|FG002|Treatment Phase|Randomized not treated|0|||
130871237|NCT05579977|471157720|FG003|Treatment Phase|Randomized not treated|0|||
130871238|NCT05579977|471157721|FG004|Treatment Phase|Randomized not treated|1|||
130871239|NCT05579977|471157722|FG005|Treatment Phase|Randomized not treated|0|||
130871240|NCT05579977|471157723|FG006|Treatment Phase|Randomized not treated|0|||
130871241|NCT05579977|471157724|FG007|Treatment Phase|Randomized not treated|0|||
130871242|NCT05579977|471157725|FG008|Treatment Phase|Randomized not treated|0|||
130871243|NCT05579977|471157726|FG009|Treatment Phase|Randomized not treated|0|||
130871244|NCT05579977|471157727|FG010|Treatment Phase|Randomized not treated|0|||
130871245|NCT05579977|471157728|FG011|Treatment Phase|Randomized not treated|0|||
130871246|NCT05579977|471157729|FG012|Treatment Phase|Randomized not treated|0|||
130871247|NCT05579977|471157717|FG000|Follow up|Death|1|||
130871248|NCT05579977|471157718|FG001|Follow up|Death|0|||
130871249|NCT05579977|471157719|FG002|Follow up|Death|0|||
130871250|NCT05579977|471157720|FG003|Follow up|Death|0|||
130871251|NCT05579977|471157721|FG004|Follow up|Death|0|||
130871252|NCT05579977|471157722|FG005|Follow up|Death|0|||
130871253|NCT05579977|471157723|FG006|Follow up|Death|0|||
130871254|NCT05579977|471157724|FG007|Follow up|Death|0|||
130871255|NCT05579977|471157725|FG008|Follow up|Death|0|||
130871256|NCT05579977|471157726|FG009|Follow up|Death|0|||
130871257|NCT05579977|471157727|FG010|Follow up|Death|0|||
130871258|NCT05579977|471157728|FG011|Follow up|Death|0|||
130871259|NCT05579977|471157729|FG012|Follow up|Death|0|||
130871260|NCT05579977|471157717|FG000|Follow up|Lost to Follow-up|0|||
130871261|NCT05579977|471157718|FG001|Follow up|Lost to Follow-up|0|||
130871262|NCT05579977|471157719|FG002|Follow up|Lost to Follow-up|0|||
130871263|NCT05579977|471157720|FG003|Follow up|Lost to Follow-up|1|||
130871264|NCT05579977|471157721|FG004|Follow up|Lost to Follow-up|1|||
130871265|NCT05579977|471157722|FG005|Follow up|Lost to Follow-up|2|||
130871266|NCT05579977|471157723|FG006|Follow up|Lost to Follow-up|1|||
130871267|NCT05579977|471157724|FG007|Follow up|Lost to Follow-up|1|||
130871268|NCT05579977|471157725|FG008|Follow up|Lost to Follow-up|3|||
130871269|NCT05579977|471157726|FG009|Follow up|Lost to Follow-up|2|||
130871270|NCT05579977|471157727|FG010|Follow up|Lost to Follow-up|2|||
130871271|NCT05579977|471157728|FG011|Follow up|Lost to Follow-up|4|||
130871272|NCT05579977|471157729|FG012|Follow up|Lost to Follow-up|4|||
130871273|NCT05579977|471157717|FG000|Follow up|Withdrawal by Subject|2|||
130871274|NCT05579977|471157718|FG001|Follow up|Withdrawal by Subject|0|||
130871275|NCT05579977|471157719|FG002|Follow up|Withdrawal by Subject|0|||
130871276|NCT05579977|471157720|FG003|Follow up|Withdrawal by Subject|0|||
130871277|NCT05579977|471157721|FG004|Follow up|Withdrawal by Subject|1|||
130871278|NCT05579977|471157722|FG005|Follow up|Withdrawal by Subject|0|||
130871279|NCT05579977|471157723|FG006|Follow up|Withdrawal by Subject|1|||
130871280|NCT05579977|471157724|FG007|Follow up|Withdrawal by Subject|4|||
130871281|NCT05579977|471157725|FG008|Follow up|Withdrawal by Subject|2|||
130871282|NCT05579977|471157726|FG009|Follow up|Withdrawal by Subject|3|||
130871283|NCT05579977|471157727|FG010|Follow up|Withdrawal by Subject|3|||
130871284|NCT05579977|471157728|FG011|Follow up|Withdrawal by Subject|1|||
130871285|NCT05579977|471157729|FG012|Follow up|Withdrawal by Subject|3|||
130871286|NCT02831764|471159638|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130871287|NCT02831764|471159639|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
130871288|NCT02831764|471159640|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130871289|NCT02831764|471159641|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130871290|NCT02831764|471159642|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130871291|NCT02831764|471159638|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
130871292|NCT02831764|471159639|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
130871293|NCT02831764|471159640|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
130871294|NCT02831764|471159641|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
130871295|NCT02831764|471159642|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
130871296|NCT02831764|471159638|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
130871297|NCT02831764|471159639|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
130871298|NCT02831764|471159640|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
130871299|NCT02831764|471159641|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
130871300|NCT02831764|471159642|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
130871301|NCT02831764|471159638|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
130871302|NCT02831764|471159639|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
130871303|NCT02831764|471159640|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
130871304|NCT02831764|471159641|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
130871305|NCT02831764|471159642|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
130871306|NCT02831764|471159638|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
130871307|NCT02831764|471159639|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
130871308|NCT02831764|471159640|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
130871309|NCT02831764|471159641|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
130871310|NCT02831764|471159642|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
130871311|NCT02831764|471159638|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
130871312|NCT02831764|471159639|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
130871313|NCT02831764|471159640|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
130871314|NCT02831764|471159641|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
130871315|NCT02831764|471159642|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
130871316|NCT02831764|471159638|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
130871317|NCT02831764|471159639|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
130871318|NCT02831764|471159640|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
130871319|NCT02831764|471159641|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
130871320|NCT02831764|471159642|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
130871321|NCT02831764|471159638|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130871322|NCT02831764|471159639|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
130871323|NCT02831764|471159640|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130871324|NCT02831764|471159641|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130871325|NCT02831764|471159642|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130871326|NCT02831764|471159638|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130871327|NCT02831764|471159639|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130871328|NCT02831764|471159640|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
130871329|NCT02831764|471159641|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
130871330|NCT02831764|471159642|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130871331|NCT02831764|471159638|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130871332|NCT02831764|471159639|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130871333|NCT02831764|471159640|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
130871334|NCT02831764|471159641|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130871335|NCT02831764|471159642|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130871336|NCT02831764|471159638|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130871337|NCT02831764|471159639|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130871338|NCT02831764|471159640|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
130871339|NCT02831764|471159641|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
130871340|NCT02831764|471159642|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130871341|NCT02831764|471159638|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130871342|NCT02831764|471159639|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130871343|NCT02831764|471159640|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
130871344|NCT02831764|471159641|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130871345|NCT02831764|471159642|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130871346|NCT02831764|471159638|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130871347|NCT02831764|471159639|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130871348|NCT02831764|471159640|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
130871349|NCT02831764|471159641|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
130871350|NCT02831764|471159642|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130871351|NCT02831764|471159638|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130871352|NCT02831764|471159639|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130871353|NCT02831764|471159640|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
130871354|NCT02831764|471159641|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
130871355|NCT02831764|471159642|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130871356|NCT02831764|471159638|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130871357|NCT02831764|471159639|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130871358|NCT02831764|471159640|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
130871359|NCT02831764|471159641|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
130871360|NCT02831764|471159642|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130871361|NCT02831764|471159638|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130871362|NCT02831764|471159639|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130871363|NCT02831764|471159640|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130871364|NCT02831764|471159641|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130871365|NCT02831764|471159642|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
130871366|NCT02831764|471159638|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130871367|NCT02831764|471159639|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130871368|NCT02831764|471159640|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130871369|NCT02831764|471159641|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130871370|NCT02831764|471159642|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
130871371|NCT02831764|471159638|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130871372|NCT02831764|471159639|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130871373|NCT02831764|471159640|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130871374|NCT02831764|471159641|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130871375|NCT02831764|471159642|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
130871376|NCT02831764|471159638|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130871377|NCT02831764|471159639|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130871378|NCT02831764|471159640|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130871379|NCT02831764|471159641|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130871380|NCT02831764|471159642|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
130871381|NCT04564846|471159643|FG000|Overall Study|Withdrawal by Subject|2|||
130871382|NCT04564846|471159644|FG001|Overall Study|Withdrawal by Subject|1|||
130871383|NCT04564846|471159643|FG000|Overall Study|Physician Decision|0|||
130871384|NCT04564846|471159644|FG001|Overall Study|Physician Decision|1|||
130871385|NCT04564846|471159643|FG000|Overall Study|Lost to Follow-up|0|||
130871386|NCT04564846|471159644|FG001|Overall Study|Lost to Follow-up|1|||
130871387|NCT04564846|471159643|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
130871388|NCT04564846|471159644|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
130871389|NCT04564846|471159643|FG000|Overall Study|Subject non-compliance|1|||
130871390|NCT04564846|471159644|FG001|Overall Study|Subject non-compliance|0|||
130871391|NCT00865345|471159645|FG000|Overall Study|Withdrawal by Subject|2|||
130871392|NCT04388111|471159648|FG000|Overall Study|Lost to Follow-up|5|||
130871393|NCT04388111|471159649|FG001|Overall Study|Lost to Follow-up|3|||
130871394|NCT04388111|471159648|FG000|Overall Study|Adverse Event|1|||
130871395|NCT04388111|471159649|FG001|Overall Study|Adverse Event|1|||
130871396|NCT04388111|471159648|FG000|Overall Study|Protocol Violation|2|||
130871397|NCT04388111|471159649|FG001|Overall Study|Protocol Violation|4|||
130871398|NCT04388111|471159648|FG000|Overall Study|Withdrawal by Subject|1|||
130871399|NCT04388111|471159649|FG001|Overall Study|Withdrawal by Subject|0|||
130871400|NCT02735239|471159650|FG000|Overall Study|Adverse Event|0|||
130871401|NCT02735239|471159651|FG001|Overall Study|Adverse Event|0|||
130871402|NCT02735239|471159652|FG002|Overall Study|Adverse Event|4|||
130871403|NCT02735239|471159653|FG003|Overall Study|Adverse Event|0|||
130871404|NCT02735239|471159654|FG004|Overall Study|Adverse Event|0|||
130871405|NCT02735239|471159655|FG005|Overall Study|Adverse Event|0|||
130871406|NCT02735239|471159650|FG000|Overall Study|Death|1|||
130871407|NCT02735239|471159651|FG001|Overall Study|Death|1|||
130871408|NCT02735239|471159652|FG002|Overall Study|Death|0|||
130871409|NCT02735239|471159653|FG003|Overall Study|Death|0|||
130871410|NCT02735239|471159654|FG004|Overall Study|Death|0|||
130871411|NCT02735239|471159655|FG005|Overall Study|Death|0|||
130871412|NCT02735239|471159650|FG000|Overall Study|Physician Decision|0|||
130871413|NCT02735239|471159651|FG001|Overall Study|Physician Decision|0|||
130871414|NCT02735239|471159652|FG002|Overall Study|Physician Decision|1|||
130871415|NCT02735239|471159653|FG003|Overall Study|Physician Decision|0|||
130871416|NCT02735239|471159654|FG004|Overall Study|Physician Decision|0|||
130871417|NCT02735239|471159655|FG005|Overall Study|Physician Decision|0|||
130871418|NCT02735239|471159650|FG000|Overall Study|Progressive disease|3|||
130871419|NCT02735239|471159651|FG001|Overall Study|Progressive disease|1|||
130871420|NCT02735239|471159652|FG002|Overall Study|Progressive disease|3|||
130871421|NCT02735239|471159653|FG003|Overall Study|Progressive disease|0|||
130871422|NCT02735239|471159654|FG004|Overall Study|Progressive disease|0|||
130871423|NCT02735239|471159655|FG005|Overall Study|Progressive disease|2|||
130871424|NCT02735239|471159650|FG000|Overall Study|Withdrawal by Subject|0|||
130871425|NCT02735239|471159651|FG001|Overall Study|Withdrawal by Subject|1|||
130871426|NCT02735239|471159652|FG002|Overall Study|Withdrawal by Subject|0|||
130871427|NCT02735239|471159653|FG003|Overall Study|Withdrawal by Subject|0|||
130871428|NCT02735239|471159654|FG004|Overall Study|Withdrawal by Subject|0|||
130871429|NCT02735239|471159655|FG005|Overall Study|Withdrawal by Subject|0|||
130871430|NCT00387881|471159656|FG000|Overall Study|Lost to Follow-up|23|||
130871431|NCT00387881|471159657|FG001|Overall Study|Lost to Follow-up|23|||
130871432|NCT00387881|471159656|FG000|Overall Study|Protocol Violation|2|||
130871433|NCT00387881|471159657|FG001|Overall Study|Protocol Violation|12|||
130871434|NCT00387881|471159656|FG000|Overall Study|Withdrawal by Subject|15|||
130871435|NCT00387881|471159657|FG001|Overall Study|Withdrawal by Subject|18|||
130871436|NCT00387881|471159656|FG000|Overall Study|Sponsor terminated Study|0|||
130871437|NCT00387881|471159657|FG001|Overall Study|Sponsor terminated Study|1|||
130871438|NCT00387881|471159656|FG000|Overall Study|Not eligible|6|||
130871439|NCT00387881|471159657|FG001|Overall Study|Not eligible|7|||
130871440|NCT00387881|471159656|FG000|Overall Study|No opportunity to treat headache|32|||
130871441|NCT00387881|471159657|FG001|Overall Study|No opportunity to treat headache|34|||
130871442|NCT00387881|471159656|FG000|Overall Study|Not otherwise specified|11|||
130871443|NCT00387881|471159657|FG001|Overall Study|Not otherwise specified|7|||
130871444|NCT01790594|471159659|FG000|Overall Study|Death|1|||
130871445|NCT01790594|471159660|FG001|Overall Study|Death|0|||
130871446|NCT01790594|471159661|FG002|Overall Study|Death|0|||
130871447|NCT01790594|471159659|FG000|Overall Study|Physician Decision|2|||
130871448|NCT01790594|471159660|FG001|Overall Study|Physician Decision|1|||
130871449|NCT01790594|471159661|FG002|Overall Study|Physician Decision|0|||
130871450|NCT01790594|471159659|FG000|Overall Study|Withdrawal by Subject|2|||
130871451|NCT01790594|471159660|FG001|Overall Study|Withdrawal by Subject|0|||
130871452|NCT01790594|471159661|FG002|Overall Study|Withdrawal by Subject|0|||
130871453|NCT01790594|471159659|FG000|Overall Study|Transplant was not done|0|||
130871454|NCT01790594|471159660|FG001|Overall Study|Transplant was not done|0|||
130871455|NCT01790594|471159661|FG002|Overall Study|Transplant was not done|3|||
130871456|NCT01790594|471159659|FG000|Overall Study|Terminated prior to week 76|0|||
130871457|NCT01790594|471159660|FG001|Overall Study|Terminated prior to week 76|2|||
130871458|NCT01790594|471159661|FG002|Overall Study|Terminated prior to week 76|0|||
130871459|NCT03291067|471159662|FG000|Overall Study|Adverse Event|0|||
130871460|NCT03291067|471159663|FG001|Overall Study|Adverse Event|2|||
130871461|NCT03291067|471159664|FG002|Overall Study|Adverse Event|17|||
130871462|NCT03291067|471159665|FG003|Overall Study|Adverse Event|3|||
130871463|NCT03291067|471159662|FG000|Overall Study|Lost to Follow-up|2|||
130871464|NCT03291067|471159663|FG001|Overall Study|Lost to Follow-up|1|||
130871465|NCT03291067|471159664|FG002|Overall Study|Lost to Follow-up|0|||
130871466|NCT03291067|471159665|FG003|Overall Study|Lost to Follow-up|1|||
130871467|NCT03291067|471159662|FG000|Overall Study|Physician Decision|0|||
130871468|NCT03291067|471159663|FG001|Overall Study|Physician Decision|0|||
130871469|NCT03291067|471159664|FG002|Overall Study|Physician Decision|1|||
130871470|NCT03291067|471159665|FG003|Overall Study|Physician Decision|0|||
130871471|NCT03291067|471159662|FG000|Overall Study|Protocol Violation|5|||
130871472|NCT03291067|471159663|FG001|Overall Study|Protocol Violation|3|||
130871473|NCT03291067|471159664|FG002|Overall Study|Protocol Violation|4|||
130871474|NCT03291067|471159665|FG003|Overall Study|Protocol Violation|2|||
130871475|NCT03291067|471159662|FG000|Overall Study|Withdrawal by Subject|3|||
130871476|NCT03291067|471159663|FG001|Overall Study|Withdrawal by Subject|4|||
130871477|NCT03291067|471159664|FG002|Overall Study|Withdrawal by Subject|7|||
130871478|NCT03291067|471159665|FG003|Overall Study|Withdrawal by Subject|5|||
130871479|NCT03291067|471159662|FG000|Overall Study|Other|0|||
130871480|NCT03291067|471159663|FG001|Overall Study|Other|4|||
130871481|NCT03291067|471159664|FG002|Overall Study|Other|4|||
130871482|NCT03291067|471159665|FG003|Overall Study|Other|6|||
130871483|NCT02038153|471159666|FG000|Overall Study|Withdrawal by Subject|1|||
130871484|NCT01050634|471159667|FG000|Overall Study|Enrolled, but Not Treated|56|||
130871485|NCT01050634|471159667|FG000|Overall Study|Death|2|||
130871486|NCT01050634|471159667|FG000|Overall Study|Adverse Event|42|||
130871487|NCT01050634|471159667|FG000|Overall Study|Lost to Follow-up|2|||
130871488|NCT01050634|471159667|FG000|Overall Study|Other|21|||
130871489|NCT01050634|471159667|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
130871490|NCT00496015|471159668|FG000|Overall Study|Other|1|||
130871491|NCT00496015|471159669|FG001|Overall Study|Other|0|||
130871492|NCT00496015|471159670|FG002|Overall Study|Other|0|||
130871493|NCT00496015|471159671|FG003|Overall Study|Other|1|||
130871494|NCT00496015|471159672|FG004|Overall Study|Other|0|||
130871495|NCT00527735|471159673|FG000|Overall Study|Disease progression|47|||
130871496|NCT00527735|471159674|FG001|Overall Study|Disease progression|61|||
130871497|NCT00527735|471159675|FG002|Overall Study|Disease progression|53|||
130871498|NCT00527735|471159673|FG000|Overall Study|Death|23|||
130871499|NCT00527735|471159674|FG001|Overall Study|Death|13|||
130871500|NCT00527735|471159675|FG002|Overall Study|Death|15|||
130871501|NCT00527735|471159673|FG000|Overall Study|Completed treatment in treatment phase|14|||
130871502|NCT00527735|471159674|FG001|Overall Study|Completed treatment in treatment phase|13|||
130871503|NCT00527735|471159675|FG002|Overall Study|Completed treatment in treatment phase|18|||
130871504|NCT00527735|471159673|FG000|Overall Study|Adverse Event|10|||
130871505|NCT00527735|471159674|FG001|Overall Study|Adverse Event|6|||
130871506|NCT00527735|471159675|FG002|Overall Study|Adverse Event|7|||
130871507|NCT00527735|471159673|FG000|Overall Study|Not identified|5|||
130871508|NCT00527735|471159674|FG001|Overall Study|Not identified|5|||
130871509|NCT00527735|471159675|FG002|Overall Study|Not identified|5|||
130871510|NCT00527735|471159673|FG000|Overall Study|Withdrawal by Subject|5|||
130871511|NCT00527735|471159674|FG001|Overall Study|Withdrawal by Subject|4|||
130871512|NCT00527735|471159675|FG002|Overall Study|Withdrawal by Subject|3|||
130871513|NCT00527735|471159673|FG000|Overall Study|No longer met study criteria|2|||
130871514|NCT00527735|471159674|FG001|Overall Study|No longer met study criteria|2|||
130871515|NCT00527735|471159675|FG002|Overall Study|No longer met study criteria|1|||
130871516|NCT00527735|471159673|FG000|Overall Study|Lost to Follow-up|0|||
130871517|NCT00527735|471159674|FG001|Overall Study|Lost to Follow-up|0|||
130871518|NCT00527735|471159675|FG002|Overall Study|Lost to Follow-up|3|||
130871519|NCT00527735|471159673|FG000|Overall Study|Poor compliance or noncompliance|0|||
130871520|NCT00527735|471159674|FG001|Overall Study|Poor compliance or noncompliance|1|||
130871521|NCT00527735|471159675|FG002|Overall Study|Poor compliance or noncompliance|1|||
130871522|NCT00527735|471159673|FG000|Overall Study|Completed treatment during maintenance|2|||
130871523|NCT00527735|471159674|FG001|Overall Study|Completed treatment during maintenance|2|||
130871524|NCT00527735|471159675|FG002|Overall Study|Completed treatment during maintenance|1|||
130871525|NCT01535807|471159676|FG000|Overall Study|Withdrawal by Subject|1|||
130871526|NCT01535807|471159677|FG001|Overall Study|Withdrawal by Subject|1|||
130871527|NCT01535807|471159676|FG000|Overall Study|Data collection error|1|||
130871528|NCT01535807|471159677|FG001|Overall Study|Data collection error|1|||
130871529|NCT02730728|471159680|FG000|Overall Study|Withdrawal by Subject|0|||
130871530|NCT02730728|471159681|FG001|Overall Study|Withdrawal by Subject|1|||
130871531|NCT02730728|471159682|FG002|Overall Study|Withdrawal by Subject|0|||
130871532|NCT02730728|471159680|FG000|Overall Study|Lack of Efficacy|0|||
130871533|NCT02730728|471159681|FG001|Overall Study|Lack of Efficacy|1|||
130871534|NCT02730728|471159682|FG002|Overall Study|Lack of Efficacy|1|||
130871535|NCT01855412|471159683|FG000|Overall Study|Death|77|||
130871536|NCT01855412|471159684|FG001|Overall Study|Death|123|||
130871537|NCT01855412|471159685|FG002|Overall Study|Death|30|||
130871538|NCT01855412|471159683|FG000|Overall Study|Lost to Follow-up|28|||
130871539|NCT01855412|471159684|FG001|Overall Study|Lost to Follow-up|46|||
130871540|NCT01855412|471159685|FG002|Overall Study|Lost to Follow-up|15|||
130871541|NCT01855412|471159683|FG000|Overall Study|Withdrawal by Subject|77|||
130871542|NCT01855412|471159684|FG001|Overall Study|Withdrawal by Subject|123|||
130871543|NCT01855412|471159685|FG002|Overall Study|Withdrawal by Subject|24|||
130871544|NCT01855412|471159683|FG000|Overall Study|Physician Decision|25|||
130871545|NCT01855412|471159684|FG001|Overall Study|Physician Decision|31|||
130871546|NCT01855412|471159685|FG002|Overall Study|Physician Decision|3|||
130871547|NCT01855412|471159683|FG000|Overall Study|Site Closure|4|||
130871548|NCT01855412|471159684|FG001|Overall Study|Site Closure|18|||
130871549|NCT01855412|471159685|FG002|Overall Study|Site Closure|1|||
130871550|NCT01855412|471159683|FG000|Overall Study|Reason not Specified|1|||
130871551|NCT01855412|471159684|FG001|Overall Study|Reason not Specified|2|||
130871552|NCT01855412|471159685|FG002|Overall Study|Reason not Specified|3|||
130871553|NCT00404651|471159687|FG000|Overall Study|Serious Adverse Event|0|||
130871554|NCT00404651|471159688|FG001|Overall Study|Serious Adverse Event|0|||
130871555|NCT00404651|471159689|FG002|Overall Study|Serious Adverse Event|2|||
130871556|NCT00404651|471159690|FG003|Overall Study|Serious Adverse Event|0|||
130871557|NCT00404651|471159687|FG000|Overall Study|Protocol Violation|10|||
130871558|NCT00404651|471159688|FG001|Overall Study|Protocol Violation|5|||
130871559|NCT00404651|471159689|FG002|Overall Study|Protocol Violation|14|||
130871560|NCT00404651|471159690|FG003|Overall Study|Protocol Violation|5|||
130871561|NCT00404651|471159687|FG000|Overall Study|Lost to Follow-up|15|||
130871562|NCT00404651|471159688|FG001|Overall Study|Lost to Follow-up|11|||
130871563|NCT00404651|471159689|FG002|Overall Study|Lost to Follow-up|13|||
130871564|NCT00404651|471159690|FG003|Overall Study|Lost to Follow-up|10|||
130871565|NCT00404651|471159687|FG000|Overall Study|Withdrawal by Subject|14|||
130871566|NCT00404651|471159688|FG001|Overall Study|Withdrawal by Subject|12|||
130871567|NCT00404651|471159689|FG002|Overall Study|Withdrawal by Subject|16|||
130871568|NCT00404651|471159690|FG003|Overall Study|Withdrawal by Subject|6|||
130871569|NCT01702844|471159705|FG000|Overall Study|Adverse Event|9|||
130871570|NCT01702844|471159705|FG000|Overall Study|Death|1|||
130871571|NCT01702844|471159705|FG000|Overall Study|Withdrawal by Subject|3|||
130871572|NCT01702844|471159705|FG000|Overall Study|Physician Decision|6|||
130871573|NCT02123134|471159706|FG000|Overall Study|Withdrawal of consent|3|||
130871574|NCT02123134|471159707|FG001|Overall Study|Withdrawal of consent|2|||
130871575|NCT02123134|471159706|FG000|Overall Study|Administrative decision|0|||
130871576|NCT02123134|471159707|FG001|Overall Study|Administrative decision|1|||
130871577|NCT03431441|471159708|FG000|Overall Study|Withdrawal by Subject|2|||
130871578|NCT03431441|471159708|FG000|Overall Study|Adverse Event|2|||
130871579|NCT03431441|471159708|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
130871580|NCT00346216|471159709|FG000|Overall Study|Other|181|||
130871581|NCT00346216|471159710|FG001|Overall Study|Other|231|||
130871582|NCT00346216|471159711|FG002|Overall Study|Other|205|||
130871583|NCT00346216|471159709|FG000|Overall Study|No longer willing to participate|600|||
130871584|NCT00346216|471159710|FG001|Overall Study|No longer willing to participate|606|||
130871585|NCT00346216|471159711|FG002|Overall Study|No longer willing to participate|585|||
130871586|NCT00346216|471159709|FG000|Overall Study|Withdrawal by Subject|661|||
130871587|NCT00346216|471159710|FG001|Overall Study|Withdrawal by Subject|692|||
130871588|NCT00346216|471159711|FG002|Overall Study|Withdrawal by Subject|651|||
130871589|NCT00346216|471159709|FG000|Overall Study|Lost to Follow-up|611|||
130871590|NCT00346216|471159710|FG001|Overall Study|Lost to Follow-up|588|||
130871591|NCT00346216|471159711|FG002|Overall Study|Lost to Follow-up|542|||
130871592|NCT00346216|471159709|FG000|Overall Study|Physician Decision|80|||
130871593|NCT00346216|471159710|FG001|Overall Study|Physician Decision|76|||
130871594|NCT00346216|471159711|FG002|Overall Study|Physician Decision|59|||
130871595|NCT00346216|471159709|FG000|Overall Study|Does not meet entrance criteria|13|||
130871596|NCT00346216|471159710|FG001|Overall Study|Does not meet entrance criteria|10|||
130871597|NCT00346216|471159711|FG002|Overall Study|Does not meet entrance criteria|8|||
130871598|NCT00346216|471159709|FG000|Overall Study|Death|189|||
130871599|NCT00346216|471159710|FG001|Overall Study|Death|192|||
130871600|NCT00346216|471159711|FG002|Overall Study|Death|228|||
130871601|NCT00346216|471159709|FG000|Overall Study|Study terminated by sponsor|11|||
130871602|NCT00346216|471159710|FG001|Overall Study|Study terminated by sponsor|4|||
130871603|NCT00346216|471159711|FG002|Overall Study|Study terminated by sponsor|8|||
130871604|NCT00346216|471159709|FG000|Overall Study|Missing Subject Summary Status|62|||
130871605|NCT00346216|471159710|FG001|Overall Study|Missing Subject Summary Status|61|||
130871606|NCT00346216|471159711|FG002|Overall Study|Missing Subject Summary Status|62|||
130871607|NCT02043938|471159721|FG000|Overall Study|Withdrawal by Subject|7|||
130871608|NCT02043938|471159721|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
130871609|NCT02043938|471159721|FG000|Overall Study|No show by subject|1|||
130871610|NCT02043938|471159721|FG000|Overall Study|Investigator decision|1|||
130871611|NCT03010527|471159726|FG000|Overall Study|Death|0|||
130871612|NCT03010527|471159727|FG001|Overall Study|Death|0|||
130871613|NCT03010527|471159728|FG002|Overall Study|Death|1|||
130871614|NCT03010527|471159726|FG000|Overall Study|Adverse Event|0|||
130871615|NCT03010527|471159727|FG001|Overall Study|Adverse Event|4|||
130871616|NCT03010527|471159728|FG002|Overall Study|Adverse Event|2|||
130871617|NCT03010527|471159726|FG000|Overall Study|Protocol Violation|0|||
130871618|NCT03010527|471159727|FG001|Overall Study|Protocol Violation|1|||
130871619|NCT03010527|471159728|FG002|Overall Study|Protocol Violation|0|||
130871620|NCT03010527|471159726|FG000|Overall Study|Lost to Follow-up|0|||
130871621|NCT03010527|471159727|FG001|Overall Study|Lost to Follow-up|2|||
130871622|NCT03010527|471159728|FG002|Overall Study|Lost to Follow-up|1|||
130871623|NCT03010527|471159726|FG000|Overall Study|Withdrawal by Subject|0|||
130871624|NCT03010527|471159727|FG001|Overall Study|Withdrawal by Subject|3|||
130871625|NCT03010527|471159728|FG002|Overall Study|Withdrawal by Subject|4|||
130871626|NCT03010527|471159726|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
130871627|NCT03010527|471159727|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
130871628|NCT03010527|471159728|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
130871629|NCT03010527|471159726|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
130871630|NCT03010527|471159727|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
130871631|NCT03010527|471159728|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
130871632|NCT03010527|471159726|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
130871633|NCT03010527|471159727|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
130871634|NCT03010527|471159728|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
130871635|NCT00764699|471159729|FG000|Overall Study|PI left and study terminated|3|||
130871636|NCT03985761|471159736|FG000|Overall Study|Withdrawal by Subject|2|||
130871637|NCT03985761|471159737|FG001|Overall Study|Withdrawal by Subject|3|||
130871638|NCT03400852|471159738|FG000|Blinded Treatment Period|Physician Decision|0|||
130871639|NCT03400852|471159739|FG001|Blinded Treatment Period|Physician Decision|1|||
130871640|NCT03400852|471159740|FG002|Blinded Treatment Period|Physician Decision|0|||
130871641|NCT03400852|471159738|FG000|Blinded Treatment Period|Adverse Event|1|||
130871642|NCT03400852|471159739|FG001|Blinded Treatment Period|Adverse Event|1|||
130871643|NCT03400852|471159740|FG002|Blinded Treatment Period|Adverse Event|0|||
130871644|NCT03400852|471159738|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
130871645|NCT03400852|471159739|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
130871646|NCT03400852|471159740|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
130871647|NCT03400852|471159738|FG000|Open Label Period|Physician Decision|0|||
130871648|NCT03400852|471159739|FG001|Open Label Period|Physician Decision|0|||
130871649|NCT03400852|471159740|FG002|Open Label Period|Physician Decision|1|||
130871650|NCT03400852|471159738|FG000|Open Label Period|Study terminated by sponsor|0|||
130871651|NCT03400852|471159739|FG001|Open Label Period|Study terminated by sponsor|0|||
130871652|NCT03400852|471159740|FG002|Open Label Period|Study terminated by sponsor|21|||
130871653|NCT01755234|471159741|FG000|Overall Study|Lost to Follow-up|11|||
130871654|NCT01755234|471159742|FG001|Overall Study|Lost to Follow-up|6|||
130871655|NCT01755234|471159741|FG000|Overall Study|Change in surgical case|2|||
130871656|NCT01755234|471159742|FG001|Overall Study|Change in surgical case|1|||
130871657|NCT01755234|471159741|FG000|Overall Study|case cancelled|1|||
130871658|NCT01755234|471159742|FG001|Overall Study|case cancelled|0|||
130871659|NCT01755234|471159741|FG000|Overall Study|Withdrawal by Subject|0|||
130871660|NCT01755234|471159742|FG001|Overall Study|Withdrawal by Subject|1|||
130871661|NCT01755234|471159741|FG000|Overall Study|unblinded|1|||
130871662|NCT01755234|471159742|FG001|Overall Study|unblinded|0|||
130871663|NCT00248495|471159743|FG000|Overall Study|Withdrawal by Subject|1|||
130871664|NCT03812380|471159744|FG000|Overall Study|Protocol Violation|3|||
130871665|NCT03812380|471159745|FG001|Overall Study|Protocol Violation|3|||
130871666|NCT03812380|471159744|FG000|Overall Study|Withdrawal by Subject|5|||
130871667|NCT03812380|471159745|FG001|Overall Study|Withdrawal by Subject|4|||
130871668|NCT03812380|471159744|FG000|Overall Study|Early termination of study|14|||
130871669|NCT03812380|471159745|FG001|Overall Study|Early termination of study|14|||
130871670|NCT02648204|471159746|FG000|Overall Study|Withdrawal by Subject|12|||
130871671|NCT02648204|471159747|FG001|Overall Study|Withdrawal by Subject|8|||
130871672|NCT02648204|471159748|FG002|Overall Study|Withdrawal by Subject|2|||
130871673|NCT02648204|471159749|FG003|Overall Study|Withdrawal by Subject|6|||
130871674|NCT02648204|471159746|FG000|Overall Study|Lost to Follow-up|5|||
130871675|NCT02648204|471159747|FG001|Overall Study|Lost to Follow-up|8|||
130871676|NCT02648204|471159748|FG002|Overall Study|Lost to Follow-up|4|||
130871677|NCT02648204|471159749|FG003|Overall Study|Lost to Follow-up|6|||
130871678|NCT02648204|471159746|FG000|Overall Study|Missing follow-up information|4|||
130871679|NCT02648204|471159747|FG001|Overall Study|Missing follow-up information|4|||
130871680|NCT02648204|471159748|FG002|Overall Study|Missing follow-up information|4|||
130871681|NCT02648204|471159749|FG003|Overall Study|Missing follow-up information|2|||
130871682|NCT02648204|471159746|FG000|Overall Study|Death|1|||
130871683|NCT02648204|471159747|FG001|Overall Study|Death|1|||
130871684|NCT02648204|471159748|FG002|Overall Study|Death|2|||
130871685|NCT02648204|471159749|FG003|Overall Study|Death|2|||
130871686|NCT02648204|471159746|FG000|Overall Study|Adverse Event|0|||
130871687|NCT02648204|471159747|FG001|Overall Study|Adverse Event|0|||
130871688|NCT02648204|471159748|FG002|Overall Study|Adverse Event|1|||
130871689|NCT02648204|471159749|FG003|Overall Study|Adverse Event|0|||
130871690|NCT03001557|471159756|FG000|Core Phase|Randomized but not treated|0|||
130871691|NCT03001557|471159757|FG001|Core Phase|Randomized but not treated|0|||
130871692|NCT03001557|471159758|FG002|Core Phase|Randomized but not treated|1|||
130871693|NCT03001557|471159759|FG003|Core Phase|Randomized but not treated|0|||
130871694|NCT03001557|471159760|FG004|Core Phase|Randomized but not treated|0|||
130871695|NCT03001557|471159761|FG005|Core Phase|Randomized but not treated|0|||
130871696|NCT03001557|471159762|FG006|Core Phase|Randomized but not treated|0|||
130871697|NCT03001557|471159763|FG007|Core Phase|Randomized but not treated|0|||
130871698|NCT03001557|471159756|FG000|Extension Phase|Adverse Event|0|||
130871699|NCT03001557|471159757|FG001|Extension Phase|Adverse Event|0|||
130871700|NCT03001557|471159758|FG002|Extension Phase|Adverse Event|0|||
130871701|NCT03001557|471159759|FG003|Extension Phase|Adverse Event|0|||
130871702|NCT03001557|471159760|FG004|Extension Phase|Adverse Event|0|||
130871703|NCT03001557|471159761|FG005|Extension Phase|Adverse Event|2|||
130871704|NCT03001557|471159762|FG006|Extension Phase|Adverse Event|0|||
130871705|NCT03001557|471159763|FG007|Extension Phase|Adverse Event|0|||
130871706|NCT03001557|471159756|FG000|Extension Phase|Withdrawal by Subject|0|||
130871707|NCT03001557|471159757|FG001|Extension Phase|Withdrawal by Subject|0|||
130871708|NCT03001557|471159758|FG002|Extension Phase|Withdrawal by Subject|0|||
130871709|NCT03001557|471159759|FG003|Extension Phase|Withdrawal by Subject|0|||
130871710|NCT03001557|471159760|FG004|Extension Phase|Withdrawal by Subject|0|||
130871711|NCT03001557|471159761|FG005|Extension Phase|Withdrawal by Subject|1|||
130871712|NCT03001557|471159762|FG006|Extension Phase|Withdrawal by Subject|5|||
130871713|NCT03001557|471159763|FG007|Extension Phase|Withdrawal by Subject|2|||
130871714|NCT03001557|471159756|FG000|Extension Phase|Lost to Follow-up|0|||
130871715|NCT03001557|471159757|FG001|Extension Phase|Lost to Follow-up|0|||
130871716|NCT03001557|471159758|FG002|Extension Phase|Lost to Follow-up|0|||
130871717|NCT03001557|471159759|FG003|Extension Phase|Lost to Follow-up|0|||
130871718|NCT03001557|471159760|FG004|Extension Phase|Lost to Follow-up|0|||
130871719|NCT03001557|471159761|FG005|Extension Phase|Lost to Follow-up|0|||
130871720|NCT03001557|471159762|FG006|Extension Phase|Lost to Follow-up|2|||
130871721|NCT03001557|471159763|FG007|Extension Phase|Lost to Follow-up|1|||
130871722|NCT03001557|471159756|FG000|Extension Phase|Administrative Reason|0|||
130871723|NCT03001557|471159757|FG001|Extension Phase|Administrative Reason|0|||
130871724|NCT03001557|471159758|FG002|Extension Phase|Administrative Reason|0|||
130871725|NCT03001557|471159759|FG003|Extension Phase|Administrative Reason|0|||
130871726|NCT03001557|471159760|FG004|Extension Phase|Administrative Reason|0|||
130871727|NCT03001557|471159761|FG005|Extension Phase|Administrative Reason|1|||
130871728|NCT03001557|471159762|FG006|Extension Phase|Administrative Reason|3|||
130871729|NCT03001557|471159763|FG007|Extension Phase|Administrative Reason|3|||
130871730|NCT03001557|471159756|FG000|Extension Phase|Loss of caregiver|0|||
130871731|NCT03001557|471159757|FG001|Extension Phase|Loss of caregiver|0|||
130871732|NCT03001557|471159758|FG002|Extension Phase|Loss of caregiver|0|||
130871733|NCT03001557|471159759|FG003|Extension Phase|Loss of caregiver|0|||
130871734|NCT03001557|471159760|FG004|Extension Phase|Loss of caregiver|0|||
130871735|NCT03001557|471159761|FG005|Extension Phase|Loss of caregiver|0|||
130871736|NCT03001557|471159762|FG006|Extension Phase|Loss of caregiver|1|||
130871737|NCT03001557|471159763|FG007|Extension Phase|Loss of caregiver|0|||
130871738|NCT03001557|471159756|FG000|Extension Phase|Others|0|||
130871739|NCT03001557|471159757|FG001|Extension Phase|Others|0|||
130871740|NCT03001557|471159758|FG002|Extension Phase|Others|0|||
130871741|NCT03001557|471159759|FG003|Extension Phase|Others|0|||
130871742|NCT03001557|471159760|FG004|Extension Phase|Others|0|||
130871743|NCT03001557|471159761|FG005|Extension Phase|Others|1|||
130871744|NCT03001557|471159762|FG006|Extension Phase|Others|3|||
130871745|NCT03001557|471159763|FG007|Extension Phase|Others|0|||
130871746|NCT01794000|471159764|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
130871747|NCT01794000|471159765|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
130871748|NCT01794000|471159764|FG000|Double-Blind Phase (DBP)|Death|1|||
130871749|NCT01794000|471159765|FG001|Double-Blind Phase (DBP)|Death|2|||
130871750|NCT01794000|471159764|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
130871751|NCT01794000|471159765|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
130871752|NCT01794000|471159764|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
130871753|NCT01794000|471159765|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
130871754|NCT01794000|471159764|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
130871755|NCT01794000|471159765|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
130871756|NCT01794000|471159764|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
130871757|NCT01794000|471159765|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
130871758|NCT01794000|471159764|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
130871759|NCT01794000|471159765|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
130871760|NCT01794000|471159764|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
130871761|NCT01794000|471159765|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130871762|NCT01091675|471159769|FG000|Overall Study|Adverse Event|7|||
130871763|NCT01091675|471159769|FG000|Overall Study|Lack of Efficacy|27|||
130871764|NCT00614380|471159770|FG000|Overall Study|Adverse Event|14|||
130871765|NCT00614380|471159771|FG001|Overall Study|Adverse Event|4|||
130871766|NCT00614380|471159772|FG002|Overall Study|Adverse Event|0|||
130871767|NCT00614380|471159773|FG003|Overall Study|Adverse Event|0|||
130871768|NCT00614380|471159770|FG000|Overall Study|Lost to Follow-up|6|||
130871769|NCT00614380|471159771|FG001|Overall Study|Lost to Follow-up|1|||
130871770|NCT00614380|471159772|FG002|Overall Study|Lost to Follow-up|0|||
130871771|NCT00614380|471159773|FG003|Overall Study|Lost to Follow-up|0|||
130871772|NCT00614380|471159770|FG000|Overall Study|Non compliant with the protocol|12|||
130871773|NCT00614380|471159771|FG001|Overall Study|Non compliant with the protocol|2|||
130871774|NCT00614380|471159772|FG002|Overall Study|Non compliant with the protocol|1|||
130871775|NCT00614380|471159773|FG003|Overall Study|Non compliant with the protocol|2|||
130871776|NCT00614380|471159770|FG000|Overall Study|Consent withdrawn|3|||
130871777|NCT00614380|471159771|FG001|Overall Study|Consent withdrawn|1|||
130871778|NCT00614380|471159772|FG002|Overall Study|Consent withdrawn|0|||
130871779|NCT00614380|471159773|FG003|Overall Study|Consent withdrawn|0|||
130871780|NCT01670721|471159787|FG000|Overall Study|Participant's decision|15|||
130871781|NCT01670721|471159787|FG000|Overall Study|Other than specified above|38|||
130871782|NCT00191334|471159788|FG000|Overall Study|Adverse Event|4|||
130871783|NCT00191334|471159788|FG000|Overall Study|Disease Progression or Relapse|8|||
130871784|NCT00191334|471159788|FG000|Overall Study|Physician Decision|1|||
130871785|NCT00191334|471159788|FG000|Overall Study|Withdrawal by Subject|4|||
130871786|NCT05274958|471159789|FG000|Overall Study|Only completed 1 set of PROMs|22|||
130871787|NCT05274958|471159790|FG001|Overall Study|Only completed 1 set of PROMs|35|||
130871788|NCT00866814|471159791|FG000|Overall Study|Lost to Follow-up|12|||
130871789|NCT00866814|471159791|FG000|Overall Study|Adverse Event|2|||
130871790|NCT00866814|471159791|FG000|Overall Study|Physician Decision|1|||
130871791|NCT00866814|471159791|FG000|Overall Study|Death|1|||
130871792|NCT00866814|471159791|FG000|Overall Study|No longer wished to participate|1|||
130871793|NCT00866814|471159791|FG000|Overall Study|Unable to meet follow-up requirements|2|||
130871794|NCT00866814|471159791|FG000|Overall Study|Moved to area without study site|1|||
130871795|NCT01420926|471159794|FG000|Overall Study|Adverse Event|6|||
130871796|NCT01420926|471159795|FG001|Overall Study|Adverse Event|4|||
130871797|NCT01420926|471159794|FG000|Overall Study|Death|18|||
130871798|NCT01420926|471159795|FG001|Overall Study|Death|17|||
130871799|NCT01420926|471159794|FG000|Overall Study|Withdrawal by Subject|11|||
130871800|NCT01420926|471159795|FG001|Overall Study|Withdrawal by Subject|17|||
130871801|NCT01420926|471159794|FG000|Overall Study|Non-protocol treatment|17|||
130871802|NCT01420926|471159795|FG001|Overall Study|Non-protocol treatment|20|||
130871803|NCT01420926|471159794|FG000|Overall Study|Physician Decision|8|||
130871804|NCT01420926|471159795|FG001|Overall Study|Physician Decision|5|||
130871805|NCT04537793|471161526|FG000|Part B (24 Weeks)|Adverse Event|0|||
130871806|NCT04537793|471161527|FG001|Part B (24 Weeks)|Adverse Event|1|||
130871807|NCT05470387|471161528|FG000|Overall Study|Protocol Violation|0|||
130871808|NCT05470387|471161529|FG001|Overall Study|Protocol Violation|3|||
130871809|NCT01255423|471161530|FG000|Overall Study|Abnormal Laboratory value|3|||
130871810|NCT01255423|471161531|FG001|Overall Study|Abnormal Laboratory value|2|||
130871811|NCT01255423|471161530|FG000|Overall Study|Use of prohibited medications|0|||
130871812|NCT01255423|471161531|FG001|Overall Study|Use of prohibited medications|1|||
130871813|NCT01176058|471161532|FG000|Overall Study|Adverse Event|1|||
130871814|NCT01176058|471161533|FG001|Overall Study|Adverse Event|0|||
130871815|NCT01176058|471161532|FG000|Overall Study|Insufficient clinical response|2|||
130871816|NCT01176058|471161533|FG001|Overall Study|Insufficient clinical response|2|||
130871817|NCT01176058|471161532|FG000|Overall Study|Insufficient mycological response|0|||
130871818|NCT01176058|471161533|FG001|Overall Study|Insufficient mycological response|1|||
130871819|NCT01176058|471161532|FG000|Overall Study|Withdrawal by Subject|1|||
130871820|NCT01176058|471161533|FG001|Overall Study|Withdrawal by Subject|0|||
130871821|NCT01858363|471161534|FG000|Overall Study|Death|35|||
130871822|NCT01858363|471161535|FG001|Overall Study|Death|9|||
130871823|NCT01858363|471161534|FG000|Overall Study|Withdrawal by Subject|28|||
130871824|NCT01858363|471161535|FG001|Overall Study|Withdrawal by Subject|14|||
130871825|NCT01858363|471161534|FG000|Overall Study|Lost to Follow-up|13|||
130871826|NCT01858363|471161535|FG001|Overall Study|Lost to Follow-up|3|||
130871827|NCT03480152|471161540|FG000|Phase I|Signed consent. Died before treatment.|1|||
130871828|NCT03480152|471161541|FG001|Phase I|Signed consent. Died before treatment.|0|||
130871829|NCT03480152|471161542|FG002|Phase I|Signed consent. Died before treatment.|0|||
130871830|NCT00101686|471161543|FG000|Overall Study|Progressive Disease|37|||
130871831|NCT00101686|471161544|FG001|Overall Study|Progressive Disease|28|||
130871832|NCT00101686|471161545|FG002|Overall Study|Progressive Disease|37|||
130871833|NCT00101686|471161546|FG003|Overall Study|Progressive Disease|38|||
130871834|NCT00101686|471161547|FG004|Overall Study|Progressive Disease|28|||
130871835|NCT00101686|471161548|FG005|Overall Study|Progressive Disease|25|||
130871836|NCT00101686|471161549|FG006|Overall Study|Progressive Disease|5|||
130871837|NCT00101686|471161550|FG007|Overall Study|Progressive Disease|7|||
130871838|NCT00101686|471161551|FG008|Overall Study|Progressive Disease|10|||
130871839|NCT00101686|471161552|FG009|Overall Study|Progressive Disease|8|||
130871840|NCT00101686|471161543|FG000|Overall Study|initiation other anti-cancer treatment|4|||
130871841|NCT00101686|471161544|FG001|Overall Study|initiation other anti-cancer treatment|3|||
130871842|NCT00101686|471161545|FG002|Overall Study|initiation other anti-cancer treatment|4|||
130871843|NCT00101686|471161546|FG003|Overall Study|initiation other anti-cancer treatment|3|||
130871844|NCT00101686|471161547|FG004|Overall Study|initiation other anti-cancer treatment|1|||
130871845|NCT00101686|471161548|FG005|Overall Study|initiation other anti-cancer treatment|1|||
130871846|NCT00101686|471161549|FG006|Overall Study|initiation other anti-cancer treatment|2|||
130871847|NCT00101686|471161550|FG007|Overall Study|initiation other anti-cancer treatment|2|||
130871848|NCT00101686|471161551|FG008|Overall Study|initiation other anti-cancer treatment|3|||
130871849|NCT00101686|471161552|FG009|Overall Study|initiation other anti-cancer treatment|3|||
130871850|NCT00101686|471161543|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
130871851|NCT00101686|471161544|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
130871852|NCT00101686|471161545|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
130871853|NCT00101686|471161546|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
130871854|NCT00101686|471161547|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
130871855|NCT00101686|471161548|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
130871856|NCT00101686|471161549|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
130871857|NCT00101686|471161550|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
130871858|NCT00101686|471161551|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
130871859|NCT00101686|471161552|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
130871860|NCT00101686|471161543|FG000|Overall Study|unacceptable toxicity|3|||
130871861|NCT00101686|471161544|FG001|Overall Study|unacceptable toxicity|9|||
130871862|NCT00101686|471161545|FG002|Overall Study|unacceptable toxicity|10|||
130871863|NCT00101686|471161546|FG003|Overall Study|unacceptable toxicity|6|||
130871864|NCT00101686|471161547|FG004|Overall Study|unacceptable toxicity|16|||
130871865|NCT00101686|471161548|FG005|Overall Study|unacceptable toxicity|10|||
130871866|NCT00101686|471161549|FG006|Overall Study|unacceptable toxicity|4|||
130871867|NCT00101686|471161550|FG007|Overall Study|unacceptable toxicity|2|||
130871868|NCT00101686|471161551|FG008|Overall Study|unacceptable toxicity|1|||
130871869|NCT00101686|471161552|FG009|Overall Study|unacceptable toxicity|4|||
130871870|NCT00101686|471161543|FG000|Overall Study|Randomized but did not receive treament|1|||
130871871|NCT00101686|471161544|FG001|Overall Study|Randomized but did not receive treament|6|||
130871872|NCT00101686|471161545|FG002|Overall Study|Randomized but did not receive treament|2|||
130871873|NCT00101686|471161546|FG003|Overall Study|Randomized but did not receive treament|2|||
130871874|NCT00101686|471161547|FG004|Overall Study|Randomized but did not receive treament|2|||
130871875|NCT00101686|471161548|FG005|Overall Study|Randomized but did not receive treament|2|||
130871876|NCT00101686|471161549|FG006|Overall Study|Randomized but did not receive treament|0|||
130871877|NCT00101686|471161550|FG007|Overall Study|Randomized but did not receive treament|1|||
130871878|NCT00101686|471161551|FG008|Overall Study|Randomized but did not receive treament|0|||
130871879|NCT00101686|471161552|FG009|Overall Study|Randomized but did not receive treament|1|||
130871880|NCT00101686|471161543|FG000|Overall Study|intercurrent non-cancer related illness|0|||
130871881|NCT00101686|471161544|FG001|Overall Study|intercurrent non-cancer related illness|0|||
130871882|NCT00101686|471161545|FG002|Overall Study|intercurrent non-cancer related illness|2|||
130871883|NCT00101686|471161546|FG003|Overall Study|intercurrent non-cancer related illness|0|||
130871884|NCT00101686|471161547|FG004|Overall Study|intercurrent non-cancer related illness|1|||
130871885|NCT00101686|471161548|FG005|Overall Study|intercurrent non-cancer related illness|3|||
130871886|NCT00101686|471161549|FG006|Overall Study|intercurrent non-cancer related illness|1|||
130871887|NCT00101686|471161550|FG007|Overall Study|intercurrent non-cancer related illness|0|||
130871888|NCT00101686|471161551|FG008|Overall Study|intercurrent non-cancer related illness|1|||
130871889|NCT00101686|471161552|FG009|Overall Study|intercurrent non-cancer related illness|1|||
130871890|NCT00101686|471161543|FG000|Overall Study|Physician Decision|10|||
130871891|NCT00101686|471161544|FG001|Overall Study|Physician Decision|13|||
130871892|NCT00101686|471161545|FG002|Overall Study|Physician Decision|6|||
130871893|NCT00101686|471161546|FG003|Overall Study|Physician Decision|7|||
130871894|NCT00101686|471161547|FG004|Overall Study|Physician Decision|8|||
130871895|NCT00101686|471161548|FG005|Overall Study|Physician Decision|9|||
130871896|NCT00101686|471161549|FG006|Overall Study|Physician Decision|5|||
130871897|NCT00101686|471161550|FG007|Overall Study|Physician Decision|5|||
130871898|NCT00101686|471161551|FG008|Overall Study|Physician Decision|1|||
130871899|NCT00101686|471161552|FG009|Overall Study|Physician Decision|1|||
130871900|NCT00101686|471161543|FG000|Overall Study|Other|1|||
130871901|NCT00101686|471161544|FG001|Overall Study|Other|4|||
130871902|NCT00101686|471161545|FG002|Overall Study|Other|1|||
130871903|NCT00101686|471161546|FG003|Overall Study|Other|6|||
130871904|NCT00101686|471161547|FG004|Overall Study|Other|2|||
130871905|NCT00101686|471161548|FG005|Overall Study|Other|12|||
130871906|NCT00101686|471161549|FG006|Overall Study|Other|1|||
130871907|NCT00101686|471161550|FG007|Overall Study|Other|5|||
130871908|NCT00101686|471161551|FG008|Overall Study|Other|3|||
130871909|NCT00101686|471161552|FG009|Overall Study|Other|3|||
130871910|NCT00101686|471161543|FG000|Overall Study|Withdrawal by Subject|9|||
130871911|NCT00101686|471161544|FG001|Overall Study|Withdrawal by Subject|8|||
130871912|NCT00101686|471161545|FG002|Overall Study|Withdrawal by Subject|6|||
130871913|NCT00101686|471161546|FG003|Overall Study|Withdrawal by Subject|8|||
130871914|NCT00101686|471161547|FG004|Overall Study|Withdrawal by Subject|8|||
130871915|NCT00101686|471161548|FG005|Overall Study|Withdrawal by Subject|7|||
130871916|NCT00101686|471161549|FG006|Overall Study|Withdrawal by Subject|7|||
130871917|NCT00101686|471161550|FG007|Overall Study|Withdrawal by Subject|7|||
130871918|NCT00101686|471161551|FG008|Overall Study|Withdrawal by Subject|8|||
130871919|NCT00101686|471161552|FG009|Overall Study|Withdrawal by Subject|9|||
130871920|NCT00687401|471161553|FG000|Overall Study|Protocol Violation|7|||
130871921|NCT00687401|471161553|FG000|Overall Study|Adverse Event|6|||
130871922|NCT00687401|471161553|FG000|Overall Study|Lack of Efficacy|6|||
130871923|NCT00687401|471161553|FG000|Overall Study|Withdrawal by Subject|4|||
130871924|NCT00687401|471161553|FG000|Overall Study|Did not return for visit|3|||
130871925|NCT00687401|471161553|FG000|Overall Study|For reasons different from those above|4|||
130871926|NCT02920892|471161554|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
130871927|NCT02920892|471161555|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
130871928|NCT02920892|471161556|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
130871929|NCT02920892|471161554|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
130871930|NCT02920892|471161555|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
130871931|NCT02920892|471161556|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
130871932|NCT02920892|471161554|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
130871933|NCT02920892|471161555|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
130871934|NCT02920892|471161556|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
130871935|NCT02920892|471161554|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
130871936|NCT02920892|471161555|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
130871937|NCT02920892|471161556|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
130871938|NCT02920892|471161554|FG000|Placebo-Controlled Period|Physician Decision|0|||
130871939|NCT02920892|471161555|FG001|Placebo-Controlled Period|Physician Decision|0|||
130871940|NCT02920892|471161556|FG002|Placebo-Controlled Period|Physician Decision|1|||
130871941|NCT02920892|471161554|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
130871942|NCT02920892|471161555|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
130871943|NCT02920892|471161556|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
130871944|NCT02920892|471161554|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130871945|NCT02920892|471161555|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
130871946|NCT02920892|471161556|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
130871947|NCT02920892|471161554|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
130871948|NCT02920892|471161555|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
130871949|NCT02920892|471161556|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
130871950|NCT04486235|471161557|FG000|Overall Study|Pregnancy|1|||
130871951|NCT04486235|471161558|FG001|Overall Study|Pregnancy|0|||
130871952|NCT04486235|471161557|FG000|Overall Study|Lost to Follow-up|1|||
130871953|NCT04486235|471161558|FG001|Overall Study|Lost to Follow-up|0|||
130871954|NCT01092728|471161559|FG000|Overall Study|Withdrawal by Subject|2|||
130871955|NCT01092728|471161560|FG001|Overall Study|Withdrawal by Subject|0|||
130871956|NCT01092728|471161559|FG000|Overall Study|Adverse Event|0|||
130871957|NCT01092728|471161560|FG001|Overall Study|Adverse Event|1|||
130871958|NCT01092728|471161559|FG000|Overall Study|Disease Progression|1|||
130871959|NCT01092728|471161560|FG001|Overall Study|Disease Progression|13|||
130871960|NCT01092728|471161559|FG000|Overall Study|Prohibited Concomitant Medications|1|||
130871961|NCT01092728|471161560|FG001|Overall Study|Prohibited Concomitant Medications|0|||
130871962|NCT03649217|471161561|FG000|Overall Study|subject had severe ataxia not initially found|1|||
130871963|NCT03649217|471161561|FG000|Overall Study|subject had cognitive issues not initially found|1|||
130871964|NCT02520726|471161562|FG000|Overall Study|Lost to Follow-up|3|||
130871965|NCT02520726|471161563|FG001|Overall Study|Lost to Follow-up|2|||
130871966|NCT00721396|471161564|FG000|Overall Study|Adverse Event|4|||
130871967|NCT00721396|471161565|FG001|Overall Study|Adverse Event|7|||
130871968|NCT00721396|471161566|FG002|Overall Study|Adverse Event|2|||
130871969|NCT00721396|471161567|FG003|Overall Study|Adverse Event|0|||
130871970|NCT00721396|471161564|FG000|Overall Study|Withdrawal by Subject|12|||
130871971|NCT00721396|471161565|FG001|Overall Study|Withdrawal by Subject|15|||
130871972|NCT00721396|471161566|FG002|Overall Study|Withdrawal by Subject|3|||
130871973|NCT00721396|471161567|FG003|Overall Study|Withdrawal by Subject|7|||
130871974|NCT00721396|471161564|FG000|Overall Study|Lost to Follow-up|7|||
130871975|NCT00721396|471161565|FG001|Overall Study|Lost to Follow-up|9|||
130871976|NCT00721396|471161566|FG002|Overall Study|Lost to Follow-up|3|||
130871977|NCT00721396|471161567|FG003|Overall Study|Lost to Follow-up|3|||
130871978|NCT00721396|471161564|FG000|Overall Study|Protocol Violation|4|||
130871979|NCT00721396|471161565|FG001|Overall Study|Protocol Violation|3|||
130871980|NCT00721396|471161566|FG002|Overall Study|Protocol Violation|1|||
130871981|NCT00721396|471161567|FG003|Overall Study|Protocol Violation|0|||
130871982|NCT00721396|471161564|FG000|Overall Study|Inappropriate enrollment|0|||
130871983|NCT00721396|471161565|FG001|Overall Study|Inappropriate enrollment|2|||
130871984|NCT00721396|471161566|FG002|Overall Study|Inappropriate enrollment|0|||
130871985|NCT00721396|471161567|FG003|Overall Study|Inappropriate enrollment|0|||
130871986|NCT00721396|471161564|FG000|Overall Study|Administrative reason|3|||
130871987|NCT00721396|471161565|FG001|Overall Study|Administrative reason|0|||
130871988|NCT00721396|471161566|FG002|Overall Study|Administrative reason|1|||
130871989|NCT00721396|471161567|FG003|Overall Study|Administrative reason|0|||
130871990|NCT03546621|471161568|FG000|Overall Study|Withdrawal by Subject|0|||
130871991|NCT03546621|471161569|FG001|Overall Study|Withdrawal by Subject|1|||
130871992|NCT03546621|471161570|FG002|Overall Study|Withdrawal by Subject|2|||
130871993|NCT03546621|471161571|FG003|Overall Study|Withdrawal by Subject|1|||
130871994|NCT03546621|471161568|FG000|Overall Study|Lost to Follow-up|0|||
130871995|NCT03546621|471161569|FG001|Overall Study|Lost to Follow-up|1|||
130871996|NCT03546621|471161570|FG002|Overall Study|Lost to Follow-up|0|||
130871997|NCT03546621|471161571|FG003|Overall Study|Lost to Follow-up|0|||
130871998|NCT03546621|471161568|FG000|Overall Study|Adverse Event|0|||
130871999|NCT03546621|471161569|FG001|Overall Study|Adverse Event|1|||
130872000|NCT03546621|471161570|FG002|Overall Study|Adverse Event|0|||
130872001|NCT03546621|471161571|FG003|Overall Study|Adverse Event|1|||
130872002|NCT03546621|471161568|FG000|Overall Study|Progressive disease|0|||
130872003|NCT03546621|471161569|FG001|Overall Study|Progressive disease|0|||
130872004|NCT03546621|471161570|FG002|Overall Study|Progressive disease|0|||
130872005|NCT03546621|471161571|FG003|Overall Study|Progressive disease|1|||
130872006|NCT02365649|471161573|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130872007|NCT02365649|471161574|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130872008|NCT02365649|471161575|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130872009|NCT02365649|471161576|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
130872010|NCT02365649|471161577|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130872011|NCT02365649|471161578|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130872012|NCT02365649|471161579|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130872013|NCT02365649|471161580|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130872014|NCT02365649|471161581|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130872015|NCT02365649|471161582|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130872016|NCT02365649|471161573|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
130872017|NCT02365649|471161574|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
130872018|NCT02365649|471161575|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130872019|NCT02365649|471161576|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
130872020|NCT02365649|471161577|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
130872021|NCT02365649|471161578|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
130872022|NCT02365649|471161579|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130872023|NCT02365649|471161580|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130872024|NCT02365649|471161581|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130872025|NCT02365649|471161582|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130872026|NCT02365649|471161573|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
130872027|NCT02365649|471161574|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130872028|NCT02365649|471161575|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130872029|NCT02365649|471161576|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130872030|NCT02365649|471161577|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
130872031|NCT02365649|471161578|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130872032|NCT02365649|471161579|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130872033|NCT02365649|471161580|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130872034|NCT02365649|471161581|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130872035|NCT02365649|471161582|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130872036|NCT02365649|471161573|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
130872037|NCT02365649|471161574|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
130872038|NCT02365649|471161575|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
130872039|NCT02365649|471161576|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
130872040|NCT02365649|471161577|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
130872041|NCT02365649|471161578|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
130872042|NCT02365649|471161579|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
130872043|NCT02365649|471161580|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
130872044|NCT02365649|471161581|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
130872045|NCT02365649|471161582|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
130872046|NCT02365649|471161573|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
130872047|NCT02365649|471161574|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130872048|NCT02365649|471161575|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
130872049|NCT02365649|471161576|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130872050|NCT02365649|471161577|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
130872051|NCT02365649|471161578|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130872052|NCT02365649|471161579|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130872053|NCT02365649|471161580|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130872054|NCT02365649|471161581|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130872055|NCT02365649|471161582|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130872056|NCT02365649|471161573|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
130872057|NCT02365649|471161574|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130872058|NCT02365649|471161575|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130872059|NCT02365649|471161576|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130872060|NCT02365649|471161577|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
130872061|NCT02365649|471161578|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
130872062|NCT02365649|471161579|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130872063|NCT02365649|471161580|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130872064|NCT02365649|471161581|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130872065|NCT02365649|471161582|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130872066|NCT02365649|471161573|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130872067|NCT02365649|471161574|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130872068|NCT02365649|471161575|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
130872069|NCT02365649|471161576|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130872070|NCT02365649|471161577|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130872071|NCT02365649|471161578|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130872072|NCT02365649|471161579|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130872073|NCT02365649|471161580|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130872074|NCT02365649|471161581|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130872075|NCT02365649|471161582|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130872076|NCT02365649|471161573|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130872077|NCT02365649|471161574|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130872078|NCT02365649|471161575|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130872079|NCT02365649|471161576|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130872080|NCT02365649|471161577|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130872081|NCT02365649|471161578|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130872082|NCT02365649|471161579|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
130872083|NCT02365649|471161580|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130872084|NCT02365649|471161581|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130872085|NCT02365649|471161582|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130872086|NCT02365649|471161573|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130872087|NCT02365649|471161574|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130872088|NCT02365649|471161575|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130872089|NCT02365649|471161576|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130872090|NCT02365649|471161577|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130872091|NCT02365649|471161578|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130872092|NCT02365649|471161579|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
130872093|NCT02365649|471161580|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130872094|NCT02365649|471161581|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
130872095|NCT02365649|471161582|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
130872096|NCT02365649|471161573|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130872097|NCT02365649|471161574|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130872098|NCT02365649|471161575|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130872099|NCT02365649|471161576|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130872100|NCT02365649|471161577|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130872101|NCT02365649|471161578|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130872102|NCT02365649|471161579|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
130872103|NCT02365649|471161580|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
130872104|NCT02365649|471161581|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
130872105|NCT02365649|471161582|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
130872106|NCT02365649|471161573|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130872107|NCT02365649|471161574|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130872108|NCT02365649|471161575|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130872109|NCT02365649|471161576|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130872110|NCT02365649|471161577|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130872111|NCT02365649|471161578|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130872112|NCT02365649|471161579|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
130872113|NCT02365649|471161580|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130872114|NCT02365649|471161581|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
130872115|NCT02365649|471161582|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
130872116|NCT02365649|471161573|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130872117|NCT02365649|471161574|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130872118|NCT02365649|471161575|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130872119|NCT02365649|471161576|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130872120|NCT02365649|471161577|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130872121|NCT02365649|471161578|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130872122|NCT02365649|471161579|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
130872123|NCT02365649|471161580|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130872124|NCT02365649|471161581|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
130872125|NCT02365649|471161582|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130872126|NCT01506271|471161583|FG000|Overall Study|Progressive disease|0|||
130872127|NCT01506271|471161584|FG001|Overall Study|Progressive disease|1|||
130872128|NCT01506271|471161585|FG002|Overall Study|Progressive disease|0|||
130872129|NCT01506271|471161583|FG000|Overall Study|Protocol Violation|3|||
130872130|NCT01506271|471161584|FG001|Overall Study|Protocol Violation|1|||
130872131|NCT01506271|471161585|FG002|Overall Study|Protocol Violation|0|||
130872132|NCT01506271|471161583|FG000|Overall Study|Death|0|||
130872133|NCT01506271|471161584|FG001|Overall Study|Death|1|||
130872134|NCT01506271|471161585|FG002|Overall Study|Death|0|||
130872135|NCT01506271|471161583|FG000|Overall Study|Adverse Event|0|||
130872136|NCT01506271|471161584|FG001|Overall Study|Adverse Event|2|||
130872137|NCT01506271|471161585|FG002|Overall Study|Adverse Event|0|||
130872138|NCT01506271|471161583|FG000|Overall Study|Insufficient supply of study drug|1|||
130872139|NCT01506271|471161584|FG001|Overall Study|Insufficient supply of study drug|0|||
130872140|NCT01506271|471161585|FG002|Overall Study|Insufficient supply of study drug|0|||
130872141|NCT01506271|471161583|FG000|Overall Study|Withdrawal by Subject|0|||
130872142|NCT01506271|471161584|FG001|Overall Study|Withdrawal by Subject|1|||
130872143|NCT01506271|471161585|FG002|Overall Study|Withdrawal by Subject|1|||
130872144|NCT01506271|471161583|FG000|Overall Study|Lost to Follow-up|0|||
130872145|NCT01506271|471161584|FG001|Overall Study|Lost to Follow-up|1|||
130872146|NCT01506271|471161585|FG002|Overall Study|Lost to Follow-up|2|||
130872147|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
130872148|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
130872149|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
130872150|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
130872151|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
130872152|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
130872153|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
130872154|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
130872155|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
130872156|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
130872157|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
130872158|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
130872159|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
130872160|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
130872161|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
130872162|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
130872163|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
130872164|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
130872165|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
130872166|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
130872167|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
130872168|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
130872169|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
130872170|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
130872171|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
130872172|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
130872173|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
130872174|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
130872175|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
130872176|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
130872177|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
130872178|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
130872179|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
130872180|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
130872181|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
130872182|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
130872183|NCT02586623|471161595|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
130872184|NCT02586623|471161596|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
130872185|NCT02586623|471161597|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
130872186|NCT02586623|471161595|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
130872187|NCT02586623|471161596|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
130872188|NCT02586623|471161597|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
130872189|NCT02586623|471161595|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
130872190|NCT02586623|471161596|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
130872191|NCT02586623|471161597|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
130872192|NCT02586623|471161595|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
130872193|NCT02586623|471161596|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
130872194|NCT02586623|471161597|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
130872195|NCT02586623|471161595|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
130872196|NCT02586623|471161596|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
130872197|NCT02586623|471161597|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
130872198|NCT02586623|471161595|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
130872199|NCT02586623|471161596|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
130872200|NCT02586623|471161597|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
130872201|NCT02586623|471161595|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
130872202|NCT02586623|471161596|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
130872203|NCT02586623|471161597|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
130872204|NCT02586623|471161595|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
130872205|NCT02586623|471161596|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
130872206|NCT02586623|471161597|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
130872207|NCT02586623|471161595|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
130872208|NCT02586623|471161596|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
130872209|NCT02586623|471161597|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
130872210|NCT02910466|471161600|FG000|Overall Study|Adverse Event|1|||
130872211|NCT02910466|471161600|FG000|Overall Study|Withdrawal by Subject|3|||
130872212|NCT02910466|471161600|FG000|Overall Study|Lost to Follow-up|5|||
130872213|NCT02910466|471161600|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
130872214|NCT02910466|471161600|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
130872215|NCT04332107|471161609|FG000|Day 3|Lost to Follow-up|23|||
130872216|NCT04332107|471161610|FG001|Day 3|Lost to Follow-up|14|||
130872217|NCT04332107|471161609|FG000|Day 3|Missing outcome data|3|||
130872218|NCT04332107|471161610|FG001|Day 3|Missing outcome data|6|||
130872219|NCT04332107|471161609|FG000|Day 14|Lost to Follow-up|13|||
130872220|NCT04332107|471161610|FG001|Day 14|Lost to Follow-up|4|||
130872221|NCT04332107|471161609|FG000|Day 14|Missing outcome data|4|||
130872222|NCT04332107|471161610|FG001|Day 14|Missing outcome data|4|||
130872223|NCT04332107|471161609|FG000|Day 21|Lost to Follow-up|10|||
130872224|NCT04332107|471161610|FG001|Day 21|Lost to Follow-up|2|||
130872225|NCT00871871|471161615|FG000|Part I|Adverse Event|0|||
130872226|NCT00871871|471161616|FG001|Part I|Adverse Event|2|||
130872227|NCT00871871|471161617|FG002|Part I|Adverse Event|0|||
130872228|NCT00871871|471161618|FG003|Part I|Adverse Event|0|||
130872229|NCT00871871|471161615|FG000|Part I|Withdrawal by Subject|3|||
130872230|NCT00871871|471161616|FG001|Part I|Withdrawal by Subject|0|||
130872231|NCT00871871|471161617|FG002|Part I|Withdrawal by Subject|0|||
130872232|NCT00871871|471161618|FG003|Part I|Withdrawal by Subject|0|||
130872233|NCT00871871|471161615|FG000|Part I|Laboratory abnormality|0|||
130872234|NCT00871871|471161616|FG001|Part I|Laboratory abnormality|1|||
130872235|NCT00871871|471161617|FG002|Part I|Laboratory abnormality|0|||
130872236|NCT00871871|471161618|FG003|Part I|Laboratory abnormality|0|||
130872237|NCT00871871|471161615|FG000|Part II|Lack of Efficacy|0|||
130872238|NCT00871871|471161616|FG001|Part II|Lack of Efficacy|0|||
130872239|NCT00871871|471161617|FG002|Part II|Lack of Efficacy|1|||
130872240|NCT00871871|471161618|FG003|Part II|Lack of Efficacy|0|||
130872241|NCT00871871|471161615|FG000|Part II|Withdrawal by Subject|0|||
130872242|NCT00871871|471161616|FG001|Part II|Withdrawal by Subject|0|||
130872243|NCT00871871|471161617|FG002|Part II|Withdrawal by Subject|2|||
130872244|NCT00871871|471161618|FG003|Part II|Withdrawal by Subject|1|||
130872245|NCT00871871|471161615|FG000|Part II|Adverse Event|0|||
130872246|NCT00871871|471161616|FG001|Part II|Adverse Event|0|||
130872247|NCT00871871|471161617|FG002|Part II|Adverse Event|1|||
130872248|NCT00871871|471161618|FG003|Part II|Adverse Event|2|||
130872249|NCT00871871|471161615|FG000|Part II|Protocol Violation|0|||
130872250|NCT00871871|471161616|FG001|Part II|Protocol Violation|0|||
130872251|NCT00871871|471161617|FG002|Part II|Protocol Violation|0|||
130872252|NCT00871871|471161618|FG003|Part II|Protocol Violation|1|||
130872253|NCT01808196|471161622|FG000|Overall Study|Lost to Follow-up|1|||
130872254|NCT00479713|471161623|FG000|Overall Study|Adverse Event|8|||
130872255|NCT00479713|471161624|FG001|Overall Study|Adverse Event|6|||
130872256|NCT00479713|471161623|FG000|Overall Study|Death|1|||
130872257|NCT00479713|471161624|FG001|Overall Study|Death|0|||
130872258|NCT00479713|471161623|FG000|Overall Study|Lost to Follow-up|0|||
130872259|NCT00479713|471161624|FG001|Overall Study|Lost to Follow-up|1|||
130872260|NCT00479713|471161623|FG000|Overall Study|Protocol Violation|0|||
130872261|NCT00479713|471161624|FG001|Overall Study|Protocol Violation|1|||
130872262|NCT00479713|471161623|FG000|Overall Study|Withdrawal by Subject|4|||
130872263|NCT00479713|471161624|FG001|Overall Study|Withdrawal by Subject|1|||
130872264|NCT03863509|471161627|FG000|Overall Study|COVID-19 shutdown period|0|||
130872265|NCT03863509|471161628|FG001|Overall Study|COVID-19 shutdown period|4|||
130872266|NCT03863509|471161629|FG002|Overall Study|COVID-19 shutdown period|0|||
130872267|NCT03863509|471161627|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
130872268|NCT03863509|471161628|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
130872269|NCT03863509|471161629|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
130872270|NCT03863509|471161627|FG000|Overall Study|Lost to Follow-up|8|||
130872271|NCT03863509|471161628|FG001|Overall Study|Lost to Follow-up|0|||
130872272|NCT03863509|471161629|FG002|Overall Study|Lost to Follow-up|2|||
130872273|NCT03863509|471161627|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
130872274|NCT03863509|471161628|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
130872275|NCT03863509|471161629|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
130872276|NCT03863509|471161627|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
130872277|NCT03863509|471161628|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
130872278|NCT03863509|471161629|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
130872279|NCT00141102|471161630|FG000|Overall Study|Adverse Event|233|||
130872280|NCT00141102|471161631|FG001|Overall Study|Adverse Event|305|||
130872281|NCT00141102|471161630|FG000|Overall Study|Laboratory Abnormality|9|||
130872282|NCT00141102|471161631|FG001|Overall Study|Laboratory Abnormality|33|||
130872283|NCT00141102|471161630|FG000|Overall Study|Lack of Efficacy|21|||
130872284|NCT00141102|471161631|FG001|Overall Study|Lack of Efficacy|26|||
130872285|NCT00141102|471161630|FG000|Overall Study|Lost to Follow-up|29|||
130872286|NCT00141102|471161631|FG001|Overall Study|Lost to Follow-up|32|||
130872287|NCT00141102|471161630|FG000|Overall Study|Other|87|||
130872288|NCT00141102|471161631|FG001|Overall Study|Other|76|||
130872289|NCT00141102|471161630|FG000|Overall Study|Withdrawal by Subject|112|||
130872290|NCT00141102|471161631|FG001|Overall Study|Withdrawal by Subject|142|||
130872291|NCT00141102|471161630|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
130872292|NCT00141102|471161631|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
130872293|NCT00141102|471161630|FG000|Overall Study|Death|2|||
130872294|NCT00141102|471161631|FG001|Overall Study|Death|2|||
130872295|NCT00990106|471161632|FG000|Overall Study|"too busy to continue"|1|||
130872296|NCT00990106|471161633|FG001|Overall Study|"too busy to continue"|2|||
130872297|NCT00990106|471161632|FG000|Overall Study|Lost to Follow-up|1|||
130872298|NCT00990106|471161633|FG001|Overall Study|Lost to Follow-up|3|||
130872299|NCT00990106|471161632|FG000|Overall Study|Withdrawal by Subject|2|||
130872300|NCT00990106|471161633|FG001|Overall Study|Withdrawal by Subject|1|||
130872301|NCT00990106|471161632|FG000|Overall Study|opted for open label prazosin|1|||
130872302|NCT00990106|471161633|FG001|Overall Study|opted for open label prazosin|1|||
130872303|NCT00990106|471161632|FG000|Overall Study|relocation/deployment|4|||
130872304|NCT00990106|471161633|FG001|Overall Study|relocation/deployment|1|||
130872305|NCT00990106|471161632|FG000|Overall Study|started exclusionary medication|0|||
130872306|NCT00990106|471161633|FG001|Overall Study|started exclusionary medication|1|||
130872307|NCT00990106|471161632|FG000|Overall Study|planned major surgery|0|||
130872308|NCT00990106|471161633|FG001|Overall Study|planned major surgery|1|||
130872309|NCT00990106|471161632|FG000|Overall Study|scheduling conflicts|0|||
130872310|NCT00990106|471161633|FG001|Overall Study|scheduling conflicts|2|||
130872311|NCT03064490|471161638|FG000|Overall Study|Physician Decision|5|||
130872312|NCT04158583|471161642|FG000|Overall Study|Withdrawal by Subject|1|||
130872313|NCT04158583|471161643|FG001|Overall Study|Withdrawal by Subject|1|||
130872314|NCT04158583|471161644|FG002|Overall Study|Withdrawal by Subject|0|||
130872315|NCT04158583|471161645|FG003|Overall Study|Withdrawal by Subject|0|||
130872316|NCT04158583|471161646|FG004|Overall Study|Withdrawal by Subject|1|||
130872317|NCT04158583|471161647|FG005|Overall Study|Withdrawal by Subject|0|||
130872318|NCT04158583|471161648|FG006|Overall Study|Withdrawal by Subject|0|||
130872319|NCT04158583|471161649|FG007|Overall Study|Withdrawal by Subject|0|||
130872320|NCT04158583|471161650|FG008|Overall Study|Withdrawal by Subject|2|||
130872321|NCT04158583|471161651|FG009|Overall Study|Withdrawal by Subject|0|||
130872322|NCT04158583|471161642|FG000|Overall Study|Study Terminated by Sponsor|0|||
130872323|NCT04158583|471161643|FG001|Overall Study|Study Terminated by Sponsor|0|||
130872324|NCT04158583|471161644|FG002|Overall Study|Study Terminated by Sponsor|0|||
130872325|NCT04158583|471161645|FG003|Overall Study|Study Terminated by Sponsor|1|||
130872326|NCT04158583|471161646|FG004|Overall Study|Study Terminated by Sponsor|0|||
130872327|NCT04158583|471161647|FG005|Overall Study|Study Terminated by Sponsor|0|||
130872328|NCT04158583|471161648|FG006|Overall Study|Study Terminated by Sponsor|0|||
130872329|NCT04158583|471161649|FG007|Overall Study|Study Terminated by Sponsor|0|||
130872330|NCT04158583|471161650|FG008|Overall Study|Study Terminated by Sponsor|0|||
130872331|NCT04158583|471161651|FG009|Overall Study|Study Terminated by Sponsor|0|||
130872332|NCT04158583|471161642|FG000|Overall Study|Progressive Disease|1|||
130872333|NCT04158583|471161643|FG001|Overall Study|Progressive Disease|0|||
130872334|NCT04158583|471161644|FG002|Overall Study|Progressive Disease|3|||
130872335|NCT04158583|471161645|FG003|Overall Study|Progressive Disease|5|||
130872336|NCT04158583|471161646|FG004|Overall Study|Progressive Disease|0|||
130872337|NCT04158583|471161647|FG005|Overall Study|Progressive Disease|1|||
130872338|NCT04158583|471161648|FG006|Overall Study|Progressive Disease|6|||
130872339|NCT04158583|471161649|FG007|Overall Study|Progressive Disease|2|||
130872340|NCT04158583|471161650|FG008|Overall Study|Progressive Disease|1|||
130872341|NCT04158583|471161651|FG009|Overall Study|Progressive Disease|2|||
130872342|NCT04158583|471161642|FG000|Overall Study|Lost to Follow-up|0|||
130872343|NCT04158583|471161643|FG001|Overall Study|Lost to Follow-up|0|||
130872344|NCT04158583|471161644|FG002|Overall Study|Lost to Follow-up|1|||
130872345|NCT04158583|471161645|FG003|Overall Study|Lost to Follow-up|1|||
130872346|NCT04158583|471161646|FG004|Overall Study|Lost to Follow-up|1|||
130872347|NCT04158583|471161647|FG005|Overall Study|Lost to Follow-up|0|||
130872348|NCT04158583|471161648|FG006|Overall Study|Lost to Follow-up|0|||
130872349|NCT04158583|471161649|FG007|Overall Study|Lost to Follow-up|0|||
130872350|NCT04158583|471161650|FG008|Overall Study|Lost to Follow-up|0|||
130872351|NCT04158583|471161651|FG009|Overall Study|Lost to Follow-up|0|||
130872352|NCT04158583|471161642|FG000|Overall Study|Due To Patient Status|0|||
130872353|NCT04158583|471161643|FG001|Overall Study|Due To Patient Status|0|||
130872354|NCT04158583|471161644|FG002|Overall Study|Due To Patient Status|0|||
130872355|NCT04158583|471161645|FG003|Overall Study|Due To Patient Status|0|||
130872356|NCT04158583|471161646|FG004|Overall Study|Due To Patient Status|0|||
130872357|NCT04158583|471161647|FG005|Overall Study|Due To Patient Status|0|||
130872358|NCT04158583|471161648|FG006|Overall Study|Due To Patient Status|0|||
130872359|NCT04158583|471161649|FG007|Overall Study|Due To Patient Status|0|||
130872360|NCT04158583|471161650|FG008|Overall Study|Due To Patient Status|1|||
130872361|NCT04158583|471161651|FG009|Overall Study|Due To Patient Status|0|||
130872362|NCT04158583|471161642|FG000|Overall Study|Death|3|||
130872363|NCT04158583|471161643|FG001|Overall Study|Death|4|||
130872364|NCT04158583|471161644|FG002|Overall Study|Death|2|||
130872365|NCT04158583|471161645|FG003|Overall Study|Death|2|||
130872366|NCT04158583|471161646|FG004|Overall Study|Death|4|||
130872367|NCT04158583|471161647|FG005|Overall Study|Death|3|||
130872368|NCT04158583|471161648|FG006|Overall Study|Death|5|||
130872369|NCT04158583|471161649|FG007|Overall Study|Death|2|||
130872370|NCT04158583|471161650|FG008|Overall Study|Death|0|||
130872371|NCT04158583|471161651|FG009|Overall Study|Death|1|||
130872372|NCT04158583|471161642|FG000|Overall Study|Clinical Progression Disease|0|||
130872373|NCT04158583|471161643|FG001|Overall Study|Clinical Progression Disease|0|||
130872374|NCT04158583|471161644|FG002|Overall Study|Clinical Progression Disease|0|||
130872375|NCT04158583|471161645|FG003|Overall Study|Clinical Progression Disease|1|||
130872376|NCT04158583|471161646|FG004|Overall Study|Clinical Progression Disease|0|||
130872377|NCT04158583|471161647|FG005|Overall Study|Clinical Progression Disease|0|||
130872378|NCT04158583|471161648|FG006|Overall Study|Clinical Progression Disease|0|||
130872379|NCT04158583|471161649|FG007|Overall Study|Clinical Progression Disease|0|||
130872380|NCT04158583|471161650|FG008|Overall Study|Clinical Progression Disease|0|||
130872381|NCT04158583|471161651|FG009|Overall Study|Clinical Progression Disease|0|||
130872382|NCT04158583|471161642|FG000|Overall Study|Clinical Progression|0|||
130872383|NCT04158583|471161643|FG001|Overall Study|Clinical Progression|0|||
130872384|NCT04158583|471161644|FG002|Overall Study|Clinical Progression|0|||
130872385|NCT04158583|471161645|FG003|Overall Study|Clinical Progression|0|||
130872386|NCT04158583|471161646|FG004|Overall Study|Clinical Progression|1|||
130872387|NCT04158583|471161647|FG005|Overall Study|Clinical Progression|0|||
130872388|NCT04158583|471161648|FG006|Overall Study|Clinical Progression|2|||
130872389|NCT04158583|471161649|FG007|Overall Study|Clinical Progression|0|||
130872390|NCT04158583|471161650|FG008|Overall Study|Clinical Progression|0|||
130872391|NCT04158583|471161651|FG009|Overall Study|Clinical Progression|0|||
130872392|NCT04158583|471161642|FG000|Overall Study|Clinical Deterioration|0|||
130872393|NCT04158583|471161643|FG001|Overall Study|Clinical Deterioration|0|||
130872394|NCT04158583|471161644|FG002|Overall Study|Clinical Deterioration|0|||
130872395|NCT04158583|471161645|FG003|Overall Study|Clinical Deterioration|1|||
130872396|NCT04158583|471161646|FG004|Overall Study|Clinical Deterioration|0|||
130872397|NCT04158583|471161647|FG005|Overall Study|Clinical Deterioration|0|||
130872398|NCT04158583|471161648|FG006|Overall Study|Clinical Deterioration|0|||
130872399|NCT04158583|471161649|FG007|Overall Study|Clinical Deterioration|0|||
130872400|NCT04158583|471161650|FG008|Overall Study|Clinical Deterioration|0|||
130872401|NCT04158583|471161651|FG009|Overall Study|Clinical Deterioration|1|||
130872402|NCT01871519|471161652|FG000|Overall Study|Death|26|||
130872403|NCT01871519|471161652|FG000|Overall Study|Lost to Follow-up|15|||
130872404|NCT01871519|471161652|FG000|Overall Study|Withdrawal by Subject|49|||
130872405|NCT01063153|471161653|FG000|Overall Study|Found Ineligible During Screening|2|||
130872406|NCT01063153|471161654|FG001|Overall Study|Found Ineligible During Screening|0|||
130872407|NCT01063153|471161653|FG000|Overall Study|Lost to Follow-up|0|||
130872408|NCT01063153|471161654|FG001|Overall Study|Lost to Follow-up|7|||
130872409|NCT01063153|471161653|FG000|Overall Study|Withdrawal by Subject|0|||
130872410|NCT01063153|471161654|FG001|Overall Study|Withdrawal by Subject|1|||
130872411|NCT01063153|471161653|FG000|Overall Study|Physician Decision|0|||
130872412|NCT01063153|471161654|FG001|Overall Study|Physician Decision|4|||
130872413|NCT02485704|471161655|FG000|Overall Study|Lost to Follow-up|4|||
130872414|NCT02485704|471161656|FG001|Overall Study|Lost to Follow-up|5|||
130872415|NCT02485704|471161655|FG000|Overall Study|Withdrawal by Subject|0|||
130872416|NCT02485704|471161656|FG001|Overall Study|Withdrawal by Subject|3|||
130872417|NCT02485704|471161655|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
130872418|NCT02485704|471161656|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
130872419|NCT01777776|471161657|FG000|Overall Study|Adverse Event|2|||
130872420|NCT01777776|471161658|FG001|Overall Study|Adverse Event|4|||
130872421|NCT01777776|471161659|FG002|Overall Study|Adverse Event|0|||
130872422|NCT01777776|471161660|FG003|Overall Study|Adverse Event|0|||
130872423|NCT01777776|471161657|FG000|Overall Study|Disease Progression|4|||
130872424|NCT01777776|471161658|FG001|Overall Study|Disease Progression|8|||
130872425|NCT01777776|471161659|FG002|Overall Study|Disease Progression|6|||
130872426|NCT01777776|471161660|FG003|Overall Study|Disease Progression|3|||
130872427|NCT01777776|471161657|FG000|Overall Study|Withdrawal by Subject|0|||
130872428|NCT01777776|471161658|FG001|Overall Study|Withdrawal by Subject|0|||
130872429|NCT01777776|471161659|FG002|Overall Study|Withdrawal by Subject|0|||
130872430|NCT01777776|471161660|FG003|Overall Study|Withdrawal by Subject|1|||
130872431|NCT00350844|471161661|FG000|Overall Study|Lost to Follow-up|1|||
130872432|NCT02775916|471161664|FG000|Overall Study|Adverse Event|1|||
130872433|NCT02775916|471161665|FG001|Overall Study|Adverse Event|0|||
130872434|NCT02775916|471161664|FG000|Overall Study|Subject/Guardian Decision|2|||
130872435|NCT02775916|471161665|FG001|Overall Study|Subject/Guardian Decision|0|||
130872436|NCT03737123|471164222|FG000|Study Treatment|Adverse Event|2|||
130872437|NCT03737123|471164223|FG001|Study Treatment|Adverse Event|0|||
130872438|NCT03737123|471164222|FG000|Study Treatment|Disease Progression|2|||
130872439|NCT03737123|471164223|FG001|Study Treatment|Disease Progression|0|||
130872440|NCT03737123|471164222|FG000|Study Treatment|Withdrawal by Subject|2|||
130872441|NCT03737123|471164223|FG001|Study Treatment|Withdrawal by Subject|0|||
130872442|NCT03737123|471164222|FG000|Follow up|Death|1|||
130872443|NCT03737123|471164223|FG001|Follow up|Death|0|||
130872444|NCT03737123|471164222|FG000|Follow up|Withdrawal by Subject|1|||
130872445|NCT03737123|471164223|FG001|Follow up|Withdrawal by Subject|0|||
130872446|NCT03737123|471164222|FG000|Follow up|Termination of study|4|||
130872447|NCT03737123|471164223|FG001|Follow up|Termination of study|0|||
130872448|NCT02173769|471164224|FG000|Overall Study|Protocol Violation|4|||
130872449|NCT01342913|471164225|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
130872450|NCT01342913|471164226|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130872451|NCT01342913|471164227|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130872452|NCT01342913|471164225|FG000|2-week Run-in Period|Physician Decision|6|||
130872453|NCT01342913|471164226|FG001|2-week Run-in Period|Physician Decision|0|||
130872454|NCT01342913|471164227|FG002|2-week Run-in Period|Physician Decision|0|||
130872455|NCT01342913|471164225|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
130872456|NCT01342913|471164226|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130872457|NCT01342913|471164227|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130872458|NCT01342913|471164225|FG000|2-week Run-in Period|Adverse Event|2|||
130872459|NCT01342913|471164226|FG001|2-week Run-in Period|Adverse Event|0|||
130872460|NCT01342913|471164227|FG002|2-week Run-in Period|Adverse Event|0|||
130872461|NCT01342913|471164225|FG000|2-week Run-in Period|Protocol Violation|5|||
130872462|NCT01342913|471164226|FG001|2-week Run-in Period|Protocol Violation|0|||
130872463|NCT01342913|471164227|FG002|2-week Run-in Period|Protocol Violation|0|||
130872464|NCT01342913|471164225|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
130872465|NCT01342913|471164226|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
130872466|NCT01342913|471164227|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
130872467|NCT01342913|471164225|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130872468|NCT01342913|471164226|FG001|Double-Blind Treatment Period|Adverse Event|3|||
130872469|NCT01342913|471164227|FG002|Double-Blind Treatment Period|Adverse Event|6|||
130872470|NCT01342913|471164225|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130872471|NCT01342913|471164226|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
130872472|NCT01342913|471164227|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
130872473|NCT01342913|471164225|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130872474|NCT01342913|471164226|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
130872475|NCT01342913|471164227|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
130872476|NCT01342913|471164225|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130872477|NCT01342913|471164226|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130872478|NCT01342913|471164227|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
130872479|NCT01342913|471164225|FG000|Double-Blind Treatment Period|Physician Decision|0|||
130872480|NCT01342913|471164226|FG001|Double-Blind Treatment Period|Physician Decision|2|||
130872481|NCT01342913|471164227|FG002|Double-Blind Treatment Period|Physician Decision|0|||
130872482|NCT01342913|471164225|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130872483|NCT01342913|471164226|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130872484|NCT01342913|471164227|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130872485|NCT04024891|471164234|FG000|Overall Study|Pregnancy|0|||
130872486|NCT04024891|471164235|FG001|Overall Study|Pregnancy|1|||
130872487|NCT01474317|471164246|FG000|Overall Study|Adverse Event|1|||
130872488|NCT01474317|471164246|FG000|Overall Study|Subject ineligible for study|1|||
130872489|NCT00453154|471164252|FG000|Double BIind Maintenance|Adverse Event|0|||
130872490|NCT00453154|471164253|FG001|Double BIind Maintenance|Adverse Event|0|||
130872491|NCT00453154|471164254|FG002|Double BIind Maintenance|Adverse Event|3|||
130872492|NCT00453154|471164255|FG003|Double BIind Maintenance|Adverse Event|12|||
130872493|NCT00453154|471164252|FG000|Double BIind Maintenance|Death|0|||
130872494|NCT00453154|471164253|FG001|Double BIind Maintenance|Death|0|||
130872495|NCT00453154|471164254|FG002|Double BIind Maintenance|Death|2|||
130872496|NCT00453154|471164255|FG003|Double BIind Maintenance|Death|1|||
130872497|NCT00453154|471164252|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
130872498|NCT00453154|471164253|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
130872499|NCT00453154|471164254|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
130872500|NCT00453154|471164255|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
130872501|NCT00453154|471164252|FG000|Double BIind Maintenance|Progression|0|||
130872502|NCT00453154|471164253|FG001|Double BIind Maintenance|Progression|0|||
130872503|NCT00453154|471164254|FG002|Double BIind Maintenance|Progression|29|||
130872504|NCT00453154|471164255|FG003|Double BIind Maintenance|Progression|26|||
130872505|NCT00453154|471164252|FG000|Double BIind Maintenance|Medical Issues|0|||
130872506|NCT00453154|471164253|FG001|Double BIind Maintenance|Medical Issues|0|||
130872507|NCT00453154|471164254|FG002|Double BIind Maintenance|Medical Issues|3|||
130872508|NCT00453154|471164255|FG003|Double BIind Maintenance|Medical Issues|1|||
130872509|NCT00453154|471164252|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
130872510|NCT00453154|471164253|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
130872511|NCT00453154|471164254|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
130872512|NCT00453154|471164255|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
130872513|NCT02152631|471164257|FG000|Overall Study|Adverse Event|32|||
130872514|NCT02152631|471164258|FG001|Overall Study|Adverse Event|4|||
130872515|NCT02152631|471164257|FG000|Overall Study|Withdrawal by Subject|13|||
130872516|NCT02152631|471164258|FG001|Overall Study|Withdrawal by Subject|16|||
130872517|NCT02152631|471164257|FG000|Overall Study|Noncompliance with study drug|1|||
130872518|NCT02152631|471164258|FG001|Overall Study|Noncompliance with study drug|0|||
130872519|NCT02152631|471164257|FG000|Overall Study|Physician Decision|1|||
130872520|NCT02152631|471164258|FG001|Overall Study|Physician Decision|2|||
130872521|NCT02152631|471164257|FG000|Overall Study|Lost to Follow-up|0|||
130872522|NCT02152631|471164258|FG001|Overall Study|Lost to Follow-up|1|||
130872523|NCT02152631|471164257|FG000|Overall Study|On Treatment|19|||
130872524|NCT02152631|471164258|FG001|Overall Study|On Treatment|3|||
130872525|NCT05473026|471164259|FG000|Overall Study|Lost to Follow-up|5|||
130872526|NCT05473026|471164260|FG001|Overall Study|Lost to Follow-up|2|||
130872527|NCT01693029|471164271|FG000|Overall Study|Withdrawal by Subject|15|||
130872528|NCT01693029|471164272|FG001|Overall Study|Withdrawal by Subject|22|||
130872529|NCT01693029|471164271|FG000|Overall Study|Kidney transplantation|7|||
130872530|NCT01693029|471164272|FG001|Overall Study|Kidney transplantation|7|||
130872531|NCT01693029|471164271|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
130872532|NCT01693029|471164272|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
130872533|NCT01693029|471164271|FG000|Overall Study|Protocol Violation|6|||
130872534|NCT01693029|471164272|FG001|Overall Study|Protocol Violation|7|||
130872535|NCT01693029|471164271|FG000|Overall Study|Change in dialysis modality|2|||
130872536|NCT01693029|471164272|FG001|Overall Study|Change in dialysis modality|1|||
130872537|NCT01693029|471164271|FG000|Overall Study|Physician Decision|0|||
130872538|NCT01693029|471164272|FG001|Overall Study|Physician Decision|2|||
130872539|NCT01693029|471164271|FG000|Overall Study|Lost to Follow-up|0|||
130872540|NCT01693029|471164272|FG001|Overall Study|Lost to Follow-up|1|||
130872541|NCT01693029|471164271|FG000|Overall Study|Adverse Event|1|||
130872542|NCT01693029|471164272|FG001|Overall Study|Adverse Event|6|||
130872543|NCT01693029|471164271|FG000|Overall Study|Death|5|||
130872544|NCT01693029|471164272|FG001|Overall Study|Death|8|||
130872545|NCT01693029|471164271|FG000|Overall Study|Non-compliance|2|||
130872546|NCT01693029|471164272|FG001|Overall Study|Non-compliance|1|||
130872547|NCT03683173|471164273|FG000|Completed Follow-up|Unavailable|235|||
130872548|NCT03683173|471164274|FG001|Completed Follow-up|Unavailable|217|||
130872549|NCT03683173|471164273|FG000|Completed Follow-up|Refused|69|||
130872550|NCT03683173|471164274|FG001|Completed Follow-up|Refused|59|||
130872551|NCT03683173|471164273|FG000|Completed Follow-up|Disconnected phone|65|||
130872552|NCT03683173|471164274|FG001|Completed Follow-up|Disconnected phone|95|||
130872553|NCT03683173|471164273|FG000|Completed Follow-up|Health issue/deceased|10|||
130872554|NCT03683173|471164274|FG001|Completed Follow-up|Health issue/deceased|4|||
130872555|NCT03683173|471164273|FG000|Completed Follow-up|Moved away|8|||
130872556|NCT03683173|471164274|FG001|Completed Follow-up|Moved away|1|||
130872557|NCT02647281|471164275|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130872558|NCT02647281|471164276|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130872559|NCT02647281|471164277|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130872560|NCT02647281|471164278|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130872561|NCT02647281|471164279|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130872562|NCT02647281|471164280|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130872563|NCT02647281|471164281|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130872564|NCT02647281|471164282|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130872565|NCT02647281|471164283|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
130872566|NCT05801991|471164284|FG000|Overall Study|Lost to Follow-up|1|||
130872567|NCT05801991|471164285|FG001|Overall Study|Lost to Follow-up|0|||
130872568|NCT03016312|471164286|FG000|Overall Study|discontinued before the treatment started|0|||
130872569|NCT03016312|471164287|FG001|Overall Study|discontinued before the treatment started|1|||
130872570|NCT03016312|471164286|FG000|Overall Study|Withdrawal by Subject|37|||
130872571|NCT03016312|471164287|FG001|Overall Study|Withdrawal by Subject|44|||
130872572|NCT03016312|471164286|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
130872573|NCT03016312|471164287|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
130872574|NCT03016312|471164286|FG000|Overall Study|Physician Decision|1|||
130872575|NCT03016312|471164287|FG001|Overall Study|Physician Decision|3|||
130872576|NCT03016312|471164286|FG000|Overall Study|Lost to Follow-up|12|||
130872577|NCT03016312|471164287|FG001|Overall Study|Lost to Follow-up|12|||
130872578|NCT03016312|471164286|FG000|Overall Study|Death|210|||
130872579|NCT03016312|471164287|FG001|Overall Study|Death|184|||
130872580|NCT03016312|471164286|FG000|Overall Study|loss to contact|1|||
130872581|NCT03016312|471164287|FG001|Overall Study|loss to contact|0|||
130872582|NCT03016312|471164286|FG000|Overall Study|started a new cancer therapy|1|||
130872583|NCT03016312|471164287|FG001|Overall Study|started a new cancer therapy|0|||
130872584|NCT02210000|471164288|FG000|Overall Study|Study Terminated|11|||
130872585|NCT02210000|471164289|FG001|Overall Study|Study Terminated|12|||
130872586|NCT02210000|471164288|FG000|Overall Study|Withdrawal by Subject|7|||
130872587|NCT02210000|471164289|FG001|Overall Study|Withdrawal by Subject|1|||
130872588|NCT02210000|471164288|FG000|Overall Study|Adverse Event|1|||
130872589|NCT02210000|471164289|FG001|Overall Study|Adverse Event|5|||
130872590|NCT02210000|471164288|FG000|Overall Study|Lost to Follow-up|0|||
130872591|NCT02210000|471164289|FG001|Overall Study|Lost to Follow-up|2|||
130872592|NCT02210000|471164288|FG000|Overall Study|Physician Decision|0|||
130872593|NCT02210000|471164289|FG001|Overall Study|Physician Decision|1|||
130872594|NCT00308139|471164293|FG000|Overall Study|Adverse Event|20|||
130872595|NCT00308139|471164294|FG001|Overall Study|Adverse Event|14|||
130872596|NCT00308139|471164293|FG000|Overall Study|Lost to Follow-up|13|||
130872597|NCT00308139|471164294|FG001|Overall Study|Lost to Follow-up|8|||
130872598|NCT00308139|471164293|FG000|Overall Study|Protocol Violation|3|||
130872599|NCT00308139|471164294|FG001|Overall Study|Protocol Violation|2|||
130872600|NCT00308139|471164293|FG000|Overall Study|Withdrawal of Consent|40|||
130872601|NCT00308139|471164294|FG001|Overall Study|Withdrawal of Consent|42|||
130872602|NCT00308139|471164293|FG000|Overall Study|Investigator Decision|11|||
130872603|NCT00308139|471164294|FG001|Overall Study|Investigator Decision|10|||
130872604|NCT00308139|471164293|FG000|Overall Study|Loss of Glucose Control|5|||
130872605|NCT00308139|471164294|FG001|Overall Study|Loss of Glucose Control|7|||
130872606|NCT00308139|471164293|FG000|Overall Study|Administrative|1|||
130872607|NCT00308139|471164294|FG001|Overall Study|Administrative|4|||
130872608|NCT00308139|471164293|FG000|Overall Study|Other|1|||
130872609|NCT00308139|471164294|FG001|Overall Study|Other|0|||
130872610|NCT00833040|471164295|FG000|Overall Study|Adverse Event|0|||
130872611|NCT00833040|471164296|FG001|Overall Study|Adverse Event|0|||
130872612|NCT00833040|471164297|FG002|Overall Study|Adverse Event|0|||
130872613|NCT00833040|471164298|FG003|Overall Study|Adverse Event|0|||
130872614|NCT00833040|471164299|FG004|Overall Study|Adverse Event|0|||
130872615|NCT00833040|471164300|FG005|Overall Study|Adverse Event|1|||
130872616|NCT03489863|471164301|FG000|Overall Study|Withdrawal by Subject|0|||
130872617|NCT03489863|471164302|FG001|Overall Study|Withdrawal by Subject|1|||
130872618|NCT02995980|471164304|FG000|Overall Study|Lost to Follow-up|14|||
130872619|NCT00657540|471164306|FG000|Overall Study|Lost to Follow-up|1|||
130872620|NCT00657540|471164307|FG001|Overall Study|Lost to Follow-up|4|||
130872621|NCT01458639|471164309|FG000|Overall Study|Physician Decision|4|||
130872622|NCT01458639|471164309|FG000|Overall Study|Equipment issue|1|||
130872623|NCT01458639|471164309|FG000|Overall Study|Inability to obtain subject blood sample|1|||
130872624|NCT01884077|471164310|FG000|Overall Study|screen fail|0|||
130872625|NCT01884077|471164311|FG001|Overall Study|screen fail|2|||
130872626|NCT01884077|471164310|FG000|Overall Study|canceled surgery|2|||
130872627|NCT01884077|471164311|FG001|Overall Study|canceled surgery|0|||
130872628|NCT01884077|471164310|FG000|Overall Study|Lost to Follow-up|0|||
130872629|NCT01884077|471164311|FG001|Overall Study|Lost to Follow-up|4|||
130872630|NCT01884077|471164310|FG000|Overall Study|study closed|6|||
130872631|NCT01884077|471164311|FG001|Overall Study|study closed|4|||
130872632|NCT00981149|471164312|FG000|Overall Study|Lost to Follow-up|1|||
130872633|NCT00981149|471164313|FG001|Overall Study|Lost to Follow-up|2|||
130872634|NCT00981149|471164312|FG000|Overall Study|Withdrawal by Subject|1|||
130872635|NCT00981149|471164313|FG001|Overall Study|Withdrawal by Subject|1|||
130872636|NCT01220167|471164317|FG000|Period 3|Urine positive for substance abuse|0|||
130872637|NCT01220167|471164318|FG001|Period 3|Urine positive for substance abuse|1|||
130872638|NCT01220167|471164319|FG002|Period 3|Urine positive for substance abuse|0|||
130872639|NCT05789745|471164320|FG000|Overall Study|Withdrawal by Subject|0|||
130872640|NCT05789745|471164321|FG001|Overall Study|Withdrawal by Subject|0|||
130872641|NCT05789745|471164322|FG002|Overall Study|Withdrawal by Subject|0|||
130872642|NCT05789745|471164323|FG003|Overall Study|Withdrawal by Subject|0|||
130872643|NCT05789745|471164324|FG004|Overall Study|Withdrawal by Subject|1|||
130872644|NCT04244253|471164325|FG000|Overall Study|Adverse Event|2|||
130872645|NCT04244253|471164326|FG001|Overall Study|Adverse Event|2|||
130872646|NCT04244253|471164327|FG002|Overall Study|Adverse Event|4|||
130872647|NCT04244253|471164325|FG000|Overall Study|Protocol Violation|1|||
130872648|NCT04244253|471164326|FG001|Overall Study|Protocol Violation|2|||
130872649|NCT04244253|471164327|FG002|Overall Study|Protocol Violation|1|||
130872650|NCT04244253|471164325|FG000|Overall Study|Withdrawal by Subject|0|||
130872651|NCT04244253|471164326|FG001|Overall Study|Withdrawal by Subject|1|||
130872652|NCT04244253|471164327|FG002|Overall Study|Withdrawal by Subject|6|||
130872653|NCT04244253|471164325|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130872654|NCT04244253|471164326|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130872655|NCT04244253|471164327|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130872788|NCT04663321|471164350|FG000|Overall Study|Study terminated by Sponsor|2|||
130872789|NCT04663321|471164351|FG001|Overall Study|Study terminated by Sponsor|1|||
130872790|NCT04663321|471164352|FG002|Overall Study|Study terminated by Sponsor|2|||
130872791|NCT04663321|471164350|FG000|Overall Study|Withdrawal by Subject|10|||
130872792|NCT04663321|471164351|FG001|Overall Study|Withdrawal by Subject|3|||
130872793|NCT04663321|471164352|FG002|Overall Study|Withdrawal by Subject|2|||
130872794|NCT04663321|471164350|FG000|Overall Study|Not provided|0|||
130872795|NCT04663321|471164351|FG001|Overall Study|Not provided|0|||
130872796|NCT04663321|471164352|FG002|Overall Study|Not provided|1|||
130872797|NCT02634333|471164355|FG000|Overall Study|Completed out of Window|3|||
130872798|NCT02634333|471164356|FG001|Overall Study|Completed out of Window|2|||
130872799|NCT02634333|471164355|FG000|Overall Study|Missed Visit|5|||
130872800|NCT02634333|471164356|FG001|Overall Study|Missed Visit|2|||
130872801|NCT02634333|471164355|FG000|Overall Study|Lost to Follow-up|12|||
130872802|NCT02634333|471164356|FG001|Overall Study|Lost to Follow-up|7|||
130872803|NCT02634333|471164355|FG000|Overall Study|Withdrawal by Subject|9|||
130872804|NCT02634333|471164356|FG001|Overall Study|Withdrawal by Subject|13|||
130872805|NCT02634333|471164355|FG000|Overall Study|Death|11|||
130872806|NCT02634333|471164356|FG001|Overall Study|Death|8|||
130872807|NCT02611479|471164357|FG000|Baseline Enrollment|Exited study|13|||
130872808|NCT02611479|471164357|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
130872809|NCT02611479|471164357|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
130872810|NCT02611479|471164357|FG000|Data Cleaning|No baseline function or pain metrics|2|||
130872811|NCT00423657|471164361|FG000|Overall Study|Withdrew consent|10|||
130872812|NCT00423657|471164362|FG001|Overall Study|Withdrew consent|8|||
130872813|NCT00423657|471164361|FG000|Overall Study|Non-compliance|0|||
130872814|NCT00423657|471164362|FG001|Overall Study|Non-compliance|1|||
130872815|NCT00423657|471164361|FG000|Overall Study|Other|15|||
130872816|NCT00423657|471164362|FG001|Overall Study|Other|16|||
130872817|NCT00423657|471164361|FG000|Overall Study|Request of sponsor/investigator|1|||
130872818|NCT00423657|471164362|FG001|Overall Study|Request of sponsor/investigator|0|||
130872819|NCT02748863|471164363|FG000|Treatment Period 1|Adverse Event|0|||
130872820|NCT02748863|471164364|FG001|Treatment Period 1|Adverse Event|1|||
130872821|NCT02748863|471164365|FG002|Treatment Period 1|Adverse Event|0|||
130872822|NCT02748863|471164366|FG003|Treatment Period 1|Adverse Event|0|||
130872823|NCT02748863|471164367|FG004|Treatment Period 1|Adverse Event|0|||
130872824|NCT02748863|471164363|FG000|Treatment Period 1|Lack of Efficacy|0|||
130872825|NCT02748863|471164364|FG001|Treatment Period 1|Lack of Efficacy|0|||
130872826|NCT02748863|471164365|FG002|Treatment Period 1|Lack of Efficacy|1|||
130872827|NCT02748863|471164366|FG003|Treatment Period 1|Lack of Efficacy|0|||
130872828|NCT02748863|471164367|FG004|Treatment Period 1|Lack of Efficacy|0|||
130872829|NCT02748863|471164363|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130872830|NCT02748863|471164364|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130872831|NCT02748863|471164365|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130872832|NCT02748863|471164366|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130872833|NCT02748863|471164367|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130872834|NCT02748863|471164363|FG000|Treatment Period 2|Lost to Follow-up|2|||
130872835|NCT02748863|471164364|FG001|Treatment Period 2|Lost to Follow-up|0|||
130872836|NCT02748863|471164365|FG002|Treatment Period 2|Lost to Follow-up|0|||
130872837|NCT02748863|471164366|FG003|Treatment Period 2|Lost to Follow-up|0|||
130872838|NCT02748863|471164367|FG004|Treatment Period 2|Lost to Follow-up|0|||
130872839|NCT02748863|471164363|FG000|Treatment Period 2|Adverse Event|3|||
130872840|NCT02748863|471164364|FG001|Treatment Period 2|Adverse Event|2|||
130872841|NCT02748863|471164365|FG002|Treatment Period 2|Adverse Event|0|||
130872842|NCT02748863|471164366|FG003|Treatment Period 2|Adverse Event|2|||
130872843|NCT02748863|471164367|FG004|Treatment Period 2|Adverse Event|0|||
130872844|NCT02748863|471164363|FG000|Treatment Period 2|Lack of Efficacy|0|||
130872845|NCT02748863|471164364|FG001|Treatment Period 2|Lack of Efficacy|1|||
130872846|NCT02748863|471164365|FG002|Treatment Period 2|Lack of Efficacy|0|||
130872847|NCT02748863|471164366|FG003|Treatment Period 2|Lack of Efficacy|0|||
130872848|NCT02748863|471164367|FG004|Treatment Period 2|Lack of Efficacy|0|||
130872849|NCT02748863|471164363|FG000|Treatment Period 2|Pregnancy|0|||
130872850|NCT02748863|471164364|FG001|Treatment Period 2|Pregnancy|0|||
130872851|NCT02748863|471164365|FG002|Treatment Period 2|Pregnancy|0|||
130872852|NCT02748863|471164366|FG003|Treatment Period 2|Pregnancy|0|||
130872853|NCT02748863|471164367|FG004|Treatment Period 2|Pregnancy|1|||
130872854|NCT02422498|471164371|FG000|Overall Study|Inevaluable|4|||
130872855|NCT00657046|471164373|FG000|Overall Study|Adverse Event|1|||
130872856|NCT00657046|471164374|FG001|Overall Study|Adverse Event|1|||
130872857|NCT00657046|471164375|FG002|Overall Study|Adverse Event|0|||
130872858|NCT00657046|471164373|FG000|Overall Study|Protocol Violation|2|||
130872859|NCT00657046|471164374|FG001|Overall Study|Protocol Violation|2|||
130872860|NCT00657046|471164375|FG002|Overall Study|Protocol Violation|0|||
130872861|NCT00657046|471164373|FG000|Overall Study|Withdrawal by Subject|1|||
130872862|NCT00657046|471164374|FG001|Overall Study|Withdrawal by Subject|0|||
130872863|NCT00657046|471164375|FG002|Overall Study|Withdrawal by Subject|0|||
130872864|NCT00657046|471164373|FG000|Overall Study|Death|0|||
130872865|NCT00657046|471164374|FG001|Overall Study|Death|0|||
130872866|NCT00657046|471164375|FG002|Overall Study|Death|1|||
130872867|NCT00657046|471164373|FG000|Overall Study|Surgery|0|||
130872868|NCT00657046|471164374|FG001|Overall Study|Surgery|0|||
130872869|NCT00657046|471164375|FG002|Overall Study|Surgery|1|||
130872870|NCT02525471|471164381|FG000|Overall Study|Screen Failure|6|||
130872871|NCT02525471|471164381|FG000|Overall Study|Withdrawal by Subject|4|||
130872872|NCT02525471|471164381|FG000|Overall Study|Death|1|||
130872873|NCT00867165|471164382|FG000|Overall Study|Adverse Event|3|||
130872874|NCT00867165|471164383|FG001|Overall Study|Adverse Event|0|||
130872875|NCT00867165|471164382|FG000|Overall Study|Withdrawal by Subject|1|||
130872876|NCT00867165|471164383|FG001|Overall Study|Withdrawal by Subject|0|||
130872877|NCT00890825|471164384|FG000|Overall Study|Withdrawal by Subject|1|||
130872878|NCT00890825|471164385|FG001|Overall Study|Withdrawal by Subject|0|||
130872879|NCT00890825|471164384|FG000|Overall Study|Alive at data cut off (DCO)|13|||
130872880|NCT00890825|471164385|FG001|Overall Study|Alive at data cut off (DCO)|14|||
130872881|NCT01054456|471164386|FG000|Overall Study|Other|1|||
130872882|NCT03935126|471164389|FG000|Overall Study|Study termination by sponsor|3|||
130872883|NCT02021565|471164390|FG000|Baseline Through Intervention|Death|0|||
130872884|NCT02021565|471164391|FG001|Baseline Through Intervention|Death|1|||
130872885|NCT02021565|471164390|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
130872886|NCT02021565|471164391|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
130872887|NCT02021565|471164390|FG000|Baseline Through Intervention|Protocol Violation|0|||
130872888|NCT02021565|471164391|FG001|Baseline Through Intervention|Protocol Violation|7|||
130872889|NCT02021565|471164390|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
130872890|NCT02021565|471164391|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
130872891|NCT02021565|471164390|FG000|3-month Follow-up|Death|3|||
130872892|NCT02021565|471164391|FG001|3-month Follow-up|Death|0|||
130872893|NCT02021565|471164390|FG000|3-month Follow-up|Withdrawal by Subject|4|||
130872894|NCT02021565|471164391|FG001|3-month Follow-up|Withdrawal by Subject|0|||
130872895|NCT02021565|471164390|FG000|3-month Follow-up|Protocol Violation|3|||
130872896|NCT02021565|471164391|FG001|3-month Follow-up|Protocol Violation|2|||
130872897|NCT03040141|471164392|FG000|Overall Study|Death|1|||
130872898|NCT03040141|471164393|FG001|Overall Study|Death|2|||
130872899|NCT03040141|471164394|FG002|Overall Study|Death|3|||
130872900|NCT03040141|471164392|FG000|Overall Study|Withdrawal by Subject|3|||
130872901|NCT03040141|471164393|FG001|Overall Study|Withdrawal by Subject|1|||
130872902|NCT03040141|471164394|FG002|Overall Study|Withdrawal by Subject|1|||
130872903|NCT03040141|471164392|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
130872904|NCT03040141|471164393|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
130872905|NCT03040141|471164394|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
130872906|NCT03040141|471164392|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
130872907|NCT03040141|471164393|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
130872908|NCT03040141|471164394|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
130872909|NCT03318549|471164395|FG000|Overall Study|Withdrawal by Subject|5|||
130872910|NCT03318549|471164396|FG001|Overall Study|Withdrawal by Subject|19|||
130872911|NCT03318549|471164397|FG002|Overall Study|Withdrawal by Subject|2|||
130872912|NCT03318549|471164398|FG003|Overall Study|Withdrawal by Subject|0|||
130872913|NCT03318549|471164399|FG004|Overall Study|Withdrawal by Subject|0|||
130872914|NCT03318549|471164400|FG005|Overall Study|Withdrawal by Subject|0|||
130872915|NCT03318549|471164401|FG006|Overall Study|Withdrawal by Subject|0|||
130872916|NCT03318549|471164395|FG000|Overall Study|Physician Decision|0|||
130872917|NCT03318549|471164396|FG001|Overall Study|Physician Decision|4|||
130872918|NCT03318549|471164397|FG002|Overall Study|Physician Decision|1|||
130872919|NCT03318549|471164398|FG003|Overall Study|Physician Decision|0|||
130872920|NCT03318549|471164399|FG004|Overall Study|Physician Decision|0|||
130872921|NCT03318549|471164400|FG005|Overall Study|Physician Decision|0|||
130872922|NCT03318549|471164401|FG006|Overall Study|Physician Decision|0|||
130872923|NCT03318549|471164395|FG000|Overall Study|Lost to Follow-up|0|||
130872924|NCT03318549|471164396|FG001|Overall Study|Lost to Follow-up|3|||
130872925|NCT03318549|471164397|FG002|Overall Study|Lost to Follow-up|3|||
130872926|NCT03318549|471164398|FG003|Overall Study|Lost to Follow-up|0|||
130872927|NCT03318549|471164399|FG004|Overall Study|Lost to Follow-up|0|||
130872928|NCT03318549|471164400|FG005|Overall Study|Lost to Follow-up|0|||
130872929|NCT03318549|471164401|FG006|Overall Study|Lost to Follow-up|0|||
130872930|NCT00462306|471164402|FG000|Overall Study|insufficient data|0|||
130872931|NCT00462306|471164403|FG001|Overall Study|insufficient data|13|||
130872932|NCT01391663|471164404|FG000|Overall Study|Withdrawal by Subject|0|||
130872933|NCT01391663|471164405|FG001|Overall Study|Withdrawal by Subject|0|||
130872934|NCT01391663|471164406|FG002|Overall Study|Withdrawal by Subject|1|||
130872935|NCT01391663|471164407|FG003|Overall Study|Withdrawal by Subject|0|||
130872936|NCT03515824|471164408|FG000|Overall Study|Death|3|||
130872937|NCT03515824|471164409|FG001|Overall Study|Death|2|||
130872938|NCT03515824|471164410|FG002|Overall Study|Death|6|||
130872939|NCT03515824|471164411|FG003|Overall Study|Death|0|||
130872940|NCT03515824|471164408|FG000|Overall Study|Lost to Follow-up|0|||
130872941|NCT03515824|471164409|FG001|Overall Study|Lost to Follow-up|1|||
130872942|NCT03515824|471164410|FG002|Overall Study|Lost to Follow-up|1|||
130872943|NCT03515824|471164411|FG003|Overall Study|Lost to Follow-up|0|||
130872944|NCT03515824|471164408|FG000|Overall Study|Study terminated by sponsor|0|||
130872945|NCT03515824|471164409|FG001|Overall Study|Study terminated by sponsor|1|||
130872946|NCT03515824|471164410|FG002|Overall Study|Study terminated by sponsor|6|||
130872947|NCT03515824|471164411|FG003|Overall Study|Study terminated by sponsor|0|||
130872948|NCT03515824|471164408|FG000|Overall Study|Status not recorded|0|||
130872949|NCT03515824|471164409|FG001|Overall Study|Status not recorded|0|||
130872950|NCT03515824|471164410|FG002|Overall Study|Status not recorded|2|||
130872951|NCT03515824|471164411|FG003|Overall Study|Status not recorded|0|||
130872952|NCT00920855|471164412|FG000|Overall Study|Adverse Event|1|||
130872953|NCT00920855|471164413|FG001|Overall Study|Adverse Event|1|||
130872954|NCT00920855|471164414|FG002|Overall Study|Adverse Event|4|||
130872955|NCT00920855|471164412|FG000|Overall Study|Withdrawal by Subject|2|||
130872956|NCT00920855|471164413|FG001|Overall Study|Withdrawal by Subject|1|||
130872957|NCT00920855|471164414|FG002|Overall Study|Withdrawal by Subject|6|||
130872958|NCT00920855|471164412|FG000|Overall Study|Disease progression|2|||
130872959|NCT00920855|471164413|FG001|Overall Study|Disease progression|1|||
130872960|NCT00920855|471164414|FG002|Overall Study|Disease progression|10|||
130872961|NCT00920855|471164412|FG000|Overall Study|Noncompliance to study medication|0|||
130872962|NCT00920855|471164413|FG001|Overall Study|Noncompliance to study medication|0|||
130872963|NCT00920855|471164414|FG002|Overall Study|Noncompliance to study medication|1|||
130872964|NCT00920855|471164412|FG000|Overall Study|Response plateau; started maintenance|0|||
130872965|NCT00920855|471164413|FG001|Overall Study|Response plateau; started maintenance|0|||
130872966|NCT00920855|471164414|FG002|Overall Study|Response plateau; started maintenance|1|||
130872967|NCT00539994|471164416|FG000|Overall Study|Lost to Follow-up|2|||
130872968|NCT00539994|471164417|FG001|Overall Study|Lost to Follow-up|1|||
130872969|NCT00539994|471164418|FG002|Overall Study|Lost to Follow-up|0|||
130872970|NCT00539994|471164416|FG000|Overall Study|Withdrawal by Subject|1|||
130872971|NCT00539994|471164417|FG001|Overall Study|Withdrawal by Subject|0|||
130872972|NCT00539994|471164418|FG002|Overall Study|Withdrawal by Subject|1|||
130872973|NCT00539994|471164416|FG000|Overall Study|Physician Decision|0|||
130872974|NCT00539994|471164417|FG001|Overall Study|Physician Decision|0|||
130872975|NCT00539994|471164418|FG002|Overall Study|Physician Decision|1|||
130872976|NCT00510835|471164420|FG000|Overall Study|Withdrawal by Subject|6|||
130872977|NCT00510835|471164421|FG001|Overall Study|Withdrawal by Subject|2|||
130872978|NCT00510835|471164422|FG002|Overall Study|Withdrawal by Subject|2|||
130872979|NCT03084796|471164423|FG000|Overall Study|Adverse Event|4|||
130872980|NCT03084796|471164424|FG001|Overall Study|Adverse Event|5|||
130872981|NCT03084796|471164425|FG002|Overall Study|Adverse Event|6|||
130872982|NCT03084796|471164426|FG003|Overall Study|Adverse Event|2|||
130872983|NCT03084796|471164427|FG004|Overall Study|Adverse Event|3|||
130872984|NCT03084796|471164428|FG005|Overall Study|Adverse Event|5|||
130872985|NCT03084796|471164423|FG000|Overall Study|Withdrawal by Subject|3|||
130872986|NCT03084796|471164424|FG001|Overall Study|Withdrawal by Subject|5|||
130872987|NCT03084796|471164425|FG002|Overall Study|Withdrawal by Subject|2|||
130872988|NCT03084796|471164426|FG003|Overall Study|Withdrawal by Subject|1|||
130872989|NCT03084796|471164427|FG004|Overall Study|Withdrawal by Subject|3|||
130872990|NCT03084796|471164428|FG005|Overall Study|Withdrawal by Subject|0|||
130872991|NCT03084796|471164423|FG000|Overall Study|Protocol Violation|0|||
130872992|NCT03084796|471164424|FG001|Overall Study|Protocol Violation|0|||
130872993|NCT03084796|471164425|FG002|Overall Study|Protocol Violation|1|||
130872994|NCT03084796|471164426|FG003|Overall Study|Protocol Violation|0|||
130872995|NCT03084796|471164427|FG004|Overall Study|Protocol Violation|1|||
130872996|NCT03084796|471164428|FG005|Overall Study|Protocol Violation|1|||
130872997|NCT03084796|471164423|FG000|Overall Study|Lack of Efficacy|0|||
130872998|NCT03084796|471164424|FG001|Overall Study|Lack of Efficacy|0|||
130872999|NCT03084796|471164425|FG002|Overall Study|Lack of Efficacy|1|||
130873000|NCT03084796|471164426|FG003|Overall Study|Lack of Efficacy|0|||
130873001|NCT03084796|471164427|FG004|Overall Study|Lack of Efficacy|1|||
130873002|NCT03084796|471164428|FG005|Overall Study|Lack of Efficacy|0|||
130873003|NCT03084796|471164423|FG000|Overall Study|Lost to Follow-up|0|||
130873004|NCT03084796|471164424|FG001|Overall Study|Lost to Follow-up|0|||
130873005|NCT03084796|471164425|FG002|Overall Study|Lost to Follow-up|1|||
130873006|NCT03084796|471164426|FG003|Overall Study|Lost to Follow-up|1|||
130873007|NCT03084796|471164427|FG004|Overall Study|Lost to Follow-up|3|||
130873008|NCT03084796|471164428|FG005|Overall Study|Lost to Follow-up|1|||
130873009|NCT03084796|471164423|FG000|Overall Study|Randomization error|0|||
130873010|NCT03084796|471164424|FG001|Overall Study|Randomization error|0|||
130873011|NCT03084796|471164425|FG002|Overall Study|Randomization error|1|||
130873012|NCT03084796|471164426|FG003|Overall Study|Randomization error|0|||
130873013|NCT03084796|471164427|FG004|Overall Study|Randomization error|0|||
130873014|NCT03084796|471164428|FG005|Overall Study|Randomization error|0|||
130873015|NCT05470985|471164429|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
130873016|NCT05470985|471164430|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
130873017|NCT05470985|471164429|FG000|Double Blind Treatment Period|Physician Decision|0|||
130873018|NCT05470985|471164430|FG001|Double Blind Treatment Period|Physician Decision|1|||
130873019|NCT05470985|471164429|FG000|Long Term Extension|Adverse Event|0|||
130873020|NCT05470985|471164430|FG001|Long Term Extension|Adverse Event|1|||
130873021|NCT05470985|471164429|FG000|Long Term Extension|Study terminated by sponsor|2|||
130873022|NCT05470985|471164430|FG001|Long Term Extension|Study terminated by sponsor|0|||
130873023|NCT02741245|471164434|FG000|Overall Study|Adverse Event|0|||
130873024|NCT02741245|471164435|FG001|Overall Study|Adverse Event|0|||
130873025|NCT02741245|471164436|FG002|Overall Study|Adverse Event|0|||
130873026|NCT02741245|471164437|FG003|Overall Study|Adverse Event|2|||
130873027|NCT02741245|471164438|FG004|Overall Study|Adverse Event|2|||
130873028|NCT02741245|471164434|FG000|Overall Study|Protocol Violation|0|||
130873029|NCT02741245|471164435|FG001|Overall Study|Protocol Violation|1|||
130873030|NCT02741245|471164436|FG002|Overall Study|Protocol Violation|0|||
130873031|NCT02741245|471164437|FG003|Overall Study|Protocol Violation|1|||
130873032|NCT02741245|471164438|FG004|Overall Study|Protocol Violation|0|||
130873033|NCT02741245|471164434|FG000|Overall Study|Withdrawal by Subject|0|||
130873034|NCT02741245|471164435|FG001|Overall Study|Withdrawal by Subject|0|||
130873035|NCT02741245|471164436|FG002|Overall Study|Withdrawal by Subject|0|||
130873036|NCT02741245|471164437|FG003|Overall Study|Withdrawal by Subject|1|||
130873037|NCT02741245|471164438|FG004|Overall Study|Withdrawal by Subject|0|||
130873038|NCT00607087|471164440|FG000|Overall Study|Withdrawal by Subject|9|||
130873039|NCT00607087|471164441|FG001|Overall Study|Withdrawal by Subject|4|||
130873040|NCT00607087|471164442|FG002|Overall Study|Withdrawal by Subject|4|||
130873041|NCT00607087|471164440|FG000|Overall Study|Adverse Event|3|||
130873042|NCT00607087|471164441|FG001|Overall Study|Adverse Event|2|||
130873043|NCT00607087|471164442|FG002|Overall Study|Adverse Event|3|||
130873044|NCT00607087|471164440|FG000|Overall Study|Other reason|1|||
130873045|NCT00607087|471164441|FG001|Overall Study|Other reason|5|||
130873046|NCT00607087|471164442|FG002|Overall Study|Other reason|2|||
130873047|NCT00607087|471164440|FG000|Overall Study|Poor compliance to protocol|1|||
130873048|NCT00607087|471164441|FG001|Overall Study|Poor compliance to protocol|0|||
130873049|NCT00607087|471164442|FG002|Overall Study|Poor compliance to protocol|1|||
130873050|NCT00607087|471164440|FG000|Overall Study|Lost to Follow-up|1|||
130873051|NCT00607087|471164441|FG001|Overall Study|Lost to Follow-up|0|||
130873052|NCT00607087|471164442|FG002|Overall Study|Lost to Follow-up|0|||
130873053|NCT00607087|471164440|FG000|Period 1|Withdrawal by Subject|7|||
130873054|NCT00607087|471164441|FG001|Period 1|Withdrawal by Subject|2|||
130873055|NCT00607087|471164442|FG002|Period 1|Withdrawal by Subject|3|||
130873056|NCT00607087|471164440|FG000|Period 1|Adverse Event|3|||
130873057|NCT00607087|471164441|FG001|Period 1|Adverse Event|0|||
130873058|NCT00607087|471164442|FG002|Period 1|Adverse Event|0|||
130873059|NCT00607087|471164440|FG000|Period 1|Poor compliance to protocol|1|||
130873060|NCT00607087|471164441|FG001|Period 1|Poor compliance to protocol|0|||
130873061|NCT00607087|471164442|FG002|Period 1|Poor compliance to protocol|0|||
130873062|NCT00607087|471164440|FG000|Period 1|Lost to Follow-up|1|||
130873063|NCT00607087|471164441|FG001|Period 1|Lost to Follow-up|0|||
130873064|NCT00607087|471164442|FG002|Period 1|Lost to Follow-up|0|||
130873065|NCT00607087|471164440|FG000|Period 1|Other reason|0|||
130873066|NCT00607087|471164441|FG001|Period 1|Other reason|4|||
130873067|NCT00607087|471164442|FG002|Period 1|Other reason|2|||
130873068|NCT00607087|471164440|FG000|Period 2|Withdrawal by Subject|0|||
130873069|NCT00607087|471164441|FG001|Period 2|Withdrawal by Subject|1|||
130873070|NCT00607087|471164442|FG002|Period 2|Withdrawal by Subject|1|||
130873071|NCT00607087|471164440|FG000|Period 2|Other reason|1|||
130873072|NCT00607087|471164441|FG001|Period 2|Other reason|1|||
130873073|NCT00607087|471164442|FG002|Period 2|Other reason|0|||
130873074|NCT00607087|471164440|FG000|Period 2|Adverse Event|0|||
130873075|NCT00607087|471164441|FG001|Period 2|Adverse Event|1|||
130873076|NCT00607087|471164442|FG002|Period 2|Adverse Event|3|||
130873077|NCT00607087|471164440|FG000|Period 2|Poor compliance to protocol|0|||
130873078|NCT00607087|471164441|FG001|Period 2|Poor compliance to protocol|0|||
130873079|NCT00607087|471164442|FG002|Period 2|Poor compliance to protocol|1|||
130873080|NCT00607087|471164440|FG000|Period 3|Withdrawal by Subject|2|||
130873081|NCT00607087|471164441|FG001|Period 3|Withdrawal by Subject|1|||
130873082|NCT00607087|471164442|FG002|Period 3|Withdrawal by Subject|0|||
130873083|NCT00607087|471164440|FG000|Period 3|Adverse Event|0|||
130873084|NCT00607087|471164441|FG001|Period 3|Adverse Event|1|||
130873085|NCT00607087|471164442|FG002|Period 3|Adverse Event|0|||
130873086|NCT00154297|471164444|FG000|Overall Study|Death|5|||
130873087|NCT00154297|471164445|FG001|Overall Study|Death|2|||
130873088|NCT00154297|471164444|FG000|Overall Study|Withdrawal by Subject|0|||
130873089|NCT00154297|471164445|FG001|Overall Study|Withdrawal by Subject|5|||
130873090|NCT00154297|471164444|FG000|Overall Study|Lost to Follow-up|3|||
130873091|NCT00154297|471164445|FG001|Overall Study|Lost to Follow-up|0|||
130873092|NCT00650767|471164446|FG000|Overall Study|Adverse Event|0|||
130873093|NCT00650767|471164447|FG001|Overall Study|Adverse Event|3|||
130873094|NCT00650767|471164448|FG002|Overall Study|Adverse Event|10|||
130873095|NCT00650767|471164449|FG003|Overall Study|Adverse Event|8|||
130873096|NCT00650767|471164446|FG000|Overall Study|Death|1|||
130873097|NCT00650767|471164447|FG001|Overall Study|Death|0|||
130873098|NCT00650767|471164448|FG002|Overall Study|Death|0|||
130873099|NCT00650767|471164449|FG003|Overall Study|Death|0|||
130873100|NCT00650767|471164446|FG000|Overall Study|Withdrawal by Subject|2|||
130873101|NCT00650767|471164447|FG001|Overall Study|Withdrawal by Subject|4|||
130873102|NCT00650767|471164448|FG002|Overall Study|Withdrawal by Subject|3|||
130873103|NCT00650767|471164449|FG003|Overall Study|Withdrawal by Subject|3|||
130873104|NCT00650767|471164446|FG000|Overall Study|Lost to Follow-up|1|||
130873105|NCT00650767|471164447|FG001|Overall Study|Lost to Follow-up|1|||
130873106|NCT00650767|471164448|FG002|Overall Study|Lost to Follow-up|1|||
130873107|NCT00650767|471164449|FG003|Overall Study|Lost to Follow-up|0|||
130873108|NCT00650767|471164446|FG000|Overall Study|Other|1|||
130873109|NCT00650767|471164447|FG001|Overall Study|Other|1|||
130873110|NCT00650767|471164448|FG002|Overall Study|Other|0|||
130873111|NCT00650767|471164449|FG003|Overall Study|Other|0|||
130873112|NCT01774799|471164450|FG000|Overall Study|Lost to Follow-up|1|||
130873113|NCT01774799|471164451|FG001|Overall Study|Lost to Follow-up|1|||
130873114|NCT01774799|471164452|FG002|Overall Study|Lost to Follow-up|0|||
130873115|NCT01774799|471164453|FG003|Overall Study|Lost to Follow-up|0|||
130873116|NCT00445549|471166055|FG000|Overall Study|progressive disease|12|||
130873117|NCT03858049|471166059|FG000|Overall Study|Adverse Event|16|||
130873118|NCT03858049|471166060|FG001|Overall Study|Adverse Event|9|||
130873119|NCT03858049|471166059|FG000|Overall Study|Other|1|||
130873120|NCT03858049|471166060|FG001|Overall Study|Other|1|||
130873121|NCT04617782|471166061|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
130873122|NCT04617782|471166061|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
130873123|NCT04617782|471166061|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
130873124|NCT04617782|471166061|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
130873125|NCT04617782|471166061|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
130873126|NCT04617782|471166061|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
130873127|NCT03493945|471166068|FG000|Phase I Dose Escalation|Ineligible|0|||
130873128|NCT03493945|471166069|FG001|Phase I Dose Escalation|Ineligible|0|||
130873129|NCT03493945|471166070|FG002|Phase I Dose Escalation|Ineligible|1|||
130873130|NCT03493945|471166071|FG003|Phase I Dose Escalation|Ineligible|0|||
130873131|NCT03493945|471166072|FG004|Phase I Dose Escalation|Ineligible|0|||
130873132|NCT03493945|471166073|FG005|Phase I Dose Escalation|Ineligible|0|||
130873133|NCT03493945|471166074|FG006|Phase I Dose Escalation|Ineligible|0|||
130873134|NCT03493945|471166068|FG000|Phase I Dose Escalation|New therapy|0|||
130873135|NCT03493945|471166069|FG001|Phase I Dose Escalation|New therapy|1|||
130873136|NCT03493945|471166070|FG002|Phase I Dose Escalation|New therapy|0|||
130873137|NCT03493945|471166071|FG003|Phase I Dose Escalation|New therapy|0|||
130873138|NCT03493945|471166072|FG004|Phase I Dose Escalation|New therapy|0|||
130873139|NCT03493945|471166073|FG005|Phase I Dose Escalation|New therapy|0|||
130873140|NCT03493945|471166074|FG006|Phase I Dose Escalation|New therapy|0|||
130873141|NCT03493945|471166068|FG000|Phase II Dose Expansion|Refused further treatment|0|||
130873142|NCT03493945|471166069|FG001|Phase II Dose Expansion|Refused further treatment|0|||
130873143|NCT03493945|471166070|FG002|Phase II Dose Expansion|Refused further treatment|0|||
130873144|NCT03493945|471166071|FG003|Phase II Dose Expansion|Refused further treatment|0|||
130873145|NCT03493945|471166072|FG004|Phase II Dose Expansion|Refused further treatment|1|||
130873146|NCT03493945|471166073|FG005|Phase II Dose Expansion|Refused further treatment|1|||
130873147|NCT03493945|471166074|FG006|Phase II Dose Expansion|Refused further treatment|0|||
130873148|NCT03493945|471166068|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
130873149|NCT03493945|471166069|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
130873150|NCT03493945|471166070|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
130873151|NCT03493945|471166071|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
130873152|NCT03493945|471166072|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
130873153|NCT03493945|471166073|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
130873154|NCT03493945|471166074|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
130873155|NCT04233801|471166078|FG000|Overall Study|Other than listed|0|||
130873156|NCT04233801|471166079|FG001|Overall Study|Other than listed|0|||
130873157|NCT04233801|471166080|FG002|Overall Study|Other than listed|1|||
130873158|NCT04233801|471166078|FG000|Overall Study|Withdrawal by Subject|0|||
130873159|NCT04233801|471166079|FG001|Overall Study|Withdrawal by Subject|2|||
130873160|NCT04233801|471166080|FG002|Overall Study|Withdrawal by Subject|3|||
130873161|NCT01690052|471166085|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
130873162|NCT01690052|471166086|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
130873163|NCT02421172|471166087|FG000|Period 1|Adverse Event|1|||
130873164|NCT02421172|471166088|FG001|Period 1|Adverse Event|0|||
130873165|NCT02421172|471166089|FG002|Period 1|Adverse Event|0|||
130873166|NCT02421172|471166090|FG003|Period 1|Adverse Event|0|||
130873167|NCT02421172|471166091|FG004|Period 1|Adverse Event|0|||
130873168|NCT02421172|471166087|FG000|Period 1|Lost to Follow-up|3|||
130873169|NCT02421172|471166088|FG001|Period 1|Lost to Follow-up|1|||
130873170|NCT02421172|471166089|FG002|Period 1|Lost to Follow-up|0|||
130873171|NCT02421172|471166090|FG003|Period 1|Lost to Follow-up|0|||
130873172|NCT02421172|471166091|FG004|Period 1|Lost to Follow-up|0|||
130873173|NCT02421172|471166087|FG000|Period 1|Patient/guardian decision|0|||
130873174|NCT02421172|471166088|FG001|Period 1|Patient/guardian decision|1|||
130873175|NCT02421172|471166089|FG002|Period 1|Patient/guardian decision|0|||
130873176|NCT02421172|471166090|FG003|Period 1|Patient/guardian decision|0|||
130873177|NCT02421172|471166091|FG004|Period 1|Patient/guardian decision|0|||
130873178|NCT02421172|471166087|FG000|Period 2|Adverse Event|0|||
130873179|NCT02421172|471166088|FG001|Period 2|Adverse Event|0|||
130873180|NCT02421172|471166089|FG002|Period 2|Adverse Event|4|||
130873181|NCT02421172|471166090|FG003|Period 2|Adverse Event|0|||
130873182|NCT02421172|471166091|FG004|Period 2|Adverse Event|0|||
130873183|NCT02421172|471166087|FG000|Period 2|Lost to Follow-up|0|||
130873184|NCT02421172|471166088|FG001|Period 2|Lost to Follow-up|0|||
130873185|NCT02421172|471166089|FG002|Period 2|Lost to Follow-up|0|||
130873186|NCT02421172|471166090|FG003|Period 2|Lost to Follow-up|1|||
130873187|NCT02421172|471166091|FG004|Period 2|Lost to Follow-up|0|||
130873188|NCT02421172|471166087|FG000|Period 2|Patient/guardian decision|0|||
130873189|NCT02421172|471166088|FG001|Period 2|Patient/guardian decision|0|||
130873190|NCT02421172|471166089|FG002|Period 2|Patient/guardian decision|3|||
130873191|NCT02421172|471166090|FG003|Period 2|Patient/guardian decision|2|||
130873192|NCT02421172|471166091|FG004|Period 2|Patient/guardian decision|1|||
130873193|NCT00928486|471166092|FG000|Overall Study|Adverse Event|2|||
130873194|NCT00928486|471166092|FG000|Overall Study|Disease Progression|7|||
130873195|NCT00928486|471166092|FG000|Overall Study|Withdrawal by Subject|1|||
130873196|NCT00683878|471166093|FG000|Overall Study|Lack of Efficacy|3|||
130873197|NCT00683878|471166094|FG001|Overall Study|Lack of Efficacy|0|||
130873198|NCT00683878|471166095|FG002|Overall Study|Lack of Efficacy|1|||
130873199|NCT00683878|471166093|FG000|Overall Study|Adverse Event|4|||
130873200|NCT00683878|471166094|FG001|Overall Study|Adverse Event|3|||
130873201|NCT00683878|471166095|FG002|Overall Study|Adverse Event|3|||
130873202|NCT00683878|471166093|FG000|Overall Study|Withdrawal by Subject|9|||
130873203|NCT00683878|471166094|FG001|Overall Study|Withdrawal by Subject|8|||
130873204|NCT00683878|471166095|FG002|Overall Study|Withdrawal by Subject|6|||
130873205|NCT00683878|471166093|FG000|Overall Study|Death|0|||
130873206|NCT00683878|471166094|FG001|Overall Study|Death|1|||
130873207|NCT00683878|471166095|FG002|Overall Study|Death|0|||
130873208|NCT00683878|471166093|FG000|Overall Study|Lost to Follow-up|4|||
130873209|NCT00683878|471166094|FG001|Overall Study|Lost to Follow-up|2|||
130873210|NCT00683878|471166095|FG002|Overall Study|Lost to Follow-up|4|||
130873211|NCT00683878|471166093|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
130873212|NCT00683878|471166094|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
130873213|NCT00683878|471166095|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
130873214|NCT04319198|471166096|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
130873215|NCT04319198|471166097|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
130873216|NCT04319198|471166098|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
130873217|NCT04319198|471166096|FG000|Overall Study|Death|0|||
130873218|NCT04319198|471166097|FG001|Overall Study|Death|3|||
130873219|NCT04319198|471166098|FG002|Overall Study|Death|3|||
130873220|NCT04319198|471166096|FG000|Overall Study|Reason Not Specified|0|||
130873221|NCT04319198|471166097|FG001|Overall Study|Reason Not Specified|2|||
130873222|NCT04319198|471166098|FG002|Overall Study|Reason Not Specified|4|||
130873223|NCT04319198|471166096|FG000|Overall Study|Withdrawal of Consent|0|||
130873224|NCT04319198|471166097|FG001|Overall Study|Withdrawal of Consent|0|||
130873225|NCT04319198|471166098|FG002|Overall Study|Withdrawal of Consent|5|||
130873226|NCT04319198|471166096|FG000|Overall Study|Site Terminated by Sponsor|0|||
130873227|NCT04319198|471166097|FG001|Overall Study|Site Terminated by Sponsor|1|||
130873228|NCT04319198|471166098|FG002|Overall Study|Site Terminated by Sponsor|0|||
130873229|NCT01329263|471166099|FG000|Overall Study|Lost to Follow-up|4|||
130873230|NCT01329263|471166100|FG001|Overall Study|Lost to Follow-up|21|||
130873231|NCT01329263|471166099|FG000|Overall Study|Withdrawal by Subject|1|||
130873232|NCT01329263|471166100|FG001|Overall Study|Withdrawal by Subject|2|||
130873233|NCT01421017|471166101|FG000|Overall Study|Withdrawal by Subject|2|||
130873234|NCT01421017|471166102|FG001|Overall Study|Withdrawal by Subject|0|||
130873235|NCT01421017|471166103|FG002|Overall Study|Withdrawal by Subject|0|||
130873236|NCT01421017|471166101|FG000|Overall Study|POD|0|||
130873237|NCT01421017|471166102|FG001|Overall Study|POD|6|||
130873238|NCT01421017|471166103|FG002|Overall Study|POD|3|||
130873239|NCT02313766|471166106|FG000|Overall Study|surgery cancelled|1|||
130873240|NCT02313766|471166107|FG001|Overall Study|surgery cancelled|0|||
130873241|NCT02313766|471166108|FG002|Overall Study|surgery cancelled|0|||
130873242|NCT02313766|471166106|FG000|Overall Study|Lost to Follow-up|0|||
130873243|NCT02313766|471166107|FG001|Overall Study|Lost to Follow-up|2|||
130873244|NCT02313766|471166108|FG002|Overall Study|Lost to Follow-up|0|||
130873245|NCT02313766|471166106|FG000|Overall Study|Adverse Event|0|||
130873246|NCT02313766|471166107|FG001|Overall Study|Adverse Event|1|||
130873247|NCT02313766|471166108|FG002|Overall Study|Adverse Event|0|||
130873248|NCT02193776|471166109|FG000|Overall Study|Consent withdrawn|1|||
130873249|NCT02193776|471166110|FG001|Overall Study|Consent withdrawn|0|||
130873250|NCT02193776|471166111|FG002|Overall Study|Consent withdrawn|0|||
130873251|NCT02193776|471166112|FG003|Overall Study|Consent withdrawn|0|||
130873252|NCT02193776|471166109|FG000|Overall Study|Failure to comply with protocol|0|||
130873253|NCT02193776|471166110|FG001|Overall Study|Failure to comply with protocol|1|||
130873254|NCT02193776|471166111|FG002|Overall Study|Failure to comply with protocol|0|||
130873255|NCT02193776|471166112|FG003|Overall Study|Failure to comply with protocol|0|||
130873256|NCT02193776|471166109|FG000|Overall Study|Investigator/Sponsor decision|1|||
130873257|NCT02193776|471166110|FG001|Overall Study|Investigator/Sponsor decision|1|||
130873258|NCT02193776|471166111|FG002|Overall Study|Investigator/Sponsor decision|0|||
130873259|NCT02193776|471166112|FG003|Overall Study|Investigator/Sponsor decision|0|||
130873260|NCT02193776|471166109|FG000|Overall Study|Death|1|||
130873261|NCT02193776|471166110|FG001|Overall Study|Death|0|||
130873262|NCT02193776|471166111|FG002|Overall Study|Death|0|||
130873263|NCT02193776|471166112|FG003|Overall Study|Death|0|||
130873264|NCT02193776|471166109|FG000|Overall Study|Adverse event/Specific toxicity|5|||
130873265|NCT02193776|471166110|FG001|Overall Study|Adverse event/Specific toxicity|5|||
130873266|NCT02193776|471166111|FG002|Overall Study|Adverse event/Specific toxicity|2|||
130873267|NCT02193776|471166112|FG003|Overall Study|Adverse event/Specific toxicity|2|||
130873268|NCT00962208|471166114|FG000|Overall Study|Could not achieve good vision|9|||
130873269|NCT00962208|471166115|FG001|Overall Study|Could not achieve good vision|0|||
130873270|NCT00962208|471166114|FG000|Overall Study|Contraindicated to continue study|5|||
130873271|NCT00962208|471166115|FG001|Overall Study|Contraindicated to continue study|1|||
130873272|NCT00962208|471166114|FG000|Overall Study|Lost to Follow-up|0|||
130873273|NCT00962208|471166115|FG001|Overall Study|Lost to Follow-up|9|||
130873274|NCT00791388|471166116|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130873275|NCT00791388|471166117|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
130873276|NCT00791388|471166118|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130873277|NCT00791388|471166119|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130873278|NCT00791388|471166120|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130873279|NCT00791388|471166116|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
130873280|NCT00791388|471166117|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130873281|NCT00791388|471166118|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130873282|NCT00791388|471166119|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130873283|NCT00791388|471166120|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130873284|NCT00791388|471166116|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130873285|NCT00791388|471166117|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130873286|NCT00791388|471166118|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130873287|NCT00791388|471166119|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130873288|NCT00791388|471166120|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
130873289|NCT02656017|471166121|FG000|Overall Study|Study burden|3|||
130873290|NCT02656017|471166122|FG001|Overall Study|Study burden|3|||
130873291|NCT02656017|471166121|FG000|Overall Study|Adverse Event|2|||
130873292|NCT02656017|471166122|FG001|Overall Study|Adverse Event|1|||
130873293|NCT02656017|471166121|FG000|Overall Study|Unable/unwilling to take study medication|2|||
130873294|NCT02656017|471166122|FG001|Overall Study|Unable/unwilling to take study medication|1|||
130873295|NCT02656017|471166121|FG000|Overall Study|Began Tolvaptan|1|||
130873296|NCT02656017|471166122|FG001|Overall Study|Began Tolvaptan|1|||
130873297|NCT02656017|471166121|FG000|Overall Study|Withdrawal by Subject|1|||
130873298|NCT02656017|471166122|FG001|Overall Study|Withdrawal by Subject|0|||
130873299|NCT02792231|471166128|FG000|Overall Study|Patient/guardian decision|32|||
130873300|NCT02792231|471166129|FG001|Overall Study|Patient/guardian decision|42|||
130873301|NCT02792231|471166128|FG000|Overall Study|Adverse Event|15|||
130873302|NCT02792231|471166129|FG001|Overall Study|Adverse Event|11|||
130873303|NCT02792231|471166128|FG000|Overall Study|Physician Decision|14|||
130873304|NCT02792231|471166129|FG001|Overall Study|Physician Decision|12|||
130873305|NCT02792231|471166128|FG000|Overall Study|Lack of Efficacy|7|||
130873306|NCT02792231|471166129|FG001|Overall Study|Lack of Efficacy|9|||
130873307|NCT02792231|471166128|FG000|Overall Study|Lost to Follow-up|9|||
130873308|NCT02792231|471166129|FG001|Overall Study|Lost to Follow-up|5|||
130873309|NCT02792231|471166128|FG000|Overall Study|Pregnancy|1|||
130873310|NCT02792231|471166129|FG001|Overall Study|Pregnancy|3|||
130873311|NCT02792231|471166128|FG000|Overall Study|Non-compliance with study treatment|2|||
130873312|NCT02792231|471166129|FG001|Overall Study|Non-compliance with study treatment|1|||
130873313|NCT02792231|471166128|FG000|Overall Study|Protocol deviation|2|||
130873314|NCT02792231|471166129|FG001|Overall Study|Protocol deviation|0|||
130873315|NCT02792231|471166128|FG000|Overall Study|Technical problems|0|||
130873316|NCT02792231|471166129|FG001|Overall Study|Technical problems|1|||
130873317|NCT05196828|471166130|FG000|Overall Study|Withdrawal by Subject|2|||
130873318|NCT05196828|471166131|FG001|Overall Study|Withdrawal by Subject|0|||
130873319|NCT05196828|471166130|FG000|Overall Study|Lost to Follow-up|0|||
130873320|NCT05196828|471166131|FG001|Overall Study|Lost to Follow-up|4|||
130873321|NCT05196828|471166130|FG000|Overall Study|Adverse Event|1|||
130873322|NCT05196828|471166131|FG001|Overall Study|Adverse Event|0|||
130873323|NCT03309878|471166132|FG000|Overall Study|Adverse Event|1|||
130873324|NCT03309878|471166133|FG001|Overall Study|Adverse Event|0|||
130873325|NCT03309878|471166134|FG002|Overall Study|Adverse Event|0|||
130873326|NCT03309878|471166135|FG003|Overall Study|Adverse Event|0|||
130873327|NCT03309878|471166132|FG000|Overall Study|Did not maintain eligibility|2|||
130873328|NCT03309878|471166133|FG001|Overall Study|Did not maintain eligibility|1|||
130873329|NCT03309878|471166134|FG002|Overall Study|Did not maintain eligibility|0|||
130873330|NCT03309878|471166135|FG003|Overall Study|Did not maintain eligibility|0|||
130873331|NCT03309878|471166132|FG000|Overall Study|Withdrawal by Subject|0|||
130873332|NCT03309878|471166133|FG001|Overall Study|Withdrawal by Subject|1|||
130873333|NCT03309878|471166134|FG002|Overall Study|Withdrawal by Subject|0|||
130873334|NCT03309878|471166135|FG003|Overall Study|Withdrawal by Subject|0|||
130873335|NCT01096316|471166136|FG000|Overall Study|Lost to Follow-up|15|||
130873336|NCT01096316|471166137|FG001|Overall Study|Lost to Follow-up|9|||
130873337|NCT02836652|471166138|FG000|Overall Study|Death|3|||
130873338|NCT02836652|471166139|FG001|Overall Study|Death|3|||
130873339|NCT02836652|471166138|FG000|Overall Study|Transplant/Explant|3|||
130873340|NCT02836652|471166139|FG001|Overall Study|Transplant/Explant|4|||
130873341|NCT02836652|471166138|FG000|Overall Study|Withdrawn|9|||
130873342|NCT02836652|471166139|FG001|Overall Study|Withdrawn|9|||
130873343|NCT02836652|471166138|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
130873344|NCT02836652|471166139|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
130873345|NCT02349633|471166140|FG000|Overall Study|Death|0|||
130873346|NCT02349633|471166141|FG001|Overall Study|Death|1|||
130873347|NCT02349633|471166142|FG002|Overall Study|Death|0|||
130873348|NCT02349633|471166143|FG003|Overall Study|Death|0|||
130873349|NCT02349633|471166144|FG004|Overall Study|Death|0|||
130873350|NCT02349633|471166145|FG005|Overall Study|Death|1|||
130873351|NCT02349633|471166146|FG006|Overall Study|Death|1|||
130873352|NCT02349633|471166147|FG007|Overall Study|Death|1|||
130873353|NCT02349633|471166148|FG008|Overall Study|Death|0|||
130873354|NCT02349633|471166149|FG009|Overall Study|Death|1|||
130873355|NCT02349633|471166150|FG010|Overall Study|Death|0|||
130873356|NCT02349633|471166151|FG011|Overall Study|Death|0|||
130873357|NCT02349633|471166152|FG012|Overall Study|Death|0|||
130873358|NCT02349633|471166153|FG013|Overall Study|Death|0|||
130873359|NCT02349633|471166140|FG000|Overall Study|Withdrawal by Subject|0|||
130873360|NCT02349633|471166141|FG001|Overall Study|Withdrawal by Subject|0|||
130873361|NCT02349633|471166142|FG002|Overall Study|Withdrawal by Subject|0|||
130873362|NCT02349633|471166143|FG003|Overall Study|Withdrawal by Subject|1|||
130873363|NCT02349633|471166144|FG004|Overall Study|Withdrawal by Subject|0|||
130873364|NCT02349633|471166145|FG005|Overall Study|Withdrawal by Subject|0|||
130873365|NCT02349633|471166146|FG006|Overall Study|Withdrawal by Subject|0|||
130873366|NCT02349633|471166147|FG007|Overall Study|Withdrawal by Subject|2|||
130873367|NCT02349633|471166148|FG008|Overall Study|Withdrawal by Subject|2|||
130873368|NCT02349633|471166149|FG009|Overall Study|Withdrawal by Subject|1|||
130873369|NCT02349633|471166150|FG010|Overall Study|Withdrawal by Subject|0|||
130873370|NCT02349633|471166151|FG011|Overall Study|Withdrawal by Subject|0|||
130873371|NCT02349633|471166152|FG012|Overall Study|Withdrawal by Subject|0|||
130873372|NCT02349633|471166153|FG013|Overall Study|Withdrawal by Subject|0|||
130873373|NCT02349633|471166140|FG000|Overall Study|Withdrawal of informed consent|0|||
130873374|NCT02349633|471166141|FG001|Overall Study|Withdrawal of informed consent|0|||
130873375|NCT02349633|471166142|FG002|Overall Study|Withdrawal of informed consent|0|||
130873376|NCT02349633|471166143|FG003|Overall Study|Withdrawal of informed consent|1|||
130873377|NCT02349633|471166144|FG004|Overall Study|Withdrawal of informed consent|1|||
130873378|NCT02349633|471166145|FG005|Overall Study|Withdrawal of informed consent|0|||
130873379|NCT02349633|471166146|FG006|Overall Study|Withdrawal of informed consent|0|||
130873380|NCT02349633|471166147|FG007|Overall Study|Withdrawal of informed consent|3|||
130873381|NCT02349633|471166148|FG008|Overall Study|Withdrawal of informed consent|0|||
130873382|NCT02349633|471166149|FG009|Overall Study|Withdrawal of informed consent|0|||
130873383|NCT02349633|471166150|FG010|Overall Study|Withdrawal of informed consent|0|||
130873384|NCT02349633|471166151|FG011|Overall Study|Withdrawal of informed consent|0|||
130873385|NCT02349633|471166152|FG012|Overall Study|Withdrawal of informed consent|0|||
130873386|NCT02349633|471166153|FG013|Overall Study|Withdrawal of informed consent|0|||
130873387|NCT02349633|471166140|FG000|Overall Study|Transition to compassionate use|0|||
130873388|NCT02349633|471166141|FG001|Overall Study|Transition to compassionate use|0|||
130873389|NCT02349633|471166142|FG002|Overall Study|Transition to compassionate use|0|||
130873390|NCT02349633|471166143|FG003|Overall Study|Transition to compassionate use|0|||
130873391|NCT02349633|471166144|FG004|Overall Study|Transition to compassionate use|1|||
130873392|NCT02349633|471166145|FG005|Overall Study|Transition to compassionate use|0|||
130873393|NCT02349633|471166146|FG006|Overall Study|Transition to compassionate use|0|||
130873394|NCT02349633|471166147|FG007|Overall Study|Transition to compassionate use|3|||
130873395|NCT02349633|471166148|FG008|Overall Study|Transition to compassionate use|0|||
130873396|NCT02349633|471166149|FG009|Overall Study|Transition to compassionate use|1|||
130873397|NCT02349633|471166150|FG010|Overall Study|Transition to compassionate use|0|||
130873398|NCT02349633|471166151|FG011|Overall Study|Transition to compassionate use|0|||
130873399|NCT02349633|471166152|FG012|Overall Study|Transition to compassionate use|0|||
130873400|NCT02349633|471166153|FG013|Overall Study|Transition to compassionate use|0|||
130873401|NCT02349633|471166140|FG000|Overall Study|Early termination of survival follow-up|0|||
130873402|NCT02349633|471166141|FG001|Overall Study|Early termination of survival follow-up|0|||
130873403|NCT02349633|471166142|FG002|Overall Study|Early termination of survival follow-up|0|||
130873404|NCT02349633|471166143|FG003|Overall Study|Early termination of survival follow-up|0|||
130873405|NCT02349633|471166144|FG004|Overall Study|Early termination of survival follow-up|0|||
130873406|NCT02349633|471166145|FG005|Overall Study|Early termination of survival follow-up|0|||
130873407|NCT02349633|471166146|FG006|Overall Study|Early termination of survival follow-up|0|||
130873408|NCT02349633|471166147|FG007|Overall Study|Early termination of survival follow-up|4|||
130873409|NCT02349633|471166148|FG008|Overall Study|Early termination of survival follow-up|0|||
130873410|NCT02349633|471166149|FG009|Overall Study|Early termination of survival follow-up|0|||
130873411|NCT02349633|471166150|FG010|Overall Study|Early termination of survival follow-up|0|||
130873412|NCT02349633|471166151|FG011|Overall Study|Early termination of survival follow-up|0|||
130873413|NCT02349633|471166152|FG012|Overall Study|Early termination of survival follow-up|0|||
130873414|NCT02349633|471166153|FG013|Overall Study|Early termination of survival follow-up|0|||
130873415|NCT02349633|471166140|FG000|Overall Study|Termination by sponsor|0|||
130873416|NCT02349633|471166141|FG001|Overall Study|Termination by sponsor|0|||
130873417|NCT02349633|471166142|FG002|Overall Study|Termination by sponsor|0|||
130873418|NCT02349633|471166143|FG003|Overall Study|Termination by sponsor|0|||
130873419|NCT02349633|471166144|FG004|Overall Study|Termination by sponsor|0|||
130873420|NCT02349633|471166145|FG005|Overall Study|Termination by sponsor|0|||
130873421|NCT02349633|471166146|FG006|Overall Study|Termination by sponsor|0|||
130873422|NCT02349633|471166147|FG007|Overall Study|Termination by sponsor|1|||
130873423|NCT02349633|471166148|FG008|Overall Study|Termination by sponsor|0|||
130873424|NCT02349633|471166149|FG009|Overall Study|Termination by sponsor|2|||
130873425|NCT02349633|471166150|FG010|Overall Study|Termination by sponsor|0|||
130873426|NCT02349633|471166151|FG011|Overall Study|Termination by sponsor|0|||
130873427|NCT02349633|471166152|FG012|Overall Study|Termination by sponsor|0|||
130873428|NCT02349633|471166153|FG013|Overall Study|Termination by sponsor|0|||
130873429|NCT02349633|471166140|FG000|Overall Study|Other|0|||
130873430|NCT02349633|471166141|FG001|Overall Study|Other|0|||
130873431|NCT02349633|471166142|FG002|Overall Study|Other|0|||
130873432|NCT02349633|471166143|FG003|Overall Study|Other|0|||
130873433|NCT02349633|471166144|FG004|Overall Study|Other|0|||
130873434|NCT02349633|471166145|FG005|Overall Study|Other|0|||
130873435|NCT02349633|471166146|FG006|Overall Study|Other|0|||
130873436|NCT02349633|471166147|FG007|Overall Study|Other|2|||
130873437|NCT02349633|471166148|FG008|Overall Study|Other|0|||
130873438|NCT02349633|471166149|FG009|Overall Study|Other|0|||
130873439|NCT02349633|471166150|FG010|Overall Study|Other|0|||
130873440|NCT02349633|471166151|FG011|Overall Study|Other|0|||
130873441|NCT02349633|471166152|FG012|Overall Study|Other|0|||
130873442|NCT02349633|471166153|FG013|Overall Study|Other|0|||
130873443|NCT01008943|471166156|FG000|Overall Study|Withdrawal by Subject|1|||
130873444|NCT01453140|471166157|FG000|Overall Study|Adverse Event|3|||
130873445|NCT03206216|471166158|FG000|Overall Study|Withdrawal by Subject|0|||
130873446|NCT03206216|471166159|FG001|Overall Study|Withdrawal by Subject|1|||
130873447|NCT01960140|471166160|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
130873448|NCT04154943|471166165|FG000|Overall Study|Study Ongoing|68|||
130873449|NCT04154943|471166165|FG000|Overall Study|Lost to Follow-up|1|||
130873450|NCT04154943|471166165|FG000|Overall Study|Decision by the Investigator|1|||
130873451|NCT04154943|471166165|FG000|Overall Study|Death|5|||
130873452|NCT04154943|471166165|FG000|Overall Study|Withdrawal by Subject|4|||
130873453|NCT06237049|471166166|FG000|Overall Study|Death|0|||
130873454|NCT06237049|471166167|FG001|Overall Study|Death|0|||
130873455|NCT06237049|471166168|FG002|Overall Study|Death|0|||
130873456|NCT06237049|471166169|FG003|Overall Study|Death|1|||
130873457|NCT06237049|471166166|FG000|Overall Study|Lost to Follow-up|11|||
130873458|NCT06237049|471166167|FG001|Overall Study|Lost to Follow-up|5|||
130873459|NCT06237049|471166168|FG002|Overall Study|Lost to Follow-up|8|||
130873460|NCT06237049|471166169|FG003|Overall Study|Lost to Follow-up|8|||
130873461|NCT06237049|471166166|FG000|Overall Study|Protocol Violation|0|||
130873462|NCT06237049|471166167|FG001|Overall Study|Protocol Violation|1|||
130873463|NCT06237049|471166168|FG002|Overall Study|Protocol Violation|0|||
130873464|NCT06237049|471166169|FG003|Overall Study|Protocol Violation|1|||
130873465|NCT06237049|471166166|FG000|Overall Study|Withdrawal by Subject|4|||
130873466|NCT06237049|471166167|FG001|Overall Study|Withdrawal by Subject|2|||
130873467|NCT06237049|471166168|FG002|Overall Study|Withdrawal by Subject|1|||
130873468|NCT06237049|471166169|FG003|Overall Study|Withdrawal by Subject|0|||
130873469|NCT00377520|471166174|FG000|Overall Study|Ineligible (Prior radiation)|1|||
130873470|NCT01917747|471166179|FG000|Overall Study|Withdrawal by Subject|1|||
130873471|NCT01917747|471166180|FG001|Overall Study|Withdrawal by Subject|2|||
130873472|NCT01917747|471166179|FG000|Overall Study|Lost to Follow-up|18|||
130873473|NCT01917747|471166180|FG001|Overall Study|Lost to Follow-up|9|||
130873474|NCT02922725|471166181|FG000|Overall Study|Withdrawal by Subject|1|||
130873475|NCT02922725|471166182|FG001|Overall Study|Withdrawal by Subject|0|||
130873476|NCT02922725|471166183|FG002|Overall Study|Withdrawal by Subject|0|||
130873477|NCT03253679|471166184|FG000|Overall Study|Screen Failure|1|||
130873478|NCT04816214|471166185|FG000|Overall Study|Progressive Disease|4|||
130873479|NCT04816214|471166186|FG001|Overall Study|Progressive Disease|0|||
130873480|NCT04816214|471166187|FG002|Overall Study|Progressive Disease|0|||
130873481|NCT04816214|471166185|FG000|Overall Study|Death|1|||
130873482|NCT04816214|471166186|FG001|Overall Study|Death|0|||
130873483|NCT04816214|471166187|FG002|Overall Study|Death|0|||
130873484|NCT04816214|471166185|FG000|Overall Study|Study Terminated by Sponsor|1|||
130873485|NCT04816214|471166186|FG001|Overall Study|Study Terminated by Sponsor|0|||
130873486|NCT04816214|471166187|FG002|Overall Study|Study Terminated by Sponsor|0|||
130873487|NCT05148234|471166188|FG000|Phase I|Ineligible|0|||
130873488|NCT05148234|471166189|FG001|Phase I|Ineligible|0|||
130873489|NCT05148234|471166190|FG002|Phase I|Ineligible|0|||
130873490|NCT05148234|471166191|FG003|Phase I|Ineligible|0|||
130873491|NCT05148234|471166192|FG004|Phase I|Ineligible|0|||
130873492|NCT05148234|471166193|FG005|Phase I|Ineligible|0|||
130873493|NCT05148234|471166194|FG006|Phase I|Ineligible|0|||
130873494|NCT05148234|471166195|FG007|Phase I|Ineligible|1|||
130873495|NCT05148234|471166188|FG000|Phase I|Company closed the trial.|0|||
130873496|NCT05148234|471166189|FG001|Phase I|Company closed the trial.|1|||
130873497|NCT05148234|471166190|FG002|Phase I|Company closed the trial.|0|||
130873498|NCT05148234|471166191|FG003|Phase I|Company closed the trial.|0|||
130873499|NCT05148234|471166192|FG004|Phase I|Company closed the trial.|0|||
130873500|NCT05148234|471166193|FG005|Phase I|Company closed the trial.|0|||
130873501|NCT05148234|471166194|FG006|Phase I|Company closed the trial.|0|||
130873502|NCT05148234|471166195|FG007|Phase I|Company closed the trial.|0|||
130873503|NCT03061201|471166196|FG000|Overall Study|Participants Terminated at Month 36|0|||
130873504|NCT03061201|471166197|FG001|Overall Study|Participants Terminated at Month 36|1|||
130873505|NCT03061201|471166198|FG002|Overall Study|Participants Terminated at Month 36|0|||
130873506|NCT03061201|471166199|FG003|Overall Study|Participants Terminated at Month 36|1|||
130873507|NCT03061201|471166196|FG000|Overall Study|Lost to Follow-up|1|||
130873508|NCT03061201|471166197|FG001|Overall Study|Lost to Follow-up|0|||
130873509|NCT03061201|471166198|FG002|Overall Study|Lost to Follow-up|0|||
130873510|NCT03061201|471166199|FG003|Overall Study|Lost to Follow-up|0|||
130873511|NCT03062358|471166200|FG000|Overall Study|Death|269|||
130873512|NCT03062358|471166201|FG001|Overall Study|Death|145|||
130873513|NCT03062358|471166200|FG000|Overall Study|Withdrawal by Subject|2|||
130873514|NCT03062358|471166201|FG001|Overall Study|Withdrawal by Subject|1|||
130873515|NCT03062358|471166200|FG000|Overall Study|Sponsor Decision|29|||
130873516|NCT03062358|471166201|FG001|Overall Study|Sponsor Decision|7|||
130873517|NCT03861273|471166202|FG000|Screening Phase (3 Weeks)|Other|1|||
130873518|NCT03861273|471166202|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
130873519|NCT03861273|471166202|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
130873520|NCT03861273|471166202|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
130873521|NCT03861273|471166202|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
130873522|NCT03799341|471166203|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
130873523|NCT03799341|471166204|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
130873524|NCT03799341|471166205|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
130873525|NCT03799341|471166203|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
130873526|NCT03799341|471166204|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
130873527|NCT03799341|471166205|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
130873528|NCT03799341|471166203|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
130873529|NCT03799341|471166204|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
130873530|NCT03799341|471166205|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
130873531|NCT03799341|471166203|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
130873532|NCT03799341|471166204|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
130873533|NCT03799341|471166205|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
130873534|NCT03799341|471166203|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
130873535|NCT03799341|471166204|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
130873536|NCT03799341|471166205|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
130873537|NCT03799341|471166203|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
130873538|NCT03799341|471166204|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
130873539|NCT03799341|471166205|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
130873540|NCT04539938|471166206|FG000|Overall Study|Death|30|||
130873541|NCT04539938|471166206|FG000|Overall Study|Withdrawal by Subject|4|||
130873542|NCT01650194|471166207|FG000|Overall Study|Progressive Disease (PD)|35|||
130873543|NCT01650194|471166207|FG000|Overall Study|Withdrawal by Subject|2|||
130873544|NCT01650194|471166207|FG000|Overall Study|Miscellaneous|10|||
130873545|NCT00880698|471166208|FG000|Overall Study|Death|0|||
130873546|NCT00880698|471166209|FG001|Overall Study|Death|0|||
130873547|NCT00880698|471166210|FG002|Overall Study|Death|1|||
130873548|NCT00880698|471166211|FG003|Overall Study|Death|2|||
130873549|NCT00880698|471166208|FG000|Overall Study|Lost to Follow-up|1|||
130873550|NCT00880698|471166209|FG001|Overall Study|Lost to Follow-up|3|||
130873551|NCT00880698|471166210|FG002|Overall Study|Lost to Follow-up|0|||
130873552|NCT00880698|471166211|FG003|Overall Study|Lost to Follow-up|1|||
130873553|NCT00320515|471166212|FG000|Overall Study|Death|33|||
130873554|NCT00320515|471166212|FG000|Overall Study|Lost to Follow-up|6|||
130873555|NCT00320515|471166212|FG000|Overall Study|Physician Decision|2|||
130873556|NCT00320515|471166212|FG000|Overall Study|Withdrawal by Subject|8|||
130873557|NCT00794950|471166213|FG000|BCG Induction|Withdrawal by Subject|2|||
130873558|NCT00794950|471166213|FG000|BCG Induction|ineligible|3|||
130873559|NCT00794950|471166213|FG000|BCG Induction|noncompliant w. BCG|1|||
130873560|NCT00794950|471166213|FG000|BCG Induction|Adverse Event|1|||
130873561|NCT00794950|471166213|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
130873562|NCT00794950|471166213|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
130873563|NCT00794950|471166213|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
130873564|NCT00794950|471166213|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
130873565|NCT00851786|471166214|FG000|Overall Study|Withdrawal by Subject|0|||
130873566|NCT00851786|471166215|FG001|Overall Study|Withdrawal by Subject|1|||
130873567|NCT00851786|471166214|FG000|Overall Study|Protocol Violation|0|||
130873568|NCT00851786|471166215|FG001|Overall Study|Protocol Violation|1|||
130873569|NCT00851786|471166214|FG000|Overall Study|Lost to Follow-up|1|||
130873570|NCT00851786|471166215|FG001|Overall Study|Lost to Follow-up|0|||
130873571|NCT00851786|471166214|FG000|Overall Study|Incarceration|1|||
130873572|NCT00851786|471166215|FG001|Overall Study|Incarceration|0|||
130873573|NCT00851786|471166214|FG000|Overall Study|Site Closure|1|||
130873574|NCT00851786|471166215|FG001|Overall Study|Site Closure|0|||
130873575|NCT00851786|471166214|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
130873576|NCT00851786|471166215|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
130873577|NCT02079740|471167437|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
130873578|NCT02079740|471167438|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
130873579|NCT02079740|471167439|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
130873580|NCT02079740|471167440|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
130873581|NCT02079740|471167441|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
130873582|NCT02079740|471167442|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
130873583|NCT02079740|471167443|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
130873584|NCT02079740|471167444|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
130873585|NCT02079740|471167445|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
130873586|NCT02079740|471167446|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
130873587|NCT02079740|471167447|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
130873588|NCT02079740|471167448|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
130873589|NCT02079740|471167449|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
130873590|NCT02079740|471167437|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
130873591|NCT02079740|471167438|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
130873592|NCT02079740|471167439|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
130873593|NCT02079740|471167440|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
130873594|NCT02079740|471167441|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
130873595|NCT02079740|471167442|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
130873596|NCT02079740|471167443|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
130873597|NCT02079740|471167444|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
130873598|NCT02079740|471167445|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
130873599|NCT02079740|471167446|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
130873600|NCT02079740|471167447|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
130873601|NCT02079740|471167448|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
130873602|NCT02079740|471167449|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
130873603|NCT02079740|471167437|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873604|NCT02079740|471167438|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873605|NCT02079740|471167439|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873606|NCT02079740|471167440|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873607|NCT02079740|471167441|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873608|NCT02079740|471167442|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873609|NCT02079740|471167443|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873610|NCT02079740|471167444|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
130873611|NCT02079740|471167445|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873612|NCT02079740|471167446|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873613|NCT02079740|471167447|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873614|NCT02079740|471167448|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873615|NCT02079740|471167449|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
130873616|NCT02079740|471167437|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873617|NCT02079740|471167438|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873618|NCT02079740|471167439|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873619|NCT02079740|471167440|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873620|NCT02079740|471167441|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873621|NCT02079740|471167442|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873622|NCT02079740|471167443|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873623|NCT02079740|471167444|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
130873624|NCT02079740|471167445|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873625|NCT02079740|471167446|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873626|NCT02079740|471167447|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873627|NCT02079740|471167448|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873628|NCT02079740|471167449|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130873629|NCT02079740|471167437|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130873630|NCT02079740|471167438|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130873631|NCT02079740|471167439|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130873632|NCT02079740|471167440|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130873633|NCT02079740|471167441|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130873634|NCT02079740|471167442|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130873635|NCT02079740|471167443|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130873636|NCT02079740|471167444|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130873637|NCT02079740|471167445|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130873638|NCT02079740|471167446|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
130873639|NCT02079740|471167447|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130873640|NCT02079740|471167448|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
130873641|NCT02079740|471167449|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
130873642|NCT01405768|471167450|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
130873643|NCT01405768|471167451|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
130873644|NCT02869633|471167454|FG000|Overall Study|Death|2|||
130873645|NCT02869633|471167455|FG001|Overall Study|Death|1|||
130873646|NCT02869633|471167454|FG000|Overall Study|Patient refused follow-up|1|||
130873647|NCT02869633|471167455|FG001|Overall Study|Patient refused follow-up|0|||
130873648|NCT02869633|471167454|FG000|Overall Study|Provider discretion|1|||
130873649|NCT02869633|471167455|FG001|Overall Study|Provider discretion|0|||
130873650|NCT02869633|471167454|FG000|Overall Study|Investigator decision|1|||
130873651|NCT02869633|471167455|FG001|Overall Study|Investigator decision|0|||
130873652|NCT02869633|471167454|FG000|Overall Study|Lost to Follow-up|0|||
130873653|NCT02869633|471167455|FG001|Overall Study|Lost to Follow-up|1|||
130873654|NCT02869633|471167454|FG000|Overall Study|Not eligible|6|||
130873655|NCT02869633|471167455|FG001|Overall Study|Not eligible|1|||
130873656|NCT02869633|471167454|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
130873657|NCT02869633|471167455|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
130873658|NCT02869633|471167454|FG000|Overall Study|Withdrawal by Subject|0|||
130873659|NCT02869633|471167455|FG001|Overall Study|Withdrawal by Subject|1|||
130873660|NCT01381016|471167456|FG000|Overall Study|Lost to Follow-up|1|||
130873661|NCT01381016|471167457|FG001|Overall Study|Lost to Follow-up|1|||
130873662|NCT01381016|471167456|FG000|Overall Study|Screen Failure|2|||
130873663|NCT01381016|471167457|FG001|Overall Study|Screen Failure|2|||
130873664|NCT01381016|471167456|FG000|Overall Study|Withdrawal by Subject|0|||
130873665|NCT01381016|471167457|FG001|Overall Study|Withdrawal by Subject|1|||
130873666|NCT01381016|471167456|FG000|Overall Study|Physician Decision|0|||
130873667|NCT01381016|471167457|FG001|Overall Study|Physician Decision|2|||
130873668|NCT06039579|471167458|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130873669|NCT06039579|471167459|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130873670|NCT06039579|471167460|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130873671|NCT06039579|471167461|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130873672|NCT06039579|471167462|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130873673|NCT06039579|471167463|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130873674|NCT06039579|471167464|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130873675|NCT06039579|471167465|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
130873676|NCT04073186|471167466|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
130873677|NCT04073186|471167466|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
130873678|NCT04073186|471167466|FG000|First Wearing Cycle|Protocol Violation|1|||
130873679|NCT04073186|471167466|FG000|First Wearing Cycle|Lens Discomfort|2|||
130873680|NCT04073186|471167466|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
130873681|NCT04073186|471167466|FG000|Second Wearing Cycle|Adverse Event|1|||
130873682|NCT00473434|471167467|FG000|Overall Study|Physician Decision|3|||
130873683|NCT00473434|471167467|FG000|Overall Study|Withdrawal by Subject|9|||
130873684|NCT00473434|471167467|FG000|Overall Study|Compliance|3|||
130873685|NCT00473434|471167467|FG000|Overall Study|Lack of Efficacy|3|||
130873686|NCT00473434|471167467|FG000|Overall Study|Adverse Event|3|||
130873687|NCT00473434|471167467|FG000|Overall Study|Patient was selling medication to others|1|||
130873688|NCT00473434|471167467|FG000|Overall Study|Safety evaluation|1|||
130873689|NCT00473434|471167467|FG000|Overall Study|Reason not specified|6|||
130873690|NCT00473434|471167467|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
130873691|NCT00473434|471167467|FG000|Overall Study|Switching to trial medication|1|||
130873692|NCT00473434|471167467|FG000|Overall Study|No longer required|1|||
130873693|NCT02356159|471167470|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130873694|NCT02356159|471167471|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130873695|NCT02356159|471167472|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130873696|NCT02356159|471167473|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130873697|NCT02356159|471167474|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130873698|NCT02356159|471167475|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
130873699|NCT00667628|471167476|FG000|Overall Study|Lost to Follow-up|1|||
130873700|NCT00667628|471167477|FG001|Overall Study|Lost to Follow-up|0|||
130873701|NCT00667628|471167476|FG000|Overall Study|Death|6|||
130873702|NCT00667628|471167477|FG001|Overall Study|Death|6|||
130873703|NCT00667628|471167476|FG000|Overall Study|Investigator Considers in Best Interest|1|||
130873704|NCT00667628|471167477|FG001|Overall Study|Investigator Considers in Best Interest|0|||
130873705|NCT00667628|471167476|FG000|Overall Study|Sponsor Terminated Study|17|||
130873706|NCT00667628|471167477|FG001|Overall Study|Sponsor Terminated Study|21|||
130873707|NCT00743249|471167480|FG000|Overall Study|Adverse Event|0|||
130873708|NCT00743249|471167481|FG001|Overall Study|Adverse Event|4|||
130873709|NCT00743249|471167480|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
130873710|NCT00743249|471167481|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
130873711|NCT00743249|471167480|FG000|Overall Study|Unsuccessful insertion of stent|2|||
130873712|NCT00743249|471167481|FG001|Overall Study|Unsuccessful insertion of stent|1|||
130873713|NCT02653326|471167482|FG000|Overall Study|Lost to Follow-up|10|||
130873714|NCT02653326|471167483|FG001|Overall Study|Lost to Follow-up|7|||
130873715|NCT05767021|471167484|FG000|Overall Study|Adverse Event|2|||
130873716|NCT05767021|471167484|FG000|Overall Study|Protocol Deviation|1|||
130873717|NCT05767021|471167484|FG000|Overall Study|Withdrawal by Subject|1|||
130873718|NCT05767021|471167484|FG000|Overall Study|Physician Decision|1|||
130873719|NCT05767021|471167484|FG000|Overall Study|Lack of Efficacy|11|||
130873720|NCT05767021|471167484|FG000|Overall Study|Assigned Treatment by Mistake|1|||
130873721|NCT01239381|471167486|FG000|Overall Study|Protocol Violation|1|||
130873722|NCT01239381|471167486|FG000|Overall Study|Withdrawal by Subject|1|||
130873723|NCT02738008|471167487|FG000|Overall Study|Study Terminated by Sponsor|1|||
130873724|NCT02738008|471167488|FG001|Overall Study|Study Terminated by Sponsor|5|||
130873725|NCT02738008|471167489|FG002|Overall Study|Study Terminated by Sponsor|3|||
130873726|NCT02738008|471167487|FG000|Overall Study|Adverse Event|0|||
130873727|NCT02738008|471167488|FG001|Overall Study|Adverse Event|1|||
130873728|NCT02738008|471167489|FG002|Overall Study|Adverse Event|2|||
130873729|NCT04621448|471167490|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
130873730|NCT04621448|471167491|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
130873731|NCT04621448|471167492|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
130873732|NCT04621448|471167493|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
130873733|NCT04621448|471167490|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
130873734|NCT04621448|471167491|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
130873735|NCT04621448|471167492|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
130873736|NCT04621448|471167493|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
130873737|NCT04621448|471167490|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
130873738|NCT04621448|471167491|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
130873739|NCT04621448|471167492|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
130873740|NCT04621448|471167493|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
130873741|NCT04621448|471167490|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
130873742|NCT04621448|471167491|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
130873743|NCT04621448|471167492|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
130873744|NCT04621448|471167493|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
130873745|NCT03550378|471167494|FG000|Overall Study|Death|0|||
130873746|NCT03550378|471167495|FG001|Overall Study|Death|1|||
130873747|NCT04590014|471167498|FG000|Overall Study|Withdrawal by Subject|1|||
130873748|NCT04590014|471167499|FG001|Overall Study|Withdrawal by Subject|0|||
130873749|NCT00468299|471167500|FG000|Overall Study|Withdrawal by Subject|0|||
130873750|NCT00468299|471167501|FG001|Overall Study|Withdrawal by Subject|1|||
130873751|NCT04908397|471167504|FG000|Overall Study|Withdrawal by Subject|2|||
130873752|NCT04264442|471167505|FG000|Overall Study|Lack of Efficacy|6|||
130873753|NCT04264442|471167505|FG000|Overall Study|Lost to Follow-up|2|||
130873754|NCT04264442|471167505|FG000|Overall Study|Sponsor Decision|23|||
130873755|NCT04264442|471167505|FG000|Overall Study|Withdrawal by Subject|11|||
130873756|NCT04264442|471167505|FG000|Overall Study|Study Termination|5|||
130873757|NCT01384734|471167507|FG000|Overall Study|Adverse Event|0|||
130873758|NCT01384734|471167508|FG001|Overall Study|Adverse Event|3|||
130873759|NCT01384734|471167509|FG002|Overall Study|Adverse Event|0|||
130873760|NCT01384734|471167510|FG003|Overall Study|Adverse Event|2|||
130873761|NCT01384734|471167511|FG004|Overall Study|Adverse Event|7|||
130873762|NCT01384734|471167507|FG000|Overall Study|Death|1|||
130873763|NCT01384734|471167508|FG001|Overall Study|Death|0|||
130873764|NCT01384734|471167509|FG002|Overall Study|Death|1|||
130873765|NCT01384734|471167510|FG003|Overall Study|Death|0|||
130873766|NCT01384734|471167511|FG004|Overall Study|Death|0|||
130873767|NCT01384734|471167507|FG000|Overall Study|Continuation criteria not met|0|||
130873768|NCT01384734|471167508|FG001|Overall Study|Continuation criteria not met|0|||
130873769|NCT01384734|471167509|FG002|Overall Study|Continuation criteria not met|1|||
130873770|NCT01384734|471167510|FG003|Overall Study|Continuation criteria not met|1|||
130873771|NCT01384734|471167511|FG004|Overall Study|Continuation criteria not met|0|||
130873772|NCT01384734|471167507|FG000|Overall Study|Lack of Efficacy|3|||
130873773|NCT01384734|471167508|FG001|Overall Study|Lack of Efficacy|7|||
130873774|NCT01384734|471167509|FG002|Overall Study|Lack of Efficacy|4|||
130873775|NCT01384734|471167510|FG003|Overall Study|Lack of Efficacy|4|||
130873776|NCT01384734|471167511|FG004|Overall Study|Lack of Efficacy|2|||
130873777|NCT01384734|471167507|FG000|Overall Study|Lost to Follow-up|5|||
130873778|NCT01384734|471167508|FG001|Overall Study|Lost to Follow-up|3|||
130873779|NCT01384734|471167509|FG002|Overall Study|Lost to Follow-up|3|||
130873780|NCT01384734|471167510|FG003|Overall Study|Lost to Follow-up|8|||
130873781|NCT01384734|471167511|FG004|Overall Study|Lost to Follow-up|5|||
130873782|NCT01384734|471167507|FG000|Overall Study|Non-compliance with study drug|1|||
130873783|NCT01384734|471167508|FG001|Overall Study|Non-compliance with study drug|2|||
130873784|NCT01384734|471167509|FG002|Overall Study|Non-compliance with study drug|6|||
130873785|NCT01384734|471167510|FG003|Overall Study|Non-compliance with study drug|0|||
130873786|NCT01384734|471167511|FG004|Overall Study|Non-compliance with study drug|2|||
130873787|NCT01384734|471167507|FG000|Overall Study|Pregnancy|0|||
130873788|NCT01384734|471167508|FG001|Overall Study|Pregnancy|1|||
130873789|NCT01384734|471167509|FG002|Overall Study|Pregnancy|0|||
130873790|NCT01384734|471167510|FG003|Overall Study|Pregnancy|0|||
130873791|NCT01384734|471167511|FG004|Overall Study|Pregnancy|1|||
130873792|NCT01384734|471167507|FG000|Overall Study|Sponsor terminated|0|||
130873793|NCT01384734|471167508|FG001|Overall Study|Sponsor terminated|0|||
130873794|NCT01384734|471167509|FG002|Overall Study|Sponsor terminated|0|||
130873795|NCT01384734|471167510|FG003|Overall Study|Sponsor terminated|0|||
130873796|NCT01384734|471167511|FG004|Overall Study|Sponsor terminated|1|||
130873797|NCT01384734|471167507|FG000|Overall Study|Withdrawal by Subject|5|||
130873798|NCT01384734|471167508|FG001|Overall Study|Withdrawal by Subject|5|||
130873799|NCT01384734|471167509|FG002|Overall Study|Withdrawal by Subject|6|||
130873800|NCT01384734|471167510|FG003|Overall Study|Withdrawal by Subject|7|||
130873801|NCT01384734|471167511|FG004|Overall Study|Withdrawal by Subject|9|||
130873802|NCT01384734|471167507|FG000|Overall Study|Investigator relocating|0|||
130873803|NCT01384734|471167508|FG001|Overall Study|Investigator relocating|2|||
130873804|NCT01384734|471167509|FG002|Overall Study|Investigator relocating|0|||
130873805|NCT01384734|471167510|FG003|Overall Study|Investigator relocating|3|||
130873806|NCT01384734|471167511|FG004|Overall Study|Investigator relocating|1|||
130873807|NCT01384734|471167507|FG000|Overall Study|Unable to come back for visit|1|||
130873808|NCT01384734|471167508|FG001|Overall Study|Unable to come back for visit|0|||
130873809|NCT01384734|471167509|FG002|Overall Study|Unable to come back for visit|1|||
130873810|NCT01384734|471167510|FG003|Overall Study|Unable to come back for visit|1|||
130873811|NCT01384734|471167511|FG004|Overall Study|Unable to come back for visit|0|||
130873812|NCT01384734|471167507|FG000|Overall Study|Prison|0|||
130873813|NCT01384734|471167508|FG001|Overall Study|Prison|0|||
130873814|NCT01384734|471167509|FG002|Overall Study|Prison|1|||
130873815|NCT01384734|471167510|FG003|Overall Study|Prison|0|||
130873816|NCT01384734|471167511|FG004|Overall Study|Prison|0|||
130873817|NCT01384734|471167507|FG000|Overall Study|As per Exclusion criteria|0|||
130873818|NCT01384734|471167508|FG001|Overall Study|As per Exclusion criteria|1|||
130873819|NCT01384734|471167509|FG002|Overall Study|As per Exclusion criteria|0|||
130873820|NCT01384734|471167510|FG003|Overall Study|As per Exclusion criteria|0|||
130873821|NCT01384734|471167511|FG004|Overall Study|As per Exclusion criteria|0|||
130873822|NCT01384734|471167507|FG000|Overall Study|Missed End of treatment visit|0|||
130873823|NCT01384734|471167508|FG001|Overall Study|Missed End of treatment visit|0|||
130873824|NCT01384734|471167509|FG002|Overall Study|Missed End of treatment visit|0|||
130873825|NCT01384734|471167510|FG003|Overall Study|Missed End of treatment visit|1|||
130873826|NCT01384734|471167511|FG004|Overall Study|Missed End of treatment visit|0|||
130873827|NCT01384734|471167507|FG000|Overall Study|Adhesion problem|0|||
130873828|NCT01384734|471167508|FG001|Overall Study|Adhesion problem|0|||
130873829|NCT01384734|471167509|FG002|Overall Study|Adhesion problem|0|||
130873830|NCT01384734|471167510|FG003|Overall Study|Adhesion problem|1|||
130873831|NCT01384734|471167511|FG004|Overall Study|Adhesion problem|0|||
130873832|NCT01384734|471167507|FG000|Overall Study|Early termination|0|||
130873833|NCT01384734|471167508|FG001|Overall Study|Early termination|0|||
130873834|NCT01384734|471167509|FG002|Overall Study|Early termination|0|||
130873835|NCT01384734|471167510|FG003|Overall Study|Early termination|0|||
130873836|NCT01384734|471167511|FG004|Overall Study|Early termination|1|||
130873837|NCT01384734|471167507|FG000|Overall Study|Physician Decision|1|||
130873838|NCT01384734|471167508|FG001|Overall Study|Physician Decision|0|||
130873839|NCT01384734|471167509|FG002|Overall Study|Physician Decision|0|||
130873840|NCT01384734|471167510|FG003|Overall Study|Physician Decision|0|||
130873841|NCT01384734|471167511|FG004|Overall Study|Physician Decision|0|||
130873842|NCT01290523|471167512|FG000|Overall Study|Death|3|||
130873843|NCT03071263|471167513|FG000|Overall Study|Adverse Event|1|||
130873844|NCT03071263|471167514|FG001|Overall Study|Adverse Event|3|||
130873845|NCT03071263|471167513|FG000|Overall Study|Withdrawal by Subject|1|||
130873846|NCT03071263|471167514|FG001|Overall Study|Withdrawal by Subject|3|||
130873847|NCT03071263|471167513|FG000|Overall Study|Physician Decision|1|||
130873848|NCT03071263|471167514|FG001|Overall Study|Physician Decision|0|||
130873849|NCT03071263|471167513|FG000|Overall Study|Participant moved to another city|0|||
130873850|NCT03071263|471167514|FG001|Overall Study|Participant moved to another city|1|||
130873851|NCT00152503|471167517|FG000|Overall Study|Adverse Event|4|||
130873852|NCT01300234|471167518|FG000|Overall Study|Adverse Event|1|||
130873853|NCT01300234|471167519|FG001|Overall Study|Adverse Event|1|||
130873854|NCT01300234|471167518|FG000|Overall Study|Protocol Violation|2|||
130873855|NCT01300234|471167519|FG001|Overall Study|Protocol Violation|3|||
130873856|NCT01300234|471167518|FG000|Overall Study|Withdrawal by Subject|5|||
130873857|NCT01300234|471167519|FG001|Overall Study|Withdrawal by Subject|9|||
130873858|NCT01300234|471167518|FG000|Overall Study|Lost to Follow-up|14|||
130873859|NCT01300234|471167519|FG001|Overall Study|Lost to Follow-up|12|||
130873860|NCT01300234|471167518|FG000|Overall Study|Pregnancy|2|||
130873861|NCT01300234|471167519|FG001|Overall Study|Pregnancy|1|||
130873862|NCT01300234|471167518|FG000|Overall Study|Participant reached stopping critera|2|||
130873863|NCT01300234|471167519|FG001|Overall Study|Participant reached stopping critera|0|||
130873864|NCT01300234|471167518|FG000|Overall Study|Participant stopped medication|1|||
130873865|NCT01300234|471167519|FG001|Overall Study|Participant stopped medication|1|||
130873866|NCT01300234|471167518|FG000|Overall Study|Participant refused return to hospital|1|||
130873867|NCT01300234|471167519|FG001|Overall Study|Participant refused return to hospital|0|||
130873868|NCT00550407|471167521|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
130873869|NCT00550407|471167522|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
130873870|NCT00550407|471167523|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
130873871|NCT00550407|471167521|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
130873872|NCT00550407|471167522|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
130873873|NCT00550407|471167523|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
130873874|NCT00550407|471167521|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
130873875|NCT00550407|471167522|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
130873876|NCT00550407|471167523|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
130873877|NCT00550407|471167521|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
130873878|NCT00550407|471167522|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
130873879|NCT00550407|471167523|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
130873880|NCT00550407|471167521|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
130873881|NCT00550407|471167522|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
130873882|NCT00550407|471167523|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
130873883|NCT00550407|471167521|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
130873884|NCT00550407|471167522|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
130873885|NCT00550407|471167523|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
130873886|NCT00550407|471167521|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
130873887|NCT00550407|471167522|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
130873888|NCT00550407|471167523|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
130873889|NCT00550407|471167521|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
130873890|NCT00550407|471167522|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
130873891|NCT00550407|471167523|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
130873892|NCT00550407|471167521|FG000|26-Week Randomized Phase|Adverse Event|0|||
130873893|NCT00550407|471167522|FG001|26-Week Randomized Phase|Adverse Event|5|||
130873894|NCT00550407|471167523|FG002|26-Week Randomized Phase|Adverse Event|2|||
130873895|NCT00550407|471167521|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
130873896|NCT00550407|471167522|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
130873897|NCT00550407|471167523|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
130873898|NCT00550407|471167521|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
130873899|NCT00550407|471167522|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
130873900|NCT00550407|471167523|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
130873901|NCT00550407|471167521|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
130873902|NCT00550407|471167522|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
130873903|NCT00550407|471167523|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
130873904|NCT00584415|471167524|FG000|Overall Study|Adverse Event|7|||
130873905|NCT05051579|471167525|FG000|Overall Study|Withdrawal by Subject|3|||
130873906|NCT05051579|471167526|FG001|Overall Study|Withdrawal by Subject|5|||
130873907|NCT05051579|471167527|FG002|Overall Study|Withdrawal by Subject|2|||
130873908|NCT05051579|471167528|FG003|Overall Study|Withdrawal by Subject|1|||
130873909|NCT05051579|471167529|FG004|Overall Study|Withdrawal by Subject|4|||
130873910|NCT05051579|471167530|FG005|Overall Study|Withdrawal by Subject|0|||
130873911|NCT05051579|471167531|FG006|Overall Study|Withdrawal by Subject|4|||
130873912|NCT05051579|471167525|FG000|Overall Study|Lost to Follow-up|1|||
130873913|NCT05051579|471167526|FG001|Overall Study|Lost to Follow-up|0|||
130873914|NCT05051579|471167527|FG002|Overall Study|Lost to Follow-up|0|||
130873915|NCT05051579|471167528|FG003|Overall Study|Lost to Follow-up|0|||
130873916|NCT05051579|471167529|FG004|Overall Study|Lost to Follow-up|1|||
130873917|NCT05051579|471167530|FG005|Overall Study|Lost to Follow-up|0|||
130873918|NCT05051579|471167531|FG006|Overall Study|Lost to Follow-up|1|||
130873919|NCT05051579|471167525|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130873920|NCT05051579|471167526|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130873921|NCT05051579|471167527|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130873922|NCT05051579|471167528|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130873923|NCT05051579|471167529|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130873924|NCT05051579|471167530|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130873925|NCT05051579|471167531|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
130873926|NCT05051579|471167525|FG000|Overall Study|Adverse Event|2|||
130873927|NCT05051579|471167526|FG001|Overall Study|Adverse Event|1|||
130873928|NCT05051579|471167527|FG002|Overall Study|Adverse Event|0|||
130873929|NCT05051579|471167528|FG003|Overall Study|Adverse Event|4|||
130873930|NCT05051579|471167529|FG004|Overall Study|Adverse Event|1|||
130873931|NCT05051579|471167530|FG005|Overall Study|Adverse Event|2|||
130873932|NCT05051579|471167531|FG006|Overall Study|Adverse Event|0|||
130873933|NCT05051579|471167525|FG000|Overall Study|Inadvertent Enrollment|0|||
130873934|NCT05051579|471167526|FG001|Overall Study|Inadvertent Enrollment|0|||
130873935|NCT05051579|471167527|FG002|Overall Study|Inadvertent Enrollment|0|||
130873936|NCT05051579|471167528|FG003|Overall Study|Inadvertent Enrollment|0|||
130873937|NCT05051579|471167529|FG004|Overall Study|Inadvertent Enrollment|0|||
130873938|NCT05051579|471167530|FG005|Overall Study|Inadvertent Enrollment|0|||
130873939|NCT05051579|471167531|FG006|Overall Study|Inadvertent Enrollment|1|||
130873940|NCT05051579|471167525|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130873941|NCT05051579|471167526|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
130873942|NCT05051579|471167527|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130873943|NCT05051579|471167528|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130873944|NCT05051579|471167529|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130873945|NCT05051579|471167530|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130873946|NCT05051579|471167531|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130873947|NCT05051579|471167525|FG000|Overall Study|Sponsor Decision|0|||
130873948|NCT05051579|471167526|FG001|Overall Study|Sponsor Decision|0|||
130873949|NCT05051579|471167527|FG002|Overall Study|Sponsor Decision|0|||
130873950|NCT05051579|471167528|FG003|Overall Study|Sponsor Decision|0|||
130873951|NCT05051579|471167529|FG004|Overall Study|Sponsor Decision|1|||
130873952|NCT05051579|471167530|FG005|Overall Study|Sponsor Decision|0|||
130873953|NCT05051579|471167531|FG006|Overall Study|Sponsor Decision|0|||
130873954|NCT05051579|471167525|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130873955|NCT05051579|471167526|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130873956|NCT05051579|471167527|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130873957|NCT05051579|471167528|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130873958|NCT05051579|471167529|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
130873959|NCT05051579|471167530|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130873960|NCT05051579|471167531|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130873961|NCT00717249|471167532|FG000|Overall Study|Lens Discomfort|4|||
130873962|NCT00717249|471167533|FG001|Overall Study|Lens Discomfort|1|||
130873963|NCT00717249|471167532|FG000|Overall Study|Unsatisfactory visual Response|0|||
130873964|NCT00717249|471167533|FG001|Overall Study|Unsatisfactory visual Response|2|||
130873965|NCT00717249|471167532|FG000|Overall Study|Adverse Event|4|||
130873966|NCT00717249|471167533|FG001|Overall Study|Adverse Event|2|||
130873967|NCT00717249|471167532|FG000|Overall Study|Lost to Follow-up|2|||
130873968|NCT00717249|471167533|FG001|Overall Study|Lost to Follow-up|0|||
130873969|NCT00717249|471167532|FG000|Overall Study|Withdrawal by Subject|1|||
130873970|NCT00717249|471167533|FG001|Overall Study|Withdrawal by Subject|2|||
130873971|NCT00717249|471167532|FG000|Overall Study|Pregnancy|6|||
130873972|NCT00717249|471167533|FG001|Overall Study|Pregnancy|3|||
130873973|NCT00717249|471167532|FG000|Overall Study|Protocol Violation|0|||
130873974|NCT00717249|471167533|FG001|Overall Study|Protocol Violation|2|||
130873975|NCT00717249|471167532|FG000|Overall Study|Subject became Ineligible|1|||
130873976|NCT00717249|471167533|FG001|Overall Study|Subject became Ineligible|1|||
130873977|NCT00717249|471167532|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
130873978|NCT00717249|471167533|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
130873979|NCT00717249|471167532|FG000|Overall Study|Gastric Surgery|0|||
130873980|NCT00717249|471167533|FG001|Overall Study|Gastric Surgery|1|||
130873981|NCT00717249|471167532|FG000|Overall Study|Diagnosed with Diabetes|1|||
130873982|NCT00717249|471167533|FG001|Overall Study|Diagnosed with Diabetes|0|||
130873983|NCT00717249|471167532|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
130873984|NCT00717249|471167533|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
130873985|NCT00717249|471167532|FG000|Overall Study|Subject relocated|1|||
130873986|NCT00717249|471167533|FG001|Overall Study|Subject relocated|0|||
130873987|NCT00717249|471167532|FG000|Overall Study|Headaches|1|||
130873988|NCT00717249|471167533|FG001|Overall Study|Headaches|0|||
130873989|NCT00360412|471167534|FG000|Overall Study|Adverse Event|37|||
130873990|NCT00360412|471167535|FG001|Overall Study|Adverse Event|65|||
130873991|NCT00360412|471167534|FG000|Overall Study|Protocol Violation|2|||
130873992|NCT00360412|471167535|FG001|Overall Study|Protocol Violation|5|||
130873993|NCT00360412|471167534|FG000|Overall Study|Patient withdrew consent|27|||
130873994|NCT00360412|471167535|FG001|Overall Study|Patient withdrew consent|52|||
130873995|NCT00360412|471167534|FG000|Overall Study|Lack of therapeutic efficacy|46|||
130873996|NCT00360412|471167535|FG001|Overall Study|Lack of therapeutic efficacy|61|||
130873997|NCT00360412|471167534|FG000|Overall Study|Physician Decision|2|||
130873998|NCT00360412|471167535|FG001|Overall Study|Physician Decision|4|||
130873999|NCT00360412|471167534|FG000|Overall Study|Other|5|||
130874000|NCT00360412|471167535|FG001|Overall Study|Other|6|||
130874001|NCT00360412|471167534|FG000|Overall Study|Study termination by Sponsor|214|||
130874002|NCT00360412|471167535|FG001|Overall Study|Study termination by Sponsor|469|||
130874003|NCT01116648|471167539|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
130874004|NCT01116648|471167540|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
130874005|NCT01116648|471167541|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
130874006|NCT01116648|471167542|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
130874007|NCT01116648|471167543|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
130874008|NCT01116648|471167544|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
130874009|NCT01116648|471167545|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
130874010|NCT01116648|471167546|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
130874011|NCT01116648|471167547|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
130874012|NCT01116648|471167548|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
130874013|NCT01116648|471167549|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
130874014|NCT01116648|471167550|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
130874015|NCT01116648|471167551|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
130874016|NCT01116648|471167552|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
130874017|NCT01116648|471167553|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
130874018|NCT00410956|471167554|FG000|Overall Study|Adverse Event|1|||
130874019|NCT00410956|471167554|FG000|Overall Study|Death|2|||
130874020|NCT00410956|471167554|FG000|Overall Study|Lack of Efficacy|10|||
130874021|NCT00410956|471167554|FG000|Overall Study|Physician Decision|6|||
130874022|NCT03100149|471167555|FG000|Overall Study|Adverse Event|0|||
130874023|NCT03100149|471167556|FG001|Overall Study|Adverse Event|1|||
130874024|NCT03100149|471167557|FG002|Overall Study|Adverse Event|0|||
130874025|NCT03100149|471167555|FG000|Overall Study|Participant Moved out of Country|0|||
130874026|NCT03100149|471167556|FG001|Overall Study|Participant Moved out of Country|0|||
130874027|NCT03100149|471167557|FG002|Overall Study|Participant Moved out of Country|1|||
130874028|NCT03100149|471167555|FG000|Overall Study|Withdrawal by Subject|0|||
130874029|NCT03100149|471167556|FG001|Overall Study|Withdrawal by Subject|3|||
130874030|NCT03100149|471167557|FG002|Overall Study|Withdrawal by Subject|1|||
130874031|NCT00966654|471168543|FG000|Overall Study|Study was terminated,PI left institution|12|||
130874032|NCT01631435|471168548|FG000|Overall Study|Adverse Event|2|||
130874033|NCT01631435|471168548|FG000|Overall Study|Withdrawal by Subject|2|||
130874034|NCT01631435|471168548|FG000|Overall Study|incomplete study procedure|5|||
130874035|NCT01005251|471168552|FG000|Overall Study|Withdrawal by Subject|2|||
130874036|NCT01005251|471168553|FG001|Overall Study|Withdrawal by Subject|5|||
130874037|NCT01005251|471168554|FG002|Overall Study|Withdrawal by Subject|3|||
130874038|NCT01005251|471168555|FG003|Overall Study|Withdrawal by Subject|4|||
130874039|NCT01005251|471168556|FG004|Overall Study|Withdrawal by Subject|9|||
130874040|NCT01005251|471168552|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
130874041|NCT01005251|471168553|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130874042|NCT01005251|471168554|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
130874043|NCT01005251|471168555|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130874044|NCT01005251|471168556|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130874045|NCT01005251|471168552|FG000|Overall Study|Adverse Event|2|||
130874046|NCT01005251|471168553|FG001|Overall Study|Adverse Event|6|||
130874047|NCT01005251|471168554|FG002|Overall Study|Adverse Event|8|||
130874048|NCT01005251|471168555|FG003|Overall Study|Adverse Event|5|||
130874049|NCT01005251|471168556|FG004|Overall Study|Adverse Event|4|||
130874050|NCT01005251|471168552|FG000|Overall Study|Protocol Violation|1|||
130874051|NCT01005251|471168553|FG001|Overall Study|Protocol Violation|0|||
130874052|NCT01005251|471168554|FG002|Overall Study|Protocol Violation|0|||
130874053|NCT01005251|471168555|FG003|Overall Study|Protocol Violation|0|||
130874054|NCT01005251|471168556|FG004|Overall Study|Protocol Violation|2|||
130874055|NCT01005251|471168552|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
130874056|NCT01005251|471168553|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
130874057|NCT01005251|471168554|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
130874058|NCT01005251|471168555|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
130874059|NCT01005251|471168556|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
130874060|NCT01005251|471168552|FG000|Overall Study|Lost to Follow-up|1|||
130874061|NCT01005251|471168553|FG001|Overall Study|Lost to Follow-up|4|||
130874062|NCT01005251|471168554|FG002|Overall Study|Lost to Follow-up|2|||
130874063|NCT01005251|471168555|FG003|Overall Study|Lost to Follow-up|0|||
130874064|NCT01005251|471168556|FG004|Overall Study|Lost to Follow-up|0|||
130874065|NCT01005251|471168552|FG000|Overall Study|Physician Decision|0|||
130874066|NCT01005251|471168553|FG001|Overall Study|Physician Decision|0|||
130874067|NCT01005251|471168554|FG002|Overall Study|Physician Decision|0|||
130874068|NCT01005251|471168555|FG003|Overall Study|Physician Decision|0|||
130874069|NCT01005251|471168556|FG004|Overall Study|Physician Decision|2|||
130874070|NCT01005251|471168552|FG000|Overall Study|Patient moved|1|||
130874071|NCT01005251|471168553|FG001|Overall Study|Patient moved|0|||
130874072|NCT01005251|471168554|FG002|Overall Study|Patient moved|0|||
130874073|NCT01005251|471168555|FG003|Overall Study|Patient moved|0|||
130874074|NCT01005251|471168556|FG004|Overall Study|Patient moved|0|||
130874075|NCT01005251|471168552|FG000|Overall Study|Wrong drug dispensed|0|||
130874076|NCT01005251|471168553|FG001|Overall Study|Wrong drug dispensed|1|||
130874077|NCT01005251|471168554|FG002|Overall Study|Wrong drug dispensed|0|||
130874078|NCT01005251|471168555|FG003|Overall Study|Wrong drug dispensed|0|||
130874079|NCT01005251|471168556|FG004|Overall Study|Wrong drug dispensed|0|||
130874080|NCT01005251|471168552|FG000|Overall Study|Randomized in error|0|||
130874081|NCT01005251|471168553|FG001|Overall Study|Randomized in error|0|||
130874082|NCT01005251|471168554|FG002|Overall Study|Randomized in error|1|||
130874083|NCT01005251|471168555|FG003|Overall Study|Randomized in error|1|||
130874084|NCT01005251|471168556|FG004|Overall Study|Randomized in error|0|||
130874085|NCT01005251|471168552|FG000|Overall Study|Lack of Efficacy|0|||
130874086|NCT01005251|471168553|FG001|Overall Study|Lack of Efficacy|0|||
130874087|NCT01005251|471168554|FG002|Overall Study|Lack of Efficacy|1|||
130874088|NCT01005251|471168555|FG003|Overall Study|Lack of Efficacy|1|||
130874089|NCT01005251|471168556|FG004|Overall Study|Lack of Efficacy|0|||
130874090|NCT01169103|471168563|FG000|Overall Study|Lost to Follow-up|3|||
130874091|NCT01169103|471168564|FG001|Overall Study|Lost to Follow-up|3|||
130874092|NCT01169103|471168563|FG000|Overall Study|Withdrawal by Subject|3|||
130874093|NCT01169103|471168564|FG001|Overall Study|Withdrawal by Subject|1|||
130874094|NCT00141453|471168565|FG000|Overall Study|Protocol Violation|6|||
130874095|NCT00141453|471168566|FG001|Overall Study|Protocol Violation|5|||
130874096|NCT02469623|471168571|FG000|Overall Study|Not consented for long-term follow-up|4|||
130874097|NCT02469623|471168571|FG000|Overall Study|Lost to Follow-up|4|||
130874098|NCT02469623|471168571|FG000|Overall Study|Withdrawal by Subject|2|||
130874099|NCT02469623|471168571|FG000|Overall Study|Death|3|||
130874100|NCT02763644|471168572|FG000|Overall Study|Patient/guardian decision|1|||
130874101|NCT02763644|471168573|FG001|Overall Study|Patient/guardian decision|0|||
130874102|NCT02763644|471168572|FG000|Overall Study|Death|1|||
130874103|NCT02763644|471168573|FG001|Overall Study|Death|1|||
130874104|NCT02763644|471168572|FG000|Overall Study|Adverse Event|1|||
130874105|NCT02763644|471168573|FG001|Overall Study|Adverse Event|1|||
130874106|NCT00861705|471168574|FG000|Overall Study|Never Began Treatment|7|||
130874107|NCT00861705|471168575|FG001|Overall Study|Never Began Treatment|3|||
130874108|NCT00861705|471168576|FG002|Overall Study|Never Began Treatment|0|||
130874109|NCT00861705|471168577|FG003|Overall Study|Never Began Treatment|1|||
130874110|NCT06418152|471168578|FG000|Overall Study|Frequent DBS setting changes|1|||
130874111|NCT06418152|471168578|FG000|Overall Study|Withdrawal by Subject|2|||
130874112|NCT03360682|471168579|FG000|Overall Study|Adverse Event|3|||
130874113|NCT01962441|471168580|FG000|Randomized Period|Randomized but Never Treated|4|||
130874114|NCT01962441|471168581|FG001|Randomized Period|Randomized but Never Treated|2|||
130874115|NCT01962441|471168582|FG002|Randomized Period|Randomized but Never Treated|3|||
130874116|NCT01962441|471168580|FG000|Randomized Period|Lost to Follow-up|2|||
130874117|NCT01962441|471168581|FG001|Randomized Period|Lost to Follow-up|4|||
130874118|NCT01962441|471168582|FG002|Randomized Period|Lost to Follow-up|4|||
130874119|NCT01962441|471168580|FG000|Randomized Period|Withdrew Consent|3|||
130874120|NCT01962441|471168581|FG001|Randomized Period|Withdrew Consent|3|||
130874121|NCT01962441|471168582|FG002|Randomized Period|Withdrew Consent|2|||
130874122|NCT01962441|471168580|FG000|Randomized Period|Adverse Event|1|||
130874123|NCT01962441|471168581|FG001|Randomized Period|Adverse Event|1|||
130874124|NCT01962441|471168582|FG002|Randomized Period|Adverse Event|0|||
130874125|NCT01962441|471168580|FG000|Randomized Period|Death|0|||
130874126|NCT01962441|471168581|FG001|Randomized Period|Death|0|||
130874127|NCT01962441|471168582|FG002|Randomized Period|Death|2|||
130874128|NCT01962441|471168580|FG000|Randomized Period|Protocol Violation|0|||
130874129|NCT01962441|471168581|FG001|Randomized Period|Protocol Violation|1|||
130874130|NCT01962441|471168582|FG002|Randomized Period|Protocol Violation|0|||
130874131|NCT01962441|471168580|FG000|Retreatment Substudy|Lack of Efficacy|1|||
130874132|NCT01962441|471168581|FG001|Retreatment Substudy|Lack of Efficacy|0|||
130874133|NCT01962441|471168582|FG002|Retreatment Substudy|Lack of Efficacy|0|||
130874134|NCT01962441|471168580|FG000|Retreatment Substudy|Lost to Follow-up|1|||
130874135|NCT01962441|471168581|FG001|Retreatment Substudy|Lost to Follow-up|0|||
130874136|NCT01962441|471168582|FG002|Retreatment Substudy|Lost to Follow-up|0|||
130874137|NCT02055898|471168583|FG000|First Intervention (5 Days)|Physician Decision|2|||
130874138|NCT02055898|471168584|FG001|First Intervention (5 Days)|Physician Decision|0|||
130874139|NCT02055898|471168583|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
130874140|NCT02055898|471168584|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
130874141|NCT01620060|471168587|FG000|Overall Study|Adverse Event|9|||
130874142|NCT01620060|471168587|FG000|Overall Study|Protocol Violation|1|||
130874143|NCT01620060|471168587|FG000|Overall Study|Withdrawal by Subject|1|||
130874144|NCT01620060|471168587|FG000|Overall Study|Did not comply with Study Produre|1|||
130874145|NCT01620060|471168587|FG000|Overall Study|Family emergency|1|||
130874146|NCT01620060|471168587|FG000|Overall Study|Per Sponsor Decision|2|||
130874147|NCT00231777|471168588|FG000|Overall Study|Lost to Follow-up|3|||
130874148|NCT00231777|471168589|FG001|Overall Study|Lost to Follow-up|0|||
130874149|NCT00231777|471168588|FG000|Overall Study|Other|3|||
130874150|NCT00231777|471168589|FG001|Overall Study|Other|2|||
130874151|NCT04551989|471168592|FG000|Overall Study|Adverse Event|4|||
130874152|NCT04551989|471168592|FG000|Overall Study|Protocol Violation|3|||
130874153|NCT04551989|471168592|FG000|Overall Study|Lost to Follow-up|1|||
130874154|NCT04551989|471168592|FG000|Overall Study|Physician Decision|3|||
130874155|NCT04698343|471168593|FG000|Overall Study|Withdrawal by Subject|6|||
130874156|NCT04698343|471168593|FG000|Overall Study|Physician Decision|2|||
130874157|NCT04698343|471168593|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
130874158|NCT04698343|471168593|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
130874159|NCT04698343|471168593|FG000|Overall Study|Personal reasons|3|||
130874160|NCT04698343|471168593|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
130874161|NCT00088530|471168594|FG000|Overall Study|Progressive/Relapsed Disease|28|||
130874162|NCT00088530|471168595|FG001|Overall Study|Progressive/Relapsed Disease|39|||
130874163|NCT00088530|471168594|FG000|Overall Study|Adverse Event|15|||
130874164|NCT00088530|471168595|FG001|Overall Study|Adverse Event|9|||
130874165|NCT00088530|471168594|FG000|Overall Study|Withdrawal by Subject|2|||
130874166|NCT00088530|471168595|FG001|Overall Study|Withdrawal by Subject|5|||
130874167|NCT00088530|471168594|FG000|Overall Study|Lost to Follow-up|2|||
130874168|NCT00088530|471168595|FG001|Overall Study|Lost to Follow-up|0|||
130874169|NCT00088530|471168594|FG000|Overall Study|Physician Decision|2|||
130874170|NCT00088530|471168595|FG001|Overall Study|Physician Decision|0|||
130874171|NCT00088530|471168594|FG000|Overall Study|Sponsor decision|0|||
130874172|NCT00088530|471168595|FG001|Overall Study|Sponsor decision|1|||
130874173|NCT00088530|471168594|FG000|Overall Study|Patient never treated|1|||
130874174|NCT00088530|471168595|FG001|Overall Study|Patient never treated|0|||
130874175|NCT00739401|471168596|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
130874176|NCT00739401|471168596|FG000|Overall Study|Death|3|||
130874177|NCT00739401|471168596|FG000|Overall Study|Withdrawal by Subject|4|||
130874178|NCT04678115|471168597|FG000|Overall Study|Lost to Follow-up|1|||
130874179|NCT04678115|471168598|FG001|Overall Study|Lost to Follow-up|0|||
130874180|NCT01787461|471168599|FG000|Overall Study|Adverse Event|4|||
130874181|NCT01787461|471168600|FG001|Overall Study|Adverse Event|3|||
130874182|NCT01787461|471168599|FG000|Overall Study|Lost to Follow-up|3|||
130874183|NCT01787461|471168600|FG001|Overall Study|Lost to Follow-up|2|||
130874184|NCT01787461|471168599|FG000|Overall Study|No longer met eligibility criteria|1|||
130874185|NCT01787461|471168600|FG001|Overall Study|No longer met eligibility criteria|0|||
130874186|NCT01787461|471168599|FG000|Overall Study|Withdrawal by Subject|3|||
130874187|NCT01787461|471168600|FG001|Overall Study|Withdrawal by Subject|4|||
130874188|NCT01787461|471168599|FG000|Overall Study|Protocol Violation|3|||
130874189|NCT01787461|471168600|FG001|Overall Study|Protocol Violation|0|||
130874190|NCT04879628|471168601|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
130874191|NCT04879628|471168602|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
130874192|NCT04879628|471168603|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
130874193|NCT04879628|471168604|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
130874194|NCT04879628|471168601|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130874195|NCT04879628|471168602|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130874196|NCT04879628|471168603|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
130874197|NCT04879628|471168604|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130874198|NCT04879628|471168601|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
130874199|NCT04879628|471168602|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
130874200|NCT04879628|471168603|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
130874201|NCT04879628|471168604|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
130874202|NCT04879628|471168601|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
130874203|NCT04879628|471168602|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
130874204|NCT04879628|471168603|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
130874205|NCT04879628|471168604|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
130874206|NCT03649074|471168605|FG000|Overall Study|Lost to Follow-up|2|||
130874207|NCT03649074|471168606|FG001|Overall Study|Lost to Follow-up|1|||
130874208|NCT03649074|471168605|FG000|Overall Study|Adverse Event|1|||
130874209|NCT03649074|471168606|FG001|Overall Study|Adverse Event|0|||
130874210|NCT03649074|471168605|FG000|Overall Study|Physician Decision|1|||
130874211|NCT03649074|471168606|FG001|Overall Study|Physician Decision|0|||
130874212|NCT03649074|471168605|FG000|Overall Study|Withdrawal by Subject|0|||
130874213|NCT03649074|471168606|FG001|Overall Study|Withdrawal by Subject|2|||
130874214|NCT03649074|471168605|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
130874215|NCT03649074|471168606|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
130874216|NCT03649074|471168605|FG000|Overall Study|Other|1|||
130874217|NCT03649074|471168606|FG001|Overall Study|Other|0|||
130874218|NCT00556894|471168607|FG000|Overall Study|Adverse Event|2|||
130874219|NCT00556894|471168608|FG001|Overall Study|Adverse Event|3|||
130874220|NCT00556894|471168609|FG002|Overall Study|Adverse Event|3|||
130874221|NCT00556894|471168607|FG000|Overall Study|Death|1|||
130874222|NCT00556894|471168608|FG001|Overall Study|Death|0|||
130874223|NCT00556894|471168609|FG002|Overall Study|Death|0|||
130874224|NCT00556894|471168607|FG000|Overall Study|regulatory decision in Bulgaria|10|||
130874225|NCT00556894|471168608|FG001|Overall Study|regulatory decision in Bulgaria|14|||
130874226|NCT00556894|471168609|FG002|Overall Study|regulatory decision in Bulgaria|13|||
130874227|NCT00556894|471168607|FG000|Overall Study|Change in therapy|2|||
130874228|NCT00556894|471168608|FG001|Overall Study|Change in therapy|1|||
130874229|NCT00556894|471168609|FG002|Overall Study|Change in therapy|2|||
130874230|NCT00556894|471168607|FG000|Overall Study|Withdrawal by Subject|1|||
130874231|NCT00556894|471168608|FG001|Overall Study|Withdrawal by Subject|1|||
130874232|NCT00556894|471168609|FG002|Overall Study|Withdrawal by Subject|1|||
130874233|NCT04612725|471168612|FG000|Overall Study|Adverse Event|1|||
130874234|NCT04612725|471168613|FG001|Overall Study|Adverse Event|3|||
130874235|NCT04612725|471168614|FG002|Overall Study|Adverse Event|1|||
130874236|NCT04612725|471168615|FG003|Overall Study|Adverse Event|0|||
130874237|NCT04612725|471168616|FG004|Overall Study|Adverse Event|1|||
130874238|NCT04612725|471168612|FG000|Overall Study|Lost to Follow-up|0|||
130874239|NCT04612725|471168613|FG001|Overall Study|Lost to Follow-up|1|||
130874240|NCT04612725|471168614|FG002|Overall Study|Lost to Follow-up|0|||
130874241|NCT04612725|471168615|FG003|Overall Study|Lost to Follow-up|0|||
130874242|NCT04612725|471168616|FG004|Overall Study|Lost to Follow-up|0|||
130874243|NCT04612725|471168612|FG000|Overall Study|Physician Decision|2|||
130874244|NCT04612725|471168613|FG001|Overall Study|Physician Decision|0|||
130874245|NCT04612725|471168614|FG002|Overall Study|Physician Decision|0|||
130874246|NCT04612725|471168615|FG003|Overall Study|Physician Decision|0|||
130874247|NCT04612725|471168616|FG004|Overall Study|Physician Decision|0|||
130874248|NCT04612725|471168612|FG000|Overall Study|Study terminated by sponsor|3|||
130874249|NCT04612725|471168613|FG001|Overall Study|Study terminated by sponsor|1|||
130874250|NCT04612725|471168614|FG002|Overall Study|Study terminated by sponsor|2|||
130874251|NCT04612725|471168615|FG003|Overall Study|Study terminated by sponsor|4|||
130874252|NCT04612725|471168616|FG004|Overall Study|Study terminated by sponsor|5|||
130874253|NCT04612725|471168612|FG000|Overall Study|Withdrawal by Subject|8|||
130874254|NCT04612725|471168613|FG001|Overall Study|Withdrawal by Subject|3|||
130874255|NCT04612725|471168614|FG002|Overall Study|Withdrawal by Subject|5|||
130874256|NCT04612725|471168615|FG003|Overall Study|Withdrawal by Subject|1|||
130874257|NCT04612725|471168616|FG004|Overall Study|Withdrawal by Subject|9|||
130874258|NCT04612725|471168612|FG000|Overall Study|Other|0|||
130874259|NCT04612725|471168613|FG001|Overall Study|Other|0|||
130874260|NCT04612725|471168614|FG002|Overall Study|Other|0|||
130874261|NCT04612725|471168615|FG003|Overall Study|Other|0|||
130874262|NCT04612725|471168616|FG004|Overall Study|Other|1|||
130874263|NCT04875195|471168617|FG000|Overall Study|Death|9|||
130874264|NCT04875195|471168618|FG001|Overall Study|Death|3|||
130874265|NCT04875195|471168617|FG000|Overall Study|Withdrawal by Subject|2|||
130874266|NCT04875195|471168618|FG001|Overall Study|Withdrawal by Subject|1|||
130874267|NCT04875195|471168617|FG000|Overall Study|Ongoing in study|49|||
130874268|NCT04875195|471168618|FG001|Overall Study|Ongoing in study|2|||
130874269|NCT05190120|471168619|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
130874270|NCT05190120|471168620|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
130874271|NCT05190120|471168621|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
130874272|NCT05190120|471168622|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
130874273|NCT05190120|471168619|FG000|Overall Study|Lost to Follow-up|5|||
130874274|NCT05190120|471168620|FG001|Overall Study|Lost to Follow-up|0|||
130874275|NCT05190120|471168621|FG002|Overall Study|Lost to Follow-up|2|||
130874276|NCT05190120|471168622|FG003|Overall Study|Lost to Follow-up|3|||
130874277|NCT02354235|471168623|FG000|Overall Study|Adverse Event|2|||
130874278|NCT02354235|471168624|FG001|Overall Study|Adverse Event|2|||
130874279|NCT02354235|471168623|FG000|Overall Study|Physician Decision|0|||
130874280|NCT02354235|471168624|FG001|Overall Study|Physician Decision|1|||
130874281|NCT02354235|471168623|FG000|Overall Study|Withdrawal by Subject|1|||
130874282|NCT02354235|471168624|FG001|Overall Study|Withdrawal by Subject|3|||
130874283|NCT02354235|471168623|FG000|Overall Study|Conflict with the stopping criteria|0|||
130874284|NCT02354235|471168624|FG001|Overall Study|Conflict with the stopping criteria|1|||
130874285|NCT03069352|471168625|FG000|Overall Study|Ongoing|12|||
130874286|NCT03069352|471168626|FG001|Overall Study|Ongoing|40|||
130874287|NCT02621424|471168627|FG000|Overall Study|Withdrawal by Subject|1|||
130874288|NCT02621424|471168628|FG001|Overall Study|Withdrawal by Subject|2|||
130874289|NCT04750642|471168631|FG000|Overall Study|Adverse Event|1|||
130874290|NCT04750642|471168632|FG001|Overall Study|Adverse Event|0|||
130874291|NCT04750642|471168631|FG000|Overall Study|Withdrawal by Subject|0|||
130874292|NCT04750642|471168632|FG001|Overall Study|Withdrawal by Subject|1|||
130874293|NCT04750642|471168631|FG000|Overall Study|Protocol Violation|0|||
130874294|NCT04750642|471168632|FG001|Overall Study|Protocol Violation|1|||
130874295|NCT04972162|471168633|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
130874296|NCT04972162|471168634|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
130874297|NCT01928927|471168635|FG000|Overall Study|Lost to Follow-up|1|||
130874298|NCT01928927|471168636|FG001|Overall Study|Lost to Follow-up|0|||
130874299|NCT01928927|471168635|FG000|Overall Study|Withdrawal by Subject|1|||
130874300|NCT01928927|471168636|FG001|Overall Study|Withdrawal by Subject|1|||
130874301|NCT00644423|471169911|FG000|Overall Study|Lost to Follow-up|1|||
130874302|NCT00644423|471169912|FG001|Overall Study|Lost to Follow-up|1|||
130874303|NCT01519323|471169917|FG000|Overall Study|Death|3|||
130874304|NCT01519323|471169918|FG001|Overall Study|Death|2|||
130874305|NCT01519323|471169917|FG000|Overall Study|Study terminated by sponsor|0|||
130874306|NCT01519323|471169918|FG001|Overall Study|Study terminated by sponsor|1|||
130874307|NCT00383552|471169929|FG000|Overall Study|Adverse Event|7|||
130874308|NCT00383552|471169930|FG001|Overall Study|Adverse Event|6|||
130874309|NCT00383552|471169931|FG002|Overall Study|Adverse Event|9|||
130874310|NCT00383552|471169932|FG003|Overall Study|Adverse Event|6|||
130874311|NCT00383552|471169929|FG000|Overall Study|Lack of Efficacy|4|||
130874312|NCT00383552|471169930|FG001|Overall Study|Lack of Efficacy|13|||
130874313|NCT00383552|471169931|FG002|Overall Study|Lack of Efficacy|29|||
130874314|NCT00383552|471169932|FG003|Overall Study|Lack of Efficacy|42|||
130874315|NCT00383552|471169929|FG000|Overall Study|Lost to Follow-up|0|||
130874316|NCT00383552|471169930|FG001|Overall Study|Lost to Follow-up|1|||
130874317|NCT00383552|471169931|FG002|Overall Study|Lost to Follow-up|5|||
130874318|NCT00383552|471169932|FG003|Overall Study|Lost to Follow-up|1|||
130874319|NCT00383552|471169929|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
130874320|NCT00383552|471169930|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
130874321|NCT00383552|471169931|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
130874322|NCT00383552|471169932|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
130874323|NCT00383552|471169929|FG000|Overall Study|Did not wish to continue (related)|1|||
130874324|NCT00383552|471169930|FG001|Overall Study|Did not wish to continue (related)|0|||
130874325|NCT00383552|471169931|FG002|Overall Study|Did not wish to continue (related)|2|||
130874326|NCT00383552|471169932|FG003|Overall Study|Did not wish to continue (related)|3|||
130874327|NCT00383552|471169929|FG000|Overall Study|Noncompliance with the protocol|11|||
130874328|NCT00383552|471169930|FG001|Overall Study|Noncompliance with the protocol|6|||
130874329|NCT00383552|471169931|FG002|Overall Study|Noncompliance with the protocol|8|||
130874330|NCT00383552|471169932|FG003|Overall Study|Noncompliance with the protocol|10|||
130874331|NCT00383552|471169929|FG000|Overall Study|Did not meet protocol eligibility|8|||
130874332|NCT00383552|471169930|FG001|Overall Study|Did not meet protocol eligibility|6|||
130874333|NCT00383552|471169931|FG002|Overall Study|Did not meet protocol eligibility|2|||
130874334|NCT00383552|471169932|FG003|Overall Study|Did not meet protocol eligibility|3|||
130874335|NCT00383552|471169929|FG000|Overall Study|Administrative|1|||
130874336|NCT00383552|471169930|FG001|Overall Study|Administrative|0|||
130874337|NCT00383552|471169931|FG002|Overall Study|Administrative|1|||
130874338|NCT00383552|471169932|FG003|Overall Study|Administrative|1|||
130874339|NCT03096834|471169933|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
130874340|NCT03096834|471169934|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
130874341|NCT03096834|471169935|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
130874342|NCT03096834|471169936|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
130874343|NCT03096834|471169933|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
130874344|NCT03096834|471169934|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
130874345|NCT03096834|471169935|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
130874346|NCT03096834|471169936|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
130874347|NCT03096834|471169933|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
130874348|NCT03096834|471169934|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
130874349|NCT03096834|471169935|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
130874350|NCT03096834|471169936|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
130874351|NCT03096834|471169933|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
130874352|NCT03096834|471169934|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
130874353|NCT03096834|471169935|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
130874354|NCT03096834|471169936|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
130874355|NCT03096834|471169933|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
130874356|NCT03096834|471169934|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
130874357|NCT03096834|471169935|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
130874358|NCT03096834|471169936|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
130874359|NCT03096834|471169933|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
130874360|NCT03096834|471169934|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
130874361|NCT03096834|471169935|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
130874362|NCT03096834|471169936|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
130874363|NCT03096834|471169933|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
130874364|NCT03096834|471169934|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
130874365|NCT03096834|471169935|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
130874366|NCT03096834|471169936|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
130874367|NCT03096834|471169933|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
130874368|NCT03096834|471169934|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
130874369|NCT03096834|471169935|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
130874370|NCT03096834|471169936|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
130874371|NCT03096834|471169933|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
130874372|NCT03096834|471169934|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
130874373|NCT03096834|471169935|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
130874374|NCT03096834|471169936|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
130874375|NCT03096834|471169933|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
130874376|NCT03096834|471169934|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
130874377|NCT03096834|471169935|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
130874378|NCT03096834|471169936|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
130874379|NCT03096834|471169933|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
130874380|NCT03096834|471169934|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
130874381|NCT03096834|471169935|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
130874382|NCT03096834|471169936|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
130874383|NCT03096834|471169933|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
130874384|NCT03096834|471169934|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
130874385|NCT03096834|471169935|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
130874386|NCT03096834|471169936|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
130874387|NCT04416204|471169937|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
130874388|NCT04416204|471169938|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
130874389|NCT04416204|471169939|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
130874390|NCT04416204|471169940|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
130874391|NCT04456504|471169941|FG000|Overall Study|Lost to Follow-up|2|||
130874392|NCT01131507|471169942|FG000|Overall Study|Adverse Event|1|||
130874393|NCT01131507|471169942|FG000|Overall Study|Lost to Follow-up|1|||
130874394|NCT01131507|471169942|FG000|Overall Study|Withdrawal by Subject|1|||
130874395|NCT01393158|471169951|FG000|Overall Study|Adverse Event|1|||
130874396|NCT01393158|471169952|FG001|Overall Study|Adverse Event|0|||
130874397|NCT00762359|471169953|FG000|Overall Study|Adverse Event|20|||
130874398|NCT00762359|471169954|FG001|Overall Study|Adverse Event|23|||
130874399|NCT00762359|471169953|FG000|Overall Study|Protocol Violation|21|||
130874400|NCT00762359|471169954|FG001|Overall Study|Protocol Violation|13|||
130874401|NCT00762359|471169953|FG000|Overall Study|Withdrawal by Subject|13|||
130874402|NCT00762359|471169954|FG001|Overall Study|Withdrawal by Subject|10|||
130874403|NCT00762359|471169953|FG000|Overall Study|Lack of Efficacy|0|||
130874404|NCT00762359|471169954|FG001|Overall Study|Lack of Efficacy|4|||
130874405|NCT00762359|471169953|FG000|Overall Study|Institution closed|2|||
130874406|NCT00762359|471169954|FG001|Overall Study|Institution closed|3|||
130874407|NCT00762359|471169953|FG000|Overall Study|Physician Decision|2|||
130874408|NCT00762359|471169954|FG001|Overall Study|Physician Decision|3|||
130874409|NCT00762359|471169953|FG000|Overall Study|Removal|0|||
130874410|NCT00762359|471169954|FG001|Overall Study|Removal|1|||
130874411|NCT00762359|471169953|FG000|Overall Study|Withdrew consent|1|||
130874412|NCT00762359|471169954|FG001|Overall Study|Withdrew consent|0|||
130874413|NCT01453049|471169955|FG000|Overall Study|Protocol Violation|2|||
130874414|NCT01453049|471169956|FG001|Overall Study|Protocol Violation|5|||
130874415|NCT01453049|471169955|FG000|Overall Study|Lost to Follow-up|2|||
130874416|NCT01453049|471169956|FG001|Overall Study|Lost to Follow-up|1|||
130874417|NCT01453049|471169955|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
130874418|NCT01453049|471169956|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
130874419|NCT01453049|471169955|FG000|Overall Study|Withdrawal by Subject|1|||
130874420|NCT01453049|471169956|FG001|Overall Study|Withdrawal by Subject|0|||
130874421|NCT01453049|471169955|FG000|Overall Study|Randomized in Error|1|||
130874422|NCT01453049|471169956|FG001|Overall Study|Randomized in Error|0|||
130874423|NCT00882440|471169957|FG000|Overall Study|Adverse Event|2|||
130874424|NCT00882440|471169958|FG001|Overall Study|Adverse Event|2|||
130874425|NCT00882440|471169959|FG002|Overall Study|Adverse Event|2|||
130874426|NCT00882440|471169960|FG003|Overall Study|Adverse Event|1|||
130874427|NCT00882440|471169961|FG004|Overall Study|Adverse Event|1|||
130874428|NCT00882440|471169962|FG005|Overall Study|Adverse Event|4|||
130874429|NCT00882440|471169963|FG006|Overall Study|Adverse Event|2|||
130874430|NCT00882440|471169957|FG000|Overall Study|Lack of Efficacy|3|||
130874431|NCT00882440|471169958|FG001|Overall Study|Lack of Efficacy|5|||
130874432|NCT00882440|471169959|FG002|Overall Study|Lack of Efficacy|2|||
130874433|NCT00882440|471169960|FG003|Overall Study|Lack of Efficacy|0|||
130874434|NCT00882440|471169961|FG004|Overall Study|Lack of Efficacy|0|||
130874435|NCT00882440|471169962|FG005|Overall Study|Lack of Efficacy|3|||
130874436|NCT00882440|471169963|FG006|Overall Study|Lack of Efficacy|0|||
130874437|NCT00882440|471169957|FG000|Overall Study|Lost to Follow-up|2|||
130874438|NCT00882440|471169958|FG001|Overall Study|Lost to Follow-up|0|||
130874439|NCT00882440|471169959|FG002|Overall Study|Lost to Follow-up|1|||
130874440|NCT00882440|471169960|FG003|Overall Study|Lost to Follow-up|1|||
130874441|NCT00882440|471169961|FG004|Overall Study|Lost to Follow-up|1|||
130874442|NCT00882440|471169962|FG005|Overall Study|Lost to Follow-up|0|||
130874443|NCT00882440|471169963|FG006|Overall Study|Lost to Follow-up|1|||
130874444|NCT00882440|471169957|FG000|Overall Study|Protocol Violation|0|||
130874445|NCT00882440|471169958|FG001|Overall Study|Protocol Violation|0|||
130874446|NCT00882440|471169959|FG002|Overall Study|Protocol Violation|1|||
130874447|NCT00882440|471169960|FG003|Overall Study|Protocol Violation|1|||
130874448|NCT00882440|471169961|FG004|Overall Study|Protocol Violation|1|||
130874449|NCT00882440|471169962|FG005|Overall Study|Protocol Violation|0|||
130874450|NCT00882440|471169963|FG006|Overall Study|Protocol Violation|0|||
130874451|NCT00882440|471169957|FG000|Overall Study|Withdrawal by Subject|2|||
130874452|NCT00882440|471169958|FG001|Overall Study|Withdrawal by Subject|1|||
130874453|NCT00882440|471169959|FG002|Overall Study|Withdrawal by Subject|1|||
130874454|NCT00882440|471169960|FG003|Overall Study|Withdrawal by Subject|0|||
130874455|NCT00882440|471169961|FG004|Overall Study|Withdrawal by Subject|6|||
130874456|NCT00882440|471169962|FG005|Overall Study|Withdrawal by Subject|0|||
130874457|NCT00882440|471169963|FG006|Overall Study|Withdrawal by Subject|1|||
130874458|NCT00882440|471169957|FG000|Overall Study|Patient Uncooperative|2|||
130874459|NCT00882440|471169958|FG001|Overall Study|Patient Uncooperative|0|||
130874460|NCT00882440|471169959|FG002|Overall Study|Patient Uncooperative|0|||
130874461|NCT00882440|471169960|FG003|Overall Study|Patient Uncooperative|0|||
130874462|NCT00882440|471169961|FG004|Overall Study|Patient Uncooperative|1|||
130874463|NCT00882440|471169962|FG005|Overall Study|Patient Uncooperative|0|||
130874464|NCT00882440|471169963|FG006|Overall Study|Patient Uncooperative|0|||
130874465|NCT05482308|471169967|FG000|Overall Study|Withdrawal by Subject|1|||
130874466|NCT05482308|471169968|FG001|Overall Study|Withdrawal by Subject|0|||
130874467|NCT05482308|471169967|FG000|Overall Study|No longer meets eligibility criteria|0|||
130874468|NCT05482308|471169968|FG001|Overall Study|No longer meets eligibility criteria|1|||
130874469|NCT01451723|471169970|FG000|Overall Study|study halted|6|||
130874470|NCT01451723|471169971|FG001|Overall Study|study halted|5|||
130874471|NCT00443040|471169974|FG000|Overall Study|Withdrawal by Subject|1|||
130874472|NCT00443040|471169975|FG001|Overall Study|Withdrawal by Subject|0|||
130874473|NCT00443040|471169976|FG002|Overall Study|Withdrawal by Subject|0|||
130874474|NCT00443040|471169974|FG000|Overall Study|Converted to an open laparotomy|3|||
130874475|NCT00443040|471169975|FG001|Overall Study|Converted to an open laparotomy|0|||
130874476|NCT00443040|471169976|FG002|Overall Study|Converted to an open laparotomy|1|||
130874477|NCT04245111|471169980|FG000|Overall Study|Lost to Follow-up|5|||
130874478|NCT04245111|471169981|FG001|Overall Study|Lost to Follow-up|1|||
130874479|NCT04245111|471169982|FG002|Overall Study|Lost to Follow-up|1|||
130874480|NCT04575155|471169985|FG000|2 Month|Withdrawal by Subject|1|||
130874481|NCT04575155|471169986|FG001|2 Month|Withdrawal by Subject|1|||
130874482|NCT04575155|471169985|FG000|2 Month|Lost to Follow-up|5|||
130874483|NCT04575155|471169986|FG001|2 Month|Lost to Follow-up|3|||
130874484|NCT04575155|471169985|FG000|2 Month|Ineligible|1|||
130874485|NCT04575155|471169986|FG001|2 Month|Ineligible|0|||
130874486|NCT00467740|471169987|FG000|Overall Study|Adverse Event|0|||
130874487|NCT00467740|471169988|FG001|Overall Study|Adverse Event|0|||
130874488|NCT00467740|471169989|FG002|Overall Study|Adverse Event|1|||
130874489|NCT00467740|471169990|FG003|Overall Study|Adverse Event|0|||
130874490|NCT00467740|471169991|FG004|Overall Study|Adverse Event|0|||
130874491|NCT00467740|471169987|FG000|Overall Study|Protocol Violation|0|||
130874492|NCT00467740|471169988|FG001|Overall Study|Protocol Violation|0|||
130874493|NCT00467740|471169989|FG002|Overall Study|Protocol Violation|1|||
130874494|NCT00467740|471169990|FG003|Overall Study|Protocol Violation|0|||
130874495|NCT00467740|471169991|FG004|Overall Study|Protocol Violation|0|||
130874496|NCT00467740|471169987|FG000|Overall Study|Lost to Follow-up|0|||
130874497|NCT00467740|471169988|FG001|Overall Study|Lost to Follow-up|1|||
130874498|NCT00467740|471169989|FG002|Overall Study|Lost to Follow-up|0|||
130874499|NCT00467740|471169990|FG003|Overall Study|Lost to Follow-up|0|||
130874500|NCT00467740|471169991|FG004|Overall Study|Lost to Follow-up|0|||
130874501|NCT00467740|471169987|FG000|Overall Study|Withdrawal by Subject|1|||
130874502|NCT00467740|471169988|FG001|Overall Study|Withdrawal by Subject|1|||
130874503|NCT00467740|471169989|FG002|Overall Study|Withdrawal by Subject|0|||
130874504|NCT00467740|471169990|FG003|Overall Study|Withdrawal by Subject|1|||
130874505|NCT00467740|471169991|FG004|Overall Study|Withdrawal by Subject|0|||
130874506|NCT00467740|471169987|FG000|Overall Study|Lack of Efficacy|0|||
130874507|NCT00467740|471169988|FG001|Overall Study|Lack of Efficacy|1|||
130874508|NCT00467740|471169989|FG002|Overall Study|Lack of Efficacy|0|||
130874509|NCT00467740|471169990|FG003|Overall Study|Lack of Efficacy|0|||
130874510|NCT00467740|471169991|FG004|Overall Study|Lack of Efficacy|0|||
130874511|NCT02903160|471169992|FG000|Overall Study|Adverse Event|2|||
130874512|NCT02903160|471169992|FG000|Overall Study|Death|1|||
130874513|NCT02903160|471169992|FG000|Overall Study|Lost to Follow-up|2|||
130874514|NCT02903160|471169992|FG000|Overall Study|Withdrawal by Subject|1|||
130874515|NCT02903160|471169992|FG000|Overall Study|Medical Insurance Barriers|1|||
130874516|NCT00730158|471169996|FG000|Overall Study|Withdrawal by Subject|1|||
130874517|NCT00730158|471169997|FG001|Overall Study|Withdrawal by Subject|1|||
130874518|NCT00844376|471169998|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
130874519|NCT00844376|471169999|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
130874520|NCT00660192|471170002|FG000|Overall Study|Lost to Follow-up|2|||
130874521|NCT00660192|471170003|FG001|Overall Study|Lost to Follow-up|3|||
130874522|NCT02734693|471170004|FG000|Overall Study|Adverse Event|1|||
130874523|NCT02734693|471170005|FG001|Overall Study|Adverse Event|3|||
130874524|NCT02734693|471170006|FG002|Overall Study|Adverse Event|3|||
130874525|NCT02734693|471170004|FG000|Overall Study|Lack of Efficacy|1|||
130874526|NCT02734693|471170005|FG001|Overall Study|Lack of Efficacy|0|||
130874527|NCT02734693|471170006|FG002|Overall Study|Lack of Efficacy|0|||
130874528|NCT02734693|471170004|FG000|Overall Study|Lost to Follow-up|2|||
130874529|NCT02734693|471170005|FG001|Overall Study|Lost to Follow-up|0|||
130874530|NCT02734693|471170006|FG002|Overall Study|Lost to Follow-up|0|||
130874531|NCT02734693|471170004|FG000|Overall Study|Protocol Violation|1|||
130874532|NCT02734693|471170005|FG001|Overall Study|Protocol Violation|0|||
130874533|NCT02734693|471170006|FG002|Overall Study|Protocol Violation|0|||
130874534|NCT02734693|471170004|FG000|Overall Study|Withdrawal by Subject|1|||
130874535|NCT02734693|471170005|FG001|Overall Study|Withdrawal by Subject|0|||
130874536|NCT02734693|471170006|FG002|Overall Study|Withdrawal by Subject|0|||
130874537|NCT00982735|471170007|FG000|Overall Study|Lost to Follow-up|6|||
130874538|NCT00982735|471170007|FG000|Overall Study|Patient ineligible for trial|224|||
130874539|NCT02898454|471170013|FG000|Overall Study|Adverse Event|4|||
130874540|NCT02898454|471170014|FG001|Overall Study|Adverse Event|1|||
130874541|NCT02898454|471170015|FG002|Overall Study|Adverse Event|2|||
130874542|NCT02898454|471170013|FG000|Overall Study|Protocol Violation|1|||
130874543|NCT02898454|471170014|FG001|Overall Study|Protocol Violation|0|||
130874544|NCT02898454|471170015|FG002|Overall Study|Protocol Violation|1|||
130874545|NCT02898454|471170013|FG000|Overall Study|Lack of Efficacy|4|||
130874546|NCT02898454|471170014|FG001|Overall Study|Lack of Efficacy|1|||
130874547|NCT02898454|471170015|FG002|Overall Study|Lack of Efficacy|0|||
130874548|NCT02898454|471170013|FG000|Overall Study|Withdrawal by Subject|6|||
130874549|NCT02898454|471170014|FG001|Overall Study|Withdrawal by Subject|3|||
130874550|NCT02898454|471170015|FG002|Overall Study|Withdrawal by Subject|3|||
130874551|NCT02898454|471170013|FG000|Overall Study|Lost to Follow-up|1|||
130874552|NCT02898454|471170014|FG001|Overall Study|Lost to Follow-up|0|||
130874553|NCT02898454|471170015|FG002|Overall Study|Lost to Follow-up|0|||
130874554|NCT02898454|471170013|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
130874555|NCT02898454|471170014|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
130874556|NCT02898454|471170015|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
130874557|NCT01601535|471170016|FG000|Phase 1|Adverse Event|1|||
130874558|NCT01601535|471170017|FG001|Phase 1|Adverse Event|0|||
130874559|NCT01601535|471170018|FG002|Phase 1|Adverse Event|2|||
130874560|NCT01601535|471170019|FG003|Phase 1|Adverse Event|1|||
130874561|NCT01601535|471170020|FG004|Phase 1|Adverse Event|0|||
130874562|NCT01601535|471170021|FG005|Phase 1|Adverse Event|0|||
130874563|NCT01601535|471170016|FG000|Phase 1|Withdrawal by Subject|2|||
130874564|NCT01601535|471170017|FG001|Phase 1|Withdrawal by Subject|1|||
130874565|NCT01601535|471170018|FG002|Phase 1|Withdrawal by Subject|1|||
130874566|NCT01601535|471170019|FG003|Phase 1|Withdrawal by Subject|2|||
130874567|NCT01601535|471170020|FG004|Phase 1|Withdrawal by Subject|0|||
130874568|NCT01601535|471170021|FG005|Phase 1|Withdrawal by Subject|0|||
130874569|NCT01601535|471170016|FG000|Phase 1|Progressive Disease|2|||
130874570|NCT01601535|471170017|FG001|Phase 1|Progressive Disease|3|||
130874571|NCT01601535|471170018|FG002|Phase 1|Progressive Disease|2|||
130874572|NCT01601535|471170019|FG003|Phase 1|Progressive Disease|1|||
130874573|NCT01601535|471170020|FG004|Phase 1|Progressive Disease|0|||
130874574|NCT01601535|471170021|FG005|Phase 1|Progressive Disease|0|||
130874575|NCT01601535|471170016|FG000|Phase 1|Started Another Treatment|1|||
130874576|NCT01601535|471170017|FG001|Phase 1|Started Another Treatment|2|||
130874577|NCT01601535|471170018|FG002|Phase 1|Started Another Treatment|0|||
130874578|NCT01601535|471170019|FG003|Phase 1|Started Another Treatment|0|||
130874579|NCT01601535|471170020|FG004|Phase 1|Started Another Treatment|0|||
130874580|NCT01601535|471170021|FG005|Phase 1|Started Another Treatment|0|||
130874581|NCT01601535|471170016|FG000|Phase 2|Adverse Event|0|||
130874582|NCT01601535|471170017|FG001|Phase 2|Adverse Event|0|||
130874583|NCT01601535|471170018|FG002|Phase 2|Adverse Event|0|||
130874584|NCT01601535|471170019|FG003|Phase 2|Adverse Event|0|||
130874585|NCT01601535|471170020|FG004|Phase 2|Adverse Event|5|||
130874586|NCT01601535|471170021|FG005|Phase 2|Adverse Event|1|||
130874587|NCT01601535|471170016|FG000|Phase 2|Withdrawal by Subject|0|||
130874588|NCT01601535|471170017|FG001|Phase 2|Withdrawal by Subject|0|||
130874589|NCT01601535|471170018|FG002|Phase 2|Withdrawal by Subject|0|||
130874590|NCT01601535|471170019|FG003|Phase 2|Withdrawal by Subject|0|||
130874591|NCT01601535|471170020|FG004|Phase 2|Withdrawal by Subject|8|||
130874592|NCT01601535|471170021|FG005|Phase 2|Withdrawal by Subject|2|||
130874593|NCT01601535|471170016|FG000|Phase 2|Progressive Disease|0|||
130874594|NCT01601535|471170017|FG001|Phase 2|Progressive Disease|0|||
130874595|NCT01601535|471170018|FG002|Phase 2|Progressive Disease|0|||
130874596|NCT01601535|471170019|FG003|Phase 2|Progressive Disease|0|||
130874597|NCT01601535|471170020|FG004|Phase 2|Progressive Disease|5|||
130874598|NCT01601535|471170021|FG005|Phase 2|Progressive Disease|7|||
130874599|NCT01601535|471170016|FG000|Phase 2|Started Another Treatment|0|||
130874600|NCT01601535|471170017|FG001|Phase 2|Started Another Treatment|0|||
130874601|NCT01601535|471170018|FG002|Phase 2|Started Another Treatment|0|||
130874602|NCT01601535|471170019|FG003|Phase 2|Started Another Treatment|0|||
130874603|NCT01601535|471170020|FG004|Phase 2|Started Another Treatment|1|||
130874604|NCT01601535|471170021|FG005|Phase 2|Started Another Treatment|2|||
130874605|NCT00647296|471170022|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
130874606|NCT00647296|471170023|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
130874607|NCT00647296|471170024|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
130874608|NCT00647296|471170025|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
130874609|NCT00647296|471170022|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
130874610|NCT00647296|471170023|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
130874611|NCT00647296|471170024|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
130874612|NCT00647296|471170025|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
130874613|NCT00647296|471170022|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
130874614|NCT00647296|471170023|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
130874615|NCT00647296|471170024|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
130874616|NCT00647296|471170025|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
130874617|NCT00647296|471170022|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
130874618|NCT00647296|471170023|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
130874619|NCT00647296|471170024|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
130874620|NCT00647296|471170025|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
130874621|NCT00647296|471170022|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
130874622|NCT00647296|471170023|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
130874623|NCT00647296|471170024|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
130874624|NCT00647296|471170025|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
130874625|NCT00647296|471170022|FG000|Part 2: 4-week Placebo Washout|Death|3|||
130874626|NCT00647296|471170023|FG001|Part 2: 4-week Placebo Washout|Death|0|||
130874627|NCT00647296|471170024|FG002|Part 2: 4-week Placebo Washout|Death|0|||
130874628|NCT00647296|471170025|FG003|Part 2: 4-week Placebo Washout|Death|0|||
130874629|NCT00647296|471170022|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
130874630|NCT00647296|471170023|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
130874631|NCT00647296|471170024|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
130874632|NCT00647296|471170025|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
130874633|NCT00647296|471170022|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
130874634|NCT00647296|471170023|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
130874635|NCT00647296|471170024|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
130874636|NCT00647296|471170025|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
130874637|NCT00647296|471170022|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
130874638|NCT00647296|471170023|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
130874639|NCT00647296|471170024|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
130874640|NCT00647296|471170025|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
130874641|NCT00647296|471170022|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
130874642|NCT00647296|471170023|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
130874643|NCT00647296|471170024|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
130874644|NCT00647296|471170025|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
130874645|NCT00647296|471170022|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
130874646|NCT00647296|471170023|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
130874647|NCT00647296|471170024|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
130874648|NCT00647296|471170025|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
130874649|NCT03883581|471170028|FG000|Overall Study|Withdrawal by Subject|4|||
130874650|NCT02926638|471170030|FG000|Overall Study|Progression|2|||
130874651|NCT02926638|471170031|FG001|Overall Study|Progression|5|||
130874652|NCT02926638|471170030|FG000|Overall Study|Ineligible|1|||
130874653|NCT02926638|471170031|FG001|Overall Study|Ineligible|0|||
130874654|NCT02926638|471170030|FG000|Overall Study|Not protocol specified|1|||
130874655|NCT02926638|471170031|FG001|Overall Study|Not protocol specified|0|||
130874656|NCT01908426|471171865|FG000|Overall Study|Adverse Event|98|||
130874657|NCT01908426|471171866|FG001|Overall Study|Adverse Event|11|||
130874658|NCT01908426|471171865|FG000|Overall Study|Clinical Deterioration|72|||
130874659|NCT01908426|471171866|FG001|Overall Study|Clinical Deterioration|38|||
130874660|NCT01908426|471171865|FG000|Overall Study|Lack of Efficacy|3|||
130874661|NCT01908426|471171866|FG001|Overall Study|Lack of Efficacy|0|||
130874662|NCT01908426|471171865|FG000|Overall Study|Lost to Follow-up|0|||
130874663|NCT01908426|471171866|FG001|Overall Study|Lost to Follow-up|1|||
130874664|NCT01908426|471171865|FG000|Overall Study|Physician Decision|3|||
130874665|NCT01908426|471171866|FG001|Overall Study|Physician Decision|3|||
130874666|NCT01908426|471171865|FG000|Overall Study|Withdrawal by Subject|11|||
130874667|NCT01908426|471171866|FG001|Overall Study|Withdrawal by Subject|6|||
130874668|NCT01908426|471171865|FG000|Overall Study|Progressive Disease|206|||
130874669|NCT01908426|471171866|FG001|Overall Study|Progressive Disease|152|||
130874670|NCT01908426|471171865|FG000|Overall Study|Protocol Violation|1|||
130874671|NCT01908426|471171866|FG001|Overall Study|Protocol Violation|0|||
130874672|NCT01908426|471171865|FG000|Overall Study|No Study Treatment Given|3|||
130874673|NCT01908426|471171866|FG001|Overall Study|No Study Treatment Given|0|||
130874674|NCT02426580|471171867|FG000|Overall Study|Death|2|||
130874675|NCT02426580|471171868|FG001|Overall Study|Death|2|||
130874676|NCT02426580|471171867|FG000|Overall Study|Lost to Follow-up|0|||
130874677|NCT02426580|471171868|FG001|Overall Study|Lost to Follow-up|9|||
130874678|NCT02426580|471171867|FG000|Overall Study|transfer to hemodialysis|5|||
130874679|NCT02426580|471171868|FG001|Overall Study|transfer to hemodialysis|5|||
130874680|NCT02426580|471171867|FG000|Overall Study|Kidney transplant|3|||
130874681|NCT02426580|471171868|FG001|Overall Study|Kidney transplant|0|||
130874682|NCT02426580|471171867|FG000|Overall Study|Allergic to egg white|1|||
130874683|NCT02426580|471171868|FG001|Overall Study|Allergic to egg white|0|||
130874684|NCT00416624|471171877|FG000|Overall Study|Withdrawal by Subject|1|||
130874685|NCT00416624|471171878|FG001|Overall Study|Withdrawal by Subject|6|||
130874686|NCT00416624|471171879|FG002|Overall Study|Withdrawal by Subject|4|||
130874687|NCT00416624|471171880|FG003|Overall Study|Withdrawal by Subject|9|||
130874688|NCT00416624|471171877|FG000|Overall Study|Death|4|||
130874689|NCT00416624|471171878|FG001|Overall Study|Death|7|||
130874690|NCT00416624|471171879|FG002|Overall Study|Death|7|||
130874691|NCT00416624|471171880|FG003|Overall Study|Death|1|||
130874692|NCT00416624|471171877|FG000|Overall Study|Adverse Event|8|||
130874693|NCT00416624|471171878|FG001|Overall Study|Adverse Event|3|||
130874694|NCT00416624|471171879|FG002|Overall Study|Adverse Event|2|||
130874695|NCT00416624|471171880|FG003|Overall Study|Adverse Event|2|||
130874696|NCT00416624|471171877|FG000|Overall Study|Other|8|||
130874697|NCT00416624|471171878|FG001|Overall Study|Other|11|||
130874698|NCT00416624|471171879|FG002|Overall Study|Other|5|||
130874699|NCT00416624|471171880|FG003|Overall Study|Other|5|||
130874700|NCT00416624|471171877|FG000|Overall Study|Cancel|1|||
130874701|NCT00416624|471171878|FG001|Overall Study|Cancel|0|||
130874702|NCT00416624|471171879|FG002|Overall Study|Cancel|0|||
130874703|NCT00416624|471171880|FG003|Overall Study|Cancel|0|||
130874704|NCT00768989|471171883|FG000|Prior to Week 24|Withdrawal by Subject|1|||
130874705|NCT00768989|471171884|FG001|Prior to Week 24|Withdrawal by Subject|0|||
130874706|NCT00768989|471171883|FG000|Prior to Week 24|Adverse Event|3|||
130874707|NCT00768989|471171884|FG001|Prior to Week 24|Adverse Event|0|||
130874708|NCT00768989|471171883|FG000|Prior to Week 24|Lost to Follow-up|0|||
130874709|NCT00768989|471171884|FG001|Prior to Week 24|Lost to Follow-up|1|||
130874710|NCT00768989|471171883|FG000|Prior to Week 24|Protocol Violation|0|||
130874711|NCT00768989|471171884|FG001|Prior to Week 24|Protocol Violation|2|||
130874712|NCT00768989|471171883|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
130874713|NCT00768989|471171884|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
130874714|NCT00768989|471171883|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
130874715|NCT00768989|471171884|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
130874716|NCT00768989|471171883|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
130874717|NCT00768989|471171884|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
130874718|NCT00768989|471171883|FG000|On or After Week 36|Lack of Efficacy|1|||
130874719|NCT00768989|471171884|FG001|On or After Week 36|Lack of Efficacy|0|||
130874720|NCT00768989|471171883|FG000|On or After Week 36|Adverse Event|0|||
130874721|NCT00768989|471171884|FG001|On or After Week 36|Adverse Event|1|||
130874722|NCT00768989|471171883|FG000|On or After Week 36|Lost to Follow-up|1|||
130874723|NCT00768989|471171884|FG001|On or After Week 36|Lost to Follow-up|0|||
130874724|NCT00768989|471171883|FG000|On or After Week 36|Poor Compliance|1|||
130874725|NCT00768989|471171884|FG001|On or After Week 36|Poor Compliance|0|||
130874726|NCT00768989|471171883|FG000|On or After Week 36|Protocol Violation|1|||
130874727|NCT00768989|471171884|FG001|On or After Week 36|Protocol Violation|0|||
130874728|NCT00768989|471171883|FG000|On or After Week 36|Did not attend termination visit|2|||
130874729|NCT00768989|471171884|FG001|On or After Week 36|Did not attend termination visit|0|||
130874730|NCT00768989|471171883|FG000|On or After Week 36|Sponsor Termination|45|||
130874731|NCT00768989|471171884|FG001|On or After Week 36|Sponsor Termination|26|||
130874732|NCT03192176|471171888|FG000|Overall Study|Adverse Event|1|||
130874733|NCT03192176|471171889|FG001|Overall Study|Adverse Event|0|||
130874734|NCT03192176|471171890|FG002|Overall Study|Adverse Event|4|||
130874735|NCT03192176|471171891|FG003|Overall Study|Adverse Event|5|||
130874736|NCT03192176|471171892|FG004|Overall Study|Adverse Event|3|||
130874737|NCT03192176|471171893|FG005|Overall Study|Adverse Event|2|||
130874738|NCT03192176|471171894|FG006|Overall Study|Adverse Event|3|||
130874739|NCT03192176|471171895|FG007|Overall Study|Adverse Event|3|||
130874740|NCT03192176|471171888|FG000|Overall Study|Lost to Follow-up|0|||
130874741|NCT03192176|471171889|FG001|Overall Study|Lost to Follow-up|0|||
130874742|NCT03192176|471171890|FG002|Overall Study|Lost to Follow-up|1|||
130874743|NCT03192176|471171891|FG003|Overall Study|Lost to Follow-up|2|||
130874744|NCT03192176|471171892|FG004|Overall Study|Lost to Follow-up|3|||
130874745|NCT03192176|471171893|FG005|Overall Study|Lost to Follow-up|1|||
130874746|NCT03192176|471171894|FG006|Overall Study|Lost to Follow-up|1|||
130874747|NCT03192176|471171895|FG007|Overall Study|Lost to Follow-up|1|||
130874748|NCT03192176|471171888|FG000|Overall Study|Physician Decision|1|||
130874749|NCT03192176|471171889|FG001|Overall Study|Physician Decision|0|||
130874750|NCT03192176|471171890|FG002|Overall Study|Physician Decision|0|||
130874751|NCT03192176|471171891|FG003|Overall Study|Physician Decision|0|||
130874752|NCT03192176|471171892|FG004|Overall Study|Physician Decision|0|||
130874753|NCT03192176|471171893|FG005|Overall Study|Physician Decision|2|||
130874754|NCT03192176|471171894|FG006|Overall Study|Physician Decision|1|||
130874755|NCT03192176|471171895|FG007|Overall Study|Physician Decision|0|||
130874756|NCT03192176|471171888|FG000|Overall Study|Protocol Deviation|1|||
130874757|NCT03192176|471171889|FG001|Overall Study|Protocol Deviation|1|||
130874758|NCT03192176|471171890|FG002|Overall Study|Protocol Deviation|0|||
130874759|NCT03192176|471171891|FG003|Overall Study|Protocol Deviation|0|||
130874760|NCT03192176|471171892|FG004|Overall Study|Protocol Deviation|2|||
130874761|NCT03192176|471171893|FG005|Overall Study|Protocol Deviation|0|||
130874762|NCT03192176|471171894|FG006|Overall Study|Protocol Deviation|0|||
130874763|NCT03192176|471171895|FG007|Overall Study|Protocol Deviation|0|||
130874764|NCT03192176|471171888|FG000|Overall Study|Withdrawal by Subject|3|||
130874765|NCT03192176|471171889|FG001|Overall Study|Withdrawal by Subject|4|||
130874766|NCT03192176|471171890|FG002|Overall Study|Withdrawal by Subject|0|||
130874767|NCT03192176|471171891|FG003|Overall Study|Withdrawal by Subject|4|||
130874768|NCT03192176|471171892|FG004|Overall Study|Withdrawal by Subject|3|||
130874769|NCT03192176|471171893|FG005|Overall Study|Withdrawal by Subject|4|||
130874770|NCT03192176|471171894|FG006|Overall Study|Withdrawal by Subject|4|||
130874771|NCT03192176|471171895|FG007|Overall Study|Withdrawal by Subject|2|||
130874772|NCT03192176|471171888|FG000|Overall Study|Miscellaneous|1|||
130874773|NCT03192176|471171889|FG001|Overall Study|Miscellaneous|0|||
130874774|NCT03192176|471171890|FG002|Overall Study|Miscellaneous|1|||
130874775|NCT03192176|471171891|FG003|Overall Study|Miscellaneous|1|||
130874776|NCT03192176|471171892|FG004|Overall Study|Miscellaneous|1|||
130874777|NCT03192176|471171893|FG005|Overall Study|Miscellaneous|2|||
130874778|NCT03192176|471171894|FG006|Overall Study|Miscellaneous|0|||
130874779|NCT03192176|471171895|FG007|Overall Study|Miscellaneous|1|||
130874780|NCT03532542|471171898|FG000|Overall Study|Death|1|||
130874781|NCT03532542|471171899|FG001|Overall Study|Death|0|||
130874782|NCT03532542|471171898|FG000|Overall Study|Study Terminated by Sponsor|41|||
130874783|NCT03532542|471171899|FG001|Overall Study|Study Terminated by Sponsor|65|||
130874784|NCT03532542|471171898|FG000|Overall Study|Withdrawal by Subject|6|||
130874785|NCT03532542|471171899|FG001|Overall Study|Withdrawal by Subject|5|||
130874786|NCT00718510|471171901|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
130874787|NCT00718510|471171902|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130874788|NCT00718510|471171901|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
130874789|NCT00718510|471171902|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130874790|NCT02314052|471171903|FG000|Cycle One|Adverse Event|0|||
130874791|NCT02314052|471171904|FG001|Cycle One|Adverse Event|0|||
130874792|NCT02314052|471171905|FG002|Cycle One|Adverse Event|0|||
130874793|NCT02314052|471171906|FG003|Cycle One|Adverse Event|1|||
130874794|NCT02314052|471171907|FG004|Cycle One|Adverse Event|0|||
130874795|NCT02314052|471171908|FG005|Cycle One|Adverse Event|0|||
130874796|NCT00117637|471171909|FG000|First Intervention (Period 1)|Adverse Event|11|||
130874797|NCT00117637|471171910|FG001|First Intervention (Period 1)|Adverse Event|16|||
130874798|NCT00117637|471171909|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
130874799|NCT00117637|471171910|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
130874800|NCT00117637|471171909|FG000|First Intervention (Period 1)|Protocol Violation|1|||
130874801|NCT00117637|471171910|FG001|First Intervention (Period 1)|Protocol Violation|0|||
130874802|NCT00117637|471171909|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
130874803|NCT00117637|471171910|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
130874804|NCT00117637|471171909|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
130874805|NCT00117637|471171910|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
130874806|NCT00117637|471171909|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
130874807|NCT00117637|471171910|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
130874808|NCT00117637|471171909|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
130874809|NCT00117637|471171910|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
130874810|NCT00117637|471171909|FG000|First Intervention (Period 1)|reason not reported|0|||
130874811|NCT00117637|471171910|FG001|First Intervention (Period 1)|reason not reported|1|||
130874812|NCT00117637|471171909|FG000|Second Intervention (Period 2)|Adverse Event|0|||
130874813|NCT00117637|471171910|FG001|Second Intervention (Period 2)|Adverse Event|9|||
130874814|NCT00117637|471171909|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
130874815|NCT00117637|471171910|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
130874816|NCT00117637|471171909|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
130874817|NCT00117637|471171910|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
130874818|NCT00117637|471171909|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
130874819|NCT00117637|471171910|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
130874820|NCT00117637|471171909|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
130874821|NCT00117637|471171910|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
130874822|NCT00117637|471171909|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
130874823|NCT00117637|471171910|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
130874824|NCT00117637|471171909|FG000|Second Intervention (Period 2)|reason not reported|1|||
130874825|NCT00117637|471171910|FG001|Second Intervention (Period 2)|reason not reported|0|||
130874826|NCT01582061|471171912|FG000|Overall Study|Lack of Efficacy|3|||
130874827|NCT01582061|471171913|FG001|Overall Study|Lack of Efficacy|23|||
130874828|NCT01582061|471171912|FG000|Overall Study|Adverse Event|12|||
130874829|NCT01582061|471171913|FG001|Overall Study|Adverse Event|8|||
130874830|NCT01582061|471171912|FG000|Overall Study|Withdrawal by Subject|10|||
130874831|NCT01582061|471171913|FG001|Overall Study|Withdrawal by Subject|4|||
130874832|NCT01582061|471171912|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130874833|NCT01582061|471171913|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130874834|NCT01582061|471171912|FG000|Overall Study|Death|0|||
130874835|NCT01582061|471171913|FG001|Overall Study|Death|1|||
130874836|NCT01582061|471171912|FG000|Overall Study|condition no longer requires study drug|1|||
130874837|NCT01582061|471171913|FG001|Overall Study|condition no longer requires study drug|0|||
130874838|NCT01582061|471171912|FG000|Overall Study|Lost to Follow-up|1|||
130874839|NCT01582061|471171913|FG001|Overall Study|Lost to Follow-up|0|||
130874840|NCT01045460|471171916|FG000|Overall Study|Physician Decision|3|||
130874841|NCT01045460|471171917|FG001|Overall Study|Physician Decision|2|||
130874842|NCT01045460|471171916|FG000|Overall Study|Lost to Follow-up|0|||
130874843|NCT01045460|471171917|FG001|Overall Study|Lost to Follow-up|1|||
130874844|NCT01045460|471171916|FG000|Overall Study|Lack of Efficacy|3|||
130874845|NCT01045460|471171917|FG001|Overall Study|Lack of Efficacy|0|||
130874846|NCT00524485|471171918|FG000|Overall Study|Withdrawal by Subject|5|||
130874847|NCT00436332|471171919|FG000|Overall Study|Adverse Event|9|||
130874848|NCT00436332|471171919|FG000|Overall Study|Withdrawal by Subject|2|||
130874849|NCT00436332|471171919|FG000|Overall Study|Progression|59|||
130874850|NCT00436332|471171919|FG000|Overall Study|Death|2|||
130874851|NCT00436332|471171919|FG000|Overall Study|Not Protocol Specified|6|||
130874852|NCT00436332|471171919|FG000|Overall Study|Ineligible|2|||
130874853|NCT00436332|471171919|FG000|Overall Study|Never Received Treatment|3|||
130874854|NCT00472108|471171920|FG000|Overall Study|Lost to Follow-up|0|||
130874855|NCT00472108|471171921|FG001|Overall Study|Lost to Follow-up|1|||
130874856|NCT02756338|471171924|FG000|Overall Study|Withdrawn by Investigator|1|||
130874857|NCT02756338|471171924|FG000|Overall Study|Device Replaced with Pacemaker|4|||
130874858|NCT01339689|471171927|FG000|Overall Study|Adverse Event|1|||
130874859|NCT01339689|471171928|FG001|Overall Study|Adverse Event|2|||
130874860|NCT01339689|471171927|FG000|Overall Study|Lost to Follow-up|9|||
130874861|NCT01339689|471171928|FG001|Overall Study|Lost to Follow-up|3|||
130874862|NCT01339689|471171927|FG000|Overall Study|Withdrawal by Subject|3|||
130874863|NCT01339689|471171928|FG001|Overall Study|Withdrawal by Subject|0|||
130874864|NCT01339689|471171927|FG000|Overall Study|Noncompliance|1|||
130874865|NCT01339689|471171928|FG001|Overall Study|Noncompliance|0|||
130874866|NCT01339689|471171927|FG000|Overall Study|Relocated out of area|0|||
130874867|NCT01339689|471171928|FG001|Overall Study|Relocated out of area|1|||
130874868|NCT01339689|471171927|FG000|Overall Study|Other|2|||
130874869|NCT01339689|471171928|FG001|Overall Study|Other|2|||
130874870|NCT01339689|471171927|FG000|Overall Study|multiple reasons|1|||
130874871|NCT01339689|471171928|FG001|Overall Study|multiple reasons|1|||
130874872|NCT00300755|471171931|FG000|Overall Study|Adverse Event|1|||
130874873|NCT00300755|471171932|FG001|Overall Study|Adverse Event|2|||
130874874|NCT00300755|471171933|FG002|Overall Study|Adverse Event|1|||
130874875|NCT00300755|471171931|FG000|Overall Study|Withdrawal by Subject|0|||
130874876|NCT00300755|471171932|FG001|Overall Study|Withdrawal by Subject|2|||
130874877|NCT00300755|471171933|FG002|Overall Study|Withdrawal by Subject|0|||
130874878|NCT00300755|471171931|FG000|Overall Study|Protocol Violation|0|||
130874879|NCT00300755|471171932|FG001|Overall Study|Protocol Violation|0|||
130874880|NCT00300755|471171933|FG002|Overall Study|Protocol Violation|1|||
130874881|NCT02694744|471171937|FG000|Overall Study|Adverse Event|2|||
130874882|NCT02694744|471171938|FG001|Overall Study|Adverse Event|1|||
130874883|NCT02694744|471171937|FG000|Overall Study|Withdrawal by Subject|2|||
130874884|NCT02694744|471171938|FG001|Overall Study|Withdrawal by Subject|1|||
130874885|NCT02694744|471171937|FG000|Overall Study|Physician Decision|1|||
130874886|NCT02694744|471171938|FG001|Overall Study|Physician Decision|2|||
130874887|NCT02694744|471171937|FG000|Overall Study|Lost to Follow-up|1|||
130874888|NCT02694744|471171938|FG001|Overall Study|Lost to Follow-up|0|||
130874889|NCT02694744|471171937|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
130874890|NCT02694744|471171938|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
130874891|NCT00686777|471171939|FG000|Overall Study|Adverse Event|2|||
130874892|NCT00686777|471171939|FG000|Overall Study|Pregnancy|1|||
130874893|NCT00686777|471171939|FG000|Overall Study|Withdrawal by Subject|2|||
130874894|NCT00686777|471171939|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
130874895|NCT00686777|471171939|FG000|Overall Study|No Visit|1|||
130874896|NCT00667888|471171940|FG000|Overall Study|Death|1|||
130874897|NCT00667888|471171941|FG001|Overall Study|Death|1|||
130874898|NCT00667888|471171940|FG000|Overall Study|Withdrawal by Subject|6|||
130874899|NCT00667888|471171941|FG001|Overall Study|Withdrawal by Subject|3|||
130874900|NCT00667888|471171940|FG000|Overall Study|Proceed with other treatment|3|||
130874901|NCT00667888|471171941|FG001|Overall Study|Proceed with other treatment|3|||
130874902|NCT00667888|471171940|FG000|Overall Study|Ineligible after SIM|0|||
130874903|NCT00667888|471171941|FG001|Overall Study|Ineligible after SIM|2|||
130874904|NCT01945021|471171942|FG000|Overall Study|Adverse Event|1|||
130874905|NCT01945021|471171942|FG000|Overall Study|Withdrawal of consent|12|||
130874906|NCT01945021|471171942|FG000|Overall Study|Lost to Follow-up|5|||
130874907|NCT01945021|471171942|FG000|Overall Study|Death|65|||
130874908|NCT03582215|471171943|FG000|Overall Study|Adverse Event|1|||
130874909|NCT03582215|471171944|FG001|Overall Study|Adverse Event|0|||
130874910|NCT03582215|471171945|FG002|Overall Study|Adverse Event|0|||
130874911|NCT03582215|471171946|FG003|Overall Study|Adverse Event|0|||
130874912|NCT03582215|471171947|FG004|Overall Study|Adverse Event|0|||
130874913|NCT03582215|471171948|FG005|Overall Study|Adverse Event|0|||
130874914|NCT03582215|471171949|FG006|Overall Study|Adverse Event|2|||
130874915|NCT03582215|471171950|FG007|Overall Study|Adverse Event|2|||
130874916|NCT02163902|471171951|FG000|Overall Study|Subject's Request|3|||
130874917|NCT02163902|471171952|FG001|Overall Study|Subject's Request|4|||
130874918|NCT02163902|471171951|FG000|Overall Study|Lost to Follow-up|6|||
130874919|NCT02163902|471171952|FG001|Overall Study|Lost to Follow-up|7|||
130874920|NCT02163902|471171951|FG000|Overall Study|Administrative Decision|2|||
130874921|NCT02163902|471171952|FG001|Overall Study|Administrative Decision|2|||
130874922|NCT02174731|471171953|FG000|Overall Study|Participant decision|67|||
130874923|NCT02174731|471171954|FG001|Overall Study|Participant decision|64|||
130874924|NCT02174731|471171953|FG000|Overall Study|Incorrect enrolment before randomization|0|||
130874925|NCT02174731|471171954|FG001|Overall Study|Incorrect enrolment before randomization|1|||
130874926|NCT02174731|471171953|FG000|Overall Study|Missing|2|||
130874927|NCT02174731|471171954|FG001|Overall Study|Missing|0|||
130874928|NCT00079040|471171955|FG000|Overall Study|Withdrew before treatment|1|||
130874929|NCT00079040|471171955|FG000|Overall Study|Ineligible|1|||
130874930|NCT03119259|471171956|FG000|Overall Study|Withdrawn as no longer eligible|1|||
130874931|NCT03119259|471171957|FG001|Overall Study|Withdrawn as no longer eligible|0|||
130874932|NCT03119259|471171956|FG000|Overall Study|Withdrawal by Subject|4|||
130874933|NCT03119259|471171957|FG001|Overall Study|Withdrawal by Subject|2|||
130874934|NCT03119259|471171956|FG000|Overall Study|Lost to Follow-up|0|||
130874935|NCT03119259|471171957|FG001|Overall Study|Lost to Follow-up|1|||
130874936|NCT00325897|471171962|FG000|Overall Study|Lost to Follow-up|12|||
130874937|NCT00325897|471171963|FG001|Overall Study|Lost to Follow-up|13|||
130874938|NCT03915717|471171966|FG000|Overall Study|EchoMark Not Implanted|6|||
130874939|NCT03748823|471171968|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
130874940|NCT03748823|471171969|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
130874941|NCT03748823|471171968|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
130874942|NCT03748823|471171969|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
130874943|NCT03748823|471171968|FG000|Extension Period|Withdrawal by Subject|9|||
130874944|NCT03748823|471171969|FG001|Extension Period|Withdrawal by Subject|12|||
130874945|NCT03748823|471171968|FG000|Extension Period|Death|2|||
130874946|NCT03748823|471171969|FG001|Extension Period|Death|2|||
130874947|NCT03748823|471171968|FG000|Extension Period|Other than Specified|0|||
130874948|NCT03748823|471171969|FG001|Extension Period|Other than Specified|1|||
130874949|NCT03748823|471171968|FG000|Extension Period|Protocol Violation|1|||
130874950|NCT03748823|471171969|FG001|Extension Period|Protocol Violation|0|||
130874951|NCT03748823|471171968|FG000|Extension Period|Lost to Follow-up|0|||
130874952|NCT03748823|471171969|FG001|Extension Period|Lost to Follow-up|1|||
130874953|NCT03748823|471171968|FG000|Extension Period|Lack of Efficacy|0|||
130874954|NCT03748823|471171969|FG001|Extension Period|Lack of Efficacy|1|||
130874955|NCT03748823|471171968|FG000|Extension Period|Physician Decision|1|||
130874956|NCT03748823|471171969|FG001|Extension Period|Physician Decision|2|||
130874957|NCT01664910|471171973|FG000|Overall Study|Adverse Event|0|||
130874958|NCT01664910|471171974|FG001|Overall Study|Adverse Event|0|||
130874959|NCT01664910|471171975|FG002|Overall Study|Adverse Event|1|||
130874960|NCT01168349|471171979|FG000|Overall Study|Death|157|||
130874961|NCT01168349|471171979|FG000|Overall Study|Lost to Follow-up|34|||
130874962|NCT01168349|471171979|FG000|Overall Study|Withdrawal by Subject|9|||
130874963|NCT01168349|471171979|FG000|Overall Study|Kidney transplantation|3|||
130874964|NCT01168349|471171979|FG000|Overall Study|Other|22|||
130874965|NCT01168349|471171979|FG000|Overall Study|Protocol Violation|76|||
130874966|NCT03535974|471171980|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
130874967|NCT03535974|471171981|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
130874968|NCT03535974|471171982|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
130874969|NCT03535974|471171980|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
130874970|NCT03535974|471171981|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
130874971|NCT03535974|471171982|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
130874972|NCT04059549|471171983|FG000|Overall Study|Withdrawal by Subject|2|||
130874973|NCT04059549|471171984|FG001|Overall Study|Withdrawal by Subject|0|||
130874974|NCT02678351|471171986|FG000|Overall Study|Withdrawal by Subject|1|||
130874975|NCT00988884|471171987|FG000|Overall Study|Adverse Event|0|||
130874976|NCT00988884|471171988|FG001|Overall Study|Adverse Event|1|||
130874977|NCT00988884|471171987|FG000|Overall Study|Lost to Follow-up|20|||
130874978|NCT00988884|471171988|FG001|Overall Study|Lost to Follow-up|16|||
130874979|NCT00988884|471171987|FG000|Overall Study|Protocol Violation|0|||
130874980|NCT00988884|471171988|FG001|Overall Study|Protocol Violation|1|||
130874981|NCT00988884|471171987|FG000|Overall Study|Withdrawal by Subject|15|||
130874982|NCT00988884|471171988|FG001|Overall Study|Withdrawal by Subject|18|||
130874983|NCT01919229|471171989|FG000|Overall Study|Subject/guardian decision|0|||
130874984|NCT01919229|471171990|FG001|Overall Study|Subject/guardian decision|0|||
130874985|NCT01919229|471171991|FG002|Overall Study|Subject/guardian decision|1|||
130874986|NCT01011673|471171992|FG000|Randomized|Secondary headache|2|||
130874987|NCT01011673|471171993|FG001|Randomized|Secondary headache|1|||
130874988|NCT01011673|471171992|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
130874989|NCT01011673|471171993|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
130874990|NCT01632020|471171994|FG000|Overall Study|Withdrawal by Subject|1|||
130874991|NCT01632020|471171995|FG001|Overall Study|Withdrawal by Subject|0|||
130874992|NCT01632020|471171994|FG000|Overall Study|Adverse Event|1|||
130874993|NCT01632020|471171995|FG001|Overall Study|Adverse Event|0|||
130874994|NCT00549640|471171997|FG000|Overall Study|Withdrawal by Subject|6|||
130874995|NCT00549640|471171998|FG001|Overall Study|Withdrawal by Subject|12|||
130874996|NCT00549640|471171997|FG000|Overall Study|Adverse Event|5|||
130874997|NCT00549640|471171998|FG001|Overall Study|Adverse Event|0|||
130874998|NCT00549640|471171997|FG000|Overall Study|Lost to Follow-up|7|||
130874999|NCT00549640|471171998|FG001|Overall Study|Lost to Follow-up|4|||
130875000|NCT00626275|471172007|FG000|Part A - Treatment Period 1|Adverse Event|1|||
130875001|NCT00626275|471172008|FG001|Part A - Treatment Period 1|Adverse Event|0|||
130875002|NCT00626275|471172009|FG002|Part A - Treatment Period 1|Adverse Event|0|||
130875003|NCT00626275|471172010|FG003|Part A - Treatment Period 1|Adverse Event|0|||
130875004|NCT00626275|471172011|FG004|Part A - Treatment Period 1|Adverse Event|0|||
130875005|NCT00626275|471172012|FG005|Part A - Treatment Period 1|Adverse Event|0|||
130875006|NCT00626275|471172013|FG006|Part A - Treatment Period 1|Adverse Event|0|||
130875007|NCT00626275|471172014|FG007|Part A - Treatment Period 1|Adverse Event|0|||
130875008|NCT00626275|471172007|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130875009|NCT00626275|471172008|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130875010|NCT00626275|471172009|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
130875011|NCT00626275|471172010|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130875012|NCT00626275|471172011|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130875013|NCT00626275|471172012|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130875014|NCT00626275|471172013|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130875015|NCT00626275|471172014|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130875016|NCT00626275|471172007|FG000|Part B|Lost to Follow-up|0|||
130875017|NCT00626275|471172008|FG001|Part B|Lost to Follow-up|0|||
130875018|NCT00626275|471172009|FG002|Part B|Lost to Follow-up|0|||
130875019|NCT00626275|471172010|FG003|Part B|Lost to Follow-up|0|||
130875020|NCT00626275|471172011|FG004|Part B|Lost to Follow-up|0|||
130875021|NCT00626275|471172012|FG005|Part B|Lost to Follow-up|0|||
130875022|NCT00626275|471172013|FG006|Part B|Lost to Follow-up|1|||
130875023|NCT00626275|471172014|FG007|Part B|Lost to Follow-up|0|||
130875024|NCT00626275|471172007|FG000|Part B|Withdrawal by Subject|0|||
130875025|NCT00626275|471172008|FG001|Part B|Withdrawal by Subject|0|||
130875026|NCT00626275|471172009|FG002|Part B|Withdrawal by Subject|0|||
130875027|NCT00626275|471172010|FG003|Part B|Withdrawal by Subject|0|||
130875028|NCT00626275|471172011|FG004|Part B|Withdrawal by Subject|0|||
130875029|NCT00626275|471172012|FG005|Part B|Withdrawal by Subject|0|||
130875030|NCT00626275|471172013|FG006|Part B|Withdrawal by Subject|0|||
130875031|NCT00626275|471172014|FG007|Part B|Withdrawal by Subject|1|||
130875032|NCT04999839|471172015|FG000|Overall Study|Adverse Event|1|||
130875033|NCT04999839|471172016|FG001|Overall Study|Adverse Event|1|||
130875034|NCT04999839|471172017|FG002|Overall Study|Adverse Event|1|||
130875035|NCT04999839|471172018|FG003|Overall Study|Adverse Event|1|||
130875036|NCT04999839|471172019|FG004|Overall Study|Adverse Event|1|||
130875037|NCT04999839|471172015|FG000|Overall Study|Lost to Follow-up|2|||
130875038|NCT04999839|471172016|FG001|Overall Study|Lost to Follow-up|0|||
130875039|NCT04999839|471172017|FG002|Overall Study|Lost to Follow-up|2|||
130875040|NCT04999839|471172018|FG003|Overall Study|Lost to Follow-up|4|||
130875041|NCT04999839|471172019|FG004|Overall Study|Lost to Follow-up|1|||
130875042|NCT04999839|471172015|FG000|Overall Study|Withdrawal by Subject|6|||
130875043|NCT04999839|471172016|FG001|Overall Study|Withdrawal by Subject|5|||
130875044|NCT04999839|471172017|FG002|Overall Study|Withdrawal by Subject|3|||
130875045|NCT04999839|471172018|FG003|Overall Study|Withdrawal by Subject|2|||
130875046|NCT04999839|471172019|FG004|Overall Study|Withdrawal by Subject|2|||
130875047|NCT04999839|471172015|FG000|Overall Study|Lack of Efficacy|0|||
130875048|NCT04999839|471172016|FG001|Overall Study|Lack of Efficacy|1|||
130875049|NCT04999839|471172017|FG002|Overall Study|Lack of Efficacy|0|||
130875050|NCT04999839|471172018|FG003|Overall Study|Lack of Efficacy|0|||
130875051|NCT04999839|471172019|FG004|Overall Study|Lack of Efficacy|0|||
130875052|NCT04999839|471172015|FG000|Overall Study|Physician Decision|0|||
130875053|NCT04999839|471172016|FG001|Overall Study|Physician Decision|0|||
130875054|NCT04999839|471172017|FG002|Overall Study|Physician Decision|0|||
130875055|NCT04999839|471172018|FG003|Overall Study|Physician Decision|0|||
130875056|NCT04999839|471172019|FG004|Overall Study|Physician Decision|1|||
130875057|NCT04999839|471172015|FG000|Overall Study|Sponsor request|0|||
130875058|NCT04999839|471172016|FG001|Overall Study|Sponsor request|1|||
130875059|NCT04999839|471172017|FG002|Overall Study|Sponsor request|0|||
130875060|NCT04999839|471172018|FG003|Overall Study|Sponsor request|0|||
130875061|NCT04999839|471172019|FG004|Overall Study|Sponsor request|0|||
130875062|NCT04999839|471172015|FG000|Overall Study|Other|0|||
130875063|NCT04999839|471172016|FG001|Overall Study|Other|0|||
130875064|NCT04999839|471172017|FG002|Overall Study|Other|1|||
130875065|NCT04999839|471172018|FG003|Overall Study|Other|0|||
130875066|NCT04999839|471172019|FG004|Overall Study|Other|0|||
130875067|NCT01362348|471172020|FG000|Overall Study|Protocol-defined stopping criteria|9|||
130875068|NCT01362348|471172020|FG000|Overall Study|Study closed/terminated|5|||
130875069|NCT00399516|471172021|FG000|Overall Study|Lost to Follow-up|2|||
130875070|NCT00539981|471172025|FG000|Overall Study|Adverse events (AE)|3|||
130875071|NCT00539981|471172026|FG001|Overall Study|Adverse events (AE)|3|||
130875072|NCT00539981|471172025|FG000|Overall Study|Lost to Follow-up|260|||
130875073|NCT00539981|471172026|FG001|Overall Study|Lost to Follow-up|251|||
130875074|NCT00539981|471172025|FG000|Overall Study|Withdrew consent|22|||
130875075|NCT00539981|471172026|FG001|Overall Study|Withdrew consent|14|||
130875076|NCT00539981|471172025|FG000|Overall Study|Death|1|||
130875077|NCT00539981|471172026|FG001|Overall Study|Death|1|||
130875078|NCT00539981|471172025|FG000|Overall Study|Other reason-unspecified|9|||
130875079|NCT00539981|471172026|FG001|Overall Study|Other reason-unspecified|13|||
130875080|NCT02675907|471172027|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
130875081|NCT02675907|471172028|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
130875082|NCT02675907|471172027|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
130875083|NCT02675907|471172028|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
130875084|NCT02675907|471172027|FG000|Study Overall|Lack of Efficacy|1|||
130875085|NCT02675907|471172028|FG001|Study Overall|Lack of Efficacy|0|||
130875086|NCT02675907|471172027|FG000|Study Overall|Withdrawal by Subject|2|||
130875087|NCT02675907|471172028|FG001|Study Overall|Withdrawal by Subject|2|||
130875088|NCT02675907|471172027|FG000|Study Overall|Lost to Follow-up|0|||
130875089|NCT02675907|471172028|FG001|Study Overall|Lost to Follow-up|2|||
130875090|NCT01611792|471172029|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
130875091|NCT01611792|471172030|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
130875092|NCT01611792|471172029|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
130875093|NCT01611792|471172030|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
130875094|NCT03525444|471173694|FG000|Overall Study|Adverse Event|0|||
130875095|NCT03525444|471173695|FG001|Overall Study|Adverse Event|1|||
130875096|NCT03525444|471173694|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
130875097|NCT03525444|471173695|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
130875098|NCT03525444|471173694|FG000|Overall Study|Other|0|||
130875099|NCT03525444|471173695|FG001|Overall Study|Other|1|||
130875100|NCT01419236|471173699|FG000|Overall Study|Adverse Event|1|||
130875101|NCT01419236|471173700|FG001|Overall Study|Adverse Event|0|||
130875102|NCT01419236|471173699|FG000|Overall Study|Lack of Efficacy|0|||
130875103|NCT01419236|471173700|FG001|Overall Study|Lack of Efficacy|1|||
130875104|NCT01419236|471173699|FG000|Overall Study|Lost to Follow-up|1|||
130875105|NCT01419236|471173700|FG001|Overall Study|Lost to Follow-up|0|||
130875106|NCT01419236|471173699|FG000|Overall Study|Physician Decision|1|||
130875107|NCT01419236|471173700|FG001|Overall Study|Physician Decision|0|||
130875108|NCT01419236|471173699|FG000|Overall Study|Withdrawal by Subject|1|||
130875109|NCT01419236|471173700|FG001|Overall Study|Withdrawal by Subject|4|||
130875110|NCT01419236|471173699|FG000|Overall Study|Entry Criteria Not Met|1|||
130875111|NCT01419236|471173700|FG001|Overall Study|Entry Criteria Not Met|0|||
130875112|NCT03585660|471173701|FG000|Overall Study|operator error|1|||
130875113|NCT03585660|471173701|FG000|Overall Study|technical error|2|||
130875114|NCT03585660|471173701|FG000|Overall Study|hip prosthesis|2|||
130875115|NCT03585660|471173701|FG000|Overall Study|did not undergo biopsy|8|||
130875116|NCT03585660|471173701|FG000|Overall Study|scanner problem|2|||
130875117|NCT00435409|471173702|FG000|Overall Study|Protocol Violation|1|||
130875118|NCT00435409|471173703|FG001|Overall Study|Protocol Violation|2|||
130875119|NCT00435409|471173704|FG002|Overall Study|Protocol Violation|0|||
130875120|NCT00435409|471173702|FG000|Overall Study|Lost to Follow-up|1|||
130875121|NCT00435409|471173703|FG001|Overall Study|Lost to Follow-up|2|||
130875122|NCT00435409|471173704|FG002|Overall Study|Lost to Follow-up|0|||
130875123|NCT00435409|471173702|FG000|Overall Study|Death|8|||
130875124|NCT00435409|471173703|FG001|Overall Study|Death|6|||
130875125|NCT00435409|471173704|FG002|Overall Study|Death|6|||
130875126|NCT00435409|471173702|FG000|Overall Study|Objective progression or relapse|158|||
130875127|NCT00435409|471173703|FG001|Overall Study|Objective progression or relapse|93|||
130875128|NCT00435409|471173704|FG002|Overall Study|Objective progression or relapse|58|||
130875129|NCT00435409|471173702|FG000|Overall Study|Global deterioration of health status|0|||
130875130|NCT00435409|471173703|FG001|Overall Study|Global deterioration of health status|0|||
130875131|NCT00435409|471173704|FG002|Overall Study|Global deterioration of health status|4|||
130875132|NCT00435409|471173702|FG000|Overall Study|Withdrawal by Subject|8|||
130875133|NCT00435409|471173703|FG001|Overall Study|Withdrawal by Subject|7|||
130875134|NCT00435409|471173704|FG002|Overall Study|Withdrawal by Subject|1|||
130875135|NCT00435409|471173702|FG000|Overall Study|Other|45|||
130875136|NCT00435409|471173703|FG001|Overall Study|Other|30|||
130875137|NCT00435409|471173704|FG002|Overall Study|Other|1|||
130875138|NCT00435409|471173702|FG000|Overall Study|Adverse Event|0|||
130875139|NCT00435409|471173703|FG001|Overall Study|Adverse Event|0|||
130875140|NCT00435409|471173704|FG002|Overall Study|Adverse Event|8|||
130875141|NCT00435409|471173702|FG000|Overall Study|Sponsor decision|0|||
130875142|NCT00435409|471173703|FG001|Overall Study|Sponsor decision|3|||
130875143|NCT00435409|471173704|FG002|Overall Study|Sponsor decision|0|||
130875144|NCT05635461|471173707|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130875145|NCT05635461|471173708|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130875146|NCT05635461|471173709|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130875147|NCT05635461|471173710|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130875148|NCT05635461|471173711|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
130875149|NCT05635461|471173712|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130875150|NCT05635461|471173707|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130875151|NCT05635461|471173708|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
130875152|NCT05635461|471173709|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130875153|NCT05635461|471173710|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130875154|NCT05635461|471173711|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130875155|NCT05635461|471173712|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130875156|NCT05635461|471173707|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130875157|NCT05635461|471173708|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130875158|NCT05635461|471173709|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130875159|NCT05635461|471173710|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
130875160|NCT05635461|471173711|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130875161|NCT05635461|471173712|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130875162|NCT03661723|471173715|FG000|Overall Study|Disease Progression|4|||
130875163|NCT03661723|471173716|FG001|Overall Study|Disease Progression|24|||
130875164|NCT03661723|471173717|FG002|Overall Study|Disease Progression|4|||
130875165|NCT03661723|471173718|FG003|Overall Study|Disease Progression|19|||
130875166|NCT03661723|471173715|FG000|Overall Study|Withdrawal by Subject|1|||
130875167|NCT03661723|471173716|FG001|Overall Study|Withdrawal by Subject|0|||
130875168|NCT03661723|471173717|FG002|Overall Study|Withdrawal by Subject|2|||
130875169|NCT03661723|471173718|FG003|Overall Study|Withdrawal by Subject|4|||
130875170|NCT03661723|471173715|FG000|Overall Study|Physician Decision|1|||
130875171|NCT03661723|471173716|FG001|Overall Study|Physician Decision|0|||
130875172|NCT03661723|471173717|FG002|Overall Study|Physician Decision|0|||
130875173|NCT03661723|471173718|FG003|Overall Study|Physician Decision|0|||
130875174|NCT03661723|471173715|FG000|Overall Study|Clinical Deterioration|0|||
130875175|NCT03661723|471173716|FG001|Overall Study|Clinical Deterioration|0|||
130875176|NCT03661723|471173717|FG002|Overall Study|Clinical Deterioration|0|||
130875177|NCT03661723|471173718|FG003|Overall Study|Clinical Deterioration|1|||
130875178|NCT03760029|471173719|FG000|Overall Study|Death|1|||
130875179|NCT03760029|471173720|FG001|Overall Study|Death|0|||
130875180|NCT03760029|471173721|FG002|Overall Study|Death|0|||
130875181|NCT03760029|471173719|FG000|Overall Study|Lost to Follow-up|0|||
130875182|NCT03760029|471173720|FG001|Overall Study|Lost to Follow-up|2|||
130875183|NCT03760029|471173721|FG002|Overall Study|Lost to Follow-up|1|||
130875184|NCT03760029|471173719|FG000|Overall Study|Withdrawal by Subject|1|||
130875185|NCT03760029|471173720|FG001|Overall Study|Withdrawal by Subject|4|||
130875186|NCT03760029|471173721|FG002|Overall Study|Withdrawal by Subject|1|||
130875187|NCT03760029|471173719|FG000|Overall Study|Withdrawal by parent/guardian|4|||
130875188|NCT03760029|471173720|FG001|Overall Study|Withdrawal by parent/guardian|4|||
130875189|NCT03760029|471173721|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130875190|NCT03760029|471173719|FG000|Overall Study|Other|2|||
130875191|NCT03760029|471173720|FG001|Overall Study|Other|1|||
130875192|NCT03760029|471173721|FG002|Overall Study|Other|0|||
130875193|NCT04890652|471173725|FG000|Overall Study|Withdrawal by Subject|2|||
130875194|NCT02269124|471173734|FG000|Overall Study|Lost to Follow-up|1|||
130875195|NCT02269124|471173735|FG001|Overall Study|Lost to Follow-up|0|||
130875196|NCT02269124|471173734|FG000|Overall Study|Withdrawal by Subject|0|||
130875197|NCT02269124|471173735|FG001|Overall Study|Withdrawal by Subject|2|||
130875198|NCT00614575|471173736|FG000|Overall Study|Adverse Event|106|||
130875199|NCT00614575|471173736|FG000|Overall Study|Lost to Follow-up|55|||
130875200|NCT00614575|471173736|FG000|Overall Study|Lack of Efficacy|14|||
130875201|NCT00614575|471173736|FG000|Overall Study|Withdrawal by Subject|6|||
130875202|NCT00614575|471173736|FG000|Overall Study|Death|3|||
130875203|NCT00614575|471173736|FG000|Overall Study|Physician Decision|2|||
130875204|NCT00614575|471173736|FG000|Overall Study|No data were collected.|18|||
130875205|NCT00614575|471173736|FG000|Overall Study|Irregularly enrolled patients|23|||
130875206|NCT00614575|471173736|FG000|Overall Study|No treatment|1|||
130875207|NCT03452540|471173737|FG000|Overall Study|Adverse Event|1|||
130875208|NCT03452540|471173737|FG000|Overall Study|Withdrawal by Subject|1|||
130875209|NCT03452540|471173737|FG000|Overall Study|Other SAE and AE|2|||
130875210|NCT01600885|471173738|FG000|First Period|Adverse Event|1|||
130875211|NCT01600885|471173739|FG001|First Period|Adverse Event|1|||
130875212|NCT01600885|471173738|FG000|First Period|moved out of area|1|||
130875213|NCT01600885|471173739|FG001|First Period|moved out of area|0|||
130875214|NCT02140047|471173740|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130875215|NCT02140047|471173741|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130875216|NCT02140047|471173742|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130875217|NCT00499681|471173743|FG000|Overall Study|toxicity|0|||
130875218|NCT00499681|471173744|FG001|Overall Study|toxicity|1|||
130875219|NCT00499681|471173743|FG000|Overall Study|disease progression|0|||
130875220|NCT00499681|471173744|FG001|Overall Study|disease progression|1|||
130875221|NCT00883779|471173745|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
130875222|NCT00883779|471173746|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
130875223|NCT00883779|471173745|FG000|Primary Study Treatment Phase|Disease progression|75|||
130875224|NCT00883779|471173746|FG001|Primary Study Treatment Phase|Disease progression|59|||
130875225|NCT00883779|471173745|FG000|Primary Study Treatment Phase|Adverse Event|16|||
130875226|NCT00883779|471173746|FG001|Primary Study Treatment Phase|Adverse Event|16|||
130875227|NCT00883779|471173745|FG000|Primary Study Treatment Phase|Death|2|||
130875228|NCT00883779|471173746|FG001|Primary Study Treatment Phase|Death|3|||
130875229|NCT00883779|471173745|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
130875230|NCT00883779|471173746|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
130875231|NCT00883779|471173745|FG000|Primary Study Treatment Phase|Other|3|||
130875232|NCT00883779|471173746|FG001|Primary Study Treatment Phase|Other|0|||
130875233|NCT00883779|471173745|FG000|Post-Study Treatment Phase|Adverse Event|2|||
130875234|NCT00883779|471173746|FG001|Post-Study Treatment Phase|Adverse Event|3|||
130875235|NCT00883779|471173745|FG000|Post-Study Treatment Phase|Death|1|||
130875236|NCT00883779|471173746|FG001|Post-Study Treatment Phase|Death|3|||
130875237|NCT00883779|471173745|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
130875238|NCT00883779|471173746|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
130875239|NCT00883779|471173745|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
130875240|NCT00883779|471173746|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
130875241|NCT00883779|471173745|FG000|Post-Study Treatment Phase|Disease progression|103|||
130875242|NCT00883779|471173746|FG001|Post-Study Treatment Phase|Disease progression|122|||
130875243|NCT00883779|471173745|FG000|Post-Study Treatment Phase|Other|3|||
130875244|NCT00883779|471173746|FG001|Post-Study Treatment Phase|Other|0|||
130875245|NCT00883779|471173745|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
130875246|NCT00883779|471173746|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
130875247|NCT00883779|471173745|FG000|Off-study Phase|Death|185|||
130875248|NCT00883779|471173746|FG001|Off-study Phase|Death|174|||
130875249|NCT00883779|471173745|FG000|Off-study Phase|Refused treatment|1|||
130875250|NCT00883779|471173746|FG001|Off-study Phase|Refused treatment|1|||
130875251|NCT00883779|471173745|FG000|Off-study Phase|Failure to return|5|||
130875252|NCT00883779|471173746|FG001|Off-study Phase|Failure to return|6|||
130875253|NCT00883779|471173745|FG000|Off-study Phase|Other|18|||
130875254|NCT00883779|471173746|FG001|Off-study Phase|Other|21|||
130875255|NCT01129622|471173748|FG000|Overall Study|Withdrawal by Subject|2|||
130875256|NCT00591006|471173749|FG000|Overall Study|Withdrawal by Subject|0|||
130875257|NCT00591006|471173750|FG001|Overall Study|Withdrawal by Subject|0|||
130875258|NCT00591006|471173751|FG002|Overall Study|Withdrawal by Subject|0|||
130875259|NCT00591006|471173752|FG003|Overall Study|Withdrawal by Subject|0|||
130875260|NCT00591006|471173753|FG004|Overall Study|Withdrawal by Subject|0|||
130875261|NCT00591006|471173754|FG005|Overall Study|Withdrawal by Subject|0|||
130875262|NCT00591006|471173755|FG006|Overall Study|Withdrawal by Subject|0|||
130875263|NCT00591006|471173756|FG007|Overall Study|Withdrawal by Subject|0|||
130875264|NCT00591006|471173757|FG008|Overall Study|Withdrawal by Subject|0|||
130875265|NCT00591006|471173758|FG009|Overall Study|Withdrawal by Subject|0|||
130875266|NCT00591006|471173759|FG010|Overall Study|Withdrawal by Subject|0|||
130875267|NCT00591006|471173760|FG011|Overall Study|Withdrawal by Subject|0|||
130875268|NCT00591006|471173761|FG012|Overall Study|Withdrawal by Subject|0|||
130875269|NCT00591006|471173762|FG013|Overall Study|Withdrawal by Subject|0|||
130875270|NCT00591006|471173763|FG014|Overall Study|Withdrawal by Subject|0|||
130875271|NCT00591006|471173764|FG015|Overall Study|Withdrawal by Subject|1|||
130875272|NCT00591006|471173765|FG016|Overall Study|Withdrawal by Subject|0|||
130875273|NCT00591006|471173766|FG017|Overall Study|Withdrawal by Subject|0|||
130875274|NCT00591006|471173767|FG018|Overall Study|Withdrawal by Subject|0|||
130875275|NCT00591006|471173768|FG019|Overall Study|Withdrawal by Subject|0|||
130875276|NCT00591006|471173769|FG020|Overall Study|Withdrawal by Subject|0|||
130875277|NCT00591006|471173770|FG021|Overall Study|Withdrawal by Subject|0|||
130875278|NCT00591006|471173771|FG022|Overall Study|Withdrawal by Subject|0|||
130875279|NCT00591006|471173772|FG023|Overall Study|Withdrawal by Subject|1|||
130875280|NCT00591006|471173749|FG000|Overall Study|Adverse Event|0|||
130875281|NCT00591006|471173750|FG001|Overall Study|Adverse Event|0|||
130875282|NCT00591006|471173751|FG002|Overall Study|Adverse Event|0|||
130875283|NCT00591006|471173752|FG003|Overall Study|Adverse Event|0|||
130875284|NCT00591006|471173753|FG004|Overall Study|Adverse Event|0|||
130875285|NCT00591006|471173754|FG005|Overall Study|Adverse Event|0|||
130875286|NCT00591006|471173755|FG006|Overall Study|Adverse Event|0|||
130875287|NCT00591006|471173756|FG007|Overall Study|Adverse Event|0|||
130875288|NCT00591006|471173757|FG008|Overall Study|Adverse Event|0|||
130875289|NCT00591006|471173758|FG009|Overall Study|Adverse Event|0|||
130875290|NCT00591006|471173759|FG010|Overall Study|Adverse Event|0|||
130875291|NCT00591006|471173760|FG011|Overall Study|Adverse Event|0|||
130875292|NCT00591006|471173761|FG012|Overall Study|Adverse Event|0|||
130875293|NCT00591006|471173762|FG013|Overall Study|Adverse Event|0|||
130875294|NCT00591006|471173763|FG014|Overall Study|Adverse Event|0|||
130875295|NCT00591006|471173764|FG015|Overall Study|Adverse Event|0|||
130875296|NCT00591006|471173765|FG016|Overall Study|Adverse Event|0|||
130875297|NCT00591006|471173766|FG017|Overall Study|Adverse Event|0|||
130875298|NCT00591006|471173767|FG018|Overall Study|Adverse Event|0|||
130875299|NCT00591006|471173768|FG019|Overall Study|Adverse Event|0|||
130875300|NCT00591006|471173769|FG020|Overall Study|Adverse Event|0|||
130875301|NCT00591006|471173770|FG021|Overall Study|Adverse Event|0|||
130875302|NCT00591006|471173771|FG022|Overall Study|Adverse Event|1|||
130875303|NCT00591006|471173772|FG023|Overall Study|Adverse Event|0|||
130875304|NCT00689390|471173773|FG000|Overall Study|Adverse Event|19|||
130875305|NCT00689390|471173774|FG001|Overall Study|Adverse Event|0|||
130875306|NCT00689390|471173773|FG000|Overall Study|Lost to Follow-up|179|||
130875307|NCT00689390|471173774|FG001|Overall Study|Lost to Follow-up|7|||
130875308|NCT00689390|471173773|FG000|Overall Study|Withdrawal by Subject|117|||
130875309|NCT00689390|471173774|FG001|Overall Study|Withdrawal by Subject|3|||
130875310|NCT00689390|471173773|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
130875311|NCT00689390|471173774|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
130875312|NCT00689390|471173773|FG000|Overall Study|Non-Compliance With Protocol|21|||
130875313|NCT00689390|471173774|FG001|Overall Study|Non-Compliance With Protocol|0|||
130875314|NCT00689390|471173773|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
130875315|NCT00689390|471173774|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
130875316|NCT00689390|471173773|FG000|Overall Study|Administrative|37|||
130875317|NCT00689390|471173774|FG001|Overall Study|Administrative|0|||
130875318|NCT02343263|471173775|FG000|Overall Study|Physician Decision|5|||
130875319|NCT02343263|471173776|FG001|Overall Study|Physician Decision|3|||
130875320|NCT02343263|471173777|FG002|Overall Study|Physician Decision|1|||
130875321|NCT00525512|471173791|FG000|Double-Blind Phase|Adverse Event|48|||
130875322|NCT00525512|471173792|FG001|Double-Blind Phase|Adverse Event|28|||
130875323|NCT00525512|471173793|FG002|Double-Blind Phase|Adverse Event|0|||
130875324|NCT00525512|471173794|FG003|Double-Blind Phase|Adverse Event|0|||
130875325|NCT00525512|471173791|FG000|Double-Blind Phase|Protocol Violation|3|||
130875326|NCT00525512|471173792|FG001|Double-Blind Phase|Protocol Violation|1|||
130875327|NCT00525512|471173793|FG002|Double-Blind Phase|Protocol Violation|0|||
130875328|NCT00525512|471173794|FG003|Double-Blind Phase|Protocol Violation|0|||
130875329|NCT00525512|471173791|FG000|Double-Blind Phase|Lost to Follow-up|3|||
130875330|NCT00525512|471173792|FG001|Double-Blind Phase|Lost to Follow-up|7|||
130875331|NCT00525512|471173793|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130875332|NCT00525512|471173794|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130875333|NCT00525512|471173791|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
130875334|NCT00525512|471173792|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
130875335|NCT00525512|471173793|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130875336|NCT00525512|471173794|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130875337|NCT00525512|471173791|FG000|Double-Blind Phase|Lack of Efficacy|13|||
130875338|NCT00525512|471173792|FG001|Double-Blind Phase|Lack of Efficacy|5|||
130875339|NCT00525512|471173793|FG002|Double-Blind Phase|Lack of Efficacy|0|||
130875340|NCT00525512|471173794|FG003|Double-Blind Phase|Lack of Efficacy|0|||
130875341|NCT00525512|471173791|FG000|Double-Blind Phase|Other reason (not specified)|12|||
130875342|NCT00525512|471173792|FG001|Double-Blind Phase|Other reason (not specified)|13|||
130875343|NCT00525512|471173793|FG002|Double-Blind Phase|Other reason (not specified)|0|||
130875344|NCT00525512|471173794|FG003|Double-Blind Phase|Other reason (not specified)|0|||
130875345|NCT00525512|471173791|FG000|Open-Label Phase|Adverse Event|0|||
130875346|NCT00525512|471173792|FG001|Open-Label Phase|Adverse Event|0|||
130875347|NCT00525512|471173793|FG002|Open-Label Phase|Adverse Event|1|||
130875348|NCT00525512|471173794|FG003|Open-Label Phase|Adverse Event|0|||
130875349|NCT00525512|471173791|FG000|Open-Label Phase|Lost to Follow-up|0|||
130875350|NCT00525512|471173792|FG001|Open-Label Phase|Lost to Follow-up|0|||
130875351|NCT00525512|471173793|FG002|Open-Label Phase|Lost to Follow-up|1|||
130875352|NCT00525512|471173794|FG003|Open-Label Phase|Lost to Follow-up|0|||
130875353|NCT00525512|471173791|FG000|Open-Label Phase|Other reason (not specified)|0|||
130875354|NCT00525512|471173792|FG001|Open-Label Phase|Other reason (not specified)|0|||
130875355|NCT00525512|471173793|FG002|Open-Label Phase|Other reason (not specified)|4|||
130875356|NCT00525512|471173794|FG003|Open-Label Phase|Other reason (not specified)|5|||
130875357|NCT03289208|471173799|FG000|Overall Study|Adverse Event|1|||
130875358|NCT03289208|471173800|FG001|Overall Study|Adverse Event|0|||
130875359|NCT03289208|471173801|FG002|Overall Study|Adverse Event|0|||
130875360|NCT03353675|471173806|FG000|Overall Study|Adverse Event|4|||
130875361|NCT00395746|471173809|FG000|Overall Study|Adverse Event|5|||
130875362|NCT00395746|471173810|FG001|Overall Study|Adverse Event|2|||
130875363|NCT00395746|471173811|FG002|Overall Study|Adverse Event|2|||
130875364|NCT00395746|471173809|FG000|Overall Study|Protocol Violation|0|||
130875365|NCT00395746|471173810|FG001|Overall Study|Protocol Violation|1|||
130875366|NCT00395746|471173811|FG002|Overall Study|Protocol Violation|0|||
130875367|NCT00395746|471173809|FG000|Overall Study|Lack of Efficacy|2|||
130875368|NCT00395746|471173810|FG001|Overall Study|Lack of Efficacy|0|||
130875369|NCT00395746|471173811|FG002|Overall Study|Lack of Efficacy|17|||
130875370|NCT00395746|471173809|FG000|Overall Study|Hypoglycaemia|2|||
130875371|NCT00395746|471173810|FG001|Overall Study|Hypoglycaemia|1|||
130875372|NCT00395746|471173811|FG002|Overall Study|Hypoglycaemia|0|||
130875373|NCT00395746|471173809|FG000|Overall Study|Subject decision|0|||
130875374|NCT00395746|471173810|FG001|Overall Study|Subject decision|0|||
130875375|NCT00395746|471173811|FG002|Overall Study|Subject decision|1|||
130875376|NCT00395746|471173809|FG000|Overall Study|Withdrawal of consent|0|||
130875377|NCT00395746|471173810|FG001|Overall Study|Withdrawal of consent|0|||
130875378|NCT00395746|471173811|FG002|Overall Study|Withdrawal of consent|1|||
130875379|NCT00395746|471173809|FG000|Overall Study|Difficultulty in use of device|0|||
130875380|NCT00395746|471173810|FG001|Overall Study|Difficultulty in use of device|0|||
130875381|NCT00395746|471173811|FG002|Overall Study|Difficultulty in use of device|1|||
130875382|NCT00395746|471173809|FG000|Overall Study|Unable to visit site on schedule|1|||
130875383|NCT00395746|471173810|FG001|Overall Study|Unable to visit site on schedule|0|||
130875384|NCT00395746|471173811|FG002|Overall Study|Unable to visit site on schedule|0|||
130875385|NCT03137992|471173816|FG000|Washout Period 1|Adverse Event|1|||
130875386|NCT03137992|471173817|FG001|Washout Period 1|Adverse Event|1|||
130875387|NCT03137992|471173818|FG002|Washout Period 1|Adverse Event|0|||
130875388|NCT03137992|471173819|FG003|Washout Period 1|Adverse Event|0|||
130875389|NCT03137992|471173820|FG004|Washout Period 1|Adverse Event|0|||
130875390|NCT03137992|471173821|FG005|Washout Period 1|Adverse Event|1|||
130875391|NCT03137992|471173816|FG000|Washout Period 1|Withdrawal by Subject|0|||
130875392|NCT03137992|471173817|FG001|Washout Period 1|Withdrawal by Subject|1|||
130875393|NCT03137992|471173818|FG002|Washout Period 1|Withdrawal by Subject|1|||
130875394|NCT03137992|471173819|FG003|Washout Period 1|Withdrawal by Subject|0|||
130875395|NCT03137992|471173820|FG004|Washout Period 1|Withdrawal by Subject|0|||
130875396|NCT03137992|471173821|FG005|Washout Period 1|Withdrawal by Subject|0|||
130875397|NCT03137992|471173816|FG000|Washout Period 1|Principal Investigator Discretion|0|||
130875398|NCT03137992|471173817|FG001|Washout Period 1|Principal Investigator Discretion|1|||
130875399|NCT03137992|471173818|FG002|Washout Period 1|Principal Investigator Discretion|0|||
130875400|NCT03137992|471173819|FG003|Washout Period 1|Principal Investigator Discretion|0|||
130875401|NCT03137992|471173820|FG004|Washout Period 1|Principal Investigator Discretion|0|||
130875402|NCT03137992|471173821|FG005|Washout Period 1|Principal Investigator Discretion|0|||
130875403|NCT03137992|471173816|FG000|Washout Period 1|COPD Exacerbation|1|||
130875404|NCT03137992|471173817|FG001|Washout Period 1|COPD Exacerbation|1|||
130875405|NCT03137992|471173818|FG002|Washout Period 1|COPD Exacerbation|1|||
130875406|NCT03137992|471173819|FG003|Washout Period 1|COPD Exacerbation|0|||
130875407|NCT03137992|471173820|FG004|Washout Period 1|COPD Exacerbation|1|||
130875408|NCT03137992|471173821|FG005|Washout Period 1|COPD Exacerbation|1|||
130875409|NCT03137992|471173816|FG000|Washout Period 1|Subject Noncompliance|1|||
130875410|NCT03137992|471173817|FG001|Washout Period 1|Subject Noncompliance|0|||
130875411|NCT03137992|471173818|FG002|Washout Period 1|Subject Noncompliance|0|||
130875412|NCT03137992|471173819|FG003|Washout Period 1|Subject Noncompliance|0|||
130875413|NCT03137992|471173820|FG004|Washout Period 1|Subject Noncompliance|1|||
130875414|NCT03137992|471173821|FG005|Washout Period 1|Subject Noncompliance|0|||
130875415|NCT03137992|471173816|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
130875416|NCT03137992|471173817|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
130875417|NCT03137992|471173818|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
130875418|NCT03137992|471173819|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
130875419|NCT03137992|471173820|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
130875420|NCT03137992|471173821|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
130875489|NCT03137992|471173818|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
130875490|NCT03137992|471173819|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130875491|NCT03137992|471173820|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130875492|NCT03137992|471173821|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130875493|NCT03137992|471173816|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130875494|NCT03137992|471173817|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130875495|NCT03137992|471173818|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130875496|NCT03137992|471173819|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
130875497|NCT03137992|471173820|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130875498|NCT03137992|471173821|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130875499|NCT03137992|471173816|FG000|Part 2 (Open-label Extension)|Per study team|1|||
130875500|NCT03137992|471173817|FG001|Part 2 (Open-label Extension)|Per study team|0|||
130875501|NCT03137992|471173818|FG002|Part 2 (Open-label Extension)|Per study team|0|||
130875502|NCT03137992|471173819|FG003|Part 2 (Open-label Extension)|Per study team|0|||
130875503|NCT03137992|471173820|FG004|Part 2 (Open-label Extension)|Per study team|0|||
130875504|NCT03137992|471173821|FG005|Part 2 (Open-label Extension)|Per study team|0|||
130875505|NCT03137992|471173816|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130875506|NCT03137992|471173817|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130875507|NCT03137992|471173818|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130875508|NCT03137992|471173819|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130875509|NCT03137992|471173820|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130875510|NCT03137992|471173821|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
130875511|NCT02370420|471173822|FG000|Overall Study|Physician Decision|3|||
130875512|NCT02370420|471173823|FG001|Overall Study|Physician Decision|3|||
130875513|NCT02370420|471173822|FG000|Overall Study|Lost to Follow-up|11|||
130875514|NCT02370420|471173823|FG001|Overall Study|Lost to Follow-up|9|||
130875515|NCT03077542|471173824|FG000|Overall Study|Death|4|||
130875516|NCT03077542|471173825|FG001|Overall Study|Death|0|||
130875517|NCT03077542|471173824|FG000|Overall Study|Physician Decision|6|||
130875518|NCT03077542|471173825|FG001|Overall Study|Physician Decision|1|||
130875519|NCT03077542|471173824|FG000|Overall Study|Withdrawal by Subject|0|||
130875520|NCT03077542|471173825|FG001|Overall Study|Withdrawal by Subject|1|||
130875521|NCT00795704|471173826|FG000|Overall Study|Withdrawal by Subject|3|||
130875522|NCT00795704|471173827|FG001|Overall Study|Withdrawal by Subject|2|||
130875523|NCT00795704|471173826|FG000|Overall Study|Adverse Event|1|||
130875524|NCT00795704|471173827|FG001|Overall Study|Adverse Event|1|||
130875525|NCT03980730|471173828|FG000|Overall Study|Study Terminated by Sponsor|0|||
130875526|NCT03980730|471173829|FG001|Overall Study|Study Terminated by Sponsor|3|||
130875527|NCT03980730|471173828|FG000|Overall Study|Adverse Event|2|||
130875528|NCT03980730|471173829|FG001|Overall Study|Adverse Event|0|||
130875529|NCT03980730|471173828|FG000|Overall Study|Sponsor Request|0|||
130875530|NCT03980730|471173829|FG001|Overall Study|Sponsor Request|1|||
130875531|NCT01300728|471173830|FG000|Overall Study|Withdrawal by Subject|1|||
130875532|NCT01300728|471173831|FG001|Overall Study|Withdrawal by Subject|1|||
130875533|NCT01300728|471173830|FG000|Overall Study|Physician Decision|1|||
130875534|NCT01300728|471173831|FG001|Overall Study|Physician Decision|0|||
130875535|NCT00880620|471173834|FG000|Overall Study|Adverse Event|4|||
130875536|NCT00880620|471173835|FG001|Overall Study|Adverse Event|5|||
130875537|NCT00880620|471173836|FG002|Overall Study|Adverse Event|15|||
130875538|NCT00880620|471173837|FG003|Overall Study|Adverse Event|15|||
130875539|NCT00880620|471173834|FG000|Overall Study|Death|0|||
130875540|NCT00880620|471173835|FG001|Overall Study|Death|0|||
130875541|NCT00880620|471173836|FG002|Overall Study|Death|1|||
130875542|NCT00880620|471173837|FG003|Overall Study|Death|0|||
130875543|NCT00880620|471173834|FG000|Overall Study|Lack of Efficacy|12|||
130875544|NCT00880620|471173835|FG001|Overall Study|Lack of Efficacy|4|||
130875545|NCT00880620|471173836|FG002|Overall Study|Lack of Efficacy|0|||
130875546|NCT00880620|471173837|FG003|Overall Study|Lack of Efficacy|1|||
130875547|NCT00880620|471173834|FG000|Overall Study|Lost to Follow-up|0|||
130875548|NCT00880620|471173835|FG001|Overall Study|Lost to Follow-up|1|||
130875549|NCT00880620|471173836|FG002|Overall Study|Lost to Follow-up|1|||
130875550|NCT00880620|471173837|FG003|Overall Study|Lost to Follow-up|0|||
130875551|NCT00880620|471173834|FG000|Overall Study|Protocol Violation|0|||
130875552|NCT00880620|471173835|FG001|Overall Study|Protocol Violation|1|||
130875553|NCT00880620|471173836|FG002|Overall Study|Protocol Violation|0|||
130875554|NCT00880620|471173837|FG003|Overall Study|Protocol Violation|2|||
130875555|NCT00880620|471173834|FG000|Overall Study|Withdrawal by Subject|4|||
130875556|NCT00880620|471173835|FG001|Overall Study|Withdrawal by Subject|3|||
130875557|NCT00880620|471173836|FG002|Overall Study|Withdrawal by Subject|1|||
130875558|NCT00880620|471173837|FG003|Overall Study|Withdrawal by Subject|3|||
130875559|NCT00880620|471173834|FG000|Overall Study|Noncompliance|0|||
130875560|NCT00880620|471173835|FG001|Overall Study|Noncompliance|0|||
130875561|NCT00880620|471173836|FG002|Overall Study|Noncompliance|1|||
130875562|NCT00880620|471173837|FG003|Overall Study|Noncompliance|1|||
130875563|NCT00880620|471173834|FG000|Overall Study|Other|1|||
130875564|NCT00880620|471173835|FG001|Overall Study|Other|1|||
130875565|NCT00880620|471173836|FG002|Overall Study|Other|2|||
130875576|NCT05893862|471173846|FG000|Overall Study|Withdrawal by Subject|1|||
130875577|NCT05893862|471173847|FG001|Overall Study|Withdrawal by Subject|7|||
130875578|NCT05893862|471173848|FG002|Overall Study|Withdrawal by Subject|1|||
130875579|NCT05893862|471173849|FG003|Overall Study|Withdrawal by Subject|3|||
130875580|NCT05893862|471173850|FG004|Overall Study|Withdrawal by Subject|3|||
130875581|NCT05893862|471173851|FG005|Overall Study|Withdrawal by Subject|2|||
130875582|NCT05893862|471173846|FG000|Overall Study|Adverse Event|1|||
130875583|NCT05893862|471173847|FG001|Overall Study|Adverse Event|4|||
130875584|NCT05893862|471173848|FG002|Overall Study|Adverse Event|2|||
130875585|NCT05893862|471173849|FG003|Overall Study|Adverse Event|2|||
130875586|NCT05893862|471173850|FG004|Overall Study|Adverse Event|1|||
130875587|NCT05893862|471173851|FG005|Overall Study|Adverse Event|0|||
130875588|NCT02919761|471173852|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
130875589|NCT02919761|471173853|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
130875590|NCT02919761|471173854|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
130875591|NCT02919761|471173852|FG000|Part 1: Open Label|Adverse Event|1|||
130875592|NCT02919761|471173853|FG001|Part 1: Open Label|Adverse Event|0|||
130875593|NCT02919761|471173854|FG002|Part 1: Open Label|Adverse Event|0|||
130875594|NCT02919761|471173852|FG000|Part 1: Open Label|Lost to Follow-up|1|||
130875595|NCT02919761|471173853|FG001|Part 1: Open Label|Lost to Follow-up|0|||
130875596|NCT02919761|471173854|FG002|Part 1: Open Label|Lost to Follow-up|0|||
130875597|NCT02919761|471173852|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
130875598|NCT02919761|471173853|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
130875599|NCT02919761|471173854|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
130875600|NCT02919761|471173852|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
130875601|NCT02919761|471173853|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
130875602|NCT02919761|471173854|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
130875603|NCT02919761|471173852|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
130875604|NCT02919761|471173853|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
130875605|NCT02919761|471173854|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
130875606|NCT02919761|471173852|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
130875607|NCT02919761|471173853|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
130875608|NCT02919761|471173854|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
130875609|NCT02919761|471173852|FG000|Part 1: Open Label|Termination by Sponsor|1|||
130875610|NCT02919761|471173853|FG001|Part 1: Open Label|Termination by Sponsor|0|||
130875611|NCT02919761|471173854|FG002|Part 1: Open Label|Termination by Sponsor|0|||
130875612|NCT02919761|471173852|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
130875613|NCT02919761|471173853|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
130875614|NCT02919761|471173854|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
130875615|NCT02919761|471173852|FG000|Part 2: Double-blind|Adverse Event|0|||
130875616|NCT02919761|471173853|FG001|Part 2: Double-blind|Adverse Event|1|||
130875617|NCT02919761|471173854|FG002|Part 2: Double-blind|Adverse Event|0|||
130875618|NCT02919761|471173852|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
130875619|NCT02919761|471173853|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
130875620|NCT02919761|471173854|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
130875621|NCT02919761|471173852|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
130875622|NCT02919761|471173853|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
130875623|NCT02919761|471173854|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
130875624|NCT02919761|471173852|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
130875625|NCT02919761|471173853|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
130875626|NCT02919761|471173854|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
130875627|NCT02919761|471173852|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
130875628|NCT02919761|471173853|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
130875629|NCT02919761|471173854|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
130875630|NCT02919761|471173852|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
130875631|NCT02919761|471173853|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
130875632|NCT02919761|471173854|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
130875633|NCT02919761|471173852|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
130875634|NCT02919761|471173853|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
130875635|NCT02919761|471173854|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
130875636|NCT02429830|471173857|FG000|Overall Study|Lost to Follow-up|1|||
130875637|NCT02429830|471173857|FG000|Overall Study|Device Explant|2|||
